<SEC-DOCUMENT>0001736730-25-000022.txt : 20250327
<SEC-HEADER>0001736730-25-000022.hdr.sgml : 20250327
<ACCEPTANCE-DATETIME>20250327161436
ACCESSION NUMBER:		0001736730-25-000022
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		116
CONFORMED PERIOD OF REPORT:	20241231
FILED AS OF DATE:		20250327
DATE AS OF CHANGE:		20250327

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Camp4 Therapeutics Corp
		CENTRAL INDEX KEY:			0001736730
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42365
		FILM NUMBER:		25779456

	BUSINESS ADDRESS:	
		STREET 1:		ONE KENDALL SQUARE
		STREET 2:		BUILDING 1400 WEST, 3RD FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
		BUSINESS PHONE:		617-651-8867

	MAIL ADDRESS:	
		STREET 1:		ONE KENDALL SQUARE
		STREET 2:		BUILDING 1400 WEST, 3RD FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>camp-20241231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:344bab39-1447-4710-a813-d0e5cea79568,g:e8dcb9a0-a4ba-432e-8d82-4b2fdbae6592,d:8049b05497804bd28b68608a093bd853-->
<html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:camp="http://camp4tx.com/20241231" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:srt="http://fasb.org/srt/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns="http://www.w3.org/1999/xhtml" xmlns:utr="http://www.xbrl.org/2009/utr" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>camp-20241231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-35">0001736730</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-36">FY</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-37">false</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-38">2024</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="c-32" decimals="5" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" scale="0" id="f-278">.08916</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-5" name="camp:CollaborativeArrangementUpfrontLicenseIssuanceFeePayment" scale="0" id="f-486">0</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-5" name="camp:CollaborativeArrangementFeesIncurredDuringPeriod" scale="0" id="f-487">0</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-5" name="us-gaap:UnbilledContractsReceivable" scale="0" id="f-488">0</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="c-60" decimals="2" name="camp:CollaborativeArrangementTieredRoyaltiesPayableOnNetSalesMaximumLowerRangePercent" scale="-2" id="f-489">1</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="c-81" decimals="2" name="camp:PercentageOfUpfrontPaymentRequiredUponFirstInvestigationalNewDrugStudy" scale="-2" id="f-490">10</ix:nonFraction><ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfOperatingSegments" scale="0" id="f-676">1</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="camp-20241231.xsd"/></ix:references><ix:resources><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="majorfinancialinstitution"><xbrli:measure>camp:majorFinancialInstitution</xbrli:measure></xbrli:unit><xbrli:unit id="sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:unit id="performanceobligation"><xbrli:measure>camp:performanceObligation</xbrli:measure></xbrli:unit><xbrli:unit id="vote"><xbrli:measure>camp:vote</xbrli:measure></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>camp:segment</xbrli:measure></xbrli:unit><xbrli:unit id="founder"><xbrli:measure>camp:founder</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-03-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-15</xbrli:startDate><xbrli:endDate>2024-10-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-01</xbrli:startDate><xbrli:endDate>2024-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-01</xbrli:startDate><xbrli:endDate>2024-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-15</xbrli:startDate><xbrli:endDate>2024-10-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-10-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-03</xbrli:startDate><xbrli:endDate>2024-10-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">camp:ComputerAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">camp:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">camp:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">camp:ComputerAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">camp:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">camp:OfficeAndLaboratorySpaceInCambridgeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">camp:OfficeAndLaboratorySpaceInBoulderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">camp:OfficeAndLaboratorySpaceInCambridgeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">camp:OfficeAndLaboratorySpaceInBoulderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:ChildrenMedicalCenterCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2018-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="camp:MilestoneTargetsAxis">camp:UponAchievementOfFirstLicensedTargetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:ChildrenMedicalCenterCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="camp:MilestoneTargetsAxis">camp:UponAchievementOfSecondLicensedTargetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:ChildrenMedicalCenterCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="camp:MilestoneTargetsAxis">camp:UponAchievementOfThirdLicensedTargetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:ChildrenMedicalCenterCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:TheWhiteheadInstituteForBiomedicalResearchMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:TheWhiteheadInstituteForBiomedicalResearchMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:TheWhiteheadInstituteForBiomedicalResearchMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:FulcrumTherapeuticsInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:FulcrumTherapeuticsInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">camp:TierOneProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:FulcrumTherapeuticsInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">camp:TierOneProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:FulcrumTherapeuticsInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:FulcrumTherapeuticsInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:FulcrumTherapeuticsInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:EliLillyAndCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:EliLillyAndCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:EliLillyAndCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:BioMarinPharmaceuticalInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:BioMarinPharmaceuticalInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:BioMarinPharmaceuticalInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-26</xbrli:startDate><xbrli:endDate>2024-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:BioMarinPharmaceuticalInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-26</xbrli:startDate><xbrli:endDate>2024-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:BioMarinPharmaceuticalInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-26</xbrli:startDate><xbrli:endDate>2024-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:BioMarinPharmaceuticalInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:BioMarinPharmaceuticalInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:BioMarinPharmaceuticalInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:TheWhiteheadInstituteForBiomedicalResearchMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:TheWhiteheadInstituteForBiomedicalResearchMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:EliLillyAndCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:ChildrenMedicalCenterCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">camp:MarauderTherapeuticsInc2016StockOptionAndGrantPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">camp:A2024EquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">camp:A2024EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">camp:A2024EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">camp:A2024EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:CertainExecutivesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:CertainExecutivesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:CertainExecutivesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">camp:RDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">camp:RDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">camp:ConsultingAgreementsWithFoundersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-09-01</xbrli:startDate><xbrli:endDate>2015-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">camp:ConsultingAgreementsWithFoundersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">camp:ConsultingAgreementsWithFoundersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">camp:ConsultingAgreementsWithFoundersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">camp:ConsultingAgreementsWithFoundersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">camp:ConsultingAgreementsWithExecutiveConsultantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">camp:ConsultingAgreementsWithExecutiveConsultantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">camp:ConsultingAgreementsWithExecutiveConsultantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">camp:ConsultingAgreementsWithExecutiveConsultantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001736730</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i8049b05497804bd28b68608a093bd853_1"></div><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-K</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________________________________</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="f-2">x</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 </span></td></tr></table></div><div style="margin-bottom:6pt;padding-left:11.25pt;padding-right:11.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3"><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="f-4">December&#160;31</ix:nonNumeric>, 2024</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-5">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from           to             </span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number  <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-6">001-42365</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-7">CAMP4 Therapeutics Corporation</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________________________________</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.960%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.778%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.962%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-8">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-9">81-1152476</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(I.R.S. Employer Identification No.)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-10">One Kendall Square</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-11">Building 1400 West</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine3" id="f-12" continuedAt="f-12-1">3</ix:nonNumeric></span><ix:continuation id="f-12-1"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">rd</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Floor</span></ix:continuation></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-13">Cambridge</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-14">Massachusetts</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-15">02139</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of Principal Executive Offices)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-16">617</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-17">651-8867</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant&#8217;s telephone number, including area code</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.252%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-18">Common stock, par value $0.0001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-19">CAMP</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-20">Nasdaq Global Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to section 12(g) of the Act:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None</span></div><div style="margin-bottom:8pt;text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.</span></div><div style="margin-bottom:9pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Yes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityWellKnownSeasonedIssuer" id="f-21">No</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</span></div><div style="margin-bottom:8pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Yes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityVoluntaryFilers" id="f-22">No</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.</span></div><div style="margin-bottom:9pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-23">Yes</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</span></div><div style="margin-bottom:9pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-24">Yes</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.172%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.960%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.172%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.963%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Large accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-25">Non-accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="f-26">x</ix:nonNumeric></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-true" id="f-27">x</ix:nonNumeric></span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span></div><div style="margin-bottom:9pt;text-align:right"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityExTransitionPeriod" format="ixt:fixed-false" id="f-28">o</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.</span></div><div style="margin-bottom:9pt;text-align:right"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-false" id="f-29">o</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. </span></div><div style="margin-bottom:9pt;text-align:right"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt:fixed-false" id="f-30">o</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). </span></div><div style="margin-bottom:9pt;text-align:right"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).</span></div><div style="margin-bottom:9pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Yes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-31">x</ix:nonNumeric></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registrant was <ix:nonFraction unitRef="usd" contextRef="c-2" decimals="INF" name="dei:EntityPublicFloat" format="ixt:fixed-zero" scale="3" id="f-32">not</ix:nonFraction> a public company as of the last business day of its most recently completed second fiscal quarter and therefore cannot calculate the aggregate market value of the voting and non-voting common equity held by non-affiliates as of such date.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 13, 2025, there were <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-33">20,161,072</ix:nonFraction> shares of the registrant&#8217;s common stock, par value $0.0001 per share, outstanding.</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="f-34" escape="true">Portions of the registrant&#8217;s definitive proxy statement for its 2025 annual meeting of stockholders (the &#8220;2025 Proxy Statement&#8221;) are incorporated by reference into Part III of this Annual Report on Form 10-K. The 2025 Proxy Statement will be filed pursuant to Regulation 14A with the Securities and Exchange Commission not later than 120 days after the registrant&#8217;s fiscal year ended December&#160;31, 2024.</ix:nonNumeric> </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><span><br/></span></div></div></div><div id="i8049b05497804bd28b68608a093bd853_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:93.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.355%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Page</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_10">Part I</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_10">3</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_13">Item 1. Business</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_13">7</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_16">Item 1A. Risk Factors</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_16">47</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_19">Item 1B. Unresolved Staff Comments</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_19">104</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_22">Item 1C. Cybersecurity</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_22">104</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_25">Item 2. Properties</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_25">105</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_28">Item 3. Legal Proceedings</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_28">105</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_31">Item 4. Mine Safety Disclosures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_31">105</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_34">Part II</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_34">106</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_37">Item 5. Market for Registrant</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_37">&#8217;</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_37">s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_37">106</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_40">Item 6. Reserved</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_40">106</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_43">Item 7. Management</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_43">&#8217;</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_43">s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_43">107</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_76">Item 7A. Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_76">119</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_79">Item 8. Financial Statements</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_79">120</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_145">Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_145">146</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_148">Item 9A. Controls and Procedures</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_148">146</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_151">Item 9B. Other Information</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_151">146</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_154">Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_154">146</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_157">Part III</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_160">Item 10. Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_160">147</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_163">Item 11. Executive Compensation</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_163">147</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_166">Item 12. Security Ownership of Certain Beneficial Owner and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_166">147</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_169">Item 13. Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_169">147</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_172">Item 14. Principal Accounting Fees and Services</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_172">147</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_175">Part IV</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_175">148</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_178">Item 15. Exhibits, Financial Statement Schedules</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_178">148</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_181">Item 16. Form 10-K Summary</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_181">150</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_184">Signatures</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_184">151</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt"><span><br/></span></div></div></div><div id="i8049b05497804bd28b68608a093bd853_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS AND MARKET AND INDUSTRY DATA</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report on Form 10-K (&#8220;Annual Report&#8221;) contains forward-looking statements that involve substantial risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. All statements other than statements of historical fact contained in this Annual Report, including statements regarding our strategy, future operations, future financial position, prospects, plans, objectives of management and expected growth, are forward-looking statements. These statements are based on our current beliefs, expectations and assumptions regarding our intentions, beliefs or current expectations concerning, among other things, the future of our business, future plans and strategies, our operational results and other future conditions. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some cases, you can identify forward-looking statements by terms such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;could,&#8221; &#8220;intend,&#8221; &#8220;target,&#8221; &#8220;project,&#8221; &#8220;estimate,&#8221; &#8220;believe,&#8221; &#8220;predict,&#8221; &#8220;potential&#8221; or &#8220;continue&#8221; or the negative of these terms or other similar expressions intended to identify statements about the future, although not all forward-looking statements contain these identifying words. These forward-looking statements include, without limitation, statements about the following:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the initiation, timing, progress, results and costs of our research and development programs and of our current and future preclinical studies and clinical trials of our product candidates, including statements regarding the timing of initiation and completion of studies or trials and related preparatory work, as well as the period during which the results of the trials are expected become available;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing of our planned good laboratory practices toxicology studies and regulatory submissions, initiation of planned clinical trials and timing of expected clinical results for our product candidate CMP-CPS-001, our development candidate CMP-SYNGAP-01, if applicable, and our other future product candidates;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing of any submissions of filings for regulatory approval of, and our ability to obtain and maintain regulatory approvals for, CMP-CPS-001 and any other product candidates;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to identify patients with the diseases treated by our product candidates, and to enroll patients in trials;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding the size of the patient populations, market acceptance and opportunity for and clinical utility of our product candidates, if approved for commercial use;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our reliance on third party manufacturing partners to comply with significant regulations with respect to manufacturing our products;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding the scope of any approved indication for CMP-CPS-001 or any other product candidate;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully commercialize our product candidates, if approved;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to leverage our RAP Platform to identify and develop future product candidates;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our estimates of our expenses, ongoing losses, future revenue, capital requirements and our need for or ability to obtain additional funding before we can expect to generate any revenue from product sales;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to establish or maintain strategic collaborations or arrangements, including potential business development opportunities and potential licensing partnerships, and our ability to attract collaborators with development, regulatory and commercialization expertise;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to identify, recruit and retain key personnel;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our reliance upon intellectual property licensed from third parties and our ability to obtain such licenses on commercially reasonable terms or at all;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to protect and enforce our intellectual property position for our product candidates, and the scope of such protection;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our financial performance;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the sufficiency of our existing cash and cash equivalents to fund our future operating expenses and capital expenditure requirements;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our competitive position and the development of and projections relating to our competitors or our industry;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our estimates regarding future expenses and needs for additional financing;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of laws and regulations;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic, industry, geopolitical and market conditions, such as military conflict or war, inflation and financial institution instability, or pandemic or epidemic disease outbreaks, many of which are beyond our control; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding the time during which we will be an emerging growth company and smaller reporting company under the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;).</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:106%">Although we base these forward-looking statements on assumptions that we believe are reasonable when made, we caution you that forward-looking statements are not guarantees of future performance and that our actual results of operations, financial condition and liquidity, and the development of the industry in which we operate may differ materially from those made in or suggested by the forward-looking statements contained in this Annual Report. In addition, even if our results of operations, financial condition and liquidity, and the development of the industry in which we operate are consistent with the forward-looking statements contained in this Annual Report, those results or developments may not be indicative of results or developments in subsequent periods.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:106%">Given these risks and uncertainties, you are cautioned not to place undue reliance on these forward-looking statements. Any forward-looking statement that we make in this Annual Report speaks only as of the date of such statement. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in any forward-looking statements, whether as a result of new information, future events or otherwise. Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance, unless specifically expressed as such, and should only be viewed as historical data. You should, therefore, not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this Annual Report.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unless otherwise indicated, market and industry data contained in this Annual Report, including potential market opportunities, is based on our management&#8217;s estimates and research, as well as industry and general publications and research and studies conducted by third parties. Although we believe that the information from these third-party publications, research and studies included in this Annual Report is reliable, and we are responsible for the accuracy of such information, we have not independently verified the accuracy or completeness of this information. Management&#8217;s estimates are derived from publicly available information, their knowledge of our industry and their assumptions based on such information and knowledge, which we believe to be reasonable. This data involves a number of assumptions and limitations and the industry in which we operate is subject to a high degree of uncertainty and risk due to a variety of factors, including those described in Part I, Item 1A. &#8220;Risk Factors&#8221; in this Annual Report. These and other factors could cause our future performance to differ materially from our assumptions and estimates.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i8049b05497804bd28b68608a093bd853_834"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">SUMMARY RISK FACTORS</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:117%">Our business is subject to a number of risks of which you should be aware before making an investment decision. These risks are discussed more fully in Part I, Item 1A. &#8220;Risk Factors&#8221; in this Annual Report. These risks include the following:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have incurred significant losses since our inception, have no products approved for sale and we expect to incur losses for the foreseeable future;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We will require substantial additional capital to finance our operations, and a failure to obtain this necessary capital when needed on acceptable terms, or at all, could force us to delay, limit, reduce, or terminate our development programs, commercialization efforts or other operations;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Raising additional capital may cause dilution to our stockholders, restrict our operations or require us to relinquish rights to our technologies or product candidates;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our independent registered public accounting firm has expressed substantial doubt about our ability to continue as a going concern in its report on our audited financial statements included in this Annual Report;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are early in our development efforts. Our product candidates are in varying stages of preclinical and clinical development and we have not completed a clinical trial of any product candidate. As a result, it will be many years before we commercialize a product candidate, if ever. If we are unable to identify and advance product candidates through preclinical studies and clinical trials, obtain marketing approval and ultimately commercialize them, or experience significant delays in doing so, our business will be materially harmed;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business is highly dependent on our lead product candidate, CMP-CPS-001, as our sole clinical-stage program, and we must complete clinical testing before we can seek regulatory approval and begin commercialization of any of our other product candidates. If we are unable to obtain regulatory approval for, and successfully commercialize, CMP-CPS-001, our business may be materially harmed and such failure may affect the viability of our other product candidates;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Drug development is a lengthy and expensive process, and preclinical and clinical testing is uncertain as to the outcome. We may encounter substantial delays in the commencement, enrollment or completion of our clinical trials and may never advance to clinical trials, or we may fail to demonstrate safety and effectiveness to the satisfaction of applicable regulatory authorities, which could prevent us from advancing or commercializing our product candidates on a timely basis, if at all;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If any of our current or any future product candidates cause undesirable side effects or have other unexpected adverse properties, such side effects or properties could delay or prevent regulatory approval, limit the commercial potential or result in significant negative consequences following any potential marketing approval;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We face substantial competition, which may result in others discovering, developing or commercializing products before us or more successfully than we do;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may enter into collaborations with third parties for the research, development and commercialization of certain of the product candidates we may develop. If any such collaborations are not successful, we may not be able to capitalize on the market potential of those product candidates;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our future success depends on our ability to retain key executives and to attract, retain and motivate qualified personnel;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may encounter difficulties in managing our growth and expanding our operations successfully;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We currently depend on third-party suppliers for the manufacture of our product candidates. The loss of these or future third-party suppliers, or their inability to provide us with sufficient supply, could harm our business;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our rights to develop and commercialize our product candidates are subject, in part, to the terms and conditions of licenses granted to us by third parties. If we fail to comply with our obligations under these arrangements or otherwise experience disruptions to our business relationships with our current or any future licensors, we could lose such intellectual property rights that are important to our business;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Third parties may initiate legal proceedings alleging that we are infringing, misappropriating or otherwise violating their intellectual property rights, the outcome of which would be uncertain and could harm our business;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we or our licensors are unable to obtain, maintain, enforce and adequately protect our intellectual property rights with respect to our product candidates and technology, or if the scope of any patent or other intellectual property protection obtained is not sufficiently broad, our competitors could develop and commercialize products and technology similar or identical to ours, and our ability to successfully develop and commercialize our product candidates and technology may be adversely affected. Further, we do not currently own or in-license any issued patents directed to the composition of matter, or methods of use, of our product candidates; if we fail to obtain such patents, our competitors may be able to develop, make or market products identical to our product candidates after expiration of any applicable regulatory exclusivities;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We rely, and intend to continue to rely, on third parties to perform some of our preclinical studies and conduct our clinical trials. If these third parties do not successfully carry out their contractual duties, fail to comply with applicable regulatory requirements, or do not meet expected deadlines, our development programs may be delayed or subject to increased costs or we may be unable to obtain regulatory approval for or commercialize our product candidates;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prior to the completion of our initial public offering, there was no public market for our common stock. An active, liquid, and orderly market for our common stock may not develop or be sustained, or we may in the future fail to satisfy the continued listing requirements of Nasdaq; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The trading price of the shares of our common stock could be highly volatile, and purchasers of our common stock could incur substantial losses.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to adequately address these and other risks we face, our business, results of operations, financial condition and prospects may be harmed.</span></div><div><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE REGARDING TRADEMARKS</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8220;CAMP4,&#8221; &#8220;RAP Platform,&#8221; &#8220;RNA Actuator&#8221; and our other registered or common law trademarks, trade names or service marks appearing in this Annual Report are the property of CAMP4 Therapeutics Corporation and are registered as trademarks in the United States and other countries. This Annual Report also contains references to trademarks belonging to other entities. Solely for convenience, trademarks and trade names referred to in this Annual Report, including logos, artwork and other visual displays, may appear without the &#174; or &#8482; symbols, but such references are not intended to indicate in any way that we will not assert, to the fullest extent under applicable law, our rights or the rights of the applicable licensor to these trademarks and trade names. We do not intend our use or display of other entities&#8217; trade names, trademarks or service marks to imply a relationship with, or endorsement or sponsorship of us by, any other entity.</span></div><div><span><br/></span></div><div style="margin-bottom:12pt"><span><br/></span></div><div style="margin-bottom:12pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:center"><span><br/></span></div><div style="margin-bottom:12pt;text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i8049b05497804bd28b68608a093bd853_823"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div id="i8049b05497804bd28b68608a093bd853_13"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Business</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Company</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a clinical-stage biopharmaceutical company pioneering the discovery and development of a new class of RNA-based therapeutics with the goal of upregulating gene expression and restoring healthy protein levels to treat a broad range of genetic diseases. Regulatory RNAs (&#8220;regRNAs&#8221;), play a central role in the regulation of every protein-coding gene by contributing to gene activation and suppression. Our approach is designed to amplify messenger RNA (&#8220;mRNA&#8221;), expression by harnessing the power of regRNAs that form localized complexes with transcription factors and regulate gene expression. Our proprietary RNA Actuating Platform, or RAP Platform, allows us to rapidly and systematically identify and characterize the active regulatory elements controlling every expressed gene and tens of thousands of druggable enhancer and promoter regRNA sequences that control protein-coding genes. Once a disease-associated target gene is identified, we apply our RAP Platform to identify the controlling regRNA and rapidly generate novel antisense oligonucleotide (&#8220;ASO&#8221;) candidates, which we also refer to as RNA Actuators. These ASOs are designed to bind to the identified regRNA and amplify the expression of the target gene in a specific and controllable way. We are currently focused on metabolic diseases and diseases of the central nervous system (&#8220;CNS&#8221;) with validated disease biology, and we believe our RAP Platform allows us to address a broad range of rare and prevalent genetic diseases in which a modest increase in protein expression has the potential to be clinically meaningful.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on our preclinical studies, we believe our lead product candidate, CMP-CPS-001, has the potential to be the first disease-modifying therapy for the treatment of the most prevalent urea cycle disorders (&#8220;UCDs&#8221;). UCDs are a group of severe, inherited metabolic diseases caused by mutations in the genes that encode one or more of the eight enzymes and transporters necessary to convert ammonia into urea. The inability of the body to properly metabolize ammonia leads to the accumulation of toxic levels in circulation, ultimately resulting in severe health outcomes, such as neurologic disability, seizure and death. CMP-CPS-001 is designed to improve urea cycle activity by amplifying expression of carbamoyl phosphate synthetase 1 (&#8220;CPS1&#8221;), an enzyme that catalyzes the first step of the urea cycle, by binding to a CPS1-specific regRNA. Our preclinical studies have demonstrated that modulating the activity of the target regRNA increases expression of the&#160;CPS1&#160;gene, resulting in increased CPS1 enzyme levels, which allows for more ammonia to be converted into urea, thereby lowering ammonia levels to normal, healthy ranges. These preclinical studies also demonstrated that CMP-CPS-001 can increase the level of, or upregulate, the production of multiple enzymes responsible for converting ammonia into urea, potentially allowing us to address more than 85% of patients with UCDs, which we refer to as our pan-UCD approach. We are evaluating CMP-CPS-001 in an ongoing Phase&#160;1 clinical trial in healthy volunteers and have completed a planned interim analysis of safety and pharmacokinetic data from all four cohorts of the single ascending dose (&#8220;SAD&#8221;) portion of the clinical trial, from which no safety trends of concern were observed. We have also completed dosing of the first two cohorts from the multiple ascending dose (&#8220;MAD&#8221;) portion of the clinical trial, and initiated dosing in the third MAD cohort. We expect to report data from the SAD and MAD portions of the clinical trial, including safety, pharmacokinetic and key pharmacodynamic biomarker data, in the fourth quarter of 2025. We also plan to initiate the expansion of the clinical trial of CMP-CPS-001 in Australia into a Phase 1b clinical trial to enroll female participants who are heterozygous for a mutation of the OTC gene in the second quarter of 2025. In addition, we are leveraging our RAP Platform to advance a preclinical program for the treatment of synaptic Ras GTPase activating protein 1 (&#8220;SYNGAP1&#8221;)-related disorders. We have nominated a development candidate, CMP-SYNGAP-01, from this program and expect to initiate Good Laboratory Practice (&#8220;GLP&#8221;) toxicology studies in 2025 to enable the filing of clinical trial applications. In addition, we have initiated a discovery program targeting a regRNA to increase GBA1 gene expression for the treatment of Parkinson&#8217;s disease (&#8220;PD&#8221;) caused by mutations in the GBA1 gene, and plan to initiate discovery programs in other CNS and metabolic indications utilizing our RAP Platform. Finally, we have entered into a strategic research collaboration with BioMarin Pharmaceutical Inc. (&#8220;BioMarin&#8221;) to advance novel therapeutics that increase protein levels by targeting regRNA sequences for two genetic targets.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transcription of DNA into mRNA, the molecular template that is then translated into protein, is a complex yet carefully coordinated cellular process involving numerous components. Only a small portion of the DNA in the human genome is transcribed into RNA that codes for proteins. The vast majority of the transcriptome originates from non-coding regions of DNA, a portion of which, referred to as enhancers and promoters, perform a crucial role in determining the specificity, timing and level at which a particular gene is expressed. RegRNAs are non-coding RNAs that are transcribed by these enhancer and promoter DNA regions that form localized complexes with transcription factors to control the expression of protein-coding genes, either increasing or decreasing their expression within natural physiological ranges. The approximately 20,000 genes that code for mRNA in the human genome are controlled by hundreds of thousands of DNA enhancers and their associated regRNAs.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deficient protein levels characterize over a thousand diseases. Haploinsufficient diseases are dominantly inherited conditions in which inadequate gene expression is driven by a mutation in a single allele, or gene copy, and results in reductions of protein levels by as much as 50%. Numerous other genetic conditions are caused by recessive mutations that result in diminished gene activity. Data from our preclinical studies and research reports published by third parties demonstrate that increasing expression of disease-associated genes by modest amounts can restore healthy protein levels and provide therapeutic benefit in these disorders. Therefore, modest increases in protein expression have the potential to be clinically meaningful in both haploinsufficient and recessive partial loss-of-function disorders, of which there are more than 1,200. Our RAP Platform has the potential to identify the regRNA associated with all of these diseases, which we believe enables us to design RNA Actuators to address the underlying biology of these diseases. We aim to leverage our RAP Platform to develop product candidates designed to regulate transcription in a gene-specific manner to restore healthy protein levels and remedy these diseases. However, our approach is unproven and may not lead to successful efforts to develop and commercialize our product candidates and to identify and discover additional potential product candidates.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our RAP Platform</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our RAP Platform can unlock the potential of the human genome and have broad applications across a range of rare and prevalent diseases caused by sub-optimal levels of protein expression. Our technology is based upon the pioneering work in transcription regulation conducted by our co-founders, Richard Young, PhD and Leonard Zon, MD. We have built our RAP Platform to identify and characterize every regRNA that controls protein-coding genes and to develop novel ASO-based therapeutics to modulate regRNA activity to increase the expression of protein-coding genes of interest and thereby address the underlying cause of genetic diseases. Based on our proprietary mapping of regRNAs and screening and optimizing of ASOs, we have established a leadership position in regRNA-targeting therapies. Our goal is to be the preeminent company focused on discovering, developing and delivering regRNA-targeting therapeutics to patients. We believe that the ability to upregulate genes selectively through targeting regRNA could provide a new way to treat a wide range of human diseases and has the potential to become a class of new medicines.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At present, very few regRNAs are described in public genomic databases, as they are often expressed at low levels and their importance was not fully understood. Our RAP Platform utilizes next-generation sequencing technologies and custom sequence analyses to map the active regulatory elements controlling every expressed gene. These data empower our proprietary machine learning algorithm, known as EPIC, to identify the specific control elements that regulate any gene of interest in the most specific manner, including elements that may restrict gene expression to a particular cell type. This enables us to identify the exact sites of regRNA synthesis and ultimately map the complete sequence of every candidate regRNA to target for therapeutic gene control. To date, we have mapped multiple cell types in as little as three&#160;months, comprising a number of potentially addressable diseases in the liver, CNS, heart, skeletal muscle and immune system. Our in-house development and application of this technology has enabled us to identify tens of thousands of enhancer and promoter regRNA sequences and their key biological properties, resulting in what we believe to be the most robust regRNA dataset available.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We combine our RAP Platform with ASO chemistry that has been utilized and validated in U.S. Food and Drug Administration (&#8220;FDA&#8221;)-approved products to develop programmable RNA Actuators that are designed to precisely upregulate gene expression at the transcriptional level. Once a target gene is nominated, our RAP Platform rapidly identifies the controlling regRNA sequence, and we perform ASO screens to identify regions where ASO binding results in optimal upregulation of that target gene. Further rational design is applied to the ASOs identified in the screen. Our proprietary technology enables us to design RNA Actuators that optimize for specificity by avoiding binding to regRNAs that act on more than one gene and any other similar sequences found elsewhere in the transcriptome. As a result, our sequence-specific approach enables us to precisely target regRNA transcripts to increase gene expression. Our approach is designed to enable the efficient and systematic creation of RNA Actuators to target regRNAs of interest. Building upon the power of this technology, our RNA Actuators can be programmed to engage regRNA targets, producing tunable increases in protein expression. While other ASOs have received regulatory approval, no regulatory authorities to date have approved ASOs that are directed towards regRNAs and, as a result, there is uncertainty as to the safety and efficacy profile of our product candidates compared to currently approved ASOs.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The key steps involved in our platform are illustrated below:</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our proprietary RAP Platform</span></div><div style="margin-bottom:15pt;text-align:center"><img src="camp-20241231_g1.jpg" alt="Image_0.jpg" style="height:286px;margin-bottom:5pt;vertical-align:text-bottom;width:562px"/></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We design RNA Actuators to leverage existing oligonucleotide delivery approaches to enable drug delivery to specific types of tissues throughout the body. We believe our RAP Platform can address any disease where a modest increase in protein expression can be clinically meaningful, including haploinsufficient diseases or recessive loss-of-function diseases. Furthermore, as we continue to map regRNAs and conduct ASO screens in more cell types, the data generated will improve the algorithms we use to identify the candidate regRNAs to specifically control gene expression. We believe the knowledge and learnings from our initial programs will significantly expedite selection of lead candidates and position us to rapidly expand our pipeline.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Pipeline</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are leveraging our RAP Platform to advance a pipeline of programs currently focused on metabolic and CNS disorders with validated disease biology and attractive potential market opportunities due to the significant unmet need of affected patients. We retain exclusive, worldwide development and commercialization rights to all of our current product candidates and preclinical programs other than pursuant to our research collaboration with BioMarin.</span></div><div><span><br/></span></div><div style="margin-bottom:8pt;text-align:center"><img src="camp-20241231_g2.jpg" alt="Screenshot 2025-03-24 095952.jpg" style="height:288px;margin-bottom:5pt;vertical-align:text-bottom;width:660px"/></div><div style="margin-bottom:8pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CMP-CPS-001: Potential Treatment for Urea Cycle Disorders</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on our preclinical studies, we believe our lead product candidate, CMP-CPS-001, has the potential to be the first disease-modifying therapy for the treatment of the most prevalent UCDs. UCDs are a group of severe, inherited metabolic diseases caused by mutations in the genes that encode one or more of the eight enzymes and transporters necessary to convert ammonia into urea, which is then excreted from the body. The inability of the body to properly metabolize ammonia leads to the accumulation of toxic systemic levels in circulation, ultimately resulting in severe health outcomes, such as neurologic disability, seizure and death. UCDs occur across all age groups, from infants to adults, and mild symptoms may go unnoticed until a stressor, such as illness, surgery, protein consumption or environmental stress, overwhelms compensatory functions, resulting in hyperammonemic crisis, or extremely high levels of ammonia. The incidence of UCDs in the United States is estimated to be approximately 1 in 35,000 births, with similar prevalence and incidence estimated for Europe. The most common UCD, accounting for approximately 60% of UCD diagnoses, is ornithine transcarbamylase (&#8220;OTC&#8221;) deficiency, caused by mutations in the&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OTC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;gene. The next two most common genetic subtypes are caused by mutations in the genes coding for the enzymes argininosuccinate lyase (&#8220;ASL&#8221;), and argininosuccinate synthetase (&#8220;ASS1&#8221;), deficiencies which affect approximately 16% and 14% of UCD patients, respectively. The prevalence of UCDs is estimated to be approximately 3,700 patients in the United States, of which we estimate 90% are late onset, defined as having severe symptom onset after one month of life, and 96% of these late onset patients have enzyme deficiencies we believe we can address.  In addition, we estimate that more than 1,200 female OTC heterozygotes, who have inherited one copy of a gene with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OTC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-related changes, experience potentially addressable UCD symptoms.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no FDA-approved, disease-modifying therapies to treat the most prevalent UCDs. The standard of care is supportive in nature and intended to reduce the frequency of, but not eliminate, hyperammonemic crises. Current protocols for patients involve efforts to lower plasma ammonia levels. Reduction in plasma ammonia is achieved through nitrogen scavengers to remove excess nitrogen, along with the dosing of supplemental citrulline. These nitrogen scavenger agents carry an onerous pill regimen and significantly diminish the quality of life for patients. Longer-term maintenance regimens involve strict adherence to a low-protein diet along with the prophylactic use of nitrogen scavenger agents. When necessary, hemodialysis is used to reduce ammonia concentrations. The existing supportive measures are not sufficient, with many patients suffering neurological disability and premature death. Therapies currently in development are targeting only a select subgroup of patients with UCD, which includes those with OTC deficiency and patients 12&#160;years and older. We have designed CMP-CPS-001 to be broadly applicable to UCD patients and to overcome the limitations of the current standard of care as well as programs in development for the treatment of late onset UCDs by using an established ASO modality and convenient once-monthly subcutaneous administration in order to provide UCD patients with the potential for a safe and efficacious treatment option. We are initially targeting our development of CMP-CPS-001 in the most prevalent late-onset patients (those with OTC, ASL and ASS1 deficiencies, which together constitute more than 80% of patients with UCDs) and we may expand into additional groups of patients with less common forms of UCD. The FDA granted Rare Pediatric Disease designation to CMP-CPS-001 for the treatment of UCDs in August 2024 and granted orphan drug designation to CMP-CPS-001 for the treatment of UCDs in September 2024.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMP-CPS-001 is designed to improve urea cycle activity by amplifying expression of CPS1, a key enzyme that catalyzes the first step of the urea cycle, by binding to a CPS1-specific regRNA. CMP-CPS-001 is a subcutaneously injected ASO conjugated to N-acetylgalactosamine (&#8220;GalNAc&#8221;), a ligand that enables targeted delivery to the liver, designed to be administered monthly. Increasing&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CPS1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;expression enhances the metabolism of ammonia and upregulates multiple urea cycle enzymes, including OTC, resulting in elevated urea cycle activity. Our RAP Platform enabled us to (i)&#160;identify the key enhancer modulating&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CPS1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;expression, (ii)&#160;screen ASOs directed to the regRNAs expressed by this enhancer, and (iii)&#160;generate a lead RNA Actuator designed to increase&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CPS1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;expression.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our preclinical studies have demonstrated that modulating the activity of the target regRNA increases expression of the&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CPS1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;gene, resulting in increased CPS1 enzyme levels, which allows for more ammonia to be converted into urea, thereby lowering ammonia levels to normal, healthy ranges. This includes studies in a mouse model where we demonstrate that increasing&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cps1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;expression can overcome a partial loss of function mutation in the urea cycle enzyme,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Otc</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and improve ammonia clearance. These preclinical studies also demonstrated that CMP-CPS-001 can upregulate the production of multiple enzymes responsible for converting ammonia into urea, which supports our pan-UCD approach. In non-human primate (&#8220;NHP&#8221;) studies, the administration of CMP-CPS-001 increased the synthesis of urea, commonly referred to as ureagenesis. In these NHP studies, labeled sodium acetate was used as part of a ureagenesis rate test (&#8220;URT&#8221;) to measure the metabolic output of the urea cycle. Carbaglu, approved for ultra-rare N-actylgluatamate synthesase (&#8220;NAGS&#8221;)-deficient patients, utilized the URT in healthy volunteers and showed that minimal increases in ureagenesis translated to substantial ammonia reductions in NAGS-deficient patients. Rates of ureagenesis were found to exceed those achieved by placebo in a statistically significant manner. This assay is also being used in our Phase&#160;1 clinical trial. An increase in the metabolic output of the urea cycle, as indicated by an increase in the amount of labeled sodium acetate metabolized, is expected to </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">correlate with an increase in the amount of ammonia metabolized. Although we believe that an increase in ureagenesis in our Phase 1 clinical trial may correspond with clinically meaningful improvements in ammonia metabolism in UCD patients, ureagenesis is not an established clinical endpoint and the URT results obtained in our Phase 1 clinical trial in healthy adult volunteers should not be interpreted as evidence of efficacy of CMP-CPS-001. For a further discussion of our use of this assay, please see Part I, Item 1A., &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk factors&#8212;The outcome of preclinical studies and earlier-stage clinical trials may not be predictive of future results or the success of later preclinical studies and clinical trials</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; in this Annual Report. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are evaluating CMP-CPS-001 in a randomized, double-blind and placebo-controlled Phase&#160;1 clinical trial to evaluate safety, tolerability and pharmacokinetics in healthy volunteers in Australia, and have completed a planned interim analysis of safety and pharmacokinetic data from all four cohorts of the SAD portion of the clinical trial, from which no safety trends of concern were observed. We have also completed dosing of the first two cohorts from the MAD portion of the clinical trial, and initiated dosing in the third MAD cohort. We expect to report data from the SAD and MAD portions of the clinical trial, including safety, pharmacokinetic and key pharmacodynamic biomarker data, in the fourth quarter of 2025. In addition, we plan to initiate the expansion of the clinical trial of CMP-CPS-001 in Australia into a Phase 1b clinical trial to enroll female OTC heterozygotes in the second quarter of 2025.</span></div><div style="margin-bottom:8pt"><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CMP-SYNGAP: Program for the Treatment of SYNGAP1-related Disorders</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our initial CNS development program, CMP-SYNGAP, aims to address the underlying cause of SYNGAP1-related disorders. SYNGAP1-related disorders are a group of neurodevelopmental conditions caused by pathogenic variants in the&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SYNGAP1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;gene leading to a haploinsufficient state that reduces SYNGAP protein levels by as much as 50%. SYNGAP plays a critical role in the development of cognition and proper synaptic function. Epilepsy is a common characteristic of these disorders and nearly all patients present with some degree of developmental delay and cognitive impairment. Patient estimates for SYNGAP1-related disorders vary significantly, with incidence estimates ranging from one to 40 in 100,000 individuals. While we believe that SYNGAP1-related disorders remain underdiagnosed, we estimate that there are approximately 10,000 individuals living with these disorders in the United States. SYNGAP1-related disorders are reported to represent 0.5% to 1.0% of all intellectual disability cases, making them among the most common causes of intellectual disability in patients with epilepsy, and indicating that the patient population may be significantly larger than incidence estimates suggest.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no FDA-approved, disease-modifying therapies for SYNGAP1-related disorders. There is also no definitive treatment protocol, which is dependent on seizure type and severity and other neurological characteristics. Treatment is often limited to supportive physical, occupational and speech therapy. A combination of non-specific anti-seizure medications may be prescribed to treat seizures, though SYNGAP1-related disorders have proven difficult to control with available therapeutics. As many as 50% of patients do not adequately respond to medication, in which case implantable devices, such as those for vagus nerve stimulation, may offer incremental therapeutic benefit.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are advancing our CMP-SYNGAP program to address the significant unmet need for these patients by targeting the direct cause of SYNGAP1-related disorders, haploinsufficiency, which we believe is amenable to targeting through regRNAs. Our CMP-SYNGAP program is a novel approach that targets the&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">SYNGAP1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;gene at the transcriptional level to restore SYNGAP function and improve symptoms, by utilizing an intrathecally delivered ASO. We have identified specific regRNA sequences involved in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">SYNGAP1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;transcription and utilized our RAP Platform to generate ASOs that function to increase&#160;SYNGAP1&#160;transcription. Upregulation of&#160;SYNGAP1&#160;gene expression may increase SYNGAP protein levels in amounts sufficient to yield therapeutic benefit. Our preclinical studies demonstrated a dose-dependent increase in SYNGAP1 mRNA levels accompanied by a reduction in&#160;SYNGAP1&#160;expression. We have nominated a development candidate, CMP-SYNGAP-01, from this program and expect to initiate GLP toxicology studies in 2025 to enable the filing of a clinical trial application.</span></div><div style="margin-bottom:8pt"><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Program for the Treatment of GBA1-related Parkinson&#8217;s Disease</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have initiated a discovery program focused on increasing </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GBA1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> gene expression as a potential treatment for PD. Approximately 5-15% of PD patients harbor</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> GBA1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mutations, which reduce glucocerebrosidase enzyme (&#8220;GCase&#8221;) activity by approximately 50%, leading to toxic substance buildup in the brain and accelerating disease progression. GCase and &#945;-synuclein, the hallmark protein of PD, create a feedback loop that accelerates neurodegeneration. We plan to explore the potential of increasing </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GBA1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> expression both in patients with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GBA1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> haploinsufficiency and in a broader subset of PD patients. Using our RAP Platform, we have identified ASOs that target the regRNAs controlling the expression of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GBA1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and that have been observed to increase </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GBA1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> expression in in vitro studies. We are continuing to advance our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GBA1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> discovery program with the objective of selecting a development candidate to progress into preclinical development.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Role of RegRNA in Controlling Transcription</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transcription of DNA into mRNA, the molecular template that is then translated into protein, is a complex yet carefully coordinated biological process involving numerous components. Only a small portion of the DNA encodes for proteins. Much of the remaining DNA comprises regions, known as promoters and enhancers, that control gene expression. The approximately 20,000 genes which code for mRNA in the human genome are controlled by hundreds of thousands of these elements and their associated regRNAs. The promoter region of the gene is located immediately before the DNA sequence encoding for an mRNA. Promoters bind transcription factors, coactivators and RNA polymerase leading to transcription initiation. Enhancers bind transcriptional regulatory proteins and interact with promoters to determine the specificity, timing and level at which a particular gene is expressed.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">More than a decade ago, it was discovered that all active gene regulatory elements are also transcribed. These non-coding RNA transcripts generated by both enhancer and promoter DNA regions are defined as regRNAs. Recently, it was discovered that regRNAs play a central role in the formation of localized molecular complexes with transcriptional activators and suppressors, which function to control mRNA transcription. As shown in the illustration below, promoters and enhancers are brought into close proximity when a gene is being actively transcribed. RegRNAs generated from these regulatory elements remain closely associated with the complex that forms at the enhancer-promoter interface. Thus, regRNAs act in a gene-specific manner, only influencing the expression of the gene near the sites where they arise.</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interactions between enhancer and promoter DNA regions are critical regulators of gene expression</span></div><div style="margin-bottom:8pt;text-align:center"><img src="camp-20241231_g3.jpg" alt="Image_2.jpg" style="height:287px;margin-bottom:5pt;vertical-align:text-bottom;width:411px"/></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deficient protein levels characterize over a thousand human diseases. Haploinsufficient diseases are dominantly inherited conditions in which inadequate gene expression, driven by a mutation in a single allele, or gene copy, results in reductions of protein levels by as much as 50%. Data from our preclinical studies and research reports published by third parties demonstrates that increasing expression of disease-associated genes by modest amounts can restore healthy protein levels and provide therapeutic benefit in these disorders. In addition to haploinsufficiencies, numerous other genetic conditions are characterized by a loss of protein function. These include recessive loss-of-function diseases caused by mutations in both alleles that reduce, but do not completely abolish, protein function. Similar to haploinsufficiencies, our preclinical studies and research conducted by third parties shows that even modest increases in expression of these partially active proteins can be therapeutically beneficial.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The figures below illustrate the concept that modest increases in protein expression can lead to clinically meaningful therapeutic benefits in both haploinsufficient and recessive partial loss-of-function disorders, of which there are more than 1,200. Our RAP Platform has the potential to identify the regRNA associated with all of these diseases, which we believe enables us to design RNA Actuators to address the underlying biology of these diseases. The image on the left illustrates that, with respect to haploinsufficient diseases, it is anticipated that an increase in functional protein levels, even below those expressed in the wild-type phenotype, would be clinically meaningful. The image on the right illustrates that, with respect to partial loss-of-function disorders, the increase of protein expression, even where the protein continues to be mutated, may be sufficient to achieve a clinically meaningful result for affected patients. We are leveraging proprietary insights into the regulatory activities of regRNAs generated internally using our proprietary RAP Platform to pioneer the development of novel therapeutics designed to achieve this objective.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gene expression increases have the potential to reduce or eliminate disease related to haploinsufficiency and loss of function&#160;disorders</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:10pt;text-align:center"><img src="camp-20241231_g4.jpg" alt="Screenshot 2025-03-13 173147.jpg" style="height:213px;margin-bottom:5pt;vertical-align:text-bottom;width:660px"/></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our RAP Platform</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The evolving view of gene regulation now recognizes RNA as a key regulator of transcription. We were founded on the pioneering work in transcription regulation conducted by our co-founders, Richard Young, PhD and Leonard Zon, MD. We believe our RAP Platform can unlock the potential of the human genome and have broad applications across a range of rare and prevalent diseases caused by sub-optimal levels of protein expression. We have built our proprietary RAP Platform to discover the regRNAs that control protein-coding genes and develop novel ASO-based therapeutics to modulate regRNA activity to increase the expression of protein-coding genes of interest and thereby address the underlying cause of genetic diseases. Based on our proprietary mapping of regRNAs and screening and optimizing of ASOs, we have established a leadership position in regRNA-targeting therapies. Our goal is to be the preeminent company focused on discovering, developing and delivering regRNA-targeting therapeutics to patients. We believe that the ability to upregulate genes selectively through targeting regRNA could provide a new way to treat a wide range of human diseases and has the potential to become a new class of medicines.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our proprietary RAP Platform is built to map every regRNA for the tunable amplification of gene expression. Only a few regRNAs are described in public genomic databases, as they are often expressed at low levels and their importance was not fully understood. Our RAP Platform utilizes next-generation sequencing technologies and custom sequence analyses to map the active regulatory elements controlling every expressed gene. Further distinguishing the robust capabilities of RAP Platform is our ability to use primary human cell lines, rather than immortalized cultured cells, to preserve the functional integrity of specific cell types. To date, we have mapped multiple cell types in as little as three&#160;months, comprising a number of potentially addressable diseases in the liver, CNS, heart, skeletal muscle and immune system. We have demonstrated that we can identify regRNA-targeting ASOs that increase specific gene expression in those tissues. These data are analyzed with our proprietary machine learning algorithms to select candidate regRNA targets that regulate transcription in a gene-specific manner to increase protein production within a physiological range. Our in-house development and application of this technology has enabled us to identify tens of thousands of regRNA sequences and their key physiological properties resulting in what we believe to be the most robust regRNA dataset available. Moreover, we believe the ability of our RAP Platform to select the most likely regRNAs controlling a given gene from the large number of candidates is a key advantage of our technology, and represents a significant barrier to others seeking to develop this approach.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our approach is designed to enable the efficient and systematic creation of RNA Actuators to target regRNAs of interest. Building upon the power of this technology, our RNA Actuators can be programmed to engage regRNA targets and induce tunable increases in protein expression. As we continue to map regRNAs and conduct ASO screens in more cell types, the data generated will improve the algorithms we use to identify the candidate regRNAs to specifically control gene expression. Thus, we believe the knowledge and learnings from our initial programs will significantly expedite selection of lead candidates and position us to rapidly expand our pipeline.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We combine our proprietary RAP Platform with validated ASO chemistry to develop programmable RNA Actuators that are designed to precisely upregulate gene expression at the transcriptional level. An ASO construct is a single-stranded, chemically modified, nucleic-acid sequence that binds to a target regRNA sequence and modulates its activity. ASOs block or remove key interactions and lead to both increased mRNA and protein expression. Once a target </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">gene is selected, our RAP Platform rapidly identifies the controlling regRNA, and we perform ASO screens to identify regions where ASO binding results in optimal upregulation of that target gene. Further rational design is applied to lead sequences utilizing established approaches to optimize ASOs. Our RAP Platform enables us to design RNA Actuators that potentially optimize for specificity by avoiding the potential of binding to similar sequences found elsewhere in the transcriptome which may result in deleterious side effects. As a result, our sequence-specific approach enables us to precisely target regRNA transcripts to increase gene expression.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our use of validated ASO chemistry to generate potential therapeutic candidates provides us the flexibility to screen using a range of target sequences and to design and synthesize multiple ASO construct variations that integrate a range of chemical modifications and tissue-targeting delivery vehicles intended to optimize therapeutic potency and target specificity.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We design RNA Actuators to leverage existing oligonucleotide delivery approaches to enable drug delivery to specific types of tissues throughout the body. Our metabolic programs utilize subcutaneous administration of GalNAc-conjugated ASOs for efficient liver delivery. Our CNS program utilizes intrathecal delivery of an unconjugated ASO which provides sufficient distribution in the CNS. Our RAP Platform has the potential to address any disease where increasing protein expression can be clinically meaningful, including haploinsufficient diseases or recessive loss-of-function diseases, by returning protein levels to a normal physiological range. Furthermore, given the versatility of our platform, we believe the knowledge and learnings from our initial programs will expedite selection of lead candidates and position us to rapidly expand our pipeline.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Programs</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are leveraging our RAP Platform to advance a pipeline of programs currently focused on metabolic and CNS disorders with validated disease biology and attractive potential market opportunities due to the significant unmet need of affected patients. Our lead product candidates and programs include: (i) a product candidate currently in a Phase&#160;1 clinical trial, CMP-CPS-001, for the treatment of UCDs, (ii) a development candidate, CMP-SYNGAP-01, for the treatment of SYNGAP1-related disorders, for which we expect to initiate GLP toxicology studies in 2025 to enable the filing of a clinical trial application, and (iii) a discovery program targeting a regRNA to increase </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">GBA1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> gene expression for the treatment of PD caused by mutations in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">GBA1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> gene. We have also entered into a strategic research collaboration with BioMarin to advance novel therapeutics that increase protein levels by targeting regRNA sequences for two genetic targets. We retain exclusive, worldwide development and commercialization rights to all of our current product candidates and preclinical programs other than pursuant to our research collaboration with BioMarin.</span></div><div><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CMP-CPS-001: Our Lead Product Candidate for Urea Cycle Disorders</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Based on our preclinical studies, we believe our lead product candidate, CMP-CPS-001, has the potential to be the first disease-modifying therapy for the most prevalent UCDs, and is designed to improve urea cycle activity by amplifying expression of CPS1 by binding to a CPS1-specific regRNA. CMP-CPS-001 is a subcutaneously injected ASO conjugated to GalNAc and designed to be administered monthly. Our preclinical studies have demonstrated that modulating the activity of the target regRNA increases expression of the&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">CPS1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;gene, resulting in increased CPS1 enzyme levels, which allows for more ammonia to be converted into urea, thereby lowering ammonia levels to normal, healthy ranges. Our preclinical studies have also demonstrated that CMP-CPS-001 can upregulate the production of multiple enzymes responsible for converting ammonia into urea, potentially allowing us to address more than 85% of patients with UCDs. We are evaluating CMP-CPS-001 in an ongoing Phase&#160;1 clinical trial in healthy volunteers, and have completed a planned interim analysis of safety and pharmacokinetic data from all four cohorts of the SAD portion of the clinical trial, from which no safety trends of concern were observed. We have also completed dosing of the first two cohorts from the MAD portion of the clinical trial, and initiated dosing in the third MAD cohort. We expect to report data from the SAD and MAD portion of the clinical trial, including safety, pharmacokinetic and key pharmacodynamic biomarker data, in the fourth quarter of 2025. In addition, we plan to initiate the expansion of the clinical trial of CMP-CPS-001 in Australia into a Phase 1b clinical trial to enroll female OTC heterozygotes in the second quarter of 2025.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA granted Rare Pediatric Disease designation to CMP-CPS-001 for the treatment of UCDs in August 2024 and granted orphan drug designation to CMP-CPS-001 for the treatment of UCDs in September 2024.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Urea Cycle Disorders</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UCDs are a group of severe, inherited metabolic diseases caused by mutations in the genes that encode one or more of the eight enzymes and transporters necessary to convert ammonia into urea, which is then excreted from the body. The urea cycle is the key metabolic pathway for removing excess ammonia, a waste by-product of protein metabolism, and toxic&#8212;particularly to the central nervous system&#8212;from the body. In the liver, nitrogen containing ammonia is converted to urea, which is nontoxic, water-soluble and easily excreted from the body through the kidneys as a component of urine. The </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">inability of the body to properly metabolize ammonia leads to toxic systemic levels in circulation, ultimately resulting in severe health outcomes, such as neurologic disability, seizure and death.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Six enzymes are involved in conversion of ammonia to urea including CPS1,&#160;NAGS, OTC, ASS1, ASL, and arginase 1 (&#8220;ARG1&#8221;). In addition, two transporter proteins, ORNT1 and Citrin, play critical roles in the proper functioning of the urea cycle. A genetic aberration, which results in deficiency or reduced function, in any one of these enzymes or transporter proteins results in a UCD and a buildup of ammonia. A schematic representation of the urea cycle is presented below.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The urea cycle converts ammonia into urea</span></div><div style="margin-bottom:14pt;text-align:center"><img src="camp-20241231_g5.jpg" alt="Image_4.jpg" style="height:303px;margin-bottom:5pt;vertical-align:text-bottom;width:359px"/></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UCDs occur across all age groups, from infants to adults, and mild symptoms may go unnoticed until a stressor, such as illness, surgery, protein consumption or environmental stress, overwhelms compensatory functions, generally resulting in hyperammonemic crisis. The incidence of UCDs in the United States is estimated to be approximately 1 in 35,000 births, with similar prevalence and incidence rates estimated for Europe. The onset and severity of UCDs is highly variable, with severity correlating with the degree of impairment of the conversion of ammonia to urea and inversely with the amount of residual enzyme function. An estimated 10% of patients with UCDs present as neonatal onset, with severe symptom onset presenting before the first month of life, with enzyme levels less than 5% of normal. In neonatal onset UCD, ammonia concentrations in the blood rise rapidly, with the clinical consequences of the disease often presenting within a week of birth. A liver transplant is typically required by six&#160;months of age. Patients with late onset forms of the disease may present as severe with numerous neuropsychological complications including development delays, learning and intellectual disabilities, attention deficit hyperactivity disorder and executive function deficit. Moreover, recurrent hyperammonemic crises are common despite existing supportive management, and acute life-threatening episodes can occur at any age, regardless of disease severity at initial presentation.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The most common UCD, accounting for approximately 60% of UCD diagnoses, is OTC deficiency, caused by mutations in the&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OTC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;gene. Unlike other UCDs, which are autosomal recessive disorders, OTC enzyme deficiency is an X-chromosome linked disorder. As such, particularly severe cases of the disorder are more prevalent in males, since males only have a single copy of the X chromosome. The incidence of OTC deficiency in the United States is estimated to be 1 in 56,500 births. The next two most common genetic subtypes are caused by mutations in the genes coding for the enzymes ASS1 and ASL, deficiencies which affect approximately 14% and 16% of UCD patients, respectively. The prevalence of UCDs is estimated to be approximately 3,700 patients in the United States, of which we estimate 90% are late onset, defined as having severe symptom onset after one month of life, and 96% of these late onset patients have enzyme deficiencies we believe we can address. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, we estimate that more than 1,200 female OTC heterozygotes, who have inherited one copy of a gene with OTC-related changes, experience potentially addressable UCD symptoms. While males with OTC deficiency almost always experience symptoms, the severity and presence of symptoms in female heterozygotes can vary. Research now </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">shows that many of these women face chronic, under-recognized symptoms and serious health risks, including the danger of hyperammonemic crises triggered by stress, illness, pregnancy, or surgery. </span></div><div><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UCD patient population by deficiency</span></div><div style="margin-bottom:8pt;text-align:center"><img src="camp-20241231_g6.jpg" alt="45860" style="height:316px;margin-bottom:5pt;vertical-align:text-bottom;width:432px"/></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Current Treatments for Urea Cycle Disorders and Their Limitations</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no FDA-approved, disease-modifying therapies to treat the most prevalent UCDs. The standard of care is supportive in nature and intended to reduce the frequency, but not eliminate hyperammonemic crises. Current protocols for patients involve efforts to lower plasma ammonia levels. Reduction in plasma ammonia is achieved through nitrogen scavengers to remove excess nitrogen, along with the dosing of supplemental citrulline. When necessary, hemodialysis is used to reduce ammonia concentrations.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Longer-term maintenance regimens involve strict adherence to a low-protein diet along with the prophylactic use of nitrogen scavenger agents that carry an onerous pill regimen and significantly diminish the quality of life for patients. The objective of maintenance therapy is to minimize nitrogen intake while facilitating its removal through alternate pathways. The existing supportive measures are not sufficient, with many patients suffering neurological disability and premature death. A liver transplant, which is usually limited to early onset patients, is intended to prevent further hyperammonemic crises and neuropsychological deterioration and is the only curative treatment, but is available to fewer than 10% of patients.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to approved maintenance therapies, we are aware of several other product candidates in development for the treatment of only a portion of UCDs. These candidates are administered through infusion as they utilize lipid nanoparticle (&#8220;LNP&#8221;) or adeno-associated virus-based (&#8220;AAV-based&#8221;) approaches that target correcting the under-expression of OTC only. Despite the therapeutic potential of these technologies, there is little published clinical data to date on these programs and some have been hampered by delays. Furthermore, the AAV-based gene therapy approach has an irreversible mechanism of action and is designed to only address OTC deficiency in patients 12&#160;years or older. This could limit initial clinical utility of these AAV-based therapeutics to a small patient pool. Like all AAV-based therapeutics, these product candidates are not able to be redosed due to immunogenicity, potentially limiting their long-term utility. Additionally, there is potential for efficacy waning as liver cells turn over, leaving additional need for other therapeutics to be used in patients where the effects of gene therapy diminish. While LNPs can be redosed, they face the challenge of potential toxicity associated with repeated administration.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Solution for UCDs: CMP-CPS-001</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our lead product candidate, CMP-CPS-001, is a potentially disease-modifying therapy designed to amplify expression of CPS1, an enzyme that catalyzes the first step of the urea cycle, by binding to a CPS1-specific regRNA. In our preclinical studies, we have demonstrated that modulating the activity of this regRNA increases expression of the&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CPS1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;gene, causing increased CPS1 enzyme levels, which allows for more ammonia to be converted into urea, thereby </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lowering ammonia levels to normal, healthy ranges. Our preclinical studies have also demonstrated that CMP-CPS-001 can upregulate the production of multiple enzymes responsible for converting ammonia into urea, potentially allowing us to address more than 85% of patients with UCDs. This includes the OTC deficient patient population as well as ASS1 and ASL, and others, with the exception of CPS1 and NAGS deficiencies.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our RAP Platform enabled us to (i)&#160;identify the key enhancer modulating&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CPS1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;expression, (ii)&#160;screen ASOs directed to the regRNAs expressed by this enhancer, and (iii)&#160;generate a RNA Actuator designed to increase&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CPS1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;expression. We commenced work on the program, identified the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CPS1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> regulatory RNA target and identified the lead ASO sequence for CMP-CPS-001 in 2021.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have demonstrated the controllability of our RNA Actuators in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;and&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;studies. The figures below illustrate the concentration-dependent increase in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CPS1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;mRNA achieved by the lead regRNA-targeting ASO in healthy human donor hepatocytes in an&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;study. This ASO, designated &#8220;CMP-CPS-001 Analog,&#8221; has the same sequence and chemical modifications as CMP-CPS-001, but lacks a GalNAc conjugate, which is not necessary for&#160;in vitro&#160;delivery. In this study, both healthy human donor hepatocytes and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OTC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> mutant hepatocytes were treated with a range of concentrations of the CMP-CPS-001 Analog and&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CPS1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;mRNA levels were measured and normalized to untreated cells. As depicted in the figures below, the results of this study show that the ASO elevated expression of&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CPS1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;in a concentration-dependent manner in both wild-type and&#160;OTC&#160;mutant human hepatocytes. The GalNAc-conjugated version of the CMP-CPS-001 Analog is our lead product candidate, CMP-CPS-001.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration-dependent increase in&#160;CPS1&#160;mRNA</span></div><div style="margin-bottom:8pt;text-align:center"><img src="camp-20241231_g7.jpg" alt="Image_6.jpg" style="height:319px;margin-bottom:5pt;vertical-align:text-bottom;width:547px"/></div><div style="margin-bottom:5pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Error bars represent standard error of the mean; UTC denotes untreated control; NTC denotes non-targeting&#160;control.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Preclinical Studies</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our Preclinical Evaluation of CPS1 Upregulation in a Mouse Otc Deficiency Model</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Otc</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">spf-ash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;mouse is an established animal model of OTC deficiency which carries an&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Otc</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;mutation that reduces Otc expression to less than 10% of wild-type levels. Following an acute ammonia challenge, these mice displayed elevated plasma ammonia levels as compared to wild-type mice. We used this model for proof of concept that elevating the expression of&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CPS1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;can overcome a deficiency in OTC,&#160;the enzyme most commonly mutated in UCDs. We applied our RAP Platform to identify a surrogate ASO targeting mouse&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cps1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;regRNA in order to conduct studies in this model.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first study, adult Otc</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">spf-ash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;mice were administered eight doses (on days 1, 3, 5, 9, 11, 13, 15 and 17) of the ASO specifically engineered to target mouse&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cps1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;regRNA, at three different dose levels (8.33 (N=4), 16.6 (N=4) and 33.3 mg/kg (N=3)). A control group received placebo (phosphate-buffered saline (&#8220;PBS&#8221;)). Two days after the last dose, the mice were challenged with an injection of&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">N-labeled ammonium chloride. Thirty minutes later, blood was drawn to </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">measure total ammonia and&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">N-urea levels. Statistical significance between groups was determined using appropriate statistical tests including two-way ANOVA and p-values reported. P-values (or probability values) are used to determine if the outcome of an experiment is statistically significant. A low p-value means that there is a very low likelihood that a given outcome was a result of a random occurrence. A high p-value means that assuming the null hypothesis is true, this outcome was very likely due to random occurrence. Generally, a p-value of less than 0.05 (or 5% odds of the event being random) is regarded as statistically significant. In our preclinical studies, p-values of &lt;0.05 were considered statistically significant. In some cases, we identified directional trends in effects that did not meet statistical significance due to limited group sizes, small effect size, and variability. As is depicted in the graph below, treatment of these Otc-deficient mice with the mouse surrogate tool ASO led to a dose-dependent decrease in ammonia, including a 48% decrease at the highest dose level (p&lt;.01), along with a trend toward increased urea synthesis, including a 20% increase at the highest dose level) compared to mice treated with PBS. This demonstrates that upregulation of&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cps1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;can improve ammonia metabolism in the context of a pathogenic mutation in the downstream&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Otc</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;gene, and that the reduction in toxic ammonia is greater than the increase in urea.</span></div><div style="margin-bottom:13pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Targeting&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cps1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;regRNA with an ASO leads to decreased ammonia levels and increased urea production</span></div><div style="margin-bottom:8pt;text-align:center"><img src="camp-20241231_g8.jpg" alt="Image_7.jpg" style="height:279px;margin-bottom:5pt;vertical-align:text-bottom;width:351px"/><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span></div><div style="margin-bottom:6.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-bottom:10pt;padding-left:7.2pt;text-align:justify;text-indent:-7.21pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt">denotes p&lt;.01; OtcD denotes Otc deficiency; PBS denotes phosphate-buffered saline; Error bars represent standard error of the mean.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A second Otc</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">spf-ash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;mouse study was conducted to investigate the onset and duration of the pharmacodynamic effect of elevating&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cps1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;expression in the context of Otc deficiency. In this study, mice were administered three dose levels of ASO totaling 10, 30 and 90 mg/kg split over three days (days 1, 3 and 5). Control animals received placebo. Ammonia challenges were administered to cohorts of animals prior to dosing and at weekly intervals beginning three days after the final dose for a total of eight weeks. Blood was drawn 30 minutes post-challenge and total ammonia levels were measured. As shown in the figure below, the onset of effect was dose-dependent with ammonia levels reduced to within the range of wild-type animals (&#8220;WT Range&#8221;) by 3, 10 and 22&#160;days post-dose for each of the high, mid and low dose groups, respectively. Ammonia levels approach baseline levels by 5 to 6 weeks post-dose, demonstrating a durable, greater than one month, pharmacodynamic effect. In addition, the impact of ASO treatment on&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cps1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;mRNA was assessed, and demonstrated a peak increase of approximately 71% for the high-dose group at day 15 that returned to baseline by day 29. The mid-dose group exhibited an approximately 27% increase in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cps1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;mRNA along with prominent reductions in ammonia. The low-dose group exhibited minimal impact on&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cps1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;mRNA at the timepoints tested, had slower onset of ammonia reduction but still exhibited an overall effect. These data demonstrate that significant reductions of ammonia result from modest effects on transcription and associated increased flux through the urea cycle.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Targeting&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cps1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;regRNA with an ASO leads to sustained decrease in ammonia levels</span></div><div style="margin-bottom:8pt;text-align:center"><img src="camp-20241231_g9.jpg" alt="Image_8.jpg" style="height:292px;margin-bottom:5pt;vertical-align:text-bottom;width:518px"/></div><div style="margin-bottom:6pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Error bars represent standard error of the mean; PBS denotes phosphate-buffered saline.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our Preclinical Evaluation of CMP-CPS-001 in Mice with Humanized Livers</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The above studies were conducted using a mouse surrogate ASO that targets mouse&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cps1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;regRNA. To assess the impact on ureagenesis of CMP-CPS-001&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;we utilized mice whose livers had been repopulated with hepatocytes from a healthy human donor. These humanized-liver mice were given a&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">N-ammonia challenge on day 1, then administered four doses of 25 mg/kg CMP-CPS-001 on days 8, 12, 15 and 19. In addition to day 1, the mice received&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">N-ammonia challenges before dosing on days 8 and 15, and then again on day 22. Total ammonia and&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">N-urea were measured at each of these time points. Consistent with the studies using Otc</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">spf-ash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;mice involving the mouse surrogate ASO above, the results of this assessment, which are illustrated in the figure below, also demonstrated that CMP-CPS-001 targeting the&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cps1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;regRNA produced a statistically significant decrease in ammonia levels (approximately 71% on day 22, p&lt;.05) along with increased ureagenesis (approximately 31% on day 22, p&lt;0.01). Similar to the Otc-deficient mouse study, this study in wild-type humanized liver mice demonstrated that large decreases in ammonia (approximately 71%) are associated with more modest increases in urea (approximately 31%).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CMP-CPS-001 produced statistically significant changes in levels of ammonia and ureagenesis in wild-type humanized mice compared to placebo treated mice at day 22</span></div><div style="margin-bottom:5pt;text-align:center"><img src="camp-20241231_g10.jpg" alt="Image_9.jpg" style="height:334px;margin-bottom:5pt;vertical-align:text-bottom;width:474px"/></div><div style="margin-bottom:4.11pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Error bars represent standard error of the mean; * denotes p&lt;.05; ** denotes p&lt;.01.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On day 22, animals were sacrificed and livers collected to measure expression levels of CPS1 and other urea cycle enzymes. As shown in the figure below, treatment with CMP-CPS-001 resulted in a directional, though not statistically significant, increase in the expression of&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CPS1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;by approximately 20%, with a similar increase in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OTC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In addition, similar elevations of two other urea cycle enzymes (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;and&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ARG1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) were observed. This demonstrates that an increase in the expression of&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CPS1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;can enhance enzymatic activity at multiple stages of the urea cycle, supporting development of CMP-CPS-001 as a potential therapeutic for urea cycle disorders in addition to OTC deficiency. The results of our studies of UCD-relevant mRNA transcription across multiple urea cycle enzymes is presented below.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CMP-CPS-001 increases transcription of mRNA of multiple urea cycle enzymes</span></div><div style="margin-bottom:5pt;text-align:center"><img src="camp-20241231_g11.jpg" alt="Image_10.jpg" style="height:266px;margin-bottom:5pt;vertical-align:text-bottom;width:396px"/></div><div style="margin-bottom:4pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Error bars represent standard error of the mean; PBS denotes phosphate-buffered saline.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An ammonia challenge cannot be utilized in a clinical trial due to safety concerns, as ammonia is an extremely toxic molecule. Instead, the metabolic output of the urea cycle can be assessed by using a URT in which subjects are administered&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C-sodium acetate. Sodium acetate is a salt that is commonly found in food sources and, like ammonia, the carbon is metabolized through the urea cycle and excreted in the urine.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C-sodium acetate, a labeled isotope of sodium acetate, is ingested by participants as part of the URT to measure the overall activity of the urea cycle, and blood is drawn at multiple time points to measure the amount of&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C-urea that is generated. This measure of ureagenesis represents a clinically meaningful signal of the metabolic output of the urea cycle. An increase in the metabolic output of the urea cycle, as indicated by an increase in the amount of&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C-sodium acetate metabolized, is expected to correlate with an increase in the amount of ammonia metabolized. The rate of ureagenesis is inversely related to the severity of UCD. Studies have shown that while baseline plasma urea levels of asymptomatic carriers of these disorders are indistinguishable from those of healthy volunteers, baseline plasma urea levels among symptomatic patients are significantly lower. Notably, the measurement of ureagenesis in prior clinical trials of therapeutics designed to treat patients with OTC deficiency has been demonstrated to translate well to clinical response. Although preclinical studies suggest increases in urea are less pronounced than decreases in ammonia, we believe ureagenesis is a reliable indicator of therapeutic efficacy. Thus, we have incorporated this assay in ongoing assessments of CMP-CPS-001 in our healthy volunteer Phase&#160;1 clinical trial. Based on our preclinical studies we believe small increases (approximately 20%) in ureagenesis may ultimately translate to meaningful clinical activity in patients in subsequent trials. It is possible that we may observe smaller increases in healthy volunteers, as their ureagenesis rates are operating at full capacity, underrepresenting the potential efficacy when tested in patients with low ureagenesis rates. However, it is possible that an increase in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C-sodium acetate metabolism, as measured by the URT, will not correlate to an increase in ammonia metabolism and that variability in the results of the assay could render interpretation difficult. For a further discussion of our use of this assay, please see Part I, Item 1A., &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk factors&#8212;The outcome of preclinical studies and earlier-stage clinical trials may not be predictive of future results or the success of later preclinical studies and clinical trials</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in this Annual Report.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our Preclinical Evaluation of CMP-CPS-001 in Non-Human Primates</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect of increased CPS1 production on ureagenesis was also studied in wild-type cynomolgus monkeys. These NHPs were administered two doses of 5 mg/kg CMP-CPS-001, 30&#160;days apart, with urea production measured one week after the second dose. To measure ureagenesis, animals were administered&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C-sodium acetate, and blood was drawn at eight time points over a four-hour period. The concentration of&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C-urea was measured utilizing a URT. As shown below, CMP-CPS-001 treatment increased ureagenesis by 40% compared to those animals administered the placebo (p&lt;0.05 at 180 minutes; p&lt;0.01 at 240 minutes). As in the humanized mouse study, this study shows that CMP-CPS-001 can increase activity of the urea cycle in wild-type animals. Moreover, the NHP study measured ureagenesis with the same assay being employed in the ongoing Phase&#160;1 clinical trial in healthy volunteers, supporting this approach to measure a pharmacodynamic effect in humans.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CMP-CPS-001 increased ureagenesis compared to placebo in wild-type NHPs</span></div><div style="margin-bottom:8pt;text-align:center"><img src="camp-20241231_g12.jpg" alt="Image_11.jpg" style="height:298px;margin-bottom:5pt;vertical-align:text-bottom;width:422px"/></div><div style="margin-bottom:5pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Error bars represent standard error of the mean; PBS denotes phosphate-buffered saline; * denotes p&lt;.05; ** denotes p&lt;.01.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Preclinical Safety Evaluations</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMP-CPS-001 was evaluated in three-month GLP toxicity studies of both mice and NHPs. Animals were dosed subcutaneously, once monthly for three&#160;months. In both species, CMP-CPS-001 was generally well tolerated with all clinical observations considered non-adverse due to low severity and lack of clinical correlates. No observable adverse effects were noted at 12.5 mg/kg and 50 mg/kg dosing, the highest dose levels tested in mice and NHPs respectively. Drug metabolism and pharmacokinetic evaluations reflected findings consistent with the drug class.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Ongoing Phase&#160;1 Clinical Trial</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMP-CPS-001 is currently being evaluated in an approximately 96-person randomized, double-blind, and placebo-controlled Phase&#160;1 clinical trial to evaluate safety, tolerability as well as pharmacokinetics and pharmacodynamics in healthy volunteers in Australia, where we are able to benefit from certain cost-effective tax incentives provided by the Australian government. CMP-CPS-001 is being administered by subcutaneous injection on a monthly basis. Primary endpoints of this trial include safety and tolerability and a secondary endpoint is to assess change in ureagenesis using the same URT utilized in our NHP study. Inclusion of the URT assessment is designed to enable the establishment of URT methodology that can be used to optimize the design of future registrational studies in patients with UCDs as well as enable a reference range of normal ureagenesis rates as both a tool for studies in patients with UCDs and as support for our engagement with regulators.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SAD portion of the trial was segregated into four cohorts of 10-12 subjects each. Nine subjects in each cohort received CMP-CPS-001 with the additional three subjects receiving placebo. We dosed the first participant in this Phase 1 SAD clinical trial in March 2024. Dosing levels began at 0.2 mg/kg in the first cohort and, per the clinical trial design, increased with each successive cohort unless a maximum tolerated dose was reached, with dose escalation between cohorts only after a two-week safety review committee confirmation of safety and tolerability. In the absence of any concerning safety trends observed in the first two SAD cohorts, the trial was designed to then initiate an evaluation of CMP-CPS-001 in four MAD cohorts of 12 subjects each, staggered concurrently to the latter SAD cohorts. As was the design for the SAD portion of the Phase&#160;1 clinical trial, the active therapeutic candidate to placebo participant ratio in each cohort of the MAD portion of the Phase&#160;1 clinical trial is 3:1. Initial dosing levels and dose ranges for the MAD portion of the Phase&#160;1 clinical trial were determined based on observations from the SAD trial portion. Dose escalation occurred after a 59-day safety review committee confirmation for the MAD portion of the Phase&#160;1 clinical trial.</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Phase&#160;1 clinical trial design</span></div><div style="margin-bottom:18pt;text-align:center"><img src="camp-20241231_g13.jpg" alt="Screenshot 2025-02-27 104028.jpg" style="height:319px;margin-bottom:5pt;vertical-align:text-bottom;width:660px"/></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Phase 1 Clinical Trial Data-SAD Cohorts 1 Through 4</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have completed a planned interim analysis of safety and pharmacokinetic data from all four SAD cohorts of the trial in 48 healthy volunteer participants. No safety trends of concern were observed, no treatment-related serious adverse events occurred, and CMP-CPS-001 appeared to be well tolerated, with no indication of a maximum tolerated dose at the tested dose levels. All treatment emergent adverse events (&#8220;TEAEs&#8221;) were Grade 1 (mild) or Grade 2 (moderate), and the two most common TEAEs across all cohorts were headache (six participants) and nausea (four participants). Pharmacokinetic data similarly was observed to be consistent with expectations, demonstrating a dose-dependent increase in exposure with clear separation between groups.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Anticipated Milestones</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dosing has been completed in the first two MAD cohorts, and we have initiated dosing of the third MAD cohort. We expect to report data from the SAD and MAD portions of the clinical trial, including safety, pharmacokinetic and key pharmacodynamic biomarker data, in the fourth quarter of 2025. We also plan to initiate the expansion of the trial of CMP-CPS-001 in Australia into a Phase 1b clinical trial to enroll female OTC heterozygotes in the second quarter of 2025. In addition, we intend to submit a clinical trial application in Europe and to open an additional European clinical trial site, pending regulatory clearance of the clinical trial application.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Planned Clinical Trials</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Assuming the successful completion of our ongoing clinical trial and regulatory feedback from regulatory agencies, we plan to utilize a stepwise development approach in which we would initiate one or more 52-week Phase&#160;2/3 clinical trials involving CMP-CPS-001, with the potential for an open-label extension. We anticipate the first of these two Phase&#160;2/3 clinical trials to enroll patients in the first years of life and older who have been diagnosed with an OTC deficiency to be randomized to either our active therapeutic candidate or to placebo. We currently expect that the Phase 2/3 clinical trial would initially start with adults in the United States, and step down by age segment into patients in the first years of life and older as required by regulators. Pediatric dosing timelines, levels, and schedule may differ between U.S. and ex-U.S. regulators. Key endpoints are likely to include responder analysis defined as a reduction and/or maintenance in ammonia levels compared to baseline, diet liberalization, nitrogen scavenger reduction, and increase in ureagenesis, along with a maintenance of no or a decrease in clinical episodes during the treatment period. Assuming a positive assessment of the OTC trial results during the interim analysis, we envision initiating a second Phase&#160;2/3 clinical trial expanding enrollment to include ASS1 and ASL deficient patient populations.</span></div><div style="margin-bottom:8pt"><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CMP-SYNGAP for SYNGAP1-Related Disorders</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our initial CNS development program, CMP-SYNGAP, aims to address the underlying cause of SYNGAP1-related disorders. CMP-SYNGAP utilizes a novel approach that targets the&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">SYNGAP1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;gene at the transcriptional level designed to restore SYNGAP function. We are advancing our CMP-SYNGAP program to address the significant unmet need for these patients by targeting the direct cause of SYNGAP1-related disorders, haploinsufficiency, which we believe is amenable to treatment by targeting SYNGAP1 regRNAs. Based on compelling data across our preclinical studies, including recent primate studies, we have nominated a development candidate, CMP-SYNGAP-01, from this program, and expect to initiate GLP toxicology studies in 2025 to enable the filing of a clinical trial application.</span></div><div style="margin-bottom:8pt"><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SYNGAP1-Related Disorders</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SYNGAP plays a critical role in the development of cognition and proper synaptic function, enabling synaptic plasticity and axon formation through signal attenuation. SYNGAP1-related disorders are a group of neurodevelopmental conditions caused by pathogenic variants in the&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SYNGAP1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;gene leading to a haploinsufficient state that reduces SYNGAP protein levels by as much as 50%. A majority of these SYNGAP1 pathogenic variants, or mutations, are mutations that result in truncation of the protein or destruction of the RNA by nonsense-mediated decay, ultimately resulting in lower protein levels and haploinsufficiency. These disorders can manifest with a variety of symptoms that can include developmental delays, movement disorders and features of autism spectrum disorder. Epilepsy is a common feature of SYNGAP1-related disorders, with seizures usually beginning in early childhood. Nearly all children have some degree of developmental delay and cognitive impairment, though disease symptoms and their severity vary widely. SYNGAP1-related disorders are autosomal dominant with clinical disease presentation if either of the two alleles have a mutation. In most cases the pathogenic variant occurs spontaneously and is not inherited. Patient estimates for SYNGAP1-related disorders vary significantly, with incidence estimates ranging from one to 40 in 100,000 individuals. While we believe that SYNGAP1-related disorders remain underdiagnosed, we estimate that there are approximately 10,000 individuals living </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with these disorders in the United States. The disorders are reported to represent 0.5% to 1.0% of all intellectual disability cases, making them among the most common causes of intellectual disability in patients with epilepsy, and indicating that the patient population may be significantly larger than incidence estimates suggest.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Current Treatments and Their Limitations</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is currently no FDA-approved treatment, disease-modifying or otherwise, for SYNGAP1-related disorders. There is also no definitive treatment protocol, which is dependent on seizure type and severity and other neurological characteristics of the disease. Treatment is often limited to supportive physical, occupational and speech therapy. A combination of anti-seizure medications may be prescribed to treat seizures, though SYNGAP1-related disorders have proven difficult to control with available therapeutics. As many as 50% of patients do not adequately respond to medication in which case implantable devices, such as those for vagus nerve stimulation, may offer incremental therapeutic benefit.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Solution</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our CMP-SYNGAP program is a novel approach that targets the&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SYNGAP1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;gene at the transcriptional level to restore SYNGAP function and improve symptoms. We are advancing our CMP-SYNGAP program to address the significant unmet need for these patients by targeting the direct cause of SYNGAP1-related disorders, haploinsufficiency, which we believe is amenable to targeting through regRNAs. As haploinsufficiency characterizes SYNGAP1-related disorders, upregulation of&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SYNGAP1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;gene expression may enable an increase in protein levels which may yield therapeutic benefit, including potential improvements to memory and incidence of seizures. Our CMP-SYNGAP program utilizes an intrathecally delivered ASO for the treatment of SYNGAP1-related disorders. We have identified specific regRNA sequences involved in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SYNGAP1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;transcription and have leveraged our RAP Platform to generate ASOs that function to increase&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SYNGAP1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;transcription.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Preclinical Studies</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently pursuing parallel workstreams to identify both tool ASOs for mouse proof-of-concept studies, as well as human-specific ASOs as drug candidates to assess the clinical effect of ASOs on&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SYNGAP1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;levels in both patient-derived neurons and mice expressing human&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SYNGAP1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lead human-specific ASOs have been identified that increase&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SYNGAP1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;mRNA in human neurons&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;as shown in the figure below (left). In addition, a mouse tool ASO was administered by intracerebroventricular injection to neonatal mice with the goal of confirming an ability to increase&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Syngap1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;expression. Assessment of brain tissue revealed a dose-dependent increase in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Syngap1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;mRNA levels three weeks post-dose. These findings are presented in the graph below (right). Future studies will evaluate the impact of increased&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Syngap1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;expression on functional deficits caused by haploinsufficiency.</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dose-dependent increase in&#160;Syngap1&#160;mRNA in the brains of mice</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr style="height:138pt"><td colspan="6" style="padding:0 1pt"><div style="text-align:center"><img src="camp-20241231_g14.jpg" alt="Image_13.jpg" style="height:172px;margin-bottom:5pt;vertical-align:text-bottom;width:599px"/></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Error bars represent standard error of the mean; NTC denotes non-targeting control.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vertical error bars represent standard deviation of fold change increase in mRNA; Horizontal error bars represent standard deviation of measured ASO concentration.</span></div></td></tr></table></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our assessment of lead human-specific ASOs in human neurons&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we have confirmed that SYNGAP1 patient-derived induced pluripotent stem cell (&#8220;iPSC&#8221;) neurons exhibit one-half as much&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SYNGAP1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;mRNA as those derived from a familial control iPSC neurons. Two representative lead ASOs demonstrated robust target engagement </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">where they increased&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SYNGAP1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;mRNA at least two-fold in both control and mutant neurons, where&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SYNGAP1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;mRNA levels were fully restored to wild-type levels. We are continuing to explore electrophysiological and biochemical phenotypes in iPSC neurons&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;to link increases in expression to benefits in disease-relevant phenotypes.</span></div><div style="margin-bottom:8pt;text-align:center"><img src="camp-20241231_g15.jpg" alt="Image_14.jpg" style="height:298px;margin-bottom:5pt;vertical-align:text-bottom;width:416px"/></div><div style="margin-bottom:6pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Error bars represent standard deviation of fold change increase in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SYNGAP1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;mRNA levels; NTC denotes non-targeting control. ASO-7 and ASO-9 denote two lead candidate ASOs of our CMP-SYNGAP program.</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dose-dependent increase in&#160;SYNGAP1&#160;protein in the brains of humanized mice</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our evaluation of CMP-SYNGAP-01 in a humanized SYNGAP1 mouse model, we assessed its ability to increase SYNGAP1 protein levels following intracerebroventricular injection. The study demonstrated a dose-dependent increase in SYNGAP1 protein across multiple brain regions, with levels rising up to approximately 1.7-fold compared to control. These findings support the potential of CMP-SYNGAP-01 to enhance SYNGAP1 expression, and we continue to investigate the downstream functional benefits associated with this increase.</span></div><div style="margin-bottom:8pt;text-align:center"><img src="camp-20241231_g16.jpg" alt="Screenshot 2025-03-13 180531.jpg" style="height:300px;margin-bottom:5pt;vertical-align:text-bottom;width:288px"/></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have nominated CMP-SYNGAP-01 as our development candidate from this program and expect to initiate GLP toxicology studies in 2025 to enable the filing of a clinical trial application.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Program for the Treatment of GBA1-related Parkinson&#8217;s Disease</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have initiated a new discovery program focused on increasing the expression of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GBA1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> gene as a potential treatment for PD. Approximately 5-15% of PD patients harbor mutations in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GBA1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> gene, which encodes GCase. We estimate that there are approximately 100,000 PD patients with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GBA1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> mutations in the United States, representing a meaningful portion of the overall PD community. </span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GBA1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> mutations have been shown to lead to a reduction in GCase activity of approximately 50%, which contributes to the pathological accumulation of toxic substances in the brain, exacerbating disease progression and symptoms. GCase and &#945;-synuclein, the hallmark protein of PD, are part of a positive feedback loop in the brain that accelerates neurodegeneration. Notably, GCase activity is also reduced in sporadic forms of Parkinson&#8217;s disease, and we plan to explore the therapeutic potential of increasing </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GBA1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> expression both in patients with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GBA1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> haploinsufficiency and in a broader subset of PD patients.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Using our RAP Platform, we have identified specific ASOs that target the regRNAs controlling the expression of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GBA1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. These ASOs have been observed to increase </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GBA1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> expression in in vitro studies. We are continuing to advance our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GBA1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> discovery program with the objective of selecting a development candidate to progress into preclinical development. We believe that future clinical development of this program will be enabled by established biomarkers and assessment tools commonly used in PD research. </span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Manufacturing Strategy</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not own or operate, and currently have no plans to establish, any manufacturing facilities. We rely on third- party contract manufacturers for the manufacture of our product candidate for our clinical trials, and, if we receive marketing approval, we will rely on such third parties for commercial manufacture. In addition, we rely on third parties to package, label, store and distribute our product candidates, and we intend to rely on third parties for our commercial products if marketing approval is obtained. We expect this strategy will enable us to maintain a more efficient infrastructure, avoiding dependence on our own manufacturing facility and equipment, while simultaneously enabling us to focus our expertise on the clinical development and future commercialization of our products. Chemistry, Manufacturing and Controls (&#8220;CMC&#8221;) is a critical element of the drug development process and involves the various procedures used to assess the physical and chemical characteristics of drug products, to ensure their quality and consistency throughout manufacture. CMC increases in complexity as the development process matures.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">License and Collaboration Agreements</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Whitehead Institute Patent License Agreement</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October&#160;2019, we and the Whitehead Institute for Biomedical Research (the &#8220;Whitehead Institute&#8221;) entered into a patent license agreement (as amended in December&#160;2021 and November&#160;2023, the &#8220;Whitehead Agreement&#8221;) pursuant to which we received a worldwide, royalty-bearing, sublicensable license under certain patent rights owned or controlled by the Whitehead Institute to develop, make, have made, use, sell, offer to sell, lease and import products, and to perform and have performed licensed processes, in each case, in the fields of human and animal therapeutics and diagnostics. The license granted under the Whitehead Agreement included an exclusive license to certain patent rights generally related to, among other things, methods of modulating gene expression using oligonucleotides, and a co-exclusive license to certain patent rights generally relating to, among other things, methods of modulating gene expression by targeting certain genomic sequences.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Whitehead Agreement, the Whitehead Institute retains the right to practice the licensed patent rights for research, teaching, and other educational purposes, including use in third-party sponsored research, and to grant non-exclusive licenses to other nonprofit and academic institutes solely for non-commercial research, teaching, and other educational purposes. The license granted to us under the Whitehead Agreement is also subject to certain rights held by the U.S. government under applicable law with respect to inventions that arose from federal research funding. In addition, the license is subject to a certain non-exclusive license for internal research purposes only that the Whitehead Institute granted to a certain third party, and to certain preexisting rights held by a certain third party who is a party to a certain sponsored research agreement (&#8220;SRA&#8221;) with the Whitehead Institute. Under the SRA, the Whitehead Institute covenanted not to sue said third party if certain inventions arising under the SRA, or SRA inventions, are dominated by the licensed patent rights and we are thereby excluded from asserting certain patent rights licensed from the Whitehead Institute that cover the SRA inventions against said third party.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are obligated to use certain efforts to develop one or more products or licensed processes and commercialize the products or licensed processes in a major market. Furthermore, beginning five&#160;years from the effective date and subject </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to certain terms and conditions, the Whitehead Agreement requires us to negotiate and potentially issue mandatory sublicenses to a third party under the exclusively licensed patent rights to make, have made, use, sell, offer to sell, or import a product or process that is not directly competitive with a licensed product or licensed process then offered for sale or in bona fide research or development by or on behalf of us.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Whitehead Agreement, we paid to the Whitehead Institute an upfront license issuance fees of $0.1&#160;million and de minimis additional fees in connection with each of the December&#160;2021 and November&#160;2023&#160;amendments to the agreement that were recorded as research and development expense in our consolidated statement of operations and comprehensive loss. We are also obligated to make annual license maintenance fees under the agreement, pursuant to which we have paid an aggregate of $0.3 million through December&#160;31, 2024. In addition, we are obligated to pay certain filing, prosecution and maintenance fees with respect to certain patent rights licensed to us under the agreement, pursuant to which we have paid an aggregate of $0.3 million through December&#160;31, 2024. We are obligated to pay potential development milestone payments of up to an aggregate of $1.9 million under the terms of the agreement upon the achievement of certain specified contingent events, pursuant to which we have paid an aggregate of $0.2 million through December&#160;31, 2024. In addition, if we successfully commercialize a product under the Whitehead Agreement, then we will be required to pay the Whitehead Institute tiered royalties at&#160;percentage rates ranging from less than one&#160;percent to the mid-single digits of net sales or of running royalties of net sales, subject to specified reductions, until either the last-to-expire valid claim of a Whitehead Institute patent covering the product or seven years after the first commercial sale, in each case on a product-by-product and country-by-country basis.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expected termination of the royalty obligations will depend on factors such as the availability and application of patent term extensions for the licensed patents in the licensed territory. The Whitehead Agreement will remain in effect until voluntarily terminated by the company and may be earlier terminated by the Whitehead Institute if the company fails to pay any amounts due under the agreement or materially breaches the agreement and fails to cure such breach. The last to expire patent, if issued, under the Whitehead Agreement, is expected to expire in 2043.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The biotechnology and pharmaceutical industries have made substantial investments in recent&#160;years into the rapid development of novel treatments for metabolic and CNS-related diseases and disorders.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face substantial competition from multiple sources, including large and specialty pharmaceutical and biotechnology companies, academic research institutions and governmental agencies and public and private research institutions. Our competitors compete with us on the level of the technologies employed, or on the level of development of product candidates. In addition, many small biotechnology companies have formed collaborations with large, established companies to (i)&#160;obtain support for their research, development and commercialization of products or (ii)&#160;combine several treatment approaches to develop longer lasting or more efficacious treatments that may potentially directly compete with our current or future product candidates. We anticipate that we will continue to face increasing competition as new therapies and combinations thereof, technologies, and data emerge within the field of antisense oligonucleotide therapeutics and, furthermore, within the treatment of metabolic and CNS-related diseases and disorders.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the current standard-of-care treatments to address the diseases we are targeting in therapeutic development programs, numerous commercial and academic preclinical studies and clinical trials are being undertaken by a large number of parties to assess novel technologies and product candidates.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the broad treatment of patients with UCDs, we will compete with Amgen Inc., who has commercialized Ravicti, a nitrogen scavenger. Other therapeutics in development are focused on patients with OTC deficiency only, where we will potentially compete with Ultragenyx Pharmaceutical Inc., Arcturus Therapeutics Holdings Inc., and iECURE, Inc. (&#8220;iECURE&#8221;), among others, assuming they are successful in clinical development. Ultragenyx Pharmaceutical Inc. is developing its potential therapy in OTC patients aged 12 and older; and iECURE is initially targeting neonatal patients only. Companies that compete with us directly on the level of the development of product candidates targeting SYNGAP1-related disorders include Stoke Therapeutics, Inc. and Praxis Precision Medicines, Inc., along with other companies with programs currently in discovery stages of development, such as Tevard Biosciences, Inc., Regel Therapeutics, Inc., and Quiver Bioscience Inc. For the treatment of GBA1 Parkinson&#8217;s Disease, we will potentially compete with Gain Therapeutics, Inc., Vanqua Bio, Inc., BIAL-Portela &amp; C&#170;., S.A., and Prevail Therapeutics Inc. (a subsidiary of Eli Lilly and Company), assuming they are successful in clinical development, along with other companies with programs currently in preclinical stages of development. Companies engaged in the commercialization and development of antisense oligonucleotides as therapeutics include Alnylam Pharmaceuticals, Inc. and Ionis Pharmaceuticals Inc.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our competitors, either alone or in combination with their respective strategic partners, have significantly greater financial resources and expertise in research and development, manufacturing, the regulatory approval process, and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">marketing than we do. Mergers and acquisition activity in the pharmaceutical, biopharmaceutical and biotechnology sector is likely to result in greater resource concentration among a smaller number of our competitors. Smaller or early-stage companies may also prove to be significant competitors, particularly through sizeable collaborative arrangements with established companies. These competitors also compete with us in recruiting and retain qualified scientific and management personnel and establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our programs.</span></div><div style="margin-bottom:10.5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial opportunity could be reduced or eliminated if one or more of our competitors develop and commercialize products that are safer, more effective, better tolerated, or of greater convenience or economic benefit than our proposed product offering. Our competitors also may be in a position to obtain FDA or other regulatory approval for their products more rapidly, resulting in a stronger or dominant market position before we are able to enter the market. The key competitive factors affecting the success of all of our programs are likely to be product safety, efficacy, convenience and treatment cost.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intellectual Property</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our intellectual property estate is a strategic asset that has the potential to provide us with a competitive advantage. We strive to protect and enhance the proprietary technology, inventions and improvements that we believe are important to our business, including pursuing, maintaining and defending patent rights, whether developed internally or licensed from third parties. We also rely on trade secrets and know-how relating to our proprietary technology and product candidates, continuing technological innovation and in-licensing opportunities to develop, strengthen and maintain our proprietary and intellectual property position. We additionally may rely on data exclusivity, market exclusivity and patent term extensions, when available, and plan to seek and rely on regulatory protection afforded through orphan drug designations. Our commercial success may depend in part on our ability to obtain and maintain patent and other proprietary protection for our technology, inventions, and improvements; to preserve the confidentiality of our trade secrets; to defend and enforce our proprietary rights, including our patents; and to operate without infringing on the valid and enforceable patents and other proprietary rights of third parties.</span></div><div style="margin-bottom:10.5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our wholly owned and in-licensed patent portfolio includes patent rights covering various aspects of our RAP Platform and current product candidates, and certain legacy programs the company is no longer pursuing. As of December&#160;31, 2024, our patent portfolio consists of 25 patent families, including two owned U.S. issued patents, 16&#160;in-licensed U.S. issued patents, 24 in-licensed foreign issued patents, 25 owned or in-licensed U.S. pending patent applications (including provisional patent applications), 51 owned or in-licensed foreign pending patent applications, and three owned or in-licensed pending Patent Cooperation Treaty applications (&#8220;PCT applications&#8221;) that have not entered national phase. Our objective is to continue to expand our patent portfolio to protect our technology, inventions, improvements and current and future product candidates. Examples of the product candidates and technology areas covered by our intellectual property portfolio are described below.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Program-related Intellectual Property</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The program-related patent rights in our patent portfolio provide coverage for product candidates designed to address certain diseases and disorders. The program-related patent applications for our lead programs include those described below. Each of the program-related patent applications described below is wholly owned by us.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CMP-CPS-001 Program</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our lead product candidate, CMP-CPS-001, is designed to amplify CPS1 expression. As of December&#160;31, 2024, we owned two U.S. non-provisional patent applications and 15 foreign patent applications in Australia, Brazil, Canada, China, Eurasia, Europe, Hong Kong, Israel, India, Japan, South Korea, Mexico, New Zealand, Singapore and South Africa relating to compositions of matter, including CMP-CPS-001, designed to amplify CPS1 expression, and methods of treating UCDs. Each of these patent applications are national or regional phase applications based on a PCT application filed in December 2022, and claiming priority to two separate U.S. provisional patent applications, the earliest of which was filed in December 2021. We expect patents issuing from or claiming priority to these patent applications, if any, to expire in 2042, excluding any patent term adjustments or extensions.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CMP-SYNGAP Program</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our CMP-SYNGAP program aims to amplify SYNGAP1 expression. As of December&#160;31, 2024, we owned one pending PCT application filed in December 2023, which claims priority to a U.S. provisional patent application filed in December 2022, as well as two pending U.S. provisional patent applications filed in June 2024, each relating to </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">compositions of matter, including ASOs designed to amplify SYNGAP1 expression, and methods of treating SYNGAP1-related disorders. We expect patents claiming priority to these patent applications, if any, to expire between 2043 and 2045, excluding any patent term adjustments or extensions.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our programs listed above, we also have patent applications relating to ASO compositions directed to regRNAs involved in the transcription of additional gene targets and their use for treating additional diseases or disorders that may benefit from upregulation of gene expression. As of December&#160;31, 2024 we owned one U.S. non-provisional patent application and ten foreign patent applications in Australia, Canada, China, Europe, Hong Kong, Israel, India, Japan and Mexico relating to compositions and methods for treating UCDs. Each of these patent applications are national or regional phase applications based on a PCT application filed in September 2022, which claims priority to two separate provisional U.S. patent applications, the earliest of which was filed in September 2021. We expect patents issuing from or claiming priority from these pending patent applications, if any, to expire in 2042, excluding any patent term adjustments or extensions. As of December&#160;31, 2024, we owned one U.S. non-provisional patent application and six foreign patent applications in Australia, Canada, Europe, Israel, Japan, and Mexico relating to compositions and methods for treating several diseases and disorders including frontotemporal dementia. Each of these pending patent applications are national or regional phase applications based on a PCT application filed in June 2023, claiming priority to three separate U.S. provisional patent applications, the earliest of which was filed in June 2022. We expect patents issuing from or claiming priority from these pending patent applications, if any, to expire in 2043, excluding any patent term adjustments or extensions. As of December&#160;31, 2024, we owned one PCT application filed in November 2023, claiming priority to a U.S. provisional patent application filed in November 2022, which relates to compositions and methods for treating cholestatic liver disease. We expect patents claiming priority from this pending application, if any, to expire in 2043, excluding any patent term adjustments or extensions.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Platform-related Intellectual Property</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the program-related intellectual property, our intellectual property portfolio includes know-how and patent applications directed to our RAP Platform and other technologies developed internally or in-licensed from the Whitehead Institute. Exemplary platform technologies that are subject to such patent applications include methods of modulating gene expression using oligonucleotides, methods for characterizing enhancer-promoter pairs, and methods for modulating condensate-dependent transcription. These platform technologies, and our intellectual property portfolio related thereto, relate broadly to our existing product candidates and those we may develop in the future.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continually assess and refine our intellectual property strategy as we develop new product candidates and technologies. To that end, we expect to file additional patent applications in support of current and new product candidates as well as new technologies.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to stop third parties from making, using, selling, marketing, offering to sell, importing, and commercializing our product candidates and technology is dependent upon the extent to which we have rights under valid and enforceable patents and other intellectual property rights that cover our product candidates and technology. We cannot predict whether or when our owned or licensed pending and future patent applications will result in the issuance of patents, nor can we predict whether any patents that may be granted to us in the future will be commercially useful in protecting our product candidates and technology.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms of individual patents depend upon the legal term of the patents in the countries in which they are obtained. In most countries in which we file, including the United States, the patent term is 20&#160;years from the earliest date of filing a non-provisional patent application. In the United States, a patent&#8217;s term may be lengthened by patent term adjustment, which compensates a patentee for administrative delays by the U.S. Patent and Trademark Office (&#8220;USPTO&#8221;) in granting a patent, or may be shortened if a patent is terminally disclaimed over an earlier-filed patent.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, the term of a patent that covers an FDA-approved drug may be eligible for a patent term extension under the Hatch-Waxman Act as compensation for the loss of patent term during the FDA regulatory review process. The period of extension may be up to five&#160;years beyond the expiration of the patent, but cannot extend the remaining term of a patent beyond a total of 14&#160;years from the date of product approval. Only one patent among those eligible for an extension may be extended, and a given patent may only be extended once. Similar provisions are available in Europe and in certain other jurisdictions to extend the term of a patent that covers an approved drug. If our product candidates receive approval, we intend to apply for patent term extensions, if available, to extend the term of patents that cover the approved product candidates. We also intend to seek patent term extensions in any jurisdiction where they are available, however there is no guarantee that the applicable authorities, including the FDA in the United States, will agree with our assessment that such extensions should be granted, and if granted, the length of such extensions.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to patent protection, we also rely on know-how and trade secret protection for our proprietary information to develop and maintain our proprietary and intellectual property position. However, trade secrets can be difficult to protect. Although we take steps to protect our proprietary information, including entering into agreements with our employees, corporate collaborators, external scientific collaborators, contract manufacturers, consultants, advisors, and other third parties, such individuals may breach such agreements and disclose our proprietary information, including our trade secrets, and we may not be able to obtain adequate remedies for such breaches. In addition, third parties may independently develop the same or similar proprietary information or may otherwise gain access to our proprietary information. As a result, we may be unable to meaningfully protect our know-how, trade secrets and proprietary information.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Regulation in the United States</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The FDA and other regulatory authorities at federal, state and local levels, as well as in foreign countries, extensively regulate, among other things, the research, development, testing, manufacture, pricing, reimbursement, sales, quality control, approval, packaging, storage, recordkeeping, labeling, advertising, promotion, distribution, marketing, post-approval monitoring and reporting and import and export of drugs. We, along with our contract manufacturers (&#8220;CMOs&#8221;), contract research organizations CROs, and third-party vendors, will be required to satisfy these requirements in each of the countries in which we wish to conduct studies or seek approval of our product candidates. The process of obtaining marketing approvals and the subsequent compliance with appropriate federal, state, local, and foreign statutes and regulations require the expenditure of substantial time and financial resources. The regulatory requirements applicable to drug development, approval, and marketing are subject to change, and regulations and administrative guidance often are revised or reinterpreted by the agencies in ways that may have a significant impact on our business. We cannot predict whether legislative changes will be enacted or if regulatory authorities&#8217; guidance or interpretations will change.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, the FDA regulates drugs under the Federal Food, Drug, and Cosmetic Act (&#8220;FDCA&#8221;), as amended, and its implementing regulations. Drugs are also subject to other federal, state and local statutes and regulations. FDA clearance of an Investigational New Drug (&#8220;IND&#8221;) application must be obtained before commencing clinical testing of a new drug in the U.S. FDA approval also must generally be obtained before a drug may be legally marketed in the United States.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure to comply with applicable regulatory requirements at any time during the product development, approval, or post-approval processes, could result in delays in the conduct of clinical trials or regulatory review and approval, as well as administrative or judicial sanctions or other legal consequences. These sanctions or consequences could include, among other things, the FDA&#8217;s refusal to approve pending applications, issuance of clinical holds for planned or ongoing studies, suspension or revocation of existing product approvals, issuance of warning or untitled letters, adverse publicity, product withdrawals or recalls, marketing restrictions, product seizures, total or partial suspensions of manufacturing or distribution, import detentions or refusals, injunctions, fines, government investigations, civil penalties or criminal prosecution.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S.&#160;Development Process</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The process for seeking approval to market and distribute a new drug in the United States generally involves the following:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">completion of nonclinical laboratory tests and animal studies according to GLP requirements and applicable requirements for the humane use of laboratory animals or other regulations;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">completion of the manufacture, under current Good Manufacturing Practices (&#8220;cGMPs&#8221;), conditions of the drug substance and drug product that the sponsor intends to use in human clinical trials along with required analytical and stability testing;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">submission to the FDA of an IND application, which must become effective before human clinical trials may begin;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approval by an institutional review board (&#8220;IRB&#8221;) reviewing each clinical site before each clinical trial may be initiated;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">performance of adequate and well-controlled human clinical trials according to Good Clinical Practices (&#8220;GCPs&#8221;), and any additional requirements for the protection of human research subjects and their health information, to establish the safety and efficacy of the drug for its intended use;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">preparation and submission to the FDA of a New Drug Application (&#8220;NDA&#8221;) requesting marketing approval for one or more proposed indications, including submission of detailed information on the chemistry, manufacture and quality controls of the product in clinical development and proposed labeling;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">satisfactory completion of one or more FDA pre-approval inspections of the manufacturing facility or facilities where the drug will be produced, including those of third parties, to assess compliance with cGMP requirements;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential FDA audit of the nonclinical and clinical study sites that generated the data in support of the NDA to assess compliance with GLP and GCP and the integrity of clinical data in support of the NDA;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">payment of user fees under the Prescription Drug User Fee Act (&#8220;PDUFA&#8221;), unless exempted;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FDA review and approval of the NDA, including consideration of the views of any FDA advisory committee, prior to any commercial marketing or sale of the drug in the United States; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">compliance with any post-approval requirements, including the potential requirement to implement a Risk Evaluation and Mitigation Strategy (&#8220;REMS&#8221;), and the potential requirement to conduct post approval studies.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before testing any drug in humans, the product candidate enters the preclinical testing stage. Nonclinical tests include laboratory evaluations of drug chemistry, formulation and stability, as well as in vitro and animal studies to assess safety and in some cases to establish the rationale for therapeutic use. The conduct of nonclinical studies is subject to federal and state regulation, including GLPs. The clinical study sponsor must submit the results of the nonclinical tests, together with manufacturing information, analytical data, any available clinical data or literature, and a proposed clinical protocol, to the FDA as part of the IND. Some nonclinical testing typically continues after the IND is submitted.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An IND is an exemption from the FDCA that allows an unapproved product to be shipped in interstate commerce for use in an investigational clinical trial and a request for FDA authorization to administer an investigational product to humans. The IND must become effective before clinical trials may begin. The IND automatically becomes effective 30&#160;days after receipt by the FDA, unless before that time the FDA raises concerns or questions about the product or conduct of the proposed clinical trial, including concerns that human research subjects will be exposed to unreasonable health risks. If the FDA raises concerns or questions either during the initial 30-day period, or at any time during the IND review process, it may choose to impose a clinical hold. In such a case, the IND sponsor and the FDA must resolve any outstanding concerns before the clinical trial can begin. As a result, submission of an IND may or may not result in FDA authorization to begin a clinical trial, or to begin a clinical trial on the terms originally specified by the sponsor in the IND. A separate submission to an existing IND must also be made for each successive clinical trial conducted, and the FDA must grant permission, either explicitly or implicitly by not objecting, before each clinical trial can begin.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical trials may involve the administration of the drug product candidate to healthy volunteers or subjects under the supervision of qualified investigators. Clinical trials involving some products for certain diseases, including some rare diseases may begin with testing in patients with the disease. Clinical trials are conducted under protocols detailing, among other things, the objectives of the clinical trial, dosing procedures, subject selection, and exclusion criteria, and the parameters to be used to monitor subject safety, including stopping rules that assure a clinical trial will be stopped if certain adverse events should occur. Each protocol and any amendments to the protocol must be submitted to the FDA as part of the IND. Clinical trials must be conducted and monitored in accordance with the FDA&#8217;s regulations comprising the GCP requirements, including the requirement that all research subjects or his or her legal representative provide informed consent. Further, each clinical trial must be reviewed and approved by an independent IRB, at or servicing each institution at which the clinical trial will be conducted. An IRB is charged with protecting the welfare and rights of study participants and considers such items as whether the risks to individuals participating in the clinical trials are minimized and are reasonable in relation to anticipated benefits. The IRB also approves the form and content of the informed consent that must be signed by each clinical trial subject or his or her legal representative and must monitor the clinical trial until completed.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some clinical trials also include oversight by an independent group of qualified experts organized by the clinical trial sponsor, known as a data safety monitoring board or data monitoring committee. This group may recommend continuation of the trial as planned, changes in trial conduct, or cessation of the trial at designated check points based on certain data from the trial to which only the group has access.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Human clinical trials are typically conducted in three sequential phases that may overlap or be combined:</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Phase&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;&#160;&#160;The drug is initially introduced into healthy human subjects and tested for safety, including adverse effects, dose tolerance, absorption, metabolism, distribution, excretion and pharmacodynamics. In the case of some products for rare diseases, the initial human testing is often conducted in patients.</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Phase&#160;2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;&#160;&#160;The drug is evaluated in a limited patient population to identify possible adverse effects and safety risks, preliminarily evaluate the efficacy of the product for specific targeted diseases, and determine dosage tolerance, optimal dosage, and dosing schedule. Multiple Phase&#160;2 clinical trials may be conducted by the sponsor to obtain information prior to beginning larger and more costly Phase&#160;3 clinical trials.</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Phase&#160;3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;&#160;&#160;Phase&#160;3 clinical trials typically proceed if the Phase&#160;2 clinical trials demonstrate that a dose range of the product candidate is potentially effective and has an acceptable safety profile. Phase&#160;3 clinical trials are generally undertaken within an expanded patient population to further evaluate dosage, provide substantial evidence of clinical efficacy and further test for safety, in a diverse patient population at multiple, geographically dispersed clinical trial sites. A well-controlled, statistically robust Phase&#160;3 trial may be designed to deliver the data that regulatory authorities will use to decide whether or not to approve, and, if approved, how to appropriately label a product candidate.&#160;</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some cases, the FDA may approve an NDA for a product but require the sponsor to conduct additional clinical trials to further assess the product&#8217;s safety and effectiveness after approval. Such post-approval trials are typically referred to as Phase&#160;4 clinical trials. These trials are used to gain additional experience from the treatment of patients in the intended therapeutic indication and to document a clinical benefit for products approved under accelerated approval regulations. The failure to exercise due diligence with regard to conducting Phase&#160;4 clinical trials could result in withdrawal of approval for products.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During all phases of clinical development, the FDA requires extensive monitoring and auditing of all clinical activities, clinical data, and clinical trial investigators. Annual progress reports detailing the results of the clinical trials must be submitted to the FDA. Written IND safety reports must be promptly submitted to the FDA and the investigators for serious and unexpected adverse events, any findings from other studies, tests in laboratory animals or in vitro testing that suggest a significant risk for human subjects, or any clinically important increase in the rate of serious suspected adverse reactions over those listed in the protocol or investigator brochure. The sponsor must submit an IND safety report within 15 calendar days after the sponsor determines that the information qualifies for such reporting. The sponsor also must notify the FDA of any unexpected fatal or life-threatening suspected adverse reaction within 7 calendar days after the sponsor&#8217;s initial receipt of the information. Phase&#160;1, Phase&#160;2, and Phase&#160;3 clinical trials may not be completed successfully within any specified period, if at all. At any time while clinical trials are ongoing under the IND, the FDA may impose a partial or complete clinical hold. Clinical holds may be imposed when there is concern for patient safety, and may be a result of new data, findings, or developments in clinical, nonclinical, and/or chemistry, manufacturing and controls or where there is non-compliance with regulatory requirements. If the FDA imposes a clinical hold, trials may not recommence without FDA authorization and then only under terms authorized by the FDA. Similarly, an IRB can suspend or terminate approval of a clinical trial at its institution if the clinical trial is not being conducted in accordance with the IRB&#8217;s requirements and either the IRB or the data safety monitoring board may suspend a clinical trial at any time on various grounds, including a finding that the research subjects or patients are being exposed to an unacceptable health risk.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the development of a new drug, sponsors are given opportunities to meet with the FDA at certain points. These points may be prior to submission of an IND, at the end of Phase&#160;2, and before an NDA is submitted. Meetings at other times may be requested. These meetings can provide an opportunity for the sponsor to share information about the data gathered to date, for the FDA to provide advice, and for the sponsor and the FDA to reach agreement on the next phase of development.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrent with clinical trials, companies must finalize a process for manufacturing the drug product in commercial quantities in accordance with cGMP requirements. The manufacturing process must be capable of consistently producing quality batches of the product candidate and manufacturers must develop, among other things, methods for testing the identity, strength, quality and purity of the final drug product. Additionally, appropriate packaging must be selected and tested, and stability studies must be conducted to demonstrate that the product candidate does not undergo unacceptable deterioration over its shelf life.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are also various laws and regulations regarding laboratory practices, the experimental use of animals, and the use and disposal of hazardous or potentially hazardous substances in connection with the research. In each of these areas, the FDA and other regulatory authorities have broad regulatory and enforcement powers, including the ability to levy fines and civil penalties, suspend or delay issuance of approvals, seize or recall products, and withdraw approvals.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information about certain clinical trials must be submitted within specific timeframes for public dissemination on the clinicaltrials.gov website. Sponsors or distributors of investigational products for the diagnosis, monitoring, or treatment of one or more serious diseases or conditions must also have a publicly available policy on evaluating and responding to requests for expanded access requests.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A sponsor who wishes to conduct a clinical trial outside of the United States may, but need not, obtain FDA authorization to conduct the clinical trial under an IND. When a foreign clinical trial is conducted under an IND, all FDA IND requirements must be met unless waived. If a foreign clinical trial is not conducted under an IND, FDA will nevertheless accept the results of the study in support of an NDA if the study was conducted in accordance with GCP requirements, and the FDA is able to validate the data through an onsite inspection if deemed necessary. The FDA&#8217;s regulations are intended to help ensure the protection of human subjects enrolled in non-IND foreign clinical trials, as well as the quality and integrity of the resulting data. They further help ensure that non-IND foreign trials are conducted in a manner comparable to that required for clinical trials in the United States.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. Review and Approval Processes</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assuming successful completion of the required clinical testing, the results of the preclinical studies and clinical trials, together with detailed information relating to the product&#8217;s chemistry, manufacture, controls and proposed labeling, among other things, are submitted to the FDA as part of an NDA package requesting approval to market the product for one or more indications. An NDA is a request for approval to market a new drug for one or more specified indications and must contain proof of the drug&#8217;s safety and efficacy for the requested indications. The marketing application is required to include both negative and ambiguous results of preclinical studies and clinical trials, as well as positive findings. Data may come from company-sponsored clinical trials intended to test the safety and efficacy of a product&#8217;s use or from a number of alternative sources, including studies initiated by investigators. To support marketing approval, the data submitted must be sufficient in quality and quantity to establish the safety and efficacy of the investigational product to the satisfaction of the FDA. FDA must generally approve an NDA before a drug may be marketed in the United States.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA reviews all submitted NDAs before it accepts them for filing and may request additional information rather than accepting the NDA for filing. The FDA must make a decision on accepting an NDA for filing within 60&#160;days of receipt, and such decision could include a refusal to file by the FDA. Once the submission is accepted for filing, the FDA begins an in-depth substantive review of the NDA. The FDA reviews an NDA to determine, among other things, whether the drug is safe and effective for the indications sought and whether the facility in which it is manufactured, processed, packaged or held meets standards designed to assure the product&#8217;s continued safety, quality and purity. The FDA likely will reanalyze the clinical trial data, which could result in extensive discussions between the FDA and the applicant during the review process. Under the goals and polices agreed to by the FDA under PDUFA, the FDA targets ten&#160;months, from the filing date, in which to complete its initial review of an NDA and respond to the applicant, and six&#160;months from the filing date of an NDA for priority review. The FDA does not always meet its PDUFA goal dates for standard or priority NDAs, and the review process is often extended by FDA requests for additional information or clarification. Each NDA must be accompanied by a substantial PDUFA user fee, which FDA adjusts on an annual basis. Fee waivers or reductions are available in certain circumstances, including a waiver of the application fee for the first application filed by a small business. Additionally, no user fees are assessed on NDAs for products designated as orphan drugs, unless the product also includes a non-orphan indication.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA may refer an application for a novel drug or drug that presents difficult questions of safety and efficacy to an advisory committee. An advisory committee is a panel of independent experts, including clinicians and other scientific experts, which reviews, evaluates and provides a recommendation as to whether the application should be approved and under what conditions. The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before approving an NDA, the FDA typically will inspect the facility or facilities where the product is manufactured. The FDA will not approve an application unless it determines that the manufacturing processes and facilities are in compliance with cGMP requirements and are adequate to assure consistent production of the product within required specifications. Additionally, before approving an NDA, the FDA may inspect one or more clinical trial sites to assure compliance with GCP and other requirements and the integrity of the clinical data submitted to the FDA.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After evaluating the NDA and all related information, including the advisory committee recommendation, if any, and inspection reports regarding the manufacturing facilities and clinical trial sites, the FDA may issue an approval letter, or, in some cases, a complete response letter. A complete response letter generally contains a statement of specific conditions that must be met in order to secure final approval of the NDA and may require additional clinical or preclinical testing in order for the FDA to reconsider the application. The NDA sponsor will have one year to submit to the FDA </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">information that represents a complete response to the deficiencies described in the letter. The FDA will then re-review the application, taking into consideration the response and determine whether the application meets the criteria for approval. If and when those conditions have been met to the FDA&#8217;s satisfaction, the FDA will typically issue an approval letter. An approval letter authorizes commercial marketing of the drug with specific prescribing information for specific indications.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if the FDA approves a product, it may limit the approved indications for use of the product and require that contraindications, warnings or precautions be included in the product labeling. Additionally, the FDA may require post-approval studies, including Phase&#160;4 clinical trials, to further assess a drug&#8217;s efficacy or safety after approval. The agency may also require testing and surveillance programs to monitor the product after commercialization, or impose other conditions, including distribution restrictions or other risk management mechanisms under a REMS. A REMS can include medication guides, physician communication plans, assessment plans, and/or elements to assure safe use, such as restricted distribution methods, patient registries, or other risk-minimization tools, which can materially affect the potential market and profitability of the product. The FDA may prevent or limit further marketing of a product based on the results of post-marketing studies or surveillance programs. After approval, some types of changes to the approved product, such as adding new indications, manufacturing changes, and additional labeling claims, are subject to further testing requirements and FDA review and approval.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Post-approval Requirements</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maintaining substantial compliance with applicable federal, state, and local statutes and regulations requires the expenditure of substantial time and financial resources. Rigorous and extensive FDA regulation of drugs continues after approval, particularly with respect to cGMP. If we obtain regulatory approval for any of our products, we will be required to comply with all post-approval regulatory requirements as well as any specific post-approval requirements that the FDA have imposed as part of the approval process. We will be required to report certain adverse reactions and production problems to the FDA, provide updated safety and efficacy information, and comply with requirements concerning advertising and promotional labeling requirements and record-keeping requirements. Further, if there are any modifications to the drug, including changes in indications, labeling or manufacturing processes or facilities, we may be required to submit and obtain FDA approval of a new NDA or NDA supplement, which may require the generation of additional data or the conduct of additional preclinical studies and clinical trials. Manufacturers and other parties involved in the drug supply chain for prescription drug products must also comply with product tracking and tracing requirements and for notifying the FDA of counterfeit, diverted, stolen and intentionally adulterated products or products that are otherwise unfit for distribution in the United States.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will rely, and expect to continue to rely, on third parties for the production of clinical and commercial quantities of any products that we may commercialize. Manufacturers of our products are required to comply with applicable requirements in the cGMP regulations, including quality control and quality assurance and maintenance of records and documentation.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturing facilities are required to register their establishments with the FDA and certain state agencies and are subject to periodic inspections by the FDA and certain state agencies for compliance with ongoing regulatory requirements. Failure to comply with statutory and regulatory requirements may result in the issuance of an FDA Form 483 notice of inspectional observations, untitled letter, warning letter, or suspension of manufacturing or other legal or regulatory action, such as product seizures, injunctions, civil penalties or criminal prosecution. Additionally, defects in manufacturing of commercial products can result in product recalls.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Systems need to be put in place to record and evaluate adverse events reported by health care providers and patients and to assess product complaints. Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in revisions to the approved labeling to add new safety information, requirements for post-market studies or clinical trials to assess new safety risks, or imposition of distribution or other restrictions under a REMS. Other potential consequences include, among other things:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">restrictions on the marketing or manufacturing of the product, complete withdrawal of the product from the market or product recalls;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the issuance of safety alerts, Dear Healthcare Provider letters, press releases or other communications containing warnings or other safety information about the product;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fines, warning letters or holds on post-approval clinical trials;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">refusal of the FDA to approve applications or supplements to approved applications, or suspension or revocation of product approvals;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">product seizure or detention, or refusal to permit the import or export of products;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">injunctions or the imposition of civil or criminal penalties; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">consent decrees, corporate integrity agreements, debarment or exclusion from federal healthcare programs; or mandated modification of promotional materials and labeling and issuance of corrective information.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA strictly regulates the marketing, labeling, advertising and promotion of prescription drug products placed on the market. This regulation includes, among other things, standards and regulations for direct-to-consumer advertising, communications regarding unapproved uses, industry-sponsored scientific and educational activities and promotional activities involving the internet and social media. Promotional claims about a drug&#8217;s safety or effectiveness are prohibited before the drug is approved. After approval, a drug product generally may not be promoted for uses or patient populations that are not approved by the FDA, as reflected in the product&#8217;s prescribing information (known as &#8220;off-label&#8221; use). In the United States, healthcare professionals are generally permitted to prescribe drugs for such off-label uses because the FDA does not regulate the practice of medicine. However, FDA regulations impose rigorous restrictions on manufacturers&#8217; communications, prohibiting the promotion of off-label uses. Prescription drug promotional materials must be submitted to the FDA in conjunction with their first use.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a company, including any agent of the company or anyone speaking on behalf of the company, is found to have promoted off-label uses, the company may become subject to adverse public relations and administrative and judicial enforcement by the FDA, the DOJ, or the Office of the Inspector General of the Department of Health and Human Services (&#8220;HHS&#8221;), as well as state authorities. This could subject a company to a range of penalties that could have a significant commercial impact, including civil and criminal fines and agreements that materially restrict the manner in which a company promotes or distributes drug products. The federal government has levied large civil and criminal fines against companies for alleged improper promotion and has also requested that companies enter into consent decrees or permanent injunctions under which specified promotional conduct is changed or curtailed.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Orphan Drug Designation</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Orphan Drug Act, the FDA may grant Orphan Drug Designation (&#8220;ODD&#8221;) to a drug intended to treat a rare disease or condition, which is generally a disease or condition that affects fewer than 200,000 individuals in the United States, or more than 200,000 individuals in the United States and for which there is no reasonable expectation that the cost of developing and making a drug available in the United States for this type of disease or condition will be recovered from sales of the product. ODD must be requested before submitting a marketing application. After the FDA grants ODD, the identity of the therapeutic agent and its potential orphan use are disclosed publicly by the FDA. ODD does not convey any advantage in or shorten the duration of the regulatory review and approval process.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a product that has ODD receives the first FDA approval for the disease or condition for which it has such designation, the product is entitled to orphan product exclusivity, which means that the FDA may not approve any other applications to market the same drug for the same indication for seven&#160;years, except in limited circumstances, such as not being able to supply the product for patients or showing clinical superiority to the product with orphan exclusivity.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competitors, however, may receive approval of different products for the indication for which the orphan product has exclusivity or obtain approval for the same product but for a different indication for which the orphan product has exclusivity. Orphan product exclusivity also could block the approval of one of our products for seven&#160;years if a competitor obtains approval of the same drug as defined by the FDA or if our product candidate is determined to be contained within the competitor&#8217;s product for the same indication or disease. If a drug designated as an orphan product receives marketing approval for an indication broader than what is designated, it may not be entitled to orphan product exclusivity.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has historically taken the position that the scope of orphan exclusivity aligns with the approved indication or use of a product, rather than the disease or condition for which the product received orphan designation. However, in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Catalyst Pharms., Inc. v. Becerra</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 14 F.4th 1299 (11th Cir. 2021), the court disagreed with this position, holding that orphan-drug exclusivity blocked the FDA&#8217;s approval of the same drug for all uses or indications within the same orphan-designated disease. On January&#160;24, 2023, the FDA published a notice in the Federal Register to clarify that the FDA intends to continue to apply its longstanding interpretation of the regulations to all matters outside of the scope of the&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Catalyst</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;order and will continue tying the scope of orphan-drug exclusivity to the uses or indications for which a drug is approved. It is unclear how future litigation, legislation, agency decisions, and administrative actions will impact the scope of the orphan drug exclusivity.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rare Pediatric Disease Priority Review Voucher Program</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Rare Pediatric Disease Priority Review Voucher program, the FDA may award a priority review voucher to the sponsor of an approved marketing application for a drug that is for the prevention or treatment of a rare pediatric disease. The sponsor can use the voucher to obtain priority review for a subsequent human drug or biologic application. The sponsor can also transfer or sell the voucher to another company.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To be eligible for a rare pediatric disease priority review voucher, the NDA must be for a drug that prevents or treats a &#8220;rare pediatric disease&#8221; defined to mean a serious or life-threatening disease in which the serious or life-threatening manifestations primarily affect individuals aged from birth to 18 years and the disease affects fewer than 200,000 individuals in the United States, or affects 200,000 or more individuals in the United States but for which there is no reasonable expectation that the cost of developing the drug will be recovered from sales of the drug in the United States. Additionally, the NDA must be deemed eligible for priority review, rely on clinical data derived from studies examining a pediatric population and dosages of the drug intended for that population, not seek approval for a different adult indication in the original rare pediatric disease product application and be for a drug that does not include a previously approved active ingredient. A sponsor may request rare pediatric disease designation from the FDA prior to the submission of the NDA; however rare pediatric disease designation does not guarantee that a sponsor will receive a priority review voucher upon approval of the NDA.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Rare Pediatric Disease Priority Review Voucher program was originally set to expire in October 2020 but was extended for an additional six years. Under the current statutory sunset provisions, the FDA may only award a rare pediatric disease priority review voucher if a sponsor has received rare pediatric disease designation for the drug before December 20, 2024, and the NDA for the product is approved before September 30, 2026. After September 30, 2026, the FDA may not award any rare pediatric disease priority review vouchers, unless the program is extended.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expedited Review and Approval Programs</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has various programs, including Fast Track designation, priority review, accelerated approval, and breakthrough therapy designation, that are intended to expedite or simplify the process for the development and FDA review of drugs that are intended for the treatment of serious or life-threatening diseases or conditions and demonstrate the potential to address unmet medical needs. The purpose of these programs is to provide important new drugs to patients earlier than under standard FDA review procedures. To be eligible for a Fast Track designation, the FDA must determine, based on the request of a sponsor, that a drug is intended to treat a serious or life-threatening disease or condition and demonstrates the potential to address an unmet medical need. The FDA will determine that a product will fill an unmet medical need if it will provide a therapy where none exists or provide a therapy that may be potentially superior to existing therapy based on efficacy or safety factors. In addition to other benefits, such as the ability to have greater interactions with the FDA, the FDA may initiate review of sections of a Fast Track BLA before the application is complete, a process known as rolling review.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA may give a priority review designation, such as a rare pediatric disease designation, to drugs that treat a serious condition and, if approved, would provide a significant improvement in safety or effectiveness. A priority review means that the goal for the FDA to review an application is six&#160;months, rather than the standard review of ten&#160;months under current PDUFA guidelines. Most products that are eligible for Fast Track designation may also be considered appropriate to receive a priority review. In addition, drugs studied for their safety and effectiveness in treating serious or life-threatening illnesses and that provide meaningful therapeutic benefit over existing treatments may receive accelerated approval and may be approved on the basis of adequate and well-controlled clinical trials establishing that the drug has an effect on a surrogate endpoint that is reasonably likely to predict clinical benefit, or on a clinical endpoint that can be measured earlier than irreversible morbidity or mortality, that is reasonably likely to predict an effect on irreversible morbidity or mortality or other clinical benefit, taking into account the severity, rarity, or prevalence of the condition and the availability or lack of alternative treatments. As a condition of approval, the FDA may require a sponsor of a drug receiving accelerated approval to perform adequate and well-controlled post-marketing studies to verify and describe the predicted effect on irreversible morbidity or mortality or other clinical endpoint. Under the Food and Drug Omnibus Reform Act of 2022 (&#8220;FDORA&#8221;), the FDA may require, as appropriate, that such trials be underway prior to approval or within a specific time period after the date of approval for a product granted accelerated approval. Under FDORA, the FDA has increased authority for expedited procedures to withdraw approval of a drug or indication approved under accelerated approval if, for example, the confirmatory trial fails to verify the predicted clinical benefit of the product. In addition, for products being considered for accelerated approval, the FDA generally requires, unless otherwise informed by the agency, that all advertising and promotional materials intended for dissemination or publication within 120&#160;days of marketing approval be submitted to the agency for review during the pre-approval review period.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, a sponsor can request designation of a product candidate as a &#8220;breakthrough therapy.&#8221; A breakthrough therapy is defined as a drug that is intended, alone or in combination with one or more other drugs, to treat a serious or life-threatening disease or condition, and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. Drugs designated as breakthrough therapies are also eligible for accelerated approval. The FDA must take certain actions, such as holding timely meetings and providing advice, intended to expedite the development and review of an application for approval of a breakthrough therapy.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if a product qualifies for one or more of these programs, the FDA may later decide that the product no longer meets the conditions for qualification or decides that the time period for FDA review or approval will not be shortened. Furthermore, fast-track designation, priority review, accelerated approval, and breakthrough therapy designation do not change the standards for approval and may not ultimately expedite the development or approval process.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pediatric Information and Pediatric Exclusivity</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pediatric Research Equity Act (&#8220;PREA&#8221;) requires a sponsor to conduct pediatric clinical trials for most drugs, for a new active ingredient, new indication, new dosage form, new dosing regimen or new route of administration. Under PREA, as amended, certain NDAs and NDA supplements must contain data that can be used to assess the safety and efficacy of the drug for the claimed indications in all relevant pediatric subpopulations and to support dosing and administration for each pediatric subpopulation for which the product is safe and effective. The FDA may grant deferrals for submission of pediatric data or full or partial waivers. The FDCA requires that a sponsor who is planning to submit a marketing application for a drug that includes a new active ingredient, new indication, new dosage form, new dosing regimen or new route of administration submit an initial Pediatric Study Plan (&#8220;PSP&#8221;) within 60&#160;days of an end-of-Phase&#160;2 meeting or, if there is no such meeting, as early as practicable before the initiation of the Phase&#160;3 or Phase&#160;2/3 study. The initial PSP must include an outline of the pediatric study or studies that the sponsor plans to conduct, including study objectives and design, age groups, relevant endpoints and statistical approach, or a justification for not including such detailed information, and any deferral or waiver requests. The FDA and the sponsor must reach an agreement on the PSP. A sponsor can submit amendments to an agreed-upon initial PSP at any time if changes to the pediatric plan need to be considered based on data collected from preclinical studies, early phase clinical trials and/or other clinical development programs.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The FDA may, on its own initiative or at the request of the applicant, grant deferrals for submission of some or all pediatric data until after approval of the product for use in adults, or full or partial waivers from the pediatric data requirements. Unless otherwise required by regulation, the pediatric data requirements do not apply to products with orphan designation. The FDA is required to send a PREA non-compliance letter to sponsors who have failed to submit pediatric assessments required under PREA, seek or obtain a deferral or deferral extension, or request approval for a required pediatric formulation. The FDA publicly posts such PREA non-compliance letters as well as the sponsor&#8217;s response. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A drug can also obtain pediatric market exclusivity in the U.S. Pediatric exclusivity, if granted, adds six&#160;months to existing marketing exclusivity periods and patent terms. This six-month exclusivity, which runs from the end of other exclusivity protection or patent term, may be granted based on the voluntary completion of a pediatric study in accordance with an FDA-issued &#8220;Written Request&#8221; for such a study.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marketing Exclusivity</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Market exclusivity provisions authorized under the FDCA can delay the submission or the approval of certain marketing applications. The FDCA provides a five-year period of non-patent marketing exclusivity within the United States to the first applicant to obtain approval of an NDA for a new chemical entity. A drug is a new chemical entity if the FDA has not previously approved any other new drug containing the same active moiety, which is the molecule or ion responsible for the action of the drug substance. During the exclusivity period, the FDA may not approve or even accept for review an abbreviated new drug application (&#8220;ANDA&#8221;), or an NDA submitted under Section&#160;505(b)(2), or 505(b)(2) NDA, submitted by another company for another drug based on the same active moiety, regardless of whether the drug is intended for the same indication as the original innovative drug or for another indication, where the applicant does not own or have a legal right of reference to all of the data required for approval. However, an application may be submitted after four&#160;years if it contains a certification of patent invalidity or non-infringement to one of the patents listed with the FDA by the innovator NDA holder.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDCA alternatively provides three&#160;years of marketing exclusivity for an NDA, or supplement to an existing NDA if new clinical investigations, other than bioavailability studies, that were conducted or sponsored by the applicant </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are deemed by the FDA to be essential to the approval of the application, for example new indications, dosages or strengths of an existing drug. This three-year exclusivity covers only the modification for which the drug received approval on the basis of the new clinical investigations and does not prohibit the FDA from approving ANDAs or 505(b)(2) NDAs for drugs containing the active agent for the original indication or condition of use. Five-year and three-year exclusivity will not delay the submission or approval of a full NDA. However, an applicant submitting a full NDA would be required to conduct or obtain a right of reference to any preclinical studies and adequate and well-controlled clinical trials necessary to demonstrate safety and effectiveness.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, pediatric exclusivity and orphan drug exclusivity, as described above, may offer a six-month or seven-year period of exclusivity, respectively, except in certain circumstances.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patent Term Restoration and Extension</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending upon the timing, duration and specifics of FDA approval of our product candidates, some of a sponsor&#8217;s U.S. patents may be eligible for limited patent term extension (&#8220;PTE&#8221;) under the Hatch-Waxman Amendments. As compensation for patent term lost during product development and the FDA regulatory review process, the Hatch-Waxman Amendments permit a patent restoration term, which is limited to a maximum of five&#160;years, or less if the extended patent term would exceed 14&#160;years after the date of the regulatory approval of the product. The patent term restoration period is generally one-half the time between the effective date of an IND and the submission date of an NDA plus the time between the submission date of an NDA, less any time the sponsor did not act with due diligence during the period and the approval of that application less any time the sponsor did not act with due diligence during the period. Only one patent applicable to an approved drug or drug product is eligible for the extension, only those claims covering the approved drug, a method for using it, or a method for manufacturing it may be extended, and the application for the extension must be submitted prior to the expiration of the patent. Moreover, a given patent may only extended once based on a single product. The USPTO, in consultation with the FDA, reviews and approves the application for any patent term extension or restoration. Similar provisions are available in Europe and other foreign jurisdictions to extend the term of a patent that covers an approved drug. In the future, we may intend to apply for restoration of a patent term for one of our currently owned or licensed patents to add patent life beyond its current expiration date, depending on the expected length of the clinical trials and other factors involved in the filing of the relevant NDA. However, we may not receive an extension if we fail to exercise due diligence during the testing phase or regulatory review process, fail to apply within applicable deadlines, fail to apply prior to expiration of relevant patents or otherwise fail to satisfy applicable requirements. Moreover, the length of the extension could be less than we request. There can be no assurance that we will benefit from any PTE or favorable adjustment to the term of any of our patents.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Regulation Outside of the United States</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to regulations in the United States, we are subject to a variety of regulations in other jurisdictions governing clinical studies, commercial sales, and distribution of our products. Most countries outside of the United States require that clinical trial applications be submitted to and approved by the local regulatory authority for each clinical study.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Regulation in the European Union</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the European Union an application must be submitted to the national competent authority and an independent ethics committee in each country in which we intend to conduct clinical trials, much like the FDA and IRB, respectively. Under the new Clinical Trials Regulation (EU) No 536/2014, which replaced the Clinical Trials Directive 2001/20/EC on January&#160;31, 2022, a single application is now made through the Clinical Trials Information System (&#8220;CTIS&#8221;) for clinical trial authorization in up to 30 EU/EEA countries at the same time and with a single set of documentation.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assessment of applications for clinical trials is divided into two parts (Part&#160;I contains scientific and medicinal product documentation and Part&#160;II contains the national and patient-level documentation). Part&#160;I is assessed by a coordinated review by the competent authorities of all European Union Member States in which an application for authorization of a clinical trial has been submitted (Member States concerned) of a draft report prepared by a Reference Member State. Part&#160;II is assessed separately by each Member State concerned. The role of the relevant ethics committees in the assessment procedure will continue to be governed by the national law of the Member State concerned, however overall related timelines are defined by the Clinical Trials Regulation. The new Clinical Trials Regulation also provides for simplified reporting procedures for clinical trial sponsors.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, whether or not we obtain FDA approval for a product, we must obtain approval of a product by the comparable regulatory authorities of countries outside the United States before we can commence marketing of the product in those countries. The approval process and requirements vary from country to country, so the number and type of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nonclinical, clinical, and manufacturing studies needed may differ, and the time may be longer or shorter than that required for FDA approval.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To obtain regulatory approval of our medicinal products under the European Union regulatory system, we are required to submit a marketing authorization application (&#8220;MAA&#8221;) to be assessed in the centralized procedure. The centralized procedure allows applicants to obtain a marketing authorization (&#8220;MA&#8221;) that is valid throughout the European Union, and the additional Member States of the European Economic Area (Iceland, Liechtenstein and Norway) (&#8220;EEA&#8221;). It is compulsory for medicinal products manufactured using biotechnological processes, orphan medicinal products, advanced therapy medicinal products (gene-therapy, somatic cell-therapy or tissue-engineered medicines) and human products containing a new active substance which is not authorized in the European Union and which is intended for the treatment of HIV, AIDS, cancer, neurodegenerative disorders, auto-immune and other immune dysfunctions, viral diseases or diabetes. The centralized procedure is optional for any other products containing new active substances not authorized in the European Union or for products which constitute a significant therapeutic, scientific, or technical innovation or for which a centralized authorization is in the interests of patients at European Union level. When a company wishes to place on the market a medicinal product that is eligible for the centralized procedure, it sends an application directly to the EMA, to be assessed by the Committee for Medicinal Products for Human Use (&#8220;CHMP&#8221;). The CHMP is responsible for conducting the assessment of whether a medicine meets the required quality, safety, and efficacy requirements, and whether the product has a positive risk/benefit profile. The procedure results in a European Commission decision, which is valid in all European Union Member States. The centralized procedure is as follows: full copies of the MAA are sent to a rapporteur and a co-rapporteur designated by the competent EMA scientific committee. They coordinate the EMA&#8217;s scientific assessment of the medicinal product and prepare draft reports. Once the draft reports are prepared (other experts might be called upon for this purpose), they are sent to the CHMP, whose comments or objections are communicated to the applicant. The rapporteur is therefore the privileged interlocutor of the applicant and continues to play this role, even after the MA has been granted.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rapporteur and co-rapporteur then assess the applicant&#8217;s replies, submit them for discussion to the CHMP, and taking into account the conclusions of this debate, prepare a final assessment report. Once the evaluation is completed, the CHMP gives a favorable or unfavorable opinion as to whether to grant the authorization. When the opinion is favorable, it shall include the draft summary of product characteristics (&#8220;SmPC&#8221;), the package leaflet, and the texts proposed for the various packaging materials. The time limit for the evaluation procedure is 210&#160;days (excluding clock stops, when additional written or oral information is to be provided by the applicant in response to questions asked by the CHMP). The EMA then has 15 days to forward its opinion to the European Commission, which will make a binding decision on the grant of an MA within 67&#160;days of the receipt of the CHMP opinion.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are two other procedures in the European Union for the grant of an MA in multiple European Union Member States. The decentralized procedure provides for approval by one or more other (&#8220;Concerned Member States&#8221;) of an assessment of an application performed by one Member State, known as the Reference Member State. Under this procedure, an applicant submits an application, or dossier, and related materials including a draft SmPC, and draft labeling and package leaflet, to the Reference Member State and Concerned Member States. The Reference Member State prepares a draft assessment and drafts of the related materials within 120&#160;days after receipt of a valid application. Within 90&#160;days of receiving the Reference Member State&#8217;s assessment report, each Concerned Member State must decide whether to approve the assessment report and related materials. If a Member State cannot approve the assessment report and related materials on the grounds of potential serious risk to the public health, the disputed points may eventually be referred to the European Commission, whose decision is binding on all Member States. Where a product has already been authorized for marketing in a European Union Member State, this national MA can be recognized in other Member States through the mutual recognition procedure.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The criteria for designating an &#8220;orphan medicinal product&#8221; in the European Union are similar in principle to those in the United States. Under Article&#160;3 of Regulation (EC) 141/2000, a medicinal product may be designated as an orphan medicinal product if it is intended for the diagnosis, prevention, or treatment of a life-threatening or chronically debilitating condition that affects no more than five in 10,000 persons in the European Union when the application is made. In addition, orphan designation can be granted if the product is intended for a life threatening, seriously debilitating, or serious and chronic condition in the European Union and, without incentives, it is unlikely that sales of the product in the European Union would be sufficient to justify the necessary investment in its development. Orphan designation is only available if there is no other satisfactory method approved in the European Union of diagnosing, preventing, or treating the applicable orphan condition, or if such a method exists, the proposed orphan medicinal product will be of significant benefit to patients affected by such condition, as defined in Regulation (EC) 847/2000.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Orphan designation provides opportunities for fee reductions, protocol assistance, and access to the centralized procedure. Fee reductions are limited to the first year after an MA, except for small and medium enterprises. In addition, if </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a product which has an orphan designation subsequently receives a centralized MA for the indication for which it has such designation, the product is entitled to orphan market exclusivity, which means the EMA may not approve any other application to market a similar medicinal product for the same indication for a period of ten&#160;years. A &#8220;similar medicinal product&#8221; is defined as a medicinal product containing a similar active substance or substances as contained in an authorized orphan medicinal product, and which is intended for the same therapeutic indication. The exclusivity period may be reduced to six&#160;years if, at the end of the fifth year, it is shown that the designation criteria are no longer met, including where it is shown that the product is sufficiently profitable not to justify maintenance of market exclusivity. Additionally, an MA may be granted to a similar medicinal product for the same indication at any time if:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the second applicant can establish that its product, although similar to the authorized product, is safer, more effective or otherwise clinically superior;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the MA holder of the authorized product consents to a second orphan medicinal product application; or</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the MA holder of the authorized product cannot supply enough orphan medicinal product.</span></div><div style="margin-bottom:8pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A pediatric investigation plan (&#8220;PIP&#8221;) in the European Union is aimed at ensuring that the necessary data are obtained to support the authorization of a medicine for children, through studies in children. All applications for MAs for new medicines have to include the results of studies as described in an agreed PIP, unless the medicine is exempt because of a deferral or waiver. This requirement also applies when an MA holder wants to add a new indication, pharmaceutical form, or route of administration for a medicine that is already authorized and covered by intellectual property rights. Several rewards and incentives for the development of pediatric medicines for children are available in the European Union. Medicines authorized across the European Union with the results of studies from a PIP included in the product information are eligible for an extension of their supplementary protection certificate (&#8220;SPC&#8221;) by six&#160;months (provided an application for such extension is made at the same time as filing the SPC application for the product, or at any point up to two&#160;years before the SPC expires). This is the case even when the studies&#8217; results are negative. For orphan medicinal products, the incentive is an additional two&#160;years of market exclusivity. Scientific advice and protocol assistance at the EMA are free of charge for questions relating to the development of pediatric medicines. Medicines developed specifically for children that are already authorized but are not protected by a patent or supplementary protection certificate are eligible for a pediatric-use MA (&#8220;PUMA&#8221;). If a PUMA is granted, the product will benefit from ten&#160;years of market protection as an incentive.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March&#160;2016, the EMA launched an initiative, the PRIority Medicines (&#8220;PRIME&#8221;), scheme, to facilitate development of product candidates in indications, often rare, for which few or no therapies currently exist. The PRIME scheme is intended to encourage development of products in areas of unmet medical need and provides accelerated assessment of products representing substantial innovation reviewed under the centralized procedure. Products from small- and medium-sized enterprises may qualify for earlier entry into the PRIME scheme than larger companies on the basis of compelling non-clinical data and tolerability data from initial clinical trials. Many benefits accrue to sponsors of product candidates with PRIME designation, including but not limited to, early and proactive regulatory dialogue with the EMA, frequent discussions on clinical trial designs and other development program elements, and potentially accelerated MAA assessment once a dossier has been submitted. Importantly, once a candidate medicine has been selected for the PRIME scheme, a dedicated contact and rapporteur from the CHMP or from the Committee for Advanced Therapies (&#8220;CAT&#8221;), are appointed early in the PRIME scheme facilitating increased understanding of the product at EMA&#8217;s committee level. An initial meeting with the CHMP/CAT rapporteur initiates these relationships and includes a team of multidisciplinary experts at the EMA to provide guidance on the overall development and regulatory strategies. PRIME eligibility does not change the standards for product approval, and there is no assurance that any such designation or eligibility will result in expedited review or approval.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aforementioned European Union rules are generally applicable in the EEA. The United Kingdom left the European Union on January&#160;31, 2020, and the United Kingdom and the European Union have concluded a trade and cooperation agreement (&#8220;TCA&#8221;), which was provisionally applicable since January&#160;1, 2021 and has been formally applicable since May&#160;1, 2021.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The TCA includes specific provisions concerning pharmaceuticals, which include the mutual recognition of GMP, inspections of manufacturing facilities for medicinal products and GMP documents issued, but does not provide for wholesale mutual recognition of United Kingdom and European Union pharmaceutical regulations. At present, Great Britain has implemented European Union legislation on the marketing, promotion and sale of medicinal products through the Human Medicines Regulations&#160;2012 (as amended). Except in respect of the new European Union Clinical Trials Regulation, the regulatory regime in Great Britain therefore largely aligns with current European Union medicines regulations, however it is possible that these regimes will diverge more significantly in future now that Great Britain&#8217;s regulatory system is independent from the European Union and the TCA does not provide for mutual recognition of United </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kingdom and European Union pharmaceutical legislation. However, notwithstanding that there is no wholesale recognition of European Union pharmaceutical legislation under the TCA, under a new framework mentioned below which will be put in place by the Medicines and Healthcare products Regulatory Agency (&#8220;MHRA&#8221;), the United Kingdom&#8217;s medicines regulator, from January&#160;1, 2024, the MHRA has stated that it will take into account decisions on the approval of MAs from the EMA (and certain other regulators) when considering an application for a Great Britain MA.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;27, 2023, the United Kingdom government and the European Commission announced a political agreement in principle to replace the Northern Ireland Protocol with a new set of arrangements, known as the &#8220;Windsor Framework.&#8221; This new framework fundamentally changes the existing system under the Northern Ireland Protocol, including with respect to the regulation of medicinal products in the United Kingdom. In particular, the MHRA will be responsible for approving all medicinal products destined for the United Kingdom market (i.e., Great Britain and Northern Ireland), and the EMA will no longer have any role in approving medicinal products destined for Northern Ireland. A single United Kingdom-wide MA will be granted by the MHRA for all medicinal products to be sold in the United Kingdom, enabling products to be sold in a single pack and under a single authorization throughout the United Kingdom. The Windsor Framework was approved by the European Union-United Kingdom Joint Committee on March&#160;24, 2023, so the United Kingdom government and the European Union will enact legislative measures to bring it into law.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The MHRA has introduced changes to national licensing procedures, including procedures to prioritize access to new medicines that will benefit patients, an accelerated assessment procedure and new routes of evaluation for novel products and biotechnological products. All existing European Union MAs for centrally authorized products were automatically converted (grandfathered) into United Kingdom MAs free of charge on January&#160;1, 2021. For a period of three&#160;years from January&#160;1, 2021, the MHRA may rely on a decision taken by the European Commission on the approval of a new MA in the centralized procedure, in order to more quickly grant a new Great Britain MA. A separate application will, however, still be required. On January&#160;24, 2023, the MHRA announced that a new international recognition framework will be put in place from January&#160;1, 2024, which will have regard to decisions on the approval of MAs made by the EMA and certain other regulators when determining an application for a new Great Britain MA.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is now no pre-MA orphan designation in Great Britain. Instead, the MHRA reviews applications for orphan designation in parallel to the corresponding MAA. The criteria are essentially the same, but have been tailored for the Great Britain market, i.e., the prevalence of the condition in Great Britain (rather than the European Union) must not be more than five in 10,000. Should an orphan designation be granted, the period or market exclusivity will be set from the date of first approval of the product in Great Britain or the European Union, wherever is earliest.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Regulation in Australia</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Phase&#160;1 clinical trial for CMP-CPS-001 is being conducted in Australia. The Therapeutic Goods Administration (&#8220;TGA&#8221;) and the National Health and Medical Research Council (&#8220;NHMRC&#8221;) set the GCP requirements for clinical research in Australia.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compliance with the regulations, standards and codes set by the TGA and NHMRC is mandatory. Under the&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Therapeutic Goods Act 1989</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;(Cth) and the&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Therapeutic Goods Regulations&#160;1990</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;(Cth), it is a condition (amongst other conditions) of all clinical trials involving investigational medicinal products to comply with the National Statement on Ethical Conduct in Research Involving Humans, published by the NHMRC (the National Statement), and the Guideline for Good Clinical Practice published by the International Council for Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (&#8220;ICH Guidelines&#8221;). The ICH Guidelines have been adopted in Australia, and must be complied with across all fields of clinical research involving therapeutic goods, including those related to pharmaceutical quality, nonclinical and clinical data requirements and trial designs. The basic requirements for preclinical data to support a first-in-human trial under ICH Guidelines are applicable in Australia. Requirements related to adverse event reporting in Australia are generally similar to those required in other major jurisdictions, although reporting timeframes may differ to other jurisdictions.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical trials conducted using &#8220;unapproved therapeutic goods&#8221; in Australia, being those which have not yet been evaluated by the TGA for quality, safety and efficacy (and including unapproved indications of therapeutic goods which have otherwise been approved for use in Australia) must occur pursuant to either the Clinical Trial Notification Scheme (&#8220;CTN Scheme&#8221;) or the Clinical Trial Approval Scheme (&#8220;CTA Scheme&#8221;). In each case, the trial is supervised by a Human Research Ethics Committee (&#8220;HREC&#8221;), an independent review committee constituted in accordance with the National Statement that ensures the protection of rights, safety and well-being of human subjects involved in a clinical trial. A HREC reviews, approves and provides continuing oversight of trial protocols (including any amendments), methods and materials intended to be used in obtaining and documenting informed consent of the clinical trial subjects.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CTN Scheme broadly involves:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">submission to a HREC, of all material relating to the proposed clinical trial, including the trial protocol;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the HREC reviews the scientific validity of the trial design, the balance of risk versus harm of the therapeutic good, the ethical acceptability of the trial process, and approves the trial protocol. The HREC is also responsible for monitoring the conduct of the trial;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the institution or organization at which the trial will be conducted, referred to as the &#8220;Approving Authority,&#8221; giving final approval for the conduct of the trial at the site, in terms no less restrictive to those advised by the HREC; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the investigator submitting a &#8216;Notification of Intent to Conduct a Clinical Trial&#8217; form (&#8220;CTN Form&#8221;) to the TGA. The CTN form must be signed by the sponsor, the principal investigator, the chairman of the HREC and a person responsible from the Approving Authority. The TGA does not review any data relating to the clinical trial however CTN trials cannot commence until the trial has been notified to the TGA.</span></div><div style="margin-bottom:6pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under the CTA Scheme:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a sponsor submits an application to conduct a clinical trial to the TGA for evaluation and comment;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a sponsor must forward any comments made by the TGA Delegate to the HREC(s) at the sites where the trial will be conducted;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the HREC is responsible for considering the scientific and ethical issues of the proposed trial protocol.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A sponsor cannot commence a trial under the CTA Scheme until written advice has been received from the TGA regarding the application and approval for the conduct of the trial has been obtained from an ethics committee and the institution at which the trial will be conducted.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approval for inclusion in the Australian Register of Therapeutic Goods (&#8220;ARTG&#8221;), is required before a therapeutic good (including pharmaceutical product) may be marketed (or supplied, imported, exported or manufactured) in Australia. Exceptions apply to therapeutic goods/pharmaceutical products that are supplied, imported, and exported to and from Australia for the purposes of a clinical trial, on the basis that certain conditions are met (e.g., the trial is conducted in accordance with the CTN or CTA scheme).</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once a sponsor decides to register a therapeutic good/pharmaceutical product in Australia, in order to obtain registration of the product on the ARTG, it is required that (amongst others):</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the sponsor submits appropriate documentation, including the outcomes of clinical trials and studies, to allow the TGA to assess the quality, safety and efficacy of the therapeutic product/pharmaceutical product; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the sponsor submits evidence which demonstrates that the manufacture of the therapeutic product/pharmaceutical product complies with the applicable GMP requirements.</span></div><div style="margin-bottom:12pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The TGA has the ultimate discretion to decide whether to include the therapeutic product/pharmaceutical product in the ARTG.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Healthcare Laws and Regulations in the United States</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of our product candidates, if approved, or any other future product candidate, will be subject to healthcare regulation and enforcement by the federal government and the states and foreign governments in which we might conduct our business. The healthcare laws and regulations that may affect our ability to operate include the following:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The federal Anti-Kickback Statute (&#8220;AKS&#8221;), which makes it illegal for any person or entity to knowingly and willfully, directly or indirectly, solicit, receive, offer, or pay any remuneration that is in exchange for or to induce the referral of business, including the purchase, order, lease of any good, facility, item or service for which payment may be made, in whole or in part, under a federal healthcare program, such as Medicare or Medicaid. The term &#8220;remuneration&#8221; has been broadly interpreted to include anything of value. Liability may be established without proving actual knowledge of the statute or specific intent to violate it;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Federal false claims, and false statement laws, including the federal civil False Claims Act (&#8220;FCA&#8221;), which prohibits, among other things, any person or entity from knowingly presenting, or causing to be presented, for payment to, or approval by, federal programs, including Medicare and Medicaid, claims for items or services, including drugs and biologics, that are false or fraudulent. Manufacturers can be held liable under the FCA even when they do not submit claims directly to government payors if they are deemed to &#8220;cause&#8221; the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:6pt;padding-left:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">submission of false or fraudulent claims; the FCA also permits a private individual acting as whistleblower to bring actions on behalf of the federal government alleging violations of the FCA and to share in any monetary recovery;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Civil Monetary Penalties Law, which covers a variety of conduct, often violations under other laws, and includes penalties for violating the AKS violations, causing the submission of false claims, and offering or transfer of remuneration to a Medicare or state healthcare program beneficiary if the person knows or should know it is likely to influence the beneficiary&#8217;s selection of a particular provider, practitioner, or supplier of services reimbursable by Medicare or a state healthcare program;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;), as amended by the Health Information Technology for Economic and Clinical Health Act of 2009 and their implementing regulations, imposes criminal and civil liability for knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program, including private third-party payors or making any false, fictitious or fraudulent statement in connection with the delivery of or payment for healthcare benefits, items or services;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">HIPAA also imposes obligations related to the privacy, security, and transmission of individually identifiable health information that apply to many healthcare providers, physicians, and third-party payors with whom we interact;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Federal consumer protection and unfair competition laws broadly regulate marketplace activities and activities that potentially harm consumers;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Federal government price reporting laws, which require pharmaceutical manufacturers to report certain calculated product prices to the government or provide certain discounts or rebates to government authorities or private entities, often as a condition of reimbursement under governmental healthcare programs;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The federal Physician Payments Sunshine Act which requires certain manufacturers of drugs, devices, biologics and medical supplies for which payment is available under Medicare, Medicaid or the Children&#8217;s Health Insurance Program, with specific exceptions, to report annually to the Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) information related to payments or other transfers of value made to &#8220;physicians&#8221; (which has the same meaning as under Section&#160;1861(r) of the Social Security Act, which generally includes doctors of medicine, osteopathy, dentists, podiatrists, optometrists and chiropractors who are legally authorized to practice by a state) and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members. Beginning in 2022, applicable manufacturers are also required to report such information regarding payments and transfers of value provided during the previous year to physician assistants, nurse practitioners, clinical nurse specialists, anesthesiologist assistants, certified nurse anesthetists and certified nurse-midwives; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Foreign Corrupt Practices Act (&#8220;FCPA&#8221;), which prohibits U.S. businesses and their representatives from offering to pay, paying, promising to pay or authorizing the payment of money or anything of value to a foreign official in order to influence any act or decision of the foreign official in his or her official capacity or to secure any other improper advantage in order to obtain or retain business. The scope of the FCPA includes interactions with certain healthcare professionals in many countries.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many states have similar laws and regulations, such as anti-kickback and false claims laws, that may be broader in scope and may apply regardless of payor, in addition to items and services reimbursed under Medicaid and other state programs. Additionally, we may be subject to state laws that require pharmaceutical companies to comply with the federal government&#8217;s and/or pharmaceutical industry&#8217;s voluntary compliance guidelines, state laws that require drug and biologics manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers or marketing expenditures, as well as state and foreign laws governing the privacy and security of health information, many of which differ from each other in significant ways and often are not preempted by HIPAA. The scope and enforcement of each of these laws is uncertain and subject to rapid change in the current environment of healthcare reform. Additionally, to the extent that our product is sold in a foreign country, we may be subject to similar foreign laws.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the breadth of these laws and the narrowness of the statutory exceptions and safe harbors available, it is possible that some of our business activities could be subject to challenge under one or more of such laws in the future. If our operations are found to be in violation of any of such laws or any other governmental regulations that apply to us, we may be subject to, on a corporate or individual basis, penalties, including civil and criminal penalties, damages, fines, the curtailment or restructuring of our operations, the exclusion from participation in federal and state healthcare programs and even imprisonment, any of which could materially adversely affect our ability to operate our business and our financial results. In addition, the cost of implementing sufficient systems, controls, and processes to ensure compliance with all of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the aforementioned laws could be significant. Any action for violation of these laws, even if successfully defended, could cause us to incur significant legal expenses and divert management&#8217;s attention from the operation of the company&#8217;s business. If any of the physicians or other healthcare providers or entities with whom we expect to do business is found not to be in compliance with applicable laws, that person or entity may be subject to criminal, civil or administrative sanctions, including exclusions from government funded healthcare programs.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is not always possible to identify and deter employee misconduct, and the precautions we take to detect and prevent inappropriate conduct may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws or regulations. Efforts to ensure that our business arrangements will comply with applicable healthcare laws may involve substantial costs. It is possible that governmental and enforcement authorities will conclude that our business practices may not comply with current or future statutes, regulations or case law interpreting applicable fraud and abuse or other healthcare laws and regulations. If any such actions are instituted against us and we are not successful in defending ourselves or asserting our rights those actions, our business may be impaired.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmaceutical Coverage, Pricing and Reimbursement</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant uncertainty exists as to the coverage and reimbursement status of any product candidates for which we obtain regulatory approval. In the United States and foreign markets, sales of any products for which we receive regulatory approval for commercial sale will depend, in part, on the extent to which third-party payors provide coverage, and establish adequate reimbursement levels for such drug products. In the United States, third-party payors include federal and state healthcare programs, private managed care organizations, private health insurers and other organizations.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, no uniform policy of coverage and reimbursement for products exists among third-party payors. One payor&#8217;s determination to provide coverage for a drug product does not assure that other payors will also provide coverage for the drug product. Third-party payors are increasingly challenging the price, examining the medical necessity and reviewing the cost-effectiveness of medical drug products and medical services, in addition to questioning their safety and efficacy. As a result, obtaining coverage and reimbursement approval of a product from these payors can be a time-consuming and costly process that could require us to provide each payor supporting scientific, supporting scientific, clinical and cost-effectiveness data for the use of our products on a payor-by-payor basis, with no assurance that coverage and adequate reimbursement will be obtained. We may need to conduct expensive pharmaco-economic studies in order to demonstrate the medical necessity and cost-effectiveness of our products, in addition to the costs required to obtain the FDA approvals. Nonetheless, our product candidates may not be considered medically necessary or cost-effective. In the United States, the principal decisions about reimbursement for new medicines are typically made by CMS. CMS decides whether and to what extent a new medicine will be covered and reimbursed under Medicare and private payors tend to follow CMS to a substantial degree. Such payors may limit coverage to specific drug products on an approved list, also known as a formulary, which might not include all of the FDA-approved drugs for a particular indication.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, the process for determining whether a third-party payor will provide coverage for a drug product may be separate from the process for setting the price of a drug product or for establishing the reimbursement rate that such a payor will pay for the drug product. A payor&#8217;s decision to provide coverage for a drug product does not imply that an adequate reimbursement rate will be approved. Even if we obtain coverage for a given product, the resulting reimbursement payment rates might not be adequate for us to achieve or sustain profitability or may require co-payments that patients find unacceptably high. There is significant uncertainty related to insurance coverage and reimbursement of newly approved products. It is difficult to predict at this time what third-party payors will decide with respect to the coverage and reimbursement for our product candidates. </span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net prices for drugs may be reduced by mandatory discounts or rebates required by government healthcare programs or private payors and impacted by any future relaxation of laws that presently restrict imports of drugs from countries where they may be sold at lower prices than in the United States. In addition, many pharmaceutical manufacturers must calculate and report certain price reporting metrics to the government, such as average sales price and best price. Penalties may apply in some cases when such metrics are not submitted accurately and timely.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The marketability of any product candidates for which we receive regulatory approval for commercial sale may suffer if third-party payors fail to provide adequate coverage and reimbursement. In addition, emphasis on managed care in the United States has increased and could increase the pressure on pharmaceutical pricing. Coverage policies and third-party reimbursement rates may change at any time. Even if favorable coverage and reimbursement status is attained for one or more products for which we receive regulatory approval, less favorable coverage policies and reimbursement rates may be implemented in the future.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Healthcare Reform</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The United States and many foreign jurisdictions have enacted or proposed legislative and regulatory changes affecting the healthcare system. The U.S. government, state legislatures and foreign governments also have shown significant interest in implementing cost-containment programs to limit the growth of government-paid healthcare costs, including price controls, restrictions on reimbursement, and requirements for substitution of generic products for branded prescription drugs and biologics. In recent&#160;years, Congress has considered reductions in Medicare reimbursement levels for drugs and biologics administered by physicians. CMS, the agency that administers the Medicare and Medicaid programs, also has authority to revise reimbursement rates and to implement coverage restrictions for some drugs and biologics. Cost reduction initiatives and changes in coverage implemented through legislation or regulation could decrease utilization of and reimbursement for any approved products. While Medicare regulations apply only to drug benefits for Medicare beneficiaries, private payors often follow Medicare coverage policy and payment limitations in setting their own reimbursement rates. Therefore, any reduction in reimbursement that results from federal legislation or regulation may result in a similar reduction in payments from private payors.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By way of example, the U.S. and state governments continue to propose and pass legislation designed to reduce the cost of healthcare. In March&#160;2010, the U.S. Congress enacted the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act (the &#8220;Affordable Care Act&#8221;), which, among other things, includes changes to the coverage and payments for products under government healthcare programs. profitability of drug products through increased rebates for drugs reimbursed by Medicaid programs, extension of Medicaid rebates to Medicaid managed care plans, mandatory discounts for certain Medicare Part&#160;D beneficiaries and, annual fees based on pharmaceutical companies&#8217; share of sales to federal health care programs. Current laws, as well as other healthcare reform measures that may be adopted in the future, may result in more rigorous coverage criteria and in additional downward pressure on the price for any approved products. Since the enactment of the Affordable Care Act, there have been, and continue to be, numerous judicial, administrative, executive, and legislative challenges to certain aspects of the Affordable Care Act, and there could be additional amendments to the Affordable Care Act in the future. It is unclear whether the Affordable Care Act will be overturned, repealed, replaced, or further amended. We cannot predict what affect further changes to the Affordable Care Act would have on our business.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, there have been several U.S. congressional inquiries and proposed federal and proposed and enacted state legislation designed to, among other things, bring more transparency to drug pricing, review the relationship between pricing and manufacturer patient support programs, reduce the costs of drugs under Medicare and reform government program reimbursement methodologies for drug products. Due to increasing political pressure and governmental budget constraints, we expect these mechanisms to remain robust, potentially even be strengthened, and to have a continued negative influence on the prices we may be able charge for our products, if approved, in the future. For example, the Inflation Reduction Act of 2022 (the &#8220;IRA&#8221;), signed into law on August 16, 2022, includes several provisions that may impact the pharmaceutical industry to varying degrees, including provisions that create a $2,000 out-of-pocket cap for Medicare Part&#160;D beneficiaries, impose new manufacturer financial liability on all drugs in Medicare Part&#160;D, allow the U.S. government to negotiate Medicare Part&#160;B and Part&#160;D pricing for certain high-cost drugs and biologics without generic or biosimilar competition, require companies to pay rebates to Medicare for drug prices that increase faster than inflation and delay the rebate rule that would require pass through of pharmacy benefit manager rebates to beneficiaries.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The IRA mandates that eligible Medicare Part B and Part D drugs participate in what the statute calls the Drug Price Negotiation Program (the &#8220;Program&#8221;). This Program will seek to lower the prices of certain Medicare Part B and Part D drugs without competition via government negotiation, starting in 2026. Through this Program, the HHS Secretary must (1) publish a list of selected drugs, (2) enter into agreements with manufacturers of those drugs, (3) negotiate and, where applicable, renegotiate &#8220;maximum fair prices,&#8221; for selected drugs that will apply to Medicare Parts B and D, and (4) monitor and enforce compliance, including through new civil monetary penalties and excise taxes. Each year, starting in 2026, a new cohort of Medicare-covered drugs (&#8220;Selected Drugs&#8221;) will be subject to a negotiated price. Specifically, the HHS Secretary must select for negotiation 10 Part D drugs for the initial 2026 price applicability year, 15 Part D drugs for 2027, 15 Part B or Part D drugs for 2028, and 20 Part B or Part D drugs for 2029 and each subsequent year. These negotiation-eligible drugs must be selected from the 50 Part B drugs and 50 Part D drugs with the highest Medicare program expenditures over the preceding 12-month period. A negotiation-eligible drug means a single source pharmaceutical product that is either (1) an FDA-approved drug for which at least seven years have elapsed since the date of its approval and for which there is no generic on the market, or (2) an FDA-licensed biologic for which at least 11 years have elapsed since licensure and for which there is no biosimilar on the market. On August 29, 2023, the U.S. government released the list of the first 10 Selected Drugs to be subject to the Program. On January 17, 2025, the U.S. government released the list next 15 Selected Drugs to be subject to the Program. Following the publication of the Selected Drugs, significant uncertainty remains regarding the ultimate impact of the Program on the pharmaceutical and biotech industries. The IRA is broadly impacting regulatory and corporate strategy for biotechnology and pharmaceutical firms of all sizes. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Companies have or are planning to review and adjust their economic projections for pipeline assets, particularly for drugs with the potential to become Selected Drugs. The IRA continues to face legal challenges from industry stakeholders and advocacy groups, as well as political opposition from certain lawmakers in Congress. These efforts in the courts and Congress may influence the future of the Program, though a full repeal is unlikely. With the transition to a new Congress and the Trump administration, changes to certain provisions and U.S. federal government guidance are possible, potentially altering the Program&#8217;s implementation and impact. </span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the state level, legislatures have increasingly passed legislation and implemented regulations designed to control pharmaceutical product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access, and marketing cost disclosure and transparency measures, and in some cases, designed to encourage importation from other countries and bulk purchasing. As of December&#160;31, 2024, at least 24 U.S. states have passed legislation intended to impact pricing or requiring manufacturers to report price increases to states, with eight of these states also allowing for drug affordability (i.e., price control) review boards. The disclosure requirements vary by state. Many states require multiple types of reporting, including for new drug applications, new drug launches, prior notice of price increases, and quarterly or annual reporting. Further, states may seek approval from the HHS Secretary to establish a Canadian drug importation program. Seven U.S. states (Colorado, Florida, Maine, New Hampshire, New Mexico, Texas and Vermont) have enacted laws authorizing the establishment of such a program. However, the HHS Secretary must approve each state importation plan before it can be implemented. As of December&#160;31, 2024, Florida is the only state to receive FDA approval for a state importation plan, which is not yet implemented. Drug importation could lower manufacturer revenue or otherwise have a chilling effect on incentives to pursue research and development of new or improved versions of drugs.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that additional federal, state, and foreign healthcare reform measures will be adopted in the future, any of which could limit the amounts that federal and state governments will pay for healthcare products and services, which could result in limited coverage and reimbursement and reduced demand for our products, once approved, or additional pricing pressures. We cannot predict the ultimate content, timing or effect of any healthcare reform legislation or the impact of potential legislation on us. We also cannot predict changes resulting from the 2024 U.S. election and resulting changes in HHS leadership, including potential changes that might impact the pharmaceutical and biotech industry.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employees and Human Capital Resources</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, we had 55 employees, all of whom were full-time and 41 of whom were engaged in research and development activities. Twenty-two of our employees hold PhD or MD degrees. All laboratory personnel and our administrative team are based in and around Boston, Massachusetts. None of our employees are represented by a labor union or covered under a collective bargaining agreement. We consider our relationship with our employees to be good.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our human capital resources objectives include, as applicable, identifying, recruiting, retaining, incentivizing and integrating our existing and new employees, advisors and consultants. The principal purposes of our equity and cash incentive plans are to attract, retain and reward personnel through the granting of stock-based and cash-based compensation awards, in order to increase stockholder value and the success of our company by motivating such individuals to perform to the best of their abilities and achieve our objectives.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Information</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were originally incorporated under the laws of the State of Delaware in 2015 under the name Marauder Therapeutics, Inc. and began operations in 2016. We changed our name to CAMP4 Therapeutics Corporation in March 2018. Our principal executive offices are located at One Kendall Square, Building 1400 West, 3rd Floor, Cambridge, Massachusetts 02139 and our telephone number is (617) 651-8867. Our website address is www.camp4tx.com. The information contained on, or accessible through, our website is not incorporated by reference into this Annual Report. We have included our website in this Annual Report solely as an inactive textual reference.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will make available on our website, free of charge, our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and any amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after we electronically file such material with, or furnish it to, the Securities and Exchange Commission (the &#8220;SEC&#8221;). The SEC maintains an Internet site (http://www.sec.gov) containing reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><div id="i8049b05497804bd28b68608a093bd853_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">A description of the risks and uncertainties associated with our business and industry is set forth below. Before deciding to invest in our common stock, you should consider carefully the risks and uncertainties described below, together with all of the other information in this Annual Report on Form&#160;10-K (&#8220;Annual Report&#8221;), including in the audited consolidated financial statements and the related notes contained in this Annual Report and in the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221; The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties that we are unaware of, or that we currently believe are not material, may also become important factors that affect us. If any of the following risks are realized, our business, financial condition, results of operations and prospects could be materially and adversely affected. In that event, the price of our common stock could decline, and you could lose part or all of your investment.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Financial Position and Need for Additional Capital</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have incurred significant losses since our inception, have no products approved for sale and we expect to incur losses for the foreseeable future.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a clinical-stage biopharmaceutical company in the early stages of development with a limited operating history. Since our inception, we have focused primarily on developing our proprietary RNA Actuating Platform, or RAP Platform, identifying, developing and progressing our product candidates through preclinical and clinical development, organizing and staffing our company, research and development activities, establishing and protecting our intellectual property portfolio, and raising capital. Investment in biopharmaceutical product development is highly speculative because it entails substantial upfront capital expenditures and significant risk that any potential product candidate will fail to demonstrate adequate effect or an acceptable safety profile, gain regulatory approval and become commercially viable. We are still in the early stages of development of our product candidates and our lead product candidate is only in a Phase 1 clinical trial. We have no products licensed for commercial sale and have not generated any revenue to date, and we continue to incur significant research and development and other expenses related to our ongoing operations. As a result, we are not profitable and have incurred losses in each period since our inception. For the&#160;years ended December&#160;31, 2024 and 2023, we reported net losses of $51.8 million and $49.3 million, respectively. As of December&#160;31, 2024, we had an accumulated deficit of $211.8 million. We expect to continue to incur significant losses for the foreseeable future, and we expect these losses to increase as we continue the research and development of, and seek regulatory approvals for, our lead product candidate CMP-CPS-001 for the treatment of urea cycle disorders (&#8220;UCDs&#8221;), along with any other current or future product candidates we may develop.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that our expenses will increase substantially if and as we:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">advance our lead product candidate, CMP-CPS-001, through clinical trials;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">finalize preclinical development for our program for SYNGAP1-related disorders;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">conduct preclinical studies and clinical trials of any future product candidates;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expand the capabilities of our RAP Platform and seek to identify and develop additional product candidates;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seek to identify additional product candidates;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seek marketing approvals for any product candidates that successfully complete clinical trials;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtain, expand, maintain, defend and enforce our intellectual property portfolio;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">hire additional clinical, regulatory and scientific personnel;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">contract with manufacturing sources for preclinical and clinical development of any future product candidates we may develop and commercial supply with respect to any such product candidates that receive regulatory approval;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ultimately establish a sales, marketing and distribution infrastructure to commercialize any products for which we may obtain marketing approval; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">add operational, legal, compliance, financial and management information systems and personnel to support our research, product development and future commercialization efforts, as well as to support our operations as a public company.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if we obtain regulatory approval for, and are successful in commercializing, one or more of any of our current and any future product candidates, we will continue to incur substantial research and development and other costs </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to develop and market additional product candidates. We may encounter unforeseen expenses, difficulties, complications, delays and other unknown factors that may adversely affect our business. The size of our future net losses will depend, in part, on the rate of future growth of our expenses and our ability to generate revenue. Our prior losses and expected future losses have had and will continue to have an adverse effect on our stockholders&#8217; equity and working capital.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have never generated revenue from product sales and may never achieve or maintain profitability.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our product candidates are in varying stages of preclinical and clinical development. To date, we have not generated any revenue. We have not completed a clinical trial of any product candidate, and we expect that it will be several&#160;years, if ever, before we have a product candidate ready for commercialization. To become and remain profitable, we must succeed in developing, obtaining the necessary regulatory approvals for, and eventually commercializing a product or products that generate significant revenue. The ability to achieve this success will require us to be effective in a range of challenging activities, including:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">identifying product candidates and completing preclinical and clinical development of any product candidates we may identify;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtaining regulatory approval for any of our current or future product candidates;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">manufacturing, marketing and selling any products for which we may obtain regulatory approval;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">achieving market acceptance of any products for which we obtain regulatory approval as a viable treatment option; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">satisfying any post-marketing requirements.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the factors listed above are beyond our control, and could cause us to experience significant delays or prevent us from obtaining regulatory approvals or commercialize our product candidates. We are in the preliminary stages of many of these activities. We may never succeed in these activities and, even if we do, we may never generate revenues that are significant enough to achieve profitability. Because of the numerous risks and uncertainties associated with product development, we are unable to accurately estimate or know the nature, timing or costs of the efforts that will be necessary to complete the preclinical and clinical development and commercialization of any of our current or future product candidates or when, or if, we will be able to generate revenues or achieve profitability.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are successful in obtaining regulatory approval to market one or more of our products, our revenue will be dependent, in part, upon the size of the markets in the territories for which we gain regulatory approval, the accepted price for the product, the ability to obtain coverage and reimbursement, and whether we own the commercial rights for that territory. If the number of our addressable patients is not as significant as we estimate, the indication approved by regulatory authorities is narrower than we expect, or the treatment population is narrowed by competition, physician choice or treatment guidelines, we may not generate significant revenue from sales of such products, even if approved.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if we do achieve profitability, we may not be able to sustain or increase profitability on a quarterly or annual basis. Our failure to become and remain profitable could impair our ability to raise capital, maintain our research and development efforts, expand our business or even continue our operations. A decline in the value of our company could also cause our stockholders to lose all or part of their investment.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We will require substantial additional capital to finance our operations, and a failure to obtain this necessary capital when needed on acceptable terms, or at all, could force us to delay, limit, reduce, or terminate our development programs, commercialization efforts or other operations.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations have consumed substantial amounts of cash since inception. We expect our expenses to substantially increase in connection with our ongoing activities, particularly as we conduct our ongoing and planned clinical trials and preclinical studies and potentially seek regulatory approval for our product candidates and any future product candidates we may develop. If we obtain regulatory approval for any of our product candidates, we also expect to incur significant commercialization expenses related to product manufacturing, marketing, sales, and distribution. Because the outcome of any clinical trial or preclinical study is highly uncertain, we cannot reasonably estimate the actual amount of capital necessary to successfully complete the development and commercialization of our product candidates.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, we had cash and cash equivalents of $64.0 million. Based on our current operating plan, we estimate that our cash and cash equivalents as of December&#160;31, 2024 will be sufficient to fund our operating expenses and capital expenditure requirements into the second quarter of 2026. However, we have based this estimate on assumptions that may prove to be wrong, and we could deplete our capital resources sooner than we currently expect. Our operating plans and other demands on our cash resources may change as a result of many factors currently unknown to us, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and we do not expect that our existing cash and cash equivalents will be sufficient to complete development of any of our product candidates, or any future product candidates we may identify, and we will require substantial capital in order to advance our product candidates through clinical trials, regulatory approval and commercialization. Accordingly, we will need to obtain substantial additional funding in connection with our continuing operations. Our ability to raise additional funds may be adversely impacted by global economic conditions, disruptions to, and volatility in, the credit and financial markets in the United States and worldwide, and diminished liquidity and credit availability. If the equity and credit markets deteriorate, it may make any necessary debt or equity financing more difficult, more costly, and more dilutive. We cannot be certain that additional funding will be available on acceptable terms, or at all. If we are unable to raise capital when needed or on attractive terms, we could be forced to delay, reduce, or eliminate our research and development programs or any future commercialization efforts, or even cease operations. We expect to finance our cash needs through public or private equity or debt financings or other capital sources, including potential collaborations, licenses, and other similar arrangements. In addition, we may seek additional capital due to favorable market conditions or strategic considerations even if we believe we have sufficient funds for our current or future operating plans. Attempting to secure additional financing may divert our management from our day-to-day activities, which may adversely affect our ability to develop our product candidates.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future capital requirements will depend on many factors, including, but not limited to:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the scope, timing and progress of our ongoing CMP-CPS-001 clinical trial;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the initiation, type, number, scope, progress, expansions, results, costs and timing of preclinical studies and clinical trials of our product candidates and any future product candidates we may choose to pursue, including the costs of modification to clinical development plans based on feedback that we may receive from regulatory authorities and any third-party products used as combination agents in our clinical trials;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs and timing of manufacturing for our product candidates, including commercial manufacturing at sufficient scale, if any product candidate is approved;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs, timing and outcome of regulatory meetings and reviews of our product candidates or any future product candidates, including requirements of regulatory authorities in any additional jurisdictions in which we may seek approval and any future product candidates;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs of obtaining, maintaining, enforcing and protecting our patents and other intellectual property and proprietary rights;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our efforts to enhance operational systems and hire additional personnel to satisfy our obligations as a public company, including enhanced internal control over financial reporting;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs associated with hiring additional personnel and consultants as our clinical and preclinical activities increase;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing and payment of milestone, royalty or other payments we must make or may receive pursuant to our existing and potential future license or collaboration agreements with third parties;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs and timing of establishing or securing sales and marketing capabilities if our product candidates or any product candidate is approved;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to achieve sufficient market acceptance, coverage, and adequate reimbursement from third-party payors and adequate market share and revenue for any approved products;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">patients&#8217; ability and willingness to pay out-of-pocket for any approved products in the absence of coverage and/or adequate reimbursement from third-party payors;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the terms and timing of establishing and maintaining collaborations, licenses, and other similar arrangements; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs associated with any products or technologies that we may in-license or acquire.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Conducting clinical trials and preclinical studies and discovering potential product candidates using our RAP Platform is an expensive and uncertain process, and we may never generate the necessary data or results required to obtain regulatory approval and commercialize our product candidates. In addition, our product candidates, if approved, may not achieve commercial success. Our commercial revenue, if any, will initially be derived from sales of products that we do not expect to be commercially available for many&#160;years, if at all.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Raising additional capital may cause dilution to our stockholders, restrict our operations or require us to relinquish rights to our technologies or product candidates.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until such time, if ever, as we can generate substantial product revenues, we expect to finance our cash needs through a combination of equity offerings, debt financings, collaborations, strategic alliances and/or licensing arrangements. We do not have any committed external source of funds. To the extent that we raise additional capital through the sale of equity or convertible debt securities, our stockholders&#8217; ownership interests will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of common stockholders. Any debt financing or preferred equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, selling or licensing our assets, making capital expenditures, declaring dividends or encumbering our assets to secure future indebtedness.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we raise additional funds through collaborations, strategic alliances or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates or grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds through equity or debt financings or other arrangements when needed or on terms acceptable to us, we may be required to delay, limit, reduce or eliminate some or all of our research and development programs, pipeline expansion or future commercialization efforts or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our independent registered public accounting firm has expressed substantial doubt about our ability to continue as a going concern.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In its report accompanying our audited financial statements for the years ended December&#160;31, 2024 and 2023, our independent registered public accounting firm included an explanatory paragraph stating that our recurring losses from operation raise substantial doubt about our ability to continue as a going concern for a period of one year after the date the financial statements are issued. See Note 1 to our consolidated financial statements appearing elsewhere in our Annual Report for additional information on our assessment. Our future viability is dependent on our ability to generate cash from our operating activities or to raise additional capital to finance our operations. There is no assurance that we will succeed in obtaining sufficient funding on terms acceptable to us to fund continuing operations, if at all. The perception that we might be unable to continue as a going concern may also make it more difficult to obtain financing for the continuation of our operations on terms that are favorable to us, or at all, and could result in the loss of confidence by investors, suppliers and employees. If we are unable to continue as a going concern, we may have to liquidate our assets and may receive less than the value at which those assets are carried on our financial statements and it is likely that our investors will lose all or a part of their investment.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to the Research and Development of Our Product Candidates</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are early in our development efforts. Our product candidates are in varying stages of preclinical and clinical development and we have not completed a clinical trial of any product candidate. As a result, it will be many&#160;years before we commercialize a product candidate, if ever. If we are unable to identify and advance product candidates through preclinical studies and clinical trials, obtain marketing approval and ultimately commercialize them, or experience significant delays in doing so, our business will be materially harmed.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are early in our development efforts and our lead product candidate is only in a Phase 1 clinical trial. We have focused our efforts to date on developing our RAP Platform, identifying our programs and commencing the preclinical and clinical development of our product candidates. Our ability to generate product revenue, which we do not expect will occur for many&#160;years, if ever, will depend heavily on the successful development and eventual commercialization of our product candidates, which may never occur. We currently generate no revenue from sales of any product, and we may never be able to develop or commercialize a marketable product.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently conducting a Phase 1 clinical trial of CMP-CPS-001 in Australia. Clinical trials conducted in Australia using &#8220;unapproved therapeutic goods,&#8221; or those that have not yet been evaluated by the Therapeutic Goods Association (the &#8220;TGA&#8221;) for quality, safety and efficacy, must occur pursuant to either the Clinical Trial Notification Scheme or the Clinical Trial Approval Scheme. In each case, the trial is supervised by a Human Research Ethics Committee (&#8220;HREC&#8221;), an independent review committee set up under the guidelines of the Australian National Health and Medical Research Council that reviews, approves and provides continuing oversight of trial protocols and amendments, and of the methods and material to be used in obtaining and documenting informed consent of the trial subjects. Commencing clinical trials in the United States is subject to acceptance by the U.S. Food and Drug Administration (the &#8220;FDA&#8221;) of an investigational new drug (&#8220;IND&#8221;) application and finalizing the trial design based on discussions with the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FDA and other regulatory authorities. In the event that the FDA or TGA requires us to complete additional preclinical studies or we are required to satisfy other requests prior to commencing clinical trials, the start of any future clinical trials may be delayed. Even after we receive and incorporate guidance from the FDA, an applicable HREC or the TGA, such authorities could disagree that we have satisfied their requirements to commence any clinical trial or continue or change their position on the acceptability of our trial design or the clinical endpoints selected, which may require us to complete additional preclinical studies or clinical trials or impose stricter approval conditions than we currently expect, which could delay the start or completion of such clinical trials or require more capital resources than we currently anticipate to start or complete such clinical trials.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that for one or more of our product candidates, clinical trials will need to be conducted utilizing sites and patients in the European Union and the United Kingdom. Similar processes and risks are applicable to clinical trial applications (&#8220;CTAs&#8221;) in the European Union as well as the United Kingdom as exist in other regions. Regulators for the European Union and/or for local countries may request additional preclinical studies or may reject the request to initiate clinical trials in humans. Requests for additional preclinical studies prior to commencing clinical trials may result in the delay of future clinical trials. Even after we receive and incorporate guidance from EU and/or local country regulators, the regulatory authorities may disagree with our position that we have satisfied their requirements, require additional preclinical studies or clinical trials, or refuse to approve the product candidate.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercialization of any of our current or future product candidates will require preclinical and clinical development; regulatory and marketing approval issued by regulators in any jurisdiction where we seek to commercialize such product candidates, such as the FDA, TGA and the European Commission (the &#8220;EC&#8221;) following a favorable assessment performed by the European Medicines Agency (the &#8220;EMA&#8221;); manufacturing supply, capacity and expertise; a commercial organization; and significant marketing efforts. The success of any of our current or future product candidates will depend on many factors, including the following:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">timely and successful completion of preclinical studies;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">acceptance of INDs or comparable foreign applications that allow commencement of clinical trials or future clinical trials for any product candidates we may develop;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">successful enrollment and completion of clinical trials, including under the FDA&#8217;s current Good Clinical Practices (&#8220;GCPs&#8221;), current Good Laboratory Practices (&#8220;GLPs&#8221;) and any additional regulatory requirements from foreign regulatory authorities;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">positive results from our clinical trials that support a finding of safety and effectiveness and an acceptable risk-benefit profile in the intended populations;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">receipt of marketing approvals from applicable regulatory authorities;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establishment of arrangements through our own facilities or with third-party manufacturers for clinical supply and, where applicable, commercial manufacturing capabilities;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establishment, maintenance, defense and enforcement of patent, trademark, trade secret and other intellectual property protection or regulatory exclusivity for any product candidates we may develop;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">commercial launch of any product candidates we may develop, if approved, whether alone or in collaboration with others;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtaining and maintaining third-party coverage and adequate reimbursement;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">effectively competing against other therapies;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">acceptance of the benefits and use of our product candidates we may develop, including method of administration, if and when approved, by patients the medical community and third-party payors; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintaining a continued acceptable safety profile of our products following regulatory approval.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we do not succeed in one or more of these factors in a timely manner or at all, we could experience significant delays or an inability to successfully commercialize any product candidates we may develop, which would materially harm our business. If we are unable to advance our product candidates into and through clinical development, obtain regulatory approval and ultimately commercialize our product candidates, or experience significant delays in doing so, our business will be materially harmed.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business is highly dependent on our lead product candidate, CMP-CPS-001, as our sole clinical-stage program, and we must complete clinical testing before we can seek regulatory approval and begin commercialization of any of our other product candidates. If we are unable to obtain regulatory approval for, and successfully commercialize, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CMP-CPS-001, our business may be materially harmed and such failure may affect the viability of our other product candidates.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is no guarantee that any of our product candidates will proceed in preclinical or clinical development or achieve regulatory approval. The process for obtaining marketing approval for any product candidate is very long and risky and there will be significant challenges for us to address in order to obtain marketing approval as planned, if at all.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is no guarantee that the results obtained in our ongoing Phase 1 clinical trial of CMP-CPS-001 or our planned future clinical trials will be sufficient to obtain regulatory approval. In addition, because CMP-CPS-001 is our most advanced product candidate, and because our future product candidates will be based on our RAP Platform and antisense oligonucleotide (&#8220;ASO&#8221;) technology, if our lead product candidate encounters safety or efficacy problems, developmental delays, regulatory issues, or other problems, our development plans and business related to our other future product candidates could be significantly harmed. A failure of our lead product candidate may affect the ability to obtain regulatory approval to continue or conduct clinical programs for our other or future product candidates.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our approach to the discovery and development of product candidates based on our RAP Platform is unproven, and we may not be successful in our efforts to develop and commercialize our product candidates and to identify and discover additional potential product candidates.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of our business depends upon our ability to identify, develop and commercialize products based on our proprietary RAP Platform. All of our product candidates are still in varying stages of preclinical and clinical development. Our research programs may fail to identify additional product candidates for clinical development for a number of reasons. Our RAP Platform may be unsuccessful in identifying additional potential product candidates and our potential product candidates may be shown to have harmful side effects. In addition, our product candidates may be successful in upregulating the expression of their target genes and may nonetheless fail to show promising signals of therapeutic effect in such experiments or studies or they may have other characteristics that may make the product candidates impractical to manufacture, unmarketable or unlikely to receive marketing approval. Further, because all of our product candidates and programs are based on our RAP Platform, adverse developments with respect to one of our product candidates and programs may have a significant adverse impact on the actual or perceived likelihood of success and value of our other product candidates and programs.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we have not completed a clinical trial of any product candidate or successfully developed any product candidates, and our ability to identify and develop additional product candidates may never materialize. The process by which we identify and develop product candidates may fail to yield additional product candidates for clinical development for a number of reasons, including those discussed in these risk factors. In addition:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may not be able to assemble sufficient resources to acquire or discover product candidates;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competitors may develop alternatives that render our product candidates obsolete or less attractive;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">product candidates we develop may nevertheless be covered by third parties&#8217; patents or other intellectual property rights;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">product candidates may, on further study, be shown to have harmful side effects, toxicities or other characteristics that indicate that they are unlikely to be products that will receive marketing approval and achieve market acceptance;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">product candidates may not achieve the optimal levels of gene upregulation or, notwithstanding such upregulation, may not be effective in achieving a meaningful clinical result in their targeted diseases or disorders;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the market for a product candidate may change so that the continued development of that product candidate is no longer reasonable;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a product candidate may not be capable of being produced in commercial quantities at an acceptable cost, or at all; or</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the regulatory pathway for a product candidate may be too complex and difficult to navigate successfully or economically.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to identify and discover suitable product candidates for clinical development, this would adversely impact our business strategy and our financial position and share price and could potentially cause us to cease operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Drug development is a lengthy and expensive process, and preclinical and clinical testing is uncertain as to the outcome. We may encounter substantial delays in the commencement, enrollment or completion of our clinical trials, or we may fail to demonstrate safety and effectiveness to the satisfaction of applicable regulatory authorities, which could prevent us from advancing or commercializing our product candidates on a timely basis, if at all.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risk of failure in developing therapeutic product candidates is high. This elevated risk exists even when preclinical studies in animal models demonstrate positive data. It is impossible to predict when or if any product candidate would prove effective or safe in humans or will receive regulatory approval. Before obtaining marketing approval from regulatory authorities for the sale of any product candidate, we must complete preclinical development, obtain regulatory authorization to commence clinical trials, and then conduct extensive clinical trials to demonstrate the safety and efficacy of product candidates in humans.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical trials may fail to demonstrate that our product candidates are safe for humans and effective for indicated uses, and earlier results, both preclinical and clinical, may not be indicative of future clinical trial results. Even if the clinical trials are successful, changes in marketing approval policies during the development period, changes in or the enactment or promulgation of additional statutes, regulations or guidance, varying interpretations of clinical data or changes in regulatory review for each submitted product application may cause delays in the approval or rejection of an application.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before we can commence clinical trials for a product candidate, we must complete extensive preclinical testing and studies that support clearance of our regulatory filings, including IND applications to the FDA in the United States and other similar regulatory filings in other jurisdictions, including with respect to the TGA in Australia and the national competent authorities (&#8220;NCAs&#8221;) in the European Union. We cannot be certain if the outcome of our preclinical studies and clinical trials will ultimately support further development of our product candidates or future programs or whether the FDA, TGA, NCAs or comparable foreign regulatory authorities will accept our proposed clinical programs or whether the outcome of our preclinical testing and studies will ultimately support the further development of our product candidates. Conducting preclinical testing is a lengthy, time-consuming and expensive process. The length of time may vary substantially according to the type, complexity and novelty of the program, and often can be several&#160;years or more per program. As a result, we cannot be sure that we will be able to submit INDs, CTAs and other similar regulatory filings for our preclinical programs on the timelines we expect, if at all, and we cannot be sure that submission of such regulatory filings will result in the FDA, TGA, NCAs or comparable foreign regulatory authorities allowing clinical trials to begin.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical testing is expensive, is difficult to design and implement, can take many&#160;years to complete and is uncertain as to outcome. We cannot guarantee that any clinical trials will be conducted as planned or completed on schedule, or at all. A failure of one or more clinical trials can occur at any stage of testing, which may result from a multitude of factors, including, but not limited to, flaws in trial design, dose selection issues, patient enrollment criteria, operational challenges, site implementation challenges, biostatistical plans, and failure to demonstrate favorable safety or efficacy traits.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other events that may prevent successful or timely completion of clinical development include:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays in reaching a consensus with regulatory authorities on trial design;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays in reaching agreement on acceptable terms with prospective clinical research organizations (&#8220;CROs&#8221;) and clinical trial sites;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays in opening clinical trial sites or obtaining required approval from institutional review boards (&#8220;IRBs&#8221;), HRECs or independent ethics committees, or the equivalent review groups for sites outside the United States or Australia, at each clinical trial site;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">imposition of a clinical hold by regulatory authorities as a result of a serious adverse event or manufacturing concerns or after an inspection of our clinical trial operations or trial sites;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">negative or inconclusive results observed in clinical trials, including failure to demonstrate statistical significance, which could lead us, or cause regulators to require us, to conduct additional clinical trials or abandon product development programs;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure by us, any CROs we engage or any other third parties to adhere to clinical trial requirements;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to perform in accordance with the FDA&#8217;s GCPs, Good Manufacturing Practices (&#8220;GMP&#8221;) regulations or those of other regulatory authorities, including, but not limited to, Australia&#8217;s GMP requirements;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure by physicians to adhere to delivery protocols, leading to protocol deviations and variable results;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">inappropriate storage or failure of storage facilities or storage equipment of preclinical or clinical trial samples;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays in the testing, validation, manufacturing and delivery of our product candidates to the clinical sites, including delays by third parties with whom we have contracted to perform certain of those functions;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure of our third-party contractors to comply with regulatory requirements or to meet their contractual obligations to us in a timely manner, or at all;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">inability to recruit patients to participate in a clinical trial, including as a result of competition with other pharmaceutical and biotechnology companies and the patient population size for our product candidates;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays in having patients complete participation in a clinical trial or return for post-treatment follow-up;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">clinical trial sites or patients dropping out of a trial;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">selection of clinical endpoints that require prolonged periods of clinical observation or analysis of the resulting data, or clinical endpoints that have broad variability or inconsistency, resulting in negative or indeterminable results;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">occurrence of serious adverse events associated with a product candidate in development by another company, which are viewed to outweigh its potential benefits, and which may negatively impact the perception of our current or future product candidates due to a similarity in technology or approach;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in regulatory requirements and guidance that require amending or submitting new clinical protocols;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the legal or regulatory regimes domestically or internationally related to patient rights and privacy;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lack of adequate funding to continue the clinical trial; or</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lack of diminished revenue potential of the programs due to competition.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical trials must be conducted in accordance with the legal requirements, regulations or guidelines of the FDA, TGA, EC, NCAs and other applicable regulatory authorities, and are subject to oversight by these governmental agencies and IRBs, HRECs or ethics committees at the medical institutions where the clinical trials are conducted. We could encounter delays if a clinical trial is suspended or terminated by us, by the data safety monitoring board for such trial or by the FDA, TGA, EMA or any other regulatory authority, or if the IRBs or HRECs of the institutions in which such trials are being conducted suspend or terminate the participation of their clinical investigators and sites subject to their review. Such authorities may suspend or terminate a clinical trial due to a number of factors, including failure to conduct the clinical trial in accordance with regulatory requirements or our clinical protocols, inspection of the clinical trial operations or trial site by the FDA, TGA, EMA or other regulatory authorities resulting in the imposition of a clinical hold, unforeseen safety issues or adverse side effects, failure to demonstrate a benefit from using a product candidate, changes in governmental regulations or administrative actions or lack of adequate funding to continue the clinical trial.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may face challenges associated with clinical testing in pediatric populations, which we currently intend to pursue with respect to CMP-CPS-001, and which could increase our clinical development timelines and operational costs, delay regulatory approval and commercialization for such pediatric indications or expose us to additional liability. For example, finding qualified clinical sites that have access to sufficient pediatric populations and that are willing to participate in our clinical trials may take more time than would be required for the assessment of CMP-CPS-001 in adult patient populations. There may be fewer eligible pediatric patients with the UCD enzyme deficiencies we are targeting for the development of CMP-CPS-001, or with conditions applicable to other product candidates we may develop and assess in future clinical trials. We may also be required to modify the formulation or other aspects of our product candidates, as compared to the comparable product candidate intended for adult patient populations, make manufacturing changes, modify the route of administration and conduct additional clinical trials, such as bridging studies and additional safety studies, before we can commence our clinical trials in pediatric populations. The FDA or other comparable regulatory authorities may require us to complete studies in adults prior to initiating testing in children. Any delays in our planned clinical development activities for pediatric patients could have an adverse effect on our business operations.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, principal investigators for our clinical trials may also serve as our scientific advisors or consultants to us from time to time and receive compensation in connection with such services. Under certain circumstances, we may be required to report some of these relationships to the FDA, TGA, EC, NCAs or comparable foreign regulatory authorities. The FDA, TGA, NCAs or comparable foreign regulatory authority may conclude that a financial relationship between us and a principal investigator has created a conflict of interest or otherwise affected interpretation of the trial. The FDA, TGA, EMA or comparable foreign regulatory authority may therefore question the integrity of the data generated at the applicable clinical trial site and the utility of the clinical trial itself may be jeopardized. This could result in a delay in </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">approval, or rejection, of our marketing applications by the FDA, TGA, EMA or comparable foreign regulatory authority, as the case may be, and may ultimately lead to the denial of marketing approval of our product candidates.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any inability to successfully complete preclinical studies and clinical trials could result in additional costs to us or preclude or impair our ability to generate revenues from product sales, regulatory and commercialization milestones and royalties. In addition, if we make manufacturing or formulation changes to our product candidates, we may need to conduct additional studies to bridge our modified product candidates to earlier versions. Clinical trial delays also could shorten any periods during which we may have the exclusive right to commercialize our product candidates or allow our competitors to bring products to market before we do, which could impair our ability to successfully commercialize our product candidates and may harm our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, conducting clinical trials in foreign countries, such as our ongoing Phase 1 clinical trial of CMP-CPS-001 for the treatment of UCDs, which is being conducted in Australia, presents additional risks that may delay completion of our clinical trials. These risks include the failure of enrolled patients in foreign countries to adhere to clinical protocol as a result of differences in healthcare services or cultural customs, managing additional administrative burdens associated with foreign regulatory schemes, as well as political and economic risks relevant to such foreign countries.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, if the results of clinical trials are inconclusive or if there are safety concerns or serious adverse events associated with our product candidates, we may:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">be delayed in obtaining marketing approval for product candidates, if at all;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtain approval for indications or patient populations that are not as broad as intended or desired;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtain approval with labeling that includes significant use or distribution restrictions or safety warnings;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">be subject to changes in the way our product candidates are administered;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">be required to perform additional clinical trials to support approval or be subject to additional post-marketing testing requirements;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">have regulatory authorities withdraw, or suspend, their approval of the product or impose restrictions on its distribution in the form of a Risk Evaluation and Mitigation Strategy (&#8220;REMS&#8221;);</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">be subject to the addition of labeling statements, such as warnings or contraindications;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">be subject to litigation; or</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">experience damage to our reputation.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of these events could prevent us from achieving or maintaining regulatory approval or market acceptance of our product candidates or could substantially increase commercialization costs and expenses, which in turn could delay or prevent us from generating significant revenue from the sale of our product candidates, if approved.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interim, topline, and preliminary data from our clinical trials and preclinical studies that we announce or publish from time to time may change as more patient data become available and are subject to audit and verification procedures that could result in material changes in the final data.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may publicly disclose interim, topline, or preliminary data from our clinical trials and preclinical studies, which is based on a preliminary analysis of then-available data, and the results and related findings and conclusions are subject to change following quality assurance, audit, and/or a more comprehensive review of the data related to the particular study or trial. We also make assumptions, estimations, calculations, and conclusions as part of our analyses of data, and we may not have received or had the opportunity to fully and carefully evaluate all data. As a result, the interim, topline, or preliminary results that we report may differ from future results of the same studies or trials, or different conclusions or considerations may qualify such results once additional data have been received and fully evaluated. Topline and preliminary data also remain subject to audit and verification procedures that may result, in the final data being materially different from the topline or preliminary data we previously published. As a result, topline and preliminary data should be viewed with caution until the final data are available. Interim data from clinical trials that we may complete are further subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and more patient data become available. Adverse differences between interim, topline, or preliminary data and final data could significantly harm our business prospects.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, others, including regulatory authorities, may not accept or agree with our assumptions, estimates, calculations, conclusions, or analyses or may interpret or weigh the importance of data differently, which could impact the value of the particular program, the approvability or commercialization of particular product candidate and our company in </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">general. Moreover, the information we choose to publicly disclose regarding a particular study or clinical trial is based on what is typically extensive information, and you or others may not agree with what we determine is material or otherwise appropriate information to include in our disclosure, and any information we determine not to disclose may ultimately be deemed significant with respect to future decisions, conclusions, views, activities or otherwise regarding a particular product candidate or our business. If the interim, topline, or preliminary data that we report differ from actual results, or if others, including regulatory authorities, disagree with the conclusions reached, our ability to obtain approval for, and commercialize our product candidates may be harmed, which could harm our business, operating results, prospects, or financial condition.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The outcome of preclinical studies and earlier-stage clinical trials may not be predictive of future results or the success of later preclinical studies and clinical trials.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are in the early stages of development of our programs and have initiated a Phase 1 clinical trial of our lead product candidate, CMP-CPS-001, in healthy adult volunteers in Australia, but we have not yet completed or received clearance for IND- or CTA-enabling activities for our other product candidates or advanced any other product candidates into clinical development. As a result, our belief in the capabilities of our platform and potential success of our product candidates is based on early research and preclinical studies. However, the results of preclinical studies may not be predictive of the results of later preclinical studies or clinical trials, and the results of any early-stage clinical trials may not be predictive of the results of later clinical trials. In addition, initial success in clinical trials may not be indicative of results obtained when such trials are completed. Moreover, preclinical and clinical data are often susceptible to varying interpretations and analyses, and many companies that have believed their product candidates performed satisfactorily in preclinical studies and clinical trials have nonetheless failed to obtain marketing approval of their product candidates. Our clinical trials may not ultimately be successful or support further clinical development of our product candidates.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our choices with respect to the design and implementation of our clinical trials will be a significant factor in our ability to successfully and timely complete clinical development with respect to our product candidates. Our Phase 1 clinical trial being conducted in Australia for CMP-CPS-001 utilizes a ureagenesis rate test (&#8220;URT&#8221;), which is an assay that evaluates flux through the urea cycle based on the rate at which an isotope is converted into labeled urea. The assay can be used to measure baseline and post-treatment urea rates and was previously shown to be able to measure ureagenesis in normal healthy volunteer studies and ureagenesis increases in specific UCD patient subtypes using carglumic acid. More specifically, Carbaglu, approved for ultra-rare N-acetylglutamate synthesase (&#8220;NAGS&#8221;)-deficient patients, utilized the URT in healthy volunteers and showed that minimal increases in ureagenesis translated to substantial ammonia reductions in NAGS-deficient patients. Although URTs have experienced expanded use in research and clinical studies and have been shown to correlate with responses in patients, making them a valuable pharmacodynamic tool, they are not an established clinical endpoint and not routinely used for clinical care. As such, it is possible that variability in the results of the assay could render interpretation difficult. While we believe that an increase in ureagenesis as measured by the URT in our Phase 1 clinical trial may correspond with clinically meaningful improvements in ammonia metabolism in UCD patients, there is no guarantee that an increase in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C-sodium acetate metabolism, as measured by the URT, will correlate to an increase in ammonia metabolism, or that such data will be predictive of positive results with respect to the established clinical endpoints that we expect to use in our later-stage clinical trials, and our use of the URT to measure changes in ureagenesis in our Phase 1 clinical trial should not be interpreted as evidence of the efficacy of CMP-CPS-001.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is a high failure rate for product candidates proceeding through clinical trials. A number of companies in the pharmaceutical and biotechnology industries have suffered significant setbacks in clinical development even after achieving encouraging results in earlier studies. Any such setbacks in our clinical development could materially harm our business and results of operations.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, some or all of our planned clinical trials may utilize an &#8220;open-label&#8221; trial design. An &#8220;open-label&#8221; clinical trial is one where both the patient and investigator know whether the patient is receiving the investigational product candidate or either an existing approved drug or placebo. Most typically, open-label clinical trials test only the investigational product candidate and sometimes may do so at different dose levels. Open-label clinical trials are subject to various limitations that may exaggerate any therapeutic effect as patients in open-label clinical trials are aware when they are receiving treatment. Open-label clinical trials may be subject to a &#8220;patient bias&#8221; where patients perceive their symptoms to have improved merely due to their awareness of receiving an experimental treatment. In addition, open-label clinical trials may be subject to an &#8220;investigator bias&#8221; where those assessing and reviewing the physiological outcomes of the clinical trials are aware of which patients have received treatment and may interpret the information of the treated group more favorably given this knowledge. The results from an open-label trial may not be predictive of future clinical trial results with any of our product candidates when studied in a controlled environment with a placebo or active control.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, some of our planned clinical trials may utilize a &#8220;placebo&#8221; and/or blinded clinical trial design. A placebo controlled clinical trial is one where both the participant and the investigator may and/or should not know whether the participants have received the product candidate or placebo. In studies utilizing placebo and/or blinded control, there exists the phenomenon of &#8220;placebo response&#8221; where participants assigned to the placebo may experience a benefit given their participation in the study. This placebo response in the control group at times may limit or prevent the detection of a numerical and/or a statistical difference between the treatment group and the placebo group.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain of the disorders we seek to treat, including UCDs and SYNGAP1-related disorders, have low prevalence and it may be difficult to identify and enroll patients with these disorders. If we experience delays or difficulties in the enrollment and/or maintenance of patients in clinical trials, our receipt of necessary regulatory approvals could be delayed or prevented.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identifying and qualifying patients to participate in clinical trials of any of our current or future product candidates is critical to our success. Patient enrollment, a significant factor in the timing of clinical trials, is affected by many factors, including the size and nature of the patient population and competition for patients with other trials. Genetic diseases generally, and especially the rare diseases for which some of our current and any future product candidates are targeted, have low incidence and prevalence. For example, the incidence of UCDs in the United States is estimated to be approximately 1 in 35,000 births, with similar incidence estimated for Europe, and accordingly it may be difficult for us to identify and timely recruit a sufficient number of eligible patients to conduct our clinical trials. Further, the pediatric population is an important patient population for CMP-CPS-001 and our addressable patient population estimates include pediatric populations. However, it may be more challenging to conduct studies in this population, and to locate and enroll pediatric patients. Additionally, it may be challenging to ensure that pediatric or adolescent patients adhere to clinical trial protocols. We may not be able to identify, recruit and enroll a sufficient number of patients, or those with required or desired characteristics, to complete our clinical trials in a timely manner. Patient enrollment and trial completion is affected by factors including:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">size of the patient population, in particular for rare diseases, including the diseases on which we are currently focused, and the process for identifying patients and screening patients;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">design of the trial protocol;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">eligibility and exclusion criteria;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">perceived risks and benefits of the product candidate under study;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">availability of competing therapies and clinical trials;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">severity of the disease or disorder under investigation;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">proximity and availability of clinical trial sites for prospective patients;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ability to obtain and maintain patient consent;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risk that enrolled patients will drop out before completion of the trial;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">patient referral practices of physicians; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ability to monitor patients adequately during and after treatment.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our inability to enroll a sufficient number of patients for clinical trials would result in significant delays and could require us to abandon one or more clinical trials altogether. Enrollment delays in these clinical trials may result in increased development costs for our product candidates, which would cause the value of our company to decline and limit our ability to obtain additional financing. Furthermore, we rely on and expect to continue to rely on CROs and clinical trial sites to ensure the proper and timely conduct of our clinical trials and we will have limited influence over their performance.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, certain of our planned clinical trials may utilize a &#8220;placebo&#8221; and/or blinded clinical trial design, which may in some situations cause additional enrollment difficulty. In clinical trials of patients, patients may decline to enroll out of concern of being assigned into the placebo group. This concern may be higher in rare diseases and may increase if other treatments become available to patients during the clinical trial or clinical development.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if we are able to enroll a sufficient number of patients for our clinical trials, we may have difficulty maintaining patients in our clinical trials. For example, patients who end up receiving placebo may perceive that they are not receiving the product candidate being tested, and they may decide to withdraw from our clinical trials to pursue other alternative therapies rather than continue the trial with the perception that they are receiving placebo. If we have difficulty </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">enrolling or maintaining a sufficient number of patients to conduct our clinical trials, we may need to delay, limit or terminate clinical trials, any of which would harm our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If any of our current or any future product candidates cause undesirable side effects or have other unexpected adverse properties, such side effects or properties could delay or prevent regulatory approval, limit the commercial potential or result in significant negative consequences following any potential marketing approval.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not completed a clinical trial of any product candidate. It is impossible to predict when or if any of our current or future product candidates will prove safe in humans. There can be no assurance that our product candidates will not cause undesirable side effects.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although other ASOs have received regulatory approval, no regulatory authorities to date have approved ASOs that are directed towards the type of RNA (regulatory RNAs) that our product candidates target. As a result, there is uncertainty as to the safety profile of any of our current or future product candidates compared to currently approved ASOs.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any product candidates we develop are associated with serious adverse events, undesirable side effects or unexpected characteristics, we may need to abandon their development or limit development to certain uses or subpopulations in which the serious adverse events, undesirable side effects or other characteristics are less prevalent, less severe or more acceptable from a risk-benefit perspective, any of which would have a material adverse effect on our business, financial condition, results of operations and prospects. Many product candidates that initially showed promise in early-stage testing have later been found to cause side effects that prevented further clinical development of the product candidates.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If in the future we are unable to demonstrate that such side effects were caused by factors other than our product candidates, the FDA, the TGA, EC, NCAs or other regulatory authorities could order us to cease further development of, or deny approval of, any product candidates for any or all targeted indications. Even if we are able to demonstrate that any future serious adverse events are not product-related and regulatory authorities do not order us to cease further development of our product candidates, such occurrences could affect patient recruitment or the ability of enrolled patients to complete the trial. Moreover, if we elect, or are required, to delay, suspend or terminate any clinical trial of any product candidate, the commercial prospects of such product candidates may be harmed and our ability to generate product revenues from any of these product candidates may be delayed or eliminated. Any of these occurrences may harm our ability to develop other product candidates, and may harm our business, financial condition and prospects significantly.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may develop certain of our future product candidates in combination with other therapies, which exposes us to additional risks.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may develop certain of our future product candidates for use in combination with one or more currently approved therapies. Even if any product candidate we develop was to receive marketing approval or be commercialized for use in combination with other existing therapies, we would continue to be subject to the risks that the FDA or similar foreign regulatory authorities could revoke approval of the therapy used in combination with our product candidate or that safety, efficacy, manufacturing or supply issues could arise with these existing therapies. This could result in our own products being less successful commercially.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the FDA or similar foreign regulatory authorities do not approve these other drugs or revoke their approval of, or if safety, efficacy, manufacturing, or supply issues arise with, the drugs we choose to evaluate in combination with any product candidate we develop, we may be unable to obtain approval of or market such product candidate.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may expend our limited resources to pursue a particular program, product candidate or indication and fail to capitalize on programs, product candidates or indications that may be more profitable or for which there is a greater likelihood of success.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we have limited financial and managerial resources, we focus on research programs and product candidates that we identify for specific indications that we believe can be addressed by our technology among many potential options. As a result, we may forego or delay pursuit of opportunities with other product candidates or for other indications that later prove to have greater commercial potential, or we may choose to focus our efforts and resources on a potential product candidate that ultimately proves to be unsuccessful. Our resource allocation decisions may cause us to fail to capitalize on viable commercial products or profitable market opportunities. Our spending on current and future research and development programs and product candidates for specific indications may not yield any commercially viable products. If we do not accurately evaluate the commercial potential or target market for a particular product candidate, we may relinquish valuable rights to that product candidate through collaboration, licensing or other royalty arrangements in </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cases in which it would have been more advantageous for us to retain sole development and commercialization rights to such product candidate. Any such event could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are conducting and intend to conduct certain of our clinical trials globally. However, the FDA and other foreign equivalents may not accept data from such trials, in which case our development plans will be delayed, which could materially harm our business.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to continue conducting certain of our clinical trials globally. The acceptance by the FDA or other regulatory authorities of study data from clinical trials conducted outside their jurisdiction may be subject to certain conditions or may not be accepted at all. In cases where data from foreign clinical trials are intended to serve as the sole basis for marketing approval in the United States, the FDA will generally not approve the application on the basis of foreign data alone unless (i)&#160;the data are applicable to the U.S. population and U.S. medical practice; (ii)&#160;the trials were performed by clinical investigators of recognized competence and pursuant to GCP regulations; and (iii)&#160;the data may be considered valid without the need for an on-site inspection by the FDA, or if the FDA considers such inspection to be necessary, the FDA is able to validate the data through an on-site inspection or other appropriate means.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, even where the foreign study data are not intended to serve as the sole basis for approval, the FDA will not accept the data as support for an application for marketing approval unless the clinical trial is well-designed and well-conducted in accordance with GCP requirements and the FDA is able to validate the data from the trial through an onsite inspection if deemed necessary. Many foreign regulatory authorities have similar approval requirements. In addition, such foreign trials would be subject to the applicable local laws of the foreign jurisdictions where the trials are conducted. There can be no assurance that the FDA or any comparable foreign regulatory authority will accept data from trials conducted outside of the United States or the applicable jurisdiction. If the FDA or any comparable foreign regulatory authority does not accept such data, it would result in the need for additional trials, which could be costly and time-consuming, and which may result in current or any future product candidates that we may develop not receiving approval for commercialization in the applicable jurisdiction.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Conducting clinical trials outside the United States also exposes us to additional risks, including risks associated with additional foreign regulatory requirements; foreign exchange fluctuations; compliance with foreign manufacturing, customs, shipment and storage requirements; cultural differences in medical practice and clinical research; diminished protection of intellectual property in some countries; and interruptions or delays in our trials resulting from geopolitical events, such as war or terrorism.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in the methods of manufacturing or formulation of our product candidates may result in additional costs or delay.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As our product candidates progress through clinical trials to regulatory approval and commercialization, it is common that various aspects of the development program, such as manufacturing methods and formulation, may be altered along the way in an effort to optimize safety, efficacy, yield, and manufacturing batch size, minimize costs, and achieve consistent quality and results. There can be no assurance that any future manufacturing or formulation changes will achieve their intended objectives. These changes and any future changes we may make to our product candidates may also cause such candidates to perform differently and affect the results of future clinical trials conducted with the altered materials. Such changes or related unfavorable clinical trial results could delay initiation or completion of additional clinical trials, require the conduct of bridging studies or clinical trials or the repetition of one or more studies or clinical trials, increase development costs, delay or prevent potential regulatory approval, and jeopardize our ability to commercialize our product candidates, if approved, and generate revenue.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If the market opportunities for any product candidates we develop are smaller than we believe they are, our revenue may be adversely affected, and our business may suffer. Because the target patient populations of certain of our programs are small, and the addressable patient population even smaller, we must be able to successfully identify patients and capture a significant market share to achieve profitability and growth.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our research and product development initiatives are focused on treatments for rare diseases. Given the small number of patients who have certain of the diseases that we are currently targeting, including UCDs and SYNGAP1-related disorders, it is critical to our ability to grow and become profitable that we continue to successfully identify patients with these rare diseases. Our projections of both the number of people who have these diseases, as well as the subset of people with these diseases who have the potential to benefit from treatment with any product candidates we may develop, are based on our beliefs and estimates. These estimates have been derived from a variety of sources, including the scientific literature, surveys of clinics, patient foundations or market research that we conducted, and may prove to be incorrect or </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">contain errors. New studies may change the estimated incidence or prevalence of these diseases. The number of patients may turn out to be lower than expected. The effort to identify patients with diseases we seek to treat is in early stages, and we cannot accurately predict the number of patients for whom treatment might be possible. Additionally, the potentially addressable patient population for each of our product candidates may be limited or may not be amenable to treatment with our product candidates, and new patients may become increasingly difficult to identify or gain access to, which would adversely affect our results of operations and our business. Further, even if we obtain significant market share for our product candidates, because the potential target populations are very small, we may never achieve profitability despite obtaining such significant market share.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Due to the recent change in U.S. presidential administration, we face uncertainty regarding potential regulatory developments that may adversely affect our business.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face uncertainty regarding the regulatory environment following the change in U.S. presidential administration in January 2025. While many of the new Trump administration&#8217;s proposed policies appear to be focused on deregulation, the new administration and federal government could adopt legislation, regulation or policies that adversely affect our business or create a more challenging and costly environment to pursue the development and commercialization of our product candidates. For example, the federal government, including the FDA, may implement legislative, regulatory or policy changes regarding the standards for approving drug products that we may be unable to satisfy or regarding the marketing of approved drug products that may limit or prohibit the advertising and promotion of our current or future product candidates, if approved. Additionally, because one objective of the current Trump administration appears to be to decrease spending in the federal government, the FDA could face staff reductions, which could impact the FDA&#8217;s ability to engage in routine regulatory and oversight activities and result in delays or limitations on our ability to proceed with clinical development programs and obtain regulatory approvals. It is difficult to predict how executive actions that may be taken under the current Trump administration may affect the FDA&#8217;s ability to exercise its regulatory authority. If such executive actions impose constraints on the FDA&#8217;s ability to engage in routine oversight and product review activities in the normal course, our business may be negatively impacted.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Regulatory Approval and Commercialization</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Even if we complete the necessary preclinical studies and clinical trials, the marketing approval process is expensive, time-consuming and uncertain and may prevent us from obtaining approvals for the commercialization of any product candidates we may develop. If we are not able to obtain, or if there are delays in obtaining, required regulatory approvals, we will not be able to commercialize, or will be delayed in commercializing, product candidates we may develop, and our ability to generate revenue will be materially impaired.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any product candidates we may develop and the activities associated with their development and commercialization, including their design, testing, manufacture, safety, efficacy, potential confirmatory studies, recordkeeping, labeling, storage, approval, advertising, promotion, sale and distribution, are subject to comprehensive regulation by the FDA and other regulatory authorities in the United States and by comparable authorities in other countries, including the TGA in Australia, the EC and the NCAs in the European Union, and by the Medicines and Healthcare products Regulatory Agency (the &#8220;MHRA&#8221;) in the United Kingdom. Failure to obtain marketing approval for a product candidate we may develop will prevent us from commercializing the product candidate in a given jurisdiction. We have not received approval to market any product candidates from regulatory authorities in any jurisdiction. We have no experience as a company in filing and supporting the applications necessary to gain marketing approvals and expect to utilize or rely on third-party experts, CROs, and other competent groups and/or individuals to assist us in this process. Securing regulatory approval requires the submission of extensive preclinical and clinical data and supporting information to the various regulatory authorities for each therapeutic indication to establish the product candidate&#8217;s safety and efficacy. Securing regulatory approval also requires the submission of information about the product manufacturing process to, and inspection of manufacturing facilities by, the relevant regulatory authority. Any product candidates we may develop may not be effective, may be only moderately effective or may prove to have undesirable or unintended side effects, toxicities, or other characteristics that may preclude our obtaining marketing approval or prevent or limit commercial use.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The process of obtaining marketing approvals, both in the United States and abroad, is expensive, may take many&#160;years if additional clinical trials are required, if approval is obtained at all, and can vary substantially based upon a variety of factors, including the type, complexity and novelty of the product candidates involved. Of the large number of product candidates in development, only a small&#160;percentage successfully complete the FDA or foreign regulatory approval processes and are commercialized. Even if any product candidates we may develop demonstrate safety and efficacy in clinical trials, the regulatory agencies may not complete their review processes in a timely manner, or we may not be able to obtain regulatory approval. Additional delays may result if an FDA Advisory Committee or other regulatory authority recommends non-approval or restrictions on approval. Changes in marketing approval policies during the development </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">period, changes in or the enactment of additional statutes or regulations, or changes in regulatory review for each submitted product application, may cause delays in the approval or rejection of an application. The FDA and comparable authorities in other countries have substantial discretion in the approval process and may refuse to accept any application or may decide that our data is insufficient for approval and require additional preclinical, clinical or other studies. In addition, varying interpretations of the data obtained from preclinical and clinical testing could delay, limit or prevent marketing approval of a product candidate. If we experience delays in obtaining approval or if we fail to obtain approval of any product candidates we may develop, the commercial prospects for those product candidates may be harmed, and our ability to generate revenues will be materially impaired.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, under the Pediatric Research Equity Act (the &#8220;PREA&#8221;), a new drug application (an &#8220;NDA&#8221;) or supplement to an NDA for certain drugs must contain data to assess the safety and effectiveness of the drug in all relevant pediatric subpopulations and to support dosing and administration for each pediatric subpopulation for which the product is safe and effective, unless the sponsor receives a deferral or waiver from the FDA. A deferral may be granted for several reasons, including a finding that the product or therapeutic candidate is ready for approval for use in adults before pediatric trials are complete or that additional safety or effectiveness data needs to be collected before the pediatric trials begin. The applicable legislation in the EU also requires sponsors to either conduct clinical trials in a pediatric population in accordance with a Pediatric Investigation Plan approved by the Pediatric Committee of the EMA, or to obtain a waiver or deferral from the conduct of these studies by the Pediatric Committee of the EMA. For any of our product candidates for which we seek regulatory approval in the United States or the EU, we cannot guarantee that we will be able to obtain a waiver or alternatively complete any required studies and other requirements in a timely manner, or at all, which could result in associated reputational harm and subject us to enforcement action.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if we eventually complete clinical testing and receive approval of an NDA or foreign marketing application for any product candidates, the FDA or the applicable foreign regulatory agency may grant approval or other marketing authorization contingent on the performance of costly additional clinical trials, including post-market clinical trials. The FDA or the applicable foreign regulatory agency also may approve or authorize for marketing a product candidate for a more limited indication or patient population that we originally request, and the FDA or applicable foreign regulatory agency may not approve or authorize the labeling that we believe is necessary or desirable for the successful commercialization of a product candidate. Any of these restrictions or commitments could render an approved product not commercially viable, which would materially adversely impact our business and prospects.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may attempt to seek approval from the FDA or comparable foreign regulatory authorities, where applicable, under the accelerated approval pathways. We may fail to obtain approval under such accelerated approval pathways. Moreover, these pathways may not lead to a faster development, regulatory review or approval process and do not increase the likelihood that our product candidates will receive marketing approval.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may in the future seek accelerated approval, where applicable, under the FDA&#8217;s accelerated approval pathway. A product candidate may be eligible for accelerated approval if it treats a serious or life-threatening condition, generally provides a meaningful advantage over available therapies, and demonstrates an effect on a surrogate endpoint that is reasonably likely to predict clinical benefit or on a clinical endpoint that can be measured earlier than irreversible morbidity or mortality (an &#8220;IMM&#8221;) that is reasonably likely to predict an effect on IMM or other clinical benefit. As a condition of accelerated approval, the FDA likely would require that we perform adequate and well-controlled post-marketing clinical trials to confirm the product&#8217;s clinical benefit. These confirmatory trials must be completed with due diligence. Under the Food and Drug Omnibus Reform Act of 2022 (&#8220;FDORA&#8221;), the FDA is permitted to require, as appropriate, that a post-approval confirmatory study or studies be underway prior to approval or within a specified time period after the date of accelerated approval was granted. FDORA also requires sponsors to send updates to the FDA every 180&#160;days on the status of such studies, including progress toward enrollment targets, and the FDA must promptly post this information publicly. FDORA also gives the FDA increased authority to withdraw approval of a drug granted accelerated approval on an expedited basis if the sponsor fails to conduct such studies in a timely manner, send the necessary updates to the FDA, or if such post-approval studies fail to verify the drug&#8217;s predicted clinical benefit. Under FDORA, the FDA is empowered to take action, such as issuing fines, against companies that fail to conduct with due diligence any post-approval confirmatory study or submit timely reports to the agency on their progress. Even if we seek to utilize the accelerated approval pathway, we may not be able to obtain accelerated approval and, even if we do, we may not experience a faster development, regulatory review or approval process for that product. In addition, receiving accelerated approval does not ensure that the product&#8217;s accelerated approval will eventually be converted to a full approval.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the EU, under the centralized procedure, the EMA&#8217;s Committee for Medicinal Products for Human Use may perform an accelerated assessment of a marketing authorization application. Applicants requesting an accelerated assessment procedure must justify that the product candidate is expected to be of major public health interest, particularly from the point of view of therapeutic innovation. Prior to seeking accelerated approval for any of our product candidates, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">we intend to seek feedback from the FDA or similar foreign regulatory authorities and will otherwise evaluate our ability to seek and receive accelerated approval. There can be no assurance that after our evaluation of the feedback and other factors we will decide to pursue or submit an NDA or similar application for accelerated approval or any other form of expedited development or review. Similarly, there can be no assurance that after subsequent FDA or similar foreign regulatory authorities&#8217; feedback we will continue to pursue or apply for accelerated approval or any other form of expedited development or review, even if we initially decide to do so. Furthermore, if we decide to submit an application for accelerated approval or other expedited development or review for our product candidates, there can be no assurance that such submission or application will be accepted or that any expedited development or review will be granted on a timely basis, or at all. The FDA or other comparable foreign regulatory authorities could also require us to conduct further studies prior to considering our application or granting approval of any type. A failure to obtain accelerated approval or any other form of expedited development or review for our product candidate would result in a longer time period to commercialization of such product candidate, if any, could increase the cost of development of such product candidate, and could harm our competitive position in the marketplace.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may seek one or more designations or expedited programs for one or more of our product candidates, but we might not receive such designations or be allowed to proceed on expedited program pathways, and even if we do and proceed on such expedited program pathways in the future, such designations or expedited programs may not lead to a faster development or regulatory review or approval process, and each designation does not increase the likelihood that any of our product candidates will receive marketing approval in the United States.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may seek fast track designation for certain of our product candidates. If a drug is intended for the treatment of a serious or life-threatening condition and nonclinical or clinical data for the drug demonstrates the potential to address an unmet medical need for such a condition, the drug sponsor may apply for fast track designation. The FDA has broad discretion whether or not to grant this designation, so even if we believe a particular product candidate is eligible for this designation, we cannot assure you that the FDA would decide to grant it for any of our other product candidates. Even with fast-track designation, we may not experience a faster development process, review or approval compared to conventional FDA procedures. The FDA may withdraw fast track designation if it believes that the designation is no longer supported by data from our clinical development program. Fast track designation alone does not guarantee qualification for the FDA&#8217;s priority review procedures.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may seek a breakthrough therapy designation for some of our product candidates. A breakthrough therapy is defined as a drug that is intended, alone or in combination with one or more other drugs, to treat a serious or life-threatening disease or condition, and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. For product candidates that have been designated as breakthrough therapies, interaction and communication between the FDA and the sponsor of the trial can help to identify the most efficient path for clinical development while minimizing the number of patients placed in ineffective control regimens. Product candidates designated as breakthrough therapies by the FDA may also be eligible for priority review and accelerated approval. Designation as a breakthrough therapy is within the discretion of the FDA. Accordingly, even if we believe one of our product candidates meets the criteria for designation as a breakthrough therapy, the FDA may disagree and instead determine not to make such designation. In any event, the receipt of a breakthrough therapy designation for a product candidate may not result in a faster development process, review or approval compared to therapies considered for approval under conventional FDA procedures and does not assure ultimate approval by the FDA. In addition, even if one or more of our product candidates qualify as breakthrough therapies, the FDA may later decide that such product candidates no longer meet the conditions for qualification or decide that the time period for FDA review or approval will not be shortened.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the FDA determines that a product candidate offers a treatment for a serious condition and, if approved, the product would provide a significant improvement in safety or effectiveness, the FDA may designate the product candidate for priority review. A priority review designation means that the goal for the FDA to review an application is six&#160;months, rather than the standard review period of ten&#160;months. We may request priority review for our product candidates. The FDA has broad discretion with respect to whether or not to grant priority review status to a product candidate, so even if we believe a particular product candidate is eligible for such designation or status, the FDA may decide not to grant it. Moreover, a priority review designation does not necessarily result in an expedited regulatory review or approval process or necessarily confer any advantage with respect to approval compared to conventional FDA procedures. Receiving priority review from the FDA does not guarantee approval within the six-month review cycle or at all.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have received orphan drug designation for CMP-CPS-001 for the treatment of UCDs, and we may pursue orphan drug designation for certain of our other product candidates. We may not be able to obtain or maintain the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">benefits of orphan drug designation, including potential orphan drug exclusivity, and even if we do, that exclusivity may not prevent regulatory authorities from approving other competing products.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA granted orphan drug designation to CMP-CPS-001 for the treatment of UCDs in September&#160;2024; however, we may not be able to obtain or maintain the benefits of such designation, including potential orphan drug exclusivity. Additionally, we may seek orphan drug designation for certain of our other product candidates in the future; however, we may never receive such designations. Under the Orphan Drug Act, the FDA may designate a product candidate as an orphan drug if it is a drug intended to treat a rare disease or condition, defined as a patient population of fewer than 200,000 in the United States, or a patient population greater than 200,000 in the United States where there is no reasonable expectation that the cost of developing the drug will be recovered from sales in the United States Orphan drug designation must be requested before submitting an NDA. A similar regulatory scheme governs orphan products in the EU and the United Kingdom based on, among others, prevalence of the disease or condition of less than 5 in 10,000.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Orphan drug designation entitles a party to financial incentives such as opportunities for grant funding towards clinical trial costs, tax advantages and application fee waivers. After the FDA grants orphan drug designation, the generic identity of the product candidate and its potential orphan use are disclosed publicly by the FDA. In addition, if a product candidate with an orphan drug designation subsequently receives the first marketing approval for the indication for which it has such designation, the product is entitled to a period of marketing exclusivity, which precludes the FDA from approving another marketing application for the same product for the same therapeutic indication for seven&#160;years.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if we obtain orphan drug exclusivity for a product, that exclusivity may not effectively protect the product from competition because different products can be approved for the same condition. In addition, even after an orphan drug is approved, the FDA can subsequently approve the same product for the same condition if the FDA concludes that the later product is clinically superior in that it is shown to be safer, more effective or makes a major contribution to patient care. Orphan drug exclusivity may also be lost if the FDA determines that the request for designation was materially defective or if the manufacturer is unable to assure sufficient quantity of the product to meet the needs of the patients with the rare disease or condition. Further, even if we obtain orphan drug designation, we may not be the first to obtain marketing approval for any particular orphan indication due to the uncertainties associated with developing pharmaceutical products.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decision of the U.S. Court of Appeals for the 11th Circuit in Catalyst Pharms.,&#160;Inc. v. Becerra, 14 F.4th 1299 (11th Cir. 2021) has created uncertainty regarding the scope of orphan drug exclusivity. Although the FDA subsequently announced that it intends to continue to apply its longstanding interpretation of the regulations to matters outside of the scope of the Catalyst order and continue tying the scope of orphan-drug exclusivity to the uses or indications for which a drug is approved, it is unclear how future litigation, legislation, agency decisions, and administrative actions will impact the scope of the orphan drug exclusivity. The FDA may further reevaluate the Orphan Drug Act and its regulations and policies. We do not know if, when, or how the FDA may change the orphan drug regulations and policies in the future, and it is uncertain how any changes might affect our business. Depending on what changes the FDA may make to its orphan drug regulations and policies, our business could be adversely impacted.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have received rare pediatric disease designation from the FDA for CMP-CPS-001 for the treatment of UCDs; however, there is no guarantee that a marketing application for CMP-CPS-001, if approved, will qualify for a rare pediatric disease priority review voucher.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Rare Pediatric Disease Priority Review Voucher (&#8220;PRV&#8221;) program, a sponsor of an NDA that receives approval for a drug for a &#8220;rare pediatric disease&#8221; may qualify for a rare pediatric disease PRV that can be redeemed to obtain priority review for a subsequent application. Under the current statutory sunset provisions, a rare pediatric disease product application may be eligible for a rare pediatric disease PRV if the drug receives rare pediatric disease designation before December 20, 2024 and receives marketing approval before September&#160;30, 2026. While we have obtained rare pediatric disease designation for CMP-CPS-001 for the treatment of UCDs, it is unlikely that this product candidate will be approved before September&#160;30, 2026. If approval is not obtained by then, we will not be eligible for a rare pediatric disease PRV, unless Congress further reauthorizes the program beyond the current sunset date. Additionally, designation of a drug for a rare pediatric disease does not guarantee that an NDA for such product candidate will meet the criteria for a &#8220;rare pediatric disease priority product application&#8221; or be eligible for a rare pediatric disease PRV at the time the application is approved. The FDA may determine that a marketing application does not meet the eligibility criteria for a rare pediatric disease PRV for a number of reasons, including:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the rare pediatric disease that received such designation no longer meets the definition of a &#8220;rare pediatric disease&#8221;;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the marketing application contains an active ingredient (including any ester or salt of the active ingredient) that has been previously approved in a marketing application;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the marketing application is not deemed eligible for priority review;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the marketing application does not rely on clinical data derived from studies examining a pediatric population and dosages of the product intended for that population (that is, if the marketing application does not contain sufficient clinical data to allow for adequate labeling for use by the full range of affected pediatric patients); or</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the marketing application is approved for a different adult indication than the rare pediatric disease for which our product candidates are designated.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rare pediatric disease designation does not lead to faster development or regulatory review of the product or increase the likelihood that will receive marketing approval.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Obtaining and maintaining marketing approval or commercialization of our product candidates in the United States does not mean that we will be successful in obtaining marketing approval of our product candidates in other jurisdictions. Failure to obtain marketing approval in foreign jurisdictions would prevent any product candidates we may develop from being marketed in such jurisdictions, which, in turn, would materially impair our ability to generate revenue.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to market and sell any product candidates we may develop in the European Union and many other foreign jurisdictions, we or our collaborators must obtain separate marketing approvals and comply with numerous and varying regulatory requirements. The approval procedure varies among countries and can involve additional testing. The time required to obtain approval may differ substantially from that required to obtain FDA approval. The regulatory approval process outside the United States generally includes all of the risks associated with obtaining FDA approval. In addition, in many countries outside the United States, it is required that the product candidate be approved for reimbursement before the product can be approved for sale in that country. We or these third parties may not obtain approvals from regulatory authorities outside the United States on a timely basis, if at all. Approval by the FDA does not ensure approval by regulatory authorities in other countries or jurisdictions, and approval by one regulatory authority outside the United States does not ensure approval by regulatory authorities in other countries or jurisdictions or by the FDA. We may not be able to file for marketing approvals and may not receive necessary approvals to commercialize our product candidates in any jurisdiction, which would materially impair our ability to generate revenue.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, foreign regulatory authorities may change their approval policies and new regulations may be enacted. For instance, the EU pharmaceutical legislation is currently undergoing a complete revision, in the context of the Pharmaceutical Strategy for Europe initiative, launched by the European Commission in November&#160;2020. The European Commission&#8217;s proposals for revision of several fundamental legislative instruments related to medicinal products, which may reduce the duration of regulatory data protection and revise the eligibility for expedited pathways in addition to other changes, was published on April&#160;26, 2023. The proposed revisions are yet be finalized by the European Parliament and European Council through the co-decision legislative process and the proposals may therefore be substantially revised before adoption, which is not anticipated before early 2026. On April&#160;10, 2024, the European Parliament adopted its position on the Commission proposal to reform. The revisions will however have a significant impact on the pharmaceutical industry and our business in the long term.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any delay in obtaining, or an inability to obtain, any marketing approvals would prevent us from commercializing any product candidates in the United Kingdom and/or the European Union and restrict our ability to generate revenue and achieve and sustain profitability. If any of these outcomes occur, we may be forced to restrict or delay efforts to seek regulatory approval in the United Kingdom and/or the European Union for any product candidates we may develop, which could significantly and materially harm our business.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Even if we obtain regulatory approval for any of our product candidates, we will still face extensive and ongoing regulatory requirements and obligations, which may result in significant additional expense.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any product candidate for which we obtain marketing approval, along with the manufacturing processes, post-approval clinical data, labeling, packaging, distribution, adverse event reporting, storage, recordkeeping, export, import, and advertising and promotional activities for such product, among other things, will be subject to extensive and ongoing requirements of and review by the FDA and other regulatory authorities. These requirements include submissions of safety and other post-marketing information and reports, establishment registration and drug listing requirements, continued compliance with GMP requirements relating to manufacturing, quality control, quality assurance and corresponding </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">maintenance of records and documents, requirements regarding the distribution of samples to physicians and recordkeeping and GCP requirements for any clinical trials that we conduct post-approval.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if marketing approval of a product candidate is granted, the approval may be subject to limitations on the indicated uses for which the product candidate may be marketed or to the conditions of approval, including a requirement to implement a REMS.&#160;If a product candidate receives marketing approval, the accompanying label may limit the approved indicated use of the product, which could limit sales of the product. The FDA may also require costly post-marketing studies or clinical trials and surveillance to monitor the safety or efficacy of a product. The FDA closely regulates the post-approval marketing and promotion of drugs to ensure drugs are marketed only for the approved indications and in accordance with the provisions of the approved labeling. The FDA imposes stringent restrictions on manufacturers&#8217; communications regarding off-label use, and if we market our products for uses beyond their approved indications, we may be subject to enforcement action for off-label marketing. Violations of the FDCA, relating to the promotion of prescription drugs, may lead to FDA enforcement actions and investigations alleging violations of federal and state healthcare fraud and abuse laws, as well as state consumer protection laws.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to comply with applicable regulatory requirements following approval of any product candidates we may develop, a regulatory agency may:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">issue a warning letter asserting that we are in violation of the law;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seek an injunction or impose civil or criminal penalties or monetary fines;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">suspend or withdraw regulatory approval;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">suspend any ongoing clinical trials;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">refuse to approve a pending NDA or supplements to an NDA submitted by us;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seize product; or</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">refuse to allow us to enter into supply contracts, including government contracts.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any government investigation of alleged violations of law could require us to expend significant time and resources in response and could generate negative publicity. The occurrence of any event or penalty described above may inhibit our ability to commercialize any product candidates we may develop and generate revenues.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, later discovery of previously unknown problems with our products, manufacturers or manufacturing processes, or failure to comply with regulatory requirements, may yield various results, including:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">restrictions on such products, manufacturers or manufacturing processes;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">restrictions on the labeling or marketing of a product;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">restrictions on the distribution or use of a product;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">requirements to conduct post-marketing clinical trials;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">receipt of warning or untitled letters;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">withdrawal of the products from the market;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">refusal to approve pending applications or supplements to approved applications that we submit;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">recall of products;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fines, restitution or disgorgement of profits or revenue;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">suspension or withdrawal of marketing approvals;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">suspension of any ongoing clinical trials;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">refusal to permit the import or export of our products;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">product seizure; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">injunctions or the imposition of civil or criminal penalties.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any government investigation of alleged violations of law could require us to expend significant time and resources in response and could generate negative publicity. The occurrence of any event or penalty described above may </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">inhibit our ability to commercialize any product candidates we develop and adversely affect our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Supreme Court&#8217;s June&#160;2024 decision in Loper Bright Enterprises v. Raimondo overturned the longstanding Chevron doctrine, under which courts were required to give deference to regulatory agencies&#8217; reasonable interpretations of ambiguous federal statutes. The Loper decision could result in additional legal challenges to regulations and guidance issued by federal agencies, including the FDA, on which we rely. Any such legal challenges, if successful, could have a material impact on our business. Additionally, the Loper decision may result in increased regulatory uncertainty, inconsistent judicial interpretations, and other impacts to the agency rulemaking process, any of which could adversely impact our business and operations. We cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative action or as a result of legal challenges, either in the United States or abroad. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, our business could be materially harmed.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Even if any product candidate that we may develop receives marketing approval, it may fail to achieve the degree of market acceptance by physicians, patients, third-party payors and others in the medical community necessary for commercial success.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any product candidate we may develop receives marketing approval, it may nonetheless fail to gain sufficient market acceptance by physicians, patients, third-party payors and others in the medical community. Sales of medical products depend in part on the willingness of physicians to prescribe the treatment, which is likely to be based on a determination by these physicians that the products are safe, therapeutically effective and cost-effective. In addition, the inclusion or exclusion of products from treatment guidelines established by various physician groups and the viewpoints of influential physicians can affect the willingness of other physicians to prescribe the treatment. We cannot predict whether physicians, physicians&#8217; organizations, hospitals, other healthcare providers, government agencies or private insurers will determine that our product is safe, therapeutically effective and cost-effective as compared with competing treatments. Efforts to educate the medical community and third-party payors on the benefits of any product candidates we may develop may require significant resources and may not be successful. If any product candidates we may develop do not achieve an adequate level of acceptance, we may not generate significant product revenues and we may not become profitable. The degree of market acceptance of any product candidates we may develop, if approved for commercial sale, will depend on a number of factors, including:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the efficacy and safety of such product candidates as demonstrated in clinical trials;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the potential advantages and limitations compared to alternative treatments;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effectiveness of sales and marketing efforts;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost of treatment in relation to alternative treatments;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the clinical indications for which the product is approved;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the convenience and ease of administration compared to alternative treatments;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the willingness of the target patient population to try new therapies and of physicians to prescribe these therapies;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the strength of marketing and distribution support;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing of market introduction of competitive products;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the availability of third-party coverage and adequate reimbursement;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the prevalence and severity of any side effects; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any restrictions on the use of our products, if approved, together with other medications.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The pricing, insurance coverage and reimbursement status of newly approved products is uncertain. Failure to obtain or maintain adequate coverage and reimbursement for our product candidates, if approved, could limit our ability to market those products and decrease our ability to generate product revenue.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the target indications in our pipeline are indications with small patient populations. For product candidates that are designed to treat smaller patient populations to be commercially viable, the reimbursement for such product candidates must be higher, on a relative basis, to account for the lack of volume. Accordingly, we will need to implement a coverage and reimbursement strategy for any approved product candidate that accounts for the smaller potential market size. If we are unable to establish or sustain coverage and adequate reimbursement for any approved </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">product candidates from third-party payors, the adoption of those product candidates and sales revenue will be adversely affected, which, in turn, could adversely affect the ability to market or sell those product candidates, if approved.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that coverage and reimbursement by third-party payors will be essential for most patients to be able to afford these treatments. Accordingly, any future sales of our product candidates, if approved, will depend substantially, both domestically and internationally, on the extent to which the costs of such product candidates will be paid by health maintenance, managed care, pharmacy benefit and similar healthcare management organizations, or will be reimbursed by government authorities, private health coverage insurers and other third-party payors. Even if coverage is provided, the approved reimbursement amount may not be high enough to allow us to establish or maintain pricing sufficient to realize a sufficient return on our investment.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is significant uncertainty related to the insurance coverage and reimbursement of newly approved products. In the United States, the principal decisions about reimbursement by government authorities for new products are typically made by the Centers for Medicare&#160;&amp; Medicaid Services (&#8220;CMS&#8221;), since CMS decides whether and to what extent a new product will be covered and reimbursed under Medicare. Private payors tend to follow CMS to a substantial degree. However, one payer&#8217;s determination to provide coverage for a product does not assure that other payors will also provide coverage for the drug product. Further, a payer&#8217;s decision to provide coverage for a drug product does not imply that an adequate reimbursement rate will be approved. Reimbursement agencies in the European Union may be more conservative than CMS.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside the United States, international operations are generally subject to extensive governmental price controls and other market regulations, and we believe the increasing emphasis on cost-containment initiatives in Europe, Canada and other countries has and will continue to put pressure on the pricing and usage of therapeutics such as any product candidates we may develop. In many countries, particularly the countries of the European Union, the prices of medical products are subject to varying price control mechanisms as part of national health systems. In these countries, pricing negotiations with governmental authorities can take considerable time after the receipt of marketing approval for a product. As a result, we might obtain marketing approval for a product in a particular country, but then be subject to price regulations that delay or might even prevent our commercial launch of the product, possibly for lengthy periods of time. To obtain reimbursement or pricing approval in some countries, we may be required to conduct a clinical trial that compares the cost-effectiveness of our product candidate to other available therapies. In general, the prices of products under such systems are substantially lower than in the United States. Other countries allow companies to fix their own prices for products but monitor and control company profits. Additional foreign price controls or other changes in pricing regulation could restrict the amount that we are able to charge for product candidates. Accordingly, in markets outside the United States, the reimbursement for any product candidates we may develop may be reduced compared with the United States and may be insufficient to generate commercially reasonable revenues and profits.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, increasing efforts by governmental and third-party payors, in the United States and internationally, to cap or reduce healthcare costs may cause such organizations to limit both coverage and level of reimbursement for new products approved and, as a result, they may not cover or provide adequate payment for any product candidates we may develop. We expect to experience pricing pressures in connection with the sale of any product candidates we may develop due to the trend toward managed healthcare, the increasing influence of certain third-party payors, such as health maintenance organizations, and additional legislative changes. The downward pressure on healthcare costs in general, particularly prescription drugs and surgical procedures and other treatments, has become very intense. As a result, increasingly high barriers are being erected to the entry of new products into the healthcare market. There have been instances in which third-party payors have refused to reimburse treatments for patients for whom the treatment is indicated in the FDA-approved product label. Even if we are successful in obtaining FDA approvals to commercialize our product candidates, we cannot guarantee that we will be able to secure reimbursement for all patients for whom treatment with our product candidates is indicated.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to CMS and private payors, professional organizations, such as the American Medical Association, can influence decisions about reimbursement for new products by determining standards for care. In addition, many private payors contract with commercial vendors who sell software that provide guidelines that attempt to limit utilization of, and therefore reimbursement for, certain products deemed to provide limited benefit to existing alternatives. Such organizations may set guidelines that limit reimbursement or utilization of our product candidates. Even if favorable coverage and reimbursement status is attained for one or more product candidates for which we or our collaborators receive regulatory approval, less favorable coverage policies and reimbursement rates may be implemented in the future.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to establish sales, marketing and distribution capabilities or enter into sales, marketing and distribution agreements with third parties, we may not be successful in commercializing any product candidates we may develop if and when they are approved.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not have a sales or marketing infrastructure and have no experience in the sale, marketing or distribution of pharmaceutical products. To achieve commercial success for any product for which we have obtained marketing approval, we will need to establish a sales, marketing and distribution organization, either ourselves or through collaborations or other arrangements with third parties.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the future, we may build a sales and marketing infrastructure to market some of the product candidates we may develop if and when they are approved. There are risks involved with establishing our own sales, marketing and distribution capabilities. For example, recruiting and training a sales force is expensive and time-consuming and could delay any product launch. If the commercial launch of a product candidate for which we recruit a sales force and establish marketing capabilities is delayed or does not occur for any reason, we would have prematurely or unnecessarily incurred these commercialization expenses. These efforts may be costly, and our investment would be lost if we cannot retain or reposition our sales and marketing personnel.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Factors that may inhibit our efforts to commercialize our products on our own include:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our inability to recruit, train and retain adequate numbers of effective sales, marketing, coverage or reimbursement, customer service, medical affairs and other support personnel;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the inability of sales personnel to educate adequate numbers of physicians on the benefits of such product candidates;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the inability of reimbursement professionals to negotiate arrangements for formulary access, reimbursement and other acceptance by payors;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the inability to price our products at a sufficient price point to ensure an adequate and attractive level of profitability;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">restricted or closed distribution channels that make it difficult to distribute our products to segments of the patient population;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the lack of complementary products to be offered by sales personnel, which may put us at a competitive disadvantage relative to companies with more extensive product lines; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unforeseen costs and expenses associated with creating an independent sales and marketing organization.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to establish our own sales, marketing and distribution capabilities and we enter into arrangements with third parties to perform these services, our product revenues and our profitability, if any, are likely to be lower than if we were to market, sell and distribute any products that we develop ourselves. In addition, we may not be successful in entering into arrangements with third parties to sell, market and distribute any product candidates we may develop or may be unable to do so on terms that are acceptable to us. We likely will have little control over such third parties, and any of them may fail to devote the necessary resources and attention to sell and market our products effectively. If we do not establish sales, marketing and distribution capabilities successfully, either on our own or in collaboration with third parties, we will not be successful in commercializing any product candidates we may develop.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our relationships with healthcare providers, physicians, patients and third-party payors may be subject to various anti-kickback, fraud and abuse, other healthcare laws and regulations, which could increase compliance costs, and our failure to comply with these laws and regulations could harm our reputation, subject us to significant fines and liability, or otherwise adversely affect our business.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business operations and current and future arrangements with investigators, healthcare professionals, consultants, third-party payors, patient organizations, and customers may expose us to broadly applicable fraud and abuse and other healthcare laws and regulations. These laws may constrain the business or financial arrangements and relationships through which we conduct our operations, including how we research, market, sell, and distribute any products for which we obtain regulatory approval. Such laws include:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal Anti-Kickback Statute (&#8220;AKS&#8221;), which prohibits, among other things, persons or entities from knowingly and willfully soliciting, offering, receiving, or providing any remuneration (including any kickback, bribe, or certain rebates), directly or indirectly, overtly or covertly, in cash or in kind, in return for, either the referral of an individual or the purchase, lease, or order, or arranging for or recommending the purchase, lease, or order of any good, facility, item, or service, for which payment may be made, in whole or </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:6pt;padding-left:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in part, under a federal healthcare program such as Medicare and Medicaid. A person or entity does not need to have actual knowledge of the federal AKS or specific intent to violate it in order to have committed a violation;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal false claims laws, including the civil False Claims Act (&#8220;FCA&#8221;), and civil monetary penalties laws, which prohibit, among other things, individuals or entities from knowingly presenting, or causing to be presented, to the federal government, claims for payment or approval that are false or fraudulent, knowingly making, using or causing to be made or used, a false record or statement material to a false or fraudulent claim, or from knowingly making or causing to be made a false statement to avoid, decrease or conceal an obligation to pay money to the federal government. In addition, the government may assert that a claim including items or services resulting from a violation of the federal AKS constitutes a false or fraudulent claim for purposes of the civil FCA. Manufacturers can be held liable under the FCA even when they do not submit claims directly to government payors if they are deemed to &#8220;cause&#8221; the submission of false or fraudulent claims; the FCA also permits a private individual acting as whistleblower to bring actions on behalf of the federal government alleging violations of the FCA and to share in any monetary recovery;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Civil Monetary Penalties Law, which covers a variety of conduct, often violations under other laws, and includes penalties for violating the AKS violations, causing the submission of false claims, and offering or transfer of remuneration to a Medicare or state healthcare program beneficiary if the person knows or should know it is likely to influence the beneficiary&#8217;s selection of a particular provider, practitioner, or supplier of services reimbursable by Medicare or a state healthcare program;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;), as amended by the Health Information Technology for Economic and Clinical Health Act of 2009 and their implementing regulations, which imposes criminal and civil liability for, among other things, knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program, or knowingly and willfully falsifying, concealing, or covering up a material fact or making any materially false statement, in connection with the delivery of, or payment for, healthcare benefits, items, or services. Similar to the federal AKS, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation. HIPAA also imposes obligations related to the privacy, security, and transmission of individually identifiable health information that apply to many healthcare providers, physicians, and third-party payors with whom we interact;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">federal consumer protection and unfair competition laws broadly regulate marketplace activities and activities that potentially harm consumers;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">federal government price reporting laws, which require pharmaceutical manufacturers to report certain calculated product prices to the government or provide certain discounts or rebates to government authorities or private entities, often as a condition of reimbursement under governmental healthcare programs;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal Physician Payments Sunshine Act, which requires certain manufacturers of drugs, devices, biologics, and medical supplies for which payment is available under Medicare, Medicaid, or the Children&#8217;s Health Insurance Program (with certain exceptions) to report annually to CMS, information related to payments and other &#8220;transfers of value&#8221; made to &#8220;physicians&#8221; (which has the same meaning as under Section 1861(r) of the Social Security Act, which generally includes doctors of medicine, osteopathy, dentists, podiatrists, optometrists and chiropractors who are legally authorized to practice by a state), certain non-physician practitioners (physician assistants, nurse practitioners, clinical nurse specialists, certified nurse anesthetists, anesthesiology assistants, and certified nurse-midwives), and teaching hospitals and other healthcare providers, as well as ownership and investment interests held by such healthcare professionals and their immediate family members; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">analogous state and foreign laws and regulations, such as state anti-kickback and false claims laws, which may apply to sales or marketing arrangements and claims involving healthcare items or services reimbursed by non-governmental third-party payors, including private insurers; some state laws require biopharmaceutical companies to comply with the biopharmaceutical industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government and may require drug manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers or marketing expenditures; some state laws that require biopharmaceutical companies to report information on the pricing of certain drug products; and some state and local laws that require the registration of pharmaceutical sales representatives.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare providers, physicians and third-party payors in the United States and elsewhere play a primary role in the recommendation and prescription of pharmaceutical products. Arrangements with third-party payors and customers can expose pharmaceutical manufacturers to broadly applicable fraud and abuse and other healthcare laws and regulations, which may constrain the business or financial arrangements and relationships through which such companies sell, market and distribute pharmaceutical products. In particular, the promotion, sales and marketing of healthcare items and services, as well as a wide range of pricing, discounting, marketing and promotion, structuring and commissions, certain customer incentive programs and other business arrangements, are subject to extensive laws designed to prevent fraud, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, structuring and commissions, support programs and other business arrangements generally. Activities subject to these laws also involve the improper use of information obtained in the course of patient recruitment for clinical trials.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Efforts to ensure that our current and future business arrangements with third parties will comply with applicable healthcare laws and regulations will involve substantial ongoing costs. It is possible that governmental authorities will conclude that our business practices, including certain consulting agreements and advisor agreements we have entered into with physicians who are paid, in part, in the form of stock or stock options, may not comply with current or future statutes, regulations or case law involving applicable fraud and abuse or other healthcare laws and regulations. Due to the breadth of these laws, the narrowness of statutory exceptions and regulatory safe harbors available, and the range of interpretations to which they are subject, it is possible that some of our current or future practices might be challenged under one or more of these laws. If our operations are found to be in violation of any of these laws or any other governmental regulations that may apply to us, we may be subject to significant penalties, including civil, criminal, and administrative penalties, damages, fines, disgorgement, imprisonment, exclusion from participation in government-funded healthcare programs, such as Medicare and Medicaid, integrity oversight and reporting obligations, contractual damages, reputational harm, diminished profits and future earnings, and the curtailment or restructuring of our operations. Defending against any such actions can be costly and time-consuming and may require significant financial and personnel resources. Therefore, even if we are successful in defending against any such actions that may be brought against us, our business may be impaired. Further, if any of the physicians or other healthcare providers or entities with whom we expect to do business are found be non-compliant with applicable laws or regulations, they may be subject to significant criminal, civil, or administrative sanctions, including exclusions from government-funded healthcare programs.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Current and future healthcare reform legislation or regulation may increase the difficulty and cost for us to obtain coverage for and commercialize our product candidates and may adversely affect the prices we may set.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States and some foreign jurisdictions, there have been, and we expect there will continue to be, a number of legislative and regulatory changes to the healthcare system, including cost-containment measures that may reduce or limit coverage and reimbursement for newly approved drugs and biologics and affect our ability to profitably sell any product candidates for which we obtain regulatory approval. In particular, there have been and continue to be a number of initiatives at the U.S. federal and state levels that seek to reduce healthcare costs and improve the quality of healthcare.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, the Patient Protection and Affordable Care Act and Health Care and Education Reconciliation Act (the &#8220;Affordable Care Act&#8221;), which became law in the United States in 2010, contains provisions will become more salient to our business if any of our product candidates are approved. The Affordable Care Act includes, among other things, changes to the coverage and payments for products under government healthcare programs, profitability of drug products through increased rebates for drugs reimbursed by Medicaid programs, extension of Medicaid rebates to Medicaid managed care plans, mandatory discounts for certain Medicare Part D beneficiaries. and annual fees based on pharmaceutical companies&#8217; share of sales to federal health care programs. We may face uncertainties because of efforts to repeal, substantially modify or invalidate some or all of the provisions of the Affordable Care Act. There is no assurance that the Affordable Care Act, as currently enacted or as amended in the future, will not adversely affect our business and financial results, and we cannot predict how future federal or state legislative or administrative changes relating to healthcare reform will affect our business.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, other legislative changes have been proposed and adopted since the Affordable Care Act was enacted. For example, beginning April&#160;1, 2013, Medicare payments to providers were reduced under the sequestration required by the Budget Control Act of 2011, which will remain in effect through 2032, unless additional Congressional action is taken. Additionally, on January&#160;2, 2013, the American Taxpayer Relief Act of 2012 was signed into law, which, among other things, further reduced Medicare payments to several providers, including hospitals, imaging centers, and cancer treatment centers, and increased the statute of limitations period for the government to recover overpayments to providers from three to five&#160;years. On March&#160;11, 2021, the American Rescue Plan Act of 2021 was signed into law, which eliminates the statutory cap on Medicaid drug rebates beginning January&#160;1, 2024. The rebate was previously capped at 100% of a drug&#8217;s average manufacturer price. Additionally, the Inflation Reduction Act of 2022 includes several provisions such as drug </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pricing controls and Medicare redesign that are likely to impact our business to varying degrees, but its ultimate effect on our business and the healthcare industry in general is not yet known. See &#8220;Healthcare laws and regulation in the United States-Healthcare reform&#8221; section for a more detailed discussion.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, there has been heightened governmental scrutiny in the United States of pharmaceutical pricing practices in light of the rising cost of prescription drugs. Such scrutiny has resulted in several recent congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient assistance programs, and reform government program reimbursement methodologies for products. There is also significant economic pressure on state budgets that may result in states increasingly seeking to achieve budget savings through mechanisms that limit coverage or payment for drugs or that would allow for importation of pharmaceutical products from lower cost jurisdictions outside the United States. State Medicaid programs are increasingly requesting manufacturers to pay supplemental rebates and requiring prior authorization by the state program for use of any drug for which supplemental rebates are not being paid. Government efforts to reduce Medicaid expenses may lead to increased use of managed care organizations by Medicaid programs. This may result in managed care organizations influencing prescription decisions for a larger segment of the population and a corresponding limitation on prices and reimbursement for our products, if approved.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, we cannot predict changes resulting from the 2024 U.S. election and resulting changes in leadership of the Department of Health and Human Services, including potential changes that might impact funding for drug research and development, reimbursement for drugs and their administration, drug mandates and recommendations, and public perception of the pharmaceutical and biotech industry.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These healthcare reforms, as well as other healthcare reform measures that may be adopted in the future, may result in additional reductions in Medicare and other healthcare funding, more rigorous coverage criteria, new payment methodologies and additional downward pressure on the price that we receive for any approved product and/or the level of reimbursement physicians receive for administering any approved product we might bring to market. Reductions in reimbursement levels may negatively impact the prices we receive or the frequency with which our potential products are prescribed or administered. Any reduction in reimbursement from Medicare or other government programs may result in a similar reduction in payments from private payors.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to privacy laws, regulations, and contractual obligations related to data privacy and security and changes in such laws, regulations, and contractual obligations and failure to comply with such requirements could subject us to significant fines and penalties, which may have a material adverse effect on our business, financial condition, results of operations or prospects.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to data protection laws, regulations, and contractual obligations that apply to the collection, transmission, storage and use of personal information, which among other things, impose certain requirements relating to the privacy, security and transmission of personal information, including comprehensive regulatory systems in the United States, European Union and United Kingdom. The legislative and regulatory landscape for privacy and data protection continues to evolve in jurisdictions worldwide, and there has been an increasing focus on privacy and data protection issues with the potential to affect our business. Almost 20 states in the United States have passed comprehensive data protection legislation, and the global regulatory environment pertaining to information security and privacy is increasingly demanding, with new and changing requirements, such as the European Union&#8217;s General Data Protection Regulation, The Personal Information Protection Law of the People&#8217;s Republic of China and Brazil&#8217;s Lei Geral de Protecao de Dados. Complying with these laws and regulations may be more costly or take longer than we anticipate, and any failure to comply with any of these laws and regulations could result in enforcement action against us, including fines, claims for damages by affected individuals, damage to our reputation and loss of goodwill, any of which could have a material adverse effect on our business, financial condition, results of operations or prospects.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are numerous U.S. federal and state laws and regulations related to the privacy and security of personal information. In particular, regulations promulgated pursuant to HIPAA establish privacy and security standards that limit the use and disclosure of individually identifiable health information, or protected health information, and impose requirements regarding the privacy and security of individually identifiable health information, including mandatory contractual terms, for covered entities, or certain healthcare providers, health plans, and healthcare clearinghouses, and their business associates that provide services to the covered entity that involve individually identifiable health information and their subcontractors that use, disclose, or otherwise process individually identifiable health information. While pharmaceutical and biotechnology companies are typically not directly regulated by HIPAA, our business may be indirectly impacted by HIPAA in our interactions with providers, payors, and others that have HIPAA compliance obligations. If we are unable to properly protect the privacy and security of protected health information, we could be found to have violated these privacy and security laws and/or breached certain contracts. Further, if we fail to comply with </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">applicable privacy laws, including applicable HIPAA privacy and security standards, we could face significant civil and criminal penalties. HHS enforcement activity can result in financial liability and reputational harm, and responses to such enforcement activity can consume significant internal resources. In some states, such as California and Washington, state privacy laws are even more protective than HIPAA. In addition, state attorneys general are authorized to bring civil actions seeking either injunctions or damages in response to violations that threaten the privacy of state residents. We cannot be sure how these regulations will be interpreted, enforced or applied to our operations. </span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the risks associated with enforcement activities and potential contractual liabilities, our ongoing efforts to comply with evolving laws and regulations at the federal and state level may be costly and require ongoing modifications to our policies, procedures and systems. States are increasingly regulating the privacy and security of personal information, requiring attention to frequently changing regulatory requirements. Almost 20 other U.S. states have enacted comprehensive data privacy laws that have taken effect or will come into effect at various times over the next few years. Similar laws have been passed or are being considered in several other states, as well as at the federal and local levels. All of these evolving compliance and operational requirements impose significant costs that are likely to increase over time, may require us to modify our data processing practices and policies, divert resources from other initiatives and projects and could restrict the way services involving data are offered, all of which may adversely affect our results of operations. We will need to evaluate and update our privacy program to seek to comply with applicable privacy and data security laws, which may impose substantial penalties for violations, impose significant costs for investigations and compliance, and carry significant potential liability for our business, and we expect to incur additional expense in our effort to comply.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also potentially subject to privacy enforcement from the Federal Trade Commission (the &#8220;FTC&#8221;). The FTC has been particularly focused on health and genetic data through its recent enforcement actions and is expanding the types of privacy violations that it interprets to be &#8220;unfair&#8221; under Section 5 of the Federal Trade Commission Act, as well as the types of activities it views to trigger the Health Breach Notification Rule, which the FTC also has the authority to enforce. We will need to account for the FTC&#8217;s evolving rules and guidance for proper privacy and data security practices in order to mitigate our risk for a potential enforcement action, which may be costly. If we are subject to a potential FTC enforcement action, we may be subject to a settlement order that requires us to adhere to very specific privacy and data security practices, which may impact our business. We may also be required to pay fines as part of a settlement, depending on the nature of the alleged violations. If we violate any consent order that we reach with the FTC, we may be subject to additional fines and compliance requirements.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside of the U.S., data protection laws, including the E.U. General Data Protection Regulation (the &#8220;GDPR&#8221;), which also forms part of the law of England and Wales, Scotland and Northern Ireland by virtue of section 3 of the European Union (Withdrawal) Act 2018 and as amended by the Data Protection, Privacy and Electronic Communications (Amendments etc.) (EU Exit) Regulations 2019 (SI 2019/419) (&#8220;UK GDPR&#8221;), also apply to some of our operations. The GDPR and UK GDPR increase our obligations with respect to the processing of personal information in relation to clinical trials conducted in the member states of the EEA and the UK, including by expanding the definition of personal information to include coded (pseudonymized) data and requiring changes to informed consent practices and more detailed notices for clinical trial subjects and investigators. In addition, the GDPR and the UK GDPR increase the scrutiny that clinical trial sites located in the EEA and UK should apply to transfers of personal information from such sites to countries that are considered to lack an adequate level of data protection. The GDPR and UK GDPR impose substantial fines for breaches of data protection requirements, which can be up to four percent of global revenue or 20 million Euros (&#163;17.5 million in the U.K.), whichever is greater, and they also confer a private right of action on data subjects for breaches of data protection requirements. Compliance with these laws is a rigorous and time-intensive process that requires review and updates that may increase our cost of doing business, and despite those efforts, there is a risk that we may be subject to fines and penalties, litigation and reputational harm in connection with our European and UK activities. In addition, as we conduct clinical trials in Australia and may in the future conduct clinical trials or seek to commercialize our products outside of the United States, we will also be subject to a variety of foreign data protection laws and regulations. For our clinical trials in Australia, to the extent that the sites for our trials include certain university, company or government agencies, we may be subject to restrictions and data protection obligations under the Privacy Act 1988 (Cth). We may, otherwise, be subject to additional data protection laws in Australia in the states and territories in which we conduct our trials, which have similar restrictions on our ability to collect, analyze and transfer medical records and other patient data. These laws may impact our business. Other governmental authorities around the world are considering and, in some cases, have enacted, similar privacy and data security laws. Our failure to comply with these privacy laws and regulations or significant changes in the laws and regulations restricting our ability to obtain required patient information could significantly impact our business and our future business plans.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Laws and regulations governing any international operations we may have in the future may preclude us from developing, manufacturing and selling certain product candidates outside of the United States and require us to develop and implement costly compliance programs.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to numerous laws and regulations in each jurisdiction outside the United States in which we operate. The creation, implementation and maintenance of international business practices compliance programs is costly and such programs are difficult to enforce, particularly where reliance on third parties is required.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Foreign Corrupt Practices Act (the &#8220;FCPA&#8221;), prohibits any U.S. individual or business from paying, offering, or authorizing the provision of money or anything of value, directly or indirectly through parties, to any foreign official, official of a public international organization, or political party official or candidate for the purpose of influencing any act or decision of the foreign entity in order to assist the individual or business in obtaining or retaining business. The FCPA also obligates companies whose securities are listed in the United States to comply with certain accounting provisions requiring the company to maintain books and records that accurately and fairly reflect all transactions of the corporation, including international subsidiaries, and to devise and maintain an adequate system of internal accounting controls for international operations. The anti-bribery provisions of the FCPA are enforced primarily by the Department of Justice. The SEC is involved with enforcement of the books and records provisions of the FCPA.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compliance with the FCPA and other anti-corruption laws potentially applicable to our business is expensive and difficult, particularly in countries in which corruption is a recognized problem. In addition, compliance with the FCPA and other anti-corruption laws presents particular challenges in the pharmaceutical industry, because, in many countries, hospitals are operated by the government, and doctors and other hospital employees are considered foreign officials.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various U.S. export and sanctions laws, regulations and executive orders also restrict the use and dissemination outside of the United States, or the sharing with certain non-U.S. nationals, of certain products and technical data relating to those products. Furthermore, such export and sanctions laws include restrictions or prohibitions on the sale or supply of certain products and services to U.S. embargoed countries or sanctioned countries, governments, persons and entities. Our expansion outside of the United States has required, and will continue to require, us to dedicate additional resources to comply with these laws, and these laws may preclude us from developing, manufacturing or selling certain drugs and drug candidates outside of the United States, which could limit our growth potential and increase our development costs. The failure to comply with laws governing international business practices may result in substantial penalties, including suspension or debarment from government contracting. Violation of the FCPA and export and sanctions laws can result in significant civil and criminal penalties, imprisonment, the loss of export or import privileges, debarment, breach of contract and fraud litigation, reputational harm, and other consequences. Indictment alone under the FCPA can lead to suspension of the right to do business with the U.S. government until the pending claims are resolved. Conviction of a violation of the FCPA can result in long-term disqualification as a government contractor. The termination of a government contract or relationship as a result of our failure to satisfy any of our obligations under laws governing international business practices would have a negative impact on our operations and harm our reputation and ability to procure government contracts. The SEC also may suspend or bar issuers from trading securities on U.S. exchanges for violations of the FCPA&#8217;s accounting provisions.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inadequate funding for the FDA, the Securities and Exchange Commission (the &#8220;SEC&#8221;), and other government agencies, including from government shut downs, or other disruptions to these agencies&#8217; operations, could hinder their ability to hire and retain key leadership and other personnel, prevent new products and services from being developed or commercialized in a timely manner or otherwise prevent those agencies from performing normal business functions on which the operation of our business may rely, which could negatively impact our business.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ability of the FDA and comparable foreign regulatory authorities to review and approve or certify new products can be affected by a variety of factors, including government budget and funding levels, ability to hire and retain key personnel and accept the payment of user fees and statutory, regulatory and policy changes. Average review times at the agency have fluctuated in recent&#160;years as a result. Disruptions at the FDA, other agencies and authorities may also slow the time necessary for new product candidates to be reviewed and/or approved, which would adversely affect our business. In addition, government funding of the SEC and other government agencies on which our operations may rely, including those that fund research and development activities, is subject to the political process, which is inherently fluid and unpredictable.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disruptions at the FDA, other agencies, and authorities may also slow the time necessary for new product candidates to be reviewed and/or approved by necessary government agencies, foreign regulatory authorities, which would adversely affect our business. For example, over the last several&#160;years the U.S. government has shut down several times and certain regulatory agencies, such as the FDA and the SEC, have had to furlough critical employees and stop critical </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">activities. If a prolonged government shutdown occurs, it could significantly impact the ability of the FDA to timely review and process our regulatory submissions, which could have a material adverse effect on our business. Further, future government shutdowns could impact our ability to access the public markets and obtain necessary capital in order to properly capitalize and continue our operations.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Reliance on Third Parties</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely, and intend to continue to rely, on third parties to perform some of our preclinical studies and conduct our clinical trials. If these third parties do not successfully carry out their contractual duties, fail to comply with applicable regulatory requirements, or do not meet expected deadlines, our development programs may be delayed or subject to increased costs or we may be unable to obtain regulatory approval for or commercialize our product candidates.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are dependent on third parties to perform some of our preclinical studies and to conduct our ongoing and planned clinical trials. Specifically, we rely on, and intend to continue to rely on, medical institutions, clinical investigators, CROs, consultants and other third parties to perform some of our preclinical studies and conduct our clinical trials and the subsequent collection and analysis of data. These third parties play a significant role in the conduct and timing of our research, preclinical studies and clinical trials. While we have and will have agreements governing the committed activities of these third parties, we have limited influence over their actual performance. Nevertheless, we are responsible for ensuring that each of our clinical trials is conducted in accordance with the applicable protocol and legal, regulatory, and scientific standards and requirements, and our reliance on third parties does not relieve us of our regulatory responsibilities. In addition, we and these third parties are required to comply with GLP requirements for certain preclinical studies, as well as GCP requirements, which are regulations and guidelines enforced by the FDA and comparable foreign regulatory authorities for clinical trials of all of our product candidates. Regulatory authorities enforce these GCP requirements through periodic inspections of trial sponsors, principal investigators, and trial sites. If we or any of these third parties fail to comply with applicable GLP or GCP or other requirements, the clinical data generated in our preclinical studies or clinical trials may be deemed unreliable, and the FDA, TGA or comparable foreign regulatory authorities may require us to perform additional preclinical studies or clinical trials before approving our marketing applications, if ever. Further, our clinical trials must be conducted with product produced in accordance with current GMP regulations. Failure to comply with these regulations may require us to repeat clinical trials, which would delay the regulatory approval process.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is no guarantee that any such CROs, clinical investigators or other third parties on which we rely will devote adequate time and resources to our development activities or perform as contractually required. If any of these third parties fail to meet expected deadlines, adhere to our clinical protocols, or meet regulatory requirements, or otherwise perform in a substandard manner or terminate their engagements with us, the timelines for our development programs may be extended, delayed or subject to increased costs, or our clinical trials may be extended, delayed, or terminated. In addition, many of these third parties may also have relationships with other entities, including our competitors, for whom they may also be conducting clinical trials or other development activities that could harm our competitive position. If these third parties do not successfully carry out their contractual duties or obligations or meet expected deadlines, if they need to be replaced or if the quality or accuracy of the preclinical or clinical data they obtain is compromised due to the failure to adhere to our protocols or regulatory requirements or for other reasons, our development timelines, including clinical development timelines, may be extended, delayed or terminated and we may not be able to complete development of, obtain regulatory approval of or successfully commercialize our product candidates. As a result, our financial results and the commercial prospects for our product candidates would be harmed, our costs could increase and our ability to generate revenue could be delayed or precluded entirely.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of our relationships with these third parties terminate, we may not be able to enter into arrangements with alternative third parties on commercially reasonable terms, in a timely manner or at all. Switching or adding additional CROs, clinical investigators, and other third parties involves additional cost and requires our management&#8217;s time and focus. In addition, there is a natural transition period when a new CRO or other third party commences work. As a result, delays occur, which can materially impact our ability to meet our desired clinical development timelines. Though we endeavor to carefully manage our relationships with our CROs, clinical investigators and other third parties, there can be no assurance that we will not encounter challenges or delays in the future or that these delays or challenges will not have a material adverse impact on our business, financial condition, and prospects.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We currently depend on third-party suppliers for the manufacture of our product candidates. The loss of these or future third-party suppliers, or their inability to provide us with sufficient supply, could harm our business.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not own or operate manufacturing facilities and have no current plans to develop our own clinical or commercial-scale manufacturing capabilities. We rely on third-party suppliers for the manufacture of our product </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">candidates. We expect to continue to depend on third-party suppliers for the manufacture of any product candidates that we evaluate in preclinical studies and clinical trials, as well as for commercial manufacture if those product candidates receive marketing approval. The facilities used by third-party manufacturers to manufacture our product candidates must be approved by the FDA and any comparable foreign regulatory authority pursuant to inspections that will be conducted after we submit an NDA to the FDA or any comparable filing to a foreign regulatory authority. We have limited control over the manufacturing process of, and are completely dependent on, third-party manufacturers or Contract Manufacturing Organizations (&#8220;CMOs&#8221;) for compliance with GMP requirements for manufacture of products. If these third-party manufacturers cannot successfully manufacture material that conforms to our specifications and the strict regulatory requirements of the FDA or any comparable foreign regulatory authority, they will not be able to secure and/or maintain regulatory approval for their manufacturing facilities.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we have limited control over the ability of third-party manufacturers to maintain adequate quality control, quality assurance and qualified personnel. If the FDA or any comparable foreign regulatory authority does not approve these facilities for the manufacture of any product candidates we may develop or if it withdraws any such approval in the future, we may need to find alternative manufacturing facilities, which would significantly impact our ability to develop, obtain regulatory approval for or market any product candidates we may develop, if approved. Our failure or the failure of our third-party manufacturers to comply with applicable regulations could result in sanctions being imposed on us, including clinical holds, fines, injunctions, civil penalties, delays in approval or other delays, suspension or withdrawal of approvals, seizures or recalls of product candidates or products, operating restrictions and criminal prosecutions, any of which could significantly and adversely affect supplies of our product candidates.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, certain of the raw materials for our product candidates are currently provided by two Chinese companies, Hongene Biotech and WuXi TIDES, a subsidiary of WuXi AppTec, and we expect to rely on these suppliers for the foreseeable future on an as-needed basis. Certain Chinese biotechnology companies and CMOs, including these suppliers, may become subject to trade restrictions, sanctions, and other regulatory requirements by the U.S. government, which could restrict or even prohibit our ability to work with such entities, thereby potentially disrupting the supply of material to us. In January&#160;2024, the U.S. House of Representatives introduced the BIOSECURE Act (H.R. 7085), which was subsequently amended on May&#160;15, 2024, and the Senate advanced a substantially similar bill (S.3558), both of which would have prohibited U.S. federal executive agencies from contracting with any entity where the biotechnology equipment or services of a &#8220;biotechnology company of concern&#8221; would be used in the performance of that contract. Generally speaking, the bills defined a &#8220;biotechnology company of concern&#8221; as a biotechnology company headquartered in or subject to the jurisdiction of a foreign adversary&#8217;s government and that poses a threat to national security. Both the House and Senate&#8217;s version of the bills named WuXi Apptec, MGI, BGI, and Complete Genomics as biotechnology companies of concern, and authorized the U.S. government to include additional Chinese biotechnology companies of concern. The amended House bill also named WuXi Biologics and provided a grandfathering provision with respect to a contract or agreement entered into with a designated &#8220;biotechnology company of concern&#8221; before the effective date until January 1, 2032. The final language, pathway and timing either of these bills or their provisions to become law remain uncertain and, although the bill was passed in the House on September 9, 2024, the Senate did not pass the bill before the end of the 118th Congress&#8217;s term. Nonetheless, if these bills are re-introduced in the House and Senate and become law, or similar laws are passed that include the proposed grandfathering provisions, we expect such grandfathering provisions will allow adequate time for us to identify alternative manufacturers, if necessary. To the extent any of our counterparties, or any of their subsidiaries or affiliates, is identified as a &#8220;biotechnology company of concern,&#8221; our ability to purchase services or products from, or otherwise work with, such counterparty could be restricted or even prohibited. In addition to the BIOSECURE Act, any additional executive action, legislative action or potential sanctions applicable to our current and any future suppliers could materially impact our relationship with such suppliers. U.S. executive agencies have the ability to designate entities and individuals on various governmental prohibited and restricted parties lists. Depending on the designation, potential consequences can range from a comprehensive prohibition on all transactions or dealings with designated parties, or a limited prohibition on certain types of activities, such as exports and financing activities, with designated parties. If any current or future supplier is designated on any U.S. government prohibited party lists, such designation could impact and potentially restrict our engagement with such suppliers. Such disruption could have adverse effects on the development of our product candidates and our business operations.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The new U.S. presidential administration has substantially altered prior U.S. government international trade policy and has commenced activities to renegotiate, or potentially terminate, certain existing bilateral or multi-lateral trade agreements and treaties with foreign countries. In addition, the new administration has initiated or is considering imposing tariffs on certain foreign goods. Related to this action, certain foreign governments, including China, have instituted or are considering imposing tariffs on certain U.S. goods. It remains unclear what the new administration or foreign governments will or will not do with respect to tariffs or other international trade agreements and policies. A trade war or other governmental action related to tariffs or international trade agreements or policies has the potential to disrupt our research </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">activities, affect our suppliers, increase the cost of materials purchased to manufacture our product candidates, impact our ability to sell our product candidates, if approved, at competitive prices and/or to affect the U.S. or global economy or certain sectors thereof and, thus, could adversely impact our business.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any failure by a third-party manufacturer to execute on our manufacturing requirements on commercially reasonable terms and in compliance with GMP could adversely affect our business in a number of ways, including:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an inability to initiate preclinical studies or clinical trials of product candidates;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays in submitting regulatory applications, or receiving marketing approvals, for product candidates;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">subjecting third-party manufacturing facilities or our manufacturing facilities to additional inspections by regulatory authorities;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">requirements to cease development or to recall batches of product candidates; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in the event of approval to market and commercialize any product, an inability to meet commercial demands for the product.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are party to manufacturing agreements with a number of third-party manufacturers. We may be unable to maintain these agreements or establish any additional agreements with third-party manufacturers or to do so on acceptable terms. Even if we are able to maintain or establish agreements with third-party manufacturers, reliance on third-party manufacturers entails additional risks, including:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure of third-party manufacturers to comply with regulatory requirements and maintain quality assurance;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">breach of the manufacturing agreement by the third party;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to manufacture according to our specifications;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to manufacture according to our schedule or at all;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">misappropriation of our proprietary information, including our trade secrets and know-how; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">termination or nonrenewal of the agreement by the third party at a time that is costly or inconvenient for us.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may compete with third parties for access to manufacturing facilities. There are a limited number of manufacturers that operate under GMP regulations and that might be capable of manufacturing for us.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not currently have arrangements in place for redundant supply or a second source for all required raw materials. If our existing or future third-party manufacturers cannot perform as agreed, we may be required to replace such manufacturers and we may be unable to replace them on a timely basis or at all. Additionally, if supply from one approved manufacturer is interrupted, there could be a significant disruption in supply. The regulatory agencies may also require additional studies or trials if a new manufacturer is relied upon for commercial production. Switching manufacturers may involve substantial costs and is likely to result in a delay in our desired clinical and commercial timelines.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These factors could cause the delay of clinical trials, regulatory submissions, required approvals or commercialization of our product candidates, cause us to incur higher costs and prevent us from commercializing our products successfully. Furthermore, if our suppliers fail to meet contractual requirements, and we are unable to secure one or more replacement suppliers capable of production at a substantially equivalent cost, our clinical trials may be delayed or we could lose potential revenue.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current and anticipated future dependence upon third parties for the manufacture of any product candidates we develop may adversely affect our development programs and our ability to commercialize any products that receive marketing approval on a timely and competitive basis.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our reliance on third parties requires us to share our trade secrets, which increases the possibility that a competitor or other third party will discover our trade secrets or that our trade secrets will be misappropriated or disclosed.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we currently rely on certain third parties to manufacture all or part of our preclinical and clinical drug supply and to perform quality testing, and because we collaborate with various third parties for the advancement of our platform and pipeline, we must, at times, share our proprietary technology and confidential information, including trade secrets, with them. We seek to protect our proprietary technology, in part, by entering into confidentiality agreements and, if applicable, material transfer agreements, collaborative research agreements, consulting agreements and other similar agreements with our collaborators, advisors, employees, consultants, and other third parties prior to beginning research or </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">disclosing any proprietary information. These agreements typically limit the rights of the third parties to use or disclose our confidential information. Despite the contractual provisions employed when working with third parties, the need to share trade secrets and other confidential information increases the risk that such trade secrets become known by our competitors or other third parties, are inadvertently incorporated into the technology of others or are disclosed or used in violation of these agreements. Despite our efforts to protect our trade secrets, our competitors may discover our trade secrets, either through breach of these agreements, independent development or publication of information including our trade secrets by third parties. Given that our proprietary position is based, in part, on our know-how and trade secrets, a competitor&#8217;s or other third party&#8217;s discovery of our proprietary technology and confidential information or other unauthorized use or disclosure would impair our competitive position and may harm our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may enter into collaborations with third parties for the research, development and commercialization of certain of the product candidates we may develop. If any such collaborations are not successful, we may not be able to capitalize on the market potential of those product candidates.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may seek third-party collaborators for the research, development and commercialization of certain of the product candidates we may develop. If we enter into any such arrangements with any third parties, we will likely have limited control over the amount and timing of resources that our collaborators dedicate to the development or commercialization of any product candidates we may seek to develop with them. Our ability to generate revenues from these arrangements will depend on our collaborators&#8217; abilities to successfully perform the functions assigned to them in these arrangements. We cannot predict the success of any collaboration that we enter into.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collaborations involving our research programs or any product candidates we may develop pose numerous risks to us, including the following:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborators would have significant discretion in determining the efforts and resources that they will apply to these collaborations;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborators may not pursue development and commercialization of any product candidates we may develop or may elect not to continue or renew development or commercialization programs based on clinical trial results, changes in the collaborator&#8217;s strategic focus or available funding or external factors such as an acquisition that diverts resources or creates competing priorities;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborators may delay programs, preclinical studies or clinical trials, provide insufficient funding for programs, preclinical studies or clinical trials, stop a preclinical study or clinical trial or abandon a product candidate, repeat or conduct new clinical trials or require a new formulation of a product candidate for clinical testing;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborators could independently develop, or develop with third parties, products that compete directly or indirectly with any product candidates we may develop if the collaborators believe that competitive products are more likely to be successfully developed or can be commercialized under terms that are more economically attractive than ours;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborators may be acquired by a third party having competitive products or different priorities, causing the emphasis on our product development or commercialization program under such collaboration to be delayed, diminished or terminated;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborators with marketing and distribution rights to one or more products may not commit sufficient resources to the marketing and distribution of such product or products;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborators may not properly obtain, maintain, enforce or defend our intellectual property or proprietary rights or may use our proprietary information in such a way as to invite litigation that could jeopardize or invalidate our proprietary information or expose us to potential litigation;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disputes may arise between the collaborators and us that result in the delay or termination of the research, development, or commercialization of any product candidates we may develop or that result in costly litigation or arbitration that diverts management attention and resources;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may lose certain valuable rights under certain circumstances, including if we undergo a change of control;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborations may be terminated and, if terminated, may result in a need for additional capital to pursue further development or commercialization of the applicable product candidates we may develop; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaboration agreements may not lead to development or commercialization of product candidates in the most efficient manner or at all.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any collaborations into which we may enter do not result in the successful development and commercialization of product candidates, or if any future collaborator terminates its agreement with us, we may not receive any future research funding or milestone or royalty payments under the collaboration. If we do not receive the funding we expect under these agreements, our development of product candidates could be delayed, and we may need additional resources to develop product candidates. In addition, if a future collaborator terminates its agreement with us, we may find it more difficult to find a suitable replacement collaborator or attract new collaborators, and our development programs may be delayed or the perception of us in the business and financial communities could be adversely affected. All of the risks relating to product development described in this &#8220;Risk Factors&#8221; section apply to the activities of our collaborators.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These relationships, or those like them, may require us to incur non-recurring and other charges, increase our near- and long-term expenditures, issue securities that dilute our existing stockholders, or disrupt our management and business. If we license rights to any product candidates we or our collaborators may develop, we may not be able to realize the benefit of such transactions if we are unable to successfully integrate them with our existing operations and company culture.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are not able to establish collaborations on commercially reasonable terms, we may have to alter our development and commercialization plans.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research programs and product candidates and the potential commercialization of any product candidates we may develop will require substantial additional cash to fund expenses. For some of the product candidates we may develop, we plan to seek collaborations with pharmaceutical and biotechnology companies for the development and potential commercialization of those product candidates.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face significant competition in seeking high-quality collaborators, and the negotiation process is time-consuming and complex. Whether we reach a definitive agreement for a collaboration will depend, among other things, upon our assessment of the collaborator&#8217;s resources and expertise, the terms and conditions of the proposed collaboration, and the proposed collaborator&#8217;s evaluation of a number of factors. Those factors may include the design or results of preclinical studies and clinical trials, the likelihood of approval by the FDA, TGA, EC, NCAs or similar regulatory authorities outside the United States, the potential market for the subject product candidate, the costs and complexities of manufacturing and delivering such product candidate to patients, the potential of competing products, the existence of uncertainty with respect to our ownership of technology, which can exist if there is a challenge to such ownership without regard to the merits of the challenge, and industry and market conditions generally. The collaborator may also consider alternative product candidates or technologies for similar indications that may be available to collaborate on and whether such a collaboration could be more attractive than one with our company.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collaborations are complex and time-consuming to negotiate and document. We may not be able to negotiate collaborations on a timely basis, on acceptable terms, or at all. If we are unable to do so, we may have to curtail the development of the product candidate for which we are seeking to collaborate, reduce or delay its development program or one or more of our other development programs, delay its potential commercialization, reduce the scope of any sales or marketing activities, or increase our own expenditures on the development of the product candidate.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are dependent on third-party vendors to provide certain licenses, products and services and our business and operations, including clinical trials, could be disrupted by any problems with our significant third-party vendors.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We engage a number of third-party suppliers and service providers to supply critical goods and services, such as contract research services, contract manufacturing services and IT services. Disruptions to the business, financial stability or operations of these suppliers and service providers, including due to strikes, labor disputes or other disruptions to the workforce or to their willingness and ability to produce or deliver such goods or provide such services in a manner that satisfies the requirements put forth by the authorities, or in a manner that satisfies our own requirements, could affect our ability to develop and market our product candidates on a timely basis. If these suppliers and service providers were unable or unwilling to continue to provide their goods or services in the manner expected, or at all, we could encounter difficulty finding alternative suppliers. Even if we are able to secure appropriate alternative suppliers in a timely manner, costs for such goods or services could increase significantly. Any of these events could adversely affect our results of operations and our business.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we or third parties, including our CROs or contract manufacturers, use hazardous and biological materials in a manner that causes injury or violates applicable law, we may be liable for damages.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our research and development activities may involve the controlled use of potentially hazardous substances, including chemical and biological materials, by us or third parties such as our CROs and contract manufacturers.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and such third parties are subject to federal, state and local laws and regulations in the United States governing the use, manufacture, storage, handling and disposal of medical and hazardous materials. Although we believe that our and such third parties&#8217; procedures for using, handling, storing and disposing of these materials comply with legally prescribed standards, we cannot completely eliminate the risk of contamination or injury resulting from medical or hazardous materials. As a result of any such contamination or injury, we may incur liability or local, city, state or federal authorities may curtail the use of these materials and interrupt our business operations. In the event of an accident, we could be held liable for damages or penalized with fines, and the liability could exceed our resources. Compliance with applicable environmental laws and regulations is expensive, and current or future environmental regulations may impair our research, development and production efforts, which could harm our business, prospects, financial condition or results of operations.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Intellectual Property</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our rights to develop and commercialize our product candidates are subject, in part, to the terms and conditions of licenses granted to us by third parties. If we fail to comply with our obligations under these arrangements or otherwise experience disruptions to our business relationships with our current or any future licensors, we could lose such intellectual property rights that are important to our business.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are and expect to continue to be reliant upon third-party licensors for certain patent and other intellectual property rights that are important or necessary to the development of our technology and product candidates. For example, we rely on a license from the Whitehead Institute for Biomedical Research. Our current agreement with the Whitehead Institute for Biomedical Research imposes, and we expect that any future license agreements will also impose, specified diligence, milestone payment, royalty, commercialization, development and other obligations on us and require us to meet development timelines, or to exercise diligent or commercially reasonable efforts to develop and commercialize licensed products, in order to maintain the licenses. See &#8220;Business collaboration and license agreements-Whitehead Institute patent license agreement.&#8221;</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, our licensors have, or may in the future have, the right to terminate a license if we materially breach the agreement and fail to cure such breach within a specified period or in the event we undergo certain bankruptcy events. In spite of our best efforts, our current or any future licensors might conclude that we have materially breached our license agreements and might therefore terminate the license agreements. If our license agreements are terminated, we may lose our rights to develop and commercialize our product candidates and technology, lose patent protection, experience significant delays in the development and commercialization of our product candidates and technology, and incur liability for damages. If these in-licenses are terminated, or if the underlying intellectual property fails to provide the intended exclusivity, our competitors or other third parties could have the freedom to seek regulatory approval of, and to market, products and technologies identical or competitive to ours and we may be required to cease our development and commercialization of certain of our product candidates and technology. In addition, we may seek to obtain additional licenses from our licensors and, in connection with obtaining such licenses, we may agree to amend our existing licenses in a manner that may be more favorable to the licensors, including by agreeing to terms that could enable third parties, including our competitors, to receive licenses to a portion of the intellectual property that is subject to our existing licenses and to compete with any product candidates we may develop and our technology. Any of the foregoing could have a material adverse effect on our competitive position, business, financial condition, results of operations and prospects. </span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disputes may arise regarding intellectual property subject to a licensing agreement, including:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the scope of rights granted under the license agreement and other interpretation-related issues;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our or our licensors&#8217; ability to obtain, maintain and defend intellectual property and to enforce intellectual property rights against third parties;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which our technology, product candidates and processes infringe, misappropriate or otherwise violate the intellectual property of the licensor that is not subject to the license agreement;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the sublicensing of patent and other intellectual property rights under our license agreements;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our diligence, development, regulatory, commercialization, financial or other obligations under the license agreement and what activities satisfy those diligence obligations;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the inventorship and ownership of inventions and know-how resulting from the joint creation or use of intellectual property by our current or future licensors and us and our partners; and</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the priority of invention of patented technology.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, future license agreements are likely to be complex, and certain provisions in such agreements may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could narrow what we believe to be the scope of our rights to the relevant intellectual property or technology, or increase what we believe to be our diligence, development, regulatory, commercialization, financial or other obligations under the relevant agreement. In addition, if disputes over intellectual property that we have licensed or any other dispute related to our license agreements prevent or impair our ability to maintain our current license agreements on commercially acceptable terms, we may be unable to successfully develop and commercialize the affected product candidates and technology. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">License agreements we may enter into in the future may be non-exclusive. Accordingly, third parties may also obtain non-exclusive licenses from such licensors with respect to the intellectual property licensed to us under such license agreements. For example, our license agreement with the Whitehead Institute for Biomedical Research grants certain co-exclusive rights to a third-party to certain patent rights generally relating to, among other things, methods of modulating gene expression by targeting certain genomic sequences. Accordingly, these license agreements may not provide us with exclusive rights to use such licensed patent and other intellectual property rights, or may not provide us with exclusive rights to use such patent and other intellectual property rights in all relevant fields of use and in all territories in which we may wish to develop or commercialize our technology and any product candidates we may develop in the future.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, some of our in-licensed patent and other intellectual property rights may in the future be subject to third party interests such as co-ownership. If we are unable to obtain an exclusive license to such third-party co-owners&#8217; interest, in such patent and other intellectual property rights, such third-party co-owners may be able to license their rights to other third parties, including our competitors, and our competitors could market competing products and technology. We or our licensors may need the cooperation of any such co-owners of our licensed patent and other intellectual property rights in order to enforce them against third parties, and such cooperation may not be provided to us or our licensors.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we may not have complete control over the preparation, filing, prosecution, maintenance, enforcement and defense of patents and patent applications that we license from third parties. It is possible that our licensors&#8217; filing, prosecution and maintenance of the licensed patents and patent applications, enforcement of patents against infringers or defense of such patents against challenges of validity or claims of enforceability may be less vigorous than if we had conducted them ourselves, and accordingly, we cannot be certain that these patents and patent applications will be prepared, filed, prosecuted, maintained, enforced and defended in a manner consistent with the best interests of our business. If our licensors fail to file, prosecute, maintain, enforce and defend such patents and patent applications, or lose rights to those patents or patent applications, the rights we have licensed may be reduced or eliminated, our right to develop and commercialize any of our technology and any product candidates we may develop that are the subject of such licensed rights could be adversely affected and we may not be able to prevent competitors or other third parties from making, using and selling competing products.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, our owned and in-licensed patent rights may be subject to a reservation of rights by one or more third parties. When new technologies are developed with government funding, in order to secure ownership of patent rights related to the technologies, the recipient of such funding is required to comply with certain government regulations, including timely disclosing the inventions claimed in such patent rights to the U.S. government and timely electing title to such inventions. A failure to meet these obligations may lead to a loss of rights or the unenforceability of relevant patents or patent applications. In addition, the U.S. government may have certain rights in such patent rights, including a non-exclusive license authorizing the U.S. government to use the invention or to have others use the invention on its behalf. If the U.S. government decides to exercise these rights, it is not required to engage us as its contractor in connection with doing so. The U.S. government&#8217;s rights may also permit it to disclose the funded inventions and technology, which may include our confidential information, to third parties and to exercise march-in rights to use or allow third parties to use the technology that was developed using U.S. government funding. The U.S. government may exercise its march-in rights if it determines that action is necessary because we or our licensors failed to achieve practical application of the U.S. government-funded technology, because action is necessary to alleviate health or safety needs, to meet requirements of federal regulations, or to give preference to industry in the United States. In addition, our rights in such U.S. government-funded inventions may be subject to certain requirements to manufacture any product candidates we may develop embodying such inventions in the United States. Any of the foregoing could harm our business, financial condition, results of operations and prospects significantly.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we or our licensors are unable to obtain, maintain, enforce and adequately protect our intellectual property rights with respect to our product candidates and technology, or if the scope of any patent or other intellectual property </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">protection obtained is not sufficiently broad, our competitors could develop and commercialize products and technology similar or identical to ours, and our ability to successfully develop and commercialize our product candidates and technology may be adversely affected.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends in large part on our and our licensors&#8217; ability to obtain, maintain, enforce and adequately protect our intellectual property rights through patents, trade secrets, and trademarks in the United States and other jurisdictions with respect to our product candidates and our technology, as well as our ability to operate our business without infringing, misappropriating or otherwise violating the intellectual property rights of others.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the early stage of development of our product candidates and technology, our patent portfolio with respect to certain aspects of our product candidates and technology is similarly at a very early stage. For example, we do not currently own or in-license any issued patents directed to the composition of matter, or methods of use, of any of the product candidates that we have thus far developed using our RAP Platform. We have filed and intend to continue filing patent applications directed to the compositions of matter, and methods of use, of our current and future product candidates. Composition of matter patents for pharmaceutical product candidates often provide a strong form of intellectual property protection for those types of products, as such patents provide protection without regard to their method of use. However, we cannot be certain that any claims in our patent applications directed to the composition of matter of our product candidates will be considered patentable by the United States Patent and Trademark Office (the &#8220;USPTO&#8221;) or by patent offices in foreign countries, or that, if issued, the claims in any such patents, if challenged, will be adjudicated to be not invalid and enforceable by courts and administrative bodies in the United States or foreign countries. Further, if issued, any composition of matter patents covering our product candidates may expire at such a date that competitors may not be prevented from developing, making and marketing a product identical to our product candidates after expiration of any applicable regulatory exclusivities. Method of use patents protect the use of a product for the specified method or indication. This type of patent does not prevent a competitor from making and marketing a product identical to our product candidate for an indication that is outside the scope of the patented methods of use. Moreover, even if competitors do not actively promote their product for indications covered by our patents, clinicians may prescribe these competitor products &#8220;off-label&#8221; for uses that are covered by our method of use patents. Although off-label prescriptions may infringe or contribute to the infringement of method of use patents, the practice is common and such infringement is difficult to prevent or prosecute. To establish our proprietary position, we own and have in-licensed certain intellectual property rights, and we and our licensors have filed and may file provisional and non-provisional patent applications in the United States or abroad relating to our product candidates and certain technologies that are important to our business. We may in the future also license or purchase intellectual property rights from others. Our ability to stop third parties from making, using, selling, marketing, offering to sell, importing and commercializing our product candidates and technology is dependent upon the extent to which we have rights under valid and enforceable patents and other intellectual property rights that cover our product candidates and technology. We cannot predict whether or when our owned or licensed pending and future patent applications will result in the issuance of patents that provide us with any competitive advantage. If we or our licensors are unable to obtain, maintain, defend and enforce patents and other intellectual property rights with respect to our product candidates and technology, our business, financial condition, results of operations and prospects could be materially harmed.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The patent prosecution process is expensive, time-consuming and complex, and we and our licensors may not be able to file, prosecute, maintain, defend, enforce or license all necessary or desirable patent applications and patents at a reasonable cost or in a timely manner. In addition, we may not pursue or obtain patent protection in all relevant markets. U.S. provisional patent applications are not eligible to become issued patents until, among other things, we or our licensors file a non-provisional patent application within 12&#160;months of the filing of one or more of our related provisional patent applications. Any failure to file a non-provisional patent application within this timeline could cause us or our licensors to lose our priority date with respect to the provisional patent application and any patent protection on the inventions disclosed in the provisional patent applications. We and our licensors may not be able to obtain, maintain or defend patents and patent applications due to the subject matter claimed in such patents and patent applications being in the public domain. It is also possible that we will fail to identify patentable aspects of our research and development output before it is too late to obtain patent protection. Although we enter into non-disclosure and confidentiality agreements with parties who have access to confidential or patentable aspects of our research and development output, such as our employees, corporate collaborators, external scientific collaborators, contract research organizations, contract manufacturers, consultants, advisors and other third parties, any of these parties may breach these agreements and disclose such output before a patent application is filed, thereby potentially jeopardizing our ability to seek patent protection.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The patent position of biotechnology and pharmaceutical companies generally is highly uncertain, involves complex legal and factual questions and has, in recent&#160;years, been the subject of much litigation. As a result, the issuance, scope, validity, enforceability and commercial value of patent rights are highly uncertain. Our owned and licensed pending and future patent applications may not result in patents being issued which protect our technology, our product candidates, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or which effectively prevent others from commercializing competitive technologies and products or otherwise provide any competitive advantage. In fact, our owned or licensed patent applications may not issue as patents at all, and even if such patent applications do issue as patents, they may not issue in a form, or with a scope of claims, that will provide us with any meaningful protection, prevent others from competing with us, or otherwise provide us with any competitive advantage. In addition, the scope of the invention claimed in a patent application can be significantly reduced before a patent is issued, and the scope of claims of an issued patent can be reinterpreted after issuance. Any patents that eventually issue may be challenged, narrowed or invalidated by third parties. Moreover, changes in either the patent laws or interpretation of the patent laws in the United States and other jurisdictions may diminish the value of our patent rights or narrow the scope of our patent protection. Consequently, we do not know whether any of our product candidates will be protectable or remain protected by valid and enforceable patent rights. Furthermore, our competitors or other third parties may be able to circumvent our owned or licensed patents by developing similar or alternative technologies or products in a non-infringing manner.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third parties have developed technologies that may be related or competitive to our own technologies and product candidates and may have filed or may file patent applications, or may have obtained issued patents, claiming inventions that may overlap or conflict with those claimed in our owned or licensed patent applications or issued patents. We may not be aware of all third-party intellectual property rights potentially relating to our current and future product candidates and technology. Publications of discoveries in the scientific literature often lag the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until 18&#160;months after filing or, in some cases, not at all. Therefore, we cannot know for certain whether the inventors of our owned or licensed patents and patent applications were the first to make the inventions claimed in any owned or licensed patents or pending patent applications, or that we were the first to file for patent protection of such inventions. If a third party can establish that we or our licensors were not the first to make or the first to file for patent protection of such inventions, our owned or licensed patent applications may not issue as patents and even if issued, may be challenged and invalidated or ruled unenforceable.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, patents have a limited lifespan. In the United States, the expiration of a patent is generally 20&#160;years from the earliest date of filing of the first non-provisional patent application to which the patent claims priority. Patent term adjustments and extensions may be available; however, the overall term of a patent, and the protection it affords, is limited. Given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such product candidates might expire before or shortly after such product candidates are commercialized. As a result, our owned and licensed patent portfolio and other intellectual property rights may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours. Any of the foregoing could have a material adverse effect on our competitive position, business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Third parties may initiate legal proceedings alleging that we are infringing, misappropriating or otherwise violating their intellectual property rights, the outcome of which would be uncertain and could harm our business.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial success depends upon our ability and the ability of our collaborators to develop, manufacture, commercialize, market and sell our product candidates and use our proprietary technology without infringing, misappropriating or otherwise violating the intellectual property rights of third parties. The biotechnology and pharmaceutical industries are characterized by extensive and complex litigation regarding patents and other intellectual property rights. We may become party to, or be threatened with, adversarial proceedings or litigation in which third parties may assert infringement, misappropriation or other violation claims against us, alleging that our product candidates, compositions, technology, or methods are covered by their patents. Given the vast number of patents and other intellectual property in our field of technology, we cannot be certain or guarantee that we do not infringe, misappropriate or otherwise violate patents or other intellectual property. Other companies and institutions have filed, and continue to file, patent applications that may be related to our product candidates, compositions, technology and methods. Some of these patent applications have already been allowed or issued and others may issue in the future. Since this area is competitive and of strong interest to pharmaceutical and biotechnology companies, there will likely be additional patent applications filed and additional patents granted in the future, as well as additional research and development programs expected in the future. Numerous U.S. and foreign issued patents and pending patent applications, which are owned by third parties, exist in the fields in which we are developing our product candidates and technology. As the biotechnology and pharmaceutical industries expand and more patents are issued, the risk increases that we may be subject to claims of infringement of the patent rights of third parties. If a patent holder believes the manufacture, use, sale or importation of any product candidates we may develop or our technology infringes its patent, the patent holder may sue us even if we have licensed other patent rights for our product candidates or technology.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are aware of certain U.S. and foreign issued patents and pending patent applications that claim subject matter that relates to certain of our product candidates and technology. Although we believe that their claims are invalid and/or not infringed, such third parties may assert these patents against us in litigation. The outcome of any such litigation is uncertain </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and, even if we prevail, the costs of such litigation could have a material adverse effect on our financial position, distract key personnel from the continued development of our business, and adversely affect our ability to enter or maintain commercial relationships with collaborators, clients, customers or other third parties. If we are unsuccessful in such litigation, we could be prevented from commercializing products or could be required to take licenses from such third parties, which may not be available on commercially reasonable terms, if at all.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is also possible that we have failed to identify relevant third-party issued patents or patent applications. Because patent applications can take many&#160;years to issue, may be confidential for 18&#160;months or more after filing and can be revised before issuance, there may be applications now pending which may later result in issued patents that may be infringed by the manufacture, use, sale or importation of our product candidates, compositions, or our technology and we may not be aware of such patents. Furthermore, applications filed before November&#160;29, 2000 and certain applications filed after that date that will not be filed outside the United States may remain confidential until a patent issues. Moreover, it is difficult for industry participants, including us, to identify all third-party patent rights that may be relevant to our product candidates and our technology because patent searching is imperfect due to differences in terminology among patents, incomplete databases and the difficulty in assessing the meaning of patent claims. We may fail to identify relevant patents or patent applications or may identify pending patent applications of potential interest but incorrectly predict the likelihood that such patent applications may issue with claims of relevance to our technology. In addition, we may incorrectly conclude that a third-party patent is invalid, unenforceable or not infringed by our activities. Additionally, pending patent applications that have been published can, subject to certain limitations, be later amended in a manner that could cover our technology product candidates, compositions, or methods.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third parties may assert infringement claims against us based on existing patents or patents that may be granted in the future, regardless of the merit of the claim. There is a risk that third parties may choose to engage in litigation with us to enforce or to otherwise assert their patent rights against us. Even if we believe such claims are without merit, a court of competent jurisdiction could hold that these third-party patents are not invalid, enforceable and infringed, which could adversely affect our ability to commercialize our product candidates or technology covered by the asserted third-party patents. In order to successfully challenge the validity of any such U.S. patent in federal court, we would need to overcome a presumption of validity. As this burden is a high one requiring us to present clear and convincing evidence as to the invalidity of any such U.S. patent claim, there is no assurance that a court of competent jurisdiction would invalidate the claims of any such U.S. patent. If we are found to infringe a third party&#8217;s valid and enforceable intellectual property rights, we could be required to obtain a license from such third party to continue developing, manufacturing and marketing our product candidates and technology. However, we may not be able to obtain any required license on commercially reasonable terms or at all. Even if we were able to obtain a license, it could be non-exclusive, thereby giving our competitors and other third parties access to the same technologies licensed to us, and it could require us to make substantial licensing and royalty payments. We could be forced, including by court order, to cease developing, manufacturing and commercializing the infringing technology or product candidates. In addition, we could be found liable for monetary damages, including treble damages and attorneys&#8217; fees, if we are found to have willfully infringed a patent or other intellectual property right. A finding of infringement could prevent us from manufacturing and commercializing our product candidates or force us to cease some of our business operations, which could harm our business. In addition, we may be forced to redesign our product candidates or technology, seek new regulatory approvals, and indemnify third parties pursuant to contractual agreements. Claims that we have misappropriated the confidential information or trade secrets of third parties could have a similar negative impact on our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be involved in lawsuits to protect or enforce our patents or other intellectual property or the intellectual property of our licensors, which could be expensive, time-consuming, and unsuccessful.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competitors may infringe our patents or other intellectual property rights, or the intellectual property rights of our licensors. To counter infringement or unauthorized use, we may be required to file infringement claims, which can be expensive and time-consuming and divert the time and attention of our management and scientific personnel. Our and our licensors&#8217; pending patent applications cannot be enforced against third parties practicing the technology claimed in such applications unless and until a patent issues from such applications. In addition, in an infringement proceeding or a declaratory judgment action, a court may decide that one or more of our or our licensors&#8217; patents is not valid or is unenforceable, or may refuse to stop the other party from using the technology at issue on the grounds that our patents do not cover the technology in question. An adverse result in any litigation or defense proceeding could put one or more of our or our licensors&#8217; patents at risk of being invalidated, held unenforceable, or interpreted narrowly and could put our or our licensors&#8217; patent applications at risk of not issuing. Defense of these claims, regardless of their merit, would involve substantial litigation expense and would be a substantial diversion of employee resources from our business.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if we establish infringement, the court may decide not to grant an injunction against further infringing activity and instead award only monetary damages, which may or may not be an adequate remedy. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during litigation. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. Moreover, there can be no assurance that we will have sufficient financial or other resources to file and pursue such infringement claims, which typically last for&#160;years before they are concluded. Even if we ultimately prevail in such claims, the monetary cost of such litigation and the diversion of the attention of our management and scientific personnel could outweigh any benefit we receive as a result of any proceedings. Any of the foregoing may have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to protect our intellectual property rights throughout the world.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filing, prosecuting, maintaining, enforcing and defending patents and other intellectual property rights relating to our technology and product candidates in all jurisdictions throughout the world would be prohibitively expensive, and accordingly, our intellectual property rights in some jurisdictions outside the United States could be less extensive than those in the United States. In some cases, we or our licensors may not be able to obtain patent or other intellectual property protection for certain technology and product candidates outside the United States. In addition, the laws of some foreign jurisdictions do not protect intellectual property rights to the same extent as federal and state laws in the United States. Consequently, we and our licensors may not be able to obtain issued patents or other intellectual property rights covering our product candidates and our technology in all jurisdictions outside the United States and, as a result, we may not be able to prevent third parties from practicing our and our licensors&#8217; inventions in all countries outside the United States, or from selling or importing products made using our inventions in and into the United States or other jurisdictions. Third parties may use our technologies in jurisdictions where we and our licensors have not pursued and obtained patent or other intellectual property protection to develop their own products and, further, may export otherwise infringing, misappropriating or violating products to territories where we have patent or other intellectual property protection, but enforcement is not as strong as that in the United States. These products may compete with our product candidates and our technology and our or our licensors&#8217; patents or other intellectual property rights may not be effective or sufficient to prevent them from competing.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of certain jurisdictions, particularly certain developing countries, do not favor the enforcement of patents, trade secrets and other intellectual property protection, particularly those relating to biotechnology and pharmaceutical products, which could make it difficult for us to stop the infringement, misappropriation or other violation of our or our licensor&#8217;s patent and other intellectual property rights or marketing of competing products in violation of our intellectual property rights generally. Proceedings to enforce our or our licensors&#8217; patent and other intellectual property rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our or our licensor&#8217;s patent and other intellectual property rights at risk of being invalidated, held unenforceable, or interpreted narrowly, and could put our or our licensor&#8217;s patent applications at risk of not issuing, and could provoke third parties to assert claims against us. We or our licensors may not prevail in any lawsuits that we or our licensors initiate and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As another example, the complexity and uncertainty of European patent laws have also increased in recent&#160;years. In Europe, a new unitary patent system went into effect on June&#160;1, 2023, which significantly impacts European patents, including those granted before the introduction of such system. Under the unitary patent system, European applications have the option, upon grant of a patent, of becoming a Unitary Patent which will be subject to the jurisdiction of the Unitary Patent Court (the &#8220;UPC&#8221;). Existing European patents and published applications may be opted out of the jurisdiction of the UPC at any time before the end of a transitional period (at least seven&#160;years from the UPC Agreement which went into effect on June&#160;1, 2023), unless an action has already been brought before the UPC in which case an opt-out request cannot be filed. As the UPC is a new court system, there is no precedent for the court, increasing the uncertainty of any litigation. Patents granted before the implementation of the UPC will have the option of opting out of the jurisdiction of the UPC and remaining as national patents in the UPC countries. Patents that remain under the jurisdiction of the UPC will be potentially vulnerable to a single UPC-based revocation challenge that, if successful, could invalidate the patent in all countries who are signatories to the UPC. We cannot predict with certainty the long-term effects of any potential changes.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many jurisdictions have compulsory licensing laws under which a patent owner may be compelled to grant licenses to third parties. In addition, many jurisdictions limit the enforceability of patents against government agencies or government contractors. In these jurisdictions, the patent owner may have limited remedies, which could materially diminish the value of such patents. If we or any of our licensors are forced to grant a license to third parties with respect to any patents relevant to our business, our competitive position may be impaired, and our business, financial condition, results of operations and prospects may be adversely affected.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Obtaining and maintaining our patent protection depends on compliance with various procedural, document submission, fee payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodic maintenance fees, renewal fees, annuity fees and various other government fees on patents and/or patent applications will be due to be paid to the USPTO and foreign government patent agencies over the lifetime of our owned or licensed patent rights. We rely on our outside counsel and other professionals or our licensing partners to pay these fees due to the USPTO and foreign government patent agencies. The USPTO and foreign government patent agencies also require compliance with several procedural, documentary and other similar provisions during the patent application process. We rely on our outside counsel and other professionals to help us comply and we are also dependent on our licensing partners to take the necessary action to comply with these requirements with respect to our licensed intellectual property. In many cases, an inadvertent lapse can be cured by payment of a late fee or by other means in accordance with the applicable rules. There are situations, however, in which non-compliance can result in abandonment, loss of priority or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. In such an event, potential competitors might be able to enter the market and this circumstance could have a material adverse effect on our competitive position, business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in patent law in the United States and in foreign jurisdictions could diminish the value of patents in general, thereby impairing our ability to protect our product candidates and our technology.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As is the case with other biotechnology and pharmaceutical companies, our success is heavily dependent on intellectual property, particularly patents. Obtaining, defending and enforcing patents in the biotechnology and pharmaceutical industry involves both technological and legal complexity, and is therefore costly, time-consuming and inherently uncertain. Changes in either the patent laws or their interpretation in the United States and in foreign jurisdictions, including patent reform legislation such as the Leahy-Smith America Invents Act (the &#8220;Leahy-Smith Act&#8221;), signed into law on September&#160;16, 2011, could increase these uncertainties and costs. The Leahy-Smith Act includes a number of significant changes to U.S. patent law. These changes include provisions that affect the way patent applications are prosecuted, redefine prior art, provide more efficient and cost-effective avenues for competitors to challenge the validity of patents, and enable third-party submission of prior art to the USPTO during patent prosecution and additional procedures to attack the validity of a patent at USPTO-administered post-grant proceedings, including post-grant review, inter partes review, and derivation proceedings. In addition, the Leahy-Smith Act transformed the U.S. patent system into a &#8220;first-to-file&#8221; system. The first-to-file provisions, however, became effective on March&#160;16, 2013. As such, the Leahy-Smith Act and its implementation could increase the uncertainties and costs surrounding the prosecution of our owned and in-licensed patent applications and the enforcement or defense of our owned and in-licensed issued patents and issued patents we may own or in-license in the future, all of which could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, recent U.S. Supreme Court rulings have narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain situations. In addition to increasing uncertainty with regard to our or our licensors&#8217; ability to obtain patents in the future, this combination of events has created uncertainty with respect to the validity and enforceability of patents once obtained. Depending on future actions by the U.S. Congress, the federal courts and the USPTO, the laws and regulations governing patents could change in unpredictable ways that could have a material adverse effect on our patent rights and our ability to protect, defend and enforce our patent rights in the future.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we obtain any patents covering our product candidates or our technology, they could nonetheless be found invalid or unenforceable if challenged in court or before administrative bodies in the United States or abroad.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability. Our owned and licensed patent rights, including any patent of our owned or in-licensed patent applications that may issue in the future, may be subject to priority, validity, inventorship and enforceability disputes. If we or our licensors are unsuccessful in any of these proceedings, such patent rights may be narrowed, invalidated or held unenforceable, we may be required to obtain licenses from third parties, which may not be available on commercially reasonable terms or at all, or we may be required </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to cease the development, manufacture and commercialization of one or more of our product candidates. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we or one of our licensors initiate legal proceedings against a third party to enforce a patent covering our product candidates or our technology, the defendant could counterclaim that the patent is invalid and/or unenforceable. In patent litigation in the United States, defendant counterclaims alleging invalidity and/or unenforceability are commonplace, and there are numerous grounds upon which a third party can assert invalidity or enforceability of a patent. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, including lack of novelty, obviousness, lack of written description or non-enablement. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent withheld information material to patentability from the USPTO, or made a misleading statement, during prosecution. Third parties also may raise similar claims before administrative bodies in the United States or abroad, even outside the context of litigation. Such mechanisms include re-examination, interference proceedings, derivation proceedings, post grant review, inter partes review and equivalent proceedings in foreign jurisdictions, such as opposition, invalidation and revocation proceedings. Such proceedings could result in the revocation or cancellation of or amendment to our or our licensors&#8217; patents in such a way that they no longer cover our product candidates or our technology or prevent third parties from competing with our product candidates or our technology. The outcome following legal assertions of invalidity and unenforceability is unpredictable. With respect to the validity question, for example, we cannot be certain that there is no invalidating prior art, of which we, our licensing partners, or the patent examiners were unaware during prosecution. If a third party were to prevail on a legal assertion of invalidity or unenforceability, we could lose at least part, and perhaps all, of any patent protection we may eventually obtain relating to our product candidates or technology. Such a loss of patent protection could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we do not obtain patent term extension and data exclusivity for our product candidates, our business may be materially harmed.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending upon the timing, duration and specifics of any FDA marketing approval of our current or future product candidates that we may receive, one or more of our owned or in-licensed U.S. patents that we may obtain in the future may be eligible for limited patent term extension under the Drug Price Competition and Patent Restoration Act (the &#8220;Hatch-Waxman Amendments&#8221;). The Hatch-Waxman Amendments permit a patent extension term of up to five&#160;years as compensation for patent term lost during the FDA regulatory review process. A patent term extension cannot extend the remaining term of a patent beyond a total of 14&#160;years from the date of product approval, only one patent may be extended and only those claims covering the approved product, a method for using it, or a method for manufacturing it may be extended. The application for the extension must be submitted prior to the expiration of the patent for which extension is sought. A patent that covers multiple products for which approval is sought can only be extended in connection with one of the approvals. However, we may not be granted an extension because of, for example, failing to exercise due diligence during the testing phase or regulatory review process, failing to apply within applicable deadlines, failing to apply prior to expiration of relevant patents or otherwise failing to satisfy applicable requirements. Moreover, the applicable time period or the scope of patent protection afforded could be less than we request. In addition, to the extent we wish to pursue patent term extension based on a patent that we in-license from a third party, we would need the cooperation of that third party. If we are unable to obtain patent term extension or the term of any such extension is less than we request, our competitors may obtain approval of competing products following our patent expiration, and our revenue could be reduced. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to claims challenging the inventorship or ownership of our patent and other intellectual property rights.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We or our licensors may be subject to claims that former employees, collaborators or other third parties have an interest in our owned or in-licensed patent rights, trade secrets or other intellectual property as an inventor or co-inventor. For example, we or our licensors may have inventorship disputes arise from conflicting obligations of employees, consultants or others who are involved in developing our product candidates or our technology. Litigation may be necessary to defend against these and other claims challenging inventorship or our or our licensors&#8217; ownership of our owned or in-licensed patent rights, trade secrets or other intellectual property. If we or our licensors fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such as exclusive ownership of or right to use intellectual property that is important to our product candidates or our technology. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to seeking patents for some of our product candidates, we also rely on trade secrets, including unpatented know-how, technology and other proprietary information, to maintain our competitive position. We seek to protect these trade secrets, in part, by entering into non-disclosure and confidentiality agreements with parties who have access to them, such as our employees, corporate collaborators, external scientific collaborators, contract manufacturers, consultants, advisors, and other third parties. We also enter into confidentiality and invention or patent assignment agreements with our employees and consultants. Despite these efforts, any of these parties may breach the agreements and disclose our proprietary information, including our trade secrets, and we may not be able to obtain adequate remedies for such breaches. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive, and time consuming, and the outcome is unpredictable. If we are unable to prevent unauthorized material disclosure of our intellectual property to third parties, we may not be able to establish or maintain a competitive advantage, which could materially adversely affect our business, operating results and financial condition. If we choose to go to court to stop a third party from using any of our trade secrets, we may incur substantial costs. These lawsuits may consume our time and other resources even if we are successful. In addition, some courts inside and outside the United States are less willing or unwilling to protect trade secrets. As a result, we may encounter significant problems in protecting and defending our intellectual property both in the United States and abroad. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor, we would have no right to prevent them from using that technology or information to compete with us. If any of our trade secrets were to be disclosed to or independently developed by a competitor, our competitive position would be harmed.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be successful in obtaining necessary rights to product candidates we may develop through acquisitions and in-licenses.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently have rights to certain intellectual property through licenses from third parties. Because our product candidates and technology may require the use of additional intellectual property rights held by third parties, the growth of our business likely will depend, in part, on our ability to acquire, in-license or use these intellectual property rights. We may be unable to acquire or in-license any intellectual property rights related to compositions, methods of use, processes or other technology from third parties that we identify as necessary to our business operations on commercially reasonable terms, if at all. We may need to cease use of the compositions, methods of use, processes or other technology covered by such intellectual property rights, and may need to seek to develop alternative approaches that do not infringe on such intellectual property rights which may entail significant costs and development delays, even if we are able to develop such alternatives, which may not be feasible. Even if we are able to acquire or in-license any such necessary intellectual property, it could be on non-exclusive terms, thereby giving our competitors and other third parties access to the same intellectual property licensed to us, and the applicable licensors could require us to make substantial licensing and royalty payments. The licensing or acquisition of third-party intellectual property rights is a competitive area, and several more established companies may pursue strategies to license or acquire third-party intellectual property rights that we may consider attractive or necessary. These established companies may have a competitive advantage over us due to their size, capital resources and greater clinical development and commercialization capabilities. In addition, companies that perceive us to be a competitor may be unwilling to assign or license rights to us. We also may be unable to license or acquire third-party intellectual property rights on terms that would allow us to make an appropriate return on our investment.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sometimes collaborate with non-profit and academic institutions to accelerate our preclinical research or development under written agreements with these institutions. In certain cases, these institutions may provide us with an option to negotiate a license to any of the institution&#8217;s rights in technology resulting from the collaboration. Regardless of such option, we may be unable to negotiate a license within the specified timeframe or under terms that are acceptable to us. If we are unable to do so, the institution may offer the intellectual property rights to third parties, potentially blocking our ability to pursue our research programs and develop and commercialize our product candidates.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to successfully obtain rights to required third-party intellectual property rights or maintain the existing intellectual property rights we have licensed, we may be required to expend significant time and resources to redesign our product candidates, the methods for manufacturing them, or to develop or license replacement technology, all of which may not be feasible on a technical or commercial basis. If we are unable to do so, we may be unable to develop or commercialize the affected product candidates or technology, which could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to claims asserting that our employees, consultants, independent contractors or advisors have wrongfully used or disclosed alleged trade secrets of their former employers or other third parties or claims asserting ownership of what we regard as our own intellectual property.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have received, and will continue to receive, confidential and proprietary information from third parties. In addition, many of our employees, consultants, independent contractors or advisors are currently, or were previously, employed at universities or other biotechnology or pharmaceutical companies, including our competitors or potential competitors. Although we try to ensure that our employees, consultants, independent contractors and advisors do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that these individuals or we have deliberately, inadvertently or otherwise used or disclosed intellectual property, including trade secrets or other proprietary information, of any such individual&#8217;s current or former employers, competitors or other third parties, or to claims that we have improperly used or obtained such trade secrets or other proprietary information. We may be subject to claims that we or our employees, consultants, independent contractors or advisors have inadvertently or otherwise used or disclosed confidential information of third parties. Litigation may be necessary to defend against these claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or be required to obtain licenses to such intellectual property rights, which may not be available on commercially reasonable terms or at all. An inability to incorporate such intellectual property rights would harm our business and may prevent us from successfully commercializing any product candidates or technology we may develop or at all. In addition, we may lose personnel as a result of such claims and any such litigation or the threat thereof may adversely affect our ability to hire employees or contract with consultants, independent contractors or advisors. A loss of key personnel or their work product could hamper or prevent our ability to commercialize any product candidates and our technology, which would have a material adverse effect on our business, results of operations, financial condition and prospects. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to our scientific and management personnel.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, while it is our policy to require our employees and consultants who may be involved in the conception or development of intellectual property to execute agreements assigning such intellectual property to us, we may be unsuccessful in executing such an agreement with each party who, in fact, conceives or develops intellectual property that we regard as our own. Moreover, even when we obtain agreements assigning intellectual property to us, the assignment of intellectual property rights may not be self-executing or the assignment agreements may be breached, and we may be forced to bring claims against third parties, or defend claims that they may bring against us, to determine the ownership of what we regard as our intellectual property. Furthermore, individuals executing agreements with us may have pre-existing or competing obligations to a third party, such as an academic institution, and thus an agreement with us may be ineffective in perfecting ownership of inventions developed by that individual. Disputes about the ownership of intellectual property that we own may have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our markets of interest and our business may be adversely affected.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our trademarks or trade names may be challenged, infringed, circumvented or declared generic or determined to be infringing on other marks. We rely on both registration and common law protection for our trademarks. During trademark registration proceedings, we may receive rejections. Although we would be given an opportunity to respond to those rejections, we may be unable to overcome such rejections. In addition, in the USPTO and in comparable agencies in many foreign jurisdictions, third parties are given an opportunity to oppose pending trademark applications and to seek to cancel registered trademarks. Opposition or cancellation proceedings may be filed against our trademarks, and our trademarks may not survive such proceedings. As a means to enforce our trademark rights and prevent infringement, we may be required to file trademark claims against third parties or initiate trademark opposition proceedings. This can be expensive and time-consuming, particularly for a company of our size. We may not be able to protect our rights to these trademarks and trade names, which we need to build name recognition among potential partners, clients or customers in our markets of interest. At times, third parties may adopt trade names or trademarks similar to ours, thereby impeding our ability to build brand identity and possibly leading to market confusion. In addition, there could be potential trade name or trademark infringement claims brought by owners of other registered trademarks or trademarks that incorporate variations of our registered or unregistered trademarks or trade names. Over the long term, if we are unable to establish name recognition based on our trademarks and trade names, then we may not be able to compete effectively and our business may be adversely affected. Our efforts to enforce or protect our proprietary rights related to trademarks, trade secrets, domain names, copyrights or other intellectual property may be ineffective and could result in substantial costs and diversion of resources. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations or prospects.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intellectual property rights do not necessarily address all potential threats.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The degree of future protection afforded by our intellectual property rights is uncertain because intellectual property rights have limitations and may not adequately protect our business or permit us to maintain our competitive advantage. For example:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">others may be able to make products that are similar to our product candidates or that utilize similar technology but that are not covered by the intellectual property rights, including the claims of the patents, that we own or license currently or in the future;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we, or our current or future license partners or collaborators, might not have been the first to make the inventions covered by the issued patent or pending patent application that we own or license currently or in the future;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we, or our current or future license partners or collaborators, might not have been the first to file patent applications covering certain of our or their inventions;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">others may independently develop similar or alternative technologies or duplicate any of our technologies without infringing, misappropriating or otherwise violating our owned or licensed intellectual property rights;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">it is possible that our current or future owned or licensed pending patent applications will not lead to issued patents;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">issued patents that we hold rights to may be held invalid or unenforceable, including as a result of legal challenges by third parties;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">third parties might conduct research and development activities in jurisdictions where we do not have patent or other intellectual property rights and then use the information learned from such activities to develop competitive products for sale in our major commercial markets;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may not develop additional proprietary technologies that are patentable;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the patents or other intellectual property rights of others may have an adverse effect on our business; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may choose not to file a patent for certain trade secrets or know-how, and a third party may subsequently file a patent covering such intellectual property.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Should any of these events occur, they could significantly harm our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intellectual property discovered through government funded programs may be subject to federal regulations such as &#8220;march-in&#8221; rights, certain reporting requirements and a preference for U.S.-based companies. Compliance with such regulations may limit our exclusive rights and limit our ability to contract with non-U.S. manufacturers.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have in-licensed certain patents and patent applications that were generated through the use of U.S. government funding or grants, and we may acquire or license in the future intellectual property rights that have been generated through the use of U.S. government funding or grants. Pursuant to the Bayh-Dole Act of 1980, the U.S. government has certain rights in inventions developed with government funding. These U.S. government rights include a non-exclusive, non-transferable, irrevocable worldwide license to use inventions for any governmental purpose. In addition, the U.S. government has the right, under certain limited circumstances, to require us to grant exclusive, partially exclusive, or non-exclusive licenses to any of these inventions to a third party if it determines that: (1)&#160;adequate steps have not been taken to commercialize the invention; (2)&#160;government action is necessary to meet public health or safety needs; or (3)&#160;government action is necessary to meet requirements for public use under federal regulations (also referred to as &#8220;march-in&#8221; rights). If the U.S. government exercised its march-in rights in our current or future intellectual property rights generated through the use of U.S. government funding or grants, we could be forced to license or sublicense intellectual property developed by us or that we license on terms unfavorable to us, and there can be no assurance that we would receive compensation from the U.S. government for the exercise of such rights. The U.S. government also has the right to take title to these inventions if the grant recipient fails to disclose the invention to the government or fails to file an application to register the intellectual property within specified time limits. Intellectual property generated under a government funded program is also subject to certain reporting requirements, compliance with which may require us to expend substantial resources. In addition, the U.S. government requires that any products embodying any of these inventions or produced through the use of any of these inventions be manufactured substantially in the United States. This preference for U.S. industry may be waived by the federal agency that provided the funding if the owner or assignee of the intellectual property can show that reasonable but unsuccessful efforts have been made to grant licenses on similar terms to </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">potential licensees that would be likely to manufacture substantially in the United States or that under the circumstances domestic manufacture is not commercially feasible. This preference for U.S. industry may limit our ability to contract with non-U.S. product manufacturers for products covered by such intellectual property. Any failure by us to comply with federal regulations regarding intellectual property rights that were developed through the use of U.S. government funding could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Business Operations and Industry</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our operating results may fluctuate significantly, which makes our future operating results difficult to predict and could cause our operating results to fall below expectations or any guidance we may provide.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our quarterly and annual operating results may fluctuate significantly, which makes it difficult for us to predict our future operating results. These fluctuations may occur due to a variety of factors, many of which are outside of our control, including, but not limited to:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing and cost of, and level of investment in, research, development, regulatory approval, and commercialization activities relating to our product candidates, which may change from time to time, including the need to conduct unanticipated clinical trials or trials that are larger or more complex than anticipated;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to enroll patients in clinical trials and the timing of enrollment;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing and success or failure of preclinical studies or clinical trials for our product candidates or competing products, or any other change in the competitive landscape of our industry, including consolidation among our competitors or partners;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">coverage and reimbursement policies with respect to our product candidates, if approved, and potential future drugs that compete with our product candidates;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost of manufacturing our product candidates, which may vary depending on the quantity of production and the terms of our agreements with third-party manufacturers;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expenditures that we may incur to acquire, develop, or commercialize additional product candidates and technologies;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the level of demand for any approved product candidates, which may vary significantly and be difficult to predict;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to establish and maintain collaborations, licensing, or other arrangements;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential unforeseen business disruptions that increase our costs or expenses;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">future accounting pronouncements or changes in our accounting policies; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing and amount of any milestone, royalty, or other payments payable by us or due to us under any collaboration, licensing, or other similar agreement.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cumulative effects of these factors could result in large fluctuations and unpredictability in our quarterly and annual operating results. As a result, comparing our operating results on a period-to-period basis may not be meaningful. Investors should not rely on our past results as an indication of our future performance.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This variability and unpredictability could also result in our failing to meet the expectations of industry or financial analysts or investors for any period. If our revenue or operating results fall below the expectations of analysts or investors or below any forecasts we may provide to the market, or if the forecasts we provide to the market are below the expectations of analysts or investors, the price of our common stock could decline substantially. Such a stock price decline could occur even when we have met any previously publicly stated revenue or earnings guidance we may provide.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face substantial competition, which may result in others discovering, developing or commercializing products before us or more successfully than we do.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The development and commercialization of new drug products is highly competitive. We may face competition with respect to any product candidates that we may develop from major pharmaceutical companies, specialty pharmaceutical companies and biotechnology companies worldwide. There are a number of large pharmaceutical and biotechnology companies that currently market and sell products or are pursuing the development of products for the treatment of some of the disorders for which we are conducting research and development programs. Potential competitors </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">also include academic institutions, government agencies and other public and private research organizations that conduct research, seek patent protection and establish collaborative arrangements for research, development, manufacturing and commercialization.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial opportunity could be reduced or eliminated if our competitors develop and commercialize products that are safer, more effective, have fewer or less severe side effects, are more convenient or are less expensive than our product candidates or that would render any product candidates that we may develop obsolete or non-competitive. Our competitors also may obtain FDA or other regulatory approval for their products more rapidly than we may obtain approval for ours, which could result in our competitors establishing a strong market position before we are able to enter the market. Additionally, technologies developed by our competitors may render our product candidates uneconomical or obsolete, and we may not be successful in marketing any product candidates we may develop against competitors.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to face competition from existing products and product candidates in development for each of our programs and product candidates. In addition to the current standard-of-care treatments to address the diseases we are targeting in therapeutic development programs, numerous commercial and academic preclinical studies and clinical trials are being undertaken by a large number of parties to assess novel technologies and product candidates.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the broad treatment of patients with UCDs, we will compete with Amgen&#160;Inc., who has commercialized Ravicti, a nitrogen scavenger. Other therapeutics in development are focused on patients with OTC deficiency only, where we will potentially compete with Ultragenyx Pharmaceutical&#160;Inc., Arcturus Therapeutics Holdings&#160;Inc., and iECURE, Inc. (&#8220;iECURE&#8221;), among others, assuming they are successful in clinical development. Companies that compete with us directly on the level of the development of product candidates targeting SYNGAP1-related disorders include Stoke Therapeutics,&#160;Inc. and Praxis Precision Medicines,&#160;Inc., along with other companies with programs currently in discovery stages of development, such as Tevard Biosciences, Inc., Regel Therapeutics, Inc., and Quiver Bioscience Inc. For the treatment of GBA1 Parkinson&#8217;s Disease, we will potentially compete with Gain Therapeutics, Inc., Vanqua Bio, Inc., BIAL-Portela &amp; C&#170;., S.A., and Prevail Therapeutics Inc. (a subsidiary of Eli Lilly and Company), assuming they are successful in clinical development, along with other companies with programs currently in preclinical stages of development. Companies engaged in the commercialization and development of antisense oligonucleotides as therapeutics include Alnylam Pharmaceuticals,&#160;Inc. and Ionis Pharmaceuticals&#160;Inc.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the companies against which we compete or against which we may compete in the future have significantly greater financial resources and expertise in research and development, manufacturing, preclinical testing, conducting clinical trials, obtaining regulatory approvals and marketing approved products than we do. Accordingly, our competitors may be more successful than us in research and development, manufacturing, preclinical testing, conducting clinical trials, obtaining regulatory and marketing approvals, and achieving widespread market acceptance, rendering our product candidates obsolete or non-competitive.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, mergers and acquisitions in the pharmaceutical and biotechnology industries may result in even more resources being concentrated among a smaller number of our competitors. Smaller and other early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These third parties compete with us in recruiting and retaining qualified scientific and management personnel, establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our programs.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we successfully obtain approval for any product candidate, we will face competition based on many different factors, including the safety and effectiveness of our products and the ease with which our products can be administered, the timing and scope of regulatory approvals for these products, the availability and cost of manufacturing, marketing and sales capabilities, price, reimbursement coverage and patent position. Competing products could present superior treatment alternatives, including by being more effective, safer, more convenient, less expensive or marketed and sold more effectively than any products we may develop. Competitive products or technological approaches may make any products we develop, or our RAP Platform, obsolete or noncompetitive before we recover the expense of developing and commercializing our product candidates. If we are unable to compete effectively, our opportunity to generate revenue from the sale of our products we may develop, if approved, could be adversely affected.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our international activities subject us to various risks, and our failure to manage these risks could adversely affect our results of operations.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face significant operational risks as a result of doing business internationally, such as:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fluctuations in foreign currency exchange rates;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">differing payor reimbursement regimes, governmental payors or patient self-pay systems and price controls;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potentially adverse and/or unexpected tax consequences, including penalties due to the challenge by tax authorities on our tax position;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential changes to the accounting standards, which may influence our financial situation and results;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">compliance with tax, employment, immigration and labor laws should we have any employees living or traveling abroad;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">becoming subject to the different, complex and changing laws, regulations and court systems of multiple jurisdictions and compliance with a wide variety of foreign laws, treaties;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reduced protection of, or significant difficulties in enforcing, intellectual property rights, or increased risk of intellectual property disputes, in certain countries;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties in attracting and retaining qualified consultants, contractors, and personnel;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">restrictions imposed by any applicable local labor practices and laws on our business and operations, including unilateral cancellation or modification of contracts;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">rapid changes in global government, economic and political policies and conditions, political or civil unrest or instability, terrorism or epidemics and other similar outbreaks or events, and potential failure in confidence of our suppliers or customers due to such changes or events;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">geopolitical tensions that affect our activities, operations and/or operations of our contractors, consultants, collaborators, vendors or partners; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">tariffs, trade protection measures, import or export licensing requirements, trade embargoes and other trade barriers.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We conduct certain research and development operations through our wholly-owned Australian subsidiary. If we lose our ability to operate in Australia, or if our subsidiary is unable to receive the research and development incentive payment allowed by Australian regulations, our business and results of operations could suffer.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September&#160;2023, we formed a wholly-owned Australian subsidiary, CAMP4 Therapeutics Pty Ltd, to conduct various clinical activities for our product candidates in Australia. Due to the geographical distance and lack of employees currently in Australia, as well as our lack of experience operating in Australia, we may not be able to efficiently or successfully monitor our clinical activities in Australia, including conducting clinical trials. Furthermore, we have no assurance that the results of any clinical trials that we conduct for our product candidate in Australia will be accepted by the FDA or comparable foreign regulatory authorities for development and commercialization approvals.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, current Australian tax regulations provide for a refundable research and development incentive plan of up to 18.5% of qualified expenditures. If our subsidiary loses its ability to operate in Australia, or if we are ineligible or unable to receive the research and development incentive payment, or the Australian government significantly reduces or eliminates the incentive program, our business and results of operation may be adversely affected.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our future success depends on our ability to retain key executives and to attract, retain and motivate qualified personnel.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are highly dependent on the research and development, clinical, financial, operational and other business expertise of our executive officers, as well as the other principal members of our management, scientific and clinical teams. Although we have entered into employment offer letters with each of our executive officers, our executive officers may terminate their employment with us at any time. We do not maintain &#8220;key person&#8221; insurance for any of our executives or other employees. Recruiting and retaining qualified scientific, clinical, manufacturing, accounting, legal and sales and marketing personnel will also be critical to our success.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss of the services of our executive officers or other key employees could impede the achievement of our research, development and commercialization objectives and seriously harm our ability to successfully implement our business strategy. Furthermore, replacing executive officers and key employees may be difficult and may take an extended period of time because of the limited number of individuals in our industry with the breadth of skills and experience required to successfully develop, gain regulatory approval of and commercialize products. Competition to hire from this limited pool is intense, and we may be unable to hire, train, retain or motivate these key personnel on acceptable terms given the competition among numerous pharmaceutical and biotechnology companies for similar personnel. We also experience competition for the hiring of scientific and clinical personnel from universities and research institutions. In </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">addition, we rely on consultants and advisors, including scientific and clinical advisors, to assist us in formulating our research and development and commercialization strategy. Our consultants and advisors may be employed by employers other than us and may have commitments under consulting or advisory contracts with other entities that may limit their availability to us. Our success as a public company also depends on implementing and maintaining internal controls and the accuracy and timeliness of our financial reporting. If we are unable to continue to attract and retain high quality personnel, our ability to pursue our growth strategy will be limited.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may encounter difficulties in managing our growth and expanding our operations successfully.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, we had 55 full-time employees. As we continue development and pursue the potential commercialization of our product candidates, we will need to expand our financial, development, regulatory, manufacturing, information technology, marketing, and sales capabilities or contract with third parties to provide these capabilities for us. As our operations expand, we expect that we will need to manage additional relationships with various strategic partners, suppliers, and other third parties, and we may not be successful in doing so. Our future financial performance and our ability to develop and commercialize our product candidates and to compete effectively will depend, in part, on our ability to manage any future growth effectively.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may engage in strategic transactions that could impact our liquidity, increase our expenses, and present significant distractions to our management.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may consider strategic transactions, such as acquisitions of companies, asset purchases, and out-licensing or in-licensing of intellectual property, products, or technologies. Additional potential transactions that we may consider in the future include a variety of business arrangements, including spin-offs, strategic partnerships, joint ventures, restructurings, divestitures, business combinations, and investments. Any future transactions could increase our near and long-term expenditures, result in potentially dilutive issuances of our equity securities, including our common stock, or the incurrence of debt, contingent liabilities, amortization expenses or acquired in-process research and development expenses, any of which could affect our financial condition, liquidity, and results of operations. Future acquisitions may also require us to obtain additional financing, which may not be available on favorable terms or at all. These transactions may never be successful and may require significant time and attention of our management. In addition, the integration of any business that we may acquire in the future may disrupt our existing business and may be a complex, risky, and costly endeavor for which we may never realize the full benefits. Furthermore, we may experience losses related to investments in other companies, including as a result of failure to realize expected benefits or the materialization of unexpected liabilities or risks, which could have a material negative effect on our results of operations and financial condition. Accordingly, although there can be no assurance that we will undertake or successfully complete any additional transactions of the nature described above, any additional transactions that we do complete could have a material adverse effect on our business, results of operations, financial condition, and prospects.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Clinical trial and product liability lawsuits against us could divert our resources, could cause us to incur substantial liabilities and could limit commercialization of our product candidates.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will face an inherent risk of clinical trial and product liability exposure related to the testing of our product candidates in clinical trials, and we will face an even greater risk if we commercially sell any products that we may develop. While we currently have no product candidates that have been approved for commercial sale, the use of product candidates by us in clinical trials, and the sale of any approved products in the future, may expose us to liability claims. These claims might be made by patients that use the product, healthcare providers, pharmaceutical companies or others selling such products. If we cannot successfully defend ourselves against claims that our product candidates or products caused injuries, we will incur substantial liabilities. Regardless of merit or eventual outcome, liability claims may result in:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">decreased demand for any product candidates we may develop;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">injury to our reputation and significant negative media attention;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">withdrawal of clinical trial participants and inability to continue clinical trials;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">initiation of investigations by regulators;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">significant costs to defend any related litigation;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">product recalls, withdrawals or labeling, marketing or promotional restrictions;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">substantial monetary awards to trial participants or patients;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">loss of revenue;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">exhaustion of any available insurance and our capital resources;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">declined in our stock price;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reduced resources of our management to pursue our business strategy; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the inability to commercialize any product candidates we may develop.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we maintain clinical trial liability insurance coverage, such insurance may not be adequate to cover all liabilities that we may incur. The cost of any product liability litigation or other proceeding, even if resolved in our favor, could be substantial. We may need to increase our insurance coverage as we expand our clinical trials or if we commence commercialization of any product candidates that receive marketing approval. Insurance coverage is increasingly expensive. We may not be able to maintain insurance coverage at a reasonable cost or in an amount adequate to satisfy any liability that may arise. If a successful clinical trial or product liability claim or series of claims is brought against us for uninsured liabilities or in excess of insured liabilities, our assets may not be sufficient to cover such claims and our business operations could be impaired.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our insurance policies are expensive and protect us from only some business risks, which will leave us exposed to significant uninsured liabilities.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not carry insurance for all categories of risk that our business may encounter. Some of the policies we currently maintain include property, general liability, employee benefits liability, workers&#8217; compensation, clinical trial liability, cyber liability, fiduciary liability, and directors&#8217; and officers&#8217; insurance. We do not know, however, if we will be able to maintain insurance with adequate levels of coverage. No assurance can be given that an insurance carrier will not seek to cancel or deny coverage after a claim has occurred. Any significant uninsured liability may require us to pay substantial amounts, which would adversely affect our financial position and results of operations.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our internal network and information technology systems, or those of our vendors, collaborators, consultants, service providers and other contractors may suffer failure, security breach, loss of data, or other disruptions or compromise, which could result in a material disruption of our product development programs, compromise sensitive information, prevent us from accessing critical information, trigger contractual and legal obligations, or otherwise disrupt our business and materially impact our operations, potentially exposing us to liability, reputational harm, or other adverse effects on our business and financial results.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are increasingly dependent upon information technology systems, infrastructure and data, some of which is managed by third parties, to operate our business. In the ordinary course of business, we collect, store and transmit large amounts of confidential information (including, but not limited to, intellectual property, proprietary business information and personal information). The secure processing, maintenance, and transmission of this information, including maintaining the availability, security, confidentiality, privacy and integrity of such confidential information, is critical to our operations and business. We have also outsourced elements of our operations to third parties, and as a result a number of third-party vendors, collaborators, consultants, service providers and other contractors (including our contract research organizations, CMOs and CROs) may or could have access to our confidential information, including our research and development efforts.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite the implementation of security measures, given the size and complexity of our internal information technology systems and those of any current or future vendors, collaborators, consultants, service providers and other contractors, and the increasing amounts of confidential information we maintain, such information technology systems are vulnerable to breakdown or other damage or interruption due to service interruptions, system malfunctions, natural disasters, terrorism, war and telecommunication and electrical failures, as well as security breaches from inadvertent or intentional actions by our employees, vendors, collaborators, consultants, service providers, other contractors and/or other third parties, or from cyber-attacks by malicious third parties (including the deployment of harmful malware, ransomware, computer viruses, denial-of-service attacks, social engineering, &#8220;phishing&#8221; scams, network security breaches and other means to affect the service reliability and threaten the confidentiality, integrity and availability of information), which may compromise our system infrastructure, or that of our vendors, collaborators, consultants, service providers and other contractors, or lead to data compromise or loss. In addition to such risks, the adoption of new technologies may also increase our exposure to cybersecurity breaches or failures. The risk of a security breach or disruption, particularly through cyber-attacks or cyber intrusion, including by computer hackers, foreign governments and cyber terrorists, has generally increased as the number, intensity, and sophistication of attempted attacks and intrusions from around the world have increased. We may not be able to anticipate all types of security threats, and we may not be able to implement preventive measures that are effective against all such security threats. The techniques used by cyber criminals change frequently, may </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">not be recognized until launched, and can originate from a wide variety of sources, including outside groups such as external service providers, organized crime affiliates, terrorist organizations or hostile foreign governments or agencies.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we seek to protect our information technology systems our efforts may not be successful. If such an event were to occur, it could result in a delay or disruption of our development programs and our business operations, whether due to a loss of our data, trade secrets or other proprietary or confidential information or other disruptions, and we could incur liability and reputational damage. For example, the loss of clinical trial data could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. If we were to experience disruptions or security breaches of our information technology systems, the costs associated with the investigation, remediation and potential notification of the breach to counterparties, data subjects, regulators or others could be material. In addition, our remediation efforts may not be successful. Moreover, if the information technology systems of our vendors, collaborators, consultants, service providers and other contractors become subject to disruptions or security breaches, we may have insufficient recourse against such third parties and we may have to expend significant resources to mitigate the impact of such an event, and to develop and implement protections to prevent future events of this nature from occurring. If we do not allocate and effectively manage the resources necessary to build and sustain the proper technology and cybersecurity infrastructure, we could suffer significant business disruption, including transaction errors, supply chain or manufacturing interruptions, processing inefficiencies, data loss or the loss of or damage to intellectual property or other proprietary information. With the evolving nature of cybersecurity threats, the scope and impact of any information security incident cannot be predicted. In addition, the global regulatory environment pertaining to information security and privacy is increasingly demanding, with new and changing requirements, such as the European Union&#8217;s General Data Protection Regulation, The Personal Information Protection Law of the People&#8217;s Republic of China, and Brazil&#8217;s Lei Geral de Protecao de Dados. Complying with these laws and regulations may be more costly or take longer than we anticipate, and any failure to comply could result in fines or penalties.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that any disruption or security breach were to result in a loss of, or damage to, our or our vendors&#8217;, collaborators&#8217;, consultants&#8217;, service providers&#8217; or other contractors&#8217; data or applications, or inappropriate disclosure of confidential or proprietary information, we could incur liability including litigation exposure, penalties and fines, we could become the subject of regulatory action or investigation, our competitive position and reputation could be harmed and the further development and commercialization of our product candidates could be delayed. As a result of such an event, we may be in breach of our contractual obligations. Furthermore, any such event that leads to unauthorized access, use, or disclosure of personal information, including personal information regarding our employees or current or future clinical trial participants, could harm our reputation, compel us to comply with federal and/or state breach notification laws and foreign law equivalents, subject us to mandatory corrective action, and otherwise subject us to liability under laws and regulations that protect the privacy and security of personal information, which could result in significant legal and financial exposure and reputational damage. Any of the above could have a material adverse effect on our business, financial condition, results of operations or prospects.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial exposure from the events referenced above could either not be insured against or not be fully covered through any insurance that we maintain and could have a material adverse effect on our business, financial condition, results of operations or prospects. In addition, we cannot be sure that our existing insurance coverage will continue to be available on acceptable terms or that our insurers will not deny coverage as to any future claim. There can be no assurance that the limitations of liability in our contracts would be enforceable or adequate or would otherwise protect us from liabilities or damages as a result of the events referenced above.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our operations or those of the third parties upon whom we depend might be affected by the occurrence of a natural disaster, pandemic or other catastrophic event.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend on our employees, consultants, vendors, service providers, and other contractors (including CMOs and CROs), as well as regulatory agencies and other third parties, for the continued operation of our business. Despite any precautions we take for natural disasters or other catastrophic events, these events, including terrorist attack, pandemics, hurricanes, fire, floods and ice and snowstorms, could result in significant disruptions to our research and development, preclinical studies, clinical trials, and, ultimately, commercialization of our products. Long-term disruptions in infrastructure caused by events, such as natural disasters, the outbreak of war, the escalation of hostilities and acts of terrorism or other &#8220;acts of God,&#8221; particularly involving those places in which we maintain office space or at our manufacturing or clinical trial sites, could adversely affect our businesses. Although we carry business interruption insurance policies and typically have provisions in our contracts that protect us in certain events, our coverage might not respond or be adequate to compensate us for all losses that may occur. Any natural disaster or catastrophic event affecting us, our consultants, vendors, service providers, and other contractors, regulatory agencies or other parties with which we are engaged could have a significant negative impact on our operations and financial performance.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business could be affected by litigation, government investigations, and enforcement actions.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently operate in a number of jurisdictions in a highly regulated industry, and we could be subject to litigation, government investigation, and enforcement actions on a variety of matters in the United States or foreign jurisdictions, including, without limitation, intellectual property, regulatory, product liability, environmental, whistleblower, false claims, privacy, anti-kickback, anti-bribery, securities, commercial, employment, and other claims and legal proceedings that may arise from conducting our business. Any determination that our operations or activities are not in compliance with existing laws or regulations could result in the imposition of fines, civil and criminal penalties, equitable remedies, including disgorgement, injunctive relief, and/or other sanctions against us, and remediation of any such findings could have an adverse effect on our business operations.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal proceedings, government investigations, and enforcement actions can be expensive and time-consuming. An adverse outcome resulting from any such proceedings, investigations or enforcement actions could result in significant damages awards, fines, penalties, exclusion from the federal healthcare programs, healthcare debarment, injunctive relief, product recalls, reputational damage, and modifications of our business practices, which could have a material adverse effect on our business and results of operations. Even if such a proceeding, investigation, or enforcement action is ultimately decided in our favor, the investigation and defense thereof could require substantial financial and management resources.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our employees, consultants, collaborators, vendors, service providers and other contractors may engage in misconduct or other improper activities, including non-compliance with regulatory standards and requirements and insider trading.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to the risk of employee and third-party fraud or other misconduct or failure to comply with applicable regulatory requirements. Any past, current or future misconduct or non-compliance by our prior, existing or future employees, consultants, vendors, service providers and other contractors with any industry or regulatory standards or requirements may result in a material adverse effect on our operations or harm our reputation. Misconduct by these parties could include intentional failures to comply with FDA regulations and/or those of comparable applicable regulatory authorities, provide accurate information to such regulatory authorities, comply with manufacturing standards, comply with healthcare fraud and abuse laws and regulations in the United States and abroad, report financial information or data accurately, or disclose unauthorized activities to us. In particular, sales, marketing and other business arrangements in the healthcare industry are subject to extensive laws and regulations intended to prevent fraud, misconduct, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of business activities, including, but not limited to, research, manufacturing, distribution, pricing, discounting, marketing and promotion, sales commission, support programs and other business arrangements. Misconduct by these parties could also involve the improper use of individually identifiable information or information obtained in the course of clinical trials or interactions with the FDA, TGA or other regulatory authorities, which could result in regulatory sanctions and cause serious harm to our reputation. We have adopted a code of conduct applicable to all of our employees, but it is not always possible to identify and deter employee or third-party misconduct, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from government investigations or other actions or lawsuits stemming from a failure to comply with these laws or regulations. If any such actions are instituted against us, those actions could have a significant impact on our business, including the imposition of significant civil, criminal and administrative penalties, damages, monetary fines, disgorgement of profits, imprisonment, possible exclusion from participation in Medicare, Medicaid and other federal healthcare programs, or other government-supported healthcare in other jurisdictions, contractual damages, reputational harm, diminished profits and future earnings, additional reporting or oversight obligations if we become subject to a corporate integrity agreement or other agreement to resolve allegations of non-compliance with the law and curtailment or restructuring of our operations, any of which could adversely affect our ability to operate. and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, financial condition, results of operations and prospects, including the imposition of significant civil, criminal and administrative penalties, damages, monetary fines, disgorgement of profits, imprisonment, possible exclusion from participation in Medicare, Medicaid and other federal healthcare programs, or other government-supported healthcare in other jurisdictions, contractual damages, reputational harm, diminished profits and future earnings, additional reporting or oversight obligations if we become subject to a corporate integrity agreement or other agreement to resolve allegations of non-compliance with the law and curtailment or restructuring of our operations, or other sanctions, any of which could adversely affect our ability to operate.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to utilize our net operating loss carryforwards and certain other tax attributes may be subject to limitations.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a history of cumulative losses and anticipate that we will continue to incur significant losses in the foreseeable future; thus, we do not know whether or when we will generate taxable income necessary to utilize our net operating losses (&#8220;NOLs&#8221;) or research and development tax credit carryforwards. As of December&#160;31, 2024, we had federal NOL carryforwards of $102.3 million and state NOL carryforwards of $97.6 million.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, under Sections 382 and 383 of the U.S. Internal Revenue Code of 1986, as amended, or the Code, and corresponding provisions of state law, a corporation that undergoes an &#8220;ownership change,&#8221; generally defined as a greater than 50&#160;percentage point change (by value) in its equity ownership by certain stockholders over a three-year period, is subject to limitations on its ability to utilize its pre-change NOLs and pre-change research and development tax credit carryforwards to offset post-change taxable income. We have not yet conducted a study to determine if any such changes have occurred that could limit our ability to use the NOL and tax credit carryforwards. As a result, if, and to the extent that, we earn net taxable income, our ability to use our NOL carryforwards and research and development tax credit carryforwards to offset such taxable income may be subject to limitations.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is also a risk that due to regulatory changes, such as suspensions on the use of NOLs, or other unforeseen reasons, our existing NOLs could expire or otherwise become unavailable to offset future income tax liabilities. Tax legislation enacted in 2017, informally titled the Tax Cuts and Jobs Act (the &#8220;Tax Act&#8221;), as amended by the Coronavirus Aid, Relief, and Economic Security Act (the &#8220;CARES Act&#8221;), includes changes to U.S. federal tax rates and the rules&#160;governing NOL carryforwards that may significantly impact our ability to utilize our NOLs to offset taxable income in the future. In addition, state NOLs generated in one state cannot be used to offset income generated in another state. For these reasons, even if we attain profitability, we may be unable to use a material portion of our NOLs and other tax attributes.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exchange rate fluctuations may affect our results of operations and financial conditions.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fluctuations in exchange rates, particularly between the U.S. dollar and the Australian dollar, may adversely affect us. Although we are incorporated in Delaware in the United States, we currently conduct clinical development in Australia. As a result, our business and the price of our common stock may be affected by fluctuations in foreign exchange rates, which may have a significant impact on our results of operations and cash flows from period to period. Currently, we do not have any exchange rate hedging arrangements in place.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Ownership of Our Common Stock</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">An active, liquid, and orderly market for our common stock may not develop or be sustained, or we may in the future fail to satisfy the continued listing requirements of Nasdaq.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock began trading on the Nasdaq Global Market (&#8220;Nasdaq&#8221;) on October 11, 2024. Given the limited trading history of our common stock, we can provide no assurance that an active trading market will develop or be sustained. If an active market for our common stock is not sustained, it may be difficult for you to sell your shares at the time you wish to sell them or at a price that you consider reasonable. An inactive market may also impair our ability to raise capital by selling shares and may impair our ability to acquire other businesses or technologies using our shares as consideration, which, in turn, could materially adversely affect our business.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to satisfy the continued listing requirements of Nasdaq, such as the corporate governance requirements or the minimum closing bid price requirement, Nasdaq may take steps to delist our common stock. Such a delisting would likely have a negative effect on the price of our common stock and would impair your ability to sell or purchase our common stock when you wish to do so. In the event of a delisting, we can provide no assurance that any action taken by us to restore compliance with listing requirements would allow our common stock to become listed again, stabilize the market price or improve the liquidity of our common stock, prevent our common stock from dropping below the Nasdaq minimum bid price requirement, or prevent future non-compliance with the listing requirements of Nasdaq.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The trading price of the shares of our common stock could be highly volatile, and purchasers of our common stock could incur substantial losses.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since shares of our common stock were sold in our initial public offering (the &#8220;IPO&#8221;) in October&#160;2024 at a price of $11.00 per share and through March 13, 2025, the price per share of our common stock has ranged from $3.50 to $12.30. The stock market in general and the market for stock of biopharmaceutical companies in particular have experienced extreme volatility that has often been unrelated to the operating performance of individual companies. As a result of this </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">volatility, investors may not be able to sell their common stock at or above the price at which they initially purchased the common stock. The market price for our common stock may be influenced by those factors discussed in this &#8220;Risk Factors&#8221; section and many others, including:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">results of our clinical trials and preclinical studies, and the results of trials of our competitors or those of other companies in our market sector;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to enroll patients in our current and any future clinical trials;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain and maintain regulatory approval of our product candidates or additional indications thereof, or limitations to specific label indications or patient populations for its use, or changes or delays in the regulatory review process;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory or legal developments in the United States and foreign countries;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the structure of healthcare payment systems;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the success or failure of our efforts to develop, acquire, or license additional product candidates;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">innovations, clinical trial results, product approvals and other developments regarding our competitors;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements by us or our competitors of significant acquisitions, strategic partnerships, joint ventures, or capital commitments;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">manufacturing, supply, or distribution delays or shortages;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any changes to our relationship with any manufacturers, suppliers, collaborators, or other strategic partners;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">achievement of expected product sales and profitability;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">variations in our financial results or development timelines or those of companies that are perceived to be similar to us, including variations from expectations of securities analysts or investors;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">market conditions in the biopharmaceutical sector and issuance of securities analysts&#8217; reports or recommendations;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">trading volume of our common stock;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an inability to obtain additional funding;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sales of our stock by us, our insiders, or our stockholders, as well as the anticipation of lock-up releases or expiration of market stand-off or lock-up agreements;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic, industry, geopolitical, and market conditions, such as military conflict or war, inflation and financial institution instability, or pandemic or epidemic disease outbreaks, many of which are beyond our control;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">additions or departures of senior management, directors, or key personnel;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">intellectual property, product liability, or other litigation against us or our inability to enforce our intellectual property;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in our capital structure, such as future issuances of securities and the incurrence of additional debt; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in accounting standards, policies, guidelines, interpretations, or principles.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in the past, stockholders have initiated class action lawsuits against biopharmaceutical companies following periods of volatility in the market prices of these companies&#8217; stock. Such litigation, if instituted against us, could cause us to incur substantial costs, divert our management&#8217;s attention and resources and damage our reputation, which could have a material adverse effect on our business, financial condition and results of operations and prospects.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A significant portion of our total outstanding shares is restricted from immediate resale but may be sold into the market in the near future, which could cause the market price of our common stock to decline significantly, even if our business is doing well.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of a substantial number of shares of our common stock in the public market could occur at any time. These sales upon the expiration of the lock-up agreements entered into by holders of substantially all of our common stock outstanding immediately prior to our IPO, the early release of the lock-ups, or the perception in the market that the holders </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of a large number of shares of common stock intend to sell shares, could reduce the market price of our common stock. As of December&#160;31, 2024, we had 20,161,072 shares of common stock outstanding. Of these shares, the 7,463,762 shares we sold in our IPO and subsequent exercise in part by the underwriters of their option to purchase additional shares may be resold in the public market immediately, unless held by our affiliates. The remaining shares are currently restricted under securities laws or as a result of lock-up or other agreements, but will be able to be sold after the lapse of the lock-up and other legal restrictions described in our prospectus, filed with respect to our IPO pursuant to Rule 424(b)(4) under the Securities Act with the SEC on October 11, 2024.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our executive officers, directors, and principal stockholders, if they choose to act together, have the ability to significantly influence all matters submitted to stockholders for approval.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our executive officers, directors and greater than 5% stockholders, in the aggregate, own a substantial majority of our outstanding common stock. As a result, such persons, if they choose to act together, have the ability to significantly influence all matters submitted to our board of directors or stockholders for approval, including the appointment of our management, the election and removal of directors and approval of any significant transaction, as well as our management and business affairs. This concentration of ownership may have the effect of delaying, deferring, or preventing a change in control, impeding a merger, consolidation, takeover or other business combination involving us, or discouraging a potential acquiror from making a tender offer or otherwise attempting to obtain control of our business, even if such a transaction would benefit other stockholders.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We do not currently intend to pay dividends on our common stock, so any returns on your investment will be limited to the value of our common stock.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have never declared or paid any cash dividend on our common stock. We currently anticipate that we will retain future earnings for the development, operation, and expansion of our business and do not anticipate declaring or paying any cash dividends for the foreseeable future. In addition, any future debt agreements may preclude us from paying dividends. Any return to stockholders will therefore be limited to the appreciation of their stock. There is no guarantee that shares of our common stock will appreciate in value or even maintain the price at which stockholders have purchased their shares.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sales of a substantial number of shares of our common stock by our existing stockholders in the public market could cause our stock price to fall.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of a substantial number of shares of our common stock in the public market or the perception that these sales might occur could significantly reduce the market price of our common stock and impair our ability to raise adequate capital through the sale of additional equity or equity-linked securities.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our IPO, our directors and executive officers and the holders of substantially all of our outstanding securities prior to our IPO entered into lock-up agreements with the representatives pursuant to which they may not, with limited exceptions and among other things, through April 8, 2025, offer, sell or otherwise transfer or dispose of any of our securities, without the prior written consent of J.P. Morgan and Leerink Partners. The underwriters may permit our officers, directors, and other security holders who are subject to the lock-up agreements to sell shares prior to the expiration of the lock-up agreements at any time in their sole discretion. After the lock-up agreements expire, these shares of common stock will be eligible for sale in the public market, except that shares held by directors, executive officers and other affiliates will be subject to volume limitations under Rule&#160;144 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as of December&#160;31, 2024, 2,119,425 shares of common stock that are subject to outstanding options under our employee benefit plans will become eligible for sale in the public market to the extent permitted by the provisions of various vesting schedules, the lock-up agreements, and Rule&#160;144 and Rule&#160;701 under the Securities Act. If there are any sales of these shares of common stock, or if it is perceived that they will be sold, in the public market, the trading price of our common stock could decline.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of 11,648,582 shares of our outstanding common stock, or approximately 57.8% of our total outstanding common stock based on shares outstanding as of December&#160;31, 2024, are entitled to rights with respect to the registration of their shares under the Securities Act, subject to the 180-day lock-up agreements described above. Registration of these shares under the Securities Act would result in the shares becoming freely tradable without restriction under the Securities Act, except for shares held by affiliates, as defined in Rule&#160;144 under the Securities Act. Any sales of securities by these stockholders could have a material adverse effect on the trading price of our common stock.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are an &#8220;emerging growth company&#8221; and a &#8220;smaller reporting company,&#8221; and the reduced disclosure requirements applicable to emerging growth companies and smaller reporting companies may make our common stock less attractive to investors.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are an &#8220;emerging growth company,&#8221; or an EGC, as defined in the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;). We are also a &#8220;smaller reporting company,&#8221; as defined in Rule&#160;12b-2 under the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;). We may remain an EGC until December&#160;31, 2029, although if the market value of our common stock that is held by non-affiliates exceeds $700.0 million as of any June&#160;30 before that time or if we have annual gross revenues of $1.235 billion or more in any fiscal&#160;year, we would cease to be an EGC as of December&#160;31 of the applicable&#160;year. We would also cease to be an EGC if we issue more than $1.0 billion of non-convertible debt over a three-year period. For so long as we remain an EGC, we are permitted and intend to rely on exemptions from certain disclosure requirements that are applicable to other public companies that are not EGCs. These exemptions include:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">not being required to comply with the auditor attestation requirements in the assessment of our internal control over financial reporting;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">not being required to comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor&#8217;s report providing additional information about the audit and the financial statements;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reduced disclosure obligations regarding executive compensation; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even after we no longer qualify as an EGC, we may continue to qualify as a smaller reporting company, which would allow us to take advantage of many of the same exemptions from disclosure requirements, including reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements. In addition, if we are a smaller reporting company with less than $100.0 million in annual revenue, we would not be required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act of 2002 (&#8220;Section&#160;404&#8221;). We would cease to be a smaller reporting company if the market value of our common stock that is held by non-affiliates exceeds $250.0 million and we had annual revenues in excess of $100.0 million or if the market value of our common stock that is held by non-affiliates exceeds $700.0 million, each as determined on an annual basis.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict whether investors will find our common stock less attractive if we rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our stock price may be more volatile.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the JOBS Act permits an EGC to take advantage of an extended transition period to comply with new or revised accounting standards applicable to public companies until those standards would otherwise apply to private companies. We have elected to take advantage of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, we will adopt the new or revised standard at the time private companies adopt the new or revised standard and will do so until such time that we either irrevocably elect to &#8220;opt out&#8221; of such extended transition period or no longer qualify as an EGC. We may choose to early adopt any new or revised accounting standards whenever such early adoption is permitted for private companies.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provisions in our corporate charter documents and under Delaware law may have anti-takeover effects that could discourage an acquisition of our company by others, even if an acquisition would be beneficial to our stockholders, and may prevent attempts by our stockholders to replace or remove our current management.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our amended and restated certificate of incorporation (&#8220;Restated Charter&#8221;), our amended and restated bylaws (&#8220;Restated Bylaws&#8221;) and Delaware law contain provisions that may have the effect of discouraging, delaying or preventing a change in control of our company or changes in our management that stockholders may consider favorable, including transactions in which you might otherwise receive a premium for your shares. These include provisions that:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">authorize &#8220;blank check&#8221; preferred stock, which could be issued by our board of directors without stockholder approval and may contain voting, liquidation, dividend and other rights superior to our common stock;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">create a classified board of directors whose members serve staggered three-year terms;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">specify that special meetings of our stockholders can be called only by our board of directors;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prohibit stockholder action by written consent;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establish an advance notice procedure for stockholder approvals to be brought before an annual meeting of our stockholders, including proposed nominations of persons for election to our board of directors;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide that vacancies on our board of directors may be filled only by a majority of directors then in office, even though less than a quorum;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide that our directors may be removed only for cause;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">specify that no stockholder is permitted to cumulate votes at any election of directors;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expressly authorize our board of directors to modify, alter or repeal our amended and restated bylaws; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">require supermajority votes of the holders of our common stock to amend specified provisions of our Restated Charter and Restated Bylaws.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These provisions, alone or together, could delay or prevent hostile takeovers and changes in control or changes in our management. These provisions could also limit the price that investors might be willing to pay in the future for shares of our common stock, thereby depressing the market price of our common stock.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, because we are incorporated in the State of Delaware, we are governed by the provisions of Section&#160;203 of the General Corporation Law of the State of Delaware (the &#8220;DGCL&#8221;), which prohibits a person who owns in excess of 15% of our outstanding voting stock from merging or combining with us for a period of three&#160;years after the date of the transaction in which the person acquired in excess of 15% of our outstanding voting stock, unless the merger or combination is approved in a prescribed manner.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any provision of our Restated Charter, Restated Bylaws or Delaware law that has the effect of delaying or deterring a change in control could limit the opportunity for our stockholders to receive a premium for their shares of our common stock, and could also affect the price that some investors are willing to pay for our common stock.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Restated Charter designates specific courts as the sole and exclusive forum for certain claims or causes of action that may be brought by our stockholders, which could discourage lawsuits against us and our directors and officers.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Restated Charter provides that, subject to limited exceptions, the Court of Chancery of the State of Delaware (or, if, and only if, the Court of Chancery of the State of Delaware dismisses a Covered Claim (as defined below) for lack of subject matter jurisdiction, any other state or federal court in the State of Delaware that does have subject matter jurisdiction) is, to the fullest extent permitted by applicable law, the sole and exclusive forum for the following types of claims, including: (i)&#160;any derivative claim brought in our right, (ii)&#160;any claim asserting a breach of a fiduciary duty to us or the our stockholders owed by any of our current or former directors, officers or other employees or stockholders, (iii)&#160;any claim against us arising pursuant to any provision of the DGCL, our Restated Charter or Restated Bylaws, (iv)&#160;any claim to interpret, apply, enforce or determine the validity of our Restated Charter or Restated Bylaws, (v)&#160;any claim against us governed by the internal affairs doctrine, and (vi)&#160;any other claim, not subject to exclusive federal jurisdiction and not asserting a cause of action arising under the Securities Act, brought in any action asserting one or more of the claims specified in clauses (a)(i)&#160;through (v)&#160;herein above (each, a &#8220;Covered Claim&#8221;). This provision does not apply to claims brought to enforce a duty or liability created by the Exchange Act.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Restated Charter further provides that the federal district courts of the United States of America are the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. In addition, our Restated Charter provides that any person or entity purchasing or otherwise acquiring any interest in the shares of capital stock of the Company will be deemed to have notice of and consented to these choice-of-forum provisions and waived any argument relating to the inconvenience of the forums in connection with any Covered Claim.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The choice of forum provisions contained in our Restated Charter may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or any of our directors, officers, other employees or stockholders, which may discourage lawsuits with respect to such claims, although our stockholders will not be deemed to have waived our compliance with federal securities laws and the rules&#160;and regulations thereunder. While the Delaware courts have determined that such choice of forum provisions are facially valid, it is possible that a court of law in another jurisdiction could rule&#160;that the choice of forum provisions contained in our Restated Charter are inapplicable or unenforceable if they are challenged in a proceeding or otherwise, which could cause us to incur additional costs associated with resolving such action in other jurisdictions. The choice of forum provisions may also impose additional litigation costs on stockholders who assert that the provisions are not enforceable or invalid.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Risk Factors</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We incur significant costs as a result of operating as a public company, and our management is required to devote substantial time to new compliance initiatives.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a public company, we &#160;incur significant legal, accounting, and other expenses that we did not incur prior to our IPO. We are subject to the reporting requirements of the Exchange Act, which require, among other things, that we file with the SEC annual, quarterly, and current reports with respect to our business and financial condition. In addition, Sarbanes-Oxley, as well as rules&#160;subsequently adopted by the SEC and Nasdaq to implement provisions of Sarbanes-Oxley, impose significant requirements on public companies, including requiring establishment and maintenance of effective disclosure and financial controls and certain corporate governance practices. Further, pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, the SEC has adopted additional rules&#160;and regulations in these areas, such as mandatory &#8220;say on pay&#8221; voting requirements that will apply to us when we cease to be an emerging growth company. Stockholder activism, the current political environment and the current high level of government intervention and regulatory reform may lead to substantial new regulations and disclosure obligations, which may lead to additional compliance costs and impact the manner in which we operate our business in ways we cannot currently anticipate.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that, as a result of the rules&#160;and regulations applicable to public companies, we will incur substantial legal and financial compliance costs. These costs will decrease our net income or increase our net loss, and may require us to reduce expenditures in other areas of our business. For example, we expect these rules&#160;and regulations to make it more difficult and more expensive for us to obtain director and officer liability insurance, and we may be required to incur substantial costs to maintain the same or similar coverage. We cannot predict or estimate the amount or timing of costs we may incur to comply with these requirements. The impact of these requirements could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors, our board committees, or as executive officers. If these requirements divert the attention of our management and personnel from other business concerns, they could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to United States and certain foreign export and import controls, sanctions, embargoes, anti-corruption laws, and anti-money laundering laws and regulations. We could face criminal liability and other serious consequences for violations, which could harm our business.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to export control and import laws and regulations, including the U.S. Export Administration Regulations, U.S. Customs regulations, and various economic and trade sanctions regulations administered by the U.S. Treasury Department&#8217;s Office of Foreign Assets Controls and anti-corruption and anti-money laundering laws and regulations, including the U.S. Foreign Corrupt Practices Act of 1977, as amended, the U.S. domestic bribery statute contained in 18 U.S.C. &#167; 201, the U.S. Travel Act, the USA PATRIOT Act and other state and national anti-bribery and anti-money laundering laws in the countries in which we conduct activities. Anti-corruption laws are interpreted broadly and prohibit companies and their employees, agents, CROs, contractors and other collaborators and partners from authorizing, promising, offering, providing, soliciting, or receiving, directly or indirectly, improper payments or anything else of value to recipients in the public or private sector. We may engage third parties for clinical trials outside of the United States, to sell our products abroad if we enter a commercialization phase, and/or to obtain necessary permits, licenses, patent registrations and other regulatory approvals. We have direct or indirect interactions with officials and employees of government agencies or government-affiliated hospitals, universities, and other organizations. We can be held liable for the corrupt or other illegal activities of our employees, agents, CROs, contractors, and other collaborators and partners, even if we do not explicitly authorize or have actual knowledge of such activities, and any training or compliance programs or other initiatives we undertake to prevent such activities may not be effective.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any violations of the laws and regulations described above may result in substantial civil and criminal fines and penalties, imprisonment, the loss of export or import privileges, debarment, tax reassessments, breach of contract and fraud litigation, reputational harm, and other consequences.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, U.S. export control laws and economic sanctions prohibit the provision of certain products and services to countries, governments, and persons targeted by U.S. sanctions. U.S. sanctions that have been or may be imposed as a result of military conflicts in other countries may impact our ability to continue activities at future clinical trial sites within regions covered by such sanctions. If we fail to comply with export and import regulations and such economic sanctions, penalties could be imposed, including fines and/or denial of certain export privileges. These export and import controls and economic sanctions could also adversely affect our supply chain.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unstable market and economic conditions and adverse developments with respect to financial institutions and associated liquidity risk may have serious adverse consequences on our business, financial condition, and stock price.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the global credit and financial markets have experienced extreme volatility and disruptions, including severely diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth, increases in unemployment rates, and uncertainty about economic stability. The financial markets and the global economy may also be adversely affected by the current or anticipated impact of military conflict, including the conflict between Russia and Ukraine and Israel and Hamas, terrorism, or other geopolitical events.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sanctions imposed by the United States and other countries in response to such conflicts, including the one in Ukraine, may also adversely impact the financial markets and the global economy, and any economic countermeasures by the affected countries or others could exacerbate market and economic instability. In addition, in 2023 the closures of financial institutions and their placement into receivership with the FDIC created bank-specific and broader financial institution liquidity risk and concerns. Future adverse developments with respect to specific financial institutions or the broader financial services industry may lead to market-wide liquidity shortages, impair the ability of companies to access near-term working capital needs, and create additional market and economic uncertainty. There can be no assurance that future credit and financial market instability and a deterioration in confidence in economic conditions will not occur. Our general business strategy may be adversely affected by any such economic downturn, liquidity shortages, volatile business environment or continued unpredictable and unstable market conditions. If the equity and credit markets deteriorate, or if adverse developments are experienced by financial institutions, it may cause short-term liquidity risk and may make any necessary debt or equity financing more difficult, more costly, more onerous with respect to financial and operating covenants and more dilutive. Failure to secure any necessary financing in a timely manner and on favorable terms could have a material adverse effect on our growth strategy, financial performance and stock price and could require us to delay or abandon clinical development plans. In addition, there is a risk that one or more of our current service providers, financial institutions, manufacturers, and other partners may be adversely affected by the foregoing risks, which could directly affect our ability to attain our operating goals on schedule and on budget.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inflation could adversely affect our business and results of operations.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From 2021 to 2023, the U.S. economy experienced a material level of inflation. The impact of geopolitical developments, such as the conflicts in Ukraine and the Middle East may continue to increase uncertainty in the outlook of near-term and long-term economic activity, including whether inflation will continue and how long, and at what rate. Increases in inflation raise our costs for labor, materials and services and other costs required to grow and operate our business, and failure to secure these on reasonable terms may adversely impact our financial condition. Additionally, increases in inflation, along with the uncertainties surrounding geopolitical developments and global supply chain disruptions, have caused, and may in the future cause, global economic uncertainty and uncertainty about the interest rate environment, which may make it more difficult, costly or dilutive for us to secure additional financing. A failure to adequately respond to these risks could have a material adverse impact on our financial condition, results of operations or cash flows.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in tax law may materially adversely affect our financial condition, results of operations and cash flows, or adversely impact the value of an investment in our common stock.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New income, sales, use or other tax laws, statutes, rules, regulations, or ordinances could be enacted at any time, or interpreted, changed, modified, or applied adversely to us, any of which could adversely affect our business operations and financial performance.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our disclosure controls and procedures may not prevent or detect all errors or acts of fraud.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to certain reporting requirements of the Exchange Act. Our disclosure controls and procedures are designed to reasonably assure that information required to be disclosed by us in reports we file or submit under the Exchange Act is accumulated and communicated to management, recorded, processed, summarized and reported within the time periods specified in the rules&#160;and forms of the SEC. We believe that any disclosure controls and procedures or internal controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by an unauthorized override of the controls. Accordingly, because of the inherent limitations in our control system, misstatements or insufficient disclosures due to error or fraud may occur and not be detected.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If securities or industry analysts do not publish research or reports or publish unfavorable research or reports about our business, our stock price and trading volume could decline.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading market for our common stock is dependent in part on the research and reports that securities or industry analysts publish about us, our business, our market, or our competitors. A limited number of securities and industry analysts publish research on our company. If a larger number of securities or industry analysts do not commence coverage of our company, the trading price of our stock would be negatively affected. In the event we obtain securities or industry analyst coverage, if one or more of the analysts who covers us downgrades our stock, or if we fail to meet the expectations of one or more of these analysts, our stock price would likely decline. If one or more of these analysts ceases to cover us or fails to regularly publish reports on us, interest in our stock could decrease, which could cause our stock price or trading volume to decline.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to maintain proper and effective internal control over financial reporting, our ability to produce accurate and timely financial statements could be impaired, investors may lose confidence in our financial reporting, and the trading price of our common stock may decline.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Section&#160;404 of Sarbanes-Oxley, our management will be required to report upon the effectiveness of our internal control over financial reporting beginning with the annual report for our fiscal&#160;year ending December&#160;31, 2025. When we lose our status as an EGC and do not otherwise qualify as a &#8220;smaller reporting company,&#8221; our independent registered public accounting firm will be required to attest to the effectiveness of our internal control over financial reporting. The rules&#160;governing the standards that must be met for our management to assess our internal control over financial reporting are complex and require significant documentation, testing and possible remediation. To comply with the requirements of being a reporting company under the Exchange Act, we may need to upgrade our information technology systems; implement additional financial and management controls, reporting systems and procedures; and hire additional accounting and finance staff. If we or, if required, our auditors are unable to conclude that our internal control over financial reporting is effective, investors may lose confidence in our financial reporting and the trading price of our common stock may decline.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot assure investors that there will not be material weaknesses or significant deficiencies in our internal control over financial reporting in the future. Any failure to maintain internal control over financial reporting could severely inhibit our ability to accurately report our financial condition, results of operations or cash flows. If we are unable to conclude that our internal control over financial reporting is effective, or if our independent registered public accounting firm determines we have a material weakness or significant deficiency in our internal control over financial reporting once that firm begins its Section&#160;404 reviews, investors may lose confidence in the accuracy and completeness of our financial reports, the market price of our common stock could decline, and we could be subject to sanctions or investigations by Nasdaq, the SEC, or other regulatory authorities. Failure to remedy any material weakness in our internal control over financial reporting, or to implement or maintain other effective control systems required of public companies, could also restrict our future access to the capital markets.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may subject to securities class action litigation.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, securities class action litigation has often been brought against a company following a decline in the market price of its securities. This risk is especially relevant for us because biotechnology and pharmaceutical companies have experienced significant stock price volatility in recent&#160;years. If we were to be sued, it could result in substantial costs and a diversion of management&#8217;s attention and resources, which could harm our business.</span></div><div id="i8049b05497804bd28b68608a093bd853_19"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1B. Unresolved Staff Comments</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i8049b05497804bd28b68608a093bd853_22"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1C. Cybersecurity</span></div><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" id="f-39" continuedAt="f-39-1" escape="true"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock" id="f-40" escape="true">We have certain processes for assessing, identifying, and managing cybersecurity risks, which are <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag" format="ixt:fixed-true" id="f-41">built into</ix:nonNumeric> our information technology function and are designed to help protect our information assets and operations from internal and external cyber threats, protect information belonging to our stakeholders from unauthorized access or attack, as well as secure our networks and systems.</ix:nonNumeric> Such processes include physical, procedural, and technical safeguards, response plans, regular testing of our systems, and routine review of our policies and procedures to identify risks and adapt our practices. <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" format="ixt:fixed-true" id="f-42">We <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag" format="ixt:fixed-true" id="f-43">engage</ix:nonNumeric> certain external parties, including independent privacy assessors, computer security firms, and risk management and governance experts, to assist with assessing and managing our cybersecurity oversight functions.</ix:nonNumeric></span></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><ix:continuation id="f-39-1"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" format="ixt:fixed-false" id="f-44">As of the date of this Annual Report, we have not experienced any cybersecurity incidents that resulted in a material effect on our business strategy, results of operations, or financial condition, but we cannot provide assurance that we will not be materially affected in the future by such risks or any future material incidents.</ix:nonNumeric> See Part I, Item 1A. &#8220;Risk Factors&#8221; in this Annual Report for additional information on cybersecurity risks we face.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" id="f-46" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock" id="f-45" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" id="f-50" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskRoleOfManagementTextBlock" id="f-49" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="f-48" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="f-47" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" format="ixt:fixed-true" id="f-51">Audit Committee</ix:nonNumeric> of the board of directors is responsible for reviewing and assessing the integrity of our information technology systems, processes and data, and is charged with meeting periodically with management to review and assess our cyber and technology-related risks, including network security, information security, and data privacy and protection, our technologies, policies, processes, and practices for assessing, monitoring, managing and mitigation those risks, and the steps management has taken to identify, assess, monitor, manage and mitigate those risks, among other matters.</span></div></ix:nonNumeric></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" format="ixt:fixed-true" id="f-52">Chief Business Operations Officer</ix:nonNumeric> oversees our company-wide cybersecurity strategy, policy, standards, and processes across relevant departments. <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" id="f-53" escape="true">The Chief Business Operations Officer has over 15 years of experience overseeing key operational activities in the life sciences industry and works closely with our experienced information technology consulting firm, which helps to assess and prepare us and our employees to maintain awareness of cybersecurity risks, including email, web, and data security.</ix:nonNumeric> Our outside information technology consultants have extensive experience designing, implementing, and running information technology and cybersecurity programs and processes using the National Institute of Standards and Technology Framework.</span></div></ix:nonNumeric></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To deter and detect cyber threats, we provide all employees with a data protection, cybersecurity and incident response and prevention training and compliance program, which covers timely and relevant topics, including social engineering, phishing, password protection, confidential data protection, asset use and mobile security, and educates employees on the importance of reporting all incidents immediately. To mitigate cybersecurity risks and bolster our employee-based cybersecurity programs, we monitor all user traffic and restrict access by country. In addition, access to web sites is filtered and monitored, and credentials for systems and services require multi-factor authentication whenever possible.</span></div></ix:nonNumeric></ix:nonNumeric><div id="i8049b05497804bd28b68608a093bd853_25"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Properties</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently lease approximately 30,000 square feet of office space and laboratory space in Cambridge, Massachusetts and approximately 5,300 square feet of office and laboratory space in Boulder, Colorado. We believe these facilities will be adequate for the foreseeable future and that suitable additional or substitute space will be available as and when needed.</span></div><div id="i8049b05497804bd28b68608a093bd853_28"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Legal Proceedings</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may be subject to legal proceedings. We are not currently a party to or aware of any proceedings that we believe will have, individually or in the aggregate, a material adverse effect on our business, financial condition or results of operations. Regardless of outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources, and other factors.</span></div><div id="i8049b05497804bd28b68608a093bd853_31"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Mine Safety Disclosures</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="margin-bottom:12pt"><span><br/></span></div><div style="margin-bottom:12pt"><span><br/></span></div><div style="margin-bottom:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><div id="i8049b05497804bd28b68608a093bd853_34"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="i8049b05497804bd28b68608a093bd853_37"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Market Information</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our common stock has been publicly traded on the Nasdaq Global Market under the symbol &#8220;CAMP&#8221; since October 11, 2024. Prior to that time, there was no public market for our common stock.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Holders</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of March 13, 2025, there were approximately 90 holders of record of our common stock. This number does not include beneficial owners whose shares are held by nominees in street name.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have never declared or paid, and do not anticipate declaring or paying, in the foreseeable future, any cash dividends on our capital stock. We currently intend to retain all available funds and any future earnings, if any, to support our operations and finance the growth and development of our business. Any future determination related to our dividend policy will be made at the discretion of our board of directors and will depend upon, among other factors, our results of operations, financial condition, capital requirements, contractual restrictions, business prospects and other factors our board of directors may deem relevant. Our ability to pay cash dividends on our capital stock in the future may also be limited by the terms of any preferred securities we may issue or agreements governing any indebtedness we may incur.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Sales of Unregistered Securities</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2024, we granted to employees options to purchase an aggregate of 462,206 shares of our common stock at a weighted-average exercise price of $10.20 per share under our 2024 Equity Incentive Plan (the &#8220;2024 Plan&#8221;) and Amended and Restated 2016 Stock Option and Grant Plan (the &#8220;2016 Plan&#8221;), and we issued and sold to employees an aggregate of 22,671 shares of our common stock under the 2016 Plan upon the exercise of stock options at a weighted-average exercise price of $0.22.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The options and common stock issued upon the exercise of options described above were issued under our 2016 Plan in reliance on the exemption provided by Rule 701 promulgated under the Securities Act as sales and offers under compensatory benefit plans and contracts relating to compensation in compliance with Rule 701, or in reliance on Section 4(a)(2), as transactions by an issuer not involving a public offering. The recipients of securities in these transactions had adequate access, through employment, business or other relationships, to information about us. The foregoing transactions did not involve any underwriters, underwriting discounts or commissions, or any public offering. On October 16, 2024, we filed a registration statement on Form S-8 under the Securities Act to register all of the shares of our common stock subject to outstanding options and all shares of our common stock otherwise issuable pursuant to our equity compensation plans.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Use of Proceeds from Public Offering of Common Stock</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On October 10, 2024, our Registration Statement on Form S-1, as amended (File No. 333-282241), was declared effective in connection with our IPO, pursuant to which we sold an aggregate of 6,820,000 shares of our common stock at a price to the public of $11.00 per share. The underwriters of our IPO were J.P. Morgan Securities LLC, Leerink Partners LLC, Piper Sandler &amp; Co. and William Blair &amp; Company, L.L.C.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our IPO closed on October 15, 2024. In connection with the IPO, we granted the underwriters a 30-day option to purchase an additional 1,023,000 shares of common stock. On November 1, 2024, pursuant to the partial exercise by the underwriters of such option, we issued an additional 643,762 shares of common stock. We received aggregate gross proceeds of $82.1 million in connection with the IPO and subsequent exercise of the underwriters&#8217; option and aggregate net proceeds of $76.4 million after deducting underwriting discounts and commissions and expenses payable by us. In connection with our IPO, no payments were made by us to directors, officers or persons owning ten percent or more of our ordinary shares or to their associates or to our affiliates. There has been no material change in the planned use of proceeds from our IPO as described in our prospectus filed pursuant to Rule 424(b)(4) under the Securities Act with the SEC on October 11, 2024. We are holding the balance of the net proceeds in cash and cash equivalents.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">None.</span></div><div id="i8049b05497804bd28b68608a093bd853_40"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Reserved</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><div id="i8049b05497804bd28b68608a093bd853_43"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the audited financial statements and related notes thereto included elsewhere in this Annual Report on Form 10-K (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Annual Report"). This discussion and analysis and other parts of this Annual Report contain forward-looking statements. Our actual results and the timing of selected events could differ materially from those described in or implied by these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in the sections of this Annual Report titled &#8220;Special Note Regarding Forward-Looking Statements and Market and Industry Data&#8221; and &#8220;Risk Factors,&#8221; under Part I, Item 1A.</span></div><div><span><br/></span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a clinical-stage biopharmaceutical company pioneering the discovery and development of a new class of RNA-based therapeutics with the goal of upregulating gene expression and restoring healthy protein levels to treat a broad range of genetic diseases. Regulatory RNAs (&#8220;regRNAs&#8221;) play a central role in the regulation of every protein-coding gene by contributing to gene activation and suppression. Our approach is designed to amplify messenger RNA (&#8220;mRNA&#8221;) expression by harnessing the power of regRNAs that form localized complexes with transcription factors and regulate gene expression. Our proprietary RNA Actuating Platform, or RAP Platform, allows us to rapidly and systematically identify and characterize the active regulatory elements controlling every expressed gene and tens of thousands of druggable enhancer and promoter regRNA sequences that control protein-coding genes. Once a disease-associated target gene is identified, we apply our RAP Platform to identify the controlling regRNA and rapidly generate novel antisense oligonucleotide (&#8220;ASO&#8221;) candidates, which we also refer to as RNA Actuators. These ASOs are designed to bind to the identified regRNA and amplify the expression of the target gene in a specific and controllable way. We are currently focused on metabolic diseases and diseases of the central nervous system with validated disease biology, and we believe our RAP Platform allows us to address a broad range of rare and prevalent genetic diseases in which a modest increase in protein expression has the potential to be clinically meaningful.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception in 2015, we have focused substantially all of our resources primarily on developing our RAP Platform, identifying, developing and progressing our product candidates through preclinical and clinical development, organizing and staffing our company, research and development (&#8220;R&amp;D&#8221;) activities, establishing and protecting our intellectual property portfolio, and raising capital. To date, we have primarily funded our operations with proceeds from the sale of convertible preferred stock and common stock, including in our initial public offering (&#8220;IPO&#8221;), which closed on October 15, 2024, as well as through revenues from our license and collaboration agreements. Through December&#160;31, 2024, we have received gross proceeds of $72.4 million from our IPO and $188.3&#160;million from the sale of our convertible preferred stock. In addition, through December&#160;31, 2024, we have recognized $18.0&#160;million in research collaboration and license revenue through our development and license agreements. Our ability to generate any product revenue and, in particular, our ability to generate product revenue sufficient to achieve profitability, will depend on the successful development and eventual commercialization of product candidates.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred significant operating losses and negative cash flows from operations since our inception. Our net losses were $51.8 million and $49.3 million for the&#160;years ended December&#160;31, 2024 and 2023, respectively. As of December&#160;31, 2024, we had an accumulated deficit of $211.8 million. Substantially all of our net losses have resulted from costs incurred in connection with our R&amp;D programs and, to a lesser extent, from general and administrative (&#8220;G&amp;A&#8221;) costs associated with our operations. Our net losses may fluctuate significantly from quarter-to-quarter and year-to-year, depending on the timing of our clinical trials and preclinical studies, our other R&amp;D activities and capital expenditures, and the timing and amount of any milestone or royalty payments due under our existing or future license or collaboration agreements. In addition, following the closing of our IPO, we expect to incur additional costs associated with operating as a public company, including significant legal, audit, accounting, regulatory and tax-related services associated with maintaining compliance with exchange listing and requirements of the Securities and Exchange Commission (&#8220;SEC&#8221;), director and officer liability insurance costs, investor and public relations costs, and other expenses that we did not incur as a private company. If we obtain regulatory approval for our product candidates, we expect to incur significant expenses related to developing our commercialization capability to support product sales, marketing and distribution. We anticipate that our expenses will increase substantially if and as we:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">advance our lead product candidate, CMP-CPS-001, through clinical trials;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">finalize preclinical development for our program in SYNGAP1-related disorders;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">conduct preclinical studies and clinical trials for our GBA1 discovery program for the treatment of Parkinson&#8217;s Disease (&#8220;PD&#8221;) and any future product candidates we may develop;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expand the capabilities of our RAP Platform and seek to identify and develop additional product candidates;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seek marketing approvals for any product candidates that successfully complete clinical trials;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtain, expand, maintain, defend and enforce our intellectual property portfolio;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">hire additional clinical, regulatory and scientific personnel;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">contract with third-party manufacturers for preclinical and clinical drug supply supporting any future product candidates we may develop, and commercial supply with respect to any such product candidates that receive regulatory approval;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ultimately establish a sales, marketing and distribution infrastructure to commercialize any products for which we may obtain marketing approval; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">add operational, legal, compliance, financial and management information systems and personnel to support our research, product development and future commercialization efforts, as well as to support our operations as a public company.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the numerous risks and uncertainties associated with the development of therapeutics, we are unable to accurately predict the timing or amount of increased expenses and when, or if, we will be able to achieve or maintain profitability. Even if we are able to generate product sales, we may not become profitable. If we fail to become profitable or are unable to sustain profitability on a continuing basis, then we may be unable to continue our operations as planned and may be forced to reduce or terminate our operations.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not have any products approved for sale and have not generated any revenue from product sales. We will not generate revenue from product sales unless and until we successfully complete clinical development and obtain regulatory approval for our current or any future product candidates, which we expect will take a number of&#160;years or may never occur. As a result, we will need substantial additional funding to support our continuing operations and pursue our growth strategy. Until such time as we can generate significant revenue from product sales, if ever, we expect to finance our operations through equity offerings, debt financings, or other capital sources, including current and potential future collaborations, license agreements, and other similar arrangements. However, we may be unable to raise additional funds or enter into such other agreements or arrangements when needed on favorable terms, or at all. If we fail to raise capital or enter into such agreements or arrangements as, and when needed, we may delay, limit, reduce or terminate our product development or future commercialization efforts or grant rights to develop and market product candidates that we would otherwise develop and market ourselves, or even cease operations.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, we had cash and cash equivalents of $64.0 million. Based on our current operating plan, we estimate that our cash and cash equivalents as of  December&#160;31, 2024 will be sufficient to fund our operating expenses and capital expenditure requirements into the second quarter of 2026. However, we have based this estimate on assumptions that may prove to be wrong, and we could deplete our capital resources sooner than we currently expect. Our capital resources may not be sufficient to fund operations through at least the next twelve&#160;months from the date the accompanying audited consolidated financial statements as of December&#160;31, 2024 are issued based on our expected cash needs, which raises substantial doubt about our ability to continue as a going concern. See the sections titled &#8220;&#8212;Liquidity and Capital Resources&#8221; and &#8220;Risk Factors&#8212;Risks Related to our Financial Position and Need for Additional Capital&#8221; included elsewhere in this Annual Report.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not own or operate, and currently have no plans to establish, any manufacturing facilities. We rely, and expect to continue to rely, on third parties for clinical supply as well as commercial supply if we obtain marketing approval. In addition, we rely on third parties to package, label, store, and distribute our clinical supply and we intend to rely on third parties to conduct the same activities for our commercial products if we obtain regulatory approval. We believe that this strategy allows us to maintain a more efficient infrastructure by eliminating the need for us to invest in our own manufacturing facilities, equipment, and personnel while also enabling us to focus our expertise and resources on the development of product candidates and continued enhancement of our RAP Platform.</span></div><div id="i8049b05497804bd28b68608a093bd853_46"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Collaboration and License Agreements</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of the key terms and financial statement impact of certain of our license and collaboration agreements. For a more detailed description of these agreements, see the section titled &#8220;Business&#8212;License and Collaboration Agreements&#8221; included elsewhere in this Annual Report.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">In-License Agreements</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Children&#8217;s Medical Center Corporation</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April&#160;2018, we entered into a development and license agreement (the &#8220;CMCC Agreement&#8221;) with Children&#8217;s Medical Center Corporation (&#8220;CMCC&#8221;). The CMCC Agreement allows us to use CMCC&#8217;s proprietary intellectual property to conduct research, development and commercialization of products utilizing CMCC&#8217;s proprietary intellectual property in return for specified payments. The proprietary intellectual property licensed pursuant to this agreement is related to certain legacy programs we are not pursuing and which were subsequently sublicensed to Fulcrum Therapeutics, Inc. (&#8220;Fulcrum&#8221;), as described below. As part of the CMCC Agreement, we issued a total of 15,123 shares of common stock to CMCC and its affiliates based on the fair value of the common stock on the date of issuance.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are obligated to pay potential development milestone payments under the terms of the CMCC Agreement of up to $7.7&#160;million for the first licensed target, $3.9&#160;million for the second licensed target and $1.9&#160;million for the third licensed target upon the achievement of certain specified contingent events. If commercial sales of a licensed product commence, we will pay CMCC royalties at&#160;percentage rates ranging in the low- to mid-single digits on net sales of licensed products in countries where such product is protected by patent rights. We incurred de minimis royalties owed to CMCC for each of the years ended December&#160;31, 2024 and 2023 under the CMCC Agreement and recorded the amounts in R&amp;D expense in the consolidated statement of operations and comprehensive loss. Further, under the terms of the CMCC Agreement, we are required to pay 10% of any upfront payment received under a sublicensing agreement entered into prior to the initiation of the first investigational new drug study. As such, we recorded de minimis amounts for each of the years ended December&#160;31, 2024 and 2023, which is presented in R&amp;D expenses on the consolidated statements of operations and comprehensive loss. We reevaluate the likelihood of achieving future milestones at the end of each reporting period. As of December&#160;31, 2024, we determined that the likelihood of achieving future milestones was not probable.</span></div><div style="margin-bottom:8pt"><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Whitehead Institute for Biomedical Research</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October&#160;2019, we entered into a patent license agreement (as subsequently amended, the &#8220;Whitehead Agreement&#8221;) with the Whitehead Institute for Biomedical Research (&#8220;Whitehead&#8221;). Under the Whitehead Agreement, we were granted a worldwide, royalty-bearing, sublicensable license under certain patent rights owned or controlled by Whitehead. Upon entering into the Whitehead Agreement, we paid an initial $0.1&#160;million license issuance fee, and paid de minimis additional fees in connection with subsequent amendments to the Whitehead Agreement. We are obligated to pay annual license maintenance fees for the term of the Whitehead Agreement. In addition, we are obligated to pay certain filing, prosecution and maintenance fees with respect to certain patent rights licensed.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also obligated to pay potential development milestone payments to Whitehead of up to $1.9 million upon the achievement of certain specified contingent events. In addition, if we successfully commercialize a product under the Whitehead Agreement, we are obligated to pay tiered royalties at&#160;percentage rates ranging from less than one&#160;percent to the mid-single digits of net sales or of running royalties of net sales, subject to specified reductions, until either the last-to-expire valid claim of a Whitehead patent covering the product or seven years after the first commercial sale, in each case on a product-by-product and country-by-country basis. We incurred fees of $0.3 million under the Whitehead Agreement during the year ended December&#160;31, 2024. During the year ended December&#160;31, 2023, the fees were de minimis. The fees are recorded in our R&amp;D expense in our consolidated statements of operations and comprehensive loss. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Out-license Agreement</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fulcrum Therapeutics, Inc.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July&#160;2023, we entered into a license agreement (the &#8220;Fulcrum Agreement&#8221;) with Fulcrum. Under the Fulcrum Agreement, we granted an exclusive license related to our intellectual property (&#8220;IP&#8221;) and granted a non-exclusive sublicense for IP obtained through the CMCC Agreement. In exchange for the license rights, Fulcrum paid us a $0.4 million upfront payment. In the event that Fulcrum achieves certain development and commercial milestones, Fulcrum will be obligated to pay us one-time milestone payments ranging from $0.6 million to $20.0 million, depending on the product developed and milestone achieved. In addition, under the Fulcrum Agreement there are potential de minimis minimum annual royalty payments as well as sales-based royalties of up to the low-double digits upon commercialization.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, we recorded $0.4 million in license revenue pursuant to the Fulcrum Agreement and none in the year ended December&#160;31, 2024. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Collaborative Arrangement</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eli Lilly and Company</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July&#160;2023, we executed a Material Transfer Agreement (as amended, the &#8220;MTA&#8221;), with Eli Lilly and Company (&#8220;Eli Lilly&#8221;). As part of the MTA, we and Eli Lilly agreed to perform R&amp;D activities to generate up to three ASOs in accordance with a prescribed workplan. We and Eli Lilly are jointly overseeing the R&amp;D activities under the MTA. In addition, both parties are exposed to the significant risks and potential rewards under the MTA. During each of the years ended December&#160;31, 2024 and 2023, we recorded $0.5 million as a reduction in R&amp;D expense in the consolidated statement of operations and comprehensive loss as a result of the earned R&amp;D reimbursement from Eli Lilly. Additionally, we had an unbilled receivable of $0.1 million recorded within prepaid expenses and other current assets on our consolidated balance sheet as of December&#160;31, 2023 and a de minimis deferred liability as of December&#160;31, 2024.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Collaboration Agreement</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">BioMarin Pharmaceutical, Inc.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2024, we entered into a Collaboration and License Agreement (the &#8220;BioMarin Agreement&#8221;) with BioMarin Pharmaceutical Inc. (&#8220;BioMarin&#8221;), pursuant to which we and BioMarin agreed to collaborate with respect to the research and discovery of regulatory RNA-targeting ASOs using our proprietary RAP Platform to modulate the expression of two undisclosed genetic targets under two distinct programs. Under the terms of the BioMarin Agreement, BioMarin paid us an upfront, nonrefundable payment of $1.0 million, and will reimburse us for certain research activities. On a per-program basis, we will be eligible to receive up to $5.0 million in future contingent preclinical milestones, up to $75.0 million in future contingent development and regulatory milestones and up to $105.0 million in commercial sales milestones. We will be further eligible to receive tiered royalties at percentage rates ranging from low to high single digits of net sales, subject to specified reductions, until either the last-to-expire valid claim of a patent covering the product, ten years after the first commercial sale, or the expiration of any applicable regulatory exclusivity obtained for the product, in each case on a product-by-product and country-by-country basis. The agreement may be terminated in its entirety or on a program-by-program basis for convenience by BioMarin. The agreement may also be terminated by either us or BioMarin under certain other circumstances, including material breach, as set forth in the agreement. The notice periods for termination provisions range from 30 days to 270 days depending on the reason for termination. During the year ended December&#160;31, 2024, we recognized $0.7 million in collaboration revenue under the BioMarin Agreement.</span></div><div id="i8049b05497804bd28b68608a093bd853_49"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Components of Our Results of Operations</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2024 and 2023, we recognized $0.7 million and $0.4 million, respectively, in research and collaboration revenue through our collaboration and license agreements. We have not generated any revenue from the sale of products, however, and do not expect to generate any revenue from the sale of products in the foreseeable future, if at all. If our or our collaborators&#8217; development efforts for product candidates and any future product candidates are successful and result in regulatory approval, we may generate revenue in the future from product sales, payments from existing or potential future collaboration or license agreements with third parties, or any combination thereof.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating expenses consist of R&amp;D expenses and G&amp;A expenses.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our R&amp;D expenses consist primarily of external and internal costs incurred in performing clinical and preclinical development activities as follows:</span></div><div style="margin-bottom:6pt;padding-left:30.96pt;text-indent:-9.37pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.87pt">external costs incurred under agreements with contract research organizations (&#8220;CROs&#8221;), contract manufacturing organizations (&#8220;CMOs&#8221;), consultants and other third parties to conduct and support our clinical trials and preclinical studies;</span></div><div style="margin-bottom:6pt;padding-left:30.96pt;text-indent:-9.37pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.87pt">internal costs, including R&amp;D personnel-related expenses such as salaries and stock-based compensation and benefits, as well as allocated facilities costs and depreciation; and</span></div><div style="margin-bottom:6pt;padding-left:30.96pt;text-indent:-9.37pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.87pt">costs associated with our licensing activities.</span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expense R&amp;D costs as incurred. Certain third-party costs for R&amp;D activities are recognized based on an evaluation of the progress to completion of specific tasks using information and data provided to us by our management and scientific personnel, vendors and third-party service providers. Non-refundable advance payments for goods and services that will be used over time for R&amp;D are deferred and capitalized as R&amp;D prepaid expenses on our consolidated balance sheets. The capitalized amounts are recognized as an expense as the goods are delivered or as the related services are performed. Since our inception, substantially all of our external costs have been related to the development of product candidates. We use internal resources for platform development, early pipeline discovery, preclinical development, management of clinical development activities, technical operations and oversight of manufacturing partners. We do not track our R&amp;D expenses on a program-by-program basis. Our third-party R&amp;D expenses consist primarily of fees paid to outside consultants, CROs, CMOs and academic research laboratories in connection with our preclinical development, process development, manufacturing and clinical development activities. Our other R&amp;D costs are internal costs primarily associated with our discovery efforts, laboratory supplies, and facilities, including depreciation, that are allocated across multiple programs.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although R&amp;D activities are central to our business model, the successful development of any future product candidates is highly uncertain. There are numerous factors associated with the successful development of any product, including future trial design and various regulatory requirements, many of which cannot be determined with accuracy at this time based on our stage of development. In addition, future regulatory factors beyond our control may impact our clinical development programs. Product candidates in later stages of clinical development generally have higher development costs than those in earlier stages of clinical development, primarily due to the increased size and longer duration of later-stage clinical trials. As a result, we expect our R&amp;D expenses will increase substantially in connection with our ongoing and planned clinical and preclinical development activities in the near term and in the future. At this time, we cannot accurately estimate or know the nature, timing and costs of the efforts that will be necessary to complete the preclinical and clinical development of our current product candidates and any future product candidates. Our future R&amp;D expenses may vary significantly based on a wide variety of factors such as:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the number and scope, rate of progress, expense and results of our clinical trials and preclinical studies and any future product candidates we may choose to pursue, including any modifications to clinical development plans based on feedback that we may receive from regulatory authorities;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">per patient trial costs;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the number of trials required for approval;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the number of sites included in the trials;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the countries in which the trials are conducted;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the length of time required to enroll eligible patients;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the number of patients that participate in the trials;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the number of doses that patients receive;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the drop-out or discontinuation rates of patients;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the potential additional safety monitoring requested by regulatory agencies;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the duration of patient participation in the trials and follow-up;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and timing of manufacturing clinical supply;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent of changes in government regulation and regulatory guidance;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing, receipt, and terms of any approvals from applicable regulatory authorities; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which we establish additional collaboration, license, or other arrangements.</span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A change in the outcome of any of these variables with respect to the development of our product candidates or any future product candidates could significantly change the costs and timing associated with the development of that product candidate.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Expenses</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">G&amp;A expenses consist primarily of personnel-related expenses such as salaries and stock-based compensation and benefits for our personnel in executive, legal, finance and accounting, human resources and other administrative functions. G&amp;A expenses also include legal fees relating to patent and corporate matters and professional fees paid for accounting, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">audit, consulting and tax services, as well as facilities-related costs not otherwise included in R&amp;D expenses and other costs such as insurance costs and travel expenses.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate our G&amp;A expenses will increase substantially in the future as we expand our operations, including increasing our headcount to support our continued R&amp;D activities and continue to advance the development of our product candidates. We also anticipate we will incur increased accounting, audit, legal, regulatory, compliance, director and officer insurance, and investor and public relations expenses associated with operating as a public company.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income, Net</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net primarily consists of interest income earned on our invested cash and cash equivalent balances and interest expense incurred on our finance lease and financing liabilities, as well as other insignificant amounts.</span></div><div id="i8049b05497804bd28b68608a093bd853_55"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comparison of the&#160;Years Ended December&#160;31, 2024 and 2023</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our results of operations for the years ended December&#160;31, 2024 and 2023 (in thousands):</span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Change ($)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and collaboration revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,817&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40,616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,799)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,923&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #cceeff;padding:2px 1pt 2px 22.6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53,740&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52,229&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,511&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(53,088)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(51,879)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,209)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,808&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,478)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(220)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:2px 1pt 2px 22.6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other income, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,297&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,588&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,291)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(51,791)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(49,291)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,500)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Collaboration Revenue</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and collaboration revenue was $0.7 million for the year ended December&#160;31, 2024, compared to $0.4 million for the year ended December&#160;31, 2023. The increase of $0.3 million was primarily due to $0.7 million of revenue recognized under the BioMarin Agreement in the year ended December&#160;31, 2024, compared to $0.4 million of revenue recognized under the Fulcrum Agreement in the year ended December&#160;31, 2023.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our R&amp;D expenses for the&#160;years ended December&#160;31, 2024 and 2023 (in thousands):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Change ($)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical and preclinical expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,049&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,012&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,963)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Personnel-related expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,056)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Facilities-related and overhead expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,026&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">585&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional and consulting fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">701&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(139)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total R&amp;D expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,817&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40,616&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,799)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D expenses were $38.8 million for the year ended December&#160;31, 2024, compared to $40.6 million for the year ended December&#160;31, 2023. The decrease of $1.8 million was primarily due to a decrease of $2.0 million in clinical and preclinical expenses primarily due to fewer external preclinical research activities, partially offset by an increase in clinical </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">trial expenses. In addition, there was a $1.1 million decrease in personnel-related expenses primarily due to decreased average headcount. These decreases were partially offset by an increase of $0.8 million in professional and consulting fees associated with preclinical, regulatory and clinical affairs and continued development of our lead product candidate and $0.6 million in facilities and overhead expenses primarily due to increased repairs and maintenance as well as increased utilities and information technology expenses. </span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Expenses</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our G&amp;A expenses for the&#160;years ended December&#160;31, 2024 and 2023 (in thousands):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Change ($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Personnel-related expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,365&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional and consulting fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,876&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,696&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Facilities-related and overhead expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total G&amp;A expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,923&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,613&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,310&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">G&amp;A expenses were $14.9 million for the year ended December&#160;31, 2024, compared to $11.6 million for the year ended December&#160;31, 2023. The increase of $3.3 million was primarily due to an increase in personnel-related expenses of $1.9 million attributable to an increase of $0.8 million in stock-based compensation and $0.8 million in cash grants to offset the tax impact to certain executive officers associated with the forgiveness of promissory notes. In addition, professional and consulting fees increased by $1.2 million, primarily due to an increase in accounting and consulting fees as well as fees paid to maintain patents.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income, Net</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net was $1.3 million for the year ended December&#160;31, 2024, compared to $2.6 million for the year ended December&#160;31, 2023. The decrease of $1.3 million was primarily due to a decrease in interest income due to lower average invested cash equivalent balances in 2024.</span></div><div id="i8049b05497804bd28b68608a093bd853_58"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources of Liquidity</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception, we have not generated any revenue from product sales and have incurred significant operating losses and negative cash flows from operations. We expect to incur significant expenses and operating losses in the foreseeable future as we advance the development of product candidates. Through December&#160;31, 2024, we have primarily funded our operations with proceeds from the sale of our equity securities and revenues from our license and collaboration agreements. During the year ended December&#160;31, 2024, we received aggregate gross proceeds of $72.4 million from the sale of shares of our equity securities. In addition, for the year ended December&#160;31, 2024, we recognized $0.7 million&#160;in research and collaboration revenue through our collaboration and license agreements. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of December&#160;31, 2024, we had cash and cash equivalents of $64.0 million. Based on our current operating plan, we estimate that our cash and cash equivalents as of December&#160;31, 2024 will be sufficient to fund our operating expenses and capital expenditure requirements into the second quarter of 2026. However, we have based this estimate on assumptions that may prove to be wrong, and we could deplete our capital resources sooner than we currently expect. Our capital resources may not be sufficient to fund operations through at least the next twelve&#160;months from the date the accompanying audited consolidated financial statements as of December&#160;31, 2024 are issued based on our expected cash needs, which raises substantial doubt about our ability to continue as a going concern. In their report accompanying our audited financial statements for the&#160;years ended December&#160;31, 2024 and 2023, our independent registered public accounting firm included an explanatory paragraph stating that our recurring losses from operations raise substantial doubt about our ability to continue as a going concern. Our future viability is dependent on our ability to generate cash from our operating activities or to raise additional capital to finance our operations. There is no assurance that we will succeed in obtaining sufficient funding on terms acceptable to us to fund continuing operations, if at all.</span></div><div style="margin-bottom:8pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future Funding Requirements</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our expenses to increase substantially in connection with our ongoing activities, particularly as we continue our development of, seek regulatory approval for, and potentially commercialize our product candidates and seek to discover and develop additional product candidates, conduct our ongoing and planned clinical trials and preclinical studies, continue our R&amp;D activities, hire additional personnel, expand and protect our intellectual property, and incur additional costs associated with being a public company.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing and amount of our funding requirements will depend on many factors, including:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the scope, timing and progress of our ongoing CMP-CPS-001 clinical trial;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the initiation, type, number, scope, progress, expansions, results, costs and timing of preclinical studies and clinical trials of our product candidates and any future product candidates we may choose to pursue, including the costs of modification to clinical development plans based on feedback that we may receive from regulatory authorities and any third-party products used as combination agents in our clinical trials;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs and timing of manufacturing for our product candidates, including commercial manufacturing at sufficient scale, if any product candidate is approved;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs, timing and outcome of regulatory meetings and reviews of product candidates or any future product candidates, including requirements of regulatory authorities in any additional jurisdictions in which we may seek approval and any future product candidates;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs of obtaining, maintaining, enforcing and protecting our patents and other intellectual property and proprietary rights;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our efforts to enhance operational systems and hire additional personnel to satisfy our obligations as a public company, including enhanced internal control over financial reporting;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs associated with hiring additional personnel and consultants as our clinical and preclinical activities increase and as we operate as a public company;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing and payment of milestone, royalty or other payments we must make or may receive pursuant to our existing and potential future license or collaboration agreements with third parties;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs and timing of establishing or securing sales and marketing capabilities if our product candidates or any future product candidate is approved;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to achieve sufficient market acceptance, coverage, and adequate reimbursement from third-party payors and adequate market share and revenue for any approved products;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">patients&#8217; ability and willingness to pay out-of-pocket for any approved products in the absence of coverage and/or adequate reimbursement from third-party payors;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the terms and timing of establishing and maintaining collaborations, licenses and other similar arrangements; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs associated with any products or technologies that we may in-license or acquire.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating plans and other demands for our cash resources may change because of many factors currently unknown to us, and we may need to seek additional funds sooner than planned.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have no other committed sources of capital. Until such time, if ever, we can generate substantial product revenues, we expect to finance our operations through the sale of equity securities, debt financings, working capital lines of credit, strategic alliances and/or license arrangements, grant funding, interest income earned on invested cash balances or a combination of two or more of these sources. However, we may be unable to raise additional funds or enter into such other arrangements when needed, on favorable terms or at all. To the extent we raise additional capital through the sale of equity or convertible debt securities, investors&#8217; ownership interest will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of a common stockholder. Debt financing and preferred equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, engaging in acquisition, merger or collaboration transactions, selling or licensing our assets, making capital expenditures, redeeming our stock, making certain investments or declaring dividends. If we raise additional funds through collaborations or license agreements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates, or grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds through equity or debt financings when </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">needed, we may be required to delay, limit, reduce or terminate our product development or future commercialization efforts or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves, or even cease operations.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Material Cash Requirements for Known Contractual and Other Obligations</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into two non-cancellable operating leases for our office and lab space in Cambridge, Massachusetts and Boulder, Colorado, which expire on June&#160;30, 2027 and September&#160;30, 2028, respectively. See Note 7 to our consolidated financial statements for additional details related to our noncancellable operating leases.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our operating leases, we are required to maintain security deposits, which were issued in the form of letters of credit with a bank. See Note 2 to our consolidated financial statements for additional details related to our restricted cash.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are continuing to invest in the clinical development of CMP-CPS-001 and have entered into contractual obligations with CROs relating to the performance of clinical trial services. Each contract shall continue until the completion of the trial. Our clinical trial costs are dependent on, among other things, the size and length of our clinical trial. We also incur R&amp;D costs related to the enhancement of our existing product candidates.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Capital Requirements and Additional Royalty Obligations</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into agreements in the normal course of business with various vendors, which are generally cancellable with a contractually defined notice period. Payments due upon cancellation typically consist of payments for services provided or expenses incurred, as well as non-cancellable obligations of service providers, up to the date of cancellation.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of when we will pay or receive royalty payments is uncertain as the payments are contingent upon future activities, including the successful discovery, development, regulatory approval and commercialization of product candidates.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flows</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding our cash flows for the&#160;years ended December&#160;31, 2024 and 2023 (in thousands):</span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(45,562)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(44,155)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.75pt solid #cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(441)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(678)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71,662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:0.75pt solid #cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net increase (decrease) in cash, cash equivalents and restricted cash</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,659&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(44,532)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Activities</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2024, operating activities used $45.6 million of cash, primarily resulting from our net loss of $51.8 million and net cash used in changes in our operating assets and liabilities of $1.3 million, partially offset by non-cash charges of $7.6 million, including depreciation and amortization, stock-based compensation expense and non-cash operating lease expense.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, operating activities used $44.2 million of cash, primarily resulting from our net loss of $49.3 million and net cash used in changes in our operating assets and liabilities of $1.3 million, partially offset by non-cash charges of $6.4 million, including stock-based compensation expense and non-cash operating lease expense.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In each of the years ended December&#160;31, 2024 and 2023, cash used in operations was primarily related to clinical and preclinical efforts, compensation and benefits for our employees, consulting and other professional fees, and rent for our Cambridge and Boulder leases.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing Activities</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2024 and 2023, net cash used in investing activities was $0.4 million and $0.7 million, respectively, due to purchases of property and equipment.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Activities</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2024, net cash provided by financing activities was $71.7 million, consisting primarily of proceeds of $72.4 million from our IPO net of offering costs. These proceeds were partially offset primarily with financing liability and finance lease principal payments totaling $0.8 million.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, net cash provided by financing activities was $0.3 million, consisting primarily of net proceeds of $0.7 million from a financing obligation. These proceeds were partially offset by financing liability and finance lease principal payments totaling $0.6 million.</span></div><div id="i8049b05497804bd28b68608a093bd853_61"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Significant Judgments and Estimates</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management&#8217;s discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;). The preparation of our consolidated financial statements and related disclosures requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, expenses, and the disclosure of our contingent liabilities. We base our estimates on historical experience, known trends and events and various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different assumptions or conditions.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While our significant accounting policies are described in more detail in Note 2 to our consolidated financial statements included elsewhere in this Annual Report, we believe the following accounting policies are those most critical to the judgments and estimates used in the preparation of our consolidated financial statements.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expenses and Related Prepaid and Accrued Expenses</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the process of preparing our consolidated financial statements, we are required to estimate our R&amp;D expenses as of each balance sheet date. This process involves reviewing open contracts and purchase orders, communicating with our personnel to identify services that have been performed on our behalf, and estimating the level of service performed and the associated cost incurred for the service when we have not yet been invoiced or otherwise notified of the actual cost. We make estimates of our R&amp;D expenses as of each balance sheet date based on facts and circumstances known to us at that time. The significant estimates in our R&amp;D expenses include the costs incurred for services performed by our vendors in connection with services for which we have not yet been invoiced. We base our R&amp;D expenses on our estimates of the services received and efforts expended pursuant to quotes and contracts with vendors that conduct R&amp;D on our behalf. The financial terms of these agreements are subject to negotiation, vary from contract to contract, and may result in uneven payment flows.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There may be instances in which payments made to our vendors will exceed the level of services provided and result in a prepayment of the R&amp;D expense. In accruing service fees, we estimate the time period over which services will be performed and the level of effort to be expended in each period. If the actual timing of the performance of services or the level of effort varies from our estimate, we adjust the accrual or prepaid expense accordingly. Advance payments for goods and services that will be used in future R&amp;D activities are expensed when the activity has been performed or when the goods have been received rather than when the payment is made.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we do not expect our estimates to be materially different from the amounts actually incurred, if our estimates of the status and timing of services performed differ from the actual status and timing of services performed, it could result in us reporting amounts that are too high or too low in any period. To date, there have been no material differences between our estimates of such expenses and the amounts actually incurred.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically grant equity-based awards in the form of stock options and restricted stock awards to employees, directors and non-employees and record stock-based compensation expenses based on their estimated fair value at the grant date. We estimate the fair value of stock options using the Black-Scholes option-pricing model as of the grant date. Stock-based compensation expenses are recognized on the accompanying consolidated statement of operations and comprehensive loss on a straight-line basis over the requisite service period, which is typically the vesting period. Determining the appropriate fair value model and related input assumptions requires judgment.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The inputs to the Black-Scholes option-pricing model, excluding fair value of common stock discussed further below, include the following:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the risk-free interest rate used is based on the published U.S. Department of Treasury interest rates in effect at the time of stock option grant for zero coupon U.S. Treasury notes with maturities approximating each grant&#8217;s expected term;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the dividend yield is zero as we have not paid dividends and do not anticipate paying a cash dividend in the foreseeable future;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the expected term for options granted is calculated using the simplified method and represents the average time that options are expected to be outstanding based on the mid-point between the vesting date and the end of the contractual term of the award; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expected volatility is derived from the historical volatilities of a select group of representative public companies, for a look-back period commensurate with the expected term of the stock options, as we have no trading history of common stock.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 10 to our consolidated financial statements for weighted-average assumptions used to estimate the fair value of the stock options granted during the years ended December&#160;31, 2024 and 2023.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intrinsic value of all outstanding options as of December&#160;31, 2024 was $0.8 million, of which approximately $0.7 million was related to vested options and a de minimis amount was related to unvested options.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Determination of Fair Value of our Common Stock</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to our IPO, given the absence of a public trading market, the fair value of our common stock was determined by our board of directors at the time of each option grant, with input from management, considering contemporaneous independent third-party valuations of common stock, and our board of directors&#8217; assessment of additional objective and subjective factors that it believed were relevant and which may have changed from the date of the most recent valuation through the date of the grant, including: the prices at which we sold shares of our convertible preferred stock to outside investors in arms-length transactions, and the superior rights, preferences, and privileges of the convertible preferred stock relative to the common stock at the time of each grant; the progress of our company&#8217;s R&amp;D programs, including their stages of development, and our company&#8217;s business strategy; operating and financial performance; the lack of liquidity of the common stock and trends in the broader economy and biotechnology industry also impact the determination of the fair value of the common stock; the likelihood of achieving a liquidity event for our company&#8217;s security holders, such as an IPO or a sale of the company, taking into consideration prevailing market conditions; and the hiring of key personnel and the experience of management.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These independent third-party valuations were performed in accordance with the guidance outlined in the American Institute of Certified Public Accountants&#8217; Auditing and Valuation Guide,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Valuation of Privately-Held-Company Equity Securities Issued as Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (the &#8220;Guide&#8221;). The methodology to determine the fair value of our common stock included estimating the fair value of the enterprise using a market approach, which estimates the fair value of a company by including an estimation of the value of the business based on guideline public companies under several different scenarios. The Guide identifies various available methods for allocating enterprise value across classes and series of capital stock to determine the estimated fair value of common stock at each valuation date.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the Guide, we considered the following methods:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Option Pricing Method (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OPM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Under the OPM, shares are valued by creating a series of call options with exercise prices based on the liquidation preferences and conversion terms of each equity class. The estimated fair values of the convertible preferred stock and common stock are inferred by analyzing these options. This method is appropriate to use when the range of possible future outcomes is so difficult to predict that estimates would be highly speculative, and dissolution or liquidation is not imminent.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Probability-Weighted Expected Return Method (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PWERM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The PWERM is a scenario-based analysis that estimates value per share based on the probability-weighted present value of expected future investment returns, considering each of the possible outcomes available to us, as well as the economic and control rights of each share class.</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Hybrid Method</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Hybrid Method is a hybrid between PWERM and OPM, where the equity value is estimated based on probability-weighted value across multiple scenarios where the OPM is used to estimate the allocation of value within one or more of those scenarios.</span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to our IPO, based on our early stage of development, the difficulty in predicting the range of specific outcomes (and their likelihood), and other relevant factors, we determined the OPM scenario was most appropriate for valuations through August 15,&#160;2024, the date of the last grant prior to our IPO. Our board of directors considered various objective and subjective factors to determine the fair value of our common stock as of each grant date, including:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the prices at which we sold shares of convertible preferred stock and the superior rights and preferences of the convertible preferred stock relative to our common stock at the time of each grant;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the progress of our R&amp;D programs, including the status and results of clinical and preclinical studies for our product candidates;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our stage of development and our business strategy;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">external market conditions affecting the biopharmaceutical industry and trends within the biopharmaceutical industry;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our financial position, including cash on hand, and our historical and forecasted performance and operating results;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the lack of an active public market for our common stock and our convertible preferred stock;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the likelihood of achieving a liquidity event, such as an IPO or sale of our company considering prevailing market conditions; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the analysis of IPOs and the market performance of similar companies in the biopharmaceutical industry.</span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assumptions underlying these valuations were highly complex and subjective and represented management&#8217;s best estimates, which involved inherent uncertainties and the application of management&#8217;s judgment. As a result, if we had used significantly different assumptions or estimates, the fair value of our common stock and our stock-based compensation expense could be materially different.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After our IPO, the fair value of our common stock is determined on the date of grant based on the closing price of our common stock as reported on the Nasdaq, the primary stock exchange on which our common stock is traded.</span></div><div id="i8049b05497804bd28b68608a093bd853_64"></div><div style="margin-bottom:8pt"><span><br/></span></div><div id="i8049b05497804bd28b68608a093bd853_67"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Standards</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A description of recently issued accounting standards that may potentially impact our financial position, cash flows, and results of operations is included in Note 2 to our consolidated financial statements.</span></div><div id="i8049b05497804bd28b68608a093bd853_70"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Emerging Growth Company and Smaller Reporting Company Status</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and we may remain an emerging growth company until December 31, 2029 or until such earlier time that we are no longer an emerging growth company. For so long as we remain an emerging growth company, we are permitted and intend to rely on certain exemptions from various public company reporting requirements, including not being required to have our internal control over financial reporting audited by our independent registered public accounting firm pursuant to Section&#160;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and any golden parachute payments not previously approved and an exemption from compliance with the requirements regarding the communication of critical audit matters in the auditor&#8217;s report on financial statements.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the JOBS Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards. We have elected to avail ourselves of this extended transition period, which means that when a standard is issued or revised and it has different application dates for </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">public or private companies, we will adopt the new or revised standard at the time private companies adopt the new or revised standard and will do so until such time that we either (i)&#160;irrevocably elect to &#8220;opt out&#8221; of such extended transition period or (ii)&#160;no longer qualify as an emerging growth company. We may choose to early adopt any new or revised accounting standards whenever such early adoption is permitted for private companies. As a result of this election, our financial statements may not be comparable to those of companies that are not emerging growth companies.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will remain an emerging growth company until the earliest to occur of: (i)&#160;the last day of the fiscal year in which we have at least $1.235&#160;billion in annual revenue; (ii)&#160;the last day of the fiscal year in which we are deemed to be a &#8220;large accelerated filer,&#8221; as defined in Rule&#160;12b-2 under the Exchange Act, which would occur if the market value of our common stock held by non-affiliates exceeded $700.0&#160;million as of the last business day of the second fiscal quarter of such year; (iii)&#160;the date on which we have issued more than $1.0&#160;billion in nonconvertible debt securities during the prior three-year period; and (iv)&#160;December 31, 2029.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also a &#8220;smaller reporting company,&#8221; meaning that the market value of our shares held by non-affiliates is less than $700.0&#160;million and our annual revenue was less than $100.0&#160;million during the most recently completed fiscal year. We may continue to be a smaller reporting company if either: (i)&#160;the market value of our shares held by non-affiliates is less than $250.0&#160;million; or (ii)&#160;our annual revenue was less than $100.0&#160;million during the most recently completed fiscal year and the market value of our shares held by non-affiliates is less than $700.0&#160;million. If we are a smaller reporting company at the time we cease to be an emerging growth company, we may continue to rely on exemptions from certain disclosure requirements that are available to smaller reporting companies. Specifically, as a smaller reporting company, we may choose to present only the two most recent fiscal&#160;years of audited financial statements in our Annual Report on Form 10-K and, similar to emerging growth companies, smaller reporting companies have reduced disclosure obligations regarding executive compensation. </span></div><div id="i8049b05497804bd28b68608a093bd853_76"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7A. Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable to a smaller reporting company.</span></div><div style="margin-bottom:8pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119</span></div></div></div><div id="i8049b05497804bd28b68608a093bd853_79"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAMP4 Therapeutics Corporation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8. Financial Statements</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Index to Consolidated Financial Statements</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:92.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.416%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Page</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial statements for the years ended December 31, 2024 and 2023:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_82">Report of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_82">121</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_85">Consolidated balance sheets as of December 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_85">4</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_85"> and 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_85">23</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_85">122</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:10.8pt;text-indent:-10.8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_88">Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2024 and 2023</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_88">123</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:10.8pt;text-indent:-10.8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_91">Consolidated Statements of Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit) for the years ended December 31, 2024 and 2023</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_91">124</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_94">Consolidated statements of cash flows for the years ended December 31, 2024 and 2023</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_94">125</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_97">Notes to consolidated financial statements</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8049b05497804bd28b68608a093bd853_97">126</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">120</span></div></div></div><div id="i8049b05497804bd28b68608a093bd853_82"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders and the Board of Directors of CAMP4 Therapeutics Corporation</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of CAMP4 Therapeutics Corporation (the Company) as of December&#160;31, 2024 and 2023, the related consolidated statements of operations and comprehensive loss, convertible preferred stock and stockholders&#8217; equity (deficit) and cash flows for the years then ended, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Company as of December&#160;31, 2024 and 2023, and the results of its operations and its cash flows for the years then ended, in conformity with U.S. generally accepted accounting principles.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Company&#8217;s Ability to Continue as a Going Concern</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the consolidated financial statements, the Company has suffered recurring losses from operations and has stated that substantial doubt exists about the Company&#8217;s ability to continue as a going concern. Management&#8217;s evaluation of the events and conditions and management&#8217;s plans regarding these matters are also described in Note 1. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. Our opinion is not modified with respect to this matter.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ <ix:nonNumeric contextRef="c-1" name="dei:AuditorName" id="f-54">Ernst &amp; Young LLP</ix:nonNumeric></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 2017.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:AuditorLocation" id="f-55">Boston, Massachusetts</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;27, 2025</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121</span></div></div></div><div id="i8049b05497804bd28b68608a093bd853_85"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAMP4 Therapeutics Corporation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Balance Sheets</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except share and per share amounts)</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-56">64,039</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-57">38,380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-58">2,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-59">1,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #cceeff;padding:2px 1pt 2px 22.6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-60">66,383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-61">40,013</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-62">1,624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-63">1,624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-64">3,858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-65">4,797</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-66">6,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-67">7,764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="3" id="f-68">427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="3" id="f-69">748</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:2px 1pt 2px 22.6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-70">78,307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-71">54,946</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities, Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit)</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-72">1,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-73">1,042</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-74">4,833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-75">3,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="f-76">385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:fixed-zero" scale="3" id="f-77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-78">2,994</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-79">2,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease liabilities, current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="f-80">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="f-81">354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing liability, current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="camp:FinanceLiabilityCurrent" scale="3" id="f-82">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="camp:FinanceLiabilityCurrent" scale="3" id="f-83">405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #ffffff;padding:2px 1pt 2px 22.6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-84">9,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-85">7,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-86">5,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-87">8,487</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease liabilities, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="f-88">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="f-89">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing liability, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="camp:FinanceLiabilityNonCurrent" format="ixt:fixed-zero" scale="3" id="f-90">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="camp:FinanceLiabilityNonCurrent" scale="3" id="f-91">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="f-92">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="f-93">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #cceeff;padding:2px 1pt 2px 22.6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-94">15,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-95">16,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commitments and contingencies (Note 7)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-4" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-96"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-5" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-97"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Convertible preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="f-98"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="f-99">0.0001</ix:nonFraction></ix:nonFraction> par value per share; <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-100">25,000,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-101">149,673,284</ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:fixed-zero" scale="3" id="f-102"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="3" id="f-103">no</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-104"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-105">130,648,426</ix:nonFraction></ix:nonFraction> shares issued and outstanding; liquidation value of <ix:nonFraction unitRef="usd" contextRef="c-4" decimals="INF" name="us-gaap:TemporaryEquityLiquidationPreference" format="ixt:fixed-zero" scale="3" id="f-106">zero</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:TemporaryEquityLiquidationPreference" format="ixt:num-dot-decimal" scale="3" id="f-107">162,885</ix:nonFraction> as of December&#160;31, 2024 and 2023, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="f-108">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-109">162,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders&#8217; equity (deficit):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-110"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-111">0.0001</ix:nonFraction></ix:nonFraction> par value per share; <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-112">175,000,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-113">210,000,000</ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-114">20,161,072</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-115">1,026,057</ix:nonFraction> shares issued, <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-116">20,145,129</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-117">460,704</ix:nonFraction> shares outstanding as of December&#160;31, 2024 and 2023, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-118">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-119">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-120">274,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-121">36,231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-122">211,753</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-123">159,962</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stockholders&#8217; equity (deficit)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-124">63,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-125">123,730</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22.6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities, convertible preferred stock and stockholders&#8217; equity (deficit)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-126">78,307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-127">54,946</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122</span></div></div></div><div id="i8049b05497804bd28b68608a093bd853_88"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAMP4 Therapeutics Corporation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Operations and Comprehensive Loss</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except for share and per share data)</span></div><div style="margin-bottom:375pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and collaboration revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:Revenues" scale="3" id="f-128">652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:Revenues" scale="3" id="f-129">350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-130">38,817</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-131">40,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-132">14,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-133">11,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #cceeff;padding:2px 1pt 2px 22.6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-134">53,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-135">52,229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-136">53,088</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-137">51,879</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="f-138">1,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="f-139">2,808</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherNonoperatingExpense" scale="3" id="f-140">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherNonoperatingExpense" scale="3" id="f-141">220</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:2px 1pt 2px 22.6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other income, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-142">1,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-143">2,588</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss attributable to common stockholders and comprehensive loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-144"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-145">51,791</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-146"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-147">49,291</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss per share attributable to common stockholders, basic and diluted</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-148"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-149">11.04</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-150"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-151">124.80</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average shares of common stock outstanding, basic and diluted</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-152"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-153">4,690,094</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-154"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-155">394,976</ix:nonFraction></ix:nonFraction></span></td></tr></table></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">123</span></div></div></div><div id="i8049b05497804bd28b68608a093bd853_91"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAMP4 Therapeutics Corporation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit)</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except share amounts)</span></div><div style="margin-bottom:355pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.086%"/><td style="width:0.1%"/></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Convertible <br/>preferred stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Common stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Additional <br/>paid-in <br/>capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Accumulated <br/>deficit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total <br/>stockholders&#8217; <br/>equity (deficit)</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-156">130,648,426</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-157">162,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-158">356,759</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-159">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-160">33,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-161">110,671</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-162">77,531</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Vesting of restricted common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-163">60,919</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Issuance of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-164">43,026</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-165">185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-166">185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-167">2,907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-168">2,907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-169">49,291</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-170">49,291</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Balance as of December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-171">130,648,426</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-172">162,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-173">460,704</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-174">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-175">36,231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-176">159,962</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-177">123,730</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Vesting of restricted common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-178">58,300</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Issuance of common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-179">513,781</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-180">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-181">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Conversion of convertible preferred stock into common stock upon initial public offering</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="camp:TemporaryEquitySharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="f-182">130,648,426</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="camp:TemporaryEquityValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="f-183">162,147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="f-184">11,648,582</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="f-185">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="f-186">162,146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="f-187">162,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Issuance of common stock upon initial public offering, net of offering costs of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-188">9,727</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-19" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-189">7,463,762</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-190">72,373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-191">72,373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-192">4,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-193">4,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-194">51,791</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-195">51,791</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Balance as of December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-196">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="f-197">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-23" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-198">20,145,129</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-199">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-200">274,895</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-201">211,753</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-202">63,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124</span></div></div></div><div id="i8049b05497804bd28b68608a093bd853_94"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAMP4 Therapeutics Corporation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-203">51,791</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-204">49,291</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22.6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-205">1,696</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-206">1,678</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22.6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-207">4,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-208">2,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22.6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="camp:NoncashLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="f-209">1,749</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="camp:NoncashLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="f-210">1,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22.6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-cash interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaidInKindInterest" scale="3" id="f-211">83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PaidInKindInterest" scale="3" id="f-212">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22.6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="f-213">711</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="f-214">420</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="f-215">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-216">1,115</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-217">1,531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="3" id="f-218">136</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease assets and liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="camp:IncreaseDecreaseInOperatingLeaseAssetsLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-219">2,704</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="camp:IncreaseDecreaseInOperatingLeaseAssetsLiabilities" scale="3" id="f-220">402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="f-221">385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:fixed-zero" scale="3" id="f-222">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-223">45,562</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-224">44,155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investing Activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22.6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="f-225">441</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="f-226">678</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="f-227">441</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="f-228">678</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financing Activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22.6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from issuance of common stock, net of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-229">76,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:fixed-zero" scale="3" id="f-230">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22.6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from exercise of common stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="f-231">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="f-232">185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22.6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from financing obligation, net of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="camp:ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction" format="ixt:fixed-zero" scale="3" id="f-233">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="camp:ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction" scale="3" id="f-234">706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22.6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal payments on financing obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="camp:PrincipalPaymentsOnFinancingObligationsFailedSaleLeasebackTransaction" scale="3" id="f-235">460</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="camp:PrincipalPaymentsOnFinancingObligationsFailedSaleLeasebackTransaction" scale="3" id="f-236">268</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22.6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal payments on finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="f-237">364</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="f-238">322</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #ffffff;padding:2px 1pt 2px 22.6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments of deferred offering costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-239">3,980</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:fixed-zero" scale="3" id="f-240">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-241">71,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="f-242">301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net increase (decrease) in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-243">25,659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-244">44,532</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents and restricted cash at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-245">40,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-246">84,536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents and restricted cash at end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-247">65,663</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-248">40,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental disclosure of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use asset obtained in exchange for lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:fixed-zero" scale="3" id="f-249">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-250">1,397</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease right-of-use asset obtained in exchange for lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" format="ixt:fixed-zero" scale="3" id="f-251">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="f-252">504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchases of property and equipment in accounts payable and accrued expenses</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:fixed-zero" scale="3" id="f-253">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="f-254">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Conversion of convertible preferred stock upon initial public offering</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ConversionOfStockAmountConverted1" format="ixt:num-dot-decimal" scale="3" id="f-255">162,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ConversionOfStockAmountConverted1" format="ixt:fixed-zero" scale="3" id="f-256">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease right-of-use asset converted to fixed asset</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="camp:FinanceLeaseRightOfUseAssetConvertedToFixedAsset" scale="3" id="f-257">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="camp:FinanceLeaseRightOfUseAssetConvertedToFixedAsset" format="ixt:fixed-zero" scale="3" id="f-258">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:2pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125</span></div></div></div><div id="i8049b05497804bd28b68608a093bd853_97"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAMP4 Therapeutics Corporation</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div id="i8049b05497804bd28b68608a093bd853_100"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="f-259" continuedAt="f-259-1" escape="true"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. &#160;&#160;&#160;&#160;Description of Business and Basis of Presentation</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description of Business</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CAMP4 Therapeutics Corporation, formerly Marauder Therapeutics, Inc., and its subsidiary (collectively, the &#8220;Company&#8221;), is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new class of RNA-based therapeutics with the goal of upregulating gene expression and restoring healthy protein levels to treat a broad range of genetic diseases. The Company is currently focusing on metabolic diseases and diseases of the central nervous system. The Company was organized in September&#160;2015 and began operations in 2016.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;). Any reference in these notes to applicable guidance is meant to refer to the authoritative standards of U.S. GAAP as found in the Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Updates (&#8220;ASU&#8221;) of the Financial Accounting Standards Board (&#8220;FASB&#8221;).</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s consolidated financial statements include the accounts of CAMP4 Therapeutics Corporation and its wholly owned subsidiary, CAMP4 Therapeutics Pty Ltd (&#8220;CAMP4 AUS&#8221;), which was established on September&#160;15, 2023. All intercompany balances and transactions have been eliminated in consolidation.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassification of Prior Year Presentation</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations or balance sheets.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reverse Stock Split</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October&#160;3, 2024, the Company effected a one-for-11.2158 reverse stock split of its issued and outstanding shares of common stock and a proportional adjustment to the existing conversion ratios for each series of the Company&#8217;s convertible preferred stock. Accordingly, all share and per share amounts for all periods presented in the accompanying consolidated financial statements and notes thereto have been adjusted retroactively, where applicable, to reflect this reverse stock split and adjustment of the preferred stock conversion ratios. The par value and the number of authorized shares of the convertible preferred stock and common stock were not adjusted in connection with the reverse stock split.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Initial Public Offering</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 15, 2024, the Company completed its initial public offering (&#8220;IPO&#8221;), pursuant to which it issued and sold an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-26" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-260">6,820,000</ix:nonFraction> shares of its common stock at a price to the public of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-27" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="f-261">11.00</ix:nonFraction> per share, resulting in net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" scale="6" id="f-262">65.8</ix:nonFraction> million, after deducting underwriting discounts and commissions of $<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="camp:PaymentsOfUnderwritingDiscountsAndCommissions" scale="6" id="f-263">5.3</ix:nonFraction> million and other offering expenses of $<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="6" id="f-264">4.0</ix:nonFraction> million. In addition, on November 1, 2024, the Company received additional proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-5" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" scale="6" id="f-265">6.6</ix:nonFraction> million, after deducting underwriting discounts and commissions of $<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-5" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="6" id="f-266">0.5</ix:nonFraction> million, pursuant to the partial exercise by the underwriters of their option to purchase additional shares in the IPO. Collectively, the Company received aggregate net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-5" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" scale="6" id="f-267">72.4</ix:nonFraction> million. Upon the closing of the IPO, the Company&#8217;s outstanding convertible preferred stock automatically converted into <ix:nonFraction unitRef="shares" contextRef="c-30" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="f-268">11,648,582</ix:nonFraction> shares of common stock (see Note 9).</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the completion of its IPO, on October 15, 2024, the Company&#8217;s certificate of incorporation was amended and restated to authorize <ix:nonFraction unitRef="shares" contextRef="c-31" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-269">175,000,000</ix:nonFraction> shares of common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-31" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-270">0.0001</ix:nonFraction> per share and <ix:nonFraction unitRef="shares" contextRef="c-31" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-271">25,000,000</ix:nonFraction> shares of preferred stock, par value of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-31" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-272">0.0001</ix:nonFraction> per share.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Going Concern</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of December&#160;31, 2024, the Company had approximately $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-273">64.0</ix:nonFraction> million of cash and cash equivalents and working capital of approximately $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="camp:WorkingCapital" scale="6" id="f-274">56.8</ix:nonFraction> million. The Company has a relatively limited operating history, and the revenue and income potential of the Company&#8217;s business and market are unproven. The Company has experienced net losses and negative cash flows from operations since its inception and, as of December&#160;31, 2024, the Company had an accumulated deficit of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="f-275">211.8</ix:nonFraction> million. During the year ended December&#160;31, 2024, the Company incurred a net loss of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-276">51.8</ix:nonFraction> million and had negative cash flows from operations of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-277">45.6</ix:nonFraction> million. The Company will continue to incur significant costs and </span></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><ix:continuation id="f-259-1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">expenses related to its ongoing operations until it successfully develops, obtains regulatory approval for and gains market acceptance of a product candidate and achieves revenues adequate to support the Company&#8217;s operations.</span></div><div><span><br/></span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From inception to December&#160;31, 2024, the Company has funded its operations primarily with proceeds from the sale of convertible preferred stock and common stock, including in its IPO, as well as through revenues from its license and collaboration agreements. Based on its current operating plan, the Company estimates that its cash and cash equivalents as of December&#160;31, 2024 will be sufficient to fund its operating expenses and capital expenditure requirements into the second quarter of 2026. However, the Company has based this estimate on assumptions that may prove to be wrong, and could deplete its capital resources sooner than it currently expects. The Company's capital resources may not be sufficient to fund operations through at least the next twelve&#160;months from the date that these audited consolidated financial statements as of December&#160;31, 2024 are issued based on its expected cash needs, which raises substantial doubt about the Company's ability to continue as a going concern. As the Company continues to pursue its business plan, it expects to finance its operations through potential public or private equity offerings, debt financings or other capital sources, including current or potential future collaborations, licenses and other similar arrangements. However, there can be no assurance that any additional financing or strategic arrangements will be available to the Company on acceptable terms, if at all. If events or circumstances occur such that the Company does not obtain additional funding, it may be necessary to significantly reduce its scope of operations to reduce the current rate of spending through actions such as reductions in staff and the need to delay, limit, reduce or terminate product development or future commercialization efforts or grant rights to develop and market product candidates that it would otherwise prefer to develop and market itself, which could have a material adverse effect on the Company&#8217;s business, results of operations or financial condition.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the ordinary course of business. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty.</span></div></ix:continuation><div id="i8049b05497804bd28b68608a093bd853_103"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-279" continuedAt="f-279-1" escape="true"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. &#160;&#160;&#160;&#160;Summary of Significant Accounting Policies</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-280" escape="true"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates assumptions, and judgments that affect the reported amounts of assets, liabilities, expenses and related disclosures in the accompanying notes. The Company bases its estimates, assumptions and judgments on historical experience when available and on various factors that it believes to be reasonable under the circumstances as of the date of the accompanying consolidated financial statements, including the fair value of common stock prior to the Company&#8217;s IPO, stock-based compensation expense, accrued expenses, lease accounting and the recoverability of the Company&#8217;s net deferred tax assets and related valuation allowance. In addition, other factors may affect estimates, including the expected business and operational changes, the sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process often may yield a range of potentially reasonable estimates of the ultimate future outcomes, and management must select an amount that falls within that range of reasonable estimates. Actual results could differ materially from the estimates and assumptions used in the preparation of the accompanying consolidated financial statements under different assumptions or conditions.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="f-281" escape="true"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments and instruments with original maturities of 90 days or less that can be liquidated without prior notice or penalty to be cash equivalents. Cash equivalents primarily represent funds invested in readily available money market accounts. As of December&#160;31, 2024 and 2023, the Company had cash and cash equivalents balances deposited at <ix:nonFraction unitRef="majorfinancialinstitution" contextRef="c-4" decimals="INF" name="camp:NumberOfMajorFinancialInstitutionsWithCashAndCashEquivalentDeposits" format="ixt-sec:numwordsen" scale="0" id="f-282"><ix:nonFraction unitRef="majorfinancialinstitution" contextRef="c-5" decimals="INF" name="camp:NumberOfMajorFinancialInstitutionsWithCashAndCashEquivalentDeposits" format="ixt-sec:numwordsen" scale="0" id="f-283">one</ix:nonFraction></ix:nonFraction> major financial institution.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="f-284" escape="true"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Cash</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with its operating leases, the Company is required to maintain security deposits totaling $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DepositsAssets" scale="6" id="f-285">1.5</ix:nonFraction> million, which were issued in the form of letters of credit with a bank. As of December&#160;31, 2024 and 2023, the Company held cash in this amount in separate restricted bank accounts as collateral for the letters of credit. The restricted cash balance is classified as long-term restricted cash on the accompanying consolidated balance sheets. In addition, the Company held less than $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:Cash" scale="6" id="f-286"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:Cash" scale="6" id="f-287">0.1</ix:nonFraction></ix:nonFraction> million in money market accounts as of each of December&#160;31, 2024 and 2023 as collateral for the Company&#8217;s credit card obligation and increased letter of credit due to an amendment to the leases.</span></div></ix:nonNumeric></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">127</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><ix:continuation id="f-279-1" continuedAt="f-279-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="f-289" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" id="f-288" escape="true"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheets to the corresponding amounts shown in the consolidated statements of cash flows as of December&#160;31, 2024 and 2023 (in thousands):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-290">64,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-291">38,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-292">1,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-293">1,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-294">65,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-295">40,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ConcentrationRiskCreditRisk" id="f-296" escape="true"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risks</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. The Company deposits cash and cash equivalents with high credit quality financial institutions in the United States. These deposits are held in checking and money market accounts and may, from time to time, exceed the federally insured amounts. The Company has not experienced any losses in such accounts. The Company believes it is not exposed to any significant risk in its cash and cash equivalents. The primary objectives of the Company&#8217;s investment portfolio are the preservation of capital and maintenance of liquidity.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to risks common to companies in the biopharmaceutical industry, including, but not limited to, risks related to the successful development and commercialization of product candidates, fluctuations in operating results and financial risks, the ability to successfully raise additional funds when needed, protection of proprietary rights and patent risks, patent litigation, compliance with government regulations, dependence on key personnel and collaboration partners, dependence on third-party manufacturers and competition from competing products in the marketplace.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="f-298" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="f-297" escape="true"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies fair value measurements to record fair value adjustments to certain assets and liabilities and to determine fair value disclosures. Fair value is measured as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A fair value measurement assumes that the transaction to sell the asset or transfer the liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market. A framework is used for measuring fair value utilizing a three-tier hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level&#160;1) and the lowest priority to unobservable inputs (Level&#160;3).</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The three levels of the fair value hierarchy are as follows:</span></div><div style="margin-bottom:8pt;padding-left:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Level&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Observable inputs such as unadjusted quoted prices in active markets that are accessible at the measurement date for identical unrestricted assets or liabilities the Company has the ability to access;</span></div><div style="margin-bottom:8pt;padding-left:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Level&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Inputs (other than quoted prices included within Level&#160;1) that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active; and</span></div><div style="margin-bottom:8pt;padding-left:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Level&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments are categorized in their entirety based on the lowest level of input that is significant to the fair value measurement. The assessment of the significance of a particular input to the fair value measurement requires judgment and considers factors specific to the investment. To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level&#160;3. The Company reviews the fair value hierarchy classification at each reporting date. Changes in the ability to observe valuation inputs may result in a reclassification of levels for certain assets or liabilities within the fair value hierarchy. The Company did not have any transfers of assets and liabilities between the levels of the fair value measurement hierarchy during the&#160;years presented.</span></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">128</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><ix:continuation id="f-279-2" continuedAt="f-279-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="f-299" escape="true"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Remeasurement</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reporting currency and the functional currency of its foreign subsidiary, CAMP4 AUS, is the United States Dollar (&#8220;USD&#8221;). At the date a foreign currency denominated transaction is recognized, each asset, liability, revenue, expense, gain or loss arising from the transaction is measured initially in USD based on the exchange rate in effect at that date. Subsequently, at each balance sheet date, balances related to monetary assets and liabilities are adjusted to reflect the current exchange rate, which is the rate at which the related receivable or payable could be settled at that date.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign exchange transaction gains and losses are included in other income, net in the accompanying consolidated statements of operations and comprehensive loss and were de minimis for the&#160;years ended December&#160;31, 2024 and 2023.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="f-300" escape="true"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comprehensive Loss</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no differences between net loss and comprehensive loss presented in the consolidated statements of operations for the&#160;years ended December&#160;31, 2024 and 2023.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="f-301" escape="true"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment, Net</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, which are all located in the United States, are stated at cost less accumulated depreciation. Expenditures for maintenance and repairs are charged to expense as incurred, whereas major betterments are capitalized as additions to property and equipment. <ix:nonNumeric contextRef="c-1" name="camp:ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock" id="f-302" continuedAt="f-302-1" escape="true">Depreciation is calculated using the straight-line method over the following estimated useful lives of the assets:</ix:nonNumeric></span></div><ix:continuation id="f-302-1"><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Computer and software</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-33" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="f-303">Three years</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laboratory equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-34" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="f-304">Five years</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-35" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="f-305">Seven years</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shorter of asset life or remaining lease term</span></td></tr></table></div></ix:continuation></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="f-306" escape="true"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates its long-lived assets, which consist of property and equipment, operating lease right-of-use (&#8220;ROU&#8221;) assets, and finance lease ROU assets, for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant underperformance of the business in relation to expectations, significant negative industry or economic trends and significant changes or planned changes in the use of the assets. If the asset is impaired, the amount of any impairment is measured as the difference between the carrying value and the fair value of the impaired asset. The Company recognized no impairment losses for the&#160;years ended December&#160;31, 2024 and 2023.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="f-307" escape="true"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commitments and Contingencies</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contractual Commitments</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into contracts in the normal course of business with contract research organizations (&#8220;CROs&#8221;), contract manufacturing organizations (&#8220;CMOs&#8221;), academic institutions and other third parties for preclinical and clinical research studies, testing and manufacturing services. These contracts generally do not contain minimum purchase commitments and are cancellable by the Company upon prior written notice, although purchase orders for preclinical materials are generally non-cancellable. Payments due upon cancellation consist primarily of payments for services provided or expenses incurred, including non-cancellable obligations from the Company&#8217;s service providers, up to the date of cancellation or upon the completion of a manufacturing run.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="camp:GuaranteesAndIndemnificationsPolicyTextBlock" id="f-308" continuedAt="f-308-1" escape="true"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Indemnifications</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Indemnification Obligations</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into indemnification agreements with its officers and directors that require the Company to indemnify such individuals for certain events or occurrences while each such officer or director is, or was, serving at the Company&#8217;s request in such capacity. The maximum potential future payments the Company could be required to make is, in many cases, unlimited. The Company has directors&#8217; and officers&#8217; liability insurance coverage that limits its exposure and enables the Company to recover a portion of any future amounts paid.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">129</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><ix:continuation id="f-279-3" continuedAt="f-279-4"><ix:continuation id="f-308-1"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases office and laboratory space under operating leases. The Company has standard indemnification arrangements under the leases that require it to indemnify the landlords against all costs, expenses, fines, suits, claims, demands, liabilities and actions directly resulting from any breach, violation or nonperformance of any covenant or condition of the Company&#8217;s leases.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of its business, the Company enters into indemnification agreements with certain suppliers and business partners pursuant to which the Company has certain indemnification obligations limited to the costs, expenses, fines, suits, claims, demands, liabilities and actions directly resulting from the Company&#8217;s gross negligence or willful misconduct, and in certain instances, breaches, violations or nonperformance of covenants or conditions under the agreements.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024 and 2023, the Company had not experienced any material losses related to these indemnification obligations, and no material claims with respect thereto were outstanding. The Company does not expect significant claims related to these indemnification obligations and, consequently, concluded that the fair value of these obligations is negligible, and no related reserves were established.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to the possibility of loss contingencies arising in the ordinary course of business. Management considers the likelihood of loss related to an asset, or the incurrence of a liability, as well as its ability to reasonably estimate the amount of the loss, in determining loss contingencies. An estimated loss contingency is accrued when it is probable that an asset has been impaired, or a liability has been incurred and the amount of loss can be reasonably estimated. The Company regularly evaluates current information available to determine whether such accruals should be adjusted and whether new accruals are required.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company may become involved in litigation relating to claims arising from the ordinary course of business. Management believes that there are no claims or actions pending against the Company currently, the ultimate disposition of which would have a material adverse effect on the Company&#8217;s consolidated results of operations, financial condition or cash flows.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeLeasesPolicyTextBlock" id="f-309" continuedAt="f-309-1" escape="true"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 842,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company determines if an arrangement is or contains a lease at inception. A contract is or contains a lease if the contract conveys the right to control the use of an identified asset for a period in exchange for consideration. The Company classifies leases at the lease commencement date as operating or finance leases and records a ROU asset and a lease liability on the consolidated balance sheet for all leases with an initial lease term of greater than 12 months. Leases with an initial term of 12 months or less are not recorded in the balance sheet, but payments are recognized as expense on a straight-line basis over the lease term.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A lease qualifies as a finance lease if any of the following criteria are met at the inception of the lease: (i)&#160;there is a transfer of ownership of the leased asset to the Company by the end of the lease term, (ii)&#160;the Company holds an option to purchase the leased asset that it is reasonably certain to exercise, (iii)&#160;the lease term is for a major part of the remaining economic life of the leased asset, (iv)&#160;the present value of the sum of lease payments equals or exceeds substantially all of the fair value of the leased asset, or (v)&#160;the nature of the leased asset is specialized to the point that it is expected to provide the lessor no alternative use at the end of the lease term. All other leases are recorded as operating leases.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into contracts that contain both lease and non-lease components. Non-lease components may include maintenance, utilities and other operating costs. The Company combines the lease and non-lease components of fixed costs in its lease arrangements as a single lease component. Variable costs, such as utilities or maintenance costs, are not included in the measurement of ROU assets and lease liabilities, but rather are expensed when the event determining the amount of variable consideration to be paid occurs.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance and operating lease assets and liabilities are recognized at the lease commencement date based on the present value of the lease payments over the lease term using the discount rate implicit in the lease. If the rate implicit is not readily determinable, the Company utilizes an estimate of its incremental borrowing rate based upon the available information at the lease commencement date. Operating lease assets are further adjusted for prepaid or accrued lease payments. Operating lease assets are expensed using the straight-line method as an operating expense over the lease term. Finance lease assets are amortized to depreciation expense using the straight-line method. Finance lease payments are bifurcated into (i)&#160;a portion that is recorded as imputed interest expense and (ii)&#160;a portion that reduces the finance liability associated with the lease.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">130</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><ix:continuation id="f-279-4" continuedAt="f-279-5"><ix:continuation id="f-309-1"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s leases provide a lease incentive in the form of reimbursable leasehold improvements. Due to the unpredictability of the payout of leasehold improvement reimbursements, the Company recognizes a reduction to the ROU asset and the lease liability once it has incurred costs that qualify as reimbursable by the lessor. The reduction to the ROU asset is recognized prospectively over the remainder of the lease term.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s leases include options to extend or terminate the lease. The amounts determined for the Company&#8217;s ROU assets and lease liabilities generally do not assume that renewal options or early-termination provisions, if any, are exercised, unless it is reasonably certain that the Company will exercise such options.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company examines other contracts with suppliers, vendors and outside parties to identify whether such contracts contain an embedded lease and, as applicable, records such embedded leases in accordance with ASC 842,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="camp:FinancingObligationFailedSaleLeasebackPolicyTextBlock" id="f-310" escape="true"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financing Obligation (Failed Sale-Leaseback)</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 842,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for potential sale-leaseback transactions, the Company assesses the contract to identify if a sale occurred in accordance with ASC Topic 606,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASC 606&#8221;). Sale-and-leaseback transactions occur when the Company sells assets to a third-party and simultaneously leases them back. The resulting leases that qualify for sale-and-leaseback accounting are evaluated and accounted for as operating leases. A transaction that does not qualify for sale-and-leaseback accounting as a result of finance lease classification or the failure to meet certain revenue recognition criteria is accounted for as a financing transaction. For a financing transaction, the Company will retain the assets sold within Property, plant and equipment, net and record a financing obligation equal to the amount of cash proceeds received. Rental payments under such transactions are recognized as a reduction of the financing obligation and as interest expense using an effective interest method. To date, the Company has entered into one failed sale-leaseback transaction. See additional discussion in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 7. Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="f-311" continuedAt="f-311-1" escape="true"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition and Accounting for Collaboration Agreements</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with ASC 606. The Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. In determining the appropriate amount of revenue to be recognized as it fulfills its obligations under its agreements, the Company performs the following steps: (i)&#160;identification of the promised goods or services in the contract; (ii)&#160;determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii)&#160;measurement of the transaction price, including the constraint on variable consideration; (iv)&#160;allocation of the transaction price to the performance obligations; and (v)&#160;recognition of revenue when (or as) the Company satisfies each performance obligation.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses judgment to determine: (a)&#160;the performance obligations based on the determination under step (ii)&#160;above; (b)&#160;the transaction price under step (iii)&#160;above; and (c)&#160;the recognition of revenue as services are performed under step (v)&#160;above. The Company also uses judgment to determine whether development milestones or other variable consideration except for royalties and sales-based milestones, should be included in the transaction price as described further below.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the five-step model to contracts when the arrangement is not a collaboration pursuant to ASC Topic 808,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;(&#8220;ASC 808&#8221;), and it is probable that the Company will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Agreements</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company analyzes its collaboration agreements to assess whether they are within the scope of ASC 808 by determining whether such arrangements involve joint operating activities performed by parties that are both active participants in the activities and exposed to significant risks and rewards that are dependent on the commercial success of such activities. To the extent the arrangement is within the scope of ASC 808, the Company assesses whether aspects of the arrangement between the Company and the collaboration partner are within the scope of other accounting literature. If the Company concludes that some or all aspects of the arrangement represent a transaction with a customer, the Company </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><ix:continuation id="f-279-5" continuedAt="f-279-6"><ix:continuation id="f-311-1"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accounts for those aspects of the arrangement within the scope of ASC 606. If the Company concludes that some or all aspects of the arrangement are within the scope of ASC 808 and do not represent a transaction with a customer, the Company recognizes the Company&#8217;s share of the allocation of the shared costs incurred with respect to the jointly conducted activities as a component of the related expense in the period incurred.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="f-312" escape="true"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Expenses</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development (&#8220;R&amp;D&#8221;) expenses are recorded to operating expenses when incurred. The Company&#8217;s R&amp;D expenses consist primarily of costs incurred in performing R&amp;D activities, including personnel-related expenses such as salaries, stock-based compensation and benefits, facilities costs, depreciation and external costs of outside vendors engaged to conduct clinical and preclinical development activities and to manufacture a product candidate. The Company accrues expenses related to development activities performed by third parties based on an evaluation of services received and efforts expended pursuant to the terms of the contractual arrangements. Payments under some of these contracts depend on preclinical trial milestones. Non-refundable advance payments for goods and services that will be used over time for R&amp;D are deferred and capitalized as R&amp;D prepaid expenses on the Company&#8217;s consolidated balance sheets. The capitalized amounts are recognized as an expense as the goods are delivered or as the related services are performed. In accruing service fees, the Company estimates the period over which services will be performed and the level of effort to be expended in each period. If the actual timing of the performance of services or the level of effort varies from the estimate, the Company will adjust the accrual or prepaid expense accordingly. Costs to acquire technologies to be used in R&amp;D that have not reached technological feasibility and have no alternative future use are also expensed as incurred.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock" id="f-313" escape="true"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General and Administrative Expenses</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative (&#8220;G&amp;A&#8221;) expenses consist primarily of personnel-related expenses, including salaries, bonuses, benefits, travel and stock-based compensation expenses for employees in executive, accounting and finance, business development, human resources, legal, and other administrative functions. Other significant G&amp;A expenses include allocated facility-related costs, legal fees relating to corporate and intellectual property matters, professional fees for accounting, audit and tax services, consulting fees and insurance costs. G&amp;A costs are expensed as incurred.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="camp:PatentCostsPolicyTextBlock" id="f-314" escape="true"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Patent Costs</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All patent-related costs incurred in connection with filing and prosecuting patent applications are expensed as incurred due to the uncertainty about the recovery of the expenditure. Amounts are classified as G&amp;A expenses.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="camp:OfferingCostsPolicyTextBlock" id="f-315" continuedAt="f-315-1" escape="true"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Offering Costs</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:36pt"><ix:continuation id="f-315-1" continuedAt="f-315-2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company complies with the requirements of ASC 340,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets and Deferred Costs</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-315-2">, with regards to offering costs. Prior to the completion of an offering of common stock, direct offering costs are capitalized as deferred offering costs. The deferred offering costs are charged to additional paid-in capital for offerings of common stock or as a reduction in the carrying value of preferred stock for offerings of preferred stock.</ix:continuation> As of December&#160;31, 2024 and 2023, the Company had no deferred offering costs recorded. During the year ended December&#160;31, 2024, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredCosts" scale="6" id="f-316">4.0</ix:nonFraction> million of offering costs related to the issuance of common stock in the IPO and recognized this amount as a reduction in the carrying value of the common stock issued in the IPO.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="f-317" continuedAt="f-317-1" escape="true"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company periodically grants equity-based awards in the form of stock options and restricted stock to employees, directors and non-employees and records stock-based compensation expenses based on their estimated fair value at the grant date. The Company estimates the fair value of stock options using the Black-Scholes option-pricing model as of the grant date. Stock-based compensation expenses are recognized in the accompanying consolidated statements of operations and comprehensive loss on a straight-line basis over the requisite service period, which is typically the vesting period. Determining the appropriate fair value model and related input assumptions requires judgment.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the IPO, the fair value of the Company&#8217;s common stock was determined by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;) at the time of each option grant by considering several objective and subjective factors. These factors included the valuation of a select group of representative public companies within the industry that focus on biotechnology that the Board believed was comparable to the Company&#8217;s operations; operating and financial performance; the lack of liquidity of the common stock and trends in the broader economy and biotechnology industry also impact the determination of the fair value of the common stock. For awards granted after the Company&#8217;s IPO, the grant date fair value of common stock was determined by using the closing price per share of the Company&#8217;s common stock.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><ix:continuation id="f-279-6" continuedAt="f-279-7"><ix:continuation id="f-317-1"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The other inputs to the Black-Scholes option-pricing model include the following:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The risk-free interest rate used is based on the published U.S. Department of Treasury interest rates in effect at the time of stock option grant for zero coupon U.S. Treasury notes with maturities approximating each grant&#8217;s expected term;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The dividend yield is <ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-318">zero</ix:nonFraction> as the Company has not paid dividends and does not anticipate paying a cash dividend in the foreseeable future;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The expected term for options granted is calculated using the simplified method and represents the average time that options are expected to be outstanding based on the mid-point between the vesting date and the end of the contractual term of the award; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Expected volatility is derived from the historical volatility of a select group of representative companies, for a look-back period commensurate with the expected term of the stock options, as the Company has limited trading history of common stock.</span></div><div style="margin-bottom:8pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company recognizes forfeitures related to stock-based compensation awards as they occur.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies stock-based compensation expense in the consolidated statement of operations and comprehensive loss in the same way the award recipients&#8217; payroll costs are classified or in which the award recipients&#8217; service payments are classified.</span></div></ix:continuation><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxPolicyTextBlock" id="f-319" escape="true"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes in accordance with ASC 740,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;(&#8220;ASC 740&#8221;). ASC 740 requires the use of the asset and liability method of accounting for income taxes. The current or deferred tax consequences of a transaction are measured by applying the provisions of enacted tax laws to determine the amount of taxes payable currently or in future&#160;years. Deferred tax assets and liabilities are determined based on the difference between the consolidated financial statements and tax basis of assets and liabilities and expected future tax consequences of events that have been included in the consolidated financial statements or tax returns using enacted tax rates in effect for the year in which the differences are expected to reverse. Under this method, a valuation allowance is used to offset deferred tax assets if, based upon the available evidence, it is more likely than not that some or all of the deferred tax assets may not be realized. Management evaluates the recoverability of deferred taxes and the adequacy of the valuation allowance at each reporting period (see Note 12,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows the provisions of ASC 740 relative to accounting for uncertain tax positions. These provisions provide guidance on the recognition, de-recognition and measurement of potential tax benefits associated with tax positions. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company had no reserves related to uncertain tax positions as of December&#160;31, 2024 and 2023. As applicable, the Company recognizes accrued penalties and interest related to unrecognized tax benefits in the provision for income taxes. As of December&#160;31, 2024 and 2023, the Company did not accrue any potential interest or penalties.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to file federal and state income tax returns in the U.S. and foreign income tax returns in Australia. The preparation of tax returns requires the Company to interpret the applicable tax laws and regulations in effect in such jurisdictions, which could affect the amount of tax paid by the Company.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s income tax returns are based on calculations and assumptions that are subject to examination by the Internal Revenue Service and other tax authorities for the tax years ended December 31, 2020 through December 31, 2024. In addition, the calculation of the Company&#8217;s tax liabilities involves dealing with uncertainties in the application of complex tax regulations.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" id="f-320" escape="true"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Classification of Convertible Preferred Stock</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s convertible preferred stock was classified as temporary equity in the accompanying consolidated balance sheet as of December&#160;31, 2023 and was excluded from stockholders&#8217; equity (deficit) as the potential redemption of such stock was outside the Company&#8217;s control. The convertible preferred stock was not redeemable except for in the event of a liquidation, dissolution or winding up of the Company. The Company did not accrete the carrying values of the preferred stock to the redemption values since the occurrence of these events was not considered probable.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><ix:continuation id="f-279-7" continuedAt="f-279-8"><ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerSharePolicyTextBlock" id="f-321" escape="true"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Loss Per Share Attributable to Common Stockholders</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined all of its convertible preferred stock qualified as participating securities, as defined in ASC 260,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;(&#8220;ASC 260&#8221;). Under ASC 260, securities are considered participating securities if the securities may participate in undistributed earnings with common stock, whether that participation is conditioned upon the occurrence of a specified event or not. In accordance with ASC 260, a company is required to use the two-class method when computing net income (loss) per share when a company has securities that qualify as participating securities. The two-class method is an earnings allocation formula that determines net income (loss) per share for each class of common stock and participating security according to dividends declared (or accumulated) and participation rights in undistributed earnings. Diluted net loss per share for the Company&#8217;s common stock is computed using the more dilutive of the two-class method or the if-converted method.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period. Diluted net loss attributable to common stockholders is computed by adjusting net loss per share attributable to common stockholders to reallocate undistributed earnings based on the potential impact of dilutive securities. Diluted net loss per share attributable to common stockholders is computed by dividing the diluted net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period, including potential dilutive common shares. For purpose of this calculation, outstanding options to purchase common stock, unvested restricted stock awards, and shares of convertible preferred stock are considered potential dilutive common shares. The Company has generated a net loss in all periods presented, and therefore the basic and diluted net loss per share attributable to common stockholders are the same as the inclusion of the potentially dilutive securities would be anti-dilutive.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="camp:EmergingGrowthCompanyStatusPolicyTextBlock" id="f-322" escape="true"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Emerging Growth Company Status</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is an emerging growth company (&#8220;EGC&#8221;) as defined in the Jumpstart Our Business Startups Act of 2012, as amended (the &#8220;JOBS Act&#8221;), and may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not an EGC. The Company may take advantage of these exemptions until it is no longer an EGC under Section&#160;107 of the JOBS Act and has elected to use the extended transition period for complying with new or revised accounting standards. As a result of this election, the Company&#8217;s consolidated financial statements may not be comparable to companies that comply with public company FASB standards&#8217; effective dates.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-323" continuedAt="f-323-1" escape="true"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2023, FASB issued ASU 2023-07, &#8220;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.&#8221; The standard expands reportable segment disclosure requirements for public business entities primarily through enhanced disclosures about significant segment expenses that are regularly provided to the chief operating decision maker (&#8220;CODM&#8221;) and included within each reported measure of segment profit (referred to as the &#8220;significant expense principle&#8221;). The Company has adopted this standard for the fiscal year 2024 annual financial statements and has applied this standard retrospectively for all prior periods presented in the financial statements (see Note 13).</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Standards</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting standards not listed below were assessed and determined not to be applicable or are expected to have minimal impact on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, Income Taxes (&#8220;Topic 740&#8221;):&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Improvements to Income Tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The guidance includes the requirement that public business entities, on an annual basis, disclose specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold (if the effect of those reconciling items is equal to or greater than 5% of the amount computed by multiplying pretax income (or loss) by the applicable statutory income tax rate). It also requires that all entities disclose, on an annual basis, the amount of income taxes paid (net of refunds received) disaggregated by federal (national), state, and foreign taxes and the amount of income taxes paid (net of refunds received) disaggregated by individual jurisdictions in which income taxes paid (net of refunds received) is equal to or greater than 5% of total income taxes paid (net of refunds received) and requires that all entities disclose income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign and income tax expense (or benefit) from continuing operations disaggregated by federal (national), state, and foreign. Lastly, the guidance eliminates the requirement for all entities to disclose the nature and estimate of the range of the reasonably possible change in the unrecognized tax benefits balance in the next 12 months or make a statement that an estimate of the range cannot be made. For public business entities, the guidance is effective for annual periods beginning after December&#160;15, 2024. Early adoption is permitted for annual </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><ix:continuation id="f-323-1"><ix:continuation id="f-279-8"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated financial statements that have not yet been issued or made available for issuance. The guidance should be applied on a prospective basis. Retrospective application is permitted. The Company is currently evaluating the impact that this guidance may have on its consolidated financial statements.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2024, the FASB issued ASU 2024-03, &#8220;Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses.&#8221; The standard requires that public business entities disclose additional information about specific expense categories in the notes to financial statements for interim and annual reporting periods. For public business entities, the guidance is effective for interim and annual periods beginning after December&#160;15, 2026. Early adoption is permitted for annual consolidated financial statements that have not yet been issued or made available for issuance. The guidance may be applied on a prospective basis or retrospectively for all prior periods presented in the financial statements. The Company is currently evaluating the impact that this guidance may have on its consolidated financial statements.</span></div></ix:continuation></ix:continuation><div style="margin-bottom:8pt"><span><br/></span></div><div id="i8049b05497804bd28b68608a093bd853_106"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-324" continuedAt="f-324-1" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="f-324-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="f-325" escape="true"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the financial instruments carried at fair value on a recurring basis as of December&#160;31, 2024 and 2023 (in thousands):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-326">60,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-327">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-328">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-329">60,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents</span></td><td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-330">37,074</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-331">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-332">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-333">37,074</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts reflected in the consolidated balance sheet for prepaid expenses and other current assets, accounts payable and accrued expenses and other liabilities are shown at their historical values which approximate their fair values.</span></div></ix:continuation><div id="i8049b05497804bd28b68608a093bd853_109"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="camp:PrepaidExpensesAndOtherCurrentAssetsDisclosureTextBlock" id="f-334" continuedAt="f-334-1" escape="true">Prepaid Expenses and Other Current Assets</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="camp:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" id="f-335" escape="true"><ix:continuation id="f-334-1"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consisted of the following as of December&#160;31, 2024 and 2023 (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="camp:PrepaidResearchAndDevelopmentExpenseCurrent" scale="3" id="f-336">979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="camp:PrepaidResearchAndDevelopmentExpenseCurrent" scale="3" id="f-337">480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insurance expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidInsurance" scale="3" id="f-338">591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PrepaidInsurance" scale="3" id="f-339">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Software and subscriptions expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="camp:PrepaidSoftwareAndSubscriptionExpenseCurrent" scale="3" id="f-340">337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="camp:PrepaidSoftwareAndSubscriptionExpenseCurrent" scale="3" id="f-341">287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Variable lease expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="camp:PrepaidVariableLeaseExpenseCurrent" scale="3" id="f-342">118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="camp:PrepaidVariableLeaseExpenseCurrent" scale="3" id="f-343">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal R&amp;D tax credit receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="camp:PrepaidFederalResearchAndDevelopmentTaxCreditCurrent" scale="3" id="f-344">108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="camp:PrepaidFederalResearchAndDevelopmentTaxCreditCurrent" scale="3" id="f-345">442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAssetsCurrent" scale="3" id="f-346">211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherAssetsCurrent" scale="3" id="f-347">245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-348">2,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-349">1,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div id="i8049b05497804bd28b68608a093bd853_112"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="f-350" continuedAt="f-350-1" escape="true">Property and Equipment, Net</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-351" continuedAt="f-351-1" escape="true"><ix:continuation id="f-350-1" continuedAt="f-350-2"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following as of December&#160;31, 2024 and 2023 (in thousands):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-352">4,518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-353">4,518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laboratory equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-354">4,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-355">3,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Computer and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-356">969</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-357">938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-358">524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-359">524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">135</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><ix:continuation id="f-350-2"><ix:continuation id="f-351-1"><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total property and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-360">10,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-361">9,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-362">6,231</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-363">4,505</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-364">3,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-365">4,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2024, title of a finance lease ROU asset for laboratory equipment with cost totaling $<ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="f-366">0.3</ix:nonFraction> million transferred to the Company. The laboratory equipment had accumulated depreciation of $<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization" scale="6" id="f-367">0.2</ix:nonFraction> million. The Company incurred depreciation and amortization expense of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="f-368">1.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="f-369">1.6</ix:nonFraction> million for the&#160;years ended December&#160;31, 2024 and 2023, respectively. Depreciation and amortization expense for the&#160;years ended December&#160;31, 2024 and 2023 includes $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="f-370">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="f-371">0.1</ix:nonFraction> million of finance lease ROU asset amortization, respectively (see Note 7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:continuation><div id="i8049b05497804bd28b68608a093bd853_115"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" id="f-372" escape="true"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. &#160;&#160;&#160;&#160;Accrued Expenses and Other Current Liabilities</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="f-373" escape="true"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities consisted of the following as of December&#160;31, 2024 and 2023 (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee compensation and benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-374">3,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-375">1,937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="camp:ProfessionalFeesAndOtherGeneralAndAdministrativeExpensesCurrent" scale="3" id="f-376">661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="camp:ProfessionalFeesAndOtherGeneralAndAdministrativeExpensesCurrent" scale="3" id="f-377">475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">External R&amp;D expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="camp:ResearchAndDevelopmentExpensesCurrent" scale="3" id="f-378">524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="camp:ResearchAndDevelopmentExpensesCurrent" scale="3" id="f-379">601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="f-380">537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="f-381">289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-382">4,833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-383">3,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:nonNumeric><div id="i8049b05497804bd28b68608a093bd853_118"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-384" continuedAt="f-384-1" escape="true"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. &#160;&#160;&#160;&#160;Commitments and Contingencies</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company currently leases approximately <ix:nonFraction unitRef="sqft" contextRef="c-50" decimals="-4" name="us-gaap:AreaOfLand" format="ixt:num-dot-decimal" scale="0" id="f-385">30,000</ix:nonFraction> square feet of office space and laboratory space in Cambridge, Massachusetts (the &#8220;Cambridge Lease&#8221;) and approximately <ix:nonFraction unitRef="sqft" contextRef="c-51" decimals="-2" name="us-gaap:AreaOfLand" format="ixt:num-dot-decimal" scale="0" id="f-386">5,300</ix:nonFraction> square feet of office and lab space in Boulder, Colorado (the &#8220;Boulder Lease&#8221;). The Cambridge Lease expires on June&#160;30, 2027. The Cambridge Lease provided a lease incentive in the form of reimbursable leasehold improvements of up to $<ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-5" name="camp:MaximumReimbursableIncentiveFromLessor" scale="6" id="f-387">3.6</ix:nonFraction> million. As of December&#160;31, 2024 and 2023, the Company had capitalized $<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-388"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-389">4.5</ix:nonFraction></ix:nonFraction> million of leasehold improvement costs under this lease. $<ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-5" name="us-gaap:IncentiveFromLessor" scale="6" id="f-390">3.6</ix:nonFraction> million was reimbursed through the lease incentive of which the final $<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-5" name="us-gaap:IncentiveFromLessor" scale="6" id="f-391">2.7</ix:nonFraction> million was received during the&#160;year ended December&#160;31, 2023. Amounts received for lease incentives were included in the changes in operating lease assets and liabilities line in the consolidated statement of cash flows. As of December&#160;31, 2024, the Cambridge Lease accounted for $<ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-392">4.9</ix:nonFraction> million of operating lease ROU assets, $<ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-393">2.7</ix:nonFraction> million of current operating lease liabilities and $<ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-394">4.6</ix:nonFraction> million of non-current operating lease liabilities.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Boulder Lease is a <ix:nonNumeric contextRef="c-53" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="f-395">five-year</ix:nonNumeric> lease that commenced on September&#160;1, 2023 and expires on September&#160;30, 2028. As the rate implicit for the Boulder Lease was not readily determinable, the Company used its incremental borrowing rate of <ix:nonFraction unitRef="number" contextRef="c-53" decimals="4" name="camp:LesseeOperatingLeaseIncrementalBorrowingRate" scale="-2" id="f-396">7.12</ix:nonFraction>% as of the commencement date. At commencement of the Boulder Lease, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-397">1.4</ix:nonFraction> million of operating ROU assets, $<ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-398">0.2</ix:nonFraction> million of current operating lease liabilities and $<ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-399">1.2</ix:nonFraction> million of non-current operating lease liabilities. As of December&#160;31, 2024, the Boulder Lease accounted for $<ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-400">1.1</ix:nonFraction> million of operating lease ROU assets, $<ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-401">0.3</ix:nonFraction> million of current operating lease liabilities and $<ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-402">0.9</ix:nonFraction> million of non-current operating lease liabilities.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LeaseCostTableTextBlock" id="f-403" continuedAt="f-403-1" escape="true"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the Company&#8217;s operating lease costs for the&#160;years ended December&#160;31, 2024 and 2023 (in thousands except for lease terms and borrowing rates):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease cost</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-404">2,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-405">2,489</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="f-406">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="f-407">119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Variable lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-408">1,362</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-409">1,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="camp:LeaseCostExcludingFinanceLeases" format="ixt:num-dot-decimal" scale="3" id="f-410">3,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="camp:LeaseCostExcludingFinanceLeases" format="ixt:num-dot-decimal" scale="3" id="f-411">3,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other information</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.64pt;text-align:left;text-indent:-8.64pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows used for operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-412">3,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingLeasePayments" scale="3" id="f-413">601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><ix:continuation id="f-384-1" continuedAt="f-384-2"><ix:continuation id="f-403-1" continuedAt="f-403-2"><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining lease term in years</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-4" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-414">2.7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-5" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-415">3.7</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average incremental borrowing rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-4" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-416">6.72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-417">6.72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-418" escape="true"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of operating lease liabilities as of December&#160;31, 2024 were as follows (in thousands):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-419">3,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-420">3,558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="f-421">1,980</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="f-422">263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="f-423">9,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: amount representing imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="f-424">769</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total future minimum lease obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-425">8,487</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance Leases</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases certain specialized lab equipment under several finance lease agreements with maturities ranging from April 2025 to November 2028. As of December&#160;31, 2024, these finance leases account for $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="f-426">0.4</ix:nonFraction> million of finance lease ROU assets, $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="f-427">0.1</ix:nonFraction> million of current finance lease liabilities and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="f-428">0.1</ix:nonFraction> million of non-current finance lease liabilities.</span></div><ix:continuation id="f-403-2"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the Company&#8217;s finance lease costs for the&#160;years ended December&#160;31, 2024 and 2023 (in thousands except for lease terms and borrowing rates):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.454%"><tr><td style="width:1.0%"/><td style="width:51.757%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.153%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.434%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.434%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance lease cost</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of ROU assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="f-429">189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="f-430">146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest on lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="f-431">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="f-432">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total finance lease cost</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="camp:LeaseCostFinanceLeases" scale="3" id="f-433">215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="camp:LeaseCostFinanceLeases" scale="3" id="f-434">179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other information</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;text-indent:-10.8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows used for finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="f-435">364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="f-436">322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining lease term in years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-4" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-437">2.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-5" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-438">1.8</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average incremental borrowing rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-4" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-439">8.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-440">8.14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="f-441" escape="true"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of finance lease liabilities as of December&#160;31, 2024 were as follows (in thousands):</span></div><div style="margin-bottom:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="f-442">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="3" id="f-443">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="3" id="f-444">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="3" id="f-445">173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: amount representing imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="3" id="f-446">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total future minimum lease obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiability" scale="3" id="f-447">161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financing Obligation</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2023, the Company (seller-lessee) sold certain laboratory equipment to an unrelated third-party (buyer-lessor) and simultaneously entered into a <ix:nonNumeric contextRef="c-1" name="camp:FinancingObligationsLeaseTermOfContract" format="ixt-sec:durmonth" id="f-448">26</ix:nonNumeric>-month lease agreement for the laboratory equipment with the buyer-lessor through June 2025. The lease requires monthly payments of less than $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="camp:FinancingObligationsLeaseMaximumMonthlyRentalPayments" scale="6" id="f-449">0.1</ix:nonFraction> million and provides a fixed price repurchase option at the end of the lease term of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="camp:FinancingObligationsLeaseFixedRepurchasePrice" scale="6" id="f-450">0.1</ix:nonFraction> million.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The repurchase option precludes accounting for the transfer of the asset to the buyer-lessor as a sale under ASC 842 since the exercise price of the repurchase option is fixed and, therefore, is not the fair value of the asset on the exercise date of the option. Thus, the agreement is considered a financing transaction (i.e., failed sale-leaseback) as the Company is reasonably certain to exercise the repurchase option at the end of the lease. The net proceeds received amounted to $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="camp:ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction" scale="6" id="f-451">0.7</ix:nonFraction> million, which is recorded as a financing liability in the Company&#8217;s consolidated balance sheet. The Company imputes </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">137</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><ix:continuation id="f-384-2"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-1" decimals="4" name="camp:FinancingObligationsLeaseMonthlyInterestRatePercent" scale="-2" id="f-452">0.86</ix:nonFraction>% monthly. For each of the years ended December&#160;31, 2024 and 2023, the Company recorded less than $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="camp:FinancingObligationsLeaseMaximumInterestExpense" scale="6" id="f-453"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="camp:FinancingObligationsLeaseMaximumInterestExpense" scale="6" id="f-454">0.1</ix:nonFraction></ix:nonFraction> million of interest expense related to this financing transaction in other expense in the consolidated statement of operations and comprehensive loss.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A liability for loss contingencies arising from claims, assessments, litigation, fines, penalties and other sources is recorded in the consolidated financial statements if it is determined that it is probable that a loss has been incurred and the amount (or range) of the loss can be reasonably estimated. There are no matters currently outstanding for which any liabilities have been accrued or require disclosure.</span></div></ix:continuation><div id="i8049b05497804bd28b68608a093bd853_121"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="f-455" continuedAt="f-455-1" escape="true"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. &#160;&#160;&#160;&#160;Collaboration and License Agreements</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">In-License Agreements</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Children&#8217;s Medical Center Corporation</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2018, the Company entered into a development and license agreement (the &#8220;CMCC Agreement&#8221;) with Children&#8217;s Medical Center Corporation (&#8220;CMCC&#8221;). The CMCC Agreement allows the Company to use CMCC&#8217;s proprietary intellectual property to conduct research, development and commercialization of products utilizing CMCC&#8217;s proprietary intellectual property in return for specified payments. The proprietary intellectual property licensed pursuant to this agreement is related to certain legacy programs the Company is not pursuing which were subsequently sublicensed to Fulcrum Therapeutics, Inc. (&#8220;Fulcrum&#8221;), as described below. As part of the CMCC Agreement, the Company issued a total of <ix:nonFraction unitRef="shares" contextRef="c-54" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-456">15,123</ix:nonFraction> shares of common stock to CMCC and its affiliates based on the fair value of the common stock on the date of issuance.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is obligated to pay potential development milestone payments under the terms of the CMCC Agreement of up to $<ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-5" name="camp:CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation" scale="6" id="f-457">7.7</ix:nonFraction> million for the first licensed target, $<ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-5" name="camp:CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation" scale="6" id="f-458">3.9</ix:nonFraction> million for the second licensed target and $<ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-5" name="camp:CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation" scale="6" id="f-459">1.9</ix:nonFraction> million for the third licensed target upon the achievement of certain specified contingent events. If commercial sales of a licensed product commence, the Company will pay CMCC royalties at&#160;percentage rates ranging in the low- to mid-single digits on net sales of licensed products in countries where such product is protected by patent rights. The Company incurred de minimis royalties owed to CMCC for each of the years ended December&#160;31, 2024 and 2023 under the CMCC Agreement and recorded the amounts in R&amp;D expense in the consolidated statement of operations and comprehensive loss. Further, under the terms of the CMCC Agreement, the Company is required to pay ten percent of any upfront payment received under a sublicensing agreement entered into prior to the initiation of the first investigational new drug study. As such, the Company recorded de minimis amounts for each of the years ended December&#160;31, 2024 and 2023, which is presented in R&amp;D expenses on the consolidated statements of operations and comprehensive loss. The Company re-evaluates the likelihood of achieving future milestones at the end of each reporting period. As of December&#160;31, 2024, the Company determined that the likelihood of achieving future milestones was not probable.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Whitehead Institute for Biomedical Research</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2019, the Company entered into a patent license agreement (as subsequently amended, the &#8220;Whitehead Agreement&#8221;), with the Whitehead Institute for Biomedical Research, (&#8220;Whitehead&#8221;). Under the Whitehead Agreement, the Company was granted a worldwide, royalty-bearing, sublicensable license under certain patent rights owned or controlled by Whitehead. Upon entering into the Whitehead Agreement, the Company paid an initial $<ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-5" name="camp:CollaborativeArrangementUpfrontLicenseIssuanceFeePayment" scale="6" id="f-460">0.1</ix:nonFraction> million license issuance fee, and paid de minimis additional fees in connection with subsequent amendments to the Whitehead Agreement. The Company is obligated to pay annual license maintenance fees for the term of the Whitehead Agreement. In addition, the Company is obligated to pay certain filing, prosecution and maintenance fees with respect to certain patent rights licensed. </span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also obligated to pay potential development milestone payments to Whitehead of up to $<ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-5" name="camp:CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation" scale="6" id="f-461">1.9</ix:nonFraction> million upon the achievement of certain specified contingent events. In addition, if the Company successfully commercializes a product under the Whitehead Agreement, it is obligated to pay tiered royalties at percentage rates ranging from less than one percent to the mid-single digits of net sales or of running royalties of net sales, subject to specified reductions, until either the last-to-expire valid claim of a Whitehead patent covering the product or <ix:nonNumeric contextRef="c-60" name="camp:CollaborativeArrangementTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale" format="ixt-sec:durwordsen" id="f-462">seven years</ix:nonNumeric> after the first commercial sale, in each case on a product-by-product and country-by-country basis. </span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred fees of $<ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-5" name="camp:CollaborativeArrangementFeesIncurredDuringPeriod" scale="6" id="f-463">0.3</ix:nonFraction> million under the Whitehead Agreement during the year ended December&#160;31, 2024. During the year ended December&#160;31, 2023, the fees were de minimis. These fees are recorded in R&amp;D expense in the Company&#8217;s consolidated statement of operations and comprehensive loss.</span></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">138</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><ix:continuation id="f-455-1" continuedAt="f-455-2"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Out-license&#160;Agreement</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fulcrum Therapeutics, Inc.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2023, the Company entered into a license agreement (the &#8220;Fulcrum Agreement&#8221;) with Fulcrum. Under the Fulcrum Agreement, the Company granted an exclusive license related to the Company&#8217;s intellectual property (&#8220;IP&#8221;) and granted a non-exclusive sublicense for IP obtained through the CMCC Agreement. In exchange for the license rights, Fulcrum paid the Company a $<ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="f-464">0.4</ix:nonFraction> million upfront payment. In the event that Fulcrum achieves certain development and commercial milestones, Fulcrum will be obligated to pay the Company one-time milestone payments ranging from $<ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-5" name="camp:RevenueRemainingPerformanceObligationVariableConsiderationAmount" scale="6" id="f-465">0.6</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-5" name="camp:RevenueRemainingPerformanceObligationVariableConsiderationAmount" scale="6" id="f-466">20.0</ix:nonFraction> million depending on the product and milestone achieved. In addition, under the Fulcrum Agreement there are potential de minimis minimum annual royalty payments as well as sales-based royalties of up to the low-double digits upon commercialization.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed this arrangement in accordance with ASC 606 and concluded that the contract counterparty, Fulcrum, is a customer. In accordance with ASC 606, the Company determined that there is <ix:nonFraction unitRef="performanceobligation" contextRef="c-64" decimals="INF" name="camp:RevenuePerformanceObligationNumberOfPerformanceObligations" format="ixt-sec:numwordsen" scale="0" id="f-467">one</ix:nonFraction> performance obligation in the Fulcrum Agreement, consisting of the exclusive and non-exclusive license rights granted to Fulcrum. The transaction price was comprised of the fixed consideration of $<ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-5" name="camp:RevenueRemainingPerformanceObligationFixedConsiderationAmount" scale="6" id="f-468">0.4</ix:nonFraction> million and was recognized upon transfer of control of the licenses at a point in time upon contract execution. The arrangement includes significant variable consideration primarily in the form of milestone payments, which is fully constrained at the inception of the contract. All variable consideration is remeasured and reassessed each reporting period. As of and for the years ended December&#160;31, 2024 and 2023, the Company determined the variable consideration was fully constrained.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sales-based royalty fee is considered variable consideration and will be recognized as revenue as such sales occur. The sales-based royalty fee qualifies for the royalty constraint exception and does not require an estimate of the future transaction price.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-469">0.4</ix:nonFraction> million in license revenue pursuant to the Fulcrum Agreement and <ix:nonFraction unitRef="usd" contextRef="c-66" decimals="INF" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-470">none</ix:nonFraction> in the year ended December&#160;31, 2024.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Collaborative&#160;Arrangement</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Eli Lilly and Company</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2023, the Company executed a Material Transfer Agreement (as amended, the &#8220;MTA&#8221;) with Eli Lilly and Company (&#8220;Eli Lilly&#8221;). As part of the MTA, the Company and Eli Lilly agreed to perform R&amp;D activities to generate up to three antisense oligonucleotides (&#8220;ASOs&#8221;) in accordance with a prescribed workplan. The Company evaluated the MTA under ASC 808 and concluded that it is a collaboration arrangement. The Company and Eli Lilly are jointly overseeing the R&amp;D activities under the MTA. In addition, both parties are exposed to significant risks and potential rewards under the MTA. During each of the years ended December&#160;31, 2024 and 2023, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-5" name="camp:CollaborativeArrangementReductionInResearchAndDevelopmentExpense" scale="6" id="f-471"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-5" name="camp:CollaborativeArrangementReductionInResearchAndDevelopmentExpense" scale="6" id="f-472">0.5</ix:nonFraction></ix:nonFraction> million as a reduction in R&amp;D expense in the consolidated statement of operations and comprehensive loss as a result of the earned R&amp;D reimbursement from Eli Lilly. Additionally, the Company had an unbilled receivable of $<ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-5" name="us-gaap:UnbilledContractsReceivable" scale="6" id="f-473">0.1</ix:nonFraction> million recorded within prepaid expenses and other current assets on the consolidated balance sheet as of December&#160;31, 2023 and a de minimis deferred liability as of December&#160;31, 2024.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Collaboration&#160;Arrangement</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BioMarin Pharmaceutical Inc.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2024, the Company entered into a Collaboration and License Agreement (the &#8220;BioMarin Agreement&#8221;) with BioMarin Pharmaceutical Inc. (&#8220;BioMarin&#8221;). Under the terms of the BioMarin Agreement, BioMarin paid the Company an upfront, nonrefundable payment of $<ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="f-474">1.0</ix:nonFraction> million, and will reimburse the Company for certain research activities. On a per-program basis, the Company will be eligible to receive up to $<ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-5" name="camp:RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentPreclinicalMilestones" scale="6" id="f-475">5.0</ix:nonFraction> million in future contingent preclinical milestones, up to $<ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-5" name="camp:RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentDevelopmentAndRegulatoryMilestones" scale="6" id="f-476">75.0</ix:nonFraction> million in future contingent development and regulatory milestones and up to $<ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-5" name="camp:RevenueRemainingPerformanceObligationVariableConsiderationAmountCommercialSalesMilestones" scale="6" id="f-477">105.0</ix:nonFraction> million in commercial sales milestones. The Company will be further eligible to receive tiered royalties at percentage rates ranging from low to high single digits of net sales, subject to specified reductions, until either the last-to-expire valid claim of a patent covering the product, <ix:nonNumeric contextRef="c-72" name="camp:RevenueRemainingPerformanceObligationTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale" format="ixt-sec:durwordsen" id="f-478">ten years</ix:nonNumeric> after the first commercial sale, or the expiration of any applicable regulatory exclusivity obtained for the product, in each case on a product-by-product and country-by-country basis. The agreement may be terminated in its entirety or on a program-by-program basis for convenience by BioMarin. The agreement may also be terminated by either the Company or BioMarin under certain other circumstances, including material breach, as set forth in the agreement. The notice periods for termination provisions range from <ix:nonNumeric contextRef="c-73" name="camp:RevenueRemainingPerformanceObligationNoticePeriodForTermination" format="ixt-sec:durday" id="f-479">30</ix:nonNumeric> days to <ix:nonNumeric contextRef="c-74" name="camp:RevenueRemainingPerformanceObligationNoticePeriodForTermination" format="ixt-sec:durday" id="f-480">270</ix:nonNumeric> days depending on the reason for termination. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">139</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><ix:continuation id="f-455-2"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed this arrangement in accordance with ASC 606 and concluded that BioMarin is a customer and there is one performance obligation, which includes performance of R&amp;D activities in accordance with a contractual work plan, participation in a joint steering committee, the grant of an exclusive license to BioMarin, the grant of a non-exclusive license to the data resulting from performance of the R&amp;D activities, and providing quarterly progress reports. The transaction price was determined to be fixed consideration of $<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="camp:RevenueRemainingPerformanceObligationFixedConsiderationAmount" scale="6" id="f-481">3.8</ix:nonFraction> million, comprised of $<ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="f-482">1.0</ix:nonFraction> million upfront consideration and expected $<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="camp:RevenueRemainingPerformanceObligationExpectedReimbursableResearchAndDevelopmentExpenses" scale="6" id="f-483">2.8</ix:nonFraction> million reimbursable R&amp;D expenses, and will be recognized over time based upon a cost-to-cost method. Any deferred revenue recorded will be classified as short-term. The Company believes this work will be completed within 12 months of contract execution and thus, the related revenue will be recognized over that period. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The arrangement includes significant variable consideration primarily in the form of milestone payments, which is fully constrained at the inception of the contract. All variable consideration is remeasured and reassessed each reporting period. As of and for the year ended December&#160;31, 2024, the Company determined the variable consideration was fully constrained.</span></div><div style="margin-bottom:11pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2024, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-484">0.7</ix:nonFraction> million in collaboration revenue under the BioMarin Agreement. Additionally, the Company had deferred revenue of $<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="f-485">0.3</ix:nonFraction> million recorded on the consolidated balance sheet as of December&#160;31, 2024.</span></div></ix:continuation><div id="i8049b05497804bd28b68608a093bd853_124"></div><ix:nonNumeric contextRef="c-1" name="camp:TemporaryEquityDisclosureAndStockholdersEquityTextBlock" id="f-491" escape="true"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. &#160;&#160;&#160;&#160;Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit)</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Convertible Preferred Stock </span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the closing of the IPO, all of the currently outstanding convertible preferred stock automatically converted into <ix:nonFraction unitRef="shares" contextRef="c-30" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="f-492">11,648,582</ix:nonFraction> shares of common stock. <ix:nonNumeric contextRef="c-1" name="us-gaap:TemporaryEquityTableTextBlock" id="f-493" continuedAt="f-493-1" escape="true">As of December&#160;31, 2023, the Company&#8217;s convertible preferred stock consisted of the following (in thousands, except share amounts):</ix:nonNumeric></span></div><ix:continuation id="f-493-1"><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Authorized<br/>shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shares<br/>issued and<br/>outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidation<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common stock<br/>issuable<br/>upon<br/>conversion</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Series&#160;A Prime</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-82" decimals="INF" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-494">68,173,692</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-82" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-495"><ix:nonFraction unitRef="shares" contextRef="c-82" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-496">62,389,791</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="3" name="us-gaap:TemporaryEquityLiquidationPreference" format="ixt:num-dot-decimal" scale="3" id="f-497">62,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-82" decimals="INF" name="us-gaap:PreferredStockConvertibleSharesIssuable" format="ixt:num-dot-decimal" scale="0" id="f-498">5,562,653</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Series&#160;B</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-83" decimals="INF" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-499">81,499,592</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-83" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-500"><ix:nonFraction unitRef="shares" contextRef="c-83" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-501">68,258,635</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="3" name="us-gaap:TemporaryEquityLiquidationPreference" format="ixt:num-dot-decimal" scale="3" id="f-502">100,504</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-83" decimals="INF" name="us-gaap:PreferredStockConvertibleSharesIssuable" format="ixt:num-dot-decimal" scale="0" id="f-503">6,085,929</ix:nonFraction></span></td></tr></table></div></ix:continuation><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common and Preferred Stock</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s amended and restated certificate of incorporation authorizes the issuance of up to <ix:nonFraction unitRef="shares" contextRef="c-31" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-504">175,000,000</ix:nonFraction> shares of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-31" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-505">0.0001</ix:nonFraction> par value common stock and up to <ix:nonFraction unitRef="shares" contextRef="c-31" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-506">25,000,000</ix:nonFraction> shares of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-31" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-507">0.0001</ix:nonFraction> par value undesignated preferred stock. The Board may designate the rights, preferences, privileges and restrictions of the preferred stock, including dividend rights, conversion rights, voting rights, terms of redemption, liquidation preference, and number of shares constituting any series or the designation of any series. The issuance of preferred stock could have the effect of restricting dividends on the Company&#8217;s common stock, diluting the voting power of the Company&#8217;s common stock, impairing the liquidation rights of the Company&#8217;s common stock, or delaying or preventing a change in control. As of December&#160;31, 2024, <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="f-508">no</ix:nonFraction> shares of preferred stock were outstanding.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Each share of common stock entitles the holder to <ix:nonFraction unitRef="vote" contextRef="c-4" decimals="INF" name="camp:NumberOfVotesPerCommonShare" format="ixt-sec:numwordsen" scale="0" id="f-509">one</ix:nonFraction> vote, together with the holders of any preferred stock, on all matters submitted to the stockholders for a vote. Common stockholders are also entitled to receive dividends. As of December&#160;31, 2024, <ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" format="ixt:fixed-zero" scale="0" id="f-510"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="INF" name="us-gaap:PreferredStockDividendsPerShareDeclared" format="ixt:fixed-zero" scale="0" id="f-511">no</ix:nonFraction></ix:nonFraction> cash dividends have been declared or paid. </span></div><div style="margin-bottom:8pt;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfConversionsOfStockTextBlock" id="f-512" escape="true"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the Company has reserved the following shares of common stock for future issuance:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares reserved for future issuance under the 2024 Equity Incentive Plan and ESPP </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-84" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-513">2,293,348</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-514">2,119,425</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock vesting</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-515">15,943</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Warrant outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="f-516">142</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-517">4,428,858</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">140</span></div></div></div><div id="i8049b05497804bd28b68608a093bd853_127"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-518" continuedAt="f-518-1" escape="true"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. &#160;&#160;&#160;&#160;Stock-Based Compensation</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024 Equity Incentive Plan</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2024, the Company adopted the 2024 Equity Incentive Plan (the &#8220;2024 Plan&#8221;), which became effective in connection with the Company&#8217;s IPO. The 2024 Plan provides for the grant of stock options, stock appreciation rights, restricted and unrestricted stock awards, restricted stock unit awards, and other stock-based awards to employees, directors, and non-employee service providers of the Company. </span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards granted under the 2024 Plan expire no later than <ix:nonNumeric contextRef="c-85" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="f-519">ten years</ix:nonNumeric> from the date of grant. The price of stock options shall not be less than <ix:nonFraction unitRef="number" contextRef="c-86" decimals="INF" name="camp:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfEstimatedFairValueOnGrantDate" scale="-2" id="f-520">100</ix:nonFraction>% of the estimated fair value on the date of grant and typically vest over a <ix:nonNumeric contextRef="c-87" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-521">four-year</ix:nonNumeric> period, although awards may be granted with different vesting terms. The 2024 Plan initially reserved <ix:nonFraction unitRef="shares" contextRef="c-88" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-522">2,143,039</ix:nonFraction> shares of common stock for the issuance of future awards and provides for an automatic annual increase in the number of shares of common stock reserved for future issuance by the lesser of (i) <ix:nonFraction unitRef="number" contextRef="c-87" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" scale="-2" id="f-523">5</ix:nonFraction>% of the number of shares of the Company&#8217;s common stock outstanding as of the close of business on the immediately preceding December 31 and (ii) the number of shares determined by the Company&#8217;s Board of Directors on or prior to such date for such year. As of December&#160;31, 2024, there were <ix:nonFraction unitRef="shares" contextRef="c-89" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-524">2,079,045</ix:nonFraction> shares of common stock reserved and available for issuance pursuant to the 2024 Plan.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024 Employee Stock Purchase Plan</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2024, the Company adopted the 2024 Employee Stock Purchase Plan (the &#8220;2024 ESPP&#8221;), which became effective in connection with the Company&#8217;s IPO. The 2024 ESPP initially reserved <ix:nonFraction unitRef="shares" contextRef="c-90" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-525">214,303</ix:nonFraction> shares of common stock for the issuance of future awards and provides for an automatic annual increase in the number of shares of common stock reserved for future issuance by the lesser of (1) <ix:nonFraction unitRef="number" contextRef="c-91" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" scale="-2" id="f-526">1</ix:nonFraction>% of the number of shares of the Company&#8217;s common stock outstanding as of the close of business on the immediately preceding December 31 and (2) the number of shares determined by the Company&#8217;s Board of Directors on or prior to such date for such year. As of December&#160;31, 2024, there were <ix:nonFraction unitRef="shares" contextRef="c-92" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-527">214,303</ix:nonFraction> shares of common stock reserved and available for issuance pursuant to the 2024 ESPP.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2024 ESPP permits eligible employees to enroll in six-month offering periods. Participants may purchase shares of the Company&#8217;s common stock, through payroll deductions, at a price equal to <ix:nonFraction unitRef="number" contextRef="c-91" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" scale="-2" id="f-528">85</ix:nonFraction>% of the fair market value of the common stock on the first or last day of the applicable offering period, whichever is lower. Purchase dates under the 2024 ESPP occur on or about January 1 and July 1 each year. As of December&#160;31, 2024, there have been no offering periods.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2016 Equity Incentive Plan</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2016, the Company adopted the Marauder Therapeutics, Inc. 2016 Stock Option and Grant Plan (the &#8220;2016 Plan&#8221;) that provided for the grant of stock options, restricted stock units, and other stock-based awards to employees, directors, and non-employee service providers of the Company. The 2016 Plan was suspended in connection with the Company&#8217;s IPO and no further grants will be made. The 2016 Plan continues to govern the terms and conditions of outstanding awards granted under the 2016 Plan.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Option Activity</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the fair value of stock options using the Black-Scholes option pricing model. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="f-529" continuedAt="f-529-1" escape="true">The weighted-average assumptions used to estimate the fair value of the stock options granted during the years ended December&#160;31, 2024 and 2023 were as follows:</ix:nonNumeric></span></div><ix:continuation id="f-529-1"><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-93" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-530">97.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-94" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-531">92.24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free interest rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-93" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" format="ixt:num-dot-decimal" id="f-532">3.98</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-94" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" format="ixt:num-dot-decimal" id="f-533">3.84</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-93" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:num-dot-decimal" id="f-534">0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-94" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:num-dot-decimal" id="f-535">0</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected term (in&#160;years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-93" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-536">5.99</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-94" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-537">5.97</ix:nonNumeric></span></td></tr></table></div></ix:continuation><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average fair value of stock options granted during the&#160;years ended December&#160;31, 2024 and 2023 was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-538">8.09</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-539">6.73</ix:nonFraction> per share, respectively. The total intrinsic value of options exercised during the&#160;years ended December&#160;31, 2024 and 2023 was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="f-540">6.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="f-541">0.2</ix:nonFraction> million, respectively.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issued $<ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-5" name="camp:UnrecordedNotesPayableIssuedForStockOptionEarlyExercise" scale="6" id="f-542">1.0</ix:nonFraction> million of promissory notes to certain executives during the year ended December 31, 2021 in order for them to early exercise stock options. Management concluded the promissory notes are recourse in form but non-recourse in substance as the Company does not intend to seek repayment beyond the shares issued. The promissory notes are therefore treated as an option for accounting purposes and are not recorded on the consolidated balance sheet. </span></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><ix:continuation id="f-518-1"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense is recorded, accordingly. The exercise price used in determining the fair value of the stock options includes the interest earned on the notes and the expected term is <ix:nonNumeric contextRef="c-96" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:durwordsen" id="f-543">five years</ix:nonNumeric>, reflecting the term of the notes. The early exercised shares were not outstanding for accounting purposes before repayment of the notes. During the year ended December&#160;31, 2024, the promissory notes were forgiven, resulting in <ix:nonFraction unitRef="shares" contextRef="c-97" decimals="INF" name="camp:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAfterEarlyExerciseDueToNotesPayableForgiveness" format="ixt:num-dot-decimal" scale="0" id="f-544">491,110</ix:nonFraction> shares of common stock that had been exercised early being treated as outstanding for accounting purposes. These shares are included in the exercised options in the table below.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="f-545" escape="true"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock option activity for the year ended December&#160;31, 2024 (in thousands, except share and per share amounts):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of outstanding options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted<br/>average<br/>exercise<br/>price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted<br/>average<br/>remaining<br/>contractual<br/>term in years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Aggregate intrinsic value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-546">2,273,221</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-547">6.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-548">8.05</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-549">6,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-550">462,206</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-551">10.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited/Cancelled</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-552">102,221</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="f-553">6.43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercises</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-554">513,781</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-555">0.22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-556">6,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-557">2,119,425</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-558">7.87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-559">7.98</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="f-560">751</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested and expected to vest as of December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-561">2,119,425</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-562">7.87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-563">7.98</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="3" id="f-564">751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercisable as of December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-565">1,221,427</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" id="f-566">6.83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-567">7.57</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="3" id="f-568">739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded stock-based compensation expense related to stock options of $<ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-569">3.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-570">2.8</ix:nonFraction> million for the&#160;years ended December&#160;31, 2024 and 2023, respectively. As of December&#160;31, 2024, there was $<ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="f-571">6.8</ix:nonFraction> million of unrecognized stock option stock-based compensation expense which is expected to be recognized over a weighted average period of <ix:nonNumeric contextRef="c-93" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-572">2.7</ix:nonNumeric> years.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="f-573" escape="true"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of restricted stock award activity for the year ended December&#160;31, 2024 is a follows:</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted average<br/>fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested as of December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-574">74,243</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-575">2.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-576">58,300</ix:nonFraction>)</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-577">0.82</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested as of December 31, 2024</span></td><td colspan="3" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-578">15,943</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-579">1.75</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All restricted common stock awards were initially issued at a price determined to be fair value on the date of grant. The Company recognizes forfeitures of restricted common stock as they occur. As of December&#160;31, 2024, there was a de minimis amount of unrecognized restricted stock-based compensation expense which is expected to be recognized over a weighted average period of <ix:nonNumeric contextRef="c-99" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-580">0.3</ix:nonNumeric> years. The fair value of shares that vested during the&#160;years ended December&#160;31, 2024 and 2023 was $<ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="f-581">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="f-582">0.5</ix:nonFraction> million, respectively.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="f-583" escape="true"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense related to stock options and restricted stock recorded in the accompanying consolidated statements of operations for the&#160;years ended December&#160;31, 2024 and 2023 is as follows (in thousands):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-584">1,876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-585">1,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">G&amp;A</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-586">2,156</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-587">1,352</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-588">4,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-589">2,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has not recognized and does not expect to recognize in the near future, any tax benefit related to employee stock-based compensation expense as a result of the full valuation allowance related to its net deferred tax assets.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">142</span></div></div></div><div id="i8049b05497804bd28b68608a093bd853_136"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:DefinedContributionPlanTextBlock" id="f-590" continuedAt="f-590-1" escape="true">Employee Benefit Plan</ix:nonNumeric></span></div><ix:continuation id="f-590-1"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;1, 2017, the Company&#8217;s board of directors approved the Company&#8217;s 401(k) retirement plan (the &#8220;401(k) Plan&#8221;). Employees of the Company are eligible to participate in the 401(k) Plan. Participants may contribute up to <ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" scale="-2" id="f-591">100</ix:nonFraction>% of their annual compensation to the 401(k) Plan, subject to statutory limitations. Effective January&#160;1, 2022, under the 401(k) Plan &#8220;Safe Harbor Match,&#8221; the Company matches <ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" scale="-2" id="f-592">100</ix:nonFraction>% of the first <ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="f-593">3</ix:nonFraction>% of employee contributions and these contributions vest in full at the time of match.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2024 and 2023, the Company made matching contributions of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="f-594">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="f-595">0.4</ix:nonFraction> million, respectively.</span></div></ix:continuation><div id="i8049b05497804bd28b68608a093bd853_130"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-596" continuedAt="f-596-1" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="f-596-1" continuedAt="f-596-2"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2024 and 2023, <ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-597"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-598">no</ix:nonFraction></ix:nonFraction> income tax expense was recorded due to the Company&#8217;s net operating loss (&#8220;NOL&#8221;) and full valuation allowance. The Company&#8217;s effective tax rate of <ix:nonFraction unitRef="number" contextRef="c-1" decimals="4" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:fixed-zero" scale="3" id="f-599">zero</ix:nonFraction> differs from the U.S. statutory tax rate of 21% primarily because of the valuation allowance maintained against the Company&#8217;s net deferred tax assets. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="f-600" continuedAt="f-600-1" escape="true">A reconciliation of the expected income tax benefit computed using the federal statutory income tax rate to the Company&#8217;s effective income tax rate is as follows for the&#160;years ended December&#160;31, 2024 and 2023:</ix:nonNumeric></span></div><ix:continuation id="f-600-1"><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax computed at federal statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-601">21.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-6" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-602">21.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State taxes, net of federal benefit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="f-603">6.78</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-6" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="f-604">7.49</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign rate differential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="f-605">0.06</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-6" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="f-606">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D credit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="f-607">2.98</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-6" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="f-608">4.03</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="f-609">29.63</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="number" contextRef="c-6" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="f-610">31.99</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Permanent differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="4" sign="-" name="camp:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" scale="-2" id="f-611">1.07</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="number" contextRef="c-6" decimals="4" sign="-" name="camp:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" scale="-2" id="f-612">0.57</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="4" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-613">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-6" decimals="4" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-614">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="f-615" escape="true"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s net deferred tax assets as of December&#160;31, 2024 and 2023, consisted of the following (in thousands):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOLs</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-616">27,667</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-617">18,936</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized R&amp;D costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" format="ixt:num-dot-decimal" scale="3" id="f-618">22,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" format="ixt:num-dot-decimal" scale="3" id="f-619">17,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D credits</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" format="ixt:num-dot-decimal" scale="3" id="f-620">9,299</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" format="ixt:num-dot-decimal" scale="3" id="f-621">7,239</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="camp:DeferredTaxAssetsLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="f-622">2,307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="camp:DeferredTaxAssetsLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="f-623">3,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized Sec. 59 (e ) R&amp;D expenditures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="camp:DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures" format="ixt:num-dot-decimal" scale="3" id="f-624">1,833</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="camp:DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures" format="ixt:num-dot-decimal" scale="3" id="f-625">2,337</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" format="ixt:num-dot-decimal" scale="3" id="f-626">3,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" format="ixt:num-dot-decimal" scale="3" id="f-627">2,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 22.6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total gross deferred tax assets</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-628">66,574</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-629">51,712</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease ROU assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="f-630">1,653</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="f-631">2,118</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total gross deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-632">1,653</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-633">2,118</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net deferred tax assets</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="camp:DeferredTaxAssetsLiabilitiesGross" format="ixt:num-dot-decimal" scale="3" id="f-634">64,921</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="camp:DeferredTaxAssetsLiabilitiesGross" format="ixt:num-dot-decimal" scale="3" id="f-635">49,594</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-636">64,921</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-637">49,594</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net deferred tax asset less valuation allowance</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:fixed-zero" scale="3" id="f-638">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:fixed-zero" scale="3" id="f-639">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024 and 2023, the Company had U.S. federal NOL carryforwards of $<ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-640">102.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-641">69.8</ix:nonFraction> million, respectively, which may be available to offset future income tax liabilities. Of the $<ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-642">102.3</ix:nonFraction> million carryforwards, approximately $<ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-5" name="camp:OperatingLossCarryforwardsSubjectToExpiration" scale="6" id="f-643">4.8</ix:nonFraction> million will begin to expire in 2036 and approximately $<ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-5" name="camp:OperatingLossCarryforwardsNotSubjectToExpiration" scale="6" id="f-644">97.5</ix:nonFraction> million are carried forward indefinitely. As of December&#160;31, 2024 and 2023, the Company had state NOL carryforwards of $<ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-645">97.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-646">66.7</ix:nonFraction> million, respectively, which will begin to expire in 2036.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024 and 2023, the Company had U.S. federal R&amp;D tax credit carryforwards of $<ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="f-647">6.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="f-648">5.2</ix:nonFraction> million, respectively, which begin to expire in 2036. As of December&#160;31, 2024 and 2023, the Company had state R&amp;D tax credit carryforwards of $<ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="f-649">3.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="f-650">2.6</ix:nonFraction> million, respectively, which begin to expire in 2036. As of </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><ix:continuation id="f-596-2"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2024 and 2023, the Company had capitalized R&amp;D costs of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="camp:CapitalizedResearchAndDevelopmentCosts" scale="6" id="f-651">22.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="camp:CapitalizedResearchAndDevelopmentCosts" scale="6" id="f-652">17.4</ix:nonFraction> million, respectively, as required by the Tax Cuts and Jobs Act of 2017.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future realization of the tax benefits of existing temporary differences and NOL carryforwards ultimately depends on the existence of sufficient taxable income within the carryforward period. As of December&#160;31, 2024, the Company performed an evaluation to determine whether a valuation allowance was needed. The Company considered all available evidence, both positive and negative, which included the results of operations for the current and preceding&#160;years. The Company determined that it is more likely than not that all of the deferred tax assets will not be realized. Accordingly, the Company maintained a full valuation allowance as of December&#160;31, 2024. During the&#160;years ended December&#160;31, 2024 and 2023, the valuation allowance increased by $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="f-653">15.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="f-654">15.8</ix:nonFraction> million, respectively, due to the increase in the deferred tax assets by the same amount, primarily due to increases in the NOL carryforwards, capitalized R&amp;D costs and R&amp;D tax credit carryforwards.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The utilization of NOLs and tax credit carryforwards to offset future taxable income may be subject to an annual limitation because of ownership changes that have occurred previously or may occur in the future. Under Sections&#160;382 and 383 of the Internal Revenue Code of 1986 (&#8220;IRC&#8221;), a corporation that undergoes an ownership change may be subject to limitation on its ability to utilize its pre-change NOLs and other tax attributes otherwise available to offset future taxable income and/or tax liability. An ownership change is defined as a cumulative change of more than 50% in the ownership positions of certain stockholders during a rolling three-year period.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has not completed a formal study to determine if any ownership changes within the meaning of IRC Section&#160;382 and 383 have occurred as of December&#160;31, 2024. An ownership change would restrict its ability to use its NOLs or tax credit carryforwards and could require the Company to pay U.S. federal or state income taxes earlier than would be required if such limitation were not in effect.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2024, the Company generated research credits but has not conducted a study to document the qualified activities. This study may result in an adjustment to the Company&#8217;s R&amp;D credit carryforwards; however, until a study is completed, and any adjustment is known, <ix:nonFraction unitRef="usd" contextRef="c-4" decimals="INF" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:fixed-zero" scale="3" id="f-655">no</ix:nonFraction> amounts have been recognized as an uncertain tax position. A full valuation allowance has been provided against the Company&#8217;s R&amp;D credits and, if an adjustment is required, this adjustment would be offset by an adjustment to the deferred income tax asset established for the R&amp;D credit carryforwards and the valuation allowance.</span></div></ix:continuation><div id="i8049b05497804bd28b68608a093bd853_845"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-656" continuedAt="f-656-1" escape="true">Segment Reporting</ix:nonNumeric></span></div><ix:continuation id="f-656-1"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company manages its business activities on a consolidated basis and operates as a single operating segment: R&amp;D, which engages in the business of developing a new class of RNA-based therapeutics to treat a broad range of genetic diseases. The Company's operations are primarily in the United States.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s CODM is its Chief Executive Officer. The CODM uses net loss, as reported on the Company&#8217;s consolidated statement of operations and comprehensive loss, in evaluating performance and determining how to allocate resources. The CODM does not review assets in evaluating the results and therefore, such information is not presented. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-657" continuedAt="f-657-1" escape="true">The following table provides the revenue and significant and other segment expenses for the&#160;years ended December&#160;31, 2024 and 2023 (in thousands):</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-657-1"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-3" name="us-gaap:Revenues" scale="3" id="f-658">652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-3" name="us-gaap:Revenues" scale="3" id="f-659">350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Significant segment expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Personnel-related expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-3" name="us-gaap:LaborAndRelatedExpense" format="ixt:num-dot-decimal" scale="3" id="f-660">20,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-3" name="us-gaap:LaborAndRelatedExpense" format="ixt:num-dot-decimal" scale="3" id="f-661">19,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical and preclinical expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-3" name="camp:ClinicalAndPreclinicalExpenses" format="ixt:num-dot-decimal" scale="3" id="f-662">18,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-3" name="camp:ClinicalAndPreclinicalExpenses" format="ixt:num-dot-decimal" scale="3" id="f-663">20,012</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Facilities-related and overhead</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-3" name="camp:FacilitiesAndOverheadExpense" format="ixt:num-dot-decimal" scale="3" id="f-664">7,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-3" name="camp:FacilitiesAndOverheadExpense" format="ixt:num-dot-decimal" scale="3" id="f-665">6,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional and consulting fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-3" name="us-gaap:ProfessionalFees" format="ixt:num-dot-decimal" scale="3" id="f-666">5,984</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-3" name="us-gaap:ProfessionalFees" format="ixt:num-dot-decimal" scale="3" id="f-667">4,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-3" name="camp:CorporateExpenses" format="ixt:num-dot-decimal" scale="3" id="f-668">1,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-3" name="camp:CorporateExpenses" format="ixt:num-dot-decimal" scale="3" id="f-669">1,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Travel and entertainment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-3" name="us-gaap:TravelAndEntertainmentExpense" scale="3" id="f-670">608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-3" name="us-gaap:TravelAndEntertainmentExpense" scale="3" id="f-671">591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plus: Other segment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-672">1,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-673">2,588</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment net loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-674">51,791</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-675">49,291</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other segment income includes total other income, net on the consolidated statements of operations.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">144</span></div></div></div><div id="i8049b05497804bd28b68608a093bd853_133"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-677" continuedAt="f-677-1" escape="true">Net Loss Per Share Attributable to Common Stockholders</ix:nonNumeric></span></div><ix:continuation id="f-677-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-678" escape="true"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net loss per share was calculated as follows for the&#160;years ended December&#160;31, 2024 and 2023 (in thousands, except share and per share amounts):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss attributable to common stockholders</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-679">51,791</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-680">49,291</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average common shares outstanding, basic and diluted</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-681"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-682">4,690,094</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-683"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-684">394,976</ix:nonFraction></ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss per share attributable to common stockholders, basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-685"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-686">11.04</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-687"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-688">124.80</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s potentially dilutive securities, which include or have included convertible preferred stock, outstanding stock options, unvested restricted common stock, and warrants to purchase stock, have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted-average number of common shares outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="f-689" escape="true"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company excluded the following from the computation of diluted net loss per share attributable to common stockholders as of December&#160;31, 2024 and 2023 because including them would have had an anti-dilutive effect:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Conversion of preferred stock</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-111" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="f-690">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-112" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-691">11,648,582</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options outstanding</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-113" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-692">2,119,425</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-114" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-693">2,273,221</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock vesting</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-115" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-694">15,943</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-116" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-695">74,243</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Warrant outstanding</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-117" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="f-696">142</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-118" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="f-697">142</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-698">2,135,510</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-699">13,996,188</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i8049b05497804bd28b68608a093bd853_139"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="f-700" continuedAt="f-700-1" escape="true">Related Parties</ix:nonNumeric></span></div><ix:continuation id="f-700-1"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2015, the Company entered into consulting agreements with its <ix:nonFraction unitRef="founder" contextRef="c-119" decimals="INF" name="camp:NumberOfFounders" format="ixt-sec:numwordsen" scale="0" id="f-701">two</ix:nonFraction> founders, related parties who hold shares of the Company&#8217;s common stock, to provide R&amp;D and strategic planning services. For the&#160;years ended December&#160;31, 2024 and 2023, the Company recognized R&amp;D expense totaling $<ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-702">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-703">0.3</ix:nonFraction> million, respectively, related to work performed under the founder agreements. The Company had <ix:nonFraction unitRef="usd" contextRef="c-122" decimals="INF" name="us-gaap:AccountsPayableCurrent" format="ixt:fixed-zero" scale="6" id="f-704"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="INF" name="us-gaap:AccountsPayableCurrent" format="ixt:fixed-zero" scale="6" id="f-705">no</ix:nonFraction></ix:nonFraction> amount due to the founders at both December&#160;31, 2024 and 2023, respectively. For the&#160;years ended December&#160;31, 2024 and 2023, the Company recognized stock-based compensation expense totaling $<ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-706">0.2</ix:nonFraction> million and less than $<ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-707">0.2</ix:nonFraction> million, related to consulting agreements, respectively.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March&#160;2019, the Company entered into a consulting agreement with an executive consultant, a related party who holds shares of the Company&#8217;s common stock. For the&#160;years ended December&#160;31, 2024 and 2023, the Company recognized G&amp;A expense totaling $<ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="f-708">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="f-709">0.1</ix:nonFraction> million, respectively, related to work performed under the consulting agreement. The Company had <ix:nonFraction unitRef="usd" contextRef="c-126" decimals="INF" name="us-gaap:AccountsPayableCurrent" format="ixt:fixed-zero" scale="6" id="f-710"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="INF" name="us-gaap:AccountsPayableCurrent" format="ixt:fixed-zero" scale="6" id="f-711">no</ix:nonFraction></ix:nonFraction> amount due to the consultant at both December&#160;31, 2024 and 2023, respectively. For the&#160;years ended December&#160;31, 2024 and 2023, the Company recognized stock-based compensation expense totaling $<ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-712">0.2</ix:nonFraction> million and less than $<ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-713">0.2</ix:nonFraction> million, respectively, related to the consulting agreement.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145</span></div></div></div><div id="i8049b05497804bd28b68608a093bd853_145"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosures</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i8049b05497804bd28b68608a093bd853_148"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9A. Controls and Procedures</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our principal executive officer and our principal financial officer, evaluated the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 as of December&#160;31, 2024. The term &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by us in the reports that we file or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company&#8217;s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of December&#160;31, 2024, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management&#8217;s Annual Report on Internal Control over Financial Reporting</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report does not include a report of management&#8217;s assessment regarding our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) or an attestation report of our independent registered accounting firm due to a transition period established by the rules of the SEC for newly public companies. Additionally, our independent registered accounting firm will not be required to opine on the effectiveness of our internal control over financial reporting pursuant to Section 404 until we are no longer an &#8220;emerging growth company&#8221; as defined in the JOBS Act.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended December&#160;31, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div id="i8049b05497804bd28b68608a093bd853_151"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9B. Other Information</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the quarter ended December&#160;31, 2024, no &#8220;Rule 10b5-1 plans&#8221; or &#8220;non-Rule 10b5-1 trading arrangements,&#8221; as each term is defined in Item 408(a) of Regulation S-K, were <ix:nonNumeric contextRef="c-128" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-714"><ix:nonNumeric contextRef="c-128" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-715">adopted</ix:nonNumeric></ix:nonNumeric>, modified, or <ix:nonNumeric contextRef="c-128" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-716"><ix:nonNumeric contextRef="c-128" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-717">terminated</ix:nonNumeric></ix:nonNumeric> by officers or directors of the Company.</span></div><div id="i8049b05497804bd28b68608a093bd853_154"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">146</span></div></div></div><div id="i8049b05497804bd28b68608a093bd853_157"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div id="i8049b05497804bd28b68608a093bd853_160"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 10. Directors, Executive Officers and Corporate Governance</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insider Trading Policies and Procedures</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have <ix:nonNumeric contextRef="c-1" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" format="ixt:fixed-true" id="f-718">adopted</ix:nonNumeric> an insider trading policy that governs the purchase, sale, and other dispositions of our securities by our directors, officers and employees, and other covered persons. The insider trading policy also applies to transactions by the Company in its securities. We believe that the insider trading policy is reasonably designed to promote compliance with insider trading laws, rules and regulations and the listing standards of Nasdaq. A copy of our Insider Trading Policy is filed with this Annual Report as Exhibit 19.1.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Code of Business Conduct and Ethics</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a code of business conduct and ethics that applies to all of our employees, officers and directors, including those officers responsible for financial reporting. Our code of business conduct and ethics is available on the investor relations section of our website. We intend to disclose any amendments to the code, or any waivers of its requirements, on our website or in public filings.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required to be included by this Item of Form 10-K will be included in the Proxy Statement and such information is incorporated by reference herein. The Proxy Statement will be filed electronically with the SEC within 120 days after the end of the fiscal year covered by this Annual Report pursuant to Regulation 14A of the Exchange Act. </span></div><div id="i8049b05497804bd28b68608a093bd853_163"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 11. Executive Compensation</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item of Form 10-K will be included in the Proxy Statement and such information is incorporated by reference herein.</span></div><div id="i8049b05497804bd28b68608a093bd853_166"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 12. Security Ownership of Certain Beneficial Owner and Management and Related Stockholder Matters</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item of Form 10-K will be included in the Proxy Statement and such information is incorporated by reference herein.</span></div><div id="i8049b05497804bd28b68608a093bd853_169"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 13. Certain Relationships and Related Transactions, and Director Independence</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item of Form 10-K will be included in the Proxy Statement and such information is incorporated by reference herein.</span></div><div id="i8049b05497804bd28b68608a093bd853_172"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 14. Principal Accounting Fees and Services</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item of Form 10-K will be included in the Proxy Statement and such information is incorporated by reference herein.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147</span></div></div></div><div id="i8049b05497804bd28b68608a093bd853_175"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div id="i8049b05497804bd28b68608a093bd853_178"></div><div style="-sec-extract:summary;margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 15. Exhibits and Financial Statement Schedules</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Statements</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a list of the consolidated financial statements and report of Independent Registered Public Accounting Firm (PCAOB ID:<ix:nonNumeric contextRef="c-1" name="dei:AuditorFirmId" id="f-719">42</ix:nonNumeric>) included herein, see Index to the Consolidated Financial Statements on page 121 of this Annual Report, which is incorporated into this Item by reference.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exhibits</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:9.506%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.021%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.960%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.203%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.144%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Description of Exhibit</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Form</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">File Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Date of Filing</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Filed/Furnished Herewith</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736730/000110465924108583/tm2426167d1_ex3-1.htm">Fifth Amended and Restated Certif</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736730/000110465924108583/tm2426167d1_ex3-1.htm">icat</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736730/000110465924108583/tm2426167d1_ex3-1.htm">e</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736730/000110465924108583/tm2426167d1_ex3-1.htm"> of Incorporation of CAMP4 Therapeutics Corporation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-423665</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/15/2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736730/000110465924108583/tm2426167d1_ex3-2.htm">Amended and Restated B</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736730/000110465924108583/tm2426167d1_ex3-2.htm">yla</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736730/000110465924108583/tm2426167d1_ex3-2.htm">ws of CAMP</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736730/000110465924108583/tm2426167d1_ex3-2.htm">4 Therapeutics Corporation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-423665</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/15/2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit41-descriptionofreg.htm">Description of Registered Securities</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736730/000110465924101618/tm2415452d9_ex4-1.htm">Third Amended and Restated Investors&#8217; Rights Agreement, by and among the Registrant and certain of its stockholders, dated June 3, 2022</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-282241</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/20/2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736730/000110465924101618/tm2415452d9_ex4-2.htm">Warrant to Purchase Stock, by and between Silicon Valley Bank and CAMP4 Therapeutics Corporation (f/k/a Marauder Therapeutics, Inc.), dated January 4, 2017</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-282241</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/20/2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1+</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736730/000110465924101618/tm2415452d9_ex10-1.htm">Patent License Agreement by and between CAMP4 Therapeutics Corporation and the Whitehead Institute for Biomedical Research, dated as of October 23, 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-282241</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/20/2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2+</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736730/000110465924101618/tm2415452d9_ex10-2.htm">First Amendment to Patent License Agreement by and between CAMP4 Therapeutics Corporation and the Whitehead Institute for Biomedical Research, dated as of December 14, 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-282241</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/20/2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3+</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736730/000110465924101618/tm2415452d9_ex10-3.htm">Second Amendment to Patent License Agreement by and between CAMP4 Therapeutics Corporation and the Whitehead Institute for Biomedical Research, dated as of November 7, 2023</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-282241</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/20/2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4#</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736730/000110465924101618/tm2415452d9_ex10-4.htm">CAMP4 Therapeutics Corporation Amended and Restated 2016 Stock Option and Grant Plan, as amended, and form of award agreements thereunder</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-282241</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/20/2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5#</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736730/000110465924106393/tm2415452d14_ex10-5.htm">CAMP4 Therapeutics Corporation 2024 Equity Incentive Plan</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1/A</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-282241</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/7/2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6#</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736730/000110465924106393/tm2415452d14_ex10-6.htm">Form of Non-Qualified Stock Option Award Agreement for Non-Employee Directors under the 2024 Equity Incentive Plan</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-282241</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/7/2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7#</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736730/000110465924106393/tm2415452d14_ex10-7.htm">Form of Incentive Stock Option Award Agreement under the 2024 Equity Incentive Plan</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-282241</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/7/2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8#</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736730/000110465924106393/tm2415452d14_ex10-8.htm">Form of Non-Qualified Stock Option Award Agreement under the 2024 Equity Incentive Plan</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-282241</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/7/2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9#</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736730/000110465924106393/tm2415452d14_ex10-9.htm">Amended and Restated Employment Agreement by and between CAMP4 Therapeutics Corporation and Josh Mandel-Brehm, dated October 3, 2024</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-282241</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/7/2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">148</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary;margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="-sec-extract:exhibit;color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:9.506%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.021%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.960%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.203%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.144%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Description of Exhibit</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Form</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">File Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Date of Filing</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Filed/Furnished Herewith</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10#</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736730/000110465924106393/tm2415452d14_ex10-10.htm">CAMP4 Therapeutics Corporation 2024 Employee Stock Purchase Plan</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-282241</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/7/2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11#</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736730/000110465924103141/tm2415452d12_ex10-11.htm">Form of Indemnification Agreement between the Registrant and each of its directors and executive officers</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-282241</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/26/2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12#</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736730/000110465924106393/tm2415452d14_ex10-12.htm">CAMP4 Therapeutics Corporation Severance and Change in Control Plan</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-282241</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/7/2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13#</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736730/000110465924106393/tm2415452d14_ex10-13.htm">CAMP4 Therapeutics Corporation Non-Employee Director Compensation Policy</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-282241</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/7/2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736730/000110465924101618/tm2415452d9_ex10-14.htm">Amended Lease agreement by and between CAMP4 Therapeutics Corporation and ARE-MA Region 59, LLC, dated October 3, 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-282241</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/20/2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736730/000110465924101618/tm2415452d9_ex10-15.htm">Lease by and between CAMP4 Therapeutics Corporation and BCSP Pearl East Property LLC, dated January 3, 2023</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-282241</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/20/2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit191-insidertradingp.htm">I</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit191-insidertradingp.htm">nsider Trading Policy</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736730/000110465924101618/tm2415452d9_ex21-1.htm">L</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736730/000110465924101618/tm2415452d9_ex21-1.htm">ist of Subsidiaries of CAMP4</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736730/000110465924101618/tm2415452d9_ex21-1.htm"> Therapeutics Corporation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-282241</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/20/2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit231-consent.htm">Consent of Ernst &amp; Young LLP, independent registered public accounting firm</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8dd35c94b6114118a530dd64f3e1b5b3_4413">Power of Attorney (included on signature page).</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311certification.htm">Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312certification.htm">Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1*</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321certification.htm">Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2*</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit322certification.htm">Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1736730/000110465924106393/tm2415452d14_ex10-16.htm">CAMP4 Therapeutics Corporation Policy for Recoupment of Incentive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-282241</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/7/2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document &#8211; the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">149</span></div></div></div><div id="i8049b05497804bd28b68608a093bd853_181"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:90.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portions of this exhibit (indicated by asterisks) have been redacted pursuant to Item 601 of Regulation S-K because they are both not material and the registrant customarily and actually treats such information as private or confidential.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indicates management contract or compensatory plan.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This certification will not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent specifically incorporated by reference into such filing.</span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 16. Form 10-K Summary</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">150</span></div></div></div><div id="i8049b05497804bd28b68608a093bd853_184"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Signatures</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-bottom:8pt"><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: March&#160;27, 2025</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.181%"><tr><td style="width:1.0%"/><td style="width:48.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.290%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.592%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CAMP4 Therapeutics Corporation</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Josh Mandel-Brehm</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:1.15pt;padding-right:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Josh Mandel-Brehm</span></div><div style="padding-right:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></div></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:8pt;text-align:center"><span id="i8dd35c94b6114118a530dd64f3e1b5b3_4413"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">POWER OF ATTORNEY</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Josh Mandel-Brehm and Kelly Gold, and each of them, as his or her true and lawful agents, proxies and attorneys-in-fact, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities to sign this Annual Report on Form 10-K of CAMP4 Therapeutics Corporation, and any or all amendments thereto, and to file the same, with all exhibits thereto, and all other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises hereby ratifying and confirming all that such agent, proxy and attorney-in-fact or any of his substitutes, may lawfully do or cause to be done by virtue thereof.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.303%"><tr><td style="width:1.0%"/><td style="width:34.512%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.435%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.117%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.435%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.801%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Signature</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date</span></td></tr><tr style="height:13pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Josh Mandel-Brehm</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President, Chief Executive Officer and Director </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 27, 2025</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Josh Mandel-Brehm</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Kelly Gold</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.15pt;padding-right:0.02pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer and Principal Accounting Officer)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 27, 2025</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kelly Gold</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Steven Holtzman</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.15pt;padding-right:0.02pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director and Chair&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 27, 2025</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Steven Holtzman</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ James Boylan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 27, 2025</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James Boylan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Ingo Chakravarty</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 27, 2025</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ingo Chakravarty</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Michael Higgins</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 27, 2025</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Higgins</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Amir Nashat</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 27, 2025</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amir Nashat, ScD</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Paula Ragan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 27, 2025</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paula Ragan, PhD</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">151</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><a style="color:#003392;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8049b05497804bd28b68608a093bd853_7">TABLE OF CONTENTS</a></span></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.303%"><tr><td style="width:1.0%"/><td style="width:34.512%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.435%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.117%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.435%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.801%"/><td style="width:0.1%"/></tr><tr style="height:13pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Andrew Schwab</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 27, 2025</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Andrew Schwab</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Murray Stewart</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 27, 2025</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Murray Stewart, DM FRCP</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:13pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Ravi Thadhani</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 27, 2025</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ravi Thadhani, MD, MPH</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Douglas Williams</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 27, 2025</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Douglas Williams, PhD</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:13pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Richard Young</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 27, 2025</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Richard Young, PhD</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">152</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>exhibit41-descriptionofreg.htm
<DESCRIPTION>EX-4.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i2a962aa260e14a71a69bb22fd01362ab_36"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 4.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">DESCRIPTION OF THE REGISTRANT&#8217;S SECURITIES<br>PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following summary describes all material provisions of the common stock, $0.0001 par value per share, of CAMP4 Therapeutics Corporation. The description of our common stock and certain provisions of our amended and restated certificate of incorporation (&#8220;Restated Charter&#8221;) and our amended and restated bylaws (&#8220;Restated Bylaws&#8221;) are summaries and are qualified by reference to our Restated Charter and Restated Bylaws, which are included as exhibits to the Annual Report on Form 10-K of which this Exhibit 4.1 is a part.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">General</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our Restated Charter authorizes us to issue up to 175,000,000 shares of common stock, $0.0001 par value per share, and 25,000,000 shares of preferred stock, $0.0001 par value per share, all of which shares of preferred stock are undesignated. Our board of directors may establish the rights and preferences of the preferred stock from time to time.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Common stock</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Holders of our common stock are entitled to one vote for each share held on all matters submitted to a vote of stockholders and do not have cumulative voting rights. When a quorum is present at any meeting of stockholders, a nominee for director shall be elected to the board of directors if the votes properly cast for such nominee&#8217;s election exceed the votes properly cast against such nominee&#8217;s election, except in the case of a contested election, in which case the election shall be determined by a plurality of the votes cast by the stockholders entitled to vote on the election. Holders of common stock are entitled to receive proportionately any dividends as may be declared by our board of directors, subject to any preferential dividend rights of any series of preferred stock that we may designate and issue in the future.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the event of our liquidation or dissolution, the holders of common stock are entitled to receive proportionately our net assets available for distribution to stockholders after the payment of all debts and other liabilities and subject to the prior rights of any outstanding preferred stock. Holders of common stock have no preemptive, subscription, redemption or conversion rights. Our outstanding shares of common stock are validly issued, fully paid and nonassessable. The rights, preferences and privileges of holders of common stock are subject to and may be adversely affected by the rights of the holders of shares of any series of preferred stock that we may designate and issue in the future.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Preferred stock</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Under the terms of our Restated Charter, our board of directors is authorized to direct us to issue shares of preferred stock in one or more series without stockholder approval. Our board of directors has the discretion to determine the rights, preferences, privileges and restrictions, including voting rights, dividend rights, conversion rights, redemption privileges and liquidation preferences, of each series of preferred stock. There is no restriction on our repurchase or redemption of shares while there is any arrearage in the payment of dividends or sinking fund installments.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The purpose of authorizing our board of directors to issue preferred stock and determine its rights and preferences is to eliminate delays associated with a stockholder vote on specific issuances. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions, future financings and other corporate purposes, could have the effect of making it more difficult for a third-party to acquire, or could discourage a third-party from seeking to acquire, a majority of our outstanding voting stock. </font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Warrants</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of December 31, 2024, there were outstanding immediately exercisable warrants to purchase up to 142 shares of our common stock at an exercise price of $11.21 per share.</font></div><div style="text-indent:36pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Anti-takeover effects of our Restated Charter and Restated Bylaws</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Section 203 of the Delaware General Corporation Law</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our Restated Charter and Restated Bylaws contain certain provisions that are intended to enhance the likelihood of continuity and stability in the composition of our board of directors but which may have the effect of delaying, deferring or preventing a future takeover or change in control of us unless such takeover or change in control is approved by our board of directors.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">These provisions include&#58;</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Classified board.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">   Our Restated Charter provides that our board of directors will be divided into three classes of directors, with the classes as nearly equal in number as possible. As a result, approximately one-third of our board of directors are elected each year. The classification of directors will have the effect of making it more difficult for stockholders to change the composition of our board of directors. Our Restated Charter also provides that, subject to any rights of holders of preferred stock to elect additional directors under specified circumstances, the number of directors will be fixed exclusively pursuant to a resolution adopted by our board of directors.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Action by written consent&#59; special meetings of stockholders.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">   Our Restated Charter provides that stockholder action can be taken only at an annual or special meeting of stockholders and cannot be taken by written consent in lieu of a meeting. Our Restated Charter and the Restated Bylaws also provide that, except as otherwise required by law, special meetings of the stockholders can only be called pursuant to a resolution adopted by a majority of our board of directors. Except as described above, stockholders are not permitted to call a special meeting or to require our board of directors to call a special meeting.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Removal of directors.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">   Our Restated Charter provides that our directors may be removed only for cause by the affirmative vote of at least 75% of the voting power of our outstanding shares of capital stock, voting together as a single class. This requirement of a supermajority vote to remove directors could enable a minority of our stockholders to prevent a change in the composition of our board of directors.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Advance notice procedures.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">   Our Restated Bylaws establish an advance notice procedure for stockholder proposals to be brought before an annual meeting of our stockholders, including proposed nominations of persons for election to our board of directors. Stockholders at an annual meeting are only able to consider proposals or nominations specified in the notice of meeting or brought before the meeting by or at the direction of our board of directors or by a stockholder who was a stockholder of record on the record date for the meeting, who is entitled to vote at the meeting and who has given our Secretary timely written notice, in proper form, of the stockholder&#8217;s intention to bring that business before the meeting. Although the Restated Bylaws do not give our board of directors the power to approve or disapprove stockholder nominations of candidates or proposals regarding other business to be conducted at a special or annual meeting, the Restated Bylaws may have the effect of precluding the conduct of certain business at a meeting if the proper procedures are not followed or may discourage or deter a potential acquirer from conducting a solicitation of proxies to elect its own slate of directors or otherwise attempting to obtain control of us.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Supermajority approval requirements.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">   The Delaware General Corporation Law generally provides that the affirmative vote of a majority of the shares entitled to vote on any matter is required to amend a corporation&#8217;s certificate of incorporation or bylaws, unless either a corporation&#8217;s certificate of incorporation or bylaws requires a greater percentage. Our Restated Charter and Restated Bylaws provide that the affirmative vote of holders of at least 75% of the total votes eligible to be cast in the election of directors is required to amend, alter, change or repeal specified provisions. This requirement of a supermajority vote to approve amendments to our Restated Charter and Restated Bylaws could enable a minority of our stockholders to exercise veto power over any such amendments.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Authorized but unissued shares.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">   Our authorized but unissued shares of common stock and preferred stock are available for future issuance without stockholder approval. These additional shares may be utilized for a variety of corporate purposes, including future public offerings to raise additional capital, corporate acquisitions and employee benefit plans. The existence of authorized but unissued shares of common stock and preferred stock could render more difficult or discourage an attempt to obtain control of a majority of our common stock by means of a proxy contest, tender offer, merger or otherwise.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Exclusive forum.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">   Our Restated Charter provides that, subject to limited exceptions, the Court of Chancery of the State of Delaware (or, if, and only if, the Court of Chancery of the State of Delaware dismisses a Covered Claim (as defined in our Restated Charter) for lack of subject matter jurisdiction, any other state or federal court in the State of Delaware that does have subject matter jurisdiction) will, to the fullest extent permitted by applicable law, be the sole and exclusive forum for Covered Claims. This provision would not apply to claims brought to enforce a duty or liability created by the Securities Exchange Act of 1934, as amended.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our Restated Charter further provides that the federal district courts of the U.S. will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act of 1933, as amended. In addition, our Restated Charter provides that any person or entity purchasing or otherwise acquiring any interest in the shares of capital stock of the company will be deemed to have notice of and consented to these choice-of-forum provisions and waived any argument relating to the inconvenience of the forums in connection with any Covered Claim.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The choice of forum provisions to be contained in our Restated Charter may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or any of our directors, officers, other employees or stockholders, which may discourage lawsuits with respect to such claims, although our stockholders will not be deemed to have waived our compliance with federal securities laws and the rules and regulations thereunder. While the Delaware courts have determined that such choice of forum provisions are facially valid, it is possible that a court of law in another jurisdiction could rule that the choice of forum provisions to be contained in our Restated Charter are inapplicable or unenforceable if they are challenged in a proceeding or otherwise, which could cause us to incur additional costs associated with resolving such action in other jurisdictions. See the section in our Annual Report on Form 10-K titled &#8220;Risk Factors&#8212;Risks Related to Ownership of Our Common Stock&#8212;Our Restated Charter designates specific courts as the sole and exclusive forum for certain claims or causes of action that may be brought by our stockholders, which could discourage lawsuits against us and our directors and officers.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Section 203 of the Delaware General Corporation Law</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are subject to the provisions of Section 203 of the Delaware General Corporation Law. In general, Section 203 prohibits a publicly held Delaware corporation from engaging in a &#8220;business combination&#8221; with an &#8220;interested stockholder&#8221; for a three-year period following the time that this stockholder becomes an interested stockholder, unless the business combination is approved in a prescribed manner. A &#8220;business combination&#8221; includes, among other things, a merger, asset or stock sale or other transaction resulting in a financial benefit to the interested stockholder. An &#8220;interested stockholder&#8221; is a person who, together with affiliates and associates, owns, or did own within three years prior to the determination of interested stockholder status, 15% or more of the corporation&#8217;s voting stock.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Under Section 203, a business combination between a corporation and an interested stockholder is prohibited unless it satisfies one of the following conditions&#58; before the stockholder became interested, the corporation&#8217;s board of directors approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder&#59; upon consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the voting stock outstanding, shares owned by persons who are directors and also officers, and employee stock plans, in some instances&#59; or at or after the time the stockholder became interested, the business combination was approved by the board of directors of the corporation and authorized at an annual or special meeting of the stockholders by the affirmative vote of at least two-thirds of the outstanding voting stock which is not owned by the interested stockholder.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A Delaware corporation may &#8220;opt out&#8221; of these provisions with an express provision in its original certificate of incorporation or an express provision in its certificate of incorporation or bylaws resulting from a stockholders&#8217; amendment approved by at least a majority of the outstanding voting shares. We have not opted out of these provisions. As a result, mergers or other takeover or change in control attempts of us may be discouraged or prevented.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Transfer Agent and Registrar</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The transfer agent and registrar for our common stock is Equiniti Trust Company, LLC. The transfer agent&#8217;s address is 6201 15th Avenue, Brooklyn, New York 11219.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Listing</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our common stock is listed on the Nasdaq Global Market under the trading symbol &#8220;CAMP.&#8221;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-19.1
<SEQUENCE>3
<FILENAME>exhibit191-insidertradingp.htm
<DESCRIPTION>EX-19.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i137bdfadc5134275b2e1bcf463e52417_1"></div><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 19.1</font></div></div><div style="margin-top:3.95pt;padding-left:116.9pt;padding-right:116.9pt;text-align:center;text-indent:-37.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:217%">CAMP4 THERAPEUTICS CORPORATION INSIDER TRADING POLICY</font></div><div style="padding-left:5pt;padding-right:6.25pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22pt;text-decoration:underline">Purpose</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Insider Trading Policy (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) provides guidelines with respect to transactions in the securities of CAMP4 Therapeutics Corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and the handling of confidential information about the Company and the companies with which the Company does business. The Company&#8217;s Board of Directors (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) has adopted this Policy to promote compliance with U.S. federal and state securities laws that prohibit certain persons who are aware of material nonpublic information about a company from&#58; (i) trading in securities of that company&#59; or (ii) providing such material nonpublic information to other persons who may trade on the basis of that information, commonly known as &#8220;tipping.&#8221; In addition, it is the policy of the Company to comply with all applicable securities laws when transacting in its own securities.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:22.6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22pt;text-decoration:underline">Persons Subject to this Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Policy applies to all directors, officers and employees of the Company and its subsidiaries.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:8.1pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Policy also applies to transactions by&#58; (i) such directors&#8217;, officers&#8217; and employees&#8217; family members who reside with them&#59; (ii) anyone else who lives in their household&#59; (iii) any family members who do not live in their household but whose transactions in Company Securities (as defined below) are directed by them or are subject to their influence or control (such as parents or children who consult with them before they trade in Company Securities)&#59; and (iv) family trusts, family partnerships and similar entities controlled by them or any person described in clauses (i)-(iii) (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Other Covered Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). Directors, officers and employees are responsible for transactions by Other Covered Persons and for informing them of this Policy.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:7.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company also may determine that other persons should be subject to this Policy, such as contractors or consultants who have access to material nonpublic information. Any such other persons will be notified by the Compliance Officer (as defined in Section 5 of this Policy).</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:21.85pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22pt;text-decoration:underline">Transactions Subject to this Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Policy applies to transactions in the Company&#8217;s securities, including the Company&#8217;s common stock, options to purchase common stock, restricted stock units or any other type of security that the Company may issue (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Company Securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), other than transactions that are expressly excluded from this Policy as set forth herein.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:9.9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22pt;text-decoration:underline">Individual Responsibility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Persons subject to this Policy have ethical and legal obligations to maintain the confidentiality of information about the Company and to not engage in transactions in Company Securities while in possession of material nonpublic information. Each individual is responsible for making sure that he or she complies with this Policy, and that any Other Covered Person whose transactions are subject to this Policy, as discussed above, also complies with this Policy. In all cases, the responsibility for determining whether an individual is in possession of material nonpublic information rests with that individual, and any action on the part of the Company, the Compliance Officer or any other employee or director pursuant to this Policy (or otherwise) does not in any way constitute legal advice or insulate an </font></div><div style="height:67.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:5pt;padding-right:9.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">individual from liability under applicable securities laws. Persons subject to this Policy could be subject to severe legal penalties and disciplinary action by the Company for any conduct prohibited by this Policy or applicable securities laws, as described below in more detail under the heading &#8220;Consequences of Violations.&#8221;</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.55pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22pt;text-decoration:underline">Administration of this Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Chief Financial Officer or such other officer as is designated by the Chief Executive Officer will serve, in consultation with the Chief Executive Officer, as the Compliance Officer for the purposes of this Policy, and in such role, will be responsible for the administration of this Policy.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:20.6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22pt;text-decoration:underline">Statement of Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. A director, officer or employee of the Company or its subsidiaries (or any other person designated as subject to this Policy) who is aware of material nonpublic information relating to the Company may not directly or indirectly through Other Covered Persons&#58;</font></div><div style="margin-top:6pt;padding-left:95pt;padding-right:5.95pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">engage in transactions in Company Securities, except as otherwise specified in this Policy under the headings &#8220;Transactions Not Subject to this Policy&#8221; and &#8220;Rule 10b5-1 Plans&#8221;&#59;</font></div><div style="margin-top:5.95pt;padding-left:95pt;padding-right:26.85pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">recommend to anyone the purchase or sale of any securities when they are aware of material non-public information&#59;</font></div><div style="margin-top:5.9pt;padding-left:95pt;padding-right:9.6pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">disclose material nonpublic information to persons within the Company whose jobs do not require them to have that information, or anyone outside of the Company, unless any such disclosure is made in accordance with the Company&#8217;s policies regarding the external disclosure of Company information&#59; or</font></div><div style="margin-top:6.1pt;padding-left:94.95pt;text-indent:-17.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.75pt">assist anyone engaged in the above activities in violation of this Policy.</font></div><div style="margin-top:5.8pt;padding-left:5pt;padding-right:1.1pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In addition, this policy applies to material nonpublic information about a company with which the Company does business, including a customer or supplier of the Company. A director, officer or employee of the Company or its subsidiaries (or any other person designated as subject to this Policy) may not trade in that company&#8217;s securities until the information becomes public or is no longer material.</font></div><div style="margin-top:12.05pt;padding-left:76.95pt;text-indent:-35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:26.95pt;text-decoration:underline">Definition of Material Nonpublic Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:12pt;padding-left:41pt;padding-right:5.6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13pt;text-decoration:underline">Material Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Information is considered &#8220;material&#8221; if there is a substantial likelihood that a reasonable investor would consider the information important in making a decision to buy, hold or sell securities. Information expected to affect the Company&#8217;s stock price, whether positive or negative, should be considered material. No bright-line standard exists for assessing materiality&#59; rather, materiality is based on an assessment of all of the facts and circumstances and often is evaluated by enforcement authorities with the benefit of hindsight.</font></div><div style="margin-top:12pt;padding-left:41pt;padding-right:4.4pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">While defining all categories of material information is not possible, the following are some examples of information that ordinarily would be regarded as material&#58;</font></div><div><font><br></font></div><div style="height:67.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font><br></font></div><div style="margin-top:3.9pt;padding-left:95pt;padding-right:27.15pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.75pt">information regarding the progress or outcomes of the Company&#8217;s clinical trials, including regarding safety and efficacy&#59;</font></div><div style="margin-top:6.1pt;padding-left:94.95pt;text-indent:-17.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.7pt">timelines for development of new products or new indications&#59;</font></div><div style="margin-top:5.9pt;padding-left:94.95pt;text-indent:-17.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.7pt">significant regulatory developments&#59;</font></div><div style="margin-top:5.95pt;padding-left:94.95pt;text-indent:-17.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.7pt">projections of future earnings or losses, or other financial guidance&#59;</font></div><div style="margin-top:5.95pt;padding-left:95pt;padding-right:43.6pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.75pt">changes to previously announced financial guidance, or the decision to suspend financial guidance&#59;</font></div><div style="margin-top:6.05pt;padding-left:94.95pt;text-indent:-17.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.7pt">a pending or proposed merger, acquisition or tender offer&#59;</font></div><div style="margin-top:5.95pt;padding-left:94.95pt;text-indent:-17.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.7pt">a pending or proposed acquisition or disposition of a significant asset&#59;</font></div><div style="margin-top:5.95pt;padding-left:94.95pt;text-indent:-17.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.7pt">a pending or proposed significant joint venture or licensing arrangement&#59;</font></div><div style="margin-top:5.9pt;padding-left:94.95pt;text-indent:-17.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.7pt">a Company restructuring&#59;</font></div><div style="margin-top:5.85pt;padding-left:95pt;padding-right:18.65pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.75pt">a change in dividend policy, the declaration of a stock split or an offering of additional securities&#59;</font></div><div style="margin-top:6.15pt;padding-left:94.95pt;text-indent:-17.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.7pt">bank borrowings or other financing transactions&#59;</font></div><div style="margin-top:5.95pt;padding-left:94.95pt;text-indent:-17.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.7pt">the establishment of a repurchase program for Company Securities&#59;</font></div><div style="margin-top:5.95pt;padding-left:94.95pt;text-indent:-17.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.7pt">a change in management&#59;</font></div><div style="margin-top:5.95pt;padding-left:94.95pt;text-indent:-17.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.7pt">pending or threatened significant litigation, or the resolution of such litigation&#59;</font></div><div style="margin-top:5.95pt;padding-left:94.95pt;text-indent:-17.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.7pt">impending bankruptcy or the existence of severe liquidity problems&#59;</font></div><div style="margin-top:5.8pt;padding-left:95pt;padding-right:16.45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.75pt">the imposition of a ban on trading in Company Securities or the securities of another company&#59; and</font></div><div style="margin-top:6.2pt;padding-left:94.95pt;text-indent:-17.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.7pt">significant cybersecurity breaches.</font></div><div style="margin-top:5.8pt;padding-left:41pt;padding-right:12.55pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13pt;text-decoration:underline">Nonpublic Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Generally, information that has not been disclosed to the public is considered to be nonpublic information. In order to establish that the information has been disclosed to the public, it may be necessary to demonstrate that the information has been widely disseminated. Information generally would be considered widely disseminated if it has been disclosed through newswire services, a broadcast on widely available internet, radio or television programs, publication in a widely available newspaper, magazine or news website or public disclosure documents filed with or furnished to the Securities and Exchange Commission (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">SEC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) that are available on the SEC&#8217;s website. By contrast, information would generally </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">not</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> be considered widely disseminated if it is available only to the Company&#8217;s employees.</font></div><div style="margin-top:12.05pt;padding-left:41pt;padding-right:7.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Once information is widely disseminated, the investing public should be afforded sufficient time to absorb the information. As a general rule, information is considered nonpublic until the end of the next full trading day after the information is released. For example, if the Company announces financial results after market close on Monday or </font></div><div style="height:67.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12.05pt;padding-left:41pt;padding-right:7.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">before trading begins on a Tuesday, the first time a director, officer or employee can buy or sell Company Securities is generally the opening of the market on Wednesday (assuming he or she is not aware of other material nonpublic information at that time). If the Company announces financial results after trading begins on that Tuesday, however, the first time a director, officer or employee can buy or sell Company Securities is generally the opening of the market on Thursday (again assuming he or she is not aware of other material nonpublic information at that time). Depending on the particular circumstances, the Company may determine that a longer or shorter period should apply to the release of specific material nonpublic information.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:10.3pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22pt;text-decoration:underline">Transactions Not Subject to this Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Policy does not apply in the case of the following transactions, except as specifically noted&#58;</font></div><div style="margin-top:12pt;padding-left:41pt;padding-right:14.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13pt;text-decoration:underline">Stock Option Exercises</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Policy does not apply to the exercise of a stock option acquired pursuant to a Company equity incentive plan or to a transaction in which a person has elected to have the Company withhold shares subject to an option award to satisfy tax withholding requirements. This Policy does apply, however, to any sale of shares as part of a broker-assisted cashless exercise of an option, or any other market sale for the purpose of generating the cash needed to pay the exercise price of or taxes associated with an option.</font></div><div style="margin-top:12pt;padding-left:41pt;padding-right:5.75pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13pt;text-decoration:underline">Restricted Stock and Similar Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Policy does not apply to the vesting of restricted stock, the settlement of restricted stock units or similar awards or to a transaction in which there is an election to have the Company withhold shares to satisfy tax withholding requirements upon the vesting of any restricted stock or the vesting or settlement of any restricted stock unit. This Policy does apply, however, to any market sale of shares received upon the settlement of any restricted stock unit or similar award.</font></div><div style="margin-top:12pt;padding-left:41pt;padding-right:9.35pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13pt;text-decoration:underline">Employee Stock Purchase Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Policy does not apply to periodic purchases under a Company employee stock purchase plan, if such plan exists, that are made as the result of an election made at the beginning of the purchase period. This Policy would apply, however, to an initial decision to participate in the plan or a decision to increase the level of contribution in a subsequent purchase period. The policy also applies to any sales of shares purchased under the plan.</font></div><div style="margin-top:12pt;padding-left:41pt;padding-right:8.65pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13pt;text-decoration:underline">401(k) Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If the Company has a 401(k) plan that provides for the purchase of Company Securities, this Policy does not apply to purchases of Company Securities in such plan as a result of periodic contributions made pursuant to payroll deduction. The Policy does apply, however, to initial elections to participate in a Company stock fund and to increases or decreases in the level of participation, as well as to transfers in or out of a Company stock fund (including in connection with a plan loan).</font></div><div style="margin-top:12.05pt;padding-left:41pt;padding-right:34.6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13pt;text-decoration:underline">Transactions in Mutual Funds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Transactions in mutual funds that are invested in Company Securities are not subject to this Policy.</font></div><div style="height:67.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:41pt;padding-right:9.3pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13pt;text-decoration:underline">Transactions with the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Any purchase of Company Securities from the Company or sales of Company Securities to the Company not already identified in this Section 8 are not subject to this Policy.</font></div><div style="margin-top:12pt;padding-left:76.95pt;text-indent:-35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:26.95pt;text-decoration:underline">Special and Prohibited Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div style="margin-top:3.95pt;padding-left:44.6pt;padding-right:10.2pt;text-indent:32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13pt;text-decoration:underline">Prohibited Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Persons covered by this Policy are prohibited from engaging in the following with respect to Company Securities&#58; (i) short sales, (ii) put options, call options or other derivative securities on an exchange or in any other organized market and (iii) hedging or monetization transactions, including through the use of financial instruments such as prepaid variable forwards, equity swaps, collars and exchange funds.</font></div><div style="margin-top:12pt;padding-left:41pt;padding-right:13.15pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13pt;text-decoration:underline">Margin Accounts and Pledged Securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Persons covered by this Policy are prohibited from holding Company Securities in a margin account or otherwise pledging Company Securities as collateral for a loan. An exception may be granted where an individual wishes to pledge Company Securities as collateral for a loan (not including margin debt) and clearly demonstrates the financial capacity to repay the loan without resort to the pledged securities. If an individual wishes to pledge Company Securities as collateral for a loan, he or she must submit a request for approval to the Compliance Officer at least two weeks prior to the proposed execution of documents evidencing the proposed pledge.</font></div><div style="margin-top:12pt;padding-left:41pt;padding-right:8.3pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13pt;text-decoration:underline">Standing and Limit Orders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Standing orders or limit orders, other than pursuant to Rule 10b5-1 Plans, are discouraged and must be approved by the Compliance Officer prior to placement of any such order.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:7.6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:16pt;text-decoration:underline">Rule 10b5-1 Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), provides a defense from insider trading liability under Rule 10b- 5 of the Exchange Act. If a person subject to this Policy enters into a plan that meets the requirements of Rule 10b5-1 (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Rule 10b5-1 Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), Company Securities may be purchased, sold or gifted pursuant to the 10b5-1 Plan without regard to certain insider trading restrictions. To comply with this Policy, a Rule 10b5-1 Plan must be approved by the Compliance Officer, and any amendment, suspension or termination of a Rule 10b5-1 Plan must be approved by the Compliance Officer in advance. Any Rule 10b5-1 Plan to be entered into or amended, suspended or terminated by the Compliance Officer must be approved by the Chief Financial Officer or Chief Executive Officer (or other designated officer).</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:13.85pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:16pt;text-decoration:underline">Pre-Clearance Procedures and Trading Windows</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. To help prevent inadvertent violations of the federal securities laws and to avoid even the appearance of trading on the basis of inside information, persons subject to this Policy are required to comply with the following procedures, except that transactions pursuant to a Rule 10b5-1 Plan that complies with this Policy are not subject to the following procedures.</font></div><div style="margin-top:12.05pt;padding-left:41pt;padding-right:5.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:7pt;text-decoration:underline">Pre-Clearance Procedures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Persons subject to this Policy may not engage in any transaction in Company Securities at any time (other than as specified in this Policy), </font></div><div style="height:67.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12.05pt;padding-left:41pt;padding-right:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">even if not subject to a Blackout Period (as defined below), without first obtaining pre-clearance of the transaction from the Compliance Officer. A request for pre-clearance should be submitted to the Compliance Officer at least two trading days in advance of the proposed transaction. The Compliance Officer is under no obligation to approve a transaction submitted for pre-clearance, and may determine not to permit the transaction. If a person seeks pre-clearance and permission to engage in the transaction is denied, then he or she should refrain from initiating any transaction in Company Securities, and should not inform any other person of the restriction. Any request for pre- clearance by the Compliance Officer should be submitted to, and approved by, the Chief Financial Officer or Chief Executive Officer (or other designated officer).</font></div><div style="margin-top:12pt;padding-left:41pt;padding-right:7.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">When a request for pre-clearance is made, the requestor should carefully consider whether he or she may be aware of any material nonpublic information about the Company and should describe fully those circumstances to the Compliance Officer. The requestor also should indicate whether he or she has effected any non-exempt &#8220;opposite- way&#8221; transactions within the past six months, and should be prepared to report the proposed transaction on an appropriate Form 4 or Form 5, if applicable. The requestor should also be prepared to comply with Rule 144 under the Securities Act of 1933, as amended, and file a Form 144, if necessary, at the time of any sale. After receiving clearance to engage in a trade from the Compliance Officer, the requestor must complete the proposed trade within four trading days or make a new trading request.</font></div><div style="margin-top:12pt;padding-left:41pt;padding-right:7.3pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:7pt;text-decoration:underline">Quarterly Trading Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Persons subject to this Policy may not engage in any transaction in Company Securities (other than as specified in this Policy) during a &#8220;Blackout Period&#8221; beginning on the day that is two weeks prior to the last day of each fiscal quarter and ending after the first full trading day following the date of the public release of the Company&#8217;s earnings results for that quarter. In other words, persons subject to this Policy may only conduct transactions in Company Securities during the period beginning on the day after the first full trading day following the public release of the Company&#8217;s earnings for a quarter and ending on the day that is two weeks prior to the last day of the next fiscal quarter.</font></div><div style="margin-top:12pt;padding-left:41pt;padding-right:6.25pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:7pt;text-decoration:underline">Event-Specific Trading Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In addition, from time to time, the Company may be involved in activities&#8212;such as proposed acquisitions&#8212;that are material and that are known only by a few people at the Company. For those individuals whose duties at the Company cause them to be aware of such activity, the Compliance Officer will notify them of an event-specific trading restriction, and those individuals will not be permitted to trade in Company Securities during such trading restriction. The existence of an event-specific trading restriction will not be widely announced and should not be communicated to anyone. Even if individuals are not notified of an event-specific trading restriction, they should not trade in Company Securities if they are aware of material nonpublic information.</font></div><div style="margin-top:12.05pt;padding-left:5pt;padding-right:13.2pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:16pt;text-decoration:underline">Post-Termination Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Policy continues to apply to transactions in Company Securities even after termination of service to the Company. If an individual is in possession of material nonpublic information when his or her service terminates, that </font></div><div style="height:67.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12.05pt;padding-left:5pt;padding-right:13.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">individual may not trade in Company Securities until that information has become public or is no longer material.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:6.45pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:16pt;text-decoration:underline">Unauthorized Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Maintaining the confidentiality of Company information is essential for competitive, security and other business reasons, as well as to comply with securities laws. Directors, officers and employees should treat all information they learn about the Company or its business plans in connection with their employment as confidential and proprietary to the Company. Inadvertent disclosure of confidential or inside information may expose the Company and individuals to significant risk of investigation and litigation.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:4.4pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The timing and nature of the Company&#8217;s disclosure of material information to outsiders is subject to legal rules. Accordingly, it is important that responses to inquiries regarding the Company from the press, investment analysts or others in the financial community be made on the Company&#8217;s behalf only through authorized individuals, as expressly identified by the Compliance Officer.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:16pt;text-decoration:underline">Consequences of Violations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The purchase or sale of securities while aware of material nonpublic information, or the disclosure of material nonpublic information to others who then trade in the Company&#8217;s Securities, is prohibited by U.S. federal and state laws. Insider trading violations are pursued vigorously by the SEC, U.S. Attorneys and state enforcement authorities as well as foreign regulatory authorities. Punishment for insider trading violations is severe and could include significant fines and imprisonment. While the regulatory authorities concentrate their efforts on the individuals who trade, or who tip inside information to others who trade, the federal securities laws also impose potential liability on companies and other &#8220;controlling persons&#8221; if they fail to take reasonable steps to prevent insider trading by company personnel.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:7.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In addition, an individual&#8217;s failure to comply with this Policy may subject the individual to Company-imposed sanctions, including dismissal for cause, whether or not the employee&#8217;s failure to comply results in a violation of law. In addition to the formal sanctions summarized above, a violation of law, or even an SEC investigation that does not result in prosecution, can tarnish a person&#8217;s reputation and irreparably damage a career.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:25.85pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:16pt;text-decoration:underline">Company Assistance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Any person who has a question about this Policy or its application to any proposed transaction may obtain additional guidance from the Compliance Officer.</font></div><div style="margin-top:12pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Effective&#58; October 10, 2024</font></div><div style="height:67.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>exhibit231-consent.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i7652d330428048f8b821a399a32bf40b_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 23.1</font></div><div style="margin-top:12pt;text-align:center"><font><br></font></div><div style="margin-top:12pt;text-align:center"><font><br></font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-282676) pertaining to the CAMP4 Therapeutics Corporation Amended and Restated 2016 Stock Option and Grant Plan, the CAMP4 Therapeutics Corporation 2024 Equity Incentive Plan and the CAMP4 Therapeutics Corporation 2024 Employee Stock Purchase Plan of our report dated March 27, 2025, with respect to the consolidated financial statements of&#160;CAMP4 Therapeutics Corporation included in this Annual Report (Form 10-K) for the year ended December 31, 2024.</font></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Ernst &#38; Young LLP</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:-0.88pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston, Massachusetts</font></div><div style="padding-right:-0.88pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 27, 2025</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:15.865%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>exhibit311certification.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i22222fe66ad149adb4301621cc94ea5a_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">EXCHANGE ACT OF 1934, AS ADOPTED</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">I, Josh Mandel-Brehm, certify that&#58;</font></div><div><font><br></font></div><div style="padding-left:33pt;text-indent:-16.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:9.65pt">I have reviewed this Annual Report on Form 10-K of CAMP4 Therapeutics Corporation&#59;</font></div><div><font><br></font></div><div style="padding-left:33pt;padding-right:10pt;text-indent:-16.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:129%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:129%;padding-left:9.65pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div style="padding-left:33pt;padding-right:14pt;text-indent:-16.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:129%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:129%;padding-left:9.65pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font><br></font></div><div style="padding-left:33pt;padding-right:33pt;text-indent:-16.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:136%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:136%;padding-left:9.65pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have&#58;</font></div><div style="text-align:center"><font><br></font></div><div style="padding-left:65pt;padding-right:9pt;text-indent:-16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:126%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:126%;padding-left:9.76pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div><font><br></font></div><div style="padding-left:65pt;text-indent:-16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:9.25pt">&#91;Paragraph omitted pursuant to SEC Release Nos. 33-8238&#47;34-47986 and 33-8392&#47;34-49313&#93;&#59;</font></div><div><font><br></font></div><div style="padding-left:65pt;padding-right:13pt;text-indent:-16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:129%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:129%;padding-left:9.76pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div><font><br></font></div><div style="padding-left:65pt;padding-right:4pt;text-indent:-16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:126%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:126%;padding-left:9.25pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div style="padding-left:33pt;padding-right:18pt;text-indent:-16.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:129%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:129%;padding-left:9.65pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:65pt;padding-right:22pt;text-indent:-16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:129%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:129%;padding-left:9.76pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div><font><br></font></div><div style="padding-left:65pt;padding-right:13pt;text-indent:-16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:136%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:136%;padding-left:9.25pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.194%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.697%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.809%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:134%">Dated&#58; March 27, 2025</font></td><td colspan="6" style="padding:0 1pt 0 72.37pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:134%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:134%">&#47;s&#47; Josh Mandel-Brehm</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:9.55pt">Name&#58; Josh Mandel-Brehm</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:9.55pt">Title&#58;  President and Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 24.37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:134%">(Principal Executive Officer)</font></td></tr><tr style="height:40pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>exhibit312certification.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ib62d36d4cd8c4bf7a195a23b902b1726_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">EXCHANGE ACT OF 1934, AS ADOPTED</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">I, Kelly Gold, certify that&#58;</font></div><div><font><br></font></div><div style="padding-left:33pt;text-indent:-16.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:9.65pt">I have reviewed this Annual Report on Form 10-K of CAMP4 Therapeutics Corporation&#59;</font></div><div><font><br></font></div><div style="padding-left:33pt;padding-right:10pt;text-indent:-16.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:129%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:129%;padding-left:9.65pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div style="padding-left:33pt;padding-right:14pt;text-indent:-16.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:129%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:129%;padding-left:9.65pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font><br></font></div><div style="padding-left:33pt;padding-right:33pt;text-indent:-16.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:136%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:136%;padding-left:9.65pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:65pt;padding-right:9pt;text-indent:-16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:126%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:126%;padding-left:9.76pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div><font><br></font></div><div style="padding-left:65pt;text-indent:-16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:9.25pt">&#91;Paragraph omitted pursuant to SEC Release Nos. 33-8238&#47;34-47986 and 33-8392&#47;34-49313&#93;&#59;</font></div><div><font><br></font></div><div style="padding-left:65pt;padding-right:13pt;text-indent:-16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:129%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:129%;padding-left:9.76pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div><font><br></font></div><div style="padding-left:65pt;padding-right:4pt;text-indent:-16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:126%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:126%;padding-left:9.25pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div style="padding-left:33pt;padding-right:18pt;text-indent:-16.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:129%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:129%;padding-left:9.65pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:65pt;padding-right:22pt;text-indent:-16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:129%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:129%;padding-left:9.76pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div><font><br></font></div><div style="padding-left:65pt;padding-right:13pt;text-indent:-16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:136%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:136%;padding-left:9.25pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:134%">Dated&#58; March 27, 2025</font></td><td colspan="6" style="padding:0 1pt 0 72.37pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:134%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:134%">&#47;s&#47; Kelly Gold</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:9.55pt">Name&#58; Kelly Gold</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:134%">Title&#58;  Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 24.37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:134%">(Principal Financial Officer and Principal Accounting Officer)</font></td></tr><tr style="height:40pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>exhibit321certification.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i65505f839e5244f8a13423349364af75_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 350,</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div style="padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:136%">Pursuant to 18 U.S.C. &#167; 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of CAMP4 Therapeutics Corporation (the &#8220;Company&#8221;) hereby certifies, to the best of my knowledge, that&#58;</font></div><div><font><br></font></div><div style="padding-left:65pt;padding-right:10pt;text-indent:-16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:129%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:129%;padding-left:7.52pt">the accompanying Annual Report on Form 10-K of the Company for the fiscal year ended December 31, 2024 (the &#8220;Report&#8221;) fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div><font><br></font></div><div style="padding-left:65pt;padding-right:13pt;text-indent:-16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:136%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:136%;padding-left:5.02pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.194%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.697%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.809%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:134%">Dated&#58; March 27, 2025</font></td><td colspan="6" style="padding:0 1pt 0 72.37pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:134%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:134%">&#47;s&#47; Josh Mandel-Brehm</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:9.55pt">Name&#58; Josh Mandel-Brehm</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:134%">Title&#58;  President and Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 24.37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:134%">(Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>8
<FILENAME>exhibit322certification.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i954ce2fcff64489e9b9fc46793f60388_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 350,</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div style="padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:136%">Pursuant to 18 U.S.C. &#167; 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of CAMP4 Therapeutics Corporation (the &#8220;Company&#8221;) hereby certifies, to the best of my knowledge, that&#58;</font></div><div><font><br></font></div><div style="padding-left:65pt;padding-right:10pt;text-indent:-16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:129%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:129%;padding-left:7.52pt">the accompanying Annual Report on Form 10-K of the Company for the fiscal year ended December 31, 2024 (the &#8220;Report&#8221;) fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div><font><br></font></div><div style="padding-left:65pt;padding-right:13pt;text-indent:-16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:136%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:136%;padding-left:5.02pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.029%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:134%">Dated&#58; March 27, 2025</font></td><td colspan="6" style="padding:0 1pt 0 72.37pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:134%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:134%">&#47;s&#47; Kelly Gold</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:9.55pt">Name&#58; Kelly Gold</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:134%">Title&#58;  Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 24.37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:134%">(Principal Financial Officer and Principal Accounting Officer)</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt 0 24.37pt"></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>camp-20241231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:344bab39-1447-4710-a813-d0e5cea79568,g:e8dcb9a0-a4ba-432e-8d82-4b2fdbae6592-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:camp="http://camp4tx.com/20241231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://camp4tx.com/20241231">
  <xs:import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/cyd-af-sub/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-af-sub-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="camp-20241231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="camp-20241231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="camp-20241231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="camp-20241231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://camp4tx.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://camp4tx.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://camp4tx.com/role/ConsolidatedBalanceSheets">
        <link:definition>9952151 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://camp4tx.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>9952152 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperationsandComprehensiveLoss" roleURI="http://camp4tx.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss">
        <link:definition>9952153 - Statement - Consolidated Statements of Operations and Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit" roleURI="http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit">
        <link:definition>9952154 - Statement - Consolidated Statements of Convertible Preferred Stock and Stockholders' Deficit</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficitParenthetical" roleURI="http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficitParenthetical">
        <link:definition>9952155 - Statement - Consolidated Statements of Convertible Preferred Stock and Stockholders' Deficit (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://camp4tx.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>9952156 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionofBusinessandBasisofPresentation" roleURI="http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentation">
        <link:definition>9952157 - Disclosure - Description of Business and Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://camp4tx.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>9952158 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://camp4tx.com/role/FairValueMeasurements">
        <link:definition>9952159 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrepaidExpensesAndOtherCurrentAssets" roleURI="http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssets">
        <link:definition>9952160 - Disclosure - Prepaid Expenses And Other Current Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyAndEquipmentNet" roleURI="http://camp4tx.com/role/PropertyAndEquipmentNet">
        <link:definition>9952161 - Disclosure - Property And Equipment, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesandOtherCurrentLiabilities" roleURI="http://camp4tx.com/role/AccruedExpensesandOtherCurrentLiabilities">
        <link:definition>9952162 - Disclosure - Accrued Expenses and Other Current Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://camp4tx.com/role/CommitmentsandContingencies">
        <link:definition>9952163 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationandLicenseAgreements" roleURI="http://camp4tx.com/role/CollaborationandLicenseAgreements">
        <link:definition>9952164 - Disclosure - Collaboration and License Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertiblePreferredStockandStockholdersDeficit" roleURI="http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficit">
        <link:definition>9952165 - Disclosure - Convertible Preferred Stock and Stockholders' Deficit</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://camp4tx.com/role/StockBasedCompensation">
        <link:definition>9952166 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlan" roleURI="http://camp4tx.com/role/EmployeeBenefitPlan">
        <link:definition>9952167 - Disclosure - Employee Benefit Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://camp4tx.com/role/IncomeTaxes">
        <link:definition>9952168 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://camp4tx.com/role/SegmentReporting">
        <link:definition>9952169 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareAttributabletoCommonStockholders" roleURI="http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholders">
        <link:definition>9952170 - Disclosure - Net Loss Per Share Attributable to Common Stockholders</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedParties" roleURI="http://camp4tx.com/role/RelatedParties">
        <link:definition>9952171 - Disclosure - Related Parties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>9955512 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://camp4tx.com/role/FairValueMeasurementsTables">
        <link:definition>9955513 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrepaidExpensesAndOtherCurrentAssetsTables" roleURI="http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssetsTables">
        <link:definition>9955514 - Disclosure - Prepaid Expenses And Other Current Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyAndEquipmentNetTables" roleURI="http://camp4tx.com/role/PropertyAndEquipmentNetTables">
        <link:definition>9955515 - Disclosure - Property And Equipment, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesandOtherCurrentLiabilitiesTables" roleURI="http://camp4tx.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables">
        <link:definition>9955516 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesTables" roleURI="http://camp4tx.com/role/CommitmentsandContingenciesTables">
        <link:definition>9955517 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertiblePreferredStockandStockholdersDeficitTables" roleURI="http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitTables">
        <link:definition>9955518 - Disclosure - Convertible Preferred Stock and Stockholders' Deficit (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://camp4tx.com/role/StockBasedCompensationTables">
        <link:definition>9955519 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://camp4tx.com/role/IncomeTaxesTables">
        <link:definition>9955520 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://camp4tx.com/role/SegmentReportingTables">
        <link:definition>9955521 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareAttributabletoCommonStockholdersTables" roleURI="http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersTables">
        <link:definition>9955522 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionofBusinessandBasisofPresentationDetails" roleURI="http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentationDetails">
        <link:definition>9955523 - Disclosure - Description of Business and Basis of Presentation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails" roleURI="http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails">
        <link:definition>9955524 - Disclosure - Summary of Significant Accounting Policies - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesSchedulePropertyandEquipmentNetUsefulLivesDetails" roleURI="http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesSchedulePropertyandEquipmentNetUsefulLivesDetails">
        <link:definition>9955525 - Disclosure - Summary of Significant Accounting Policies - Schedule Property and Equipment, Net Useful Lives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>9955526 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsDetails" roleURI="http://camp4tx.com/role/FairValueMeasurementsDetails">
        <link:definition>9955527 - Disclosure - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrepaidExpensesAndOtherCurrentAssetsDetails" roleURI="http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails">
        <link:definition>9955528 - Disclosure - Prepaid Expenses And Other Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyAndEquipmentNetScheduleofPropertyandEquipmentNetDetails" roleURI="http://camp4tx.com/role/PropertyAndEquipmentNetScheduleofPropertyandEquipmentNetDetails">
        <link:definition>9955529 - Disclosure - Property And Equipment, Net - Schedule of Property and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyAndEquipmentNetNarrativeDetails" roleURI="http://camp4tx.com/role/PropertyAndEquipmentNetNarrativeDetails">
        <link:definition>9955530 - Disclosure - Property And Equipment, Net - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesandOtherCurrentLiabilitiesDetails" roleURI="http://camp4tx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails">
        <link:definition>9955531 - Disclosure - Accrued Expenses and Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesOperatingLeasesNarrativeDetails" roleURI="http://camp4tx.com/role/CommitmentsandContingenciesOperatingLeasesNarrativeDetails">
        <link:definition>9955532 - Disclosure - Commitments and Contingencies - Operating Leases Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesScheduleofOperatingLeaseCostsandOtherInformationDetails" roleURI="http://camp4tx.com/role/CommitmentsandContingenciesScheduleofOperatingLeaseCostsandOtherInformationDetails">
        <link:definition>9955533 - Disclosure - Commitments and Contingencies - Schedule of Operating Lease Costs and Other Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails" roleURI="http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails">
        <link:definition>9955534 - Disclosure - Commitments and Contingencies - Schedule of Maturities of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesFinanceLeasesNarrativeDetails" roleURI="http://camp4tx.com/role/CommitmentsandContingenciesFinanceLeasesNarrativeDetails">
        <link:definition>9955535 - Disclosure - Commitments and Contingencies - Finance Leases Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesScheduleofFinanceLeaseCostandOtherInformationDetails" roleURI="http://camp4tx.com/role/CommitmentsandContingenciesScheduleofFinanceLeaseCostandOtherInformationDetails">
        <link:definition>9955536 - Disclosure - Commitments and Contingencies - Schedule of Finance Lease Cost and Other Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesScheduleofMaturitiesofFinanceLeaseLiabilitiesDetails" roleURI="http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofFinanceLeaseLiabilitiesDetails">
        <link:definition>9955537 - Disclosure - Commitments and Contingencies - Schedule of Maturities of Finance Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesFinancingObligationNarrativeDetails" roleURI="http://camp4tx.com/role/CommitmentsandContingenciesFinancingObligationNarrativeDetails">
        <link:definition>9955538 - Disclosure - Commitments and Contingencies - Financing Obligation Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationandLicenseAgreementsChildrensMedicalCenterCorporationNarrativeDetails" roleURI="http://camp4tx.com/role/CollaborationandLicenseAgreementsChildrensMedicalCenterCorporationNarrativeDetails">
        <link:definition>9955539 - Disclosure - Collaboration and License Agreements - Children's Medical Center Corporation Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationandLicenseAgreementsWhiteheadInstituteforBiomedicalResearchNarrativeDetails" roleURI="http://camp4tx.com/role/CollaborationandLicenseAgreementsWhiteheadInstituteforBiomedicalResearchNarrativeDetails">
        <link:definition>9955540 - Disclosure - Collaboration and License Agreements - Whitehead Institute for Biomedical Research Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationandLicenseAgreementsFulcrumTherapeuticsIncNarrativeDetails" roleURI="http://camp4tx.com/role/CollaborationandLicenseAgreementsFulcrumTherapeuticsIncNarrativeDetails">
        <link:definition>9955541 - Disclosure - Collaboration and License Agreements - Fulcrum Therapeutics, Inc. Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationandLicenseAgreementsEliLillyandCompanyNarrativeDetails" roleURI="http://camp4tx.com/role/CollaborationandLicenseAgreementsEliLillyandCompanyNarrativeDetails">
        <link:definition>9955542 - Disclosure - Collaboration and License Agreements - Eli Lilly and Company Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationandLicenseAgreementsBioMarinPharmaceuticalIncNarrativeDetails" roleURI="http://camp4tx.com/role/CollaborationandLicenseAgreementsBioMarinPharmaceuticalIncNarrativeDetails">
        <link:definition>9955543 - Disclosure - Collaboration and License Agreements - BioMarin Pharmaceutical Inc. Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertiblePreferredStockandStockholdersDeficitNarrativeDetails" roleURI="http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitNarrativeDetails">
        <link:definition>9955544 - Disclosure - Convertible Preferred Stock and Stockholders' Deficit - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertiblePreferredStockandStockholdersDeficitSummaryofConvertiblePreferredStockDetails" roleURI="http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitSummaryofConvertiblePreferredStockDetails">
        <link:definition>9955545 - Disclosure - Convertible Preferred Stock and Stockholders' Deficit - Summary of Convertible Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertiblePreferredStockandStockholdersDeficitScheduleofCommonStockIssuanceUponConversionDetails" roleURI="http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitScheduleofCommonStockIssuanceUponConversionDetails">
        <link:definition>9955546 - Disclosure - Convertible Preferred Stock and Stockholders' Deficit - Schedule of Common Stock Issuance Upon Conversion (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation2024EquityIncentivePlanNarrativeDetails" roleURI="http://camp4tx.com/role/StockBasedCompensation2024EquityIncentivePlanNarrativeDetails">
        <link:definition>9955547 - Disclosure - Stock-Based Compensation - 2024 Equity Incentive Plan Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation2024EmployeeStockPurchasePlanNarrativeDetails" roleURI="http://camp4tx.com/role/StockBasedCompensation2024EmployeeStockPurchasePlanNarrativeDetails">
        <link:definition>9955548 - Disclosure - Stock-Based Compensation - 2024 Employee Stock Purchase Plan Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationScheduleofStockOptionsFairValueAssumptionsDetails" roleURI="http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsFairValueAssumptionsDetails">
        <link:definition>9955549 - Disclosure - Stock-Based Compensation - Schedule of Stock Options Fair Value Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationStockOptionActivityNarrativeDetails" roleURI="http://camp4tx.com/role/StockBasedCompensationStockOptionActivityNarrativeDetails">
        <link:definition>9955550 - Disclosure - Stock-Based Compensation - Stock Option Activity Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationScheduleofStockOptionsActivityDetails" roleURI="http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails">
        <link:definition>9955551 - Disclosure - Stock-Based Compensation - Schedule of Stock Options Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationScheduleofRestrictedStockActivityDetails" roleURI="http://camp4tx.com/role/StockBasedCompensationScheduleofRestrictedStockActivityDetails">
        <link:definition>9955552 - Disclosure - Stock-Based Compensation - Schedule of Restricted Stock Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationRestrictedStockAwardsNarrativeDetails" roleURI="http://camp4tx.com/role/StockBasedCompensationRestrictedStockAwardsNarrativeDetails">
        <link:definition>9955553 - Disclosure - Stock-Based Compensation - Restricted Stock Awards Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationScheduleofStockbasedCompensationExpenseDetails" roleURI="http://camp4tx.com/role/StockBasedCompensationScheduleofStockbasedCompensationExpenseDetails">
        <link:definition>9955554 - Disclosure - Stock-Based Compensation - Schedule of Stock-based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlanDetails" roleURI="http://camp4tx.com/role/EmployeeBenefitPlanDetails">
        <link:definition>9955555 - Disclosure - Employee Benefit Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://camp4tx.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>9955556 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" roleURI="http://camp4tx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails">
        <link:definition>9955557 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://camp4tx.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>9955558 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingDetails" roleURI="http://camp4tx.com/role/SegmentReportingDetails">
        <link:definition>9955559 - Disclosure - Segment Reporting (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareAttributabletoCommonStockholdersScheduleofBasicandDilutedNetLossperShareDetails" roleURI="http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofBasicandDilutedNetLossperShareDetails">
        <link:definition>9955560 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Schedule of Basic and Diluted Net Loss per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareAttributabletoCommonStockholdersScheduleofExcludedAntidilutiveSecuritiesDetails" roleURI="http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofExcludedAntidilutiveSecuritiesDetails">
        <link:definition>9955561 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Schedule of Excluded Anti-dilutive Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartiesDetails" roleURI="http://camp4tx.com/role/RelatedPartiesDetails">
        <link:definition>9955562 - Disclosure - Related Parties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="camp_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="camp_FinanceLiabilityCurrent" abstract="false" name="FinanceLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_FinanceLiabilityNonCurrent" abstract="false" name="FinanceLiabilityNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_TemporaryEquitySharesConversionOfConvertibleSecurities" abstract="false" name="TemporaryEquitySharesConversionOfConvertibleSecurities" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="camp_TemporaryEquityValueConversionOfConvertibleSecurities" abstract="false" name="TemporaryEquityValueConversionOfConvertibleSecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_NoncashLeaseExpense" abstract="false" name="NoncashLeaseExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_IncreaseDecreaseInOperatingLeaseAssetsLiabilities" abstract="false" name="IncreaseDecreaseInOperatingLeaseAssetsLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction" abstract="false" name="ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_PrincipalPaymentsOnFinancingObligationsFailedSaleLeasebackTransaction" abstract="false" name="PrincipalPaymentsOnFinancingObligationsFailedSaleLeasebackTransaction" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_FinanceLeaseRightOfUseAssetConvertedToFixedAsset" abstract="false" name="FinanceLeaseRightOfUseAssetConvertedToFixedAsset" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_PrepaidExpensesAndOtherCurrentAssetsDisclosureTextBlock" abstract="false" name="PrepaidExpensesAndOtherCurrentAssetsDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="camp_CollaborationAndLicenseAgreementsAbstract" abstract="true" name="CollaborationAndLicenseAgreementsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="camp_ConvertiblePreferredStockAndStockholdersDeficitAbstract" abstract="true" name="ConvertiblePreferredStockAndStockholdersDeficitAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="camp_TemporaryEquityDisclosureAndStockholdersEquityTextBlock" abstract="false" name="TemporaryEquityDisclosureAndStockholdersEquityTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="camp_GuaranteesAndIndemnificationsPolicyTextBlock" abstract="false" name="GuaranteesAndIndemnificationsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="camp_FinancingObligationFailedSaleLeasebackPolicyTextBlock" abstract="false" name="FinancingObligationFailedSaleLeasebackPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="camp_PatentCostsPolicyTextBlock" abstract="false" name="PatentCostsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="camp_OfferingCostsPolicyTextBlock" abstract="false" name="OfferingCostsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="camp_EmergingGrowthCompanyStatusPolicyTextBlock" abstract="false" name="EmergingGrowthCompanyStatusPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="camp_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock" abstract="false" name="ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="camp_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" abstract="false" name="ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="camp_DescriptionOfBusinessAndBasisOfPresentationTable" abstract="true" name="DescriptionOfBusinessAndBasisOfPresentationTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="camp_DescriptionOfBusinessAndBasisOfPresentationLineItems" abstract="true" name="DescriptionOfBusinessAndBasisOfPresentationLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="camp_PaymentsOfUnderwritingDiscountsAndCommissions" abstract="false" name="PaymentsOfUnderwritingDiscountsAndCommissions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_WorkingCapital" abstract="false" name="WorkingCapital" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_ComputerAndSoftwareMember" abstract="true" name="ComputerAndSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="camp_LaboratoryEquipmentMember" abstract="true" name="LaboratoryEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="camp_NumberOfMajorFinancialInstitutionsWithCashAndCashEquivalentDeposits" abstract="false" name="NumberOfMajorFinancialInstitutionsWithCashAndCashEquivalentDeposits" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="camp_PrepaidResearchAndDevelopmentExpenseCurrent" abstract="false" name="PrepaidResearchAndDevelopmentExpenseCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_PrepaidSoftwareAndSubscriptionExpenseCurrent" abstract="false" name="PrepaidSoftwareAndSubscriptionExpenseCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_PrepaidVariableLeaseExpenseCurrent" abstract="false" name="PrepaidVariableLeaseExpenseCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_PrepaidFederalResearchAndDevelopmentTaxCreditCurrent" abstract="false" name="PrepaidFederalResearchAndDevelopmentTaxCreditCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_ProfessionalFeesAndOtherGeneralAndAdministrativeExpensesCurrent" abstract="false" name="ProfessionalFeesAndOtherGeneralAndAdministrativeExpensesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_ResearchAndDevelopmentExpensesCurrent" abstract="false" name="ResearchAndDevelopmentExpensesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_OfficeAndLaboratorySpaceInCambridgeMember" abstract="true" name="OfficeAndLaboratorySpaceInCambridgeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="camp_OfficeAndLaboratorySpaceInBoulderMember" abstract="true" name="OfficeAndLaboratorySpaceInBoulderMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="camp_MaximumReimbursableIncentiveFromLessor" abstract="false" name="MaximumReimbursableIncentiveFromLessor" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_LesseeOperatingLeaseIncrementalBorrowingRate" abstract="false" name="LesseeOperatingLeaseIncrementalBorrowingRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="camp_LeaseCostExcludingFinanceLeases" abstract="false" name="LeaseCostExcludingFinanceLeases" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_SupplementalInformationRelatingToLeasesAbstract" abstract="true" name="SupplementalInformationRelatingToLeasesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="camp_LeaseCostFinanceLeases" abstract="false" name="LeaseCostFinanceLeases" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_FinancingObligationsLeaseTermOfContract" abstract="false" name="FinancingObligationsLeaseTermOfContract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="camp_FinancingObligationsLeaseMaximumMonthlyRentalPayments" abstract="false" name="FinancingObligationsLeaseMaximumMonthlyRentalPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_FinancingObligationsLeaseFixedRepurchasePrice" abstract="false" name="FinancingObligationsLeaseFixedRepurchasePrice" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_FinancingObligationsLeaseMonthlyInterestRatePercent" abstract="false" name="FinancingObligationsLeaseMonthlyInterestRatePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="camp_FinancingObligationsLeaseMaximumInterestExpense" abstract="false" name="FinancingObligationsLeaseMaximumInterestExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_ChildrenMedicalCenterCorporationMember" abstract="true" name="ChildrenMedicalCenterCorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="camp_MilestoneTargetsAxis" abstract="true" name="MilestoneTargetsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="camp_MilestoneTargetsDomain" abstract="true" name="MilestoneTargetsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="camp_UponAchievementOfFirstLicensedTargetMember" abstract="true" name="UponAchievementOfFirstLicensedTargetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="camp_UponAchievementOfSecondLicensedTargetMember" abstract="true" name="UponAchievementOfSecondLicensedTargetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="camp_UponAchievementOfThirdLicensedTargetMember" abstract="true" name="UponAchievementOfThirdLicensedTargetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="camp_CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation" abstract="false" name="CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_PercentageOfUpfrontPaymentRequiredUponFirstInvestigationalNewDrugStudy" abstract="false" name="PercentageOfUpfrontPaymentRequiredUponFirstInvestigationalNewDrugStudy" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="camp_TheWhiteheadInstituteForBiomedicalResearchMember" abstract="true" name="TheWhiteheadInstituteForBiomedicalResearchMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="camp_CollaborativeArrangementUpfrontLicenseIssuanceFeePayment" abstract="false" name="CollaborativeArrangementUpfrontLicenseIssuanceFeePayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_CollaborativeArrangementTieredRoyaltiesPayableOnNetSalesMaximumLowerRangePercent" abstract="false" name="CollaborativeArrangementTieredRoyaltiesPayableOnNetSalesMaximumLowerRangePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="camp_CollaborativeArrangementTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale" abstract="false" name="CollaborativeArrangementTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="camp_CollaborativeArrangementFeesIncurredDuringPeriod" abstract="false" name="CollaborativeArrangementFeesIncurredDuringPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_FulcrumTherapeuticsInc.Member" abstract="true" name="FulcrumTherapeuticsInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="camp_TierOneProductMember" abstract="true" name="TierOneProductMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="camp_RevenueRemainingPerformanceObligationVariableConsiderationAmount" abstract="false" name="RevenueRemainingPerformanceObligationVariableConsiderationAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_RevenuePerformanceObligationNumberOfPerformanceObligations" abstract="false" name="RevenuePerformanceObligationNumberOfPerformanceObligations" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="camp_RevenueRemainingPerformanceObligationFixedConsiderationAmount" abstract="false" name="RevenueRemainingPerformanceObligationFixedConsiderationAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_EliLillyAndCompanyMember" abstract="true" name="EliLillyAndCompanyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="camp_CollaborativeArrangementReductionInResearchAndDevelopmentExpense" abstract="false" name="CollaborativeArrangementReductionInResearchAndDevelopmentExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_BioMarinPharmaceuticalInc.Member" abstract="true" name="BioMarinPharmaceuticalInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentPreclinicalMilestones" abstract="false" name="RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentPreclinicalMilestones" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentDevelopmentAndRegulatoryMilestones" abstract="false" name="RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentDevelopmentAndRegulatoryMilestones" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountCommercialSalesMilestones" abstract="false" name="RevenueRemainingPerformanceObligationVariableConsiderationAmountCommercialSalesMilestones" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_RevenueRemainingPerformanceObligationTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale" abstract="false" name="RevenueRemainingPerformanceObligationTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="camp_RevenueRemainingPerformanceObligationNoticePeriodForTermination" abstract="false" name="RevenueRemainingPerformanceObligationNoticePeriodForTermination" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="camp_RevenueRemainingPerformanceObligationExpectedReimbursableResearchAndDevelopmentExpenses" abstract="false" name="RevenueRemainingPerformanceObligationExpectedReimbursableResearchAndDevelopmentExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_NumberOfVotesPerCommonShare" abstract="false" name="NumberOfVotesPerCommonShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="camp_MarauderTherapeuticsInc2016StockOptionAndGrantPlanMember" abstract="true" name="MarauderTherapeuticsInc2016StockOptionAndGrantPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="camp_A2024EquityIncentivePlanMember" abstract="true" name="A2024EquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfEstimatedFairValueOnGrantDate" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfEstimatedFairValueOnGrantDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="camp_CertainExecutivesMember" abstract="true" name="CertainExecutivesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="camp_UnrecordedNotesPayableIssuedForStockOptionEarlyExercise" abstract="false" name="UnrecordedNotesPayableIssuedForStockOptionEarlyExercise" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAfterEarlyExerciseDueToNotesPayableForgiveness" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAfterEarlyExerciseDueToNotesPayableForgiveness" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="camp_WeightedAverageExercisePriceRollForward" abstract="true" name="WeightedAverageExercisePriceRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueRollForward" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="camp_OperatingLossCarryforwardsSubjectToExpiration" abstract="false" name="OperatingLossCarryforwardsSubjectToExpiration" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_OperatingLossCarryforwardsNotSubjectToExpiration" abstract="false" name="OperatingLossCarryforwardsNotSubjectToExpiration" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_CapitalizedResearchAndDevelopmentCosts" abstract="false" name="CapitalizedResearchAndDevelopmentCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="camp_DeferredTaxAssetsLeasingArrangements" abstract="false" name="DeferredTaxAssetsLeasingArrangements" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures" abstract="false" name="DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_DeferredTaxAssetsLiabilitiesGross" abstract="false" name="DeferredTaxAssetsLiabilitiesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_RDMember" abstract="true" name="RDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="camp_ClinicalAndPreclinicalExpenses" abstract="false" name="ClinicalAndPreclinicalExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_FacilitiesAndOverheadExpense" abstract="false" name="FacilitiesAndOverheadExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_CorporateExpenses" abstract="false" name="CorporateExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="camp_ConsultingAgreementsWithFoundersMember" abstract="true" name="ConsultingAgreementsWithFoundersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="camp_ConsultingAgreementsWithExecutiveConsultantMember" abstract="true" name="ConsultingAgreementsWithExecutiveConsultantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="camp_NumberOfFounders" abstract="false" name="NumberOfFounders" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>camp-20241231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:344bab39-1447-4710-a813-d0e5cea79568,g:e8dcb9a0-a4ba-432e-8d82-4b2fdbae6592-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://camp4tx.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="camp-20241231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://camp4tx.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_91fdc9dc-4070-4c9d-9ecc-4b78f7ba5e92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c3e83137-5004-492d-a42c-e30b0df54b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_91fdc9dc-4070-4c9d-9ecc-4b78f7ba5e92" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c3e83137-5004-492d-a42c-e30b0df54b5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9a9f5790-6267-4dab-bb4b-190cc9df5ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_91fdc9dc-4070-4c9d-9ecc-4b78f7ba5e92" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9a9f5790-6267-4dab-bb4b-190cc9df5ba0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_083d5f4d-080f-4d86-a6b6-601704fd7251" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_82b00462-6e6a-4314-8e4b-d8e15efd3862" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_083d5f4d-080f-4d86-a6b6-601704fd7251" xlink:to="loc_us-gaap_AssetsCurrent_82b00462-6e6a-4314-8e4b-d8e15efd3862" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_573ba70f-1179-40df-89f9-25d54527898a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_083d5f4d-080f-4d86-a6b6-601704fd7251" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_573ba70f-1179-40df-89f9-25d54527898a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_f903a347-cc6e-4bd2-8855-2d84ccd839fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_083d5f4d-080f-4d86-a6b6-601704fd7251" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_f903a347-cc6e-4bd2-8855-2d84ccd839fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_7dd0f869-253a-465b-ba6c-a8e8cfe90973" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_083d5f4d-080f-4d86-a6b6-601704fd7251" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_7dd0f869-253a-465b-ba6c-a8e8cfe90973" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e63e2328-5111-4342-af11-d507b63a893b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_083d5f4d-080f-4d86-a6b6-601704fd7251" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e63e2328-5111-4342-af11-d507b63a893b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_6d96f7bd-688d-4631-9a76-fe1dd1166a47" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_48747835-5321-458a-a738-f7f0dd2c52f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_6d96f7bd-688d-4631-9a76-fe1dd1166a47" xlink:to="loc_us-gaap_StockholdersEquity_48747835-5321-458a-a738-f7f0dd2c52f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_32b6b921-1227-4200-9736-6d6797216aee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_6d96f7bd-688d-4631-9a76-fe1dd1166a47" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_32b6b921-1227-4200-9736-6d6797216aee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_33f12829-e318-4638-a108-4526700b52e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_6d96f7bd-688d-4631-9a76-fe1dd1166a47" xlink:to="loc_us-gaap_CommitmentsAndContingencies_33f12829-e318-4638-a108-4526700b52e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_19ccaa4f-8396-4c8d-a672-59f1b11076af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_6d96f7bd-688d-4631-9a76-fe1dd1166a47" xlink:to="loc_us-gaap_Liabilities_19ccaa4f-8396-4c8d-a672-59f1b11076af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_7859d90a-2688-494f-9f5b-8734735552d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_d04f9244-37a3-479b-8ce5-4fb059a75d2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7859d90a-2688-494f-9f5b-8734735552d4" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_d04f9244-37a3-479b-8ce5-4fb059a75d2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_3c920905-17d2-41b6-9080-5915d177b7fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7859d90a-2688-494f-9f5b-8734735552d4" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_3c920905-17d2-41b6-9080-5915d177b7fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_db11d09a-493f-4949-a4e8-68193de58d01" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7859d90a-2688-494f-9f5b-8734735552d4" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_db11d09a-493f-4949-a4e8-68193de58d01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_FinanceLiabilityCurrent_0af19546-eb38-40b2-9173-1afa2690231f" xlink:href="camp-20241231.xsd#camp_FinanceLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7859d90a-2688-494f-9f5b-8734735552d4" xlink:to="loc_camp_FinanceLiabilityCurrent_0af19546-eb38-40b2-9173-1afa2690231f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_dab79f94-d5c0-4ed7-a3b2-ad945f6c8632" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7859d90a-2688-494f-9f5b-8734735552d4" xlink:to="loc_us-gaap_AccountsPayableCurrent_dab79f94-d5c0-4ed7-a3b2-ad945f6c8632" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_3411ad57-e490-46f6-95fe-c47975430648" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7859d90a-2688-494f-9f5b-8734735552d4" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_3411ad57-e490-46f6-95fe-c47975430648" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_78dc3eac-764c-4942-9cb9-cad5c9cb4b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_5959ab0b-31f2-496f-b8dc-98914e39ddee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_78dc3eac-764c-4942-9cb9-cad5c9cb4b2f" xlink:to="loc_us-gaap_AdditionalPaidInCapital_5959ab0b-31f2-496f-b8dc-98914e39ddee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_422e01a4-8f05-4f1c-a59a-0ca02972e4bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_78dc3eac-764c-4942-9cb9-cad5c9cb4b2f" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_422e01a4-8f05-4f1c-a59a-0ca02972e4bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_9e4de636-4ea9-48c5-ab65-de364d78d373" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_78dc3eac-764c-4942-9cb9-cad5c9cb4b2f" xlink:to="loc_us-gaap_CommonStockValue_9e4de636-4ea9-48c5-ab65-de364d78d373" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_0fc62586-3f23-40ca-b156-3ad493a3c8ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_0bfeb7a1-2c83-4cf1-a749-a3b469112dd1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0fc62586-3f23-40ca-b156-3ad493a3c8ea" xlink:to="loc_us-gaap_LiabilitiesCurrent_0bfeb7a1-2c83-4cf1-a749-a3b469112dd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0b108a38-8363-4cf6-b934-52ab4255c58e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0fc62586-3f23-40ca-b156-3ad493a3c8ea" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0b108a38-8363-4cf6-b934-52ab4255c58e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_30ea3ed4-4388-46b5-ae09-f94958ca2240" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0fc62586-3f23-40ca-b156-3ad493a3c8ea" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_30ea3ed4-4388-46b5-ae09-f94958ca2240" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_782b9dbc-cd07-462e-b388-bf1ec517ad28" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0fc62586-3f23-40ca-b156-3ad493a3c8ea" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_782b9dbc-cd07-462e-b388-bf1ec517ad28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_FinanceLiabilityNonCurrent_6ecf0b4d-2a76-4a8e-ac62-466275ea2463" xlink:href="camp-20241231.xsd#camp_FinanceLiabilityNonCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0fc62586-3f23-40ca-b156-3ad493a3c8ea" xlink:to="loc_camp_FinanceLiabilityNonCurrent_6ecf0b4d-2a76-4a8e-ac62-466275ea2463" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="camp-20241231.xsd#ConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://camp4tx.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_328ca045-5fc3-436b-a219-5efc9ebfbf80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_56a8f267-8276-40b9-997c-98b83f43f30f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_328ca045-5fc3-436b-a219-5efc9ebfbf80" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_56a8f267-8276-40b9-997c-98b83f43f30f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6864dc83-c260-4e98-a40e-7cd745798e11" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_328ca045-5fc3-436b-a219-5efc9ebfbf80" xlink:to="loc_us-gaap_OperatingIncomeLoss_6864dc83-c260-4e98-a40e-7cd745798e11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_04839453-eb02-436a-bb5b-4f3e57c59081" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_e5008794-c6fb-4b83-b72e-c7139fd9a67b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_04839453-eb02-436a-bb5b-4f3e57c59081" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_e5008794-c6fb-4b83-b72e-c7139fd9a67b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_3a59794f-ea77-4844-85a4-09e76f9f79dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_04839453-eb02-436a-bb5b-4f3e57c59081" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_3a59794f-ea77-4844-85a4-09e76f9f79dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_51f89c55-7fdc-4f16-b065-4aaa66e90f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_8c49dc7a-2acd-4193-b503-3f9bebfe4b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_51f89c55-7fdc-4f16-b065-4aaa66e90f3f" xlink:to="loc_us-gaap_InvestmentIncomeInterest_8c49dc7a-2acd-4193-b503-3f9bebfe4b5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingExpense_0e979c05-8400-4b14-a110-e8cc4771e1e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_51f89c55-7fdc-4f16-b065-4aaa66e90f3f" xlink:to="loc_us-gaap_OtherNonoperatingExpense_0e979c05-8400-4b14-a110-e8cc4771e1e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_28c20e25-c684-4eb8-ad77-cd0f2b0e9491" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_88d4732b-92e1-4f69-9639-0f07d5a3f7c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_28c20e25-c684-4eb8-ad77-cd0f2b0e9491" xlink:to="loc_us-gaap_NetIncomeLoss_88d4732b-92e1-4f69-9639-0f07d5a3f7c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6bf59efd-aad4-4f18-8096-d2457aa7eac7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_25379824-fed4-4ab3-96d5-7fd0ae7d1099" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_6bf59efd-aad4-4f18-8096-d2457aa7eac7" xlink:to="loc_us-gaap_OperatingExpenses_25379824-fed4-4ab3-96d5-7fd0ae7d1099" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_e234752c-d054-41e8-a5a3-c866f83d6f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_6bf59efd-aad4-4f18-8096-d2457aa7eac7" xlink:to="loc_us-gaap_Revenues_e234752c-d054-41e8-a5a3-c866f83d6f5b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="camp-20241231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://camp4tx.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c008b75b-4ea4-4017-8660-80fb8ae07af7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_59ec6cca-bf6c-438a-83bc-3a0d3e9cf03e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c008b75b-4ea4-4017-8660-80fb8ae07af7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_59ec6cca-bf6c-438a-83bc-3a0d3e9cf03e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_75ba300a-34a1-4a5f-b53d-809455901530" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c008b75b-4ea4-4017-8660-80fb8ae07af7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_75ba300a-34a1-4a5f-b53d-809455901530" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_19eb2c01-17f0-42b6-8ec8-375fc10d310e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c008b75b-4ea4-4017-8660-80fb8ae07af7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_19eb2c01-17f0-42b6-8ec8-375fc10d310e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_467befc8-4e7f-42ad-b39c-b84c53f36a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_IncreaseDecreaseInOperatingLeaseAssetsLiabilities_fe28e221-aa40-4255-b2d9-573cc275e331" xlink:href="camp-20241231.xsd#camp_IncreaseDecreaseInOperatingLeaseAssetsLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_467befc8-4e7f-42ad-b39c-b84c53f36a8f" xlink:to="loc_camp_IncreaseDecreaseInOperatingLeaseAssetsLiabilities_fe28e221-aa40-4255-b2d9-573cc275e331" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2c50f182-c20c-4ee9-964b-2303fa919bba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_467befc8-4e7f-42ad-b39c-b84c53f36a8f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2c50f182-c20c-4ee9-964b-2303fa919bba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_67076e57-be82-4f2e-aed7-07a334471fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_467befc8-4e7f-42ad-b39c-b84c53f36a8f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_67076e57-be82-4f2e-aed7-07a334471fa2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_5dcdffc0-df36-4b4e-8835-f8390d35ef47" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_467befc8-4e7f-42ad-b39c-b84c53f36a8f" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_5dcdffc0-df36-4b4e-8835-f8390d35ef47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaidInKindInterest_195bafcb-03bf-4f6d-9801-d29c34430c52" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaidInKindInterest"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_467befc8-4e7f-42ad-b39c-b84c53f36a8f" xlink:to="loc_us-gaap_PaidInKindInterest_195bafcb-03bf-4f6d-9801-d29c34430c52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_NoncashLeaseExpense_0e8a6a92-9d7c-40c4-8c28-9204c09cbf45" xlink:href="camp-20241231.xsd#camp_NoncashLeaseExpense"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_467befc8-4e7f-42ad-b39c-b84c53f36a8f" xlink:to="loc_camp_NoncashLeaseExpense_0e8a6a92-9d7c-40c4-8c28-9204c09cbf45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_44c84bea-25d2-4bfa-a98d-62ceb98ed16a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_467befc8-4e7f-42ad-b39c-b84c53f36a8f" xlink:to="loc_us-gaap_ShareBasedCompensation_44c84bea-25d2-4bfa-a98d-62ceb98ed16a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_23a1e409-a461-401f-a83e-88fccd051a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_467befc8-4e7f-42ad-b39c-b84c53f36a8f" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_23a1e409-a461-401f-a83e-88fccd051a9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_da76041a-1f8c-428a-b2f9-56d195e0eec7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_467befc8-4e7f-42ad-b39c-b84c53f36a8f" xlink:to="loc_us-gaap_NetIncomeLoss_da76041a-1f8c-428a-b2f9-56d195e0eec7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_4994b70b-c9a2-44c1-bd41-365b304b5bce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_467befc8-4e7f-42ad-b39c-b84c53f36a8f" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_4994b70b-c9a2-44c1-bd41-365b304b5bce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_326a6617-d6e5-411b-b6ed-f7dbac30bcf1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_66366c80-cf93-4509-83ec-c2a987234076" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_326a6617-d6e5-411b-b6ed-f7dbac30bcf1" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_66366c80-cf93-4509-83ec-c2a987234076" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_63e4ff0f-f5a8-459d-be63-7c5800bb37e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_f2a859d4-ebcd-4b99-8cc0-f13de87d7228" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_63e4ff0f-f5a8-459d-be63-7c5800bb37e6" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_f2a859d4-ebcd-4b99-8cc0-f13de87d7228" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_PrincipalPaymentsOnFinancingObligationsFailedSaleLeasebackTransaction_06ece654-30b3-4ebe-ac9b-4a015bcbfa47" xlink:href="camp-20241231.xsd#camp_PrincipalPaymentsOnFinancingObligationsFailedSaleLeasebackTransaction"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_63e4ff0f-f5a8-459d-be63-7c5800bb37e6" xlink:to="loc_camp_PrincipalPaymentsOnFinancingObligationsFailedSaleLeasebackTransaction_06ece654-30b3-4ebe-ac9b-4a015bcbfa47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_b5115884-dd4a-4042-8b6d-f4db9e4c8002" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_63e4ff0f-f5a8-459d-be63-7c5800bb37e6" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_b5115884-dd4a-4042-8b6d-f4db9e4c8002" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_02c0c2d4-4638-4246-805d-b2b830da7e13" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_63e4ff0f-f5a8-459d-be63-7c5800bb37e6" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_02c0c2d4-4638-4246-805d-b2b830da7e13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_a215b5fa-667d-4a81-a3e0-f1b9d8b40c40" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_63e4ff0f-f5a8-459d-be63-7c5800bb37e6" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_a215b5fa-667d-4a81-a3e0-f1b9d8b40c40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction_36a39c99-bcc6-4d4c-9dbc-7096db4696f5" xlink:href="camp-20241231.xsd#camp_ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_63e4ff0f-f5a8-459d-be63-7c5800bb37e6" xlink:to="loc_camp_ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction_36a39c99-bcc6-4d4c-9dbc-7096db4696f5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:calculationLink xlink:role="http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_db319dc4-fe1a-422b-9240-58865792660c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_d304a51f-2d79-4c91-a99a-0ff89b4f6fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_db319dc4-fe1a-422b-9240-58865792660c" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_d304a51f-2d79-4c91-a99a-0ff89b4f6fa0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3e2ecc3d-4ec6-4a8c-909e-93c7605b231b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_db319dc4-fe1a-422b-9240-58865792660c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3e2ecc3d-4ec6-4a8c-909e-93c7605b231b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#PrepaidExpensesAndOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_256a901b-7e1c-4908-8bc8-a60d816aefb4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_PrepaidFederalResearchAndDevelopmentTaxCreditCurrent_7ae83878-62a9-44f9-88f3-490339b00990" xlink:href="camp-20241231.xsd#camp_PrepaidFederalResearchAndDevelopmentTaxCreditCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_256a901b-7e1c-4908-8bc8-a60d816aefb4" xlink:to="loc_camp_PrepaidFederalResearchAndDevelopmentTaxCreditCurrent_7ae83878-62a9-44f9-88f3-490339b00990" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_0a194f7f-fb9d-40af-993d-a4df12d9c325" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_256a901b-7e1c-4908-8bc8-a60d816aefb4" xlink:to="loc_us-gaap_OtherAssetsCurrent_0a194f7f-fb9d-40af-993d-a4df12d9c325" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_PrepaidVariableLeaseExpenseCurrent_1b3ab1d8-a1e5-4700-83e7-2bafe41bf9a5" xlink:href="camp-20241231.xsd#camp_PrepaidVariableLeaseExpenseCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_256a901b-7e1c-4908-8bc8-a60d816aefb4" xlink:to="loc_camp_PrepaidVariableLeaseExpenseCurrent_1b3ab1d8-a1e5-4700-83e7-2bafe41bf9a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_PrepaidSoftwareAndSubscriptionExpenseCurrent_de3c7337-3943-49ef-b2fd-40723bbb0fc0" xlink:href="camp-20241231.xsd#camp_PrepaidSoftwareAndSubscriptionExpenseCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_256a901b-7e1c-4908-8bc8-a60d816aefb4" xlink:to="loc_camp_PrepaidSoftwareAndSubscriptionExpenseCurrent_de3c7337-3943-49ef-b2fd-40723bbb0fc0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_fdcc6e7b-8bcc-4ce0-8d88-198ccf453562" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidInsurance"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_256a901b-7e1c-4908-8bc8-a60d816aefb4" xlink:to="loc_us-gaap_PrepaidInsurance_fdcc6e7b-8bcc-4ce0-8d88-198ccf453562" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_PrepaidResearchAndDevelopmentExpenseCurrent_973424cd-6acc-4c52-a59f-6b228769b74b" xlink:href="camp-20241231.xsd#camp_PrepaidResearchAndDevelopmentExpenseCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_256a901b-7e1c-4908-8bc8-a60d816aefb4" xlink:to="loc_camp_PrepaidResearchAndDevelopmentExpenseCurrent_973424cd-6acc-4c52-a59f-6b228769b74b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/PropertyAndEquipmentNetScheduleofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#PropertyAndEquipmentNetScheduleofPropertyandEquipmentNetDetails"/>
  <link:calculationLink xlink:role="http://camp4tx.com/role/PropertyAndEquipmentNetScheduleofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f1abc064-eb71-4c28-b4a0-225de3d6482f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_e895ddee-19aa-42f7-961b-14121096e95d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_f1abc064-eb71-4c28-b4a0-225de3d6482f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_e895ddee-19aa-42f7-961b-14121096e95d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1e34a9de-c7fb-4bc6-8069-88d296a15d44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_f1abc064-eb71-4c28-b4a0-225de3d6482f" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1e34a9de-c7fb-4bc6-8069-88d296a15d44" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#AccruedExpensesandOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://camp4tx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_84fd71d8-9f7d-4d00-bee0-076c013489ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_7e90206f-b510-4c8c-85a3-6f7ea635563e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_84fd71d8-9f7d-4d00-bee0-076c013489ff" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_7e90206f-b510-4c8c-85a3-6f7ea635563e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ProfessionalFeesAndOtherGeneralAndAdministrativeExpensesCurrent_0ddcdecb-b384-457f-b3b3-d5c629810828" xlink:href="camp-20241231.xsd#camp_ProfessionalFeesAndOtherGeneralAndAdministrativeExpensesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_84fd71d8-9f7d-4d00-bee0-076c013489ff" xlink:to="loc_camp_ProfessionalFeesAndOtherGeneralAndAdministrativeExpensesCurrent_0ddcdecb-b384-457f-b3b3-d5c629810828" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ResearchAndDevelopmentExpensesCurrent_d9a311b3-df7c-444d-b7b5-dc11d987db5a" xlink:href="camp-20241231.xsd#camp_ResearchAndDevelopmentExpensesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_84fd71d8-9f7d-4d00-bee0-076c013489ff" xlink:to="loc_camp_ResearchAndDevelopmentExpensesCurrent_d9a311b3-df7c-444d-b7b5-dc11d987db5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_3077f6c2-1e7a-48ed-be85-422872899772" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_84fd71d8-9f7d-4d00-bee0-076c013489ff" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_3077f6c2-1e7a-48ed-be85-422872899772" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/CommitmentsandContingenciesScheduleofOperatingLeaseCostsandOtherInformationDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#CommitmentsandContingenciesScheduleofOperatingLeaseCostsandOtherInformationDetails"/>
  <link:calculationLink xlink:role="http://camp4tx.com/role/CommitmentsandContingenciesScheduleofOperatingLeaseCostsandOtherInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_camp_LeaseCostExcludingFinanceLeases_0f16052e-1f70-4072-94c9-3d42ef274bf0" xlink:href="camp-20241231.xsd#camp_LeaseCostExcludingFinanceLeases"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_07bc6838-96ea-4662-b92a-bcd6acaab621" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_camp_LeaseCostExcludingFinanceLeases_0f16052e-1f70-4072-94c9-3d42ef274bf0" xlink:to="loc_us-gaap_VariableLeaseCost_07bc6838-96ea-4662-b92a-bcd6acaab621" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_99302654-ede7-4811-aa3d-135db5a06000" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_camp_LeaseCostExcludingFinanceLeases_0f16052e-1f70-4072-94c9-3d42ef274bf0" xlink:to="loc_us-gaap_ShortTermLeaseCost_99302654-ede7-4811-aa3d-135db5a06000" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_3cca3cc4-e767-42cf-a8f1-3d7291927476" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_camp_LeaseCostExcludingFinanceLeases_0f16052e-1f70-4072-94c9-3d42ef274bf0" xlink:to="loc_us-gaap_OperatingLeaseCost_3cca3cc4-e767-42cf-a8f1-3d7291927476" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#CommitmentsandContingenciesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7cbdbe7a-c493-43cc-8f6e-7e98f2b80717" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_a0868663-0974-4ea5-8f3b-aa43c6ef11e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7cbdbe7a-c493-43cc-8f6e-7e98f2b80717" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_a0868663-0974-4ea5-8f3b-aa43c6ef11e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_7345d7de-90e1-471c-882e-706e13762306" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7cbdbe7a-c493-43cc-8f6e-7e98f2b80717" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_7345d7de-90e1-471c-882e-706e13762306" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_e853da88-646a-4ccf-8bb0-91bfa9a18fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7cbdbe7a-c493-43cc-8f6e-7e98f2b80717" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_e853da88-646a-4ccf-8bb0-91bfa9a18fa2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_3152f208-539a-4333-b205-ad98f27916fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7cbdbe7a-c493-43cc-8f6e-7e98f2b80717" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_3152f208-539a-4333-b205-ad98f27916fd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/CommitmentsandContingenciesScheduleofFinanceLeaseCostandOtherInformationDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#CommitmentsandContingenciesScheduleofFinanceLeaseCostandOtherInformationDetails"/>
  <link:calculationLink xlink:role="http://camp4tx.com/role/CommitmentsandContingenciesScheduleofFinanceLeaseCostandOtherInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_camp_LeaseCostFinanceLeases_d5a4fe97-e793-4950-bb83-74173fb28e52" xlink:href="camp-20241231.xsd#camp_LeaseCostFinanceLeases"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_656aa2cb-538a-472c-954d-2d419ddb2963" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_camp_LeaseCostFinanceLeases_d5a4fe97-e793-4950-bb83-74173fb28e52" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_656aa2cb-538a-472c-954d-2d419ddb2963" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_da609034-ca6f-4838-9430-c7f074c6450b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_camp_LeaseCostFinanceLeases_d5a4fe97-e793-4950-bb83-74173fb28e52" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_da609034-ca6f-4838-9430-c7f074c6450b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofFinanceLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#CommitmentsandContingenciesScheduleofMaturitiesofFinanceLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofFinanceLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_114373ba-7a2a-4505-8879-14d778d73bd7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_7057baac-2d2d-48a1-97f4-732d4df8497a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_114373ba-7a2a-4505-8879-14d778d73bd7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_7057baac-2d2d-48a1-97f4-732d4df8497a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_d0c21f00-64cb-4fee-80f4-a77025370060" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_114373ba-7a2a-4505-8879-14d778d73bd7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_d0c21f00-64cb-4fee-80f4-a77025370060" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_7fd0d561-f91c-4883-822a-8d88d5809305" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_114373ba-7a2a-4505-8879-14d778d73bd7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_7fd0d561-f91c-4883-822a-8d88d5809305" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"/>
  <link:calculationLink xlink:role="http://camp4tx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9547e836-bd70-4ffa-85b2-dcf91922caf5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_9d40eebc-b9db-4c7e-bf62-a6e54a71b41f" xlink:href="camp-20241231.xsd#camp_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9547e836-bd70-4ffa-85b2-dcf91922caf5" xlink:to="loc_camp_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_9d40eebc-b9db-4c7e-bf62-a6e54a71b41f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_7dce9b4f-3e5e-471d-8140-be0e19efb16c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9547e836-bd70-4ffa-85b2-dcf91922caf5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_7dce9b4f-3e5e-471d-8140-be0e19efb16c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_2a536301-268f-438e-b784-b7c0123d2393" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9547e836-bd70-4ffa-85b2-dcf91922caf5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_2a536301-268f-438e-b784-b7c0123d2393" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_c277be56-47e0-4935-bf6f-ea530bc5a33b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9547e836-bd70-4ffa-85b2-dcf91922caf5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_c277be56-47e0-4935-bf6f-ea530bc5a33b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_69b4fe7e-5519-4e0d-9793-9c5b3876cbb9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9547e836-bd70-4ffa-85b2-dcf91922caf5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_69b4fe7e-5519-4e0d-9793-9c5b3876cbb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_e07b385b-8dce-4f99-9a50-4a04f5a232c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9547e836-bd70-4ffa-85b2-dcf91922caf5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_e07b385b-8dce-4f99-9a50-4a04f5a232c6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://camp4tx.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_f8258b20-3a77-480e-96db-634556ba2f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_714063b5-5a13-42c1-8f0a-ae3dc4e4d453" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_f8258b20-3a77-480e-96db-634556ba2f3e" xlink:to="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_714063b5-5a13-42c1-8f0a-ae3dc4e4d453" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_88bef6a6-ebc0-414e-90d7-dd162bf440a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_f8258b20-3a77-480e-96db-634556ba2f3e" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_88bef6a6-ebc0-414e-90d7-dd162bf440a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_c29d591a-323e-45ce-8658-dc162c89d89d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_f8258b20-3a77-480e-96db-634556ba2f3e" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_c29d591a-323e-45ce-8658-dc162c89d89d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_d6dd1d6c-2a5d-4e7b-99cb-640732e2d70b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_f8258b20-3a77-480e-96db-634556ba2f3e" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_d6dd1d6c-2a5d-4e7b-99cb-640732e2d70b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_DeferredTaxAssetsLeasingArrangements_01d1b081-5cd5-44eb-bed7-4335e90bb725" xlink:href="camp-20241231.xsd#camp_DeferredTaxAssetsLeasingArrangements"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_f8258b20-3a77-480e-96db-634556ba2f3e" xlink:to="loc_camp_DeferredTaxAssetsLeasingArrangements_01d1b081-5cd5-44eb-bed7-4335e90bb725" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures_660a110f-6a1f-4905-9966-9d8ecf75efe1" xlink:href="camp-20241231.xsd#camp_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_f8258b20-3a77-480e-96db-634556ba2f3e" xlink:to="loc_camp_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures_660a110f-6a1f-4905-9966-9d8ecf75efe1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_7a38c8e3-f0bf-458b-b104-a72cf552ef5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_3dfddeae-e654-4359-96c3-c8bbd69d9cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_7a38c8e3-f0bf-458b-b104-a72cf552ef5b" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_3dfddeae-e654-4359-96c3-c8bbd69d9cd8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_DeferredTaxAssetsLiabilitiesGross_9ba8cc36-05f3-4fcf-8351-2e63a1f3d28d" xlink:href="camp-20241231.xsd#camp_DeferredTaxAssetsLiabilitiesGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_e0272695-5a0c-41ad-8d16-3c046e3d25e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_camp_DeferredTaxAssetsLiabilitiesGross_9ba8cc36-05f3-4fcf-8351-2e63a1f3d28d" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_e0272695-5a0c-41ad-8d16-3c046e3d25e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_5bdd7036-a90e-48b9-9b4f-f72685159e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_camp_DeferredTaxAssetsLiabilitiesGross_9ba8cc36-05f3-4fcf-8351-2e63a1f3d28d" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_5bdd7036-a90e-48b9-9b4f-f72685159e2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_a68dffb3-5ff9-4678-adee-f39812d0318c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_DeferredTaxAssetsLiabilitiesGross_92f2c0c7-ac8f-46c9-8f30-91b14c2b2513" xlink:href="camp-20241231.xsd#camp_DeferredTaxAssetsLiabilitiesGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_a68dffb3-5ff9-4678-adee-f39812d0318c" xlink:to="loc_camp_DeferredTaxAssetsLiabilitiesGross_92f2c0c7-ac8f-46c9-8f30-91b14c2b2513" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0c6eacc2-2311-4bc1-a9c2-c35b1523ee7f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_a68dffb3-5ff9-4678-adee-f39812d0318c" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0c6eacc2-2311-4bc1-a9c2-c35b1523ee7f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/SegmentReportingDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#SegmentReportingDetails"/>
  <link:calculationLink xlink:role="http://camp4tx.com/role/SegmentReportingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a8068943-b1f0-4f5a-8339-b09a26e2fc3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TravelAndEntertainmentExpense_17cb6395-fdf6-4fe2-889d-fe0798c2ad05" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TravelAndEntertainmentExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a8068943-b1f0-4f5a-8339-b09a26e2fc3f" xlink:to="loc_us-gaap_TravelAndEntertainmentExpense_17cb6395-fdf6-4fe2-889d-fe0798c2ad05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_CorporateExpenses_a8f369fb-1d73-4ace-8a81-962c9ee78f6f" xlink:href="camp-20241231.xsd#camp_CorporateExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a8068943-b1f0-4f5a-8339-b09a26e2fc3f" xlink:to="loc_camp_CorporateExpenses_a8f369fb-1d73-4ace-8a81-962c9ee78f6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees_a1dc2e90-edd8-4cf1-a74d-c9116da072b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a8068943-b1f0-4f5a-8339-b09a26e2fc3f" xlink:to="loc_us-gaap_ProfessionalFees_a1dc2e90-edd8-4cf1-a74d-c9116da072b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_FacilitiesAndOverheadExpense_c9410da6-5766-470e-8bc4-3120d95a8bff" xlink:href="camp-20241231.xsd#camp_FacilitiesAndOverheadExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a8068943-b1f0-4f5a-8339-b09a26e2fc3f" xlink:to="loc_camp_FacilitiesAndOverheadExpense_c9410da6-5766-470e-8bc4-3120d95a8bff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_5eec7e9d-ec25-4748-8fac-a768c404d8ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a8068943-b1f0-4f5a-8339-b09a26e2fc3f" xlink:to="loc_us-gaap_Revenues_5eec7e9d-ec25-4748-8fac-a768c404d8ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ClinicalAndPreclinicalExpenses_91b8b748-ee1b-4e5c-9363-80c9d220e527" xlink:href="camp-20241231.xsd#camp_ClinicalAndPreclinicalExpenses"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a8068943-b1f0-4f5a-8339-b09a26e2fc3f" xlink:to="loc_camp_ClinicalAndPreclinicalExpenses_91b8b748-ee1b-4e5c-9363-80c9d220e527" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_00bb7323-1a5c-4789-ba5f-e89d56368360" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a8068943-b1f0-4f5a-8339-b09a26e2fc3f" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_00bb7323-1a5c-4789-ba5f-e89d56368360" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_1fd80c4d-a00d-46c8-8932-ef5c86eaa984" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a8068943-b1f0-4f5a-8339-b09a26e2fc3f" xlink:to="loc_us-gaap_LaborAndRelatedExpense_1fd80c4d-a00d-46c8-8932-ef5c86eaa984" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>camp-20241231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:344bab39-1447-4710-a813-d0e5cea79568,g:e8dcb9a0-a4ba-432e-8d82-4b2fdbae6592-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit" xlink:type="simple" xlink:href="camp-20241231.xsd#ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit"/>
  <link:definitionLink xlink:role="http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2308cbd9-1ff0-4435-8484-209650d6802a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f3be4b44-32c9-442d-b02f-bd28b3e446a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_2308cbd9-1ff0-4435-8484-209650d6802a" xlink:to="loc_us-gaap_StatementTable_f3be4b44-32c9-442d-b02f-bd28b3e446a9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3a5021d1-ed12-4031-b35d-bc132bdd2302" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f3be4b44-32c9-442d-b02f-bd28b3e446a9" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3a5021d1-ed12-4031-b35d-bc132bdd2302" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3a5021d1-ed12-4031-b35d-bc132bdd2302_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3a5021d1-ed12-4031-b35d-bc132bdd2302" xlink:to="loc_us-gaap_EquityComponentDomain_3a5021d1-ed12-4031-b35d-bc132bdd2302_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1d5f4b03-fbf3-4cbb-8061-afe361dd9d60" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3a5021d1-ed12-4031-b35d-bc132bdd2302" xlink:to="loc_us-gaap_EquityComponentDomain_1d5f4b03-fbf3-4cbb-8061-afe361dd9d60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_6f05c5a4-4ca7-4407-b5e7-fb7c21ca9a66" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1d5f4b03-fbf3-4cbb-8061-afe361dd9d60" xlink:to="loc_us-gaap_CommonStockMember_6f05c5a4-4ca7-4407-b5e7-fb7c21ca9a66" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_2e29e167-668b-4c68-88d7-88526111dffa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1d5f4b03-fbf3-4cbb-8061-afe361dd9d60" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_2e29e167-668b-4c68-88d7-88526111dffa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_07d1ed47-41f5-4ea5-a839-618d468d70c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1d5f4b03-fbf3-4cbb-8061-afe361dd9d60" xlink:to="loc_us-gaap_RetainedEarningsMember_07d1ed47-41f5-4ea5-a839-618d468d70c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_b55961ba-4dfe-4620-a202-cfa4e8c7afbb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f3be4b44-32c9-442d-b02f-bd28b3e446a9" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_b55961ba-4dfe-4620-a202-cfa4e8c7afbb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b55961ba-4dfe-4620-a202-cfa4e8c7afbb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_b55961ba-4dfe-4620-a202-cfa4e8c7afbb" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b55961ba-4dfe-4620-a202-cfa4e8c7afbb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c673bcc0-523d-4f71-bdc5-135cb2520bee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_b55961ba-4dfe-4620-a202-cfa4e8c7afbb" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c673bcc0-523d-4f71-bdc5-135cb2520bee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_7dfe285d-9bce-4931-b7b2-613d1ccc4cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c673bcc0-523d-4f71-bdc5-135cb2520bee" xlink:to="loc_us-gaap_IPOMember_7dfe285d-9bce-4931-b7b2-613d1ccc4cb6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ed78165f-7210-4fd5-b97a-4966116ec152" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2308cbd9-1ff0-4435-8484-209650d6802a" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ed78165f-7210-4fd5-b97a-4966116ec152" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_b7c0dd96-c780-4c6f-919f-466538756f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ed78165f-7210-4fd5-b97a-4966116ec152" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_b7c0dd96-c780-4c6f-919f-466538756f5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_e4bb0e24-9034-487c-bcbd-dfbb3c04e79e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ed78165f-7210-4fd5-b97a-4966116ec152" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_e4bb0e24-9034-487c-bcbd-dfbb3c04e79e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_TemporaryEquitySharesConversionOfConvertibleSecurities_cb363abb-d2e5-45b0-a0ce-d0dc6296360a" xlink:href="camp-20241231.xsd#camp_TemporaryEquitySharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ed78165f-7210-4fd5-b97a-4966116ec152" xlink:to="loc_camp_TemporaryEquitySharesConversionOfConvertibleSecurities_cb363abb-d2e5-45b0-a0ce-d0dc6296360a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_TemporaryEquityValueConversionOfConvertibleSecurities_6d61dd69-0c1a-4dc1-9b2f-fd69a45605a4" xlink:href="camp-20241231.xsd#camp_TemporaryEquityValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ed78165f-7210-4fd5-b97a-4966116ec152" xlink:to="loc_camp_TemporaryEquityValueConversionOfConvertibleSecurities_6d61dd69-0c1a-4dc1-9b2f-fd69a45605a4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_c164236d-a8a4-4f0f-ace5-617aad969d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_9dfc8414-6495-4344-b28b-6d68e5111df5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e320cd0e-b5e6-462f-a7da-5df6548994de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2308cbd9-1ff0-4435-8484-209650d6802a" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e320cd0e-b5e6-462f-a7da-5df6548994de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_70fbab80-8feb-4c2f-9f75-304f1092e166" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e320cd0e-b5e6-462f-a7da-5df6548994de" xlink:to="loc_us-gaap_CommonStockSharesIssued_70fbab80-8feb-4c2f-9f75-304f1092e166" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_35dabe4e-4a38-4569-bd99-04ee42ad4a42" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e320cd0e-b5e6-462f-a7da-5df6548994de" xlink:to="loc_us-gaap_StockholdersEquity_35dabe4e-4a38-4569-bd99-04ee42ad4a42" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_648b285e-8cf7-4560-a35b-6d3977d7be74" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e320cd0e-b5e6-462f-a7da-5df6548994de" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_648b285e-8cf7-4560-a35b-6d3977d7be74" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_501c6bb7-219c-4c0b-906a-d1c461d662db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e320cd0e-b5e6-462f-a7da-5df6548994de" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_501c6bb7-219c-4c0b-906a-d1c461d662db" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_12740bd0-8f52-47d8-8e77-94e42240bc82" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e320cd0e-b5e6-462f-a7da-5df6548994de" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_12740bd0-8f52-47d8-8e77-94e42240bc82" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c1791937-2e93-4e37-b2cb-4264cfc76f80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e320cd0e-b5e6-462f-a7da-5df6548994de" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c1791937-2e93-4e37-b2cb-4264cfc76f80" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_cf6088ea-7da7-4f03-8717-bc0804e867c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e320cd0e-b5e6-462f-a7da-5df6548994de" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_cf6088ea-7da7-4f03-8717-bc0804e867c7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_595e447e-016a-4670-a21d-44458330e493" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e320cd0e-b5e6-462f-a7da-5df6548994de" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_595e447e-016a-4670-a21d-44458330e493" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b378a28d-7751-4610-b7ee-de5c26183d23" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e320cd0e-b5e6-462f-a7da-5df6548994de" xlink:to="loc_us-gaap_NetIncomeLoss_b378a28d-7751-4610-b7ee-de5c26183d23" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_4b5dc68a-978f-4310-b753-8bade73c77f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_16776e1a-f9dc-4fd6-b383-00b33454aa04" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentationDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#DescriptionofBusinessandBasisofPresentationDetails"/>
  <link:definitionLink xlink:role="http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_fc46c857-a157-4cf3-97ae-bbbe07de28c8" xlink:href="camp-20241231.xsd#camp_DescriptionOfBusinessAndBasisOfPresentationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_DescriptionOfBusinessAndBasisOfPresentationTable_701169d7-16ab-470c-b3c6-3504edc49e8e" xlink:href="camp-20241231.xsd#camp_DescriptionOfBusinessAndBasisOfPresentationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_fc46c857-a157-4cf3-97ae-bbbe07de28c8" xlink:to="loc_camp_DescriptionOfBusinessAndBasisOfPresentationTable_701169d7-16ab-470c-b3c6-3504edc49e8e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_04cd7de7-7e22-45f4-99b8-5cb5bb1e353b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationTable_701169d7-16ab-470c-b3c6-3504edc49e8e" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_04cd7de7-7e22-45f4-99b8-5cb5bb1e353b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_04cd7de7-7e22-45f4-99b8-5cb5bb1e353b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_04cd7de7-7e22-45f4-99b8-5cb5bb1e353b" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_04cd7de7-7e22-45f4-99b8-5cb5bb1e353b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_16ba9ae1-624d-4b09-9a79-962399178286" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_04cd7de7-7e22-45f4-99b8-5cb5bb1e353b" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_16ba9ae1-624d-4b09-9a79-962399178286" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_74385cdf-9da3-42b2-a059-2e3fea6c3246" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_16ba9ae1-624d-4b09-9a79-962399178286" xlink:to="loc_us-gaap_IPOMember_74385cdf-9da3-42b2-a059-2e3fea6c3246" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_75ec4dd3-e5e9-4506-9987-ceeffc789e80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_16ba9ae1-624d-4b09-9a79-962399178286" xlink:to="loc_us-gaap_OverAllotmentOptionMember_75ec4dd3-e5e9-4506-9987-ceeffc789e80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_2904761e-dbf9-4382-bda6-5154307aba4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_fc46c857-a157-4cf3-97ae-bbbe07de28c8" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_2904761e-dbf9-4382-bda6-5154307aba4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_29065377-e055-4c3c-91c7-1bd756153c64" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_fc46c857-a157-4cf3-97ae-bbbe07de28c8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_29065377-e055-4c3c-91c7-1bd756153c64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_cfa3c5dc-b047-4aff-ba8a-f3f6ce705db3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_fc46c857-a157-4cf3-97ae-bbbe07de28c8" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_cfa3c5dc-b047-4aff-ba8a-f3f6ce705db3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_c2e4fab9-5fb2-4902-a505-5126e20fb51b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_fc46c857-a157-4cf3-97ae-bbbe07de28c8" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_c2e4fab9-5fb2-4902-a505-5126e20fb51b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_PaymentsOfUnderwritingDiscountsAndCommissions_e1c66f78-cbd5-4ba9-bb78-2d295b75799d" xlink:href="camp-20241231.xsd#camp_PaymentsOfUnderwritingDiscountsAndCommissions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_fc46c857-a157-4cf3-97ae-bbbe07de28c8" xlink:to="loc_camp_PaymentsOfUnderwritingDiscountsAndCommissions_e1c66f78-cbd5-4ba9-bb78-2d295b75799d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_76752b9a-80a0-411a-9017-7100ceb9181d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_fc46c857-a157-4cf3-97ae-bbbe07de28c8" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_76752b9a-80a0-411a-9017-7100ceb9181d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_5312effb-0ff9-41d8-9488-be7536e8ad02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_fc46c857-a157-4cf3-97ae-bbbe07de28c8" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_5312effb-0ff9-41d8-9488-be7536e8ad02" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_b58be6d4-4f2f-41c9-a439-5103f6b9113f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_fc46c857-a157-4cf3-97ae-bbbe07de28c8" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_b58be6d4-4f2f-41c9-a439-5103f6b9113f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_ceddb53b-683b-426b-8890-9e5f68766d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_fc46c857-a157-4cf3-97ae-bbbe07de28c8" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_ceddb53b-683b-426b-8890-9e5f68766d1d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_57534140-1df5-44fe-88f5-a736820f10c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_fc46c857-a157-4cf3-97ae-bbbe07de28c8" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_57534140-1df5-44fe-88f5-a736820f10c7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9806b0c8-fa27-4ce4-9828-275b57516dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_fc46c857-a157-4cf3-97ae-bbbe07de28c8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9806b0c8-fa27-4ce4-9828-275b57516dd2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_WorkingCapital_7dd338de-eaaa-45b2-a6d0-06b66bb6fa17" xlink:href="camp-20241231.xsd#camp_WorkingCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_fc46c857-a157-4cf3-97ae-bbbe07de28c8" xlink:to="loc_camp_WorkingCapital_7dd338de-eaaa-45b2-a6d0-06b66bb6fa17" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8e23cef5-fa85-4939-9da9-6ce0660ba1a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_fc46c857-a157-4cf3-97ae-bbbe07de28c8" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8e23cef5-fa85-4939-9da9-6ce0660ba1a6" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_060bf143-4b1a-47a8-886e-aca535b90dab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_fc46c857-a157-4cf3-97ae-bbbe07de28c8" xlink:to="loc_us-gaap_NetIncomeLoss_060bf143-4b1a-47a8-886e-aca535b90dab" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_12f66c15-989f-4502-8e5a-deda12ce4d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_fc46c857-a157-4cf3-97ae-bbbe07de28c8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_12f66c15-989f-4502-8e5a-deda12ce4d5c" xlink:type="arc" order="14"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesSchedulePropertyandEquipmentNetUsefulLivesDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#SummaryofSignificantAccountingPoliciesSchedulePropertyandEquipmentNetUsefulLivesDetails"/>
  <link:definitionLink xlink:role="http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesSchedulePropertyandEquipmentNetUsefulLivesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a618d46b-61c6-44e6-a432-bea1f6589c07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_498cb9e8-8325-489a-9a68-d8439038a562" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a618d46b-61c6-44e6-a432-bea1f6589c07" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_498cb9e8-8325-489a-9a68-d8439038a562" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e3e1d990-9998-4f49-a215-fd0a914809d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_498cb9e8-8325-489a-9a68-d8439038a562" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e3e1d990-9998-4f49-a215-fd0a914809d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e3e1d990-9998-4f49-a215-fd0a914809d2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e3e1d990-9998-4f49-a215-fd0a914809d2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e3e1d990-9998-4f49-a215-fd0a914809d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2637ab0f-34c4-4130-82ec-c6ce48acd43f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e3e1d990-9998-4f49-a215-fd0a914809d2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2637ab0f-34c4-4130-82ec-c6ce48acd43f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ComputerAndSoftwareMember_33772756-6ecb-4442-988c-8138bf898f18" xlink:href="camp-20241231.xsd#camp_ComputerAndSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2637ab0f-34c4-4130-82ec-c6ce48acd43f" xlink:to="loc_camp_ComputerAndSoftwareMember_33772756-6ecb-4442-988c-8138bf898f18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_LaboratoryEquipmentMember_6639f910-2137-4c9f-a2fa-9136e4d02a3f" xlink:href="camp-20241231.xsd#camp_LaboratoryEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2637ab0f-34c4-4130-82ec-c6ce48acd43f" xlink:to="loc_camp_LaboratoryEquipmentMember_6639f910-2137-4c9f-a2fa-9136e4d02a3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_0e7088d6-03b6-4cac-9c81-9713ce51279d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2637ab0f-34c4-4130-82ec-c6ce48acd43f" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_0e7088d6-03b6-4cac-9c81-9713ce51279d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_76ead696-7e8a-4b6c-bc45-af847a984ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a618d46b-61c6-44e6-a432-bea1f6589c07" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_76ead696-7e8a-4b6c-bc45-af847a984ba6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://camp4tx.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#FairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://camp4tx.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5bae32ce-d13e-4df4-8e35-9c1c10b06c54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d1d40be6-a4a8-49dd-9167-b216f82e4c54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5bae32ce-d13e-4df4-8e35-9c1c10b06c54" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d1d40be6-a4a8-49dd-9167-b216f82e4c54" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d7e39688-4f27-4a9f-82f7-9ebfc9173b99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d1d40be6-a4a8-49dd-9167-b216f82e4c54" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d7e39688-4f27-4a9f-82f7-9ebfc9173b99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_d7e39688-4f27-4a9f-82f7-9ebfc9173b99_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d7e39688-4f27-4a9f-82f7-9ebfc9173b99" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_d7e39688-4f27-4a9f-82f7-9ebfc9173b99_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_97e92520-9dcd-4b30-b2d4-34198b804b08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d7e39688-4f27-4a9f-82f7-9ebfc9173b99" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_97e92520-9dcd-4b30-b2d4-34198b804b08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_6393ba55-ce14-485a-bdc9-d86fcd61d996" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_97e92520-9dcd-4b30-b2d4-34198b804b08" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_6393ba55-ce14-485a-bdc9-d86fcd61d996" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b9615850-4a27-4654-88e4-a40d23ae1703" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d1d40be6-a4a8-49dd-9167-b216f82e4c54" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b9615850-4a27-4654-88e4-a40d23ae1703" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b9615850-4a27-4654-88e4-a40d23ae1703_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b9615850-4a27-4654-88e4-a40d23ae1703" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b9615850-4a27-4654-88e4-a40d23ae1703_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_29e09f7f-e6d9-4048-a823-aa6c885a505c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b9615850-4a27-4654-88e4-a40d23ae1703" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_29e09f7f-e6d9-4048-a823-aa6c885a505c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_0a0b7a50-c6ed-4a76-9d97-e8da057401d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_29e09f7f-e6d9-4048-a823-aa6c885a505c" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_0a0b7a50-c6ed-4a76-9d97-e8da057401d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_74aa6679-78d3-44de-8fa8-914465ead03f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_29e09f7f-e6d9-4048-a823-aa6c885a505c" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_74aa6679-78d3-44de-8fa8-914465ead03f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a63bb472-d68b-436e-a29f-615f339e01e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_29e09f7f-e6d9-4048-a823-aa6c885a505c" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a63bb472-d68b-436e-a29f-615f339e01e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_47f9f30f-f2c8-441b-aa05-0c721784ac98" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5bae32ce-d13e-4df4-8e35-9c1c10b06c54" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_47f9f30f-f2c8-441b-aa05-0c721784ac98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_0a5240ec-c8f0-4d2b-8419-09e7df450340" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_47f9f30f-f2c8-441b-aa05-0c721784ac98" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_0a5240ec-c8f0-4d2b-8419-09e7df450340" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://camp4tx.com/role/PropertyAndEquipmentNetScheduleofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#PropertyAndEquipmentNetScheduleofPropertyandEquipmentNetDetails"/>
  <link:definitionLink xlink:role="http://camp4tx.com/role/PropertyAndEquipmentNetScheduleofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_fd72a6e4-0ea4-4948-b116-f82406563b22" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6ed0a36a-7efc-4cb9-b79d-2f6280f54c65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_fd72a6e4-0ea4-4948-b116-f82406563b22" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6ed0a36a-7efc-4cb9-b79d-2f6280f54c65" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_de251f09-0eae-4516-8323-aee14881c815" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6ed0a36a-7efc-4cb9-b79d-2f6280f54c65" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_de251f09-0eae-4516-8323-aee14881c815" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_de251f09-0eae-4516-8323-aee14881c815_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_de251f09-0eae-4516-8323-aee14881c815" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_de251f09-0eae-4516-8323-aee14881c815_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ec7ff4eb-c2fe-4a58-8026-6096abdad26e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_de251f09-0eae-4516-8323-aee14881c815" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ec7ff4eb-c2fe-4a58-8026-6096abdad26e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_LaboratoryEquipmentMember_2dec505c-9dcf-42ee-b236-003592d6d864" xlink:href="camp-20241231.xsd#camp_LaboratoryEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ec7ff4eb-c2fe-4a58-8026-6096abdad26e" xlink:to="loc_camp_LaboratoryEquipmentMember_2dec505c-9dcf-42ee-b236-003592d6d864" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ComputerAndSoftwareMember_2332e1f8-3c79-4a5f-b1e0-cd0acc691400" xlink:href="camp-20241231.xsd#camp_ComputerAndSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ec7ff4eb-c2fe-4a58-8026-6096abdad26e" xlink:to="loc_camp_ComputerAndSoftwareMember_2332e1f8-3c79-4a5f-b1e0-cd0acc691400" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_15e5deff-fe14-4bcd-846c-c8a20ffff1ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ec7ff4eb-c2fe-4a58-8026-6096abdad26e" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_15e5deff-fe14-4bcd-846c-c8a20ffff1ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_27d33527-cb06-439d-9d8b-4e8e8bd403c2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ec7ff4eb-c2fe-4a58-8026-6096abdad26e" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_27d33527-cb06-439d-9d8b-4e8e8bd403c2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_8d6f9cc4-f58b-4fdc-b470-acd4db18628c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_fd72a6e4-0ea4-4948-b116-f82406563b22" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_8d6f9cc4-f58b-4fdc-b470-acd4db18628c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e8527245-5d1d-4b74-bae2-b3b5097b3b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_fd72a6e4-0ea4-4948-b116-f82406563b22" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e8527245-5d1d-4b74-bae2-b3b5097b3b2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_60abdfdb-c52e-4857-a07d-18b16561db8c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_fd72a6e4-0ea4-4948-b116-f82406563b22" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_60abdfdb-c52e-4857-a07d-18b16561db8c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://camp4tx.com/role/PropertyAndEquipmentNetNarrativeDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#PropertyAndEquipmentNetNarrativeDetails"/>
  <link:definitionLink xlink:role="http://camp4tx.com/role/PropertyAndEquipmentNetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_268bae71-5da0-4c2e-9a90-66bace393cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8f12ae61-245f-451b-bd03-c3ca2631cab5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_268bae71-5da0-4c2e-9a90-66bace393cd4" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8f12ae61-245f-451b-bd03-c3ca2631cab5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_66d23a5b-5848-48ae-8f99-2972903aec7a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8f12ae61-245f-451b-bd03-c3ca2631cab5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_66d23a5b-5848-48ae-8f99-2972903aec7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_66d23a5b-5848-48ae-8f99-2972903aec7a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_66d23a5b-5848-48ae-8f99-2972903aec7a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_66d23a5b-5848-48ae-8f99-2972903aec7a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_863344d0-ad21-459f-9e1b-b38ec8710626" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_66d23a5b-5848-48ae-8f99-2972903aec7a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_863344d0-ad21-459f-9e1b-b38ec8710626" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_LaboratoryEquipmentMember_79743e5b-de29-4c35-85c8-d1dbf8fce380" xlink:href="camp-20241231.xsd#camp_LaboratoryEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_863344d0-ad21-459f-9e1b-b38ec8710626" xlink:to="loc_camp_LaboratoryEquipmentMember_79743e5b-de29-4c35-85c8-d1dbf8fce380" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_30cb9857-ff09-4b4d-bdaf-972fc037b9a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_268bae71-5da0-4c2e-9a90-66bace393cd4" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_30cb9857-ff09-4b4d-bdaf-972fc037b9a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_366b2966-b567-4536-947f-3db7231a273f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_268bae71-5da0-4c2e-9a90-66bace393cd4" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_366b2966-b567-4536-947f-3db7231a273f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_90cfa93a-abb1-4f04-9f2e-863bef8550c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_268bae71-5da0-4c2e-9a90-66bace393cd4" xlink:to="loc_us-gaap_DepreciationAndAmortization_90cfa93a-abb1-4f04-9f2e-863bef8550c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_7b26b8c5-9600-40c0-98ae-80904de3f4af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_268bae71-5da0-4c2e-9a90-66bace393cd4" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_7b26b8c5-9600-40c0-98ae-80904de3f4af" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://camp4tx.com/role/CommitmentsandContingenciesOperatingLeasesNarrativeDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#CommitmentsandContingenciesOperatingLeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://camp4tx.com/role/CommitmentsandContingenciesOperatingLeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_1c90551a-5a92-4217-b89b-955b8ec97435" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_d598ba6f-4eba-498b-8409-89b887d680d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1c90551a-5a92-4217-b89b-955b8ec97435" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_d598ba6f-4eba-498b-8409-89b887d680d5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2e2648aa-e224-4b0b-9ad0-486d63a5c8f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_d598ba6f-4eba-498b-8409-89b887d680d5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2e2648aa-e224-4b0b-9ad0-486d63a5c8f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2e2648aa-e224-4b0b-9ad0-486d63a5c8f1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2e2648aa-e224-4b0b-9ad0-486d63a5c8f1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2e2648aa-e224-4b0b-9ad0-486d63a5c8f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_11a900d3-268c-47cb-9595-d6d068595e61" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2e2648aa-e224-4b0b-9ad0-486d63a5c8f1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_11a900d3-268c-47cb-9595-d6d068595e61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_OfficeAndLaboratorySpaceInCambridgeMember_0aedfd0c-57f8-435e-a482-ec743137ab22" xlink:href="camp-20241231.xsd#camp_OfficeAndLaboratorySpaceInCambridgeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_11a900d3-268c-47cb-9595-d6d068595e61" xlink:to="loc_camp_OfficeAndLaboratorySpaceInCambridgeMember_0aedfd0c-57f8-435e-a482-ec743137ab22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_OfficeAndLaboratorySpaceInBoulderMember_6a498435-82cc-436d-bc25-1f5c587c69de" xlink:href="camp-20241231.xsd#camp_OfficeAndLaboratorySpaceInBoulderMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_11a900d3-268c-47cb-9595-d6d068595e61" xlink:to="loc_camp_OfficeAndLaboratorySpaceInBoulderMember_6a498435-82cc-436d-bc25-1f5c587c69de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfLand_85daf129-4cbb-4f50-879b-c8cc224f9320" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AreaOfLand"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1c90551a-5a92-4217-b89b-955b8ec97435" xlink:to="loc_us-gaap_AreaOfLand_85daf129-4cbb-4f50-879b-c8cc224f9320" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_MaximumReimbursableIncentiveFromLessor_c2d9212d-9d8c-4519-8e3c-397c1c032702" xlink:href="camp-20241231.xsd#camp_MaximumReimbursableIncentiveFromLessor"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1c90551a-5a92-4217-b89b-955b8ec97435" xlink:to="loc_camp_MaximumReimbursableIncentiveFromLessor_c2d9212d-9d8c-4519-8e3c-397c1c032702" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_e0584953-e7f1-47c5-9236-5bdc64990993" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1c90551a-5a92-4217-b89b-955b8ec97435" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_e0584953-e7f1-47c5-9236-5bdc64990993" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncentiveFromLessor_ec3d5cc3-fe92-46bf-8360-717f5df80284" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncentiveFromLessor"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1c90551a-5a92-4217-b89b-955b8ec97435" xlink:to="loc_us-gaap_IncentiveFromLessor_ec3d5cc3-fe92-46bf-8360-717f5df80284" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1fb94272-d6f6-478e-bd5f-e6d8aedee040" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1c90551a-5a92-4217-b89b-955b8ec97435" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1fb94272-d6f6-478e-bd5f-e6d8aedee040" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_d4712819-b5cd-44a8-84d0-5ea3d93673d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1c90551a-5a92-4217-b89b-955b8ec97435" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_d4712819-b5cd-44a8-84d0-5ea3d93673d5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4c5beef2-8e63-4ebd-b72f-28a2d9390fde" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1c90551a-5a92-4217-b89b-955b8ec97435" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4c5beef2-8e63-4ebd-b72f-28a2d9390fde" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_dd9864a4-2adf-41a5-8510-c08bf66430b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1c90551a-5a92-4217-b89b-955b8ec97435" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_dd9864a4-2adf-41a5-8510-c08bf66430b0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_LesseeOperatingLeaseIncrementalBorrowingRate_086da5e9-0754-4597-a3c4-16e037013698" xlink:href="camp-20241231.xsd#camp_LesseeOperatingLeaseIncrementalBorrowingRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1c90551a-5a92-4217-b89b-955b8ec97435" xlink:to="loc_camp_LesseeOperatingLeaseIncrementalBorrowingRate_086da5e9-0754-4597-a3c4-16e037013698" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://camp4tx.com/role/CollaborationandLicenseAgreementsChildrensMedicalCenterCorporationNarrativeDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#CollaborationandLicenseAgreementsChildrensMedicalCenterCorporationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://camp4tx.com/role/CollaborationandLicenseAgreementsChildrensMedicalCenterCorporationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_a403a8fc-f138-4294-838d-b5d88bb5b5fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_38a780f7-0829-411a-9842-95776f35741f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_a403a8fc-f138-4294-838d-b5d88bb5b5fb" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_38a780f7-0829-411a-9842-95776f35741f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_fcbf8508-e381-4c04-a483-981d7087c511" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_38a780f7-0829-411a-9842-95776f35741f" xlink:to="loc_us-gaap_TypeOfArrangementAxis_fcbf8508-e381-4c04-a483-981d7087c511" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_fcbf8508-e381-4c04-a483-981d7087c511_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_fcbf8508-e381-4c04-a483-981d7087c511" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_fcbf8508-e381-4c04-a483-981d7087c511_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_59358269-d9ad-4f2c-8ea8-69a1616559ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_fcbf8508-e381-4c04-a483-981d7087c511" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_59358269-d9ad-4f2c-8ea8-69a1616559ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_3143c5e9-7640-4953-93ba-4e6c294cb502" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_59358269-d9ad-4f2c-8ea8-69a1616559ce" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_3143c5e9-7640-4953-93ba-4e6c294cb502" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_22d31959-82ae-4bba-ae73-264c256b866b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_38a780f7-0829-411a-9842-95776f35741f" xlink:to="loc_srt_CounterpartyNameAxis_22d31959-82ae-4bba-ae73-264c256b866b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_22d31959-82ae-4bba-ae73-264c256b866b_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_22d31959-82ae-4bba-ae73-264c256b866b" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_22d31959-82ae-4bba-ae73-264c256b866b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0c64f7d2-955a-435a-aa93-ecb56d01ecc8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_22d31959-82ae-4bba-ae73-264c256b866b" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0c64f7d2-955a-435a-aa93-ecb56d01ecc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ChildrenMedicalCenterCorporationMember_c2b2a2ea-29fd-4ea3-b95b-642d11a52aef" xlink:href="camp-20241231.xsd#camp_ChildrenMedicalCenterCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0c64f7d2-955a-435a-aa93-ecb56d01ecc8" xlink:to="loc_camp_ChildrenMedicalCenterCorporationMember_c2b2a2ea-29fd-4ea3-b95b-642d11a52aef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_MilestoneTargetsAxis_00823460-380b-4148-82ba-62f029a48ec2" xlink:href="camp-20241231.xsd#camp_MilestoneTargetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_38a780f7-0829-411a-9842-95776f35741f" xlink:to="loc_camp_MilestoneTargetsAxis_00823460-380b-4148-82ba-62f029a48ec2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_MilestoneTargetsDomain_00823460-380b-4148-82ba-62f029a48ec2_default" xlink:href="camp-20241231.xsd#camp_MilestoneTargetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_camp_MilestoneTargetsAxis_00823460-380b-4148-82ba-62f029a48ec2" xlink:to="loc_camp_MilestoneTargetsDomain_00823460-380b-4148-82ba-62f029a48ec2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_MilestoneTargetsDomain_12458346-4e93-4b73-85b0-5058cec672aa" xlink:href="camp-20241231.xsd#camp_MilestoneTargetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_camp_MilestoneTargetsAxis_00823460-380b-4148-82ba-62f029a48ec2" xlink:to="loc_camp_MilestoneTargetsDomain_12458346-4e93-4b73-85b0-5058cec672aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_UponAchievementOfFirstLicensedTargetMember_98e64498-4920-4248-a55d-bd62e94d9163" xlink:href="camp-20241231.xsd#camp_UponAchievementOfFirstLicensedTargetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_camp_MilestoneTargetsDomain_12458346-4e93-4b73-85b0-5058cec672aa" xlink:to="loc_camp_UponAchievementOfFirstLicensedTargetMember_98e64498-4920-4248-a55d-bd62e94d9163" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_UponAchievementOfSecondLicensedTargetMember_08f43af1-2851-470b-bd3c-61c78a02fca2" xlink:href="camp-20241231.xsd#camp_UponAchievementOfSecondLicensedTargetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_camp_MilestoneTargetsDomain_12458346-4e93-4b73-85b0-5058cec672aa" xlink:to="loc_camp_UponAchievementOfSecondLicensedTargetMember_08f43af1-2851-470b-bd3c-61c78a02fca2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_UponAchievementOfThirdLicensedTargetMember_4b4fb0d6-2a0f-4f83-8d1b-913b63b03ad7" xlink:href="camp-20241231.xsd#camp_UponAchievementOfThirdLicensedTargetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_camp_MilestoneTargetsDomain_12458346-4e93-4b73-85b0-5058cec672aa" xlink:to="loc_camp_UponAchievementOfThirdLicensedTargetMember_4b4fb0d6-2a0f-4f83-8d1b-913b63b03ad7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_f552abb0-59dd-45d7-bdfd-2d49e2089736" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_a403a8fc-f138-4294-838d-b5d88bb5b5fb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_f552abb0-59dd-45d7-bdfd-2d49e2089736" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation_9a4bb44a-ccba-4757-9ad7-400348fe713e" xlink:href="camp-20241231.xsd#camp_CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_a403a8fc-f138-4294-838d-b5d88bb5b5fb" xlink:to="loc_camp_CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation_9a4bb44a-ccba-4757-9ad7-400348fe713e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_PercentageOfUpfrontPaymentRequiredUponFirstInvestigationalNewDrugStudy_ecef8111-0f53-4c45-8a55-128853f98746" xlink:href="camp-20241231.xsd#camp_PercentageOfUpfrontPaymentRequiredUponFirstInvestigationalNewDrugStudy"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_a403a8fc-f138-4294-838d-b5d88bb5b5fb" xlink:to="loc_camp_PercentageOfUpfrontPaymentRequiredUponFirstInvestigationalNewDrugStudy_ecef8111-0f53-4c45-8a55-128853f98746" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://camp4tx.com/role/CollaborationandLicenseAgreementsWhiteheadInstituteforBiomedicalResearchNarrativeDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#CollaborationandLicenseAgreementsWhiteheadInstituteforBiomedicalResearchNarrativeDetails"/>
  <link:definitionLink xlink:role="http://camp4tx.com/role/CollaborationandLicenseAgreementsWhiteheadInstituteforBiomedicalResearchNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_278c2dd9-5ba6-41f7-8c94-96ff4cfc7beb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_2500b1b4-1611-45cf-9753-02fc262a73f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_278c2dd9-5ba6-41f7-8c94-96ff4cfc7beb" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_2500b1b4-1611-45cf-9753-02fc262a73f9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_f6ef8e5d-a648-4eab-9f4c-77c31f18915f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_2500b1b4-1611-45cf-9753-02fc262a73f9" xlink:to="loc_us-gaap_TypeOfArrangementAxis_f6ef8e5d-a648-4eab-9f4c-77c31f18915f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f6ef8e5d-a648-4eab-9f4c-77c31f18915f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_f6ef8e5d-a648-4eab-9f4c-77c31f18915f" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f6ef8e5d-a648-4eab-9f4c-77c31f18915f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ee68fafe-a32f-48ab-8c34-da5a2ac8f828" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_f6ef8e5d-a648-4eab-9f4c-77c31f18915f" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ee68fafe-a32f-48ab-8c34-da5a2ac8f828" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_4600dc45-66a4-4dce-a6cb-a61d0ee8dec7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ee68fafe-a32f-48ab-8c34-da5a2ac8f828" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_4600dc45-66a4-4dce-a6cb-a61d0ee8dec7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_23c6754e-6f0b-4011-862d-3cb1e0da71f6" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_2500b1b4-1611-45cf-9753-02fc262a73f9" xlink:to="loc_srt_CounterpartyNameAxis_23c6754e-6f0b-4011-862d-3cb1e0da71f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_23c6754e-6f0b-4011-862d-3cb1e0da71f6_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_23c6754e-6f0b-4011-862d-3cb1e0da71f6" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_23c6754e-6f0b-4011-862d-3cb1e0da71f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6e5966dc-b6f1-48f4-b616-2c7b11c23c3e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_23c6754e-6f0b-4011-862d-3cb1e0da71f6" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6e5966dc-b6f1-48f4-b616-2c7b11c23c3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_TheWhiteheadInstituteForBiomedicalResearchMember_f24dfe2e-41b7-404e-a860-699c91d666b5" xlink:href="camp-20241231.xsd#camp_TheWhiteheadInstituteForBiomedicalResearchMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6e5966dc-b6f1-48f4-b616-2c7b11c23c3e" xlink:to="loc_camp_TheWhiteheadInstituteForBiomedicalResearchMember_f24dfe2e-41b7-404e-a860-699c91d666b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_CollaborativeArrangementUpfrontLicenseIssuanceFeePayment_46fa780b-e6b1-40d3-ac9c-7b825eed1792" xlink:href="camp-20241231.xsd#camp_CollaborativeArrangementUpfrontLicenseIssuanceFeePayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_278c2dd9-5ba6-41f7-8c94-96ff4cfc7beb" xlink:to="loc_camp_CollaborativeArrangementUpfrontLicenseIssuanceFeePayment_46fa780b-e6b1-40d3-ac9c-7b825eed1792" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation_15bd81b4-2c44-46bf-a25e-435879d21824" xlink:href="camp-20241231.xsd#camp_CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_278c2dd9-5ba6-41f7-8c94-96ff4cfc7beb" xlink:to="loc_camp_CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation_15bd81b4-2c44-46bf-a25e-435879d21824" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_CollaborativeArrangementTieredRoyaltiesPayableOnNetSalesMaximumLowerRangePercent_4ca6b1e8-a6c2-44fa-91a2-9be144b0a40c" xlink:href="camp-20241231.xsd#camp_CollaborativeArrangementTieredRoyaltiesPayableOnNetSalesMaximumLowerRangePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_278c2dd9-5ba6-41f7-8c94-96ff4cfc7beb" xlink:to="loc_camp_CollaborativeArrangementTieredRoyaltiesPayableOnNetSalesMaximumLowerRangePercent_4ca6b1e8-a6c2-44fa-91a2-9be144b0a40c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_CollaborativeArrangementTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale_e8642567-e2dd-48aa-8dcb-efdb8ed7a4dd" xlink:href="camp-20241231.xsd#camp_CollaborativeArrangementTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_278c2dd9-5ba6-41f7-8c94-96ff4cfc7beb" xlink:to="loc_camp_CollaborativeArrangementTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale_e8642567-e2dd-48aa-8dcb-efdb8ed7a4dd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_CollaborativeArrangementFeesIncurredDuringPeriod_2e5fb09c-4452-44b9-89b6-98ab6abb6562" xlink:href="camp-20241231.xsd#camp_CollaborativeArrangementFeesIncurredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_278c2dd9-5ba6-41f7-8c94-96ff4cfc7beb" xlink:to="loc_camp_CollaborativeArrangementFeesIncurredDuringPeriod_2e5fb09c-4452-44b9-89b6-98ab6abb6562" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://camp4tx.com/role/CollaborationandLicenseAgreementsFulcrumTherapeuticsIncNarrativeDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#CollaborationandLicenseAgreementsFulcrumTherapeuticsIncNarrativeDetails"/>
  <link:definitionLink xlink:role="http://camp4tx.com/role/CollaborationandLicenseAgreementsFulcrumTherapeuticsIncNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d1c45b4f-5d4d-4199-b3f1-20dee63b3dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_7003ec85-534e-4cac-82d4-4b3d903ec325" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d1c45b4f-5d4d-4199-b3f1-20dee63b3dd5" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_7003ec85-534e-4cac-82d4-4b3d903ec325" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_7266d144-a8d6-460e-bdd1-29b5f08f05d0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_7003ec85-534e-4cac-82d4-4b3d903ec325" xlink:to="loc_srt_CounterpartyNameAxis_7266d144-a8d6-460e-bdd1-29b5f08f05d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7266d144-a8d6-460e-bdd1-29b5f08f05d0_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_7266d144-a8d6-460e-bdd1-29b5f08f05d0" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7266d144-a8d6-460e-bdd1-29b5f08f05d0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a5eaea31-c0d5-40fa-ab0c-a9e7311f71e8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_7266d144-a8d6-460e-bdd1-29b5f08f05d0" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a5eaea31-c0d5-40fa-ab0c-a9e7311f71e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_FulcrumTherapeuticsInc.Member_bc325373-f773-42eb-8017-7698cc1966a5" xlink:href="camp-20241231.xsd#camp_FulcrumTherapeuticsInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a5eaea31-c0d5-40fa-ab0c-a9e7311f71e8" xlink:to="loc_camp_FulcrumTherapeuticsInc.Member_bc325373-f773-42eb-8017-7698cc1966a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_405d3bbd-0110-465c-b773-ed306c3e076d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_7003ec85-534e-4cac-82d4-4b3d903ec325" xlink:to="loc_srt_ProductOrServiceAxis_405d3bbd-0110-465c-b773-ed306c3e076d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_405d3bbd-0110-465c-b773-ed306c3e076d_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_405d3bbd-0110-465c-b773-ed306c3e076d" xlink:to="loc_srt_ProductsAndServicesDomain_405d3bbd-0110-465c-b773-ed306c3e076d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_fd6d0533-8cca-4cec-989f-267866d83db9" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_405d3bbd-0110-465c-b773-ed306c3e076d" xlink:to="loc_srt_ProductsAndServicesDomain_fd6d0533-8cca-4cec-989f-267866d83db9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_TierOneProductMember_a06390bc-838a-4118-bf78-d349a302403f" xlink:href="camp-20241231.xsd#camp_TierOneProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_fd6d0533-8cca-4cec-989f-267866d83db9" xlink:to="loc_camp_TierOneProductMember_a06390bc-838a-4118-bf78-d349a302403f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9acd69e4-d352-41ce-89cf-f5925e047acb" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_7003ec85-534e-4cac-82d4-4b3d903ec325" xlink:to="loc_srt_RangeAxis_9acd69e4-d352-41ce-89cf-f5925e047acb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9acd69e4-d352-41ce-89cf-f5925e047acb_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_9acd69e4-d352-41ce-89cf-f5925e047acb" xlink:to="loc_srt_RangeMember_9acd69e4-d352-41ce-89cf-f5925e047acb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2c8b79f6-7dc0-41cf-8777-4918d63b1318" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_9acd69e4-d352-41ce-89cf-f5925e047acb" xlink:to="loc_srt_RangeMember_2c8b79f6-7dc0-41cf-8777-4918d63b1318" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_9cf2346b-e7d6-48ea-b251-b34b82b0bf62" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2c8b79f6-7dc0-41cf-8777-4918d63b1318" xlink:to="loc_srt_MinimumMember_9cf2346b-e7d6-48ea-b251-b34b82b0bf62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d831b7f4-eeb1-4369-8b36-83bea9554166" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2c8b79f6-7dc0-41cf-8777-4918d63b1318" xlink:to="loc_srt_MaximumMember_d831b7f4-eeb1-4369-8b36-83bea9554166" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_c0f208ed-9fb5-4c27-8524-d40b0c48127d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d1c45b4f-5d4d-4199-b3f1-20dee63b3dd5" xlink:to="loc_us-gaap_ContractWithCustomerLiability_c0f208ed-9fb5-4c27-8524-d40b0c48127d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmount_2624aeb1-2875-46e8-a98c-c3e591af8324" xlink:href="camp-20241231.xsd#camp_RevenueRemainingPerformanceObligationVariableConsiderationAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d1c45b4f-5d4d-4199-b3f1-20dee63b3dd5" xlink:to="loc_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmount_2624aeb1-2875-46e8-a98c-c3e591af8324" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_RevenuePerformanceObligationNumberOfPerformanceObligations_9771d55a-b066-4fd9-80af-eef44b0984ed" xlink:href="camp-20241231.xsd#camp_RevenuePerformanceObligationNumberOfPerformanceObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d1c45b4f-5d4d-4199-b3f1-20dee63b3dd5" xlink:to="loc_camp_RevenuePerformanceObligationNumberOfPerformanceObligations_9771d55a-b066-4fd9-80af-eef44b0984ed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_RevenueRemainingPerformanceObligationFixedConsiderationAmount_4daf5be6-769c-48b3-9a61-1aa31bc2cc2f" xlink:href="camp-20241231.xsd#camp_RevenueRemainingPerformanceObligationFixedConsiderationAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d1c45b4f-5d4d-4199-b3f1-20dee63b3dd5" xlink:to="loc_camp_RevenueRemainingPerformanceObligationFixedConsiderationAmount_4daf5be6-769c-48b3-9a61-1aa31bc2cc2f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_981dc377-91b7-4998-b671-6e2a8273f2a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d1c45b4f-5d4d-4199-b3f1-20dee63b3dd5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_981dc377-91b7-4998-b671-6e2a8273f2a2" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://camp4tx.com/role/CollaborationandLicenseAgreementsEliLillyandCompanyNarrativeDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#CollaborationandLicenseAgreementsEliLillyandCompanyNarrativeDetails"/>
  <link:definitionLink xlink:role="http://camp4tx.com/role/CollaborationandLicenseAgreementsEliLillyandCompanyNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_c7454460-ad22-42fc-897f-2b4e32548ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_2184f802-3430-4fcf-b872-f7f0fe987c87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_c7454460-ad22-42fc-897f-2b4e32548ef7" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_2184f802-3430-4fcf-b872-f7f0fe987c87" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_7e487f13-eef6-43c4-8df9-cd48def21a02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_2184f802-3430-4fcf-b872-f7f0fe987c87" xlink:to="loc_us-gaap_TypeOfArrangementAxis_7e487f13-eef6-43c4-8df9-cd48def21a02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_7e487f13-eef6-43c4-8df9-cd48def21a02_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_7e487f13-eef6-43c4-8df9-cd48def21a02" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_7e487f13-eef6-43c4-8df9-cd48def21a02_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_25428166-44aa-4394-a73d-c897666c8284" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_7e487f13-eef6-43c4-8df9-cd48def21a02" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_25428166-44aa-4394-a73d-c897666c8284" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_324b04db-004a-466b-9414-159d0e503cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_25428166-44aa-4394-a73d-c897666c8284" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_324b04db-004a-466b-9414-159d0e503cdc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_69f7b96e-59e7-4aba-b8f9-260871d3a066" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_2184f802-3430-4fcf-b872-f7f0fe987c87" xlink:to="loc_srt_CounterpartyNameAxis_69f7b96e-59e7-4aba-b8f9-260871d3a066" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_69f7b96e-59e7-4aba-b8f9-260871d3a066_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_69f7b96e-59e7-4aba-b8f9-260871d3a066" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_69f7b96e-59e7-4aba-b8f9-260871d3a066_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_912765d2-0c85-47d0-9fa4-364cf94c1178" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_69f7b96e-59e7-4aba-b8f9-260871d3a066" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_912765d2-0c85-47d0-9fa4-364cf94c1178" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_EliLillyAndCompanyMember_9808251c-a3d8-4b78-9dc2-d2dbcd97a898" xlink:href="camp-20241231.xsd#camp_EliLillyAndCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_912765d2-0c85-47d0-9fa4-364cf94c1178" xlink:to="loc_camp_EliLillyAndCompanyMember_9808251c-a3d8-4b78-9dc2-d2dbcd97a898" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cddf0853-b867-4b1e-89fe-a2b909e4e110" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_2184f802-3430-4fcf-b872-f7f0fe987c87" xlink:to="loc_srt_RangeAxis_cddf0853-b867-4b1e-89fe-a2b909e4e110" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cddf0853-b867-4b1e-89fe-a2b909e4e110_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_cddf0853-b867-4b1e-89fe-a2b909e4e110" xlink:to="loc_srt_RangeMember_cddf0853-b867-4b1e-89fe-a2b909e4e110_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6f495250-574b-41d9-bf88-055cd6571a93" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_cddf0853-b867-4b1e-89fe-a2b909e4e110" xlink:to="loc_srt_RangeMember_6f495250-574b-41d9-bf88-055cd6571a93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1d3c7e28-ab75-4b53-a290-a3ec00fda255" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6f495250-574b-41d9-bf88-055cd6571a93" xlink:to="loc_srt_MaximumMember_1d3c7e28-ab75-4b53-a290-a3ec00fda255" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_CollaborativeArrangementReductionInResearchAndDevelopmentExpense_b48efc5c-0fc6-4602-a227-158be3db3135" xlink:href="camp-20241231.xsd#camp_CollaborativeArrangementReductionInResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_c7454460-ad22-42fc-897f-2b4e32548ef7" xlink:to="loc_camp_CollaborativeArrangementReductionInResearchAndDevelopmentExpense_b48efc5c-0fc6-4602-a227-158be3db3135" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable_cd4caaf3-dea0-4d8e-8944-a39efcc00a19" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_c7454460-ad22-42fc-897f-2b4e32548ef7" xlink:to="loc_us-gaap_UnbilledContractsReceivable_cd4caaf3-dea0-4d8e-8944-a39efcc00a19" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://camp4tx.com/role/CollaborationandLicenseAgreementsBioMarinPharmaceuticalIncNarrativeDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#CollaborationandLicenseAgreementsBioMarinPharmaceuticalIncNarrativeDetails"/>
  <link:definitionLink xlink:role="http://camp4tx.com/role/CollaborationandLicenseAgreementsBioMarinPharmaceuticalIncNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_90141318-1305-48bb-a2c8-ffe701ab8e73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_13bf256b-b361-4966-9f37-471b9bc055ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_90141318-1305-48bb-a2c8-ffe701ab8e73" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_13bf256b-b361-4966-9f37-471b9bc055ee" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_d95d9f36-9782-4356-b720-630a25568d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_13bf256b-b361-4966-9f37-471b9bc055ee" xlink:to="loc_us-gaap_TypeOfArrangementAxis_d95d9f36-9782-4356-b720-630a25568d5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d95d9f36-9782-4356-b720-630a25568d5b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_d95d9f36-9782-4356-b720-630a25568d5b" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d95d9f36-9782-4356-b720-630a25568d5b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e5a4297d-2e23-42c9-9bdb-004c9caeeaba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_d95d9f36-9782-4356-b720-630a25568d5b" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e5a4297d-2e23-42c9-9bdb-004c9caeeaba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_ff6a885a-98b6-461d-9b4f-329f9f81e633" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e5a4297d-2e23-42c9-9bdb-004c9caeeaba" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_ff6a885a-98b6-461d-9b4f-329f9f81e633" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_27093582-fe6c-4033-8d1b-2faba6b2a526" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_13bf256b-b361-4966-9f37-471b9bc055ee" xlink:to="loc_srt_CounterpartyNameAxis_27093582-fe6c-4033-8d1b-2faba6b2a526" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_27093582-fe6c-4033-8d1b-2faba6b2a526_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_27093582-fe6c-4033-8d1b-2faba6b2a526" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_27093582-fe6c-4033-8d1b-2faba6b2a526_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b3f9f2f1-df3b-4b00-a2ea-a0a750731873" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_27093582-fe6c-4033-8d1b-2faba6b2a526" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b3f9f2f1-df3b-4b00-a2ea-a0a750731873" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_BioMarinPharmaceuticalInc.Member_366d6683-5feb-44bd-88a7-df0022ac2334" xlink:href="camp-20241231.xsd#camp_BioMarinPharmaceuticalInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b3f9f2f1-df3b-4b00-a2ea-a0a750731873" xlink:to="loc_camp_BioMarinPharmaceuticalInc.Member_366d6683-5feb-44bd-88a7-df0022ac2334" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3c1913b6-6755-4be7-8945-acf6c5abce7f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_13bf256b-b361-4966-9f37-471b9bc055ee" xlink:to="loc_srt_RangeAxis_3c1913b6-6755-4be7-8945-acf6c5abce7f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3c1913b6-6755-4be7-8945-acf6c5abce7f_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_3c1913b6-6755-4be7-8945-acf6c5abce7f" xlink:to="loc_srt_RangeMember_3c1913b6-6755-4be7-8945-acf6c5abce7f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_326f5a41-d6f4-420a-95c0-27d3b82f5703" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_3c1913b6-6755-4be7-8945-acf6c5abce7f" xlink:to="loc_srt_RangeMember_326f5a41-d6f4-420a-95c0-27d3b82f5703" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c9428668-b2aa-41b5-b276-4eec5db2037a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_326f5a41-d6f4-420a-95c0-27d3b82f5703" xlink:to="loc_srt_MinimumMember_c9428668-b2aa-41b5-b276-4eec5db2037a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a5aada84-70d5-455f-8477-e0b310e6ce5e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_326f5a41-d6f4-420a-95c0-27d3b82f5703" xlink:to="loc_srt_MaximumMember_a5aada84-70d5-455f-8477-e0b310e6ce5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_ab09bec3-85af-4a18-b44e-845ec568c26c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_90141318-1305-48bb-a2c8-ffe701ab8e73" xlink:to="loc_us-gaap_ContractWithCustomerLiability_ab09bec3-85af-4a18-b44e-845ec568c26c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentPreclinicalMilestones_34632618-f778-4773-98ba-cc0fed7bd974" xlink:href="camp-20241231.xsd#camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentPreclinicalMilestones"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_90141318-1305-48bb-a2c8-ffe701ab8e73" xlink:to="loc_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentPreclinicalMilestones_34632618-f778-4773-98ba-cc0fed7bd974" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentDevelopmentAndRegulatoryMilestones_1665fcb8-1b7a-410b-8184-e9acb298079a" xlink:href="camp-20241231.xsd#camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentDevelopmentAndRegulatoryMilestones"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_90141318-1305-48bb-a2c8-ffe701ab8e73" xlink:to="loc_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentDevelopmentAndRegulatoryMilestones_1665fcb8-1b7a-410b-8184-e9acb298079a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountCommercialSalesMilestones_9314582a-e7f5-4374-89e0-b9f90609b708" xlink:href="camp-20241231.xsd#camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountCommercialSalesMilestones"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_90141318-1305-48bb-a2c8-ffe701ab8e73" xlink:to="loc_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountCommercialSalesMilestones_9314582a-e7f5-4374-89e0-b9f90609b708" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_RevenueRemainingPerformanceObligationTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale_014e7f51-af76-4819-a9d2-1a21ac791418" xlink:href="camp-20241231.xsd#camp_RevenueRemainingPerformanceObligationTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_90141318-1305-48bb-a2c8-ffe701ab8e73" xlink:to="loc_camp_RevenueRemainingPerformanceObligationTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale_014e7f51-af76-4819-a9d2-1a21ac791418" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_RevenueRemainingPerformanceObligationNoticePeriodForTermination_4f95ada6-5d53-4ca5-aa4a-243fd33a3f5f" xlink:href="camp-20241231.xsd#camp_RevenueRemainingPerformanceObligationNoticePeriodForTermination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_90141318-1305-48bb-a2c8-ffe701ab8e73" xlink:to="loc_camp_RevenueRemainingPerformanceObligationNoticePeriodForTermination_4f95ada6-5d53-4ca5-aa4a-243fd33a3f5f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_RevenueRemainingPerformanceObligationExpectedReimbursableResearchAndDevelopmentExpenses_62ac41b2-6e21-4790-9057-a2908506918d" xlink:href="camp-20241231.xsd#camp_RevenueRemainingPerformanceObligationExpectedReimbursableResearchAndDevelopmentExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_90141318-1305-48bb-a2c8-ffe701ab8e73" xlink:to="loc_camp_RevenueRemainingPerformanceObligationExpectedReimbursableResearchAndDevelopmentExpenses_62ac41b2-6e21-4790-9057-a2908506918d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_RevenueRemainingPerformanceObligationFixedConsiderationAmount_23eebbff-4eb6-446d-af87-878082df158e" xlink:href="camp-20241231.xsd#camp_RevenueRemainingPerformanceObligationFixedConsiderationAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_90141318-1305-48bb-a2c8-ffe701ab8e73" xlink:to="loc_camp_RevenueRemainingPerformanceObligationFixedConsiderationAmount_23eebbff-4eb6-446d-af87-878082df158e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_75e225a6-1621-4b34-ba6e-eb2df785fbc3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_90141318-1305-48bb-a2c8-ffe701ab8e73" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_75e225a6-1621-4b34-ba6e-eb2df785fbc3" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitNarrativeDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#ConvertiblePreferredStockandStockholdersDeficitNarrativeDetails"/>
  <link:definitionLink xlink:role="http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_06b8023d-c9fa-4339-879f-462559474f38" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_53b1537f-333f-4623-b54c-857397c2d25f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_06b8023d-c9fa-4339-879f-462559474f38" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_53b1537f-333f-4623-b54c-857397c2d25f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_cd8165a3-24eb-4376-aa98-e7b22361fe22" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_53b1537f-333f-4623-b54c-857397c2d25f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_cd8165a3-24eb-4376-aa98-e7b22361fe22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_cd8165a3-24eb-4376-aa98-e7b22361fe22_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_cd8165a3-24eb-4376-aa98-e7b22361fe22" xlink:to="loc_us-gaap_EquityComponentDomain_cd8165a3-24eb-4376-aa98-e7b22361fe22_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_df9a984a-a897-4b78-a74b-25df59bcefbf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_cd8165a3-24eb-4376-aa98-e7b22361fe22" xlink:to="loc_us-gaap_EquityComponentDomain_df9a984a-a897-4b78-a74b-25df59bcefbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_03be9ea4-e1bd-459b-9d14-b57ab04732ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_df9a984a-a897-4b78-a74b-25df59bcefbf" xlink:to="loc_us-gaap_CommonStockMember_03be9ea4-e1bd-459b-9d14-b57ab04732ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_987f48c3-3f76-400f-862c-40373b809b23" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_06b8023d-c9fa-4339-879f-462559474f38" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_987f48c3-3f76-400f-862c-40373b809b23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_7a71e9c1-3ba3-4d4f-806f-23d62a72485d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_06b8023d-c9fa-4339-879f-462559474f38" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_7a71e9c1-3ba3-4d4f-806f-23d62a72485d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_9554a8b1-c8a4-467d-ade1-504498add2d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_06b8023d-c9fa-4339-879f-462559474f38" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_9554a8b1-c8a4-467d-ade1-504498add2d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_d7371364-42b3-4d09-9083-36f5a272afef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_06b8023d-c9fa-4339-879f-462559474f38" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_d7371364-42b3-4d09-9083-36f5a272afef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5449907a-45a0-43bb-80a6-e1dddcb34525" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_06b8023d-c9fa-4339-879f-462559474f38" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5449907a-45a0-43bb-80a6-e1dddcb34525" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_97683115-cb99-4418-9b26-36c53cc02e86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_06b8023d-c9fa-4339-879f-462559474f38" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_97683115-cb99-4418-9b26-36c53cc02e86" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_NumberOfVotesPerCommonShare_565027a5-5e67-4fe1-9db5-f9ebb2617e54" xlink:href="camp-20241231.xsd#camp_NumberOfVotesPerCommonShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_06b8023d-c9fa-4339-879f-462559474f38" xlink:to="loc_camp_NumberOfVotesPerCommonShare_565027a5-5e67-4fe1-9db5-f9ebb2617e54" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_5098b6d4-bdb4-46e2-97c0-619101599e50" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_06b8023d-c9fa-4339-879f-462559474f38" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_5098b6d4-bdb4-46e2-97c0-619101599e50" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareDeclared_207310c0-743d-4742-9a4a-add1ccec3b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_06b8023d-c9fa-4339-879f-462559474f38" xlink:to="loc_us-gaap_PreferredStockDividendsPerShareDeclared_207310c0-743d-4742-9a4a-add1ccec3b3c" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitSummaryofConvertiblePreferredStockDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#ConvertiblePreferredStockandStockholdersDeficitSummaryofConvertiblePreferredStockDetails"/>
  <link:definitionLink xlink:role="http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitSummaryofConvertiblePreferredStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_f3933efe-0ddc-4589-8ba9-1b80121b00dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_01f29b40-de5a-46d3-9684-7f1388f00df5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TemporaryEquityLineItems_f3933efe-0ddc-4589-8ba9-1b80121b00dd" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_01f29b40-de5a-46d3-9684-7f1388f00df5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_dd14a038-a1ae-485a-ba56-8f6b30806692" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_01f29b40-de5a-46d3-9684-7f1388f00df5" xlink:to="loc_us-gaap_StatementClassOfStockAxis_dd14a038-a1ae-485a-ba56-8f6b30806692" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_dd14a038-a1ae-485a-ba56-8f6b30806692_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_dd14a038-a1ae-485a-ba56-8f6b30806692" xlink:to="loc_us-gaap_ClassOfStockDomain_dd14a038-a1ae-485a-ba56-8f6b30806692_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_08387c2e-61d6-4074-9a96-c130040c75ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_dd14a038-a1ae-485a-ba56-8f6b30806692" xlink:to="loc_us-gaap_ClassOfStockDomain_08387c2e-61d6-4074-9a96-c130040c75ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_8099025a-2a86-46e8-8809-d499727aed6a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_08387c2e-61d6-4074-9a96-c130040c75ee" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_8099025a-2a86-46e8-8809-d499727aed6a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_07d6284e-0a3a-4a42-b1d8-be34c4e87262" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_08387c2e-61d6-4074-9a96-c130040c75ee" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_07d6284e-0a3a-4a42-b1d8-be34c4e87262" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_d04ecdf2-9a51-486a-a65e-efb1237929f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_f3933efe-0ddc-4589-8ba9-1b80121b00dd" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_d04ecdf2-9a51-486a-a65e-efb1237929f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_4052f75b-b572-4cc1-82fe-ab6a7abe4a72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_f3933efe-0ddc-4589-8ba9-1b80121b00dd" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_4052f75b-b572-4cc1-82fe-ab6a7abe4a72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_9e98dbe5-741c-4bdc-92c5-9057e0168b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_f3933efe-0ddc-4589-8ba9-1b80121b00dd" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_9e98dbe5-741c-4bdc-92c5-9057e0168b3b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLiquidationPreference_8f3e2f7f-8248-4b6a-bd82-15ef6e33547a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_f3933efe-0ddc-4589-8ba9-1b80121b00dd" xlink:to="loc_us-gaap_TemporaryEquityLiquidationPreference_8f3e2f7f-8248-4b6a-bd82-15ef6e33547a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockConvertibleSharesIssuable_66406e23-a08d-4604-a452-21a11296cd8a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockConvertibleSharesIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_f3933efe-0ddc-4589-8ba9-1b80121b00dd" xlink:to="loc_us-gaap_PreferredStockConvertibleSharesIssuable_66406e23-a08d-4604-a452-21a11296cd8a" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitScheduleofCommonStockIssuanceUponConversionDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#ConvertiblePreferredStockandStockholdersDeficitScheduleofCommonStockIssuanceUponConversionDetails"/>
  <link:definitionLink xlink:role="http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitScheduleofCommonStockIssuanceUponConversionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_1717f4ea-a63e-4893-b185-28ef1b69d6cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_fa781c9b-dcb5-4c1d-8946-7f6bfa2928d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_1717f4ea-a63e-4893-b185-28ef1b69d6cc" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_fa781c9b-dcb5-4c1d-8946-7f6bfa2928d1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_58e79240-01f9-4254-8ccb-3c9048cb0137" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_fa781c9b-dcb5-4c1d-8946-7f6bfa2928d1" xlink:to="loc_us-gaap_PlanNameAxis_58e79240-01f9-4254-8ccb-3c9048cb0137" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_58e79240-01f9-4254-8ccb-3c9048cb0137_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_58e79240-01f9-4254-8ccb-3c9048cb0137" xlink:to="loc_us-gaap_PlanNameDomain_58e79240-01f9-4254-8ccb-3c9048cb0137_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_0bc28cb5-ca49-4fb8-89a7-3b33b7458efc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_58e79240-01f9-4254-8ccb-3c9048cb0137" xlink:to="loc_us-gaap_PlanNameDomain_0bc28cb5-ca49-4fb8-89a7-3b33b7458efc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_MarauderTherapeuticsInc2016StockOptionAndGrantPlanMember_2aaca45d-7b50-4d5d-af0f-9c9147594d48" xlink:href="camp-20241231.xsd#camp_MarauderTherapeuticsInc2016StockOptionAndGrantPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_0bc28cb5-ca49-4fb8-89a7-3b33b7458efc" xlink:to="loc_camp_MarauderTherapeuticsInc2016StockOptionAndGrantPlanMember_2aaca45d-7b50-4d5d-af0f-9c9147594d48" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_2de3f643-dffb-475e-a9b9-10a7ed0b7da4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1717f4ea-a63e-4893-b185-28ef1b69d6cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_2de3f643-dffb-475e-a9b9-10a7ed0b7da4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f887e64e-5049-46ff-90b4-42261de9463e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1717f4ea-a63e-4893-b185-28ef1b69d6cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f887e64e-5049-46ff-90b4-42261de9463e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ddb7ce6c-d536-435f-8445-994e62d1f00a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1717f4ea-a63e-4893-b185-28ef1b69d6cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ddb7ce6c-d536-435f-8445-994e62d1f00a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_412ccebe-cb4e-4d76-b252-6f4df8d9a7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1717f4ea-a63e-4893-b185-28ef1b69d6cc" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_412ccebe-cb4e-4d76-b252-6f4df8d9a7ef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_811e9900-4e76-4695-a0fd-67ea87187479" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1717f4ea-a63e-4893-b185-28ef1b69d6cc" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_811e9900-4e76-4695-a0fd-67ea87187479" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://camp4tx.com/role/StockBasedCompensation2024EquityIncentivePlanNarrativeDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#StockBasedCompensation2024EquityIncentivePlanNarrativeDetails"/>
  <link:definitionLink xlink:role="http://camp4tx.com/role/StockBasedCompensation2024EquityIncentivePlanNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c58e6cad-0260-425b-a263-194d86429593" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_93c0f07b-e7c8-4ad0-9ab3-dfa988d5e2fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c58e6cad-0260-425b-a263-194d86429593" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_93c0f07b-e7c8-4ad0-9ab3-dfa988d5e2fe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_b8141095-393a-4b4e-8fdc-3459133ac396" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_93c0f07b-e7c8-4ad0-9ab3-dfa988d5e2fe" xlink:to="loc_us-gaap_PlanNameAxis_b8141095-393a-4b4e-8fdc-3459133ac396" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_b8141095-393a-4b4e-8fdc-3459133ac396_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_b8141095-393a-4b4e-8fdc-3459133ac396" xlink:to="loc_us-gaap_PlanNameDomain_b8141095-393a-4b4e-8fdc-3459133ac396_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_238a297d-0a92-4d55-a06a-1f6a9337df9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_b8141095-393a-4b4e-8fdc-3459133ac396" xlink:to="loc_us-gaap_PlanNameDomain_238a297d-0a92-4d55-a06a-1f6a9337df9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_A2024EquityIncentivePlanMember_6edd468c-e836-45d8-af7a-4b8c1f1c5f4c" xlink:href="camp-20241231.xsd#camp_A2024EquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_238a297d-0a92-4d55-a06a-1f6a9337df9d" xlink:to="loc_camp_A2024EquityIncentivePlanMember_6edd468c-e836-45d8-af7a-4b8c1f1c5f4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_331ef839-8920-46a3-8fea-1357d4c5622d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_93c0f07b-e7c8-4ad0-9ab3-dfa988d5e2fe" xlink:to="loc_srt_RangeAxis_331ef839-8920-46a3-8fea-1357d4c5622d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_331ef839-8920-46a3-8fea-1357d4c5622d_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_331ef839-8920-46a3-8fea-1357d4c5622d" xlink:to="loc_srt_RangeMember_331ef839-8920-46a3-8fea-1357d4c5622d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1be38ea4-a51a-46da-b0af-f31b9c47c5e5" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_331ef839-8920-46a3-8fea-1357d4c5622d" xlink:to="loc_srt_RangeMember_1be38ea4-a51a-46da-b0af-f31b9c47c5e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6109345d-8b49-428e-93f3-abfb1566cde8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1be38ea4-a51a-46da-b0af-f31b9c47c5e5" xlink:to="loc_srt_MinimumMember_6109345d-8b49-428e-93f3-abfb1566cde8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_8a1f1608-2619-4314-a1d8-27045c8feaf8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c58e6cad-0260-425b-a263-194d86429593" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_8a1f1608-2619-4314-a1d8-27045c8feaf8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfEstimatedFairValueOnGrantDate_efd0994e-4bab-4072-b34c-333214fcbb5d" xlink:href="camp-20241231.xsd#camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfEstimatedFairValueOnGrantDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c58e6cad-0260-425b-a263-194d86429593" xlink:to="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfEstimatedFairValueOnGrantDate_efd0994e-4bab-4072-b34c-333214fcbb5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c2509774-b47f-42f2-8b10-0d2f5b85d521" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c58e6cad-0260-425b-a263-194d86429593" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c2509774-b47f-42f2-8b10-0d2f5b85d521" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f31b55c6-9ac6-4a31-b4ad-bfd67162d660" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c58e6cad-0260-425b-a263-194d86429593" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f31b55c6-9ac6-4a31-b4ad-bfd67162d660" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_a1f13618-026a-43ca-b5a4-765a6cddc8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c58e6cad-0260-425b-a263-194d86429593" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_a1f13618-026a-43ca-b5a4-765a6cddc8f2" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://camp4tx.com/role/StockBasedCompensation2024EmployeeStockPurchasePlanNarrativeDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#StockBasedCompensation2024EmployeeStockPurchasePlanNarrativeDetails"/>
  <link:definitionLink xlink:role="http://camp4tx.com/role/StockBasedCompensation2024EmployeeStockPurchasePlanNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7bc04fb7-bc12-4030-831b-29d36b00e998" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fc039c0d-e2c5-495b-b24c-8747bb2fbaf8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7bc04fb7-bc12-4030-831b-29d36b00e998" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fc039c0d-e2c5-495b-b24c-8747bb2fbaf8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f4c26e5d-fa4e-4937-9716-072aad15e6a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fc039c0d-e2c5-495b-b24c-8747bb2fbaf8" xlink:to="loc_us-gaap_AwardTypeAxis_f4c26e5d-fa4e-4937-9716-072aad15e6a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f4c26e5d-fa4e-4937-9716-072aad15e6a7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_f4c26e5d-fa4e-4937-9716-072aad15e6a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f4c26e5d-fa4e-4937-9716-072aad15e6a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_87cd4379-608e-4374-95c4-7afed41894b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_f4c26e5d-fa4e-4937-9716-072aad15e6a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_87cd4379-608e-4374-95c4-7afed41894b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_a61b14c6-34c4-417e-84ea-2977583b4517" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_87cd4379-608e-4374-95c4-7afed41894b1" xlink:to="loc_us-gaap_EmployeeStockMember_a61b14c6-34c4-417e-84ea-2977583b4517" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_7059e726-28bc-4ec5-85de-63807ad84c53" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7bc04fb7-bc12-4030-831b-29d36b00e998" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_7059e726-28bc-4ec5-85de-63807ad84c53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_97faa049-6c57-4c4e-9a5e-1de6da7902eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7bc04fb7-bc12-4030-831b-29d36b00e998" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_97faa049-6c57-4c4e-9a5e-1de6da7902eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_d3fb1448-540d-4647-8696-d8faba7bc8d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7bc04fb7-bc12-4030-831b-29d36b00e998" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_d3fb1448-540d-4647-8696-d8faba7bc8d1" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsFairValueAssumptionsDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#StockBasedCompensationScheduleofStockOptionsFairValueAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsFairValueAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86f4f028-e783-4965-86fd-0006f5013a44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4477c5cf-fae1-422d-a1ef-8080f092f8cb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86f4f028-e783-4965-86fd-0006f5013a44" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4477c5cf-fae1-422d-a1ef-8080f092f8cb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a92db3b9-1405-4cae-9c7e-724d2e305433" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4477c5cf-fae1-422d-a1ef-8080f092f8cb" xlink:to="loc_us-gaap_AwardTypeAxis_a92db3b9-1405-4cae-9c7e-724d2e305433" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a92db3b9-1405-4cae-9c7e-724d2e305433_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_a92db3b9-1405-4cae-9c7e-724d2e305433" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a92db3b9-1405-4cae-9c7e-724d2e305433_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bc9ab28b-315f-4120-b4b5-8f9234de577e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_a92db3b9-1405-4cae-9c7e-724d2e305433" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bc9ab28b-315f-4120-b4b5-8f9234de577e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_05b8ecc5-5841-4fa8-9f2b-a58e1b4ae349" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bc9ab28b-315f-4120-b4b5-8f9234de577e" xlink:to="loc_us-gaap_EmployeeStockOptionMember_05b8ecc5-5841-4fa8-9f2b-a58e1b4ae349" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_b363fd4a-1bc6-4b79-a78c-640cb11cb2f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86f4f028-e783-4965-86fd-0006f5013a44" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_b363fd4a-1bc6-4b79-a78c-640cb11cb2f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_a5e490ad-b583-4e72-8712-f2009208d100" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86f4f028-e783-4965-86fd-0006f5013a44" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_a5e490ad-b583-4e72-8712-f2009208d100" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_5c804717-5b76-4746-906c-68dab80d9b35" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86f4f028-e783-4965-86fd-0006f5013a44" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_5c804717-5b76-4746-906c-68dab80d9b35" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_bed40e21-8169-403d-b61d-e0ed17419e53" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86f4f028-e783-4965-86fd-0006f5013a44" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_bed40e21-8169-403d-b61d-e0ed17419e53" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://camp4tx.com/role/StockBasedCompensationStockOptionActivityNarrativeDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#StockBasedCompensationStockOptionActivityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://camp4tx.com/role/StockBasedCompensationStockOptionActivityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_81038954-b7b9-4d0f-bfa3-95a1dbdb7983" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9ae5ea74-d183-441c-bc94-21d1aa000bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_81038954-b7b9-4d0f-bfa3-95a1dbdb7983" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9ae5ea74-d183-441c-bc94-21d1aa000bb5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_a1107340-aade-4dff-8ab6-31c4a94b8420" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9ae5ea74-d183-441c-bc94-21d1aa000bb5" xlink:to="loc_srt_CounterpartyNameAxis_a1107340-aade-4dff-8ab6-31c4a94b8420" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a1107340-aade-4dff-8ab6-31c4a94b8420_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_a1107340-aade-4dff-8ab6-31c4a94b8420" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a1107340-aade-4dff-8ab6-31c4a94b8420_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_64a2a287-5d9b-4ca6-9727-53d0a542e53d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_a1107340-aade-4dff-8ab6-31c4a94b8420" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_64a2a287-5d9b-4ca6-9727-53d0a542e53d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_CertainExecutivesMember_2a26c7c7-2fae-4f0f-8707-8cb479461d67" xlink:href="camp-20241231.xsd#camp_CertainExecutivesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_64a2a287-5d9b-4ca6-9727-53d0a542e53d" xlink:to="loc_camp_CertainExecutivesMember_2a26c7c7-2fae-4f0f-8707-8cb479461d67" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e33c080b-caa4-41cd-b147-9e2776f7c425" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9ae5ea74-d183-441c-bc94-21d1aa000bb5" xlink:to="loc_us-gaap_AwardTypeAxis_e33c080b-caa4-41cd-b147-9e2776f7c425" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e33c080b-caa4-41cd-b147-9e2776f7c425_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_e33c080b-caa4-41cd-b147-9e2776f7c425" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e33c080b-caa4-41cd-b147-9e2776f7c425_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_399298c6-23ac-49c3-b0c9-7d869665d6f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_e33c080b-caa4-41cd-b147-9e2776f7c425" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_399298c6-23ac-49c3-b0c9-7d869665d6f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_7e708530-6852-4c16-be31-65b439895ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_399298c6-23ac-49c3-b0c9-7d869665d6f6" xlink:to="loc_us-gaap_EmployeeStockOptionMember_7e708530-6852-4c16-be31-65b439895ef9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ce61e993-a804-4b3f-8462-9d9fbd15d213" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_81038954-b7b9-4d0f-bfa3-95a1dbdb7983" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ce61e993-a804-4b3f-8462-9d9fbd15d213" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_a5eac051-979c-4162-917d-52c1f8f4a234" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_81038954-b7b9-4d0f-bfa3-95a1dbdb7983" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_a5eac051-979c-4162-917d-52c1f8f4a234" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_UnrecordedNotesPayableIssuedForStockOptionEarlyExercise_127ab87e-798e-49f8-a9c7-b6d9d92fc45f" xlink:href="camp-20241231.xsd#camp_UnrecordedNotesPayableIssuedForStockOptionEarlyExercise"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_81038954-b7b9-4d0f-bfa3-95a1dbdb7983" xlink:to="loc_camp_UnrecordedNotesPayableIssuedForStockOptionEarlyExercise_127ab87e-798e-49f8-a9c7-b6d9d92fc45f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1d3285d3-dd0e-40d3-a703-276cdea8050b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_81038954-b7b9-4d0f-bfa3-95a1dbdb7983" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1d3285d3-dd0e-40d3-a703-276cdea8050b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAfterEarlyExerciseDueToNotesPayableForgiveness_0ef63e88-dc2a-405a-b809-c041adf1cf12" xlink:href="camp-20241231.xsd#camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAfterEarlyExerciseDueToNotesPayableForgiveness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_81038954-b7b9-4d0f-bfa3-95a1dbdb7983" xlink:to="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAfterEarlyExerciseDueToNotesPayableForgiveness_0ef63e88-dc2a-405a-b809-c041adf1cf12" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_0326814f-c227-4ecd-94fd-8e0b9810a6a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_81038954-b7b9-4d0f-bfa3-95a1dbdb7983" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_0326814f-c227-4ecd-94fd-8e0b9810a6a0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_a62aaa69-bb18-4135-9a17-51d8af964b97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_81038954-b7b9-4d0f-bfa3-95a1dbdb7983" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_a62aaa69-bb18-4135-9a17-51d8af964b97" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d97e064e-d03f-4599-b2ab-9a437007b4bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_81038954-b7b9-4d0f-bfa3-95a1dbdb7983" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d97e064e-d03f-4599-b2ab-9a437007b4bb" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#StockBasedCompensationScheduleofStockOptionsActivityDetails"/>
  <link:definitionLink xlink:role="http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28c6c5de-4921-4346-abc8-dc650b91dce3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c4fe07f1-07e5-4be6-80ea-dd16af95faf0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28c6c5de-4921-4346-abc8-dc650b91dce3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c4fe07f1-07e5-4be6-80ea-dd16af95faf0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d15ca2a0-eb2f-4d78-8e21-c9887fe4a59e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c4fe07f1-07e5-4be6-80ea-dd16af95faf0" xlink:to="loc_us-gaap_AwardTypeAxis_d15ca2a0-eb2f-4d78-8e21-c9887fe4a59e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d15ca2a0-eb2f-4d78-8e21-c9887fe4a59e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_d15ca2a0-eb2f-4d78-8e21-c9887fe4a59e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d15ca2a0-eb2f-4d78-8e21-c9887fe4a59e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6868243b-ade2-4317-97a1-1caa491b2cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_d15ca2a0-eb2f-4d78-8e21-c9887fe4a59e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6868243b-ade2-4317-97a1-1caa491b2cc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e79d5b27-5155-40f2-af40-9b30481225fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6868243b-ade2-4317-97a1-1caa491b2cc4" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e79d5b27-5155-40f2-af40-9b30481225fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0b9941dc-9c4a-4fa4-bf44-3b4b438a6418" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28c6c5de-4921-4346-abc8-dc650b91dce3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0b9941dc-9c4a-4fa4-bf44-3b4b438a6418" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9b99e704-7a9e-4915-8fa1-39690d6e4610" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0b9941dc-9c4a-4fa4-bf44-3b4b438a6418" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9b99e704-7a9e-4915-8fa1-39690d6e4610" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_72c8bd1e-1a79-484a-a907-8ca47e688a43" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0b9941dc-9c4a-4fa4-bf44-3b4b438a6418" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_72c8bd1e-1a79-484a-a907-8ca47e688a43" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c4996154-1fbc-4e87-ac02-ca5f8177c7fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0b9941dc-9c4a-4fa4-bf44-3b4b438a6418" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c4996154-1fbc-4e87-ac02-ca5f8177c7fe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d0b4fef0-fd4e-41e1-a79a-6d12ced8bde5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0b9941dc-9c4a-4fa4-bf44-3b4b438a6418" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d0b4fef0-fd4e-41e1-a79a-6d12ced8bde5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_28dbc3ef-f861-4782-a013-b36299f19237" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_341de741-beef-4cc3-a14f-15368e2140bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0b9941dc-9c4a-4fa4-bf44-3b4b438a6418" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_341de741-beef-4cc3-a14f-15368e2140bd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_3edf22c7-13a9-41c7-b5ae-1faf5ce388c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0b9941dc-9c4a-4fa4-bf44-3b4b438a6418" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_3edf22c7-13a9-41c7-b5ae-1faf5ce388c9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_WeightedAverageExercisePriceRollForward_bc81d3ab-9456-4924-befe-c2b73370bb26" xlink:href="camp-20241231.xsd#camp_WeightedAverageExercisePriceRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28c6c5de-4921-4346-abc8-dc650b91dce3" xlink:to="loc_camp_WeightedAverageExercisePriceRollForward_bc81d3ab-9456-4924-befe-c2b73370bb26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_87d76c80-f381-46b4-9cc9-b64ba5873f57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_camp_WeightedAverageExercisePriceRollForward_bc81d3ab-9456-4924-befe-c2b73370bb26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_87d76c80-f381-46b4-9cc9-b64ba5873f57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_14e878ed-d7dd-4a05-bc33-a7d9ce5d9dd1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_camp_WeightedAverageExercisePriceRollForward_bc81d3ab-9456-4924-befe-c2b73370bb26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_14e878ed-d7dd-4a05-bc33-a7d9ce5d9dd1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_393d3eb1-3e81-45e0-b660-b6b78d9367d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_camp_WeightedAverageExercisePriceRollForward_bc81d3ab-9456-4924-befe-c2b73370bb26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_393d3eb1-3e81-45e0-b660-b6b78d9367d5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d1c5c4e9-8c7b-4470-a061-3fed15cdec08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_camp_WeightedAverageExercisePriceRollForward_bc81d3ab-9456-4924-befe-c2b73370bb26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d1c5c4e9-8c7b-4470-a061-3fed15cdec08" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_8eac2b9c-8c35-45fe-b9b0-9050e36ff69b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_5ed1428f-d54d-4ddd-bbd5-1c0e26890dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28c6c5de-4921-4346-abc8-dc650b91dce3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_5ed1428f-d54d-4ddd-bbd5-1c0e26890dfa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_eeb4e8d8-da43-4795-840d-7449dd524086" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28c6c5de-4921-4346-abc8-dc650b91dce3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_eeb4e8d8-da43-4795-840d-7449dd524086" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_922becc9-4c15-4e80-a97f-70e6361d99a4" xlink:href="camp-20241231.xsd#camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28c6c5de-4921-4346-abc8-dc650b91dce3" xlink:to="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_922becc9-4c15-4e80-a97f-70e6361d99a4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_14e60843-dc4c-4de8-b53c-785bc714365a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_922becc9-4c15-4e80-a97f-70e6361d99a4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_14e60843-dc4c-4de8-b53c-785bc714365a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_4464cbf5-4029-4e26-89d7-bd86b361969c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_922becc9-4c15-4e80-a97f-70e6361d99a4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_4464cbf5-4029-4e26-89d7-bd86b361969c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_f428f6a3-16d6-47d0-a2d7-e47df9d506cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_922becc9-4c15-4e80-a97f-70e6361d99a4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_f428f6a3-16d6-47d0-a2d7-e47df9d506cf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueRollForward_1970cbdd-ea70-4e2b-b3e3-25f7fb34c3e6" xlink:href="camp-20241231.xsd#camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28c6c5de-4921-4346-abc8-dc650b91dce3" xlink:to="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueRollForward_1970cbdd-ea70-4e2b-b3e3-25f7fb34c3e6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_349c30d7-ea62-4b0f-a692-ff0a04cbb3cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueRollForward_1970cbdd-ea70-4e2b-b3e3-25f7fb34c3e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_349c30d7-ea62-4b0f-a692-ff0a04cbb3cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_e45d77b5-8381-4866-b835-285eb2ca0831" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueRollForward_1970cbdd-ea70-4e2b-b3e3-25f7fb34c3e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_e45d77b5-8381-4866-b835-285eb2ca0831" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_6c6d3ac2-011b-4bd9-8e37-7d9c4c6578db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_4dfceab6-9e26-46c9-b89d-1221d4369d11" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28c6c5de-4921-4346-abc8-dc650b91dce3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_4dfceab6-9e26-46c9-b89d-1221d4369d11" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2e7658d5-e281-45f7-af44-a2b84ff5c108" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28c6c5de-4921-4346-abc8-dc650b91dce3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2e7658d5-e281-45f7-af44-a2b84ff5c108" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://camp4tx.com/role/StockBasedCompensationRestrictedStockAwardsNarrativeDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#StockBasedCompensationRestrictedStockAwardsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://camp4tx.com/role/StockBasedCompensationRestrictedStockAwardsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1fb00965-796b-473a-aa80-0cabcb63cbe5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1ff54fb4-0a74-4977-8028-f427348ab52b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1fb00965-796b-473a-aa80-0cabcb63cbe5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1ff54fb4-0a74-4977-8028-f427348ab52b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_605f7130-4b63-4842-9153-a68ff0251b20" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1ff54fb4-0a74-4977-8028-f427348ab52b" xlink:to="loc_us-gaap_AwardTypeAxis_605f7130-4b63-4842-9153-a68ff0251b20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_605f7130-4b63-4842-9153-a68ff0251b20_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_605f7130-4b63-4842-9153-a68ff0251b20" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_605f7130-4b63-4842-9153-a68ff0251b20_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa611204-c514-469f-a7d0-260e2bd99b06" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_605f7130-4b63-4842-9153-a68ff0251b20" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa611204-c514-469f-a7d0-260e2bd99b06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_fbcb2207-c1b8-4c02-8d22-af35977c0b78" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa611204-c514-469f-a7d0-260e2bd99b06" xlink:to="loc_us-gaap_RestrictedStockMember_fbcb2207-c1b8-4c02-8d22-af35977c0b78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_8c840d37-a0da-49e3-860b-bd6ff365480b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1fb00965-796b-473a-aa80-0cabcb63cbe5" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_8c840d37-a0da-49e3-860b-bd6ff365480b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_a832643e-ab5a-458f-9975-bccb5bb75cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1fb00965-796b-473a-aa80-0cabcb63cbe5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_a832643e-ab5a-458f-9975-bccb5bb75cc1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://camp4tx.com/role/StockBasedCompensationScheduleofStockbasedCompensationExpenseDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#StockBasedCompensationScheduleofStockbasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://camp4tx.com/role/StockBasedCompensationScheduleofStockbasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_f9ae070e-de64-4dcd-b04a-efd65c283dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b4857a3c-2ad1-4b07-8384-69004f0d3652" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_f9ae070e-de64-4dcd-b04a-efd65c283dcb" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b4857a3c-2ad1-4b07-8384-69004f0d3652" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_5691c320-b226-41de-a65d-ff20b9f04151" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b4857a3c-2ad1-4b07-8384-69004f0d3652" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_5691c320-b226-41de-a65d-ff20b9f04151" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5691c320-b226-41de-a65d-ff20b9f04151_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_5691c320-b226-41de-a65d-ff20b9f04151" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5691c320-b226-41de-a65d-ff20b9f04151_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_12bd8db7-0093-4e02-9a4b-e39bcbd7081d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_5691c320-b226-41de-a65d-ff20b9f04151" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_12bd8db7-0093-4e02-9a4b-e39bcbd7081d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_ce8ec9ce-2d55-42ce-97be-42ef1a8f19fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_12bd8db7-0093-4e02-9a4b-e39bcbd7081d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_ce8ec9ce-2d55-42ce-97be-42ef1a8f19fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_10b1f210-96e5-4627-a098-18b3e6c549e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_12bd8db7-0093-4e02-9a4b-e39bcbd7081d" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_10b1f210-96e5-4627-a098-18b3e6c549e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_96d7d9c0-81ce-4a6c-98f5-0226b350516b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_f9ae070e-de64-4dcd-b04a-efd65c283dcb" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_96d7d9c0-81ce-4a6c-98f5-0226b350516b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://camp4tx.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://camp4tx.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_c51027cf-fb8f-40cd-bcd4-4087f0feab06" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_5a0fc1cf-0165-486c-8ab4-355c47770b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_c51027cf-fb8f-40cd-bcd4-4087f0feab06" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_5a0fc1cf-0165-486c-8ab4-355c47770b9e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_97754ddf-28e7-4b54-9996-561fd6cf7ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_5a0fc1cf-0165-486c-8ab4-355c47770b9e" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_97754ddf-28e7-4b54-9996-561fd6cf7ddd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_97754ddf-28e7-4b54-9996-561fd6cf7ddd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_97754ddf-28e7-4b54-9996-561fd6cf7ddd" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_97754ddf-28e7-4b54-9996-561fd6cf7ddd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_b501b81a-bd41-4337-a194-39e488ad39d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_97754ddf-28e7-4b54-9996-561fd6cf7ddd" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_b501b81a-bd41-4337-a194-39e488ad39d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_057e5464-1f35-4cbf-a831-70b920e2e68e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_b501b81a-bd41-4337-a194-39e488ad39d7" xlink:to="loc_us-gaap_DomesticCountryMember_057e5464-1f35-4cbf-a831-70b920e2e68e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_54cbe34a-0a12-4ca1-b793-63b4b5b0f3cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_b501b81a-bd41-4337-a194-39e488ad39d7" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_54cbe34a-0a12-4ca1-b793-63b4b5b0f3cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_672e2498-a0ff-4de5-90f2-e25a07745d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_c51027cf-fb8f-40cd-bcd4-4087f0feab06" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_672e2498-a0ff-4de5-90f2-e25a07745d3e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_11960781-5bdb-4bab-8972-0a41cadb763e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_c51027cf-fb8f-40cd-bcd4-4087f0feab06" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_11960781-5bdb-4bab-8972-0a41cadb763e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_df370bd4-d48a-409c-96a0-564004826af3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_c51027cf-fb8f-40cd-bcd4-4087f0feab06" xlink:to="loc_us-gaap_OperatingLossCarryforwards_df370bd4-d48a-409c-96a0-564004826af3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_OperatingLossCarryforwardsSubjectToExpiration_36ea628e-c265-4cc2-bec1-76630a47d0e2" xlink:href="camp-20241231.xsd#camp_OperatingLossCarryforwardsSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_c51027cf-fb8f-40cd-bcd4-4087f0feab06" xlink:to="loc_camp_OperatingLossCarryforwardsSubjectToExpiration_36ea628e-c265-4cc2-bec1-76630a47d0e2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_OperatingLossCarryforwardsNotSubjectToExpiration_c5a1ceae-a7d1-42ca-aa09-5797ea921b42" xlink:href="camp-20241231.xsd#camp_OperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_c51027cf-fb8f-40cd-bcd4-4087f0feab06" xlink:to="loc_camp_OperatingLossCarryforwardsNotSubjectToExpiration_c5a1ceae-a7d1-42ca-aa09-5797ea921b42" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_2e77bb9f-1104-4b79-9ad4-2911cdbea604" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_c51027cf-fb8f-40cd-bcd4-4087f0feab06" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_2e77bb9f-1104-4b79-9ad4-2911cdbea604" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_CapitalizedResearchAndDevelopmentCosts_28159017-b3db-48d7-9a2f-ccc6c695fe95" xlink:href="camp-20241231.xsd#camp_CapitalizedResearchAndDevelopmentCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_c51027cf-fb8f-40cd-bcd4-4087f0feab06" xlink:to="loc_camp_CapitalizedResearchAndDevelopmentCosts_28159017-b3db-48d7-9a2f-ccc6c695fe95" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_f728ad15-6067-4c65-a6ae-e36d9e2824b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_c51027cf-fb8f-40cd-bcd4-4087f0feab06" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_f728ad15-6067-4c65-a6ae-e36d9e2824b5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_92f5bf18-ff33-4c78-9efb-432008a84d10" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_c51027cf-fb8f-40cd-bcd4-4087f0feab06" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_92f5bf18-ff33-4c78-9efb-432008a84d10" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://camp4tx.com/role/SegmentReportingDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#SegmentReportingDetails"/>
  <link:definitionLink xlink:role="http://camp4tx.com/role/SegmentReportingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_56e1cc7b-e522-4a7c-b721-0019a964c626" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_cf09617d-0c3b-4304-b9b3-3e7bfdd8ae04" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_56e1cc7b-e522-4a7c-b721-0019a964c626" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_cf09617d-0c3b-4304-b9b3-3e7bfdd8ae04" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_60316b70-7be0-4b9e-906f-c7faa52aacaa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_cf09617d-0c3b-4304-b9b3-3e7bfdd8ae04" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_60316b70-7be0-4b9e-906f-c7faa52aacaa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_60316b70-7be0-4b9e-906f-c7faa52aacaa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_60316b70-7be0-4b9e-906f-c7faa52aacaa" xlink:to="loc_us-gaap_SegmentDomain_60316b70-7be0-4b9e-906f-c7faa52aacaa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_34192ad9-c0f9-4918-9434-f3369a157fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_60316b70-7be0-4b9e-906f-c7faa52aacaa" xlink:to="loc_us-gaap_SegmentDomain_34192ad9-c0f9-4918-9434-f3369a157fa8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_RDMember_a996bc12-5dd5-47ad-9705-13cfbb59776b" xlink:href="camp-20241231.xsd#camp_RDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_34192ad9-c0f9-4918-9434-f3369a157fa8" xlink:to="loc_camp_RDMember_a996bc12-5dd5-47ad-9705-13cfbb59776b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_f9f55a20-97b6-4431-b5b7-9f67e1141566" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_56e1cc7b-e522-4a7c-b721-0019a964c626" xlink:to="loc_us-gaap_Revenues_f9f55a20-97b6-4431-b5b7-9f67e1141566" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_b67c92d6-8d92-48e7-b182-fa566244c1ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_56e1cc7b-e522-4a7c-b721-0019a964c626" xlink:to="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_b67c92d6-8d92-48e7-b182-fa566244c1ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_dbe0b79d-2f65-47bc-bb27-fb5125676105" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_b67c92d6-8d92-48e7-b182-fa566244c1ea" xlink:to="loc_us-gaap_LaborAndRelatedExpense_dbe0b79d-2f65-47bc-bb27-fb5125676105" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ClinicalAndPreclinicalExpenses_ab3cce85-2e06-41ad-b4dc-0015bd6a209a" xlink:href="camp-20241231.xsd#camp_ClinicalAndPreclinicalExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_b67c92d6-8d92-48e7-b182-fa566244c1ea" xlink:to="loc_camp_ClinicalAndPreclinicalExpenses_ab3cce85-2e06-41ad-b4dc-0015bd6a209a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_FacilitiesAndOverheadExpense_35ad6f47-0cd6-4953-8134-d3a020249ec4" xlink:href="camp-20241231.xsd#camp_FacilitiesAndOverheadExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_b67c92d6-8d92-48e7-b182-fa566244c1ea" xlink:to="loc_camp_FacilitiesAndOverheadExpense_35ad6f47-0cd6-4953-8134-d3a020249ec4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees_d0253223-3f75-4caa-8d28-5c8d96dfd757" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_b67c92d6-8d92-48e7-b182-fa566244c1ea" xlink:to="loc_us-gaap_ProfessionalFees_d0253223-3f75-4caa-8d28-5c8d96dfd757" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_CorporateExpenses_043334b5-8678-42e7-a465-083672ca2eb6" xlink:href="camp-20241231.xsd#camp_CorporateExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_b67c92d6-8d92-48e7-b182-fa566244c1ea" xlink:to="loc_camp_CorporateExpenses_043334b5-8678-42e7-a465-083672ca2eb6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TravelAndEntertainmentExpense_dd21465f-5d85-4ad8-8ae3-c627c4c41f75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TravelAndEntertainmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_b67c92d6-8d92-48e7-b182-fa566244c1ea" xlink:to="loc_us-gaap_TravelAndEntertainmentExpense_dd21465f-5d85-4ad8-8ae3-c627c4c41f75" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_d7b011b8-c6a3-4302-9053-60bde4723522" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_56e1cc7b-e522-4a7c-b721-0019a964c626" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_d7b011b8-c6a3-4302-9053-60bde4723522" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2e76bfa2-14be-4f85-b560-d5d97b7d7685" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_56e1cc7b-e522-4a7c-b721-0019a964c626" xlink:to="loc_us-gaap_NetIncomeLoss_2e76bfa2-14be-4f85-b560-d5d97b7d7685" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofExcludedAntidilutiveSecuritiesDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#NetLossPerShareAttributabletoCommonStockholdersScheduleofExcludedAntidilutiveSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofExcludedAntidilutiveSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_000aa9c4-7aae-44ce-9cb6-887950f75dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0eabf2f6-36cd-4dc8-a794-dcad8ded7329" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_000aa9c4-7aae-44ce-9cb6-887950f75dbb" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0eabf2f6-36cd-4dc8-a794-dcad8ded7329" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_06aa0e83-89b4-4a3d-8215-c0c54bdf82b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0eabf2f6-36cd-4dc8-a794-dcad8ded7329" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_06aa0e83-89b4-4a3d-8215-c0c54bdf82b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_06aa0e83-89b4-4a3d-8215-c0c54bdf82b2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_06aa0e83-89b4-4a3d-8215-c0c54bdf82b2" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_06aa0e83-89b4-4a3d-8215-c0c54bdf82b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7a5d8414-b8c3-4297-810e-d1aca3a3d06c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_06aa0e83-89b4-4a3d-8215-c0c54bdf82b2" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7a5d8414-b8c3-4297-810e-d1aca3a3d06c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_6a5f7fb8-b33d-44b7-adbf-aa93914d6add" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7a5d8414-b8c3-4297-810e-d1aca3a3d06c" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_6a5f7fb8-b33d-44b7-adbf-aa93914d6add" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_9b6857f6-32a2-447d-81c3-303e12980eb9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7a5d8414-b8c3-4297-810e-d1aca3a3d06c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_9b6857f6-32a2-447d-81c3-303e12980eb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_0ecb08bc-84ab-4cb1-99e0-67caad50acea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7a5d8414-b8c3-4297-810e-d1aca3a3d06c" xlink:to="loc_us-gaap_RestrictedStockMember_0ecb08bc-84ab-4cb1-99e0-67caad50acea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_d367d2ad-cf52-49fe-89a9-14ff5a085549" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7a5d8414-b8c3-4297-810e-d1aca3a3d06c" xlink:to="loc_us-gaap_WarrantMember_d367d2ad-cf52-49fe-89a9-14ff5a085549" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_081411f4-461c-4842-ad73-8bdbc24a744d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_000aa9c4-7aae-44ce-9cb6-887950f75dbb" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_081411f4-461c-4842-ad73-8bdbc24a744d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://camp4tx.com/role/RelatedPartiesDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#RelatedPartiesDetails"/>
  <link:definitionLink xlink:role="http://camp4tx.com/role/RelatedPartiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_efba5c9c-80c1-4f23-903c-e612b13bfc18" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d7aef392-4214-453d-8da4-43715a76efae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_efba5c9c-80c1-4f23-903c-e612b13bfc18" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d7aef392-4214-453d-8da4-43715a76efae" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_248e9257-4f6f-4d53-97a6-72984d4cd262" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d7aef392-4214-453d-8da4-43715a76efae" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_248e9257-4f6f-4d53-97a6-72984d4cd262" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_248e9257-4f6f-4d53-97a6-72984d4cd262_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_248e9257-4f6f-4d53-97a6-72984d4cd262" xlink:to="loc_us-gaap_RelatedPartyDomain_248e9257-4f6f-4d53-97a6-72984d4cd262_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_5cf600b8-97da-4b12-91d4-232cd068146e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_248e9257-4f6f-4d53-97a6-72984d4cd262" xlink:to="loc_us-gaap_RelatedPartyDomain_5cf600b8-97da-4b12-91d4-232cd068146e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_e8485fca-b9fa-4ea6-b947-5783bf5a9586" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_5cf600b8-97da-4b12-91d4-232cd068146e" xlink:to="loc_us-gaap_RelatedPartyMember_e8485fca-b9fa-4ea6-b947-5783bf5a9586" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_1405ce9b-789e-4dc8-a842-232cb26d9cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d7aef392-4214-453d-8da4-43715a76efae" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_1405ce9b-789e-4dc8-a842-232cb26d9cd2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_1405ce9b-789e-4dc8-a842-232cb26d9cd2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_1405ce9b-789e-4dc8-a842-232cb26d9cd2" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_1405ce9b-789e-4dc8-a842-232cb26d9cd2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_6281bd1b-397f-478e-af24-e5b9ecf638f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_1405ce9b-789e-4dc8-a842-232cb26d9cd2" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_6281bd1b-397f-478e-af24-e5b9ecf638f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ConsultingAgreementsWithFoundersMember_c8e6d078-83e3-44ae-a6c6-e129575278f0" xlink:href="camp-20241231.xsd#camp_ConsultingAgreementsWithFoundersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_6281bd1b-397f-478e-af24-e5b9ecf638f4" xlink:to="loc_camp_ConsultingAgreementsWithFoundersMember_c8e6d078-83e3-44ae-a6c6-e129575278f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ConsultingAgreementsWithExecutiveConsultantMember_98233817-417f-4a12-8aa2-cefbba556377" xlink:href="camp-20241231.xsd#camp_ConsultingAgreementsWithExecutiveConsultantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_6281bd1b-397f-478e-af24-e5b9ecf638f4" xlink:to="loc_camp_ConsultingAgreementsWithExecutiveConsultantMember_98233817-417f-4a12-8aa2-cefbba556377" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a58a7807-8301-44b3-adc6-58afef4bcd6e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d7aef392-4214-453d-8da4-43715a76efae" xlink:to="loc_srt_RangeAxis_a58a7807-8301-44b3-adc6-58afef4bcd6e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a58a7807-8301-44b3-adc6-58afef4bcd6e_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a58a7807-8301-44b3-adc6-58afef4bcd6e" xlink:to="loc_srt_RangeMember_a58a7807-8301-44b3-adc6-58afef4bcd6e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bd5175d1-6115-4fd6-af4f-e8aefe9ddd7a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a58a7807-8301-44b3-adc6-58afef4bcd6e" xlink:to="loc_srt_RangeMember_bd5175d1-6115-4fd6-af4f-e8aefe9ddd7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3efa9273-64f3-4990-960e-cb49cbdf83ec" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bd5175d1-6115-4fd6-af4f-e8aefe9ddd7a" xlink:to="loc_srt_MaximumMember_3efa9273-64f3-4990-960e-cb49cbdf83ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_NumberOfFounders_3afc49e3-32d2-4055-bab4-61b07bde1b02" xlink:href="camp-20241231.xsd#camp_NumberOfFounders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_efba5c9c-80c1-4f23-903c-e612b13bfc18" xlink:to="loc_camp_NumberOfFounders_3afc49e3-32d2-4055-bab4-61b07bde1b02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_d26d612f-6c16-4a19-b63b-8516f9db3f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_efba5c9c-80c1-4f23-903c-e612b13bfc18" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_d26d612f-6c16-4a19-b63b-8516f9db3f7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_75572e2e-8170-4728-ade9-1664b76a2ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_efba5c9c-80c1-4f23-903c-e612b13bfc18" xlink:to="loc_us-gaap_AccountsPayableCurrent_75572e2e-8170-4728-ade9-1664b76a2ad0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_25ea3c9a-bdf1-4a71-a001-9601bf72916c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_efba5c9c-80c1-4f23-903c-e612b13bfc18" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_25ea3c9a-bdf1-4a71-a001-9601bf72916c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_cff4c599-6b52-43ba-9117-b4a4c6638486" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_efba5c9c-80c1-4f23-903c-e612b13bfc18" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_cff4c599-6b52-43ba-9117-b4a4c6638486" xlink:type="arc" order="4"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>camp-20241231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:344bab39-1447-4710-a813-d0e5cea79568,g:e8dcb9a0-a4ba-432e-8d82-4b2fdbae6592-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4b708970-1fd0-4ee7-93bd-4f67c6a8c2c0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maturity of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_526f0702-d4bd-4c03-be32-2aac470042f7_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested and expected to vest at the end the period (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b397ae86-2906-4436-8172-69c99c1277e8_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_7613c98c-b1c0-4a03-8bcd-50679d1cbf32_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_05eef13f-79c7-42d6-b6a9-75d32eaded5d_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Parties</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_bc569bcd-8bf1-4e93-b67c-ff0734ccc1f7_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Lease Costs and Other Information</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_DeferredTaxAssetsLiabilitiesGross_ac4063c6-45a9-4f35-ad6c-4aaa074e27b8_totalLabel_en-US" xlink:label="lab_camp_DeferredTaxAssetsLiabilitiesGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net deferred tax assets</link:label>
    <link:label id="lab_camp_DeferredTaxAssetsLiabilitiesGross_label_en-US" xlink:label="lab_camp_DeferredTaxAssetsLiabilitiesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets (Liabilities), Gross</link:label>
    <link:label id="lab_camp_DeferredTaxAssetsLiabilitiesGross_documentation_en-US" xlink:label="lab_camp_DeferredTaxAssetsLiabilitiesGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets (Liabilities), Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_DeferredTaxAssetsLiabilitiesGross" xlink:href="camp-20241231.xsd#camp_DeferredTaxAssetsLiabilitiesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_DeferredTaxAssetsLiabilitiesGross" xlink:to="lab_camp_DeferredTaxAssetsLiabilitiesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d3bf2476-3232-417d-bec9-d3fbda2b7688_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_a98c57e8-26d9-4237-8a1c-6bc38ea41824_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Maturities of Operating Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_FinanceLiabilityCurrent_0dac94db-ef8d-4798-a864-a4114fb8bbb2_terseLabel_en-US" xlink:label="lab_camp_FinanceLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing liability, current portion</link:label>
    <link:label id="lab_camp_FinanceLiabilityCurrent_label_en-US" xlink:label="lab_camp_FinanceLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Liability, Current</link:label>
    <link:label id="lab_camp_FinanceLiabilityCurrent_documentation_en-US" xlink:label="lab_camp_FinanceLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The amount of financing liability classified as current.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_FinanceLiabilityCurrent" xlink:href="camp-20241231.xsd#camp_FinanceLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_FinanceLiabilityCurrent" xlink:to="lab_camp_FinanceLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_b3ee3cb8-44d1-4992-8f38-2cdc1e4edf0a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_fa32d3e0-6406-4608-80f7-81553f01edf6_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_a1c0c689-eac7-4e0e-a977-8122bbfd49f2_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_ed4ac0b5-c7a1-41f3-bfa1-3624944a2099_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Basic and Diluted Net Loss per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_166fecfe-aa81-4c59-b9fc-80a25b1ad832_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting period of the award (in years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_59304eb7-db54-46b9-b88b-df6f3c09531d_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development tax credit carryforward</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_38d2989c-a00b-4a2a-82d6-24ead89fe851_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock dividends declared (in USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_MaximumReimbursableIncentiveFromLessor_2f333077-b329-4c1c-aee9-0d4b99040390_terseLabel_en-US" xlink:label="lab_camp_MaximumReimbursableIncentiveFromLessor" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum lease incentive reimbursable</link:label>
    <link:label id="lab_camp_MaximumReimbursableIncentiveFromLessor_label_en-US" xlink:label="lab_camp_MaximumReimbursableIncentiveFromLessor" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum Reimbursable Incentive From Lessor</link:label>
    <link:label id="lab_camp_MaximumReimbursableIncentiveFromLessor_documentation_en-US" xlink:label="lab_camp_MaximumReimbursableIncentiveFromLessor" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Maximum amount of lease incentive reimbursable by lessor to lessee.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_MaximumReimbursableIncentiveFromLessor" xlink:href="camp-20241231.xsd#camp_MaximumReimbursableIncentiveFromLessor"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_MaximumReimbursableIncentiveFromLessor" xlink:to="lab_camp_MaximumReimbursableIncentiveFromLessor" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AreaOfLand_9f2b2f4a-0e81-4e4c-a176-3b469d8df1d2_terseLabel_en-US" xlink:label="lab_us-gaap_AreaOfLand" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Area of lease (approximately)</link:label>
    <link:label id="lab_us-gaap_AreaOfLand_label_en-US" xlink:label="lab_us-gaap_AreaOfLand" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Area of Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfLand" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AreaOfLand"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AreaOfLand" xlink:to="lab_us-gaap_AreaOfLand" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_5187eee1-d2ee-4c3e-acc0-6afbb8d52f68_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of convertible preferred stock into common stock upon initial public offering (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_9d2e8cb5-5c71-4ea5-a3ba-84c3bb4e98b0_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Loss Per Share Attributable to Common Stockholders</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_c3e3c5f7-572f-4932-8dc3-9cc9a35689d4_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Description of Business and Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockAmountConverted1_b08155fe-2416-4825-82a8-b4f73e58b86e_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockAmountConverted1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of convertible preferred stock upon initial public offering</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockAmountConverted1_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockAmountConverted1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion of Stock, Amount Converted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockAmountConverted1" xlink:to="lab_us-gaap_ConversionOfStockAmountConverted1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_181db8a3-28e2-4292-804b-d56bafdf7ae3_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting of restricted common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_25e0a047-bdb1-4aef-8a5f-65271ea7e749_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_ce2d95df-db5a-4bbc-9fbe-13e14b9d8c93_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from exercise of common stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TravelAndEntertainmentExpense_205dd685-a025-466a-8d4a-4f9d802c870f_terseLabel_en-US" xlink:label="lab_us-gaap_TravelAndEntertainmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Travel and entertainment</link:label>
    <link:label id="lab_us-gaap_TravelAndEntertainmentExpense_label_en-US" xlink:label="lab_us-gaap_TravelAndEntertainmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Travel and Entertainment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TravelAndEntertainmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TravelAndEntertainmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TravelAndEntertainmentExpense" xlink:to="lab_us-gaap_TravelAndEntertainmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_d76326d7-1cf9-4770-8751-12c30d35b573_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Restricted Stock Award Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_c636dbba-1145-417d-a1aa-e53528339c72_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_8afb9c98-efed-49b6-9912-45e1c5f86b7e_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_OperatingLossCarryforwardsNotSubjectToExpiration_28bd55c4-8a5d-4e25-a434-e5a645cb1926_terseLabel_en-US" xlink:label="lab_camp_OperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">NOL carryforwards, not subject to expiration</link:label>
    <link:label id="lab_camp_OperatingLossCarryforwardsNotSubjectToExpiration_label_en-US" xlink:label="lab_camp_OperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards, Not Subject To Expiration</link:label>
    <link:label id="lab_camp_OperatingLossCarryforwardsNotSubjectToExpiration_documentation_en-US" xlink:label="lab_camp_OperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards, Not Subject To Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_OperatingLossCarryforwardsNotSubjectToExpiration" xlink:href="camp-20241231.xsd#camp_OperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_OperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="lab_camp_OperatingLossCarryforwardsNotSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_888974b2-e441-48e2-8ae7-d336bdd17141_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostAbstract_cc88f8f3-86a3-42ef-aa57-1875639dc4b5_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostAbstract_4b77132e-0953-4dfa-87ff-cc2a3474ac16_verboseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Finance lease costs:</link:label>
    <link:label id="lab_us-gaap_LeaseCostAbstract_label_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostAbstract" xlink:to="lab_us-gaap_LeaseCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_UponAchievementOfThirdLicensedTargetMember_81aac853-f8a6-4dda-be05-b0975cafde1b_terseLabel_en-US" xlink:label="lab_camp_UponAchievementOfThirdLicensedTargetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Upon Achievement of Third Licensed Target</link:label>
    <link:label id="lab_camp_UponAchievementOfThirdLicensedTargetMember_label_en-US" xlink:label="lab_camp_UponAchievementOfThirdLicensedTargetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Upon Achievement Of Third Licensed Target [Member]</link:label>
    <link:label id="lab_camp_UponAchievementOfThirdLicensedTargetMember_documentation_en-US" xlink:label="lab_camp_UponAchievementOfThirdLicensedTargetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information pertaining to scenario upon achievement of third licensed target.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_UponAchievementOfThirdLicensedTargetMember" xlink:href="camp-20241231.xsd#camp_UponAchievementOfThirdLicensedTargetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_UponAchievementOfThirdLicensedTargetMember" xlink:to="lab_camp_UponAchievementOfThirdLicensedTargetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_ConvertiblePreferredStockAndStockholdersDeficitAbstract_label_en-US" xlink:label="lab_camp_ConvertiblePreferredStockAndStockholdersDeficitAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Preferred Stock and Stockholders' Deficit [Abstract]</link:label>
    <link:label id="lab_camp_ConvertiblePreferredStockAndStockholdersDeficitAbstract_documentation_en-US" xlink:label="lab_camp_ConvertiblePreferredStockAndStockholdersDeficitAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">No definition available.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ConvertiblePreferredStockAndStockholdersDeficitAbstract" xlink:href="camp-20241231.xsd#camp_ConvertiblePreferredStockAndStockholdersDeficitAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_ConvertiblePreferredStockAndStockholdersDeficitAbstract" xlink:to="lab_camp_ConvertiblePreferredStockAndStockholdersDeficitAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_e9165a22-a905-48b6-800f-aacc875ebd4d_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shares reserved for future issuance under the 2024 Equity Incentive Plan and ESPP (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_35a7f8d2-f64f-4da8-ae29-0197d0267fb9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities, net of current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_e52021f1-a4af-420e-8f51-bef960f98e47_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Non-current operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_PrepaidVariableLeaseExpenseCurrent_bf7987eb-654b-4360-8169-9b0af1906081_terseLabel_en-US" xlink:label="lab_camp_PrepaidVariableLeaseExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable lease expenses</link:label>
    <link:label id="lab_camp_PrepaidVariableLeaseExpenseCurrent_label_en-US" xlink:label="lab_camp_PrepaidVariableLeaseExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Variable Lease Expense, Current</link:label>
    <link:label id="lab_camp_PrepaidVariableLeaseExpenseCurrent_documentation_en-US" xlink:label="lab_camp_PrepaidVariableLeaseExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of consideration paid in advance for variable lease expense that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_PrepaidVariableLeaseExpenseCurrent" xlink:href="camp-20241231.xsd#camp_PrepaidVariableLeaseExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_PrepaidVariableLeaseExpenseCurrent" xlink:to="lab_camp_PrepaidVariableLeaseExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_dbd3973e-865b-4580-9efe-188b6dac0119_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaboration and License Agreements</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_37b92c01-89bc-4607-828d-d5e9f0fc6b1f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_21d6d87e-9cb7-466b-95fe-482c8b8d4f8a_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_b21e67e6-dbcd-4f8e-9026-e6ec728935ef_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_d90d5fae-89bc-4617-97c4-cb053b8cdd00_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net proceeds received</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance or Sale of Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_5b3beff3-25ae-4f9a-b8f0-8f0510b97a6f_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesIssued_eaede763-c456-4917-9a53-2eedc74c8e23_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesIssued_a20b4132-b63f-4bea-b419-a193f9400e2b_verboseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesIssued_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesIssued" xlink:to="lab_us-gaap_TemporaryEquitySharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_1c9fa202-69e3-4c32-8f3d-9333945d247a_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_OfferingCostsPolicyTextBlock_1d4aa24c-5d6a-4c14-a19c-8342e7f97831_terseLabel_en-US" xlink:label="lab_camp_OfferingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Offering Costs</link:label>
    <link:label id="lab_camp_OfferingCostsPolicyTextBlock_label_en-US" xlink:label="lab_camp_OfferingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Offering Costs [Policy Text Block]</link:label>
    <link:label id="lab_camp_OfferingCostsPolicyTextBlock_documentation_en-US" xlink:label="lab_camp_OfferingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of accounting policy for offering costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_OfferingCostsPolicyTextBlock" xlink:href="camp-20241231.xsd#camp_OfferingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_OfferingCostsPolicyTextBlock" xlink:to="lab_camp_OfferingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_897f4161-19d0-478d-9a47-2e4fec76c7f8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">R&amp;D credits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction_c8a062a7-5170-4e88-8ad8-04ec42ba894e_terseLabel_en-US" xlink:label="lab_camp_ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from financing obligation, net of issuance costs</link:label>
    <link:label id="lab_camp_ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction_label_en-US" xlink:label="lab_camp_ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds From Financing Obligations, Failed Sale Leaseback Transaction</link:label>
    <link:label id="lab_camp_ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction_documentation_en-US" xlink:label="lab_camp_ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of cash inflow from proceeds received by the entity from the financing obligations related to the failed sale-leaseback transaction during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction" xlink:href="camp-20241231.xsd#camp_ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction" xlink:to="lab_camp_ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_AuditInformationAbstract_label_en-US" xlink:label="lab_camp_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_camp_AuditInformationAbstract_documentation_en-US" xlink:label="lab_camp_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Audit Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_AuditInformationAbstract" xlink:href="camp-20241231.xsd#camp_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_AuditInformationAbstract" xlink:to="lab_camp_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_16bf5df5-a816-4ec4-9589-a0a9847d163a_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_7a9c820f-cc4c-4444-932f-eccc9e74fffd_negatedLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Cash flows from operations</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_507a72cb-79d5-474a-9291-bc7760b17ed8_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_1970cdf5-955f-47af-be5a-c456ddc7301a_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_DescriptionOfBusinessAndBasisOfPresentationTable_fa833b91-87b5-456c-990e-be2ae2570710_terseLabel_en-US" xlink:label="lab_camp_DescriptionOfBusinessAndBasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Description of Business and Basis of Presentation [Table]</link:label>
    <link:label id="lab_camp_DescriptionOfBusinessAndBasisOfPresentationTable_label_en-US" xlink:label="lab_camp_DescriptionOfBusinessAndBasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of Business and Basis of Presentation [Table]</link:label>
    <link:label id="lab_camp_DescriptionOfBusinessAndBasisOfPresentationTable_documentation_en-US" xlink:label="lab_camp_DescriptionOfBusinessAndBasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of information about description of business and basis of presentation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_DescriptionOfBusinessAndBasisOfPresentationTable" xlink:href="camp-20241231.xsd#camp_DescriptionOfBusinessAndBasisOfPresentationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationTable" xlink:to="lab_camp_DescriptionOfBusinessAndBasisOfPresentationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_bd2324bd-ff71-4528-82e6-9481b0f34f08_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_b6bdcfce-5090-410d-a622-e48bfe28ddfe_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total lease payment</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_cb4a8f36-8f9d-4e49-ab62-e661b70400a0_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_811383af-c350-4c13-a5f2-0691cd8124a5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation_6306cf6b-933c-4d8e-a609-9d3a20e529e0_terseLabel_en-US" xlink:label="lab_camp_CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum development milestone payable</link:label>
    <link:label id="lab_camp_CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation_label_en-US" xlink:label="lab_camp_CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Maximum Development Milestone Payment Obligation</link:label>
    <link:label id="lab_camp_CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation_documentation_en-US" xlink:label="lab_camp_CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The maximum amount payable upon achievement of development milestone under the collaborative arrangements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation" xlink:href="camp-20241231.xsd#camp_CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation" xlink:to="lab_camp_CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_321e9148-df68-45ff-92fd-994e1d0af6bf_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and Development Expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_59566c4c-91d5-40f4-9366-e43cb43cdab9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable at the end of the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanTextBlock_40f523f6-b73f-48e8-9644-fa125922cc21_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Benefit Plan</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanTextBlock_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanTextBlock" xlink:to="lab_us-gaap_DefinedContributionPlanTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_89b0934a-6002-46b8-9a31-dce8f8c5b933_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_ec2a2848-3293-4e14-b32a-3b093d8934e3_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_ConsultingAgreementsWithExecutiveConsultantMember_3525130c-4f3d-47bc-9bcf-6b8dca470096_terseLabel_en-US" xlink:label="lab_camp_ConsultingAgreementsWithExecutiveConsultantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consulting Agreement with Executive Consultant</link:label>
    <link:label id="lab_camp_ConsultingAgreementsWithExecutiveConsultantMember_label_en-US" xlink:label="lab_camp_ConsultingAgreementsWithExecutiveConsultantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consulting Agreements with Executive Consultant [Member]</link:label>
    <link:label id="lab_camp_ConsultingAgreementsWithExecutiveConsultantMember_documentation_en-US" xlink:label="lab_camp_ConsultingAgreementsWithExecutiveConsultantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information pertaining to consulting agreement with executive consultant .</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ConsultingAgreementsWithExecutiveConsultantMember" xlink:href="camp-20241231.xsd#camp_ConsultingAgreementsWithExecutiveConsultantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_ConsultingAgreementsWithExecutiveConsultantMember" xlink:to="lab_camp_ConsultingAgreementsWithExecutiveConsultantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_ea42a500-a8ac-46f0-8b10-e651733de4f7_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average remaining lease term in years</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_2ee9fa68-7f89-4c47-893e-8a2f2afd3ae5_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfEstimatedFairValueOnGrantDate_263ef618-1cfa-485c-b6cd-2c2027e04835_terseLabel_en-US" xlink:label="lab_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfEstimatedFairValueOnGrantDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of estimated fair value on grant date</link:label>
    <link:label id="lab_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfEstimatedFairValueOnGrantDate_label_en-US" xlink:label="lab_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfEstimatedFairValueOnGrantDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Of Estimated Fair Value On Grant Date</link:label>
    <link:label id="lab_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfEstimatedFairValueOnGrantDate_documentation_en-US" xlink:label="lab_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfEstimatedFairValueOnGrantDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Of Estimated Fair Value On Grant Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfEstimatedFairValueOnGrantDate" xlink:href="camp-20241231.xsd#camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfEstimatedFairValueOnGrantDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfEstimatedFairValueOnGrantDate" xlink:to="lab_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfEstimatedFairValueOnGrantDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_f369920b-c0ce-43df-81ce-147302fd126c_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_b025f02c-4635-4ec2-af86-31ac91fc6a90_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_LesseeOperatingLeaseIncrementalBorrowingRate_5f2a7302-c92c-4a87-8442-00981d8ad061_terseLabel_en-US" xlink:label="lab_camp_LesseeOperatingLeaseIncrementalBorrowingRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Incremental borrowing rate used for lease</link:label>
    <link:label id="lab_camp_LesseeOperatingLeaseIncrementalBorrowingRate_label_en-US" xlink:label="lab_camp_LesseeOperatingLeaseIncrementalBorrowingRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Incremental Borrowing Rate</link:label>
    <link:label id="lab_camp_LesseeOperatingLeaseIncrementalBorrowingRate_documentation_en-US" xlink:label="lab_camp_LesseeOperatingLeaseIncrementalBorrowingRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Incremental Borrowing Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_LesseeOperatingLeaseIncrementalBorrowingRate" xlink:href="camp-20241231.xsd#camp_LesseeOperatingLeaseIncrementalBorrowingRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_LesseeOperatingLeaseIncrementalBorrowingRate" xlink:to="lab_camp_LesseeOperatingLeaseIncrementalBorrowingRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_98da93c2-1c7a-44c9-b957-dffebd6e6468_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: Significant segment expenses</link:label>
    <link:label id="lab_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_label_en-US" xlink:label="lab_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract" xlink:to="lab_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_1974b1a8-f41a-44c6-b573-2655e836ba73_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_PaymentsOfUnderwritingDiscountsAndCommissions_baf03c9c-15b0-4cf8-9c6a-2954308bcb5e_terseLabel_en-US" xlink:label="lab_camp_PaymentsOfUnderwritingDiscountsAndCommissions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments of underwriting discounts and commissions</link:label>
    <link:label id="lab_camp_PaymentsOfUnderwritingDiscountsAndCommissions_label_en-US" xlink:label="lab_camp_PaymentsOfUnderwritingDiscountsAndCommissions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments Of Underwriting Discounts And Commissions</link:label>
    <link:label id="lab_camp_PaymentsOfUnderwritingDiscountsAndCommissions_documentation_en-US" xlink:label="lab_camp_PaymentsOfUnderwritingDiscountsAndCommissions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payments Of Underwriting Discounts And Commissions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_PaymentsOfUnderwritingDiscountsAndCommissions" xlink:href="camp-20241231.xsd#camp_PaymentsOfUnderwritingDiscountsAndCommissions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_PaymentsOfUnderwritingDiscountsAndCommissions" xlink:to="lab_camp_PaymentsOfUnderwritingDiscountsAndCommissions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_4d298462-e0b5-47f8-8dbc-bff39e17c2fb_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_f21e5fe6-b294-47b5-aba5-87e832ce6969_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase in valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_065a65c6-3586-4bc5-a0b4-eccaceeaf187_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0f20ddd8-d2f7-4b7a-bb74-125709475780_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanAbstract" xlink:to="lab_us-gaap_DefinedContributionPlanAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_f0c2c78e-a940-4bcd-9fb7-602790ee79d6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_ea4551c3-4a91-484e-a940-c8999338073b_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_766c89c9-1020-4604-85b4-e65c69e0ed61_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1b2c2596-1d28-464c-b6f0-1d07fb851f3c_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Anti-dilutive securities excluded from diluted earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_6fabf413-c372-4044-a97c-c4bc9f1a5c07_negatedLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: amount representing imputed interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockConvertibleSharesIssuable_9761d55c-d4e4-48ee-82b2-01bfcc01a778_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockConvertibleSharesIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock issuable upon conversion (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockConvertibleSharesIssuable_label_en-US" xlink:label="lab_us-gaap_PreferredStockConvertibleSharesIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Convertible, Shares Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockConvertibleSharesIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockConvertibleSharesIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockConvertibleSharesIssuable" xlink:to="lab_us-gaap_PreferredStockConvertibleSharesIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_b6f5508f-26cd-4f9a-8fef-71f6f31cb976_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c106030d-a51c-40b2-aa29-8cdcc7e790e3_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_31021934-e630-4854-9c40-1b6dc7141bca_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c84a954c-9d98-4670-98a6-6232526fefef_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_7303f756-87b8-4b02-883a-eb0693d16ca4_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount of gross unrecognized stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_CollaborationAndLicenseAgreementsAbstract_label_en-US" xlink:label="lab_camp_CollaborationAndLicenseAgreementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaboration and License Agreements [Abstract]</link:label>
    <link:label id="lab_camp_CollaborationAndLicenseAgreementsAbstract_documentation_en-US" xlink:label="lab_camp_CollaborationAndLicenseAgreementsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">No definition available.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_CollaborationAndLicenseAgreementsAbstract" xlink:href="camp-20241231.xsd#camp_CollaborationAndLicenseAgreementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_CollaborationAndLicenseAgreementsAbstract" xlink:to="lab_camp_CollaborationAndLicenseAgreementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_ce10af17-4977-447c-b509-24101f11cbde_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_f52171b3-07c8-43ec-a216-9db231553988_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_7e5f4906-ff5e-424d-b2c0-38cf1074db32_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Options to purchase common stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_cfe80598-5b23-48f9-a1f8-03ca6eb9ecb2_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock options outstanding</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_df12e1ac-252e-42be-9a57-015400514427_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-term lease cost</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-Term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_5ee10b2e-003c-4b77-9dba-1112b30c7bc0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1d8af65f-ecfb-4660-9838-41467330442d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5bb468d5-c75e-49ae-ba50-6d63c670593c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_35181585-901a-4cc5-be8a-66511c13933f_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_f3df4b64-b9d0-4384-b1e7-ee34fa04948c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average incremental borrowing rate</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_88d3ce48-595c-4a33-9f96-522701f62493_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_31665293-eb55-4e2d-868b-0080241d33fa_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant outstanding</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_43599a91-bf51-40fb-8249-84cd2d0f4dfd_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_367db74a-713d-43fa-b26b-b703f184be71_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaidInKindInterest_eac5578e-852b-4ba0-bb86-1f151f6282e5_terseLabel_en-US" xlink:label="lab_us-gaap_PaidInKindInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash interest expense</link:label>
    <link:label id="lab_us-gaap_PaidInKindInterest_label_en-US" xlink:label="lab_us-gaap_PaidInKindInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Paid-in-Kind Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaidInKindInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaidInKindInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaidInKindInterest" xlink:to="lab_us-gaap_PaidInKindInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_aaeb88a7-9a88-4c41-90a6-37cc530ba0a9_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_fb86ac52-9b10-40fe-9cf2-3055f340c290_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_124401c1-f8c9-4fa7-9cbc-3360b1f5bdda_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options exercised (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_5777b80c-05be-42c0-98ee-87c85dfe63fc_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f9c2d42b-4219-486f-8f23-8fe0586d38bc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCosts_34cd879c-8db6-433b-9301-44ef34d99b72_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred offering costs</link:label>
    <link:label id="lab_us-gaap_DeferredCosts_label_en-US" xlink:label="lab_us-gaap_DeferredCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Costs, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCosts" xlink:to="lab_us-gaap_DeferredCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_440616fa-cb0a-4754-911e-762d6a8b6779_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_01e6c95b-944d-41f0-9691-c238b37b0377_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_6f7c23a7-0e6d-41a7-ace6-87b9a8d33db3_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_02e5710c-9402-4d3c-933c-6e68dcc410b0_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LaborAndRelatedExpense_db042043-6e48-4646-8040-84584a6a96e6_terseLabel_en-US" xlink:label="lab_us-gaap_LaborAndRelatedExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Personnel-related expenses</link:label>
    <link:label id="lab_us-gaap_LaborAndRelatedExpense_label_en-US" xlink:label="lab_us-gaap_LaborAndRelatedExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Labor and Related Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LaborAndRelatedExpense" xlink:to="lab_us-gaap_LaborAndRelatedExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_cc061fea-b5d3-4fde-bfab-b8db1ac02a72_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_61e63425-d729-4678-9e41-054809ee183b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested and expected to vest at the end the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_ProfessionalFeesAndOtherGeneralAndAdministrativeExpensesCurrent_5dae42cb-9ced-4061-88b0-a63551ca9a8c_terseLabel_en-US" xlink:label="lab_camp_ProfessionalFeesAndOtherGeneralAndAdministrativeExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Professional fees</link:label>
    <link:label id="lab_camp_ProfessionalFeesAndOtherGeneralAndAdministrativeExpensesCurrent_label_en-US" xlink:label="lab_camp_ProfessionalFeesAndOtherGeneralAndAdministrativeExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Professional Fees And Other General And Administrative Expenses, Current</link:label>
    <link:label id="lab_camp_ProfessionalFeesAndOtherGeneralAndAdministrativeExpensesCurrent_documentation_en-US" xlink:label="lab_camp_ProfessionalFeesAndOtherGeneralAndAdministrativeExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees and other general and administrative expenses. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ProfessionalFeesAndOtherGeneralAndAdministrativeExpensesCurrent" xlink:href="camp-20241231.xsd#camp_ProfessionalFeesAndOtherGeneralAndAdministrativeExpensesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_ProfessionalFeesAndOtherGeneralAndAdministrativeExpensesCurrent" xlink:to="lab_camp_ProfessionalFeesAndOtherGeneralAndAdministrativeExpensesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_7575b1c9-5989-4a17-ab22-239ca666fea3_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_2b679eef-18e4-4640-93a9-9b5622e13464_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_f3aecf9f-7e5c-4308-bd4b-135076ca9b54_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_75ce150d-eb8a-40dd-8c52-e3a486dbac33_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_ccd3ac54-56a7-4fac-8a4b-e55705fffff9_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Currency Remeasurement</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrExpirationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration Date</link:label>
    <link:label id="lab_ecd_TrdArrExpirationDate_label_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrExpirationDate" xlink:to="lab_ecd_TrdArrExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_da529d39-3524-43df-9bdb-9f3a147876fa_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance lease right-of-use asset obtained in exchange for lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8b5c15b3-59e2-4315-8d7d-5d62714984a4_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_5a746b70-5e33-47fd-95f3-21c369d5b855_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities, current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_90cdeb5b-becd-4c04-b229-3a6291dfdd04_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_444c4c25-a453-4cd6-a4b5-d4ab3b36798e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_ceb49161-0e39-4fce-a78d-3e5083d92a1b_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_03d4982b-a9a7-4251-a130-32b8c890c638_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at ending (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_FinancingObligationFailedSaleLeasebackPolicyTextBlock_d908b9ce-6aa8-4a92-9a44-a49ee9fa10a6_terseLabel_en-US" xlink:label="lab_camp_FinancingObligationFailedSaleLeasebackPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing Obligation (Failed Sale-Leaseback)</link:label>
    <link:label id="lab_camp_FinancingObligationFailedSaleLeasebackPolicyTextBlock_label_en-US" xlink:label="lab_camp_FinancingObligationFailedSaleLeasebackPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Obligation Failed Sale-Leaseback [Policy Text Block]</link:label>
    <link:label id="lab_camp_FinancingObligationFailedSaleLeasebackPolicyTextBlock_documentation_en-US" xlink:label="lab_camp_FinancingObligationFailedSaleLeasebackPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of accounting policy for transactions involving the sale of property to another party and a lease of the property back to the seller.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_FinancingObligationFailedSaleLeasebackPolicyTextBlock" xlink:href="camp-20241231.xsd#camp_FinancingObligationFailedSaleLeasebackPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_FinancingObligationFailedSaleLeasebackPolicyTextBlock" xlink:to="lab_camp_FinancingObligationFailedSaleLeasebackPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_d6c3d883-e9c5-44d8-9eb0-9e37e62f7f45_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">NOLs</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_TemporaryEquityValueConversionOfConvertibleSecurities_5c61e7e1-3dcd-4f0a-98ed-577889c962a3_negatedLabel_en-US" xlink:label="lab_camp_TemporaryEquityValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Conversion of convertible preferred stock into common stock upon initial public offering</link:label>
    <link:label id="lab_camp_TemporaryEquityValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_camp_TemporaryEquityValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Value, Conversion of Convertible Securities</link:label>
    <link:label id="lab_camp_TemporaryEquityValueConversionOfConvertibleSecurities_documentation_en-US" xlink:label="lab_camp_TemporaryEquityValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Temporary Equity, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_TemporaryEquityValueConversionOfConvertibleSecurities" xlink:href="camp-20241231.xsd#camp_TemporaryEquityValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_TemporaryEquityValueConversionOfConvertibleSecurities" xlink:to="lab_camp_TemporaryEquityValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_6e63ced6-6eee-471d-8cbc-b148627a7387_terseLabel_en-US" xlink:label="lab_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining contractual term in years</link:label>
    <link:label id="lab_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_label_en-US" xlink:label="lab_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Weighted Average Remaining Contractual Term [Abstract]</link:label>
    <link:label id="lab_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_documentation_en-US" xlink:label="lab_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">n/a</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:href="camp-20241231.xsd#camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="lab_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e558f5f1-3f4a-4822-bc00-d1ba18c67784_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Cash_d78cef7b-d27f-402a-b72d-cc56921172bb_terseLabel_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_Cash_label_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Cash" xlink:to="lab_us-gaap_Cash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_0e6d78c1-b35a-418b-95b0-4281e4793311_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_3f442027-65f7-40ee-bc57-afcea2b7e69c_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Capitalized cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidInsurance_815bb1ef-68ad-4abe-8159-3fb7f9d96391_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidInsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid Insurance</link:label>
    <link:label id="lab_us-gaap_PrepaidInsurance_label_en-US" xlink:label="lab_us-gaap_PrepaidInsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Insurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidInsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidInsurance" xlink:to="lab_us-gaap_PrepaidInsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_9d067896-080f-42c2-b3ca-6b6891409201_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Options exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_db88d962-6ce3-44ef-9b4d-4916182f126a_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">R&amp;D</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_ba97263e-a759-4f9b-9ace-51bcb3d5cbd9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4123f94f-4a47-4a2c-8d16-9c481deec480_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average shares of common stock outstanding, diluted, (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueRollForward_b5854d69-dc48-47f5-b98f-8c255c544952_terseLabel_en-US" xlink:label="lab_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate intrinsic value</link:label>
    <link:label id="lab_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueRollForward_label_en-US" xlink:label="lab_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Aggregate Intrinsic Value [Roll Forward]</link:label>
    <link:label id="lab_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueRollForward_documentation_en-US" xlink:label="lab_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">n/a</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueRollForward" xlink:href="camp-20241231.xsd#camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueRollForward" xlink:to="lab_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_CapitalizedResearchAndDevelopmentCosts_188914e5-c7cd-4d94-abb7-465a6a2634ea_terseLabel_en-US" xlink:label="lab_camp_CapitalizedResearchAndDevelopmentCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capitalized research and development</link:label>
    <link:label id="lab_camp_CapitalizedResearchAndDevelopmentCosts_label_en-US" xlink:label="lab_camp_CapitalizedResearchAndDevelopmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalized Research And Development Costs</link:label>
    <link:label id="lab_camp_CapitalizedResearchAndDevelopmentCosts_documentation_en-US" xlink:label="lab_camp_CapitalizedResearchAndDevelopmentCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Capitalized Research And Development Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_CapitalizedResearchAndDevelopmentCosts" xlink:href="camp-20241231.xsd#camp_CapitalizedResearchAndDevelopmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_CapitalizedResearchAndDevelopmentCosts" xlink:to="lab_camp_CapitalizedResearchAndDevelopmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_MilestoneTargetsAxis_feed4f18-6784-40c0-a618-68ab12d495ba_terseLabel_en-US" xlink:label="lab_camp_MilestoneTargetsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Milestone Targets [Axis]</link:label>
    <link:label id="lab_camp_MilestoneTargetsAxis_label_en-US" xlink:label="lab_camp_MilestoneTargetsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Milestone Targets [Axis]</link:label>
    <link:label id="lab_camp_MilestoneTargetsAxis_documentation_en-US" xlink:label="lab_camp_MilestoneTargetsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Milestone Targets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_MilestoneTargetsAxis" xlink:href="camp-20241231.xsd#camp_MilestoneTargetsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_MilestoneTargetsAxis" xlink:to="lab_camp_MilestoneTargetsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_DeferredTaxAssetsLeasingArrangements_1c5c4e94-8816-4a12-ba8e-408b9b1e0adb_terseLabel_en-US" xlink:label="lab_camp_DeferredTaxAssetsLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_camp_DeferredTaxAssetsLeasingArrangements_label_en-US" xlink:label="lab_camp_DeferredTaxAssetsLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Leasing Arrangements</link:label>
    <link:label id="lab_camp_DeferredTaxAssetsLeasingArrangements_documentation_en-US" xlink:label="lab_camp_DeferredTaxAssetsLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_DeferredTaxAssetsLeasingArrangements" xlink:href="camp-20241231.xsd#camp_DeferredTaxAssetsLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_DeferredTaxAssetsLeasingArrangements" xlink:to="lab_camp_DeferredTaxAssetsLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_LeaseCostFinanceLeases_dd7f0c36-af74-411f-b709-f3e5213afa48_totalLabel_en-US" xlink:label="lab_camp_LeaseCostFinanceLeases" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total finance lease cost</link:label>
    <link:label id="lab_camp_LeaseCostFinanceLeases_label_en-US" xlink:label="lab_camp_LeaseCostFinanceLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Cost, Finance Leases</link:label>
    <link:label id="lab_camp_LeaseCostFinanceLeases_documentation_en-US" xlink:label="lab_camp_LeaseCostFinanceLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease Cost, Finance Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_LeaseCostFinanceLeases" xlink:href="camp-20241231.xsd#camp_LeaseCostFinanceLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_LeaseCostFinanceLeases" xlink:to="lab_camp_LeaseCostFinanceLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_cbf2d762-5dbc-4f2e-b933-d8338af5b50b_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders&#8217; equity (deficit)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_cbce271f-e3c3-4e04-a5ea-88060fa113cb_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_b197ad2d-7be4-4c40-ab15-e59b259e93d6_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at ending</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_552c1e11-3c02-4c9a-8410-2921b5256829_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total gross deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_cd851f40-22d8-47d7-89e3-f5d7ee3c84cc_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_fa20ac72-78f3-4415-8b32-96e0f91b6b22_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaboration and License Agreements</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyMember_f47b82eb-0059-4782-a82d-d8f5dea270e9_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyMember_label_en-US" xlink:label="lab_us-gaap_RelatedPartyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyMember" xlink:to="lab_us-gaap_RelatedPartyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_ResearchAndDevelopmentExpensesCurrent_3abdf606-9e4e-4b6e-8b0d-06ea444f4434_terseLabel_en-US" xlink:label="lab_camp_ResearchAndDevelopmentExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">External R&amp;D expenses</link:label>
    <link:label id="lab_camp_ResearchAndDevelopmentExpensesCurrent_label_en-US" xlink:label="lab_camp_ResearchAndDevelopmentExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research And Development Expenses, Current</link:label>
    <link:label id="lab_camp_ResearchAndDevelopmentExpensesCurrent_documentation_en-US" xlink:label="lab_camp_ResearchAndDevelopmentExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Carrying value as of the balance sheet date of obligations incurred through that date and payable for research and development expenses. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ResearchAndDevelopmentExpensesCurrent" xlink:href="camp-20241231.xsd#camp_ResearchAndDevelopmentExpensesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_ResearchAndDevelopmentExpensesCurrent" xlink:to="lab_camp_ResearchAndDevelopmentExpensesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_8e64b2a0-0288-476e-ba23-bb166870b776_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_TemporaryEquityDisclosureAndStockholdersEquityTextBlock_1fdbb45c-5342-453c-b0e6-6cf5b78f84ef_terseLabel_en-US" xlink:label="lab_camp_TemporaryEquityDisclosureAndStockholdersEquityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Preferred Stock and Stockholders' Deficit</link:label>
    <link:label id="lab_camp_TemporaryEquityDisclosureAndStockholdersEquityTextBlock_label_en-US" xlink:label="lab_camp_TemporaryEquityDisclosureAndStockholdersEquityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity Disclosure And Stockholders' Equity [Text Block]</link:label>
    <link:label id="lab_camp_TemporaryEquityDisclosureAndStockholdersEquityTextBlock_documentation_en-US" xlink:label="lab_camp_TemporaryEquityDisclosureAndStockholdersEquityTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The entire disclosure for temporary equity and equity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_TemporaryEquityDisclosureAndStockholdersEquityTextBlock" xlink:href="camp-20241231.xsd#camp_TemporaryEquityDisclosureAndStockholdersEquityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_TemporaryEquityDisclosureAndStockholdersEquityTextBlock" xlink:to="lab_camp_TemporaryEquityDisclosureAndStockholdersEquityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_WorkingCapital_570cbab7-883f-4275-8bf9-adbe8e62963e_terseLabel_en-US" xlink:label="lab_camp_WorkingCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Working capital</link:label>
    <link:label id="lab_camp_WorkingCapital_label_en-US" xlink:label="lab_camp_WorkingCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Working Capital</link:label>
    <link:label id="lab_camp_WorkingCapital_documentation_en-US" xlink:label="lab_camp_WorkingCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the amount of working capital.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_WorkingCapital" xlink:href="camp-20241231.xsd#camp_WorkingCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_WorkingCapital" xlink:to="lab_camp_WorkingCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_180bad7a-1dad-4db9-90d3-6cf71a4ec51d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contributions made</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_PatentCostsPolicyTextBlock_ec4ad8d5-d5ca-42c2-873d-783c2d39ceff_terseLabel_en-US" xlink:label="lab_camp_PatentCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Patent Costs</link:label>
    <link:label id="lab_camp_PatentCostsPolicyTextBlock_label_en-US" xlink:label="lab_camp_PatentCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Patent Costs [Policy Text Block]</link:label>
    <link:label id="lab_camp_PatentCostsPolicyTextBlock_documentation_en-US" xlink:label="lab_camp_PatentCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of accounting policy for patent costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_PatentCostsPolicyTextBlock" xlink:href="camp-20241231.xsd#camp_PatentCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_PatentCostsPolicyTextBlock" xlink:to="lab_camp_PatentCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_0aabd0ef-a9d2-4f4b-a111-18e8410d54fe_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recurring basis</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock_4bbb5f5e-b50e-427e-ae2f-30edb73aff20_terseLabel_en-US" xlink:label="lab_camp_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Estimated Useful Lives of the Property and Equipment</link:label>
    <link:label id="lab_camp_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock_label_en-US" xlink:label="lab_camp_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Property, Plant and Equipment, Useful Life [Table Text Block]</link:label>
    <link:label id="lab_camp_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock_documentation_en-US" xlink:label="lab_camp_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tabular disclosure of the useful life of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:href="camp-20241231.xsd#camp_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:to="lab_camp_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_113c0af2-c4ad-48c1-af87-8d00d84f4a5e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_177e98c3-52b7-4830-a27f-2c9e600ff46e_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Loss Per Share Attributable to Common Stockholders</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_5d7676dc-ecaf-422f-b1ec-83eafa9991e2_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:to="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_e3c0141a-3968-456a-acfc-2b3af7eac6ca_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_179dccb7-e8ca-4d80-8097-8025223d624d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company matching percentage of employee contributions</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_3a0c9977-3e64-4110-94c7-7994c12d25a3_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining contractual term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_f36c2fdb-325e-4672-96ef-8eb733505a96_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_36fcc5f5-840d-46d7-9f7d-30427abd9696_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_ba000372-5c94-4d90-9a2c-846b349c8ad6_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_12c3c8d5-2343-4bee-a68e-e49f68fb0a23_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee contribution percentage</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:to="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:to="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_3779cb32-fdd3-4e78-80fe-c01853f897c5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_53bc9146-ea86-451f-9865-03c24e6f715b_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_640f680d-903d-45c4-90e1-0b0264452f8c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_94a74d9b-1401-4ff7-a764-40c1862ba4f1_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable at the end of the period (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_FinancingObligationsLeaseFixedRepurchasePrice_1febfe5b-4de0-48a1-b5cd-fe89aafda2c6_terseLabel_en-US" xlink:label="lab_camp_FinancingObligationsLeaseFixedRepurchasePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fixed repurchase price</link:label>
    <link:label id="lab_camp_FinancingObligationsLeaseFixedRepurchasePrice_label_en-US" xlink:label="lab_camp_FinancingObligationsLeaseFixedRepurchasePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Obligations, Lease, Fixed Repurchase Price</link:label>
    <link:label id="lab_camp_FinancingObligationsLeaseFixedRepurchasePrice_documentation_en-US" xlink:label="lab_camp_FinancingObligationsLeaseFixedRepurchasePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The amount of repurchase option available for lease under financing obligations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_FinancingObligationsLeaseFixedRepurchasePrice" xlink:href="camp-20241231.xsd#camp_FinancingObligationsLeaseFixedRepurchasePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_FinancingObligationsLeaseFixedRepurchasePrice" xlink:to="lab_camp_FinancingObligationsLeaseFixedRepurchasePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_67efe99c-79d3-47dd-90d2-4e68585465e6_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dc4fb563-6f30-4bf3-a4f5-121ef29cdfc2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_20ad8a17-6dd6-4c74-a3ee-0b80d785a126_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_70152fca-dcf2-4a0c-87d7-a008463654c0_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_A2024EquityIncentivePlanMember_0d1fe604-b1a6-40c2-aa42-0461bef43495_terseLabel_en-US" xlink:label="lab_camp_A2024EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024 Equity Incentive Plan</link:label>
    <link:label id="lab_camp_A2024EquityIncentivePlanMember_label_en-US" xlink:label="lab_camp_A2024EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2024 Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_camp_A2024EquityIncentivePlanMember_documentation_en-US" xlink:label="lab_camp_A2024EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2024 Equity Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_A2024EquityIncentivePlanMember" xlink:href="camp-20241231.xsd#camp_A2024EquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_A2024EquityIncentivePlanMember" xlink:to="lab_camp_A2024EquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_9c36ad49-f25e-495c-ae40-785c7602bd29_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_NumberOfFounders_c6c87e38-60aa-4f10-bb07-161e86c1c519_terseLabel_en-US" xlink:label="lab_camp_NumberOfFounders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of founders</link:label>
    <link:label id="lab_camp_NumberOfFounders_label_en-US" xlink:label="lab_camp_NumberOfFounders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Founders</link:label>
    <link:label id="lab_camp_NumberOfFounders_documentation_en-US" xlink:label="lab_camp_NumberOfFounders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of founders.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_NumberOfFounders" xlink:href="camp-20241231.xsd#camp_NumberOfFounders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_NumberOfFounders" xlink:to="lab_camp_NumberOfFounders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockMember_5079552e-9c51-45bc-aa46-582287f73ef7_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of preferred stock</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockMember_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockMember" xlink:to="lab_us-gaap_ConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d4f67099-35ef-4d94-8aff-29febb90322e_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_5a116919-3add-4a02-ae8c-dd501f90288e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_90dc3994-e136-43fd-b5dc-863d3c747655_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_79b0e086-367d-4fd1-a2da-c6e57b1e8ec6_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_fc3f2795-1b79-45e7-b892-71311296312b_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_bf001f6c-f5ce-43df-9224-e2d0c4ecdb0f_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leasehold Improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_68e0b07b-ad56-485b-b74a-970cb0947f17_terseLabel_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale price per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_label_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_us-gaap_SharesIssuedPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_6a8e92ba-dd56-4629-a4ec-361d2a09ea2c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value Weighted Average Assumptions for Stock Options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_d7daca2b-01ed-4c44-8747-a4ffd9de2afb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_e793eb5b-73fc-485e-b14f-b5cfdaf793c7_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_56bfb132-2b95-4e8d-988c-a10df40d3adc_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: amount representing imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_af4946d2-deb4-4644-ae1c-4e0995addb38_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discount from market price, purchase date</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Discount from Market Price, Purchase Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_99b93717-a1ff-4ef2-abbc-d0e1dccd78db_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_e5a26037-9870-4826-af73-4788dfed1c4f_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_b4fcbb25-696a-418a-8104-57ed893da52e_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:to="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_b2367175-74c5-479d-b251-6fff2610e69e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance lease right-of-use asset accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06f8b384-19d0-4300-b067-f8146af864bb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Award Types</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_NumberOfVotesPerCommonShare_06a91318-78f0-4d57-a70c-2d87aca2c2c1_terseLabel_en-US" xlink:label="lab_camp_NumberOfVotesPerCommonShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of votes per common share</link:label>
    <link:label id="lab_camp_NumberOfVotesPerCommonShare_label_en-US" xlink:label="lab_camp_NumberOfVotesPerCommonShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Votes Per Common Share</link:label>
    <link:label id="lab_camp_NumberOfVotesPerCommonShare_documentation_en-US" xlink:label="lab_camp_NumberOfVotesPerCommonShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Votes Per Common Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_NumberOfVotesPerCommonShare" xlink:href="camp-20241231.xsd#camp_NumberOfVotesPerCommonShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_NumberOfVotesPerCommonShare" xlink:to="lab_camp_NumberOfVotesPerCommonShare" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_5ec011f7-be53-4ca4-a850-f9d4c13e6809_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable lease expense</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_5471c02d-801f-421d-9e12-8dee58443407_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Excluded Anti-dilutive Securities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesAuthorized_7af1c538-2d29-4b2f-802d-0dfc1c6485c7_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesAuthorized_98287010-2061-45e7-88b5-12a55a6a74db_verboseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Authorized shares</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesAuthorized_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesAuthorized" xlink:to="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare_126292da-d5af-4cc4-b503-a57c4bdba7f6_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_dff21111-1e56-4877-a5c4-cd1089b27fde_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_CollaborativeArrangementFeesIncurredDuringPeriod_fa3a0178-1752-4f8f-a7ea-b589f2a04c1d_terseLabel_en-US" xlink:label="lab_camp_CollaborativeArrangementFeesIncurredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fees incurred during period</link:label>
    <link:label id="lab_camp_CollaborativeArrangementFeesIncurredDuringPeriod_label_en-US" xlink:label="lab_camp_CollaborativeArrangementFeesIncurredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Fees Incurred During Period</link:label>
    <link:label id="lab_camp_CollaborativeArrangementFeesIncurredDuringPeriod_documentation_en-US" xlink:label="lab_camp_CollaborativeArrangementFeesIncurredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Fees Incurred During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_CollaborativeArrangementFeesIncurredDuringPeriod" xlink:href="camp-20241231.xsd#camp_CollaborativeArrangementFeesIncurredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_CollaborativeArrangementFeesIncurredDuringPeriod" xlink:to="lab_camp_CollaborativeArrangementFeesIncurredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_055ee41b-c7a0-4285-aea4-7cf479fbe53d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance lease liabilities, net of current portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_efae71d1-0116-43b5-8a37-2bc30e02c7d5_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Preferred Stock and Stockholders' Deficit</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_LeaseCostExcludingFinanceLeases_d43c7a1f-5501-4224-ab56-291fede55e27_totalLabel_en-US" xlink:label="lab_camp_LeaseCostExcludingFinanceLeases" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total lease cost</link:label>
    <link:label id="lab_camp_LeaseCostExcludingFinanceLeases_label_en-US" xlink:label="lab_camp_LeaseCostExcludingFinanceLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Cost, Excluding Finance Leases</link:label>
    <link:label id="lab_camp_LeaseCostExcludingFinanceLeases_documentation_en-US" xlink:label="lab_camp_LeaseCostExcludingFinanceLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease Cost, Excluding Finance Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_LeaseCostExcludingFinanceLeases" xlink:href="camp-20241231.xsd#camp_LeaseCostExcludingFinanceLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_LeaseCostExcludingFinanceLeases" xlink:to="lab_camp_LeaseCostExcludingFinanceLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_242297b6-2062-4b65-af7a-70d58274f657_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_3486722b-863e-41a0-ba67-57f629531a49_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recently Adopted Accounting Pronouncements and Recently Issued Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_df42a46d-ae05-4395-bd73-66669878bf72_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series&#160;A Prime</link:label>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series A Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesAPreferredStockMember" xlink:to="lab_us-gaap_SeriesAPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_358cada1-c5a5-46e5-b678-79e8e8ab82da_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_16a8c6f8-2be2-4c0b-a14f-3496e68ca8e4_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share attributable to common stockholders, diluted, (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_8b7020a3-21d7-4ecf-8f12-1c63d1cb5a23_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_67bb313b-882b-4286-9c8b-0bd2bb66218c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Recognition and Accounting for Collaboration Agreements</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_fb5d1151-f2db-46bf-aff3-9faa24ab0e20_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_84a67702-b47c-4184-aff8-46d1c5f22731_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_b3db1f79-36a0-4720-890c-c043d26d4168_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_1edc0788-93c6-416c-bd93-7805d02a98d7_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_UnrecordedNotesPayableIssuedForStockOptionEarlyExercise_252c05aa-e2e1-44af-81fe-44430095de62_terseLabel_en-US" xlink:label="lab_camp_UnrecordedNotesPayableIssuedForStockOptionEarlyExercise" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecorded notes payable issued for stock option early exercise</link:label>
    <link:label id="lab_camp_UnrecordedNotesPayableIssuedForStockOptionEarlyExercise_label_en-US" xlink:label="lab_camp_UnrecordedNotesPayableIssuedForStockOptionEarlyExercise" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecorded Notes Payable Issued For Stock Option Early Exercise</link:label>
    <link:label id="lab_camp_UnrecordedNotesPayableIssuedForStockOptionEarlyExercise_documentation_en-US" xlink:label="lab_camp_UnrecordedNotesPayableIssuedForStockOptionEarlyExercise" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Unrecorded Notes Payable Issued For Stock Option Early Exercise</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_UnrecordedNotesPayableIssuedForStockOptionEarlyExercise" xlink:href="camp-20241231.xsd#camp_UnrecordedNotesPayableIssuedForStockOptionEarlyExercise"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_UnrecordedNotesPayableIssuedForStockOptionEarlyExercise" xlink:to="lab_camp_UnrecordedNotesPayableIssuedForStockOptionEarlyExercise" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_5460f17b-a18c-4023-98c2-d684535c3147_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employer contribution percentage</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_a410bcae-c7d7-4aea-8cc7-46b942867cfe_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_FinanceLiabilityNonCurrent_b902a6da-4b31-46d0-9d1b-64795458c65f_terseLabel_en-US" xlink:label="lab_camp_FinanceLiabilityNonCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing liability, net of current portion</link:label>
    <link:label id="lab_camp_FinanceLiabilityNonCurrent_label_en-US" xlink:label="lab_camp_FinanceLiabilityNonCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Liability, Non-current</link:label>
    <link:label id="lab_camp_FinanceLiabilityNonCurrent_documentation_en-US" xlink:label="lab_camp_FinanceLiabilityNonCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The amount of financing liability classified as non-current.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_FinanceLiabilityNonCurrent" xlink:href="camp-20241231.xsd#camp_FinanceLiabilityNonCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_FinanceLiabilityNonCurrent" xlink:to="lab_camp_FinanceLiabilityNonCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_b0181e00-693a-468a-bff5-d126ad6c4b4e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_1603b5f7-eba1-4cbd-8f53-675efe4607c7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of restricted shares vested during the period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_88ed0b29-c8f7-40fb-aa3d-1dcb514545e3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_82e394f3-3605-49b4-bcb5-23c52f5fb273_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income, net:</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_OperatingLossCarryforwardsSubjectToExpiration_8b2da4f2-edac-4603-8d67-1f37b2821716_terseLabel_en-US" xlink:label="lab_camp_OperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">NOL carryforwards, subject to expiration</link:label>
    <link:label id="lab_camp_OperatingLossCarryforwardsSubjectToExpiration_label_en-US" xlink:label="lab_camp_OperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards, Subject To Expiration</link:label>
    <link:label id="lab_camp_OperatingLossCarryforwardsSubjectToExpiration_documentation_en-US" xlink:label="lab_camp_OperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards, Subject To Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_OperatingLossCarryforwardsSubjectToExpiration" xlink:href="camp-20241231.xsd#camp_OperatingLossCarryforwardsSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_OperatingLossCarryforwardsSubjectToExpiration" xlink:to="lab_camp_OperatingLossCarryforwardsSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_7dc0ac84-2dd0-4767-92e1-c9ec98cd0fe8_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental disclosure of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_651d2826-c340-4768-84a4-971f3423a520_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average period over which unrecognized stock-based compensation expense to be recognized (in years)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4f6b6cc6-9165-463d-ab48-dabc092cc1fa_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue recognized</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_RevenueRemainingPerformanceObligationExpectedReimbursableResearchAndDevelopmentExpenses_70952915-9377-442a-a1bf-a503a12a49bd_terseLabel_en-US" xlink:label="lab_camp_RevenueRemainingPerformanceObligationExpectedReimbursableResearchAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected reimbursable research and development expenses</link:label>
    <link:label id="lab_camp_RevenueRemainingPerformanceObligationExpectedReimbursableResearchAndDevelopmentExpenses_label_en-US" xlink:label="lab_camp_RevenueRemainingPerformanceObligationExpectedReimbursableResearchAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Reimbursable Research And Development Expenses</link:label>
    <link:label id="lab_camp_RevenueRemainingPerformanceObligationExpectedReimbursableResearchAndDevelopmentExpenses_documentation_en-US" xlink:label="lab_camp_RevenueRemainingPerformanceObligationExpectedReimbursableResearchAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Reimbursable Research And Development Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_RevenueRemainingPerformanceObligationExpectedReimbursableResearchAndDevelopmentExpenses" xlink:href="camp-20241231.xsd#camp_RevenueRemainingPerformanceObligationExpectedReimbursableResearchAndDevelopmentExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_RevenueRemainingPerformanceObligationExpectedReimbursableResearchAndDevelopmentExpenses" xlink:to="lab_camp_RevenueRemainingPerformanceObligationExpectedReimbursableResearchAndDevelopmentExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_85ce86c3-5c53-46a0-ab50-b0fcf93300a6_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capitalized R&amp;D costs</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Asset, In-Process Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_30fdc6ab-f3d3-44bf-bdb3-a2ffeeb30d2b_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other income, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_fb0a1c14-d81b-44c0-b17f-2abd54a074f2_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plus: Other segment income</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_8bbca247-1488-4816-9451-f4ebab1b9750_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_61886cf7-3c0f-4e44-b25c-554333cea656_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_99dee0cb-4904-4c89-9429-587f40bb46f3_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_06062057-54e7-4dd1-a062-c7bd63acef00_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_39c80617-080b-4b31-8fe9-04339b6184ee_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_f7ae2f2c-d552-41d7-a976-1c779f072d48_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_3d8caefe-d9b3-47ea-8237-0e0af7af0163_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities, convertible preferred stock and stockholders&#8217; equity (deficit)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_75d4a302-8153-45f8-9bf9-cc5a92cf12b9_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_09b7894f-225d-4870-b000-ac15a626f57a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_5fc24649-1d5b-4db6-9a40-7b96794e9d05_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_0102042a-fd86-4922-a204-e4423454d1ff_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures_952c8252-a46f-4ce3-bc5d-f703ab979040_terseLabel_en-US" xlink:label="lab_camp_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capitalized Sec. 59 (e ) R&amp;D expenditures</link:label>
    <link:label id="lab_camp_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures_label_en-US" xlink:label="lab_camp_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Capitalized Research And Development Expenditures</link:label>
    <link:label id="lab_camp_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures_documentation_en-US" xlink:label="lab_camp_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Capitalized Research And Development Expenditures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures" xlink:href="camp-20241231.xsd#camp_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures" xlink:to="lab_camp_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_41a2c048-c735-4ec9-9fad-f82c364c8839_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_8ab3e074-c957-4c05-aa05-b6332007b251_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_FinancingObligationsLeaseTermOfContract_bcfebe37-a067-4109-9772-c1f64b239b9f_terseLabel_en-US" xlink:label="lab_camp_FinancingObligationsLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease term</link:label>
    <link:label id="lab_camp_FinancingObligationsLeaseTermOfContract_label_en-US" xlink:label="lab_camp_FinancingObligationsLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Obligations, Lease, Term Of Contract</link:label>
    <link:label id="lab_camp_FinancingObligationsLeaseTermOfContract_documentation_en-US" xlink:label="lab_camp_FinancingObligationsLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Term of lease under a financing obligations expressed in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_FinancingObligationsLeaseTermOfContract" xlink:href="camp-20241231.xsd#camp_FinancingObligationsLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_FinancingObligationsLeaseTermOfContract" xlink:to="lab_camp_FinancingObligationsLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_bddfa924-4361-47fb-9cca-2513ad36c87d_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_bf2394d4-c9a8-4d7a-9404-5564f624ef9a_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease right-of-use asset obtained in exchange for lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_3710c65d-dde0-4cf1-8e8c-37a053c00929_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_b628adca-84e0-49a5-b74a-606e605613bc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options cancelled (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_69b3fc3a-375f-487f-a796-b6caf13a67d9_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected term (in&#160;years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_646ede51-8cca-4692-9f2f-5cf47444773f_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_07b4adee-2d26-4f02-b190-0264d693e017_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_677cbfd3-61bc-493f-a323-39125b965ca1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_e255b59e-f33c-47d7-af8c-c305ed3b180d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentDevelopmentAndRegulatoryMilestones_b4277a2f-6a05-4185-a62d-cf95783aa532_terseLabel_en-US" xlink:label="lab_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentDevelopmentAndRegulatoryMilestones" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable consideration amount, contingent development and regulatory milestones</link:label>
    <link:label id="lab_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentDevelopmentAndRegulatoryMilestones_label_en-US" xlink:label="lab_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentDevelopmentAndRegulatoryMilestones" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Variable Consideration Amount, Contingent Development And Regulatory Milestones</link:label>
    <link:label id="lab_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentDevelopmentAndRegulatoryMilestones_documentation_en-US" xlink:label="lab_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentDevelopmentAndRegulatoryMilestones" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Variable Consideration Amount, Contingent Development And Regulatory Milestones</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentDevelopmentAndRegulatoryMilestones" xlink:href="camp-20241231.xsd#camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentDevelopmentAndRegulatoryMilestones"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentDevelopmentAndRegulatoryMilestones" xlink:to="lab_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentDevelopmentAndRegulatoryMilestones" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_PercentageOfUpfrontPaymentRequiredUponFirstInvestigationalNewDrugStudy_55376ea3-c576-44aa-9ee8-a73210d5cfa6_terseLabel_en-US" xlink:label="lab_camp_PercentageOfUpfrontPaymentRequiredUponFirstInvestigationalNewDrugStudy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of upfront payment required upon first investigational new drug study</link:label>
    <link:label id="lab_camp_PercentageOfUpfrontPaymentRequiredUponFirstInvestigationalNewDrugStudy_label_en-US" xlink:label="lab_camp_PercentageOfUpfrontPaymentRequiredUponFirstInvestigationalNewDrugStudy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage Of Upfront Payment Required Upon First Investigational New Drug Study</link:label>
    <link:label id="lab_camp_PercentageOfUpfrontPaymentRequiredUponFirstInvestigationalNewDrugStudy_documentation_en-US" xlink:label="lab_camp_PercentageOfUpfrontPaymentRequiredUponFirstInvestigationalNewDrugStudy" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage Of Upfront Payment Required Upon First Investigational New Drug Study</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_PercentageOfUpfrontPaymentRequiredUponFirstInvestigationalNewDrugStudy" xlink:href="camp-20241231.xsd#camp_PercentageOfUpfrontPaymentRequiredUponFirstInvestigationalNewDrugStudy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_PercentageOfUpfrontPaymentRequiredUponFirstInvestigationalNewDrugStudy" xlink:to="lab_camp_PercentageOfUpfrontPaymentRequiredUponFirstInvestigationalNewDrugStudy" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_RevenuePerformanceObligationNumberOfPerformanceObligations_d79ad3be-ba64-41fe-bbfa-e4075beb56e8_terseLabel_en-US" xlink:label="lab_camp_RevenuePerformanceObligationNumberOfPerformanceObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of performance obligations</link:label>
    <link:label id="lab_camp_RevenuePerformanceObligationNumberOfPerformanceObligations_label_en-US" xlink:label="lab_camp_RevenuePerformanceObligationNumberOfPerformanceObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Performance Obligation, Number Of Performance Obligations</link:label>
    <link:label id="lab_camp_RevenuePerformanceObligationNumberOfPerformanceObligations_documentation_en-US" xlink:label="lab_camp_RevenuePerformanceObligationNumberOfPerformanceObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue, Performance Obligation, Number Of Performance Obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_RevenuePerformanceObligationNumberOfPerformanceObligations" xlink:href="camp-20241231.xsd#camp_RevenuePerformanceObligationNumberOfPerformanceObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_RevenuePerformanceObligationNumberOfPerformanceObligations" xlink:to="lab_camp_RevenuePerformanceObligationNumberOfPerformanceObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_OfficeAndLaboratorySpaceInCambridgeMember_3d42d089-051c-45cd-87f4-127077416636_terseLabel_en-US" xlink:label="lab_camp_OfficeAndLaboratorySpaceInCambridgeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Office space and laboratory space in Cambridge, Massachusetts</link:label>
    <link:label id="lab_camp_OfficeAndLaboratorySpaceInCambridgeMember_label_en-US" xlink:label="lab_camp_OfficeAndLaboratorySpaceInCambridgeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Office And Laboratory Space In Cambridge [Member]</link:label>
    <link:label id="lab_camp_OfficeAndLaboratorySpaceInCambridgeMember_documentation_en-US" xlink:label="lab_camp_OfficeAndLaboratorySpaceInCambridgeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information pertaining to lease of office and laboratory space in Cambridge.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_OfficeAndLaboratorySpaceInCambridgeMember" xlink:href="camp-20241231.xsd#camp_OfficeAndLaboratorySpaceInCambridgeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_OfficeAndLaboratorySpaceInCambridgeMember" xlink:to="lab_camp_OfficeAndLaboratorySpaceInCambridgeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_8fd2e3fe-2b21-47cb-8772-149839e5ba8b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_892b87f1-6d6d-4b50-bff4-e8c25a32364b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmount_eca5a9ce-2bb7-4dfc-93d7-be8a15324ee7_terseLabel_en-US" xlink:label="lab_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable consideration amount</link:label>
    <link:label id="lab_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmount_label_en-US" xlink:label="lab_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Variable Consideration Amount</link:label>
    <link:label id="lab_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmount_documentation_en-US" xlink:label="lab_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Variable Consideration Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:href="camp-20241231.xsd#camp_RevenueRemainingPerformanceObligationVariableConsiderationAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:to="lab_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IPOMember_4f198bc8-cab3-422c-bc40-56bd087cfa9d_terseLabel_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Initial public offering</link:label>
    <link:label id="lab_us-gaap_IPOMember_label_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">IPO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IPOMember" xlink:to="lab_us-gaap_IPOMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5734b27f-ff36-4b85-bb1a-f49fcf1ab73d_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f116bc15-24b2-41d0-8e52-af403149d2f4_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_618407ae-d343-4c53-92d4-47e65cee3208_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities, Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_25ad0985-e4f9-4869-814f-8a3598a838a5_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_12eca7a4-08e5-44da-8a4f-af6f77581795_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_d78d5d02-7e9e-4f64-b111-45c057b77385_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested and expected to vest at the end the period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8f119097-5734-45e7-bc03-c25d72c591fd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_CollaborativeArrangementReductionInResearchAndDevelopmentExpense_48f7694a-6f58-4348-8f01-fb629809ed03_terseLabel_en-US" xlink:label="lab_camp_CollaborativeArrangementReductionInResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reduction in R&amp;D expense</link:label>
    <link:label id="lab_camp_CollaborativeArrangementReductionInResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_camp_CollaborativeArrangementReductionInResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Reduction in Research and Development Expense</link:label>
    <link:label id="lab_camp_CollaborativeArrangementReductionInResearchAndDevelopmentExpense_documentation_en-US" xlink:label="lab_camp_CollaborativeArrangementReductionInResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of reduction in research and development expense under the collaborative arrangement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_CollaborativeArrangementReductionInResearchAndDevelopmentExpense" xlink:href="camp-20241231.xsd#camp_CollaborativeArrangementReductionInResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_CollaborativeArrangementReductionInResearchAndDevelopmentExpense" xlink:to="lab_camp_CollaborativeArrangementReductionInResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e73682e8-8ac9-4d04-9f05-0ead069cc8b5_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_36d6d906-60c3-4940-bee3-ab3364f3f521_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at the end (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_PrepaidExpensesAndOtherCurrentAssetsDisclosureTextBlock_afb9ef79-4066-4503-8c68-bed050fec6cf_terseLabel_en-US" xlink:label="lab_camp_PrepaidExpensesAndOtherCurrentAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid Expenses and Other Current Assets</link:label>
    <link:label id="lab_camp_PrepaidExpensesAndOtherCurrentAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_camp_PrepaidExpensesAndOtherCurrentAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expenses And Other Current Assets Disclosure [Text Block]</link:label>
    <link:label id="lab_camp_PrepaidExpensesAndOtherCurrentAssetsDisclosureTextBlock_documentation_en-US" xlink:label="lab_camp_PrepaidExpensesAndOtherCurrentAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The entire disclosure of prepaid expenses and other current assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_PrepaidExpensesAndOtherCurrentAssetsDisclosureTextBlock" xlink:href="camp-20241231.xsd#camp_PrepaidExpensesAndOtherCurrentAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_PrepaidExpensesAndOtherCurrentAssetsDisclosureTextBlock" xlink:to="lab_camp_PrepaidExpensesAndOtherCurrentAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_63877b8d-379b-414f-97dc-a8ecaa577545_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c4c15a11-08cf-49d5-8a40-0762e6b48dfd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock options outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a606b289-5c0b-4648-8d1d-8aa1eb93f867_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_43d10850-a79e-4c24-81a7-645820f4b4c4_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at the end (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_416e96ba-89d3-4c8a-9b25-3509bae2935f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</link:label>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:to="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_4a11d390-730d-49c1-9a3c-af3c6917c86e_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax computed at federal statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityByClassOfStockTable_525b660f-2204-4ded-ac42-ce5a5796ab36_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityByClassOfStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Temporary Equity, by Class of Stock [Table]</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityByClassOfStockTable_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityByClassOfStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, by Class of Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="lab_us-gaap_TemporaryEquityByClassOfStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_TheWhiteheadInstituteForBiomedicalResearchMember_414dfd7c-0418-4b48-8415-c5b95c3dae34_terseLabel_en-US" xlink:label="lab_camp_TheWhiteheadInstituteForBiomedicalResearchMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">The Whitehead Institute for Biomedical Research</link:label>
    <link:label id="lab_camp_TheWhiteheadInstituteForBiomedicalResearchMember_label_en-US" xlink:label="lab_camp_TheWhiteheadInstituteForBiomedicalResearchMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">The Whitehead Institute For Biomedical Research [Member]</link:label>
    <link:label id="lab_camp_TheWhiteheadInstituteForBiomedicalResearchMember_documentation_en-US" xlink:label="lab_camp_TheWhiteheadInstituteForBiomedicalResearchMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The Whitehead Institute For Biomedical Research</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_TheWhiteheadInstituteForBiomedicalResearchMember" xlink:href="camp-20241231.xsd#camp_TheWhiteheadInstituteForBiomedicalResearchMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_TheWhiteheadInstituteForBiomedicalResearchMember" xlink:to="lab_camp_TheWhiteheadInstituteForBiomedicalResearchMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_e8769bce-d54b-4ed5-9306-a5d815f34cf1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_81b23d13-88b7-4168-839e-a0a681e74849_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Loss Per Share Attributable to Common Stockholders</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_a0732179-d8c2-4688-87e1-1f7a745b1348_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">NOL carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_01d4adc4-d6b3-4bd4-9cb1-55e1a7f1a9d7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">R&amp;D credit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_MarauderTherapeuticsInc2016StockOptionAndGrantPlanMember_5ba9f333-d362-4ab7-a145-512b4aec77e1_verboseLabel_en-US" xlink:label="lab_camp_MarauderTherapeuticsInc2016StockOptionAndGrantPlanMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">2016 Stock Incentive Plan</link:label>
    <link:label id="lab_camp_MarauderTherapeuticsInc2016StockOptionAndGrantPlanMember_label_en-US" xlink:label="lab_camp_MarauderTherapeuticsInc2016StockOptionAndGrantPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marauder Therapeutics Inc 2016 Stock Option and Grant Plan [Member]</link:label>
    <link:label id="lab_camp_MarauderTherapeuticsInc2016StockOptionAndGrantPlanMember_documentation_en-US" xlink:label="lab_camp_MarauderTherapeuticsInc2016StockOptionAndGrantPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the information pertaining to Marauder Therapeutics, Inc. 2016 Stock Option and Grant Plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_MarauderTherapeuticsInc2016StockOptionAndGrantPlanMember" xlink:href="camp-20241231.xsd#camp_MarauderTherapeuticsInc2016StockOptionAndGrantPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_MarauderTherapeuticsInc2016StockOptionAndGrantPlanMember" xlink:to="lab_camp_MarauderTherapeuticsInc2016StockOptionAndGrantPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_86f805aa-6c64-4c58-9e3a-fe94096753b1_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders&#8217; equity (deficit):</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_f832f001-4857-476a-9bd9-343f6d641b7e_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Domestic Jurisdiction</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Domestic Tax Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_6ccf3e08-d927-4f45-b18d-3aa8542e9e53_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_f7f50a99-495a-4af8-a5f9-b4e86f99a98c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_FinancingObligationsLeaseMonthlyInterestRatePercent_9cb43f12-155a-490f-9a4c-ce0745d958a5_terseLabel_en-US" xlink:label="lab_camp_FinancingObligationsLeaseMonthlyInterestRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Monthly interest rate</link:label>
    <link:label id="lab_camp_FinancingObligationsLeaseMonthlyInterestRatePercent_label_en-US" xlink:label="lab_camp_FinancingObligationsLeaseMonthlyInterestRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Obligations, Lease, Monthly Interest Rate, Percent</link:label>
    <link:label id="lab_camp_FinancingObligationsLeaseMonthlyInterestRatePercent_documentation_en-US" xlink:label="lab_camp_FinancingObligationsLeaseMonthlyInterestRatePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Monthly interest rate on lease entered under a financing obligations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_FinancingObligationsLeaseMonthlyInterestRatePercent" xlink:href="camp-20241231.xsd#camp_FinancingObligationsLeaseMonthlyInterestRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_FinancingObligationsLeaseMonthlyInterestRatePercent" xlink:to="lab_camp_FinancingObligationsLeaseMonthlyInterestRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_52ec7d4c-ee92-47e2-ab69-35c07c39d689_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Maturities of Finance Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_e824ec9a-1fb3-43e4-997f-ad341752d917_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total future minimum lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_0b7f64c9-94af-43b1-bf8d-7e0fbadd6768_terseLabel_en-US" xlink:label="lab_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Description of Business and Basis of Presentation</link:label>
    <link:label id="lab_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_label_en-US" xlink:label="lab_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of Business and Basis of Presentation [Line Items]</link:label>
    <link:label id="lab_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_documentation_en-US" xlink:label="lab_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems" xlink:href="camp-20241231.xsd#camp_DescriptionOfBusinessAndBasisOfPresentationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems" xlink:to="lab_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityLineItems_35f65591-1d98-4f75-bbe1-eae0aaab224e_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Preferred Stock and Stockholders' Deficit</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityLineItems_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityLineItems" xlink:to="lab_us-gaap_TemporaryEquityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountCommercialSalesMilestones_adbebdb0-6dc6-4762-9a56-61ef2da911ac_terseLabel_en-US" xlink:label="lab_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountCommercialSalesMilestones" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable consideration amount, commercial sales milestones</link:label>
    <link:label id="lab_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountCommercialSalesMilestones_label_en-US" xlink:label="lab_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountCommercialSalesMilestones" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Variable Consideration Amount, Commercial Sales Milestones</link:label>
    <link:label id="lab_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountCommercialSalesMilestones_documentation_en-US" xlink:label="lab_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountCommercialSalesMilestones" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Variable Consideration Amount, Commercial Sales Milestones</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountCommercialSalesMilestones" xlink:href="camp-20241231.xsd#camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountCommercialSalesMilestones"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountCommercialSalesMilestones" xlink:to="lab_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountCommercialSalesMilestones" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_PrepaidFederalResearchAndDevelopmentTaxCreditCurrent_9a53f0f3-ad78-49b3-9eb9-3a15148eaf69_terseLabel_en-US" xlink:label="lab_camp_PrepaidFederalResearchAndDevelopmentTaxCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal R&amp;D tax credit receivable</link:label>
    <link:label id="lab_camp_PrepaidFederalResearchAndDevelopmentTaxCreditCurrent_label_en-US" xlink:label="lab_camp_PrepaidFederalResearchAndDevelopmentTaxCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Federal Research And Development Tax Credit, Current</link:label>
    <link:label id="lab_camp_PrepaidFederalResearchAndDevelopmentTaxCreditCurrent_documentation_en-US" xlink:label="lab_camp_PrepaidFederalResearchAndDevelopmentTaxCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of federal research and development tax credit that is receivable within one year or normal operating cycle, if longer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_PrepaidFederalResearchAndDevelopmentTaxCreditCurrent" xlink:href="camp-20241231.xsd#camp_PrepaidFederalResearchAndDevelopmentTaxCreditCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_PrepaidFederalResearchAndDevelopmentTaxCreditCurrent" xlink:to="lab_camp_PrepaidFederalResearchAndDevelopmentTaxCreditCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockDividendsPerShareDeclared_971d2c4c-db29-4360-b1a2-47d0774f58e6_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock dividends declared (in USD per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_PreferredStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Dividends Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_PreferredStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_af08b98e-f9c3-4c7a-a59a-c39f0774a520_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_22fd0c24-4cf6-4174-9f4f-1792f6f97193_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_UponAchievementOfFirstLicensedTargetMember_47223110-bcc3-4542-84f9-d1c1cebc5970_terseLabel_en-US" xlink:label="lab_camp_UponAchievementOfFirstLicensedTargetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Upon Achievement of First Licensed Target</link:label>
    <link:label id="lab_camp_UponAchievementOfFirstLicensedTargetMember_label_en-US" xlink:label="lab_camp_UponAchievementOfFirstLicensedTargetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Upon Achievement Of First Licensed Target [Member]</link:label>
    <link:label id="lab_camp_UponAchievementOfFirstLicensedTargetMember_documentation_en-US" xlink:label="lab_camp_UponAchievementOfFirstLicensedTargetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information pertaining to scenario upon achievement of first licensed target.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_UponAchievementOfFirstLicensedTargetMember" xlink:href="camp-20241231.xsd#camp_UponAchievementOfFirstLicensedTargetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_UponAchievementOfFirstLicensedTargetMember" xlink:to="lab_camp_UponAchievementOfFirstLicensedTargetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_291dd6d4-1dcb-4ef4-bcfe-c2e3bcab74c6_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b96df889-87d2-4c50-8589-331ac597c258_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_108f154c-9c3d-4707-bac8-3be5ffaf2c03_netLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Total (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_a4764db9-8b1c-4476-975d-6e65e645ee43_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares reserved for future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_UponAchievementOfSecondLicensedTargetMember_5a4a1455-6172-49ad-b34a-0e03c86251d6_terseLabel_en-US" xlink:label="lab_camp_UponAchievementOfSecondLicensedTargetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Upon Achievement of Second Licensed Target</link:label>
    <link:label id="lab_camp_UponAchievementOfSecondLicensedTargetMember_label_en-US" xlink:label="lab_camp_UponAchievementOfSecondLicensedTargetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Upon Achievement Of Second Licensed Target [Member]</link:label>
    <link:label id="lab_camp_UponAchievementOfSecondLicensedTargetMember_documentation_en-US" xlink:label="lab_camp_UponAchievementOfSecondLicensedTargetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information pertaining to scenario upon achievement of second licensed target.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_UponAchievementOfSecondLicensedTargetMember" xlink:href="camp-20241231.xsd#camp_UponAchievementOfSecondLicensedTargetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_UponAchievementOfSecondLicensedTargetMember" xlink:to="lab_camp_UponAchievementOfSecondLicensedTargetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</link:label>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_label_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:to="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_42d34b9a-1ad3-4268-8251-3c53745115f5_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related and Nonrelated Parties [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related and Nonrelated Parties [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_e5c2cde5-dabb-42ac-a280-3fd91afacdda_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_5444ccb5-24e0-4ad7-9889-4dbf968af5d7_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_TierOneProductMember_4e56668e-0723-4cbf-a46c-34021748a990_terseLabel_en-US" xlink:label="lab_camp_TierOneProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tier 1 Product</link:label>
    <link:label id="lab_camp_TierOneProductMember_label_en-US" xlink:label="lab_camp_TierOneProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tier One Product [Member]</link:label>
    <link:label id="lab_camp_TierOneProductMember_documentation_en-US" xlink:label="lab_camp_TierOneProductMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information pertaining to Tier 1 Product.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_TierOneProductMember" xlink:href="camp-20241231.xsd#camp_TierOneProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_TierOneProductMember" xlink:to="lab_camp_TierOneProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_5eda092e-f630-414a-ab4a-d2b573029807_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_RevenueRemainingPerformanceObligationFixedConsiderationAmount_67c648fc-5750-43d9-9b30-dfacf5df0433_terseLabel_en-US" xlink:label="lab_camp_RevenueRemainingPerformanceObligationFixedConsiderationAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fixed consideration amount</link:label>
    <link:label id="lab_camp_RevenueRemainingPerformanceObligationFixedConsiderationAmount_label_en-US" xlink:label="lab_camp_RevenueRemainingPerformanceObligationFixedConsiderationAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Fixed Consideration Amount</link:label>
    <link:label id="lab_camp_RevenueRemainingPerformanceObligationFixedConsiderationAmount_documentation_en-US" xlink:label="lab_camp_RevenueRemainingPerformanceObligationFixedConsiderationAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Fixed Consideration Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_RevenueRemainingPerformanceObligationFixedConsiderationAmount" xlink:href="camp-20241231.xsd#camp_RevenueRemainingPerformanceObligationFixedConsiderationAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_RevenueRemainingPerformanceObligationFixedConsiderationAmount" xlink:to="lab_camp_RevenueRemainingPerformanceObligationFixedConsiderationAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_818b3746-95e0-4830-911a-f9051f658e4c_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_9cdf7ca5-5ef9-49e4-a98b-089b7c1c17f6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_0343bba5-02f1-4400-b28b-b9bbeb7ef69c_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign rate differential</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_RevenueRemainingPerformanceObligationTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale_4a6a6a46-2b8c-411a-a7bf-98aee9f50f42_terseLabel_en-US" xlink:label="lab_camp_RevenueRemainingPerformanceObligationTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tiered royalties payment, period after first commercial sale</link:label>
    <link:label id="lab_camp_RevenueRemainingPerformanceObligationTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale_label_en-US" xlink:label="lab_camp_RevenueRemainingPerformanceObligationTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Tiered Royalties Payment, Period After First Commercial Sale</link:label>
    <link:label id="lab_camp_RevenueRemainingPerformanceObligationTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale_documentation_en-US" xlink:label="lab_camp_RevenueRemainingPerformanceObligationTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Tiered Royalties Payment, Period After First Commercial Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_RevenueRemainingPerformanceObligationTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale" xlink:href="camp-20241231.xsd#camp_RevenueRemainingPerformanceObligationTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_RevenueRemainingPerformanceObligationTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale" xlink:to="lab_camp_RevenueRemainingPerformanceObligationTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_FinancingObligationsLeaseMaximumInterestExpense_e660d7ff-fc79-463b-897f-2cf13115de53_terseLabel_en-US" xlink:label="lab_camp_FinancingObligationsLeaseMaximumInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum interest expense</link:label>
    <link:label id="lab_camp_FinancingObligationsLeaseMaximumInterestExpense_label_en-US" xlink:label="lab_camp_FinancingObligationsLeaseMaximumInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Obligations, Lease, Maximum Interest Expense</link:label>
    <link:label id="lab_camp_FinancingObligationsLeaseMaximumInterestExpense_documentation_en-US" xlink:label="lab_camp_FinancingObligationsLeaseMaximumInterestExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of maximum interest expense of lease under the financing obligations recorded during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_FinancingObligationsLeaseMaximumInterestExpense" xlink:href="camp-20241231.xsd#camp_FinancingObligationsLeaseMaximumInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_FinancingObligationsLeaseMaximumInterestExpense" xlink:to="lab_camp_FinancingObligationsLeaseMaximumInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_26752b4a-3e99-4a84-b5a6-5c87ab96a23c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepositsAssets_7976c572-5e54-4635-86ff-aafe04b0a458_terseLabel_en-US" xlink:label="lab_us-gaap_DepositsAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security deposits</link:label>
    <link:label id="lab_us-gaap_DepositsAssets_label_en-US" xlink:label="lab_us-gaap_DepositsAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deposits Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositsAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositsAssets" xlink:to="lab_us-gaap_DepositsAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_abf53283-3328-4dbb-9416-66674c993e11_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_7d364911-b49d-4011-bc25-46de0280737d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_a276a95c-01d7-424b-b519-65bb15150d5a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Expenses and Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_93a6387a-2a46-4914-a775-32cbc723c5e0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_4c3ece8d-1844-4386-90ce-fe8b8bb6dfa9_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_566ddc7d-4125-4e35-b0b1-88ce4b655be6_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_908cc561-a69d-422b-be48-e1ecd5c75191_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Payments of deferred offering costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_3b471ec1-9e53-4f9a-a82c-f5ebf304903d_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_a103863f-db6b-4483-8452-958add99b1a6_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_da5de97c-abc0-4d0a-bdc0-3cfca17c15d9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_d67834c5-8b07-44ae-87e2-053e1d6065bf_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_cf926d3e-4b55-4b39-9b5e-e3720be60b0c_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_c06a56e2-2352-459f-8c70-8865fa7df670_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reverse stock split ratio</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Note, Stock Split, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_fd83639a-ecc2-4a8d-8c95-952a88ea4820_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0ddd479f-c51b-4ecb-87af-ae628fe4c277_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shares issued</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_MilestoneTargetsDomain_c5874727-7315-4cf4-996f-15cad2ad4ad2_terseLabel_en-US" xlink:label="lab_camp_MilestoneTargetsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Milestone Targets [Domain]</link:label>
    <link:label id="lab_camp_MilestoneTargetsDomain_label_en-US" xlink:label="lab_camp_MilestoneTargetsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Milestone Targets [Domain]</link:label>
    <link:label id="lab_camp_MilestoneTargetsDomain_documentation_en-US" xlink:label="lab_camp_MilestoneTargetsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Milestone Targets [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_MilestoneTargetsDomain" xlink:href="camp-20241231.xsd#camp_MilestoneTargetsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_MilestoneTargetsDomain" xlink:to="lab_camp_MilestoneTargetsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_9228d8c3-f864-4f6e-b825-a84fc3a0c487_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_8999bb0c-aa42-43a0-bf9e-c21c84854877_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance costs</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_8a1d4f63-14e2-4820-8c33-c3581ccba09c_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_fbd8a950-c686-4c9a-b080-648293d589a2_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">G&amp;A</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_ee3ef419-4b6c-41ef-90f3-5946a6899574_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_2907186b-2bbb-4859-9053-65f39bc4dbe1_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued Expenses and Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_927989a7-8a37-46ad-af72-260f26baa6e8_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_a0be9d00-b1a4-4d31-bb60-4d9c6ed1e6bc_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_03f07325-ff37-4437-99b7-8b1fc4edee96_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_13d36f06-897d-4a4c-a336-b015da216024_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_4095f5ef-f4cb-4377-b586-eddc25de47db_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_5c87336b-60e3-4c7e-a389-d2fa381a4029_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at ending (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_b2381d61-ef5c-475a-8742-d19d5856ccc4_verboseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:to="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_e719d110-d221-4acd-8743-66675694ff7a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_FacilitiesAndOverheadExpense_a4f2eb96-3593-433a-86f1-7871681a4c11_terseLabel_en-US" xlink:label="lab_camp_FacilitiesAndOverheadExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Facilities-related and overhead</link:label>
    <link:label id="lab_camp_FacilitiesAndOverheadExpense_label_en-US" xlink:label="lab_camp_FacilitiesAndOverheadExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Facilities And Overhead Expense</link:label>
    <link:label id="lab_camp_FacilitiesAndOverheadExpense_documentation_en-US" xlink:label="lab_camp_FacilitiesAndOverheadExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Facilities And Overhead Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_FacilitiesAndOverheadExpense" xlink:href="camp-20241231.xsd#camp_FacilitiesAndOverheadExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_FacilitiesAndOverheadExpense" xlink:to="lab_camp_FacilitiesAndOverheadExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_PrepaidSoftwareAndSubscriptionExpenseCurrent_45607e31-4592-4cab-98b3-f9830c8db21a_terseLabel_en-US" xlink:label="lab_camp_PrepaidSoftwareAndSubscriptionExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Software and subscriptions expense</link:label>
    <link:label id="lab_camp_PrepaidSoftwareAndSubscriptionExpenseCurrent_label_en-US" xlink:label="lab_camp_PrepaidSoftwareAndSubscriptionExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Software And Subscription Expense, Current</link:label>
    <link:label id="lab_camp_PrepaidSoftwareAndSubscriptionExpenseCurrent_documentation_en-US" xlink:label="lab_camp_PrepaidSoftwareAndSubscriptionExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of consideration paid in advance for software and subscription expense that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_PrepaidSoftwareAndSubscriptionExpenseCurrent" xlink:href="camp-20241231.xsd#camp_PrepaidSoftwareAndSubscriptionExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_PrepaidSoftwareAndSubscriptionExpenseCurrent" xlink:to="lab_camp_PrepaidSoftwareAndSubscriptionExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d158fc00-3c20-44e6-beba-b1577b821576_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfessionalFees_1b54cd0f-7177-42f2-8645-d8054f8b16ad_terseLabel_en-US" xlink:label="lab_us-gaap_ProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Professional and consulting fees</link:label>
    <link:label id="lab_us-gaap_ProfessionalFees_label_en-US" xlink:label="lab_us-gaap_ProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Professional Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfessionalFees" xlink:to="lab_us-gaap_ProfessionalFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_df3dbd9a-019f-434a-98b8-c09dc88c77cb_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Unvested Restricted Common Stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_43e97170-d8b7-4f05-bef5-d7b304851988_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted stock vesting</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncentiveFromLessor_da3a817c-4776-4c6c-93f8-005b251a6af3_terseLabel_en-US" xlink:label="lab_us-gaap_IncentiveFromLessor" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease incentive received</link:label>
    <link:label id="lab_us-gaap_IncentiveFromLessor_label_en-US" xlink:label="lab_us-gaap_IncentiveFromLessor" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incentive from Lessor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncentiveFromLessor" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncentiveFromLessor"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncentiveFromLessor" xlink:to="lab_us-gaap_IncentiveFromLessor" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_056b127c-9d32-43a7-bbdb-b9a48987ffd7_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_d3e8da76-4f5a-4575-b8bc-df5efddaa6e5_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_WeightedAverageExercisePriceRollForward_f18fd241-e5b3-46c7-8fa7-62331a784e4b_terseLabel_en-US" xlink:label="lab_camp_WeightedAverageExercisePriceRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price</link:label>
    <link:label id="lab_camp_WeightedAverageExercisePriceRollForward_label_en-US" xlink:label="lab_camp_WeightedAverageExercisePriceRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price [Roll Forward]</link:label>
    <link:label id="lab_camp_WeightedAverageExercisePriceRollForward_documentation_en-US" xlink:label="lab_camp_WeightedAverageExercisePriceRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_WeightedAverageExercisePriceRollForward" xlink:href="camp-20241231.xsd#camp_WeightedAverageExercisePriceRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_WeightedAverageExercisePriceRollForward" xlink:to="lab_camp_WeightedAverageExercisePriceRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_d7687240-e00f-490b-bb62-bd290902e185_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_5e586c33-8ba5-4e36-854c-a5ee857c3c48_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityLiquidationPreference_5ea173b4-e310-4089-b2e0-03d8712eabc1_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible preferred stock, liquidation preference</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityLiquidationPreference_5bb1bb7c-e608-4873-85cf-54a7b5e488e0_verboseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Liquidation Value</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityLiquidationPreference_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Liquidation Preference</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLiquidationPreference" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityLiquidationPreference" xlink:to="lab_us-gaap_TemporaryEquityLiquidationPreference" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_3597a94e-7927-4d77-be3d-80b5d0717a67_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_6f813b10-5a25-4a11-85e9-8988eccea7e1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_0ffb9964-b607-4d88-ab8b-2246d6bd2552_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_13f522d7-5641-46d0-9c82-75baf349545f_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Uncertain tax position</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_c57a4b5d-db36-4069-9f6d-d5ee87b479a3_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_848438d7-934e-4b6b-9d38-460037f4d616_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_4b9d8d12-e334-47a9-8067-62474efc5e5f_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_543b05bf-4c54-42c0-a2c0-5d94e435675e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_e59166ff-dc4a-48ef-af71-fce5e8378664_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_CorporateExpenses_3d50539b-52d9-4409-9189-464d44531ad0_terseLabel_en-US" xlink:label="lab_camp_CorporateExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Corporate expenses</link:label>
    <link:label id="lab_camp_CorporateExpenses_label_en-US" xlink:label="lab_camp_CorporateExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate Expenses</link:label>
    <link:label id="lab_camp_CorporateExpenses_documentation_en-US" xlink:label="lab_camp_CorporateExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Corporate Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_CorporateExpenses" xlink:href="camp-20241231.xsd#camp_CorporateExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_CorporateExpenses" xlink:to="lab_camp_CorporateExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_d6e5d639-9d11-45b8-910d-2dab54bca98f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable at the end of the period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentPreclinicalMilestones_b149b187-ce7d-4bd6-8bb8-62ac5c1068e6_terseLabel_en-US" xlink:label="lab_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentPreclinicalMilestones" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable consideration amount, contingent preclinical milestones</link:label>
    <link:label id="lab_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentPreclinicalMilestones_label_en-US" xlink:label="lab_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentPreclinicalMilestones" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Variable Consideration Amount, Contingent Preclinical Milestones</link:label>
    <link:label id="lab_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentPreclinicalMilestones_documentation_en-US" xlink:label="lab_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentPreclinicalMilestones" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Variable Consideration Amount, Contingent Preclinical Milestones</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentPreclinicalMilestones" xlink:href="camp-20241231.xsd#camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentPreclinicalMilestones"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentPreclinicalMilestones" xlink:to="lab_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentPreclinicalMilestones" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_12c2bedc-d8f6-44ea-affd-58b89ae33e36_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_IncreaseDecreaseInOperatingLeaseAssetsLiabilities_b08a3904-31ef-4d08-8c6a-19b3e85b0fd2_negatedLabel_en-US" xlink:label="lab_camp_IncreaseDecreaseInOperatingLeaseAssetsLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Operating lease assets and liabilities</link:label>
    <link:label id="lab_camp_IncreaseDecreaseInOperatingLeaseAssetsLiabilities_label_en-US" xlink:label="lab_camp_IncreaseDecreaseInOperatingLeaseAssetsLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase Decrease In Operating Lease Assets (Liabilities)</link:label>
    <link:label id="lab_camp_IncreaseDecreaseInOperatingLeaseAssetsLiabilities_documentation_en-US" xlink:label="lab_camp_IncreaseDecreaseInOperatingLeaseAssetsLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The increase (decrease) during the reporting period in the assets (liabilities) created through operating leases.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_IncreaseDecreaseInOperatingLeaseAssetsLiabilities" xlink:href="camp-20241231.xsd#camp_IncreaseDecreaseInOperatingLeaseAssetsLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_IncreaseDecreaseInOperatingLeaseAssetsLiabilities" xlink:to="lab_camp_IncreaseDecreaseInOperatingLeaseAssetsLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_53c1786d-17de-40cf-a52a-eb2988f6b9c8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average grant date fair value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_450fef41-b7e6-437d-b2b9-a249ded94d90_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_PrincipalPaymentsOnFinancingObligationsFailedSaleLeasebackTransaction_38bfb7bc-5e99-48da-a62a-3ed76656c5eb_negatedLabel_en-US" xlink:label="lab_camp_PrincipalPaymentsOnFinancingObligationsFailedSaleLeasebackTransaction" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Principal payments on financing obligation</link:label>
    <link:label id="lab_camp_PrincipalPaymentsOnFinancingObligationsFailedSaleLeasebackTransaction_label_en-US" xlink:label="lab_camp_PrincipalPaymentsOnFinancingObligationsFailedSaleLeasebackTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Principal Payments On Financing Obligations, Failed Sale Leaseback Transaction</link:label>
    <link:label id="lab_camp_PrincipalPaymentsOnFinancingObligationsFailedSaleLeasebackTransaction_documentation_en-US" xlink:label="lab_camp_PrincipalPaymentsOnFinancingObligationsFailedSaleLeasebackTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of cash outflow for the principal payments on the financing obligations arising from the failed sale-leaseback transaction during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_PrincipalPaymentsOnFinancingObligationsFailedSaleLeasebackTransaction" xlink:href="camp-20241231.xsd#camp_PrincipalPaymentsOnFinancingObligationsFailedSaleLeasebackTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_PrincipalPaymentsOnFinancingObligationsFailedSaleLeasebackTransaction" xlink:to="lab_camp_PrincipalPaymentsOnFinancingObligationsFailedSaleLeasebackTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_c5777a9b-f101-4908-a394-928cd0e231d0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_1b76cece-fa0f-4c1b-9a2b-5fc14068dd9d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAbstract_5fc8cdd5-d571-41b9-b0b0-d5984ec993f2_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAbstract" xlink:to="lab_us-gaap_NetIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_8013e102-142c-43f6-adf9-07969f0fe8fe_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_26215551-a3a6-417c-81cd-e2d46d4227cc_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_70f13866-08de-4f1f-a7b5-7486279e5c57_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_e7cefa93-f591-4335-9d13-d31b7f385cec_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_3a7f448f-b2ac-4d17-acb9-e685fceece9d_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Parties</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_2aa96108-f887-49b0-9760-3475a796c3f0_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="lab_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_e96a39cc-0425-41cf-8aea-7e76999fe46f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average incremental borrowing rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_f703b950-2a63-41cb-bca0-48566d7d1932_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Total future minimum lease obligations</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_FinancingObligationsLeaseMaximumMonthlyRentalPayments_e7542f57-d951-460a-97fa-4d0c20cfb4eb_terseLabel_en-US" xlink:label="lab_camp_FinancingObligationsLeaseMaximumMonthlyRentalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum monthly rental payments</link:label>
    <link:label id="lab_camp_FinancingObligationsLeaseMaximumMonthlyRentalPayments_label_en-US" xlink:label="lab_camp_FinancingObligationsLeaseMaximumMonthlyRentalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Obligations, Lease, Maximum Monthly Rental Payments</link:label>
    <link:label id="lab_camp_FinancingObligationsLeaseMaximumMonthlyRentalPayments_documentation_en-US" xlink:label="lab_camp_FinancingObligationsLeaseMaximumMonthlyRentalPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The amount of maximum monthly rental payments of lease under the financing obligations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_FinancingObligationsLeaseMaximumMonthlyRentalPayments" xlink:href="camp-20241231.xsd#camp_FinancingObligationsLeaseMaximumMonthlyRentalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_FinancingObligationsLeaseMaximumMonthlyRentalPayments" xlink:to="lab_camp_FinancingObligationsLeaseMaximumMonthlyRentalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ca4d7ce-11cf-4e64-8db9-0b7c1eba7fd6_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_GuaranteesAndIndemnificationsPolicyTextBlock_c77b3475-e36d-4047-8fcd-4c48df3dd44b_terseLabel_en-US" xlink:label="lab_camp_GuaranteesAndIndemnificationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Guarantees and Indemnifications</link:label>
    <link:label id="lab_camp_GuaranteesAndIndemnificationsPolicyTextBlock_label_en-US" xlink:label="lab_camp_GuaranteesAndIndemnificationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Guarantees And Indemnifications [Policy Text Block]</link:label>
    <link:label id="lab_camp_GuaranteesAndIndemnificationsPolicyTextBlock_documentation_en-US" xlink:label="lab_camp_GuaranteesAndIndemnificationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of accounting policy for guarantees and indemnifications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_GuaranteesAndIndemnificationsPolicyTextBlock" xlink:href="camp-20241231.xsd#camp_GuaranteesAndIndemnificationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_GuaranteesAndIndemnificationsPolicyTextBlock" xlink:to="lab_camp_GuaranteesAndIndemnificationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_ComputerAndSoftwareMember_2f649ee5-ffb9-4060-8b51-d118220d45e7_terseLabel_en-US" xlink:label="lab_camp_ComputerAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Computer and software</link:label>
    <link:label id="lab_camp_ComputerAndSoftwareMember_label_en-US" xlink:label="lab_camp_ComputerAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Computer And Software [Member]</link:label>
    <link:label id="lab_camp_ComputerAndSoftwareMember_documentation_en-US" xlink:label="lab_camp_ComputerAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information pertaining to computer and software used in an office setting.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ComputerAndSoftwareMember" xlink:href="camp-20241231.xsd#camp_ComputerAndSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_ComputerAndSoftwareMember" xlink:to="lab_camp_ComputerAndSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_FulcrumTherapeuticsInc.Member_a4d0f90d-aace-41df-8702-7456564b61c2_terseLabel_en-US" xlink:label="lab_camp_FulcrumTherapeuticsInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fulcrum Therapeutics, Inc.</link:label>
    <link:label id="lab_camp_FulcrumTherapeuticsInc.Member_label_en-US" xlink:label="lab_camp_FulcrumTherapeuticsInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fulcrum Therapeutics, Inc. [Member]</link:label>
    <link:label id="lab_camp_FulcrumTherapeuticsInc.Member_documentation_en-US" xlink:label="lab_camp_FulcrumTherapeuticsInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fulcrum Therapeutics, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_FulcrumTherapeuticsInc.Member" xlink:href="camp-20241231.xsd#camp_FulcrumTherapeuticsInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_FulcrumTherapeuticsInc.Member" xlink:to="lab_camp_FulcrumTherapeuticsInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_3c94bd38-6199-413b-82d8-b4ea3cfa6d2c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_607114e3-adcd-4ae2-9131-c9a7115c7139_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_0186a9db-799e-4e99-a3ad-391077bae8b1_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_22f1b71b-4cce-4807-8321-5182273adea8_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_10b3e2a3-f985-4bfa-b79e-72a88cbb10ae_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_6537b77b-10f4-4239-8698-c153ce5fd4cd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Restricted Cash</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_72265ae7-632c-4b24-bf39-dcee4256d3d7_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of ROU assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_0fa7235a-33f2-47d7-9094-465586367951_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and Administrative Expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expenses, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_ClinicalAndPreclinicalExpenses_bcaaf673-b72d-49ff-aeac-e511aeda3388_terseLabel_en-US" xlink:label="lab_camp_ClinicalAndPreclinicalExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Clinical and preclinical expenses</link:label>
    <link:label id="lab_camp_ClinicalAndPreclinicalExpenses_label_en-US" xlink:label="lab_camp_ClinicalAndPreclinicalExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Clinical And Preclinical Expenses</link:label>
    <link:label id="lab_camp_ClinicalAndPreclinicalExpenses_documentation_en-US" xlink:label="lab_camp_ClinicalAndPreclinicalExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Clinical And Preclinical Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ClinicalAndPreclinicalExpenses" xlink:href="camp-20241231.xsd#camp_ClinicalAndPreclinicalExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_ClinicalAndPreclinicalExpenses" xlink:to="lab_camp_ClinicalAndPreclinicalExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_f0ba23ca-ae2e-4819-9d2c-4af7b761330f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested and expected to vest at the end the period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_233a4697-cb72-430a-87fd-e86cda258f62_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy_ab839a2d-c984-4218-99fd-5db48b8b1991_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classification of Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Note, Redeemable Preferred Stock, Issue, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" xlink:to="lab_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b239a9b7-70ab-43f3-8b1f-8365751d4e92_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_BioMarinPharmaceuticalInc.Member_0c7918fd-cbfb-4e94-b03e-a07816c8bb88_terseLabel_en-US" xlink:label="lab_camp_BioMarinPharmaceuticalInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BioMarin Pharmaceutical, Inc.</link:label>
    <link:label id="lab_camp_BioMarinPharmaceuticalInc.Member_label_en-US" xlink:label="lab_camp_BioMarinPharmaceuticalInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">BioMarin Pharmaceutical, Inc. [Member]</link:label>
    <link:label id="lab_camp_BioMarinPharmaceuticalInc.Member_documentation_en-US" xlink:label="lab_camp_BioMarinPharmaceuticalInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">BioMarin Pharmaceutical, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_BioMarinPharmaceuticalInc.Member" xlink:href="camp-20241231.xsd#camp_BioMarinPharmaceuticalInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_BioMarinPharmaceuticalInc.Member" xlink:to="lab_camp_BioMarinPharmaceuticalInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_6620e3af-d4e2-40a8-be0c-416ef7a806d7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_RevenueRemainingPerformanceObligationNoticePeriodForTermination_e77378fe-3351-42f8-9528-3649773a2164_terseLabel_en-US" xlink:label="lab_camp_RevenueRemainingPerformanceObligationNoticePeriodForTermination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notice period for termination</link:label>
    <link:label id="lab_camp_RevenueRemainingPerformanceObligationNoticePeriodForTermination_label_en-US" xlink:label="lab_camp_RevenueRemainingPerformanceObligationNoticePeriodForTermination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Notice Period For Termination</link:label>
    <link:label id="lab_camp_RevenueRemainingPerformanceObligationNoticePeriodForTermination_documentation_en-US" xlink:label="lab_camp_RevenueRemainingPerformanceObligationNoticePeriodForTermination" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Notice Period For Termination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_RevenueRemainingPerformanceObligationNoticePeriodForTermination" xlink:href="camp-20241231.xsd#camp_RevenueRemainingPerformanceObligationNoticePeriodForTermination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_RevenueRemainingPerformanceObligationNoticePeriodForTermination" xlink:to="lab_camp_RevenueRemainingPerformanceObligationNoticePeriodForTermination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnbilledContractsReceivable_59f4c066-f9ee-42ad-ab4d-58ba3fb2500d_terseLabel_en-US" xlink:label="lab_us-gaap_UnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unbilled receivable</link:label>
    <link:label id="lab_us-gaap_UnbilledContractsReceivable_label_en-US" xlink:label="lab_us-gaap_UnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unbilled Contracts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnbilledContractsReceivable" xlink:to="lab_us-gaap_UnbilledContractsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_81954f5d-875d-4839-a33d-2fbfdc07bb28_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_dd3aa032-53d2-4f94-a483-fc0f863910d5_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_f1961685-408b-41bb-900a-9af09a50a9a9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock-based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_afd81f4c-b92a-49d2-868c-665760d37f9a_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_ff9e9dc5-1931-456a-849e-36f1b3f9a663_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_dc8d6785-5c40-4698-8df4-86031ea0581d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, $0.0001 par value per share; 175,000,000 and 210,000,000 shares authorized; 20,161,072 and 1,026,057 shares issued, 20,145,129 and 460,704 shares outstanding as of December&#160;31, 2024 and 2023, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_933dfe90-c14d-41af-9a3a-adaca139193a_terseLabel_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_label_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_4fa4a065-acdf-43b5-a732-5d4d4f136397_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating cash flows used for finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_ce2373c3-5f01-4c02-be1e-24bcc998fe68_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_31f7888a-db16-48fd-9d2d-b1cec3cf11ac_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Unrestricted cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAfterEarlyExerciseDueToNotesPayableForgiveness_6bae26ab-ac81-4464-b4eb-2409b03ea5aa_terseLabel_en-US" xlink:label="lab_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAfterEarlyExerciseDueToNotesPayableForgiveness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options outstanding after early exercise due to promissory note forgiveness (in shares)</link:label>
    <link:label id="lab_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAfterEarlyExerciseDueToNotesPayableForgiveness_label_en-US" xlink:label="lab_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAfterEarlyExerciseDueToNotesPayableForgiveness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding After Early Exercise Due To Notes Payable Forgiveness</link:label>
    <link:label id="lab_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAfterEarlyExerciseDueToNotesPayableForgiveness_documentation_en-US" xlink:label="lab_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAfterEarlyExerciseDueToNotesPayableForgiveness" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding After Early Exercise Due To Notes Payable Forgiveness</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAfterEarlyExerciseDueToNotesPayableForgiveness" xlink:href="camp-20241231.xsd#camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAfterEarlyExerciseDueToNotesPayableForgiveness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAfterEarlyExerciseDueToNotesPayableForgiveness" xlink:to="lab_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAfterEarlyExerciseDueToNotesPayableForgiveness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_637a6d87-8cb8-4775-9cdf-782fca88af05_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State taxes, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_label_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:to="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_NumberOfMajorFinancialInstitutionsWithCashAndCashEquivalentDeposits_a9448e6c-37f0-42a8-b953-85da1cb95f01_terseLabel_en-US" xlink:label="lab_camp_NumberOfMajorFinancialInstitutionsWithCashAndCashEquivalentDeposits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of major financial institutions with cash and cash equivalent deposits</link:label>
    <link:label id="lab_camp_NumberOfMajorFinancialInstitutionsWithCashAndCashEquivalentDeposits_label_en-US" xlink:label="lab_camp_NumberOfMajorFinancialInstitutionsWithCashAndCashEquivalentDeposits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Major Financial Institutions With Cash And Cash Equivalent Deposits</link:label>
    <link:label id="lab_camp_NumberOfMajorFinancialInstitutionsWithCashAndCashEquivalentDeposits_documentation_en-US" xlink:label="lab_camp_NumberOfMajorFinancialInstitutionsWithCashAndCashEquivalentDeposits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Major Financial Institutions With Cash And Cash Equivalent Deposits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_NumberOfMajorFinancialInstitutionsWithCashAndCashEquivalentDeposits" xlink:href="camp-20241231.xsd#camp_NumberOfMajorFinancialInstitutionsWithCashAndCashEquivalentDeposits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_NumberOfMajorFinancialInstitutionsWithCashAndCashEquivalentDeposits" xlink:to="lab_camp_NumberOfMajorFinancialInstitutionsWithCashAndCashEquivalentDeposits" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_b48e9a41-c65c-404c-abb2-719710bfb100_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_68abc370-1ae8-4d3c-886f-c907a46a48ad_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c6f84457-5707-4bf7-8410-c5abdabacce1_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_terseLabel_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_label_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:to="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_RDMember_f7e68bd0-5593-4819-a0ff-8b20f9068108_terseLabel_en-US" xlink:label="lab_camp_RDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">R&amp;D</link:label>
    <link:label id="lab_camp_RDMember_label_en-US" xlink:label="lab_camp_RDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">R&amp;D [Member]</link:label>
    <link:label id="lab_camp_RDMember_documentation_en-US" xlink:label="lab_camp_RDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">R&amp;D</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_RDMember" xlink:href="camp-20241231.xsd#camp_RDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_RDMember" xlink:to="lab_camp_RDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_LaboratoryEquipmentMember_1599f8e2-3b56-4a3e-921c-a6efd1efb3e7_terseLabel_en-US" xlink:label="lab_camp_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Laboratory equipment</link:label>
    <link:label id="lab_camp_LaboratoryEquipmentMember_label_en-US" xlink:label="lab_camp_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Laboratory Equipment [Member]</link:label>
    <link:label id="lab_camp_LaboratoryEquipmentMember_documentation_en-US" xlink:label="lab_camp_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information pertaining to laboratory equipment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_LaboratoryEquipmentMember" xlink:href="camp-20241231.xsd#camp_LaboratoryEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_LaboratoryEquipmentMember" xlink:to="lab_camp_LaboratoryEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_d1cd9aae-c3da-426c-aad1-7d6f5953dcbb_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f3b62da9-ea84-4769-9866-f0f4e5bc09ba_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of outstanding options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_412f0fad-87b6-419f-8f8e-5db6defc160d_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total gross deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_257f235e-b83e-4aff-b126-80fd3af8229b_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_4d525c56-3e98-4ca2-a841-f0bbc17ca149_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization expense</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_27472cd1-351c-4f75-a705-13c7150bd9f8_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share attributable to common stockholders, basic, (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_ee826f11-379f-424f-bd83-8b9423314176_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_5dc5aa7e-b1a6-46fc-801a-9f96b5236060_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of common stock, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_f50591d3-6139-4789-bcb4-3090d7349fe8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating cash flows used for operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_SupplementalInformationRelatingToLeasesAbstract_17d7ada6-8259-4bbf-9a23-34d626d1c247_terseLabel_en-US" xlink:label="lab_camp_SupplementalInformationRelatingToLeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other information</link:label>
    <link:label id="lab_camp_SupplementalInformationRelatingToLeasesAbstract_label_en-US" xlink:label="lab_camp_SupplementalInformationRelatingToLeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Information Relating To Leases [Abstract]</link:label>
    <link:label id="lab_camp_SupplementalInformationRelatingToLeasesAbstract_documentation_en-US" xlink:label="lab_camp_SupplementalInformationRelatingToLeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">No definition available.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_SupplementalInformationRelatingToLeasesAbstract" xlink:href="camp-20241231.xsd#camp_SupplementalInformationRelatingToLeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_SupplementalInformationRelatingToLeasesAbstract" xlink:to="lab_camp_SupplementalInformationRelatingToLeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_1c0c06a5-b8b5-4bc4-a4ec-5d98ae53fa34_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_e39793da-3fea-453c-b42c-6515057922dc_negatedLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Principal payments on finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_f7fc941c-7c6e-4d4b-a5e1-8fcbe33c62de_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchases of property and equipment in accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_ConsultingAgreementsWithFoundersMember_53d80167-86ad-422a-a8dd-57aaeef25ecc_terseLabel_en-US" xlink:label="lab_camp_ConsultingAgreementsWithFoundersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consulting Agreement with Founders</link:label>
    <link:label id="lab_camp_ConsultingAgreementsWithFoundersMember_label_en-US" xlink:label="lab_camp_ConsultingAgreementsWithFoundersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consulting Agreements with Founders [Member]</link:label>
    <link:label id="lab_camp_ConsultingAgreementsWithFoundersMember_documentation_en-US" xlink:label="lab_camp_ConsultingAgreementsWithFoundersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information pertaining to consulting agreement with founder.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ConsultingAgreementsWithFoundersMember" xlink:href="camp-20241231.xsd#camp_ConsultingAgreementsWithFoundersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_ConsultingAgreementsWithFoundersMember" xlink:to="lab_camp_ConsultingAgreementsWithFoundersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_048529e6-913f-4009-bd66-e59a4af66abd_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_72b4e0f9-bdf2-40f2-a5d6-c78f3f605ef4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock, Class of Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock, Class of Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_31436ff4-2da9-4b6b-8aef-e0a3c100b7e4_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</link:label>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:to="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_4031436e-3f3c-4c9f-9024-a639a37b16f8_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible preferred stock, $0.0001 par value per share; 25,000,000 and 149,673,284 shares authorized; no and 130,648,426 shares issued and outstanding; liquidation value of zero and $162,885 as of December&#160;31, 2024 and 2023, respectively</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_d4fc221a-174d-4a77-acb9-ab8b1d08ff55_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_966068d0-d09a-402c-b20d-0e842f73bff9_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at ending</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_34be470e-f327-4f57-82be-563c6fe9b50b_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_44c42b42-392d-48f2-a93a-c8a177c9efd9_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration of Credit Risks</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OverAllotmentOptionMember_f9adc777-3b86-4f9f-9ddd-25db91b41181_terseLabel_en-US" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Over allotment</link:label>
    <link:label id="lab_us-gaap_OverAllotmentOptionMember_label_en-US" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Over-Allotment Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OverAllotmentOptionMember" xlink:to="lab_us-gaap_OverAllotmentOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_c5706076-6fff-41a5-8a2e-240608413798_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Assets Measured for Fair Value on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_45cf6070-8cdc-47ff-8343-ef6d53b57e73_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_6f48d04e-3004-4e09-9f84-c64daed7b948_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_9c84b2ab-818b-426c-9a92-bc91f425436d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of outstanding stock maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_4cf273c7-9a0f-48f5-96a2-7537e3d61498_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies (Note 7)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_850802ae-5fa9-476c-80f9-5ab8bac60aa3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_772b8557-cdff-4ffc-adc2-62143af8078b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_EmergingGrowthCompanyStatusPolicyTextBlock_e3cbd6bb-66b6-412a-9fca-2d9d2225edbb_terseLabel_en-US" xlink:label="lab_camp_EmergingGrowthCompanyStatusPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Emerging Growth Company Status</link:label>
    <link:label id="lab_camp_EmergingGrowthCompanyStatusPolicyTextBlock_label_en-US" xlink:label="lab_camp_EmergingGrowthCompanyStatusPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Emerging Growth Company Status [Policy Text Block]</link:label>
    <link:label id="lab_camp_EmergingGrowthCompanyStatusPolicyTextBlock_documentation_en-US" xlink:label="lab_camp_EmergingGrowthCompanyStatusPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of accounting policy for emerging growth company status.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_EmergingGrowthCompanyStatusPolicyTextBlock" xlink:href="camp-20241231.xsd#camp_EmergingGrowthCompanyStatusPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_EmergingGrowthCompanyStatusPolicyTextBlock" xlink:to="lab_camp_EmergingGrowthCompanyStatusPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_NoncashLeaseExpense_cdf6b7f9-753e-4af6-af0e-1dec48684e01_terseLabel_en-US" xlink:label="lab_camp_NoncashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash lease expense</link:label>
    <link:label id="lab_camp_NoncashLeaseExpense_label_en-US" xlink:label="lab_camp_NoncashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncash Lease Expense</link:label>
    <link:label id="lab_camp_NoncashLeaseExpense_documentation_en-US" xlink:label="lab_camp_NoncashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The total noncash lease expenses incurred by the entity during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_NoncashLeaseExpense" xlink:href="camp-20241231.xsd#camp_NoncashLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_NoncashLeaseExpense" xlink:to="lab_camp_NoncashLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_CollaborativeArrangementTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale_0279e739-a36d-4636-b06b-6cafffa21d0b_terseLabel_en-US" xlink:label="lab_camp_CollaborativeArrangementTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Period of payment of tiered royalties after first commercial sale</link:label>
    <link:label id="lab_camp_CollaborativeArrangementTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale_label_en-US" xlink:label="lab_camp_CollaborativeArrangementTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Tiered Royalties Payment, Period After First Commercial Sale</link:label>
    <link:label id="lab_camp_CollaborativeArrangementTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale_documentation_en-US" xlink:label="lab_camp_CollaborativeArrangementTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Period of payment of tiered royalties after first commercial sale under the collaborative arrangements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_CollaborativeArrangementTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale" xlink:href="camp-20241231.xsd#camp_CollaborativeArrangementTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_CollaborativeArrangementTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale" xlink:to="lab_camp_CollaborativeArrangementTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_18a490cf-d948-4483-95fe-931a1b794ec0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_CollaborativeArrangementTieredRoyaltiesPayableOnNetSalesMaximumLowerRangePercent_20d9dfc2-2493-43f9-b0f1-93a50517a453_terseLabel_en-US" xlink:label="lab_camp_CollaborativeArrangementTieredRoyaltiesPayableOnNetSalesMaximumLowerRangePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum lower range tiered royalties on net sales percentage</link:label>
    <link:label id="lab_camp_CollaborativeArrangementTieredRoyaltiesPayableOnNetSalesMaximumLowerRangePercent_label_en-US" xlink:label="lab_camp_CollaborativeArrangementTieredRoyaltiesPayableOnNetSalesMaximumLowerRangePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Tiered Royalties Payable On Net Sales, Maximum Lower Range, Percent</link:label>
    <link:label id="lab_camp_CollaborativeArrangementTieredRoyaltiesPayableOnNetSalesMaximumLowerRangePercent_documentation_en-US" xlink:label="lab_camp_CollaborativeArrangementTieredRoyaltiesPayableOnNetSalesMaximumLowerRangePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The maximum lower range percentage of tiered royalties on net sales under the collaborative arrangements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_CollaborativeArrangementTieredRoyaltiesPayableOnNetSalesMaximumLowerRangePercent" xlink:href="camp-20241231.xsd#camp_CollaborativeArrangementTieredRoyaltiesPayableOnNetSalesMaximumLowerRangePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_CollaborativeArrangementTieredRoyaltiesPayableOnNetSalesMaximumLowerRangePercent" xlink:to="lab_camp_CollaborativeArrangementTieredRoyaltiesPayableOnNetSalesMaximumLowerRangePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_55689736-a4c7-4b3a-8f0b-3ae9730fa47f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_58e9e2d3-9044-4887-9861-b5883bb5c869_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and collaboration revenue</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d3f42685-9e2a-4cd4-87f9-e9bef398e761_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_913f2f49-e144-410d-8eb8-adead52dd179_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_037bbd00-d8cb-4759-b042-0e441bf99f75_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGrossAbstract_979b5d0d-17a8-4509-84f6-b3b7e60d838c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGrossAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_f5038ab1-b862-494e-bb8e-1f7597b53bab_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_d2a096d1-ac50-49f7-a6a7-e913a3d3cf9c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityTableTextBlock_e12b628e-0705-48b4-a458-4f52aa70ad2c_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityTableTextBlock" xlink:to="lab_us-gaap_TemporaryEquityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3c9cbfa6-62c5-46e0-bc01-3ba4cd4727d9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_7b6855e2-4db9-4704-9c14-54c59ccfac51_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense recorded</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_b66c6e2f-2482-4b87-8590-52e47b634937_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_376125f5-5692-439c-81e4-14ab3ccfb380_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss attributable to common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_699d4438-a7cc-4f3f-8fe4-58f32be4a352_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_2c36891f-f42d-4f3a-9891-39562a216772_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_2ea720dd-0e00-4d1a-8305-8d5c05e8e8ea_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net loss attributable to common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_FinanceLeaseRightOfUseAssetConvertedToFixedAsset_1e036515-de28-4e79-8e2d-7e4e1a311368_terseLabel_en-US" xlink:label="lab_camp_FinanceLeaseRightOfUseAssetConvertedToFixedAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance lease right-of-use asset converted to fixed asset</link:label>
    <link:label id="lab_camp_FinanceLeaseRightOfUseAssetConvertedToFixedAsset_label_en-US" xlink:label="lab_camp_FinanceLeaseRightOfUseAssetConvertedToFixedAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease Right-Of-Use Asset Converted To Fixed Asset</link:label>
    <link:label id="lab_camp_FinanceLeaseRightOfUseAssetConvertedToFixedAsset_documentation_en-US" xlink:label="lab_camp_FinanceLeaseRightOfUseAssetConvertedToFixedAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Finance Lease Right-Of-Use Asset Converted To Fixed Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_FinanceLeaseRightOfUseAssetConvertedToFixedAsset" xlink:href="camp-20241231.xsd#camp_FinanceLeaseRightOfUseAssetConvertedToFixedAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_FinanceLeaseRightOfUseAssetConvertedToFixedAsset" xlink:to="lab_camp_FinanceLeaseRightOfUseAssetConvertedToFixedAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_56000e54-27e2-40fa-9927-ebe158f51aa4_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of convertible preferred stock into common stock upon initial public offering</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_da2105b6-e97a-4a3a-be0b-3a508bcf8ec3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options granted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</link:label>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_label_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:to="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_OfficeAndLaboratorySpaceInBoulderMember_18603321-60ed-4b19-b0f0-29ac7d6d2ce1_terseLabel_en-US" xlink:label="lab_camp_OfficeAndLaboratorySpaceInBoulderMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Office and lab space in Boulder, Colorado</link:label>
    <link:label id="lab_camp_OfficeAndLaboratorySpaceInBoulderMember_label_en-US" xlink:label="lab_camp_OfficeAndLaboratorySpaceInBoulderMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Office And Laboratory Space In Boulder [Member]</link:label>
    <link:label id="lab_camp_OfficeAndLaboratorySpaceInBoulderMember_documentation_en-US" xlink:label="lab_camp_OfficeAndLaboratorySpaceInBoulderMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information pertaining to lease of office and laboratory space in Boulder.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_OfficeAndLaboratorySpaceInBoulderMember" xlink:href="camp-20241231.xsd#camp_OfficeAndLaboratorySpaceInBoulderMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_OfficeAndLaboratorySpaceInBoulderMember" xlink:to="lab_camp_OfficeAndLaboratorySpaceInBoulderMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_70127a87-f70a-4b5e-b321-a9c4e946a69f_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_44233505-6849-47d2-8dc2-8633a18a1d72_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Operating lease ROU assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_3702205b-0dd1-4c52-9768-bd48d6d6d73b_terseLabel_en-US" xlink:label="lab_camp_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Permanent differences</link:label>
    <link:label id="lab_camp_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_label_en-US" xlink:label="lab_camp_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Permanent Differences, Percent</link:label>
    <link:label id="lab_camp_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_documentation_en-US" xlink:label="lab_camp_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Permanent Differences, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:href="camp-20241231.xsd#camp_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:to="lab_camp_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_7802f32d-bee0-4d0c-8de7-83c26d298fb9_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maturity of finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_TemporaryEquitySharesConversionOfConvertibleSecurities_cd3b5edb-200a-443c-b202-9cce1c0ae3bd_negatedLabel_en-US" xlink:label="lab_camp_TemporaryEquitySharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Conversion of convertible preferred stock into common stock upon initial public offering (in shares)</link:label>
    <link:label id="lab_camp_TemporaryEquitySharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_camp_TemporaryEquitySharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Shares, Conversion of Convertible Securities</link:label>
    <link:label id="lab_camp_TemporaryEquitySharesConversionOfConvertibleSecurities_documentation_en-US" xlink:label="lab_camp_TemporaryEquitySharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Temporary Equity, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_TemporaryEquitySharesConversionOfConvertibleSecurities" xlink:href="camp-20241231.xsd#camp_TemporaryEquitySharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_TemporaryEquitySharesConversionOfConvertibleSecurities" xlink:to="lab_camp_TemporaryEquitySharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_58ddb37f-d391-49fb-a390-5f3afd2c6608_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series&#160;B</link:label>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series B Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesBPreferredStockMember" xlink:to="lab_us-gaap_SeriesBPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_75e67273-46b2-4021-8f80-fedaddba38a3_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingExpense_559db5b4-71d0-447b-8cc4-7ec0ab1847ed_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other expense</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingExpense" xlink:to="lab_us-gaap_OtherNonoperatingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_eda2e158-e560-41b7-9fc0-d542dcb31f4d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_f7e9a928-816f-4b9f-b808-bf4fa988f74c_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine3_8273014d-1dd3-413c-ba68-92768e73ad2f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Three</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine3_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine3" xlink:to="lab_dei_EntityAddressAddressLine3" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_513c8cfc-84f8-4558-aa28-655fec7c7e26_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_648f977d-e1e6-4a1f-bd87-0557e7b98b9a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term of lease</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_e5a44da9-bb83-4110-b910-53d8c7771c25_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_732e636e-9035-4e8c-a896-39faeaf33686_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_e5aa4d25-8b57-46d4-bce8-6fbb56206e33_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable at the end of the period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_0db4bce8-bd6a-46c8-a934-a0efc02d0e94_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average remaining lease term (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_4f98697e-b45e-423b-8d9f-f594c85c2194_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_ea9d6f86-1715-43a5-ad12-476c08a673f2_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_da483ee6-ce6d-49d3-b954-d7aee128b51e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance lease liabilities, current portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_810ba497-f76e-4b57-ac9a-554feeb6fde6_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total lease payment</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f5e80d02-5acd-4b0a-b2b5-aa489a4febc3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted stock vesting (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e0f5c5ff-5130-4cd2-8598-f02528d6a2a2_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_91d3edf2-32cd-4bf7-a3b2-e9f391872f94_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_CertainExecutivesMember_e0ad9acf-0642-46a6-a3a0-02d1f1498cd1_terseLabel_en-US" xlink:label="lab_camp_CertainExecutivesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Certain Executives</link:label>
    <link:label id="lab_camp_CertainExecutivesMember_label_en-US" xlink:label="lab_camp_CertainExecutivesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Certain Executives [Member]</link:label>
    <link:label id="lab_camp_CertainExecutivesMember_documentation_en-US" xlink:label="lab_camp_CertainExecutivesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Certain Executives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_CertainExecutivesMember" xlink:href="camp-20241231.xsd#camp_CertainExecutivesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_CertainExecutivesMember" xlink:to="lab_camp_CertainExecutivesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_94ec843b-4201-433d-be2b-6755b21a5197_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e49a6fa5-5ad5-40f1-b35a-dde3a9eb2718_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_026814e3-5fa3-40c2-b3fe-5750bd4cfbd4_totalLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_815d9bd7-1ce8-48cf-8b7b-90743e52952a_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_73966902-9de6-467b-86d6-b4c264d0dd5d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_b1f22e3b-c8ab-47a7-82f5-dc9d043e7e12_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_PrepaidResearchAndDevelopmentExpenseCurrent_248f1a56-875d-4c1f-8032-d5f88da7e91a_terseLabel_en-US" xlink:label="lab_camp_PrepaidResearchAndDevelopmentExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">R&amp;D expense</link:label>
    <link:label id="lab_camp_PrepaidResearchAndDevelopmentExpenseCurrent_label_en-US" xlink:label="lab_camp_PrepaidResearchAndDevelopmentExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Research And Development Expense, Current</link:label>
    <link:label id="lab_camp_PrepaidResearchAndDevelopmentExpenseCurrent_documentation_en-US" xlink:label="lab_camp_PrepaidResearchAndDevelopmentExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of consideration paid in advance for research and development expense that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_PrepaidResearchAndDevelopmentExpenseCurrent" xlink:href="camp-20241231.xsd#camp_PrepaidResearchAndDevelopmentExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_PrepaidResearchAndDevelopmentExpenseCurrent" xlink:to="lab_camp_PrepaidResearchAndDevelopmentExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_f6dcd9ae-9909-45d5-9c2f-1099a7a2865b_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsSvcCstMember" xlink:to="lab_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_3aa63c34-5f4e-46e1-98cc-1324b93cb746_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related and Nonrelated Parties [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related and Nonrelated Parties [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_90cb0e61-ae5b-4d05-84b2-c549805cb963_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average shares of common stock outstanding, basic, (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfConversionsOfStockTextBlock_e7cfce84-4703-4787-8257-d71472fb91e7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfConversionsOfStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Common Stock Issuance Upon Conversion</link:label>
    <link:label id="lab_us-gaap_ScheduleOfConversionsOfStockTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfConversionsOfStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Conversions of Stock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfConversionsOfStockTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfConversionsOfStockTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfConversionsOfStockTextBlock" xlink:to="lab_us-gaap_ScheduleOfConversionsOfStockTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_731cff2b-3701-4901-959a-462cc62e276b_terseLabel_en-US" xlink:label="lab_camp_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Prepaid Expenses and Other Current Assets</link:label>
    <link:label id="lab_camp_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_label_en-US" xlink:label="lab_camp_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Prepaid Expenses And Other Current Assets [Table Text Block]</link:label>
    <link:label id="lab_camp_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_documentation_en-US" xlink:label="lab_camp_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tabular disclosure of prepaid expenses and other current assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:href="camp-20241231.xsd#camp_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:to="lab_camp_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_CollaborativeArrangementUpfrontLicenseIssuanceFeePayment_c7ba9f80-37c4-47cf-9d71-5f88fee18975_terseLabel_en-US" xlink:label="lab_camp_CollaborativeArrangementUpfrontLicenseIssuanceFeePayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Initial license issuance fee payment</link:label>
    <link:label id="lab_camp_CollaborativeArrangementUpfrontLicenseIssuanceFeePayment_label_en-US" xlink:label="lab_camp_CollaborativeArrangementUpfrontLicenseIssuanceFeePayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Upfront License Issuance Fee Payment</link:label>
    <link:label id="lab_camp_CollaborativeArrangementUpfrontLicenseIssuanceFeePayment_documentation_en-US" xlink:label="lab_camp_CollaborativeArrangementUpfrontLicenseIssuanceFeePayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of initial payment for license issuance fees under the collaborative arrangements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_CollaborativeArrangementUpfrontLicenseIssuanceFeePayment" xlink:href="camp-20241231.xsd#camp_CollaborativeArrangementUpfrontLicenseIssuanceFeePayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_CollaborativeArrangementUpfrontLicenseIssuanceFeePayment" xlink:to="lab_camp_CollaborativeArrangementUpfrontLicenseIssuanceFeePayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7c26f246-8bbd-41ce-9b77-fcc3f1bfd7f7_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in Stockholders' Deficit</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_EliLillyAndCompanyMember_04151c73-3554-4f02-9aeb-07ece82e3ec3_terseLabel_en-US" xlink:label="lab_camp_EliLillyAndCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Eli Lilly And Company</link:label>
    <link:label id="lab_camp_EliLillyAndCompanyMember_label_en-US" xlink:label="lab_camp_EliLillyAndCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Eli Lilly And Company [Member]</link:label>
    <link:label id="lab_camp_EliLillyAndCompanyMember_documentation_en-US" xlink:label="lab_camp_EliLillyAndCompanyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Eli Lilly And Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_EliLillyAndCompanyMember" xlink:href="camp-20241231.xsd#camp_EliLillyAndCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_EliLillyAndCompanyMember" xlink:to="lab_camp_EliLillyAndCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_fe258488-edcd-4032-a4f9-f7aa0af13408_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Options cancelled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_camp_ChildrenMedicalCenterCorporationMember_2553c6be-d2e7-4315-82d0-5ffd6f40bce4_terseLabel_en-US" xlink:label="lab_camp_ChildrenMedicalCenterCorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Children Medical Center Corporation</link:label>
    <link:label id="lab_camp_ChildrenMedicalCenterCorporationMember_label_en-US" xlink:label="lab_camp_ChildrenMedicalCenterCorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Children Medical Center Corporation [Member]</link:label>
    <link:label id="lab_camp_ChildrenMedicalCenterCorporationMember_documentation_en-US" xlink:label="lab_camp_ChildrenMedicalCenterCorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Children Medical Center Corporation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ChildrenMedicalCenterCorporationMember" xlink:href="camp-20241231.xsd#camp_ChildrenMedicalCenterCorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_camp_ChildrenMedicalCenterCorporationMember" xlink:to="lab_camp_ChildrenMedicalCenterCorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_f78cb5b5-0d8a-46c9-b246-82282d313cb5_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_e7b402a2-896d-4719-bc7d-65f76732c28c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>camp-20241231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:344bab39-1447-4710-a813-d0e5cea79568,g:e8dcb9a0-a4ba-432e-8d82-4b2fdbae6592-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://camp4tx.com/role/CoverPage" xlink:type="simple" xlink:href="camp-20241231.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_f26a7b9c-4c97-4faa-bb51-04cfc80aae25" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_DocumentType_f26a7b9c-4c97-4faa-bb51-04cfc80aae25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_b86c8d8f-cc0a-4d09-8ed3-7022187c1821" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_DocumentAnnualReport_b86c8d8f-cc0a-4d09-8ed3-7022187c1821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_d0ac8dec-d4f5-4c67-b99b-36873f335343" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_DocumentPeriodEndDate_d0ac8dec-d4f5-4c67-b99b-36873f335343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_3c35a5ee-609a-4b8f-bceb-11505c231387" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_CurrentFiscalYearEndDate_3c35a5ee-609a-4b8f-bceb-11505c231387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_b83944ce-ca15-4e3f-85eb-1d5ba4e828f4" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_DocumentTransitionReport_b83944ce-ca15-4e3f-85eb-1d5ba4e828f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_0b0d9719-3dff-4db6-a58f-01f2ed932aaf" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_EntityFileNumber_0b0d9719-3dff-4db6-a58f-01f2ed932aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_3c266c53-dcfb-4692-a9d1-e71a24494815" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_EntityRegistrantName_3c266c53-dcfb-4692-a9d1-e71a24494815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_6be3ad88-5a27-44a7-9c5f-dedd9fd51f13" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_EntityIncorporationStateCountryCode_6be3ad88-5a27-44a7-9c5f-dedd9fd51f13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_2068379b-6276-4bba-a5c7-a2a943550680" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_EntityTaxIdentificationNumber_2068379b-6276-4bba-a5c7-a2a943550680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_f7221d82-7dbd-40c2-adc1-e17104cdb37f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_EntityAddressAddressLine1_f7221d82-7dbd-40c2-adc1-e17104cdb37f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_26d6dc4d-fb2f-449f-8bdf-f41aab59efc6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_EntityAddressAddressLine2_26d6dc4d-fb2f-449f-8bdf-f41aab59efc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine3_c3a3dcbd-a526-4b86-9c30-fecc59d3af9d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_EntityAddressAddressLine3_c3a3dcbd-a526-4b86-9c30-fecc59d3af9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_6bd0fd13-9d1e-4451-8739-495997cb7711" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_EntityAddressCityOrTown_6bd0fd13-9d1e-4451-8739-495997cb7711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_01babb97-ed56-4d10-8ac8-ca78eff58ec0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_EntityAddressStateOrProvince_01babb97-ed56-4d10-8ac8-ca78eff58ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_06bde5ad-8d3d-4da6-b10d-370bc11bea40" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_EntityAddressPostalZipCode_06bde5ad-8d3d-4da6-b10d-370bc11bea40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_c6610eef-b37c-4299-ade7-1015ce6998b1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_CityAreaCode_c6610eef-b37c-4299-ade7-1015ce6998b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_5076b4ce-60d1-4258-a304-b0314993158c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_LocalPhoneNumber_5076b4ce-60d1-4258-a304-b0314993158c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_f78d6daf-87a5-4f6d-90ac-cc0ff1e94668" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_Security12bTitle_f78d6daf-87a5-4f6d-90ac-cc0ff1e94668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_ca831e70-1a45-4270-98c1-e67b41181300" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_TradingSymbol_ca831e70-1a45-4270-98c1-e67b41181300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_331f328b-44eb-401d-81d8-7dd27e225fae" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_SecurityExchangeName_331f328b-44eb-401d-81d8-7dd27e225fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_388388eb-351b-448e-a9b6-f3605801c4c5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_388388eb-351b-448e-a9b6-f3605801c4c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_855abefb-10d4-42b7-83c3-292fb721e39f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_EntityVoluntaryFilers_855abefb-10d4-42b7-83c3-292fb721e39f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_66f5e07a-9eca-4d9c-80d2-ce8c3dad2af5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_EntityCurrentReportingStatus_66f5e07a-9eca-4d9c-80d2-ce8c3dad2af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_1f1cc8ae-8756-4896-94aa-854e31f38628" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_EntityInteractiveDataCurrent_1f1cc8ae-8756-4896-94aa-854e31f38628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_6280078b-c8a7-4acb-8753-967a95c69cdb" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_EntityFilerCategory_6280078b-c8a7-4acb-8753-967a95c69cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_87be0c6a-b26a-4c2e-aedb-609fffba6f0e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_EntitySmallBusiness_87be0c6a-b26a-4c2e-aedb-609fffba6f0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_bd724e54-f3e9-41ef-9f08-1c069e604e3c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_EntityEmergingGrowthCompany_bd724e54-f3e9-41ef-9f08-1c069e604e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_94f6aae8-1ab8-43eb-acda-5a6210cf3f68" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_EntityExTransitionPeriod_94f6aae8-1ab8-43eb-acda-5a6210cf3f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_b064cf7f-4c23-4063-bdb7-b91967d558be" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_IcfrAuditorAttestationFlag_b064cf7f-4c23-4063-bdb7-b91967d558be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_8528c75b-30bb-4a7a-8cb5-f95f4927d471" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_8528c75b-30bb-4a7a-8cb5-f95f4927d471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_51037d63-4fe0-4242-8cac-4f990691c883" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_EntityShellCompany_51037d63-4fe0-4242-8cac-4f990691c883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_9dfa2f7f-0d47-4576-a64e-ac64e3ffc436" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_EntityPublicFloat_9dfa2f7f-0d47-4576-a64e-ac64e3ffc436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_25ee9858-2946-4063-89ae-098c9654c463" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_25ee9858-2946-4063-89ae-098c9654c463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_f30aae7f-d998-4c2c-bc32-181c85f342f4" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_f30aae7f-d998-4c2c-bc32-181c85f342f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_53fe54c4-ae48-443a-9753-f4df07084a06" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_EntityCentralIndexKey_53fe54c4-ae48-443a-9753-f4df07084a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_5ec8a654-31cf-40ff-b02f-65496a9df30e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_DocumentFiscalYearFocus_5ec8a654-31cf-40ff-b02f-65496a9df30e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_46444177-478f-46bf-aba4-75c7bab2f367" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_DocumentFiscalPeriodFocus_46444177-478f-46bf-aba4-75c7bab2f367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_bdb2dd44-eeb6-410f-8364-262a6f41ab26" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_09ca4145-6241-4f6b-9f9d-65885c026847" xlink:to="loc_dei_AmendmentFlag_bdb2dd44-eeb6-410f-8364-262a6f41ab26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/AuditInformation" xlink:type="simple" xlink:href="camp-20241231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_camp_AuditInformationAbstract_c10a82d6-4798-4d10-81f3-8e349d59df48" xlink:href="camp-20241231.xsd#camp_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_68d3602c-b792-4706-9de3-6e1ef5fee7f3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_AuditInformationAbstract_c10a82d6-4798-4d10-81f3-8e349d59df48" xlink:to="loc_dei_AuditorName_68d3602c-b792-4706-9de3-6e1ef5fee7f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_57f3bcd6-1949-453f-aa8b-ba6d380a83f7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_AuditInformationAbstract_c10a82d6-4798-4d10-81f3-8e349d59df48" xlink:to="loc_dei_AuditorLocation_57f3bcd6-1949-453f-aa8b-ba6d380a83f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_1f42c0a0-8ab1-469c-b305-bd4fd4d01f4c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_AuditInformationAbstract_c10a82d6-4798-4d10-81f3-8e349d59df48" xlink:to="loc_dei_AuditorFirmId_1f42c0a0-8ab1-469c-b305-bd4fd4d01f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="camp-20241231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_73019a4b-9040-44ad-8a08-0d8d164bb5a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_6b78d2e8-b873-4e43-b368-7de86f7f0379" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_73019a4b-9040-44ad-8a08-0d8d164bb5a4" xlink:to="loc_us-gaap_AssetsAbstract_6b78d2e8-b873-4e43-b368-7de86f7f0379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_80eb8c32-f506-4eb1-98c6-21c5aa38f2e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6b78d2e8-b873-4e43-b368-7de86f7f0379" xlink:to="loc_us-gaap_AssetsCurrentAbstract_80eb8c32-f506-4eb1-98c6-21c5aa38f2e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5f8fca66-f450-429d-ba6f-ab599a0ff858" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_80eb8c32-f506-4eb1-98c6-21c5aa38f2e9" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5f8fca66-f450-429d-ba6f-ab599a0ff858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_08db9174-92d8-4e4f-bd2e-8e342ff6e838" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_80eb8c32-f506-4eb1-98c6-21c5aa38f2e9" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_08db9174-92d8-4e4f-bd2e-8e342ff6e838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_1004bdce-5fc9-4995-9796-cf64c7be1a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_80eb8c32-f506-4eb1-98c6-21c5aa38f2e9" xlink:to="loc_us-gaap_AssetsCurrent_1004bdce-5fc9-4995-9796-cf64c7be1a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_6aed08b7-a178-4c26-8b40-88cfa1546663" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6b78d2e8-b873-4e43-b368-7de86f7f0379" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_6aed08b7-a178-4c26-8b40-88cfa1546663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9fc71ceb-3298-4270-b78e-a5b4f99ab63a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6b78d2e8-b873-4e43-b368-7de86f7f0379" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_9fc71ceb-3298-4270-b78e-a5b4f99ab63a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_64a6f075-8604-4d3e-ace0-e59b70505551" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6b78d2e8-b873-4e43-b368-7de86f7f0379" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_64a6f075-8604-4d3e-ace0-e59b70505551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_b99407fb-64c2-4529-a1e5-fd32f9c9a83c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6b78d2e8-b873-4e43-b368-7de86f7f0379" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_b99407fb-64c2-4529-a1e5-fd32f9c9a83c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_a0557fb2-8e36-411e-8292-82d325e465f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6b78d2e8-b873-4e43-b368-7de86f7f0379" xlink:to="loc_us-gaap_Assets_a0557fb2-8e36-411e-8292-82d325e465f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_60221024-97f4-4389-a4ea-b195b880b3d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_73019a4b-9040-44ad-8a08-0d8d164bb5a4" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_60221024-97f4-4389-a4ea-b195b880b3d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_358a79ed-8a1a-4af9-b526-67b6e4f900ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_60221024-97f4-4389-a4ea-b195b880b3d6" xlink:to="loc_us-gaap_LiabilitiesAbstract_358a79ed-8a1a-4af9-b526-67b6e4f900ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_a0d12a0d-3304-4e60-9be0-9bf44bfa9703" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_358a79ed-8a1a-4af9-b526-67b6e4f900ac" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_a0d12a0d-3304-4e60-9be0-9bf44bfa9703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_b6c3864b-972e-4191-b017-ac1367fdd29b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a0d12a0d-3304-4e60-9be0-9bf44bfa9703" xlink:to="loc_us-gaap_AccountsPayableCurrent_b6c3864b-972e-4191-b017-ac1367fdd29b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_f795a172-34c2-4dc2-b1a6-ad7e15f758ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a0d12a0d-3304-4e60-9be0-9bf44bfa9703" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_f795a172-34c2-4dc2-b1a6-ad7e15f758ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_ddc4d93a-b3a2-4ea2-8c82-74ebe5d6a143" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a0d12a0d-3304-4e60-9be0-9bf44bfa9703" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_ddc4d93a-b3a2-4ea2-8c82-74ebe5d6a143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_f4a05641-4073-479a-bc24-26b2c7372499" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a0d12a0d-3304-4e60-9be0-9bf44bfa9703" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_f4a05641-4073-479a-bc24-26b2c7372499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_6ba26ab8-5b30-4ef4-9273-b4ec624de3f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a0d12a0d-3304-4e60-9be0-9bf44bfa9703" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_6ba26ab8-5b30-4ef4-9273-b4ec624de3f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_FinanceLiabilityCurrent_cf933a0d-292b-4ee3-a48a-72dabe795596" xlink:href="camp-20241231.xsd#camp_FinanceLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a0d12a0d-3304-4e60-9be0-9bf44bfa9703" xlink:to="loc_camp_FinanceLiabilityCurrent_cf933a0d-292b-4ee3-a48a-72dabe795596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_89007cd1-c0c3-4509-8751-9e41d839ed35" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a0d12a0d-3304-4e60-9be0-9bf44bfa9703" xlink:to="loc_us-gaap_LiabilitiesCurrent_89007cd1-c0c3-4509-8751-9e41d839ed35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_c5cea267-7736-482a-97ca-95643866c89d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_358a79ed-8a1a-4af9-b526-67b6e4f900ac" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_c5cea267-7736-482a-97ca-95643866c89d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6057962d-432c-41c9-b991-7827f285f39e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_c5cea267-7736-482a-97ca-95643866c89d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6057962d-432c-41c9-b991-7827f285f39e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_343d33a1-dc34-4349-867b-8dacd14d14e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_c5cea267-7736-482a-97ca-95643866c89d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_343d33a1-dc34-4349-867b-8dacd14d14e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_FinanceLiabilityNonCurrent_99fc298e-6482-4d68-9051-3c7d4ed3e7c4" xlink:href="camp-20241231.xsd#camp_FinanceLiabilityNonCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_c5cea267-7736-482a-97ca-95643866c89d" xlink:to="loc_camp_FinanceLiabilityNonCurrent_99fc298e-6482-4d68-9051-3c7d4ed3e7c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_bf432e8b-bfce-41b9-9da5-bd617a792c54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_c5cea267-7736-482a-97ca-95643866c89d" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_bf432e8b-bfce-41b9-9da5-bd617a792c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_64d6a97d-1030-4849-b4b7-f0447fb29b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_c5cea267-7736-482a-97ca-95643866c89d" xlink:to="loc_us-gaap_Liabilities_64d6a97d-1030-4849-b4b7-f0447fb29b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_587c5d43-6c3a-4623-8b56-3150ba343688" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_358a79ed-8a1a-4af9-b526-67b6e4f900ac" xlink:to="loc_us-gaap_CommitmentsAndContingencies_587c5d43-6c3a-4623-8b56-3150ba343688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_102fd8f1-4fbf-4046-a279-0cc82a12f040" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_60221024-97f4-4389-a4ea-b195b880b3d6" xlink:to="loc_us-gaap_EquityAbstract_102fd8f1-4fbf-4046-a279-0cc82a12f040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_818f0545-563d-4c25-97e6-2eb2f24680d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_102fd8f1-4fbf-4046-a279-0cc82a12f040" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_818f0545-563d-4c25-97e6-2eb2f24680d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_894af2e9-3575-453b-9625-c567d0537ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_102fd8f1-4fbf-4046-a279-0cc82a12f040" xlink:to="loc_us-gaap_StockholdersEquityAbstract_894af2e9-3575-453b-9625-c567d0537ea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_c3b1637f-55f5-4233-ac48-ba3f8e6a28ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_894af2e9-3575-453b-9625-c567d0537ea8" xlink:to="loc_us-gaap_CommonStockValue_c3b1637f-55f5-4233-ac48-ba3f8e6a28ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_596d125c-8a0a-42b2-85d7-0e55acc8888b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_894af2e9-3575-453b-9625-c567d0537ea8" xlink:to="loc_us-gaap_AdditionalPaidInCapital_596d125c-8a0a-42b2-85d7-0e55acc8888b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2c3e400c-6291-4d96-ad82-7a461dbc18de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_894af2e9-3575-453b-9625-c567d0537ea8" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2c3e400c-6291-4d96-ad82-7a461dbc18de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b83bbbb4-a06d-44ff-a4b7-68597d8be3ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_894af2e9-3575-453b-9625-c567d0537ea8" xlink:to="loc_us-gaap_StockholdersEquity_b83bbbb4-a06d-44ff-a4b7-68597d8be3ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_01f88ff7-5015-4513-b743-a26b98e13a28" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_60221024-97f4-4389-a4ea-b195b880b3d6" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_01f88ff7-5015-4513-b743-a26b98e13a28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="camp-20241231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_92ac2e22-2dba-4a72-9047-1be01d6de4a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_ad65dd49-380d-4433-9ab0-76c795f42e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_92ac2e22-2dba-4a72-9047-1be01d6de4a0" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_ad65dd49-380d-4433-9ab0-76c795f42e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_f06e6432-efc1-4f59-ad15-6d3d0541390b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_92ac2e22-2dba-4a72-9047-1be01d6de4a0" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_f06e6432-efc1-4f59-ad15-6d3d0541390b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_eb1d29ff-9870-4d51-8dab-9b70d3c0aec0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_92ac2e22-2dba-4a72-9047-1be01d6de4a0" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_eb1d29ff-9870-4d51-8dab-9b70d3c0aec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_3c1cf409-28f7-4218-bc1a-d5286ab8e001" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_92ac2e22-2dba-4a72-9047-1be01d6de4a0" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_3c1cf409-28f7-4218-bc1a-d5286ab8e001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLiquidationPreference_13020058-b7f7-4134-b5f7-31f6d914d90c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_92ac2e22-2dba-4a72-9047-1be01d6de4a0" xlink:to="loc_us-gaap_TemporaryEquityLiquidationPreference_13020058-b7f7-4134-b5f7-31f6d914d90c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_3749f8ed-637d-45c6-b5fd-f4f75c5d17b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_92ac2e22-2dba-4a72-9047-1be01d6de4a0" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_3749f8ed-637d-45c6-b5fd-f4f75c5d17b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_941eec9c-149c-47ce-bd21-c7e6dac649fa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_92ac2e22-2dba-4a72-9047-1be01d6de4a0" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_941eec9c-149c-47ce-bd21-c7e6dac649fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_56289464-3240-4e8c-856d-fbc020669979" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_92ac2e22-2dba-4a72-9047-1be01d6de4a0" xlink:to="loc_us-gaap_CommonStockSharesIssued_56289464-3240-4e8c-856d-fbc020669979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_5d0de9d7-522c-497e-a78c-233a13cdbe15" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_92ac2e22-2dba-4a72-9047-1be01d6de4a0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_5d0de9d7-522c-497e-a78c-233a13cdbe15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="camp-20241231.xsd#ConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_98401b10-bc62-469a-9c17-6bb5a3187112" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_c6e680a1-40c2-460a-9601-5ee8c0fc33c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_98401b10-bc62-469a-9c17-6bb5a3187112" xlink:to="loc_us-gaap_RevenuesAbstract_c6e680a1-40c2-460a-9601-5ee8c0fc33c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_4f722539-2e56-4e4b-a630-c7ea4a4aa2ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_c6e680a1-40c2-460a-9601-5ee8c0fc33c6" xlink:to="loc_us-gaap_Revenues_4f722539-2e56-4e4b-a630-c7ea4a4aa2ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_406b1da2-4971-4cbc-9b50-77412846d714" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_98401b10-bc62-469a-9c17-6bb5a3187112" xlink:to="loc_us-gaap_OperatingExpensesAbstract_406b1da2-4971-4cbc-9b50-77412846d714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_8b0b6131-c76f-4092-9db1-76460f7f1ff5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_406b1da2-4971-4cbc-9b50-77412846d714" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_8b0b6131-c76f-4092-9db1-76460f7f1ff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_2f58ed6b-fd98-40af-a06c-9ad2f3cda834" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_406b1da2-4971-4cbc-9b50-77412846d714" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_2f58ed6b-fd98-40af-a06c-9ad2f3cda834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_4bd88f18-ea8c-4113-bda4-9339bbe0fc47" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_406b1da2-4971-4cbc-9b50-77412846d714" xlink:to="loc_us-gaap_OperatingExpenses_4bd88f18-ea8c-4113-bda4-9339bbe0fc47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_570fac78-a6e3-4b00-b66d-6408b82fa24b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_98401b10-bc62-469a-9c17-6bb5a3187112" xlink:to="loc_us-gaap_OperatingIncomeLoss_570fac78-a6e3-4b00-b66d-6408b82fa24b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_27dba0cd-ef7e-4b7a-8a26-9c8b2ca34f14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_98401b10-bc62-469a-9c17-6bb5a3187112" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_27dba0cd-ef7e-4b7a-8a26-9c8b2ca34f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_a0034278-caf2-4414-ad5c-d862c69eaab5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_27dba0cd-ef7e-4b7a-8a26-9c8b2ca34f14" xlink:to="loc_us-gaap_InvestmentIncomeInterest_a0034278-caf2-4414-ad5c-d862c69eaab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingExpense_5741c891-7893-41d8-91ea-8cffb154ce17" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_27dba0cd-ef7e-4b7a-8a26-9c8b2ca34f14" xlink:to="loc_us-gaap_OtherNonoperatingExpense_5741c891-7893-41d8-91ea-8cffb154ce17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_ba68f43f-25b0-4094-8f7e-00efcd510d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_27dba0cd-ef7e-4b7a-8a26-9c8b2ca34f14" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_ba68f43f-25b0-4094-8f7e-00efcd510d1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_16406b50-0fe4-4171-86ec-01392a2e1fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_98401b10-bc62-469a-9c17-6bb5a3187112" xlink:to="loc_us-gaap_NetIncomeLoss_16406b50-0fe4-4171-86ec-01392a2e1fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_f53fd541-a2ef-4439-953f-a2237409b54d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_98401b10-bc62-469a-9c17-6bb5a3187112" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_f53fd541-a2ef-4439-953f-a2237409b54d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_45a89f2c-d102-4ef3-999c-4ace48a09d22" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_98401b10-bc62-469a-9c17-6bb5a3187112" xlink:to="loc_us-gaap_EarningsPerShareBasic_45a89f2c-d102-4ef3-999c-4ace48a09d22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_a3041b22-502b-49c0-a604-2a954d4abc6f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_98401b10-bc62-469a-9c17-6bb5a3187112" xlink:to="loc_us-gaap_EarningsPerShareDiluted_a3041b22-502b-49c0-a604-2a954d4abc6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cab4c129-46ef-4b09-9f59-d51d26874199" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_98401b10-bc62-469a-9c17-6bb5a3187112" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cab4c129-46ef-4b09-9f59-d51d26874199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_88669cbb-9f19-43b5-b930-a350ce8685c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_98401b10-bc62-469a-9c17-6bb5a3187112" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_88669cbb-9f19-43b5-b930-a350ce8685c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit" xlink:type="simple" xlink:href="camp-20241231.xsd#ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_104b461f-9d49-44b1-917e-2e25575567d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f3be4b44-32c9-442d-b02f-bd28b3e446a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_104b461f-9d49-44b1-917e-2e25575567d1" xlink:to="loc_us-gaap_StatementTable_f3be4b44-32c9-442d-b02f-bd28b3e446a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3a5021d1-ed12-4031-b35d-bc132bdd2302" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f3be4b44-32c9-442d-b02f-bd28b3e446a9" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3a5021d1-ed12-4031-b35d-bc132bdd2302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1d5f4b03-fbf3-4cbb-8061-afe361dd9d60" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3a5021d1-ed12-4031-b35d-bc132bdd2302" xlink:to="loc_us-gaap_EquityComponentDomain_1d5f4b03-fbf3-4cbb-8061-afe361dd9d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_6f05c5a4-4ca7-4407-b5e7-fb7c21ca9a66" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1d5f4b03-fbf3-4cbb-8061-afe361dd9d60" xlink:to="loc_us-gaap_CommonStockMember_6f05c5a4-4ca7-4407-b5e7-fb7c21ca9a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_2e29e167-668b-4c68-88d7-88526111dffa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1d5f4b03-fbf3-4cbb-8061-afe361dd9d60" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_2e29e167-668b-4c68-88d7-88526111dffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_07d1ed47-41f5-4ea5-a839-618d468d70c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1d5f4b03-fbf3-4cbb-8061-afe361dd9d60" xlink:to="loc_us-gaap_RetainedEarningsMember_07d1ed47-41f5-4ea5-a839-618d468d70c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_b55961ba-4dfe-4620-a202-cfa4e8c7afbb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f3be4b44-32c9-442d-b02f-bd28b3e446a9" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_b55961ba-4dfe-4620-a202-cfa4e8c7afbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c673bcc0-523d-4f71-bdc5-135cb2520bee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_b55961ba-4dfe-4620-a202-cfa4e8c7afbb" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c673bcc0-523d-4f71-bdc5-135cb2520bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_7dfe285d-9bce-4931-b7b2-613d1ccc4cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c673bcc0-523d-4f71-bdc5-135cb2520bee" xlink:to="loc_us-gaap_IPOMember_7dfe285d-9bce-4931-b7b2-613d1ccc4cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2308cbd9-1ff0-4435-8484-209650d6802a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f3be4b44-32c9-442d-b02f-bd28b3e446a9" xlink:to="loc_us-gaap_StatementLineItems_2308cbd9-1ff0-4435-8484-209650d6802a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ed78165f-7210-4fd5-b97a-4966116ec152" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2308cbd9-1ff0-4435-8484-209650d6802a" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ed78165f-7210-4fd5-b97a-4966116ec152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_b7c0dd96-c780-4c6f-919f-466538756f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ed78165f-7210-4fd5-b97a-4966116ec152" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_b7c0dd96-c780-4c6f-919f-466538756f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_e4bb0e24-9034-487c-bcbd-dfbb3c04e79e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ed78165f-7210-4fd5-b97a-4966116ec152" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_e4bb0e24-9034-487c-bcbd-dfbb3c04e79e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_TemporaryEquitySharesConversionOfConvertibleSecurities_cb363abb-d2e5-45b0-a0ce-d0dc6296360a" xlink:href="camp-20241231.xsd#camp_TemporaryEquitySharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ed78165f-7210-4fd5-b97a-4966116ec152" xlink:to="loc_camp_TemporaryEquitySharesConversionOfConvertibleSecurities_cb363abb-d2e5-45b0-a0ce-d0dc6296360a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_TemporaryEquityValueConversionOfConvertibleSecurities_6d61dd69-0c1a-4dc1-9b2f-fd69a45605a4" xlink:href="camp-20241231.xsd#camp_TemporaryEquityValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ed78165f-7210-4fd5-b97a-4966116ec152" xlink:to="loc_camp_TemporaryEquityValueConversionOfConvertibleSecurities_6d61dd69-0c1a-4dc1-9b2f-fd69a45605a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_c164236d-a8a4-4f0f-ace5-617aad969d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ed78165f-7210-4fd5-b97a-4966116ec152" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_c164236d-a8a4-4f0f-ace5-617aad969d6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_9dfc8414-6495-4344-b28b-6d68e5111df5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ed78165f-7210-4fd5-b97a-4966116ec152" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_9dfc8414-6495-4344-b28b-6d68e5111df5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e320cd0e-b5e6-462f-a7da-5df6548994de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2308cbd9-1ff0-4435-8484-209650d6802a" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e320cd0e-b5e6-462f-a7da-5df6548994de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_70fbab80-8feb-4c2f-9f75-304f1092e166" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e320cd0e-b5e6-462f-a7da-5df6548994de" xlink:to="loc_us-gaap_CommonStockSharesIssued_70fbab80-8feb-4c2f-9f75-304f1092e166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_35dabe4e-4a38-4569-bd99-04ee42ad4a42" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e320cd0e-b5e6-462f-a7da-5df6548994de" xlink:to="loc_us-gaap_StockholdersEquity_35dabe4e-4a38-4569-bd99-04ee42ad4a42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_648b285e-8cf7-4560-a35b-6d3977d7be74" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e320cd0e-b5e6-462f-a7da-5df6548994de" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_648b285e-8cf7-4560-a35b-6d3977d7be74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_501c6bb7-219c-4c0b-906a-d1c461d662db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e320cd0e-b5e6-462f-a7da-5df6548994de" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_501c6bb7-219c-4c0b-906a-d1c461d662db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_12740bd0-8f52-47d8-8e77-94e42240bc82" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e320cd0e-b5e6-462f-a7da-5df6548994de" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_12740bd0-8f52-47d8-8e77-94e42240bc82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c1791937-2e93-4e37-b2cb-4264cfc76f80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e320cd0e-b5e6-462f-a7da-5df6548994de" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c1791937-2e93-4e37-b2cb-4264cfc76f80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_cf6088ea-7da7-4f03-8717-bc0804e867c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e320cd0e-b5e6-462f-a7da-5df6548994de" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_cf6088ea-7da7-4f03-8717-bc0804e867c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_595e447e-016a-4670-a21d-44458330e493" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e320cd0e-b5e6-462f-a7da-5df6548994de" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_595e447e-016a-4670-a21d-44458330e493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b378a28d-7751-4610-b7ee-de5c26183d23" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e320cd0e-b5e6-462f-a7da-5df6548994de" xlink:to="loc_us-gaap_NetIncomeLoss_b378a28d-7751-4610-b7ee-de5c26183d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_4b5dc68a-978f-4310-b753-8bade73c77f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e320cd0e-b5e6-462f-a7da-5df6548994de" xlink:to="loc_us-gaap_CommonStockSharesIssued_4b5dc68a-978f-4310-b753-8bade73c77f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_16776e1a-f9dc-4fd6-b383-00b33454aa04" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e320cd0e-b5e6-462f-a7da-5df6548994de" xlink:to="loc_us-gaap_StockholdersEquity_16776e1a-f9dc-4fd6-b383-00b33454aa04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficitParenthetical" xlink:type="simple" xlink:href="camp-20241231.xsd#ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficitParenthetical"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficitParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_0aaae8c2-8bcd-49c3-9935-f6f72d2c096e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_d302f37d-0dae-4f85-acbb-47f1e848f44b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_0aaae8c2-8bcd-49c3-9935-f6f72d2c096e" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_d302f37d-0dae-4f85-acbb-47f1e848f44b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="camp-20241231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_07a39b86-0968-4cfe-9729-0189998719bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e5f99561-c436-4920-a568-7ef9a577c21e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_07a39b86-0968-4cfe-9729-0189998719bb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e5f99561-c436-4920-a568-7ef9a577c21e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5b353a4f-7f9e-4e2b-9653-163269c7ef71" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e5f99561-c436-4920-a568-7ef9a577c21e" xlink:to="loc_us-gaap_NetIncomeLoss_5b353a4f-7f9e-4e2b-9653-163269c7ef71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6e81e546-800f-4359-8040-7b30e0e52aab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e5f99561-c436-4920-a568-7ef9a577c21e" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6e81e546-800f-4359-8040-7b30e0e52aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_e2f30e98-f597-4ee1-9560-def3805be584" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6e81e546-800f-4359-8040-7b30e0e52aab" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_e2f30e98-f597-4ee1-9560-def3805be584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_473785d4-90ce-412b-850a-61380237a4e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6e81e546-800f-4359-8040-7b30e0e52aab" xlink:to="loc_us-gaap_ShareBasedCompensation_473785d4-90ce-412b-850a-61380237a4e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_NoncashLeaseExpense_a5805917-ebf4-4f77-9123-61a68a22a8f5" xlink:href="camp-20241231.xsd#camp_NoncashLeaseExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6e81e546-800f-4359-8040-7b30e0e52aab" xlink:to="loc_camp_NoncashLeaseExpense_a5805917-ebf4-4f77-9123-61a68a22a8f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaidInKindInterest_a95249dd-480e-41d9-b06d-56b2bd60ebff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaidInKindInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6e81e546-800f-4359-8040-7b30e0e52aab" xlink:to="loc_us-gaap_PaidInKindInterest_a95249dd-480e-41d9-b06d-56b2bd60ebff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_06f4ee34-7f88-4382-9f50-8e32777c9003" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6e81e546-800f-4359-8040-7b30e0e52aab" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_06f4ee34-7f88-4382-9f50-8e32777c9003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e6e96146-d25b-4399-9fa4-69458a06fab4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_06f4ee34-7f88-4382-9f50-8e32777c9003" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e6e96146-d25b-4399-9fa4-69458a06fab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_7bf39020-d30b-4e11-a7f2-b69ed6510885" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_06f4ee34-7f88-4382-9f50-8e32777c9003" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_7bf39020-d30b-4e11-a7f2-b69ed6510885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_e3d50db7-8bdb-4526-973a-bc9146721c99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_06f4ee34-7f88-4382-9f50-8e32777c9003" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_e3d50db7-8bdb-4526-973a-bc9146721c99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_IncreaseDecreaseInOperatingLeaseAssetsLiabilities_4fff46e7-bc7c-4a6b-be75-efa5ce9afbc6" xlink:href="camp-20241231.xsd#camp_IncreaseDecreaseInOperatingLeaseAssetsLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_06f4ee34-7f88-4382-9f50-8e32777c9003" xlink:to="loc_camp_IncreaseDecreaseInOperatingLeaseAssetsLiabilities_4fff46e7-bc7c-4a6b-be75-efa5ce9afbc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_00f18fe2-f05c-45b7-85a5-1e9114ef2e47" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_06f4ee34-7f88-4382-9f50-8e32777c9003" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_00f18fe2-f05c-45b7-85a5-1e9114ef2e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f33d893f-2799-4c55-9328-663e8237a784" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e5f99561-c436-4920-a568-7ef9a577c21e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f33d893f-2799-4c55-9328-663e8237a784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7779a0ec-2ead-4c0c-a6ca-fea388d7edd1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_07a39b86-0968-4cfe-9729-0189998719bb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7779a0ec-2ead-4c0c-a6ca-fea388d7edd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_01569986-c926-4745-a1f7-46ff1ba3d414" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7779a0ec-2ead-4c0c-a6ca-fea388d7edd1" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_01569986-c926-4745-a1f7-46ff1ba3d414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f2f44474-7ac3-4c7a-8c2d-f4dc91b45228" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7779a0ec-2ead-4c0c-a6ca-fea388d7edd1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f2f44474-7ac3-4c7a-8c2d-f4dc91b45228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_825a2cb6-f130-4926-a33c-5476df8f1da6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_07a39b86-0968-4cfe-9729-0189998719bb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_825a2cb6-f130-4926-a33c-5476df8f1da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_8ec5dd42-8ad9-4dfb-b5ae-0ea29833e06a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_825a2cb6-f130-4926-a33c-5476df8f1da6" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_8ec5dd42-8ad9-4dfb-b5ae-0ea29833e06a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_ffd83690-e7e0-4ea8-b61c-485a2836d005" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_825a2cb6-f130-4926-a33c-5476df8f1da6" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_ffd83690-e7e0-4ea8-b61c-485a2836d005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction_32659876-e599-4f1d-95a2-9ed9c8988abb" xlink:href="camp-20241231.xsd#camp_ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_825a2cb6-f130-4926-a33c-5476df8f1da6" xlink:to="loc_camp_ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction_32659876-e599-4f1d-95a2-9ed9c8988abb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_PrincipalPaymentsOnFinancingObligationsFailedSaleLeasebackTransaction_b5277f6b-54c0-476a-8f0b-a5e0d6a20b2c" xlink:href="camp-20241231.xsd#camp_PrincipalPaymentsOnFinancingObligationsFailedSaleLeasebackTransaction"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_825a2cb6-f130-4926-a33c-5476df8f1da6" xlink:to="loc_camp_PrincipalPaymentsOnFinancingObligationsFailedSaleLeasebackTransaction_b5277f6b-54c0-476a-8f0b-a5e0d6a20b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_bd0adce5-0518-4b5a-82c3-e8c9ccdd9601" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_825a2cb6-f130-4926-a33c-5476df8f1da6" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_bd0adce5-0518-4b5a-82c3-e8c9ccdd9601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_acad724c-b1d2-44a3-8f0e-626faabaee63" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_825a2cb6-f130-4926-a33c-5476df8f1da6" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_acad724c-b1d2-44a3-8f0e-626faabaee63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_47a14377-79d4-403e-9607-701f446c88a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_825a2cb6-f130-4926-a33c-5476df8f1da6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_47a14377-79d4-403e-9607-701f446c88a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_52432981-8fd4-40fd-8b73-3f14129718dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_07a39b86-0968-4cfe-9729-0189998719bb" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_52432981-8fd4-40fd-8b73-3f14129718dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_45d8f289-3a3d-4f3e-b7e9-bd61650195a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_07a39b86-0968-4cfe-9729-0189998719bb" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_45d8f289-3a3d-4f3e-b7e9-bd61650195a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8818a496-327f-4dcc-9f62-5071a93a8f34" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_07a39b86-0968-4cfe-9729-0189998719bb" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8818a496-327f-4dcc-9f62-5071a93a8f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_a88d1e38-ef68-48f0-b853-be689f6956b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_07a39b86-0968-4cfe-9729-0189998719bb" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_a88d1e38-ef68-48f0-b853-be689f6956b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_df063553-f172-463a-b1f8-e95aea2611e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_a88d1e38-ef68-48f0-b853-be689f6956b3" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_df063553-f172-463a-b1f8-e95aea2611e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_82b96e92-3617-49a4-a943-4b468a88b4f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_a88d1e38-ef68-48f0-b853-be689f6956b3" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_82b96e92-3617-49a4-a943-4b468a88b4f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_ab155070-19e4-47b4-ab43-f76b5fb8641a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_a88d1e38-ef68-48f0-b853-be689f6956b3" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_ab155070-19e4-47b4-ab43-f76b5fb8641a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1_a691d931-4e68-4a8c-97d3-ef90243ea02f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_a88d1e38-ef68-48f0-b853-be689f6956b3" xlink:to="loc_us-gaap_ConversionOfStockAmountConverted1_a691d931-4e68-4a8c-97d3-ef90243ea02f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_FinanceLeaseRightOfUseAssetConvertedToFixedAsset_5c8a6b47-247c-455c-a32d-6ba124b4694b" xlink:href="camp-20241231.xsd#camp_FinanceLeaseRightOfUseAssetConvertedToFixedAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_a88d1e38-ef68-48f0-b853-be689f6956b3" xlink:to="loc_camp_FinanceLeaseRightOfUseAssetConvertedToFixedAsset_5c8a6b47-247c-455c-a32d-6ba124b4694b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentation" xlink:type="simple" xlink:href="camp-20241231.xsd#DescriptionofBusinessandBasisofPresentation"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f8de4ee9-437b-4851-833e-4420778d8629" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_3ee13021-9d3f-4e7d-87a4-75cc4113e19a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f8de4ee9-437b-4851-833e-4420778d8629" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_3ee13021-9d3f-4e7d-87a4-75cc4113e19a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="camp-20241231.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_207a4ef4-2552-4520-8429-da3b37f8d4e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_69932080-b131-491b-9623-664232ffac99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_207a4ef4-2552-4520-8429-da3b37f8d4e2" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_69932080-b131-491b-9623-664232ffac99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="camp-20241231.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_fc4adfdf-759d-4d0f-a5bb-31e75ca17c21" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_41ce6600-9730-4795-a970-f1183fae5ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_fc4adfdf-759d-4d0f-a5bb-31e75ca17c21" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_41ce6600-9730-4795-a970-f1183fae5ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssets" xlink:type="simple" xlink:href="camp-20241231.xsd#PrepaidExpensesAndOtherCurrentAssets"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_116f0974-9e38-496e-9014-089b88cee3ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_PrepaidExpensesAndOtherCurrentAssetsDisclosureTextBlock_975e9761-3a65-4e34-a732-3e3949713b3e" xlink:href="camp-20241231.xsd#camp_PrepaidExpensesAndOtherCurrentAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_116f0974-9e38-496e-9014-089b88cee3ba" xlink:to="loc_camp_PrepaidExpensesAndOtherCurrentAssetsDisclosureTextBlock_975e9761-3a65-4e34-a732-3e3949713b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/PropertyAndEquipmentNet" xlink:type="simple" xlink:href="camp-20241231.xsd#PropertyAndEquipmentNet"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/PropertyAndEquipmentNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_819671c5-b46f-4273-95b3-00334f0f6893" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_24954d5c-d361-4543-bf2b-03079269a3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_819671c5-b46f-4273-95b3-00334f0f6893" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_24954d5c-d361-4543-bf2b-03079269a3c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/AccruedExpensesandOtherCurrentLiabilities" xlink:type="simple" xlink:href="camp-20241231.xsd#AccruedExpensesandOtherCurrentLiabilities"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/AccruedExpensesandOtherCurrentLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_dc9b5550-eebc-4005-b5b6-e1392f8c3162" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_add0f23c-9d13-4c9a-b4fb-f0c2571f5751" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_dc9b5550-eebc-4005-b5b6-e1392f8c3162" xlink:to="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_add0f23c-9d13-4c9a-b4fb-f0c2571f5751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="camp-20241231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f8b9a239-1f36-44aa-8cf8-4904596bd613" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_5f019067-572d-4bc3-9fdc-4550bf2dea86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f8b9a239-1f36-44aa-8cf8-4904596bd613" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_5f019067-572d-4bc3-9fdc-4550bf2dea86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/CollaborationandLicenseAgreements" xlink:type="simple" xlink:href="camp-20241231.xsd#CollaborationandLicenseAgreements"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/CollaborationandLicenseAgreements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_camp_CollaborationAndLicenseAgreementsAbstract_8cc75fe7-63c2-4871-a242-e292cad5550d" xlink:href="camp-20241231.xsd#camp_CollaborationAndLicenseAgreementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_34c47fe6-b1ad-4290-914e-aecd475d6903" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_CollaborationAndLicenseAgreementsAbstract_8cc75fe7-63c2-4871-a242-e292cad5550d" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_34c47fe6-b1ad-4290-914e-aecd475d6903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficit" xlink:type="simple" xlink:href="camp-20241231.xsd#ConvertiblePreferredStockandStockholdersDeficit"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_camp_ConvertiblePreferredStockAndStockholdersDeficitAbstract_583a58b8-23ce-4631-8102-0841350fe55d" xlink:href="camp-20241231.xsd#camp_ConvertiblePreferredStockAndStockholdersDeficitAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_TemporaryEquityDisclosureAndStockholdersEquityTextBlock_85138310-9b19-4d7e-a20d-528853ac30ea" xlink:href="camp-20241231.xsd#camp_TemporaryEquityDisclosureAndStockholdersEquityTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_ConvertiblePreferredStockAndStockholdersDeficitAbstract_583a58b8-23ce-4631-8102-0841350fe55d" xlink:to="loc_camp_TemporaryEquityDisclosureAndStockholdersEquityTextBlock_85138310-9b19-4d7e-a20d-528853ac30ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="camp-20241231.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9c043f8c-694f-478c-8bab-929dac6f551b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_325df728-c0ce-49f7-8b04-4632ca068a21" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9c043f8c-694f-478c-8bab-929dac6f551b" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_325df728-c0ce-49f7-8b04-4632ca068a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/EmployeeBenefitPlan" xlink:type="simple" xlink:href="camp-20241231.xsd#EmployeeBenefitPlan"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/EmployeeBenefitPlan" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanAbstract_9a0502da-f956-4191-bd63-2a1e1da0c359" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanTextBlock_84676d97-4a92-42ad-9fc6-3b0ab3e1ab89" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPlanAbstract_9a0502da-f956-4191-bd63-2a1e1da0c359" xlink:to="loc_us-gaap_DefinedContributionPlanTextBlock_84676d97-4a92-42ad-9fc6-3b0ab3e1ab89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/IncomeTaxes" xlink:type="simple" xlink:href="camp-20241231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6d95dd94-498f-4084-8b6c-ff631086c4e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_41ac05d8-af70-40e5-a862-c7f106ab6d99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6d95dd94-498f-4084-8b6c-ff631086c4e6" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_41ac05d8-af70-40e5-a862-c7f106ab6d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/SegmentReporting" xlink:type="simple" xlink:href="camp-20241231.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_1685ddae-01bf-49eb-8129-8d9adabe3c90" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_f7e14cdf-625b-474a-a5ab-a58609a01c67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_1685ddae-01bf-49eb-8129-8d9adabe3c90" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_f7e14cdf-625b-474a-a5ab-a58609a01c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholders" xlink:type="simple" xlink:href="camp-20241231.xsd#NetLossPerShareAttributabletoCommonStockholders"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholders" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_04b73ec1-44a9-4ff7-b9d1-da84e359f9eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_b474fcbe-7c50-4a6e-8729-342446269cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_04b73ec1-44a9-4ff7-b9d1-da84e359f9eb" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_b474fcbe-7c50-4a6e-8729-342446269cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/RelatedParties" xlink:type="simple" xlink:href="camp-20241231.xsd#RelatedParties"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/RelatedParties" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_3bf57727-e985-4098-ba3a-356b27e11aad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_86d31202-ba3f-417f-bc9f-c73c86d550c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_3bf57727-e985-4098-ba3a-356b27e11aad" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_86d31202-ba3f-417f-bc9f-c73c86d550c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="camp-20241231.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d9d0d162-c47a-434b-a75d-1830006c9784" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_2772e264-6aed-47d1-b8c2-d39001403700" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9d0d162-c47a-434b-a75d-1830006c9784" xlink:to="loc_us-gaap_UseOfEstimates_2772e264-6aed-47d1-b8c2-d39001403700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_4ddab1c2-0259-401d-8897-263858c4f88c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9d0d162-c47a-434b-a75d-1830006c9784" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_4ddab1c2-0259-401d-8897-263858c4f88c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_83f9005e-a32d-44a2-9afb-40e50aa01e85" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9d0d162-c47a-434b-a75d-1830006c9784" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_83f9005e-a32d-44a2-9afb-40e50aa01e85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_5fac5d33-35aa-49aa-aa0d-083789a05898" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9d0d162-c47a-434b-a75d-1830006c9784" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_5fac5d33-35aa-49aa-aa0d-083789a05898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_344815ae-bc04-4f9d-9b2f-7646e6a02a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9d0d162-c47a-434b-a75d-1830006c9784" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_344815ae-bc04-4f9d-9b2f-7646e6a02a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_af4b44b9-2dfc-410b-8dd8-1517209319b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9d0d162-c47a-434b-a75d-1830006c9784" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_af4b44b9-2dfc-410b-8dd8-1517209319b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_048094ce-4f1d-416f-93d6-c0fac70c6b65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9d0d162-c47a-434b-a75d-1830006c9784" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_048094ce-4f1d-416f-93d6-c0fac70c6b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_710f59c3-7628-45f4-8622-6ad7893629a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9d0d162-c47a-434b-a75d-1830006c9784" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_710f59c3-7628-45f4-8622-6ad7893629a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_224185ab-3b6a-42bc-9f8b-e50c373b62ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9d0d162-c47a-434b-a75d-1830006c9784" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_224185ab-3b6a-42bc-9f8b-e50c373b62ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_e477e87b-ba87-4df9-b04f-a4636c920c37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9d0d162-c47a-434b-a75d-1830006c9784" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_e477e87b-ba87-4df9-b04f-a4636c920c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_GuaranteesAndIndemnificationsPolicyTextBlock_d197e084-caa3-4b8f-a590-725cb92f836d" xlink:href="camp-20241231.xsd#camp_GuaranteesAndIndemnificationsPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9d0d162-c47a-434b-a75d-1830006c9784" xlink:to="loc_camp_GuaranteesAndIndemnificationsPolicyTextBlock_d197e084-caa3-4b8f-a590-725cb92f836d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_f9916154-bf42-42a8-bca7-0ff762bcb070" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9d0d162-c47a-434b-a75d-1830006c9784" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_f9916154-bf42-42a8-bca7-0ff762bcb070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_FinancingObligationFailedSaleLeasebackPolicyTextBlock_461c5917-d434-4520-93cf-b1984f87da18" xlink:href="camp-20241231.xsd#camp_FinancingObligationFailedSaleLeasebackPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9d0d162-c47a-434b-a75d-1830006c9784" xlink:to="loc_camp_FinancingObligationFailedSaleLeasebackPolicyTextBlock_461c5917-d434-4520-93cf-b1984f87da18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_805a98f7-96e6-432e-b2f0-e15944955732" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9d0d162-c47a-434b-a75d-1830006c9784" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_805a98f7-96e6-432e-b2f0-e15944955732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_4111cc1e-845f-44b7-9ac0-b868520548dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9d0d162-c47a-434b-a75d-1830006c9784" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_4111cc1e-845f-44b7-9ac0-b868520548dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_105a256f-872d-49a6-adff-b2b2c6ad4724" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9d0d162-c47a-434b-a75d-1830006c9784" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_105a256f-872d-49a6-adff-b2b2c6ad4724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_PatentCostsPolicyTextBlock_e6c520be-fe85-48be-85eb-e59d0aa3a2c4" xlink:href="camp-20241231.xsd#camp_PatentCostsPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9d0d162-c47a-434b-a75d-1830006c9784" xlink:to="loc_camp_PatentCostsPolicyTextBlock_e6c520be-fe85-48be-85eb-e59d0aa3a2c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_OfferingCostsPolicyTextBlock_3d86076c-4bd4-4b64-b5b5-f54b07b7b85e" xlink:href="camp-20241231.xsd#camp_OfferingCostsPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9d0d162-c47a-434b-a75d-1830006c9784" xlink:to="loc_camp_OfferingCostsPolicyTextBlock_3d86076c-4bd4-4b64-b5b5-f54b07b7b85e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_044d8401-df87-44f7-81ab-f74d04a28a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9d0d162-c47a-434b-a75d-1830006c9784" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_044d8401-df87-44f7-81ab-f74d04a28a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_703ae8e7-e542-4f80-bc27-e255e61a2e55" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9d0d162-c47a-434b-a75d-1830006c9784" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_703ae8e7-e542-4f80-bc27-e255e61a2e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy_b335b1f7-3498-416e-965d-b8ae1d30f697" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9d0d162-c47a-434b-a75d-1830006c9784" xlink:to="loc_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy_b335b1f7-3498-416e-965d-b8ae1d30f697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_4a476838-cfa0-4d9d-a341-9514b3fe8822" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9d0d162-c47a-434b-a75d-1830006c9784" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_4a476838-cfa0-4d9d-a341-9514b3fe8822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_EmergingGrowthCompanyStatusPolicyTextBlock_29c53372-b344-4e3d-90a1-7675d8a70f5f" xlink:href="camp-20241231.xsd#camp_EmergingGrowthCompanyStatusPolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9d0d162-c47a-434b-a75d-1830006c9784" xlink:to="loc_camp_EmergingGrowthCompanyStatusPolicyTextBlock_29c53372-b344-4e3d-90a1-7675d8a70f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_19cf1b0b-42f0-4183-b615-c2ce42d9c3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9d0d162-c47a-434b-a75d-1830006c9784" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_19cf1b0b-42f0-4183-b615-c2ce42d9c3f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="camp-20241231.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f8b76a20-a417-490b-808f-305fbda9efb0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_eb0ef990-efad-4b11-936f-c9af3e7974bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f8b76a20-a417-490b-808f-305fbda9efb0" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_eb0ef990-efad-4b11-936f-c9af3e7974bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_c887104d-3d03-4f04-b0c6-ecaffb04c230" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f8b76a20-a417-490b-808f-305fbda9efb0" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_c887104d-3d03-4f04-b0c6-ecaffb04c230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock_9f68c319-52b9-4aa4-b9ea-561fc61f4e26" xlink:href="camp-20241231.xsd#camp_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f8b76a20-a417-490b-808f-305fbda9efb0" xlink:to="loc_camp_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock_9f68c319-52b9-4aa4-b9ea-561fc61f4e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="camp-20241231.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_364ad1d6-5e78-42db-8bf0-951125448c7b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_7bb1f180-3b19-48b5-9769-56f336eef9bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_364ad1d6-5e78-42db-8bf0-951125448c7b" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_7bb1f180-3b19-48b5-9769-56f336eef9bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssetsTables" xlink:type="simple" xlink:href="camp-20241231.xsd#PrepaidExpensesAndOtherCurrentAssetsTables"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_cb975c9a-cd4d-42ec-b4ac-8db9c06775cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_a1f3d591-6f7d-46d8-8b3b-c6034c3d41cd" xlink:href="camp-20241231.xsd#camp_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_cb975c9a-cd4d-42ec-b4ac-8db9c06775cc" xlink:to="loc_camp_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_a1f3d591-6f7d-46d8-8b3b-c6034c3d41cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/PropertyAndEquipmentNetTables" xlink:type="simple" xlink:href="camp-20241231.xsd#PropertyAndEquipmentNetTables"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/PropertyAndEquipmentNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_7702ebd5-7fd3-4324-9199-9a104a8003f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_b6ed9493-9591-4638-856a-6ee54a2541c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_7702ebd5-7fd3-4324-9199-9a104a8003f3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_b6ed9493-9591-4638-856a-6ee54a2541c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables" xlink:type="simple" xlink:href="camp-20241231.xsd#AccruedExpensesandOtherCurrentLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_2e99cfba-05e8-4408-8b80-41e86b7fed1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_55a83e2e-6d24-489c-b533-115be59e91f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_2e99cfba-05e8-4408-8b80-41e86b7fed1d" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_55a83e2e-6d24-489c-b533-115be59e91f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="camp-20241231.xsd#CommitmentsandContingenciesTables"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/CommitmentsandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bc356e80-5040-48c1-bb86-d0585d8b2f05" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_c9a593ff-86d9-42d9-96b9-f60ad493ac53" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bc356e80-5040-48c1-bb86-d0585d8b2f05" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_c9a593ff-86d9-42d9-96b9-f60ad493ac53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_495f8d0b-82f5-4abe-ae83-5183d367a7b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bc356e80-5040-48c1-bb86-d0585d8b2f05" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_495f8d0b-82f5-4abe-ae83-5183d367a7b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_057d7ff9-d609-40f7-96bb-e793ae697bb4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bc356e80-5040-48c1-bb86-d0585d8b2f05" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_057d7ff9-d609-40f7-96bb-e793ae697bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitTables" xlink:type="simple" xlink:href="camp-20241231.xsd#ConvertiblePreferredStockandStockholdersDeficitTables"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_camp_ConvertiblePreferredStockAndStockholdersDeficitAbstract_6106d2af-4129-44ca-a6af-4bf09a6520de" xlink:href="camp-20241231.xsd#camp_ConvertiblePreferredStockAndStockholdersDeficitAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityTableTextBlock_cf4ee04a-9ab7-4639-b3b6-74a220ade000" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_ConvertiblePreferredStockAndStockholdersDeficitAbstract_6106d2af-4129-44ca-a6af-4bf09a6520de" xlink:to="loc_us-gaap_TemporaryEquityTableTextBlock_cf4ee04a-9ab7-4639-b3b6-74a220ade000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfConversionsOfStockTextBlock_f7bdd927-1b25-41aa-8c4f-964bdf32480f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfConversionsOfStockTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_ConvertiblePreferredStockAndStockholdersDeficitAbstract_6106d2af-4129-44ca-a6af-4bf09a6520de" xlink:to="loc_us-gaap_ScheduleOfConversionsOfStockTextBlock_f7bdd927-1b25-41aa-8c4f-964bdf32480f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="camp-20241231.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d392e82c-f56b-42a0-985c-315b62c390ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_bcc4fb93-4fc3-400d-999a-cd539e9754c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d392e82c-f56b-42a0-985c-315b62c390ea" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_bcc4fb93-4fc3-400d-999a-cd539e9754c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_07b8ffc7-91e1-4929-8f42-55e59fe76fac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d392e82c-f56b-42a0-985c-315b62c390ea" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_07b8ffc7-91e1-4929-8f42-55e59fe76fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_7ce4e57a-7f90-45f5-bea4-80ef8a09e13e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d392e82c-f56b-42a0-985c-315b62c390ea" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_7ce4e57a-7f90-45f5-bea4-80ef8a09e13e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_76d6c7fc-9173-4aff-b51c-51486ba69645" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d392e82c-f56b-42a0-985c-315b62c390ea" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_76d6c7fc-9173-4aff-b51c-51486ba69645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="camp-20241231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ff7f2007-53cd-4dde-8d30-afad03176abe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_06b20526-c802-4d8b-a64a-6d62ae4a98d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ff7f2007-53cd-4dde-8d30-afad03176abe" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_06b20526-c802-4d8b-a64a-6d62ae4a98d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_ef167611-960b-48c1-98fd-4b86b8aa9a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ff7f2007-53cd-4dde-8d30-afad03176abe" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_ef167611-960b-48c1-98fd-4b86b8aa9a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="camp-20241231.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_0051438d-30cc-4a89-b166-c08517121c29" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_33833b4f-b64d-4eaa-8977-7b386ae102ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0051438d-30cc-4a89-b166-c08517121c29" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_33833b4f-b64d-4eaa-8977-7b386ae102ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersTables" xlink:type="simple" xlink:href="camp-20241231.xsd#NetLossPerShareAttributabletoCommonStockholdersTables"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f1677c80-21be-4bc2-90fa-51761c72ab57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7717d805-df8a-40aa-9aea-d0c9787b190e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f1677c80-21be-4bc2-90fa-51761c72ab57" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7717d805-df8a-40aa-9aea-d0c9787b190e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_e89e4e99-214e-4727-917d-b04bcb4bfff2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f1677c80-21be-4bc2-90fa-51761c72ab57" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_e89e4e99-214e-4727-917d-b04bcb4bfff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentationDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#DescriptionofBusinessandBasisofPresentationDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_30b7f3d0-9b4b-4f61-8f57-055fa9441507" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_DescriptionOfBusinessAndBasisOfPresentationTable_701169d7-16ab-470c-b3c6-3504edc49e8e" xlink:href="camp-20241231.xsd#camp_DescriptionOfBusinessAndBasisOfPresentationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_30b7f3d0-9b4b-4f61-8f57-055fa9441507" xlink:to="loc_camp_DescriptionOfBusinessAndBasisOfPresentationTable_701169d7-16ab-470c-b3c6-3504edc49e8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_04cd7de7-7e22-45f4-99b8-5cb5bb1e353b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationTable_701169d7-16ab-470c-b3c6-3504edc49e8e" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_04cd7de7-7e22-45f4-99b8-5cb5bb1e353b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_16ba9ae1-624d-4b09-9a79-962399178286" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_04cd7de7-7e22-45f4-99b8-5cb5bb1e353b" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_16ba9ae1-624d-4b09-9a79-962399178286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_74385cdf-9da3-42b2-a059-2e3fea6c3246" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_16ba9ae1-624d-4b09-9a79-962399178286" xlink:to="loc_us-gaap_IPOMember_74385cdf-9da3-42b2-a059-2e3fea6c3246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_75ec4dd3-e5e9-4506-9987-ceeffc789e80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_16ba9ae1-624d-4b09-9a79-962399178286" xlink:to="loc_us-gaap_OverAllotmentOptionMember_75ec4dd3-e5e9-4506-9987-ceeffc789e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_fc46c857-a157-4cf3-97ae-bbbe07de28c8" xlink:href="camp-20241231.xsd#camp_DescriptionOfBusinessAndBasisOfPresentationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationTable_701169d7-16ab-470c-b3c6-3504edc49e8e" xlink:to="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_fc46c857-a157-4cf3-97ae-bbbe07de28c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_2904761e-dbf9-4382-bda6-5154307aba4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_fc46c857-a157-4cf3-97ae-bbbe07de28c8" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_2904761e-dbf9-4382-bda6-5154307aba4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_29065377-e055-4c3c-91c7-1bd756153c64" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_fc46c857-a157-4cf3-97ae-bbbe07de28c8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_29065377-e055-4c3c-91c7-1bd756153c64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_cfa3c5dc-b047-4aff-ba8a-f3f6ce705db3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_fc46c857-a157-4cf3-97ae-bbbe07de28c8" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_cfa3c5dc-b047-4aff-ba8a-f3f6ce705db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_c2e4fab9-5fb2-4902-a505-5126e20fb51b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_fc46c857-a157-4cf3-97ae-bbbe07de28c8" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_c2e4fab9-5fb2-4902-a505-5126e20fb51b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_PaymentsOfUnderwritingDiscountsAndCommissions_e1c66f78-cbd5-4ba9-bb78-2d295b75799d" xlink:href="camp-20241231.xsd#camp_PaymentsOfUnderwritingDiscountsAndCommissions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_fc46c857-a157-4cf3-97ae-bbbe07de28c8" xlink:to="loc_camp_PaymentsOfUnderwritingDiscountsAndCommissions_e1c66f78-cbd5-4ba9-bb78-2d295b75799d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_76752b9a-80a0-411a-9017-7100ceb9181d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_fc46c857-a157-4cf3-97ae-bbbe07de28c8" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_76752b9a-80a0-411a-9017-7100ceb9181d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_5312effb-0ff9-41d8-9488-be7536e8ad02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_fc46c857-a157-4cf3-97ae-bbbe07de28c8" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_5312effb-0ff9-41d8-9488-be7536e8ad02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_b58be6d4-4f2f-41c9-a439-5103f6b9113f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_fc46c857-a157-4cf3-97ae-bbbe07de28c8" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_b58be6d4-4f2f-41c9-a439-5103f6b9113f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_ceddb53b-683b-426b-8890-9e5f68766d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_fc46c857-a157-4cf3-97ae-bbbe07de28c8" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_ceddb53b-683b-426b-8890-9e5f68766d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_57534140-1df5-44fe-88f5-a736820f10c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_fc46c857-a157-4cf3-97ae-bbbe07de28c8" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_57534140-1df5-44fe-88f5-a736820f10c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9806b0c8-fa27-4ce4-9828-275b57516dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_fc46c857-a157-4cf3-97ae-bbbe07de28c8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9806b0c8-fa27-4ce4-9828-275b57516dd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_WorkingCapital_7dd338de-eaaa-45b2-a6d0-06b66bb6fa17" xlink:href="camp-20241231.xsd#camp_WorkingCapital"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_fc46c857-a157-4cf3-97ae-bbbe07de28c8" xlink:to="loc_camp_WorkingCapital_7dd338de-eaaa-45b2-a6d0-06b66bb6fa17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8e23cef5-fa85-4939-9da9-6ce0660ba1a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_fc46c857-a157-4cf3-97ae-bbbe07de28c8" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8e23cef5-fa85-4939-9da9-6ce0660ba1a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_060bf143-4b1a-47a8-886e-aca535b90dab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_fc46c857-a157-4cf3-97ae-bbbe07de28c8" xlink:to="loc_us-gaap_NetIncomeLoss_060bf143-4b1a-47a8-886e-aca535b90dab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_12f66c15-989f-4502-8e5a-deda12ce4d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems_fc46c857-a157-4cf3-97ae-bbbe07de28c8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_12f66c15-989f-4502-8e5a-deda12ce4d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4f171fab-8c4f-4b85-9af1-222339459c32" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssets_ab727af5-70ff-45de-88a9-742c56f61dda" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositsAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4f171fab-8c4f-4b85-9af1-222339459c32" xlink:to="loc_us-gaap_DepositsAssets_ab727af5-70ff-45de-88a9-742c56f61dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_e98cf350-97be-497a-b88d-ad67148b04e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4f171fab-8c4f-4b85-9af1-222339459c32" xlink:to="loc_us-gaap_Cash_e98cf350-97be-497a-b88d-ad67148b04e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e25df5c9-c7cb-4477-a516-60090323732d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4f171fab-8c4f-4b85-9af1-222339459c32" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e25df5c9-c7cb-4477-a516-60090323732d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_4b53be6a-92b9-4988-9350-6d8f437244a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4f171fab-8c4f-4b85-9af1-222339459c32" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_4b53be6a-92b9-4988-9350-6d8f437244a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b07b0b8b-3a96-454f-9ea4-80c69fc78e75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4f171fab-8c4f-4b85-9af1-222339459c32" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b07b0b8b-3a96-454f-9ea4-80c69fc78e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesSchedulePropertyandEquipmentNetUsefulLivesDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#SummaryofSignificantAccountingPoliciesSchedulePropertyandEquipmentNetUsefulLivesDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesSchedulePropertyandEquipmentNetUsefulLivesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8dacad25-b4eb-4307-896a-43dbe570cdb1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_498cb9e8-8325-489a-9a68-d8439038a562" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8dacad25-b4eb-4307-896a-43dbe570cdb1" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_498cb9e8-8325-489a-9a68-d8439038a562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e3e1d990-9998-4f49-a215-fd0a914809d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_498cb9e8-8325-489a-9a68-d8439038a562" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e3e1d990-9998-4f49-a215-fd0a914809d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2637ab0f-34c4-4130-82ec-c6ce48acd43f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e3e1d990-9998-4f49-a215-fd0a914809d2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2637ab0f-34c4-4130-82ec-c6ce48acd43f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ComputerAndSoftwareMember_33772756-6ecb-4442-988c-8138bf898f18" xlink:href="camp-20241231.xsd#camp_ComputerAndSoftwareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2637ab0f-34c4-4130-82ec-c6ce48acd43f" xlink:to="loc_camp_ComputerAndSoftwareMember_33772756-6ecb-4442-988c-8138bf898f18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_LaboratoryEquipmentMember_6639f910-2137-4c9f-a2fa-9136e4d02a3f" xlink:href="camp-20241231.xsd#camp_LaboratoryEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2637ab0f-34c4-4130-82ec-c6ce48acd43f" xlink:to="loc_camp_LaboratoryEquipmentMember_6639f910-2137-4c9f-a2fa-9136e4d02a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_0e7088d6-03b6-4cac-9c81-9713ce51279d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2637ab0f-34c4-4130-82ec-c6ce48acd43f" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_0e7088d6-03b6-4cac-9c81-9713ce51279d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a618d46b-61c6-44e6-a432-bea1f6589c07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_498cb9e8-8325-489a-9a68-d8439038a562" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a618d46b-61c6-44e6-a432-bea1f6589c07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_76ead696-7e8a-4b6c-bc45-af847a984ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a618d46b-61c6-44e6-a432-bea1f6589c07" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_76ead696-7e8a-4b6c-bc45-af847a984ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_929ccc1b-aa8f-4503-a8fe-09ad4f4445b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_NumberOfMajorFinancialInstitutionsWithCashAndCashEquivalentDeposits_80147646-b526-4693-8148-1b49e2c0f1ba" xlink:href="camp-20241231.xsd#camp_NumberOfMajorFinancialInstitutionsWithCashAndCashEquivalentDeposits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_929ccc1b-aa8f-4503-a8fe-09ad4f4445b4" xlink:to="loc_camp_NumberOfMajorFinancialInstitutionsWithCashAndCashEquivalentDeposits_80147646-b526-4693-8148-1b49e2c0f1ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCosts_810a7d54-c442-4a0a-a8a8-67159c459c14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_929ccc1b-aa8f-4503-a8fe-09ad4f4445b4" xlink:to="loc_us-gaap_DeferredCosts_810a7d54-c442-4a0a-a8a8-67159c459c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_817ca07e-35a2-4f7f-95f9-6e41e35aaa32" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_929ccc1b-aa8f-4503-a8fe-09ad4f4445b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_817ca07e-35a2-4f7f-95f9-6e41e35aaa32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#FairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_73a9dbab-d346-471c-9871-fa78e944b917" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d1d40be6-a4a8-49dd-9167-b216f82e4c54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_73a9dbab-d346-471c-9871-fa78e944b917" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d1d40be6-a4a8-49dd-9167-b216f82e4c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d7e39688-4f27-4a9f-82f7-9ebfc9173b99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d1d40be6-a4a8-49dd-9167-b216f82e4c54" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d7e39688-4f27-4a9f-82f7-9ebfc9173b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_97e92520-9dcd-4b30-b2d4-34198b804b08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d7e39688-4f27-4a9f-82f7-9ebfc9173b99" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_97e92520-9dcd-4b30-b2d4-34198b804b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_6393ba55-ce14-485a-bdc9-d86fcd61d996" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_97e92520-9dcd-4b30-b2d4-34198b804b08" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_6393ba55-ce14-485a-bdc9-d86fcd61d996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b9615850-4a27-4654-88e4-a40d23ae1703" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d1d40be6-a4a8-49dd-9167-b216f82e4c54" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b9615850-4a27-4654-88e4-a40d23ae1703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_29e09f7f-e6d9-4048-a823-aa6c885a505c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b9615850-4a27-4654-88e4-a40d23ae1703" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_29e09f7f-e6d9-4048-a823-aa6c885a505c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_0a0b7a50-c6ed-4a76-9d97-e8da057401d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_29e09f7f-e6d9-4048-a823-aa6c885a505c" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_0a0b7a50-c6ed-4a76-9d97-e8da057401d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_74aa6679-78d3-44de-8fa8-914465ead03f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_29e09f7f-e6d9-4048-a823-aa6c885a505c" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_74aa6679-78d3-44de-8fa8-914465ead03f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a63bb472-d68b-436e-a29f-615f339e01e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_29e09f7f-e6d9-4048-a823-aa6c885a505c" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a63bb472-d68b-436e-a29f-615f339e01e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5bae32ce-d13e-4df4-8e35-9c1c10b06c54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d1d40be6-a4a8-49dd-9167-b216f82e4c54" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5bae32ce-d13e-4df4-8e35-9c1c10b06c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_47f9f30f-f2c8-441b-aa05-0c721784ac98" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5bae32ce-d13e-4df4-8e35-9c1c10b06c54" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_47f9f30f-f2c8-441b-aa05-0c721784ac98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_0a5240ec-c8f0-4d2b-8419-09e7df450340" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_47f9f30f-f2c8-441b-aa05-0c721784ac98" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_0a5240ec-c8f0-4d2b-8419-09e7df450340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#PrepaidExpensesAndOtherCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_c3c36126-d1a9-4c35-8fdf-13767de6a0c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_PrepaidResearchAndDevelopmentExpenseCurrent_35cd3fa0-787e-4f7e-85d3-c2d8ea4eaf21" xlink:href="camp-20241231.xsd#camp_PrepaidResearchAndDevelopmentExpenseCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_c3c36126-d1a9-4c35-8fdf-13767de6a0c8" xlink:to="loc_camp_PrepaidResearchAndDevelopmentExpenseCurrent_35cd3fa0-787e-4f7e-85d3-c2d8ea4eaf21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_abcde07a-c941-4fa9-8b70-d459db1b4531" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidInsurance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_c3c36126-d1a9-4c35-8fdf-13767de6a0c8" xlink:to="loc_us-gaap_PrepaidInsurance_abcde07a-c941-4fa9-8b70-d459db1b4531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_PrepaidSoftwareAndSubscriptionExpenseCurrent_54c3c4f7-c338-483d-bfe4-ecea54d967f8" xlink:href="camp-20241231.xsd#camp_PrepaidSoftwareAndSubscriptionExpenseCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_c3c36126-d1a9-4c35-8fdf-13767de6a0c8" xlink:to="loc_camp_PrepaidSoftwareAndSubscriptionExpenseCurrent_54c3c4f7-c338-483d-bfe4-ecea54d967f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_PrepaidVariableLeaseExpenseCurrent_e328e4d9-0077-4325-8e1d-c5d44833baf5" xlink:href="camp-20241231.xsd#camp_PrepaidVariableLeaseExpenseCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_c3c36126-d1a9-4c35-8fdf-13767de6a0c8" xlink:to="loc_camp_PrepaidVariableLeaseExpenseCurrent_e328e4d9-0077-4325-8e1d-c5d44833baf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_PrepaidFederalResearchAndDevelopmentTaxCreditCurrent_c3e497a6-a2eb-4436-bdf2-53609d32cdf7" xlink:href="camp-20241231.xsd#camp_PrepaidFederalResearchAndDevelopmentTaxCreditCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_c3c36126-d1a9-4c35-8fdf-13767de6a0c8" xlink:to="loc_camp_PrepaidFederalResearchAndDevelopmentTaxCreditCurrent_c3e497a6-a2eb-4436-bdf2-53609d32cdf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_ebdf0197-57f0-47e3-8a44-358e29284df4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_c3c36126-d1a9-4c35-8fdf-13767de6a0c8" xlink:to="loc_us-gaap_OtherAssetsCurrent_ebdf0197-57f0-47e3-8a44-358e29284df4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a0443f2c-defe-49ce-a315-1c575c8f0fab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_c3c36126-d1a9-4c35-8fdf-13767de6a0c8" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a0443f2c-defe-49ce-a315-1c575c8f0fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/PropertyAndEquipmentNetScheduleofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#PropertyAndEquipmentNetScheduleofPropertyandEquipmentNetDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/PropertyAndEquipmentNetScheduleofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_25c9f745-aaf8-4f2c-ba8e-d4dbb62f303a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6ed0a36a-7efc-4cb9-b79d-2f6280f54c65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_25c9f745-aaf8-4f2c-ba8e-d4dbb62f303a" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6ed0a36a-7efc-4cb9-b79d-2f6280f54c65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_de251f09-0eae-4516-8323-aee14881c815" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6ed0a36a-7efc-4cb9-b79d-2f6280f54c65" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_de251f09-0eae-4516-8323-aee14881c815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ec7ff4eb-c2fe-4a58-8026-6096abdad26e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_de251f09-0eae-4516-8323-aee14881c815" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ec7ff4eb-c2fe-4a58-8026-6096abdad26e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_LaboratoryEquipmentMember_2dec505c-9dcf-42ee-b236-003592d6d864" xlink:href="camp-20241231.xsd#camp_LaboratoryEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ec7ff4eb-c2fe-4a58-8026-6096abdad26e" xlink:to="loc_camp_LaboratoryEquipmentMember_2dec505c-9dcf-42ee-b236-003592d6d864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ComputerAndSoftwareMember_2332e1f8-3c79-4a5f-b1e0-cd0acc691400" xlink:href="camp-20241231.xsd#camp_ComputerAndSoftwareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ec7ff4eb-c2fe-4a58-8026-6096abdad26e" xlink:to="loc_camp_ComputerAndSoftwareMember_2332e1f8-3c79-4a5f-b1e0-cd0acc691400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_15e5deff-fe14-4bcd-846c-c8a20ffff1ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ec7ff4eb-c2fe-4a58-8026-6096abdad26e" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_15e5deff-fe14-4bcd-846c-c8a20ffff1ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_27d33527-cb06-439d-9d8b-4e8e8bd403c2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ec7ff4eb-c2fe-4a58-8026-6096abdad26e" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_27d33527-cb06-439d-9d8b-4e8e8bd403c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_fd72a6e4-0ea4-4948-b116-f82406563b22" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6ed0a36a-7efc-4cb9-b79d-2f6280f54c65" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_fd72a6e4-0ea4-4948-b116-f82406563b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_8d6f9cc4-f58b-4fdc-b470-acd4db18628c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_fd72a6e4-0ea4-4948-b116-f82406563b22" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_8d6f9cc4-f58b-4fdc-b470-acd4db18628c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e8527245-5d1d-4b74-bae2-b3b5097b3b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_fd72a6e4-0ea4-4948-b116-f82406563b22" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e8527245-5d1d-4b74-bae2-b3b5097b3b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_60abdfdb-c52e-4857-a07d-18b16561db8c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_fd72a6e4-0ea4-4948-b116-f82406563b22" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_60abdfdb-c52e-4857-a07d-18b16561db8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/PropertyAndEquipmentNetNarrativeDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#PropertyAndEquipmentNetNarrativeDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/PropertyAndEquipmentNetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_ce0e4941-4d76-4174-b66f-bfb7ec651f47" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8f12ae61-245f-451b-bd03-c3ca2631cab5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_ce0e4941-4d76-4174-b66f-bfb7ec651f47" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8f12ae61-245f-451b-bd03-c3ca2631cab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_66d23a5b-5848-48ae-8f99-2972903aec7a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8f12ae61-245f-451b-bd03-c3ca2631cab5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_66d23a5b-5848-48ae-8f99-2972903aec7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_863344d0-ad21-459f-9e1b-b38ec8710626" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_66d23a5b-5848-48ae-8f99-2972903aec7a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_863344d0-ad21-459f-9e1b-b38ec8710626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_LaboratoryEquipmentMember_79743e5b-de29-4c35-85c8-d1dbf8fce380" xlink:href="camp-20241231.xsd#camp_LaboratoryEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_863344d0-ad21-459f-9e1b-b38ec8710626" xlink:to="loc_camp_LaboratoryEquipmentMember_79743e5b-de29-4c35-85c8-d1dbf8fce380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_268bae71-5da0-4c2e-9a90-66bace393cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8f12ae61-245f-451b-bd03-c3ca2631cab5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_268bae71-5da0-4c2e-9a90-66bace393cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_30cb9857-ff09-4b4d-bdaf-972fc037b9a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_268bae71-5da0-4c2e-9a90-66bace393cd4" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_30cb9857-ff09-4b4d-bdaf-972fc037b9a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_366b2966-b567-4536-947f-3db7231a273f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_268bae71-5da0-4c2e-9a90-66bace393cd4" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_366b2966-b567-4536-947f-3db7231a273f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_90cfa93a-abb1-4f04-9f2e-863bef8550c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_268bae71-5da0-4c2e-9a90-66bace393cd4" xlink:to="loc_us-gaap_DepreciationAndAmortization_90cfa93a-abb1-4f04-9f2e-863bef8550c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_7b26b8c5-9600-40c0-98ae-80904de3f4af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_268bae71-5da0-4c2e-9a90-66bace393cd4" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_7b26b8c5-9600-40c0-98ae-80904de3f4af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#AccruedExpensesandOtherCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_fb842ef9-97e7-420c-a0ca-0c2f634b2586" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_79da0561-db19-4e99-b9c1-83e079f5e78e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_fb842ef9-97e7-420c-a0ca-0c2f634b2586" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_79da0561-db19-4e99-b9c1-83e079f5e78e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ProfessionalFeesAndOtherGeneralAndAdministrativeExpensesCurrent_36a81223-f295-48cf-86a3-ab3dd5f90b2f" xlink:href="camp-20241231.xsd#camp_ProfessionalFeesAndOtherGeneralAndAdministrativeExpensesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_fb842ef9-97e7-420c-a0ca-0c2f634b2586" xlink:to="loc_camp_ProfessionalFeesAndOtherGeneralAndAdministrativeExpensesCurrent_36a81223-f295-48cf-86a3-ab3dd5f90b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ResearchAndDevelopmentExpensesCurrent_b3d87e34-9c48-4ecd-9823-bcc8552628e2" xlink:href="camp-20241231.xsd#camp_ResearchAndDevelopmentExpensesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_fb842ef9-97e7-420c-a0ca-0c2f634b2586" xlink:to="loc_camp_ResearchAndDevelopmentExpensesCurrent_b3d87e34-9c48-4ecd-9823-bcc8552628e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_f4e84da3-55fe-474a-9457-6068abca6ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_fb842ef9-97e7-420c-a0ca-0c2f634b2586" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_f4e84da3-55fe-474a-9457-6068abca6ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_d2ca4a18-7a8a-46c3-99a9-5003d6681547" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_fb842ef9-97e7-420c-a0ca-0c2f634b2586" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_d2ca4a18-7a8a-46c3-99a9-5003d6681547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/CommitmentsandContingenciesOperatingLeasesNarrativeDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#CommitmentsandContingenciesOperatingLeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/CommitmentsandContingenciesOperatingLeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_efbb3bac-151e-4652-af5b-5ecf4f43c0eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_d598ba6f-4eba-498b-8409-89b887d680d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_efbb3bac-151e-4652-af5b-5ecf4f43c0eb" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_d598ba6f-4eba-498b-8409-89b887d680d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2e2648aa-e224-4b0b-9ad0-486d63a5c8f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_d598ba6f-4eba-498b-8409-89b887d680d5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2e2648aa-e224-4b0b-9ad0-486d63a5c8f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_11a900d3-268c-47cb-9595-d6d068595e61" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2e2648aa-e224-4b0b-9ad0-486d63a5c8f1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_11a900d3-268c-47cb-9595-d6d068595e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_OfficeAndLaboratorySpaceInCambridgeMember_0aedfd0c-57f8-435e-a482-ec743137ab22" xlink:href="camp-20241231.xsd#camp_OfficeAndLaboratorySpaceInCambridgeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_11a900d3-268c-47cb-9595-d6d068595e61" xlink:to="loc_camp_OfficeAndLaboratorySpaceInCambridgeMember_0aedfd0c-57f8-435e-a482-ec743137ab22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_OfficeAndLaboratorySpaceInBoulderMember_6a498435-82cc-436d-bc25-1f5c587c69de" xlink:href="camp-20241231.xsd#camp_OfficeAndLaboratorySpaceInBoulderMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_11a900d3-268c-47cb-9595-d6d068595e61" xlink:to="loc_camp_OfficeAndLaboratorySpaceInBoulderMember_6a498435-82cc-436d-bc25-1f5c587c69de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_1c90551a-5a92-4217-b89b-955b8ec97435" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_d598ba6f-4eba-498b-8409-89b887d680d5" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_1c90551a-5a92-4217-b89b-955b8ec97435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfLand_85daf129-4cbb-4f50-879b-c8cc224f9320" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AreaOfLand"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1c90551a-5a92-4217-b89b-955b8ec97435" xlink:to="loc_us-gaap_AreaOfLand_85daf129-4cbb-4f50-879b-c8cc224f9320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_MaximumReimbursableIncentiveFromLessor_c2d9212d-9d8c-4519-8e3c-397c1c032702" xlink:href="camp-20241231.xsd#camp_MaximumReimbursableIncentiveFromLessor"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1c90551a-5a92-4217-b89b-955b8ec97435" xlink:to="loc_camp_MaximumReimbursableIncentiveFromLessor_c2d9212d-9d8c-4519-8e3c-397c1c032702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_e0584953-e7f1-47c5-9236-5bdc64990993" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1c90551a-5a92-4217-b89b-955b8ec97435" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_e0584953-e7f1-47c5-9236-5bdc64990993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncentiveFromLessor_ec3d5cc3-fe92-46bf-8360-717f5df80284" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncentiveFromLessor"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1c90551a-5a92-4217-b89b-955b8ec97435" xlink:to="loc_us-gaap_IncentiveFromLessor_ec3d5cc3-fe92-46bf-8360-717f5df80284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1fb94272-d6f6-478e-bd5f-e6d8aedee040" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1c90551a-5a92-4217-b89b-955b8ec97435" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1fb94272-d6f6-478e-bd5f-e6d8aedee040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_d4712819-b5cd-44a8-84d0-5ea3d93673d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1c90551a-5a92-4217-b89b-955b8ec97435" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_d4712819-b5cd-44a8-84d0-5ea3d93673d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4c5beef2-8e63-4ebd-b72f-28a2d9390fde" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1c90551a-5a92-4217-b89b-955b8ec97435" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4c5beef2-8e63-4ebd-b72f-28a2d9390fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_dd9864a4-2adf-41a5-8510-c08bf66430b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1c90551a-5a92-4217-b89b-955b8ec97435" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_dd9864a4-2adf-41a5-8510-c08bf66430b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_LesseeOperatingLeaseIncrementalBorrowingRate_086da5e9-0754-4597-a3c4-16e037013698" xlink:href="camp-20241231.xsd#camp_LesseeOperatingLeaseIncrementalBorrowingRate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1c90551a-5a92-4217-b89b-955b8ec97435" xlink:to="loc_camp_LesseeOperatingLeaseIncrementalBorrowingRate_086da5e9-0754-4597-a3c4-16e037013698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/CommitmentsandContingenciesScheduleofOperatingLeaseCostsandOtherInformationDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#CommitmentsandContingenciesScheduleofOperatingLeaseCostsandOtherInformationDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/CommitmentsandContingenciesScheduleofOperatingLeaseCostsandOtherInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9d029e9e-7eb6-4fa0-b30c-b631e24db870" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_fecdd75c-7910-4919-ada2-c4cb5407b863" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9d029e9e-7eb6-4fa0-b30c-b631e24db870" xlink:to="loc_us-gaap_LeaseCostAbstract_fecdd75c-7910-4919-ada2-c4cb5407b863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_aa068788-83d9-4e27-8eb6-2fefeef56296" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_fecdd75c-7910-4919-ada2-c4cb5407b863" xlink:to="loc_us-gaap_OperatingLeaseCost_aa068788-83d9-4e27-8eb6-2fefeef56296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_c1a5b8f5-2fc6-4e8b-a11a-122e51d1072f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_fecdd75c-7910-4919-ada2-c4cb5407b863" xlink:to="loc_us-gaap_ShortTermLeaseCost_c1a5b8f5-2fc6-4e8b-a11a-122e51d1072f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_b3212208-ae0e-4c78-818d-9234b9019327" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_fecdd75c-7910-4919-ada2-c4cb5407b863" xlink:to="loc_us-gaap_VariableLeaseCost_b3212208-ae0e-4c78-818d-9234b9019327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_LeaseCostExcludingFinanceLeases_bea82202-7557-4744-9e8a-a4e277c61e97" xlink:href="camp-20241231.xsd#camp_LeaseCostExcludingFinanceLeases"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_fecdd75c-7910-4919-ada2-c4cb5407b863" xlink:to="loc_camp_LeaseCostExcludingFinanceLeases_bea82202-7557-4744-9e8a-a4e277c61e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_SupplementalInformationRelatingToLeasesAbstract_bac4a545-056d-4d71-ab93-44220439feed" xlink:href="camp-20241231.xsd#camp_SupplementalInformationRelatingToLeasesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9d029e9e-7eb6-4fa0-b30c-b631e24db870" xlink:to="loc_camp_SupplementalInformationRelatingToLeasesAbstract_bac4a545-056d-4d71-ab93-44220439feed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_bb1aea9d-7b9b-4968-ad68-01c19a9b57c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_SupplementalInformationRelatingToLeasesAbstract_bac4a545-056d-4d71-ab93-44220439feed" xlink:to="loc_us-gaap_OperatingLeasePayments_bb1aea9d-7b9b-4968-ad68-01c19a9b57c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_129c6dde-c002-4684-bcde-772c00fc2c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_SupplementalInformationRelatingToLeasesAbstract_bac4a545-056d-4d71-ab93-44220439feed" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_129c6dde-c002-4684-bcde-772c00fc2c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_46dc553e-4b00-4464-87c9-0e562d6c0c52" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_SupplementalInformationRelatingToLeasesAbstract_bac4a545-056d-4d71-ab93-44220439feed" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_46dc553e-4b00-4464-87c9-0e562d6c0c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#CommitmentsandContingenciesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7d2227bf-1aa5-494b-99dd-2aa43be009a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_498ebae5-541e-49c5-971d-85adc5c69e60" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7d2227bf-1aa5-494b-99dd-2aa43be009a4" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_498ebae5-541e-49c5-971d-85adc5c69e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f23e0083-3c78-44e4-8b12-eace8d9cc6cb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_498ebae5-541e-49c5-971d-85adc5c69e60" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f23e0083-3c78-44e4-8b12-eace8d9cc6cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_bf66e0e1-6c1c-450b-ab43-b31f93bd3c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_498ebae5-541e-49c5-971d-85adc5c69e60" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_bf66e0e1-6c1c-450b-ab43-b31f93bd3c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_a630266b-ded8-4b72-8423-7b3ec3f32e93" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_498ebae5-541e-49c5-971d-85adc5c69e60" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_a630266b-ded8-4b72-8423-7b3ec3f32e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_646f14d0-f3b4-41ef-ad20-c76c572f1b65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_498ebae5-541e-49c5-971d-85adc5c69e60" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_646f14d0-f3b4-41ef-ad20-c76c572f1b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_aa1c0702-73b3-452f-ab74-77974e0cd8c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_498ebae5-541e-49c5-971d-85adc5c69e60" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_aa1c0702-73b3-452f-ab74-77974e0cd8c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_45020fe3-5e6c-4a09-9017-c81989bb6394" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_498ebae5-541e-49c5-971d-85adc5c69e60" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_45020fe3-5e6c-4a09-9017-c81989bb6394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_bcb2c739-a5b4-4dcc-a89c-5fa97178b201" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_498ebae5-541e-49c5-971d-85adc5c69e60" xlink:to="loc_us-gaap_OperatingLeaseLiability_bcb2c739-a5b4-4dcc-a89c-5fa97178b201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/CommitmentsandContingenciesFinanceLeasesNarrativeDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#CommitmentsandContingenciesFinanceLeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/CommitmentsandContingenciesFinanceLeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e4f0e71d-c94a-4d6b-9d4b-f08d3eb5f9ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_93249faa-f935-4e01-937d-70dd4643173b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e4f0e71d-c94a-4d6b-9d4b-f08d3eb5f9ab" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_93249faa-f935-4e01-937d-70dd4643173b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_11d709bb-61f8-4723-a32a-40fd5f864814" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e4f0e71d-c94a-4d6b-9d4b-f08d3eb5f9ab" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_11d709bb-61f8-4723-a32a-40fd5f864814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_4e77e5f1-c3e1-4817-b861-c7dae2735111" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e4f0e71d-c94a-4d6b-9d4b-f08d3eb5f9ab" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_4e77e5f1-c3e1-4817-b861-c7dae2735111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/CommitmentsandContingenciesScheduleofFinanceLeaseCostandOtherInformationDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#CommitmentsandContingenciesScheduleofFinanceLeaseCostandOtherInformationDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/CommitmentsandContingenciesScheduleofFinanceLeaseCostandOtherInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7f1a9b59-c11b-450c-bba7-203475cbaef1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_38663f77-a4d9-4ce6-9e86-b81858faedb2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7f1a9b59-c11b-450c-bba7-203475cbaef1" xlink:to="loc_us-gaap_LeaseCostAbstract_38663f77-a4d9-4ce6-9e86-b81858faedb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_e5af9728-856c-498a-aacc-f7c34f378c81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_38663f77-a4d9-4ce6-9e86-b81858faedb2" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_e5af9728-856c-498a-aacc-f7c34f378c81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_95db108c-5fdb-42cf-a993-c291dd77cf23" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_38663f77-a4d9-4ce6-9e86-b81858faedb2" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_95db108c-5fdb-42cf-a993-c291dd77cf23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_LeaseCostFinanceLeases_6aa7fee4-77ee-4ccd-99a7-cab3da2c82af" xlink:href="camp-20241231.xsd#camp_LeaseCostFinanceLeases"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_38663f77-a4d9-4ce6-9e86-b81858faedb2" xlink:to="loc_camp_LeaseCostFinanceLeases_6aa7fee4-77ee-4ccd-99a7-cab3da2c82af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_SupplementalInformationRelatingToLeasesAbstract_724889e0-f288-47cb-a8aa-0216f64be3d0" xlink:href="camp-20241231.xsd#camp_SupplementalInformationRelatingToLeasesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7f1a9b59-c11b-450c-bba7-203475cbaef1" xlink:to="loc_camp_SupplementalInformationRelatingToLeasesAbstract_724889e0-f288-47cb-a8aa-0216f64be3d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_7dfcf6d7-f0ed-4e3c-a5e5-9d7f928ba32e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_SupplementalInformationRelatingToLeasesAbstract_724889e0-f288-47cb-a8aa-0216f64be3d0" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_7dfcf6d7-f0ed-4e3c-a5e5-9d7f928ba32e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_cf54e7dc-a086-451a-b826-b84afdf960f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_SupplementalInformationRelatingToLeasesAbstract_724889e0-f288-47cb-a8aa-0216f64be3d0" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_cf54e7dc-a086-451a-b826-b84afdf960f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_7d118d3b-51e2-445a-b0ed-64d74a98e719" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_SupplementalInformationRelatingToLeasesAbstract_724889e0-f288-47cb-a8aa-0216f64be3d0" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_7d118d3b-51e2-445a-b0ed-64d74a98e719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofFinanceLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#CommitmentsandContingenciesScheduleofMaturitiesofFinanceLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofFinanceLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_945cf701-ee69-4e0e-a506-146e68ab6c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_af0e252e-dbad-459a-a35d-6c8913dbd711" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_945cf701-ee69-4e0e-a506-146e68ab6c9f" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_af0e252e-dbad-459a-a35d-6c8913dbd711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_13bfd94f-d4ea-4c7f-84ef-53d2f933ba9f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_af0e252e-dbad-459a-a35d-6c8913dbd711" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_13bfd94f-d4ea-4c7f-84ef-53d2f933ba9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_00b4fd0b-5e10-463e-844d-35ca5e4d350f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_af0e252e-dbad-459a-a35d-6c8913dbd711" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_00b4fd0b-5e10-463e-844d-35ca5e4d350f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_5a1f68f9-316c-40d5-aff9-7e57325fa426" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_af0e252e-dbad-459a-a35d-6c8913dbd711" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_5a1f68f9-316c-40d5-aff9-7e57325fa426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_16ebf14c-4d29-4ead-b28e-e8a31e5d228c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_af0e252e-dbad-459a-a35d-6c8913dbd711" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_16ebf14c-4d29-4ead-b28e-e8a31e5d228c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_992b0e10-dff2-434c-b256-305e14b121b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_af0e252e-dbad-459a-a35d-6c8913dbd711" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_992b0e10-dff2-434c-b256-305e14b121b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_ee7a05dd-c35e-42d9-80a4-08ff27a4dc6d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_af0e252e-dbad-459a-a35d-6c8913dbd711" xlink:to="loc_us-gaap_FinanceLeaseLiability_ee7a05dd-c35e-42d9-80a4-08ff27a4dc6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/CommitmentsandContingenciesFinancingObligationNarrativeDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#CommitmentsandContingenciesFinancingObligationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/CommitmentsandContingenciesFinancingObligationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d30e9e94-9066-447e-97e4-33c64b62b320" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_FinancingObligationsLeaseTermOfContract_ac6fa2ff-cee5-4e69-8281-4393bff00234" xlink:href="camp-20241231.xsd#camp_FinancingObligationsLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d30e9e94-9066-447e-97e4-33c64b62b320" xlink:to="loc_camp_FinancingObligationsLeaseTermOfContract_ac6fa2ff-cee5-4e69-8281-4393bff00234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_FinancingObligationsLeaseMaximumMonthlyRentalPayments_75beda97-b27e-4d92-bc66-df3bfb850fc8" xlink:href="camp-20241231.xsd#camp_FinancingObligationsLeaseMaximumMonthlyRentalPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d30e9e94-9066-447e-97e4-33c64b62b320" xlink:to="loc_camp_FinancingObligationsLeaseMaximumMonthlyRentalPayments_75beda97-b27e-4d92-bc66-df3bfb850fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_FinancingObligationsLeaseFixedRepurchasePrice_a8a881c0-4328-4b9e-b42c-966f3e689fa1" xlink:href="camp-20241231.xsd#camp_FinancingObligationsLeaseFixedRepurchasePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d30e9e94-9066-447e-97e4-33c64b62b320" xlink:to="loc_camp_FinancingObligationsLeaseFixedRepurchasePrice_a8a881c0-4328-4b9e-b42c-966f3e689fa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction_088a1c40-63fc-406e-83ab-94575606d9d4" xlink:href="camp-20241231.xsd#camp_ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d30e9e94-9066-447e-97e4-33c64b62b320" xlink:to="loc_camp_ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction_088a1c40-63fc-406e-83ab-94575606d9d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_FinancingObligationsLeaseMonthlyInterestRatePercent_79764f89-33a7-4c38-af94-f8de731a9b68" xlink:href="camp-20241231.xsd#camp_FinancingObligationsLeaseMonthlyInterestRatePercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d30e9e94-9066-447e-97e4-33c64b62b320" xlink:to="loc_camp_FinancingObligationsLeaseMonthlyInterestRatePercent_79764f89-33a7-4c38-af94-f8de731a9b68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_FinancingObligationsLeaseMaximumInterestExpense_5b1b1f90-7125-4d7d-999c-a6c5afdfbb50" xlink:href="camp-20241231.xsd#camp_FinancingObligationsLeaseMaximumInterestExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d30e9e94-9066-447e-97e4-33c64b62b320" xlink:to="loc_camp_FinancingObligationsLeaseMaximumInterestExpense_5b1b1f90-7125-4d7d-999c-a6c5afdfbb50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/CollaborationandLicenseAgreementsChildrensMedicalCenterCorporationNarrativeDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#CollaborationandLicenseAgreementsChildrensMedicalCenterCorporationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/CollaborationandLicenseAgreementsChildrensMedicalCenterCorporationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_camp_CollaborationAndLicenseAgreementsAbstract_c61a68ce-d6a3-449e-aca7-5375f17048bc" xlink:href="camp-20241231.xsd#camp_CollaborationAndLicenseAgreementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_38a780f7-0829-411a-9842-95776f35741f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_CollaborationAndLicenseAgreementsAbstract_c61a68ce-d6a3-449e-aca7-5375f17048bc" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_38a780f7-0829-411a-9842-95776f35741f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_fcbf8508-e381-4c04-a483-981d7087c511" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_38a780f7-0829-411a-9842-95776f35741f" xlink:to="loc_us-gaap_TypeOfArrangementAxis_fcbf8508-e381-4c04-a483-981d7087c511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_59358269-d9ad-4f2c-8ea8-69a1616559ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_fcbf8508-e381-4c04-a483-981d7087c511" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_59358269-d9ad-4f2c-8ea8-69a1616559ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_3143c5e9-7640-4953-93ba-4e6c294cb502" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_59358269-d9ad-4f2c-8ea8-69a1616559ce" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_3143c5e9-7640-4953-93ba-4e6c294cb502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_22d31959-82ae-4bba-ae73-264c256b866b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_38a780f7-0829-411a-9842-95776f35741f" xlink:to="loc_srt_CounterpartyNameAxis_22d31959-82ae-4bba-ae73-264c256b866b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0c64f7d2-955a-435a-aa93-ecb56d01ecc8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_22d31959-82ae-4bba-ae73-264c256b866b" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0c64f7d2-955a-435a-aa93-ecb56d01ecc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ChildrenMedicalCenterCorporationMember_c2b2a2ea-29fd-4ea3-b95b-642d11a52aef" xlink:href="camp-20241231.xsd#camp_ChildrenMedicalCenterCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0c64f7d2-955a-435a-aa93-ecb56d01ecc8" xlink:to="loc_camp_ChildrenMedicalCenterCorporationMember_c2b2a2ea-29fd-4ea3-b95b-642d11a52aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_MilestoneTargetsAxis_00823460-380b-4148-82ba-62f029a48ec2" xlink:href="camp-20241231.xsd#camp_MilestoneTargetsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_38a780f7-0829-411a-9842-95776f35741f" xlink:to="loc_camp_MilestoneTargetsAxis_00823460-380b-4148-82ba-62f029a48ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_MilestoneTargetsDomain_12458346-4e93-4b73-85b0-5058cec672aa" xlink:href="camp-20241231.xsd#camp_MilestoneTargetsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_MilestoneTargetsAxis_00823460-380b-4148-82ba-62f029a48ec2" xlink:to="loc_camp_MilestoneTargetsDomain_12458346-4e93-4b73-85b0-5058cec672aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_UponAchievementOfFirstLicensedTargetMember_98e64498-4920-4248-a55d-bd62e94d9163" xlink:href="camp-20241231.xsd#camp_UponAchievementOfFirstLicensedTargetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_MilestoneTargetsDomain_12458346-4e93-4b73-85b0-5058cec672aa" xlink:to="loc_camp_UponAchievementOfFirstLicensedTargetMember_98e64498-4920-4248-a55d-bd62e94d9163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_UponAchievementOfSecondLicensedTargetMember_08f43af1-2851-470b-bd3c-61c78a02fca2" xlink:href="camp-20241231.xsd#camp_UponAchievementOfSecondLicensedTargetMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_MilestoneTargetsDomain_12458346-4e93-4b73-85b0-5058cec672aa" xlink:to="loc_camp_UponAchievementOfSecondLicensedTargetMember_08f43af1-2851-470b-bd3c-61c78a02fca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_UponAchievementOfThirdLicensedTargetMember_4b4fb0d6-2a0f-4f83-8d1b-913b63b03ad7" xlink:href="camp-20241231.xsd#camp_UponAchievementOfThirdLicensedTargetMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_MilestoneTargetsDomain_12458346-4e93-4b73-85b0-5058cec672aa" xlink:to="loc_camp_UponAchievementOfThirdLicensedTargetMember_4b4fb0d6-2a0f-4f83-8d1b-913b63b03ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_a403a8fc-f138-4294-838d-b5d88bb5b5fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_38a780f7-0829-411a-9842-95776f35741f" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_a403a8fc-f138-4294-838d-b5d88bb5b5fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_f552abb0-59dd-45d7-bdfd-2d49e2089736" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_a403a8fc-f138-4294-838d-b5d88bb5b5fb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_f552abb0-59dd-45d7-bdfd-2d49e2089736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation_9a4bb44a-ccba-4757-9ad7-400348fe713e" xlink:href="camp-20241231.xsd#camp_CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_a403a8fc-f138-4294-838d-b5d88bb5b5fb" xlink:to="loc_camp_CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation_9a4bb44a-ccba-4757-9ad7-400348fe713e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_PercentageOfUpfrontPaymentRequiredUponFirstInvestigationalNewDrugStudy_ecef8111-0f53-4c45-8a55-128853f98746" xlink:href="camp-20241231.xsd#camp_PercentageOfUpfrontPaymentRequiredUponFirstInvestigationalNewDrugStudy"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_a403a8fc-f138-4294-838d-b5d88bb5b5fb" xlink:to="loc_camp_PercentageOfUpfrontPaymentRequiredUponFirstInvestigationalNewDrugStudy_ecef8111-0f53-4c45-8a55-128853f98746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/CollaborationandLicenseAgreementsWhiteheadInstituteforBiomedicalResearchNarrativeDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#CollaborationandLicenseAgreementsWhiteheadInstituteforBiomedicalResearchNarrativeDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/CollaborationandLicenseAgreementsWhiteheadInstituteforBiomedicalResearchNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_camp_CollaborationAndLicenseAgreementsAbstract_41feb934-31a6-4916-b324-edf7772fab08" xlink:href="camp-20241231.xsd#camp_CollaborationAndLicenseAgreementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_2500b1b4-1611-45cf-9753-02fc262a73f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_CollaborationAndLicenseAgreementsAbstract_41feb934-31a6-4916-b324-edf7772fab08" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_2500b1b4-1611-45cf-9753-02fc262a73f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_f6ef8e5d-a648-4eab-9f4c-77c31f18915f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_2500b1b4-1611-45cf-9753-02fc262a73f9" xlink:to="loc_us-gaap_TypeOfArrangementAxis_f6ef8e5d-a648-4eab-9f4c-77c31f18915f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ee68fafe-a32f-48ab-8c34-da5a2ac8f828" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_f6ef8e5d-a648-4eab-9f4c-77c31f18915f" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ee68fafe-a32f-48ab-8c34-da5a2ac8f828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_4600dc45-66a4-4dce-a6cb-a61d0ee8dec7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ee68fafe-a32f-48ab-8c34-da5a2ac8f828" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_4600dc45-66a4-4dce-a6cb-a61d0ee8dec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_23c6754e-6f0b-4011-862d-3cb1e0da71f6" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_2500b1b4-1611-45cf-9753-02fc262a73f9" xlink:to="loc_srt_CounterpartyNameAxis_23c6754e-6f0b-4011-862d-3cb1e0da71f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6e5966dc-b6f1-48f4-b616-2c7b11c23c3e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_23c6754e-6f0b-4011-862d-3cb1e0da71f6" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6e5966dc-b6f1-48f4-b616-2c7b11c23c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_TheWhiteheadInstituteForBiomedicalResearchMember_f24dfe2e-41b7-404e-a860-699c91d666b5" xlink:href="camp-20241231.xsd#camp_TheWhiteheadInstituteForBiomedicalResearchMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6e5966dc-b6f1-48f4-b616-2c7b11c23c3e" xlink:to="loc_camp_TheWhiteheadInstituteForBiomedicalResearchMember_f24dfe2e-41b7-404e-a860-699c91d666b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_278c2dd9-5ba6-41f7-8c94-96ff4cfc7beb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_2500b1b4-1611-45cf-9753-02fc262a73f9" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_278c2dd9-5ba6-41f7-8c94-96ff4cfc7beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_CollaborativeArrangementUpfrontLicenseIssuanceFeePayment_46fa780b-e6b1-40d3-ac9c-7b825eed1792" xlink:href="camp-20241231.xsd#camp_CollaborativeArrangementUpfrontLicenseIssuanceFeePayment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_278c2dd9-5ba6-41f7-8c94-96ff4cfc7beb" xlink:to="loc_camp_CollaborativeArrangementUpfrontLicenseIssuanceFeePayment_46fa780b-e6b1-40d3-ac9c-7b825eed1792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation_15bd81b4-2c44-46bf-a25e-435879d21824" xlink:href="camp-20241231.xsd#camp_CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_278c2dd9-5ba6-41f7-8c94-96ff4cfc7beb" xlink:to="loc_camp_CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation_15bd81b4-2c44-46bf-a25e-435879d21824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_CollaborativeArrangementTieredRoyaltiesPayableOnNetSalesMaximumLowerRangePercent_4ca6b1e8-a6c2-44fa-91a2-9be144b0a40c" xlink:href="camp-20241231.xsd#camp_CollaborativeArrangementTieredRoyaltiesPayableOnNetSalesMaximumLowerRangePercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_278c2dd9-5ba6-41f7-8c94-96ff4cfc7beb" xlink:to="loc_camp_CollaborativeArrangementTieredRoyaltiesPayableOnNetSalesMaximumLowerRangePercent_4ca6b1e8-a6c2-44fa-91a2-9be144b0a40c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_CollaborativeArrangementTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale_e8642567-e2dd-48aa-8dcb-efdb8ed7a4dd" xlink:href="camp-20241231.xsd#camp_CollaborativeArrangementTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_278c2dd9-5ba6-41f7-8c94-96ff4cfc7beb" xlink:to="loc_camp_CollaborativeArrangementTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale_e8642567-e2dd-48aa-8dcb-efdb8ed7a4dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_CollaborativeArrangementFeesIncurredDuringPeriod_2e5fb09c-4452-44b9-89b6-98ab6abb6562" xlink:href="camp-20241231.xsd#camp_CollaborativeArrangementFeesIncurredDuringPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_278c2dd9-5ba6-41f7-8c94-96ff4cfc7beb" xlink:to="loc_camp_CollaborativeArrangementFeesIncurredDuringPeriod_2e5fb09c-4452-44b9-89b6-98ab6abb6562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/CollaborationandLicenseAgreementsFulcrumTherapeuticsIncNarrativeDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#CollaborationandLicenseAgreementsFulcrumTherapeuticsIncNarrativeDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/CollaborationandLicenseAgreementsFulcrumTherapeuticsIncNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_camp_CollaborationAndLicenseAgreementsAbstract_5538ce89-02b7-4ba2-94bf-c053e08c0940" xlink:href="camp-20241231.xsd#camp_CollaborationAndLicenseAgreementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_7003ec85-534e-4cac-82d4-4b3d903ec325" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_CollaborationAndLicenseAgreementsAbstract_5538ce89-02b7-4ba2-94bf-c053e08c0940" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_7003ec85-534e-4cac-82d4-4b3d903ec325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_7266d144-a8d6-460e-bdd1-29b5f08f05d0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_7003ec85-534e-4cac-82d4-4b3d903ec325" xlink:to="loc_srt_CounterpartyNameAxis_7266d144-a8d6-460e-bdd1-29b5f08f05d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a5eaea31-c0d5-40fa-ab0c-a9e7311f71e8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_7266d144-a8d6-460e-bdd1-29b5f08f05d0" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a5eaea31-c0d5-40fa-ab0c-a9e7311f71e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_FulcrumTherapeuticsInc.Member_bc325373-f773-42eb-8017-7698cc1966a5" xlink:href="camp-20241231.xsd#camp_FulcrumTherapeuticsInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a5eaea31-c0d5-40fa-ab0c-a9e7311f71e8" xlink:to="loc_camp_FulcrumTherapeuticsInc.Member_bc325373-f773-42eb-8017-7698cc1966a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_405d3bbd-0110-465c-b773-ed306c3e076d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_7003ec85-534e-4cac-82d4-4b3d903ec325" xlink:to="loc_srt_ProductOrServiceAxis_405d3bbd-0110-465c-b773-ed306c3e076d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_fd6d0533-8cca-4cec-989f-267866d83db9" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_405d3bbd-0110-465c-b773-ed306c3e076d" xlink:to="loc_srt_ProductsAndServicesDomain_fd6d0533-8cca-4cec-989f-267866d83db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_TierOneProductMember_a06390bc-838a-4118-bf78-d349a302403f" xlink:href="camp-20241231.xsd#camp_TierOneProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_fd6d0533-8cca-4cec-989f-267866d83db9" xlink:to="loc_camp_TierOneProductMember_a06390bc-838a-4118-bf78-d349a302403f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9acd69e4-d352-41ce-89cf-f5925e047acb" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_7003ec85-534e-4cac-82d4-4b3d903ec325" xlink:to="loc_srt_RangeAxis_9acd69e4-d352-41ce-89cf-f5925e047acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2c8b79f6-7dc0-41cf-8777-4918d63b1318" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_9acd69e4-d352-41ce-89cf-f5925e047acb" xlink:to="loc_srt_RangeMember_2c8b79f6-7dc0-41cf-8777-4918d63b1318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_9cf2346b-e7d6-48ea-b251-b34b82b0bf62" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2c8b79f6-7dc0-41cf-8777-4918d63b1318" xlink:to="loc_srt_MinimumMember_9cf2346b-e7d6-48ea-b251-b34b82b0bf62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d831b7f4-eeb1-4369-8b36-83bea9554166" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2c8b79f6-7dc0-41cf-8777-4918d63b1318" xlink:to="loc_srt_MaximumMember_d831b7f4-eeb1-4369-8b36-83bea9554166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d1c45b4f-5d4d-4199-b3f1-20dee63b3dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_7003ec85-534e-4cac-82d4-4b3d903ec325" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d1c45b4f-5d4d-4199-b3f1-20dee63b3dd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_c0f208ed-9fb5-4c27-8524-d40b0c48127d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d1c45b4f-5d4d-4199-b3f1-20dee63b3dd5" xlink:to="loc_us-gaap_ContractWithCustomerLiability_c0f208ed-9fb5-4c27-8524-d40b0c48127d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmount_2624aeb1-2875-46e8-a98c-c3e591af8324" xlink:href="camp-20241231.xsd#camp_RevenueRemainingPerformanceObligationVariableConsiderationAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d1c45b4f-5d4d-4199-b3f1-20dee63b3dd5" xlink:to="loc_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmount_2624aeb1-2875-46e8-a98c-c3e591af8324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_RevenuePerformanceObligationNumberOfPerformanceObligations_9771d55a-b066-4fd9-80af-eef44b0984ed" xlink:href="camp-20241231.xsd#camp_RevenuePerformanceObligationNumberOfPerformanceObligations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d1c45b4f-5d4d-4199-b3f1-20dee63b3dd5" xlink:to="loc_camp_RevenuePerformanceObligationNumberOfPerformanceObligations_9771d55a-b066-4fd9-80af-eef44b0984ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_RevenueRemainingPerformanceObligationFixedConsiderationAmount_4daf5be6-769c-48b3-9a61-1aa31bc2cc2f" xlink:href="camp-20241231.xsd#camp_RevenueRemainingPerformanceObligationFixedConsiderationAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d1c45b4f-5d4d-4199-b3f1-20dee63b3dd5" xlink:to="loc_camp_RevenueRemainingPerformanceObligationFixedConsiderationAmount_4daf5be6-769c-48b3-9a61-1aa31bc2cc2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_981dc377-91b7-4998-b671-6e2a8273f2a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d1c45b4f-5d4d-4199-b3f1-20dee63b3dd5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_981dc377-91b7-4998-b671-6e2a8273f2a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/CollaborationandLicenseAgreementsEliLillyandCompanyNarrativeDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#CollaborationandLicenseAgreementsEliLillyandCompanyNarrativeDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/CollaborationandLicenseAgreementsEliLillyandCompanyNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_camp_CollaborationAndLicenseAgreementsAbstract_1a9baa2e-e300-4f07-b059-f2ca4de0341f" xlink:href="camp-20241231.xsd#camp_CollaborationAndLicenseAgreementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_2184f802-3430-4fcf-b872-f7f0fe987c87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_CollaborationAndLicenseAgreementsAbstract_1a9baa2e-e300-4f07-b059-f2ca4de0341f" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_2184f802-3430-4fcf-b872-f7f0fe987c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_7e487f13-eef6-43c4-8df9-cd48def21a02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_2184f802-3430-4fcf-b872-f7f0fe987c87" xlink:to="loc_us-gaap_TypeOfArrangementAxis_7e487f13-eef6-43c4-8df9-cd48def21a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_25428166-44aa-4394-a73d-c897666c8284" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_7e487f13-eef6-43c4-8df9-cd48def21a02" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_25428166-44aa-4394-a73d-c897666c8284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_324b04db-004a-466b-9414-159d0e503cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_25428166-44aa-4394-a73d-c897666c8284" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_324b04db-004a-466b-9414-159d0e503cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_69f7b96e-59e7-4aba-b8f9-260871d3a066" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_2184f802-3430-4fcf-b872-f7f0fe987c87" xlink:to="loc_srt_CounterpartyNameAxis_69f7b96e-59e7-4aba-b8f9-260871d3a066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_912765d2-0c85-47d0-9fa4-364cf94c1178" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_69f7b96e-59e7-4aba-b8f9-260871d3a066" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_912765d2-0c85-47d0-9fa4-364cf94c1178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_EliLillyAndCompanyMember_9808251c-a3d8-4b78-9dc2-d2dbcd97a898" xlink:href="camp-20241231.xsd#camp_EliLillyAndCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_912765d2-0c85-47d0-9fa4-364cf94c1178" xlink:to="loc_camp_EliLillyAndCompanyMember_9808251c-a3d8-4b78-9dc2-d2dbcd97a898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cddf0853-b867-4b1e-89fe-a2b909e4e110" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_2184f802-3430-4fcf-b872-f7f0fe987c87" xlink:to="loc_srt_RangeAxis_cddf0853-b867-4b1e-89fe-a2b909e4e110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6f495250-574b-41d9-bf88-055cd6571a93" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_cddf0853-b867-4b1e-89fe-a2b909e4e110" xlink:to="loc_srt_RangeMember_6f495250-574b-41d9-bf88-055cd6571a93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1d3c7e28-ab75-4b53-a290-a3ec00fda255" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6f495250-574b-41d9-bf88-055cd6571a93" xlink:to="loc_srt_MaximumMember_1d3c7e28-ab75-4b53-a290-a3ec00fda255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_c7454460-ad22-42fc-897f-2b4e32548ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_2184f802-3430-4fcf-b872-f7f0fe987c87" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_c7454460-ad22-42fc-897f-2b4e32548ef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_CollaborativeArrangementReductionInResearchAndDevelopmentExpense_b48efc5c-0fc6-4602-a227-158be3db3135" xlink:href="camp-20241231.xsd#camp_CollaborativeArrangementReductionInResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_c7454460-ad22-42fc-897f-2b4e32548ef7" xlink:to="loc_camp_CollaborativeArrangementReductionInResearchAndDevelopmentExpense_b48efc5c-0fc6-4602-a227-158be3db3135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable_cd4caaf3-dea0-4d8e-8944-a39efcc00a19" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_c7454460-ad22-42fc-897f-2b4e32548ef7" xlink:to="loc_us-gaap_UnbilledContractsReceivable_cd4caaf3-dea0-4d8e-8944-a39efcc00a19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/CollaborationandLicenseAgreementsBioMarinPharmaceuticalIncNarrativeDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#CollaborationandLicenseAgreementsBioMarinPharmaceuticalIncNarrativeDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/CollaborationandLicenseAgreementsBioMarinPharmaceuticalIncNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_camp_CollaborationAndLicenseAgreementsAbstract_aeae19c0-2d51-42d5-9ded-bad46b580b7a" xlink:href="camp-20241231.xsd#camp_CollaborationAndLicenseAgreementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_13bf256b-b361-4966-9f37-471b9bc055ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_CollaborationAndLicenseAgreementsAbstract_aeae19c0-2d51-42d5-9ded-bad46b580b7a" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_13bf256b-b361-4966-9f37-471b9bc055ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_d95d9f36-9782-4356-b720-630a25568d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_13bf256b-b361-4966-9f37-471b9bc055ee" xlink:to="loc_us-gaap_TypeOfArrangementAxis_d95d9f36-9782-4356-b720-630a25568d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e5a4297d-2e23-42c9-9bdb-004c9caeeaba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_d95d9f36-9782-4356-b720-630a25568d5b" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e5a4297d-2e23-42c9-9bdb-004c9caeeaba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_ff6a885a-98b6-461d-9b4f-329f9f81e633" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e5a4297d-2e23-42c9-9bdb-004c9caeeaba" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_ff6a885a-98b6-461d-9b4f-329f9f81e633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_27093582-fe6c-4033-8d1b-2faba6b2a526" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_13bf256b-b361-4966-9f37-471b9bc055ee" xlink:to="loc_srt_CounterpartyNameAxis_27093582-fe6c-4033-8d1b-2faba6b2a526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b3f9f2f1-df3b-4b00-a2ea-a0a750731873" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_27093582-fe6c-4033-8d1b-2faba6b2a526" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b3f9f2f1-df3b-4b00-a2ea-a0a750731873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_BioMarinPharmaceuticalInc.Member_366d6683-5feb-44bd-88a7-df0022ac2334" xlink:href="camp-20241231.xsd#camp_BioMarinPharmaceuticalInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b3f9f2f1-df3b-4b00-a2ea-a0a750731873" xlink:to="loc_camp_BioMarinPharmaceuticalInc.Member_366d6683-5feb-44bd-88a7-df0022ac2334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3c1913b6-6755-4be7-8945-acf6c5abce7f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_13bf256b-b361-4966-9f37-471b9bc055ee" xlink:to="loc_srt_RangeAxis_3c1913b6-6755-4be7-8945-acf6c5abce7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_326f5a41-d6f4-420a-95c0-27d3b82f5703" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3c1913b6-6755-4be7-8945-acf6c5abce7f" xlink:to="loc_srt_RangeMember_326f5a41-d6f4-420a-95c0-27d3b82f5703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c9428668-b2aa-41b5-b276-4eec5db2037a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_326f5a41-d6f4-420a-95c0-27d3b82f5703" xlink:to="loc_srt_MinimumMember_c9428668-b2aa-41b5-b276-4eec5db2037a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a5aada84-70d5-455f-8477-e0b310e6ce5e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_326f5a41-d6f4-420a-95c0-27d3b82f5703" xlink:to="loc_srt_MaximumMember_a5aada84-70d5-455f-8477-e0b310e6ce5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_90141318-1305-48bb-a2c8-ffe701ab8e73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_13bf256b-b361-4966-9f37-471b9bc055ee" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_90141318-1305-48bb-a2c8-ffe701ab8e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_ab09bec3-85af-4a18-b44e-845ec568c26c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_90141318-1305-48bb-a2c8-ffe701ab8e73" xlink:to="loc_us-gaap_ContractWithCustomerLiability_ab09bec3-85af-4a18-b44e-845ec568c26c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentPreclinicalMilestones_34632618-f778-4773-98ba-cc0fed7bd974" xlink:href="camp-20241231.xsd#camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentPreclinicalMilestones"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_90141318-1305-48bb-a2c8-ffe701ab8e73" xlink:to="loc_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentPreclinicalMilestones_34632618-f778-4773-98ba-cc0fed7bd974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentDevelopmentAndRegulatoryMilestones_1665fcb8-1b7a-410b-8184-e9acb298079a" xlink:href="camp-20241231.xsd#camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentDevelopmentAndRegulatoryMilestones"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_90141318-1305-48bb-a2c8-ffe701ab8e73" xlink:to="loc_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentDevelopmentAndRegulatoryMilestones_1665fcb8-1b7a-410b-8184-e9acb298079a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountCommercialSalesMilestones_9314582a-e7f5-4374-89e0-b9f90609b708" xlink:href="camp-20241231.xsd#camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountCommercialSalesMilestones"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_90141318-1305-48bb-a2c8-ffe701ab8e73" xlink:to="loc_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountCommercialSalesMilestones_9314582a-e7f5-4374-89e0-b9f90609b708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_RevenueRemainingPerformanceObligationTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale_014e7f51-af76-4819-a9d2-1a21ac791418" xlink:href="camp-20241231.xsd#camp_RevenueRemainingPerformanceObligationTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_90141318-1305-48bb-a2c8-ffe701ab8e73" xlink:to="loc_camp_RevenueRemainingPerformanceObligationTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale_014e7f51-af76-4819-a9d2-1a21ac791418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_RevenueRemainingPerformanceObligationNoticePeriodForTermination_4f95ada6-5d53-4ca5-aa4a-243fd33a3f5f" xlink:href="camp-20241231.xsd#camp_RevenueRemainingPerformanceObligationNoticePeriodForTermination"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_90141318-1305-48bb-a2c8-ffe701ab8e73" xlink:to="loc_camp_RevenueRemainingPerformanceObligationNoticePeriodForTermination_4f95ada6-5d53-4ca5-aa4a-243fd33a3f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_RevenueRemainingPerformanceObligationExpectedReimbursableResearchAndDevelopmentExpenses_62ac41b2-6e21-4790-9057-a2908506918d" xlink:href="camp-20241231.xsd#camp_RevenueRemainingPerformanceObligationExpectedReimbursableResearchAndDevelopmentExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_90141318-1305-48bb-a2c8-ffe701ab8e73" xlink:to="loc_camp_RevenueRemainingPerformanceObligationExpectedReimbursableResearchAndDevelopmentExpenses_62ac41b2-6e21-4790-9057-a2908506918d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_RevenueRemainingPerformanceObligationFixedConsiderationAmount_23eebbff-4eb6-446d-af87-878082df158e" xlink:href="camp-20241231.xsd#camp_RevenueRemainingPerformanceObligationFixedConsiderationAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_90141318-1305-48bb-a2c8-ffe701ab8e73" xlink:to="loc_camp_RevenueRemainingPerformanceObligationFixedConsiderationAmount_23eebbff-4eb6-446d-af87-878082df158e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_75e225a6-1621-4b34-ba6e-eb2df785fbc3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_90141318-1305-48bb-a2c8-ffe701ab8e73" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_75e225a6-1621-4b34-ba6e-eb2df785fbc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitNarrativeDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#ConvertiblePreferredStockandStockholdersDeficitNarrativeDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_7a7266c8-8bc4-4bd9-a5e3-09eb5a140d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_53b1537f-333f-4623-b54c-857397c2d25f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7a7266c8-8bc4-4bd9-a5e3-09eb5a140d3a" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_53b1537f-333f-4623-b54c-857397c2d25f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_cd8165a3-24eb-4376-aa98-e7b22361fe22" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_53b1537f-333f-4623-b54c-857397c2d25f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_cd8165a3-24eb-4376-aa98-e7b22361fe22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_df9a984a-a897-4b78-a74b-25df59bcefbf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_cd8165a3-24eb-4376-aa98-e7b22361fe22" xlink:to="loc_us-gaap_EquityComponentDomain_df9a984a-a897-4b78-a74b-25df59bcefbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_03be9ea4-e1bd-459b-9d14-b57ab04732ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_df9a984a-a897-4b78-a74b-25df59bcefbf" xlink:to="loc_us-gaap_CommonStockMember_03be9ea4-e1bd-459b-9d14-b57ab04732ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_06b8023d-c9fa-4339-879f-462559474f38" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_53b1537f-333f-4623-b54c-857397c2d25f" xlink:to="loc_us-gaap_ClassOfStockLineItems_06b8023d-c9fa-4339-879f-462559474f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_987f48c3-3f76-400f-862c-40373b809b23" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_06b8023d-c9fa-4339-879f-462559474f38" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_987f48c3-3f76-400f-862c-40373b809b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_7a71e9c1-3ba3-4d4f-806f-23d62a72485d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_06b8023d-c9fa-4339-879f-462559474f38" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_7a71e9c1-3ba3-4d4f-806f-23d62a72485d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_9554a8b1-c8a4-467d-ade1-504498add2d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_06b8023d-c9fa-4339-879f-462559474f38" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_9554a8b1-c8a4-467d-ade1-504498add2d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_d7371364-42b3-4d09-9083-36f5a272afef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_06b8023d-c9fa-4339-879f-462559474f38" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_d7371364-42b3-4d09-9083-36f5a272afef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5449907a-45a0-43bb-80a6-e1dddcb34525" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_06b8023d-c9fa-4339-879f-462559474f38" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5449907a-45a0-43bb-80a6-e1dddcb34525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_97683115-cb99-4418-9b26-36c53cc02e86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_06b8023d-c9fa-4339-879f-462559474f38" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_97683115-cb99-4418-9b26-36c53cc02e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_NumberOfVotesPerCommonShare_565027a5-5e67-4fe1-9db5-f9ebb2617e54" xlink:href="camp-20241231.xsd#camp_NumberOfVotesPerCommonShare"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_06b8023d-c9fa-4339-879f-462559474f38" xlink:to="loc_camp_NumberOfVotesPerCommonShare_565027a5-5e67-4fe1-9db5-f9ebb2617e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_5098b6d4-bdb4-46e2-97c0-619101599e50" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_06b8023d-c9fa-4339-879f-462559474f38" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_5098b6d4-bdb4-46e2-97c0-619101599e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareDeclared_207310c0-743d-4742-9a4a-add1ccec3b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockDividendsPerShareDeclared"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_06b8023d-c9fa-4339-879f-462559474f38" xlink:to="loc_us-gaap_PreferredStockDividendsPerShareDeclared_207310c0-743d-4742-9a4a-add1ccec3b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitSummaryofConvertiblePreferredStockDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#ConvertiblePreferredStockandStockholdersDeficitSummaryofConvertiblePreferredStockDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitSummaryofConvertiblePreferredStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_camp_ConvertiblePreferredStockAndStockholdersDeficitAbstract_53e92e6c-4520-484c-9015-b0a0d94e6d01" xlink:href="camp-20241231.xsd#camp_ConvertiblePreferredStockAndStockholdersDeficitAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_01f29b40-de5a-46d3-9684-7f1388f00df5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_ConvertiblePreferredStockAndStockholdersDeficitAbstract_53e92e6c-4520-484c-9015-b0a0d94e6d01" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_01f29b40-de5a-46d3-9684-7f1388f00df5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_dd14a038-a1ae-485a-ba56-8f6b30806692" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_01f29b40-de5a-46d3-9684-7f1388f00df5" xlink:to="loc_us-gaap_StatementClassOfStockAxis_dd14a038-a1ae-485a-ba56-8f6b30806692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_08387c2e-61d6-4074-9a96-c130040c75ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_dd14a038-a1ae-485a-ba56-8f6b30806692" xlink:to="loc_us-gaap_ClassOfStockDomain_08387c2e-61d6-4074-9a96-c130040c75ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_8099025a-2a86-46e8-8809-d499727aed6a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_08387c2e-61d6-4074-9a96-c130040c75ee" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_8099025a-2a86-46e8-8809-d499727aed6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_07d6284e-0a3a-4a42-b1d8-be34c4e87262" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_08387c2e-61d6-4074-9a96-c130040c75ee" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_07d6284e-0a3a-4a42-b1d8-be34c4e87262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_f3933efe-0ddc-4589-8ba9-1b80121b00dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_01f29b40-de5a-46d3-9684-7f1388f00df5" xlink:to="loc_us-gaap_TemporaryEquityLineItems_f3933efe-0ddc-4589-8ba9-1b80121b00dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_d04ecdf2-9a51-486a-a65e-efb1237929f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_f3933efe-0ddc-4589-8ba9-1b80121b00dd" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_d04ecdf2-9a51-486a-a65e-efb1237929f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_4052f75b-b572-4cc1-82fe-ab6a7abe4a72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_f3933efe-0ddc-4589-8ba9-1b80121b00dd" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_4052f75b-b572-4cc1-82fe-ab6a7abe4a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_9e98dbe5-741c-4bdc-92c5-9057e0168b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_f3933efe-0ddc-4589-8ba9-1b80121b00dd" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_9e98dbe5-741c-4bdc-92c5-9057e0168b3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLiquidationPreference_8f3e2f7f-8248-4b6a-bd82-15ef6e33547a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_f3933efe-0ddc-4589-8ba9-1b80121b00dd" xlink:to="loc_us-gaap_TemporaryEquityLiquidationPreference_8f3e2f7f-8248-4b6a-bd82-15ef6e33547a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockConvertibleSharesIssuable_66406e23-a08d-4604-a452-21a11296cd8a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockConvertibleSharesIssuable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_f3933efe-0ddc-4589-8ba9-1b80121b00dd" xlink:to="loc_us-gaap_PreferredStockConvertibleSharesIssuable_66406e23-a08d-4604-a452-21a11296cd8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitScheduleofCommonStockIssuanceUponConversionDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#ConvertiblePreferredStockandStockholdersDeficitScheduleofCommonStockIssuanceUponConversionDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitScheduleofCommonStockIssuanceUponConversionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_camp_ConvertiblePreferredStockAndStockholdersDeficitAbstract_fb6ada88-3cad-4aa8-912a-419c3723899c" xlink:href="camp-20241231.xsd#camp_ConvertiblePreferredStockAndStockholdersDeficitAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_fa781c9b-dcb5-4c1d-8946-7f6bfa2928d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_ConvertiblePreferredStockAndStockholdersDeficitAbstract_fb6ada88-3cad-4aa8-912a-419c3723899c" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_fa781c9b-dcb5-4c1d-8946-7f6bfa2928d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_58e79240-01f9-4254-8ccb-3c9048cb0137" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_fa781c9b-dcb5-4c1d-8946-7f6bfa2928d1" xlink:to="loc_us-gaap_PlanNameAxis_58e79240-01f9-4254-8ccb-3c9048cb0137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_0bc28cb5-ca49-4fb8-89a7-3b33b7458efc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_58e79240-01f9-4254-8ccb-3c9048cb0137" xlink:to="loc_us-gaap_PlanNameDomain_0bc28cb5-ca49-4fb8-89a7-3b33b7458efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_MarauderTherapeuticsInc2016StockOptionAndGrantPlanMember_2aaca45d-7b50-4d5d-af0f-9c9147594d48" xlink:href="camp-20241231.xsd#camp_MarauderTherapeuticsInc2016StockOptionAndGrantPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_0bc28cb5-ca49-4fb8-89a7-3b33b7458efc" xlink:to="loc_camp_MarauderTherapeuticsInc2016StockOptionAndGrantPlanMember_2aaca45d-7b50-4d5d-af0f-9c9147594d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_1717f4ea-a63e-4893-b185-28ef1b69d6cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_fa781c9b-dcb5-4c1d-8946-7f6bfa2928d1" xlink:to="loc_us-gaap_ClassOfStockLineItems_1717f4ea-a63e-4893-b185-28ef1b69d6cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_2de3f643-dffb-475e-a9b9-10a7ed0b7da4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1717f4ea-a63e-4893-b185-28ef1b69d6cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_2de3f643-dffb-475e-a9b9-10a7ed0b7da4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f887e64e-5049-46ff-90b4-42261de9463e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1717f4ea-a63e-4893-b185-28ef1b69d6cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f887e64e-5049-46ff-90b4-42261de9463e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ddb7ce6c-d536-435f-8445-994e62d1f00a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1717f4ea-a63e-4893-b185-28ef1b69d6cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ddb7ce6c-d536-435f-8445-994e62d1f00a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_412ccebe-cb4e-4d76-b252-6f4df8d9a7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1717f4ea-a63e-4893-b185-28ef1b69d6cc" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_412ccebe-cb4e-4d76-b252-6f4df8d9a7ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_811e9900-4e76-4695-a0fd-67ea87187479" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1717f4ea-a63e-4893-b185-28ef1b69d6cc" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_811e9900-4e76-4695-a0fd-67ea87187479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/StockBasedCompensation2024EquityIncentivePlanNarrativeDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#StockBasedCompensation2024EquityIncentivePlanNarrativeDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/StockBasedCompensation2024EquityIncentivePlanNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_343d0e74-c75c-45d9-8f31-f0e3fa5a9d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_93c0f07b-e7c8-4ad0-9ab3-dfa988d5e2fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_343d0e74-c75c-45d9-8f31-f0e3fa5a9d7b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_93c0f07b-e7c8-4ad0-9ab3-dfa988d5e2fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_b8141095-393a-4b4e-8fdc-3459133ac396" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_93c0f07b-e7c8-4ad0-9ab3-dfa988d5e2fe" xlink:to="loc_us-gaap_PlanNameAxis_b8141095-393a-4b4e-8fdc-3459133ac396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_238a297d-0a92-4d55-a06a-1f6a9337df9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_b8141095-393a-4b4e-8fdc-3459133ac396" xlink:to="loc_us-gaap_PlanNameDomain_238a297d-0a92-4d55-a06a-1f6a9337df9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_A2024EquityIncentivePlanMember_6edd468c-e836-45d8-af7a-4b8c1f1c5f4c" xlink:href="camp-20241231.xsd#camp_A2024EquityIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_238a297d-0a92-4d55-a06a-1f6a9337df9d" xlink:to="loc_camp_A2024EquityIncentivePlanMember_6edd468c-e836-45d8-af7a-4b8c1f1c5f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_331ef839-8920-46a3-8fea-1357d4c5622d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_93c0f07b-e7c8-4ad0-9ab3-dfa988d5e2fe" xlink:to="loc_srt_RangeAxis_331ef839-8920-46a3-8fea-1357d4c5622d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1be38ea4-a51a-46da-b0af-f31b9c47c5e5" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_331ef839-8920-46a3-8fea-1357d4c5622d" xlink:to="loc_srt_RangeMember_1be38ea4-a51a-46da-b0af-f31b9c47c5e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6109345d-8b49-428e-93f3-abfb1566cde8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1be38ea4-a51a-46da-b0af-f31b9c47c5e5" xlink:to="loc_srt_MinimumMember_6109345d-8b49-428e-93f3-abfb1566cde8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c58e6cad-0260-425b-a263-194d86429593" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_93c0f07b-e7c8-4ad0-9ab3-dfa988d5e2fe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c58e6cad-0260-425b-a263-194d86429593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_8a1f1608-2619-4314-a1d8-27045c8feaf8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c58e6cad-0260-425b-a263-194d86429593" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_8a1f1608-2619-4314-a1d8-27045c8feaf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfEstimatedFairValueOnGrantDate_efd0994e-4bab-4072-b34c-333214fcbb5d" xlink:href="camp-20241231.xsd#camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfEstimatedFairValueOnGrantDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c58e6cad-0260-425b-a263-194d86429593" xlink:to="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfEstimatedFairValueOnGrantDate_efd0994e-4bab-4072-b34c-333214fcbb5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c2509774-b47f-42f2-8b10-0d2f5b85d521" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c58e6cad-0260-425b-a263-194d86429593" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c2509774-b47f-42f2-8b10-0d2f5b85d521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f31b55c6-9ac6-4a31-b4ad-bfd67162d660" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c58e6cad-0260-425b-a263-194d86429593" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f31b55c6-9ac6-4a31-b4ad-bfd67162d660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_a1f13618-026a-43ca-b5a4-765a6cddc8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c58e6cad-0260-425b-a263-194d86429593" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_a1f13618-026a-43ca-b5a4-765a6cddc8f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/StockBasedCompensation2024EmployeeStockPurchasePlanNarrativeDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#StockBasedCompensation2024EmployeeStockPurchasePlanNarrativeDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/StockBasedCompensation2024EmployeeStockPurchasePlanNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6475cdc9-0f6c-489f-aed9-c2fcca42dc2b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fc039c0d-e2c5-495b-b24c-8747bb2fbaf8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6475cdc9-0f6c-489f-aed9-c2fcca42dc2b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fc039c0d-e2c5-495b-b24c-8747bb2fbaf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f4c26e5d-fa4e-4937-9716-072aad15e6a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fc039c0d-e2c5-495b-b24c-8747bb2fbaf8" xlink:to="loc_us-gaap_AwardTypeAxis_f4c26e5d-fa4e-4937-9716-072aad15e6a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_87cd4379-608e-4374-95c4-7afed41894b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_f4c26e5d-fa4e-4937-9716-072aad15e6a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_87cd4379-608e-4374-95c4-7afed41894b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_a61b14c6-34c4-417e-84ea-2977583b4517" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_87cd4379-608e-4374-95c4-7afed41894b1" xlink:to="loc_us-gaap_EmployeeStockMember_a61b14c6-34c4-417e-84ea-2977583b4517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7bc04fb7-bc12-4030-831b-29d36b00e998" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fc039c0d-e2c5-495b-b24c-8747bb2fbaf8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7bc04fb7-bc12-4030-831b-29d36b00e998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_7059e726-28bc-4ec5-85de-63807ad84c53" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7bc04fb7-bc12-4030-831b-29d36b00e998" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_7059e726-28bc-4ec5-85de-63807ad84c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_97faa049-6c57-4c4e-9a5e-1de6da7902eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7bc04fb7-bc12-4030-831b-29d36b00e998" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_97faa049-6c57-4c4e-9a5e-1de6da7902eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_d3fb1448-540d-4647-8696-d8faba7bc8d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7bc04fb7-bc12-4030-831b-29d36b00e998" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_d3fb1448-540d-4647-8696-d8faba7bc8d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsFairValueAssumptionsDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#StockBasedCompensationScheduleofStockOptionsFairValueAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsFairValueAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0c77f28b-4e59-40ca-8c31-cd30769af186" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4477c5cf-fae1-422d-a1ef-8080f092f8cb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0c77f28b-4e59-40ca-8c31-cd30769af186" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4477c5cf-fae1-422d-a1ef-8080f092f8cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a92db3b9-1405-4cae-9c7e-724d2e305433" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4477c5cf-fae1-422d-a1ef-8080f092f8cb" xlink:to="loc_us-gaap_AwardTypeAxis_a92db3b9-1405-4cae-9c7e-724d2e305433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bc9ab28b-315f-4120-b4b5-8f9234de577e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a92db3b9-1405-4cae-9c7e-724d2e305433" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bc9ab28b-315f-4120-b4b5-8f9234de577e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_05b8ecc5-5841-4fa8-9f2b-a58e1b4ae349" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bc9ab28b-315f-4120-b4b5-8f9234de577e" xlink:to="loc_us-gaap_EmployeeStockOptionMember_05b8ecc5-5841-4fa8-9f2b-a58e1b4ae349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86f4f028-e783-4965-86fd-0006f5013a44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4477c5cf-fae1-422d-a1ef-8080f092f8cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86f4f028-e783-4965-86fd-0006f5013a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_b363fd4a-1bc6-4b79-a78c-640cb11cb2f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86f4f028-e783-4965-86fd-0006f5013a44" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_b363fd4a-1bc6-4b79-a78c-640cb11cb2f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_a5e490ad-b583-4e72-8712-f2009208d100" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86f4f028-e783-4965-86fd-0006f5013a44" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_a5e490ad-b583-4e72-8712-f2009208d100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_5c804717-5b76-4746-906c-68dab80d9b35" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86f4f028-e783-4965-86fd-0006f5013a44" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_5c804717-5b76-4746-906c-68dab80d9b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_bed40e21-8169-403d-b61d-e0ed17419e53" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86f4f028-e783-4965-86fd-0006f5013a44" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_bed40e21-8169-403d-b61d-e0ed17419e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/StockBasedCompensationStockOptionActivityNarrativeDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#StockBasedCompensationStockOptionActivityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/StockBasedCompensationStockOptionActivityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_445fdb47-130a-4bee-9dd8-23919743560d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9ae5ea74-d183-441c-bc94-21d1aa000bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_445fdb47-130a-4bee-9dd8-23919743560d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9ae5ea74-d183-441c-bc94-21d1aa000bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_a1107340-aade-4dff-8ab6-31c4a94b8420" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9ae5ea74-d183-441c-bc94-21d1aa000bb5" xlink:to="loc_srt_CounterpartyNameAxis_a1107340-aade-4dff-8ab6-31c4a94b8420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_64a2a287-5d9b-4ca6-9727-53d0a542e53d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_a1107340-aade-4dff-8ab6-31c4a94b8420" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_64a2a287-5d9b-4ca6-9727-53d0a542e53d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_CertainExecutivesMember_2a26c7c7-2fae-4f0f-8707-8cb479461d67" xlink:href="camp-20241231.xsd#camp_CertainExecutivesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_64a2a287-5d9b-4ca6-9727-53d0a542e53d" xlink:to="loc_camp_CertainExecutivesMember_2a26c7c7-2fae-4f0f-8707-8cb479461d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e33c080b-caa4-41cd-b147-9e2776f7c425" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9ae5ea74-d183-441c-bc94-21d1aa000bb5" xlink:to="loc_us-gaap_AwardTypeAxis_e33c080b-caa4-41cd-b147-9e2776f7c425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_399298c6-23ac-49c3-b0c9-7d869665d6f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_e33c080b-caa4-41cd-b147-9e2776f7c425" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_399298c6-23ac-49c3-b0c9-7d869665d6f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_7e708530-6852-4c16-be31-65b439895ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_399298c6-23ac-49c3-b0c9-7d869665d6f6" xlink:to="loc_us-gaap_EmployeeStockOptionMember_7e708530-6852-4c16-be31-65b439895ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_81038954-b7b9-4d0f-bfa3-95a1dbdb7983" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9ae5ea74-d183-441c-bc94-21d1aa000bb5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_81038954-b7b9-4d0f-bfa3-95a1dbdb7983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ce61e993-a804-4b3f-8462-9d9fbd15d213" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_81038954-b7b9-4d0f-bfa3-95a1dbdb7983" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ce61e993-a804-4b3f-8462-9d9fbd15d213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_a5eac051-979c-4162-917d-52c1f8f4a234" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_81038954-b7b9-4d0f-bfa3-95a1dbdb7983" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_a5eac051-979c-4162-917d-52c1f8f4a234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_UnrecordedNotesPayableIssuedForStockOptionEarlyExercise_127ab87e-798e-49f8-a9c7-b6d9d92fc45f" xlink:href="camp-20241231.xsd#camp_UnrecordedNotesPayableIssuedForStockOptionEarlyExercise"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_81038954-b7b9-4d0f-bfa3-95a1dbdb7983" xlink:to="loc_camp_UnrecordedNotesPayableIssuedForStockOptionEarlyExercise_127ab87e-798e-49f8-a9c7-b6d9d92fc45f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1d3285d3-dd0e-40d3-a703-276cdea8050b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_81038954-b7b9-4d0f-bfa3-95a1dbdb7983" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1d3285d3-dd0e-40d3-a703-276cdea8050b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAfterEarlyExerciseDueToNotesPayableForgiveness_0ef63e88-dc2a-405a-b809-c041adf1cf12" xlink:href="camp-20241231.xsd#camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAfterEarlyExerciseDueToNotesPayableForgiveness"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_81038954-b7b9-4d0f-bfa3-95a1dbdb7983" xlink:to="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAfterEarlyExerciseDueToNotesPayableForgiveness_0ef63e88-dc2a-405a-b809-c041adf1cf12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_0326814f-c227-4ecd-94fd-8e0b9810a6a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_81038954-b7b9-4d0f-bfa3-95a1dbdb7983" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_0326814f-c227-4ecd-94fd-8e0b9810a6a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_a62aaa69-bb18-4135-9a17-51d8af964b97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_81038954-b7b9-4d0f-bfa3-95a1dbdb7983" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_a62aaa69-bb18-4135-9a17-51d8af964b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d97e064e-d03f-4599-b2ab-9a437007b4bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_81038954-b7b9-4d0f-bfa3-95a1dbdb7983" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d97e064e-d03f-4599-b2ab-9a437007b4bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#StockBasedCompensationScheduleofStockOptionsActivityDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1049e1f3-7803-45df-96e1-c79863a041c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c4fe07f1-07e5-4be6-80ea-dd16af95faf0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1049e1f3-7803-45df-96e1-c79863a041c6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c4fe07f1-07e5-4be6-80ea-dd16af95faf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d15ca2a0-eb2f-4d78-8e21-c9887fe4a59e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c4fe07f1-07e5-4be6-80ea-dd16af95faf0" xlink:to="loc_us-gaap_AwardTypeAxis_d15ca2a0-eb2f-4d78-8e21-c9887fe4a59e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6868243b-ade2-4317-97a1-1caa491b2cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_d15ca2a0-eb2f-4d78-8e21-c9887fe4a59e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6868243b-ade2-4317-97a1-1caa491b2cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e79d5b27-5155-40f2-af40-9b30481225fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6868243b-ade2-4317-97a1-1caa491b2cc4" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e79d5b27-5155-40f2-af40-9b30481225fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28c6c5de-4921-4346-abc8-dc650b91dce3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c4fe07f1-07e5-4be6-80ea-dd16af95faf0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28c6c5de-4921-4346-abc8-dc650b91dce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0b9941dc-9c4a-4fa4-bf44-3b4b438a6418" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28c6c5de-4921-4346-abc8-dc650b91dce3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0b9941dc-9c4a-4fa4-bf44-3b4b438a6418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9b99e704-7a9e-4915-8fa1-39690d6e4610" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0b9941dc-9c4a-4fa4-bf44-3b4b438a6418" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9b99e704-7a9e-4915-8fa1-39690d6e4610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_72c8bd1e-1a79-484a-a907-8ca47e688a43" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0b9941dc-9c4a-4fa4-bf44-3b4b438a6418" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_72c8bd1e-1a79-484a-a907-8ca47e688a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c4996154-1fbc-4e87-ac02-ca5f8177c7fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0b9941dc-9c4a-4fa4-bf44-3b4b438a6418" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c4996154-1fbc-4e87-ac02-ca5f8177c7fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d0b4fef0-fd4e-41e1-a79a-6d12ced8bde5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0b9941dc-9c4a-4fa4-bf44-3b4b438a6418" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d0b4fef0-fd4e-41e1-a79a-6d12ced8bde5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_28dbc3ef-f861-4782-a013-b36299f19237" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0b9941dc-9c4a-4fa4-bf44-3b4b438a6418" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_28dbc3ef-f861-4782-a013-b36299f19237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_341de741-beef-4cc3-a14f-15368e2140bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0b9941dc-9c4a-4fa4-bf44-3b4b438a6418" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_341de741-beef-4cc3-a14f-15368e2140bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_3edf22c7-13a9-41c7-b5ae-1faf5ce388c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0b9941dc-9c4a-4fa4-bf44-3b4b438a6418" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_3edf22c7-13a9-41c7-b5ae-1faf5ce388c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_WeightedAverageExercisePriceRollForward_bc81d3ab-9456-4924-befe-c2b73370bb26" xlink:href="camp-20241231.xsd#camp_WeightedAverageExercisePriceRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28c6c5de-4921-4346-abc8-dc650b91dce3" xlink:to="loc_camp_WeightedAverageExercisePriceRollForward_bc81d3ab-9456-4924-befe-c2b73370bb26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_87d76c80-f381-46b4-9cc9-b64ba5873f57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_WeightedAverageExercisePriceRollForward_bc81d3ab-9456-4924-befe-c2b73370bb26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_87d76c80-f381-46b4-9cc9-b64ba5873f57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_14e878ed-d7dd-4a05-bc33-a7d9ce5d9dd1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_WeightedAverageExercisePriceRollForward_bc81d3ab-9456-4924-befe-c2b73370bb26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_14e878ed-d7dd-4a05-bc33-a7d9ce5d9dd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_393d3eb1-3e81-45e0-b660-b6b78d9367d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_WeightedAverageExercisePriceRollForward_bc81d3ab-9456-4924-befe-c2b73370bb26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_393d3eb1-3e81-45e0-b660-b6b78d9367d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d1c5c4e9-8c7b-4470-a061-3fed15cdec08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_WeightedAverageExercisePriceRollForward_bc81d3ab-9456-4924-befe-c2b73370bb26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d1c5c4e9-8c7b-4470-a061-3fed15cdec08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_8eac2b9c-8c35-45fe-b9b0-9050e36ff69b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_WeightedAverageExercisePriceRollForward_bc81d3ab-9456-4924-befe-c2b73370bb26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_8eac2b9c-8c35-45fe-b9b0-9050e36ff69b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_5ed1428f-d54d-4ddd-bbd5-1c0e26890dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28c6c5de-4921-4346-abc8-dc650b91dce3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_5ed1428f-d54d-4ddd-bbd5-1c0e26890dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_eeb4e8d8-da43-4795-840d-7449dd524086" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28c6c5de-4921-4346-abc8-dc650b91dce3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_eeb4e8d8-da43-4795-840d-7449dd524086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_922becc9-4c15-4e80-a97f-70e6361d99a4" xlink:href="camp-20241231.xsd#camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28c6c5de-4921-4346-abc8-dc650b91dce3" xlink:to="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_922becc9-4c15-4e80-a97f-70e6361d99a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_14e60843-dc4c-4de8-b53c-785bc714365a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_922becc9-4c15-4e80-a97f-70e6361d99a4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_14e60843-dc4c-4de8-b53c-785bc714365a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_4464cbf5-4029-4e26-89d7-bd86b361969c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_922becc9-4c15-4e80-a97f-70e6361d99a4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_4464cbf5-4029-4e26-89d7-bd86b361969c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_f428f6a3-16d6-47d0-a2d7-e47df9d506cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_922becc9-4c15-4e80-a97f-70e6361d99a4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_f428f6a3-16d6-47d0-a2d7-e47df9d506cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueRollForward_1970cbdd-ea70-4e2b-b3e3-25f7fb34c3e6" xlink:href="camp-20241231.xsd#camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueRollForward"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28c6c5de-4921-4346-abc8-dc650b91dce3" xlink:to="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueRollForward_1970cbdd-ea70-4e2b-b3e3-25f7fb34c3e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_349c30d7-ea62-4b0f-a692-ff0a04cbb3cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueRollForward_1970cbdd-ea70-4e2b-b3e3-25f7fb34c3e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_349c30d7-ea62-4b0f-a692-ff0a04cbb3cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_e45d77b5-8381-4866-b835-285eb2ca0831" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueRollForward_1970cbdd-ea70-4e2b-b3e3-25f7fb34c3e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_e45d77b5-8381-4866-b835-285eb2ca0831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_6c6d3ac2-011b-4bd9-8e37-7d9c4c6578db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueRollForward_1970cbdd-ea70-4e2b-b3e3-25f7fb34c3e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_6c6d3ac2-011b-4bd9-8e37-7d9c4c6578db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_4dfceab6-9e26-46c9-b89d-1221d4369d11" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28c6c5de-4921-4346-abc8-dc650b91dce3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_4dfceab6-9e26-46c9-b89d-1221d4369d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2e7658d5-e281-45f7-af44-a2b84ff5c108" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28c6c5de-4921-4346-abc8-dc650b91dce3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2e7658d5-e281-45f7-af44-a2b84ff5c108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/StockBasedCompensationScheduleofRestrictedStockActivityDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#StockBasedCompensationScheduleofRestrictedStockActivityDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/StockBasedCompensationScheduleofRestrictedStockActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bd828d3a-f60b-46f8-8527-459833ca2434" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f6c063c6-6957-48c9-8164-bfd830e5adef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bd828d3a-f60b-46f8-8527-459833ca2434" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f6c063c6-6957-48c9-8164-bfd830e5adef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5c99f679-87fb-4bf6-bd75-bd318a61d309" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f6c063c6-6957-48c9-8164-bfd830e5adef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5c99f679-87fb-4bf6-bd75-bd318a61d309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_aff6512c-9872-4db2-b6fe-14a78953c069" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f6c063c6-6957-48c9-8164-bfd830e5adef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_aff6512c-9872-4db2-b6fe-14a78953c069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3f14f460-5e76-4d53-9069-faf541f0bb00" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f6c063c6-6957-48c9-8164-bfd830e5adef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3f14f460-5e76-4d53-9069-faf541f0bb00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_WeightedAverageExercisePriceRollForward_f07e81ec-d4ee-4412-aaad-be3c790dda2d" xlink:href="camp-20241231.xsd#camp_WeightedAverageExercisePriceRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bd828d3a-f60b-46f8-8527-459833ca2434" xlink:to="loc_camp_WeightedAverageExercisePriceRollForward_f07e81ec-d4ee-4412-aaad-be3c790dda2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_41e533ca-5b4f-41be-963f-f71b5f0a5092" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_WeightedAverageExercisePriceRollForward_f07e81ec-d4ee-4412-aaad-be3c790dda2d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_41e533ca-5b4f-41be-963f-f71b5f0a5092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_458f58e3-8167-4a6c-87d6-c5f4c8bace17" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_WeightedAverageExercisePriceRollForward_f07e81ec-d4ee-4412-aaad-be3c790dda2d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_458f58e3-8167-4a6c-87d6-c5f4c8bace17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d82dd368-41b2-47cd-b44e-1440219d3b99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_camp_WeightedAverageExercisePriceRollForward_f07e81ec-d4ee-4412-aaad-be3c790dda2d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d82dd368-41b2-47cd-b44e-1440219d3b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/StockBasedCompensationRestrictedStockAwardsNarrativeDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#StockBasedCompensationRestrictedStockAwardsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/StockBasedCompensationRestrictedStockAwardsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1d740aec-90ba-4a95-9f8b-4d9bc1ddfa68" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1ff54fb4-0a74-4977-8028-f427348ab52b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1d740aec-90ba-4a95-9f8b-4d9bc1ddfa68" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1ff54fb4-0a74-4977-8028-f427348ab52b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_605f7130-4b63-4842-9153-a68ff0251b20" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1ff54fb4-0a74-4977-8028-f427348ab52b" xlink:to="loc_us-gaap_AwardTypeAxis_605f7130-4b63-4842-9153-a68ff0251b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa611204-c514-469f-a7d0-260e2bd99b06" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_605f7130-4b63-4842-9153-a68ff0251b20" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa611204-c514-469f-a7d0-260e2bd99b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_fbcb2207-c1b8-4c02-8d22-af35977c0b78" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa611204-c514-469f-a7d0-260e2bd99b06" xlink:to="loc_us-gaap_RestrictedStockMember_fbcb2207-c1b8-4c02-8d22-af35977c0b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1fb00965-796b-473a-aa80-0cabcb63cbe5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1ff54fb4-0a74-4977-8028-f427348ab52b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1fb00965-796b-473a-aa80-0cabcb63cbe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_8c840d37-a0da-49e3-860b-bd6ff365480b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1fb00965-796b-473a-aa80-0cabcb63cbe5" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_8c840d37-a0da-49e3-860b-bd6ff365480b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_a832643e-ab5a-458f-9975-bccb5bb75cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1fb00965-796b-473a-aa80-0cabcb63cbe5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_a832643e-ab5a-458f-9975-bccb5bb75cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/StockBasedCompensationScheduleofStockbasedCompensationExpenseDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#StockBasedCompensationScheduleofStockbasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/StockBasedCompensationScheduleofStockbasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7488387b-2a33-40f9-8f6d-9eced94f0372" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b4857a3c-2ad1-4b07-8384-69004f0d3652" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7488387b-2a33-40f9-8f6d-9eced94f0372" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b4857a3c-2ad1-4b07-8384-69004f0d3652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_5691c320-b226-41de-a65d-ff20b9f04151" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b4857a3c-2ad1-4b07-8384-69004f0d3652" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_5691c320-b226-41de-a65d-ff20b9f04151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_12bd8db7-0093-4e02-9a4b-e39bcbd7081d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_5691c320-b226-41de-a65d-ff20b9f04151" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_12bd8db7-0093-4e02-9a4b-e39bcbd7081d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_ce8ec9ce-2d55-42ce-97be-42ef1a8f19fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_12bd8db7-0093-4e02-9a4b-e39bcbd7081d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_ce8ec9ce-2d55-42ce-97be-42ef1a8f19fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_10b1f210-96e5-4627-a098-18b3e6c549e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_12bd8db7-0093-4e02-9a4b-e39bcbd7081d" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_10b1f210-96e5-4627-a098-18b3e6c549e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_f9ae070e-de64-4dcd-b04a-efd65c283dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b4857a3c-2ad1-4b07-8384-69004f0d3652" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_f9ae070e-de64-4dcd-b04a-efd65c283dcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_96d7d9c0-81ce-4a6c-98f5-0226b350516b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_f9ae070e-de64-4dcd-b04a-efd65c283dcb" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_96d7d9c0-81ce-4a6c-98f5-0226b350516b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/EmployeeBenefitPlanDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#EmployeeBenefitPlanDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/EmployeeBenefitPlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanAbstract_7d40150c-405e-42ea-a047-5d078c1d28c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_93d00d4d-95fe-4521-99f3-81e71f2b6587" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPlanAbstract_7d40150c-405e-42ea-a047-5d078c1d28c6" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_93d00d4d-95fe-4521-99f3-81e71f2b6587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_1ceb9702-6754-4696-a2c4-72804e068802" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPlanAbstract_7d40150c-405e-42ea-a047-5d078c1d28c6" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_1ceb9702-6754-4696-a2c4-72804e068802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_1445ce5f-6f5b-4ded-8006-973a77dff586" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPlanAbstract_7d40150c-405e-42ea-a047-5d078c1d28c6" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_1445ce5f-6f5b-4ded-8006-973a77dff586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_52bd6b60-a34c-4243-a3d2-b878f9623c27" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPlanAbstract_7d40150c-405e-42ea-a047-5d078c1d28c6" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_52bd6b60-a34c-4243-a3d2-b878f9623c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6691ade3-fd82-44a2-a512-653f0cf54a32" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_5a0fc1cf-0165-486c-8ab4-355c47770b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6691ade3-fd82-44a2-a512-653f0cf54a32" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_5a0fc1cf-0165-486c-8ab4-355c47770b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_97754ddf-28e7-4b54-9996-561fd6cf7ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_5a0fc1cf-0165-486c-8ab4-355c47770b9e" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_97754ddf-28e7-4b54-9996-561fd6cf7ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_b501b81a-bd41-4337-a194-39e488ad39d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_97754ddf-28e7-4b54-9996-561fd6cf7ddd" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_b501b81a-bd41-4337-a194-39e488ad39d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_057e5464-1f35-4cbf-a831-70b920e2e68e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_b501b81a-bd41-4337-a194-39e488ad39d7" xlink:to="loc_us-gaap_DomesticCountryMember_057e5464-1f35-4cbf-a831-70b920e2e68e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_54cbe34a-0a12-4ca1-b793-63b4b5b0f3cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_b501b81a-bd41-4337-a194-39e488ad39d7" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_54cbe34a-0a12-4ca1-b793-63b4b5b0f3cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_c51027cf-fb8f-40cd-bcd4-4087f0feab06" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_5a0fc1cf-0165-486c-8ab4-355c47770b9e" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_c51027cf-fb8f-40cd-bcd4-4087f0feab06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_672e2498-a0ff-4de5-90f2-e25a07745d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_c51027cf-fb8f-40cd-bcd4-4087f0feab06" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_672e2498-a0ff-4de5-90f2-e25a07745d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_11960781-5bdb-4bab-8972-0a41cadb763e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_c51027cf-fb8f-40cd-bcd4-4087f0feab06" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_11960781-5bdb-4bab-8972-0a41cadb763e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_df370bd4-d48a-409c-96a0-564004826af3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_c51027cf-fb8f-40cd-bcd4-4087f0feab06" xlink:to="loc_us-gaap_OperatingLossCarryforwards_df370bd4-d48a-409c-96a0-564004826af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_OperatingLossCarryforwardsSubjectToExpiration_36ea628e-c265-4cc2-bec1-76630a47d0e2" xlink:href="camp-20241231.xsd#camp_OperatingLossCarryforwardsSubjectToExpiration"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_c51027cf-fb8f-40cd-bcd4-4087f0feab06" xlink:to="loc_camp_OperatingLossCarryforwardsSubjectToExpiration_36ea628e-c265-4cc2-bec1-76630a47d0e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_OperatingLossCarryforwardsNotSubjectToExpiration_c5a1ceae-a7d1-42ca-aa09-5797ea921b42" xlink:href="camp-20241231.xsd#camp_OperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_c51027cf-fb8f-40cd-bcd4-4087f0feab06" xlink:to="loc_camp_OperatingLossCarryforwardsNotSubjectToExpiration_c5a1ceae-a7d1-42ca-aa09-5797ea921b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_2e77bb9f-1104-4b79-9ad4-2911cdbea604" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_c51027cf-fb8f-40cd-bcd4-4087f0feab06" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_2e77bb9f-1104-4b79-9ad4-2911cdbea604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_CapitalizedResearchAndDevelopmentCosts_28159017-b3db-48d7-9a2f-ccc6c695fe95" xlink:href="camp-20241231.xsd#camp_CapitalizedResearchAndDevelopmentCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_c51027cf-fb8f-40cd-bcd4-4087f0feab06" xlink:to="loc_camp_CapitalizedResearchAndDevelopmentCosts_28159017-b3db-48d7-9a2f-ccc6c695fe95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_f728ad15-6067-4c65-a6ae-e36d9e2824b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_c51027cf-fb8f-40cd-bcd4-4087f0feab06" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_f728ad15-6067-4c65-a6ae-e36d9e2824b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_92f5bf18-ff33-4c78-9efb-432008a84d10" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_c51027cf-fb8f-40cd-bcd4-4087f0feab06" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_92f5bf18-ff33-4c78-9efb-432008a84d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_dcc27e43-6495-4b85-a6d6-35d5a3191e75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_58eae7a2-6e35-4e98-a538-60a34f054064" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dcc27e43-6495-4b85-a6d6-35d5a3191e75" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_58eae7a2-6e35-4e98-a538-60a34f054064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_95a69527-ecec-40d6-a82a-b6cded6809b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dcc27e43-6495-4b85-a6d6-35d5a3191e75" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_95a69527-ecec-40d6-a82a-b6cded6809b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_1fc043bc-62e2-413b-9749-0c9d512d6e7b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dcc27e43-6495-4b85-a6d6-35d5a3191e75" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_1fc043bc-62e2-413b-9749-0c9d512d6e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_7b573409-9213-4bae-8d1a-ec6e1139172b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dcc27e43-6495-4b85-a6d6-35d5a3191e75" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_7b573409-9213-4bae-8d1a-ec6e1139172b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_385717c7-a2da-4882-ac19-0f6158dad6e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dcc27e43-6495-4b85-a6d6-35d5a3191e75" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_385717c7-a2da-4882-ac19-0f6158dad6e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_3e75ae33-7713-4739-8b71-c8a0c61ad22c" xlink:href="camp-20241231.xsd#camp_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dcc27e43-6495-4b85-a6d6-35d5a3191e75" xlink:to="loc_camp_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_3e75ae33-7713-4739-8b71-c8a0c61ad22c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_4c4d3269-c216-4173-8f78-82a1ec3a836e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dcc27e43-6495-4b85-a6d6-35d5a3191e75" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_4c4d3269-c216-4173-8f78-82a1ec3a836e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_80b277cc-b3b8-4fe2-a259-1c30b45266f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9d7fbdbd-9082-4dde-9708-83ac912ddace" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_80b277cc-b3b8-4fe2-a259-1c30b45266f6" xlink:to="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9d7fbdbd-9082-4dde-9708-83ac912ddace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_442f1b2a-82f2-43ef-9771-0f293542abc1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9d7fbdbd-9082-4dde-9708-83ac912ddace" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_442f1b2a-82f2-43ef-9771-0f293542abc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_be6221f6-a269-425e-ad75-77b3ad72d228" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9d7fbdbd-9082-4dde-9708-83ac912ddace" xlink:to="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_be6221f6-a269-425e-ad75-77b3ad72d228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_83e7a2ef-4356-41ca-b463-2b11835d45ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9d7fbdbd-9082-4dde-9708-83ac912ddace" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_83e7a2ef-4356-41ca-b463-2b11835d45ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_DeferredTaxAssetsLeasingArrangements_50d8b068-834d-4587-95c9-f61dbc1c5e68" xlink:href="camp-20241231.xsd#camp_DeferredTaxAssetsLeasingArrangements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9d7fbdbd-9082-4dde-9708-83ac912ddace" xlink:to="loc_camp_DeferredTaxAssetsLeasingArrangements_50d8b068-834d-4587-95c9-f61dbc1c5e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures_cfdf4064-a06d-4021-b3fd-11683bde77a8" xlink:href="camp-20241231.xsd#camp_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9d7fbdbd-9082-4dde-9708-83ac912ddace" xlink:to="loc_camp_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures_cfdf4064-a06d-4021-b3fd-11683bde77a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_f6f359be-31c1-41d2-ba4e-460fdcf4feb1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9d7fbdbd-9082-4dde-9708-83ac912ddace" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_f6f359be-31c1-41d2-ba4e-460fdcf4feb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_49c17710-f3a7-4980-8223-a794277188aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9d7fbdbd-9082-4dde-9708-83ac912ddace" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_49c17710-f3a7-4980-8223-a794277188aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6ed2bc5a-1248-4cbd-9ca6-6c13e066b362" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_80b277cc-b3b8-4fe2-a259-1c30b45266f6" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6ed2bc5a-1248-4cbd-9ca6-6c13e066b362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_e549a8b1-82cf-40eb-ae24-8fcffc907c40" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6ed2bc5a-1248-4cbd-9ca6-6c13e066b362" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_e549a8b1-82cf-40eb-ae24-8fcffc907c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_60df838f-5727-48b4-a636-06593ed7c5f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6ed2bc5a-1248-4cbd-9ca6-6c13e066b362" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_60df838f-5727-48b4-a636-06593ed7c5f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_DeferredTaxAssetsLiabilitiesGross_53402be0-2a42-4aa4-a4ac-7be1127e2f8e" xlink:href="camp-20241231.xsd#camp_DeferredTaxAssetsLiabilitiesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_80b277cc-b3b8-4fe2-a259-1c30b45266f6" xlink:to="loc_camp_DeferredTaxAssetsLiabilitiesGross_53402be0-2a42-4aa4-a4ac-7be1127e2f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_9d52c7a0-b578-482f-9f16-3038ec67cff1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_80b277cc-b3b8-4fe2-a259-1c30b45266f6" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_9d52c7a0-b578-482f-9f16-3038ec67cff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_73b40e88-6910-4ec6-93ad-30e9b32804ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_80b277cc-b3b8-4fe2-a259-1c30b45266f6" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_73b40e88-6910-4ec6-93ad-30e9b32804ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/SegmentReportingDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#SegmentReportingDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/SegmentReportingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_62ea1c1c-b7e3-4e33-b00d-658a146f103d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_7c305358-6a84-4d06-a241-d963ffbae1d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_62ea1c1c-b7e3-4e33-b00d-658a146f103d" xlink:to="loc_us-gaap_NumberOfOperatingSegments_7c305358-6a84-4d06-a241-d963ffbae1d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_cf09617d-0c3b-4304-b9b3-3e7bfdd8ae04" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_62ea1c1c-b7e3-4e33-b00d-658a146f103d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_cf09617d-0c3b-4304-b9b3-3e7bfdd8ae04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_60316b70-7be0-4b9e-906f-c7faa52aacaa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_cf09617d-0c3b-4304-b9b3-3e7bfdd8ae04" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_60316b70-7be0-4b9e-906f-c7faa52aacaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_34192ad9-c0f9-4918-9434-f3369a157fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_60316b70-7be0-4b9e-906f-c7faa52aacaa" xlink:to="loc_us-gaap_SegmentDomain_34192ad9-c0f9-4918-9434-f3369a157fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_RDMember_a996bc12-5dd5-47ad-9705-13cfbb59776b" xlink:href="camp-20241231.xsd#camp_RDMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_34192ad9-c0f9-4918-9434-f3369a157fa8" xlink:to="loc_camp_RDMember_a996bc12-5dd5-47ad-9705-13cfbb59776b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_56e1cc7b-e522-4a7c-b721-0019a964c626" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_cf09617d-0c3b-4304-b9b3-3e7bfdd8ae04" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_56e1cc7b-e522-4a7c-b721-0019a964c626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_f9f55a20-97b6-4431-b5b7-9f67e1141566" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_56e1cc7b-e522-4a7c-b721-0019a964c626" xlink:to="loc_us-gaap_Revenues_f9f55a20-97b6-4431-b5b7-9f67e1141566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_b67c92d6-8d92-48e7-b182-fa566244c1ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_56e1cc7b-e522-4a7c-b721-0019a964c626" xlink:to="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_b67c92d6-8d92-48e7-b182-fa566244c1ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_dbe0b79d-2f65-47bc-bb27-fb5125676105" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_b67c92d6-8d92-48e7-b182-fa566244c1ea" xlink:to="loc_us-gaap_LaborAndRelatedExpense_dbe0b79d-2f65-47bc-bb27-fb5125676105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ClinicalAndPreclinicalExpenses_ab3cce85-2e06-41ad-b4dc-0015bd6a209a" xlink:href="camp-20241231.xsd#camp_ClinicalAndPreclinicalExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_b67c92d6-8d92-48e7-b182-fa566244c1ea" xlink:to="loc_camp_ClinicalAndPreclinicalExpenses_ab3cce85-2e06-41ad-b4dc-0015bd6a209a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_FacilitiesAndOverheadExpense_35ad6f47-0cd6-4953-8134-d3a020249ec4" xlink:href="camp-20241231.xsd#camp_FacilitiesAndOverheadExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_b67c92d6-8d92-48e7-b182-fa566244c1ea" xlink:to="loc_camp_FacilitiesAndOverheadExpense_35ad6f47-0cd6-4953-8134-d3a020249ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees_d0253223-3f75-4caa-8d28-5c8d96dfd757" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_b67c92d6-8d92-48e7-b182-fa566244c1ea" xlink:to="loc_us-gaap_ProfessionalFees_d0253223-3f75-4caa-8d28-5c8d96dfd757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_CorporateExpenses_043334b5-8678-42e7-a465-083672ca2eb6" xlink:href="camp-20241231.xsd#camp_CorporateExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_b67c92d6-8d92-48e7-b182-fa566244c1ea" xlink:to="loc_camp_CorporateExpenses_043334b5-8678-42e7-a465-083672ca2eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TravelAndEntertainmentExpense_dd21465f-5d85-4ad8-8ae3-c627c4c41f75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TravelAndEntertainmentExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_b67c92d6-8d92-48e7-b182-fa566244c1ea" xlink:to="loc_us-gaap_TravelAndEntertainmentExpense_dd21465f-5d85-4ad8-8ae3-c627c4c41f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_d7b011b8-c6a3-4302-9053-60bde4723522" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_56e1cc7b-e522-4a7c-b721-0019a964c626" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_d7b011b8-c6a3-4302-9053-60bde4723522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2e76bfa2-14be-4f85-b560-d5d97b7d7685" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_56e1cc7b-e522-4a7c-b721-0019a964c626" xlink:to="loc_us-gaap_NetIncomeLoss_2e76bfa2-14be-4f85-b560-d5d97b7d7685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofBasicandDilutedNetLossperShareDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#NetLossPerShareAttributabletoCommonStockholdersScheduleofBasicandDilutedNetLossperShareDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofBasicandDilutedNetLossperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_163acece-3fa6-4026-8c55-6118e1e606c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract_f929f612-13f1-474b-af4f-6b7dfca00fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_163acece-3fa6-4026-8c55-6118e1e606c1" xlink:to="loc_us-gaap_NetIncomeLossAbstract_f929f612-13f1-474b-af4f-6b7dfca00fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_aec483eb-7689-45b8-aec9-62140a978a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_f929f612-13f1-474b-af4f-6b7dfca00fe5" xlink:to="loc_us-gaap_NetIncomeLoss_aec483eb-7689-45b8-aec9-62140a978a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_fb858f24-aa01-421e-9c7c-ca6fdb56c4ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_163acece-3fa6-4026-8c55-6118e1e606c1" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_fb858f24-aa01-421e-9c7c-ca6fdb56c4ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a0708f8d-cd24-46aa-8989-7e2cf6567a38" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_fb858f24-aa01-421e-9c7c-ca6fdb56c4ce" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a0708f8d-cd24-46aa-8989-7e2cf6567a38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cc8aabd8-ba01-4fd4-a9b3-79825738700b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_fb858f24-aa01-421e-9c7c-ca6fdb56c4ce" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cc8aabd8-ba01-4fd4-a9b3-79825738700b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_df2df012-90e6-4b91-b0ce-8067e651c0f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_163acece-3fa6-4026-8c55-6118e1e606c1" xlink:to="loc_us-gaap_EarningsPerShareBasic_df2df012-90e6-4b91-b0ce-8067e651c0f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_5869144f-9b95-4362-a5fe-5d619362754f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_163acece-3fa6-4026-8c55-6118e1e606c1" xlink:to="loc_us-gaap_EarningsPerShareDiluted_5869144f-9b95-4362-a5fe-5d619362754f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofExcludedAntidilutiveSecuritiesDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#NetLossPerShareAttributabletoCommonStockholdersScheduleofExcludedAntidilutiveSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofExcludedAntidilutiveSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_d81548aa-56c9-4d20-ae5d-29ed991b4f14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0eabf2f6-36cd-4dc8-a794-dcad8ded7329" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d81548aa-56c9-4d20-ae5d-29ed991b4f14" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0eabf2f6-36cd-4dc8-a794-dcad8ded7329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_06aa0e83-89b4-4a3d-8215-c0c54bdf82b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0eabf2f6-36cd-4dc8-a794-dcad8ded7329" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_06aa0e83-89b4-4a3d-8215-c0c54bdf82b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7a5d8414-b8c3-4297-810e-d1aca3a3d06c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_06aa0e83-89b4-4a3d-8215-c0c54bdf82b2" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7a5d8414-b8c3-4297-810e-d1aca3a3d06c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_6a5f7fb8-b33d-44b7-adbf-aa93914d6add" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7a5d8414-b8c3-4297-810e-d1aca3a3d06c" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_6a5f7fb8-b33d-44b7-adbf-aa93914d6add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_9b6857f6-32a2-447d-81c3-303e12980eb9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7a5d8414-b8c3-4297-810e-d1aca3a3d06c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_9b6857f6-32a2-447d-81c3-303e12980eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_0ecb08bc-84ab-4cb1-99e0-67caad50acea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7a5d8414-b8c3-4297-810e-d1aca3a3d06c" xlink:to="loc_us-gaap_RestrictedStockMember_0ecb08bc-84ab-4cb1-99e0-67caad50acea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_d367d2ad-cf52-49fe-89a9-14ff5a085549" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7a5d8414-b8c3-4297-810e-d1aca3a3d06c" xlink:to="loc_us-gaap_WarrantMember_d367d2ad-cf52-49fe-89a9-14ff5a085549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_000aa9c4-7aae-44ce-9cb6-887950f75dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0eabf2f6-36cd-4dc8-a794-dcad8ded7329" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_000aa9c4-7aae-44ce-9cb6-887950f75dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_081411f4-461c-4842-ad73-8bdbc24a744d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_000aa9c4-7aae-44ce-9cb6-887950f75dbb" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_081411f4-461c-4842-ad73-8bdbc24a744d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://camp4tx.com/role/RelatedPartiesDetails" xlink:type="simple" xlink:href="camp-20241231.xsd#RelatedPartiesDetails"/>
  <link:presentationLink xlink:role="http://camp4tx.com/role/RelatedPartiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_3d870b0d-63a4-49e9-accb-0d08b5870b93" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d7aef392-4214-453d-8da4-43715a76efae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_3d870b0d-63a4-49e9-accb-0d08b5870b93" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d7aef392-4214-453d-8da4-43715a76efae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_248e9257-4f6f-4d53-97a6-72984d4cd262" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d7aef392-4214-453d-8da4-43715a76efae" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_248e9257-4f6f-4d53-97a6-72984d4cd262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_5cf600b8-97da-4b12-91d4-232cd068146e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_248e9257-4f6f-4d53-97a6-72984d4cd262" xlink:to="loc_us-gaap_RelatedPartyDomain_5cf600b8-97da-4b12-91d4-232cd068146e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_e8485fca-b9fa-4ea6-b947-5783bf5a9586" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_5cf600b8-97da-4b12-91d4-232cd068146e" xlink:to="loc_us-gaap_RelatedPartyMember_e8485fca-b9fa-4ea6-b947-5783bf5a9586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_1405ce9b-789e-4dc8-a842-232cb26d9cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d7aef392-4214-453d-8da4-43715a76efae" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_1405ce9b-789e-4dc8-a842-232cb26d9cd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_6281bd1b-397f-478e-af24-e5b9ecf638f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_1405ce9b-789e-4dc8-a842-232cb26d9cd2" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_6281bd1b-397f-478e-af24-e5b9ecf638f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ConsultingAgreementsWithFoundersMember_c8e6d078-83e3-44ae-a6c6-e129575278f0" xlink:href="camp-20241231.xsd#camp_ConsultingAgreementsWithFoundersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_6281bd1b-397f-478e-af24-e5b9ecf638f4" xlink:to="loc_camp_ConsultingAgreementsWithFoundersMember_c8e6d078-83e3-44ae-a6c6-e129575278f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_ConsultingAgreementsWithExecutiveConsultantMember_98233817-417f-4a12-8aa2-cefbba556377" xlink:href="camp-20241231.xsd#camp_ConsultingAgreementsWithExecutiveConsultantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_6281bd1b-397f-478e-af24-e5b9ecf638f4" xlink:to="loc_camp_ConsultingAgreementsWithExecutiveConsultantMember_98233817-417f-4a12-8aa2-cefbba556377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a58a7807-8301-44b3-adc6-58afef4bcd6e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d7aef392-4214-453d-8da4-43715a76efae" xlink:to="loc_srt_RangeAxis_a58a7807-8301-44b3-adc6-58afef4bcd6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bd5175d1-6115-4fd6-af4f-e8aefe9ddd7a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a58a7807-8301-44b3-adc6-58afef4bcd6e" xlink:to="loc_srt_RangeMember_bd5175d1-6115-4fd6-af4f-e8aefe9ddd7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3efa9273-64f3-4990-960e-cb49cbdf83ec" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bd5175d1-6115-4fd6-af4f-e8aefe9ddd7a" xlink:to="loc_srt_MaximumMember_3efa9273-64f3-4990-960e-cb49cbdf83ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_efba5c9c-80c1-4f23-903c-e612b13bfc18" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d7aef392-4214-453d-8da4-43715a76efae" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_efba5c9c-80c1-4f23-903c-e612b13bfc18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_camp_NumberOfFounders_3afc49e3-32d2-4055-bab4-61b07bde1b02" xlink:href="camp-20241231.xsd#camp_NumberOfFounders"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_efba5c9c-80c1-4f23-903c-e612b13bfc18" xlink:to="loc_camp_NumberOfFounders_3afc49e3-32d2-4055-bab4-61b07bde1b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_d26d612f-6c16-4a19-b63b-8516f9db3f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_efba5c9c-80c1-4f23-903c-e612b13bfc18" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_d26d612f-6c16-4a19-b63b-8516f9db3f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_75572e2e-8170-4728-ade9-1664b76a2ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_efba5c9c-80c1-4f23-903c-e612b13bfc18" xlink:to="loc_us-gaap_AccountsPayableCurrent_75572e2e-8170-4728-ade9-1664b76a2ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_25ea3c9a-bdf1-4a71-a001-9601bf72916c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_efba5c9c-80c1-4f23-903c-e612b13bfc18" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_25ea3c9a-bdf1-4a71-a001-9601bf72916c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_cff4c599-6b52-43ba-9117-b4a4c6638486" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_efba5c9c-80c1-4f23-903c-e612b13bfc18" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_cff4c599-6b52-43ba-9117-b4a4c6638486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_us-gaap_NetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrExpirationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>camp-20241231_g1.jpg
<TEXT>
begin 644 camp-20241231_g1.jpg
M_]C_X  02D9)1@ ! @$!] 'T  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" 72"VH# 2(  A$! Q$!_\0
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M\IZ4A*@[@#Q3"TBX*LOXFE9PWRMR3Z4)O[2%R]5JQ6)SNS3=I+;AU[4@B#'
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MK.W.0 :&;'RL,YI7B_B1-X^:%4B4#;V]:JK?VTC/#:7<)E!QM\P$Y^E?-/\
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MQ#--!X@O$A26]F9]H '\3DXZ5^X.G:C8ZC81ZA8SK+%.NY'1@01]16>/PE3
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MX<TH*4UKV%(E+$C&,4X*"O[SJ/2FJZ*,TX%&&X9_&AN+W16MKVL([*PYZ4U
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M5E^%?%&D^*]%MO$&DW*2PW,"2(R,#PR@]OK6LQ4#>17C24D[2W/M5:7O+KU
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MHO"EK(Z-J&J^0"K8Y9R*Y<KP5*NY^UZ';Q/G.*P5>B\/+XU=)]]#]*?VE/\
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M,FM+]F;X):-^R]\$9?"&CZA/=06L3SK)/<&4\*3U)/%?B7_P5I_:!\1?'_\
M:J;0WU27[$-EN((Y6";@P7.T<=JX<!@Z.)Q4H+X4?19]GE?*<IC4_P"7DCW'
MXJ_\%_\ ]H+4-9DC^#VE07%J'.TOII8XS[+Z5O\ P,_X.!/B)#XAM]-^.5C'
M;Q2.JNL.G[6Y..ZBO7/^"6/_  2^^$?_  I*'QK\0M-:?5)Y"5#8==C D=?K
M6#_P4+_X(CW7Q)UI/%O[/]E##<_NT*S2B-<<9. >O6NKFRM7I26I\]]5XJA3
M6,A4O?6Q]_\ P&_:+\!_M"_#M?'W@;4%EB\G+*S#=N"Y/%?"/[<G_!8CXA?L
MU_'F/X=Z0MM]FPAD+VP)VD@'G'H:]:_X)E?L0_&C]DCPA-HWQ"U!9(##*S(M
MV9,$JWN?6OS$_P""U20K^U](D).TV*X]<\5.7X/#5<9*F]8^1Z&?YOF.#R:E
M7;Y9MZGV=\=O^"]-AI7PXAA^%^9?$C1QNRR6FZ/!4$]JZC_@E?\ \%1_CG^U
M]\3CX*^)^GP1@0RR>=;V>Q JYQEMH&<"OGC_ ()#_P#!+OP'^U!\.6^+7Q8>
MZ>$7$ENHBG/0;@.,^U?>*?LM?!7_ ()]_"75_$OPWMI4F-K<!)[@!F!9&[]>
M]1B8X*#=.DO>,LN_U@Q')C*U7]UO;R,G]OW_ (*I?#']DIY/!&DZEY^OF,2)
MY2B6/D#@D9YR:^#;W_@OI^V))JWGZ?X?MI--\WB1-*)^3/J$]*^4;74=5_:G
M_:;N--\::T[(^M2 R7%R0!&)R,98\<5^T7PS_8+_ &+O"GPFMO#\7B'1I7NM
M+1IGFU"W9A(T0SR6XY-=,J&$P2CS*[>YQPQF>\15:CP]90C%Z'!?L0?\%I_
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MU&9QY0F;S%$; D<,3VQ7?5P^!P^%C5DMT>/@L?Q!F6/JX;#5+)?UH?/O@O\
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M, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#PS]M?]C?PI^UWX63PW
MXGNKI$2!HPMO.4!!)ZX(]:\A_8:_X)8?"G]CO6=4\27T$;B2X62VEO95=5
MZEB<=*^SIUR*\5_;QT[QQXB_9C\3Z'\-79=7FL2MHP8J0WU'-=5&M6Y/9IV3
M/*Q6!P:JRQ3AS32N?'?_  7#^,OP&E^%A\(VK6$VJ2V3I;-9+&VULMW7I7R[
M_P $'_A%XYUCXQMXMTNRNH;"QU!&NFF5T#C:O3/!KYY^/?[+?[3?PYNAXX^-
M0O[JT.97822RA!^.<5^G?_!'[]M;]FS7/!]A\*/#UF+76A$D$ADM5C+R=>N
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MX.&/C1#N+V]FI'17L@"/J-M>W_MJ?LA_L&?L>_#F[UK4WN&U26W;^SH0ZO\
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M%_,U_2H(=N.:_FD_X)W7#7'[5'A9F_Z#4/\ ,U_3 ?NBL,__ -YCYG;P!>>
MK)O[0V%'5CTQVJ6D3I^-+7@IW/OUL%%%%,84444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !0> :*.M $>2R88=^U,*J\GF$]!TJ41J*1H%9MV:-'N
M"^*YSOQ.99?A[K6%&!I=QV_Z9-7\R^LX'[3EUC_H<)/_ $K-?TT_%9/+^'6L
M[%))TRXX Z_NVK^9G6M+UG_AIJZ1-$O-W_"82-N^ROC'VL^U?0Y$XTU4OU1^
M;\>QG*>'<4W9O\;']+OP0!_X55X</_4"M/\ T2E=)J&H6.G1^=>W*1+TW.P
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M>_\ @J7XP^$.K1_!SX3W,2B\A=;Z21/F5QQPV,BOF3]G;]A3]LC]NC?XXO\
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M"^W@3Q%IO@#P5&D9>/3=*=+AADC[TG?\:\]_X)$^ /VN?B3\9=+^(.K7]^-
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M>ME^17"U-3SO$.M#=R_]*9^9O_!7O_@F6WP)UW_A;'PMTV4Z;<%[C4AR=@Y
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M07OG6>D6_E:>)&+$+D^OU-?J;_P;B.DOAOQBR @E8MV>G\%?EY^T[^SGXD^
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MF%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5%=2QPQ[Y" /4]!4M>;_ +57Q/7X
M5?!?7/$<2.US'ITK6H1"?G XZ4XQ<Y**(JU(4J;G+9'RC_P52_X*;Z-^SSX8
MO?AMX'U&-M<F5X+G@,%!'!!'3O7Y6?LV?LP_''_@H5\7SJDMZ9H_-274Y+JZ
M8#RB3G:6/6O./VEOB/\ $GX\_%;4?'GB:QU"2>YDW,HADV=3T&,=Z[O]FO\
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MFVJ1K;*%[LK;>WTK5_:)_P""LG[6G[15F_A_4;4Q6LRX/]GVSHQSQCY0*/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH \G_:9_:_^$O[+,%I<_$VZFC%W&7A\I<Y )_PK%_9G_;?
M^!/[7?\ :$/PXNS+_9\@2XBO% W$@'@'KUKS#_@KI^QI=_M/?"%]=T.6<:IH
MUBRV213%0Q)8\@'GK7XW?LY_M#_'W_@GY\6[RSM=,O5E2^_?>?;R-&Q 'J,$
M<5ZV$P5'$T/=E[Y\;FW$.-RC,U&I3O1?5:L_<S_@HOX5\"7/[)WBUM9TC3T
MTX[7,$88?0D9K\)_V-?$&H>&?VV]"_X0^YE6&/5_E1'(#C [#K7L'[7O_!7/
M]HG]J/P9_P *_BTS%G<P&*_6VLF5CDGIA:[[_@C;_P $[/%_CGXKZ?\ '/QO
MI4T,&C7:SVPE#(74@=0>O4UZ="E/+\#-56FV?-YEBX9YG-&&"A\-FV]&?LS\
M.]?6Z\!:=JFLSK%(UL&E,K;><GUK5L]9TJ[G LM6M9"Q^ZDZD_H:^9/^"HGQ
M&\9?!?\ 9[O];^'\;"2VT]F58U).<GL*_/C_ ()E?MP?M)_$3]IOP_X9\6I<
M'3[_ %%5F\R.3A<#U'%>-2P,L10=6ZL?9XK/Z>!Q\,)*#;=E>VB^9^VE%%%>
M>?1GQ-_P6T^#NH?$']G._P#%=C;&3^Q]-=BJC)ZGM^-?D1_P38^.I^ O[3&@
MZCK\AM]/.I*U\",$ #WK^C#XF^ M ^)W@Z]\#^)8 ]G?Q>7,-H/%?A7_ ,%,
M_P#@F#\3_@#\1KGQ_P""M)D?1+BX>:$VFYG5 ".B]#Q7T63XFG4H3PU1[['Y
MWQ9EV*HX^GF&'C>VY^YGPW^(_A'XE^&;3Q7X6U.*:&]B$D86520/< \5KZKJ
MVGZ1;/=:K>PP(HSNED"@#ZFOYY_V:O\ @J/^U9^RW&GAO1[.1[9,)$NHVSN5
M _W@<5UWQ^_X+/\ [6WQN\/OX6GLHXHI(RDK6-FR-SZ%5!K">25U4=FN7U.J
M/&^!^K-34N>VUC;_ ."Z_P"U+I/QR^*5AX$TJ_65/#MQ)"[0L"#G<>HZ_>KW
M?_@W1^!FI:99^*/&/B.Q989#%)8.RD!A\GKU[U\1?LH?L*?&W]KWXE)JFM:9
M=_8KJZ#7DUX)%8J0.06K]\?V4OV?= _9U^$6D> ='LTC>ULQ%.X4;F(/<]ZZ
M<?B*='!*A3>O4\OAW!XK,\[>.JQM'I<_(+_@O@GD_%_3N3B2ZD_]FK[!_P""
M#7Q \.Z_\*;W0+>XA6>QM(TD4$ L<K^?6OD'_@OG,!\6M-@CZ_:I!D_1J\@_
M8H^+?[2?['3+\3?!FG23:1>;9[P^2\@V# Z $=A71.A[;*HQ3...8O+^*ZDF
MKQ\M6?O!^UAJ^F:#\ ?$NHZC,JPIIY+AR.1D>M?SSZ;=P>+OVTX)= 4$3:U^
MZV#K\OM7T3^V%_P6;^-'[07@)_AWHFFLEO?6[0Z@$L&1\$GIA:J_\$A_V _'
MWQE^,UC\8==TB:*ST*\2X!NE9-X( Z-][K6>"H_V=AINJU[RTL[EY]C_ /6/
M,Z.'PT6U%K5JW]6/TN_:(T758?\ @F-K=FRXD3PP0X?K]\5^,/\ P3@MYXOV
MX_ Z2@!UUU<Y_P!TU^]_[97A+4-4_9+\6^$=!M0TLFD&.")$ZG<.,"OYY?#/
MB'Q[^S)^T9:^-TT>5+_0M2\U%DMFV[@,=".>M8Y6U4IU(7]Y[&_&,'A<=A:L
MK^XHI_)H_IXMPRH6?'/I7\Y__!7&,O\ MA>*]C?\Q=L\^U?J3_P2Z_X*6?$3
M]L+4=7TKQWIZQ?V?L$1CLRF<[?89ZU^6W_!5^.]U3]L7QA';Z+?/LU9L,ELY
M!X[$"GE-&6'QDHU-['5Q=C</F634Z])O='[&?\$F?+/[&'A.')S_ &.H)_&O
MQK_X*/VRR?MX>,;28 J^N,/_ !VOV5_X)/6]Y;_L9>%X9+=HY!HZX61"#U]Z
M_&G_ (*,P7Y_;Q\87$6BWSM'K9+.ELY4\=B!5Y=:..JMOI^IS<2\W^KV#:3O
M=?D?N9_P3FL(;/\ 8O\  UO&" -) 'YFOS,_X.(Y(YO%WAQ(=V^&\DW;NG1Z
M_33_ ()RW#S?L:^!VDA=&.E#<KJ01R>QK\T?^#A>TO;WQEX>:STJXE$=Y(6,
M,#-V?T%<>73<<R<ET;/9XB4GPS%VO91T^2/;?^#>SRI/!.M28 8V<>=H]TKT
M[_@MW(EA\ Y'&3OLI,C\37E/_!O!'>1^&/$JW5E/#FSCV":(K_$GJ*]1_P""
MWLETGP,C@2REF9K20;8HBWKZ43<9YPI/N3@N>/![;7V3\]/^"'Y:;X\))&2
M;R/(/X5]Y_\ !>IMGP;T_ _Y8R?^S5\)?\$58-0T[X^0M<:1=1"6]CYDMV4=
M!ZBONW_@O/-(OPDTVVCLIIGEBD""&(MC[W7%=.*G?-H-['E93"<>$JNF]SXF
M_P""#2Q+\9=0DE)R9H]@'_ :_8/]JK]IWP?^S7\-M0\9^(=3ACG@M6DMXBZD
MLP/3'>OR(_X(0Z5J%C\8]2DO],N8CYL>#) P'\/J*S?^"V?QH^+'CK]H"_\
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M>6")$^Z*6D7&.*6F6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MFA3JIWB]1.C&=)4[)I=#Y'U?_@C!^R=JFI-JDEI>!W/*HV!^6:ZOX<?\$O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M # ]*,#THHH ,#T%&!Z"BB@ P/2BBB@ P/2C '0"BB@!"JG@J/RI0 . ***
M# Z8HP/2BB@ P#U%&!Z"BB@ P/2DVK_='Y4M% !@>E! /)%%% ";5_NC\J7
M]*** # ]*,#THHH ,#THP!T%%% !@>E&!Z444 & 3DBBBB@!"JD8*@_A2"*(
M'(C4?\!IU% !@>@HP/2BB@ P!T%&!Z444 &!Z"C ]*** # ]****  @'J*,#
MT%%% !@=,48'I110 8'I1110 4444 &!G.*, ]1110%D&!Z"C (P1110 FU?
M[H_*EP/2BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HP#U%%% !1@8
MQBBB@ P/04444 &!UQ1110 8'I1110 8'H*,#T%%% !1110 48 Z"BB@ P/2
MC ]***  @'@BDVK_ '1^5+10 8'I1110 8 Z"C ]*** # ]*,#THHH , ]11
M@>@HHH ,#IBC ]!110 8'I1@=,444   ' %&!Z444 &!UQ1@>E%% !@#H*,
M]1110 8'3%&!TQ110 8 Z"C ]*** # ZXHHHH ,#KBC ]!110 8'I1@9S@44
M4 & .@HP#U%%% !1@#H*** "C /4444 & .@HP/2BB@ P/04444 &!Z48'3%
M%% !@'J*,#THHH ,#THP/0444 &!Z48'H*** # ZXHP/2BB@ P/2C /4444
M! /448'I110 8'I1@=<444 %%%%  0#U%&!UQ110 8!ZBC ]***   #H*, ]
M1110 8'I1@>E%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 & >HHP/2BB@ P/048'I110   =!1@>E%% !1110 $ ]12;5]!2T4
M '048'H*** # '048'I110 8'I1@>E%% !1@>E%% !@>@HP/2BB@ P/04  <
M 444 &!Z48'H*** # ]*,#THHH ,#THP/2BB@ H(!ZBBB@ P/048'I110 8
MZ"C ]*** # ]*, =!110 4444 %& .@HHH ,#T%&!Z444 &!Z"DVK_='Y4M%
M !@>E&!Z444 )M7^Z/RI<#THHH *,#KBBB@ P/2C ]!110 8'H*,#T%%% !@
M>E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%&1G% !1133*@..: '44#D9I';:N10 M%-20-UH$BEMHH =12,2.12-*J
MXW=_2@!U%-C?>,XI<L#R.*!7%HHHH&%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 44FX9QFEH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HH) ZFB@ /(--C5E^]3LCUJ-S(> 1^= F[#R%SN)
MI00>AJO+>6MDF^ZN$08_B<"J2^*]%N)C!'J<&X?]-5_QIJ,GLB/:13LV:M%0
MVMW;W*YAG1_]U@:FR/6ELRTT]@HHR#T-% PHHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ KD_BG-)%H[['*\=C765Q_Q;)&CN1Z5</B(G\)YI_K&W-R
M?6F2H3"WUIT6<C-2-C[.WUK>.QD=_P#".21[1@[DX?')KN%ZFN&^$/\ QZO_
M -=*[E>I^M<];XC:.XM%%%0MBALP!B;([5X1XK:27Q','<MB1L FO=Y?]4WT
MKPKQ*O\ Q4,[?]-36U+<PJ? 4 HV$,!UK6^'\K1>)H$5B 2>AK+ RK8]:T/
MQV^)H#[UK(SB>XVQS AS_#3ZCM/^/9/]T5)7*SJ6P4444#"BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MN'Q">QYHGWA1)_J7^M"?>%$G^I?ZUT1V.=['?_!__CV?_?KNC]T_6N%^#_\
MQ[/_ +U=T?NGZUS,UB.7H/I2/]TTHZ"D?[IJ30CG_P!4?]VO#/$7_(PS_P#7
M4_SKW.?_ %1_W:\,\1?\C#/_ -=3_.MJ>YA4^!E%/O-]:U/!7_(SP?6LM/O-
M]:U/!7_(SP?6M);F<=SVZT_X]D_W14E1VG_'LG^Z*DKF>YU+8****0PHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHR/6@ HHR/6C(]: "DD7<A7/44;EZ;A^=1W5U;6T)DN+A(U Y9V %
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@20HC%BW&/QKI^K22C*IL?M&4^$E?(\=@,1Q;^XP==V<NJZI2OM?\CA/&?\
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M_P >L?\ NBI*YF=*V"BBB@84444 %%%% !1110 4444 %%%% !1110 4444
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M(PQAWB!/\JEOM(TG446&]TFWF12"JRQ @'\:T,#T%(57TH SWT?39!]CFTV
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4C,$7<:6FR@E"
M !^-"W$W97$\Z/CGKTI&N8E."3^55RPW!5/^][5'?7UOI%NUY=-^[49<^E.U
MW8(ZM=?+KJ5O%_BS0/"FEOK.O:@D%O"FYRS <?B:^&?^"J.C>//VCO -C?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MMJ..0_U_M!_\*O&9KCL8_?EIVV0\GX4R+)'S82@HRZO=_>?;)U.P\X*]] J
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MZ$4E47O=^EO4]=+;0!WH5\\'K30Q(WT*6,N<<8KZSK8_$%JKCZ*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MP.*XZVQVTMS;BC\L".*,!0,#%2%<\J.1VINYD<)QM]:>, XSUKF.@4=****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MGPYFO/)_NZFDD>8_LF_'K3HO#$7AOQ!?8,2DAF.23^/TKVR?XC^&/L\<K7N
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJKP7\USU7XL_MA_"OX5">PU76\7L.0T04,-WYUY=\'O^"E/A/XH_$@^"(KA
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]Y_;-^$P^*'PVFCC@W/;!Y@ /[HS_2O@K]F#XE:G\$?C2;C5)##%+*+<H6X
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M\-_#EWXE\37Z006]N[DLP[*3WK\Z_P!D7]JK4O@OJ,UIXEO&7388)"-[$_.
M>QKY7_X*J?\ !4'Q]\<O%$OPS\!:@]OHZA6-Q;2F.1F&,J0!TX]:^EX>XZPN
M<9*IO2M'1Q_4\S$^$.:KBB6!I?P+\W/T4>U]K^1R_P#P5E_;\U+]I#XFW'AC
MP7JSRZ*DJQJ$<C+JV#\H^E>[_P#!#?\ X)_76NZU%\?/'.D,U@4=(_.3<-XR
M0<'WQ7SM_P $S?\ @G?XS_:N^)5MXQ\3Z?/_ &)%*)6F.<NZ-N((/7I7[V_"
MKX9^&/A-X(M/"?AC3X[>"")%*Q1!06"@$\5ZN68*>.QBQ%;;<^DX^XAR_AC)
MEP]E+7-:TGU7?;J='86D-O'';6P^2.,(J]L 8K0' JK&H&%4\U:' Q7V323T
M/YT33T6P4444%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'DXRK_<)%,@ED=7:1!^[Z&OU%M33E'Y'^9J:FTT/F+$;%ZFF>=':QMYV=PZ
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M5"VU6W$DYZ"I4.5I]#6SWZ"T444 %%%% !1110 4444 %%%% !1110 4444
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MUNBDC;<@;U%+7,;K8****!A1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHH.0.* "BH%NBS%1V-*UP44N?NCK2O97!-/J3455?5((8C/.X51W)K@?'O[3
MGPS\ 12'6=;"LF>% /\ 6NBAAL1B9J%*+D_)7.'&YE@<NHNKB:BA%=6['I%1
M3LKJ8PW)]ZX#3_VC/ WB3P1<^+?#.H^>MM&&DRHX_6OF/Q1_P4QUVP\4W>D6
M&GVK+!.53(Y/Z5[67<,9SF<YPHT]8;IZ6/F,]X_X6X?HTJN+KI*I\+6M^NEC
MQW]M2?5?^%HWZQZU<QA+I@%24BOKC_@GQ<7$OP[/GW+RXB7ESD]J^)?BCXIN
MOBEKMUXHND >:0NRKT&:]H^ '[8^A_!'PVFB7#1AGC ;<N>E>CBN%<X51854
M_?W/-P7B)PI/ O,I8E1I-\MWIKMLS[TAE/FL,<9ZU\H?\%-[F[L-*T\6=]+%
MYENV3&Q'<UZ/\)?VU?AA\2KN'24U4+=S$ ((P!G\Z\R_X*:W$-WHNDRP-D-;
M,5/KRU?/5<NQ> Q7L\1!Q]3Z[ 9UEF>8)U\!552/>+O^1YS_ ,$WDO'\83S7
M&KW$W^DK\LCDCH*^_P NX8!>E?G_ /\ !-Y]WBRX X*W*Y&/85]_&0C&X 5S
M8[E]I[IW8&4G32EN>8?M>>:OP=U66WG:-Q:G!0XK\Z_A3=Z__P +CTY&UJY9
M6NOF4RG'2OT/_:UN#+\(M451P+8YKX ^"%M'>_&>RAD'!O,9'TKHPJC[)MHR
MQ+E[5)'Z>> 6F7P7INP;F-N,D_4U-XRW/X:N1N*MY?4'I2^![9;7PK91(Q($
M QFE\7+_ ,4]=?[E<"LZAVV;@D?EY\<I-;/Q>U#.NW4<<=Z<!)3C&/K7W]^S
M)(FF_"'2KZ[NW>-K)2[R'IR?6OS^^-L4ES\:M1CA8G%\=P/T%?2?QU_: T;X
M#_L;6\%MJ*IJM[HN;./<!E@Q[]NE>M]6GB)0II;GB8G,:648*OBZTERP6K?]
M=S\[?^"J1\*:[\<]4U7P9(+F2UOW-^K*, X_'/45\^?#F]UZXL[LS0?NCC:K
M'A1QTKJ=4\5:GXM\3WOBC5_WTU]-YDR2-N&<#U^E2^(+T6F@27]A91)-#'E(
MT& Q]Z^[_LB>60A*'0^BX.^E8_$WP^J^&6:X-8C&8J7L</*7NP4&_=E)M:.&
MZU5[)&:TY2$PQ1!MP^<L/N_2DC@DC W#Y&ZFL+0?BK=33FVUO3H(HV.)&0<C
M]*Z95$R+,#_H\XS$XZD5[F$S2GBI<NS73N?S-XX?1;\0O GV.*S)*MA:EOWM
M/6,9/[,M[?-ZD%FKW\CZ5IRE[B4[85QU-?JQ_P $FOV4(/A[X*;Q_P"(]- N
M[Z%)HF=,D'@<$_2OB3_@GM^SQ=_&[XVV5T]@7T[2KU?MC[?X2!^?6OVE\*^&
M-,\(Z%:Z!HT*I!;1[(\+C(KY/B[->2/U:D]]R/!?A&.)F\ZQ,=(W4/7JS75V
M<!E4'/7-4O$VD67B'1Y=#U!RL=RFUBO6K2D#*DX8]!2X*#YP">V:_/5:*5C^
MEU&77<\"E_X)]?#!?%9\5QZE=-,\OF$%. ?SKV_PSX?M?">@0Z-8R,R0IM3<
M*O.\B\J,YZ^U)',7#"0 !?2KDY2C8B,(0=HDT!/EAV[BOGK]I+]ESX?:S;:E
M\4-2NI3/:*9VC" @GISS[UJ?M5?MO_##]F?PS/<ZUK*+?>63;0,H(9AV/-?#
M/PS_ ."R'B[XK_&0?#WQ)HMB-%UB\$,4D8W$IC/3;[55"-6W-%'Z?POX4<5<
M3Y?/,Z>'OAZ7O2YGR\R6ZC??3L?'?[5_QB\8^.OB9J7@;1;NXBL-.N3'%%"[
M+N7'3 ^M?HM_P16_9^\>_#[P5=^,?$=_>/;:O;H]M'/,Q"@%>@/3I76VO_!*
MOX(_$#XC67QRAO;K-S<_:GMA"!&_&,$;NE?7O@WP9I/@K18/#^B6<<%O FV-
M8T"C'T%=5;&*=+DC'4_3_$3Q8X<Q/ F&X9R"AR1LE435N5QW6VK;5[G.?&;X
M*:-\9=,72-:E=$12 8QSS7&?!S]BGP%\)M?&MZ1J%R\J.&Q(N!D?C7N7D+@<
M]*/)7&!QZFN159QCR+8_F-PANEJ(P7D 9K,\6^'H?%'ARZT*Y)"7$.QL>E:G
MDC&,FE6,*NW)K+6+7*5T9\U0_P#!//P"?%*^)7O;D2"7><+_ /7KZ#\)^'K+
MPOH-MH-G(S1VJ;5+#G%:>P4,@92O3/I6M2I*HU<SIP4$->/S006QGIBO!/B]
M^Q)X0^*GB>;Q%JEY.'>4N0JY'\Z]\5-J;,_C2[1MVU"DX[#<>;<X'X,_!K0_
M@]HG]DZ/<2.#&%PXZ?K7;Q(<$M@YZT\6B9+%CS2+9JI)$C<^]*I[]GU&ERVC
M'8^+/^"KG[(\7Q:\ GQOX>L/]+TF-YY#&F"QY')'7K7Y+O!<V&[2]50QW-MQ
M(OO7]%7BOPMIOB?0+G0=27=#=1%),C/%?CK_ ,%$OV2[OX*?&,Z]I5D_]F:O
M?$(VTX50#V[=*_0.%LXC*F\)B)625U\M=S^;O&G@Q76=X6/O72G^5V>!_"K7
M(-#UG[??093<#N*9KT?Q_P#&/0[716&DSAIKI""".E:FB^"?#L?@]!- @$L.
M(Y @S7AOC&Q33_$US96\S.D3X0,:XL/3R;C;B%UI)J5#IT=F?CN)GC^'LJ4:
M<O=J_J5KJ22_G>[NW+23]B<X-?2'_!,O]J#5/@?\7T\):U>;;+5;A($#OD =
M>!^%?,J&42EF)'/'-6+*^O-"U>#Q%I[L)[:3?&=V.:_1,?@:&)PDZ-KIK1;6
M/'R#.:^2YO3QE&33BUKY75_O5S^B)/$5I=Z"WB/2)1+%Y>\'L17RY\3/^"AM
M]X*^(4_A&*UMSY<^SYAS_*H_^";/[3#_ !L^!;>$KZY1]1TW3AYJLW)8D=37
MS=^T?8FT^.]]'?0*)?MF" /K7XX\$\-C9T:FZ/[OR_-Z.;Y12QM&5U*S1^D/
MP2\?W/Q(\%VGBBZB1?M,>[Y*["7)7$8R1ZUY5^Q]$Z_!W2@W3[,,?I7JQC"M
MG/6O+G%<UCW:;<HIO<^:OVI/VTM6^!6N)I<5I;M^^*_./K[5UG[*?[2-[\>[
M6>]N+>)2L08A.G./:OEK_@I5"DWC^/>,[;LG]#7K'_!,B-$TN^VJ!_HJ]/J*
M[94XQPREU.&G5JRQ+B]K'UL%;N/I7G'[1/QBF^#GA5M>CB0D(S#</2O1P,J1
MFOG_ /;^3=\,-@7<?+?@]ZYJ%I5$CKFVHW9P7P1_;SU7XS^)%\+7NE6C6\[A
M&&W.0?PKKOCO\.?A-\%+6_\ B[+H%K]K,9EB!M5(5AZ5\G_L/VULWQ,MD8!7
M6=,@"OO7]I3X?V_C[X5ZII<T98BS8* ,TLQHQ;:BM3Y_,*,L7E523@I3BFXM
MK9]#YH_9N_X*2W/CC5=0LM;M;6WM+>(&U:,?>/Y"NIUC_@HI!:^,H?#ELD+"
M6<("5KX.N[&_^'OCB;PCIMK+&;*0!V5"-P]Z['0UFU+QII6H7$8W-=@MGK49
M3%U(SYNA\3P%Q/F&.PE7"XV7-4BWK;S/U<\ ^)F\6>%[;7G4?OUR,5O)G:,U
MQ?P,V-\---5.T==HOW119K<_5J5_9QOV%HHHH- HHHH **** "BBB@ HHHH
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M/@GG7H\?WJUD0>R6Q+6Z$_W:?4=I_P >R?[HJ2N5[FZV"BBB@84444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MC;5&(_4>M.9A&H8]*C+LX D^50>HI[@L :EQ;=QJU[,2< Q%RV HS7Y0?\'
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH,0;FWU5U^\CT[2[G4))-JQ0,_Y#-6!E0 /6O.OVH_&G_"&_#*\O!)M\R"1
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\/PRQF'Q/#$%3WBW<^J\8*&+H\95I3>C2L#[V?>BCWKX"_X*H:II4?B1K=G
MEW)T'N*^^]0N(],TR>\D;B*)G)/L,U^2O[=_QJ@^)'[4>H^%+.59(H+57 ![
M@G_"L_$QPGPQ63ZV_ Z/!G#UZW&5.K#[$6W^!]+_ /!+'794T8Z;(W BD8#\
M#7UU?Z^T*E20&]J^.?\ @FY:SZ5H/]J2)M4QNN?P-?1NL>(O,!/F<YKIX O'
M@[#>>OY'S/BSBJ<..<4H=+)^NMS8OO%"Q2,QEY/'6LFY\5"-S*DO/?FN5UGQ
M$J$DRU@7OBU<D>;^M?4SQ4(:=3\DK8Z+=D]3T-/%RF3S%FPQ&"!5RS\2Q1Q^
M69=P)SDFO)T\5J>%E_6K5KXED=@1-W]:SCC%?4RCF$8Z2E8]ATWQ$2X43G;]
M:Z"PUY!MZ')Q7C^D>(&7:3+^M=;H&MAY 'D]^M=E*I)J_P#5ST,+BW.21\N_
M\%4H7DE6=5^0R1Y/XBMG_@ED-(BA#V[_ +TQN"-OL:N_\%&O#,_B'P NLV\>
MXBX3)'H,5YQ_P3/^(UGH'Q+?P_<NJK]G< '^\<BOQ#%265^*L75VFU9^I_5F
M ?\ ;7@K/V7Q4[W2\C]% VU>M.WE>2!BH;9FEVW#_=9013+^YBL8);R1SM2-
MF/X#-?O2NU?H?S>]'8^)O^"IVKVC0BR67]Z)(SM_$50_X):O<+XA+,OR&&3G
M\#7D?[?_ ,9;/Q_^T1<>%+"Z#11VJM@'N/\ ]5?1'_!,#P=<6WA<>(Y8< O(
M@./K7X+AZ2Q/BWS0=^6[?R/Z4Q5-Y;X-0C5T=1?FM#["W%F!0<8J8=.:KL L
M@YP*L#H*_>TVS^;%L%!(')HI&QCDTP NH&<TBR(QP#33G/R\TUBN,/\ +]*7
MG<5^EM28$'I14=L%$?RL3SWJ2G=/8:O;4**** "BBB@ HHHH **** "BBB@
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M  3]_P""<7A[X/Z/#XV\;V)?5+I5E:*>,,(FX& 3]*^S+2WAM8TM+2)52/@
M#&*_..(N(7B6Z&'?N]S^J/#'PQ_LKES+,X?O'JHOI_P;#D B3RTC  '0=JG
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,K1,3E3CL0*\C'8_"X#F=625OO-,AX8S;B+&JG@Z;EKNMEYMG@?P!_9G\?\
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M_9\UBQL+6_DO]+215D:[N"=J#OC!K[.^)O[?'PI_:,^$R6PUE8]3^SL7@C0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7_A\SY?3H24445TGGA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !564.\P55W(?O9[5:JN9%5RK'KUH;=FEN1-Q5KG@?[4'[/O
MPC\58\8>--1-J+-"24C!S^M=?^S7JWPN'AX:3\/-3^T);J$E)0+S^!->4_\
M!2'2?$Y\$-=Z%<3+ +4F8HY'K7BW_!._XD7?A7QM'X<O]1DD^W7(W"1LXZ5^
MC4<FQ>;<&O$SKN7L]>3M8_!\?Q5@.'?%FGET,'&/UA*]7JV]M?/8_1,A7[TA
M3:/DJ.UNHKR 2PMU%.CW;CD5^<G[V,F<H,R5@>.OB'X8^'/AZX\2^,+\6UG
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M_@S5WUKPU;W\@^^N3BM:*1. AX[5^6OF4FET/ZZIN,X*75ZEFBBBD:A1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "F2C(X.*?39@2O%-;@[VT*MW=0V=N]U=2%8XURY]J^7OVMO
MVM/@1H%[96.M>+/)DLKP.Z*H./UKZ2\4Z//XAT"]TE)&C>>!D#(>037P'\6?
M^"/FJ_%WX@7.O^(/&^L16TS@A4D) Y/O7/*O.,]$?:<&9-PEFM62S[$NC".N
MF[/._P!HO_@I[X9MM8O1\(7COWNX_*#E-I[^F:^?_A;^R1^T;^W7\13XF\1:
M-/%I<C+(9$E8X&23P17Z*_!#_@DA\$/A?86KWU[+J<MNP9C>VX8G'XU]0>#?
M /@CP/9+:^$]!M;557&((0O'X5$XUL5+]YLC]5H>)'!'AY@:E'@_#.5>6GMZ
MBU7FEIN>2_L:_L8^!/V8?!5IIVG62RWP7;+<2Q .>!U->_A$*@;1CTJN/+**
MTG'/'%61TXKIBH1BE$_!\US;,,]QLL;CIN=2>K;ZA@>E($4<A:6BF><-\J/.
M=@S]*4QH?X12T4 >+?M:_LE?#_\ :4\)3Z1K6F11W85FCN8X 9&;' )_"ORV
M^)/[(G[4/[#?C6?QIX$TFYNM'1_D\V=@, DG@ ]B*_:JX\H.3(<5C^(O"/AW
MQ;:2:9KNB6]W ZD$3QANM<]6C%OFAN?IW!'B?F?"5*6 Q,(XC!S^*E/73R?0
M_,7]F_\ X*@^#[U;Q?C,T>G7T]F8?ECR2V" ,G%?97[%/[0?PR^(/AE-#\*Z
MX)KE-TAC  X/XUS?QL_X)4? 7XGBXOK=VTN293L^Q6P7#?G6)^QK_P $U8_V
M8O']SXBM?&VJW5N\(5([AOEZGMGWK55JZ24CTN(,+X.9K@*N899.IAL3NJ35
MX7?9V_4^QK=F9-KKR!G%2P!BNY^#Z5%;JOE!HF+8&,FI826.XU:]Y7/QU*W6
MY)11104%%%%  <8YJ%(4#&0=#VJ8]*ADR1@>M3)+XNP+5V.4^+GPWT?XE>$[
MCP]?VJ2,8GV;DS@D<5^:'[0_[.7C'X*Z[/-/I3-I[R$1R-G@D_3Z5^K3*KGG
MAN]<S\1?A5X7^(^EOI>OZ;$RLIP[1@D'UKX7C/@G"<4T%4CI4CL?H/ G'N,X
M1Q/LJBYJ,GJC\N/@S^T!XS^"VH?;-#OI)T"X\B64A1^%=%\=/^"RGQL\$^&I
MK'1_!>GN[QE%?S#GD8S]VO=_BW_P3+M-0NI+OPA>W+%CD(HP!7)>#_\ @E;>
MZEJ"IXXLI&@# EG&[O[U^:9+EGB#PSB7A:4>>D_._P#PQ^QX[._"SB",<PQ?
M+SQW5FG_ ,$_)[XB>/OVI/VX_B;Y&HVUW)]KF55LUG<QKEN".*_1C_@G)_P1
M<T_X<M:?$?XW64JWCJ&6SGCWH#U!YQZU]P_!K]B3X(_!J))]$\*V5S<(N1+-
M:*&!^M>M:='(MN$DME0+PJ#H/2OU[*<HKQY:V-?OM;;GY[Q7XH+%4WE^0P]E
MA[6OLSYJ_:M_8>T?QWH/]H^ ].$-Q @Q;V\>U<*!Z?2OAW7-(^(?P-\3M'J:
M3V4\;[3'&Y (SQVK]@&C22'$QP#QCUKS7XO_ +.O@;XD6;KJNCP(S9_?K""U
M?)<6^&E+-JRQ>6R]G5W?1/L8<$^*>)R'#_4LSA[6AWW=G^9\(^&?VTM>TK17
MTN]M8IIGB9 TK9/(Q7R=\??@QK?[1/Q(.N>)-5NDAF==L$;$H.:_0GQQ_P $
M[]$\]Y-!N[AUSG=LQ@52\&_L?^'?!5T;JZNY;B=1_JYER!7R5/A_Q.Q$XX*M
M7M33W?1>3/J:?''A/PK5J9ME]%O$26B47OY]CYV_9U_8\\+?!_2X]6@MC+.R
M8\R2/GD5Z+J7A::>4S-#M&,9%>TZCX2F$?V:"S41KTP*Y_5O!\TOR+%@#TK]
M 644J&"C24KM;ONS^0^+\TQ?%>>5LRQ<KSJO;LNB/(F\)$28\GCUQ6GIGA%0
MAC*?>4CI7>+X2W?NA'DCVK3TCPM PV%?F'(XK*EE\7/E2TZKN?+T,#.FU)>[
M*]_3L?.'Q2^&NL^'KG^V-+MV # LR\8%'PY^/?BCPCJ CM/](1%P3,YKZE@\
M!V>NQO8ZE9J59" 2N:X'Q9^P[::Q.]WH=S.CMR%C&!7PN:<!9S@\8\=D;LGT
MOK]Q_7W _BOP_G>24\HXLI*<X>ZIM7NO7_@G,>(_VY?&UKX=FL-!TFV:X>)E
M#!\$9&/2OB/XK?"G]I7]J3QHPO+O4)TGEP+0W+% "W7&*^_O '_!.K7M5U-?
M[=DN8H<_>!SWKZK^!?['OP\^%3)?);K=3A<'[1"#CWKTLIRSQ'S.<:6/ERTT
M]6^B\CZ^/$_A5P6ISRB@IU&M+)O7UU/AG_@G=_P12T_P?JUMX_\ C!;S;P-R
MVT\>],]1U_"OL7]IC]B3PA\1O"ZP^&K%;2:WB41K:Q!=VT#'3Z5]"PV<5H@A
MAA6.+& %%-%HT>0C%P>S5^E5^',!B\L^IXJ*E%_:ZW/RC%<>Y_B\[_M15'&:
MVCTMV/R/\>?##XC? _Q*T5Y'/:/"WR/&YY&>.U>M_ '_ (*">,/AZT6E>)RL
M]N#M,MQ(20.G>ONGXD? _P &_$_2WT[7-'@5VY^T"(%J^3/CE_P35U3[8]S\
M.HIKKG=M;@?UK\<S'@7BCA+$_6,DJ.<;WY5_EU/V/*O$'@[C3!?5<_I*%1K=
M[7[I]#VK3_V_?@K=>&SJ7_"0+]H$98Q[!C(&?6OST_X*;?\ !2#XJ?&71KCX
M6_":QC73R^6O;>4I(>Q' Z=>]=-XL_96^.7@^[-E=Z ZJ.,!SS^E3>#_ -B#
MXI_$.Y6.+P/%R<R/SG&>>U/_ %]XUQ,HX.IA'S;/1G=EO!7AQD-59DL1&<5K
M&[5DS\P?!OP"^+/Q \6Q>'=.T.2:ZO+M?,.3G#OR<X]Z_<?_ ()4_P#!.+1O
MV6? EKXH\3:>6UN>,LQGC!(5USU_&N\_9-_82^'_ ,*[>+Q)K_AZWDU,94QS
M6X.WWS7TO;Q+ 5ABB5(U4!0O:OU;AG*\="DJ^-CRR>O+V/@/$SQ%CG$_[/RU
MM45I)_S/R\A\4*I%L(X'05#/;QW,+P2#[ZD'CJ,5-(SB3 '%-NHR4!0<YKZZ
M<>8_&(NQ^??_  4?^ M_X;\4CXD:38&*R!0&2)<?/D'M5?\ 9J_;UN/AUX/&
MA>(9$DBB)VR3-EL@<"ONCXF_#C0OB/X:E\/Z]:)+&Z'&Y <''%?"WQ4_X)M>
M.[#Q++J'@>QEN;61SA68A1D^E?AG$F0\2</<0RS7)(\RGK**[^A_0?"G%'#/
M$_#2R3B&2BZ5N1O2Z]7U/$/V_/VF?B9^U[9?\*TT7-GI3S(_VFSE(8D$<8Q7
MJ7_!)K_@GGHGP\OX_B%XDTTW$V'^>YBSR<G.37?_  %_X)H:L-?BU3XBI/:)
M&=^U1D$@Y [5]H>%O">E>#-%ATG0K1%2)0N53&<#&:]WA3*>)LUQ*QV=>[%:
MQCM;O<YN->,N'LER%Y'P_;E?Q-?Y]6:UK;+!$L,8^1%"JO8 5/&B*^5//I4*
MLSR  X&.:DADB=_E?)K]9TYK=3\#Y:D4B:BBBF,**** "BBB@ HHHH ****
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M?:_#FH^=$0/F'_ZZVI6D PA.T=37YP_L8?M#7GPT\:VWA;7=<FEAO9AQ,Y.
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M*'56D4@]Z_.KI^](_>M&[,EHHHJ@"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I"JDY(Z4M% !@>@I-H]*6B
M@+(38F,;143:=8O()FM$+ Y#%>14U%&XFDS-\0>$_#OB:W^SZYI$%RO831AJ
MYN+X!?#*.<3#PE8X!X'V<8KM2 1@TSRV#^WUI.,7T,:F&HU)7E!/U2*EAX?T
M72;$:7IVFPQ0@8\M$P,?2BU\,Z%9R&:VTJ%'/WF6, FKQ*K]: <C-%D6J<%;
M1:"")%&U1@>@IDUK!-$8I(@ZD<JPR#4M(WW33-.AQ7C/X%?##QM9R6^M^#[!
MFE4@R&V!:OE_XX?\$B/A1XZ$VI>'+V>WG?)6.WA"C/YU]H@EA@B@E4&3@5VX
M3,\;@_X50\/-.&LCSBFXXJBG\C\@OBC_ ,$@/C/X3#S>"-(GO$&<F60C _*O
M!/&G['G[0G@*Z==9\(,H0\G<3_2OWRFB6<$20JRGU'6LO4/A]X(U=3_:GA>R
MF)'S&2$&OH</QCCJ2Y:L>;S/R[-/!#AC&2E/#SE3;Z7T_(_GCUGPYXDT28Q:
MUI;QE3R-AX_2O0_V-_AMK?Q-^/6A+9V$GE6&I1R.P4C(YZU^T/BS]D'X(^,'
M:2Y\(6$9/)V6BTOPT_95^%7PEOY-3\.>'+43$#8XMP""*]*MQG"MA94XQLVC
MYC+_  +K8'-J5>5=3A&2=K:Z:G?^&M*&B:-#IS+@(,5H$J&55 ZU';2W$T8>
MXA"_2I A9]X]:_/^9M-]S^D805+EBB>BBB@L**** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %1>7()..A[U+1
M2:NK 0O S@H>AK#\:>!=-\<:!<>'M9LT:&==I8KDXKHJ9.,QGG%:4IRI55.+
MU6S[&5>C3Q--TZJO%Z-/9W[GQO8_L":)X-^)S?$2^O[A;*UN3( 5^55X[5N:
M/_P4!\":!XQ/P\6[A%K93&"24KRN/_UU])^(M-M=>TF70KB0HLXP64<U^>_[
M2/[(OC3X>>+K_P 2:%ICSQ7L[2B1O3\O:OT?A_$X'BFM['.*KNE:-]$?@/%^
M5YOX;X*.(X4H+D<W*M9.4FNUD[GZ >"_&VA^.-*BU70;P2QR(",&MF,B7+%1
MN3BOAG]@#4/BIX?U2^G\1M.=,AN5\YI921$,#H"*^@F_;8^$-MXL?PU+KJ!D
MEV2_*.#^=?/9QPS7P68U*&%_>QCK=:[GWW"G'V SC(*&.QZ6'E5NE&;L[K32
M]NUSV?:5&[UJ3/R _I7->$_B/X9\<P-/X<U$3IGGIQ^M;QG2*/;-(H)Z<]:^
M8J4:E&JXSBTUY'WE#%4<10C4IR3B]GT)U* _,.33965AM;@>M10-&P^24-GW
MJGK.O:;HT+7.JW*QH@YYJ%S2>E_3J:SJ4H0YI-6]?U-")D0':^?>F74EO GV
MBXEVJO4DUY]>_M)_"BPU:+2)?$($LK8 P.OYUX]^W?\ '#QEX:\'P2^"$+6U
MU;,QN$<@@9/I7MY?D&-QN-I8=QY/:;.6GYGS&><89/D>55\:YJ<:2NU'5^6Q
MZCXO_:X^$/A7Q3!X3OO$2K-*Y5QM!P?SKY?_ &L/V9O'OQ6\;6/BKP3!)>Z?
M?NTAF+_<4YZ=:\-\!?#GXB?&[Q/;7&E375Q++)FXE9SF,GTK])O@?\.9_!'@
M?3-%UZ:2:XCM@I$YR0<FONL;2PW ->%;!5%*M:TD]?RL?BF4XS,?&W U\)G&
M&='"J2E3E'1]':[NG?TTOW./_9._9MTSX0^%H[J^MO\ 398U:0NG*M]?PKW!
M48QJR\\5$T)BC8(@4#H!5FWR85)':OS;'X_$9EC98BLVY2=_(_?\ER7+<@R^
MG@<'#EA!)?\ #^?488Y"RD#ZT0K*9"9%X!XJ:BN1))6/62LWYA1110,****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** &O'O(.XC'I3L<8%%% #0G<FG444 %(X)4@4M% $
MBESS3]A Y&:DHHLA<L>Q&4+?PXQ0%;=C;Q4E%%V'+&^PUHE/0X^E,,38VXS[
MFI:*%H/H0B.11M I(UG$IRN!V-3T4T["L%%%%(84444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !2-C'S4M(RAA@F@!J,A^X.:'12OS&G!0!@#%+0 B@  "EHH
MH **** "FR1+)U%.H(SW- #%!08<9%*NTJ1&,4NT=R31@9R* %'3FBBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJYZU/& J  ]J3RQM"D]*<!@8K'7J="T5D%%%%, HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ ) Y- (/(H
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #&N85Y9P
M/J:8;^S!P;E/^^A7S3_P4O\ A?\ 'KXF? K5;3]GF\O4UP1#[,EE,4)(#9Y
M/M7\X'[0G_!3K_@HM^R=\0+[X:?%+6M6M+E+EUB,NHN254X[@>M!5D?UK?;K
M3.T7"9/3YQ2->VZKN:>/ _VA7\=9_P""[/[:%G\C>,-1.XY4G46_PKL?@S_P
M54_X*._M-^,K3X:_"G5=4OM3O7"Q11ZBX)Y /0'UH)9_7 ^IVR,$,JDMTP<U
M81MRAO6OE/\ X)9?"[X[> ?@9;WG[0U_?2ZM?113%+Z8N8\@Y ) XKZI@(*D
MKTSQ0!)1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'5)T!33+D[XP!\RL,XY.17[<:?91V%G%9Q'*Q1*BGV Q0!/11D9Q10 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@BC48C11P!5FW#JA5UQ@\>].15*],8]*55V]Z %HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BF[F)PHIU !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ",
M<#-)M#\L*5@2,"@808)H :$4. !3BH/:FL=S?+3E! YH 0I@?*32J"!S1N4=
MZ4$'I0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !15<W!\XI[U.IRH- "T
M4TL=V!ZTZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I" >M+03@9H 0
M%5XS2U7DD(; J:)MR]: '4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 C,1VH+';E1FD5MPR1Q3
M'F<C]PNZ@!V[/#'!]*55"_-NI@<%OWIPV.13'OK:([3(/QH GR&X!I% 08+5
M%_:-F.1**1=2M&'S2"@"?>OK1O7UJ'^T++_GHM']H67_ #T6@";>OK1O7UJ'
M^T++_GHM']H67_/1: )MZ^M&]?6H?[0LO^>BT?VA9?\ /1: )MZ^M'#<@FH?
M[0LO^>BT#4+3M(* )MO^T?SHV_[1_.HO[0M?^>@H_M"U_P">@H FHJ#^T+?_
M )Z"C^T+?_GHM $Y(')I-Z^M0_VA;?Q2"C^T++_GHM $V]?6C>OK4/\ :%E_
MST6C^T++_GHM $V]?6C>OK4/]H67_/1:/[0LNT@H GHJ#^T+?_GH*/[0M_\
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MT6C^T+?_ )Z+0!.3CDTF]?6H?[0MN\@H_M"R_P">BT 3;U]:-Z^M0_VA9?\
M/1:/[0LO^>BT 3;U]:-Z^M0_VA9?\]%H_M"R_P">BT 3T5 =0M^T@H_M"W_Y
MZ+0!/14']H6__/1:/[0M_P#GHM $]!&>YJ#^T+?_ )Z+0-0MN\@H FV_[1_.
MC;_M'\ZB_M"U_P">@H_M"U_YZ"@":BH#J%OVD%']H6__ #T6@">BH/[0M_\
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M6H?[0LO^>BT?VA9?\]%H FWKZT!@>AJ'^T++_GHM']H6G\,@H GHJ#^T+?\
MYZ+1_:%O_P ]%H F+ =31O7UJ'^T+3^*04?VA9?\]%H FWKZT;U]:A_M"R_Y
MZ+1_:%E_ST6@";>OK0&!Z&H?[0LO^>BT?VA:?PR"@">BH/[0M_\ GHM']H6_
M_/1: )Z*@_M"W_YZ+1_:%O\ \]%H GHJ#^T+?_GHM']H6_\ ST6@">BH/[0M
M_P#GHM']H6__ #T6@">BH/[0M_\ GHM']H6__/1: )Z*@_M"W_YZ+1_:%O\
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M^>@H EV_[1_.C;_M'\ZB_M"U_P">@H_M"U_YZ"@"7;_M'\Z-RCC-1?VA:_\
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M_P">AH#YGD'_  ICQI_T,E]_WW2?\*8\:?\ 0RWW_?=>P;%_YZ&C8O\ ST-
M:]SQX_!OQQGCQ-?_ /?5'_"F_''_ $,M_P#]]5[#L7_GH:-B_P#/0T!\SQX?
M!KQN3AO$M]_WU3O^%,>-/^ADOO\ ONO7]B_\]#1L7_GH: ^9Y!_PICQI_P!#
M)??]]T?\*8\:?]#)??\ ?=>O[%_YZ&C8O_/0T!KW/(/^%,>-/^ADOO\ ONC_
M (4QXT_Z&2^_[[KU_8O_ #T-&Q?^>AH#7N>0?\*8\:?]#)??]]T?\*8\:?\
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MP[%_YZ&C8O\ ST- ?,\>_P"%-^./^AEO_P#OJC_A3?CC_H9;_P#[ZKV'8O\
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M6_\ ^^J]AV+_ ,]#1L7_ )Z&@/F>/?\ "F_''_0RW_\ WU1_PIOQQ_T,M_\
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MW@W$<0\]1V-,9UBL" ,TM,B=7' &1UI] !1110 4444 %%%% !1110 4444
M%%%% &!XN&86)ZXXJ/P;?I) ULS_ # 8Q4WB[)A) Z"L#PG?>5J10_Q,!6\5
MS1/.]IR5[G<1\G [=:DJ.,C[P.=U25AU/06JOW"BBB@84444 %%%% !1110
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MX-^. <?\)-??]]4'X-^.!U\37W_?=>O1[#,27.>XJ0%2QST%)M=!)2ZGCO\
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M743D%:K^$O#6K?%_Q9+K&JRR-803E0I.5*U[+HVCZ7H%B++2[=(T488H,9H
M\FTSX1_$6YCW:EKM]&WIOJ:3X.>."VU/$=]CUW5Z_&TS=8^.QH<^:A6/KWQ0
M,\B'P6\;(/D\37YSU^>C_A3'CK_H9+__ +[KV! RJ <YIPWXZ?G0(\<_X4SX
MZ_Z&6^_[[IP^"WC4\_\ "27W_?=>Q_6B@#QW_A2WC7_H9+[_ +[I#\%O&P&1
MXDOO^^Z]CH/M0!XW_P *8\=?]#)?_P#?='_"F/'7_0R7_P#WW7L>7]!1E_04
M >.?\*8\=?\ 0R7_ /WW1_PICQU_T,E__P!]U[(,XY%% 'C?_"F/'7_0R7__
M 'W0/@SXT/7Q+??]]U[)3"I8D+0&AX^/@MXU//\ PDE]_P!]T'X,>- <'Q)?
M?]]UZ_(R(FUW(]Z;&%(X<D'O2UZ"U/(3\&?&8Z^);W_ONC_A37C+_H9KW_ON
MO7_+3^\?RI?+3^^?RIB^9X\WP:\:?P^);[_OJD_X4UXW_P"ADOO^^J]B\M!T
M<T;%_P">AH'\SQW_ (4UXW_Z&2^_[ZH_X4WXX_Z&6^_[ZKV+8O\ ST-&Q?\
MGH:!?,\>_P"%-^./^AEO_P#OJ@?!KQN3@^)K_P#[ZKV'8O\ ST-&Q?\ GH:
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M_P"S+#_GT3\J/[,L/^?1/RH_L_#A_:&-[H_;C_B*NT7_ *%;1O\ OZ?\:/\
MB*NT7_H5M&_[^G_&OQ'_ +,L/^?1/RH_LRP_Y]$_*C^S\.']H8WNC]N/^(J[
M1?\ H5M&_P"_I_QH_P"(J[1?^A6T;_OZ?\:_$?\ LRP_Y]$_*C^S+#_GT3\J
M/[/PX?VAC>Z/VX_XBKM%_P"A6T;_ +^G_&C_ (BKM%_Z%;1O^_I_QK\1_P"S
M+#_GT3\J/[,L/^?1/RH_L_#A_:&-[H_;C_B*NT7_ *%;1O\ OZ?\:/\ B*NT
M7_H5M&_[^G_&OQ'_ +,L/^?1/RH_LRP_Y]$_*C^S\.']H8WNC]N/^(J[1?\
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M]F6'_/HGY4?V?AP_M#&]T?MQ_P 15VB_]"MHW_?T_P"-'_$5=HO_ $*VC?\
M?T_XU^(_]F6'_/HGY4?V98?\^B?E1_9^'#^T,;W1^W'_ !%7:+_T*VC?]_3_
M (T?\15VB_\ 0K:-_P!_3_C7XC_V98?\^B?E1_9EA_SZ)^5']GX</[0QO='[
M<?\ $5=HO_0K:-_W]/\ C1_Q%7:+_P!"MHW_ ']/^-?B/_9EA_SZ)^5']F6'
M_/HGY4?V?AP_M#&]T?MQ_P 15VB_]"MHW_?T_P"-'_$5=HO_ $*VC?\ ?T_X
MU^(_]F6'_/HGY4?V98?\^B?E1_9^'#^T,;W1^W'_ !%7:+_T*VC?]_3_ (T?
M\15VB_\ 0K:-_P!_3_C7XC_V98?\^B?E1_9EA_SZ)^5']GX</[0QO='[<?\
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MZ'7CR?>%?7T?X4?0^*G_ !I^H^BBBM CN%%%%!84444 %%%% !1110 4444
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M"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"1I%]C_GRE_] -0U-_S"+[_KRE_] -1V]2/^7:/YV/\ @H?S^T]J!_Z;3?\
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M_ &/[5\5O ,NF1(I9FD)Z?E7%03_ &R-9+==RX^8^E?K/?\ _!;+]D+]K+X
MZKX8^-WPS\,:5K)C6*W.S<YX.3DM7Y5?$2YT;6/B#J>K^$75=+^V,81",+L[
M5="IB91][8BO3P\-8&>K[045<Y_2D+%>2GZTUPDF)(9"2!T]:>?,:/[G-="5
MC&]Q4A>4;PO2DR<D$8Q3H9Y(QM*4TY+EB,9IC6X4444%!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4C'"FEI'^Z:F6P^C+OPX^3
MXP^'=G&;GG'XU_7-^P23_P ,?^ N?^8&O_H;5_(S\.O^2Q>'/^OG^AK^N;]@
MG_DS_P !?]@-?_0VKS,WWB>EDVS/85Z"O&=._P"2P2_]?G]!7LZ]!]*\8T[_
M )+!+_U^?T%>(>Z>S-U'UI:1NH^M+0 4444 %%%% !1110 4444 %%%% !11
M10!@^*,X/XUPNN8YP*[OQ5]P_C7 ZVQW=>]=E#H>)C'N<EJ,[6FJ17:MM*/G
M->U^!]174_#]M<K)EF3+&O#O%&0C[>O:O2?@7K2W6CBRD?+1Q@8K7$P<HW.3
M+*RAB.3N>A;MS8)[]*<.I%-0?-G%*OWC7FH^E2=QU%%%,84444 %%%% !111
M0 4444 %%%% !1110 4C=1]:6D;J/K0!P/Q[_P"0"OT-:?P6_P"2<:;_ -<_
M\*S/CW_R 5^AK3^"W_).--_ZY_X4 =5@ L<=J^</VF@&\28(Z2\5](=V^E?-
M_P"TS_R,I_ZZT ><YRBDT^F?P+]*?05$*,.?F49QUHILD<CH3&3D#IZT% )H
MBX:5MH-%R44AT;*D]:=;JTT'[^ *L8R6KFM4^+O@&TUZ/PS+K$:SB0*4]Z .
MC@+22%47/O3FVPR%).">QKSWXS?M'^%/@WL>ZGB*O(5#/WK2^&GQP\)_$;PJ
M/&"W<:Q>49,KTQ09O<Z\QA&WN^,GBD+*)B&.!6%X<^+?@CQS>2:=I&J1O+",
MA%[UT#)<!-TUN%-!41) L1WAL@TP^8Q\QEPIZ4JN)!L(Y%(9F(\@KC;04*/N
MCZU)#_KD_P!ZHQ]T?6I(?]<G^]0!\$?\%_\ _DB.D?\ 7])_(5^,NB_\@R/Z
MU^S7_!?_ /Y(CI'_ %_2?R%?C+HO_(,C^M?0Y?\ [G\SY3-/]]^1>3[HI:1/
MNBEKOZG)'X$%%%%!04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 QS'&#)<2;1_!_M'TKT3X.?L>?M-_M 6@U7X9?#B:_B()!B)P0._2JG[
M)O@S1_B9^TAH'@[Q#-BU?5K8,I&0^9 ""*_>_P#;<\8ZQ_P37_9_T+5_@%^S
M;I&KH[Q+),4*%E*IDG'U-<M?$QH-<NK.C"X5XIOFE:*W/P/^+O[,'[0WP$OF
M3XI> )=-7(4F0GC]*X.ZO+&QMA<2W/+' !]?2OTY_:@_X+"_#/X]_ N?PW\7
M_@9X>T7Q'(LJE5!9U)4!3DGUKY+_ ."5?[%>M?MM?M-2>'X;&2?2K%EOI=J9
M41AV8\>F!51K7I\]0SJ46J\:-%WBSS?X,?LJ_M%_M#2&7X4?#Z;4DV%@8B>@
M_"K7Q=_9&_:8^!5M_:'Q/^&TVFQ!L%I">/TK]@/VTO\ @HA^SM_P2?MH?@E\
M(_A/X>U37K2.,7/F1[),, #G!]0:XCX*_P#!;O\ 91_:6^'>K^&/VH?A9X9T
MFXDTRX^S22IO;S"A"XRWKBLG7KR2DEH=,\)AZ7NN6I^//A>PO/&VKQZ/X;A-
MQ?3.(X[=>[$X _.O<M&_X)>?MW^(;=+K3?@G=.)%#  G[I&<_=]*H_#NX\":
MI^WYI6H?#WR9-"N-?M1#Y2X0@W'3'T(K]C?^"P?_  4E;]@3P)HMCX,^%FF3
M'R;0-.Q*EMR)D'GWHKXFNYQC!$X?!T.1RDS\6/BY^Q)^U5\";(ZM\1_AA/8V
MN=K22$\>O:O-O#^GW'BC4(O#_AY#<W\THCC@'4L3@#\Z_=__ ()A_MW^$/\
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MI&$Q2>Z&OB1<\,_\AJ'_ 'J_%_\ X+V?\EGTWZ2_S-?M!X9_Y#4'^]7XO_\
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M)O;9">/-'%6CT_&JMY_Q_P!M_P!=14O9D3_AR/Z6?^#?!5'[%_AW _Y=F_\
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MXX_%2RB&GS:B]Q<).=R88C_"IPL*T7=O0K$U*52R5D<!+:ZIIL@?6=/%NO\
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M_P"0"OT-:?P6_P"2<:;_ -<_\* .K[M]*^;_ -IG_D93_P!=:^D.[?2OF_\
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M *Y/]Z@H^"/^"_\ _P D1TC_ *_I/Y"OQET7_D&1_6OV:_X+_P#_ "1'2/\
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M81#//T.23_45\Q_"']G'XP_'JWGO/A7X/DOHK6W::9H<\(H)/8^E?K1\'_\
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M[X6_\%>_V8=%\.>);FW/CG1/$T=W)(J[YC%;RJPR?3]W7RIXA_X*%?![5/\
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M>2JT?8X2K[?#1GU:'44S)SO!XIXY&:S.@**** "BBB@ HHHH **** "BBB@
MHHHH **** "O'?VB#CQ5IY/_ #Q/]*]BKQS]HK_D:-/_ .N)_F* /4_"A'_"
M.67/_+ 5=E_I5#PI_P B]8_]>ZU?E_I0!\H_&G_D=F_ZZ-_.N:_Y8M]:Z7XT
M_P#([-_UT;^=<U_RQ;ZT&BV H64'<0 *$MT=2^\G'6EBCDDG51G;CFFR0FY9
MH8'*@'!(H);=S-\8>,-/\":2^M:Y,(;:)<O(W85P^G?M%>$/C9X<U'P3X:O8
MS>2/Y</E?>:M7XR7'@7XB>&9_A\?$>R\F3R]BCG->=_LX_LHZO\ "3QB?$5S
M--)"]QYD9<<$<4"YF<A\*/V:?BSX2^,:^)-:DO$L6NR^YCQMX]J[WXI?L=P_
M$3Q%:^)#?2MY .X[/6O=I;LW#XDA 5>,U"TDXDV)(5C/WB*!\S/"_P!HWX">
M*M5^&]MX5\%WER[I9^61%Q@\U6_9]TO5_P!F7P3=ZA\2KJ5 <./M)[5[['*C
MAMQW[3QFN-^/_P -)_C'X-ET'3F=',6S$8YSS0+F9!\,OVB/!7QAU&33]!O(
MFF238B1_Q5VSPR*[*R\J>17@7[/'P5\/_LY:Z^H^--?DMW:8/&)5ZBO>(-5T
MWQ%!)J/A^\\^/.=PH*6J)(R,[>]#,,$4DCKM17^5B.<4@QV.?>E]I#7Q(O\
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M_:O^(UI\1OA!KMM<7EU?/+>FU7GD-C)R?45&&^L4L2Y/J/&?5ZV&45T/IO\
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M(5*L?&'X9'XN>%O[":^>%D!P$&<Y[5\MK\/OB?\ LL^-(M0L;*>;3A, \CG
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M*28)ZD4*S5F3>S!TFF4PS)M*_P ?>A8?LT7F-(>!PQ[T\2?NO++9/=L]::H
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MTF_3=#(I&UN1S7B_C7P+\'_V==>;QSKDENA8Y"R1X&6.?ZU[@LWV=A/MR_\
M<KR_]IWX%S_'71Q:VUS(K J=B#/2@@Z'X6_&KP_\9-/$GAZXC=4^5?+]!_\
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MO_K4?\,#7O\ T,MW^7_UJ\@_X6Q\4/\ H>]0_P"_G_UJ/^%L?%#_ *'O4/\
MOY_]:CZCQ5_T&0_\!8?VGP3_ - $_P#P,]?_ .&!KW_H9;O\O_K4?\,#7O\
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MW_\ 6I?^&&/VLCS_ ,)7K?\ WV/\*\Y<3+E5LVI?<CU%PE&WOY'6;_Q'(?\
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M"+W_ *&2Z_[YKL/^&&OVL_\ H:=<_P"^Q_A1_P ,-?M9_P#0TZY_WV/\*/\
M6:7_ $-J7W(7^I]/_H15O_ CD1^P1=XY\2W7_?/_ -:C_A@BZ_Z&6Z_[Y_\
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M'B_7!_P(?X5Y7^LDO^AM2^Y'T$.$Z,O^9%6_\".0_P"&!KM7(_X2:[(]U_\
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M?ZS2_P"AM2^Y!_J?3_Z$5;_P(X__ (8(O?\ H9+K_OFG#]@BZ_Z&6Z_[Y_\
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MU+[D'^J5'_H15O\ P(Y#_A@BZ_Z&6Z_[Y_\ K4?\,$77_0RW7_?/_P!:NO\
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M^^:</V"+O'/B6Z_[Y_\ K5UW_##7[6?_ $-.N?\ ?8_PI1^PQ^UF?^9KUO\
M[[_^M1_K,^N;4ON0UPA26^15O_ CD/\ A@BZ_P"AENO^^?\ ZU'_  P1=?\
M0RW7_?/_ -:NO_X88_:S_P"AKUO_ +['^%'_  PQ^UG_ -#7K?\ WV/\*/\
M6;_J;4ON0?ZI4?\ H15O_ CD/^&"+K_H9;K_ +Y_^M1_PP1=?]#+=?\ ?/\
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M%K_D=]/_ .OY/YUZ['_JU_W17D7Q:_Y'?3_^OY/YUZ['_JU_W17.=)XS>_\
M):T_Z]17LL'^H3_<'\J\:O?^2UI_UZBO98/]0G^X/Y4 4?$O_()G_P"N+?R-
M?'^ND_V_<^TS_P S7V!XE_Y!,_\ UQ;^1KX_UW_D/W7_ %V?^9H+CL1#[_X4
M( "6 YS2C[__  &D7O\ 6@8%03DBG(S1G*,1]*2B@+(5V9_OG--*@C!%+10
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M3@<Y[T[[F!ZU\ZVKV/TI149MDBG(S2TBC I:0+8****!A1110 4444 %%%%
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MD2X/]]OSHP?[QJ+#_P#/0TJ!B<%S1RP[K[PM4_I$F#ZFC!]32;3_ 'S1M/\
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M]Z:H:.7$0R*D/JD0_"@8F]?6C>OK2Y?_ )Y?K1E_^>7ZT )O7UHWKZT>8?\
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M_HG&C?\ ?)_^*I_ZKY'_ -"9_P#@?_!#_6K/O^B@A_X#_P  Z?\ X>K>,?\
MH3(/^_Q_QH_X>K>,?^A,@_[_ !_QKFQ^U3^ST1_R3;1?^^3_ (T?\-4_L\_]
M$VT7_OD_XTO]5\D_Z$S_ / _^"'^M6??]%!#_P !_P" =*/^"JWB_/S>"H"/
M3S3_ (UY5^TU^UMXC_:(TO\ LN\\,1PJ4"Y5R:Z]OVJ/V>B,?\*XT8>^T_XT
M^+]JO]GF/I\/]&_[Y/\ C7;E^4X'*\9#$X;*7&4=O>77YG%F6=8W-L!/!XS/
M82A/?W?^ ?+Z6.MV[(D-D2NWFG&UUK/.G$U]/O\ M9_  G"_#[1_R/\ C3!^
MUC\ S_S3_1_R/^-?5+B#-];8"7_@43XA<+</*W_"K#[F?,?V76?^@8:/LNL_
M] PU]._\-8_ /_H0-'_(_P"-'_#6/P#_ .A T?\ (_XT_P"W\Y_Z )?^!(?^
MK'#_ /T-8?<SYB^RZS_T##1]EUG_ *!AKZ=_X:Q^ ?\ T(&C_D?\:/\ AK'X
M!_\ 0@:/^1_QH_M_.?\ H E_X$@_U8X?_P"AK#[F?,7V76?^@8:/LNL_] PU
M]._\-8_ /_H0-'_(_P"-'_#6/P#_ .A T?\ (_XT?V_G/_0!+_P)!_JQP_\
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MWR?_ (JC_AJK]GO_ *)QHW_?)_\ BJ/]5\C_ .A,_P#P/_@A_K5GW_100_\
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M:/\ AK'X!_\ 0@:/^1_QKM_U@SE[8"7_ ($CSUPOP^E_R-8?<SYB^RZS_P!
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M8_X:J_9^_P"B<:-_WR?_ (JFG]JK]GS//PXT;_OD_P#Q5'^J^1_]"9_^!_\
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M-5?L_?\ 1.-&_P"^3_\ %4C?M5?L_P"/^2<:-_WR?\:/]5\D_P"A,_\ P/\
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M $3;1O\ OD_XTH_:I_9\SQ\-]&_[Y/\ C1_JODG_ $)G_P"!_P#!#_6K/O\
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MO.6M]_O$J<'I)7ON$4#G>[2DA3P.U+2AB 0._6DI)**LC172L%%%%, HHHH
M**** "BBB@ I'^Z:6D?[IJ9_"'1EWX=?\EB\.?\ 7S_0U_7-^P3_ ,F?^ O^
MP&O_ *&U?R,_#K_DL7AS_KY_H:_KF_8)_P"3/_ 7_8#7_P!#:O,S?>)Z>3;,
M]B7H/I7C&G?\E@E_Z_/Z"O9UZ#Z5XQIW_)8)?^OS^@KQ#W3V9NH^M+2-U'UI
M: "BBB@ HHHH **** "BBB@ HHHH **** ,#Q=_JC^-<)K?W#^-=YXO $?X&
MN!UQCMP!771V1XF,6YR.N_=/UKE-9^Z:ZO7<;3SWKE-9^Z:]*D?,8G<Y#6^]
M<OK,0EMI%/I74:WWKF=4)\IE Z]Z]*F[(^=Q?PL]O_8D\9I']KT*:48CC55&
M?<5]*+N#,QZ=J^%OV;/%J^%OB+';/+\MU.JMD]*^Y;*X2^MEGB;*XR#ZUX>;
M4?8UD[;GW'".,6)RSD;]Z+U+49)09I:1/NBEKS#ZS<**** "BBB@ HHHH **
M** "BBB@ I&ZCZTM(W4?6@#@?CW_ ,@%?H:T_@M_R3C3?^N?^%9GQ[_Y *_0
MUI_!;_DG&F_]<_\ "@#J^[?2OF_]IG_D93_UUKZ0[M]*^;_VF?\ D93_ -=:
M /,M0ODTW3WOY,;8D+'-<I_PO;0_6+_OJNOF@BNK?[/.@9'&&4]Q6?\ \*]\
M)?\ 0'@_[XH*B8'_  O;0_6+_OJFGX\:$I^[$>/6NA_X5[X2_P"@/!_WQ1_P
MKWPD.FD0?]\4#>QSW_"^M#_YXQ?G1_POK0_^>,7YUT7_  K[PG_T"8/^^*/^
M%?>$_P#H$P?]\4$V9SP^.^AD9Q$/;-+_ ,+VT/UB_P"^JW_^%>^$O^@1!_WQ
M1_PKWPE_T!X/^^* LSGS\=]"'/[H^V:3_A?6A_\ /&+\ZZ'_ (5[X2_Z!$'_
M 'Q2_P#"OO"?_0)@_P"^* LSG?\ A?6A_P#/&+\Z5?CUH.26BB&!ZUT/_"OO
M"?\ T"8/^^*5/A[X3SDZ/ 1_NT D[F#9?'/1-5N%LH(HLDXR#79V$HNHXKN,
MY!.<"LEO GA>V=9K71X$(;@JM:]IMA,<,:@*&Z"@L^"/^"_S[_@CI#8Q_ITG
M\A7XRZ+_ ,@R/ZU^S?\ P< *!\$-((_Y_I/Y"OQDT,;M,C^IKZ' ?[G\SY7-
M/]^^1>3[HI:0?*,4M=W4Y(_ @HHHIC"BBB@ HHHH **** "@I*Q!B&<<GZ44
M$N#E6QZ^] G%35F->X9.5M!(#QSVI8XY$!E8G:PQL["G;L-D*,8Z4@W!RQ/!
M' ]*7OP^!B;>D6KVV?4A:UT]CN,"C\*;]CL"?]2OY5/L'8?K1L3^[34I6)4(
M]ABZ?8[.8UZ5%]CLO^>*_E5@C(Q1L7TI7D$J=-]"O]CLO^>*_E2K8V+'!B7\
MJGV+Z4A0=J+S(]E3_E_(C_L^P_YYK^5']GV'_/-?RI^P^HHV'U%.['[*'\OY
M$9TVQ)X1:3^S;+^ZM3JH Y%&!Z"B[%[*'\OY$ TVRSRJTO\ 9]A_SR'Y5,5&
M. *;L/J*3<@]E#^7\B/^S[#_ )Y+^5']GV'_ #R7\JDV'U%&P^HHO(?LH?R_
MD1_V?8?\\E_*C^S[#_GDOY5)L/J*-A]11>0>RA_+^1'_ &?8?\\E_*C^S[#_
M )Y+^52;#ZBC8?447D'LH?R_D,_L^P_YY+^5+_9EE_SR7\J=L/J*?1>8O90_
ME_(B_LRR_P">2_E0-.LEY\M?RJ6BB\P]E3_E_(B^Q6/_ #S3\J/L5C_SS3\J
MER/049'H*?-(/94_Y?R(6L+ G/E+^5)_9]A_SR7\JE92QR,4FP^HI7D/V4/Y
M?R(_[/L/^>0_*D_LVR_NK4NP^HIV!Z"A.0O90_E_(@_LVR_NK2C3;3^&)34V
M!Z"@CTXIW8U3@G\/Y$/]G6X/_'JI_"G+96X&/L:_E4@W _>I<GUJ=2N3R_(B
M:TM,\6B4GV2U_P"?1*FHJN::&HKL0_9+7_GT2C[):_\ /HE344<]0.5=B'[)
M:_\ /HE'V2U_Y]$J:BCGJ!RKL0_9+7_GT2C[):_\^B5-11SU Y5V(39VG>S7
M\J3[':?\^:?E4]%+FGV#ECV_(A^QV?\ SYK^5'V2U_Y]$J:BCGF'+'L0_9+7
M_GT2AK.SQ\T*ISUJ:CCN,U2E-NST&HQ3ORD:VMJ)/GLUZ<'%.* Q^8LA4 X"
MBG L)=^>,8Q30AV;"W?-0W.4+-:DRC4=[/??057=_OIBEH)S15RM?0T6B"BB
MBD 4444 %%%% !1110 4U^GXTZFOT_&IG\#$]F,N_P#5M_N5^N?_  :Q_P#(
MSR?]?D__ *$U?D9=_P"K;_<K]<O^#60X\32'_I\G_P#0FK#&_P"Z?(Z<#_O\
M?0_>8_?'TKR_]JO_ ))V_P#U\QUZACG->6_M6/\ \6[?_KYC_G7S!]0=)\%?
M^1-A_P!Q?Y5U]<A\%>?!D)_V$_E77T %%%% !1110 4444 %%%% !2'[X^E+
M36.&!I/8.I7U;_CT;Z_TKA->^\U=WJ@W6K"N%UT99JZ<.>5F!QFN]37'ZWT;
MZUV&OG!-<=K>=K'WKU*>C/F<4T<AX@SY+8]:YR^"[<MZ5TNLKO4HW<US6KQ%
M%/S5Z--^^FCYS$M)R;%^"GB5_"7Q6M)C)M1L]_<5]WZ+="]TFWNP<B2)6S]1
M7YRZE=R:7K$&L1'#1$# [\BON_X)^-AXL\!VES'" T,"(0#[5P9S2LHS1[_!
M6+OST)O7H=K13%D)4$KS2JQ)Y%>#?2Y]^.HHHH **** "BBB@ HHHH ****
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M!2T%1V"BBB@H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-?I^-.IK]/QJ9_ Q
M/9C+O_5M_N5^N7_!K-_R,TG_ %^S_P#H35^1MW_JV_W*_7+_ (-9O^1FD_Z_
M9_\ T)JPQO\ NGR.G _[_'T/WGKRK]JO_DG;_P#7S'7JM>5?M5_\D[?_ *^8
MZ^8/J#IO@I_R)D'_ %S3^5=?7(?!3_D3(/\ KFG\JZ^@ HHHH **** "BBB@
M HHHH *:_7\*=37Z_A2>P+<@U/\ X]6_SVKA-<^^U=WJ?_'JW^>U<)KGWVKI
MP^YY68'&>(>I^E<?K7W#]:[#Q#U/TKC]:^X?K7J0/E\3\+.1UDG+<US>K9,1
M/O72ZX (R1UYKF-4)\@UZ%$^?Q4;HY3Q$F]#@=*^FOV&?'<>J^&KC1YI066X
M"J"?3-?-.I*9%8&N^_8Y\90>'/B/#X>DD %Q(SD'ZC_&KQU'VN$;['/D6+>$
MSBG'^8^X.HXXI4)W8QQZU'%*)84E09#+GBI$))&17Q\;\MC]EOI<?1113 **
M** "BBB@ HHHH **** "BBB@ KQW]H?_ )&K3_\ KB?Z5[%7CO[0_P#R-6G_
M /7$_P!* /4O"G_(N6?_ %P%79?Z52\*?\BY9_\ 7 5=E_I0!\H_&@9\;L/^
MFC?SKFB,1-]:Z3XU';XW8'_GHU<T#F,K0: K,1QZ4O[RE!"J*-Z^M "?O*3<
MWK3MZ^M+@'L* &;V]:4.V>#3L#T%(<*,XH 7>_H?SHWOZ'\Z;YGM1YGM0 I,
MA_\ UTG[RE#@]:-Z^M "?O*<,XYI-Z^M!8 9I=4+[:-#PP1_;4(SWK\7O^"]
MIS\9]-'_ %U_F:_9[PP<:W"?]JOQ?_X+V$?\+GTW/?S?YFN_+?\ >#R\T_W3
MYGP?%_Q[K]*<?N?A38O^/=?I3C]S\*^B/G!QZ#Z44'H/I106M@HHHH&%%%%
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M5&$Y)-=3*BWNYA R,?>IRQ2@_9F7A>?,K4\6^!_$?P^UZ/P3J=FXO9&0 /\
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M!B8XO!PJQZH=1114'8%%%% !1110 4444 %%%% !1110 5X[^T/_ ,C5I_\
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M9'.?F^M<]X:_;+\8^!/AN? O@:-[ FX:0FVDP3NZBJ2J*-B(RH1K>UN>X_\
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M?W-'),GZSA3#_9@_9P\2_$/]K>XT>^TZ2=M.@DN2C#.7B);/YK7T[^V!X/\
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MHK_D:-/_ .N)_F* /4_"A'_".67_ %P%7G&3^%9_A3_D7K'_ *]UK0;[WX4
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MS_C2]JA2\4Z$9M/#O3S1^4HT3Q'&^X:4S[NJ^E$V@^)?-CD.E, IR$K]66^
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MI<.Q7M91EH?L-X9^)>H_%K2DB\&6'V6WD0;#;-PP]><UYK\</V0O@\_AN_\
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M05[.O0?2O&-._P"2P2_]?G]!7B'NGLS=1]:6D;J/K2T %%%% !1110 4444
M%%%% !1110 4444 8'B[_5'\:X37?]77>>+1F(\^M<'K7S(1Z5UT=D>+B]F<
M?KOW3]:Y36?NFNKUOYE;VKE-8Z$5Z5(^9Q2.0UOO7,ZF,JQ]!73ZZ,9KF=2D
MV KMZUZ=+9'S>+V9SFH?<:N>U [MRFNCU)<*P'>N<OT(=N:[('SN*.O_ &4/
M'#>#_BI%:/)L2[N51N>W^17Z(V=VM[#'<P/E&YR.]?E=H^KOH/C;3=2BX\NZ
M#$@_6OTJ^"FN_P#"1_#;3M7W[C)!N(S7AY]2Y91FMC[KP\QTI4ZN&;U3T1V
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M\@88X/H:9'-;SV^(T'FC[P'I34NHE4>=+@YZ&A<TMD*T+V0^)WDSYR;^/XJ
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M23"BBBI*"BBB@ HHI&.!FIG\#$]F17W^J;_<_I7ZY_\ !J__ ,C)+_U^S_\
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M%^='_"[/"W_/:+\Z .J;<2!MIPWX^Y7)_P#"[/"W_/:+\Z4?&_PP!CSHOSH
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M1?"!&\*>+)MFFR@E9)3\NT=*RG*SL;T875RI\8/B+I6H?#K_ (26+4%@N;"
M)(5/);!Z_E7YU_M-?M0ZY\7;Z7P\"T:6V81('SNQWKHOVR?VAM0U3Q%/X1\"
M:XZV=R6,AMWX_P \U\^[MV7,>^5N9)#U)H@M;F=2=Y\HZQMH]-B.YO-D<YR>
MM.<&-PYZGD"EE) &$!;%''FKYYP<<5J0*#D9HH.,\44 %%%% !1110 4444
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MFMQ;Q7=J;:=0R.N&![BLK_A6GA'_ *!D'_?)K9_@7Z4[>OK05$Q/^%:>$?\
MH&0?]\FC_A6GA'_H&0?]\FMO>OK1O7UH*,3_ (5IX1_Z!D'_ 'R:/^%:>$?^
M@9!_WR:V]Z^M&]?6@##_ .%:>$?^@9#_ -\TO_"M/"/_ $#(/^^36WO7UHWK
MZT&;,,_#3PC_ - R'_OFE_X5IX1_Z!D'_?)K;WKZT;U]:"HF)_PK3PC_ - R
M#_ODTA^&WA%2,Z9#C/\ =K<WKZTC@.O#8Q048_\ PKCPE93)=6EG$&#9X6MR
MVN/)>.U1-J!NU1)!&5#&XSCM4D6PW"*<?>ZT ?!7_!P$ /@GI 5LC[=)S^ K
M\9-%_P"09']:_9O_ (. 0!\$M( .1]ND_D*_&31?^09']:^AR_\ W/YGRN:?
M[]\B\GW12TB?=%+7?U../P(****"@HHHH ****  ]*Z[]G7X577Q[^)T?P]M
MI6MD#H9IXQDA22/Z5QMVS+;.R#D+Q7V/_P $WOAAX(T+P)J/Q:\<^*5T>6ZT
MUUM;AUY\Q02,'\:^;XNSB>0\/5<53_B/W865WS2VTUO;5[=#HPE&-?$*+V6I
MXM^VE^S--^RAX_E\.V-R^H6#;%CN77 R>O0"LC]E+X!7/[1/Q"E\(27<EO;I
M&KB95SU)_P *^J?VH?!W@'XP?LK66LZ;\1!KFN17$SS3,,R;0%QGCZUE?L(>
M O OP\_9ZMO'?BWQN-&U*Y$L8N67YR0!@9Q[U\31XPS##\$2<Y.6*BU2OR.[
MFOM\MKV=F]CM^H1J8Q1^S>_R/FS]K_X#R?LO?$ZZ\&F\>^M(E3R9Y%P&8Y^G
MM7<_L6_L27O[6.EZIJ]]J<NG06.FO<VY1 PD8 G;R#Z"O6_VU?A3X,^*7[/W
MAKQ;X?\ '/\ ;>KSZTPO)]HWF,;,9XZ<FN\^$@\ ?![]G?PGI=I\21H>I3:K
MY>I^2 &:([.&R.G6N7&\8YJ^#J4,--_7)2]DY<CT<-Y<MMI<NFG4J.7T?[1;
MZ6OO^!\0V_P=O+?X\7/P7U*9T:V9,RL.3N9A_2H_C?\ #.'X3_&>'X807!D\
MZ:&,S$8/SG%?3G[6G@OP%X,^/>F?%?PGXECN['4[ZWA-^BX#8;)_]"KG/VE_
MV7?&/Q8_:$T[XE^"TGN]*^TVSO>1+\H53ENU>]EG%T,3/#8C$/DIU*+;O[O[
MQ6NM=G>^GX&,\#S*48])?@>6_&+]E^_\!/I5CH%S)<3:E=QPL57!4-CGI[UZ
M$W[('P=\$Z0GAWXA?$Y;'7$0226\L8W\@8[?6NG^/7Q)\%>$_C%I?@Z^UJ*;
MR+JWS(YYC.0,_ABN=_:M_9C^)?Q9^,=S\0O VMWE[H\UK%Y=[$!MXR3V[9%<
M=+.<PKO"4L3B'0C.$I\]E[SO&RNTTM&]-&:3HT)2J6C?L> ?$CP+IWAOXCP^
M&_#&K?VA'=7"1*X&/O'&:]S^-'[ J?"G]GC3OC';^(I;C4+F=A<Z<8P/+0*I
MSG'^T?RK _9A_9Y27]H6YTSQSXADEBTR".X:6X4?+@L2>GM7V!??\*J^)6O>
M*/"+_%=;RQB\/.+&Q8 HLVQQQQUX%<_%/%>*RW'86EA*DIPI)5*KY6^:.BMH
MK+XK_(C"X:E.+4HZGP9^S/\ LY>(OVA=4GU<O+8:/:Q&26]C4%2JYW Y'H*[
MGXG_ +.OP/L=$\SP-\3HKBYA8^9'%& 3CKVKU+]D;4_#?AWP1K_[.[ZJFG:O
M'8W312K_ *R3>&"KC\/2O M2_8T^,G@6RGU[Q%KNH00Q323'S ,.N<XZ>E>G
M#-:V/X@J4J^*]A"GRNG"WQJ2;N[K7Y;=2HT(86G+V>M]Q?&?[.R^$OV?K+XU
MO?O)]LO'@$97@8V\]/>E^$/[.2_$;X.7'Q0?4'#10S/Y6T'[BY]*]QL?",'[
M17[#6E^!O!>J-/J]G?S22V$(RR@!.?T-1>!?!=W^SG^R);Z#X[O'M-0U"YGM
M1;S\$EP /YU+XHQ<Z-2A&HEB%7<$K:\MWK:VUEHQ0PT834WLXGDG[$7[)LG[
M5UUJGVW4)-/AL;266.9$!WE-WR\@^E</X]^&=[X&^-H^%&QGC,Z1K,1R=S;:
M^U?V<O#'P[^#7[+>A75[\15T'6;G6W^V[%P[PL5^4\="":XC]OSX>_#^VO?#
MGQJ^'WB6.]$^MVR7$\*X^570DD_B:\_+>-,96XNQ%&;D\/+GIT_<:2G#2_-9
M7YMUKT*J82"P2DMT]?0^?_CY\"C\%_%VF:(\[.VI7,$/S+C'F$#/ZUV7B?\
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M7'2^YIB,%&IB(<NVS^1P'[87[%D_[,?A6U\066IR7WG>7O#H!C< 3V'K7+>
M_P!G_P#X2OX'-\9#J+A<R+Y.W@;1GTK[6\1^'_A3\<_AUK&F7OQ;76;FSL[B
M2*"4 D%%;';VKP/]FG3V\7_L^ZC\&-*F)U&*>[86J?>VG(!_2NG).*\S>3I8
MN;=:C4C[63@XWA*_1I::;FDL-2>)45U3_"QYM\!?V78_C+\&[WXG0WS 6@N&
M\I4R/W8)]/:I_P!AS]DZW_:VUO5+75M;?3+>QM[AHG1-P=XPV%Y!ZE1^=>V?
M"'PJ_P"RY^R?-X<\9:H]M?:C>W, MI>#^]^4?^A5TGP'\!>!O@W^R]INKO\
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M>G>%HI?A]\74N[O[<L3P11@'[P![5WG[($^G_$C]FW4OA7H&O&QU9M1N[A1
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M-?1G[-'P"U_]G9?$7BSQI=30VMS)?&*290 ?,,A7MWR*Y7]@CQWX<NM5\0^
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MCKY@^H.B^"O_ ")L/^XO\JZ^N0^"O_(FP_[B_P JZ^@ HHHH **** "BBB@
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MK1O7UH Q/^%:>$?^@9!_WR:/^%:>$?\ H&0?]\FMO>OK1O7UH Q/^%:>$?\
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M\R@+Z8HC06V5MHA@\$CTISB**(*+C<<4D;%%^9L9H#W1U%%%!04444 %%%%
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M7_K\_H*]G7H/I7C&G?\ )8)?^OS^@KQ#W3V9NH^M+2-U'UI: "BBB@ HHHH
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M..U,PO\ >_2I "RJ .:?]DE_YYB@"#"_WOTH&T'DY_"I_LDO_/,4U[2;/$=
MUN,RGM^5&4]ORIWV2X_YYFC[)<?\\S061X4_Q?I1A?[WZ5*MI-CF.G?9)?\
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M\(6G_'I^%./W/PIMI_QZ?A3C]S\*^B/G!5Z#Z4M(O0?2EH+6P4444#"BBB@
MP/2AB6&&Y%%% !VQ1T&!WHHH % 0$*,9ZT@10<@<TM%  0"<FFLH53@4ZC('
M+#(H 2+RCR),L/X:1C+(^$BVX_B%,BC"3F<],YQ4@::>4F-"$!Y(H,[L3[CA
MBN[!^:G1']X7GC\M2?E]ZCFGM;2.1I+@8_C8_P -;OPY^&7Q ^+VHQ:/X&\/
MS:A"[!9KF(?ZD>M2TEJ"4FSGI;^V64PEP78_NU]:].^$'[(WQ-^+ 75-4TRY
MTG1S@OJ"J"NS^]T->K:-\"_@;^S#I\'B;XF^)+75=3*^9)I-\F/+8=5XQZ?K
M7G'Q=_;'\;^-6E\._#NTDT'2.43[#)\C)^.:GG<]#=0BE<]-E^(_[//[)NBR
M>'O"6F:;XKUT)MDN) 5DAD'?@CGC]:\ ^)'QM^)'Q9U:6[U/Q#=063.3_9F\
M%$4_PUR[6[&9M2FD-[=R',LKCYBU2!RX#& 1M_$!WH4=3)5'4=MAMO;PVC%K
M:,(3U(I[$MG<<YZT45I9#220BJ$.5&*7)R3GKUHHHLAAZ^_6@C.,]NE%% !1
M@<^_6BB@ P,8H "]***  \]:, <8HHH 4L2,9Z4%B>":2BBR &&X8;F@  8Q
M110 $ C!'%"_)]WBBB@ R>>>O6D"J#D"EHHL@$VKG..:4@$8-%% ";1C;CBE
M50/E4=>HHI&SCY>O:E8'<?IU_KWAR_&J^$]6ET^ZC;=YEOP2:^A/@U^V'X;U
MC16\#_M!>&[:_66/REUC4F)92>K<$?RKYUWX.-_S?Q>U,>UMKMMMSB51V;M6
M7+8F$G'1GO\ \2_V,8O$]K-\2OV>M7?7;%E,LMK:( D*?E]*\&U7[=H&HG2=
M>M#;WJ-B2V;JI]*ZWX5?'7XC_!J^:3PYKUU)IS8$FG*X$;H/X3QG%>YZ9XB_
M9_\ VM-*_LK6[+3_  QX@9?EEB!:260]N2::33-72C/WD['R_*$;RY#U8_.O
M]VA@H=MIW#M7<_&C]FOXD_ B];[9I%Q>Z4[%8M4D& RC^+M7G]O=6<F&M[H.
M#TQ5IW,DFGV18@B(!=G(SVI!&SL2JY [TK2E!F1<#UIH8$Y@FX/4"J*%VJ>U
M&Q?2EHH 15"_=&*4<# -%% "*H4Y48-*Q+_>.:** &F-#U6E*J>HZ4M% !11
M10 4444 %%%% !1110 4444 (>GXU5O/^/\ MO\ KJ*M'I^-5;S_ (_[;_KJ
M*F6S(E_#E\C^EK_@WQ_Y,O\ #O\ U[-_Z"M?H&?O'Z5^?G_!OC_R9?X=_P"O
M9O\ T%:_0,_>/TKYG%?QF?58/_=8>AY'\6O^1WT__K^3^=>NQ_ZM?]T5Y%\6
MO^1WT_\ Z_D_G7KL?^K7_=%<YTGC-[_R6M/^O45[+!_J$_W!_*O&KW_DM:?]
M>HKV6#_4)_N#^5 %+Q%C^RI\C/[EOY&OD'73N\1W $FT>:_(_P!XU]?>)/\
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M6AG%MH****"@HHHH **** "BBB@ I'^Z:6D?[IJ9_"'1EWX=?\EB\.?]?/\
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M\+K\Q1Y?Q:_YX77YBO3_ #9??\Z/-E]_SH*/+]OQ9'6&Z_.C'Q8_YXW7Y_\
MUJ]0\V7W_.CS9??\Z">4\OQ\6/\ GC=?G2^7\6O^>%U^8KT_S9??\Z/-E]_S
MH&E8\P\OXM?\\+K\Q2JGQ;W#$-WU]17IWFR^_P"="W,D9R2?SH&>:V:_%-]4
MC6\M[GRMXR2>,5Z7802+%#YTA+AOF!H:[9WSCBGQ-ON <]Z /@;_ (. <?\
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MFD'RG;0B;<\]:LF.XZBBB@L**** "BBB@ HHHH **** "BBB@ HHHH ****
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MFU*%7 .3Z'I<'XR6$XCI1@_=EHS]&HCD9IU1V^[!R,<U)7P*V/Z(UZA1113
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M@ J8_P#('OO^O*7_ - -0U,?^0/??]>4O_H!J.WJ9/X8G\['_!0[_DZ#4/\
MKK/_ .AUXZGWA7L7_!0[_DZ#4/\ KK/_ .AUXZGWA7UU#^%$^0K?QI>H^BBB
MM2([A11106%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110)[!4<G?ZU)44O0T$'U?_ ,$V_BMH/AR^DT74_ EO?F6YSYTA.5_6
MOM+Q=/X(\0Z(R;8-.,J9^7/R\5\ _P#!/OXGZ9X \4?9M0\)1:EYEP6WR$_+
M[=17Z#GQ#X(\?^%7,^AVVG,R##KGY>/J:YI[G=0_AL_+[]K30M-\-_%!K6PU
M?[8LQ=@^/N\]*\YB^Y7L'[:OAS2-"^)6W3K];H.'(<#&WD<5X_%]RMX[''/X
MF!^^/I3J:?OCZ4ZJ%'<****"PHHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH * KLX(.%'WJ*0[C\H? /6D]AI7%*IY@")GU-=A^S]X
MMU3PEX_M[K2&8.)L@(<<\5R";H2&V9'K6U\+;.>[\80OITAW^;T6ML)2^L8B
MG1[LYJE7V>'E/L?HE\-OVLSI6C>1XO\  \5Y 5'FO.YQ_.OFO_@H%XO^$_C>
MWBU7P1H%E97;1,7%MG(;)]2:Z31?$>N>&]"9-6\+FZA*_,\AX _.O%?C]XC\
M,^(U":;9PV\H4[E3/!KZ;-<BRW!P]I2J-2[,^=RC/<WS"M*EB:<7&^DEV/)K
M/SH[2+[3(2Q7O4U1(A8!0Y;9Q]*EKY-<EWRGU245I%!1113 **** "BBB@ H
MHHH *1_NFEI'^Z:F?PAT9=^'7_)8O#G_ %\_T-?US?L$_P#)G_@+_L!K_P"A
MM7\C/PZ_Y+%X<_Z^?Z&OZYOV"?\ DS_P%_V U_\ 0VKS,WWB>GDVS/8EZ#Z5
MXQIW_)8)?^OS^@KV=>@^E>,:=_R6"7_K\_H*\0]T]F;J/K2TC=1]:6@ HHHH
M **** "BBB@ HHHH **** "BBB@#!\6?ZH_0UP>K=&^M=YXL_P!4?H:X/5NC
M?6NVAT/$Q?4X_6OXZY36?NFNKUK^.N4UG[IKT:>Y\QB=SD-;[US&J]?QKI];
M[US&J]?QKTJ6R/G<7LS!U/H?K7/:A]]OK70ZGT/UKGM0^^WUKL@?.XHQ-4(X
M*CD=:Q-3)V%DZM6U?C!;(SGI6+?R $[AP*[:9XU;2+3,-XVU#7;'0U7+74VP
MC\Z_47]DWP3;^#/@SI%JL864VP#<<U^=7[.O@\>/OC3ID)7<EO?*2,>QK]5]
M T2'0M&M]+A 58%P *\#B*JTH4UU/T#PRP-JE?%5-UHOF7SN6+'<"GVY8QC?
MUJ/DDE<D5)$V1C%?*6T]#]>?Q:#Z***8PHHHH **** "D;J/K2TC=1]: .!^
M/?\ R 5^AK3^"W_).--_ZY_X5F?'O_D K]#6G\%O^2<:;_US_P * .K[M]*^
M;_VF?^1E/_76OI#NWTKYO_:9_P"1E/\ UUH \Y_@7Z4^F?P+]*?05$****"@
MHHHH **** "BBB@ H;H?I10W0_2@!#]Q?K3X?]<G^]3#]Q?K3X?]<G^]0!\$
M?\%__P#DB.D?]?TG\A7XRZ+_ ,@R/ZU^S7_!?_\ Y(CI'_7])_(5^,NB_P#(
M,C^M?0Y?_N?S/E,T_P!]^1>3[HI:1/NBEKOZG)'X$%%%%!04444 %%%% !QW
M.*<DBQ@M%"&)'S/3'QM.:V_AY\-_$'Q1U0Z+X?BD_= /-)&.B^]-*<GRQ6IG
M6J4J-)U*CV,2-"Y+1SYSU6A9%B B6, #K7H_C7]F&^\'Z:VHV7B.2XDB4M-#
ML' 'X5R?P\^&?B?XK:HUEHMG*L<0W221C.%[FJEA\2FJ=M6<=',<#B*$JW/R
MJ.[[&,H59"\4 8$4U'DF^2.8J%Y*"O2?&O[,^I^"M)_MJVUZ6X"@F2+:  !^
M%<E\*O &M_%[Q1+X<\.V;^<J#/E#)ZG_  IU</B54C1MJRHX_!5,.ZZG:"W?
M0PQ\\A8)QCBE,:D!C)M)K>^*OPTUSX.^*9O!_B&.19[=0SB48/.?\*TOA'\!
M_%WQR:YE\+PS.MK;F9O)7/ S[>U-X?$^T=%+5;A+&8)X=8J4_<LFGWOU..,3
MY/FGY<?+2QX=?*F&W'3ZU:\2Z;>^$_$3^#-2A/VR)AA&ZDDX _2O0/!_[*_B
MKQ1H4?B?6[J?3XKC*Q J,$_E[BG3HUJE1P4=@JYE@:5"-2<U&$MF>:M$A013
M2Y(.1FE5I%)!BSGOZ5N_$;X=:E\*=973-39[CSW$4,D@Q\Q.!71:Q^R[XX\/
M_#6W^*&IS7"6URY58V48X /I[U%.AB)<[:^$4L=@Z?(IU%[_ ,/F>?1-''*P
MF<, . :"WVT[F&T+R!ZU9\*>']5^(.J1^&]"L&>42#?(G7&<?TKU#Q#^R!JN
MB:2]TWB287$,1D>V*#H!GTJHX?$UZ?/%;!7S'!82:I5'J]CR=IEN%V1P!6'0
M#O35,LD(2:W(D!SBNQT/X"^+M6\(R>.H8IE@@#EP%XPG)JOX/^%'B+XB>%9?
M'^DB7[-$'W;!D?)UK-4L2UJC58G"5$U[2UK)^O0Y<.X.YH,.>U!98WW2G#L,
M8-=9IWP;\2ZK\._^%J1>;]C,CH"!\N4Z_P Z9X-^$>N^.O!;?$&SCD-LN\94
M<?+UIJCB%NAK&817:J+1V_[>['*F.-CY)D^<<XIX:(L2[?,!TK?N?A1X@B^'
MD7Q2,<@MI;AH0<<97'^-3^'_ (0:]K_@I?B#;I(;9V9 0.,BG[*NN@OK=%2T
MFM79^O8Y?SH]HD##>3TIMP@EDWY^<<E:Z?4?A#KFF?#^#XD31R?99KDQ*2.,
MC'^-2P_"/7KKP,OQ0ACD-G(S(#CY<J.?YTN6OV(IXO"32?-[O-R_]O=CE1/Y
MDN9CM!&!2.C6=SY:C<&'!^M=O\(OV>O%WQJTBY\0Z!;S&"VBDD)B7(^0$G^5
M<9JD<VB7TNFZDI$L3$'=UX./Z45L-5A%2JP:3V-%B\'7Q#I0DI.-DUV?08B+
M;W1CDDP=N1FB7:,/.V 3@$UZ%\//V7_'/Q0\%2?$'2K:X:")'=F101A1D]JY
MWX<?#+6_BGXCN_"FEQR&6RA>1P@R<+G_  JWAL32BFX63V.?^TL#4J58^T7[
MI^\ET?9F#,$1 I8;#T-*LL<0,"@% ,AO>MW1/AIK7B#Q[/\ #&%)#>6\1E(
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M8,@;<^E:T<-B*D)NVQG+,LOBHRG57-+5(\C7,TF&7RT X4>M"I&@,DB^6_\
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MP.,UWJ:X[6ONM]:['7>IKCM:^ZWUKTX'S.+V9R6K_P"M;\:YK5NC?6NEU?\
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M=:OR_P!*H>%/^1>L?^O=:OR_TH ^4OC5_P CRW_71JYH?<;ZUTOQJ_Y'EO\
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M\4_C?\1/C-?2S:GK]U;VC,=ED6!6-3_"*Y1+=Y)S>7J>;<.<R3-U<^M3N%@
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MR4E&4H*FOE]H^P/C'\,]3^*WPPN++5+I[A[)'9;=QG:$7@_I7D?PSTW5;/\
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MQN&J\K>ROH<F+RG-*->;PJ3YTO>>\;>O34](_9VL=%TKX3:EI7A>5)M82]N
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M3W_@WP=I/B+5_%<M](]]:EDE X)93Z5QOPJ^/?B'X:::^AW-L^H6C3-*(W;
M5B2?;IFJWQ7^-'B#XO!;;4+9XH$962 MD KT/Z5'U_#5*=TK:)&^'RK'87,5
M!)**ES.76SZ'K_[5WAWQ%XY^!^@OX8L9+T)=V081]@-F:=^V!#<Z-\ --\.7
MK&.YV6S&$]1\JUYY\.?VG_$/@+PX-!U716U6)&RB2OPA[$<CI7*_%'XL>)OB
M[J8U'5;B58% 5;=FR%QT_*G6Q.'EAK+=CPF59C2Q%.C4MR4Y.5UUO:QS5HOE
M62KC!P*>Y( *FB50J!0/2G#!0>M>0?8"MCC [4E!.:* "BBB@ HHHH ****
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MG[,WQ$\36BWYM[F.-AG 48(_*L#QIX"\5_#TR1ZSI<H@7_EHXP,5+:01BT9
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M!_M^Y]YG_F:^P/$G_()G_P"N#_R-?(.M_P#(=N?^NS_^A&@N.Q7'W_PH7O\
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MQ%']I <"3H:^F]$@GN+.+3]+D,)*XPE?*OP^UO\ L?Q5%.8_W7F9;FOJK0-
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M[M]*^;_VF?\ D93_ -=: //-PV#FBF?P+]*?05$****"AC [NE*@(.2*=10
M4444 %%%% !2,< TM(_3\: &."57'K4UI\LR9_O5&/NCZU)#_KD_WJ /@G_@
MX!_Y(EI!_P"GZ3^0K\9-%YTR/ZFOV<_X. /^2'Z/_P!?\G\A7XR:#_R#(_\
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M&?8TFQ<YQ[TI-<EI7[K_ "'*THQDE;_,L.I:3<1M4K]WW]:6!EMR4)SG^/\
MI49FV#S93^[Z!C3//6.<H1N0C.ZDXRJ4]5JRG4M+ED_>MOTUZDR6TB2&4S%E
M/:E+*R92,(,]!5>=C-#OBNB!N'RBI"[)$'DX]J<HRII0E'45&<*C;O9=_P"N
MXXG<F\YQGK0J..2IQ39)(_.%Y*P2$#&P]":2:9C*)KA_)BQA<]#5-6@IM63V
M[B4U&7*Y)][#PRGO0'4G /-1SSQP*"_3L?6DFO42W%U! &YVX%2E)I=V[%*<
M4[/YDQ.%WGIGK1UH12 -IW@C./2C\,4_>3M):_@5\PHHHH **** "BBB@ I'
M!(X%+14S^!B>S(KO_5M_NU^N?_!K$0?$TA'_ #^3_P#H35^1=]_JF_W/Z5^N
M?_!J_P#\C)+_ -?L_P#Z$U<^-_W0ZL#_ +_'T/WF/WQ]*\O_ &J_^2=O_P!?
M,=>H'[X^E>7_ +5?_).W_P"OF.OF3Z<Z+X*_\B;#_N+_ "KKZY#X*_\ (FP_
M[B_RKKZ "BBB@ HHHH **** "BBB@ I#]\?2EI#]\?2D]A=2MJW_ !Z-]?Z5
MPNO=7^E=UJW_ !Z-]?Z5PNO=7^E=6&W/+S XS7>IKCM:^ZWUKL==ZFN.UK[K
M?6O3@?,XO9G):SQ(37-:KSG'O72ZUU:N:U'H?J:]"GT/G,6KMG,:B1O/UK U
M%U&036[J'^M-86KH%;..U=U(^<Q-DK]3!OV#*SCH.IKG/$MTL%BT@;'S 9KH
M[S"QM%C[QS6,^DC7/$MKX=1-WG$$C'N/\:[8245=GA8Q.4>5?%+1?,^W?^">
M'@"WT3P!+K,ML%EEF5T)')!!KZ1Y (VY%<=\"/"EKX1^'FF6<$87?9QEL#OB
MNSSA]@7KWKX+%U'6QDI']$9+AOJN54:5K>[J209V\C%/I$/%+7(G<]8****8
M!1110 4444 %%%% !7CG[17_ "-&G_\ 7$_S%>QUXY^T5_R-&G_]<3_,4 >H
M^%/^1>L?^O=:OR_TJAX4_P"1>L?^O=:OR_TH ^4?C3_R.S?]=&_G7-?\L6^M
M=+\:?^1V;_KHW\ZYK_EBWUH-%L.7H/I10O0?2B@ HHHH **** "BBB@ I&&5
MXI:* &8/H:>O0?2BBD]-16O)%[PN,:W%_O5^+O\ P7NY^,VG ?\ 37^9K]H_
M"_\ R&XO]X5^+O\ P7L_Y+/IOTD_F:[\NTQ5O(\S-/\ =/F?!UKQ:@'N*<?N
M?A38O^/=?I3C]S\*^B/FQPZ#Z44'H/I106M@HHHH&%&0.2,^U%!.WG&?:@!L
MDBL-_3;VKU7]DKX>V?C'QJEUJL0:.*<8WCMQ7E<;B>"2%H=K'H:]-_9.^)=I
MX%\7&TUJ1526<8+GM@4#A9'V%,]I9,NDZ=8K#';C;E.C5SOQ-\">&_B7X:FT
M2XTN)9FCV"4C))]:WEFL]8M/[9TF[$PF&X!>U<[\4?B;X7^%_AIM4O;Z+[2(
MMPA8X.:RE?F--&.^%GP]T/X6Z%_9UK9QM*Z ;P,$8KHEO+\SK=>>VR,\IZUR
M'P:^*6F?%C39KZW=!(@!2,'.<UV,FE:BUS&K1M%'GYSVI*Z'[IR'Q#^#/AOX
ME:Q::U<VL2/;DELKG.<UT^EV]KHNEPZ7I<*Q"U3:2G\5<+\4/CQH/PXUVVT@
MSQL9&(<%L=,UV^@7]EXST2VUS1I 0\>Z1$[T[L/=+37$BVLD%^OVA+@?=;M7
M%Z9\!?"^C>)V\:BVAWR2^:$V]*[&2V?3K.?4M7F,<<0RH?TKSOP_^TAX<U;Q
MI)X1EDB*K/Y88M[4:A[IZ0;BZ=!##,4C<?*!_"*SO%^B:9XUT.3PSJ%FDI=-
MGFMS^-7YM.NY86FL"TB2C,97L*S/'?B/3/AIX6?6M2NE\X1;PK]<TFFP]TS_
M (;_  OT#X70SQ:?:Q^9-]UE&""*Z9]0N8")II3(1R$-<?\ "OXP:'\5+::.
MWEC69,!2&R<UV,.EWD;!+J E3]V1J5F./Q)IV74XOXH?"WP_\3)[74+RSC#6
MV2^1G'7_ !K4\$^%=.T"S%A:PJ5C7"$"N>^+?QKT#X8ZC;Z9,\;FZ8AP3C'7
M_"M[P3XWL/$&EIJ%FJ$2KD;3TI-.Q_:_T3ZN2/*L9&'+]<<M;VYN3NK_ *&W
MJFBV]W;F&)1&T@^<@=:X$?L_^&U\2KKBV48N#)O,NWG/K7=WNN6<-F]T;D;H
MQDK7E_\ PTKH@\9CPZLR&03;,;ZYXJJ?T%QGBN#,(L#_ *PN%W4M2YM^=O3S
MMZZ'J-KH]G:(EN &V\.,=:I^+O"%CXDTN:PO2OD,N#&1P15_3]<TNZMX[PS+
M\XR_/W:R/'7CW2/#&E7&IW%PAC1-V2>*;56Y]=F2PM+*J\\8X^PY'SWVY;?=
MMM8Q/AQ\'_#?A6YGGTN"*/<1E57K7:+IMNJ.QC&X?<_V:\^^%/QW\-^,I[J.
MS>+$1'S*V?2O05UBPNH.)U4L/E/K2;K'SW!&*X9Q/#U*?#S7U9OW>5;.^M^M
M[WWZ'(?$+X/Z-XTA2YUF!)RF2GF+TK6\%^!M-\,Z)'9PQ+L"84 ?=KE_BM\;
M-+\ >7;7MPGSY"AFQFNA^''Q(TGQAHL-X)$560$ 'K32JM''EV)X,EQQBZ."
ME3>81BG5M;FY=/O>U[:F[-IZ7$*VH.%88S7!:Q\!O#=YXJCU9K.)I?.W>;MY
MSCK7=7VKV S);WB_N^JCM7F>K_M%Z+8>,X_#RR1O)Y^PKNYSBE%52^-<5P=A
M%A)<1.+4II4N=?:;TM_P=#T[2]*L]+@%@ENK%!C?Z>]5=>\+V'B:TFTRZ12K
M+M)(ZU/IOB*PO;6.?>H,X^;G[M5/$GB[3_"VEW%]<2*45,B0FAJKS'U..]E#
M+ZKQ#C[#EM+^7EMOVM;L<]X)^#7AOPAJ<TUKIL09R,L%ZUVT5C#,K0QQB(+V
M'\5>?_#'XZ>'O%^IW5C'=1R%"!NSTZ5WIU:QG1DAN0"HY(-4XU6CR.#Y\/8C
M+8?ZON'U>[MR=6M_.][[_(YOXA?"C2O%]HD=Y$CJH.05SFK/@;X>:+X,TN.U
ML[1-NW!0#I63\3_C#I'@2PC$]XA=@0<FKWP\^).D>,-'@U&"Z0Y3<P!I?O4C
MS\-B>#9\8U:6&=/^T+7D[>_R]NU^_4Z6;2H+N-F&%11\J>E<#XC^ _A[7?$U
MMKUS!&76;>I*\YP:[RYU6P\EY_M81,<UYEXG_:&T+0_%]GH*7,<F;C8?F]C2
M_?#XXQ/">#PE"?$?+[/GCR*:WG]EKR_IGI5EH%GIT MH[57\L?+QTJMK_ARS
MU.U$-U@K*,%2.E2V'B6RU6#[8+D1K(/E]ZJ^)/$^GZ+IK:A-<!A$NX9/6DO;
M7/JJ\\/2RR56K;V/+?IR\K6NVEK;'-^"_@UX<\-^([S5[6&/>Y! "]*[<6Z1
MLNV$)YI^<^M>:_#_ /:#T'Q-K]]I&V-'7 5MW)->B#4K9H(V6<.?2JY:MKGS
M? N)X7Q>4.?#?*L,YM>ZOM:\U^N]VK_(QO'?PVT?Q98S6MW9I(H4\D4SP'\/
M='\&Z)#8:?;(%VX(4=*I?$SXNZ7X'TUY[BX12RG()J;X:?%30O''AV"ZM9X\
MA,L0:7[TPIXC@Z''/L8.']I*/_;W)ZO2_P"-CIET^W\J2$H"H' ]:X#4_@=H
MOCSQ(VJW%BB'3I/-)*YSV_K7H9U#3'MO-^U*IC&?]ZO+O%'Q^TOP'XI;2_M2
M,-2D\IQN^Y_G%:TG)'SGC?5R>AX:9@LTMJOW:>KYM/AZW/2=,ECL=,BTRQ@"
M)$,*5J2[ECN+&2RU&,3K.NT(W\-0>'VMM:T:VU+2IQ*'&6V]JFN(X]*M[K6-
M3?;'$F] _2M7=NY_E]2YO8PYWK9?EU\SCO"_P&\,>&O%%QXR-I%OE8/''MZ$
M5VLNHS3DS0CR<_PK7G/A#]HKP_XL\:7/A*6:./8X6-MW<UZ1+HUPLC) QD0=
M) .M*TB]#'\:>%=+^(.C#2=2LD=MI!=AGK5?X=_#G1OA-IYM=/LD=I4VD@8V
MT[XA>.-,^&6@?VM?2*7"$[6..E9_PC^*FD_&#3WN[:[1'6/<$!SDT68:'4F]
MNX)TE1V:,M\R9[5RWQ!^#7ACXCZK#K,]G$DD<N\Y7-=6NAZ@SJ9 RH#\WTK@
MOB=\?_#OPVUN'09GB+R3;"2V"*+,-#N=)M+70=&@\.Z?;K&L P)%[TLMS(Z/
MIU]^_CD&TEJK^&M1M_%.B6^O:9.)?M R47^&K<\"Z3!<:GJ9VI$FX!Z+,+Q.
M)L/@)X6TSQG-XRMXHMQ<.$"^E=O<:M/<$"V4P ] IKS71_VEO"^N^-YO!T3Q
M(5<*&#>OXUZ.VG76=ML#(AX26FKC3[%7Q1H-AXR\/3:!K%LDKM&5C=QDDFOE
M;QC^Q=\4QXDG;0M#NELRW[J2-1M85]1>.?$6G> /"\^HZKJ"K.(CY8?J&KY+
M\0_M5_%R^\1W$>E>+;U+13F)4<;1^E.\@M#J3K^QE\:(D<C1;U@1P=HJ*X_8
MZ^,MMIID31KW<R\_(.*J2_M1_&P,(U\7W^W/'SBFR_M._&:>.:V/B^^R%X^<
M5//5[&?-1[GV1_P3*_X)K0213?$[XYZ$)K2.V6:UBOXOED8=0,5]>>,OV;?V
M<OCOX7U;PCI/PATK1IH;-OLMW$C$R,?3)-?$O_!-/_@I3=^!;J?X=?'37C/I
M]Q;K!:R7\ORPD]6&/I7V'\2/VV?V9O@SX'U#Q%X1^(FG:M?2VS""U1R"K#IC
MI7U>5U<H6635>/[QW/S;B&CQC/BC#3R^=L-]KMYW/R)_:4^#5[^SQ\=-8^'#
MRLRVDFP C&.3_A7'%2I(9]Q]:ZOX_P#QCU']HKXPZI\3M4B:W>^??L+9[G_&
MN4((.#7S%-0BI<NUS]$7,JDD_P"O3R"BBBK+"BBB@!&_K56[!-_;$#_EJ*LM
MU'UJ&Y_X_K7_ *ZBIELR)?!+Y']*_P#P;X@C]B_P[G_GV;_T%:_0,_>/TK\_
M?^#?3_DS#PY_U[-_Z"M?H$?O'Z5\SBOXS/JL'_NL/0\C^+7_ ".^G_\ 7\G\
MZ]=C_P!6O^Z*\B^+7_([Z?\ ]?R?SKUV/_5K_NBN<Z3QF]_Y+6G_ %ZBO98/
M]0G^X/Y5XU>_\EK3_KU%>RP?ZA/]P?RH I>)/^03/_UP?^1KY!UO_D.W/_79
M_P#T(U]?>)/^03/_ -<'_D:^0=;_ .0[<_\ 79__ $(T%QV*_P#'^%"=/QH_
MC_"A.GXT#%HHHH **** "BBB@ HIOF>U*IW#- "T444 (_W35J+_ )!%]_UY
MR_\ H!JJ_P!TU9C.-&OF_P"G*7_T U#V0D[05S^=7_@HA_R=%J/_ %VF_P#0
MZ\>3[PKV'_@H@<_M1:A_UUF_]#KQY/O"OKZ/\*/H?%U?X\_4?1116A,=PHHH
MH+$CCVJ6<\U;T/3I+ZZ 921FJ4ZO(X"DC/:NU\+:6EI9K.PR3BBE%R9E)LT-
M/T^.VB6*-<'%:-O:%ATHM[=682 XXK5LM.D8CS!M!KH]U:(SN16=L58<5J6\
M+!@0G:GV=FH&5&XYZ5K6EC&P&Y0*3V*2N06<.6 *5K0Q I@BB"P7(6,;C[5I
MPZ8R*"XP?2N6<:G0[X2IN%VR.WMUABW,N3V!JUIML9WW*O/I5VUL T?G31].
M OK5[2[1?/\ -6#;CL*Q=3DE:1T>P]I#FAL<MXP\(6NJV;B]B!^7C<*^<OB%
MX0;P[K#3)#MCR3P.*^O]0\-V^J+Y]QJ/DA1C81UKR7XS>"[+6M,E-JJAHQ@,
M!UQ70DTC@=GL?/@='^= ,TN2>IIL<)M[F:UD.&20@ ]\4HW9((QBF(6BBB@
MHHHH  P0AJ:S'=N I7* 9=L#UIQVF/YQM]/>AZ$2T&[$8;V. *-/M-8\4ZU#
MX9\(:4]YJ,YQ#%%]X\@<?G4+I?7\\>CZ9;F6[G8"*%>K9XS7[;_\$-_^"*NF
M^%=)M/VD_P!H71%DE0K/9Z?J,'^LB8;L@@=.!WK#$XA86%WN;4,++%2Y>AE?
M\$9_^"#5E;6UG^T+^TO9BZ\LK-#HNIV_$D;?-G( Z8]>]?0?_!1#_@LA^SQ^
MP1X3E^$OP&M=,OM0CM]GV6RF*M"Z@C;]X=,UY[_P6>_X+5>&OV??!ES^SO\
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MXC^#\S:;?-)?6,N<%CA=H_*OT3!83#9;AXREK3[I:QE_>/R'.<14XBXBJ8+
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M+OKY[+3N>[PUA\+B,ZIRQ,DJ</>=_+I;J<W^W1\)_!OA77%USX1SPOI,\JI
M]FN$)'7&?K5[X&_#'P;X0^&%I\4/'FF0:C+>EHX[6Y'\0 QR,>M=3X_^*GP;
M^+'P%@\-Z4UE97VGR2W \LDLYP,#]*P/@GX_\&?$'X46'PZ\5:K#83:7.\ZR
MR')D/&!^E?$4,=FT^%Z-'%0J?NI\DW]MPBFDVX[IV5[:GV=3+LM7$U6OAYT_
MWL.>"^RI.UU9Z75WN<3\?5\.ZQ%INKZ+X(AT5KB_",L6?F&1QU/K6A\<_AOX
M;\*_!+0/%4$$45U=:ALE8#DC"?XUU/[3?Q$^&@^%FD^$M!L+6XU2QOC)+=(3
MO(^7'?V-2:)=> OC[\#M#\$>(_%$&G7FG7QGF=^6(^7@\'TKOH8[%TLNPN(E
M3J04:DN:]Y>YK9VU=MM-S@K83"3QN)H1G&<IPCRVM'W]+J^BOOKL<QXT^&_A
MJS_9W\*^,],MHC>WVKF*X91\Q3Y.OYFHOC[\-O#OA;X6^'M=T>UC^TW>IB.?
M8.=OR?XFM3]I/QGX2\-_#C0_A1X*U2*_&D:D+A[N$_?!V\?^.UT,$WP\_:!^
M$VC:#J/C"#2+K3KS[1)GDL!MXZ'TI4<?C:5.CC:JFJ?M9R>COR2ORW6_RMH5
M/!X"I7KX*GRNI[.$5JK<T;<UGM\[ZG*_$WX0>'Q\(/#FI:'%&FH:CJ@@F:-?
MFVG9U_,UT>J:1\'?V=O#%GH?B;1[+4-9=P+HS APC 8)P1[UB_M!?$_PWX=T
M30O _A:^CO)-(U-+B2YC."R@K_\ $UO^,='^$O[3.@V?BK4?&MKINI,RBXB(
MRVU0.O!]ZYGB,7/#X:6,E4CAIU*C;BGS:OW+VU2M<ZG2P<<97A@X0EB(0IJ*
M;5M%[S3>E[GC'QQU;P#K^KVS?#VTMX)+JX6-HK;/ )%?1/P__9R^$]M^SVMS
MXEO+4:_Y,C%)4_>'Y05_7->*7OPZ^&GA3XIV-A9^);>Y@L[N*628#AE#<YX]
MJ^AO$O[3OP,L_'PT!+&PDM&@CC\_<<9/![U'%&+S2>&PV'RWVKC"\W):-J-D
MHOFZ-,GAO!8%XFOB,>Z:E-<B5[I=VK==#YO^!/P6N_&7Q,U#1]==HK*PA,[!
MURI4%OZ"O4/$VH_"^6SO/"OA_P"&%E<VUK;LT6H1YP7P??VINI_$[P-\//V@
MM5UC1+Z";2-7L%M4"$A$+;@3_P"/5UG@R3X2_#VYU+5;S6+74+*XLG\J)^%5
MR#]/6C-,;B\37^L3IU+.G"4(*Z3;MS;6UOT9>58#!4,-+#TJD%[\E*3LW97Y
M=[Z6['EGP!^&?AKQ;I^L7&OVT<(@T^:2)'!X(#$5RG[+?A7P[XP^+6L:!K@C
M>VMK1WA#CC.6_P !7;?!OXQ^"(/BUK5E?>1;:1?6#00.2=BLVX9'YBNG\#_#
M7X0_ O7]5^(\7Q$M;_[;9ND5J5QAB&/H/[U>IC<RQE"KBJ4E)2K0A[-6;UZZ
MK1/O>QQ87!8"O##5(<LH4I2]H[I:=-'JUZ7.9\._ 70M7^,&IW>H!!IEE9><
MJ,OR-MW$C]*O>*]9^'_B7PW=0>&?A+:+!#$X748L\L!_O>U9GPC^/>D:A\1M
M4M?$2I:Z??6C013R-\N6W#^HKTCPC>?"?X1:-J>G7^LVNI6=Q9RB!7R '8'I
MT]17EYC7S"GB?WU*;FE#D46TG;XMG:^VYZ.74,!B*,GAZE.-.\^9R2;5_AM?
M6V^QYO\  GX4^'?$GP@U#Q)J-M')+%;W#(S#D%5)%4_V;_AIX6\;_#'5=<U8
M1/<V\-RR*XY&T''\JVOV>OBSX-:[U7P'JEW#IUA=6TR0NQ^4,^X?X5M)#\.O
MV=_AG>Z=I'B^#4[B]29/+48(#@^P]:ZL5CL;2Q%>A%34ZLX\BU>FM]=ETO=G
M-@<-EL\)1K2<'&E&?.]-]+:;O[CE/@K\,/#7B/X&7WB?5+2-IHC<[2XY^4'%
M-_9Z^'/A?QI\%M0U^^LH?.A6Y*,1SE0<5;_9:^('A>Y\#7GPX\3ZE%8+.)B)
MI/\ ;SVKHYK_ .'7[/GP;N?#.D>+(-2ENFF52.#EQ]!ZU.,QN.AB*N&M/GG4
M3CH_AUOKL=&#PN5SP]+$^XX0IM2U7Q:;K=G%_LR?!CPO?^'+CXE^-I8Y[=9)
MDBM9UX+*3C^E3_&+5/!GB#P09_#?PTMK!DF91=PYR0,>IJ;]ECXF^$I/!MQ\
M,O&EW%9C=-+'+,>[9Q77>-O%'PF\&?!:3PFEQ:7]\9)"DAR&^8<4\9BLQH\0
M-583E+VBY;.T5#7732^U[G-A*&6U,A3I3A&/(^:Z5^?33O;?8XW]FGX0>#$\
M%-\5?'C17,+F2.&VN%X+KT''U%5/C3>^%=?\*+J.B?#*WTM_M&SSXLY*@CW-
M:?[,GQ%\&ZY\-#\*/&M]#8207$MQ$\QY))R!^E=1\4_&/PP\-_!W_A$HA:WU
M^)G839.[!QBG4Q.,?$LW6A.3<[*S:BH=&K67K?4FAAL"^'HJ$X)1A=NT;N?5
M=_0X+5/AOX;L/V4[/QQ'#'->R:@R%L?,!\O^-.\*?#CP[J'[+J>.YTC746O)
M(\D?-@8Q6]\#M>\"?$WX()\(/%7B&#29(;N2X6>3DG/08Y]*3XBZQX)^&7PF
MT[X2Z#XCAU*1=862:=>"(V=<YZ<8S6D,PQZK2P<N=36(;6C_ (6NO:VVF_D9
MK!X%48XR*AR.BD]5_$TTM??SV-?]B?X(_#+Q5X*O/$WQ1EMHGDCGCMS=+GY\
M';C'OBO+=2^";ZI\?)? %G=F.UC(E+*O'E[C_05[IJGQZ^"'PZ^&FD>!=,CL
M9YDOXII[E6()!*D@\_6L#XY?%?X8:5X_M/B_X,O+5C<K!;36D)/RKP&;]37E
MY;F'$:SO$XATYVKQDJ:?PQY6N5I=')-[]COQN7</_P!C4://"]&47-K>7-?F
MOW4;+;N-\8ZQ^SU\%-5;X>W?A[3;R86H9KM\@[F7ZBO O$.EZ?XW^)T6G_#^
M-1;O*AECM^@0MS^F:]T^(/PD^#GQP\3GXF'X@VMIFS4&S"Y^95SZ&N7^ EA\
M-? GQSN=6O\ 5K8V<%BV$8$*Q4-_.O7R;%8; 8*59.I/$1A>4&I6YOROZ:'F
MYMAJN.Q4:25*%!S]V<7%/E_.WKJ>G?%?]G/X2Z?^SQ"WA.:UE\11'S;B*)#Y
M@0*"2?R->4?LM?!W1=<T>Y^)7CLI+80F6-;:=?E+IG']*]STC]JCX%>(/'6I
M6\^G:?;0S:3+;I\QQN*,N>M>9_##Q[X,T?4;[X0WNI0QZ7*9IXKLGY0SY(&/
MRKP,FQ?$=#*:]#$*I%\RG>5G+EG?F4;?RV7GKH>YF6$R&OF6'J4Y4VK.-HWM
M>-K.5^^I!XJUGP!XR\+7/]D_"NTM(H2XCNH\\LN??VK(_9P^$?A.;P_<_%OX
MAK%/9(TL<5O<CY=RYQ_2O5?!_B+X-?"/P5J&BZO=V>LB:"<PF3(PS*<8Z="1
M7G'P$^*?A'Q#X=OOA+XH,-C:2SSRPSR'(4L6QC]*]!8G'0RW$TL/&:IJ<;R=
MVW!WNXWO*_='!/"Y?2S+#5,0X2G*,K15DE)6MS6T]#)^(?Q+^!'BSPX]EI/A
MC3[/44G**\9.XJ#@=ZDO_AEX<M?V7E\<26\;7;:B4#D<[<C%5/%W[/OPF^'W
MAZ?5[?Q];:C=/*S(-O(SR!T%=1\$?%/@SXE?!AO@WXOUJ'3 EX\RWLIR2,\#
M'/I7K5JU/"X2A7P<JDXJI%SNI74=;NS5V>9"E+%8JO1Q,:<).FU"SCK+2RT>
MA@^ OAUX4UG]FIO&5RD1O?MTD:S$?-@=!5[X#_#7P/X0^'TOQD^)D$%S";F2
MWC@NE.,Y(7I^%7OB=K'@/X,_ _\ X5EX7\00:M-]N,WF1\'#'\*K_!?QEX(^
M*7P>;X,>-]4AT_%T]PMS,<X/4<?A7)5Q.98G*YUXN?L9UKO1J7LM=5?7Y;^1
MTTJ. HYE2P\E#VL*-NC7M--&]OGL87Q(\<_!7QIIEKIF@>'K&SNWU*-=T1.2
MA<#UJ3]J#X=:!\.-#TBZTVSC_P!*N+5&9!CARF?YUG_$?X,_"_X5:/;ZOI'C
MBWU6>+4$?<%P0 X..@KT_4E^&G[2W@K3CKGC6WTEK&>%PK#.[RMIQT/7;6\\
M5A\#"AB<-*I[!.7,VFWK:VC][OT,Z.%GBYXC#XN-/V\E'E47%+K?7;\3C/VB
M_A9H'ACX8Z3<>'UC6[N[FV5S&.</MS_.NJMOA_\ #KX*>"[2;6M'MM5U>X6-
MC:R@ARK@<]O6N9_:N^*?A>YGT[PEX9N8KF.PDMW^T1G[VPK_ (5VK^*?AQ\;
M?#UAXENM>M[#4;411O;]6*H!D]_2O.KU<REE&%E6]IRS<G)ZWZ<JTUL]3TJ%
M/*99SB(8=04X1BH[6OKS/73L>3?'2STS7;ZSB\.^"X]&:XN(D98?1F )Y)]:
M]5/@CX:? ?PY;6%_X/M-=U*YA1VAD!# .H.>HZ9K"_:D^)7P_3P_I]KX3M+:
M6YMKN!I+J(G<0K+D?I786_BOX:?%?3[#QY<^)+:"YMHXHI+/J6"  _RIXW$X
MZKEV&52%2-)<W-O=M6Y;M:V>ICA</E\,?B%"<'-\MGI;KS63TNM/(^>/CW%9
M-XFB;PUH*Z7Y^Q?LD/;<1SS]:^@OA!^SK\,+;X$27'CBYMDUN0-)$DZ'?@J2
MO]*X?]H#Q3\-/B+\8M-MO#\%K86EJENTMQ$20Q0KNSUZX->P^+/VG_@5H_BZ
MPTB/3K"\MTTZ&)Y-QP&" $]:RSG'9[B<LP.&PE*HI2O.5FKQ4+63;WO=_<:Y
M7@<DPV:8VMBJD7%6C'^5N5[M);6LCYH^#GP2OO%OQBN?"NN.R6<"RW"AU^4H
MI)'Z"O6M2U#X4R7-QX=T+X7V5W'!:NC7R9X=5(/?U%1>*OBYX"\'?M#IXT\+
MS6\VFW>EBW>*(X12ZX)_#-=;X D^#W@#Q/<>*;W7[2]T^ZLY':U?(42.I./K
MDU.9YGCL=RXJK2J<S@N2,;J\E\5[6L]MRLIRS X'FP\*L'&,WSRERM\OV;7Z
M;[:GDW[.7PR\.^+M<U./6M.B\N*&YD1''"[0Q _#%<]^S5X1T'Q]\=K_ ,.:
MP(WM8$N-L+C(^4MC^5=I\-_C=X(L_CM>26L$%EI-Q:S0X5ODW-D9_6NF^'7@
M#X1_!/QU>_%E/B);70N;>8+:;< ,X)]/>O3Q>9XO#O$JI":=2FE36K?,[WUZ
M=-6S@PN6X3$QPSC*#C2J2<WHO=TZ=5Y:F#I?[.?A[Q;\;)8WN$MM%M;-Y&3;
M\A=.<?I5C6=<^&NO:7=Z7HGPHLYX;3?']N3/WDR,]?45G?"G]I70XOBK>:5K
M5M'%8W,<RK.[?*-V0._O7HOPWO\ X,?!XW]S>ZS9ZQ;7D<\@MGR K2!B/3IF
MO*Q]7,,++FQ%.I)J,/913=F]>;KOMOH>E@H99B$_JSA&,I3]HVEHM+6OTWVU
M/'/V;/@/:_$S5+OQOXA<1:7:2S P.N4^0GC],5U^N:W\-/&.C75CX0^%%FL5
MJSPM>0Y^\F5)^][5G? WX_>&M!\::CX)FMXK;2+V2X</N^52Y;'\Z]$^&%_\
M'/@A8ZC->ZM9ZM;WGGRK$^0%:3<1Z=,UMG6)S2&.J5ZL)N2Y?90BVD^]VFE=
M:;Z&&18/*Y8*-*C.')[WM922;OY7UMZ'R)J$7D:O-ISR>0/,8AO3D\4F,<;L
M^_K5[QQ?Z=KGBV\U:QA6.U>YD*%>@RQP*HC&.#QVK]2I3G4I1E+2Z6G;_@GY
MK)1A4E"&L4W9]_\ @!1116@@HHHH **** "BBBIG\#$]F0WW^J;_ '/Z5^N?
M_!J__P C)+_U^S_^A-7Y&7W^J;_<_I7ZY_\ !J__ ,C)+_U^S_\ H35AC?\
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M >12<9([T6079/XFUG6?&>HG5];U21I VY0_.*ZOP5^T#X[\$6@LK"^G>&,
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MA:W+S/;LWN2Z-K.M>$+_ /M2UNY#-*<MCK7H%C^U7XJTZR2U;3Y)7 P7+_\
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MMP"'KS;Q#K&M>/M1;6O$&I2"56WIYG)S4 ^0!DY)ZTDC%6"LN,\4>Z',SM?
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M_N#^5>-7O_):T_Z]17LL'^H3_<'\J *7B3_D$S_]<'_D:^0=;_Y#MS_UV?\
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M2YK16[/MK_@@S_P2^U?]HOXJ6OQQ^*>@.^A:;<E/(NXLQR*2"&R!_LU]\_\
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MXQ7I.D_L\7-QI!:Z)!=0<E:ZHX2<X/L]/F>KA,EQ>(@ZT+>[U>QYOX0GMO\
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MQ-\\L@..QJ4ZC7O6D_0;C33]U.*ZZD7D6\\7G'$4JGA^].%WJUS!Y<VJ/@'
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M./W/PIL7_'NOTIQ^Y^%?1'S0X]!]**#T'THH+6P4444#"BBB@ HHHH ****
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MFU&S#(@89/5_6O:/V8/V/?%_QR\336VMVDUM;V4@#NZ9&#C_ !KZLC_X)8^
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M/_5K_NBO(OBU_P COI__ %_)_.O78_\ 5K_NBN<Z3QF]_P"2UI_UZBO98/\
M4)_N#^5>-7O_ "6M/^O45[+!_J$_W!_*@"EXD_Y!,_\ UP?^1KY!UO\ Y#MS
M_P!=G_\ 0C7U]XD_Y!,__7!_Y&OD'6_^0[<_]=G_ /0C07'8K_Q_A0G3\:/X
M_P *$Z?C0,6BBB@!FX^M.0DCFF4].GXT +1110 8'H*, =!110 4444 -<\8
MJ>-C_8U\,_\ +E+_ .@&H).U3Q_\@:^_Z\I?_0#4OH1_R[B?SL?\%#_^3H=0
M/_36;_T.O'D^\*]A_P""A_\ R=!J'_76;_T.O'D^\*^NH_PH^A\94_C3]1]%
M%%:"CN%(W0_2EHQGB@LU/ L@&M*R\'FO6-*DDDF1&;/RBO'-"G_L[68WS@$5
M['H;QRP17:_W151E8RY3HK2W".%"<D5O>'-1U#0+D7NG!HY@,!UZXJCIEJER
MJ2[@.!S6W'I^T QRYXZ5KRPE&[(?.G9'3^%_C5\1/#H,=M>7(1FRRAN":WU^
M/_Q U!/+-S<*A^\F[@UQD*$($*Y]:U;>T&T%..*PE.%]C2$:JUN=#HOQ2\3:
M/<?;=*62&8DDNIYR:UU^-7CK4WSJ%U/+_OM7*VMN3P6K2M[;: 0U<U2$9=#I
MA-I:G3Z3\9/%FGW(>SFEB.""0U9-QJ<VO:N=0O(BSG.7;K3(+%WA,GE=ZM6=
MB\2$[.2:F-.,58Z/:RF]"IJFGQ3Q%S ),=C7)^*_"YD;[5;Q^5M0]!7H-U%_
M9VDR7DB;L=C7E/C#XB2_8KDLA0(2O6NFCRPIM'BYI#%5,73G1]&?+?QOG67Q
ME]C') ;)_&N41RPP5QCBM3X@:FNK^*I;^-MQ61AQ]:S=X?D#''-%O>.WW^9V
MVZA1115 $!!4EN>>]*1D[AT':D7[XC'>E7Y9A#V/6@4I6*VI2B*R:Y!Z';CZ
MU^S7_!LG^Q+ EI<_M-Z\H6XTN^(@$D?)1LG@X_V17XZ^"_"][\0/B-IW@"Q1
MF:[E4D*.P8#^M?TU_"CP_P"&_P#@GI_P3GC\8VTT42S:1;S7  V_.T3=:X,?
M/W%!=3LR^G^\=5[(_,S_ (./_P!O&\^*OQ*B^ _@S5FCT_[(\=Y%!)E3(A Y
M'XFORZM(Q%:"VSD8&_W-==^T3\2]3^,?QU\2>-=3G:0OK$YMW8YPA;/%<M\F
M!L&..:Z,/!4J2B<]>I[>NY=@(! ![=*  HPHQ116Y 8S][FD9\?**,[N%/-
M15^\/SH%)H0.@Z@"GEE$?'3O2-;B3[IIJL,^23S03&S0R^^U606\TZ9D91G*
MBOH_]ES]N>P^".A-I_B+3%OI'<%&EDP0/S%?.R[L>7+]T^M5KW3;&XCR(U9P
M>*F231I"3@[W/U6^$?QE^)GQQ\.2ZEHEO<VUO*1Y9C8$*#7 ?$;_ ()R:?X[
M2\\6^-?' %VSEHUFBR0#_P !KYR_9E_;?\6?#F[M/!"64L=LV TGF<<<>M?>
M_@?4(?B7I5KK=_XQVQ21 R1-R.?PK%IHWI<F)BW)V2/R@^*'@+7/A9XOO-(E
ML9+BVAG98YB, J#UK&C42C[0.<C.STK],?VR/!'P/M?AO>I9:%8W6I-'E)E!
MW$X-?FO;^$/%U]XIN=*M])F19)SY..PJX5(R.62I4JG)&2?E?4IEHTR)I A)
MX!K9\ :GX9M=0W>*(XI8@W_+7IBO2?"'[(.OW5LEUX@NI(_- 93(G0?E6SJ_
M[$RW]KBQUO+X^ZL?7]*5>$:T53O:^YLIU<))5.52?1;G*>-/!_ASQ7I*W'P\
MT")'"<R6X[UQ][\*_%FFF...SFG=UR5QTKM=2L?'7PBE'A:RT"=Q)TN!QC%>
MX_!/X=MI5I%JGC*Y^V27@$J+./\ 5@]J^6CB,PR:5IP=2DWI;5^1]K+#<.<0
M*<Z,E3K*&M_=C%_+<^4_%'P2^(*:29;K0[@K(FY21T%?KA_P;0?MY7:ZG<?L
MT>,KT_:KO44ALEFDY55P, 9]Z^6+'Q=X:UK4Y_#NJ:5$JK*4C+'M7/> -,U3
M]EC]I[P_\;OAH[1Q6KM-<"V&T%B0>3^%>Y&MA\TP7.U:_1[IH^:Q&$Q>3XZ*
MJ6=DM5LT^I]%?\'*?[$>F_##QS:_&GP?8*(9[62YOVA3 +D]2?PK\K+6XEEM
M8IUB(.S[WI7].O[9OP@\+_MH?\$]HO$.KPQ7>H7.@QLV]=S*S!LU^)'B[]G[
MX;^&;R]\(2PVT=S%*8U!4Y&*K"XF,<(Y3>VAEC,#4J5^6BKN:T]3Y'@=IPQA
M7=@_.1V-/A83/L"XQUKKOB]\)=6^%6K+=0QO)97&7+A<*!7'(ZM$US#]<"N^
M#3B>:^:/NOIH*TR)+Y>/QS2B'>=^_@=J:44PF=NHIV'9%V9P1S3;LKCC'F>K
MVU^X53\W*Y%1EFCFWLOR]Q2R7!4>5$F7/I72>$/AKKGBK'E6CG)["KI4IUX\
MR.K!8'%8^3CAUKNSG0\7G*2XP>HII6)Y?)\_[QX%>G7_ .SCJEI9>>TC[BN=
MNWI6+!\"O$-M=B^ECD,2'DE:Z(8+&5)J,8W:M?T'CL#6RR2GBK*+>COOY'IG
MP+\#Z596<.IWD2.2 P5AUKTV?5[=+F.PETX0Q-_RTSQBLO1/"<FG?#Y-4L3E
M[6 ;D4=ZU9-<\/>*?"#VB&.*]BC"[@?FS7Z'@LE]E7VYII*<5TLEK^3/D>(N
M/JV/I4Z&#@U1<O9SY=TVM'IYM:F7\043X7?9O%FEW.Y6C\UMO%<)\8_C-I'B
M;PRESISHMYY/^L5N0:M?$CQ=;W?AN7PYJ-X)'";(]QKYZODO8M4>!Y6,>_"@
M^E<&>9E'"J7LY751)O\ NR71?<:Y/PA6PF71QF/?[^+:3_FB]OP876H:AJ3O
M-JMPTK9^4OVIGE J)&'(Z4^4J^(U7IU-,+[E\OTKX!\U:;YGN>Y3CR)+L:7A
M'7$T:=Y[M-QW90D]*W?#5K%XM%_?WUJ)?+D_=%NPKDL1SC:!TXK0T#Q3<>'[
M6>VA0_O#V->C@<<J,88>>M/7<YZ^']KS5%NK%6XL+R/4IPUL5BCDP&[ 5&)$
M!90X?GBNNTX0ZMX4OYIP%E<94FN=F\,W%C9&\R6P,]*6)RR5&*E2=TU?\1TY
MN=^;H9^&)($?.>*520-I)R.M)";ELSM"=J]33L#[X/WJ\_F35WI=G3&TE<4L
M6&":;M7TI:*93U$90^-PZ=*524&%.***+NP+1W6X@4 D@<GK2T4462 *1_NF
MEI'^Z:F?PAT9=^'7_)8O#G_7S_0U_7-^P3_R9_X"_P"P&O\ Z&U?R,_#K_DL
M7AS_ *^?Z&OZYOV"?^3/_ 7_ & U_P#0VKS,WWB>GDVS/8EZ#Z5XQIW_ "6"
M7_K\_H*]G7H/I7C&G?\ )8)?^OS^@KQ#W3V9NH^M+2-U'UI: "BBB@ HHHH
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M_P %(_@M;>'/$G_"5Z19"%9KD NB]1_DU]R>%O".B>"=)BTGPY D<,0PBQC
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MX=O9=*TF2PMLW$7W"Y5/U-<Y\6_A?-X>\8Z9?>-M?.H6KQ0,KSC@D[2!TK#
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M?^#K1]9UGQ- L2C<L;G@^U?'?C/_ (*-16/Q^@TJR(;1O[1VO,)/DV8//6C
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ML))VN31Q%*2:N1^./A_X9^,OAH^%O&NG17EBD95O/&5533_ 'A#0O@]X4MO
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M+TSPA%]ET!%CBD&TB/IBN"^-WQX\(^!/#IBTB]AEN I'R-@YK(_9Z_:)\/\
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MT#3N+11104,VGTIR @<TM% !1110 4444 %%%% #9.U3Q_\ (&OO^O*7_P!
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MF T)X_G7CSA7P]3563\T?F^)P^.R_-/:17O+;F=DU]YCSZC>QCR9W)C7A,]
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MW3V9NH^M+2-U'UI: "BBB@ HHHH **** "BBB@ HHHH **** ,'Q;_JC]#7
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M_P"1F;_KL:^D*^;_ -IK_D9F_P"NQH \X_@7Z4^F?P+]*?05$****"@HHHH
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M2445VG59+8*:_3\:=37Z?C4S^!B>S&7?^K;_ '*_7/\ X-8_^1GD_P"OR?\
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MX-5-&LUL]*@L#TCC"U<C.#M XKXFM)SJ.3/W3#TU0H1IK9)#Z***DW"BBB@
MHHHH **** "BBB@ HHHH *\=_:'_ .1JT_\ ZXG^E>Q5X[^T/_R-6G_]<3_2
M@#U+PI_R+EG_ -<!5V7^E4O"G_(N6?\ UP%79?Z4 ?*/QI_Y'9O^NC?SKFO^
M6+?6NE^-/_([-_UT;^=<U_RQ;ZT&BV'+T'THH7H/I10 4444 %%%% !1110
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M"7_K\_H*]G7H/I7C&G?\E@E_Z_/Z"O$/=/9FZCZTM(W4?6EH **** "BBB@
MHHHH **** "BBB@ HHHH P?%G^J/T-<'JW1OK7>^+1B(D^AK@=8^52?6NVAT
M/%QB:N<AK7\=<IK/W376:V,!_P :Y/6?NFO1I[GR^(W.0UOO7+ZJVU@?>NHU
MOO7,:F,G[N>:]&EL?/8KJ<_J,1U+4(=+0<SOL%?<?[-'A)?"_P ,]/B\K:YM
MP&XKXZ^&/AR?Q9\3M-M$0JL5V-YQVP:^^O#FG#1-)ATM/NQ+@&O/SFKR6IWW
M/?X,POM*E7$M:)V3-)3D9-+2)]T4M> ?H@4444 %%%% !1110 4444 %%%%
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M?*YCIC=>Q='W.*9)!%>1B.?Y2ARCGUIZ?=%!7/#<CTKM>DKVN<<6^2W0].^
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MD,"B83[CTQ2^>)$WPRC=W KT_P#9\^!MM\6OB?>^&=2OUM-/MS,HNW7*ED+
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MO_(,C^M?0Y?_ +G\SY3-/]]^1>3[HI:1/NBEKOZG)'X$%%%%!04444 %%%%
M#+F-I;=XT&2RX %?1/[)/B_0]1^&=]\,+B_CL=02PDVN3\TI88"X_"OGD$@Y
M!Q[T_3=5U;1]5^W:/=M;3K@_:5ZMBNC"UWAL1&ITZH\_,L LRPKH)\KW3[-'
MU/\ #/X0^$O!_P -=6B^(FCPVMR+&4Q7=R.9&QP*Q/@+)I'C3X1ZA\-=,UE(
MI4M9O*C7JQ88 _2O#?$?Q;^)WBFV_LS6O%=S=0+V<C!K(\.ZUXD\,:B-2\,^
M()+"0$$F/JWM78L=0E53BK0UOYGAO(,<L/4@ZB=1R4E;5)KUUL?1_A3PO'\
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M!MZN5'3W%?+D&I:G9ZG_ &HM^S7@;<+KOGKBMG7OB_\ %3Q9:K8:WXMNI85
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M^V+$64,4J*.$^5<^G2LWXH3_  S^&?QST[7?#L]K&K:;%'*D>?E<JH/Y'->
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M_B0+XD7_  O_ ,AN+_?K\7?^"]__ "673OI)_,U^T7A?_D-Q?[]?B[_P7O\
M^2RZ=])/YFO0RW_>#R\U_P!S^9\'VG_'I^%./W/PIMI_QZ?A3C]S\*^A/FQ5
MZ#Z4M(O0?2EH+6P4444#"@KO^7;G/:BD?<%RC8/8T,!DTLR6LD-O;G)].U>X
M_L/II2>()!.R?:&G& >N<"O$29+9DD+[@WWJV_AMX\O_ (<>*X-=L@Q3S=[A
M3BLPB?>>HEUN9?M,WR@\ ]J@G:&+3Y)M5D"VN,EGZ8KSGPS^U;X UO2D.K/
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M#L]_M/ZLZ+WU:V5SZ8\):YX1UG4[V/PKJ,,DT0S=+%U'UK7N-TI22WX6,YF
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M^E+2'[X^E)["ZE;5O^/1OK_2N$U_[S5W>K?\>C?7^E<)KWWFKIPYY>8'&Z\
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M.U5LSW4GF/UR:D$A4[!)G/4>E*=L8ROS$CI51;C&R)BU>Z(Q%'<@I*=H'3-
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MA1/BZO\ 'GZCZ***U)CN%%%%!84444 %%%% !37W9XS3J* &?/[T[:/2EHH
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MJ<-CX/TN.VM%B*-Y396JC4D]T14I4Z<+J5R;]B*TL+KXK6MWJVE"^B\_A6Z
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MB]F<?K9P&/M7):M&LFYQUQ76ZW@Y!KD=6;ED3O7ITUI<^;Q.IR7B:39;EB>
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MI#ED[6W*Q6%S2.*J5H0YG*W+?9=['+_LY^$Y-4\=RZU>::;J&'>&B(Z%2?\
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MZ?C4S^!B>PR]!,38_N?TK]<O^#6 8\2R@_\ /[/_ .A-7Y&W?^K;_<K]<_\
M@UC_ .1GD_Z_)_\ T)JY\;_NAU8%VQT?0_>4_?'TKR_]JO\ Y)V__7S'7J!^
M^/I7E_[5?_).W_Z^8Z^9/ISHO@K_ ,B;#_N+_*NOKD/@K_R)L/\ N+_*NOH
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M #OMDW]\_G1]LF_OG\Z;O3^X* R$X""@!WVR;^^?SH^V3?WS^=)@>@HP/04
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M"/\ WU_]>@#L<M_SS_2C+?\ //\ 2N._X7K8?] (_P#?7_UZ/^%ZV'_0"/\
MWU_]>@#L<G(S'2Y_Z9UQA^.MC_T ?_'O_KT?\+ULO^@#_P"/?_7H):=SL\_]
M,Z3)SQ'7&_\ "];+_H _^/?_ %Z/^%ZV/?0?_'O_ *] ).YV66_YY_I1EO\
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MH=Z,JIG/)%?3/[&FD6GQ@^$NL?#F:R%U>2W?[D]2H4-Q^M--P=QQ=WKN>'_
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M?\$#_&?Q3U>U^,_[1%K):60E65=+U*W_ -<C8/4 ^GK7Z _MR_\ !0+]G?\
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M303YFU277'4>M+%ND7]X?+]C1=\W+?5#D^1\][WT:&R:9;C_ $@.%)[4L<:
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MK8?] (_]]?\ UZ/^%ZV'_0"/_?7_ ->@#M/,_P!C]*/,_P!C]*XO_A>MA_T
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M"/$'Q4DU%;OQD;;0I+%?M&GNN4,?=3QTJ%A93FE3U8GB%1@Y5IV25V_(UO\
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M'_\ 0!BH_P"$+\'_ /0!BK1W'^X:-Q_N&@#._P"$+\'_ /0!BH_X0OP?_P!
M&*M'<?[AHW'^X: ,[_A"_!__ $ 8J/\ A"_!_P#T 8JT=Q_N&C<?[AH SO\
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M6Y/)!^4>E;'[2W_!9O\ 8R_86\.MH/P.@TG6T6'(M--N",$=!R17Y!_ML?\
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M72*)5\W<,?SJE^V9HGA[QQ\*=5M$^'X:\,6+=A]X<'IS7RO^QY^UGKGA;R_
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M_P "ZKX0\7Q>#9)F>YFV#=CGYN*]+_X0?QY:?M!S:JN@W+6WDJYN,#;C)/\
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M>!M5T+QK_P (/?EFGX =AZG J7Q]X#U#P!J\&@:H[2W$Q0K(1@@-C'\Z]?\
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M?\(/X)_Z 4/Y5I?)[4?)[4 9O_"#^"?^@%#^5 \$>"QRNA0Y]A6E\GM1E1R
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M;:?\>GX4X_<_"OHCYL<.@^E%(O0?2EH+6P4444#"BBB@ HHHH *,#THHH ,
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M_0,_>/TKYG%?QF?58/\ W6'H>1_%K_D=]/\ ^OY/YUZ['_JU_P!T5Y%\6O\
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M1]: .!^/?_(!7Z&M/X+?\DXTW_KG_A69\>_^0"OT-:?P6_Y)QIO_ %S_ ,*
M.K[M]*^;_P!I@%O$IQ_SUKZ09@.WUKYQ_:579XE,I/RF;I32N!YN 2BX%/H\
MR)OFCQBASG)H:L5$,CU%&0>AJ.G1]Z10ZBBB@ HHHH **** "D<\4M(W;ZT
M,<'"CT-21!C*G'\7--/W_P :EM?^/C\10!\#?\%_0?\ A2&CG_I^D_D*_&;1
M 3ID>!WK]F_^#@#_ )(AH_\ U_2?R%?C-X?_ .08GU-?0X#_ '/YGRN9>]C?
MD7%X7FEIK]/QIU=_4XX? %%%%!04444 %%%% !G;\V,XIDDBRMN6#!]:?12:
MN[B^U<-\I&V5RX]*;MR<=!Z4ZBJ;=@Y5RV0C,A_=F/)_O>E(Q*#:QW TZBDF
MUN"20BI& 45-IQ]ZD10&/FKNXX-.HI-7V'KT8*\98[HN .!22CS(5F0[3G[M
M+11RKJ2XWW8TI), \<WEG/-/( 8J'^;'+^M)11RQ[%22E!1[##M48\O)_O4]
M)%$9C:/.>]%%'+'L*<5.*78;%$85)\S/M3UEC>#:T/-)11RQY6K U=#(!&L8
MS'AB>M.\Q0VR2'?[TM%)1220DI+J(,&4@+A?2GRRJHV(O IM%/E023EU$VAV
MWQG8:2=3<$;VR1WIU%+EC<:7O78TK@[F.6_O5($?;N:?CTIM%.R'&\4!\ISC
MR\8I!&5DWQR87^[2T46L+5[B.8RVY8L'UQ2/ 9#O,N/:G44_47*FK#"GF_NX
MSY?JU"I]G;#'>?[PI]%)QCV':SNARSQC*S1;\C@^E1LH6($C<-WW/2G44N4(
M7BF!=?,Y7*$<+1N"1[47'-%%/5+0+:A'$J+YC."?2F-('^8IS3Z*>Z&[-6!3
MGY V!]:2,K;$C;O!%+12Y8]@5E&PU1&XP(\'/6@3&,>6(\^].HHMV(<$XV&E
M409*;O:B0,J"2-L'/04ZBFM"]+::"$NZX+D4,%#^61D8SFEHI6TT$E)+<:)/
M,X\O;Z&G1QL_^MG&!V-%%"5E8(WBMP(*R?:%?C&/+H0ECY@.WC[M%%*48R0G
M&\;")&'?>K>7[^M$KA&V1KD'O2T52TM8=ES7&QVZH^[>.:>[(LF0F1CK244:
MW"RO<1Y T?S+GGI1+L\D>6N#GD4M%39]P][N%Q@P 1<'(SBE<;HP';=2455A
MQNKZB%?)8&)^W:EHHI$V?5A1113#E"BBB@H**** "D92RY49YI>E"[_]:A^7
MH14S^!BE\-R*^(2!I&.!MQFOUS_X-8?F\2R.O(^V3\_\":OR.NT46[>?RN"=
MIK]</^#5]B_B:4Q?*@O9QM_X$U<^-_W4WP#;S!>2/WEZOD=J\P_:K_Y)TY_Z
M>8_YUZ?%T/UKS#]JK_DFC_\ 7U'_ #KYD^J.B^"O/@V$_P"PO\JZ^N0^"G_(
MF0?]<T_E77T %%%% !1110 4444 %%%% !4>#G&*DI#]\?2D]@O8K:K_ ,>S
M?6N%UPX=L"NZU;_CT;Z_TKA-?."QKIPYY>/W.,\3-M0Y%:_P+T5I[M]2>'[D
MI&:Q_$C>;\JCG->D_"31VTS1B2N-[!J[*T^6@>3@J'M\7S/H=9;A@I##O4E,
MB).<^M/KRDVU<^J"BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %>
M.?M%?\C1I_\ UQ/\Q7L=>.?M%?\ (T:?_P!<3_,4 >H^%/\ D7K'_KW6K\G/
MY50\*?\ (O6/_7NM:#_>_"@#Y0^- /\ PFS\'_6-7-,"D95A@GH*Z;XPR17_
M (TEB@F"L)6!-<W& )!Y\F0O&:3;0U(1>@I:-X=CCH.E%"=T6%%%%, HHHH
M*8P.3Q3Z* &H",Y%.HHH);LPJ.I*CJ7J[#B[R-#PM_R&X?\ >K\7_P#@O?\
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M]5H"Z%HI/,C[2 T>8G]X4!="T4GF)_>%)YL8ZN* NAU%-\V+^^/SH\Z+^^*
MN@D[5/'_ ,@:^_Z\I?\ T U6,J,V ?QJQ:LDNF7T;.%'V*;G_@!J7ND2_=I)
MOH?SL_\ !0__ ).@U#_KK-_Z'7CR?>%>N?\ !0^^M%_:CU%)+A5Q--U/^W7C
MBZGIX.?MB?G7UM#6DK'Q=1I59>I:HJO_ &KIW_/XGYTAU?3P?^/I/SK:S$I1
M74LT55_M?3_^?E/SH_M?3_\ GY3\Z+,?/#N6J*K_ -JZ=_S]I^=']JZ=_P _
MB?G19CYX=RQ15?\ M73O^?Q/SH_M73O^?Q/SHLPYX=RQ15?^U=._Y_$_.D.K
MZ>.ETA_&BS#GAW+-%5?[7T__ )^4_.C^U]/_ .?E/SHLPYH]RU15?^U=._Y_
M$_.C^U=._P"?Q/SHLPYX=RQ15?\ M73O^?Q/SH_M73O^?Q/SHLPYX=RQ15?^
MU=._Y_$_.D.KZ>.ETA_&BS#GAW+-%5?[7T__ )^4_.C^U]/_ .?E/SHLPYH]
MRU15?^U=._Y^T_.C^U=._P"?Q/SHLPYX=RQ15?\ M73O^?M/SH_M73_^?I:+
M,.>'<L457_M73_\ GZ6C^U=/_P"?I:+,7M(=RQ15?^U=/_Y^EH_M73_^?I:+
M,/:0[EBBJ_\ :NG?\_B?G1_:NG?\_B?G19CYX=RQ15<ZMIP&?M:?G3?[7T__
M )^4_.BS#GCW+5%5?[7T_P#Y^4_.E&K6)Z7*T68<\>Y9HJM_:EC_ ,_24?VI
M8_\ /TE%F'/'N6:*J_VO8=[E?SH_M?3_ /GY3\Z+,.:/<M455_M?3_\ GY3\
MZ/[7T_\ Y^4_.BS#GAW+5%5?[7T__GY3\Z4:MIY_Y>EHLQ>TAW+-%5_[5T__
M )^EH_M73_\ GZ6BS#VD.Y8HJO\ VI8?\_:4?VI8?\_:468>TI]R:16==J]:
M?*D151D @<U6&K6*'=]K3BFMJNG,#FY3)Z&BS#F@^I8:*-L%R" *AFM;.8%I
M(A)(/]7ZBHTU2P"%'ND.>G-*FI::I#).FX=\TFF)S7<MQ/<V]N6T>[^RRC^[
MU)I6U36!*EXE\RW$0XF[YJI_:=CNW"Y3/KFE_M.QZ&Y3!Z\U-GV%S+N7+O5M
M:UV/R=<OFN%Q@;_2JMS)J$A2S2Y81 8VXXIHU6R PMXOMUH_M33\AOM:Y%5R
M^0.4+;EB3*B."W.WCYB*6.WCE.(!L<=7]:KKJFG#.;I<GH:'U2RP/(O45O6I
M<62I174F+N[>3(A##HYI1YH)62,C'0GO4/\ :MB5&Z\4L/XJ)-9LR 'O%.!Z
MT).Y49QON3T55_M?3_\ GY3\Z/[7T_\ Y^4_.KLR^:/<M456&JV)Y^U)1_:E
MC_S])19ASQ[EFBJQU6Q'/VI*3^U]/_Y^4_.BS#GCW+5%5?[7T_\ Y^4_.E&K
M6!Z72468<\>Y9HJM_:EC_P _24?VI8_\_2468<\>Y9HJN-5T_O=+1_:NG_\
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M_> QS0%T*?O_ (U+:_\ 'Q^(J+"D[]XJ2S*M<<N!S0%T?!/_  < ?\D0T?\
MZ_I/Y"OQF\/_ /(,3ZFOV6_X.!+BWC^!^C%IAS?R#]!7XQ:+J-G%9K$;A< _
M>KZ/+XMX3E6]SY;,FEBN9[&D_3\:=5<ZIIA4$WJ#\:/[4L/^?M*[;/F9PQE&
M,5=EBBJ_]J6'_/VE(=5L%ZW24[,:J0?4LT55_M?3_P#GY3\Z/[7T_P#Y^4_.
MBS'S1[EJBJO]KZ?_ ,_*?G1_:^G_ //RGYT68<\.Y:HJM_:^G_\ /RGYTO\
M:NG?\_B?G19ASP[EBBJ_]JZ=_P _B?G2'5M.'_+VGYT68<\.Y9HJK_:^G_\
M/RGYT?VOI_\ S\I^=%F'-'N6J*KC5M.(_P"/M/SH_M73O^?Q/SHLPYX=RQ15
M?^U=._Y_$_.C^U=._P"?Q/SHLPYX=RQ15?\ M73O^?Q/SI#JVG ?\?:?G19A
MSP[EFBJO]KZ?_P _*?G1_:^G_P#/RGYT68<T>Y:HJK_:^G_\_*?G1_:^G_\
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M*6XNHHKFX:--I1RN64\#G)->3CZR5+EZGK9=0G]8]HUI8^CHNA^M>8?M5?\
M)-'_ .OJ/^=>G1L 2I//I7EW[5<C#X;NI3 ^U1\_C7B'OG2_!3_D3(/^N:?R
MKKZX_P""3;O!<)Q_ O\ *NPH **** "BBB@ HHHH **** "D/WQ]*6FL<,#[
M4GL'4KZM_P >C?7^E<)K^"S UW>K?\>C?7^E<%K[Y+"NG#;GEYAHSE7LVU#5
M4ME'4U[#H-HMEI<,:\?NQFO./ FG'4O$B3,,*I(.>]>I"(A%B7CBJQ$NA&64
MK7DQ\8XIU(HPH'M2UR)61ZX4444P"BBB@ HHHH **** "BBB@ HHHH ****
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MO:4UU+5%5?[7T_\ Y^TIPU;3\<W:?G19@JD'U+%%5_[5T[_G\3\Z#JVG ?\
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MI8_^ ;?_ !%?MU11_:&+_F#^S\#_ ,^T?B-_Q"9S_P#1=+'_ ,!&_P#B*/\
MB$SG_P"BZ6/_ ("-_P#$5^W-%/\ M'%_S!_9^"_Y]H_$0_\ !IK<Y_Y+I8_^
M ;?_ !%'_$)K=?\ 1=+'_P  V_\ B*_;NBE_:.+_ )@_L_ _\^T?B)_Q":W7
M_1=+'_P#;_XBC_B$UNO^BZ6/_@&W_P 17[=T4?VAB_Y@_L_ _P#/M'XB?\0F
MMU_T72Q_\ V_^(I5_P"#32X(Y^.EC_X!M_\ $5^W5%']H8O^8/[/P/\ S[1^
M(W_$)G/_ -%TL?\ P$;_ .(H_P"(3.?_ *+I8_\ @(W_ ,17[<T4_P"T<7_,
M']GX+_GVC\1#_P &FMSG_DNEC_X!M_\ $4?\0FMU_P!%TL?_  #;_P"(K]NZ
M*7]HXO\ F#^S\#_S[1^(9_X--+D]?CG8_P#@&W_Q%'_$)E<?]%SL?_ -O_B*
M_;RBFLPQ?\PGE^"_Y]GXA_\ $)E<?]%SL?\ P#;_ .(H_P"(3*X_Z+G8_P#@
M&W_Q%?MY11_:&+_F%_9^"_Y]GXA_\0F5Q_T7.Q_\ V_^(H_XA,KC_HN=C_X!
MM_\ $5^WE%']H8O^8/[/P7_/L_$,?\&FER./^%Z67_@&W_Q%+_Q":W7_ $72
MQ_\  -O_ (BOV[HI?VAB_P"8K^S\#_S[1^(B_P#!II<YY^.EC_X!M_\ $4[_
M (A,Y_\ HNEC_P" C?\ Q%?MS13_ +1Q?\P?V?@O^?:/Q&_XA,Y_^BZ6/_@(
MW_Q%!_X--)AU^.MC_P" C?\ Q%?MS1\O=<T?VCB_Y@_L_!+[!^(W_$)K+_T7
M6P_\!&_^(I/^(367_HNMC_X"-_\ $5^W?R?W!2?)_<%']H8O^8/J&"_E/Q&_
MXA,YO^BZ6/\ X"-_\11_Q"9S_P#1=+'_ ,!&_P#B*_;FBC^T<7_,']GX+_GV
MC\1C_P &F<QX/QTL?_ 1O_B*3_B$QE_Z+G8_^ C?_$5^W5%']HXO^8/[.P7_
M #[1^(O_ !"8R_\ 1<['_P !&_\ B*1O^#3*<=/CG8_^ C?_ !%?MW11_:&+
M_F#^SL%_S[1^(?\ Q"97'_1<['_P#;_XBC_B$RN/^BYV/_@&W_Q%?MY11_:&
M+_F#^SL#_P ^T?B$?^#3*Z[?'.Q_\ V_^(H_XA,KK_HN=A_X!M_\17[>T4O[
M0Q?\PO[.P7_/M'XA+_P:97.[GXYV/_@&W_Q%2?\ $)G/_P!%TL?_  $;_P"(
MK]N:*?\ :.+_ )@_L[!+_EVC\1O^(3.?_HNEC_X"-_\ $4?\0FDPZ_'6Q_\
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M3&7_ *+G8_\ @(W_ ,17[=44?VAB_P"87]GX'_GV?B+_ ,0F,O\ T7.Q_P#
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M(T"C\!4E !1110 4444 %%%% !1110 4U^OX4ZFOU_"D]@6Y7U;_ (]&^O\
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MO^?:/Q$_XA,9_P#HN=A_X"-_\11_Q"9W(X'QTL?_  #;_P"(K]NZ*/[1Q?\
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MP4?)V3%']H8O^8/J&"_E/Q%_XA,Y_P#HNEC_ . C?_$4?\0F<_\ T72Q_P#
M1O\ XBOVYHH_M'%_S!_9^"_Y]H_$8_\ !IE,>OQTL?\ P$;_ .(I/^(3&7_H
MN=C_ . C?_$5^W5%']HXO^8/[.P7_/M'XB_\0F,O_1<['_P$;_XBE_XA,YO^
MBZ6/_@&W_P 17[<T4?VCB_Y@_L[!+_EVC\1O^(3.?_HNEC_X"-_\11_Q"9S?
M]%TL?_ 1O_B*_;FBC^T<7_,']G8'_GVC\1?^(3&7_HN=C_X"-_\ $4?\0F,O
M_1<['_P$;_XBOVZHH_M#%_S!_9V"_P"?:/Q%_P"(3.5?^:Z6/_@(W_Q%+_Q"
M:R_]%UL/_ 1O_B*_;GCN,TOR?W!1_:&+_F#ZA@E]@_$7_B$UE_Z+K8?^ C?_
M !%'_$)K+_T76P_\!&_^(K]NOD_N"CY/[@H_M#%_S!]0P7\I^(O_ !":R_\
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M;?CM8XS_ ,^C?_$5^WA7+;LT.N_J:?\ :&+_ )@_L_!?\^T?D#\&_P#@U?\
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MK_A3/@C_ * \/_?-'_"F?!'_ $!X?^^:+("K_P +I\-?\]8_^^Z/^%T^&O\
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M'A_[YHL@*O\ PNGPU_SUC_[[H_X73X:_YZQ_]]U:_P"%,^"/^@/#_P!\T?\
M"F?!'_0'A_[YHL@*O_"Z?#7_ #UC_P"^Z/\ A=/AK_GK'_WW5K_A3/@C_H#P
M_P#?-'_"F?!'_0'A_P"^:+("K_PNGPU_SUC_ .^Z/^%T^&O^>L?_ 'W5K_A3
M/@C_ * \/_?-'_"F?!'_ $!X?^^:+(=V5?\ A=/AK_GK'_WW1_PNGPU_SUC_
M .^ZM?\ "F?!'_0'A_[YH_X4SX(_Z \/_?-%D(J_\+I\-?\ /6/_ +[H_P"%
MT^&O^>L?_?=6O^%,^"/^@/#_ -\T?\*9\$?] >'_ +YHL@*O_"Z?#7_/6/\
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MNGPU_P ]8_\ ONC_ (73X:_YZQ_]]U:_X4SX(_Z \/\ WS1_PIGP1_T!X?\
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M#MFMM9A\<E:VYK0.!PY\3<T$/S''2GTQ<@@^]/K$[D]0HHHH&%%%% !1110
M4444 %%%% !1110 4444 %%%% !2,< G-+3)6((&W.:  * OF+U[^]<K\3/A
MAI/Q+TQ+>^1%GAR8)'&=C>M=3)NCQY8X]*4[",]": /"++6?B1\&;PZ+=VUS
MJ5C <)(@ 4C]*[+0_C_I.KP![RR^R$#)1VKO+_2['5(C!J40E0C&&K"G^$'@
M2Y<NNBQ<^U &>WQK\-LP1)H\#_:J3_A=?AP_\MH_^^ZF/P9\" X32(1^%/\
M^%,^"/\ H#P_]\T 5?\ A=/AK_GK'_WW2CXU^'!P)H_^^JL_\*9\$?\ 0'A_
M[YH_X4SX(_Z \/\ WS0!6_X77X<_Y[1_]]T?\+K\.?\ /:/_ +[JS_PIGP1_
MT!X?^^:/^%,^"/\ H#P_]\T 5O\ A=?AS_GM'_WW1_PNOPY_SVC_ .^ZL_\
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M:+(15_X73X:_YZQ_]]T?\+I\-?\ /6/_ +[JU_PIGP1_T!X?^^:/^%,^"/\
MH#P_]\T60%7_ (73X:_YZQ_]]T?\+I\-?\]8_P#ONK7_  IGP1_T!X?^^:/^
M%,^"/^@/#_WS19 5?^%T^&O^>L?_ 'W1_P +I\-?\]8_^^ZM?\*9\$?] >'_
M +YH_P"%,^"/^@/#_P!\T60%7_A=/AK_ )ZQ_P#?='_"Z?#7_/6/_ONK7_"F
M?!'_ $!X?^^:/^%,^"/^@/#_ -\T60%7_A=/AK_GK'_WW1_PNGPU_P ]8_\
MONK/_"F?!'_0'A_*D_X4QX)_Z!$5%D!7_P"%T^&O^>L?_?='_"Z?#7_/6/\
M[[JQ_P *8\$_] B*@?!CP3GG2(ORHL@*_P#PNGPU_P ]8_\ ONC_ (73X:_Y
MZQ_]]U:_X4SX(_Z \/\ WS1_PIGP1_T!X?\ OFBR J_\+I\-?\]8_P#ONC_A
M=/AK_GK'_P!]U:_X4SX(_P"@/#_WS1_PIGP1_P! >'_OFBR J_\ "Z?#7_/6
M/_ONFCXU>'&X$D8Y_O5<_P"%,^"/^@/%_P!\TA^#?@9_N:-$/PII6V#<K3?&
M3PP8L/+&P]-U8^N?M%:=IT#'3-(-U)T$<;<_SKH5^#/@E?O:1$1]*GMOA1X!
MLY/.@T&+>.A% 'EJ3_$7XUWPAD6XT[3R?GBD&5.#[9KU;P3X,T?P/I(T_2+=
M03@R,@ZMW-:VF6-GID1MK*T\I/05/&B1J63GGM0 ^)@RY!S3J;$(P/W?XTZ@
M HHHH **** "BBB@ HHHH *8_6GTC+N.<TNH%75^+5CFN1M+4W6M*CKE>>*Z
M[6>;-L5C^'[+=?B<C@$UO#X3AKP<JT?4W;2)4B48Z#BG(GS[CVJ0 #@4<"L3
MN226@@4+T%+110 4444 %%%% !1110 4444 %%%% !1110 4444 ! /44444
M %1Y#/N5\@=14E1E4B;Y8^O)(H \[^)_P=M];E_M_P -[;:^C!*R*N3FN7T+
MXN^-/A_<#0_%6BW-S'G NW( 4#\:]M5"O*_E6?K'A/0/$*&/5]-653U#4 <C
MIOQV\/W\>)H5CSUW-5Q_C'X: P+N,#TW5;E^#W@(_+!H42U%_P *6\$YRVDQ
M'\* (F^-/AI0 MQ&?^!4G_"Z_#G_ #VC_P"^ZL#X,^!L?+HT/Y4O_"F?!'_0
M'A_[YH K?\+K\.?\]H_^^Z/^%U^'/^>T?_?=6?\ A3/@C_H#P_\ ?-'_  IG
MP1_T!X?^^: *W_"Z_#G_ #VC_P"^Z#\:_#AX,T?_ 'U5G_A3/@C_ * \/_?-
M'_"F?!'_ $!X?^^: *O_  NGPU_SUC_[[H_X73X:_P">L?\ WW5K_A3/@C_H
M#P_]\T?\*9\$?] >'_OF@"K_ ,+I\-?\]8_^^Z/^%T^&O^>L?_?=6O\ A3/@
MC_H#P_\ ?-'_  IGP1_T!X?^^: *O_"Z?#7_ #UC_P"^Z!\:O#8Y$L?_ 'W5
MK_A3/@C_ * \/_?-'_"F?!'_ $!X?^^: *W_  NOPY_SVC_[ZI!\:/#0Z2Q\
M_P"W5K_A3/@C_H#P_P#?-'_"F?!'_0'A_P"^:+7#8J?\+G\,]?,B_P"^J7_A
M='AK_GK'_P!]U:_X4SX(_P"@/#_WS1_PIGP1_P! >'_OFE9!=E4?&CPR.DD?
M_?='_"Z?#7_/6/\ [[JU_P *9\$?] >'_OFC_A3/@C_H#P_]\T60%7_A=/AK
M_GK'_P!]T?\ "Z?#7_/6/_ONK7_"F?!'_0'A_P"^:/\ A3/@C_H#P_\ ?-%D
M&Q5_X73X:_YZQ_\ ?='_  NGPU_SUC_[[JU_PIGP1_T!X?\ OFC_ (4SX(_Z
M \/_ 'S19!=E7_A=/AK_ )ZQ_P#?='_"Z?#7_/6/_ONK7_"F?!'_ $!X?^^:
M/^%,^"/^@/#_ -\T60%7_A=/AK_GK'_WW1_PNGPU_P ]8_\ ONK7_"F?!'_0
M'A_[YH_X4SX(_P"@/#_WS19 5?\ A=/AK_GK'_WW1_PNGPU_SUC_ .^ZM?\
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M=/AK_GK'_P!]T?\ "Z?#7_/6/_ONK7_"F?!'_0'A_P"^:/\ A3/@C_H#P_\
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MGPU_SUC_ .^ZM?\ "F?!'_0'A_[YH_X4SX(_Z \/_?-%D!5_X73X:_YZQ_\
M?='_  NGPU_SUC_[[JU_PIGP1_T!X?\ OFC_ (4SX(_Z \/_ 'S19 5?^%T^
M&O\ GK'_ -]T?\+I\-?\]8_^^ZM?\*9\$?\ 0'A_[YH_X4SX(_Z \/\ WS19
M 5?^%T^&O^>L?_?='_"Z?#7_ #UC_P"^ZM?\*9\$?] >'_OFC_A3/@C_ * \
M/_?-%D.[*O\ PNGPU_SUC_[[H_X73X:_YZQ_]]U:_P"%,^"/^@/#_P!\T?\
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M\]8_^^Z/^%T^&O\ GK'_ -]U:_X4SX(_Z \/_?-'_"F?!'_0'A_[YHL@*O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "D89Z#GUI:* & NGWN:<!_$!CU%+10 SS&WA=AI6  + <TZB@"
M-1*Q#;\#TJ2BB@ HHHH **** "BBB@ HHHH **** "BBB@#&UR(S7"*@SAN<
M5H6<9CM%3VIKVY,Y;WJS$FQ<&G?0PA'EFY"#.%&*?112-EW"BBB@84444 %%
M%% !1110 4444 %%%% !1110 4444 %(S;?X<TM% "+D_,>_:DVJ_+)^=.HH
M 38O0].PI!&!T/'I3J* &E$R#MIU%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4TC;]U:=10 @!QACFF\ \1\^M/HH 8B/U=L^U+@
M)\JIUIU% "(@0$ =32T44 %%%% !1110 4444 %%%% !2$D#WI::YPV: *^J
MD-9L,<U5\/P-'&S,I^]Q5R]A\V/(%.LH_+CP15*32L1*"E*Y(NXMDBA]V< <
M4ZBI+ <"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "F21N
MWW7Q3Z* &+NC&&.ZAU<L&!X'5:?10 U0",XP:4Y'!&:6B@   ' HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $)(Z+FD8'.0:=10
M PHY.2W'I2@ C&S%.HH 0*N,[:3C^X:=10 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% ";1G.*6BD()XS0)*PA;YL"G4T)@
MYS3J!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !39$+#BG44 )@%<$4H
M' HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH H7=S<B.2VC
M<B1D)C/X5^&W_!3'_@L/^W7^PU\9+VRU7PUXC;01-*T-T,+$$!&/XO2OW0G2
M'SA.V 5_B]*\!_;X_P""?_P9_;H^%5]X*\>^'K6>^FAV6]W<+G:,'V/J* /P
M-/\ P=>_M 2R!5AU=1W_ -('_P 52#_@Z[_:#+[!;ZQ]?M _^*KXW_X*B?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% #99!&N<9/8>M0S3. DQ?8HY?-22[=ZEDS[^E1W<,=R
M!$\@"M]Y3_%0!\$?\%EOVEOVM?V;?!]G\0/V?]*UB^LK:)Y=1&F*,!1NQDDC
MVK\B[[_@ZC_:6\/W?]D:Y8:W#=0MMN(I)P"I]#\U?TJ^*?!GAOQ]X5OO OBS
M2%N=+NXO*N+9_NR)Z5_/1_P7S_X(%3_#O4;W]H#]GG0%^P3O)=7ME86^3&O(
M 8X'M0-'GG_$5M^T'(Y^36%';_2!S_X]75_!_P#X.._VT?VA?&ECX#^&?A_Q
M%=W5W.(@UM(&P3_P*OR:^#_[-_Q)^-WQ.L?A)X7\+7;ZE+=""2-(\LC$9Y%?
MTY_\$2?^"(/PY_8[^'6G_%;XH^';:^\3WELDT(>+;+:2@CKQUP#^= ^A]N?L
M4>*OBMXO^!>B:S\7[6[M]:FL@UW'>##A\]^:]@\PJI(^8CM4*?O%613C;U2G
MIF/=(3R>BT$CX7WY);\/2GTR%5P7"8)ZT^@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44$X
M&:B^T_-C;QZTF[";2):*B%S\^W;^-.:4#H*8^H^BFM* ,XH$@(SBE="NKV'4
M4SSU[J://0$ ]_>AM*5AK57'T4U)-_\ "13J$TP"BBBF 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M112,=HSB@!:*:9%'0YH:15&323N'0=140N@6VA>/6G/-M. ,TWIN*+4MA]%-
MW_+G;1YG^S2N@;2'44T2#N,4B2[VP!QZTQK4?1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %-=@>!2L<#-0-*<X I-M*Z"R9(0@Y YIDD@/RF,_6N;\<?$
MKPI\/-/EU/Q/XDM[9(T+8F?&<#.*^,_VCO\ @L9X/\%3S:#X)TF2\E1B/M%K
M-D?SKMP>78W'.U.)X.<\1Y+P_2=3%UE%=KZ_<?=RB../+,,GI2!_+^_(.>E?
MCSXK_P""O7QVUN4CP_JE_:#=D#=G _.I/#7_  5[^->B;)?$6I7VH!6&Y%;_
M .O7M1X2S.W-:Y\%+QHX,=50<Y>MC]A0[!OF;@T\R-C&#^5?#O[,_P#P5Y\
M?$D6^D>,;!K"X=@N^ZG Y/%?9/ACQGH7C*PCU+P]JT5Q'(H8&)LCIFO&Q. Q
M6$G:M&W8_0,GXCR?/*7/@ZBEW\C8W*Z%20#26T4D7RN^::3N&[9S4L1W'.*X
MGH['MR5MA]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11D>H
MHR/44 %%&0>AHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J(R.&/!XJ
M6J\Y<H<-@YXI.2B)NS'O(Q7<IQCK5:]U-;.W:ZFDVJG7-5]4UNQT*P?4]9O%
MM[>(9DDD. *_.?\ X*#?\%7#X6UA_ WP?O9'D3='<3VDN0&'K711I>UJ*+V9
M]+PQP=Q%QEB94,GI.<TF]=(JRV;Z7/L#XX?MS?![X*VA:_\ $=I=7(4DVB3X
M?([5\H_%?_@MCI=K="W\*>&[H=1F.8'/ZU^=_B3QMJWQ7UB7Q+XN\1+/=RN7
M6.0_-DUB7MM!8RX(&\_<Q7Z)E/#&65*7/.7,?RAXI\8>)W!.>U,HS#!O"33T
MYE>Z[J6J:?DS] ?#7_!;?6HK\-J_AR_>+=R#(.GYU]-? G_@J9\(?BQ/:Z7J
M,D6F32X!-S<=Z_&.3RXX/WDP?<.1Z58TUS;W<-]HUT+:XCY23/>NW$<)Y5B8
M/E3B^A^?Y+XS<6X/$16(DJL;[67SUL?T5Z!XHTCQ-:+J.BZK%<0L,AXFR,5>
M6X#G:CY]2.U?CM^Q1_P4K^(?PB\00^&?B)JUQ?:6)0NTOA0@^I^M?JU\)OBK
MX-^+?A6V\5^$-5@E6XA$DL,3Y*$]C7YWFN48O+*FJO'HS^F>$>-<JXNPOM*,
ME&:WCU1UZSLS%6! '>GQR-(>F /UJ.-A)&=Z8 ]:D0E2!GCM7E:\B/L=>:S)
M****8PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"2WOV?J?CR6EG0-Y9,@.5;TK[;_X)9_MQW/PV\1Q?"CQYK!-B5(@:5]J;VR
M/KTKY$\=>!/%'PPUR72]=L944\H[K@8/2L"VGFTN\M=8MSLNK:Z28'OA6!'\
MJ_2<=A</G&#:OHUH^S/Y.X>S;,^"<^59JTX.THNZ32W3]3^B_2-0LM5LXM7L
M9%99D#*RGL1G^M7B8R_'WL<U\B_\$Q_VO+#XV?#.U\):S?@ZK;*=PD?YMBC
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MN*=.6SV/[ X.XHPO%.40Q,&E):275,N44T2+NV 4DA=3D5YI]8/HI%.1DTM
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M8_A?Z466\,>(F:Y=F>*PL=:2E&7VFM-)/=KU9\'Q_P#!)/7/&7PHMOB5X/\
M$%O"983(+=8B6/3BOE3XA_##Q;\+/$-WX;\0:/.9;8X>4I@#WK]K?V59[R/]
MFBP.\[H[$E/KQ7S?IOP8\&_M#_'+QAX<\;V<4DPC A>?LQ->UE_$^+C5_?I2
MBMWV/XSXD\&\DS'"N>6WI5&M([I^6NQ^7R0/&L>I:<X\]3NW#J#7W+_P3*_X
M*%:OX,UB#X4_$?49);-PD%FTCX52>_7VKY__ &UOV8-;_9C^)UWIUBA&ERW'
MEP>6F%QS7C]G-=6%]%K>ES[+BV?S+=EZJP[U]AB\-A<[P=XNZ?4_ LKQ^=\
M9^D[Q<':<;NS7^1_1-I&HVVJVXU+3;I9K>4?NG0Y%7XNH1OF(KX6_P""4G[;
M#_$?PJOPO\?:UC4=/MEVR3OCS&.!P*^Y(G/F *V6S\Q%?D>-P53 8B5"I\C^
MULBSO"<0Y93Q^&DK26J[,N4445R'LA1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IG
M5BRGM3^M-PL:X ZTM;AHD027!B#22RA55<DGM5"P\7^&]4NVTNTUZWEN$&6C
M5N0*=XL!C\-7[J?F6U<@_A7Q[^S#K'B/4OVI]:M+S4RULEF"D1['<];1A&I%
MVZ&$I2A-7ZGV'K'BK0?#JI_:^J0Q>8VU=[8R:G&J::UD;Z*_C, &XN#QBOES
M_@H3J>O:-:Z,^BZ@8"^JQJV.XRM>F>%9=0E_9PN+N>YW7 L)2)??9Q2]BN5/
MN4JK<FNIZ;I/BCP]KKE=%U2&=Q]Y8VR13=0\3:#HUP$U'588IY"%5';DDU\J
M_P#!/+7?$FJ>++]=9U7S\1R84]N6I?VPO$FM:#\5K:_?5OL]G!=PNX;H0&YI
MNDXRY8[L2JI*]M-V_(]2_;-_:%TSX'?!^[U2XU-8[FZADAB._!R5X_G7X@>/
M/%VO?$3QS>^,-<OS-/<.R[VZXW''\Z^F_P#@J'^U4GQA\;CP%HER9M.M!%(K
M*^5+#K_*OE*0102%X5R)!M2,=<FOU+AG*?[-P2FU:<M?0_D'Q6XM7$F=/"TI
M7H4FUILW_P  U/ /A35/'/C.P\&Z79/<R3W<:2O&N0%9@.:_5J/]GW1OV:/V
M2['2+2R07CEF>2,8R&1>*\(_X) _LFC5=>_X6GXST8R6KP$6YD3 #KD@Y_$5
M^CWC_P"&^D?$KP\GAW5[=6AC^ZC]N,?TKYSB?-E5Q2P]-Z+<_3/!K@_^S,N>
M:8B%JM3X;](]_GH>/_L)M/<_L]EW)1O-G+ CG&*\J\%7*Q_MDZA%&./LB_-^
M+5]9_#7X2Z+\-_#)\,Z3"B0'=E4]^M8FG?LT^"--^($OCZ#38A=2H%+@<]3_
M (U\G3K1@I1MN?MSIS<$W\1Y]_P4'9#\'-,$OS$:A&<?BM;_ .R9(TW[.3.A
MP DW'_ :[WXH_"'P]\4M#AT+7[5)8HI0ZJXZ$8_PJUX(^&VC^!?"'_"(:- D
M5L=P*+T.1@UG*25%17<UY&JE_(^0?@8ZQ?M<ZE-$.MI@D?5J[?\ X*&SK;:!
MHTSC=G5K?<!Z;TKV'PY^S5X,\,^/IO'>G:?$D\L>UB!SW_QJ_P#%7X'>&/BQ
M:P6_B&SCF2&99%#]B"#_ $K2=5>T36Q'LG*BX[,^'_V\_P!E*+XK? .T^)?@
MJR"7T+J\Q1<ML15)_K7YOR6K2;WN6_TB.0QO&>N <5_07)\-] @\#7/@*ULE
M6"2UDCV@<?,I%?C)^WU^S'J_[/OQ?O+S3=,>/39R-LR)A-S,<\_C7W?".;;X
M:<O3S9_-GC-P;RUUF]&&Z]^WYG.?L?\ [06I?L]?&6TUK3'D2&YDC@E"-CAF
MP?YU^X/PQ\?:=\1?!UGXFT>42130IDJV1NV@FOYZQ$Y=+J"4*\;!U?W'-?HW
M_P $S_VU7L?A9/\ #;Q%J^VZM;6>:&:1\ D(=H'Y5KQ?E<91CB::N]F<G@EQ
M>\+BYY3B96C/6#?1]5\S]'PYV",KNYZT]$=6(9P1C[M>#_L>_&?QC\4=,GF\
M37DDF))?+,GH"<5R?Q2_:,^(?AC]HY?A[9ZM*EF5B) /R\MR*_/%0J*7(NA_
M4,:L7!2>ESZCA\K>0D>/>F3W+1'8D1;/&17F?[27Q)USX>_"V#Q)X?NGCN'"
M[I$Z\@'^M4OV3?BGXD^*'PHE\4:_>/+.LDRJS]?E!Q6:BVKE\T;V/6HR8/EW
MACC.T4Z ^<_GE".V#7S%I/[1/CB?]HV;P'-J$IME@R%[=37T[9L[6\;N<EHP
M3^5.<)0=I!&49JZ)J***DH**** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBF--MX"\T /HK/U;Q)I
MVAV;W^J3K#%&,L[G %)HOBC1_$,/GZ1>QSH.K1MD"C7V?/;2]K^9DJU)U?9\
MRYK7MUL:-%9%MXY\,7E^VE6NKPR7*MM,*O\ -GTIVL>,O#^@ ?VUJ,5J6&5$
MKXS6GLJO.H\KN^A/UG#NFY\RLNMS3DZXJ"-W,V''&:KW7B#3(;!=7DOHTMBN
M[SB?EQZYK.'CSPQ/I5SJUGK,$T=L?WLB-POUJ6FU8UC*,EIK?8\Y_;'_ &C-
M-_9P^$NJ>+'O MW%#YEO&KX8]>GY5^&GQ+^)'B3XW?$W4O&OBJ9Y?/O&DM&D
M_@4XKZ$_X*H_MC:O\<?BM'\,O#VILEC:M);W,>[(D_SFOEZ^NGTJP6S09G1,
M1J.I^E>M1PGL*7,]W9G^A7@=P##A3AF&.Q$%]9Q*O=[Q@]K,V/"G@CQ3\9_%
M-MX"\)6\I,S>7)*BY"GWK[B_X(R>";KX9_$;7/"5Y,/M$6J*DIQCD!:Z/_@D
M)^R&_A?PAJ?Q7\?Z47GN)4N-/:1,%5('3\J?_P $]DUN']L3QRUWIDT<!\3M
MY+.."N$K/&8F,[N&VAX?B'QVN(,NSO)</*+HX:G#5?:GS:_=^A%_P5IAC/[7
MWPPBD7<QCD^;T^8U]@_$%63]C,1P<L-(7I^-?(__  5<TC5[W]K+X;:C:6$D
MT4$<F\HOW?F-?7/CY9T_8UW6T+"4Z0ORCKGFN.>M2#71?J?SUX@NWACD,5)-
M<L[I='S3.6_X)W2C^P=:1TY\Y=Q_ 5YS\14"?M;:,$Y+7S8([5Z/_P $[%E.
M@ZZ;J HQG7=N^@KS;XC"]C_:VT9[>R<H+YLN!P*J6E2274_"HP;P\8WV/0?V
M^_"^F>)?@A)HVH1J[3V)"Y[<FOR"^*/PTU3X::['%JEFZPW3$VK%<#;[5^PO
M[<K7,?PHCN[6!GD6R)&WKU->'_M6_LD:!\7OV2=/^(^BZ.@UC2=%#* N79B6
MZ5]'P]FTLOKQIR?NR=C\M\5>"GQ'E,L;0_C4E?UCV]>Q^9FGZUJGAR^77](O
M?+O+<YMI!U6OV&_X)A_M::?\;/AI;^&O$&L(=1TJ!(2LC_-(W7@?C7XYS6$N
MF75SINK0F.XM'V.C\'->[_L">+O%7P@^,FF>)X[IXM,DNA)=Q] XX_PKZCBV
MCE]3 NM5DDEL_/HOF?@7AKQ3BN%N(84ZJ;A4?+)?.U_EN_)'[E"-%^=:!*&;
M;MKG_!/CC3O$_A2T\1Q3KY-S"'SG[H]ZU[;4K6=3+:N) /[IK\J33V/[:IU:
M=6,91=U+5%RBJ5MKEA/,UNMRA<'!3/(J6YU.SL^;J98\]-QZTN96;[#4X-73
M+%%5WU&)8Q,O*$9# \46VJ6EX2+:57(^]M/2JL[7#F3+%%-,J@X!H\SVI%#J
M*9),D8&3R>@]:/-. 2AI)IO0.EQ9".!G%-;+# ;]*1F#L,K4>[:[)C&>E*I)
MP5PCH[B7,BVJB1G"K_$Q[5P7BK]J;X#>!;F6Q\3?%32;:>,X>&:XPRGT/%>
M?\%<OVU=6_9+^$?E>';J2#4M4LG-I<1MC8P+<_I7X _$S]HGXN_&#Q5=^*O&
M'BF6Z>YF,AWYR<_C7UF0\+SSB#JR?*N_<\7,<XA@'[_4_J-\%_';X3?$=HCX
M-\?Z=?,W\%O-N)KK8[IY+@Q,A7:>">]?S"_L<?MS_&']GGXLZ7J-MXIG;2DN
M@;BVC./E Z=:_H\_9B^+^G_'7X-Z!\1;>Y#R:A9":1=V2I)(YKES[AZID<D]
MT^IKE>:TLPB['I%%%%?/GJA1110 4444 %%%% !1110 4444 %%%% !1110
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M7.6P%^E<]!VJW/Q7Q;C#ZADSM=_5XZ+T1J?LO2RR?LRV4R1,G^@G&1]*\3^
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %-D[4ZFR=J%N)[&;XP_Y%K4?^O-__ $$U\<?LI?\
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M[['H^(?&,N&>%J-'"S_?U8)*V\5RJ\K[^GF<GX_T34/$6J7'C[3[H'4"YDD
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M7ESX(U*+P%XGO&:WEDR2S85,<8/YU]X^.?"FC>.-$F\-Z]"LUK,OSHW3./\
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MIUM8LN4445F6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%0RLH<Y8"IJJ3 23Y9.AHU>B$^>WNK4^=/V^@[6NA /P9VR/7AJ[+P<I'[*I
M$8QMTLX_,5Q_[?"?Z#H;HN=LS<#Z&NJ\':Q8Q?LMK'<W:1NVF'Y6/)Y%?:RN
M^'<(NU3MYGY9&2I<99E9_P#+GTULCA?V#HL^)]?=2-QB7?[\BO,?V]_BKHWP
M=^*NF>+]3LFD^S:B9$VG&W -3_!K]HOP[\&KS7I1;E[B>$+&R/SG(KYC_;>^
M).I_&Z"?6?$-RRPQ[GA2:OL,)E&-GQ%7Q3A:FX)7[WC8_).(N+<NPO U#+\/
M/FQ,9\^GV;3OJ>5?MC?M:^)?VH_&;S7<TQTNTG,EI%(<@ YZ?G7DND:-J7BK
M5;;P[X9LI))IY-B)&N2I-7?AW\,O'/Q(U"#PWX(T.YE61P@FBCW 9[U^H?[
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M-,GSO@G'2K4[SIRT4E?;M)?J?8'_  3@DM-6\8ZSKNG7">7/:+B,'[O-<O\
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
MW0_2N$^/'AK5/&?PTUC0=*F\N:73YE0D9R2N*[NF200R#:XJJ<YTZBG%[&->
MC#$494I[237WGX(^,OV+/V@(/B'?:$_@;4KI1(S)=I;':V6/2NP\!_\ !,GX
M\^*DC$UA<6+.V&:>V/2OVV72;)9-XC%6E1 NU0,5]?\ ZY8Y04802TL?C4/
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]>@^E%"]!]**_/3ZP**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT]LTAF0 [SC\:CBDCN7),1&T\$T/ECK<7/IJB;S'5@A&<_Q5(ISWJ#S';,:
MCTJ6$DKSU'6FM5<;]UV8^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HZT44 (54]11M7GCK2T4; ,=0"
M,"HY85=2K?Q5+(#U%1YWC(ZKUJ9WY1-7/"/V[?V-?"W[7?PJN?!^J00_;5M&
MCLIY1D1DD\_J:_"7]H'_ ()+_M*?"'QU>:%H7A2^U:S2<K!)8V9*A0*_I-DB
M:5PZC!'K3?((5\A2W;BO?RCB7%9-%^R5T^AY^*RVACM*JN?@G_P3M_X(V_%C
MQ_\ %"S\4_%?1Y++3+*Z5Y[2^MBID7 X&?K7[I_#+P1H?PS\%Z=X$\/0+%::
M= (HHTZ*,UK['0+)&R@*/W@ ZTZSM425KA,#S#FN?-<ZQ.=SYJFEB\%E^&P,
M;01<Z4445Y1W!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MPRGWS7PO\%_A#K_QG^(UA\/_  O:/-)>OM)C3=@Y'^-?T9_L'_LVZ?\ LZ_
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M^GW9^/JZT?WCZ***"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #+A6:(A6P:YW
MQIX)TCQUX:N/#6M0K+#./F0^N#_C722)O7;4+62@[X\!NQK*M2I5Z;A-73Z/
M9^I=*K6H5HSIRLT[W[-;'Y?_ +3G[*GBOX-^*KBXT.R>32[AVE<0Q\ DY )_
M$UP_PK^-WBWX,ZA_:'AO47MHT?,MK_$S>O6OUA\7?#[0/'.DR:-XDLUG@E'S
M*:^4_BK_ ,$O['Q#K[ZSX3N[6T0DD*XSU-?@W$7ASF^79@\=DC=[WLM+7WL?
MT=PQXHY/G&7_ %#B&RLOBM=2MW\SYY^*O_!83XG>!M#*V.A:K)(L?$L:'&<5
M\#_M+?M7_M7?MN>)?[%OTU.\L924^R"!B<9 '>OU0?\ X)2^*=;E%IKWB:QF
MM^ACV=1^=>S_  (_X)L_ KX/&/51X6@?4$(;ST(Z]^U?29''C;,H+#YG3<+?
M:=OT>XZW$OAGPM?$Y7"-6J]DEM\VE;Y'Y\_\$T?^"+5QXDN+;XE?&G3HC:(X
M)L;F+:[ \@\Y]*^\_C]^PGX'U+P$EK\/=)BM+FSMUBA;&< #IT]J^E]/TB'3
MX([2V0+%&@55 Z 5.;--A3 PQYK[BMPUEF,P#PV*@IWW?ZKL?D^-\0^(L5G4
M<QC4<>5Z1OHEV/R \3>!_B/\#/%INDTVY@EA8[+CRB%Z]:]F^$'_  4;\9>%
MK$6GC"XN+Z*(;0D9QBON3XH? #P%\5;%X/$^CI.Y7:K' P/RKYL\7?\ !+*R
MO+Z2;PE>VMI&[$[6&:_(:O G%G"^/G5R2HY0EKOK\UL?JV&\0N"^+L$J7$-%
M1DNOEY-:GPI^W9KOCG]M+QC!>OJ+?V8D1B-E*"6/(QWKZ1_X)4_\$SO#/PUN
M8/BEXBT2,7$$@,)9,':>?Z5[?\'O^"9ND>#/$T.J^,9;6^MD.7BC&"37U1H?
MAO3?#NG1Z3I%N(H(D"JGH!TKZKA3A[B:KB?K><U+-?9[]KGB\9\?9'1RA9+P
M^K4K:R6FG8EABCM8DM(!A$7"CT%2<[?D8>]+]D(E#JW&.11%;2(Q9G!R<BOU
M:RLF?A%W-.^C_,K7<$=W"UI-'D,.<U^??[?W[+^L>$O%8^('A?3'DAV-)*8(
M\X8G/]*_0Z2W9CD&L[Q-X/TGQCHLN@^(;99[:8?.A[U\KQ5POAN)LK>'J/WU
M\+[,^NX*XMQG"&;K%TM8[2CW74_+SX8?MF_%_P"&,2:;'KLJ6\> ;?!SQ^->
MKW7_  5$UVU\&3DV]VVH #RI ?8UWOQ=_P""8^G>(-3EUCPC<VMHK,2%89/-
M<99_\$J_%]Q,LEQXELB!T!3_ .O7X]A\J\3\B?L,,I5(+9W6WE=G[GB,Y\(<
M]2Q.)485'JU9_C9'P!^U3X^_:[_;/UN72M<\43SZ:[%(K-H6SLSP.M>M_L"?
M\$1=4\2ZW:>._B\D#Z= X,EE-'M>0'GC/TK]$_@I^P/X!^'DD>H>(K""ZNXB
M"LB <?I7OEAH]I86T=E8H$BC4*JCTK]&X=R//ZTUB<UG9_R]?F?*\3^)V6X3
M+Y99P[25.#T<EIIY>I\\?%_]@_X9ZM\/(-"\+:'%!+96JQ0$\X 'TKX:^)/P
M1^)GP9UZ2YN;&<B%S]GF2(@*M?KH;16()QQ7.>/_ (0^#?B5:&R\6:6MQ&4V
MD' X_*N?BOPZP.?_ .TX;]U76S6S]3Y_@SQ1S#ARV'QD?;4&]4]6O2Y^>GP(
M_;V\?>!Y8M'\1ZE-/:H0IC7C ';K7UWX0_;B^%GB/18[B^O(X) @WB6< YKQ
M/XV_\$RV5[O6/A_<V]NC.66(+DU\W>)/V7?BQX5GEMI] O+H(Q :&$X-?GM#
M-O$'@Q>SKTY5%W>O^9^E8C)?##CNG[>A45&>[2TU]-$=)_P5#_X*9^,)O"MY
M\,?@K:7JSWD1"WD'S(I&1SC'K7Y-W'A#XI^,?$4^H'P_>W%[=S%[@+"2SN>I
MK].?"/[*'Q#\9WXM'\(WEL[M@33VYPM?6/[,G_!,_P %>"[B+Q7XXTZWNKH,
M'4A0"/;I7O9'GO$?%&*O6PTE#9MJR3^9ZZS3@[PTRR<,+*,IM7LG=RZ>GXGB
M7_!&;_@FE#\)=(B^-/Q'T=7U:21+BQ+Q[6B4\XY^E?I5:R+Y>%B*A. *32-,
MMM#T^'3K"()!"@2-!V JQY)DR8SCUK]EP>#IX*BH0^9_,G$&?XKB3,IXS$N[
MEM_=78 2R$8ZU\-_\%)_V?[GS4^(VBV)?[+"S2^6F22:^YF@D"C8V#6+X\\!
M:7X_\-S^'=;@66*=<.K=Z\7BCA^AQ'DU3!S5F]4^S.K@_B/$\+9W3QD'>*=I
M+NC\_?V0?VS;WX52+X?\622W%H7 9%.-@'8UQ_\ P4:_;9\?_&?35^''PBU"
M;3K"]@*W9<;E+<X/&/6O0OC_ /\ !.3QCH6JW.I^!KZ$03N7\J.,DU5^#'_!
M.#QIXAOXY_%U]"+<-^]CECQFOQ; U?$7*:"RNC3<HIV3>Z7?T/Z$J2\+Z^91
MXCG6CS+7DU^+TMN>-_\ !+O_ ()PZ=KWQ-@^+?Q#TM+EK6[#R2,F-^<9(S7Z
MV:+IEKHNFPZ7I\6R"W0)$H["L#X4_"3PS\+/#D'A[0;-(U$:B8K_ !$=ZZPP
MR JJ-\@[5^W<-Y36RC+U&M+FJ2U?J^A^$<=\4RXMSF5>"Y:2T@NR7^8BNZJ6
M8_2GQ8()'>D,+,I5R/:G1QK&, 5]"NY\7N[CJ***!A1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4Y/:@.MB59%8X!IKX'S ].M9UQJ-MI5K)J>I7:000KNEED. H]2:^'OVW/\
M@N1\!?V8=3O/!VE6[ZQJ",8UET^Z! ;UQCVK6C0JXAVIJYE6KTL.KU'8^\E=
MF7S ./2CS@H+-QZ9K\.1_P '(WQ)/B$W<7A?6_[.5\[,<;?K7V=^Q#_P7)^
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MHH **** "BBB@ HHHH **** "BBB@ HHHH *1@I&&I::R%F#9I-7 :MNBON
MI[#Y< 4M%+E'<!P****H04444 %%%% !1110 4444 (ZAUVFFB+;P,4^@'/:
M@+V&&,G@XI8T"9QWI2'SP:49QR: N%%%% $(";BK+UZU6N-$TV8EWME)/L*L
MR.Q)Q34$S-R_'>H:4_B1-.<J3M!E:+1[&W!1+=0#UP!5KR$,/EJ,"E8?Q&G
M$C@@?6B,(Q=WN7*4V]7=" (JA=I-/CVX^6F-)Y9SC-.B"X) QFJU;N)*VP^B
MBBF!7>"*8GS5#>U'V:-(RD2!0:<JJ"VWCGK2Y('S'-2H+GYFM2>9<MDW82V4
M1':3R:FJ&,*9 VWI4U/WKOF"/+;0****904444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 604444 -$2#/'6E"*!
M@"EHI65QW8WRUI?+7TI:*;5Q"%%/&*%4+TI:*-@"BBB@!OEKSQUI0BCC%+10
M]=P2LK(3:,YQTI:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5$/X#,Y?[S#T)[?_ (]5^E6(_N#Z445HOA1;^,6BBB@H**** "BBB@ HHHH
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;4444QA1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>camp-20241231_g10.jpg
<TEXT>
begin 644 camp-20241231_g10.jpg
M_]C_X  02D9)1@ ! @$!] 'T  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" ;&":4# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ2^('CWPE9W7BQ[EG>+YO.C(YV^]?54UOF=&3N.: -..4L@-2 @C(J*VCQ$
MU2*,#% "T49&<44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 444'@9H CG; P:@52QP*6
MXD); />@'8NXF@!X@XW8J*6],+9F&,4Y;P=.:JWIMW!EN[E(U'4R,!0!,I$S
M>>G(ZBFLYFG#2< 55?7='$(M['4X)&'4)(#1;+//9L3+M8G@F@"T2LK^6IX'
M2KENAC3!K-TY75]KMG'>M7)"9'I0 TJV>E/!SR*!TYI$Z?C0 M%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !0
MW0_2B@C(Q0 B?=%1W/\ 2I ,#%-F7*T 4'!W=*>B2(/E6B9#GK3<7$8SOXH
ME^9QMDXJ"XLV^]&,U3O/$FF::W^GZC%'_ON!3['Q5H^J?)8:E#(?]B0&@"ZC
M-Y*Q,,$4]K-=A8FHRX!&>M2R3$18!/2@"2TC"?E4XSW%5;&0LQW>E6L@]#0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4GXES[TRZDVQX'I3YHF.9F? /051S(Y*$Y)/% $]OL6-KB4X5%+,?85\0_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MG%?.W_!-SX]Z=\8?@9HTL-PID^Q;B-V3TKZ&2U4W0=V'XT >6?M>?$UOA?\
M#R;7HY@C+;,^2?2ORK\/?\%:FD^.B>'[_7T">8P(\P=FQ7Z-?\%.+.6Z^"EX
MENV,6$G3\:_E$_:S^(/C'X7_ +1D]_I=]. DDAQ'_OT ?T_?$G_@IY\-_ ?P
M0MM>;Q%&L[Z>7^;;UR?>OR/_ &I/^#@'Q!%XUGA\.^)(3$K, 1,!WKY\^']_
M\??VH_ FG>'=*U'4BAMPA"IG@UZ)X7_X(.?%3QAX5?Q#K$=P\KDG,D SSSZ4
M ?3_ /P3Y_X+R)XV\31:'XF\30[I)E3'F ^GK7[/_!KXY>&/B7X!C\817X:-
MDSN7'IFOX^?C_P#LG_&']A_XAQZS!)>I'%>%_DCP, 'V]J^M_P!F7_@M?X^T
M#X-1>!8+^\-U]T;7Y^[CUH _6;_@I3_P5^\"? :&XT+3_$\:7"!D"LRCD9]Z
M_,"7_@X*\2KXN+3>)HOLVX8/G>]>*']F']I?]O+XEC7[Z_U0VEQ>>8!)$"-I
M'T]Z])^/O_! [X@>#?A8?$=N)3,A)++ ,\#/I0!^@G[$W_!<CPQXVU6PT;4O
M%$)-RZJPW*:_5CX6_$O0?BIX6@\0Z'=B7SNA&/3VK^+2\TSXI?LM_%*RM)]4
MNH_(N\ 8QTS7]%7_  0+_:PU[XK>!=+TC7;Z64FW!/F'_9H ^^OVF?&%WX!^
M']_KL#[3! 6R3BORC@_X*VZCI7[1DO@_4M=18DEB!'F>KD5^G?[<]PA^$6IV
M[M@36?!K^5__ (*!^*-=^&G[1VHZUHM](I%P@!B]G- ']*WQ6_X*2?"[P)\#
MT\4-XBC%P--23D+U*Y]:_(K]J3_@X'UN/QA<67AWQ+"8EE&,3 <;O:OF+X2>
M._V@?VK?"T7A.RU#4VA,*PX"Y&,8KU7P]_P0F^)?C/09=?U1)VD:!VR\ SD*
M3Z4 ?2?[#_\ P7K&L74>FZ_XFAW2R]#(#W]Z_9']F7]I/P]\8OAW;>+HK]9%
MD@,A9<= ,U_(M^T3^Q;\9_V0?$4MZMQ>QI"[,"L6./RKZ:_8Y_X+&?$+X:_#
M6#X?R:I>&=;5HA\_.67% '[1_P#!3?\ X*H>$?V?=.NM-TSQ#''.L.0&('.*
M_)[Q1_P<">*SXH;R?$L7EK*#_K^V:\9\9_"O]IW]OCXCPWXU/53:7#,"&C!7
M!(]J]*\<?\$#_B#X<^%X\37+2M.+=W8F$9X'TH ^Z/V"O^"ZVC>/9[;3_$'B
M:$EI "-X/>OU9^!?Q\\*_&K08[[1[]9F:+<=N*_B_P#$^F?%+]D;XE?87N[N
M-()7/W<=&K^@#_@W[_:GUGXDZ%#9:M?2.?L@X=O:@#]>!#<.?*C!P?>N3^+?
MQH\'_![PS<:OK^HB$I"S<X[?4UTOB7Q!;^&/#+:W<8PJ DD^V:_ C_@N;_P4
M\\4:3JEWX'\*:M/&QF:'$+^N: /H;]M'_@O5X2^'MW=Z5X>\50;D+  LHZ5\
M.^*O^#AKQ7?:PS0>)(=@DX_?5\+_  *_9K^._P"UUKXU*\O;^5+F9N7CSU;Z
M5]I_#C_@@9XYUK1DO;VWEW-'G+0=?TH ]S_9J_X.&\:K!9^(/%%N,D9!D!K]
M3?V,_P#@I;\-OVF-/2P;Q!%)*R!0$"]3CW]Z_G._:V_X)'?&/X%ZK-JFA17B
MI"F1Y4 _PK@/V)_VT/C)^RS\:[+P]KNK7ZQG4EC97X& /_K4 ?V,V%C;C"61
M)B(R#7S'_P %&/VDKWX ^$3J%G=",_9RV2V/6N@_X)R?M-VG[0'P1L?$,MR)
M)Y54'+9/W:^=/^"X.G7=]\-Y98W*A;)N?SH ^7?V>_\ @L^C_%#[-XD\1QK&
M%Y_> ]S7JW[67_!<CP5X4\')<:-XIAWK:Y/S**_G1^+7BGX@:'\5[BQ\+:O<
M))NPOD]?O&O<OV?_ -BG]IG]IBZLUU+7-2EMI2 R/$""#^% 'U7XZ_X."?$>
MHZFUQIOB:(H6!!$WO7TE^PA_P7RM?$NH)I'B/Q/#EY0N/,!KYBUK_@@?XYTS
MPF;_ .PRLP1CD0>WTKXB^/7[,GQ3_9!\7?:8Y[J%4E+9$>* /Z]OV:/VG/#'
MQX\-VU[IFHI,TB[OEQZ ]J]=NIU_L]VDX '45_/%_P $'OV^O$^J^(-/\(:O
MKDTA6) 5=_7C^E?T&VMZFL?#^WOHV ::T1LY]10!^;G_  5"_:WTKX+ZA<>9
M?(I2YQ\^/[U<[_P2^_;FT?XX^*(M'_M")]]V4^3'][%?'7_!PE+XF3Q5J$-I
MJ<BJ+T<+_OUQ_P#P;PQZS-\3;47>ILW_ !,V^]_OT ?TBPV4::=');DE1R3[
M5Y'^U!^USX$_9WT&;4]5U9(9(8@WS >F>]=[XN\1-X4^'US?/)N,=I(RG/<+
M7\\7_!:3]J/XU?$/QQ=^$?"$^HB.170"$9''% 'T'^U]_P '#6AZ%J,^GZ!X
MJM\JY ^=17R1K7_!P'XLU35S/'XFCQD])_>O#/V7_P#@D]\>OVE+V+6/$+7Y
M6?#'SH!_A7V3IO\ P;<^(9]$6\,P638ORF$9Z?2@#-^#/_!P9J^E:[:KJOB6
M$1O*H.9@>*_5K]A;_@JSX!_:,N;'3Y/$,4DDX487;["OP*_;?_X)'^/?V=]+
M.JVKRCR"6RL0'3\*\F_X)Z_M<?$7X$?'/3]&O=7NA'#*P*DXZ.* /[*K&]M=
M6M4OK5]R.,J:F,:D8KYV_P"">'QON_C+\*=.U*YE9V-D&)8U]"S%UX!- "B
M%_QJU$@4<54@+EN<U<C5@.30 ZBBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MUGQ?%8>+;VU/[V $D ]AFOU,_:%>#3/@3?V]P<>79J,?05P_[$G[)VB_LX^
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M_P $Q[G7#^TE;?:]0D8;QPW^_0!_5]\$_&;>.?!MOJ$DFXO;ALUUEW"8=,(
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M^#=CQ9<Z:LUS;S*=N?F@'I_NU\N?ML_\$C_'?[.MH=>L)+@?9U,GR1 =,^U
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MQC=.>% [&OLW_@W-\RUCTR%&.!;#O_LU\R_\%O;[SOBA$=O_ "\/_)J^G?\
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M&GAC1K*.SL]-AVQ+C_4K7S[_ ,$K98S^S=9-"H7Y8NG^[7TN)Y"Y0,3GK[4
M>3?M#?LG>!/C%X<N4NM'B>5T/2!?2OYE?^"OO[)MK\ ?C6=>TRP\@1ZDSJ0N
M.@-?UBF,+&\?VG.4/RY]J_G'_P"#BK2BOBZ:</\ \O#G_P!"H ^B_P#@W'_:
MPN->\,Z7X.OM0RHQ\I;/;%?5_P#P7$OUA^"K75E@F73&.3]37Y@_\&U%\_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!DL*R@;ATIC1A5^3M4CGM0
M(^>3Q0M+L+M,I:M#)<:7/"HY:,@5\/\ [4_[/7BGQ%XODU6SM-R[3SS7W3<P
M[TVAL UAZKX5TR_R]W:I(3_>%?.<193+-:,5'HSZ7AOB2MP]BG5IQ/S63]E;
MQM.#FQ_0U)8_LD^-C/G[!^AK]$[CX:Z*BB9+2,9YP!18^$]%M3O.F1M]17C4
MN$*D*>Y^B/QCQ_(H\J/SL\3_ +*_CC3],>\:SPL29)YZ5\_Z_P"&M0TWQJ]K
M<+A@/ZU^POC/P+I.O>'[N".SCC/E$8 K\V/VK/AY+X'^(MQ>1PDJOH/>OEL^
MR:>#H<R5S],\/O$2IG6)E"M9/9'!Z=I,\05G';UK=L;*:4!&'%8^AZS;:J%C
M\Y49.,9K>CG\A-H/XU^59G2G&HJRCL?H.*K5HUU>.I!<6AL$;:,;JA@U)%B\
MJ<]*34KR42@E21FJ%])YJ[RFP>M8QQ*Q4DJB+HJ6(J6FB+7]=M+*SD0L<,*Q
M? 4+^*==:RT^,DD#''UJ;756]9+&W3S&D&..U?0O[$?[.]QJFNQ:G?Z8?+9!
M\S+QWK[?(LHI8JJHVT//X@XIRKAO R<G:>RT.>\/_LQ^,=8@6:.S.&&0>:TU
M_9+\7V\N^2Q/Y&OO_3OAGH/A_3H0+2(D1CC;6CI_AK0+OF32XNG<5^D3X)5>
MBI16A_/N.\7\76;II==#\[KO]F;Q)#=(HL&Z>AKZ=_97^%>J^%;:)[NW*@(.
MWM7N<_@OPU+<JQT>'C_9K9M-)TVSM0EI9I'@?PBNS*^&/J57WEHCYK../L7F
MN&]E.(DMI//:!8^R@4V+3)UB7S0*6&>2W;826&:E?4'0 F/.>U?8QHPII<I^
M?RI>V?,]R:UM-G&*FEB&*9;7?F]4Q3YYPBYQG%5S)"4'3(8[<"8,!5V)-HS6
M=%JA-P(O)'UK1ADWCIVIII@Y<P^DD&4(%#?=H)PF3Z4Q&;+"YF)8?+7/Z_\
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M].^)'AR[T'4;='5X'4!QGJ*_G3_X+T_\$YM1^&GC2Y\:>#M,<;(&DW6\>.6
M/I0!^T'_  3#_;&T3]H;X9Z>1J@FF^R[F^<'M7._\%C;>XN?@=JY1<J81_Z
M:_$C_@B=_P %'/$WP3^)-M\.O$CS*J21P$32 =>/6OVK_P""A?Q&T;XD_LC7
MWB>W:-MUE"3M.>L1- '\_'[+,0'[9<D3#E=9B_F*_J9_9+6.'X.V+S'Y1;0_
M^@5_+=^S-!O_ &U+B>,<?VU$1C\*_IY^ EY<Q_L\03VX*N+>'&.OW* +'CC]
ML/X8?#K5Y-,UO5EC9)-I&\5B7G[?_P $)!NAUX'_ +:+7X/_ /!8G]I?XV^"
M?BUJ-MX>N-2"B^(7RG KXW\,?MC_ +2MQIYNIKG63ANAD7_&@#^JR+_@H%\"
M@BI/KXR>G[Q:]#^&?QZ\ ?%FW6/PS?B4O]W# _RK^0K6?VR/VEEU&U5+K60&
MDYQ(O^-?LY_P;[?%_P")?C^YTU/&%U>D,!N-PP_I0!ZK_P %Z[=E^&;"0?+]
MB?'YM7XM?\$W((O^&D+?9_?'_H5?MO\ \%^5A;X1KL(W?8'_ !Y:OQ&_X)II
M+_PTE;A@<;Q_Z$: /Z@OV-Q%#\,K$G_GR7^=>M7302Q2LO7RS_*O)_V/%V?#
M*Q9ES_H2UZRZQ/%)(" ?+/R_A0!^+G_!P%&HT6XW?\^[X_(U\ _\$7&'_"[K
M-?\ 9B_F:_0G_@X&LS+H4[(/^79OY&OSZ_X(P(8?C=:*8L_+'S^)H _IU\&1
M%OA-8)&.NGQ_RK\'O^#A>:>RU+4D4C+71'_CU?O'X0!_X5)8;>"=.C_E7X$_
M\'"#2'Q;?I-<$K]M'!_WZ /F;_@AI^S39?%?XPP7^K6'F!=5;DKG^*OZ</A-
M\#?"7P[\(V=C::;&K1\<Q#VK\'_^#=^'2[3QG'((T+?VCG_QZOZ%T1K^PB:-
MBHW=J .3_:%\30^!_A5?ZI:*L9BB!!48QP:_E@_X+4?&;5_B'\9;C3+B]9HC
MJB<;CW>OZ>OVST>+X&:LH?<?)&/R-?RB_P#!5,/<_%N_"#:\5X&![G#4 ?H;
M_P $#_AO\#]'\/VVK>-4CW?:@S%MO=B>]?LQH'[2_P"S-X M?L.FWD"A%P/N
M5_)+^S1^TO\ ''P+IXTWPF-3$8?AH' '!^M>C:]^VO\ M1PSDO<ZVV\XP9%X
M_6@#^HW6?VC_ -FCXAVSV^J74#JW!X2OP=_X+O?#3X&S^)#XG\'*H=+LR KM
M'0GTKY0M?VV?VG["$L-0UM2><>8O^->9_&[Q?\?OCI'"-9359 6R?,(.: /T
MC_X-U_VBYM)\7:=H3WY$:WF "WH^*_H"\2Z7??$3P'$+?#K<VY#<]C7\SW_!
M%?X1^/O"/Q"TV8Z==)^^R3@?WJ_I&\+>,5\!_ J'6]=N!&UOIQ?$IQT- 'QM
M^T)_P3:^''B#Q-+XH\:Z<I7DL6Q]>]3>!?VD_P!DW]E/23H<5U#%+:1[,$1\
M$5\)?\%A?^"TFJ^&+[4?!'@F5_.PP5K:7GT]:_+G4_$O[6G[1MQ-XCT[5->2
M.4^8H1E(8&@#^AOQM_P78^ V@6TD=IKT( R!PE?!G_!03_@K#\(OC?X1U"Q@
MU1)"UNP&%7O7YJ>&?V1_VL/&EPMI>C7@'/+,%KU:[_X)5_&6R\&S:[KVIZEC
M[/O*RH/7Z4 ?.?PDU?3_ !9^T-#?Z,28VF0C_ONOZP/^"1-PL'P*L8V;YO[-
MC R?<5_*Q\+_ (8S_";X\PV%XY:1)4&QA@_?K^IS_@D%;-??!>SN&GVA=/C.
MW\10!]H0EY%R]2#/<TUE#+A#CZ4D);D&@!]%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %(/OGZ4M(/OGZ4 *W0_2J\B,Y(6K#=#]*@=MI)
MH$]C*UGPK9ZJA-Q"K''I6/#X"TI',0MEX]A74E9%4G<3FH8H2LYE(Z]JUA7G
M2^%F,L+3J_$CF9OASHT=P"UJ.?\ 9%>=_'[P)H%MX9GE$ !$3_PCTKVN>W,]
MRDF<8'2O-/VA[%I_#=PB_P#/)_Y5WX+'5GBXIO0\7.<!0A@)VB?C'^UVEK%\
M16@B'&YAC'O7G \F.R51Z5ZM^V3H4UEX]DO-I8*[\?C7DD,ANK4$QXP*_9\K
MC"MAT[G\-<5Q^KYY)R5ES7*@@#$X'>IHXU0<TV)&=BN3UJ26V(3ASTJZD.5G
M@8W%1KXA-/01TB/2I;F0B&-%_"LZ9YXB1M)I\E\S>4A3G-7SJ$+MFKC"LHJ.
MNI]A_P#!.'PU%J'B2S::/.7_ *U^GNG?#W3)-$M=]N.4]!7YQ_\ !+O3GNO$
M%D[<#S!_.OU(MK<PZ3:QKD_+7YCQ/F-:-?W=C^M_"G*</')Y>[JW?\C%TSX=
M:+$,?9AG_=%6Q\-M$ED#&U7@_P!T5N6ML(R)#)GVJTDX!^YTKY/Z[4FN9O<_
M7(Y=24KN%C/T_P -V>C1C[/%MQTXK5M"N,&FRN)(\'%0^88ONG.:YI34Y7;U
M.J-*-/8OAD' -*"#T-45FD8]/TJ>%V[BJ+)ZCF7'(%/#>HQ2,RLI!H C1RIZ
MT]5S4&6:7:.E2R.(X]I;!- 'F_[3_C^Q^'/PXOM9N[D1C[)-@[L=$-?RM_\
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M=3))_P"ABOZ9OVQ?'6F^-_V6?[>6=)&FTF1NN?6OYA/BUJ+']MA&0Y3S)/\
MT8* /Z</^"13QM\$M-Q_T#5KZ^G5E!8=,5\@?\$B)(Y?@3I;HHR=,7^=?7#3
M2M*8F0@8ZT ?CE_P<K+YG@"V8?PVS_S>ORR_X(JRM)\8[%3_ ,]?_9J_4W_@
MY<!7P!:>6<YMGSCZO7Y5?\$6IDB^-=BID&?-Z?\  J /ZJOV=I)5^&FD@?\
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M_B:-_P"AUL?\'"NHM#K-Y$T61]N S_P,5SO_  ;CW]I9?%*SE:52?[38X/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@!K]J=110 V09%5IT/I5LC/!II11RQXH>H$$\9,
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MKDAW-I*_]\T@_P""8VL/<(QTD<-_=K]28_#>F@X&FQ_E4O\ PCVE)@G38_\
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MG+QYK<^&OP?\+_#JV2+2[""/8,#8N* .%_:Z\'7_ (G^#6H6,,>YOL6W&*_
M+XX_\$^_&OB?]H27Q%!HY*M=Q-N\H]I":_I<UW2K'Q!IDND7,2%95VG(KRV?
M]COP#=:P=1ETRU+Y!R8N>#0!Y#_P2]^%FI_#GX;6NGZC!L*01C!&.E?7MQ<
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MN&33XU(^BUQOA;]D'P#X,U@ZAINF6JL ,%(L5ZI8:0D>G_83PJJ% H _%?\
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MF*K*5 K0MXV506- $E%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4]Q$)DVD4V"V$(/.,T 5M2N+CR\0-@YJM8M=-Q>-D$]JTI;97'%1BTVG/]*
M()X-OS6HP:16D9,2C)JZD (QVI?LZ>OZ4 9+)>+)F,\5.Z"5,2*2:O\ V=/7
M]*/LZ>OZ4 4(5D&4D^[V%+*TR1%+9L5;-MSU-'V?W/Y4 5$0R ?:>2.M.D:<
M/BV.$],59^S^Y_*G);@#DT 4I;9I$).-V*2VMW^RF"YYR:T/(']XT>0/[QH
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M/$8Y#WJO'#''N!7K6DT /-1FU![?I0!2B6-6X%/>23(\H]*L&SQS_2E2U]:
M&0W%QG]XV:;=B25U:,_6K*VXIPA7UH @AD:-<$TTRW&3M:K/D#^\:/(']XT
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MKP*<<4L;(YR6H =^^WXW<4%I(V&\YI6W*-\?-.P7&6'TH 4'<N5- 8-TI$W
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M:* "DWBEI-HSF@!2 PI.%'2EHH ;]X@CM3J0 #I2T & :*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBC(]: "BBB@ HHHH **** "BBB@ HHHH
M**** "B@D#J:,CU% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MA8 X-  &300&% "%_2AG(3-(5([4V0;DVT /C?>,TC2$-MID+!.,TI7<^10
MYSD@^U)2N,$#VI* )**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "F
MM%&PY IU0S-&(V4L: !H;<#C'YU&RPJ<;?I4.+?C;,<Y]:AUW7='\/Q_;=5N
MO+1%Y)]* +^/W8 %,\ILYQ7E?C']LGX-^$)3#>^)D0@X(*C_ !K*T_\ ;]_9
M\NI!')XRC!/^RO\ C33L![9&Q0\#-2!MS ]*X;PI^T/\*/&!4Z%XA68R?=&!
M_C78R7>^T^TQ=",J:&[@6Z*K6-Q]I'/:K!<!]E(!:0D8^8TI&:KWQ8KL4\T
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *:R]Q3J* &*I:GX&,8HHH 38OI1L7TI:* $"J.<4M%% !1110
M 4444 %-926XIU% "*"!@FEHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M:4).<TZB@ &0.31110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !28?U%+10 F']11A_44M% !1110
M 4444 -+G/%*IR*6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ /(Q43Q*P*-SFI::8U=@^>E '(?$GQMI7P
MYT2;6]2D39'&S8+8Z#-?E'_P4E_X+>>$_ TMWX9T.X99%4KF.4]1Q7T9_P %
M>OVHI_A5\/-0LH;T1D12I][';%?RS_M/?%W7_C/\5+N:/4992;N50!,<?>H
M^@/V@?\ @JG\:OB-XCGE\+>(KX(TF52,$XYKSVU_;]_:4TM_M5YKNIJJ]VC(
MKZK_ ."2/_!)&W_:6NEU77].N)!+ '. 3VS7W?\ M!?\&[G@W2?AK<ZKINB7
M.](EY\LC^$^] 'Q%^PA_P6(\8Z'XHL;'Q9XBN"HF0,)7(K]^_P!C#]N?P/\
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M?M:?%.WT+4VN9Q.P)_>,>K?6@"2+]O?]I*\O'U27Q#J31AMP.P]*^DOV&_\
M@LI\0?A_XXMK+Q5KMWY:[0WF,1WK]!/#W_!NCX-_X4VNL2Z-=>:^G!\^6>N?
MK7Y1_P#!1C_@GM=?LM^)[N?0[:YB\A^"68=#0!_2=_P3T_X*(^#_ -H[PW#
MM_&\XC5>9LG)Q7U_<1.8Q-&>I[5_*)_P10_;6U[X2_$B#1-;UAT0WP4"28G@
M8]:_I[_9S^..E?&'P9;:M:7:R&49R,>@- 'I-I%(R A^@JRH_=@/S5>PD<A@
M?7BIV#LN<4 &3ZT]6SP:@Y!IX.1F@"6FC[YIU,;[U #+HG!Q5>%G\S!_"K3+
MYG6F+;[6)Q5)JP#LMN'TI: ,\"G!/6I ;DCH:D'3F@  8%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %,;J?K3Z0H"<T ,HI^P>IHV#U- #**?L'J:-@]30
MRBG[!ZFF.H4YS0 HCW<X%->,CD4&X5.":7S0XP* &+(HR';''&:IR[YK@#S
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQ.T[Q'J-N\FR]5R73/7\*_J$_96^"]G\$_ %GI$=JJ&(8QMQV KYE_X)@_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1>M<^(M'LW9GW'S8R>]<>G_!++X!1G/_  C6E^_[@_X5].BQPVX4/;3'@&J
M^88?^"7?P#2XWGP]I9&?N^0?\*M:C_P2_P#V>=0M_)'@[25)&-WV<U]#M:W/
MG'FK=O#(HR] 'S+IW_!+;X!6.5?PKI3C&,& UT_P_P#V O@M\/=8CUS2/"^G
M1O$>/+A(]Z]U?*BA49H3F@#(ET?3DT9O#RVZ?9VCV;,<8KQ;QI_P3T^"/C_4
MVU?5?#.FO(Q.2\!)YKW5[)F;.*0^?"=JT >2>!/V+/A!\-YHY]"\,:?&Z$'=
M%"17K-E';Z=9BSM8E55' %2PPRR@EN:4VA)QB@"&&<@LL@W*W4&N'^*/[.7P
M\^+<;P^(- M)!)U\V/->@1Z>W7%2M:M&N10!\S0?\$OO@+'>M=R>&-,;<V<&
MW/'Z5WWP^_9 ^$_PTN5NM"\-6$3(./*A(KUP0N:22T8B@"@L=M9P);6<*QJJ
MXPM$:F0@/S[FK!L&# XJ2*U(;.* )UC+JK!L;1TIYS)P.*<J@+CVH"X;/:@!
MIB).0U$@W?*>W>GTUP<YH :, 8 KD?C2PC\$WC$9S:R<?\!-==7(?&W_ )$>
M[_Z]9/\ T$T ?S,_\%U&\OQ-J"@=1(:_,[X(+N\<61W8_P!+C_G7Z8?\%V?^
M1IOO]V2OS0^!W_(\67_7W'_.@#^FS_@A=AO!M@"/XXZ_56 B50FWITK\J?\
M@A9_R)UA_OI7ZKVG2@"6/A:=2)TI: "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ (R,4
MUUY'-.I&ZCZT 87Q%_Y%FX_ZXO\ RK^<?_@O:KOK=VP<C!?@?C7]'/Q%_P"1
M8N/^N+_RK^<C_@O5_P AB\^K_P!: /R ^&,@_P"$J@4KG]ZG/XU_0W_P07</
M%9(%Q\Z?S%?SP_#+_D;(/^NJ?^A5_0[_ ,$$_NV/_71/YB@#]M4B;:,N:>!@
M8S0GW12T %)L&<GDTM% ".I88!H1=HQFEHH :0%)<FLW4)':Z$HEP /NBM-E
M##!JE=6!=L@4 <?X[^#OA7XDV36NMV4$@=2#YB9ZUY'=?\$RO@)=7;7USX5T
MN1RQ.6@-?1<5G(@S3O)E8XS0!\U2_P#!,#X SMD>%-+'M]G-"_\ !+C]GYEP
M_A32C_V[FOI<6\@/44Y89,\4 ?-2?\$O/V?H^GA'2@._^CFK>C?\$T_@!HVH
M+J5MX/TH,OI;FOHQX'*D4VWMY%7#=* .4\$_#[P]\.M-?2/#^EPP1NFTB%<#
M%<[\1?V9?AW\5X'C\5Z-:7)D^\9X\YKTJXM@W05']DDQ\M 'SWI'_!-/X!:)
MJBZO8^$]*217W!D@.<U[;X/\-Z;\/]#CT'2($2&/[JQC K82*?[IISZ>9/O"
M@#/N9VO+I)1\H0\CUK.\9>!/"?CZP;3=;T>WE#9R94SUK;.EE6R!]:EBTWG=
MB@#Y[\0_\$V_@)XCNVO+OPKI99V).ZW-6?!__!/3X&>![Y=1T_PKI@92/N0$
M=*]^>S;.*!8EUP: ,+2]$T3PW8+IFA:7%;(% _=+BM32?.B;]XY?CO4C:9M;
M.VK%O:",9Q0!+M9R&SCVI3&#BG  # HH 0C(Q2",@YW4ZB@ QSG-%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %<?XKU"X2X:*%CG..#785
MS.M^'[Z\O#<0L  V351G&#NS&M!S<;=S TZVUA;M9Y7DV]\FNGOB\^F*L;_,
M%[4*$73F1E^8=ZS+?5R\KVZG[GK6=2LK:,WJU5R*F]SA/BS\0F^&_A2XUR^O
M"GEG@.WUK\]_V@?VS/%^O>)OLF@WLVQ9\$Q2=J^@O^"F7Q97P]X5O=",I.Z/
M.%/M7PWH=IH]W"-5FA)><;E^M?)YKF:IR<8R/Z:\'^$<+1R*6/Q%/FYGU^1]
MR_L&_%_Q#K45N=>U"8Y;YO,?->G?M9?M.:9X,\-?9=-U-!*\)!VM@YR:^:/V
M3M2N=!T9-4EC<1*>ZFO(OVBOB#JGCWQK)IL=P3'%<E<$=!C_ .O7G5,S]KET
MXJ7O'#C.#*6<\63JTZ=HQ:VVW(?&/QF^(7C6:2XL=6NP&8X*2UBZ1XW^*7AZ
MX.I2ZY?%8SN(:7BI;+4-,\*60TUDS..?E-33:K/=V;Q7T3[)EPN5/2OS"&)Q
M,,P]M[1\J9^V4<)EN#PZPCHP=]G97/J']C_]M6YO&M_#NNZAEQC/F/DU]P>'
M]>C\2Z1%J%O*#NC# BOQBT<GP-K<.NZ=\C>:HS^-?JA^R'XY7Q3\.[>4R%C'
M:KO^M?L>39K];48IZV/YR\4.$OJ,ZF.A&T&].QZTMM<&$/D_A5*Z@O6E78S\
M'L:T8M322W"(2#[T\))&1*YR/:OJ:D5;S/Q?#8A3I<MM1VCQ7",/,S^-:HZ<
M^E5[26-U#**G9@.#44U)+5&;7*]0^3VI%)'!'%*0HY(I>M:@(6 Z<TGF>U+L
M7THV+Z4 )\A^8@9I"P(P%IVQ?2C8OI0 T)NY(I>$^7&:=2!6W9)H ,+W J.6
M!7/W:D9=W>EH C55C7  HVYY"_I3@AR=W-.  X% " C &:&.!G%&T9SBE(!X
M- "*P/'2ER#T-)L7TH"@=!0 $ ]10% [4M SCF@!H?)QBE<X'6F[&##!I74L
M.* '=:1AN&*4<#%% $+MC@5R/QL_Y$6[_P"O63_T$UU[*2<BN0^-HQX&NQ_T
MZR?^@F@#^9G_ (+L_P#(TWW^[)7YH? [_D>++_K[C_G7Z7_\%V?^1IOO]V2O
MS0^!W_(\67_7W'_.@#^FK_@A=_R*-A_OQU^K%ITK\I_^"%X(\'6#]@\=?JQ:
MC:@8]#0!/103@9-'6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *1NH^M+2-U'UH P_
MB+_R+%Q_UQ?^5?SD?\%ZO^0Q>?5_ZU_1O\1?^18N/^N+_P J_G(_X+U?\AB\
M^K_UH _'WX9?\C9!_P!=4_\ 0J_H=_X()_=L?^NB?S%?SQ_# 9\6P#_IJG_H
M5?T._P#!!-#MLC_MI_,4 ?MNGW12T@&!BEH **** "BBB@!&.T9Q2;P3@BG$
M ]:38OI0 #:>!B@X SBE  Z"@C/!H ;YGM3LCU%)L7THV+Z4 +D>M(6 ;::
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M\$$_NV/_ %T3^8K^=_X7?\C=!_UU3_T*OZ(/^""?W;'_ *Z)_,4 ?MK1110
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M?JW"Q$*XH D8$C I1P*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I&ZCZTM(W4?6
M@##^(O\ R+%Q_P!<7_E7\Y'_  7J_P"0Q>?5_P"M?T;_ !%_Y%BX_P"N+_RK
M^<C_ (+U?\AB\^K_ -: /Q^^%W_(W0?]=4_]"K^B#_@@G]VQ_P"NB?S%?SO_
M  N_Y&Z#_KJG_H5?T0?\$$_NV/\ UT3^8H _;6BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *XSQ3?M!<RO)@+'SFNSK
MEO&&F)=6%V54;O*;^58UYX.$;XB5D73]I[1*/5ZGS]\</VW-'^$1DM7OXE95
MSA@*\CN/^"I=I>C$5_;XQU&VO%?^"@>EWD7BV99XV,>QL\<=J\<\!Z5X.FM5
M6\MXBVWYLL*_.^(N+*>5I_5IW/ZLX<\,>$<?PY2Q.)I.4GO:Q]?W7_!3ZUL;
M8W3:E!Q]*DTK_@J_ILK#SKJT8#^\JG^E?*FN>$?!%W 4CMX-I[;A6;!X6\"P
M?NUL(L^NX5\MA?$7,*\5S3_,]^GX4>':I-NA+F^1]I7W_!4[3[JUW6:V)]Q&
MG^%4X/\ @J;#.WE136@9>" J_P"%?*%EHG@>RM=KVL)]MPJC<:7X*L':[2TB
M'?&[K14X_P T]IR4))R>VYQ1\+."JE[T9.738^QO^'GS(V^XEMMON%_PIU__
M ,%-?,MM]B;1CMY.U?\ "OBF_P!=\)7EF4@TU0<]:=X=U_PK&)(KJP7GIDU<
M\WXRJT?K6A>"\(N'L+AI.I1?,_0^R?"W_!2=+K64.L74$:,P'&/6OK+X1_%S
M3/B9H:W]E<(^8P1M K\=?&3Z3.D<NB1*K><N"ASW%?H?^P9JMW#X1ACF5AF%
M>2*^PX7SO-<RQ:6+WL?$^(?AUE&2Y!]:HQMY=3ZE6XFBEV/G ]35LWRK$?FY
MQ3+&R-Z@FWCGM3I[9(5*.GXU^A5)TIUG3D?S=3BG0O$OZ/=>:@YK1!!&ZLO1
M8PB@ "M3^'CTK*-'V.@0DY;C"23FI!R*800,T\=*LL**** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *:R]Q3J* (ZY#XV_\ (CW?_7K)_P"@
MFNM<GI7(_&S_ )$6[_Z]9/\ T$T ?S,_\%V?^1IOO]V2OS0^!W_(\67_ %]Q
M_P Z_2__ (+L_P#(TWW^[)7YH? [_D>++_K[C_G0!_35_P $+Q_Q1U@?^FB5
M^K,9Q"IK\IO^"%__ ")MA_UT2OU7R1"H'I0!.K9X/6EJ.(DGFI* "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MR_Z^X_YT ?TU?\$+_P#D3;#_ *Z)7ZLI_J4^M?E-_P $+_\ D3;#_KHE?JQ
M<Q"@">D7J:0D^8!FE7J?K0 M%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]J '44 Y&<4C XX- KZBT4U<E<9H*,?XJ!CJ*:$8#[U*0<C!H$W86BF2JS<
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHJ.;>3A332N)Z(DHJL3*.I-1M-*!P33Y2>9EQ
MFV]J-Z^M5K65W)#Y_&H[H3'E"16;;3L:15T7=Z^M&]?6LN.6=6^<FK,=QD=:
M5V5RHLN0>E)5*:Z*'AJC6_).,U2V#E1H]*>K _6JD,^1UJ1)23_]>K<26K%B
MD9L<"F;CC.34;2D-22N(L45")3CC^=+YI]_SI 2T5%YI]_SJ1#N7- "T444
M%%%% !1110 4444 %%%% !1110 4C=1]:6D;J/K0!A_$7_D6+C_KB_\ *OYR
M/^"]7_(8O/J_]:_HW^(O_(L7'_7%_P"5?SD_\%ZP5UB\!]7_ *T ?CY\,O\
MD;(/^NJ?^A5_0Y_P03^[9?[Z?S%?SQ_#,X\60'_IJG_H5?T.?\$$N5L3_MI_
M,4 ?MRGW12T 8&** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M ,,O^1L@_P"NJ?\ H5?T/_\ !!3[EA_OI_2OYX/AE_R-D'_75/\ T*OZ'_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/^(&MHYQ&-P*@GD5^C\+T*F'J\CV/G_$?.N)\LRV57)(KD2U=KO[STGX _\
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M3/VTM2\8PQ2V5FD[(T?.R(D=*^SII8I3MD08^E<WX\^'7A[QEI\D4]K$\C#
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M5.R*[20._&:NQ_=&:B229C*5Y6ZBT445(@HHHH **** "BBB@ HHHH ****
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MR:>G3\::Y ;F@!9/N&N0^,PQX%O/^O23_P!!-=>YW(<5R'QGX\#7@_Z=)/\
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D(?L:6DR_H*
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M4YL6>8R5-'IC6^7VT27ZPJ5.,UHZLD'^SX5>Z6+,K&0I-:"D$<"N>M]4+7
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=^V/XTU7XKZEH-AK<HVR<!;AA_$: /W]'_!=;X#13-"T=N=K8S]I_P#KT/\
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MZD94'L/6OUK+\O\ J^#]I#<_C_BRI//^*X8*%3EC+J<LO[)WC^+2QJ:6-PJ
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M:_\ !'/X W:AK7PWIA/LM?F+X?\ ^#EC3_"?A.QT-?%<(-O;A,%A7L/[+O\
MP<<Z3XZ\10Z;J/BF$J^,_,M 'Z%?#'_@EQ\$OAOJ":A#X3T\NK[E*K7T1X;\
M)Z1X*L$T[0M-6%$X C%>5?LP?MG^ ?V@](6[M-862;8" I'4_C7M[W:A,I@F
M@"Q:12F/<S\FI05'R2<X[FJ4.IR1(TES@(M<KXM^/WPV\(2M%K6K"-E."-P_
MQH [@@/RO:DWC[I[5YA;?M>?!EU)77AP?[R_XTU_VNO@R92#KH_[Z7_&@#U
MR;>GZ5R_Q?MY+OP1?+"?F^R2YQ_NFN;3]K'X,OPNN_\ CR_XUD>/?VK?@T/"
M]\KZX.;20#YE_NGWH _G*_X+J:;<VOBS43,Y/^LZU^:GP,#'QO9%?^?J/I]:
M_2[_ (+E?$?P3XT\1ZA/H5[O)#@8Q7YI? ^41>.;+9WNHQ^M ']-7_!"YL^"
MK#C'SI_6OU8B_P!2OTK\J/\ @A>''@NPW]W3^M?JO%_J5^E $M%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^%>0?$;]GKXP_LTZBUP(M0@:!QEM@'0_2O[.;/\ 9?\ A9!HCZ-#H\?EO%L
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M]2OTH EHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M, ]111126X#9>!FJ\G*$FK$O3\*@D^X?I6;_ (J%+X3\[/\ @HB2;Z3)_C/]
M:V?^"69S86P/_/7^M8W_  40_P"/^3_?/]:V?^"6?_'A;?\ 77^M?HT_^27F
M?SWB/^3Q8/\ PR_.)]\VQ/E_\!IEQQDBGVOW/^ TRYZ'ZU^>Q^+[C^A:^Y'"
M 7&?6KB 8!Q5.#[X^HJXGW16U38SI[DJ]!]**%Z#Z45D:!1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M8*^;?^&<OB;_ - I_P#OT?\ "D;]GKXCH/*?29-QZ?NF_P * /HR/_@KY\<
M,CQ+J0_[:"O3_P!EK_@K;\7-:^*.GZ9J&NW[*[G(:0<\BOB,_LY?$H*&_LB3
MG_IDU>G_ +*7[-7Q%3XNZ9=RZ5( K?\ /-O44 ?U;_\ !-?XSZM\6O %G=ZI
M+(Q:UW9<^U?4L@$*_+%Q7Q9_P24\,ZUX7^&MA!J,.TBSQ@CVK[<5X9(/WAH
MIWVGVFOV+V%VBE&0@JW2O*]9_9"^'%YXB&OR>'+0R#/S%#GK7JP:&*7,9JVK
M^8N&(Q0!YM\3_"^C>$_A1J%E9)'$BZ>ZA5K^7+_@N$+9OBMJ,D; G#_SK^H[
M]IRVE'PVU%XS_P N3]Z_EA_X+3)*WQ/U M_M_P Z .?_ ."1UTH^)UHJKC_3
M$S^0K^K']C1P?@O:#V3_ -!K^4K_ ()'0[?BC:D][U/Y"OZM/V,T(^"UGG^Z
MG_H- 'KR-E./2A&SP:$ "]*4*!T% #9< 9QG':JMY-YMG-%&-I\IOY5:R%)5
M^]4IY$CNGC<\%2* /PT_X."/$/B72(IX[2UGE5HGX4=>#7X.:1\-/&_Q5\5%
M;+0[H/*1PJ<\FOZW_P#@H;^Q!\/?C_;%M?ME?=&<Y(]Z^2?V=O\ @C5\&_#/
MCB.]M=(0JNW'W3T)H _&/P+_ ,$AOCC\1-)34H-.U( H",0#_"N ^-7["/QF
M_9KG>_NM/U%#$^"YB Z'Z5_8-\(OV3_AE\/_  Y!IT6C1C]TH&85KY>_X*H?
ML#>!O'_PYN=9L=#3>WF-D1#L : /YN_V0OVVOB?\'OB+8:9>ZU>I&LV&#, !
M@U_33_P2G_;#L?B_\-=-CO\ 55DF>WR=[Y.=HK^7_P#;7^#<7P1^)<JV$'E,
MD[E<<=Z_4'_@W^^,OB>_DTW2Y;LE!$HQN/I0!_0[$V^-90=P89!I)Y.!E2#G
MK47AN0R:!92.?F:UC)_[Y%27R/)@+V- UHQ9,/&2%JH\D@8J&/L*NVZ8B/F5
M4E*&4JAH%=<P0/MG JAX@D;<N >M:*0LMPI/05!J-FMPPX^E)[%5E=:&9"X$
M?W.:MQQAMC%>_6GC3@IVD"I=8\O3=%EO >8XB<US.G*4DD3AYJFGS$6JW%A#
M 6DD4''4UYQXO^$/AKQ[,9YY("5.>17SW^U)^W _PUO)[#^T0A3.!FO"+#_@
MJOJ^GSNB:N,,?6OK<!E&/<?=9^:\3<8Y)@,7[+$P;5C[\\(>"_#GP]A&G%X6
M0?P]JY3Q_P#L=?#CXD7AUIUL]S,7/%?%NJ?\%--1U>4SRZL,?6E@_P""KFHZ
M)']G&L#G@<UW0R3,U4;3.3,.-N")Y5!3CTV>WYGU=I_['OP_\-WPA"6A*GKM
M->N>"OA5X6\,PQ/;SVZX (VU^=LO_!46_P!1N/MTFKC!]ZLK_P %6;V0+ FL
M#Y1CK6M3(LSJ*R9\WE?'W!L)M4Z9^G4:6$!\Z+4T(] :DB>UD!9;U?SK\Q8_
M^"JFH+)Y/]L]/]JF3?\ !6C6;1O+36!@]>:\V7#&-B]4?0KQ?X6PL71@W?M_
M3/TPN==M[6Y\A;M3[YJ]YANH@\<^1CG!K\Z/A?\ \%&KGQWK:07.JABQ&>?>
MOMKX'_$ ^.-'2X,N[*C&*X\1EU7#4FY+8^FR#B[!YY-.B[G=^2__ #T-%7?L
M1_NG\Z*\+E9][SKL:=%%%:G(%9VH6<+N#M&2>:T:K30AG)]ZRJJZ*CZG'^._
MA#X:\: _;[&%R5Q\RYKC!^R3\.G++-I%GSQRAKV,PL?F Z54DM)6DR3WKS:N
M64,15YI*YZN$S?,L-!QIU'%>3/(/^&.OANH*KI%G@GM&:/\ AC7X=-S_ &/:
M?]^S7L9B,0^:FB[C7ACQ6TJ-&@N6%%.WD6^(,Y6V*E]YY O[&OPXZ'1[/_OV
M:BO?V-_AW#$6CT2T)QVC->T+<1-RE#W*(I\W\*4*=";NZ"^XB/$6=0DI/$R?
MS9\_V?[(7@AM0!?0+;'KY9KHKC]CCX<W=JJG2K-2%_YYFO5HY%+;DQFI8IF9
M\5;P.&D[NBON.FMQ/G%5*U>7WL\GT?\ 9"\!Z3AH]+M<@\80UV_AWPG;^$T%
MK86ZJHX^05TLTLX&(SQ22RJR8/7%:4Z-'#2O""1YF+S#,<QM&M5<DO,JSW$G
MDY!(-5[8M*29)<_6KC0%XSNJO'8.6.Q>_6NNA-S;<CB]K'GY8HT]/1%C!7%3
MN2#P:KV,4T0 )XQ5K )SBFW<E*Q$ZN>A-+/%%+'MD0'CI3SNSP12.H(W>E(H
MIQPAF,*+M ':G0Q1V\OE>8"6J7[KEAUIJVT<DPG;[PH ^>/^"E:X^!MX /\
MERF_]!K^0S]OT&/XUWO_ %\S_P#H=?UX?\%+KA8?@A>ESQ]BF_E7\B/[?-Y9
M7/QEO2@^;[5/C_ON@#]4O^#?&+==:>W^RG]*_HBTO8=(M2>HMD_]!%?SJ_\
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MQ/U&//'[S^= '._\$AF,_P 4K8#^&\3^0K^K/]CE@OP6LR?[J?\ H-?R@?\
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MXC?M'?&&UU(V3S0S7;&0M&3G)K^F;_@D;^PW9_";P!INM:AI0CE^S\G9CHM
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M*(7EY)(=R1Y&*H^>Q?E<<]:GA>41E W&:>+&-ANDD4?5A5SDX+=&2<INW*)
M=W\=.F@,@R9*AN9K2S4D3QC_ ($*H2Z]"7")>1X[_.*=.O3:LVCI6"JSC>,2
MTLQADV;N*T++$G.ZLV*6RG^9KJ+)_P"F@I;C5[32H][W<8&/^>@IRJTH_:0J
M6$Q3G8VF 0Y/2ECAB;YE?-<A<?%;PY#^[GU"/K_SV%:/AWQ-%JK[[*<,A/9L
MUS2KTI2M>YVU,#BZ,/:23L;4[E)-NSCUILM['#A549(IVHR!8MR@YJG:JES)
MEQW[U:5MC"-&$X\QH6=V93C;5JH+:")#E14]49"%\'&*'^Z:"H)R136;/ H
MC8'=TIR @<TM!.!F@#P;]OOX<ZG\0_A)=:3IJNSO:RJ%0<\BOYMOVIO^"/\
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MK_GM)7YI? K+>.;/_KZC_G7Z4?\ !=CYO&%_CTDK\V/@1QXYL_\ KZC_ )T
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J"3IP*
MGJ!R?, /2@+-["[@B98U&\X=#M&?PITYC8!??FL7Q)XLT;PK;M)>RA0HR?F
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M<_IC)>.^$)5(T%A8WT/@D_M9?%.+4Q9N+H9?'^MKO-/^.7Q/U#2A+$UT2?\
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MJT" D=JV6 P.>:@L;<1H!FIF1BV2:P@IIZF$4DARX"TM)M^7&:6M@UN%%%%
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M$CTZUEW_ (BBMI?+*,<GM4L>K(\);RVZ=Q5RHU7)2MH9.K33LV?GW_P44/\
MQ,'Q_?;^M;7_  2X.--M_P#KK_6N>_X*"WJW^JR11QD$2$<CZUT'_!,!OLUO
M;6D@.[S,Y_&OO*E>C'AR5-RU?0_ ,34IS\7L+.+TC%I^K:/OJVYC&?2HW"B;
M.>U):W4;1[0<$"JUZ\D(,Q?BO@EI(_H.K[TFD68&19<9[U9 0S9S7+Q>)D%U
MY11L[O2MBWOVD(E'0]JVJ)M:&5!\]^4U,J.XI<CU%1(VY0V.HI:S29=T29'J
M**CIZ?=%%AW0M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MP=/Z5YV-IX2G2?/N=663E#,X3A+2Z/S'^)T\D?Q,54S_ ,?M?;?['EX[:=;
M("<#BOBCXG:7<I\13.TJD"\SBOMG]B6'[=86TZ<# X->!EU/!UJ[Y$?T=QQB
M\-5X1I<LTW;8^FH[]8H4S$,XJS%?>?&$*@51DM69E7(&#WJ7R_)(VN/P-?84
ML-3A$_EZG+VE6436LXFB&?6K=5K.99HU&.@JS5HNR6@4444P"BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *1NH^M+2-U'UH P_B+_R+%Q_UQ?\
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M\$..!1L;TIX.1D45ES!9L9L;TIRC P:6BANXTK!1112*"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]: /Q^^%W_(W0?\ 75/_ $*OZ(/^""?W;'_KHG\Q7\[_ ,+O^1N@_P"NJ?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1G[2FI=S^5ZU&IAZKIS5F@HHHK4R"BBB@ HHHH **** "BBB@ HHHH ****
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M,N=B&/UJ-G8C J_-9%F)P/RJ)[(A<A?_ !VNCVB(]C(SKD.UK+M&?D-?#O\
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M%(6 X)HW+ZT +1102!U- !11D>HI-Z?WA^= "T4F]!_$/SH# ]#0 M%%%*Z
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M:<,YQ[TOB/4QIVC2W07.R(GBE1D^96,\0HQIN_8^-_VM?V4M,\?WL\\UNY+
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M8<=_>HI(Y%Z&K"SJ#@@4X-&_4"J(DBI%(ZM@U.)&8 U(((\YQ3MB =*!QT1
M'D)Z5+&#NR:9N0-T_6I$VDY!_"@IRT'4444""BBB@ HHHH **** "BBB@ HH
MHH AF3+9R::BMGK4TBCJ335"YXH*YM+#U&!2.$;[QIU0RJ6.0V,&@FP.BX.#
M5>1)?X:G+;3R0:8UXB'D T"<&R"-)W?#]*MQ#8.#TJ%[R-AA5 /M3HG\P<5+
MBFQ*\-"1Y^<9H$H*DTQHSG/]*%7'&>M+V:8^=B^;_M?I1YO^U^E.\H>WY4>4
M/;\JGZO$.=C?-_VOTH24G@BG>4/;\JCD*1<G%-4+;![2/VB<;",DFD;:.AJN
MFH1@X(''O3VO(R. *KV,Q>TIDK$$9!^M03R.,XIPNE/IS2';*.!64I5H;#TD
M53=,AZT"Z+'DU.;5"<D"HWLB6W+^E1]8K)ZH?L8[DL$ZCJ:L"1'&2U4A;.O0
MFI%20<9-;PFZFY+]S8LDJ?NFE5<]>E10JRYW9I[3B(<UI8(RNA7#+T%,WLYV
M8ICWZ9QZ5')>(!E<4-- Y**N/G,RKP*I-=NIPQJ9[X2+M JNZ;GSMS4>VIQ^
M,TIT8UUS,L17P"Y)Z5,EVLIQFH;>) !E/TJ?8F/E2A5J$M8(3I-/1@\9/*FH
MY'G3IVI6$N"0IJ-DF8\DUC.K4Z(:Y8[LC:[N,_,,"E2[C!S(YI9(8U'[R4+]
M:@<Z:AS+J,8]<FLFYU=)1L:*5-[2+BW<;?=:G>9,_P!T?C5 ZOH%O\KZK#_W
MU3)?'OA6T!5M7M\C_;J'3P]#WG,(PG-^YJ:<;S(?G%3))OKEKSXL^$+8$MJM
MN<?[=8>J?M$>#-.S_P 3&VX_VZSEFF6T5[U0ZZ>4YC7^"DW\CO[E+C=^[&12
M)]HVX([>M>,:[^V3X.TP&-98']P__P!>N+US]O#P[;EO),?X/_\ 7KDGQ%ED
M'=5(GIT.$N(,1I&A*Q])7CS(V[O]:B&H*B[IWP!Z5\@:Y^WW8.Y\IACV?_Z]
M<UK?[=+7,>R"X*Y'9ZY*W&&"IQ;4DSW,+X7Y_B&G*FS[9O?'6A6(*W-UC'TK
M,N_C)X*L%+2:CC YZ?XU\!>(OVJ=<U<LUOJ4@STPU<9K/QM\8W^5BU6X.[T(
MKP\3QM1?PGUV!\(:\H_[1/D/T0U/]I[P':.5;50 /I65/^UW\.8,E]9'Z?XU
M^<5_XE^(6J-^[U"ZY^E4&LOB->-SJ-V!]!7CU.,,=/\ A;'KQ\(LCA&]7&V?
M;^D?H-XK_;5\&1Q,-.U<$]N17GFN?MM70+M:7Z%/7=7R+9^ OB%J# F\NFS_
M +(K8L/@Y\0+HB(BZ;=_L5Y5;/\ -*O5GK8+P]X4P:]_%)V[_P##'MVN?MI:
MY.Y>TOU//'SU@WW[9'C.="@NU(QV>N;\.?LO>--3"K)!<#/JE==I?[$?BN]9
M3)+*H/J@_P *XU3S+':1J2._ZEP7E^KG%G,W7[3?BV]+-)?'D<8D-<[?_&#Q
MWJ[LGGDACQ^\->V67[!&M[%,E\P]BG_UJW=,_8>NK65/.N,@=25_^M6L."\Y
MQNJKRB0^)N#,([1A%GR_<:QXWO'W,6.[C[YJ>'P7XZU9/.2W8_\  C7V+IO[
M(=C;%/."-AAG*_\ UJ].\+_LZ>&=.T[;+IT+' ZK732\/<P@[SQ,OZ^1Y>.\
M3<AP,?\ 8J4;GP!I?P7\?:@1_H).>V36W!^S#\0;Q _]F'!^M?H+I?P8\,V@
M$@TN'Z8K=M_!7ANU0(-(B_*O3H<#)NTIMGS=?Q?E47N4;,_/;0/V/O&UW(#/
MI;?K74V7[%WB07""72CLQSP:^Z(=#T.U/R:4@^@J9(=):<1BP3I7NT.!L/3L
MV[GA5_%'-9WLK)GR_P"&_P!C:QL='#W&FD2-'CE.]> ?M4_LJ:YX>@GUS2],
M(6-3@X(K]'[G[.7\E(@%!Z5RGQ:\!:7XU\,3Z7]C1GD'7'L:[L3P7@U0NMSF
MR/Q&S+"YQ&5=^ZV?D+X9UC4[/4)-+UH[?).U1FM^X,DUT)X>1BO3/VE?V1/%
M>AZU)JVBVTRH9"Q$<?:O'6NM8\&W'V/5]/E8KU+BOR;B/A^IAYRC!:']+9?Q
M5EV=UE&A)7:1TS:S'+"EJ2-P&*E?3&DTXL1Q7.6GC'2[J8,8T4@],T_6?'DJ
M,;.RM&<$<;:^)PN1XEXA22ZGNU*5;#S4HNR,C4O%$NDM<V,1!+\#->F?L??"
MG4_'7BZWU&ZM2R,1SC/>LKX3?L_:_P#$S68[E[*54>0$[DK[[_9B_9HM_ASI
MT$\L*AU _AYK]DR;A^I6I1E);'Y[XA<:X#+\FG0HRO49Z_\ "OP?9>%O#MM;
M1Q[6$(!&*Z^J%@HC18@/N\"K]?JN$I^QP\8=C^2:M66(FZLMWJ%%%%=)F%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4C=1]:6D;J/K0!A_$7_D
M6+C_ *XO_*OYQ_\ @O7_ ,AJ\^K_ -:_HX^(O_(L7'_7%_Y5_.-_P7K_ .0W
M>?5_ZT ?C_\ #+_D;(/^NJ?^A5_0_P#\$%/N6'^^G]*_G@^&7_(V0?\ 75/_
M $*OZ'_^""GW+#_?3^E '[;T444 %%%% !1110 4444 %%%% !1110 4444
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M,=J7(4?.<&J7VTDY5<4_[5O[=:Q]HULC7G30ZXD+<)4$2F*82RCD5(22:?$
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M_KJG_H5?T/\ _!!3[EA_OI_2@#]MZ*** "BBB@ HHHH **** "BBB@ HHHH
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MD$V^I?K7S:OA+QK?@#[+<MFM#3_A%XTO5VC3KCGVKS*W%?$U57C0E\DSV:/
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "D;J/K2TC=1]: ,/XB_\
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M./[U:1XXX97_ "^_!G-/PRXEAKR'V$9%88+C\Z;B'KD?G7R W[?\8_Y81_\
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M]BM1_8.>XM^]?4=3C?@S#QM1GL?'CR:OJ3Y6.0Y/]TU9MO"7B+41LBMI.?\
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M8^6,UNU]M1J5*E-.:LS\)J4Z%*M*-)W284445H2%%%% !1110 4444 %%%%
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MAV8)%6:AMW+XR,5*QP,UA1O;48A0DYS3J:C%NHIU:Z7 ****8!1110 4444
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M=JG7M'2EX7U7M-?<=D?%W+5O2?W_ / /@!O#7B1.4@?Z^6:ELCXLL#@1R_\
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M2Q(TK?ZPC\:M3@BG3<OB+L=G&!D8_.I-C#C(J**V*X)D-3A=O -%Y=2+\NQ
MD<ID))XJ;8,4[R@1F@18J5!7O<=VR(8[U)%("M#0;N]+' $&,U2N2HVUN/!S
MR*1ES]:0Q@]#1L'K3&*B;>:6BB@ HHHI/8 HHHI)-, ^E-.\#DTZBJ B.[L:
M,/ZBI:* (]H8\BGJB@8Q1L'J:-@]30 I&>#28;L:-@]32T )A_448?U%+10
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M21C#+VK0KJY5%6.&-3VEW8****104444 %%%% !1110 4444 %%%% !1110
M4444 %%%!X&: "D;J/K1N^7=BD;D@T 8GQ%_Y%BX_P"N+_RK^<;_ (+U_P#(
M;O/J_P#6OZ-_B,^/#-P,?\L7_E7\Y'_!>O\ Y#=Y]7_K0!^/_P ,O^1L@_ZZ
MI_Z%7]#_ /P04^Y8?[Z?TK^>#X9?\C9!_P!=4_\ 0J_H?_X(*?<L/]]/Z4 ?
MMO1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&D750,*4'Y5/!>0R]2*2PM-&7)7CJV-C29>K=*D$+8SQ4A\IAUQ]*;)-Y:X
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MA!'78:Y_4M(N8[I+>W!5BV,8K],Q^P?H^G_#4ZDL)9@O=?:OA_X@> K;PO\
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MHH #P,T Y&10W0_2D3[HH ;-T_"N/^-8SX&NP/\ GUD_]!-=A-T_"N0^-/\
MR(]W_P!>DG_H- '\S'_!=92_B>_([!Z_-#X'#'CBR_Z^H_YU^F'_  72_P"1
MEU#Z25^9_P #_P#D>+'_ *^H_P"= ']-/_!#(8\%V'^^G]:_5FW_ ./=/I7Y
M3_\ !#/_ )$NP_WX_P"M?JQ;_P#'NGTH D?K^%.7H/I37Z_A3EZ#Z4 %%%%
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M^4S&C&IB[I']@U<)1_X@U5G%^];]&?IW8:LT,*%D8DCDXJ^VI?Z+YY!H@TJ
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M1TJQ]F]J/LWM5\VEC)I,DB.8P:=2(-JA:6LS1;!1110,**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *0D XI:8Y.[I0 ^H+AF0>M3(21S221AQB@"K%<LQ
M.WBG&1W/6GBT .0*>(B#G% K:C$A9A\U*+=5&=M2JNT4I&1@T#;=AO")D50N
M[TB3 4UH,N5VU6>Q#-DC]*-R.9CK*82#H:L4R&%8A@4^DE8I.X4444QA1110
M 4444 %%%% !1110 4444 %%%% !1110 4$9&*** $V_+MS2,,%13J1NH^M
M&#\1D)\-7!S_ ,L7_E7\Y'_!>O\ Y#=Y]7_K7]'/Q%_Y%BX_ZXO_ "K^<;_@
MO7_R&[SZO_6@#\?_ (9?\C9!_P!=4_\ 0J_H?_X(*?<L/]]/Z5_/!\,O^1L@
M_P"NJ?\ H5?T/_\ !!3[EA_OI_2@#]MZ*** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *0D 9-+02 .: 8QLMDK^M5Y6
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M-V39_:G!F?<-OAZG2G4IIVZJ)5DTOQA"FZ7Q.C'UW"H%B\6Y('B(?]]5M_\
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M/J(II[F@44$@=:"<<FJ **0,"< TH(/2@ HI ZL2 >E#NJ#+&@!:*175^5-
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M4  &.!1110 4444 %-WX)!IU(RYH -X]#2%QC@4FQO2E5.YI60"KG'-+113
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M10 4444 %%%% !1110 4444 %%%% !1110 48!ZBBD.[L* %I"P'44HZ<T$
MC!H 0,&Z4M- 93P*7+^@H 6BBB@!KDCI0'P.:<>1BH]C[\XH"R';B2 *=2*N
MT4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2-U'UI:
M1NH^M &'\1?^18N/^N+_ ,J_G&_X+U_\AN\^K_UK^CGXB_\ (L7'_7%_Y5_.
M-_P7K_Y#=Y]7_K0!^/\ \,O^1L@_ZZI_Z%7]#_\ P04^Y8?[Z?TK^>#X9?\
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M7ZJI_J$^E?E5_P $,_\ D2[#_?C_ *U^JJ?ZA/I0!83I^-+2)T_&EH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *1N
MH^M+2-U'UH P_B+_ ,BQ<?\ 7%_Y5_.-_P %Z_\ D-WGU?\ K7]'/Q%_Y%BX
M_P"N+_RK^<;_ (+U_P#(;O/J_P#6@#\?_AE_R-D'_75/_0J_H?\ ^""GW+#_
M 'T_I7\\'PR_Y&R#_KJG_H5?T/\ _!!3[EA_OI_2@#]MZ*** "BBB@ HHHH
M;("5X-5I))5; 8U9E?8N:HO=,9L4 3;Y,9)-13O)+&4#$4LUP43/'2JPNG<]
MJ 'W%U+"J1JY)-/?5K73+7?>W"+_ +QK.UZ^AT'2YM8O6VI%&7S7YY_M[_\
M!6/PO\&KNZTF#Q!'&\:G@L.U 'Z-0Z[I=_&S65[&2HY"MFFZ??2R7&225]:_
M'7]D7_@MBWQ,\>OX;37X9$>Y$>-X/! K]:?@GXK@\=^"8=<BD#%P#D?3- ':
M$#;N4=:6,97+"B/.W:>U!)+[.V* $VCEG&<53NM1\N0QHOXU=;.T@]/6LK5W
M6)-T'+9[T $NHSH,I&Q^E3VFI'RQ+=?(#_>JA>^(;+PSH\NI:PX1$3<21VKX
M?_;A_P""N?PZ^!D5SIEIXCBCDA8C#%1_6@#[O?7]&CD .H0CVWT_^UM,GYBO
MHVSV#5^!'B[_ (.,8+?6I(;3Q5 560@?.*Z7X5?\'%FEZEK,-IJ'BJW :10?
MG7UH _<ZZN)K:92@+*1GBI+2\6:8@QX..]?,W[&__!0GP-^TCH,,]MK,<TA"
MCY=O6OI:V>-P+V#E7Z&@"[E@PYXH9,,6]:6-UE7(Y]:<".@[4 073GRR0*SX
M7=KDCWK4E56&#56*V"SEL=Z"'"[N/N$++CO5;R''+-WJ]."$W#TJ !VY(I.5
MM#>$K1L/MW"+\PJ"XEC+?=I7<CACBD\M #*QZ<U+CS$M:D<SJ\)5X^OK54Z/
M%,=RD#-)>ZQ"TGE1.#4D$]PR@J.,5#HM;H<:M&I/DOJ31Z9Y=OC-3"P)09;'
M%):WA)\N6K&\-TI1IQ;T%)RHRM<JMIQ'(<4Y(I8Q@25.0[' %'V=FZUO%<NA
M#G*11O(2YRW)]:HS:<7F4X_2M6Z7RQM]*@D)W+P*;W(=%SU+VF0^3;*N.E3Q
M]ZBM7/DBIZ1<8\JL%%%% PHHHH *JSQKOW!@>>:M56EA'F$CUJ91YD-2<2&X
MA/EEHQS[5482,"I)^AK3CD$*'S!52=H6EWIZU$8\CW)ES5-"&R@DC?S'DVCW
MHU25SM\IMWKBFZE))+\L?I3=(24LZR=^F:UFWR7MN:1PEL/)W.+^.$(;P#<.
M(=S8/\J_*+XPWEOI?Q#U M&%+W9S^0K]?/B=HKZAX6FM8DR2#@?A7Y7_ +5_
M[/OCV3QK<:AH6GDJ]R68X/I7YYG="523<+M]C][\%<RP^!4X5I*+EY^APOPY
MG>Z^)4-Q"-R_+T^M?JW^R[<S3^#+:-T( M@,FOS8_9O^!?CIO$<%QJFGXP1D
MX/K7Z<? .S;1?#,-E<KM80 57"^45*55U)-^AW>->:8?%55"FT[):G=W< QM
M#BELW:"-OF[56N[J/SS"AYIZ2DJ!GM7Z%%<L-$?SK[DH73U&7-U*7. 2*AMF
M+R$.F 35T(H7+"F_9UDR1VK%XN<7;E(IX:<M9.Q;LX8T&58&K8(  ]JI6$93
MK5Q .M6I.3V!P]FQ'^]4-X3C9OQQ5A^GXU"\/VGYF[=*H9ER6=QYOF"0XSS6
M9XW^)OA+P)ICSZQK5O RKD^8^.U87QW^+D/PG\)W.KR3A/+@=@3["OP8_P""
MJW_!:;Q/;>([OPKX:U\;L.@59,=..U 'VS_P5._X*J^"?!?@>^\/Z)XAMY)3
M#)'^ZGYY&*_F\_:2_:#\3?%KQ]=ZM%J4V'N)=JYSD%JW_BSXY^.7[1!DUV\E
MEEAD)?/F/C'6O%KW2M3\+ZJ/[23#J3G- '[2_P#!OY<Z\^OV3W5Y(P(CR#^%
M?T7Z>JOHEH21G[+'_P"@BOYX?^#?J<7>L6<T@'*H>/H*_H<T_#:7:;?^?:/_
M -!% %VTVJN/:I%/S9)J",$"IJ %=1(P(/2HKVXBMXVEE48"GDU*J@\GM7!_
M'WQ\/!7@RYU 2A2BGG\* /SH_P""Q7_!167X&Z-/I.DZDR.T;)B.3G//^%?S
M_?'7]JOXN?M3^,9]+TR^OG$[G 7GJ:^DO^"Z7[1U]XP^)#Z5#?%A]M=" _L:
MP/\ @BQ^RU8?&#XGZ=J&MV'FQ2%225SW]Z /#M-_X)Z?M"ZOH)\4"RU39Y7F
M;O('^%<9H/CSXS_LL>/T^W7]_"L#KD,,=Z_KL\'_ +"/PKB^"T.E)H<>^33@
MO^H7UK\0/^"Y'_!/W0_A_>ZEKVE:28]KM@A,=Z /IW_@BE_P4_N?B.+3PIK^
MMLS%DB_>R?2OVDT:6SUNW6_MI5D1NCKT-?QB?\$]/V@]0^ ?QOM=-AOVBSJ0
M !<CI7]6/_!.3]H/4OC)\*M.GN+D2>8F2<_[(H ^GXV5!Y:GVIP7!SO%5YGM
M[+F0D$\TU=0BEX0T 7:CF!)X%-%PJ#D]:7S%8;LT +$,=:Y/XUG'@B]_Z]9/
M_0373->J#LKF/BO#+J'@V^C R!9R_P#H)H _F6_X+IL&\4:@5.?OU^:'P2Y\
M;V./^?J/^=?IE_P77M#8^*=1B8$$B2OS/^!Z[?&UBPZ_:H_YT ?TT_\ !#3C
MP789_OQU^JB$>0G-?E1_P0RE>7P?I\9_OI7ZKA$2%=U %A",=:=D>M5Y+J")
M?O?G42WJEAM/4T 7"RKU-+5.XN%,O7M2R7C(JA30!;R,XS1D>M4Y+K">9NYJ
M.34O*B))[4 :&1C.:,CUK/L-12XA!8]ZMM(IP0>E $N1TS1D>M1EU5?-+4PS
MIC.: )MRYQFER!QFJD]PL$?GD]34$FI,2'!Z4 :5&0#C-5(;[S%\S/6FR7RL
M=ZGIUH NY&<9I RGD&JL5]"WS%N2*;]I*PL4/.>*25A7N37) &2>]1VS9Z&J
M4EW=3!4;&,U./-M@&7TJI2]VPE"SO<O[B!]VJ]P^X<U5;674[2:BFU"20X7F
MLB[D>HW36ZY09YKA_BUJVL#PU.VG0R%P.-@]J[:2*:0;V7@U'+:VES;FUNT!
M#=L5U4:BC:ZV.#&X>IB*4H1TOU/S&^,NI_&2^\6W"6*Z@%6;@*E<RWB_XZ:*
MXMI]/U25,9(\NOTZN?@+X-OKMM2N+)26;<3Y8J._^!/@6^&4TY">G,0KZ'*L
MTP^73E+D3NON/RC.?#;'YO5CRXN4+/HK_J?E-X[^$?Q ^), OKFPNE<#=M9*
MJ_#GP)\5/AO(J66E7Q"'@I'7ZM0_L_>$8P1]@7_OV*>OP#\)A"O]G)_WZ%57
MXCC*I\*/$K>!;==5XXR7M%UM_P $_,V]UOXX:G(BPVVI(%//R5[;^R[JWQ5L
MM1AAU:6]QQG>M?7<'P&\,V\KXTY/F/'[H5+;?"K3-"NQ<6MFHQTP@K2MG%"I
M0Y?9K4^GX<\,\5E.(E5JXR4G=:-?\$M^$;[5)K&-[H.QV#.:ZK1[^0W(5U(J
MOHMLEO&$=0,#TK1AMK82^>IQ7RF+Q4WI&)^I4,%[!I\US8C.4!]J6J/G7B+G
M V]J;'J$N=I-0MC<T**I+=SNXQ3[BYE50<=Z8%K(]:"0.IJ)9DVAY&[5!=:C
M   &YS0!<HR.F:J)J2'@-1'>;I" : +190<$TM46D?SP:LI<*05SS0!+02!U
M-4+B\NHGVQCBD6]G89>@#0H) &35)+V1>6/%!O6=&&>U %P,K#(84M48+R.*
MV/F-WI'U>--N&[T 7MPSMSS2U16^CFFW1-36U*4/L!% &AD#J:*H_P!I+GRW
M;FI4N79?KTH LT54-S,O H$]VQ^7% %NC('4U6BN)!.8Y>M++=PJW)H L9'J
M**I/>J3\IXS2W%\\8!C/&* +F1ZT53M[]7YE-.?5;<,%#4 6J,CUJL^HQ$?(
M:9'>QOSNYH N454-XX. :<UYY:Y<]* +-&1ZU4BU"-R<-3%U!3)LS0!>R/6C
M( SFL\:@RR$9X)J2YNMEL2AY^M %S(]:3<H.">:H)JD(51(U/%TL\V830!=R
M#T-%5GGD3 '6G))<;=S 4 3T552[;S-K&G->1I,5)H L9'K15">_<R@1GO4G
MVN7;EA0!;R#WH/UJD+QBXVGBI)KR(("QH%;4>4R<YIPC#(,D5'O1H"X-11WB
MLH0'I0)*Q9$07YMU.&%^8'-5S/E=DAZ]JBDODA79&:"BX7W#&*3.!BJD.I%4
M.\\YI5O!,V,]* 'W2 C IB1?+R.*9/=%VV4\R@*H'XU+C%[E*5B:"((.M1W*
M2=1TI[3H$^4U#)>NPVI^-2J<22M,S$$;JHRO>))\LK8]*T?D8_O12P6\+,>.
M,U<4H[&52E&HK;&9Y]WYVPLV*TX]/9XPV>HYXJ1K6T5MU3Q7,(7RP?:JNBJ4
M/90Y4R"&R5#EAGWJ1[.RF&V2-2:>C8EVCI1)%"K;V)H4FGH5>;5FS/O?"NC7
M(V36D9'N*P-8^#WA+4E(?2H3N]JZR>2/&4-0+<2$,R]O6M5BJU+6+.>>"PM;
MXXIGDGB?]F3PS<[GM]*B!([+7E/C[]DR+:\EI:!<=-JU]7F_FQD@?B*KWZ17
MD!,T:\#TKMP^;8J,KMW/)Q_#^6UZ;4*:3[V1^>7CC]F7Q=L,.F^<FT]52N:L
MO@Y\1?"LHGFN+HA3G[M?H]#X:T?428VMU) S]P5S?BGX9V.J*T"V:X(QP@KV
M(9Q"II-'Q];A"K2;E"H_N/B2P^+_ (N\$*(94N#MX/%=-X=_:\UBTG26X27Y
M>H)KV7QA^R=::QNECL22>>!7F_B']C*]1'%G8MN_AX-==.I@:[5WJ>74H9S@
MW[B;2.U\$_MCP7S*MR=N?[S5ZOX5_: T#5U4S7<0SZO7QUXH_9N\<^%K?SK.
MS8%?<UR3W7QA\-*PBB("'C+-73/)\%6A?VB3,(<8YQ@JJC/#2:[ZGZ267Q#\
M+WD0V7L&XCL],U76+>73GEMKM2>VTU^<^A?'_P")FD7BQ:A-@(PS\QKV?P7^
MU)//HV^[O.1@$$UY"R+EK>Y.Y]*N-Z%;#VG'E9YE_P % _C+K7A\/!:ZA(N'
M(^4U\,+\9_$.J:@TDNJR$%SU/O7O'[9GCS_A/[^Y5)MP#GH:^4+;2A:W+1C.
M2Q/ZU]ME^7.%-)H_FOC['U<5C'+#UY>B?_!/1/\ A9VNRKA]5D*@=,U@ZW\0
MK\7IE=W?CK6,CQC]W(QX]Z;<0)*/D.?K7H4L/[-\\NA^7T<=C:<[U*LOO-2Q
M^,VMVCM'!/+%[BKK_%GQ+=P_+JTI)[@UQDVE/,Y 6I+&SELY_)'W<5=1SFN>
M,3TGCL54I>T]HTEYG>_#WXP>+],\<Z<BZO.0]R,C/L:_7_\ 8^\:7NN?#2SG
MO;EF=L9W'V%?BOX%*/\ $/2E<_\ +V/Y&OV'_8[@"> K,QD_P_R%?(9]"$J;
MN]3]J\(\VKU\:Z4I.R\V?3YE9+1'"GE:KQS2SOMVFI0TS:?#\O1*CM;LP2?-
M7P.D58_K&G.E*@G:[)UM8 P:; ^M:-I% B[H<8]JPM;OPTD<:GDCM5S1[U8H
MQ"S'@=ZR<IWM8P?)S;6->C('4U2_M2':VUN:2+4EG.W=TIEEZC(/0U434(^C
M-QWH^WQ!B4:@"W1D#J:H-J#^8,&IA<^8HYH L%E!P32UGM<3/<C/2K0ND1?G
M- $V1G&:0L%Y)JI]L5[@;3Q4DL\4BD \B@"P"#R#16<;]HGV@U.MYN4,U %J
M@$'H:A@G:;D=*<0T9)3O0!)0"#T-5O-N V&'%.4R1\GO0!/D=,T52>[E68@]
M*<;Q\A<]: +=&1ZBJ0N;@R^5VJ;S0J_/0!/D>M%5TGA)^4FG&\B!QF@":BH3
M/_&M,%VRGYS0!9R,XS1D>M5?M2J^_/6I?.B5=^Z@"7(Z9HJNERDC$ TLL_\
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M\FJK%*(MW6AKR3=O4]30!H9 ZFBJK7(V[G.#3X[M&CY/:@"<$'H:,CUJFM_
MIVAN:C-_*')!X[4 :&1ZTFX9QFJEK=E^6-1RWP20X/>@#0HJBNH%VVD\4CZG
MAMB&@"_D>M%5(IYL;C4BWJ@X<T 3Y&<9IK$;A51[^-+G -2_:HMA<F@#)^(O
M_(L7'_7%_P"5?SD?\%ZQ_P 3J\/N_P#6OZ-/'#"[\+SA#D^4_P#Z#7\YW_!>
MNVG76+TD<9?^M 'X]_#+_D;(/^NJ?^A5_0]_P04(V6'/\:?TK^>3X61"3Q=
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M@_05_59^QHF?@Q:'OA/_ $&@#UMFY!%*[!?F R: H"?A2)UH 21B\+8&.*H
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MJ/1?&WA/6VV6.IP2-G&$:OS,_P""LG_!0#6_@$94L-1>/9,1P3ZUXC_P3/\
M^"K6O_&7QS;Z/?:P[A[IE()/]_%+E0C]M;F<1HK10[E/<4@07*[Q#BL[X?Z]
M'XD\(VFHY),D><FMB*;RCLJDTE87O]-@O+RST^R\R\G6-0IY8U@0?$WP1$QA
M77;9I,_=#G->$?\ !1']H>_^"_PXN-7M+HH5M78$>V:_&3P+_P %F_&FN?M
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M%'QF^)*Z1?:R[@WVS!)]:_<7X?:T/$W@RWUF0Y,G?\!0!JXDGB.TD4PPVEE
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MO&Q!2WD;/T% %K6_'WA'PW,(;W6+=&Q_$U7=$\5:'XDC#Z=>12<9!0U^$/\
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M5)KI=IW _P .?Z5\3_'[]A#6-"D,UA:R-R?N1_\ UJ_7Q](6\4R,@/U%<?\
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M\/\ 39/[0M$611DX9:^./C1I6A1^(6A\,K@"8@\@U\KGO"V:8.G*/MDUY?\
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M!K^0O_@H#.3\;;P?]/,__H= 'ZK?\&^* W.G_P"XG]*_HAT; T>T/7_1D_\
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M.7X#R,OCJS4'_EZC_G0!_2O_ ,$+[8S>#; E-OSIQ7ZOVL#I$HWG'I7Y7_\
M!#3*>$+ 9Y+QU^JT!+Q@4 <3\>/A^OQ \$W6BJ<F4=,>QK\9/VN_^"+VN_$+
MXL#Q+;6<S*+\296+_P"M7[FS;XI?]FJ]QHVE:AEYK<%O<4 ?&7_!,[]C2\^
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M'>J5_P"'=%U(;[JV!YST% 'QM_P2]_9#OO@%X,2QNXG0KM^\N.E?:+0MYO\
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MZ5^KVB6@L])@LU_@CP:K6GAW3;%O.LX N/:M!I%@C!'I0 HVC,1/)'6OD?\
MX**_L@O\<_"<UO9*6+6[ A5SUS[5]:())AYJTZYABFB\BY4$,,4 ?A)\(/\
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M4S_@F==_M#ZC>7UG"\@E<D;8\]_I7Z;3_O"&3M45S8VM[%F[B# ^U 'XS_\
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M+S_@IS_P3&U#X_ZK<:I##)(LMQN $>?XL^E?J4[3*PC!X-1WNF6>I0B&[B#
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MN(_U:BN-^&UA#>^)((KP94RIG\Z_>_\ X(F_LW_##QK#9-K6E"0EDSP/;VH
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M*^6.A^.U<3B<75<ZLKI_F/D>1?E7.,U+-''%!O>7DCI4*O()/GZ4NH21O!O
MZ"M')0J,RJKD5T6=,D62,<=JL$;3Q6=HDZR( @QQ6D5W8-5&HI&2N*?G6HI#
MY:%0.M3 8X%-D16&2*T&0Q,%&3Z5&(3),)!3I%(..U2PG8* /F3_ (*;:E);
M_!&]00Y_T.;G\*_D3_;PNVN/C3>,T>/])G_]#K^R[]KKX1/\7?AY/H$, <O
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MTO@?&'\<6+>9C-U'_.OTM_X+I/N\4:B7//[ROS1^!V3XXLO^OJ/^= ']-?\
MP0QB$7@_3]SY&Z/FOU60'RP4Z5^4_P#P0S)/@NPR?XT_K7ZLVQ(MUQ0 +(7E
M"LGYT@:,.5R,U(R@/N IC01YWXY/6@!Q8*-J\U6?S5;.",U8"@<@4I&[@T ,
MA*='Z^]$:KYA)'&:)(E(W <TT;P, B@"9F(;(&:'!<AAVIB>9MQFE7>#UH >
M78#[M'#@DCI2%B>II,D4 -$NU]H':FRA74LF 13]HSG%"QJH( Z]: &6OKG/
M'2FRO-YH*J:E1%C^[3@Q'0T 1?-G<W&:>P15W4K /]ZD,:D8(H ;\TJ\4V!
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MQQZ5]/:E^WUX4,81+N0# _CKBS+-<PHXBU/8?"E#A;,,N]IB_P"(V>+^#_\
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M 3\HVYOYT/)%)\NX4G[R48<TJ6B?>Q0 J1JW --=3G[QI0CHQVG%(4D)SF@
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ML=*N+C4&C;4MK SC'3ZU_2K^P'\2M8^(OP+T[6M9@??*N&WG)^Z*_+?X1_\
M!OU8>!?B=#XJ;PQ  MYYH*HOI7Z]?LS?"FV^#_PQM/"PM@BPCA0/8"@#P/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5PW_ $Q?^5?SE?\ !>DXUB\/N_\ 6OZ-OB+_ ,BQ<?\ 7%_Y5_.1_P %ZO\
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M4E@:H:4K(H!/:M \#-9PTC8V D#K12$;AQ2U74 HHHI@%%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%'2@ I&ZCZT;AC=2-R10!B?$7_D6+C_ *XO_*OYR/\ @O5_R&+SZO\ UK^C
M;XC,!X9N ?\ GB_\J_G(_P""]1_XG-X/=_ZT ?C]\,O^1L@_ZZI_Z%7]#O\
MP03^[8_]=$_F*_GB^&7_ "-D'_75/_0J_H=_X(**0MB?]M/YB@#]N$^Z*6D
MP,4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%(S;:!/8AGSY9(K.MW=[H@]C6I(N$R:IPVH2X:3CDTG)(TCK$EO9/*
M4,>NVH8;T$$G'3KBIKI//[< 5$EHHSD5>\-#GO)5-!8KE9.>/RH%VCAXR!C'
M2FP^5 ?+?U]:BOFALK66Z;&-I-<48U7422.B;487D9VI^&]&U2V8W-I$Q/\
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M_P#8S_9AU/Q'J%MKM[:,,,KG>E/&X?ZS6;4+'V^6K"\-<$Q<J_-S+OY'W/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%3+8!
M'Z?C3*>_3\:-H]*FUP&45)@>@HP/04<H#=P*XSSBFF(DY(I>C?C3ZT6P$>S9
M13V7=WH"#O0-.PRBG[%]*-B^E ^8B=L<>M-"Y.0.:ED1?2FJNTYS0-.Y%,&"
MU0NQ/*P1/7UK5(!ZBF+!&)-^VFMQ-IHA@BG$.".WK3%B?>35[* 8 XIH16/
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M.1FD8X&:4=!2-]TT *.1FB@=!10 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%%)JX"."1Q29?TIU%"5@$R_H*,OZ"EH
MI@-"MG)'>G444 %(2V>!2T4 )E_049?T%+10 TAVZBDV-Z4^B@!FUO2D .[Y
MA@5)2/T_&@.@F$]30"J\@TVB@ SS0!D_+S13D7'- ",&ZFHIRI0J:F=NU12)
MN[9S0-.Q3M(U5LECUJTOE!LTJ6ZJ:<85'<4:E.7/N1SH'4B( U0O]+DN8]LL
M0Q]*U$CPV,TSRW=F#,<4X3L]495*<91L>;>-?A;H_B2%H);<;F[!:^=OC/\
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M2[N<NH^M:4%M%'#Y0(Z5S4YN3LMCG4IU'>*LAAO(1U- OX0W!HDL4VY%0"!
M":TFW'8F;J1+B7X<XS4V\NO\ZSHD;.:O1!@N":$RX2<MQ6QC)[41S0L?E)-,
MN'(7 J.V7YLY[U1K9%O>OK1O7UIN#Z&C!]#02/ZT4#H** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MHHR,9S1D>HH%S!11D>HHR#T-!04449 ZF@ HHR/449'J* "BC(/0T4 %%%%
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M4U^OX4Y>@^E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*L+Z#(R"2 :?2*H4DCO2T""BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !2-U'UI:1NH^M &'\1?^18N/^N+_ ,J_G(_X+U?\AB\^K_UK^C?XB_\
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M (]T^E $K_=-*O0?2D?[II5Z#Z4 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !2,I;I2T9 ZF@!NP^HHV'U%.R/449'J* (I8R4P<5GFU!EW8[\5
MIRLNPY-9?VP"4K@=:RG1A4>I4(.<B3=Y3YJ9Y890' Y IAC\Y-U,M(L,69N
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M^(O_ "+%Q_UQ?^5?SD?\%ZO^0Q>?5_ZU_1O\1?\ D6+C_KB_\J_G(_X+U?\
M(8O/J_\ 6@#\?OA=_P C=!_UU3_T*OZ(/^""?W;'_KHG\Q7\[_PN_P"1N@_Z
MZI_Z%7]$'_!!/[MC_P!=$_F* /VUHHHH **** "BBB@ HHHH **** "BBB@
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M;RSK$RVR0A68XX%>CA,%@8QLK7,<WXWS7-:?U>HFEZG6_L_^%Y[_ ,?17%C
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MAQS4C.C+D&F:>8I#GD&D&[.,T)*",'MTI"^U]QZ4!<?A_44 -GDT@D0]Z=0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-:=TVDSIM-):V#-^M3JQ.<U! 0L QTJ=%P,YZU\BUU9^YJ/+H+1112 ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[9X%*GW14%VL+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%%3( HHR!14@%%->0)4<=SODV9JUL!,3CDT@8$XILCXZTP/
MSS3 FHI$;(I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "D;J/K2TC=1]: ,/XB_\BQ<?]<7_E7\Y7_!>?\ Y#%[]7_K7]&OQ%_Y%BX_
MZXO_ "K^<K_@O/\ \AB]^K_UH _'SX9_\CA!_P!=D_\ 0J_HA_X(+_ZNQ_WT
M_F*_G>^&?_(X0?\ 79/_ $*OZ(?^""_^KL?]]/YB@#]LT^Z*6D3[HI: "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *1^GX
MTM(_3\: &YQ&:K3<DD>M6&.%(JN?O'ZU<=B'\0^) W!JGJC^6V%K0CXY/K6?
MJZY;(]:SJ;%RV(H+@M#UIDS"ZMI;-^1(I!%/MH&\GI3$B82$J.<UG3TD$+6U
M/G3]HG]BOP_\2%FU:2PA9F'4XKQ"'_@GUX-TWS'U&TM0!R-S**^V_B;XSA\,
M>&Y9[K:NWU ]*^!/VH/VV;O2I[C3-%FBW*2ORX'\J^XR*>,Q'N+8_'^.7PYE
MJ>)KWOV(/%'[*OPK\.RM*(K+CTF6N1UCX ?#0R*\,=GUYQ*M?/'C#]J/XA:O
M*[%S@D])37,S?'[QQ&P8RN<]0937W,8QHI1OJ?A>,XIR#%27L[_<?8W@OX&_
M"Z2=;6XAM,'N95KVKX;_ +$GPZO+R'5K&WLV (8[)%-?FI%^TIXOT^-;A;A@
MX8<>::^EOV4/^"BE_H2FS\0WT:@$ ;V!_G7FYE1Q.(A:#/I>%N(.&:>+4*Z;
MOUL?IQ\*? &A^"($TS3K5$$:\;375W"2-)D-P#7C/[._[1.E?%2"+4[*\23S
M%XV@5[+#YMSA@O!K\QS2AB*=:TMS^G<CQ.65,.GA=K:&I8KNM5SUJ=#Q45C'
MY4(0]:E5@>E<-VK(])N[;%HHHJ@"BBB@ K(UK2EO6# CY3DUKUGWD\,<A!;F
MLJL825I(34;JY46.!(#;!0">]0ZG9*^GO&1NW(14C127#YC%6$1(HPMUP*R^
MK82:]Z*.I55!71^>G_!1+X?:Y=:A<3Z=82NOEG[B9KY0TO4+_P /C[)JN@7&
M.FYHR!7["_$WX;^&_&]N_P!I@1PPP28P:\3^(7[$W@GQ)9,MM:D2%3C;$!S^
M!KYS-N&L)B8MTDDV?T)P%XI97EV54\)C(?#I?8_/5Y='U*(RP*D+GLQYJQHO
MBWQ?X-NUN]$UAE4-EA'7O/CW_@G'XJL;][G0]-N&09Q\S"O+O%G[/WQ1\$Q2
MPIH>0H(8N2<?I7YAB^%<[PE=U:=1V79'Z=E>9<'9[6E[-QL];-I[^IUOA;]M
MOQUH%BGVC4[A@O!'->^_L^?\% M,O"\.OS')P,ROCTKX%O+C5=+U Z7KT"Q'
M/(%:VG^&I)8?M>F7,H8\C:Y'\C6^5\2YIE7NUFV7G7A_PQCL,Z,(1@GU1^N7
MA/X[> _'962VU&V4L.%\X5V^G3P7.UK6574]"IR*_'3P9\2_'WPYUF*9[F40
M*ZC+3MZU^F_['GQ*/COP?'/<3[G6!<\Y]*_4\IXBP^;12>C['\W<6^'U7A>F
MZ].7-"^Y[!J%O$8A&ZCK4-OIBV9#IC!YJ6^$IG,:#(%);W3(K+.,=A7T"HTX
M,_,G&%2I=EVU!*[JL!\G!%5[*1)8_D/-3A6STJANW0>3BD+ =:4D#K0<8YH)
MU$# ]*6D#*. :"P7K0,6D# G&#2"13WH:11WH =0#GFD5PW2@L!U- "T4TOZ
M4X9QR* "BBD+ =30 M%)O7UI00>10 44A0'D4*N.30 M .1FD) %"MF@ + =
M:4'(S01G@T 8&!0 CG ^M"?=%*1D8I%&!@T )*VU:XSXU28\#W>1_P NLG_H
M-=E+\W2N.^-P_P"*&NAZ6TG_ *": /YFO^"ZK;/$^H ]P]?FC\#06\<67M=1
M_P Z_2W_ (+L_P#(TWW^[)7YI? H@>.++/\ S]1_SH _IJ_X(9?\B38_[\=?
MJO;_ /'NGTK\J/\ @AD0?!-B1_?2OU7M_P#CW3Z4 2O]TTJ]!]*1_NFE7H/I
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MNQR4>A,5.<4H8*,'M03R&I -S'TI$7'!P3BER/6D*_+@4U8_6@!]% &!@44
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M]$D>R:9+/+$ Q/XU?C^[TQ4&G(OV53TJR  .*^(DTV?N*<F]0HHHI#"BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!VD]:^IM8_X-UO$Q@\Y/"9Y/]PT ?*OP9_X+1_&/Q!\1=/L&MM35)9<-EO\
MZ]?OU_P3(^.?B+XP_#^PU;5XYMTL&X^8?]FORW^&'_! +Q'X/\56VKS^%RIB
MDR#L-?KW^PC^S]J/P/\  UEHTMF(O*AVD$?[.* /I$-A Q]*%VGYAWJ,B0PX
MDZTL##&STH 61RIXI%D)[FG&-30$1.: "7A,@5")&P<BI9)45>33$>-@2/2I
MFKPN)27-8H7+N9\<TL[2&((&//>GSE!-UI9E 0/Z"N%3J1GH:S5U<Q_$.CPW
M^D/93('#=C7S#\>_V)/#_CUGOAID1?EON9KZHN=>T6SC*ZA<!3Z9%8=[X_\
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ME<^'SO-JRM)_B>KA_#_AJM%KE>GDCZ2\)_M[>)9=6C6XN)F0L!@O[_6ON+X
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MQGI$6N_M&0+>+NSJ4N<_]=*8'[X?\$!_V7M#T?PM;7&N>'XFVV60TJ=3MK]
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M^]7U]_P<&^.+?5/&ES:F;)6Y< 9^M?DO\-_B9XP^'VLC4O"4K+.C?*1GU]J
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M364A>32(G.*NV@.34K$E%- P^!3JA-]2PHHHJ@"BBB@ HHHH **** "BBB@
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M(M+UE9) -BG_ &J_3_\ X.$-$@NDG=T&07Q_X]7Y#_L"6<EK^T1:K'P/,_\
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M8U[\(I[36V0@1RY!8#^'WH _C6U_P[XB^ GQ@$4R36WD7;XSQT-?O9_P0O\
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M7[?_ .TIHN@/H*:S=*@BV!?L\G3\ZP;3PM\?_P!K'7$2X::?SW&=ULYZGZT
M<Y\.[/Q)\2_CI9WNF:=).LFHDDKSU%?U)_\ !$+X9ZIX3^#.DWVHZ<T,GDX)
M8<_<%?GG_P $B_\ @BW?W%Y:>*/&N@1L8W63+18]/6OW9^"_PBT+X+>&8?#>
MDV0BCA& JXQTQVH ZJ*;[=*\3IP#@CUJ'4/ O@W5_DU3P[:SMG),D>:L+$(&
M,D2XW'-3J9?*\T]30!AR^!?AY9 Q1^#;  ]0(1S2VO@+X=S<CP;8C(_YX5HM
M )Y/W@JQ':1PIN5: ,G_ (5Q\.T.Y?!MCGVA%97C[X4_#:[\)WTDOA.Q4BSD
M(/DC^Z:ZZ!E9L.*YKXT3W5IX*O'LFQFUD'_CIH _FB_X+T:1HFA^+[ZUTBPB
MB7:_^K7%?F5\"S_Q7-D?^GI/YBOTW_X+K1&Z\0ZA/.P+A7K\R_@,@/CFT#=K
MF/\ G0!_3+_P0R;=X+L#G^-/ZU^JEL"8_P *_*K_ ((7 ?\ "&V(_P"FB?UK
M]6;0 )CVH 6,-Y1SUJ5/NBF@ (<>M/7H/I0 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4$9&*** &,F*3I4E,88.* &D G)I:#R,4B@C@F@!RMC@
M]*<-O;%,IRJW44 *0#U%-=(R.%%.?[IJ)F(. : (V3N*?&C 9)IVQ?2D.5&
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MYSQ4D;9/%%T ^BBBF 4444 %%%%  0#U%&!C&*** # ]!2;1Z4M% ";5]*7
M]*** # ]!1@>E%% !@>E&!G.*** "BBB@ P#U%%%% !1110 4444 %%%% !1
M110 4444 %%%% !2-U'UI:1NH^M &'\1?^19N/\ KD_\J_G)_P""\MK!+K%[
MB?G+Y'YU_1K\1N?#%R/^F+_RK^<3_@N_9S+KE\Y88+/_ %H _(GX6VULGB^!
M96!'FIU_WJ_H5_X(:^"_!NNVED+[1K68[D^_'GTK^>+X>(X\60;3_P M4_\
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M^D!$=C)_W[-9S?"76OF9;-^?^F9KZ'&8#+%B.?1'RN$S_C?$0LIU+'M^I?\
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M2-52\^R%@IY!A/\ A7[&_:)CQNIZRN@PIH ^7_V3O^">'P\^"6F6RQZ3;^9
M@P3!SD5],1645I&D%K$%C10,*..*L"4Y.>]*%9DVQG H P?B!X5LO&_@^_\
M#US$I%Q:M&01ZU^6O[17_!"+PO\ %?QU/XC-AS(S'*P^IS7ZR+ \3EO6I4D8
MC"G% 'YO?L@?\$;?"?P*U^'53:@%)58;HO2OT1\.:%;>%M*CTRQC!"(  !Z"
MKTPF&&=LTU9OFW9H R?$/A/1/&^G7&EZWI,+B1"N9(P:^&?VP/\ @D)\./C3
MJ%PT&F0KYI)_=V]??@.&+#O36):7<W6@#\8-:_X-T_!SWJ-# P#-SB$U[_\
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M /!(GX6>!-36[O-,M\HH^_;^E?<H=EZ&C>V<YH Y#X<_!SP?\-K-;'1]-MU
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MFDVY@&W)( [FM*JMMM[598$]#09V0M% ]Z*!A2;!2T4  X&**** $*ANM($
M;.:=10 4@4 Y%+10 A4'K2T44 %%%%  1G@TFP>II:* $V#U- 4 YI:* "@@
M$8-%% #7;'%-(!&#3GZ_A3: &L@ R#7*?&8X\"WG_7I)_P"@FNL?[IKD_C-_
MR(MY_P!>DG_H)H _F8_X+GICQ)J)'_32OS2^!'S>.+('M=1_SK]+O^"Z'_(Q
MZE_VTK\T?@/_ ,CS9_\ 7U'_ #H _IG_ ."&Z >#K#_?C_K7ZKVH"PJP[CFO
MRJ_X(;_\B=8?[Z?UK]5K?_CW3Z4 2E 5VTH&!BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'?\ @@G]VQ_ZZ)_,4 ?MP#D9I:1/NBEH **** "BBB@ HHHH **** "BBB@
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MHCRHO#+CW-><?'NVDE\/SS)D\?TKIRU*4HW9Q\02J1RN;B?FQ\5KJXD^*T;
M<?;Q7WU^R%JS/X.M[$@9P/Y5\"_%$M'\58D:,Y:_ K[R_9)TJYMO#UM>G)4
M<8]J^OS*FZ>$5^Q^$^'N+QSX@Q#FW:^A[C9&19VW#J:;K%Q&C9SCZ5+#/''*
MJE<ES^51:Y 2Q B)]\5\-6E+FT9_16(JRC%32+FA.DB$JV:U:R=  2,CRR*U
MJUI_"92DI2YEU"BBBM!!1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %(W4?6EI&ZCZT 8?Q%_P"18N/^N+_RK^<C_@O5_P AB\^K_P!:_HW^(O\
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MCK]6+3I0!,G3\:6D3I^-+0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MN/\ CU^UKK TR9+'7'!"\;7]JX'PMB*\N:.Q]+'Q"RO+LN<JU9>T_E/T.O\
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MK,Z HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D;J/K2TC=1]:
M,/XB_P#(L7'_ %Q?^5?SD?\ !>K_ )#%Y]7_ *U_1O\ $7_D6+C_ *XO_*OY
MR/\ @O5_R&+SZO\ UH _'[X7?\C=!_UU3_T*OZ(/^""?W;'_ *Z)_,5_._\
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M<=Q7GYAD> S2'[V)^A9+XF<0Y!A_986IIYGYD)_P3I\66[?N].DW#W-+??\
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MH8]#7Y4_\$-O^1-L/]Z/^M?JO;_\>Z?2@"500.:6BB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<=Q%#ES,E0Y6(RH.33NE(R[N]*.!BIMJ4%%%%, HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH *1NH^M+2-U'UH P_B+_ ,BQ<?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !0W0_2BB@!!]S\*J2 _:0<5<IKJN
M,[14M78#8@",&H-17*E0.U60N4Q2-'V(S^%6G8F2NBE;6P6/?CMZ5GWQ<SY(
M-;F !C%07%G'(A.VDDG.[+A+V=G:Y1>.46+-G^&N772(-6E:.\B)!8YR*[22
M!#$(]V..:AN;"!;1DB0;CR"!70JK@M#EQ%&%><5)Z7.4/PC\.7;+++:@\YZB
MN>^*/PW\,6>ARA;0 @=<CTKT&Q@N$D(9FQGO7%_'*8)H\T9F*Y7M]*Z<#B:L
MZZ]X\W.,OR[#X:=1P3/SH^*OAW2X?BI'$D0V_;NQK[;_ &9_AIX<U/PE QM0
M6('.1Z5\-_%J_,'Q3B"R;LWPQ7WQ^R!.9?!UOND.>.#]*^@S"I6I89N,KNQ\
M%PI3RK,<=47LDN5GH3_"SPO RK)8YJ:V^'?AFUNQ);V>#VSBNCN2B*&8@U4:
MY\S[G)KY5XG$3C[TK'Z=' 8%64::+.E6-O:CR[=, 5HU2TP3 $LIJ[6'-S'7
M;E5@HHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4C=1]:6D
M;J/K0!A_$7_D6+C_ *XO_*OYRO\ @O40=:O,'N_]:_HU^(O_ "+%Q_UQ?^5?
MSD?\%ZO^0Q>?5_ZT ?C]\-/^1N@_ZZI_.OZ'?^""GW+#_?3^E?SP_#+_ )&R
M#_KJG_H5?T._\$$_NV/_ %T3^8H _;FBD7[M+0 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MAE_R-D'_ %U3_P!"K^AW_@@G]VQ_ZZ)_,4 ?MPGW12TB?=%+0 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P#*OYRO^"]2@:U>#W?^M?T:_$7_ )%BX_ZXO_*OYRO^"]?_ "&[SZO_ %H
M_'SX:#'BZ #_ )ZI_.OZ'?\ @@H!ML?]]/Z5_/%\-/\ D;H/^NJ?SK^A[_@@
MI]RP_P!]/Z4 ?MN!C@4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQ^)[\#NKU^:7P.<_\)O9#_IZC_G0!_33_P $,/\ D4=/_P!^.OU7M.E?E/\
M\$+SGPCI_P#OQU^K%ITH F3I^-+2)T_&EH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]W$9#%D$GG->Z_MW?!CQSXN\0R:SI6G%\1'!R>^/:OG;2O#_ ,6_#\9L9-,
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MQO*=L57#[),+W-?J,$I:WU/YEU]KJ:%O&D?"X_"I2,C%5;=W;K5H=.:+HH0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=C_UT2OU9M_^/=/I0!*HVC%+110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:?;QK;MY63GWH T0P*[J1I0%W#FF0EW4B0<4JJ%?9GB@!4E##+#%1RWR1MM
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MX,?[QC3%FB6/=$?O=*4.7CQ)U]J "X*_9W,9PQ':LVU6XA3SY6)]C6E&D;9
M_6JMXY8_98\4 16_^FABWR@'J:QO%GQ \+> ;,WFKZ_!$%R")'Q7.?'WXSZ)
M\$O!]SJ^J7BQ%8-X.X"OPR_X*C?\%J]1LM5OO#_A+Q+PKD*!)[^U '[1:O\
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MHN2W6.D\^P_Y^H_^_@H\^P_Y^H_^_@H 7[1_TR_2C[1_TR_2D\^P_P"?J/\
M[^"CS[#_ )^H_P#OX* %^T?],OTH^T?],OTI//L/^?J/_OX*//L/^?J/_OX*
M %^T?],OTH^T?],OTI//L/\ GZC_ ._@H\^P_P"?J/\ [^"@!?M'_3+]*/M'
M_3+]*3S[#_GZC_[^"CS[#_GZC_[^"@!?M'_3+]*/M'_3+]*3S[#_ )^H_P#O
MX*//L/\ GZC_ ._@H 7[1_TR_2C[1_TR_2D\^P_Y^H_^_@H\^P_Y^H_^_@H
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M#_GZC_[^"CS[#_GZC_[^"@!?M'_3+]*/M'_3+]*3S[#_ )^H_P#OX*//L/\
MGZC_ ._@H 7[1_TR_2C[1_TR_2D\^P_Y^H_^_@H\^P_Y^H_^_@H 7[1_TR_2
MC[1_TR_2D\^P_P"?J/\ [^"CS[#_ )^H_P#OX* %^T?],OTH^T?],OTI//L/
M^?J/_OX*//L/^?J/_OX* %^T?],OTH^T?],OTI//L/\ GZC_ ._@H\^P_P"?
MJ/\ [^"@!?M'_3+]*/M'_3+]*3S[#_GZC_[^"CS[#_GZC_[^"@!?M'_3+]*/
MM'_3+]*3S[#_ )^H_P#OX*//L/\ GZC_ ._@H 7[1_TR_2C[1_TR_2D\^P_Y
M^H_^_@H\^P_Y^H_^_@H 7SR>B8H\Y_0TGVBQ'W;J/_OX*/M-I_S]Q?\ ?P4
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M#_GZC_[^"CS[#_GZC_[^"@!?M'_3+]*/M'_3+]*3S[#_ )^H_P#OX*//L/\
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M<^FVT[2H"'3JP'<4 ?M&9UC.U8\CUIPN3VCJ-)+$( +J+_OX*=Y]G_S]1?\
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M\?\ ?X?_ !5?@W_9]_\ ] ^X_P"_34?V??\ _0/N/^_34 ?O)_Q$@W/]\?\
M?X?_ !5'_$2#<_WQ_P!_A_\ %5^#?]GW_P#SX7'_ 'Z:F_8-1_Y\I_\ OV:
M/WF_XB0;G^^/^_P_^*H_XB0;G^^/^_P_^*K\&?L&H_\ /E/_ -^S1]@U'_GR
MG_[]F@#]YO\ B)!N?[X_[_#_ .*H_P"(D&Y_OC_O\/\ XJOP9^P:C_SY3_\
M?LT?8-1_Y\I_^_9H _>;_B)!N?[X_P"_P_\ BJ/^(D&Y_OC_ +_#_P"*K\&?
ML&H_\^4__?LT?8-1_P"?*?\ []F@#]YO^(D&Y_OC_O\ #_XJC_B)!N?[X_[_
M  _^*K\&?L&H_P#/E/\ ]^S1]@U'_GRG_P"_9H _>8?\'(%T> X_[_#_ .*I
M3_P<?W0ZN/\ O\/_ (JOP:33M3/*V4W_ '[/^%.CL=09MKV,_P#WZ- '[Q#_
M (./[H]''_?X?_%4O_$1_=XW;QC_ *[#_P"*K\'&L=0#;4LI_P#OT:8]IJ$0
MV26TJCW0B@#]Y1_P<@71Z./^_P /_BJ4_P#!Q_=#JX_[_#_XJOP57>N00<BI
M%AFEB++&['V!H _>8_\ !Q_=CDN/^_P_^*I/^(D&Y_OC_O\ #_XJOP<^QZ@X
M -C.<>D9I/L%]_SXS_\ ?LT ?O)_Q$@W/]\?]_A_\51_Q$@W/]\?]_A_\57X
M-_8+[_GQG_[]FC[!??\ /C/_ -^S0!^\H_X./[L\[Q_W^'_Q5'_$1]=_WQ_W
M^'_Q5?@U]AU3M8S_ /?H_P"%'V'5/^?*?_OT?\* /WE_XB/KO^^/^_P_^*IP
M_P"#D.Z4;<K_ -_Q_P#%5^#'V'5/^?*?_OT?\*/L%_\ Q6,^?^N9H$U<_>?_
M (B1;KU3_O\ C_XJC_B)%NO5/^_X_P#BJ_!C[!??\^,__?LT?8+[_GQG_P"_
M9H%RH_>9_P#@Y#N6Q\RCZ3#_ .*IO_$2#<_WQ_W^'_Q5?@W]@OO^?&?_ +]F
MC[!??\^,_P#W[-!1^\G_ !$@W/\ ?'_?X?\ Q5'_ !$A70Z,I^LP_P :_!O[
M!??\^,__ '[-'V"^_P"?&?\ []F@#]Y/^(D2[_V?^_P_^*H_XB1+O_9_[_#_
M .*K\&_L%]_SXS_]^S1]@OO^?&?_ +]F@#]Y5_X.1+O/\/\ W^'^-'_$2'>^
MJ_\ ?[_Z]?@U]@O_ .&QGS_US-'V'5/^?*?_ +]'_"@31^\O_$2'>^J_]_O_
M *]+_P 1(=Y_$1C_ *[#_&OP9^PZI_SY3_\ ?H_X4?8=4[V,_P#WZ/\ A0%C
M]Y/^(D&Y_OC_ +_#_P"*H_XB0;G^^/\ O\/_ (JOP;_L^_\ ^@?<?]^FH_L^
M_P#^@?<?]^FH&?O)_P 1(-S_ 'Q_W^'_ ,53_P#B)$NE&#M_[_#_ .*K\&/[
M/O\ _GPG_P"_34IT_4I.%LI^/^F1H _><?\ !R%>'LO_ '^'^-(?^#D6Z'!V
M_P#?X?XU^#9L=7C&/L,__?IJ8--U20_\>,__ 'Z:@#]Y'_X.0KLMU'_?\?XT
MG_$2%=^H_P"_X_QK\'3I>J9YL9_^_3?X4G]EZI_SXS_]^F_PH _>/_B)"N_4
M?]_Q_C2C_@Y!NN[C_O\ #_&OP;_LO5/^?&?_ +]-_A1_9>J?\^,__?IO\* /
MWD_XB0;G^^/^_P /_BJ/^(D&Y_OC_O\ #_XJOP;_ ++U3_GQG_[]-_A1_9>J
M?\^,_P#WZ;_"@#]Y!_P<@71. X_[_#_XJE_XB/KO^^/^_P /_BJ_!L:9J@Z6
M4_\ WZ;_  H_L[5O^?*?_OT?\* /WD_XB/KO^^/^_P /_BJ/^(CZ[_OC_O\
M#_XJOP;_ +.U;_GRG_[]'_"E73=5)P;*?_OTW^% '[Q_\1'UW_?'_?X?_%4?
M\1'UW_?'_?X?_%5^#S:7JN.+&?\ []'_  IG]G:M_P ^4_\ WZ/^% '[Q_\
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M +X_[_#_ .*II_X.0;L'&X?]_P ?XU^#_P#9>K?\^4__ 'Z-']EZM_SY3_\
M?HT ?O!_Q$A7?J/^_P"/\:/^(D*[]1_W_'^-?@__ &7JW_/E/_WZ-']EZM_S
MY3_]^C0!^\'_ !$A7?J/^_X_QH'_  <@W7=A_P!_Q_C7X/\ ]EZM_P ^4_\
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M]_SXS_\ ?LT?8+[_ )\9_P#OV: /WD_XB0;G^^/^_P /_BJ/^(D&Y_OC_O\
M#_XJOP;^P7W_ #XS_P#?LT?V9J7_ #Y3?]^V_P * /WD_P"(D&Y_OC_O\/\
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M]'_"@#]Y?^(CZ[_OC_O\/_BJ/^(CZ['\8_[_  _^*K\&OL.J?\^4_P#WZ/\
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M^'_Q5?@V=/U4\&PG_P"_1_PI?[*U7_GPG_[]-_A0!^\?_$2#<_WQ_P!_A_\
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M5^#/V#4?^?*?_OV:46&HYYLI_P#OV: /WE_XB1+O_9_[_#_XJC_B)%N_1?\
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M&?\ []F@#]Y/^(D&Y_OC_O\ #_XJC_B)!N?[X_[_  _^*K\&_L%]_P ^,_\
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M(:'=D'/:O;F"R3",+CCJ*^&_^"/^HW-C\,["&='!^QX.5([5]RQ2KO$A!Z4
M?)7_  51N;ZT^#=ZMNSL/L4G /UK^3#]MRY<?&>[DG7GS9>#_O5_6A_P50NV
MB^#MZR=[*3^M?R6_MPN;CXSW<I/_ "UE_P#0J /Z ?\ @VSMX'^'T<SQ@'["
MI'Y"OV)C;<H.,?)_2OQC_P"#</6BG@6VMU)_X\U!_2OV8ECN3$&MR #'W^E
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MO(?^"\_[(5_X2\?3>(;/2R%-V[DK&3V-?,/_  3$_:X'[.OQ7LFU>XDACA8
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M72UM"WG,!PN>]>0_M',+GXG:K-&?^7LG'X5]W_\ !"O48XOB!I:S9)#CI]:
M/L7X=_\ !O8GB#PO::I)IDG[Z -_J3_A6W_Q#FQ_] V3_OP?\*_;;X&7D%S\
M-=)$*D$6:]?J:Z_;+ZT ?@U_Q#FQ_P#0-E_[\'_"C_B'.B_Z!LG_ 'X/^%?O
M+ME]:-LOK0!^#8_X-TX0,?V9)_WY/^%+_P 0Z</_ $#)/^_)_P *_>8=.:*
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MX/\ A1_Q#G0?] R7_OP?\*_>;#^HHP_J* /P9_XASH/^@9+_ -^#_A5[2_\
M@V^THMOFBD&>H,)X_2OW8P_J*3Y4_&@#\.)?^#<#P^3S&W_?D_X4Y?\ @W \
M/A>(V_[\G_"OW&*JXS2 %6^M 'X<_P#$.!H7_/)_^_)_PH_XAP-!_P">3_\
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M_?D_X5^XY!QA32C..: /PW_XAP=#_P">;_\ ?D_X4?\ $.#H?_/-_P#OR?\
M"OW(HH _#?\ XAP=#_YYO_WY/^%'_$.#H?\ SS?_ +\G_"OW(HH _#?_ (AP
M=#_YYO\ ]^3_ (4?\0W^@MP4<?\ ;$_X5^Y%!SC@T ?AO_Q#=Z!Z/_WY/^%'
M_$-WH'H__?D_X5^X^']11A_44 ?AQ_Q#=Z!Z/_WY/^%'_$-WH'H__?D_X5^X
MS;P.M-S)ZB@#\._^(;O0/1_^_)_PH/\ P;=Z!W#_ /?D_P"%?N)F3U% +]S0
M!^&5Y_P;>Z&!F.-S_P!L3_A65<_\&XUK&Q,5G(W_ &Q/^%?O'E/0TX  <4 ?
M@PG_  ;JHG']ER'_ +8G_"@_\&Y\3'(TV3_OR?\ "OWE993]UJ LN.30!^#7
M_$.;'_T#9?\ OP?\*/\ B'-C_P"@;+_WX/\ A7[R[9?6C;+ZT ?@U_Q#FQ_]
M V7_ +\'_"C_ (AS8_\ H&R_]^#_ (5^\P$F.M+A_44 ?@Q_Q#FQ_P#0-E_[
M\'_"C_B'-C_Z!LO_ 'X/^%?O/A_448?U% 'X,?\ $.;'_P! V7_OP?\ "C_B
M'-C_ .@;+_WX/^%?O/A_448?U% 'X,?\0YL?_0-E_P"_!_PH_P"(<V/_ *!L
MO_?@_P"%?O,1)V-)ME]: /P:_P"(<V/_ *!LO_?@_P"%'_$.;'_T#9?^_!_P
MK]Y=LOK1ME]: /P:_P"(<V/_ *!LO_?@_P"%'_$.;'_T#9?^_!_PK]Y=LOK1
MME]: /P9_P"(<Z(==-D_[\'_  H_XAU$'_,,D_[\G_"OWFQ(.2:42#N* /P8
M/_!NHF/^09)_WY/^%,?_ (-U$!S_ &9)_P!^3_A7[U[QZ&HIIE/:@#^8;]MC
M_@CC;_!3PS+J M739$QYCQTS[5^5/Q.\*#P7XIDTM23L9A^M?U2_\%HKR$?#
MVZ6-2&^S/G/U-?R^_M','^(]PTW/[U__ $*@#U_]A?\ 93E_:!\21Z8]LQ#3
M*HPN>H%?JC\.O^#>Z'Q!H<5^VGR$.H.?*/I]*^5_^")-SIEOXVM6\LY^T)W]
MA7]-OP&N!<?#VVG@X&Q?Y4 ?BU/_ ,&Y]JX&W3I/?$)_PJ/_ (AS8 ,G39.G
M_/$_X5^[<=W*S;23^52K*S' ;]: /P<_XASHCTTZ3_OR?\*7_B'-C_Z!LO\
MWX/^%?O+M?M1ME]: /P:_P"(<V/_ *!LO_?@_P"%'_$.;'_T#9?^_!_PK]Y=
MLOK1ME]: /P:_P"(<V/_ *!LO_?@_P"%'_$.;'_T#9?^_!_PK]Y=LOK1ME]:
M /P:'_!N?$IR=-D_[\G_  IW_$.G#_T#)/\ OR?\*_>11)GDTZ@#\&?^(=.'
M_H&2?]^3_A2?\0Z</_0,D_[\G_"OWGH/3B@#\%_^(<Z(]--D_P"_!_PH_P"(
M<V/_ *!LO_?@_P"%?O+B3UHVR^M 'X-?\0YL?_0-E_[\'_"C_B'-C_Z!LO\
MWX/^%?O+ME]:-LOK0!^#7_$.;'_T#9?^_!_PH_XAS8_^@;+_ -^#_A7[R[9?
M6C;+ZT ?@U_Q#FQ_] V7_OP?\*/^(<V/_H&R_P#?@_X5^\NV7UHVR^M 'X-?
M\0YL?_0-E_[\'_"C_B'-C_Z!LO\ WX/^%?O+ME]:4"3N: /P9_XAS8_^@;+_
M -^#_A1_Q#FQ_P#0-E_[\'_"OWGP_J*,/ZB@#\&!_P &YT/?3)?^_!_PI?\
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MHP_J* /Q._XAL?!O_/8_]^3_ (4\_P#!MAX+*X\\Y_ZXG_"OVNP_J*12<X-
M'XG?\0U_@W.?/;_OR?\ "H;C_@VP\(8^6=O^_)_PK]M+F?RER#53[>S,1SU]
M* /PYUO_ (-PM)M)?+LK=Y5QU$)_PK.7_@W+@!.=.D_[\G_"OW@MYLI[^])-
M-*I^4]Z /P>E_P"#<^!>!ITG_?D_X4#_ (-SX2HQILF?^N)_PK]Y(BSKECS[
MTH#Y.#0!^#?_ !#FQ_\ 0-E_[\'_  H_XAS8_P#H&R_]^#_A7[R[9?6C;+ZT
M ?@U_P 0YL?_ $#9?^_!_P */^(<V/\ Z!LO_?@_X5^\NV7UHVR^M 'X-?\
M$.;'_P! V7_OP?\ "C_B'-C_ .@;+_WX/^%?O+ME]:-LOK0!^#7_ !#FQ_\
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M?:5&\PSN'\Z /1+7_@W8M]0TZ"X73Y/F7/$)_P *D@_X-SHHY<_V=+_WY/\
MA7[G>$YY(_#EHSG.815];XNV%- 'X3G_ (-S[9@2-.D/_;$_X5%_Q#GP_P#0
M.D_[\_\ UJ_>2'>>=PJ3#^HH _!?_B'/A_Z!TG_?G_ZU'_$.?#_T#I/^_/\
M]:OWHP_J*,/ZB@#\%_\ B'/A_P"@=)_WY_\ K4?\0Y\/_0.D_P"_/_UJ_>C>
M/0T;QZ&@#\%_^(<^'_H'2?\ ?G_ZU'_$.=$>FG2?]^#_ (5^]&\>AII#DY!H
M _!K_B'-C_Z!LO\ WX/^%'_$.;'_ - V7_OP?\*_>7;+ZT;9?6@#\&&_X-S(
MB?\ D'2?]^3_ (4G_$.7'_T#Y/\ OR?\*_>I0P'S&EH _!3_ (ARX_\ H'R?
M]^3_ (4J_P#!N;$/^8=)_P!^3_A7[U4CAB/E- 'X,?\ $.;'_P! V7_OP?\
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M$\4  4D]*>  ,"BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J]Y*$4N#TJQ
MUJ"YCB6!BP^M '.^._"5C\0/#<VCW2KAX77&/45^-O\ P5E_X(]CX@&^UK0-
M'=I'C9@T4>#R*_:>"41G=#Q5#Q'X1T+QM9O:ZU;"0,,$,: /XPOC=^Q3\>O@
M)J\EOH5KJ<2QR8!25E[UQ>G?#/\ :6^(&I1Z/>IJLL;C:0]PQZ<5_6]\<_\
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M(JX(%0JTEK-^\!//I0!KRV2W:AF^7CM2QZ>L2XW%OK2V<QGBRO&!4PW*,L:
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M5^WN0T6TT 6K,8!!-3U#:\Y(-34 %%%% !1110 4444 %%%% !1110 4444
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MN[<TL9?>05X]:7!R-IX% D!8KB@!U%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
MV3M3:D(!&#43'"\4 ?F#_P %CM*U._\ "&H^3 2!!)C]:_F/_:2T?4+7XCW
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MT>U2064C+DGCT- $UA]PU8J&U&PE2*FH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH 38/4T;!ZFEHH 38/4TM%% !1110 4444 %(5!ZT
MM% "!0.E+110 V4N!A!UJI/<1V\PB+<D9JW)NQ\IJM/:K+)YKKD@=: ()?/6
M0.@)#&I9\.-A&..U/",0%SP*<\&_D]: *]RLD(C,9)^M/:[ND< Q\8J1H6;
M/;I2F)V.2: ())X\@R-@GM07@E'DO@4]K%)&!9>1TIS6"_? ^;UH J6\$5O*
M=IZFGO\ O;DKN.,=*/L<QD^]W]*LI9X&[OZT 4I;EBXBB.><&I(@IDVR\58%
MC$C[P@!S2FV4MO(&: *5[$KRJ%.:/LI7@2$'T!JZ;9"V[ XI&A);(% $,+2V
MW &<^M$]RZ-O8;<G'%3&-SU%-DMO-&)%S0 CK%L#AN".:6WDM,X27FE,'R["
M.*6&RA1MX3F@":-=GS9XJ3 Z@4B@@8-+0 4444 %%%% !1110 4444 %%%%
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M<')R: )XU8$DTZFH^\=*=0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4U^OX4ZFOU_"@"%U))8=JADM+
M34QMNK='[?,@-6 "VX TVWC\DX- &?=^%/#]R0C:;;\?],%_PJUI^EZ;HT'D
MV]M&F.FV,"IA&WF%L\9I9D61N&% $:%II.G -322^4-JXIK;(%&,<T^/:Z;V
MYH 6)<#<>]/J(2[FVIVJ6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H(!ZBD?..* "!R:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>.M7N/"?@C4)RTDYC"VTF<9/UKX#\#_LM_M$?M(*^KW,&JRI/*3EH@1R3[4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !112%@#@T +2.,J:7(]136/.W'6@"O-$'!%<O\1/
MB!H'PQ\.3ZUK%UY0BY)./<T?%OXK>'_AAX?FU;5+R)=D3-\[8QBOQA_X*X_\
M%B-,T_3-1\(^%-97>R, 8)NX&/6@#-_X*V?\%G[;PQ=7WA3PCXD3S$=HPHD
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MP@TJT\0>( '6P4$&0=<^YKZJ\$?M;_![XAWR6>DZV'=^@WK_ (U_(?:_&O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;V]: +0Z<44 8&** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR]%C_9^J%2V",U^A_P#P2O\ ^"*6JMK]CK'CG0I>&!8W$6>_TH ?_P $3/\
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M&/\ @Y,T^+PJ\=UXIF\S)'WS[U\J_P#!1O\ X)U_'3XF?$R^U>QM-3>.:\+
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M* *LR'=D>M!A#N)5_AJ1TST[TD=ND:%3)UH \X_:0^#T7Q9\#7>DM"KDV\N
MWNM?SG?\%//^"47BV^^*TM]H>B@AY)&!6'/4^U?T[_9T97C9LAE((->6>/\
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M/CGXZ^+D5XC7KK/>H3^_/M7]*'["6@:GXV^%EIJ7C'2!*Y5,^>N[M0!^>O\
MP2__ ."#&E?#;Q!'XO\ %?AF'>LBR@[5!R,5^QO@3X<Z!X"T6+1-&L_*6-%
M ]A6CHEG8::AM+'38H0HQ^[4"M6)0J9(R?>@"E- 5&!586DC/G%:<D>\]*<E
MNB]10 RRAV*.,58I.%P .M+0 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1D9Q110 4A8#K2T4 ,=(YAEUSBFJV?EC!%2T8'I0 F=HYH#
MKNI:* &LA)ROXT;0!EA3J* $8,<;30H8=32T4 %(RD]Z6B@ ' Q1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %1U)10 Q1DTC#RHVXJ2
M@@'@B@"C?70M;<2JIR?05!:7-S<QF220;0>0:O7<:NNTJ"*I"W<2?+P,T 2Q
MFWL?]*V?>]*@GDCOIQ=QC&WCFGS0.PQ@_C3?LQ$1 &* ,_Q5H>B>,M$N-#U.
MU\S?"R<^XK\@_P#@K;_P2)M/B!::AXE\/Z#$2R,00@/)&:_8>"U99"V*I^*_
M!^A>+]%ET?5K2*3S/[Z T ?Q4^,_V=OBC\#_ (Q2:!IFFW,02^$8V6K8_2OW
M?_X(*_#WXI'0M-U?7)G"K*N1)$5_F:^F?C7_ ,$?OAMX^\>?\)6ND1[FNA*=
MMO7TY^RY^S#X:^!?AN+3=+M(X_+((Q&!TH ];L8GBTV*&<Y<+@FGI L'[QA4
MJ)\V,<=J;=H6& * !9'F.(FQCUJ14?'S'FH+2(JQSD9JU0  8&*0L <&EHH
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MA;X'LOAGX5C\.V<00(%X4^@IW@'P7X<\ :)#H.B6<,8@3;A(P/Y5N.K.-P%
M$<2W!N-Z/U-:D.57RW.3BJ%NQ5]N*OPK_'0 I&TYIRN&[4M& .@H , T444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-NQWJRJ[1B@NHX)HP"=PH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH , ]1111
M0 4444 & .@I-HSG'-+10 A4-P10%4=!2T4 )M7TH"*#D"EHH **** # '04
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %(W3-+10!GWELDC[V3D'@TP^<PR6/%:$D0?H*:+9=OO0
M!1)=AM<Y]!4D$$9?=MY]:F>U;/ I8HBAR: )1$K*-XSCI3P !@"D4@BEH 0J
MIY(I0,<"BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***0,"<
M T +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2%01TI:  .!0
M U%()S3J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HR!U-%-D[4 .R/449'J*CHH
M DR/449'J*CHH DR/449!Z&HZ5/O"@!S' S3 <'-*YR<4E $@Y&:*:A/2G4
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% ";ANVTM-<<YI<_+GVH ;),L?4U&;E&4DD<56OI6$A4&A$C2/=-^
M= %A9U89IT4GF9%8.J^-/#^@@B]N0N/5A61_PO+P' Y5M14<_P!\4 =LSA6Q
MUIRKD9S7#2?';P&#O345_P"_@H_X7YX'QD:DO_?8H [=W5.,YIIF4+N'7TKC
M;+XT^!+Z;8-17)]9!72Z=JVE:K )[&X1A_O"@"X+C/)&,T22&,;@<^U13(^P
M%2"/:HQ=J!M)H NQ,74,>*D!R,D5 DR")<GK4IE0=: '4TR$'A:!*AZ&G @\
MB@ !R,T4A91QFC>OK0 N0.IHJ-W[G\*1)>.M $@8$XI:A>4+R#2)=;CC/Z4
M3%P,^U(DF\XQ3)>!D'K21-M.6H E+ 8S06P,U')*#RII%ESP30!*#D9Q2TQ9
M5Z$T[>OK0 GF>U+N/]PTTE0V1TIP=3WH  Q)P5I:3>OK1N7UH 6BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"\=+JPG$D;+G<O2OY#O^"<O_  4,^)7PR\>6&F3Z\R6_GQIC>>A./6OZA?\
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MW3J1['-3VZ/$ 6/6@"]10O0?2B@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^Z/I2T#&.** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@_\ $BY@>UEC=+B4AO*(_BH _=W_ (($?L,_#'QAHPU36[&WF>.U#@RP!LG
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2%TNLR$A<5ROA3X7Z%\.;;&E621(HYV^E;K>,O#GV,S7VHP1D=?,E H \/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (RYY%'0?0
M4M!&1B@"G<J7E)(I?*")]15@P@G) I'C&.10!3+S [%'%6+7*?>')I?LQ/(%
M/2%@<L: #G>2W3L:<8QU!IQ /444 ,S(. *AE.U\JH)]*LTR6,$;@.: (H7D
M5B\HQQQ3%G,\OR*" :DVLPP?UI8H50_(.: &I+&&92!D#TJK//-O\N)!S5_R
M(\YV\GK44MMAMR]: (;>Y(.R6I99G7Y(1G-$5ID[FI\L!QN4\T 0QW$B,2Z
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 R20KTH20MU]:** 'T444 %%%% !1110 4W>?0444 &\^@HWGT%%%
M "$EC@TX?*VT444 5KYS"1M&=W7-0365I>PYN+>-N>C(#110 D/AW14(9-,M
MP<]1"O\ A4MXZV$&+>-1@]ABBB@"&"9KQ"TG8<4Z&5@^P444 61"K88U/& %
MP*** &-*P/ I5D8C-%% #5D+.,U(Q(&1110 F\^@I0<C-%% "T444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
(4 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>camp-20241231_g11.jpg
<TEXT>
begin 644 camp-20241231_g11.jpg
M_]C_X  02D9)1@ ! @$!] 'T  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" 5D" D# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7PDTOQ3=6R)]IA+X0#'0'M7\6O[.!\_XN:>%'//\Q7]>W_!'Z!E_9@\-Y/\
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M8D4 *45DVYIBPB)BP/6E<.#E#Q0S9 !H 5(\*?>D#,@P!2'S01@\4Y]RC=0
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M)'.Y3Z_6OZQ?^"=W[7>@?M1? [1M<L+TS7D\!>9B^<C - '>_M3_ !9;X/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !12,<#-*#QF@ HI-V6P*4YQQ0 44@+YY%+
M0 444A8#J: %HI-Z^M*"#TH **;(S@83K2KDJ-W6@!:*0')XZ4ISVH ***1I
M%3[QH 6BFAF;D#BG4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% #&;RWVJG7O7#?M$%8_AS>R9_Y=Y/_ $$U
MW?4?,*X']HY"?AG>@?\ /"3_ -!- '\<O_!5!@W[3_BIL?\ ,:;_ -!%0_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 (Q &2*8TP QM-.E8JN0,TQ'
M=NJ"@ 63G.TTXS =J;)(R#A/TI%9VY*XH <+A2<;34@.1FH7(3D 4L,V[@T
M/>0(,FF_:(SU'YTZ1%8?,:B-LIY#\4 2!T(Z4*">AJ-513C?4H4 ;LT *!CK
MUICN2< '%*)1NVFE? 4MB@!%=5X)I#.N"!_.JY5I7X/%2?9UC3+/VXS0 P32
M!QGIFI9)4D7@5';!@C!UY[9IBF<3'Y/E]: +,4@9=HXP*>H(')J(PD@."<U*
MI)'(H 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MUY^?^!&@#VK_ ((TZI>6O[5UBD,Q Q'Q_P "K^PC]G<N?@EX=G8_,VG*2?\
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MX# Q0 44$X&: <C- !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M26\;920'JH/:OX2?AA\0_$_PF\7V?B30M3GM9;*Y65TB;!)':OW _P""6?\
MP<./H'AJS\'?$F RL&1?.O9>@7C^]0!_03YH5 Q[UQ_QT\?Z-\./ASJ7BW5;
MR.-+2#>=T@!_6OD2'_@N#\ IO#3ZLVOZ2)! S"'SSG(&?6ORL_X*U_\ !?G4
M?BG:7G@+X>!X(+B-H6DLY>#[_>H'<\2_X*]?\%7_ (GW/[3FK0?"GQ68K57)
MC^<D??/H16C^PE_P7J_:+T+Q;H_@[7?&TTBW%RD.R/?W_&OR_P#%WB_6/&FL
MMJ^MSR7%Q*?FDE.2>:^_?^"&_P"P+XE^/_QBM_$FJ^&Y_LNG:A'*KR1Y4J O
M^- C^GW]BWXQZQ\;_A!#XNUZ9W=TC)+@@\J3WK\4O^#G%$%C*8./]/'_ *&*
M_>/X0?#O1_AKX(L_"VD6\<*K:Q!EC&.0@%?@U_P<]2HFG20QL"PU  X_ZZ"@
M#\// D;/X^M\?\_!K^I__@WE4C]FG08^^Q?_ $ 5_*UX<O4T?Q?#?L^0DQ)K
M]T?^"0/_  6"^&W[.'PATKPMKHLM]NHSYLF#]T#UH _H,QTY'%1SS1H-TL@"
M]\G%?F+??\'&7P?BE/EP:<0#VE/_ ,57DO[0G_!R_P""M,TF9/#FAVTS[?E\
MF7GI_O4 >X?\%Z/VO_!?PY^!$FA)J:BX<21%5F&?FP.E?RF?$O69?$?CS5M6
M#;EGOY'7Z%C7TE_P4/\ ^"CWC_\ ; \9WLUS?W=O9R3AXX&D&T<Y]37@_P #
MOAAXH^+7CZQ\.Z)HT]V;J?:S1+GF@#]/_P#@V[_9NU'QW\8=*\3"P)1XHSO9
M/?-?TU>$='.A^&+'20,&WA"L/Q-?GM_P0<_807X!? '1?$VMZ;]GU%%4.DJ8
M<845^CV J8'I0 T2AI01T%2J&R6'?I4,:8;(-2[RHQMH S/%#.="N4<]4XK^
M9/\ X.48EC^-.O!NN]O_ $(U_3=XH7SM"N,_+\G6OYD?^#E:V$?QLUYA<;OW
MC<?\"- 'YC_LQMM^._A8'H=8BK^R/_@F"4B_9RL\#Y?(@S_WP:_C>_9;V/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#E5?GO4(9WZ,1CN:\K_:/_:X^%_[-FB-K/BC5K-BL1<QFZ4'CMC- 'KCK$9
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M^$7TE0S&T^Q\9<X^Y7YS?M<_M8?''_@K!^T1I6@:%::O]FNKAHHFEM'*HN,
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MRQRH^,Q!CDC%?S#?!K_@M+^VC\$95TGQM=^)GBLV\MUDL)1D+QZ5]B_LW?\
M!TUX>T;5+?3?B/X9U64Y =IX95]NXH(/2/AG_P &_P#X@^'?[5T_Q=TGPW<Q
M6QUX7:.H900 !V^E?LKX+TNYT?PQ:Z;>KAX+:./!_P!E0*\'_8@_X*0?"#]M
M'0S?^$]0M+62.$,T,ER-Q/'&#SWKZ&GG;(*G((R".E $L/WN*L,Q!P*KV9W'
M)]*G<$L* %4Y&:6D P,4M !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 -SM.!WJ.ZD=%XZ&GR$XW =*:9%>$,Z_A0!\M_\
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M'_@V8\&C43<R:=II7(.-R5[A\!?^"$?P(^&#K+XH\%Z==LK9!!7C\J /Y_\
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M0/\ @WL^'_BS2/C+IDU]9;4&I9)Y]:_J#U^*7^P+@*/^7=__ $$U\Y_L_?\
M!,OX0_ #5H]8\,>%;2V>*3>IB(Z_A7TY/Y1L626/<K*05_"@D_DM_P""Y/P^
M\6ZY^T)J\D%ENC_M=B.O3%?+?[)_PI\::?\ &_2[NWT_Y5SR<^J^U?UE_'/_
M ()7?!/XX:[+XAUWP?9S2SRF1FD(SFN5\&?\$7?@!X1U^'6K3P/8*T70J5H
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M3;(R92+'S8QVK]:!;NKF13UK%\>> M$\?^&[KPSXBLUN(+N/8Z-T(H _A?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *:_6G4A7)R: %'04'H:*:Y/2@!C D<5G^(=7
MAT70[K6KI@B6D1=F/85?D<J.*\[_ &HI=9/P5\06F@L1<S:8XCP,_-D4 ?C'
M_P %YO\ @LQJ_@C5M1^#G@/4U/FQ,1)!(%8$#';GO7X=2ZQ\<OVB?'<E[I>H
MZI>3W<R[HA>.<9/UKZJ_X*3?L7?M&?$#XZW?BC4K"2;YY0K+:N>"WUK[C_X(
M!?\ !)ZVUGQI)KWQ=\+^9&EN)(MT.W#!<CJ/6@#\S/%G_!.[]J_PSX.;Q?=^
M&]72%(%E,AN'Q@C->9_"SX_?&+]G#QM#??V[J4=Q!(F^ WC  !OK7]D?Q0_8
MU^#6N_#&?P7>>'P4:U6)0=N, 8]*_E]_X+;?LH>$_@#^T?KEIX:L(X;6%B$5
M2./G;TH _:K_ ((3_P#!5*?]I[P9_P (CXNO(TFTRV6)2S LQXZ_G7ZFPS1W
MENLL;9#*""*_D[_X-X/B#XET'XVG3-,N2D-QJ:+* #R,+7]7/AZ2--!LW ^]
M:QD_7:* +6]1E,]JC@@"D@G.32,K.^]>E/0NSC XH \W_:C^/&B_L]_#:Z\9
M:G>1Q!8Y #(!C(6OY9_^"KG_  56^)GQ_P#BIJOA/2-5N([:VOWBB-O<E0RX
M]OK7[#?\'&7[2]SX*^"%_P"%+#4/+E2:0$;OH*_FV^'WA>Z^+?[05G:.OF_V
MAJX$G&<Y% '4?![]EG]I#X[6_P#:_AS3=4NXI9/]8MRYY)KG_$VG_&[]F[QN
M8=>O=3LI;.X4[3=N.0>G6OZC_P#@D%_P3S^$_@+]G6VO?$/AH&Z)B<, .ZD^
ME?G9_P '%_[!/@CP58/\0/"V@")[J[W,^T<C=["@#;_X('_\%BO&&L:A9_"?
MQS=;_M5P(8WN9=[8!QQFOWYT34;3Q!9KJ5I.&5^A%?Q&?L*?%'6_A'^T[H=S
MIMV8DM]0.['L:_L/_P"">GQ)N?BQ^S5I/C2XN?,>XZN3U^530![B!(W7C;TI
M\3EAE^#4,\\A(6,\]Z%>3.&- %FBHU9L=:5G;!YH <<-QFFR*#R#R.V:K7%V
M;8;VSCVJ9)DEAWKUQF@!K2S.VS;QZU+&NP98U':RL1MDZT1B9IR)#\O:@">B
MBB@ HHHH **** (KR,2V[(>ZD?I7Y?\ _!73X+ZC+-:ZXEJQ16+EO;YJ_4&X
M+*F5ZUY'^U?\!;'XU^!;BQGLQ+*EJPCR!P:]'+,;]0Q*J'R/&F01X@R6=#JM
M4?@;IYA\UE$N75B-OTJRS"239.=@'?UKU7]I?]CKX@_!/Q)<WZ6&RU1G8A(C
MZY[5Y#)>!U$5W:R[Q][*&OV#!XJAC<.JC9_#V:91B<HQTJ%:F[IZ%A\K<)';
M'<#U-5M7>5KA;-%^8N!C\:62ZE90NEVDOF?P_NR:]Q_8^_9%\;?&?Q=;:EK6
MG,]M(5;YX2.^>]3B,90P&'=1,K(\BQN=XV,*4&W<^S/^"0GP8N-&TV[URYB=
M?/C#KGO]VOT-MB\5N!MZ "O//V??A!H7P@\$V6FZ?9>5)]F"RX ZUZ+#,DJ[
M<=:_'\SQSQ^+=0_N7@_)7D>20H.-GU'0RM)PPQ3PH7K0J*O(%&&)Y/%<!]0?
MD%_P='ZNVD_LN7DT:@YO''\J_+/_ (([_P#!*+PO^WKJNM7&L>(;JT^SMN)@
M=AV7T/O7ZA?\'4YMQ^RE="3_ )_V_P#9:\6_X-0M0B@G\4K"3RH_E'0!Z#-_
MP:C_  D 5D^)6JG*@G]_+_C3-"_X-5?A.FJ@7GCS4I(PP_UDLA'\Z_:JVE=[
M59 ?X14A;:H8=30!\+?L>_\ !#W]G[]DS4;;6M-G@O[B%Q(K7-ON(/U:OMH1
MVNG:?+9Z;:QQQ+$V%C4 #CVJ\UNDHWSC/I45S;1)93-&N!Y3?RH _FJ_X.>9
M?-^)GAVW=MH>_(;'&>7KZ$_X(0_\$L?@=^TY^RD_CGQ;- +P7:*%:#<>0_\
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MC]I[QKHG[1?_  4=2'X<V\DIB\9+N8#</N^H'O7]/G_!/+P+KW@']GVSTGQ
M,3-;P,!C'&S_ .O0#6A[M:(<Y-6:AM^M39 .,T$B#[Y^E+2#[Y^E+0 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?-7]<G_!%'7Y-5_8P\/V[RD\9SG_ &%K^1CP&$F^.I1C\W]IR8_[Z-?UE_\
M!#F*>#]C/0=PX$?_ +36@#ZR^(7QO^&?PG*-XS\8V-EYOW?M,F/\]*Y(?MT?
MLTR<I\6]$/\ V\'_  K\H_\ @XU\8_&333I2^ FD"@GS-DS+_?\ 2OQA@^+_
M .U?#*\27%SC>?\ E\D]?I0!_7X/VY_V;/\ HK6B?]_S_A0?VY_V;/\ HK6B
M?]_S_A7\A2?%K]KJ5\)+<8[?Z9)_A5+Q#\>?VJ?"]N;S5[NXCC499OMDG^%
M']B/AO\ :Z^ GC#4!I6B?$?2;J8XQ'%,2?Y5Z EW%<017MA*)(I!N4J>"*_D
MB_X)0_M=?%_Q1^TS:V.HZO.\+"+AKIS_ !'UK^KS]GV>74?@[H-]='+RZ<K,
M2<\Y- '813!H?-6/D5*AWJ'(P:;!$L,9"BG [N"* '4444 %%%% !1110 V0
M K@U7NF5$\MUWAAC!JRRAA@TQK=&QGM22O+78+1W9YI\6?V=_!/Q:TF:RU71
M[96E&-[I7S!\0_\ @DAX4U&Z^V:;J4$8=Q\J)TY^E?=4EM'(FP\4W[%#M"D9
M ]:[J.9XZA[L'[IX&8\,Y-F4_;5:2<SXI^'G_!*#P=X?NHKC4)[:X .2'3_Z
MU?3OPV^!O@'X8:-%I>C>'K2.2+I+&G-=XL$:C:!3?LD>_?DYI8G,<9B6E)Z&
MF7\/Y3E<_:8>BE(@C\J*$#:" .!4MJPE'F% GM3OL<60WI3_ "U[5QM)/0]I
M\S=[_(!EFQFAW&=N>M*% Z4TPJ6#>E S\FO^#F_X,>//B?\ LO7.G^"M"N]0
MN&O6/DVR9./EKQC_ (-B/@-\2_A%=^(6\9>$KVS\\#'VF/'9/\*_:GQ_\*?"
MOQ(L3I_B.S26,G)5X@P_6J?PZ^!W@GX8O*_AJPCB\[[VR%5_E]* .I@(_=H%
MXV#/Y4Z*0R3-&R' [U(D"(<@TX(H.X"@!K@B-@#SVJE=7<BV<T B)/E,!^57
MPB@YII@C+%B.HH _G3_X.0?V6_B[\4/%FG:OX.\(:A=&WN6<?9H@>[5\)_LU
M?&/_ (*$?LS^#W\&>%OA]XNAA\X,%@10.,^_O7]</Q _9\^'_P 2)%D\1:;%
M(4.1N@5OYUR,O["OP.E?>?#]M_X!)0-:'\S@_;^_X*8NFQ_!/C8=LD+_ /%5
MC:]\6O\ @IM^T C>&SIGC:&*Y^1AA<5_3V_["7P-D7:= MO_  "2MCP7^R-\
M(O ]TMWI6@6I96R-UDE ^8_!;_@E!_P0B^*/COXO6?Q5^.]_?;Y%1I8]5C&<
M@YYPM?T&?#'X9:!\-_ .G>!=/MH5AL;00-L'#@&NCMM%TS3TVV&G018Z>5"J
M_P A3FL]QR:"6?G!_P %I?\ @D;X6_:Z\ :KXN\+:=!;ZJ8MD301_O.5/3@^
M@K\,'^"__!0?_@G_ .+Y;;P/:^+KFSMY B"U50I7./:OZ\#;(\9BEA5U/4.N
M1^M<)\0_V;_AO\2HFBU_0+4[NI%HA/\ *@#^:G1?^"PO[=NAZ6FC:E\+_%3R
M",*7<+DD=_O5YU\3_P!H[_@HS^V!?/X2TO1?&-A:W#=4"[0"<>IK^D35_P#@
ME7^S3K5S]JN=(0,3GY;-/\:Z[X9_L'? [X6S)/H&B0,T>-I>S2@JZL?D1_P1
M%_X(=^(/#_BR;XO?&B2:6]>=;M1J4?S;L*.PK]S=-TRR\/Z5#IEA"L:0PJ@"
M#C@8JUIFBZ;I%LMKI]G%$JK@>7&%_E4SVD;_ 'J!-C+-]U2D[F!HB@2+[M."
M '- @ .\GVI:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** # ]**** "BBB@ HP/2BBH>X!1112 **** # ]*0A1
MU I:0J#UH 7(]:*38*6@ HP/2BBJ3L 49'K00#P:38*?,@%HHHJ # ]****:
MW ****L HHHJ'N 4444@"BBB@ P/2BBB@ HHHH **** "BBB@ HHHJUL 4$
M]1113 , =!1110 4444FT@"BBBES( HHHHYD 4444-W ****D!#P,@4;C_<-
M+10 FX_W#1N/]TTM% !111570!2'[X^E+1@9S3NF 4444P&_\M*=1@9SBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****3:0!1112YD 4444
M<R ****=TP"BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4A^^/I2T4 %!.!FBF2'G
MZ"@!KS>4-Q!-+*P>+:%QN%,W'.<9/I6/XY\96O@OPG?^(]2=8TL[<R9;I@4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%%0]P"BBBD 4444 %%%% !1110
M 4444 %%%% !1110 4444UN 44458!1114/< HHHI %%%% !1110 4444 %%
M%% !1110 4445:V ****&[ %%%%+F ****EZ@%%%% !1110 4444 %%%% !1
M110 4444 %%%% !11136X!1115@%%%%2W9@%%%%', 44450!1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%%3S %%%%', 4444<P!1114O4 HHHH **** "BBBFMP"BBBK ****ENS
M ****.8 HHHJ@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^9K^/K_@C_\ \G=VWTB_]#-?V$?L^?\ )$_#G_8,7^9H ["(87FG4B=/QI:
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI-V ****GF8
M!11132N 4444<J ****D HHHH **** "BBB@ HHHH **** "BBBC8 HHHI\S
M ****0!1110 4444 %%%% !1110 4444 %%%% !1113NP"BBBAML HHHI %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444; %%%%/F8!1112
M**** "BBBK6P!1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBBLP"BBB@ HHHH **** "BBB@ HHHH
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M_F: .Q3I^-+2)T_&EH **** "BBB@ HHHH ***,CUH **,@]#10 449'K10
M4449'K0 4449'K0 444FY?[P_.@!:*** "BC(/0T4 %%!('4T4 %%&1ZT4 %
M%&0>AHR/6@ HHR",@BB@ HH) ."11D9QF@ HHR/449'K0 449&<9HR#T- !1
M1D#J:* "BC(ZYHR,9S0 449!Z&B@ HHHH **,CU%&0>AH **,CIFC(/0T %%
M%&1ZT %%)N7ID4N1G&: "BBC(ZYH **,CKFC(]: "BC(SC-% !11D=,T4 %%
M%% !1114RV **"0.IHR/45(!11D=,T54=@"BC('4T9!Z&J ****S ***,@]#
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1115)( HHHH:0!1
M114@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4445:V ****8!1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M5F 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4445:V **
M**8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 48'I110 4444 %& >HHHH **** # ]!1@#H*** "BBB
M@ HP/2BB@ HP,YQ110 8'I1110 5^;?_  <)_P#)NVO_ /8+_P#9:_22OS;_
M .#A/_DW;7_^P7_[+0!_/3_P1_\ ^3N[;Z1?^AFO["/V?/\ DB?AS_L&+_,U
M_'O_ ,$?_P#D[NV^D7_H9K^PC]GS_DB?AS_L&+_,T =BG3\:6D3I^-+0 444
M4 %%%% !1110!%.Q&:9 7(.<T^<#.344MS#!@&=%SZL*4FHQNQ>ZG?J/!8+D
M&G;LKEC4(OK-%^>ZCQ_OBAKRSD VW4?_ 'V*F,J-KW*DIN'PL>H89()H:4QK
MGO49NH,@)=Q#_MH*0W-J.9;N/_OX*KGHVO=&:<K<L8,E>4X&>].BB </N-1"
M6"<#R94.!V8&I8F9EVTDE+WD6O=7*]R:D9-QSFD+%% /6D>0A@!5 $Q94PM<
M7\5_C7\./@EI+:U\0O$D=A%Y9=6E]/\ (JG^TC\?O"7[._P\N/'/B^Y\N"-'
MP0X7D+FOYO?^"EG_  5C^/?[</QI;X*_!7Q+/+:1ZF;,QE7<!3DXX..]!2/U
MC_::_P"#@G]G;X37$]GX'\>Z;?S1 X0A>2/K7AOA?_@Z"\-:EK'V36+C3(8-
MP'F;$Z5\E?LE?\&W'QD^,VCP>.OBKHEM<"<J[EHL$AN>Y-?0_BK_ (-=/ UU
MX:^SZ'X&MUOEC.6*+UQQVH"R/OG]E#_@L9^R]^T':I;O\3+!;Z0@1P)C)/IP
M:^MM%\2:;XGTA-7T2Y$T+_==>]?RE_MD_P#!-G]J?_@EQXRA\8>$A'96]N3.
MK0PMP,9'W37Z=?\ ! W_ (*]:O\ ';P_I/PJ^*'B&2ZU01*TV7.#D8[Y[B@D
M_5WXN_$C3?AKX*O?%VHW2QQV%JTSEN@ KX$G_P"#@OX*VOC)O"\WBW3EV2LC
M9"\$'%?2?_!2[4=_[)'BW4].; E\/2LIS[U_&EXQU#Q/<?$;4]1M'9IEU*<*
MP4G_ ):&@#^X#]GG]H/P3\?? ]GXN\+:U%=&ZBWXCZ=,UVRZA-+(863 )QQ7
MXQ?\&T/[8Z>+8(_A7XAU,M+I^G$&-GQ@[#V/TK]G?DF1;J#HPR* )?.EA.Q!
MDUY/^UC^UCX'_9;\*'7O&.MPVAD@+Q"7&#C/K]*]4WRQQR7<AR%C+'\!FOY^
M/^#HG]M?6-?N=(\!^#=5;%K*T%V@)/=_3ZB@#]!/@3_P72^#7Q<\=Q> [;Q=
M8-/-*RJJ!<G#8_K7W?X?\<6>N>"%\7V4RO"8&DWCI@#)K^,'_@EUJ5ZW[96@
MK=;@9'9B&&.KI7]>O[/[2C]E ,YX_L2XQ_WZ- 'SQ^TU_P %H?@]\ /%Z^&]
M7\66,4F\JRR!<@CZUY?+_P '&?P%BNC"_C73 H[X6OQ9_P""O7AN\\:_M@6W
MARVP?M&I2KM;\:^F/V2_^#<WQ'^T-\';'XB1>'[:4771V0>@/K[T%GZ&M_P<
M8_L_L<KXXTS\EKT3X-?\%WOV6?']U&FM_$W3H"S8P M?GO)_P:K^,!GR_#%G
M_P!^Q_C7BW[7/_!O!^T5^SEX O?B%X,TNVABLQP(X<G.">Q]J!/8_HS^$GQ]
M^&/QGTZ/5_A_XGBU!)DW Q],5VTDJVT9VMEB.!7\OW_!'/\ X*C?&_\ 9A_:
M#;X-?&GQ4PL8I([2W@&Y=K/\O<GOBOZ7?A_XB/C7P?I7BN"<.EW8QS @Y^\H
M-!)TD)EG@'FC:WH*E)5%"LU54>ZEDWHXV^]2LCDCS.: %(P-@/![U5U76M/T
M.R>]U6Y$4,2%FD/8 9)JS<3PVRYE8!.Y)P*_'3_@NC_P6/U;X)6$OPK^#GB=
M[?5C<_99PDA;(=@N,+]: /M3]IS_ (*_?LN? (361^)MB;N($&*3'WAU'-?%
MWC3_ (.@O"NC:X]CH-WIEQ;J>)-J>M?G'^R;_P $P?VM/^"E6L7'Q!\9)'=V
MLETTA,\##*LW^T:^Y?"7_!K7X,L]"1?$?@BW>ZQ\S!%]* /I/]G/_@X=^ GQ
M-U*#3_&?C;3;)YG"X 7O]*^_?A9\?/AG\:_#R:_\.?$L6H0.%^>+IDBOY]OV
MMO\ @VZ^)7P7\-WGQ&^&>@6UNNFPM<@K$"1CZ&O./^"4O_!6'XQ_L@_&JP^"
MWQ>\23)I273">W 9<A'"]SZ&@#^G>^OOL&FSW\YPL$+2,3V !)KX8_:8_P""
MUWP;_9X\8#PGJ7BRQ24R,A64+D$?6OJ/P3\7](^./[/%Q\0_#$A-O?Z-<.A8
MY./*-?RL?\%AM&;Q/^UQ#HL0!DFU*51GUYH _;R7_@XN^ EL,R^-M-#>FU:K
MC_@XU^ \3;AXUTT@^RU^=O[%O_!O!XB_:=^!MA\3AX?MI3=X^=D!)^4'U]Z]
M3/\ P:M>,F)1/#-GCM^['^- 'Z ?"'_@O?\ LO\ CVYCM=6^).FPNYQ@!:^O
M_@O^TS\(_CE9)=_#_P 60W[NFXK%Z8S7\]'[4W_!N;\>_@!\/[WQ[X(TBV@D
MM!\A2')'!/8^U>:?\$H_^"C7Q]_9*_:8;X2_$WQ44A2XBM1$-R\N=O<^] ']
M3ET91"9XERP' ]:Y#XC_ !Y\ _"'PT_B+XBZ]%IT29W-+T&!3_#7Q(MKSX2Z
M=\0)Y\Q2Z9%<2-NZ[E!K\ O^"]__  5#\:^.?C-JW[-GPS\02+B?"1$DC#.5
M[?2@K<_0;]I3_@X4^ WPIU";3O!?C33;Z2)RI4A>#^->(>'_ /@Z'T6^UI=.
MU1],A@8G,FQ..:^2/V-?^#=OXK_M$^&;+XI?$+1;:YBU: 7*LT7)!X[GVKZ1
MU[_@UP\(3^'G&G>"+87V!L?8OI0#L?=?[*G_  6A_9A^/4L.F:K\2K"&YD
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MQM'C!!KTZ)=JU\?_ /!'K3UM/V6/"D<XRZZ&FXCUW&OL"-PZY6IEL ZBBBI
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHJUL 4444I; %%%%2 4444 %%%%
M !1110 4444 %%%% !11151V ****H HHHK, HHHIK< HHHJP"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ****F6P!1114@%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%%5'8 HHHJ@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBBB@ HHHH **** "BBB@ HHHH **** "BBBIEL 4445(!1110 4444 %%%%
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M IQQ_C7<_M-_M!>"/@!\,=2\2>*=;BM)(;%I(!)_$17\NG_!2_\ ;$\<?\%
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M110 4444TV@"BBBB[ ****0!1110 4444 %%%%--H HHHHYF 44458!1110
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M6I&9$Y-(HP"Q[4GF+(VPK^-9@#+CYDZ'K3HV5A\M1QQ2(YWMD$\"I0H48 H
M6BBB@ HHHJH[ %%%%4 4445F 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44454=@"BBB
MJ **** "BBB@ HHHH ****A[@%%%%( HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBBK6P!1113 **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH ,@]#10 !P** $89%"@@8-->3;T
MI5D!'- #J*3>/0T;QZ&@!2,C!I  .E&\>AH#!NE "TA0$YR:4G R:8TZ*<4
M+YB]&.* ,#*'-1OL?M3X\(F,T +ESQMH "=349E<MA309D#>7)R30!*RAQP:
M10$'+5'-(ZJ-AQ38_.E^\U $P +;@:=488*=@X-*';UH ?10"",BB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *_-K_@X4_P"3==?_ .P7_P"RU^DM
M?FU_P<*?\FZZ_P#]@O\ ]EH _GH_X(^?\G=VW_;+_P!#-?V%?L^?\D3\.?\
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M444 %%%% !D'H:*CPV\;.E++.D2,['A%);V H )(R3D4WRV'0G\J^6?VMO\
M@J3\ _V;2;/6?%RP7*9#*VWJ,^IKY"UO_@X_^#-I?F&T\=PE 3U9/\: /UC\
MM_4T>6_J:_)7_B(\^%17>/&\.T]/F7_&F6__  <D?"";4H]/'CJ$LYX&Y/\
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M1110 4444 %%%% !1110 4445#W ****0!1110 4444 %%%% !1110 4444
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M<3KY; )P#UKY$_X)D?L,#]C_ .&^G>$OM_FFT4#=C&> /0>E?7<@R5QSCK0
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MB*VN_.9;"$NQ;/)45_*I_P %7/V?-+^ ?[6M]'H92-(M<B")$N-O[P5^\O\
MP;D>/K_Q!^SM=1:C<M*T:HJ;ST .* /TP,,,AV.O-/CC*@J>G841$'JN#3Z
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MHHJP"BBBH>X!1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX_9@N/%>I62?;;C0Q*-JC<&R.P^E?CM_P7._;Z^/FL_&J\^'.@:CJD=M)'(
MBP.5X(']: /FO_@J)^T;I7[0?[7%_-IMZLT<VMQ&,KCG]X/2OWP_X-SOA]<^
M'?V>;FZOXBF]49?H37X-_P#!.#_@GW\5/VI?C)9Z_P"(-&O'47D,TDL]JP#
M,">2*_JS_8P_9YTO]GOX3Z?X9LK..)GL(1($]0HS0![(FQOG4TZF(I1L#I3R
M0.IH **** "BC('4T4 %%%&0>AH **** "BBB@ HHHH **** "BBB@ K\V_^
M#A/_ )-VU_\ [!?_ ++7Z25^;?\ P<)_\F[:_P#]@O\ ]EH _GI_X(__ /)W
M=M](O_0S7]A'[/G_ "1/PY_V#%_F:_CW_P""/_\ R=W;?2+_ -#-?V$?L^?\
MD3\.?]@Q?YF@#L4Z?C2TB=/QI: "BBBLP"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH ****J.P!1115 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4445,M@"BBBI **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBBK6P!1113 **** "BBBH>X!1112 **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBBK6P!1113 **** "BBBH>X!1112
M **** "BBB@ HHHH **** "BBB@ HHHH ****:W ****L HHHJ'N 4444@"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBBK6P!1112EL 4445(!1110 4444 %%%% !1110
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MA'[/G_)$_#G_ &#%_F:_CW_X(_\ _)W=M](O_0S7]A'[/G_)$_#G_8,7^9H
M[%.GXTB_>-*G3\:1?OF@!U%%%9@%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M454=@"BBBJ **** "BBBIEL 4445(!11151V ****H HHHH **** "BBB@ H
MHHH **** "BBBLP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBBFMP"BBBK ****A[@%%%%(
M HHHJUL 4444I; %%%%2 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%%6M@"BBBE+8 HHHJ0"BBB@ HHHH ****M; %%%%*6P!1114@%%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH ****I.P!1111S( HHHHYD 4444-W ****D HHHJD[ %%%%',@"BBBCF
M0!1111S( HHHHYD 4444<R ****.9 %%%%*S ****+- %%%%( HHHH ****
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M[L8XH2N ^BFM( N5-)"[NN7'>HYES6'9CZ***H04444 %%%% !1110 4444
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M$^,FG1KC/V9/ZT ?TL:$^W1+8#KY0JTBD?,U4]!7=HEJQ[1"KGFGS0BCCUH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1115K8 HHHI2V ****D HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH ****M; %%%%*6P!1114@%%%% !1110 4444 %%%% !1110 4444
M%%%% $1D .TBF.-C[VZ>E/88Y/:FNHFCZTX)\EV$6N:S(IH\CS-P4#DDUSGC
M7XL^$/ NFR7>JZY:(T?_ "S>X4$_AFN&_:D_:3T/X*>$Y9I;^-96@;:&QUYK
M\A_VI?VS?&WQ@\8RMI>KW$<&67$$Y4=<=J]W*,CJYA.[V/S[B_Q!RWAJC*'Q
M370_535?^"@WPOL+LVCW,#;3C<)Q6_X&_;-^&?C&=;6VU6TC9VP UR*_"B;Q
M#XIE/FW/B"\!;CFX;_&IM$\?>./!>KPZO8>(KYQ&VXK]J;'\Z^KJ<(1]C=/4
M_',-XZ8Z=3DE1]V_?_@']%&B:[8:S&L]A>12J>ACD!%75,A8Y:OS/_X)\?\
M!174-0O+/P;XLN%5<+F25@3Z5^C_ (?\06/B/1[?5;"<.L\>X$=Z^'Q^4ULM
MQ/*]C]\X9XEP'$^"4Z3M+JC4C;,>:!*,_-^5-B&U"N>M-V/NSCC-<#2O='U%
MN6F^Z+0.1FBD3[HI:D HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &R@E< TFY44
M9P:<XR.M5Y)!"CR3'"J,YI*_/KL-*^@\RJYR%I -S';7&:_\:O!?AZ]^Q7VL
M1QL,Y!JI%^T-\.@V3XBB&:Y)YAEGM.1U$GZG=3R?.)QYXTFX^C.^E#!@*&7"
MXR,UPZ_M!?#J0@_\)#%37_:!^'HGVGQ!%3_M/ Q_Y>1^]&D<CS.7_+F7W,[L
M(<?,<U)&, @5P<G[0/PY+I&/$466/2NM\->(M*\267VW2;H2Q_WA6E/%X:O*
MT)IOR:.6ME^,PJYJM-I=VF:-%%%;G,%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% %942<^9*.17EW[7GQ.N?A3\)+[Q';7!B_T>4 @_[%>IS-
MY<P4#@]:^<?^"I%AJ&H_LUWD&DQN\FR;B,<XV"M /Y<OVCO$WC#]L+]NB;P]
M;3FY\KQ28P"I/5?_ *]?J-\<;W7OV&_^":NJ_#O4;@6TSI%,(UX_Y9/V_&OS
MH_8CUSPGX _;]U34/B*;>!4\6[E:\./X5KZK_P"#B']J_P #^.+:3PG\/_$=
MK+:R:4@,5I)E2?+44 ?F_P#L\?!35?VS/C]J%M:6PN7N9USE<]:]9_;T_P""
M>?Q%_8!\7:!XGL;6.T\RRCN0R)C[R!NQ]Z^CO^#:_P#9JBU+XNZCXY\4H$M5
MM?/62=?EPJ$UZO\ \',WQ\^&WB'Q'H_@SP==65]-'I20$VS$E66(#% 'W#_P
M;J_M2ZW\6?V;O#^@Z_J)FE,8+#)Y^1:_49][ >7T[U^*_P#P:]^%=>TWX7Z%
M?7]G-'$8!PPX^Z*_:=B3C;0 2;8EW#K7&?$#P;\/&T^;7_%$486)&D=GD5<@
M#/>NPDB)N [M\H[&OR/_ .#@+_@IAJ7P%\!MX5\'Z@\-RTC02&WDPPW''/-
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M_P $=_B]^S=X,N_%/B/3(DAMH/,<K$1QCZU_7:_PY\%J03X=MCS_ ':_//\
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MMK_6OT'PSJ5:V=OGDW9/J?DWC%0P]'AN+A!)N2V7F>V4445^^-6/Y>"BBBD
M4444 %%%% !1110 4444 %%%% !1110 44455D 4444-6 ****D HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHIK5@%%%%/E0!1112>C KQLTGRW P>
MU<A\<?A\/B#X%N_#S0>8'@D &,]5Q77;@5\P]JCV3S9D,F$(Y!JP/Y2O^"N'
M_!./XT?!OXWW?Q%\&>'I(XYM3:X\Q2R\8// ]J^1](^$G[0/[1WCJWT34M/D
MN)G78%:5VZ8'I7]??[2W@#]EGQ*D=G\6++29I)00JW=VBDGGL:X3X._\$]OV
M,4N5^(?A/P)I,<,3_P"OBG4J"3GK^% 'R3^PC^Q-J7[,7[&I\6C2FM]3N/#E
MP'^7'S>40.:_%WQ;\&OCA^T]^V<NB^(-/DGC.N3Q1 R,WRAR!U%?T5_M0?\
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MV_\ MP_!"^^"E\BZ_ILSO!* B7RD\I]: /Y?_@!#=_#G]NJ'P_8DQK9>*1&
M#C@+7]=G[#.OR^)/@K8W5U)N<00CKG^"OY"]"\>:)8_\% ;GQ3(5-I+XM\U3
MNX"[1WK^H3]B?]NCX):)\$K19=?TZ$I#$"CWJ@_<^M 'VPOF!L8XI7)W<5\]
M6G_!1GX(7U\MC'XETT,SA0?MR\_K7LG@+XD:!\0]-&I:#=PS1X!WQ2!@/RH
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M'Y4#!^84M9O5FB5D($4'.VC:O]T?E2T4AA1110 4444 %%%% !1110 4444
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M4 %%%% !1110 4444 %%%% !1115K8 HHHI2V ****D HHHH **** "BBB@
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M* "BBB@ HHHH **** "BBB@ HHHH *_-O_@X3_Y-VU__ +!?_LM?I)7YM_\
M!PG_ ,F[:_\ ]@O_ -EH _GG_P""0G_)W%M](O\ T,U_8/\ L[_\D2\.?]@Q
M/YFOX^O^"0*AOVNK8'TB_P#0S7]@_P"SVH7X)^',?] Q?YF@#L1]P_6A.OX4
M(,K@TH4#I4/<!:***0!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M* "OS;_X.$_^3=M?_P"P7_[+7Z25^;?_  <)_P#)NVO_ /8+_P#9: /YZ?\
M@C__ ,G=VWTB_P#0S7]A'[/G_)$_#G_8,7^9K^/?_@C_ /\ )W=M](O_ $,U
M_81^SY_R1/PY_P!@Q?YF@#L4Z?C2TB=/QI:A[@%%%%( HHHH **** "BBB@
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M]6QP:A!'8T]6&.368$M%(",#GM2TUN 44458%?4HWELY$C&24(_2O@K]I?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<T:U/%4HU8;,_/:^'K82O*E5W6@X=!10.!BBK,@HHHH **** "BBB@ HHHH
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MH<C)J*:001F22H7N7,0G$@5.OS4W"4=@CSREKHBWDO\ ,3P*:S*W0UPOC_\
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M,^>2_42!7?%T9"H'\-0ZG-B2*XA&UHY P8=>#FGSW$:CR8SUJ"]D0QI&3RS
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ME=*V]D?PMG4I/.:W-_,R8=.**%Z#Z45Z"V/,"BBB@ HHHH **** "BB@\#-
M!13!, "6Z#O33<!AF,T+4-MR6BH'N"@ /?I3DE?&YNE.S#3N2T4QI<_ZL_G3
MLL1\OXTM;@+13'D*CWIJW .03S2;2=@6I+147FN#EN!2-< G"GFJL)M(FHI%
MR1DTM(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4J[M'\J\2X6C@<]JT:'PQ=B9>@^E% &!BBO5/$"BBB@ HHHH **** "BBB@
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M&+_,T =BG3\:1?OFE3I^-(OWS4/<!U%%%4M@"BBBE+8 HHHJ0"BBB@ HHHH
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MI[TLRXCP*7N,UX5\*L^QV,7UN/+!&Y^PM^SQ;_!WP BW%HJRSP(YP,')YKZ
M16=MP;BF6L-M%;K;6T2JJ+@!%Q4\:"-=H.:_,,9B*F(Q'.S^L\KRVAE> CAJ
M2T2%)P/I3=Y)S3R">WUH( J;IH[I)IJP]3E14,JDYP:F0@CBHI%'(I?;0I['
MRI^UM )/$=PDAR-W]:\6\806R>'\",<15[9^UE#YGB:X4$_>_K7BWC*#9H/!
M_P"61K\PXBDEB:J/VGAR=L%AU;K_ )'@U\+9=6SY'\1_G4T\5HRC]S4>HN5U
M,KM'WC4FYF7D"OPRJN:O/U/Z5IQYL/2=^@U+=%Y XIJQ1&<DJ*>LFXX(I1;%
MVW FFHQ=/E!RGRIE=+"*348GXX?->X> 8(&\.;S.@QC@M[5XDUM)'*'&>#ZU
MLVOCW4M&LC:19P?>O<R3&T<OFW-Z69\SQ3EN*S6,(T5K='U'^SZ8#XM*"53@
MCO7V/I+_ /$MAQ_SR'\J_.O]DGQM?ZIXY,<N<97(S7Z(:&S'2K8G^*%3^E?N
M7!N,PV*P+<3^:/$7!XO YO&%5%N)B7P14M,5@&VT^OL$HK8^ W"BBBF 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% #)E#)\U1(0P("]!4TH!7!]
M:CD9(EQNZT1;;:!J]B))F)VX.,UP_P >? DOCCPP--A R01R/6N]0*4.,9IL
MZQ% )P,>XK'%4H8C".$CHPN)GA,9&O3W1\&ZC^P%KK:E-J F3:\I;  [FO(?
MC-\)K_X7ZM+;W# ",GI7ZBR?V<%.Z)"._P HKX1_X*&-%_PD=ZUE&I&\XVCW
MK\AXRX4P&694\12>I^]^'W'6=Y[G*PM;:W^1\Z0W2,H)CSFG2,K'*+@54TB>
M=HQNBZ"KF[SOF9<?2OR&E94S]\JTJRGS2>@J]!]*&Z'Z4TL5.!VHWD\'O5$#
M0,YY[5<^'\8_X32R/_3TM56!496K7P]<?\)I9;C_ ,O2U5-7Q%+_ !"J3@L-
M53WY6?J#^SPV/ \0 _A3^5=W@>82PKA?V>=I\#Q$'/RI_*NZ/^L(K^L<L7_"
M?2]#^%\\L\XK6_F9)10.117:>8%%%% !1110 4444 %#=#]**1ONGZ4 0*X9
MBN#R:) L R!^5(CDDE1T]J:\G!D?H!3LV[(E.\.:.PYQO"L?YTX,'^0?SKYP
M_:1_;LT+X(7:6=S=P+\^T[P/ZUY5:_\ !7;PE(N$U&T+9Z86NV&7XBI&\5<^
M>Q?%&1X&IR5JZ4NVA]RM^[' I(S(6SGBOBV#_@K/X):+,^K6BMCIA:I3?\%=
M?#44I"7=F5SUPM=']C8_EOR,YEQWPP_=^L1^]?YGV]-(5XQ0JH@#-WKXCL/^
M"NGA&^U!;3^T+/YB!]U?6OJOX1_$S3OBIX>M]<L;E7$T0?Y.E<M3!U:*_>1L
M>GEV>95F5=QP]52\D=E/,D<9.*9&0X#A,9]J22-5Y8\ =Z!*<!8ER :Y4KL]
MB+FTWRV+2]!2TB9VC-+4C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH ****M; %-9%9LFG4QL[\YZ4I
M*Z ?P!3)0QX7O2$<YH:;"$CM0URQ$G>5A-H5-AZTT-M!+=!7 _%#XQ1^ D>6
M1D&W^\*X:;]KB*33YI8A$2J'L*\^KF.#PK:JO4]'#95C\9)*C'1GN37]D'\M
MYD!]VIEU=6'V=PMS']P_QCTKX4^)O[>GB72M;,%C:HPYZ$5A67_!0/QU.K1M
MIZX*D=17R6(\0,JH5W39^AX7PIXDQF&56G:S/7_VC_(C^(.G,ERA!DR<,/0U
M[U\#KBS_ .$+A+74>>/XAZ5^=GC/]HOQ'XOUF+59[?YHFSUKK?"?[;WBOPO8
M+I*6HPO<L*\' \=9-2Q4IM;GT>9>%^?U\NHT4U>/H?HNU[8GAKF,X_VQ3X)E
MF7]S(,?6OSQ;_@H-XRCOHT%DI#. >17NOPE_;*N-:T#[1JR11R9&%XKZK*.-
M\HS2NZ5/='Q&>>&^?9/0C7JVY=CZ<5&#',@/XT19B;#'J:\4\-?M0V^L:U]B
M$D?+ <8[U[-IUXFH645V#]] U?487&TL9?E/A\;@*^":YU8L@#S,YI]1HP+X
MJ2ME?J8L****8@HHHH **** "BBB@ )P,U5PY8\\59D&5J(N"I53DT:A=(\^
M_:1M[BX^$>I16I(8@8P,]C7X3_M*6EQ:_&;5!-D.'&21[FOZ /$VB1^(]&ET
M.Y&%EZ\5^.?_  4J_9D\1> OB+J'C#2-,DDAFG #=L;O_KU]KPACJ&&K_O#\
M)\:LCQF,RJG7I:J+U1\PVWF3VY9ST'&:;"K@9$E1P:FA7['<X1QPP]Z'6"W'
M$V1]:_26XSU@?RG4A!.T-">%8P'9@"0*U?A9'_:/CRUCMAB7)"X'/45@"YM8
M@0LV2W;->Y?L+_L\Z[\3?BOIOB"&QD>U1R'9>G4?X5QYAC*5'"2YNQ['#>7U
M\QS>E2I1?-S)W]&?L'^QC'-9_L^:)#<9WA#G(]EKU8?.FXCGM7,?";PHOA/P
M/9Z"J[?('3\!73%RA" ?6OQ.O.]24EW/[_P$'0P-&F]U%?D/@&1N)%2U'&BY
MW U)6-K(Z^H4'@9HI&^Z?I0! K><21VK.\0^)K#P[;&>[=0!URV*O@&!CCG-
M<7\6/ EUXNTZ2&">12V?N,16=>K./PKH;X2GAJF)M-Z&=XE^._AB31+VV22/
M/DL#^\K\]/VC]=M=?\>&[M""N6Z'WKZJUW]F#5[>QOKM]0N\&,G!E:OCWXN^
M%W\*>*S8/,[DLW+G)ZU^,^)&(Q-3#TXS6ES^A/";!Y?1QU2="5W;]#%C_P!2
M/K21=?QI8_\ 4CZTD77\:_*X['[I+XR0??/TJG!_R'[7_KN/YU;)(8D53M^=
M>M?^NP_G7/+IZHJ'Q/T?Y'Z/_L0C'PZ(_P!I?ZU[D3@@>M>'?L1#_BW)/^TO
M]:]Q;J/K7]5\.?\ (CH>B/XAXM_Y*.O_ (F2CD9HH7H/I17MGS@4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%-;@%%%%6 444
M5#W JLBNX=.WK7 _M)>/[[X9?#V;Q3ITYCEC5R7'H!FN]FA*G:'P/6O/?VC?
M 5QX]^&]YH44I):"3:0.Y6K _/'X#_\ !>WP _QNU/X7_$K7Y7F34_LML#-@
M*<#U_&OTN^&GQ)\)_%7P]%XDT*_BDBD52 )E8\C/:OY+/^"F'[*'[0O[.7[1
M.I^/?#NCZPT$VL/.LT,8 48Z_I7T#_P3-_X+K^//@!;6GA'XD27=T(W&_P"V
M2CH.,=10!_3+XH\2>'?".ERZOJUW%'%#&SL7E"\ 9[U^8/\ P4P_X+S_  V^
M!ES-X,^'WB&2*^*%%,<^1N ]J^ O^"C?_!Q%XI^+'A8^%/A[9SV+N2GFV<O+
M G']XU^>WPF^#G[1W[:/Q+BU*ZL=9OX[F[8F5E#!030!_3%_P1[_ &U?'?[6
M/@73?$_B?5VNA<Q@DMGGY0>]?>CPPJ"ZK\U?"7_!%;]D+6OV;_@'HNFZ_%+'
M<P( Z2K@CY17W@R[N] $0<M'B7DT(9%P5.*<R =J1F"\XS[4 ?)?_!8#PEK'
MB3]E?Q.=,0MBPQ@+D]#7\N?[._Q]U/\ 8U_:^;QQJ4DMLR&-'8*5X#G_ !K^
MQSXJ_#O3/BUX(O?!VJ0IY5W'L;S!Q7\_G_!8S_@AAXFM/%^I^/?AG93W&Z0[
M(;*+/0D^E 'Z1_LH?\%Q/V9O$?PJT6#7=5D-VM@HE+7*CYLGU%=-\<?^"W_[
M,?@;PA<7NG:NPN4&59;I3V^E?R\Z_P# #]M'X77,ND:?H_B6)83L0(@%5M"^
M#O[:WQ$N1I>IV/B:0R'[CJ#F@#U7_@IA^V1%^UU^T9)/H5S+<13:U$T(Y;'[
MP5^^O_!N9X#\3>%/V<KMM=C*^:J/&"I'!.:_++_@EO\ \$(_B1\1_'UMXR^)
M]I>VT:RI./MT(P2O..E?T7_LX? ?0_@#\/[7PSHL$2+':1H_E#&2 * /2(V!
M&!3JBMW\T>9C\*EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MK\V_^#A/_DW;7_\ L%_^RU^DE?FW_P '"?\ R;MK_P#V"_\ V6@#^>G_ ((_
M_P#)W=M](O\ T,U_81^SY_R1/PY_V#%_F:_CW_X(_P#_ "=W;?2+_P!#-?V$
M?L^?\D3\.?\ 8,7^9H [%.GXTB_?-*G3\:1?OFH>X#J***+L HHHH;; ****
M0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5%+* _EFI:BF(+=.?6D^;H--)ZD$_E#&%YIR.NW:_0TX-'D[P
M#QWJO-<Q0@W5PX1%^\S=!6E1<Z4>I#IR4G)/0?(H7Y%X6G^?:0)_K4''=A7@
M'[2G[=7@SX(13QQO;7<T608P_/\ ,5\7>/O^"PVI76IRQZ=H3J@DXV-_]E7K
MX/),QQ4$XK0^,SKCWA_(FUB*FW3<_4^.6UE^=)D+=L,*D\MB3ENM?E;\.O\
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MK1)"=W4BGH-JD'UXJ.&,JH&.*EK\LHW5.SZ'[+.\JK=QCJQ.5H1&!^:GT5H
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M_&UQ*8KV(7($T.TD<_X5^D'_  2\\*:MX]_80OO#GA'<MRUZJJL:[CD!QTH
M_6O]G'_@I'^R7XJ\72?"_P (>(;8W5H0GEQPQ@Y/3H:^L8M074+**_@8&"6,
M.K>Q%?QXZ[\;OC+^R/\ MFWDE_?WUNK:Q"CLT3*"-^*_IN_X)9?M/-^T7\$+
M74[VY:=H+*)'9B3S@"@#ZFLI&?\ U/,?8U:J.$)&?*B7"BI* "BBB@ HHHH
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M; %1R?ZP5)4<G^L%,.C/R-_X*L?\E2B_[#4'_HY:^]_V!/\ DE5K_P!>4?\
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M ?14:S>8<Q]!UI)VGVYA% $M%,AE#K@GD#FG@@\B@ K\V_\ @X3_ .3=M?\
M^P7_ .RU^DE?FW_P<)_\F[:__P!@O_V6@#^>C_@D#_R=U;?2/_T,U_8/^SS_
M ,D3\._]@Q?YFOX^/^"0/_)W5M](_P#T,U_81^ST /@GX<]],7^9H ["'[M*
MOWS1& %XH7[YJ&F ZBH]\F>G%)OD\P\?+4IW5QI7):*@6:0L>.!3EFW'K3C[
MZNB;^1+14;RL/N_E09=O#'DT--#5GL245&'?.1^M(LDG);@4:WL"LR6BF*[-
MTYI \P<[AQ1:PTKDE%%% @J%R_G  <5-37ZXQ35UL)JZ*]UJEE9)NN)D7ZU4
M'BS17.T:C%],UX;^V9\4]=^&_AU+_17 =GP<G'>OD;3_ -M3XC-/)YMPORN0
M/WA]?I7P^<\<8')L9]7J1?-Y(_2^'?#7,^(LM^N49+D\WJ?I8/$VC%L'48A^
M-+_PDVB$X_M.'\Z_-Q_VU_'YD(^TK_WW_P#6J-OVT_B"K9%TO_?P_P"%>/'Q
M/RVWO0?W'NKP6SC^=?>?I.WB;0UZZI%^=/CUO2KG BOXSSV-?FG=_MI?$%83
M*+E<C_IH:]3_ &5_VG?%?Q#\4?V7K4X**1C#UV8/Q%R_&XV.&IP?,_(Y,Q\(
MLTR_!5,3.:M#5ZGW0A#*"#QBEJ#2Y/-TV"4_Q1*?TJ>OT-7<;GY))<LF@HHH
MH$%%%% !1110 4444 %%%% !3)G"C@9-/IIC!;=0&I$S!U ?C'K4=VB./+EC
MWH>H-3S6R38W'H:<8E9-A%"E*.Q7N)WL>1?&O]D[P!\8[*5;W1K199,YD9#F
MOS9_X*#?L-:?\#(H=5TV_0)<98*@P .?;VK]@1"D<95>PKX-_P""S$[-X7TR
M/ P(CV]VKZ'(,QQL<7&BW[K/S'Q&X<RG&</UJTH6FM;K<^;?^"='[&&D_'K1
M%U[5[B,HMSL*R+D'D^WM7Z4?!3]E'P#\'D7[#I%H9%7&]$Y-?*W_  1:D(^%
MSQ8&#?\ 7_@35^@;VZ2*,_6GGF+KK'2IRD]#/PWR'*H<.8?$QIKF:O>VI$MK
M'L$<7R*HP *D0BW3:/FH"G.T4JQJM> HIZO<_4$VO=6PKEI0#TIH 5@ >*E7
MD;336C53P34V?-<+V%4]1[4QN$9CV-2*BCGUJ-N5*XX---*21.J@[GRG^UF8
MY/$5R2@)W'^=>2)'&D4;"(=*]<_:TA5/$-R0?XC_ #KR7>3#&OM7YEG"BLTF
MS]FR%R_L6G?L>A?"P6;PKYMNI^;N*[2X@TX.<6B?E7#_  O7,*Y_O5V<_#\=
MZ*<82B*HY<V_X@C:<&V-8I0YMDE(MK8*?]D5&\:CYO:I;=0B^;U-;PDE&]M3
M)1LO>;N<O\19&6S!9.=O%>9,[,C$J1S7J7Q.Q]A1L?PUY<\F^)LCO7EXI<[=
MV>C@W*ZTU.Y_9[E8^*<%>XK[*TQLZ=!_UR''X5\<?L^ ?\)1G'=:^Q]. _L^
M#_KD/Y5]OPU%1P.A\#QG)O&JY9 !;<*6FHH S3J^A/C@HHHH **** "BBB@
MHHHIV8"/T_&F4L\BQIEC3#( FXGKTHL["N.HJO-?1P0F>1L*.IKP#]HG]O[X
M2?!6*2TOO$8BNHR5*G;U[=ZUH8>KB)6@CBQ^98'+,/[;$U%"/=NQ]#T5^:?B
M+_@LW=1W,BZ+K4#(&(0EATK:^&/_  6/T;4KN*W\9>((H]Q ;:P_^M7KRR',
M8+6)\DO$?A5U%!5DV_3_ #/T2IZ=/QKSKX+_ +0G@CXPZ-%J'AW5/.9X@QQC
M_&N_29P<-T->-7C4H5/9SB[GVF&Q-#%TE4I23B^J)Z*B:5R?EIV]O6L[,W'M
MT/TJ->I_SVI/-)<KFACM&10E>Y,M-0_@_"O&_P!LS_DGJ_[K5[&"2M>8?M1:
M5;ZKX+6"XZ8->=G5.5?+*D(]4>UP[6AA\[H59;)GY>:LUPFN796)O]>W;WIT
M1OI&PL#UZ]??";2Y-2N)?+/,S'I[U>\+?";2;O4UMI8CCZ5_.[X4Q<IMZ;]S
M^LZO'>!ITHW3V70\<_L[5G3<+>3\JC2QU@/M%I)]<5]?67[.OA)K&.0Q-EEY
M^6A?V?O!L4H+(<_[HK5\'XZVEOO.9>(>7_RM_(^7/A/9WY\8!+NQ<KYB_>'O
M7VCHFE:)%X24S:7$6,"]1[5REC\"O!^DWO\ :%JC!\@_=KLY8ECTEK=?NJ@
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MHLPNA:*:7'8499NE*SO8+Z#J*86<'%*"YY % ^EQU%%%.S ****+- %%%%(
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M:JB6MN=[^8.._6I<:<Z4O:&N&G['%02WOH?M?_P39^)]SX[^&5E8W,K,T%B
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M_P!:N!:!HVVM(9"#R7.:_2LJX=HJFG61_+'%GB]G.*QLJ6"]R,?Q/T/\)?\
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M'5X2H_X^W_G506D6. *N?$['_"=7GS?\O;_SJHI7^]7\IU_X\O5_F?W3A_\
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M_%5K*[Z9A51^?NT ?S^_\$@ 3^UO:R=L1?\ H9K^P?\ 9[_Y(EX;_P"P8O\
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M7?-7>$'>DEG2$98U0MIU$H\N7S$_OCI2,]J\[$7JL?[F>E'*@-!9D89!H,Z
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MXD;$AR*EEL42W)45,K;>U(\K$%-F11&"3NA7LMC<^ 4>WQ_$'_Y[1_SK]4/
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M'QY_9ZT+3]7U$2W+Q@L-^?X17Z-K&I&?6OQ@_P"#8+PAKFF?"O0KZ]MY%C,
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M4K_>]![5^/L7_!<K]KP7+XOX^'('^E-Z_2OZ9OVX?^";'@W]L:. :SI-M*8
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MXM/AB:-8!T"D8(_*N6\ ?L=? [X<>('\0^&?!%O;74DYE:5,9+$Y)H+/B_\
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MP_"SX3Z7>Z-X3\,0VL%[$8YHX\?,N!Q^E?C45:3/[NFUR-(_-_X:_P#!3?\
M:"\2?ML:7\)KOR/[.N))0^)#GB1 .WO7V-^U;\8_%VE^ K.6R5-\LP63GL2
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MQ0DWP=5:E_5F?,VH_P#!47]HFR_:NG^&=N(/[/\ [>6V'[PYV$#_ &:^FO\
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MUQI$;VU[8JLT?9ABOV?PI_W:J?SIXW)_7<-Z/\D?!7_!.S_@HU\=OCS\?(O
MOC,0_9&3)V.2>OT%6_\ @H%_P43^-OP)^(^BZ%X5\D0W>I+%)N?'&2/2OL_X
M3_L:?!CX2^)5\5>%?!]O:W:C E3&:F^*G[('P2^+>JVVJ^*?!EO<S6DHD1Y,
M9!!ZU^N1V/PI'BVO_M9?$L?L5ZK\8@L?]HVL<90[N.48^GM7CG_!+O\ X*$_
M&;]IOXP:OX)\9F$V]GI[S1['R<A'/I[5]UZA\!_AU>?#Z;X:+X>B_LVX4"2V
M[' ('\ZY[X.?L?\ P;^".N3Z_P" O"-O87=Q$8Y98L992",?D33 ^%/VY_\
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M +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MPW^S_P",K_PSX'\32P&W8A0DV>Y':@#RI/\ @V%\%VQ,R:A=DR<L#OXIR?\
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MCT@:3<@Z= /]'?GRAZ&OEG_@GDF/#&!_S\_U-?4/B*'?I5T?^F#_ ,C3Q?\
MO<Q<.5%_85+T/SE_:B2-/')$484&9N%%>?6 QJ4''_+5?YUZ#^T]G_A.N?\
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M,R?6I60@<TW8OI0 P$CH:,GKFG[%]*-JCM0 .I(J(A@< FK.T$8--:($YK1
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MG'RO$V0:TH@0Q)_"OSK_ ."%?[1/Q(^-GP.T6_\ '#AGEC!8^86_A'J*_1C
MQ@4 1R*K-G> :JQI-'<$Y)!-69(%(S4?FNI"J!P: /F+_@J[\3[SX??LK>)Y
MM/+),+#*2(>1P:_E,T_X7^/_ -N3]IBZ\*#6;N668*QZ$\LWM[5_4A_P63T&
M^U?]E3Q/);QYQI_]*_G _P""97QH\._L[?MVGQ#X[GC@MBL4>YP",[V]?K0!
ME?MN_P#!*/Q/^RIX?\.ZEK5_/C5H0V9$QC[WM[5ZK^Q-_P $0-1_:C_9^F^*
M.B>)G>5)P@@B7).0W^S[5^D'_!=/2--_:4_9@\'_ ! ^'-M'<1:;H?VB9TC
MP,OZ?6O(O^#=?_@HM\//A#\/$^%GQ*UF&%3J1WHZJ>C,._UH _,J?]CV^_9P
M_:8M_"WCV!TMK?6H(Q)=K@']X!7]3O\ P3"\.^"-%^!>G#P7<6K(^G0&;[-T
MSM'6OP,_X+S_ !X^#OCWXL6^M?";5%ENCKT+ML55Z2@_PFOU<_X-T/B3XM\8
M?L\W7]NN6\I46/+D\ X[T ?II@9SBHW/7)I869D^<<TK1JW6@"!FVG&*AO88
M[ZSELYD!26,HP/<$8JV;=#U- MD!SF@#Y<^,G_!,#X(?&75VUG6O">F&1F)+
M21$DDUT/[-G[ ?PM_9SUM-5\,Z'8Q%$VJ8(R*^@6 ;K0R!DV'I0!!-Y*;8H2
M !P *Q_'?A/3O'FA2^%-:LTFMYOO"09!_P YK:-C$7#Y.0:E90QR: /C_P 5
M_P#!(GX!^)_$DOB"Y\)Z3YLD@8LT)SFO:/@!^RQX*_9YTA].\,V-M"KG.(4Q
M7K#(&Q[4R:W2<@N3Q0!$DK2KTZ]:\^^-/[-_PN^-FC2Z1XL\*6,[R1E$DN(R
M2">]>CQ0B+A*9<6(N'5WZJ>,4 ?GWXN_X((_ ?Q!>R7O]G:4K.Q(7R3W/TKM
M/@9_P1C^ ?PDU-=4N/#6E76T@JIA/!'X5]IFW8RB7N!2R1/(,']* .=\)^!_
M"WP^TU-$\+:+!:Q; I$"X'%=!9[438QR1UID=LJ'*BI%MQYGF=Z '0R%F97&
M/2I%4*,4AC!P3VIQ&1@T &0>AK\W/^#A$@?LZ>(/^P9_[+7Z1!0O2OS;_P"#
MA/\ Y-VU_P#[!?\ [+0!_/3_ ,$?O^3O;;_ME_Z$:_L'_9YP?@KX=]]-7^9K
M^/C_ ((_+C]KNUP?^>7_ *&:_L&_9Z^7X+>',?\ 0-7^9H"QVFP8Q^M1WO%E
M*/\ IF?Y4YI& SFHKUV-E*<_\LS_ "IK<&G8_*S_ (*^.5\2P\_\LOZ5\"V$
MH&F+A,FOOG_@K\0WB>$?],C_ "KX&L<QV*>7SDBOUGAG7*TC^+/%JRXIFGU'
M*M_(1Y5FY^@JU'9:Y/%]G@TB5F/<+7T!^S'\"]&^(T+OJD!.T C"_2O?=&_9
M0\!:1=H)H#NQT*"MJV:483<=;H\S*^#L7B\)&IIROS/D[X!?LV>(O'&NQW&J
M030QJRM\Z\>M?=W@#P=IWPVT&/3K H[F)<[!SG%/T/PGH_A&#R=*@48&,[ *
ML6P9[L2,<D'I7@8G$U*\M]#]'R?(<'E-*T/B[G#?M/W$D_PW>>9B&);Y3]*_
M.W7E+:_?DG_EJ:_1#]JG$GP_D8]<M_*OSSUX$:W?8_YZ&O<R:,?9VCW/@_$.
M51XFFV?07_!--=WQQTG _B_]F%?MAX.(.@0+Z+7XI_\ !,Y%;XX:46/\?'_?
M0K]K/!XQH4./[M?'\82_VV*/VOP3O_8TV^_^1L;1Z4N!Z"F*[#[X^E*9 .2*
M^0YD?N#T'8'H*8P^;%!F0=Z8TZ!N3S3NVM!72W/EG_@H?*(O"$>3_P M/ZBO
M@W2KZ/[7-G'^M/\ .OT9_:\^$7BCXG:(++3;+S0&)&,^M?)^F?L+_$L74K/H
M38,AQU]?I7X'QMDV98O/?:4Z;:MV/ZD\->(LFP'#'L*]:*E?NCRAKF*5L+BH
MY+I(B,D=:]1\9?LF^/O!EL=1O=(*1 XW'/\ A69X)_9U\6>-9IHK33B[1_6O
MB?[!S:%7V;I._H?H4>(\BG357V\>7U1YWJ%^AM& Q7M/[#-PK^.&(QSBB;]B
M#X@M:%9M$8,>@Y_PKT_]E?\ 9=\:>!/%#7U]I91..3FO<X?R'-8YW3JRI-);
MZ'SO%/%.05<CKTJ=9-R6FJ/M71^=*MS_ -,5_E5FJM@LUO900$<K$ ?RJ<S;
M3S7]*1=J:;/X_GK4=NX,A'2E5>.13?,D/W!FG1ER/G%#::,[ZV'8'H*,#T%%
M%(88 Z"BBBJ3L 4444<R ****.9 %?/_ /P4)8#X#:L,]O\ V5J^@*^?_P#@
MH- [_ K5G(^7 S_WRU=.#DOK4/5'CY]9936;?V7^1^'WC!$/C:^/O_C71_L^
M+CQ[9!?^>_:N<\7F%O'5_$#T)X_.NB^!%Q;Z1XUM;W46V1I/DGVK]GE=8/;=
M'\+4?=XD;;^U^I^CW@>-_P#A'HR<_P"17S=^WXQ_LZV'^R?ZU[9X1^/?PMM=
M"2VN-7PP'3 ]/K7SS^W%\1_!WB:RM4T._P#,..>GO[U\G@:52&+NT]#]@SZO
M0EE#ES;Z&G_P3RC9O#.1T^T_U-?4?B#*Z5=;A_R[O_Z":^1/V%/B-X8\(:.M
MMKEYY:?:,GIZFOH_7?CW\++NPNH(-9R3 X'3T/O1BZ=3ZU)\KU'PY4H?V-"#
MDKI'P9^U"?\ BNC@_P#+=JX.P_Y"4'_79?YBNR_:.U:RUGQJ;G3I-Z><QS7(
M:8@;48,CGS5_G7UV#BXX))GXOQ*XO.JDT[IL_;3_ ()R@#X6V!Q_RXK_ #KZ
M6KYI_P""<G_)+K+/:Q'\Z^E4;<.:_'<V=\?4?F?W+PI_R3V&_P *_)$@ P.*
MA?H?J:GZ5#(H'%>;:\XL^BD]#Y5_:S&?$5P/]H_SKR,<11CVKUW]K,8\27 _
MVOZUY$O,*$]A7YGG*MFDV?LN1?\ (F@>@?"K_4K]17;S+AJXCX4\JJG^]7;3
ML?.*TZ?O1T%4^(BE^^/I4D(!FY]*CE'1O2GQ'"^9W-7%^Z9RW.;^)(Q9C_=K
MRUO]6_\ O&O4OB8=M@K#NM>6GF)S_M5P8E:,]+"?&CO?V? /^$HSCNM?8^G?
M\@^#_KD*^./V?/\ D:/Q6OL?3O\ D'P?]<A7V_#?^XGY]QI_OJ+* ;>E+@>@
MI$^Z*6OH#X\,#T%&!Z444 %%%%.S ****-@# /448 Z"BBGS("*^_P"/*;_K
MDW\J_$7_ (*;9_X6I/C_ )_S7[<Z@2+&;'_/)OY&OQ'_ ."FH*?%*X+=#?FO
MJ^$=<P;/R#QG_P"27OY_Y'SI;L!$"QJ)[F))">#39ILP;+8Y;' KV7X6_LI:
MI\0]!AU:.P9VD3<2 ?K7Z5B,72P=)RJ'\EY1E6*S9NG0M==]#QBXF%W(IC7Y
MAT KOO@?\&/$'COQ-%//8S>0V#DKQUKVGP5^PS:C44FUNQD4(W]TU]&?#GX6
M>'/ASI\<&F0#*#C<@KQ\9G$:T+4S[W)^"J]'$JKBK:=$[FA\+O ?ACP1X:M8
M)-,@:7R0"2O.:\%_;RFC_LNY>"V$8$?  ]J^C.;F<.3@*>,5\X_MWR,VEW*'
MIY7]*\;".<\6I7/M\[?)DU2E&*45%_D?%[)F$3/W]:^YO^"0L3G6"5)P+O\
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M _G;_9\_9S_:/_:P^*=A9:WI6K.5U"%I)9[%P"-P/4BOZJ/^"2O[)=[^RO\
M!&#0M71?-O+2)S@ 8) /-?-WP,_:"_X)Q_ [6HG\+>+?#UQ)(ZI&QL4R3T'-
M?H1\$OC1X,^+>@1W_@R\@FME1<- H  _"@#T-5^?<&R/K3ZCAA\K^(FI* "B
MBB@ P/2C ]!110 8'H*,#T%%% !@>@HP/0444 & .@HHHH **** $VJ.U+@#
MH*** "BBB@ K\V_^#A/_ )-VU_\ [!?_ ++7Z25^;?\ P<)_\F[:_P#]@O\
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MFN[A[-I)&.[G"9[UL?\ !6__ ()$7W[6^JV^IZ3J[(8;4)^[3/\ "!Z&K/\
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MM<Y[1P7[48*_#F1F/=OY"OST\0L5UJ]]Y#_2OT,_:G_Y)O)_O-_*OSR\2?\
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M_#?^Y'Y]QG_OR+2C Q2T45[Y\>%%%% !1113NP"BBBAML HHHI 17QQ93?\
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M/\8_G6=&I*K05QXG#2PN.E3L?KG_ ,$BB/\ A&I1#T^S#^0K[DA/R9:OAO\
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MR;0%0<[>.AJM_P %7/V>O&7Q3^ VN:[X#O3;W%O9XC5!EB<8X%?RX?M*:O\
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M>';'X4ZK>>*64621?OV90<#\:_E<_P""Q/Q0^%_A7]J'5_%/P@U3_3%F!78
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M3^E<AR^MEV ]G,DA=9&R*E*J!UIBF-+<,%P<TQICU;(KSWN>JEH2$9&#32@
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M7?\ 'L/]ZNT8'S#]*5'8*GQ#9>GX4Z/_ %(^M-EZ4Z,9B IQV,Y?$<W\3O\
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MTM95\T_MX_\ 'I<'_IG_ $KJP7^^1/'S_P#Y%%7T?Y'QK+_Q[CZU]V?\$?\
M_D*-_P!?G_LU?"DO-N,>M?=7_!'\C^U&Y_Y>_P#V:OH>(/\ D7R]#\T\+?\
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MG^Z0]#\3QW^^S]1:***V.4**** "BBB@ HHHJH[ %%%!Y&*H#X;_ ."N+;=
MP.]K_2OR*D4LQ&>*_77_ (*XJ3H.?^G3^E?D8W!.:_5.$O\ D7G\=^-7_)5K
MT?Z'M7[#ZX\5W!!_Y;#^0K[SF<B"($<>6.?PKX+_ &(6QXKN!_TV&?R%?><P
M+6T1_P"F8_E7+FO^^H]3@U.600^?YD MXI"2TF*1(4CD'EMNH\MCP*6**1)
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M:7\)_P!GCQ!JFH::ERD=IN:)_P"+CZU^(/[/G_!1GX(^/_C\/"6N?!S3'+E
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MWV/RKQ"_C4OZZ'T+_P $S'_XOCI7^^?_ $(5^UOA%/\ B1P?[M?B?_P3+/\
MQ?+2O]X_^A"OVQ\(D_V% /\ 9KX_C!6S%7/VKP4_Y$53U_R-(?=_ T'[AI$)
M*&E0Y&"*^/:Z'[?\,5<YWXL?\B/J/_7FW\Z_*SXP?\E!?_>?^=?J;\7I)5\$
M:@J][5J_+#XPAU^($FX?Q/\ ^A5^-^*G_+KR/Z%\$%K7CU?^1G'_ %0^M2+]
MPU6%TA&UCTI3=[6"YX[U^0JI",=S]ZJ0DI$ZD#DC--TV99==ME$?_+4<XJ-K
MR, A#^=1:1=(GB"U8'GSA44Y.I4ARK9@U+V4[[6/MOX&JD/@+#J.J_R-</\
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MW'_7^:_;?4/^/*7_ *YM_(U^)'_!3G_DI]Q_U_FOJ>%/^1@C\=\:?^28^?\
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MHHH **** "BBBJN@"N,^/W_),K[Z?T-=G7%_'[CX8WWX?R-:46O;1]4<F/\
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M-SM\41G_ *:I_.OM[PMSH%I_UP6OJ>%?AF?&\;;TS4HIJC#4ZOK&?"!1112
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M^RO_ ,BX/^N@_G7M*_?-?I.4_P"X4_0_),\_Y&53U'4445Z)XX4444 %%%%
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M*??_ /($N/\ KW?_ -!-,FZ?A3[_ /Y EQ_U[O\ ^@FA;B>Q^=G[3W_(]?\
M;=JX'3O^0K!_UV3^==]^T]_R/7_;=JX+3O\ D*P?]=D_G7VN"_W")_/7$?\
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M:>Q^N="U95\V?MY_\@JZ_P"N?]*^D[*OFS]O/_D%70_Z9_TKJP7^^1/&S_\
MY%-7_"SXQ3_CW7Z5]U?\$?O^0NW_ %^?^S5\++_J%K[I_P""/W_(7;_K\_\
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M?9O[!/\ Q[1_]<3_ "-?&2_\>+_6OLW]@KBVCS_SQ_H:^]S;_=/F?S-X?_\
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M?YU+H_\ R%1]*BU__D8KG_KN?YU+H_\ R%1]*_**G^]OU/V^C_NB]#V+1_\
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M "54O4^ROV&/^/27_=']*^E=2ZK]*^:OV&/^/27_ '1_2OI;4NJ_[M>)BO\
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MQ7_<'\J^?H_ ?7XKXB1_O&@_>6A_O&@_>6M7\".*/Q#Y?N_A7D7Q$_Y##_\
M72O79?N_A7D7Q$_Y##_]=*RQ'\$UH?QS&G^XO^[7T]^R9_R +;_='\J^89_N
M+_NU]/?LF?\ ( MO]P?RKNX<_P!_9Q\5?\BL]LI8>5YI*6'[M?H7<_)X_ /H
MHHI""BBB@ HHHH **** "O /^"A'_)!=7^@_]!:O?Z\ _P""A'_)!=7^@_\
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M\?ZU^VFH@FREQ_SR;^5?B=_P4]1?^%F3Y_Y_C_6OK>$/^1@S\<\:O^28^?\
MD?,UH?\ 2D7VK] OV.0/^$+MN/\ EW/_ *#7Y^6YQ=(1Z5^@7[&YSX*MAG_E
M@?\ T&OML]_@,_ _#?\ WFIZ'I\_^N;_ 'J93Y_]<W^]3*^9I_"?JZW+5E7S
M5^WC_P >5R/^F?\ 2OI6RKYJ_;P_X\[G_KG_ $KIP7^^1/*S_P#Y%-7_  L^
M-)>+<8]:^Z?^"/G_ "%F_P"OS^M?"TO_ ![CZU]T_P#!'S_D+-_U^?UKZ'B#
M_D7R]#\V\+?^2QH?]O'ZVT445^,0^)G]RRV8J]1]:\[_ &C^/"H_&O1%ZCZU
MYW^T?_R*GX&N3&_[F_0]#*O]^I^I\=W/_']/_P!=C_.KGA+G61GV_G5.Y_X_
MI_\ KL?YU<\)?\AD?4?SK\PA\?S/VC$_ CV.R_Y!\/\ N4J?>%%E_P @^'_<
MH3[PKTHGD3'RCY!4-R,V<F:GE^X/I4-Q_P ><GTJ8[%3^)'DWBW_ )#;_6LB
M G^U[7G_ ):BM?Q;_P AM_K61!_R%[7_ *ZBO+J?Q(^IZL?]VEZ'V9^SQ_R(
M_P"*_P!:] 3I^-<!^SQ_R(__  )?ZUWZ=/QK]8PG^Z0]#\1QW^_3]1:***V.
M8****:W ****L HHHH **** /AW_ (*X@?\ "-MQ_P NG]*_(9#SBOUZ_P""
MN/\ R+;?]>?]*_(5/O"OU3A+_D7G\>>-7_)5+T?Z'M_[#G_(VW/_ %V'\A7W
ME/\ \>D?_7,?RKX-_8<_Y&VY_P"NP_D*^\I_^/2/_KF/Y5SYM_O:/2X._P"2
M?AZO\RI'RYS2@G>O-$7WS]:/XU^M>8]SZE&-\8P!X!E('8_RK\W?B%_R.FH_
M]?!_D*_2+XR?\B!+]#_*OS=^(?\ R.FH?]?!_D*][(/CD?FWB3_NU#U?Y&W^
MSN2?B]IV3Z_S6OW@_9A_Y(QI/_7/^@K\'OV=O^2O:?\ 4_S6OWA_9A_Y(QI/
M_7/^@KPN,OCB?I/@+_NM?U_R/0(.II&_UI^M+!U/TI&_UI^M? _91_1:^)E;
M6_\ D$W'_7(U\:_'G_D;S]#_ #K[*UO_ )!-Q_UR-?&OQY_Y&\_0_P Z^8XI
M_@Q/KN#/]\?H<--UC_WA7K/PU_Y!3?05Y--UC_WA7K/PU_Y!3?05\EA]S[_'
M=#HGZ?C4:@;CQ4K]/QJ)?OFNOJ<*^,DM^>M<1\3/]6?K7;VU<1\3/]6?K45-
MBZ'\8\\O/]4YKV[]D G^U(.>PKQ&\_U+_6O;OV0/^0I!]!6F1_\ (U)XD_Y%
M$SZ<DZ#Z5)%T_"F2]!]*?%T_"OTE[GXX^@ZBBBD 4444 %%%% !1110 5Q?[
M0'_),+[\/Y&NTKB_V@/^287_ -!_(UK0_C1]4<F/_P!RJ>C/P@_:Q_Y+=J__
M %T_J:YOX6_\CQ8?]=Q72?M8_P#);M7_ .NG]37-_"W_ )'>P_Z[BOW"C_N4
M?\/Z'^?N8?\ )0U/^OG_ +<?H_\ "_\ Y$.+\/Y5K#^*LGX7?\B'%^'\JUA_
M%7Q,_C9_0E'^%'T&P]?QJ[8?=E_ZYM_(U2AZ_C5VP^[+_P!<V_D:E;FR/BW]
MNG_D8(?J?Y5\VR?ZM/\ ?'\Z^DOVZ?\ D8(?]X_R-?-DG^K3_KH/YU]K@/\
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MHH 9<?ZA_P#=-?D%_P %<O\ D9X_^OH_S-?K[<?ZA_\ =-?D'_P5R_Y&B/\
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M>HKV'P-\._#/PYTX:-X;TF"UC( Q"N!7XYZ+_P '0?@+5]6M=,7QQ;DS3JF
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M_>_I4C]%^M0^'B3X93_/:IGZ+]:^*>Y^^KX4/?[II=1XT2Y_Z]W_ /032/\
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M/]4O^]7;7"@MSZTJ#T"?Q$,O]*?%_J:9(?F ]14D(RWE=L5M#8REN<U\3O\
MD'I_NG^=>6G_ %3?[U>I_$L9LE4]EKRQN(W_ -XUPXKX6>EA'[R.]_9\_P"1
MH_%:^Q]._P"0?!_UR%?''[/G_(T?BM?8^G?\@^#_ *Y"OM.&_P#<3\^XT_WY
M%E/NBEI$^Z*6OH#X\**** "BBB@ HHHH **** (KX9LIA_TR;^5?B=_P4_&/
MB7.?6^/]:_;*]_X\Y?\ KDW\J_$O_@IZY;XES@_\_P U?6\(?[^S\=\:5_QB
M_P _\CYBMCB\3GM7Z"?L;?\ (EVW_7 _^@U^?L"+YH?'(%?H!^QJ<>"K8_\
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M" T3#-G(/:J?PDJ+3N>.^.O^0X_T_K64_P#KH?\ >%:_CQ0-;<C_ #S60_\
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M1Q:)S^E '\K<_P#P0C^/!+%;.X'I_HM5U_X(0_']AC[-<9_Z]:_K&&E?">X
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M 'J&(X-+L;UIW0<TPRC/!% "[7 ZTJDD<T*P;H:6@ HHHH *#TXHIK.%[B@
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M<YXR_P"1VOO\^M='^SS_ ,C[9?\ 7Q7[1B/]S^1_">'_ .2E?^/]3]$O#O\
MR+,?^>U3/T7ZU#X=_P"19C_SVJ9^B_6OB'N?O_V4/?[IIVH?\@6Y_P"O=_\
MT$TU_NFG:A_R!;G_ *]W_P#030MQ/8_.K]I__D>S_P!=V_G7!Z=_R$X/^NR_
MS%=Y^T__ ,CV?^N[?SK@]._Y"<'_ %V7^8K[; _[@C^>N(_^1[4]?\C]M_\
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MXKX6>C@_C1WO[/G_ "-'XK7V/IW_ "#X/^N0KXX_9\_Y&C\5K['T[_D'P?\
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MO^0K:_\ 745Y53^)'U/7I_[O(^S/V=_^1'7ZK_(UWY^Z*X#]G?\ Y$=?JO\
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M,+%+73/AAI"R1@ 2)"<Y'XT ?D;_ ,$F?^"!>M^&-=L?BK\9_#D,TQ5"[B,
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MST_\$@#C]KNV^D7_ *&:_L&_9[<-\%/#@'_0-7^9K^/C_@D#_P G=6WTC_\
M0S7]@O[._P#R17P[_P!@U?YF@#M%8 8-,O>;*7_KF?Y4M)>?\>,O_7(_RIK<
M3V/RI_X*^?\ (R1?]<OZ5\ 6G_'DG^\*^_\ _@KY_P C)%_UR_I7P!:?\>2?
M[PK]:X8_Y%J/XL\6_P#DK*GK_D?97["O_'M/_NC^E?2^JD>8!_LU\T?L*_\
M'M/_ +H_I7TMJO\ KE_W:\3$_P"\S]3[3A]VRFEZ%6(9<T^V8>>![TV#[[?2
MBU_X^1]:YSW%J<!^U6O_ !;R0YZEOY5^>VNC.KWP_P"FA_I7Z%?M5_\ ).W_
M -YJ_/77/^0Q??\ 70_TKZ7(5=21^4^(ONU:5CZ#_P""98/_  O/2@?[Q_\
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M /72LL1_!-*'\<QIAE5'^S7T]^R8"- MO]T?RKYBDZ+_ +M?3W[)W_( MO\
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M/R._*VWCZ7J?'\KC[;<+_P!-6_G5SPI_R&A]1_.J,O\ R$+C_KLW\ZO>%/\
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M[PMSH%I_UP7^5?4\*?#,^,XVWI&F'!.*6F!?FI]?6,^$"BBBD 4444 %%%%
M!1113CN V8XA<G^Z:_(+_@KP=_B6(#M=?U-?KY<?ZA_]TU^0?_!7+_D:(_\
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MXK_\BX__ %S;^58U_A9T8?2I%GQ-XCX\17'M<'^=6-$8'4UJ#Q+_ ,C'<_\
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M)ESZ5>;.< XKC/C_ *N/#?P=\0ZO"X1X=-=PV?<4 ?C#_P '%7_!3/6/ _\
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MA;\!H?$'Q!L]->YBG0D372JW\1Z5^@/@_P#:L_8.\<:^=*&BZ.K%@-S7J]Z
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MYZZY_P AB^_ZZ'^E?H5^U7_R3M_]YOY5^>NN?\AB^_ZZ'^E?39!]H_*?$?\
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M[4/^0+<_]>[_ /H)H6XGL?G5^U!QXZ)_Z;-_.N#TX;M2@Q_SU7^8KO/VH?\
MD>3_ -=FKA-)Q_:,&?\ GLO\Z^UP7^X(_GOB-?\ "Y5]?\C]M?\ @G* /A?8
M@?\ /DO\Z^EN_P"%?-?_  3IX^%UAM_Y\5_G7TDF2?PK\?SC_D85#^Y>%/\
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M /R**OH_R/C67_CW'UK[L_X(_P#_ "%&_P"OS_V:OA.7FW&/6ONO_@C_ /\
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M*R/^$]T[_KL*_;:/^YQ_P_H?P#C_ /DH*G_7S_VX_2+X8_\ (AQ_A_*M2/\
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M <#P1=Y./W0_E50_BQ]488O7"5/\+/@N_P &[D^E?0__  36'_%V=/\ ^O\
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M*]!;'CA1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3/\ D 6W^X/Y5W<.?[^SBXJ_Y%9[92P_=I*6'[M?H7<_*(_ /HHHI""BBB@
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MN-_W2H=^5?[_ $_5'QY<?\?MQ_UU/\ZN^$O^0R/P_G5.Y_X_;C_KJ:N>$O\
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M#_,5]D:[_P @N?\ ZY&OCCX]?\CI_P !/\Q7S?$W\!'V/!W^^/YG$3?\L_\
M?'\Z]7^&/.E'/]T5Y1-_RS_WQ_.O5_AC_P @H_[HKX_ ;L_0<=LC>;_6T*!S
MQWH;_6T+W^M=</B.!?&/MP#U%<1\3/\ 5GZUV]M7$?$S_5GZUG6-,/\ QSSR
M\_U+U[?^Q[_R%8/H*\0O/]2_UKV_]CW_ )"T'T%:Y'_R-2.)?^11,^G)>WTI
M\73\*9-_#]*?%T_"OTEGXX^@ZBBBD 4444 %%%% !1110 5Q?Q\_Y)M>_0?R
M-=I7%_'S_DFU]]!_(UK0_C1]4<>8?[C4_P +_(_!_P#:V _X7CK''\8_F:Y?
MX6_\CYIW_7<5U'[6W_)<=8_WQ_,UR_PM_P"1\T[_ *[BOW&A_N<?\/Z'\!8W
M_DH*G_7Q_P#I1^DOPR_Y$2/Z#^5:T0&#Q63\,O\ D1(_H/Y5KQ=#]*^(J?&S
M]_H_P(^@U.E6=/ZS?]<V_E5=.GXU9T_K-_UR;^52MS:!\7_MR_\ (P0_7^E?
M-UUT3_?'\Z^D?VY?^1@A^O\ 2OFZZZ)_OC^=?:X+_=HG\_\ $G_)0U?7_(_7
M3_@DE_R*I_Z]1_2ON)/N'Z"OA[_@DE_R*A_Z]1_2ON%/N'Z"ORC/?^1A,_M/
M@/\ Y)?#>@J=?PI!T/TI4Z_A2#H?I7BP^ ^PE\:/G#]KH#_2./XC7@$?W!]*
M^@/VN>ES_O&OG^/[@^E?G.?_ .^'ZYPI_P BQ>IWGPL W+Q_%7?S_>/TK@?A
M9]Y?]_\ K7?3_>/TK*C_  $=E7^,R./O2I_K:2/O3D_UOX5I'8YY[F5XY_Y!
M;?\ 7.O'Q_Q\/_OG^=>P>.?^06W_ %SKQ\?\?#_[Y_G7#B-_F=^!^+Y&W\.A
M_P 55&?^FR?SK[?\*_\ (!M/^N"U\0?#K_D:8_\ KLG\Z^W_  K_ ,@&T_ZX
M+7U7"OPS/C.-MZ1IT445]:MCX,****8PHHHK, HHHH ****<=P&7'^H?_=-?
MD'_P5YX\1Q8_Y^3_ #-?KY<?ZA_]TU^0G_!7K_D8XO\ KY/\S7T_"?\ R-T?
ME?C!_P D?5^7YH^)$_X\7^E?:/[!Q(T^(_\ 3'^E?%R?\>+_ $K[1_8._P"0
M=%_UP_I7Z!G?^Z?,_F?P_P#^1K/T/HK4?]:/K4-3:C_K1]:AKY-;'[0.@_UR
M_6O(OVSY-O@VZ4''[H?^@UZ]!_KE_P!ZO'?VT_\ D3[K_KD/_0:J'\2/JC+$
M?[M4_P +_(^%=V;B3)[&OHG_ ()J8_X6Y89_Y_Q7SDA)GD/^R:^BO^":9)^+
MMA_U_BOK<U=\JEZ'XUP>K<6T_P#'^I^X&G?\>J?[H_E4]0:=_P >J?[H_E4]
M?B\OC/[K7PB/]TUR?Q7_ .1=D_W&_E76/]TUR?Q7_P"1<D_W&_E6-;X6=-#X
MX^I\3^(O^1BN/^O@_P ZDT@D:LN#4?B+_D8KC_KX/\ZDTG_D++7Y14_WM^I^
MW4/]S7HCV'2?^05%_P!<Q4J$^23[U%I/_(*B_P"N8J6/_4GZUZ3V1YL-B0?Z
ML4VX_P"/.3Z4X?ZH4VX_X\Y/I5/X2%\1Y!X^_P"0XWX_SK(?_70_[PK7\??\
MAQOH?YUD/_KH?]X5Y=3XV>K0_A(^I/V6?^1?_P"!C^M>T-UKQ?\ 99_Y%_\
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MK&Z2TNU=0?X37\T7QH_X.&_VB?"7QHU#PW;:G;B&*Y"J//\ ?Z5^JG_!$_\
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M$3_D,/\ ]=*]=E.1^%>0_$,YU>3_ *Z?UK+$?P[&M#^.8\_W%_W:^GOV3/\
MD 6W^X/Y5\OW#$!1["OJ']DP#_A'K8_[(_E7;PY_O[./BO\ Y%9[72P_=I!W
MI81@8K]#?4_)X_ /HHHJ1!1110 4444 %%%%.S *\!_X*"_\D&U;Z?\ LK5[
M]7@/_!0CY?@+JQ'H/_06KIP:MBH>IX^?Z9/6_P +_(_#?QM_R/E]]:Z[]GW_
M )'NR_Z[URGC) ?'5\3Z_P"-=3^SRQ;QU9Y_Y[U^T8E?\)L8^1_"N&7-Q.[?
MS?J?HEX>_P"15C^O]*D?HOUJ'P^Q'A:.K#J-JFOBF]6?OL?@7H*_W33M0_Y
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M/@_ZY"OLN&_]Q/@.-/\ ?D64^Z*6D3[HI:^@/CPHHHH **** "BBB@ HHHH
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M\9?^1"E^A_E7YM_$;_D<]0_Z^#_*OTC^,I_XH.4?7^5?FY\1O^1SU#_KX/\
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MN/Q'!\,KLEMJXCXF?ZL_6NWMQP*XGXEC]V?]ZLJ^AIA_XO,>=WG^I?ZU[?\
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M?3\)ZYNC\K\8/^2/J_+\T?$J?\>+_2OM']@[_D'1?]</Z5\7Q#-DXK[1_8-
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MOD>,O^1E'T/VOP5_Y$53U_R-->@^E.?[QIJ]!]*<_P!XU\<^A^VK8YGXG_\
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M^16D_P"O4?R%?<:_ZJOAS_@D5_R*TG_7J/Y"ON-?]57Y/GW_ ",9G]K\"_\
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M;,7&?O5(B!!@4M% !7YM_P#!PG_R;MK_ /V"_P#V6OTDK\V_^#A/_DW;7_\
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M_P#9J^%I/^/9?PK[J_X(]_\ (4?_ *_/_9J^AX@_Y%\O0_-O"W_DL:'S/UL
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MM_UY_P!*_(>/I^!K]4X2_P"1>?QYXT_\E6O3_(]M_8=X\67?_74?R%?=\O\
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M ':^1PON;'Z!CMD;[9+[J:W4_6GTQNI^M=D?B."?PHFMN@^M<1\2_P#5_P#
MJ[>VZ#ZUQ'Q+_P!7_P "K&N;8?<\ZNSF-UKW#]D%"NI0,?05X?=_=>O<_P!D
M7_C_ (/]T5KD7_(T,^)/^11,^F).54^U21<"F/\ <7Z4^/O7Z4S\<?0=1112
M **** "BBB@ HHHJK( KB_C\0/AE?#V_H:[2N*^/_P#R32^^@_D:TI*U6/JC
MEQW^Y5/\+/P=_:S'_%]-7'^V/YFN=^%O_(]:<?\ IM71_M:?\EUU?_KH/YFN
M<^%W_(]Z=_UWK]NH-_5(_P"']#_/_'_\E!4_Z^/_ -*/TA^&/S>!(\>W\JUH
MSR165\+?^1$B^@_E6I']XU\54^-G[_0_W>/HAR [<U8L!GSA_P!,S_*H(_\
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M_75'Q+$"+1P:^T?V#ABSC_ZX?T-?%R?\>K_2OM']A#_CSB_ZXG_T&OT'._\
M<_F?S-X?O_A5EZ'T5J?^N%0N#G-3:G_KA43_ '37R:V/VBR"%"9%/O7F7[70
MSX!O(^YC'\C7J$'WU^M>8?M<_P#(CW?_ %R'\JJG_%CZHY\;_N=3T9\ WX9;
MZ12>U?0W_!-*14^+>GJ?^?\ KYZU/_D(R_2OH+_@FQ_R5W3O^PA7U>;.V5R]
M#\=X+_Y*RE_C_4_<&S.8(_\ =%3U7L?^/:/_ '15BOQF7\0_NQ?"(_W37)_%
MG_D6I/\ KF_\JZQ_NFN3^+/_ "+4G_7-_P"585_A9TT/CCZGQ-KZD^)+D_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M )&FO0?2G/\ >--7H/I3G^\:^.?0_;5L<S\3_P#D6[K_ *]S7Q/XI_Y&1O\
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M;(^KCL8OQB_Y$67Z-_*OS;^(O_(ZZE_U\G^5?I)\8O\ D19?HW\J_-SXB_\
M(ZZC_P!?)_E7T'#_ ,<C\S\1?X=#U?Y&Y^SK_P E>T[\?YK7[O?LP_\ )%]*
M_P"N9_D*_"']G7_DKVG?C_-:_=[]F'_DB^E?]<_Z"O"XP^.!^E> O^X8CU_R
M/0$Z?C3Q]_\ &F)T_&GC[_XU\!+9']#KXF4==_Y!<_\ UR-?&_QX_P"1O/T-
M?9&N_P#(+G_ZY&OC?X\?\C>?H:^8XH_@(^QX-_WU_,XJ7_EG_O\ ]:]5^&__
M ""6_P!VO*92/W?/\0_G7JWPW_Y!+?2ODL.?H&.V1T%,;J?K3Z8W4_6NQ?$<
M,_A1-;=!]:XCXE_ZO_@5=O;=!]:XCXE_ZO\ X%6-<UP^YYU=_=>O<_V1?^/^
M#_=%>&7?"OFO<OV1?^/^#Z"M<B_Y&AGQ)_R*)GTT_P!Q?I3X^],?[B_2GQ]Z
M_2F?CCZ#J***0!1110 4444 %%%%6M@"N*^/_P#R32^^@_D:[6N*^/\ _P D
MTOOH/Y&M*7\6/JCEQW^Y5/\ "S\'OVM/^2ZZO_UT'\S7.?"[_D>]._Z[UT?[
M6?\ R775_P#KH/YFN<^%W_(]Z=_UVK]KH?[I'_#^A_G_ (__ )*"I_U\?_I1
M^D7PM_Y$2+Z#^5:D?WC67\+O^1$B_#^5:D?WC7Q<_C9^_P!#_=X^B'Q_ZLU8
MT_K-_P!<F_E5=/\ 5FI]/ZS?]<V_E26YO ^*_P!NS_D8K?ZG^1KYME^\G^^/
MYU])?MV GQ%;X]_Y&OFV4'*?[X_G7VV"_P!U@?S[Q'_R4-;U_0_7C_@D7_R*
M[_\ 7J/Y"ON.OAS_ ()%@_\ "+N,?\NH_D*^XZ_*,^_Y&$S^T^!/^2=P_I_D
M.3K^%(/NFE3K^%(/NFO$A\!]E+XT?-_[7O2X_P!XUX#!]Q?I7OW[7O2X_P!X
MUX#!]Q?I7YQQ!_O9^M\*?\BU?,]!^$WWE_WOZUZ'-]_\*\\^$WWE_P![^M>A
MS??_  HPG\$K&?QQE(B R]*<P'8T0C,V,UU)*QSMNYC>/HP-+;_<KQH?\?#_
M .^?YU[7\04 TDG_ *9FO%!_Q\/_ +Y_G7F8Q:?,];+_ (_D;GPU_P"1IC_Z
MZI_.OM_PS_R +3_K@O\ *OB#X:_\C3'_ -=4_G7V]X9_Y %I_P!<%_E7T?"N
MU0^0XV^*G_78TQU/UHH'4_6BOKUL?!A1113&%%%%9@%%%% !1110 RX_U#_[
MIK\A?^"N?_(RQ_\ 7U_4U^O5Q_J'_P!TU^0O_!7/_D9(_P#KZ_J:^GX2_P"1
MLC\J\8/^2/J_UU1\2I_QZO\ 2OM']A#_ (\XO^N)_P#0:^+T_P"/5Z^T/V$/
M^/.+_KB?_0:_0,[_ -S^9_,WA_\ \C67H?16I_ZX5$_W34NI_P"N%1/]TU\H
MMC]J'P??7ZUYA^US_P B/=_]<A_*O3X/OK]:\P_:Y_Y$>[_ZYC^573_C1]4<
MV-_W.I_A9\!:G_R$9?I7T%_P38_Y*[IW_80KY]U/_D(R_2OH+_@FP#_PMW3N
M/^7^OJLV_P"19+T/QW@O_DK*7^+]3]P+'_CVC_W15BJ]C_Q[Q_[HJQ7XS+^(
M?W8OA$?[IKD_BS_R+4G_ %S?^5=8_P!TUR?Q9_Y%J3_KF_\ *L*_PLZ:'QQ]
M3XGU[_D8KG_KX;^=3:/_ ,A4?2H=>_Y&*Y_Z^&_G4NC_ /(5%?E-3_>WZG[;
M0_W->B/8M%_Y!</^X*E?[IJ+12/[+A/^Q4K<K7I/9'FQT08!4"E88M) 1VH4
M' XI[1DVCGGI6B7NF5_>/(/'X/\ ;+FL.7_60_[PK>^(6!K+@U@R_P"LA_WA
M7F8CXF>MAOX1]2_LK_\ (N#_ *Z#^=>TK]\UXM^RO_R+@_ZZ#^=>TKPQ)K]&
MRG_<*9^2YY_R,JGJ.HHHKT3QPHHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH ****T **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MCX1_Y D'TK\3O^"9?_)<M*_WC_Z$*_;'PC_R!(/]VOD>,O\ D91]#]J\%?\
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MW ****L HHHH **** /A[_@KC_R+;?\ 7G_2OR%0G.*_7K_@KC_R+;?]>?\
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M3S/IJ3[HIT/W:;)]T4Z'[M?I+W/QM[H?1112&%%%% !1110 4444 %<7\?\
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M_P"1G/U'T445Z"V/'"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBBK6P!1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MOS;_ .#A/_DW;7_^P7_[+7Z25^;?_!PG_P F[:__ -@O_P!EH _GI_X(_P#_
M "=W;?2+_P!#-?V#?L\#_BRWAS_L&K_,U_'S_P $@/\ D[NU_P"V7_H9K^P7
M]GLE?@MX<Y_YAJ_S- 6.S<=Z9>?\>,O_ %R/\J<6)&*BO7(LI1_TS/\ *FMP
M>Q^5G_!7S_D9(O\ KE_2O@.T_P"/"/\ WA7WY_P5\_Y&2+_KE_2O@&T8_8HQ
MZ,*_6N%_^1<C^*_%O_DK*GK_ )'V7^PS_P >TW^[_A7TIJ'_ !^K_NU\U?L+
M$FVFS_=']*^E=0_X_5_W:\3%?[S/U/L^'_\ D4TO0K+_ *TTL'_'POTI%_UI
MI8/^/A?I7.>ZMS@?VJ?^2;2?5OY5^>>N_P#(6OO^NA_I7Z&?M3_\DWD^K?RK
M\]M=0?VO?_[YKZ7(DW"=C\K\1/X]+^NA] ?\$R_^2Y:5_O'_ -"%?MCX1_Y
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M3CO;::^;?V] !I=RW_3+^E=.#_WR)X^?_P#(IJ^C/C0_\>H^HK[F_P""/?\
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MKFN'^/E/.=0^XU>X_L??\A&#_=%>':A]QJ]O_9!)&HP8]!6V1_\ (U,^)/\
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MN+]*]_\ VNUW"X_WC7@$7"#%?G/$'^]GZYPHF\M7S/0?A-]Y?][^M>AS??\
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M%V_Z_/\ V:OH.(/^1=(_-O"[_DL</\S];:***_&H;L_N66S%7J/K7G?[1_\
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M8_K7M#=:_1\M_P"1?3/R3/?^1G/U'T445Z"V/'"BBBF 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11151V ****H HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH ,@G&:_-O_@X2!/[.NOD?] S_P!EK](E^^:_-_\
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M?\C+<_[W]:\?7I']:_-,X_Y&TS]HX?\ ^15#T/3/A4?]'7ZUVDH^>N+^%/\
MQ[K_ +U=K)]X_3^M;46[')52^L$9^^/I3E_UIII^^/I3E_UIK:2_>&4O@.:^
M)O%@ ?[O]:\GZ0,/]K^M>L?$[_CR'^[_ (UY0?\ 4M_O_P!:\S,&^8]?+?A1
MW'[/?_(U_P# A7V3IW_(/@_ZY"OC;]GO_D:_^!"OLG3O^0?!_P!<A7V/#?\
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MQ[T0=3]*1O\ 6GZU\#ND?T2DN9E770?[*N#_ -,C7QO\>OF\7D#T-?9.N?\
M((N/^N1KXV^.W_(X?@:^9XH7[A'U_!J_VMG"SC9Y>?[P_G7K?PT<-I# ?W:\
MEO>D?^\/YBO6/AA_R"7_ -VOD</N??X[H="6"MD^M(3DY%)+_6E'3\:[%\1Q
M1^/Y#K0_-BN+^)K!8SGUKM+3[X^M<5\4?]7_ ,"_K65<O#_QSSJ_YC8BO;OV
M02#J4"]\"O$;W_4M7MO[( /]K0'_ &16N1_\C0CB3_D43/IY_N"GQ]Z9)]T4
M^/O7Z2S\<?0=1112 **** "BBB@ HHHH *XOX_\ _),;[\/Y&NTKB_C_ /\
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M2M:=_P!?PKZG-_\ D62]#\9X0]WBRDU_/^I^WMA_J$_W1_*K%5]/_P"/>/\
MW1_*K%?C$M*A_>'V$(_W37)_%CGPW)_US?\ E76/]TURGQ7_ .1<?_KFW\JQ
MK_"SHH?''U/B3Q"I'B2YS_SW:I]#4C5@:B\2?\C+<_\ 7=JGT7_D*CZU^527
M^UV\S]MA_N:]$>SZ&"=)A_W*E?K^-,T#_D$1?]<Z>_7\:]E.]CP7J.?B,"GL
M,V,H_P!FF2_<'UJ1O^/*3_=K2?PCJ?$CQCXBG_B?R9'K6&_^NA_WA6W\1O\
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MND/0_$,=_OT_46BBBMCF"BBB@ HHHH ****E_$ 4445<=P/A[_@KC_R+;?\
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MHHH ****F6P!1114@%%%% !1110 4444 %%%% !1110 4444 %%%%: %%%%
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MPW/8RWX%ZG>_L^ ?\)1T[K7V/IW_ "#X/^N0KXX_9\_Y&C\5K['T[_D'P?\
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M>+]ES_DBND?]<_Z"OP=_9W_Y*[IWX_S%?O%^RY_R172/^N?]!7A<9?'$_3O
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M )#[_4UB/_KH?]X5X=?^*SWJ'\%'U)^RS_R+_P#P,?UKVANM>+_LL_\ (O\
M_ Q_6O:&ZU^CY;_R+Z9^19[_ ,C.?J/HHHKT%L>.%%%%, HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHK0 HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHJ9; -7[YK\W_^#A'_ )-S\0?]@O\ ]EK](L '.*_-
MO_@X2)'[.NO@?] S_P!EI1W _GG_ ."/_P#R=_;?2+_T,U_8/^SY_P D6\.?
M]@U?YFOX^?\ @D ,?M=VQ'I%_P"AFO[!?V>?F^"OAW)Z::O\S5COH=E45]_Q
MYR_]<S_*I:9>H#92D_\ /,_RIK<3V/RK_P""OG_(R1?]<OZ5\ 6G_'DG^\*^
M_P#_ (*^?\C)%_UR_I7P!:?\>2?[PK]:X8_Y%J/XK\6_^2LJ>O\ D?97["O_
M ![3_P"Z/Z5]+:K_ *Y?]VOFG]A7_CVG_P!T?TKZ6U+YKI5/]VO$Q/\ O,_4
M^UX>_P"132]"M!]]OI1;?\? ^M"?+(0.]$/$XQ7.>V<#^U7_ ,DYE^K?TK\]
M=<_Y#%]_UT/]*_0W]J1%D^',A8?Q-_*OSSU\;=:O@/\ GJ?Z5]+D:]UGY/XA
M->WIH^@O^"97_)=-*_W_ /V85^V'A#_D!P?[M?B?_P $TR(OCGI.T?Q?^S"O
MVP\'<Z! W?;7QO&"_P"%"/D?MO@IKDDUY_Y&DE/?[QIB=J>_WC7R+V1^W1^$
MYGXG_P#(MW7_ %[FOB;Q7_R,3_[[?SK[9^)__(MW7_7N:^)?%)SXF=3_ 'F_
MG7R'%70^_P"!?XDP\/?\A5?]\5['HW_'@G_7,5XYH8VZF"/[XKV'0B6LD!_N
M"OG:/PGU^*^(LI]T4-U'UIVT! 122 #!K9_ CCA\8Z7[E>1?$7_D*O\ [XKU
MV7[E>0?$1C_:[C_;'\ZSK_P32A_',:?[B_[M?3W[)G_( MO]P?RKYAE(.U2/
MX:^GOV3QMT.W _NC^5=W#G^_LXN*O^16>V4L/W::Y(Z4^,8R!7Z$^I^3Q^$=
M1114@%%%% !1110 4444 %> ?\%!_P#DA&J_3_V5J]_KP#_@H./^+"ZLWI_\
M2U=>!TQ4/4\C/O\ D45O\+_(_#OQG_R/-[_O?XUU7[/O_(\V?_7>N6\9#/CB
M^/N?ZUU/[/F/^$ZLO^N]?M$G; *72Q_"F'_Y*9_XOU/T/\/?\BQ']?\ "IGZ
M+]:A\/C'AB,5/*  IKX=:R;\S]]C\"]!S_=-.U#_ ) MS_U[O_Z":CE8@8I]
M_P Z)<'_ *=W_P#035+<'L?G9^T]_P CU_VW:N!T[_D*P?\ 79/YUWW[3YQX
MZ_[;-7!:=_R%(#_TV7^=?:X+7 (_GKB/_D>U?7_(_;G_ ()S?\DKLO\ KP'\
MZ^D4Z_A7S;_P3F;_ (M=8KC_ )<5_G7TF %YQ7X_F^N85#^YN%->'L-_A7Z$
MM12=34HY&:B?FO.6DHH^BG\)\K?M;?\ (RW/^]_6O'D^[%7L'[6G_(RW/^]_
M6O'UX2(U^:9Q)?VK(_:,@_Y%,/0]/^%/_'HO^]77S_ZTUQWPI8_9E7_:KLYE
M!<DUT4M8HXZNF(8P?>'TIZ_ZT_6F)SR>U2*.=WJ:MZ53.7P',_$S_CP'^Y_6
MO)3_ *IO]ZO6OBA\FG*1W3^M>2 _*P]Z\[,-SV,M^!'??L^?\C1^*U]CZ=_R
M#X/^N0KXX^ 'R>*./5:^QM,).G09_P">0K['AO\ W$^!XT_WY%I/NBEH P,"
MBO?/CPHHHH **** "BBB@ HHHH AU#_CRE_ZYM_(U^*'_!3O_DID_P#U_-7[
M87PS9RC_ *9-_*OQ,_X*=NW_  LRX/\ T_-7UO"'_(P/QOQK3?#"]?\ (^8X
M/]<OTK] OV-/^1+MO^O<_P#H-?G[$<.K#TK] /V-"?\ A"+8_P#3N?Y5]KGG
M\!GX#X=:XZ;\CU63_6O_ +QJ-_O&I)/]:_\ O&HW^\:^:I_"?KQ9LJ^;/V\_
M^05=?]<_Z5])V5?-G[>?_(*NO^N?]*Z<%_OD3QL__P"135_PL^,4_P"/=?I7
MW5_P1^_Y"[?]?G_LU?"J?\>Z_2ONK_@C]_R%V_Z_/_9J^@X@_P"1=(_-O"[_
M )+'#_,_6].OX4VG)U_"FU^-0W9_<LMF"_ZP?2O._P!I/_D4A]#7HB_ZP?2O
M._VD_P#D4A]#7'C?]TD>AEG^_4_4^.9_^/RX_P"NI_G5[P?_ ,A\?0?SJI-&
M#>W'_75OYU>\'HO]O#\/YU^84E_M',?L^(_W9'M]A_R"H?\ <%-4'!/O3K'G
M281_L41\ BO;O=71\_'X'ZD4@/!]Z+P'^SI.?X:?(,''O1>#.GR#_9JH?PV6
MY+G1XSXT_P"0Y)60/^0G:?\ 745L>-?^0Y)]?ZUCH,ZI:#_IH*^?J_Q8^I]!
M3_W:7H?97[.W_(D#ZK_6O03]P?6O/_V=@/\ A!@?=?ZUZ"H!4 U^KX1KZI _
M$<?_ +Y/U%HHHK8Y HHHH **** "BBBJCL 44450'P]_P5Q_Y%MO^O/^E?D*
MGWA7Z]?\%<?^1;;_ *\_Z5^0J?>%?JG"7_(O/X[\:O\ DJEZ/]#V_P#8<_Y&
MRZ_ZZC^0K[RF_P"/./\ ZY+_ "KX-_8<_P"1LNO^NH_D*^\I!FTB!_YYK_*N
M7-?]]1Z?!G_(@AZO\RK'_K#1_&OUI<;6)%" %QD=Z\Z2/JXF-\8?^1"D^A_E
M7YN_$3_D==1_Z^#_ "K](?C$<>!)1]?Y5^;OQ".?&FH_]?!_D*]_($^>1^9>
M)'\&AZO\C;_9W_Y*[IWX_P Q7[Q?LN?\D5TC_KG_ $%?@Y^SV<?%W3@/?^:U
M^\?[+G_)%=(_ZY_T%>#QE\<3]-\"?]UK?UV._?[QI1]_\::3DYIP^_\ C7P#
M^%']"Q^)E'7?^07/_P!<C7QQ\>?^1U_!OZ5]DZTH.ESD_P#/(U\:_'LA?&6>
M^&_I7S7%'^[H^QX-UQK]&<3==(_]\5ZO\,_^04_^[7DUPQ(C_P!\5ZW\,8R=
M*8X_AKY+")U'H??Y@U&QN-_K::W4_6I/+8S<BF.K GBNQQ<=6<$))RN/M^OX
MUQ?Q(_U;?6NQMBYE"UQ_Q01HH,CJ6K.O%\G,:X=_OSSFX^X_UKW#]D/_ )"D
M'T%>'W/RQ.<5[?\ L@$G5(,^@J\C_P"1H9<2)_V1,^G)>@^E/BZ?A3)>WTI\
M73\*_27N?C_8=1112 **** "BBB@ HHHH *XOX^?\DVOOH/Y&NTKB_C_ ,?#
M*^8>@_D:UH_QH^J.3'_[E4]&?@]^UI_R736/^N@_F:Y?X5?\CYIW_7<?RKI_
MVL"6^.FL9_YZ?U-<U\)U#>/M.'_3<?RK]MH_[I'_  _H?P#CG_QD%3_KY_[<
M?I'\,?\ D0X_P_E6M'WK+^&RA? L>/;^5:L8X)KXN?Q,_?Z/\"/H"=/QJQ8?
M\M?^N9_E56-B3CWJUI_67_KF?Y4EN;0/C+]N7_D.0_0_R-?-DO\ Q[I_OC^=
M?27[<9_XGT(QZ_R-?-DYPJH.@<?SK[7!?[M$_G_B5_\ "_5]?\C]=?\ @D1_
MR+,G_7M_05]Q-V^E?#W_  2( _X1B4_].P_D*^X!\R[C7Y1GW_(QF?VGP&[\
M,8;T')U_"D'W32IU_"D'W37BP^ ^PE\:/F_]KWI<?[QKP&#[B_2O??VO.3<#
MW->!P*"@]J_.>(/][/USA17RU'H'PF^\O^]_6O0YOO\ X5YW\)\AE(_O5Z'*
M<N:6$_@HO&1?MQA^\*<_WC33]X4YQS72_P"(<]FXW,KQS_R!F_ZYFO&8_OR?
M]=#_ #KV;QP,Z0P_Z9FO&(_OO_OG^=>=F'Q(]/+E>5_(V/AG_P C8G_75?YU
M]O>&O^0!:?\ 7NM?$/PS_P"1L3_KJO\ .OM[PU_R +3_ *]UKZ3A7X9GR'&_
M_+K^NQI1?TI],B_I3Z^MO8^$"BBBES(84445(!1110 4444 ,N?]0W^Z?Y5^
M0O\ P5X_Y&.+_KZ_J:_7N< PMG^Z?Y5^07_!7,E_$D>3TNOZFOI.%HMYI$_*
M_&!-\'U?ZZH^)T_X\&^M?:7["'_(.@_ZXG_T&OBY>+)A7V=^P8[-91*>T'_L
MM?HF>/GPZDNY_,OA^O\ A5GZ'T9J/^M7Z5$_W34NI<3**B?[IKY,_:4/@^^O
MUKS#]KG_ )$>[_ZY#^5>GP?ZQ>.]>8?M=<^"+OC_ )9C^572_C1]48XQKZE4
M7]U_D? .J_\ (1DKZ%_X)K_\E=T[_K_KYWU1R=3E'MFOHG_@FN/^+MZ<?^G^
MOJ\W_P"17)>1^+\'>[Q=2O\ S?J?MY9?\>J?[H_E4R]1]:@LCF!/]T5.!C!]
MZ_%:B:B?WC'0<_W37)_%?_D7)/\ <;^5=8_W37)_%?\ Y%R3_<;^59U_X#]#
M?#?[PCXF\0_\C'<_]=VJQHO_ "%1]:K^(O\ D9+G_KNU6-%_Y"H^M?E+_P![
M/VZ'^YKT1[3H'_((B_ZYU)+U_&H] _Y!$7_7.GR')_&O;['@L=+]P?6I&_X\
MI/\ =J.7[@^M2-_QY2?[M7/X2JGQ(\7^(W_(??ZFL1_]=#_O"MOXC?\ (??Z
MFL1_]=#_ +PKPZ_\5GO4/X*/J3]EG_D7_P#@8_K7M#=:\7_99_Y%_P#X&/ZU
M[0W6OT?+?^1?3/R+/?\ D9S]1]%%%>@MCQPHHHI@%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444[, HHHHLT 4444@"BBB@ HHHK0 HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHJ9; %?FW_P<)_\ )NVO_P#8+_\ 9:_22OS;_P"#A/\
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MR$X/^NR_S%?;8'_<$?SUQ'_R/:GK_D?MO_P3F_Y)?8_]>*_SKZ5/3\:^:O\
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M5^M<,?\ (M1_%GBW_P E94]?\C[)_86(%M-G^Z/Z5]+Z@<WBD?W:^9_V&?\
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M^5? %H#]B0X_B%?K7#'_ "+4?Q9XM_\ )65/7_(^R/V&?^/:;_=_PKZ7OO\
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MY%F/ZU*_1?K46@ GPS'@5*X/R\5\/]J7J?OD?@7H/?[IIVH?\@6Y_P"O=_\
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MYIW_ %W'\JZC]K7_ )+IK'_70?S-<O\ "K_D?-._Z[C^5?MU#_=(_P"']#^
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M-!&?^>@KVIB,]:_1\M_W"F?D>>?\C*IZCZ* 0>E%>@MCR HH) ZFB@ HHHH
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M*TL2(VWD[J\ _P""@1+_  (U5!ST_P#06KWU@"<5X#_P4$5XO@3JTBC@ ?\
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MTK:-+@R?^62XKXX^ 0#>*0R]-RU]CZ5@Z9 /^F0K[3AO_<3X7C-_[<B>,@@
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M>5W^E?2%D(R>E?-G[=DBBPN(QWC_ *5UX/\ WF/J>-Q!:645;]G^1\;"Z81
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MUHVI_>_6C8?44;#ZBJ&&Q3T-+L'J:0*5.XTN\>AH -@]31L'J:-X]#1O'H:
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M_P#!RK\<4D:.?6[8 ,?^6_O]* /Z:7\4^'!Q_:\)_P"!5^=W_!?_ %32+O\
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M /UJ:5PNS^E__A)-!_Z#$7_?5'_"2:#_ -!>+_OJOYHS_P '+GQC S_;UO\
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MQ<1CO[5_+3X8_P""_7Q4\.WOVNVUBW!)_P">O_UJ]"LO^#E3XR"%5DUVW^4
M#]]_]:O?R;!5L#AO9U+7/F.(LRP^9XE3HWMYG]+@\1Z%U.K1?G2_\))H/_08
MB_[ZK^:6;_@Y>^,*C:FO6W_?[_ZU1?\ $2]\9/\ H/VW_?[_ .M7L).QX"T/
MZ7_^$DT'_H,1?]]4?\))H/\ T&(O^^J_FA'_  <O?&//.O6__?[_ .M3C_P<
MM_&/'&O6W_?_ /\ K4^5A<_I<_X230?^@Q%_WU1_PDF@_P#08B_[ZK^9]/\
M@Y?^,Y)W:[;?]_\ _P"M4P_X.6OC 1DZ_;_]_P#_ .M1RLF[/Z6O^$DT'_H,
M1?\ ?5'_  DF@_\ 08B_[ZK^:&3_ (.7OC&/N:];_P#?_P#^M1%_P<N_&9AE
M]=M_^_\ _P#6HLT.[/Z7O^$DT'_H,1?]]4?\))H/_08B_P"^J_FD/_!RW\8,
M<:];Y_Z[_P#UJ3_B)<^,G_0<MO\ O_\ _6I#NC^E:_\ $FAFRE"ZK$?W;?Q>
MU?C#_P %,/[-N/B//,-03!O2>M?)*_\ !RW\8RK*==MN5(QY_P#]:OF+]H3_
M (*S^-/C%JKZI>ZE$TC2%^)._P"5>_D&-HX#$^UJ['YQXD<.XWB?*%A<(O?O
MUT70^M'O=,201_;T_.OT#_8PDTMO =HQU!.;<]_:OY[S^WEXT>X$DMV@4?[=
M>_\ P:_X+3?$+X=:-%H\&JPJD<949D]OI7TF9Y_@<72<87^X_+.%O"[/LFQ3
MJ5DK-='<_>2Y72/-;.K)U]:@9-'#?\A:/\Z_$J?_ (+K?$1F9EUF DG_ )Z_
M_6JLW_!=7XF$_P#(6A_[^_\ UJ\3^T<.?>?ZKYG_ "G[E6,>D9S_ &LGYU\W
M?MVPZ2-.N'&IQG]WZ^U?F=:_\%W/B7'][6(!_P!M?_K5P'QP_P""O_Q ^)MC
M+#-J<+;UP=LOM]*VH9MA:552E>R.',>#,UQV"G0BE>2:W/J'SM.*[1J"?G7W
M3_P2"_LR*_DE?4$&+ON?]JOP0M/V]?&GF?OKM,?[]>Z?LO?\%DO'WP$D+:3J
M<*[I-QW28[Y]*]/,^(\OQ>$E3A>[\CY3@WPKS[(>(*6,Q'+R1O>SNS^M?_A(
MM"B.&U6(?\"I%\4>'V)7^UHC_P "K^:J^_X.7?C+-.7_ +<ML'TF_P#K5#!_
MP<I?&<R$KKEMU_Y[_P#UJ_/8IQ;N?TG*47%\I_2X/$6A ?\ (5B_[ZK@_CSJ
MNA7?AG:-5AZ'^*OYZ'_X.6OC'LYURVS_ -=O_K5@^,O^#CKXR^(-/^R2ZS;%
M<''[[_ZU88BE*KAW".YU8+$0H8F%26R/V!O8-(:]G;^V8Q^\/?WK0\%V^C_V
MLI_MB/MWK\))?^"[/Q=DG=SJEOAFS_K?_K59TS_@O#\6=.N!<1:M!D?]-?\
MZU?"0X=S"-?G=K>I^EU>*LMG0Y%>_H?T;6LFCIIT(&M1_=[-2>?HP?\ Y"\1
M_&OY\(/^#A[XT^4L)U>VPHP/WW_UJ</^#ASXRAN=8M_^_P!_]:O6_LK%:;'A
MK.L-?J?T'M-HQQ_Q-HNOK3[J31?L$G_$UCZ>M?SWG_@X?^,>.-7M_P#O[_\
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M\Z/^$I\-_P#06@_.OYEA_P '*_QJ Q_;=M_W_P#_ *U'_$2O\:O^@W;?]_\
M_P"M74MCG/Z:?^$I\-_]!:#\Z/\ A*?#?_06@_.OYEO^(E?XU?\ 0;MO^_\
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MQ_:L?YU)$NCAQ_Q-H_SK\-A_P73^*B_\Q6#_ +^__6I1_P %UOBL#G^U8/\
MO[_]:N9YIAO,]=<)YDNB^\_:[XO3Z"G@B7SM7B  .<M[5^:_Q%\0^%X?'6HQ
M#6(/^/D_Q>PKYA\??\%N/BQXJ\/OI!U2$A@>!+[?2OE'Q3^VS\4=:\1W&J+.
MI,LNXD2G_"N_+>(<-@IMN]F?,\3>%N9<04J;A))Q;Z^1^M'[/VI^'I/B[ISI
MJT/0_P 7NM?NC^S3X@T*#X,Z4/[3B^YUW>PK^.'X:_M^?%7P9XLMM9:X13%W
M,A]1[5]V_#K_ (.,OC%X,\$6GAY-:MU6%< &;_ZU>?G^<4\S<?9K;N?6^&W
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MY+6?W'[S^-(])GTE@-6C_P!6?XJ\@33-.6=]NHH1O/.?>OQSN_\ @X8^)-Y
M8)=;M\$8_P!</\*RH?\ @O/XTB5@-;@R3G_6C_"N3%9!BZ\O=M]YVX+BW#8=
M>^G]Q^W/PXBTV#Q4I-^G#KW]Z^Q?"^N:1#HULC:C'_J5[U_,/H__  7Q\;:7
M?_;8M;MPV0?]:/\ "O0+/_@Y?^*L%ND UZV 1<#]\/\ "O7R+*ZV7J7MNO8\
M'B//J>:<OL4].ZL?TE_\)%HJG!U*+\31_P ))H?_ $$8?SK^;:3_ (.8?BJY
M_P"0_;?]_A_A3/\ B)>^*O\ T';;_O\ #_"O?Y4?+^VJ7U1_29_PDFA_]!&'
M\Z/^$DT/_H(P_G7\V?\ Q$O?%7_H.VW_ '^'^%'_ !$O?%;_ *#UM_W^'^%'
M*@]M/L?TF_\ "1Z'_P _\7YT?\)'H?\ S_Q?G7\V)_X.8OBT#@:_;_\ ?X?X
M4G_$3%\6O^@];?\ ?T?X4N5%>VEV/Z3_ /A(]#_Y_P"+\Z/^$CT/_G_B_.OY
ML/\ B)B^+7_0>MO^_H_PIR_\',/Q9QSKUM_W^'^%'*@]M+L?TF_\)'H?_/\
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MI+^5EO!C'6OH;_@FY;VMI\5; RWJC%]W-?E.G_!1:XDD9QJ<?(_O"NJ^#?\
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MGXU_:]NKJ'Q;?Q/Y,8*['SV'M[U^GEL5N8$ESU0']*4M@!&SP:D0]J!$HI0
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MRQJ>J^*[_P 67%G($CG656YQC"5_1?K?BC1O 7AA-7UZ\6"TMX5$DK]!A?\
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MP_[ZC_QIW_$+3XM_Z"EC^<?^-?OT]K;C[MNG_?(I!;6XZVR?794\\B^>?8_
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MGV/P!7_@UG\8G_F*6/\ WU'_ (T[_B%D\8?]!2Q_[[C_ ,:_?W[': 9\E/\
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M_P#V.W_Y]D_[YH^QV_\ S[)_WS2YB3\ /^(5[QE_T%K#\X_\:4?\&L'C$?\
M,4L/SC_QK]_OL=O_ ,^R?]\THL;4CFW3_OD4<P'X _\ $+#XQ_Z"EA^<?^-'
M_$+#XQ_Z"EA^<?\ C7[_ /V&T_Y]T_[Y%'V&T_Y]T_[Y%',!^ '_ !"P^,?^
M@I8?G'_C1_Q"P^,?^@I8?G'_ (U^_P#]AM/^?=/^^11]AM/^?=/^^133N!^
M'_$+#XQ_Z"EA^<?^-'_$+#XQ_P"@I8?G'_C7[_\ V&T_Y]T_[Y%)]AM/^>"?
M]\BF!^ 2?\&L/C%E._5[ ^GS1_XT]/\ @UH\7Q'!U.Q_./\ QK]]7LX%<8@3
M_OFI!;V^.;=/^^13YF.S/P&;_@U?\72J2-4L <>L?^-1Q?\ !K#XRB&UM6L/
MSC_QK]_'@MP1BW3_ +YIQMK< '[,G_?(H4F)Z'X!_P#$+/XP_P"@K8?]]1_X
MT?\ $+/XP_Z"MA_WU'_C7[^?9[?_ )]H_P#OFC[/;_\ /M'_ -\T[L7.NQ^
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M'_C0G_!K5XOVX;4['/J2G^-?OGI4-NVDVY,2XV=,582"T8X$$?\ WS0)MH_
M)O\ @UF\7D_+J=C^<?\ C2#_ (-9_&0Z:K8_G'_C7] /V2U_Y]T_[Y%-:VM1
MP+=/^^135A<TC^?]?^#6?QF[8.J6/YQ_XT[_ (A8O&7_ $%;#\X_\:_?X6UI
MC(MDS_NBC[-!_P ^J?\ ?%%D'-(_ '_B%B\9?]!6P_./_&D;_@UB\9@Y_M:Q
M_./_ !K^@ 6MN3S;)_WS2_9+7_GW3_OD4:(.:1_/^_\ P:S>,6&!JEB,=]R?
MXTB_\&L7C,\G5;'\X_\ &OZ /L-KT\A?^^11]DM5'%NG_?(J+6-7-L_ $_\
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MCKS'_C4&K_\ !K%\0 N(M;L<@]C'_C7] \=G9Q$DQ)S_ +-'V.T:3<;="/\
M=H)/S]_X)3_\$L-6_8S>XDUB>!V>,#,>WT'I]*_0:U58X%C4?=4"E6V@C'[N
M)5_W1BEC55&%.:F6P#J***D HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBBM "BBB@ HHHH **** "BBB@ HHHH ****
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M')S2CITQ0 FUBWS=*:\),@9>U244 )\V[)Z4%%;DBEHH 8(\/D=*<X)Z4M%
M$9ZC!^M-D4M_JQS4V!Z48 Z"LWJ*Q$B2[=KT+&R<+G'I4M%-.PN7084 &2.:
M380.E244M.Q1"VY1D4H#N.:>4!/!IP  P*N+T!:$*PLK<"J'C.,'PCJ9;_GP
MFS_WP:U&SCBLSQ3')=^';^S0$M+:2(/J5(JKA+WMS^3S_@XFFM?^&AK=47!\
MV3^5?HA_P:S7)'@;04)X\A>/^ BO&?\ @L__ ,$I/C%^T!\:(?$7AK1M1EC6
M1S^YB!'(^E?9W_! 3]B;X@?LR>&])L_%^FW<!@A4,+B/':D*UC]6Y(EEPU.6
M,H,(:9(HFXCDZ=:?$I5<$T#$W,.]&YCWH;J?K0O4?6@!WS8Z\T8?U%*3@9 I
M-Q_N&I;:8!A_44O.*3<?[AHW'^Z:5V BA\\FAPY^Z:=15@1A9^YIRJ2/GZTZ
MD+ '!J9; ,(P<4 9.*DP#U%& .@J1W8A08XI GK3J* NQ-B^E(4.>*=10%V-
MWKZ4J[<\"EP/2C '055D(*:8D)W8IU(S;3C%.R 1DS]V@H2,8%'F>U'F>U.R
M 0QA1Q24XN2, 4FT^E3>S$)C/%*%;I_.@J0>*4/C@BE<+#5$O.XT;'W5)15H
M>PPK)V-?EW_P<6SQP_LZ^("XY\G_ -D:OU'K\_?^"VO[,_B[]H3X,ZQX>\,V
M-Q+)<187R%R?ND4 ?SV_\$@7BD_:S+R<@WD&/^^J_KP^%1;_ (5IH&PC']E0
M_P#H K^<?_@FI_P2,^-GPJ_:%_X2C6]"U..$7$3;I80!P?I7]'GP[L'TKP/I
M&F7#[7M]/B1@W7(4"@5C<"C?G^+UI^']10J@#UI:EQ38Q,/ZB@;NYI:*7(@$
MVJ.<4H.1D4'D8I/NK]*+L!:#G'%-#Y.,4ZFF[@1MY@[TI9L=:<_3\:8.3BJ
M$,A?YCQ4E(J[3G-+4/<!I"#J*:>O%.?K^%-I#NQY08XI-A]13J* NQH3UIV!
MC&*** NQ-J^E+110(1D5NHH"**6BFFT W:?[HI2BD4M%',P&;3GI2[#ZBG9'
MK11<5AA4BDP<XQ4E(?OCZ4UJ-:$;AU&14992>!S4\@RN*KD8>GRH=SC_ (\.
MJ?#N\>7D>1)_Z":_D0_;[G6;]N?4,,,#Q3_[**_K[^,.CSZ[X'N=/MD+.\+@
M #U7%?S;?M?_ /!(CXZ>-_VL[WQMIGA[5'MI?$'G!DA! 7 ]J$K"9^P?_!!U
MT;]E>/:1GS(?Y-7W@85D;+D&OC__ ()'? ?Q'\#_ -GU/#7B*.:&8/&=LPP>
M W^-?6]FCBZ;,Q84Q6+BD$<4M%%9C$*J><4+C'RTM-;.>,_A0 ZBF?/[T?/[
MT /I&SCBF$L!GFC)/'-"BF X/QS0V\\J:0(3UXIX&!BGR(!N']:7#^HI:*0"
M8?U%*,XY-%% !1110 4444TV@"BBBB[ :Z%F!':D<2AL@\4^BFHH=V1OEL>U
M* S=Z=M'I0HVC%'*@N)L/J*-A]13J*.5!<859>:>.1F@C(Q0.!BCE0A/FQUY
MJ"\1OLLS-T\IOY5.2 ,U!>,6MY$]4(_2CE0'X _\'/MR9?$-E"IQ_HY'_CAK
MPC_@V8EBB_:/TJV_C$*?SK[J_P""^G["GQ)_:0UBUO?!^D7DWEP$'[-&#SMK
MQ_\ X(1?\$V?B[^SS\9].\5>+-#U&"..)0QN(@!UJ@/WAT8.VCV^#QY?-65!
M#YCZ57TF#R=*AB>7!5,$&K$'7KFD]@+"-D8/6D* GBA.OX4ZHNP$PJ\XII=O
M6GT8'H* &J6/)/%.HHH *;N8?>%.ICGYJ=V*R0K/GI2+O(ZTX 8'%+4VUN,3
M#^HHP_J*6BF @#9Y-+1151V ****H!FQO2EV-C&:=168K6$  %-?[U/IK]?P
MH&-(!ZBE5 <XI*='WI6%9#=DF[':G;#ZBG44:CT8P@@X-)4A /448'I3U"R[
M#%C/<TPP@2;R.*FR!U-'6E8329&0Q^[7RO\ \%:)3#^R5XC:4_P#_P! >OJS
M@5\]_P#!2#X3:M\6?V:]=\.:*)'GG4!$B&2?E85<6[C/Y/?A_+ /VV))F!PV
MJ6V/^_M?UJ_L(-_Q8O0BIX.D0_\ H(K^>#P1_P $@?CO!^U&WBJ7PWJHMQJ$
M#B0PC&!)GTK^C7]D#P-J'@'X2Z3HFJ[UDATZ)&$@Y! %7<#U;=E^0?>G@(W0
M4 JQX QZTI(7H*SEN ;%]*0[ <8H\SVI1AAG%( V+Z4;%]*6BG=BL)L7TIKH
M^?DZ4^BB[8UH1[)?04;)?05)12'<8$?N!2[#ZBG44!<;L/J*38:?12L%R,I)
MV HV2^@J2BF%R/9+Z"E"-WQ3Z* N-V'U%&P^HIU&0.IH"Y'(C;>*0 XP:ER#
MWHP/04K ]2,1!CNP*)$D_@IYSCBFY/J:+"5D 1L<TNP^HIU%78-.PW8?44;#
MZBE!R2/2EHL&G8:8E88:F+"Z?=J6BCE!)(JW@G^S3;FX\IOY5_*#_P %\\']
MI6\$IX&N>M?UA7ZEK.1!W0C]*_G:_P""QO\ P3"^,WQK^.$_B#PUX>U*:*75
M?,#0Q C%.P/4^B/^#9);=O@J/LHP?MJ_^A-7[/1@2*(Y>2*_+7_@@[^QE\0?
MV</ALFF>*[2[@?[4KE;A,=V_QK]26)@ *C<<TN5!<D\I!VI0BCM0I)4$BEHY
M4 FQ?2E  X%%%#BF A#9X- #YY-+12Y$.X4CDCI2T5222$-#^M#;V&5IV!Z"
MBF!&(2P._P#"E",L>T4^BHNP&*LO1C3@H7@4M%%VP"BBBD 4444 %%%% !11
M1560!1110U8 HHHJ0"BBB@ HHHH **** "BBB@ HHHH ****I*X!1115 %%%
M% !1110 4444 %%%% !1110 4444 %%%%  2!R::Y?'RTK$ <BH_+EW;MW'I
M0!5NHT>;,O#>U2I'(8]GEAE]ZG,4<AWLO-#@M\B\8H J^1''_P >L">YVBAK
MAXX]DBA3W JU&JXX&*:T"R/^\7- %1!=)DA>&[TZ*!%;SW/S#M5E^<*J\"@*
MJ#:RYH K^;.\GRQKC/'%/N-GF+'P"1VJ8QKM!08I&MPT@=NU $$AN(3LC4%:
M9%;+(Q=#ENXJ\44\D4Q8@K?NQCUH K&6"-_*GA3=[J*<)$A^8QJJG@8%3R6\
M4C[F3YNQH:%-N'7('04 59[&&696W&IDW1OY"=!4B(K'..E-"'[26% $I;:!
MGK2C)'(I@/)9AG%+&_F#.,4 .HHHH *"0.IILLT4"[YI%4>K'%49_$_AR-MD
MFN6@(/(,Z_XT 7]Z^M!=1WJG!JEA>C=9WL4@_P"F;@_RIS2MGG- %K>OK0&!
MZ&JRR-T)/X5%-KND63;+S4X(F':24 _K68%^D/WQ]*JVVO:+>'9:ZM;R'T28
M&K)(W@YXQ0 ZF>9@X-//0X]*JO(=U %H'/(IA;YN>QJG)K^D63>7>:I!&PZB
M24"F+XG\/3-LAUJU=B>%6=2?YU4=@-$,#P#4<T:M_6J[W9'S G'J*='<;\>]
M4!!<Z/HUY,LMUIEM(R]W@4_S%3VMC;6KXM+"&)>WEQ!?Y"K!B!&5ZTT*T2\F
M@!(T2$LR'D^M.C>7'SBH979B E12ZKIU@,:AJ,,1_P"FD@'\Z +NP'D]Z-@'
M([5DR?$'P+ =DWC#348=0UZ@_K1'X_\  ]P=D'B_37)Z!;Q#_6@#5,A')Q1Y
MP]JJ+JEA>1YL;Z*7_KG(#_*FF9QU)'UJ'N!=\X>U'G9]*I?:#G&XY]*5)F+!
M02>>E("^.1FBH9]0L;) UY=QQ<?\M' _G6=-X^\$6[^7<>+M.1AU5KQ ?YUH
M!KTR1@&YK*A^('@6X;9!XPTUSZ+>H?ZU;CU73+XAK._AE!Z>7(#_ "J9; 61
M* ,9IR.&JI+*RGGBGPNQZ@U(%JBD4Y7FEH **** "@D#DTA.!UIC-CJ<^U6M
M@'%_2D#*_)-1%SZ_@*AN=1L;)=]WJ$4 '4RR!?YTP+F$]31A/4UA2^/O!,#;
M)O&FF*?1KU!_6I+;QGX3O3BT\6:?*?\ IG=H?Y&@#9&P<YI=Z^M5HYDEB\Z&
M=9%/0HV14<D[CUJ'N!=# \ T% 3FJ27>P;G; ]32'Q-X?B/ES:W:JPZAIU!_
MG2 OT51_X2;P[U_MRT_\"%_QH_X2;PZ3@:[:?^!"_P"-6M@+U5]1L;.\MVCN
M[6.0'J'0'^=1KXBT!SM36;4GT$Z_XU.9H+J$F"97'JK9I@4K/1-'MAFVTFU5
ML=5MU!_05,(H&D#2G!7H!3&$D+X5\\]!3Y8]P&#SB@"VA4KE>E+5& O;R[Y[
M@!/<U'=^,/"E@<7WB.RA/_32Y4?S- &E16*/B-X 8X7QII9/M?)_C5RS\3>'
M=0_X\-<M)O\ KE.K?R- %ZD# ]#4-S<;5W*>/45##<EN<\>M9@6V"KS3?/&<
M<5#<7!"9&:K13N[9P::W T,E^E!!4U7DU"SL$\R_NXX5]9'"C]:@7Q5X:N)/
M*M]>LW;H%2X4G^=6!?\ ,.<<4N\^@JO#.DKY1@1[&IJA[@. W\FEV"A.E+2
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MOVI/VQ?AI^RYX7G\0>)_$D%O*8&>..;&"1VY^E?C1^VK_P '+?B"[\1W&@^
M5M9K0;U\^$J,$'':OB3_ (+ ?\%7OB%^TG\3-3\$Z%XF>2PL+UHA&S,?DZ^O
MO7R_^RC^QC\4?VI_%MOIWA/3S(EU(=Q:$D9)]: /H_XB?\%U_P!H#6=7DN-/
MN;D*6R EW@=:Z3X)?\' ?Q]\*7Z2:@DLBA\MYMQG'YU]/_ W_@V#^('B3PE#
MJFO>&[5I9(&.6B YQ[FOGO\ ;G_X($?&?]G/2;K6[+1(4MXHB[>5 3Q^!H _
M2_\ X)S?\'$'A[XNWMEX'^(NHV-F7"[V;:3D\5^K/@+XC^%_BCX?M-?\+ZDE
MS'/$'W)TQFOX9-/U#QA\"/&:RVDC6]_ P)8J1T-?T%?\&\?_  5/O_BI:2_#
MGQAK$TTEE$MO&"3@'"GO]: /VR5V>00%, ]35HCRT")SBJ^GR1W%I%?@</&&
M'XC-6!(H_>8ZT 2#IS10.1FB@ HHHJ9; %%%%2 C#*\4TJ9.&R*<S!1DU'/(
MZ@;#UH <D0CY+&HK^Z^R64]XYPL,+.3] 349N)2WDL>37FG[6OQDL/@Q\)-2
MUS4+KR]^G7 4[L<^6:M; ?FC_P %D?\ @M'??LS>,+?PUX1N(9'(*LH8 Y -
M?GYX<_X../C+-K,4EU9J(RZ@YE'K7QE_P5-_:'F^/WQWO[QKQIQ:ZE,J9.<#
M)%?,(-W;%<Q.JA@<E33 _LC_ ."4G[>4G[9_@=)KYXEFL[0,XC(SG@\X^M?8
MDJM-.$4?+CJ*_FS_ .#;S]N5OAMXSN/!FI:N46]F2!%WXSE5K^D?1[L:GI5M
MJ-M("LUNCY!]5!H EGMOM"^4#C9R/>J%[J%KIEA+J^NR^1!;#+R'TK2E6;:#
M"1NSS7QQ_P %?_VM+K]G;X":W'I]^T%Q)INZ,@]\4 >+?\%/?^"X_@[]EV:_
M\*>!M6LKRYMRP52%R>W>OR*^/'_!PY\:_'%]+)IR-$H<E/)G"Y_*O@[]HGXZ
M>./VF/B7-KFL:C]HDNGP2<G.6^M?=G_!/'_@@G\3/VF=%A\2ZEHL$UK/$)4W
MQ=C]30!Y5IG_  77_:+AU >=/=;<GDW=?37[-'_!QU\4?"FHVEOKD2/'YB*[
M3RJ>,@'K7O7C7_@UO-AX1EN]/\(6PNE4;6\M?2OR3_;Z_P""?7Q._8W\8W::
M]IGEV:3A(A'"0,[L4 ?U.?\ !/#_ (*E?"G]KWPJC7?B:T2_"*JPQ@9+=,<5
M]91M*]Z6B3,?9J_C5_X)<?MF^./V>/C3HMA::E+#;37P,JA6Y'6OZUOV)_CB
M_P >/@K9>.VG:3S@/F8\_=!H [GXA?$;P]\,O#UYXA\2WJ6R00&16<>E?D5_
MP4;_ .#B#3_A=K=UX,^'EY978"L Z[0<CBNY_P"#B/\ ;;\1_!SX=VWA[PKJ
M[0->6[Q2@$\Y9O3Z5_-?867C;]I+XNC1WG$]_>3R&,D$]7_^N* /MWXO_P#!
M?C]H+Q=J$C:8LR+OR/*N<?RK$\%_\%W/V@M/ODNKVXN?W;9VM=YS7T_^Q'_P
M;A^.OBGX*LO%GBCP];2I=PDY,0ST]S7<_M'?\&QNL^$/ E_X@\,^%+9)8(-P
M*Q@\_A0!2_8Z_P"#EGQGI&MVMAXTAMT@RH:2=E/\Z_:_]D#]M7X?_M5^#K37
M="UVWEN'MQ)+'#C@_A7\:7[2?[.?C7]G?XA7'@GQ'8O'/;')Q$0.#BOT#_X(
M%_\ !0OXC?"WXI1^!O$.LRBSN;R.W@0!A\I"T ?U0Q2,T.YDQZ4^-@5R.M9'
M@;Q);>+?"]EJUN25EM(G;/J4!KB_C7^T_P##?X'Z5-J'BC48XQ$C$CSU!X%
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MY_A!H ^P8$,,+[_P)J(RRQ0_:8%W^U6;F&5_W>1@\5#/,FG:=(KC[D;'CZ4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7\*_-[_@H3_P0)\'?M/_ !!?XA>"?$%M!$T;?);)QEL'^Z?2OPK^"W_!4?\
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M=V"K$,_<'I3 _EM_8D^+^L?!'X^:-/#=21JNKQF0 XR!7]@7_!//X[1?'[X
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M_P#!>W>O[(NJJQ/WG_\ 0:^_K>YAN(!/ V589!KX%_X+Z@']CS59H_O[W_\
M0: /Y1-8\O\ X7X^\#']JKU_"OZD_P#@WBL?#5S^R?))/!"TPGCPIZ_QU_*U
MX_OGTSXN7FI(?FAO@_Y8K]"OV#/^"Z7Q(_9&\!#PEH&JV\<0=6Q))CIGV]Z
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M>*?@!\5]2TG4;2:U8:A,(220<!CTKS:;7-4U:/[/J.I32+_TTD)_G0!]\?\
M! Z-U^/-MA^NJQ_R6OZU/!9?_A'[&*4Y!M(L_P#?(K^2W_@@7 LGQ[A.\X75
MDQ^2U_6-:^(=.\+_  ^MM6U*<1QQVD67/;Y!0!^;7_!QM^U/;?#?X"P:+I&J
M+#,[M$X63GD@5_,)/KR>*/B1<:AKS^<DU](QWGL6-?IA_P '&G[57_"T?B'?
M^!M+UII([/4AA4D[;\_TK\R_ GP?^(GQ(NUC\'Z)-=.S8S&><T ?MG_P2'_X
M*4?L^_L@_"W2[34=)A%S;H S++@_='I7T+^V=_P6R_9R_:"^$6K^&?[)C,LF
MG/%&7F/!)K\$/^&+?VQK%-EEX.U9$'0).P%(G['O[94K"W?PIJ[!S@@W#<T
M<=^T3JFB7WQ NKG18E6"6:1@$.1RV:_5_P#X-M_VV!X%^(Y\'ZIJA6'R!%&C
MO@9*D5^4GQ0_9G^-OPRC>\\<^$KFV1%R\DQ)Q76?L+?&G4/@O\9=)U6TOGC\
MS4[=7P^.-X% ']M5MJ">(?"5O?0$,MS:H_!SU&:_F6_X.7/ >HZ;^T9XB\02
M6DA@:1@&V''WSWK^@_\ 8)^.5A\<?@=I.HVURDI@TJ!7*^NT"OSH_P"#D_\
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M'UK]\O\ @XI\0?LSV/PDU#2?"']DPZBL[_NK:S1&'3T%?@)\/KF)?C-IDUN
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MT./=JFNV=H<?\M[A4_F:L_9L"6?<<LAP,^U?D%_P<$?M1?&3]GN[B;P;'<K
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MI B$G !"UR?_  <3Z9\&M/\ VB];;X:75F\8+[/LT(4?>/I7S=_P29CU0?M
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1116@!1110 4444
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MR(KU)661 ,X _P!FOMG_ (*Z?LA_$3]IOX?S^ ?#>L7D5O-9)&5@'&0FWTH
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M#QW^T1\8-,LM*TV21;F\Q,6@8@DU_6K_ ,$EOV4W_9M_9BTOP?JEBL5S"H#
M+C^ "O*/^"=7_!%3X;?LI6-OJVK165_=+MD5Y(SN4_D*^^[>&TL(1IVFVBPH
MO1$H _'7_@X=_P""9,?Q-\,P^// F@ W$<;3W;B/=DY;T_"OYUM<T#QS\$/&
MLDL<,EO=6TSA&,3#&&_^M7]S'C;P9X<^)^@7GAGQ3H<,R2PF-6G7(&:_*/\
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M]CO04,.G6-S<O  91&0<\<]!Z4 >P_LI?!BU^!OPMLO"MI;K"/LT)91ZA/\
MZ]>EL$F.)!P.:ABMC+*LL;[408"=L5)Y@DE,0&,=Z .8^-DR#X6ZL0.!;U_)
MO_P71OHI/VE=9C .<M_Z$:_K4^)6A'Q/X+OM!BDV-<1;00*_"W_@IA_P0I\>
M?M!_&/4?%6EZS=JDY./+CS_$3_=H ^4_^#;'5X)/B_>P!&R+Q!G'^RE?U*Z(
M"VBV;#_GTC_]!%?B_P#\$>/^",GBC]E'QM<Z[K.H3OOG5_WB8Z!?;VK]I=,@
M^S:=;VQ;/EPJN?H *3=@)=A]11L/J*=14\S :J$')-.HHI-W **** "BBB@
MI&) X.*6JVI022P,(Y"I]J:W _'7_@Y#_;RTOX??"M_ FGZDR7*7+1. _P#>
M8"OYS_!MA<?%+XQ10;#(VHW[,.,YS7] G_!8/_@D5\5/VO?B)J-[I^NWXMY;
ML.BHH*CYL_W:^>OV0O\ @W%\;>"?BWH_B/7-9N7BMKL.ZRQ\8_[YJP/O7_@B
M=_P32^$D/[,.C^+?&/A8/>G:'?:!_"/45]NO_P $^_V;93O/A+EOO?=_PKJ_
MV<?A):?!#X7VW@>S92L./NCT %=U++*%!4&@#QE?^"?G[-4#;(O"6"?]W_"O
MQ)_X..?^">WAWX8^&W\=^#?#WEQSWO#*@/ <>@]Z_H=MV8CSGR,=C7S1_P %
M)/V-]+_:M^%#^&YX$9MLA0E<X)'!H _CW_9J^(FJ?"'XZ:/K:W!B2ROLOVQB
MOZT_^"4_[0?A']J;]E#3[34KG[3-<1XP9 2<H*_%WQ[_ ,&UOQ*_X36_U;2_
M$%Z%>\=X@D0^4$]OEK]._P#@BG^P]\5/V38]-\->*-;OY[6V5<K. %XX]!0!
M^97_  7]_P""8?C/P1XXN_B5X6T4"VO;MIV*0DDKR.WTK\N_@K\9_'W[/GCF
M'7_#MS):7%E(P#,C#!!_^M7]K/[3O[+?@']I'PG/X;\2:5:,SP-&DDZ9P3W_
M %K\9/VXO^#9G[;J-YJW@?7]HD+NJ6L?J<_W: /!/V8_^#DGXI_#3PQ;:/XN
M\<S%8HR-JLW7'UI?VG?^#DGX@_$_PO<:-X8\:3AI8=F&=NOYUY%XB_X-W_CE
MHLS0V_\ :DRJ>"(1_P#$TSPY_P &\'QPUFZ6*X35(E+<EH1_\30!\/\ QG^.
MGQ _: \7R>(/%5U+>37+8+*C'.3^-?J7_P &]'_!-KQWXA\>'XB^(M(_T19D
MN+<O"00 %]:]P_81_P"#:%-,U"SU?Q[K/FJNTM%=Q?\ V-?L[^S1^RIX"_9R
M\'VWASPYI=I$\5N(VEA3&Z@!_P"T38Q^'_V=+JQ1<>3:Q(<>R$5_(E_P5GOX
MV_:<\0O "'^T#)_X$:_L0^,?@J7Q=\-;[PTDY9I_ND#IP?\ &OP4_;U_X-^/
M'WQI^,6J>--,UR[1+N8,%2,?WB?[M 'Y:?L0_MO^+_V3]6&I:'J[6S>=ORN?
M7VK[?E_X.4OCZI\N+X@3>6!P-S_XU-'_ ,&RGQ+,0SX@O>G_ #S'_P 32-_P
M;)_$L''_  D%[_WZ'_Q- $%Q_P '*/QY95\KQ]-D=>7_ ,:C'_!R?^T3-= 2
M?$&8P8^9=S_XU8;_ (-DOB7U'B"]_P"_0_\ B:BA_P"#9KXGV^II(VO7Q0#E
M?*&/_0:35P/VQ_X) ?MH>)_VK_A;I>O:_JKW#7%J7);/7;GO7VTGF(Q$AX-?
M%G_!)#]B[4_V2_A;I>@:C=.[6]L4.]<'[N/05]I32L""%S2Y4 H=A-L!XJ6F
M0?,N\CGUI])Z, HHHI %%%% !7F/[7?Q9L_@O\#]5\>75SY8LP"6#8(X8_TK
MTZOF#_@IG\&O%_QO^!NL>!?#5[<1-=Q@#R?]TC^M-;@?RR_\%:/VHI/C_P#M
M#ZY*E\TL$ER&C!.>=QKW#_@@I^QC)\>OB?9ZSX@T@SZ?:Z@//!C_ (<X[UZ/
MXO\ ^#<;XN>,/';>([S7-0/F3JS!HAR V?[M?KO_ ,$:O^":EC^Q_P"";NWU
MB%9+F0 J\B8;.0?058'TO8?\$\OV9K32TT^+PCB,*./E]/\ =I+?_@GS^S:)
M#GPGP#Q]W_"O9I[B5#L53QVI8Q)(A8$@XH ^-/V_O^";OP&\2_LXZW:^&?">
M-19 (&PIQ\K>U?RB_MM?";5O@M\>]6\+7-L8DLYAL&S !W'_  K^W;6="@\3
M:+-HFHQAEE/._IWK\/?^"KW_  0>UO\ : ^*VJ>+O"5Q+ ;JX#9MX^V[_=H
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M!_#!\?\ X+Z]\"_B'/X-\0V31SP,2?W9 &#7Z8?\$!O^"I6K_ SQT? _BOQ
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MWCLQ@527&,X(]J^U,QYRJ@^]  AP2:6,Y%5T$@E)).,U97&.*GE0"T444<J
M****3T8!1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M ****T **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@".YYCQL!]B*C&F:=(NY]/@)
M/4F(?X5.PW#%1H[*&)R<4 ,BBM[;]Q'$J#T50*<(H@<J>32PNER/,*8P>]2;
M57^&@"!K2 N'.<^E)+963ONN+"%AZM$#_2IWP#@#DT@4DX?F@"%++3Q_J+.)
M<=2L8%*]A9R_ZRWC<_[: _SI\T3%@8SCGFG9\L989- %1=+TV23:VGP<'(_=
M#_"IGM(68%$ "]E&*E103O\ 6DD)12,=: $%NF-RG--N&FC*+"HP>M.B+/&
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M]E7%/MT$4>YZ<T<AQ\U.5!MVMS0  I)R*<  ,"F(5)*JN*6-64?,: '4444
M%%%%0]P"BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4445H 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1@>E%%   !T%%%% !1110
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M@(8<4FQ?2E  Z4 ($ .:7 ]***A[@' I,KZBE(SP:3:OI2 7 ]*0@,,&EHH
M;Y:T$E.!3J0KEL]J %!R,T$X&:.E% #0Q8[32A0.E 3#9%+51V *0H"<TM%4
M @0 YI:3>,XI: $9L<"D0#&<4I53SBE  X%2]@"C ]***D HHHH *, =!110
M 8'I2,<#-+00#P:M; ,+D]0*<IW#FD*>E*HP,4/8!<#IBC '0445 "-@#I0"
M".*4@'@T  =!0 4C-BEI"H)R10 M! (P:**M; ,*D'I3D&!R*6BD]@"BBBI
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M28ZU&QE&,"E!5C\U%F!)YH]OSH\T>WYU$0J99^%QUID4\-R"8&R%ZT68$YF
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M[Q/83;UO+<2;AWY-2T[@=#D^IHR?4TW),>X=:;+((HPS'K2LP)?- Z_SI#,
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M@13@P/>JWG0L D39;TI7F$-M)-(<>7&6/X#-*S LTUVQP*^$?V[O^"N/@_\
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M>!VI?- ^X<BE+8"6BFQN6ZTZH **** "BBB@ HHHH **** "BBB@ HHHJD[
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MZT ?9GP0_P""IGPA^._C^Z\">'%B\RU&7=9LC'/^%;/[4'_!2#X,?LNVL?\
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M0?LP?\%8_@E^TYK5SH6BK#:_9;=I3)+/@$!2W?Z5_+U^Q9^S_P#'3]KWQ/\
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M&YMGC<*V,Y9Z /SF_P"";_AO6?V\O^"@&E_$OQ06NM/@U&XA=9UXQYRCJ?\
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M:DF\)O=7#/J.L2@,SDD<D\4 ?T:_\$4_V\_ OQ"^"^D_#265/M056,CR\?=
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M% (/AUKEY)':VJJ#'T'WR*_:?_@E[+>^._V2)+75)'E$^C19\QMV>GK7X?\
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M,DR'.3Q@]:_7G4/@MJ6B_LTCP!X:NWMKBWTR9$:'@Y*8':OYX/VT?AA^W?\
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MJ2__ ."H?Q>U_P" UU\'_$W[-^HW=_.$7[5/%E_E5E/\?O7"_L _\$V/B_\
M'O\ :,A^*.H^$M1TBW:^@N1&\( &U]V.] 'Z%_\ !Q/XCF\9? O2?$I<DWOA
MR&=V/<M$#7@__!K'>Z=!XKT6.6ZCC;R$^^X':OL+_@M5^RKXO^(O[-&FZ5X>
MTVXGDTSPW# RPIDDK&!7XI?L'>+/VG_V/_C'::9IO@?7$C@*+N1 !]['K0!_
M7I>.LR1M#(K#U4YK&^([HG@RX9ON\9_(UY1^PI\2?%OQ(^#^E:SXLTRXAGET
M\.PN.N<UZ=\38)[GP1=)!DN3PHZ]Z /Y1/\ @J;J$W_#PR_'FCRQXEM<#/\
MTW%?O%\";LS?\$W-6(.5'AN'/Y"OQ+_X*7_LC_&CQ9^W9>^(=(\)ZE+;MXAM
MG#QQ C G!K]O?V>? WBC2?\ @GGJWAJ]TF?[2_A^)%C9?F)P* /P0^&?EG_@
MI/-(.%^3_P!&&OT>_P""[$CK^QW\/O,8;?[#X_[^2U\-_#W]F3XQM_P45FU%
MO FI):_+B?RAM_UAK[__ ."U7P0^)'BW]E/P)I.B>'KVZE@T;;)'$F2IWR4
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M#/7+2'PUIDJ2ZA#K,?FM'*K _OE]*]F_X-<1<6OPZU95.%>8$?\ ?8K\C_\
M@H!X!_:"DNK?QS\:7U>+[3?QDPZF!PV\>GN:_7O_ (-A[V'4?AQJ7D1!!#(
M<=_F% '[2S ;&(^]M/-?AQ_P<W1ZBVDZ*X4A58\D?[3U^WMQ=2F[,:1$K_>%
M?F)_P<E_!1_'_P &=-U72-,.^SLG>5HUY^\_7\Z / _^#86]MY_AKL9@9_[5
M^4Y_VWKN/^#H2]8? /3XG/S#41G_ +^)7S1_P;-?$^7POXTM_AQ=.3)+J\F
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M%)_BMI^D>(/"WB*VMI8! YF0$<;5]3Z5_0'_ ,$E_P!@*#]F_P#9KMM&\20
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M@T;BGB"V;(<$8\\>E;_P#^)G_!0:;X>W'PKM?"WBY;5Y=@O J[5"Y [U\O\
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MRIBW(F&X>E1FTC>%3$F/:E=@8OBGPCH/C/29M#\06R-%.NT@Q@\?C7A^J_\
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MB@ HHHH **** "BBB@ HHHJUL 4444I; %%%%2 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1116@!1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%3+8 HH
MHJ0"BBB@ HP/2BB@ P!T%%%% !@>E%%%-;@&!Z4  =!BBBK ,#KBC /4445#
MW ****0!1115K8 P!T%%%%*6P!@>E  '0445(";5SG I:**J.P!1@'J***H
MHP,YQ1168!1110 8'I1@>E%% !@=<4444 ! /44  < 444 %& >HHHH ,#TH
MHHH " >HHHHH ,#.<44454=@"C ]***H HP#U%%% !00#U%%%3+8 P/2BBBI
M " 1@BBBB@ P.N**** # ]*, ]1110 8'I1110 8&<XHP.N*** "@@'J***
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M&N2,8--HHI@%2444 %%%% !1110 4445F 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 44454=@"BBBJ **** "BBB
MIEL 4445(!11151V ****H HHHK, HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH6X!1116@!1110 4444 %%%%9O< HHHH **** "B
MBB@ HHHH **** "BBB@ HHHIK< HHHJP"BBBH>X!1112 **** "BBB@ HHHH
; **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>camp-20241231_g12.jpg
<TEXT>
begin 644 camp-20241231_g12.jpg
M_]C_X  02D9)1@ ! @$!] 'T  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" 8+")$# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&&,6ZOR*$#2G=*,!>E?SB_#C_@XA_:CTS68S\0?'T[Q*R^:,..,\]37ZH?\
M!.'_ (+ ?"C]KO33H_\ ;+MJ$0$<GGS@;GR,X!^M [.Q]W*1))O7D>M-BDED
ME*R)@#H:9;SQ>2/)((89!!J9IE0#<>300T/HH'(S104%%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !112,X4\T";L+13&D/&S\:&,NX;1QWH&G<?13#(1)@]*<6QC
M'>@!:*0NH;;GFD5R6(/:@!U%(KJ_(/2D+XY/2@!U%(6P,C\*!DCD4"33%HHH
MH&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !113%=@</^% #Z*8TF'V@TUIV8X3MUH EHIJ%ROS#FA9,
MMM- #J*C9I@W X[T]6##(H 6BBB@ HHHH **** "BBB@ HHIAN(A*(2?F/:@
M-A]%1RR/'\Q Q3(KM;@[H3E1UH$G<GHIOF CY:4L ,F@8M%(&!&1TIB/)O(<
M<=C0*Z)**C9I/, 097O22W*AO+1OF[T#):*A>2;*[!QWJ7+%<CK0 M%1RRM'
MCWIQ9@0<<=Z '44SS@6VBEW$J2!S0*^MAU%,5V_BI9) F/>@&[#J*:)%(SFE
MW#&Z@+IBT4R.3>3STIP8'@&@8M%(QP,TQ;B.3(C;)H%<DHIH=@N".:C>\2%P
MDQP6/RT#)J*CEF$/SO\ =QR:<DBN PZ'I0*Z'4444#"BBHY)3$=S?=[F@"2B
MHFN J[B>OW:19I N'')Z4 22$@=*;^[9=Q4$B@.VW#'GO4:,&)$9SZT 2>;&
M\1:0X'O7SK^U7_P4 ^%/[.VA7=SK'B6P%Q;1,5@DE(+,.U?0LMOYL1B?[N.H
MK^;C_@K1X$^/OQV_:8U?P/X>@FDMX]7$=NL<[C.3TX% &%_P4Z_X+'>-?VM=
M:N_#WA:2YTO3@&@>""3Y)=OR[NI],_C7P%HLT]UXLL?MZEG^VQ9=^_SBOT[^
M"G_!"C5]$_9OU3XM_'SP_<VE_:@26Y4,04.2#SCMBOST^,7AC2O!OQO7POX=
M),$%]#LR.?\ 6?\ UJ#1:[']*_\ P1-2%/@;#Y2@9TV/./JM?:6N:A_9=DUV
M(MQ KXI_X(DQR1? V$..NFQ_S6OMO4;&+48C:3?=- GN?S)?\%D_V@?C_P#&
M+X]:YX!C\.ZO]@T_42MNX V%<YXYK;_X)*_\$9/$/[7VC-\0?%>J3:8MO=E'
M@N$^]\Y&>A]*_;[XE?\ !*_]F_XF^))_%'B"T8W%Q+OD(MU//YUW'PH^$_P3
M_8H^']W;:')Y&G!_,G=HU4@Y)]: N?C-_P %1?\ @@_:?LW_  F'Q+\,^*5O
M'>9E-O O( V\_='K7YU?LD_$CQ]\!OVEM".A>)KNU@M=8'VNVB? E !X-?N'
M_P %G_\ @I[^S_J'P$/@[X?>*DN=6$T@E@D"< [1ZGWK\3?V6_A;XM_:%_:;
MT^YT&P\^.YUK,FW/&0?2@I-6/ZG_ -B/XS2?'3X+6?C.> HS(BD$_P"S7K\4
M.V0L[9!Z5XQ^PI\&=1^!GP/M/!6HVS13*J-L;_=]Z]I"G_EIQ09O<EHIAD)7
M,?:D9Y3'N4<]Z!$E%,24NIP.138S<;_G'% $M%1I<([%0>G6D,^]#Y9YH EH
MJ)+C:F)#\PZTZ.>.8'RSDB@!]%,,C8VC[WI38Y)58B;@=J ):*8TZ*P6C<Y.
M5Z4 /HIK&3(VCZT%P#M'6@!U%-5GR=XXIOVA0=K=:!-V)**0-D9 I&D56"L>
M3TH#F0ZBF%V\S;CBA6D#$/T[4#'T5#/=""0!CQBE25Y1OCY4]#0!+136D5 -
MYI58,,J: %HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***.E !13?-3&
M<TQ)9"Y+#Y>U $M%-#[C\OXTZ@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *1L8YI:1E!Y)H$U<\J_:K^.5M\#?A_<^*)X'816LDGR ]@?2OR(\4?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC/\ M0?$2\/E^+M<U%Y&)#!P3UH*Y3^GQO\ @L5^RRMR+4WS[BV/^/E?\*]
M^'W_  4!^!/Q&NXK/1M7C5I?N[[I:_E-G\,_M<Z4?[6ELO$+I)SN*C"^]5(?
MV@_VC_AWK$4LOQ UFQD3I&90"/TH'RH_LCT?Q!I&NVRW.G7\,JMT\N4-_*I_
M.2)]I')K^?3_ ()-?\%M_%7@_P :6?@;XJZC<7D*HB?:K^7AF/'8U^\OPI^)
MFA?%?P?9>*M&N8I%NK99<1-G&:"7HS4\50Z/J&GO9:VFZ$_>R:^1O'OP!_8'
MUOQ=>W7BO1H&O"^9R;F(<_B*^A_VFM1O-(^%EY?V,C1RKG#+UZ&OY9_VU?VH
M_P!H+3OVH/%6GZ?\4M7M8(KTB.-)@ !CITH&MC^CO]GWX+_L8:#XHMM2^&6E
MP17L4G[DK<1DYS["OJ.?+KM0\U_,Y_P1=_:!^-WC7]JWPSI?B'XE:G<6TEZ1
M)#-*"K#</:OZ7G!AMCOD^XI8L?2@)*P^;[- @EN'5=HR69L 5Y_\3OVG_A=\
M*HW?Q#K=O^['(6Z7-?%G_!8'_@J_H_[*GAL^$/##QW=YJ%N8O,@D^:%N3ZCT
MK\$/C+^W5^TE\;/%DVJVGQ!UI$E9L6BS#N:!QBFKG]+VN?\ !7?]E_0;@VUW
MJ)+ XXN5_P *T/"W_!57]FOQ9(([#4MI8X&^Y7_"OY=+*P_:R\5Q"^MT\07
MQN##!S535?%G[4'@]"VJ:GKFE[.\A _&@KD1_8+\/_C+X&^(^F1:IH&M6S)+
M]U?M*D_SKJE974,K @]"#7\DW[)G_!3?X_? /QG;7^K_ !"U;4[021J;:2<;
M0-W)[5_11_P3;_X*(^#?VN_AW GVRV@O+.T42KO^9FR/<^M!$E9GUE1D>M01
M2,D@3JIYS1AH)-Y;(;MZ4$D]% .1FB@ J.1%9^:DJ*[*+'\\@0?WC0!\1?\
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MJ4DVC>"/#-_:2L#MD5),#]*_+']M3]M+Q3^UGK\U_J^HSR0-/YD:3 C'.>]
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M.DN^N>3MLXH[< $X/H?I7X8? W_@KC^U=\-KB*UN?BA?M:P$8C /3TZU]G_
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<@JKK+3RVK00IDLN#5MV<C]W3-CJ#SSB@QB?S8?\')>G/IG[9=Q<2@EQ9O\
M*?JM?G%X<TN[UO6[6PM58S74ZQQHI_B)P,5^S?\ P<G_ +.-WJ7CG4OC1)IY
M9(+9E,H3.. >OX5^.?@'64T#QKIFM9*BROXIB?\ =8&@VB?97PX_X)#?M0?$
M#PS%X@TSP[K!CEA1XQ'.X!!&16X__!%O]KA( 4\*ZV6ST^T/7Z^_\$5_VZ?!
MOQY^#,>FRZPGGV21VRB:< Y7Y>_TK[UEU;2K='NGU"#:J%B?.7L/K03SL_F*
MN?\ @B/^U9=P%[CPCK$A ^Z\SFL]/^"''[3<REI_AQJ*_B:_8C_@I5_P6'\
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MN)E&S&0SEOZUO_\ !)O]IG3?V7/VD8?'5U=-"MR(H-ZMCJQ'_LU!LMCUX_\
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M?[)M!+_95N\[97. I+5_,=XCL?*\3ZEI5U&5EMK^6(9&/NN1_2@$?2W[+O\
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M':%7+'T%?D?_ ,%O_P#@JOXF_99^,5GX3\ LMPLEF&8!P/FVJ?ZU]/?MZ?\
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MQG(S_6OI_P 9A5\(:JW_ %#9_P#T6U!B?RB?\%6]LO[0>KDC[NKR_P!:SO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!X?LXXHH85C4)$%R%&.U!#D:D]O#;:9+%;H% B; 'TK^>C_@YM?=X^\.*/\
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MM8(T4>7",#(&*Z2-R3MQP.]*T2L,4J@*,"@@6BBB@ I&(7YB*6HYW)78GWJ
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M0*I(]\4$N1M> ?"%AX)\*6&@6$"(MM911$J.I5 ,_I4_C,@>#]5)_P"@;/\
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MCZ=9ZM8F&]21&VLO;;0.6Q]QH[,HXQ3P21R*6B@D: =^:=110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MG_\ :&\;3AET+4+TN>/,E+9/XU]/_L+_ /!'+X__ !N\<6-Q\1O %[I^G)=
MM.<X*>O%!+:2L?5/_!N'^S#XFN/&NB?&Z6V>.T@F565X\?Q9_I7[T*05PHZ5
MXG^P]^Q[X*_8_P#A';^ /#0CF5-CF9H_F!QZGGO7M+.58&(;L]109MCP3."0
MI&*4Q%H]A;D4N\9"@8SUXI5C"ONW?A0 !-J[5IARQ\EQG-.$A8D =*4O@9V\
MT "(%&*;\N\$"FF24G&WC-2!@1\PYH &.#D\^U)^[E;++RM*H4-G=0[^7T%
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M]:\>Z4HDN;*/,:'OP3_2OY<?VI[GXL?M7_M3W_CF31IW75;J-#&KY4 N>W_
MJ"TM#NO^"1O[)?B#]H/X^Z#XIBM6DL])U16N1Y>1C&/ZU_4U\-O!.D> O"]O
MH6BVBPQ)&OR+TSBO@'_@A5_P3^M?V8_A?<^(O$&E9GU>V6=3<1Y*DE3QGITK
M]&K=D,?R'@4"D/HHHH)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@!-PZ9HW#.,U&B-&P4MGWHFA+'<),
M4 />18R >].ZU&=FT?-DBE4EOG;C% "^8N[%*6 .*1=A8E2#0S$.!MS[T *6
M .#2Y!Z&FLG.[-)'&8\L6SF@!^0.IHJN^^9]JD@'O4J*T:X)S0 XL <&AF"C
M)H*AN0::P(X- "I('X%.!!Y%-!5%R,=*(WWC)% #J*** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH #G'%,\O?Q)R*?10!&MM"C;E7FI**
M* $VJ#G% 7#;J6B@".:(R$<=*=LVIM2G44 -*!@ W:FNCEQMZ5)10 U8D5MP
M'-.HHH **** &N')^6@+Q\W6G44 ( >AINV02<'Y:?10!&8</N6GD-N&#QWI
M:* $<$C IODJ!D#FGT4 -56*X?FA8P#3J* &M&K'=WIH68R'<?EJ2B@!BH_)
M)^E4M7T&VUNU:TOTW(W45H44 >'>,O\ @GM^S;X\O9M1\2>$_-EG.9#\O/Z5
MQ,__  1T_8CN+K[9)\/<OG.<)_\ $U]3T4 ?/7AG_@F1^RIX3D5]&\%^7L(*
M_=[?\!KV;P;X T/P-8C2] M?*@5-H7VK?HH 8+>,1F(#@TT0>7CROQJ6B@5D
M,\O#AA^-*%._)Z4ZB@8W8%!*=330DC+EOO5)10 V,./OF@Q[CEL4ZB@!HC4=
MJ5D5Q@BEHH 1$"# I%5PQ)/TIU% "(".M W;N>E+10!'ME#9!XIQ#%O:G44
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MW6G44 -=7. O3O2JH08%+10 A53U%-$,8.0*?10 PK(#\O3ZT&%"<D<T^B@
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MNO>*M-W11ES$U\@8X[8S7YY?M6?\'&WP7^':77A?1-#N);I<[+BW+,...H%
MUN?J@BK IDSVYK USXF^'] FV:A>[ .O2OYPOCI_P7S^-_CF[G/P^\9ZCIZ.
M3L4AN/SKYU\3_P#!4S]M77KAYI?C'>E2QP#G_&@:B?U9M^T%\-F;RFUCG\/\
M:Z'P]XUT7Q/&6TBZ\Q0.37\A_P#P\E_:]0!V^+-YG/7G_&NJ\&_\%9_VU?"%
MQ'*OQDOO*)RRC/3\Z!\J/ZV'G6(;5/-/CD=E^:OYQ/@!_P '!GQ(\"F&Z^)6
MOZAJ:QD>8 KG/Y5^@O[*_P#P<-? _P"+!MM$U#1I;>9\*9;EF49/U% 61^G
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ K\=_^#CSQCK-OX<U?PXDSBU>W8LH''W:_8BO
MS<_X+Z_LJZS\4/V>]>\:^&-/DNK]8RL<*#K\A_PH'%V9^ _[&W[*7BO]J_XH
M+X2\-2;#%<)YN5R"N>:_:_X&?\&\_A*P\.6.H^+M*L+F1[:-WRR9Y -?GO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQI)ONUJ"N/R,9H!!&14:.S*5Q3T!"X- Q:*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &A
M0$(6FHC,-K#BA%=3AC7P3_P5._X*:6W['&FW3-!<EH)BI,*L>_L* /O5XMWS
M/_#TK/UWP_HWBFR;3M6L898W^\)(@W\Z_%C]GS_@X:M/BA\9O#?P^\B_4ZKJ
M26_SH^.0?;VK]"?^"BG[;-G^RS\ KGXB-!-NBM$ES$#GF/=VH!*Y]!?\*=\
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M /!M1\ -"U6/5Q:7WFQME08SC_T*O ]!_P"#E6RT[Q$MYJ-MJ,EO)*N(PDG
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.GZG;[X2,$4#3LS^0IO^"=/[8+#+_"&^ />FI_P3D_;!4&1?@_?''M7]:1^
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M ((@_LN_LJ6&GZ?\:?C5\1- 1K:91)IVIR$%@3GL/;UK]<-'_;I_9)\*Q?\
M",^'OB7X>MK*U7$"0W!"@>U?R@0ZY\4;723H]EJ%U!"3G$-RZ_RJ(:M\5DB$
M?]N7^!W^VR?XT$M.Y_7!X._;6_9]\<ZU%HGAWXGZ1<W4S;8K>&X)9S[5R?\
MP4C^+_B_X2? !_&7@;2+B\NP[YCM1\P  YZU_.E_P2MU#XI3?MK^#&GU2\DM
M1??O0]VY'4=C7]1GB;X?:1\3/ ,VA:Y")(Y8) %9 W)7'>@+H_G*\;?\%M_C
M9:?%4VEQ<:G:+I]^1- TF-V!T//O7[+?\$I?^"A'P^_:9^ ,7B+Q7XOL[+53
M*B"TN)OWAX//>OQ]_P""L_\ P2(^)OPR^(]_\0?AWX6=[2^O7N)Y"& "\\C
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<@?E3)D$JJSOCVI3*RN(]O&.M!(N0HWD4DB2NRE7P.XI027/R\4B$S-SQ@T
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *^6/^"IG[9T7[)W[.^L^+M'U,VVIVBYC
M<-@CY2>WTKZGK\;?^#DC5/$__".:QID)G^PM;G=C[F=M UN?CC^T_P#M/^-_
MVD_B/J7B[Q#JAN%O)MZDDDDUY1'I$Y)WZ;.S,?E(B)'\J^@?^"??[&=]^V'\
M34\(:?JC6_V69&D*C.1UYX-?N)\*_P#@@5\,="\(6<6KR6%U-+:QLTDD?(.T
M'TH+/YP$T?5E&QM-GP.G[EO\*B33]7+,G]G7&!U_<M_A7]-B?\$(_@\T8C%O
MII/<^7_]:GQ?\$(/@[&C V>FY(Z^5_\ 6H#F2/YE%T6_$7F6VFSB3L?);_"O
MZ;O^"%&Y?V>= CFA99!IWS;EQ_#5.3_@@O\ "29"(TTU2>G[O_ZU?7G[.'[.
M6A_L\>%+7PQHJPE;>+9F(?A0)R31ZH.@HH'2B@@**** &B, DCO21HZJ0>M/
MHH :$[MUI=B^E+10 FQ?2@H,<"EHH B-OO;?)U'2I%7:,4M% ",I/2@KN7:_
M-+10 @7 VYXJ/R2D@,8P#UJ6B@!I0LQSTID<;EB9>QXJ6B@ P,YIC"3=P>*?
M10 @W8YZTA3?P_(IU% $3K.&41MQWJ1EW##=.]+10 F,#"TI 88-%% #$5E;
M ^[VI]%% !1110 4444 %>.?MR_\D$U/_/\ ":]CKQS]N7_D@FI_Y_A-!4=S
M^4G]JO\ Y.UU7_L+)_Z%7]"'_!OG_P FZ7G^^O\ ,U_/?^U7_P G:ZK_ -A9
M/_0J_H0_X-\_^3=+S_?7^9H-)? ?H3W_  HH[_A108(****!A1110 4A=0<&
MEJ*7 ?<6J9.P:=21I%7DT,ZJ,DU$\PP,IG'2F22*Y\UC@"CFN[;!K:Y81U?[
MM+7 >)/CSX-\*:Q)I&HZO;1O'U#OS5+_ (:?^'?_ $,%G_W\KS:F<Y;2FX3J
MQ37=H]2GDF:U8*<*4FGV3/3*#T->9_\ #3_P[_Z&"S_[^4C?M/\ P[VG_BH+
M/I_STJ/[=RG_ )_Q^]%_V!G/_/B7W,H?M<HC?![5S)RWD\'\#7Y;7ZHMT1(*
M_1']HW]H'P/XC^%&JZ79ZQ:R22Q87:_/>OSRN%C^T&4.) :_FWQCQN!Q6;T9
M4*BDN7IZG])>"V!QN#R>LJU-Q?,M_0C#)&NTC[W2E4,@V,>#1!F;=YB8Q]W-
M--J6;S//_"OR*,(RIQMLKG[$WRU9N6K=O0)"N0JUJ>$[>)O$EL2.<\5E7$AC
M4 1Y]ZT_"3);:[;WMU*$53D[C3H5*<,13;V37YDUJ4EAJBBKMQ?Y'ZC?LFQ)
M%\'-.;'/_P!85Z;O'H:^=OV<OVB/ VA?#&RTR\U>U0IUW/["N]_X:?\ AQ_T
M,%E_W\K^V<DSO*(Y302K17NKJET/XASG(LWEFU=JC)^\^C?4],WCT-&\>AKS
M/_AI_P"''_0P67_?RD;]J#X<A21X@LNG_/2O4_MW*?\ G_'[T>9_8.<?\^)?
M<STT.II#(HK@O"7QT\(^+;M;;3=5MY&9L?(^>]=Q$PD'F*V0>]=F&QV%Q<.>
MC)27D>?BL'B\'/DK0<7YDD<Z29V]NM.5@PR*K/(4)54QGO4UN"$YKK3<M;:'
M-HM&]22BBBF,1B0.*:8Q)R_/I3F&X8J&YN'B98DC)W=3Z4 <#^TGXV'@#X:7
M>N-+L$?\6?8U_/9\!_AI;_M"?\%*/%/B&Z:)H[/6H[C=(X'"_-WK]J_^"OWC
M35_ 7[&FO:WHEE)<W$>=L<7WC\C5_.3\+;_]I+4?C?JNL?#GPKK<=UJTX262
MSC&Z/=QD_2@I),_IKN_VQO@S\'_#&C^&]=UB$R0:9!'A+E.-L:BNM^%O[3?P
MO^+4BCPSK,&YQD!KE:_##P[_ ,$K?VV_B=X>'BKQ#\;/$D<CQJZ6\Q7*@C.W
M[G:O&?B!X?\ VXOV!_&YU_5O%_B>?2K:90)GVB-L-R.@[4#M8_IX+K,H:*16
M4]U.<T^"-!'A*^ /^"/_ /P5,TG]KKPA+X6\3Q)8WVD0+"7N'^:=LKSU/K7Z
M 6^&0.K9!&10)Z#F(5<&HV#11%^_:GS*6 YI048;6_6@D_/+]OG_ (*V^'_V
M5?B)-X0OM5FADAND1PK$#!?%'QK_ ."[?[/'PP^$NE:I<ZA<RZGJVG![9H)=
MQ#G/7 SVK\_O^#B/3X8OC!J\\"@2/=@*1U!\SBK/_!&#_@F#XA_:M#^,/BSX
MFENK'22LMK::@ 5*?*-HPO\ M&@JWNW.FO\ _@XD^(\7B<WL6LZBNE GAHI!
MQGCG'I7W)_P3X_X+2?!K]J5;O19]9?[;IMJ9+LW$P7.%SW%=W\7?^"1W[.OC
M'X<2^$M$^'FCV5TZ "[CA.X?+BOYX/VB/"7C[]F+]K_6OA;\,O%=UIGVC54L
MR]DP&X,=OI0$5=G[8?MY_P#!=3X:_!C7?^$6\!ZA=F[>/"-;L7&X#_9%?+'@
MW_@XK\:6/BE)/'&MWXT\NHPZ.O?GK7N7_!+_ /X)'V>N>"(/'WQ\ND\0W,ZI
M<1G54RVU_FP, =C7=?\ !3+_ (),?!K7?@U/J'@#PCINEW$1DD\RUB((  /?
M- 61]0?L'_\ !0#X1?MN^$WO? UZS3V$ -WYLH)+9'L/45]"2/%;KF1PL?<L
M<5_.A_P1T^+_ (H^!?[3&J?"NTUZ=H7UW[-(BM@8&#_2OV)_X*D_M5_\,S?L
MG:AX_LI_]*@@5@J-AO\ 5DT!8X+]OS_@LE\#?V6(Y- DU.4:@CF/]S,#\^<#
M@"O@76_^#B#XHWGB95TO5]1.GLY) BD/R]NU> ?L*?LQ?$'_ (*N?M1:SK_C
M+Q-=P:?;7:W4<5U@HP W8Z&OVZ^'/_!*O]F;PIX"B\.ZK\,-$N[H6R)]K> Y
MR%P3UH"R1\X?L[?\'!W[/>O^$$T#QC?7@UJ*!FF:1]O\/'4>H-=%^Q[_ ,%A
M?!_[2/Q5U#PEX=U6:2./4#"JL^1CC_&OD+_@LY_P2";X&>$[KX]_"75A;K=3
M,@TW3TQL4$'T_P!KU[5X;_P0-TJZTWXQ7]OJT;-.FI@.9!SGY: Y4?T?6LYD
MBCD7HR!OS%?E9_P<J_&2]T/X:>%O"WAF]"2ZA?K;S*&ZAI,8XK]4+!E73H&;
M@>2O\A7\]W_!67XY:G^T+^V%I7PAM@\T>C^++=753D >:#0*Q^@7_!NU\"-1
M^#'[.VK+?VGE/J=X;K[N,[W9\_K7YU_\%^FEA_:MU!ST_M2'I_UV-?O#^RC\
M,],^&?P:T&RL+=(_.T6U>0(,?,8E)_G7X1?\%_KN.U_:EO9A'YF[5H05]/WW
M6@$]3]9O^"0@MW_9_P!*=!S_ &1'D_B*]%_;D_;D^&W['OPMOO&WB[4@GV3)
M98Y@&Z$].O:OG#]DW]HOX:_LM?L50>,]:\7V/VH>&DFALY)<,S9'RBOR\^-7
MCO\ :%_X+#_M+'P[X8CUC3?"U\7C=X0#!G<!WSVH':[/NSX"?\%J]>_:6^)R
M^'_AYJ=X;0W2 ;U8C:37ZA^%=;GF\*6VM:W,%9[6-V=SC!*@]Z^4O^"<'_!,
MCX:?LO>!;"76?#]E>Z@ML!)<21G?NQU[58_X*U?M6V_[/7[.>NZ+H%P+:^-F
M#;/"V&4;3TH"R.-_;^_X+5_!']F>XN_ 6FZG,-;M'(D:"7(ZX'0>H-?"4_\
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MH/:/8?L@^,8&'S#0&#^_S+7\^O\ P1HN9;3_ (*1Z68<@?:6Z?\ 785_0O\
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M@F-PQS2A55L@_A7V-U:Y\?KS>0])U=]@'-/IJ!<].?6G4E?J4%%%%, HHHH
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M_P""**NWP-M2W0:8G7ZB@O[!]P(^\;W%?RY?\%$8$C_X*9S2(H.[QC;9&/\
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MMA);]RF,5_-;_P '(7P\OK+]M&\U+R#Y0M7RWXK7]+2]3]:_(+_@XZ_9$O\
M7OA]K?Q]TW3C/)#$RA8H]SGY2>@Y[4#6Y]7?\$8/%=CJG[)OA31;>;,EOI>&
M7TXK[,B#,A#U^(G_  ;Q_MY:.-<N/A3XSU(61L+;RHTOI/*YV]MV*_;'3M4L
MM:M([W2[Z*:.1 P:*0,.1GM0$MRR;90,@U3N]6&F6LU_?D+# NYV]!5T*R*2
M[< <U\R?\%(?VN?!WP(^ 7B2T77[6+4KG2F%H1<J&#Y'09]J!'K%K^TI\(M7
M\0#PY;:]FZ;HF!Z_6I_C[>VT_P !O$]Q ^Z-]!N=A_[9FOYYO^"8_P"T!^U#
M^TK^VOI^@0^*;YK*XN& G>%O+ \P ?-TK^@'QQI>H:'^RQK>E:_+YUS%X=N1
M))ZGRS0!_-I^QY(EI_P5!TR\+8D7Q+=[?^_]?M=_P6'^ M_^TQ^Q7;Z':6'G
M2V]Q+.=J\\*A_I7XE?LBML_X*C:89>5_X26[X_[;U_2[K/ABQ\;?!R[T=[<%
M38S[0?4QT%GY ?\ !NA\<[3X+^/_ !O\*?$^I-%,VH&UMXG;/(:,XY^E?6?_
M  <$_M$V/@S]B_7O#&GZD4U%XRR(K8./+;_&ORBDF\6_L=?\%$H]1U"ZDM=/
MU+Q@SNK+M5DVD]?PKT__ (*Q?'W5?VR_VI8O@UX#U%IK*]T]1Y,)WJ3\H[?6
M@9]6?\&]/[+^O_#O3]4^.6KZ<RCQ!I;R"9\G=\F.IKY%_P"#AC4!J'[9?A]V
M;(6UQ_XXE?M=^P'\+(/AE^QQX<\/26PCNH-(*2\8.<5^)G_!P-'#9?MBZ%;S
M#<7ML@_\!2@+G[%?\$:]I_X)_P#A;9TV/C_OW'7YH_\ !T5<?9/$/A88&YB=
MN?\ =DK]+O\ @C2 O[ 'A8#IM?\ ]%QU^8G_  =2>9-XM\&K VWYSG_OB2@6
MS/E[]@3_ ()2?%[]KGX11_$SPSI=Y)"\H56@FD YS_=KZ%3_ (-]/CI,$6?2
M=5&#SBYEKZ]_X-HM4N8?V1+'2WE)4W2<?@:_4)8B'+,>.U 7L?ACX(_X-U/$
M-_.B^,;3554GYLS2'^9K[C_8L_X(A_LZ?LSS6_CBUMIY=8VA98[J ,!CIU8^
MIK[M  .#^%.P.N*!7.0^(&L6OPE^$FI^(-."QII-@73    (']:_(SX\?\'#
M7COX=^.I_#NEZK:>3&S#YG&>#CTK]C?%_AFS\8>%[[PQJ4(D@O83'*C=",C_
M  KXV\=?\$6?V<_&NNR:U??#^Q=W))+%>Y^E )GP8?\ @Y>^(**$?5[+GC[X
M_P *^X/^"8/_  4KU?\ ;:\+SWFN7L,C?:C&/*8'C<1Z>U0S_P#!"S]EUX]O
M_"M+#=ZY7_"O=_V0OV"_A;^RIH\NG>$O#5O:[YC(/*(XR2>WUH'H?@)_P6X^
M'S:)_P %%M8\231E8&U2WPQ]IVK]X_\ @E[XMT[Q%^SCX?M[&<.;;1(@P]*_
M.S_@XY_9(U#0_#TGQ]TK2WGDN-3!(MX]S@*ZMT'/\5=)_P &]/[=VA>(O#FI
M^ /%NLQVLUFBV\,5[,(R2&7@!L4#/V&&91L;I3R $VCMUJOINI6.H0+-9W,<
MBL 0T;@C]*E&(RSR2@*!R2>E!F5-8UBQT/3I-2U"79#&,NWI7%Z#^T;\*O%'
MB)_"6DZYYEY& 6CP.^??VKYU_P""N/[9WAKX!_L[Z_I>E^(K>/56M0UOY=R-
MP.TGH#FOR2_X(^?&S]J/]I3]K^XN_P#A*+_[!);Q.'DA8(1ER>3QTH+2/V[_
M ."@;P7?[)OC:X=OE&A,5/MN6OY??V?O@-XG_:>_:?7X7^#[>26>ZN7V")B&
M_P!9CMSWK^F[]N6"]T[]B+Q/:Z@Y>=?#1$S>IW+7X"?\$8=36R_X*2:5) "K
M"Y;G_ML*!GONA_\ !O\ ?'F*V^U/I&J RK_S\RUL>%O^#>KXO22XU;3=5",Q
M+?Z3+T_.OW:\$)/<Z!;W%S)N#)D5L8V.%7I0*Y^1_P"SK_P;C_"*SUV'6_B/
M%J E0JS"0,PR#GNU?I;\ ?V:OA]^SWX:C\/>"+-%C2$1D^2%)QCT^E>C8 .[
M%1'=*Q\OC% FRMK.MVVA:<U]J$@15ZFL31?B'X&\>W$FCV<D5S)&,2I)&K ?
MGFO$/^"K5]\2-+_9'U>Z^%^H36VK#/E2P(68?(>PK\B/^"7_ /P4:^+7P^_:
M?U;P?\:_&DUPLMZL")<DIM) '<T#T9^UGQF_8A^"OQP1O^$DT6WBWK@F&S3_
M .M7R7\=O^#=C]D7Q_937]JUX+IP2%C@P,]NC^M?H!X-\6:%XH\/6.IZ5J]M
M<">TBD/DSJV-R ]C[UI"-_M!9G!7TH%=W/YU/VO_ /@AU\;?V=;:[\<?"'0[
MYM.TP&:24S2+A!QGC/M7??\ !#+_ (*/_&+PY\<])_9H\?W:C36D'FF28LPP
MP7N/>OV>_;!U;PA;_L^>*AXDO[5$_LMLQ33JI8;AP,U_/'^S/%::O_P4JLI_
MAG;F*,R-M, W#/FCTH'NC]H_^"IW_!1^7]BGX;:)XQT348H_[5;:#(0,_-BO
MS]/_  <I_$6T+1PZM9Y8_+EQ_A7Z<_$_]BSP!^UG\$O#N@_%3P[%J#6,08"X
MP,'.>]>03?\ !##]F*4&1?AM8 CH<K_A0+0^/O G_!R#XVU[Q'9:1J.L6@-Q
M=1Q, X_B8#T]Z]T_X+);?C1^RUH_Q)=BS7'AY;EF7IDYKU?P_P#\$/\ ]F32
M-2@U3_A7-@)(9ED5@5X*D$=JZ7_@II^S]!)^QYK.GZ%9A;?0_#I2.%!GY00,
M#\Z!Z7/AO_@VWOK :=IUFLG[W[6./^!5^U1*I\QK^>O_ (-ZOCE8^'?VG]+^
M%>IL;(FZ)/VD[!_K,=\5_0?#-#<1+/%,LJ-]UT;(/XB@3/-/VP)X8_@%K=PS
M<+%R?P-?SX? ?3$\2?\ !3/6/LXW8\@_^1)*_=3_ (*C_$72/AQ^QOXKU>;5
M(8IXK8%(FE <_*W0=:_$O_@B+X>U']H7_@H#J?B:YLI3#+91NLTL9VG!E/4T
M#6Q]]?\ !9[PK+>_LPZ'(L9Q;^'UW>W#5XU_P;?26T4&FVRM\PNQQ_P*ON3_
M (*D_!&?Q+^R/KLL,(=]+\/D( ,G@@<?G7Y5?\&\WQN;P?\ M/Z5\+?$-P;4
M&[)/VD[!_K,=Z >Q_0\&^=L]J\P_:^N8;?X#ZU>.WRI%R?P->F6MW:WENMU;
M2K(CCAD;(-?._P#P5"^(^D?#[]D#Q3?RZG#%.EOE(S* Q^5N@H,H_$?A5\#M
M'@\8_P#!3C62A+*! P(_ZZ25_1O\(8GM?A?H5K O$>GH#7\\O_!%?P]J?[0?
M_!0;5-7-A-Y364;B>2,[3@RGJ>*_HP\-:4VB^'[+2T(!@@"'\*#6?Q%W$<7[
M^<X/I7@W_!0PE_@!KSJ./[&GQ_WR:]]D1#'B49]:\!_X*&GROV?]= Z'1I\#
M_@)H(/P[_P"")W_)XX_[&>[_ /2AJ_I$3K^%?S=?\$3F7_AL<<_\S/=_^E#5
M_2(G6@;%C[TZFQ]Z=0(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'AJ4%96CEQ",\]!QT!KW;_@V<L5T?]H/Q-H]T-KPQ8(/7[E?:W_!8S4/@O\
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MP_\ .FE)9CM3J>O5:\J@_P"#=[]AC[7Y ^&0\M2"!LC_ /B:"KIGYG?M%?\
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MG;2Q;'>OF[]N7_@I-\>O^"A'B3_A6GPO\+R7>GW\9AD:R< 9 "]!7Z2>+?\
M@WS_ &%/$>LRZE!\- 6E?,A*1\_^.UZI^S3_ ,$AOV1OV:+V+5/ ?@<6MU%)
MO1@$X.<]EH*NCQS_ ((D_P#!/%/V<OASI7Q*\3Z6;;7)X/+N8I4^8 *._P#P
M(U^B,84?TJIIUDNG(+*U7;&O05=V#%!+U8W9F3=VKP+_ (*&VE[?? 378[6
ML1H\^ /]TU[Z"4.#6)X_\":+\0M"F\/Z];^;;7,+1S+ZJ1S0(_G:_P""+?A[
MQ#8_MA_:[K3F1%\37?)_Z^&K^CZW;S4\X\9KY_\ @_\ \$U/V7_@IXJ_X3#P
M#X1^S7AN7G:3"_?9MQ/ ]37ONR6$[4.$H EWQC(5N:<N<<U'Y<:8..34HSCF
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4QXV9MP; I],D9@W/W>YH "%1>%!/M3$FS\A&,T)(RN2W [4X1AVWMVZ4
M AP^6?(]*<R*V,'I3'$QD.U>/6AY%A7!/S-TH <W,F :5%*L2:B5_)B,]R<8
MJ02^8@>'D&@!]% Z<T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %>.?MR_\D$U/_/\ ":]C
MKQS]N7_D@FI_Y_A-!4=S^4G]JO\ Y.UU7_L+)_Z%7]"'_!OG_P FZ7G^^O\
M,U_/?^U7_P G:ZK_ -A9/_0J_H0_X-\_^3=+S_?7^9H-)? ?H3W_  HH[_A1
M08(****!A1110 4444 %%%% !1110 4-T/THH/(Q0!7+?QXIR#=\Y[]J>(5
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M6X^M-60E_*"X [U,5!&*3REV[: &D^5]U<TCJ95R>/:I<#&*" 1B@"-%4*5
MP<=:C"- =V=QS4^P>IH"@#% #%?CS-O)[4DCN77:./:I-BYS2X'I0 A9=VTX
MJ,$Y(I_E+YGF=Z4(H.10 WK&=HQ2;<Q@.U24V2,2#!H 1H]Q!W=*?2!0 !Z4
MM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !110>AQ0 P_P"J-+%]RF?/M((IREE7&*AZ
M3%%WID.J?\>C_P"[7S/'_P G<I_US_\ 9J^EM0#O;L!TQS7S5MV?M>(G_3,_
M^A5\=Q<GS85_]/8'VG"%K8K_ *]3_0^E[7_CV'TJ1>IIEL!]F3W%/'6OL%\!
M\;+^+]X].OX4ZD0#&:6M"4%%%% PHHHH **** "BBB@ HHHH **** "BBB@
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MF@J.Y_*3^U7_ ,G:ZK_V%D_]"K^A#_@WS_Y-TO/]]?YFOY[_ -JO_D[75?\
ML+)_Z%7]"'_!OG_R;I>?[Z_S-!I+X#]">_X44=_PHH,$%%%% PHHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3?\ 8AG_ &NO@KJOA/0-.274KM<1%QD?=(KZHJIJFJ6&D1F]U.[2"%?O22'
M% :G\CW[;/\ P3B^-7[)?B.YD\1:,1;B?:ODV[''..U<K^R?^UY\4/V7?&MI
MK'@[5VLTMY]\F00<Y^M?T.?\%,/VD/V,-(\"ZE8>(-,\-ZWJ3VTJ;978NCD$
M \$<YK^;3X\ZGH6M>/-3OO#EI%;6SW\K1I#T"EC@4%QU/O']HS_@OK\?_B5\
M*?\ A%-'\<N;UV82%G;!4@#U^M?GWXC\0>*OB=XN;5;[?<7VI7&^1D0MES7.
MK:R>2)"Q*_WJ^IO^"8_C'X3^&/BC:3_%+1["ZMUOE(-]G &!Z&@MI6T/1_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M% !111D#J: "BC(/0T4 %%%% !11D#J:* "BBC(]: "BBC('4T %%&0.IHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P!E?$[P]]LBN(!O&%YRON*\K_8'_P""8?@;]B'XE>(/$?PZ\/K96VIN0F%
MRNT#M]* TV/L?>@786Y/2O)?VP?VF_#'[+OPON/&OB/4XK=3#*L)FZ,X7@?F
M17HGB[Q1I/@G09/$FORJL-NOSL6 [>]?S\_\%T?^"B?BSX_^,-2^ WA'67N-
M/T^Y\R&!"7 RWM_NT$I7-OP=_P %[?B[\1/VL[+P)'H@2PEUQH(9$=<.G.#7
M[F_ OQK=>.O 5OKM^FQW521^%?R-?L=:3J-G^UCX.?Q AW/JX(XQV-?UE_LW
M2V=E\(+>:/A1"#_X[0:/X3R7_@HE_P %&?!G[&_@HZHFK6SWLD+>7!+C)?D
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ML]+UJWD:!<N AFYZ>R4"LC[C_P"".G[4GQQ_:SO];\3^.]!N+.WM[LM;DO\
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MG[<O_)!-3_S_  FO8Z\<_;FS_P *#U/'7_[$T#CN?RD_M5_\G:ZK_P!A9/\
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MALTW.96P,5^(G_!1?_@M9\0?B;\1=1^#7P'TB]>2%LQWFE-DL"2!C+>U??\
M_P %NOB-JWA;]EOQ+I>FSE/-L0<JY!^Z?2ORO_X-_P#]F[P%\</VCAK7C1WN
M+A[1'83+OY&X]S0"[GF/A/X-?\%+?CI)<>(-0\8>-+*%CYD,<BI@@^GRFF>)
MO@]_P4L^#1;6K#Q=XTGCA_A15P?_ !VOZ9?#OP^\&>'](MM%L/#]B$MH@BD6
M: D#\*/$OPW\'>)]-?3+_P /6)1^I^QI_A0%S\-O^"=7_!;WXC?!WQQ;_#;X
MW:'?74\DR6LDFIM@H6P,\$5^XOPS^)/AWXG^%;3Q/X?U"&>.YM8Y7$+9"%E!
MQ^M?AU_P6F_X)A:[\._&5K\6/@7H3R7UYJ:2RJJE%&'[;<U]R_\ !!+5?CC<
M_ *_L/C18>1<P3B.W4RLWR*Q Z@=@* :/T"C7Y]P/%24R%0G I]! 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 444'IQ0 45$)G!^>@W /2DVD"U):*:&9E)'7M4;2S!=H W4
M75[!T)J*C#3;02.>]<W\0_BKX7^'>E2ZCKU]Y*QC+'C_ !K/$5Z6%HNK4=HK
M=FM"C5Q-54J:O)[(W=7U"TTVV\^\E5$'4M7C?QT_:M\)?#[2Y;32;V"\N70[
M8HGRP/I7B7QB_;0\7?$*^E\+_"J2.Z5FVCYL'!X[ UF_!C]C7Q1\0->C\6?$
M>"X0^;YH D9AS]<5^69EQQC\VQ4L!D5/G;T<WI%=[/5,_4LLX'R[*,/',,^J
M<BW4%K)^JT:.5N=5^,G[3_B'[)!'J.G6<YZX&T<_C7TU\ /V0O#_ (#LH]1\
M1PPWUPZ9+3+R#Z\8KU7P+\,_#?@33DTW1K2,J@&&:( UT8"-\D:X(]*]'A[@
M"C@*GUS,ZCK5WK=[+R2V/,XD\0*V94OJ>5TU1H1TLMWZO?\ $K:=IECIUM]F
MT^W6) ,;4Z4R71-*FD,D]DC.>K$<FKRH%0L*185?YS7Z%RQ24;?+H?GG-.5Y
M2>O?J9EUHNBVMNTK:;&V!TQ7SM";9OVN8YK6V$2^7]U?]ZOI;4X@+1QG^&OF
MF'Y?VM$C'39_[-7QG%L>6M@VMO:PZ'V7!\I.GBU+_GU/KZ'TY9G-JI]J4'-1
MVC$6J@>E/7CK7VJWN?&2WL2T4U6).#3JI*R ****8!1110 4444 %%%% !11
M10 4'&.:*1AN!!H KM/B01A,@]Z^ /\ @K!_P5KTG]COP[)I>D:0E[?+<&(Q
M1,=XR0!W%?H#)"(XRL?+&OSG_;5_X(^^'_VMOB[<^)_%T5X;>6[27]WN*\/G
MID"@:L?G'??\%T_CZ-7'B-_!6L169?S,?P[?^^J^J/V1_P#@Y/T'7;6W\&^,
M? Z02'!:\N7(]O[]?4E]_P $(OV4M5^'</AF_6X5Q9+&Q6V&>/\ @5?$?[2O
M_!M_!X>U*>7X%Z5?W$8)\IOG4_H30/F1[K^TA_P<$^#?#@TC3?"/AV"]FU"9
M8L6TA)4DD?WJ^TO^"??QWU?]H7X5R>,];TF6U=G4HDO7!R?4U^4G[,?_  ;V
M>/;GQW9:M\8-"OX;>PNTE@)>1LXY[XK]H?@1\%O#7P(\#6_A+PXI6-((U8,N
M.57% 71U?B)_^)!?IMX%E+_Z :_GU_:^E_XVB_#I$AP#XI.X@?[#U_07XA.[
MPU?/ZV4O_H!K^?G]KF1/^'GWP]3N?%#8_P"^'H!'] 'AM1%HMN\?3R4X'^Z*
MT'EC@A:XG<*H&68]A5#PH#'H%OY@_P"6*?R%<K^TIXPN_!?P3\2^(M-8>=::
M/-+%DXY"\4!NSX*_X+C_ /!1>R^%/P\U3X"^";M9=4U*VW075J_SH=O0<_[7
MI7QC_P $G_\ @F=XE^+\NL_M$_&9YM0@O= N)4344!&Y87;L.N2*^)_C)^UE
MJWQ^_:KD\5_&'4#'!I^HW%O\LA9=BR;1P<=EK])?A-_P6R^ _P '_P!G$?"+
MPOXHM5FCT^>';Y:!OFCV^N:!J+L?FYX9N;$?\%'-.\*Z5IBPQZ?XMD@14'!
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MA7XGW_Q&^)]GIKWI*Z??,H5CTX;_ !K]-_\ @@/X@GE_8)T;3W),:V,A!/\
MUQ6OQR_X+':I-KGQ]U:%I#B#5G Y]C0-_&=Q_P &^7PNL/$G[:GAO5]4MUEA
M! 93W^=:_I7UC0[2#P??:+!$%MVLI$">Q4BOY[O^#<S0E'[1.@:GDG;(!G_@
M8K^A[6"YTB[^7@V[_P C0*>Y_,E_P7W^&6C?#C]H6TM]*M%B%UOD<+W) /\
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MOY6:6>]1F#'/.X5_2;_P;YR/)^SG>EDY#+_Z$: >Q^A@&3N]:6FQDE>13J"
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M  3<^.7ACX(?MAOKWB9E\J'Q+=.VY\<>>QK^A/\ X*-[?^%#ZQO. -)N.?\
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MCCQ7^VWX6^+T-A>-!IVNFX9@3M VL/ZT%1/UH\/_ #:;;C.5\E.GT%8_Q?\
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M7%VB/(0Z= 3DU\V?\$?M8L_%G_!7>RU_0[-EM60 2*,K_K?6CXA_\$:/VC?
M7C2[\)?#J[U]M'OKIDG-M=2*A3W'X"OT!_X)*_\ !(C1_P!ERYT_XPZ_J,_]
MM0[0T5QN+>O4^] <Q^B>)/\ GI14GDI_?HH"XR17=MHZ5\ _\%</^"97CO\
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M:!2NS^=#_@Y$1Y_VC=)(Y(@/_H KS;_@A'I]U?\ [7Z6D(W.+>,G'/=JU/\
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M?^A5_09_P;XMN_9SO/\ >7_T(T%25HGZ%4444&2"BBB@84444 %-?=_#3J*
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M.;AI<&P/]^M!WVGRDZU/3'5=^['- 7/GC_@HS%YOP&U</VTF?/\ WR:_!_\
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MWBIJ"6%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11D#J11D8SF@
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MJN#_ ,Q5/_0J_H/_ .#?/_DW2\_WU_F:_GO_ &J_^3M=5_["R?\ H5?T(?\
M!OG_ ,FZ7G^^O\S0:R^ _0GO^%%'?\**#!!1110,**** "BBB@ HHHH ****
M "BBB@!-J^@I<#&,444 %%%% !@>@HP/2BB@ P.N**** "BBB@ HHHH ****
M "BBB@ HHHH " >HH  Z"BB@ HHHH *,#THHH , ]11@>E%% !@>E&!Z444
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M//!571K1M)=]R4=.:***Z3$**** "BBB@ HHHH **** "BBB@ HHHH ****
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M[*\A\9.[&:DJ*(@R$"I:F#NF;;)!1115B"BBB@ HHHH **** "BBB@ HHHH
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M;M%%%!(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5XY^W+_R034_\_P )KV.O'/VY?^2":G_G
M^$T%1W/Y2?VJ_P#D[75?^PLG_H5?T(?\&^?_ ";I>?[Z_P S7\]_[5?_ "=K
MJO\ V%D_]"K^A#_@WS_Y-TO/]]?YF@TE\!^A/?\ "BCO^%%!@@HHHH&%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX=R9Y)EL<*Y\S1_,O$.<QSS,YXJ,.5,LCI10.1FBO?/$"BBB@ HHHH ****
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KQS]N7_ )()J?\
MG^$U['7CG[<O_)!-3_S_  F@J.Y_*3^U7_R=KJO_ &%D_P#0J_H0_P"#?/\
MY-TO/]]?YFOY[_VJ_P#D[75?^PLG_H5?T(?\&^?_ ";I>?[Z_P S0:2^ _0G
MO^%%'?\ "B@P04444#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI\%O'!;"'J ,9Q3P5  (&!TK]_IIQCKOW/Y]G%5'Y=B9>@^E+0.E%6,****
M"BBB@ HHHH **** "BBB@ HHHH **** &R' YJ"1E4XDYSTQ4TX'EDD\ 5P'
MQ*^-/@WX=:?-<ZAK42S*N4C<]37'C<9A\%1=2O-1BNK-\)@\3C<0J="#G)]$
M==>:E9Z5F>\OHHHP/^6D@4?K7S_^T'^VAH/@N.72-"CDGN6RB-:Y?!['Y:\:
M^+_[2_Q.^-5])X7\#:1*]O+D+<6S 'T[5UG[/O[%]YJ5W'XE\=7MPTCD2&*Y
M8L,^G-?EN9<69CQ#5>#R*#Y=G4>WR_X<_5,MX1RWAV@L9GTUS;JFGK\_^&/.
M_"GA#XU?M/ZV+O5M3G6S>0CRKF(K\N>/O>U?4_P._91\)?"Z"*6ZTJ)KM5P\
MJD<UZ9X<\':!X7M8[;3-+MXPB ;HX@.@K5=3_K(QFOH.'^!\/E4UB,3^^K/[
M4O\ @W/G>(^.L7FT/J^#_<T%]F/_  +!;I#;PB&W3"J, 5/$<KG-5WDCBC*N
MV&(X%26.XPY85]W%\KY3X9>^N9[DU%%%6 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MTKX=M(5MQA/,CQVQZFO-/VK/^"KOP(_9LTFYFO-2M;]XDSBSO%<_^.YKRO\
MX)X_\%>/#'[;7[0+^"_#6E7L$#VX=/.C<+SN[D8[4#UL?H'<&+Y?..&["IHB
MY7YA39$BD D=<XZ4Z-PXR!B@D=1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %>.?MR_\D$U/_/\ ":]C
MKQS]N7_D@FI_Y_A-!4=S^4G]JO\ Y.UU7_L+)_Z%7]"'_!OG_P FZ7G^^O\
M,U_/?^U7_P G:ZK_ -A9/_0J_H0_X-\_^3=+S_?7^9H-)? ?H3W_  HH[_A1
M08(****!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MVQ^105!(S38R&^ZN*4DY&/QHY->:!-VE:9*.!BBBBM"PHHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHR#T-% !11D>M&1ZB@ HHR/449'
MJ* "BC(/0T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?^A5_0A_P;Y_\FZ7G^^O\S7\]_[5?_)VNJ_]A9/_ $*OZ$/^#?/_ )-TO/\
M?7^9H-)? ?H3W_"BCO\ A108(****!A1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#KWKZ/AS@7+\EBJU9^TQ#U<I:_AL?,<1<=YGG2="BO9T%M&.FGRL,*!4 3@
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M":G_ )_A->QUXY^W+_R034_\_P )H*CN?RD_M5_\G:ZK_P!A9/\ T*OZ$/\
M@WS_ .3=+S_?7^9K^>_]JO\ Y.UU7_L+)_Z%7]"'_!OG_P FZ7G^^O\ ,T&D
MO@/T)[_A11W_  HH,$%%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#PLDTEQS&'MP7Y/TKR#X<?"+XR?M%:\OB+Q-J<OV3S2#%<QE?ESQ][VKU?\
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MF1LWG%2IQVH$[HFHHHH&%(S!!DTM-F!:,@4 *&!7<*$</R*:K87:12X"*2*
M%9@HR:1ID4@9ZTC,#'\W>JT:&S62>>3*]>>U %MF"C<3Q1O7&0:^,/\ @H!_
MP5U^'_[%DUSH]YIUK?WD,986YD.YL>P(KSC]@?\ X+C>'_VQ/'=QX3M?!"69
MC PP9NXSW8T#LS]%MX]#06 &[/%5M/N?M6G17P7_ %L:N!Z9&:E5RZ#(Q0((
M;R.9F50<KUJ0,#T-?.7[<?[??@G]BNTLKCQ%;VTC7RY02N1Z^X]*^4H_^#C#
MX7JK2KX7LVVG&/,;_P"*H'9L_3N@D#J:_,-?^#CKX:2OM_X0VT '?S&_^+JW
MIG_!Q#\,M9U.+3T\+V:^8<9$C?\ Q5 K2/TN>X1#@T><N,BO/_V:_C=IG[0W
MPILOB5IEND<5Y]U4.0. ?ZUV=Y>6>C6LVHZI>+%!$NZ220X"B@:7<NF= NXT
M+<(W2OBK]M#_ (+%_!S]E>]N+;3KO3M;D@4GRHIR22.W!%?*J?\ !T7X.O-2
M%JGPFC1=X&[<V,?]]T#Y3]@596Z&EKXF_9 _X+&_"#]IVYAL[FYT_29Y'"K
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO&?L'927YGD'PG^3]KG50>T2_P WK[HTF93I4/\ US%?G/X"^,NDZ-^T#?\
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M&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !112.2J$CTH 8S!1S0"",CO4(E%Q&5SM.>*Q?'/CWP[\/= ?5/
M$&K06Z(C$-,^ 2!TIQC.HTHF-:K3H0<YNUNIL:GM>RDBW@%EP,FOB$VS0?\
M!1J*T+JS>5_"<_QBN'_:G_X+ Z;X;O[CPYX8T992K-&)X'/;O]ZO-_\ @G=\
M=]4^/O[:5CXGU7S/,E0#]X<G[XKWL)@*]"E.K-=&?F.<\597FF8X;!X=WE[6
M-_0_6'36"6:1D<A:DWCM2(@CB  YI( =WS5\_P#'>Y^II).R)(R">*?35'S&
MG4)W!*P4444QA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MV5;H:'GBBD$1(R>F:X_X%>([GQI\*])\0NCQM<1;BLJD$?@:ZZ6)699F7E:
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M# $?9[M'Z_2@7M#S#_@DO\./%7PM_8S\/^%/&=JT.H0#]ZC,21\B^OTKR?\
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M%!1110,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7!8; 8=4L-344NB/Y2Q>-KYAB'7Q-1SD^K&R/&1NW?,.@J>U=GCRPYJ*6-0
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M68XY/\\U^J_P& C^$VBE.]L*_>_ ^*IXO%7=_=7YGX%XYR<\)A7%6]Y_D=N
M , 48'H*!R**_I _G"P$ ]11110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ,G8JN14
M2L9AR2,4Z\?8@]Z:@*)O[5-HN6FC!<Z=^@Y-B-M+TKYVG%4[O4].M(C<W-PB
M8[NX%?/'[3G_  46^$?P&L)+._U%OM;@I!Y,@/S]NE=%+"8C$:4U=GGYCFN#
MRRG[3%345YGJ_P =K_0E^'=]9:_J"P(PY+=N#7X/?MB6VCQ_'O6)-'O1-!D;
M''0\M7U)X^_:M_:D_:X\1GPU\--5=K"[8JJ2(_(S@=ZY7XQ_\$R/C?HO@1?'
MGB/3HVO9-QF=8SDX /K[U]9E%)8"=JLK-GX;QKF=7BZ#C@:$I1CO*VA\9?:9
M)\H\>W'W?>OLS_@C'%L_:@TMCUVK_P"A"OD/6O#>J:!JEQI>JVKK)!(4Y0CD
M5]>_\$:#(O[4>EQR'^%?_0A7NYFIRR^<T[JQ\!P=>/$>'AM:2T/VC#C &: H
M'2F1K\Q)J13\V*_,(-*)_7W3[AR#K3J1>II:B&Q844458!1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'#,3"MO<G##GJ !ZT H-/4\J^,'C^_\ BI\2+OQ#>R/+NN9=N_G@O7]%'_!
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH C94F^^..^:K3QVUPKV$B9C92I'8@C%/6<RQF.8;">@H2
M!A&(\].] 'YQ_P#!53_@C)X3_:5TF7QA\+M#M;&^AC::[D<KF1N>><>HK\+/
MVD/^">OQE^ .O7&D7WAO4+LQLQ$MM8.ZX!]5!%?UXSV\$\#6\\89&&&##.:X
M;Q_^SS\*?'FDRV6J^ ]+FDDZS262EOSQ06F?QMOX%\;:?*\-_P"%M20C^_8R
M#^8JHWA;Q3!+YL6@7W!Z"T?_  K^J/XA_P#!''X%?$&9[IK.RM#(<D16N,?D
M*XRV_P""#'P*M)O-.HPMSG!A/^% ^<_F<L_ GC;5762W\':K*[D#Y-/D/\EK
MZI_8Q_X)*_&G]IGQ/87<&EW%A;1SJ9EO;0Q[E_X%CUK^@#X7_P#!)+X#_#NZ
MCO&TC3[K9C"RV@/\Q7T;X-^$'P[\%6*66@>#M.M/+3 >WM54G\A0#EH?.'_!
M._\ X)D?#C]D?PA:3ZCX>MFUR#8R7<)4XXYZ>]?6D<@9O*C&,=S38]EHOE(<
MMV4U(R>8 <8.><4&;9,.G-% X&** "BBB@ HHHH 9,F]<56N5FE7;$VWBK;,
MH'S&FL$=2N,9[T#N?D+_ ,%D?^"-_P 9/VUOV@'^(W@C7;:",VS(/,*Y&=OJ
M1Z5B_P#!)3_@BY\;OV3/BQ>>)_&&NV\T;@?<V]A[&OV-.F6."9K9)&]77)I(
M++3[9R\5G'&3U*J!F@?,,TE#:Z1;V+C+10JA/N!BI9HHI;=H)1N5U*E?8\42
M2NDZQ1194]6]*D6-?..6S[4$GPE_P45_X(^^ OVJ-.?4_!^@6EOJ+(S-/(RY
M+G//./6OR5^+/_!NK^TGX.UJ80:_;R1!F(6)5/&?9J_I88*H(< Y['O6?=>&
M=!U%O/U#2+=SWWQ T#6A_-)X"_X-\/VC_$6LPPSZO$B&5=WF(H&,^YK]3/\
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M$%%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*_X\(O\ =J2O,J]3ZRGLOD.3K^%.IJ=?PIU,:ZA11104%%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@"*;*PED.3VKF?&/PQ\)_$'3_LWB;38)06R?,MU;^==4% 7#4TQ
MQM\N* /-X/V8OA/&FRW\-V!P/^@?'_A4L?[,OPN"X;PQ8?\ @!'_ (5Z"BHH
M8)P:=$KHN)#S0.[//O\ AF;X6_\ 0L6'_@!'_A1_PS-\+?\ H6+#_P  (_\
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M":G_ )_A->QUXY^W+_R034_\_P )H*CN?RD_M5_\G:ZK_P!A9/\ T*OZ$/\
M@WS_ .3=+S_?7^9K^>_]JO\ Y.UU7_L+)_Z%7]"'_!OG_P FZ7G^^O\ ,T&D
MO@/T)[_A11W_  HH,$%%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M (44&""BBB@84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;Q]?[@IYAM2 OV>/D?W!0'-(_"/P=_P:Y^*!(HO?BJS#C[RI_P#$5[O\'/\
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M ";I>?[Z_P S0:2^ _0GO^%%'?\ "B@P04444#"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH ***9),D?!/- FTA]%0_:&<_
MN^:<)?EY/-2I)[%6'N 5P352>5(<L^,=R>U/OKV&TMS<7#85023[5\^?M#?M
M?^'/"%O)H7A/5$EOI%*+&V!\WIWKR\WSK+<FP[K8J:5MEU;\CTLIR3-,]Q*H
MX*#;>[Z)>9Z/\3_CIX2^'.GR7=UJENTL?_+$R<U\@?$_XM_$SX\^(FT3PG;7
MT%NTP4RP#*[3]<U2\+?"CXP?M+^)UUCQE8RQV,Q^9H96(P3Z8%?8GP7^ _A3
MX5:-##8P"28IMD,T0)'YYK\L53B#Q"J2A*+P^&6SU3:_ _4_9<.^'5!3C)8C
M%/=;J+]==CRW]FW]C.S\*VJ:SXPE34)V;S,SCD9YQP!ZU]':5HMAI5NMGIUN
ML,2_=1!P*N16D42;8U 'H!3A"H[U^F9%P_@.'L$L-A5IU?5_/<_+\\SW,N(<
M9]:Q<KOMT7RV(0!#D*.OI4D!^3<1]*<($&?>G;!MVU[<8I(\F3DV-+$C@4J;
M>].  &*:(E#;LU6@E<!'A]^:=1@9S10,**** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBD8D*2* %HJ".69CR.]2"0GY1UHL#LA]%
M,WL.#37E?.U0*'H"U):*A-P4QYG&:62XVL/2@)>[JQTQPO3-1N%5=^RFW.HP
MVD+7-PV(U4DGV%?/O[0W_!0GX*?!VTGLI/%:I?A2(HF"\MZ=:UHT*N)ERTU<
MX<;F67Y;2]MB:BBO-I'N&K^*=%\/1G4=:U2*VC7KYK8%?,G[2_\ P4O\!?"F
MVFT_0!:ZE<,"BK!(2<_G7R!\6_VROVK?VJ=5D\,_"?18;O3;@D)+%,RDYX_A
M0UW_ .SG_P $FYO'E_!XQ^.)O[>Y9A+Y8D=EW>G)%>[0RO!X.//B)*_9.[/S
MS%<69QGE=T<GIOE_F:M'Y/8\;\;?&3]J#]L;QS'I?A>SUW1M-N&*L\2#8!G
M/.:^E?V7?^"3,>B3P^./B9KB:Q-*!YD5X!G(Y[ >M?9?PF^ '@+X2:''HV@Z
M7 ZJB@226R[N!ZUVL5I%#Q&H4>BC KGQ6;SG'DH+E7D>AE/ ]*-?ZWF=1UJG
M9_"OEM^!RG@;X3>!/ .FQV>@>&+:U*(%)B4C/ZUTL );'3TJR85-((5!R*\5
MN<M9N[\S[J-"G3MR))+HM"%PZG(I58CG-3E%(QBF^0N<U/+=[FW-->8D39:I
M*:D01MP-.JF,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %1R1*[9)_
M6I*K7@\K]_N_"@F5K78.=A^0X]:Q?&/C?1/">E2ZC?W\*^6,[&E )_#-</\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (TR?\
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M$%%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MIQ576=8TWP_8R:EJ<VR*-=SMZ"O"?VC_ -OOX8? '3YI[^>.^;YD5+2<.<]
M<+FOS_\ BY^V_P#M!_M->*T\.?"2YU:QM+J<QDO92[<'/<@"O1P>65L2O:-6
MCW/D<\XPR[*?W"]^KTBM]=C[4_:;_P""F/P6^$]O/IVA^+$;58\[8'"X_GZU
M\7>,_C=^V)^VIKW]C^%M 6723, )K>X928SU/RI7J?[./_!*3QMXSU*#QO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5_0?_P &^J[?V<[S/=E_F:#27PGZ$=_PHI,C=COBEH,4%%%% PHHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HILAD _=C)S2Y(7)'- "T4V-BRY-!9AVHL3S(=14;SY3,?:B.1W7-)
M--V*>BN256NLB3=N_"I'N5C'S'FO,/CC^T7X-^%VG2I=:J$OT!(C8#'\ZX<P
MQ^"R_#NMB*BC%'7@<!C<RQ,:&&IN4GT.P\8>/?#OA'37O=2U2"(HA(61\9Q7
MR/\ M!?M9>(_'FL'PIX!L9RLH*>=:<@$<>M<3XG\9?&7]ICQ.VEZ59E[!9A\
M\4K [>_05]%_LX_LB:!X!LDU74HW>ZR'(F7=R>3UK\EK9SQ!QYBGA<NBZ5!/
M6;5K^E_\S];I9+P_X?X6.-S*2JXEK2FM;>MO\CRKX ?L>^)/$FJIXW\>:I+<
M"8 M;W2C@CGT]Z^N_"7@W0O#&E)8Z5I<<!2/:2@ZUIV-D(#Y*6R(@Z;5 JZL
M:JNT5]_PYPOEV0T+4HWGUD]6W\S\^X@XGS'/Z_/5E:'2*T2*:;H8L.FX^]+(
M3($V\<\BK811UYIOD)NW5]/[T'[JNCYJ5Y1WLQR_='TI:**L HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *1CD[:6F-O#Y X]:F3
ML%KC6Y4\XXKC?B[KVC:1X(O8]3U2)#MZ.WUKRO\ :U_;=\'? 71Y1;ZTBW@5
M@(WQ][L.M?F3\??^"JGQD^(U[<:8WD+:.[*&CEQE<X'1?2O;P63XO$I5()6/
MAN(N-<FRE3HU).]FM%<]1_9ZO]#_ .'A>OZO<:["EN\"!&+\9W25^J?@K5=,
MU#1(!8ZC'*!$,%&K^=?1?C1XGT7QQ)X[L)V^U2XR?,/."3U_&OJ[]FW_ (*X
M?$_P=J]EH?BZ6WCL2X221I,D+^(KV,VRO%XBTH+1)+[C\VX'XURO+'4IXEM<
MTY-.VEF]+L_8]P0YYR*4LJH2V!CO7D/P9_; ^%_Q/\"Q^,(=?#Q, "Z@=<?6
MO#_VH/\ @JE\.? 2S>'_ (>>)(KC4AF,Q.%'S=NYKYRG@,34E[-1U/V7$\2Y
M-AL$L1*JN66UFKOT/J7QI\4/ _@>SDN]>\36EL4&2DTF,U\7?M3?\%5K'2)[
MGP1\-O#9U*Y7*K/8DL3GC/6OF_4=5_;%_;9\1"6Y\/LNERN5:6UN7'RYP.BC
MM7U5^RC_ ,$H/AYX%,'C3QE+>/J;@>=%< N!C_>;W/:O2A@<%EWO597?;<^&
MQ.>\0<3/ZOEM-PIO3GEH_N9\G?#SX+?M1_MA>)9KCQ-XFUO3;"XN"5AN54+L
M/;E3Q7W'^RY_P3*\!_!6TMV\4V5IJ\R$%I)5Y/Y8KZ7\,> _#GA6PBL=*TR!
M%B0*&6!0?TK<11LQ7'C,SK5O=I/E7D>]DG ^"RUJMBINM5[R_P M3+T;PUH'
MANU2ST72([>-!A4C& !5IRY<..@[5;V+C%((E%>9S.2UW/M8PC"*BD5XBS2E
MV; /0&I),#H,Y[TZ2V1P!G%.$:@8S4J,5T*:;6Y&L9<=Z<L9S@GI3A&!3L#T
MZ4V^PHQY0' Q11104%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#_#7_H*Z=_X[0%F?II7CW[;\1F^ ^I(._P#\2:^+/^(@?X:_]!73O_':X?\
M:(_X+H_#;Q_\,;OP[!JM@9)>BKC/0T D[GXK?M46Q'[7.KB3MJJ8S_O5_09_
MP;ZMG]G6]&[.'7_T(U_.Q\;/'%O\2/VAKKQ/8,K)=:BC IT^]7]$?_!O;%)#
M^SI>^9G[Z]?]XT&DOA/T-P,YQ12 @G@TM!B@HHHH&%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M26P3VYKZCT3PKHWAZU6TTO3H854#'EQXKX_!</9QQ=BXX[-[QI;QII[]K_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M95_9V_Z)+I7_ 'PW^-'_  RK^SM_T272O^^&_P : YF?R9?\,)_''_H"R?\
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M]U34HX@J[@)&QFLZE>%-7EMW+A2G6DHP5V^AK221QG+. /4G%>*?'_\ :O\
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M5X27F?IFHPK(1@4L:E5P:=11825F%%%%,84444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=#6$<:'GFEM#NCS4;HP/S\U-;@!.!2BYK2V@W[-RO?4?1115#"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHR.N:,CU% !111D8SD4 %%&0>AHR#T-
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5;HF0>OV!/\ "NY# G -+0!CZ!\/_!7A= GA[PO968]+>W"_RK8P/2BB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH AC?>,E<5\H_MX_\ !-G2_P!L;3Y[
M2YU.&W::0L6D ]?H:^LO+7M1Y0SDF@:=C\P?@G_P;Y^'?A-\2-(\>/XCM9VT
MV]6=%VC/'_ :^POVROV,=,_:D^#MQ\-+BXCA\VW2+S&'HFWTKWM854YS39W9
M$*Q#+=A0/F9^4UG_ ,&V_AA5W2>)[0G'0JO_ ,34D/\ P;<^% _F2^([-@#T
MVC_XFOTI\>_&?P)\,8X)/%VK?9C<2!$X'+$X[FMWPWXLT7Q38KJ.BW7FPLH;
M=[&@.:1^7S_\&X'A%V+IX@LU!Z#:/_B:@?\ X-O?"Q88\168Y_NC_P")K]%?
MCC^U+\&_V?\ 0I-=^)OB06-NF07('4?4BOD@_P#!>W]CR/QG_8#_ !0B$0N?
M+SL3./\ OJ@+S9X_<_\ !MUX;6/<OB:S)]-H_P#B:^]/V1?V6+7]F+P+8^%+
M6X246T/EY0>V/2M/X(?ME? ?]H6"&?X9>+!?^;@+\JC)/T8UZG&SLVUE&*";
MR)!T%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4'D8HHH ;Y?O2
M@$=3FEHH **** "BBB@!""1P<4 $#DYI:* "BBB@ HHHH **** "O'/VY?\
MD@FI_P"?X37L=>.?MR_\D$U/_/\ ":"H[G\I/[5?_)VNJ_\ 863_ -"K^A#_
M (-\_P#DW2\_WU_F:_GO_:K_ .3M=5_["R?^A5_0A_P;Y_\ )NEY_OK_ #-!
MI+X#]">_X44=_P **#!!1110,**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MTUSUFKN4M?SN?R'Q3QCF6=U71@_9T4](QT5EZ6(%18^%&!V%*F'^<#;ZBIS
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KR?]L7]H
MGP[^S)\&=0^*6OS#RK(?,BOANA/]*]8K\I?^#C#XPZKH7P4UWP5;74D<<D).
M5?'\)_QH&E=GYD_M7_\ !6+X[_&;]I%5T3QS<KH0UJ%K:U;=POF#CK7[D?\
M!/K]HQ-1_9<F\?\ B&20I86,1F:3(R<>]?SM?\$[/V0M=_;*^,=MH]N)R+&\
MBFDDC)S@$,<X^E?O9^TMX%T']B?_ ()V>(/#NE:SNO)-#B8*20V[9DT%\I^1
M7_!:#_@H!\2OBQ^T/KG@WPQXKD70 Q,-KDE1EF[Y] *^![6/Q!JMZ^JVEA<S
M2QMN>6*%FP?7@5L>,/&&I_$SQF-:U1F,MU*JLS')Y;_Z]?L7_P $HO\ @D%X
M,^*GP?U/6_%#J'U+3P\+2QDD$E>G%!5K1/SU_8-_X*-?%C]E/XI:=J.K>(+I
M='MCF6U6-@3@CT_&OZ=?V,?C_IW[1?P)T+XAV%QEK^W\PAF^;\1UK^93_@K9
M^R;:?L=?M)/\+M&8RPM"\@EP1CD>OUK]E?\ @W[^+-UXM^%NG>"Y;IF6QT\X
M4MT^6@SD?IL.G-% X&**"0HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KQS]N7_D@FI_Y_A->Q
MUXY^W+_R034_\_PF@J.Y_*3^U7_R=KJO_863_P!"K^A#_@WS_P"3=+S_ 'U_
MF:_GO_:K_P"3M=5_["R?^A5_0A_P;Y_\FZ7G^^O\S0:2^ _0GO\ A11W_"B@
MP04444#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *AE4,^,5-44HPV
MX4=!7DFN41&)RH/2DVNQW,:&+)\V,Y/-#.(QOD. .IJ7%6NWH)R>S1\5?\%%
MI&-E,F>//X'XBOC>OLK_ (**BSDTR6>&X#,9^@^HKXUK^.O$WV3XJJ<CNK(_
MLWPN37"5.ZZO] HZT45^?'Z*,08:O8/V+V)^*./]A/YFO'N5->O_ +&)_P"+
MH@C^XG\S7N<+_P#(_H?XD?/\5*^05O\ "S]./#N#H5I_UQ%:"?=%9_AS_D 6
M?_7 5H@8&*_N;#_P8^B_(_A2O_'EZO\ ,****V,@HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH ;(,BH!'';'*KUZXJ>0X7.*YGQI\
M3O!GP_LWO/%VMQ6:*N=TOI1&#J2MN95JGLJ;DW9+J;4DUNLGG/A?<G%<3\6_
MV@/ OPIT675-7UJT?RHRQB6Z7=QVQG-?)W[57_!4VS\-7EQX;^#D5OK<@!\L
MP8))_&OE[P=\&_VF/VQ_&DFI^,8-9TFPN9@PVSD)M/7I7N8?)%4@I8I\D3X+
M..,H*^'RM>UJ[76R_0]2_:._X*C>(/BQ?S^$?@I:ZE;2,6B66.WD9=PXSD#U
MKGO@5^P3\?OVC]5C\5?%[6UO+.XPQ@N4"G/4]37UY^RY_P $U_AW\"[*&[O+
MB+5)CB1VN8RQ#'DCFOI?2]"T71T$6E:?# HZ+$@ %:5\TP^$BX86/SZG#E_!
M^-SBV(SN;;_D3]W_ "/(/@%^Q+\'_@G912:;X6ABNE0%I4(Y;UX%>T!8D($:
M8P.*;+/$7"F0"I8VC"[N#7A3KU<1+GFS]"P>7X7!8=4Z$4HKL*B$?._2D\P2
MMM .*21GD( &![5(2D*;FJ#LBK"(%#X YJ2F1;7_ 'JG.:?04%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M04444#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%5<F,%!^[H1[7"_+0T E0K*.M244BQL42PH$0<"G444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^T_A]J-G%"9-HM!=H7)Y[9S^E>HARQ\N/C!ZT")AP,44#IS10 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4->C\)>5J$>F1R.PC7[^W)[>M!J[(_%;_@EYINJR?M3PV&JW,L4B^465F/\
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M#D@FD"8;):D4Q!R!UI=RE@,<]J3<&]"?>^UH(SMN(/ '>G,V]<J>GI4$]S%
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M/EMXR\+A1_%]G'^%6K/]O/\ 88T25(]&^(N@1 '&Z*/&/TH*;9XK_P $[?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MOL3X/?LO^#?AKIT%X8O,N67YQ-&#@_B:L?LG:9I\/PSBN;6#:P*\_A7JC!'
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5^:?\ P7T^'OQ)\=? [7-.\":/<W,TD1V+;GD_*:_2RN=\<_#KPUX]LGTW
M7K;S$D'S# H"]C^/UOV0OVI;V=H+[X::FP!ZL,U%/^Q?^TK:.(T^%>H,6_V1
M7]9-Q^QA\&Y#N31!NSS\BTC_ +&OP-4B673(PP'?;04IG\G'_#$O[2KQ"9OA
M=J <]5VBD?\ 8N_:0A(V?"^_)/;:*_K'7]C_ .!<DFX:?$6] 4IK_L7_  ,#
MB5M&7.<@[5H'S79_)U)^Q5^TO=M]G?X6:A'G^(**_HY_X(F^"O%?@;X#:)H?
MBC1I+66&PVL)1SG;7TB/V-O@O*X?^QE/T5:[[P;\/?#W@:T6RT.V"1HN%&*
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MZ_NFH%9']2G_  ^._93_ .BJZ5_WU2_\/C_V4_\ HJND_P#?5?RT_P#"M?'
MX_L^X_[]-2?\*V\<?] ^Y_[]/0'LS^I?_A\?^RG_ -%5TG_OJO.OVH/^"L_[
M,7BSX3WNDZ;\3-+FEDZ(K<G@U_-;_P *V\<?] ^Y_P"_3T^3X9>-(;,WES83
MB(=28VH'&%F=?^T+XLTCQM^U!J'B+1+M)H+C4T9&CZ8W5_0U_P &^@#_ +.]
MXP;HR_\ H1K^:3PK;6-GXOMH50B872;LC'>OZ6?^#>R.1?V=;\2=W7'_ 'T:
M!/8_0U1E]P/%.IJD!MHIU! 4444 %%%% !1110 4444 %%%% !1110 4444
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M(%?SX:;J5SX?NUO;1RLBG*D&OH+]F?P[\2?VM==B^&$\@GM8=LAC8D\$\_\
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MYE_F:"FG8_0E"&&['-.I H!XI:#,**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***8[D':
MO6@3=A]%1":13^\4#TIC7$_F@(N5[FG97M<7-Y%BFN2.E#2!$W-3!,90?+J;
MI,K=7)$)(YJ*[O8+2,O-(%4#))/2N:\=_%WP;\.+*2Y\3ZF+<)RQ('^-?+7Q
MG_;>\4Z]=/H/PE\J]\UO+.3@X/T!KYG/.+<GR"/^T3O+I%:O[MSZ7).$\XSZ
M?[B%H]9/2/W['OOQ;_:5\&_#2PE<7UM<.JYV"3FOE/XG?M*_$KXVWIT?P+IM
M_;12.,3VZY&"??-/\ _LK_$GXQZ@NH?%&UN;>.=RQ\N9B,$_A7U3\'/V=/!W
MPAL(K'2+=9_*& T\0)Z>^:^!=+C#CBM9_P"SX?K_ #-?@S[V5;@[@*BFO]HQ
M/3K%/\4?,B_L/>,[GP'>>,M=\1S7=Q]E\Y;>0#=G(XZ5\V:E\,?'\=XZIX.O
M<*Y  AZU^F/QP^+-E\-=*S^Z56C^92HQ7SW_ ,-D>#))#/<06((8_P#+NG^%
M?,<4<(\)X?$4Z+KN$HJTF];WZW;/J^$^,.+\1AJE>%!5(R=TMK+M9(^2'^%'
MQ!N@7D\+7J*G)S%VJ@='UB#4DT2329?-DX"E>:^P;W]L+P'J-C<6ULECO:,C
M MT]/I7@<_Q*L+CXF6^O210B-)2>(QC&:_.<SX:X<PM9+"XZZ>]TO\S](RWB
M3B/&4I/%X&S6UF]?P.);X6>/Q<$P^$[UD'0B+BM;PM\-/'W_  DMBTGA6]0+
M,,DP^U?3>F?M@^!M*L$L[A+'<IYS;I_A5B;]LKX?&6*2T-B9 <@"W3K7K87A
M?A6ER.&/UNG:R_S/(Q?%'%4E*+P&EGK=_P"1[[^R[!?:1\/8K+4+1XGXX<8/
M2O4$/\0/6O+?@)\6[+XG:#'>AHU+$ ")0!^E>H(N% 7H*_J+(I8:.64XT)\R
M22N?RQGL<5+-*LJ\.23;=B>B@=.:*]H\@**** "BBB@ HHHH ***#P#0 45$
M)F)P>*1I9E?&WBFE?8=B:HV;]Y@T@ED(SBFE@XWGI18GF2"0%FP.U$K;(]W<
M"G?*.0.M<K\1_B]X&^%UB^H>--6^S11KEF(' Z^HHIWG4Y4KF-6K##T7*H[+
MN?G]_P %HM;U.?P3)87+/]G%T=H/3.17Y=VJ& R><_F;C\H/:OOW_@JS^U;\
M*OC7X>D\->!]>2Z*W!9=JJ">1Z'VKX A5B#NZC[M?I&1TN3+TI*SNS^5/$&I
MA\PXBE*E432BM4[KTN2*D22>80 /2H84EDN&+3$*3QFG.(V7_2&P?:E,,CH,
M#Y1T(KUE&+=F?$6]RRE=(6Z<+<+8;-V\?ZWTKZ>_X)8>);OPS^T T-ON?]R@
MROU85\Q192(^;P/6OLC_ ((\_"35_$OQ[DU:]LS]A-JACE]2-Q_PKCS.IRX!
MW2;/H>%</+$<2TN1V::V/V3\*3BZ\-V5RRX9X 3FKD@WMY:_]]57TFS2STR&
MPC'$4845?@A BP:_+)7<W<_L6DI0IKFU=AD4/EC+-NJ3&33A$!WH$2@YII11
M4&]VA$VAL T^FK&%;=FG4@5^H4444#"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MPUI:AVSM%F,#]*!\Q_-7^SA^QG\9OVM/B/:Z?;:%?P3WER1)/=6#JNXGDDL
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$*(1V)]*\'_X)I_L5^&OV@/'NI6FN:F%6R&]58$@X&:^OIYW1GE[K=C\2Q/
MV/P6>T\N3]^6W8^=?@+^SMXY^-7BFUT'3M*N8UG?;ODMF"CG')(K]H_V%/V2
MM%_9]^'=A%>Z?&-4C3;-.N.>!_\ 7KLO@K^RM\._@[IJVNGZ+9RRKC;-Y W#
M\<5Z<@B@C"8$:]L5\=F><3Q"Y(['[9P;P!1R&2K5M9  (FQCK5F($)43+M *
MC<".M20$E.:\1-VU/TMKF?,/HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M ?H3W_"BCO\ A108(****!A1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?^?X305'<_E)_:K_ .3M=5_["R?^A5_0A_P;Y_\ )NEY_OK_ #-?SW_M5_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "ORL_X.+?C3J>E? K7OAO#=[8YH2Q3/^P?\:_5.OQD_X.2DEETK5HDR
M!]G;YO\ @- UN?C#^SW^SQXV_:%\;Q>&_!-KYT[SHL@()X)KZW_:D_X(J_';
M]G[X3M\3=5\/1Q6<6GI<3.(SW7-;O_!NO#X2O_VB=2M?%D,&(T4PO.<9;:<8
M_&OW*_X*1^ M+\:?L+>)=/@M$D=M(187 S@;>,4%W:/YI/\ @GQ^Q=K'[:'Q
M5'P[\+:>L]\8 Y5QG@Y_PKZT^./_  ;N?M'^!?!MYXOT_P +1+%96QFE(B/0
M5Y1_P2J\87/[,/[;A%[J1ML11QDL<?Q,*_IE\'/I?Q'^#MA=ZNB3V^HZ<#+O
MZ,I- W)G\G_[+7[//@<?M'67P[^/NGG[,799T*@=' [U_3Y^PE\&?A7\,/@;
MHG_"M;7R[0VNV+ITQ[5^"'_!P3X&T?X*_ML?VA\*KF+3%2T=@ED>^4.>:_5W
M_@A;^TGJ?Q6^!^C>#=8NY)I[*PR\DAY)VYH$[L_0A588V]*&B1_O"G#I109B
M;1MV]J$0(,4M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %>.?MR_\D$U/_/\)KV.O'/VY?\ D@FI
M_P"?X305'<_E)_:K_P"3M=5_["R?^A5_0A_P;Y_\FZ7G^^O\S7\]_P"U7_R=
MKJO_ &%D_P#0J_H0_P"#?/\ Y-TO/]]?YF@TE\!^A/?\**._X44&""BBB@84
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 ,FF2!=ST?:(L ENM1WY"P%BN<<XKY^_:4_:RB^"UU;0RZ6TGF' Z
M^_O[5Y.<9Q@\DP<L3B96BK'J91E&/SO&1PN$AS2?H?0OGQC^*E$L9&=U?$4/
M_!4.S$FP^$W/O\W^-.E_X*=V3G(\-.OMS_C7R,?$_A2?PUOS_P C[!>%G&2=
MI4/Q7^9]MB5#T:D,T8;:6_6OB-?^"G%JZEQX;? ^O^-/'_!3VR6//_",.Q/U
M_P :E>*G!]F_;_@_\AU/"OC*-E[#\5_F?;+7$:C.[]:8)XY&W*:^9_@%^VK:
M?%/49+6?2C /,P"Y/M[U[-XS^,O@SP+I#7][K5J95&?):3GI7TF6<293FV">
M*I55R+KL?,YGPYF^4XV.%K4GSOMJ=C)($4L[@#U)KA_BE\=_!/PKL)+G7;O;
MM7<=K"OFKXS_ +;>N>+Y&\/>!=$N-X;;YMJI/7OUKE?AW^SW\8/C7?"^\7^(
M[U()'),5RH ()Z=*^/S#Q"EC,0\%DM)UI[7MHOOL?99=X=+!X=8[.JRHT]^6
M_O/[KF_\2OVW]=\;7#V/PEOW+2'"[B>A^E8/A/\ 9;^+GQLU2+7/B!;"6$N'
MZ'H?K7TI\+OV0_!7@*WC6\TVVN)4ZOCDUZOI>C:=I,*V^GVZQ*HQA>E<^'X,
MS?/*JK9U5;_NQ=H_-:Z]S3%<;Y3D5'V&14$G_/+67R>FG8\P^$_[)?P]^'MI
M')!I>V=,<[17SU\?_P!C+XF^-/%]W>:58(UJ\N8?E-?;X0A_O<4V:"!_O(#7
MTV:\"Y%FF7PP?)RQCK[NA\[E?'7$&59C+&1J<TY*SYM?N/SB'_!/KXU,I9=-
M3 _V#35_X)__ !H:3RQIR9'^P:_1QK*$'Y4&/2F2Z;"QRBA37RR\'>%IKW93
M_P# O^ ?5OQJXG7_ "[A]W_!/SF?_@G]\:$8*=.3)Z?(:=<?\$^?C/$G[S34
M_P"^#7Z,26\ "J803_>I4M(2/WB!OK2EX-<,M6YI_P#@7_ *CXT\4](0^[_@
MGSC^Q3^SQXS^#6IW%_XKM0B3180@'TKZ6B=2GRU"JQ)\H08'2GIM<YC; ]C7
MZ+D&0X;A_+HX/#M\D;VOJ]3\VS[/\3Q!F,L9B4E.5MMM!PG56PW6G&YC'>J\
MQ+/Y07GUJ2*(8RQS7L75[(\9<T?B1.'4C(--6XC9B@/(J/S2)?+V''K3)Y[>
MV4R2,H Y))Z46E'=AS)K0L[UH# G%<OKGQ:^'7AW)UCQC86Y7J)9@*\3^.'_
M  4>^%OPGM7N-,OK+5&0D!()BQ/Y&MZ&'K5](*YY^+SC+<!!RQ%117J?2;2Q
MI]]@/J:SM9UW3M,MS=W%W&%7K\XK\W_B3_P6-\1>/X9=)\$_"V_5P"BRVT;'
M/O\ >KQ5?&/[9/QX\0A;"^\1:7;3$\&(!1D^X->I3R7$17/5DHH^+QGB/E,9
M^SPE.5:7DG^J/TE^)?[?_P #OA898/$.JD21Y'R2#K7S)\;?^"R7@UQ)8?#3
M6)Q.01'R>OX5P?@3_@DM\;?B//%K_C+XM74BR,'>&YV_E]VOI[X-_P#!,KX8
M>!X(QXHT"QU*5<9>5>3^5=7L\FP<;N\I'G2Q''F?R_=15&F^KW_!GQ:/VM/V
MZ?VA+YM*\(ZIOM91\@</WJWX<_X)G?M7?%_5H]7^*%@DL$DF]L*W0_6OTZ\,
M_L]_";PD570?!%E:LG1HU/\ C796UE;V$ @M( H P M82SS2U""4?-:G;0X"
M597S&O*K+U]W[F?%'P@_X(\?!3188KKQ=X:)G7&\[!^-?1WP\_9.^$WPU2.+
MPUI7EF(<945Z? 6\O#@T[ &6KSJN/Q=5ZS9]9EG#>2Y7&U"BD^]M2&.W6"-8
M8XU"*H &/2ATC5,LN![5*D@E!(7&*;*Z!2K)FN&2][4]U/V;Y3'\0^,-,\,1
MB359PJD97G%<;XF^*WPM\7Z:^B:I=H\3_>7>M<5^V=\'/'GQ.T,0^#?%4^GN
M(2 82/?U!KX>E_8&_:M579/C+JN=Q(^Y_P#$U[&$PN%FDYRY3XC-\[S7"8KV
M=#"NI'KML?0GQJ_80_9'^+-G>ZU;Z4CWJ1-*3E.H&17Y[:Y^SAX(L/VB-/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !7YH?\'"'[.,_C/]FWQ#\0=)M7EO(XRJ 9Q]QO
M\*_2^N2^,?PE\)?&;P;<>"/&.FK=65R/WD+$<\$=_K0-;G\A7[-_[1'Q _95
M^)MOJGAN%4NA=QBY4OC R,]J_HR_80_:9\1?\%"/V0]5T[5XHI98K2.W*Q8/
M(^7L/:OSV_X*-_\ !!CQ]X6^)Z_$/X?06\>E7^IH8[>% S*F\9!P?Z5^D_\
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M9M&.HZ[L5_2G^Q/^S+IO[,WP5T7X?+9HFH:?;>7<2QXPW'M0)GMP&!BB@ @
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M!^K5Z,<CA1C^_G8^8J<?K%RY<KP\JC[_ &?\SZ_^,/\ P5;_ &?_  M83?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J-P@DWLWX&I*QO&WB[1?!
M6C2Z[KLP2"+[S%@.U (C\3VOA6]@,GBNSMY((AN4W";@,<YKSW6/VM/V7/AE
M'):ZC\0M*T[9D,GW<8_"OR3_ ."J7_!=_P 7^$/%&H_#3X(>+=DUK,8IE,I^
MZ3CM[5^67Q4_;?\ C9\8+F>^\3ZN\HD8ERK,>M!7*?U)Z'^WI^R)\6?$C>"+
M'XD:-JCD?\>[#=G/'0BMCX@?"7]DZ)+3Q)XC\&>'88IAYBS26*_..>>E?S+_
M /!+35]>U3]IJWOHIW+-Y6<L?[QK]=O^"S/[17B'X%?L[>!?[%OC#/>:.,X8
MC)R_^% FC]&OA-X1^ =Q;IXB^%&@:0$C.!/8VP7!_+VKT.-5'(3%?SY_\$C_
M /@MCXK\!^/K+X8_%?Q21I,UP6F02GGYO?V-?O7\,?B-H?Q4\%V7CCPU/YEG
M?)OB;.<B@1T=% Z<T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !2,N[O2TDA*KD4 ,D=@,*,T1,Y&"N*53M^9NXIQ;*Y6@ 4X.
MREID:MNW-3Z "BBB@ HHHH *\<_;E_Y()J?^?X37L=>.?MR_\D$U/_/\)H*C
MN?RD_M5_\G:ZK_V%D_\ 0J_H0_X-\_\ DW2\_P!]?YFOY[_VJ_\ D[75?^PL
MG_H5?T(?\&^?_)NEY_OK_,T&DO@/T)[_ (44=_PHH,$%%%% PHHHH **** "
MBBB@ HHHH **** "BBB@ IC\'-/ICL"VV@3N)@]0: Y8<]J;ME7ITKC?BA\9
M?#'POM'N-?N"@5=QP:Y,9BJ&"I.M6GRQ1OAL+B,;75&A#FDSL@VY]@-/W$ X
M-?/=K_P4#^"S'_D)OO[_ #"IQ_P4%^":_P"LU-_^^A7@KC/AA*SQ4?O1]"N"
M>*^7F^IS?HF>^*QZYI7<E2*\#'_!0CX& 8&I/U_OBF_\/ _@JYRNIOC_ 'A5
MQXOX7Z8J"^8O]3.+*FGU*I_X"SW16DR0,D9IRQNQPSD5XKX8_;B^$?BC7H-#
MTG4',DQP 6%>SZ;J-OJMJM[;ME&Z5Z66YSE>:P<\+44DNJ9Y..R7-<FE&&,@
MZ;[-6)<N1@YX[TZ*4Y^8\>M,=GR & '?)K/U[Q/H_ARR:[U"Y41KU^89KT*E
M6,(<TI)+N>?2A.<G&$6VV:C.[-\H)%.DN8H(R\[[0.YKPKXA?MR?"WPHLEE!
MJ+^>@(^5AUKPCQA^W%\2O%MZVG>"-0<I(2%SNKXK-?$#A_+)NE&?//M'4^UR
MGP_XBS.'M7#DAWEHC[%\3?%CP/X9C<ZKK\$04'[Q[U\+?M\?%+P]\1]3LCHU
M]$XM7/,?\77_ !J]:_"3]I/XWL+G5U$EO)ST:O./VI_@/JWP1M+*ZUN 1F5,
MOC\?\*_+N-N(L^XDRET8X25.C=>\T[O56_$_5.">'>'.'<XA4J8M5*]G[J::
MBK:M_*YX_<:I]GC+2KM [U2N->TNV'FRWB_-U!KR[XL_&<VOF6FE76,#CFO+
M[_XI>+=0 07/&?4UW<(_1]S;.\&L;BZGL85.G7\4?'^(OTKN%.$\SG@,KI^W
ME#23^S=>:9]01^*]+ \NWNU;/7!K0BN+:ZM5E$XY]*^3[/XC>+;%2_VG!'/4
MUW/@+X[2DQVNN71QQGFNWB;Z.F:Y5ETL5@*OME%7EW^Y(\_@KZ7W#/$.8+!Y
MK2^J\ZTGTOMJVS[X_8<$0\5((Y<YN!G'X5^CMBH6",;OX!_*OS1_8!UC3-8U
MZ&XT\Y+3 FOTPL41;6-YB =@_E7J^$N'Q&&R:K3J*S4K69U^+6+PV-SJG6H.
M\7&ZET:=G=$LN['RC-1H93G*GZ4]KFW7K.@^K"LW7?&VA>';5KK4+^,*HR<2
M"OUE4ZL]$?E$Y4:<>:;1?D9EY7KZ4L3*,[C7C7C7]NKX&>!&=]:U4C9UVR+7
MD/CO_@L'^S5ID<D&E:Q/YXR%PPZUUT,NQE72";\SQ\5Q%D>"3=6M%-=+ZGV)
M-/Y?SL?E]:_%S_@K#\5M1\0_$"[\.M</)';7F%4MD#FO8/B1_P %@/%FIWKV
M_@/69?).=F=U?#'Q[\:^-/B#XLNO&7C%F9;R7>C$'D_C7T^0Y=5P^(YJZ/QW
MQ XQP6;Y;]7P,KQZL\[#S;MWE?I2-)F7+H![U(6N-I;MVI8XHKF+#<M7UY^(
M*JXZ,CN8BVV6)BVWJ*:)VB'V\+\XZ1T1N]LQ1NA/%*Z,'\X_<%4EHS1-I<Z/
MIW]A;]FGQW^T]K,^AOXVU*TMHH^(XYV"@8ST%?>GP9_X(^^"/ LL=_K/BLZB
MY.]A<AFZ\]Q7F'_!#SP[K5GK^H:C=QX@EM3Y9(_V*_2KR<?.1P*_/\XS"JL0
MX1T/Z*X$X5RVODL<7B*;<I=[[' ^ /V;/A7X,MTLX?!FFRF/I*;49-=YI_AW
M0M)79IFDP0#TCC J:V8%_EZ8J>O"J5*DG[S/U3#X;"4::C1@DEY"!0.@I2 >
MHHHK*R.H,#THP#U%%%*R ,#IB@ #@444P# ]*,#T%%% K(, =!00#U%%% PP
M/2C ]*** # ]*3:O7%+10 8'H*, =!110 48 Z"BB@!-JYS@4N!Z444 &!G.
M.:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MCZ%H>]80 3*<MP,@_P!ZOR1_9\@FF_X*$74$(W$>4<GK_K&K^COX=ZCIVE_
M'2K_ %3:+>VTA6N-P! &3G.:!.US^1C]H#X/>,_V5_B9+X9OY+BVU")G*2.N
MUL!O_P!5?T7?\$+OVC-0^*'P#T/P9J<DDDMCI_S2.>ORYK\=?^#@_P 8^"?'
M7[:[:SX#EB>U6UD5C%&%&[*]A]*_2/\ X-Q8M771%DNX=L)TX[#G_8H$]C]:
M@<C-% X&**" HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI?#[3KEEQEF0\_K7SM_P4Z_8)\->+?A_:W'PR\.PZ>]IF206B<D YQSFOO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M***"0!DT %%-+.?NBB254&">: '44B-N7-+0 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !7Y__ /!=K]EBX^+O[+OB#Q!H6G&74-A6,HFY
MON-V%?H!63XO\-Z-XMTF31-;L8KF"3[T,R;E/X4#6Y_&UH7B?XA_LP_$=)-.
MN9K.ZM+M#,3&P/!K]&_#'_!?^TF_9]O/A;\0KB_O;N>S2&)PKX  QZ&O;/\
M@JW_ ,$+AKFM:C\6/AC'+<W-_*9#86B$!,'IC&*_)SQY^PY^TO\ #K4;BRU?
MX4:BBQRL(VD0<@'@]:"SJOA3^V)X8\&_M.3?&&>TF^S.%PH!SPQ/I[U]K?M)
M_P#!P9:^,O@[:?#KX17=_I\RZ=]GNF=7PQR?8>U?FHW[.'QMF4,GP^O Y/0*
M*ZCP+^PC^TUXSUBUL=*^%6I31SR!9'1!\@_.@#D]5U?XB_M#>.B-2GFO]3N7
M8H\<18X)]!GVK^G'_@C=^SJ_PG_9E\-:[=6/D7MQ88F++M8\ <BOBK_@D?\
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M$CIPWARI:X[%5*GI*27W7/AKPE_P1@^,MS<K=>.=:LKJ(]5RO_Q1KB_VV/\
M@FM>?"GPI#J_A_3446]N7N#$@.>OI7Z/M^VW^S !A?BSIH'H'/\ A7.?$?\
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MTW_OH_X4?\-M?LO_ /17--_[Z/\ A3&>L8?U%&']17D__#;7[+__ $5S3?\
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MR_\ ]%<TW_OH_P"%'_#;7[+_ /T5S3?^^C_A0!ZQA_448?U%>3_\-M?LO_\
M17--_P"^C_A1_P -M?LO_P#17--_[Z/^% 'K&']11A_45Y/_ ,-M?LO_ /17
M--_[Z/\ A1_PVU^R_P#]%<TW_OH_X4 >L8?U%&']17D__#;7[+__ $5S3?\
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MR_\ ]%<TW_OH_P"%'_#;7[+_ /T5S3?^^C_A0!ZQA_448?U%>3_\-M?LO_\
M17--_P"^C_A1_P -M?LO_P#17--_[Z/^% 'K&']11A_45Y/_ ,-M?LO_ /17
M--_[Z/\ A1_PVU^R_P#]%<TW_OH_X4 >L8?U%&']17D__#;7[+__ $5S3?\
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MR_\ ]%<TW_OH_P"%'_#;7[+_ /T5S3?^^C_A0!ZQA_448?U%>3_\-M?LO_\
M17--_P"^C_A1_P -M?LO_P#17--_[Z/^% 'K&']11A_45Y/_ ,-M?LO_ /17
M--_[Z/\ A1_PVU^R_P#]%<TW_OH_X4 >L8?U%&']17D__#;7[+__ $5S3?\
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MPPHX[4!=C@,#%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MWF5>>M>KA,VQ6"CRT['R.=<$9#GN-^LXF'O;66Q\%']ICX-3HJL)]P.1\O\
M]:NRT;]OKPQHEFECIM[.L:KMQS7Z[K_P0E^#:G(T/3./]BI%_P""%GP<7_F"
M:;_WQ3KYQBL3'EJV?J8Y?P1D^52D\&Y0OO9V_0_)6U_X*(>'K8^8-0N,^N35
MNX_X*7:$L*JFI7&1UY-?K"?^"%_P<(Q_8>F_]\4QO^"%7P<8_P#(#TS_ +XK
MA]O=W<4>Q_8ZNG[:>G]X_)Y/^"GNBIQ_:=Q^9JQ#_P %2='BZ:I<?F:_5K_A
MQ'\&O^@%IG_?%'_#B/X,_P#0"TO_ +XJI5X2_P"7<?N(_L6?_035_P# C\JS
M_P %6+%?]7JT_ ]36!XJ_P""FUMXL5M*U/4YWLW^^O-?KG_PXC^#/_0"TO\
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M:_&^&)B;Z7C_ 'ZC3]KCXP@^9<ZJPSV+M7]#LG_!"CX,")@="TS'^[7X>_\
M!6;]G30OV?/VH==^'V@)#%;V;#8(>GWV']*%9="HIRZM'DS_ +6OQDE_U&IN
MP[[68T+^U=\9V_Y?IO\ Q^OM#_@A%^PEX2_:U/B)O%"6TPLGP@G&>Z?XU^I<
M7_!"7X,!!_Q(M,Z?W*7*KW!R>S/YY?\ AJWXS_\ /]-_X_1_PU;\9_\ G^F_
M\?K^AS_AQ-\&/^@%IG_?L4?\.)O@Q_T M,_[]BF3='\\?_#5OQG_ .?Z;_Q^
MC_AJWXS_ //]-_X_7]#G_#B;X,?] +3/^_8H_P"'$WP8_P"@%IG_ '[% 71_
M/'_PU;\9_P#G^F_\?H_X:M^,_P#S_3?^/U_0Y_PXF^#'_0"TS_OV*/\ AQ-\
M&/\ H!:9_P!^Q0%T?SQ_\-6_&?\ Y_IO_'Z/^&K?C/\ \_TW_C]?T.?\.)O@
MQ_T M,_[]BC_ (<3?!C_ * 6F?\ ?L4!='\\?_#5OQG_ .?Z;_Q^C_AJWXS_
M //]-_X_7]#G_#B;X,?] +3/^_8H_P"'$WP8_P"@%IG_ '[% 71_/'_PU;\9
M_P#G^F_\?H_X:M^,_P#S_3?^/U_0Y_PXF^#'_0"TS_OV*/\ AQ-\&/\ H!:9
M_P!^Q0%T?SQ_\-6_&?\ Y_IO_'Z/^&K?C/\ \_TW_C]?T.?\.)O@Q_T M,_[
M]BC_ (<3?!C_ * 6F?\ ?L4!='\\?_#5OQG_ .?Z;_Q^C_AJWXS_ //]-_X_
M7]#G_#B;X,?] +3/^_8H_P"'$WP8_P"@%IG_ '[% 71_/'_PU;\9_P#G^F_\
M?H_X:M^,_P#S_3?^/U_0Y_PXF^#'_0"TS_OV*/\ AQ-\&/\ H!:9_P!^Q0%T
M?SQ_\-6_&?\ Y_IO_'Z/^&K?C/\ \_TW_C]?T.?\.)O@Q_T M,_[]BC_ (<3
M?!C_ * 6F?\ ?L4!='\\?_#5OQG_ .?Z;_Q^C_AJWXS_ //]-_X_7]#G_#B;
MX,?] +3/^_8H_P"'$WP8_P"@%IG_ '[% 71_/'_PU;\9_P#G^F_\?H_X:M^,
M_P#S_3?^/U_0Y_PXF^#'_0"TS_OV*/\ AQ-\&/\ H!:9_P!^Q0%T?SQ_\-6_
M&?\ Y_IO_'Z/^&K?C/\ \_TW_C]?T.?\.)O@Q_T M,_[]BC_ (<3?!C_ * 6
MF?\ ?L4!='\\?_#5OQG_ .?Z;_Q^C_AJWXS_ //]-_X_7]#G_#B;X,?] +3/
M^_8H_P"'$WP8_P"@%IG_ '[% 71_/'_PU;\9_P#G^F_\?H_X:M^,_P#S_3?^
M/U_0Y_PXF^#'_0"TS_OV*/\ AQ-\&/\ H!:9_P!^Q0%T?SQ_\-6_&?\ Y_IO
M_'Z/^&K?C/\ \_TW_C]?T.?\.)O@Q_T M,_[]BC_ (<3?!C_ * 6F?\ ?L4!
M='\\?_#5OQG_ .?Z;_Q^C_AJWXS_ //]-_X_7]#G_#B;X,?] +3/^_8H_P"'
M$WP8_P"@%IG_ '[% 71_/'_PU;\9_P#G^F_\?H_X:M^,_P#S_3?^/U_0Y_PX
MF^#'_0"TS_OV*/\ AQ-\&/\ H!:9_P!^Q0%T?SQ_\-6_&?\ Y_IO_'Z/^&K?
MC/\ \_TW_C]?T.?\.)O@Q_T M,_[]BC_ (<3?!C_ * 6F?\ ?L4!='\\?_#5
MOQG_ .?Z;_Q^C_AJWXS_ //]-_X_7]#G_#B;X,?] +3/^_8H_P"'$WP8_P"@
M%IG_ '[% 71_/'_PU;\9_P#G^F_\?H_X:M^,_P#S_3?^/U_0Y_PXF^#'_0"T
MS_OV*/\ AQ-\&/\ H!:9_P!^Q0%T?SQ_\-6_&?I]NF_\?HD_:L^-$6"]]-S_
M +]?T.?\.)?@R>FA:9Q_L4U?^"%?P:D)1] TSCI\E KZG\\47[6GQADF\G^T
MY%/^TS"@_M:_%_S#&-6<D>CM7VW_ ,%I_P!A'P9^RY?:BOAF"U@:"-BH@&.U
M?.O_  2Y_9VT3X^?%%M$UUX9%\]!B;WQ06M3S'_AJWXSGI?S?^/T?\-6_&?_
M )_IO_'Z_H1T'_@A=\&KO0[*Z;0],)EM(W)V#NH-6_\ AQ-\&/\ H!:9_P!^
MQ03='\\?_#5OQG_Y_IO_ !^C_AJWXS_\_P!-_P"/U_0Y_P .)O@Q_P! +3/^
M_8H_X<3?!C_H!:9_W[% 71_/'_PU;\9_^?Z;_P ?H_X:M^,__/\ 3?\ C]?T
M.?\ #B;X,?\ 0"TS_OV*/^'$WP8_Z 6F?]^Q0%T?SQ_\-6_&?_G^F_\ 'Z/^
M&K?C/_S_ $W_ (_7]#G_  XF^#'_ $ M,_[]BC_AQ-\&/^@%IG_?L4!='\\?
M_#5OQG_Y_IO_ !^C_AJWXS_\_P!-_P"/U_0Y_P .)O@Q_P! +3/^_8H_X<3?
M!C_H!:9_W[% 71_/'_PU;\9_^?Z;_P ?H_X:M^,__/\ 3?\ C]?T.?\ #B;X
M,?\ 0"TS_OV*/^'$WP8_Z 6F?]^Q0%T?SQ_\-6_&?_G^F_\ 'Z/^&K?C/_S_
M $W_ (_7]#G_  XF^#'_ $ M,_[]BC_AQ-\&/^@%IG_?L4!='\\?_#5OQG_Y
M_IO_ !^C_AJWXS_\_P!-_P"/U_0Y_P .)O@Q_P! +3/^_8H_X<3?!C_H!:9_
MW[% 71_/'_PU;\9_^?Z;_P ?H_X:M^,__/\ 3?\ C]?T.?\ #B;X,?\ 0"TS
M_OV*/^'$WP8_Z 6F?]^Q0%T?SQ_\-6_&?_G^F_\ 'Z/^&K?C/_S_ $W_ (_7
M]#G_  XF^#'_ $ M,_[]BC_AQ-\&/^@%IG_?L4!='\\?_#5OQG_Y_IO_ !^C
M_AJWXS_\_P!-_P"/U_0Y_P .)O@Q_P! +3/^_8H_X<3?!C_H!:9_W[% 71_/
M'_PU;\9_^?Z;_P ?H_X:M^,__/\ 3?\ C]?T.?\ #B;X,?\ 0"TS_OV*/^'$
MWP8_Z 6F?]^Q0%T?SQ_\-6_&?_G^F_\ 'Z/^&K?C/_S_ $W_ (_7]#G_  XF
M^#'_ $ M,_[]BC_AQ-\&/^@%IG_?L4!='\\?_#5OQG_Y_IO_ !^C_AJWXS_\
M_P!-_P"/U_0Y_P .)O@Q_P! +3/^_8H_X<3?!C_H!:9_W[% 71_/'_PU;\9_
M^?Z;_P ?H_X:M^,__/\ 3?\ C]?T.?\ #B;X,?\ 0"TS_OV*/^'$WP8_Z 6F
M?]^Q0%T?SQ_\-6_&?_G^F_\ 'Z/^&K?C/_S_ $W_ (_7]#G_  XF^#'_ $ M
M,_[]BC_AQ-\&/^@%IG_?L4!='\\?_#5OQG_Y_IO_ !^C_AJWXS_\_P!-_P"/
MU_0Y_P .)O@Q_P! +3/^_8H_X<3?!C_H!:9_W[% 71_/'_PU;\9_^?Z;_P ?
MH_X:M^,__/\ 3?\ C]?T.?\ #B;X,?\ 0"TS_OV*/^'$WP8_Z 6F?]^Q0%T?
MSQ_\-6_&?_G^F_\ 'Z/^&K?C/_S_ $W_ (_7]#G_  XF^#'_ $ M,_[]BC_A
MQ-\&/^@%IG_?L4!='\\?_#5OQG_Y_IO_ !^C_AJWXS_\_P!-_P"/U_0Y_P .
M)O@Q_P! +3/^_8H_X<3?!C_H!:9_W[% 71_/'_PU;\9_^?Z;_P ?H_X:M^,_
M_/\ 3?\ C]?T.?\ #B;X,?\ 0"TS_OV*/^'$WP8_Z 6F?]^Q0%T?SQ_\-6_&
M?_G^F_\ 'Z!^U9\:"<"^F_\ 'Z_H<_X<3?!C_H!:9_W[%,E_X(3?!L+E="TS
M_OB@+H_GG7]JKXTN2%OIN/\ ?IC_ +6/QDC^_J$H]R6K^AQ?^"$WP:VC&B:9
MGO\ +7S;_P %/_\ @DA\+_@1^R_XB\?:-IUA%/96X9#$N#]TG^E!2LS\<S^U
MO\7@H8ZNV">/WC?XT]_VK_C,FW_3Y3NZ8+UR/PA\.P>(_&^GZ5<R*R37L*$'
MI\S@5_0M^SU_P1/^#_BWX->'O$U_HFG/+>Z7'*69.<D4 [)GX,G]JOXT#K?3
M?^/TC?M6?&A1DWTW_CU?T-#_ ((5_!F:+C0-,!]=E+'_ ,$)?@TOW]"TP_\
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M[% 71_/'_P -6_&?_G^F_P#'Z/\ AJWXS_\ /]-_X_7]#G_#B;X,?] +3/\
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M_P"";OQUA3[6=$O#M[?8'K^@_P#X(V_"7Q1\./@9HECKL+QNECAE>,J?N^]
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M)8I, ;I 3D_2O6?G*C!Y[T&;3'44?6B@H**** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6Q_4?X/_ .12TO\ [!T'_HM:T:SO!Y!\):61T.G08_[]K6C00%%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** (96#*7*9Q7XK_\'%OP\\8^+M$U%_#_ (8N
M[HM<L08(B<\BOVK9<<5Y_P#%O]G/P'\9+-K3Q591.C-DEX W/XT#32/X]D^!
M'QG4%!\+M7(]?LAH7X ?&<<_\*QU;_P%-?UHP_\ !/7X#QPB)=#M#@8_X\$I
MO_#O'X$L,KH=I_X I0:<T;'\F#_ ;XV 87X:ZN/^W4TP? /XVAL_\*SU<_\
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M9\O?\$O/V5[W]G3X,:1::E(?.-@%D5A@@^]?5I/G1$@8(Z&HH;*&W@2"VB5
MHQM1< 5/O2%?GXH!NXL.0@5CS3ZB)R/.AYS2^>N, _-Z4")**;&S%-T@Q0TJ
MCO0 ZBF">,\ T(\C2$$?+0 ^BD9BISV[T*P89% "T444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 -D<(N37RI_P4C_X*'?#O]BGP/*=:UG[/J5_:DV&
MV0#Y^?\  U]*>/O$5IX8\*7VK7<ZQB*SE=2QQR$)K^6K_@KK^V=XJ_:-^.FI
M>%Y]7G^SZ'JLD**S<$ 'I^= TKFU^TM_P6Y_:P^+7B2YM?#OBCS-,D9@%$C$
M]>.A]*\8M_\ @H-^TUI^HKK"ZI*LJN'!)?&17U'_ ,$7?^"7$W[3/BC3/BCK
MX6;1S*JRV\J#83GOQ[5^JO[3W_!&/X%^+O@K/IG@KP+IMAJ&GV$C&>%/FE8
MD#F@?*C\[/\ @FE_P76^*UKX_P!+\(?&GQ:/LDD^QU$I^Z#[^U?O)\)/BOX7
M^+_@:U^(7A*Y\VTN^(WR#V![?6OY4O&'_!.W]I#P=\6+NT\.^!];01:A,L%U
M#9G  <X(XK]^_P#@C'H?Q.\%?LZ:'X0^)"WOFP1YD-XFTYV+_A0$DD?77Q:^
M(^A?"SX>:IX[UVX$=OIUH9Y6R!@ @5^#W_!2;_@O_P#$[7?%=]X0^ 7B[_B3
M_.NUI3]X'';\:^T?^#@_]K2^^"/P_MO!6DZ@Z+K=DT4BQM_O'^E?@+\#/AAJ
M?[0_Q>B\#6<K&>\D9@X&3RW_ ->@+6C<[^__ ."A_P"TOJMZ^OWVKR-+(=P8
M%\9KVW]CS_@MW^TG\)/%=K#XW\5>7IBS9F!D;.W/O7ZQ_LN?\$</@HW[,EDG
MB?P5IUUJ4VDNOGRI\X<KP?K7XP_\%9OV';O]CWXWQZ'$<V]VSS1HJX"J?F Z
M>AH*W/Z0OV!OVS_"/[6GP@TSQEI6J_:+B[7+$N"?N@U[^LJ.2 >E?SQ_\&XO
M[7VM:/\ M"I\,-7U.0:;;V2>5!(WR G>/Z"OZ$].U"#4M-BU&W *S(&&*"9)
M)EF218UWMTH616 (/6FQ'S8\-3OEC  6@D=1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%!.!F@ R
M<9H) &334?S 21C%>:?M2?M'>&/V9OAXWCOQ1-"L(WA?.? ) !Q^M '<^*O%
MVC^#_#]WXDUFX6.WLXC)*2P'&:_#7_@M?_P6'U@>,-1^&OP9\38MFC?:OF]Q
MQVKDO^"DW_!?#6?BRUW\./AEIMUIP<M;&2U8D2^_)-?E=X\OO'VOWTOB7QH+
MNXF=B3+<)S@G-!:BFS]"?^"1_P"V)\;/B-\;!9:MJWF W48<;V]J_H^\(3S3
M^%-.FN^6>PA9C[E!7\O7_!$8QR_'0,JA3]JC_I7]0O@\?\4II:D_\P^'_P!
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MC:Y']*_H2_X-^_VC=9\=_ /0_ FL74LDEO;EV:0_[ _PH"22/OKX]?%_P_\
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M#?D'.:Z=B778!@GOB@EDM%-B78H4MDTZ@04444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** &,K!"1UJ"?3+2_B N[2*3GD/&#_.IY&(<+2LXCXQ0!4&
MB:.BA%TJVZ<_N%_PI1HNCKQ_9MO_ -^%_P *M%=PW+WI%&W_ %@R?:@"N="T
MAO\ F&6W_?A?\*3^QM&3_F&VW_?A?\*MD@#--(5FX% [LKKI6E _NM.@!]H5
M_P *F6WCB'[M !Z 8Q3R@ ^08-1QK-&',K9':@0XA=N\TV*V17,H8\T1RI(F
M-AQFGKE>>U #Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MHU_59\%68_"C02W5M.2@E[G4^8"VVAV*XQ353:=[4Y9%<XQ0(=1110 4444
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M-XUNH[.Q2^8W4DF#M(?W_&OW'_X*R?MB?LY? 'X2RV7Q?TL:F^HVLD-G';S
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M'/:OZ%/^#=5%_P"&5;Z8G[MVN/S>OP _:[FN+O\ ;"\12W$F9&UH;V/?I7]
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4'@9HH.,<T 1^8)5()Q57423I]Q#MR/(< _@:L)Y4F=H[\TVX1&C,+_=((-
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MP3>_X)J_#K]C#X=0626]M>WL\<<YN)8<O$Q&XC)'J?TKZFUR,-H]WL.0UM(
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MN%Z4M @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ ILA4+EFQ[TZF3JCIB3I0!&"93\W '0T&7=(/*&X#J:<C1.GE#
MI63XS\4:1\/O#-QXCU241V\ R[$XH Y#]H[]HGP)^SYX&N?%GC'Q!;V2B"3R
MO/. S!>!^9%?SE_\%4/^"L'Q _:>\;W?AG1-2N+#3[*Y>%?LLV%N$&0"0#SU
MKT'_ (+F_P#!37Q+\8_B'JGP/T#7C)IEC<;X8Q(>,M[?[HKX<_99^'/ACXI_
M%_2+'XAQ^9I\]\!=].5P?6@J)UG[$'["WQ1_;'^(]IH*:%>C2[I@6U%!D<FO
MZ1O^"=/_  3S\ _LE?#^Q%K96\M\]H%G=H?GSTY)%>)_L<>,_P!@S]C'PA::
M)X)<6TT"JPRT8P<>U>_Q?\%2/V85QC7_ )CUQ*M W<]Z\<:]+X9T":]@BW>6
MO K^8/\ X+5?M,^,/B-^UIXE\ :GJEQ]BMI@T=NTN47YV[?A7]'>@_'7P/\
MM)?#F\O?AK=^?\VP'<#SR.U?B!_P4$_X(B?M;_'#]IO7OB3X'\-I)%?,"CF)
MCD;F/;ZT"31X+_P2M_;;\(?L@F_U?6?"5A?W)E\R"6ZB4LAR.A-?;_QI_P"#
MC>3QWX F\/Q>$[0;U(!7;Z8]:^,4_P"#??\ ;Y1=DWA:,*>O[IZH^,?^"#O[
M:'@3PQ)XBUKPTBVT?WB(W]*!W3/E+XP^/V^(?QGU+XD+&%:[OO/,:]!7Z/\
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M'S9QD >M?UMO&CH4900>H(KS7XW_ ++7PR^.NA3Z)XJT6TQ/]Z86:%^GKC-
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M4UGXHT:U0S##2I9H6_/K02M&?RQZ=^UU^V=IOA;_ (0'2_'7B"TLX83%]F4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%&0>AH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHR#T-!('4T %%&1ZT4 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1TH
MH(R,&@!JA6.5;.*4L%// ]:C($1V1]Z>$WJ!)0 TDJ<+SFE88/)KE/C?\1;+
MX4_"S6_'=U-Y::99&9G!Z8(']:_)CQO_ ,'''A?0_$4^G0^,2$CD9<>;Z'%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 WAE+-1C*#90_7 I>$% &7XU8IX4O3W\@_TK^7O_@OS+)_PVQ=R,>D#
M_P#H0K^H7QB ?"]Z6[P'K7\O?_!?TK_PW!=J!Q]G?C_@0H*B[,W?^"!>GVNL
M_'6Z$JY,<R$?D*_IJ\-(8O#NGJ.BV47_ * *_FC_ .#?UX5^.5Z$4 ^8O/X"
MOZ7/#*X\/V(:3/\ H<7_ *"* D?F/_P<K22#]E:,H>#J#_SCK\ ?@W9";XVZ
M&MH/F;4AN_(U^_W_  <KMYG[*\<04KC4'Y_[XK\!O@)<"+X\Z$C+G.J#G\#0
M..Q_5!_P2CTR:U_9CLTN4^;]W_Z":]P^.S2)\&/% 7MHEQ_Z :\@_P""8P#?
MLWVA63 _=_\ H->N_M 3&W^"WB;";LZ)<<C_ '#03>[/Y$?VR2LWQQUF9_OK
MK%UM_P"_K5^N/_!ML6GU^T$IY^Q#_P!!-?DA^V-&)/C/K;J>?[8NO_1K5^MW
M_!M?"PUZT8R G[$./^ F@T9^K/[:D+-^RGXYW=M#?'_?2U_(O^T*K_\ "Q[R
M.7IY\G_H1K^N;]MYWC_98\;%0<?V(^<?[RU_(Y^T,5E^(UY(/^>\G'_ C03'
MXC]U/^#;UD_LF9$/33S_ .@5]_\ [?A,G[*WB4-_SP_HU?G]_P &X*F/2IFV
M];#_ -DK] OV_ (_V5_$I'/[C^C4$]3^3_\ :HB\OX\Z@;;[YD7=]-QK]MO^
M#6[3M.@\"^+I+1/G:(&3Z[XZ_$7]K":0_'F_V(1^\7G_ ($:_<'_ (-=Y$N/
MA[XL6)-A$ R?7YXZ#2>A^M)63?@#BORU_P"#G"W@?X'>'_-7_EH<?]]FOU)M
MT>&/$C[CZU^6G_!S0CP_!'0I9&W N<#T^<T&<'=GX-?LX>7%\=M/B;O=-_Z%
M7]67_!-.$M^R7X>3^$;L?]\)7\I?[.+?\7WL)7'(NW_]"K^K3_@FC=;OV2_#
MQV?WO_0$H*>Q[\B%C@]NE2$]AUH!48XZTRY)6/*]:""KK!;^RKK/_/%OY5_.
M#_P<HQ^=^TWIDDF<BSX_[X2OZ1)U$MH8G&=ZX.:_ G_@Z ^&OV;X^Z7JEI;?
M(--4LRCCF-*"HGS1_P $"D _:ZD;M]EB_F]?T]> FSX2T]7[6RXK^5__ ((P
M^+E\(?M3B=FV[HXESG_::OZEOA3>+J/PYTB]0Y\RQ1@: DKHZ%S(')/W<5_*
MI_P6;,O_  U9XJ,_W3JAVU_57'\T9!-?RF_\%DI9C^UEXM2=3M&J':3TH%3=
MCO?^"$(CC_:A\-)W-Z?_ $,5_3F %&37\O\ _P $+=8T?1OVG/#EQK&KPP*M
MZ3F5\8&\5_318_$7P1J<WV?3?$MG</\ W8Y@30.1MAUE!(ZBOQA_X.2BC^'M
M:0'Y_*?^5?LXH255FB8;2.OK7X;_ /!R9XRAB\5ZOX:\T9,+_+F@(NS/R\_8
M72*S^/OAV1^&.M6__H0K^NCX3-++\,] DE'(T2TQ_P!^5K^3K_@F-X'O?&O[
M0VFD1,ZV^K0MC'3!%?UH_#FV^Q_#_0[4_P .CVH_*): DS;1BRY-+0!@8HH)
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M  ZX/_ C7[;_ /!K=?)_P@OBZ.1@"8@%_P"^XZ]K\=?\$(_V>?&GBB7Q)?\
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M;/I]:"WL?;OA+Q DWP]L];N7P?L2NY]*_G6_X.-/BY%XB_:RU'0;.ZW1M _
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
DB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>camp-20241231_g13.jpg
<TEXT>
begin 644 camp-20241231_g13.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" /-!]<# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?R(_*/[>S3_G_(^B?^&Y?'G_ $"?#O\ X#3_ /Q^C_AN7QY_T"?#O_@-/_\
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M'G_0)\._^ T__P ?KYVHH^I8;^1!_;^:?\_Y'T3_ ,-R^//^@3X=_P# :?\
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M1_PW+X\_Z!/AW_P&G_\ C]?.U%'U+#?R(/[?S3_G_(^B?^&Y?'G_ $"?#O\
MX#3_ /Q^C_AN7QY_T"?#O_@-/_\ 'Z^=J*/J6&_D0?V_FG_/^1]$_P##<OCS
M_H$^'?\ P&G_ /C]'_#<OCS_ *!/AW_P&G_^/U\[44?4L-_(@_M_-/\ G_(^
MB?\ AN7QY_T"?#O_ (#3_P#Q^C_AN7QY_P! GP[_ . T_P#\?KYVHH^I8;^1
M!_;^:?\ /^1]$_\ #<OCS_H$^'?_  &G_P#C]'_#<OCS_H$^'?\ P&G_ /C]
M?.U%'U+#?R(/[?S3_G_(^B?^&Y?'G_0)\._^ T__ ,?H_P"&Y?'G_0)\._\
M@-/_ /'Z^=J*/J6&_D0?V_FG_/\ D?1/_#<OCS_H$^'?_ :?_P"/T?\ #<OC
MS_H$^'?_  &G_P#C]?.U%'U+#?R(/[?S3_G_ "/HG_AN7QY_T"?#O_@-/_\
M'Z/^&Y?'G_0)\._^ T__ ,?KYVHH^I8;^1!_;^:?\_Y'T3_PW+X\_P"@3X=_
M\!I__C]'_#<OCS_H$^'?_ :?_P"/U\[44?4L-_(@_M_-/^?\CZ)_X;E\>?\
M0)\._P#@-/\ _'Z/^&Y?'G_0)\._^ T__P ?KYVHH^I8;^1!_;^:?\_Y'T3_
M ,-R^//^@3X=_P# :?\ ^/T?\-R^//\ H$^'?_ :?_X_7SM11]2PW\B#^W\T
M_P"?\CZ)_P"&Y?'G_0)\._\ @-/_ /'Z/^&Y?'G_ $"?#O\ X#3_ /Q^OG:B
MCZEAOY$']OYI_P _Y'T3_P -R^//^@3X=_\  :?_ ./T?\-R^//^@3X=_P#
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MR(/[?S3_ )_R/HG_ (;E\>?] GP[_P" T_\ \?H_X;E\>?\ 0)\._P#@-/\
M_'Z^=J*/J6&_D0?V_FG_ #_D?1/_  W+X\_Z!/AW_P !I_\ X_1_PW+X\_Z!
M/AW_ ,!I_P#X_7SM11]2PW\B#^W\T_Y_R/HG_AN7QY_T"?#O_@-/_P#'Z/\
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M*/J6&_D0?V_FG_/^1]$_\-R^//\ H$^'?_ :?_X_1_PW+X\_Z!/AW_P&G_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJ;6?&%FNGW5S=M]D@2 PC[.%3#;22W+;_O<D $<$5\]?LA?\G >+?^P?=_\
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M^:,DKV?FM^_W]#<TS]CW3?$'_",:QX9\46OB#09)(1J@E8KO52//,3(,C/S
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/_H2?#O_ (*8/_B*/[8I_P C#_4G$?\ /Z/W,_+^BOU _P"%0> _^A)\._\
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M_P"(H_MBG_(P_P!2<1_S^C]S/R_HK]0/^%0> _\ H2?#O_@I@_\ B*/^%0>
M_P#H2?#O_@I@_P#B*/[8I_R,/]2<1_S^C]S/R_HK]0/^%0> _P#H2?#O_@I@
M_P#B*/\ A4'@/_H2?#O_ (*8/_B*/[8I_P C#_4G$?\ /Z/W,_+^BOU _P"%
M0> _^A)\._\ @I@_^(H_X5!X#_Z$GP[_ ."F#_XBC^V*?\C#_4G$?\_H_<S\
MOZ*_4#_A4'@/_H2?#O\ X*8/_B*/^%0> _\ H2?#O_@I@_\ B*/[8I_R,/\
M4G$?\_H_<S\OZ*_4#_A4'@/_ *$GP[_X*8/_ (BC_A4'@/\ Z$GP[_X*8/\
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M%0> _P#H2?#O_@I@_P#B*/\ A4'@/_H2?#O_ (*8/_B*/[8I_P C#_4G$?\
M/Z/W,_+^BOU _P"%0> _^A)\._\ @I@_^(H_X5!X#_Z$GP[_ ."F#_XBC^V*
M?\C#_4G$?\_H_<S\OZ*_4#_A4'@/_H2?#O\ X*8/_B*/^%0> _\ H2?#O_@I
M@_\ B*/[8I_R,/\ 4G$?\_H_<S\OZ*_4#_A4'@/_ *$GP[_X*8/_ (BC_A4'
M@/\ Z$GP[_X*8/\ XBC^V*?\C#_4G$?\_H_<S\OZ*_4#_A4'@/\ Z$GP[_X*
M8/\ XBC_ (5!X#_Z$GP[_P""F#_XBC^V*?\ (P_U)Q'_ #^C]S/R_HK]0/\
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M/_H2?#O_ (*8/_B*/[8I_P C#_4G$?\ /Z/W,_+^BOU _P"%0> _^A)\._\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#R/]K#_D@'BG_MU_\ 2J&NN^$'_))?!/\ V!++_P!$)7(_M8?\
MD \4_P#;K_Z50UUWP@_Y)+X)_P"P)9?^B$KM?^ZK_$_R1X$?^1Q/_KU'_P!+
MD==1117$>^%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% 'D?[6'_) /%/_ &Z_^E4-==\(/^22^"?^P)9?^B$KD?VL/^2
M>*?^W7_TJAKKOA!_R27P3_V!++_T0E=K_P!U7^)_DCP(_P#(XG_UZC_Z7(ZZ
MBBBN(]\**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P#Y^/\ QQ?\*/82#^T*79_A_F=E17&_\)!?_P#/Q_XXO^%'_"07_P#S\?\
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MAY-VN1/,J,(N33T]/\STZBOSM_X:P^*G_0T_^4^U_P#C5'_#6'Q4_P"AI_\
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MO_"07_\ S\?^.+_A1_PD%_\ \_'_ (XO^%'L)!_:%+L_P_S.RHKC?^$@O_\
MGX_\<7_"C_A(+_\ Y^/_ !Q?\*/82#^T*79_A_F=E17&_P#"07__ #\?^.+_
M (4?\)!?_P#/Q_XXO^%'L)!_:%+L_P /\SLJ*XW_ (2"_P#^?C_QQ?\ "C_A
M(+__ )^/_'%_PH]A(/[0I=G^'^9V5%<;_P )!?\ _/Q_XXO^%'_"07__ #\?
M^.+_ (4>PD']H4NS_#_,[*BN-_X2"_\ ^?C_ ,<7_"C_ (2"_P#^?C_QQ?\
M"CV$@_M"EV?X?YG945QO_"07_P#S\?\ CB_X4?\ "07_ /S\?^.+_A1["0?V
MA2[/\/\ ,[*BN-_X2"__ .?C_P <7_"C_A(+_P#Y^/\ QQ?\*/82#^T*79_A
M_F=E17&_\)!?_P#/Q_XXO^%'_"07_P#S\?\ CB_X4>PD']H4NS_#_,[*BN-_
MX2"__P"?C_QQ?\*/^$@O_P#GX_\ '%_PH]A(/[0I=G^'^9V5%<;_ ,)!?_\
M/Q_XXO\ A1_PD%__ ,_'_CB_X4>PD']H4NS_  _S.RHKC?\ A(+_ /Y^/_'%
M_P **/82#^T*79_A_F=E1117.>F%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >1_M8
M?\D \4_]NO\ Z50UUWP@_P"22^"?^P)9?^B$KD?VL/\ D@'BG_MU_P#2J&NN
M^$'_ "27P3_V!++_ -$)7:_]U7^)_DCP(_\ (XG_ ->H_P#I<CKJ***XCWPH
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ JMJ/_ "#[K_KDW\C5FJVH_P#(/NO^N3?R--;HB?PLX6BB
MBO4/CPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N:^)W_)-O%G
M_8)N_P#T2]=+7-?$[_DFWBS_ +!-W_Z)>M(?&O4PK_P9^C_(_/FBBBOKS\4"
MBBO1OA]\(H_%'AZ\\2^(=?M_"'A:WD^S+J-S"9WN)\;O+BB4@N0 2<?@#@XB
M<XTUS2-Z%"IB9\E)7?R22[MO1+S9YS17JWQ+^!/_  KKP7:^)!XAM]7L[^^2
M"P-M 0MS;M#YGG[BWRG/R[,'US7#>!O"EQXY\8:/H%LYBEU"Y2#S=N[RU)^9
M\9&0JY;&>U1&K"<7.+T1M5P=>C66'G'WW:RT>^VW<PJ*][C_ &7;._US6?#>
MG>.K*]\6V22S1:0+)AYD:/M&^4.4C8\'9EB PSCG&/J?[/\ 81>%?$5]I/C?
M3]<UGP["DVJ:;:VT@BB4@[MEP3MD(((X';G!XK)8JB]$_P 'U^7XG9+)\;%-
MN"Z_:CTW6^ZW:WMT/'**]/\ !'P8M]:\&2^+O%'B6#P?X;,WV>VNI;9KJ2ZD
MR00D2$,0"#DC/0\8!(I_$WX02^ X]$O],U>#Q3H6M!Q8ZE8QD"1U;:R%<G#9
M(XR><CJ#6BKTW/DOK_778YI9?B8T?;N/NV3W5[-V3M>]F]G:QYY17O\ JG[+
M^D>'_%]KX;UCXB66GZG?B--/MSI[223RMV8*Y$2[B%5F(+$-A< $W?V=_ASH
M&A^*?%VJ^*M3A2]\'&X26V-F\T4#H2HN@XX8JROM3:6R PP0*QEBZ2@YQU^3
MU.ZGDN*=>-"JE&[:;<HZ6U=]=--;.UUMH?.=%?2?PG\&VB?!CXG36/B&VM=-
MOM3ATD:]>KY$8M(G#-)L.7S(DN/+ZDLHSD$UYE\1?A+;>$]$\/:YH&OCQ7HF
MMO+#;W4=D]L_FQMM*>4Q+<G./I[C-0Q,)3<-M;?A?Y>GD8ULKK4J$:ZU37,]
M5HN9Q[W:VU2LKH\YHKZ7^*'P^C\??%JT\"V^I_V;_P (MX5BBC40F17EBC$F
MP N.661?FR?NC(.,UXW\/?AXGC.Q\1ZI?:D='T30K+[5=7@A$Q,C';%"JETR
M\AW <XR/<4X8B$H<[TV_';[Q8C+*U&M[&/O:M7T6L5[W72WGZG&45H:!96>I
M:Y86FH7QTRRGF2*:\\KS/(4G!<KN7('4\CBO4T_9NU&T\:^)]-U;58]+\.>'
MHC<W?B%K<NC1%-\6R/<-[N"/D#<'<,D@!M)U84W:3.6A@Z^)7-2C=7MNM[-Z
M]E9-W>FCU/'**DN%B6XE$#O) &(C>1 C,N>"5!(!QVR<>IKV#X5_$V^\(>$7
MT?P'X>N+SQW>W#RW&I+9B[D2 *0%A0 D8ZG<".6SGC#J3<(WBK_@3AJ,*U3D
MJ3Y5Y*[?DEI=OU7J>-T5[C^TN'N+3P7?:[:V5E\0+NSF?78+-=C!=Z_9C*H)
M <H3GOQCH% \.I4JGM8*=AXS#?5*\J-[VMTMND]5T:O9KH[H*]+_ &;_ /DM
M'AW_ +>/_2:6O-*]+_9O_P"2T>'?^WC_ -)I:*_\*7H_R*P'^]T?\4?S1]P4
M445\D?L@4444 %%%% !1110 445\N_\ !0CXFZKX"^#EIIFCW+6<_B"\-G<3
MQLRR"V5"TBJ1TW'8I_V2PQSD5%<SL-*[L=_XA_;!^#WA?6Y=)O\ QO:"]B?8
MXMK>>XC5LD$&2.-D!!!SSQ7IGA7Q?HGCG18=7\/ZK::SILO"W-E,LB9P,J2.
MC#/*G!'<"OF'X0?L$_#1_ACI$_B>QN-=U[4;*.YFOEO)H5@>1-VV)4900NX
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[SUGXCW4GAG]GCX;^' VV35'N=8N1')P5+XAR!URK=^A6NVD\/1WFL_L^^!
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M]ML+#YXW*N3'CCERN<D=00/&JVM&\;>(O#EE-9Z3K^IZ7:3,7DM[*\DAC=B
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M!-<!QM$JO*C.-H(&.@9L$$U[_P##/X/^$/@[IEUI_@_1DT>UNI!+,HGEF,C
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% 'D?[6'_ "0#Q3_VZ_\ I5#77?"#_DDO@G_L"67_ *(2N1_:P_Y(!XI_
M[=?_ $JAKKOA!_R27P3_ -@2R_\ 1"5VO_=5_B?Y(\"/_(XG_P!>H_\ I<CK
MJ***XCWPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ J"]C::SGC09=HV4#U)%3T4UH)JZL<;_PC]__
M ,^__CZ_XT?\(_?_ //O_P"/K_C7945O[>1YO]GTN[_#_(XW_A'[_P#Y]_\
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M3_H5O_*A:_\ QVC_ (9/^*G_ $*W_E0M?_CM?HE11_:]?LOQ_P P_P!2\O\
MYY_?'_Y$_.W_ (9/^*G_ $*W_E0M?_CM'_#)_P 5/^A6_P#*A:__ !VOT2HH
M_M>OV7X_YA_J7E_\\_OC_P#(GYV_\,G_ !4_Z%;_ ,J%K_\ ':/^&3_BI_T*
MW_E0M?\ X[7Z)44?VO7[+\?\P_U+R_\ GG]\?_D3\[?^&3_BI_T*W_E0M?\
MX[7<?!/]G/XA^$?B=HVK:MX>^R:?;^=YLWVVW?;NAD4<+(2>6 X'>OMJBIEF
MM:<7%I:^O^9K1X0P%&I&K&<[Q:>\>G_;IQO_  C]_P#\^_\ X^O^-'_"/W__
M #[_ /CZ_P"-=E17G>WD?3?V?2[O\/\ (XW_ (1^_P#^??\ \?7_ !H_X1^_
M_P"??_Q]?\:[*BCV\@_L^EW?X?Y'&_\ "/W_ /S[_P#CZ_XT?\(_?_\ /O\
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M_C1_PC]__P ^_P#X^O\ C7944>WD']GTN[_#_(XW_A'[_P#Y]_\ Q]?\:/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >8_M(Z3XV\1_!W7]
M#^'T,+^(]6B^PK/<7 A6WADXFD#'^+9N5<<AG#?PU^-'B;X&^*?"7QEA^%^H
M0VJ^*Y;VTL%CCG#0^;<B,Q#?TQB5,GMSZ5^\M?E/\>?^4HNF?]C3X;_]%65>
ME@ZC7-%=KG!BH)VEYV/MO]B_P'\1/A5\)1X-^(-O:A]*N&&EW-M=K/NMGRWE
MMCD%'+X)XVNH'W:]]HHKSY2YY.3ZG;&/*E%!1114E!1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 >1_M8?\ ) /%/_;K_P"E4-==\(/^22^"
M?^P)9?\ HA*Y']K#_D@'BG_MU_\ 2J&NN^$'_))?!/\ V!++_P!$)7:_]U7^
M)_DCP(_\CB?_ %ZC_P"ER.NHHHKB/?"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *_*?X\_\I1=,_[&GPW_ .BK*OU8K\I_
MCS_RE%TS_L:?#?\ Z*LJ[<)\4O1G'B?ACZH_5BBBBN([ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@#R/]K#_D@'BG_MU_]*H:Z[X0
M?\DE\$_]@2R_]$)7(_M8?\D \4_]NO\ Z50UUWP@_P"22^"?^P)9?^B$KM?^
MZK_$_P D>!'_ )'$_P#KU'_TN1UU%%%<1[X4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !7Y3_'G_E*+IG_8T^&__15E7ZL5
M^4_QY_Y2BZ9_V-/AO_T595VX3XI>C./$_#'U1^K%%%%<1V!1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?%/@/X6_&KXA^$M/\0Z;\1[B"ROE9HX[K7+U9 %=D.0JD=5/0FL2P^,'Q,^
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MRMOMJCVBBBBN(]X**** "BBB@ HHHH \C_:P_P"2 >*?^W7_ -*H:Z[X0?\
M))?!/_8$LO\ T0E<C^UA_P D \4_]NO_ *50UUWP@_Y)+X)_[ EE_P"B$KM?
M^ZK_ !/\D>!'_D<3_P"O4?\ TN1UU%%%<1[X4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%<)J/_(0NO^NK?S-:TX<[
MW.3$8CZND[7N=W17GE%;>P\SA_M'^Y^/_ /0Z*\\HH]AYA_:/]S\?^ >AT5Y
MY11[#S#^T?[GX_\  /0Z*\\HH]AYA_:/]S\?^ >AT5YY11[#S#^T?[GX_P#
M/0Z*\\HH]AYA_:/]S\?^ >AT5YY11[#S#^T?[GX_\ ]#HKSRBCV'F']H_P!S
M\?\ @'H=%>>44>P\P_M'^Y^/_ /0Z*_+?XG?\E)\6?\ 86N__1SUS->O'*.9
M)^T_#_@GQ-3C;DFX?5]G_/\ _:GZW45^2-%5_8__ $\_#_@F?^O'_4-_Y/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[[STKXD_ ^Y^*GQ%T>^UW5EF\&:? 6_L2,.C23YZL0<$$$Y88("A0/F+5I_
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MB-/\/_"KQO\ #WQKXKTSP]<:#/H5C)#_ &;/J$LL?G2D+:7 <G);<KC821G
M.>"?G>LZ555;JS37<WQ6#>%4).:DI*Z:OM>W5)[IKY!17TUKW@OX6^ /&'A'
MPI>^'9/$FO7MO8VNH1PZE+!%#-*</,Q#$[SN4B,;0%Y)Y%3Z;\//A/;?%X?#
MB#1[_P 37MS/<1S:JVHM$NGD1LXCC5.)"@4ABW1@>N-HY_KD;7Y7:U^FW??^
MNAZG]AU>;D=6%^91W>DGLOAW]+VZV/EZBO9_!7PT\*:/IOB+QGXNFFU#PCIM
M_)INF6EM)M;5IQN*@.IX3: <KUYY^4@N\1>'? GCOX3:SXM\):-<^%-5\/SP
M+?Z8]V]W#+%,_EQLLC\YR">,8PP(.5-:_6(\UK.UTK]+LXUEE7V?.Y14K.2C
M?WG%;M:6V3>K3:5TK'BU%>^7/A+X?_#KX3^"-<\4:'<:UXBU9);L6%O>2P+<
MQ%OD,D@)"*J,IPB[F8KSM#9WM%\ >%-%_:*\"V]EH$SZ9KVE6VKPZ;=WCJVG
M3,&D'S?>?8(<[6/)8YXQ6;Q<;-J+TOVUMOU.B.357*,74C=N%UK=<^U]/PO?
MY:GA5G\./$M]XQ@\*1:3,/$4P5ET^1ECD&8O-PVX@*0G)#$$<@X((K!O;.73
MKVXM)U"3P2-%(JL& 93@C()!Y'4'%?5WP[\4:'XY_:%\6>.+:QCT/3-%TJX>
M;4GG^T+)-N,:W(W8"%HL_(,CY#SEJ\]7P_\ #SQK\*O&NHZ!X?O-#N_#$=H\
M6JWVH-+)>F1V7$D60B,=I "YY8?0Q'%2YK3C_+?R;^?IYF]7*:;I\U"HFVYV
MO?6,%?3W=])7;LM+(\E3PAJTGA*3Q.+4#0X[P6!NFE09GV;]@0MN)VG/ QBL
M:O>O$(M/#WP9^$.A:F@DLM4U*76+]&D9%\KS BC/&,QR'D$8P<'G-5[SX,:;
M-^TCK'AA4&G>%=)<ZA?-)(VVWL$C25LLS;L$,J[LDC>#VK2.)6KEY_<G8YJN
M5SO!47=OD3OTE./-VV2_)GAM%:OBF]TW4?$6HW.C:>-*TF29C:6>]W,46<*&
M9F8EL8)Y(R3C P*]QT#X'^'/BAX:\(^)M'=/#FBP130>*I#<,RVTD(#-(GF%
ML&13GKM4%3CKG6I6C22E/1,X\-@*N+G.G0:;C^*O:ZOT5[N]K+7HSYYK9\)>
M#=:\=ZRFE:#ITVIW[*7\J+ VJ.K,Q("CD#)(&2!U(JS\0-1T#4_%E_+X7TD:
M/H2N8[6#SI)7= <"1S(Q(9NN!P.!S@DZ/P\\>:[X9AU+0M%U"VT<>(6@M;C4
M9V,;6ZASR)1_JU^<[C@\?2KE*3AS16OG^IE3IT5B/9U97BF]8]?2]MWU:TWL
M1^._A+XN^&8MF\2:++IL=QQ%+YB2QL?[N^-F4-P3@G..:Y"OH7X@Z;)\*/V?
M+/PI=ZA'XEDUZ_\ MUM?Z=(TNG6D:$?+%*1AF8@DA0/O-GH-WSU6="HZL6WW
M^\Z,QPL,)64(75TFTVFTWTNDD]+.]NO<*Z;X8_\ )2?"?_86M/\ T<E<S73?
M#'_DI/A/_L+6G_HY*VG\+.+#_P :'JOS/T%HHHKX\_:PHHHH **** /%OV@_
MVK/"7[/L4-K?K)K'B&XC\V'2+1P'"9QOD8Y$:GG&02<' ZD>+>#/^"FWAS5=
M66W\2^#[WP_9.0!>6EZ+T)UR63RXR ./N[CR>..>/^#7A[3OB]^WO\19?%-N
M=831)=0GM(+MO,C#P74=O%E2,%55B0O0$+Z5]@_&3X%>$_CIH4.F>)K1SY,J
MRPWEH52YBQG*K(5.%.3D=#]0*Z&H1LFC3W5HSN=.U"VU;3[:^LYDN+2YB6:&
M:,Y61& *L/8@@U8KYU_:)^)EO^R/\!-)TWPG#F^.S2-)%VYF\@!&+3-N^]M
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M/_KU'_TN1UU%%%<1[X4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4=,COK275]>UU#+9QW"F:*VB0,&=!\P'F)QGCY@17D5%7[!/5OJG]W_#'/\
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MD'!(2-,XX!)'.,GL/!__ "C>G_[%V^_]'2U]<T4<]]^]PYCX,^"_PGOOC/\
ML$:CX=TGR_[8_M66ZLEFDV(\D<B,4)Z#<N]1G R020*B^&?[;K?!WX66?@'7
MO!6L?\)UHL)T^SMS$$AF8,5C$@)$BD#:I"JVXJ<$9X^^**?.G>Z'S7W1\0_
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MP(YYP.*TM.FLOC!^T'X=O/AUX7;PU864]O-.T,"JL8CD+M.Z)^[3Y0%"YPQ
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M/N7+8'!/.!@5]#^&_P!F[P!H7A.'1+CP[8ZJVS$]_=0 W,KX&YA)]Y,D<!2
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MB>&[C$K6-JUMNMU(!(E'EH05)VD!B0>*].^-?COQ]X9T'0M/\*>'I-0\1ZD
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MA1110 4444 %%%% !1110 4444 %%%% 'D?[6'_) /%/_;K_ .E4-==\(/\
MDDO@G_L"67_HA*Y']K#_ )(!XI_[=?\ TJAKKOA!_P DE\$_]@2R_P#1"5VO
M_=5_B?Y(\"/_ ".)_P#7J/\ Z7(ZZBBBN(]\**** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "L*Y\+_ &BXEE^T[=[EL>7G
M&3GUK=HJHR<=C&I2A55IJYSO_")?]/?_ )#_ /KT?\(E_P!/?_D/_P"O7145
M?M9]S#ZG0_E_%G._\(E_T]_^0_\ Z]'_  B7_3W_ .0__KUT5%'M9]P^IT/Y
M?Q9SO_")?]/?_D/_ .O1_P (E_T]_P#D/_Z]=%11[6?</J=#^7\6<[_PB7_3
MW_Y#_P#KT?\ ")?]/?\ Y#_^O7144>UGW#ZG0_E_%G._\(E_T]_^0_\ Z]'_
M  B7_3W_ .0__KUT5%'M9]P^IT/Y?Q9SO_")?]/?_D/_ .O4=SX;ALK:6XN-
M02"")#))+*H544#)8DM@ #G-=-7R%_P4F^.O_"MO@ZO@_3;CR]=\7;[9]C?-
M%8KCSV/IORL6#U5Y,<K6E.52I)13W(GA</"+DX_BSZ$\'C2_'GA;2?$6B:HM
M[I.J6R7=M.L6-R.,C()R".A!Y!!!Y%:__")?]/?_ )#_ /KU\/\ _!+/XZ_;
M]'U?X5:I<?OK'?J>C;VZPLW^D0C_ '782 #)/F2'HM?H%5574I3<;DTL-AZD
M%+E_%_YG._\ ")?]/?\ Y#_^O1_PB7_3W_Y#_P#KUT5%8^UGW-?J=#^7\6<[
M_P (E_T]_P#D/_Z]'_")?]/?_D/_ .O7144>UGW#ZG0_E_%GRWXG_8@_X2/Q
M+JVK?\)I]G^WW<UUY/\ 96[R][EMN?.&<9QG K,_X8'_ .IZ_P#*1_\ ;Z^M
MZ*[%F.*2LI_@O\CQ)<,Y3)N3HZO^]+_Y(^2/^&!_^IZ_\I'_ -OH_P"&!_\
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M_P D<[_PB7_3W_Y#_P#KT?\ ")?]/?\ Y#_^O7145Q^UGW/;^IT/Y?Q9SO\
MPB7_ $]_^0__ *]'_")?]/?_ )#_ /KUT5%'M9]P^IT/Y?Q9SO\ PB7_ $]_
M^0__ *]'_")?]/?_ )#_ /KUT5%'M9]P^IT/Y?Q9SO\ PB7_ $]_^0__ *]'
M_")?]/?_ )#_ /KUT5%'M9]P^IT/Y?Q9SO\ PB7_ $]_^0__ *]'_")?]/?_
M )#_ /KUT5%'M9]P^IT/Y?Q9SO\ PB7_ $]_^0__ *]'_")?]/?_ )#_ /KU
MT5%'M9]P^IT/Y?Q9SO\ PB7_ $]_^0__ *]'_")?]/?_ )#_ /KUT5%'M9]P
M^IT/Y?Q9SO\ PB7_ $]_^0__ *]'_")?]/?_ )#_ /KUT5%'M9]P^IT/Y?Q9
MSO\ PB7_ $]_^0__ *]'_")?]/?_ )#_ /KUT5%'M9]P^IT/Y?Q9SO\ PB7_
M $]_^0__ *]'_")?]/?_ )#_ /KUT5%'M9]P^IT/Y?Q9SO\ PB7_ $]_^0__
M *]2VWA?[/<12_:=VQPV/+QG!SZUNT4>UGW&L)03NH_BPHHHK([ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !%HUW/;S31I)Y6U9D\LMM=0V ZLKY'(!XP>:^ZXHD@B2.-%CC0!511@*!T
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MR(2\@(!7!VCH<<8KW;X9:Y_PI+]F/1=5\36MT5L8/.EM[=5:8+/<DQC#,H!
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MK"! 0?QKNDFL+&_\S_)'SU.49YQ4Y7>U.*?D^:6AU5%%%<)]"%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !7YO\ _!0C]F7QAJD_B[XRZQXGT^?2=-2UM;+1
MXHI/,AMC,D*(&/&=TK2-VR[8[5^D%?.O_!0C_DT'Q]_VX?\ IPMJZ,/-PJ*W
M4PKQ4J;OT/B3]A/]F7QAXZNM.^*_A3Q/I^C3^'=<:U^R7D4A,X6*)Y$++T22
M.<QGO@M7ZRU\8_\ !*;_ )-X\0_]C3<?^DEI7V=5XJ;E4:?0C#Q4:::ZA111
M7(=04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M>ZC#+'/&LJANH##(S[\U/7S7^TM\9/%GPXTGX?W>A:F+5M2@FEO5-O$XG*K
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MQPDY1Y[I7O9-ZNQZ]3.J-.JZ*A.7+;F<8W2;VOK?[DSZ9HKY6^(7QR\::_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KP?]M'_D
MC!_[",'\GKWBO)?VG? NN?$/X9'2?#]C_:&H?;89O)\U(OE4-DY=@.X[UU86
M2C7@Y.RN>/G%.=7+Z\*:;;B[):L\:T/]I#PSHW[-[^&K@W"^)DTR734L#;L
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MA>$M#\+M<MHVBZ?I#7)4SFQM8X3*1G&[:!NQN;&?4^M=$\;&4JDN7XN7\/\
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MHHKG/1"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG+%54$\]@*Z>BJG5G-6D[BC3A!WBCQ']HG]DCP?^TS>Z'=>*-2UNPDTB.6.
M:1/#&&$A4MO\R)\_<&,8[UX__P .IOA+_P!##XT_\#;3_P"1:^SJ*<:U2*M%
MZ"E2A)W:,7P3X4M/ ?@S0?#.GR336&C6%OIUO)<L&E:.&-8U+D  L0HR0 ,]
MA7C'[0/[$_@?]I#QG9>)O$VJ^(+&_M+!-.2/2;B".(QK))("1)"YW9E;G.,
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M"7-?R84445D:!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^T'XE\&-X[TR\LWTN:0O!HMI91R3O'NVYC3RV8J#G@OOX)P1@GU#Q7\>-5\
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M\BV$I+F)99&V!21_#'"%[<-TP:@M?^3]KS_KD/\ TVK7I?5:<9SIO>,+_/\
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MI>[>QUW_  W+X#_Z!/B+_P !H/\ X_5K2OVU?!&KZI9V$.E>(%FNID@1GMX
MH9F"C.)CQDUG_M6_#WPKX=^#U[>Z3X9T?3+Q;J!1<6=A%#( 7Y 95!P:Z/\
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M6XZ\4ROD3]KS_DI.F_\ 8)B_]'35U8;!TZU3DDV>3FF=XC!89UJ<8MW6Z?\
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MAI_\I]U_\:H_X:P^%?\ T-/_ )3[K_XU7YVT4?V10[O\/\@_UTS#^2'W2_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ33_  MHND:3+I=CI%A9:9,&$EE;VR1PN&&&R@ !R.#D<UFL7!<R<;WES?\
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MY(!XI_[=?_2J&NN^$'_))?!/_8$LO_1"5R/[6'_) /%/_;K_ .E4-==\(/\
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MX7_'#P)\:+*>Z\%^)K+75@QYT,1:.>('H7B<*Z@\X)4 D$=C7PC^PWX"T?\
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MQ]X!\4?%2TL9IX;31]!T7^TX[?$OEP>=$T@41K&C@*=P+'/4<^K?L_>#)_\
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M;6O!NNV^NZ<LGE/)"&1HWP#M=' 9#@@X8#@UU]? G[$/@C6O#'[57Q#U'3_
MOBSP1\/=4TJ:6QM?$&DRV2(_VFW,<1W97<H:<* Q.W/OC[[KCJP4)66QUTIN
M<;L****Q-3SRBBBO5/C HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^1
M/VO/^2DZ;_V"8O\ T=-7UW7R)^UY_P E)TW_ +!,7_HZ:O0P/\;Y'SG$'^XO
MU1X?1117T9^8!17IO[/7@C2_&_Q 9=:_>:3I=E-JES;X)\](\?)D'@$L"?8$
M=Z]F^"?QUOOB1X^U.+Q'9::GA[2[.35]/@6".,:28"N"DF <%6(8M^&T9!XJ
MV(=._+&]E=ZV/<P66PQ2@ZM3DYVU'2^V[>JLM;+>[[+4^3**L:C?SZKJ%S>W
M4GFW5S*TTLF -SL26.!P.2>E?1FK^/+KX+? WX<V.E6T \0WZ3:LEY=6Z2?9
MED)VR(K9'F%'50Q!^7=QSQK5J.'*DKM_Y')A,+#$>TG.?+""O>UWNDE:ZU=^
MY\UT5]>?%'XEZQX1^(GA;1/#]EI^G^-M7M[!=9UEK!'EEF?:BH%R=O5LC&2"
MH!X!JAJ?AWPW#\</BMXRNM.@O-.\)Q0W<6E!0L=Q=O&OS,1D?ZQ7)R#DMD]"
M#RQQC:O*.ZNM?-+\6]/T/7J9)%3=.G5NU+E=U9+W7)O=MV4=5;?1-GRE17TY
M\-?BMK'QW;Q=X;\;_P!GW6B_V/=:A'<?9DA.F%"FUD;C"KD?>R>!EB,YQ? G
MB"'X4?LW7VMG3[+4-5\1:RL%I'=IYL82 9$DB<!MCB0J#D!F1L'&*T>(DKQ<
M?>NE:_?SMZG/'+*4TJL*O[MJ3NXV:Y;:6N]VTD[]?(^?:[G6_A;/HEWX)L7U
M".XU'Q-:V]XMO#&2+>.=]L.6)&YB,DCC&.ISFO6_'.M:YXR^'7PB\0W\T)\>
MWVL2K8ZA) D9*+, A>-5VLH81$?(1C_>.>PU3QGJWQ'_ &K]/\+27T5QX8\/
M7_VQ(0D1"300$L[-C)8297&?E] 036,L3/=*UE*^O;3M_D=M+*:"?+*3;DZ:
MCI;XUS:^]I9:/>UU\OF/XG>#(OAYX[U;P[#J(U5+"18S=B'RM[%%9AMW-C!)
M7J>GX5=\"_#?_A,O#'C#6Y-0-A;^'K-;DJ+<R^>[E@D>=PVY*GGGZ5] _"[X
MR7?Q*^)GBS3FM+)? [:=>W=S8FU5VF0-_KI&(W,[%Q\I.T X"C KS#3$'AK]
ME36KEX_+G\2:]#:(P49DA@7S <YZ!U<=.OUR*5>I90DK2]W\=^F]DR)8#"\[
MQ%-\U*U1VLU;E7NV=VVKM6;LWU1XQ17TMXT\ S?&#7?@XR2,%U'P[#'J-RN
M(8;<YFE)"X4_.0,\;MJ\5Y#\9?'4/C_QU=7EA&L&AV:)I^E6Z+M6*TB^6, 8
M!&>6P>F\CM712K^U:27KY:V_S/,Q>7_5(RE*6ETHZ?%=*3>^EDUWU9P]%?1?
MP"T:#XT_#G5_ &L23PVNCW<.K6E]%$S&"-F(GC! V@LI<J#G)9CM.WCS;XS_
M !.7XBZ_!!IUNNG^%]'0V>CV*# CA&!O(_O/M4GTP!SC)(UG*HZ?+MO^GWA6
MP$:6%ABG4TG\*MJVG:2WT4>_6ZTWMA?#OP%J7Q+\6V6@Z8%6:<EI)Y,^7!&H
MRTCGL /S) ZD5WFN_ C1SX?UF]\)>/=.\7:AHL1NK_3H;<P,L"@>9+$Y<B55
MR,D8&,\[L*?)[#4KS2IFFLKJ>SE92ADMY"C%3U&0>A]*]]\.OX7TKX'^-M6^
M'T-_-K@M8=/UM]<VF6&TG^60VZQC:59A_$<@*2<87,5Y5(23B]-%MIOU?^1T
M9=3PU>G.%2"<DI-N[O9*ZY4M&U:[O=6/GFBBBNT\ *_0;X8_\DV\)_\ 8)M/
M_1*5^?-?H-\,?^2;>$_^P3:?^B4KR<Q^&)]EPU_&J>B_,Z6BBBO"/T ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH \C_:P_P"2 >*?^W7_ -*H:Z[X0?\ ))?!/_8$LO\ T0E<C^UA_P D
M \4_]NO_ *50UUWP@_Y)+X)_[ EE_P"B$KM?^ZK_ !/\D>!'_D<3_P"O4?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*_\ H5O_ "H77_QVC_AD_P"%?_0K?^5"Z_\ CM>N44?6:_\ S\?WL/[)R_\
MZ!X?^ Q_R/(_^&3_ (5_]"M_Y4+K_P".T?\ #)_PK_Z%;_RH77_QVO7**/K-
M?_GX_O8?V3E__0/#_P !C_D>1_\ #)_PK_Z%;_RH77_QVC_AD_X5_P#0K?\
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MS^*3?S9O2P&$H-NE1C&_:*7Y(SO^$?L/^??_ ,?;_&C_ (1^P_Y]_P#Q]O\
M&M&BHYY=SH]A2_E7W(SO^$?L/^??_P ?;_&C_A'[#_GW_P#'V_QK1HHYY=P]
MA2_E7W(SO^$?L/\ GW_\?;_&C_A'[#_GW_\ 'V_QK1HHYY=P]A2_E7W(SO\
MA'[#_GW_ /'V_P :/^$?L/\ GW_\?;_&M&BCGEW#V%+^5?<C._X1^P_Y]_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#R/]K#_D@'BG_MU_\
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M***\\[@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#S
MC7/CUX:\/_'#P]\*KJ.^/B?7+%M0M7CA4VPB59V.Y]V0<6TG&T_P^O'H]?&/
MQ1_Y2B_"#_L5I_\ T5JE?9U:U(J*C;JC*$G)ROT84445D:A1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'D?[6'
M_) /%/\ VZ_^E4-==\(/^22^"?\ L"67_HA*Y']K#_D@'BG_ +=?_2J&NN^$
M'_))?!/_ &!++_T0E=K_ -U7^)_DCP(_\CB?_7J/_I<CKJ***XCWPHHHH **
M** ('L;:2Z2Y:WB:Y0;5F* NHYX!ZCJ?S-3U\U^.OC7XLT/]NGX=_#2SOHH_
M".LZ#+?7EH;=&=YE2_((D(W#FWBX!QP?4U]*5<HN-K]2(R4KVZ!1114%A111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^8OVP/V2]9_:7^)>F>)].UVQT2&TTB+33;W4;R,S+--)N!7 QB4#'L:^OO\
MA+?^G3_R)_\ 6KGJ*TE%22B]D0L35BVT]_0Z'_A+?^G3_P B?_6H_P"$M_Z=
M/_(G_P!:N>HK/V4.Q?URO_-^".A_X2W_ *=/_(G_ -:C_A+?^G3_ ,B?_6KG
MJ*/90[!]<K_S?@CH?^$M_P"G3_R)_P#6H_X2W_IT_P#(G_UJYZBCV4.P?7*_
M\WX(Z'_A+?\ IT_\B?\ UJ/^$M_Z=/\ R)_]:N>HH]E#L'URO_-^".A_X2W_
M *=/_(G_ -:C_A+?^G3_ ,B?_6KGJ*/90[!]<K_S?@CH?^$M_P"G3_R)_P#6
MH_X2W_IT_P#(G_UJYZBCV4.P?7*_\WX(Z'_A+?\ IT_\B?\ UJ/^$M_Z=/\
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M1:M966I?:9E\J%A*"OEAQ&W$\O+*3\W7@8[2M9S4E&W16,X1<;WZL****R-
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MU[JS:5F<'X:^"WC7QAI^F7VCZ%)?6NI-*EM(DT0#>6<.6!8%%!XW-@9(&<D
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M*;@<'!Z9^<OV5]1U33_V2/CI+I3R+=10LRF,G,:F B5QZ$)N.1R-H/:O<_\
M@GEX>\/O^S]+=06EK<:A>W]S!J;LBN[8VA8GR/N^7L.SI\Y./F-2X1C=L3BE
M<]\^&'Q7\+_&+PTFN^%=334;+=Y<JE2DL$F,E)$/*D9^AZ@D$&O!%_X*/_"L
MZ2UZ;'Q(DHE\I;(V<)F<8!+C$VT*,XY8$]@<&O/_ -B](-%_:O\ B_HWAPA?
M""+=&..!LPAH[Q5@"]B KS!3SQWYYK?\$O\ 0[-SX^UEHMVH1_9+1)2?N1-Y
MCL /<JF?]T=.<G)%7;\@Y4KG+?&3]KS[9^TUH-Z\GB*T\&>%KT)>:#)&D4C7
M,3NLC>4)-KG(&-[ C!X7)S]^^!/&5E\0O!NC>)=.BGAL-5MDNH8[I565489
M8*2 ?H37QK\:O^4B7P\_ZXV7\YJ^Z*52UE9"E:R/F[]J#]HOQ+X%\2:=\./
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'D?[6'_) /%/\ VZ_^
ME4-==\(/^22^"?\ L"67_HA*Y']K#_D@'BG_ +=?_2J&NN^$'_))?!/_ &!+
M+_T0E=K_ -U7^)_DCP(_\CB?_7J/_I<CKJ***XCWPHHHH **** /E'XB?#[Q
M+J/_  42^%_BZUT*^G\,6'AR:VNM6C@8VT$ICU$!&?H#F6/C_;7UKZNHHJY3
M<K>2L1&/+?S"BBBH+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#XQ^*/_*47X0?]BM/_ .BM
M4K[.K%NO!/AV^\4V?B:YT'3+CQ'9Q&"VUB6SC:\@C(<%$F*[U7$DG ./G;U-
M;5:SGS<ODK&<(\M_-A11161H%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2"5=&'.&5E92,GE3R:4H.*OT*C-2=NITM%%%9EA1110 4444 %%%% !1110
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M!]=M?"-_;Z7XGFLY$TV]NU#107!4['<%'! .,_*WT-?*7_"KOVV?^BO^"_\
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M\.>&=2@^+OB?2O%.M/>;[2YTF)4CCM]BC8P6"'G<&/W3U'/:KOQZT/XE>(/
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M2JH6(G.Y ,$$@AN-OT1-#'<1/%*BR1.I5D<9# \$$=Q6%62E;J;4HM7/B_\
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M!H]A\0M9L].T=KZ>"VMI?,W33[(F7,CB5%W$D@(,8K-_90_9]T'X[_#?7_\
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MX^=P<]#U'/8=I117).7/)RM]Q[-&DJ--4TV[=6[OYM[A1114&P4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 445\87?[1W[0_Q!\2>(;SX.>#/!GC7P'::@]G9:NUV@>3:
MB-APU[&0V'4_<'4<5I"#GL9RFH;GV?17R5X)^(_[7U]XST&V\3?"SPEIWAR:
M_MX]3O+:ZC,L%J9%$TB 7[994+$?*W(Z'I7UK1.')U3]!QES= HKY*\;?$?]
MKZQ\9Z];>&?A9X2U'PY#?W$>F7ES=1B6>U$C"&1P;]<,R!2?E7D]!TJ[\,_B
M%^UAJGCW1+3QK\,O"ND>%);@+J-]97,;30Q8.64"^<DYQ_ WTJ_9.U[K[R/:
MJ]K/[CZHHHKX]UOXF?MEP:S?QZ9\)O!]QIJ7$BVTTEW&&>(,=C'_ (F Y*X/
M0?05$(<_5+U+E/EZ'V%17S7\%/'7[3FN?$*QL_B7\._#7A[PB\<IN;_3;A'F
M1PA,8 %Y*>7V@_(>#VZU]*4I1Y':X1ES*]@HKXQ_X6C^VS_T2#P7_P"!<7_R
MQKT;X"^-?VCO$'CB2U^*O@#P[X9\,"SD=;W2YT>4W 9=B8%W*<$%_P"'L.1W
MT=)I7NOO(55-VL_N/HBBJ6MRWT&BW\FF0I<:DEO(UK#*<+)*%.Q3R."V!U'U
M%?'W_"T?VV?^B0>"_P#P+B_^6-1"'/U2]65*?+T9]G45X)^SWXP_:!\1^)M2
M@^+O@;0/"VBI9[[2YTF='DDN-ZC8P6ZFXVEC]T=!SVKV'QM=:W8^#->N?#-G
M#J/B.&PN)-,L[D@13W0C8PQN2RX5G"@_,O!ZCK2E'E=KC4N97L;5%?&/_"T?
MVV?^B0>"_P#P+B_^6->P?L[>*_CGXDO=<7XP>#-$\*VT4<1TY](F60S.2WF!
M]MS-C "8X7J>O:Y4G%7NOO)C44G:S^X]NHKDOBQJ7B_2/A[K-YX"TJTUOQ=%
M&IT^POV"PS/O4,&)DC PA8_?'('TKY>_X6C^VS_T2#P7_P"!<7_RQI0IN:O=
M+U8Y3Y7:S^X^SJ*\>_9V\3?&7Q)9:XWQ@\):/X5N8I(AIR:1*L@F0AO,+[;B
M;&"$QRO4]>W3_&O5_'NA_#V^O/AIHEAXA\7))$+:PU)PD+H7 D))EB'";B/G
M'([]*EQM+EN-2O'FL=U17QC_ ,+1_;9_Z)!X+_\  N+_ .6->]?L]^(?BQXC
M\,ZE/\7?#&E>%M:2\V6EMI,JO');[%.]BL\W.XL/O#H..]7*FXJ]U]Y,:BD[
M6?W'JE%><?'K7/B5X?\  \=U\*O#VF^)O$YO(T:RU214B%N5;>^3-$,@A/XN
MYX/;YX_X6C^VS_T2#P7_ .!<7_RQI1IN2O=?>$JBB[6?W'V=17G'P%USXE>(
M/ \EU\5?#VF^&?$XO)$6RTN17B-N%78^1-*,DE_XNPX'>E^T)XA^+'ASPSIL
M_P (O#&E>*=:>\V7=MJTJI'';[&.]2T\/.X*/O'J>.]3R^]RW*YO=YK'JE%?
M&/\ PM']MG_HD'@O_P "XO\ Y8U]*?!35_'NN?#VQO/B7HEAX>\7/)*+FPTU
MP\*('(C((EE'*;2?G/)[=*J5-P5[K[Q1J<SM9_<=U17CW[1/B;XR^&[+0V^#
M_A+1_%5S+)*-135Y5C$* +Y93=<0YR2^>6Z#IW\2_P"%H_ML_P#1(/!?_@7%
M_P#+&G&DY*]U]XI5%%VL_N/LZBN2^$^I>+]7^'NC7GCW2K31/%TL;'4+"P8-
M#"^]@H4B20'*!3]\\D_2O/OVB?%?QS\-WNAK\'_!FB>*K:6.4ZB^KS+&87!7
MRPFZYASD%\\-T'3O"C>7+<IRM'FL>W45\8_\+1_;9_Z)!X+_ / N+_Y8U]6_
M#Z]\1:CX'T*Z\76%OI?B>:SC?4K*T8-%!<%1O1"'<$ YQ\S?4U4Z;AK=/T8H
MSYNC^XZ&BO!/VA/&'[0/ASQ-IL'PB\#:!XIT5[/?=W.K3HDD=QO8;%#74/&T
M*?NGJ>>U>6?\+1_;9_Z)!X+_ / N+_Y8TXTG)7NOO)=1)VL_N/LZBLOPO<:I
M=^&=(GURVBL]:DLX7OK: YCBN"@,B*=S<!MP'S'IU/6O"_CUXU_:.\/^.([7
MX5> /#OB;PP;.-VO=4G1)1<%FWI@W<1P $_A[GD]HC'F=KERERJ]CZ(HKXQ_
MX6C^VS_T2#P7_P"!<7_RQK['L7GDLK=KI%CN6C4RHO17QR!R>^>].<.3JGZ,
M49\W1D]%?-?QK\=?M.:'\0KZS^&GP[\->(?"*1Q&VO\ 4KA$F=R@,@(-Y$>'
MW ?(.!WZUR.B?$S]LN?6;"/4_A-X/M]->XC6YFCNXRR1%AO8?\3 \A<GH?H:
MM4FU>Z^\EU4G:S^X^PJ**^7OBQX__:ITCXA:S9^ OAKX7UOPC%(HT^_O[F-9
MIDV*6+ WT9&'+#[@X ^M9PCSNU[>I<I<JO8^H:*^2O!/Q'_:^OO&>@VWB;X6
M>$M.\.37]O'J=Y;749E@M3(HFD0"_;+*A8CY6Y'0]*^M:<X<G5/T",N;H%%?
M*/Q!^(G[6^G>.-=M?"/PO\*:IX8AO)$TV]N[J-99[<,=CN#?H02,9^5?H*F^
M&?Q"_:PU3Q[HEIXU^&7A72/"DMP%U&^LKF-IH8L'+*!?.2<X_@;Z5?LG:]U]
MY'M5>UG]Q]4445\B>*/B3^V):>)M7@T/X4^$+S18[R9+&YGNHQ)+;AR(W8?V
M@O)7:3\HZ]!TJ(0Y^J7J7*?+T/KNBOF3X.>/?VHM:^(^D6?Q%^''AC0/!LOG
M?;]1TZY1YXL0N8]H%[(>9!&I^0\,>G4?3=*<>1VO?T",N97L%%?&/_"T?VV?
M^B0>"_\ P+B_^6->@? WQQ^TKKWCV&T^*'P]\.>'/"AMY&>^TRX1YA*!\B@"
M\E."<Y^3\16CI-*]U]Y"JINUG]Q]'452UN6^@T6_DTR%+C4DMY&M893A9)0I
MV*>1P6P.H^HKX^_X6C^VS_T2#P7_ .!<7_RQJ(0Y^J7JRI3Y>C/LZBOG[]G[
MQG^T/XB\9WMM\6_ ?A_POX<6P>2WO-)G1Y7NA)&%C(%W-\I0RG[HY4<]C[/X
MVNM;L?!FO7/AFSAU'Q'#87$FF6=R0(I[H1L88W)9<*SA0?F7@]1UI2CRNUQQ
MES*]C:HKXQ_X6C^VS_T2#P7_ .!<7_RQKUK]GCQ=\>O$>M:O'\7O!.A>%=-C
MMU:QFTF9)&EEW?,K;;J;@+ST'UJY4G%7NOO(512=K/[CW2BN8^)M_P"*=+\!
M:W=^"=-M=8\5Q6Y;3K&]8+#-+D85B70 8S_&OUKY8_X6C^VS_P!$@\%_^!<7
M_P L:4*;FKW2]65*?*[6?W'V=17C'[.?BCXV>)?^$A_X7%X/T7PIY/V?^RO[
M(F63[1GS?.W[;F;&W$6/N_>/7MV?QCU3QMHOPXU>\^'6CV6O^,HO)^P:=J+A
M()<S()-Q,D8XC,C#YQRHZ]#+C:7+<:E>/-8[2BOC'_A:/[;/_1(/!?\ X%Q?
M_+&O<_V>/$?Q?\1Z-J\GQ>\*Z1X5U*.X1;&'295D66+;\S-MN)N0W'4?2KE2
M<5>Z^\F-12=K/[CUNBO/OCEK/Q$T'P%+=_"_0=/\1^*Q<1JECJ<@2$Q$G>V3
M+$,@8Q\_X&OG+_A:/[;/_1(/!?\ X%Q?_+&E&FY*]U]X2J*+M9_<?9U%>8_L
M_:]\4?$7@R]N?BWX;TSPOXC6_>.WL])D5XGM1'&5D)$TWS%S*/O#A1QW)^T#
MKWQ1\.^#+*Y^$GAO3/%'B-K]([BSU:14B2U,<A:0$S0_,'$0^\>&/'<3R^]R
MW*YO=YK'IU%?&/\ PM']MG_HD'@O_P "XO\ Y8U]&_ W6?B)KW@**[^*&@Z?
MX<\5FXD5['3) \(B!&QLB649(SGY_P !52IN*O=?>3&IS.UG]QZ#17DG[0_B
M/XO^'-&TB3X0^%=(\5:E)<.M]#JTJQK%%M^5EW7$/);CJ?I7AG_"T?VV?^B0
M>"__  +B_P#EC3C2<E>Z^\)5%%VL_N/LZBN+^#FJ>-M:^'&D7GQ%T>RT#QE+
MYWV_3M.</!%B9Q'M(DD',8C8_.>6/3H.,_:,\4?&SPU_PCW_  IWP?HOBOSO
MM']J_P!KS+']GQY7D[-US#G=F7/WONCIWA1O+EN4Y6CS6/9Z*^,?^%H_ML_]
M$@\%_P#@7%_\L:^K?A]>^(M1\#Z%=>+K"WTOQ/-9QOJ5E:,&B@N"HWHA#N"
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M$X'%8-VQ%*4?5-%BBBBNHX0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *^,?^"4W_)O'B'_L:;C_ -)+2OLZO&/V4_V<_P#AF/X>:CX6_P"$
MA_X27[7JLFI_:_L7V79OAACV;/,?./)SG/\ %C''.T9)4Y1>[L92BW.+[7/9
MZ***Q-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME?W%VBJ7]L6?_/;_ ,=/^%']L6?_ #V_\=/^%'/#N@]E4_E?W%VBJ7]L6?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#H?R-39[E71NT444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MR!GCKR:](\#_ !:T"?PMX0@U[Q7H\/B?4M*M+F2SN;V"&XFD>!'9A%D'G=G
M&,'TK;V,_9JHMG^AC[>'M'2>ZM^)Z)117+P?%/P7=:]_8</B_09M:W!/[-CU
M.!KG<<8'EAMV3D<8[BL4F]D;.26[.HHK/U[Q!I?A729]4UK4K/1],@V^=>W\
MZ00Q[F"KN=B ,LP R>20.]<[=?&?X?6,=L]SXZ\-6Z747VB!I=7MU$T?/SH2
M_P R\'D<<4U&4MD)SC'=G945\J?LM?M>O\9O&_C.T\4:GH>@Q)-96V@:7]I2
M.2X9C.)/++D-,Q*Q<+TRN!SS]5U=6E.C+DGN9T:T*\.>&P45\_\ [97[1?\
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M8S6(A*LZ"W2N>NT5GZ]X@TOPKI,^J:UJ5GH^F0;?.O;^=((8]S!5W.Q &68
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@""]_P"/.?\
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M7%MYJ2["9I& W(S*>&!X)ZUE5Q"5&7L96O-[:.UOR-:6';K0]M&]H+?57O\
MF?''_!/'X2^%/&/CCQOJVKZ5]KU#PO?6,VD3?:)4^S.7N<G"N _^J3[X;[ON
M<_H3XBUZS\+>']3UK49/)T_3K66\N9 ,[8HT+N<>P!KXQ_9^^"?QL_9Z^,^L
MVVFZ!I.I>!]?U&+^T-6FNHV9+5))"KQIYJ.) LK @HPR1P<9K[.\0:#8^*M
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ML4O'N]-BN4:YMU:]G*F2,'<H(8$$@9!'K7.?&O\ 8/\ A]_PJ_7O^%>^!_\
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MDJ>#X9^V'<_&K6_AUH6I?%AM'\.01:BEM8^&],E1GNG\J4R7D@660$H B<'
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\8_\
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M<UZQ_8]G_P \?_'C_C3EA9Q;BQ+&TY*Z3.9HKIO['L_^>/\ X\?\:/['L_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MCW-?H758MQ=1VW(PRDJ:N%%%%<9UA1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!\8_P#!*;_DWCQ#_P!C3<?^
MDEI7V=67X?\ "^C>$K)[/0](L=&M'D,K0:?;)!&SD %BJ  G"J,^P]*U*TJ3
MYYN7<SIQY(J(4445F:!1110 5X_XF_Y.7\)_]@Q__0;FO8*\?\3?\G+^$_\
ML&/_ .@W->/F?P4O^OD/_2D?19)_$K_]>JG_ *2SV"BBBO8/G0HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-Q_Z26E?9U7B/XLB:'\.(4445SFX4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
MYU_X*$?\F@^/O^W#_P!.%M7T57SK_P %"/\ DT'Q]_VX?^G"VK6C_$CZHRJ_
MPY>C/._^"4W_ ";QXA_[&FX_])+2OLZOC'_@E-_R;QXA_P"QIN/_ $DM*^SJ
MO$?Q9$T/X<0HHHKG-PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !7C'[*?[1G_  TY\/-1\4_\
M(]_PC7V359-,^R?;?M6_9##)OW^6F,^=C&/X<YYX]GKXQ_X)3?\ )O'B'_L:
M;C_TDM*VC%.G*3W5C*4FIQ7>Y]G4445B:A1110 4444 %%%% !1110 4444
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MEO;AD=4 "[OE!]1[UJ5K&2FKHYYP=-\L@HHHJS,**** "BBB@ HHHH ****
M"BBB@ HHHH ^-_\ @EC8W-A^S[X@CN;>6VD/BBX8)*A4D?9+3G!^AK[(HHK2
MI/VDG+N1"/)%1[!1116984444 %>/^)O^3E_"?\ V#'_ /0;FO8*\?\ $W_)
MR_A/_L&/_P"@W->/F?P4O^OD/_2D?19)_$K_ /7JI_Z2SV"BBBO8/G0HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y[P3\/O#7PVTJ73/"VA
M6/A_3Y9C<R6VGP+%&TI55+D#N0BC/^R*Z&O"_P!CW]H?4?VEOAGJ?B?4](M=
M&GM-7ETU8+21G5E6&&0,2W.<RD?@*M*3BVMB&TI)/<]THHHJ"PHHHH ****
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M9(SC%>T?'S]H7PO^SSX9@U3Q 9KFZO&:.PTVT ,UTZ@;L9("HNY=S'IN'!)
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M)9[!1117L'SH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ME%=G11]6\P^N_P!W\?\ @'&45V=%'U;S#Z[_ '?Q_P" <9179T4?5O,/KO\
M=_'_ (!QE%=G11]6\P^N_P!W\?\ @'&45V=%'U;S#Z[_ '?Q_P" <9179T4?
M5O,/KO\ =_'_ (!QE%=G11]6\P^N_P!W\?\ @'&45V=%'U;S#Z[_ '?Q_P"
M<9179T4?5O,/KO\ =_'_ (!QE%=G11]6\P^N_P!W\?\ @'&45V=%'U;S#Z[_
M '?Q_P" <9179T4?5O,/KO\ =_'_ (!QE%=G11]6\P^N_P!W\?\ @'/^'_\
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M!976A[;72='8RQ_:S_I*"-@RY" ID*>1G&:L?L^:UH.K_P!O_P!B>'/^$?\
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MLJQN,KRP]&DW..ZVMZWLD>P45YE\//CQI'CK48]-EMI=*U*7/E1R.)(Y,#.
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'?;W$DR1R1,3C*ENQX!'0_4 CL:\/_:"^%^I:_=6WB'1;<W4\,0AN+>!/WK
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M6TK[8U&$&50@\ECU[UF_M!ZM+XK^(]CH%F1(;0);(H)(,\I!/Z%!^%>M6_P
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M2;[6TU9!>65OJ-NT%W;Q7,#$$Q3('4D$$'!XX(!^HKQ']J9%CT/P\B*$19Y
M%48 &T<5[K7A?[5/_(&T#_KXE_\ 0171GJ7]GU7Y+\T<?##?]KT(WTN__26>
M@?!K_DF/A_\ Z]S_ .A-7:5Q?P:_Y)CX?_Z]S_Z$U=I7I8'_ '6E_AC^2/'S
M/_?J_P#CE^;"BBBNT\T**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_$/_ &*UQ_Z5VE=M#^%4^1QUOXE/YGZL4445Q'8%%%% !1110 4444 %%%%
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MZ,>>I)17=NR,*-"KB)^SHP<I=DFW]R.EHK@[?XZ>!KF58TUY QXS);S(/S9
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MBH&..N?YBNKK*E6IUH\U*2DO)W_(WK8>MAI<E>#B][--.WS"BBBMCG"BBB@
MHHHH **XRQ^,/A#4M8BTNVU<27\LOD)$;:9<OG&,E,=?>MWQ+XJTOP?IHO\
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M"810/O2.>F>:^H:^1/\ @F-X7UGPE\!=>L]<TB^T:[?Q+<2K!J%L\$C(;6U
M8*X!(RK#/L?2MXI>SE\OU,97]I'YGUW1116!L%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !7Y3_\$IO^3A_$/_8K7'_I7:5^K%?E/_P2F_Y.'\0_
M]BM<?^E=I7;0_A5/D<=;^)3^9^K%%%%<1V!1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!\X_L)? WQ3\ /A%J_A[Q;#:PZE<Z
MY-?QK:3B9?*:WMT!)'?=$W'TKZ.J"TOK:_C,EK<17,8.TO$X8 ^F1]14]7.3
MG)R9$(J$5%!1114%A1110 5X_P")O^3E_"?_ &#'_P#0;FO8*\?\3?\ )R_A
M/_L&/_Z#<UX^9_!2_P"OD/\ TI'T62?Q*_\ UZJ?^DL]@HHHKV#YT**** "B
MBB@ KYU_:2^S?\)SX:^V_P#'GY(\[K]SS?FZ<],].:^BJ^>OVA[:*]^(?A2W
MF7?#,B1NN2,J9L$9'M7SF?IO M+O'\S[#A1I9G%O^66V_P +.=^(C?"D>&Y1
MX72<ZP64Q-$;@*!D9W^;QC!/3G('09K4UHW9_9ETD7:%,78$6X8+1[WVG_#V
MQ]:]8MO@;X&M91(F@QLP[23RR+^3.16+^T>BQ_#/8BA$6[A 51@ ?-Q7CU<M
MK4*6(Q-90C[C5H)I=[NY]#0SG#8JOA,%AW4G:HI.51IR[65NAYYX6;X/)X8L
M&UI2^L" &Y5?MF3)W'R_+^7%6/V=HM_Q'UZ;2(Y5T)8'4&XY95,@,0)'\1"G
M\ U6X_@=IOB7X4:9JFDP-;Z^UJMP3YKLMP>ZD$D D9QMQSUXK?\ V=O'4&HZ
M7/X<N((++4K,M(JQ1"+ST)^8D#C>IX/3C'H:YL)1G'%X:->,8*UXN*MS:;-]
M^_\ P3MQ^)ISR_&3PLYU7?EDIROR*^\5V[:Z==F<]^SG_P C_P"*/^N;?^C:
M\G\)FXT=H_$T#+_Q*K^U#(V?FW^8W;M^Z(/?YJ]8_9S_ .1_\4?]<V_]&URG
MPXT$ZW\+OB$JJ'E2.VG0$ E3$9')'N5W#\3ZUYOLI5</AE'=>U:]5JOQ1["K
M1H8O&2GL_81?I+W7^#9V'[0EY_PDWB+2M'MF\V"UTVYU1Y(2&!'ELRY/IB+\
MGXZBM7]EG_D6-9_Z_%_] %<-\+(9_%2>,-7O\3?8/#[6*<XV@PE%[]=D39]R
M3WJS\-/$G_"+?!CQA=JVV>2<6\/KO= H(^@)/X5WX?$*6.CF,]%)3?RBK?H>
M9B\&XY7+**6K@Z<?^WIRN_S1GZGI=S\8O$_C?68I2UOIMLTEJ<\$(?W:\<?,
MB.?J?QKV#]GWQ6OB'P#!9NY:\TL_9I Q).SDQGZ;?EQ_LUYY\+O GQ$M/#,5
M_P"'=9TW2K/4?WQBN%#2'!*@G,38R!D8/0TGPA2]^&/Q:NO#6K20J;^(1EHI
M,1-)C?&PR!G(W*!@'+8]C6 G4PV(HXFI"2]K=2;V;D[QMK^:1GFM*EC<)B,'
M1J1E[&SA%/WDH+EG?1?@WJ4_'7_"/?\ #06I_P#"4?\ (%VQ^;_K.OV5-O\
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MY&<9R/<"N0N/B3?>'?@GI/B+3].TRUN)9/+^R10,EL@+N#M16!'3/7J36_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHKY1_X)N?$'Q+\2?@;KFI^*==OO$&H1>(Y[:.YU"=I9%B%M:L$!/8
M%V./]HU:@W%R[$.5I*/<^KJ***@L**** "BBB@ HHHH **** "BBB@ HHHH
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ME_>_#_@G9T5QE=G6U*K[2^ARUJ/L;:WN%%%%;G,%%%% !1110 4444 %%%%
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M-<S8*.5WY0L5))50 %SG 7K@_)G[.E_>?M$?MO>(/BII5I-8^&=+C;+R@(9
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MOX,\<>/KR$0WGBWQ#/=$?>/EJ2>7/+8DEF'/H3W->F?M>_\ )M7Q _[!Q_\
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M]BUJ7_I+)7?45G4KNI551K:VGH:TL.J5)TT][Z^I\9?L._\ )F_C'_KXU/\
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M  KH**/80#ZU4.?_ .$?N/[\7YG_  H_X1^X_OQ?F?\ "N@HH]A /K50Y_\
MX1^X_OQ?F?\ "C_A'[C^_%^9_P *Z"BCV$ ^M5#G_P#A'[C^_%^9_P */^$?
MN/[\7YG_  KH**/80#ZU4.?_ .$?N/[\7YG_  H_X1^X_OQ?F?\ "N@HH]A
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M^OD/_2D?19)_$K_]>JG_ *2SV"BBBO8/G0HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** /)/V:/V>-._9I\"7_AC3-7NM9@N]
M2DU)I[N-496:**/: O&,1 _B:];KS[X)_'+PM^T!X5NO$/A*6ZFTVVO7L)&N
MX#"WFJD;D 'MME7GZUZ#5SYG)\VY$.517+L%%%%06%%%% !7C_B;_DY?PG_V
M#'_]!N:]@KQ_Q-_R<OX3_P"P8_\ Z#<UX^9_!2_Z^0_]*1]%DG\2O_UZJ?\
MI+/8****]@^="BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K+
M\/\ BC1O%MD]YH>KV.LVB2&)I]/N4GC5P 2I9"0#AE./<>M:E?&/_!*;_DWC
MQ#_V--Q_Z26E:*%X.7:QFY6DH][GV=11169H%%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110!^4_P&_P"4HNI_]C3XD_\ 15[7
MZL5^4_P&_P"4HNI_]C3XD_\ 15[7ZL5VXOXH^B./#?#+U84445Q'8%%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 ?&/_!*;_DWCQ#_V--Q_Z26E?9U>
M8_L_?L_>'?V;_!E[X9\,WNIWUA=W[ZB\FK2QR2B1HXXR 8XT&W$2\8SDGGT]
M.K:K)3FY(RI1<(*+"BBBL34**** "O'_ !-_R<OX3_[!C_\ H-S7L%>/^)O^
M3E_"?_8,?_T&YKQ\S^"E_P!?(?\ I2/HLD_B5_\ KU4_])9[!1117L'SH444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>"?L9?L]ZS^S9\+]4
M\,ZYJ5CJEW=ZQ+J2S:?O\L(T$$84[U4YS$QZ=Q7O=<]X)^(/AKXDZ5+J?A;7
M;'Q!I\4QMI+G3YUEC64*K%"1W =3C_:%6I-1:6Q#2<DWN6=8OY[6Y5(I-JE
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M4I/?5?(]*CIBJL5MH_F=#6SX=_Y>/^ _UK&K9\._\O'_  '^M<U'^(CHQ/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^OI2HPDIIM"Q%2$J32:-.BBBO2/&"BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MU6XM5O8K?[!=3[H6=T#;HHF4?-&XP3GCIR*XO_AX1\ /^A^_\HVH?_(]>O\
MBOX3>!_'FHQZAXF\&^'_ !%?QQ"!+K5M+@NI5C!+! TB$A068XZ98^M8O_#.
M'PE_Z)=X+_\ "?M/_C=4O96]Y._R)?M+Z-'>:;J-OJ^G6M_:2>;:W423PR;2
MNY& 93@X(R".M>4_$S]K;X4?![Q3)X<\7^*_[(UF.))VMO[.NY\(XRIW1Q,O
M/UKUJVMH;*VBM[>)(((D$<<42A510,!0!P !QBN4\3?!WP#XUU1M3\0^!_#F
MO:DR+&;S4])M[F8J.BEW0G [#-9QY;^]L7+FM[NYY+_P\(^ '_0_?^4;4/\
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M_P#*-J'_ ,CU]!WME;ZG97%G>6\5U:7$;1303H'CD1AAE93P002"#US7 _\
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M^$_@OX:7Q!XRU7^Q](:X2U%Q]FEGS(P8JNV)&;D*W.,<5Y)_P\(^ '_0_?\
ME&U#_P"1Z]R\4^#M \<:8-.\1Z'IOB#3Q()1::I:1W,0< @-L<$9 )YQW-<E
M_P ,X?"7_HEW@O\ \)^T_P#C=*/L[>]>X2]I?W;&M\+OBWX3^-'AIO$'@W5?
M[8TA;A[4W'V:6#$BA2R[945N R\XQS5;XL?&OP7\#M&L]6\;:S_8NGW=Q]E@
MF^RS7&^3:6VXB1B.%)R1CBN@\+>#M \#Z8=.\.:'IOA_3S(93::7:1VT1<@
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MJ'_R/75_#/\ :V^%'QA\4Q^'/"'BO^U]9DB>=;;^SKN#*(,L=TD2KQ]:VO\
MAG#X2_\ 1+O!?_A/VG_QNM7PS\'? /@K5%U/P]X'\.:#J2HT8O-,TFWMI@IZ
MJ'1 <'N,UH_96T3O\B%[6^K19^'WPR\+?"K1IM)\):):Z#ILUPUU);6@(5I2
MJJ7.2>2J*/P%=/116+;>K-4DM$%%%%(84444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
; %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>camp-20241231_g14.jpg
<TEXT>
begin 644 camp-20241231_g14.jpg
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MZMWD= E       /U(XX_]/,2_P#!:[_LK8\]D^.?&^B<M_M5_3'J28:U@
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MG[<NS[)N1_JY*^!M_P#=_*#M6+YH3]GYS]N?0]JCRKZ^
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                            X6K:A2B2:C21GM3VGIZ"UT 4YB?*F?2>
M0:O#,YQB%3'D<&=:5D2%-.98U\> XE!?.2"03:2>W?JUM+-.[N]NNA+ Y-YV
ML,0Y'C\>4I8^U)76L6+LS)+%VM:4])D.,HCMFVPZ6_1!+U7H6BNT#18=IRMQ
MC16#U1>9G1UMO&,D2H,NRBL/-+,B5HM#CB5)/0R/J0(;;%LMQO-:HKS%+)JU
MJ#==CIF1S,VU.,+-"R29D6I$9=I=#[2U(!N@
M
M             S(NWI_[0  [>I
M                                   /A[QO!<\OM\QM5X7B:[-^G=W:
M==->W0!0_'W%G,F(761W]K?8Y:WN0M2G9%X[#F+L/-FUMAM;E.DA,1A9)_4M
MI3W>G;H9$L[/N+^4\WA/43N24B:#(ZN%796EVK,Y+#\<R4^_7.)41J)U6IH1
M)4KP^U)Z@+$=XVX_DJ2]88Q56,PD-MN3IT&-)E.^$@D)4XZXV:EJT274S!"
M^S"TS'X[L6([:66&LCO4---I)"$(3/<(DI26A$1%T(B!,KG!
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M3/:HT*2I*B(TJ2I)I4D^I&0(;L
M     'FKVC*S)T<@\1WCV1.)Q0\VH843%V&2;;5*6MU;DJ0^2MSAD220VWIM
M+51^D$OGVN<BG2L<Q/#J"5'D0;[+JRBRN.4U41OP)"5N(B3)#!FY';?-*=YE
MHLT%W>T!C\.Y/F5'Q1(J>*\+/(;+&\FL\>LZ6;D"3@P_*&2EG739+6]V(2EI
M)E#FKB=3)2CTU 3GCKEW/;_DJ=QGR%A,?$[>/2)R%A<:U:M4N1U2BBDE7A-H
M))[MQ]3UZ>Z"%S
M                          IKV9_]0+3_ &EO_P"T' 3*Y00
M    (G=9)DM9;1*V-11Y3-@\MB#(58>":C;96^HUH\NK;T0HNAJ] H9<^6EX
MK%(GBG9[W@UZG0P\OBO2;3>8X8UGW=>G3YDGBKD.1FERVDL2E(2;S*%^*E"S
M+JDE[4[B(_3M(7:S,QMV2HVB(F=)UAVC)B
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M:E*-2S4I2E&>IJ4HS,!4L+_C&L_]WC']L E>X(
M                                        !BV%E75,94VUF,08:/AR
M)3B&6D_=4LR(@&+49+CN0$M5#;PK0F_Z0X,EJ22?N^$I6@#:     *:]F?\
MU M/]I;_ /M!P$RN4$             ",9'_ *QXA_\ G2?^P2!2S_[F/QS_
M *97^7_VLOZ8_P!54G%U0
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M O1Y*=_A:%6_^]3Q6_!=Q_[%_'7_ +DK%I2
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M-MU2B?6=K$;89\)))-)Z*2>[<HM"[-0%C @
M  !P>I$9D6I^@@'E/%LYYBS6O*_D\M8EB3\B2^TYBS\6*](@+8?6T<=U3SJ%
MFHMOW]=2/J0)77S1G>3<<X/(R3$\:=RBU0\VSY)DG%$RTLE&J0XEI*EJ0C:1
M&2?C=I%J!#R_07UWSOR%C&,YER85GCMS"FS;3&L7)ZD:B2(>S9%?-Y*7W-QJ
M/7>6O=/:>G>!+W%V="[ 8@    "B(7_&-9_[O&/[8!*]P0
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ML1VFW5.(63Q*;,U&HB2I.G9HH_< 62"    %->S/_J!:?[2W_P#:#@)E<H(
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M&K94BD?6>B46L=R*G_[JB\(_O."8YS''Q:T_5&GIW>DGD<L[:Z7C^F=?1O\
M0D,69$G,E(A2&Y,=7P765I<0?W%),R%NMHM&L3K"E:EJSI:-)=PR8@
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MR)2'2E'#8T)"64?JB<-/>W=#/J1"7HD$    *:]F?_4"T_VEO_[0<!,KE!
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MTU;94HEK+I^20#A648RF]3BZKF"G)5(\5-,<EDIQMZ;MQ,;O$TTZZ[0&V
M                          <'H9&2O@Z=?N /!B9O';B?H5"Y"RN]X6AV
M&J,3A8^Y*C/-,2O'*.FR3^L6QXB?B=2[/08,GL3CW F< K;9@K%ZUL[RTEWE
MK8R2)*G)4LTET01GM0A"$(26OH!B\>8WGF.VL;S>;<RYZQEA3)+=BSCRI#U*
MMQJ0M!*AFQ&<2;*TD1H[.A_!+L!D]Y@Q     %$0O^,:S_W>,?VP"5[@@
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MPJ@      QU08*U&M<9I2U'JI1H29F?K,S(1PPGBED$6G0NP2@
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M=-/U1[6>TXEYM#J-=BR)2=Q&D]#Z]2,B,OOBY6T6B)CI5;5FLZ2^QDQ
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M64R;Q2O"033K^Y9QT&:5*9;23;FA[5$8#UL#$
M     ,B,M#ZD?:0#Q929;F/&\,\-J^:,!A5E3(D(9K5,.OG%2M];BHZ3(E*,
MD&I24I4I2B[-P,GM+H9=>P_08,7G/%N*?:/PNHCXYCF>8_$H(;CJH4(ZI3B6
M&GGE.FTDU:J-*369)W*,].FX$O1H(     %$0O\ C&L_]WC']L E>X(
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MMMVM+A)F;):.I-/^<:H(R,S/S!]>A^@<ON:?=W_-_JETN]H][S?Z82\>C<
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MM%7N92VDFV[I45DYR4D6TB)\T[RT+H7>[.@#=@
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M]>UU#4A!DAY'4C2M.FH"#U<F-+]L&R>BOMOM'QXP6]I:7$Z_/'89I,]#!*_
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M:\DQG5FY>3K"H7,=0X\I:%.J<0XI:T)42341Z'IKH78#)[-/70]"U/T$#%Y
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M:O7H1$0QBL1.O6RFTS&D]#O&3$
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M=I#2#DSC-+:226OG'B["]PM!5Y6(C'Y9]<N;W;6*X(TC3;;_ %2E(M.D
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M1"K8S<6*CX+3222G[O3M/W1UJ4K2-*QI#BWR6O/%:=990S8
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M;F_Q>]KJ1#3,4^A&GQ<5O]4[U#EYO]&.*M8VWVQ;6=>.=\:1Y-KT$*C:
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M]H[5<-:S$Q^6-/(\];/:T3$_FGBGQ_Q+=C<T
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M.MJ(^-9MU$O%3DQ7&+^.U$<0[Y5LFDDRH]4$E,A:]^TSU(^P!>P(
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M+711>@Q=B=8<^8TG1VB4
M     #SWR3R<EV)S90Y/C5=D&-8%'HGHE=)WI\Y\ZLD^YXZCWDDVUZ&VIM)&
M6GKZ@E:?'7'V#X'3DG"J"-1MV2&I$Q+&Y;BU&G5)+=<-2U$G<>TC/0M3T[00
M@?M/4\B[PS'X<>G<R/;D<!U[&T2VX*+%EM#ZEQW%N.-F9*+JE*-RO$))[3(C
M!,-;P905]5E<^3$X5=XW<77K;.[=FMRB>2;[)G&VI,S+=H3FO9W/N 2O\$
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M9PY[N@
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M0([48GC+::R902"/34]-=/6.5>W%:9ZWJ*5X:Q'5U;(\S/&#,
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M8B9WS,>;1S^7[JY;'S=K5K\,5F.J)GB]FSJ7 .8](
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M-M,U+(R29D2R2HRU4DP-5J @
M   !YXATM:?M73\?\'_N1G"6+5N#N7X29_SKL\?377?M[OW!5[+BUUX8U7.V
M9N'AXITZGH<6E,  &'9G:%"=.F)@['IX)2]Y,GUZ[O#[W9ZAA?BTGAW^%G3A
MXHXM=/!O1[#JG*:7QH=L<!5<M;\E*HIO&]X\ATW#(]_=V%N,O7V"OR^/)36+
M::;9V:],K7,Y,5])I%M=D;=.B-.A+1;4@
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ML/L(!@/<D<>1K%VHD9;2M6S+IQWH#EC%3(0^2MAMJ;-S<2B5TVF6NH"3@
M                                     *(A?\8UG_N\8_M@$KW!
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M/OEZ#-6HF'I+^97"_J_E?_E^=\@$:'\RN%_5_*__ "_.^0!H?S*X7]7\K_\
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M9QVK9B8G#^EN136(4=N3/N)KJFH34EU"$N*2@B7)41J,EJV[B/0$/0@(
M                                <&9$9$9Z&?0O=/M <+6AM"G'%$E"
M2-2E*/0B(NIF9F Y2HE$2DF1I,M2,NI&1@*)A?\ &-9_[O&/[8!*]P0
M
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MB_\ 72OE 'TS]L;^[/%_ZZ5\H ^F?MC?W9XO_72OE 'TS]L;^[/%_P"NE?*
M/IG[8W]V>+_UTKY0!],_;&_NSQ?^NE?* 1[.>:/:GXZQ.SS7*..,;8H:E"'9
MKC-LMYPDN.):3M0DS,^\L@&^:S?VPWFT/-\:8NIMQ)+0HKI74E%J7Y0#[^F?
MMC?W9XO_ %TKY0!],_;&_NSQ?^NE?* /IG[8W]V>+_UTKY0!],_;&_NSQ?\
MKI7R@#Z9^V-_=GB_]=*^4 ?3/VQO[L\7_KI7R@$:M.;O:BILRQ_ I_'6-(R3
M)V9LFI83;.*0MNM0EQ_>LCT29)5W=>T!)?IG[8W]V>+_ -=*^4 ?3/VQO[L\
M7_KI7R@#Z9^V-_=GB_\ 72OE 'TS]L;^[/%_ZZ5\H ^F?MC?W9XO_72OE 'T
MS]L;^[/%_P"NE?* /IG[8W]V>+_UTKY0"4\%<HYER(YF55G=+"H\AQ"T34R8
M]:^N2RI2F4NF>]7;INTZ +?!                            ")\G9@Y@
M''V1YDRPF3(IH+TJ/'<U\-;Y%HVE>TR/::S3NTZZ (-Q!F^<3\JO<$SV=$M[
M*#6U5]"M(47R1>#:MJ-R.MLEK(_!6G1"^U1=3]0)7*"    %;\WY;E>'X2B;
MA41^5D,VPA5["HT%VT6RV^Z1O.^6:T->UM*M"U+O&1:@F%80^5<ZR%&%83C.
M71'<JRNSO(T_(I-&J(]5IQ^*A]V$_5O/ZI?-:TH4:E]$GJ1'T,!;7"V=S.2^
M+\<S:Q81'L;-APIC3.I->8C/.1G%((S,R2I31J(M3T(]-3 E/00  "FO:.Y!
MY X\PA^ZP>N9\-@FW++()2VUMPD+DL,(0W&5JIYQTW="[$I21F9Z[03",\N\
MO9_CV2Y:6'R(,:FXXK*VWN($R,;[EJJS?-*F2>):? 2AHMR5)2:C7T/IV!TW
MG-&<QLTF7-?(A?9[4995X7*HUQ3.6^5BRVMV;YG?JE;:W2)#1(VJ277KVC1Z
M1!   -#F-EDM70OR<0IT7F0*4AJ)"?D(AQTFXK:;KSJ^QMLN^HDD:E$6B>I@
M*#1S#R;-X$P#+ZE#T_,LHLO*V<ROJ%V:H\-+TKQ7D0HYIW&E+2$$6Y.[7M($
ML69S%R!;UM95X5E,"9:1,=NLOM[Z13J8*3\T23816G"<>(XRR5JA]9J4HM"4
MGIVC1Z#P+)CS/",=RU3)1EWE;$L'(Z3-26UR64N*01GU,DF9D1@A(0 !T3E3
M$0I*Z]MMV>EI9Q6GE&VTIXDGL2M2249)-6FID1Z$ \QRN9^3L /.6LILZK+)
M6-XVW<3U5L)<:)47TN2B/'K%N)<,WD*)PW-5;7-J/0"=';*Y?Y/QGZ28#;V5
M?9YG'M,8JJ;)4PCCL)++$J-2W8B7#)1Q3;62.^6_NFHNT@%I<,9ED645^3U&
M6/,S+_#[^;CTBSC,^6;FMQB;<:D&R2EDVI:7-%(2HR(R[0)68"   4/E&9\K
MXSRAC]<]9U,JNR.^165N#PXRGIOT>)&K]L]+-25(6SHI2F_#\/3H2C/4$HS7
M<X9G%S'()65SG:K'H$C(%X_CDO'Y$5-M#IF'EM%'M7%DDWC)!.*1X79T(^O0
M:)'PYR7GUSEU;C>;S8=HWE6'Q,\K'H43R7D$RWTM*@F7B.&ZE*7$*2ZK17:1
MZ@+[!                                                      B
MN2\:X#F-S4Y#E..P;:[HU$Y53I;*7'6#)6\M#/M(E%N22M2)74NH#HMN*.-K
MV/?1;C&*^8QD[S4J^2\RE7FY$=.UIU9]N]!?!46AD WN.8W08C31<>QBN8JJ
M2"G9%@Q$$VT@C/4]"+M,S/4S/J9]3 1MGC>.SR[)Y9*Q<.5)H$8V=5X:?"2A
MN7YOQB<UW;C/N[=- $X         8T&NKZQE4>MB,PV%K6\MJ.VAI!N.'N6L
MR01$:E'U,_2 R0       0OEKCR/ROQY><?2Y[E9'NVVFG)S3:75MDR^V_J2
M%&DCU\/;V^D!+HD<HD1B*2C63#:&B4?0SV)).OX '<       #&=KJ]^;'L7
MXC+EA$2M$66MM"GFDNEHLD+,MR241=[0^H#)         03 N-(V"9!F]^Q8
MN37,UMOGEYAQM+:8RO"2UX:3(SW%TUU/0!.P
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M&AM^C7H8&JWZ"DK\:HZS':ELVJNIBL0(3:C-2DL1FTM((U'U,]J2U/T@AL0
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M U9'&G"L7CVY.]E7\S(K")4L8S1.36H[/D*.*X;K<4O+H1XA[M-SB^\>TBZ
M:K3!
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M33<GX!D*:A=+?QIS=\_(B5#C)J-$B1#;\5YM*MNA*2CO;5&1F79J EH
M
M          ("SPGQ<QR OE%K'(Y9NXI3IV.YTTD^M'AJ?2P:_!)Y2>ZITF]Y
M^L!/@                 !7=?P3Q/5YTYR1 QF.QESCKDKS:5O&RF6^1I=D
M(CFLV4/+(^\XELE'Z]=0';A?"?%O'F06.48=CD>KO;0E(DRD+=<VM.+\1;;*
M7%J2RVI??-#24I,P$_                 :)S#,8=RXL[<KD+RPJTZ3YR-2
MS5\VJ>\P;&S=LVFYWM=NONZ (EC? '#V)*OU4.)Q(R,FCNP;AE1NO,N0GS-3
MD9#;JUI:94HS4;;1)3KUT[ &XX[XIP#BF!+K<"ID5,:>Z3\P_%>D.NJ06ULE
M.R%N+-+:>ZA.[1)=@"9
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MLD^O5I:BT])& ]I@Q
M                                          $=S7.L3X[I3R+,[)%5
M3D\W&*2XAQS5YW7:DD-)6HS/0SZ)[",^P@'QEO(&'X-1-9+E%JU"II"VVHKY
M$M]4AU\C4VAEME*UN*41&9$A)].O8 UV.\N\<Y5C]IE%/?L*IJ0U)N7I27(;
MD,T$9GX[4E+;C>NA[=R>]Z-0&%AG.?%F?W!4&+7Z9-PMHY$>(_'E0ER&4ZZK
M8\TTT3I$23/]7NZ%KV G1)<OS3&,"IEY!EE@BMJTN(82ZI*W%N/.Z[&VFVDK
M6XM6AZ)0DS[?4"&@E\T\8PL2K\Y=R%E>-6SOEJR2PT^^[(D:J(VD1VFU/&M)
MI/<CP]4Z== 3HD^-9-09C21,CQB>U9TDY)KBS&#,T+)*C2HM#(C)25$:5)41
M&1EH?4$/F@RFBR==JFBE>;*EGO5-@XE"TH1.C$DW6DJ6DB7LWDE1HU(E:IUU
M(P&X :G(\EI<3K/G>^D>6@F_'B)62%NJ4_,>1'90E#:5*,U.+270NG:?0C ;
M8!K[6\IZ0X)6\UJ&=E+:KJ\GE$DWYCY*-MELOREJ)*CT+T$9^@!CT64T>2O6
MS%-)5(=HYKE79DIIUGPYC*4J6@C=0DED1*+O(U3ZC ;@   &GFY315V15>*3
MI9,7MVS)D5,9:5D4A$$D&^2%Z;36A+B5&C=NV]2+0CT#<
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MY>AJUT 2X
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M$
M
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GMZ^8\#=X6_N[/$T[P)3\$                            /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>camp-20241231_g15.jpg
<TEXT>
begin 644 camp-20241231_g15.jpg
M_]C_X  02D9)1@ ! @$!] 'T  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" 8+"'<# 2(  A$! Q$!_\0
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M\_;_ )FNPWCT-&\>AH X_P#X4]I7_/V_YFC_ (4]I7_/V_YFNPWCT-&\>AH
MX_\ X4]I7_/V_P"9H_X4]I7_ #]O^9KL-X]#1O'H: ./_P"%/:5_S]O^9H_X
M4]I7_/V_YFNPWCT-&\>AH X__A3VE?\ /V_YFC_A3VE?\_;_ )FNPWCT-&\>
MAH X_P#X4]I7_/V_YFC_ (4]I7_/V_YFNPWCT-&\>AH X_\ X4]I7_/V_P"9
MH_X4]I7_ #]O^9KL-X]#1O'H: ./_P"%/:5_S]O^9H_X4]I7_/V_YFNPWCT-
M&\>AH X__A3VE?\ /V_YFC_A3VE?\_;_ )FNPWCT-&\>AH X_P#X4]I7_/V_
MYFC_ (4]I7_/V_YFNPWCT-&\>AH X_\ X4]I7_/V_P"9H_X4]I7_ #]O^9KL
M-X]#1O'H: ./_P"%/:5_S]O^9H_X4]I7_/V_YFNPWCT-&\>AH X__A3VE?\
M/V_YFC_A3VE?\_;_ )FNPWCT-&\>AH X_P#X4]I7_/V_YFC_ (4]I7_/V_YF
MNPWCT-&\>AH X_\ X4]I7_/V_P"9H_X4]I7_ #]O^9KL-X]#1O'H: ./_P"%
M/:5_S]O^9H_X4]I7_/V_YFNPWCT-&\>AH X__A3VE?\ /V_YFC_A3VE?\_;_
M )FNPWCT-&\>AH X_P#X4]I7_/V_YFC_ (4]I7_/V_YFNPWCT-&\>AH X_\
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M\_;_ )FNPWCT-&\>AH X_P#X4]I7_/V_YFC_ (4]I7_/V_YFNPWCT-&\>AH
MX_\ X4]I7_/V_P"9H_X4]I7_ #]O^9KL-X]#1O'H: ./_P"%/:5_S]O^9H_X
M4]I7_/V_YFNPWCT-&\>AH X__A3VE?\ /V_YFC_A3VE?\_;_ )FNPWCT-&\>
MAH X_P#X4]I7_/V_YFC_ (4]I7_/V_YFNPWCT-&\>AH X_\ X4]I7_/V_P"9
MH_X4]I7_ #]O^9KL-X]#1O'H: ./_P"%/:5_S]O^9H_X4]I7_/V_YFNPWCT-
M&\>AH X__A3VE?\ /V_YFC_A3VE?\_;_ )FNPWCT-&\>AH X_P#X4]I7_/V_
MYFC_ (4]I7_/V_YFNPWCT-&\>AH X_\ X4]I7_/V_P"9H_X4]I7_ #]O^9KL
M-X]#1O'H: ./_P"%/:5_S]O^9H_X4]I7_/V_YFNPWCT-&\>AH X__A3VE?\
M/V_YFC_A3VE?\_;_ )FNPWCT-&\>AH X_P#X4]I7_/V_YFC_ (4]I7_/V_YF
MNPWCT-&\>AH X_\ X4]I7_/V_P"9H_X4]I7_ #]O^9KL-X]#1O'H: ./_P"%
M/:5_S]O^9H_X4]I7_/V_YFNPWCT-&\>AH X__A3VE?\ /V_YFC_A3VE?\_;_
M )FNPWCT-&\>AH X_P#X4]I7_/V_YFC_ (4]I7_/V_YFNPWCT-&\>AH X_\
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MY4<T+G;\W6@!<#T%&!Z"F,[?P4Y-Q7Y^M "X'H*,#T%-D+@?(*(RX7]Y0 [
M]!1@>@J-9_G*MT%+YC,WR<B@!^!Z"C ]!3?,7?LSS3J # ]!1@>@HHH ,#T%
M&!Z"BB@ P/048'H*** # ]!1@>@HHH ,#T%&!Z"BFRLZC*CCO0 [ ]!1@>@I
MB3)*,QG-.;=CC\: %P/048'H*:7 7/>D#MMW&@!^!Z"C ]!4<LC*5V]ZD'(S
M0 8'H*,#T%%% !@>@HP/0444 &!Z"C ]!110 8'H*,#T%%% !@>@HP/0444
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M*3)D8'UH =@>@HP/05&TZK)M8TX%R"1^% #L#T%&!Z"F1F3^,4!V#D'I0 _
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M>@HP/04R%G*XE&#3Z # ]!1@>@HHH ,#T%&!Z"BB@ P/048'H**23=M^3K0
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MQ??+IGAOXA07%RW_ "S7'^->J:=>0:A9Q:C9R;XYEW*WJ* +,Q.W"]:12L2
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M 1U#+S3(9@Y* 8Q2S,ZI\@R:Y[QK\2/!?PUL_P"T/%^LI:(R[MS>E '0X;S
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MU4]<U?3- L9-2U6Z\J&%-SN>P%>6:M^W?^S%H<[:?K7Q'MH95)!4X[?C0![
MD:Y\Q0 3U-#QB1MP88[UYQ\-/VJO@K\6;^;3/ _C&&]>&,NX3'  SZ^U1>,?
MVLO@1\-KC[%XN\<0VLKGY5?_ /70!Z6L,@GWA_E]*EKQ6/\ ;\_99:,2?\+,
MML>O'^-+_P -^?LL?]%,MOR'^- 'M-%>+?\ #?G[+'_13+;\A_C2?\-^?LL?
M]%,MOT_QH ]F8_(6[BDB+;=[9KQN+]OW]E3H/B=;'VX_QK8\&?M@? ?Q]K(T
M7PMXV@N96&0BXY_6@#U ,'! H52HP34%O/'/"MU:ON209#>M6!DCD4 %%%%
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MI;2+&ORK2*B2#<RTQIW6?:Z?)ZU,"K+P>M #0 ?N]/2A3\Q7OBA1Y;;!7/\
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ML&<9%>,C_@H%^RG"!'_PLZVW9P,X_P :ZSP/^T=\(?B,P_X17Q7%<DG V?\
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MXH\;0VNH2 E(&QD@8]_<5W7AKQ#HWBK18=9T2]$UM*,QR+WH TQTYHH'2B@
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MRA@R^E &NI4/M*\^M/IH52VX&G4 %%%% !1110 4444 %%%% !1110 4444
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MC#?_ !5,?]OC]HZ1-\GB_)^C?_%5]D3_ /!NQ\;(HV:.SU0]\"/_ .M2V/\
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M%S;1SVDHD1AE74]10(G+ =:&=5&<TF]<9?CZU#/-%%$]Q/($CC4LS'H !UH
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M^TH6^3QB!^#?_%5]U_\ !$+]K+X\_$']IVRTGQ%XH$T+1IE<-ZG_ &JYP_\
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M^.FP&J>&/%-LD^8YH+I#P<8(85_2K_P;4?M*ZKKOPENO#/B34-TC2+'"I?/
M;WK^=C]I338/"WQTU?3X8<)!<C:H[<U^J7_!MW\<KA/&UEX;5W FO]H'_ J
M/Z(?V@?CCX4^ ?@2;QAXKOOL\$:OA\CJ!GO7X)_\%(O^#B[QE?>(M4\"?##Q
M7"\=O,T 'G8./PK[._X.(OVAM:\&_ F_\/Z7?20ND\@RI]@*_F@T;'CCXY1)
MKERI6]U0>:\IP,$=304CU'XB_P#!1_\ :+\;ZC+J6IZVX#L3E;E^A-8WA[_@
MH%\=-'O$G379?D8$9N7K]I_^"=G_  1\_9H^-WPDM_$NL:KX=N)WV9B>[CW'
M(/;->W?&#_@W1^"^M>!K^\\(:-I,<L-E+(C1,I)(4D8H&V?EU^Q5_P %^_C-
M\(M3M=/\3^)8TM@XWEYR>/QK]^/^"<'_  4J^&O[9_P\T^:U\0+<ZK<*&=58
M'L/>OYF/CQ_P2E^-7A3XOS>#=$\(ZDZ27TB13PV1*J 3CD"OTE_X(C?L)?M1
M_ 'XE6-[K.N:A!I\<2 020;0.OM00?OI8M=,&,J_)_!5E"2.:S/!RW<?AVTA
MOI"TJP@2,>YK3!!' H 6BBB@!LA ')K\U/\ @XH&?@</3^S'_FU?I7*0!R*_
M-#_@XN+_ /"D4*MQ_9CY_-J!H_E"UHE?$-YY77[5)_Z$:_J0_P"#;L6UY\%=
M(BN[.)L:8<[HP?X*_EQUZ1!K5YM3G[5)R/\ >-?4G[,__!4_XV_LUZ##HW@[
MQC?6D<46Q5A)X&,4#6FY_9P=*TORF\C38,^\*_X5''I6GHADDTVW#@9(\E?\
M*_D:N?\ @O=^UE.XE@^*FJH!U&3S47_#^K]K7ES\5M6.1TR: T/W4_X+N_$[
M]F_3/@M=:5X]N8H+]M-=;-4B09?)_P#KU_*1X\N-.N/%-[+H[;H6NI2A]MQQ
M7MG[4W_!03XX?M0+;P>*_&%[=+'D$3=^O^-<#\!OV?/'_P :/&=OH>A^'+V<
M7!_UD5L6&<CV]Z >Q^Q'_!J1X+U34/BWJ%W;HQ']GENI_P">;5_1%IT,\=FD
M-RO*H!7YM_\ !!K_ ()_:M^S#X$L?'>IQ"&XO;$K(C* P^3'(_&OMO\ :Q^,
MEG\&_@YK'BB:[6.6UMMZ'=@T$GAO_!3'_@IM\/?V*_ %W/+XA2VU* NI5F [
M5_/%^W3_ ,%T_P!H/XZ^);BW\.>($>RCG(0QW!^[^'UK@_\ @KO^W-X[_:)^
M/NK:6WB.>33YI#LA+97)8UZ#_P $CO\ @D;XA_;(UXZO=7""VMY5>995&&7C
MU^M 'R>W[=GQTDNCJ[:[-Y@)_P"7I\5]+_L>_P#!;[X^_ S7[:>X\1*L1D19
M#)<$\9P>M?M#I?\ P;I? ^#28M.G\.Z2TQC7+Y7KBORP_P""QW_!%_4_V3;9
M_&^@/$EG+<_NHX%&% ;VH _:C_@EK_P5P\%_MA^%XK#6_$B3:B0L:JC@_-T-
M?>\GE118<\ 5_%E_P3A_:]\>_LW?'W2+.RUZ>*UCU B>). <&OZU?V(?VB8?
MV@?V>K;QV9"TDT#-ECS]S- '!_\ !2/_ (*,^$/V.O!#Z@VN);W<ELS0!V R
MP)_PK^>_]MO_ (+W?&_XVZS>OH_B5'&YTC\N<CC.!TKK/^#C+]ISQKXF^*W_
M  BEMK4R6]GJ#1-'V(^8X_6OE;_@EU^S]X#_ &AOC_I'ACQKJ%C;6UT_[U[Z
M547.Y1R3]:!K<\_U+]OWX_:C<-J%UKLH+^ET];WPM_X*:_M ^ _$UMJD6O.$
MBDW$O<M7] GP]_X(._LK>(/#D)LX/#UZS)P\-PC9X]J^:O\ @I'_ ,&^NC>"
M/AQJ7BCX;:+;%X+7>B6:!B3CMB@K4R?^";?_  <:^++_ %^Q^''Q,\5PI8@(
M#^^R<GCO7[>?##XW^&OC%\)U\6^$K[SS<:?YKMD?TK^1[X%?\$L_VFM<\4VX
MT/1=6T^975O/:R([^XK^C#_@BY\#OC/\+OAS<^'OBIK=S=(MD(XTN$QC[M!+
MW/RY_P"#@_\ :7^*G@/XU7-CH&HO'"+9SA9F']WTK\=O&_Q,\0?$:Y:Y\1W)
MDD9MS%G)/ZU_8-^V?_P2H^%O[5-Y-KFM:!9&9D*^9/CO]:_F8_X*T?LN^'?V
M9OC)J_A#0+>!$M+P(/)(QC=CM0(^7/!OQ!UOP%=K?^'+@H\;9!#$<U]@?\$Z
M?VU_C7K'QWM-.EUB1E+1Y!N&/\5<1_P3"_9Y\/?M#_&;1_">M6T+Q75YY;B;
M&#S7]$W[.7_!"GX+_#?5H/%MCX:TT2J5_>)MSQS0!]E_LA:U?Z]\$M U35F)
MD?35=SGODUX)_P %-_\ @K%\*?V)/"]_I5WXG2VUZ*/?!$SJ.,>Y^E>K_M-?
M%7PQ^R3^SQ=%'BMS8:.WD /CH>U?R=_\%4_VX/&'[6GQWN];76IWM$:6$PL<
MYPP']*!K<^H_VR/^#B#XV_&VVFT30O$T3VV3L,<Y!Y^E?#>M_MZ_':\U.6_G
MUV7=)(6&+E^YKT[_ ()P_P#!,[X@?M=>-X+6SM9DMRZ,S/#\I7J>37[G?"#_
M (-OOA7I7@RU3Q3H&FW5S+:H2[[<@XH*OH?A'^SE_P %7?V@_@_XSB\1)KS!
M4 Y>Y;L?>OUQ_P""=/\ P<A:A\0M;L?!'Q9\6PJ&E6&$+*#G/U_&N5_X*7?\
M&\MIX#^'5WXM^'6FVZ%&<K#:(&8 #/:OQ&UW3_&?P"^*MQ9B.XL9])O\;VCV
M[B .E!+/[B?A-\5/#'Q@\)1>)?#UYYT,D:$L".I&>U2_%2\N=-^'&O7,)P8]
M'N6C/N(F(K\2_P#@WN_X*F:AXLM=-^%'C369)YIYE :=R. <?UK]KOB%?VVL
M?"37M2A8/')HET5(.1_JFH$?R4_\%-?VOOC/H7Q^U2P75Y8XDU2=4"W##@,:
MV_V+/^"M_P 6/V?;2'Q!=>(BB+%MW2W!/;WKQ_\ X*O-&G[0FKATY.K7&/\
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M["'_  <R>%=+T>QTGXI6,]].ZA))IV89)XS0-GZA_P#!1S]D_P &_M!_L_\
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M!^S_ /P;1_ \0_$#1/&*VIQ#<#YL>K _TK^B3Q#??V%X?O\ 5\X^RV4LH/\
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M?AWX;N'$2A[>;RV)!(!%?EU^QS\"?$'Q\^+5IX6L-,FG\QT/R1$@C=0!]_\
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MM*R)K=Q' JSM]W>0*_KC_:F_9_UOQ#\"X?AUX2N?LZ>4\16,<88 5^??[/\
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M^%+2R\1>((Y[\LD2JC@]./Z5_,_^WI^S++^S5\6M6\,SJI2&^,:!1P*^G/\
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MYT ?M\'E,94_>[4^/)3:XY]*;!/');I.!PR!L_44Y3O.Y30 ^BBB@ K\"?\
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M^*_B)-<6C YC$,G<8_O&OE+QUXWU_P ::W<ZWX@E>2:YE+LQ4C)/UH _HO\
M^#;;]L#4/&W@'3OAW<7(/G7"#;NR>"1_6OVD;9Y8#G&*_E!_X-^?VJ+;X/\
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MG^):_K[_ &7M/N-$_80CLKD$.OARZ!&,?\L30!_)U_P5I(/[1FJJ>!_:T_\
MZ$:WO^"(%A8WW[8UI#=P)*FR/Y9$##[Q]:P?^"M"E_VC=5 [ZM<?^A&O1O\
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MY<F.W15'S'/8"OO#_@WS^.$WACXXKI2WI7/EIC?Z@BO0+W_@U%_;$5O*BO\
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M?M6:K+I>/*8D#!!_C-?8G_! ']DK0?B7\4E\0:[I0G^RWJ2(<#C 6@#]0?\
M@@1_P2(\-_ ;X;V?Q1\;Z<T>L0S1R0P7$9;(;+=_H*_6%+6.S %I"J+_ '57
M 'Y5D>#/#=CX3\.V6G:1$(X4M8P5^BBMDS$(">] "DHJ>83C'6OYT_\ @Y^^
M.&L:7\6M?\)6ERQC61\)OX^\1TK^A?QQJO\ 8/A2[U7=M\J/=FOY:_\ @XL^
M($?C/]I+7IVFW[G;O_MF@#\Y/@O92^)?C/H44Z9-SJB!A]:_K@_X)*_L_: W
M['G_  C&J6,>RX,#,KQ Y^1O7ZU_+?\ \$\?AK_PL7]H/P_$+?>L&LQ9&.G^
M<U_8Q^QAX%B\"_!>PTFVA";K2 X_X!0!_+3_ ,%W_P!E?6/A)^U;XF\46FD&
M*PFO@(9%7"GYSV_&NI_X(&?M;7_P4^*UCX9NM2,<%WJ/[P-)QC=FOTZ_X.7_
M -D2P\5?!F+QAH.CDWKW1DGE5-V0'4]A]:_GE^%_Q1NO@;\1&U"WD:&>QO6P
MP!X(- '[!?\ !RC^T?X;^)OA;5M$TS4TE9IG("X]:_'3]FOP/)XW^*>CV2(6
MQJ"# KJOVG?VL_$?[0%S/-J^I-,)22=V?ZUTG_!-#1!KO[0.A6/E%@^L1*0!
M]* /ZH/^"*OPX_X5W^RLFCS6_EL[0M]WG[K?XUYQ_P '#6M7&D_LN0B!RNXR
M D''<5]=_LD^"(_ ?PCT^P2'8'LX&P/]S_Z]?(O_  <.:9_:7[+,#1QEL%SP
M/<4 ?R?ZI =:^*U]:2<^=J,F?S-?TB?\&V/POTWP[\*]#U1!B7RT!)'^R*_F
MYUF_3P_\5KZ^FSB+49"<?4U_1?\ \&V7Q^\,^(_ FA^'/M2K+Y2</(!_"/6@
M#]F=SL=J#@=Q7YL_\%_OVC]1^%?P)UW0-+U62VF>W#*T,I1A\A[CZU^E,4T)
M02Q$$,,@@U^<G_!93_@FM\=?VV[RXC^'E_:I8S6VQHYTSD[0/[P]Z /YA=>_
M:F^+=WXKN;Z/XA:WM;E0-7FQ_P"A56_X:]^-.XD>.]:^7I_Q-I?_ (JOTP3_
M (-//VS-2OWFL]3TI4QD[H1T_P"_E?,_[?7_  1P^*_["]NB?$'4-/DDDAWX
MMRH[9_O&@#YB?]J/XU^(KA+5/'FN!FD'W=7F]?\ >K^A7_@VOL/B7JN@W^J>
M*]1U"Y1[8,C75V\G9?[Q-?SK_ 'PU;>(_B5:Z4\&]6E3@#_:K^O'_@D#\ K'
MX0?L^:#KEM9"(ZEI*L3Z\X_I0!]AP %5:1L$*!BOB;_@LE^VKIW[.'P+N)=,
MU1%N;B&6%D) ^\-O]:^N/B7XWT_X<>&9_%6LS*MM /GR^.Q/]*_EX_X+\_\
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MC#!T_P#B* /YT/V#_P#@AM^T%\9O'VGZCX]\ WEK8+=H[2*6P4XYZ"OZ6?\
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MPC(Y'?%?I9JJ12Z7<!XU8>0_!&>QK\[/^#=US+^S[= ?\^L?\Q7Z)WZE-*N
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MR5;CGV(H _NA\+77AC5]*CU;PO# +:0?NV@B50?RK0WN3EQ@#O7Y5?\ !O\
M_M^_$CX]_#[2_#_Q,\3&^E6T+,.1SL]R?2OU3@D:YA$A;Y6&0* ')([284?+
MV-2+U/UJ*"-T; /R^E2KU/UH X7]H_\ Y)+J/^[_ $-?Q[_\%B./VOO$^/\
MGN/_ $)J_L)_:/\ ^22ZC_NC^1K^/7_@L1_R=]XG_P"NX_\ 0FH ]!_X(0_\
MG2>&/^PRO\J_KX7_ )!8_P"O?_V6OY!_^"$/_)TGAC_L,K_*OZ^%_P"06/\
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M?>I@>4%2"?8FOGRQMM8UN800W,TA)QAI":];^"?[%WQ=^->O0:!X7T4S//\
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M_EFCX'W@?Z5_1A_P<'?\$S-'^-G@%/'?@W0/-N;"U>>=UBZ-EO3ZU_,?\1O
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MS>]?.W_!<#_@CC\2X/%%]\3?!N@3-%=SO<R/\V,<CM]*_'V/PS\4/V?/%?\
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M0!^+,'_!HO\ #8NR2?&*(8Z?*_/_ )#KX?\ ^"KO_!#WPQ^Q)X>O9-'\8IJ
MA@WB15;^[GNHK^H,JLARYK\JO^#CG0K63X(Z[K<Z<1VP&['^P?\ "@#^;?\
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M @HU?._[1W_!-']G;X[:;<"Y^'>GB[GC/[^0<[CWKZ04R$Y9:=)$)""3T]*
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MR[\NM 'XF_#?_@UK\3?#WQ3:>);#QY9J8+F.0A"F2%8'TK]9?V9?@CJOP1\
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MT'?,@93BGEE/':A5Q],4 >$?MI_LES?M/>"+OPQ'?QQ"XMO+._'I7Y:^(/\
M@U/U/7]?_MZ/QC8JA8'82GKGTK]OF6-/E9NM'S1IB-<B@#Y1_P"">_\ P3<T
M7]B_0C82M;3RF$*7CQUX]/I7U9M)4+&VW P!3C%O&[)R.U($&?.EXQ0 Z-@1
ML<9Q7S;^W]^PEIG[9GA&XT*<P)+);>4DDN..,=Z^DB1CS(^<T*\4AR#TZB@#
M\,[S_@TSU.\E$\/C2PC&<XW)_A7WS_P2Z_X):0_L$0:@E[>V]VUU'@-%CKA1
MV^E?:;*LAV]O:G#:@VB@".*3<N[;@#C!I-OER&<<Y[4K%)4,?0GTIZ1K'&$/
M:@"CKNB:1XGTJ;2]<T]9[>5<21..&%?,_P"TG_P2L_9E^.GAB:WL?A?IMMJ$
MV?\ 2F7GGZU]3[TZ#%(,XPRX'>@#\4_B#_P:LCQ7XBN=3TKQ+86\$DVZ.(%/
ME'ITK+LO^#3RZMY@\OB_3V0=1E/\*_<!F*CIQ49?=\JG*]S0!^;/[,?_  0!
M^$GP:FB/C+0=-U-8P 00#G\J^V/A?^QQ^SU\)H(CX.^'-C93(!\\2\Y]:]/>
M3:H$0R<\Y%#VXDQ)DY'8&@!T%O%#$(HU 'H*\-_;8_9;\1_M-^!Y?">A>(5L
MB]LT3,2.Y/K]:]S#%5QWI@@*MO!)SUH _#O7_P#@U2\4ZWJ%SK>L>/K.XDDG
M=P6*9Y)/I7US_P $Z_\ @B3X5_8ZUX>(]7%E=RF+;N7&<X(SQ]:_0QY")A%M
M!!HF@CF 0'&#VH ;IUC;Z;9165N@58D"J!V J9EW#%,V%<#)XIZ@@8-  $ Z
MU\]_MZ_L4VG[87PIU+P \T,4E\@42RXX^4CO]:^@FEPV!ZTIW$;N] 'X<R_\
M&GVIOX@35H?&U@!',K[ 4['/I7Z8_P#!.?\ 8=N?V*? =SX0N=2CN#,H :/&
M!@@]OI7TA#;LDS3$G)'0TZ-F=6\P8'M0!^?G_!3'_@C7K'[=OB>_URU\3V]J
MMVQ(64KQD^]?,_P"_P"#7>^^$?C>U\5ZEXML;@6]TLH4%.WT%?L[&%"[E.13
M5D=RRLO H XOX%?">+X/>!XO"D#J1&B+E.GRC%=KM9T W<T(\4?R;NOK0BMY
MA;MB@"0<#%%%% !44B-YPD\S  Z5+4<L:2'86(S0 !(V<L5_&N(^._PNNOBY
MX&O_  G:7@A^UP>7DD8KN8X]B[.V.M-\M8@3F@#\:?V@/^#8O5/C)XXG\8'Q
M=9*\Q_C*9ZY]*^B/^"<?_!%./]BG5Y]5O-6M;EI6!!C*]@!V^E?H<")$Z<^U
M( LN5!Z>AH CAMTB2*W*@A(POY#%.AA,4Y;.!Z4J^;&VT+GW-289_O<4 .HH
M' Q10 4QU;S P;@=J?377^+- '%_''X51_%KP7=^&=RK]HMI(\M_M*17Y#_%
M7_@ULO/B'XXU#Q=#XJL8UN[QYBA*?Q'/I7[6!01DFD4[_E 'O0!^??\ P36_
MX(UM^Q#XEM/$<FL6TWV=0,1E>WTK] 8X1# (AZ8I[QD1[4I0 $VMZ4 ?(_\
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MY6\R+';/I]:]\2". EMV2?6GKO<_,* %4[CS2C@<G\Z;(QC4;?6B0;DZ\XH
MAU"PAO[9X7 (92.:_,_]O?\ X(%:9^UUXGE\1Z9J=E:227!D<N5R?SK]-(@4
M3:QIJQ,CEAT)H _$7P7_ ,&J'B+PAXK@\36GCNR4P$X"E,]1[>U?KI^RC\%;
MW]GSX)Z1\,-0OEN7T]-K2+C!X [?2O2R<I\H_"FHR,=K'GTH D'2BBB@ KX3
M_P""H?\ P22N?V]_$#:[#K5O;?Z/Y>)BOH!W^E?=E-DC60;6H _#SPW_ ,&I
MFH>'=:M-:D\7V+B"YCDVY3^%@?3VK]9?V0_V:Q^S9X @\)M.DIBMDCRF.V/2
MO7/+C8>7GI0PV,%% ";6D)<GY2.E>1_'K]C/X'_'?1;FR\4^![*ZN)HF599A
MT8]Z]?9]A^;A:K+%F4R2,0.W- 'X_P#Q^_X-A?#GQ,\3R:OX4O\ 3M/A=F(C
M&WC)]Q7GVF?\&H&H:1?I=7GB^QGB#@[,IZ_2OW'98Y%WLW3TIL+.6*%,J.A-
M 'Y]_LL?\$+/@A\$5@F\6>$=-U%X\'=@?TK[;^'/P1^&?PPL8[7P-X4M]/2/
M[BPCI76(Y.=Z].E"22&3:%^7UH 85BF;#QY*]#1(S*?)4')Z-4@2-6)SUI)'
M(E"!>O>@#Q[]L7]E;0_VJ/AU_P (/K$,,@ 8CS<8R<5^6'Q&_P"#5@^,?%4V
MNZ3XGL+:*2=G,>4Z'\*_:](XUE9E<DXZ4BE3E&XS0!\7_P#!-C_@E#H/[#FE
M644TEI<W5J!^_BQDX^E?:9VQJ$CZ#TIJVZ*-FXT^-57@-G% #L#IBD95(P13
M68B4#M3GY^44 <+\8OV?/AC\:]'EL/'?A:VU M'M0S#.!7YO?M8?\&X'PZ^.
M7B:YUGP+9Z;I*S9VJ-HQS[U^K&"BDIS2Q9=,NN#0!^&L?_!IQJ5M=++-XSL&
M3=]W*?X5]%?LP_\ !O1\,/@W+##XTTO3M456RV0#GGVK]0)2 N#4<<148*YS
MWH \Y^#7[+/P8^!^FQ6W@GP/:6,L:[=\ [5Z(XV*(8Q@8P,=JF6-5&2:0H%4
MM'R1ZT ?FU_P4Q_X(9R_MV?%:^^(L6N6MO+=@\RE<C)SW%> ?!+_ (-;+[X6
M^/\ 3?&%[XQL95L;Q)P@*<[?PK]I$:4Q[F4;J26W67#.Q&/2@#E_A3\/(OAM
MX1M?"\3+F"WCCW+_ +*@5/XT^&W@GXD:>VA^-- BO8<'Y91QS6_("[ Q]A2,
MX9=B#YAUH ^%_P!K+_@B/\"?CG:3KX0\'Z;ILTZG,@ Y)[\U\7W_ /P:?3W%
M\US%XML%0]%RG^%?MUF8X)'3WI6,K_+CB@#\5OAO_P &JT/A3Q''JNM^(]/N
MH5F#&,E.GITK]$OV4_\ @F1^SS^SMHD5M_PK[3I-0BV[+I!R,?2OIF,;!\QI
MDT;9\U1\PZ"@"OIFG6>DP+I]A (H4^Z@Z"IY[D0R+"(R0W>G>69X@9!@^U*H
M?(#(#CIQ0 DD)Z(V!]:4L%3E<XI)(FD?!SCUJ15 4+UQ0!SOQ"\*)X\\(W/A
MH80S\?-^/^-?DY^U)_P;5W7[0?Q<U/Q_#XELX?MK;L.4SU)[CWK]@FMT:42Y
MP1V% <>:5(% 'Y/_ +%G_!NS=_LM_$O3?'DOB6SF-A=B8!"F?T%?JNMLQL_L
M;')V;<_ABIWD"D+GK0'0-L!YH*Z'YC?\%!_^"#US^V5XJ?7K;7[6W+W/F?O"
MOK[BO&/@;_P:Z:E\*?B-8^.)?&-C(+0YV*4SU!]/:OV>F?80 .M/1"%WKR:!
M-W1QOP(^%LGPA^&.G^ _M"M]C&-RXP> /Z5UTA>-?*8D[N]2E6E&).,<\4A9
M9%Q'R10(_-W_ (*9_P#!#V]_;G^)=[X_M/$-M;-= C]X5R,G/<5\[_"7_@UL
MO?AMXXTKQ?=>*[&8V-XD^ 4['Z5^U2[77RG/-(KY)0@8% ')_!3X;'X6>#;7
MPPTROY%O''E?]E<5V#;4.[;R::BHWS*:=C)V'H* '#D9HHHH **** "BBB@
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M*1$/\=/HH C$;[CN/%.V!5(2G44 -"N$QGFDD1VP%;ZT^B@!K1_+A>M&'V@
M\TZB@!IB5N7'-"J5;@\4ZB@!CHY8%#CUIS(KKM<9I:* &)&R97/R]J:MOL5M
MO!)J6B@!D,91?G.3ZT2(S$%?QI]% #/)4'<!SZT_&1@T44 ,,0# K^-$JR,,
M(<4^B@!NS*;7&:%B15V@<4ZB@!BPJIR!3BI'W>*6B@! @SD]:0J^?E/%.HH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB@D#J: "B@D
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M-P=I!=>P %?E7_P4^\2WWB3]HSQ)J1U2.XMI-89K;RG#8&!Z&OJK_@W<\?\
MA/P1^T%X?UOQ3>P1+%/\S33JG\:^M ']4'AF)TT2&.4G>!SDU?C+/_K>,=*\
M]\'_ +1?PQ\6QQP:#XDT]V;HL=_&Q_(&O0+699(EE+;@X!4@\4 +.\RC$8R*
M4!F09ZT.LB2[BWR^E*KACC% T?C?_P '*/Q8\>^ /#6J-X9U*ZMPMKD-!<M'
M@[?:OP$T/]L3XU2Z_IL1\;:N6-_""O\ :LO/SCWK^PS]L']CW]GC]I'3Y[;X
MS66GRQRIMD%W=QQ\8_VZ^4[7_@A[_P $OK._@OH] \->9',KI_Q.K7.00104
MMC?_ .#?GXB>+_'GP$NKOQC=322"!/+,TQ<GD>M=Y_P7-\8:[X(_8SO-6T"[
MEAF$KX>*4H?NCN*]_P#V9/@)\'?@7X7_ +"^$MG:Q6NP BVG1Q@>ZU\Z_P#!
M>B-'_8IO1+ROFR?^@B@7VC^6#XB_MF_&S3?B%J\,7C35@!=$8_M27C@>]9"?
MMP_'%#M'C35L?]A67_&N"^+XA/Q.UI%7_E]./R%?1O[#/_!)?XV?MP^'1XE^
M'NH6\4)F\O;,H)SD^K#TH'J>8/\ MN?'609'C+5L#_J*2_XT^T_;H^.MG<K-
M_P )CJIVG@'5)?\ &ONZY_X-6OVTI;5);7Q'IRY[>6O_ ,77)_%3_@VP_:W^
M%OANXUO5]3M)Q!'N(AA!/Z.: U.%_9,_X+:_M&_ ;Q3;:E#?/<QQE1_I=X7&
M,_[0-?OK_P $F_\ @L=H/[9&E?V/X^UFV@O;>(+''"%R6.#CC'K7\IGQG^#G
MC+X&^+IO!GBFSE2>W/S.T)4=<=Z^@/\ @EO^UAXE^ OQHTU8M5:*&ZU.,.JY
MY' _I02]S^T**=+N))83F-U!##T(KB/C[\?_  %^SUX&N_%OCO6ELXX[65X&
M<#YG53@<GUQ7,_L6?&J#XY?!RT\46TQ;;!"K,3WV?_6K\9/^#D;_ (*#^*M%
MCO/A-I&L31BUO/+=0#@@N :!',_M\_\ !S/\1[K5=7\!?#:6QGM5FD@$J,JM
M@$CL*_+OXJ?\%*OC_P#$;Q#+K%UXEOX7DZI#J,B@<^QKPW2="U;XE^.4T_3\
MM=:C<DAMN<D\U]S?L^?\&]_[5WQ_\,V_BKP]J-M#%.!M$L..V>["@I'R]:?M
ML?';3+M;U?&.K%MV0#JLO^-?1'[,W_!:W]H[X)ZG;Z@M_).L)_Y>;QF'Z@U[
M)?\ _!J[^VO!9M>R^)=.947=@1KG_P!#KX^_;$_X)Q?'#]C_ ,1MX;\<V[S;
M8RS2PVQV\8[@D=Z 9_0/_P $M_\ @OQX;_:+N;;PA\5O$%I:3F,*%C"9+D<#
MMWK]4- UFSUW2[?5]+F\R"ZB61']0>17\,/[/WQ<\4_![XB:=JNAW4D$D=_
M9,*<X#BOZU?^"+?[7L_[3?P(CFO[J2633;**)C)GJ,#O02?;!8JO'2N<^(?Q
M&\,_"_0Y_$/B74!!!%$9'=NP%;=W=QVEO)=S2!8T0GYCCH*_$'_@X _X*VR>
M + _#7P/K<L,K![:X",2#DMZ4 >E?\%)_P#@XM\*_!6YN_"OP7\165_*JL%$
M@3.X<8[]Z_'7]J;_ (+3_M!_'BYFN;S4Y+597S_HEXR=_P#9Q7QCXX\<^(/B
M/KT^LZK*]S<2RNRE5)/)S7T1^R7_ ,$K?V@/VL5B/A6SD@BF3<CSVC =/4D4
M >;S?MM_&V:=YSXUU8$MD#^U9?\ &O1?@5_P5-_:#^$^NPZE8Z_>7!CQ\MQJ
M#L.#[YKZJL_^#5_]LF:R6<Z_IV94#+F->,_\#KQ/]IW_ ((8_M0?LM:1/J_B
M=TNT@)#&UMBV<?1C06DS]%_V#/\ @YO\;:UJNE> OBG/86MOYB0>82A8@_4"
MOVX_9]_:,^'WQ]\(P>)_!NMK=I)&A9E ^\1G'!K^&2XAUOP!XH=)HI(+RRG^
M5GC*X8?6OV&_X-_?^"J_BWPOXNTKX*^-]<GG-U.",!@NT,![_P!Z@EG]*YEP
M^U^E*[L& '0UA^"?$MMXR\+6VOVC9689'/TK:+YPH'.*!$N.<TQFW'"]C2(L
MJOEW&*1&\MF8CK0!(0I/)IN\H<-T[56U/5[/2K)M2O9ECB3[S.P _,UYWK/[
M5GPBTV^?3;OQ?I<<L9^97U*(']30!Z;(P !'7M35N%7_ %K8;TKDO!7QJ\">
M._\ D!:[9W&#C]S=H_\ (UH^+_B!X.\(6[7>N:U9P[>HENT3^9H V@6E;+\
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MI-N06!Y]*Y[QK\3O"O@.U:X\1:G;P(IY,UPJ#]37%R_M@?!F.=+<>,-+W.<
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M_P!: /2UV(QP>M.;<>!6;INNZ+KMNEYIFJVTRN,CRIU;^1J_YZCC!- "F1
MK'FFRM)$FZ,9I61)!O YH,J\(1UH 2V=Y4\R08-2TU5VMM'2G4 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MHS3M(\<^.]5U&V:V4D7ET7!//K7]#=Q<I$GRMD*/F/I7\VO_  :G.Y_:.TQ
M>/LB?UK^A#]H+XDZ;\*?A?K'B&XN/+EBL'DB;..102TSQ3_@H-_P4:^'O['W
MP_U#4KC7+1[^W3<EK(WS'@FOYW/V\O\ @O+\9_CWXJOM"\+&\L;8R_NIK2X"
M@Y/;!KD/^"U'[=?CWX[?'*[T=]:,M@PEC91(>S 4[_@DO_P21\=_MJ>.89;O
M1%N=-&V5LKD[!R?T% 69\\6G[4_[5[:D=5'C_P 0E'D+X^VG !_&O=?V:O\
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M63<$+YY6$>GO7JG[7_\ P;A_LLS> YY/@]X+;[5':L3NA7KSCI0!^;/["/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^R3>^.$TN%;N2XDR^/FZ U^G:JB\$#)]17P#_P '$.J6UG^Q'=HS@'SY./\
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M]G^ <JVD(8+I4F[CIRU S^4;XP^.;CQ]XYOM2O2S/]KE&6_WS7V;_P $Z/\
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M=^%8PWQ%A5NAN3G\Z 9_47_P;J> - TW]FCP_P"++72(TN&11YP'/W!7Z@+
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M'_T"OYR_"'/BW31_U$(?_1BU_1I_P=&?\B?J_P#UZ'_T"OYR_!__ "-VF?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-@M N5C-_'QQ]:_)K_@X[_;<^&U[X&MO!>CW\,TZVSPN8;D-SEO2OR#^'?\
MP66_:%\-^&H_"MEJ6I2X&T'[7ZC'K6#J/@3]J3]M6XO/%6NZ/K$MK 3*&>8L
MNW\_>@5V?)^I.)KZZO !\]P[#\6)K^EK_@U_@"^$[28#DZ6W/_;,U_.;\:/A
M?J'PM\6#PYJ<;QOM)8/UR,?XU^_G_!L3\=O!VGPP>&;K6H4ECTXKM)YR4- [
MG[7>.F<>%+O<?^6? K^4_P#X.)9S_P -:^(4 P=S=?\ ?:OZNM3MHO$6B,D;
MY2:,$$=Q7\T'_!R1^RQX[C_:&\0>,]%T&XGMV=L2*./O$T"/C[_@CA=VD/[1
M.D1W]S'$KZQ&-TKA1T'K7]?/PGUSPGI?@C3K5?%FF,QL83A;^,_P#_:K^''X
M<_$[Q+\'O%,6IZ:)8+JRG#D(V"&%?<W[,_\ P6;_ &B=;\<Z=X62YU*5"@4?
MZ5G@8'K0-;G]+/\ P4(NX;WX%:FUK(LBG3+G#QG(/[L^E?QS_MCQ%?C5KA)_
MYB\__H9K^L9/&&H_$?\ X)TV?B_Q&&6ZN-!NFD\PY.?*K^33]KB]MM1^-WB(
M+*/DUJX'_CYH*Z'ZI_\ !JB3_P -'Z9M//V5/ZU^WO\ P4J^!\?Q?^ ^L126
MJRF#29.#]?\ Z]?A[_P:GW,(_:<TVV\P<6B?UK^C[Q9X<M_&'AN^\-7JCRKR
M Q,Q'0&@3;N?Q"?MO?"EOA1\9+S0DTUXE,\S?<('W_\ Z]?J]_P;@_M[> _@
M_P")H?#'BVY"JUKY*;Y@H#,I7O\ 6NX_X+I?\$4=2>YU+XK?#JPGOGBC9@EN
MAP2PS_2OQ9L;3XT_LU^,'8V>H6$UM("0LFTC!H%=G]P.@_$KP1K^CVNL6OB_
M2PEQ L@']H1Y (S_ 'J\\^./[9_P?^!T#W>O:_8S;7VGR[]#_(FOY2_!W_!:
MW]H;PGHR:4-6U.001A!F[Z8_&N"^,'_!2']H;]H=WL(]6U0/(V=J71_QH$?V
M!?"/]JSX4?%RT6\T+Q-IT>]0VU]0CS_.O2H+JPU%!/87D,PQPT4H8?I7\C_[
M!OQ9_;IN/&5AIVB:;XBNK>2Y12RW1QC\Z_I5_P""<UM\4(O@]#)\3K*\@O6\
ML[+M\MC!H&KL^ _^#JAA_P ,Z:6K Y%^/_1BU_.!X-Q-\2H$ Q_I1K^CK_@Z
MVO8;3]G+2B2,MJ !_P"_BU_.'X5EBB\?PW*OTN":"F?UJ_\ !OPB)^PWX<B*
M\ +_ .@+7WR'\EL$9!Z5\"?\&]-U'>?L%^&[G<,D+_Z+6OOM7#9R!Q0)K4_#
M/_@Z=>1K74PI^7[$<C_@(K^>[P2X'B[2!&N&_M*#)/\ UT6OZ"/^#IJ]D']I
M1"/Y?L1Y_P" BOY]_!DBGQ?I#+VU.#_T8M FM#^N#_@@,TLG[.C>8?\ ESBQ
MG\*^OOVBG,?PZO59<CR).G^Z:^0/^"!-TEY^SBWED#;9Q X_"OMSXD>'H?%7
MA&ZT@O\ .T$GU^Z: NS^,O\ X*E2K)^T[XL"H1C6GZ_[HKZU_P"#;?4M,B_:
M3\.65[?P6Y:?.Z>55 ^=?4UX]_P6=_9B\?>!?V@_$.OCP[<&VN-6=Q*1P5QU
M_2OE[]G;]I?QA^SGXLM_%WAB6=)[-SM$4FT@Y_\ K4!=L_N.TCQ'X6BM4M8_
M%.FR,O9+Z,D_D:U8)HID+(05/0@\&OY:_P!A#_@KO^T7\5_C!I^AW+:C)%)?
MP*^;G(P7 />OZ;?A9JM]JOPY\/:E<1'?<:7#)+GU* F@1U6%V9 IK-M[4^0@
M+3 0W44#2N?B?_P=%KN\&:P_86G_ +)7\YG@Q"_B[3>W_$PAZ_\ 705_1A_P
M=&7IA\*:O $!!M/_ &2OYS_"IW>*=,9./^)A#G_OL4#9_67_ ,&[A'_#/%SS
MTMT_F*[S_@O2Q/[%%Z ?^6LG_H(KSO\ X-U9T?\ 9UNPK9/V>/C\17>_\%[9
MC#^P_>,PP?-DZ_[HH'U/Y%?BX,_%#6,_\_I_D*_>'_@U8E)^']K$ <?V@N?^
M^FK\&_BZ0/B5J\B-DF\.1^ K]W/^#5._(\"VL<D8 .H+R?\ >:@39^^J\G:*
M5E/0]Z:Y5,2*>":69V10P&>*"1JG9+MQTI66-07(S3H&,B!V3!H**O+-Q0!P
M?[0_P_M_BS\)=0\&3PAUN2,JW?@C^M?R4?\ !9_]F.;X*?'_ %Z[M-&>)&O
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M2HK*SCL[<6T;?='2ID8MG(H$",KG<!S3J8)/GVA?QI] !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@<\?_7K\Z/VZ_P#@@=\$OC>)M6\ >#@VI3R$S,T:^OL*_3,1+&N\)DT>5O\
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M<NTG&V@#\?\ ]B7_ (-ZM*_9_P#&D/B?5/"*1-$Z.&$0ZJ<U^MOA+1_^$?\
M#%GHB+A;2U2)1CI@8K3!R2H%((V4$ELT - WQ#<.]1SS"%E7/6I)"TB[0"*8
MH#G#IG;T)H&CXA_X*I_\$V+K]MS1;RTM='6Y>XAV#*9_AQ7YLZ/_ ,&LOBC3
MM8M;[_A"H@L5PCD^3V# U_0.?O =J0,68J5XH'<^;?\ @G1^QS#^Q[\-Y/"S
M:<+=I(E#*%QR*WOV^_V:1^UA\#)_AQ#9"<RNQV$9Z@"O=",_*PR#2JJH-JC
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M3^% 8R':1B@:/RA_X)J_\$+Y_P!D;QG;^);[PRD#077F!A'CO7ZP$$+A*"H
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M* "BBB@ HHHH *  .@HHH ,#.<48'I110 4444 %%%% !1110 48'I110 8
MZ"BBB@ HHHH *,#KBBB@ HHHH **** "C '0444 &!G.*,#THHH ,#THHHH
M" >HHHHH **** "C ]*** "BBB@ HP,YQ110 8'I1110 8'I1@#H*** "C ]
M*** "BBB@ HP#U%%% !1110 8'I1110 48'I110 48 Z"BB@ HHHH **** "
MBBB@ P.F**** "BBB@ HHHH ,#THHHH **** "C '0444 &!UQ1110 8'I11
M10 8!ZBBBB@ HHHH **** "BBB@ HHHH ,#THHHH **** "BBB@ P!T%%%%
M!1@'J*** # /44444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%)YD?_/1?SH\R
M/_GHOYT +12>9'_ST7\Z/,C_ .>B_G0 M%)YD?\ ST7\Z/,C_P">B_G0 M%)
MYD?_ #T7\Z/,C_YZ+^= "T4GF1_\]%_.CS(_^>B_G0 M%)YD?_/1?SH\R/\
MYZ+^= "T4GF1_P#/1?SH\R/_ )Z+^= "T4GF1_\ /1?SH\R/_GHOYT +12>9
M'_ST7\Z/,C_YZ+^= "T4GF1_\]%_.D,D>.)%_.@!U%0/<I$A=Y!Q[TEO="Y'
MF(_!]Z!V+%%1-* ,>8/Q-)',<?-*"?K0(FHJ 3D.091[9-,>\\M_+8Y)Z'-
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M1?SH 6BD\R/_ )Z+^='F1_\ /1?SH 6BD\R/_GHOYT>9'_ST7\Z %J$%HV)
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M>B_G0 M%)YD?_/1?SH\R/_GHOYT +12>9'_ST7\Z/,C_ .>B_G0 M%)YD?\
MST7\Z/,C_P">B_G0 M%)YD?_ #T7\Z/,C_YZ+^= "T4GF1_\]%_.CS(_^>B_
MG0 M%)YD?_/1?SH\R/\ YZ+^= "T4GF1_P#/1?SH\R/_ )Z+^= "T4GF1_\
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MYD?_ #T7\Z/,C_YZ+^= "T4GF1_\]%_.CS(_^>B_G0 M%)YD?_/1?SH\R/\
MYZ+^= "T4GF1_P#/1?SH\R/_ )Z+^= "T4GF1_\ /1?SH\R/_GHOYT +12>9
M'_ST7\Z/,C_YZ+^= "T4GF1_\]%_.CS(_P#GHOYT +12>9'_ ,]%_.CS(_\
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M2_\ />>C[/XE_P">\]>@^4O_ #Q3\J/*7_GBGY4 >??9_$O_ #WGH^S^)?\
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M3PC=Z==S20.@"A,C(QFOQ6_;;_;,^(/_  4*^/%D7DF>22=DAMXY<AATQ@4
MKGZV?\&MWB?Q%?>'=$TZ]DE, MUP&4X^[7[D5^:/_!OA^R%=_![]FSP_XLUN
MP>WO=@5XG'(^1:_2Z@E[A110>1B@0UI M#2*%W#D>U,<1@&,OR:54:&':!G'
MK0 \,, ^M#,$&2*BMI)79A(F .E/F=U'R+F@!P<%0WK074#((/XU%&[S?(RX
MIT4 AR2V10 ]6#C(%+D>HJ)IL-@\+ZTDD <APYP* )B<#)HR,9S40=G(7'%$
M@#X16Y!H EHH' HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH 0JK=112T4 %%%% !1110 4444 %%%% !111
M0 =*0,#TI3R,4B@ <&@!0 .E?.'_  40_;@\)_L@_!S4_&&I:B8+BT7(*R8/
MW2?Z5]$WDC1KN6OP/_X.D?B]XGTW5M4\%VFI3QVTEHQ:-6^7[H_QH&MSY/\
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M%'2BB@"-DA8^:1R*89G1O,8_(>E++$)CE)<"HYRL%LV]N$4L3]* )3,7P4;
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MB37]<OQU?9\,-3#+G]SZ5_)'_P %O"!^USKTBG+;_E4=<[VH'T/W+_X)U_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHZ4 ,D!+C%$QPN!2[T/.*;O1WP: ([Z
M?R+1G'9:_(G_ (+=_P#!3SQ_^R7XDO=)\*P;_+@++\X'0"OUWOK<7$#1XX*X
MK\;/^#BO]E;PQXH\(ZQ\1=0MX3)%"1EG4'[N>_TH&MS\_M%_X.5/CC%;1Q7F
MBQOLY^=U.:U'_P"#G3XT-<1Q)\/=/:,<-)Y<?^%?'W[(_P#P3&^*?[6GQ+N?
M#'@*P1HHF!&^(D8Z^M?HAX8_X-8/C;/X6'VK1;(W$T2LA\H=Q]:"M3S#4?\
M@Y8^,<[%K;PS;0CL8]@_D*P;W_@Y0^/9OXI8M)7:CY(\Q:\P_;O_ ."%'[2'
M[(^F3>)->L(!812[2(83V/L:/^">W_!,/2_VPXM4\/Z/I]N=2L5\MO/*_?\
ME[''K0/4_1#]@;_@YDUGQ=XEL?!OQ*M;&SMYF'F3R!"5Y'^-?M'\!/CIX.^.
M?@RS\6^&-5BN!=1[\QCM7\B'_!03_@F-\;/^"?WCI[C6(888H(3(#%'@8X/K
M7[5?\&T_[3'B'XE>%+;P3J^I^8MEIQ(3)X^2@1^J?QU8)\,-38KG$5?R)_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/QIYDFBV@']X6R9_E5B)8XH%73XE"^BKC^5 7%TVSBTO3X=/MXPJ0Q*B@=
M,5,N2VX_K3@,@%ASBDE.$S0(7<OK3),$?+21QECEQ]*4@*=HH&CY;_X*JR,O
M[.^IC'_,+N/_ $ U_&E\9LGXN>)/^PU<?^C#7]EG_!5L@?L\:F3_ - RX_\
M0#7\:OQDV_\ "V?$A'_0:N/_ $8:"MS]EO\ @U(8?\+^TX?].2_UK^CVOYO_
M /@U'!/[0&GG_IS3^M?T@4$O<****!!1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=L!]]AT!]J!GT]_P49_X.,]=\43:CX/^$VI7MDTA:%9(-Q%? ?PJ^&'[3O\
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MDG\C7]'U?S@_\&HO_)?-._Z\E_D:_H^H$PHHHH$%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MVBF/)M<(J9!ZF@5V?%G_  3*_P""8^G?L2V]FMKI$5NUO&%^0#TQVK[;ID8
M.!3Z!/<****!!10"#T-!('6@ HH!!Z&DW C.: %HH) YS0"#T- !11D#J:*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444A=0=I;F@!
M:*3</6@2(> U "T4FY<XS2Y'J* "BD+*!DL* RGD&@!:*3<O3-+D>HH **,C
MU%&1C.: "BBB@ HHR,XSS10 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT$]M!8;D1^@^63_"@-#Z)7_@N1\9%RLFK6^1U_>?_6I#_P %R_B^#C^UH/\
MOY_]:ON _P#!+?X$L-Q\#V))]A3#_P $LO@23G_A![']* NCXB_X?F?%_P#Z
M"T'_ '\_^M2VG_!=+XL/J"6<^L6X#?\ 33_ZU?;G_#K+X$C_ )D>Q_2F2?\
M!+'X#9W+X%L!)_"V!Q02['5_L1?M0:O^T+X6M=6U2Z21YHBQVGVS7OS&YW\#
MBN$^"OP&\,_!S2HM.\/:=% L:;0(_IBN\AW(2)'SD\4"'JG.YNM.I,'=G/'I
M2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MB@1^%0_X-,/@I# (?^$BU3D8SYDO_P 55G0_^#1CX!SS;+_Q;JR*3R?-E_\
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M_1]02]PHHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9^#0MRDF\/N7K_WS7J6E:+8:)9BRTV+RXU  'TJQ#$R$MDG/:B56D'EC(]Z
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M<T_DU?T>T$O<****!!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 CGY:B'VC/'2I7P%YJ)XY)<;'QBFMQ/8D.[>*\(_:5_P""@_[/
MG[+$37/Q2UTVP$FPX=1SG'>O=P#&N3R:_ /_ (.*;CQ7XB\7KH.E:^]LIUJ)
M2 1T,RC%9UI*,&^QI0CSS4>Y^C*?\' G[ *ML;QL^0>?WB?XU)_Q$!_\$_\
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MO(H6BAW,V1SPW^%>M@^/\DQN K8F#=J:/(QOASG6!S"EAI)7J:'[_#_@O_\
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M0\/XCAC&>QK;L^TT!"C/6EH7H/I17M'@[A1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 ,F0.N":12$4!3^=/?[M,(Z47L2WT%5B#M[5^!'_  7XA(^*X=R0
MO]NP8_[_ "U^^[D[^M?@1_P7Y8O\4U1CQ_;L'_HY:PQ3OAJDNR9TX/\ WJ$>
M[1UWPHD;_A7>BX'_ ##X_P"5=+YK;<;>:YKX4?\ ).]&&?\ F'Q?RKI*_@K&
M-O%U/\3_ #/] ,%&/U.G_A7Y(!*YZ"CS)/2FH.33JYKR.GEB'F2>E'F2>E%%
M%Y"Y4 D?^[33#$?F#G)IU*R@ $"G&SFK[A[ZLEL<=\;U\OX<7QW'ITS[&OE#
M]A1)9/VI=;:;(7[-P1]'KZO^.I)^'5[]/Z&OE#]A>5V_:AUI2>/LW]'K])X5
MYX<%YH^MG;\#\QXL2?&65=N97_$^X-T@X"\4;I?[AHW-ZT;V]:_-$Y'Z=RQ#
M=+_<-)OD_NTN]O6D))Y-.\@Y4'F2>E'F2>E%%%Y!RH=$[%L,O%0^2UQ(WF$A
M0>,4]B0,@TBNP!YIMJ4.6RN5%6DCYB_X*!AQX1O+6$Y4Q<\_[-?K7_P1!;9^
MQ7X3@!RP@.1_P!:_)/\ ;_8IX6O"I_Y9?^RU^MO_  0_16_8Q\*RD?-]G//_
M  !:_K/P?F_]6&FE?8_D?QD:EQ&EY7/MI<[1D=J6BBOU$_)@HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** (I,'YGXQWKR#]L[X1Q_&#X.WOA
M[R?/S!*0FW/.RO7YWC8B!_XJ;):K]G:VV@HRD$'T- '\7_[;7P2^(W[(W[6M
M_P".#IMW:I'X@::W;.T$ =ORK]4_^"6W_!P]:^%_A_:^!OB;<0JRLBFXO9 2
M !CUK[=_X*O_ /!&_P"'_P"U]H#ZUX;\-"?4X(6=3Y0/S\_XU^ O[5G_  1:
M_:<_9]UBZG'AMH;>)F*[(VZ9XH&MS^C+PU_P6R_97UC28KV\^*&C0R2+RA<\
M5B_$?_@N5^S9X2T&XO\ 1_B#I-S(B95%?K7\J.H_!_XTZ!<-I]S:W(:,X("O
M5CP]\"?CGX_O4T73K.X=Y3M4,KT%;'Z._P#!7K_@N-J_[3>E7GPV\,6X^QO*
M3'+;R#!R<8Z^U<Y_P0+_ &.?B)\:?C>WQ'UGPS=16]IJ:7*RLO#C"\_K7)?L
M-?\ ! +]J#XX^*;+4/%/A3S=,9T<EHFSUR>OM7])/[!7["OPW_8Z^&&G:'X:
MT<6U^UBJ7X,8'S@__6% 7U/=?#>EP:/H-I8P0*OEVT:D >B@5=CEWML*XQ2[
M@.1TIB+L<NW0T"'L5QN"Y(J"ZB::TEW-C=&RX^HJ19-ZGR:9>.T=A-(WWDB9
MOR% 7/Y[O^#E#]E2_N/'OAWQ5+YC0&\,KY' 'SU[;_P0G_9L_9+\<?L[IJOC
MB;0WU-+I%$%S;[F/WO:O _\ @Y2_;.\:IK]AX/CO1Y<<S0H.>GSU^7O[/?\
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M\*/^2=Z+_P!@^+^5=)7-_"C_ ))WHO\ V#XOY5TE?P3BO]ZJ?XG^9_H!@_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MO<_^@+7]8^$/_)-OU/Y&\8O^2D7^']3[9HHHK]3/R9;!1110,**** "BBB@
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MKI=OH'Q(UW0[4@QVNJSQ(1Z*Y H _:#_ (-20Q^/>G/GC[&G\C7]'=?SA_\
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ME).G)Q^M?6W_  19_P""'7CJ]^)FE_%SXP^& T:3;I7,1_B8'O\ 2OW'T/\
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M:_H^H)84444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"'_DFWZG\C^,7_)2+_#^I]LT445^IGY,M@HHHH&%%%% !1110 4444 %%%%
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M\E\T[_KR7^1K^CZ@EA1110(**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M * M?UEX0_\ )-OU/Y&\8O\ DI%_A_4^V:***_4S\F6P4444#"BBB@ HHHH
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M?K7RY_P4<_X)^>$/VQ_A==>&+[15N9Y"[@,H/)'_ -:@NQ^+W_!'/_@O;?\
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M^QCD_P#0C7[RV_\ JT_W1_*@I[(?)VIU-D[4Z@D**** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<+_@U'5E^/FG9'_+DO\ (U_1[02PHHHH$%%%% !1110 4444 %%%% !1110
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M_P#!0'_D5;S_ *X_^RU^N'_!#W_DRWPK_P!>Y_\ 0%K\C_\ @H#_ ,BK>?\
M7'_V6OUP_P""'O\ R9;X5_Z]S_Z M?UCX0_\DV_4_D;QB_Y*1?X?U/MFBBBO
MU,_)EL%%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_@COI7A.[D\+Z!<)="/,1\V/K_WQ7X/_  H^&_QV^+.HS:9H%SJDDT*%FBB
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MU;W?&<1-GB@1II)'_#WIK3%)2#TI9=HC++VK-U#Q9X:T2#S=;U>"WQU,K8H
MTU(8YCH8.J;L\]JRM'\5:!JBR3V&KPRQ@9+(W&*K77Q+\!6,WV*]\66D<IZ(
MTG- &Z&5%W'J:1?M&[)/%4[#4;*^C%YI]XMQ&_W2AR*M2.70P[MI;I0!),25
MPAYJCX@U!-(T2YU24\6\1<D>U6X(6@A$;R;F]:S_ !'I8U'0;VPDFVK/"5+'
MM0-'Y[?M/_\ !:GP)\"?C/%\,+[5;A)I$8A58XX*CT]Z^VOV:_C#I_QS^$FE
M_$'3I6=+Z/<K,>>@_P :_.;]L3_@D#X:^.7QXB^)$OQ.M[62-' @)&3DK_L^
MU?H!^R=\+K+X"? W2/!TFM)<16,) GSPPP/84%GKB;%&!^M12K<;_D/RUAZ=
M\2?!NL3M96OB"V,H;:$5^<U9U'QKX9\.@QZUK<$ '5I6Q019FJ!Y>,=3UJ0L
M!6+HGC7POKSL-)UV"X_ZYMFM9"<8//O0(55C5RX!R:)A+N!2G%00!D"FO*8W
M";<Y[T ()&1=TE+*96VF(\=ZH:YXL\-^'XR^MZO!;*.IE;%&F^+- U:$SZ5J
MD,Z*,LT;< 4 7I8]Z[X_OXI(I1(?)?[PZUB77Q+\!VE^+.Y\5VD<Q_Y9-)R:
MT[2^M+I!>V$RS(_1D/!H L.%)&>O:G#..:SM:\5Z!X> ;6=4AMAC.96Q4>C>
M./"/B'']B:_;W.>GE/G- RYJ%Q)9V,UR3]Q"17P+^W9_P5_\'?LB^,F\+^(M
M;DBD$;/A),<#'^-?=WC&=D\.W7EC@PGD=J_F2_X../[9U']JZ/2+/69$22RD
M^Z>/X*"E8^]A_P '*OPLE@5HO$%T2>XD/^%1O_P<E_#QS^[\0W7_ '\/^%?)
MO_!/[_@A+K7[1OP3TGQY<^-'B%[;EAN4?W0?[M>UP_\ !LMK!=Y?^%DL &/&
MT?\ Q% 61]!_ G_@X\_9YUOQ7%I'C37+EE; (,V.<^XK] _V=_VK_AI^TGIO
M]K> ;]7B\O?AI03C\*_GN_;=_P"" 'Q;^!?AJY^(7@KQO?73PL2(K5!G Y_N
M5#_P1)_X*'?$'X'_ !VNO@KXVU&\GD&I)9!+E^5.U: LC^CGXY?$6V^%?PYO
M?&EU*42VQE@?8G^E?FYI7_!P9\(K#X]W7PN\0^()LQ7"1*OG8 +-CTK['_;Z
MU:XU/]C'4]71S$TUG#(/^!1,:_D-_:F\1>,-'_:PU75=$NKCS(+Z.4F+J=KD
M_P!*!*Q_:;\'_BSX>^,'A2U\2>';D20SVZ29#@\$>U=6\;CY5/'I7XO_ /!O
M1_P4ZB\5>$C\-OB#?B.[++;VXO)/F."!QS7[0P7=M<Q":"8,IZ,* >AX_P#M
M=?M(Z9^SGX//B/5+IHD6 R$J<="?\*\*_8E_X*E^"_VIO%2:!HNK/,S7+18:
M3/(;%<__ ,%X;F[A^ LGV*=D+:9)\R_5J_,7_@W&GUO_ (7=;+?ZE)*IUF;[
MQ_Z;&@:V/Z,P0PJCK.HV>CV;W5WQ&HRU6W42@!'QCTKRC]M#XH:9\*?V?O$7
MBF\NXXY+2Q+KN.#02CY'_;!_X+7_  B_9J^,MS\+KO7)(I('P568 ?>Q7UK^
MR?\ M3^"OVE_!5IXA\+7GFF6V$DA,@-?RA?MJ:I\2?VOOVG[_P >>%+^]>*?
M++]GP1]XFOU#_P"#;#]LB\\/>)]>^%'CW5V,MD1:PI=OR#M0\?G04?NFZS&8
M;3\N.:%FC=S$!R*BANOM BN$^[)&K#'N,U,#&'^5>?:@6I..!BB@<C-%!(44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %!&1@T44 ? O_  6,_P""B'B;]B738HO"VLO:3W-KO3:3UVD]J_,W
MP;_P7Q_;;\9:&NJZ+XYF,;GY3B0_UKZ3_P"#FB.*Z\9^';:>(,C6P!!'!^0U
M\U?L-_#'X=W/P1LY[KPI:2N2,LRGT'O7Q/''%SX3P4*JA>Y]UP%PI3XLQLZ3
ME;E-9?\ @N/^W@I_>>-YN/\ 9E_QI6_X+G?MW#_5^.)O^^9/\:]-/PE^&+_>
M\&60SZH?\::/@_\ #,#_ )$ZR_[X/^-?ET_'2O)J*POST/U/_B!M!W;KV7S/
M,_\ A^=^WE_T/$WY2?XT?\/SOV\O^AXF_*3_ !KTW_A4/PS_ .A.LO\ O@_X
MT?\ "H?AG_T)UE_WP?\ &I_XCABO^@;\A?\ $#<+_P!!/YGF1_X+G?MXD<^.
M)ORD_P :)?\ @N;^W<H!'CB;G_9D_P :],;X0?#,C_D3K+_O@_XTYO@[\,F4
M?\4;9'_MF?\ &G_Q&[$VO]6_(/\ B!>&?_,3^9YDG_!<W]O!AC_A.)ORD_QJ
MIXF_X+>?MU7VA7-E<>-IC'/;O&XQ)R"I![^]>L_\*>^&2GCP?9#_ ( ?\:R_
M&OPM^&EKX?N73P?9 BW?'R'^Z?>M*?C5B:TK?5OR(EX(86*;^L_F?!/PL_;M
M_:#\&?& ^,M(UUTNI=1::1P&Y8G/K7UY?_\ !<']NQKOR;/QM,$ _NR_XUX#
M\+O"_@ZZ^+;6,OA^W93J# *5Z#/UK[-MOA!\-((P\G@^R)QU*'_&O9S[Q7J9
M16@O8;KR/'R?PBI9JIOV^S\SS"/_ (+C_MUA2O\ PF\V5'/RR_XTU?\ @N9^
MW@O \<3?B)?\:]2M/@]\,4>25_!]E@\\H?\ &F-\)OAA,<IX-LAC_8/^->#_
M ,1OK\L6L/\ D>[+P0H<[@Z]EIT9YC_P_._;R_Z'B;\I/\:/^'YW[>7_ $/$
MWY2?XUZ;_P *A^&?_0G67_?!_P :/^%0_#/_ *$ZR_[X/^-'_$<,5_T#?D3_
M ,0-PO\ T$_F>8O_ ,%S?V[B/WOC>;'TD_QH/_!<7]O&508?'$W'JLO^->G#
MX0_#+^+P;9'_ ( ?\:DM_A5\,U#JO@BR/']P_P"-+_B.%:;4)4+?<->!E""Y
MU7O]YY;!_P %P_V\9;@&7QO,5[_++_C7+>*O^#B3]KSP[K]MH=WXZG$DMY'$
M1^\YW.!Z^]>[V_PG^'!!/_"#V8Y_YYG_ !KXK^/7@CP(_P"T#8:='X6M54:[
M:@@*?^>Z^]?6<(>)TN)<W6%=$^4XO\+H<-90\2JI^]?_  2R_:%^,7[1/PR?
MQ3\4-1:X>2W22%F##@D>IKZN948^4>E>:_LC^"O#/@[X#>%T\-Z/#:B?1(#)
MY*XR=HKTR12J9'7UK]>W/QW8:'.=B' %2KC'%,#(%& ,GK3U&!B@!:*** $?
M[IIIZ#Z4Y_NFFGH/I2?0A[@_W_PK\"/^"^__ "55?^P[!_Z.6OWW?[_X5^!'
M_!??_DJJ_P#8=@_]'+6.)_W*MZ,Z\%_O]'U1UWPH_P"2=Z+_ -@^+^5=)7-_
M"C_DG>B_]@^+^5=)7\$XK_>JG^)_F?Z 8/\ W2G_ (5^0B]3]:6D7J?K2U@=
M 4444 %%%% !1110 4444 %%%% !1110 C_=--'0_2G/]TTT=#]*%\2&MSYA
M_P""@/\ R*MY_P!<?_9:_7#_ ((>_P#)EOA7_KW/_H"U^1__  4!_P"15O/^
MN/\ [+7ZX?\ !#W_ ),M\*_]>Y_] 6OZQ\(?^2;?J?R-XQ?\E(O\/ZGVS111
M7ZF?DRV"BBB@84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4'H<T4=: (F
M)VDIR:^,O^"WHD;]CZY\Q?XY>/\ @(K[-;$9Y%?&?_!<&Y1?V0;EB."\N/\
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MX/;:Q%?V@?\ !5"\N+/]GG5#;R;=VEW(./\ <-?QG?&IB?BYXD<GDZU<$_\
M?PT ]KG[,_\ !J6(F^/NG.Q^?[&F1^=?T=U_.#_P:C<_'W3F/7[$O\C7]'U
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M3/V=?B+XEG=Y[TJRW&5&%?;W^M>@?\'+VE/_ ,(_I6K+,KQ2ZW%MVG.?WRT
MCK/^#8?]FC0M,\ ZYXI_LQ)7>^:4R21 D$R9[U^S>L:3IM]I<]E/:1,C0L"I
MC!'0U^:O_!M4D,?P#U@*N,L/_0J_3.\ -K+@\^6W\J!,_FO_ ."[/[/W@[X4
M?M'^'_'6E0^3-/KGG,4C"\_-Z?2OTP_X)S^)-3^,_P#P37U%+:5IYA-#&F6)
MX"2#^E? 7_!RE=/IWC_P\TN6+7QV8[<O7V__ ,&X.I/KO[',FA:K&SQR7R9#
M#C^.@9^<?[)FLZ5\/?\ @J#XITWQBXA/VZ)$X!^8E@.OO7ZW_P#!6/Q[X+T#
M]AW4(M5O=CW'AR)H1@<@H#ZU\4_\%/?^"7GQ)\%?&Z]_:!^%@:*2]U%)C]EB
MWMA7SVYKRGQIX7_:\_:Z;3?A)KFJ:I]D-NMI(+FT8+A5QU/% RC_ ,&U_A'6
M)OVI(OB=90DZ=_9VY)<G&0&/TK>_X*D?M'^*OVWOVL]%^!XF$UKHGB$6<B1/
MR%Y/('^]7TS?_"KP;_P25_X)_6=^L]I'XI@9H)9K>5?,(**/NCGJ37B/_!*K
MX(Z=XE\=^.OVJ_C+:*\$,YU2S:]_=E@%0?+NZ]^E =3]6/\ @G3^RWH?[+'P
M(M_!^CZ8L3W"13DM$ <E2?\ V:OH6%\CY_O=Z_'+XY?\%M+KXB?$)/"'P0LM
M0BB@0VZ_9(G=<IA>H'M79_L@_P#!=+P[_P +%_X57\3]+O1?1NL+S7BN@+-P
M.H]:!'ZOAMR'VH0XCS67X-\6Z5XS\-VOB'2I4>*ZMTE4(P. PS6FC!^%'%!!
M'J4@AT^67/.S-?AI_P %J_\ @I[XV_93_;(M?"FEZJL-G]B=V!FQSE.WXU^Y
M6K*#ITH/0)7\L'_!U3*)OV_K;3805+:7)SC_ *Y4#6YZ)\2?^"]/[0WQ'\'6
M'AOX8WMO<W$4HWKYY!QD>@-?=W_!&_\ :N_:,^*V@7?BSXQVR16UK/EG69FP
MN[W KS?_ ((3?\$B/ACXL^#VB_%_XC^&[/48M1L]RHQ7((7_ .O7V=_P4#LO
MA#^Q)^R=XHE^&/A=-+F33MRM!USZ\4%GSI_P5Q_X+YZ)^S?=ZA\.OA'XG@EU
MN!V402LHXSCWK\R[K_@J_P#MY^.KZ7QIIMG"\+MYVX738Q_WS7C_ .R3JOA?
M]KS]L$^.OC7>V]Y87**SQWLH7G<3_%7[4> _%O\ P2]^'_@G3_"M_P##?1I9
MFMA%*RWBGG)]*"6F?*W_  3J_P"#A7XFZ#\1=/\ AK\>M7MK2VF?]]B4,1A@
M.X'K7[J? SXX^$OC?X&L_&?A/4?M$-W'O5^.1C/8U_.!_P %F/ W[+^DM=_%
M+]G;3--TR2W@/EK:W2LP)&>,<]J^S/\ @VX_:T\<?$/P5J'A'Q!JT\T6D^'+
MB9 X. 5@=N/RH%9GZ#?\%$?^"B_PT_8R\ 7U_JWB)+;5UM?,LXGVX8XSW-?@
MU\<O^"[W[8?[1?CZ?_A78MKBSD.Z-H[@CO[+6?\ \%DOVBO'O[4W[86E?"C3
M=:E$$E_):O$^<' (K]2O^"0/_!'7X$>&/@/I7B'XG> K2^OB@$DKXR?E%!6Q
M\+? W_@NU\8O#OPVU_P%\=[^WM%NK!K>(>;N+9QZ@>]?,W[#WCGPY\7_ /@J
MCX9\8Z+=^; [2EG'JTL9[5^OW_!5#_@AU\*/&?PBUCQU\)O"UCI;Z5ITEQ-@
MKEL9_P 17X@?\$D_!VJ^!/\ @I]X>\):E+Q'=SI@C'W9D% ']+/[8'Q<U7X.
M?LJ6VO>'I@'2TE8$MCHM?EG_ ,$U_P#@J7\5OC%^UE'X'U?45>$Z_+!M$Y/
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M#FN*_9J15^ ?A$@?\P&W_P#0!7<5_69_(:M8CV*C98T]6##(H*ANHI0 .@H
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M$K/"S22:?XZ\*K<.Y9"MA&#UK^39/ GQRP2^B7^T#@?8I/\ "J=OX$^-%U>
MC0;_ ,T'Y";&3C]* L?VG? #]JSX)?&_RK7X5>)[2\A=<QK:J /TKUNOQ(_X
M-HM$^(FDOI,7BZUFC MESYD++_#[U^V]!+W"@X R:*1@"I!]*!'BG[3?[''@
M3]J!U_X2J1-JQ["K)D$8Q7@\7_!$/]G2"/[.+"R('<V8_P *^W$C15(A&#[T
MZ/?M^?K04F?#;_\ !#']G$Y?[/: GM]D%.T;_@AS^SQI6JIJMNEJ'3IBUK[C
M; &XCI30PDC+IU'2@&SS=?V=/",'PJMOA2D,36=O T2YCXP1BO$? _\ P2,^
M!W@SQI_PFUA:6HN?M+396V .2<^E?6Z(D:AV')I[LPCR#S0*[,CP]X/TSP_H
M2Z"ENCPJ,;63CI7D'QO_ &!O@G\; [Z]X6TQ7?.9#8J3GUSBO<P96A&3SWH&
M&&&ZB@%<^+/#_P#P14_9PT+7%UE-.L)2I)\MK,$=?<5].?"CX!_#[X0:7%IW
MA7PU80>6NW?!:*A(_ 5VXB0-N YI026(-!1(H 4 # Q2T#..:*" IK]?PIU-
M?K^% 'RS_P %6O\ DWC4_P#L%W'_ * :_C2^-/\ R5KQ'_V&;C_T8:_LM_X*
MM?\ )O&I_P#8+N/_ $ U_&E\:?\ DK7B/_L,W'_HPT%OX3]E_P#@U%_Y+YIW
M_7DO\C7]'U?S@_\ !J+_ ,E\T[_KR7^1K^CZ@EA1110(**** "BBB@ HHHH
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M1!X*1A;"\N,^0=H!\]/2OT$_X.%/".K1?LJ>$?$FIQ/N;5(V9G.>DJ5\P_\
M!O=^SOXJ^.7[3&E?'/Q=IDDEJ+]R[R0D?>E#=3]*_5O_ (+T?LLZE\;?V6[3
MPUX3L0ZZ6'G5-F<!2&[?2@9Y!_P;,?%71-6^#>M:4UZ@E2?8$'4D/7ZO791;
M>9V;&(F)_(U_*K_P2O\ ^"A=W_P3R^,]UX&^)5Q<V]E+K4@EC563*AR>]?LO
M\6?^#@[]DC1_A#+XQTN_N \T;HN+@9SMX_A]Z!/4_.[_ (.)/%OA;Q1\7_#F
M@VFI)).NJ>6T?H?GXK]'/^#>[X>3>&OV2LW%N4)NXV!QVP]?@YXB\<?$#_@I
M%^W+8ZIX<,USI:^*5>,/$S8C(]?QK^HG]ACX"M^SU\$+'PC);+&9+:"1E48Y
MV?\ UZ N>L:QX5\.>(;8VNL:1;70((Q/"&_F*XG5?A?\+?A=I=UXQD\.Z;"M
MOF1I!:*-OZ5Z(B ,9!TKXH_X+"?MG:'^S]\'-6\'-?E=0U"QS;"-^^,]!0);
MGYA_\%7/BWXL_;*_:YOO@3\-[F:\LA=I(D%K*0N/-(Z#V%>Z_P#!335-0_8\
M_81\"^#_  Y9"RO=8\,^1?F$;'+%Y.I'7H*PO^"%O[+6H_&3XPV7[5/C/3_.
MBOH%!F:/DGENI^M>K_\ !S3\.[_4?A5X<ET&S=H]-LV(V1D[0&?T^M!1X+_P
M;H_L>>'?BEX(D^*OCB4W%TNK-\MT"^0SN>_TKYR_X+9^!+3]FC]I.+QGX(G,
M#7'B6V5DM_D 'GJ.WUKZO_X-HOVFO">@_"AOA]XKNO+OI-5^42.%X#.._P!1
M7RO_ ,%[O&&G_&']HF'P?X28S30>)K8ML.X8\]?2@3/VD_X(\?&G5_C#^S[:
M3ZD[.;?3X4RS9[ 5]BPJJ+L'6OB;_@B=\,-8^&7[/=O;ZM!Y9N;&)ERI&<@&
MOMD1GS2_8T$$%^S&QGW#C8:_E?\ ^#J65HO^"B5FT:Y_XE<G_M*OZH-2<R6,
MR@]$.:_E>_X.IG6U_P""B=FTJDI_9<F<#_KE0-;G[E_\$)=A_80\%2D8)L#G
MC_96O.?^#A-M0'[-OB 6:-Y?]E?.1]*[W_@A%<B7]ACP60I"?83@'_=6O1?^
M"H_[.W_"]_V9_$NDVMD)9I-/V("N:"NI_*M_P3P_9"^(/[1GBZWT[X=RW[W\
ML8(CLYF4X_"OL[4O^")'[9$;^?%%XG<L<X-]+Q^M>'?LL_M%^-?^"2G[:K1:
M])/965BJQD1QLO1R*_>OX&?\%^/V4/&GPZL=8U;4)FNA9A[IFN ,MGW% ;(_
M'/7/^"%O[6OBK1I+'7=(\07 ?JD]U(P/YU^EO_!''_@GEXJ_8X\&^(]1\3Z5
M<6TK^%KR,B;/4V[CO]:P/VU?^#F+X$>"I9]!^%FIWL=\4)B*2%AG_@(KZ&_X
M)@?MF>-_VW?"=Y/XANYYH-2TB98_.1ADM$WK]: /P>^,4\<'_!4C0WU3'E#Q
M/-DOR,;C7]/_ .Q])I5]\$+"32W00G&TH,#[HK^>W_@N=^Q7X^_96_:BTGXQ
M:-IYB@2X>\>2*(G&X$]17V5_P25_X+W_  +L/A'IGPV^)NIW!U*%09=TNT?=
M [CVH#<_5S]JZ2*+]F_Q@+@CRAHDN]CZ<5_+[^R:=%E_X*_:%+H$ZN!=W.=@
MQSY\=?IS_P %2?\ @O7\,-0^$FI>!/@[J5T)-2T][><(Y8')/]T?2OQN_P""
M1GB36O$'_!3+P]XCUW>6ENYI 64CAID/>@-C^C__ (*,:'J&N_L8I%:Q,[QZ
M?<,P'LF:_"G_ ((T 1?MZQP7GRNOBN< '_KH:_HB_:&\--XP_9,O(K2+<W]B
MW6T8_P"F1K^8#X"_&35?V.OV^)/$_BQI8+2'Q3<2L0I7Y=Y- ']AMZSF-QC@
M*>:_"'_@Y[\9^&AKW@RQ@U!&E%UB1?0[I*^S=/\ ^#@3]EVY^$_]NW&HW#W4
MD;#*W )SM^E?@[_P52_;<F_:^^.=E<6+W,EC!JVZW\Q6P%Y[D>] +0_93_@D
M,=1F_P""4VO'PZ&><ZA%L$9P?NS5^0^DC5[7_@IMJC^+$8$ZY:X\X[N?-]Z_
M;S_@W;\*:?K_ .P-=:)>0;HI;V(LOX2?XU^0W_!;'X0>./V6/VM[[XR^&+&6
M"U?7H)!)'"WW5F!/(H _IP^!>Q_@UX990,?V);[?^^!6MXMNO"]EI#3>+88&
MM1G<+B,,OY&OR9_X)<?\'"OP3\3?"JU\*?%G6+B2^T^UCMH]\VW&W [BLG_@
MJW_P7Q^%MK\.;SP9\&=:GCU;>P4K+N&#QV H%:Y^E$OQ1_9VU+P[X@L/AY<Z
M6+Z*W99UM;=48-@=<?A7\WO_  6,N;F^_;QM)I@<_9Y=N3VW1U]7?\$&O%?[
M3/[3'Q(\8:[XEU!Y+"ZN-Z^;$XRA6/U-?/W_  <3^']/^!7[=6F7%Y:LL::4
MS2,B\9_='K0-*Q^Y_P#P25@O8?V)/#,TZD(=.?:2?]@5^27_  <R*;CXLZ0[
MGYEB.T>OR5][?\$3_P#@H+\+OB;^S?H?PLL[YC<V6GMN1I1Q\GI^%? O_!SG
M/L^*>@WUH#L>WW C_<H&?4?_  2EEO7_ ."0NCV^F0;KH0MD+U_U*U^2W[+5
MU<6?_!3W4X[MBTC^-D#*YSM.Q*_8C_@WS6R\>?L#Z-X9U",N'M3\I]3$!7Y)
M_P#!1_X7^,?V#_VW)/C'IMC+;6UWXG%V9$A;E0,9R/\ =H _JR\%JUOX(THQ
M\DZ; <?]LUK(^-VH:':?";Q!+XA$04Z'=[?-4'GR6]:_-;_@G?\ \'"/P,^(
MWPSL['XAZS/)?0QQ0[GGQ@*NT]1["O)O^"M__!?OX92?#^X\#_!K6;B.^F#P
M2[9=P*O\N. .Q-!-CX9_9S?2KW_@J/ITFA2(%_X2^?(B&/XSZ5][?\'(!=_@
MC?VM[]W[4W+?A7Q#_P $*_@'XY^/O[3$7QMUJPDD2WUY[@RR0D<,_7FOM7_@
MYPUJSMOAEJ6DQJVY;IN@]Q049/\ P;$3+:76OI!;(P9 -VWI\J5^W<<0:)&(
MS\HXK\/?^#8&[5YM>"@_<'_H*5^X4(FPAS\NT4"9_+#_ ,%R%,G[?Y3[.J@>
M+[+Y@/\ IZ6OZ*_^">Y"_LY>&?+&?^)#;9_[X%?SI_\ !="]9/V_FCC4Y_X2
M^RS@?]/2U_13_P $ZW+_ +.7AHD?\P*V_P#0!0'0]Z1R5RW!K#^)Y(\ :MM'
M_+FU;I7+9-<_\4[@0^ -6_Z\VH$K'\K7_!8])6_X*+V&5_Y=YO\ T**OW"^"
M0Q_P2DT('OH-U_Z)K\._^"Q5^[_\%%]/ZX^SS=O]J*OW!^"TRM_P2DT-B#_R
M ;K'_?F@H_$+]AH6]E_P4.B#(LC-XLGQN&<?.:_J?^&R_:?"<7R;/9>.U?RJ
M_L+7<3?\%#8VN4)9?%L^TX_VS7]4WPHN'F\+0L3Z?RH$]C\TO^#G%+0?!K2%
MND4D6+["PS_$]?/?_!J\A/PYF)8_\AML#_MI)7T!_P '/(B_X4_HYN 3_H3;
M<?[SU\_?\&L3N?A[*(Q\O]MM_P"C'H _=L<#%(K;NU*.10 !TH%OH?B=_P '
M4X4? O5"?^?MOZ5B_P#!HPKPIXM*+]Z 9/\ P".MC_@ZF('P0U3=T^U-_2L7
M_@T7FGF'BU8S@"$9_P"^(Z!ZG[ _M;2/!\#=4>,9(QQ_P%J_ERT^.&]_X*IZ
MVUZBY_MJV(W#OYIK^HW]K<,?@=JF.O'_ *"U?RX6I7_AZAK08$D:U;9_[^F@
M$?U6_ M47X-^&5' &BP8_P"^!7Y,?\'+UT4^%FI1B%7'VMN2/<5^L_P(Q)\&
M?#.?^@+!_P"@"OR1_P"#FO4;73_A5J1D4D"[;I]10"W-'_@VOA'_  @_B>0<
M?\2\\#_=2OA?_@XK@%Y^V9;1RQ@C[!)\IZ?\LZ^X_P#@VDO?M?@3Q.\8(7^S
MSP1_LI7PS_P<4ZK%;?MIVI96XL9/_:= S]>/^"*OPE^&6I?L<^%+FY\):9<7
M#V9\PR62$_=7U%=[_P %!/\ @F?\)/VB_A/JJ6?A>PM[T6FV 6]FJL3[$"N3
M_P""&4R-^R1X6N<'#V9Q_P!\"ON6XA>7A1\A'S"@3>I_*'HGB;XC_P#!(C]L
M][!_#1;3[!E3== %>'(Z-7]'/_!/;]LGP9^U9\(]+UCP[JEO+>#3U>\@@ _=
MMGIQ^%?!?_!QM_P39B^+/PGU3XR>"]#5M8DF=O.V9.!\W;FO@K_@@Y_P4!\4
M?LH?&J_^#GCS6'B-S?I91IDJ.57U^E S]]_^"DC&/]DSQ!-CD8X_X"]?S(?L
MV2RG_@HUJ,L4>XG5+?(_[:&OZ6_V\_$=GXJ_8IU;5[>99%GMHI-RMG[T3&OY
MH?V;;HVO_!1K46C!YU.W[?\ 30T"/ZL?!/A+3_'7[/FC>&=7A1H;O0X%D5UR
M/N"OY]O^"]'_  3Q\0?L\?&;4_V@OAA87$4"7'R/:9C7 ?/:OZ&/@K/(WPB\
M.2 \?V/!G/\ N"O,/V\/V2_#G[5_P<O?!U_I8GDD1VPP'7;0"6I^,OPZ_P""
MEOA[XW_L<S?"7QEK$*WVA^&WM@DA!;?DG\_FJE_P;OP21?'.VD491]8F8'V,
MQK\X/VY/@9\5_P!BSXY^)M*L(C:V%UJ31QA8B 4P/\*_1;_@V2U"\\2>+M+U
M:[;<PO?F)_WZ!G[.?\%-?VB+3]GOX!7^MW-VL/VRPN(5+'J60K_6OY+-:\4?
M$[X@_M2ZA\2_"5A/?BSUZ:52KD@98U^T7_!SC^VM W@2T^#_ (?U%A=Q:JD,
MD8;/WI57H*YK_@WH_P""8OP]^+7@#6_&?Q9\+_:'N)O.C8H!PSCU!H$CX]M/
M^"AG[:7AB :7I/A"^2%/NJEQ@?E7E'[47QZ_:G_::\/B#QKX,NA'91$J\C[L
M=3G]:_IE3_@DE^QLZ8G\ Y/_  #_ .)K)\>_\$D?V0G\#ZK:Z1X#Q/):,(^$
MZ_\ ?- 71^$/_!O#^T_?_!O]I+0OA7XMU)[6"YO&>1)).!B0=O\ @5?U :!X
M@TSQ'ID>KZ1.LL4HRKJ.M?R>_P#!1/X.ZA_P3X_;VT[6?!]FUC#;QRR*RI@#
MYHR.17]$G_!)3]H[3_CE^RIX9U&>^$U_+;%ICOS_  @T T?60Y%% .1FB@@*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@#\;_P#@YA_Y'#P]_P!>P_\ 0#7SY^PI_P D#LO]X?\ H-?0
M?_!S#_R.'A[_ *]A_P"@&OGS]A3_ )('9?[P_P#0:_%_&W_D0X?_ !?YG[;X
M&?\ (ZQ/^'_(]KCZ?@:*(^GX&BOYACL?U''X6%%%%4 41_Q?C11'_%^-..X+
MXA$Z?C61\1?^15N?^N$G\JUTZ?C61\1?^15N?^N$G\JTP'^\KU1ABO@?H?&?
MPC_Y++_W$6_G7W&GW!]*^'/A'_R67_N(M_.ON-/N#Z5]CQ]_OF'_ ,)\=P3_
M  J_^(1?OFG4U?OFG5\1+XT?<!1113 <G7\*C_Y:5(G7\*C_ .6E3/X6"ZBI
MT_"OA;X__P#)QFG_ /8?M/\ T>M?=*=/PKX6^/\ _P G&:?_ -A^T_\ 1ZU^
MI>$7_)7KT1^5>+O_ "2$C^EO]FS_ )(%X0_[ -O_ .@"NWKB/V;/^2!>$/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_DK7B/\ [#-Q_P"C#7]EO_!5K_DWC4_^P7<?^@&OXTOC3_R5KQ'_ -AFX_\
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M=?$K2M5,5[':F*)(TRW*CIP?[M?J1"D@)WC'I23QQN,7$",O<,H- 79^"_\
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M[><M'BOJ:\TK1[N3?-90L_J8@34\%G$(A!Y2^6.@VC% [L_!S]F;_@C[\0/
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MF(9S5J',28"@*.@ H"[%4!1AW ILR)*AB=0588(/>G-#',/,8TDT;X41#.*
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M\.:9'IUJ@"Q(JC QT&*N[-XR!0*Y1\1_V<^CS?VLBM;[?WBN>#7P[^T%=?\
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MIH&Y=AYIB0A,MO//;-/61LX(XH 02!/D"]*42H#C;CZT.0IRO-,V>:V7.,4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJO\ ;'_Z%3Q'^0_QH_X57^V/_P!"IXC_ "'^- 61_5/_ ,1!G[%G_/6X_P#
MI?\ XFC_ (B#/V+/^>MQ_P"!2_\ Q-?RL?\ "J_VQ_\ H5/$?Y#_ !H_X57^
MV/\ ]"IXC_(?XT!9']4__$09^Q9_SUN/_ I?_B:/^(@S]BS_ )ZW'_@4O_Q-
M?RL?\*K_ &Q_^A4\1_D/\:/^%5_MC_\ 0J>(_P A_C0%D?U3_P#$09^Q9_SU
MN/\ P*7_ .)H_P"(@S]BS_GK<?\ @4O_ ,37\K'_  JO]L?_ *%3Q'^0_P :
M/^%5_MC_ /0J>(_R'^- 61_5/_Q$&?L6?\];C_P*7_XFC_B(,_8L_P">MQ_X
M%+_\37\K'_"J_P!L?_H5/$?Y#_&C_A5?[8__ $*GB/\ (?XT!9']4_\ Q$&?
ML6?\];C_ ,"E_P#B:/\ B(,_8L_YZW'_ (%+_P#$U_*Q_P *K_;'_P"A4\1_
MD/\ &C_A5?[8_P#T*GB/\A_C0%D?U3_\1!G[%G_/6X_\"E_^)H_XB#/V+/\
MGK<?^!2__$U_*Q_PJO\ ;'_Z%3Q'^0_QH_X57^V/_P!"IXC_ "'^- 61_5/_
M ,1!G[%G_/6X_P# I?\ XFC_ (B#/V+/^>MQ_P"!2_\ Q-?RL?\ "J_VQ_\
MH5/$?Y#_ !H_X57^V/\ ]"IXC_(?XT!9']4__$09^Q9_SUN/_ I?_B:/^(@S
M]BS_ )ZW'_@4O_Q-?RL?\*K_ &Q_^A4\1_D/\:/^%5_MC_\ 0J>(_P A_C0%
MD?U3_P#$09^Q9_SUN/\ P*7_ .)H_P"(@S]BS_GK<?\ @4O_ ,37\K'_  JO
M]L?_ *%3Q'^0_P :/^%5_MC_ /0J>(_R'^- 61_5/_Q$&?L6?\];C_P*7_XF
MC_B(,_8L_P">MQ_X%+_\37\K'_"J_P!L?_H5/$?Y#_&C_A5?[8__ $*GB/\
M(?XT!9']4_\ Q$&?L6?\];C_ ,"E_P#B:/\ B(,_8L_YZW'_ (%+_P#$U_*Q
M_P *K_;'_P"A4\1_D/\ &C_A5?[8_P#T*GB/\A_C0%D?U3_\1!G[%G_/6X_\
M"E_^)H_XB#/V+/\ GK<?^!2__$U_*Q_PJO\ ;'_Z%3Q'^0_QH_X57^V/_P!"
MIXC_ "'^- 61_5/_ ,1!G[%G_/6X_P# I?\ XFC_ (B#/V+/^>MQ_P"!2_\
MQ-?RL?\ "J_VQ_\ H5/$?Y#_ !H_X57^V/\ ]"IXC_(?XT!9']4__$09^Q9_
MSUN/_ I?_B:/^(@S]BS_ )ZW'_@4O_Q-?RL?\*K_ &Q_^A4\1_D/\:/^%5_M
MC_\ 0J>(_P A_C0%D?U3_P#$09^Q9_SUN/\ P*7_ .)H_P"(@S]BS_GK<?\
M@4O_ ,37\K'_  JO]L?_ *%3Q'^0_P :/^%5_MC_ /0J>(_R'^- 61_5/_Q$
M&?L6?\];C_P*7_XFC_B(,_8L_P">MQ_X%+_\37\K'_"J_P!L?_H5/$?Y#_&C
M_A5?[8__ $*GB/\ (?XT!9']4_\ Q$&?L6?\];C_ ,"E_P#B:/\ B(,_8L_Y
MZW'_ (%+_P#$U_*Q_P *K_;'_P"A4\1_D/\ &C_A5?[8_P#T*GB/\A_C0%D?
MU3_\1!G[%G_/6X_\"E_^)H_XB#/V+/\ GK<?^!2__$U_*Q_PJO\ ;'_Z%3Q'
M^0_QH_X57^V/_P!"IXC_ "'^- 61_5/_ ,1!G[%G_/6X_P# I?\ XFC_ (B#
M/V+/^>MQ_P"!2_\ Q-?RL?\ "J_VQ_\ H5/$?Y#_ !H_X57^V/\ ]"IXC_(?
MXT!9']4__$09^Q9_SUN/_ I?_B:/^(@S]BS_ )ZW'_@4O_Q-?RL?\*K_ &Q_
M^A4\1_D/\:/^%5_MC_\ 0J>(_P A_C0%D?U3_P#$09^Q9_SUN/\ P*7_ .)H
M_P"(@S]BS_GK<?\ @4O_ ,37\K'_  JO]L?_ *%3Q'^0_P :/^%5_MC_ /0J
M>(_R'^- 61_5/_Q$&?L6?\];C_P*7_XFC_B(,_8L_P">MQ_X%+_\37\K'_"J
M_P!L?_H5/$?Y#_&C_A5?[8__ $*GB/\ (?XT!9']4_\ Q$&?L6?\];C_ ,"E
M_P#B:/\ B(,_8L_YZW'_ (%+_P#$U_*Q_P *K_;'_P"A4\1_D/\ &C_A5?[8
M_P#T*GB/\A_C0%D?U3_\1!G[%G_/6X_\"E_^)H_XB#/V+/\ GK<?^!2__$U_
M*Q_PJO\ ;'_Z%3Q'^0_QH_X57^V/_P!"IXC_ "'^- 61_5/_ ,1!G[%G_/6X
M_P# I?\ XFC_ (B#/V+/^>MQ_P"!2_\ Q-?RL?\ "J_VQ_\ H5/$?Y#_ !H_
MX57^V/\ ]"IXC_(?XT!9']4__$09^Q9_SUN/_ I?_B:/^(@S]BS_ )ZW'_@4
MO_Q-?RL?\*K_ &Q_^A4\1_D/\:/^%5_MC_\ 0J>(_P A_C0%D?U3_P#$09^Q
M9_SUN/\ P*7_ .)H_P"(@S]BS_GK<?\ @4O_ ,37\K'_  JO]L?_ *%3Q'^0
M_P :/^%5_MC_ /0J>(_R'^- 61_5/_Q$&?L6?\];C_P*7_XFC_B(,_8L_P">
MMQ_X%+_\37\K'_"J_P!L?_H5/$?Y#_&C_A5?[8__ $*GB/\ (?XT!9']4_\
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M%3Q'^0_QH_X57^V/_P!"IXC_ "'^- 61_5./^#@O]BT]);C_ ,"E_P#B:/\
MB(+_ &+>?WMQQ_T]+_\ $U_*ROPM_;'4Y_X1+Q&?P'^-(/A3^V2Q+?\ ")^(
MP/HO^- 61_51%_P<$?L82C<);C'_ %]+_P#$TQO^#@S]BM'(\RXS_P!?2_\
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MW%1_\M*\O3D=D>J[V=WT%3I^%?"WQ_\ ^3C-/_[#]I_Z/6ONE.GX5\+?'_\
MY.,T_P#[#]I_Z/6OU3PB_P"2O7HC\I\7?^20D?TM_LV?\D"\(?\ 8!M__0!7
M;UQ'[-G_ "0+PA_V ;?_ - %=O7]:O<_D-;!1112&%%%% "/]TTT]!]*<_W3
M33T'TI/H0]P?[_X5^!'_  7W_P"2JK_V'8/_ $<M?ON_W_PK\"/^"^__ "55
M?^P[!_Z.6L<3_N5;T9UX+_?Z/JCKOA1_R3O1?^P?%_*NDKF_A1_R3O1?^P?%
M_*NDK^"<5_O53_$_S/\ 0#!_[I3_ ,*_(1>I^M+2+U/UI:P.@**** "BBB@
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MK!=V=KYD)8@5_-?^V;_P5Z_:'_;*\?W?A?X=:PMP)VS&(KAAU)_NBOW_ /\
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M)>= NP/^>1K^6O\ X.=/,3]KQW4<?8I/_9*_J4\3<:'<X_YY&OY;/^#GH_\
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M=>?LU_\ 0%7_ ,!EH_X=>?LU_P#0%7_P&6OI3 ]!1@>@H#F9\U_\.O/V:_\
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M_P! 5?\ P&6C_AUY^S7_ - 5?_ 9:^E,#T%&!Z"@.9GS7_PZ\_9K_P"@*O\
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MUY^S7_T!5_\  9:/^'7G[-?_ $!5_P# 9:^E,#T%&!Z"@.9GS7_PZ\_9K_Z
MJ_\ @,M'_#KS]FO_ * J_P#@,M?2F!Z"C ]!0',SYK_X=>?LU_\ 0%7_ ,!E
MH_X=>?LU_P#0%7_P&6OI3 ]!1@>@H#F9\U_\.O/V:_\ H"K_ . RT?\ #KS]
MFO\ Z J_^ RU]*8'H*,#T% <S/FO_AUY^S7_ - 5?_ 9:/\ AUY^S7_T!5_\
M!EKZ4P/048'H* YF?-?_  Z\_9K_ .@*O_@,M'_#KS]FO_H"K_X#+7TI@>@H
MP/04!S,^:_\ AUY^S7_T!5_\!EH_X=>?LU_] 5?_  &6OI3 ]!1@>@H#F9\U
M_P##KS]FO_H"K_X#+1_PZ\_9K_Z J_\ @,M?2F!Z"C ]!0',SYK_ .'7G[-?
M_0%7_P !EH_X=>?LU_\ 0%7_ ,!EKZ4P/048'H* YF?-?_#KS]FO_H"K_P"
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M""BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\;_\ @YA_Y'#P]_U[#_T
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MBB@ HHHH **** "BBB@ HHHH **** $?[IIHZ'Z4Y_NFFCH?I0OB0UN?,/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% "/]TTJ]!]*1_NFE7H/I0 C_=-?"/\ P7J_Y-:'^Y+_ $K[N?[IKX1_
MX+U?\FM#_<E_I0!_*?\ "[_D[F'_ +#LG\S7]?'_  2'_P"3/](_X#_Z *_D
M'^%W_)W,/_8=D_F:_KX_X)#_ /)G^D?\!_\ 0!04MCZCIZ=/QIE/3I^-!(M%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110!^-__!S#_P CAX>_Z]A_
MZ :^?/V%/^2!V7^\/_0:^@_^#F'_ )'#P]_U[#_T U\^?L*?\D#LO]X?^@U^
M+^-O_(AP_P#B_P S]M\#/^1UB?\ #_D>UQ]/P-%$?3\#17\PQV/ZCC\+"BBB
MJ **** "BBB@ HHHH **** "BBB@!R=?PJ/_ ):5(G7\*C_Y:5,_A8+J*G3\
M*^%OC_\ \G&:?_V'[3_T>M?=*=/PKX6^/_\ R<9I_P#V'[3_ -'K7ZEX1?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?I3G^Z::.A^E"^)#6Y\P_P#!0'_D5;S_ *X_^RU^N'_!#W_DRWPK_P!>Y_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (_W32KT'
MTI'^Z:5>@^E "/\ =-?"/_!>K_DUH?[DO]*^[G^Z:^$?^"]7_)K0_P!R7^E
M'\I_PN_Y.YA_[#LG\S7]?'_!(?\ Y,_TC_@/_H K^0?X7?\ )W,/_8=D_F:_
MKX_X)#_\F?Z1_P !_P#0!04MCZCIZ=/QIE/3I^-!(M%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110!^-__  <P_P#(X>'O^O8?^@&OGS]A3_D@=E_O
M#_T&OH/_ (.8?^1P\/?]>P_] -?/G["G_) [+_>'_H-?B_C;_P B'#_XO\S]
MM\#/^1UB?\/^1[7'T_ T41]/P-%?S#'8_J./PL****H HHHH **** "BBB@
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M5K_DWC4_^P7<?^@&OXTOC3_R5KQ'_P!AFX_]&&O[+?\ @JU_R;QJ?_8+N/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZ_K5[G\AK8****0PHHHH 1_NFFGH/I3G^Z::>@^E)]"'N#_?_"OP(_X+[_\
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M#_R.'A[_ *]A_P"@&OGS]A3_ )('9?[P_P#0:_%_&W_D0X?_ !?YG[;X&?\
M(ZQ/^'_(]KCZ?@:*(^GX&BOYACL?U''X6%%%%4 4444 %%%% !1110 4444
M%%%% #DZ_A4?_+2I$Z_A4?\ RTJ9_"P745.GX5\+?'__ ).,T_\ [#]I_P"C
MUK[I3I^%?"WQ_P#^3C-/_P"P_:?^CUK]2\(O^2O7HC\J\7?^20D?TM_LV?\
M) O"'_8!M_\ T 5V]<1^S9_R0+PA_P!@&W_] %=O7]:O<_D-;!1112&%%%%
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M_4S\F6P4444#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "@\#-%!&1B@!
M@D+?=KD/C/\ "3P_\9_"C>$O$:@PL3G*9ZUV$:; :8NUICQ0!\5:S_P0\_9B
MUW4YM7NT7S)GWM_H@Z_G4#_\$,/V773;Y2?^ 8_QK[=&X]^/K7Q+_P %>/\
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M5K_DWC4_^P7<?^@&OXTOC3_R5KQ'_P!AFX_]&&O[+?\ @JU_R;QJ?_8+N/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZ_K5[G\AK8****0PHHHH 1_NFFGH/I3G^Z::>@^E)]"'N#_?_"OP(_X+[_\
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M, _+TV-ZT#6Y^.'_  11_P""0/P]_;ANW'B'QC':,EH92K!CT7.. :_2U_\
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MF,0ZA2>]!5E8_EZ\3^$/&GAOQ3;77C:WN!<3SYE^TG)W<]:_J3_X-=VMO^&
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 1_NFE7H/I2/]TTJ]!]*
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M7_L'Q?RKI*_@G%?[U4_Q/\S_ $ P?^Z4_P#"OR$7J?K2TB]3]:6L#H"BBB@
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MIZ;!<Q_W+B%7'Y$4"OK<_C-O_P#@DI^TE=:I=2'P-K0^<X)L^OZ57'_!(O\
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M?Z5]W/\ =-?"/_!>@9_9:&/[DO\ 2@#^4_X7?\G<P_\ 8=D_F:_KX_X)#_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH :Y <9I70.,&FNN]ABD(*].: (=4D
M:&S;9_=K\"/^#EK5_BA<^,M0TKPVEV]JUJV5BMW89P/2OW]EB6>(H>XKP;]I
M+]@[X=?M&-+<>)[2U9Y%VEIH=Q_E0-:,_C,\/>#?C/INH'5-.TK4(YB<E_L,
MG^%=C)X]_:LC58(+C4@J+@#[!)7]3]I_P1+^ T$.!9:=T_Y]?_K4B_\ !$OX
M#,^XV>G=?^?7_P"M0.ZL?RO2^./VK_+WS7&I$?\ 7A+7T#_P31^(G[1>J_'S
M1[;67U#RDU9 WF64@&,>]?T2S?\ !%3X!O%Y!LM.^OV7_P"M6Q\,/^"0OP3^
M&'B&+Q%I-I8B2*82#9;XY_*@=T>^_LTS:A+\,K.3423)]GBSN&/X:]"P& W5
M0\.Z+:>'M.33K10$10HVCT%79,D96@5QQ7Y<"HFA\S,<O*D=*D#X3<PQBF2S
MQF%I PRJD_I0"/SK_P""YG_!.RV_:J^&7]KZ)I*/=:99,Z$J"=V6Z#\:_FT\
M>?!O]IK]DC5[JVTN&_M_(G<J4L), !CZ5_4?^V5_P4]\%_L[^)[+P=XJL;&6
M._G\DBZ4$$<^OTK.TW]DG]G;_@HQ\/)/'MEH6D6R3$*7M[4<$@^@]J!G\KI_
M:X_:SN\6+:MJ1W_*R_8I>]>J?LJ?L6_M _MA?%72K_6]-O9(C/B1I[%P.?<U
M_0E8_P#!NO\  "RUD:L=2LVVR!O+,!QP>G2O5I?"W[-/_!/'P\;34]"T2)TC
M#+<2VH!'&<YQ0!UW_!+?]D#1/V7?V=-(\+7&EI'J5J,/(N/[JBOJ*O!_V5_V
MQ/ G[1$<'_"%W]K+!*N4-MTZ5[Q02]PHHHH$,4*Y^852\1:6^K:5/IL9 \V)
MDY]QBKC#+@K2,6:79CCUH _(+]K?_@W;U#X^_%"^\<6UM8?Z;?&<EV3/(]S7
MW3_P2V_8AN/V$O@$WPENT@#M<+)^X(QQN]#_ +5?2@593CN*=LV<AJ /(/VQ
M_P!G.Z_:.^'DO@^W\LEX'3$F,<CWK\T/@9_P;@ZM\-_CE'\4[JWT\B/4GN/E
M9,\MGUK]BS/+OVB,XIY\O'7% '"^$O@YH=C\.X_A]KMDLL" @H,8Y&*^$?V]
M?^"!OP=_:.OQJ_@;P;9V]Y(Y>:61D^9CGGG%?I0%5!N4YI&)0AB,T ?A9X<_
MX-4]7T_75O=;M=,EM03NC#1^OUK]+?V*O^"7/P _99\+V4>E^"8(=3BC"S31
MLO)Q["OJ?SHV&%8'VIJP?-OW'GM0 ZW@BM8$MH5PD:A5'H!3Z** "FOU_"G4
MU^OX4 ?+/_!5K_DWC4_^P7<?^@&OXTOC3_R5KQ'_ -AFX_\ 1AK^RW_@JU_R
M;QJ?_8+N/_0#7\:7QI_Y*UXC_P"PS<?^C#06_A/V7_X-1?\ DOFG?]>2_P C
M7]'U?S@_\&HO_)?-._Z\E_D:_H^H)84444""BBB@ HHHH **** "BBB@ HHH
M/(Q0 F589/:D*(Z8 H*$(0#G-,A5E;F@"KXAADET>>"+^*(BOYRO^#AO]@?X
MW_&[]K(>*?!]K,]E]B=2$M6<9^3N/I7](3A7!1QP:Y[Q!\*/AWXHD,OB#PCI
M]W*?^6D]N&- '\BO[+7_  2\_:)T/XQ>']2N]*NEBM]:M9&+6+@8652:_K>^
M!FEW.D?!GPQI%X<36^AVT;@C'(C I;3X$_"*P*26GP\TF-T8%76T4$&NE6QA
MC\M+=@B1 !47@ #M0!-"K(-KG)Q3Z0 9W4M !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !3)68, #P>M/)(&0*C61V)!3IZT +)%&PWR+
MSBDY*A8^*#*2VPC%. V\CF@ #@#!S2[QZ&D\SVH\SVH 7>/0T;QZ&D\SVHWD
M]%H 7>/0T;QZ&C<?[AI-Y_NT (SCJ!36=(L$J3FG-(<<+FD5P_#KC% !(Q>/
M*=:2%7 S(:<%&[@\4UB)6V ]* ):* ,#%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4Q<L2"?I3G)"\5%(_D#/<T ->X9)Q$X)%3* 1N7@TV)O-7S
M'CY%.8\ +^5 "C..32T#IS2%B#PM ",YS@4+)D<@T;C_ '*-Q'1* %WCT-&\
M>AHW'^X:-Q_N&@!"RL,$&D#[>,4I<C^&FO(W&$H )%=P1$<4B>9$/WASFE.W
M^]SZ4\ $#(H 4<C-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ! (P1300P
M*@4ZFX&<J: $"MC$C<5\:_\ !:#X3^*?BQ^SN-$\+*S2A9,A$+>GI7V1(#-$
M4.0:IZMX?T;7;,66M645Q&/X)DR#0!_(#\._^"9G[0-I^TO'K+:->"$:P[EC
M8/C&3WK^H#_@EUX$UOX=?LNZ7X;UY&6>/;N#(5/W1V->PQ_ WX.070NX_AWI
M"RYR'%FN<UT>GZ;8Z3$+'3+&."$=$B7 % %DKC+.<@41R"09 H+8XQFE0*!\
MM "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'XW_P#!S#_R.'A[
M_KV'_H!KY\_84_Y('9?[P_\ 0:^@_P#@YA_Y'#P]_P!>P_\ 0#7SY^PI_P D
M#LO]X?\ H-?B_C;_ ,B'#_XO\S]M\#/^1UB?\/\ D>UQ]/P-%$?3\#17\PQV
M/ZCC\+"BBBJ **** "BBB@ HHHH **** "BBB@!R=?PJ/_EI4B=?PJ/_ ):5
M,_A8+J*G3\*^%OC_ /\ )QFG_P#8?M/_ $>M?=*=/PKX6^/_ /R<9I__ &'[
M3_T>M?J7A%_R5Z]$?E7B[_R2$C^EO]FS_D@7A#_L V__ * *[>N(_9L_Y(%X
M0_[ -O\ ^@"NWK^M7N?R&M@HHHI#"BBB@!'^Z::>@^E.?[IIIZ#Z4GT(>X/]
M_P#"OP(_X+[_ /)55_[#L'_HY:_?=_O_ (5^!'_!??\ Y*JO_8=@_P#1RUCB
M?]RK>C.O!?[_ $?5'7?"C_DG>B_]@^+^5=)7-_"C_DG>B_\ 8/B_E725_!.*
M_P!ZJ?XG^9_H!@_]TI_X5^0B]3]:6D7J?K2U@= 4444 %%%% !1110 4444
M%%%% !1110 C_=--'0_2G/\ =--'0_2A?$AK<^8?^"@/_(JWG_7'_P!EK]</
M^"'O_)EOA7_KW/\ Z M?D?\ \% ?^15O/^N/_LM?KA_P0]_Y,M\*_P#7N?\
MT!:_K'PA_P"2;?J?R-XQ?\E(O\/ZGVS1117ZF?DRV"BBB@84444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 444$X&: &@A!@TJL&Z4S)?G&,4@>.,Y>0#V-
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M^QTI_>:U-_WVM?+J?\$$_%D5N ?B4"W_  '_ .)IQ_X(&>*P@9OB4#D?[/\
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M_85)P==N?^^U_P *\D/_  ;WZ41C_A*[7\E_^)I8_P#@WRTE5P?%=KGZ+_\
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M!_O_ (5^!'_!??\ Y*JO_8=@_P#1RU^^[_?_  K\"/\ @OO_ ,E57_L.P?\
MHY:QQ/\ N5;T9UX+_?Z/JCKOA1_R3O1?^P?%_*NDKF_A1_R3O1?^P?%_*NDK
M^"<5_O53_$_S/] ,'_NE/_"OR$7J?K2TB]3]:6L#H"BBB@ HHHH **** "BB
MB@ HHHH **** $?[IIHZ'Z4Y_NFFCH?I0OB0UN?,/_!0'_D5;S_KC_[+7ZX?
M\$/?^3+?"O\ U[G_ - 6OR/_ ."@/_(JWG_7'_V6OUP_X(>_\F6^%?\ KW/_
M * M?UCX0_\ )-OU/Y&\8O\ DI%_A_4^V:***_4S\F6P4444#"BBB@ HHHH
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M*':-1MQG_ILO^- RUB-26)IJ%5))/6J[ZIIA&!J5OG_KLO\ C0^M:3$ &U"
M_244$\K;T)RD0?S"QXISE#]U 3[BH!J^CL,G4(/^_P O^-"ZKI:G/]HV^/\
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M"WQ__P"3C-/_ .P_:?\ H]:_4O"+_DKUZ(_*O%W_ ))"1_2W^S9_R0+PA_V
M;?\ ] %=O7$?LV?\D"\(?]@&W_\ 0!7;U_6KW/Y#6P4444AA1110 C_=--/0
M?2G/]TTT]!]*3Z$/<'^_^%?@1_P7W_Y*JO\ V'8/_1RU^^[_ '_PK\"/^"^_
M_)55_P"P[!_Z.6L<3_N5;T9UX+_?Z/JCKOA1_P D[T7_ +!\7\JZ2N;^%'_)
M.]%_[!\7\JZ2OX)Q7^]5/\3_ #/] ,'_ +I3_P *_(1>I^M+2+U/UI:P.@**
M** "BBB@ HHHH **** "BBB@ HHHH 1_NFFCH?I3G^Z::.A^E"^)#6Y\P_\
M!0'_ )%6\_ZX_P#LM?KA_P $/?\ DRWPK_U[G_T!:_(__@H#_P BK>?]<?\
MV6OUP_X(>_\ )EOA7_KW/_H"U_6/A#_R3;]3^1O&+_DI%_A_4^V:***_4S\F
M6P4444#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "@]**#T- $#OY;9"@
M#O2H^]BZG@TUF!_=2CK4;.L?^C0'!'6@=CPC]OO]E;PQ^TM\#]?T6]L89KL:
M6Z6VZ/+!B>WYU_+9X]_9M^(?_!//]LN.]U;PI-/:02RR%+I<J1Y@(X/M7]:W
MQ4^-G@'X0VJW'BK4XD69<L/.4'_/%?$G[4'@O_@FQ^V-XF?7OB/8I=ZDZ%-Y
MEB/'XCVH&D=?^Q9\ ?V=OVL?V6/#OB#5/!VB'4+RS+3QFQ4LAP/:LSXI?\$'
MOV??&T,\EO;V%L9,D"*UQC\A7MW[$'PQ^$OPJT2'0_A488M.A@VVZ"1>%Q[5
M]%JXD7*&@-;GXC_'G_@UO^&_BN::;2/%<L1;)"PJX_D*\U_9J_X-Y?$7[/?Q
MALO$FE7VH7$5KJ*R9);! 'O7[_Q^69L$?-3UCA5B57YC[4">YQ7P \,7OA?X
M?V^CZA$R/'&BD-UX7%=NA<G8>@[T8E#?-]VG,PQA:!&)X[\1+X6\-76N@#$"
M9.:_)C]M3_@X1N/V;_C#J'@"TTNUF^R_WMN?O$=S[5^J_P 7M#FU_P !7^D6
MZY,T> ,=:_G._P""JO\ P1G_ &A_C-^T1J_C;P#HB,ERWRL8B>-Q/;ZT%)(]
MYLO^#H^^&]I=#L\GL2G'ZT]?^#HV[W<:-9DGME/\:_+/X\_\$H_BQ^SEX<BO
MOB)ID4<US#NBVKCGGU^E<!^SM_P3A^.OQ^U-$\):3YL3R%03"Q'6@+6/V/7_
M (.D[M<C^P[/Z?)_C4+_ /!T;?3OG^Q+0$=!E/\ &OSYNO\ @@!^U=%I<VI_
M\(]'B.%G/[ANPS7R?\2?V1OB7\'?B'#X(\:Z<8[B:8K&#&0./K04?U=?\$PO
M^"F;_MK6UDTUI#$UQ$&(CQZ>U?<%?D%_P;>_LJ>*?AU\.M$^(.H0QBV>$*"O
M7[H_QK]?:"'N%%%% AI<["5'(HB=F3<XP:BDF$<@1#UI\DRQ)F6@!^3@X'TH
M1BPR1BH'O;=,%KJ-1Z,X%31313KOAD5AZJV: '4444 !.!FHHYV9F#KC'2GR
M'"Y-1-+$!F655QTW-B@"4RJB;Y#@4>8&4,G(-5C=6%Q$89KV$Y["45-&JK&$
MMV4KVP: ),GCBAVV+FC., GFDE&4P* %W';N J-69N7&*(Y"O#GZ4XL&Y% '
MRU_P5:_Y-XU/_L%W'_H!K^-+XT_\E:\1_P#89N/_ $8:_LM_X*M?\F\:G_V"
M[C_T U_&E\:?^2M>(_\ L,W'_HPT%OX3]E_^#47_ )+YIW_7DO\ (U_1]7\X
M/_!J+_R7S3O^O)?Y&OZ/J"6%%%% @HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *S_$DD
MZZ:_V52TG8"M"H98U\T,1S1>*W&E<_$/_@HQ_P %G/VD/V2/C3JGARW^&DLF
MGQW:Q07+E<-EL=S7D%E_P<$?M&:E;I?6WPZD;*@X#)_C7IO_  <F^"_"L=A8
M:E96^+N76(O-;'7]\M?&/PL\%>'QX8CEFA^;R5/;TKW,BRF.9<]Y;'YQXA<;
MU^#HT7"GS<U[^>Q]#G_@OW^TI,?,;X;R@_W=R_XTT?\ !P%^TN6VCX8RG'^T
MO^->+Q>#O#KR;C!2'PKX?B<@05[JX4@HV<M3\W7CAFK7NX-?B>U3?\%_OVEI
M#M/PUE'_  )?\:5_^"_O[2B0A1\-I/KN7_&O$SX0T.5]P@I7\)>'0-KP=_04
M4^$4]YC_ .(X9K!>]A%^)[6G_!?G]I8<_P#"M9?^^E_QI7_X+^_M*@8_X5I+
M_P!])_C7BJ^$- ( %O2-X/T#.WR/T%'^J5+_ )^#CXX9EUPB_$]L@_X+^_M+
M9Y^&DI^K+_C7E7[6O_!9GX]_&;X<7WA36O \MO#<@;CN7C@CL:RXO"/A\<>1
MW]*X']H'PMHMKX.NKA(<8'I[&L:W"U*E2<O:'7EOC-F.,Q\*+PZ2;\S>_8M_
MX*L?&/\ 9_O&OO#O@M[IW@*$ KZ$=S7T--_P<!_M+2 AOAG(,_[2?XU\:_LU
M>'-'O[HF:+(\O/Z5[%/X/\-NRHMO^E+!\+TJV'<G4U-LZ\8<RP&8.A##W^\]
MKM_^"_W[2,<0S\-9#]67_&HF_P""_?[2LLFX_#:4 '^\G^->+OX-\-QIL^S\
M_04J^#O#0&?L_P"@K5<(P4E>H>;_ ,1NS1ZK"K\3VN3_ (. OVDRPC_X5I)_
MWTO^-%W_ ,%__P!I;R%5/AG+U[,G^->)OX,\.L-Z6_/TI%\):&1M\C]*<^%J
M"7\0/^(WYM->[A%^)[6G_!?[]I39D_#67_OI?\:7_A_]^TILW?\ "M9?^^E_
MQKQ%O"'AY0?]'_2A/"/AUDP8/TI_ZJ0_G(_XC?FO_0*OQ/;E_P""_P!^TH5+
M?\*VEX_VE_QJCX>_X.(_VDM9\>6_@&U^&+R7%P"5C#)D\@>OO7C\WA3PY% Q
M$';TKF?V6/!GAO5O^"AOAFUNX,VS1MO'']^.O,S7(HY=A?:J5]4C['@GQ+QG
M%><_4:M!07*W?7H?T8?L$?%'Q[\7/A'I?C7QMH<EC->0%GB?'RG KWN639&7
MC&2.U<1^SQINFZ1\*M,TW2(]L,<?RC\!7;-&T;94<=Z^9/U\+662:(-*FUNX
MJ6F(69]PZ4^@ H(R,444 ,C^4XSUI90&7FD7J/K3GZ?C02W8I>(0%T.Y4?\
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M^+_,_;? S_D=8G_#_D>UQ]/P-%$?3\#17\PQV/ZCC\+"BBBJ **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4'IUHH;H?I0!$0A//6O/?VE?C+IOP+^'%WXTU"-"%ADP6..0M=^J%CN/;I7Q
MU_P6SU2_TO\ 9)N9H'*9>495L?PB@I;G\]7_  5&_P""M'QR^,/QDU?PQX,\
M::I90V>HO%&EO(,$8Z#.?6ODB#X]_MEQ ZE'X_\ $4:9SYORX'Z5W'P$^%N@
M?&G]NBU\'^+)I/LVH^*5AF(Y.TK]:_I*T7_@W3_8KUCX?V>F7%Q=A;FSBD=A
M:C.2@/\ ?]Z!L_$+_@G=_P %J_C7\ /&UAHWQ!\0ZGJ<3W$<3"ZDX&2!GC%?
MTN_L-_M=^'?VKOAC;>*=&$2LEK'YHC8GYB.<\FOYA?\ @L5_P3HTS]B'XI7-
M_P"$+:9-+CU%19S."I8!_K7Z!_\ !LK^V#XED\-3> +N]#K/>>6H>3)P']Z
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M@^+^5=)7\$XK_>JG^)_F?Z X/_=*?^%?D(O4_6EI%ZGZTM8'0%%%% !1110
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M*UB_^)W[;\EOH=KYR_\ "16QW1^GFB@>J1_45_P21\57?B;]GG3IKJ8N4TR
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M]O>L_P#X*]?LH>(_VD?V<9_"7A&YNOMCS,VVU<AL$#TKX/\ ^"2O_!)_XO?
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M';\:*R74V?QOU"BBBF 4444 %%%% !1110 4444 %%%%  .A^E5]2_X]9/\
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M5\U_M5_\%-?A%^R=.+?QK;;F,XB_UF.2P'I[U]*+A8E*MG:H%?DI_P %J_\
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M]GV)<L#)GL#_ %KYC_X+A?L,_$7]JKX;WVF>!WOS--,Q5;.1@?TK)_X((_\
M!/WXA?L=2:[=>.;K4"U]%A5O96;!VJ.,_2@#],5BG*_?YKY?_:X_X*=?"/\
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M49.VRF/]*UH_^"L_[86=K7?B$Y_ZATW^%?0O[('[#.B?#;Q"^H:]X.MF1HL
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M_P!:_4VTM6L5$8<M[F@K0^=?VL_^"DWPE_9+U*?3/&D8>2 X9?-P:Z_]E/\
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M5*N..5Q7YZ_\%(_^"#O@C]HS[5XI\(_9=-O)=TI>"/YBQSZ@T#3L>,_MF?\
M!>7]F[XK?L+ZEX6T'5IVU1K>)$!E!Y$3 \8K\H?^"<_PIU_]K;]KV36])TZ6
M6)-0AG+/$2,!L_TKZU\#?\&T?Q@NO&2Z3J_Q*OVT]I&W0R(NP\_[GI7ZZ?\
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MPS'?*.:<@B/[H#[M24@50<@4"(W\XR#RS\O>DD\K?M(YJ:D**3DB@!C1B0#
MZ4H5MN).E/P!T%% $0MH$.\+2[4D;>!TJ2@ #H* &!6+;Q2R'Y=O<TZ@@'J*
M *Y2788QU-/CC;9B3TJ7 SFB@"OAPX\OIWIS@-\M2A5'04;%ZXH'<A0.N=QX
MJ2)E8\4[:OI0%5>@H!NXQPL1WCJ:3RXY3YCCITJ0J&X(I0 . *!$:R'><=.U
M([O)Q$?K4FU1VH"@=!0!7,<3GRYER34D43+\I^Z.E2%%)W$<TM $<J2,P"GY
M>XIICB#>6HYJ:DVC.['- #&C<@8[4P+<;OG/RU/10 Q1&AR :;+# ["=QRO2
MI<#T%! (QB@"-'5_W@'!HC@CC)9!RU/"J!@#BEH A(&/)/4T/"NS;*.!T%2[
M5)W8YI2 1@B@"O'&BH1",9I,%EV'K5@(HZ+1L7.=M [D(B! W]NE.)&S*]C4
MFU?2A@ N *3"]S\-?^#DB%ETO3I6/!UB+_T<M?&GPTG23PO%CJ(%_E7V9_P<
MDL3INGJ3Q_;$7'_;9:^,?A> /#<.!_RQ6OL>$_MGX%XY[87Y_H=!$SB/>300
MKGYQFG #<5[4N!Z"OL7LC\*CLA(Y+9/E"\TDB+(?EIVQ0<XI::DBG.IT8T;0
M,$"E^3VI:*5V+EAYB?)[4AV9Z?E3J*%)H.6GYC,IZ&C*>AI]%/F8<M/S&,8\
M<@TTH"!MJ4@'J**&XO=#YIQTB]!B"51UI6((PW6G48'I6;A%L3UV(YNGX4W_
M )9TZ;I^%-_Y9U:!_ O4=<?\><G^Y7)?LKR*/^"@/AM._EMC_ON.NMN/^/.3
M_<KD/V5 /^'@_AHX_@;_ -#CKP>)?^19\T?HWA(K\:R_P2_)']-W[/:!?A1I
M;=S'_05V4B19$KCI7'?L^_\ ))M+_P"N?]!7:R*IX(XK\\/ZJ")Q+^\7H:/)
M50=@Y-+&H5<*,4Z@"O !%)LD'S'I4I5BQW]*<54G<1SZTM # ><IT'6ABI/
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MON2T/!A_P5;U]DVQZI<;_7#5$_\ P5,\1_?DU.X)[\-7OH_X)V_#X'(MK/\
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M-%(W0_2@"+>C X->/_MJ?M$I^S-\(9?B"+E8]A8!G]@#_6O7UV.#A<5\B?\
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M_H<=>!Q+_P BSYH_1_"/_DMI?X)?D?TX?L^?\DFTO_KG_05VK]?PKBOV?/\
MDDVE_P#7/^@KM7Z_A7YX?U2*GW12TB?=%+0 4444 ,7J/K3GZ?C35ZCZTY^G
MXT$R*?B+_D"W/_7%J_G+_P""['_)_EA_UXR?SBK^C3Q%_P @6Y_ZXM7\Y?\
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M%%% !1110 4444 (_P!TTT=#]*<_W331T/TH7Q(:W/F'_@H#_P BK>?]<?\
MV6OUP_X(>_\ )EOA7_KW/_H"U^1__!0'_D5;S_KC_P"RU^N'_!#W_DRWPK_U
M[G_T!:_K'PA_Y)M^I_(WC%_R4B_P_J?;-%%%?J9^3+8****!A1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !0>E%'TH B9&*' Q63XJ\(:/XTT=]#UJVBFC
M=2"DR!AR,=ZVER 2QJ,1CSC+0!^;?[>G_!!3X,_M Z/J6O:=)';7C1L\<=M
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M^>Z_XTK^(-'5@/[7MO\ O^O^- K%Z.5V7+#FG;SZ"J7]N:-][^UK7'_7=?\
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M 4-T/THH;H?I0!'7PS_P<!_\F.WG_7TW_H(K[FKX9_X. _\ DQV\_P"OIO\
MT$4U_$0EU/A;_@BG_P ?'B#_ *Y_^RK7WHQPY.!UKX+_ ."*?_'QX@_ZY_\
MLJU]Z/\ ?/UK\%XA_P"1M4]3]VX9_P"13$8R%FW;S3R<C! I**\0]\,#9M '
MUIOE^].HHLAJ36PWR_>@)@]:=12LA\\NX444460<\@II0E]^[\*=119!S28$
MYHHHHY4+F8N3C%)110DD+<*5/OCZTE*GWQ]::W!['Y]?\%J/^1LT'_K@/_0#
M7Z)_\$)?^3#="_WE_P#0!7YV?\%J/^1LT'_K@/\ T U^B?\ P0E_Y,-T+_>7
M_P! %?M/!W_(E7J?BO%G_(S9]GQ]Z5.GXTD?>E3I^-?4Q^$^46XM%%%4,***
M* "BBB@#\;_^#F'_ )'#P]_U[#_T U\^?L*?\D#LO]X?^@U]!_\ !S#_ ,CA
MX>_Z]A_Z :^?/V%/^2!V7^\/_0:_%_&W_D0X?_%_F?MO@9_R.L3_ (?\CVN/
MI^!HHCZ?@:*_F&.Q_4<?A844450!1110 4444 %%%% !1110 4444 .3K^%1
M_P#+2I$Z_A4?_+2IG\+!=14Z?A7PM\?_ /DXS3_^P_:?^CUK[I3I^%?"WQ__
M .3C-/\ ^P_:?^CUK]2\(O\ DKUZ(_*O%W_DD)']+?[-G_) O"'_ & ;?_T
M5V]<1^S9_P D"\(?]@&W_P#0!7;U_6KW/Y#6P4444AA1110 C_=--/0?2G/]
MTTT]!]*3Z$/<'^_^%?@1_P %]_\ DJJ_]AV#_P!'+7[[O]_\*_ C_@OO_P E
M57_L.P?^CEK'$_[E6]&=>"_W^CZHZ[X4?\D[T7_L'Q?RKI*YOX4?\D[T7_L'
MQ?RKI*_@G%?[U4_Q/\S_ $ P?^Z4_P#"OR$7J?K2TB]3]:6L#H"BBB@ HHHH
M **** "BBB@ HHHH **** $?[IIHZ'Z4Y_NFFCH?I0OB0UN?,/\ P4!_Y%6\
M_P"N/_LM?KA_P0]_Y,M\*_\ 7N?_ $!:_(__ (* _P#(JWG_ %Q_]EK]</\
M@A[_ ,F6^%?^O<_^@+7]8^$/_)-OU/Y&\8O^2D7^']3[9HHHK]3/R9;!1110
M,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M110 4444 1S=/PIO_+.G3=/PIO\ RSJD#^!>HZX_X\Y/]RN0_94_Y2#>&O\
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M5_X.<=!=MWD7A7/3YZ^(8_\ @@%^UC<';#X U;"]<2/5F/\ X-]?VL!\W_"
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M=-MK74-/M7E9;>+YYGY]CSS7\Y/COX)_M/\ [&7Q)EM=-T77+2&WE<K(@"C
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MUC&23*.E4Z%5.UB%C\"U?VB/Z2/^$J\+_P#0R6'_ (&)_C1_PE?A;_H9=/\
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MA_QIIW]E^(].6YMR<^6_2@&['\96H?\ !)S]M5-2FCM_"$I5GP/FD_PJ,_\
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M\95^-SZ\V@)]E.,-M/\ >/M7W2DN?W;@E>XJ:*VT%/WBV"B3^]1?R->6F+X
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MC0!^/W_!=C]B;]ICXZZMHMQ\*](FF2*8ERDCCC+?W1[U[C_P0M_9J^-WP ^
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MB>*?PI:2.@U"-B59N@<'M7V+A]V=U(=(TFXD$E_:K(=P//K13J1N)]S\NO\
M@H+X4UKP+:>';'Q#&5F-@@ 8GKM]Z_5/_@AWONOV M)0#YF3 _[]BOSQ_P""
MTZ6Y\5:"8(]JI;C@?[IK]#_^"%1,W["&AX.W++U_W!7[)P<O^$8_&>,IIYN?
MEQ_P4\_X)I_MH?%']JNT\7> _#]Q)IP\0K,7664#9^ K]@/^"7OPG^(7P?\
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M^)_F?Z 8/_=*?^%?D(O4_6EI%ZGZTM<YT!1110 4444 %%%% !1110 4444
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M ."&'[8?PX@DO-#\(:WB,$@K=2CI7SMXV^&'[9O[/MS(GB)-=L$B8\_VE*,
M?C7Z]_MC?\'-_P &O&D-WH/PNFU&"4!E4L[$<_117Y0_M+_MO_'/]IWQ+)!:
M7-[<07$C!0+61N#TH!;'.^!O^"BO[0GPTO$">+]7E,>/EEU20_S-??O_  2Z
M_P""UGQX\3_%'3?!^OJTD,]\D+-+/N.,#UKX)^#?_!-K]HO]H'5(H="TN6.2
M;'S3V3@<_4BOU$_X)?\ _!OU\?OAYXWT[QSXVBM&BAN4GXAP0/Q8T"M=G[[?
M!;QA-XT\$VNM.P+201L<>ZYKJEE_>':V3Z5SOPH\%KX#\)V^@A ICA12!ZA<
M5T4:()2RCGO0+0G8KMR_I4;SP1P&5B-H&:?L+*5DYJKJ4"-I\T*#I$V,^N*!
M'Y^?\%F/^"LP_8B\%QZ3X=:UFGU2V9-DRJ>?FZ9^E?SU?&K_ (+,?'?XD^,)
MM:@5[,EWV_99]G!/^SBOL+_@Y[L?&>H?$_PWIM^7>"6_*Q8C. /GK8_X)(?\
M$+_ /[5_P)7XC^+M%LKJ3SU4EW3=R&]?I0-;GP,__!6[X]/9I97]U<7*@8Q/
M=%_YU%9_\%6?C'IUPLEA:;')SN20 Y_*OVYE_P"#8_X$2C;'X$M 1WW1_P"%
M1)_P;&?!*(^:? ]IQ_M1_P"%!74M_P#!O%^UA\1/C\^F2^+IYB)8%+*\Q8=*
M_8FOD3_@GO\ \$W_  3^QQ!:_P#"-:'%;&W0*/+(]/:OKN@E[A01D8HHH$9'
MBOPEIWB_P_<^'=5C5X;E<.KKD'\*_(K_ (*A?\&^OA'XZ^(=0\?^"(KA;R=R
M5BLE9 .<C&TU^Q7W@3WJ-UG)R6XH _F(\/?\&]/[0GB+Q,F@:_::\FGP3>6A
M-Y,1L^F:_6W_ ()0?\$;OAO^QMHEIXCO-SZG;2*RK<QEF]3RU?H0EI;QDNJ?
M,>].6%&/[T9- 'SY_P % _@+J?QH^$5SX9T"T>1I+65!'%D8R/:OQ:_98_X(
M7?%CX>_M1Q?$2[\-WZ0KK,L^YG?&"Y-?T4&*;E01M]*A6QLH)-Z1?,3UH'=G
MDUE^SOI'C;X'I\,_%L0";&!61-V,J!7X_P#[>_\ P;6Z;XB\77WC;X:3:C)<
M75PTQ2V>10#[8-?O (E;]X/O4]E4@*U 79_+[X4_X-ZOVDM9U$>'/$%OXA2P
M=B&9KZ8C&<=,U^IG_!*G_@AY\//V2KU/&.L(\][+#\ZWL9?! _VLU^F@MH4.
MX+3F4D#;0*[(=.TVVTRRBL;9 J11A%"C' %3>6/6G#IS10 T1@4C#!Q3Z:_7
M\* /E;_@J_%YG[/&I?,1C3+CH?\ 8-?QK_&F4GXK^(UQ_P QFX_]&&O[*_\
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MN"U]CPG]L_ _'/;"_/\ 0Z/.9#2TT??/TIU?8OH?A2V"BBBD,**** "BBB@
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M#1&!)YF?PI0N"3GK2T460"$;FW$TX98A?>DI4^^/K0HI,&?GW_P6D<Q^*M"
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M4]:=10 UD4#--P .!3W^Z::>@^E)]"6V-V!&P#VK\"O^"^QQ\55XS_Q/(/\
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MZB@! @#;A0JX.<TM%    ,"D"@-NS2T4 %%%% !1110 4444 %%%% !1110
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MW M1X#B=9#][>O'_ (_7P!>?\&^O[:X;-QX$D##KA9/\*IW/_! ']M0R*8O
MLAQ_LR?X4%G]!O\ P3*_X*>VG[;5O9K%HT=LUQ&&PI!QQ]37VY7Y/_\ !!/]
M@?XM_LKP:9+\2-$>VFA@"N&#<<>]?K!00]PHHH/(Q0(8P5S\KTTR/$-NPM[T
MOD[#N3K3TW;?FZT (/F3)7%,1V$FPIQZTX^83CM2L"J_(.: "5R@R!0JJ1DK
M1MW*-W6C#_=[4 -VA7W[^/2GAE;[IS33$&X/2E6,1@[>M "AB3RM!=0<$TQ#
M,6^8<4IA4MN- #Z*!P,44 %-?K^%.IK]?PH ^6?^"K7_ ";QJ?\ V"[C_P!
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M^2'>&/\ L!6W_HL5\]BOXI]UE'_(O1Z G7\*=34Z_A3JQ9Z"V"BBBD,****
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M.A^E5]2_X]9/]P_RK2/\&9S8C^#'U1O_ /!&'_DZ/6/^PTO_ *"E?TIZ%_R
M[/\ Z](__017\UG_  1A_P"3H]8_[#2_^@I7]*>A?\@.S_Z](_\ T$5^2XS_
M 'J?J?W-DG_(DPW^"/Y(M4445RGIA1110 4444 %%%% !1110 4444 %%%%
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M_O#_ -!KZ#_X.8?^1P\/?]>P_P#0#7SY^PI_R0.R_P!X?^@U^+^-O_(AP_\
MB_S/VWP,_P"1UB?\/^1[7'T_ T41]/P-%?S#'8_J./PL****H HHHH ****
M"BBB@ HHHH **** ')U_"H_^6E2)U_"H_P#EI4S^%@NHJ=/PKX6^/_\ R<9I
M_P#V'[3_ -'K7W2G3\*^%OC_ /\ )QFG_P#8?M/_ $>M?J7A%_R5Z]$?E7B[
M_P DA(_I;_9L_P"2!>$/^P#;_P#H KMZXC]FS_D@7A#_ + -O_Z *[>OZU>Y
M_(:V"BBBD,**** $?[IIIZ#Z4Y_NFFGH/I2?0A[@_P!_\*_ C_@OO_R55?\
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M0 444C=#]* &5\<_\%B?%7B_X;?LYS>,?#.I2Q2),Y'D]> #7V")O+!#\'/
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MQ]*_6W\$?0_B#"[O_$_S']OQHH[?C162ZFS^-^H4444P"BBB@ HHHH ****
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MWJFE^$G1IYPZQQ >OUK(\"?LS_M+7&C2ZMX<\"ZQ&$Y5H !_6@/(_KB^&/\
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MG-_P<&?!- 676=++@\+OZ_K04KGV+^S?^QG\)/V;8X8?A[X;6R6%<( 1QQ[
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M^#47_DOFG?\ 7DO\C7]'U?SA?\&I+8^/^G*?^?)/Y&OZ/:!/<****!!1110
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MC_V ;?\ ] %=O7]:O<_D-;!1112&%%%% "/]VFGH/I2R=*0]!]*3Z$/=B/\
MZS\*_ G_ (+[_P#)55_[#L'_ *.6OWU=?WG6OP*_X+^)CXHH?^H[!_Z.6L<3
M_N5;T9U8/_?Z/JCKOA1_R3O1?^P?%_*NDKFOA-_R3K1<_P#0/B_E72U_!6+_
M -ZJ?XG^9_H#@_\ =*?^%?D(O4_6EI%ZGZTM<YT!1110 4444 %%%% !1110
M 4444 %%%% "-]TTT G.!3\XYI$(W'BA?$AK<^8/^"@0/_"*WG'_ "R_]EK]
M;O\ @A[_ ,F6^%?^O<_^@+7Y(_\ !0B3;X5N_E_Y8_\ LM?K7_P0[8M^QAX4
MR/\ EW/_ * M?UCX0_\ )-OU/Y&\8O\ DHU_A_4^W:***_4S\F6P4444#"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "@]#10>AH JL)A*/*^[WKYD_P""
MKOQDUOX,_LV7/B7P[<>7<@R './X17TX^7/RM@UXQ^VG^SR_[1GPO;P(TBC=
M(22X&.<#^E!:/Y(?VC_VTOVB_CA\6-:\)'4Y)$EOVBC597Z$"MK]F?\ X)0_
MM1_M$>+[6S7PY)/;W9R=P<YR1_C7]"/P*_X((_!CP3XP;QCXL\,Z;?O)<"8A
MP,]J^V_ 7[+7P-^'!AD\)^ K*SEA4!7B7D8% 'X^_L*_\&U^F>%+NVUSXM>#
M70'#,?)[CZU^EW@/_@EU^S/X'\.IH-CH("M$JN# O7%?2<5JEL@C@ 55Z 4H
M(F!XP1T- 7/E#Q;_ ,$;_P!D/Q;-)<ZKX?)9P<X@6O)[/_@AE^SYX#^(%EXM
M\&^''5H;L2AO* _E7Z$HAV!6;\:7<C'#)G%!!S?PS\&?\('X?BT*TCVQQHH
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MDH4 [E/)^AK\"?VBO^"#7Q/^%O[.-I\7M/\ $[-<6^C&[G\M%W9!(YXKQ?\
MX(G_ /!0[XD_!']J/2OAIXQUZ[>RCNG62.8X4[9 *!2/ZO%F&XH3TI#&SN&/
M:N9^$7C.U^)7P_T_QA9,-EVFX$&NH:7:P0#/O02-NYC#"T@/W02:^8_VJO\
M@J)^SA^RYIMQ#XT\2_9[S81& ZCYOQ/M73?\%#_V@A^S?\!;KQSDYVR("IYS
MM_\ KU_+I\6OBY\9_P#@H!^UG-X(L/%=ZMM/X@\E%/*JI'O]:!I7/VA\'_\
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MZT;V]:=]GG_YXM^5'V>?_GBWY4!S,;O;UHWMZT[[//\ \\6_*C[//_SQ;\J
MYF-WMZT;V]:=]GG_ .>+?E1]GG_YXM^5 <S&[V]:-[>M.^SS_P#/%ORH^SS_
M //%ORH#F8W>WK5W0HS)J*-WJI]GG_YXM^57-"M[C^T4PC#\*!2=T?GO^WQ
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX[?]"QJO_@LE_P */^%+?';_ *%C5?\ P62_X57^M.-_E0O^(+\.?S,^]_\
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M;=_R+&J_^"R7_"C_ %IQO\J'+P7X=6TG^!]ZWO[3OPHC@(3Q%&<CT'^-<I\
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M^TQ\)E;][XC0#_='^-*/VF_@_P"<5_X2=-N.NT?XU\&CX+_'1XB7\+ZJ2/\
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M^% <J/ZRO^'ZG["7_19;7_OE?_BJ/^'ZG["7_19;7_OE?_BJ_DU_X5+\?/\
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M(PW_ !+)>?TJ0_"3X_QDX\.:KR?^@;+_ (5\9C>#*.-Q+JU)63ZH^RP'&%;
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M[_GZ_P  _P!?<Q_Y]Q_$_HJ_X>M?LB?]%,@_[X7_ .*H_P"'K7[(G_13(/\
MOA?_ (JOYU/^%4?'_P#Z%S5?_!9+_A1_PJCX_P#_ $+FJ_\ @LE_PH_U"R[_
M )^O\ _U]S'_ )]Q_$_HK_X>M?LB?]%,@_[X7_XJC_AZU^R)_P!%,@_[X7_X
MJOYU/^%4?'__ *%S5?\ P62_X4?\*H^/_P#T+FJ_^"R7_"C_ %"R[_GZ_P
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M !H_X;]_9Z_Z'B+_ +Y7_&OQX_X4Y\>O^A9U7_P63?X4?\*<^/7_ $+.J_\
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MJG'_ %#)O\*/^(*Y#_T$2_#_ "#_ (C=GO\ SYA^/^9^PW_#?O[/7_0\1?\
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M_P =6O[''['6BVVM(L;6&GN2LW'1?_K5\K? [_@OWX1^(?QC'PP,-D&EU!X
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MPMT(_P#;D*]P:V&2<4Y(F5<4ES[MC32T/#_^'?\ ^S9_T2K0O_ (4?\ #O\
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M/^'?_P"S9_T2K0O_  "%>X[&]*-C>E <QX=_P[__ &;/^B5:%_X!"C_AW_\
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M9T4/URO?_8%%F'.T>K']@O\ 9PFD;_BT^A*/^O$4G_#O_P#9L//_  JO0O\
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MPS_AW]^S;_T2O0O_  "%'_#O[]FW_HE>A?\ @$*]SV+Z4;%]*.7S#G9X:O[
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M: /P%_X.S62'X<6#3#<#J:X![?O5K\[O^"$CEOVS/""QW.S.K?=SUYK]L?\
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M _"_]BW4+>T^.6@"5 <ZY: 9_P"NJU_:E^RSM_X4-X6?=G.@VV/^_8K^<KX
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M^@;X"(!\,]/E+9RG]!79G!(.>E<Q\)-!OO#O@>ST6_B*/"F"#^%=*R9Y4T
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MS4^FA2']J=0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% $3,%&XUPGQX^//@;X ^"I?'7C2_6&V3()W@'(&>]/^//QY\$?
M;P+?>,?%>LVL(LX?,\F>7:6%?S<?\%J?^"SWC+]I?QUJWPC^$%Y=P6>YFC>Q
M<LF"2.Y/I04C]F/V<O\ @L5\&OC[\5-1\ ^'O$+2M;7OD*AE![ _UK[ETV2.
M:SCN(CQ)&KCZ$9K^0+_@C?\ &;Q'X3_:5LU\5Z])'->ZU&&^T-@N<#_"OZX?
MA7K<6O>"M/O8I0X-E#R#_L"@':QT=%%%!(4444 %%%% !1110 4444 %%%%
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MC"@>U+0.E%! 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6#$GUK](_P!GWX ^%?@'\,8OAUX6TV.VMX8RJQH1@?+CM07I8_D]_:8^!O\
MPR'^W1I<&E"2WL;/Q6HC?)7*@5_3[_P3+^,4'QG_ &>;+Q!:70F2&&",L#WV
M$?TK\7/^#G;]D#Q)\._$VB?$WPU"$:XNC<L\29QRXR<?2O=/^#8/]O**]^$4
M/P+\8:T)-4N=041M)+C 4LO0_44!+8_;:>=P0D R<\U)OQ@-U/6JD;><0+=P
M3W8'(-6BFX@DCCK00.#J6VYYI:8"OF8"\^M/H **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *AN3*K+Y:\=ZE;)'RTR:3: G7- #MY9,IR
M:_!W_@YL_; \>>'/#:>!=#N"B?VDL+;)BIPTB@]*_=Z&*5&!W\>E?BO_ ,'*
M_P"P_P")/'?P\7QQX:TYI9?MGG,8HMY 5PW:@#Y(_P""%G_!*SX=_MCPWOQ%
M^)$MR\L%X7/!<<M[FOI#_@K%_P &^_@'2O!=_P"./A'874UT"Y54C*C &>Q-
M?G?_ ,$G/^"H_C7]@WXKQ>"?&=]>QZ8VIE;JW\IU#*&Z5^T7[0W_  7Q_95\
M4? N;6/[-=TF1U6 3$MDKZ;<]Z"^A_./\.?BS\5?V(OCM);V5Y<0-INJ 21O
M<N , 5_1Y_P1E_X+%^'?VG?!UAX/\;^(85U>1HXHX$*DD#Y?;VK\.-)_9ZOO
M^"A?Q9\?^.OA]X;N8K6UNWN$\VW;E=J="0,]:YK]F7QO\1?V OVOM'@U6_EM
M+6V+L\90KG#I0)[']D5I>F]03VY#1MT-2/,47!^\>E>'_L&?'>V^/'[/NA^,
M8;L2/=P;BQ;)/ KV^->-TO;I02/@:1H\R#!I](C!UW"EH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ I&SCBEJ.19"X*N /2@!Q<*H+T.S@@J..]-F=4C!<9^E
M07&J6&F(9-1OX8EZYEE"_P Z )KNZ2VMGF9L;4)_2OP3_P"#D7_@I[\2/#JV
M?PJ^']RA$TC6MP(Y=I );T%?NEK>N:9?:)/<:9J=O<*87QY$RO\ PGT-?RD_
M\%P;C6)?VI)?[:F+0?V]^Z##&!S0-*Z.R_X(X_\ !&OQ5^V[<Q?&?XB:=>R:
M>;T_:)][N!N<GO\ 0U^M%K_P;O?LV^3:1,MP#;S*^?L_H0?[WM5W_@V@U;08
M/V,I]/MM3MA(U['B(3KN/^L[9S7Z3\%R%ZT#:1Y7^RY^RG\/_P!ECPD?#O@N
M/]T\:JY:(*>/QKT36O%&D>&[+^U=4NO+@SC?1XKN)[3P]<SQ9WJGRX&37\\W
M_!<O_@I]^U/\$OV@=4^''@GQY=V.G03'9"(W 'SX]10"2/Z&]"\4Z1XB3S=(
MN1(,9/%:BG(YK\T_^"!O[6/C7]HSP$[>,M>:\N(+(%V<GDX'J?>OTJ@SMY.:
M!-6'T444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *:S%6]J=
M3&)+X)XH %=F<CMZU%<W;0#S2/D7[QI\Y(&(_P ZCFC$D1MI1D.* /RF_P""
M[W_!677OV:/#6J_#[P)?0F\B+A49PI]/0U^)G[,?[-7QX_X*3_'Q]?UK3[JY
MM9]426Y*W#L%4@9XQ7[_ '_!37_@C2?VSO$%WXETVWLQ+<R$[IF7/7/<UZK_
M ,$\O^"7WP[_ &.O#\:_\(_;+?& "66%E.6'?CZ4%+8_%+_@J7_P2W\,?L8_
M"^37_"EG+YT.FQR.9$((<Q@GG)[U]F_\&Q/[25W\0;"V^&]W>;GLM.9C'NSC
M]V?\*^F?^"\/[+FH?&/]D[Q)J.AQ+]H2W"1';D@;&_PK\/O^"-_[6VJ_L'_M
M;3^&/%5_(C2-%:$+E>7)3^M _0_K!:\\K]W(<,?NBI4F98M\_%<U\*_%&G^/
M_A[H_BZWN8YC>:?',"C@D;AGFNA6*25]TC?)Z&@@F,J  YZ]*4$D9--9$V@8
MZ=*<H(')H 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "F
MF,%P_<4ZD=PB[C0 V5XXQND.,U^<?_!?O]H;Q'\)/@GJ6C^'Y]GVS2SDA]IZ
M9[5^BL[+P\J[E)Z"O@K_ (+G?LG>)/C_ / 75]=\-J&:QTL_(%W,3C' H _"
MC_@CE^R!X4_;[_:0LK3XF:E=R278!==Y?JWN:_5/]L[_ (-TO@?=?")KKP+#
M=27EC8L^U82OS#/HU?AY^R/^TQ\5O^";7[0T.MW[7]F;-P"!;.IP&K]_?AK_
M ,'!G[//B_\ 9L1]>BD?4GT9OM+R3$%FY[$4#1_.A^T#\-OB1^PC\<QIL,EW
M9W$$LC0)]H=<J&&#_*OVS_X(-?\ !=G3?&%II_P,^/'B6&UM[2W"V\A8.[2,
MN "3@]0.]?GC^T5:Z=_P4[_:]L[WX>Z)/]GEDEBR\18?>4=2/:O OC'\$?B+
M^P?\>DNBLMJMMJ< +B$@'$@[T%-(_M#\/ZY9>(]&MM>TV7?;7<(E@?\ O*>A
MJQYT@EY'R>M?#O\ P1"_;'G_ &JO@)&MU>22OH^GQQ,7SP00.]?<4BDPX!Q0
M02!PPR*$)(YIJ;8T QUIXQVH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MMU"?:#NW GK7X:_\' G[$'BOX)_M:Z[\0_#.DSC38Y<Q3Q#"G$A-?T^?L^_
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MT_PKK'C79@],<B@0Y"C#>AX-.J.W143;&/EJ2@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **3<O3-))(L:[FH =4<D8=OO?A3PP*AO6JFJ:E:Z9$;V[F5(UZEF H J
M^(?$^F^%]-GU'6KA888(6<N_3"@G^E?C9_P63_X+CVWPIU5O WPBU*&_E9#%
M(;:0 HP!JY_P70_X+76_P<T2_P#A9\+/%)BU2-W@N0LW!5CM/3VS7X_?L(_!
M/6/^"@7[25KJ/CKR[NTN]88W.]LY!/O0!^UG_!!?]M?XW?M-:+IMMX[\/70L
M;F$ W4[AAR/K7R7_ ,')_P"P!KFC:G:_$[PY:SR^?<-<RF,'Y!EA_2OV>_86
M_89^$_[)'PVLO#/@;2%M_LP&W:%P, >E=%^V'^RAX%_:K^&.H>%/%NE_:9_L
M+QV8V@X8_7ZT#1_,]_P11_X*E>(OV2_B)8?#[Q!J+KIHNV\\SR_*"'QR"?<U
M_35^S'^UA\,OVCO!MIXA\,>)[:XNKB/<\$)^[QFOY:?^"J7_  2.^+W[&/Q8
MN]:\/^'C#IJM+,?*@/0D,.GM7-_L+?\ !8#]IK]CK75LK?Q#/:V4*!%4AQ@8
M(-!1_7YXP\3Z)X8T2;5=>NHXK6)-TCR= *_EV_X.0?BU\-/B#^U;K2^"M5M;
MGS)3M: =?G-=/^TG_P ')GQY^*7PXN/"/ACQC/(UU:".9=SG)KYN_8-_8>^-
M?_!2?X_VGBCQQI#WD-X4=FDA;GYL]Z!75K'["_\ !LG\-/$GA;P-<ZU?0S+#
M>6(:,L>",*/Z5^PMK&8X\%LUXG^Q#^ROX4_9?^#>B>$]&TP6]S;Z>(K@  <Y
M->WH"!S0)L6BBB@04444 %%%% !1110 4444 %%%% !1110 4444 %%-,B@X
MH:55&<4 .ILH)& /QJKJ>NZ7I%E)?7UY%&D:EFWR <?C7COC/]OCX$>"+]M-
MU;7(_,&?NW"=J /;$ V=.:8 7;<XQCI7FGPT_:N^%7Q1F">'-9B8L,C-PM>D
M17<5TBR0R*RL,@@YH EE",N6Y%9>K:YHWATJVJ:@L7F_<#=ZI?$GXA^'_AMX
M;E\0^(+E8X(P22S@=![U^&7_  5N_P""]^O^%?'%MX2^"OBUTDL+[RYP)2>Y
M/;ZT#1^V?Q=\&:-\;/AE?>%)2DD-S@$XSV(_K7\K/_!8/]D+Q=^R-^U9??%/
M3[.X@T\ZQ T,HRJG;+FOVD_X(>?\%(_B/^U5X!CC^(^JRW%U)=!%+;L8RP[_
M (5Z/_P6C_X)M^&_VQ?@E);6.@BXOH/,GR4!Y&&'\J!W1Y%_P0=_X*B^$/C/
M\+X?!'C+Q/!#>6=O';6T4KY+$$"OU/BNK6^MA/;S H>C"OY;/^";W[#/[3OP
M(_:RMM,TK3S!I\.O.I'E,/E!K^G#X2Z=K=IX-@M?$AS< #=CZ4$G4)M5>&S2
MJ21DBHH5?<5)X'2I5W8^:@!:*** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MT"&VD30#RY"6(_B-3TW<=^,<4Z@ HHHH **** "BBB@ HHHH **** "BBB@
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MYXPUZ:%;E0\%RP P,<< 5_4P_P#P3Q^ 4_@<>"1HUO\ 90#A_L*9Z8K\H?\
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MWE@ *>@Z4#U1^.G[/7_!K3X3^&WB%-7\6>*[+5(4GWF"9001Z<**_2S]FO\
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M\#;O5I-.GTP/<_V6H9&!4]>*_ GQMX.^,O\ P3Z^/9LY8I[&73[^'S%^T.N
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M0.G-% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+G')ZT%'W94\4^B@!C*_K2E@B\BG44 ,3<S;\\4^BB@ HHHH **** "BBB@
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M;-#&_DAF!/<5_/Y_P5^_X(P^*OV9?&UUX_\ @Q%>W5BJ/-]JMBRA2V&Q_/\
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M&=PZ4WRTE3>JX)J7 Z8H  Z"@1&<%=F.1WIT2LJX<YIV!Z44 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MBWKM4#-;K#S(^'Q[T$#&B9FWR<A>E212+(N5Z4T H,,<YIX55X48H 6BBB@
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M3-#@[E^;/S>^*_4?]E?_ ((:? ;X!>([;7];\-:3JAMVSB2(\\Y[8K[:\,>
M_!G@.T2S\(>&[>QA086.W4@ ?G0)LI_"OX;:#\*?!]EX7T&U\I;>T2+;CIM
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M.+_8I_9/\&?LI_"ZR^'WAK2A;+;8VH !C QVKVZHT5=X.*DH(84444 %%%%
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M\ET^U1NP>"*_IC_X)G?\%2/A1^U=\.M/TN^\31S:G'9JL\8"G#GMU]Z^+?\
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MGWX>WGC3Q?K5I&MKRT4MRJL>">F<]J^>_@E_P6#_ &=?BSXPE\*6NK6-K*F
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M:&7';TK^U+QKX!\+_$#1YM#\4V"75O.NUT8]17QA\;_^"&_[*GQ4\6S>(_\
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MU'"C%MQ;-34$/<:8U/6@1*#FG44""BBB@ HHHH **** "BBB@ HHHH ****
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M1*I_N^U?R[>/='^.?_!/7XK:KI\%@UB1>%%_>LN< >WM7]K+16.N6A6:,.C
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7PQ;Z%:A=L4**2O?"XK2%E8QD-';1JWJJ 9JW;[MGS#Z4$MW'T444""BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:3;B@+C8U>$[6.0>@J4A0,XI<#THH$-4$@XXI(4=%(=L\T^B@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4'IS110
MQ>%)%1BV65_,<5*[!.BT!LID\4 )P1M4=*<I)&32(H7)!ZTX'(R10 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !44BW!8;
M&XSS3Y!N7 ;% .$X.2* &RHH'FD<BFMO*!XCR3S3DS*A#"G+A?E(H 3+X )H
M *G<U/ILWW* $,R@TY6##(IL484;B<TY2I'RT +1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4C' R*6F2O@;1UH 81(&
MW@]:<6$BY'44D4I8['7%/"!3U_"@!(O-ZN:;)Y3M\PZ5)N .VD51DG% #5=0
M-B#% 1D;<:61MAR$S2*QEQD8H DHH P,44 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !2-N'(I:21]BY S0 PJ)/]9R!S49\JX!
M9%^9.AJ977;N88S2,L8&T8&Z@!+<OLQ(<FI*@BDD2;R"A(_O5/0 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (5!.30RAA@T
MM% "*H48%+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% ",H88-"HJ=*6B@ I&4-UI:* # ].E(RAA@TM% "%05V]J2.,
M1C IU% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4TQJSASVIU% ",H;K04!(SVI:* $**3NI>E%% !00#P:** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *0@$Y
M(I:* &R1+* &[4C0(Q!].E/HH ,#.<4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM.;;MZ\UK%3&>.]?(W[>7CO7/"WVMM.NY$"DXVUXG$&:+)<JGB7T/<X;R?\
MMW,Z>&D[7/HY_C7X/?:(KX<]>14@^,/A4?,UYQ]17Y9VWQW\?ZE,T5CJ5RS(
M>0@S5B3XP_%E(RC7-^#V^0U^/+QEJ\R4:%X]['[5/P-46Y?6-ULV?J(GQD\(
M;OFO>/J*U-"\;Z-XC5FTV?=CKTK\F-0^,_Q>@C#+<7YY[1FOJ?\ X)[>.O&W
MB>"X;7IKDXEQ^]4CO7T?"_B)_K)F7U><'!'RO%?AA+AG)_K?M5)]C[5\TE<
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<UXE^W1_P2UT_2]%N/$'P_L);@Q0[L*I S7A'P-_X*E_$KP*L.E>)M;NF@@
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M=17['SU+BSB?,<F^L83#V=KGWS^SI^W-\)?C1;^5IOBB*6X)V[% Z_@:YO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#<HR >M20C"U7>&9BI5L8JS$"%Y-?36YK2>Y\K=\[ML.HHHIC"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^(\;Z\3XGU' Y XJ08[4S  !'>G*"!S7TR/F%L+1113&%%%% !1110 4444
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M8> (;:\C.X(G##_9KRW]L3]BGP[^T%X;GC2PACG5&?S&')(YKWKP.B)I**B
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M*^_X;R[^S,HI8>,KI'YQQ3F3S?.ZN*E&W,]MSP?]IG]G2P^(FD3SQ6R>80S
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M5Q+5N=[=A ^X8QTJ0'(SBF4]?NU["/(6B%HHHI@%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
.%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>camp-20241231_g16.jpg
<TEXT>
begin 644 camp-20241231_g16.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" -\ U8# 2(  A$! Q$!_\0
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M"#\1O_!-!_\ )-'U:M_*P_M3!?\ /V/WGUS17R-_P\L\!_\ 0@_$;_P30?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MN(=\*Y+22NP^5"!QC!*_,",@UW6E>"/V;/%FIG0]+G@&IR2"VC87MY&7D)(
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MC4445\V?J05\,?\ !1__ )*'\$?^XY_Z)M:^YZ^&/^"C_P#R4/X(_P#<<_\
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MM-Y<:A$[_NMQ1%&UE[H_&<<=.<UXM\)OBQXJ^*'QS\!_\)-JO]I_8;B?[/\
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MGI7_ *(%>:?L??%72/A[XKU;3=;N(["QUF*(+>S.%CBEC+;0Y/"J1(WS$X!
MSUR,Z=)_5JE2FO?N_NNK_J=.)Q<?[4PN%Q$K4>6+:>SE9V;^=M]#Z0L-=^)M
M[X\FTK4OA[I<?@&29H$F^UPM*L0.!*R^80P."=@C!&X#/&3\U?''X?\ AKX-
M_&_2IY='>^\(W:I>OID<^W^)E>,$\X! ;!X(.W([>MZY\!?B3?\ BR[O+'XM
M7MEX4GFDF28ZG=-+;QDL50(&",!\JYWKW..U>;_#W5-,\/?M'Z)%XI\=#QQ!
M;0O'::O)<O/;P7#@[%+R,1C!ZJ2 [+SE20\/:+<Z;3]W5*_]7%F?/64*.(@X
MMU%RSFX-+75))*\;=-O,]A\._&3QGXG\5Z3:>%OAI<V7@MVC6ZGU.U-JX1CA
MGC.X1X4<X 8G&.,UY9^V'X"\/:#\0?"^I1QKI,&M&0:DUM& HVR)NF"@<N1(
M<]<[1QDG/MOQ"T_QC:^-K?Q%<_$+3O#OPYLGAGEM\".5]I&^(MCY]^" =_\
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M_:>3X.>-YO"7A+PMI,6CZ6WEW*JGE>8Y 8B,1X"8+$$D,2<].Z?'CP=HNJ^
M=!^,OANPBTS4;?['?SVVW$<RNZ;0X&,LKE067&1GT!#_ (H_LO#XL^,9_%WA
M3Q1I3:;J;QS7(=BRQC: SHR9#9QNP=O)/-9O[27Q%\.^%?A5IGPO\-ZG'J\T
M2PP7<T;K*(HH3]UV4X$AD13MYP V0,K6=-4W*E[#XOM;[=;G5BGB8TL6\PM[
M)7]EMO?W>6VNUK_CU/7_ !'\7]9TC]G&+Q_#;6+:R]G:W!@DC<V^Z66-&&T.
M&QASCYNN.M>=?LU^ X/$NF^)/BIJVCVVL^(=2O+JXL;!,+&C99F";R0K/(2H
M+$[0HYY-;OA?28_C1^R7;>&]%U&SBOQ9P6LIFD.V"6&9'*R8!*Y"9Z=&!Y%8
M_P"S_P")M-T72?%'P?U7Q!'I^L6ES<V]EJ5C-Y7F*_!,+_\ /5'+''7D8SM-
M<ZCR4:D8*TN;7_#_ )'I2J.OC,+5Q#O3=-<M[6]IKWZV[];=3O?"J^.?B0=3
MT+XI?#_2[30+B%C'-!=H^#N7:A597;=U(D4K@J,8.*\F_9K\%GX=_M-^,_#H
ME,T5CIDZPR,V6:)I[=HRQP!NV,N<#&<XJZWP(^)NEQWUWKWQJGTC2H@3!>'5
M;HAQG@R;W14^7GAF_K6!^R3/<7'Q_P#$[7.M-XCF&DSH=5:220W(6>W4-ND^
M8C '7T]*V22I57"2:MLD[7^9Q2G.6,P:KTI*:GI*;@Y-6>GNVTOM=?F;GPL_
MY/.\9_[EU_Z%'5SXL_M)1?"+XJW^CZ%X9L&99X9=7U"929KG>B,P0JPP0A0
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M#^"/_<<_]$VM=N"_WB'J>#GW_(LK_P"%GSQ1117W9_/ 4444 %%%% !1110
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MBBB@ HHHH **** "BBB@ KH_AQJUIH/Q#\+ZG?R^18V6JVMS/+M+;(TF5F;
M!)P 3@ FN<HJ9+F33-*<W2G&:W3O]Q[M^UE\2_#?Q,\3:'=^&M2_M*WMK-HI
M7\B6+:Q<D#$BJ3QZ5X3116=&E&C!4X[(Z<;BZF/Q$\3524I=MNWF%%%%;'$%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!C^,O\ D4-<_P"O&?\
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MZ _-@HHHH Q_&7_(H:Y_UXS_ /HMJ_4#]F[_ )-V^%O_ &*NE?\ I)%7Y?\
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MISA&I%QDM&10K5,/4C6I.THNZ9]GZY\2?V=?B-?0:UX@A5-4(61S-9W4<I;
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M]17/]2I^Q]C=VO?^M#TEGV)6-^O\L>>W+:SM:UN]_P 0KZ)_9%^+'A7X7_\
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MW;X6_P#8JZ5_Z215\WG'V#]3X)VK?(]&HHHKYL_4@KX8_P""C_\ R4/X(_\
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M0![3^U#\<?%O[/WA#3O&.D^!X_&'AJSD:3Q((M12WNK&VVC$L*N,2D,>5ZG
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M:Q^"'_19/A__ .%18_\ QVO*O^'7'[,7_1,O_*_JG_R31_PZX_9B_P"B9?\
ME?U3_P"2: /5?^&L?@A_T63X?_\ A46/_P =H_X:Q^"'_19/A_\ ^%18_P#Q
MVO*O^'7'[,7_ $3+_P K^J?_ "37@'[>G[!/P)^"_P"R?XZ\9>#? O\ 8_B3
M3?L/V2]_M>_G\OS+ZWB?Y)9V0Y21QRIQG(Y - 'Z/:3JUCK^E6>IZ9>V^I:;
M>PI<VMY:2K+#/$ZADD1U)#*RD$,"00015NO*?V3/^36/@W_V)NC?^D4->K4
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M?*O[ WWOVCO^RR^(_P#VWKZJKY5_8&^]^T=_V67Q'_[;U]54 %%%% !1110
M4444 %%%% !1110 4444 %?*W_!47_DQ3XF_33/_ $YVE?5-?*W_  5%_P"3
M%/B;]-,_].=I0!ZG^R9_R:Q\&_\ L3=&_P#2*&O5J\I_9,_Y-8^#?_8FZ-_Z
M10UZM0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_13?_*!JG_R-1_P]'_9B_P"BF_\ E U3_P"1J /JJBOE7_AZ/^S%_P!%-_\
M*!JG_P C4?\ #T?]F+_HIO\ Y0-4_P#D:@#ZJHKYJ\)_\%'OV=?''BG1O#FB
M?$/[;K.L7L.GV-M_8FHQ^=/*XCC3<]N%7+,!EB ,\D"OI6@ HHHH *^5O^"H
MO_)BGQ-^FF?^G.TKZIKY6_X*B_\ )BGQ-^FF?^G.TH ]3_9,_P"36/@W_P!B
M;HW_ *10UZM7E/[)G_)K'P;_ .Q-T;_TBAKU:@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#X@_8[^"/PZ^)6K_M$:GXO
M\ ^%_%6I1?%_Q%;1WFMZ-;7DR1!H6$8>1&(4,[':#C+$]S7T5_PR=\$/^B-_
M#_\ \)>Q_P#C5>?_ +$OA/7/"C?'S^V]&U#1_P"TOBSKVI6/]H6KP?:K63R/
M+GBW@;XFVG:ZY4X.#Q7TK0!Y5_PR=\$/^B-_#_\ \)>Q_P#C5'_#)WP0_P"B
M-_#_ /\ "7L?_C5>JT4 >5?\,G?!#_HC?P__ /"7L?\ XU1_PR=\$/\ HC?P
M_P#_  E['_XU7JM% 'E7_#)WP0_Z(W\/_P#PE['_ .-4?\,G?!#_ *(W\/\
M_P )>Q_^-5ZK10!Y5_PR=\$/^B-_#_\ \)>Q_P#C5'_#)WP0_P"B-_#_ /\
M"7L?_C5>JT4 ?#_[8WP0^'/PUU/]GC4_"/@#POX5U*7XO^';:2\T31K:SF>(
MM,QC+QHI*ED4[<XRH/85]P5\J_M]_=_9S_[++X<_]N*^JJ "BBB@ KY6_P""
MHO\ R8I\3?IIG_ISM*^J:^5O^"HO_)BGQ-^FF?\ ISM* /4_V3/^36/@W_V)
MNC?^D4->K5Y3^R9_R:Q\&_\ L3=&_P#2*&O5J "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]P.5P^WY@-S %3_AZ/\ LQ?]%-_\H&J?_(U>U?!3X]^!/VB?"UUXC^'NN_\
M"0:+:WKZ?-<_8Y[;;.J1R,FV9$8X66,Y Q\W7(.,K_AD[X(?]$;^'_\ X2]C
M_P#&J\?_ ."=^DV.@:7^T#IFF65OIVFV7Q?\06UK9VD2Q0P1(MLJ1HB@!550
M %     H ^M:*** /E7]@;[W[1W_ &67Q'_[;U]55\J_L#?>_:._[++XC_\
M;>OJJ@ HHHH *^ /C-_RF0^!'_8FW/\ Z)UFOO\ KX ^,W_*9#X$?]B;<_\
MHG6: /O^BBB@ HHHH ^5?V^_N_LY_P#99?#G_MQ7U57RK^WW]W]G/_LLOAS_
M -N*^JJ "BBB@ KQ7]LOX*ZY^T1^S9XP^'OARZT^RUK6/L?V>?5)'CMU\J\@
MG;>R([#*Q,!A3R1T'(]JJ*YNH;*!YKB:."%.6DE8*J_4F@#CO@?X)OOAI\%O
M /A#4Y;>?4M \/V&E74MHS-"\L%O'$[(6525+(2"0#C&0.E=M34=9$5E8,K#
M(8'((IU !1110 4444 %?!'[6O[._P "O@AX)^,WQ3^(LDWBWQ-XTCE33?\
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M(&/FZY!QZ!7P!_P16X_9=\6?]CG=?^D5C7W_ $ %%%>5?\-8?! ?\UD^'_\
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M^#_$&LW6[[/IVEZ]:W-Q-M4NVR-)"S8568X' 4GH* /0**** "BBB@ HHHH
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M.N?_ $5K% 'W_1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.LU]_P!? 'QF_P"4R'P(_P"Q-N?_ $3K- 'W_1110 4444 ?*O[??W?V<_\
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MCP?I/P[L_M-[;^"Y[19)9[*WD9)6:0Q[R1Y<F?WR%MK%0,J* /TVHKAO@?\
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M]&C?^9*TO_XW1_PT/^T[_P!&C?\ F2M+_P#C= 'U517RK_PT/^T[_P!&C?\
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M] 'U51110!\J_L#?>_:._P"RR^(__;>OJJOE7]@;[W[1W_99?$?_ +;U]54
M%%%% !7P!\9O^4R'P(_[$VY_]$ZS7W_7P!\9O^4R'P(_[$VY_P#1.LT ??\
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M\ ?\$5O^37O%G_8YW7_I%8U]_P! !7P!_P $5_\ DU_Q;_V.=U_Z165??]?
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MQTOP0^*/BCQWJ7B#PUXK\0>.M$\7Z!(JW<%KX]UIH94;[KIF\)';C)X*D'G
M^X/V%A>SZ9\3YK_7?$&N26WB:/3[<Z[KEYJ7D0+IEE.$C^T2OLS)<S,2N"VY
M020B!?A_X6?#_P#X4]+X@\9?$/Q5ILWB77I4%W?RRK;VL2KG;&C/MSV[#A0
M.,G[9_8!U6RUSPO\4;[3KRWU"RF\8@QW-K*LD;C^Q]+&5920>01QZ5W\,X^M
MC,]K<E64Z/L^LIN'/>'-R\SVO>U];>1Q<0X*EA<FI<U*,*O/T45/E]_EYN7K
M:U^E_,^IJ***_7S\L"BBB@ HHHH **** "BBB@#X _X(K?\ )KWBS_L<[K_T
MBL:^_P"O@#_@BM_R:]XL_P"QSNO_ $BL:^_Z "O@#_@BO_R:_P"+?^QSNO\
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MGC?2E:VLM?\ !FO7<5O,P+Q,9])WQDCJ5964D?W37Q1X7_98^/Z?"KQ?\/O
M_P 6[>S^#/\ :VOZ2-#NK9)-1DBM]0N+9X@X@S^^\AF8+(BYD;Y?F:OE3X=?
M"GX=ZK\*[7Q?K7Q)U'1?&FG:/K=W]F2_CBDT^\LI+5=.MU1E\S]YYSD;6!)
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MD67Q0^(GQHU*:SNM&\*?$;PS9BTU"Z,C-;W\+',9$7EN.A&6)Z%,*"*^^_\
M@F1\&KCPYJ/Q8\<^*M3_ +=\?7&L1Z'<WT8VPBW2RM+H"-<#&3<*IXQB%, <
MY\'^"WP8F^&L^M:SK6LOXC\6:Y(LE_J+IL7"YVHB]@,^W0<  "OLS]A7_D#?
M%?\ ['(?^F;2Z^HX7S2GC,YGA\.H^SA2T:C9W3A=)OWN3F;Y8O96TT1\[Q'E
MM3"Y3"O7<O:2J:IROHU*UTO=YK)7:W=]3Z;HHHK]?/RP**** "OD#_@I_P#
M7QW^T1\ =!\-_#W0O^$@UJU\36^H2VWVN"VVP+:W4;/NF=%.&E08!S\W3 ./
MK^B@#RKXW^(/BQH%UX'3X8>&-*\1V]UK4,'B-]3E5#9:<2/,FBS/%EP,X W]
M/NFO*OB=K/[5/P]^*_B6Z\%^'-&^+'@75[55T:RN+ZUTJ70;C!RTI8*UPF3D
MJ&)("X*'=N^JJ* /FO\ 9%_9&LO@K^S%:_#+QW::1XO>^N9-0U>QNK9;JP>9
MG5U0)*N'">7'@E?O+N '%=__ ,,G?!#_ *(W\/\ _P )>Q_^-5ZK10!\ ?\
M!%;C]EWQ9_V.=U_Z16-??]? '_!%;_DU[Q9_V.=U_P"D5C7W_0!X7^V!^TTO
M[+_PTL]9L]$?Q-XFUG48M'T31D<I]INI 2-Q )V@*> ,DE5XW9'C?P\_:_\
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M_#?PU'_:L\$0\8KJ[^(A<QVY CC#$LJ/"]P97^?]X!@#-??U !1110 4444
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M^V?XFT#XL^*/ /PL^%LOQ-U+P=IJ:GXFN&U>/3XK-602)#%N1O-D*'.%YSD
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M3(KB#3=?TRVU6UBNU59DBGB65%<*S ,%< @$C.<$]:Z"O*?V3?\ DUCX-_\
M8F:-_P"D,->K5]@?*GY'_M:_&GX9^#_VH_BOI_BC1%\37XUBTN8S%IT5XML@
MTC3XV)=S\N'C=2!D@J<BJ-KXK\0_%SPKH&K>'="T>;2H[Z"]CE366&1"^3&5
M-N"IXQ@CCTKF?'NMZK^S/^TQ\==*OO!^J>,UU;Q%)>P:GID!EWFX07:6\K%>
MHCNX\XSR6P"#74?LH^ -8\ ?#*>/7+3^S;W5-1FU(:=_SZ(ZHJQD=CA,X[9
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M[';:W&;;*87&?MC]HV;P_;_ #XC3>*[.\U#PS'X>OGU*UT]@MQ+;B!S(L9)
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MI:)W:6O];FV31Y\7'6UCR;XQ_L;_  \^,'BX^)-4\-V<^JS1A+F<7-Q;&8C
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M8_[3^;S?L&_R?O';MW\_=QG/?-:%%%=AR!1110 4444 %%%% !1110 4444
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M_P#(DH?]O?\ I<@KWO\ 85_Y WQ7_P"QR'_IFTNO!*][_85_Y WQ7_['(?\
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M_AG1_%6FQ3"YCL];L(KR%)0K*) DBL P5W&[&<,1W-<5_P ,G?!#_HC?P_\
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M-7W_ *9=2H _2FO*OVL?^36/C)_V)FL_^D,U>JUY5^UC_P FL?&3_L3-9_\
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MK]LP_P#!AZ+\C\BK?Q9>K/B#]IK_ ).EU;_L3-%_]+M7KB*[?]IK_DZ75O\
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MQ8_8U_9*\ ^%/ GA;3O'OC9]9#^(+=IQ'!;0S^=)+(C%TW&+$$><G=R0,'@
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M?_T_7]>S5^V8?^##T7Y'Y%6_BR]6?$'[37_)TNK?]B9HO_I=J]<17;_M-?\
M)TNK?]B9HO\ Z7:O7$5_+G&W_(_Q/_;G_I$3^CN#_P#D24/^WO\ TN05[W^P
MK_R!OBO_ -CD/_3-I=>"5[W^PK_R!OBO_P!CD/\ TS:77N>''_(VJ_\ 7M_^
ME0/'X^_Y%E/_ *^+_P!)D?3=%%%?T<?@84444 %?EAHGPW\,?M:>+/VS_&7C
M^Q?6M4\-O=:3X=FFF<?V5#:I=>4T*AL*Q,$;'J"=_'SOG]3Z_.[Q#\)_C'^S
M[XY_:,TKP/\ #&;X@^'OBT9;O2-5LM0MX%TVZN%F$R7"2,"$5KAB#PI"+\WS
M-L /H+_@GA\1]5^*?['WP]UG6[F6]U:*WGTZ>YF8L\HM[B2&-F8DEF,<:$L>
M2<FOE7]H^U/B7]O;QCK_ (N^!?BCXK^"?"WA"#3[>"STTM;%\K<-.'?:K[?-
MN4"J2S,&P/E-?17PR\(_$3]D+X ?!;X?>%?!T7CB\-\EMXFN(9]J:<D\S37$
MZGC>J-*X&1R%%3_$?XK_ +1WPO\ BSXI@L/A;!\3_ =[9J_AJYT.ZBM9K2YP
M<Q7@D?<1NZNH"[0I&2650#L?V<_BU\&/^&;=*\9>")M,\!_#.-GW1ZG)'81:
M;,TVUXYBS[(W,K@?>(8NI4D,">B_X:Q^"'_19/A__P"%18__ !VO,OV+/V3O
M^%0_LK6OPZ^).E:5XAGU.[EU+5='O88KVS1V=&2(JP*2;/*C;." X)!. :]-
M_P"&3O@A_P!$;^'_ /X2]C_\:H ^5?\ @BMS^R[XL_['.Z_](K&OH#]NW_DV
M?7/^PQH'_IZLJ^?_ /@BMQ^R[XL_['.Z_P#2*QKZ _;M_P"39]<_[#&@?^GJ
MRH _-WX^_#[5?'7AG3IM!\M]9T>^CU"VMYB DY7.4.>,]",\<8XSFN,LM$\>
M_%SXA^%M5\3^&XO"FD^&Y6N1^^$DEQ+E3A<'.W*+[8SR>*^@:* .I^"/_)RW
MP>_[#5[_ .F74:_2JOS5^"/_ "<M\'O^PU>_^F74:_2J@#RO]JW_ )-<^,7_
M &)NL_\ I#-5^/[B_050_:M_Y-<^,7_8FZS_ .D,U7X_N+]!7AYG]CY_H>QE
M_P!OY?J.KSOX[?\ (GZ%_P!CCX6_]/UA7HE>=_';_D3]"_[''PM_Z?K"O*H?
MQH>J_,]*M_"EZ,^AZ***^Q/E3XS_ &<_^3?/AE_V+&F?^DL=>B5YW^SG_P F
M^?#+_L6-,_\ 26.O1*_%,1_&GZO\S]<H?PH^B_(\\_:*_P"3??B=_P!BOJG_
M *22U]DQ_P"K7Z"OC;]HK_DWWXG?]BOJG_I)+7V3'_JU^@K[GAG^#4]5^1\=
MQ!_%I^C'5^?OQ,_Y.)^,?_8<LO\ TR:;7Z!5^?OQ,_Y.)^,?_8<LO_3)IM>7
MQ_\ \B27^*/YGI<$?\C>/^&1ET445_,1_1!]._L0?\F\V/\ V'_$/_IZO:]Y
MKP;]B#_DWFQ_[#_B'_T]7M>\U_:F _W.C_AC^2/Y'QO^]5?\3_-A1117><04
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7P
M!_P14_Y-8\4_]CG=?^D-C7W_ %\ ?\$5/^36/%/_ &.=U_Z0V- 'O_[=W_)L
M^M?]AKP__P"GJQKXLK[3_;N_Y-GUK_L->'__ $]6-?%E !75? [_ ).8^#W_
M &&K[_TRZE7*UU7P._Y.8^#W_8:OO_3+J5 'Z4UY5^UC_P FL?&3_L3-9_\
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M>LO_ $QZ9677\C\5?\CO%?XOT1_4'#7_ "*,-_A"OI[]B#_DW;3O^P]XB_\
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M<\./^1M5_P"O;_\ 2H'C\??\BRG_ -?%_P"DR/INBBBOZ./P,**** "BBB@
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M#?P]^+/P_P##^BW5Z^H36VQKG=.R1QL^Z;37896*,8!Q\O3).0#Z_P#V[O\
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M&\*Z-X;T3XV?#^RT71[*'3[&V^RI)Y,$2".--SZ66;"J!EB2<<DFM;_A3?\
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M_#\:AK5TE[?S>2/WTRV\5NK8_LS"XBMXEPH ^7.,DDYYIA*F-PSHTVD[K?\
MIFF78J&#K^UJ)M6>Q]145\S?\,L_MV_]%G^'_P#X#K_\JZ/^&6?V[?\ HL_P
M_P#_  '7_P"5=?&_ZMXO^:/WO_(^K_M_"_RR^Y?YGUW^R-_R1J3_ +&GQ/\
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MFL7%QH>J:N@>V@C6[B2;*M%*"&6*X4?NS\S=C\PTO^%-_P#!0S_HNWP__P#
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MT7;X?_\ @##_ /*JC_A3?_!0S_HNWP__ / &'_Y55[YXIV?[.?\ R;Y\,O\
ML6-,_P#26.O1*^5?#G['/[;OA+P]IFAZ3\7_ (?VFEZ9:Q6=I!Y6_P N&- B
M+N;3"QPH R22>YK1_P"&6?V[?^BS_#__ ,!U_P#E77YY5X=Q<ZDI*4=6^K_R
M/NJ>>X:$(Q<9:+LO\SU;]HK_ )-]^)W_ &*^J?\ I)+7V3'_ *M?H*_,_P 1
M_L=?MN^+/#VJ:'JOQ?\ A_=:7J=K+97<'E;/,AD0HZ[ETP,,JQ&001G@BNR'
MP:_X*&  #X[?#_ _Z<8?_E57TF49?5R^$XU6G=]+_JD>!FF.IXZ<94TU9=?^
M'9^@%?G[\3/^3B?C'_V'++_TR:;3_P#A3?\ P4,_Z+M\/_\ P!A_^55>?:G^
MP_\ MHZQXBUG7;SXL_#^;5=8G2YOKC:R^=(D$4"MM&FA5Q'#$N% 'RYZDD\7
M$^4U\ZRYX3#M*3:?O72T]$_R.OAW,Z.48]8JNFXI-:6OKZM'545R'_#"W[9G
M_15_A_\ ]\M_\K:/^&%OVS/^BK_#_P#[Y;_Y6U^._P#$.,V_Y^T_OE_\@?JO
M^OV6?\^ZGW1_^2/LS]B#_DWFQ_[#_B'_ -/5[7O-?G%X'_9A_;P^''AV/0O#
MOQH^'^G:4EQ<72V_V99<23SO/,VY]+9OFDE=L9P-V!@  =[\/OA/^W9IWCWP
MW=^+?C1X'U3PI!J=M+J]C:6<2S7%FLJF>-"-,0AFC# '>O)'S#J/Z%PM)T:%
M.E+>*2^Y6/PS$5%6K3J1V;;^]GW!11172<X4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!\_P#Q4_83^#?QC\;7GBKQ'X<N&U34/*&IK8:E
M<6L&IB,@Q_:(XW"OC:.< \#G@5V/C_\ 9O\  OQ(U#X=W6JZ;)%_P@-]#J&@
M06,Q@BMI(C&8P47@HODH O3 Q7I]% 'A_P :?V,?A5\>_$Z^(_%.B70UPVOV
M&XOM+U&>R>\M?^>$_E,!(GU&< #.!7K'A#PCHW@'POIGASP]I\.E:)ID"VUI
M96XPD4:C  SR?<G))R2236Q10 4444 %%%% !1110 445R'Q>^(UG\(?A;XK
M\:W\37%KH&F3Z@T"'#3&-"RQ@GH6("CW- '7T5^8_P 'OV>/V@OVT_ D?Q<\
M7_M >(/A^VO&6?1-!\.B>.VMH Y6-S&D\04$@X'S.R!&:0L2!]5?LJZ;\8_A
M!\,O$T/[07BO1=6LM$=YK#Q%]L+SBQC5O,>Z=HU&T!%=79F<AVWXVC(!]'45
M\?+_ ,%._ATUG_PD)\&^/U^&OVS[#_PGYT$_V3YF[;NSO\S9N^7[F[=QMS7>
M_M"_MM^ _P!G*3X=R:U;:GKFF^.%FDTW4-!B2YC\N,0,'P&#.'%Q'MV!L^U
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M4 9?ACPQI/@OP]IVA:%I]OI6CZ= MM:65J@2.&-1A54"M2BB@ HHHH ****
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M"0 ?8-%>2_LQ_M+>%OVJOAH/&7A2*]L[>.[DL+NQU&-5GMKA K%&VEE(*NC
M@GAAG!R!ZU0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7=Z\#Y_EK+^-'P^UCX?R?\$ZO"?BJ)AJ]GK"07MK-C="6O=+;R&QQE%8(?\
M=K]11X$\-#Q%_;X\/:4-=Z?VI]BB^U?]_=N[]:GUCPEH?B*^TV]U71=/U.\T
MV3SK&XO+6.62UDRIWQ,P)1LHARN#E1Z"@#X,_P""UMC<7'[.'A"YCA>2"W\4
MQ>;(HR(]UK<A2?0$\9]<>HKS;]K+Q+9ZS^V]\)/BSH?Q.B\(_#_5]$ET73_B
M1IEM#J-K974;7B2Q9DRB9,H4L>@D<] Q'ZBZQHVG^(=.GT_5;&VU*PG&V6UO
M(5EBD'HRL"#^(K/_ .$$\-?\(X/#_P#PCNE?V".FE_8HOLHYS_JMNWJ3V[T
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M[4 ?$W[67QWT']IK]FCX6?!7P78:E<_%F_O=+2Z\+2Z;/!-I;1VS+(92Z !
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MOO\ #P_%#P?\$]=\3_".V8O>>)+K5;>PNA;HX66X@LF#/-&OS<EDR5.=J@L
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MIZ+X9T?PWH-OH>DZ58Z7HMM%Y$.G65LD-O%'_<6-0%"\G@#% 'S/_P $N/\
MDQ/X9?\ <3_].EW3/VC(DF_;J_9&61%=0WBU@&&1D:9$0?J" ?PKZ7\+>$]#
M\#:%:Z)X;T;3_#^BVN[[/IVEVJ6UO#N8NVR- %7+,S' Y+$]31J/A/0]8UW2
M-;O]&T^]UK1_._LW4;BU22XL?-4)-Y,A!:/>H"MM(W 8.10!\M_MA_\ )SO[
M)W_8S7__ *3QUS/P"^)?A7X0_MD_M+^'?&VOV'A/4=;U/3]7TLZU.MI%?6_V
M=PQA>3:KE2PR ?7&0K$?9&L>#]!\1:II.I:KHFG:GJ.D2M/IUY>6D<LUE(P
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MYAC";8YADXD4!AD\UMZ1X4T3P_?:I>Z7H]AIMYJLPN=0N+.U2*2\E VB25E
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MJ?\ ;=M&FDVX6#4,Y^UH-GRSY&?-'S>]=?0!S7P^^&WA7X4^'(] \'>']/\
M#>CHYE%GIL"Q(7.,NV/O,<#+').!SQ7SQ86B_$/_ (*2:K?-$[V?P[\#06@)
M1BJ7U_.T@8-]T9MU9<=3SR0I ^K*R=.\)Z'H^NZOK=AHVGV6M:QY/]I:C;VJ
M1W%]Y2E(?.D #2;%)5=Q.T' P* -:BBB@ HHHH **** "BBB@ HHHH ****
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MV=OCOI'[2/PQM?'>@V5U8:/>7=U;VJ7N!,Z0S-$'8#(7=LSMR<9ZUZ97PO\
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M^D,->JT ?(7[:/\ R6/X5_\ 8!\0_P#I1H]>35ZS^VC_ ,EC^%?_ & ?$/\
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M]GI,UW&EU<QIR[QQ$[G5>Y ('>OD+XAZW=^"OCY^SK\?;NRCTNP\8:-'X/\
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M;GW0?"_]C.Z^'O[0T/Q@U/XE:SXS\27.BRZ3J_\ ;-I$!=.SHRR0"(HELB[
M!$$88[@Y)^D[JZAL;6:YN9H[>WA0R2S2L%1% R68G@  9)-.BE2>))8G62-U
M#*Z'(8'H0>XH ^4+']B?Q=\._P"W]%^$GQMU3X;^ M:O9+V7PXFAV]\]B9<>
M<EC<NZM; C(7"ML."/F!)VM5_8&^'\WP%\'_  TTB\U3P]+X1O8]6T;Q-8S
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M/DDG<[*6%G6CS1:/H>BOGC_A1.@?]!_X@?\ AQ-?_P#DVC_A1.@?]!_X@?\
MAQ-?_P#DVL?[2I=G^'^9M]0J]U_7R/H>BOGC_A1.@?\ 0?\ B!_X<37_ /Y-
MKA?CQ\+K+P9\#OB)X@T;Q1\0+/5])\.:C?V5Q_PL#77\J>*VD>-]K7A5L,H.
M&!!QR#3684I-))_A_F)X&HE>Z_KY'V#1117J'G!1110 4444 %%%% !1110
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MLC55W$ 9.,\"MVB@#'\,^#]!\%6=Q:>'M$T[0;2XN'NYH-,M([9)9WQOE94
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M9CND9F.22>3745PR=W>]SLBK*UK!1114E!1110 4444 %%%% !1110 4444
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8@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>camp-20241231_g2.jpg
<TEXT>
begin 644 camp-20241231_g2.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" )<!68# 2(  A$! Q$!_\0
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M4KQ5_P"#:?\ ^*KS2BCECV#VM3^9_>>E_P##37Q;_P"BE>*O_!M/_P#%4?\
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MXM_]%*\5?^#:?_XJC_AIKXM_]%*\5?\ @VG_ /BJ\THHY8]@]K4_F?WGI?\
MPTU\6_\ HI7BK_P;3_\ Q5'_  TU\6_^BE>*O_!M/_\ %5YI11RQ[![6I_,_
MO/2_^&FOBW_T4KQ5_P"#:?\ ^*H_X::^+?\ T4KQ5_X-I_\ XJO-**.6/8/:
MU/YG]YZ7_P --?%O_HI7BK_P;3__ !5'_#37Q;_Z*5XJ_P#!M/\ _%5YI11R
MQ[![6I_,_O/2_P#AIKXM_P#12O%7_@VG_P#BJ/\ AIKXM_\ 12O%7_@VG_\
MBJ\THHY8]@]K4_F?WGI?_#37Q;_Z*5XJ_P#!M/\ _%4?\--?%O\ Z*5XJ_\
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M@J>6/,M#55:GLW[SW77U&_\ #37Q;_Z*5XJ_\&T__P 51_PTU\6_^BE>*O\
MP;3_ /Q5>:457+'L9>UJ?S/[STO_ (::^+?_ $4KQ5_X-I__ (JC_AIKXM_]
M%*\5?^#:?_XJO-**.6/8/:U/YG]YZ7_PTU\6_P#HI7BK_P &T_\ \51_PTU\
M6_\ HI7BK_P;3_\ Q5>:44<L>P>UJ?S/[STO_AIKXM_]%*\5?^#:?_XJC_AI
MKXM_]%*\5?\ @VG_ /BJ\THHY8]@]K4_F?WGI?\ PTU\6_\ HI7BK_P;3_\
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M\&T__P 51_PTU\6_^BE>*O\ P;3_ /Q5>:44<L>P>UJ?S/[STO\ X::^+?\
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MY8]@]K4_F?WGI?\ PTU\6_\ HI7BK_P;3_\ Q5'_  TU\6_^BE>*O_!M/_\
M%5YI11RQ[![6I_,_O/2_^&FOBW_T4KQ5_P"#:?\ ^*KT(?M!_$W_ (9^;5/^
M$_\ $?\ :7_"4"V^U_VG-YOE?9"VS=NSMW<X]:^<J]-'_)M#?]C</_2(U,HQ
MTT-85:FOO/;N-_X::^+?_12O%7_@VG_^*H_X::^+?_12O%7_ (-I_P#XJO-*
M*KECV,O:U/YG]YZ7_P --?%O_HI7BK_P;3__ !5'_#37Q;_Z*5XJ_P#!M/\
M_%5YI11RQ[![6I_,_O/2_P#AIKXM_P#12O%7_@VG_P#BJ/\ AIKXM_\ 12O%
M7_@VG_\ BJ\THHY8]@]K4_F?WGI?_#37Q;_Z*5XJ_P#!M/\ _%4?\--?%O\
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M?DP%)R^T'L3D4W.*=FQ*E4DN91=O0\9HKVOQ%^Q?\9_"ESH=MJ?@>XAN=;U
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MG<E ?F^4/(K-@9!98Y%^Z7QXM^VE\43\6OVD?&.JPR%]-LKG^R;!<@JL-O\
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M<\UMZC\;/B)K$%_#?^/?$][#?A!>1W.L7$BW(3[@D!<[]N.,YQ6KI-M:[6_
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M_P#)O?Q&_P"PWH?_ *!J%>95Z;X3_P"3>_B-_P!AO0__ $#4*B6QK3^+Y/\
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M?_PR-XK_ .@_X2_\'*?X4?\ #(WBO_H/^$O_  <I_A19]@]I#^9?>CG?%/\
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M?^#E/\*+/L'M(?S+[T>(45[?_P ,C>*_^@_X2_\ !RG^%'_#(WBO_H/^$O\
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M"QM9^4[88>3DB0G/*@KNROBO_#(WBO\ Z#_A+_P<I_A1_P ,C>*_^@_X2_\
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M@S_Q+/B6/^FUC_Z#-17:?\$SOA1JGPML_'<6IW^E7S7LEHT9TN\%P%VB3.[
MX^\,?C17B8C^*S[C+FGA8-/O^;/G&BO1/A'\#=>^,XU;^Q+O3K;^S/*\X7\L
MB;O,W[=NU&S_ *LYSCJ*E^%WP"\3?%B\UFVTQ[+3Y-)=8[G^TGDC =BPV#:C
M<C8V?2ON)5Z<.;FEMO\ ,_GNGE^*K*FZ=-OGOR^=M_N/-J*L7]F^G7US:2%6
MD@D:)BG0E20<>W%=!X.^'6L>.-.\07^G+"+/0[)[Z\EGDV[4568*H&26.QL<
M8XY(K5RC%<S>AR0I5*L_9P5WV]-SEZ**ZW3OAGJFI_#;5?&T4]HNE:==K9RP
MN["=G;9@J-NTC]X.K#H>*)24=V%.E.JVH*]DV_1;LY*BBBJ,@HKTO6?@1JGA
MWQ3'H6J^(/#NF3R:4-62YO+UH8&0L5$09D!,IP3MQC /->:5G"I&HKQ=SHK8
M>KAW:K&S_P @HHKH? '@B^^(_B[3_#FFRV\%[>EQ')=LRQC:C.<E58]%/0'G
M%5*2BG)[(RITY59JG!7;=DO-G/45U>M_#Z70=#N]0GUO19)[74)-.DTR*[)O
M-R$@R>45!\O*\-GN.*Y2B,E)70ZE*=)VFK,****HS"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*-^;5-*2NXO1_P#;MGY,N^.]/NM/\?:G;:SI=GH%T+G-U8:8P,%L6P66/#.
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M33[ SMI/B;1XFMXS'%N5K*Z@D" \')9I<' PHR#\4Z_XMUSQ4T+:WK.H:PT
M(B-_=23F,'&=N\G&<#IZ5/?>//$NJ:0NDWOB+5KO2U54%C/?2O %7&T;"VW
MP,<<8%"P,DHV:T?^6W](4N(*<I5>:$FII+=:V36K2OU[O1;&%1117L'Q(444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!]=_L&_ZCQ=_O6_\GHH_8-_U
M'B[_ 'K?^3T5\1F'^]3^7Y(_?N&?^131^?\ Z4SSK_AC+XA_W=+_ / EO_B*
M/^&,OB'_ '=+_P# EO\ XBOOBBM_[5Q'E]QY_P#J?EG][[_^ ? __#&7Q#_N
MZ7_X$M_\11_PQE\0_P"[I?\ X$M_\17WQ11_:N(\ON#_ %/RS^]]_P#P#X'_
M .&,OB'_ '=+_P# EO\ XBC_ (8R^(?]W2__  );_P"(K[XHH_M7$>7W!_J?
MEG][[_\ @'P/_P ,9?$/^[I?_@2W_P 11_PQE\0_[NE_^!+?_$5]\44?VKB/
M+[@_U/RS^]]__ /@?_AC+XA_W=+_ / EO_B*/^&,OB'_ '=+_P# EO\ XBOO
MBBC^U<1Y?<'^I^6?WOO_ . ? _\ PQE\0_[NE_\ @2W_ ,11_P ,9?$/^[I?
M_@2W_P 17WQ11_:N(\ON#_4_+/[WW_\  /@?_AC+XA_W=+_\"6_^(H_X8R^(
M?]W2_P#P);_XBOOBBC^U<1Y?<'^I^6?WOO\ ^ ? _P#PQE\0_P"[I?\ X$M_
M\11_PQE\0_[NE_\ @2W_ ,17WQ11_:N(\ON#_4_+/[WW_P# /@?_ (8R^(?]
MW2__  );_P"(H_X8R^(?]W2__ EO_B*^^**/[5Q'E]P?ZGY9_>^__@'P/_PQ
ME\0_[NE_^!+?_$4?\,9?$/\ NZ7_ .!+?_$5]\44?VKB/+[@_P!3\L_O??\
M\ ^!_P#AC+XA_P!W2_\ P);_ .(H_P"&,OB'_=TO_P "6_\ B*^^**/[5Q'E
M]P?ZGY9_>^__ (!\#_\ #&GQ!)(!THL.J_:6R/3^#_.*/^&,OB'_ '=+_P#
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M !%'_#&7Q#_NZ7_X$M_\17WQ11_:N(\ON#_4_+/[WW_\ ^!_^&,OB'_=TO\
M\"6_^(H_X8R^(?\ =TO_ ,"6_P#B*^^**/[5Q'E]P?ZGY9_>^_\ X!\#_P##
M&7Q#_NZ7_P"!+?\ Q%'_  QE\0_[NE_^!+?_ !%??%%']JXCR^X/]3\L_O??
M_P  ^!_^&,OB'_=TO_P);_XBC_AC+XA_W=+_ / EO_B*^^**/[5Q'E]P?ZGY
M9_>^_P#X!\#_ /#&7Q#_ +NE_P#@2W_Q%'_#&7Q#_NZ7_P"!+?\ Q%??%%']
MJXCR^X/]3\L_O??_ , ^!_\ AC+XA_W=+_\  EO_ (BC_AC/X@DD Z46'5?M
M+9 ['[GU_*OOBH(_^/R;_<3_ -FH_M7$>7W!_JAEG][[_P#@'P=_PQE\0_[N
ME_\ @2W_ ,11_P ,9?$/^[I?_@2W_P 17WQ11_:N(\ON#_4_+/[WW_\  /@?
M_AC+XA_W=+_\"6_^(H_X8R^(?]W2_P#P);_XBOOBBC^U<1Y?<'^I^6?WOO\
M^ ? _P#PQE\0_P"[I?\ X$M_\11_PQE\0_[NE_\ @2W_ ,17WQ11_:N(\ON#
M_4_+/[WW_P# /@?_ (8R^(?]W2__  );_P"(H_X8R^(?]W2__ EO_B*^^**/
M[5Q'E]P?ZGY9_>^__@'P/_PQE\0_[NE_^!+?_$4?\,9?$/\ NZ7_ .!+?_$5
M]\44?VKB/+[@_P!3\L_O??\ \ ^!_P#AC+XA_P!W2_\ P);_ .(H_P"&,OB'
M_=TO_P "6_\ B*^^**/[5Q'E]P?ZGY9_>^__ (!\#_\ #&7Q#_NZ7_X$M_\
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M_ EO_B*^^**/[5Q'E]P?ZGY9_>^__@'P/_PQE\0_[NE_^!+?_$4?\,9?$/\
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MQL_]2?\ ??\ ]"-3T?VKB/+[@_U0RS^]]_\ P#X'_P"&,OB'_=TO_P "6_\
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MDENH6*/+*)%;RD8<AM@8[AT.VOUAKYC&QA&K[OS/U#):M:IA5[5:+9]U_P
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MCXGBG+L5F-&E#"PYFFV]4NGFT?&M%?6__# __4]?^4C_ .WT?\,#_P#4]?\
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M^"?6?^9]_P#*/_\ ;ZG^T<+_ #_@_P#(I<-9M_SY_P#)H_YGQVU1-TK['/\
MP3WS_P S]_Y1O_M],/\ P3TS_P S_P#^4;_[HH_M'"_S_@_\BO\ 5K-?^?/_
M )-'_,^-WZ5&W2OLL_\ !/+/_,__ /E&_P#NBF'_ ()W9_YJ!_Y1?_NBE_:&
M&_G_  ?^1HN',T_Y\_\ DT?\SXR:HG[U]H'_ ()UY_YJ#_Y1?_NBF'_@G1G_
M )J#_P"47_[HJ?[0PW\WX/\ R-%P[FG_ #Z_\FC_ )GQ8U0MTK[6/_!.3/\
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MTW=.S/(O@/\ #GXB>%)M;USXE>.V\4ZYJYC/]F6,?E:9IJIG"P*1NR<\MQG
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M:T4-_P ?R?\ 7-OYK10!/15?-UZ0_F:,W7I#^9H L457S=>D/YFC-UZ0_F:
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M_,T9NO2'\S0!8HJOFZ](?S-&;KTA_,T 6**KYNO2'\S1FZ](?S- "V?^I/\
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MF?LN>.=9^)?P"\&^)_$-TM[K.I6KS7,ZQ+&&;S7 PJ@ 8  X':BPSU2BBBD
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M-5M/UB\\/:O::GI\[VM]9S+/#,AP4=3D']*LW/W363==36,M3TZ+:::/U_\
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M:'\1_&_A_P"*-WX*\5+H?B&YD\+R>(K*YT*UDT[#PSK#+;.L\\H.XRQ%9-Z
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M$L<@V1;0L)9@IVG::5AW/JFBBBI&%%%% %>/_C]G_P!Q/_9JL57C_P"/V?\
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M_9LJP"P5!)KWWO\ Y?(****XCV0HHHH **** "H(_P#C\F_W$_\ 9JGJ"/\
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MB&*-=-TG38OEEU;496+$*.H3>[,2?NK[XS,XN44I6YK]+;?(J+46VK\OG?\
M4I?ME_M+:E\)/#%WX<\#1_;_ (A7.G3ZB3&BR+I-C$I,MY*#P,8(0-U;UQ@^
MJ>#(M7\>?"[P3JTNO75AJ=WHMI<W-S;JN999(8G9BI&WKNXQCYCC%> >(OA-
M_P *\_9;^,7B+Q5JMKKGQ.\4Z%>76NZFDBD*WDMLM(.?EAB'R@#KC/H!]$?
MJ>.;X*^ ?+D1ROA_3PP5@<'[-'P:F:C&"Y>CW*BY.;YNVQVMM$T-M%&\AF=$
M"M(W5B!R?QJ6BBN4Z"!O^/Y/^N;?S6BAO^/Y/^N;?S6B@# \<?##P;\3K:UM
M_&/A+0O%D%HYDMXM<TV&]6%B,%D$JL%)  )%<_I'[-OPC\/O=/I?PM\%::UW
M;26=PUIX>M(C-!(-LD3[8QN1APRG@CJ*]&HH P;CP#X8N[30;6?PYI,UMH$D
M<VD0R6,3)ISQKLC:W4KB(JORJ4P0.!Q7G/P+_9<\&_!?0=!W:-H6M>,-*2>-
M?%QT6&#4'6221MHE^:10$E,>-YRH]#BO9** .1UOX/\ @/Q-XKM/%&L>"?#F
MJ^)K3RS;ZS?:3!->0[#E-DS(77:3D8/!Z5=T;X>>%?#DNERZ3X9T?2Y=*M'L
M-/>SL(H6L[9V#/#$54>7&Q5247 )4''%=#10!S&J_"[P9KNB:GHVI^$="U'1
M]4NS?W^GW>FPRV]W<DAC-+&RE7D)53O8$Y4'/%0Z;\(O NC^%?\ A&;#P7X>
ML?#?VA;O^Q[;2H([/SU=767R0@3>'1&#8R"H.<@5UM% ')^*/A+X'\<:[I^M
M^(_!GA_7]9T_:+/4=4TN"YN+;:V]?+D="R8;YAM(P>>M;;>'-)?Q"FOMI=D=
M=CM6L4U,VZ?:5MV=7:$2XW",NJL5S@E0<9%:-% &?HWA_2_#L5U'I6FV>F1W
M5S+>W"6<"0B:XE8O+*X4#<[L2S,>6))))K0HHH **** "BBB@ HHHH ****
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M>:G.LB*+:$Q@!R&()&01\H)KWZBI51II]E8ITTTUWU"N$^)_P,\"?&?^S?\
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M:9_WY?\ ^+H_X:8\6_\ /#3/^_+_ /Q=>3T4?VQF'_/YA_J[E/\ T#Q/6/\
MAICQ;_SPTS_OR_\ \71_PTQXM_YX:9_WY?\ ^+KR>BC^V,P_Y_,/]7<I_P"@
M>)ZQ_P -,>+?^>&F?]^7_P#BZ/\ AICQ;_SPTS_OR_\ \77D]%']L9A_S^8?
MZNY3_P! \3UC_AICQ;_SPTS_ +\O_P#%T?\ #3'BW_GAIG_?E_\ XNO)Z*/[
M8S#_ )_,/]7<I_Z!XGK'_#3'BW_GAIG_ 'Y?_P"+H_X:8\6_\\-,_P"_+_\
MQ=>3T4?VQF'_ #^8?ZNY3_T#Q/6/^&F/%O\ SPTS_OR__P 71_PTQXM_YX:9
M_P!^7_\ BZ\GHH_MC,/^?S#_ %=RG_H'B>L?\-,>+?\ GAIG_?E__BZ/^&F/
M%O\ SPTS_OR__P 77D]%']L9A_S^8?ZNY3_T#Q/6/^&F/%O_ #PTS_OR_P#\
M71_PTQXM_P">&F?]^7_^+KR>BC^V,P_Y_,/]7<I_Z!XGJX_:4\5ARP@TS<0
M3Y+]O^!TO_#3'BW_ )X:9_WY?_XNO)Z*/[8S#_G\P_U=RG_H'B>L?\-,>+?^
M>&F?]^7_ /BZ/^&F/%O_ #PTS_OR_P#\77D]%']L9A_S^8?ZNY3_ - \3UC_
M (:8\6_\\-,_[\O_ /%T?\-,>+?^>&F?]^7_ /BZ\GHH_MC,/^?S#_5W*?\
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MCQ;_ ,\-,_[\O_\ %UY/11_;&8?\_F'^KN4_] \3UC_AICQ;_P \-,_[\O\
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MXM_YX:9_WY?_ .+KR>BC^V,P_P"?S#_5W*?^@>)ZQ_PTQXM_YX:9_P!^7_\
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M^7_^+H_X:8\6_P#/#3/^_+__ !=>3T4?VQF'_/YA_J[E/_0/$]8_X:8\6_\
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M@_P]I?P8\0WFFW]GXAD6\B$>HBS\J:+YXPR?-E@.IX."&J;Q-\))?$7Q(O\
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M9_V[X5NM.L[R_CT7S-]UJK(+J<.I0KE.!\IZ]2<9'!)I>,?BEHFI:?-!IO\
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M'_(/]>L#_P ^I_\ DO\ F?'5%?8O_"D?!G_0&C_[Z/\ C1_PI'P9_P! :/\
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M(_C_ )!_KU@?^?4__)?\SXZHK[%_X4CX,_Z T?\ WT?\:/\ A2/@S_H#1_\
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M#/\ H#1_]]'_ !H_X4CX,_Z T?\ WT?\:/\ 57%?\_(_C_D'^O6!_P"?4_\
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M^0?Z]8'_ )]3_P#)?\SXZHK[%_X4CX,_Z T?_?1_QH_X4CX,_P"@-'_WT?\
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MI_\ DO\ F?'5%?84'P6\'3H6;18LAF7@D< D#O[4_P#X4CX,_P"@-'_WT?\
M&C_57%?\_(_C_D+_ %ZP/_/J?X?YGQU17V+_ ,*1\&?] :/_ +Z/^-'_  I'
MP9_T!H_^^C_C1_JKBO\ GY'\?\A_Z]8'_GU/_P E_P SXZHK[%_X4CX,_P"@
M-'_WT?\ &C_A2/@S_H#1_P#?1_QH_P!5<5_S\C^/^0?Z]8'_ )]3_P#)?\SX
MZHK[%_X4CX,_Z T?_?1_QH_X4CX,_P"@-'_WT?\ &C_57%?\_(_C_D'^O6!_
MY]3_ /)?\SXZHK[%_P"%(^#/^@-'_P!]'_&C_A2/@S_H#1_]]'_&C_57%?\
M/R/X_P"0?Z]8'_GU/_R7_,^.J*^Q?^%(^#/^@-'_ -]'_&C_ (4CX,_Z T?_
M 'T?\:/]5<5_S\C^/^0?Z]8'_GU/_P E_P SXZHK[%_X4CX,_P"@-'_WT?\
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH @C_P"/R?\
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M$\LRCIW]* -.BBB@ HK#\.^-=%\67^NV>E7OVJYT.].GZ@GE.GDS^6DFS+*
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M84444 %06GW9/^NC?SJ>H+3[LG_71OYT 3T444 %%%% !1110 4444 %%%%
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MQ_;6E6]TUE+<?9IK?;,J(Y7;*BL?ED0Y QSUX-;'@?QOHOQ(\*:=XE\.WO\
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M\*:;X%\3>#[N"XUG0?$.H7>I7UO?RC)DN)?-=4:,(5"M@J1\RX!W9&:B\+?
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M9FMO@UH7C>U^&6O:AH)UN#.G:=?S&ZT_2KC:W[R*-LD;B1G)/W1P<8JCX?\
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MU,BB2")(XU"QHH55'8#H*?6)J0-_Q_)_US;^:T4-_P ?R?\ 7-OYK10!X_\
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MFN#>.E]-;P);P1^9+,[)&K$(&_B; 4'%"[N[WX2?'WQQXGU;0=9U?0/$VDV
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M$ @@>D5(PHHHH **** "BBB@ HHHH **** "BBB@"O'_ ,?L_P#N)_[-6/\
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M_P#C\F_W$_\ 9JGJ"/\ X_)O]Q/_ &:@">BBB@ HHHH **** "BBB@ HHHH
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M+O WKDC^\,XR*L>*?'OAGP-IT&H>)/$6D^'["X<10W6JWT5M%(Y!8*K.P!.
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M0 4444 %5Y/^/V#_ '7_ *58JO)_Q^P?[K_TH L4444 %%%% !1110 4444
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M (/L<?K)_P!_6_QH^QQ^LG_?UO\ &IZ* (/L<?K)_P!_6_QH^QQ^LG_?UO\
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M %%%% !4'_+]_P!L_P"M3U!_R_?]L_ZT 3T444 %%%% !1110 4444 %%%%
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M,?=P,@]>O6O/O 6@ZI\7_P!KGQ3X]UK3;RR\-^!(3X>\-QWL#Q">Y?FZND#
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M?\?L'^Z_]* +%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!!9_ZD_P"^_P#Z$:GJ"S_U)_WW_P#0C4] !1110 4444 %%%%
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M,?-3!5<'</>L+6_!VDZSXMT+Q*+R6PUG21+"ES:2(#<6T@'F6TP96W1%EC?
MPP:-2&'S ]!'&OVN;Y1]U>WUJ?RT_NK^5,0S[5!_SVC_ .^A1]J@_P">T?\
MWT*?Y:?W5_*CRT_NK^5(8S[5!_SVC_[Z%<WX$\':3\/]*NK2RO);R>]O)M1O
MK^]D1I[NYE;+RR%%5<\*H"JJJJJJ@!0*Z?RT_NK^5'EI_=7\J &?:H/^>T?_
M 'T*/M4'_/:/_OH4_P M/[J_E1Y:?W5_*@!GVJ#_ )[1_P#?0H^U0?\ /:/_
M +Z%/\M/[J_E1Y:?W5_*@!GVJ#_GM'_WT*Y7QAX#T;QMKWA+5[Z]GBN?#6H-
MJ5FMO*@221H7B(D!4DKMD8X!!R!SVKK?+3^ZOY4>6G]U?RH 9]J@_P">T?\
MWT*/M4'_ #VC_P"^A3_+3^ZOY4>6G]U?RH 9]J@_Y[1_]]"C[5!_SVC_ .^A
M3_+3^ZOY4>6G]U?RH 9]J@_Y[1_]]"C[5!_SVC_[Z%/\M/[J_E1Y:?W5_*@!
MGVJ#_GM'_P!]"C[5!_SVC_[Z%/\ +3^ZOY4>6G]U?RH 9]J@_P">T?\ WT*/
MM4'_ #VC_P"^A3_+3^ZOY4>6G]U?RH 9]J@_Y[1_]]"C[5!_SVC_ .^A3_+3
M^ZOY4>6G]U?RH JQW,(O)CYJ8*+@[A_M5/\ :H/^>T?_ 'T*CCC7[9,-H^XG
M;_>J?RT_NK^5 #/M4'_/:/\ [Z%'VJ#_ )[1_P#?0I_EI_=7\J/+3^ZOY4 ,
M^U0?\]H_^^A1]J@_Y[1_]]"G^6G]U?RH\M/[J_E0 S[5!_SVC_[Z%'VJ#_GM
M'_WT*?Y:?W5_*CRT_NK^5 #/M4'_ #VC_P"^A1]J@_Y[1_\ ?0I_EI_=7\J/
M+3^ZOY4 ,^U0?\]H_P#OH4?:H/\ GM'_ -]"G^6G]U?RH\M/[J_E0 S[5!_S
MVC_[Z%06=S"MNH,J Y/!8>IJUY:?W5_*H+*-3;+\HZGM[FF(D^U0?\]H_P#O
MH4?:H/\ GM'_ -]"G^6G]U?RH\M/[J_E2&,^U0?\]H_^^A1]J@_Y[1_]]"G^
M6G]U?RH\M/[J_E0 S[5!_P ]H_\ OH4?:H/^>T?_ 'T*?Y:?W5_*CRT_NK^5
M #/M4'_/:/\ [Z%'VJ#_ )[1_P#?0I_EI_=7\J/+3^ZOY4 ,^U0?\]H_^^A1
M]J@_Y[1_]]"G^6G]U?RH\M/[J_E0 S[5!_SVC_[Z%'VJ#_GM'_WT*?Y:?W5_
M*CRT_NK^5 #/M4'_ #VC_P"^A1]J@_Y[1_\ ?0I_EI_=7\J/+3^ZOY4 ,^U0
M?\]H_P#OH4?:H/\ GM'_ -]"G^6G]U?RH\M/[J_E0 S[5!_SVC_[Z%06MS"J
MR9E0?O&/+#UJUY:?W5_*H+2-2LGRC_6-V]Z!$GVJ#_GM'_WT*/M4'_/:/_OH
M4_RT_NK^5'EI_=7\J!C/M4'_ #VC_P"^A1]J@_Y[1_\ ?0I_EI_=7\J/+3^Z
MOY4 ,^U0?\]H_P#OH4?:H/\ GM'_ -]"G^6G]U?RH\M/[J_E0 S[5!_SVC_[
MZ%'VJ#_GM'_WT*?Y:?W5_*CRT_NK^5 #/M4'_/:/_OH4?:H/^>T?_?0I_EI_
M=7\J/+3^ZOY4 ,^U0?\ /:/_ +Z%'VJ#_GM'_P!]"G^6G]U?RH\M/[J_E0 S
M[5!_SVC_ .^A1]J@_P">T?\ WT*?Y:?W5_*CRT_NK^5 #/M4'_/:/_OH4?:H
M/^>T?_?0I_EI_=7\J/+3^ZOY4 ,^U0?\]H_^^A4$=S"+N8^:F"JX.X>]6O+3
M^ZOY5!'&OVR;Y1]Q.W^]0!)]J@_Y[1_]]"C[5!_SVC_[Z%/\M/[J_E1Y:?W5
M_*@!GVJ#_GM'_P!]"C[5!_SVC_[Z%/\ +3^ZOY4>6G]U?RH 9]J@_P">T?\
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MI_=7\J &?:H/^>T?_?0H^U0?\]H_^^A3_+3^ZOY4>6G]U?RH 9]J@_Y[1_\
M?0H^U0?\]H_^^A3_ "T_NK^5'EI_=7\J &?:H/\ GM'_ -]"C[5!_P ]H_\
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M;@6CVQCE,4<Q_P"6;3A/*5@?E(+@AOE.#Q6W<_'SP'9+XY,^OK#_ ,(2$/B
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M 4444 %%%% !1110 4444 %%%% $%G_J3_OO_P"A&IZ@L_\ 4G_??_T(U/0
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M)ESV>601G_KU''J6"Y]?UD-XKTE?%B>&3>I_;KV3:B+( EOLXD$9D)Q@#>P
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M#,#D^3_$OP?KFM?&3XD366DWEQ;7_P +AIEK<K"PAFNC<7I$"R$;2^'0[<Y
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M8F/E7VE2!]#>&- U&#]JSQUK$NFW4>EW'AK2[>"_>!A#+(LUR71)"-I8!E)
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M]2?]]_\ T(U/0!P'QJ^-WACX#>#G\0^)KB0(\@M[2QM4\RYO9S]V*)/XF/Y
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MPL5SSC-:/@OP#H/P]TV>RT'3Q9QW$[W5S-)*\]Q=3,?FEFFD9I)7/ WNS'
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MF?A<_P##0/[9>L>(&_?^$?A5"VDZ?GF.;5YA_I$@[$QJ-GL0I[U]3JH50J@
M 8 ':HX+6&VW^3$D6]B[[%"[F/4G'4^])32;<5N-P;239QNJ_!;P9J>A^,M,
M7P_864?BZ.1-9EM;=4DNV="N]R!\S#<2">YSU->3?L4>,[^'P'KOPU\3SY\4
M?#>^;1;EW/,UH,FUFY_A,8P/9 >]?2%1):PQS2RI#&LLN/,<* SXX&3WQ4J?
MNN+'R>\I(^8_V$+:/Q=\+/''BV^A$R^-/%>J:@XD&1) 7\I5/MA&%>-_LP?#
MKQ _[2H^'VMJ9?"OP8FU"YTLN"?,:^?-J6^D1=E],5^@%O;0VD*Q01)#$O1(
MU"J/H!38K"VM[J>YBMXH[FXV^=,B /)M&%W'J<#@9Z5K[9WEIO\ A_2,_9:1
MUV_K\SYG\:2_\(7_ ,% ? &H#]U;^+_"E[H\C=GEMY//7\<8%4_VQM-M-8^,
MO[-]C?VL-]97'BB:.:VN8Q)'(IB7*LI!!'L:^II+6&:6*62)'EBR8W9063/7
M![42VT,[QO)$DCQ'<C.H)0^H]#4JK9IVV5OS*=.Z:ON[G/Z)\-/"'AJ^6]TC
MPIHFE7B@A;BRTZ&&0#V95!KSW]H_]GBZ_: C\+Q1>,;OPQ!H=Z=0%O%91W<-
MS.-OE/)'(=K;,-@$$?.>*]GHK-3E%\R>IHXIKE>Q\;_M(_"'XH>'/@)X^U/4
M_CEJFO:=;:/<27&F2Z!90I=1[#NC+H-R@CC(Y%>R?LJ^%/$/AOX1^'IM<\8W
M7BF"_P!)L)[&WN+*&W&G1?9U_<J8P"XP0,MD_+[FO89H8[B)XY462-QM9'&0
MP]"*5$6-%1%"HHP%48 'I6DJKE#E:_!$*FHRYD.HHHK U(&_X_D_ZYM_-:*&
M_P"/Y/\ KFW\UHH GHKR;_AJSX3?]#SI7_?ZC_AJSX3?]#SI7_?ZNOZIB/\
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MPU9\)O\ H>=*_P"_U'U3$?\ /N7W,/95/Y7]QZS17DW_  U9\)O^AYTK_O\
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M/A-_T/.E?]_J/JF(_P"?<ON8>RJ?RO[CUFBO)O\ AJSX3?\ 0\Z5_P!_J/\
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MO^&K/A-_T/.E?]_J/^&K/A-_T/.E?]_J/JF(_P"?<ON8>RJ?RO[CUFBO)O\
MAJSX3?\ 0\Z5_P!_J/\ AJSX3?\ 0\Z5_P!_J/JF(_Y]R^YA[*I_*_N/6:*\
MF_X:L^$W_0\Z5_W^H_X:L^$W_0\Z5_W^H^J8C_GW+[F'LJG\K^X]9HKR;_AJ
MSX3?]#SI7_?ZC_AJSX3?]#SI7_?ZCZIB/^?<ON8>RJ?RO[CUFBO)O^&K/A-_
MT/.E?]_J/^&K/A-_T/.E?]_J/JF(_P"?<ON8>RJ?RO[CUFBO)O\ AJSX3?\
M0\Z5_P!_J/\ AJSX3?\ 0\Z5_P!_J/JF(_Y]R^YA[*I_*_N/6:*\F_X:L^$W
M_0\Z5_W^H_X:L^$W_0\Z5_W^H^J8C_GW+[F'LJG\K^X]9HKR;_AJSX3?]#SI
M7_?ZC_AJSX3?]#SI7_?ZCZIB/^?<ON8>RJ?RO[CUFBO)O^&K/A-_T/.E?]_J
M/^&K/A-_T/.E?]_J/JF(_P"?<ON8>RJ?RO[CU*S_ -2?]]__ $(U/7D</[4W
MPHMTVOXYTC));Y9P>"<CI[&G_P##5GPF_P"AYTK_ +_4?5,1_P ^Y?<P]E4_
ME?W'K-%>3?\ #5GPF_Z'G2O^_P!1_P -6?";_H>=*_[_ %'U3$?\^Y?<P]E4
M_E?W'K-%>3?\-6?";_H>=*_[_4?\-6?";_H>=*_[_4?5,1_S[E]S#V53^5_<
M>LT5Y-_PU9\)O^AYTK_O]1_PU9\)O^AYTK_O]1]4Q'_/N7W,/95/Y7]QZS17
MDW_#5GPF_P"AYTK_ +_4?\-6?";_ *'G2O\ O]1]4Q'_ #[E]S#V53^5_<>L
MT5Y-_P -6?";_H>=*_[_ %'_  U9\)O^AYTK_O\ 4?5,1_S[E]S#V53^5_<>
MLT5Y-_PU9\)O^AYTK_O]1_PU9\)O^AYTK_O]1]4Q'_/N7W,/95/Y7]QZS17D
MW_#5GPF_Z'G2O^_U'_#5GPF_Z'G2O^_U'U3$?\^Y?<P]E4_E?W'K-%>3?\-6
M?";_ *'G2O\ O]1_PU9\)O\ H>=*_P"_U'U3$?\ /N7W,/95/Y7]QZDW_'\G
M_7-OYK17*^!OBCX5^)MS<R>%];M=92S3;.UL^[RRQ^4'Z[3^5%<\X2@^6:LS
M-IQ=F?B[17:_"CX/^)?C-XA?2?#EK&YA0375Y=2"*WM(L@&21ST'/0 L<' .
M#74^._V8O$W@SP7+XMLM8\.>,_#EM*8;S4?"VIB\CLWR@"R953D^8OW0V.K;
M<C/[7+%485%2E-*7;UV^_IW/N'5A&7(WJ>0T45W^@_!;6_$/PJU#Q_;76GIH
MUCJ<>DR02R.+@ROY>&"A"NW]ZO)8'@\>NTZD*:3F[7=OFRI24=V<!17:_%_X
M3:O\%?&L_AC7+FRNK^&&.9I-/=WB*N,C!=%.?PJG\,/AWJ7Q8\=:5X4TB>UM
MM1U%G6*6]=EA4K&TAW%58CA#T!YQ4JM3=/VR?NVO?R[BYXN//?0Y:BM'Q)H4
M_A?Q%JFC73QR76G74MI*\))1GC<HQ4D D9!QD#Z5G5JFI*Z+3OJ@HHHI@%%=
MGX%^$VO?$+P]XMUS3%MDTSPQ9"]U">XEVX!W;$10"69@CD<;1M.2,C-+Q7X&
M_P"$5T3P]J7_  D&A:Q_;%N;C[)I5[Y]Q8X"G9<IM'EO\W3)^ZWI6/MJ;GR)
MZ_\  O\ D1SQORWU.9HHHK8L**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&>3SCN:32OB/XLT'0YM%TSQ1K6G:/,'$NGVFH316[AQA]T:L%.X<'(Y[U?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=?<>G];J]SX*_P"&$_B'_P __A__ ,#)?_C5'_#"?Q#_ .?_ ,/_ /@9+_\
M&J^]:*/[4Q7=?<'UNKW/@K_AA/XA_P#/_P"'_P#P,E_^-4?\,)_$/_G_ /#_
M /X&2_\ QJOO6BC^U,5W7W!];J]SX*_X83^(?_/_ .'_ /P,E_\ C5'_  PG
M\0_^?_P__P"!DO\ \:K[UHH_M3%=U]P?6ZO<^"O^&$_B'_S_ /A__P #)?\
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MU,5W7W!];J]SX*_X83^(?_/_ .'_ /P,E_\ C5'_  PG\0_^?_P__P"!DO\
M\:K[UHH_M3%=U]P?6ZO<^"O^&$_B'_S_ /A__P #)?\ XU1_PPG\0_\ G_\
M#_\ X&2__&J^]:*/[4Q7=?<'UNKW/@K_ (83^(?_ #_^'_\ P,E_^-4?\,)_
M$/\ Y_\ P_\ ^!DO_P :K[UHH_M3%=U]P?6ZO<^"O^&$_B'_ ,__ (?_ / R
M7_XU1_PPG\0_^?\ \/\ _@9+_P#&J^]:*/[4Q7=?<'UNKW/@K_AA/XA_\_\
MX?\ _ R7_P"-4?\ #"?Q#_Y__#__ (&2_P#QJOO6BC^U,5W7W!];J]SX*_X8
M3^(?_/\ ^'__  ,E_P#C5'_#"?Q#_P"?_P /_P#@9+_\:K[UHH_M3%=U]P?6
MZO<^"O\ AA/XA_\ /_X?_P# R7_XU1_PPG\0_P#G_P##_P#X&2__ !JOO6BC
M^U,5W7W!];J]SX*_X83^(?\ S_\ A_\ \#)?_C5'_#"?Q#_Y_P#P_P#^!DO_
M ,:K[UHH_M3%=U]P?6ZO<^"O^&$_B'_S_P#A_P#\#)?_ (U1_P ,)_$/_G_\
M/_\ @9+_ /&J^]:*/[4Q7=?<'UNKW/@K_AA/XA_\_P#X?_\  R7_ .-4?\,)
M_$/_ )__  __ .!DO_QJOO6BC^U,5W7W!];J]SX*_P"&$_B'_P __A__ ,#)
M?_C5'_#"?Q#_ .?_ ,/_ /@9+_\ &J^]:*/[4Q7=?<'UNKW/@K_AA/XA_P#/
M_P"'_P#P,E_^-4?\,)_$/_G_ /#_ /X&2_\ QJOO6BC^U,5W7W!];J]SX*_X
M83^(?_/_ .'_ /P,E_\ C5'_  PG\0_^?_P__P"!DO\ \:K[UHH_M3%=U]P?
M6ZO<^"O^&$_B'_S_ /A__P #)?\ XU1_PPG\0_\ G_\ #_\ X&2__&J^]:*/
M[4Q7=?<'UNKW/@K_ (83^(?_ #_^'_\ P,E_^-4?\,)_$/\ Y_\ P_\ ^!DO
M_P :K[UHH_M3%=U]P?6ZO<^"O^&$_B'_ ,__ (?_ / R7_XU1_PPG\0_^?\
M\/\ _@9+_P#&J^]:*/[4Q7=?<'UNKW/@K_AA/XA_\_\ X?\ _ R7_P"-4?\
M#"?Q#_Y__#__ (&2_P#QJOO6BC^U,5W7W!];J]SX*_X83^(?_/\ ^'__  ,E
M_P#C5'_#"?Q#_P"?_P /_P#@9+_\:K[UHH_M3%=U]P?6ZO<^"O\ AA/XA_\
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MPG\0_P#G_P##_P#X&2__ !JOO6BC^U,5W7W!];J]SX*_X83^(?\ S_\ A_\
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MPPG\0_\ G_\ #_\ X&2__&J^]:*/[4Q7=?<'UNKW/@K_ (83^(?_ #_^'_\
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M_P ,)_$/_G_\/_\ @9+_ /&J^]:*/[4Q7=?<'UNKW/@K_AA/XA_\_P#X?_\
M R7_ .-4?\,)_$/_ )__  __ .!DO_QJOO6BC^U,5W7W!];J]SX*_P"&$_B'
M_P __A__ ,#)?_C5'_#"?Q#_ .?_ ,/_ /@9+_\ &J^]:*/[4Q7=?<'UNKW/
M@K_AA/XA_P#/_P"'_P#P,E_^-4?\,)_$/_G_ /#_ /X&2_\ QJOO6BC^U,5W
M7W!];J]SX*_X83^(?_/_ .'_ /P,E_\ C5'_  PG\0_^?_P__P"!DO\ \:K[
MUHH_M3%=U]P?6ZO<^"O^&$_B'_S_ /A__P #)?\ XU1_PPG\0_\ G_\ #_\
MX&2__&J^]:*/[4Q7=?<'UNKW/@K_ (83^(?_ #_^'_\ P,E_^-4?\,)_$/\
MY_\ P_\ ^!DO_P :K[UHH_M3%=U]P?6ZO<^"O^&$_B'_ ,__ (?_ / R7_XU
M1_PPG\0_^?\ \/\ _@9+_P#&J^]:*/[4Q7=?<'UNKW/@K_AA/XA_\_\ X?\
M_ R7_P"-4?\ #"?Q#_Y__#__ (&2_P#QJOO6BC^U,5W7W!];J]SX*_X83^(?
M_/\ ^'__  ,E_P#C5'_#"?Q#_P"?_P /_P#@9+_\:K[UHH_M3%=U]P?6ZO<^
M"O\ AA/XA_\ /_X?_P# R7_XU1_PPG\0_P#G_P##_P#X&2__ !JOO6BC^U,5
MW7W!];J]SX*_X83^(?\ S_\ A_\ \#)?_C5'_#"?Q#_Y_P#P_P#^!DO_ ,:K
M[UHH_M3%=U]P?6ZO<^"O^&$_B'_S_P#A_P#\#)?_ (U1_P ,)_$/_G_\/_\
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ME=TZL7;80%.%PW)SGC!CC^ 7B:\L/ &GZKXYM+C3O!E[9W=G!9:&;<W0MP$
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M)TXL3@F>1W7[/=MXHM/%<WBW6&U;7O$*6\4FH:?;?8TLDMWWVZV\;/(5VO\
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MVXGBT#Q%JS:/<V4G"6VA2,L-E<$?PD2HLK'TG^M?1WQTY^"7Q QU_P"$?O\
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MC4FL]<T.2)(]UM!<*'"!0HE5 T+[I6Y)(S]!_P#"O/"O_"3_ /"2?\(SH_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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5-OYK15>WG:>]7< ,1MT^HHI ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>camp-20241231_g3.jpg
<TEXT>
begin 644 camp-20241231_g3.jpg
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M/O_M $A0:&]T;W-H;W @,RXP #A"24T$!       #QP!6@ #&R5'' (   (
M @ X0DE-!"4      !#\X1^)R+?)>"\T8C0'6'?K_^X #D%D;V)E &3
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M?5'VGP<&VTY[K_+]Q*3XB!\-9OZ(XUA;"X\97I^:B#ZI:6$-O;7>G+Z6>O\
MEQ3=U?O]Z\_$[&3_   )^61;QN7/XC/YU-96K2__ %H?\MZ'_?F\_P#$9?\
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M MXY@0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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MFWFX7%IDO+T&^KC6" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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MDKC[9_A[KL/X98P^N/FS78>BWM-Y86Y7QQI&YV_+/SY/M+XNR>=" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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M]!M?_'V5R]]ZY_+CW9S?HHB[@878//GU $ 0! $ 0! $ 0! $ 0! $ 0! $
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MV<@AK3?\0X$B%[2QY#?' /CA8E!QS,IIDHH&0@" ( @" ( @" ( @" ( @"
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M1OQ8V3U7#_H+D]36J$(?-.*]=?J.]T9Z;ER?R6YOU4^LN8\%UC@A $ 0! $
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MDG)QA<W8[:5JNJ*6%*IOWNWRQ.[U??0W+3A.4DVWIDDE!/[JIR\R+^NJ>>"
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MOL)F&.2?P:QCO%D8^!\R?%6-%;(?F6WJ4[;]50;Z^Q:>R8]I[8W$=&@?K/\
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M.N!;&-"\U*5.A'Z-*O'6B)+BR%C6-R?/#0%23,Z ( @" ( @" ( @" ( @"
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M1\+M_JC8RUW'_P"OKO _J7)WKI>LO]IKTH[W3EJV^XC^PGZ)(NBZQP0@" (
M@" ( @" ( @-#<6-;5UUNSN#$W4PPODNF=H?$(6C+NYI!R,>6%7=E&,6YY<2
MZQ"<[D8VZZF\*9U(KCV\TV\99V-&C/1FKMCCG-RF^G,8>WU(\=[07,P<C'A\
MBJ+-^%Q.235.:IAP\QM;K:W;#4924JY:9*2KD\N)E;S/C!&1L68/]E__ +JH
M_,MM\_T^PS^6[CY?H]ICW7(>.Q:)VRV);=U%I[:\<#838=8DD=V-B9"6DO<Y
MW0#"MGNK3M:W[T7AEGV4,6-I?=[1#W9QQK6FE+%MO@C=XY>UNPU->SJ(#4H
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M F< ?KC.>K3^J.A\PM76\C8THO#0&@ #  P .G0*LF?4 0! $ 0! $ 0! $
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MIQ[#IV@X1QZC-7W<6I%#8.C:\TR\R15Y7#+BQI):'>60M1R;PJ;*BD6Q0)!
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M\4+D6PIP78?]7.QKV_+(\/N7M;<U.*DN)\VNVW;FXO-,V%85! $ 0! $ 0!
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ME_Q+[3Z?;C^(Z)2.:C_PRJ?H-?2CY@<:_F W+:U/CVB!^O8V9[) _8I19/\
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MX_6S]38\]7#'4X'0JB_2O:;-NM"^^*UBT( @" ( @" ( @" ( @" ( @" (
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M+O</W-IF/!P!.,],^/@OF=C<7>D[B5N?PO/ZI(^L7-OMNKV;=WD_/^U!F?\
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M7&N#WM)BED;U8Y[.A<T^!!^2TYQTNALQ=43"@2" ( @" ( @" ( @" ( @"
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MS\ALXGN.(9OW,OP^H]#]Q6[M;FB:Y/ YN^M>):?-8G15Z$\F$ 0! $ 0! $
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MRF^?W^*]#8N:X)\3R>ZM>'<:X<"05YJA $ 0! $ 0! $ 0! $ 0! $ 0! $
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MEFOH+>NL<$( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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MLFLR\<6U^NT-B&SNMQ<V&P81V M+:S'.Z= ,N=X^+C]RJFIM4X%L*(ZDM0V
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M%<M'4O!=GN'19<:(%\40$ 0%(]R9./U*%2_NZ4UV=DCHJ,==_I.]21N2'.R
M&X;YY5MNM<"$Z4.5?WVVVLG=+6U#*]'_ *N&8RRX'SE&,D_8MI+F:K)_3S<M
MY2&R5>/F*L__ /%R2F&'!\V^HWN=_F@K#N1B3C%L[/49-%5ACL.#IV,:V1S<
M]I<  2,_-:3-HS+ " ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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M0".YN6^:@G2*?>9XE/UGN1RC1[+W?Y+NJ1U_N+%KM#QP4P1^^WLC9:<4M<-
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M;H3_ ):TR0_A/T/_ ,EW^)7VI:9&O>AKBT6A=,XH0! $ 0! $ 0! $ 0! $
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ME:R-Q80_+GG(+3XN*\5N+,K5QPEFCVUJY&Y!2CDRP+7+0@" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" (#0VFZUFE9!)LYQ7CLRMKQ/<"6F1_@"0#CP\3
MT4E%O(PVEF>[FTI4)Z=>U)Z<U^7T*K>TGOD[2[&0#CH/-82J&S<6#(0&H[94
MV[%FI=)_Q\D+K+(L'K$QP879QCQ(\UFF%3%<:&VL&0@" ( @" ( @" ( @"
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MC4L>MG,]5O<?KC^AWW>!_0NE:E6)R+\-,C;5I0$ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ \>B HVYU.TXGL['+N*027:5MPEY+QN(Y=9PT--RF
M"0&VFM [X_PSM&.CPTK(+9I]OK-_K*VXT]EEO6VV>I7L1YPX9P000"US2"US
M7 %I!! (6 ;J ( @.<>]_,=UPC@DNVX_*ROMI[5>G!8EC;,(_6<>YW8[HX@
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MI.&2_3C^UY*^S*C[S4W$:QKR)Q;QS0@" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ("C;?4;/B6SL\MXE6?<I7'^MR7C4.,V3CZKE-IP&VP!];.C
M9P,'$@:XY!:]/N-9O]96W&GLLMZVVSU*]B/.'#.""#@M<T@M<UP#FN!! (6
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M):T.WL'NM._+X,L$S_&3Z3ZC'N^KZ7 D],>6W>W4%J1Z&_:TXH_8RYIJ! $
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MK-U4KO\ 3/7MGD$,C#CXM>00N)N[:=J7<>YOQK%G]15Y$X@0! $ 0! $ 0!
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M_P"DQGRZC["KX/@:UU8U-E6%(0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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MRLH'A]=SS_K"&^0'Z"@,3W/@_=RDOA>" 0>HRLI5(MT-&HY\$IJ=_IO/4@C
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M[H_X@!DR!H =V=<=%FB=&*M51MMH7Z',='%=V#]BTUKICEFC8R5KL1]P+HP
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M:TC'4!H+B!X%Y.$<JF%&A3[7%;ETR:ZMJ;%%DU@2/<^Z)-; !('NEAB!R7O
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MX+A7BN9?O]DMK<T:XS=,=/!\B>6^<X( @" ( @" ( @" ( @" ( @" ( @"
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MJT:=&>@C.,E5.J)35-+-?7!\>W/^D2?\*K>98C<6#(0! $ 0! $ 0! $ 0!
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M#1&TC)H-A^99G\G*0VW&/ M\G8^+?ZE-^\B*P9>VD. <TY:1D$>8*H+#Z@"
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MZ5G(J\%NZKC^&./G+!0UL=NFTSL+@\DL.2'=O3IU \5FM#86*,&NJUJ'+/R
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MMC<BGBI*7FI0T;J:W<)4P<9+SU3^HZZN(=,( @" ( @" ( @" ( @" ( @"
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M^U+)^98][/T&O/G5" ( @" ( @" (!@=?GXH @" ( @" ( @" ( @" ( @"
M( @" UY8BT]\?WM']:RC%#XR4863!KV&20R_G(.IQB5GCD?'XGY >:&3+%LJ
MLF YXCD\.QW3J.AZ^?58H*F*[;UDD3Z]EXDCE:0]C<D%IP#U'VK*J1DE)4>3
M*M'JI;5X5*LDL%&9WJ.[QD%C<@MPW#>@^D#RPKM:S9J?AZ+3%T522JZ>K3V$
M%!C7.A#1),]^<2R-'XG#\!/09Q@J$IMXEMJS&VJ+S]I9SCS51LD?)I]9(_U#
M &NZ$]I+0<$GP'3Q)4JLQ1'R.EK:#?5CB:ST@7&5WU$!K0"<G/ZH3$P5ACIN
M0F6_/<DBH!W97AB('X7!X^H$M=VD='>)S@J=*$<S R.UI)(I+DDMK2SO[&]V
M>\>>3DAK1DESW$XP,!9;KD$J9E^9V]C>S'9@=N/#'EA4EAZ0! $!YD>V-CI'
MGM8P%SC\ !DH#G=2E)[@[*Q?OR.''JDO;1]"3Z90,$C+26N <ULC7CM>QV6E
M65T]Y7\7<3NS]O\ CEZFZM!6_)2AKFQ3UW%KVEP[<^/7H2WX@$XPHJ3).*9J
M<(W&P_-7^*[F43['5?AL-!(?&7>>&]K0,M[&]Q=V_BZK,EQ1B+X,NB@3" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" JGN+PVMSGBUO2RX;;&+&NF/7T[<
M.3&[KY$_2?D5*,J.IH=0V:W5B5MX5R?)K)^D_/,'$>4<?U$NXY'1&FUM5O=9
MLW9XHF-QTP/J)<2?PAHR?@JKD')X8G@=OTS=Q6J<-"XUE'VE(V_N)QNPP-KF
MQ)AN,F+L'_2(6+>VFGC0EN=I.[&B]9#4MJ;>9&,DCJD]T8D(P7.\2&@G&?BK
M;E%AQ*-CT^YMU)2::>/<_+UF#D%.?:UH/RUM]2Y4D,U65N3];@&D$#KU"Y][
M:JY+6L)I9]G;[3W'1.M_EZG9O05[;7?CMYNO.';S7'AB;=>UM]6RK)(>S8S0
MXMP-.6$YPX'Y'Q'P*U=AO?Q$)2E]R5*\)&YUK].0M[R&WVNIQOQ4HQE\5M/-
M2[%GCW'ZVX+MM1M>.ZZ[K7@4G0MB]-^.Z-\8#7QO'[0/C^E=N,E**:R.A<VC
MVLO!E]S#O7/SEJ_+,+>^K(,>;<Y'W$)4@1.YV#M=4<9V!X<>R.)V',<X]? Y
M'3Q*L@JD)88E8KQ6+L@GL9DD_5 'TM'P:!T 5S="M(FJVHFEQW-]-OQ/C^A5
M.18D28UK(XPQK>@_25'42H0]S3QQN,M?,3_$AOX3]RL4B#1&C9V-?+VO!QY]
MO@?N4M-2-:&]*)+\;[-R5E?65F.GEEE=V1,CC!<Z20GH T GKX*.669-)R/S
M+S?^8;>;2_/I_;)C==I8G%@WDL0??LD>+XP_+86']4 =^.I(\%W;'3XI:KN+
MY'<V_3XTK,H;#RZ_,;]_>[*>VX]YF?;F[@[QR/JZ+:<K:P453N.FH6XX**]!
M>^-^YWNGHZ]BA#R6Q:JSQF)@O 6YH3X=\4LF7-(\@21\EPM[.U6BC1\ST/3>
M@;?<)7KGP_+'#^+[!MO=B[S,4N(^X%5AY-KK#?X/R"LT1LL13]'1VH\X:7MQ
MVO9T[AU:N;)>[5#I]I]-WLK:?N3PIZXM$-SOA_\ %]1%#JX7VMY7D!JU8AW/
MF#_I?$UHZN<1U:/B%=T[=>'<H\(R\D0_5NP>\VGB17O6?>7=]Y>C$C>'\H,/
M%V:^PXQSZR22K*V3+7L:#EK7!V"",D8*^B;:58'YKWNPB]PYTPE1DO[GZG;4
M> \3]WZ'')8I-=-9UG*K+8G026*A[6TK;A@9;@F-TI'4D9*X4MQ&SNY).J>.
M?'BCV&TV*O[50E[LDJ5?)<S@=OGVQW[C'.UD%7N#OR[/J.0<C+CU.%MO=RGA
MDCT6QZ5:VTE)5<N?L)&ONHX:TDCS]+&ES@WJ2 ,]!\58KB2.Y4\\1UNT]Q>1
MZWBM1L%/;;F<0TOS#_3B9&X9S(YWBX 'Z6C+O!N2M>[<TP<WZN1H/>154TXO
MMXG]/?;O@VI]M^'ZOA^F^JIKHL26'-#7SSO)?+,\#S>\D^/3P\EXZY<<Y.3X
MG-E*KJ3VPV=#55S;V-AE:N.G?(<9/P:/$D_ =5!*I!NA!?G.0\@Z:V-VEU+O
M&]:8#<D;_P!E"[HP']J3K_94J)9D:M]@XKQYFGN[BUZ+HS:F8R.25WJ32QPL
M&97N\S(]SBDI5H(QI4LZ@3.*[#^6?B%F[9LZSD/)M#4M2.F=J]3M7UZ3'R.+
MG%D98[MR3\5T9;^Y/&2C)TI5KD4V[,;:I'!5;]+J9/8IFQJ;#F.EK[O8[[AF
MEV#-?IK^YF_-6C9BCS::V8 =T;7$ *_J$4H6FTHS<:NF&%?=JN=#6VLW.=S&
ML5*B]&-.ROKJ=F7'-\( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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M_P!F6].F2!T\2>KG$K.:,9,R3.&KY3ZV>RI<A=), .UO>UIZDAH&26^+W^>
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MMUBC8STP?#J.O]*O3I$KI5DY-JHX&=[6@PGQ'CVGY_)5*1.AJU+#JEAU8.S
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M@R<(2DU&*JWDC\W\H_F)W&V&SKV.*TMUP&=W:VE.Z2&^*[?PR^HWN:'$CO\
MP?0IN"7'$]W^17=I"-VW-JY'.G!_6N#*KQK><<WU:>6D'PB(EKZ-HLDF;&[P
M[BT!KP1T[@%H78RBSV&SW2W,.&K[RX?X&II/:MN[WLKN$[NOK]\"^2IH=B'1
MPVHL9?%!8;GK_8>WIT(. <;$9ZHTDCB[VU<Z=-7X+5;XTX=C['P9QSW4V_,-
M1N)N/;W2W=#5K/ DCN1.C=.\=>[OQV.C'BSL<<^*[.SMQC[U:LY75.N?C/<M
MX6_7+O[BO:&?9[JU%K]-5GV-Z4AL=:I$^>1Q)P &L!*[7CI*K9P'=2S/V3[
M_P M&PUNPJ<Y]S*[8[U9S9]/Q]Q$GI2@9;-:QD=[?%D8/TGJ[J,+C;S?ZUIA
MES-"]N-6"/UBN*:(0! $ 0! $ P/'XH @" ( @" ( @" ( @" ( @" ( @"
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M=:ET^JF=W24XB[S/8 ?Z$JSVE$?8=3K*[@^*I$UP\'=H)'Z4JQ0W%@R:QU]
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M_=1D=W83];02WZBR5O:]G0')5D53%D)/@BV:345=#JZVJIC$%9@:,9P7>+B
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MR-P/F1DD?>MDUF3E?>$2QR:O9 Q.<W/HRAS2"X9RW/\ @6=*9.+H=77/-H(
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M/#>A=U\T!+( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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MP-@\JT6RE:*MDML._!%(QS)"?EC.?N*L$6=NKN+Z\3B,%S&D@^60N:;AD0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @'5 $ 0!
M$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $!4_<.JVUQYS)721U#)&RY)7
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MC'?4R#L#8&9_9C:0/T]5NJ*62-63;S)"G[?LH216)]O9-3\3X:H]&0_(.)(
M^>%G$BCK7$[M":B:-&%\#*9#>R5YE>0[KW%QZG)RM6Y%IX\3:BZHL"J)A $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $!P_3:7;:;G6
M^=>,C;QCFL0W8FDM='8>7F3NQT^D$'S!6VG%Q536:DI.A=N$\\J;VM>%F?$.
MN=%&VY-B,S";NP>WY=OCYJJY"CP+82JB[Q30SM[X9&R,_:80X?I"I+#V@" (
M @" ( @" ( @" (#%8LUZL9FLRMBC'BYY#1_2LI5! .YII);C=7#8]*Y9:\4
M99F]D,LK1T8'''7KD XSY*;MM8LAJ611MQ%M=Y!89:FE-T-<8.TEABFC^IO8
M!CM(<%N*,4L"B4F1'#N3R[IT]??2^KLX&-=',6AKY8V?2X/Q@%[>G7S"PE18
M$&VS+M.)1<LVLEG2VV4][&QLC(9 1%-Z7ZP>.K7CIY$%0E*A*,:F35\/Y;N-
MF*FU@?K(JY:ZW<R""1U'H$'#B<>/ZOG\%&5Q4P+(P?$[3&STXV1]Q?V@-[G'
M+C@8R3\5JEYZ0! $ 0! $!\< X%K@"T]"#X8* Y1R67AG$9G4-7KYK^[: X4
MXI)!''WC+3(\YP#G(#>OV+8BY2XE,]**HS>^X=J/Z-8'PC\(;7 P">@SW9/V
ME;"-<OW!W3ZZ4V.0;&K'>MM;$RA6#B&DG([Y.H[OD.@^*IN5DLLC8AAQ.BK5
M+@@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" T]O#/
M9U5ZO6;W69J\L<+2< O>PAH)\NI65F89P/@]&WJMW;T.WHS1["6)C8ZQ;AY<
MPY+F^1;C]8'"W=2I4U-+R)3AG+^[G0:&NK:F2&>".MXO+V?4"X#Q>2W'R4;B
MU(G"5'B7+:>X-W3PSWK=6+\H#^X@)+97$_A8#X$G[.BCX*YDO%+93Y#K[F@@
MY$Q^*,T(F&.K@3XL\LN#OI^U:^EUH75PJ:0YOH0WOGDDKQC'<^5A#6Y('4C(
M\2INU)$=:)N[?J:^(3W91#$7!@<[/XCX#HJTF\B3=#!5W>IN2-BK7(I)7'#6
M!V'$XS@ XST67%K,)IF>2]2A>8IK,4<@QECWM:X9\.A*Q1F3)'/!*PRQ2L?&
M/%[7 M&/F%B@/(M520!/&2>@ >WKG[UF@/-F_2J$"U8CA<1D![PTX^."B38-
M<[O5_EK%N.RR:&KCU_2/>6]WAD#KU6=+K0Q5$%<]PM)1#)9V3-I][&2V7- ;
M&'GM#B,YP#XJSP94(ZT:V\Y!MV79:M*1D=8!ICEC <Y[7M#@>XY'7/DK+=N+
M560E-IT*55YA;V=ZUQ'=YGL,M.?K+F!W_3DF*3[B>UWW%34=,JH@YU5#5Y[J
M@./ML8S+6G8\@=7!C@6N/3PQT4ZE539X_P G:_C]25[R;T0,,\KCE[G1GHXD
M_$86!2IG9P.#?T8>4\1F;4VS'/;:HO)_+RRM.'X/4L+@<_L]?)4ZW%T9?H35
M42O#>#[INQ@WN[D?0-9Y=7HQN!D>0,'U'#(#3^R/%8G<35$2C"F+.H#HM<M"
M ( @" ( @" ("@<^X7L-W?I;72-C_.1@P7!([TPZ+\3'9P<EIR/L*MMSTYD)
M1J0ER23A-1DW(9X@Z7Z8:<#S)/+\>UN ,#S<>BO4U)X&O*%"N2<UUFPL-KZZ
ME;GL2.#(HV-9W%Q/3SZ*U.AA':])>=<HQ"P^,[")C&W(XI!*&2$>!<WH3]BT
M)*C-M$DHF0@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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MR5*NM(M\-5+KHN/ZOCE,TM5$8XG.[Y'.<7O>_ !<XGS("J<F\R:5"46#(0!
M$ 0! $ 0! $!CG$IAD$#FLG+7")SQW-#\="0,9&4!^>+=6=W(;0Y>PV=VU_;
M.9G'L+?%OIM& (R/P@+>C2F!JR6.)<S<T>KUK#9-?61O!]$=@C,@'0]H RY9
M3*Z4-7BO)&V^1P5..LELO=UMO+3' RN#]3WD^0_5Z>*C=:TXET&ZG7HIH9VE
MT,C96M):7,(< X>(Z>:TJ&P9$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M 0! $ 0! $ 0! $ 0! $ (R,'P0$#<X7Q6_*)K.IKF0$'N8WT^HZ]>PMRI*;
M7$Q1&ES;@];F5.K ;!I6*;R^"=K!)]+F]I86DCH<#]"S&>DC*.HK?$?;#9:'
M:B78WX;6IC/K111->U[IF]&]S7=.WS\?$*R5VJHB$;='B17(.(;K5\LV6[U&
MNEMUKO[V%\(:XQOD'[X=N<Y+A\/ J4)JE&8E!U)CBN@N[^EM&[^O+6K2Q/I1
MPSL+7][Q]4@:['X>G:?BL7)\C,8<SG6CM.XHZ_2N.$6P;.Z&QDXZ0$M&/D3]
M2O3KB4Z:$_R73S\@X''RB/N=+3G?(W!^EU,XC>X#Y.'=GX95>KWJ$]'NU-/7
M\D;VU-=4D#G 1UXFM.3GHP>'S5CP(:22YSQ=W&.1U^1Z^)QU]T.9,V-I=Z=L
MMP< 9.) ,_;E56YUP9;.&),\'K[+9;"8;/73C43U98I'6(RR*02%H[<.QG(6
M+DE3 S"-&8(_:;:5K\]:CL(H-#ZADK/>'26 U_4L+>@/;X9[NJQXV&6(\,Z)
MI='%J=/'IY93<A:U[9'2M [VR$EP+>HQUPJ7*KJ6I45#9UNGU>G@_+:NI%4A
M\VQ-#2?M/B?O6&VS-#=6 $ 0! $ 0! $ 0! $ 0! :-RE4R_8FC':V$,3A"2
MUGJN RX,:]PZ9*R#\_6G.Y1O)]ER:61MKO,3J+/W?H-8<"$9ZCM\^G4]5NQ2
M2P-656\2[4J>BU^ME=KVQ:^N0TVGE_:)"W\/>YQZGY?T+**ZFOQOF%2OOX-=
MJ)?S3;+B+0 [*[8F#+I7/=C\ ^ Z^"C=2:[2Z$L3JFOVU#:,<^E,)>PX<WJ'
M#[0<'!6HXM9EZ=3=43(0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0
M! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0
M! $ 0! $ 0! $ 0! $ 0! 8)J-.R<V*\4I^+V-=_6"@/0JUFP?E6PL%7M+/1
M#0(^T^([<8P4!BAUNOKD.KU(8G#P,<;&D8^P(#:0! $ 0! $ 0! $ 0! $ 0
M! $ 0! $ 0%?V/"N.;7:-W%ZIWW.WLDPYS&28_"7M:1W$> *FIM*B(N*9RGG
MD]?D.\CT&M=%3X]IW%CWQ@$/M'H\M:,9+!] )\\K8MK"KXE%QU=$2^IU?'-;
M2<*G;7PW-BW.X%S@WQ+W'P'R'16U*LB'I\FBM\FU^NT,I8U\P_,;,Y:&PL^J
M0L:?$=H(R[]"Q-UB3B\3IS>;T_SCHI8'LI^$=CQ/VEGB J'8="_Q$62M9KW(
M6V*LC98']6R,.0<=%0U0L,JP @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
M@" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" (
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MCLMP<]T1[/\  K:U170[%4T53DO$'4-FS,5\&1K\?7&0?W;VY\",9"U9RI+
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M ( @" ( @" ( @" ( @" ( @" ( @" ( @!\$!IO_P!>[_T\D!MM_"/L0'U
G$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>camp-20241231_g4.jpg
<TEXT>
begin 644 camp-20241231_g4.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" '&!7X# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *P?&7_(+B_Z[#_T%JWJP?&7
M_(+B_P"NP_\ 06IK<3V-ZBBBD,**** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HKY6_X>C?LQ_P#13/\ R@:G_P#(U>G_  ._
M:L^%G[2-UJ]O\.?%'_"13:2D4EZO]GW5KY2R%@AS/$F[)1ONYQCF@#UJBBB@
M HHHH **S_$'B#3?"FAW^LZS?V^EZ380O<W5[=R".*"-1EG9CP  .M<QXD^-
M7@OPCHW@W5=5UM;?3O&&I66D:'.EO-*MY=7:EK9!L0E X4G<^U1W(H [>BBB
M@ HHHH ***Y'5_BSX4T+XDZ#X!OM5\CQ;KMM/>:=I_V>5O/BA!,C>8$,:X /
M#,">P- '7445ROPN^*/ACXT>!-,\9>#=3_MCPWJ7F_9+W[/+!YGERO$_R2JK
MC#QN.5&<9'!!H ZJBBB@ HHHH ***KZAJ%KI-A<WU]<PV=E;1--/<W$@CCBC
M4$L[,>%4 $DG@ 4 6**\#\/_ +=WP.\4Z?=7^E^-)+NPMKJWLI+H:+J"Q&:>
M4PPJKM  ^YP1E20,9) YKV#4_'&@:-XIT7PW>ZM:V^OZRLSZ?IKR?O[E8EW2
MLJ]=JCJ>G('4B@#<HHKEOAU\3_#/Q9T.XUCPIJ7]JZ;;WL^GR3>1+#MGA<I*
MFV15)VL",@8/8F@#J:*** "BBB@ HHHH **** "BBB@ HHHH **YZP^(7AG5
M?&-]X4LM<L;WQ'86XNKS3;>8236L98*#*%SLR3P&P3R0" :Y?X>?M&_#OXK>
M/?%G@OPMXA_M3Q+X5GDMM8L?L5Q#]ED25HG7?)&J/AT891F'&>G- 'I-%%%
M!1110 445YM\0_VC?AW\*?'OA/P7XI\0_P!E^)?%4\=MH]C]BN)OM4CRK$B[
MXXV1,NZC+LHYSTYH ])HHKG-/^(_AC5O&VH>$+'6[.\\2Z?;+=WFFV\GF26T
M3-M4R8X0D]%8@D<XQS0!T=%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%?
M*-W_ ,%$/#K^,_%WAO0OA%\7/&5QX6U:XT74;SPQX:COK9;B&1HVPZ7&0"4)
M&X*2,' KO_@W^U'_ ,+C\7/H/_"H_BGX'VVKW7]I^,O#7]GV1VE1Y8E\UOG.
M[(7'(5O2@#V^BBB@ HHHH ***\,UW]LGX>Z1^SIK/QMLVU/7O ^FW/V;S=-M
ME\^Y/VQ;3?$DKH"OF.#EBIV@G'0$ ]SHHHH **** "BBO./C;\=] ^ MAX3N
M_$%GJ5Y'XE\16GAFS&FQ1N8[FX$A1Y-[IB,>6V2,GD84T >CT45P'PB^-6A_
M&C_A-?[$M=0M?^$3\37OA2^_M"-$\RZM=GF/%L=LQ'S!M+;6.#E10!W]%%%
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MPD_:$^)-G^T==?!?XO:'X<M]9N-"_M_1M>\*FX%E?1+($>(QS%V1@=_+,/\
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M44 %%%% !1110!^9W[,G[1O_  I/XQ_M-6'_  J_XD>/?MOQ'U2?[3X(\/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#4O%?CR#QCH=AI6@V>IK%X9NK-PTE]9>6"TDH$KX;?N&"L? ^[WH [VBBB@
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M25P,E5:5E#''.!6AX9\5Z)XUT:#5_#VL:?KVDSY\J_TRZ2Y@DQUVR(2I_ T
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M'Q\^&-GJ6G:?/\1O"4%_J-O%=V5K)KEJLMU!*N^*6)#)ET=?F5E!##D$UWE
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !6#XR_Y!<7_78?\ H+5O5@^,O^07%_UV'_H+4UN)[&]1112&%%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!\N?M=?\ER_9@_['.;_P!))*\FT/\ 9X\-?M!?M[_M-6GC47FJ>%-.
M3PQ)-X>COIK:UO;EM.4PRS")E,GE".7:I.W]Z<@\8^EOCI\&-;^)WQ'^#GB#
M2[JPM[/P;X@DU74$O)'626)H&C"Q!48%LL.&*C'>H_A7\%=<\#_M)_'/X@W]
MUI\NB^.O["_LV"WD=KB'[%9O!+YRE JY9@5VLV1UVGB@#YN^$NKM^R;\8_VJ
M/"GAV>[O? GA+PQ#XOTC0KZXDF2PD%H\SP0Y;B-CQCKM2,9RI+:/P&_8N\&?
MM!_ #PWX^^)M[KGBWXD^*K)-:;Q5=:O<"XTZ23$D2VB*ZI"L?R855QQC[H4+
M[/H_[-E]+^TQ\7?&_B'^R=3\%>./#UGH?]E^9(T[JD7ESK,A0*$8%@-KDD'D
M"O-/"/[/'[2GP;^'MU\+/ 'C[P7=>!D6>#1_$6OPW8U[2()7<A%6,&&5HPPV
M,Q7!)XVJJ@ X7]IGX5ZY/\:/V-/ /B;QMJ6OZGG7]/U+Q+9%M-N[^ 6]J)02
MCNR-)"&C=@^YMS'<I;(S/VK-%T+X(^-_A1\"? WASQ3H_P ,=?N+[Q#XET?X
M?K=7>IZFL<:H+=%5_,$3;,2!6QAMV 4^;V33/V(KOP+XK_9D'A75;.?P[\+!
MJQU6;4Y9%O+Y[R&,>9$JHR_ZQ7.UG4(NQ5) KT3]HO\ 9UU+XK>)/ WCGP=X
MDC\)?$;P5=2S:5J-W;&ZM)H)DV7%M-%N7Y9%XWJ=P&<=<@ ^0]+DM/A=\5?A
MWJO[/7P9^,/@9+GQ!!9^*-&UCP]J,>AWFFS8CFGD61Y!'-'MC*NNT#YBV[&#
MZ+^T\OP+_P"&B[J+XV>/=4\;"[T^"+1OA=IUO?SQ:6RIOEN9([1R'>0#</,5
M2%YPP52GJ&A_"S]H7XA?$#PCJ_Q/\=>'O"GASPY<+?2:%\,Y[V,:U<+@JMW+
M.%;R,YS"-RL,ALD@KAW_ .SM\8OA1\=/B1X^^#NI>!-1MO'8M[B]LO'$=U'+
M:7,:NO[J6V0EXN0=K8^]V*[F /%OV9-:U73OC+\>_ 7PBL_%/A30;OP6-7\)
M^'O&0FMUT[4-IBCDBAG9GBA>1PV3MRH7*E50CQZQT_X+^&/">C6OQ1\+?$GX
M!?&_3KB&WE^*%Y'?72W&I YFN4G$I657V,<%<!)!L9E!:OL#P+^Q_P#$JT^.
M?C[QUXQ^)<>HS>,O":Z5-JWAU9--O-)O5FC*)9Q$2*($CC4AVDW,^[=&=Y-5
MM;^!O[4GBKX4W?PEUGQQ\.K[PK>6"Z+<^,;FTO[C7;BR*+'*\D#L8FG*[_WA
MDR3@Y5SO4 X_]L7XQ:AJ?BWX ^ (M4\5^*/!_B.PEU[Q!>?#6VD.H:]!% IA
M$"0-N6"1RSN%;A'!#90&N'T&#2_A;\8/A;JWP"^#'QD\"6C:W!IOBG2=3\.Z
MC'I5]IDP,;W$QE=QYL.0RLV.I+-\HKZ+^)_[%ES-X3^$,_PP\4_\(OX^^%=L
MMEH6KZE")HKRW,21317849(=5/*\#?( OSY%_0/AC^T/X]^)7AK6OB7XY\.>
M%/"WA^Z^VKX>^&\MX#J\H "I>S7 4M"#NS&%VL#@C.&4 \D^"_P6\)?MO>,_
MC+X[^+$%[XML+#Q=>^%=!T*[OIH+?2[.U5 '2.)T,<TGFY;/S#&1]\D]%^P=
MX$;X9_'+]ICPR=<U3Q&FGZWI:1:CK5PUQ=R1M:N\:R2,<N45E3/<(.!T'3C]
MG3XJ_!/XB^-->^!>M^#AH'C34O[6U/P[XUM[LQV5XZMYUQ;2V[;B'8H3$P"X
M&%90!6M^R-^SEXY^!WBWXJZ[XY\3Z=XLU#QG?V>H_;[)&B=I4B<3;XBBK&H=
MR$"EOD49P>* (/\ @H3\1=9\#_ FPT;P]K$_AS6O&_B+3_"5OK<& VGBY=FE
MESD%1Y44BY4[AO!!4_,/#/VROV&O 7PD_99\:>)?AVVM>'/$NG6&_4]035IY
MGU^W:11<1WPD<K*&R9> -KJI4 ?+7TI^VWH'@7Q#\ =4A\?>)3X+TV"[M[BQ
M\2BUDN/[+OU?-O/L3[V&^7!(!W8R"0:^3/VX;7X^R?LJ:W9?%?QG\.TT%EM(
MK:'PE;7;ZCXDN1.IB#>8 D?S"*5EB1@2K8*C& "_^TA\3I]7^*/P0^$NJZ=X
M\UGP"O@N#Q)KNB_#R":6]U7<###%.(663[.C0'=M(YE'<*R+\,([3X;?M(?#
MN[^"/PF^+G@+P?J]W)IOB_0==\/:A!H\D<B!8;[]Z[I')$P&YCC*XQCY]WNG
MQ1_9;\6^(KOX7_$?X<^(K'PI\5_!VBII0.K6[2:?J-LT)#6MR%'F!0[,0<';
MN8A=VTC<\%?#'X\^*?BWH/BWXH>.=$T3P_H4,AMO"/P_ENEM=0G<%2][). T
MRJIR$VX#;2,$$N >&?"/]FCPG\?/VF/VD[CQ_%=:_P"'-/\ $\,=GX>-]-!9
M_:6MU,EQ*D;+YCA1&J;B0OSG&2",GX4^.]5_99T3]LCPKX?U"\U'0OAK'9WW
MA:#5)WNC8M=6DI2'+L<PQM'#A>"0K9)+9KZO^!?P8UOX8_$?XR>(-4NK"XL_
M&7B"/5=/2SD=I(HE@6,K*&10&RIX4L,=ZXWPS^R9<W7Q,_:7OO%\^GWGA#XK
MP:?:6UO8RL;N"*&UFAE:0/'L1P959"I?!7)P0* /CSP1X5^'7B[X5:3K'B_X
M6?M">)/BQJ6E17$OQ%AT/4[FYMKMU,BRV4@E">5&\AV84!E W9R:^\/V,?%7
MC;QA^S5X*O?B-I6K:/XTAMWLM0AUNUDM[J5H97C2:19 'W21JCDD<EB>G->1
M>%/@G^U7\+_AW!\-/"GC[X?7GAFQB:PTSQ5K%K>#6;*R"E(46!%,+/&H4*69
MA@8(.!7TY\*/ UU\-?AUH/AF^\2:MXPO=.MQ%/KFN3F:[O)"2S.[$D]20 22
M%"C)QD@'QM^W#\3I]7_:>^'WPEU73O'FL^ 5T*7Q)KNB_#R":6]U7=-)##%.
M(663[.C0'=M(YE'<*R<Q\,([3X;?M(?#N[^"/PF^+G@+P?J]W)IOB_0==\/:
MA!H\D<B!8;[]Z[I')$P&YCC*XQCY]WTE^T?^S9XF\=?$7PC\5OAAXDL?"WQ/
M\,6\UC$^K6YET_4K.17S;7(0;]H=R0PSMW,0N[:1%X0^&7Q]\4?%?1/%WQ+\
M;Z%HVB:#;RFT\'^ 9KN.SU&Y<%=U]+.H:5 #D+MP#M( *DN ?*O[0GB?Q/\
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M@M]0U72K6ZEM5OH6OII!;3;<.T7F-&Q0E<^6 >,J?3_B'^SQ\>_C]HUE\/\
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MOC#XNO/A_P#"/QOXHT^U^VW^B:'?:G;VP_Y;20V[R(G0]2H'0]>AKY=_8_\
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M^'D-RDEQHD.BP6-UJ,".62"[O4D,DH^Z"0%W8SC=M*@'$?MRPZC\+_"GPO\
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M]G\CS\$G=Y>YMO7IN/UH [ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^6';/"X>)]T;*3M8 X)P>X-=310 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !7!ZQ\ _ACXA\1?\)!JOPY\):G
MKWFB;^U+S0[66Z\P-N#^:T9;<#SG.<\UWE% !1110 4444 %%%% !1110 5%
M=6L-]:S6US#'<6\R&.6&50R.I&"K \$$'!!J6B@"AH'A_2_"FC6FD:)IMGH^
MDV:"*VL+"!((($'14C0!5'L!5^BB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"L'QE_R"XO\ KL/_ $%JWJP?&7_(+B_Z[#_T%J:W$]C>HHHI#"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\.#S[<&HQXKTHKIS"[!74)6@MFV-B1USE<XX/RMUQTK6HHT#4****0PHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K*U'Q9H>D:[I&
MB7^LZ?9:UK'G?V;IUQ=)'<7WE*'E\F,D-)L4AFV@[0<G K5KY6_:'_Y/K_9'
M_P"YN_\ 39'0!]4T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445Q,
M_P ;/ 5O%XOE?Q;I/D^$ #K\JW*LFFDACMF8<*_R-\GW@1C&2* .VK!\9?\
M(+B_Z[#_ -!:N9^"O[0OP\_:)T*\UCX>>)K?Q'964WV>YV12P2PN1D;XI41U
M!&<,5P<'!.#CIO&7_(+B_P"NP_\ 06IK<3V-ZBBBD,**** "BBB@ HHHH **
M** "BBB@ HHHH **** /)/V@/@MX@^.&G6/A^V\>W/A7P9=*]OXETBST]))M
M8M69"8$N=ZO;!E62-BH;<LA&!@Y]6M;6&QM8;:VACM[>%!'%#$H5$4# 50.
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M6_!O0K>XO]&B@1CK-U<V,ETTK2#YP(HRBA,$,V"!FO=/BW\:O!/P(\-VVO\
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M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\K?M#_\
M)]?[(_\ W-W_ *;(Z^J:^5OVA_\ D^O]D?\ [F[_ --D= 'U31110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !7Y!:!XATKQU\%?!7[,NE:?<77Q=\2^.
M3_PLV&YT^:*Y>"&^EN)[B:<*@< +$P(8L$C(P&(-?H3\=/$?[0FC^+;2'X3>
M$?!NO^'&L4>XN?$-_+!.MUYD@9%5& *!!$0?5F]*\U_X2[]LW[5]I_X5A\*_
MM.SR_._M6??MSG;G?G&><4 3?">?0=<_;]\;R> =.M;/PSX7\$0>'/$$EA:_
M9H/[6%\7@AVA55FB@21=RY !"_PBOIKQE_R"XO\ KL/_ $%J\B_9_P!4^/<_
MBO4+?XG>"?!'A?PV]M+<QW'AB[DDGEOFEC^^K$C#*96+=<A>>:]=\9?\@N+_
M *[#_P!!:FMQ/8WJ***0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** /*OVL/^36?C)_V)FL_P#I#-1^R?\ \FL_!O\ [$S1O_2&&C]K#_DUGXR?
M]B9K/_I#-1^R?_R:S\&_^Q,T;_TAAH ]5HHHH **** "BBB@#C?$#8U>X_X#
M_P"@BL[?[U=\1MC6;C_@/_H(K,W?6M5L9O<FW^]&_P!ZAW?6C=]:8B;?[T;_
M 'KE_'GC[3/A[H4FI:E)ZK#;J?GG?LJC^9[5\[>$/VF=:M?&=Q=ZZ?/T2\<!
MK6(?\>@Z Q^N!U!Z]>M?/8_/<%EM>%"O+WI=NB[OLO\ ASZW*N%\RSG#5,5A
M8>[#:^G,^T>[_#IN?6._WHW^]4=.U2UU>P@O;*=+FUG0/'+&<JRGN*L;OK7O
MIJ24HNZ9\I*,H-QDK-$V_P!Z-_O4.[ZT;OK5$G8>%3G3Y/\ KJ?Y"MFL3PB<
MZ;)_UU/\EK;K)[FBV"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH H:SH&F>(K5;;5M.M-
M3MT<2+#>0+,@8 @, P(S@D9]S7R/^T?\5&\%^)/$?A7X3_!SPMXPUWPKHW_"
M0>([_5K6*"QTRV*2/'"<*I>>18V95##@$]CC['KX=_:4T+XF?!3XA_%[Q-X4
M\ :G\3?!/Q5T*&QU*/0\2:EHNHQ6CV<;I;JI>:%XS&6QT(8DH% D .C\,?&_
M3=%\0? 2^\0_"G0=+\-?$O0]-GM/%6FVT*I8>(+B+SULV5AE59=OEMNW%L@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M .@K6_63W-%L%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5\V_&O]E6RU3Q;KGQ.\-?%
MCQ1\(/$]P@GU#4K+45;29FCMT@22ZM)B(W"I%&/O(#MR><$?25?"W[9^@_ O
MPM\1W\0_&[Q)XW\;?;HUO=/^'.G7<TFGV5M%"J27(MHBFU=\32/(\@!)Q@A3
M0!B_"']O[QN?CCHOPIU.W\,_&R.\U%+!_&'PX^T@6<#.$6ZNXS$T)Q\SN8I
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M[XN_!G5+#]E#X.?!G2]%OK^VO-4\.Z+KC64#R"ULX72>\N)6485<P'); )D
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M$ @B1WX(!KD_V:_"FKKX_P#CSXZU;2+G2=4\1^+&LK$:C;RPM/I]A;QV]K*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW]KXDB\<1^*_";7%L\?VVZLH+2>W,)8 2(\D!BW*<?,PW \C[9HH _/SQ?\
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M5DLM4\;:'\'-?USX&Z7/+!=?$*/4((V=8W,;W,%@09IK4.5S,IX02,5S&RT
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M** "BBB@ KY6_:'_ .3Z_P!D?_N;O_39'7U37RM^T/\ \GU_LC_]S=_Z;(Z
M/JFBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OE#6_^"A>AS:OJ-MX
M%^%/Q.^*.FZ?=RV,^O>%/#KW.G-/&0'2.7=\Y!ZG &"""00:^KZ_.K]D_P#:
MQM_V?/AC:_#+4OA#\6+_ $C0[V[32-;L_"3_ .E6<DTD\;7$64,<P,I1@@<$
MKNW?,< 'T_\  C]J'4/C9XNO-#N_@[\1OA[';V+WHU/Q?HK65K*5DC3R5<GF
M0^86"^B,>U>L>,O^07%_UV'_ *"U>:_!?]J31_C=XINM"T_P5X[\.36]F]Z;
MKQ/X?DL+9U5T38LC$@N3("%]%8]J]*\9?\@N+_KL/_06IK<3V-ZBBBD,****
M "BBB@#\K_!7AWPIKWPH^$7C^_MM-U#XSZC\;-*_X2_4)4#ZE8W3:G*/L;%R
MTD,:QQQ 1@A2$#8.<U].?"[1]$\,?\%"_B58^!@L6C:AX2AU7Q=;V=P&MHM=
MDO#Y+-&&^29X/.=^.=P8\N<_/?Q$L?V</B9\2X=4^/?PD\7? +QU>3()]6N&
MD@TJ^N6&_<M[!^Z=@58F4HA.<L20=OW!^S;\'_A3\(? 0M_A'::7_8&H/]I?
M4M.NQ>F])R59KC<QD #?+\Q !XZ\@'K%%%% !1110 4444 %%%% !1110!Y5
M^UA_R:S\9/\ L3-9_P#2&:C]D_\ Y-9^#?\ V)FC?^D,-'[6'_)K/QD_[$S6
M?_2&:C]D_P#Y-9^#?_8F:-_Z0PT >JT444 %%%% !1110!Y5XV;'B>]_X!_Z
M M8>^MCQRV/%-[_P#_T!:P=];K8Q>Y-OHWU#OHWTQ'@_CE,^+M4/_38_R%8?
ME^U=#XT&?%6I'_IJ?Y"L3;[5_/N.7^UU?\4OS/ZQRQ_[#0_P1_)'>_!H;-3U
M'_KBO_H5>K[Z\I^$7RZEJ'_7)?YUZAOK]:X:5LMAZO\ -GX+QGKG-3TC_P"D
MHFWT;ZAWT;Z^H/B#TWX<'.AS_P#7PW_H*UU5<E\-#G0I_P#KY;_T%:ZVL9;F
MRV/G_P#;:\+:K\0_A1H?@C3='O=8MO$_BO1M-U06EL\RVUB+M)YYIMH.R)5@
MPS$@?,!G+ %OC3PGJ?B_]M+X9SMHUX/#'@SPQJFIIJ36K"R^W74D5JD*R8V&
M58DE;:#N53G@,,_05%2,^'?&'P)\9?&7P1^U_<VFD7NG^(O%^KP:5HMMJ:-:
M_P!H6NEP0B+RS)M BG?SU63(5MY;(!W5Y'\,_P!E[X;_ !6\=^#K7PE^R=XD
M^'=O87<5[XIUKXC76JP06\2C=Y&GI]M4W4KN"!*P"(%4O$P?"_I]10!^;'QH
M^'9\7_';XA6WQ?\ @1\3/C9JUUJ8'@-M'O)X/#=G8-$BQ1-<1S1I9L\B_OY'
M#XVJQ48)?3^!WP2\2P? ;]EKP)?>#=8TG=XWN_%?B2"73[B*+3UM)+J:&*X,
M@)C5F-LJB0_O-@P3R:_12B@#YQ\5Z3K6H_MEQ^*IO#^J7?ASP/X!NI+&XBM9
M/+N]2NKC]Y#"V-KN(+=1M7)S*N<<9\7^%WP;\4MX)_9+\*ZSX;U5&CUV^\>^
M*+B>QEB2RO$2:X@6Y)&(Y#-=(JHV&S&>!M-?>U% 'S#XS^&VO?%/]JKQI.]I
M?Z7HVE_#>3P]I6JS021VSWVH32--)%)@!VCCBB!"9V[N>2 /F#X@_&WXA>&O
MV,-.^!B_!CQ3X3\2I;67@34]=UFW2+1CYCBT,MG,'S=O-C.V-<+YC-N94&[]
M)?&'A'2/'_A/6/#6OV:ZCHFKVDMC>VC.R"6&12CKN4AE)!/S*01U!!&:\$^'
M7["'A#P+XOT#7M4\;_$+XAKX>83:)I/C3Q ;[3],G7 CG@A$: 2(H*KDD*&S
MC<%90"70/ &HO^V/IMS_ &3>P>$/ _P_CTG3+Z6V=;>:[N;@>8(Y&&UF2&VC
M!"DD;^3T%?,EOXY^+GA+]G+XM?#S0?@CX[E^(^L:KKM]K6NW&F^7I7^F74RF
M6QE5F>[D,;0JBQI@%C(6V1DG]*:* /E?PY\*-0TG]ICX,Z(FD7Z^%?AI\/9T
MM]5-LZV;7TQ@M/*67&QI/)A=BH.0&![UT7[>=GK.J?LZ:AIVD^&]9\5P7>JZ
M9'JFF^'[0W=[)IXO(GN1'""#(2B%2H(X8DD*"1]#44 ?->FZ;K'Q-_;)\*>,
M+SPQK&D^&/#WP_-Q9RZM9O T6I:A.OF0'JGFQV\.V158E2^#VSY+\1O!_C;Q
M!X/_ &N?$FG^%]=_M_QIJUGX)T>Q?3[CS)=/ACALWNXEVY-N?M5U*9!\C!&.
M<8K[NHH ^2?VWO@$/$WP)^'VD:9X-NO'7A;P1K%E>:AX/TV9X;F_TV&VEMV2
MWV,',J+(&5%8%L$#DC/FG[+?[-7@S4_C5:>.O!7[/.I_"3PSX>M93::CX^N-
M1CUF[U-EVJ(K-KQD2!$=BTDBOO) 3!#%?T!HH _,KXF1^-OBAJ5A<P? #QSX
M _:MM;F.!/'WA2S^R>''<2*&DN+[S72>W-N!E9%D/RB+=@D'ZQ^&?A36=7_;
M&^+WC;6=(N[2PT[1M(\+Z'J%Q;R11WD6U[J[:$N,,@FE1<J2-R-SD5]"44 ?
MGY<?"3Q]K_P"U+XA67@_4K_Q-/\ %P_$6Z\':C$]I?7NGVMV8H[54E *MY,,
M<BJP^8#Y0Q95/>R>)/&W[8WQ8^'"P_#+Q7\-_AIX*UA/$VIZAX[L!IU_?:A
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KX?\ !%C\=OVS]-;XC:1\9?\ A4WPYO+VZB\.Z-H&B":ZN[2*
M>6)+FYEF961W* [1E2H!"J3S]P5\8>&_AG^TA^RS)<^$_A=I_A/XD_"]]0EG
MT>TUN]>QU#18)"7:!F&$>)7<[2-[8!X4$* #L_V=O'7Q0\'?&GQ!\%?BSKUG
MXUU"#1E\1^'_ !9:626<E]8B802I<0H=J.DCQ@8ZC<2S=:]^\9?\@N+_ *[#
M_P!!:O#?V;O@I\1+3XC^(_B]\9[_ $6Y^(FKZ=#H=EIOAY'%EI&FQR&4PHSD
ML[22G>V2V"HPQ!PON7C+_D%Q?]=A_P"@M36XGL;U%%%(84444 %%%% 'QUKW
MQQ^,O[3&GW'A_P"&?P3CT'PAJ<+0W?B7XO6PAM98'0_<TY2SS!N=I.Y#E=Z@
M-QK?L@?L(Q?LQ^-M>\;7OB]M;\1:[8_8[K3M)TV'2](A!='_ '=M'G+(8PJO
ME>&D)7+G'S_)JGCGXHZ=\&?VA=5^(GBBS3Q7\3M*TO2_!MA>?9-*L]';47C6
M.:&,GSIG6'<[EN0^T@[1CZ5^%FN>*OA[^V1XZ^&&K^+KKQ=X<\0:++X\TB/4
MG\RYT4->B"6S5B<^1N<&-<854V@ ABP!]-4444 %%%% !1110 4444 %%%%
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MQ0 5P'[0GBG5/ _P#^)?B/1+K[%K6C^&=3U"QN?+63R9XK622-]K@JV&4'#
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MY.01CKQ2'6+ )<,;ZV"VSB*9O.7$3G&%;G@\C@^HKEHH(+>,)%#'&@E,X5%
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M4U"UEN(X$N87GDB\Y(UD!9H\@;P.I7)'/3D4V;2[*Y%R)K2"472A)P\2GS5
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MS!\#M+\(WMY8^#-1TKQ=KWC.1433+62T\YY((G RTTDQ;Y=N0DB9)WNZ?;M
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M#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *^ -5_:P^*T'[*'B#XN/KFE6VH_$'7(=$^'.B6]C&1I
M>ZFA62>9Q^_=HHWDPR8!B4D .R)]_P!?FVGP]^ /PG_::\!^#[_XX:GK46C^
M*?M7AOX96]J+FTTG5;BY/EH9H4*PJDT@/E-M(.">-V0#WW]GC6/B/\+/CQJ/
MP7^(?C>3XE_:?"T?BW3O$,]BEM-"5N5M;FU?:YW*':-T)&<.P)X KZ)\9?\
M(+B_Z[#_ -!:O$_@!X6\*:U\=OBY\0+;XDS?$7Q?'?/X9N;66,6Z^&[6&9W7
M3TA7&Y0Y/[T@[S&Q!W&0M[9XR_Y!<7_78?\ H+4UN)[&]1112&%%%% !7AG[
M1'[-VI?%O7_#'C+P9XXO/AQ\1O#*3PZ=KEO:1WD,D$P'F03V\F%D4[01D_*2
M3AN,>YT4 ?/7P(_97O\ ]G[P1\0)=.\93>*OBGXO:2\O/&.N6W$EV(F6VW0!
MVQ%&[LVS<2=[#.-H5_[,G[-.M?"OQ!XK\?\ Q#\4)XW^*OBORH]2U:"W6"VM
MK:(8BMK= !A<!2QP-Q5>,KEM3Q?^VA\'_!/Q?TGX8:AXMCE\;:E>6^GQZ;96
MTMP(KB:01Q1RR(I2-BS#*LP*@@L "">_\ _%SPA\4+WQ+9^%]=M]6O/#>IS:
M/J]LBLDMG=1,4='1P#C<K . 5;:=I.#0!U]>>?M#VWC&]^!GCJW^'QD7QI+I
M%Q'I1AD$<HG*$#RW) 5^NTDC#8.:]#K@?CU8>/M1^$7B2+X7ZG;Z1X]6%)M*
MN+N&.6-Y$D1VA82 H/-17BW'[OF;LC&0 ?"7@GPQ^R;X\T>+2M)\7ZE\+/CN
MMI S>(/$=[J&G:Y::JRA@\OVF58[AS)@M$KLK!@%*Y1A]>?$_P".FO?#/5_!
MWP_\.^&)OBK\3]6L?M<MK!<Q:5;16T)CCGO[F1@X@C+O\JA7+-E!DXSXI\6?
MC%JGQT^%>M^ ]>_9;\=ZCX\U'3S9?8]1TF$:/!=M'E94U0RA!$DC9#J5<$=%
MY(YOX@?LQ7?@WQE\)?%/CGPOXH^*&B:;X M_!^NS>%-2O1J=E>P.9UN@EM+'
M-<1.SRH5!8C"-C(&X ]JN/VO-7LO OQ3:\^'$UC\3?AY:1ZCJ/@N;5E9+NS<
M;UN;6\CB82QF-9#Q&&#IL=4)S7:_$K]HJP\(>'/AIJ7A^PA\4S_$#6-/TS1[
M<7H@5X;E#*UT7"2$QQQ N<*<\#/S"O,?V/\ X:V<'C'QYXNL/AEJ?@'PO>QQ
M:/I7_"77NI7&MZG!&S&22>"\GD%O#YA;RTVAF#%C@8W87[+?PM\9:7\:)=$\
M4Z+>6?@_X165]HGA&_NXY%CU)+ZZ:2*:)BH$GD644%NQRV"[<DDF@#N=0_:F
M\:^(/$GBJ+X:?!V[\?>%O#%[)IU_KS:[!8?:KF(C[1%8PLCFX,>67)9%+J5!
MS6=XN_;@BG'P6_X5CX,D^(S?%.#4)-*5M433OLSVBQ&59BT<@&S?+O()*F!@
M Y(KY]M/@AH?P6D\?:1XU^"_Q*\:ZTVN7]_X?U3P3J>K-8ZS;SR&6!9?LDZQ
MV<B[UC<N@'!93)@UZI\/_@MXE^'OQ%_9-LY_"4>E1Z%I?BJ36TT+[7=Z=I=S
M=I!*(WN)Y)F!>1Y "\K;F#[3@   ])UW]I7QN?&5CX%\)?"@>*?'EKID&I^)
M[0^(HK73= $P?RHGO#"QED<QL518@2N&X ;'>? GXX6?QMT'5Y&TB[\,>)=
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MKVXM=1M2HFA$J2;25# ;D)4\$=#QTZU4<HPD[<LV[^:_R%+-<7"_-!*WD_\
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M-1^R?_R:S\&_^Q,T;_TAAH ]5HHHH **** "BBB@#\_?VI?^2[^)_P#MU_\
M26*O*:]6_:E_Y+OXG_[=?_26*O*:_5,%_NU+_"OR1^98O_>:G^)_F26T:37,
M4<LH@C9PK2L"0@)Y8@<G'7BOJ_Q2OPR_:*\9Z;X?TS7]9BU.WTQH--EB@5+
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MZUI-[JVH//=6=FUZD5W;R* (V5I8K=XW"AL*ZDMC( /MVBBB@ HHHH ****
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MQ&+J\U[*3V\Y6[/\CY1TCP!XCUWQ._AVQT>ZFUI&*R6938\6#@E]V @&1RQ
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M@J#F,+\WVA0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% %#7]&A\1:%J.DW+2);W]M):RM$0'"NI4E201G!XR#7P?\ #+]E
MOXY:]XI^"/A/XDV?A^P^'7P@O#?VVI:5?EWUV:  6#^5C=&8]H)W;00SY!R!
M7W3XNU2ZT3PIK6HV42SWMG93W$$3J6#R)&S*I ()!( P#FOROOOV;=-\2_!O
M]GWXK>+_ !7XM\4ZSX]\4:;9^*+MM;=8TMK\RA=G01+%*85('JPX&  #[B^!
M_@'QU<?'KXC_ !-^(&G:;X<N=6@@T'0M#L[L74JZ=:22-]IDE4A297E#!=H*
M@J#@\'Z$KXP_8V^"WAW]G']HWXM?#VRU#4?$%Y#INFZKI^KZK?//=+93[UDM
MIE 6)62:'>&5 665<_=K[/H **** "BBB@ HHKYW_P""@FN:YX=_9)\:WOAS
M7=0\-:UY^EPP:KI=P]O<6_F:G:QL4=&5AE78'!&02.AH ^B**^>_V6/BAJ5K
M^S3<7?Q%U&5]=\ R:CHOB/4KV4.SMI[NK3O(6);="D;EV.6)+$D'<?EG]GCX
MO>*=0^%7[46O_%?Q5XYL[6 :?K/DZ'JC_P!I:'!>P-=>18F9@L#()D3 "@;,
M8&,  _2JBOF[1_&M]%^VQ/I<NO:@GA.+X46FJ_8[Z\86R2G4IU:Y="VP2>6H
M#28S@8S@5Y#^US^V[8:M^S'XWOO!NG^/O#D%Y''!X?\ 'L.FRV=A>R^?'S;W
M$;^;&&4.%>1(U;! )SR ?=]?*W[0_P#R?7^R/_W-W_ILCKZIKY6_:'_Y/K_9
M'_[F[_TV1T ?5-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M >>_$-MNM0_]>Z_^A-7+^9[UT?Q(;;KD'_7LO_H35RGF>];K8Q>Y8\SWH\SW
MJOYGO1YGO3$>$>.H=_B[5&]9C_(5@_9_I74^,8]WB?43ZRG^58WE#VK]7PT?
MW%/T7Y'\D9I/_;Z_^.7_ *4SM?@RGE:GJ)]85_\ 0J]8\SWKRSX4+Y>HWY]8
ME_G7I?F>]?!YSIC)?+\C]^X+=\EI>LO_ $IECS/>CS/>J_F>]'F>]>(?<G>_
M#=MW]H_]L_\ V:NUKAOADV[^TO\ ME_[/4?QQ^-/A_\ 9^^'-[XT\3BY?2;6
M>VMFCM/+\UFFF2%<>8Z+@%]S$L,*K'G&#C+<UCL=[17RT/\ @HM\-8]9N],N
M?#_CNQN);3[9X>%UX:F0^*U+!8QI29WSF0NFW>J##;B0H8CNOAU^USX%\>?#
M7Q9XVOX]8\!Z?X2N)+;7K+Q?8FRO=.=45P)(@7R65UVJI+,6"@;CBI*/:Z*^
M=_AE^V_X/^)'CC2/#4_A/QUX*;70YT'5?%V@M86&M%5WA;68LVXM'\ZA@N1@
M?>(4S?%']M'PS\.O&FI>%M*\%>/OB7J^D!1K"^ _#[:C%I;NH>..XD+HJNRD
ML "V,'.",4 ?05%>$>._VU?A?\/?@UX.^*>H:C>7'@OQ1?V]C9WMI:EWB,@D
M+221$A]D8BDWA0SC;A58X%6O@Q^UCX=^,WQ!UKP0OA7QEX(\3:;8+JL>G^,]
M&.FRWUD93";F!"S,8PX527"G+@ '#;0#VVBOE#1?VN?AK\)_A3I_Q(U76O&^
MH^&?B#XSO+>QDUH+>S6+;Y(F$,,;%H[%#:-L1 [_ +P':2YQZ!\&/VM?#'QC
M\1^(O#\OAOQ;\/\ 7=#LDU.XT[QSI0TR9[-F9?M* NW[L,N"S;>OUP >WT5\
MG7__  4L^%VG6.HZS+H/C@>#(8[@Z?XR?0&BT;69X5<FVM+EW4-*QBE50X0%
MHV&X<9\T_:?^.>M_%C]I'X>?!O1;3XQ^#](6/^U-<U#P/;?9+VXCN(X4M9DG
M#'%I!+,Z3R,"@=2 &*AJ /ORBO)?!OQZ\+7/PA\6>+HCJX\-^"9=1T^[O=3*
M23W@T[<DTZ,)&\P.8VVLY5F/) S7GWC/XJ7_ ,2_BW^S-8>'+K6-!TKQ)%>>
M,-2M//,$QL8K%3#!<K$Y#!I;J/*%F3*'.2!0!]-UYW\<?ACKWQ1\)VEGX7\?
M:Q\./$-A?1:A9:SI2B5"Z!AY=S;L0EQ"P8DQ,0"RH3G&#PG[<GQWU?\ 9[_9
M\UGQ!X=T_5KOQ'>R)I6EW6F6*W2V-U,&$4\X<%1&&"H,AMSR1KM.[CQGXB?M
M,2^%_%_[-Z7A\<Z)9KI&I:OJGA6ZMIQX@UJ6*!;6RM'M4D9II99W:39(2/E#
MN5 9E /:_@K^S3KW@KXA7?Q!^)'Q*O?BMXZ-@VD6&H3:7#I=KI]DSK(Z16L)
M*^8[KEI<Y*A5P,$M[U7@WA7]LOP7XH^#_COX@R:/XET"'P3YRZWX?UW3UM-6
MMGCC$@C,+2;=SJR[07&2<''-9TG[=7P_L]"UW7[_ $CQ7IGAK3S;06&MWFCL
MMKX@NYPVRTTLABUW*&21247R_D+[S'AR ?15%>*?!3]J_P .?&?Q5>^%G\,^
M+_A_XLM[0:A'H/CG1SIMW=6F[8;B%=S!XP_RDYR#VQS7$:E_P4.^'VE:[>+/
MX6\>GP79Z@=-N/B(GAYCX;BD$HA9C=;\[!,?*W;/O=,@@D ^HJ*^//C/^TJ/
MAO\ MF6FES2>)]>T[1O!IEB\%^$K>6]O=6U&ZN3AA:HP5Q#;6\CEY,*@?@Y=
M0WJ6F_MD_#6Y^ =S\7=1OKWP[X:M)I;.ZM-7M3%?P7D;E&M&@!8F;<,;5)XY
M) !( /<:*\&^#O[8OAGXM^/7\%7GA+QM\./%4EH;ZQTOQYHATV74H5)$C6_S
MN'\O W D'!RH8*^W@? '[1NF^!+7X\?%'QYXBU$^%QXXD\-Z#IN^6Z,AM(8[
M=8;& $C=-,LQP@ )!=S@,P /K>BOAKQQ^U?)\=OBK\$?A[X9M/'?PP\17/C!
M-2UG0_$%G+H^I3Z7:VTLY#HKD/;3$,I&XY,+ C@9^Y: "BBB@ JMJ4-Q<Z==
M0V=R+.[DB=(;DQB01.00K[20&P<'&><59HH \=^ OP"O_A9J7B+Q-XO\93_$
M?XA^(##'J'B6YT^*Q MH5VP6T%O&2D,:Y+$*?G=F8\XQ[%110 5^=OC']KGQ
MK_P3VUH_#OX@W<7QITLZ;)>>'M2MKR.WUF"-01%!?QG<2F(V)N<,<;C\Y&U?
MT2KX?^%&H?LS?LC_ !#MOA=<^*#XQ^+_ (GNH=/U?6-3MI-1O;RZN7$0AGF"
M,D*LSX\DMD+@R;B=S 'HG[*7AGXA>.M:/QK^(/Q L-;?6],DLM)\+>%;A9M"
MTRV>6)F9) S>=/NMP&?)P2ZY(P%]^\9?\@N+_KL/_06KY^_9D^%/PK\+_&'X
MAZY\'O%]U;Z/;7%QHGB'X?VSNFG:?JL<L:M<1P.%,;8@D3< R.&;8P5,5] ^
M,O\ D%Q?]=A_Z"U-;B>QO4444AA1110 4444 ? WBO7/V:/"'CCQ[\#FD\5Z
MU;_$_P 06^F:KIECOGT?1M7GG.T0L^$MYC*RRL$WX\F/C$84=]^Q5\.?AYX=
M^(7Q&O-/^(GB#XE?$O0IO^$5U6\\62'[=IUK ^%AB1N?(=T+B0$JY08P0V?E
M?2_B_P"#?AU\(/A?\*_%M];>%_B?X(^+VFZAXOM[]##]H U&6634A,RA9HFC
M:-M^<A0O 383]2_ OQGX<^.W[;?C;XC?#MVO?!NE^#[?PYJFN01M%:ZKJ;70
MG0IG E:&!-A<@D"0+PNPL ?7U%%% !1110 4444 %%%% !1110!Y5^UA_P F
ML_&3_L3-9_\ 2&:C]D__ )-9^#?_ &)FC?\ I##1^UA_R:S\9/\ L3-9_P#2
M&:C]D_\ Y-9^#?\ V)FC?^D,- 'JM%%% !1110 4444 ?G[^U+_R7?Q/_P!N
MO_I+%7"0>.?$EMI46F0^(-4BTV%E:.S2]D$*%7#J0@; (8!A@<$9ZUW?[4O_
M "7?Q/\ ]NO_ *2Q5Y37ZEA(J6%I<RO[J_(_-,5)QQ-6S^T_S-.7Q/K%QK@U
MF75KZ36 RN-0>Y<W 8 !3YF=V0  .>@IVN^*];\4-"=9UG4-7,&1$;^Z>?R\
MXSMW$XS@9QZ"LJBNODC=.VQR<\K-7W.@_P"%A^*O+LH_^$FUC98D-:K]OEQ;
MD*4!C&[Y<*2O&."1TK/'B+55UK^V!J=X-6W^9]O%P_G[_P"]YF=V??-9]%"A
M!;)#<Y/=EZXU[4[K5QJT^HW<VJ"19OMTD[-/O7&UMY.[(P,'.1@58_X2W7/[
M>_MS^V=0_MK_ *"7VJ3[3]W9_K,[ON_+UZ<=*R:*?)'MY"YI=SV7X2?%[P]X
M(U&^\6>(%\0Z_P"."DD4$DEPCVTB%$5#(['S WRE<_, N,#/3R;6-5N-=U>^
MU*Z8-=7D[W$I48!=V+-^I-4Z*QA0A3FZBW?Y+HC6=:<X*#V7YOJS[7_8G_Y)
M7JO_ &&I?_1$%?0-?/W[$_\ R2O5?^PU+_Z(@KZ!K\YS+_>ZGJ?H.7_[K3]
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M44 %4-;TA-=TV:RDN+FVBE&UWM9/+<CN-W49]JOT5,HJ2<9;,N$Y0DI1>J/
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M /7JO_H;UQ?F5W?Q0TF_O]?MY+6QN;F,6JJ7AB9@#O?C('7D5Q__  C>L?\
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M^D9?_NM/T"BBBO-/0"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9L_]GO=;F(3G"L#UD48 /K533/A/9^,?B)8>&?!OB-/$5M<0^=-J<EC):)
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M>&HX?V?LHVO?]#Z#)\15K^T]K*]K?J%%%%?,'T@4444 %%%% !1110 4444
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M***\T] **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/?/&7_(+B_Z[#_T%J:W$]C>HHHI#"BBB@ HHHH **** "BBB@ HHHH ****
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M93*9ERLN1^ZQ],_-TXJ.QU#4;B'36N-)-K).I-TGVA'^RL!D#(^_D\9%:=%
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MZ]TT2W#%[<;]@>%)3,1GYF!R&486ONS4]4LM%L9+W4+R"PLXL;[BYE6.-,D
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MU9W""2*:(Y5U/<5^>>A^')-?UK3],MRB3WMQ';1M*2$#.P4$D G&3V!KZO\
M@Q\,O'7PPNFL[O4-)OO#\Q+26R7$I>)O[\>8P,^HR ?8UZ?"^-Q<5]7E!RI+
M2_\ +_P/R/%XXRS+YR^MPJ*%9J[B].==_P#%^9[/16;:>)M'O]=U#1;75;&Y
MUG3TBEO-.AN4>XMDDR8VDC!W('VMM+ 9VG&<5I5^FGXF%%%% !1110 4444
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MA_Y=?]O?H?49#_R]^7ZA1117QY]8%%%% !1110 4444 %%%% !1110 4444
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M4T4 ?*W_  P-_P!7&_'_ /\ "X_^T4?\,#?]7&_'_P#\+C_[17U310!\K?\
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M@9P ,^PK0_X8&_ZN-^/_ /X7'_VBOJFBLFW)W9JDDK(^5O\ A@;_ *N-^/\
M_P"%Q_\ :*/^&!O^KC?C_P#^%Q_]HKZIHI#/E;_A@;_JXWX__P#A<?\ VBC_
M (8&_P"KC?C_ /\ A<?_ &BOJFB@#Y6_X8&_ZN-^/_\ X7'_ -HH_P"&!O\
MJXWX_P#_ (7'_P!HKZIHH ^5O^&!O^KC?C__ .%Q_P#:*/\ A@;_ *N-^/\
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M (8&_P"KC?C_ /\ A<?_ &BOJFB@#Y6_X8&_ZN-^/_\ X7'_ -HH_P"&!O\
MJXWX_P#_ (7'_P!HKZIHH ^5O^&!O^KC?C__ .%Q_P#:*/\ A@;_ *N-^/\
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M_'?C?]LOX _ 6ST;QG::!JGB?Q=/8:C=66C+<VU\-.:>=+]8IBK+&#9)+Y+
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M/_M%?5-% 'RM_P ,#?\ 5QOQ_P#_  N/_M%'_# W_5QOQ_\ _"X_^T5]4T4
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ME;7A+Q_X8\?6]Q/X8\1Z1XC@MV"32Z3?172Q,1D!C&Q )'8U^:GQ?U?6-4\
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M,5A)X65I;=&:Y5FU#-:7/3=I+==O^ 3T445Q'N!1110 4444 %%%% !1110
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M8_#:YUGS/!>GZ5'<VVF?98!Y<AM;5RWFA/,/S2N<%B/F] ,>#? S3]<\+_\
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M('O"\\)EM\=%A(A 4#I\P:O?**OVL[6N3[.&]CR7_AFCPQ_PSW_PIW[?J_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#+\5#/A?6/^O.;_ - -
M?$?E"BBON^&_X=7U7ZGX5XC_ ,?#>DOS1+9Q#[7!_OK_ #K[KHHK'B7>E_V]
M^AV>&WPXO_MS_P!N,VY\-:/>Z]9:W<:58SZU8Q206NHRVZ-<6\<F/,2.0C<J
MMM7(! .T9Z5G_P#"N?"9\*-X7_X1C1O^$9:0RMHW]GQ?8RYE\XL8=NS)E)DS
MC[_S=>:**^*/VDB\<?"WP9\3H;2+QCX1T'Q9%9LS6R:YID-ZL!; 8H)5;:3@
M9QUP*UE\.:2NMQZRNEV0UB.U-BFH"W3[0MN6#F$28W"/<JMMSC(!QD444 8O
MB7X2^!O&?B+3]?\ $'@SP]KNNZ>$%GJFI:7!<75L$<NGERNA9-KDL-I&"21S
M5CQO\-?"/Q,L;>R\8>%=$\5V=O)YT-OK>G0WD<3XQN5958 X)&1S@T44 3>'
M_ 7AGPG=S7>B>'=)T:ZFA2WEGT^QB@=XE9V5&9%!*AI)& / +L>YK.\#_!_P
M'\,9[N?P=X)\.>$YKM52XDT/28+)IE4DJ',2+N ). >F3110 _2?A+X'T'Q?
M>>*],\&>'].\4WF\W.N6FEP17L^\@OOG5 [;B 3D\XYK<U_P_I?BO1KO2-;T
MVSUC2;Q#%<V%_ D\$Z'JKQN"K#V(HHH R?&GPR\'_$C3[6P\6^%-#\4V-J_F
MV]KK6G0WD4+XV[D616"G!(R.U33_  _\+W-L]O-X;TB6!]1&KM$]A$5:^#AQ
M=$%<><& ;S/O9 .<T44 7CX<TD^(1KQTNR.NBU-B-3^SI]I%N7#F'S<;O+W@
M-MSC(SC-9&E?"OP5H?B^]\6:;X/T'3_%-Z&6ZURUTR"*]N Q!823JH=LE5)R
M3G ]*** (X_A'X%AN;^XC\%^'DN-0U"/5KR5=*@#W-[&Y>.YD.S+S*Q++(<L
M"20<TOBOX3>!_'FKV&K>)O!OA_Q%JFGX^QWVK:7!=3VV&W#RWD0LF&YX(YYH
MHH VI/#FDS>((==DTNR?6X+=[.+4VMT-S' S*SQ++C<$+*I*@X)4'' HT?PY
MI/ATWYTK2[+3#?W3WUX;.W2+[3<. 'FDV@;Y&"KECDG R>*** -&BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
=** "BBB@ K!\9?\ (+B_Z[#_ -!:BBFMQ/8__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>camp-20241231_g5.jpg
<TEXT>
begin 644 camp-20241231_g5.jpg
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M/O_M $A0:&]T;W-H;W @,RXP #A"24T$!       #QP!6@ #&R5'' (   (
M @ X0DE-!"4      !#\X1^)R+?)>"\T8C0'6'?K_^X #D%D;V)E &3
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M'3Z4E+.U (" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M=W_9Z:JSL+<?'JK^(IP<&C*ODLYW/@N;Y;A#I6B'E--T^/#]-GWG08YS>I\
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M87[]Q)D?KK[%GFS]I&Y7BP]GKMWHB+Y6;T??$]WOWHB-8YIV;^Z?@W;]KO\
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M_P#T B%R@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M @(" @(" @(" @(" @(" @(" @TCW<_[:NQW_P!0SG_Z>U0RC<W<I8B @("
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M]J.[)[M8V?DN+XUD</PYVC</ELMZ4$M\@Z/=%68Y[A&#T$CCH[R\%+&8;'1
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MZT$5BN/8_#7LI?HA\;\O,VU;AW:Q"8,#'/8W\DNTU=[2@E0QH! : #X@!!]
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M? ,)PVL1)/1@#LE:\7V<A.3+:G<[0$F25SCU\M!Y*42S1$" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M2T;6D#:W330:=.GDH'M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$$3R7/T>,86WG,D[;4IQF1VGBYWY+1]
M)/13$:SHU^9YBG+XK9;SI6L:RUUA.$Y3N&V'E'<B:4T;&DV-XO$]T-:&%Q#F
M&<-(+GD:'3\?L5TVBFRN_K>7P]WY.\HC-SFO!.VN+68K$;XX_M6\>[J9BSMK
MV_8T,;QK';1T&M:,G\9!*P[6_7+K_<G(>XQ^S#U_+?@'\-8W]EB_14]K?KD^
MY.0]QC]BOU'\M^ ?PUC?V6+]%.UOUR?<G(>XQ^Q7ZE!G ^VTEB6I'@,4ZW &
MNG@;!"9&-DUVES0-0':'37Q3M;]<L([G[NFTUC#CUC?'#757_EOP#^&L;^RQ
M?HIVM^N6?W)R'N,?L5^H_EOP#^&L;^RQ?HIVM^N3[DY#W&/V*_4?RWX!_#6-
M_98OT4[6_7)]R<A[C'[%?J/Y;\ _AK&_LL7Z*=K?KD^Y.0]QC]BOU/+^W7;Z
M-I>_C>-:QH)<XUH@ !XDG1.UOURB>Y>0C_TX_8K]3Q6X!VXN01VJG'\5/5F:
M'Q3100OC>T^!:YH((/T)VM^N6-.Y^[KUBU<..8GIBM57^6_ /X:QO[+%^BG:
MWZY9_<G(>XQ^Q7ZE&MP'MO=A;9IX#%6*S]?3FA@AD8[0D'1S00="-$[6_7+"
MG<_=UXUKAQS'@K56_EOP#^&L;^RQ?HIVM^N6?W)R'N,?L5^H_EOP#^&L;^RQ
M?HIVM^N3[DY#W&/V*_4?RWX!_#6-_98OT4[6_7)]R<A[C'[%?J4:_ NV]OU#
M5P&*F$+W0RF."%^R5G1S': Z.'F"G:WZY85[G[NMKIAQSIL]6N]6_EOP#^&L
M;^S1?HIVM^N6?W)R'N,?L5^IY9V[[>R%P9QS&.+#H\"O$2#XZ'IT3M;]<HCN
M7N^?_3C]FOU/KNVO;]S2T\:QVAZ'2M&#^,!1VM^N4_<G(>XQ^S'U,2SG;W(\
M-#^1]KYI*LU?]=;XXY[GT[<3>KFL:XG8_3PT\5G%XMLM]+EY^Z\G)?SN1V:;
M;8IGT+QTZ?9MU:=+.N(\DH\MP-3/4/=CM,UDB/VHI6]'QN^EIU"JM6:SH]!R
M7.8^;PURTW6CRQUQ/AB=B<6+=$! 0$!!#7N)<8R=QN0R.'I6[S3J+$U>-\FO
MTDCK^%!7RM/#S8R6EEXZYQ$C1#-#8#6P%A(#6D'0::Z ! @KXG!TZ^.KL@HT
M-17JUAMCC+GZD1L;YD]>@0647&N(8O)1W*V+Q]3+6"?1F9#%',YS1J=G3773
MQVH)] 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$!!K'N^WXZSPS 3:? 97-P1W&G\ID0W@>S0E6X^F? \WW
M[''7#BGU;Y:1/BC6WXX;. T\/!5/2,8Y_G+W'>+VLGCBQEIKX819E;OBKMGE
M;$Z=[?-L8=N*SI76='*[UYF_+\O:]--=8C6=U=9B)M/@KKJQ_*W[_&\+- WE
M5C,Y"_:ITZ+F1TOB89K9( WZ-C:V30EKI&^[Y;EG&EIW:?2YV?)?E<,Q.:V2
MU[5K79CXHFVSJBND]$VC9X=S'V\DYDT2<?.5E@OU>1X_%LO6&5Y[ KW*QF>R
M7T@(G[3X$!I\-?8LIBN_3H<ZO-\UMQ<<Q:N:E.*8K,\-J<4Q.D16?!IIT:KW
MX*X[GO):<?)G8>Q#B\49KVROZT[HFSCU7>JW:&@]7AK0.ODHUCAC9TROG%>>
M=RUC-..8QXO2]'6=./;MC3QZ1]"U9S'D?),;B(:EVS4R[L7+E<@['MJ11&*.
M9\$5C=;#MS9#&7>FP#H>KAT4\,5VZ*:]X9^:I2M;6K?@F]N#@TTUFL6]/79;
M29B(Z-\QL5<7GN5\KGJ[,W)BXY^+5,O8;5AB<3;DFF:7,]5KMH/IC<.OX$F*
MUZ-=LIY?FN9YNT?S)QQ."EYX8CUIFVV-==-VV-OD><+RWED9XYE[E]V2&>P>
M0R$V*$,<<39Z,4<D8B+!NU<7D.U)2U8VQU2GE>?YG7#DM;C[7%>\UTB(UK%9
MC3IV\6W657&Y[/[>*7G<G&5?R]Q@MXZ*.%OPWJUWRF:KM;O:*[@&O]3=KYZ%
M3-8VQIN,'-9_Y%YS<?Q&R:Z5]'6DVUILU]&8TGBU\DON-Y1G\VZEQJ>R?O'!
M5\@[F+@UH,KJS75Z[#TT G+O6]WR:L;5B-O7N6<OSN?--<,SZ6*+]MNV\/HU
M\7'Z_BC1(<+S5RCP;C>/KXRW+%)AHY?O>(1&K \0N(#]SP_4%H\&'Q"B]8XI
MG7I7]V<S>G)X:12TQ.*)XXTX8]'IVZ_1$HC"\DY%#A^&<BFY)][6<W-4HW<*
M8ZX:]M@$/<STVAXDB^T\DZ: Z@+*U8UF--S2Y7G,\8>7S3E[2<O!6::5V\6^
M8TC7BKOG;II$[(6G&7Y[ \0X?EJ69<W'V,K!C78GT815-6Y=?"[5VF_>-=P=
MN_ IG29F)A3RG;<ORN"],GH\=:<'#'#PVOP^/6-===?(OI^7<A8+')1F&MD@
MSPPC>)F.+1T'Q3:^W73U?7<T^L';M-OEHD5C=IT:ZK[\_GC7-VF[-V?9:1NX
MXK^MQS'IQ.NFG1TI+[^S]+F(&:O3QX>UE/N_&R4OA+..>U[2(Z\[1^OBGW:[
MG^&OT+'ACAV;VW\5GIS?\VTQ2U^&O#P33P5M^?6VO3NW(.IRGDL.)K<C?R/X
MFTS//Q3L ^.#2:"2^ZN(]6M$GJ-9[[7:^ \"LN&-VG1^1SZ<[S%<5<W:ZSVT
MTX-*[8G)PZ=?%$;8GP;8EXCLYS"4<_R#%91U>"ORV:N<8(HG0S-M78H)?5>X
M%Y)WZMVD:)LG9/5^1%;9<%,F7'?2(YB8X=(TGBR16VL[^G6---%YG^7\A@R5
MW-8F[:=B<9F8,/)7E;493>YTT<,T9CT]<D;R6R[O]';U416--)ZM5_-=X9HR
M6RX[6X*9*X])X.&?2BMMGK].RVODX=JQAR64XC6[C9FA?EN7*^59 V.P(W,C
M]9M=IM/:T-)]-K]O4ANC1KYE3I%N&/ UXS9.4KS>2MIM,9(C;II&L4].=WJQ
M/7$:5V],LQXA:Y0S-R4+\MJ]A9:OQ LY%U#XJ.QO &P4GG=%(TZC<WW2/$JN
M_#ILW^5V^[[<S7--+S:])KKK?L^*+:_H;ZS'@V:;YUV9ZJGH6L^V,3<=R7GF
M'K'3'5LJ)H(?$,=:C$CP/8-3X*V\ZQ$^!YON:L8\O,XX]6,NL?M5B9\[9BJ>
MD$! 0$&KN:<MS%#/9+'0YVOQRMC,:W(5/B88Y79&9Q?JQIE_):6!I:SW]7*1
M 3\[YK-A^6Y\7F8X86E0D@Q;J\3C%9O012$N>X:[07$AI]OB@K\@SN>BK\CP
MF9O5\M'4;@[M=\]2%K6?'W&QO88]"UP&FK2[J#YH(* 7I:OP3\U\1DH^=1Q1
M^NR-SJ\FLH$QC&G23Q:S[(T]U!-#DF;??@CREJO?R.%RN;HP9%]:%LI;4Q3[
M#'  :,<':;MNFH'5!5QG-^8TZ].Y=OQ9B3)<8GSL-/X:.$,LUVQD!IB]YP=N
M.X?BT03';?E_(\[DY:V2F%[&NI1VQ;)ILDCG<X-V!E61Y]-P)+?4&X:=5"6S
MT0(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(,&[J\=OY_C0EPXW9W$3QY+'-TU+I:[MVT>'B/I5F.VD[=SB]\
M\I?F.6F,?]2DQ>GZU9UB/+N2_#.7XWFF%BRN/=MF&D=ZF[I+7L-^W&]IZC0^
M'M"B])K+8[N[PQ\YBC)3?NM7IK;IB83\T,5B)\$[&RP2-+9(W@.:YIZ$$'H0
M5@Z%JQ:-)W(:#AO%*N/LXFOA:46-N$.M560,$<A'@7#3KIY>SR6<WM,ZZM&G
M=O*TQSCKCK%+;XX8TGQJD'%..5MOP^+K1;9XK;=D31_O$#=D<O3\MK>@=XJ.
M*5E>2P5W4K&V+;NF(TB?'ITO.1XCQC,32V,KB*EVQ.(Q-+8A9(YPAUV EP/0
M:E(M,;I8YN0Y?-,SDQUM,Z:ZQ$[MWT*UWC> R3JKK^-K6'4FEE0R1-/I,(T+
M&].C2!]GP2+3#/)RF'),3:E9FN[9N\7@>JO'\+1+74Z,,!96;0:8V!NE1A+F
MQ#3\@%Q('TJ)F998^5Q8_5K$;.'9'YL;H\6U]KX'#5#1=5HPPNQD;X,>6, ]
M"*0 /9'[ =HU362G+8J</#6(X(TKLW1/1'T*5+C''\9=GR>,Q=2GDK.OK6X8
M&,D<7=3J6@'J>I]JF;3,:3*O%R6#%>;TI6MK;YB(B96''.)-PTF7O9&T,EE\
MY*V3(VC$V!CF1QB*.)L;2=&M;[22225-K:Z1U*.3Y",,Y+VGCOEG6TZ:;HTB
M-.J(_*EQBJD&*.'H1MJ4VP.K011-T9&PM+0&M]@U\%CKMU;L8:UQ]G6.&--(
MTZ$+Q?@F"XS4QH94K3YFA5CIG+"NR.>1K&[2=1J07>?59VO-M>IH<CW7AY6E
M-*UF]*Q7CX8B9T_#K2K>/81E&MC&4(!CJ<K)ZE8,'IQ2QO,C7M;Y$..X?2L-
M9;D<KBBD4X8X:SK$:;(F)UC3RAX[@G989XXVJ<T&[1?,+/7T\/MZ:ZZ=-?8I
MXITTZ$?!X>U[7@KQ_:TC7Z7AG&./1Y4YR/%U6YAQ+G76PL$Q<1H7;M/M$=-W
MBG%.FFJ(Y+!&7M8I7C^UI&OTHGC7 ,+@&QSS5Z][+PV+=B#)OKL;.P6YGR[0
M[WC[H?MUU65KS+3Y/NK#@TF8K:\6O,6X8UCBM,_ET3+N/81]:>FZA :MFQ\=
M8A+!L?:+Q)ZKAYOW .U]JPUEO?"X>&:\,:3/%,:?G:ZZ^/7;KUJ-GB7&;MN6
M_;Q-6:[,Z-\L[XFE[GPD.8XG3[32!H?%3Q3UL+\CR][3>U*S:=-NG5N^A<#!
M89MVUDA0K_'WH_0N6/3;OFB'Y$AT]X?6HUE;'+8HO-^&.*T:3.FV8ZIZU+#\
M8X]Q\RG!XRMCG3Z>LZM$V,OT\ 2T:Z#R"FUIMOE5RW(\ORVO94K37?PQ$*?*
M>48KB&'GS.6E#(8@1%"#^LFE/V8XQYN<4K6;3I".>YW'RF*<F2=D?3,]4>&6
M.=J\%D<?B+>=SD?I9[D=E^2N1'QB;*=8X_\ 1;IT6628F=FZ&AW+RV3%AF^6
M-,F6TWM'5KNCR1I#/56[H@\,E9(7-:X%S#H]H()!\=#IX(/: @M+F,QV1,3K
M]2"TZN[? 9XF2F-WYS-P.A^D(/,F*Q\K;#9:L$C;>WXL.B81-M #?4!'O: =
M-R!+BL=,Z1\U2"1TH8V4OB8XN;"=S XD=0T]6Z^!\$%ICXN/Y=GWOCHJEIDT
MHD^,BCC?OFKET8?OTU+F$.:#XA!=?=&-+G/-2#>Y[Y7.])FIDE;L>XG3Q<WW
M7'S'0H/<>,H0OADBK0QOKQF&NYD3&F.(Z>XP@>ZWH/='1!\J8S&8WUI*5."I
MZIWSN@B9%N/M<6@:_A0>L?D:65J17\=.RS2G&Z&Q$=S'MUTU!_ @ND! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$!!@'(>V-:[EG<DXUDI^.<BD_ZQ:I_V4^FO]K$?=<>OBK:Y)B-)VPX/-]ST
MR99S8K6PY9WVK^=^M6=D_C6D>&[TL:&?O-BI-O3>:)U.GMT(ZIK3J\ZJ.5[T
MC9V])_\ U_Q/?W1WH_B/%?L)_236G5YSX;O3WV/^W/[Q]T=Z/XCQ7["?TDUI
MU><^&[T]]C_MS^\?='>C^(\5^PG])-:=7G/AN]/?8_[<_O'W1WH_B/%?L)_2
M36G5YSX;O3WV/^W/[Q]T=Z/XCQ7["?TDUIU><^&[T]]C_MS^\?='>C^(\5^P
MG])-:=7G/AN]/?8_[<_O,9YIF.]/#,>W+39"A?QK3MM35J8U@U\'/:7:[3YN
M'AYJRD8[3IIYW'[TS][\EC[2+4O2/6TI/H^'3BW=<]#!!WN[CD:B]4(/4'X1
MOZ2N[*G5+S<?,W>$_G4]C^)]_G=W'_\ ?:G[(W])1V5/"G_9>\/M4]C^(_G=
MW'_]]J?LC?TD[*GA/]E[P^U3V/XGUO>WN+N;ZE^JV/4;W-IM<0WS(&[KI[$[
M*G5YR/F7O#7;:FGZG\6ULCCV1[E\JHC(X+E^'M5S]H"B6R,/L>PNU:?H*HMP
MQ.DQ/TO8\K?GN9QQDQ<QBM6?_P <^>.+9/@E+_='>C^(\5^PG])8ZTZO.VOA
MN]/?8_[<_O'W1WH_B/%?L)_236G5YSX;O3WV/^W/[Q]T=Z/XCQ7["?TDUIU>
M<^&[T]]C_MS^\?='>C^(\5^PG])-:=7G/AN]/?8_[<_O'W1WH_B/%?L)_236
MG5YSX;O3WV/^W/[SR_$=Z7-+1R7%,)_*^!/3^DIK3J\Y\-WI/_OQ_P!N?WE;
M"]KHADX>0<PRL_)<W7ZUG6@&UH#T.L<+=&@Z^:B<FL:1LA9RW<U:Y(S9[VS9
M*[IMII7]6L;(\;8:K=\0$'/]ZUD<%F^3T\;GKM;+6N18N$B1S9'BI;#6F4,<
MP!P/]F/+1H"D7G+.59[#\AFK4LQ9B.#DQ]5E6W+&U]P3.8)9O0$/ZV-P<=9-
M[=KO!$KF#-\ECGAS?WW:>T\OFP7W=)Z;JWP<DCF[2-NXN;I[IW=/!$+*CS;D
M]=O(65<A+F\[%2LVH):SV6*##%,UNXU3$R6O(QA.V-[G!^B)7UWE$=?C[(,+
MS*UE([UZM!8RUAT==E+?$Z1[7V1 =C7ENC0&DM/NH/'$\]R7D>1X_CK&=L10
MA^8BLRP^F7VHL;/"(M[BS3<0[0O:T$CZT0BN"<@L8R/ PX?+3WKLMV]'D^+-
MC#XHZ#9)Y73,T:"UX(!:[?[Q=M04:7..2OJ9>PS-2R_$X*_DVQNF9-+4M5GL
M],:-BC$,C0[1\8W!!?9/-\LQ;>0.CY)<D^Y:&*S4(D;"?4L6W 21OT8/U)'_
M $8]OBB4_'E.3NY:[@LMRRZ*&Y)FY<CTWOPKHM[*^NG^N/I'SVA$,+@Y+E,=
MQ+ 4<=E9,3\)A9<E$1*R".Q.V23;'&'12>JX;??C+FC1!DE3F>9EY?AW7<G)
M/%D!08W%4)&1F(VJ[7R>M5DB)D87NW&:.3W!]2)?.$\KYAE>5U(+]K]=/)99
MFL5/8A(@9%N#?1K-C$D180.KGG>.J(;L4 @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @\2Q1S1NAE
M8V2*0%KV.&K7-/0@@HB8U<[]R>S<^'-C/\1A,V*ZR6<3&"Z6'S<Z$?E-_P @
M>'DMO'EUV6^E\V[Y^7.RB<W*QK7?;''1X:?N^SU-0M<'#<TZA;#PT3$QK#ZH
M2(+W#YG+<?OMR>$N24;K=-TD9]U[1^3(T]'M^@I,1,:2OY?F,O+9.TQ6FEOQ
M_K1T_AI+=_#^_=&<1TN90"C9.C3DH036>?:YO4LU_$M6V&?S=KZ'W=\U8LD1
M7F8[.WVOS)_=\OTMRU+E6_ RS2F98K2#5DL3@]CA]!"UWMJVBT:Q.L2KHR$!
M 0$! 0$%-U>![_4?$QTG3WBT$^Z=1U^@^" ^O7D?ZDD3'OTV[G-!.W7734^6
MO5 ]"#P])FF_U/LC[?YWU_2@^LAAC>^2.-K'R'61S6@%Q'F2/%!Y^%J^DZ#T
M8_1<=SH]HVDZZZD::>*#ZV"!C@YD3&N&I#@T @N\?Q^:!'7KQ.WQ1,8_3;N:
MT [===-1Y:]4'GX2K[WZB/W]V[W&]=_VM>GGYH/KJ]=V[=$P[P&OU:#JUO@#
MTZ@((W'<;Q>+R%_+5V/?DLFX&W9FD?*\M;KMC9N)V,;KT:WH@D35JEK&F",M
MCU]-NT:-W=#ITZ:H/0KUP]LHB8)&-V,>&C<UOL!\A]"#ZV&)LCI6QM$K] ]X
M #B!X:GQ*#V@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @U#W&[,U,])+FN-%E+-N!=-5/NUK+
MAUZ@?9>?SA^%7X\O#LG<\AWQ\NTYJ9RX?0R_];?K=4_I1Y=7/N0H7\3>EQF5
MK/IY&'^UKRC1P!\P?!S3Y$+;C28UC<^89L63#DG'DK-;QT3^..N/#"W16(""
M5P')N0<6G]?C^0EI==7P [Z[]/SHG>[^+11:L6WMSD^=YCE)UP7FL?9WU]GZ
MM&V>._,&]FV#E6+Z>#KM EP^LQ.Z_B*UYP=4O;\G\W5G9S%)K^E7TH^CUH\[
M:>"[A</Y&UOW7E8'RNT'H/<(Y03Y;7:%46K-=\/7\KWCRW,QKBR5MY=OT;V3
M-(< 1U!]G58N@^H" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M#'>6<)P',Z0IYJL'O9U@M1^Y/$[VL>.H^KP65;36=CG<]W=@YRG!EKKU3NF/
M%/0YRYAVGY/Q(OLP1NR^%'46Z[298QJ?[6,=>@_*:MRN6+>"7S+O+Y>YGE-;
M4URX^N/6CQUZ?'7Z&"M<UXW,(</:%:\U$Q,:P^J$B @\NC8XASF@N'V7?E#Z
MCXA3JQM2L[9C:F\7S#EN$ ;BLY<KQ#PB,IEC_P"3+O"PFM9WPZ.#O'F\/]/+
M:(ZIGBC_ +:LJJ=\.X58CUYZEU@\1+7V$CV;F.'^!83AKX79Q_-//T];@OY)
MK^*9_$FJ_P PW)&G2UA:;V^7I2RL.G^D"L>PCK="OS?F_.PU\EI_=7E?YB;8
MG@%W QLJ>H!9ECG<][8?-S6EHU(]FJCL/"OI\XQQ1QXIBO3,6UT\.FFUO7&Y
M&GEJ4.1Q\S;%&RQLD$[#JU['#4$+6F-'O\>2N2L7K.M;1K$QTPU;W,YWSW@]
MUEBE1IS\<LD,@MN;)NCETZQRZ'H3^2? J['2MM\[7E>_.]>;Y"8M2E;X[=,Z
M[)ZI\?1/D8,SO_S5K@7T,>]OFW]:/Z=5;V%>MYR/F[F_=4]JWU+FO\PO)6._
MWK#4I&?^JDE8?^<"H[".M?7YPS?G8:^2\_NIBE\Q<7N#(\?E83KZCZ\S'@:>
MP.T)6,X)ZX;N/YPQ3Z^*\>*:S^5DN-[\\$NEK;<EC'/=IK\3$0P$GPW-U'3V
MK"<-^IUL/S/R&3??@_6K-6:XGEO&\X&NQ.3K6MW4-CD;N]OV3H55,3&]W\',
MXLT:X[5M'@F)30.HU4-@0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M#Y@^$'7_ '?(="0?]W'0CQ'VEEV%O TO]NY+JO[$G_B#X1_[OD?V<?I)V%O
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M>""N@(" @@LKDC(35@/ZOPD>//Z C5RY.B$0C6$'T D@ :D] !XDH)S'8D,
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M6J^A" @(" @TAWBJ<CY;RKCW$L%2?)%4W7YK4T;_ (+U_P D2/TVD-:T]/\
M*T4P(3&4N?<3[A6[67Q463L<GI2LFBI1N./DGVZ1-E)&UFKFZ.W>108O/QS)
MY+(4Z_%N%Y/C/+V3QNL6XII/N^/0^\]H>/= /4>_T'3JI0FN>8N2WE\A%FN
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MT;B7 =1T0>:66Q^1I5LE2L,EHW&L?6G#@&O$@U;IKH=3[/%!>H" @(" @("
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ML8B(W0VN8YSF.8T[:\WX=VNFS7Q1'G3_ &NR?W5W!PDY.D=F1]*3ZIV]/^<
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M-KFW;CC'*[P O97'03VM  #-MVR. '0!S@3HN1>O#:8=6EN*L3ULR6#(0$!
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M]XBD]MG&"FV.B8&L#XF.L RQ-C+=6>C]H>*#>+&EK0"=Q  U/B=%"'I 0$!
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MQ.2_C=4?/;!'6XAPBO"W;#%DIXXV^QK:N@'X@M/E/6GQ-SFO5CQ_6ROY(?\
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MWF/2WLLL4B?1?H1\N7_8;P7_ .EQ?X7+EYO7GQNEB]2/%#:"J6B @(" @("
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MTEK-.CX7GS>S_ K+Q$QQ0X_=N7-RV>>3S6X]G%CO.^U>FMOTJ^>&SU2].("
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M,>6L?B[;Z[9Z=@G4/9)(Z1@C>.A;N]UPUZ@C0[62UJQK$:M;'6MO6G1M2O\
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ML6696=GI392W(ZS;,9Z[ ]W1K3YA@&OFIOEM?>BF.M-T-D*I8(" @(" @("
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M+4K6 =1*V)NX'QZ'\"QFTSOEM8.[^6P3KCQUI/@K$,CT"Q;P@(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @QG*UO0MN('ZN7WV
MGZ?,(TLM=+>-8HI$&18:UZU;T7']9#T^DM\BC=Q6UA)(N$! 0$! 0$! 0$!
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M&Q0QMZ!K&#0 ?4%SGW.M8K$1&R(5D9" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(&B"WO3_#U991]H#1O^
M<>@1C>VD:L31SGWP.HZ$=01X@H,BQ5_XF/TI3^O9_P X>U&[CR<4>%(HN$!
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M53TCJ?'#;CZH(T(AC!'^B%BE<H" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @("#'<ICC7<ZQ"-:[C[S1^03_B1IY<>F
MV$:B@0>FO<QP>QQ:]O5KAXA$Q.B>Q^6;/I#8T;-X!W@UW_E1MTRQ.R=Z41>(
M" @(" @(" @(" @(" @("#7_ '![IXCA49I0@7^0O;NAH,=H& ^#Y2/LM_I/
MDK:8YMXG [V[ZP\C'#ZV28V4_+;JC\(<RYC-9;D.1ERV;LNM7Y>FX]&1LUU#
M(V_DM'_G6Y$1&R'R7F>:R\SDG+FGBM/T1'56.B/Q]*Q4M809EVZ[>V^>9/\
M7;H>.TWC[PL=092#_8QD>9_*/D/I6%\G!XW?[G[FGO"^MM8PUGTI^U/V8_\
MM/1NWNKZ=.M0K14Z<38:L#1'##& UK&M&@  6@^PTI%8BM8TB%=&0@(""$Y;
MQYO*\!<P#[<M*&ZT,EG@#3)L#@2!NU&ATT*#%7]E>$NXY]PBFUMH0"'[X#&_
M&;QU]0NTTW$_U*=1&V^P^#M04G,S&1KY:I RH_)0R!DDT,6H8'M'0;6Z-&W3
MP]J:B[N]D^-S\4AXG4LV*E=EP9&:X"V2Q-.&.CU>7C331W0#P342'".V4/"<
MC9R$6;OY/XB 5_0N/W1L =NW- \_)0,\0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'QS6O:6.&K7#0@^PH,;R&-
M?4<9(P75CX'S;]!1IY,?#MC<L$4" @DJ67EKZ,GUDB\-?RA_6B^F73>G8+$-
MEGJ0N#F^?T?6C;B8G<JHD0$! 0$! 0$! 0$! 06N1R5'$U)+^2L,JTX072SR
MN#6- ]I*1&K#)DKCK-K3$1&^9V0T1SGOI8M^IC.$:PUR"R3,RMT>?+]0QP_Y
M[EM4P]-GS[O3YIUUQ\I_<G_Z1T^.=GC:9>^2622>>1TUB5Q?--(2^1[SXN<X
M]25L/!3,S,VM,S,[YG?/CE\1 @RO@O <KSJ_Z=?6MA8' 7\B1H /..+\YY_Y
MJPO>*^-W.Z>Z,G/W^SBCUK=?Z-?#UST>-U9@\)C^.XROB,5"(*-9H9$P>/3Q
M)/F2?$K1F=9UE]?P8*8<<8\<<-:QI$)%0O8US?E/[IXF.\R&.S9GF96@@EF]
M %S]>O1KW.TTZAC24&,4>Z-[*S8.GCL()KN5=<CL1FT&LKNQ\C62O#]OOLT=
MN&FA\M%(^,[F9&X['SQX-\7'LY<DH8K*_$M$KFL9*?5=#M);J8_<!/AXJ$HN
MAW+S..P=9M?%2YDT\'6SN0NVKC&3>C,Y^\']6 ]X#?=T U1"[F[A6<=E\M-4
MK6,DRS9PD%&C+.R.-GWI7W#T_<]TZZ;MSCJ?8I%]'W)R4D8Q;<$#R]V1FQ;,
M6+3?0W00BPZ4SEOV-CA^3KKT4"WO=VGU*564X@0WG6;-'),MVA#4K6*1:'Q?
M$!CFET@<'1ZZ CS"D7^1[B24:/*+C<<)?W<CHR-8)PX3_'1LD(WM:0-F[34:
MZJ!=1\VOW,I<;C<.;'&L7.ZIE<P^PV(Q2Q,#Y2R$C5[(@='=02?#5!C^9YUG
MLAPW(\ABQ-C%X%\$=K$Y6"W&VW)&;$;6AT98[9ZC3J/M>[X]5(O;/<S(5;EO
M=@B_!4,K%A[F1%EOJ!T_IACVQ;=7:&0;AK]2@4W=TK4V=LX.IC(GN=)9J8RP
MVT'!]NJQSP)!LVM8[8?>:YVT]'(E&XONOE*_&,!/EZ]:QR'+0RVM\EEM.J:T
M+]HD>[80U[R=K6 'KYH-D\8Y!4Y1@ZF=I-?'!;:3Z<@T>QS'%CFGVZ.!&OFB
M$N@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @^$!P((U!Z$'PT00%_$OA)FK#=%XNC\VCZ/:$:F3%IMA%HUQ 0>XII8'[X
M7EC_ &C_ !HF)F-R6K9QPT;:9T_UC/\ &$;-<W6EH;,%ANZ%X=] /7\2-B)B
M=RJB1 0$! 0$! 0$%CD\QC,-7?;RMN*G68"72S/#!TZ^:1&JO)EICK-KS%8C
MIG9#4G*>_P#BZQ?6XG4.2G'079M8JK3[0/M._ MBN">G8\;SWS7@Q^CR\=K;
MKW4^GI_9AI;D/*.0\LL_$\AO/M[3K%6'N5H_\R,=/PG4K9K6*[G@.=Y_F.<M
MKGMQ=58V5CR?EG5$J6D(/A( ))T ZDGP 0F=&?\ ;WM7D^:OBR60]2AQ@>\9
M]-LMH#\F+7J&^U_XE7?)%=D;WI>Y^X<G.Z9,FM,/_:_BZJ^'?/1UNGL7BZ.&
MHPXS&P,KT:[0R&&,!K6@?X2?,K2F=7UC%BIBI%*1%:QNB%XH6B"$Y'Q?'\E9
M4-J2:M<Q\OKT+U1_I6()"-KBQVA'O-):01X((_%=O\)B,C3RE>2S)<I/NR1/
MFE]3<_).#IB_4:N.HZ(,1H=KLLWD56S:M5Z_'<?<EOTZ-6:R\!TS7@L9#*=D
M(.\N=M+NOAH@RB#MKQZO3L4F/LF&UB8\#(3+[WPD._:0=OV_?/O(/I[;<?-@
M62^P9!-CK('JZ#?B(_3@'AX$?;]J#W=[=X.ZZY*9K4%RW>.4CNUYC%8KVC$V
M$NA>![H+&Z%IU!04INVV%?BX<57N7Z<#/6-I]>T]LEOXH[IC9+MPD,A\21KY
M#0(+?(=I^,9#UXFON4J-JM7J6*%2P^.N]E,!L+G-ZZN8T!H)023^"8@YLYR&
M:U6?(]L]NA7G?'2LSL;L$DT(Z.=MT#O)WGJ@CSVLX\:5[%BU?;B+C#%'CA:>
M:U9CI6S.$##J&ZN:/;IY*1?3]O\ !6*MZI(ZQZ.1R,67L:2=?B(#&6AITZ-_
M5C4*!0J]M\)4OUKL5FX8:5F:Y1Q[IR:D$EEKVR!D9'1KO4<=-?$H*4/;#!U<
M?3HTKF0K2XY\IQUZ*R6V:\,^F^!C]/[+I]D@H,MH4H\=3AI1/DDC@8(VOF>9
M)'!OFYSNI)\R@N4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 01=[$,G+IH"&3'J6_DN/T^Q%-\43MC>@I8I(7F.5I8\
M>11IS$QLE\:USOL@GZAJAHH6+5.H-;=F&N!X^K*QG_I$(KM>M?6F(\<H>SS;
MAU0[;&=I-</%HE#C_P W59QCM.Z'/R=Z\GCG2V6D?M0L7=S^!PNU;FXRX>#H
MVR'_   ++LK]36GO_D*_^VJXB[U<1BT!RKI&^Q]>37\8"GL;]3./F7DH_P#9
MYI7\'>_@#@!-D?3/TL>/\(4=C?J75^9N[YWY(A(Q=WNW,I ;GZXU&I+]S /K
MW )V5^J6U3O[N^V[-3Z=/QIFIS7B5YC7U,U3D:\[6:3-!)^HD%5Z2Z>/FL.3
MU;UGQ6A/*&RI3V(*S/4L2,B83IND<&#4_22$$?/R7C]4Z6<I5B)\ ^9@\M?,
MIHJMFQUWVB/+#'K_ '<[>X_<)<W!*]NNK(-97:CRT:/$^2LC':>AR\O??(XI
MTMFIKU:ZSYF(Y3YA^.PMTPV-MWY.NAD K1CV$EVI_H5D8+=.QQ<WS;RE?Z=;
MY/)PQ]-M&"YGOIS?);F8YM;$0'4:Q-,\W7_*DZ _Z*MC#6-^UYSF?FKG,NS'
M6N./:M^2(^B6O<ED,CF;!MYBY/D+)Z^I9D,FGU-/NM_ %;&S=L>7SY<F>W%E
MM-Y_2G7Z(W1Y(6Z*Q 05*U:U>M14:$$EN],0(:T#2^1Q/T#R]I/1/#+*E+9+
MQ2D3:T[HC;/_ ,>&=C>7 .QHADAS'-MDT[/?AP[3NA8?(S'\LC\WP6M?-KLJ
M^B=T_+$4F,G-:6MT4CU8\?VI\S>#&,C:&,:&L:-&M T  \@%K/>/2 @(" @(
M" @U!B.<VN.6;YS),V!L9C-PONRO<Y]>:II+#"-20&/8'AH]O@B7G)=UN28R
MA2MR8NH^5E&+*9NJQUA[J\5EY]*/<UA;&\QZ.UD.A.H302[^X]^#D\V-R-.'
M'X=C7OK?$F=MNU$R$R^K7>&&!^[3:(]^[VH//#.YMODF7KT+F/;%6R<3YZ,M
M9ME_H!C0_P!.R^2-L9+FG4.C<1J-$&S$0(" @(" @(" @(" @(" @(" @("
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M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M>0^U\CM7%:MK3:=KZ+R?(8.4IPXJQ6///CG?*?6+>$! 0$! 0$! 0$! 0?-
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M/U'.<'AOZS9^5M#=4&1]CLKDLSP2&[E;DUZTZQ.WU[#B^0M#N@)/L21LA0"
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @C\WA<7R/%7,%FZL=[#Y"%]:[4F&K)(I!H0=.H^@CJ#U
M"F)TG6$3&KA[N#\D'*Z-^:UVUR5?+8=SR^OCLC)\->@!)(:)M/3D#?)QVN^A
M=&G-1^<T+\K/YK'^-_)=W@S.18.3RT<!1U L79K(R-CTP>HC9$2''3P#GM"R
MMS5(C8QCEK3.V7</;3MMQKM5Q:MQ7C,);6B)EM6Y='6+5EP]^:5PTU<=/#P
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MUVZG3[7M03R @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
&@(" @__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>camp-20241231_g6.jpg
<TEXT>
begin 644 camp-20241231_g6.jpg
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M;1/ OC?Q =$\%_$;5;.!=.U2]+ND:E%E,T"2LC"-W0!L<A<-M]4^/W[16B_
MN\\(>&QX<NM<U_QSXGAT7P_HEC*J22LP+S7#%ONPPQ*9)'P<# [B@#T6BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BO-?VL/VIOAG^Q[\';SXQ?$Z6XD@BF2UTS3+
M% USJ5Y)GR[:%20"QVL23P%5F/2O"++XU_\ !9+QKHZ_$;PG^RI\*M!TJ>+S
M[7PAXG\073ZT\9&51I$=(8Y",<.JE2<,%((H ^P:*\%_9(_;;B_:U^%_BFZT
M;X>7/A_XB>"IYM/\3^ ]5N!YEEJ*J_EIYAVYBD=&4,0I!1P<;<F'X@_M>_$G
M]FK]A>;]J/\ :G^# TWQ3IL(&K^#M"U.&5(YY;W[/;H)Q)(@5E>)V8,Y4,V
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MNS2-:+]C^RED7 DW[B^9%XVXZ\UZ90!X/XPMO G_  3[^&.HZA^SM^ROXO\
M%DOB;Q/<:CJ&B>#8Y;ZXEOI8BTEU/)/(S)&?*5>-V&8!4Y->(_\ !+7P]H?Q
MN^!WQS\17GC*QM/$_P 4/&.K3^*O"=C%-')X1ENDEC6VECF2-S*"TA+A=K;,
M DHV-_X6_P#!3_2_@WXB\6_!S_@I!J=IX$\8:#KEPVC7MOH-VNG:YI/'DW%J
MR"4L>N03DY4#Y@ZK7_X)Q:1XB^+W[5GQM_;HTOP7J'AWP-\0)=.LO"%MJ5H;
M>75DM81')?\ E'!"N4W*W<S.,Y5J .$\-?!S]J7XD? KX1?L%>*/V;=;\.R_
M#OQGIMYXM\>W5U;'1I=-T^:1TDLI$D,D\TRE,)Y:E"3NP,E?2/AG\8?A9X^^
M/'BS_@H5\;_B#I&@_#_PO--X)^$E]K5\D-O<!7/]HZC$6.'>>9#%&5^8Q0."
M,9KT/_@H'\4/%VF?#_1_V;_A!J!A\>_%[4V\/Z#-'DMIUF4W:AJ) P=L%MN.
M0<AW0CI7D7[2G@+X1_LR?M)?LM:9XXBL=+^$/@ZPUK28+S6M@T^QU,V*+:2W
M;N/+61RK,LC]'#OD<F@#[!^'GQ)^'_Q;\)VWCOX8>--,\0:-> _9M3TB]2>&
M0@X8!D)&0>".H(P0#6W7R7_P33DT;7/BW^T'X]^%*PGX;:W\1H'\(W&GH%LK
MNYCM0FH3VV/E:-I=GSI\K%>"<5]:4 %%%% !17-_%#XQ?"GX)^&W\7_%WXBZ
M-X;TU,XN]9U".W5R!]U-Y!=O15R3V%> :3_P4FO_ (X>);;0?V+?V8O&'Q'T
MTWR1ZAXTO(O[&T2&'>!(\5Q= &=U7<?+"J3Q@G- '<?\%"OVFO%G['_[*7B'
MX^>"- T[4]2TBYL8X+/51)Y#B>[BA8MY;*W"R$C!Z@58_87_ &OO"G[:OP T
MWXMZ)!'8ZK&QLO%&B!R6TW4$ \R/GG8<AT)Y*.,\A@/+O^"X'_*-SQO_ -?^
MD?\ IRMZ\U^,&EZE_P $U/VB?#_[<'@BPF/PK^)%O9:9\8M(M(R4T^]=1Y.J
MJB],LQ+''+&1<[IUP ?0_A#]JSQCXA_X*'>*_P!CVZ\.Z8FAZ!\/K?7[;4XQ
M)]KDGDFMT,;9;9L F8\*#P.:M?MY_M3^(/V5?A!I^M_#SPW9:YXS\4>*+#P_
MX-T._=A%>7MQ*!A]C*VT1JYR"/F* GFO'/@YJFFZY_P6S^(&MZ-?PW=G>? O
M3Y[2ZMY \<T3W%BRNK#AE((((X(-</\ M+?M/_ +Q'_P5I\+>'/CC\5=*T#P
MA\#] FU!3J<Q$=YXANEC*H-H.3%&\+@_PO"X[XH ^J/V%/VI%_:__9OTCXP7
M^D0Z9K1GGT_Q-H\&[%AJ$$A26+#$LH(V2 $DA9%R<UD?MI?MO:9^RL/#W@+P
M?\/KWQQ\1O&MTUMX/\%Z9,(WN2N-T\TF#Y4*YY;'.#T57=/FO]A/]I/X)>$?
M^"F?Q-^!_P &OB7IFN^"/BP@\4^&I=.F)BMM95"]Y;@$#:S@3OC'W88@*['P
M@L7BG_@O%XK;Q@HDD\-?!>'_ (1-9_\ EDKRVOFO'GOFYN5X[.U &U>>/O\
M@MKI.F-XZN/@E\#=0MDC,K^#;#5;]=3*CGRUG>7[.9,<9W%3V%>O?LA_MF>
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M#&_WD20C<JG R <'%&O^'?#_ (JTF70?%&AV>I6,X GLK^U2:*0 Y&Y'!!Y
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M<&H:;<#_ ):031AT)'8X89'8\4 ;%%>8_M;?MA_L]_L-_"&7XY_M,^.7\/\
MAN.^CLEO(M+N;QI+F17:.)8[>-VRVQL$@*,<D5^7/[2W_!W_ /!+P]]HT?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***RO''C?PE\-
M?!^I>/\ QWK]OI>C:/9R7>I:A=OMC@A099C^ Z#))P "3B@#5HKXXT'_ (*/
M?M6?'J&3QA^QU_P3PUSQ9X,29A9^*/$WBVTT3^TT4D%[>&<99"0<,&;T(4@B
MO2/V4?V_?"/[1?CC5?@?X[^&^M?#GXF:%!Y^J>!_$N#(\/'[ZVF 47$8W*<[
M5.&# %?FH ]_HKY6^-W_  40^+7@;]J_5_V3/@C^QS?_ !%UG1O#L&LW4]EX
MQ@L"+:3RP6V30D85I47[Y)W9QUK!\:?\%,OVF?@QH;^/OV@?^"9WC+P[X3LW
M7^UM<TSQ;9ZFUE&6 \QHHXUPHSU9E7IR,T ?8]%>"_M1?MY^"O@!^Q_:_MC>
M#/#?_"9:'J(L)--MH-0^QF>&Z("OO:-RA4'E2N000<$5WO[,O[1/@#]JKX):
M%\<?AO=;M/UFU#2VKN#+97"_++;28Z.C@J>Q&&&0P) .]HKQ'2OVQ;G7?VK?
MB-^RMHOPKFN=0\!>#[?6[>_35@/[5DFBC=+98S%^Z.9 N\LPXSBO#/B[_P %
M5_VJ?@+X%N?B7\7_ /@F+XAT+0K.2..YU*[\?VQ2-I'"(#LMB>68#IWH ^X:
M*^8?@W^VI^V#\2O'F@Z!XM_X)M^(?#&@ZO<QK=^)KCQK;3Q6,#C/G&-8%9P!
MC@$'FO1/VR?VROA%^Q3\([SXF_$S58I+LQ.N@>'H[D)=:O<@?+%&,$A<D;Y,
M%44Y.3@$ ]:HKE/@3\3O^%U_!'P?\9/[$_LS_A+/"]AK']G?:?.^R_:;=)O*
M\S:N_;OV[MJYQG SBNKH **P?BE\3/!?P9^'6L_%7XB:RNGZ)H&GR7FI7;*6
MV1H,D!1RS$X"J.68@#DU\M?\/-?V@Y? )_:!L_\ @F]XTD^%GV7[</%!\4V*
MZB;#&[[4-,QYI39\^=^W;\V[;\U 'V'17A_Q4_;M^%_@O]EC1?VHO &G7/BZ
MT\6W%E9>"]'LI!!-JU_=R>7#:EG!$+!@X<L"4\M^"0 6?L__ +67CWQK\;]5
M_9D_:$^#$/@?QS8^&XO$.GV^G^(%U.RU/3'F\EI8YA'&5>.7Y&0K_M D4 >Y
MT5Y7X/\ VC;WXA?M4^*/@'X-\*Q7.B>!]#MI/%'B=KL@0ZK<G?%I\<87#D0#
MS7?=\A*J5R<UZI0 4444 %%%% !1110!!J6FZ?K.G7&D:M9QW-K=P/#<V\R!
MDEC8%65@>"""01[U\K_\$X-2U#X&>,/B'_P3U\67DCR_#C5VU/P-+<.2UWX:
MOG,L&">7,,CM&[= 9%4?=KZOKY-_X*'VEU^SU\4_AQ_P4-\.VTGD^#-27P_\
M1E@0DW'AR^D"%V Y;[/.RR*O]Z3)Z4 =3_P5D_9<_P"&Q_\ @G?\5/@39:=]
MJU6]\,2W_AV)4R[:G9D7=JBGJ"\L*QDC^&1AR"17\@E?W 6EW:W]K%?6-S'-
M!-&LD,T3AE=",A@1P00<@U_(I_P6 _9<_P"&/?\ @H]\5?@Q8Z=]FTA?$DFJ
M^'(U7"#3KX"[@1/41K-Y.?6)AVKTL!/>'S.'&0VD?-5%%%>D<(4444 ?L!_P
M;7^*/^$A_9$_:<^$\LGSZ;=^&M>LH\]=TES'.P'LL$8_X$*^K*^#?^#7?Q1Y
MO[2?QG^$$TF$\3_ W49K=,_?N;6ZMO+&/4+-*?\ @)K[RKWLBE[E6/FG]Z7^
M1X6=Q]^G+RM]S?\ F%%%%>\>(?8?[('Q<^&?P;_9EA\1_%3QQIV@6%SXIGM+
M>\U.Y$4;S-&KA QXR51S]%->AP?MN?L?W#^7'^TOX*!QGY_$4"C\RP%?"'[7
MG_*-GP[_ -E=_P#<?<U\25\TN'\/F-6I6E-I\S6ENAXO$'B1F/#.-A@:5"$X
MJ$7=MWU7DS]X],_:?_9IUG TC]H;P-=$]!;^++-S^0DKI]#\9>$/$ZA_#7BK
M3=1##(-C?1S C_@!-?SZTJLR,'1B"#D$'D&E+@^D_AK-?*_ZH\VEXU8M/]Y@
MHOTFU^<6?T-T5^!GA?XY?&OP0RMX,^+_ (HTDKT_LW7[B#'_ 'PXKTSP=_P4
MM_;>\%.GV#X]ZE>1K]Z+6+:"]#CT+31LWX@@^]<=3A#%+^'4B_6Z_P SVL+X
MT91-_P"T86<?\+C+\^4_:>BORV\#?\%P?VC=%:.'QW\.?"NN0J?G>WCGLYW_
M .!!W0?@E>X_#S_@N'\ ->\NW^(_PS\2>'I7QNELVBOX$^K QOCZ1FO,K<.Y
MM1U]GS+R:?X;_@?4X'Q+X.QS2^L<C[3BX_C9Q_$^V**\J^&'[;_[)WQA\N+P
M+\=M EN)<".QO[K[%<,?017 1V/T!KU165U#HP((R"#P17D5:-:C+EJ1<7YJ
MQ]GA<;@\=3]IAJD9Q[Q:DOO5Q:***S.H**** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ KXO\ ^"YFK:F?V4_"WP\M[Z6VT_QG\4](T?6Y8VP#:E;B<J?^VD,;
M?\ K[0KQW]O']E*R_;+_ &:=;^"W]JIIVJ2-'?>'=3D!VVFH0G=$[8R0K9:-
MB 2%D8@$@4 >KZ!H.C>%M"LO#/AW38;+3].M([6QL[=-L<$,:A410.@"@ #T
M%?%O_!3JTM_ '[8O[+?QP\*1BW\1S?$B/P[=3P#$EWIUS+#')$Q'50LLP [>
M>WK5OP#_ ,%-?BA\$O#-M\-?VW/V1OB?9>--*B6UGUGPGX:&I:;KC(-HN(94
M=5W/C)52R@D\C[HJ_#3P!\?_ -OW]L#PG^U?\</@_JOP]^&GPR6:?X?^%?$J
M>7JFJZA)M_TR>'K"%*1N >ABC"[P7:@#@OB=\<O&7P!_X+0>._%W@CX ^*/B
M+=77PDLK.31O"<0>X@C:6S<W# @_(#&J'WD6K?QN_P""B/Q\_:OMO$/[!?PJ
M_8QUCPKXZ\9>'KBQN$^(NMV^G_9-/GC:.:XCAE"M<8B,A'EY(P6 ;:5/J?PY
M^'_CRS_X+3>/_B1=^"=7B\.W?P;MK2UUZ3395LIK@7%@3"DY7RVD 1CM!SA3
MQP:Z3_@IK^QYK'[2GPCMOB%\())-/^*?P]N/[8\"ZO9'9</)&0[V@;_IIM!7
M/ D5.BEL@'AG_!2SX&']FC_@C!I?P)DUD:C-X:GT:UNKY%(6:?[3OE90>0F]
MFV@\A<9K7;/_  2F_;56[&;7X#?&[4P)1TM_"OB)AU_NQPR?@-F>UL,YO[;G
MC?XU_MF_\$BEU>;X">+[+QU)K&FP:_X3/A:[2[%U#,OFS10&/>T# B16 (4-
MM)RK5]D_M(?L]> OVI/@?KGP-^)%GOT[6K+RUN$0&6SG7YHKB//1XW 8=C@@
MY!((!\Y? D@_\%JOC@0?^:;Z+_Z+LZO?\%R_^4<?BW_L+:3_ .ET->1_\$G_
M (._M5_#+]N#XE0?M->%]8>?2/!-IH%EXKN=-F6SU:&TEABMWBN&7;,3 B'.
M=V!\PW!J]P_X+,^!O&WQ&_8"\4>%/A[X/U77M4GU/2VATW1M/DNKB15O8F8K
M'$K,0 "3@< 9H ^D? 7_ "(NB_\ 8)MO_12U\J_\%%OV-?@+#\'?C=^UGJ_A
M>75_&VH> YX[/4-8N3/'I$<5FL 2SB/R0;@A9F +[I),, Q%?5G@F":V\&:1
M;7,+1R1Z7;K)&ZD,K"-000>A%>9?\%!/#VO^+/V)?BCX:\*Z'>:GJ-]X,O8;
M+3]/MGFGN)#&0$2- 6=CV !)H N?L)_\F1_![_LEV@?^FZ"O5:\S_8LT76/#
M?['?PI\/>(M)N;#4+#X;Z);WUC>P-%-;S)80J\<B, R.K @J0"""#5;]DK]J
M"+]JGPAXB\3?\*RUKPG<>&_%USH%[I.O+MN/-AA@E\PK@%599UP",\9[B@#M
M/BK\*OA]\;O .H?"[XJ>&(=9T#55C74--N'=4F"2+*N2A###HK<$=*\-_;Q_
M:I\(_LU?">']G[X6Z#_;WQ&\7Z2VB^ ? NEIYLV'C,*SRI_!;QC)RV-Y0@'
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M@^F7,J+^,D,8_&OU'U73YM)U2YTJX_UEM</$_P!58@_RK\2_^"4WQ _X5?\
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MC-^RKO[$GHW_ '9=?1V?D]SWRBBBO"/T **** "BBB@ HHHH **** "BBB@
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M1_Z;;FOB:LLM^"I_CE^9^/\ B+_R4"_Z]P_(****]$^#"BBB@ HHHH ****
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MLUNF?T1A<5AL;AXUZ$U*$E=-.Z:"BBBH-PHHHH **** "BBB@ HHHH ****
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MN7FOHUO:VZ78_6O"WAG/.'/K?]HTO9\_L^7WHROR\]_AD[6NMSX.TKQQH?\
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M%64C(+$R2#/.V1,@'(K!_; _Y2Y_LO?]@[Q#_P"D<M?:-<WXA^#_ ,,/%GQ
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MZS^RO^T'^QY<^$/V6] U7PYX F34="BM%5[:ZM6D4^>T;.\C*^9BP<DG<2:
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M8)K.62:-5+3.-BJA;<%!.!7Z#44 %>/?MR?MO_ _]@#X!:E\?/CCK)CMK?\
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M-]YY(C#,WO-CM7T=\+].\-^+=1U+X5^-[-;G0?&>B7>AZS:N?EF@N(F1D/\
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M7_072_\ !D?\SW/]4^*?^@"M_P""I_\ R)['17CG_#?W[)'_ $5G_P H-_\
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MZ'G<XRL2MS'&>BM))GX;HHKZJG3A2@H1V1^7XG$5<56E5J.[844459@%%%%
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M93CO[+S6AC.7F]E.,[7M?EDI6O9VO:U[.W8_'.BOV,HK\P_XA;_U%_\ E/\
M^W/V[_B.7_4O_P#*O_W(_'.OV,HHKZWA;A;_ %:]M^^]I[3E^SRVY>;^\[WO
MY;'P''/'/^NGU?\ V?V7LN?[?-?FY?[L;6Y?.]SYM_83_9;^*WPI^)/Q:_:(
M_:$&G'QE\2O%GG0Q:=>&Y2RTF%2+6 2%5Y <H0/X88^3VW_^"C'[*=Y^V-^R
MMK?PE\.R6\/B*&>#4O"UW=2E$@OX&RN6 )3?&TL>[' D)[5[G17UI\ ?'WQP
M_8R_:G^*6D?"O]I_P%XZT7PQ^T!\/M 6PU62\D:XTO6XRA6>"1E0D*[-*Z_*
M<>>P."%=<WQ1J?\ P6G^,WAB[^$M[\)OA3X#CU:U:SU+QK!K<MR88G4K(]M"
MLDC*Y!.W>K8SU!^8?:=% 'QA^U#_ ,$UO%%]_P $S]#_ &'?V=+VSO;[1-0M
M+@WNM7'V9;IQ-)-<S$@-M+22NP3G (7)QFM7_A-_^"W'_1&/@%_X-=1_^/5]
M=44 <]\*+KXFWOPXT:Z^,VFZ39^*I+%#KMKH4CM9Q7'\2PER6*>F2370T44
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
M^-'_  =(?\%'CHNBV'_!.CX4Z]BZU%(-6^)<UM)S';Y$EGI[8[N0MPXX.U8.
MH=A7ZI?M:?M*> _V/_V</%_[27Q)G TKPGH\EVUN) K7<_"06R$_QRS-'$O;
M+C/%?R.?'7XT>//VB_C)XF^.OQ/U0WFO^*]9GU+4YN=HDE<ML0$G:B#"*O15
M50.!7J99A_:5?:2V7Y_\ ^9XDS#ZOAEAX/WI[^2_X.WWG)T445] ? A1110
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M$W-)]OC,O_IKGKXJK[5_:N_Y1N:5_P!EG7_TUSU\55[.7?!4_P <C\$\1/\
MD?Q_Z]P_(****] ^$"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *^D/^"8W[5Y_9G_:!M],\2ZGY7A3Q88]/USS'Q';2;OW
M%T?38S$,>R2.>2!7S?16&*P]/%X>5&IM)6_KT/0RK,L5D^8TL;AW:<&FO/NG
MY-:/R9_0YUZ45\R_\$KOVH#^T+^SG;^&O$>I>=XD\&>7INIF1\O/;[3]FN#W
M.Y%*$GDM$Q/6OIJOR+%8:IA,1*C/>+M_P?F?V?E&9X;.<MI8V@_=J)/T[I^:
M=T_-!1117.>B%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MU;_RC=TO_LM"_P#IJGKXKKZ#+O@J?XY'\^^(G_(_C_U[A^04445Z!\(%%%%
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M38^)'Q^^ /C#^P/%N@?V/_9.K?V?;W7D>?K%C;2_NKF.2)MT4TB_,AQNR,$
MBH0=2:BNNAE7JQH4959;13?W*Y]045_,!_Q$1?\ !8K_ */ _P#,?^'O_E?1
M_P 1$7_!8K_H\#_S'_A[_P"5]>E_9.)[K\?\CY[_ %JR_P#EG]R_^2/Z?Z*_
MF _XB(O^"Q7_ $>!_P"8_P##W_ROK^G^N7$X2IA;<[6O8]/+LUP^9\WLDURV
MO>W6_9OL%%9OC#Q=X9\ >%-2\<^,]9@T[2-'L9;S4[^Y;$=O!&A=W;V"@GUK
M)^#_ ,:?A9\?O \'Q(^#GC6SU_0[B:2&+4+(MM,D;;74A@&!![$#J#T(-<IZ
M9U%%<]\4/BS\,_@IX.N/B!\6O'.F>'M%M2%FU'5;M8HPQ^Z@)^\YP<*,L>P-
M>._#[_@JM_P3Z^)_BV'P1X1_:9T=M1N)1%;QZE97=A'*Y. JRW4,<;$D@ !N
M2<"@#Z#HJOJNJZ7H6F7&MZWJ5O9V5G \UW=W<RQQ01J"S.[L0%4 $DDX %?/
M%W_P5T_X)RV7B8^$IOVHM(:Z$OE^;#IM]):YSC/VE8##C_:WX]Z /H^BJ/AK
MQ-X<\9Z!:>*_"&O6>J:7J$"SV.HZ?<K-!<1L,AT="593Z@XK'^)OQE^&'P:M
MM)N_B=XSM-'37=:M](T<7)8M=WL[;8H45026)SVP "20.: .FHHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_)O\ X.L_VOO^%??L
MX^$_V.?#.J;-1\?ZG_:OB**-^5TJR<&)''I+=%&4_P#3FXK]9*_E3_X+2?M7
MS_M@_P#!1KXA_$&SU/[3H>AZFWAOPN5?=&+"Q9H0Z'^[++YT_P#VW->AEM'V
MN(N]HZ_Y'@<18OZME[@MYZ?+K_E\SY7HHHKZ0_.@HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *])_98_:@^(G[)OQ5M?B9X!G\V/ AUC2)92L&I6I(+0
MOC.#QE7P2C '!Y!\VHIIN+NB9PC.+C)73/WM^ 7QY^''[2GPOT_XL_"[5_M.
MG7H*3028$]C<* 9+:= 3LE3<,CD$,KJ61U8]G7XA?L5?MD>._P!CCXHKXJT(
MR7V@:D8X?$_A\R82^@4G#KGA9H]S&-^V64Y5W!_9WX6?%'P-\:/ &F?$[X;Z
M['J.C:M;B6TN8^".<,CKU1U8%64\JRD5[F%Q*KQL_B1^?YQE4L!4YX:TWMY>
M3_0Z"BBBNL\4^!O^"HO[/H\(>.K7XZ^'+';I_B)Q;ZP(UPL5^JY5_;S8U)_W
MHG).6KY8TG5=2T+5+;7-&OI;6\L[A)[2Y@<J\,J,&5U(Y!! (/J*_7CXT?"O
M0OC7\+]8^&7B'"PZI:%(I]N3;S AHI0.,E'"MCO@@\$U^2/C'PEKO@+Q7J/@
MOQ/9&WU#2[R2UO(2<[71BIP>X.,@C@@@CK7'5@HRMT9[^"KNI23OJOZ3/W9_
M9"_:!L?B?X \$?M!Z0$1-2M(;F]@@SMAF!,=U I/)"2++'GOMS7X7_\ !>7]
MF"/]E?\ X*A?$GP[I-B(=#\67Z^+?#Q1<(]OJ.9I @Z!$N?M,0 XQ%^%??/_
M  1)^.9U#P_XH_9VU>\+2Z?(-;T1&+,?(<K%<H">%59/(8*.IGD/K5;_ (.A
M_@%_PL+]F;X/_MFZ/9;[SPOJ$_@OQ/,BY8P2J;BR9CV5&BG&?[UT!WY_(,JH
M_P!B<1XG+GI%^]'T>J_!I?)G]98K,%Q1P=@LXWFER5/\2T?I=IM>4D?C%X!\
M6WO@'QWHOCO3,_:=%U:VO[?!P=\,JR+^JBOZ8OVOXK)OC_K6KZ7()+/5(;2_
MM)1T=);:)]WXDFOYAZ_I)O/%'_"Q_P!GCX$?%KS/,?Q-\#/#=U=OG/\ I(M
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M$?Q5\)?$NDSV@9M1UV\LH[FU4KT9Y2L]LX';*./:@#=_80_9?\/?LH_"74/
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MMOM@/C'8#%<;7V%&'LZ48]D?D>,K/$XJ=7NVPHHHK0YPHHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ K[1_X)??\%%7^!NIVW[/WQLUP_\
M"%WUP1HVJ74G&A3NV2K,?NVSL26[1L2_ 9S7Q=15TZDJ4U*.YAB</2Q=%TJB
MNF?T/JRNH=&!!&00>"*6OS>_X)7_ /!1YO#SZ=^RW\?M>SIK%;;P9XBO)>;,
M]$L)V/\ RQ/ B<_ZLXC/[O9Y7Z0D$'!%>_0KQKPNOF?G.88"KE]?DGJNC[K^
MMSY#_P""IG[/W]N^&;+]H#PY99NM(5;/7E1>7M6;]U*?]QV*G@DB4=DKD?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MR^,__!"#_@I+\%OAU?\ Q3N_A#IOB;1](@:;67\%^)+74Y[!%&YB\$3^:VT
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M%\4"YB4GE(KF!,#Z;X)#]2:_+ZON?_@A9XO:Q^,GC?P%YF%U/PU#?[<]3;7
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ML?L!7/\ P20_9RFT7]D_Q);6WB'P]XK3X/PR>-IG/A*=;NW6>2Y/_+\'D*,
MWW0I'>L)N;Q,)2B][+;:S\_FSNI0HK+ZM.G4C;E3>][\T=]-ELO-WZZ>?^#?
MA[;_ +<'[-G[('B;X+?&CP/H$'P-GNM/^*5GXD\:6>DS^&-NJQW?]J^7<2(T
MT4L2;]\(<[U"XR&VV->^+OPO\-?M&_M*_P#!;+PM!#-I=IXON_#/[/QN+;:F
MK>*+J#RCJBQN/F2VM1)=D,!EIXNCC%?G)\*/A?XV^-GQ-T#X0?#?1GU#7_$V
MKV^F:19I_P M;B:0(@)_A7+9+'@ $G@5^H/[/^O_  "\0_\ !8?]G[_@GGX>
MGT_6/AA\ DU+2M,:Y"_9?$7B^.QN;J\U)P<@F34HHTC!)&+>,+PV*JK!4[ZW
MT;^5[O[WIZ7(PU9XCETL[Q2?]ZW+%VZ<JO)[ZV[GY9^+_#_CC1-1%YX]T/5;
M.[U)3=K+J]M+')=!R29<R %PQ).[G)[UE5^COB;XP?M%_M4?\$E_VD_&7[?>
MN:QK.N^"?BEX<'PWO_%5N5N=/UFXO)(M6T^V9P&C1+4!FMEPJ8!VC%?G%752
MFYIW6SM^%_U/+Q-"-%Q<6VI*^JL]VM5KV^X****U.8**** "BBB@ HHHH LZ
M+K6L>&]8M/$7A[5;BQO["YCN+&]LYFCEMYD8,DB.I!5E8 A@<@@$5^O/_!.7
M_@H%I/[6GA >"/']S;VGQ!T>V!U"%%6--6A7 ^UPJ,!6Z>9&HPK'<H"MM3\?
M:UO GCKQ?\,O&&G>/_ 6OW&EZQI-RMQ87ULP#Q./8Y# C(*D%64E2""16]"O
M*A.ZV.#,<OI9A0Y):-;/L_\ +N?L7_P41_9]/QD^"TGBK0K$R:[X4$EY:!%R
MT]M@>?"/4[5#@<DF, ?>-=GXA\2WW[>G_!#K5_%NGM_:'CGX/W%CXTLOWGF3
M+J6B.K7;G@'S);(22!1WNUZ]#R/[!O[<?@[]LKX=E[A+?3?&>D0*/$N@HYVG
MHHN[?<26@<]B2T3'8Q.4DD[G_@F[-I_[*7[?/B#]F77;:-O OQ6L);[P[9W&
M3!YFUDNK()C;_JV+-_TSMHL_>KDXDH1K86&-I[TW?_MUZ27W>\_\)U^'.85<
MNSFIE6(T5:/+_P!O+WH->;?NKRFSW/\ X*O163?LN7VK:5()+/4_C78WUI*.
MDB3>'C)N_,FOSEK]+_\ @K?\/[?X8?L)^"_!5O>O<C3O&6DVK7,ARTI@T:YM
MPY]21$#^-?FA7O<.3]IEJ?G^22/S[Q4AR<6S7]R/ZA1117O'YP%%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M7U!_P1_\3?V#^V]HNF;\#6M&U&R//7$#7&/S@KY?KVK_ ()U:U_8'[;7PZOM
M^WS-=^S9_P"NT4D./_'ZXLR@JF7U8_W9?D>[PO7>&XDP=3M5A]W,K_@?ME11
M17Y ?VF%%%% !1110 4444 %%%% !1110 5YE^V+_P FX^(_^W/_ -+(*]-K
MS+]L7_DW'Q'_ -N?_I9!79E_^_TO\4?S1X_$/_(@Q?\ UZJ?^D,^&****_4#
M^5PK]-*_,NOTTKY'BK_ES_V]_P"VG[!X4?\ ,9_W#_\ ;S\]/^"E?[2GPSO?
MV^/A)\#_ (D2ZG<>#_AS<#QAXPM]&TF:^>6_VM]@A>*)2?EVJQR,;+H_2N6_
MX;A^".C_ /!5SP?\>_A1)KUIX>^)FCQ>$_'HUSP[<Z>@O=P6RN<S*JL<K;H3
M_"D4AX#5]1?L)_LM_%;X4_$GXM?M$?M"#3CXR^)7BSSH8M.O#<I9:3"I%K )
M"J\@.4('\,,?)[;_ /P48_93O/VQOV5M;^$OAV2WA\10SP:EX6N[J4HD%_ V
M5RP!*;XVECW8X$A/:OD3]@/GW_@JE;_%>Z_;F_9AM_@=?Z):^+&O-?&B7'B2
M.5K%)?+M<F81 N5V[ON\YQ7/?M<?'_\ X*Z?LRZ-IM[\;/'WPTT/P;K=^NGZ
ME\0_ GAJZU!_#YERJR2PW!5AD]&5'&0!G<55O8/&O[+G[3_Q8^-?[,/QK\>P
M:(NH_#2TOO\ A8C1ZIN\RYE@@C\V#Y/W@=HF?'&W<!S7TO\ %+X9>"_C-\.M
M9^%7Q$T9+_1-?T^2SU&U?^*-QC*G^%E.&5ARK*".0* /DOQO^S!X6_94_P""
M0/Q'\!? _P 8S^)CJW@^_P!;U/Q2&!;6FN(4-Q=#:6 C:V7"@,WR*,LQRQ]H
M_P""<$OAR;]@SX2/X6,1MAX$T]9?*QC[2(@+CIW\X2Y]\UR'_!/7]FW]H3]G
M/X6^)?V7?V@I](\2^"=.OKB'P-JJW?FRW.ES,X>UN864;!@[@N6 \UTSM5<^
M>>$OV5_^"@/[!%]J'A?]B+7/"GC_ .&5Y?RW>F^!O'-U);WNB-(Q9H[>X#*K
M(3SEFP22=FXL[ &9^T#_ ,%#?^"CG[,OPWG^+GQM_8$\+Z7H-E=0Q2WJ_$*W
MN2DLC;$PD)=^2<9 XS7VSJ'A/PCXQFTCQ!XF\*:=?W>ERB[TF>]LTE>QG9-I
MDB9@3&^TE=RX."1GDU\6?$[]E7_@H_\ \%![*W^'?[7NO^"?AE\.4O8;G4O#
MW@W-_J>H-&=R@S2%XTP<X8, #@F-\5]SV\*6T"6\>=L:!5SUP!B@#Y _X)M_
M\G7_ +5W_94X?_0;BOL*OGW]CO\ 9K^)/P0^.WQU^(?C=; :=\0O'$>J^'OL
MEUYCFW"R@^:NT;&^<<<U]!4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 5_/Q_P=>^)[ZT_P""A?P_MM*OY;>XTOX36-U!/;RE'AF;5=2(96'*
ML/+4@CD<5_0/7\Z'_!U!/-+_ ,%,]/CD;*Q?"_2EC'H/M-Z?YDUZ.6*^*^3/
MG^)7;+'ZH_/3X@?$CXB?%CQ1/XX^*?CW6O$NM72(MSK'B#5)KVZE5%"(&EF9
MG8*H"@$\  #@5%X(\=^./AGXIM/'/PW\9:KX?UNP9FL=8T349;2ZMBR%&,<L
M3*Z$JS*<$9#$=#6517T5E:Q^><TN;FOJ=%I'Q?\ BUX?^(LGQ?T'XH^(K+Q;
M+>R7DOBBTUN>/47N)&+23&Y5Q*9&))9MV2223S7<_%']OG]M[XV>$7\ ?%W]
MK?XC>(]#E0+<:1K'C"\GMK@#_GK&TFV7_@8->244G"#=VBU5JQ32D[/?4?:W
M5S8W,=[97$D,T,@>*6)RK(P.0P(Y!!Y!%>T?\/)?^"A'_")'P*?VW?BL=):+
MRC:'Q[?D>7C'E[O-W;,<;<[<<8Q7BE%#C&6Z%"K4IWY9->C'SSSW4[W-S,\D
MDCEI))&)9F)R22>I)[UL>%_B7\1_!&B:SX:\%_$#6](T[Q%:K:^(-/TO59K>
M#4X 21%<1QL%F0;FPK@CD\<UB455DR4VG='J?[%7[0>G_LJ?M0>$/VAM2M->
MNHO">HG4%L/#FMG3I[V1(V,=L\X5B+>5]L<Z@$O"\JCK7G_C7Q9JOCWQEJWC
MG7?+^W:UJ<]_>>4NU?-FD:1\#L-S' K,HJ>5<W-U*=2;IJ'1._W_ /#!6WK?
MQ+^(_B7P?H_P\\1_$#6]0T#P\9CH&AWNJS2V>F&9M\IMX68I#O;YFV ;CR<F
ML2BJLB4VM@K;\0?$SXC^+/"NC>!?%/Q UO4]$\.+,OA[1M0U6::UTL2L&E%O
M$[%( [*I;8!N(!.<5B4460)M;'4?!KXT_%']GSXAV7Q8^#/C"XT#Q)IJ3+I^
ML6:(9K;S8GB<QEU.QC&[KN'(W'!%8>C>(O$'AS7[7Q7X>UV\L-4L;M+JRU*S
MN7BN+>=&#I*DBD,CJP#!@001D'-4Z*5E>X^:5DKZ(]4_:(_;>_:X_:TT_2](
M_:1_:#\3>,+/123IEGK&H%X8'*[3((QA3(5X,A!<CC->5T441C&*LE8)SG4E
MS3=WYA1113)"BBB@ HHHH **** "BBB@#IO@_P#%[Q]\"?B)IOQ1^&FN/8:O
MI<V^&0<I(IX>*1?XXV7*LIZ@_C7ZQ_#;]HCP[^VQ\$='^/\ \&+=8/B#\.=6
MM]6;P\+@K/;W<?S2V9889K>ZB61$<?*_ .&C=%_':NZ_9S_:'^(_[,'Q3L?B
MM\,]3\J[MOW5[9RDF#4+9B#);3*#\R-@'U5E5U(95(UIU$HNG-7C+1HXL7A9
M59PKT7RU8.\9>:UMZ?D?T4?\%6_B9H7QF_X)Y_#KXK>&+T7-AXA\5:9?6LX4
MKO633;YLX/(Z]#7YJU[U-^UO\./VF/\ @F%IUG\/M1(M]-^*]O=1:5<3%KC3
M#<V6H236CY/(CG,A4@!?*FB"@#BO!:]7ARC+#Y=[)N]I-7[]G\]SX'Q+QD<P
MXD^L)6YJ<&UV=M5\G=!1117O'Y\%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !7HO[(5__9O[5WPTO2V GCW2
M Y_V3>1 _H37G5=C^SO(8?V@/ LRG!3QCIA!^EW%6.(7-AYKR?Y';ELG#,:,
METG'\T?O71117XR?W&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %?SH?\'4"X_P""F=@?7X7Z4?\ R9O:_HOK\^?^"IWAC1)OVD-,
MU>[T:UEGE\(V^)Y+=6< 7%RN-Q&>WZUY^9\04N&<*\;4IN:32LG;<]+*N#J_
M'6,65T:RI2:<N9IM>[TLK'\V-%?N+;006046<*1;,[?*4+C/7&/K5N+5M4A
M$.I7" '(VS,,'\Z^6GXSX5?#@Y/UFE_[:SZ^G]&/'/X\SBO2DW_[>C\.]/\
M#OB#5]G]E:%>77F$A/L]J[[B/3 .:U[/X._%W40IT_X6>(YPS;5\G0[ALGT&
M$K]JKB_OKK/VJ]EDR<GS)"<_G4582\:7TP/_ )5_^YG9#Z,"^UFWW4/_ +L?
MC7;?LW?M$W@!M/@)XTERVT>7X6NVRWIQ'UJW'^RC^U), 8OV:_'[9?8-O@Z^
M/S>G^JZ^U?L316$O&?$OX<$E_P!OM_\ MJ.JG]&+ KX\SD_2DE_[>S\?[?\
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M=KCI[8Z5;A_X)J_L8Q!=_P (Y)-N<[_$-_\ -]<3C]*]VHK&7&7%4]\;4_\
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M^45OQ2_[@?\ Z?-/KHP<8RQ=--73DOS/.S><Z64XB<'9J$VFM&FHO5'Y(_\
M#]7_ (*I?]'2_P#ED:'_ /(5'_#]7_@JE_T=+_Y9&A__ "%7R117W?U+!_\
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MG   KT?P?^V3\>O!?AZT\-67B.TO(--3;I4NJZ7#<S6('3RY)%+#&!@$D#
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M%2=WK=GKOA+X6_"#7?V,_%OQ9O)]83QIH'BNRLX!O"V#VERHV*,KEYOW=R2
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MLNHP=HSV#@LA/8.3VK\N[FVN+.XDM+N!XI8G*2QR*0R,#@@@]"#7[$U\#_\
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MI[R^*G2^6E2:[\BWBT%%%%?T4?PD%%%% !1110 4444 %%%% !1110 4444
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MOK)]9/NW_P !:)(****Y3U@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]84-GZ.J[P7]U3V=F9]%%%?UH?YEA1110 4444 %%%% !1110 4444 %%%%
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M"U2-=5L4?:))!;[UDE@+1KDJ5PT8PX^8'QSXG?LJ_P#!1_\ X*#V5O\ #O\
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MN8Y1FF4U?9XRC*F_[R:OZ/9_(K4445T'G!1110 4444 %%%% !1110 4444
M%%%% !1110 444 %B%49)Z 4 %%>Q_!O]@/]K3XYM#<>#O@[J5M838(U;6T^
MPVVT_P :M-M,@_ZYAC[5]?? _P#X(<^%M-,.K?M"_%2?4I1AI-'\,Q^3!GT:
MXE!=U/\ LI&?>O,Q><Y=@_XE17[+5_AM\['U>3\$<39XT\/AVHO[4O=CZW>_
M_;J9^=.A:!KOBC5H-!\,Z+=ZC?7+[+:RL;9II96]%1 2Q]@*^MOV=/\ @CA^
MT#\4?(U[XQ7T/@;2'PQM[E!/J,J^T*D+%GI^\8,/[AK]*/@_^SQ\$O@%I/\
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MHHKA/H HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
>**** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>camp-20241231_g7.jpg
<TEXT>
begin 644 camp-20241231_g7.jpg
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MN3)BFD&XLFFDZE:4EQ,Z ,A$DLS8K$R.>J/(;0\THR,C-#B24DZ'T<# >X
M              !HN\>97S;[;B^9ICT)BXW"S-MR3ARC63:V.:A+IU;,CJE"
ME+_H!F&BSN\'V3NXL;W%"CJN<B.V35LUKY!SURNR+;(R\;2E1*5TUH0%C\V%
M[P:MU<!R3+L@@Q[7,QEYXYL:*M:F^R-QB?0Y5RID9T<3_P ($PUO#=]]Y\_V
MF<S[$L(MURO:KX=LCVI$A32.P-QS6[(-3SB*F3IH;(B5[)T L;3N)O9DF#[B
M;98.BT1'$YLXPS=''EN<R*MQ]IIPFM!Z3TZSI6M: 6+5)EQ8;9.S'VX[1J)!
M+=6E"34KH*JC+B8,)!:]Y+S/[Q=[V8<ML5%FM=M1<6;DE3AREJ6Q&=-*DGXA
M%5]1<"Z"(&;%1R65>8./76;CL)-QO\>(^[:[>XHFT2)2&U*::4HS*A+41),Z
MD##D[+N\SWB,#FV:WY9MG;;=,R!Y4:SM*EFZ<AY*FT&DC:D+))U=1\(RZ0<K
M%NVJS+>"^2;HC=O$(>(1&$,_1;S,MM[M#JS7S$GI>=II(B/P=(,*JXXVT@W'
M5DALNE2C))%7ATF##P3)CK4A"'D*6M.M"241FI)^$BKQ+VP'Y&EQ9C9NPWVY
M#1*-!K:6E:24GI*J3/B0#\D38<13:94AIA3RM#*75I0:U>PG495/W 'O
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M#C:W"-Q:JZ&R2VJJB2KC0J<09B%$BOIDQVGTJ0K6DC,VU$M-3+C0RZ08>X
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MNWEAQB2[;EMI6VGY7BKEJUI(ZF1%1)?!!QE>P8
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MG0NDZJ,S,PW<
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MR/B5&#;(B\! Q*J@P      "<;_^I//?,DWJC!F&Z8WZ.VCR*-U2089,
M                        !\5VLUHOT%RUWR!&N=M>H;L.:RB0PLTGJ+4V
MX2DG0RJ7 !^VRU6NRPV[=9H,>W6]K\5$B-(8937ITH;)*2_T /%=EL[ES;O3
MEOC*O+2.6U<5,MG)2@R,M*733K(J*/A7P@/N
M
M                          $>W65WC2R**6T*+&K&NQ([4=WKS^W<UW7I
MH9>)R^53VZ@RE[B.]TI<NS.QL#4N21R9UO439FZ2C*KCK1GXU3IXRB]@&>AT
MA@IY@>)VL\_*,68<H_I4H'YMS=:J:/\ ATU]L'%L(       )QO_ .I//?,D
MWJC!F&Z8WZ.VCR*-U2089,
M                              !B;WE&,XTEE61WF#9TR5:(YW"4S%)Q
M14X(YJDZCX^ !E&W&WFT/,K2XTXDEMN(,E)4E15(R,N!D9 ,'<,WPNTS'+==
M,CM<&X-&1.Q),V.R\@U$2BU(6LE%4C(RJ0#.D9&1&1U(^)&0#]
M                                                           :
MKN;.O]LVZRJXXJA2\CBVJ:]:TMIUN=H0PHT&A-#U*(RJE-.)\ ' ^(3ME+>M
MZ5/RV7HRK )S.97!]QUVY'?WID9Q3#:5(.JS4V>@CJ2T%4U<:F<G:G=VGY%<
M]D\,GY4MUV]/0*K>D&9O.,$ZM,9:S5Q4:F";5J/B=:@Q*G P      "<;_\
MJ3SWS)-ZHP9ANF-^CMH\BC=4D&&3
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ME1L=BQF'H.0'):6F4^Z:N:R4<BUHY="\97!50&<
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M/AQ(Z&2B,C2I*BJDR,CXD##3-_\ U)Y[YDF]48,PW3&_1VT>11NJ2##)@
M
M     (KGW=RMV>Y\6XKF99#8[\S'1$@*M$EJ,45A*#0I+*^4:TZS4M2O&XFH
MP9M;%;=IG[>SB+3N;Y).7BDJ5+6]+G<QRY]J62R:GGI^50W32V7"A -3N?=<
MQ&XW2Y$B_7N'A-\N'TQ?,*CRB3:Y4[63BE'5)N)0I1$:D)5X"H:=*:"U<6FF
MF&D,,H2VRTDD-MH(DI2E)4(B(N@B(&$BW%]>>RWW^3?W6D&5@!@
M8.(SEJ<IN+TV3!7ARX[";5%:;<*>B41GSE/+,]!H/AITE7_:&<
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MG77$$E"*_"4H^! 1"^XX5,>M)>Q"C='S2089,
M                     !XDM!K-LE$:TE4TUXD1^T,6Q;8S9-EKR&6
M          8NYY+CMDBG.O-WA6Z$3Q13DRY+3#12#Z&M;BDEK_W>D!DD+0XA
M+C:B6VLB4E23J1D?$C(R >0        "/[B^O/9;[_)O[K2#*P P
M ,%#L4N-E5RR!=\F2(<Z-'8:L+JD'"BJ9-576B))*)3GW53_ -E SH
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M.VM*N*30R;:32?P:4!B5.!@       !']Q?7GLM]_DW]UI!E8 8
M&GVR+@"-QK],MCK"MQ78,-N^LH?<6^F$@U''-3)J-"2\;I2DC/A7P -P
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M!@/J 3C?_P!2>>^9)O5&#,-TQOT=M'D4;JD@PR8
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M4/&;B'4DVI:=)H4DDT4=2X@XME         1_<7UY[+??Y-_=:096 &
M    !KD&\VJ1FEVLC-FE,7>'$C/RKVY#Y<22TZ:M#3<K_P!13=#JC[G_ $@-
MC                          &MY[>;3C^*SKM>[-*O]L8-DGK5!A_24AT
MUO(0G3'/X>E1DL_8(J^ !L:3J1'2E2Z#X& _0
M   ,R(C,SH1<3,P$;W#[T&S^W9NQ)=Z*]7MNJ2M-E(ICVLON5K29-(.O22W"
M/V@9L;_M]E;V<X;:<LD6MZRN75I3_P!&2C,WF4\Q24ZC-*/A)22O@^$&&R@
M      G&_P#ZD\]\R3>J,&8;IC?H[:/(HW5)!ADP
M                        &NP_3:[>;X/6R!JL+C<2Y1OK;;%X+#OU[J&Q
M#:M2             /!Y*EM.(2LVU*29$X72DS+IX^P X%MV,[D;>7/'L;D;
M0/Y-*L;&1P)]WA(Y\#(F\@)!,/2GTMJ\5"2HI+KAGI_J'4')UYL?AUYV_P!J
M,7Q'('"<O-MBJ*9I43B6UO.K>Y1*+@9-$OEU+AXO#@#$J"#        "/[B^
MO/9;[_)O[K2#*P P         ,'$N.2NY3<K;+LJ(^+QXS#ENOA2D..29#AG
MS6CCD6ILFZ%XQG0_![09P                          8/,+CDUJQZ7.P
M^RHR#(6C:*):792("'24ZE+AF^X2DITH-2^)<:4\(#-E4R(S*A^$@'Z
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M_HM!GP;I#9N%LDM38$E).1Y49Q+S+B#Z%(6@S2HC]DC!P?0       "<;_\
MJ3SWS)-ZHP9ANF-^CMH\BC=4D&&3
M             :[#]-KMYO@];(&JPN-Q+E&^MML7@L._7NH;$-JU( ]$Q4M,
M9U4!#;DPD_(H>4;;9J]A2DI49%_0.O$FN*9[D1-7PMZ([79A11-4=^9BGXV=
M,]B0RMZKG%O3MI<M$8S9?5$<63[FGF)7H-1'RZZ:_P"[40F)S1BT8TX<X=/1
M/=\4]=MGW=7T7N'RMA5X,8D8E73'>\,=5EOW]?U5Z&J8J*TJ>AMN89?+(94;
MC9*_W5*2DS+^@7>%-<TQWXB*OC9TQV(+%BB*I[DS-/PMZ)[7O'8ZP
M'!EQR)G;^_'9NZWG=_RJ>3Q&YA90UWRSH):J+I(7H)M)=.ILE'[*R!R=HX'.
MRRYXA:)^<VYFTY:^P2[K;HRM;3+VH^"3UN=*:&9:U4/A4P<6Q         (_
MN+Z\]EOO\F_NM(,K #          P<2+E2,IN,N9<(KN(NQV$6RVH8-$MF2D
MSYRW'M1DI*N&DM/#^CB&<                          &$RZ+E,W'Y<;#
M+A&M61K-KL<Z<P<J.V274FYJ:)23/4@E)+CP,Z@,T5:%7B?A/H ?H
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MW_\ 4GGOF2;U1@S#=,;]';1Y%&ZI(,,F
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M^3I#TR+&878'9*5P(J6C51YF.22-"W..I1GXU &?
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M&8;IC?H[:/(HW5)!ADP
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M 5\&   3C?\ ]2>>^9)O5&#,-TQOT=M'D4;JD@PR8
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M*2:B+P$8,2W<   $XW_]2>>^9)O5&#,-TQOT=M'D4;JD@PR8
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MT>[9&@VNR0)KYQ&'"4ZDG-3I)5ITH-2BX<3(!FRK0JE0_"72 _0
M!ALKL#63V";9'5\HY*"Y3M*Z'4*):%4]C415]H:_4,G&;P*L*9L[WQ^?7#8:
M?G)RF/3BQ%O=^'RZI<[O;5YTU-[$5K4[QHF0VM!LF7];6:BH7NT,?*JN7\]%
M?=[EOSMBS^+ZO3S!D:J.]W[/E9-O\%YP#%#P_'F[8ZM+LUU:I$Q:*Z.:LB*B
M:\:)2DB]OI'TS1]/_P ++QAS-M4S;5M?,M8U'_-S$XD193$64[&T#<M*
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MB9\3/B8.+(@   G&_P#ZD\]\R3>J,&8;IC?H[:/(HW5)!ADP
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MO$I^[2XD9B397)G,B1VFC5H=;B_^FIRIU7]U_I ;$
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MJ:>22DU(^)'0^)'Q(^!@PR0   )QO_ZD\]\R3>J,&8;IC?H[:/(HW5)!ADP
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MP6XC<&&N^N(9<2^<)9J[/K=-)(47 ^"5&?17P -O
M      &G[HR]OX.$7*5N@AA>$(5'^DDRF7)#-52&R9U-M)6L_E312B?]0#;T
MTTEI^#3A[@#]         3_=Z]W>P8U'GV>6J(_VQ#;BT4,S;4TX=/&(_"1"
M8YBS.-E\O35A5=V>]$?RE4\MY7"S.9FC%I[T=V9^ML-,R*-NM8<><O\ ,R5+
MT$DMZVX]2=)+YDDCJ;::4-721C09RC4\#+_O58UM/1U=?3_I4.2KTK,9B,&G
M!LJZ>OJZ/JD"E*4HU*,S49U,SXF9F(&9M7D18JV#Q]SLFLW:++D28L"&X<-#
M<DU*5\FE)\#)M7 B41<3%QI5&I9K!MP\7NTTSW>G9'_3/WHC5:],RF-W<7![
MU54=[H^?UAM>UMYR6=?,AM>07%4Y5J4E@CX:.8EQ:%*31)'0]/A&YT',YG$Q
M\7#QJ^]W.CZVS'8TG,&5RV'@8.)@T=S]SI^ED3VJB+-%I-NMZ7X-Y9^78$1S
M!Q66O>:E<\O<)FKOEJ;7FEZ?B)39SQ69D=OG,K[2<9*%-)*I%H7J/I/I(;[4
M<Q-,?M_M58M-4=-G_P"&DTO*TU_]W]^G!JHGHMZ]L(Q;+5:F\FDN*P^X38"$
MH5$LO/;<=;=34W.:6NJT]%$^#PU$%@9?!C,S/[-54?"FW?\ '[=+Z%CYC%G+
M4Q_D44U?&ONS$3'PLZ.B?G_!;L?R&=?(D]$S'YEB1%;)+)3"0E+A*2K@C2?W
M-!] RV:KQJ*HJPZL.R/C]H?.<YDJ,O71-.+3B]Z>GN_#;M:EL-Z,7#R]?4MC
M0\I\-7?\M+><W<31<[9506B) ',G>R=W9PMBW[I[>95,MEF@)9MM_M2"2]%:
M0M]1M3>2XE:%&:G":<\75313A4&8?##S7OC8W#CW"3C=AW"L3[:'V+C:'4MN
M/,.)UI<;)"V3,ED9&5(Y@ST.A\$O]WRC$;5?K_97L=O,UHUS++)-1NQG$K4@
MTF:DH/CIU%5)<#!Q3#=7O/XGM-E9XE>+#>;C,*,U+[3;F65L:7]5$U<=0=2T
M\> ,V)5G/>]L>>X;?<+Q'!K_ #K_ )!"?M<5B3&;4T1S4&R:C2RXZM1I)54I
M)/$_"0,V.A]D,5NF$[38EC%[1R[O @(*:S4E<MYU2G5-F9&9&:#7H.G#AP!B
M6_@P  "<;_\ J3SWS)-ZHP9ANF-^CMH\BC=4D&&3
M                  &-OD^?;H"W[;;W;E+HHD,-&A-#TF9&K6I/"I4\6ICR
M9K&Q,*B9HHFN?NBSMF'LRF#AXM<177%$??-O9$_@C&!Y_G,_)U1Y2'[O'<)P
MY4)"6VS:TUHI)JT$C2JA4,_]=!\^TC6,]B9GNU6XD3;;3T19LZK/M\7T+5]'
MR.'EN]39AS%EE73-NWKM^WP7DN)$=*>T/ICYB )/M"=+[FIGT=M3\=X1/+OK
MYB]VU+CF3T,M<[*7R6'=6W7#<%U)0G&X5T)FVQI!J(U$IE;FA:D4X$LUTZ>
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M.+6=_P#U)Y[YDF]48,PW3&_1VT>11NJ2##)@
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MQ-GO&M7!I"W'W73U'3Q$'Q.G !808     $?W%]>>RWW^3?W6D&5@!@
M    8.(]EBLIN+$V+"1AR(["K5+:=<5.7*,SYR76S+02"X:32?\ ]P9P
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M9)L]39/)DK-!J+AJ))T = 8Y3ZO6FA4+L4:A?_A)!ADP
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MDXY*C1V8&/G&:0F*^T:N:\4@CUKYE2\57 @&<
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M22$ZW'$*6M5"XJ4HU'TF=0&V-MMLMH::03;39$E"$D24I2DJ$1$7 B(@'D
M "<;_P#J3SWS)-ZHP9ANF-^CMH\BC=4D&&3
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M1$1$YIUT+AQX< <9;T   "<;_P#J3SWS)-ZHP9ANF-^CMH\BC=4D&&3
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M7&Q/6.1'M,..P_%OZW&SC2G7C/6TA!'K)3=.)J+_ &5#-@
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M)$2:<* XOL   !.-_P#U)Y[YDF]48,PW3&_1VT>11NJ2##)@
M                        /3,_-)'S:_BF.O%\$['9A>.-J9[$>BT[R]?5
M-B0Y3X:J_P!D+'F[BJ+D;Y;9C[K3F3Y6EMQ*U%(B$:4J(S+3$;(ZD7L&5!NL
MG5$YG'LGXT_T0T><IF,K@6Q^FK^N6FSO7M;O(?R+XT>-[U1=\LJ#"]CKO^:E
M6!:H9)]H?V[FGER>L>$3R[Z^8O=M2XYD]#+7.RE6!;(=)\]]:6%^ZGKB$5JW
MN67^F]<Z1[7F?M^E6!:H9)\)];F8?-?E4B*TOW3'^N^E<ZK[3E]O9*L"U0R3
M[S?M##O+U^^T(KF7QX%[MI7/+'IYBY'F5@6J&      !#N\=?<V9+!L)P>]J
MQR?F=[3;)5Z93K?882V:ST<2,JF=3TFD^%*D1F#,,5LY<<S9SO+=E-U;A'S-
M>,M0KS8[Y)CH-U;+_$N8E9*\=!J3I49FI)ZO&,J4$NA@8<\=XS>S:3'8<G;/
M/[7(O+MQ.+VVV&V]'2F"^JO;&9!-FE1LFFJ20K5K33P&#,0C&"7[NRXGGN*2
M=MTWK.\NFW:-:X#-V6^A%KC2S-M<IE*XR$K4U4J)5X#U53IJ#+NX'$     1
M_<7UY[+??Y-_=:096 &         !@XAY?\ 6FY%.*W_ %+[-'^B39-[Z2[7
M57/Y^KY/133HT\?9 9P                          8+,3S$L>E'@16X\
MJJUV(KT;Q0-/-1S>9V?Y3\7KTZ?NJ5X ,X5:%J^%X:=%0'Z  /AO4I^#9KA-
MBIU28\9YYE-*U6VV:DE3W2'FS6)5AX-=5/733,QMB'IRN'3B8U%-7555$3LF
M7'S[[TI]R3)<4[(>4:W75GJ4I2CJ9F9])F8^#5US75-54VS+[W11313%-,61
M"T;"W&<XB[6M:E+M[!-/M$?$FW'#42B+V-1%7^@?0>4<>N8Q,.?#%D[)FW>^
M>\WX%$3AXD>*;8GYQ%FY9Q]!?/0!,-]_0QCRYOJG1(\U<+3?C=4LN4N,FY.^
ME1;9^SH?S#7Q"%/E_2IV1N2F8]2K;.]]0[W0 )-M=Z;9UY8KKWA$:#QF9O>:
MI<Z_P65N^6E61;H9)MUO2_!O+/R[ B.8.*RU[S4KGE[A,U=\M2LBW0P ]4K\
MV>^;5[QCKQ/#.QV8?BC:F&PWHQ</+U]2V(_E/AJ[_EI67-W$T7.V54%HB0!S
M]O)WCBV=SV5C]YC-KLTC%%W:Q+Y+RG'[\F2^TW&6Z@S2EI26TZCT529UK0P9
ML8ZP]]C9J59+=)R"?(@WUV,TNY0F84EUIF2I!&XVA9)/4E*JD2O"!8N^(999
M<YQNWY9CKRG[+<T*=B.N(4TI24K4@ZH61&7%)](,&87*]VC%[M<\;MWTO?XL
M5QVVVRNDI$A*?$;,^%",^D!S9<MB][-]38?WQOMNQVPMN$\SCEBBL/2V_P#=
M.4LEFGI_^:ZGV@9M=)XABUKPC&+7B5DYGT5:(Z8L0WU\QTT(\*E4*IG[@,,V
M   "<;_^I//?,DWJC!F&Z8WZ.VCR*-U2089,
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M;MEEGQ[A%K3G174/((_8,T&9$854S3T3%AA8U&+%M$Q5'RFU]PXNT
M    !@\OLMVR#'Y=IL=\?QNYOFT;-YBM-OO,\MU*U$E#I&D]:4F@Z^ P&;(C
M(B(SJ?A/V0'Z ='$P&)R"V3;O"1&M]U=M+Z7"<.1')*E*21&6@R5X#K7^@>'
M.8%>-1W:,2<.;>N-SW9/'HP:^]7AQB19U3O17)-IXMEG62.BZ./_ $Q.3#6H
MVDIY9+XFHB)7'W!\\SW+U.!7ATQ7,_N5]WJZOYOHF1YBJQZ,6J<.(_;H[W7U
M_P G[%OMFVMO+T"UW&7>B:4I,V(E+<>*;NG3Q7XZE*1[14+V>D9P\W@Z3C31
MAUU8MGBCHBFW;TVS#&)E,;5L&*\2BG"M\,]-55FSHLB57PW.[/FD=Q4$E,38
M]#D0W::TDKH4DRX*3[?^D6^F:M@YZF>YT51UTS]NF$1J>DXV1JCO]-,]54?;
MHEM W+2IAOOZ&,>7-]4Z)'FKA:;\;JEEREQDW)WTJ+;/V=#^8:^(0I\OZ5.R
M-R4S'J5;9WOJ'>Z !)MKO3;.O+%=>\(C0>,S-[S5+G7^"RMWRTJR+=#)-NMZ
M7X-Y9^78$1S!Q66O>:E<\O<)FKOEJ5D6Z& 'JE?FSWS:O>,=>)X9V.S#\4;4
MPV&]&+AY>OJ6Q'\I\-7?\M*RYNXFBYVRJ@M$2 -5W&A8;)PR^2,\AM2\:B6^
M6[<>8@EN(BDRHWC:45%)6:2\4T&2JTH=0')EFS;<MC%8V7XKL/9%[1VZ,DX*
M):&WKNY;(R:$\;BUFXLS0G5S.0NO3XW2#DZUVYR7'LPP>QY-BL=,2PW*,EZ)
M#0A#1,<32MHT(\4C0LE(5IX5+@#BE>\=OVBQJ\9-FV;9-+A7NZXO)M#EACSH
M[+[\!?!2X3#Q$9OF:=*#U::]) S"(-[8=U!S%494>Y5W;)< KE]#.7NWE<TZ
MFN;V8V>6?R]?D]%?A\ 9MEU;LE+QZ=M3BLG%.V_5Y4)*8'TJI"YVAM:D&3RF
M_%-6HCXIX Q+?@8  !.-_P#U)Y[YDF]48,PW3&_1VT>11NJ2##)@
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MI67-W$T7.V54%HB0!A,QQF'F>*7K$K@M34.]PGX#KJ.*VRD-FC6DCX529ZB
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M[IC#V=7BTQ+:IG*XT.*[<KH<(VDOQG#5R6REZ2)S0=?$U'I_T@-H
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M^DF/S';C8;7<'EDX]+AQWW%I^"I3K25&9>T9F)2N+*IA]LP*YKPZ:I^,1/\
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M//?,DWJC!F&Z8WZ.VCR*-U2089,
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MRZZ=6GII7A46R&2;=-]AW,L*;;<0MQJ;I=0E1&:%<Z.=%$70=#(^(B.8(_\
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M3'^N^E<ZK[3E]O9*L"U0R3[S?M##O+U^^T(KF7QX%[MI7/+'IYBY'F5@6J&
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MAL0!K<"[V9_-;O9F+/(8O<2)%>F7I<+EQI#+IJY;2)=/E#;XU1]S7W0&R
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M   &L;B8_?,KPB^8WCET*RWBZ1E1(]T-*E\E+IDEPR)"DJ(S1J2E1'5)G7P
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M]*YU7VG+[>R58%JADGWF_:&'>7K]]H17,OCP+W;2N>6/3S%R/,K M4,
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M4A:6B-*B\!D=09A7,;XX]:#/I[%&ZI(,,F
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M=]*YU7VG+[>R58%JADGWF_:&'>7K]]H17,OCP+W;2N>6/3S%R/,K M4,
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M] K#Y,7QE#GHO!8>SMEG7N/Q;S;!N6B $G;]?#WD">H$5'O7^GRPN:O8HO\
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M72<G3NWZ+ZUAMG9R6T0[!>FF":DV:V&E4*,3:C2AMG29EI)!)X$?#H!Q;(
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MYY22/B23<6K37C0'%N(       )QO_ZD\]\R3>J,&8;IC?H[:/(HW5)!ADP
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M?Z[Z5SJOM.7V]DJP+5#)/O-^T,.\O7[[0BN9?'@7NVE<\L>GF+D>96!:H8
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MO9ZY,0';O'>;>6NXW4XK"F67'D)<2V^\9NJ0DR;1I;,B6NB=5$])D0B^6/\
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M19<ECM3EDMTF>W'.I$XMAI2TI,RXD1F15/P$ Y:M> ]X7)L";WJ3O!(AWV9
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M5#)/A/K<S#YK\JD16E^Z8_UWTKG5?:<OM[)5@6J&2?>;]H8=Y>OWVA%<R^/
MO=M*YY8]/,7(\RL"U0P      /!U9MM+<2@W%(2:B0GX2C(JT+VS <78M9LO
MW=PJZ;VW?>*?C%]0Y->B6:')[/;+2F$XLFV)+.M-:DDE'XI&:5$9ZSZ3DZ5V
M1S&[[@;4XOE]^;)N\7*(:IFE.A*W&75LFZ22X$3FCF4+AXW#@#$M_!@
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MOI7.J^TY?;V2K M4,D^\W[0P[R]?OM"*YE\>!>[:5SRQZ>8N1YE8%JA@
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MLAHU<U[M!'K7S*EXJBH0#.  #GZX_P":^T>:7/T9X;*.%G:DJO>(N.@1K5:
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M^E<ZK[3E]O9*L"U0R3[S?M##O+U^^T(KF7QX%[MI7/+'IYBY'F5@6J&
M               1_<7UY[+??Y-_=:096 &'.?>_]%<8\\(ZM0I=!]2NZU^=
M\,;71+7XM'WI>\)N6P>8P #F_NO>DFY_G5'7S!3:UX,&[V4M?E/%7M_%T@)E
ML !K,"T6%C-[O>8UU>>R&7$BLSK0J:;K,=AHU<MQ,35\D:ZG5=/&_P!(#9@
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M,=>)X9V.S#\4;4PV&]&+AY>OJ6Q'\I\-7?\ +2LN;N)HN=LJH+1$@
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M"7V/HZ6OEN$E)$I.I*545X2(!2_L,V9_D&P?PV-^ !:'L7LP? \!L'\.C?@
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M>=.C-2)-JDG5Z*XZ@E*:6="\9!GI/@0,,F
M-=+#+26=JW#YC_TZJT)L!M:R[-V1,DY1*T::\S6KX6KH\ #8@
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MJNN4H@-W%#BR4PDK6VXTSRDDDC34G#U54=?: ;$
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M_;!R?T:P4K8G",:39'WY5F*U02MTF9J[4[%*,CE+>U$1\Q2*&NI5J#@V
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M,Q(\R-&=@L1HZ(IK4@Y,=Z,^^AQ*EF3:DJ-*DFGX-#(P8E= 8
M       !SK<>]I!MUPEV\]M\O?.(\XP;S4!)MKY2S3J29K+@=*D#-C7\4O63
M;X;_ &)[@Q<-N>+8EA4&>V_<;PR<=^6]-:6REE/"BB2;FHDI-5/&,Z5*H=5
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M0MPX,##K!(*4R7T<^Y+M]W<)A;B8B4&;B6Y):3>2M9MJ-#:B3J^"9ET@#
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MOQ^S,E'M-KCM0X3!&9Z&6$$A!5/B9T+B9](,,@
M   TW<ZZ[;V?&#E;J%!/%3D-(--TC]KCG)/4;?R>ARJN"J'I 1&=G?<?[&]S
MH^,.-$@S4ABRJYIT+H1HBDJOL4!GI9WN<1Y+.TTI]+#\7'YM]N,G&F)-=:;6
MM2";(JF?#6ESW3J?A ET&#          @TGNIXK*?>>=S?-=+ZUK<8*]%RZ.
M&9FFG(KIXTZ09M;IM_L_;-NK@4RVY'D%RB,P$6F%:+I.2_;HL5HT&@F8[;32
M246@BUG55#/CQ M44&   >*T(<0IMQ)+;61I6A15(R/@9&1])& U MI=JDF2
MDX-CY*+B1E:81&1_\H"UE[%AV(XNY(=QFP6VS.RZ'+7;H;$13ID9F7,-E"35
M0S,^(#-    P*<VQ)=[NV.?3$9-ZL,=$V\Q%K)"HL9Q!.)==-5$I3I,E5KP+
MI :?BO>%V<S7(_JIC>4QY=\4HT,1U-OL)?41&9DRX\VA#A\.A"CKX 9L4X&
M        !J6XF 0-R+$W8+C=;I9V&I*)92K)*[%*-3:5H)!KTKJ@]=333I(C
M\ ":0^ZKBT&:Q<V,VS([I#YAP)KEV;==C+>;4RM;)KC&25&A:DZJ5X\ 9M5W
M$<:9P_'8..1[A/NK4%*TIN%WD',G.\QQ3AFZ\HB-5#51/#@DB(N@&&;   !B
MK[C&-90RU&R6S0;S'84;C#5QC,RT(694-24O)41'3A4@&#/:7:HT*;/!L>-M
M=#4CZ)A:3TG4JERO 8#:H4&%;8C%OMT9J' C(2U&BQT):9;;25$I0A!$E)$7
M01$ ]X  ^6Y7&#:+=+NUS?1%ML!ER5,DN'1#3#"#6XM1^ DI(S,!IN0[T;88
MMBMOS2]9'&8QR[D9VJ4@G'ERB+IY+3:5.*I]U1'B^&@,V,K@VX>&;DV@[YA-
MW9NUN2KEO*;)2'&G*$K0ZTX25H50ZT4D@8;.                       #
MP>0;K3C:5FVI:323B?A),RI4O;(!R=M9W?(UYV_R+:7=#"&;3=;+)4NV9]%Y
M:I-Q7*=>6B4RZ1:ZLD2$FA2S(TFE*DD=0<K7GM%A6\UC[PJ9NYT=5SAVO&'K
M';LN8;,X\Z.S);<84^Z1G\N9*42B<HL]/W7PC#K$'%^&9)(U&="(JF?M$ Y5
MB]Y/>"7:W]U8>WK$[9!N2\VF1'?,[SV&,ZIIR8:#<-)I2:3U)Y5$F1U5I+6#
M-C<,>W<LN9;[6*WXO#M%QQ^\8FJ\,9*ABMW2HI*VE15/:JH2C3X[*DZB5T@+
MV#       .(]T]K=[HLO<R#9<,:R'%<YO<2\%)BSFTOI:@/\Y+:V#6A:B<+@
MHB+Q3XD9T!R4K(-OYMTW<VQ;P_;^/BMKQM#5^O63QFVHR$,K;6VJU%R4()Q5
M2TJ+QCHJM$IU5,.D@8 '*.Y/=VOUPW=A7R%><EE8'E3\@[ZU:KB3,BT37?&0
M\@G:I5%-1T-!(U(*M#/Q2!RM;QBW=<Q[%<CM>2,9IE<Y^U2$2FXDZXH=C.J;
M.I)<03*3-)^$J\08M78& !RY9MH(URW<W'QS<K 4WRQY>^]>+3G:RUDQ&4E"
M4PT.T-3#C9JHC2I*CTGP-)$8,M.3MKN[A&Z^U^*7=#^3;:8Q>G'<:R9#:G7H
MT.6A*>RS#17037++2:DZ?ZJM-$(,NU <0!S]W@\.R2=F.W^X%IQ-O/+1C;LV
M-=L7=-!F:9Z6THD(0X2DJ-!IJ?BJH9)X4J:3,-/WKV&RS&(>2W_8:,@K7E<%
MVWY=@[:2[.ZEPC(I4)JJ4I=14Z(3T<=)'4T@S$K[M!!FVS:K"K=<HSL.X1+)
M;V)420A33S3K<9"5H6A1$:5),J&1@XMT 23>G=#*L+FXMA^WME8OF?9B_):M
M;$U9MQ&F8#1.ONN&2D&>E*B.FLN!&?@H9F&B?^0MW18\TPG=/&85AW1LUFFW
M*%9YIE(LUZ898<<+DZEGK(]!DIHEJ-15H=24E(L6#:"^+R7:_$[^Y"BVY=QM
ML>0J!;FN1#9-::Z&6ZGI07@*H,2W8                              8
M^\6*R9%#.W9!;8MVMYJ2X<2>PW*9UI^"K0ZE2:E7@= & 3M/M:A1+1@^/I6D
MZI45JA$9&7A(^4!:VQIIIAI##"$M,-))#;:")*$H25"2DBX$1%T$ \P
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MO0YI4LR4E1'4P9;Q%5(5&95+2E$I2$F^A!U2EPR+41'X2(^@&'M
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MG62_^4XEQ*DU,_:4HJ*,?!V*#B
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MEB7&6I&66:X$\Y;6[62#-QXS=9CDE2*^*>D^/W15TJ#N4'$
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M=5X::5':N!M(.2EE9DI39.TU$@S(C--: /L
M      !CK7?;1>W+BU:I:)3EIEKMUQ2BM69;;:'5-*J1<22ZA7#V0&1
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M7'6F*^XXTVX?"E%+:6GI\ #(
M )CO7LOC^\>-G;Y:68>30C)VQ7U3*778KJ5$K2HCIK:72BVSX'TTJ1 S$O=;
M-C]KTVV(F]X-C,B\DRV5P?BVB,TPY())<Q;:%(4:4J54TI,SH7"H%JA0XD6W
MQ&($%E$:%%;0Q&CLI)#;;3222A"$IH1)21$1$0,/<
M      B$SNV8:K=4\\B6JSNX[=(KC.28W<+>U*9=E5UMRXIJ\5ETU4YE$T46
MK[I1F#-JAV/:_;?&;DU>,=Q*T6J[,DI+,V%!CQWT$XDTJ)*VT$95(S(^/0##
M;                                        1*PYSCNV^6[@V7+3G0W
M;A?_ *8MSC5LN$QE^+,MT).M#L6.Z@]+C;B%%6I&D&6Q_;UMC^\+A_!+S^I
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M7*HLO,KGAB([J9EL@0[F[)/3R5MSW9#24)H>K4DXZC.I4XD SX
M          #7E9;$3G*,%[.[VYRTKO92_%Y/*1)3&-OIU:JJKT4H V$   &%
MO>3V^PW*P6N8AU4C(YJ[;!4TDE(2\W%>EF;AFHJ)T,**I$?&@#-
M            ,#E&6VW$DVA5R;><*]72)9(G(22],F<HTMJ752:((R\8RK[@
M#/
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ME6F,[)ER5J=>=<4CBI:U&9J,_9,P)4$&
M
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MB;RM[LV%.-W?:R Q>L7MBE1\FP9+49';8*DI2@F5.MF:20DE)TM_[IZ5$1D
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M8]M-AUCO<5<*[0+7'CS(CM-;;J$T-*J&95("6^ P
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M1'P/B0!0C*AEP]@ H1E3P>P  /7V=CG=IY2.T$G03VDM>GV-730![
M          'R3[I;+4VAZZ36(++BR;;<DNH92I9D9DDC69$9T+H ?6   #YG
MKC;X\MB!(ELM3I6HXT9QQ"77=!55H09U50NFA /I
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M LO8[OV%89=KM;+;GUOOR[]:L<O4AI4*4MPU4@&DS4EQP]>K2DE)JM2#^%J
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MX;T3MH]P+/:(3MLL97-R?:5R'42GN:TE+K)O&1I:4ETRY:T:DJ2?C&0"\ P
M
M               F^[.SEDW58M<IV?*L.5V!XY-@R.W*TRHKBC2:BH=-2#-*
M3I4CJ7 RXU,VM9P;N].V;-HVXNX>83L^RZVLG'L[\YE,6-#2K41J0RE;GCT4
M=#U4(S-5-5#(6L=>NZU9[YB>:XO)R!XOK?D:\K;E]F09PI"UF9MI1S/'+2I2
M-54](%K9+)L1;+!F>#Y;!NSI-X1CY8U'MYLHTR4$AQ!OK<)54J4;AJ41)Z0+
M66V?VGC[26N^6R/=7+JF]W>1>ENNLI8-M4E#:#;(DJ54BY?PO]0$M_D0XDPD
MIEQVWTH.J"=0E9$9\*EJ(Z PE^Z.QMIW#GV;)+1=I6(YQCJ3;L^06HDZVV%5
M/DN-U22VZJ51.I/PE%T*,C,VO@VWV!:Q#,7]Q\QR>;G&?.,=DC7:X-I8;BL&
M1I43#)*<T&:3--=70:J$6I51:V#:#:>/M+;+[;8]U<NJ;W=Y%Z6XZRE@VE24
MH0;9$E2JD6CX7#W '[N]M!8MWK-"@W&7(M-YM$E,ZQWV"9)E0Y*:<4F=*I.B
M3,B,N*4F1D9$ TW'>[O=SS&RYGN?N!<,[F8TLWL?A/QFX,6.^=*.J0AQS6LC
M2E52TF:DIU5I0"U8KCCEBNL*= G0&'(]R8>BS2)"4J<9E(-MU)J21*\9*C(^
M(,(;B7=:18+]C;UYS6?D&&85*<GXCC$F.TTB+(<7S"4\^A1F]H71:?$30R_J
MU29FU]>>=VE63Y-D-\Q?,YV)V_-&FX^:6F+';DM3T-$::H4M:#:4HC,E'15=
M2O HR,6JDG!+3#V\7MO9S5!LQ6ERR17"(G'&F7(YL$X=:$I?'4=?A&##U[8X
M,UMK@EFP=B<NY-6=I;29KC9,J<YCJW:FA)J(J:Z=)@-M
M                               !^*KI/2554X$? J@.=<)[JN./O9%D
M.]$2#EF99!='[BJ3'7*;C,,NT-+39:FSX*-7271I+P S:P%U[JE_BV3<S"L.
MN=NA8/F;MOFV.!*5)4Y;Y4*2T\X1T2LC0M)+01U,Z$CV# M4+,]G+]DMWV@N
M$2XPV6MNY+;]U2Z3NJ0EM$5)DQI(^/R"OATZ2 M36?W8]RN;G]FM=WQI5BS6
M7*GJR.XPGY.1ME(5K*(3E-"6C^"I9*4954I*2,Z$9M;S;MCLGCY+LW?9-Q@<
MO;>U.VRZ--<XSD+7%[,E3&I!<.%3UZ08M:^>Q.\>&JRG&MJ,JM$/;[+Y4B6^
MQ=F'U3[8J:G0]V1325(6>FB4FLRX$7W55&+6M[M;?XEL_C.TL&W92_C61XE(
ME(L&33(+DNUO2)2T/2FYQLZC8)Y:S6C@HB1K3Q(C41EX[$2;GD_>6R/*7<D9
MS-+.-(C76_VZ.<:UM2WGV#;B1N)U0A"#HHSJHR4H_"!+K\'$
M
M         3G>7>3'-E,;C9%D$=^;VV4F%$@P]'/6LT*<4KY122)*4IXG[)D7
MA!F&VXED]KS3&+3EEE6:[7>(K4R-JIK2EU)*T+(C,B4DZI45>!D8,,R  -%S
MS="UX#?<.L-P@R9<C,[D5HA.Q]&AAU1MIUNZU$>GY0O@U/I ;T
M                                                        /GFP
M(-RC+AW&,U,B.4YD>0VEUM5.)52LC(P'KMMJM=GC]CM$&/;XE=7(B-(8;U'T
MGI;(BKP ?8
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M2NQO7%Z>Q!D.LOU0CF+7I)Q*4.\M1G0SU="D@?!UT#B
M
M
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M&
M
E                                             '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>camp-20241231_g8.jpg
<TEXT>
begin 644 camp-20241231_g8.jpg
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M%!04%!04_\  $0@!M (E P$1  (1 0,1 ?_$ -4  0 " @,! 0
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M/G$P[ <HVM;, @$ @$ @$ @$ @$ @$ @$ @,:DCF8!,0&>< @$ @$ @$ @$
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M_9><(*TR/(D<XV>&WK\\TNYO/W#XS%@LB^SAQHEQLZV9CG*+9,_%11HFMK]
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M'1WK9;:G),@;RN_X=:KCD2"E7UC44J%NJ4CBE3G"2SXU@P&[MLAH);; 2VD
M!*0  $B0  X2$N$!]3R@-"W7PVLSK'6K%2W$6NG-0A^LJC/XILS*9"0,_ HR
MCKU,WRK^JE45Y33_ '6&<<STVSS0RKIKQWTTYJW-4BOS6$S\,O.X&):WR%]M
M?AGBI<_:>O$<,O\ >&R[.6C;?"<EO-BM5Y7<<JIQW5=4U#8980VDST-K]%0F
M>PQQ;,Y;[(F8X)?P^+3U<MV*VZM\<Z_]4\=ZG1.0T_S1%?@N7YN;H.C\HY1D
MI5T^0W<VBRW"ZH05JI&UN)2>14.7\\<^U,VXYEU:F/YV6VSVRK_<+;>KG9$Y
MO<[@ISUBM0TBF))$E+](2,A+P12YMORVSEFZG'I?1\.?%CR?M.C_ (UJV^L?
MOF-;CT2EU7>VZ_I;!9220EN24&:2>!!'"7.._'EOPY[;*]R%QX<>SH98I2;)
MX2FQ(DD#P"46U2&8! 8E )0&I;@V_,[IBM=;]O[M367*WM HKG6MEYAJ2@5:
MD@*XD<!P@*L;5VK<*R]8]10[GWRDR'*?ND'/K"@9-.SZL73H;TE*?.!F290%
MU.TP&8! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (
M! (! (! (! ("G/5#09;<^HK:"AP6Y,6;*WJ:O%NN=6V7F&E#5JU( ,YCAR@
M)IVGQG?2PW.X/;M9C;,FMSS+;=MI;=3*IUM5"5S4M14A$QIX2@)=@$!B0@,P
M" & A_J,HLFN.#LT6-,5%4X[5M^N4])/O%L#CV=DY3CMT[HMOK*N?<&/+DUN
MG'6LSZ(^MO2\FLM]-55.0KIGZAI#CE.:8?HU*2"4\5<P8DKO)Q;=PM5G%]HW
MW8[9NS3_ %^;6;1T^7FYY7><=K7JJ@LMMF*&^*9&FJ.H>B)_ECIR^2MFR)IQ
MERX/MK+=LWQ-TQ;;/"[VK'_=6^?<3[G_ %\OZX]6]4-^[O\ 2Z=.G7IGZ6GM
MG$!\Z/F=5%^_:7_M_E=?&E.INJ^*93/9Q$<R5YNONE"U<J&JMSX_05+:FU2'
M(+X$_DC5FLZK:-F'+-E\3[$$W+;_ #VVI=LM#KK['WH?:2TH:"I)X**5'@?#
M%*W?'[$6=.+MK7\WTC!Y?2OB,E\4OI3\:._Q+#[]4Y-37W-*D)JJ0)]5I'%I
M+JE)]"29\ D1VX-/).>R_+SM1?D-_#;KSBUH^&[G/_=-(Y"+:H[, @$ @-.W
M'8SNHQ2X-;:5-)29FK3]7OW%.JF3YPU:A(\QR@*K[1T^Z%+UAOM;NUE!6Y?]
MTPKO;4G13"E+AT)E(><#.?" NS (! (! # ?DJJVGI5Z7ZAIHJ$TI<6E!\O$
M\8S%LSR>9OMM[IB'S1<Z5Y6BGJF5N=C:5I4HRYR ,S";+HYO-N2R^:6W1+]\
M8;" 0" 0" 0" 0" 0" 0" 0" 0" Q,<NV <8\\1F/00" 0" 0" 0" PHD ]G
MCC _%6W*FM].NIK'VZ=E$IN.$)3Q\L>+\EMD5NEMQXK\MW39%9<K?<*:Y,)J
M:&H;J&#_ -HV=0C-F2R_MFIEPWXYI?%)?LCVU$ @$ @$!37JG8S2HZA=H6MN
MZFFI<U535WU4]7C52I4-6O6)&?F\N$!,FSE!U$4=SN2MZKK9J^V+8;%K;M*-
M#J*D+\\KDE,TE,!,T @$ @$ /* T'=O'\NR3&46_#*[U"ZA]#BG^\+,VT\TZ
MAX8Z<%]MMU;D3Y/!FS8NC%-)]J%!M-OZ1(Y%YO8#7*E^3A$K^[U__'BIW\)Y
M.8I.7A[W=XG@6[% ,BH+MDC;]QK+>MFW->N%Q;3Y4"'".:?!JC5DV,4TFB2T
M_'[EMMULY(FZE/S]O-V@V^W7_=6K'/KC_P Z&N%2*WUDS[@3\WO9>/P1S?-Q
M==:<'9_'[?[;Y?7'7U5K^">%STR!D?#$>M+@LIY%0GX(5.'JX#2E10 !,3,O
M!&#AR0YE15^^*TI"CQ13SXF7;%7VKLD;UL1R77Q^.S^,R7SSBO\ HFL1:5*(
M! (! :?N*YGS>*7!>V3-$]FJ=)MK5T)%(KSI*UD%/N>7& JKM"[NH]UAU*]X
MF;;3YB,4 #=FF:7U3O"6_24LZYE4^,!=GM,!F8@$ G (#!@*J=4X)RRPR4J0
MH7"4A12/C#QX$1/^-MBZWC[7S#[SOFVZRDTX-+V&U#=2RJ!49HJ9S42#)HGM
M,=/DL<6VHK[9F8WHB9]%X!RBKOLA (! (! (! (! 8F/# )B 3$!F 0" 0"
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MK4I($AQYP%5MI;[N#D?6'47/<S&FL4R;[I!H6EA]-2CU9+A*'-:5*$U&8E.
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M%QH43)J&N/\ [Q)_YX]=%_L:_FXX_P"4/U@H4@* F#+E'B;J<VV/;#[1D(!
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M/+%T\D*45%>Z_;ZX6QVA4U68[6-OTZ0E275#W8D>9$^?;%3G!FG7FL16V_\
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M6$)Y/-Z$JFA7CXQWS;$HFLPDO;W<FR[E8U4978Z.NI;8S45%.A%<PIAY]-,
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M$R; )/& JOM5N5ANZW614Y7@KZW[%]TQ1ZG&#3*[]IPJ4-"@"9!0XP%S*_\
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MCRX0$V[7[L[-;BW*X4&V-;1U-?1-(?N":2D-,KN2O2DDE"=0U& E6 0" 0"
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M (V[/EB8Y.JZ9,FM[N^%WP_S_K:T4%4BJ(3)HJ9<0%2//MB-\ALQ?P6?[?\
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M[%)W_J)"/(^0Q[CM<<JUM?CPQOWE/]&7$9M=RY>-^C'YO14=OEC3+OAF,,D
M@//?>3\>V,_JK5\FJ-.;LETZW?"X*O25Y3^>(.]8XYM<W"_8#+OL:O\ HZXV
MX><-&;MGW(?_ (<OLLR'[7_J1$ZK2RV[T_W49Q]@73Z(Y 4+Z<ZJIH^GN]OT
M;JV*A-R7H=;.E2?1Y&)KQUO5/%2ON3)-EDS'.CM7<FR8-E7UO5A0T\>\_P#5
M$]&"V'RZ-W-/&9=+U/J4O(=I%K45+55(*E'F27V)F*ONQ2Y]B\%QQS+TK;^+
M1[T?FB/62'* 0" H+_$%]HNT7OZGZ721YNY2]V=T>];17N/>I^"(@UHM<J?X
M]OWP_/&OUAYOY2J9T&^UG=S]8KZ:[%@LY0K63NE>Y\J"'#Q] E/@$A&R.;3=
MVRHU5[L;CHK:E*<BJM+=2ZA*9B6E+B@!R[!%KQ:&.ZWD^+;/G]RW+='7VS-.
M'XIWV[W2=H-H7<LR2L^L[O2/51]66ZA-2XVV[H0D \>WP1#9]28R],<E_P#'
M>5IH_.RW1==%>7_1U"^J^UMM:SC59,)U?'-&7"?*/?\ &SQFJ,C[RPW<(LFJ
M>K1<S=[30W1 [E-;3-524*D2D/)"@D_RQ%76TFB]X[^NR+N553>IO%\=SGJ*
MV=Q?+FDO8[<J:O37L*<+(4E&I29K!$I'QQY;)YINVMV0VDVHN=PN6W=&FEK[
M@RBFK2FJ54DLI7K2-*E'3YW; 2Q (! (! 8/* TS<_-F, Q6JR!:0[4HDU14
MYX=X^X9)!/, <S'3KX9RWQ'IZHORF]&IKW7TK/I'XJ]TF1=2614R<BMB'V[:
MY-RG0TA#+:TC^@VN:E)\$^<3.3'JVW1;_NHN+=\QEQ_-MCA[*<TG;+;J7'-U
M5V/9.QZOD]L 6[)!:+K8.F:D'BE:3P*?RQ'[^K;9QL[96;P?E[]FMF6*7V\^
M%$RS,^?"?/QRB.]%F]4<'.;@SEF0VRL*#:;52JJ64H3)TE"09$CF)Q!7[\69
M9B[E$2G_ ..B=>V__P KHC]6L4^3;KU]M5EM.VS]4";HI/,TEM/, <SY8COW
M.]?;\RV(Z%@R>/\ %X\L:\S/7[>-*_HE3%[XC(;%17A#7=JJ6]2VQ[E8X$18
M=;);EQQ=$<50W=>=?-=CYQ;+MBI0'%$@>WF8Z[8B.-'#,3+]">"1Y(R&H0 *
M29R,Y<X 5)',P#4GPP&J9]A&.[B8O7XEE'?*LE?I]9]7=-.[YB@H%+@XB1$!
M5C:S;7%MJ.LBIQ/#DOILOW2362JGU53G>NN%*CK49R\WE 7*N']PJ_U+GP3
M>?\ T+?';E?/J?X;L<&SS2NGR7![!$5'-+SR56Z\_9CC_P!KGY%42.HC=[DN
M3MQ[.\1^Q;;]%;B30LJD?Q)?V(PC[4JOD$P]68Y)/LG^P;1\PI?D4Q-1RCW*
M)L?4EV+?QB/*/SQESJX=+/XQL[^:7'Y9B(C)SE>M7Z4>YZ&)Y'RQJAT.49"
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M9^'J[?/J+X9C U#8GV.X;\Q_QC$OB[%)W_J)#/(^0Q[CM<<JU-?CPQOWE/\
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M_P"B.[^3S6Q2)05GVKI1'*?U;CA.V^,8!3/HQRF4TY5D&IJ7G"Z\I(Y)*CR
M\$<>;8NR\TUX[QF#2MICAN$_=>YG_P T<WHD/5]5F228Q,O3KZ^L9I:9=94J
M**=E)6ZZ/<H2)DQXS9;<=LS=R>[,<Y+HBWG*&,NSS%+\32T>/INE2KS6ZM8[
MM<^P@(\X_EBH[FYK9ZVV65GVKYI>'V,$5R98LCUA^; \%RAB^4E[J*?ZOM[*
MPYW:E2<4C^CI!_/&GQOCKNJLSTMWE_)ZDX9QV3U7>WT6!3+2".4HO$12'SIF
M,A (! :AN(SGE3BM>QMK5TE#F*M(H*JXH[RF0-7GZDD$3ERX& JMM)3;GTG6
M)4,[N5U#<<N&)@^LVML-4_JG>GNQI 2-4YSX0%S[A_<*K]2Y\$P% .A7X[<K
MY\Q\-V.#9YPE-/DN!V"(N.:8GDJKUY^S''_M=7R*HD-1&[W)<K;CV=XC]B6W
MZ*W$FA52/XDO[#X1]J57R"8>K,<DGV/_ &#:/F%+\BB)J.4>Y1-CZDNQ;^,1
MY1^>,M"N'2S^,;._FEQ^68B(R<Y7G5^E'N>AB>1\L:H=#E&0@$!Y][*?C%W7
M]Y7_ "[<<NWVNW3[EO/!$0G90MU9>P;)_P#1OE1'1K=SFV^Q(72!^'+!/FC_
M -*>B:5YK/79^'J[?/J+X9C U#8GV.X;\Q_QC$OB[%)W_J)"/(^0Q[CM<=RM
M;7X\,;]Y3_1UQ&;7<N?C/HQ^;T5';Y8TNZ&8PR0" \]]Y?QZXQ^JM7R:HTYN
MV73K=ZX*O35Y3$'>L<<VM[A?L!EWV-7_ $=<;,/.&C-VS[D0?PY?9;D7VO\
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MX]]KJ^15$AJ(W>Y+E;;^SS$OL6V_1&XDT*J/_$E_8?!_M.J^03#U9]$H6/\
MV#:/F-+\BF)N.4>Y1-CZDNQ;^,1Y1!SJX=+/XQL[^:7'Y9B(C)SE>M7Z4>YZ
M&)Y&-4.ARC(0" \^]D_QB[K^\K_EVHY=OM=NGW+>F(A.RA7JR]@V3^6F^5$=
M&KW.;;[$A=('X<L$^:/_ $IZ)I7FL]=GX>KM\^HOAF,#4-B?8[AOS'_&,2^+
ML4G?^HD(\CY#'N.UQW*UM?CPQOWE/]'7$9M=RY^-^C'YO14=OEC2[F8PR0"
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M'CX>$;;>UPW55J9_'?C8\"*?Z,N(K-W+GXV?\3T3;,P?*8T.^'.#) 8) '&
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M_P#^<'^3'/&K/MAV?OH]DHDZ@;GO#O5BEOQRDVAOEH=HJSUQ50Y)X*'=E$I
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M("(K7D]\VSS1[?O;"A59=L,RR9FPM8+< ::INK3R"I=93L>=H3KGHD.!\7"
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MV5UWH:/[Y^HT[-YNC##27G:E+20\2ZE.H@J![8#9D-A!)',\_P D!S@$ @$
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M,P'&B0X"1Z/'L@*K[S;+U.VRL:R&PW^XU/31<KFQ?*>LMI+M99#7)&I;)'$
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MI=X',6JZ#,[L!>'+?=JIVK%!758"W"EIQ12'4DZ=1Y=DH"<VP #Y9P'. 0"
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MMM(VEFFI6$A#3;:/12E(D (#]\ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$
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MI:I 0%7ZK<GK0N%D3NQ:,7LPP9U KJ?"W$EVYN6U2=25K,@X5%)"I)(/^#*
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MC(DP%LK;;:"U6^FM=LIVZ2VTC:6*6E92$-MM($DI2D<@! ?K @,P" 0" 0"
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M75%! DF3?/PP%K-(,I\QRGQE <@)"7@@,P" 0" 0" 0" 0" 0" 0" 0" 0"
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>camp-20241231_g9.jpg
<TEXT>
begin 644 camp-20241231_g9.jpg
M_]C_X  02D9)1@ ! @$!] 'T  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" 7Q"H4# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]_**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBFR-M7- "A@W0TH(/0U%)O5<(.O>FG<0/GVGOGO0!,753@FER*A#
MH!B0C(Z&ECF+,5:,C ZGO0 \RQ@9+"G Y&140C60;ATSTI\;;ATQB@!U%%%
M!1110 4444 %%%% ";AG&:"P7DFH99RLFU82<GK3S$Q.YFR/2@"2BHXF:0[N
M@':I* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHYSUJ%Y3&"[
M-P.U $H96. >E!8#@FH$N<D,D/WNXH6Y1YFB88"_Q>M %C(]:0.I&0:C24%M
MH&1CK0<(>.E $N1TS14,D^T\1$\4Z,N%,CM@>AH DR"<9I&=4^\<9I%9"OF
MC'K3 BRMYF_*]A0!+D8S148C8R;_ #/EQTH$@C?87R?2@"2C(/0TW<3_  T;
MB.B4 .I-Z9V[N?2FMF3@'&*B:=4EV^7N/<T 3[E(R#2U7+B1OW7*]\5-'TY;
M- #LCIFBD4<DD4M !D=,T4A*CDT!U/0T +D>HHR/44FT>E 0"@!:*** #(]1
M11@>@HH **** "BDW\XQ2Y ZF@ R!U-&0>AI,J>I%&5'0B@!:,CUHR#T-&!Z
M4 &0>AHHP!T%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !0"#T-(P)& <5!/.L,BGS  /O&@"QD$XS2%U!P3S7'
M:_\ '#X3Z%J#6&J?$'3[6:)L31R2D$?7BJ3_ +2/P(),@^*VD^P\\_X4 =\S
MJ@RQQ2Y!KBM,^/OP>UHK;:?X_P!.GD8X5$E))_2NJ;4$%NMS;CS59059?0T
M6BP!P32U6C8S1[E;D]/:I@3M"YR?6@!])N7.,U&\FP@&3OS4<LZL^U!SGDT
M6!(AZ-1N4';GFJS7D"7(M% WXS@=:>LPG8J5VM0!*LB,<*V32[E]>E0*VV0#
MR\>IIZ AR2<@T 2!U*[@>*%8,,J<BFD*G Y'I2(P#F)4P.QH <9$#^66Y]*<
M"#T-1,J0_OGY/K3H\ <D?-R* 'D@#)- ((R*B9FC;9C<#^E.+97Y#R.PH ?1
M3(2[#>Q(]J?0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%&0>AI X/_P!>@!:*:DH=BH!XIU !112,P09- "T4F]0<
M$]:1I K!<'F@!U%)N&<4M !12%@#@TM !103@9-(748R>O2@!:*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *1P&4@B
MEI)&"H6)[4 5YKH0H0\P4?WR>!7D?QJ_;9_9Z^"EL\_BWXE:,)H%)>V.I(KY
M';%?)G_!;_\ X*RZ=^PG\,KWPAX#U%CXLO;/SM.$8\P#@YR!D]2*_*/]E_\
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MO&1_P5N_92C^$-Q\9'\31?8+>Z:W>V%Y'YVY2<_+U[>E CZD=MJYIHF4]:^
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MO]IEQCCUKWK_ (+S?M5_M%:O^SN]]^SY/'<Z%=EUDDB@,H,3*N[E>.AH /\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !0>G-%% #(E0*0K$\\YIDJOYZ@?=[TDY9<CH@Y+5S\GQ
M/\&[Y;6;5PKQ-M;V- '21MEB .G6GUG:5K^G:K&K:5.)4_B:M&@ I&Z=*6FR
M%POR#)H CV+<9+$C''%.WY7;$,E?6E8QG]T3@GTINWR3A.2: '!6=<R<$>E
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M"QACF&[/S*@!Y/O73U! B,^]6)^M3T$O<****!!1110 4444 %%%% !1110
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M^"C&G_&G_@D+X2T;PAXH,WB6[\4065Q:QR?-Y9:%#S^)KW+]F']GC6OV9O\
M@C#XCM]5TPQ7FJZG]O\ G')$JROG_P >H \R_P"#8JSL+?XN>.G1R!%XQE$:
M]L;S7)_ML?\ !/G]OW]OO]ONY\/>-)KK3_AU:>(GC>XL]7EA)MBN<X&T=3ZU
MO_\ !LLT&F>.O'?C35K@Q6=MXND-P_8?.:9_P4-_X+&?'OXY_M":Q^RO^QQ\
M.+&^U1=3?3VN["3RYM^,@Y4$YY% 'T;=_P#!L9^PIH/PAGBO/BGK?V^WLF.6
MU@D[OKYV:_,+]G#7/%'_  3>_P""KU[\$OA#XTU'4='%Q:6JI?:E)*H5YI$.
M 689Q7T!\,_^"8'_  64^*]K*OQ8U;QEHD4\>&$6J2XY_P" BOD+0?@/XQ_9
M3_X*R+\(OB7K5[J6J6.JV/G76IR%Y6S.PY)^AH&C]!/^#FS4-4_LKP_K]MJU
MU#<7#Z:SI%.RK\WE$]#[UZ'\4HC'_P $%?$B:IK%VK2?8F\Y9VWC]Q-T.<UY
MO_P<W7"?\(5X9@"C).E$-_WZKT?XL'S/^"!/B-KCC L0"?\ KA-0-['YV_\
M!&C_ ()G^/O^"C'C?6]/\2>-?$0\'V6J^1J;V^L3J50X_A#@'K7VE_P4K_X-
MJO@=^SK^SOJGQ>^!/C/Q/)>^'-,>ZG>?491M(.!SYA]17<_\&BT"V?P\^)$9
MME_>:TI5\<_PU^B__!6&?[-^PY\08 ORR>') Y_X&M!)^7G_  ;B?%;QE^U%
M\$?$G[,/Q0UBYFT^Q\-/'YS7+/+AEP3DG.>/6OSU_;&_X)^?"OX?_P#!4^\_
M9OT;6M2?23=6S-/+,WF_O)V#<[L_K7W7_P &J$ 3XK>.C$?D&@C;[\&O#?\
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M%SXA_P#!4C7?A)X&\3ZM'%<WT$%YY&IRQD1/(X/W6],U^JUO_P &K/[-6L_
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M* "BBB@ K'\;1L_ANZ9^,1\5KLP5<FLCQO,G_"+W;@](^: /Y'OV^?AIX_\
MC5_P5S\3>"OA7+(FIS>*5CC:&=HFW$''*\U]:^-_^"*G_!7'PIHMWXIT[5=9
M=((&D(;Q+='A1GIFO((V@?\ X+ZZHWG$9\=Q<>ORFOZFKRUM[JS-E<6RR12)
MM9&&001TH _COL=*^.?B3]H&#]FW]KWQQX@T^S:ZC67R=7GZL^WJS"OZ-O\
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M;6WBC\Y1UVJ%KN+175<-0(D9R#C%.!R,TC+N[TH&!B@ HHHH **** "BBB@
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M/A1X!MM+GN4V320#EA5#XV_L;?LZ?M$J9/C!\-[367=P6^T"@#\THOC)8_\
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M07!\R)R, _ZSKFOV=^)_P<^'7QLT8^'?B/X8BU&U="CQ3#@@UX'%_P $8_\
M@GXFNMJX^ &E;P0R-MZ&@+L_)3_@DI^R)^U#_P % ?VK-5_:/^.*:MI6C:KI
M<L<=S=J&0G$A"YP?[PK&_P""HG["?[0/_!-;]L?3_P!J?]G'P[J-_INGV"+/
M>Z>@1=QV%@2<>AK^@;X5?!_P%\$_#$7@GX;^'8]-TZ$YC@A'RBG?$SX3> _C
M-X<E\$_$GPW'J6G3G,D$P^4T!=GXX_#W_@ZAUWPS\,+>U\1_ :";5]/MDBDB
MEN#OF<#DG]YUKYS_ &6=9_X*,?\ !3_]MNT^*4^J>)]!\(0Z[YK6\;JT$,+
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M\;?&UEX<63R#-;B,1^6.AQY?2O5/B)_P;+_$V2?P9\1Y?B7J6JZUY_G:O,\
M\PMAAECL'M7] DJJA$*0G#]32R.(0L2IN^E KL_.#]I?_@FMX\^)G_!.GPQ^
MSQ8ZC=?;])27S'6,%FRJCD8]JW_^"&O_  3]\8?L0?"*#PYXQN;EIDEF)%P@
M!^;/L*_0$RE%R%)_V:2-1*GF.NT>AH ^2_\ @LG^R3XC_;-_9 U/X,>%IYH;
MBZNDD6:!<L, ^Q]:X#_@@[^P7XR_8-^"?B+P7XONKF6:_P!3$T?VE I(&[T
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MA+(RG4-)8X Z]: /Y3?VJ]?F\6_'[Q#XADFW-=WQ8MGVK]A_^#?#]L?]G_\
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M'YU>SO(_,B?((9?K6NES&\C1CJM $E%(IR,TM !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*Y&8Y5Z$?Y- 'R3_ ,%,O^"4GP!_:J^$.KW0\)VFGWEM937$7]FV$<7S)&6
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M^#8U5C_9@U 9ZK#_ "K]/%^9_F X/6@&2T444$A1110 4444 %%%% !1110
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M /Y"OHG_ ()V?\'(7PG_ &I?&\/PT^,MSIF@ZY<7/E16<+ EN<'O[T >V_\
M!:;4?VC/ 7P5?XS? 6U\X^'M/>>[5IV49RV. #GJ*RO^"(?_  4LC_;9^$-O
MX/\ %]]"OBO1+ /K%LN!L8X[\$]?2OLCQ_X0\*?'?X37GAV>1+C3-<L]H9ER
M&0GT_"OYX_!OCG7_ /@FA_P5]UKP5H]W)::#XC\2Q64"A]B%.>@_"@#^D:,R
M?:"Q Z5*RG/FQC)K%\.Z[IWBG1[?7-)O/,CE4$%>_ K:48<<]NE #E((XI:1
M5V]Z6@ HHHH **** "BBB@ HHHH *1C@9I:1_NT6N!2URZEMM.DEC'(%>:W/
MC34EO9%5_NMZUZ/XB<-H\H]!7DET56]G8*#\U5&)SUG*)HKXYUO>=I!'N:?_
M ,)SK?HO_?59& \88\9]*38O_/0UKRHY%.31L?\ "<ZWZ+_WU1_PG.M^B_\
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MSMN0%)6 '_CM<1\.?BY\._V;_P#@LQH_Q,^(VJ16FD:)K=PLSS ;0!(G7\J
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M" >HHHH " >HH(!'-%'6@#\N_P#@YD D_8[UT"3'R1\_\ :OY5M<57URX0G
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M7PM_P='_ ++OQ3\<>!;+XJ_#V^O5M=$TUVNTME&TD[NN17T;_P &\O@KQ?\
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MZ9J*7+11PX+;>W2OIK_@L5_P5Q\+?L$?#27P-X7NA?\ BNY9[..WLYOWT,C
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M$SQRC(52&_\ BJGE9VPE[AH?"O\ 9T\6?L!?M%^#_%^M3SP1:CXDM;9Q(H4
M>8!Z>]?:/_!P_P#M*W7QD\0>%?@=X8OC=6TMYI3-'$V0-S1 G%>K?\'./[,,
M/@3X(>$/BEX%LA'/9^)!<$P+R C1FOSO_P""=,_Q!_X*$?MQZ=:>+8[B]M["
M"!PTRY ,39_]EJ+.X[)JY^F?_!0#]G31/V=/^"'EYX/A9(Y-1@L+YP%P<M S
M'_T*OQ(T3]J?]H^/X*^(/A[\,HM3M_#SMLU.2T<>62,\MFOZ"?\ @XJBC\+?
M\$S9])\T*EII]C 1Z;8-N/TKY7_X-[?V)_V?OVK?V2?'7A3Q-X3L[B^OK]%C
MNY>=G6J<785-)-GMO_!N-H/[)NN?"&Y\0:39Z-?^,K:TC?4)%5O/BGRO7MG&
M*]?_ ."Y7[$OC']MOX$P6'@Q+BXU'24DF6S@0,S-V'(K\EO NO?$?_@B_P#\
M%'[O1[J2XT_PCKWBG#H%V130J@[^F4K]0_\ @HY_P57U3X(? #PC^TQ\#;*Y
MU6P\12L]Y;Z4^XQ1#NQR.*7*3.+<M&?EM^Q__P %$OVS/^"/UE%\(O'/P.U>
M:PTQR/LMU*$5<\9P''85]K_![_@LY^P5_P %%?%-KI7[5GP0\,:-J#% -0U6
M21G#*0%'$A[@=J]J_8V_:"_X)H_\%2/@E:?$3]HG3-!M_$MZKF]M-7NP)E 4
M'D8/?-?GQ_P7:_9%_8+^!6B)XI_91U;P[#JXU"#RK'2Y]TO+KR!@54=RU!N.
MK/W3^#>F_#K3_ T%Q\&[JV;0S$ACCL0?+QCY>OM7YH_\'5.A6-[\+=&U4PJT
MD6C-AB.1]ZOHW_@W\UGXD>(_V,)S\28KEY8[B%;4W"X_=;7QCVQBOEW_ (.K
M/'%AI/A?0?!PN%>>_P!*81Q!N?XJM_"84ERUFCZ,_P"#>?Q9>Z]^QII^DW+M
M(EIH2",$_=^9:^U1"4C#F3)/:OD;_@@K\/)_AY^Q'H6M7ML4.JZ"A7(Q_$/\
M*^N/G/S,W![41V9B_C84444""BBB@ HR1T-%% "Y/J:,GU-)10 8'I1@>@HH
MH ,#THHHH **** "BBB@ HHHH *,D=#110 N3ZFC)]3244 /4 C)%+@>@I$^
MZ*6@ P/05&8E<';)M/8U)22QI'@G'/?TH6X,Y;]I%+JX_94\>Q;3A=$8;O[W
MS)7X9?\ !$F>RM?^"F7C*'4V4\1>6']<M7[[ZSH2^./A]K?@.\ ,>JVA@&[H
M<D'^E?SYVFEW_P"Q)_P6=U7PZT;6=C?Z_;6L4I&U'R[# J:VQV83<_HR^.?P
M(\-?M#> 8/!WB=(GM<*[12KD,,#(_(5P_P )?^"=?[)OPB\+RZ#I7P6T-DFG
M:279"PW,Q.3][W->V>&=0M-2T*SO+6971[2,[U/!RHJZWEA_*V<8SFL3H/B+
M]K3_ ((6_L@_M*,;SP_\.]$\/7#1D--;VS$ECWYS7%?LI_\ !O'^S1^SSXUC
M\8ZQI^EZU);W DA6:V(V].!@"OT0MY!(2H7: <8/>G@,3\Q^4>M &5X?T'2O
M"NFP>&_#>CQV=C;#;#!"#M4>@R:^._\ @N=&_P#PR1J 4846MQ_Z *^VB=QQ
M&V,5\8?\%O-&U_7?V3;RPT'3)KN9K>X&R%<GE10-;GYV_P#!J7O_ +6N!C(\
M^[_]">ON7_@MM\$/VH_B_P#"*]TO]FWQ)K&FW[QIY;Z2%W9V\_>!KXQ_X-=/
M 7CSP/K<Z^*/"=Y9*9KKYKB/'4O7[AN6>8*5^4B@H_F%NO\ @GE_P6H53Y/Q
M4\?OCT$7/_CE?L+_ ,$8OAW^T1\!OA/JUQ^U1XJU6Y>.T0F?6=N8L%<GY0*^
M]WC8<QOM ZU\#_\ !>/]I3XI_ ;]G.\\/_";1K^:_P!=TN15N+%<^6VX\GG_
M &:!*Q\J_P#!9G_@MEXGD\0W/[+?[)]B^JZW<7#6)N-(G_> MD X+>WI7%?\
M$<?^"#?Q!\?>-(?VM/VY+F[U'6[] SZ-X@@!>%ERZME5'=O7M7Y<?L;?%KXR
M_ WXXW?QX^,/P'U[Q/JL\J307(@PR2+_ !=:_0O4_P#@X]_:JDG)TSX ^+8(
MP@54\OH /]Z@3/W[\/\ A#0O!FAV_AWPUI\=I:6\2HL<(POR@#^E:]M@+Y=?
ME7_P1U_X*O\ QS_;0^.\/@#XA?#W7-,LY+9W,NH)A 1GW-?JRD2AMRC&.U C
MYN_X*P_"&V^-'[#7CCP:FG+-<W6FE(2%R1UZ5^#G_!-W]K1?V1?@]^T3\"_&
M%P(;H:!]DTQ)WP0X> _*/P-?TR^)M#TOQ-I$V@ZO:"2VN%VRJW0BOY8/^"P?
M[&WQ;^'G[<>K_P#"N/"5\-+\3Z\R2"V@RK)M/_Q- 'MO_!-O]BV+]HO]DKQC
M\;O%>EB6XE\(7$\4LR9)81Y'/XUP?['7_!2&7]E_]AZ[_9ON-0^SSO>WMNL)
MDP?W@*#C-?L9_P $I_V8K/P#_P $N+/P;=Z']GU.]\/3V]Q&R88[HU&"*_GV
M_;A_8<^,WAC]OF'X>:!X#U%M(;7+9W:*W^3:UR-WZ4 ?L#_P;.?LVZ?H_P"R
MMXK^,VM6BIJ5SKM_-')(OS%)'F?K^(K\G?VE_P!G7Q'^V?\ \%26^ _A'4IM
M,FU76[J,7=NH)4^8HSR#Z^E?TN?L4?L^Z)^SI^R7:>$-#TA8/M.@QSS0HN"9
M&M\G/OEC7X4?LS?#WXO>'_\ @NUHOBI/!>HQ6"^(KIC=^3\@'FISF@%N>9Z!
M\!_B[_P0G_:R\&^+O&EU?7^EZIJ7VBZEN@$1U4$9. O]VOZ/?V>?VH/AG^T]
M^SI8_&B6XM%TG5; S7D.XF-(^^>>E?.G_!9G_@GSI7[<G[+-WJ]SI276OZ1H
M[#2R4W.CDGH/Q-?FM_P1U^/G[1WP3F\6_L'_ !B\/ZM):7-@-*T2>YCVQVSM
MM^8#/L:"]CZ#_P""@?\ P1E_91_X*/?%#4_%_P"S'\==,TCQ%&?M,UGH\):0
M*I+ '<C>]?"GQ1_X)K_\%</V(IY-;^!'Q \;ZM:Z?EW^PK$J^6O+'E!Q@&NL
M^+2_MQ_\$@?VV]5\<Z+;:WK7A^>2*%Y]/MR(Y(][[AG([-7TA\9?^#G#Q!XW
M^$$W@/P-^SMX@&KWUF;62>$Y)+IL/&[U)H)9U7_! 3_@L9\2OCMX[A_9.^.F
MGW$WB26\>-[S49P9D,;%&& <=2.W:OU4_:C:TL_@AK9N2OE^3\[-T'6OQ2_X
M-VO^">WQD;]IYOVU/BEH5YI+-K%S-';7]OM<I-*9 <_0"OU>_P""LOQ5LOA#
M^PWXU\8M?K#):V.] 6P3P>E C\&/^":]G<7_ /P6 \4W6F.3"GC12VSH1Y:5
M_3[&C*Y=GX/0>E?S]?\ !LK^S]<?'C]H[XF?'KQ-IY58=1CO+&:=?OY$(RI_
M$U_0&H9V+Y^7M0!,.!UHI%8.,BEH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?!C]M/\ X+ _L0Z!=?!_3VURYMK2Z>.)K30KAUPA*K@ACVJWX2_8O_X*"?\
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MOB;!T>4'TKR+44Q?2X_O5K3.:N ZDTM1AP4"^E%:LXT245'3TZ?C2&+1110
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ME:SN)SDSQ/\ X*.?L?R_M^_L^ZA\";>XMXI+^1&1[M@$ 4$=R/6N._X)9?\
M!/J^_P"":?@O4_!\M[:3'4;D2AK-@0,?0FOIJV+(<AL'U!HG9G?+,3]33)YI
M=SY3_P""IW_!*3X<_P#!3#0;&:'3[6#7-+B86EW=NJA9"6YYQ_>]:Q_V7O\
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M]E+7IO@N@/B$%1:;D)_A?/3GTKXZ_P""-'_!,GQ!\,O'GB']IK]H"Q5M>O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MFC:=W Y]:18G,GF,Q&/X: )**** "BBB@ HHHH **** "BBB@ HHHH ****
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M;#8,@C)/I03?4911106%% !/ I=C>E%T E%+L;THV-Z470"44NQO2C8WI1=
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M '2E*%@,GI0 JC:,9I:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH :\B1GYWQGI3!(\D
MC1&,@ <-5;5YREE/-Y9!B0E37\^G_!9G_@NG^U#^RS^V?XC^#/PZ\=:A96>F
MLA1(6.T NX]?]F@#]_\ QP&B\#ZS&7W'^RKC_P!%M7\9G_!7&,I^U[J?&?\
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M_ BC_B(F^!?_ $(TW_@10!^C6T_WS1M/]\U^<O\ Q$3? O\ Z$:;_P "*/\
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MC[<R_P#SQ/YT9?\ YXG\Z^(_^'_/[/O_ $3R;_O_ $?\/^?V??\ HGDW_?\
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MX0B7 /\ S\4 >I_\%R/B5XT^%'[!GB+QCX%U*>TOX+F(136Y 8 J_K]*RO\
M@B5\2_''Q/\ @3<:QXXU^XOYPL9#7!!*Y^E?%G_!6/\ X+0?"C]I']D?6/A;
MH'A.2">]GB*R&;(& P_K7V!_P0>L3;_LXO>;@5N(8G4#MQ0!]Y(N!2D@#)I%
M.0*&&1Q0 H.1FBD7[M+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !03@9HH)"C)H 0,",T;E/0@_0TTA=I<=Q4$3Q
M1N2,[L=Z +*MN[4WSANV[35"^\3Z)I8(U/7;*W8<_OKI%X_$UYW\2_VQ_@9\
M+49_$7C*PRJY/EWT9_K0!ZM2;AG%?+E__P %<?V2;&0I+XOC)4]KA/\ &I-(
M_P""MG[)6LW"V<'BZ,.YP-UP@_K0!]04A<!L$5PGP_\ VC/A1\2-/6_\/>--
M-VNN5$FH1 _^A5UMAKFEZ@H-MJ]K..WD7"M_(T 7R1C--64,<8--CD!Y7[M'
MS,^,#'>@!^X<>]+43>8I^7[HZU(I!&10 M%%% !1110 4444 %%%% !1110
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M 'QE_P .$O\ @F]_T2>Y_P# M?\ XBD;_@@A_P $WR./A1<_^!:__$5]G44
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M ,"U_P#B*^S:* /C%O\ @@A_P3?/_-*+G_P+7_XBD_X<'?\ !.#_ *)1<_\
M@6O_ ,;K[/HH ^,/^'!W_!.#_HE%S_X%K_\ &Z/^'!W_  3@_P"B47/_ (%K
M_P#&Z^SZ* /C#_AP=_P3@_Z)1<_^!:__ !N@?\$#_P#@G #G_A5%Q_X%K_\
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M?_$5]/9N/449N/44-MBO/NSYA_X<B?\ !/'_ *)A<?\ @4G_ ,11_P .1/\
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M  +7_P"(KZ?S<>HHS<>HH'S3_F?WGS!_PX__ ."=G_1+[C_P+7_XBC_AQ_\
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MY#_X)VQG(^%]QS_T]I_\17T]FX]10IFS\QHNV'-/^9_>?,/_  Y(_P""=O\
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M5RK0[*$Y,N_\.#O^"<'_ $2BY_\  M?_ (W1_P .#O\ @G!_T2BY_P# M?\
MXW7V>.G%%9&Y\8?\.#O^"<'_ $2BY_\  M?_ (W1_P .#O\ @G!_T2BY_P#
MM?\ XW7V?10!\8?\.#O^"<'_ $2BY_\  M?_ (W2K_P00_X)OC_FE%S_ .!:
M_P#Q%?9U% 'QE_PX2_X)O?\ 1)[G_P "U_\ B*/^'"7_  3>_P"B3W/_ (%K
M_P#$5]FT4 ?&7_#A+_@F]_T2>Y_\"U_^(H_X<)?\$WO^B3W/_@6O_P 17V;1
M0!\9?\.$O^";W_1)[G_P+7_XBFM_P00_X)ODY_X51<_^!:__ !%?9]% 'QA_
MPX._X)P?]$HN?_ M?_C='_#@[_@G!_T2BY_\"U_^-U]GT4 ?&7_#A+_@F_\
M]$HN?_ M?_B*/^'"7_!-[_HD]S_X%K_\17V;10!\9?\ #A+_ ()O?]$GN?\
MP+7_ .(H_P"'"7_!-[_HD]S_ .!:_P#Q%?9M% 'QE_PX2_X)O?\ 1)[G_P "
MU_\ B*#_ ,$$?^";Y&!\*+G_ ,"U_P#B*^S:* /C#_AP=_P3@_Z)1<_^!:__
M !NC_AP=_P $X/\ HE%S_P"!:_\ QNOL^B@#XME_X((_\$WU7!^$]R<^EVO_
M ,13H_\ @@?_ ,$VXH]B_"BX Z\WB?\ Q%?9TLJQ@%AG)IC1B4 4 ?D;_P %
MBO\ @DC^Q!^SO^Q1KOQ#^&WP]FL]6M+F+R+A[E2%!#G^X/05]"?\$'[AY_V=
M)+5#\D$42Q_3%=Q_P6K^"?C;X\_L.:_\/_!$ DN[BXB*+SV5QV^M4_\ @CA\
M#?'/P.^!\WA_QQ;+%.R1A0 >U 'V,BD#FEHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHIK2;1DB@!U(^0I('/
MO02=NX#->0_MO_M&I^R]^SCXF^, @CEET;36N$BD. Q! H ZSXL?'+X>?!/P
M]+XG^(^N1V5I!&7=P02 .O!(K\L_V\_^#HOX"?!Z^O/#?[/7B6SU;4(B5\N[
MA0#'3K\WO7XN_P#!0;_@L+^T;^V1\1;Y](\7ZAIFG75P?*LK.[_=X.>,>E>#
M_#3]CK]I[]H+78SX1\$7FKW%TZ@R9)8Y/TH'9GU3^UK_ ,'"/[6_[0WB">2.
M:+38'SM.G7K)QG_945\G_$3]M3]H;XG2,-8^(>LKN&"$U24_UK[>^!W_  ;1
M_MA>/U@G\<> M6TN*90Q<(> ?PK[)^ O_!I/H:VR7?CGQUJ-O(2"R20YQ^E
M69^$,OQ5^*3DE_B!K9;WU"3_ !J6P^+GQ5M)EG3Q]K2LARN-0DY/YU_2+HW_
M  :7?L_2J&NOBA<@CJ/LW_UJ76_^#2W]G]("UA\4+IVQT%MT_2@5C\!? /\
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MFCC/"DDC^E>H(ZR*'0Y!H 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **;)($'OV%8FJ?$7PQHUVVGZCJ21SI]^,]J )_'A \#ZR,_\PFX_P#1
M35_&/_P5I5!^UYJN?^@G<_\ HT5_8MXV^*7@>Y\&:O'%K<98Z5<<?]LVK^.;
M_@K-/:7W[6FJ7>GW'F)_:5SR/^NHH&C^A;_@V3"C]ER_Q_<A_I7Z<+T.:_,3
M_@V/8#]EV_*MGY(?Y5^G>]N %'/6@&-8K%^\#=>M17MG::G"!/:QS)G[LJ C
M]:F$ $A8G(/8T[RP!A3CZ4"*UCI.GZ:VS3K**!.I2) HS^%6Z;%'Y8P6S3J
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MNHV=MJ?^@7]G'- W+)*@8'\#3]/L+.PC,-G910J/X8D"C]*G5 O-+0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=37Z_A2*&T444 %%%% !1110 4444 %%%% !1110 4Y.OX4VG)U_"@!U%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I"BEM^
M.:6B@!&16.3VKQO_ (*!V5WJ'['OCFSL+=Y9GT=A''&A9B<CH!UKV6J?B#1+
M+Q'H\^BZC"LD-PFV1&4$$?C0!_$!^TS\%_BY<_&[7)(?AMKTBM/]Y-)F(/\
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M5  Z56T>\@U'2[?4+7_53P))'C^ZR@C]#5F@@" 1B@  8%%% !1110 4444
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M?2EHH 38OI1L7TI:* $V+Z4;%]*6B@!-B^E! 49 I:1_NF@!N]O6C>WK244
M*6)ZFDHHH **** "BBB@ HHHH **** "BBB@!=[>M&]O6DHH 4L3P32444 %
M )'2BB@!=[>M&]O6DHH "2>M%%% !1110 4444 /"KCI1L7TI5Z#Z44 (57'
M2F5(W0_2HZ "BBB@ HHHH 50">:=L7TI$Z_A3J $V+Z4U@ >*?37Z_A0 VBB
MB@ HHHH *<0 E-IY^Y^%"W ?8 &]CS_>KUOPU_R!XOI7DFG_ /'['_O5ZWX:
M_P"0/%]*FM\)U8<OT445B=04444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 449 .,T4 %%% (/(H **** "BD9@HJ,29;F@"6BD4Y&32@@]*
M "BFR-@8I-_R\^E #Z*C1_2GJ<C-  -W<TM%% !1110 4444 %%%% !1110
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M/DV[ 99 I(YR:_FV^"G_  =@?%;P=H,.EZ_X M[R6- IEN+G)/OUKGOVB?\
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M,.K"20DGRL$]N*_4@%DVCKZF@'N2T444""BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI/8#/\3?\
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M #**5B">*2@ HHHH **** )%Z#Z44+T'THH &Z'Z5'4C=#]*CH ***51EN:
M$HJ3 ]!1@>@H :G7\*=37X''%)D^IH ?37Z_A29/J:2@ HHHH **** "GG[G
MX4RGG[GX4=0'Z?\ \?L?^]7K?AK_ ) \7TKR33_^/V/_ 'J]:\-_\@>&HJNZ
ML=6'ZFA11161U!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'AKR73_^/R/_ 'J]:\-_\@>&LYG5ANIH4445F=04444 %%%% !1110 4444
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M=G^JS7X+_P 1"XDB[1:L?T_2\*.$ITTY*5_Z\S[M'_!2/PF3C^Q8_P#O[_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2.0%)-+22
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7ZW_ ,$Y_A[XB\.^%_!=OJ4VL62Q"5Y=K(04.1R/[M S]H_^#F/XQ_#GP/\
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MED%K(D[@$[W/0#W%?T^W 9@%"Y!/-<OXA^"/PJ\5W[:IXF\$6%Y,YRSSQ9-
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M/]FT%43WN^OWH^XX0RW@_,HS_MG$NE);)+I]S/81^U/\)-V!KRD_[H_QI?\
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M#N.P_#E>,?=E42MY6O\ YGS7'?%F Q/&6'K*U2-&ZE?:SM_D?F3\//C]X_\
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M??7B^9)U&0"/\YH&F?R0:E^S+\>].F\C4?A9JL31G#J\0X/YTVP_9B^.^IW
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M/S(=12;QZ&C>/0TBAK=3]:2@G)S10 4444 %%%% !1110 4444 %%%*%)Z4
M)13MA]11L/J* &T4KKL4,2.:54+#.>*+E1BY1<ELMQM//W/PII4AL'IZT[&5
MP33:<5J'*^3GZ#]/_P"/V/\ WJ]:\.?\@>&O(["3%_$H&?FZUZUH$HCT>'(S
M6#=T;X:4>7FZ&E149N%'\)I#=+MW!2?I4Q]Y:'5)J*NR6BF+,I[4[=[&@:U5
MQ:*3</6ER#T- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MT4K=;(Z<5Q'GF.ARU\1)KU95M[8,@.-J#@)5RVBA48 %/6WPWS'(]*5(%0Y
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M* "BBB@"I?7ICC=XSCRAEB:_,#_@H7_P</?";]A[X\ZG\'?$\6H27&GNJO\
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M%O*V#,P/0?D:_EB_;7_X+#?M2?M0^/K_ %?1_B%J^DZ=)*6BLK>Z&Q!SP.M
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MG# )^M?C/_P58EW?M9ZL&C _TB3G_MH:_;[_ (-$[Y9OV5M:4J,#Q !C\9:
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M^^?I2LD^;J--QV)H55H9@% Q"QX^E?%7[0+;OV@+:<#!5,<?5:^UK;_4S_\
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MFOL[5!S$?^F*_P A7QC^RA_R6&?_ '#_ #-?9^J=8?\ KBO\A7Q/AK_R3/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/V6UCASZ[5"Y_2KM9OA#4'U7PQI^IRYWW%E%(Y/<L@)_G6E0(**** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW\S2_P#!+3=_P@\&%X-KS^0IG[=2A?A<I'>U;/YFI/\ @EHS?\(3$N>/LO\
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MO]!7Y7BO^3B4O\/^1^Z9=_R9ZM_U\_S/L.BBBOTH_(5L%%%% PHHHH ****
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M_<X+_A^/^UY_T,M]_P"#%J1O^"XW[7C*0?$U\/?^T6KOO^(=+]M7_HFFM_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3<IYYK&\<^"]#\?>&Y_#'B#3HY[6?ATE&0?\YJJ:IK$PG65X+H-_"?E+J?\
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M''^%07__  <%>.(K8W*^&M.^0=-__P!:OMIO^"5_[/&?+7PCIH4\G$!IDO\
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M-+D_9YBA!]J_<#_@I'\2/#_@?]FO5GO=0C\_<N(&/)^5J_$2POX]0^)<E_"
M1<73.H'O6_#[JRP4^<\?Q?PN74,]P\H1M5E:]NUS^@#]C>-1^SCX4;UTM?\
MT(UZA7EW[&C$_LW>%,_] M?_ $(UZC7R&(TKR]3^B,KO_9M&_P#)'\D%%%%8
MG>%%%% !1110 $ C!KG_ (GHB_#K76;'&CW1!]/W35T%9OC#1F\0^%=1T-&
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MW:SW*/#)(/+<8*FOSB_;J_X(#?!W]LCXWZE\7O$VA6,TNHLI9I2N3AF/<>]
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M\5?M!?\ )?K?_='\UK\_\1U_PCX=_P#3Q?FC]@\'?^1YB_\ KR_R9]A^"O\
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M3B4O\/\ D?NN7+_C3U;_ *^?YGV'1117Z4?CZV"BBB@84444 %%%% !1110
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M$AX!]Q7] GP3?S?A1X>;S,?\2],C\37Y[_#+_@A_XL\#^/;;Q6NN:<$A8G
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M(X'Q!U;GGG5YO\: /[6_^%F?#3_HH.A?^#:'_P"*H_X69\-/^B@Z%_X-H?\
MXJOXHO\ AY7^T[_T4#5O_!O-_C1_P\K_ &G?^B@:M_X-YO\ &@#^UQ?B-\.I
MY!#!X]T-W8X5%U2$DG_OJM6"[MIH \,Z2*W1XV!!_$5_&/\ LS?\%#OVE?$/
M[0/A/2[OQ]JKQ3:LBR(VK3$$8/;-?UM_L/ZYJGBK]G/0]3UR9GFD0EG9R2>%
M[F@#V&,"/CK4E1KMA^4G(]34G6@ HHI' *D&@!K98X%<K\:=5DTGX2^)[VU;
M;);:%=2*WN(F/]*ZD*%CZ\#I7!_M)K-<_ 7Q=':#Y_\ A'+W/_?EJ /XUO\
M@IC\4=4^+G[4FK:OK%[)/,MW+ OSDCB0@5[_ /\ !.+_ ((0_M$?M\?#NX^)
MN@1V*:7:S^4XN'",?O8QDC^Z:^3?VGHY+3]I6_AO.0=?DW%N>/M!K^I3_@WH
MA\)/^Q?)%X8:(J\D/G8"@[]CYZ?C04K)'\M_[2_[,7B7]F;XSWWPL\8+&IM[
MYX24/'R^]?H-^RQ_P;8?%7]J/X(:9\6?!5SI;Q:C8"XC#W:[@"<<C=Q6!_P<
MN_LXZO\ "S]HVW\4+8F*/4I99RXXSG-?J!_P:S_M"-\4/@3J'@:YU)9#H.E1
M(D;R9Q\R>OUH"Z/P4_;Z_P"":'QP_81\=7&A?$#2";..X\M);>%BIY/1N17Z
M,?\ !LI^R1^S'\4O%UMXWU1@OB-+4O(LMTJ\*"1\IYZYK]+_ /@X.^ ?P\^)
MG[*DNKZ]H]G%=V$$T\<Z6Z!W8 =6X)K^>S_@C9^T-XK^ ?[9<%SHNL7$<-S=
MQVGD^>P3:TI7ITZ&@+H_L<T*QMM-TJ"PM/\ 5PPK&G/8  5<K&^'NH/JW@;1
M]3D.6N-+MY&/NT:G^M;-!(4444 %%%% !12;QG%!8 $^E "T4BNK]*6@ HHH
MH **** "BD9@O6ER,9H ** 01D44 %%%% #&3<Q#]#TI@6,MY S\O/-/9FW]
M.!2;1N8C[V* ,WQV%/@C60.O]DW&/^_35_&1_P %:@S?M>ZHTS9 U*YXS_TU
M%?V9^-$F7P)K*L.?[+N/_1;5_&9_P5LB8?M=:HISDZE<_P#HT4#6Y_0;_P &
MQSR2?LQZAC[JK#7Z?%5<\]17YA_\&QOR?LO:AZ[8OY5^G>4!R30]-P:LQ]%(
M76C>/0T"%HIID4=:1IXU<(3R: ZCZ*;YJ9QGK3@0>10*Z84444#"BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HI"P'6D,BCK0#T5QU%-$J'H:&E55W'I
M0*Z:N.HIOG)C.:0S1A=Q/%*ZO8$T]A]%1K<Q/]TTHGC+[ >10VD[=1O0?12;
MUSC-&]>N:')+<%J+13?,3KFE617X!HNK7"XM%%%, HHHH **** "BBB@ HHH
MH **** "BBB@ SSBHYHP06J0YQQ39 Q3"T 4;C."%[=*HW&GV&J1"VUBR25!
M]T/&#@_C6JMLV26%"J#(5V#:.AQ2M'=K4&E*/*S&B\#^%T;]UH=J ?\ IV7_
M  J6+P;X;BZ:':9S_P ^Z_X5M")2,TW:N>:KVM:ZML8JE34>515O0^(/^"I6
MA:-I>DH=/L887-H2#'&%_E5W]B3P_P"&[WX>Q3:GI\4KK;+R\0/?W%0_\%7H
MX)[*!&<@_9#@ ^U6_P!A^,1?#@"0G;]F7!_$5\%E_._$:<FOL?YGZ_FBOX.4
MJ?*FO:;-:;H]E?P_X6'32+8+_P!<%_PJ&;P_X1W#S-%MR@/RX@7K^53!$?\
MC.W''-(%*_NUY4=S7Z,YW>VI^'^RIQ?+4@I1Z:; 5M((_)L(%CB_NJH%.#[^
MW2C ;Y&Z4F_G# #'3 J>6I?F=OU-&WLDK"T4F]?6C>OK0(6BDWKZT;U]: %J
M.G[U]:90 4J]1]:2@<'- $E%)O7UHWKZT #_ '33*<S C -(%)Z"@!**4JPY
MQ24 %%%% !12A2>@HV-Z4 )3X?XOI3=C>E.0B/.X]136Y,B:R_X\)O\ KFW\
MC7Q5^T%_R7ZW_P!T?S6OM6T^6UFB/7RF/Z5\4_M L#\?K?!_A'\UK\^\1_\
MD38?_KXOS1^O^#J_X7<7_P!>7^1]B^"?^1$L?^O1/Y58C_B_&JW@H@>!;$'_
M )]4_E5F+D,:^ZPW^[0]%^1^58O_ 'NI_B?Y@_W5^M%# E5QZTNQO2MCG$I4
M^\*-C>E* 5.2* '44F]?6C>OK0 /T_&F4YV!&!3: "BBB@ HHHH **** "BB
MB@ I5ZCZTE X.: )**3>OK1O7UH 6HS_ *T?6G[U]:802P?L#5?9!?$/FZK]
M*R/BQ_R3R[_Z]G_E6O+\P4CL*R/BQS\/+O'_ #[/_*N7'_\ (MJ_X6=V4?\
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M3B4O\/\ D?NV7?\ )GJW_7S_ #/L.BBBOTH_'UL%%%% !1110 4444 %%%%
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MY]J_C7'[4/QG3<$\42?,?F^]_C3A^U#\9@H5_%3D'W;_ !H'9']<_@_X8_\
M!'[P)JT>O^$]4\'6MW"X>.:.ZY4CH>E>^^#?VJ?V8M?F3PYX0^,FA7<P "06
M]UEO0<8K^)I/VHOC)%F-/%#X(P?O?XU]8_\ !'3XW_$_7_VK=/BU7Q-OC:6
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M9>XM[B\,MLC9RN1]:];_ &!/^".7[0O[>\3ZIX%V6-G]G\V.YO+8['&,X!R
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M7[TZBF,;Y?O1Y?O3J* &^7[T>7[TZB@&-\OWH\OWIU%!/O#",'%)2O\ >I*
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MI.Z$W'^X: 2>HQ2TASV-,0M%)A_448?U% "T4F']11A_44 +128?U%&']10
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MN *5)Z4ZF[#ZBE^;'7FF I /444F']11A_44 &Q?2EI!GN:6@ HHHH ****
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M[%)_PF_AC_H))_WV*?.@]G/L;N\>AHWCT-87_"<>&/\ H))_WV*/^$X\,?\
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MPQ_T$D_[[%'_  G'AC_H))_WV*/:1#V=3LS=WCT-&\>AK"_X3CPQ_P!!)/\
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MD6HZ>[%3>19!Y'F"J4DVTN@VK*Y=#!NE+443 #<C @]"*D!R,TU),0M%%%,
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MK4U;GZ&O[-_^"6FNIK_[%/A35DY$D)Q@_P"RM!2V,C_@K0<?LH:N?^G6X_\
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M>&H8]8B:YGLC^0_$#Z0^4<'\<U<FQN#A>-O>:O?1>9Z])\/OVM(E :SU'/\
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MG_F?FROPV_:WSS!J7_?\_P"%._X5M^UK_P ^^I_^!!_PK])/^$=T;_H&1_\
M?-'_  CNC?\ 0,C_ .^:/^(?P_Z"ZGW_ / #_B*DO^@"C]S_ ,S\V_\ A6W[
M6O\ S[ZG_P"!!_PH'PU_:U/_ "[ZE_W_ #_A7Z2?\([HW_0,C_[YIDVAZ+"
M3ID?/M1_Q#^'_074^_\ X ?\14E_T 4?N_X)^;__  K3]K;_ )]]3_[_ +?X
M4T_#+]K8G/D:G_W_ &_PK](4TK13P=+B_*GKHNBG_F%Q?E4?Z@1_Z"ZGW_\
M #_B*DO^@"C]S_S/S;B^&/[6RRAVBU/ [>>W^%/7X;?M=2RXBL]2;_MNW^%?
MI$V@Z%C+:=']*C.D:3&W[C3$^H%->'J>V+J?>$/%2;?^X4?N?^9^;<_P[_:[
M2<1RV.I 9_Y[G_"I%^&G[6B2,RVNI8(X/GG_  K]$?$4W@GPY:_VAX@-O @&
MXM)FOGWXZ?\ !03]G;X1PS"QUK3-0N8\YM@[ @_I712\.*U5VI8JHWZ_\ Y,
M7XT8+ 1<\1A:,$NK5OS9\WM\-_VNY!A;34BJ\D^>?\*Y+X@_$/XL?"Q=WC77
M[VT*CD/.>*YCX]?\%;_&WQ4U&?PO\*/ 4MJ[Y"364W)SQW8UYKX%_9=_; _:
M<O!JWBV;7$MIY?\ ELJD $_2O9H^$U.$5/$XVHOZ]#\TQ_TH7B,2Z&5Y3&M+
M^91T^\[A_P!M>_M9QYWCBX+#[H,U=#X1\=_';XZA]/\ "]U>W4,AVC;.>17M
MW[-__!'70O"T4&M_$+Q$M^W#/!=0],]N%%?97P[^ 'PL^&&GQ6WAOPC91LJ@
M&2)2,G\ZY,;X<Y70E^XQM1OU_P" ?4Y#XO\ $^84^;,LJH4UVM^O,S\R[K]B
M7XKZG>M+XA\"-<R%N#,NXY_*K%O^Q[\0/!:OJTGPUCBCC7._9Z?A7ZKCPYHL
M[&2738P>Q(KG_BIH>C1>!-2WZ?&=MG(03_NUQ5N#)PI.7UJH[)Z7T/H<-QQE
M4\=3E+*Z";:VCKZWN?EA<33BY,-Q:B*1."H]J2-PZEI!R#5CQ8RR>++IHN!Y
MC# ^IJN0!'NQ@U_/:AR5W*;UU1_5%.4O8J<(\O-;3MW'93V_*C*>WY5%YGM1
MYGM3+)&ECC0L5!.. 15";5TLA_:,DOE&/Y@!VQS5LS(@RR ^@/>L/6_#.H>+
MENK/3I'CE>%@D2]02#BNS+L/#&9C1H3=E*6YYN<8NM@<IQ%>E!2<8MV[VZ'H
MGPZU;XI?%JP_M#P=?W<Z(2@2.4XXX_I6S-\/?VD22KI?JP/"B8_X5\N_!OXX
M?$[]B_XF)I/BNVNI[-I-YCG8!<,W7C'8U^J/[.GQW^&'[2?@V'6-"^R)=JB(
MT,3$DMCG]17]%XOPLAAHJ:Q4^627R_ _C7ACZ2#SF57!ULMIQK4Y-.-EJEUW
M^\^31X"_:3B<)-:7V#W,Q_PI\OP^_:1CD1XK>_*D\_OC_A7W$\%C;RO97FC+
MG.%8_P#ZZ=:P:/&)!+8(<#C->?\ \0ZH_P#07/[_ /@'V/\ Q&6K_P!"VG]W
M_!/AU_!7[1@8@6]\/^VII/\ A"_VC?\ GA??]_C7W )-&QQHD9'K_DTN_1_^
M@%'_ )_&C_B'5'_H*G]__ )_XC'/_H6T_N_X)\/?\(7^T;_SPOO^_IIO_"#_
M +1W_/.__P"_I_PK[BWZ/_T X_\ /XTA_L7_ * T?Z_XT?\ $.J/_07/[_\
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M:2_Y]+__ +^G_"ON#;HW_0+C_P _C1MT;_H%Q_Y_&C_B'5+_ *"I_P!?(/\
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M3^Y?YGP]_P (-^T?_P \K_\ [_'_  H_X0;]H_\ YY7_ /W^/^%?<7_$D_Z
ML?Z_XT?\23_H"Q_K_C1_Q#JC_P!!<_O_ . 5_P 1EJ_]"VG]R_S/AT>!OVCL
M_P"JOO\ O\?\*7_A!_VCO^>=_P#]_3_A7W#_ ,23_H#1_K_C1_Q)?^@-%^O^
M-'_$.J/_ $%S^_\ X GXR5/^A;3^Y?YGP]_P@_[1W_/._P#^_I_PI4\#?M&G
MCR[_ /[_ !K[@_XDO_0&B_7_ !I0VB@8_L:/_/XT?\0ZH_\ 07/[_P#@"_XC
M)4?_ #+:?W+_ #/B#_A!?VC?^>=__P!_C1_P@O[1O_/._P#^_P :^W]^C?\
M0&CHWZ-_T!HZ/^(=4?\ H+G]_P#P!_\ $8Y_]"VG]W_!/AX^#_VCD.T0WQQ_
MTV/^%'_"(_M'_P#/"^_[_'_"ON(/H6/FT.,G\?\ &EWZ#_T HOU_QH_XAU1_
MZ"Y_?_P _P"(QS_Z%M/[O^"?#G_"(_M'_P#/"^_[_'_"C_A"_P!HQN3;WW_?
MT_X5]Q[]!_Z 47Z_XTW?HW;0H_\ /XT?\0ZH_P#05/[_ /@ O&2HO^9;3^Y?
MYGP__P (5^T9_P ^]]_W]-'_  A7[1G_ #[WO_?TU]P[]'_Z 4?^?QI"^C=]
M"C_7_&C_ (AU1_Z"I_?_ , /^(R5?^A;3^Y?YGQ#_P (-^T7VAO_ /OZ?\*8
MW@;]HP''E7__ '^/^%?<0?13Q_8T0_/_ !H*Z,>3HT7ZT?\ $/*'_07/[_\
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MU=K5&%>4L+2J5[7LGIT/1M*^'?[45UI\<VB+J)@* ILG.,=NU6/^%:?M<?\
M/#4_^_Y_PK[_ /A7I.C/X,TU4TJ,[K./<P'?%=-_PC^D?] Q/RK]XH\!TZM&
M$OK4U=+J?S97\3Y4:TH+!4G9O5KS]3\VO^%:?M<?\\-3_P"_Y_PH_P"%:?M<
M?\\-3_[_ )_PK])?^$?TC_H&)^5'_"/Z1_T#$_*M/^(?P_Z"ZGWF/_$5)_\
M0!2^Y_YGYM?\*T_:X_YX:G_W_/\ A1_PK3]KC_GAJ?\ W_/^%?I+_P (_I'_
M $#$_*C_ (1_2/\ H&)^5'_$/X?]!=3[P_XBI/\ Z *7W/\ S/S9/PT_:X_Y
MX:G_ -_S_A1_PK3]KC_GAJ?_ ($'_"OTG'A_1N^F)^5+_P (_HO_ $"X_P!:
MG_B'ZZ8NI]XUXJ2_Z */W?\ !/S7_P"%:?M<?\\-3_\  @_X4G_"L_VM_P#G
MAJ7_ ($'_"OTI_X1_1?^@7'^M*/#NB$<Z;'^M'_$/_\ J+J?>'_$59+_ )@*
M/W?\$_-7_A6?[6__ #[ZE_X$'_"C_A6?[6__ #[ZE_X$'_"OTJ_X1W1/^@;'
M^M'_  CNB?\ 0-C_ %I?\0__ .HNI]X?\15?_0!1^Y_YGYJ_\*T_:X_YX:E_
MX$'_  I?^%:?M<?\\-3_ / @_P"%?I0?#^B@_P#(+C_6C_A']%_Z!<?ZT_\
MB'__ %%U/O#_ (BI+_H H_=_P3\U_P#A6G[7'_/#4_\ P(/^%'_"M/VN/^>&
MI_\ @0?\*_2C_A']%_Z!<?ZT?\(_HO\ T"X_UH_XA_\ ]1=3[P_XBI+_ * *
M/W?\$_-?_A6G[7'_ #PU/_P(/^%(?AG^ULPPT&IX_P"O@_X5^E/_  C^B_\
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M[?TCX3!?25QV'S/^S\]RJE2D]I\KY7^)Z0WPO_:[N)=R6VI]/^>Y_P *=/\
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M?_@0?\*/^%:?M<?\\-3_ / @_P"%?I1_PC^B_P#0+C_6C_A']%_Z!<?ZT?\
M$/\ _J+J?>'_ !%27_0!1^[_ ()^:_\ PK3]KC_GAJ?_ ($'_"D_X5G^UO\
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M/\O_ *]2^ (W_P![J??_ , /^(J3_P"@"C]S_P S\V_^%:?M;?\ /OJ?_?\
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M+R:,.TEU$=V&7/;'K7WV/ADG">64Z<X*<VMGU.&/M<2VT?&O[,/_  68\?\
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MU.;E3T2>Z75L[RZ9WO(=D+*/.7G'N*_2C]C6XMA\,4@692Q5. ?8U^3-Q/\
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ME*3ZGX%%S4$N@E%%%*[0"AF'&:-[>M)12 4LQXS244478!1113NP"BBBCF8
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MV.;KX9GXI?L1OIUI\;-'GU/:(7U& 1ACT.^OZ-/")MF\+V#P7"LGV.+!4_[
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MK_\ K5\AP9Q7D^7X&I2KR:;F^G1V/NO$#@KB'/\ &TIX6":C!)^]V/N7)60
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M8'DU+1@>E)12V#4@92S%6'RXZBHS!" Q()4C!%67^E-4@<,HII-+0%='Y/\
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MN\;&VVAE8L<\#M0!]$VRE$P4QS4E0V%Y'?VD=Y$04E0,C#H01D&IJ "BBB@
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M+C<CGN/6OR/_ &H?V0?BM^QU\2&\8^ +N\>R20RBZMD"JH+;MO05]D?L!?\
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M8]+\'>';2V=$VF6!",C'O7UN(S#(.%:2HX&'M*W\SV3,%"KB-9/0^8/V(_\
M@D'\-?@3IMMXE\70+J>H[?GBO8,D''^)K[2\/>'=*\.V*66D:9%:1( HCB7
MX%7X(95.YG)'85*,L#E*^!S'-,PS?$<V)GS+MT.N$(4%9$>P[2RIGGI4B(2H
M.V@[HT)"D^U/0EE!(Q[5RI6T6PW9NX*N.3UI:**8!1110 4444 %,G!*\+FG
MTV4A1DT+<3OT(?-E3I$,4@F\S[K<^E)-/N&U1QZUA^.?%MKX&\.S^(+A0T<(
MRQ)X%$$Y5>1&=::H4G4F]%N;J&7/S1\4DP?<-JU\T+_P44\*?VA=62V,)-M)
MM/[P\_K3O^'C'A13A],AS_OG_&O6IY+F51\T:3L?-RXXX;I2]ZO&_J=1^W6K
MO\)90!@B.3^0KYO_ ."7#>9XKEC?D@2_S:NF_:2_;(\/?$_P)+H^FV<0D"/O
M57R0"/K7D?[%GQ[T'X/7SZOJ5I&%)<;W;&<Y]Z_,<XRS,7XA8.BJ>O*_T/V[
MASB7(JG@YF6+E77LU):]%OU/TOCGF2Y6$Q?*5ZTLLDD<H$:9SVKYK3_@H]X-
MD&?[,@R.,^8?\:;=?\%&?!UK9O>2V$&$]9/_ *]?IRR+-[-NF?AD>.>$Z47_
M +5'[SZ5AN;LN1+#A0>M3EBQ#1MGU%>6? _]I'2?C1$\NFVR*JXR4;/I[UZA
M RJ[+NZ5YDZ<Z4N6:LT?28+&4<=156E*\7LR5P7YS@YJ4=.:A0 ODOQZ5-47
M.A*S"BBB@H**** "BBB@ HHHH **** $+KNV&@J".E(8\ONS2DD=!F@!%5@>
M:=2;C_<-+0 4444 %%%%  >1BF^7[TZBE9,!OE^]'E^].HHL@&^7[T>7[TZB
MER@-\OWH\OWIU%.R ;Y?O1L.>M.HHL@$"@"D,?I^5.HI<H[L8H)/2GT@&"3Z
MTM.R$,<8.<4^D(R,4M%D 4'D8HHHL@&^7[T>7[TZBBR 8X9%)49XJ%8#<QGS
MEVG/%6'4LN V*0*53&<TG%,"(VP<@K(?EKSC]I']G+P1^T'X0F\+^*[*%GD@
M,<,SQ[F3)ZBO3-I53@<U')%_$R[CV]JJE6K8::E2=FNHG&,E9GY%?'K_ ((:
M:WI^HR3?#VZO;E)'.%C3  KR=?\ @B=^T(DP0Z-J6S/O_A7[E/"[A<CO4AB8
M'DYKZ^AQYG%"DH*SMW.>>$HR/R8_9Y_X(67-SJD%[\1[^\M51@S121Y'!S7Z
M3_L^? 3P=\ O"">$_"5K$(U"[Y$CVDD#K7>,'C7<%R>E"PD)M3Y<\\5XN9Y_
MF><3MB)>[V-J5"%-:"QA@2TBX -2C81D'%0R6\KLK>80%'(]:E .. :\2G>2
M--F+A?[WZ487^]^E&#Z&C!]#6G*@NQ<;^>E'E^]*@('-+3LA#'4[=H/6LO6_
M#UKK&FW&DZA&)8;M"DB.,C%:LBEA@'\:;L+#:W;O4VDG>.C[CNK69^?/[8W_
M  1G\$_%/6KKQEX-U"2UN[AB3!:PX [X_6OD+7O^")GQSL[UAHNDZBZYP) #
MR/RK]OQ:LLC2,VX8X%+&K,I8QX]J^JP/&>?Y?15.$N:*[F$L-AF]M3\4O G_
M  0Y^*]_K44'B:VU"WC8Y>8J>/TK] /V,?\ @F?\-?V7H8=8@F6^U %9-T\/
MS*WIFOJORY)5)Q@YI[0JJ_=Y]:PS3BS.,SA[.<N5=;!##48:C;>%?+"J@4 <
M =JG4;1BH5$D?<G-3+G:,]:^;BN65MS;3H+1115<P!1115 %%%% !0<8YHI'
M7<,4 ,F!"X44C3E&6,]2*?&Q/!J&ZPLZR'M0!X!_P4-_;C\$_L6_!S4/&/B"
M]C%T+%I+.+S=K.P/0?D:_F3_ &[/^"^7[6O[17C&]MO"/Q)U"PT-I2;6R9B0
MBG/'6OK_ /X.R?VF/%.I^*?#?@72=2>.W@N)8KB,D_,,2>]?B;H&A77B:_M]
M(T73)[FYFD"!(8RY)/L*"EL=_=_MD?M#WUPUY=>/KAI&/+G/^-1C]L#]H1OO
M>/IQ^?\ C7N/PB_X(R?M;?&G08O$&A>'Y[*"496.\TV16Z9[D5V9_P"#?7]L
MV;YO*B_\ F_^*H'J?+?_  U]^T%_T/\ /^9_QH_X:^_:"_Z'^?\ ,_XU]1_\
M0^'[9O\ SSA_\ F_^*H_XA\/VS?^></_ (!-_P#%4 >+_LP_M4?'74?VA/"%
MK>>.II$EU= R_@?>O[!?V$-0OM;_ &8] U+6;@S3.A)<]_E6OYEOV=O^""_[
M7G@WXV^&O$FJQ1>3::FDCXLVZ8/^U7]/O['/@76/AQ\ M&\)^(<&>W4A@!CL
MO^%!!ZBBM(F2<#/2I@,#%,"GMP/>GT %%%% $3NI+9CSMZ5S?Q;NYU^%7B"[
MMY/*=-'N2K'U$9KIMI!9L]:SO%.A0>*/#-]X>NERMY:20G/^TI% '\;_ /P5
M;^.GQ/N_VD=7\+:GXDEFL1-*1#V^^:^/;F=KJ5I) =S'.37]1?[1G_!M%\*?
MCO\ $ZY\?:GH]F[7#,27G0'DYKA1_P &GOP,/RGPY9Y/_3PE!2V/YM]-U[4=
M&4_8;DJQZ$5HK\1?%Z)SJCGC\J_HV;_@U'_9ZM3B]T/3US_>NXQ2VW_!J/\
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M3\: %HHHH **** "DA^XW^]2TD/W&_WJJ),OA^:/)OVY_P#DEB_]>C?S-/\
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MH **** "BBB@ HHHH **** "BBB@ HHHH JZM!-<V<EO!C+KCFOPU_X*S_\
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M9:'Y]5X>XOX6BZF35G5I]*4W=V\I=/N/I;PYXR\-^*-/74=*U*)E?H/-7/\
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M8]_]4M,I[_ZI:96QSA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !3I""!3:<W0?2G:\12T5P) P#ZUD?%?_DGMX?\ IV?^5:TGWU^HK)^*
M_P#R3V[_ .O9_P"5<V.]W+JMOY7^1WY2K9QAW_>7YGRG^RD"?C//C^X?YFOL
M[5?N1?\ 7-?Y5\9?LG_\EHG_ -P_S-?9VJ_<B_ZY+_*OB?#3W>&6EUFS]*\8
MM>+H?]>T4V4DYHV'U%.HK[[[3/R9;#=A]132,'!J2F/]XT^@Q****0!1110
M4444 %*GWA24J?>% #Z*** $?I^-,I[]/QIE !3TZ?C3*>G3\: %HHHH 0L
M<4;QZ&FO]XTE #]X]#1%PI'J:93TZ?C31,OA^:/)OVZ?E^%B9_Y]&_F:?_P2
MT_Y$R(_].O\ 04S]NS_DER?]>K?S-/\ ^"6O_(EQ?]>O]!7Y9BO^3BTO\/\
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MY4@8QQ38II",,*GBY&2*^144Y*9^_.[MY"1QMUJ2D8X&:6K%U"BBB@ HHHH
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M\'_^#;C]I_XE>'+?7-<M-5TJ28 F&6V&0, ^AKOA_P &KWQZ8!CXOO\ D?\
M/J/_ (B@=K'Y<?\ "U?B5_T.-]_W^H_X6K\2O^AQOO\ O]7ZC_\ $*Y\>?\
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MBC1(RA2!V-6-^,*#DU\N]#]:34MA]%%% PHHHH **** "BBB@ HHHH ****
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M@_FM?GWB/_R)L/\ ]?%^:/V#P=_Y'N+_ .O+_(^Q/!7_ "(UA_UZ)_*K,?\
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M=37Z_A2&-HHHH **** "I*CJ2@ HX[CBB@X[T ]B,K 6+!:<C.C[H\CTI5$
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MFFMR9=":'_CVF_ZYG^5?%/[0G_)P=M_US'\UK[6A_P"/:;_KF?Y5\4_M"?\
M)P=M_P!<Q_-:_/?$?_D38?\ Z^+\T?L'@]_R/,9_UY?Y'V#X,_Y$BQ_Z]$_E
M5Z/_ %1^E4?!G_(D6/\ UZ)_*KT?^J/TK[O#?[M#T7Y'Y3B_][J?XG^8A^Z*
M2E/W125L<X4444 %%%% "H0#R:&!)R!24]/NB@!J@@Y(H<@G@TY_NFF4 %%%
M% #T^Z*'Z?C0GW10_3\: &4444 %*O4?6DI5ZCZT /HHHH 1_NFD;H/I2O\
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M_.C_ (*(+(GBIKAA]ZX4=/>G?\$_[B./XF1[CS]F/?V-<L7%\*_]NL[ZO/\
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M7YWBO]YGZL_H[+(\N745>_NQ_)"T445@=P4444 %%%% !2.&*X6EHH 8H*L
M* J19)/6ESF08IEP?G44 ?AA_P ';&IZMINA^$9-/U:ZMLB7BWN&3/\ K>N"
M*_GEO=<O=34'4;J29P<[Y7+$_4FOZ\O^"Q/_  2O3_@HII6C69>[0Z6KX^RD
M\YW=<'_:K\XX?^#1FQ>,23WVM*3Z,W_Q5!2O8_"2&XO4/G0W#)Q_ Y%.&L:S
MR$U:Y S_ ,_#?XU^[C?\&BMF!^ZU'6\?[S__ !5"?\&B-FX_X_M:_P"^F_\
MBJ!,_"/^V-;_ .@Q=?\ @0W^-']L:W_T&+K_ ,"&_P :_=W_ (A#[3_G^UK_
M +Z;_P"*H_XA#[3_ )_M:_[Z;_XJ@1^,_P"R=K6KS_M'>#H)=5N<'64!_?MZ
M'WK^S_\ X)]HZ?LN>'U#EAY9Y8Y/W5K\=OA3_P &HY^''Q.T3QK:W&KM_9U\
MLS;V;' /O[U^VO[._P ,Y_@Y\+-.\!KO)M!@^9UZ ?TH ] !4':!2U&LI!Q(
M,5)UH ***"0!DT -*EFY[4FQA(7R.G%)YL:-N+?>Z56N[O;(T8/$8W,?:@".
MYE?S?+_Y:#DYZ8KG_&OAGX5^-M.?2/&%MHLN\88W*0LP_P"^J^!_^"Q7_!<K
MPW^P+:W7@_P)<V%WXD$8Q:707[K#KGGU]*_#'XO?\'"O[7?Q+\23ZE&Z6D<D
MCE5M;UE&"?9:"EL?T>>.O^"6'[$/CW4GU;5H=,1W8LWDM !S]#4W@'_@EW^Q
M'\/=2CU;1[?2Y)(G#*)V@89_$U_,9'_P7&_:^C5HSKDYS_U$G_PIH_X+C?M?
MM^[_ +<N/;_B8O\ X4#/Z^O"FC?";P9I\>G^'CH-JL8P# 8$/_CM:R:[X?O[
MDP0Z]92$#A8[I"?R!K^.^+_@M]^UU&S";Q!<@XZ?VD_^%?27_!+7_@K'^U'\
M7OVE[+P[XAU>>2UDDA#!KYV&"^#QB@-S^I&Q5EB.XCKQBIZS/!ES+>^$-+O)
M_OS:= [_ %,:DUIT$,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH :T8))'>D4+%P<TN7#'(XH)#CY: ,KQ\#_PA&LE0/\ D%7'/_;)J_C'
M_P""MV]OVNM4+$\:E<]_^FHK^SGQWAO VLX_Z!5Q_P"BFK^,7_@K:&_X:YU7
M(_YB=S_Z-% T?T(_\&QS%_V8+]3_ '(?Y5^GNU5(YK\PO^#8O_DV&_\ ]R+^
M5?I\<9&?PH![BT444""BBB@ HHHH ****+ ->)77::3RU1>*?2/]TU-DKV$T
MF[E>6TAGC:*9 RO]Y6&0:_*;_@LU^PO<:'JT?Q_^'6G,MX+IKFY:($ !<_W:
M_5ZN0^,WPZT?XI> ]3\'ZW8I*M[:/%'NC#$$^E>OD.;5<HS.%>.VS7=>9-6'
MM(N^Y\+_ /!%G]OA/BCX'M?@OXSU,#4["!I'$K8)^7 Y//\ #7Z'I+(S@+C:
M0",5^ GQW^'_ ,0/^";_ .V++KOAQ9H=*>]@BWM(RC;YASQ]#7[0?L=_M&Z#
M^T=\*K'QAI=ZDL@B2-PF.H49KVN+LGI8>?U[":T:NMUT;Z'/A*KFG">Y[*'&
M!D4!R6Q3!%D9IZJ1R:^+BW8ZQU%%%:K8 HHHH **** $90W!IH@0'-/HH ;Y
M,>W:5X/8U7;2--#F4V4)/J8A5JD?[II65Q;(IC1M*W9&G09_ZY+_ (5YU^TO
M!9V/PRU3R;" %K0\^4/7Z5Z>O4?6O,OVH_\ DF6I?]>C?S%=>$TQM/U1P9GK
ME5;_  2_(\(_8#DAG\1:@EU:0D>2,9C!KZV:QTD'>;"')_Z9"OD3]@)@?$U^
M!_SR%?8<K1B/:3SBO3XA268M+LCYC@",7PM3D]^:7YGFGQ[^ _ACXG>&)H9M
M,B\S&5*Q '('%?%EGXJ^*/[)'Q$%K-"%TKS6<DJ3@9&/TK]&(Y&$!5T!!/0U
MYG\?OV=?#?QCT26VGM@D[)A6CC&>GK5Y3FJI)X7$ZTY?AYHYN,N$:F:1^N99
M/V6+AK&2TO;I+NC8^#'QG\/_ !8\(1:AH]ZK7'D@RJ6 ^8^U=?97+;_*<_,O
M6OSAM?$?Q,_8Z^)RV-PLG]ER7))::4D!1[$5]S_!3XP^&_C'X8M]7T>]5Y_*
M#S*N!@_A1F^2O M5J#YJ$MI=O)AP?QM#/>; 8Q>SQE/24)?:M]J/=/R/16G?
M'RXIPE++[U3MY95)288Q5@.,9!KP-);'WZ<.9+6[)D9R?FQ3JCB;+8J2I3;W
M0[6"BBBF 4444 %%%% !1110 4444 %%%% !1110 4$ \&BBD]@,_P 3<:3)
MCTKR*]&-0F_WJ]=\3?\ ()D^E>1WO_(0F_WZUIMG/6W& D=*7>?04VBM6<2'
M;SZ"D)).3244AA1110 4444 %*'(I** ';SZ"D+DC%)10 8&W8.E X&W/%%%
M "JN1MI9(LL"#@CTIHSGBG/%(%W^U.]U8-;6)[/4GL&V,H='^^KC(-?-_P"W
M1^P!X._:"\-7/C#PA9;-75&EE$>$&>V,5]&1^5,NQSR*?;S36,P$*[P3\R-T
M(K:AB*N'GS09PYIEF SC!2PN*C>+T]#\A?V>?CW\7?V#?BG_ ,(GXM:5+.-E
MB82[F&"Q'>OU3^"'QL\%_M%>#(?%/A?4$:Y*!6C+@<XYXKR[]M_]AKP9^T[X
M:N-3T&Q$.O1AIGAM(@OW1D<CW![5^>_PH^,?QD_8'^,"^&_$BR)#%*?W-Q,Q
M79NZX(]*]WV=#-L/S0TFC\NH8S-?#S-%A,<W+!3?NS['Z]36]S:(^]<,#W'6
ME>6,A!&#G'S5R7[/O[2'@3]J;PA!JGAO48WOTC6-X(P -^.>A]177V=K=2WS
MP746UH7P .]?/RIRHS<)[H_6L)7P>8455P[O!JZ:VL"*;G,=M&VX=<BAK6ZC
M 6:,Y[X%?.7[0?\ P4[\'?L^>*YO">I&T6:&8Q_/&N2:X#_A]IX-.)"+ DGO
M$M;0P&(FN9)M'@XKBGAW#8ATJM?E:W/M-+>::*9;:-N(F)ROM7Q)^T V_P#:
M%MH"")/+]/=:NM_P6M\,MF*&'3P)1LR(U[\>E>;^+OVA=*^)WCR'XBPF(!(\
M_(HQV/\ 2OSSQ+PV)IY507(_C7YH_9O!7B/*<;GF+^JU8R?L7I\GJ?H#X+M+
MI?!=@'B.#:)T'M5Z**3#+Y3?]\U\96'_  6:\*>'=.C\-/'8[K)!"<Q+GCBB
M'_@MGX.B<[TL.O>):_0L+EN.^K0?L^B_)'XYC.-.'(8VK&6(C=2?5=_4^S/+
M9<F2)MH_V::5\X;[;[O;=7RCX'_X+%>"?'/B:S\+*+$&^G$0*Q+GFOJ^UD76
M=%AU333E'.<CCTJ:]"M0:52-COR[.,NS>,I82HIJ.CL)'&<;9/O4A4IE9.O;
MZ4Z5R80P/S9P:9.6,JY_NU@>B%%%% !2AB!BDHH 4L3Q2444 %%%% "AB!B@
ML3UI** "BBB@ HZ444 .WGT%&\^@IM% "ER1@BG2J H(IE23?<6A_"*6D;H8
MP!*UD_%?_DGMV?\ IV?^5:Y_AK(^*_\ R3V[_P"O9_Y5S8[_ )%E7_"_R._*
M=,XP_P#B1\J?LG_\EHG_ -P_S-?9VJ_<B_ZY+_*OC']D_P#Y+1/_ +A_F:^S
MM5^Y%_UR7^5?$^&O_),_]OL_2_&+_DKH?]>T4WZ_A3:<_7\*;7Z ]S\E6P44
M44AA1110 4444 %%%% !1110 4444 %*&(XI** %+$C%)110 4444 .2/>#M
M(S31'-"W^DXV^U*BY;@\CM2O)YQ\MCTII75Q.45[STL(S1,1Y><>II21&,.>
M3TQ3B8POE(,FD@!#%[@8 Z55.G*H[Q3!RC->ZUK^!Y+^W2X?X7(%_P"?5OYF
MG?\ !+DLO@J(+C/V7^E-_;I*R?#-6C/ M6_F:=_P2X./!T97G-KS^5?EF+][
MQ&INUFH_Y'[GEEUX0UKJZYS[ $DI&>*4.Y'--,@4",'FG*#MZ<U^D?9NS\AM
M]H42\[.].^?VJ-2HE )Y-2T:"7-U#ZT444#"BBB@ HHHH *A>=A*8U[#-35!
M=JXYC')ZT728=&(D[LN]R,57GNFAER[ )C))I?*V189N,UXE^W/^T;I'[/\
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MQSF@< >]$G:CLOUI=1=3Y@_X*H1AO@+(#_<E_D*^/_\ @A8,?$^XQ_SRF_\
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M![F675H5(M/F>_8^0_\ @H+'*^H6B$@*LQQ^M<?^Q,\</C]P">44<_C76?\
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M.]MXYN!GYI'*\^Y(K]-/'4[-X)U!R@):T?C\*_,#XLPZ\?B&_E6?R_:!@_\
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M]VTZ/S-KEP?X>1Z&OY8OVN?^"LO[3W[4OC2\UV[\>ZK9V-Q)NBL'E!$?7ZT
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MNI)=S23G))+ F@:/ZC_^#8P%OV7]0Q_=AK]/6C8D'=7Y;_\ !K]<FX_9AU5
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MX^O^(ZJ.,::M'9GZT\K\'90Y9UIQ>FW_  QF?M+_ +2G@?XD^#SH6D:A"[B
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M_;8--.Q'91B-=HY]ZL4V.,(, TZO/BE%6/KKM[A1113 **** "BBB@ HHHH
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MT/\ :*U_&Y_:/B=0(Q<WH [*[BG&]\4X&;R_YZ?O'_QH#1G]DDG_  6>_9'
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M0OI5C?\ ^FW<CV[QQOEL, O0<]ZWPU!XFLJ:ZGEYSF>'R?+YXNL[1@KGP/\
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MDJS6@4444#"BBB@ HHHH **** "D?[II:1_NF@"AXD_Y!$O^[7D=[_R$I/\
MKI7KGB3_ )!$O^Y7D=[_ ,A*3_KI6D3FK[#'^]24K_>-)6AQK8****!A1110
M 4444 %%%% !1110 4444 %%%% !3DZTVG)U_"@!U%%% "/\L9D':D1C*N&'
M%+(?W9%*CHT11.M "1K+:GSXR>.>M8OQ3^$WA7X_^#IO"GB73(68PL$E$*[L
MD=S6W'<+%&8Y:S/B5\0M,^$7PWU'Q=J\ZPK)92?9F/=@*NDINHN4PQ2H/!U%
M6C>%G?T/QY_;._9VO_V7?BQ=^#/#^HRI:J0P5+D_Q$^AKR*66[C.V\"D,,DC
MFNW_ &COC-J'QK^+-]XMUF]9HY"40[\C@G%<+'"\#[96+ G(+>E?IN!@UA%S
M;G\0<25L!/-*LL$K4KNWH?3'_!,7]I*?X/\ QAL=#U6^9;.YNMSJS9&,BOUF
MOKK3]1MK/Q+I+EXM23S6([#G_"OP'T_5]3\+:E'XAT$;I8>0<XQ7ZV_\$_/V
MT_AG\4OAM;>"?%6OHFJ6EJL*1X!._/U]Z^8XAP,(5%4IH_;?"+BRG/#/+<14
MY?Y;GT+<J8,/ ?O=:8"5^5>OO5YM&G$?VNR!DA(RA)JHSQN<7)V-Z"OEM>Q^
M]^SE""?1[!LB0;[DG\*0.C-^YSM[YH,;8R!E>Q-/65RFQ8AM[F@D2BBB@!K]
M*;3WZ?C3* "BBB@ HHHH **** "BBB@ HHHIK<-QRL ,4C'<:2@9W@]JL4XJ
M&Q,D:NN6)%.%LP!EA=3MZY-9_BG5KC1="EU&SC#.G137RMXI_;#^)FC>([C3
M+32(602E5RW_ -:O S?B/*\CE;$1DY-7T70^NX5X+SCBQ3EAY145I[SL[GUP
M]MYR^>[KE.3AJPOBI=23> +Y(F0XM7SDCTKY9;]LKXG&)XWTB$9'3=_]:LW4
MOVK/B/K6DR:1>:7$J31E,AO7\*^5J^(V0UL)5I1A-2DFEH_\C['+/"'BK!XV
MG6E.'+"2>C7?U+G[)\3M\6IG) ;![^YK[2O;9IUB\Z1!^Z7HWL*_.WP3XS\6
M_#O7&\065BK.W9C_ /6]Z]#D_;1^*3H%_LB'Y5Q]_P#^M7SG _%V59+E3H5E
M/XF]F?;<?^'V=\3<0+%X.4>102>JW/L5;<ROY22+^+4V>!PVTL"%Z[37QK-^
MV1\6(;=KE=&A^7I\_P#]:O5?V8?CUXW^(^H2P:]IL:*9 .#GT]J^XP''>48[
M%1H4U+7R/S#,?"WB7),MGB,1*/(O/4]R1X6RJ9W+2;V?YG&#5B53;3NZH,GM
M4#.SG<Z@'T%?93255<GPM'YTIPFO=Z:"44450$B]!]**%Z#Z45F -T/TJ.I&
MZ'Z5'0 4444 %%%% !1110 4444 %%%% !D],T444 &3TS3C]RFT\_<_"CJ
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M4Z7IAX.G0?\ ?E?\*6/2M+&<:;;_ /?E?\*L[!ZF@*%Z4DF! -*TL<C3;?\
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M!*S:LK"4444^81(O0?2@D#J:%Z#Z4V3M4@*Q&#S3*** "BBB@ HHHH ****
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MHA)W<FI:=[EV?09ANF#0$SR:?12!)C?+]Z/+]Z=10,;C;_#FE"@CE<4M%*R
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2U;6/$=_/J&HSS7$]PY9LL6))JY9_#7X@WE@^IQ>!]8-NB[A,-,EV8]<[<4
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M^W!_R>;9!7#'9]X'(^\E>SE./Q.(G[\C\Q\0>&,FR_+:$J-&,7*:Z+;0^I_
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M\ )_S&+?GL+E:='\:? DG"ZM!_X$+2E2J0^),F.-PDVU&HM/,ZEB^*9E_?\
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M3J=F3)N8AE/>K(Z<U"D)C^1/UJ;ZUFW=(]AKWKA1112 **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI&.!F@!C9\X>E.9 7!H5.=Q
MZTI!R#0!\9?\%1/^"5G@/_@HAI^EV?B\W(_LP-Y7V:0KG.[K@C^]7Q!9?\&G
M/P'AMTC<:F<>MPW_ ,57[4NK.X*CH>:=(P44 ?B]'_P:A_ %)2-NI8Q_SW;_
M .*J*/\ X-0_@&SYVZEGWG;_ .*K]H#=H'RQ&*D61&Y7KZ4 ?B[_ ,0G_P !
M78!UU(#_ *^&_P#BJBE_X-0?@"L@C0:GS_T\-_\ %5^M7QJ_:-^$GP$T]M=^
M)OB<6$$2;G9L8 _$BOSD_;2_X.;?V;?@I)+IWP@\7:;JU[&&'E3A!\PSQU-
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M *;+&'QZBG4CL5QQUH KM9+(QW$YQ3(('AE*2#*X[U:,?S%@3SVI P4$,.U
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ML1C/X&OB#XD_L4_M(?LN:])XE\'/=_983E0+N0\#GH#7ZO07-Q!(VR5E+#&
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M]#0/W"NP8K\QI$C9FY)_.K!T]P.0:C:&2#H*!:=!'8PKTJ,/Y@W8J5)5?Y9
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MAC7%BN(<QQ$>6]EY'T&4^'O#&4U_;0H\\_YI/F9@^&_AUX5\+6B6UAI, "C
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M39B6%A"3W)B%(-,TT'YM/A_[]#_"K!(9@8ATZXHDW' Q1S-22(483EJCR/\
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ML]<\9VFE>(+ZR972X\H@[AW^Z*_13P[X?T;PII\7AWPYIZV=G ?W<*]!_G%
M&^%._>&XQTI77<N <4Q WF9SQBI* $*DC&:\&_X*8^#CXU_8H\?:)''ODFT1
ME08Y/S"O>JR/'?A73_&WA.]\+ZK LMO>1;)8W'!% '\+'Q_\.W?P_P#C)J>@
M21F.:RN.AZ@U^]/_  ;=?\%>?@WX*^ ^F_LV_&SQ?9Z1'HUJ\RW5U(<LQ0#&
M,_[%?%?_  < ?\$K?B%\$OCOJOQC\!^$;F[TK5;]FV6D'RPH,\D\<5^9&D>)
M/%'@S59+G1;N2RG*[9 O7'/%!5C]N_\ @YG_ ."K7P[^,GAVX_9_^"?CJ#4K
M%FCG^UVDO4\9&*_#C2K/4-=U:.TMX&FGFD!QW.34NL^)-6\3ZH-1UJ=[J=OE
M!;J:^[_^"+/_  2N^*'[7WQVTC7]8\-75KX?28K/>309B4[AC)Y[ T$L_=G_
M (-V_P!F:]^ 7[+O]KZUIAA.N6D-PK2+CT_PK[2^.'[5?P7^ 'ANYU_Q]XUM
M;%8(2ZK,< XJ#PW\-6^#G[/ECX'\.2A'TG34@5HA][;FOY4O^"Q'[:_[56J_
MM3^,_AIXA^(>I#1K357AMK64C9LQG H!'4?\%_?^"D=C^V9\<M1\*^"-02[T
M.PO_ #;.X@DRCC)Z<_2O#/\ @C]\,=6^*'[6>EZ3I=NSR6US;SN$'.U9,G^5
M?,VFV&N^+-2CT_2K.2ZO)W"HL8RSL>@K]^/^#8S_ ():>(_!UW;_ +2?Q6\*
MRV4MW9/$MK>PX8$*2#_X]059'[J?#JS&G^ -$LMFTQ:1;(P]Q$HK9JMI>Q;-
M((TVK$H11[ 8JS02%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 -,8.<\[NHKD_$/P(^$?BW4I-7\3^ M/O;B3[\L\1)/ZUUU% 'F'C3]F?
MX"V_@S5Y8/A;I2,FF7!!$)ZB-O>OX_?^"M-CIFF?M::C9Z-81VL*7]PHBB&!
MQ*!7]GGCOCP/K)_ZA5Q_Z*:OXP_^"MS%OVO-4_["5S_Z-% T?T)?\&Q^T_LN
MWX5,?)#FOT\5 QR>U?F+_P &Q@'_  R]?\?P0_RK]/< =!0#"BBB@04444 %
M%%% !1110 4444 %%%% !1110 4444 (PR,4TP*PP_/UI]%2TV!&8 PVD"F3
MVZM"RL@;<,'Z5/3+ARD9(%3*+W!+4_,7_@M3^PA_PEGAFZ^-'PXT\V]WI]J=
MWV2/EF(SG/X5B_\ !%;]NJ]NFN/@=\1KTK>6LJ6EJES)ECC:>/S-?IEXV\*:
M)X\T*;PCKFFK/:70_?*_0U^'_P"VS^S_ ..OV"?VG8?C'X1\Z+3IM2>ZVP)A
M54#'7CTK]&R#$4>(,HED^*?O;P;Z?U8Y)T_8U><_=RW8("R'*]A4@NE(&.I[
M5\]_\$^_VK]%_::^"VFZU#J*3:@MF)+N,/EP3CK7OT$L<J$B/:V.E? XG#U<
M#7E0K:.+M]QU1?M%S(G>:16PL>13T8L.15=9':+.><U- <KR<UCS/FM8=UL/
MHHHJ@"BBB@ HHHH **** "BBB@ HHHH *" >HHHH :$(D+[NO:E*@]:6B@"G
M/!##&5# ,3FH(BV\*\7XUH211.=SKS2&&)U^0#ZT-7 \Y^._P*\.?%3PS+97
M&F1><T1"R[,E3GK7PO+8?$S]C[XG23Q&ZNM),RHB.V$50>2.E?I7*_DQE'Y!
M%>:?';X&^'OBUX:FLY[:(3&-MKL.<FO=RG-98:7L:SO3?0_/N,^#*>=P6,P3
M]GBZ;O":ZM='T:?F)^S_ /'GPY\:/#$&H6=]&MRR_/ ASC KT8S8^4#+>E?F
MM<6WQ4_8O^)!N86NI]+\U4 C7" %L'T[&ON'X#?'_P +_&/PW#J&G7L0N]H5
MH0^6R!S5YSD[PM15L,^:C+KV\F1P5QG_ &TWE^8KV>-IZ3B].:WVH]T_(]1$
MN,!ACBD:=AG:N?2J[2F0 @]!S4Z,NT9.:^=OS.T3]$5KV[#EG)QE<5)4(;+=
M,U-33?4-;ZA03@9HI'^[3 H^)!NTB0^U>0WV?[0EP/XZ]>\1$?V/)SVKR.^*
MG4)>/XZN!S5R-20>!2[R.JT;@I-&\'JM:G&M@,AQPM*C%ADC%(&4]5 IPQVH
M&!&1BF^7[TZB@",C!Q12O]XTE !1110 4#@YHHH =YGM1YGM3:* 'A\G&*6F
M)]X4^@ I&.T9Q2TC]/QH 3S/:CS/:FT4 .($@YZ>E* 0-N[CTH3I^-+1'W7=
M!'W7=";% ^0;?I3!"0^]GS4E&0.IH?O.[!ZL3'[PN.XQBA$14*$9YZTN1ZBC
M(]13NQ-7;?<82!PHQ[TYIF9-F33#R311=CV'PO$N \0;ZTLH1G+1+L!["F+U
M'UI](35P4 #GD^M,*  DG)]33Z1AE>*226P60B/@_,,CWH>/<=R'%)@^AIP(
M Y-,;UC8%55()&2.].<AI"^.HQBDR#T-%"A&]Q4U[+X1;-WLFW0.1]*)[31=
M94P>)]"AU"-CR;@9 'I24A+CD-D=U]:MQ30/EYKRC?R/ /VBO^":/PE^-.GW
M5]X8^S:;=R*2([:'G<?P-?"WQ1_8_P#VG/V5M;%]X,N=6>T@DRLD9 ! _"OU
MIBN9X)!-:L82.]&N6VB^,K/^SO%&F+>(1@B2O1PN:5H?NZCO$^.X@X%RK.9^
MWH?NJG>.GY'YK_LX?\%7/'7PVU:/PE\5=):0QX626\FY]/7VK[P^$W[5/P<^
M.NFQ:CI7B>TM[B0#]Q$<\UY5^T5_P3$^$_Q:@NM8\*6EEI]XZE@%0EL]NU?#
M?Q%_9,_:F_95U)M0\#WFIW%O!+N#6L0QC.>^*[Y4<LQJM2=I?J?*+,.,N$)\
MN,@Z]!:*2WLMOP/UYO-,N(T%Q"2T)4$2]L54DPL@13NS7YR_LW_\%7O&G@B_
M@\)?&+2;N;8=K_:Y .!QZU]S_"C]JCX)?'.PBDT?Q+I]E<,H!B\TDY->5B,K
MQN%]YJ\3[K)>*\FSR-J$TI=8RT:.R?$9 8XSTIS(R@.%.#5NXLH@JM:$72$?
M+*G3ZU5:)RYB>7;C^$UQ.-]W8^DE-?"EK^ J%68[C@#O2>8C<1MNIH!A_=E"
M_N*D'V5(P%4(U"U5P2NRGXQUQ/!'@JZ\:7:#9;'E6Z'@_P"%?%WBG_@L1:Z/
MXCO-"MO!]M(+6<Q[_,/./QK[#^-VFS^*/@IJ?A6P4RW-P08T0<GAO\:_&/QW
M^Q+^T2OQ.U>\MO"&J/;RWS,A6$8(KZ7AS*<'F*<JTTM;6;/D^)L/Q5.*EE4X
MQ7GO<^S1_P %CHFQ_P 4G;@]QYAX_6E_X?)6Y_=_\(O;DCMYO_UZ^*)/V,OV
MA(267P#JC9Z?N1574/V1?CIX?M&US6? ^I00QJ6=Y(AC _&OI)\*Y9S-QJQ]
M+GR5;#^)>'PCK3KPLE=Z?\ ^X5_X+&H?O^$K<?\ ;3_Z]!_X+):>O#^&+8'T
M\T_XU\ >'_ 'B'X@WQ\/>%K"6:\7K'"N6_SQ72)^Q-^T.@WW?PZU4[AD,8!T
M_.E_JKET'RSJ13]3R,@S+C_B+!?6</6ARIVV_P" ?;1_X+(0@@IX1MFST'F_
M_7KUO]E+_@H7I?[26O2>'WT.WM)$F$8V/DGI[^]?F0O[''[0BDE? 6J9'W1Y
M(_QKZA_X)9?LM_%OX:?$F;Q!XV\.WMO";U7'VB( 8P*XLRR#+<)A)5(U$WTL
MSZO*\'X@4\=%XRI%T_(_2:Y@\BZ:(#@'@U&\?S=:NZ[-%=7;&V78 >U4P,#!
M.?>O@H+W&VWN?HU:FX55VM\KC?+]Z/+]Z=13)(SP<44K=3]:2@ '!S3O,]J;
M10 [S/:C=N^7%-I4^\* %\OWH\OWIU% #&7:,YI*>_3\:90 4444 %%%% !1
M110 4H^Z:2E'W30MP)+'_C]B_P!^O7/#7_('B^E>1V/_ !^Q?[]>N>&O^0/%
M]*FM\)U8?J7Z***Q.H*:S@J=AR1VIQ(49)Q4<:>7N?.<G- #1)@$R<5!<S1/
M%A ":GD429,A 'O5+49[73+*?4)B!%!$79CTP!29G)NQXW^V5^T+I7[/?P=O
M/$M[.GFRH\*H[8P67 /ZU^57[&'PAUG]LW]J4>)O$3RRZ<;Z?]\XW*O[W('Z
M5W__  5B_:8U7XS?%C_A3?A*:26R:YB&(6RN2X!K[0_X)@_LH:?\"/A!%JVH
M:8HO[ETN$D*X8!P6_K7TL(PR[+?;?;D?CF/4N-^,XX>F[X;#;]G+M^!]-^"_
M"]KX-\*V/AK35 2SMEB!48SBM9$9P2R<CH:AMKAUW/(A49[TZYO+;2[674KZ
M\6.%1N9VZ**^:J<U2;MO^9^R4H0IT^1;=#RG]L7X]Z-\ /A#J7B'5;Y()Y+*
M3[-O.-S#TK\=OV7OAGXN_P""AW[8US\0?%@F;34:.XB>3YE8H[-C]!7IG_!8
M/]KG7/CC\78?V>? =S+<+;:GY+-;MD.&)[5]L?\ !)7]D*Q^ GP'TO5=?TI8
MM5D1A*9$P^"HZ_F:_1<';A;A_P"MU%:M5T7=1?\ 2.6_UC$6Z1/J3P%X+TWP
M-X/L_#V@V"6\<,$:E(A@$A0,UNJ"L>/+Y[KZT]Y/)B#A?84$$L)0>,=*_-TI
MU92JMZR._K=DL:X7ICVIQY&*!R,T5:2)$5=O>EHHI@%! (P1110 FT=N/I39
M,*AQU/>GTR;[M)I,"LK-]UI.!^M<E\6?BIX?^&NBRZK?W<:,JD ,>^*T?'OB
M?_A$] N-4%N9"D3$ >PK\^OCW\<_$OQ5\5S:5-/+;VJM_J7/'!_^M7M9+E,\
MQK66RW/C.,N+,/PM@N=ZU9Z17=COCK\;M?\ C/XD<VMY)!9J60LC<'!Q_2N1
MM888ML(B&<<G^_[T6MI!81>7$H"GE@.YI6B95-T'Y3[HK].H4J.$HJE!67YG
M\Q8S'8O,<1/$8IWG+\""&74/#^L1ZUI%\]L\+[RL9QNKZE^!?[9]C!X;73O%
MDZ+)!%_K)7Y8U\PNT;Q;YHMQ8=*IW]FL,/V@1[%;JN*Y<3EV'S2E:<=4>CD7
M$^9\*5'7PUY1>C7ZGU'\2/V_?*22P\):/'<, =IC?DG\Z\@N?B_^TY\8KQK;
M3?#VH6L$C$"2*08%=S^Q9\.? GCV[$6M^'(I'6(L9)!UX/\ A7UUX>^'G@_P
MXJP:/HD<2CIM%?*U<9EN45'"-!2G'J?K&!R7BGC2$<76Q[IT9)>[%*[3[Z;G
MQ=X)_82^*GBN]34?&7C'4=DIW-', 0,]NE>^> ?V$?AYX6\B[N[:"YE4 N7B
MY)KWB%$0! N .@JRH7 P*\;&9_F.-WERQ[+3\CZ_)_#[AG)X<M.CS/>\VY._
M?WF_P.=T'X<^$/#ULD&G>'[>,H.&5*VXHUBC$4<>T#TJQ@>@HP/05X\I2F[R
M=S[2G2IT8*,%9>1 \(;[IQ3/LH)RS9JU@>@HP/04KZ%\J*Z6V#A6P*E\HX W
M4_ ]**2T!12=QHCYR32E!VI:*5E<=V &!C-%%%, I"I)SNI:* $ (ZG-+110
M 4444 97B:&ZN=)GBL&99"OR[>M?%/QE^#_[1EWXVN+_ $&^U0P23941L, ?
ME7W/\H)P.M,EMXI00Z Y[UWX#,*V E>$3Y_.\@P^<Q2J2:]&T?GX_P 'OVF0
MHVWVK9)YPP_PJGXN^$7[1=OX3NWU*\U0Q"WD+%V&/NGVK]"%TJ!#O8#':N=^
M+T%NO@'4X_)! L9L?]\&O:_UFQ%2T536K['S'_$.LMIP;=:;2U^)_P"9^$/P
ML\-Z_>?M(BPLY)5OOM,H^7[V=XS7Z$1_![]HV32M.>TO=4$)MQPK#!_2OB[X
M"IYO[>"K'+Q]MN?E_P"VPK]M_ \4-QX/TX2Q<K:J.:]#,L_Q>%Y/<6J[(^!\
M/^#\'FV%Q$ZM2=XS:NFUV['P@WP9_:;8R".]U;';##_"O1?V9?A=\<M"\5FY
M\5W6H-#E<B9ABOK\V-JG"P#GJ:=':0PY,: $]:\C$<0U\52<)07W'Z/@. L#
M@,2JT*LV_.3_ ,QM@FV3+'YMO-6ZBA15?/>I:^<7-U/O5\*04444QA1110 4
M444 %%%% !1110 4444 %%%% !2,H;K2T4 &!Z4CKO&,TM% #/* ^[^-#X7
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M?U( '*B('BOU"C+9SGK0#1)1110(**** "BBB@ HHHH **** "BBB@ HHHH
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M;_@DQ^REXE_:H^.5W\=/B!#YBH\=W%+<)C<1Z$_6OVNL--M[2UCT^"+:D:C
M^E>+_L)_LU:-^SK\%-)\,0V2Q7\-OLN6&.>!7NJ!0,BN7B?-JF;9FXQ_APTB
MO0NC",(7ZO<C*AV$1'%*Y*N(\<8J4 #H*" >M>$U=6-=0'044=**:T ****
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M<BIJCA0J>34E5KU&M@HHHH&%%%% !1110 4444 %%%% !1110 4444 %%%%
M!102 ,FD!!Z4 +3)>H^M.+8(%)(!Q2O:2&G9GD'[9'_)*;O_ *X2?^@U\^?\
M$QO]:_\ UUE_F:^A/VR /^%4W?\ U[R?^@U\]?\ !,7_ %C_ /727^9KZW+O
M^28Q'^)?J?D&>_\ )V,M_P"O53_TJ!]PKT'TI1]TTB]!]*4?=-?(KX$?KKZ#
MUZ#Z44+T'THJAA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5E^-=)GUWPCJ>CVHS)=:?/#&/5FC91_.M2F7#RHF84W'/
M2@#^4C_@K+_P11_;%\!_&+6OB?#X,272KB\N+@.CLS8=]PX ]*_.'QA\,O''
M@/4)--\0^'[J&1&*MNMW R/J*_N[\2^ /!_C:/R?&'ABSOT9<-'=0!P?SKY=
M_:K_ ."-G[*?[4%G)%<^$M/T>1D*F2PT]0W/?B@#^-6R\1^)M#D4Z/K]_9R
M];>Z>,@_\!(KWC]G'_@IC^TY^S5J<%[X6\:ZA>^2RXCO]3ED7CV8FOU/_;:_
MX-2_$6C7=QK/[/Z:IJ[,698MA4#T'&:_+C]I3_@E[^UK^R[K%S;?$?X;3V<$
M+$"20MV^JT%(_3S]B_\ X.N?B-I<EGX?^/DFG06P95>2"!6;GCJ5%>"_\' 7
M_!0#X+?MO^)X_&'PQUEKE'T^%7)0##[5ST/J#7Y;7=I/8WS6]^#%(A[=C3FU
M._NW\F:]DE0#@.V10#9Z1^QVL\GQRTKR0"=YQN^HK^U#]C)UC_93\"22GE=
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MY1&/I7ZBQ9VC=^-?F#_P;(;F_9BO^. D.?R%?I\K*S;0>E V2T444$A1110
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MF^\H&*\FK.5:ISRW/J(8>GA(*G!*WY!1114EC'^\:2E?[QI* "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ IZ?=%,IZ?=% "T444 ,;J?K24K=3]:2@
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M\&TG[/?QZN;_ ,1^ [VS\//+&S1V]E:G@X)QRIK\A?VL/^#</]I;X'W]Y/\
M#_1=6U^SC9F6X2$ =<X^Z*_JMU[Q5H?A2S;5?$.IQ65HH):69L* .M>7Z_\
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M(1<]:?S!<W4-YW8Q0N=QYH5E(W8Q2*P+$J>E,8\<#K2*".2: 01FD9PIP10
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MGL3(?D%,)WR>7GC-.DC>(XC;CVH 3$B\8-*%D3YB,T*6*Y9N?K2#S6."QQ0
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M;C-(%9H\L>]&PHMV)%N;A7$L#E2!VJ/6M/\ #OC&R;3_ !3X=@NT(P6F!/\
M6B-'V$F3 ]35S2[<2W*>9_J,_O9.R_6J7M4KPE8J48RIO2_=/L?'7[>_[#GP
M4T/P)=?$&RN+/3)Q;M-%''$<L?2OS"#Q1SOLE\\$?*YK[?\ ^"MW[3-YKNOP
M_#7PMK6(;*=H;A8GR&&&KX<L8A;6ZQLG*CDU^@Y''$/"<TY7/Y,\5<5@:^>\
MN#27)H[)+4>%E\DJZ98]Z^G_ /@F-^U+_P *,^*-KX<\0W BL)2S.)&PN2>O
MZU\Q37+3*LD:_P 72I;NZ>*9-3L6,4Z  ..M>CC:/U^C[)H^&X=SO$9%FD,5
M3TMN?O?I?BGP+XYLH=4\*>(XKF6YC#^3%ZGM5R33-2MH_P#2[)HU(X8]Z_%G
MX.?M(?M,^#98]7\)ZKJ5S;6I (MQP/UKZ5^$_P#P6&\1:5?0Z+\4/#]Y*48*
MYN7Q]>]?"XS(,=AI^XU*/;J?T[E?BMD68X9?782INZL[.TMM4T?H1Y?E_,6)
MH;RI>CX;TKRCX5?MV? OXK6T>=;L=/D8 ^7)-S7JVG7WA'Q'"M[X?\3VUP'^
MZ(FS_2O*K4:E.I:46C]%PN.P..C[7#S4D^S%4-'P4R/6FM$A.?-_"K,UI>VR
M;9+=B/[V*K&!@=[2 >U9\T8[G3>4-?S&ON0\+D4-(67&S!H1F5OG;BB1&?YH
MVI )'(R_*4SD4X*RG!7/UI%0CDMSZ4X;VY+<T (8Y!R%/TIT*$G<PP!2%Y.C
M,:"7Q@'(]J '2,G0&F[@HY>D91C.X9I%AW<LW'O0 AC9L.'XSTI<K,=JG'TI
MX94&W(YXI8XHXEWAQF@!LD(! \RE95!49XQS049B6)XIG;!;GM0 -"%<2>9Q
MZ42.LC *<<TH1MN"W6A8D (R,T )/"[(/+)Z]13PI$>PCFF!I8_ES2_._(>@
M!KK)$A8@FG@A]JCC-)^\F/DDD#WI654E0!AQUH ?I^T:E$C-G+UZWH*>5ID6
M'XQQ7D=M&IU.!E;^.O7-%5FTF$Y[5E+4Z\.6I)750=O>G#<!GGD4W(9>>W:E
MWDIR".:GI8Z$[2Y2"&-BS!VR<\5\7_\ !6S]JO3_ (3?"VY\"Z/J:I=ZO9LJ
MLCX93D_X5]9?$'QK9?#GPO<^,=9N%6WMOO[S@=_\*_%3]H#X@>(?VX/VKX_!
MNFP33V=OJK0HP^954C_Z]>GDN$Y\0ZD]HZGP7B!G<LLRSZKAM:M;W5\]'^![
M1_P1^_93U#QWXJNOBUXRWRE@EQ;S3KG<>.G%?J\(H@H@A4,!V':O,OV2_@II
M/P2^#>C>&;33EBN8;4).RK@M7J+>7&<QJ%8]:PS'%O%UVULCU>#LCAD&2PPR
M^+1R?6[U(KE(+2W>:=]J1H79CV &:_)K_@MQ^V?=>)?$0_9X^'FLF3[;"A=K
M9^0P"@C'_ J^\?V_/VIM!_9N^#-[K][?(+B6-X4CWX;++@?J:_)G]@'X&>*O
MVYOVIO\ A:GC"TEET^+49T62X3*@>;QS]%KZKA#+Z%/#U<VQG\.DM/-]+'T&
M(?M'RQ/O;_@CU^Q=#\&/AJ/&GB?1 VH:GLNH;F:/#C/I7W>JQNH7=R*S/ _A
MRV\)>%+#PS;@!+.V6) /05IB#82^:^4S/,:V:XZ>)J;R?W+H:THJ$$AZHBCI
M2D<8!Q2*-W.ZG$@<FN,T # P32 $'.ZE!!Y%(&!. :  @GH<4O:@D#J:,CKF
M@! ".IS2DX&0*0,#T-!=5^\V*  'C)&*AO0Q@8(V3V%3!E<<'-0R+(ISR1Z4
MG+E5Q-75BJTGG0[)!@*,$^E?+O[;W[3B>%-.7P)X7N1)=W#-"XC;Y@:]+_:H
M^/NC_"/P9="TO4^W30$PHKX;=Z?I7RC^S7\&_%G[1'Q(F^(7CB.62U,RS0K<
M)Q^%?4Y'EM*C?,L7I37PI]6?F''/$6+JXB&091KB*OQ/_GW'JWZ[?,[S]B']
MFG4-=NE^)'CNT:22XC!'VA<X(Y_K7V5!86&G6*VJHNU0 !53P]H>G>%]&BT;
M28%BBC'RJO3M6@(HY8R7<9KQLRQ]7,L3*K/;HO(^QX:R+"\.Y7##45JOB?5O
MK=^H^WAM98^(5Q3DMX7/S0  =*KZ=YB.4/3-72P7@"N#<]\8T$.,>2#0+>#'
M^J J3(QDTA.!FG=BLAOV>$]8P:<$0#@"D\T'H/UH!"<$TGKN-)+801_-R*4*
M<]>*=1D9QF@!"">AQ2C@=:,@=31UZ&@!%SCF@YW>U+D>M!('4T %% (/0TW>
M-VV@!U%(S!1DT @C-   0>M!!/0XH# \ T%@.IH 6D.<C'XTN1US2!@>AH 4
M].*1<XYI<@=31D=<T  &.]% (/0T$@=30!GZYI5KKNFS:7>(-DJ[3GI7R=\5
MO^"3/PD^)_BVX\52FVAFGEWR$0\M^E?76X2,VY>!WJ))R)" <BM:=:O1^%G!
MC,OP6/5JU-/U5SXL_P"'-/P@&$_M"W!!_P">'_UJ?_PYE^#N[(U&VS_UP_\
MK5]JD1%]VSD]:=Y('.TUJ\QQ?\S/.7"^0/:A'[D?%C?\$:_A(T?EG4[?;Z>1
M_P#6IH_X(R_!X+SJ%M_WX_\ K5]K!%8XQ2F, <4?VCBV]9,/]5>'U_RXC]R/
MB:7_ ((W?!XQ&'[=;9(P#Y'_ -:NU^!'_!,_X8? KQ /$>GK;S3!@P;RL$$?
MA7TU-L=]@&TCO3R-D020[ZBIBL5-6;-*&09-AJJG2HI/T061!(5%P H Q5A
M0<$U#:..FS;5CCK7.G)K4]UM/8:X.<@TX<BC(/&:,@<9IB YQQ3,,#GFGT9!
MZ&@!%^[02=X%+D#C-''6@!'SM.#1@E1\U (;BE) ZT ';&:3! /S=J7(ZYI
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@!DK $ CKWILD1=29>0.E/D)^Z.IIIW
M*FV0\&@#Y>_X*MZMJ.D_LI:I=Z3,4D6TN2"/:.OX^_&W[1'Q,C\<:U:W&O,T
M0U6Y&T9_YZM[U_8%_P %94\C]E#6&3H;&ZZ_]<J_C$^(('_"=:X_?^V+G_T:
MU 'ZO?\ !L/\2/''B3]M/P[IVI:L7M);]O,C.>?G7WK^GS"R QX^4<$&OY</
M^#5^-Y/VS_#<[8PM\?\ T-:_J2"X)S_%0.YSOC/X3^"OB UL_B72EG-HVZ$\
M<'\O>M72?#.BZ!I\>E:;:;(8ON+Z5HJ !@4M B..(Q-A3\N.E2444 %>,?\
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M'X:\5V%\ZL05M;E7((Z]#1JOQ*\!>'KE;'7_ !?I]G.XRL5Q=*K$?0U^1/\
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MX??\%$/^'BFF7^C7K?V5F8J0DFS;YD>,X..E?<W_  4]\._M,7G[!?D?"ZX
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M<.MK]J7S!^&<U\9_\$@M%_:9\._LJ2P_&*Y4W\FB2+!YJL&$FP8SN.:^.Y?
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M_ N]'U:WN;;KYT$@9<>N17Y]?\%X="_:<\1>#M)E^!,LF^'1@MV($<DR;?\
M8KU#_@FWI'[1.F?L:ZI;_%:Y5M9?1D&F[@P8/N'4$Y]:.8?LUW/K%?$W@6ZF
M;3;'Q?ITMXG#6T=RI<'TQFFOJ_AS19MWBKQ#9Z>K<*;R8)D^G-?D'^S=X/\
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M159U(/G87'7FB[$Z:74^C(O%7@V[8Z/HOB_3[J[09:WM[E6<#W -*=8\-Z-
M7\4>)[*PYX%W.$^G4U^0G_!+KP?^WW9?MMZO>_%:Y8Z>;49+QR!,;I,XW''2
MO6_^"Z&@?M=ZKX@LG^ TS_8,6HD6%')W_)N^Z?K3&J274_1^UO-.OI/.M-4@
MGLOXIXW!3\Z\V_:;_:Y^&'P8^&>J:7I'BNRGU*6$^7';7:LRMZ$"O(/V7+']
MH?1/V -2TKQ5,I\5RB$V;%6X78^<YY]*_,-/V8/VTM8^(WBGX@_%::9]-M-3
M9X@!(!L./4UVY93PE;'J%9V?0\?B/$U\NR.MB,-!SJ)-**-'XJ^+[SXB>/\
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M*_<#)6UN%<X_"OC?XLZ!^TPW_!.VVT_3+E/^$I71I1=,H;E\#&.<U\S_ /!
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M.>(K,ZGH&N6UY;X/[ZWF#KQUY%4H_BE\.WU'^PU\:::;P]+87:[S^&:^#?\
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M$<U,N96<79K4>^A_/3^WW^SSK'[._P >+JWEL3%9ZK=R3(<'&W->1QEHTWJ
M5<?+FOV(_P""R7[):?%CX57GQ&TG3<7>EV9"-$G))![U^-UO;S:=<-HMPY,U
MH=LRMV-?OW#.<_VME4)MZQT9XN*IN,BPQ)!\P  ^@IEAX?N_&.M67AK159YI
MKN-"H)Z,P%32.(T+[<COFM3X3>+;CP!XXA\<PZ;'<PV\B2*)1\N5.:]^O4G0
MHR4)7DUI?;[S&C%\UTKG[6?\$OOV4=+^"GP)MK7Q3X<M7OY9!,KSVZNV&&1R
M1GO7U!=:18W$!L;W3H)X3_RQFB#)CZ$8K\J_!W_!P--HUC;Z/J/A;2[:.WB6
M+*L/X0!_2O0/#/\ P7U^&VI7"1ZU=:?!GJ01Q^M?AN/X:XHQ6*GB:E)OF>ZU
M/:I5J7+:Z/T5TWPYH^F(W]F:1:V>>2+6W6,-]=H&:@N/"'A:_N!>W'ANPDN8
MSN69[-"X/KDC-?*_PZ_X*_?LP>+9(CK'CVUMPW7;M_QKU+2_^"@/[+6N$+I7
MQ&@D#]" /\:\6KE&:X=VG1E]S-/:TOYD>MW>F6%_;"TO[""95^]'+$&7'T(I
M--T70-,M_P#B1Z/:VR'^"WMUC'Y**Y'PU^T'\(O$LO\ Q)/%23LXX''/ZUV=
MA<VFKVPGM9?E)R,5R3HU:7QQ:+O<J3>'/#-U?"ZO/#.GR78'RRO9(6 _WB,U
M//HEG?1?9=0TV":'&/)EB5DQ]",5>5(XSO(SC^*GY;/3BL>:/<>IFVGA_3-*
MRNBZ+:6BM]\6MNL>[Z[0*)/!_ABYF^WW'AC3Y+G.X3O9(7SZ[B,UIGIQ3-\B
MMC'3WI[K0.A2N-)M[^#[)JFF6\\(_@FA5A^1%-L=$T+2[?9H&D6MLI/*6]NL
M8]^%%7LH)F<RYR,;2:=$BQ_(!QZTO>06?4S+KPIX5GO%O9?#=@]T!Q,]DA<?
M\"QFIKO2;74+?[%?Z5;3P8P89H59<>F",5?94W;L=.],$;*2 20:::%>S*.G
M:!I>C1M'H^BVEJ&&"MO;J@_\=%0MX6\-R7'V^;POISW.<O</9(7^N[&:U(W)
M8J1TZ4\ ,Q0C%,3U,V]T6PU3Y+[2[>ZM^T=S"KJ/P((HL]#T[30;31=%M+2W
M/++;6ZQC/T4"M)K<-&(PQ !I&4L1$O ]10(RQX1\,M=#5I_#E@;B/[LQLTWC
M\<9J6ZT.PU>W:VU?3;:>'&!%+"K*1]",5?D=E7;&F1BHA&ZRAMQY/(]*!W90
MT_0-&TP>3I6D6MHB=5MK=8P1_P ! KY4_P""J?B'XF>"/A7%K'P3\%:9=:G<
MS.D\TMHN_;QSN"$^M?7,Z&0G=\H[$=ZR]7\/Z1XD@%AKFBP74*\@31AA71@\
M7'!XN-24.9+H'(JB<6?SUR:G^VMKM]+JNM>'R)F=L@.YP,_[M5O^$B_:FLF-
MC>Z65<G(S(_^%?T#1?!;X3Y,?_"OM+VD'YOLHZUXK^TS^QMX8URSD\1>#O"5
ML+F-0%@B@ !&.OZ5^EX+CC#UFJ5:@HKIY'R6<9=AL#AI8G#X=3FNEMT?BQJO
MQ7^/GA2$W'B* 1*.<^:W3\JELOB-^T3XFACOM$M0\(&<B5NGY5[1_P %&?";
M^#='?2;W18[.?R" $7!.*Z_]A+P%=^-?!-O8V7AV*Y<P*&9ER>M?9UL7AOJ:
MQ'*FCYC^TL'3RCZ[+")S;LHI:_<?-I\5_M5W;20:?H_F$#GYV/\ [+4VC?$+
M]L7P?>6MW!H(#>>OF%F?(&1G^&OV5^ /[+7A7PCI*:IXC\$V<LTR?-'-;@X-
M=AXI^!7PFUJ)Y+_P1IMJK*=A2V'6OD*G'>#C7</8)Q[H]_ X2G6R[ZPL-&-6
M2V:V['SG^Q/^UM'=_"B#3?C%86LUWOPT=U;K*.G^V*]_T7QC\//$4RR^$C;V
MS.,^5;QK&I/T7%>4^+OV/=&OC)/X:GD@0D[4@7 %><ZI\!OC'\.)S/H$M[-@
M[D#2$5\YB<+D>:UW4PE10;W3T1\W//\ C+*I.&,P/M::V<=7;T5SZY:*TECW
MKX4T@W 'R7 LX_,SZ[MN<TRUF@A61-8T2SNRPXCNK=9 OT# U\D>'_C_ /&#
MX>3-;^+-(98P>9)9"<#\J])\%?MG>%-598-:N8(V7KTKS:V1XV/\'WO34]++
M/$'(,:^2LW0DMU/3\['LMQY+_+;Z7;6D(Z16T*HOTPH I\::0;/%OX8TWSN]
MS]C3S#_P+;G]:R?#?Q3^'_B^)7L]80L1PJ@<_K6VELTC^?;+E".,5Y%6E4H/
MEJJS7<^NH5</B8\]":DGKH[E:QEC#F&YTFUO5S_JKR!9%_)@12WH0J?[.TNV
MM%_BCM85C4_@H%2&!HI-C#"GDM3,N7^49 /-*$)35XJYLYRVDMA[7>BM9^2O
MA73!<;<?:!8QB3/KNVYS4=KY2#&HZ1:7@_A2[@60#\&!IS3\!1"N?6F>83G<
M<>E*2Y=Q0FI_#J(YM9KMECTVWLXQR(+2%43Z84 5,9=!$6R/POIRS?\ /RME
M&)/^^MN:CW))&(7."/XNYI;;-KF5$#YXP:5D$IMA:RV<63J.CVEY'G_5W<"R
M+^3 U(9A#,MS9:1:6L8Z16T*HI^H4 4S>H?+*.><5'AGW1-(0K'KGI2LB54D
M6U?2@DDUOX5TL2R<O.+*,/GUW;<YJK92645P\FHZ5;7J_P#/.[@611] P-.*
MK%MV2D[?UH\X!S+Y8R>V*=D.]]1MY=1SS9T/2[:V3/S000JB8[\ 8JQ&^C;?
M+C\,:<DN.;A;.,2?]];<U551),UPWR$C[HIPF=K,PE &W?>[TK(OG9/;W5O$
M#97^AV5Z7.52\MED7'I\P-17D3&='MM,MK95_P"65M$J(?P  IK2;D%LW&1S
M)W%)"[YV,Y('0DT[(F[D]":Z?3C$%3PKIB3GK<)91AR?4MMS19S6EJH76=&L
M[X'A5O+=90#[!@:C(:)MR'?NZY_AIL@,7SJ=Y/4'M18?O+<=J+V?V@/:Z?!:
MKQ^XMH0B?DH J:6?2)$$</A?3(9\<7$5E&K_ /?07-0AU>+8ZC/K30OE1&-3
MDDYW=Z+(+DEL]G9$IJ>A65\CG)%Y;)*![?,#3)0OFB[TS3;:&-#DPQ1*B8],
M 8H0#>!*<KCDFFQ;[@R*YV*I^3'\5%D'.RP]WH\\>^+PMID4[??GBLHU<_\
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M "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MOBG!\//#DU]OF9 !);D?>./[M C]8HY!(,@4ZJF@WL6IZ+::G#G;<VR2C/\
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MA"P7 /YU^2?_  :HZ#K>A?LR:];>)-/NH)9-0C,8N(F4XY]17ZT.V"(B.#0
MEW:I=6TD.,^8N#7YI_MV_P#!OA\*?VR?CGJGQFUW1K*2[U(KYCRNH) +'O\
M6OTQ50B[12T ?BYKG_!J;\"-)\.WVH'PYI^;:SEE&)$ZJA/I[5^#/[<_P&T?
M]G[X[7'@31(4C@MKJ2,*A&/E<#M7]NGCOCP/K)_ZA5Q_Z*:OXQ/^"MUP\O[7
M>J@GC^TKG_T:*!H_H-_X-CK.*']ES4?LB[698223UXK]0(XW &\\]Z_,+_@V
M-)'[+^H8_NPU^GZMN% /<6BBB@04444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !3)8W89C.#ZT^B@""2*0C[WS=C6%\2?!=E\
M1/ NH^"]4B5XK^W,4JGH1D?X5T3@]:C9,G(H6DU-;H'JK,\9_9>_8Z\$_LWZ
MA=:GX9TV.&2[B".4(Y_(5[0(FZ,>*>G" 4M76J3Q%3GJ.[$HI;$8A/0GBCR3
MGDU)167*EMH%AH5AQNI#"A.2*?13LAC!"H/2E\L [EZTZBA12$DD1F-V?+'B
ME\KG':GT5+NGN5<:(44Y7@T%&;J13J*6@B,PY_A!_"@VT9ZQI^5244: 8GB+
MP!X:\4+MUC3TDR,=!_A7$:]^QS\!O$>?[5\(K)N^]RO_ ,37J5%;T:U:CK3D
MUZ,7*F?/VO\ _!,O]DG787%Q\/078<'>O_Q->-?$?_@B/^S=XG>232?!\$1?
MH7D7_"ON:H7W-(5KOHYUFN%J<].M)/U8G"+/R\\2?\&\W@Z[=YO#UO8P,<[=
MTB\5YKXL_P"""'QA\.R,WA;Q'I\:J,J!S_[-7[&B*9.4Q28)XEC4_P# <UZU
M+C;B&DOXM_57,)86E+<_"_5?^"9_[<'PZ60Z1XNA81D[!';L>/P>N>?P!_P4
M8^&TC/#K5U($/_+.PD/_ +-7[VR6%C)S-I\+#WB%5;SPUX;NXREQHEHP/4FU
M7_"O1CQWBIK]_0@_^W4OT$\+32T;^\_"_P /?MO_ /!0GX5SA=0EU=Q$>J:;
M+_C7::1_P6L_:QT:XV^*M/UV5%ZD6$H!K]<?$/[/_P -/$BLE[X<M2'X8BV0
M?TKY_P#VIOV5_@IX4\++<6/A;<S.0?+M@?3T%=='B3(L?44:V#3??^D<6,G'
M 4'7<VDO*Y\>1_\ !:FQ^(_AZY\)?%'PKK,\4UM(JB2)E <J0#RI[U\+^+WL
M-2\87>L:(GD07-S)*L;]0&8D?SK[>\5?LN_#+Q$S36OAB\1V? Q;D?TKQG]H
MC]C6\\$>&I?&&@:1<B.(#K&Q[?\ UJ^TR:ID>#DOJ\>1RZ7/DL+QKEN9XE4(
MJ3E>U[61\]B:4OY,YR#T.*0O B.3&5(Z$U#'>M=%[<H5EA.U@1CFI+X_;(4L
MHT9I6& %')-?32>EWHSZ)N\KO<]H_P""?W[/.N_'CXU6\TMMOLM+NHYGW)P5
M]C7[71Z#I/AKP_;^&--54MH #'"#R#@?X5^,7[&'[;MQ^RAJLUI/ILT33((Y
M'DM#R/J17V1X2_X*36/Q%O8;K2=51)9G4$2D =?>OS3B_*,SS/&)WO3C:WZG
M!CL_P^2V5>+:>UC[)GC9!NVE>>XJ7[RCS#VK)^%NLZA\0_!\>M:C>V\A.,")
MQGI[5JLKJQ#QL-IP,K7YQ6_V:LZ4G=GL4)O%X=5H/1_(;Y=L#D8!H."=K?A3
M&BB#^:P/';-*V7 >)3QZUGR5'J;J7*M13&1]QL4IB#+A^3ZTJ,SJ&;J:6J4I
M(3ES;ZA!F(]>*E-Q,5V3?,OIBHJ0SJ3M)K.4;E1FH%/4?"7A'74:/4--W$_3
M_"O.?'?['O@;Q67O++3XTDZH68<&O42P!RM*EQ.K?(U=F%Q^-P;_ '<W\]3R
M,PR3),TC;$T8R]4CY8\2_LO_ !'\&L9O"NHQIM/&U<_R-9%A\3?CK\,+D)K,
MUS/&AY\J!O\ &OL7S2\6Z5$;Z@&LZ^\,^%?$2F'5;!#GJ?+'^%>U2X@=9VQ5
M-/T5CXVOX<8;#?O,IQ4J<NGO.WW7/#O!/[;AN)DL?$^GW:Q]',B%1G\17J?A
MCXV^"/%:@VM[%&3T$DPK"\:_LM>!/$D3PV=L4+\Y# 5Y9XI_9#\8>%V-]X4N
M" O(!F)_K71*.08]<T/<?FSFCB^/\C]VO%8F*ZI6E;M;7[[GTO;W-C?)YEKJ
M,+ ]-K@TKP3!ONDCU KY(M?%'QQ^'%QLO 6CC/.$8\5V7A7]M2]LY%LO$5O*
M".&/V<_X5PU<@Q%G.A)31Z>&\1,H<E3Q\)4)?WD?0GEL/O<?6D*GMS7'^$_V
M@_AWXQMU'VHI*W9V"UUMA=65ZOF65["RG_IH#_6O(K8>O0E:<&?98/&X;,(*
MIAIJ<?)DGS[=@.,T^V,+(X ^8=Z?)"P3$;*3[&HUC6U4NX;)YK%PDFI*27D=
M49>RYN>]W^!XM\9/VD]=^&FK?8;33;R7]YM!AB8C]*XVW_;H\9S,4;2-1! Z
MF!N?TKZ$UGX?>$/$H-WJ=H'<<Y*BJ$'P:^'<D:LVG#/?""OH,+CLFA34:U)R
M9^?YEPYQEC,7*M@\<J<.BY4W^9XA'^VYXSD7<NF:C]/):G+^V[XI,9,D5VK?
M\\VC;->]V'P1^&\1EO)K%5C$+8+ =0#7S!\6--T"P^+\5MHJH+4###(ZY%>I
MET\DS"<E##[;'RV>X/CK(,/2KULP3C-VMRK_ #-W_AMKQ@KY&CZ@V>X@;_"E
MD_;8\7&,N-(U#@<CR&_PKW'PM\*OAO>>'K.X2Q5V>!3(0H/.*D;X._#A93LT
M[J><H*Y/[0X?BFY8=Z'J_P"K7'_LU5_M1<LMO=_X)XMX%_;)\5>*?$=OHLNC
MZ@B2RA79X& Q^5?1EF3=PB51C(S@U@Z?\+OA_I5S]IM-.Q*#D'8.M;\;""+R
MTZ=J\7,*^"Q$E+#0Y5V/M.'\MSK+:$HYCB/;2=K.UK('PAQFF[@RDBF*6/)I
MX0+&:\^']X^@&T444 %%%% !2A2>E)3TZ?C0 FP^HHV'U%.HH 8RX[TJH6[T
M V^XC!W^IZ4Y%>)B;G[I]*(N/-RO<2:8QDQP#GZ42OL7&TGCG':GPV[&7?;J
M2*GO%TSPW:'4?$.IVT,&-S"2=5./Q-.RNTG[RZ=RU%]2*"WFE V1LP/H.E-\
M1:UX5\%Z0^M>)O$MC;QQ(6>*:X5&(';DU\O?M7_\%8O@[\";:?0/!=U+-JF"
MBF-1(N\?0&O@3QK\>?VQ?VZ?%W]GZ"TRV%U,!'B&1!@^N,5]+E7"V.S&G[7%
M+V%/O+J@LC[._:[_ ."Q7P[^',$_A'X7V-Y+? E%EM7\P'/ ^Z*^)KF[_;(_
M;R\4_9'N;V.PN9/^7FSD VY]2?2OJG]DC_@C%;V=U!XK^.Z&>? =]MQNY'/<
MFON[P+\-/AC\']-CTKP'HT2&)0 SPJ3TQUQ7LK-LAX?P_L<KIJI/^9ZDMN6Y
M\>?LC?\ !&[X?_#!+;QK\8-/M;^X&V1TC=0W//0YK[1\-Z3X9\!:6FD>"]/^
MRVR(%"8'0?@*DO;V?4)O.NCAAP O Q4;$&,_2OC\;FF89I753%2;:Z=+>@;1
MY5L275Y/<@M(^<]*XW]J>*UE_9\U**YCW%=.FP?0[:ZW^!?I7)?M3?\ )!-4
M_P"P=-_Z#7-@[+,*<4OM(.9I:'YB?\$O[.QG_:DNTNX=RA&*CWW-BOUW\0*)
M_LR3C.+9-N/3:*_(O_@E]_R=-=_[C?\ H35^NNN??MO^O9/_ $$5]9QQ;^UH
MNWV4*+:2\C/0.S#><J. *L6MS)8AFMFPQ/!J%.GXTM?&64MT"34U*^Q8U1M,
M\4Z>=+\5VPN(2N"H';]:\4^+_P#P3N_9M^-%K+!!X/2&Z<$F69U R?\ @->Q
MTJ/(3M=L(.F#@UM1Q6)PDU.C-Q?DROBO<_,KX]?\$2/&7@6ZFU_X1:C90E26
MC6+#$=^Q%>*:?XK_ &[OV2=7"S:A>RP6['B"QD/ /LU?M5;:G=:><V81QT(E
M ;^=9/BKP1\/OB'"T/C71('W#!,=NO3\J^NP?&N,E35+'4E4CZ(3I19^>'P#
M_P""XGB2QOX- ^-FF:M*B$(Y>%D&!UZ@U]F?"#]N#]G'XY+'_8FHV]C.^,_:
M[U!R?J!7G_QU_P""4'[//Q9LYKGPGI4D%RZGYBX0;OTKXQ^,?_!([X]_!&>3
MQ'\,;]A'&2Z!;MFX'L&KH]EP?FRM3J>QF^C[A*%:*]YGZQQII&ID_P!C^)+*
MY4<CR)U;/Y&F-83JY1H6&.Y%?C7X(_:^_;-_9?OQ#XDBN'AMR Y^RR/P/P-?
M4_[/W_!;[P;XH>*P^+$5U&[ *Y%J4YZ=UKS<5P3F^$@ZU'][!]F3#E;NM#[J
M6&)GV<9^M1LV"8\<5R_PH_:0^!/Q@M4OO">O1(\@X%Q<HIS^)KN3ID<L9N;2
M]@E3MY4H;^1KY>I3G3GRSO%]FBW&_4H;L+@D>U19=VPPX[5-)931ON9#CW%-
M=BV% J7%WT=T+EGW ;HT #?A2KYK'@\4@ 0?*.:7S)/3]*/:QBN7<5FO(DB>
M6VD\V-L$5->W=IK=N;'7XQ+$1@KCM54,S'+"CRDW>:>HI+DYKQ33*<I.'*S@
MOB?^R%^SS\5K)[2[\(@7$JD&1W4#/_?-?+'QQ_X(PZ>EI)JWPXFL;=VR5&\$
MC\B*^XWQ+]YL8Z8J6UOY+4^6K;AZ-S7H4,QQ-#X7]^I\]FG"V19O&V(H1OW2
M2?WGY">*/V9_VL_V;%%WHFH22)&^!]GMG;I]&KK_ (*?\%,?VD?A)<KI'Q &
MIR6D7WE%K(/YYK]3]2M]#\0VOV'7M-@DAZ_ZE<_RKS7XB_L8?L_?$ZUD231&
M260$95%7^E>C1SK#UXNG6II=W8^/EP'F6 Q'M,DQ<HI;1EJEY;GD7P1_X*Q_
M"+XCND/C&PN8Y0VPM<2[!^HKZ.\'_&_X1>*](D\5Z7XFL%CMAGRC>+NKXJ^,
M7_!&:XD\ZX^%[B-W)9 ;G'7Z&OE?XJ?"?]H#]D>>31=6UHK'.2=HN6.0/QJH
M9?@,8[4)VMYG%BN,.,N%_P#D<8?GBK^_'1;::6-W_@I#\?V^,7QBGT32+AC:
MZ7?LK$G(9<'H?QKP6W;5KF]M=!L+O9%=RB)1GIGUJ/5K^YU*Y;5[^3?/<'=(
MV<Y-007D]G/!JD)^:W<2+D=Q7V5'"PH8'DYM?Q/YXS/.JV:YO+&5):2EJNMN
MQ^S/_!*']FO2/A/\%['Q?+'$VH3ADDGC(Y!4<?J:^O8Y$2/,9RO<"OA[_@D+
M^U!;_$_X86?PWU&_07=NCR,K,!P%]_I7V3XO\3:5X"\+W.NZG<*D,43-N9P.
M=I-?F6:0K1Q,E.[E?0_M'@ZI@:O#&'^HZ0LE;\[GSS_P4T_; T7]FKX'ZK_9
M5V8M7>#S+<H_(^4]J_.7_@EI^RYXJ_:B_:)O?CQXRB$EM!JXN6\Z/!<$+TS7
M,?MQ?&SQC^W;^U;;?"KPK,]Q8[Y;:14!QD,J]N*_6_\ 81_9D\/_ +/WP=TN
MPM;'RKNXL4^T\#E@?_K5]O4<>%^'?9/2O55WZ/\ (]J\<16TV1[5H^AZ?X=T
M^+2M)A"01C:J#L*T8QM.T5%&KJY!/TS4J;@QW8S7YO!MJ[W.Z71(<R@TM%%6
M(**** "HWN%1]A4_6I*@G/S=N.::M<3ERK:Y(LZEMM(URBJ6(/%01R1RG<3T
MIKS1=9' 4=232;M4L)7>SN4O$&L:=H5HVJWEPD2(,DNV!7P9^UA\>/%/QL^(
M,/PR\'2S/ +HPS,BEE*D'N/PKT']N+]I">>*3X>>"+HM=3HT9V<_-^%7?V&/
MV9;G3K/_ (3OQQ:J]S<HLJ%N3NX]:^QRFC1R3#O'5U>4OA3Z?(_'^*L=BN,L
MU_U<RR;C2CK5FNV_+?SZ^IWG['/[,NC?![PU!J-]8K]OEBVS2+CGBO>2N/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBNM^!_\ P0__ &=/@3\0%\>>&$A$\:C:%M .AR*!:'V3X!Q_P@^CCTTNW_\
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M4 %%%% !1110 4444 %%%% !3'D . .:?1@>E #5:0\D42;L950:<1D8S^5
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MZ@5^=9_FE7.LQG7F]-EZ(_I&A1A1I**'*%<\GD=:<H7>6&<FFQ(N]F!ZT\*
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M/,!,8S_>K\A+/_@O5XGO S+X"U488@'=_P#7JPO_  7D\4K*%;P%JI![[O\
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M;!H8Y;BDHI@%%%% $B]!]**%Z#Z44 (P)! J-#)'U!J1B0I(%1+)(YRRGK0
MY@'//%*'>W3>'W8_AI*$3+Y?[OO1:^@;%^SU&^LX#(FH,H89\NJ>H:3X&\31
MR1^,?!=M>K(,;YP?Z&FRD2'"KP/2G ^>GE2'@= :F$HT7[M[]P3YCP[XY_\
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M*%MV*> !P*:7(XQ2J#G<:!"T444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1>U?A#_P1<_X)6?$W]KSX\:3XRG\.2QZ+HVHQR:DUS"R;HR!]W. ?O"OZO\
MX)_![P]\%/AOIWP\\.0&.TTZ/;$GH*"3/_:)_:+\"_LX>!U\=>/WV6C2%%)E
M"<C'<CWKY@B_X+P_L??=:_&_SO+ ^WIG.<?W:X+_ (.7[N\C_8>M/L$TT;C4
MWR86(/\ RS]*_E+&L>+3XN)_M?4]O]I?\_$G_/3ZT ?W'? ?X_\ @K]I#P6_
MBOP3.)+4LHRLH;&0?3Z5^:__  <4_MW?M>?L56&CS_L]>+#IUK=6+27C+;NX
MR"W4JPQTKT__ (-NKB\F_8[NC>S3R2_:X=IF8GL_K7MG_!57]@'1/VV/@%JW
MAU+%9=8^PF*Q9B, G/\ C0!_-'X,_P""]G_!0'5?B?HVN^-_BR)[*VO0]TBP
M."RX/^V:_I@_X)A_MV> _P!J']EOP]X[U7QK8_VG>0EIX9KQ!(/E4\J3D=:_
MDK_;3_8E^+7[(7Q7U'P7XK\-72P079BBEBMG*D ?WL8J3]G+_@H#^T5^RCY<
M?PY\02Q0* BPSROA1_NYXH*5K']?_P"VK^VA\%?V<?@AK?BCQ5XGLI6N-,N8
M(K>*^0/O:(@'')ZD5_&U^V)\9(OCI\<];\66N\QOJER(M_\ =,K8_2NV_:=_
MX*1?M'?M:)]A\>^(I7C8@M';RN <>V?:N9_9<_8\^+'[5?Q+L?!'PY\-W;W5
MS.K--/;.(\;AN^;&*!,_2G_@U:_9R\2^)?CSIWQ<&F2)::5JFV1WA//S#O\
MA7],YD\DK&5)STQ7R)_P2*_8 T#]B#]G^RT1M+CBU&_MH9[P@ GS,<X_.OKJ
M'SRS&7&/X:! LBR2% I!'>@*RN=QXH>3=D)P1UHWDQ!G_2@#,\=+_P 43K(/
M_0)N/_135_&1_P %;$,G[7FJMN'&I7/_ *-%?V;^.CO\$:RX_P"@5<?^BFK^
M,G_@K1Y;_M=:JJY!_M.YQ_W]% T?T'_\&R4;?\,O7Y=P0$AX%?IW"Z.2JJ>/
M6OS#_P"#8R,VW[,&H[S]Y8<?E7Z>A0"&3OUH![CZ***!!1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M LG_  :H?LD?:/M2^(M:\S[1YI&T]<Y_YZ5^M@10VX*,^M+@9SB@1XC^Q?\
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M'=AZ5]":V2-+N/E_Y9G'O7\K?_!P'X _:4UO_@HKXPU'P=%J!TN39]G6&0A
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M."1%93USW/?':O@_]JC_ (*T?%+XY:E-X/\ @CIXV2/L22QFVDC.*P_V:O\
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MY)&!P/M3U]9>&=/U_P"(.L)X?M$>.17&YHSR1FOK3X)_"F#X;:.ESJ-L))R
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M%% !1110 4444 %#=#]**.M &;XH_P"19U'_ *\)O_0#7\AW_!PI_P GR?\
M;L__ *$M?UX^*/\ D6=1_P"O";_T U_(;_P<(_\ )\1_Z]W_ /0EH*1^J_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"B5FSOY]:E)F*X:;-8IT4K+<1&9 XY'/>DI2$'0<^M)19H IZ=/QIE/3I^-
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M_H2U_7EXH_Y%G4?^O";_ - -?R&_\'"/_)\1_P"O=_\ T):"EL?JO_P:/?\
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M*3X\_P#!)#X@6/Q/^&GQ#U&^LOMAE5[6,(J*H;GE1Z5^R'_!OS^W[XB_:Z^
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M;S"=A7G\2:]5_P"")0+_ +8=C 2-JF$_^/FN.F_X)0?M9Q%7E\(2X8]K=_\
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M.?RH&R2BBB@D**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0#PAX6L/"&@0Z'8PA5CB4$#V&*YWX+?"G0_A3X4@TFPLU255&Y@HST]:[B$
M_,F<^]3G.8SS#$<L'[D=$:\&\*4^'<O<YOGQ%36<WO=]$+9ERI#?RJ=6 ZBH
M&D&< ?6I(LD5XL4DM#[ANY,#D9%%(!@8I:8@HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *&Z'Z44-T/TH S?%'_(LZC_ ->$W_H!
MK^0[_@X4_P"3Y/\ MV?_ -"6OZ\?%'_(LZC_ ->$W_H!K^0[_@X4_P"3Y/\
MMV?_ -"6@I'ZK?\ !H]_R0WQ#_V%$_K7[6U^*7_!H]_R0WQ#_P!A1/ZU^UM
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M?_@IBOA_PP_DW\UE&L;OT!+*!Z5_5EXD#G0;PIVMG_\ 037\O?\ P6.N /\
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M_:MNP6L6W'_ * /RR_X*.^%8?B3_ ,%K9_!>JH)(+SQI'%(A[@[J_II_8_\
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M[BV$FHWK$^;Y729@.6(K]LK+_@V:_P""=%W&+BR35I(GYWI=Y!_$-0!^1/\
MP7B_X*)_LA?\%"+C1?$7PC^&&M6>I:;;.!--&1\YW<\1CUK]7?\ @VI^.OB7
MXB?LK:?\.M72X6+0='181/&PQRO<_6O(OVO?^"7W_!&']A-;9_B]J.K%[R,O
M%'!=*Y &>"-Q]*^X/^"6G@W]E31OA9!KW[*L=XNE7]DI#7@P2F1C^E 'U?;E
MR?)<Y([U8J"-X0YA!.5'6I8B2N30 ZBBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML>\D$GZ\T >(?L7?\$#O$G[;?PD/Q.^&%O=WD,3K%,5E*X<@Y& 3W4UZR_\
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M==RE<XS0!R]Q\)/A9+<&:X^'NC.['EFTZ,G^5+_PI[X5J23\.-% QU_LZ/\
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M%% !3D8 <TVB@!^]?6C>OK3** %8@G(I*** "BBB@ HZT4=*  C!P: "3@4
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M&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^&=O=7#SV-B(93<$EN#W))KTKP1\!O@_\,@J^ _A_IFD^HLX-N:ZR/<S$,F
M.E #7M?-(#<;3G([U,HPH&*CCG+S-&1@ 5*"#R* "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%)[
M9_B;_D$R?2O([W_D(3?[]>N>)AG2)3Z"O([WG4)1_MUI3.:MN-C[TZFCY.O>
MEWCT-;,XT+37Z_A2[QZ&FL<G-(8E%%% !1110 444NPT )13MA]12%"!F@!*
M*** "BBB@ HHHH **** 'IT_&EI$Z?C2T %-E8';&!U.":=2.FX9'!'0T7:
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MD>$_&-PT6D:E QW8^0DUXH?V,KV2(J=3A!/J*[/X-_L_W?PTOVN[J^CF!<,
MHKS<=ALGA3_<5+_>?28+-.*ZN(BL1A$H]SU,V\T,CAWW+VH&W'RK@>E22SEV
M.W@'M418+Q7@<WV3[*=I24K):"T4F\>AI-X]*0A&ZGZTE!Y.:*  8SS4C1P2
M+O20?A48 )PPR*4PJI_=C HMJ 03'=L=<T36JN?D !IRJ!SCGUI'$I.5?%$T
MWH@^+<6#4KBV(@))'3%9_B3PEX7\:6[66LZ5$2XP'<9K0>*-BK@88=333$"X
M9N<=*NG.=%ITY<K1"I4*\)4ZT;KSU3/G_P"+'['C6>_6/!%_Y+H2P6!.>/PK
M@_!_Q@^+'P@U4:9XDT^]GMHS@O*0%Z_6OL'[2Z,=S_*W!%8GBSX;>"/'%LUO
MJFCH[N#\S>M?087/ER*&,CS+N?GV/X$C4Q+Q&25'AZRZ)^X_EK^1S'PV_:.\
M">-XX[:ZN;>WG( *L_.:]#BA@O46XTV_$B$9^3I7S5\3OV1-5\,7#Z]X!NX[
M?;RJQKD^M8'A+X^?$_X47RZ-XL2[FC!X;80,"M:V3X/,(^WP<]?Y3"GQAFF2
M5%A\\H<B6CJ+6+?3;77T/K"YEDMSL-N<GO21QLP\V0\>E<?\._CWX.\?6D<4
MU[%#/M (DDYS7:LBF+?;W"S(>A0]J\#$X?$85M2C8_0\+C,'F6$5:C433[,:
MKM.XC1<*#UKR/]N[6/B)H?P-GN_A3!=2:D)?E^QXWXQ[UZSO>) 5;9SRIH"V
MD[>7J$'G6Y'*#UK/#55A,1'$3CS>1TQ<8Q5V?C+!\>?^"AZ:C<I<:'XGVK.P
M0DITR?>I;KX\?\% (YD^RZ?XE5CUQL_QK]CW\%?"QK5W?PVC2,V>#S_*HE^'
M_P )<"0^$!N'?C_"OM%QOA.5<V#3?HBXP4VG>Q^+OQ(U_P#;3^,^E)H/CCPY
MKUU$%* 3A2,'\:?\)9OVV/@!IW]G_#?P?X@MD,>P_90@&/Q-?M!I_@3X5RWZ
M1MX2&"W!S_\ 6KOM.^#_ ,-7M%EA\.( PZ?Y%=$>/*"I>S>$2@^FA-/#WJ.2
MEH?B._[0O_!2Z9MZZ7XK/.2?W?\ C45[^T-_P4PO7CAM-+\5[@XR04X'?O7[
M@CX._#R,;DT) #P5XK@/CM<_!GX*^%)]=N-,A6X4$+$) &Y%33XNP->O[.E@
M8MRTL3BYT<!A_K5:I:G!7;>Q\J_LX?M:?&'PY\ -03XLR7W]LAE\F.\8"3&#
MG&#]*W?V4_V;]<^*?Q$F^*'C(2/";L3QI.N1@X]*YOX1^!/$/[5'Q:34A:R6
MVC1W+1R1SI\K#(P<_G7Z > _ ^D?#[PW!H>EP*GEQ!&*]\5Q9OBJ.40E3P\5
M&I4^*W1=C\LRS"XCQ%SJ.98Z+6%HR_=QZ3:^U;\K]B_H^CVNDV:Z7I\0CBB&
M%"] *OP0*H\OKCO449;("''][WJU$A4YS7P:BU)MN]S]GDE=6TL,\HC_ /54
MJ#BE(!ZT50!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !0W0_2BANA^E &;XH_Y%G4?^O";_T U_(=_P '"G_)\G_;
ML_\ Z$M?UX^*/^19U'_KPF_] -?R'?\ !PI_R?)_V[/_ .A+04C]5O\ @T>_
MY(;XA_["B?UK]K:_%+_@T>_Y(;XA_P"PHG]:_:V@3W"BBB@04444 %%%% !4
M;E%?=(_'8&I*9) DIRXS0 TL1*$6/*D=:4A$?RA&,'J:>%(;(/'I054G)% #
M>,[0,BDE?RL*L><]<4\*!]T8H5,')H B;RU4.2$-.0+(/-*TLD"2M^\&1V%"
M1LCY4_+CI0 *6;MBG+M!PH^IH(;=G=QZ4B)MSSUH =1110 V39@;QGGBD?*-
MYF_CTIS*K?>%(T8<X;IZ4 -9 SB9C@"E*D*65OI2-"[. 6^3TI^W P.E ")(
MNWEN>]-*JS%RV1V%*($#$XZTC0GCRSCUH 86?=O.3_LU(63;AA^%.V '=CGU
MIAA+-EVR* (YH3(XD\WY!U6I<J4"(, _I2B) I7'!H\L 87@^M ".2B!=N?6
ME 4( !M'I2[25P3SZTBHV?G;- $9MR[[MV%_NU'-A0;4QX1A\S'I4[+(7R'P
M/2B2(2C:_([B@#X#_P""D'_!!_X"?MUW0UK1%TWPWJ#1MY]\(&9G<_Q'Y6KX
M7B_X-'?%PU9=,;]I[=IT;[1%]E.TIZ?ZJOWA%J "A(VGM2B%U.T-\OI0!\#_
M /!.G_@@U^S]^Q)J \1:[9:9XCU%(U\F[:!@R..C=!7WND"Q@>6P$:KA5';%
M.:)^%1L#TI?*_A'3TH 5&WG=GCTIBJJ@R>7R*<\;"/;"=II=K'&6^M #8T)R
MS\YZ9IAFE\W8(CC/6I^W%(P8CY6Q0 R1HXSE5&3UIT:[5QFD$*GE^3ZT\# Q
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MY5'B;U6C$WJM3S"YAYD,G)I*80W\5)2<KZ!>Y)3&^\:2BE:VH!1110 4444
M*O4?6GTQ>H^M/H **** "BBB@!&0/P:)U\L90X/UIL[%0"!WI61G7(/-'/?W
M6M C*TM-R2"Z:2+9=@,N>F*YSQM\&_!'Q'LG:]L%\X#"L2!_2MX"=1MXI45
M<2.0QZ8-:4:N(P]12IRL<^(H8/%KV>(I*2?<^6_B#^ROXT\ WK^(/!TZ*B,7
M"J=Q_0TSX=?M3^-O ]^-"\9)<%(R%)$# ?F:^JOM3X-O=0H\;<'*YXKC?B1^
MS]X*^(%JTT%MLG8$DH O/X5])0SNEB$J>8QOV:/S_$\#U\NQ+QN05W2E_P ^
MV]'_ %Z%[P'\7? WQ$M5>*Z1)7' DE YKHIK6:SE_=2+)$1QY9S_ "KY)\<_
ML_\ Q'^%.H-JGA1Y#%&V0/-8\"NC^%/[7>N^'V30_'*%2IP28C].XK.OD%"N
MG5P$[Q>K0\'Q]4P>*6%X@H^QJ;*37NOSZ'TD;.-&$\7!_P!JFRLZ\(<J?O@=
MZSO"7Q!\)^/[)9M.OEWL!P7 YK5OIM/T'3Y-5OIE$,(R3N'2OGIT<13;IJ&J
MV\S]"H5Z&)I.K2FFK7YKZ%>ZU2W\,/#J&K3HENQW$,P'%>G>#_%&B>)- @N_
M#]Y&\;+G:L@8@?A7PU^T/\?-3\;W,OAS0YP(8245EX./J*C_ &8/VA_$7PAO
MC8^([PM9E0B98L?UKWI\.8BMEZK_ &NQ\'#Q(RS"9V\'+6DG9S[2_P C[C\=
M>,=,\#^'YM;U2X5-D;$ L <@5\"_%+Q)XI_:]^+BZ%I+R-8!MK!E./E8#KT[
M5TW[4_[17B'XRW\?A'P'*S123H& !!P2 >E>X_L:?LX:=\,_#$>O:Q:DWTC[
MR7&?O<]_K73@J5#),N>*KK][+2*[>9P9S7Q/'^;_ -EX1\N$IN]672?]U>NM
MST+X"_!C0OA-X/M]/TZS"3-$AD88^]CFN^5)'.#3K*2+/D;>O3BK8C4'(%?(
MU:];$5'.J[R/UK!87#8/"QI4(VBEH16]N5Y-3@8X%%%9G4%%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !0W0_
M2BANA^E &;XH_P"19U'_ *\)O_0#7\AW_!PI_P GR?\ ;L__ *$M?UX^*/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ I&.!FEI'^Z: */B0YT:4^U>17G_(
M1E_WZ]=\2?\ (%E_W:\BO/\ D(R_[]7 YJXU^E-I[]/QIE:G&@HHHH&%%%%
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M,0PX[4Y<XYKS7]F']H#2/VD/A3I?Q3T5HS:ZG#YD31'((KTE7)?!% #J***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MWA3Q!)\PTJ7C[QQ0GA3Q "%;2I<'OCI7]>,7_! #_@G@SL8_@W8,KG/#+_\
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M_99^!&F?L[?!#1/A7I,:>7I<'EAHUP#7I,*,#N9LTN\_,W4 <4D#B0;P,>U
M$E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MBC(/0T4 %%%% !1110 4444 %%%% !111D#J: "BBB@ HHHH **** "BBB@
MHHHH *1_NFE) ZFD?[IH H>)/^01+_N5Y'>_\A*3_KI7K?B/G2)<?W:\CO?^
M0E)_OUI$YJ^PU_O&DI7^\:0\=:T.-;!110>.M PHHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *1F(.!2TF5<<&@!% 0%B:Y'X\_$7_A5'PCUOXA$+C3+0R_/TX(KL,#&*
M^;_^"KWC(>$/V%?B%>QOM<:"Y4YQCYA0!_*K_P %@_VN?$_[47[6WB:YUK4&
M:RBOR]E"LN4'7H.U<W_P3@_X)Z_$[]OKXQP?#GP9HLUQ';F.>],).4A+'<W
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M[7'P \-^,D\ ZOX^M(M6>?R5M&/S%_2@1Z0K2.[*1A>QIBR&.7[.ISCFN?\
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MX"^%^@IXJ\<>(HM/L)#A)Y3P3Q_C53X;?&SX;_&'2G\3?#KQ5%J5I$Q1WA/
M(SG^1H$=BQ&X.QZ=:17;!DE& .GO7G%S^UC\![#QE%X N_'MHNJ3$A+5C\Q(
M(!_G6_XW^,'@'X<:!_PE'B_7XK33S'YAN)3\H7UH'9G4)/'<';$V<=:>R':
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M.CQ;J6N116!0,)ST((R#^50==F=!)L $>>::NU.-V:X+X<?M-_!WXMW<NG^
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M_:\LWDBSS\V_TKHO'OQ>\!?##3?[>\8>(8K2U92WF2G@ 4$G61 K'AJ/,4G
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+?#JR\;Z=\0])LI9HT5[.XU!?,W;1DX^M>SV?Q1^'U[$+BQ\9Z?-&>\=RIH
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M?IG_ #[6447_ 'R@']*OT""BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MN3_P2;\"^.OC3_P2S\=>!?ASJ,UEJEQ9Q1VTL"Y;..HKNO\ @B)^PO\ M;?
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MQ;J&N?&'Q;J36HUF5OLMY$ )%+L0>G^<UPO_  49_P""??[9/Q._;&\/^,/
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M[/;61)Y-I$&$*Y//2OJ;X3_!#XJ>&O\ @GY%\(]9\17$GB5+.X#W;I^\8M"
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ME_P3P_;+^+_[=VD^.?AEXXU6'1H[6/S&MH04&&C)&<>QK[A_;M_9W^,?Q/\
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M(CM&WR0P@HGS1G'3V-?;/[=/[.7QH^)/_!."3X4^!_$EU!KZ^'8X/-A3,C2
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M#44!<^%?^",?[,GQV^ G[$UWX#^,/B:\NM7D6Z"&Z0!P6C8*>GJ17Q+\#?\
M@G'^VUX9_P""E]O\2=?\<:O-H!O+N0,\(\M%:965<X]*_</?)Z&C?)Z&@1^;
M/_!:C]DK]H_XW?!ZQTGX1>([]+BWTGRYDM(PQD?GGD5U/_!+G]E/]H+X2?LH
M:IX2^(WC&]?4[[15CMFN(P&@?<OM['\Z^_0[DX-+0-.Q^'OPZ_X)Q?MJ:/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MR=+=:3JB6VK><ZG;*%."!CD<T70U!W/I>+6?#NH@IX?UBTNMIPWV>Y63GO\
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MB^E&Q?2EHH 38OI1L7TI:* $V+Z4;%]*"7SP!1E_04 &U?2EI/G/!%&P>IH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4UT&=^:=4;H^,*2: 'CD#->2_M@_M&Z3^S'\)M4^*FL3QQVNE69G
MG>3&  <5ZR20 HZXKYV_X*B? C7OV@OV.?&GP[\*V<D^HZAHK0VL40RS,6'
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M_E6_9:?I^FP^586D<2*,!8UQ7QUX>_X+=_L2ZW:+<O\ %_1T+#)7>:@\2?\
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M,"37>QER@+C![BO%/V$?AOJGP>_9F\&^ _%,;P7UEHL<,L,H^96!/%>VCI0
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MZ?PK! )8[B3[6(1]YLGK06C]TOV5;Z75/@+X;O+BY:61[$%I'.2W)ZU>^/\
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MW'Q).+D0VY0W/)+>9+BOZ&O$,-\?"][ DS_9O^$=DR@/&WR#_2@SMRG\S_\
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MC>Z@=+GED<6L8..)1_6OH;_@V)MVA_9@U([AEEBQ7Z#?$[X$_#'XS(MM\0]
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ME\4_#0O[,-O*/C&?Q!]*X;X5_P#!.S]DKX'7#7WP[^&26<C%B64KU;KT7WH
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M[*.@?M"_L?7&HVFBH=5MK@7(N-N6 10P_E7X\_\ ! ']FW7/VA?VX++Q!\1
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M\(>._"G_  @'C?23=Z4(Q$MOV" 8 Z>E'*R55IIZ'Y4^(/\ @YG^)-]^SV?
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M 913]B^E-< 'B@!**** "BBB@ IY^Y^%,IY^Y^%"W ?I_P#Q^Q_[U>M^&O\
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M&7[]O[J0YK]-I(XY")@O*\U^8?\ P;#7"R?LPZFO4XBK].#J-NDIA!^;/<4
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MRQA00OWJ81&K'8O)]:@%RMK&/M=Q$F1\I9P,_G3[6\M[D%+>=)&QSL8$?I0
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M &@!TNNZ7:N5U#5K:#GA9YU0G\S4T<D0MVN ZR(W*E#D$?A7XV_\'$7_  4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\L" ,&^^,$X_VJ!K<U[#]JS_ (+2_$[P,O[2OA[X$3'1#&;DM'>OY>Q!N/\
M!Z&OKC_@BQ_P7&\6_M<_$,_L\_&S1K+2M?M+=Y)H(G#.-NX>@/5:^//V3?\
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M7]ECX5^%OBO\--)MKW3]9T47K3.^T '=CM[5\[?"W_@H1_P3A_X*6^,[2_\
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M>=%/'T%?JI_P3$_9:^%'P>_9?TKP[HGA&Q6.YMDEE=(R-Q>,%@?S- '\\O\
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M:1^GXT ,HHHH **** "BBB@ HHHH D7H/I10O0?2B@ HHHH *1_NFEI'^Z:
M&4444 %%%% !1110 4444 %%%% !2C[II*4?=-"W DL?^/V+_?KUSPU_R!XO
MI7D=C_Q^Q?[]>N>&O^0/%]*FM\)T88OT445B=@4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXVCAS\QR<U.8U,F[)SZ4X #I0!5-H)@$&>/O4]K.%45?[M3G*C*@4@^?KVH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 *OWA3ZCHH DIK]*;10 4444 %%.3I3J (
MZ*DIC?>- "4444 2+T'THJ.B@"1NA^E1T44 %%%% !1110 4444 %%%% !11
M10 4444 %//W/PIE//W/PHZ@/T__ (_8_P#>KUOPU_R!XOI7DFG_ /'['_O5
MZUX<_P"0/#457=6.K#]30HHHK(Z@HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ4 ?0(.>117SY/\ \%3?V"K5ECE_:,T-2[!5!D;DGIVKUOX6?&#X=_&?0/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCZT /HHHH 1_NFA.GXT/]TT)T_&@!6Z'Z5'4C=#]*CH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH D7H/I39.U.7H/I39.U #:***
M "BBB@ HHHH **** "BBB@ HHHH **** "GG[GX4RGG[GX4+<!^G_P#'['_O
M5ZWX:_Y \7TKR33_ /C]C_WJ];\-?\@>+Z5-;X3JPY?HHHK$Z@HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#<KXL?MG?M6Z[\=O"$5H8=5*X,UR <!F/3</[U?M>ZDN3[TJKV% '\X&J?\
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M_8Y\,3O8>1J]UIVR]!3!SQWZF@1]FQ/Y.+8#[B +^52Q+(T>9B,YHA5?NO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:G]"/_!L:<?LNZ@?]B&OT[5@ 6-?F)_P;**8OV7KY6.,I#@?A7Z<12%F973
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M6E8[L*./6DV%%Y.3GK1&<'90 ^BBB@ HI"2.@S1N/]PT +12;C_<-&[C)XH
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M"YSBFM0*-%7XM'27A;CI[4G]EVX4YNQN!Z4[,91HJZNEQ,,K<9I1IEK@[KP
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQ>1GAX3C_OE:!]#G/^"L\2R_LH:NK#_EUN/_ $77\8?Q$CW?$;7P#TUJZ_\
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MV=_^A6LO^_Z?X4 ?EM_Q$D_MX_\ 18-6_P"^S_C1_P 1)/[>/_18-6_[[/\
MC7ZD_P#$)]^SO_T*UE_W_3_"C_B$^_9W_P"A6LO^_P"G^% 'Y:'_ (.2OV]#
M_P U?U;_ +[/^-!_X.1OV\F'_)8=6_[Z/^-?J3_Q"??L\G_F5;+_ +_I3A_P
M:??L[XY\+67_ '_3_"@#\M!_P<A_MXY_Y+#JW_?1_P :7_B)%_;Q7I\8-6_[
M[/\ C7ZE#_@T^_9W!_Y%:R_[_I_A0W_!I_\ L[G)'A:R_P"_Z?X4 ?EH?^#D
MK]O0\?\ "W]6_P"^S_C0O_!R1^WF&S_PN#5O^^S_ (U^I(_X-/OV>>O_  BM
ME_W_ $IW_$)]^SO_ -"M9?\ ?]/\* /RV_XB2?V\?^BP:M_WV?\ &C_B))_;
MQ_Z+!JW_ 'V?\:_4G_B$^_9W_P"A6LO^_P"G^%'_ !"??L[_ /0K67_?]/\
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M '_3_"C_ (A/OV=_^A6LO^_Z?X4 ?EM_Q$D_MX_]%@U;_OL_XT?\1)/[>/\
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M ?EM_P 1)/[>/_18-6_[[/\ C1_Q$D_MX_\ 18-6_P"^S_C7ZD_\0GW[._\
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MU/F8<L7N<>/^#A;]MP ,WQ7U0^VX_P"-'_$0S^VS_P!%4U3_ +Z/^-?J^/\
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M/'_0K67_ '_2CF8>SIGY/_\ $0S^VS_T535/^^C_ (T?\1#/[;/_ $535/\
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M/'_0K67_ '_2CF8>SIGY/_\ $0S^VS_T535/^^C_ (T?\1#/[;/_ $535/\
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MO"ME_P!_T_PI/^(3[]G?_H5K+_O^G^% 'Y;?\1)/[>/_ $6#5O\ OL_XT?\
M$23^WC_T6#5O^^S_ (U^I/\ Q"??L[_]"M9?]_T_PH_XA/OV=_\ H5K+_O\
MI_A0!^6W_$23^WC_ -%@U;_OL_XT?\1)/[>/_18-6_[[/^-?J3_Q"??L[_\
M0K67_?\ 3_"C_B$^_9W_ .A6LO\ O^G^% 'Y;?\ $23^WC_T6#5O^^S_ (T?
M\1)/[>/_ $6#5O\ OL_XU^I/_$)]^SO_ -"M9?\ ?]/\*/\ B$^_9W_Z%:R_
M[_I_A0!^6W_$23^WC_T6#5O^^S_C1_Q$D_MX_P#18-6_[[/^-?J3_P 0GW[.
M_P#T*UE_W_3_  H_XA/OV=_^A6LO^_Z?X4 ?EM_Q$D_MX_\ 18-6_P"^S_C1
M_P 1)/[>/_18-6_[[/\ C7ZD_P#$)]^SO_T*UE_W_3_"C_B$^_9W_P"A6LO^
M_P"G^% 'Y;?\1)/[>/\ T6#5O^^S_C1_Q$D_MX_]%@U;_OL_XU^I/_$)]^SO
M_P!"M9?]_P!/\*/^(3[]G?\ Z%:R_P"_Z?X4 ?EM_P 1)/[>/_18-6_[[/\
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M?X4 ?EM_Q$D_MX_]%@U;_OL_XT?\1)/[>/\ T6#5O^^S_C7ZD_\ $)]^SO\
M]"M9?]_T_P */^(3[]G?_H5K+_O^G^% 'Y;?\1)/[>/_ $6#5O\ OL_XT?\
M$23^WC_T6#5O^^S_ (U^I/\ Q"??L[_]"M9?]_T_PH_XA/OV=_\ H5K+_O\
MI_A0!^6W_$23^WC_ -%@U;_OL_XT?\1)/[>/_18-6_[[/^-?J3_Q"??L[_\
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M]O'_ *+!JW_?9_QK]2?^(3[]G?\ Z%:R_P"_Z?X4?\0GW[.__0K67_?]/\*
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MXP\?Z#X%L3K7B6_BMK7D!Y9 G/U-</!^VC\!94++XVT_ ?;S?Q=<X]:^1_\
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M_!&R7[1^R-I<A."$B&/^ 5];T">X4444""BBB@ HHHH **** "BBB@ HHHH
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MXL_^"AKG_AK35+J( @:[< Y_Z^* LC^G3_@@/+)/^R);K&>1:P#GZ&OO-%9
M%/4]:^#/^#?\H?V2;=H3G-M!G\C7WMN&-Q[4!9",&& @IU-&3\Z<YIU 6044
M44!9!1110%D%%%% 604444!9!1110%D%%%% 604444!9!1110%D%%%% 60=:
M*** L@KX0_X+ZS^3^R1=#<1NM;CI_NBON^OA#_@OKY/_  R/=^<V/]$N,?\
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M_P#@U)>)/VE=<*'YS91[A^= ']05MS;1G_8'\J?3+7_CVC_ZYC^5/H ****
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M;^6.B8["KD?F$%)$QC[I]:F*(2&*\CH:6@0B A0#2T44 %%%% !2,,J:6@D
M9- 'G7[3G@S4/B1\"_%7@;1%=[O4M&FMXD3J688%?S<>*?\ @W$_;%O?C%#X
MJ@\":K) NKQSF3!^Z)=WIZ5_4,88R_F(<$]:'D;S-BQG _BH'<\!_P"";OP.
M\2_ #]GRR\!^++22"[A";DEZ\+BOH2F*1O "=NM(92D@C/.:!/4DHIH)4X8]
M:4'D\T +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !37Y^
M7%.I"5)VYP: (GC!D60,0%Z@5\)?\%POV+OB5^V5\)[;PQ\/-&N+N:.R>/;
M.<DM[>]?=V]@^PQG!ZFG*%+<-T[4 ?SG_P#!-/\ X('_ +4W[/G[0&F>.O&7
M@C4;>VM;^*4O*IQA3]*_HATZWN/[)MK:3*R1QJ&'T K0D QD]JC63+X*;?\
M:H >"XP"O;K3Z8V7&U7_ !IXX'- !1110 4444 %%%% !1110 4444 %%%%
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MJD*1Y#E><=:"KBQ9Q@]J=4:)M?/F9]J59"Y*XQZ&@D?13>HVA^1UI5! P30
MM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44TDAN#GVI)&*/N!S
M[4 /J*5$\P2N<8I71G8.),#N*0H-A#/F@#\>O^#@7_@E%\=/VZ-<\/:E\,M!
MOKN/3[F1Y?LP.,$/[?[0KA?^"$'_  1J_: _8J^-6I^-_B)X:O[2WN[=%0W
M.,C/M7[@JJB/!/&*CP(<8.0>@H E@4I"B'LH'Z4ZFJ<':32L2!D#- "T4TR
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M#UH _./_ (+\?\$__BK^W'\'-*\'_#/1[J[GM-1:9A; YQE?;VKX4_X)#?\
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MD'I39%,@&PXSUI\7RKL]* '4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5&V#*,+SZTLS,.E5GDN6?$3@#')- %C>"VSS 2?>@B&,D!@&-
M?/?[8/\ P44_9Z_8RT"77/B%K]O/-%$7-M;7R>8?8+R:_*?]H'_@[5^&$'B*
MXL?AIIVLVX@E(5GC8@_3Y!0!^[O&W#]>U-#!V\IEZ=S7\^'@3_@[@BBUJ ^,
MAJT]L9!O2.%P<=_X37Z2_L#?\%VOV6_VV+F/P]HUY)I5\T._=JMVL8)QP/F5
M>>* /NHHJGY&Q4HZ5G6&J6=_9)<V]RD\;@,DD+A@0>1R*T%(*@CTH 6BBB@
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M$5^/B_\ !V-^RGNP/#NN?F?_ (W5;5O^#M+]EFTLVN(/#FNE@0 %!/\ [3H
M_8UE4J'+!?K1$TC,0QR#T-?-W_!/3]OOP5^WO\/[KQEX,M;F*. +D7.<C/X"
MOI*-&BA$>?FQ0!(!@8HI$#A<.>:6@ HHHH **** "BBB@ HHHH ***1^!^-
M PW#&:0(.YI5.X9S4-S=+%\H.#Z4 /D_=_O,\#M0I0J6;I7->.?B9X2^'VCR
MZ]XS\16=A:0C+F[N5BX^K&OS2_;0_P"#FO\ 9:^ ]_?>#?#5GJ-U>V[M&+BS
ME\R,L.X*H?YT ?J>Y2,KLC)#'J*<ZQ1D%4R?:OYX;W_@[?U$:DYLI=46W#?(
MI@?./RKZ#_9(_P"#K?X!>/=7MO#GQ&TW5S=3,J-/)E$!/&<E* /V< D=]V[
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MT#6]J#..?_B* /V&W[D#9Q3Z_,S]C+_@XD^ '[7?Q6_X5[X:T?58W94*>?G
M+$C^X/2OTNL+I+VQAO8Q\LT2NN?0@&@"6BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/F5-#G(>>V1BG'49'!K^,#]L_1/#V@_M :QIWA1P;5)"5VJ /OMZ4 S^HO\
MX(#?\%#S^V+^S19P^+-0\W68)O( _P!E 5[_ $K]%%Z#Z5_/5_P:8-XJF\0V
MT,:.-*W2[G#'&[)[5_0JHVJ%SG H)8M%%% @HHHH **** "BBB@ HHHH ***
M* "BBB@ H/ S110!7>7SP0/N#[U))))  [RHL0^\SMCBI9%?<$1!M/6OA/\
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MK\[O^"-O_!(B?_@G4=3O#?ZB9-2MU2:*YD8JN-O3)]J_1!&)<@#B@0^BBB@
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MG)H)9Z@.!BD8$CBEHH$%%%% !1110 4444 %%%% !1110 4$@<FBFR@D<>M
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M_N#_ -"%?V0?"C_DF^B?]@R'_P!!% ^AT# DBEHHH)>X4444#"BBB@ HHHH
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MQ+_P21_X*D> OV_OA)93PRV]AK2!8CIYE+2$(N"W4^E?;*@A0">U MQ:***
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MW^JF7(KC]2_9E_9]G3S+OX3:-(=V=S6O?UKOD)W^5(N0.=QI96@ECPQ!7^M
M&/X<\'^&O!MB-&\*:3!86[X/EVZ;17B/_!0_]M7X>?L6_ ?6/&OB/6X(M2AL
MS+96TQQYO7_"KG[;O[>'PC_8E^%6H>.O'>O62W]J@:WTRXD*O*I4G(_(=^]?
MRN_\%4/^"JWQ?_;N^*E[:C7+VST""YDCBMC*&C>,],<GCF@=CPC]NK]HR^_:
M>_:0\2_%2XF/DZIJ)GB4-E5R,<5^@O\ P;%_L9:[\7?V@;KQU>VTJ6=G;QW,
M,H7(;;DU^>/[*7[,/CW]J#XPZ3\._!'A^YO(I[Y8;NYMT!$(()R<_A^=?UQ?
M\$CO^"?OAC]B3]G31?#Z:3$FN+:^5>W8CVO(,#KQ]: M8\$_X.7O"%Y>_L*6
MS6D;,8[]5( ]!'7\K)9+#Q;Y-RNW9J6YF/;$E?V\?MP_LS:-^U%\!]6^'>MQ
MQOLLKB6V\Q<YD\L[<<=<@5_';^WI^Q=\4?V1/CEJWAOQOH%Y!#)?3SP33QA1
ML,A*X]L$4!=G]-W_  ;N_$[0_B1^R03H]PDG]GK!#(5[$ BON#XN:YI?A7X?
MZGKVLS+';6\!:5FZ8K^1+_@E?_P6)^+7_!/KQ/%8Q7-[?Z')<B6YTU90J28/
M?D>]?8'_  4'_P"#G_Q7^T3\)A\./AOX%N=$FOK$PSW%O< Y))Y/SGVH&NY\
M%?\ !8GQ_HWC3]NKQSJ.B>7);2:H3$Z=".:QO^"6/B"Z\/?M6^'+BRE9?-UB
MT5]IQQYM>'^,]7\0^*=7G\6>+;F2>[O6W22S?>8UZU_P3B\T?M2>&/)4@MK=
MH,#_ *ZB@&?VP>!;A+_P7I%U'-D'3+?)]_+6MD-E@&4>QKFOA%#);?#O1[>X
M7G^S+<\_]<UKI%Y?>W %!)+11UHH **** "BBB@ HHHH **** "FR('&,X-.
MIDH.-P/2@  $9"HN<]33/+ E+&4\GI4G1,@<TA"E,MP3W- $%[I6GW:G[1;(
MQ_A)'0^M?G)_P5;_ ."W]G_P3<\6W/PUM=#L]2OA:[T2X?# ,.._O7Z+:G<3
M1:=<"-"SI"QC/J<5_/[_ ,%O/^"8W[4G[;?[6MUXUT#PKJYL#9K&LL<*LI(_
M_50!^:__  4M_P""LGQ:_P""@GBR6ZUXRV&GLC1FPBGS&XX ./P_6NH_X)(?
M\$H/C5^V=\4].U>'P;=2>&K>Z"ZC?HN5B4XY/%>:?M=?\$N/VD/V3+-M;\8>
M -5CL(8P\EY/"H5>,UZ7_P $R_\ @L/\3?V#_%=KIUG!>2Z6\X:\LTE"I)C'
M!Y% ']97[+'P8TOX _ [P_\ "G3HAMT:Q$"MMP3@YK\1O^#O+XM:C>>&M$\%
MV]ZR"UUAMRJW;-?L)^P;^V?X*_;)^"NC?$+PM>0-=W-BLU_9Q.6:W).,-^8_
M.OPV_P"#M1)O^$S@8L<'6#@?B: /QG^'!L5\;:;J.HS;(K:_AFD)Z$+(&/\
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M!KFKI/L-QIMW"#G'6(C^M?0V P&QL?2OCS_@M3\"?B7^T+^RT/!'PMDNA?\
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MV2Q&PM?*90N/2@=V>QV[&1A%&OR*H"M5L  5&(EB0+&,?2I*!!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ?!__(]:5_V&(/\ T:*_L?\ ^"*)Q^R!IY'_ #RM_P#T6:_CA\(C;X[TH?\
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M#;R7<APL2%FSZ 9H S/&?B_P[X&T&;Q1XKU:"RL+<?OI[E]JKQGK^%?SN_\
M!>W_ (+U:]\3]7OOV?\ X ZS<6.G0>99ZHT,I9+HC/S#!Z<BO7_^#D__ (+)
MZIX*@N?V6?A'X@>/^U+(F=HF+*LBC!R5Z?>-?S[ZIKVK>(]>FUK5;HR7=Q*7
M>1B?O4 :.B^&O&WQ4\7Q6>F6D]_J.H3A=D,>YF8^U?NM_P $)_\ @@&TD&F_
MM ?M!:%$S21I-:6%Y!LD@E7D$Y'J?TKQ[_@A%\"OV%_!$3?&O]IG[%<ZG#$E
MSI6-2B0QRC:.58$^M?LSI7_!7_\ 8ST2R73=+URTBAB^ZJ:A$ /R% 'U9X:\
M,V/AC18/#^FQ".*!%5<=,  ?TJ].TEO'O@0X'&!7R=%_P6;_ &1+BYAM(O$$
M)::58T U&,_,3@=O>OI?P#\2]!^(WAI/$WA^97M7B$@8.&&",]10%F6O$WBG
MP[X.\.S^*O%6I0V5I;C,MQ</M5/J:_G\_P""]_\ P7QUCQ??W7[/'[/&N3V-
MI&9++6)H)=T=UU(/!Z<C\J]<_P"#E+_@L+J'PNT:;]FCX5>(2G]L6+"Z\EMP
M#@8Y*].M?SO>(_$FK>)M9F\0:S=&:YN9-[N23S^- &CI6D^,?BIXW6SMK.?4
M-3OIP@\I"S%C[5^X/_!"_P#X-_3XAFT[X^_M(>'(Y861);33KZ#9)#*GS!N0
M>Y'Y5XO_ ,$%/@3^Q)X<N#\;/VGVLKBZA@2YTI?[1B1HY1CDAL^]?MCH_P#P
M5^_8QT'38](TC6K2&&(854OXAQ^ H ^K?!OA'1_"/AJW\-Z!;+!;V\:HBCH
MH _I6O:6@MP<\DFOD>'_ (+-?LA;HX(?$$):64(H&HQDY)P.U?2_PN^*GA[X
ML>'XO$GAB826TJJRL'#<$9'(H"S.HHHHH **** "BBB@ HHHH **** "BBB@
M I&!((!I:* *MS/):IM92VXXXKPS]MW]MKX6_L6?"*_\;>.=9MS-'&PBLS.%
M?<5^4_GBO4_C#\0M$^&'@#5/&>OZA#;Q65A-.C2RA,E$+8&>IK^33_@M]_P5
M#\=_MH?'#4?#VB^(9#X<MY&A-N2P)=&VYZ]./2@#A_\ @JA_P5*^*W[>OQ:O
M9-1\0W)T."66WCMIB2"@;"XYZ8%>(?LM?LG_ !>_:M^)%A\.?A_H5VZ7L_E/
M>QP%HXOK7(?"CPE8^/O'EEX7FN(X(9S^]>XD"KU'<X]:_I$_X)E7W_!-+]AG
MX3Z/KUBMBFO75G'-?3#5(6S+W.,<=*"EL>U_\$<_^",?PJ_8L^'MAXM\4^'K
M27Q'=6J/<W2J%;S 1R>/:OT568"3@Y'M7R)+_P %C_V/9(4)\1VP ^Z%U&,8
M_2NB^$7_  5*_9C^+'BE?"7A36XGNI&"J/MJ-DG@=!0-['TO.[*=S?.IXVBO
MD?\ X*6_\$G?@5^W[X.N6UKPO9CQ*\82#4KG'R*%QCI]*]'_ &^?V@_$7[.7
MP(N/B1X3AG>=(W<&"%G( 7.<+7X%?$S_ (.I/VL+#7[_ $[P_P"*IX);:^DB
M42V;\!7(_I005/VG?^#57]H/P'XEDG\(^-+2YM7+/'%;6^=H["NN_8E_X-7/
MBEK/C"W\5_%_Q;8?V58SJ]S:74.WS$XXYK]"/^"&O_!:"S_;C\%:A:_'CQ;9
M_P!M)?"*V>^E6$8Y!X?\*^N_VXOVP_A%\ /V?/$/C&/QMI#SVU@9(8[74(B[
M$'L <F@I'\L?_!97X$_"O]G/X\ZA\)_AS96\*Z5J!B8V[ C'/I7&_P#!)GP1
MJ/C+]K;0;:RA,IM=5M)7VKG $F?Z5Q?[=GQWG_:1_:2\3_$N2X=[?4+PRP;\
MU]\?\&N7[(?B/XH?M,WGCB^TX_V?%IT<T$TD1"DKO/!/![4"9_3YX*AV^#])
M3&"FF6X(^D:UJ$!UV 55TRW>RMH+12-L4"I^0Q5I<E#LZYH$/ P,44#..:*
M"BBB@ HHHH **** "BBB@ I'QC%+44D@695(_&@""^FN$VK!D9ZXK'UWXC>"
M/#"JGB?Q;96;YQBXF"G-:Z32F=D8]3\IQ7X-?\',7[0O[67[-OB>QUSP)K<D
M&FWVHLL7EP.<+SU(- '[<P?M"_ Z_NAI%I\3M'ENF("P)=@MD].*Z2*Y86P3
M[X;YE<="*_C$^ O_  4\_:-T'X[:)XR\4^,I)(O[6MC>;2^#&) 6[^A-?UD_
ML2_MR?!7]J;X#Z5X[T;QMIENRVT4,T%YJ4:R;E0!C@D'&0: ,#_@J3^S=X%_
M:2_98U[1_$^EQ2.R@!YN@ 1J_CF_:(\-6/@;XU^*/"%I&ICL-6DA@V=% K^L
MW_@LI_P4(^$?[.O[+.NP:=XMLKK4&16C2RODD8Y1NRDGO7\D7Q>\4'X@_$W7
M_':-\NH:B\XW=3F@#]Q_^#2C]I+Q';WGBKP/K-W++;^5%%;)V49BJ7_@[R^%
MUY8^'-$\;P6#%;O6&RX7WJQ_P:/_ +.>J7[>+O''B#39$B6&*6RD>,J&YB'!
M/7O7V-_P<Q?LYZQ\</V4;"?1M.,S:,TUS+MB+$  'M0!_*;X3@:Z\4Z;'<<(
MVH0JQ/3&\5_7;_P;Z>'M)T+]B"VMM$15#7:LS)TR0<U_(JLLNA:\%O8706MY
MN"%2""K_ /UJ_I*_X-CO^"EOP;UCX$1?L[^+-:CLM;>]:2.>^NEBC" L,?-C
MU'>@#]C-2TNRUFP:QU.#S(VX93WK^,G_ (+*>!M)\&_MJ>-9=(1$$_B&9F5?
MH*_KB_:1_;%^#?[.OPDU+XI^(_'>DW,%@NXPVNIQ,[#!/ !)/3TK^.'_ (*,
M?':P^/G[5/B[QOI3L]E=ZW)+;[CGY2!0--'U;_P;A>+M7\*_M0)!IUTP6_OX
MDF"^G'7\J_K-MQ)OR3QBOY@/^#7?]E[Q#\0?CEJ?C7[(?L^G213HS(1Q\O\
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MM4GMIUGMV4%2AR"*_C.;_@LC^W!J/BVVU/7/B$&:*Z02@(XX##/\7M7])_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*9@,PW]NE/4,&.>E "T444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]JI_ ?\ ;=^/O[-C>3\/O$-[%&(]@AFN9 H'TSBO["_VL_\ @G7^S_\ M?\
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MI:O!&!C;#-*HQ] :/[?^).2/[>UW'_7U-_C7]5R_\&QG[&$0'EZ]?GZVH_\
MBZ#_ ,&RG[%X)#:]?<_].@_^+H&C^6?X<Z]\1O\ A/-$:;7-;*G6+;(-S-_S
MU7WK^LO]ECX[2_ ?_@FZWQ&U*:5GAT^% T@+-DP-ZUQFE?\ !M#^QMHNK6^H
M)KU]_HTZ2IFU'WE8$?Q^U?7=Y^Q=\,]1^!K_   _M"<:9(B N$Y^52HXSZ&@
MI+0_CH_;I^,GCG]H#]HKQ-XG\2)=3HFLS_9<JYPA;CK7C"Z3JBO@Z9<;?^N+
M?X5_63J7_!LW^QMK6JW6LWOB+4/,N9C(X^RCJ?\ @=1+_P &RG[&JJR#6KTC
M^$_9!_\ %T$'\J%EJWC^T@^RZ5J.K6\*#A89I4&/H#2?\)%\2MY,6NZYC'>Z
MF_QK^JZ;_@V/_8P=%W^(+]?7%J/_ (NI(O\ @V2_8L";4U^^.>_V0?\ Q= '
M\KW@SQ+\14\5Z7G7-;)_M*#(:YF(_P!8OO7]A7_!%N[U*\_9*T^74I9'D\BV
MYF8D_P"K/K7B*_\ !LE^QKIMW#J%IK]^TD,RR*#:CJ"#_?\ :OO#]G[X%>$O
MV>O!<'@'PI.[P11H%WK@_*,#O0.^AW]%%% @HHHH **** "BBB@ HHHH ***
M* "@D 9-%!QCF@#\LO\ @YX_:]?X+?LEVN@>%KRY2_NM3>WN!"&^XWEKV^IK
M^6C5DUG4]5N=5:RNI'GG>1B\;'[S$_UK^TC]N#_@E_\ !O\ ;KLULOB;J]U%
M$MP)0D4>X Y!Z;AZ5\W6W_!L?^Q;;QYC\07S<][4?_%T ?RAPVVK).)X[.[B
M=>C11LI'Y5J2^*_B9=JD+:]K@BB&%5;J8<?G7]5@_P"#9/\ 8M5LC7;[)[?9
M!_\ %U&/^#8W]C!BQ?7[\9]+4?\ Q= '\J8\0?$(DD:]KN!T_P!*F_QK["_X
M(J:_XME_:WTE=5UC6'1M1MP!+/*1][ODU^]#_P#!LG^Q0V(AXAOP>G_'H/\
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M-V&3SG[&G^%/3PWX:=&8^&[#@?\ /FG^%:+$D[,<9IMP#'"1&O.* /._VB-
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M>8",<@Y)SQ0!P'_!'3_@F/X;_8*^ >E6.I::(_$WV7RK]L C&T#KU]:^RLS
M[2.<TL=PUM,?.0)&>$Q4UQ*T48E"#)- 'YG_ /!SS\4;_P -_L >(/#>EJS3
M221,%52?X&]/K7\JUKIMSJ>O&;5-.N=LLA9]L+?X5_;5^V7^PM\,_P!MOP5-
MX,^(U_/#;3A=XA3=T&/45\D:?_P;*?L5VUU]IB\0W[,IZ&T&/_0Z /4_^"&W
MPPL/ ?[&/A;5+&V,?]HZ#&YW+@GYC_A7VM C*-S=ZY#X&?!CP]\"OAWIGPV\
M,LQLM)M!;V[,N"5!)_K77N6+8 X% "I*&D*#M3ZC<;&WJ,DU(.E !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !12/G:<'![4Q&D2/\ >'+9YQ0!
M)14372B3R]IZ=<56N?$6A6K^7<:W9QM_=>Y0']30!>HK-3Q7X<)/_%16/_@6
MG^-(?%7AY2<^(;'GI_I:?XT#LS3HK,B\4:!ORWB&R(]!=)_C5B/6=+G;-MJ=
MO*,=(YE;^1H$6Z*A%UO!=5.![4V&^2YRD8*D''- %BBHH;D3%D"D%>I(IY?:
M!GDGTH =1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 C+N%1HD@E+,.,4^0 XRV*38
M?,+$\8H I:_<75OH5W=6BKYD=N[+GV4FOYNO^"M__!:;]K']GW]I";PAX%O;
M9;2.64$2,>S >E?TBZ_&I\/WQ5S_ ,>DO_H!K^/W_@OB8S^UY=>4>DT^<?[P
MH!&L_P#P<6?MVK@QWMEQ_M'_ .)H7_@XM_;OD.YKVQ^7_:/_ ,37Q#\.?"FK
M^/O%%IX1T.R\ZXO)-D:#J37W3X+_ .#?']M#QYX,L?&?A_X9W,T%]'O1@SXQ
M_P!\T%^9#:_\'&/[>.]I8KRP+8Y!8_\ Q->F?!3_ (.@?VPO!MW%<>()M.;#
M?.&CW#'XK7F_B/\ X-YOV[=!TN2^@^%%R6"$D%W_ /B:^6OCK^PU^T?^SBCM
M\5/ K:?&DF"Q+'O[J*"#^@[]@/\ X.>/A;\:-:L_#'QQUF.VN)F"G[/ JCKC
MK@5^LO@_QIX>^(FA6'C'P?J4-Q9WMNLT31R!OE/3..E?P?6&J:UH5\E_H5_-
M;R1,#OA<J01]*_;?_@W+_P""T_B7P[XUL/V8OB[XA^T)J]VL=M+>W'F.B @?
M+NZ=: /Z*EV*-K\%NN*3#*P6'G!YS5#2-0MM:T^+5])F\VWNEW(_M6C'#A0,
M].] $E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7H'[.G_!.W]I+]IBV2\\ _"[5[FT<X%W;P!ER/QH+/UOT#_@[_\ $\=YMO\
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MZ\B@:/Z*I_$VGV'A>/Q-KMX+2!K832.W11MW&O@/]NG_ (.%_P!FW]EG59=
M\">(]+\07D"$20F4@AQP5ZCO7CW_  <<?\%/->_9>^&%Q\%_AY<RV6J@(GG6
M\F&\L@+C&>F*_FI\2>(/'WQ@\:2W^IS7%_?WUPTBJ1ECN;/]:!VU/W>\;_\
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M\\;*P$A?MS3E8YP>]4K?44GABF@AW))&KY!]1FKB_.0W3CI0(?1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% "-V^M#]/QI6Z'Z4T_<'UH J^(?^0!??]><O
M_H!K^/O_ (+Y _\ #7ET?^F]Q_Z$*_L$\0_\@"^_Z\Y?_0#7\?G_  7P8_\
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MO+']MGP<L$AQ-X@B#X_W37]?GQ>\'P>//AGKOA"XC#?VAILL'/0[EQ7\@/\
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MF6O[Q8D3&<DU_7W_ ,$)?V7-$_9[_88\+64FD"#6!&RW,A7!(V)V_.OYL?\
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MQUJI!>1R>7+&V8I(PZG/8C(JS'(\KAH_N#@YH$2T444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MH **** "BBB@ HHHH **** $=E489L9Z4Q8WC^8-NS3I%1A\XZ4V,-MW%N*
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MOB&]CL8/@[JDA=L A17]I/B7]FCX+>+[DWNO>"K6Y<G+EQU-4M,_9,^ &G7
MGTSX>V<3QG(910!_+E^R?_P;Q_M3_%W7=+N/&7@K5M,LIYT\^5H@0B]STK^@
M_P#X)G?\$IOA#^P+X/M;738K6^U=("DM\T.V1@5Q@\#U-?7.C>&](\.VBV.B
MV:PHHP%7M5@6B>9EU^8<EZ $2VWQ8!V$=#[5(DOSA(UR!U:D64/<X0Y7'6I(
MA& ?+'?F@!]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ! 88--"8!4=,=*
M=10!%' 88RL9 .<U+CC!HHH 38OI00<84XI:* &B)2=S=:'1@N(SBG44 -",
M1\QYI#%NY;KVI]% #0IP0W(H"$'GIVIU% "$-G@TC1(YW,.:=10 SR5QLQQW
M% 1P" W3I3Z* (TMU4%OXCU-?.__  4X\#:AXN_93\4OIRYGM=#N9$(7/(3B
MOHRLCQSX8T;QKX6OO".OP&2TU&V:"X4#JK#!H _AJ\?>-OC-I7BC4M%NYKD!
M;N8%3$W3>1ZUQ2Z#XMU>Z,L&CW,L[G[J1$DFOZV/B#_P;G?L">-=6EUQ?!EV
M+J>0O(?.4#DY/:I/ O\ P;G?\$__  CJ4>KMX*NC<1'*YE4CC\* /Y^/^"2'
M_!*3XS_M<?';1[GQ%X1N[/11<;+AKZR94(R.<GCUK^LGX _"JV^!GP<\._##
M2(E7^RM.6W)C^[P2?ZU!\&?V?_A3^S[HB^%_AOX;BMD &UC N1CW KT"WWP+
MOG&2WM0 ^T:?:1.V2!UJ4?,GWL^XICS1LH5E.']J?%$L2!$Z"@!%B9DVRG)I
M8U=1ASGTIU% "+&JYP.M(D:(25')ZTZB@!NPALJ:4@E=I/7K2T4 ,BMXH1B-
M<4)$(S\G /6GT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4$ ]1FBB@"-Y8H^3U/ I8E.,O^
M%*\:OU%. QWH C"@M\Z#V.*5VC#*K=^E$T(EC*;B,]Q2I&%4*><#J: (VD82
M;-@QGBI5! P:-BYSBEH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
K "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Mar. 13, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-42365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CAMP4 Therapeutics Corporation<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">81-1152476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One Kendall Square<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Building 1400 West<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">3rd Floor<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cambridge<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">651-8867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.0001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CAMP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,161,072<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference [Text Block]</a></td>
<td class="text">Portions of the registrant&#8217;s definitive proxy statement for its 2025 annual meeting of stockholders (the &#8220;2025 Proxy Statement&#8221;) are incorporated by reference into Part III of this Annual Report on Form 10-K. The 2025 Proxy Statement will be filed pursuant to Regulation 14A with the Securities and Exchange Commission not later than 120 days after the registrant&#8217;s fiscal year ended December&#160;31, 2024.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001736730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Ernst & Young LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Boston, Massachusetts<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">42<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 64,039<span></span>
</td>
<td class="nump">$ 38,380<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">2,344<span></span>
</td>
<td class="nump">1,633<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">66,383<span></span>
</td>
<td class="nump">40,013<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">1,624<span></span>
</td>
<td class="nump">1,624<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">3,858<span></span>
</td>
<td class="nump">4,797<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">6,015<span></span>
</td>
<td class="nump">7,764<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance lease right-of-use assets</a></td>
<td class="nump">427<span></span>
</td>
<td class="nump">748<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">78,307<span></span>
</td>
<td class="nump">54,946<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,210<span></span>
</td>
<td class="nump">1,042<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">4,833<span></span>
</td>
<td class="nump">3,302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">385<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current portion</a></td>
<td class="nump">2,994<span></span>
</td>
<td class="nump">2,704<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liabilities, current portion</a></td>
<td class="nump">91<span></span>
</td>
<td class="nump">354<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_FinanceLiabilityCurrent', window );">Financing liability, current portion</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">405<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">9,598<span></span>
</td>
<td class="nump">7,807<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-term liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="nump">5,493<span></span>
</td>
<td class="nump">8,487<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liabilities, net of current portion</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_FinanceLiabilityNonCurrent', window );">Financing liability, net of current portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Other long-term liabilities</a></td>
<td class="nump">15,163<span></span>
</td>
<td class="nump">16,529<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 7)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Convertible preferred stock, $0.0001 par value per share; 25,000,000 and 149,673,284 shares authorized; no and 130,648,426 shares issued and outstanding; liquidation value of zero and $162,885 as of December&#160;31, 2024 and 2023, respectively</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">162,147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity (deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value per share; 175,000,000 and 210,000,000 shares authorized; 20,161,072 and 1,026,057 shares issued, 20,145,129 and 460,704 shares outstanding as of December&#160;31, 2024 and 2023, respectively</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">274,895<span></span>
</td>
<td class="nump">36,231<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(211,753)<span></span>
</td>
<td class="num">(159,962)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity (deficit)</a></td>
<td class="nump">63,144<span></span>
</td>
<td class="num">(123,730)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, convertible preferred stock and stockholders&#8217; equity (deficit)</a></td>
<td class="nump">$ 78,307<span></span>
</td>
<td class="nump">$ 54,946<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_FinanceLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financing liability classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_FinanceLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_FinanceLiabilityNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financing liability classified as non-current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_FinanceLiabilityNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.E.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Convertible preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible preferred stock, shares authorized (in shares)</a></td>
<td class="nump">25,000,000<span></span>
</td>
<td class="nump">149,673,284<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Convertible preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">130,648,426<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">130,648,426<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Convertible preferred stock, liquidation preference</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 162,885,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">175,000,000<span></span>
</td>
<td class="nump">210,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">20,161,072<span></span>
</td>
<td class="nump">1,026,057<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">20,145,129<span></span>
</td>
<td class="nump">460,704<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations and Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Research and collaboration revenue</a></td>
<td class="nump">$ 652<span></span>
</td>
<td class="nump">$ 350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">38,817<span></span>
</td>
<td class="nump">40,616<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">14,923<span></span>
</td>
<td class="nump">11,613<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">53,740<span></span>
</td>
<td class="nump">52,229<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(53,088)<span></span>
</td>
<td class="num">(51,879)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income, net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">1,330<span></span>
</td>
<td class="nump">2,808<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingExpense', window );">Other expense</a></td>
<td class="num">(33)<span></span>
</td>
<td class="num">(220)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income, net</a></td>
<td class="nump">1,297<span></span>
</td>
<td class="nump">2,588<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to common stockholders</a></td>
<td class="num">(51,791)<span></span>
</td>
<td class="num">(49,291)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (51,791)<span></span>
</td>
<td class="num">$ (49,291)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share attributable to common stockholders, basic, (in USD per share)</a></td>
<td class="num">$ (11.04)<span></span>
</td>
<td class="num">$ (124.80)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share attributable to common stockholders, diluted, (in USD per share)</a></td>
<td class="num">$ (11.04)<span></span>
</td>
<td class="num">$ (124.80)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares of common stock outstanding, basic, (in shares)</a></td>
<td class="nump">4,690,094<span></span>
</td>
<td class="nump">394,976<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares of common stock outstanding, diluted, (in shares)</a></td>
<td class="nump">4,690,094<span></span>
</td>
<td class="nump">394,976<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Convertible Preferred Stock and Stockholders' Deficit - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Initial public offering</div></th>
<th class="th"><div>Common stock</div></th>
<th class="th">
<div>Common stock </div>
<div>Initial public offering</div>
</th>
<th class="th"><div>Additional paid-in capital</div></th>
<th class="th">
<div>Additional paid-in capital </div>
<div>Initial public offering</div>
</th>
<th class="th"><div>Accumulated deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at beginning (in shares) at Dec. 31, 2022</a></td>
<td class="nump">130,648,426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at beginning at Dec. 31, 2022</a></td>
<td class="nump">$ 162,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at ending (in shares) at Dec. 31, 2023</a></td>
<td class="nump">130,648,426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at ending at Dec. 31, 2023</a></td>
<td class="nump">$ 162,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at beginning (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">356,759<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning at Dec. 31, 2022</a></td>
<td class="num">(77,531)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (110,671)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Changes in Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Vesting of restricted common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
<td class="nump">185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">2,907<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,907<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (49,291)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(49,291)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at ending (in shares) at Dec. 31, 2023</a></td>
<td class="nump">1,026,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">460,704<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at ending at Dec. 31, 2023</a></td>
<td class="num">$ (123,730)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(159,962)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Changes in Convertible Preferred Stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_TemporaryEquitySharesConversionOfConvertibleSecurities', window );">Conversion of convertible preferred stock into common stock upon initial public offering (in shares)</a></td>
<td class="num">(130,648,426)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_TemporaryEquityValueConversionOfConvertibleSecurities', window );">Conversion of convertible preferred stock into common stock upon initial public offering</a></td>
<td class="num">$ (162,147)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at ending (in shares) at Dec. 31, 2024</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at ending at Dec. 31, 2024</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Changes in Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Vesting of restricted common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">513,781<span></span>
</td>
<td class="nump">7,463,762<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">$ 72,373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="nump">$ 72,373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible preferred stock into common stock upon initial public offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,648,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of convertible preferred stock into common stock upon initial public offering</a></td>
<td class="nump">162,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162,146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">4,032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (51,791)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(51,791)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at ending (in shares) at Dec. 31, 2024</a></td>
<td class="nump">20,161,072<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,145,129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at ending at Dec. 31, 2024</a></td>
<td class="nump">$ 63,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 274,895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (211,753)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_TemporaryEquitySharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Shares, Conversion of Convertible Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_TemporaryEquitySharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_TemporaryEquityValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Value, Conversion of Convertible Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_TemporaryEquityValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.E.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Convertible Preferred Stock and Stockholders' Deficit (Parenthetical)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance costs</a></td>
<td class="nump">$ 9,727<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (51,791)<span></span>
</td>
<td class="num">$ (49,291)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,696<span></span>
</td>
<td class="nump">1,678<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">4,032<span></span>
</td>
<td class="nump">2,907<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_NoncashLeaseExpense', window );">Non-cash lease expense</a></td>
<td class="nump">1,749<span></span>
</td>
<td class="nump">1,728<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaidInKindInterest', window );">Non-cash interest expense</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(711)<span></span>
</td>
<td class="num">(420)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">168<span></span>
</td>
<td class="num">(1,115)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="nump">1,531<span></span>
</td>
<td class="num">(136)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_IncreaseDecreaseInOperatingLeaseAssetsLiabilities', window );">Operating lease assets and liabilities</a></td>
<td class="num">(2,704)<span></span>
</td>
<td class="nump">402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">385<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(45,562)<span></span>
</td>
<td class="num">(44,155)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(441)<span></span>
</td>
<td class="num">(678)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(441)<span></span>
</td>
<td class="num">(678)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock, net of issuance costs</a></td>
<td class="nump">76,353<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of common stock options</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction', window );">Proceeds from financing obligation, net of issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">706<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_PrincipalPaymentsOnFinancingObligationsFailedSaleLeasebackTransaction', window );">Principal payments on financing obligation</a></td>
<td class="num">(460)<span></span>
</td>
<td class="num">(268)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Principal payments on finance leases</a></td>
<td class="num">(364)<span></span>
</td>
<td class="num">(322)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of deferred offering costs</a></td>
<td class="num">(3,980)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">71,662<span></span>
</td>
<td class="nump">301<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="nump">25,659<span></span>
</td>
<td class="num">(44,532)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of year</a></td>
<td class="nump">40,004<span></span>
</td>
<td class="nump">84,536<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">65,663<span></span>
</td>
<td class="nump">40,004<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating lease right-of-use asset obtained in exchange for lease liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,397<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Finance lease right-of-use asset obtained in exchange for lease liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">504<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Purchases of property and equipment in accounts payable and accrued expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Conversion of convertible preferred stock upon initial public offering</a></td>
<td class="nump">162,147<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_FinanceLeaseRightOfUseAssetConvertedToFixedAsset', window );">Finance lease right-of-use asset converted to fixed asset</a></td>
<td class="nump">$ 127<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_FinanceLeaseRightOfUseAssetConvertedToFixedAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease Right-Of-Use Asset Converted To Fixed Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_FinanceLeaseRightOfUseAssetConvertedToFixedAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_IncreaseDecreaseInOperatingLeaseAssetsLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the assets (liabilities) created through operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_IncreaseDecreaseInOperatingLeaseAssetsLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_NoncashLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total noncash lease expenses incurred by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_NoncashLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_PrincipalPaymentsOnFinancingObligationsFailedSaleLeasebackTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the principal payments on the financing obligations arising from the failed sale-leaseback transaction during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_PrincipalPaymentsOnFinancingObligationsFailedSaleLeasebackTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from proceeds received by the entity from the financing obligations related to the failed sale-leaseback transaction during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478345/912-310-45-11<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaidInKindInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaidInKindInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Description of Business and Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. &#160;&#160;&#160;&#160;Description of Business and Basis of Presentation</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description of Business</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CAMP4 Therapeutics Corporation, formerly Marauder Therapeutics, Inc., and its subsidiary (collectively, the &#8220;Company&#8221;), is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new class of RNA-based therapeutics with the goal of upregulating gene expression and restoring healthy protein levels to treat a broad range of genetic diseases. The Company is currently focusing on metabolic diseases and diseases of the central nervous system. The Company was organized in September&#160;2015 and began operations in 2016.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;). Any reference in these notes to applicable guidance is meant to refer to the authoritative standards of U.S. GAAP as found in the Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Updates (&#8220;ASU&#8221;) of the Financial Accounting Standards Board (&#8220;FASB&#8221;).</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s consolidated financial statements include the accounts of CAMP4 Therapeutics Corporation and its wholly owned subsidiary, CAMP4 Therapeutics Pty Ltd (&#8220;CAMP4 AUS&#8221;), which was established on September&#160;15, 2023. All intercompany balances and transactions have been eliminated in consolidation.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassification of Prior Year Presentation</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations or balance sheets.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reverse Stock Split</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October&#160;3, 2024, the Company effected a one-for-11.2158 reverse stock split of its issued and outstanding shares of common stock and a proportional adjustment to the existing conversion ratios for each series of the Company&#8217;s convertible preferred stock. Accordingly, all share and per share amounts for all periods presented in the accompanying consolidated financial statements and notes thereto have been adjusted retroactively, where applicable, to reflect this reverse stock split and adjustment of the preferred stock conversion ratios. The par value and the number of authorized shares of the convertible preferred stock and common stock were not adjusted in connection with the reverse stock split.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Initial Public Offering</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 15, 2024, the Company completed its initial public offering (&#8220;IPO&#8221;), pursuant to which it issued and sold an aggregate of 6,820,000 shares of its common stock at a price to the public of $11.00 per share, resulting in net proceeds of $65.8 million, after deducting underwriting discounts and commissions of $5.3 million and other offering expenses of $4.0 million. In addition, on November 1, 2024, the Company received additional proceeds of $6.6 million, after deducting underwriting discounts and commissions of $0.5 million, pursuant to the partial exercise by the underwriters of their option to purchase additional shares in the IPO. Collectively, the Company received aggregate net proceeds of $72.4 million. Upon the closing of the IPO, the Company&#8217;s outstanding convertible preferred stock automatically converted into 11,648,582 shares of common stock (see Note 9).</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the completion of its IPO, on October 15, 2024, the Company&#8217;s certificate of incorporation was amended and restated to authorize 175,000,000 shares of common stock, par value $0.0001 per share and 25,000,000 shares of preferred stock, par value of $0.0001 per share.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Going Concern</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of December&#160;31, 2024, the Company had approximately $64.0 million of cash and cash equivalents and working capital of approximately $56.8 million. The Company has a relatively limited operating history, and the revenue and income potential of the Company&#8217;s business and market are unproven. The Company has experienced net losses and negative cash flows from operations since its inception and, as of December&#160;31, 2024, the Company had an accumulated deficit of $211.8 million. During the year ended December&#160;31, 2024, the Company incurred a net loss of $51.8 million and had negative cash flows from operations of $45.6 million. The Company will continue to incur significant costs and </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">expenses related to its ongoing operations until it successfully develops, obtains regulatory approval for and gains market acceptance of a product candidate and achieves revenues adequate to support the Company&#8217;s operations.</span></div><div><span><br/></span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From inception to December&#160;31, 2024, the Company has funded its operations primarily with proceeds from the sale of convertible preferred stock and common stock, including in its IPO, as well as through revenues from its license and collaboration agreements. Based on its current operating plan, the Company estimates that its cash and cash equivalents as of December&#160;31, 2024 will be sufficient to fund its operating expenses and capital expenditure requirements into the second quarter of 2026. However, the Company has based this estimate on assumptions that may prove to be wrong, and could deplete its capital resources sooner than it currently expects. The Company's capital resources may not be sufficient to fund operations through at least the next twelve&#160;months from the date that these audited consolidated financial statements as of December&#160;31, 2024 are issued based on its expected cash needs, which raises substantial doubt about the Company's ability to continue as a going concern. As the Company continues to pursue its business plan, it expects to finance its operations through potential public or private equity offerings, debt financings or other capital sources, including current or potential future collaborations, licenses and other similar arrangements. However, there can be no assurance that any additional financing or strategic arrangements will be available to the Company on acceptable terms, if at all. If events or circumstances occur such that the Company does not obtain additional funding, it may be necessary to significantly reduce its scope of operations to reduce the current rate of spending through actions such as reductions in staff and the need to delay, limit, reduce or terminate product development or future commercialization efforts or grant rights to develop and market product candidates that it would otherwise prefer to develop and market itself, which could have a material adverse effect on the Company&#8217;s business, results of operations or financial condition.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the ordinary course of business. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. &#160;&#160;&#160;&#160;Summary of Significant Accounting Policies</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates assumptions, and judgments that affect the reported amounts of assets, liabilities, expenses and related disclosures in the accompanying notes. The Company bases its estimates, assumptions and judgments on historical experience when available and on various factors that it believes to be reasonable under the circumstances as of the date of the accompanying consolidated financial statements, including the fair value of common stock prior to the Company&#8217;s IPO, stock-based compensation expense, accrued expenses, lease accounting and the recoverability of the Company&#8217;s net deferred tax assets and related valuation allowance. In addition, other factors may affect estimates, including the expected business and operational changes, the sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process often may yield a range of potentially reasonable estimates of the ultimate future outcomes, and management must select an amount that falls within that range of reasonable estimates. Actual results could differ materially from the estimates and assumptions used in the preparation of the accompanying consolidated financial statements under different assumptions or conditions.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments and instruments with original maturities of 90 days or less that can be liquidated without prior notice or penalty to be cash equivalents. Cash equivalents primarily represent funds invested in readily available money market accounts. As of December&#160;31, 2024 and 2023, the Company had cash and cash equivalents balances deposited at one major financial institution.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Cash</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with its operating leases, the Company is required to maintain security deposits totaling $1.5 million, which were issued in the form of letters of credit with a bank. As of December&#160;31, 2024 and 2023, the Company held cash in this amount in separate restricted bank accounts as collateral for the letters of credit. The restricted cash balance is classified as long-term restricted cash on the accompanying consolidated balance sheets. In addition, the Company held less than $0.1 million in money market accounts as of each of December&#160;31, 2024 and 2023 as collateral for the Company&#8217;s credit card obligation and increased letter of credit due to an amendment to the leases.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheets to the corresponding amounts shown in the consolidated statements of cash flows as of December&#160;31, 2024 and 2023 (in thousands):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64,039&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,380&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65,663&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40,004&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risks</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. The Company deposits cash and cash equivalents with high credit quality financial institutions in the United States. These deposits are held in checking and money market accounts and may, from time to time, exceed the federally insured amounts. The Company has not experienced any losses in such accounts. The Company believes it is not exposed to any significant risk in its cash and cash equivalents. The primary objectives of the Company&#8217;s investment portfolio are the preservation of capital and maintenance of liquidity.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to risks common to companies in the biopharmaceutical industry, including, but not limited to, risks related to the successful development and commercialization of product candidates, fluctuations in operating results and financial risks, the ability to successfully raise additional funds when needed, protection of proprietary rights and patent risks, patent litigation, compliance with government regulations, dependence on key personnel and collaboration partners, dependence on third-party manufacturers and competition from competing products in the marketplace.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies fair value measurements to record fair value adjustments to certain assets and liabilities and to determine fair value disclosures. Fair value is measured as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A fair value measurement assumes that the transaction to sell the asset or transfer the liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market. A framework is used for measuring fair value utilizing a three-tier hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level&#160;1) and the lowest priority to unobservable inputs (Level&#160;3).</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The three levels of the fair value hierarchy are as follows:</span></div><div style="margin-bottom:8pt;padding-left:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Level&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Observable inputs such as unadjusted quoted prices in active markets that are accessible at the measurement date for identical unrestricted assets or liabilities the Company has the ability to access;</span></div><div style="margin-bottom:8pt;padding-left:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Level&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Inputs (other than quoted prices included within Level&#160;1) that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active; and</span></div><div style="margin-bottom:8pt;padding-left:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Level&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments are categorized in their entirety based on the lowest level of input that is significant to the fair value measurement. The assessment of the significance of a particular input to the fair value measurement requires judgment and considers factors specific to the investment. To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level&#160;3. The Company reviews the fair value hierarchy classification at each reporting date. Changes in the ability to observe valuation inputs may result in a reclassification of levels for certain assets or liabilities within the fair value hierarchy. The Company did not have any transfers of assets and liabilities between the levels of the fair value measurement hierarchy during the&#160;years presented.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Remeasurement</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reporting currency and the functional currency of its foreign subsidiary, CAMP4 AUS, is the United States Dollar (&#8220;USD&#8221;). At the date a foreign currency denominated transaction is recognized, each asset, liability, revenue, expense, gain or loss arising from the transaction is measured initially in USD based on the exchange rate in effect at that date. Subsequently, at each balance sheet date, balances related to monetary assets and liabilities are adjusted to reflect the current exchange rate, which is the rate at which the related receivable or payable could be settled at that date.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign exchange transaction gains and losses are included in other income, net in the accompanying consolidated statements of operations and comprehensive loss and were de minimis for the&#160;years ended December&#160;31, 2024 and 2023.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comprehensive Loss</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no differences between net loss and comprehensive loss presented in the consolidated statements of operations for the&#160;years ended December&#160;31, 2024 and 2023.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment, Net</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, which are all located in the United States, are stated at cost less accumulated depreciation. Expenditures for maintenance and repairs are charged to expense as incurred, whereas major betterments are capitalized as additions to property and equipment. Depreciation is calculated using the straight-line method over the following estimated useful lives of the assets:</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Computer and software</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laboratory equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Five years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Seven years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shorter of asset life or remaining lease term</span></td></tr></table></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates its long-lived assets, which consist of property and equipment, operating lease right-of-use (&#8220;ROU&#8221;) assets, and finance lease ROU assets, for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant underperformance of the business in relation to expectations, significant negative industry or economic trends and significant changes or planned changes in the use of the assets. If the asset is impaired, the amount of any impairment is measured as the difference between the carrying value and the fair value of the impaired asset. The Company recognized no impairment losses for the&#160;years ended December&#160;31, 2024 and 2023.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commitments and Contingencies</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contractual Commitments</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into contracts in the normal course of business with contract research organizations (&#8220;CROs&#8221;), contract manufacturing organizations (&#8220;CMOs&#8221;), academic institutions and other third parties for preclinical and clinical research studies, testing and manufacturing services. These contracts generally do not contain minimum purchase commitments and are cancellable by the Company upon prior written notice, although purchase orders for preclinical materials are generally non-cancellable. Payments due upon cancellation consist primarily of payments for services provided or expenses incurred, including non-cancellable obligations from the Company&#8217;s service providers, up to the date of cancellation or upon the completion of a manufacturing run.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Indemnifications</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Indemnification Obligations</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into indemnification agreements with its officers and directors that require the Company to indemnify such individuals for certain events or occurrences while each such officer or director is, or was, serving at the Company&#8217;s request in such capacity. The maximum potential future payments the Company could be required to make is, in many cases, unlimited. The Company has directors&#8217; and officers&#8217; liability insurance coverage that limits its exposure and enables the Company to recover a portion of any future amounts paid.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases office and laboratory space under operating leases. The Company has standard indemnification arrangements under the leases that require it to indemnify the landlords against all costs, expenses, fines, suits, claims, demands, liabilities and actions directly resulting from any breach, violation or nonperformance of any covenant or condition of the Company&#8217;s leases.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of its business, the Company enters into indemnification agreements with certain suppliers and business partners pursuant to which the Company has certain indemnification obligations limited to the costs, expenses, fines, suits, claims, demands, liabilities and actions directly resulting from the Company&#8217;s gross negligence or willful misconduct, and in certain instances, breaches, violations or nonperformance of covenants or conditions under the agreements.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024 and 2023, the Company had not experienced any material losses related to these indemnification obligations, and no material claims with respect thereto were outstanding. The Company does not expect significant claims related to these indemnification obligations and, consequently, concluded that the fair value of these obligations is negligible, and no related reserves were established.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to the possibility of loss contingencies arising in the ordinary course of business. Management considers the likelihood of loss related to an asset, or the incurrence of a liability, as well as its ability to reasonably estimate the amount of the loss, in determining loss contingencies. An estimated loss contingency is accrued when it is probable that an asset has been impaired, or a liability has been incurred and the amount of loss can be reasonably estimated. The Company regularly evaluates current information available to determine whether such accruals should be adjusted and whether new accruals are required.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company may become involved in litigation relating to claims arising from the ordinary course of business. Management believes that there are no claims or actions pending against the Company currently, the ultimate disposition of which would have a material adverse effect on the Company&#8217;s consolidated results of operations, financial condition or cash flows.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 842,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company determines if an arrangement is or contains a lease at inception. A contract is or contains a lease if the contract conveys the right to control the use of an identified asset for a period in exchange for consideration. The Company classifies leases at the lease commencement date as operating or finance leases and records a ROU asset and a lease liability on the consolidated balance sheet for all leases with an initial lease term of greater than 12 months. Leases with an initial term of 12 months or less are not recorded in the balance sheet, but payments are recognized as expense on a straight-line basis over the lease term.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A lease qualifies as a finance lease if any of the following criteria are met at the inception of the lease: (i)&#160;there is a transfer of ownership of the leased asset to the Company by the end of the lease term, (ii)&#160;the Company holds an option to purchase the leased asset that it is reasonably certain to exercise, (iii)&#160;the lease term is for a major part of the remaining economic life of the leased asset, (iv)&#160;the present value of the sum of lease payments equals or exceeds substantially all of the fair value of the leased asset, or (v)&#160;the nature of the leased asset is specialized to the point that it is expected to provide the lessor no alternative use at the end of the lease term. All other leases are recorded as operating leases.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into contracts that contain both lease and non-lease components. Non-lease components may include maintenance, utilities and other operating costs. The Company combines the lease and non-lease components of fixed costs in its lease arrangements as a single lease component. Variable costs, such as utilities or maintenance costs, are not included in the measurement of ROU assets and lease liabilities, but rather are expensed when the event determining the amount of variable consideration to be paid occurs.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance and operating lease assets and liabilities are recognized at the lease commencement date based on the present value of the lease payments over the lease term using the discount rate implicit in the lease. If the rate implicit is not readily determinable, the Company utilizes an estimate of its incremental borrowing rate based upon the available information at the lease commencement date. Operating lease assets are further adjusted for prepaid or accrued lease payments. Operating lease assets are expensed using the straight-line method as an operating expense over the lease term. Finance lease assets are amortized to depreciation expense using the straight-line method. Finance lease payments are bifurcated into (i)&#160;a portion that is recorded as imputed interest expense and (ii)&#160;a portion that reduces the finance liability associated with the lease.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s leases provide a lease incentive in the form of reimbursable leasehold improvements. Due to the unpredictability of the payout of leasehold improvement reimbursements, the Company recognizes a reduction to the ROU asset and the lease liability once it has incurred costs that qualify as reimbursable by the lessor. The reduction to the ROU asset is recognized prospectively over the remainder of the lease term.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s leases include options to extend or terminate the lease. The amounts determined for the Company&#8217;s ROU assets and lease liabilities generally do not assume that renewal options or early-termination provisions, if any, are exercised, unless it is reasonably certain that the Company will exercise such options.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company examines other contracts with suppliers, vendors and outside parties to identify whether such contracts contain an embedded lease and, as applicable, records such embedded leases in accordance with ASC 842,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financing Obligation (Failed Sale-Leaseback)</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 842,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for potential sale-leaseback transactions, the Company assesses the contract to identify if a sale occurred in accordance with ASC Topic 606,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASC 606&#8221;). Sale-and-leaseback transactions occur when the Company sells assets to a third-party and simultaneously leases them back. The resulting leases that qualify for sale-and-leaseback accounting are evaluated and accounted for as operating leases. A transaction that does not qualify for sale-and-leaseback accounting as a result of finance lease classification or the failure to meet certain revenue recognition criteria is accounted for as a financing transaction. For a financing transaction, the Company will retain the assets sold within Property, plant and equipment, net and record a financing obligation equal to the amount of cash proceeds received. Rental payments under such transactions are recognized as a reduction of the financing obligation and as interest expense using an effective interest method. To date, the Company has entered into one failed sale-leaseback transaction. See additional discussion in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 7. Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition and Accounting for Collaboration Agreements</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with ASC 606. The Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. In determining the appropriate amount of revenue to be recognized as it fulfills its obligations under its agreements, the Company performs the following steps: (i)&#160;identification of the promised goods or services in the contract; (ii)&#160;determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii)&#160;measurement of the transaction price, including the constraint on variable consideration; (iv)&#160;allocation of the transaction price to the performance obligations; and (v)&#160;recognition of revenue when (or as) the Company satisfies each performance obligation.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses judgment to determine: (a)&#160;the performance obligations based on the determination under step (ii)&#160;above; (b)&#160;the transaction price under step (iii)&#160;above; and (c)&#160;the recognition of revenue as services are performed under step (v)&#160;above. The Company also uses judgment to determine whether development milestones or other variable consideration except for royalties and sales-based milestones, should be included in the transaction price as described further below.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the five-step model to contracts when the arrangement is not a collaboration pursuant to ASC Topic 808,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;(&#8220;ASC 808&#8221;), and it is probable that the Company will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Agreements</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company analyzes its collaboration agreements to assess whether they are within the scope of ASC 808 by determining whether such arrangements involve joint operating activities performed by parties that are both active participants in the activities and exposed to significant risks and rewards that are dependent on the commercial success of such activities. To the extent the arrangement is within the scope of ASC 808, the Company assesses whether aspects of the arrangement between the Company and the collaboration partner are within the scope of other accounting literature. If the Company concludes that some or all aspects of the arrangement represent a transaction with a customer, the Company </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accounts for those aspects of the arrangement within the scope of ASC 606. If the Company concludes that some or all aspects of the arrangement are within the scope of ASC 808 and do not represent a transaction with a customer, the Company recognizes the Company&#8217;s share of the allocation of the shared costs incurred with respect to the jointly conducted activities as a component of the related expense in the period incurred.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Expenses</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development (&#8220;R&amp;D&#8221;) expenses are recorded to operating expenses when incurred. The Company&#8217;s R&amp;D expenses consist primarily of costs incurred in performing R&amp;D activities, including personnel-related expenses such as salaries, stock-based compensation and benefits, facilities costs, depreciation and external costs of outside vendors engaged to conduct clinical and preclinical development activities and to manufacture a product candidate. The Company accrues expenses related to development activities performed by third parties based on an evaluation of services received and efforts expended pursuant to the terms of the contractual arrangements. Payments under some of these contracts depend on preclinical trial milestones. Non-refundable advance payments for goods and services that will be used over time for R&amp;D are deferred and capitalized as R&amp;D prepaid expenses on the Company&#8217;s consolidated balance sheets. The capitalized amounts are recognized as an expense as the goods are delivered or as the related services are performed. In accruing service fees, the Company estimates the period over which services will be performed and the level of effort to be expended in each period. If the actual timing of the performance of services or the level of effort varies from the estimate, the Company will adjust the accrual or prepaid expense accordingly. Costs to acquire technologies to be used in R&amp;D that have not reached technological feasibility and have no alternative future use are also expensed as incurred.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General and Administrative Expenses</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative (&#8220;G&amp;A&#8221;) expenses consist primarily of personnel-related expenses, including salaries, bonuses, benefits, travel and stock-based compensation expenses for employees in executive, accounting and finance, business development, human resources, legal, and other administrative functions. Other significant G&amp;A expenses include allocated facility-related costs, legal fees relating to corporate and intellectual property matters, professional fees for accounting, audit and tax services, consulting fees and insurance costs. G&amp;A costs are expensed as incurred.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Patent Costs</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All patent-related costs incurred in connection with filing and prosecuting patent applications are expensed as incurred due to the uncertainty about the recovery of the expenditure. Amounts are classified as G&amp;A expenses.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Offering Costs</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company complies with the requirements of ASC 340,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets and Deferred Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, with regards to offering costs. Prior to the completion of an offering of common stock, direct offering costs are capitalized as deferred offering costs. The deferred offering costs are charged to additional paid-in capital for offerings of common stock or as a reduction in the carrying value of preferred stock for offerings of preferred stock. As of December&#160;31, 2024 and 2023, the Company had no deferred offering costs recorded. During the year ended December&#160;31, 2024, the Company recorded $4.0 million of offering costs related to the issuance of common stock in the IPO and recognized this amount as a reduction in the carrying value of the common stock issued in the IPO.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company periodically grants equity-based awards in the form of stock options and restricted stock to employees, directors and non-employees and records stock-based compensation expenses based on their estimated fair value at the grant date. The Company estimates the fair value of stock options using the Black-Scholes option-pricing model as of the grant date. Stock-based compensation expenses are recognized in the accompanying consolidated statements of operations and comprehensive loss on a straight-line basis over the requisite service period, which is typically the vesting period. Determining the appropriate fair value model and related input assumptions requires judgment.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the IPO, the fair value of the Company&#8217;s common stock was determined by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;) at the time of each option grant by considering several objective and subjective factors. These factors included the valuation of a select group of representative public companies within the industry that focus on biotechnology that the Board believed was comparable to the Company&#8217;s operations; operating and financial performance; the lack of liquidity of the common stock and trends in the broader economy and biotechnology industry also impact the determination of the fair value of the common stock. For awards granted after the Company&#8217;s IPO, the grant date fair value of common stock was determined by using the closing price per share of the Company&#8217;s common stock.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The other inputs to the Black-Scholes option-pricing model include the following:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The risk-free interest rate used is based on the published U.S. Department of Treasury interest rates in effect at the time of stock option grant for zero coupon U.S. Treasury notes with maturities approximating each grant&#8217;s expected term;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The dividend yield is zero as the Company has not paid dividends and does not anticipate paying a cash dividend in the foreseeable future;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The expected term for options granted is calculated using the simplified method and represents the average time that options are expected to be outstanding based on the mid-point between the vesting date and the end of the contractual term of the award; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Expected volatility is derived from the historical volatility of a select group of representative companies, for a look-back period commensurate with the expected term of the stock options, as the Company has limited trading history of common stock.</span></div><div style="margin-bottom:8pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company recognizes forfeitures related to stock-based compensation awards as they occur.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies stock-based compensation expense in the consolidated statement of operations and comprehensive loss in the same way the award recipients&#8217; payroll costs are classified or in which the award recipients&#8217; service payments are classified.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes in accordance with ASC 740,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;(&#8220;ASC 740&#8221;). ASC 740 requires the use of the asset and liability method of accounting for income taxes. The current or deferred tax consequences of a transaction are measured by applying the provisions of enacted tax laws to determine the amount of taxes payable currently or in future&#160;years. Deferred tax assets and liabilities are determined based on the difference between the consolidated financial statements and tax basis of assets and liabilities and expected future tax consequences of events that have been included in the consolidated financial statements or tax returns using enacted tax rates in effect for the year in which the differences are expected to reverse. Under this method, a valuation allowance is used to offset deferred tax assets if, based upon the available evidence, it is more likely than not that some or all of the deferred tax assets may not be realized. Management evaluates the recoverability of deferred taxes and the adequacy of the valuation allowance at each reporting period (see Note 12,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows the provisions of ASC 740 relative to accounting for uncertain tax positions. These provisions provide guidance on the recognition, de-recognition and measurement of potential tax benefits associated with tax positions. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company had no reserves related to uncertain tax positions as of December&#160;31, 2024 and 2023. As applicable, the Company recognizes accrued penalties and interest related to unrecognized tax benefits in the provision for income taxes. As of December&#160;31, 2024 and 2023, the Company did not accrue any potential interest or penalties.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to file federal and state income tax returns in the U.S. and foreign income tax returns in Australia. The preparation of tax returns requires the Company to interpret the applicable tax laws and regulations in effect in such jurisdictions, which could affect the amount of tax paid by the Company.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s income tax returns are based on calculations and assumptions that are subject to examination by the Internal Revenue Service and other tax authorities for the tax years ended December 31, 2020 through December 31, 2024. In addition, the calculation of the Company&#8217;s tax liabilities involves dealing with uncertainties in the application of complex tax regulations.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Classification of Convertible Preferred Stock</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s convertible preferred stock was classified as temporary equity in the accompanying consolidated balance sheet as of December&#160;31, 2023 and was excluded from stockholders&#8217; equity (deficit) as the potential redemption of such stock was outside the Company&#8217;s control. The convertible preferred stock was not redeemable except for in the event of a liquidation, dissolution or winding up of the Company. The Company did not accrete the carrying values of the preferred stock to the redemption values since the occurrence of these events was not considered probable.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Loss Per Share Attributable to Common Stockholders</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined all of its convertible preferred stock qualified as participating securities, as defined in ASC 260,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;(&#8220;ASC 260&#8221;). Under ASC 260, securities are considered participating securities if the securities may participate in undistributed earnings with common stock, whether that participation is conditioned upon the occurrence of a specified event or not. In accordance with ASC 260, a company is required to use the two-class method when computing net income (loss) per share when a company has securities that qualify as participating securities. The two-class method is an earnings allocation formula that determines net income (loss) per share for each class of common stock and participating security according to dividends declared (or accumulated) and participation rights in undistributed earnings. Diluted net loss per share for the Company&#8217;s common stock is computed using the more dilutive of the two-class method or the if-converted method.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period. Diluted net loss attributable to common stockholders is computed by adjusting net loss per share attributable to common stockholders to reallocate undistributed earnings based on the potential impact of dilutive securities. Diluted net loss per share attributable to common stockholders is computed by dividing the diluted net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period, including potential dilutive common shares. For purpose of this calculation, outstanding options to purchase common stock, unvested restricted stock awards, and shares of convertible preferred stock are considered potential dilutive common shares. The Company has generated a net loss in all periods presented, and therefore the basic and diluted net loss per share attributable to common stockholders are the same as the inclusion of the potentially dilutive securities would be anti-dilutive.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Emerging Growth Company Status</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is an emerging growth company (&#8220;EGC&#8221;) as defined in the Jumpstart Our Business Startups Act of 2012, as amended (the &#8220;JOBS Act&#8221;), and may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not an EGC. The Company may take advantage of these exemptions until it is no longer an EGC under Section&#160;107 of the JOBS Act and has elected to use the extended transition period for complying with new or revised accounting standards. As a result of this election, the Company&#8217;s consolidated financial statements may not be comparable to companies that comply with public company FASB standards&#8217; effective dates.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2023, FASB issued ASU 2023-07, &#8220;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.&#8221; The standard expands reportable segment disclosure requirements for public business entities primarily through enhanced disclosures about significant segment expenses that are regularly provided to the chief operating decision maker (&#8220;CODM&#8221;) and included within each reported measure of segment profit (referred to as the &#8220;significant expense principle&#8221;). The Company has adopted this standard for the fiscal year 2024 annual financial statements and has applied this standard retrospectively for all prior periods presented in the financial statements (see Note 13).</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Standards</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting standards not listed below were assessed and determined not to be applicable or are expected to have minimal impact on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, Income Taxes (&#8220;Topic 740&#8221;):&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Improvements to Income Tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The guidance includes the requirement that public business entities, on an annual basis, disclose specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold (if the effect of those reconciling items is equal to or greater than 5% of the amount computed by multiplying pretax income (or loss) by the applicable statutory income tax rate). It also requires that all entities disclose, on an annual basis, the amount of income taxes paid (net of refunds received) disaggregated by federal (national), state, and foreign taxes and the amount of income taxes paid (net of refunds received) disaggregated by individual jurisdictions in which income taxes paid (net of refunds received) is equal to or greater than 5% of total income taxes paid (net of refunds received) and requires that all entities disclose income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign and income tax expense (or benefit) from continuing operations disaggregated by federal (national), state, and foreign. Lastly, the guidance eliminates the requirement for all entities to disclose the nature and estimate of the range of the reasonably possible change in the unrecognized tax benefits balance in the next 12 months or make a statement that an estimate of the range cannot be made. For public business entities, the guidance is effective for annual periods beginning after December&#160;15, 2024. Early adoption is permitted for annual </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated financial statements that have not yet been issued or made available for issuance. The guidance should be applied on a prospective basis. Retrospective application is permitted. The Company is currently evaluating the impact that this guidance may have on its consolidated financial statements.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2024, the FASB issued ASU 2024-03, &#8220;Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses.&#8221; The standard requires that public business entities disclose additional information about specific expense categories in the notes to financial statements for interim and annual reporting periods. For public business entities, the guidance is effective for interim and annual periods beginning after December&#160;15, 2026. Early adoption is permitted for annual consolidated financial statements that have not yet been issued or made available for issuance. The guidance may be applied on a prospective basis or retrospectively for all prior periods presented in the financial statements. The Company is currently evaluating the impact that this guidance may have on its consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the financial instruments carried at fair value on a recurring basis as of December&#160;31, 2024 and 2023 (in thousands):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,819&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,819&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents</span></td><td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37,074&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37,074&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts reflected in the consolidated balance sheet for prepaid expenses and other current assets, accounts payable and accrued expenses and other liabilities are shown at their historical values which approximate their fair values.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Expenses And Other Current Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract', window );"><strong>Prepaid Expense and Other Assets, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_PrepaidExpensesAndOtherCurrentAssetsDisclosureTextBlock', window );">Prepaid Expenses and Other Current Assets</a></td>
<td class="text">Prepaid Expenses and Other Current Assets<div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consisted of the following as of December&#160;31, 2024 and 2023 (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">979&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insurance expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Software and subscriptions expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Variable lease expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal R&amp;D tax credit receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,344&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,633&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_PrepaidExpensesAndOtherCurrentAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of prepaid expenses and other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_PrepaidExpensesAndOtherCurrentAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property And Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text">Property and Equipment, Net<div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following as of December&#160;31, 2024 and 2023 (in thousands):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,518&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,518&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laboratory equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,078&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Computer and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">969&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">938&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">524&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">524&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total property and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,089&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,302&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,231)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,505)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,858&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,797&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2024, title of a finance lease ROU asset for laboratory equipment with cost totaling $0.3 million transferred to the Company. The laboratory equipment had accumulated depreciation of $0.2 million. The Company incurred depreciation and amortization expense of $1.5 million and $1.6 million for the&#160;years ended December&#160;31, 2024 and 2023, respectively. Depreciation and amortization expense for the&#160;years ended December&#160;31, 2024 and 2023 includes $0.2 million and $0.1 million of finance lease ROU asset amortization, respectively (see Note 7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">Accrued Expenses and Other Current Liabilities</a></td>
<td class="text"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. &#160;&#160;&#160;&#160;Accrued Expenses and Other Current Liabilities</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities consisted of the following as of December&#160;31, 2024 and 2023 (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee compensation and benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,937&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">External R&amp;D expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,833&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,302&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. &#160;&#160;&#160;&#160;Commitments and Contingencies</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company currently leases approximately 30,000 square feet of office space and laboratory space in Cambridge, Massachusetts (the &#8220;Cambridge Lease&#8221;) and approximately 5,300 square feet of office and lab space in Boulder, Colorado (the &#8220;Boulder Lease&#8221;). The Cambridge Lease expires on June&#160;30, 2027. The Cambridge Lease provided a lease incentive in the form of reimbursable leasehold improvements of up to $3.6 million. As of December&#160;31, 2024 and 2023, the Company had capitalized $4.5 million of leasehold improvement costs under this lease. $3.6 million was reimbursed through the lease incentive of which the final $2.7 million was received during the&#160;year ended December&#160;31, 2023. Amounts received for lease incentives were included in the changes in operating lease assets and liabilities line in the consolidated statement of cash flows. As of December&#160;31, 2024, the Cambridge Lease accounted for $4.9 million of operating lease ROU assets, $2.7 million of current operating lease liabilities and $4.6 million of non-current operating lease liabilities.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Boulder Lease is a five-year lease that commenced on September&#160;1, 2023 and expires on September&#160;30, 2028. As the rate implicit for the Boulder Lease was not readily determinable, the Company used its incremental borrowing rate of 7.12% as of the commencement date. At commencement of the Boulder Lease, the Company recorded $1.4 million of operating ROU assets, $0.2 million of current operating lease liabilities and $1.2 million of non-current operating lease liabilities. As of December&#160;31, 2024, the Boulder Lease accounted for $1.1 million of operating lease ROU assets, $0.3 million of current operating lease liabilities and $0.9 million of non-current operating lease liabilities.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the Company&#8217;s operating lease costs for the&#160;years ended December&#160;31, 2024 and 2023 (in thousands except for lease terms and borrowing rates):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease cost</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,489&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Variable lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,852&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,821&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other information</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.64pt;text-align:left;text-indent:-8.64pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows used for operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining lease term in years</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average incremental borrowing rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of operating lease liabilities as of December&#160;31, 2024 were as follows (in thousands):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,980&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,256&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: amount representing imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(769)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total future minimum lease obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,487&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance Leases</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases certain specialized lab equipment under several finance lease agreements with maturities ranging from April 2025 to November 2028. As of December&#160;31, 2024, these finance leases account for $0.4 million of finance lease ROU assets, $0.1 million of current finance lease liabilities and $0.1 million of non-current finance lease liabilities.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the Company&#8217;s finance lease costs for the&#160;years ended December&#160;31, 2024 and 2023 (in thousands except for lease terms and borrowing rates):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.454%"><tr><td style="width:1.0%"></td><td style="width:51.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.153%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.434%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.434%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance lease cost</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of ROU assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest on lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total finance lease cost</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">215&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">179&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other information</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;text-indent:-10.8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows used for finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining lease term in years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average incremental borrowing rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of finance lease liabilities as of December&#160;31, 2024 were as follows (in thousands):</span></div><div style="margin-bottom:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">173&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: amount representing imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total future minimum lease obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">161&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financing Obligation</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2023, the Company (seller-lessee) sold certain laboratory equipment to an unrelated third-party (buyer-lessor) and simultaneously entered into a 26-month lease agreement for the laboratory equipment with the buyer-lessor through June 2025. The lease requires monthly payments of less than $0.1 million and provides a fixed price repurchase option at the end of the lease term of $0.1 million.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The repurchase option precludes accounting for the transfer of the asset to the buyer-lessor as a sale under ASC 842 since the exercise price of the repurchase option is fixed and, therefore, is not the fair value of the asset on the exercise date of the option. Thus, the agreement is considered a financing transaction (i.e., failed sale-leaseback) as the Company is reasonably certain to exercise the repurchase option at the end of the lease. The net proceeds received amounted to $0.7 million, which is recorded as a financing liability in the Company&#8217;s consolidated balance sheet. The Company imputes </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">interest at a rate of 0.86% monthly. For each of the years ended December&#160;31, 2024 and 2023, the Company recorded less than $0.1 million of interest expense related to this financing transaction in other expense in the consolidated statement of operations and comprehensive loss.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A liability for loss contingencies arising from claims, assessments, litigation, fines, penalties and other sources is recorded in the consolidated financial statements if it is determined that it is probable that a loss has been incurred and the amount (or range) of the loss can be reasonably estimated. There are no matters currently outstanding for which any liabilities have been accrued or require disclosure.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration and License Agreements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_CollaborationAndLicenseAgreementsAbstract', window );"><strong>Collaboration and License Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Collaboration and License Agreements</a></td>
<td class="text"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. &#160;&#160;&#160;&#160;Collaboration and License Agreements</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">In-License Agreements</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Children&#8217;s Medical Center Corporation</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2018, the Company entered into a development and license agreement (the &#8220;CMCC Agreement&#8221;) with Children&#8217;s Medical Center Corporation (&#8220;CMCC&#8221;). The CMCC Agreement allows the Company to use CMCC&#8217;s proprietary intellectual property to conduct research, development and commercialization of products utilizing CMCC&#8217;s proprietary intellectual property in return for specified payments. The proprietary intellectual property licensed pursuant to this agreement is related to certain legacy programs the Company is not pursuing which were subsequently sublicensed to Fulcrum Therapeutics, Inc. (&#8220;Fulcrum&#8221;), as described below. As part of the CMCC Agreement, the Company issued a total of 15,123 shares of common stock to CMCC and its affiliates based on the fair value of the common stock on the date of issuance.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is obligated to pay potential development milestone payments under the terms of the CMCC Agreement of up to $7.7 million for the first licensed target, $3.9 million for the second licensed target and $1.9 million for the third licensed target upon the achievement of certain specified contingent events. If commercial sales of a licensed product commence, the Company will pay CMCC royalties at&#160;percentage rates ranging in the low- to mid-single digits on net sales of licensed products in countries where such product is protected by patent rights. The Company incurred de minimis royalties owed to CMCC for each of the years ended December&#160;31, 2024 and 2023 under the CMCC Agreement and recorded the amounts in R&amp;D expense in the consolidated statement of operations and comprehensive loss. Further, under the terms of the CMCC Agreement, the Company is required to pay ten percent of any upfront payment received under a sublicensing agreement entered into prior to the initiation of the first investigational new drug study. As such, the Company recorded de minimis amounts for each of the years ended December&#160;31, 2024 and 2023, which is presented in R&amp;D expenses on the consolidated statements of operations and comprehensive loss. The Company re-evaluates the likelihood of achieving future milestones at the end of each reporting period. As of December&#160;31, 2024, the Company determined that the likelihood of achieving future milestones was not probable.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Whitehead Institute for Biomedical Research</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2019, the Company entered into a patent license agreement (as subsequently amended, the &#8220;Whitehead Agreement&#8221;), with the Whitehead Institute for Biomedical Research, (&#8220;Whitehead&#8221;). Under the Whitehead Agreement, the Company was granted a worldwide, royalty-bearing, sublicensable license under certain patent rights owned or controlled by Whitehead. Upon entering into the Whitehead Agreement, the Company paid an initial $0.1 million license issuance fee, and paid de minimis additional fees in connection with subsequent amendments to the Whitehead Agreement. The Company is obligated to pay annual license maintenance fees for the term of the Whitehead Agreement. In addition, the Company is obligated to pay certain filing, prosecution and maintenance fees with respect to certain patent rights licensed. </span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also obligated to pay potential development milestone payments to Whitehead of up to $1.9 million upon the achievement of certain specified contingent events. In addition, if the Company successfully commercializes a product under the Whitehead Agreement, it is obligated to pay tiered royalties at percentage rates ranging from less than one percent to the mid-single digits of net sales or of running royalties of net sales, subject to specified reductions, until either the last-to-expire valid claim of a Whitehead patent covering the product or seven years after the first commercial sale, in each case on a product-by-product and country-by-country basis. </span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred fees of $0.3 million under the Whitehead Agreement during the year ended December&#160;31, 2024. During the year ended December&#160;31, 2023, the fees were de minimis. These fees are recorded in R&amp;D expense in the Company&#8217;s consolidated statement of operations and comprehensive loss.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Out-license&#160;Agreement</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fulcrum Therapeutics, Inc.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2023, the Company entered into a license agreement (the &#8220;Fulcrum Agreement&#8221;) with Fulcrum. Under the Fulcrum Agreement, the Company granted an exclusive license related to the Company&#8217;s intellectual property (&#8220;IP&#8221;) and granted a non-exclusive sublicense for IP obtained through the CMCC Agreement. In exchange for the license rights, Fulcrum paid the Company a $0.4 million upfront payment. In the event that Fulcrum achieves certain development and commercial milestones, Fulcrum will be obligated to pay the Company one-time milestone payments ranging from $0.6 million to $20.0 million depending on the product and milestone achieved. In addition, under the Fulcrum Agreement there are potential de minimis minimum annual royalty payments as well as sales-based royalties of up to the low-double digits upon commercialization.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed this arrangement in accordance with ASC 606 and concluded that the contract counterparty, Fulcrum, is a customer. In accordance with ASC 606, the Company determined that there is one performance obligation in the Fulcrum Agreement, consisting of the exclusive and non-exclusive license rights granted to Fulcrum. The transaction price was comprised of the fixed consideration of $0.4 million and was recognized upon transfer of control of the licenses at a point in time upon contract execution. The arrangement includes significant variable consideration primarily in the form of milestone payments, which is fully constrained at the inception of the contract. All variable consideration is remeasured and reassessed each reporting period. As of and for the years ended December&#160;31, 2024 and 2023, the Company determined the variable consideration was fully constrained.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sales-based royalty fee is considered variable consideration and will be recognized as revenue as such sales occur. The sales-based royalty fee qualifies for the royalty constraint exception and does not require an estimate of the future transaction price.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, the Company recorded $0.4 million in license revenue pursuant to the Fulcrum Agreement and none in the year ended December&#160;31, 2024.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Collaborative&#160;Arrangement</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Eli Lilly and Company</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2023, the Company executed a Material Transfer Agreement (as amended, the &#8220;MTA&#8221;) with Eli Lilly and Company (&#8220;Eli Lilly&#8221;). As part of the MTA, the Company and Eli Lilly agreed to perform R&amp;D activities to generate up to three antisense oligonucleotides (&#8220;ASOs&#8221;) in accordance with a prescribed workplan. The Company evaluated the MTA under ASC 808 and concluded that it is a collaboration arrangement. The Company and Eli Lilly are jointly overseeing the R&amp;D activities under the MTA. In addition, both parties are exposed to significant risks and potential rewards under the MTA. During each of the years ended December&#160;31, 2024 and 2023, the Company recorded $0.5 million as a reduction in R&amp;D expense in the consolidated statement of operations and comprehensive loss as a result of the earned R&amp;D reimbursement from Eli Lilly. Additionally, the Company had an unbilled receivable of $0.1 million recorded within prepaid expenses and other current assets on the consolidated balance sheet as of December&#160;31, 2023 and a de minimis deferred liability as of December&#160;31, 2024.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Collaboration&#160;Arrangement</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BioMarin Pharmaceutical Inc.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2024, the Company entered into a Collaboration and License Agreement (the &#8220;BioMarin Agreement&#8221;) with BioMarin Pharmaceutical Inc. (&#8220;BioMarin&#8221;). Under the terms of the BioMarin Agreement, BioMarin paid the Company an upfront, nonrefundable payment of $1.0 million, and will reimburse the Company for certain research activities. On a per-program basis, the Company will be eligible to receive up to $5.0 million in future contingent preclinical milestones, up to $75.0 million in future contingent development and regulatory milestones and up to $105.0 million in commercial sales milestones. The Company will be further eligible to receive tiered royalties at percentage rates ranging from low to high single digits of net sales, subject to specified reductions, until either the last-to-expire valid claim of a patent covering the product, ten years after the first commercial sale, or the expiration of any applicable regulatory exclusivity obtained for the product, in each case on a product-by-product and country-by-country basis. The agreement may be terminated in its entirety or on a program-by-program basis for convenience by BioMarin. The agreement may also be terminated by either the Company or BioMarin under certain other circumstances, including material breach, as set forth in the agreement. The notice periods for termination provisions range from 30 days to 270 days depending on the reason for termination. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed this arrangement in accordance with ASC 606 and concluded that BioMarin is a customer and there is one performance obligation, which includes performance of R&amp;D activities in accordance with a contractual work plan, participation in a joint steering committee, the grant of an exclusive license to BioMarin, the grant of a non-exclusive license to the data resulting from performance of the R&amp;D activities, and providing quarterly progress reports. The transaction price was determined to be fixed consideration of $3.8 million, comprised of $1.0 million upfront consideration and expected $2.8 million reimbursable R&amp;D expenses, and will be recognized over time based upon a cost-to-cost method. Any deferred revenue recorded will be classified as short-term. The Company believes this work will be completed within 12 months of contract execution and thus, the related revenue will be recognized over that period. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The arrangement includes significant variable consideration primarily in the form of milestone payments, which is fully constrained at the inception of the contract. All variable consideration is remeasured and reassessed each reporting period. As of and for the year ended December&#160;31, 2024, the Company determined the variable consideration was fully constrained.</span></div><div style="margin-bottom:11pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2024, the Company recognized $0.7 million in collaboration revenue under the BioMarin Agreement. Additionally, the Company had deferred revenue of $0.3 million recorded on the consolidated balance sheet as of December&#160;31, 2024.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_CollaborationAndLicenseAgreementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_CollaborationAndLicenseAgreementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org/808/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Preferred Stock and Stockholders' Deficit<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_ConvertiblePreferredStockAndStockholdersDeficitAbstract', window );"><strong>Convertible Preferred Stock and Stockholders' Deficit [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_TemporaryEquityDisclosureAndStockholdersEquityTextBlock', window );">Convertible Preferred Stock and Stockholders' Deficit</a></td>
<td class="text"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. &#160;&#160;&#160;&#160;Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit)</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Convertible Preferred Stock </span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the closing of the IPO, all of the currently outstanding convertible preferred stock automatically converted into 11,648,582 shares of common stock. As of December&#160;31, 2023, the Company&#8217;s convertible preferred stock consisted of the following (in thousands, except share amounts):</span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Authorized<br/>shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shares<br/>issued and<br/>outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidation<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common stock<br/>issuable<br/>upon<br/>conversion</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Series&#160;A Prime</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68,173,692</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62,389,791</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62,381&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,562,653</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Series&#160;B</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81,499,592</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68,258,635</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100,504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,085,929</span></td></tr></table></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common and Preferred Stock</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s amended and restated certificate of incorporation authorizes the issuance of up to 175,000,000 shares of $0.0001 par value common stock and up to 25,000,000 shares of $0.0001 par value undesignated preferred stock. The Board may designate the rights, preferences, privileges and restrictions of the preferred stock, including dividend rights, conversion rights, voting rights, terms of redemption, liquidation preference, and number of shares constituting any series or the designation of any series. The issuance of preferred stock could have the effect of restricting dividends on the Company&#8217;s common stock, diluting the voting power of the Company&#8217;s common stock, impairing the liquidation rights of the Company&#8217;s common stock, or delaying or preventing a change in control. As of December&#160;31, 2024, no shares of preferred stock were outstanding.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Each share of common stock entitles the holder to one vote, together with the holders of any preferred stock, on all matters submitted to the stockholders for a vote. Common stockholders are also entitled to receive dividends. As of December&#160;31, 2024, no cash dividends have been declared or paid. </span></div><div style="margin-bottom:8pt;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the Company has reserved the following shares of common stock for future issuance:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares reserved for future issuance under the 2024 Equity Incentive Plan and ESPP </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,293,348</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,119,425</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock vesting</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,943</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Warrant outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">142</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,428,858</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_ConvertiblePreferredStockAndStockholdersDeficitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_ConvertiblePreferredStockAndStockholdersDeficitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_TemporaryEquityDisclosureAndStockholdersEquityTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for temporary equity and equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_TemporaryEquityDisclosureAndStockholdersEquityTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. &#160;&#160;&#160;&#160;Stock-Based Compensation</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024 Equity Incentive Plan</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2024, the Company adopted the 2024 Equity Incentive Plan (the &#8220;2024 Plan&#8221;), which became effective in connection with the Company&#8217;s IPO. The 2024 Plan provides for the grant of stock options, stock appreciation rights, restricted and unrestricted stock awards, restricted stock unit awards, and other stock-based awards to employees, directors, and non-employee service providers of the Company. </span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards granted under the 2024 Plan expire no later than ten years from the date of grant. The price of stock options shall not be less than 100% of the estimated fair value on the date of grant and typically vest over a four-year period, although awards may be granted with different vesting terms. The 2024 Plan initially reserved 2,143,039 shares of common stock for the issuance of future awards and provides for an automatic annual increase in the number of shares of common stock reserved for future issuance by the lesser of (i) 5% of the number of shares of the Company&#8217;s common stock outstanding as of the close of business on the immediately preceding December 31 and (ii) the number of shares determined by the Company&#8217;s Board of Directors on or prior to such date for such year. As of December&#160;31, 2024, there were 2,079,045 shares of common stock reserved and available for issuance pursuant to the 2024 Plan.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024 Employee Stock Purchase Plan</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2024, the Company adopted the 2024 Employee Stock Purchase Plan (the &#8220;2024 ESPP&#8221;), which became effective in connection with the Company&#8217;s IPO. The 2024 ESPP initially reserved 214,303 shares of common stock for the issuance of future awards and provides for an automatic annual increase in the number of shares of common stock reserved for future issuance by the lesser of (1) 1% of the number of shares of the Company&#8217;s common stock outstanding as of the close of business on the immediately preceding December 31 and (2) the number of shares determined by the Company&#8217;s Board of Directors on or prior to such date for such year. As of December&#160;31, 2024, there were 214,303 shares of common stock reserved and available for issuance pursuant to the 2024 ESPP.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2024 ESPP permits eligible employees to enroll in six-month offering periods. Participants may purchase shares of the Company&#8217;s common stock, through payroll deductions, at a price equal to 85% of the fair market value of the common stock on the first or last day of the applicable offering period, whichever is lower. Purchase dates under the 2024 ESPP occur on or about January 1 and July 1 each year. As of December&#160;31, 2024, there have been no offering periods.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2016 Equity Incentive Plan</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2016, the Company adopted the Marauder Therapeutics, Inc. 2016 Stock Option and Grant Plan (the &#8220;2016 Plan&#8221;) that provided for the grant of stock options, restricted stock units, and other stock-based awards to employees, directors, and non-employee service providers of the Company. The 2016 Plan was suspended in connection with the Company&#8217;s IPO and no further grants will be made. The 2016 Plan continues to govern the terms and conditions of outstanding awards granted under the 2016 Plan.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Option Activity</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the fair value of stock options using the Black-Scholes option pricing model. The weighted-average assumptions used to estimate the fair value of the stock options granted during the years ended December&#160;31, 2024 and 2023 were as follows:</span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97.20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92.24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free interest rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.98%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.84%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected term (in&#160;years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.99</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.97</span></td></tr></table></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average fair value of stock options granted during the&#160;years ended December&#160;31, 2024 and 2023 was $8.09 and $6.73 per share, respectively. The total intrinsic value of options exercised during the&#160;years ended December&#160;31, 2024 and 2023 was $6.6 million and $0.2 million, respectively.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issued $1.0 million of promissory notes to certain executives during the year ended December 31, 2021 in order for them to early exercise stock options. Management concluded the promissory notes are recourse in form but non-recourse in substance as the Company does not intend to seek repayment beyond the shares issued. The promissory notes are therefore treated as an option for accounting purposes and are not recorded on the consolidated balance sheet. </span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense is recorded, accordingly. The exercise price used in determining the fair value of the stock options includes the interest earned on the notes and the expected term is five years, reflecting the term of the notes. The early exercised shares were not outstanding for accounting purposes before repayment of the notes. During the year ended December&#160;31, 2024, the promissory notes were forgiven, resulting in 491,110 shares of common stock that had been exercised early being treated as outstanding for accounting purposes. These shares are included in the exercised options in the table below.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock option activity for the year ended December&#160;31, 2024 (in thousands, except share and per share amounts):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of outstanding options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted<br/>average<br/>exercise<br/>price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted<br/>average<br/>remaining<br/>contractual<br/>term in years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Aggregate intrinsic value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,273,221</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.06&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.05</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,893&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">462,206</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited/Cancelled</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(102,221)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercises</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(513,781)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,119,425</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.98</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">751&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested and expected to vest as of December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,119,425</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.98</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercisable as of December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,221,427</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.57</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded stock-based compensation expense related to stock options of $3.8 million and $2.8 million for the&#160;years ended December&#160;31, 2024 and 2023, respectively. As of December&#160;31, 2024, there was $6.8 million of unrecognized stock option stock-based compensation expense which is expected to be recognized over a weighted average period of 2.7 years.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of restricted stock award activity for the year ended December&#160;31, 2024 is a follows:</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted average<br/>fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested as of December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74,243</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.02&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(58,300)</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested as of December 31, 2024</span></td><td colspan="3" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,943</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All restricted common stock awards were initially issued at a price determined to be fair value on the date of grant. The Company recognizes forfeitures of restricted common stock as they occur. As of December&#160;31, 2024, there was a de minimis amount of unrecognized restricted stock-based compensation expense which is expected to be recognized over a weighted average period of 0.3 years. The fair value of shares that vested during the&#160;years ended December&#160;31, 2024 and 2023 was $0.1 million and $0.5 million, respectively.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense related to stock options and restricted stock recorded in the accompanying consolidated statements of operations for the&#160;years ended December&#160;31, 2024 and 2023 is as follows (in thousands):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,876&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,555&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">G&amp;A</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,156&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,352&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,032&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,907&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has not recognized and does not expect to recognize in the near future, any tax benefit related to employee stock-based compensation expense as a result of the full valuation allowance related to its net deferred tax assets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanAbstract', window );"><strong>Defined Contribution Plan [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanTextBlock', window );">Employee Benefit Plan</a></td>
<td class="text">Employee Benefit Plan<div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;1, 2017, the Company&#8217;s board of directors approved the Company&#8217;s 401(k) retirement plan (the &#8220;401(k) Plan&#8221;). Employees of the Company are eligible to participate in the 401(k) Plan. Participants may contribute up to 100% of their annual compensation to the 401(k) Plan, subject to statutory limitations. Effective January&#160;1, 2022, under the 401(k) Plan &#8220;Safe Harbor Match,&#8221; the Company matches 100% of the first 3% of employee contributions and these contributions vest in full at the time of match.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2024 and 2023, the Company made matching contributions of $0.3 million and $0.4 million, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480794/715-70-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/715-70/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2024 and 2023, no income tax expense was recorded due to the Company&#8217;s net operating loss (&#8220;NOL&#8221;) and full valuation allowance. The Company&#8217;s effective tax rate of zero differs from the U.S. statutory tax rate of 21% primarily because of the valuation allowance maintained against the Company&#8217;s net deferred tax assets. A reconciliation of the expected income tax benefit computed using the federal statutory income tax rate to the Company&#8217;s effective income tax rate is as follows for the&#160;years ended December&#160;31, 2024 and 2023:</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax computed at federal statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State taxes, net of federal benefit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign rate differential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.06)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D credit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.98&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.03&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(29.63)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(31.99)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Permanent differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.07)</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.57)</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.00&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.00&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s net deferred tax assets as of December&#160;31, 2024 and 2023, consisted of the following (in thousands):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOLs</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27,667&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,936&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized R&amp;D costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,059&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D credits</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,299&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,239&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized Sec. 59 (e ) R&amp;D expenditures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,833&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,337&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 22.6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total gross deferred tax assets</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66,574&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51,712&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease ROU assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,653)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,118)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total gross deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,653)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,118)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net deferred tax assets</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64,921&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49,594&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(64,921)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(49,594)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net deferred tax asset less valuation allowance</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024 and 2023, the Company had U.S. federal NOL carryforwards of $102.3 million and $69.8 million, respectively, which may be available to offset future income tax liabilities. Of the $102.3 million carryforwards, approximately $4.8 million will begin to expire in 2036 and approximately $97.5 million are carried forward indefinitely. As of December&#160;31, 2024 and 2023, the Company had state NOL carryforwards of $97.6 million and $66.7 million, respectively, which will begin to expire in 2036.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024 and 2023, the Company had U.S. federal R&amp;D tax credit carryforwards of $6.7 million and $5.2 million, respectively, which begin to expire in 2036. As of December&#160;31, 2024 and 2023, the Company had state R&amp;D tax credit carryforwards of $3.3 million and $2.6 million, respectively, which begin to expire in 2036. As of </span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2024 and 2023, the Company had capitalized R&amp;D costs of $22.1 million and $17.4 million, respectively, as required by the Tax Cuts and Jobs Act of 2017.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future realization of the tax benefits of existing temporary differences and NOL carryforwards ultimately depends on the existence of sufficient taxable income within the carryforward period. As of December&#160;31, 2024, the Company performed an evaluation to determine whether a valuation allowance was needed. The Company considered all available evidence, both positive and negative, which included the results of operations for the current and preceding&#160;years. The Company determined that it is more likely than not that all of the deferred tax assets will not be realized. Accordingly, the Company maintained a full valuation allowance as of December&#160;31, 2024. During the&#160;years ended December&#160;31, 2024 and 2023, the valuation allowance increased by $15.3 million and $15.8 million, respectively, due to the increase in the deferred tax assets by the same amount, primarily due to increases in the NOL carryforwards, capitalized R&amp;D costs and R&amp;D tax credit carryforwards.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The utilization of NOLs and tax credit carryforwards to offset future taxable income may be subject to an annual limitation because of ownership changes that have occurred previously or may occur in the future. Under Sections&#160;382 and 383 of the Internal Revenue Code of 1986 (&#8220;IRC&#8221;), a corporation that undergoes an ownership change may be subject to limitation on its ability to utilize its pre-change NOLs and other tax attributes otherwise available to offset future taxable income and/or tax liability. An ownership change is defined as a cumulative change of more than 50% in the ownership positions of certain stockholders during a rolling three-year period.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has not completed a formal study to determine if any ownership changes within the meaning of IRC Section&#160;382 and 383 have occurred as of December&#160;31, 2024. An ownership change would restrict its ability to use its NOLs or tax credit carryforwards and could require the Company to pay U.S. federal or state income taxes earlier than would be required if such limitation were not in effect.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2024, the Company generated research credits but has not conducted a study to document the qualified activities. This study may result in an adjustment to the Company&#8217;s R&amp;D credit carryforwards; however, until a study is completed, and any adjustment is known, no amounts have been recognized as an uncertain tax position. A full valuation allowance has been provided against the Company&#8217;s R&amp;D credits and, if an adjustment is required, this adjustment would be offset by an adjustment to the deferred income tax asset established for the R&amp;D credit carryforwards and the valuation allowance.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text">Segment Reporting<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company manages its business activities on a consolidated basis and operates as a single operating segment: R&amp;D, which engages in the business of developing a new class of RNA-based therapeutics to treat a broad range of genetic diseases. The Company's operations are primarily in the United States.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s CODM is its Chief Executive Officer. The CODM uses net loss, as reported on the Company&#8217;s consolidated statement of operations and comprehensive loss, in evaluating performance and determining how to allocate resources. The CODM does not review assets in evaluating the results and therefore, such information is not presented. The following table provides the revenue and significant and other segment expenses for the&#160;years ended December&#160;31, 2024 and 2023 (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">652&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">350&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Significant segment expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Personnel-related expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical and preclinical expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Facilities-related and overhead</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,979&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional and consulting fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Travel and entertainment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plus: Other segment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment net loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(51,791)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(49,291)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other segment income includes total other income, net on the consolidated statements of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Common Stockholders<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share Attributable to Common Stockholders</a></td>
<td class="text">Net Loss Per Share Attributable to Common Stockholders<div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net loss per share was calculated as follows for the&#160;years ended December&#160;31, 2024 and 2023 (in thousands, except share and per share amounts):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss attributable to common stockholders</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(51,791)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(49,291)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average common shares outstanding, basic and diluted</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,690,094</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">394,976</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss per share attributable to common stockholders, basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11.04)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(124.80)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s potentially dilutive securities, which include or have included convertible preferred stock, outstanding stock options, unvested restricted common stock, and warrants to purchase stock, have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted-average number of common shares outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company excluded the following from the computation of diluted net loss per share attributable to common stockholders as of December&#160;31, 2024 and 2023 because including them would have had an anti-dilutive effect:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Conversion of preferred stock</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,648,582</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options outstanding</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,119,425</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,273,221</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock vesting</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,943</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74,243</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Warrant outstanding</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">142</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">142</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,135,510</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,996,188</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Parties</a></td>
<td class="text">Related Parties<div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2015, the Company entered into consulting agreements with its two founders, related parties who hold shares of the Company&#8217;s common stock, to provide R&amp;D and strategic planning services. For the&#160;years ended December&#160;31, 2024 and 2023, the Company recognized R&amp;D expense totaling $0.3 million and $0.3 million, respectively, related to work performed under the founder agreements. The Company had no amount due to the founders at both December&#160;31, 2024 and 2023, respectively. For the&#160;years ended December&#160;31, 2024 and 2023, the Company recognized stock-based compensation expense totaling $0.2 million and less than $0.2 million, related to consulting agreements, respectively.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March&#160;2019, the Company entered into a consulting agreement with an executive consultant, a related party who holds shares of the Company&#8217;s common stock. For the&#160;years ended December&#160;31, 2024 and 2023, the Company recognized G&amp;A expense totaling $0.1 million and $0.1 million, respectively, related to work performed under the consulting agreement. The Company had no amount due to the consultant at both December&#160;31, 2024 and 2023, respectively. For the&#160;years ended December&#160;31, 2024 and 2023, the Company recognized stock-based compensation expense totaling $0.2 million and less than $0.2 million, respectively, related to the consulting agreement.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (51,791)<span></span>
</td>
<td class="num">$ (49,291)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management and Strategy Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have certain processes for assessing, identifying, and managing cybersecurity risks, which are built into our information technology function and are designed to help protect our information assets and operations from internal and external cyber threats, protect information belonging to our stakeholders from unauthorized access or attack, as well as secure our networks and systems. Such processes include physical, procedural, and technical safeguards, response plans, regular testing of our systems, and routine review of our policies and procedures to identify risks and adapt our practices. We engage certain external parties, including independent privacy assessors, computer security firms, and risk management and governance experts, to assist with assessing and managing our cybersecurity oversight functions.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the date of this Annual Report, we have not experienced any cybersecurity incidents that resulted in a material effect on our business strategy, results of operations, or financial condition, but we cannot provide assurance that we will not be materially affected in the future by such risks or any future material incidents. See Part I, Item 1A. &#8220;Risk Factors&#8221; in this Annual Report for additional information on cybersecurity risks we face.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag', window );">Cybersecurity Risk Management Processes Integrated [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock', window );">Cybersecurity Risk Management Processes Integrated [Text Block]</a></td>
<td class="text">We have certain processes for assessing, identifying, and managing cybersecurity risks, which are built into our information technology function and are designed to help protect our information assets and operations from internal and external cyber threats, protect information belonging to our stakeholders from unauthorized access or attack, as well as secure our networks and systems.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag', window );">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock', window );">Cybersecurity Risk Board of Directors Oversight [Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Audit Committee of the board of directors is responsible for reviewing and assessing the integrity of our information technology systems, processes and data, and is charged with meeting periodically with management to review and assess our cyber and technology-related risks, including network security, information security, and data privacy and protection, our technologies, policies, processes, and practices for assessing, monitoring, managing and mitigation those risks, and the steps management has taken to identify, assess, monitor, manage and mitigate those risks, among other matters.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Chief Business Operations Officer oversees our company-wide cybersecurity strategy, policy, standards, and processes across relevant departments. The Chief Business Operations Officer has over 15 years of experience overseeing key operational activities in the life sciences industry and works closely with our experienced information technology consulting firm, which helps to assess and prepare us and our employees to maintain awareness of cybersecurity risks, including email, web, and data security. Our outside information technology consultants have extensive experience designing, implementing, and running information technology and cybersecurity programs and processes using the National Institute of Standards and Technology Framework.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To deter and detect cyber threats, we provide all employees with a data protection, cybersecurity and incident response and prevention training and compliance program, which covers timely and relevant topics, including social engineering, phishing, password protection, confidential data protection, asset use and mobile security, and educates employees on the importance of reporting all incidents immediately. To mitigate cybersecurity risks and bolster our employee-based cybersecurity programs, we monitor all user traffic and restrict access by country. In addition, access to web sites is filtered and monitored, and credentials for systems and services require multi-factor authentication whenever possible.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Audit Committee of the board of directors is responsible for reviewing and assessing the integrity of our information technology systems, processes and data, and is charged with meeting periodically with management to review and assess our cyber and technology-related risks, including network security, information security, and data privacy and protection, our technologies, policies, processes, and practices for assessing, monitoring, managing and mitigation those risks, and the steps management has taken to identify, assess, monitor, manage and mitigate those risks, among other matters.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Audit Committee of the board of directors is responsible for reviewing and assessing the integrity of our information technology systems, processes and data, and is charged with meeting periodically with management to review and assess our cyber and technology-related risks, including network security, information security, and data privacy and protection, our technologies, policies, processes, and practices for assessing, monitoring, managing and mitigation those risks, and the steps management has taken to identify, assess, monitor, manage and mitigate those risks, among other matters.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskRoleOfManagementTextBlock', window );">Cybersecurity Risk Role of Management [Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Audit Committee of the board of directors is responsible for reviewing and assessing the integrity of our information technology systems, processes and data, and is charged with meeting periodically with management to review and assess our cyber and technology-related risks, including network security, information security, and data privacy and protection, our technologies, policies, processes, and practices for assessing, monitoring, managing and mitigation those risks, and the steps management has taken to identify, assess, monitor, manage and mitigate those risks, among other matters.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Chief Business Operations Officer oversees our company-wide cybersecurity strategy, policy, standards, and processes across relevant departments. The Chief Business Operations Officer has over 15 years of experience overseeing key operational activities in the life sciences industry and works closely with our experienced information technology consulting firm, which helps to assess and prepare us and our employees to maintain awareness of cybersecurity risks, including email, web, and data security. Our outside information technology consultants have extensive experience designing, implementing, and running information technology and cybersecurity programs and processes using the National Institute of Standards and Technology Framework.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Audit Committee of the board of directors is responsible for reviewing and assessing the integrity of our information technology systems, processes and data, and is charged with meeting periodically with management to review and assess our cyber and technology-related risks, including network security, information security, and data privacy and protection, our technologies, policies, processes, and practices for assessing, monitoring, managing and mitigation those risks, and the steps management has taken to identify, assess, monitor, manage and mitigate those risks, among other matters.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Chief Business Operations Officer oversees our company-wide cybersecurity strategy, policy, standards, and processes across relevant departments. The Chief Business Operations Officer has over 15 years of experience overseeing key operational activities in the life sciences industry and works closely with our experienced information technology consulting firm, which helps to assess and prepare us and our employees to maintain awareness of cybersecurity risks, including email, web, and data security. Our outside information technology consultants have extensive experience designing, implementing, and running information technology and cybersecurity programs and processes using the National Institute of Standards and Technology Framework.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock', window );">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</a></td>
<td class="text">The Chief Business Operations Officer has over 15 years of experience overseeing key operational activities in the life sciences industry and works closely with our experienced information technology consulting firm, which helps to assess and prepare us and our employees to maintain awareness of cybersecurity risks, including email, web, and data security.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Audit Committee of the board of directors is responsible for reviewing and assessing the integrity of our information technology systems, processes and data, and is charged with meeting periodically with management to review and assess our cyber and technology-related risks, including network security, information security, and data privacy and protection, our technologies, policies, processes, and practices for assessing, monitoring, managing and mitigation those risks, and the steps management has taken to identify, assess, monitor, manage and mitigate those risks, among other matters.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Chief Business Operations Officer oversees our company-wide cybersecurity strategy, policy, standards, and processes across relevant departments. The Chief Business Operations Officer has over 15 years of experience overseeing key operational activities in the life sciences industry and works closely with our experienced information technology consulting firm, which helps to assess and prepare us and our employees to maintain awareness of cybersecurity risks, including email, web, and data security. Our outside information technology consultants have extensive experience designing, implementing, and running information technology and cybersecurity programs and processes using the National Institute of Standards and Technology Framework.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To deter and detect cyber threats, we provide all employees with a data protection, cybersecurity and incident response and prevention training and compliance program, which covers timely and relevant topics, including social engineering, phishing, password protection, confidential data protection, asset use and mobile security, and educates employees on the importance of reporting all incidents immediately. To mitigate cybersecurity risks and bolster our employee-based cybersecurity programs, we monitor all user traffic and restrict access by country. In addition, access to web sites is filtered and monitored, and credentials for systems and services require multi-factor authentication whenever possible.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskRoleOfManagementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskRoleOfManagementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates assumptions, and judgments that affect the reported amounts of assets, liabilities, expenses and related disclosures in the accompanying notes. The Company bases its estimates, assumptions and judgments on historical experience when available and on various factors that it believes to be reasonable under the circumstances as of the date of the accompanying consolidated financial statements, including the fair value of common stock prior to the Company&#8217;s IPO, stock-based compensation expense, accrued expenses, lease accounting and the recoverability of the Company&#8217;s net deferred tax assets and related valuation allowance. In addition, other factors may affect estimates, including the expected business and operational changes, the sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process often may yield a range of potentially reasonable estimates of the ultimate future outcomes, and management must select an amount that falls within that range of reasonable estimates. Actual results could differ materially from the estimates and assumptions used in the preparation of the accompanying consolidated financial statements under different assumptions or conditions.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments and instruments with original maturities of 90 days or less that can be liquidated without prior notice or penalty to be cash equivalents. Cash equivalents primarily represent funds invested in readily available money market accounts. As of December&#160;31, 2024 and 2023, the Company had cash and cash equivalents balances deposited at one major financial institution.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash</a></td>
<td class="text"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Cash</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with its operating leases, the Company is required to maintain security deposits totaling $1.5 million, which were issued in the form of letters of credit with a bank. As of December&#160;31, 2024 and 2023, the Company held cash in this amount in separate restricted bank accounts as collateral for the letters of credit. The restricted cash balance is classified as long-term restricted cash on the accompanying consolidated balance sheets. In addition, the Company held less than $0.1 million in money market accounts as of each of December&#160;31, 2024 and 2023 as collateral for the Company&#8217;s credit card obligation and increased letter of credit due to an amendment to the leases.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risks</a></td>
<td class="text"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risks</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. The Company deposits cash and cash equivalents with high credit quality financial institutions in the United States. These deposits are held in checking and money market accounts and may, from time to time, exceed the federally insured amounts. The Company has not experienced any losses in such accounts. The Company believes it is not exposed to any significant risk in its cash and cash equivalents. The primary objectives of the Company&#8217;s investment portfolio are the preservation of capital and maintenance of liquidity.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to risks common to companies in the biopharmaceutical industry, including, but not limited to, risks related to the successful development and commercialization of product candidates, fluctuations in operating results and financial risks, the ability to successfully raise additional funds when needed, protection of proprietary rights and patent risks, patent litigation, compliance with government regulations, dependence on key personnel and collaboration partners, dependence on third-party manufacturers and competition from competing products in the marketplace.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies fair value measurements to record fair value adjustments to certain assets and liabilities and to determine fair value disclosures. Fair value is measured as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A fair value measurement assumes that the transaction to sell the asset or transfer the liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market. A framework is used for measuring fair value utilizing a three-tier hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level&#160;1) and the lowest priority to unobservable inputs (Level&#160;3).</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The three levels of the fair value hierarchy are as follows:</span></div><div style="margin-bottom:8pt;padding-left:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Level&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Observable inputs such as unadjusted quoted prices in active markets that are accessible at the measurement date for identical unrestricted assets or liabilities the Company has the ability to access;</span></div><div style="margin-bottom:8pt;padding-left:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Level&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Inputs (other than quoted prices included within Level&#160;1) that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active; and</span></div><div style="margin-bottom:8pt;padding-left:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Level&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments are categorized in their entirety based on the lowest level of input that is significant to the fair value measurement. The assessment of the significance of a particular input to the fair value measurement requires judgment and considers factors specific to the investment. To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level&#160;3. The Company reviews the fair value hierarchy classification at each reporting date. Changes in the ability to observe valuation inputs may result in a reclassification of levels for certain assets or liabilities within the fair value hierarchy. The Company did not have any transfers of assets and liabilities between the levels of the fair value measurement hierarchy during the&#160;years presented.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Remeasurement</a></td>
<td class="text"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Remeasurement</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reporting currency and the functional currency of its foreign subsidiary, CAMP4 AUS, is the United States Dollar (&#8220;USD&#8221;). At the date a foreign currency denominated transaction is recognized, each asset, liability, revenue, expense, gain or loss arising from the transaction is measured initially in USD based on the exchange rate in effect at that date. Subsequently, at each balance sheet date, balances related to monetary assets and liabilities are adjusted to reflect the current exchange rate, which is the rate at which the related receivable or payable could be settled at that date.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign exchange transaction gains and losses are included in other income, net in the accompanying consolidated statements of operations and comprehensive loss and were de minimis for the&#160;years ended December&#160;31, 2024 and 2023.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Loss</a></td>
<td class="text"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comprehensive Loss</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no differences between net loss and comprehensive loss presented in the consolidated statements of operations for the&#160;years ended December&#160;31, 2024 and 2023.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment, Net</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, which are all located in the United States, are stated at cost less accumulated depreciation. Expenditures for maintenance and repairs are charged to expense as incurred, whereas major betterments are capitalized as additions to property and equipment. Depreciation is calculated using the straight-line method over the following estimated useful lives of the assets:</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Computer and software</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laboratory equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Five years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Seven years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shorter of asset life or remaining lease term</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates its long-lived assets, which consist of property and equipment, operating lease right-of-use (&#8220;ROU&#8221;) assets, and finance lease ROU assets, for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant underperformance of the business in relation to expectations, significant negative industry or economic trends and significant changes or planned changes in the use of the assets. If the asset is impaired, the amount of any impairment is measured as the difference between the carrying value and the fair value of the impaired asset. The Company recognized no impairment losses for the&#160;years ended December&#160;31, 2024 and 2023.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commitments and Contingencies</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contractual Commitments</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into contracts in the normal course of business with contract research organizations (&#8220;CROs&#8221;), contract manufacturing organizations (&#8220;CMOs&#8221;), academic institutions and other third parties for preclinical and clinical research studies, testing and manufacturing services. These contracts generally do not contain minimum purchase commitments and are cancellable by the Company upon prior written notice, although purchase orders for preclinical materials are generally non-cancellable. Payments due upon cancellation consist primarily of payments for services provided or expenses incurred, including non-cancellable obligations from the Company&#8217;s service providers, up to the date of cancellation or upon the completion of a manufacturing run.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_GuaranteesAndIndemnificationsPolicyTextBlock', window );">Guarantees and Indemnifications</a></td>
<td class="text"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Indemnifications</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Indemnification Obligations</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into indemnification agreements with its officers and directors that require the Company to indemnify such individuals for certain events or occurrences while each such officer or director is, or was, serving at the Company&#8217;s request in such capacity. The maximum potential future payments the Company could be required to make is, in many cases, unlimited. The Company has directors&#8217; and officers&#8217; liability insurance coverage that limits its exposure and enables the Company to recover a portion of any future amounts paid.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases office and laboratory space under operating leases. The Company has standard indemnification arrangements under the leases that require it to indemnify the landlords against all costs, expenses, fines, suits, claims, demands, liabilities and actions directly resulting from any breach, violation or nonperformance of any covenant or condition of the Company&#8217;s leases.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of its business, the Company enters into indemnification agreements with certain suppliers and business partners pursuant to which the Company has certain indemnification obligations limited to the costs, expenses, fines, suits, claims, demands, liabilities and actions directly resulting from the Company&#8217;s gross negligence or willful misconduct, and in certain instances, breaches, violations or nonperformance of covenants or conditions under the agreements.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024 and 2023, the Company had not experienced any material losses related to these indemnification obligations, and no material claims with respect thereto were outstanding. The Company does not expect significant claims related to these indemnification obligations and, consequently, concluded that the fair value of these obligations is negligible, and no related reserves were established.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to the possibility of loss contingencies arising in the ordinary course of business. Management considers the likelihood of loss related to an asset, or the incurrence of a liability, as well as its ability to reasonably estimate the amount of the loss, in determining loss contingencies. An estimated loss contingency is accrued when it is probable that an asset has been impaired, or a liability has been incurred and the amount of loss can be reasonably estimated. The Company regularly evaluates current information available to determine whether such accruals should be adjusted and whether new accruals are required.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company may become involved in litigation relating to claims arising from the ordinary course of business. Management believes that there are no claims or actions pending against the Company currently, the ultimate disposition of which would have a material adverse effect on the Company&#8217;s consolidated results of operations, financial condition or cash flows.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 842,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company determines if an arrangement is or contains a lease at inception. A contract is or contains a lease if the contract conveys the right to control the use of an identified asset for a period in exchange for consideration. The Company classifies leases at the lease commencement date as operating or finance leases and records a ROU asset and a lease liability on the consolidated balance sheet for all leases with an initial lease term of greater than 12 months. Leases with an initial term of 12 months or less are not recorded in the balance sheet, but payments are recognized as expense on a straight-line basis over the lease term.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A lease qualifies as a finance lease if any of the following criteria are met at the inception of the lease: (i)&#160;there is a transfer of ownership of the leased asset to the Company by the end of the lease term, (ii)&#160;the Company holds an option to purchase the leased asset that it is reasonably certain to exercise, (iii)&#160;the lease term is for a major part of the remaining economic life of the leased asset, (iv)&#160;the present value of the sum of lease payments equals or exceeds substantially all of the fair value of the leased asset, or (v)&#160;the nature of the leased asset is specialized to the point that it is expected to provide the lessor no alternative use at the end of the lease term. All other leases are recorded as operating leases.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into contracts that contain both lease and non-lease components. Non-lease components may include maintenance, utilities and other operating costs. The Company combines the lease and non-lease components of fixed costs in its lease arrangements as a single lease component. Variable costs, such as utilities or maintenance costs, are not included in the measurement of ROU assets and lease liabilities, but rather are expensed when the event determining the amount of variable consideration to be paid occurs.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance and operating lease assets and liabilities are recognized at the lease commencement date based on the present value of the lease payments over the lease term using the discount rate implicit in the lease. If the rate implicit is not readily determinable, the Company utilizes an estimate of its incremental borrowing rate based upon the available information at the lease commencement date. Operating lease assets are further adjusted for prepaid or accrued lease payments. Operating lease assets are expensed using the straight-line method as an operating expense over the lease term. Finance lease assets are amortized to depreciation expense using the straight-line method. Finance lease payments are bifurcated into (i)&#160;a portion that is recorded as imputed interest expense and (ii)&#160;a portion that reduces the finance liability associated with the lease.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s leases provide a lease incentive in the form of reimbursable leasehold improvements. Due to the unpredictability of the payout of leasehold improvement reimbursements, the Company recognizes a reduction to the ROU asset and the lease liability once it has incurred costs that qualify as reimbursable by the lessor. The reduction to the ROU asset is recognized prospectively over the remainder of the lease term.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s leases include options to extend or terminate the lease. The amounts determined for the Company&#8217;s ROU assets and lease liabilities generally do not assume that renewal options or early-termination provisions, if any, are exercised, unless it is reasonably certain that the Company will exercise such options.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company examines other contracts with suppliers, vendors and outside parties to identify whether such contracts contain an embedded lease and, as applicable, records such embedded leases in accordance with ASC 842,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_FinancingObligationFailedSaleLeasebackPolicyTextBlock', window );">Financing Obligation (Failed Sale-Leaseback)</a></td>
<td class="text"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financing Obligation (Failed Sale-Leaseback)</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 842,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for potential sale-leaseback transactions, the Company assesses the contract to identify if a sale occurred in accordance with ASC Topic 606,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASC 606&#8221;). Sale-and-leaseback transactions occur when the Company sells assets to a third-party and simultaneously leases them back. The resulting leases that qualify for sale-and-leaseback accounting are evaluated and accounted for as operating leases. A transaction that does not qualify for sale-and-leaseback accounting as a result of finance lease classification or the failure to meet certain revenue recognition criteria is accounted for as a financing transaction. For a financing transaction, the Company will retain the assets sold within Property, plant and equipment, net and record a financing obligation equal to the amount of cash proceeds received. Rental payments under such transactions are recognized as a reduction of the financing obligation and as interest expense using an effective interest method. To date, the Company has entered into one failed sale-leaseback transaction. See additional discussion in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 7. Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition and Accounting for Collaboration Agreements</a></td>
<td class="text"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition and Accounting for Collaboration Agreements</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with ASC 606. The Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. In determining the appropriate amount of revenue to be recognized as it fulfills its obligations under its agreements, the Company performs the following steps: (i)&#160;identification of the promised goods or services in the contract; (ii)&#160;determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii)&#160;measurement of the transaction price, including the constraint on variable consideration; (iv)&#160;allocation of the transaction price to the performance obligations; and (v)&#160;recognition of revenue when (or as) the Company satisfies each performance obligation.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses judgment to determine: (a)&#160;the performance obligations based on the determination under step (ii)&#160;above; (b)&#160;the transaction price under step (iii)&#160;above; and (c)&#160;the recognition of revenue as services are performed under step (v)&#160;above. The Company also uses judgment to determine whether development milestones or other variable consideration except for royalties and sales-based milestones, should be included in the transaction price as described further below.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the five-step model to contracts when the arrangement is not a collaboration pursuant to ASC Topic 808,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;(&#8220;ASC 808&#8221;), and it is probable that the Company will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Agreements</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company analyzes its collaboration agreements to assess whether they are within the scope of ASC 808 by determining whether such arrangements involve joint operating activities performed by parties that are both active participants in the activities and exposed to significant risks and rewards that are dependent on the commercial success of such activities. To the extent the arrangement is within the scope of ASC 808, the Company assesses whether aspects of the arrangement between the Company and the collaboration partner are within the scope of other accounting literature. If the Company concludes that some or all aspects of the arrangement represent a transaction with a customer, the Company </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accounts for those aspects of the arrangement within the scope of ASC 606. If the Company concludes that some or all aspects of the arrangement are within the scope of ASC 808 and do not represent a transaction with a customer, the Company recognizes the Company&#8217;s share of the allocation of the shared costs incurred with respect to the jointly conducted activities as a component of the related expense in the period incurred.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expenses</a></td>
<td class="text"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Expenses</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development (&#8220;R&amp;D&#8221;) expenses are recorded to operating expenses when incurred. The Company&#8217;s R&amp;D expenses consist primarily of costs incurred in performing R&amp;D activities, including personnel-related expenses such as salaries, stock-based compensation and benefits, facilities costs, depreciation and external costs of outside vendors engaged to conduct clinical and preclinical development activities and to manufacture a product candidate. The Company accrues expenses related to development activities performed by third parties based on an evaluation of services received and efforts expended pursuant to the terms of the contractual arrangements. Payments under some of these contracts depend on preclinical trial milestones. Non-refundable advance payments for goods and services that will be used over time for R&amp;D are deferred and capitalized as R&amp;D prepaid expenses on the Company&#8217;s consolidated balance sheets. The capitalized amounts are recognized as an expense as the goods are delivered or as the related services are performed. In accruing service fees, the Company estimates the period over which services will be performed and the level of effort to be expended in each period. If the actual timing of the performance of services or the level of effort varies from the estimate, the Company will adjust the accrual or prepaid expense accordingly. Costs to acquire technologies to be used in R&amp;D that have not reached technological feasibility and have no alternative future use are also expensed as incurred.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock', window );">General and Administrative Expenses</a></td>
<td class="text"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General and Administrative Expenses</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative (&#8220;G&amp;A&#8221;) expenses consist primarily of personnel-related expenses, including salaries, bonuses, benefits, travel and stock-based compensation expenses for employees in executive, accounting and finance, business development, human resources, legal, and other administrative functions. Other significant G&amp;A expenses include allocated facility-related costs, legal fees relating to corporate and intellectual property matters, professional fees for accounting, audit and tax services, consulting fees and insurance costs. G&amp;A costs are expensed as incurred.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_PatentCostsPolicyTextBlock', window );">Patent Costs</a></td>
<td class="text"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Patent Costs</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All patent-related costs incurred in connection with filing and prosecuting patent applications are expensed as incurred due to the uncertainty about the recovery of the expenditure. Amounts are classified as G&amp;A expenses.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_OfferingCostsPolicyTextBlock', window );">Offering Costs</a></td>
<td class="text"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Offering Costs</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company complies with the requirements of ASC 340,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets and Deferred Costs</span>, with regards to offering costs. Prior to the completion of an offering of common stock, direct offering costs are capitalized as deferred offering costs. The deferred offering costs are charged to additional paid-in capital for offerings of common stock or as a reduction in the carrying value of preferred stock for offerings of preferred stock.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company periodically grants equity-based awards in the form of stock options and restricted stock to employees, directors and non-employees and records stock-based compensation expenses based on their estimated fair value at the grant date. The Company estimates the fair value of stock options using the Black-Scholes option-pricing model as of the grant date. Stock-based compensation expenses are recognized in the accompanying consolidated statements of operations and comprehensive loss on a straight-line basis over the requisite service period, which is typically the vesting period. Determining the appropriate fair value model and related input assumptions requires judgment.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the IPO, the fair value of the Company&#8217;s common stock was determined by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;) at the time of each option grant by considering several objective and subjective factors. These factors included the valuation of a select group of representative public companies within the industry that focus on biotechnology that the Board believed was comparable to the Company&#8217;s operations; operating and financial performance; the lack of liquidity of the common stock and trends in the broader economy and biotechnology industry also impact the determination of the fair value of the common stock. For awards granted after the Company&#8217;s IPO, the grant date fair value of common stock was determined by using the closing price per share of the Company&#8217;s common stock.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The other inputs to the Black-Scholes option-pricing model include the following:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The risk-free interest rate used is based on the published U.S. Department of Treasury interest rates in effect at the time of stock option grant for zero coupon U.S. Treasury notes with maturities approximating each grant&#8217;s expected term;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The dividend yield is zero as the Company has not paid dividends and does not anticipate paying a cash dividend in the foreseeable future;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The expected term for options granted is calculated using the simplified method and represents the average time that options are expected to be outstanding based on the mid-point between the vesting date and the end of the contractual term of the award; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Expected volatility is derived from the historical volatility of a select group of representative companies, for a look-back period commensurate with the expected term of the stock options, as the Company has limited trading history of common stock.</span></div><div style="margin-bottom:8pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company recognizes forfeitures related to stock-based compensation awards as they occur.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies stock-based compensation expense in the consolidated statement of operations and comprehensive loss in the same way the award recipients&#8217; payroll costs are classified or in which the award recipients&#8217; service payments are classified.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes in accordance with ASC 740,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;(&#8220;ASC 740&#8221;). ASC 740 requires the use of the asset and liability method of accounting for income taxes. The current or deferred tax consequences of a transaction are measured by applying the provisions of enacted tax laws to determine the amount of taxes payable currently or in future&#160;years. Deferred tax assets and liabilities are determined based on the difference between the consolidated financial statements and tax basis of assets and liabilities and expected future tax consequences of events that have been included in the consolidated financial statements or tax returns using enacted tax rates in effect for the year in which the differences are expected to reverse. Under this method, a valuation allowance is used to offset deferred tax assets if, based upon the available evidence, it is more likely than not that some or all of the deferred tax assets may not be realized. Management evaluates the recoverability of deferred taxes and the adequacy of the valuation allowance at each reporting period (see Note 12,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows the provisions of ASC 740 relative to accounting for uncertain tax positions. These provisions provide guidance on the recognition, de-recognition and measurement of potential tax benefits associated with tax positions. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company had no reserves related to uncertain tax positions as of December&#160;31, 2024 and 2023. As applicable, the Company recognizes accrued penalties and interest related to unrecognized tax benefits in the provision for income taxes. As of December&#160;31, 2024 and 2023, the Company did not accrue any potential interest or penalties.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to file federal and state income tax returns in the U.S. and foreign income tax returns in Australia. The preparation of tax returns requires the Company to interpret the applicable tax laws and regulations in effect in such jurisdictions, which could affect the amount of tax paid by the Company.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s income tax returns are based on calculations and assumptions that are subject to examination by the Internal Revenue Service and other tax authorities for the tax years ended December 31, 2020 through December 31, 2024. In addition, the calculation of the Company&#8217;s tax liabilities involves dealing with uncertainties in the application of complex tax regulations.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy', window );">Classification of Convertible Preferred Stock</a></td>
<td class="text"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Classification of Convertible Preferred Stock</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s convertible preferred stock was classified as temporary equity in the accompanying consolidated balance sheet as of December&#160;31, 2023 and was excluded from stockholders&#8217; equity (deficit) as the potential redemption of such stock was outside the Company&#8217;s control. The convertible preferred stock was not redeemable except for in the event of a liquidation, dissolution or winding up of the Company. The Company did not accrete the carrying values of the preferred stock to the redemption values since the occurrence of these events was not considered probable.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Share Attributable to Common Stockholders</a></td>
<td class="text"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Loss Per Share Attributable to Common Stockholders</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined all of its convertible preferred stock qualified as participating securities, as defined in ASC 260,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;(&#8220;ASC 260&#8221;). Under ASC 260, securities are considered participating securities if the securities may participate in undistributed earnings with common stock, whether that participation is conditioned upon the occurrence of a specified event or not. In accordance with ASC 260, a company is required to use the two-class method when computing net income (loss) per share when a company has securities that qualify as participating securities. The two-class method is an earnings allocation formula that determines net income (loss) per share for each class of common stock and participating security according to dividends declared (or accumulated) and participation rights in undistributed earnings. Diluted net loss per share for the Company&#8217;s common stock is computed using the more dilutive of the two-class method or the if-converted method.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period. Diluted net loss attributable to common stockholders is computed by adjusting net loss per share attributable to common stockholders to reallocate undistributed earnings based on the potential impact of dilutive securities. Diluted net loss per share attributable to common stockholders is computed by dividing the diluted net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period, including potential dilutive common shares. For purpose of this calculation, outstanding options to purchase common stock, unvested restricted stock awards, and shares of convertible preferred stock are considered potential dilutive common shares. The Company has generated a net loss in all periods presented, and therefore the basic and diluted net loss per share attributable to common stockholders are the same as the inclusion of the potentially dilutive securities would be anti-dilutive.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_EmergingGrowthCompanyStatusPolicyTextBlock', window );">Emerging Growth Company Status</a></td>
<td class="text"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Emerging Growth Company Status</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is an emerging growth company (&#8220;EGC&#8221;) as defined in the Jumpstart Our Business Startups Act of 2012, as amended (the &#8220;JOBS Act&#8221;), and may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not an EGC. The Company may take advantage of these exemptions until it is no longer an EGC under Section&#160;107 of the JOBS Act and has elected to use the extended transition period for complying with new or revised accounting standards. As a result of this election, the Company&#8217;s consolidated financial statements may not be comparable to companies that comply with public company FASB standards&#8217; effective dates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncements and Recently Issued Accounting Standards</a></td>
<td class="text"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2023, FASB issued ASU 2023-07, &#8220;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.&#8221; The standard expands reportable segment disclosure requirements for public business entities primarily through enhanced disclosures about significant segment expenses that are regularly provided to the chief operating decision maker (&#8220;CODM&#8221;) and included within each reported measure of segment profit (referred to as the &#8220;significant expense principle&#8221;). The Company has adopted this standard for the fiscal year 2024 annual financial statements and has applied this standard retrospectively for all prior periods presented in the financial statements (see Note 13).</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Standards</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting standards not listed below were assessed and determined not to be applicable or are expected to have minimal impact on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, Income Taxes (&#8220;Topic 740&#8221;):&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Improvements to Income Tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The guidance includes the requirement that public business entities, on an annual basis, disclose specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold (if the effect of those reconciling items is equal to or greater than 5% of the amount computed by multiplying pretax income (or loss) by the applicable statutory income tax rate). It also requires that all entities disclose, on an annual basis, the amount of income taxes paid (net of refunds received) disaggregated by federal (national), state, and foreign taxes and the amount of income taxes paid (net of refunds received) disaggregated by individual jurisdictions in which income taxes paid (net of refunds received) is equal to or greater than 5% of total income taxes paid (net of refunds received) and requires that all entities disclose income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign and income tax expense (or benefit) from continuing operations disaggregated by federal (national), state, and foreign. Lastly, the guidance eliminates the requirement for all entities to disclose the nature and estimate of the range of the reasonably possible change in the unrecognized tax benefits balance in the next 12 months or make a statement that an estimate of the range cannot be made. For public business entities, the guidance is effective for annual periods beginning after December&#160;15, 2024. Early adoption is permitted for annual </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated financial statements that have not yet been issued or made available for issuance. The guidance should be applied on a prospective basis. Retrospective application is permitted. The Company is currently evaluating the impact that this guidance may have on its consolidated financial statements.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2024, the FASB issued ASU 2024-03, &#8220;Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses.&#8221; The standard requires that public business entities disclose additional information about specific expense categories in the notes to financial statements for interim and annual reporting periods. For public business entities, the guidance is effective for interim and annual periods beginning after December&#160;15, 2026. Early adoption is permitted for annual consolidated financial statements that have not yet been issued or made available for issuance. The guidance may be applied on a prospective basis or retrospectively for all prior periods presented in the financial statements. The Company is currently evaluating the impact that this guidance may have on its consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_EmergingGrowthCompanyStatusPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for emerging growth company status.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_EmergingGrowthCompanyStatusPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_FinancingObligationFailedSaleLeasebackPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for transactions involving the sale of property to another party and a lease of the property back to the seller.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_FinancingObligationFailedSaleLeasebackPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_GuaranteesAndIndemnificationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for guarantees and indemnifications</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_GuaranteesAndIndemnificationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_OfferingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_OfferingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_PatentCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for patent costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_PatentCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 450<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477850/954-450-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478898/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for redeemable preferred stock issued. This disclosure may include the accounting treatment for the difference, if there is any, between the carrying value and redemption amount. For example, describe whether the issuer accretes changes in the redemption value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481288/505-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Schedule of Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheets to the corresponding amounts shown in the consolidated statements of cash flows as of December&#160;31, 2024 and 2023 (in thousands):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64,039&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,380&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65,663&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40,004&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock', window );">Schedule of Restricted Cash</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheets to the corresponding amounts shown in the consolidated statements of cash flows as of December&#160;31, 2024 and 2023 (in thousands):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64,039&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,380&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65,663&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40,004&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock', window );">Schedule of Estimated Useful Lives of the Property and Equipment</a></td>
<td class="text">Depreciation is calculated using the straight-line method over the following estimated useful lives of the assets:<div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Computer and software</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laboratory equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Five years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Seven years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shorter of asset life or remaining lease term</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the useful life of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of Assets Measured for Fair Value on a Recurring Basis</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the financial instruments carried at fair value on a recurring basis as of December&#160;31, 2024 and 2023 (in thousands):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,819&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,819&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents</span></td><td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37,074&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37,074&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Expenses And Other Current Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract', window );"><strong>Prepaid Expense and Other Assets, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock', window );">Schedule of Prepaid Expenses and Other Current Assets</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consisted of the following as of December&#160;31, 2024 and 2023 (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">979&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insurance expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Software and subscriptions expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Variable lease expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal R&amp;D tax credit receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,344&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,633&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of prepaid expenses and other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property And Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment, Net</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following as of December&#160;31, 2024 and 2023 (in thousands):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,518&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,518&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laboratory equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,078&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Computer and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">969&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">938&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">524&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">524&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total property and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,089&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,302&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,231)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,505)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,858&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,797&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses and Other Current Liabilities</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities consisted of the following as of December&#160;31, 2024 and 2023 (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee compensation and benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,937&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">External R&amp;D expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,833&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,302&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease Costs and Other Information</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the Company&#8217;s operating lease costs for the&#160;years ended December&#160;31, 2024 and 2023 (in thousands except for lease terms and borrowing rates):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease cost</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,489&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Variable lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,852&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,821&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other information</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.64pt;text-align:left;text-indent:-8.64pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows used for operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining lease term in years</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average incremental borrowing rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the Company&#8217;s finance lease costs for the&#160;years ended December&#160;31, 2024 and 2023 (in thousands except for lease terms and borrowing rates):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.454%"><tr><td style="width:1.0%"></td><td style="width:51.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.153%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.434%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.434%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance lease cost</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of ROU assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest on lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total finance lease cost</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">215&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">179&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other information</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;text-indent:-10.8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows used for finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining lease term in years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average incremental borrowing rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturities of Operating Lease Liabilities</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of operating lease liabilities as of December&#160;31, 2024 were as follows (in thousands):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,980&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,256&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: amount representing imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(769)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total future minimum lease obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,487&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturities of Finance Lease Liabilities</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of finance lease liabilities as of December&#160;31, 2024 were as follows (in thousands):</span></div><div style="margin-bottom:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">173&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: amount representing imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total future minimum lease obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">161&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Preferred Stock and Stockholders' Deficit (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_ConvertiblePreferredStockAndStockholdersDeficitAbstract', window );"><strong>Convertible Preferred Stock and Stockholders' Deficit [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityTableTextBlock', window );">Summary of Convertible Preferred Stock</a></td>
<td class="text">As of December&#160;31, 2023, the Company&#8217;s convertible preferred stock consisted of the following (in thousands, except share amounts):<div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Authorized<br/>shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shares<br/>issued and<br/>outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidation<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common stock<br/>issuable<br/>upon<br/>conversion</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Series&#160;A Prime</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68,173,692</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62,389,791</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62,381&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,562,653</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Series&#160;B</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81,499,592</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68,258,635</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100,504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,085,929</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfConversionsOfStockTextBlock', window );">Schedule of Common Stock Issuance Upon Conversion</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the Company has reserved the following shares of common stock for future issuance:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares reserved for future issuance under the 2024 Equity Incentive Plan and ESPP </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,293,348</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,119,425</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock vesting</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,943</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Warrant outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">142</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,428,858</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_ConvertiblePreferredStockAndStockholdersDeficitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_ConvertiblePreferredStockAndStockholdersDeficitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfConversionsOfStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to converting stock into another financial instrument(s) in a noncash (or part noncash) transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfConversionsOfStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Fair Value Weighted Average Assumptions for Stock Options</a></td>
<td class="text">The weighted-average assumptions used to estimate the fair value of the stock options granted during the years ended December&#160;31, 2024 and 2023 were as follows:<div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97.20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92.24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free interest rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.98%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.84%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected term (in&#160;years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.99</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.97</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock option activity for the year ended December&#160;31, 2024 (in thousands, except share and per share amounts):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of outstanding options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted<br/>average<br/>exercise<br/>price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted<br/>average<br/>remaining<br/>contractual<br/>term in years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Aggregate intrinsic value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,273,221</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.06&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.05</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,893&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">462,206</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited/Cancelled</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(102,221)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercises</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(513,781)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,119,425</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.98</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">751&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested and expected to vest as of December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,119,425</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.98</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercisable as of December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,221,427</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.57</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Restricted Stock Award Activity</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of restricted stock award activity for the year ended December&#160;31, 2024 is a follows:</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted average<br/>fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested as of December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74,243</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.02&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(58,300)</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested as of December 31, 2024</span></td><td colspan="3" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,943</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Stock-based Compensation Expense</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense related to stock options and restricted stock recorded in the accompanying consolidated statements of operations for the&#160;years ended December&#160;31, 2024 and 2023 is as follows (in thousands):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,876&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,555&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">G&amp;A</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,156&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,352&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,032&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,907&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text">A reconciliation of the expected income tax benefit computed using the federal statutory income tax rate to the Company&#8217;s effective income tax rate is as follows for the&#160;years ended December&#160;31, 2024 and 2023:<div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax computed at federal statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State taxes, net of federal benefit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign rate differential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.06)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D credit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.98&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.03&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(29.63)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(31.99)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Permanent differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.07)</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.57)</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.00&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.00&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s net deferred tax assets as of December&#160;31, 2024 and 2023, consisted of the following (in thousands):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOLs</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27,667&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,936&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized R&amp;D costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,059&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D credits</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,299&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,239&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized Sec. 59 (e ) R&amp;D expenditures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,833&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,337&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 22.6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total gross deferred tax assets</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66,574&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51,712&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease ROU assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,653)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,118)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total gross deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,653)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,118)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net deferred tax assets</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64,921&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49,594&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(64,921)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(49,594)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net deferred tax asset less valuation allowance</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting</a></td>
<td class="text">The following table provides the revenue and significant and other segment expenses for the&#160;years ended December&#160;31, 2024 and 2023 (in thousands):<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">652&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">350&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Significant segment expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Personnel-related expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical and preclinical expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Facilities-related and overhead</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,979&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional and consulting fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Travel and entertainment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plus: Other segment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment net loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(51,791)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(49,291)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Common Stockholders (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Basic and Diluted Net Loss per Share</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net loss per share was calculated as follows for the&#160;years ended December&#160;31, 2024 and 2023 (in thousands, except share and per share amounts):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss attributable to common stockholders</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(51,791)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(49,291)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average common shares outstanding, basic and diluted</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,690,094</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">394,976</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss per share attributable to common stockholders, basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11.04)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(124.80)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Excluded Anti-dilutive Securities</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company excluded the following from the computation of diluted net loss per share attributable to common stockholders as of December&#160;31, 2024 and 2023 because including them would have had an anti-dilutive effect:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Conversion of preferred stock</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,648,582</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options outstanding</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,119,425</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,273,221</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock vesting</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,943</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74,243</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Warrant outstanding</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">142</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">142</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,135,510</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,996,188</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business and Basis of Presentation (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Nov. 01, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 15, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th"><div>Oct. 03, 2024</div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems', window );"><strong>Description of Business and Basis of Presentation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Reverse stock split ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.08916<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Net proceeds received</a></td>
<td class="nump">$ 72,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,980<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175,000,000<span></span>
</td>
<td class="nump">210,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock par value (in USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Unrestricted cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,039<span></span>
</td>
<td class="nump">$ 38,380<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_WorkingCapital', window );">Working capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(211,753)<span></span>
</td>
<td class="num">(159,962)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,791<span></span>
</td>
<td class="nump">49,291<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash flows from operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,562<span></span>
</td>
<td class="nump">$ 44,155<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">Initial public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems', window );"><strong>Description of Business and Basis of Presentation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,820,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Sale price per share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Net proceeds received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_PaymentsOfUnderwritingDiscountsAndCommissions', window );">Payments of underwriting discounts and commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over allotment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems', window );"><strong>Description of Business and Basis of Presentation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Net proceeds received</a></td>
<td class="nump">6,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance costs</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_DescriptionOfBusinessAndBasisOfPresentationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_DescriptionOfBusinessAndBasisOfPresentationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_PaymentsOfUnderwritingDiscountsAndCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments Of Underwriting Discounts And Commissions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_PaymentsOfUnderwritingDiscountsAndCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_WorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of working capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_WorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsAssets', window );">Security deposits</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">64,039<span></span>
</td>
<td class="nump">38,380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">1,624<span></span>
</td>
<td class="nump">1,624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents, and restricted cash</a></td>
<td class="nump">$ 65,663<span></span>
</td>
<td class="nump">$ 40,004<span></span>
</td>
<td class="nump">$ 84,536<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-21<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule Property and Equipment, Net Useful Lives (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=camp_ComputerAndSoftwareMember', window );">Computer and software</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=camp_LaboratoryEquipmentMember', window );">Laboratory equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=camp_ComputerAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=camp_ComputerAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=camp_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=camp_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>majorFinancialInstitution</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>majorFinancialInstitution</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_NumberOfMajorFinancialInstitutionsWithCashAndCashEquivalentDeposits', window );">Number of major financial institutions with cash and cash equivalent deposits | majorFinancialInstitution</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCosts', window );">Deferred offering costs | $</a></td>
<td class="nump">$ 4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_NumberOfMajorFinancialInstitutionsWithCashAndCashEquivalentDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Major Financial Institutions With Cash And Cash Equivalent Deposits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_NumberOfMajorFinancialInstitutionsWithCashAndCashEquivalentDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">60,819<span></span>
</td>
<td class="nump">37,074<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring basis | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">$ 60,819<span></span>
</td>
<td class="nump">$ 37,074<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Prepaid Expenses And Other Current Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract', window );"><strong>Prepaid Expense and Other Assets, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_PrepaidResearchAndDevelopmentExpenseCurrent', window );">R&amp;D expense</a></td>
<td class="nump">$ 979<span></span>
</td>
<td class="nump">$ 480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidInsurance', window );">Prepaid Insurance</a></td>
<td class="nump">591<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_PrepaidSoftwareAndSubscriptionExpenseCurrent', window );">Software and subscriptions expense</a></td>
<td class="nump">337<span></span>
</td>
<td class="nump">287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_PrepaidVariableLeaseExpenseCurrent', window );">Variable lease expenses</a></td>
<td class="nump">118<span></span>
</td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_PrepaidFederalResearchAndDevelopmentTaxCreditCurrent', window );">Federal R&amp;D tax credit receivable</a></td>
<td class="nump">108<span></span>
</td>
<td class="nump">442<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other</a></td>
<td class="nump">211<span></span>
</td>
<td class="nump">245<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">$ 2,344<span></span>
</td>
<td class="nump">$ 1,633<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_PrepaidFederalResearchAndDevelopmentTaxCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of federal research and development tax credit that is receivable within one year or normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_PrepaidFederalResearchAndDevelopmentTaxCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_PrepaidResearchAndDevelopmentExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration paid in advance for research and development expense that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_PrepaidResearchAndDevelopmentExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_PrepaidSoftwareAndSubscriptionExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration paid in advance for software and subscription expense that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_PrepaidSoftwareAndSubscriptionExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_PrepaidVariableLeaseExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration paid in advance for variable lease expense that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_PrepaidVariableLeaseExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482955/340-10-05-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property And Equipment, Net - Schedule of Property and Equipment, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 10,089<span></span>
</td>
<td class="nump">$ 9,302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation and amortization</a></td>
<td class="num">(6,231)<span></span>
</td>
<td class="num">(4,505)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">3,858<span></span>
</td>
<td class="nump">4,797<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=camp_LaboratoryEquipmentMember', window );">Laboratory equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">4,078<span></span>
</td>
<td class="nump">3,322<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=camp_ComputerAndSoftwareMember', window );">Computer and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">969<span></span>
</td>
<td class="nump">938<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">524<span></span>
</td>
<td class="nump">524<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 4,518<span></span>
</td>
<td class="nump">$ 4,518<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=camp_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=camp_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=camp_ComputerAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=camp_ComputerAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property And Equipment, Net - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Finance lease right-of-use asset obtained in exchange for lease liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 504<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of ROU assets</a></td>
<td class="nump">189<span></span>
</td>
<td class="nump">$ 146<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=camp_LaboratoryEquipmentMember', window );">Laboratory equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Finance lease right-of-use asset obtained in exchange for lease liabilities</a></td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization', window );">Finance lease right-of-use asset accumulated depreciation</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated amortization of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=camp_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=camp_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee compensation and benefits</a></td>
<td class="nump">$ 3,111<span></span>
</td>
<td class="nump">$ 1,937<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_ProfessionalFeesAndOtherGeneralAndAdministrativeExpensesCurrent', window );">Professional fees</a></td>
<td class="nump">661<span></span>
</td>
<td class="nump">475<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_ResearchAndDevelopmentExpensesCurrent', window );">External R&amp;D expenses</a></td>
<td class="nump">524<span></span>
</td>
<td class="nump">601<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">537<span></span>
</td>
<td class="nump">289<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued expenses</a></td>
<td class="nump">$ 4,833<span></span>
</td>
<td class="nump">$ 3,302<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_ProfessionalFeesAndOtherGeneralAndAdministrativeExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees and other general and administrative expenses. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_ProfessionalFeesAndOtherGeneralAndAdministrativeExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_ResearchAndDevelopmentExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for research and development expenses. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_ResearchAndDevelopmentExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Operating Leases Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 01, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Capitalized cost</a></td>
<td class="nump">$ 10,089<span></span>
</td>
<td class="nump">$ 9,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">6,015<span></span>
</td>
<td class="nump">7,764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liabilities</a></td>
<td class="nump">2,994<span></span>
</td>
<td class="nump">2,704<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current operating lease liabilities</a></td>
<td class="nump">$ 5,493<span></span>
</td>
<td class="nump">8,487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=camp_OfficeAndLaboratorySpaceInCambridgeMember', window );">Office space and laboratory space in Cambridge, Massachusetts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfLand', window );">Area of lease (approximately) | ft&#178;</a></td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_MaximumReimbursableIncentiveFromLessor', window );">Maximum lease incentive reimbursable</a></td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Capitalized cost</a></td>
<td class="nump">4,500<span></span>
</td>
<td class="nump">4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncentiveFromLessor', window );">Lease incentive received</a></td>
<td class="nump">3,600<span></span>
</td>
<td class="nump">$ 2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">4,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liabilities</a></td>
<td class="nump">2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current operating lease liabilities</a></td>
<td class="nump">$ 4,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=camp_OfficeAndLaboratorySpaceInBoulderMember', window );">Office and lab space in Boulder, Colorado</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfLand', window );">Area of lease (approximately) | ft&#178;</a></td>
<td class="nump">5,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liabilities</a></td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current operating lease liabilities</a></td>
<td class="nump">$ 900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Term of lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_LesseeOperatingLeaseIncrementalBorrowingRate', window );">Incremental borrowing rate used for lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.12%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_LesseeOperatingLeaseIncrementalBorrowingRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Incremental Borrowing Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_LesseeOperatingLeaseIncrementalBorrowingRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_MaximumReimbursableIncentiveFromLessor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum amount of lease incentive reimbursable by lessor to lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_MaximumReimbursableIncentiveFromLessor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfLand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area of land held.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfLand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncentiveFromLessor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of incentive received by lessee from lessor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481178/840-20-25-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481475/840-20-55-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481178/840-20-25-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 5<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479924/842-10-30-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncentiveFromLessor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=camp_OfficeAndLaboratorySpaceInCambridgeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=camp_OfficeAndLaboratorySpaceInCambridgeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=camp_OfficeAndLaboratorySpaceInBoulderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=camp_OfficeAndLaboratorySpaceInBoulderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Schedule of Operating Lease Costs and Other Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Lease cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 2,436<span></span>
</td>
<td class="nump">$ 2,489<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease cost</a></td>
<td class="nump">54<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease expense</a></td>
<td class="nump">1,362<span></span>
</td>
<td class="nump">1,213<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_LeaseCostExcludingFinanceLeases', window );">Total lease cost</a></td>
<td class="nump">3,852<span></span>
</td>
<td class="nump">3,821<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_SupplementalInformationRelatingToLeasesAbstract', window );"><strong>Other information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows used for operating leases</a></td>
<td class="nump">$ 3,390<span></span>
</td>
<td class="nump">$ 601<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term (in years)</a></td>
<td class="text">2 years 8 months 12 days<span></span>
</td>
<td class="text">3 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average incremental borrowing rate</a></td>
<td class="nump">6.72%<span></span>
</td>
<td class="nump">6.72%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_LeaseCostExcludingFinanceLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Cost, Excluding Finance Leases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_LeaseCostExcludingFinanceLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_SupplementalInformationRelatingToLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_SupplementalInformationRelatingToLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Schedule of Maturities of Operating Lease Liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Maturity of operating lease liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 3,455<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">3,558<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">1,980<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2028</a></td>
<td class="nump">263<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payment</a></td>
<td class="nump">9,256<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: amount representing imputed interest</a></td>
<td class="num">(769)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total future minimum lease obligations</a></td>
<td class="nump">$ 8,487<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Finance Leases Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance lease right-of-use assets</a></td>
<td class="nump">$ 427<span></span>
</td>
<td class="nump">$ 748<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liabilities, current portion</a></td>
<td class="nump">91<span></span>
</td>
<td class="nump">354<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liabilities, net of current portion</a></td>
<td class="nump">$ 70<span></span>
</td>
<td class="nump">$ 148<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Schedule of Finance Lease Cost and Other Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Finance lease costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of ROU assets</a></td>
<td class="nump">$ 189<span></span>
</td>
<td class="nump">$ 146<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_LeaseCostFinanceLeases', window );">Total finance lease cost</a></td>
<td class="nump">215<span></span>
</td>
<td class="nump">179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_SupplementalInformationRelatingToLeasesAbstract', window );"><strong>Other information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows used for finance leases</a></td>
<td class="nump">$ 364<span></span>
</td>
<td class="nump">$ 322<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term in years</a></td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">1 year 9 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average incremental borrowing rate</a></td>
<td class="nump">8.28%<span></span>
</td>
<td class="nump">8.14%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_LeaseCostFinanceLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Cost, Finance Leases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_LeaseCostFinanceLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_SupplementalInformationRelatingToLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_SupplementalInformationRelatingToLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Schedule of Maturities of Finance Lease Liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Maturity of finance lease liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total lease payment</a></td>
<td class="nump">173<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less: amount representing imputed interest</a></td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total future minimum lease obligations</a></td>
<td class="nump">$ 161<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Financing Obligation Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_FinancingObligationsLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">26 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_FinancingObligationsLeaseMaximumMonthlyRentalPayments', window );">Maximum monthly rental payments</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_FinancingObligationsLeaseFixedRepurchasePrice', window );">Fixed repurchase price</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction', window );">Proceeds from financing obligation, net of issuance costs</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 706<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_FinancingObligationsLeaseMonthlyInterestRatePercent', window );">Monthly interest rate</a></td>
<td class="nump">0.86%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_FinancingObligationsLeaseMaximumInterestExpense', window );">Maximum interest expense</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_FinancingObligationsLeaseFixedRepurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of repurchase option available for lease under financing obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_FinancingObligationsLeaseFixedRepurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_FinancingObligationsLeaseMaximumInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of maximum interest expense of lease under the financing obligations recorded during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_FinancingObligationsLeaseMaximumInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_FinancingObligationsLeaseMaximumMonthlyRentalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of maximum monthly rental payments of lease under the financing obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_FinancingObligationsLeaseMaximumMonthlyRentalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_FinancingObligationsLeaseMonthlyInterestRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Monthly interest rate on lease entered under a financing obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_FinancingObligationsLeaseMonthlyInterestRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_FinancingObligationsLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lease under a financing obligations expressed in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_FinancingObligationsLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from proceeds received by the entity from the financing obligations related to the failed sale-leaseback transaction during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration and License Agreements - Children's Medical Center Corporation Narrative (Details) - Collaborative Arrangement, Transaction with Party to Collaborative Arrangement - Children Medical Center Corporation<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>Apr. 30, 2018 </div>
<div>USD ($) </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaboration and License Agreements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued | shares</a></td>
<td class="nump">15,123<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_PercentageOfUpfrontPaymentRequiredUponFirstInvestigationalNewDrugStudy', window );">Percentage of upfront payment required upon first investigational new drug study</a></td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember', window );">Upon Achievement of First Licensed Target</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaboration and License Agreements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation', window );">Maximum development milestone payable</a></td>
<td class="nump">$ 7.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember', window );">Upon Achievement of Second Licensed Target</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaboration and License Agreements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation', window );">Maximum development milestone payable</a></td>
<td class="nump">3.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember', window );">Upon Achievement of Third Licensed Target</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaboration and License Agreements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation', window );">Maximum development milestone payable</a></td>
<td class="nump">$ 1.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum amount payable upon achievement of development milestone under the collaborative arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_PercentageOfUpfrontPaymentRequiredUponFirstInvestigationalNewDrugStudy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Upfront Payment Required Upon First Investigational New Drug Study</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_PercentageOfUpfrontPaymentRequiredUponFirstInvestigationalNewDrugStudy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=camp_ChildrenMedicalCenterCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=camp_ChildrenMedicalCenterCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_MilestoneTargetsAxis=camp_UponAchievementOfFirstLicensedTargetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_MilestoneTargetsAxis=camp_UponAchievementOfFirstLicensedTargetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_MilestoneTargetsAxis=camp_UponAchievementOfSecondLicensedTargetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_MilestoneTargetsAxis=camp_UponAchievementOfSecondLicensedTargetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_MilestoneTargetsAxis=camp_UponAchievementOfThirdLicensedTargetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_MilestoneTargetsAxis=camp_UponAchievementOfThirdLicensedTargetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration and License Agreements - Whitehead Institute for Biomedical Research Narrative (Details) - Collaborative Arrangement, Transaction with Party to Collaborative Arrangement - The Whitehead Institute for Biomedical Research - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1">62 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaboration and License Agreements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_CollaborativeArrangementUpfrontLicenseIssuanceFeePayment', window );">Initial license issuance fee payment</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation', window );">Maximum development milestone payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_CollaborativeArrangementTieredRoyaltiesPayableOnNetSalesMaximumLowerRangePercent', window );">Maximum lower range tiered royalties on net sales percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_CollaborativeArrangementTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale', window );">Period of payment of tiered royalties after first commercial sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_CollaborativeArrangementFeesIncurredDuringPeriod', window );">Fees incurred during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_CollaborativeArrangementFeesIncurredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Fees Incurred During Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_CollaborativeArrangementFeesIncurredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum amount payable upon achievement of development milestone under the collaborative arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_CollaborativeArrangementTieredRoyaltiesPayableOnNetSalesMaximumLowerRangePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum lower range percentage of tiered royalties on net sales under the collaborative arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_CollaborativeArrangementTieredRoyaltiesPayableOnNetSalesMaximumLowerRangePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_CollaborativeArrangementTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of payment of tiered royalties after first commercial sale under the collaborative arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_CollaborativeArrangementTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_CollaborativeArrangementUpfrontLicenseIssuanceFeePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of initial payment for license issuance fees under the collaborative arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_CollaborativeArrangementUpfrontLicenseIssuanceFeePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=camp_TheWhiteheadInstituteForBiomedicalResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=camp_TheWhiteheadInstituteForBiomedicalResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration and License Agreements - Fulcrum Therapeutics, Inc. Narrative (Details) - Fulcrum Therapeutics, Inc.<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jul. 31, 2023 </div>
<div>USD ($) </div>
<div>performanceObligation</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaboration and License Agreements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_RevenuePerformanceObligationNumberOfPerformanceObligations', window );">Number of performance obligations | performanceObligation</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_RevenueRemainingPerformanceObligationFixedConsiderationAmount', window );">Fixed consideration amount</a></td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=camp_FulcrumTherapeuticsInc.Member', window );">Tier 1 Product | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaboration and License Agreements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmount', window );">Variable consideration amount</a></td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=camp_FulcrumTherapeuticsInc.Member', window );">Tier 1 Product | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaboration and License Agreements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmount', window );">Variable consideration amount</a></td>
<td class="nump">$ 20,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_RevenuePerformanceObligationNumberOfPerformanceObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Performance Obligation, Number Of Performance Obligations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_RevenuePerformanceObligationNumberOfPerformanceObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_RevenueRemainingPerformanceObligationFixedConsiderationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Remaining Performance Obligation, Fixed Consideration Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_RevenueRemainingPerformanceObligationFixedConsiderationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Remaining Performance Obligation, Variable Consideration Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_RevenueRemainingPerformanceObligationVariableConsiderationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=camp_FulcrumTherapeuticsInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=camp_FulcrumTherapeuticsInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=camp_TierOneProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=camp_TierOneProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration and License Agreements - Eli Lilly and Company Narrative (Details) - Collaborative Arrangement, Transaction with Party to Collaborative Arrangement - Eli Lilly And Company - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaboration and License Agreements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_CollaborativeArrangementReductionInResearchAndDevelopmentExpense', window );">Reduction in R&amp;D expense</a></td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaboration and License Agreements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnbilledContractsReceivable', window );">Unbilled receivable</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_CollaborativeArrangementReductionInResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reduction in research and development expense under the collaborative arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_CollaborativeArrangementReductionInResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnbilledContractsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478345/912-310-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnbilledContractsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=camp_EliLillyAndCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=camp_EliLillyAndCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration and License Agreements - BioMarin Pharmaceutical Inc. Narrative (Details) - BioMarin Pharmaceutical, Inc. - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaboration and License Agreements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_RevenueRemainingPerformanceObligationTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale', window );">Tiered royalties payment, period after first commercial sale</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_RevenueRemainingPerformanceObligationExpectedReimbursableResearchAndDevelopmentExpenses', window );">Expected reimbursable research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_RevenueRemainingPerformanceObligationFixedConsiderationAmount', window );">Fixed consideration amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=camp_BioMarinPharmaceuticalInc.Member', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaboration and License Agreements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_RevenueRemainingPerformanceObligationNoticePeriodForTermination', window );">Notice period for termination</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=camp_BioMarinPharmaceuticalInc.Member', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaboration and License Agreements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentPreclinicalMilestones', window );">Variable consideration amount, contingent preclinical milestones</a></td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentDevelopmentAndRegulatoryMilestones', window );">Variable consideration amount, contingent development and regulatory milestones</a></td>
<td class="nump">75.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountCommercialSalesMilestones', window );">Variable consideration amount, commercial sales milestones</a></td>
<td class="nump">$ 105.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_RevenueRemainingPerformanceObligationNoticePeriodForTermination', window );">Notice period for termination</a></td>
<td class="text">270 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_RevenueRemainingPerformanceObligationExpectedReimbursableResearchAndDevelopmentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Remaining Performance Obligation, Expected Reimbursable Research And Development Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_RevenueRemainingPerformanceObligationExpectedReimbursableResearchAndDevelopmentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_RevenueRemainingPerformanceObligationFixedConsiderationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Remaining Performance Obligation, Fixed Consideration Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_RevenueRemainingPerformanceObligationFixedConsiderationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_RevenueRemainingPerformanceObligationNoticePeriodForTermination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Remaining Performance Obligation, Notice Period For Termination</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_RevenueRemainingPerformanceObligationNoticePeriodForTermination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_RevenueRemainingPerformanceObligationTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Remaining Performance Obligation, Tiered Royalties Payment, Period After First Commercial Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_RevenueRemainingPerformanceObligationTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountCommercialSalesMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Remaining Performance Obligation, Variable Consideration Amount, Commercial Sales Milestones</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountCommercialSalesMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentDevelopmentAndRegulatoryMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Remaining Performance Obligation, Variable Consideration Amount, Contingent Development And Regulatory Milestones</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentDevelopmentAndRegulatoryMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentPreclinicalMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Remaining Performance Obligation, Variable Consideration Amount, Contingent Preclinical Milestones</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentPreclinicalMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=camp_BioMarinPharmaceuticalInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=camp_BioMarinPharmaceuticalInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Preferred Stock and Stockholders' Deficit - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 15, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Convertible Preferred Stock and Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares) | shares</a></td>
<td class="nump">175,000,000<span></span>
</td>
<td class="nump">175,000,000<span></span>
</td>
<td class="nump">210,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in USD per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares) | shares</a></td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock par value (in USD per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock outstanding (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_NumberOfVotesPerCommonShare', window );">Number of votes per common share | vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Common stock dividends declared (in USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsPerShareDeclared', window );">Preferred stock dividends declared (in USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Convertible Preferred Stock and Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible preferred stock into common stock upon initial public offering (in shares) | shares</a></td>
<td class="nump">11,648,582<span></span>
</td>
<td class="nump">11,648,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_NumberOfVotesPerCommonShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Votes Per Common Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_NumberOfVotesPerCommonShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of preferred stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Convertible Preferred Stock and Stockholders' Deficit - Summary of Convertible Preferred Stock (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Convertible Preferred Stock and Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Authorized shares</a></td>
<td class="nump">25,000,000<span></span>
</td>
<td class="nump">149,673,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">130,648,426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">130,648,426<span></span>
</td>
<td class="nump">130,648,426<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Liquidation Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 162,885,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series&#160;A Prime</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Convertible Preferred Stock and Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Authorized shares</a></td>
<td class="nump">68,173,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares issued (in shares)</a></td>
<td class="nump">62,389,791<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares outstanding (in shares)</a></td>
<td class="nump">62,389,791<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Liquidation Value</a></td>
<td class="nump">$ 62,381,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleSharesIssuable', window );">Common stock issuable upon conversion (in shares)</a></td>
<td class="nump">5,562,653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series&#160;B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Convertible Preferred Stock and Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Authorized shares</a></td>
<td class="nump">81,499,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares issued (in shares)</a></td>
<td class="nump">68,258,635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares outstanding (in shares)</a></td>
<td class="nump">68,258,635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Liquidation Value</a></td>
<td class="nump">$ 100,504,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleSharesIssuable', window );">Common stock issuable upon conversion (in shares)</a></td>
<td class="nump">6,085,929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConvertibleSharesIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common shares issuable upon conversion of preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConvertibleSharesIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Convertible Preferred Stock and Stockholders' Deficit - Schedule of Common Stock Issuance Upon Conversion (Details) - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Convertible Preferred Stock and Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock options outstanding (in shares)</a></td>
<td class="nump">2,119,425<span></span>
</td>
<td class="nump">2,273,221<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Restricted stock vesting (in shares)</a></td>
<td class="nump">15,943<span></span>
</td>
<td class="nump">74,243<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrant outstanding (in shares)</a></td>
<td class="nump">142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total (in shares)</a></td>
<td class="nump">4,428,858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=camp_MarauderTherapeuticsInc2016StockOptionAndGrantPlanMember', window );">2016 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Convertible Preferred Stock and Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares reserved for future issuance under the 2024 Equity Incentive Plan and ESPP (in shares)</a></td>
<td class="nump">2,293,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=camp_MarauderTherapeuticsInc2016StockOptionAndGrantPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=camp_MarauderTherapeuticsInc2016StockOptionAndGrantPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - 2024 Equity Incentive Plan Narrative (Details) - shares<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,428,858<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=camp_A2024EquityIncentivePlanMember', window );">2024 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period of the award (in years)</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="nump">2,143,039<span></span>
</td>
<td class="nump">2,079,045<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum', window );">Percentage of outstanding stock maximum</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=camp_A2024EquityIncentivePlanMember', window );">2024 Equity Incentive Plan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfEstimatedFairValueOnGrantDate', window );">Percentage of estimated fair value on grant date</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfEstimatedFairValueOnGrantDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Of Estimated Fair Value On Grant Date</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfEstimatedFairValueOnGrantDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=camp_A2024EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=camp_A2024EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - 2024 Employee Stock Purchase Plan Narrative (Details) - shares<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,428,858<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="nump">214,303<span></span>
</td>
<td class="nump">214,303<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum', window );">Percentage of outstanding stock maximum</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate', window );">Discount from market price, purchase date</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discount rate from fair value on purchase date that participants pay for shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Stock Options Fair Value Assumptions (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">97.20%<span></span>
</td>
<td class="nump">92.24%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">398.00%<span></span>
</td>
<td class="nump">384.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in&#160;years)</a></td>
<td class="text">5 years 11 months 26 days<span></span>
</td>
<td class="text">5 years 11 months 19 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Stock Option Activity Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in USD per share)</a></td>
<td class="nump">$ 8.09<span></span>
</td>
<td class="nump">$ 6.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Options exercised</a></td>
<td class="nump">$ 6,581<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense recorded</a></td>
<td class="nump">$ 4,032<span></span>
</td>
<td class="nump">$ 2,907<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in&#160;years)</a></td>
<td class="text">5 years 11 months 26 days<span></span>
</td>
<td class="text">5 years 11 months 19 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense recorded</a></td>
<td class="nump">$ 3,800<span></span>
</td>
<td class="nump">$ 2,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Amount of gross unrecognized stock-based compensation expense</a></td>
<td class="nump">$ 6,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average period over which unrecognized stock-based compensation expense to be recognized (in years)</a></td>
<td class="text">2 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=camp_CertainExecutivesMember', window );">Certain Executives | Stock options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_UnrecordedNotesPayableIssuedForStockOptionEarlyExercise', window );">Unrecorded notes payable issued for stock option early exercise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in&#160;years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAfterEarlyExerciseDueToNotesPayableForgiveness', window );">Options outstanding after early exercise due to promissory note forgiveness (in shares)</a></td>
<td class="nump">491,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAfterEarlyExerciseDueToNotesPayableForgiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding After Early Exercise Due To Notes Payable Forgiveness</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAfterEarlyExerciseDueToNotesPayableForgiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_UnrecordedNotesPayableIssuedForStockOptionEarlyExercise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrecorded Notes Payable Issued For Stock Option Early Exercise</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_UnrecordedNotesPayableIssuedForStockOptionEarlyExercise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=camp_CertainExecutivesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=camp_CertainExecutivesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Stock Options Activity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of outstanding options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance at beginning (in shares)</a></td>
<td class="nump">2,273,221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="nump">462,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options cancelled (in shares)</a></td>
<td class="num">(102,221)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (in shares)</a></td>
<td class="num">(513,781)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance at the end (in shares)</a></td>
<td class="nump">2,119,425<span></span>
</td>
<td class="nump">2,273,221<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest at the end the period (in shares)</a></td>
<td class="nump">2,119,425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at the end of the period (in shares)</a></td>
<td class="nump">1,221,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_WeightedAverageExercisePriceRollForward', window );"><strong>Weighted average exercise price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at beginning (in USD per share)</a></td>
<td class="nump">$ 6.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted (in USD per share)</a></td>
<td class="nump">10.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Options cancelled (in USD per share)</a></td>
<td class="nump">6.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised (in USD per share)</a></td>
<td class="nump">0.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at the end (in USD per share)</a></td>
<td class="nump">7.87<span></span>
</td>
<td class="nump">$ 6.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Vested and expected to vest at the end the period (in dollars per share)</a></td>
<td class="nump">7.87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Exercisable at the end of the period (in dollars per share)</a></td>
<td class="nump">$ 6.83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract', window );"><strong>Weighted average remaining contractual term in years</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual term (in years)</a></td>
<td class="text">7 years 11 months 23 days<span></span>
</td>
<td class="text">8 years 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Vested and expected to vest at the end the period (in years)</a></td>
<td class="text">7 years 11 months 23 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable at the end of the period (in years)</a></td>
<td class="text">7 years 6 months 25 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueRollForward', window );"><strong>Aggregate intrinsic value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Beginning balance</a></td>
<td class="nump">$ 6,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Options exercised</a></td>
<td class="nump">6,581<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Ending balance</a></td>
<td class="nump">751<span></span>
</td>
<td class="nump">$ 6,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Vested and expected to vest at the end the period</a></td>
<td class="nump">751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable at the end of the period</a></td>
<td class="nump">$ 739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>n/a</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>n/a</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_WeightedAverageExercisePriceRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_WeightedAverageExercisePriceRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Restricted Stock Activity (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance (in shares) | shares</a></td>
<td class="nump">74,243<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(58,300)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending balance (in shares) | shares</a></td>
<td class="nump">15,943<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_WeightedAverageExercisePriceRollForward', window );"><strong>Weighted average exercise price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance (in USD per share) | $ / shares</a></td>
<td class="nump">$ 2.02<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in USD per share) | $ / shares</a></td>
<td class="nump">0.82<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance (in USD per share) | $ / shares</a></td>
<td class="nump">$ 1.75<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_WeightedAverageExercisePriceRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_WeightedAverageExercisePriceRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Restricted Stock Awards Narrative (Details) - Unvested Restricted Common Stock - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average period over which unrecognized stock-based compensation expense to be recognized (in years)</a></td>
<td class="text">3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of restricted shares vested during the period</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Stock-based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Stock-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 4,032<span></span>
</td>
<td class="nump">$ 2,907<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">R&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Stock-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">1,876<span></span>
</td>
<td class="nump">1,555<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">G&amp;A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Stock-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 2,156<span></span>
</td>
<td class="nump">$ 1,352<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plan (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanAbstract', window );"><strong>Defined Contribution Plan [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent', window );">Employee contribution percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Company matching percentage of employee contributions</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Employer contribution percentage</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Contributions made</a></td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480794/715-70-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution matched.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_CapitalizedResearchAndDevelopmentCosts', window );">Capitalized research and development</a></td>
<td class="nump">$ 22,100,000<span></span>
</td>
<td class="nump">$ 17,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase in valuation allowance</a></td>
<td class="nump">15,300,000<span></span>
</td>
<td class="nump">15,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Uncertain tax position</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">NOL carryforwards</a></td>
<td class="nump">102,300,000<span></span>
</td>
<td class="nump">69,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_OperatingLossCarryforwardsSubjectToExpiration', window );">NOL carryforwards, subject to expiration</a></td>
<td class="nump">4,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_OperatingLossCarryforwardsNotSubjectToExpiration', window );">NOL carryforwards, not subject to expiration</a></td>
<td class="nump">97,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Research and development tax credit carryforward</a></td>
<td class="nump">6,700,000<span></span>
</td>
<td class="nump">5,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">NOL carryforwards</a></td>
<td class="nump">97,600,000<span></span>
</td>
<td class="nump">66,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Research and development tax credit carryforward</a></td>
<td class="nump">$ 3,300,000<span></span>
</td>
<td class="nump">$ 2,600,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_CapitalizedResearchAndDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capitalized Research And Development Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_CapitalizedResearchAndDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_OperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards, Not Subject To Expiration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_OperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_OperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards, Subject To Expiration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_OperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Income tax computed at federal statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State taxes, net of federal benefit</a></td>
<td class="nump">6.78%<span></span>
</td>
<td class="nump">7.49%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign rate differential</a></td>
<td class="nump">0.06%<span></span>
</td>
<td class="num">(0.04%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">R&amp;D credit</a></td>
<td class="nump">2.98%<span></span>
</td>
<td class="nump">4.03%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(29.63%)<span></span>
</td>
<td class="num">(31.99%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent', window );">Permanent differences</a></td>
<td class="num">(1.07%)<span></span>
</td>
<td class="num">(0.57%)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Permanent Differences, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.1.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGrossAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">NOLs</a></td>
<td class="nump">$ 27,667<span></span>
</td>
<td class="nump">$ 18,936<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">Capitalized R&amp;D costs</a></td>
<td class="nump">22,059<span></span>
</td>
<td class="nump">17,413<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">R&amp;D credits</a></td>
<td class="nump">9,299<span></span>
</td>
<td class="nump">7,239<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_DeferredTaxAssetsLeasingArrangements', window );">Operating lease liabilities</a></td>
<td class="nump">2,307<span></span>
</td>
<td class="nump">3,052<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures', window );">Capitalized Sec. 59 (e ) R&amp;D expenditures</a></td>
<td class="nump">1,833<span></span>
</td>
<td class="nump">2,337<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">3,409<span></span>
</td>
<td class="nump">2,735<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total gross deferred tax assets</a></td>
<td class="nump">66,574<span></span>
</td>
<td class="nump">51,712<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Operating lease ROU assets</a></td>
<td class="num">(1,653)<span></span>
</td>
<td class="num">(2,118)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total gross deferred tax liabilities</a></td>
<td class="num">(1,653)<span></span>
</td>
<td class="num">(2,118)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_DeferredTaxAssetsLiabilitiesGross', window );">Net deferred tax assets</a></td>
<td class="nump">64,921<span></span>
</td>
<td class="nump">49,594<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(64,921)<span></span>
</td>
<td class="num">(49,594)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Capitalized Research And Development Expenditures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_DeferredTaxAssetsLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Leasing Arrangements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_DeferredTaxAssetsLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_DeferredTaxAssetsLiabilitiesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets (Liabilities), Gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_DeferredTaxAssetsLiabilitiesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGrossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGrossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from in-process research and development cost acquired in business combination or from joint venture formation or both.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Research and collaboration revenue</a></td>
<td class="nump">$ 652<span></span>
</td>
<td class="nump">$ 350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract', window );"><strong>Less: Significant segment expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Plus: Other segment income</a></td>
<td class="nump">1,297<span></span>
</td>
<td class="nump">2,588<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to common stockholders</a></td>
<td class="num">(51,791)<span></span>
</td>
<td class="num">(49,291)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=camp_RDMember', window );">R&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Research and collaboration revenue</a></td>
<td class="nump">652<span></span>
</td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract', window );"><strong>Less: Significant segment expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LaborAndRelatedExpense', window );">Personnel-related expenses</a></td>
<td class="nump">20,299<span></span>
</td>
<td class="nump">19,433<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_ClinicalAndPreclinicalExpenses', window );">Clinical and preclinical expenses</a></td>
<td class="nump">18,049<span></span>
</td>
<td class="nump">20,012<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_FacilitiesAndOverheadExpense', window );">Facilities-related and overhead</a></td>
<td class="nump">7,625<span></span>
</td>
<td class="nump">6,979<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional and consulting fees</a></td>
<td class="nump">5,984<span></span>
</td>
<td class="nump">4,029<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_CorporateExpenses', window );">Corporate expenses</a></td>
<td class="nump">1,175<span></span>
</td>
<td class="nump">1,185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TravelAndEntertainmentExpense', window );">Travel and entertainment</a></td>
<td class="nump">608<span></span>
</td>
<td class="nump">591<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Plus: Other segment income</a></td>
<td class="nump">1,297<span></span>
</td>
<td class="nump">2,588<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to common stockholders</a></td>
<td class="num">$ (51,791)<span></span>
</td>
<td class="num">$ (49,291)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_ClinicalAndPreclinicalExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Clinical And Preclinical Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_ClinicalAndPreclinicalExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_CorporateExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Corporate Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_CorporateExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_FacilitiesAndOverheadExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Facilities And Overhead Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_FacilitiesAndOverheadExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LaborAndRelatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LaborAndRelatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TravelAndEntertainmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses incurred for travel and entertainment during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TravelAndEntertainmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=camp_RDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=camp_RDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Common Stockholders - Schedule of Basic and Diluted Net Loss per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to common stockholders</a></td>
<td class="num">$ (51,791)<span></span>
</td>
<td class="num">$ (49,291)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares of common stock outstanding, basic, (in shares)</a></td>
<td class="nump">4,690,094<span></span>
</td>
<td class="nump">394,976<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares of common stock outstanding, diluted, (in shares)</a></td>
<td class="nump">4,690,094<span></span>
</td>
<td class="nump">394,976<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share attributable to common stockholders, basic, (in USD per share)</a></td>
<td class="num">$ (11.04)<span></span>
</td>
<td class="num">$ (124.80)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share attributable to common stockholders, diluted, (in USD per share)</a></td>
<td class="num">$ (11.04)<span></span>
</td>
<td class="num">$ (124.80)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Common Stockholders - Schedule of Excluded Anti-dilutive Securities (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Net Loss Per Share Attributable to Common Stockholders</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from diluted earnings per share (in shares)</a></td>
<td class="nump">2,135,510<span></span>
</td>
<td class="nump">13,996,188<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember', window );">Conversion of preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Net Loss Per Share Attributable to Common Stockholders</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from diluted earnings per share (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">11,648,582<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Net Loss Per Share Attributable to Common Stockholders</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from diluted earnings per share (in shares)</a></td>
<td class="nump">2,119,425<span></span>
</td>
<td class="nump">2,273,221<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Restricted stock vesting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Net Loss Per Share Attributable to Common Stockholders</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from diluted earnings per share (in shares)</a></td>
<td class="nump">15,943<span></span>
</td>
<td class="nump">74,243<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrant outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Net Loss Per Share Attributable to Common Stockholders</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from diluted earnings per share (in shares)</a></td>
<td class="nump">142<span></span>
</td>
<td class="nump">142<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2015 </div>
<div>founder</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Parties</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,817,000<span></span>
</td>
<td class="nump">$ 40,616,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,210,000<span></span>
</td>
<td class="nump">1,042,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense recorded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,032,000<span></span>
</td>
<td class="nump">2,907,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,923,000<span></span>
</td>
<td class="nump">11,613,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related party | Consulting Agreement with Founders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Parties</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_camp_NumberOfFounders', window );">Number of founders | founder</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related party | Consulting Agreement with Founders | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Parties</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense recorded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related party | Consulting Agreement with Executive Consultant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Parties</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related party | Consulting Agreement with Executive Consultant | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Parties</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense recorded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_camp_NumberOfFounders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">camp_NumberOfFounders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>camp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=camp_ConsultingAgreementsWithFoundersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=camp_ConsultingAgreementsWithFoundersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=camp_ConsultingAgreementsWithExecutiveConsultantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=camp_ConsultingAgreementsWithExecutiveConsultantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>110
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( -"!>UI&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( -"!>UIUKEX3\@   "L"   1
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MNIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X8-DOV]:[MR_>X%<R)!%!,!FGK_#
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M"CS<_N\-L,+$CN'MB[\!4$L#!!0    ( -"!>UH1]\HSF0@   HU   8
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MM<"R:@1LJ35AU4; .\@(;&?+R_G>8BB#Q#8W0\,5OS-35(!'=:9V#!?@U2[
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M,0H/3WT [%]PKK8_] FJUY^N_@]02P,$%     @ T(%[6M[<RC\\ @  O04
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M*RCK8/;W4N+1L =T'3OY"U!+ P04    " #0@7M:C-[81I(&  "Z'   &
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MV8DHL8OHL2P-': //>"0J:E1]$D\PK9356)7U;E8K3*I&IRV6$E$H?8FA_"
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MXD5]N:$DHT(;P/L5Y^KE1G^@/;&>_P=02P,$%     @ T(%[6MA/$DYO#
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MLAW>.W8L=E!"7$K?T'Q [GR0X..#IK$RCS>X89<=>@%Y-'KA#(RO^;4Z7<C
ME/CNN?^U?W._C"^LA^7QM?]'Z=8T?QI58NLL>W4ZB671?0FVX=?7*QMPMN:/
ME<*XZ6@!GI<6?)R^D(+^_S-<_!]02P,$%     @ T(%[6O,[$EQ9*0  5H8
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MQ@,%<'C9QL/Z=K!0Z<BNRU8C[#YPVN6'G[VQVB(^%6/&0.N11W]*'RVK<NU
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M(8--</B>GN3F;DX(.[) Y2I'FB P';,VOXO=@WA/(XU\9:U:P9*2?#9,?&^
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MV"\L+E Y^(:Z);@D]*TC[GCPLS0PN)BD10]TV@'ESP"-<KBT)E0>WIN2RL<
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MT@9FS+BM^!=%3@Q8O[(VW!\DP/#36_P&4$L#!!0    ( -"!>UIR-,<0R@(
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;+U9:V_;.!;]*X0G':2
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M9R^&K*VP0BK/I_2;)"^'JQF+H\6+X&H1 1M>X1)/=^#JF9C\W\ JCN,:JN*
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M#-L67:GBLD#D4J1;ZW%DR&@G"8 [)&T$AB S5VW-$S2Q&E%&WNE$PCZM:H-
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MAA;@_;)&?QM^T 'IB_GK_P%02P,$%     @ T(%[6F<!J)$R!0  " T  !D
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M[UN>,*H'ZJUH9 0?=@\E<)RJ@IIJ4"Z^KE:,2<Q%(:A#[G)!>7G$S""W:,!
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M2Z>2]/SB =<48@_WV!KKI5Z?#3S!\N&@W$%<1HC\.Q##'&Z,]K6##[K"ZCG
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M#YL5>G?Q'ET@RM#WG->2L$Q&6.G:A@&G79U%6\<_4<?ST1UG*I?H,\L@>TF
MM>A>N7]4OO#/,JX@G:# ^X!\UP]'!"W_'AZ<D1/T%QE8ON!?+G+LOEJZ<)S.
M-.]<5B2%V-'=*4$<P$G>OO%F[J<QK_^)[(7SL'<>GF-/ONE9HVV./HH6.;5(
M,U .R>74N[KV(GP8RA])"Z_]05HK# _>>0EB;]M?HI373+4/I]]M)\Q"3QC;
MB:_V]>2YL0V'_]"T8^N.B#UE$A6PTY3NY$J+$NTH: /%*]M-6ZYT;]IEKJ<G
M").@SW><JV-@"O3S./D-4$L#!!0    ( -"!>UHL=6B^0P(  (H&   9
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M6.J?!0@3H)_GG*OCQ&PP_'Z2-U!+ P04    " #0@7M:/*4S.!$"  #=!
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M9$*V9PN3:#6BO3BNPD^Y=\;O<H]SY8T_7@8&?3*4<56CG1:\XF 150SMC*Z
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MP=>+5%$BSAM>]JGK$I\2H J&>S))5*\*:"VXT8LULZ[=YM91.A\Q_$5C*.)
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MADIM;EHI(0Z@\"V27/EG6"!8R,60DRE2D(@$;;6I!K0[ T%&?::&* X7"9@
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M\_JD\/90\8MB\ U+*PI=8\PH*E_<>%7 :46<5>+W\;AR(V9RJE(9/2AV+:=
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MP;R[^U,.?:34:\K$T(<B[$\5RZ'M \K%V)%5Z&DEA"5YJ4O(_J $3G2*I'4
M,F846#!J"#KH!E+:1#HE) U<PDG#,!!Y"K&-U;B%E>9V;QT&'\($VDFHC\E<
M;="DS9-PY5+DH9--#\A/Y,8"_@Z0OZ+1=6QJZ5$,,ZX].1%WNA# 9WHE'=Q*
MEMS&LZS0\Z/$7(CZFW,P)(ZUVQM6G$A>>P'6V/+2)5PC;1!5RHR0H>W2HD&Y
M,,6"B/F+%G$?)Y#X:20=\@7K-6)G+EK9;5U,E$Z-*_HYIN@D>I,6]#&=$@-6
MA 7T5WV1<$Y'&DZR=C&YS-5GZJMJPR*MT>#9%KW!V"CK;+G!U7L]HH'X?&G,
MC5=2/CKK[WWEF%GRA#5RPEFVO[G=_EDX!6_:@]OT,'K?XX2.V!,!2[,G^V7X
M^,Y\&\1T=V$;1&3B=#I$W,VD<XHV4SL>;69L) 2V&,Q$UM>AUMM4-.QKOZ'"
MW8W+-50NR=HD <52F'+O4J1-TD:"RAIH]O6UD\.O0I%9<G;'GFU).NBEXIYJ
M]$._-^J$-6JD-S(&*;'712R8"LL#TR3J*3UT%#P C-_$#ARH+=1V"6W-""T;
M&*F7V9%PK!E)MH5'#W7DN6$DR^I4<X9'+'R29%H0&PU:UFP9V2D1FST5T$6K
MFXL.6H^M +G'/'8,RWUZZH>M,K+==6G<OPVMTK7G?EZ<!\)R17PE4"8I66FO
MSJTCDZ/+^ISF7\/>/*2J;]Q(%C<[&5\20S.1NY@K==;R9'#Q@&S+9YOD5Z64
M>6?K1&+X[6 .D64;/VX['%N#&U%*>.-RQS"Z(C:27\S_2=LA)B<QM@--J8',
M8\<#G$Q(,#M%)C=3:]-0;6@0G,YT0X)BVN=\)L;+F769F:I=,Y-B#XB/;7O0
MJNW$(,WEY!'V;=*&3KQ*[9^N-$,T2,6A4H^0;Y&9PXM(\!OO0ODVXE >3PJ$
MY)@,U0E1;X"NB1E]DU==5':QI<S9<@^87SC#R,'' FWHKA=C?E'=??6HF7W&
MI<^HRON%4'LQ57GS1P,/*ABKAJ*.63?U0#]&?0( W$BWS_LN?V!9Y'?[JKGS
M'('SGWP^X )6XPL@)#6RBN==C(1?9=L!Z!ZMI&9H<[Y%XMI5*U-*-4*0]MK!
M.A#V=HR#(5A+#D)2'CLZA:(W[P*F1'O2O"0JTG+MIMTWW.VEYLH*<OV1D\+Q
M?&"^GO*W\,W&4QA?A]HTUKB'90W8]IADB/MD8L*XJWJJ1L\QVD-I5$.FJV-U
MGI2[/) YSF.CE?/E'BGON)DL28,Y+OB,UZFJCYO3IDA/C*EQ[_A-62D)89D#
MD1>:4CRP)+)C/F@.$]K\FTM&)-^&XF?=#'HA#1W8"P4D/G8..<DNC-)*6ZZ/
MR6P1Y;$MR_ER(Y6W># ?UW@8Z9\SP+CDD.-OH9)'#CR$GC3H27WS]'0E7'41
M:S->JM4P U>ZU-B)XWRY;\8529@7)&$NC8297?27#94LG[4PZB&0E]>MDYI:
M% ,LYAR'(T9U27Q;3F/N"C*-./E'+(Q10;@RAW>UH#-*25O2?K^$M6%M[( 8
MSO?8KL%,Q+2>;&IEIT9.6A><KBQ6J;VH' !VE6\;/-[*OQ\GC1_-745VXJM[
M5S2R_?[R%E7WE\<3R>,=&_%8.]&%[>UUMQ<JP1=NI#^!&G$O%[)GMD$>XZF.
M]Q9QNTA[,<RD.23X$_96)KJ%:;IO\Y:XN=KIUB4AX+3'07CE14.W*&RREX%@
MC_ Y,3[HY]@]1OHLE^S?\(4.7'#/%+".+5K8[+XAZR9TGV>C8@@?I?&E]G;0
M/IAE/&EH.RG2L3JY0NBZ;88]IUV2NX_VPQK4@6DH;V)%H3<+WSK4Y /1RKIL
M@H%Z%^/\C!DY9%40.FG45@^>S:$S$N<S&UQ-^L(;(_\9F_58%&!;YT>/T^PG
MF0K<2$8/C[2-0W^3CQJP,9TN)JR8#&@\R2>YBDE2=)[ + !25<+BD;8;I>6F
M]_-E?8%LHVQ8NHAL2JU1%&$;<VT[2YR:1N&6N(#EH+;%TP[8#Y1O:C+V-D/]
M([/&=\^X<*GL/AYOL$E6J!(A$Y']HE%.DF@3#[CRS7HO\9J87A._O[>4"+Y+
M!^K&71$C]UG!+4A&&_-/WZ*M2K7:-$T8F&[%8[5O+F$BR?6);@;#8!FR- T6
MT!E/=L#F/$M63ZTF,*3!UX?!>FEV-^U"C=X@>9KZBK2XT'HK/+^"B82>PAS<
MVYR*@\(442$#MWMN,TU.8@I2 BTA1%6;DNS!/FM434^&G9:&<X,X%B_225M[
M0I1:@!IL@NFU;.:T=DH(N[(XYA,T-GV@.J90'X/LT'@\QL:?DE[8R)*<FE9,
MO%) S)UTE!%L*?85 @;F=CGSY$/D;!"P*SD+534-:GV\4Y"#*'P" !V7WD=C
M,]T?C9I;&V0U1S^AE4'K")T,^-U8C!PLV0$8-U[Z )H0X^$(*XLYAD1N"#AX
MSO$^&VZY#^3#;!I-=SB@NUMW%S<>5UGN2Z10[68"'-0VVI%C[+10UV335.+0
M(,$PLB<1XCB+CDYLR76^W$+K#74JS7YWG^8C+/>\/HHDQSP5=T!%S_IP!?/W
MZ.)8 ))R /C5M-KE+Z*I1G[DJ#=;<I;H+C1JW-@PR!@VB8_*$7?LNF.OO0S]
M%W+NXYAFL?A IK1T6W-=Q9T*LUCQ3H9:[9CG8-#*W79I44F?IM0)%:%;K1X-
M%[J1N!RU;3N)_N#HDL[QB2JKV),BG0,=Z.Z]:%'#)F+6'^QB+1EHECAZ)^8,
M9J4[4HQ>:E^#I.;E?KC0:H?A6P\S!6_*8G^LTVT?O)0O;>?9L6[!8H@6CUI\
MD-8FU-T/Z0V$Y]S5J.%2$<R,;3;=@0M6R\WJ\%$O3XJ8BM&XG2!V?*<>&60T
M4X^T:297.&1NMJ3[(Z<'DOX&L0>$"="8<SYV3$T_(<0%%AOGP8B>0\>TK[LH
MK2.P+;CJ]NQ\)!T>I_)?;@B9X;8H+2K6E7SMAI4!(09%^- F"\$/,N/IR:EK
MO HSW*Z4%)]AON^X'=70CLH*XSD%8AN)]4X/=J70O XI__#&N! 4"<Z^Q?>\
MKOT!\J"W.WC$D30@,N-#,;Q%Z*6Z3V3_#3!SJ[4=B3D@762D>XQ1YP?0*H&*
MA?Z2V W(GH@Y4!"@QQ#YVM$R1&?58+>0F !'@O)PRY!L\8Q.^+S61-K>GX&C
M4_QQMP-LX;+4"3Y'%V]NL".<W'DG.0!NSJX0!NFF39K1R2 /5UJ7SS]Z@8XH
M<+G3B^G2RW;-PXF633K=P5K@O5XC+K)=4:VQP1YN,S-R5CO2_0%N3X?G!=G2
MU$:[6.1H;B=/M"'[+6GX9+YZ8&;A5#&E*D_=CF#GV3"0N>4E-#L:<P9&@VK)
MY&OQ^Y78::81)XK8R#U!Q^#W2_U63^&IEII;3DAOYDB;6<PA1YSV);D/AVK/
MT _A"UQ)YL1XO+G_ST3UQ<;?5_Z3H#9L\*(1&IM&GB^W>+R<W,-QB7U30"\@
M<;UK5<U08'/62OT+QY\EK-P\OP_/Q\!)FI, 8P035=*GFR]D6PZPIAU2YJ7E
M-]PUB;J0B%E$;B1!@>=K33M%F?<(-#0>3W\<[ID+<@G@][O0/X18,RY':U,.
M%!O@R0HQG._!"^>@"^]W;,'$\N?2]AJ0=EU\VS0KU!(48S7HH:W;DIWX83\B
M]?F+5E 2>SD3FW93#@'S,;2A0#6@19[O2BWMC7T[8VV)V*VZ5HV]^B+4+2^R
M2.R6=+[<] @[^-/M".^ (*XH^';1]VVY'GJ-AEZR&WYER&&65_X=$XUNGPW.
MAAB@7'![F%2T,0YQ3ZAI[3F"G4N@;,4%[AL:&/496'GGWX$+^<JU-34'BR!;
M1Q*>B8XDV^OAU3@Z>]=F^PY H2V>S#=H1L?'*=@PU'@(A;"&!0 *H/2-CN&2
ME2DR=KV=E$N<0P<NZQ&D=.CTTBJ<Z$:\6*#%DT-G:&GA3N)'$^MCD'X]_6US
M3%)-_6@JWLOID@)J84Q7FY"Z/<+XR&,3%J9'XPS4"36B:WP$_Q"FY=[ ,1PE
M%RHI2DT%*,;T03'Q!*8 ?@E4JIZ@ZGF:8QP4IY3W''QWL5*'?/D05"WP5BG$
MY1&7&^B]&(_'8V$O.KX^]B"]@']?5O1-N/$DA?S>%%39R98E@5;R# H<&ITC
MK>(?(UJ[*FZ.A75#7/8D>P%N?SX'E1O)"@N-R@H+%);-(^X4M'BURP,&$HOL
MUB,>47A(;+@>2&^B7D.@IMMJX\**QY!8'*/\"Y;$M5[*)E^ (FY,*84RAZ1)
MFMJ('@<GF= _URVV3+5 4E^[><67H.[?L(E)O6_ 2\"&CD+#LH^]'UH\)<&\
M8/(3?+;'3&2:<"3-[:- '^C*0#]3G\ A;:ZGLFLZK!?'.NG>M:1NNG;N(+3&
M72DI$".X,K<EK32" U TTN=\38S.S="_BF[T(G.*GSN]$1=VJ;-'2W6!V&ID
M2KSQ;F3,5AWK$XL65NQ^<;[<GN+5SK?7N,6_P*MX?EG0B'<?#?.6U-<,.(X
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M3Z7!^>&V)0YL4-8![PLIS?Y@"?J_@.0/4$L#!!0    ( -"!>UJQ8E6)9P0
M (,,   9    >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;,5766_;.!#^*P/U
M0 JXMBE9LNS:!G*T:($$"9*T?5CL RV/;:*2Z"6I..FOWR$I7XUKQ,4"^Q#Q
M&GYS?3-F!DNI?N@YHH''(B_U,)@;L^BW6CJ;8\%U4RZPI).I5 4WM%2SEEXH
MY!-WJ<A;8;N=M HNRF T<'LW:C20E<E%B3<*=%447#V=82Z7PX %JXU;,9L;
MN]$:#19\AG=HOBYN%*U::Y2)*+#40I:@<#H,3EG_++'R3N";P*7>FH/U9"SE
M#[OX,AD&;6L0YI@9B\!I>,!SS',+1&;\4V,&:Y7VXO9\A?[)^4Z^C+G&<YE_
M%Q,S'P9I !.<\BHWMW+Y&6M_8HN7R5R[+RR];-P)(*NTD45]F2PH1.E'_EC'
M8>M"VO[-A;"^$#J[O2)GY04W?#10<@G*2A.:G3A7W6TR3I0V*7=&T:F@>V9T
M+HM"&(JRT<#+"9S+THARAF4F4,/)/1_GJ-\-6H9TV1NMK,8]\[CA;W!9"%<$
M-=?PL9S@9!>@14:N+0U7EIZ%!Q$O,&M"Q!H0ML/. ;QH[7GD\*(_\OQ"Z"R7
MNE((?YV.M5%$G[_WA<$KZ>Q78DNJKQ<\PV% -:-1/6 P>ON*)>T/!USHK%WH
M'$(?W5&)3JH<04[A$HF;Y(2NW;DV<U3PI?1U2P6PS_C#\/=S!&,) &-;O'7A
MBI\4'@(G7<6"ET]O7Z4AZW[00(U"<1M"R)TMF;.%]#OI)^1* UHR *42BS&9
MMTJGLY@F$9R(DL1EI6F'Q!\S7!B'X3$-JL+[-Y:*HF6UD5*B:-\#.9#+M7ZX
MWF,4O(:PT8D2/Z8]N)M+9=Y;[&VIN .,]> ;N>R"X(_PD?HAC:P1)2%]0Q;!
MO30\WU40-=(X]&/(ZF2(33*V[,JXGL.4XJNATA0<Z^POH=0.*.JU:4S:#+Z[
M7H.3]_R!Y&9(W='VWXV7SA6*I ]ZV.Q"1'_/KHDRHYM4 63];CPA:79#>+,:
MCF3"5)2\S/!_XL%YSK464Y'Y2&]H\>F967!:4.;%3R])571[_17H-I+!%T@5
MFPE_9#7Q;=G7P(@X].TD5&1D#A(:[7OLG!@C<F%L)_&Y_UC3)DP@6A'F>9@L
M(UEL8;N]HTFS ^<HDW3L-PR/)TP,K)D>19BT&:;$E+3).O#F0&^+U[TM?G%O
MN^*F4CZ:M-I$P=?YY2;8^WK<037[&_2NOE_[VG9RN9-XSN,E$<(>3F7NDK1#
M9]^K8E?4G3BV"V)%(XY3.^U24^FE;3NE=;+;71;\R88?>HTP3LA_K?N6EQ5M
M*70.N!\Q$,6BHL11PFIJGG23WKL5[RIC?]?H-2&*:M7RY#@7,T<S2YV4^F(7
M#J0Q6:<Q^<,TKJKQ14D\J.0E2=RMM?\PA8RQ.H',9X_&?1ECW>BH?+'PB'2Q
MA.U-5FOK85B@FKGGKZ960P;X-^)Z=_W"/O4/RXVX?YY?<343I"S'*5UM-[M4
M5\H_>?W"R(5[9HZEH4>KF\[IOP145H#.IU*:U<(J6/_?,?H74$L#!!0    (
M -"!>UJ2'TAT>0,  .L'   9    >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM
M;*U5VX[;-A#]E8%2I D@K.Y>V;$->"]!%V@ 8YTT#T4?:&EL$2N1"DFM=_OU
M'5*RZBT</_5%XI S9RZ'G)D?I'K2%:*!EZ86>N%5QK2S(-!%A0W35[)%02<[
MJ1IF2%3[0+<*6>F,FCJ(PW 2-(P+;SEW>VNUG,O.U%S@6H'NFH:IUQNLY6'A
M1=YQXY'O*V,W@N6\97O<H/G6KA5)P8A2\@:%YE* PMW"6T6SF\SJ.X4_.![T
MR1IL)ELIGZSP4"Z\T :$-1;&(C#Z/>,MUK4%HC!^#)C>Z-(:GJZ/Z)]=[I3+
MEFF\E?5W7IIJX>4>E+AC76T>Y>$W'/)Q 1:RUNX+AUYWDGE0=-K(9C"F"!HN
M^C][&>IP8I"'/S&(!X/8Q=T[<E'>,<.6<R4/H*PVH=F%2]594W!<6%(V1M$I
M)SNSO)7B&97AVQIA305!I;"$C9'%$S QK"I9EZCTKW"'.UYP Q^^,C+0'^>!
MH1@L4E ,_FYZ?_%/_$4Q?)'"5!KN18GE6X" @A\SB(\9W,07$>^PN((D\B$.
MX_0"7C)6)'%XR?]:D3]76VT4W;&_SM6D]YB>]VC?W4RWK,"%1P]+HWI&;_G^
M730)/UW()QWS22^A+S?]<P.Y@PNIG8OZ,NY*6TBJ/C9;5$<&$A],A>2I:9EX
M??\NCZ/K3QJ*$\_MZ%F[HM*9YMJ03'C6>"=KZA5<[.$#%[0C.TV%US[@2X&M
M 5TQA< :V0FC/\Y@U9&.XG_;7.R1AM_YCXZ7S+U["J6A7^]K@XK3^8K2I]8"
MD]R/KA-_,HUA$OM)/O6OIQ'\T@L19'Y&JTF6'.UN((_\=#KU,VN1^W&6^Y,D
M(XLH#/TL3&'BAWGF3^/I!>:RD;GL,G/4@<N.*N:H<UGTU_!!ZXZ) N%;ZQ*T
MM;5=\AR)EUV<)S%]0R)43,-P+\O_$*3[>A-&<5IF&A:PZTQ'-/$AUMF1FQ'I
MC!)TU!24\V'#@'NBT;S" QT)V[UA73/A7N']9KV&V(^GB9^D^5 7V5K&*9S.
M:$-:-L+8CZ*IG\89/"*]4%Z8\>(]TX95B8BP-('O3"DFS!OK*(WAJS2LAI0P
M<C_/\G/$!B<-N$&U=V/&WGJZH7TO'G?'2;;J&_B_ZOT8_,+4GE,.->[(-+RZ
M)@)5/UIZP<C6M?.M-#0<W+*B:8S**M#Y3DIS%*R#<;XO_P%02P,$%     @
MT(%[6DN-*E/:!   A@P  !D   !X;"]W;W)K<VAE971S+W-H965T,S8N>&UL
MG5?;;N,V$/V5@;I9)(!BZV)9<C8QX&0O[<.V0;*7AZ(/M#2VB4BB2])VTJ_O
M#"7+3M?Q[A8P)(KDG)GA.1S2EQNE'\P"T<)C5=;FREM8N[SH]TV^P$J8GEIB
M32,SI2MAZ5//^V:I413.J"K[41 ,^Y60M3>^='VW>GRI5K:4-=YJ,*NJ$OKI
M&DNUN?)";]MQ)^<+RQW]\>52S/$>[>?EK::O?H=2R IK(U4-&F=7WB2\N$YY
MOIOP1>+&[+6!,YDJ]< ?OQ577L !88FY901!KS7>8%DR$(7Q=XOI=2[9<+^]
M17_O<J=<IL+@C2J_RL(NKKS,@P)G8E7:.[7Y%=M\$L;+56G<$S;-W#3P(%\9
MJZK6F"*H9-V\Q6.[#GL&V4L&46L0N;@;1R[*M\**\:56&] \F]"XX5)UUA2<
MK)F4>ZMI5)*='=];E3^<7U->!=RHBK@VPBW7Z2<Q+=&<7?8MN>')_;R%O&X@
MHQ<@PP@^JMHN#+RK"RR> _0IOB[(:!OD=704\2WF/8A#'Z(@&AS!B[ND8X<7
MOY3T0FALD[X53Z0Q"Q.M13U'U_YS,C56DV#^.I1]@STXC,V;Z,(L18Y7'NT2
M@WJ-WOCU+^$P>',D\D$7^> 8^OB>-F6Q*A'4#-X+J>&+*%<(7YWX*)O)&C7M
M)9@8VF5+)M( [5QP-,,?3<^AI(Z[_;1 V+0^SD7K0^SY6/%26@5HK*2M@F#)
M8L8!KEV %"[W&!>&:HWFM.(<=+'2LIZ["4\HM %DW0"QCM44=<<\B+K@1DRQ
M:/9/J9545<Q%,^R&WCTN:<.3^5J5I.12VB<8I;TH@!,813V:=@)WTCR<SS0B
M2 J 6+*@.>BX-\I.Z)D-3G8XA5S+@B*")XEE <$)_[I1,J_@5-9-Y&>0]$8C
M?J1'R$XZLI,?)GN?0)AP*:/$#A%Y%/*P.IG=9B4=#;SOVR(M_T'SC+2FBO*:
MLJJVC+U(&"^,7:B5(>:,#_B8X]*"X>WGR%S2Y/:K4JO:FK,+^'WE,"AG.D.,
MI6D<U58SG=)WDI_/-<Z9/B*3A&1DWHKN6I2BSIU0".V_T<40^5$:^U$4PBL8
M]H(A9+T@X;:?C6+XT*IS,*1Y-/@*PH!E1(?!#"6-]&\8O2QISFD81 QTYI &
MK$+4N32T>J=)&/MIYH;(/G+X219^)SI2LQ^&(W\0<41I+TOI,<JXG83PA21+
M;GD)L5.B@C4K^?_@M>$ZYE^R#SE!LD]=CEE,]@FWTW@$1\0^[,0^_&&QWU$>
M6KJL&MU/-D(71V5_%/RP["?;FPB[U#N7C=Z%<_ES<I<&Q*XF[83L)+ZGW6T%
M_5RO6R)?4&@Z\"-2TRN(>D&T9?TTR?PX"!I!9='W4(BYQ!\YE+"7)L>X2CNN
MTI\K3.?3;R\07")K@X?(.HI^F*Q]-_F^&VS<$(%4[IMM\/R4X4WR#;L:<Z69
M1%>@2/0Y@XKZB6M-3F:JE(5HYM.+;P5N<>DRK,7N6/V)(XNUT1U8SPOCV?[Y
M=?=:5,LW;YDM/TM=V?&3)($/KG_"VS@94E^<<"D9^$',[\@?!>E!:OM[=\,*
M]=S=@ WE2.6VN29VO=TE>]+<+7?3FQOZ1Z'G5%^AQ!F9!B0F#W1SZVT^K%JZ
MF^946;JWNN:"_BB@Y@DT/E/*;C_80??78_PO4$L#!!0    ( -"!>UJ'R2EI
M. 0   P*   9    >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;(U6VV[;.!#]
ME8':#6Q L'6S9#FV@5Q:;(&V"9RT^[#8!UH:VT0E4DM2<;)?OT/)5IW4]NZ+
M>-',F3/D&9+3K50_] ;1P'-9"#US-L94D^%09QLLF1[("@7]64E5,D-#M1[J
M2B'+&Z>R& :>%P]+QH4SGS9S]VH^E;4IN,![!;HN2Z9>KK&0VYGC._N)!5]O
MC)T8SJ<56^,#FF_5O:+1L$/)>8E"<RE X6KF7/F3ZY&U;PR^<]SJ@S[83)92
M_K"#3_G,\2PA+# S%H%1\X0W6!06B&C\O<-TNI#6\;"_1__8Y$ZY+)G&&UG\
MP7.SF3EC!W)<L;HP"[G]'7?Y- 0S6>CF"]O6=A0ZD-7:R'+G3 Q*+MJ6/>_6
MX<!A[)UP"'8.0<.[#=2PO&6&S:=*;D%9:T*SG2;5QIO(<6$WY<$H^LO)S\P_
MB4R6"(_L&37T'MFR0-V?#@U!6X-AMH.Y;F&"$S!^ %^D,!L-'T2.^6N (7'J
MB 5[8M?!6<1;S 80^BX$7A"=P0N[1,,&+_S/1.&6ZZR0NE8(?UXMM5$DC;^.
MY=PB1L<1;;E,=,4RG#E4#QK5$SKSBW=^[%V>X1MU?*-SZ/,'*K^\+A#D"CZL
M5MBH%PZR6#"#L,!,BHP7G%F-'\OA?)0K*JQ#!!O-;!#PN:*(F -O QH*N$2!
M*VZ )JK:_JLU%^O&?(4Y*E: -LS41JJ70S]EB1K9&-Z0+Q,O%^_&@9]<:L N
ML[<.7 /3L)(%'1NV58W_"S)%7E9C0 K!<HFJ4PDPD=M..&F'MKM?,8O;$6?F
M".,F:N // ]^Z]H'TY"WU>&"H#.2UF?ONE^/>)",(1E$*= Y0:> :*%R3KDI
M%(:3;<\;>'$?Z!O!XH*5U>4M9 IS<@\&Z1BB@1?"=U;4[2XPFS43&4(O2 =Q
MV(=>Z _2M _W2$>1(-0./[.%2W23OHTRHN;#R47UVJS:YHQ(1YU(1_];I+=(
M="BE1IQ76J/1S89\YFQ)\C(<]3%]G@UPO,8>CPC)[DV^9V#S93L&NN5V2BHN
MJ8)N&&UEL=-^JSDK[1X7-"-K3=:Z?ZBJVU]#3>#KW6<-[R%(W#A.J../W32,
MX895W+""_T/FW=Y+3>2"P/5&*?B)&_GA&UUH2-T@32%Q@S"%NXHD9RRG ND.
M@N+GHD+@AEX"(4$%KV(]V!.4X'L(_0[<%K8@>#K\-/CN. RM?YC ':5.Z^-&
M7DHS23B"1TE(L%92ZZ-+&\?N*(E@Y+L)'?^O5N2 WN07[HN[;WN(GN_&(ZON
MP/7]<?]TR,-\WSI]/;'U<>2F@0]1ZH[2Z'AQM28$U1J=PB+B1.CI",)[:!08
M7![TCM75\."&+E&MFW>()AG4PK27=3?;/76NVAO^IWG[3OK"U)H+39Q6Y.H-
M$JH@U;X]VH&157/?+Z6AUT/3W=!S#94UH/\K*<U^8 -T#\#YOU!+ P04
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MMG9OR.3GKU\(J,T#2G-!:1XHS8>BM;6O32,"M$>EXK16%M/.'A5SM,&Z@?I
MH#0?BM;6K7:5R(_N5"'=[1E.5R]0CPB4YH'2?"A:J9?5V$<<,_%4[/B6J$A&
MR_VVAZOEKG(/7_K%YNNCZ]?X\KK88VW5F'*K^D<JGL)$HHAM--*^F&DE1;G[
MNSQ1/"UV*S]RI7A<'&X9U=EQ7D!_O^%<O9SD 0Y[\%?_ 5!+ P04    " #0
M@7M:P_KS[/,"   ?"@  &0   'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6RM
M5EUOFS 4_2L6JZ9.R@KA*UF7(+5AT_8P*6K:[6':@P,WP:K!U#9)^^]G V5)
M(#2K^@(VW'.XYUQ\[<F6\7N1 $CTF-),3(U$ROS2-$640(K%!<LA4V]6C*=8
MJBE?FR+G@.,2E%+3MBS?3#')C&!2/IOS8,(*24D&<XY$D::8/UT#9=NI,32>
M']R0=2+U S.8Y'@-"Y!W^9RKF=FPQ"2%3!"6(0ZKJ7$UO Q'.KX,^$E@*W;&
M2"M9,G:O)]_CJ6'IA(!")#4#5K<-S(!23:32>*@YC>:3&K@[?F;_6FI76I98
MP(S17R26R=08&RB&%2ZHO&';;U#K\31?Q*@HKVA;QUH&B@HA65J#508IR:H[
M?JQ]V $,W2, NP;8IP*<&N"<"G!K@%LZ4TDI?0BQQ,&$LRWB.EJQZ4%I9HE6
M\DFFR[Z07+TE"B>#155NQ%9H0=8969$(9Q)=11$K,DFR-9HS2B(" GU$"_73
MQ04%'3W#(AF45_3EH2 ;3"&38H!P%J,;$)*32$)<!9R'(#&AXH/BN%N$Z/SL
M SI#)$.W"2N$0HB)*948G9(9U8E?5XG;1Q(/(;I SG" ;,MV.^"ST^%.!SP\
M'6[OPTU5@:8,=E,&N^1SCO!U^?W[:JEL5 OC3Y<[%9_;S:>;Q:7(<0130W4#
M 7P#1O#^W="W/G=Y]99DX1N1[?GH-#XZ?>S! J*"$_FDEG[.!)&=/U9%X944
MNBUN@J%G61-SLVM)[W?^UY(W(MNSQ&TL<7LMT2NPRX4*Y>^ZT#+!;3MU&!/V
M?OV5VKQ&F_>BMK+C1'H __I0EV"O)=AW+>?3@>1VE#-VQH>B>]-ZI6B_$>WW
MBM[IKM&1VOKMVOJZ2^XI/24H[$WEE4)'C=!1K]!;)C$M-0Y:!:XV&OZR%:/6
M+^Q[ON\<>-&.<BW+.C2C'35V/<=OHBJ5YLYNK(]./S!?DTP@"BN%LRY&BH!7
MQY%J(EE>;M!+)M5V7PX3=8(#K@/4^Q5C\GFB]_SF3!C\!5!+ P04    " #0
M@7M:@T'C X<"  "N"   &0   'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6RU
MEFMOVC 4AO^*E4G3)G7DPJUT(5(+JS:IFU!1M\\F.0&KCIW:)PW]][--R)@$
MJ=3+%V([?E\_YQP;)ZZENM<; "3;@@L]]3:(Y87OZW0#!=4]68(P;W*I"HJF
MJ]:^+A70S(D*[D=!,/(+RH27Q&YLH9)85LB9@(4BNBH*JIZN@,MZZH7>?N"6
MK3=H!_PD+ND:EH!WY4*9GM^Z9*P H9D41$$^]2[#BZLPL (WXS>#6A^TB0UE
M)>6][?S(IEY@B8!#BM:"FL<CS(!SZV0X'AI3KUW3"@_;>_=K%[P)9D4US"3_
MPS+<3+USCV20TXKCK:R_0Q/0T/JEDFOW2^IF;N"1M-(HBT9L" HF=D^Z;1)Q
M( @')P11(X@<]VXA1SFG2)-8R9HH.]NXV88+U:D-'!.V*DM4YBTS.DR6NVH0
MF9,E6PN6LY0*))=I*BN!3*S)0G*6,M#D"UF:/9%5',A"F6VA\(E0D9%O#Q4K
M3:'PC/PRV^A.0UYQ<F.2K<FG.2!E7'^.?32T=DT_;<BN=F31";(YI#W2#\](
M%$2#_^6^";*--&HCC9S?X(3?3!9EA: <LY8YUE3!,:Q.&WM*+G1)4YAZYAAH
M4(_@)1\_A*/@:P=DOX7L._?^"<B.Q!Y#[;\#ZJ!%'73FLZDS9_G1+':+^^0)
MJ-(=&,,68]CI=$-74E&49@_#/E_'>#I=7IBJ4<LX>LNJCMX!==RBCE]3U6[Q
M\-FJGK<8YYU.UY42#"L%+F4YV]JV/D;4Z?/"9$U:RLE;UG7R#JAA\.^//GA-
M99]1CT^7UC^X?>Q-_I.J-1.:<,B-5= ;FZ.G=I?CKH.R=!?22J*YWEQS8SXH
M0-D)YGTN)>X[]HYK/U&2OU!+ P04    " #0@7M:, J&M=L"  #&!P  &0
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MP=EG3+FJID:U,+)PC7<I#;9Q)V8X:$%9!3Q/I33;A770C.[H#U!+ P04
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M@V^'M>6@72M<S5?#%1$KFDK$8*EUSNE(&XBB$"\ZBJ_S6O:!*UT9Y\U8?[R
M, /T_27GZJ5CRN/J<RC\!U!+ P04    " #0@7M:R0\-/00#   $"0  &0
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MS.KMPZLECQDI5<_BI^K8ZW#X?GC$VK7Q!J$9MM_"]D_"OF)&\#(#E(%LAGM
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M4 TG@*_!B(\_V(%U/9;U?S+;JX';U< ]Y![?Y25E+P H8;G>%[AI.;4U%E!
M2N3H9VX\_=I3GQ[KV+5M.S+7_;2&0?:E&W9!>[A>A^L=Q)USEH+0!PNF* 48
MI6LL@MZ+@^ UW##&"_UQ-K]C\P^7<BN!:Z[[8YR7US,$;:>-,?J#]_NZ)?88
MAS&!98\S!AUC<)"Q[O<QGF#(T_M6#<\PQKFX'.<).Y[P(,\CDZI@N&W$0P4+
M![O)NW#=5X3#(->UG%>(9N\,U??7-\Q7I!"(0JIDUGFH]+RY$YJ)9&5]K"Z8
M5(=T/<S4-0I<!ZCUE#&YF^B3NKN8X[]02P,$%     @ T(%[6J*.UMW\!
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M")/N;N?D\."('! FR-=2-AJI=.H;%&BW\?-.S&4K)GI&S!SR$Q*'QR0*HF0
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MS0W^7T"[!3A?*&5?.Z[FM7^L] ]02P,$%     @ T(%[6N"\C@8M P  YPD
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MSKFEJ=Z&IM3(4V^4RS".HG&8<U$$\ZE_M]3SJ:JL% 4N-9@JS[E^OD&I]K.
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M[4ULME"H7Z!)+RYLGCP815\YX<R<!$[8HU2LM$U$\"</*0T0KM8*D3+":/@
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M2D,/CJ)H;]6H; ?ZOI+2["LV0/V,G?\'4$L#!!0    ( -"!>UJNHB&BK@,
M #X2   9    >&PO=V]R:W-H965T<R]S:&5E=#4X+GAM;+686W.;.!2 _XJ&
M[NRT,VVXQKFL[9DX---TFC:3M-UG&8YM34%B)6&GG?[X2H ).$1K[ZIYB+F=
M3SJ?. (TWC#^3:P )'K(,RHFSDK*XMQU1;*"'(LC5@!59Q:,YUBJ7;YT1<$!
MIU50GKF!YXW<'!/J3,?5L5L^';-29H3"+4>BS'/,O\\@8YN)XSO; W=DN9+Z
M@#L=%W@)]R"_%+=<[;DM)24Y4$$811P6$^?"/X_]4 =45WPEL!&=;:13F3/V
M3>]<IQ/'TSV"#!*I$5C]K.$2LDR35#_^::!.VZ8.[&YOZ5=5\BJ9.19PR;*_
M22I7$^?402DL<)G).[9Y!TU"QYJ7L$Q4_]&FN=9S4%(*R?(F6/4@)[3^Q0^-
MB$Y %#T3$#0!P4Y $#P3$#8!X;X!41,056;J5"H/,99X.N9L@[B^6M'T1B6S
MBE;I$ZK'_5YR=9:H.#E5OC(\9QS7HT!3]($D:E@!72PY@!IA*= ;=%5F"2]S
M]'D%'!=02I*(U^B:)D?H(^8Z>@WH90P2DTR\,@:,7:GZK5MWDZ:/L[J/P3-]
M]-$-HW(ET%N:0CH0?_DO\8$!X"IAK;5@:VT6&(GOR^P(A?YK%'A!B+[<Q^CE
M'Z]0 ;PJ1)K IWE&EI73H>Z:X3$D+3S:P@<P\?Z8<!C3RSUL[YBPXH;_XXX9
M&N.:&@U3]?1V+@J<P,11\Y< O@9G^N<+?^3]-630)BRV!.O9C%J;D8FN1FD!
MG$.JYM UT!*&S-6$XXJ@Y_'U-/+TW]A==YT8&SK4B258S\EQZ^38Z.1CF<^!
M([;H5A1B;4D)]'/O6IO538TZ\OP=;\;.'.K-$JSG;=1Z&QF]79$'=2,E2A!)
M85N?.2NI'!(SVN^N,C9YJ!U+L)Z=D];.B='.75U@JM 2MJ3DQ^"39&9D'#I+
MG3Q1O&,W?GK%SB#T4CUM4STUIOJ9J/+QT2UG:9E(52TWA)*\S(<2-I(.3=@F
M++8$ZQD\:PV>_9:'W)E-FS9AL258SZ;O/;YE>L8[\BOF!,\SV'MV:GC=>7LT
M-#V9VSU4DBU:WU+G7=P_L&[QPW-U:T8=>JM9I<6V:'V-P:/&X+<4;X.UI=0F
M+;9%ZRM]?.?WC2_!_Z%^PR=/ML#S!BO8ZKN\+5KMR>U\6.? E]4"A5 25-;U
MUV)[M%X$N=2+(/K#?.?XA7]^42T)N(^8>F7E!O,E4:^T&2P4TCLZ4<IXO5A1
M[TA65)_O<R8ERZO-%6 U!/H"=7[!F-SNZ ;:):/I+U!+ P04    " #0@7M:
M?'9+1=H"  #/"   &0   'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6RU5FMO
MVC 4_2M65E6MU)(07E,+D7ATVJ0Q(;INGTUR(58=.[/-Z]_OVH$L5, VC7T!
M/^XYON=<RS?=M52O.@4P9)-QH7M>:DS^X/LZ3B&CNB9S$+@SERJC!J=JX>M<
M 4T<*.-^& 1M/Z-,>%'7K4U4U)5+PYF B2)ZF654;0? Y;KGU;W]PI0M4F,7
M_*B;TP4\@WG))PIG?LF2L R$9E(0!?.>UZ\_##LVW@5\8[#6E3&Q2F92OMK)
MIZ3G!38AX! ;RT#Q;P5#X-P281H_=IQ>>:0%5L=[]@]..VJ940U#R;^SQ*0]
M[[U'$IC3)3=3N?X(.STMRQ=+KMTO6>]B X_$2VUDM@-C!AD3Q3_=['RH .KM
M$X!P!PC? IHG (T=H.&$%IDY62-J:-15<DV4C48V.W#>.#2J8<)6\=DHW&6(
M,Q'*YW0F%2U,%0GYS&(L$I#^0@%@O8PF]^2),]S@?.M"AC++J=B2+U19X K(
MS0@,95S?8FR%$G?Z&"(6CNB.?,6QID4!U\RD9$*5V1(C3X,.#N]7#K\G+\\C
M<G-U2ZX($V2, 4BKN[Y!6ZPX/]Y9,"@L"$]84 _)6 J3:O(D$D@."7STLS0U
MW)LZ",\RCB"ND4;]CH1!V#R2T/#/X8TSZ33*&C<<7^,?:GS,MH*U>9S5/B\/
M.J<Q]#Q\/S2H%7C1];MZ.W@\)OE"9 <&-$L#FN?8HRDDR^+2X4697M,L?QP1
MV.36@V/""[9Z41_[#JZBH-;J^JNJH-\$'23:*A-MG4UT3#<L6V;'<CH+_-MB
M7(CL0&.[U-C^+[>Q?4D#+D1V8$"G-*!SML@O8H9O%238!&-@*SKC1R]A0=*J
M7J\W-[!S[ ;6W]Q O](;,E +US(UB>52F.)%*U>+KCS KNRZUYMU[-9]UZ3\
M7S1%JQ]3M6!"$PYSI QJ'4Q:%>VSF!B9NPXTDP;[F1NF^,4!R@;@_EQ*LY_8
M \IOF.@G4$L#!!0    ( -"!>UJI25:BKP0  /P;   9    >&PO=V]R:W-H
M965T<R]S:&5E=#8P+GAM;+59:V_;-A3]*X16#"V01@^_TLPVD$0JUF$I@F3M
M/M/2M4U4$C62MN/]^EU*LFS%,A-C[!=;DGD.R7,NKWG%\8:+'W()H,ASEN9R
MXBR5*JY=5\9+R*B\Y 7D^,N<BXPJO!4+5Q8":%*"LM0-/&_H9I3ESG1</GL0
MTS%?J93E\""(7&49%=M;2/EFXOC.[L$C6RR5?N!.QP5=P!.H;\6#P#NW84E8
M!KED/"<"YA/GQK^._)$&E"V^,]C(@VNBIS+C_(>^^9),'$^/"%*(E::@^+6&
M.TA3S83C^*<F=9H^-?#P>L?^N9P\3F9&)=SQ]&^6J.7$N7)( G.Z2M4CW_P.
M]80&FB_FJ2P_R:9NZSDD7DG%LQJ,(\A87GW3YUJ( X#?/P$(:D#P$C \ >C5
M@-Y;>^C7@/Y; 8,:4$[=K>9>"A=21:=CP3=$Z-;(IB]*]4LTZL5R'2A/2N"O
M#'%JB@*G=,8%K6S+$_(GBS$.@-PL! "&A)+D([EE_)X*EI.')45[8E@I%M.4
M?,GC2_*5"HU? WD?@J(LE1].0RXJS$?R[2DD[]]](.\(MKEG:8H#D&-7X:3T
MT-RXGL!=-8'@Q 3\@-SS7"TEB?($DC:!BVHTD@0[26X#(^,3%)<D&%Z0P OZ
M70,RPT/ Z?7\D_#P#;WWO)/PR S_8Y4VO?<,8O2:^.B5?+W_$1\=H[RM6/O=
MK#K[7<L"8V+B8'J3(-;@3'_]Q1]ZOW4);I,LM$D662)K6=-OK.F;V#'0YB $
M))BOUY"OH,L&(\.Y-E1D?A5Z^A]H/?4N,<C6A_)6C08';?QVB\C2F%J:#1K-
M!D;-_F)0*L:W-%4,)"GH5L?P!2E ,)X0.E<@R)P)J4C,LPQ$S##/29IVZFON
MS??(%JCHS&I&Y+DQ;9,LLD36\F?8^#,T*A8]%[B#*&.:9;.5D'26 M']4!$O
MR_R38+2GO-"N$<#FF(LZ,Y"QHW-#WR99:),L&AXORN#RJEER+1=&C0LCHPN?
MV3-:$./_,4M@E_HSOLI5E]!&KG.%MDD6VB2+1L="]TX)?=4(?644^K'*W!C@
M,5_D[-^7^Y=*8"/'N0)?=27QT8LD;K/'R!)92^!/C<"?C +?LYQEJZQ+52/P
M7%5MDH4VR2)+9"WU?6]?77@_9?M8TUIRQRI;:)4MLL76-NB@_/.-"^0KQZH,
M=KN?.1<$]S]89Y:&=3ICYNMY)*';[CK.B#S;!9MLD2VVM@O!WH7 G*;H\ZDT
M94:>O1)LLH56V2);;&T/]H6N_W,J7=]JJ6N5+;3*%MEB:QNT+W=]<[W[G0I6
ME@-=&],+_52Q?*'+ NP^1G3YABIC*4C%\^XBP3\N5P?MO="=>51G.V*3+;+%
MUG9D7TS[YOKV[8X<%FUZ:0E8K%*JN-B^9E U@N&!0:,CAZS6TE;9(EML;8?V
MY;1OKJ=?=:CUAD.^9L;P^.6.=^2&U5K9*EMDBZWMQKZL]LUU]?F;+3-?,#+L
MMJQ6TE;9(EMLE0WNP>D'1O.B/':2&-L8XM5!2/.T.=JZ*0]TW'WSZESLGHH%
MRR5)88Y0K(LQU$5UU%3=*%Z49RDSKA3/RLLE4%Q7N@'^/N=<[6YT!\V!W_0_
M4$L#!!0    ( -"!>UH6%W@MY ,  #\3   9    >&PO=V]R:W-H965T<R]S
M:&5E=#8Q+GAM;+U8;6_;-A#^*X0V;"W06J+\FLPVT$0MM@_M@@9=/]/2V2)"
MD1I)V>VP'S^24F3+<10)%>8/%D7=/<?GX>ETX/(@Y(-* 33ZEC&N5EZJ=7[M
M^RI.(2-J)'+@YLE6R(QH<RMWOLHED,0Y9<P/@V#F9X1R;[UT<W=RO12%9I3#
MG42JR#(BO]\ $X>5A[W'B<]TEVH[X:^7.=G!/>@O^9TT=WZ-DM ,N**"(PG;
ME?<.7T=X8AV<Q5\4#NIDC"R5C1 /]N:/9.4%=D7 (-86@IC+'FZ!,8MDUO%W
M!>K5,:WCZ?@1_8,C;\ALB();P;[21*<K;^&A!+:D8/JS./P.%:&IQ8L%4^X?
M'2K;P$-QH;3(*F>S@HSR\DJ^54*<.(S#9QS"RB$\=Y@_XS"N',9=(TPJ!R>U
M7U)Q.D1$D_52B@.2UMJ@V8$3TWD;^I3;?;_7TCREQD^O;P7?@]1TPP#=&<E!
M2DC0O1;Q R*\&J6")2#5KRB"+8VI1F_1)R(EL5N&7D6@"67J]=+79D$6UH^K
MX+=E\/"9X#A$'P77J4+O>0))$\ W3&HZX2.=F[ 5\<]8CQ">OD%A$$[0S\A'
M*B425'6YM,1VP CB$1KC"G O-'1"C;JCCE\"; @QKO=U["*,A]S7"T1NRC"3
MRV%L5;I6.8EAY9FRHT#NP5O_\A.>!;]=TGI(L&@@L(:\DUK>21NZD3?+3-52
M5L4WCYM'"IT*2?\Q0K^BO)I]C?Y]/DUNRB@S%\66Z/T:SZ>!^RW]_:ETG2VC
MIY8A#LXL&Z2G->EI#](YD6A/6 &.[)?[".4@2ZJ6\S&I+_$N \U/UAB,S/KP
M&>EN9M&+9@VZLYKNK)7N\;7YX6V>/=V2R[O<NJ*^+\A 8 WQYK5X\S[B_5BV
MS+ME2^N*^HHW$%A#O$4MWJ*7>*9?4]I4;<IWG5.N-4+?NKUXDK_G16>@< VY
MKFJYKEKE^E1D&Y-,8NN^S\IE5ES5*JN/T<D^N*12*W!?E:Z>EN@SE08*UU )
M!\=6+^A<OU%"]S0!GBC3)<>,R*J:]7PSVR/V%;!"F[;DV5 !FQ*>=,NXUYLY
MD(JM07NKB%]6<:" 317#HXIAYT2\J$>K>V\]AD2+AD)K2G=LZ_'_U-?C01O[
M0=&BH=":&A][>_Q2<V\U=B<;YIL2GRB>G[W^E&M1?VK<3)&;(>544\)07FP8
MC0V(<>KS[<87FGT\FRRFB_"LY>EL&;5S[JNI?W+BD('<N9,;9:0HN"X/'^K9
M^G3HG3L3\8_FY='21R)WE"O$8&M<@]'<%"Y9GM:4-UKD[OQB([06F1NF0$R"
M6P/S?"O,Q[VZL0'J,[/U?U!+ P04    " #0@7M:5M'QW34$  #4&0  &0
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M<G.+D5P250/Y_9I2\;*CGM,W+W+F_P%02P,$%     @ T(%[6DI_$8D7 P
MWPH  !D   !X;"]W;W)K<VAE971S+W-H965T-C,N>&ULO59=;],P%/TK5I!@
M2+ T3OHUVDC0@> !J5H9>_:2V\9:8@?;:<>_Y]I)H[;KL@]5O+2V<^_Q.<?Q
MS9ULI+K3&8 A]T4N]-3+C"DO?%\G&11,G\L2!#Y92E4P@U.U\G6I@*4NJ<A]
MVNL-_()QX<43MS97\416)N<"YHKHJBB8^OL%<KF9>H&W7;CBJ\S8!3^>E&P%
M"S#7Y5SAS&]14EZ T%P*HF Y]3X'%[.QC7<!OSEL],Z86"6W4M[9R8]TZO4L
M(<@A,1:!X=\:9I#G%@AI_&DPO79+F[@[WJ)_<]I1RRW3,)/Y#4]--O5&'DEA
MR:K<7,G-=VCT]"U>(G/M?LFFB>UY)*FTD463C P*+NI_=M_XL),01(\DT":!
M/C<A;!)")[1FYF1=,L/BB9(;HFPTHMF!\\9EHQHN["DNC,*G'/-,/)-B#<KP
MVQS('!T$I2 E"R.3.\)$,\IDGH+2[\@E+'G"#?E(%O@ZI14FR269R:+ $ZF3
M?FA=,9$ N2YQK89W1WYV"8;Q7+_';)TQ!7KB&U1@>?A)P_9+S98^PO82DG,2
M!A\([='H2/KL^>GA?KJ/OK7FT=8\ZO#"4YIW3'6]371\&WN1+W3)$IAZ>%,U
MJ#5X\=LWP:#WZ9@')P+;<R1L'0F[T.-:NRSM%=4$JX8V: 07*W+&17/L[X\Y
M4,,.'*RM/.N8!L$XHOV)O]X5=R2.#D-*@S9NCW?4\HXZ>5^!-HHG!H]/.PEK
M7'@&[>@!G: _CL(#T@^CAA'=B=JCW&\I]SLIWS"EF# O,;G_D&U$#[AV;OK*
MMV?02AIT2OHE#<N?$C%X("**Z&C4'QT(Z=SJE4*&K9!AIQ#:"P;;>HBU4-A/
M%9GG3!P3U GUTLM_(K ]U:-6]>C_E,/1*1TY$=B>(^/6D7%W.72O,6F 4X)=
M%UE6IE) ^/8[60GT@Y@,W$>-?/U3<?/WX+5Q]GU=S.=/78[QD?(X#L/H\')T
MTGZI*?Y.^V%;OY],K3B6_QR6"-\['V)-474[54^,+%U'<BL-]C=NF&$'"LH&
MX/.EE&8[L4U.V]/&_P!02P,$%     @ T(%[6HA_;.-Q P  )@X  !D   !X
M;"]W;W)K<VAE971S+W-H965T-C0N>&ULM5=M;YLP$/XK)R9-G;25U[QU"=*:
M=MH^=(M6K?OLPB58!9O9)FFE_?C9AM*D(TBMV!?PV_-PS_G.G.<[+NYDAJC@
MOLB97#B94N69Z\HDPX+(4UXBTS-K+@JB=%=L7%D*)*D%%;D;>-[8+0AE3CRW
M8RL1SWFE<LIP)4!614'$PSGF?+=P?.=QX ?=9,H,N/&\)!N\1O6S7 G=<UN6
ME!;().4,!*X7SB?_;.F'!F!7W%#<R;TV&"FWG-^9SM=TX7C&(LPQ48:"Z-<6
MEYCGADG;\;LA==IO&N!^^Y']LQ6OQ=P2B4N>_Z*IRA;.U($4UZ3*U0^^^X*-
MH)'A2W@N[1-VS5K/@:22BA<-6%M04%:_R7WCB#V YND&! T@> Z(C@#"!F ]
MY]:665D71)%X+O@.A%FMV4S#^L:BM1K*S#9>*Z%GJ<:I^%KQY.[#N79$"DM>
MZ.B0Q/KW P1>$,'E[XJJ!_C*$F3&X;#*"8-O1 ABNR<7J C-Y3L-D!D1*.>N
MTG89=C=I;#BO;0B.V.##%6<JDW#)4DP/\:[6TXH*'D6=![V$WQ-U"J'_WDKH
ML&?9#[_ Y!C\P)RP]7%H^<(7^KC+4S53U,UD<OI,EB3!A:.35J+8HA._?>./
MO8]=,@<B.Q =M:*C/O;X\KZDH@ZE$@7E:9?:?@K?@P<DHBNBEKW(5TH;M=)&
MO79=VSB'AC@%?9C"NE*50*!25D3G"IQ0UN3#NR[AO1]XZ3;79&-+9H[M;1Q%
MP70ZFL[=;8?,<2MSW"OS>/YW*>KE>JFB@<@.9$]:V9/!LG4RI.B!R Y$3UO1
MT]Z]OD&I*-LTJ0I\#2I#(#LB4AO*-@\[([F?-SJ>P;W 5\J=M7)G_SN#9_\D
M7>!'H1?.VJ2K97:L\R8S+QIU)Z?O/?VXO5X-*Q0F)W6M9;9+5VA2$9::390F
M@DV10(NJZ/P=U\SFU5KEG7JC9Z;W&_#*+?+W*A/_E></_($KRHZJZZ5]:58.
MQ7;HA.#)"<%@IU%#-93P@=@.A3_53'YO=?(LO,WQI&MVDZJ$"MB2O-+C##:"
M, 6IGNET2/AOG/O/@WS0(LG=J\0+%!M[09&0\(JINBAO1]M+T"=;^KM/R^L;
MU!41&\HDY+C64.]THG_SHKZ4U!W%2UO7WW*E;PFVF>F+' JS0,^O.5>/'?.!
M]FH8_P502P,$%     @ T(%[6C$MA7#] @  2@H  !D   !X;"]W;W)K<VAE
M971S+W-H965T-C4N>&ULM59=;]HP%/TK5B9-J[22#\)7!Y$*=-H>NJ&B;<]N
M<D,L8CNS'6C__6PG9-"EF9C8"]C./<?GW-S8=[KG8BLS (6>:,[DS,F4*FY<
M5\894"Q[O "FGZ1<4*ST5&Q<60C B071W T\;^A23)@33>W:2D137JJ<,%@)
M)$M*L7B>0\[W,\=W#@L/9),IL^!&TP)O8 WJ6[$2>N8V+ FAP"3A# E(9\ZM
M?[.8F'@;\)W 7AZ-D7'RR/G63#XG,\<S@B"'6!D&K/]VL( \-T1:QL^:TVFV
M-,#C\8']H_6NO3QB"0N>_R")RF;.V$$)I+C,U0/??X+:S\#PQ3R7]A?MZUC/
M07$I%:<U6"N@A%7_^*G.PQ% \[0#@AH0O 2$KP#Z-:!OC5;*K*TE5CB:"KY'
MPD1K-C.PN;%H[88P\Q;72NBG1.-4M%8\WE[/=2(2M.!4%X?$-K_7*/""$-W1
M(N?/ ,@&HE4IXDP'HU6.&?J"A<#F-:!W2U"8Y/)*XV2&!<BIJ[0\LXD;UU+F
ME93@%2D^NN=,91+=L0224[RK;37>@H.W>=!)^#56/=3WWULG+7H6W? EQ*_!
M3^3TFU3W+5__S%2W9:IB"MN9S)=](PL<P\S1GZX$L0,G>OO&'WH?VFQ>B.S$
M=-B8#KO8H[4M!E03)TB?.R@M52D $2E+S&)=/(3517/5EHO.#<[-144VM&3F
MA-M%81B,QX/QU-VUV!PT-@>=-D\_DS87G?AS75R([,3JL+$ZO%@9#R]I^D)D
M)Z9'C>G1_R[CT1^5%_AAW^LWA5>Y_&O8B?YQHW_<J7\%(@:F]+V,>(KT;2X5
M9@EA&R3MN:YO%$)+VJ:[(O:](T5>S_-?R.[<_A]?SJ0Q-^DTMR0RYB53*!6<
M:BMBJ[N?0I 8WJ/B<&$E6$&;O4F;O?'@A;U. >?:<X^N:PIB8[L8B:R'ZN9N
M5IM&Z=;V!^[O\*K+NL=B0YA$.:0:ZO5&^F005>=2310O[.7_R)5N)>PPT\T>
M"!.@GZ><J\/$;-"TC]$O4$L#!!0    ( -"!>UKL$4VV%0,  +X*   9
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MQI%8ZYQQN)%$K8N"RJ<IY&([<7QGOW#+5IDV"VX<E70%<]!WY8W$F=NHI*P
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MHV35Q:J)%J7M' NAL0_988:='Z39@.^70NC]Q#AH_DO$?P!02P,$%     @
MT(%[6O#O"EW2 @  2P<  !D   !X;"]W;W)K<VAE971S+W-H965T-S N>&UL
MK55=3]LP%/TK5QF:0!K-5PN(M9%HNVE[8$(@QK.;W#86B9W93@O[];MVTBR@
M4&W37A)_W'-\S[%]/=U)]:AS1 -/92'TS,N-J2Y]7Z<YEDR/9(6"9M92E<Q0
M5VU\72EDF0.5A1\%P9E?,BZ\9.K&;E0RE;4IN, ;!;HN2Z:>YUC(W<P+O?W
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M<\RD)K0[)UW]F?$GX1M:"+5HUDKC7$=*S.N3>SV0K*P.OT],JJ-T=;E57SO
MM8%ZOF9,O@[T>;K]?DK^!U!+ P04    " #0@7M:STY@XHX$   <$P  &0
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M5O=VGG#_T)13V0.5*\85R6")E%Z[CZU#EI-.N=%B;8>%A= X>MAEBL,A2&.
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M)<O*S0U0]:JE ]3O*\;D?D>?H%FF6_P/4$L#!!0    ( -"!>UJ\M7F;4@,
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M2!29]^#.^RA8OZ>"S:^TH[]02P,$%     @ T(%[6I>*NQS     $P(   L
M  !?<F5L<R\N<F5L<YV2N6[#, Q ?\70GC 'T"&(,V7Q%@3Y 5:B#]@2!8I%
MG;^OVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XU
MA]) 1-MC0[!:+#Y +AEFM[UD%J=SI%>(7->=I3W;+T]!;X"O.DQQ0FE(2S,.
M\,W2?S+W\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8%II%R=.B':5_'<?VD-/IKV,B
MM'I;Z/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " #0@7M:R!(RBM,%
M  !Y-   #P   'AL+W=O<FMB;V]K+GAM;,6;76_;-A2&_PKAJPY89EN?;=$4
M2)-T"]"F1ASTMJ E.B8BB1Y)N4E__4BYP8[2^,5NSGR5B++D1_PXSR%%O_MN
M[/W*F'OQT#:=.YULO-^^G4Y=M5&M='^8K>K"F;6QK?3AT-Y-W=8J6;N-4KYM
MILEL5DQ;J;O)^W=/]UK8*3TP7E5>FRX4QH*O6GUW_YZ/AV*GG5[I1OO'T\GP
M?Z,FHM6=;O4/59].9A/A-N;[7\;J'Z;SLEE6UC3-Z62^/_%56:^K7XJ7$?)6
MKMQ0XN7J1@:0TTDQ"S=<:^O\\(GA_C(P[E3X\/ZH]^:C;KRR%]*K/ZWIM[J[
MB[<)3S$ECS'4P]/??26^M?^E&LUZK2MU8:J^59W?UZ-5303LW$9OW41TLE6G
MDW.S4U8LY)V*#Q6^Y:K>/Z /9*2Z[%L=3MBK>F#DXSGK:^W%5;>_.)PE6 G
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M?\KZT_O])\?/SWIPW?B2S^9_7U__!E!+ 0(4 Q0    ( -"!>UI&QTU(E0
M ,T    0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#
M%     @ T(%[6G6N7A/R    *P(  !$              ( !PP   &1O8U!R
M;W!S+V-O<F4N>&UL4$L! A0#%     @ T(%[6IE<G",0!@  G"<  !,
M         ( !Y $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #0
M@7M:$??*,YD(   *-0  &               @($E"   >&PO=V]R:W-H965T
M<R]S:&5E=#$N>&UL4$L! A0#%     @ T(%[6M[<RC\\ @  O04  !@
M         ("!]!   'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0
M   ( -"!>UJ,WMA&D@8  +H<   8              " @683  !X;"]W;W)K
M<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " #0@7M:WP8."T,#  !8"P
M&               @($N&@  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L!
M A0#%     @ T(%[6N^*3,!O!   #A$  !@              ("!IQT  'AL
M+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( -"!>UK];1!OB <
M "5)   8              " @4PB  !X;"]W;W)K<VAE971S+W-H965T-BYX
M;6Q02P$"% ,4    " #0@7M:?HS#>%4"  #S!   &               @($*
M*@  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ T(%[6CX>
MPCKZ!@  O1X  !@              ("!E2P  'AL+W=O<FMS:&5E=',O<VAE
M970X+GAM;%!+ 0(4 Q0    ( -"!>UK83Q).;PP  -L@   8
M  " @<4S  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " #0
M@7M:\SL27%DI  !6A@  &0              @(%J0   >&PO=V]R:W-H965T
M<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( -"!>UH'89?4$ ,    '   9
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M970Q-2YX;6Q02P$"% ,4    " #0@7M:_Y6BY#H.   ]+P  &0
M    @(%<@   >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    (
M -"!>UIG :B1,@4   @-   9              " @<V.  !X;"]W;W)K<VAE
M971S+W-H965T,3<N>&UL4$L! A0#%     @ T(%[6DN)GFG6"@  4R$  !D
M             ("!-I0  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"
M% ,4    " #0@7M:F4I\W4,#  !=!P  &0              @(%#GP  >&PO
M=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( -"!>UI77"7;&@D
M $P9   9              " @;VB  !X;"]W;W)K<VAE971S+W-H965T,C N
M>&UL4$L! A0#%     @ T(%[6OSJ;)EV!   K D  !D              ("!
M#JP  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4    " #0@7M:
M8QF85CP$  !="@  &0              @(&[L   >&PO=V]R:W-H965T<R]S
M:&5E=#(R+GAM;%!+ 0(4 Q0    ( -"!>UKC.8BH9 ,  /L)   9
M      " @2ZU  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%
M  @ T(%[6N_;#-A$ @  FP4  !D              ("!R;@  'AL+W=O<FMS
M:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " #0@7M:+'5HOD,"  "*!@
M&0              @(%$NP  >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+
M 0(4 Q0    ( -"!>UH\I3,X$0(  -T$   9              " @;Z]  !X
M;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ T(%[6J^91UU=
M"0  -#<  !D              ("!!L   'AL+W=O<FMS:&5E=',O<VAE970R
M-RYX;6Q02P$"% ,4    " #0@7M: !=,T@0O  # HP  &0
M@(&:R0  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( -"!
M>UI)>=CPO ,  *0*   9              " @=7X  !X;"]W;W)K<VAE971S
M+W-H965T,CDN>&UL4$L! A0#%     @ T(%[6HOG4MNV @  .08  !D
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M=#,T+GAM;%!+ 0(4 Q0    ( -"!>UJ2'TAT>0,  .L'   9
M  " @7 - 0!X;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%     @
MT(%[6DN-*E/:!   A@P  !D              ("!(!$! 'AL+W=O<FMS:&5E
M=',O<VAE970S-BYX;6Q02P$"% ,4    " #0@7M:A\DI:3@$   ,"@  &0
M            @($Q%@$ >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4
M Q0    ( -"!>UJRY?KD)P,  +4&   9              " @: : 0!X;"]W
M;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ T(%[6BZ:\6O2 P
MS @  !D              ("!_AT! 'AL+W=O<FMS:&5E=',O<VAE970S.2YX
M;6Q02P$"% ,4    " #0@7M:0CA;A6\&  "/+P  &0              @($'
M(@$ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( -"!>UK#
M^O/L\P(  !\*   9              " @:TH 0!X;"]W;W)K<VAE971S+W-H
M965T-#$N>&UL4$L! A0#%     @ T(%[6H-!XP.' @  K@@  !D
M     ("!URL! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"% ,4
M" #0@7M:, J&M=L"  #&!P  &0              @(&5+@$ >&PO=V]R:W-H
M965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( -"!>UI3>!%'W@(  !H-   9
M              " @:<Q 0!X;"]W;W)K<VAE971S+W-H965T-#0N>&UL4$L!
M A0#%     @ T(%[6LD/#3T$ P  ! D  !D              ("!O#0! 'AL
M+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    " #0@7M:](G*HY #
M   '$0  &0              @('W-P$ >&PO=V]R:W-H965T<R]S:&5E=#0V
M+GAM;%!+ 0(4 Q0    ( -"!>UK_KEU>-0,  !D+   9              "
M@;X[ 0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%     @ T(%[
M6M]]Y4*^ @  I <  !D              ("!*C\! 'AL+W=O<FMS:&5E=',O
M<VAE970T."YX;6Q02P$"% ,4    " #0@7M:HH[6W?P$  "Y'   &0
M        @($?0@$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0
M   ( -"!>UH&-*61= ,  "D+   9              " @5)' 0!X;"]W;W)K
M<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ T(%[6@T"90"\ @  - <
M !D              ("!_4H! 'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6Q0
M2P$"% ,4    " #0@7M:Y\4"P84"  "S!@  &0              @('P30$
M>&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    ( -"!>UI"E&H-
M>P,  (P*   9              " @:Q0 0!X;"]W;W)K<VAE971S+W-H965T
M-3,N>&UL4$L! A0#%     @ T(%[6G=H5?J? @  O08  !D
M ("!7E0! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q02P$"% ,4    " #0
M@7M:X+R.!BT#  #G"0  &0              @($T5P$ >&PO=V]R:W-H965T
M<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( -"!>UJPELA(=0,  "<,   9
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M970V,"YX;6Q02P$"% ,4    " #0@7M:%A=X+>0#   _$P  &0
M    @($G;@$ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4 Q0    (
M -"!>UI6T?'=-00  -09   9              " @4)R 0!X;"]W;W)K<VAE
M971S+W-H965T-C(N>&UL4$L! A0#%     @ T(%[6DI_$8D7 P  WPH  !D
M             ("!KG8! 'AL+W=O<FMS:&5E=',O<VAE970V,RYX;6Q02P$"
M% ,4    " #0@7M:B']LXW$#   F#@  &0              @('\>0$ >&PO
M=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    ( -"!>UHQ+85P_0(
M $H*   9              " @:1] 0!X;"]W;W)K<VAE971S+W-H965T-C4N
M>&UL4$L! A0#%     @ T(%[6NP13;85 P  O@H  !D              ("!
MV( ! 'AL+W=O<FMS:&5E=',O<VAE970V-BYX;6Q02P$"% ,4    " #0@7M:
MRIX)&,,$   E%P  &0              @($DA $ >&PO=V]R:W-H965T<R]S
M:&5E=#8W+GAM;%!+ 0(4 Q0    ( -"!>UJS.(3'- 4  %L;   9
M      " @1Z) 0!X;"]W;W)K<VAE971S+W-H965T-C@N>&UL4$L! A0#%
M  @ T(%[6K>I_&3? @  5P@  !D              ("!B8X! 'AL+W=O<FMS
M:&5E=',O<VAE970V.2YX;6Q02P$"% ,4    " #0@7M:\.\*7=("  !+!P
M&0              @(&?D0$ >&PO=V]R:W-H965T<R]S:&5E=#<P+GAM;%!+
M 0(4 Q0    ( -"!>UJ=ZR%.X0(   $+   9              " @:B4 0!X
M;"]W;W)K<VAE971S+W-H965T-S$N>&UL4$L! A0#%     @ T(%[6N"FTY^V
M @  .@@  !D              ("!P)<! 'AL+W=O<FMS:&5E=',O<VAE970W
M,BYX;6Q02P$"% ,4    " #0@7M:GZ>$^/T#   7$0  &0
M@(&MF@$ >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4 Q0    ( -"!
M>UIFI2H[60,  $,*   9              " @>&> 0!X;"]W;W)K<VAE971S
M+W-H965T-S0N>&UL4$L! A0#%     @ T(%[6D9Y%&&B P  2PT  !D
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M=#<Y+GAM;%!+ 0(4 Q0    ( -"!>UJ\M7F;4@,  +(5   -
M  "  3*W 0!X;"]S='EL97,N>&UL4$L! A0#%     @ T(%[6I>*NQS
M$P(   L              ( !K[H! %]R96QS+RYR96QS4$L! A0#%     @
MT(%[6L@2,HK3!0  >30   \              ( !F+L! 'AL+W=O<FMB;V]K
M+GAM;%!+ 0(4 Q0    ( -"!>UJ[2=+?8@(  +0N   :              "
M 9C! 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( -"!
M>UK=)VL+& (  (4M   3              "  3+$ 0!;0V]N=&5N=%]4>7!E
<<UTN>&UL4$L%!@    !7 %< V!<  'O& 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>128</ContextCount>
  <ElementCount>375</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>47</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>10</UnitCount>
  <MyReports>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>9952151 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>9952152 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>9952153 - Statement - Consolidated Statements of Operations and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Operations and Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>9952154 - Statement - Consolidated Statements of Convertible Preferred Stock and Stockholders' Deficit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit</Role>
      <ShortName>Consolidated Statements of Convertible Preferred Stock and Stockholders' Deficit</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>9952155 - Statement - Consolidated Statements of Convertible Preferred Stock and Stockholders' Deficit (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficitParenthetical</Role>
      <ShortName>Consolidated Statements of Convertible Preferred Stock and Stockholders' Deficit (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>9952156 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>9952157 - Disclosure - Description of Business and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentation</Role>
      <ShortName>Description of Business and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>9952158 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>9952159 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>9952160 - Disclosure - Prepaid Expenses And Other Current Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssets</Role>
      <ShortName>Prepaid Expenses And Other Current Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>9952161 - Disclosure - Property And Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/PropertyAndEquipmentNet</Role>
      <ShortName>Property And Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>9952162 - Disclosure - Accrued Expenses and Other Current Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/AccruedExpensesandOtherCurrentLiabilities</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>9952163 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>9952164 - Disclosure - Collaboration and License Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/CollaborationandLicenseAgreements</Role>
      <ShortName>Collaboration and License Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>9952165 - Disclosure - Convertible Preferred Stock and Stockholders' Deficit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficit</Role>
      <ShortName>Convertible Preferred Stock and Stockholders' Deficit</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>9952166 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>9952167 - Disclosure - Employee Benefit Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/EmployeeBenefitPlan</Role>
      <ShortName>Employee Benefit Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>9952168 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>9952169 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9952170 - Disclosure - Net Loss Per Share Attributable to Common Stockholders</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholders</Role>
      <ShortName>Net Loss Per Share Attributable to Common Stockholders</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>9952171 - Disclosure - Related Parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/RelatedParties</Role>
      <ShortName>Related Parties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure</Role>
      <ShortName>Cybersecurity Risk Management and Strategy Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://camp4tx.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9955512 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://camp4tx.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9955513 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://camp4tx.com/role/FairValueMeasurements</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9955514 - Disclosure - Prepaid Expenses And Other Current Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssetsTables</Role>
      <ShortName>Prepaid Expenses And Other Current Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssets</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9955515 - Disclosure - Property And Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/PropertyAndEquipmentNetTables</Role>
      <ShortName>Property And Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://camp4tx.com/role/PropertyAndEquipmentNet</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9955516 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://camp4tx.com/role/AccruedExpensesandOtherCurrentLiabilities</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9955517 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/CommitmentsandContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://camp4tx.com/role/CommitmentsandContingencies</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9955518 - Disclosure - Convertible Preferred Stock and Stockholders' Deficit (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitTables</Role>
      <ShortName>Convertible Preferred Stock and Stockholders' Deficit (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficit</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9955519 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://camp4tx.com/role/StockBasedCompensation</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9955520 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://camp4tx.com/role/IncomeTaxes</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9955521 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://camp4tx.com/role/SegmentReporting</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9955522 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersTables</Role>
      <ShortName>Net Loss Per Share Attributable to Common Stockholders (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholders</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9955523 - Disclosure - Description of Business and Basis of Presentation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentationDetails</Role>
      <ShortName>Description of Business and Basis of Presentation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentation</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9955524 - Disclosure - Summary of Significant Accounting Policies - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9955525 - Disclosure - Summary of Significant Accounting Policies - Schedule Property and Equipment, Net Useful Lives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesSchedulePropertyandEquipmentNetUsefulLivesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule Property and Equipment, Net Useful Lives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9955526 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9955527 - Disclosure - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/FairValueMeasurementsDetails</Role>
      <ShortName>Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://camp4tx.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9955528 - Disclosure - Prepaid Expenses And Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails</Role>
      <ShortName>Prepaid Expenses And Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssetsTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9955529 - Disclosure - Property And Equipment, Net - Schedule of Property and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/PropertyAndEquipmentNetScheduleofPropertyandEquipmentNetDetails</Role>
      <ShortName>Property And Equipment, Net - Schedule of Property and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9955530 - Disclosure - Property And Equipment, Net - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/PropertyAndEquipmentNetNarrativeDetails</Role>
      <ShortName>Property And Equipment, Net - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9955531 - Disclosure - Accrued Expenses and Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://camp4tx.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9955532 - Disclosure - Commitments and Contingencies - Operating Leases Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/CommitmentsandContingenciesOperatingLeasesNarrativeDetails</Role>
      <ShortName>Commitments and Contingencies - Operating Leases Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9955533 - Disclosure - Commitments and Contingencies - Schedule of Operating Lease Costs and Other Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/CommitmentsandContingenciesScheduleofOperatingLeaseCostsandOtherInformationDetails</Role>
      <ShortName>Commitments and Contingencies - Schedule of Operating Lease Costs and Other Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9955534 - Disclosure - Commitments and Contingencies - Schedule of Maturities of Operating Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails</Role>
      <ShortName>Commitments and Contingencies - Schedule of Maturities of Operating Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9955535 - Disclosure - Commitments and Contingencies - Finance Leases Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/CommitmentsandContingenciesFinanceLeasesNarrativeDetails</Role>
      <ShortName>Commitments and Contingencies - Finance Leases Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9955536 - Disclosure - Commitments and Contingencies - Schedule of Finance Lease Cost and Other Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/CommitmentsandContingenciesScheduleofFinanceLeaseCostandOtherInformationDetails</Role>
      <ShortName>Commitments and Contingencies - Schedule of Finance Lease Cost and Other Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9955537 - Disclosure - Commitments and Contingencies - Schedule of Maturities of Finance Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofFinanceLeaseLiabilitiesDetails</Role>
      <ShortName>Commitments and Contingencies - Schedule of Maturities of Finance Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9955538 - Disclosure - Commitments and Contingencies - Financing Obligation Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/CommitmentsandContingenciesFinancingObligationNarrativeDetails</Role>
      <ShortName>Commitments and Contingencies - Financing Obligation Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9955539 - Disclosure - Collaboration and License Agreements - Children's Medical Center Corporation Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/CollaborationandLicenseAgreementsChildrensMedicalCenterCorporationNarrativeDetails</Role>
      <ShortName>Collaboration and License Agreements - Children's Medical Center Corporation Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9955540 - Disclosure - Collaboration and License Agreements - Whitehead Institute for Biomedical Research Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/CollaborationandLicenseAgreementsWhiteheadInstituteforBiomedicalResearchNarrativeDetails</Role>
      <ShortName>Collaboration and License Agreements - Whitehead Institute for Biomedical Research Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9955541 - Disclosure - Collaboration and License Agreements - Fulcrum Therapeutics, Inc. Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/CollaborationandLicenseAgreementsFulcrumTherapeuticsIncNarrativeDetails</Role>
      <ShortName>Collaboration and License Agreements - Fulcrum Therapeutics, Inc. Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9955542 - Disclosure - Collaboration and License Agreements - Eli Lilly and Company Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/CollaborationandLicenseAgreementsEliLillyandCompanyNarrativeDetails</Role>
      <ShortName>Collaboration and License Agreements - Eli Lilly and Company Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9955543 - Disclosure - Collaboration and License Agreements - BioMarin Pharmaceutical Inc. Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/CollaborationandLicenseAgreementsBioMarinPharmaceuticalIncNarrativeDetails</Role>
      <ShortName>Collaboration and License Agreements - BioMarin Pharmaceutical Inc. Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9955544 - Disclosure - Convertible Preferred Stock and Stockholders' Deficit - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitNarrativeDetails</Role>
      <ShortName>Convertible Preferred Stock and Stockholders' Deficit - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9955545 - Disclosure - Convertible Preferred Stock and Stockholders' Deficit - Summary of Convertible Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitSummaryofConvertiblePreferredStockDetails</Role>
      <ShortName>Convertible Preferred Stock and Stockholders' Deficit - Summary of Convertible Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9955546 - Disclosure - Convertible Preferred Stock and Stockholders' Deficit - Schedule of Common Stock Issuance Upon Conversion (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitScheduleofCommonStockIssuanceUponConversionDetails</Role>
      <ShortName>Convertible Preferred Stock and Stockholders' Deficit - Schedule of Common Stock Issuance Upon Conversion (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9955547 - Disclosure - Stock-Based Compensation - 2024 Equity Incentive Plan Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/StockBasedCompensation2024EquityIncentivePlanNarrativeDetails</Role>
      <ShortName>Stock-Based Compensation - 2024 Equity Incentive Plan Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9955548 - Disclosure - Stock-Based Compensation - 2024 Employee Stock Purchase Plan Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/StockBasedCompensation2024EmployeeStockPurchasePlanNarrativeDetails</Role>
      <ShortName>Stock-Based Compensation - 2024 Employee Stock Purchase Plan Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9955549 - Disclosure - Stock-Based Compensation - Schedule of Stock Options Fair Value Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsFairValueAssumptionsDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Stock Options Fair Value Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9955550 - Disclosure - Stock-Based Compensation - Stock Option Activity Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/StockBasedCompensationStockOptionActivityNarrativeDetails</Role>
      <ShortName>Stock-Based Compensation - Stock Option Activity Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9955551 - Disclosure - Stock-Based Compensation - Schedule of Stock Options Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Stock Options Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>9955552 - Disclosure - Stock-Based Compensation - Schedule of Restricted Stock Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/StockBasedCompensationScheduleofRestrictedStockActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Restricted Stock Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>9955553 - Disclosure - Stock-Based Compensation - Restricted Stock Awards Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/StockBasedCompensationRestrictedStockAwardsNarrativeDetails</Role>
      <ShortName>Stock-Based Compensation - Restricted Stock Awards Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>9955554 - Disclosure - Stock-Based Compensation - Schedule of Stock-based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/StockBasedCompensationScheduleofStockbasedCompensationExpenseDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Stock-based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>9955555 - Disclosure - Employee Benefit Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/EmployeeBenefitPlanDetails</Role>
      <ShortName>Employee Benefit Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://camp4tx.com/role/EmployeeBenefitPlan</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>9955556 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>9955557 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails</Role>
      <ShortName>Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>9955558 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>9955559 - Disclosure - Segment Reporting (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/SegmentReportingDetails</Role>
      <ShortName>Segment Reporting (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://camp4tx.com/role/SegmentReportingTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>9955560 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Schedule of Basic and Diluted Net Loss per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofBasicandDilutedNetLossperShareDetails</Role>
      <ShortName>Net Loss Per Share Attributable to Common Stockholders - Schedule of Basic and Diluted Net Loss per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>9955561 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Schedule of Excluded Anti-dilutive Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofExcludedAntidilutiveSecuritiesDetails</Role>
      <ShortName>Net Loss Per Share Attributable to Common Stockholders - Schedule of Excluded Anti-dilutive Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="camp-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>9955562 - Disclosure - Related Parties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://camp4tx.com/role/RelatedPartiesDetails</Role>
      <ShortName>Related Parties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://camp4tx.com/role/RelatedParties</ParentRole>
      <Position>79</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="camp-20241231.htm">camp-20241231.htm</File>
    <File>camp-20241231.xsd</File>
    <File>camp-20241231_cal.xml</File>
    <File>camp-20241231_def.xml</File>
    <File>camp-20241231_lab.xml</File>
    <File>camp-20241231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>camp-20241231_g1.jpg</File>
    <File>camp-20241231_g10.jpg</File>
    <File>camp-20241231_g11.jpg</File>
    <File>camp-20241231_g12.jpg</File>
    <File>camp-20241231_g13.jpg</File>
    <File>camp-20241231_g14.jpg</File>
    <File>camp-20241231_g15.jpg</File>
    <File>camp-20241231_g16.jpg</File>
    <File>camp-20241231_g2.jpg</File>
    <File>camp-20241231_g3.jpg</File>
    <File>camp-20241231_g4.jpg</File>
    <File>camp-20241231_g5.jpg</File>
    <File>camp-20241231_g6.jpg</File>
    <File>camp-20241231_g7.jpg</File>
    <File>camp-20241231_g8.jpg</File>
    <File>camp-20241231_g9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="556">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="15">http://xbrl.sec.gov/cyd/2024</BaseTaxonomy>
    <BaseTaxonomy items="41">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="5">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>117
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "camp-20241231.htm": {
   "nsprefix": "camp",
   "nsuri": "http://camp4tx.com/20241231",
   "dts": {
    "inline": {
     "local": [
      "camp-20241231.htm"
     ]
    },
    "schema": {
     "local": [
      "camp-20241231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-af-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-af-sub-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "camp-20241231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "camp-20241231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "camp-20241231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "camp-20241231_pre.xml"
     ]
    }
   },
   "keyStandard": 308,
   "keyCustom": 67,
   "axisStandard": 18,
   "axisCustom": 1,
   "memberStandard": 26,
   "memberCustom": 19,
   "hidden": {
    "total": 11,
    "http://camp4tx.com/20241231": 4,
    "http://fasb.org/us-gaap/2024": 3,
    "http://xbrl.sec.gov/dei/2024": 4
   },
   "contextCount": 128,
   "entityCount": 1,
   "segmentCount": 47,
   "elementCount": 645,
   "unitCount": 10,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 556,
    "http://xbrl.sec.gov/dei/2024": 41,
    "http://xbrl.sec.gov/cyd/2024": 15,
    "http://xbrl.sec.gov/ecd/2024": 5
   },
   "report": {
    "R1": {
     "role": "http://camp4tx.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://camp4tx.com/role/AuditInformation",
     "longName": "0000002 - Document - Audit Information",
     "shortName": "Audit Information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://camp4tx.com/role/ConsolidatedBalanceSheets",
     "longName": "9952151 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AssetsCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://camp4tx.com/role/ConsolidatedBalanceSheetsParenthetical",
     "longName": "9952152 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:TemporaryEquityParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:TemporaryEquityParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://camp4tx.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
     "longName": "9952153 - Statement - Consolidated Statements of Operations and Comprehensive Loss",
     "shortName": "Consolidated Statements of Operations and Comprehensive Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingExpenses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit",
     "longName": "9952154 - Statement - Consolidated Statements of Convertible Preferred Stock and Stockholders' Deficit",
     "shortName": "Consolidated Statements of Convertible Preferred Stock and Stockholders' Deficit",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:TemporaryEquitySharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:TemporaryEquityCarryingAmountAttributableToParent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficitParenthetical",
     "longName": "9952155 - Statement - Consolidated Statements of Convertible Preferred Stock and Stockholders' Deficit (Parenthetical)",
     "shortName": "Consolidated Statements of Convertible Preferred Stock and Stockholders' Deficit (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows",
     "longName": "9952156 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "us-gaap:ComprehensiveIncomeNetOfTax",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "unique": true
     }
    },
    "R9": {
     "role": "http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentation",
     "longName": "9952157 - Disclosure - Description of Business and Basis of Presentation",
     "shortName": "Description of Business and Basis of Presentation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://camp4tx.com/role/SummaryofSignificantAccountingPolicies",
     "longName": "9952158 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://camp4tx.com/role/FairValueMeasurements",
     "longName": "9952159 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssets",
     "longName": "9952160 - Disclosure - Prepaid Expenses And Other Current Assets",
     "shortName": "Prepaid Expenses And Other Current Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "camp:PrepaidExpensesAndOtherCurrentAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "camp:PrepaidExpensesAndOtherCurrentAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://camp4tx.com/role/PropertyAndEquipmentNet",
     "longName": "9952161 - Disclosure - Property And Equipment, Net",
     "shortName": "Property And Equipment, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://camp4tx.com/role/AccruedExpensesandOtherCurrentLiabilities",
     "longName": "9952162 - Disclosure - Accrued Expenses and Other Current Liabilities",
     "shortName": "Accrued Expenses and Other Current Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://camp4tx.com/role/CommitmentsandContingencies",
     "longName": "9952163 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://camp4tx.com/role/CollaborationandLicenseAgreements",
     "longName": "9952164 - Disclosure - Collaboration and License Agreements",
     "shortName": "Collaboration and License Agreements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficit",
     "longName": "9952165 - Disclosure - Convertible Preferred Stock and Stockholders' Deficit",
     "shortName": "Convertible Preferred Stock and Stockholders' Deficit",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "camp:TemporaryEquityDisclosureAndStockholdersEquityTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "camp:TemporaryEquityDisclosureAndStockholdersEquityTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://camp4tx.com/role/StockBasedCompensation",
     "longName": "9952166 - Disclosure - Stock-Based Compensation",
     "shortName": "Stock-Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://camp4tx.com/role/EmployeeBenefitPlan",
     "longName": "9952167 - Disclosure - Employee Benefit Plan",
     "shortName": "Employee Benefit Plan",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedContributionPlanTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedContributionPlanTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://camp4tx.com/role/IncomeTaxes",
     "longName": "9952168 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://camp4tx.com/role/SegmentReporting",
     "longName": "9952169 - Disclosure - Segment Reporting",
     "shortName": "Segment Reporting",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholders",
     "longName": "9952170 - Disclosure - Net Loss Per Share Attributable to Common Stockholders",
     "shortName": "Net Loss Per Share Attributable to Common Stockholders",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://camp4tx.com/role/RelatedParties",
     "longName": "9952171 - Disclosure - Related Parties",
     "shortName": "Related Parties",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "us-gaap:ComprehensiveIncomeNetOfTax",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R25": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-128",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-128",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure",
     "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure",
     "shortName": "Cybersecurity Risk Management and Strategy Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "longName": "9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:UseOfEstimates",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:UseOfEstimates",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesTables",
     "longName": "9955512 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://camp4tx.com/role/FairValueMeasurementsTables",
     "longName": "9955513 - Disclosure - Fair Value Measurements (Tables)",
     "shortName": "Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssetsTables",
     "longName": "9955514 - Disclosure - Prepaid Expenses And Other Current Assets (Tables)",
     "shortName": "Prepaid Expenses And Other Current Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "camp:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "camp:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://camp4tx.com/role/PropertyAndEquipmentNetTables",
     "longName": "9955515 - Disclosure - Property And Equipment, Net (Tables)",
     "shortName": "Property And Equipment, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://camp4tx.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables",
     "longName": "9955516 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)",
     "shortName": "Accrued Expenses and Other Current Liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://camp4tx.com/role/CommitmentsandContingenciesTables",
     "longName": "9955517 - Disclosure - Commitments and Contingencies (Tables)",
     "shortName": "Commitments and Contingencies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitTables",
     "longName": "9955518 - Disclosure - Convertible Preferred Stock and Stockholders' Deficit (Tables)",
     "shortName": "Convertible Preferred Stock and Stockholders' Deficit (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "camp:TemporaryEquityDisclosureAndStockholdersEquityTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "camp:TemporaryEquityDisclosureAndStockholdersEquityTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://camp4tx.com/role/StockBasedCompensationTables",
     "longName": "9955519 - Disclosure - Stock-Based Compensation (Tables)",
     "shortName": "Stock-Based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://camp4tx.com/role/IncomeTaxesTables",
     "longName": "9955520 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://camp4tx.com/role/SegmentReportingTables",
     "longName": "9955521 - Disclosure - Segment Reporting (Tables)",
     "shortName": "Segment Reporting (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersTables",
     "longName": "9955522 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Tables)",
     "shortName": "Net Loss Per Share Attributable to Common Stockholders (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentationDetails",
     "longName": "9955523 - Disclosure - Description of Business and Basis of Presentation (Details)",
     "shortName": "Description of Business and Basis of Presentation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-29",
      "name": "us-gaap:ProceedsFromIssuanceOrSaleOfEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-29",
      "name": "us-gaap:ProceedsFromIssuanceOrSaleOfEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails",
     "longName": "9955524 - Disclosure - Summary of Significant Accounting Policies - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details)",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DepositsAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DepositsAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesSchedulePropertyandEquipmentNetUsefulLivesDetails",
     "longName": "9955525 - Disclosure - Summary of Significant Accounting Policies - Schedule Property and Equipment, Net Useful Lives (Details)",
     "shortName": "Summary of Significant Accounting Policies - Schedule Property and Equipment, Net Useful Lives (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-33",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-33",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
     "longName": "9955526 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)",
     "shortName": "Summary of Significant Accounting Policies - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "camp:NumberOfMajorFinancialInstitutionsWithCashAndCashEquivalentDeposits",
      "unitRef": "majorfinancialinstitution",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "camp:NumberOfMajorFinancialInstitutionsWithCashAndCashEquivalentDeposits",
      "unitRef": "majorfinancialinstitution",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://camp4tx.com/role/FairValueMeasurementsDetails",
     "longName": "9955527 - Disclosure - Fair Value Measurements (Details)",
     "shortName": "Fair Value Measurements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-37",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-37",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails",
     "longName": "9955528 - Disclosure - Prepaid Expenses And Other Current Assets (Details)",
     "shortName": "Prepaid Expenses And Other Current Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "camp:PrepaidResearchAndDevelopmentExpenseCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "camp:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "camp:PrepaidResearchAndDevelopmentExpenseCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "camp:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://camp4tx.com/role/PropertyAndEquipmentNetScheduleofPropertyandEquipmentNetDetails",
     "longName": "9955529 - Disclosure - Property And Equipment, Net - Schedule of Property and Equipment, Net (Details)",
     "shortName": "Property And Equipment, Net - Schedule of Property and Equipment, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "unique": true
     }
    },
    "R47": {
     "role": "http://camp4tx.com/role/PropertyAndEquipmentNetNarrativeDetails",
     "longName": "9955530 - Disclosure - Property And Equipment, Net - Narrative (Details)",
     "shortName": "Property And Equipment, Net - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DepreciationAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "unique": true
     }
    },
    "R48": {
     "role": "http://camp4tx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails",
     "longName": "9955531 - Disclosure - Accrued Expenses and Other Current Liabilities (Details)",
     "shortName": "Accrued Expenses and Other Current Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://camp4tx.com/role/CommitmentsandContingenciesOperatingLeasesNarrativeDetails",
     "longName": "9955532 - Disclosure - Commitments and Contingencies - Operating Leases Narrative (Details)",
     "shortName": "Commitments and Contingencies - Operating Leases Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-50",
      "name": "us-gaap:AreaOfLand",
      "unitRef": "sqft",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-4",
      "ancestors": [
       "span",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "unique": true
     }
    },
    "R50": {
     "role": "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofOperatingLeaseCostsandOtherInformationDetails",
     "longName": "9955533 - Disclosure - Commitments and Contingencies - Schedule of Operating Lease Costs and Other Information (Details)",
     "shortName": "Commitments and Contingencies - Schedule of Operating Lease Costs and Other Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails",
     "longName": "9955534 - Disclosure - Commitments and Contingencies - Schedule of Maturities of Operating Lease Liabilities (Details)",
     "shortName": "Commitments and Contingencies - Schedule of Maturities of Operating Lease Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://camp4tx.com/role/CommitmentsandContingenciesFinanceLeasesNarrativeDetails",
     "longName": "9955535 - Disclosure - Commitments and Contingencies - Finance Leases Narrative (Details)",
     "shortName": "Commitments and Contingencies - Finance Leases Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FinanceLeaseRightOfUseAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R53": {
     "role": "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofFinanceLeaseCostandOtherInformationDetails",
     "longName": "9955536 - Disclosure - Commitments and Contingencies - Schedule of Finance Lease Cost and Other Information (Details)",
     "shortName": "Commitments and Contingencies - Schedule of Finance Lease Cost and Other Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FinanceLeaseInterestExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "unique": true
     }
    },
    "R54": {
     "role": "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofFinanceLeaseLiabilitiesDetails",
     "longName": "9955537 - Disclosure - Commitments and Contingencies - Schedule of Maturities of Finance Lease Liabilities (Details)",
     "shortName": "Commitments and Contingencies - Schedule of Maturities of Finance Lease Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://camp4tx.com/role/CommitmentsandContingenciesFinancingObligationNarrativeDetails",
     "longName": "9955538 - Disclosure - Commitments and Contingencies - Financing Obligation Narrative (Details)",
     "shortName": "Commitments and Contingencies - Financing Obligation Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "camp:FinancingObligationsLeaseTermOfContract",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "camp:FinancingObligationsLeaseTermOfContract",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://camp4tx.com/role/CollaborationandLicenseAgreementsChildrensMedicalCenterCorporationNarrativeDetails",
     "longName": "9955539 - Disclosure - Collaboration and License Agreements - Children's Medical Center Corporation Narrative (Details)",
     "shortName": "Collaboration and License Agreements - Children's Medical Center Corporation Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-54",
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:CollaborativeArrangementDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-54",
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:CollaborativeArrangementDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://camp4tx.com/role/CollaborationandLicenseAgreementsWhiteheadInstituteforBiomedicalResearchNarrativeDetails",
     "longName": "9955540 - Disclosure - Collaboration and License Agreements - Whitehead Institute for Biomedical Research Narrative (Details)",
     "shortName": "Collaboration and License Agreements - Whitehead Institute for Biomedical Research Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-58",
      "name": "camp:CollaborativeArrangementUpfrontLicenseIssuanceFeePayment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:CollaborativeArrangementDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-58",
      "name": "camp:CollaborativeArrangementUpfrontLicenseIssuanceFeePayment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:CollaborativeArrangementDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://camp4tx.com/role/CollaborationandLicenseAgreementsFulcrumTherapeuticsIncNarrativeDetails",
     "longName": "9955541 - Disclosure - Collaboration and License Agreements - Fulcrum Therapeutics, Inc. Narrative (Details)",
     "shortName": "Collaboration and License Agreements - Fulcrum Therapeutics, Inc. Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-61",
      "name": "us-gaap:ContractWithCustomerLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-61",
      "name": "us-gaap:ContractWithCustomerLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://camp4tx.com/role/CollaborationandLicenseAgreementsEliLillyandCompanyNarrativeDetails",
     "longName": "9955542 - Disclosure - Collaboration and License Agreements - Eli Lilly and Company Narrative (Details)",
     "shortName": "Collaboration and License Agreements - Eli Lilly and Company Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-67",
      "name": "camp:CollaborativeArrangementReductionInResearchAndDevelopmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-67",
      "name": "camp:CollaborativeArrangementReductionInResearchAndDevelopmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://camp4tx.com/role/CollaborationandLicenseAgreementsBioMarinPharmaceuticalIncNarrativeDetails",
     "longName": "9955543 - Disclosure - Collaboration and License Agreements - BioMarin Pharmaceutical Inc. Narrative (Details)",
     "shortName": "Collaboration and License Agreements - BioMarin Pharmaceutical Inc. Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-77",
      "name": "us-gaap:ContractWithCustomerLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-77",
      "name": "us-gaap:ContractWithCustomerLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitNarrativeDetails",
     "longName": "9955544 - Disclosure - Convertible Preferred Stock and Stockholders' Deficit - Narrative (Details)",
     "shortName": "Convertible Preferred Stock and Stockholders' Deficit - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-31",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "camp:TemporaryEquityDisclosureAndStockholdersEquityTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:PreferredStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "camp:TemporaryEquityDisclosureAndStockholdersEquityTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitSummaryofConvertiblePreferredStockDetails",
     "longName": "9955545 - Disclosure - Convertible Preferred Stock and Stockholders' Deficit - Summary of Convertible Preferred Stock (Details)",
     "shortName": "Convertible Preferred Stock and Stockholders' Deficit - Summary of Convertible Preferred Stock (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:TemporaryEquitySharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-82",
      "name": "us-gaap:TemporaryEquitySharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "camp:TemporaryEquityDisclosureAndStockholdersEquityTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "unique": true
     }
    },
    "R63": {
     "role": "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitScheduleofCommonStockIssuanceUponConversionDetails",
     "longName": "9955546 - Disclosure - Convertible Preferred Stock and Stockholders' Deficit - Schedule of Common Stock Issuance Upon Conversion (Details)",
     "shortName": "Convertible Preferred Stock and Stockholders' Deficit - Schedule of Common Stock Issuance Upon Conversion (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfConversionsOfStockTextBlock",
       "camp:TemporaryEquityDisclosureAndStockholdersEquityTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "unique": true
     }
    },
    "R64": {
     "role": "http://camp4tx.com/role/StockBasedCompensation2024EquityIncentivePlanNarrativeDetails",
     "longName": "9955547 - Disclosure - Stock-Based Compensation - 2024 Equity Incentive Plan Narrative (Details)",
     "shortName": "Stock-Based Compensation - 2024 Equity Incentive Plan Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-85",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-85",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://camp4tx.com/role/StockBasedCompensation2024EmployeeStockPurchasePlanNarrativeDetails",
     "longName": "9955548 - Disclosure - Stock-Based Compensation - 2024 Employee Stock Purchase Plan Narrative (Details)",
     "shortName": "Stock-Based Compensation - 2024 Employee Stock Purchase Plan Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfConversionsOfStockTextBlock",
       "camp:TemporaryEquityDisclosureAndStockholdersEquityTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-90",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "unique": true
     }
    },
    "R66": {
     "role": "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsFairValueAssumptionsDetails",
     "longName": "9955549 - Disclosure - Stock-Based Compensation - Schedule of Stock Options Fair Value Assumptions (Details)",
     "shortName": "Stock-Based Compensation - Schedule of Stock Options Fair Value Assumptions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-93",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://camp4tx.com/role/StockBasedCompensationStockOptionActivityNarrativeDetails",
     "longName": "9955550 - Disclosure - Stock-Based Compensation - Stock Option Activity Narrative (Details)",
     "shortName": "Stock-Based Compensation - Stock Option Activity Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails",
     "longName": "9955551 - Disclosure - Stock-Based Compensation - Schedule of Stock Options Activity (Details)",
     "shortName": "Stock-Based Compensation - Schedule of Stock Options Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "unique": true
     }
    },
    "R69": {
     "role": "http://camp4tx.com/role/StockBasedCompensationScheduleofRestrictedStockActivityDetails",
     "longName": "9955552 - Disclosure - Stock-Based Compensation - Schedule of Restricted Stock Activity (Details)",
     "shortName": "Stock-Based Compensation - Schedule of Restricted Stock Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "unique": true
     }
    },
    "R70": {
     "role": "http://camp4tx.com/role/StockBasedCompensationRestrictedStockAwardsNarrativeDetails",
     "longName": "9955553 - Disclosure - Stock-Based Compensation - Restricted Stock Awards Narrative (Details)",
     "shortName": "Stock-Based Compensation - Restricted Stock Awards Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c-99",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-99",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R71": {
     "role": "http://camp4tx.com/role/StockBasedCompensationScheduleofStockbasedCompensationExpenseDetails",
     "longName": "9955554 - Disclosure - Stock-Based Compensation - Schedule of Stock-based Compensation Expense (Details)",
     "shortName": "Stock-Based Compensation - Schedule of Stock-based Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-101",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "unique": true
     }
    },
    "R72": {
     "role": "http://camp4tx.com/role/EmployeeBenefitPlanDetails",
     "longName": "9955555 - Disclosure - Employee Benefit Plan (Details)",
     "shortName": "Employee Benefit Plan (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R73": {
     "role": "http://camp4tx.com/role/IncomeTaxesNarrativeDetails",
     "longName": "9955556 - Disclosure - Income Taxes - Narrative (Details)",
     "shortName": "Income Taxes - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://camp4tx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails",
     "longName": "9955557 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)",
     "shortName": "Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R75": {
     "role": "http://camp4tx.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails",
     "longName": "9955558 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)",
     "shortName": "Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R76": {
     "role": "http://camp4tx.com/role/SegmentReportingDetails",
     "longName": "9955559 - Disclosure - Segment Reporting (Details)",
     "shortName": "Segment Reporting (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-109",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "unique": true
     }
    },
    "R77": {
     "role": "http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofBasicandDilutedNetLossperShareDetails",
     "longName": "9955560 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Schedule of Basic and Diluted Net Loss per Share (Details)",
     "shortName": "Net Loss Per Share Attributable to Common Stockholders - Schedule of Basic and Diluted Net Loss per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "us-gaap:ComprehensiveIncomeNetOfTax",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R78": {
     "role": "http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofExcludedAntidilutiveSecuritiesDetails",
     "longName": "9955561 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Schedule of Excluded Anti-dilutive Securities (Details)",
     "shortName": "Net Loss Per Share Attributable to Common Stockholders - Schedule of Excluded Anti-dilutive Securities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R79": {
     "role": "http://camp4tx.com/role/RelatedPartiesDetails",
     "longName": "9955562 - Disclosure - Related Parties (Details)",
     "shortName": "Related Parties (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-119",
      "name": "camp:NumberOfFounders",
      "unitRef": "founder",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "camp-20241231.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "camp_A2024EquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "A2024EquityIncentivePlanMember",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensation2024EquityIncentivePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024 Equity Incentive Plan",
        "label": "2024 Equity Incentive Plan [Member]",
        "documentation": "2024 Equity Incentive Plan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "presentation": [
      "http://camp4tx.com/role/AccruedExpensesandOtherCurrentLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued Expenses and Other Current Liabilities",
        "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]",
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r339"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheets",
      "http://camp4tx.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r659"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://camp4tx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://camp4tx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails",
      "http://camp4tx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other current liabilities",
        "totalLabel": "Total accrued expenses",
        "label": "Accrued Liabilities, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedLiabilitiesCurrentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/PropertyAndEquipmentNetScheduleofPropertyandEquipmentNetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/PropertyAndEquipmentNetScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: accumulated depreciation and amortization",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r128",
      "r481"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r727"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r659",
      "r917"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r530",
      "r807",
      "r808",
      "r809",
      "r810",
      "r864",
      "r920"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r740"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r740"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r740"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r740"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r42",
      "r295"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance costs",
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs",
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r83"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table",
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r785"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r698",
      "r709",
      "r719",
      "r752"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r701",
      "r712",
      "r722",
      "r755"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Pension Adjustments Service Cost",
        "label": "Aggregate Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r786"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r740"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r747"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r702",
      "r713",
      "r723",
      "r747",
      "r756",
      "r760",
      "r768"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r766"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://camp4tx.com/role/RelatedPartiesDetails",
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockbasedCompensationExpenseDetails",
      "http://camp4tx.com/role/StockBasedCompensationStockOptionActivityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense recorded",
        "verboseLabel": "Total stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r327",
      "r337"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofExcludedAntidilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Anti-dilutive securities excluded from diluted earnings per share (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofExcludedAntidilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities [Axis]",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofExcludedAntidilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Loss Per Share Attributable to Common Stockholders",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofExcludedAntidilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_AreaOfLand": {
     "xbrltype": "areaItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AreaOfLand",
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesOperatingLeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Area of lease (approximately)",
        "label": "Area of Land",
        "documentation": "Area of land held."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsBioMarinPharmaceuticalIncNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsChildrensMedicalCenterCorporationNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsEliLillyandCompanyNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsWhiteheadInstituteforBiomedicalResearchNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r384"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r100",
      "r129",
      "r150",
      "r184",
      "r192",
      "r210",
      "r214",
      "r222",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r385",
      "r387",
      "r417",
      "r471",
      "r566",
      "r632",
      "r633",
      "r659",
      "r676",
      "r826",
      "r827",
      "r876"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r134",
      "r150",
      "r222",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r385",
      "r387",
      "r417",
      "r659",
      "r826",
      "r827",
      "r876"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsFairValueDisclosureAbstract",
     "presentation": [
      "http://camp4tx.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Assets, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "camp_AuditInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "AuditInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Audit Information [Abstract]",
        "documentation": "Audit Information"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://camp4tx.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Firm ID",
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r681",
      "r682",
      "r705"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://camp4tx.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Location",
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r681",
      "r682",
      "r705"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://camp4tx.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Name",
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r681",
      "r682",
      "r705"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r763"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r764"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r759"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r759"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r759"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r759"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r759"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r759"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensation2024EmployeeStockPurchasePlanNarrativeDetails",
      "http://camp4tx.com/role/StockBasedCompensationRestrictedStockAwardsNarrativeDetails",
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails",
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsFairValueAssumptionsDetails",
      "http://camp4tx.com/role/StockBasedCompensationStockOptionActivityNarrativeDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r298",
      "r299",
      "r300",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r762"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r761"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r760"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r760"
     ]
    },
    "camp_BioMarinPharmaceuticalInc.Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "BioMarinPharmaceuticalInc.Member",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsBioMarinPharmaceuticalIncNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BioMarin Pharmaceutical, Inc.",
        "label": "BioMarin Pharmaceutical, Inc. [Member]",
        "documentation": "BioMarin Pharmaceutical, Inc."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "crdr": "credit",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchases of property and equipment in accounts payable and accrued expenses",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r19",
      "r20"
     ]
    },
    "camp_CapitalizedResearchAndDevelopmentCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "CapitalizedResearchAndDevelopmentCosts",
     "crdr": "debit",
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalized research and development",
        "label": "Capitalized Research And Development Costs",
        "documentation": "Capitalized Research And Development Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Cash",
     "crdr": "debit",
     "presentation": [
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash",
        "label": "Cash",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r474",
      "r541",
      "r561",
      "r659",
      "r676",
      "r795"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheets",
      "http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentationDetails",
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Unrestricted cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r126",
      "r620"
     ]
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://camp4tx.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash equivalents",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r865",
      "r866"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "presentation": [
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Cash",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r90"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows",
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of year",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "totalLabel": "Total cash, cash equivalents, and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r71",
      "r148"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r71"
     ]
    },
    "camp_CertainExecutivesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "CertainExecutivesMember",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationStockOptionActivityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Certain Executives",
        "label": "Certain Executives [Member]",
        "documentation": "Certain Executives"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r738"
     ]
    },
    "camp_ChildrenMedicalCenterCorporationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "ChildrenMedicalCenterCorporationMember",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsChildrensMedicalCenterCorporationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Children Medical Center Corporation",
        "label": "Children Medical Center Corporation [Member]",
        "documentation": "Children Medical Center Corporation"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year",
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r735"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested",
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r733"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitSummaryofConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Domain]",
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r130",
      "r131",
      "r132",
      "r150",
      "r173",
      "r174",
      "r176",
      "r178",
      "r186",
      "r187",
      "r222",
      "r248",
      "r250",
      "r251",
      "r252",
      "r255",
      "r256",
      "r260",
      "r261",
      "r264",
      "r265",
      "r267",
      "r417",
      "r521",
      "r522",
      "r523",
      "r524",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r542",
      "r553",
      "r575",
      "r597",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r791",
      "r804",
      "r811"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitNarrativeDetails",
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitScheduleofCommonStockIssuanceUponConversionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Preferred Stock and Stockholders' Deficit",
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r131",
      "r132",
      "r186",
      "r260",
      "r261",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r521",
      "r522",
      "r523",
      "r524",
      "r642",
      "r791",
      "r804"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitScheduleofCommonStockIssuanceUponConversionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant outstanding (in shares)",
        "label": "Class of Warrant or Right, Outstanding",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "camp_ClinicalAndPreclinicalExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "ClinicalAndPreclinicalExpenses",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/SegmentReportingDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Clinical and preclinical expenses",
        "label": "Clinical And Preclinical Expenses",
        "documentation": "Clinical And Preclinical Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r739"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r739"
     ]
    },
    "camp_CollaborationAndLicenseAgreementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "CollaborationAndLicenseAgreementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaboration and License Agreements [Abstract]",
        "documentation": "No definition available."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaboration and License Agreements",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r109",
      "r119"
     ]
    },
    "camp_CollaborativeArrangementFeesIncurredDuringPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "CollaborativeArrangementFeesIncurredDuringPeriod",
     "crdr": "debit",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsWhiteheadInstituteforBiomedicalResearchNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fees incurred during period",
        "label": "Collaborative Arrangement, Fees Incurred During Period",
        "documentation": "Collaborative Arrangement, Fees Incurred During Period"
       }
      }
     },
     "auth_ref": []
    },
    "camp_CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation",
     "crdr": "credit",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsChildrensMedicalCenterCorporationNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsWhiteheadInstituteforBiomedicalResearchNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum development milestone payable",
        "label": "Collaborative Arrangement, Maximum Development Milestone Payment Obligation",
        "documentation": "The maximum amount payable upon achievement of development milestone under the collaborative arrangements."
       }
      }
     },
     "auth_ref": []
    },
    "camp_CollaborativeArrangementReductionInResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "CollaborativeArrangementReductionInResearchAndDevelopmentExpense",
     "crdr": "credit",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsEliLillyandCompanyNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reduction in R&amp;D expense",
        "label": "Collaborative Arrangement, Reduction in Research and Development Expense",
        "documentation": "Amount of reduction in research and development expense under the collaborative arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "camp_CollaborativeArrangementTieredRoyaltiesPayableOnNetSalesMaximumLowerRangePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "CollaborativeArrangementTieredRoyaltiesPayableOnNetSalesMaximumLowerRangePercent",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsWhiteheadInstituteforBiomedicalResearchNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum lower range tiered royalties on net sales percentage",
        "label": "Collaborative Arrangement, Tiered Royalties Payable On Net Sales, Maximum Lower Range, Percent",
        "documentation": "The maximum lower range percentage of tiered royalties on net sales under the collaborative arrangements."
       }
      }
     },
     "auth_ref": []
    },
    "camp_CollaborativeArrangementTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale": {
     "xbrltype": "durationItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "CollaborativeArrangementTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsWhiteheadInstituteforBiomedicalResearchNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Period of payment of tiered royalties after first commercial sale",
        "label": "Collaborative Arrangement, Tiered Royalties Payment, Period After First Commercial Sale",
        "documentation": "Period of payment of tiered royalties after first commercial sale under the collaborative arrangements."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsBioMarinPharmaceuticalIncNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsChildrensMedicalCenterCorporationNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsEliLillyandCompanyNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsWhiteheadInstituteforBiomedicalResearchNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement",
        "label": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]",
        "documentation": "Collaborative arrangement transaction between parties to collaborative arrangement."
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "camp_CollaborativeArrangementUpfrontLicenseIssuanceFeePayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "CollaborativeArrangementUpfrontLicenseIssuanceFeePayment",
     "crdr": "credit",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsWhiteheadInstituteforBiomedicalResearchNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial license issuance fee payment",
        "label": "Collaborative Arrangement, Upfront License Issuance Fee Payment",
        "documentation": "Amount of initial payment for license issuance fees under the collaborative arrangements."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsBioMarinPharmaceuticalIncNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsChildrensMedicalCenterCorporationNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsEliLillyandCompanyNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsFulcrumTherapeuticsIncNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsWhiteheadInstituteforBiomedicalResearchNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaboration and License Agreements",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r384"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies (Note 7)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r94",
      "r473",
      "r552"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r242",
      "r243",
      "r613",
      "r821",
      "r823"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "presentation": [
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r614"
     ]
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitScheduleofCommonStockIssuanceUponConversionDetails",
      "http://camp4tx.com/role/StockBasedCompensation2024EmployeeStockPurchasePlanNarrativeDetails",
      "http://camp4tx.com/role/StockBasedCompensation2024EquityIncentivePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Total (in shares)",
        "terseLabel": "Shares reserved for future issuance (in shares)",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockDividendsPerShareDeclared",
     "presentation": [
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock dividends declared (in USD per share)",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit",
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r666",
      "r667",
      "r668",
      "r670",
      "r671",
      "r672",
      "r673",
      "r807",
      "r808",
      "r810",
      "r864",
      "r916",
      "r920"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitNarrativeDetails",
      "http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in USD per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitNarrativeDetails",
      "http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r553"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares issued (in shares)",
        "periodStartLabel": "Balance at beginning (in shares)",
        "periodEndLabel": "Balance at ending (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r60",
      "r553",
      "r572",
      "r920",
      "r921"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, $0.0001 par value per share; 175,000,000 and 210,000,000 shares authorized; 20,161,072 and 1,026,057 shares issued, 20,145,129 and 460,704 shares outstanding as of December\u00a031, 2024 and 2023, respectively",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r475",
      "r659"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r744"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r743"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r745"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r742"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive loss",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r136",
      "r138",
      "r144",
      "r466",
      "r485",
      "r486"
     ]
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "presentation": [
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Comprehensive Loss",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for comprehensive income."
       }
      }
     },
     "auth_ref": []
    },
    "camp_ComputerAndSoftwareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "ComputerAndSoftwareMember",
     "presentation": [
      "http://camp4tx.com/role/PropertyAndEquipmentNetScheduleofPropertyandEquipmentNetDetails",
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesSchedulePropertyandEquipmentNetUsefulLivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Computer and software",
        "label": "Computer And Software [Member]",
        "documentation": "Represents information pertaining to computer and software used in an office setting."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration of Credit Risks",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r111"
     ]
    },
    "camp_ConsultingAgreementsWithExecutiveConsultantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "ConsultingAgreementsWithExecutiveConsultantMember",
     "presentation": [
      "http://camp4tx.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consulting Agreement with Executive Consultant",
        "label": "Consulting Agreements with Executive Consultant [Member]",
        "documentation": "Represents information pertaining to consulting agreement with executive consultant ."
       }
      }
     },
     "auth_ref": []
    },
    "camp_ConsultingAgreementsWithFoundersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "ConsultingAgreementsWithFoundersMember",
     "presentation": [
      "http://camp4tx.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consulting Agreement with Founders",
        "label": "Consulting Agreements with Founders [Member]",
        "documentation": "Represents information pertaining to consulting agreement with founder."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiability",
     "crdr": "credit",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsBioMarinPharmaceuticalIncNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsFulcrumTherapeuticsIncNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Contract with Customer, Liability",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r269",
      "r270",
      "r281"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Contract with Customer, Liability, Current",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r269",
      "r270",
      "r281"
     ]
    },
    "us-gaap_ConversionOfStockAmountConverted1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConversionOfStockAmountConverted1",
     "crdr": "debit",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of convertible preferred stock upon initial public offering",
        "label": "Conversion of Stock, Amount Converted",
        "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r19",
      "r20"
     ]
    },
    "camp_ConvertiblePreferredStockAndStockholdersDeficitAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "ConvertiblePreferredStockAndStockholdersDeficitAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Preferred Stock and Stockholders' Deficit [Abstract]",
        "documentation": "No definition available."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertiblePreferredStockMember",
     "presentation": [
      "http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofExcludedAntidilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of preferred stock",
        "label": "Convertible Preferred Stock [Member]",
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option."
       }
      }
     },
     "auth_ref": [
      "r260",
      "r261",
      "r264",
      "r670",
      "r671",
      "r672",
      "r673"
     ]
    },
    "camp_CorporateExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "CorporateExpenses",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/SegmentReportingDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate expenses",
        "label": "Corporate Expenses",
        "documentation": "Corporate Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsBioMarinPharmaceuticalIncNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsChildrensMedicalCenterCorporationNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsEliLillyandCompanyNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsFulcrumTherapeuticsIncNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsWhiteheadInstituteforBiomedicalResearchNarrativeDetails",
      "http://camp4tx.com/role/StockBasedCompensationStockOptionActivityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Axis]",
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r154",
      "r155",
      "r257",
      "r263",
      "r453",
      "r460",
      "r470",
      "r622",
      "r624"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r690",
      "r779"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r690",
      "r779"
     ]
    },
    "cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Expertise of Management Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r692",
      "r781"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]"
       }
      }
     },
     "auth_ref": [
      "r692",
      "r781"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]"
       }
      }
     },
     "auth_ref": [
      "r694",
      "r783"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r692",
      "r781"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r685",
      "r774"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r686",
      "r775"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r686",
      "r775"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r684",
      "r773"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r684",
      "r773"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]"
       }
      }
     },
     "auth_ref": [
      "r684",
      "r773"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r687",
      "r776"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r689",
      "r778"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r689",
      "r778"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r690",
      "r779"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r693",
      "r782"
     ]
    },
    "cyd_CybersecurityRiskRoleOfManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskRoleOfManagementTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Role of Management [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r691",
      "r780"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r688",
      "r777"
     ]
    },
    "us-gaap_DeferredCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredCosts",
     "crdr": "debit",
     "presentation": [
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred offering costs",
        "label": "Deferred Costs, Noncurrent",
        "documentation": "Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r796"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "camp_DeferredTaxAssetsLiabilitiesGross",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total gross deferred tax liabilities",
        "label": "Deferred Tax Liabilities, Gross",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r55",
      "r93",
      "r361"
     ]
    },
    "camp_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalized Sec. 59 (e ) R&amp;D expenditures",
        "label": "Deferred Tax Assets, Capitalized Research And Development Expenditures",
        "documentation": "Deferred Tax Assets, Capitalized Research And Development Expenditures"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "camp_DeferredTaxAssetsLiabilitiesGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total gross deferred tax assets",
        "label": "Deferred Tax Assets, Gross",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r362"
     ]
    },
    "us-gaap_DeferredTaxAssetsGrossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsGrossAbstract",
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets:",
        "label": "Deferred Tax Assets, Gross [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalized R&amp;D costs",
        "label": "Deferred Tax Asset, In-Process Research and Development",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from in-process research and development cost acquired in business combination or from joint venture formation or both."
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "camp_DeferredTaxAssetsLeasingArrangements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "DeferredTaxAssetsLeasingArrangements",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Deferred Tax Assets, Leasing Arrangements",
        "documentation": "Deferred Tax Assets, Leasing Arrangements"
       }
      }
     },
     "auth_ref": []
    },
    "camp_DeferredTaxAssetsLiabilitiesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "DeferredTaxAssetsLiabilitiesGross",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net deferred tax assets",
        "label": "Deferred Tax Assets (Liabilities), Gross",
        "documentation": "Deferred Tax Assets (Liabilities), Gross"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net deferred tax assets",
        "label": "Deferred Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r860"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NOLs",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Deferred Tax Assets, Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "R&amp;D credits",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Valuation allowance",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r363"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesAbstract",
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liabilities:",
        "label": "Deferred Tax Liabilities, Gross [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Operating lease ROU assets",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements."
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "us-gaap_DefinedContributionPlanAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Contribution Plan [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanCostRecognized",
     "crdr": "debit",
     "presentation": [
      "http://camp4tx.com/role/EmployeeBenefitPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contributions made",
        "label": "Defined Contribution Plan, Cost",
        "documentation": "Amount of cost for defined contribution plan."
       }
      }
     },
     "auth_ref": [
      "r291"
     ]
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "presentation": [
      "http://camp4tx.com/role/EmployeeBenefitPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employer contribution percentage",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
     "presentation": [
      "http://camp4tx.com/role/EmployeeBenefitPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company matching percentage of employee contributions",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match",
        "documentation": "Percentage employer matches of the employee's percentage contribution matched."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
     "presentation": [
      "http://camp4tx.com/role/EmployeeBenefitPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee contribution percentage",
        "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent",
        "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanTextBlock",
     "presentation": [
      "http://camp4tx.com/role/EmployeeBenefitPlan"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Benefit Plan",
        "label": "Defined Contribution Plan [Text Block]",
        "documentation": "The entire disclosure for defined contribution plan."
       }
      }
     },
     "auth_ref": [
      "r290",
      "r291"
     ]
    },
    "us-gaap_DepositsAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepositsAssets",
     "crdr": "debit",
     "presentation": [
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security deposits",
        "label": "Deposits Assets",
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future."
       }
      }
     },
     "auth_ref": [
      "r796"
     ]
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "presentation": [
      "http://camp4tx.com/role/PropertyAndEquipmentNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization expense",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r29"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r184",
      "r197",
      "r214",
      "r632",
      "r633"
     ]
    },
    "camp_DescriptionOfBusinessAndBasisOfPresentationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "DescriptionOfBusinessAndBasisOfPresentationLineItems",
     "presentation": [
      "http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Description of Business and Basis of Presentation",
        "label": "Description of Business and Basis of Presentation [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "camp_DescriptionOfBusinessAndBasisOfPresentationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "DescriptionOfBusinessAndBasisOfPresentationTable",
     "presentation": [
      "http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Description of Business and Basis of Presentation [Table]",
        "label": "Description of Business and Basis of Presentation [Table]",
        "documentation": "Disclosure of information about description of business and basis of presentation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r293",
      "r297",
      "r328",
      "r329",
      "r331",
      "r648"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Annual Report",
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r681",
      "r682",
      "r705"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Financial Statement Error Correction [Flag]",
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r681",
      "r682",
      "r705",
      "r748"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r726"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Documents Incorporated by Reference [Text Block]",
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r679"
     ]
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Domestic Jurisdiction",
        "label": "Domestic Tax Jurisdiction [Member]",
        "documentation": "Designated federal jurisdiction entitled to levy and collect income tax in country of domicile. Includes, but is not limited to, national jurisdiction for non-U.S. jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r347"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year",
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r737"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofBasicandDilutedNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per share attributable to common stockholders, basic, (in USD per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r171",
      "r173",
      "r176",
      "r177",
      "r178",
      "r183",
      "r380",
      "r383",
      "r396",
      "r397",
      "r467",
      "r487",
      "r625"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofBasicandDilutedNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per share attributable to common stockholders, diluted, (in USD per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r173",
      "r176",
      "r177",
      "r178",
      "r183",
      "r380",
      "r383",
      "r396",
      "r397",
      "r467",
      "r487",
      "r625"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Loss Per Share Attributable to Common Stockholders",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r22",
      "r180"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholders"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Loss Per Share Attributable to Common Stockholders",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r179",
      "r181",
      "r182"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "calculation": {
      "http://camp4tx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesNarrativeDetails",
      "http://camp4tx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective tax rate",
        "totalLabel": "Effective income tax rate",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r347",
      "r651"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "calculation": {
      "http://camp4tx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax computed at federal statutory rate",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r347",
      "r371",
      "r651"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "calculation": {
      "http://camp4tx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation allowance",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r352",
      "r651",
      "r806",
      "r858"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "calculation": {
      "http://camp4tx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign rate differential",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile."
       }
      }
     },
     "auth_ref": [
      "r348",
      "r351",
      "r651",
      "r806",
      "r858"
     ]
    },
    "camp_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent",
     "calculation": {
      "http://camp4tx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Permanent differences",
        "label": "Effective Income Tax Rate Reconciliation, Permanent Differences, Percent",
        "documentation": "Effective Income Tax Rate Reconciliation, Permanent Differences, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "calculation": {
      "http://camp4tx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State taxes, net of federal benefit",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r350",
      "r651",
      "r806",
      "r858"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
     "calculation": {
      "http://camp4tx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "R&amp;D credit",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit."
       }
      }
     },
     "auth_ref": [
      "r651",
      "r806",
      "r858",
      "r859"
     ]
    },
    "camp_EliLillyAndCompanyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "EliLillyAndCompanyMember",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsEliLillyandCompanyNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Eli Lilly And Company",
        "label": "Eli Lilly And Company [Member]",
        "documentation": "Eli Lilly And Company"
       }
      }
     },
     "auth_ref": []
    },
    "camp_EmergingGrowthCompanyStatusPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "EmergingGrowthCompanyStatusPolicyTextBlock",
     "presentation": [
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Emerging Growth Company Status",
        "label": "Emerging Growth Company Status [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for emerging growth company status."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee compensation and benefits",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "crdr": "debit",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationStockOptionActivityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount of gross unrecognized stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r330"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationRestrictedStockAwardsNarrativeDetails",
      "http://camp4tx.com/role/StockBasedCompensationStockOptionActivityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average period over which unrecognized stock-based compensation expense to be recognized (in years)",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r330"
     ]
    },
    "us-gaap_EmployeeStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockMember",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensation2024EmployeeStockPurchasePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock",
        "label": "Employee Stock [Member]",
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofExcludedAntidilutiveSecuritiesDetails",
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails",
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsFairValueAssumptionsDetails",
      "http://camp4tx.com/role/StockBasedCompensationStockOptionActivityNarrativeDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Options to purchase common stock",
        "terseLabel": "Stock options outstanding",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Three",
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r678"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r678"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Ex Transition Period",
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r790"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r678"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r788"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Public Float",
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r678"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r678"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r678"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r678"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Voluntary Filers",
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Well-known Seasoned Issuer",
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r789"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Footnote",
        "label": "Equity Awards Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r731"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table",
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r784"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments",
        "label": "Equity Awards Adjustments [Member]"
       }
      }
     },
     "auth_ref": [
      "r784"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table",
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r784"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityAbstract",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity [Abstract]",
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit",
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r121",
      "r140",
      "r141",
      "r142",
      "r156",
      "r157",
      "r158",
      "r160",
      "r165",
      "r167",
      "r169",
      "r185",
      "r223",
      "r224",
      "r235",
      "r268",
      "r369",
      "r370",
      "r377",
      "r378",
      "r379",
      "r381",
      "r382",
      "r383",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r446",
      "r484",
      "r511",
      "r512",
      "r513",
      "r530",
      "r597"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r741"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r698",
      "r709",
      "r719",
      "r752"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r695",
      "r706",
      "r716",
      "r749"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r747"
     ]
    },
    "camp_FacilitiesAndOverheadExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "FacilitiesAndOverheadExpense",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/SegmentReportingDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Facilities-related and overhead",
        "label": "Facilities And Overhead Expense",
        "documentation": "Facilities And Overhead Expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://camp4tx.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r399",
      "r400",
      "r410",
      "r652"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://camp4tx.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r399",
      "r400",
      "r410",
      "r652"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "presentation": [
      "http://camp4tx.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Assets Measured for Fair Value on a Recurring Basis",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r865",
      "r866"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://camp4tx.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r398",
      "r400",
      "r401",
      "r402",
      "r403",
      "r409",
      "r410",
      "r412",
      "r455",
      "r456",
      "r457",
      "r640",
      "r641",
      "r644",
      "r645",
      "r646",
      "r652",
      "r654"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://camp4tx.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Axis]",
        "label": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r399",
      "r400",
      "r401",
      "r403",
      "r652",
      "r868",
      "r870"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://camp4tx.com/role/FairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r405",
      "r407",
      "r408",
      "r409",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r465",
      "r652",
      "r655"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://camp4tx.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r283",
      "r288",
      "r400",
      "r410",
      "r455",
      "r644",
      "r645",
      "r646",
      "r652"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://camp4tx.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r283",
      "r288",
      "r400",
      "r401",
      "r410",
      "r456",
      "r640",
      "r641",
      "r644",
      "r645",
      "r646",
      "r652"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://camp4tx.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 3",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r400",
      "r401",
      "r402",
      "r403",
      "r410",
      "r457",
      "r640",
      "r641",
      "r644",
      "r645",
      "r646",
      "r652",
      "r654"
     ]
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://camp4tx.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Domain]",
        "label": "Measurement Frequency [Domain]",
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r399",
      "r400",
      "r401",
      "r403",
      "r652",
      "r868",
      "r870"
     ]
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://camp4tx.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r398",
      "r400",
      "r401",
      "r402",
      "r403",
      "r409",
      "r410",
      "r412",
      "r455",
      "r456",
      "r457",
      "r640",
      "r641",
      "r644",
      "r645",
      "r646",
      "r652",
      "r654"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://camp4tx.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recurring basis",
        "label": "Fair Value, Recurring [Member]",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r652",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870"
     ]
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseInterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofFinanceLeaseCostandOtherInformationDetails": {
       "parentTag": "camp_LeaseCostFinanceLeases",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofFinanceLeaseCostandOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest on lease liabilities",
        "label": "Finance Lease, Interest Expense",
        "documentation": "Amount of interest expense on finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r429",
      "r435",
      "r658"
     ]
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "crdr": "credit",
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofFinanceLeaseCostandOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating cash flows used for finance leases",
        "label": "Finance Lease, Interest Payment on Liability",
        "documentation": "Amount of interest paid on finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r431",
      "r439"
     ]
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofFinanceLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maturity of finance lease liabilities",
        "label": "Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofFinanceLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total future minimum lease obligations",
        "label": "Finance Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease."
       }
      }
     },
     "auth_ref": [
      "r428",
      "r443"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesFinanceLeasesNarrativeDetails",
      "http://camp4tx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease liabilities, current portion",
        "label": "Finance Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r428"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Maturities of Finance Lease Liabilities",
        "label": "Finance Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r874"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesFinanceLeasesNarrativeDetails",
      "http://camp4tx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease liabilities, net of current portion",
        "label": "Finance Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r428"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofFinanceLeaseLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofFinanceLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total lease payment",
        "label": "Finance Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease."
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofFinanceLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofFinanceLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofFinanceLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofFinanceLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofFinanceLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofFinanceLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofFinanceLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: amount representing imputed interest",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease."
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeasePrincipalPayments",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Principal payments on finance leases",
        "label": "Finance Lease, Principal Payments",
        "documentation": "Amount of cash outflow for principal payment on finance lease."
       }
      }
     },
     "auth_ref": [
      "r430",
      "r439"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesFinanceLeasesNarrativeDetails",
      "http://camp4tx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease right-of-use assets",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r427"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseRightOfUseAssetAccumulatedAmortization",
     "crdr": "credit",
     "presentation": [
      "http://camp4tx.com/role/PropertyAndEquipmentNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease right-of-use asset accumulated depreciation",
        "label": "Finance Lease, Right-of-Use Asset, Accumulated Amortization",
        "documentation": "Amount of accumulated amortization of right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r793",
      "r794"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofFinanceLeaseCostandOtherInformationDetails": {
       "parentTag": "camp_LeaseCostFinanceLeases",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofFinanceLeaseCostandOtherInformationDetails",
      "http://camp4tx.com/role/PropertyAndEquipmentNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of ROU assets",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r429",
      "r435",
      "r658"
     ]
    },
    "camp_FinanceLeaseRightOfUseAssetConvertedToFixedAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "FinanceLeaseRightOfUseAssetConvertedToFixedAsset",
     "crdr": "debit",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease right-of-use asset converted to fixed asset",
        "label": "Finance Lease Right-Of-Use Asset Converted To Fixed Asset",
        "documentation": "Finance Lease Right-Of-Use Asset Converted To Fixed Asset"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofFinanceLeaseCostandOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average incremental borrowing rate",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for finance lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r442",
      "r658"
     ]
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofFinanceLeaseCostandOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average remaining lease term in years",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r441",
      "r658"
     ]
    },
    "camp_FinanceLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "FinanceLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing liability, current portion",
        "label": "Finance Liability, Current",
        "documentation": "The amount of financing liability classified as current."
       }
      }
     },
     "auth_ref": []
    },
    "camp_FinanceLiabilityNonCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "FinanceLiabilityNonCurrent",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing liability, net of current portion",
        "label": "Finance Liability, Non-current",
        "documentation": "The amount of financing liability classified as non-current."
       }
      }
     },
     "auth_ref": []
    },
    "camp_FinancingObligationFailedSaleLeasebackPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "FinancingObligationFailedSaleLeasebackPolicyTextBlock",
     "presentation": [
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing Obligation (Failed Sale-Leaseback)",
        "label": "Financing Obligation Failed Sale-Leaseback [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for transactions involving the sale of property to another party and a lease of the property back to the seller."
       }
      }
     },
     "auth_ref": []
    },
    "camp_FinancingObligationsLeaseFixedRepurchasePrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "FinancingObligationsLeaseFixedRepurchasePrice",
     "crdr": "credit",
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesFinancingObligationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed repurchase price",
        "label": "Financing Obligations, Lease, Fixed Repurchase Price",
        "documentation": "The amount of repurchase option available for lease under financing obligations."
       }
      }
     },
     "auth_ref": []
    },
    "camp_FinancingObligationsLeaseMaximumInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "FinancingObligationsLeaseMaximumInterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesFinancingObligationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum interest expense",
        "label": "Financing Obligations, Lease, Maximum Interest Expense",
        "documentation": "Amount of maximum interest expense of lease under the financing obligations recorded during the period."
       }
      }
     },
     "auth_ref": []
    },
    "camp_FinancingObligationsLeaseMaximumMonthlyRentalPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "FinancingObligationsLeaseMaximumMonthlyRentalPayments",
     "crdr": "credit",
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesFinancingObligationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum monthly rental payments",
        "label": "Financing Obligations, Lease, Maximum Monthly Rental Payments",
        "documentation": "The amount of maximum monthly rental payments of lease under the financing obligations."
       }
      }
     },
     "auth_ref": []
    },
    "camp_FinancingObligationsLeaseMonthlyInterestRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "FinancingObligationsLeaseMonthlyInterestRatePercent",
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesFinancingObligationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Monthly interest rate",
        "label": "Financing Obligations, Lease, Monthly Interest Rate, Percent",
        "documentation": "Monthly interest rate on lease entered under a financing obligations."
       }
      }
     },
     "auth_ref": []
    },
    "camp_FinancingObligationsLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "FinancingObligationsLeaseTermOfContract",
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesFinancingObligationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease term",
        "label": "Financing Obligations, Lease, Term Of Contract",
        "documentation": "Term of lease under a financing obligations expressed in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Currency Remeasurement",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r418"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r702",
      "r713",
      "r723",
      "r756"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r702",
      "r713",
      "r723",
      "r756"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r702",
      "r713",
      "r723",
      "r756"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r702",
      "r713",
      "r723",
      "r756"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r702",
      "r713",
      "r723",
      "r756"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year",
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r736"
     ]
    },
    "camp_FulcrumTherapeuticsInc.Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "FulcrumTherapeuticsInc.Member",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsFulcrumTherapeuticsIncNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fulcrum Therapeutics, Inc.",
        "label": "Fulcrum Therapeutics, Inc. [Member]",
        "documentation": "Fulcrum Therapeutics, Inc."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://camp4tx.com/role/PropertyAndEquipmentNetScheduleofPropertyandEquipmentNetDetails",
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesSchedulePropertyandEquipmentNetUsefulLivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Furniture and fixtures",
        "label": "Furniture and Fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://camp4tx.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r577"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "G&amp;A",
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "camp_GuaranteesAndIndemnificationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "GuaranteesAndIndemnificationsPolicyTextBlock",
     "presentation": [
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Guarantees and Indemnifications",
        "label": "Guarantees And Indemnifications [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for guarantees and indemnifications"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IPOMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IPOMember",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit",
      "http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial public offering",
        "label": "IPO [Member]",
        "documentation": "First sale of stock by a private company to the public."
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ICFR Auditor Attestation Flag",
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r681",
      "r682",
      "r705"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of Long-Lived Assets",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r78"
     ]
    },
    "us-gaap_IncentiveFromLessor": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncentiveFromLessor",
     "crdr": "credit",
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesOperatingLeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease incentive received",
        "label": "Incentive from Lessor",
        "documentation": "Amount of incentive received by lessee from lessor."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r102",
      "r103",
      "r792"
     ]
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Income Location, Balance [Axis]",
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r236",
      "r238",
      "r239",
      "r404",
      "r406",
      "r411",
      "r508",
      "r510",
      "r582",
      "r617",
      "r653",
      "r887"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Income Location, Balance [Domain]",
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r238",
      "r239",
      "r404",
      "r406",
      "r411",
      "r508",
      "r510",
      "r582",
      "r617",
      "r653",
      "r887"
     ]
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Jurisdiction [Axis]",
        "label": "Income Tax Jurisdiction [Axis]",
        "documentation": "Information by income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r347",
      "r348",
      "r356",
      "r366",
      "r651",
      "r861"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Jurisdiction [Domain]",
        "label": "Income Tax Jurisdiction [Domain]",
        "documentation": "Income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r347",
      "r348",
      "r356",
      "r366",
      "r651",
      "r861"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r342",
      "r347",
      "r353",
      "r354",
      "r355",
      "r358",
      "r365",
      "r372",
      "r374",
      "r375",
      "r376",
      "r526",
      "r651"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax expense",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r117",
      "r168",
      "r169",
      "r184",
      "r200",
      "r214",
      "r346",
      "r347",
      "r373",
      "r488",
      "r651"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r344",
      "r345",
      "r358",
      "r359",
      "r364",
      "r368",
      "r520"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other liabilities",
        "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities",
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other."
       }
      }
     },
     "auth_ref": [
      "r802"
     ]
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r462",
      "r802"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "camp_IncreaseDecreaseInOperatingLeaseAssetsLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "IncreaseDecreaseInOperatingLeaseAssetsLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Operating lease assets and liabilities",
        "label": "Increase Decrease In Operating Lease Assets (Liabilities)",
        "documentation": "The increase (decrease) during the reporting period in the assets (liabilities) created through operating leases."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other current assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in Stockholders' Deficit",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in Convertible Preferred Stock",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r702",
      "r713",
      "r723",
      "r747",
      "r756",
      "r760",
      "r768"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r766"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r683",
      "r772"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r683",
      "r772"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r683",
      "r772"
     ]
    },
    "us-gaap_InvestmentIncomeInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentIncomeInterest",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Investment Income, Interest",
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r195",
      "r214",
      "r632",
      "r801"
     ]
    },
    "us-gaap_LaborAndRelatedExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LaborAndRelatedExpense",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/SegmentReportingDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Personnel-related expenses",
        "label": "Labor and Related Expense",
        "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit."
       }
      }
     },
     "auth_ref": [
      "r800"
     ]
    },
    "camp_LaboratoryEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "LaboratoryEquipmentMember",
     "presentation": [
      "http://camp4tx.com/role/PropertyAndEquipmentNetNarrativeDetails",
      "http://camp4tx.com/role/PropertyAndEquipmentNetScheduleofPropertyandEquipmentNetDetails",
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesSchedulePropertyandEquipmentNetUsefulLivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Laboratory equipment",
        "label": "Laboratory Equipment [Member]",
        "documentation": "Represents information pertaining to laboratory equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCostAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCostAbstract",
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofFinanceLeaseCostandOtherInformationDetails",
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofOperatingLeaseCostsandOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease cost",
        "verboseLabel": "Finance lease costs:",
        "label": "Lease, Cost [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "camp_LeaseCostExcludingFinanceLeases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "LeaseCostExcludingFinanceLeases",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofOperatingLeaseCostsandOtherInformationDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofOperatingLeaseCostsandOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total lease cost",
        "label": "Lease Cost, Excluding Finance Leases",
        "documentation": "Lease Cost, Excluding Finance Leases"
       }
      }
     },
     "auth_ref": []
    },
    "camp_LeaseCostFinanceLeases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "LeaseCostFinanceLeases",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofFinanceLeaseCostandOtherInformationDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofFinanceLeaseCostandOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total finance lease cost",
        "label": "Lease Cost, Finance Leases",
        "documentation": "Lease Cost, Finance Leases"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Lease Costs and Other Information",
        "label": "Lease, Cost [Table Text Block]",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://camp4tx.com/role/PropertyAndEquipmentNetScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold Improvements",
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r444"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesOperatingLeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Leases",
        "label": "Lessee, Lease, Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r434",
      "r445"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeaseDescriptionTable",
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesOperatingLeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Table]",
        "label": "Lessee, Lease, Description [Table]",
        "documentation": "Disclosure of information about lessee's leases."
       }
      }
     },
     "auth_ref": [
      "r434",
      "r445"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r433"
     ]
    },
    "camp_LesseeOperatingLeaseIncrementalBorrowingRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "LesseeOperatingLeaseIncrementalBorrowingRate",
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesOperatingLeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Incremental borrowing rate used for lease",
        "label": "Lessee, Operating Lease, Incremental Borrowing Rate",
        "documentation": "Lessee, Operating Lease, Incremental Borrowing Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Maturities of Operating Lease Liabilities",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r874"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total lease payment",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: amount representing imputed interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseTermOfContract",
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesOperatingLeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term of lease",
        "label": "Lessee, Operating Lease, Term of Contract",
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r872"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Other long-term liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r56",
      "r150",
      "r222",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r386",
      "r387",
      "r388",
      "r417",
      "r551",
      "r626",
      "r676",
      "r826",
      "r876",
      "r877"
     ]
    },
    "us-gaap_LiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAbstract",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities [Abstract]",
        "label": "Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities, convertible preferred stock and stockholders\u2019 equity (deficit)",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r95",
      "r478",
      "r659",
      "r805",
      "r819",
      "r871"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities, Convertible Preferred Stock and Stockholders\u2019 Equity (Deficit)",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r125",
      "r150",
      "r222",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r386",
      "r387",
      "r388",
      "r417",
      "r659",
      "r826",
      "r876",
      "r877"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities:",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term liabilities:",
        "label": "Liabilities, Noncurrent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "camp_MarauderTherapeuticsInc2016StockOptionAndGrantPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "MarauderTherapeuticsInc2016StockOptionAndGrantPlanMember",
     "presentation": [
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitScheduleofCommonStockIssuanceUponConversionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2016 Stock Incentive Plan",
        "label": "Marauder Therapeutics Inc 2016 Stock Option and Grant Plan [Member]",
        "documentation": "Represents the information pertaining to Marauder Therapeutics, Inc. 2016 Stock Option and Grant Plan."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsBioMarinPharmaceuticalIncNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsEliLillyandCompanyNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsFulcrumTherapeuticsIncNarrativeDetails",
      "http://camp4tx.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r244",
      "r245",
      "r246",
      "r247",
      "r292",
      "r338",
      "r403",
      "r461",
      "r507",
      "r509",
      "r516",
      "r543",
      "r544",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r615",
      "r616",
      "r637",
      "r642",
      "r647",
      "r654",
      "r655",
      "r656",
      "r657",
      "r661",
      "r828",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883"
     ]
    },
    "camp_MaximumReimbursableIncentiveFromLessor": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "MaximumReimbursableIncentiveFromLessor",
     "crdr": "credit",
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesOperatingLeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum lease incentive reimbursable",
        "label": "Maximum Reimbursable Incentive From Lessor",
        "documentation": "Maximum amount of lease incentive reimbursable by lessor to lessee."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r739"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r739"
     ]
    },
    "camp_MilestoneTargetsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "MilestoneTargetsAxis",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsChildrensMedicalCenterCorporationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Milestone Targets [Axis]",
        "label": "Milestone Targets [Axis]",
        "documentation": "Milestone Targets"
       }
      }
     },
     "auth_ref": []
    },
    "camp_MilestoneTargetsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "MilestoneTargetsDomain",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsChildrensMedicalCenterCorporationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Milestone Targets [Domain]",
        "label": "Milestone Targets [Domain]",
        "documentation": "Milestone Targets [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsBioMarinPharmaceuticalIncNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsFulcrumTherapeuticsIncNarrativeDetails",
      "http://camp4tx.com/role/StockBasedCompensation2024EquityIncentivePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r244",
      "r245",
      "r246",
      "r247",
      "r292",
      "r338",
      "r403",
      "r461",
      "r507",
      "r509",
      "r516",
      "r543",
      "r544",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r615",
      "r616",
      "r637",
      "r642",
      "r647",
      "r654",
      "r655",
      "r656",
      "r661",
      "r828",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r759"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r767"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r740"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing Activities",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investing Activities",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows",
      "http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "negatedLabel": "Cash flows from operations",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r72",
      "r73"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Activities",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      },
      "http://camp4tx.com/role/SegmentReportingDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows",
      "http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit",
      "http://camp4tx.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentationDetails",
      "http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofBasicandDilutedNetLossperShareDetails",
      "http://camp4tx.com/role/SegmentReportingDetails",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss attributable to common stockholders",
        "terseLabel": "Net loss",
        "negatedLabel": "Net loss",
        "verboseLabel": "Net loss attributable to common stockholders",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r73",
      "r96",
      "r123",
      "r135",
      "r137",
      "r142",
      "r150",
      "r159",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r168",
      "r169",
      "r175",
      "r222",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r380",
      "r383",
      "r397",
      "r417",
      "r483",
      "r574",
      "r595",
      "r596",
      "r674",
      "r826"
     ]
    },
    "us-gaap_NetIncomeLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAbstract",
     "presentation": [
      "http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofBasicandDilutedNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Numerator:",
        "label": "Net Income (Loss) Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recently Adopted Accounting Pronouncements and Recently Issued Accounting Standards",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r739"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r702",
      "r713",
      "r723",
      "r747",
      "r756"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r730"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r729"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r747"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r767"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r767"
     ]
    },
    "camp_NoncashLeaseExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "NoncashLeaseExpense",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash lease expense",
        "label": "Noncash Lease Expense",
        "documentation": "The total noncash lease expenses incurred by the entity during the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://camp4tx.com/role/SegmentReportingDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://camp4tx.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other income, net",
        "terseLabel": "Plus: Other segment income",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income, net:",
        "label": "Nonoperating Income (Expense) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "camp_NumberOfFounders": {
     "xbrltype": "integerItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "NumberOfFounders",
     "presentation": [
      "http://camp4tx.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of founders",
        "label": "Number Of Founders",
        "documentation": "Number of founders."
       }
      }
     },
     "auth_ref": []
    },
    "camp_NumberOfMajorFinancialInstitutionsWithCashAndCashEquivalentDeposits": {
     "xbrltype": "integerItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "NumberOfMajorFinancialInstitutionsWithCashAndCashEquivalentDeposits",
     "presentation": [
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of major financial institutions with cash and cash equivalent deposits",
        "label": "Number Of Major Financial Institutions With Cash And Cash Equivalent Deposits",
        "documentation": "Number Of Major Financial Institutions With Cash And Cash Equivalent Deposits"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://camp4tx.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of operating segments",
        "label": "Number of Operating Segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r633",
      "r814"
     ]
    },
    "camp_NumberOfVotesPerCommonShare": {
     "xbrltype": "integerItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "NumberOfVotesPerCommonShare",
     "presentation": [
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of votes per common share",
        "label": "Number Of Votes Per Common Share",
        "documentation": "Number Of Votes Per Common Share"
       }
      }
     },
     "auth_ref": []
    },
    "camp_OfferingCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "OfferingCostsPolicyTextBlock",
     "presentation": [
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offering Costs",
        "label": "Offering Costs [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for offering costs."
       }
      }
     },
     "auth_ref": []
    },
    "camp_OfficeAndLaboratorySpaceInBoulderMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "OfficeAndLaboratorySpaceInBoulderMember",
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesOperatingLeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Office and lab space in Boulder, Colorado",
        "label": "Office And Laboratory Space In Boulder [Member]",
        "documentation": "Represents information pertaining to lease of office and laboratory space in Boulder."
       }
      }
     },
     "auth_ref": []
    },
    "camp_OfficeAndLaboratorySpaceInCambridgeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "OfficeAndLaboratorySpaceInCambridgeMember",
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesOperatingLeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Office space and laboratory space in Cambridge, Massachusetts",
        "label": "Office And Laboratory Space In Cambridge [Member]",
        "documentation": "Represents information pertaining to lease of office and laboratory space in Cambridge."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r627",
      "r813",
      "r815",
      "r816",
      "r817",
      "r818"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofOperatingLeaseCostsandOtherInformationDetails": {
       "parentTag": "camp_LeaseCostExcludingFinanceLeases",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofOperatingLeaseCostsandOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease cost",
        "label": "Operating Lease, Cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r436",
      "r658"
     ]
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maturity of operating lease liabilities",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Total future minimum lease obligations",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r428"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesOperatingLeasesNarrativeDetails",
      "http://camp4tx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities, current portion",
        "verboseLabel": "Current operating lease liabilities",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r428"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesOperatingLeasesNarrativeDetails",
      "http://camp4tx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities, net of current portion",
        "verboseLabel": "Non-current operating lease liabilities",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r428"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofOperatingLeaseCostsandOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating cash flows used for operating leases",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r432",
      "r439"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesOperatingLeasesNarrativeDetails",
      "http://camp4tx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r427"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofOperatingLeaseCostsandOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average incremental borrowing rate",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r442",
      "r658"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofOperatingLeaseCostsandOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average remaining lease term (in years)",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r441",
      "r658"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NOL carryforwards",
        "label": "Operating Loss Carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r367"
     ]
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwardsLineItems",
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Loss Carryforwards [Line Items]",
        "label": "Operating Loss Carryforwards [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r367"
     ]
    },
    "camp_OperatingLossCarryforwardsNotSubjectToExpiration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "OperatingLossCarryforwardsNotSubjectToExpiration",
     "crdr": "debit",
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NOL carryforwards, not subject to expiration",
        "label": "Operating Loss Carryforwards, Not Subject To Expiration",
        "documentation": "Operating Loss Carryforwards, Not Subject To Expiration"
       }
      }
     },
     "auth_ref": []
    },
    "camp_OperatingLossCarryforwardsSubjectToExpiration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "OperatingLossCarryforwardsSubjectToExpiration",
     "crdr": "debit",
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NOL carryforwards, subject to expiration",
        "label": "Operating Loss Carryforwards, Subject To Expiration",
        "documentation": "Operating Loss Carryforwards, Subject To Expiration"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwardsTable",
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Loss Carryforwards [Table]",
        "label": "Operating Loss Carryforwards [Table]",
        "documentation": "Disclosure of information about operating loss carryforward. Includes, but is not limited to, tax authority, amount and expiration date of operating loss carryforward, and likelihood of utilization."
       }
      }
     },
     "auth_ref": [
      "r367"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Description of Business and Basis of Presentation",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r89",
      "r517",
      "r518"
     ]
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Accrued Liabilities, Current",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_OtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Assets, Current",
        "documentation": "Amount of current assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r659"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other long-term liabilities",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "us-gaap_OtherNonoperatingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingExpense",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other expense",
        "label": "Other Nonoperating Expense",
        "documentation": "Amount of expense related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r739"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r700",
      "r711",
      "r721",
      "r754"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r703",
      "r714",
      "r724",
      "r757"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r703",
      "r714",
      "r724",
      "r757"
     ]
    },
    "us-gaap_OverAllotmentOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OverAllotmentOptionMember",
     "presentation": [
      "http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Over allotment",
        "label": "Over-Allotment Option [Member]",
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaidInKindInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaidInKindInterest",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash interest expense",
        "label": "Paid-in-Kind Interest",
        "documentation": "Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "camp_PatentCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "PatentCostsPolicyTextBlock",
     "presentation": [
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Patent Costs",
        "label": "Patent Costs [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for patent costs."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r728"
     ]
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows",
      "http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments of deferred offering costs",
        "terseLabel": "Issuance costs",
        "label": "Payments of Stock Issuance Costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "camp_PaymentsOfUnderwritingDiscountsAndCommissions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "PaymentsOfUnderwritingDiscountsAndCommissions",
     "crdr": "credit",
     "presentation": [
      "http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments of underwriting discounts and commissions",
        "label": "Payments Of Underwriting Discounts And Commissions",
        "documentation": "Payments Of Underwriting Discounts And Commissions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r738"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r738"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r730"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r747"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r740"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r729"
     ]
    },
    "camp_PercentageOfUpfrontPaymentRequiredUponFirstInvestigationalNewDrugStudy": {
     "xbrltype": "percentItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "PercentageOfUpfrontPaymentRequiredUponFirstInvestigationalNewDrugStudy",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsChildrensMedicalCenterCorporationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of upfront payment required upon first investigational new drug study",
        "label": "Percentage Of Upfront Payment Required Upon First Investigational New Drug Study",
        "documentation": "Percentage Of Upfront Payment Required Upon First Investigational New Drug Study"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitScheduleofCommonStockIssuanceUponConversionDetails",
      "http://camp4tx.com/role/StockBasedCompensation2024EquityIncentivePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Axis]",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitScheduleofCommonStockIssuanceUponConversionDetails",
      "http://camp4tx.com/role/StockBasedCompensation2024EquityIncentivePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Domain]",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Prior Service Cost",
        "label": "Pension Adjustments Prior Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r731"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Service Cost",
        "label": "Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r787"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Benefits Adjustments, Footnote",
        "label": "Pension Benefits Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r730"
     ]
    },
    "us-gaap_PreferredStockConvertibleSharesIssuable": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockConvertibleSharesIssuable",
     "presentation": [
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitSummaryofConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issuable upon conversion (in shares)",
        "label": "Preferred Stock, Convertible, Shares Issuable",
        "documentation": "Number of common shares issuable upon conversion of preferred stock."
       }
      }
     },
     "auth_ref": [
      "r262"
     ]
    },
    "us-gaap_PreferredStockDividendsPerShareDeclared": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockDividendsPerShareDeclared",
     "presentation": [
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock dividends declared (in USD per share)",
        "label": "Preferred Stock, Dividends Per Share, Declared",
        "documentation": "Aggregate dividends declared during the period for each share of preferred stock outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitNarrativeDetails",
      "http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock par value (in USD per share)",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r260"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitNarrativeDetails",
      "http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares authorized (in shares)",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r553"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock outstanding (in shares)",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r553",
      "r572",
      "r920",
      "r921"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheets",
      "http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Prepaid expenses and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r799"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "camp_PrepaidExpensesAndOtherCurrentAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "PrepaidExpensesAndOtherCurrentAssetsDisclosureTextBlock",
     "presentation": [
      "http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid Expenses and Other Current Assets",
        "label": "Prepaid Expenses And Other Current Assets Disclosure [Text Block]",
        "documentation": "The entire disclosure of prepaid expenses and other current assets."
       }
      }
     },
     "auth_ref": []
    },
    "camp_PrepaidFederalResearchAndDevelopmentTaxCreditCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "PrepaidFederalResearchAndDevelopmentTaxCreditCurrent",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal R&amp;D tax credit receivable",
        "label": "Prepaid Federal Research And Development Tax Credit, Current",
        "documentation": "Amount of federal research and development tax credit that is receivable within one year or normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidInsurance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidInsurance",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid Insurance",
        "label": "Prepaid Insurance",
        "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r621",
      "r638",
      "r820"
     ]
    },
    "camp_PrepaidResearchAndDevelopmentExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "PrepaidResearchAndDevelopmentExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "R&amp;D expense",
        "label": "Prepaid Research And Development Expense, Current",
        "documentation": "Amount of consideration paid in advance for research and development expense that provides economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "camp_PrepaidSoftwareAndSubscriptionExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "PrepaidSoftwareAndSubscriptionExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Software and subscriptions expense",
        "label": "Prepaid Software And Subscription Expense, Current",
        "documentation": "Amount of consideration paid in advance for software and subscription expense that provides economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "camp_PrepaidVariableLeaseExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "PrepaidVariableLeaseExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable lease expenses",
        "label": "Prepaid Variable Lease Expense, Current",
        "documentation": "Amount of consideration paid in advance for variable lease expense that provides economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "camp_PrincipalPaymentsOnFinancingObligationsFailedSaleLeasebackTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "PrincipalPaymentsOnFinancingObligationsFailedSaleLeasebackTransaction",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Principal payments on financing obligation",
        "label": "Principal Payments On Financing Obligations, Failed Sale Leaseback Transaction",
        "documentation": "Amount of cash outflow for the principal payments on the financing obligations arising from the failed sale-leaseback transaction during the period."
       }
      }
     },
     "auth_ref": []
    },
    "camp_ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesFinancingObligationNarrativeDetails",
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from financing obligation, net of issuance costs",
        "label": "Proceeds From Financing Obligations, Failed Sale Leaseback Transaction",
        "documentation": "Amount of cash inflow from proceeds received by the entity from the financing obligations related to the failed sale-leaseback transaction during the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common stock, net of issuance costs",
        "label": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "crdr": "debit",
     "presentation": [
      "http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net proceeds received",
        "label": "Proceeds from Issuance or Sale of Equity",
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r521"
     ]
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from exercise of common stock options",
        "label": "Proceeds from Stock Options Exercised",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r10"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsFulcrumTherapeuticsIncNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r217",
      "r464",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r619",
      "r643",
      "r660",
      "r661",
      "r662",
      "r664",
      "r665",
      "r824",
      "r825",
      "r830",
      "r886",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsFulcrumTherapeuticsIncNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Domain]",
        "label": "Product and Service [Domain]"
       }
      }
     },
     "auth_ref": [
      "r217",
      "r464",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r619",
      "r643",
      "r660",
      "r661",
      "r662",
      "r664",
      "r665",
      "r824",
      "r825",
      "r830",
      "r886",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915"
     ]
    },
    "us-gaap_ProfessionalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProfessionalFees",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/SegmentReportingDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Professional and consulting fees",
        "label": "Professional Fees",
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer."
       }
      }
     },
     "auth_ref": [
      "r632",
      "r674",
      "r918",
      "r919"
     ]
    },
    "camp_ProfessionalFeesAndOtherGeneralAndAdministrativeExpensesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "ProfessionalFeesAndOtherGeneralAndAdministrativeExpensesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Professional fees",
        "label": "Professional Fees And Other General And Administrative Expenses, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees and other general and administrative expenses. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesOperatingLeasesNarrativeDetails",
      "http://camp4tx.com/role/PropertyAndEquipmentNetNarrativeDetails",
      "http://camp4tx.com/role/PropertyAndEquipmentNetScheduleofPropertyandEquipmentNetDetails",
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesSchedulePropertyandEquipmentNetUsefulLivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset [Axis]",
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r444"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://camp4tx.com/role/PropertyAndEquipmentNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and Equipment, Net",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r112",
      "r115",
      "r116"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/PropertyAndEquipmentNetScheduleofPropertyandEquipmentNetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesOperatingLeasesNarrativeDetails",
      "http://camp4tx.com/role/PropertyAndEquipmentNetScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total property and equipment",
        "verboseLabel": "Capitalized cost",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r127",
      "r482"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://camp4tx.com/role/PropertyAndEquipmentNetNarrativeDetails",
      "http://camp4tx.com/role/PropertyAndEquipmentNetScheduleofPropertyandEquipmentNetDetails",
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesSchedulePropertyandEquipmentNetUsefulLivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and Equipment, Net",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r444"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://camp4tx.com/role/PropertyAndEquipmentNetScheduleofPropertyandEquipmentNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheets",
      "http://camp4tx.com/role/PropertyAndEquipmentNetScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r444",
      "r469",
      "r482",
      "r659"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and Equipment, Net",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r112",
      "r115",
      "r480"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://camp4tx.com/role/PropertyAndEquipmentNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property and Equipment, Net",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesOperatingLeasesNarrativeDetails",
      "http://camp4tx.com/role/PropertyAndEquipmentNetNarrativeDetails",
      "http://camp4tx.com/role/PropertyAndEquipmentNetScheduleofPropertyandEquipmentNetDetails",
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesSchedulePropertyandEquipmentNetUsefulLivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset [Domain]",
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r444"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesSchedulePropertyandEquipmentNetUsefulLivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Useful life",
        "label": "Property, Plant and Equipment, Useful Life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r728"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r728"
     ]
    },
    "camp_RDMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "RDMember",
     "presentation": [
      "http://camp4tx.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "R&amp;D",
        "label": "R&amp;D [Member]",
        "documentation": "R&amp;D"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsBioMarinPharmaceuticalIncNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsEliLillyandCompanyNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsFulcrumTherapeuticsIncNarrativeDetails",
      "http://camp4tx.com/role/RelatedPartiesDetails",
      "http://camp4tx.com/role/StockBasedCompensation2024EquityIncentivePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r244",
      "r245",
      "r246",
      "r247",
      "r282",
      "r292",
      "r323",
      "r324",
      "r325",
      "r338",
      "r403",
      "r458",
      "r459",
      "r461",
      "r507",
      "r509",
      "r516",
      "r543",
      "r544",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r615",
      "r616",
      "r637",
      "r642",
      "r647",
      "r654",
      "r655",
      "r656",
      "r657",
      "r661",
      "r668",
      "r822",
      "r828",
      "r868",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsBioMarinPharmaceuticalIncNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsEliLillyandCompanyNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsFulcrumTherapeuticsIncNarrativeDetails",
      "http://camp4tx.com/role/RelatedPartiesDetails",
      "http://camp4tx.com/role/StockBasedCompensation2024EquityIncentivePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r244",
      "r245",
      "r246",
      "r247",
      "r282",
      "r292",
      "r323",
      "r324",
      "r325",
      "r338",
      "r403",
      "r458",
      "r459",
      "r461",
      "r507",
      "r509",
      "r516",
      "r543",
      "r544",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r615",
      "r616",
      "r637",
      "r642",
      "r647",
      "r654",
      "r655",
      "r656",
      "r657",
      "r661",
      "r668",
      "r822",
      "r828",
      "r868",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883"
     ]
    },
    "us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReconciliationFromSegmentTotalsToConsolidatedAbstract",
     "presentation": [
      "http://camp4tx.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less: Significant segment expenses",
        "label": "Segment Reconciliation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r695",
      "r706",
      "r716",
      "r749"
     ]
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://camp4tx.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related and Nonrelated Parties [Domain]",
        "label": "Related and Nonrelated Parties [Domain]",
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r221",
      "r289",
      "r450",
      "r451",
      "r472",
      "r479",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r571",
      "r573",
      "r602"
     ]
    },
    "us-gaap_RelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyMember",
     "presentation": [
      "http://camp4tx.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related party",
        "label": "Related Party [Member]",
        "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r153",
      "r450",
      "r451",
      "r452",
      "r453",
      "r472",
      "r479",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r571",
      "r573",
      "r602"
     ]
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionAxis",
     "presentation": [
      "http://camp4tx.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Axis]",
        "label": "Related Party Transaction [Axis]",
        "documentation": "Information by type of related party transaction."
       }
      }
     },
     "auth_ref": [
      "r450",
      "r451",
      "r875"
     ]
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionDomain",
     "presentation": [
      "http://camp4tx.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Domain]",
        "label": "Related Party Transaction [Domain]",
        "documentation": "Transaction between related party."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://camp4tx.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Parties",
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r221",
      "r578",
      "r579",
      "r582"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://camp4tx.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related and Nonrelated Parties [Axis]",
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r221",
      "r289",
      "r450",
      "r451",
      "r472",
      "r479",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r571",
      "r573",
      "r602",
      "r875"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://camp4tx.com/role/RelatedParties"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Parties",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r447",
      "r448",
      "r449",
      "r451",
      "r454",
      "r527",
      "r528",
      "r529",
      "r580",
      "r581",
      "r582",
      "r600",
      "r601"
     ]
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsBioMarinPharmaceuticalIncNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsChildrensMedicalCenterCorporationNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsEliLillyandCompanyNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsFulcrumTherapeuticsIncNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsWhiteheadInstituteforBiomedicalResearchNarrativeDetails",
      "http://camp4tx.com/role/StockBasedCompensationStockOptionActivityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Domain]",
        "label": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r154",
      "r155",
      "r257",
      "r263",
      "r453",
      "r460",
      "r470",
      "r623",
      "r624"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://camp4tx.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "verboseLabel": "Research and development expense",
        "label": "Research and Development Expense",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r341",
      "r617",
      "r632",
      "r884"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "R&amp;D",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development Expenses",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r340"
     ]
    },
    "camp_ResearchAndDevelopmentExpensesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "ResearchAndDevelopmentExpensesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "External R&amp;D expenses",
        "label": "Research And Development Expenses, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for research and development expenses. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r696",
      "r707",
      "r717",
      "r750"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r697",
      "r708",
      "r718",
      "r751"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r704",
      "r715",
      "r725",
      "r758"
     ]
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCashNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      },
      "http://camp4tx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheets",
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Restricted Cash, Noncurrent",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r796",
      "r803"
     ]
    },
    "us-gaap_RestrictedStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockMember",
     "presentation": [
      "http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofExcludedAntidilutiveSecuritiesDetails",
      "http://camp4tx.com/role/StockBasedCompensationRestrictedStockAwardsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Unvested Restricted Common Stock",
        "terseLabel": "Restricted stock vesting",
        "label": "Restricted Stock [Member]",
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheets",
      "http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "verboseLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r83",
      "r477",
      "r514",
      "r515",
      "r525",
      "r554",
      "r659"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r156",
      "r157",
      "r158",
      "r160",
      "r165",
      "r167",
      "r169",
      "r223",
      "r224",
      "r235",
      "r369",
      "r370",
      "r377",
      "r378",
      "r379",
      "r381",
      "r382",
      "r383",
      "r389",
      "r391",
      "r392",
      "r394",
      "r395",
      "r425",
      "r426",
      "r511",
      "r513",
      "r530",
      "r920"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsBioMarinPharmaceuticalIncNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsFulcrumTherapeuticsIncNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue recognized",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r98",
      "r184",
      "r193",
      "r194",
      "r208",
      "r214",
      "r217",
      "r219",
      "r220",
      "r279",
      "r280",
      "r464"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Recognition and Accounting for Collaboration Agreements",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r618"
     ]
    },
    "camp_RevenuePerformanceObligationNumberOfPerformanceObligations": {
     "xbrltype": "integerItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "RevenuePerformanceObligationNumberOfPerformanceObligations",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsFulcrumTherapeuticsIncNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of performance obligations",
        "label": "Revenue, Performance Obligation, Number Of Performance Obligations",
        "documentation": "Revenue, Performance Obligation, Number Of Performance Obligations"
       }
      }
     },
     "auth_ref": []
    },
    "camp_RevenueRemainingPerformanceObligationExpectedReimbursableResearchAndDevelopmentExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "RevenueRemainingPerformanceObligationExpectedReimbursableResearchAndDevelopmentExpenses",
     "crdr": "debit",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsBioMarinPharmaceuticalIncNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected reimbursable research and development expenses",
        "label": "Revenue, Remaining Performance Obligation, Expected Reimbursable Research And Development Expenses",
        "documentation": "Revenue, Remaining Performance Obligation, Expected Reimbursable Research And Development Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "camp_RevenueRemainingPerformanceObligationFixedConsiderationAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "RevenueRemainingPerformanceObligationFixedConsiderationAmount",
     "crdr": "credit",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsBioMarinPharmaceuticalIncNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsFulcrumTherapeuticsIncNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed consideration amount",
        "label": "Revenue, Remaining Performance Obligation, Fixed Consideration Amount",
        "documentation": "Revenue, Remaining Performance Obligation, Fixed Consideration Amount"
       }
      }
     },
     "auth_ref": []
    },
    "camp_RevenueRemainingPerformanceObligationNoticePeriodForTermination": {
     "xbrltype": "durationItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "RevenueRemainingPerformanceObligationNoticePeriodForTermination",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsBioMarinPharmaceuticalIncNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notice period for termination",
        "label": "Revenue, Remaining Performance Obligation, Notice Period For Termination",
        "documentation": "Revenue, Remaining Performance Obligation, Notice Period For Termination"
       }
      }
     },
     "auth_ref": []
    },
    "camp_RevenueRemainingPerformanceObligationTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale": {
     "xbrltype": "durationItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "RevenueRemainingPerformanceObligationTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsBioMarinPharmaceuticalIncNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tiered royalties payment, period after first commercial sale",
        "label": "Revenue, Remaining Performance Obligation, Tiered Royalties Payment, Period After First Commercial Sale",
        "documentation": "Revenue, Remaining Performance Obligation, Tiered Royalties Payment, Period After First Commercial Sale"
       }
      }
     },
     "auth_ref": []
    },
    "camp_RevenueRemainingPerformanceObligationVariableConsiderationAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "RevenueRemainingPerformanceObligationVariableConsiderationAmount",
     "crdr": "credit",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsFulcrumTherapeuticsIncNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable consideration amount",
        "label": "Revenue, Remaining Performance Obligation, Variable Consideration Amount",
        "documentation": "Revenue, Remaining Performance Obligation, Variable Consideration Amount"
       }
      }
     },
     "auth_ref": []
    },
    "camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountCommercialSalesMilestones": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "RevenueRemainingPerformanceObligationVariableConsiderationAmountCommercialSalesMilestones",
     "crdr": "credit",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsBioMarinPharmaceuticalIncNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable consideration amount, commercial sales milestones",
        "label": "Revenue, Remaining Performance Obligation, Variable Consideration Amount, Commercial Sales Milestones",
        "documentation": "Revenue, Remaining Performance Obligation, Variable Consideration Amount, Commercial Sales Milestones"
       }
      }
     },
     "auth_ref": []
    },
    "camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentDevelopmentAndRegulatoryMilestones": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentDevelopmentAndRegulatoryMilestones",
     "crdr": "credit",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsBioMarinPharmaceuticalIncNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable consideration amount, contingent development and regulatory milestones",
        "label": "Revenue, Remaining Performance Obligation, Variable Consideration Amount, Contingent Development And Regulatory Milestones",
        "documentation": "Revenue, Remaining Performance Obligation, Variable Consideration Amount, Contingent Development And Regulatory Milestones"
       }
      }
     },
     "auth_ref": []
    },
    "camp_RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentPreclinicalMilestones": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentPreclinicalMilestones",
     "crdr": "credit",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsBioMarinPharmaceuticalIncNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable consideration amount, contingent preclinical milestones",
        "label": "Revenue, Remaining Performance Obligation, Variable Consideration Amount, Contingent Preclinical Milestones",
        "documentation": "Revenue, Remaining Performance Obligation, Variable Consideration Amount, Contingent Preclinical Milestones"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      },
      "http://camp4tx.com/role/SegmentReportingDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://camp4tx.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and collaboration revenue",
        "label": "Revenues",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r98",
      "r143",
      "r150",
      "r184",
      "r193",
      "r194",
      "r208",
      "r214",
      "r217",
      "r219",
      "r220",
      "r222",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r417",
      "r468",
      "r632",
      "r826"
     ]
    },
    "us-gaap_RevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenuesAbstract",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue",
        "label": "Revenues [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows",
      "http://camp4tx.com/role/PropertyAndEquipmentNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease right-of-use asset obtained in exchange for lease liabilities",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r440",
      "r658"
     ]
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use asset obtained in exchange for lease liabilities",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r440",
      "r658"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r767"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r767"
     ]
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit",
      "http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Domain]",
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://camp4tx.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accrued Expenses and Other Current Liabilities",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of accrued liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofExcludedAntidilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "label": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Excluded Anti-dilutive Securities",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "presentation": [
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Cash and Cash Equivalents",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "documentation": "Tabular disclosure of the components of cash and cash equivalents."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsBioMarinPharmaceuticalIncNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsChildrensMedicalCenterCorporationNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsEliLillyandCompanyNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsFulcrumTherapeuticsIncNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsWhiteheadInstituteforBiomedicalResearchNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r384"
     ]
    },
    "us-gaap_ScheduleOfConversionsOfStockTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfConversionsOfStockTextBlock",
     "presentation": [
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Common Stock Issuance Upon Conversion",
        "label": "Schedule of Conversions of Stock [Table Text Block]",
        "documentation": "Tabular disclosure of information related to converting stock into another financial instrument(s) in a noncash (or part noncash) transaction."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r19",
      "r20"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r860"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Basic and Diluted Net Loss per Share",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r812"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r349",
      "r651",
      "r858"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock-based Compensation Expense",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restricted Stock Award Activity",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "camp_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
     "presentation": [
      "http://camp4tx.com/role/PrepaidExpensesAndOtherCurrentAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Prepaid Expenses and Other Current Assets",
        "label": "Schedule Of Prepaid Expenses And Other Current Assets [Table Text Block]",
        "documentation": "Tabular disclosure of prepaid expenses and other current assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://camp4tx.com/role/PropertyAndEquipmentNetNarrativeDetails",
      "http://camp4tx.com/role/PropertyAndEquipmentNetScheduleofPropertyandEquipmentNetDetails",
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesSchedulePropertyandEquipmentNetUsefulLivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r444"
     ]
    },
    "camp_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock",
     "presentation": [
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Estimated Useful Lives of the Property and Equipment",
        "label": "Schedule of Property, Plant and Equipment, Useful Life [Table Text Block]",
        "documentation": "Tabular disclosure of the useful life of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://camp4tx.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Table]",
        "label": "Related Party Transaction [Table]",
        "documentation": "Disclosure of information about related party transaction."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r44",
      "r578",
      "r579",
      "r582"
     ]
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
     "presentation": [
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restricted Cash",
        "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]",
        "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r90",
      "r885"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://camp4tx.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r27",
      "r28"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://camp4tx.com/role/SegmentReportingTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r27",
      "r28"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensation2024EmployeeStockPurchasePlanNarrativeDetails",
      "http://camp4tx.com/role/StockBasedCompensation2024EquityIncentivePlanNarrativeDetails",
      "http://camp4tx.com/role/StockBasedCompensationRestrictedStockAwardsNarrativeDetails",
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails",
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsFairValueAssumptionsDetails",
      "http://camp4tx.com/role/StockBasedCompensationStockOptionActivityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r294",
      "r296",
      "r298",
      "r299",
      "r300",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock Option Activity",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r9",
      "r85"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value Weighted Average Assumptions for Stock Options",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitNarrativeDetails",
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitScheduleofCommonStockIssuanceUponConversionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock, Class of Stock [Table]",
        "label": "Stock, Class of Stock [Table]",
        "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r80",
      "r81",
      "r82",
      "r83",
      "r130",
      "r131",
      "r132",
      "r186",
      "r260",
      "r261",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r521",
      "r522",
      "r523",
      "r524",
      "r642",
      "r791",
      "r804"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r680"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentDomain",
     "presentation": [
      "http://camp4tx.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Domain]",
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r98",
      "r99",
      "r100",
      "r184",
      "r189",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215",
      "r216",
      "r220",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r240",
      "r241",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r629",
      "r632",
      "r633",
      "r639",
      "r663",
      "r886",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://camp4tx.com/role/SegmentReporting"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r184",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r204",
      "r206",
      "r207",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r220",
      "r628",
      "r630",
      "r631",
      "r632",
      "r634",
      "r635",
      "r636"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://camp4tx.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Information [Line Items]",
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock",
     "presentation": [
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and Administrative Expenses",
        "label": "Selling, General and Administrative Expenses, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption."
       }
      }
     },
     "auth_ref": [
      "r857"
     ]
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeriesAPreferredStockMember",
     "presentation": [
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitSummaryofConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series\u00a0A Prime",
        "label": "Series A Preferred Stock [Member]",
        "documentation": "Series A preferred stock."
       }
      }
     },
     "auth_ref": [
      "r797",
      "r798",
      "r829"
     ]
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeriesBPreferredStockMember",
     "presentation": [
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitSummaryofConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series\u00a0B",
        "label": "Series B Preferred Stock [Member]",
        "documentation": "Series B preferred stock."
       }
      }
     },
     "auth_ref": [
      "r797",
      "r798",
      "r829"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensation2024EquityIncentivePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting period of the award (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r648"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensation2024EmployeeStockPurchasePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discount from market price, purchase date",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Discount from Market Price, Purchase Date",
        "documentation": "Discount rate from fair value on purchase date that participants pay for shares."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitScheduleofCommonStockIssuanceUponConversionDetails",
      "http://camp4tx.com/role/StockBasedCompensationScheduleofRestrictedStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted stock vesting (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r310",
      "r311"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofRestrictedStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofRestrictedStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance (in USD per share)",
        "periodEndLabel": "Ending balance (in USD per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r310",
      "r311"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofRestrictedStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Vested (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r314"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "crdr": "debit",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationRestrictedStockAwardsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of restricted shares vested during the period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash."
       }
      }
     },
     "auth_ref": [
      "r317"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofRestrictedStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested (in USD per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r314"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsFairValueAssumptionsDetails",
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected dividend yield",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r324"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsFairValueAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r323"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsFairValueAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free interest rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r325"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensation2024EmployeeStockPurchasePlanNarrativeDetails",
      "http://camp4tx.com/role/StockBasedCompensation2024EquityIncentivePlanNarrativeDetails",
      "http://camp4tx.com/role/StockBasedCompensationRestrictedStockAwardsNarrativeDetails",
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails",
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsFairValueAssumptionsDetails",
      "http://camp4tx.com/role/StockBasedCompensationStockOptionActivityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r294",
      "r296",
      "r298",
      "r299",
      "r300",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitScheduleofCommonStockIssuanceUponConversionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Shares reserved for future issuance under the 2024 Equity Incentive Plan and ESPP (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueRollForward",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate intrinsic value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Aggregate Intrinsic Value [Roll Forward]",
        "documentation": "n/a"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable at the end of the period (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r304"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and expected to vest at the end the period (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r304"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails",
      "http://camp4tx.com/role/StockBasedCompensationStockOptionActivityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options exercised",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares."
       }
      }
     },
     "auth_ref": [
      "r317"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Options cancelled (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r308"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r306"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationStockOptionActivityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average grant date fair value (in USD per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r316"
     ]
    },
    "camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAfterEarlyExerciseDueToNotesPayableForgiveness": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAfterEarlyExerciseDueToNotesPayableForgiveness",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationStockOptionActivityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options outstanding after early exercise due to promissory note forgiveness (in shares)",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding After Early Exercise Due To Notes Payable Forgiveness",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding After Early Exercise Due To Notes Payable Forgiveness"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitScheduleofCommonStockIssuanceUponConversionDetails",
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options outstanding (in shares)",
        "periodStartLabel": "Balance at beginning (in shares)",
        "periodEndLabel": "Balance at the end (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r302",
      "r303"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of outstanding options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance at beginning (in USD per share)",
        "periodEndLabel": "Balance at the end (in USD per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r302",
      "r303"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable at the end of the period (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r319"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and expected to vest at the end the period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r318"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and expected to vest at the end the period (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r318"
     ]
    },
    "camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining contractual term in years",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Weighted Average Remaining Contractual Term [Abstract]",
        "documentation": "n/a"
       }
      }
     },
     "auth_ref": []
    },
    "camp_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfEstimatedFairValueOnGrantDate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfEstimatedFairValueOnGrantDate",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensation2024EquityIncentivePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of estimated fair value on grant date",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Of Estimated Fair Value On Grant Date",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Of Estimated Fair Value On Grant Date"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensation2024EmployeeStockPurchasePlanNarrativeDetails",
      "http://camp4tx.com/role/StockBasedCompensation2024EquityIncentivePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of outstanding stock maximum",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum",
        "documentation": "Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensation2024EmployeeStockPurchasePlanNarrativeDetails",
      "http://camp4tx.com/role/StockBasedCompensationRestrictedStockAwardsNarrativeDetails",
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails",
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsFairValueAssumptionsDetails",
      "http://camp4tx.com/role/StockBasedCompensationStockOptionActivityNarrativeDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Award Types",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r298",
      "r299",
      "r300",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options exercised (in USD per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r307"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options cancelled (in USD per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r308"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options granted (in USD per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r306"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r293",
      "r301",
      "r320",
      "r321",
      "r322",
      "r323",
      "r326",
      "r332",
      "r333",
      "r334",
      "r335"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensation2024EquityIncentivePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r649"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsFairValueAssumptionsDetails",
      "http://camp4tx.com/role/StockBasedCompensationStockOptionActivityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected term (in\u00a0years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r322"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable at the end of the period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable at the end of the period (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining contractual term (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and expected to vest at the end the period (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r318"
     ]
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesIssuedPricePerShare",
     "presentation": [
      "http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale price per share (in dollars per share)",
        "label": "Shares Issued, Price Per Share",
        "documentation": "Per share or per unit amount of equity securities issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofOperatingLeaseCostsandOtherInformationDetails": {
       "parentTag": "camp_LeaseCostExcludingFinanceLeases",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofOperatingLeaseCostsandOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term lease cost",
        "label": "Short-Term Lease, Cost",
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less."
       }
      }
     },
     "auth_ref": [
      "r437",
      "r658"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://camp4tx.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Significant Accounting Policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r149"
     ]
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State Jurisdiction",
        "label": "State and Local Jurisdiction [Member]",
        "documentation": "Designated state or local jurisdiction entitled to levy and collect income tax."
       }
      }
     },
     "auth_ref": [
      "r347"
     ]
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://camp4tx.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Axis]",
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r98",
      "r99",
      "r100",
      "r122",
      "r184",
      "r189",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215",
      "r216",
      "r220",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r237",
      "r240",
      "r241",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r629",
      "r632",
      "r633",
      "r639",
      "r663",
      "r886",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitSummaryofConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Axis]",
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r130",
      "r131",
      "r132",
      "r150",
      "r173",
      "r174",
      "r176",
      "r178",
      "r186",
      "r187",
      "r222",
      "r248",
      "r250",
      "r251",
      "r252",
      "r255",
      "r256",
      "r260",
      "r261",
      "r264",
      "r265",
      "r267",
      "r417",
      "r521",
      "r522",
      "r523",
      "r524",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r542",
      "r553",
      "r575",
      "r597",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r791",
      "r804",
      "r811"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit",
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r60",
      "r63",
      "r64",
      "r121",
      "r140",
      "r141",
      "r142",
      "r156",
      "r157",
      "r158",
      "r160",
      "r165",
      "r167",
      "r169",
      "r185",
      "r223",
      "r224",
      "r235",
      "r268",
      "r369",
      "r370",
      "r377",
      "r378",
      "r379",
      "r381",
      "r382",
      "r383",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r446",
      "r484",
      "r511",
      "r512",
      "r513",
      "r530",
      "r597"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r157",
      "r158",
      "r185",
      "r426",
      "r464",
      "r519",
      "r542",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r553",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r562",
      "r563",
      "r564",
      "r565",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r573",
      "r576",
      "r577",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r597",
      "r669"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r157",
      "r158",
      "r185",
      "r221",
      "r426",
      "r464",
      "r519",
      "r542",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r553",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r562",
      "r563",
      "r564",
      "r565",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r573",
      "r576",
      "r577",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r597",
      "r669"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r699",
      "r710",
      "r720",
      "r753"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit",
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of convertible preferred stock into common stock upon initial public offering (in shares)",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r35",
      "r60",
      "r63",
      "r83",
      "r259"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsChildrensMedicalCenterCorporationNarrativeDetails",
      "http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit",
      "http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock (in shares)",
        "verboseLabel": "Shares issued",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r59",
      "r60",
      "r83",
      "r521",
      "r597",
      "r609"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting of restricted common stock (in shares)",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r59",
      "r60",
      "r83"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Options exercised (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r59",
      "r60",
      "r83",
      "r307"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of convertible preferred stock into common stock upon initial public offering",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r60",
      "r63",
      "r64",
      "r83"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r59",
      "r60",
      "r83",
      "r530",
      "r597",
      "r609",
      "r675"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheets",
      "http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders\u2019 equity (deficit)",
        "periodStartLabel": "Balance at beginning",
        "periodEndLabel": "Balance at ending",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r63",
      "r64",
      "r75",
      "r555",
      "r572",
      "r598",
      "r599",
      "r659",
      "r676",
      "r805",
      "r819",
      "r871",
      "r920"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders\u2019 equity (deficit):",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteRedeemablePreferredStockIssuePolicy",
     "presentation": [
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Classification of Convertible Preferred Stock",
        "label": "Stockholders' Equity Note, Redeemable Preferred Stock, Issue, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for redeemable preferred stock issued. This disclosure may include the accounting treatment for the difference, if there is any, between the carrying value and redemption amount. For example, describe whether the issuer accretes changes in the redemption value."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r57",
      "r58"
     ]
    },
    "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": {
     "xbrltype": "pureItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteStockSplitConversionRatio1",
     "presentation": [
      "http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reverse stock split ratio",
        "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio",
        "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one."
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit",
      "http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Axis]",
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosure of cash flow information:",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "camp_SupplementalInformationRelatingToLeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "SupplementalInformationRelatingToLeasesAbstract",
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofFinanceLeaseCostandOtherInformationDetails",
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofOperatingLeaseCostsandOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other information",
        "label": "Supplemental Information Relating To Leases [Abstract]",
        "documentation": "No definition available."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r746"
     ]
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardAmount",
     "crdr": "debit",
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development tax credit carryforward",
        "label": "Tax Credit Carryforward, Amount",
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r367"
     ]
    },
    "us-gaap_TemporaryEquityByClassOfStockTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityByClassOfStockTable",
     "presentation": [
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitSummaryofConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Temporary Equity, by Class of Stock [Table]",
        "label": "Temporary Equity, by Class of Stock [Table]",
        "documentation": "Disclosure of information about equity instrument classified as temporary equity. Includes, but not is limited to, description of share, value, share authorized, issued, and outstanding, redemption price per share, and subscription receivable."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r32"
     ]
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://camp4tx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheets",
      "http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible preferred stock, $0.0001 par value per share; 25,000,000 and 149,673,284 shares authorized; no and 130,648,426 shares issued and outstanding; liquidation value of zero and $162,885 as of December\u00a031, 2024 and 2023, respectively",
        "periodStartLabel": "Balance at beginning",
        "periodEndLabel": "Balance at ending",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r248",
      "r250",
      "r251",
      "r252",
      "r255",
      "r256",
      "r336",
      "r476"
     ]
    },
    "camp_TemporaryEquityDisclosureAndStockholdersEquityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "TemporaryEquityDisclosureAndStockholdersEquityTextBlock",
     "presentation": [
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Preferred Stock and Stockholders' Deficit",
        "label": "Temporary Equity Disclosure And Stockholders' Equity [Text Block]",
        "documentation": "The entire disclosure for temporary equity and equity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityLineItems",
     "presentation": [
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitSummaryofConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Preferred Stock and Stockholders' Deficit",
        "label": "Temporary Equity [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityLiquidationPreference": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityLiquidationPreference",
     "crdr": "credit",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitSummaryofConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible preferred stock, liquidation preference",
        "verboseLabel": "Liquidation Value",
        "label": "Temporary Equity, Liquidation Preference",
        "documentation": "The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityParOrStatedValuePerShare",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible preferred stock, par value (in dollars per share)",
        "label": "Temporary Equity, Par or Stated Value Per Share",
        "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r32"
     ]
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquitySharesAuthorized",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitSummaryofConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible preferred stock, shares authorized (in shares)",
        "verboseLabel": "Authorized shares",
        "label": "Temporary Equity, Shares Authorized",
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "camp_TemporaryEquitySharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "TemporaryEquitySharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Conversion of convertible preferred stock into common stock upon initial public offering (in shares)",
        "label": "Temporary Equity, Shares, Conversion of Convertible Securities",
        "documentation": "Temporary Equity, Shares, Conversion of Convertible Securities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquitySharesIssued",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitSummaryofConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible preferred stock, shares issued (in shares)",
        "verboseLabel": "Shares issued (in shares)",
        "label": "Temporary Equity, Shares Issued",
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquitySharesOutstanding",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit",
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitSummaryofConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible preferred stock, shares outstanding (in shares)",
        "periodStartLabel": "Balance at beginning (in shares)",
        "periodEndLabel": "Balance at ending (in shares)",
        "verboseLabel": "Shares outstanding (in shares)",
        "label": "Temporary Equity, Shares Outstanding",
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_TemporaryEquityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityTableTextBlock",
     "presentation": [
      "http://camp4tx.com/role/ConvertiblePreferredStockandStockholdersDeficitTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Convertible Preferred Stock",
        "label": "Temporary Equity [Table Text Block]",
        "documentation": "Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r32"
     ]
    },
    "camp_TemporaryEquityValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "TemporaryEquityValueConversionOfConvertibleSecurities",
     "crdr": "debit",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofConvertiblePreferredStockandStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Conversion of convertible preferred stock into common stock upon initial public offering",
        "label": "Temporary Equity, Value, Conversion of Convertible Securities",
        "documentation": "Temporary Equity, Value, Conversion of Convertible Securities"
       }
      }
     },
     "auth_ref": []
    },
    "camp_TheWhiteheadInstituteForBiomedicalResearchMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "TheWhiteheadInstituteForBiomedicalResearchMember",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsWhiteheadInstituteforBiomedicalResearchNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "The Whitehead Institute for Biomedical Research",
        "label": "The Whitehead Institute For Biomedical Research [Member]",
        "documentation": "The Whitehead Institute For Biomedical Research"
       }
      }
     },
     "auth_ref": []
    },
    "camp_TierOneProductMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "TierOneProductMember",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsFulcrumTherapeuticsIncNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tier 1 Product",
        "label": "Tier One Product [Member]",
        "documentation": "Represents information pertaining to Tier 1 Product."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r738"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r745"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r766"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r768"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://camp4tx.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TravelAndEntertainmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TravelAndEntertainmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/SegmentReportingDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Travel and entertainment",
        "label": "Travel and Entertainment Expense",
        "documentation": "Expenses incurred for travel and entertainment during the period."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r769"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date",
        "label": "Trading Arrangement Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r768"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r768"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r771"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r769"
     ]
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsBioMarinPharmaceuticalIncNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsChildrensMedicalCenterCorporationNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsEliLillyandCompanyNarrativeDetails",
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsWhiteheadInstituteforBiomedicalResearchNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r384"
     ]
    },
    "us-gaap_UnbilledContractsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnbilledContractsReceivable",
     "crdr": "debit",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsEliLillyandCompanyNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unbilled receivable",
        "label": "Unbilled Contracts Receivable",
        "documentation": "Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet."
       }
      }
     },
     "auth_ref": [
      "r463"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r765"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Uncertain tax position",
        "label": "Unrecognized Tax Benefits",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r343",
      "r357",
      "r650"
     ]
    },
    "camp_UnrecordedNotesPayableIssuedForStockOptionEarlyExercise": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "UnrecordedNotesPayableIssuedForStockOptionEarlyExercise",
     "crdr": "credit",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationStockOptionActivityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecorded notes payable issued for stock option early exercise",
        "label": "Unrecorded Notes Payable Issued For Stock Option Early Exercise",
        "documentation": "Unrecorded Notes Payable Issued For Stock Option Early Exercise"
       }
      }
     },
     "auth_ref": []
    },
    "camp_UponAchievementOfFirstLicensedTargetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "UponAchievementOfFirstLicensedTargetMember",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsChildrensMedicalCenterCorporationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Upon Achievement of First Licensed Target",
        "label": "Upon Achievement Of First Licensed Target [Member]",
        "documentation": "Represents information pertaining to scenario upon achievement of first licensed target."
       }
      }
     },
     "auth_ref": []
    },
    "camp_UponAchievementOfSecondLicensedTargetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "UponAchievementOfSecondLicensedTargetMember",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsChildrensMedicalCenterCorporationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Upon Achievement of Second Licensed Target",
        "label": "Upon Achievement Of Second Licensed Target [Member]",
        "documentation": "Represents information pertaining to scenario upon achievement of second licensed target."
       }
      }
     },
     "auth_ref": []
    },
    "camp_UponAchievementOfThirdLicensedTargetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "UponAchievementOfThirdLicensedTargetMember",
     "presentation": [
      "http://camp4tx.com/role/CollaborationandLicenseAgreementsChildrensMedicalCenterCorporationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Upon Achievement of Third Licensed Target",
        "label": "Upon Achievement Of Third Licensed Target [Member]",
        "documentation": "Represents information pertaining to scenario upon achievement of third licensed target."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://camp4tx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r24",
      "r25",
      "r108",
      "r110",
      "r113",
      "r114"
     ]
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "crdr": "credit",
     "presentation": [
      "http://camp4tx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in valuation allowance",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset."
       }
      }
     },
     "auth_ref": [
      "r360"
     ]
    },
    "us-gaap_VariableLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofOperatingLeaseCostsandOtherInformationDetails": {
       "parentTag": "camp_LeaseCostExcludingFinanceLeases",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://camp4tx.com/role/CommitmentsandContingenciesScheduleofOperatingLeaseCostsandOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable lease expense",
        "label": "Variable Lease, Cost",
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases."
       }
      }
     },
     "auth_ref": [
      "r438",
      "r658"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year",
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r734"
     ]
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantMember",
     "presentation": [
      "http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofExcludedAntidilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant outstanding",
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r666",
      "r667",
      "r670",
      "r671",
      "r672",
      "r673"
     ]
    },
    "camp_WeightedAverageExercisePriceRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "WeightedAverageExercisePriceRollForward",
     "presentation": [
      "http://camp4tx.com/role/StockBasedCompensationScheduleofRestrictedStockActivityDetails",
      "http://camp4tx.com/role/StockBasedCompensationScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price",
        "label": "Weighted Average Exercise Price [Roll Forward]",
        "documentation": "Weighted Average Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofBasicandDilutedNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average shares of common stock outstanding, diluted, (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r178"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://camp4tx.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofBasicandDilutedNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average shares of common stock outstanding, basic, (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r178"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "presentation": [
      "http://camp4tx.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofBasicandDilutedNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Denominator:",
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "camp_WorkingCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://camp4tx.com/20241231",
     "localname": "WorkingCapital",
     "crdr": "debit",
     "presentation": [
      "http://camp4tx.com/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Working capital",
        "label": "Working Capital",
        "documentation": "Represents the amount of working capital."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested",
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r732"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481288/505-10-05-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-4"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "460",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/360/tableOfContent"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480091/360-10-S99-2"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SAB Topic 4.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-4"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481178/840-20-25-1"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481178/840-20-25-6"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481475/840-20-55-3"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "210",
   "Topic": "946",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-20"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "210",
   "Topic": "954",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477220/954-210-45-5"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/606/tableOfContent"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/808/tableOfContent"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-17"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-19"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/715-70/tableOfContent"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480794/715-70-50-1"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.E.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-10B"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.1.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/830/tableOfContent"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478345/912-310-45-11"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478345/912-310-45-2"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-21"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "450",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477850/954-450-50-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-217"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r792": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479924/842-10-30-5"
  },
  "r793": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r794": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r795": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r796": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r797": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r798": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r799": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r800": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r801": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r802": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r803": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r804": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r805": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r806": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r807": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r808": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r809": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r810": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r811": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r812": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r813": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r814": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r815": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r816": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r817": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r818": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r819": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r820": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1"
  },
  "r821": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r822": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r823": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r824": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r825": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r826": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r827": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r828": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r829": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r830": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r831": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r832": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r833": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r834": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r835": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r836": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r837": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r838": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r839": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r840": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r841": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r842": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r843": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r844": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r845": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r846": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r847": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r848": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r849": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r850": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r851": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r852": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r853": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r854": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r855": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r856": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r857": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "720",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1"
  },
  "r858": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r859": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r860": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r861": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r862": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r863": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r864": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r865": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r866": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r867": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r868": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r869": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r870": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r871": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r872": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r873": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r874": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r875": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r876": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r877": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r878": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r879": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r880": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r881": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r882": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r883": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r884": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r885": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r886": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r887": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r888": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r889": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r890": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r891": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r892": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r893": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r894": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r895": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r896": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r897": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r898": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r899": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r900": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r901": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r902": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r903": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r904": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r905": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r906": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r907": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r908": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r909": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r910": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r911": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r912": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r913": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r914": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r915": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r916": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r917": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r918": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r919": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r920": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r921": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>118
<FILENAME>0001736730-25-000022-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001736730-25-000022-xbrl.zip
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MNUOON[#C][?W]K>[O[PIW?41#]'*\5.0>FYX 9?'_B?X+#4/VMMZ_^F?W_Z
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MN+G"D1]<TZYDD(W?A!_K?:P?> OJ&?F-)N28Y^/!K;C_B*TXAUU;4:!B>$]
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M*^=645R<53C^8J0B1:01J(;EV9QLT-*2NN%&4%YR?X/,N(,P2,>< !4/5V?
M/ 0%23R''6GX<9(@%RV)B!T\-#%ZDUHK!5,*0UO'?HH?A($'<FI;:EB-6.N/
MNUF6<%HU-'$F,=BLI[5*/CK'*<T9P\8!2F62!1L;?15^.*Z/E^1!)D% $KJO
M:H8AX#2.(A5N5N6E/*=\"KL!,U]AJ#A]#,H8]\9,]B4J?]31A7]E,M.UL3)*
M;<I/B8NZV'PAJGT75A@#IT5&SJ7<V6;)7VXCPA)G>"@3[ /91CUE,!?S<J 1
M)8L#Z3HX9KME) ?R(/CQ9GF?>7DM!% !TU@\ZRO$>ZX RU>_FMN+P:8;W.CZ
MXT8WJN0;,VEICF1_@8J\6>%+!BFQ WANRF@%^@?ZBS?@M FB##U NKP,5(2?
M:5]4?LKN)GT([B/[HH7KN3DKGOFLP"BXR@)"2)G379_@);=MR+X:H[LD"AOR
MDJ+)9]T+'3&Q#V#R<_ A9YMU?+&03Q$;EZU7VG 8PN'<MQVN88,A&FV6Z;G!
M89,I!BU@,X7N;0GY@CMJ,_W/./T<<X2CQHNC>!)X+:.<6LY(Q=,87")*]C+$
M@W+$!9:[98"Z$_2=W 33%=$0O-L,==VMF^#]AF&!B"NL\"""S9GE] W^6]RO
M%OX0)L=7,!K\MYH&_&^!(H &S<C<I*1U1"<P@^$(7J]FL9RQ""A-XO =/G<C
M0BO+0X(&5F70XJUR$+V-^'J,?T\4+L%(RBKHO*24)98:3%QPMS$:@]%1,J_D
M6ZK_H_O_5SZ9@O0DF7,. _F@@ZM7^%$^39TCUBS];J_O_(0_$&3T?YU_N,(O
M=>G-8JB]Y8[]"5LC&,X: +7O[H%$'&E\]2T7E@AX^AZ,-&Y#JZ2$BB3PQXPW
MIRUDA:!NQRJ"34:8:LQ6\&Y%1#_]\)[GX(T0]#W*W<0%%Y:S+CKY9=5)L%4%
M-YLOT"#;VB[E,;K#*_5D#@,PC7W2'0ML-$8@LUY#/)*10[Z]HCH1+O"P2SXD
MKA>GBB8!?PD**<U'(S LEBG?>*B\J>.<%AFB%A5D8297D,\O/ <NE^FDX,C@
M3PP$[-M?KR639]ZE!"!-34790!E< I<D+/H!A4\'*;A"A%\B0'1-C<SB>MFU
MV-6_!2@'O)47E/1Q60VM&&]*6 *<28Q=ABZ&K6&E507_<[]JZ,#:W5.<8U3%
MQ/VJZI?;2:=X+,/#8.^X!I!.$&$=\#3W0WX<A)KAA>+;TH8""Y"4#6DIU"%.
M/(!%8@L"7B^?TOT>5'33''[FA6Q/E'XG"BZM:ANJ\;E?"Q0%0C[WFKROFJF%
MZI/ -/"*KCP&)R(",0F*'E8FW2SUF+H&YQ;LG0[1C;L@!8+3M3';=KT##F4*
MVR'1N\)H8+MJ1ZIY[.*U#&[ATT,+:- "78W5=R'^')%?! S#Z2D*VURNVV(-
MQ+58+ NPOV\"=<N76!6@L")NQ_DG2+)4;N'R))0=;]'807YGR\@N"Q&.0S%'
M(VI0?&0J<H@O3.MOJ0^8#UL\:[3S(W3'/37ZU=^M5,'T=D#!_,[+:*1,+[WR
M"QQHY!>G!:[38RIUB]2UW*V4W88KTW(9;%%HB\98;_]=:GGN[ UR&5"I)L8,
M#Z_0?@QO>ZN ME1!I&LK\.S,/7.$6XD[K&2V;"HQBTCW\0%JMJW6"U0\A[=H
M,[;2'D&K_O%2J+9@)G%Z2'&;ZHE;;9BE4SR?T3(;2B&?B\78+L<A2<&6% O\
M<.S>:#V@68DSV%0W*#E8@EJ^2:)+EA09T7I;6#?M6!SH=:N5H.&1!#<Z+:KU
M<%%\5!XB/#](J-XW5/[(U!^7%I>OL>U6(S[5=Z;KS=U:A95CEI+J>@L;%^L*
MX0U)Q*7Z&+5UE$\&H+E1=5B/94M+%Q6FQM2ZUZX*4"U283DA-$ !CA"-@0V*
M\?[%N<XOBR>^@X<W77P#NE\QQEH*F^V-QJ>2KU(O"08L3TP=V7*8H>JHH]V=
M2[SM)[Z%+@9=8)-RH:55PBT5U7Q %N74-=8\C'G! 4KF?64JC=A\HPFWR=%M
MO=]Y"D*8@^V=#2/,6F?V&D#_TNLC_<OO7[X<7?[3N3R]^H?SZ>CX^OSR:ADS
MJC3HY3VW1_]LM<;7/LS0N<6N,7<V%,<..WXFMCDS1C*%S6XYUDDX4G#(N(\]
MGE^@4LE; P$,4CJNKVT_,J&*+B\G>WV"OV:0^5,>'/PHL7$>*K-?:N4V0=KO
M#M+^(98@+ MZC7ZIN(=AS_!19'!.Z)J3?2;VHRGI*==S(2!9FZ@%D)D>HN^J
M+564U50IL@#9<M@D=IYWP2G(+K&5$D^4E>344 ,$)U!H494Y?02YYH(1&(04
M+S! 1M( D<)*%4K\R)TH9HP)53;0I:#0 !I;!:*Q)18EX^MR0DCX8+W-6FQD
MH_<$,J<XA ,_A@%F:JX.75-!M.I@S$.XN153L5YL(WW/*'V7;D" ]1I)*RB9
M?) H'=9C'B_318L]YRRA1&))'ATJ4&>99I%!7SF"#]*Q0V29J;Y?IKQQA*0*
M0KJQJ;EY41DX9S=>!QTP+8BI!3Q\."B ND$W51D&R03.&ILGR]98?IP/,B'N
MJ6!U-<,11UFYCD?XSM!."8BM1=/PT6_!=\;03Y%*F><06A":69F\'*$K_2JE
MY ^.;2DW83.TJMU%@W<HNSN_@^G'\+,;.((D)CSB7*--_5,J6[?O+J:+"9+I
MZ!>>>&4Z%1U%GAM"QSDJPOLMD#>3W"9TP@S>++5+ODKEG.[\_:B6$\L*.\[I
M4(?^<BD)J!05NOX-'=DU\Y*-$XIB+LF U-*G.D=L27=K[@_*/H4<JIDK2(53
M=4('-%4,(292E6Q+.M I<^?3UDSC5HE@T)HM$S :N\ED4\?Z[,K9]D(Q*(DD
MAT9;B[(,E>O7R6B)&0AS+'A^QR"B6J[:M!.U<6;BV),\+7:9)82*T;/ETDAP
M%[[6LM'@S09PG$0U)I_L4XDC+Z*7J=]<L@?J'DD$-A3$7UB<W9KG2S)3C%9/
MG9#K6XZ-@8U7NL,AN5)C3)SIL^Z!-]ILEV?<+B=)/BH=' 'J_%!%HVP\,^RP
M44J X23VB-6.D<$+3B$M\7 CDP$@IC?.2H*A@Y1M'></E@C0JV@J(3.C;189
MY8J_(6&$>W&))]/P,/K#I'5D@Q \KH8MC  9>/:8DP4-K+F3(F$<P(QDEKVV
M"9CF5!7KI.Y022I#D1@CF@&W@+P9=LY.A]PYDS:KH0HK[;L\&\>)Y LY!,;.
MXI0*HS.T_9F'E09*.=^DM!TK7"3VV8AN*>'2,#?MIH'P)VS*[)Y[&YV6=+/&
M+PCQR$)F!'$7$?*7!@E)2@IFD(@7N79DP+%FS"/#= >R :ZDTI5Z)$N,0JG\
MO+A HT!P8_$W+&XU1X)$*8JMEPB_M$Y^QQK%1;@ERR8R[*L(MR(T@D>!,HF2
MLIU9R:';%ME&1I_7(1DB@LK6LZ8>A)+JI(U0_16K2Z*74FP]QM0ZTIO*<;%
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M8G]C9G90Q#5M!ND2[.-6ZK+*[66-S";Q !L>R(-PBZ787%FWPEU#I?L'"?0
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MJ_?=+?D2U#G+D X!IA,K?L0U P9NG!8 ?DN0Q5.W<0FD.$LQ+#BZ;TA>:G9
M325*&3S_4_ S#[X$#N ](<#Y@DIQL_0/+WT+IE3/*:,X&"%:;>JI41=%20[7
MTA=,-QPC@+OIVQFV90XAE] [994H$)C->CV\7LL>ADT"<*V4"W4C3O51VS5@
MA45/5CMO%O\?0N?0048 72APNMN2(%6I/!HI"=.T 9)001H:K]0MD7S@AC*
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M1?XT#B+#\T.'CVDX/>#^[@^\C'56$7++/K'@M$(N&AS"0'&Q[Y0Q<,B^<%-
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M[7F@-:P3I9Y(N PA$[$86/O%:K\>:..:4+%$VB:C*&:[)5%BH7F@1A]6]?+
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M=P_N[X7DQ/62@.9#WUC":X]<6$S@K*"S=WY12>,CAS<76;/*YER/ 9JA6FR
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M##]&T[^J9<<& >)":$=#9I(,>7<4>O7I3='Y'VDJ-$EIG96LZ"%$0IH41NS
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M""\98(Y+ '(AJ;OI4!!.!S%,97\9:1L2KZ*D1R1-8&F=D?M/FM I$[%RH]N
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M=A'.6400OG/P^)P@@YI5PDH277-K)L5 .-I]?Q J=$8DNRLE/IAO&F$0NHU
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MQU&Q0WF*0:VWT*ER"6,3QS6(KH?7_)"1#7X#LI&T$C@X_J &4BI#B(,PXI!
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M"(H2],J\=^B^G-:7!V%5@!N6NTZGW419F+(NF*U"&CKY>DIMN$H?/[T^W=!
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MWARN-?6F&'CH??-F#H-;8-8HWF<(1W6$'8%XGMIL;_);O=WX8YGR"=KLI"$
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M!+70\M%Z%TZ^O&ERT;EJ>[U-JI@81IBHPK_7#7*N&"AD[=.]LPI;*D>:F (
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M/LN+_BQQF9.3@4D2'1PC^\@*<4L9(ZV*K$OF$2F$$8SV.?GZ "A1)CI8R3T
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MGE]\\8V=0%WPM'9K.D.J/1VU%"P]^?KB3T]G7W]U<?;G/W_])W[8VV+>EAT
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M.U4,3\(C(P007O;"SYFT(D[?)3_RD$Y.C\KLI>B3KO9R[,=;)U7LD=[T5,]
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MIB6<D8**FGQW.B0_9?*$(@H)-$0.NSU2%AO:1(NG&8 $<YI >(188\F]?M&
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MGCNBIN1I'J'-[>MJ_SM$+UCB/LTDDUPL)W*YF1F+$6ONC^P[#&!D@=#X.(Q
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M-+?FT_2B,'*PQ$[DLS:F#B 6($J[:\I%X6B^+66\4>TIX32BH](3KY\ 2\<
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MOG!> <(B'P.;99VV'HXOB&D%]F-*9_Q^S38)!#+GEEELK*@1#D)C*E$4RCA
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MC4*+[&":.#M\B?Y),8H:X>M9*@5 8D2-SM9ITC[9I&UL'YU S@\[[L0AW92
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M$MO8@G6F0$MLI^ZOB#Y)-I [%>*2'Z+8#J\!OYDF-JMLH )\O:7EOEJ]X)X
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MD*8K]GL'CGF&U4Q,F&7_F'2AV>^25DUXC .5TJ@+LKC.S,D4?CH,O=BV!P8
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M33+8-#N1,NI;P)/P)HM3GJ]*1B0\7GW3-XWV >_(;5TT.ZKW;AH]PD%DGWO
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MW_&P\= T"QL5#KD.#4P$H<N9 SF?E#<DCU"SGE1X>#?Z81:)!3PV](=U\<(
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MV\S)967P/[OGT)E$6A55?'IDO2K9LQ!K4C=)U*,\ITP_T'F_#-XO43G7[7J
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MX626#N1@RY@,F.,R%EZ)5,NZ4.4OA36EA,HM03Y9"K1F6+K8M<)OD#J4X(\
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MU[JON4K)'%513:9X0\H%+D)LD>3(Z/&T-8V2TV'=[/OFL115RFV_XV5:^H*
MR3KPQR;'Y4UX)N.$GQBIQSU,W%81B>,]!\@*,7L\@K5FX;EM(DZGS.D@=Q2L
M#SVI1\ZMFIK"HMNP9%1DB%, L6"A:EY*UB0$/=:3[P%3^F@'_JZVV#R*/RP^
M0W"X=!Q,JAGJ,C+U3:;*$AYM#KS8(VYW,?O';;LZEJ(0EK_8@D@#MSMLZ7LK
M[I(QXEEEOP*2 LM\ GINX@<24[I?@.H-6L=,=R98N=UMTK@J[ 86Z<OPP$;R
M91R#@/,]5=(IE2CCEC5P/6-7'+<#1W<.M$U$7]QZ3_!8PF:GBN;%RZM]HG0
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M]W@VH-5U3?V$_:' 8<>313@A!<2P; G)L6D2-FE0_I\0AH$4B2[^[O45=W<
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MTD $0AFN1XB:NDET!P/RZMG+Q4N_""'DQ'(0_@33P<K!(XU[3.Y &?IL8OG
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MH!P"L8/)[?><E]\M_2Y]PG=YQ./Y]^BJ77O3OG6)LS*T JF;0 @1*#+K)IN
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MDV'Q2)94T-7&9L'$_96N+&4W)#I=F$CF/19)L521P<TYZ$D.CEC)"07O776
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M@ZP![&[>U*![A'5'S&R@/":7LBQ1KAGPZ92%<@PZAAM,BD9IP6@ 3?;D6*<
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MSDQ("+L,REE'.K2FGFS=3 *) $?,#7_8RW+"ZTJNP%Q[+.;:8O4<S<I$"IG
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MA/%@XY<' /)H,C1N'0'LEE;B:(D9L$0A=NH#\<&=N(A[!@;:38WO""<]G&;
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M"*HE,I#%3K1I^8(9"@&$JQPZU0E#Q%R&X2>!*RQ^Z#=(1$Y"40J!5P3\A4'
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M!VJHS/$3\_N0X4&$;^XW81W17BCGG1_D18-ALFVK!ST8:KVU?DEHF(RMGE#
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M(@QS% )BO\NN\1FP_,<&O3Y6'(FM$XXT_PS>*+:-=T]8;L[8/!&>@_^@:KG
M8#BA.O:"J6CVL17-&U$IF*OK^@@SWP"M68W;D6KW7'?J WZ"\\H3)B%,U<4)
M:I@.HZE-QQ3OE-.2ZXED,C'8:2_G)!6/,C[^TZI=7PSM!?T7Z?=8ZB>@=*M0
MU0* *9!4A1?J":8-WQ%"00QSRGX(RMC((@I$GROE53=Y>Z -A<8C;R$>(Z(6
M"[=([\5SE9W %2OC(;A.9A\'H:Q$P ]A>X3@LE6B32@!0TY*2Y>ECPSV?+15
M.B'BEM(T(C:/V,9N',AAM+D58 I4N=OG;X1<\O 384)<E?W0)T4LP7Q1QQ=N
M^BI08>DOLM_&7/8=GXI@4KNN6IE"#3)9^C^OWO(TK#&7EU3Z+Q>O$;W.WZ1K
MR#?I=U0WBGB2L?*\=0*^$MD.!EOZ_^@'3-N;\8?6.N1@?%2%O[LK[GB;YQ*J
M-,YG,L6W(N)T/U!?DW0FX#'!\7'@-XYH^Q7)L'2PH/@@PK)'1/>/M0_LEGR8
MHWL"1](Q;5&_W!M_/\@$AF'QING:7XD$#R29K.24.$-F5B8)R1E&?IO1D.9"
M+&M1I^>\_ Q"-$F^=N8[%!1'@C;A;XIEQ\INQ^+!BV;<+J'>M>'C-+GVH2M2
MQE094,3PH.)M78=Q!*,*1Q7T!TB=+N&.C]I?T;T"3B[Y*ZB$"AIQ#9(*:P'C
M*+4G:@%1S8^-<[XM6'IR+A<O<X(]9[SAH;WTM\_.>,./&6_XYP5ZZ-MIDTY.
MZK>(@/=")AT4Q[E!@Q!GU0U)):O\[Y6W6/^VG5@I?T!!#-'<N64Y]/P%0Y++
M1&0H\1TR6&B.9@ 2<24C>P(]PI/UQ1CQ$EAV;NT2\7X\0N3!<P-@3X/^7+69
M5%;G17<SC'/E!B0W2$Y=N&8+\B8W[I;0&RA\C,KK@)!::UA9X"48VP' _(I[
M*1#\ 3\*%-;H^!PAM9-F$PW:3SSR6S@'H-3(75F1B_$B&1V5'F=ED1^^>Q92
M !GXC1RCE8&KXBMWY:Y:&Y?.7#/Z+1%/6R'8./"R#Z>[ Q>W7X6@WRC>@#*&
MLX_)1[4R+3?2G4+?]]&W%FX S!;1*T3-0^E3D#.,LS S8V/CK6O3;D5O5V8@
MZJ@4.95(9X:>[8#253*W0JINE0 ?W_[^5<)&@F$FWBZZK*J>HJN,$;_I *'$
M4_#"-AC)@67>R&P%_>V,PK9MYI$X5WK?($):E]WZHMU<K&!MJ>M(S8O,^<J^
M(R2V>UF% WB\+$F-?67E#OW>K,=8@*OL.A^A6JL72=/G<"YHT%*T$L;F<%_,
M]5%3I%_3)?O@P2<7TAML)>SA/9H6*FG1OI@9M,>WXGY@YW_9M<"C94, !7]A
ME/7/Y]]1.R++E1K0QK.M]PVHU_.G9G59H)P5]A?;4V6]>%7> !U0 2%0Y4V6
M_]6B7_DCQ!_HG;? K/>H:V*RAF$2-^UJ9#[X^ %?O'D.LDB0CH?FJ[8A9"[3
M#N%36ZWZZ W^60^ ?6GV[Q8OHV#,OM6S#MP)OQ;?V$?\G[9&30;[350%^/[Y
M/U]]7RS@D\4GW)%*'W(_ZJ>%0)XPC5!@6^66H[5]1K%-U[09$Z(4L,&A?:\1
MDA-^APR4Z8S*PO,A872.ZGY]_?__X\=G+Y]<"*-]B K%B7P]M&]=-#I%&!4<
ME)==Z<V7_S\?5B/S_"^0=(2B6!&-'XH%$""(<&8AI(8/U7:%2!A6"J=A,(<%
MY1JL?1N?4-@>WK@;$+KZMFI1FP[[N^G&K]R5'YSH#19A2O_?$1CSS>]H<G_(
MQ<\_?OOLR>*E/\3\J=0VJG_Z'9G#XOB2_!$<A-R3_']E\Z^QA*>03[[]Z=G/
M%R^])^AG9O&?Y7;WS>*Y'\ZO/OO&__'UY3-^?#_JH'H9+U]:GB7FO:IU!45_
M__3?U]7BYZKFO#VML/VG[[="WW<Z8\N>F5"[]+T)*:^L:-X$!9TD)3 A._C9
MP/YG'^>WS;BJ73MXOQ4K (D=HA7^K&[V=;E-C,1DF?_4-K#*XR^%[SR^4^*7
MT%QK4U_L<VE&2!8PN/;IWQ!1SG^/"3,PB(B1)E>PE9PM'FB7,46'[Z GJR+N
MC;G$4Q($%M&*&AQZ487-8"4^0\%N.B6W)@Z_<*^KGYK@:GJ;Q%T\6ZU:["Y#
MV>R,([UT:1J8?C_V?\8[9MX,OTV^UW7E;BK<TGZS^#N6:\U$KD"L$HH$!8<&
M\T#"@_'8X]LC<13ES<^5$^5PP,Y13"8"X,=SOEQ#$P6C$ MB.8<B2]T3Y-FB
MPB:T5L+Q3*Z%-^Q;8-#LC(.;K+[+Q6O^2LCL.%"+ND"K:_8[TM] 6(P+G47;
MS,:U5TV$IZ1#\D R!X\"<L:C!%!,H$0=4C$]9>KRX'Y9=6,U2.ZG<[+(_=%9
M$^G"";JT11QHQWO'O[G@&MD1C97D-E.X/1R@WB#4**X,\3^"*O$\M<$%-< @
MK0WRHQ"-C!*F^ L740CW&*O0)"X>U;QR29%L\!^\ITF(K%I1V \'2$77$=4'
M]\G%K4M,6H/K3;):))6QL48K-+L@2,LP9$1?8H*4<NU=));&*FR+#)9I5BWU
M1&1/%,XA]2$%QP*U)%<>ZO59P'8194W6R&D*3[6C7V)%"\O$10+PC[#_DH_E
M+!)Y67$7".>G=G J03I@Q.)]9SQ@P_\=#?IRS[8JS23:!&-($A9I>K 5\3>P
M</"*P#D<7TM2;1&[2)PMTG>*>6!;2T..5ADF!@1[R?:AOD%Z68N'AM7PZMG+
MQ4L_L0 1*=(CSG;(A.P<B)V)3!IC_HRKF\M?SQ^J"*"8J*MEY,\*1M=$^H["
M,J/E?R7O07[<=%?$HYKT?6A"^OW54!\T8N %J_O@,D?4N^FT%.H=:OX%M TD
ML3KH=0\RE=*N17P.L/]H[^/7!(&3#!Z#8S*=_P]S4(^E.PET87P(?2%P^G$@
M$F+P->K1*98VFH(Z2$6?.YGO$S1K 8!5H\*R%,"OD */6@.[P_U;YQ+_7_[^
MMR?G$O_'7.(_6YCWL##DNI/ZQQ[+_-9AA4 +I5)C!E#X)G<,4T#F#\[-Q0[X
MJ/?>']=B5X51 _)AG)LK_I V&%2")(XC/P7_13H@6.D$[HCR';:"(V'X*@X8
MO#?L8PDL18^*MU55$"3>\[\NQ^&Z[<CU$J%@_[$<#^<Y_D-:G:1-AF?)M,E(
MP3CJ,*P:[T9@&06=84WU^CD;0]*>?=WS%-YK[W_,_NGW3K%P_K-V3TGF:KNM
MKKHP*9C#\_][JPT5 BV'\)A^"?1U=77#0.BA\W_%QH$22\WG^;S'^5QZAV=+
M$@O* $M@#,Z'%4JR@YD%V+?P=9A0Y1;2YAZ_B[M!3U!(.OD-6?E?)Q(_G*2(
M5E*)-8*(L8I#!;H79HS.W>#WNQP$$6@@ED [!>31)O#6MF[6;R*9+DPK'I:"
MQ7X6ZE]=8\A.+4 S&@Z[D2A"&N4DQE.B.R^"^W>H[?26 W)P'JJ0@$_F?U R
M0S21=F(6'=UHJ9*<I^U>]RX4 =G"5EM0.$ L)C,Y /,XY'CK%O+5="SO<%ZE
M5(Z'=$(H2AE(S1Q:?WML*H#W #GJ"LQX77.W#G0IK=%62/>.K(CSOKW7!0#P
M8=N!?E6W2S\[(?+UKAJ#;)EK"6H]L!R4MXE.9B:.A2*0?@5JE-Y' YH"6&ED
MRWOI @4P<-?YP*K?(IS</PF +FT/@&J^C@,FIXBXX,:I;(JA?N)T-YK\9N.O
MU82NQWZ$Q2S2P6/OUPNVUE'0ASE=&0.]P7G=W>.ZNW)M6"8#E-^TD<-4(D+)
MHTA(B/\K=.YR ZRRD,HIDIPOD5RTG^!U2O]VYEBX9XX%[Z5O-NB5@UJ <1>W
MWKD#;J@"CZ!N8'82^"]E2$@4)>@:;KOT\])&;4/T%_]Y5]U!E.I!UP)_U4Y(
MH[0QTPYI-H6@8F!GW%[[#;"_(!7D9P#]*2&0,L!,*>VB4DG""4071=NJOY7N
M=3*O"N^L>E,8%L465%.9>^(*8458*B<NC459U^TM.2+F44W@6$S]C3Q=.>OA
MC1"8/LRE<!C&TBQ>NYT/C)>N(X#GT\^>?HX %0   $KAA)DM%L^?_?+RKS$R
M]Z6?V9^'=6&I=:60K+@B4W(^0.5I5\7EXKN02/5&_LK?\9HPNQ7) ;#;N,(X
M+N1R(G"N660&T@2WUQ\"1)-0TH' (?YEW/^C_4D;PO C9KV+(4+;M@%T&1TE
MF3&(KQ\1C<X ("\7/XP=F"4 D12:QIJ*'/$.D26,7#%)CXGTG,ELS<Y(])R$
M9%HZQDX&-1GN.",Z%!P=R9U8[)#)?,/]CO?=*]KH4<+&K,*0M".9/059?YN_
M$J(.Q)*!3-C8K'$H3S%V=8EQSKB#9?GDZ\LO_A_X9XB/+6NB$I<82PN&ND<M
ML1,M->-V_%O7U17(;)!@^H<9ZV+!_0EFF$Q?;PR\IE11'S6/]BQ)I-<EV.&)
M)E[ S1\Q"HAQ[$+$3'RH&G2;N:<DR^*M X"$6XT(CR-L82L)F4*^A:#4=J"^
MZK#H-.WR,(?O&-X'UC<S?- XH4O4'%S3A5I:HX121$BAX%WJ@@P] AQ[Z)#[
M#_R"YY8K/;Q0D(OZVCN_V*L="+_CP:[12\ (%RE\V(#ND>KB6>WM,OAV<J(@
MP@0[5.",T]H*/(N#UNEA@!MATMRV:>8>.O\Y;C12B(050ZW(YD:"CF;A-6#R
M1V*5=8LGL/)(<JL:+%)::R*?6#5R( HR-WU&(PFN?L/EXM5=L-AVKA-P:Z@G
M BSTBF>=0*YQPX+N$3I;$;/N3="JDW"V95.-&_8QGH- L>./%V%L6_C+W&#*
M;W;9A*E!\Q/<.G3 ?5CGUH[+MM#>X:1+BO&&4XZ%.5H?K#BI88/W(X8I5;DV
M!C%R[BI!O<<'"P+JW=4^\=0ZY\]G*$_DWA7N'+\FGT*!NY96S)ZD(_T$^GEU
MI*)(?'(PL"!ZL72LED,#+5(IH9T">.*\CS&"!\BM^LI_QI36T%[KRO6 N[I_
MZ]>D:6,B'YF#Y_5D5!1<>T51Y91X +W1.0H' W6F/NYK$'-D6&_5Z_OLVK:&
MT!#J-DT?-^@O+93X&EF@_9R0.@F:#$P.\TE%$-9@/6 7H@H)-@;A19#_^PJ@
M]K%L@&H :-?W'9B1-FU(1H8S$@P<;G\SU%%+/?M&U]2& =,S8]?#V^#@C0WT
M@O;D>+/O0X>795#!+OHS^/$0^/'I&?SX,8,?_T0]Q1 H8H\%M<";G#/UYJUO
MH(\]JH'-F8#P7>*&J/J!V\T@US.RMI(],"?16?[,#$<<L=#D'U%L,1]JF"?@
M_X;CG=D3J&543C=T/>&&%=-SL-@YW8*Q.7R#?:CHV69M&(I!Z06"J",YF%%G
M$I+ITDM(,(3@?2:*(F/-/80F2M*#7UQ$\44K%F/L&E(^1,"F]F*5P&Y9KJ@A
M"L[JNK*]6[9WF$6/YYICX,XLKD9!F'%4,5HA5W78V]; Q)5!JCW*RUYU[:T?
M/IE53?#P6?LP [>[9[QA*?@#%7QROTQ2? '&2K(?>$38YRE9+62,*D36ZWF,
M+ODS7'G?N95)!G_^I%@\_>SI7SFQN%Y\\<4"7O "74L3(SWK.7%(*S$U&;RX
ML''8<BA.*35G-5NX8U+$VF@:XHTRJS$W"<6J!AF0R:=4;\ST'Q8S#8B4T+3R
MKW$K[] &;EUT)*,?DYPBCE:R>.AU\#6%0$F4Z>U;<YN542HA=\M?XKK:L=F3
M)#OO7R 9X@ID$<K4A2UHV5<X3FU%#4Q]2X:2DT?!6AEZ:>T4,W9FGK5M)OG/
MZ:5,"R"-#1EB1&3!*Q29O)4,&Q GT^/RAC87^[BL&K")P(B$->#_H^G+5<1G
MR)%SR<7PNO(QW!IQ$Y&@@^@X,"!"NF8C[%U/:"R\>)LDFQZC-?QAJAJI)" -
MD -V,V,;:'HBV@3$&RDO+Q!S#6 55]>E#FP[#A>A&HU(%OOO&4QB$6O;V49\
MRXQG[.YT):1O%O.;*,>FA<&&O+GA0(B<T)U__!;+\5-#!,:J6/SF#<D 2(F!
M:O.(%1O92/M_KR$+,U3\5[VC'\=EU4B=%KFJ5'.T9_%L>O+H37FYVX7=N))8
M(X#@YP+B^J@F(A+5:%I,)\BZJBE?4_7]2 +DDK;R,^['IW?>LV-421B1E!Q=
M"QLH4M4)FFCMED/!1^D5;+2Z,OWOY19<03XO96.B$[SB!(P?=K\BT'F==>/M
MCC:RN]RR&^ Q6=UN8R9FZ^*0[&)=$K,)E("#LT7<7BS$"6&Q\GWA' []%E)G
M)8\=BDL^<"EOVLYD96 @L+RO3!MV">!5@-\S.=0DVI#'LJ8-;0"&,0.N@."F
M& .WB.IZ-*=^Q7?JUL PZP*V>XZG+=ERV)5.(CML@9DT,2I7265*P/ %HI?W
M(J3;0T$,<H(P1C'U=1@(OQGP\*6;HY_?N$TU9 K+>+*$-!2D;QUK\I)W8K:A
MLLM;JQ>V0M(2;1K)Y7FTN4J>1S:+:,X;G]&T8IF] C_@AG6[NE/I^L9=60T1
M\1[FQ>DS>R*A1RJE=C(@>Q_3:DQ+\N+=*:/C!"] $SN0ZV+V1[2J.;/K+2(J
M4[I^U55+0&XLVQM7'/RI/,:Z#;?*#Y-TO\6C),NQR(]7D3<@3#Z)K/<?!W[J
M><RL8]DU:]4I 23SB-5TYA8;Y5""@ZY3:@3B1!(""LK>DZ$D-4,K\6#7._>Z
MU&M.<-PAOGJ8DW"L%ALH=%#NYIJH<J2#8W7*G  ($)"!UHR1QB?9V]D1RRA*
M:^04/1?270D?'#X; 27"[(!H"=9P+3-+AO_Y<O'K=54CXTK ,@G:9XY"&O^^
M!/4VY7?;1+H>&.32F<5EHLRE2')J[I4MOTI.H;&/3[="3I)6%W:8D%5=5EOE
MR:)_+;8P[\@PA\C+?6!.Q7<<>TXMT.V*Q;4#$XS,OAR-(Z'7G 2&5!9[G ?J
M.UM=FQ(49=W\>( +DE2W-HYB7/_3&\,IR$^.SS=/!VZHEY 4MFJ@)<WF.PYN
M>:A-7Y7=NN:TH9_2:E!\.6I5C8-_3U=,1C@F93N3C=QGYY*3YK)$R?0H*_BY
M0> >IP7WVEZR%9W;C4-H$+81@'J(6[>NRA 'G&?G'F<',IGKKKPE?$!REA,U
M8[73$I/W,D.V3[/0R6%UGJ][W4W^1%(ODR+!ZHK#IN4^).//TW"?TQ"SF?:D
M9\!."APYXN:"_T"S<YZ.^^06X1,>I!=K<)>#64/_KRZ72"IAF2_)+00\$A=X
M0@/M>:[N<^L8'WO;-@[):_U,=6MBA)F>/(&HZ3PS]SDS A1E4L\S&]]!0-KG
M9T#:QPQ(.UN0][ @[MUU.?:V&!.J2*$M0- *JW('F=^0BSU;]_M-C\ 7UP(^
M-W+0YW'_ UB5@@K#I*Z9X (G+0UG1H/[9C3 2G*4V["(J9.2B(\1?6.[S[2Q
M*TD"A8QVL. B!, @G/ 'BQ]8NW^-V.G1TO<!+A 5TFSM!?/O6(Y0S0([ZJ:Z
MIQ%UZ%1"'(9;8X"'=:!J@]NMO@GF#A$,AFW>A"&J&R[POPB\,GUKZ@:TT,BT
MPUO;='$=<3/)M$AX2)-4FGBG\CJ @I@\$K;DX%-C<3Q((827B]OG=;IS[S<@
M;*#L6P(_TXP@7JG$WIL1\*9F?GO_2OV&V*;"5"D0O.RJWF%YI[1PD&2AA3I-
M6D7!>KU#C1M,4F)AQ;_Q$FDQ!EOH1>AG@^\TA2D 6]V[%1=Q,M]AL#: QOH8
MERE< V$Q$]40/8HL S7<$^(*?Q$   )PZ&'6@-^CG3DLG$ @U;FP\J04/+#
M ?9#@=PBB<;K8$7@$2S&U0ZJJ6//Q4MJ=C,9M^P$/T;[&]IJ5V7760N+M2L0
MT 0'H)6ECW5MK77J"$8(^\O%:QA>1JOHU$35;+/Y"7,84(XD[6',?J'X\X 1
M,G^\;;U]ZGI6+B3X<-.7S+PP<Y3XO^RA+=)\L*G\SB<ZA/ AXNE0F+(-M\#=
MQAV<\ID.G&U5?MNTM\7BNKT%!%;!%EE9-.;M(#&2BGE#(4P&EI)]O%S\PV*,
M&'<DC8K8-VVM*A$8,< <"MN@9@YV!'GS%DC& 2PA:GTA40!H,S1]H(_:KG#J
MU@2Z/+P3]A'"CLK^R&QNTFYDP<.>FU<0,7!S48N>QR)^/(:-6XD:-\#RYM)7
MKI5!Z&X98]H&%@$F)IL0ED5D9MR.'= 3IEO 4*#AE!+WD6#X"@&_[K%G&'JN
M)7WGG0AB"J'K,+Z1(&R$$_2&N$)QT:R(N$&CA=^F")V\#'.X^ (4,TG R(P<
MZ@X"9D+/@Q*] 23<D:[[Z/O><%Q=F=$8&6)$C?WMLI;B5WCC6[B]174F8$YZ
M-VHD%TB^Q=)9"#(>0,AW&>-G"E/(]L\!B!<SY#&(+T^K&4E6PF9ZF-OG%)Z.
MR/$,;!WC#GKVCFP;__>N%#@ZN0RT?GL^Q&B-5CV'R\QZ%#72&+8<.\R(%D:V
M#D",EMBW"/@A"ZLOR$E'M#\ Z%M^!D1O KB/A0;)8#*;*5)2HB&U;_>)PFX!
M0S^@J9>N>=#FF^\JV ':'Y[/B!6%ZP8.W?B&GU*TA&; +1B*SC4N[,XG=4WS
M-GW/&QD[^J-M%B##MJ<RE90+1J>(QJ&B%ZENI,N24-D5M3"0ISPS; 5,;4JX
MD2"!PX3^*NSQ &YOQX$R*NN%JUD<DJV4Y<YK<WU7%AA=&I(&_.H%?'7_^UKP
M3]+^!.YMT]:!MKLJ&XX-_76?__*"+O7\U8O^4SP T'@'S##US?*('1C>Z+[S
MG0H;_YM':82^<_VN(D*)T"&L(;:>DH&:,C!*])3<60NPGQ=L:WV PP:,<9E\
M[B/9&Y.-M=JR]WNNHP $#4;W).MD$CR:M#G\8O#D8PW! 'O*6,9:M[<F\;(N
MM^"QMCQ>XBL(&R^_D_T;O"K>P3].O1D;:>9"5#UY'"5(8O:&4]@;:>X?\A84
M) NV8R/\TM@J#%:U0P/"WE',V)1X2HY=#W\FP#D]\&RAS30*?0RHP;80:< M
MWG,RBXQ%$.[;7&LH+!YX1(R2+LIA*%=O\6FVX,9BUVG<#_M)K%?J#^' &X7>
M">1;ME!\1$X<O]W:+?TW+/T1 HZ;JANQ5<DO'[]Z+MK-A;P'/P <RNBQ.)"!
M<(YZ?)D':G=-ZK?" M6OT",4%WHZ!V%]^ZU)AIH##T-4!$ :#6QHZ2/$6QAA
MDC,HG#MHY"WG &9\PN%I&YZ,UXJ%$5J?L6?"#GXYW(=_CQ>O01X;4$3>_8D>
MJ4///NI]4JYKSIW@0;UNU5-OO&F-I(*U(RQM."54/D2CL-2FL]1JQ$%@<87]
ME^F48B"K\<*<KG.TH.%$PSR GS>_^)+S:KD/B_/:?Q_WD5!;!F9";LC ZXC)
M@+&'P)F3&<A%*N!@IG"C,[]@(B/--O0M+.3!T-<##G6+?)ORV.SAT!-+'./?
MCRVS7^]R2.M=Y[*P$) #S 5:C[RQ&O8[2O3HV-)ZSW:+RS4"'Q8'5X2AI>..
M$Q)6^%;3I7!'7$7IW6BF<0%5_QK]1496$Z!1]NX:D,?5/5.M^Q% 2:X!!<W]
M YZ!(X> (W\] T<^9N#(GU=<9;L ,M%7/I3P6Q9H$$'NP_M9UZ"UC)82V&J[
MZHKH'\EX3=27M#G.A@\#=*T#I<.XZ[7['OCPT%'..3T4TX!$3(?MO9N-/XR)
M:$1-=1SYP)G@W>FA,C3&UM9#6MQ;]=4=$OX/*%:Q]59) TN%A**.@SXYGMD4
MJ.5I0[#&1C-#'7%07Z7S'7/(?CZ'3+YO[2WP/CZ_Q<W)Y?D.U;O KW(4&S!3
MDN8E\7*8VR%F_Q[Z=88^*N-J*J2=CVFSJ4T]()5^8#3E!4Y:FXP=12Z7BQ]0
MH:"$(Y3<*'G:I'3!7ED\<CANRN:8XUR4V4IZ78Q#PN$[0\A%XAV53"G72I$M
MW%\:Y&1*39-XDN3-^'&;$Q98P5XU/$S9H[,/?H^R4T;M!I "Q4Z=D*52Z@N_
M,",)(*&V] L3"ZA8J-)H!\>6)>AZPR=D.P:UC"KYVX0+@"8@/,^1;?*+-RVM
M5(7HU0[OO'M(ZJ/ZGK/:>\=F4>D!V+DT=6E8.)C<%.<.K4 <)!H7$B_ 2RAI
MPPHX):B.$=I"LRN8+T],3"'4099RR#JE(@_"M$UDES@Y0@H]FI3DYGHJ%6/5
MR]"Q<5D/1"56Z#%#[&]HBIA^B"FB^24:!Y->4@?:<JR@T@5O//98]>-^UIWK
M[+1K1*%3D$:#:FFX+&-'4,VB#8=,@!Z8 19X" I?U![\::9)M3Q::0(EY'J!
M IZ7P"IL)3)A763.6DW6(+XE)[J7M<-F7_@81@R!NVEK5.SD^0)[&0V7ABT8
MRZ_\'615\ J"5)G=<V:@5VCTI0UX"?/C0#P2HJ@)_P>K7!G;ZYJ;JFN)M'Y'
M(BLXZFW^?@12H-1U"J*A/E*B1X%7A[ :EX8(8<92-N(2P7-]/\*P^BWRSZ8B
M:NPG7WW3+W[DZOIW,$\O@W#.*]4B*##V>BD)_Y_,,YOO_US>BEU]Z5J_U?0.
MKQRS*/H_/[_V3AYMSV^[\M]5K=_ZV57^63#AYOBZ)6Q@_V#KELF ZSV\HAA_
M;UI0(HY.TJ"<P.0HP%XB7"BP](!E ]A^A&L2V!0UUN4</! (!482S,'N)V?L
M!K828H-$X?D1^GUOB.T N:,'P0CL(W=K8N[UF+>>&F_G(MK/=/JQB @?43S3
MR4EE/M4#2S^;G%L"KE##8$XO^1L:''#*26,PE&+]RMN1(0%3[=]T55.N*<U2
MM[,&IYCWYX(U-7A 26<51@V<2ZVN-Q?C@Q=-$Q^^V/42W+>5S$GB\3"U%-%"
M@\1%#(K0UF;U5B#UZM::M-\0U<\I].BSA!AZ;?0^$102L_PDAW,@Y_8K2%)U
ML<K:&)?2$THB6*EX33JX<?5"LA*/\[%A91F(\J@F54"ZJ.!PPLQZKH@92[A/
M_PZS4G9:O@H\[:C^EU9:#K0O"_)3V>7#;%$.W-5<XV<[A'9OX]9H)#E7[UV&
M01W9R,=5TVADBY&ES <!<CC02J.;P+E":VW5=IWDY5:!MR<@&>(?ABU #+U9
MFXQ3)'$E>3BA-JMF9G9*\K 0Z^$$684 8]!D\FRL]8PXT#!9#9Q)[TF!E.4Z
MRO-(D6VY&P'20\('@BN0&6&FY5?ON7,HU[T2,BH>6%>AL6$O2H!B$B"T^A?A
MP+I!X1%)U9.'EA)I*5PNL"#]4?,7.W^!* 9#N\X%7*2RN&6@S8C"LTS.*=/=
M1(! ZSX">27]%0;S)= ]*F,%9D3$\&$Z_1!!F0I&!!%,>]1%MKIGN!X0?*/R
MMBM9 $H1B\! A]\)1B2%X2; :-JA?<H7=V")/4PG[#W ?O%JTU(^DE-%T3/"
MF6ZO_>#=.D8Y!<(DT:H2339&;#+59#DI;T-YK$&17.-=>5?*1YA0@%K1L#]&
MD_6K#@YO?%,\C](DFDO))(Z/8FAB>$Q4[;=^'&>*YSF81==#+(*1NQ8G*:"/
M!&E";1N@]T+KQJ\'C'?@8A,<PZ'YI?BX=_HODR30]#A5'<."@=(FY$6\-<$W
M0)V53=VV:ZY,<H=EW[2W &C;JN^3/\MMTDE)>N8$MN"UQ<GJ!_^H.*T9LC+O
M!'H'',Z$&L%BA_U;/[@_*S6L?2#$94<(06;P DV#FSCLSD%(8"NRXC2""<N.
M/G2]?UY]$BHX!'8_-+-@!*RJ-4TBHQWD&S^VZT(0#U'!VP<.G"(ADP(B1,1F
M9\A!^2@E,/O"[]:58V95[@\T.: V[3+RDS@$^L(L>EN6KDN$QJC9P* -#78G
MU]4!T<M^![<6)CS<J[U,47P^1=XGT]FQV*U,&?V #TTRHG"8^G7GC>P:WG72
M0,9M!4Z:?+"9C*A1M<\(K2[YF>EBP/&;;$ >+ +XRF-]B(TJLN8G9-;X+,'@
M0A<"5N>12CQQJ;+L6))#:W)0R2P]_/PQ<J['_^7O?_OB7(__R.OQ#]L#-83K
M[-A;;S+DMPHKQQHS?Y$UXGB LDJK!]R3<\R!#(UJ1@77PK2!O;-?,UL3_9'%
M0MG\8M\OB>LEE>%E5'$[971G!Q?#18N:V):DSLEUI7\V"/Y_/0@-J22'HL<W
M7A^5&;S#8J+!V<8!*[LRZ9LM;!D$%%MN =56NR7HL7L?:./]-*%]5>A^@2GZ
MB[?5ZNT274[\YQ)8KKN _2>73QVZPFB'1H=B:(VE;%%HTC8G-G8&,]8U:&_'
M;C<<YVLGBJ58H)5X/ [>C, W'*G@48#O ?F\*C3V:78 4V=M%V7.4D>9RYZ2
MY@4.=4HFK_R=* ,F:+B0="Y(GX#UHZ$F'2-IO$]RU78B$ O\F TE  'LZC9%
M# WV>XF76VAS%D6 4._FDAKZPINJH6&VSD1S)"_S'HU\#RGL_#E=8^]C+25#
M$[<P@S+!!;J%6RQ&/PM#R;2_O&!@;@E/)3,1/4]"U@C D]PC' K5)$V#;&F%
MK$6[\-[Y189M/IHCE!QV3-;,#7OFP[5;0K%B9DE.&/8R&5X:UVV[UKQXGP;1
M_CKPH@@M.Z06<&2M'M##^)[Y'R@JC*@ATF).;@*@!APB5S\H4(U.220F6!@.
ME#<@]D%J!%CEHIEDK0O3?QN\=.I(5!X8A2T\S'/[/9R;N>Q/ J"9#[0.=,0&
M^:5MU?/Q$6*M:LNXCG L6"/L7=&+]&@PL1O,U1HY"6FMA3H_P[])P0>0;& 4
M'J'%Y.9-0[$P&'B_]OQ3Z3)TQ6VZ<ER'48Y'?EK.IUYZ*@[3>:A#; >53OF=
M#\^+3%TOODDR<]RCXWT8V)IZNH=?WST!.;/FZ%VP+,*ZS6V77S/XN5DR$0G\
M<3L7NS69DN7EXI<P))1RAAP39Q>T9([4#K:O25HYT@GZX;MGD1O$#HAFPY'#
MGQK!\G/)16#:9*+,1\*;0P*ND\Z5F1_;QXHS8#J\\9?,$49K$S-XRW$.L))U
MSNDW75NN"Y8!-48ZP9XBY$'>#;*;H=+MTGJX.J0L>?I38]*$!0D?6E+:L/"R
MPE_R\.:==2V67139(-8$?9B946 9<PO)@^$KS&XK%A(+X"ZI-SZ6+^OX.6&D
M$0HA![MH2LRBA81IEZM[U]6R&@2"CJ\:ZY[EK'>^PSK(SR<RE"B;5RU';DSR
M-Y>/$8J:$ ,S;0TQ Q<B3@G:N#VU* %8#U9(C(>>G[53=BLW9T'26,&6='RQ
M6DB0CX?L,H)G-A43*T;+,_HG*GZ1_T)E#FF SS%601).W%#%_'K34"S>_/@L
MF/RYG9N'#5C[&"*91@1WX/""=D8T<A.- -/Q#=UML*7\#=8"(L(!-08):J]U
MK2)QP>[#:O&+# "F"""%U!V =_I*>JAH0/?LR$'"6$_ MHL.0+L]!->3JP8A
M(!9SX+2@!#U3Z9K>6W1R:,_"F!4UC'&KC0WPV.#4CHV0(&#?G[0&*KF50&V)
MKP(C@-D@R+!5K/0#E4X"U/,VQ#-S![O!!<:!-)%]21@D=R![1;+W!HDP8J4&
MK&<<!&6RX''R.V *XO;7.&*/N-HA;"]"S(YV?^W_&X4U"=,5HBF.MXK 4\T1
MEXW@6<H'>)$*W+553VF7(JRP)"Q38!)77!:_ , 5VW'IOZJUL2D' SB=Q3#1
M%VR?_ A'YP1_,4D^60R8OF^&W&1=X2A=D]P0LD!AP8%]K+)K*,J--'-93QN?
M$AP=K/08I!ES,DV1\+#-NUW+WH,V]5YUCL=<%Z]^1$A)M)_>"+BK$(#F7'V$
M7)0,YQVA.E7+A2-YS"FC1%[+,5=^,WR2G,>\E%RDY*<2Q5\4$. ,& L=M41(
MUP7->!C$#]\Q=T#AE%9'[KS7SGOM#]QKTS3H!^V_<R7T4"7TRW,E]%P)_1.3
MA6;#C@#(^;?(1P]B$Z!L RT0B&#Q<<ZMIN@$8L(PK_(= *<PZ'/:I!(5_A1N
M^3!SK<=R=WS40UD/8BL(B,;M2/9*H@+JLE&&B4@,UV)@6?S0 KSI J(GV4)H
M34!3.H2^\9^/U%-AR#:U]Q<UD%VC-R,>#GB$\AW'K'@*1<UYAZ<<2&X8?/6/
M%S_W#+KZE ^1/*D5K((5-(\-\8+!E@D_8M_YVT-)^3__UY,O/_OF\R?%XNEG
M3_^*;W5=KM49\/=+%IS_[7\\^>SIY><^&O11FHC987M _MM_^^KR2_GR(UQP
M/S7"I5)PX\%KZ>G\_.NG^/:??_VY &?_>?D:4EU,#/"*Y&06SSEP?_*WK[]$
MQ&:YQ124ZK/#%T14NV,L&#:&!+ 9N)@XRMZ?*(SGHE5A?+BK%A>_@/5\].R=
M@^MJQWPEBM@+]##>\\8\"0*@1446&]>^^(Q6AU^,<#A#P6'75N#>$O?))\O]
MXJ:L1_<I@A6]J\;B].&N0)S"U@E%%Z[;&K/,1(J.O9+N8N^7,("VJG:-G'AY
M6P5^/+J#4TL)'^\Z=\'/!9M$,@_RV9TW"KI.FTWO=Z/W< :Y3KR+0Y(&[,#>
M#9*:P70-H$3WD@R!$KX#1U13 W3%GGXO/+<TE59C.7'G1(D6]AKF8 YM=$&T
M0Z^W]BHG[7BXY\&Q1LL3OU^1NSM\--WI7)=\[T&FINW81OXN9]=#*CQ1,P2D
MP2#G61I2:Z:,,"E#7AX!Y-N//=;F>2\,04X9%KR)%\:&3ZV&F>P9WZD%(MP@
MW"CS;@<EVHA EN.DL0G=(6&>.!+C&8*)C=2"W\ '[JKJ&6+LH]P509+\ ?/D
MJT)RM&!YAFJH'641X6?/1P[V_G>[[!?/_(1_ G]B2P;?\)_)X6>MJ'0>/&\[
M'Q BF=OB6>5MR:L *EE\[W=F"TT'KZ4)++W#\V>OOG\=WX,+2;WN53\.:.'E
M?(3W[[2,@E7$L78]V4V*E7G TX4O,*"$&B/P\LYXA#AW83J2'1.I8"=M0WI&
M]^J44'7?VR7Z6^@J&KDNRG?AJT<_*QN.3@?,[OQ )UGOPIH3/8I;HM&C+.T&
MT$%"H*Y;?&QDF<&2-E5"#.T#:%Y->\[7?9C.Q1V#@>_?R8F%'$4U9 A,!<G$
M^/,9JTR"ZU&:RQ_LVY."11B;/N'96[KAUC$[(N[1-> L.MV8SZ!66$)RAO]"
MA&V3],F8= PPS;/DB7#M?^=J "+I?HLJJD4L."#%&BT[V8/1_UZ?*SFQ)Z@?
M[F9=*<\Z%.9:=JQD(UG\["89/L%@IL,8Z""/)E'GU]RJ[*^A%^>6JR_DSV&-
M%?_KTMMW'A(;.S%";Q\_U.+:K9%E(JT 8R_)79;RO:_<_"Y^A46J5RR%ZP?A
MA;K$?N@@X'].D_<:)N]CL%L #<0B7N$= A\&,.5:V_F#$@EJH,:,[2O9I4L-
MI42B0STP3%/#09)J)9GS#4MS5H,G;F>KV=N)X"C@+97]NOS7PSPL#IK#%^G
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MD/,29%O@+N<YO<]HDH$)-VT];K,UZO/PWZM+ YB]:7XU1.>;$3OSSK-PC[-
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M6$7!TS0*$2 6XK."R[6+#A "1/'2X80[2R<E6XXEH'->T&)EOR7VE9ECN7(
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M<.)KK?@(WG(6G2Q]R;+'O\"2#V3PN\:UBI.BU56-G2Q(%BT=Q5K\K1 EEGL
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M_?QHH%6M% 5#%*F^YC!I.!%PCJ0P%;DT6IHZ,KEA"L%!<4> SW>4]*JFL4+
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MQ92Z!7G)A.BM@!';P)CWU5)BV&)TD)D+LRP6X"(O7!X7";!=U9WYF JJMF6
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M@L)R>(<QQ?8E87M7E!^PM%;P\X*7@W'Q9Y%2_!+]X\H8U90]HW#&"DRE9<C
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M8=V'@[9^6X^CL\L'6NO[;=W>;<4HW_/A/LKW!=>=.OU_,_4@*ZI.9FC-])W
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MK;M^_?;@^NW[@Z.C8>O6_;C?I,?=)%ALD+D"4;7 _<H;]'4BW3[=,Q%5%=O
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MAEHK1=Y);<6#S*PMNEQ>;-"+<LC-RO&HX\E#>QNW?-14*64.Z8;<QF5:--4
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MZ3['[W>*Q8H&L+JFEE-=/ZT'(N73MHMF]E6&;;$W)&&3@N2KS]UJ92:?LYE
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M2Y.#>0%"R+JMOGZG0+,ZJGB:Q+[Q031I=AKH1GMOSPSUR(?+[NUM@2X_5?7
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MUG*\E,C$*0OJ3)'/C!;<D_<?T>U$@,FA(:[3EX1!6@5)>*H"-ZZDD6C J;D
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MPAF??%'WZ0G.E!>W5E>/Z,P%^B^=GS-N'2P_I]90*T@_99R])OUDZ*1=H7C
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M@69?$@$-] YSR-SI%F3Q\\ZQ["G6?]@>.L,LSX^ YL#RMVS$-(B<VP!!#>R
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ML=6QBE41?^5[X-^[,V?VX?$/. U#6]%U[F45X YV'^PW^H.L!E-: ][Z*$]
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M;F'-YMB*V>U[&UZ,PD]PJ3P&WY.W&7WI!$M<[YR"Q(M%T_HRMU#$1;0]4S<
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MD$Q\@RPQ#'?GT/P-*HQ H9XQUH::J:0K7>EQ3X<L%%Y^A#E!O "WC'PS%/L
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M#*4O3$05ES*%)5Y6-)ZL/Y@52;>?_@I8<] :5/*0?C!.+2<-7"7OD*LX!!9
MK^AS'J*LX<.]A%W4^+W$T' '%9PH'XSV$LJSQ7YPH=1K,,?),AM,B@85\2*R
M/>S-ME!9S##&TL*W2(U5YE^:J<92Y:5RMNS\1(M9RI] +4<D ,U$BJ?LGD%A
MCAP/NW69;&Y'J+<RC:_$JUG?)S1_\A&;;IDTKG\@XQD+#%!0:SA0RJ7R)6".
MI8;.A7XRE,6I6,DUR7@8>8KT6IK69PKMY'[9R*IW@2-T/^6B"M'R$9T%)(Y*
M@VK1HS32@"=L&M%VT7RK3D7D:(\T1[0SF?)'5IQ\%*KVB$WK!WL5E5>+$U])
M#4I0938\:MI>,GR4-R&BD3#KZV*WFRW!G]G8%+^1KK>?OD!X3J<R)TJZ?&X=
MB;=EL:@$QG,2;6;1IQN'(7>+J**,^P87@#5LFN76Q:7D%5'S=D8"$ (=$\RD
M./\G<(64Y84*7CN;FM1NGTC=J+S$?AA2" _X4LL\%#]7B7;#ERH?_01S(+>Z
MMD_/\?$SWSLE;YD"#0NT@@+$#OVHR 7&5%O>'9"LG(4D$XL8FF9)?7UN?7]&
M'@M9DMX0[6S%/2 <' 1TKY1$,[1XIX+K$7K*.#@O>_TZPA^8R$T".0VR///B
MIO7%RX8V5]RYF_*0U,TDE\IQS>0=XT;8_&[NHNI#A;E&RCW?5)2SK5@B>5&(
M6H\PE;,21LXJ-%)19#*6;@G$0<.B336 O8E^WQLAFTSO)NF=V# D7J^)TA2S
M>$(#!QBC<<=4N,1 3DPC<T[ $W(1B2G*.:8BV?@[4SVC;G_F2R6=8'#,H]S6
M_,CT>R-%Q5X0!+6QGYE7J)20_&5SA;#*-C$U-8-HB#_>D([V6U)=AE%"RF:B
MLNK\EYR@C]64%W%HMC@ST^V!NFTS62A_BY-1\B3I"CT06,4,2$Y\[-SX9F*,
MG3W7Y*.I9^E0I\;S!0=KA[G,@5%C8_A[<_"D,+47H;]FAQ0KS;#/ED\JM@7G
M!=JG[W%R"#LH"[(P,)5JQ?F-@?]H+U0R#&J@X3GOK!ZO890ZI#-+LCN(]?($
MR#Q!"T1$X"<PS8=3= 4G3D5TE6=KX=XYIW.D]GE6(H-)V;^IQ%URUUO3A$ID
M5CYJU\6H-:JDZ\)0Y^ ^O302FIZW@R?NE.FT@/TSL(>PUC*G)"ECX>+)J#8Z
M"8X1^7ZH62PX&R.K2^1H$E3^K'KGR;)4H0U1-R2=IRV33AL<XTMXP=Q$[(B5
M#:.C7S@%VQL%D-#,UCC6LE-4%[L8D*X<]68"$='YZ*PQJ0:1!;(Y*<PBY 8S
M[JDUQ*297W#3BAP4<2OK=$Q1>HF$F#^/[ 5;\#M,]Q17[DE69Z6XLJR155EY
MZ]F+QW\+F,NDU#3JS-&=2!2>53"+6 2D P;$314_6>)G)FJ*8C#K7Y3]J_V#
MHN,O7@CZ?H=159A/,@FEL(H&U=P+UEW9GH9J,P8BIQE"PS"5F^7!@1O^*4L<
M'FP,]ZD7S!PL$'.\2-<T+)<8BD7W>TRMWW'EHGI1OBS;)39S7ZW9OP(1([?1
M#MGXDN"3QK@F5J0^Z9F8>.)J9'2 PJ-D'<=PLB[0"4I9W2JAT4#^),5%;%N(
M97ZBO&/-7 -'IE_:"<G$U1Q*DB<WHTY9VS-EK5VGK+WHE+5^;LK:H#AEC9RB
MS^T&S3\X(7U"PY^T1IZLT=D.)+$V77NDS_DBK7L'X6;H<7GI2^&=K4MJLGX4
M^EK71H@@;A)(@R\ENFT7M L8IW%FB6LR)#-*E$OH@B3&4) Q&K$%JBZ1WW;8
M"N0? HOTTIM]U+;X)YX!^_VUN[]S"OD<<D5$*<::++&H4U0J$VLR?28*XOQ_
MV<O5>]6G5@.@)@JP,%J73N@7QKZB+M/RT4E]/+Q^)A>7-<450+Y"K\37R2$T
M%YA>3OAAZ'N>LSA/,4&H2H=">P%O(F=.Y$__%$X>9"+XG0YV3AS/F1,\TMR>
MRIQ#45V4*$!@596JVP1V%ZED(M=-YK\YWJTMVND)3K82H+XFZ*UY,"F=F& ;
M)>8K9OJ"T<J#(<H.UX$D+ <J[ CU+ACX*@6O2>CP231BY6G$>"^G#PB9IHQH
M&9/F;9G#2)%X.Q*.Z>,A(]=!QW[*S8V1;]/P,,!]A=>0;@ )X*.]3:S^6V0P
MZ]V,"-I!._&X2@XN>AB,7"#V[)[LX 0<,+L'R!4HET:W#[E')E3#*!O\(9 &
M/J(HDRR1N:, 6U+-$.7O9/V-.IMM\"82Q<_"OY 87V38YD3Z=:V,;;I >+K8
M-R%@T&/QK:24? <NA8:(N@QT:6ON.&F,-%$$%9I7$.T; W&HT>7&:O+3F=]
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M87#;_D4^JAC>'$B AVQ:F>KF;I@I!=LJ$C(V)*\U,<?-1*,OJ!:6O9;  #
MI[1WVIR.F<!E[KNLZ)7GG'.Y[Y!P-W-G[/"C&5*K2'WN:H)8UB2G?N(\Z*HL
M$=KON8N.2V>F2EWH8C7V5=VK8O\I#D Q?2!6]]8K^.DEAMY!O-I,B%04%NB
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M58Y->(0!^ :#J+\9R>3T4_V&.\(P5]N5[BU:M-.L)V7FX3(.C]Q2 Q@.D[O
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M" MC(84%)Y21'"5PA3V*28N-$N)EJT)>ZPV)%#\.,?#VV[98G\P^(D(GC9H
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M613/P:6#9O9*Z,P8G%T,.JV1/$YTLX\G0%5_?<@M2EUC"=ZTPCBBO*TAP(8
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M6*#WP2=1;2<-3P2* 6P#C($? 6Z2TJHQM)S@+6B/ VODGX*&.*&4-OI,Y><
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MICR**T4KCD:-O3##XEX[1%%#7'9H^G_ 7R.4NH#2OUY=A7A '\I?/G)W7PF
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MABY$&IWE[_@1=#.;;*RRS3_'-/2^->B-6OU1<L!E1@/0=L$)8/Z95OC)$^H
M*5Q#25;5CI5DI^V</E_Q-*5HY7OFY8J:C$BAA(5=?1$G/I"Z9GF E1IH9CQ!
MFH/$[\3V\7.B&#Y&.!F.%CI6'E/L$!G1W+W0DTA#_DC.+AWVV?_+%TUWEH;Z
M]EDWB2CH1U_BZZ%[;67&'U$M_SKTO+4[W/LF1HR*-XNOV_#5I^3GO5Y;Z?=2
MO^JTY=3/LY:2N^W.*/TG64ME?][K#)I-O?^F^KE+K1E@ZX^K[."P2K%.SF,I
MXUBY>WQ/PT?3Q>RE!TS$1MW^;Q/[TP5GJ9G#G(\<&%R.$2#\AMDFATM$&I\J
M<+[K(!\UWM4?0?)/;)U]JL"XBB@< ;Z@;*-_H.>,_C(-5*(8H"J:(E^32<\9
MM,2PK[#(D@0-'M8N@"R91R\\1?A 9SVG*^2C[AJ%?$5YY0PLY.FE-6XPR >C
MECQ46H-Q4N/>Y@(+LH$& 2I  &ZAE;[\_CMM[RX4IJ7W.  $[;:4T;@U'!<8
MN58UQE:#I1VI7AP\'57_H_ <^'*'/U "3?'AQM%?68/\$06*.[0PEZP8 83U
MHN.A(( D\G-9NYM+PZ]*75YY!M\(B)T(B,!W2KZ[J%\N$!6\[J@D(QZ=7?1;
M?4#%03\9=-A.VYW1_PY6V_VZD=!9?^C#QU7EG;79\=G%2&[!?UO]JK39E6LJ
MS:R::ZY29^UW.N^TO<UUUGY')J.JVQ^U!DJ!@MJJ\;(,+AZ;9IIVQ ,EMC3]
M4WEO_;/?P9A<I]/J=Y*-6THJH.FL<&=J9L.YMV>-NU$F^QT%.&2K,^JWQMWD
M;(6D,OF)PHB%"B/JD\Y #F-,SUC)9LA,9MA_ZH+<C>>R!S%KT>)%9.I1"P>-
M:I<HV5!,S#2GD;&UJJ_%\>E:P;"9H&EFV50%>0VJ<H 3A+?4(X'5 <\;]EL
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M7;D#H_0=<:?0U?ZJ_L1Y[JF4K9Q=)+W: 5VG06Q=_E6L7Y<:_ 05:+K(B>>
M@'&"A#)]L6 :R'1&'8;9E-$/_<BWI,ATV1]T@';JEB+-*\45K>Z.IPAB.-V7
MV_ANR@S3+4KWH3F]Q*CPYNE?2.7KLE5XMVE*JRI+F>.]4R;%-3K#<:O32V+
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M?$+[4=F%8HZESR55]D&W&I7]L/V[A\1YWTEE7\]8"VKR!?I4#I0*-?F&S9X
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M/WO1+<^!*P5NAR^AK_SKY'MI2[\!4&UL^T*<41#_J$M'4D:*S\!NT;XPT?T
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M)&C*,]* Q8",TITY#W#1TWDHPG64=!6^7<3AB1>SWM\TPDA4L3E9NV4,Z3.
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MW3KN&(E2>UAFA^])HVY^^$R*=EJX4;@@!S.WA5E.X0> I*':TLPSIZ)R%LA
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M7ME!,HR(K9W@"W?'Q!>0^Y,(@#N?AH?> V&#./)%]I\>6$WP4*[/FC05ZF4
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M%+![HXQZ^:RRNO)MGU0H5-!.HW-O>6O#(73 HPB=HVT\!M+6"5K45@0MUI*
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MDO<)-MHL?U;P^VUR4A\$X<Y,3J0__O+_4$L#!!0    ( -"!>UHV,2]Z!1T
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M'8,'3H3G@D=&WV_\[F_"LG</UN\_=YW-7+_+JZ0FXT7XJ!ADU'4$89;@3;U
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M,++SF<N<M;XJT/NBGMZ$@]+DF-(4][WJ+\:?QQDG>;E G1Q3EEO0L38ZM,J
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M/8N\=7/$S4C_F"[N IMTX D#UJL>O.88:WTO\Z"MMQB\X%'MRX^[G_QH*-)
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M_U$O)K)>5_[S <U_>E%<"?CO!::K5+>EJ9D?&]+8>;/<D7E_C?5)<FYM#ZV
MK!&&[;7/.!V[H-S:7>Q_JOV/9O^_*1;^?TNS_U.Q_TNO><!U2@JR\RB9 "
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MHDBJ9A(JAFN=>NEXJ7YV!9[VQ_Z)L*?@,<="#,O9).9OEM^/1O#-NGG);>,
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M_CE3D+6//E<H9KY=C>G(6DU.^HH&89WZ4W#&:TV=ZXJ<M.)RK<5&P0XO,Y7
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MLN?ZUG)H_+++ZF:&'G2!7#G$;R<"Y^IF7D+L7DM\1B[*XT3QSPA"\%4DDI;
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M8JK<4/0ZJ=P>]+X3:UEH%BNN&).5=KZNLR DN6J2Z'HP&V?/09@89X[U4(_
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MQ-P%9V($1^]<N-#^VV [ A^0,315 P;>P^"RW0.F=53@KLR7,[I(([WFX/]
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MY(D"?W"D1S#:42B1AL'0;LIFJ0H%I =_K'^N@-XP$A6;4^A,RB<70.!"TEK
M0<#JX0&89O>1S<(@PB7Q-6N:6@3"T+9^XY ?%["&C*SJL%J/ZX^:F5 ]JO52
M)+AB&$FTT5AX_\J52X"[JMC:0%K-)6 NP+([<0=R]#*,YH4W.!>(L=:?YS#
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MQH)4%(+!#\RSK,6LJC;[8V0I$J:$:%B);5R93S_KG:Y\A=!LFCH-EQC6#:,
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M"!BBR]#+,9Y<T<SLD&K_@KP86$'EB#CU_D:_@0BLR>.O\&(T3:"=G#KA)XW
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M9:.!>>*G!]/-O91NW" Z]-P]@K$YQAP.[2[_6A#M8SR%Z>K>:R#>!E*>V(N
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M6)H6&CNF-O6X:XKKJ8L#MG.>:)"I9A9-[BUKJAO>$8ON@U5.EZUX;^O!NYF
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MIT _3@N/AH"$,SYEM6):IF_:GS]/_!BPY2LOUKV\KVCH)YZIIO"^=$Y_! D
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M5LFPUD/;8MWH1Q[:PBLV2]$R+WAP$\-,LSK**#$=_P?S!F:0#_4X^UA8UDI
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M>T3KW1;HE'!G/WBVXAC 5/WTQ*UT<WK=:]>\1W?7.P#Z]JG4=B9$^*GW$!7
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M+DU!QO?G.-2F;''=MG,+<&],D1-6C=D^Z08)7V6P%MA(0*TB9+0!_C-FTI<
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MEF0U*E*',X>-D3\BS+(LI;8J6O-+A[J:E[90%$7[_J?L3?D(/;?K[I> YY<
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MC[R&P0>7J@V7*I9FO>*H&O%_@F5.()%+U1L=^1$RP2ZM9(B+ZL]V9*)6W&]
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M6G&%)H;KALEI?70N:^ 5?BV9WN*;?>+,05?%U<R#?Y?(6OX:G^:4UN$#7SU
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M0)\$?LKFJ?F%^>F;3;-5 FQY^+O'+T/V7I;J6I@-]GK[.;=K=IIKJJ4UL>]
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MYH33]_+)U 'E!I88R6#;5>/D?!N;^/?OV+,(Z$V-.]QV4I1CQEN,2[=++1+
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M\721X=HT5MCHTH>,&7Q[7"(E(U]0FNV![6DU6$'SV(7?TA-+>Y^W?F)_YVA
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MR//'V>\<6IO.(N&V?+"E[NM0?:+U]ZJG"8XU]_&=V;"LFN,5G/2-!7\>W-/
M^"3O<X!C70.#'6-8KUKI(2>%=H.X]H1418#HU51DR?DYO67LN,OKC1RJ<N,J
MTT$>EF3+BYG/E+0VG@!K_*VU[J*]ZG39R18@NM8TGS.#"QWXY/4T,\6R3(KV
MC0VT-Y8UN\PB6BB2"_<PN@7 =?F+KD#1=*[:QM:VYBQ3("8E]2G\Q=T2=_NB
M7\G?8MBY0&42*2MH9:Z-Z/<J;I.%^2J.';'\U>G36[5E/P3>?GMQ[0OO@7R6
M<4])4<C:CO%17U6(7+2&T$,G)N:*DO&FL,PZ&;+]8B9/S_33:2E48;>\K*8)
MMP"#"? YI@=5#2+?.(8:%A^? YA'(,+FS&DEOM20=S=/D]ZY08=Z+I!]L0GE
MY:<-S;HN!,T#;'-AY-T@5>L'QV64/=R<7-<\U[_@!BHYZAT,,4[%QX<+\.9Z
M_"('ET[!'4#3YX .4#5'=*6ES9WY:YW:7"\ PO4&I+M^6YUPHD'''__TIUI9
MEE>=\F.S:(Z'H*($+1QS;"LGU&&T6I*..Q%GN1R_.GOU&HWZ>"_:(NPE?\0J
M=RK+:@9+MF';J="!\)<[B:[[F\'DLMK"K;#2*X^:=X/%7#<S'!K. 1%I6=]_
M^AM=+, TR@B;)%7B?[76<-E)?U'&)ODX^<^I!K>F]Y>)(:N,ROC]G.4W)I(U
MEIZ":SG%+U:<]A6J%G+^RYXZ[!#C%CWUH>TW2G0JX]%K%,'98WZN=.:/O0<%
MR9-Y6P@1(D>N<!6.1J[B+N^'(:/D^WT5@8:WG40D'F3]R)2RN--;5%YOSIOD
M=X-'^X!G$E]F\CD0@_07[^!(TPLUD+ + .R*QY! N;U^WFX%5LDP6?$)%E.E
MC@\AU'9&T()JW+VGE?%Y=@5B#]+?2@O<'\VY%9]G4ME#R\##WY%<$0+ 3U0T
M5&EG61-Y.MX[):67/J,8]^$:4I*\+<$[EVSZ<&4J#_ *(V;M2^7BO8XATPMZ
ME,%/EZS9LAJ_]KW5\(W^[6:U0Q6];Q!V\Q3]3L+A7>U#;J3JU+<G223P$P)N
M8Q$C,.T_-Y(Q8JN7.[&>%U=WR]U0UZIG\]5%),SU7U>6_)^*B1_7-*V"T/VG
M\P#UZMOR:6.?/HI2TPB,)!K<NU3-D#2DMT+MIK1?$'#KF5G2R/>"S!%^A&9X
MSS-E^4+/O[D('>,CG:P?Z2UIMX@,H0%#XCHJH>"@2<THRU6FP!%MP>^/PAZM
M98Q47??SC!_'@FHQ^/3%["G=-MG-Z?+2FPLZ?)(Y[WCK>:G0+=Y8PFB7R8O0
MIH1:'L;(0?$2D[I LP/WFV0= CQ$@L>(:%.9LMX@Z,Z]-*.P6GL1 ;T 3?WX
M2W:*60+-4\6^LT$=C<,$82,+==F][M/I/>^Y%!ZDRZ=!M:C#!L(VUP'E]Y>P
M[G@A5Q?A//NQEW:Q3?7UP6T^:)W3=Z"K6*SN6<D/(]C;LP>TV/F;R3QV+D5#
M6^6(]:7V!1;R[26\LH(!O3-Q5NM6/WD)]+VL:&5VAO=U"!Z"AF_]6]%^G=1[
M*NN?-3%Q#C#)VFW3*?8\/)[$6^UZ:,#F87WP&I%0E!,Z;$+] 6$[E[?L_35[
MKBO7:=Z=8B(R/"@"HLZZ9NK%L\<V@E@KAZ?))CMZ!Q8SF!HT&'!9>_$W^DZ\
M%G\U0C!:-L?HQF Z2H5P4U\E6U3DKN;IQV>E_5DMHOWW>VN:?H>9/S),,'A;
M)\6VMFG,I:FRI5A29W27A7,%+)SWB7$YT4MW9>NX%Z)C]JAGE4M^.7?(6\<
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M"S9X!=$?08+QB#K2,V"VQ5D^ 1DNC[ZV;MIX-8XNC^//%H(^-OI876HH0.#
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MWJX%-2@B.Y+JG/(W*A4ZT66/Z(6]=K\ENRS6C][W+@QK-PX<2U[XL; 'LB=
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MAPI^D?]%]9&FL5*4-IY!E$G']\SYZX^)SZY_O3RM007^86F.DN2:\;\<DP&
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MDW\MK\Q>:#7W7R_&^F^+GO>DW@$@+P'N;IW<*F?C(7<YT8_1ES\O]]1&5'%
M2MTM'?SY(;SAK=M,N.-"=SIY?8WG<+]HN_G4]2)UFN)44/.%Q<_K]DJ[7!E?
MK;[P>#112!Y<X&R2QSW#H,X!,20-R&>;:=V?#D#%4(]'9T(X& %./,(N3*.7
M7#MSE4@_GWA[E#+G=;]P\N-YO*TO?Y;2"'+%>;>S>58X',ZVS[49C&NOAS2$
M%,)CH37G@*YSP'0^RL5%AOI[7 =12\LY=5+2?Y$*77^6"7+B-"ULSIC>-F=K
MZD2U>X $3Z,(HF>?%&EQ1[^G63OH;YI_].'L_9S8JOBX)*PZ'/3H),)DL$D"
M&"=3RH_;SK>HR'K4(;<X]NS**+AZ]DPJ.N1SNBSUZJU>.6>Q]W^'(.4]9@J.
M_D<DMQ"]D %@;5TG>BH*18@R'ZMX$X%6WRG?J6#+NQ=PFV$<^09I+S9=V@JO
M7@@7D=FFT(];?M=;LOB.8K[ERED5Z#6(QK\1$T$"XRR%1;6Z1V90/*,J>G2J
MRM]:[,]"H<[ 6^1^.-O7D;6QNZ=7.];=A6]U^W8V1O-3H492*/TJ_SJD@ZB(
M<ZW[:"]U0=,_0@OA0POE$Q8'H)"ESKY+,3[>8-H6?J(W%A3A0K+"- XIE?\)
MK5#(NH!UC_YR>,FAW%D**F!+#:-.F)(&(Z."[(Q@CKMYN:S"=GNC7H]&2S2V
M58;@%M0JJOM;<DZFRZ*!GB\HA_X7['BR^*84#>4NT_;T:-5_F>AM^*"3:L^7
M6K;2)O,!VVK].'%ET;0&MA50\^X6"U4^7_'2>$-!D^.07:S0 _8K/&-QPL:<
M-Y>+>S1G9@P#B98ZS"KC$;"')1L3_, [:/-%T%LXA6Q\"/>":5E0NLBR#]MN
M;2->4+V+,O8EJZ_^@H6VL\0Q?VSQ"8-^7+L:^_MB56<-(>90U&BO9_)FNW\C
M/ %)=^@*7MSM9$M<B7TA-@KJAZ7U(<9@43F"(Q>)2\C*6_/7/D.>?L(& (%V
M)]ZG;#4C\Y#4X:@3B&AMXL\RG6O*D'\JXL?. 8M9\.H@RRF!B[1VRRI2G$^]
MHC]1XZ_\B0F&BR)=]X-_8JW^IZ.7F36$H75$^ADC]J$1G0A&\6%PQ%'1]=/Q
M^7&34]BW$"7_356B#R[) D\9[=X4*MT;QJ"TT"L'S!'"36#H8W?)$B&#YFFQ
M=VUOYSC>,1[PHOC!3 "16",( \K,N*<D-EQM0;[>J6;U.M<790M7;K5:YS5Z
M(C^\U>(<$#VL5J+KY'N#P_ VMXX&H@C/4^/23GO(]:BIZ"Y38QURF8?9?@A3
MP=GA0$1[:IB!CP-!Z2=*IZ+^KA!6W,^KB2+Q'4E=W\O/ 3<W[:F9D[C&IG+!
M=&_U_^(Z 7&JCWG&.OSS#438KY,")V9?XY+WLBKBZ7+B&300RD5[L%L.S%*Q
MJRV/#,A\;BO:01T.GCSNF(P5'S!KJPNUEF=LT(3"$H+3XF_9GM6LZXO7.H$9
M>!@GR6KTGE_\V&#L.2"H!A(/1?WR54UVTMP/9BD/G+%UHUWD$5[:>A9O16?N
M.).]?;2%]HG WDWJK73[=3*.BHK5NMDK!C0_Y@5]Y$!5E8]5I=G,AH_]/0?0
MM8C1&AA5-GC\7"KT3P='LPF[W3$H.;:8WN@:Q8/"FMS;CNVJJ$MP,%1OPS%0
MYR\/OV.*1MIAQ43[R6C4:Y/=3>L[%_CSIHJPD\"74I_?B.>XVHI)$]5N :Z)
M=3;-$??T9I:B%?\7ECN9S>< BAIB#>84"O2_O*:>0)$2-O>$NVUB[1P04=.O
MM@CO9*I?89LO^2$ ?)"(?-XD^T@'[2[V0%A%)[A3: DQD[^8O1 !,9B7'G'M
MJ?'50\"P]Y /\;K"I<+<-*OA1\7(@&,1V(;89?_P)$1T=R5LMA2'D/4^$,"H
MQ;LJ!B_.6%G_T=MP';VEY!M3C$_JFA9KAT6>U$4K:OC>4?E1SU!)/DJ=1*1
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M<3HR2=XH'T=!?B>]>]W8O$JF^_.\C=%%B<_J&I19'CM9XVKOB !JG&[WB,Z
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M4I0<C+=Z:'\UN^EI_TO&_K=V\E=%S67ZKSC7<-Y)I:86GJ%4"-G*W1C YRY
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M]]2^9+@/?1++>:BJ>,E<E]+5QO;NME&@EN>U6LFU@ES5SD,>A6K86\5YE;(
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M2NR4K$6 $ " UN3;\S43^#4%]'12PC:E  U4U-P6^@7=&:JG-(O<^+M\GX<
M]'KB?_:.P7]"4=E+SVDB"."G:#LU%JA7E)TEL;1\KF#81<F8=>F>N^6DBGX9
M>IQI)6O6].JT%%/2?LV0VXZTUQE<O20RRW6[\TRQS@=6D(_S$T-5:^9L!/F/
MJ=*E7N0YRHYITK4MR66FI]#A.]LF$"L?G\M_^<;CA.89*@4K[NZ]@*G89_^G
M7N>BE026./JLT6:-*3)D;[?MATR>DG5+RPG>_<K9,YRJI8PQ+V>[=%C-F8_;
M:;;RN&BO'-KKJ- S9?/%46N,)NM@D6W3H?'E0,X+A /(+IST"Q4KL>[U4NV,
M>!P6F[ISTNLV^E"8-(_#6HX930%]L,B9=K P7GY'[KE74TA.-M;J?%_<[<P7
M=;)KD9(0@SHOX]"Q[94HN%S29B]N)+Q2HM6]/>;8F0K]+*C1_H-5 UL@(*'V
M((3]'I+C6EMNWE3S]3VU&CJ =QMYR"&KC1IL:B9.*Z'.A%\KLN9.UR0_W[;1
MB(F33^6I]#@YLYB]5.VZ<>QL-=B!#76L'<K!:.<6H8OY5L.SAWS\ ^4!XS@$
M2V('5T1=P95\RZUDH3#T^Y"3"ERZ BV8)8FPA&C/HFV!3I(L#/^Z6M06=/!>
M!Z/=J4+3-D5^,2$%J.$,$GV)QW/<HLLZVOWV^#B7?,+]TTY[,QPF<T<J!79X
M<%+HV-*#;ZWV5'963XKM*]B\BG4:<X!V&L]M7Y-,*V#58)=E7640;3F2V-4P
MBLZ-$OKBX)9S1BT0!S'P?VVL8P._FZ@AP"'6W3TW7_5LRWL,\A#"[07+5JKF
M/>U&KW/PRA-_7.ZR;M (9;(>5L]J#/QH ^HP6+AOV/WSY8GI?(_88#014&O&
M&VYTL7,Q55#6XA&E2;)YZ!TGG9@IC #[N.2 [L<:_0W'V?P..U^O8^]ESW_2
MR32^XAJ3D;',-O.L&:>(E1Q%!I785NB$.D8!%%T?4<;/'3RPQ-_T909H^ZID
MU&I:0.H%FZ"1;(<'=GM]_M:+:>.2G<)U>QD61K^T[,Z0L$,7\E2*1G.3BA5N
M" ,8;75%'6AU+]YA9\]SG;LGQO:8!+GO?O;U^K_*7^6O\E?Y[Q8:RFBEPRL_
MF_W\!Q3.4?RD0D1OR,H!]^GNYSBOC[.7KEV,]!5T='Z70D/)0:V\%9>=M6?"
MRD%_1[NX,F3U6H"-;FM&7Z0;[YDH\,Z<S_$7I?0,#]9>Y'_@]^H1P&\(GRE8
M?+SD^1#@NA4 T)I\1Z76'W5V(NK+G(@&?<#4_B?@>_ZZ[J%0#/<.+>")^0L/
M/>VP<I#<>.+/WR3X%PN]W5.CV#N*+YXZ+=34E.ONS!BU@='Z1$  $<!;?=R+
MML\!;)7POG=@[_F%%LM3Y]3W)RDI]N%&H9W): ,$5K!T(1&S9V<LJT',[DI1
MN6;<U;"*T"A#'7G?>>4K:NOY&_-:BX=HHGNF6<,]'7/+L^"4^%1(DS$1X+=
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MK2AK<Z["$=9.A#?\,(@:9Z_3CY'>Q*_KD/IP"J7[M0_KJ\5;E' 3&7'<FE0
MPJ493&JQY_M #'BEO@\$,HA<[>QZ#9M.39%>>@#$"<$Y89TMWD2 =S>L]BDF
M"T]?.K+YQ9.Z@10D@>&AI*C:3X%P:8+7(+FMX,PC1,#(95AM J:)5(\(V.SS
M9/BQXJJ"NQ<GIES6B7D$-G)Y^0_:5;1Z_*VI.%)3TM7[W0>]1\@2A@ORAP@>
MG+MC 'X@N<L *DN2CR49:CN=;"/PC"62_-KDP?OD*O8DI+%F?(8:0;_ .1,!
MYTFACE]7PPDAN6&=[V&D$1F]6B!7(;?<"9(D^58;BR($DN;.SAS\1]V(FS]V
M#O[C^ 2QDBA]B>%CU3B3*O];I%EW7G5WP#Y;2<I$ *UY8_*:! 0V<B\9_4+!
MAMR'3?RF60U94_IN;26[SQ@4VJF) U4_0-8'^K&O9G4_5/3JX 515SKJ<-63
M'- G3V!M"@=_"\^!C1^&.P'ZUM0Q4E-J/_AO /'K:#DW%?Q_T##SFTC![SJ+
MBVQJ2K/I'WWQHVHSY&]'L8JV:O2Q<(_=(6QGD-2=1L&W.4B@L_QR@^<'?5/N
MFS\X0(]D(J<FT)H$.6[^A[T;5(/@B@[$B/W-Q/AQN%._B?BN'SSH.K_S2^^H
MJSH._ZCBA[E4!?LQ" ;*44VC ^$U[S#2_P.Q]Z>Q\AL7@'_07A7TVS ]^Z,/
M_G3N>O[@A.S_1!?_7S"BV]=AWJ[^9L0S*)>>^@'2C/:DN=!TPB;+4>F<S;5=
M!'R.0>+I26>^ $DA]-2*P.RY).^(N,F4=5\J+.3 Q*A'3UG?I\^8^>2'9O*!
M@T6\1ZN^1"A"B\\UX\RQ[HLYUZ^VN3EQ?#:Q8=1MK:J6F>&*6= ^[^SD<(=W
M:./DK !MF,2^C*$2WY>?)Z'<7F:="O:-0_(-AT*4DJ@(U&L%;2'R%J"W_96>
MX\MUGLLTZ@HVHS/T4!V+,O5 :N_Y,JPA2A!W?>RIU?#^>F?&LVKF6E97\_91
M2A4U)UZ[0ZUFXOV'VQTWW,MN'Q0HD,W&<4&CE/H_$ $GV1NTQQ>>:E"FY#'2
MC#PPB3R/TZ)R8FMC:=]X'K/DQK1R1]XU1UBV>>?=M*O&5=>S5"^1=])"!/_!
MFVIE5.\HZ8W$ U1=;P\R\F6_E%LJSG*'MJWOOS*JQGS"&'[SRM()L?RTJ =/
M!97CG)3-CJ!$$JU0 A&9:$30,O_.L;#RQ+2SE[<[J:I@XT3 (]R#;,T,W)FB
M0Y<$OL3+U!Q-Z:X^B#/HJ_$V-ZPJOG7&$!HS2Z!''PP:K3HJIMC>?G*F3-*A
M3MHQ16B3P=O6P)[Q",1?43I(N/I8M9.^2;SB?O?)<MYC7[G%>V$ 5TY*JF.E
MM[ /I@YMUT2)"'8BH8HA]A3J_ORX*1E50BGN[&NWZ:5 (=&9E7:_@KL3)Q'P
M#=U?ZRGQRD#IW4>YQ7?%P3]0BJJPV(X]8<B4%$;N7=Q"D'"+%-*_K0,7GQ%\
MOTT+P'3\2$#(6"Y)%B#KW-!"IF0<2>!@I4"1$IK773EL[%>JU!&!G+'\.IS/
MIT9I <)/*%!!HR,1%$TX?G)P TF?@1"671SM6I!DOC9=ED.AWW26ZOB \K$3
M61%$0&T\IOJ.ES9Y* ;('_#TH;WS8YNW9-1@*9/_)[/6K8'R?S8+NN,X,66R
MD%T^\N>\A0M3KH"-)Z-)YO=V=TVR_P_31_?IFF1.WYC=E/.;G/\_@RSD+C8^
M^)II-+]G+M*X7!>X?@#=%<8?6%?Z'["(_9Z_92\_4  /PF^9WS]')-V)@*^&
M>4\VC/ZW80S\PRP#\3>3 7ON,I[?U_MG^0O\-"GQ4P;L,N(_I0<D IO\E< B
M_XBL>?TV[Y\G49X42R]-[UUU]O]**H*38(%/C#S)Y^+^O<YXC./ 9'- OO)F
MKG\E[:)&.\+5W^\RNLS_/D'\3>!E@*F];*F-OCJ6^B^:\9_/U<;(BY3I^MW&
M1'!<F)+17-*2&K731XJMG:GXIL04%Y7.;J><"?]19/@>1\5CU0+XN8Y*K L&
MHN)4/.LV$*=5Q><F"\[TO!NFJK.PW7OJL\I=C> W/F,)PR]0O2NZ-#B7/B_Q
M>U*ZP0=S+#1OJ+=%SXCT2[W/%E^,(G2/MG"'<.B^YLAC)+_\JTB<<Z;#HO]1
M*7!*(T;14<07:U" #7T'/0%BK#S/]^IQ87UWZ1%EU%8?Q<+,)?\WB5J^W>IU
MC>X*/3. [S>)?R\O>+[,K@W,8_4]#L\9]?KLB#@5.*E518Q +BT'3%5HFQ+.
M<LWC10*0Y3*EXS<\KO2BVN'RAP1H@],['SZZ?%*!T\TD,[/]1!Z?,[XKOBR#
M*:Q?VWAP.:P\)>.$B\I1[NEY367E?WA?58QFF%!6/R1$&JL@G:F9-RQ[=9P[
M6HFUTAE%!#"Z,]=_MCMDQ^70&KAL=C/'O6[<J3Z57Y&A>_#CJ;KK%R;87A*8
MT?WY&%A#U#QGWAOIARPQM#J7\SU/A*?/>E ]>M.]V"VE%RAX*AZPXB Y!JHW
M?;II:[*XYC!;_2)Z=#J"SD&7:<1\P-4#YR#I"H]H#%*T98,CO"Y)-@?5.'$=
MWE+0AKH,3)/S!"G#6R!W,_P!B6S@F:S]V-FM3KXF$N)@212"S%*>*]*Y]ZX2
M 32[L[]I_7=;(K.,)(T4D>.[:3W"?U&)]S09UIH@)%@CQ=LNK@V08(0485\\
M>2&=>G%K7WF&@BL944@39S>1\Y"R*SE8!][0HR)5 .XC/WS7J4B/[5S'[.)V
MBY;PU<=%U$%PN-^PM *)8&B08;J3Q) ZN4',NTQD1>*H@QO?< *[ONQ=Y65-
M,[_>%182I)N3^!>,3(ZTW=\3 NU&R*NZ][K+H-8XTC&Y]6FU%3FG<,(8R3SK
MI2[6P.ST5UC;1MQ:Z;SG\G6Z^N(Z>$@33QH%VT7-7^8U">FK0G^8UKZ_!P @
M>:'J/V[W]P#@WYN5?\-6>G1)[?K[_OUV_W^X2$207)Q<]:>9^7>;+=I@ZDI'
M!F P OFG@[U$8O^?GX-8('\SUI_#S7Z_R??LVR9?W]]L\OW/)CX]TM1[:$%>
M46PC;OS1;N _2S#^S=:+AY)\]G5A]7\MCO\_Q4)&R)O?I('&?W7Q='B'[NZB
M<D'1Q"->1GPS7"3H X8(()E#IE$WV F>\D47M,_+=6*1]W 5D/OF_ #'U?"7
MNE)]X0-,A=SB7NMI,QD):L%-8["P8?JW=O-2Y=7A9XX:,YP$T\[B:##='4:]
MR%<*ER.'S,(H#TQ'FX6>>L#>H&!^D]MS@ YC.N806)J5:*I2>G"S9"OZGHC?
MQ/WC3WE0#]13GC%P9<HOS,YO&R5X[<<LI;X\-\R& 1 !VL5:92[1!'>$RLB#
M(?%^'P53U+')I2J,*B-=8V;^.;4C'*@S/+D?I1P4N7B.TUGST>[5?*P8,Q$?
M)8KDBM*@AG6IF6S(6V]\.KH$O@,3!AA9OW]P _?N"CBTTC(->UHY^AI&9;2H
M-.QY>3Y7^:T>T1=OGZU.-K9?W=EC-P8><ALO#4%:@QZUH7OJ3!Z^LNDZL-)F
MC^]=.87ES"@Z-M=AC#F$8V51BZMONH!UL['+4:V4>OM*N9WQXD@I/K\X^Z;^
M/?6K;P+!I\]Y&H6X.[VKYD'?3^2-L<EJ$,72;XHF*SJWV3YP7J,5O,]]J\.$
M" BL[$?.4 #),2P]54P$*.T#+[]<<1(#5P@I%!%F<H0_K"=C[1;-"3XGR6OO
M.H@=:(W"GQ2^QU?2"*.X[*]'.LE^V!BB&+X-J/D:&ON]\V"=U(P[<Y4)K:$[
M_BOIN\<4T0YC4I/5_> 9RJ]-;KPF-<F^VZ2P^!)C*WSWZ%-XUHK N7.5"$BA
M!Y'GPT %2>]35M+G!Z=C#FT")Y4#%;QKMBX=M,I%+KKDUI;+\0,)5)K..\9V
MD;.K9LD,[R[H23XO33E>F=#RZ B]SVIOWQ-?AABO#RGP5ZTRR9O[C^/7MNEB
M5!/[IUM'2/E_=&H_>+2C/A@'=!MS$/$2'5V.2WZ"ZB\'8T/>JI "V525"$!F
MX>Q6D@FT1VY:D<:GEAUM'[39XPI:'(C8+U/_W/L93'B;]BJGI)_]5D5YQ'%I
MSM!!_%LBX%%N$62;K<AI9QO6"/^=-@S7CG =P3MN)9/3TH<(B+N,RX4LX,[0
MG6IT4UMLPJE<3R,".O/382,]!"E8O>&0.)YVZ#0>#T9!2/3Z8RQH=28Y!O3+
M7RP),JS-/=,W4(2C!5VPF2M=R.59(H 3/"Z\>(@0X,!%("1C$/6PA?>,6VNZ
MK?!?_N)D8?])<J!_)#=-.)K?203,&'61(&J9"# CV;7P/,FN$#6279%X#]P%
M0BLIKI+OX;*_?\B!68W5[:AQ34"_)&/E2B]0PNFL25"X200@-(@ )B-KY)J(
M]<CF&A$0#N7;?Z*>&_\,+ SYUG3R!I0;7'2J^E]QRAU"9^/F7X)_"?XE^)?@
M7X+_]P4+B8":OB%9@\+:^#.*2:1%#B<II?OGWGM<'ETK1V+W)>0$I"%GZ<M^
M,!M,>TCK#27U1\8QS1TP VB(?81O8X@1*]=1MZ+%#*&?F9,<@A"J/*T6LH@
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M(!_[]8B 7#TNU$2DFK"WW;PX]I@NCM5S'+80B1G11$>4C^?F)M(2ED0<2HU
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MI+XRUZ%<K^_'=4Z>;+<9.?VG7I_-X\9 N_&W4567WJ-K%5V*6'_<_6D1=!^
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M^PU.[,QA=%.]NS:5$(^_X19"CHN])\P^S'-:ZVR9V3;UYG/>G==LOK^3&.*
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M WV7'K,W#(L&$NY01(9!3%3XWQ>:RCV$63IG,_E?&D>R/^%_LS-W%T"@@>5
M?OQ48Z' J/I."V6*0'\.V(85H$  W@0FQ8VS5AP(XN]V)VLG#_2DD=EM+H0,
MU'C[%8NVB55C?>9 9M_@6<@.][<H8/=O00QZXPJ1W>"!?67T:K$!I*(_7@LR
M$IG%V%)C$I89_Y4#^8;O_+[[_Z8"@D2HI;/Q=L= QJB;Y7@U,UR;L.O(@XV<
MGZZM_S\/>8JF<3LTE>;JU<S?YEWKD)RVI353DH)<*Y9M?66/1='%&O>E&SY0
M_D*PZ]JW-UQJNN[B*Q:)?5AYT.+!!D8KWM\!7K99_73+/%C@T!09H1L?E%IP
M1_F I&@C\B"!-,S4[*M[7'E/1+"G=O98*/9X9=BIRLB4P]CJ%M-(9QD3#27]
MIND\7<DO/8__.\R)E6&]/V1@7Y3!@1C -[&WL$=8[_&S/H,<R$H\^]9C0WCS
M4W2SKE<O\ZOH(\22G<'_O6DQ:_<J=R=,"CW[*&!WD=A3@]VY171>0H%8\<<J
M<:L?_R8(L='64"FE\OB=%W<@A/?PI(S5NI*,[ZT4"R5[R8D4W_*+]ZZ_>]+Y
M^+[YVY>3OX@2H2UPJF+Z[DC-F=AQA:X?DS'W=T,HHF3!Y+PC0TAA<O%H]VSJ
M7,M<Y'P)(BE+E@N()V>SH5"AU;IL@_H$W>XPXNH,X\0R!\)C< MI$J0Y<'%;
MUM.K8W_@^9KL'\@3K!S4:<!J1@K(<$ZGG79>;9@W\)\9KR4F(,I^PX0,3/RF
MC2.5PR!K^H9^DP6UVH+QQ_8X)@VIR$];QQ]SZITZ_N2/!@BU?(B/\TX-HZ0G
M0AV;0K)4E[SGTL0E#(8#QK:MACF0VXC]D\O0PZ4%Y^_/4)1P$:L/\F-_AU ,
M;G\CIG(@ DI !VGLH8SNFR-M%4(I0=U[YSVA_'B?5"[DS2'/P4WI'SF>&;?D
MT6UN%2W':Y753H6)DA 5'4T(07:/\\JRD29AMOK1*X-;]LO*4T>''Q*%+BCF
MDQF]1@8+]]\6?)9/2J*L&Y]I$DG7HYB@,Y\MB$3+I$0N17[0HAWG0&)-@S]"
MV%NH,^BFB L@4^TMI(TCYOWHT6"?-HY$LY:9-\#H0$?_O#V(G\S8R5GOPJ>$
M96,9.5M&AQ+9AH2E*[ @:F$;!R*[LED$K0$<^Z&:.IM0RQ.&W ,)?"Y_:_G_
MU=%C^V_[#/W(EW^(<$Z8LN&.?TBYZ-3\)>"EJ-RIVACO-I,(?L>J]=L9_ED2
M22DXY:E[BL'G*D99JP"15!)$SP&%T@E%7P$L/O<:]J21ZK.JJCJ2VTU)[%OX
M/<'U?+;4E]@04J_0TA,M:<>-<>[E;L*!!I!I1WF!P< 9:<,X+H\11)T<[T"3
MESI;^^\(H]:[)&:.!+9%_B!6.3*%NCJVOR*O$+X@%62+U/^4^@M\E N;D9QT
M1QJ62OF[& ]B19.2E"2O%W@O>H -?B?R((,8>L@#- ZD/2!^Y,'X8DA5FNO$
MZ85M?XF-CKDF["L.Y!9&8A$M!"-5Z^$3D2?*7NOCC_"(M/4)JOA5_2WB!9OQ
M8PI,@R.R#0-)I-<;\2ME@_)5?@Z1"O1[KNDZ/^G8YS!2%E%6$SHV2"\<-%)A
MFN'-,X--OM7F!"VJI_L.YCL@!_WR>6Z=V1PZ65RK0;_&YC6;#@ 4,K'M$L=8
M^776[YWOK#PBSWROXN\!='M_*<\3Q_%L/C6&&E*9]68K &S6O$]3]]C0YHPO
MO6M/V8^>"XU*?8XM(.C C,,:\;BXCG<S 9#E,M=FM:GS-Y>B! '"+P>Z^76O
MO*-21IN+-V9.^?; +\QH\'Z^HOG]!=--H:=R'!./\]G^341NQ.DV82=@@'R2
M#;H%RSYN6@:1;EZ41),""=,OZ^\1G)%]+KH>QV>6$(7HKW"FB 9INQ$S&M$&
MXT9:E[@8?[P3+C7QWAQUJ^G%+L-^VJ[(6MXC"SXVA%QEC@.U?,:T:VT7);X6
M/PQ*;<:[@01HTO0/V@N?I)_"33= [XK8[_#0]KPGH(Z&1K>&!_>_Y%O:[DAY
M&HAX2Z2:0R=6R&JK:52K#K88K;W,GW^7GI?6)K+PZ8!&!VQU^-8[I2B+>Z]N
M?KZHFULPT-'U/>?OF>JVHH)@P..!(X ]V#'81!>]< COQ4",=;CCZM7'#%8)
M@>O-WY]H(WXX3B?WMKXY%S!1@S)4[5U%4(BX,$Q3Q3WEE5Y N9I"HU;3BP M
MZHPI$%3B4K\=>R/RY]VP_>L=:/KG0$TOO1<S_?F757RN%=@3/^WZ32/&,LB6
MH>).H,&\&B.:JBE4Z74>39P3>%[OUXGWP(S[76<5-!QD]QGI--3[OLLPNWXC
MJ<%N+W43FUYG#Z**Q'Y54#>O7L+*ZU/R>49<6A3;R?OQ1JRQA9QY-"D'78UO
MQH]UT:_0B"UHV67ZR"[F6:5)]:57S%_DY[L<2(5KHH#61?CG<!E:FPV]S&))
MX1,8)9J.*T*I?QC5+H'9!A:R9MLH&V<T-;"D!4MQ'\A']JT<%D6L(TO^8V<B
M@_6>*425II-K@9;I9-,3E8QD7U"[@IUVO'^WV]:P!QKVLDI@=V24.HSXZZ(B
MC8A.85A^V,-WCD?8MZJ++#_X_7%YK_@EWT _R3O?L)=]$/3F_4/50.9T%NLC
M6VMQ7D#0V&>=,A5:;7;\?I$14<L6;'45%!'>VZXFJ[0Z3+6>+N\ST']('T@V
MNGRZ[/EOH=Z/6"RH.4 9OPJG>M#M^E&"R[M3:1ZZ@USU(#A3Z0G;J2]^/0(#
M:00@AXG'!B!-/JX82=8,X02SQZVNNH00@CWG;*;5;"1-4U4%TW/[@1(0PK<(
MATY,BSTA^4E46X2%'O-$S)!R'3=-PA@GF%Z);!YX(5(<$")ERP]OI?)K%2SB
M=ES?-";15I4W-,C85L$Q3!.&:J.+.MD2 @+H@U6OI[F^X62=-NKJ/]S7&,S9
MA;-Y3_Y=8Z.95F"7=L57L?<_%2P1^'D&[YW;^^IN8"_.+Z'H67$GJ=)4%^E#
MSJV9+>W%XDEIQ*]*%!?0WKR .*H5_3FUC97C)[5W;&GE45NU#"T=TLA>PK9B
M)@@DF875,<95H(B\]@%[Y"KBU;OX]CT= 0,--:PDT'QJ8;)U,%HBO [H+G$U
MRW_=IH'K'CLE?(0 <HNF.VQ=)B^KF"WGC#0%+I1.N+J[(0RJ"X?#9L^=?1!I
M8BJ](E*F"O](PSB6Q-JX"1:"[8WP.>')'D#?9ZX)?B>;/F0_X0>4ZC(Z @=.
M;*=&-?*PQP->#T:[EX%#?815CQ)!-7_?3O &/GUV;E+\M-_WWKU4^5CC#KD^
M0@^&:DM,"A>G*#$00-$T(4IU(,+0RE;C4A_F19+44L&5J[\4C)+FWERY6_4/
MW![]:VL=.&J>0Z2W7JW0.##T?JH(YPZ:"\G=)13-YDV6Q3UXVR2>T/5+NO!<
M?1@6)*[T.&K<:@7#N#JEX=B4B=^] +G[?V3/G*IFBK;,X)]R('=2QR,<@&SJ
MA)W5-U6<G*;M^5";Z!_,%>TK#]HMW4X'\%_R(:4/5VPIT;< _1G06=D\AJ1U
M8:9"^4L_0S7CEQ%S.,8[O2#"D".I)YL<Z; <@8A[OB3'N(S/E-KS1UQK5PE4
M024H8M<=?/G4$Z4F>$K5USMYDM^>^#L;VM[R2#&("OVQB2U=0_LC +F8JB*E
M-H8^E$? !(X1>%8I<4C?.Z3>&N87-V_C^&UAM:POJ>9+?S7C&&!EQ\J"D5*G
MCD(EMVHHKYVI+FU%U]V@6:&>.C*& DA=$%GO3DXL(ZJNE'R\_O[9;.W3C^[1
M:=?QU&OK@')L </I>@<53W;/#B@ ;HU-'F5WOWBJGDM?&/^F!LCA*<=(,-"W
M9Q0Z$@P"/E]ZN6$E*2[.+:-N*:)(W8!3[IR<U@T\,S=L9KP)GTEEBOC9L$ S
M(GU$J0!RM%-+WM3>!%S!X+CT3XTC-AM7N*&3V+(&8=1/&#];$(B83NT0C$DW
MU42(+BZL%N^/\."5A$,S4;SH)C! ^L+YV/T<"*YDH1T1DY,;%#-L_4O8):].
M&U8226 (@+;ZP$"<C!X3"WB"E\"Y^*@=Z^_^;A&HZO8[<YM>&OY"22HP?7*1
M;?:.WQ[JKVR8MA//\*FS9K@!N)NZ:F'/.C[-?W,H']9LOXZ+\#AL&2AIN#*T
MA7DVQ36,OH<#JHM- D+([2/I89?SU>L\='MQD=J@Q_JP/L(\,"E_RTU5WJ)Z
M&H[TK>)<+(Y,-62)$72Y)6<)A7.VO.K5QBTQ:GZZEO1:H\/L7R/!XNE^?!=I
ME[3U]_79^7%1^ETB)!)K<R$"D7.@/2RQ"O$>V%AH.0?RS("'5GRQ7]7 V.CI
MS>H\]NFN^;DP;KD\@5"SU2":/JGH"?ZN7Z\4\W)%659S-UIZHNUA3>*-GM!N
MV8'(9#%)M)Z!T.KZ9DUWX2>AY*9V 3V?JL<.#9F@O7U!7@=X:-B9X)$:AO[2
M;F352T+;C-0=?[=<1LY.@969E$MT_9,%+;NBD^VK"U]>G'(^6J^^9&5NTIC]
M]"M%)K5$Q>=-)^Z_(W5[93')]G4<2"HC8'?Y5/\2,.S2"W @("XJ?5_H<E:!
MJ8M,7?)C"X#P*D.-NLZ*T&9'X78/H&B[C@L+3.D9#D0102;NT@-87'Z;_*R9
M36QV&UH28Q_-@03'O9M%B^%G0_X2EQW8F_!5]#*!U>]N0O-CFT7"V/B,'4)I
M![L$/2G:\S!/(X(#42B!K0PYEC>QW\%^0SOK[FRSK9S1A(]8KVC61?0W6";$
MAJ;&C/(&95-A)B/1I2"M0:VP:V%_M.C<\;!981@K,&#6;U8F4 /KBMF]N\/L
MYNJX)?0?14H#M")=_C$.Q,'73!"XQB/$@7PX(['4O>]>NV/KI+X]P4#<,#9%
M2C?[T'#JHM\\_ ET'UL;<)G.6 E9":,'*>=6!$:U[CH.RRJ,>%%[8Q8(>4?)
M0E]+-K7^8,$\/'%JO14O FW1EK)3-YG7XW;D0/Q$>!=W'^V2O:OCYG=>*@AL
M-78;^PK#@QA-3^WD,04JOT^KO,]1QYS30O_:9_WX5TSL&4E>]@OAVV';J3#?
M5)Y0I=8E<L=+L<ROWSQZE42G? F/"..NX?4-LB>?:W_]K8$P0H$>5OZH;'JB
MFI8:NZ4?KSJ8&<-=!!OXC/J%E\'U[EWV(&/;?K!_[8.JNL3^))'--MZ:#8RD
M==U.?_N"/.W?T)JP(SW#W01-EDIM:QVIW GX/]A[\W HW_]O>$I16:9"EC 5
M1824/4PEA#11498F*6NB1/:K4I0PH2AD1/880G9C2?;L)/N^+V,=LUQS7T-]
M/BW?S^_Y_K[/[[Z/XWZ.YP\.UYCK?9[G>WV]KO,ZS_-Z5@^;JCUCGX?89$B'
M\H/6O2]>/5(_=>N3V;ZB&\379,NJM^Z:F#*G,*6=SP=4C*A1(@QC:*;+O>-7
M6#^FM3)O#1'JSL=UIW X"+D-&$>THI@G,FQ(FXMRA8Z[/-][\.N-$\FZ0&HG
MSW20"/\K%><Z%(+R /=]VP\)^:KD+5C"@:)1T#B6!FM@U1Y#KCIA1M'@-AX:
M3%@M 6B_C%]4)%0O(XDB=H@L@2CD^/M>$K_SL(?CWSN6O7NAJV:YXU_L !(U
M=_3X9H[60"-YY6/-W7PYEQAGCECOE^%*P,5^B@[[\,Z?_+&23VI1>@JC:["_
M1DRYI$KX:G2P8(MNX,1!$^:P?8V:@1,BE4L<)DS2:M'!KJ3&0@_+/+&S?>7'
M:^[&[SQ@DGY5X&O<L8WR(Z&;+Y^CY/*KB?<\JHJ/XN&07PC=!"\<U^TH#M2Z
M$=:74[\AL9&24!XJKZRC>%-V6QRCXK4 (^N5_6H.$I_.E=9P!&M:P^OGTQ=C
MG<]$&6?<9*[@%,S/D#C"P<*Y]$XH@XU-6:1QQL=&_!@(JQ<*I$9V.[TEUQ9E
M/M\2=>T^"PWF5GB:\]$-#C/EL>N'\IT<)M4:<@W=_",E,]]>#K<!F.\EI 1&
M"I-O/KY\=@?&^,(4]_.Z;V%)25O$(DC-H[;=4<,FC$]N;?>(/#V/^T*Z%\;@
MWW#?][#AR]>=/ [E8HHNYOL*K1V-]J4.$[97SP$)0;8EJU736HE#\COYQ\J\
ME1.'BL];^2%<3U='OS3+;U9._ :NG"L(><.TT\S>:;I>5??,@4N&&IMD/?5G
M1,\O'-PTJ@R/91HIOG5\6K.[.6UF]O:S[5XWPPL^"RHUB.^W_+:\5?.&TDE%
M7F?8X9MWIW5>\H-#CU5>])8^#S):XB:\3U+*V8"L0%RS2C,JWU3DUI-^<7+K
M^&+B"]O/S96SDUKZ1SK]KI(PAO?LC+9'-S><KICU;%2H-8N.?+EQO&TL*$_N
MY8CL"<,TK(3J';C9Z9K<,O9B?E%!3PW'A*;;^J<V5C.:1)X+0?4=4DC>5L_!
M^,UR0SW.6OW<]<M<PV+C6ENK).YY6)42C-A:>@A[M]K&>QU@\*IBRM(4+] 6
MNG=H:.,1KO3X1#^&HCT]GV-6G]WP]F!4/!^0?.% =$^)-*N2CDK=DS>7=.'!
MVZZ[=\Q8HJ7Y=NU'79RR*B\QB>;3T_JRS/\R4S60TB+/T7('1UQY=[+RSJ[[
M1D[360:<KP:KZCART+.>+TR!0I+NG9G]'/&6/-VD\_=P*5S,S]0.+"W%(N2Z
M>:+[[:-?;.@:G'MGK@:*2G!M._C^$TN E<GS4]?UOS!)MZ7$YD2D<!YX@WV>
M>5Y][BW6O\S7D?7RU[B4 P__V"L.'%_;-L%BSD?=A.@(9>AG9=BE!2HK8-P+
M4<77--A]_-2_N6E"?/#-^FM7O,:O2,4#55=#03PR"F?QV_7V%93YK9A)[=/T
MC1/^\56)PTHF(,0Y2FWP$Y/YA'LD_)<<';L7Y8Z-'6LO(Y#Z*I'GC;WSKLAI
M-O1]<C#QSMPJ+Y!5,:EBNA#]\C"WQ\3B6(=U?>BGWK#):&5RGV>1#&YKR8Z;
MF5*LK=T'A1RN<)(EG5/V12ZH.3%=>WP2=>7E3&"00=B\E'2WXA<J*JW:QLV=
M97^+(X?N)8'G_[1H2D].=RGV'324XWSP?[&A7BT1*DI[.$F\S41Q&DQH4 <J
M:4#_<7[T+WLFM#?Q=XZCY<!FY/P1+&GRN,!M&NQ015-D(M\#S?X' V$;1-ZJ
MHZPOJSO%4/Q8-Y\*JC;E'PKLNM>O27_F82/IU<M%.3\8VZJT)_N.T;,WQ>I=
M&U8-F@.-CGZ8[;.8;7_LV8+,A##MMJR$N\^8169DSQHXR,J=DTL? S(^/QO
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M9A1]CT]2;'U51=D?W6Q9^&1<>=M@OB,&X["A_%"@^M7+N[=*R%>D2'.=SXD
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M=X)MH2&=PP39CP4  'VF5P'!J=9-+P4DVYDH6X#'+NA)(?P8!&XU&E0?C=6
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M09G:WR1>\"=#U]CRN5YU&JP(16Q'D'!!0,-KJ!(#<V?KEY)5:+#HAP@BG,(
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M\^ZE^/P CK=DT(6?'U$#73B^K<G_@S'0_(.WZ:8'<$^T&QK3 "9\:F\PH'2
M]1QB[OW?.X3]F#W+]3%D)V:RMB!& ]9M:X?[-C Z[>Y'$'S/6?\(00/[A?QT
M ]7=-+#ZG#/[P7U4@,$WY<?KX3O_I(/_0.,1DPD_J)  ,%W^2\K07WE\UE]X
M Y3&8U0G>AWU@W86Z3(9]A+(L#<("C$-QA0C4-BNG[W L']/F"D0,E%=C,<9
MP!\]XQ8@(7PIN<'KBS:H,/4OU/C7W_\E$^PNM06SO8K8L :,L"(C +1'0YG4
MWJR>)F\T2]_X5$Q^L@[A4?_[F?^ZV_V7<FZ0+-!!_V19.99,@N;S"T%[C>G+
M(GFU(3A^X8*P_X%44&<.09R98.S^@W/C_I%R'U[[[RBWT>]\#?B=)=__72VJ
M,\D;A4G>?HQL=(#T$O//]#(.,?BF__@(0_S3?ZCKK[+T!"Y??781M$1U(C]0
M =) \#]]1BM(BO_0J;A?BXQ82?^S:OR5J]YE-D=4<PB:5?5'XN!7WZ5+/0UT
MG/Z#NC,%FC?;#L*(6KU3U#^8F0*T_&_6#@TF!U^'H"D_+%\'5CS1/RM>\-\J
MQR^M^0\&_HN8'F3[U=05T#_:]G^C]"SD5)3Y-DJH3E/1JL,L'_IIB2,8L,$Q
ME&@*3$,P3BS\GVHEB+U@$6+_U1  V-27DWSV_:3>_U[E=']7>;C?4R[X2QWK
M1(/?SJOM_UV?@2%+QH;4(UFK-\S:^1=_ZJS%=,NX_PSX=?Y0?+]W /QCJX[\
MK57;;'2*? *:05/005,,,(V\^JN1+SDQC2'&N/B'0_WW!@B0/=)_Z#L&**H8
MPIG,?(;^5+N_>?C?D00TQ*&?AL#]9@<02#XK;[PX8G7Y1Z70W0NT_RPN[J_>
M84,TPIFB<:/V@4:081J!]2]&2 -=1=*QMI;!Y] >?<8)$%)8C8F8N#RR\.:4
M] 5=,OXH+A\Q2_*@*78$T+: V;*1,NA)];H!Q7"? )J-V?%(Z0]N&_U7L+7O
MB;6I9-^C ]]!*\"X<(.@K^#QNG'[P1RL^G6+V>Y;_I86AX:<-GOITY/+)4S[
MM5AK^ZEI]D7\$W9)*_.<C,^@D)@&VW*Q BC6,E )I%Y"M'^D2FRU$V2*%"N]
M=X>SC8;E5'_9;'&,F#0ZMTEVP$K1MKG/5JR_#W,Z?OB=<1FJIV4)[: CDQ A
M\3W_ZSGD5Y$:):=J3$ ?HM+[>(]6PL5XJ?".9YS,2!;Q!T)GAP5T%+8!3\%\
M=Z.":WR4>VX3=8,7TNP#.0@?/KJ_*;?_I$R$-0^@\)]'C>V;C@4]?IW:=3]R
MR6-JS-5+8??M-L7FZ9M7%6U[U=C7(5;&4O2JC@L\LTFG_LM8O1X^\H9+#,0<
M;B8C,Z8Y$.! BJR9@+K!"QAMHIU>AUBT@/(KV^<1IM0GF@)^SZU@'6^();LQ
MRA+6(6=-Z"P(%%UJ_!ZRSOKS]77(]QN3[K!_BLL;[O5/,7R=$\5"^L'T['77
M5GAFWP$9NJMLBUB!LG5(1 ]F95JJ%TSR,F8>.G:&6UEG>Z=8/8W(W(Q,VRK&
M:;>9:#H_Z +CL%AEK9_A>H,!$>2!F=23N/M?U9E;:+>'LM9;QA*!FK+3E:O"
M5]^K?>-X_4&]OHQ#KS!5:W:7BTGZDSQMQ\NK)$[%>B+[VP%HJ:@N[1'8_,K%
M]X*^JHK43K\)_LA$#'G:6+P'!@S:@:HR0BQ]T\8MZY GGD,R:RR58..[O'4;
M>2PY_$4M!:SG.^K/K@0SIUZ0C?JY0.M=@JW6P@C84A#BSSQ'+ 1!)MKJM5FW
MG7K*='?E#Z"4$2A]91V"SQXAK%;= CX=AE&'(QD\$T^ 2="/$\]*GWZ._/4^
M9BS#U?9 T2.J#%;3=0@!JRP%IEP(+ 2Q/506?P%85OADG1&=O_[+&T#K':!L
MSW$+;R:-*BRXQ!(%H-3A*#)+U7D8.?(LL_QZNN!K[%YNXQN3=F6)@)M,BR*L
M.A?NQVUMU(]D#+W-EJJ./_ID'2(LX'5OZ45&K7T --6BU \Q>05TK9OD95Y*
M]'$6T:: 2E42;DXU0P-*RT] DX50:]Y#%O5@$]XC#M@)J=H]HO86 SB+4QB4
M44\'@ULW)(OFOH9^%21UQ;(0K)F\OZE)KD?QXLE;ZX8?'$6X5HR$+8?</B_>
M<_/2.H0S_?RK8VJ;6O;OV=JZA-;DDPU-N!1X=DE-^SMC"[(WQF8H:%.2YG B
M20I&&<=$7](9B9"056%EO^^][4%*\U>C(KXO;X&)>)^KH3=NZJZET=[<09_5
M:"H<O1D@L:-7E0(<A,U2H9117#2LEP1;:@ D(V^L<-^!OXH>15A!QVA/PQ*L
MDGAL&"T?&-/=0VJ*FT.@9W5F+1HQBXSS(MJY;9R9I!3JR6\P,DF??+7&X]Z9
MG1QN/E&)O9KQ6A<HG-G1Q>N0IGC&5?DT+'^>KD>L6'?'N?NFN\ZZTI[Z--BO
M0^"!ZKW2P$2'I)W$4C=,<E:5I(6D+&O"?US3UU-7.3-F_M=;Q2<R!+/>0S=^
MB9^,29S%+V9FI"3=:"S9[1W6Q?#J6DR9=<4L@=;0O7#4UI56':.".PC[T$?*
M0S:B/_2M0]I>,0SD><PZ.:Z1#E"EL;0U:=@ML-UBSF=FI+7!'S4)UR!^_$[N
M[7/+13:^3GD/CW)N5KQ9_-<,=!X?:SB5NG-[+3.?6AO7 U2A=!HE?4S]RQQB
MH@4AB0GKY@K3%NR<HSQY^25@-L:2888''_Z(6YK$16L5Z7J8V%V!'4&>@_TL
MUE7OB&[08J^ZN_4GGMVO_^,EJ8? 0A[2OG#4XQ'XDO08/,.;[S_):%^ N[,=
M\?S[:<$_7U!F##2>+JU8&CR[N'%V(\5?7ONRHM&-\$JG357#>[YORWQ5<"[U
M$^.&RMXWQ]B>"]7-/MCJAVONSWXT*5XZEKU*K<FLG#KD.<]Y9L(S+_6),D=W
MWLNG6SCHMA*BK]Z&\G0R T-4_#;\!YN/-U&GOGX-;'M@-1" 7+Q6JK@.02+:
M\2LM5!#6&C#D'8P*>^9Z84 $P8$;?8]R9I0#+[$S":3MZY!(!(&/_A#/C,.U
M).<][.%^LIET:!(>/2+@1HO9#LPLK;&37'[_380^(-V>AN?EA79[V]K\;3+W
MSX.%I79@&CUB=KA@%3IB/A%<P<G86BAT+^S;)O,'KNJ!(:8OPDI6=7N*M*WG
MXZ=7OCDHK^;H&U-?ETFJ-]]T4]SE5'9_K?F<J2WWFI%>]FJ.]56Q1BL6K,=R
M9HG(Q#U@APJ.)$J,5R>5L=NJB80:J'G7>HN7^,D))V8-.?7FUH)_G[[_JHR3
M[I[.CNPL'_M0J#5CE72X<63_&CX@08\D'_EQXMO=L.,W[[>JT2?+M/0B+M_>
M6 &#/;;6\H^A'O]O"?,H?8YRXKO*PFC=EV?O6T!15):'N :ZUIEQ7ZDL(+?U
M47C=7MU[QDS'[ 4RIS,HT.6S!X+\=,=7U95@QMIK#%I@#Z:$<Z2G&$8V*M\#
M(H3R#X3P$E6RW0T,<.^:=1X@E.<A*"-\$^HTF6PH U5+P5\ "T>M I:W^S'(
M*0R>U<>@E.1B _'AI+4R_/3D+6M.Z)W./WU^%L#@67B,F^0$;U&G20UL!]J%
M0:__,%=QB3AP3I Q2;T=R>#K"5B'*-^DS;S\B69;F&AP!4REG("A;[[.Q+D=
M<HG@Q17PCC9^G)(!>25Y-";HP*,9<RA-:@&LB^V'P62CX<)D744EY2U "1-Z
M>KV<.^1-GWSP%?^@([O+U75/<,9P2<@HUPOV!J?-*(O>'GMSX2T'"B7SL;8?
MN02/9[#O2T[.'4239986R"*I)W^.!_^Q[,D'Y""5%>QLE;OV_QQ#OM5>-R>+
MR,2^K "*:&W1+8B!\@NCU%<QS[Q2N/._=X^B*Y@;M![[M7(GI[X]^]1:$)/&
MO6=PS%2X?'E[K;9QJ*>_CF&[!E20E!:FN'OOM<2WQW/?I3M6WQ*O4[JRJ[*)
MJU(0JFE!@V\]W!]N1^I=.6!OKA(VLAE=E4 ZO1GHQH[ISPH%S*C5,.;D):Y%
M;R/Q%WN'M5I:1/-]F<5-!#$,KH>$Z+WWEK X*_E@X!SNQ\FK698WZ[<>HKWQ
M#I[2N.SZ:DFD5Y^!_(2FPJL9[M@Q=9)W &T)V8AYMQ9T$J:G,^O3"&NB<":>
MK$GBM$7DWL$5YRMEL(2KL26_ E$'O+1[U\DFY3?@E[?^ K0=H%RM53NU.0%\
M6/N32A0B=E&$T?9N'9*D1=&C8VZ 'SMV,1-,5JUZ6KPT8/8E#1<.8V:X" +!
M3]B[^"/C"Z/"&QG_2/<0+>./=*XF0#-20$BT.,M\_%G;S\=D2%:QS&02P<>]
M^9Z7,?,^R&C^L/',Y1,SAR::D(UIKX*;5:(1((J6UUJ"A6'BAB%B"<2%6)%V
MO?!)B26-'Y=-JBI>4+0H5X ?F;\QO%(OP@UFG.8.W<!HQ$:N"$G=V:\R\]E:
M8)ZN;,DO%7\ .'3CI'B7 \+_D/Q)MN1DM([$]U!]7P ZJDI/=(32/#)I$DU6
MCEOA=;AH#066U<S[WG8N4I%-BP?MM2X1;:(P?Z# F_%X@:#_#0S^ YX$5UBB
M70^<=&4B<NI/)-3OT(KW]MM X/>]8*.*9V(<"%1[7K\*<P]@PM;&+__<W/H6
M]G05.[M3\W)7TT[.+@N$Z.,D!/KZ N&>\E.5M:>2CU."#USFV!QT]\BA@:3C
M(?KGA!)VN+6H.D<=Z4EME!>:71TX:_"=L78SQM?Y@EFV]R[>IR#TG/F-9.&G
MR%V9V"YB)J:BAF1Y=!WRN8 :S>3.6T&*_JE-C.X#4O:7\CYJYB!C=UK=&&RX
M=8IX(H"!^6U$ 4JE_>,:(W_%%G>GN6N@['5D#C$P7);8NH7$_A(J;*+R&8;$
M]8^1PIBC"5K:EOY;([\H1:\XD9>=L,LY7!;4%O/^# 63=SE\YGMOY[Q0'+O-
MMO?/<&'E=[7O]?6[OE_%7DD*H;S05S\PO),BC3:9D/&=:_(PTGJ;LR+^O<79
MI/0"-^WS9)?/F@VE6>MBPWL?=E0T[1#1I-/R</>=U56>59_@!S(/$CS?W1<-
M-$7H(5\41W^+MWB_]3UG]?DS%0N?L"6,[>0OJ-P*U]CC52RJFP] J$9;G34;
MY=1QE==*EMH3\"_[.BX9;[^LN:3Y]N*HD9_W46_R]+_LP,E.'.B#,=2R$8Q"
MS)1%K<5IJBKX!3XSI[EST<59NDLEUB$'QS#TNSRN9TM"2&\LN$%$NM_&*&0O
M.U#9MC'&$-2C-]*S/Y):ER-2:R&31V@I46G6JIBXEX,?T8OV0C5'"+J'=A9)
MZVN][SEX?, D)>3Z/#='\QC72-WCB\)7Q827%\@6:U :(7@)%%,]LSX0PDNS
M=8AE!33#(F^!;,3@ :'J*F*UA54Z!/K+G5T!]>9L0@=I,V[,.T#5P@.E+ZG_
M @Z/0/U2]@"F@5-2)\^]W+0..8)3 F7?$^\AQ-H6IGRZ OS F_U,O&%A8?!]
M#)CAHZ^ V.< [9&A3A>L0X8LR%J,AP00'7_58/]P;S$K&1@"<?<Y$U1E:/N%
MF0![ OP? H+J3ZC&J)%K4\@1E"-'4D(43YW6=@"J-C&E'!/\]+.5]PYE*XTY
MSN8]O^FB8F#KG7H^>C0LH&I.UOYDI]*HL#NV=H LDU K4^=PPK]RLP6""YEG
M(?C]<-&F5@C"%<<'#)9OPQ&*\KYQ@#Y9SISB1.P='P?F,7*#,[KD91IS1RWN
MKT#$%ZB>#L*9@'T%OVO 7$5E"?$6_Z<(8G*C[RXPX(RH/.OC'XYM20KH?-QW
M\UY(?.%%.X6,<%K+0)6MOY2BEAI!DOM4A9!MQX+:SI875T)+XAI'"TPNMGC&
M7Q/MPIQ(:>EZ^1.3KGJ'-3%0V+$KHQ[LH"R"V^ZEBIX]E!C&-A^[^)K^XYJA
M!EM&ZI?R*.P!3W$7(ZF?9]5_@IKES340U,1+:V<SUR$RHT94H5@:$=D8?6?6
M#<A$-J:##[+J]?WAZ!GU5J"C-V(*!.12+?#3T8N75F^@7O#/L_"?=V7>5V'=
M*^S['Y3X>3KU).^6B490=WQ:YNY\G'3\PO@/</H)#QDG>2'6X.74+]X7CE;/
M7?BIU.!_R3KQW#%1SD7ZO,?EC,5,E.6WK.XU/??@#<C@M+KM89I)$Z?N2@?%
MSZ5CD#ZEK@21AXJSS((R;\!]<4!,=-C.6%F%W=";"WJ6&!Q7?L6#_>ZWRQKO
MQ]3[035TD2TW'813Z$]UN4]*$,@"B[0'])#312OI%_,A-\L\]%JK>[O ]\;^
M <8I&[ O,Z;_XW/P/?>4!$!,#]['V7F(ENGS7YOEM7QBV,**%,4@!)2P!KIV
M,L=(5]<AL8M_?#'-CZ[&L.(?G\0!J?G'99&?7PS]OA=HXZ&],4.?55-/?K4$
MM=(%WU3FG3%"^ KC*G#;> -Z]9?_ ]JXW".XB0C&U;KW[_71TH#D>S!3O7/W
M?SR'^_GBWD'U#/?T,<.3,FG[^#HQ)_PV/C3VIQR'W02!)<F68A :/*56NYP2
M?_9'+3I+LA>=VOR"JA_1U_R"'HJ0C$I.@W#XAMGR9M9*XP[*.=Q2ZA,;TS@8
MB%X[LDESY>L5V?D%38R8Y#%/C(EB8OVGF('DL/GW@8?%Z%U:F).'HG6^K4.V
MI5XW_O -K:D?<ET<\F!S>G3K486"E5%VSE$[S:$+W :\?QW!/C!%_FS:1EZ'
M?%R'Y+S*%L:$&I;"IGKJ&?%!<7<^Q1+&%A%IF']:G83!$)S0M#@@ )CY?W(/
M*_6?>UAM+$TJU""RMN7]6+*D2]G2M@XQ0U($P)<!H?L9'4]W!<9MCI[>_385
M,73&S>?"?M5Q'^Z,<R%<_8\"%L3I8T<WAHS;-Q71$2;F"Y. DE/<G'K<W!F.
M?D; 4HKG&JPU8=QS8Y5J >XE;7(T)%Q[2253-<3Y#(MCZP4%9X\N/Y;V]JN<
MG0\%6N^U&*LCOA2D,UYL[#UO$*[!SW/C5(>,.EUQ8^^FV/9 VG%$(D 6=YX@
MI>!@RSW,0#>/X 2LQ3K$UQ]-;CP- HOV;?#AF4_Z"^QKTX@J]$MB/A"*T%O6
MNV!SR0U$3-]_#>[_OWKX?:KE?KB'+!RU?9;]9(C^>=T2D5.OC)5S7H4O&'#!
MNW=?W",X5&93: $W"<WQ%;_N$72PD$L (K(KR=M.4X=5FE6=N26:^+_-'OC'
MV;__WY7_]<<9+E7V=NQ<<Z#\KQ.A[;IK,N*5>KMX<EG9S*)Y9*6G5;WL?G';
M=_G/,UG/-(1VW8\'_Y^Z K?D*?ID[SV3T*U)<=P^9WZXH+\H^Z+"9JF.@"JO
M<9G;UZ>ZFEZB7M5?#6P<]HHD"U"7!GO>%2]4S\%IY28:][5]O.V']3C#E6H_
MR:^TS:J/[$/O)LM198W$9F-&,E=YVEYT3KQZXZIBL;O64[#N&C!NI/)MYTYV
M">8$:TKD,N&?WB?UCVW/'YZ"_2TZ"$\<<8%Q1FI9/IU@RKA8EP"V%E#U/E0J
M_VT^-3;U]*^= 0^5)\B\F#(Z=.(2<YHU):F;A_/K0#OC@1.@2NGR:K-3;K-C
M%V)>5UM=1B0J-)-2FDG)D+CM+;#2-([3S,VA-R'<=9@M*K6_/"_).A]RFMFR
M(ENLIA$FNG)]OFZ^XIL.Q=['JDQK.<?I(_HSC,\8K'7W#,SHTZ<A9)E_W^"
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MQ,%6 ,&4IG[KSYN;F=%ZZ,D.N4U:2>/H'>QZI\)ZH"ID^"$?LX&$_@)([)?
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M,#+W-#05:(X[Z?;*GUK9?&^T?$R^<WI7H<"$?/? CA#7G$:3"RGC1,D6>/T
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MBR=S6I#NLKXBZSOP\N/,!T:;7?3Z3VW[ OWJXR?CW&%?+HZK!TSQ: ;/!TC
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M>\Z63^1\IJDD]Z6$K^*MH>.[-]O/G+Z).@7\+-[4_?(S@DSCXN/CO4=HCN$
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MSCZQHE#25<6==WD*$*70]UG5Y7+URP>-+ )')?UI@-WV"(N\3NZO>0([=ZJ
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MG&L53V!N%,<ER9\"M/Y4SWIE#I^24]&C()+D0G>$_^DHH?[QOW*J)/N@]*>
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M1WQ+4C.H+)58/US".V:P_NKFK>.GO^9KA2+2+Q)4"^PAF"_>#[73IN<E!&D
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MVBKW>,O_> 6Q#LFG*Z^I;/'*PD=+$POD.,]"I-+\:)D L*7?X!1@J:G4\.Z
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M '9EKHQ[^,"# GMF]>P9<0*PY$^3A="?=+!+<"DX1IN)FB#&_O5#BL^ VRF
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MV]!A/O-/([Y)2P<FJ$@/YAU=(V3!"!:A%M=^'&&R3)7;2[1/&Y3#^]MG#)X
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M\]((QO4-<W/R>)GA2AUNEK:$%]']=9K A3H8"V_;4-=DK@[/B]QM,9M!%+^
MHY$[<CDA@L[.[$YG!7KQ#;""8=, M-DV!X;<,+!SA?A,FV!6R24 6J8;1I4!
MIP#K4P!.C40AT:J85V74CM2<)N]+5\.#FV% G"X6/3=<\LV$ #:V6N[IF7_Z
M]<M%>24'ST,$&3')_1 +W\3G$1C[OW%K?_"KN)5_5)$2 %=;^_T(\=!'ZE5U
MI6'D4[S!HT?3-"CEN"0G6WXQ[C!M8UT"OT_E+\B8)R@"1;X#XU:$_C*\%K(;
M*P+RO+I_F'\*,$6/2<T<5@P?J!N#P?XBTZW3<YGN&@W3#T9-Y-=?P#RVTJ]
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M-\D75^1,_.L+AE'FY0-(3E@/PUD"^7JH+M7X7LW=*1\KQM?4"Q\&<<:8]5/
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MJ988EI#RB9'&E_>TF,:2L05P["+$SZ#RS"_XQ#13'6@^8:5_N?^2U>KURYX
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MGW&A%6ZQ>/B.\4;\#&^P3T_^6T.'V.AT<OX%'/Z;&_>_#?[@ ?_A$5_N,VJ
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MD1S'<G2''<"4<H\7M50C!TP".-8"?A;()"S *-?'#W@WU%4<P[1BJY(B^PS
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ML@W;@47/.U+4>>5(;;G2C#\FC_'9#A_Z !ZO3VFSO]K&U9+)>C(/#_,)M&<
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M4]E3P?L,NX\'9T,BW>EU3>G_50@<;!Y'J#Q?I%M+,A%1AHUG@)@^Z.G6?V;
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M.C1;);04-B?>E!6O=JCIU?O5E3KXU%R0<W91&UZO7"QZI2=OQF)J,(P^*F-
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MBXG+@R-9]>N,S9CCO;%RF#IWBBN E7;V(,EP@NG4G"EJK<652; A$A-5<:X
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M72GDLMT]:[OHK>R>6L3D \KE?& X'.2)@YVWX7X#Y7R?)V-[;$JGW-Q3%N+
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M+;IHPFW'*E*+5$'S Y4/LC4@"AET,DY6+V0.M%[>0'UW\:K/LUQ'B3.Q'*H
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MUF99T&EN;&:<1M#,]%8%MCN:NX(_9(=2A,63.0J-?/4@!![%VKGTS]EA F^
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M9>WW979R_]G%0(^VE!<!7-\F@OSF%TP-7<GG2@S2AW\6F*@9CVQN@16"D#^
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M@<[(@BJ^U?1_?=X['[@*EG5+-$+Q1IS8FRT#B92)N>))"%8O)B-%==K&QO5
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M&U'CU83>F:NF<'YAK651>I6<V(2]CFCQ;45^.5#VVCT\@N4A<<;ZT)TFU=L
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ME@.0HGHMLEUO#IQ3*:7YT:$K345,V<;*NLNF%K_GD[,46(#?BX=:4RLS8Q>
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M!4??(EH571/8O+2\*MXU5CKPD.-J==L8?*5UBW D8)<7$8TOKU$G<-[K_!O
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M8/, D07=*SF(7H_=3%155=T(#,.HY+FM&EN;Z/Z(>K46OOE# ^UPJ#$F-&M
M5/MK23/"XU-9M^6#X$1'%ULE)YUJ?4^B4%>)Z)&J-'U=CQ#EWSNCFU,+J#6@
M19._8!\LEOEU3#'LD<V7:LXQ'0,D5H'7:7:V2./#H"[EXIC.4_O:2N4JN=["
M!L*]?HY1NS/D@L$% ]J<LY*[P^T\>RT.CV'TS9]9GNW5^0,+UQXMHK (2-X?
MIWG"G2'JTDX#1ET=)G+BW7K#F<+&A#_K*V4U8^5""0R\R-P\>M6F\M>L=9Y
M1Z/PF(A(,U <Y,DS]DKCL8,*_ZHK@?8(7:^=R^<,(*5,H)06H^"DB_MQ/Z><
MOMQF:IMUGI%"&A?]_7CHV*^TV#O^JF+P-R-[3MV4-OK.S9O6CL;B9>75]8K[
MIIH;:]\E=.ZS/,GS:ZT[RDV-&0RAV=9.\ L/HWN6WN!7\U]F5L"#!'WYJ^QL
M&+Z3V>+_3Z<P& N(%+%6ZN:(;8*EP7<3SPAN -$@)/7UU\D;P&NK8P&O%0]W
MX?ZSIUO2,:MTKIA8 MCN\27AF?-_KZ/(G,X^__40"Q_SLK3X7V_3_E5P\?Z-
M!>/:Q$T3%+T%\9F0UF*?J+=PDC3\9+7YN C&Z) P-"\T 3'!N0'0K9W^!RWF
M"!W^#RVF*7]6%^BQ(]1TVF]EPGZPF?"/4AIGWM .'Z/RNT!EF?[#$ITY6+G\
MM[C6&P#Q";JAJ-BZV89S%1X@S9#:D4I>,?OF50'EU(+][/VF2^1&DJ *&R.W
M])[R5\C0H-61?O*Y%):X]4HIQI[;(CE:\.>:Z<@(^SQ%Y1(P_=[_@#'_%);_
M=$_#:<;\7Q9AA4/_BQY#@3.A<YNP5TQBPFX_C,*]'H-%O4=O>X.20VQ7".".
M0/*.I*I,O?D49X]=_IT;*LNV>MVF8!A1(/,Z-_LB9<P]90RP\PR/1? =P/W^
M+[\MRY-WN"^\2![?=:9\RG*"L<#!FP?J1P%/>["G<M);EV/?;Q&#VGDN[E(D
MFO<0\T.*!8M8^TN-J0!?W&>_ZD1\ABTAYJ"/AH>N03T8?V\!BQSLT[P#%2]2
MW.NA#6BQ2;:(<<?PN6BVXEV='T&;%TH,&:GZ'E[#,H;(N4BE?0^EL]HNJ@ON
M/R>'7X&5X AO K"LY5G/ ==[GW)O"L(KM677_6ED5Q<57U_!#E55](L+OVX'
MSF/W<2/)*G#<2"*QPS3CC%,V.78 &NO>HJ?JSJZA*&>;MV)21BPL=&S<?PT&
M5H!;:MI4;@ $ ]]I!D6 R&*\E9S]222B1=RQ)]V*JOKXP:N][VN3FS3CDLJ^
M147=,HP$N>PAD$QU9][X7@>]^LFA94GN'N2I6/Y[!Z,ZIL] OZWA@B'QI+[2
M'1#PK]<)(\9Q+*L\1'&_,-3LTV),A[MSX9U.4"F<&Z.VJV%B^O'QA?U8Q,D+
M[@ &$9=3^)\272YIH\ ((!&I+KS],DF:*9:4:3!JV"\]]XAB"2Z6#;AS$>D8
M>::BR!5"WL]RUZ%KHA[NDXH+]^:TBMX5*4^TYED "O;WQ3 [PU\ETTX47@C5
MTB3)<I$0:.7N4]@1V!,QN'_54'0.>+C*G$+76+\":N/]QKV<9XY,#2[<J*F6
M,]>5Z6F^U 9]Q=[7<XM>REQ\9-J@9;$<,\'?J/05HN-?G+EJK=Y%O(GWW/ H
M)F9D7*A@ZFC2M"+,?..3QZCL=B01_QI?,WNEAVT+PL\%_ !+,H!BNT29N*7_
MZJCG4>L6V-:I4/.9L<F[$NM I1BL'3]U_ZD7L^X"<$SR'+W,<KW':3%^OF7T
M90COE95 ;+%A(BC4"(3;HTSDWGLQK2&6+=QF?Q:T04^6Y9':"O>M<XW XJ4&
MBU!O,]3$O:#LN7@I!:,K6<2IV+6=KNI;I0-G-,Z/E=*_;"C^T[ )W']7$C-C
M,\MY4,7FGDU**<90N;$VC='?1@OTK/UT;_JBL6X ^!3K.<6]\E!A%=;H$?BM
MB<BR[KS9$Q:4:OTFQ=U48?_L. 87.%B)I< .8NDJD"35[?"0RW9M/F/585G*
M&=2/2)G#-R]B=B1DG1#=(1=-1&2DEGW[#EN)KOMF>:M49?*L,.YFDK<ILOX^
ME@[3M^L+.,+X'I+*_\YN"C&*I*'[L/+3-R9[M([1E9!WWP286I+1?17TR$HY
M)W]&X8_\<W//9ZPX+>FQCQH]>F.$W(6\AD63=G']6JZM*I(^>EHE'VY#L'C!
MPC8FBV?)!5J9C?ZF1R;Q+PYDG5S 9$(#D!5H*NG)K!Z1+//Q'=(0W3!LS'X4
M!A_-L=2]A@P,AAI]2JB3J5V-43WM7JV>B&K5_ND>-6H3$'/\19JNP6(0,^#(
MR7;BY?3V8ISJK@DHB19_B4S_39W/7$#8LSV(27L31?4(]G'',B/5EO&LY);D
M&@-@(&RR FI]'762B@ME*D=M!!8_G>\O6X$HC,9/$CJXG0MN?T!1Y@W:Z;Q;
MO-PQ@B[B!B0_TXI)5F')F+@!Q/4C1==\YWZ9V;TG%7AKX ,32^" 5IQ0PI&V
MK44H@\YW;DKW9D+Y+T9QOA?4XUWH9'M/ <NK$I%L],JIQ%80K[LCG6'#/(!!
M@2F/D1Q_N'9B'F7Z7'YM[*,4<1HQI7'61.71(9,N.HN.0>(V@'.Z[1/%<U8?
MW[ UG5P(\&Y% 7 :>PN?SWRI:VHL,,D-8?<.(STBFV\ =PLQLDA]8%#GJ8EK
M\G#Z[+3]OO+.^/L+[B+X$9M8[*-W&QNCB='8A3WW0LW0*AX,CZC@UAO[;G#^
MC[#)+'3.TD!$,))I=*6H<:=ZAC>!C)GW[<.AW;>C32331AC\T!77LZA#]^2[
M])Y?09T_2TY-ZK9A/][UOXC6T?C753.'OD1=IW $R/3<26:^>Q',WK=O/'W%
MC>V_Y.U,O;O@EF$XGC&:%4(;]NE-C\/O)2<I2!?4.F/>[77[*%ICA;Q.Y#'-
M#8":E;!N2FF,H]-16V/VO2J0O_43ROG%6);[*#KN%-&=;O/1G'N3^*'/:;I8
M>C TKHUO2\4+#\E[]NI/ PSI#:-Q"VWGFS+J(AZ1MWUN%I^_YB(%\;E.\2:2
M1\FO\.0M#6ALZ?=\A'"US#O6\.S!MH0<FC]]6DI GXTS5)1CB@N*?]X _%!;
M)S< T(_- %UNZO,0(J:%GZQWTVHMA3<K/8!^38\LF[C05U[(8LAI.#<W<:L#
MPI.^YIJ3MPM&:C[B+=Z%A*M\[T?4\8M'UA7:J:WK20J9W9.PF&\R]^S\.&ZN
MG+B@K@E;]E(5EX@/,(F2J:^4")*[RJOIHH4[7.? S%0$EME]N1NTEN?-A#A8
M.3;D'WTH?CGT<51H ','?<\61:Y@2^LV9$#G$D=CLM%?JVW6,_MGHJSY4YK1
M2-1Y7(+H]J:[EV&CR2V(JS;=._2>6$1*5DG$LTNP?/#:'N"-N:J5[]N!3&'9
MH!)H,?ME/:$A7+>JGNR@LD0WG*&^Q2R-ZRB8.;H)-&_84K"3WKOP+,NTQKG[
M\SL[<:#28 15HWMNBQ5F6*L\C!1X3Y-:JQ+?9L[L0G_OJ*1JN/A*!V^2(H]5
M1_TPXD/-3N4,YB7Z=O?"5^MT0EN2-$<)N[74X(8)?*KP%H0RCWK30M^6(E6R
M9OKC(#9O\VM:OH?= ,2?!A3='S6P&- V^Q8=$M;T[)B;*<\9HR;B^\;U:#W^
M&>, OV>?V\9#ZKLPCT;VU1M BP66R:VJJV6&/K2G.'8^M+.&61K467]ZG>I-
MB1$<7@E=X0W>9VE*>?ID85W!;$Y42FJ[C<#8.K-J\;VYY.P]?,TXH>OLTC+K
MBKIIB*W 9FW8VW0%F]=7A"[#]F0)H_Y=5F=DA% \9&H(EGG>S;$-^SC TV+/
MV#E%:-6?G5&JP+\:J=5P.V81RX#CYM"PO@CQE?3WSU\E)$YO6:OQMXUOK'OR
MF&\YY#E]#AUXM/_./N%^FC7.QLOV<[@6"KZWZI)*DXZV7ZX-*_$*D?AE%NP&
M"*L^+6Y[C^9$"BCY8+@]5PWNC;%4\U.9252;Y*CI#W\HJ/1TKMIUC*WR],WJ
MC;:N2/EA*[_0I_;K>*_Z%06YQ/V[2!(FM^]?[",$C/.0CDO2B2BR3OW( +;Q
M!S(0$Z%VQYANZY!VTI1QO&9;WU@PI3?SCC=EW5CLXI[P^:/[G,FM+Q86]R;L
MV\:C0Y177(QS5-Z.XJFHI6BO*6D,;Z5TQ<M+-4P__*ZP&:+5-)/BR-N7_'NC
ML:\-46X36>"F^0[%*I(;,+RIXN.Q-[^_;YBZ5XKT[EH-#!*2HCO;MH[J)?IU
M?WWP[<?(DR(FL@?Y<E03!E9A"]8^[ZVT-LXM,?I29"**:1%O^Y@EZDQ/LLP4
MU.+-2<EDC(?2L8,)4H=MUO)=(N))GD4\&_X?.2<_,C.EC =?<4&IRM&S]GGR
MN<;<N>4ARV/\F]*ZGT QGW.U'-\IZY0H"[5T$6D^6#]H6QG>/IH[EO_>G/Y1
M>G64HLGMATC;L_DYPMN9/GV\9%W= 0\^;Z(=@T^,JE4+/*MW[HU]U4PV4G(#
ML$C]%@UE1G]+H1O)%-$^\B=P\,/E>MFUJXV,&:?4@CO70[L81@DD86-C"'<;
MB-[^;FF[BE!E@OLDN>_T5?;/!I$@'I;XQ\!6SOD&X)4H6J(UA3:T TQ^6F.2
MX)7&51R7)"*WY!FR)LT&Y4>FA*^&&@!)( ]5[K6$W0MVHP\Z.\^19'J26!%G
M4Y!'X0BE>MRD:#RYM9]]N><^(ZY"I?^AD..'X@9C6MDJHM(#;Y\16=:U=![L
M-$]''Q-O+&.SWMPIV8Q8U;\=H]@[LDNP0!=IMN&#CHZ!M>\YL:'=9)&HP@6F
M_(W1Y;F96+-O298JRDH)'=,[[K*=&:8(5I>=@;F-)#CQ;MT3G!/*PR;@=:HT
M$U0*>4(-?NA\97'(DZ%CX!GS^*L=OI34[@"6UPU7:1AJ=#]R23D30?V8] /0
MU1[8)Z3UHG([>RWLQ70Q.;71<X>ZIC-+RXT344MG(HC>-\VO#A)CB46?KB_G
M\O#0LI[8U"M)J B2*IA8&H1Z6K[CRL<5:FN7R5] '#%?;N@,;[D!$.[ :%F0
MTC\*VNQMN7.26&5:44E.MV%B>Y)\$5.%4<I)7GZN-C^KG9R<8)#R:3!"<K/F
MPL,ZR_?HW@6K^E"1*Y8++?\QS?N/<"I!U*DQ?:A0_)R)/SN#=\7AC,$R4R+2
MO*.JB::Z43E#*LSQPL<^O)<4I*]&HO=*$Z)PX#S:CXP/DQ5_X'TR*>@T[Y'B
M=J75T!T'4O+H/2(U8?88!A@U&7Q-LG])BG<EMFLXUQ<CO:EOI=I]BTY-_CFV
M 3G!6(Y-;J/'AI8^>?+%P79FKWO_:D/[Z=X ULRCL0CV&\"?! 0+SPU@O/HJ
MYG+S!G"_] ;0/<1^[:UV"UR%/OY5,[I@% 6>HR^!#3G_4[SH%/>\:Z0!<59P
M"\5<;@"GQXS0EE,\6:0.]LT4; Z\;N3E +P'6U,)O.[ :DW^^?<3O_\4!6_T
MI<;(7PI,2NN.]CAB=;@),5*CXGDHY.I1C?$0F;S4(8 C_TW,*'+B4F2B;M\+
MJ7K/@6ZZ4SX/KA&[.? I0DU?\L5Y,5A+XCU6:'37)&]HV7#@,C3P^:8M6_UR
MYO"Q6^6AH,/E7KKH@&?D'N/2K[OE;K$;+%?U43@LDT)+V">63^7>&Y;8W;F<
MG+X!E*5^6VR#D0$2N(OLRV1^[%DYBC=UD?1>)MIU4HD6CK_W? W[<_JR,(<3
MK3F&6=(T ?(H;G<\?TQ*\&6RK\@D[[+R(KG'(CU$]O^$LFZ'^V0W !;MU!N
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M+W(F?!4 ;57)U;RR'X< *0."?IZ!MV8FPBLZ@H:BDET12.J%[LYC5<;MH;(
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M\!Q6YH&Q3+;![M>^1A]L@N0L+:W6?9RAI7TV7Q:.X",ID[CM#FBD,M-W<N]
MHZF7 YU<S)5.(4H(FB&Z">4 K!U<&(^\UC;2\EOP\RO,M@AO.GRX-WLMLX(4
M VMQC6)<4>;#GY=-+Y1ZI0DY2M9 ZAF:R_MLM)3]Q@_I?3!8%V/Y=  5=Z$D
MAL)2.85^2BM9FXVY/FXJ M.)S#EM _UO5^<0%O'!>[EYW?/@JJK.67Z>ZYUW
M"Z/;'B;QBVQL63[)Y&2K_^R8+R!J:NEE:?1INQ[:27=Y%51%T]TP>DO;5$K2
M@7-2ENOE0T0&.)00?W*;T ;";_9'>&XS:SGGA?;4:*6]6/PQU&CY>^00Z%3_
ML?M^(-8:)=>_6Y8>)!-@'JCH$#7/482EJJ2.=NX4/S+,L [O$)M10Q\:"V;H
MP5J-8YZ(&/W"9HNZ%#N--MM]#>I&]\7/97ZH#P]15"V[E6$I <EMB']GFO!9
M;-D2^A,:6C-[H1%:"IGM9*_3-B^A@@LL65R>*7OF><B\L\">6&A7? IP%#F1
MGG-N76_VPU9[;4>= I@531VKV6>C7/+?/^#2SK@'/!XIMBYZ3"DJKS;-9KWS
MQ-DLWO-K/GOQ0Q.SU5%HBW(D@7&>CH[X$%=6,??!RWYCZT[B:H[30K6/]>Y7
M1#FT%=P_4:_CVC%[;3^$R; -\IV49>V-._&C/6+>-8XO!6?<&'G\ U.JO\E]
MHS+PMR,D$XMJ1["NKA= 0CI0LD_#N.L^1K\P'G';LS:07!R3_7&],83QCCD=
M>W6A\=3A3.^1\]0QXUQ_1  0;XUI_H$CS^PH""6+N>1'I25V.P5Y<6]TX]8.
M#SP&O9SMD'[QCUR"1IE ]M>[ EN@7^"I4K/7""&M-27%!&VCN#']Z"_U)V-)
M$<J" =KX<A%8A**)QYWR%\$"\SSY]+]?I!]YQ2 _=(DWCMH_!H^/5IV4>"N7
M$IASB1*X\);U3 9PLV35L.L2ZLZ;(3NWF#S^X0(:6_*8O,E;14/<,1)+$=JH
MZEJDR/[YO'KXH*GFYB9(:(WK)JK*G#YW9JW_3NW-4)=D)C-"4KM\4&* $E?%
MK1_"S]$A.\MCGRL^*,KGR_L%%=!C' Q^&?-)+RQ,HW>&=9>'9^FES(&Q]=Y)
M\V*4LR*+397>![L.@^[G'F2G[DF'GVB-$^5Q=PH2BDT#,X06,B:X[O1A>A90
M(01#+$5L(X,9-S4DSI]#O5O\T1M9KH*OD! 35("M7#U>^=MA-.UBG%6[9W')
MEY=K@^"DF6&<3"ON0##LUD-IAIS4&G_O0*#A"A!M.!=6BM^9?X0/?[=?7?O\
M9:4I W/?0+;D9#6-*2D_P B3&5[_. :CZ64/M_M@YOMC^=*5B;B@A#DR%Z$!
MK]HZ]GJX;4:\KB;T_$6W3Y$=H_M-UAVR=D9XR[;IJ?B8H7UD*6/GT\/<*V@]
M ]P$BT1\OE:IFJ"G8?G:]NQP/NRK,@]$1BS2;"Q^/OTJM$:8H6]&("?:]NG[
MIX'RUGO?Q&"SN+(@-LCRDQ'/9]5B!Q"6YX;OHKV7=^!4 \W\ >HXY^"A1J%Y
M[2BPS *2_D@%^-X6S%Y=A8V" =OE*Z:FO!@TQ[Z666^^(DV#K#*7A,7HK-\,
M1=L:R>LW)9DK+X_,R.$4@Y3P9<EX#KVHDU?MIJI,1;FA1R;*Z4*RV- _'A$;
MT6.X:I:V_ZS95";W/-\CBZ\A1S=0;PG^V-GV?JKQ=/['>.=?QE.P6U<Z;"S7
MY9OA[EXTWOM;KT4^;OG>&#07SS7><MR<Q+%PA+M)_: 4S?&<9\DM:6XZ=E@(
M%,="@]&%40C[&"#V /95<I5^U2V"7^WHPB6#QVX;X'Z@,X)Y94:*D WVR)[*
M>S>I%TMQ9NI\C53(1FWH !M":8&]3I:#\OUZ[=? M6O1YRQV-#TDE<C9WJ^3
MOR2^7H\W->X82F![3#G566=E!&O!%H^TZV@:PH0]QV9>Z;8<++QX>]?XCDQL
M1N4'.;Z7T7N_J>HN_PK(VX=+<%-:PG(C%S]6ZJO9/_\3.C $%<[K%B#T.@N@
M%Q@G_N_2\1VQ^9!+$5-P%) @#2,_]@6N[T!)5TNH74\*NU9_G@(0R '2(C @
M4*CWSR<J1_RNIP"0.*J(NUDY8?$44 4BQM>< N!?UI?HBN3%WB%V^-K(9Z97
M<'W](T'H%'#;";@EME/6_/9?0LE_%]5#Y%#BGUQ]>0>L!M7_4G*"A)0$@AO^
M)KKI7?-R+?4<&-_9I>D3 JT33'C*O(!FZU5DQ'MW^67#_7^2V]1-L09Z6DM5
MU3M3\A?>R96EFMWZTBF?LN05\&'"/&7O!5PJ8$;DY%!2\4XNC)'XH&)07U8X
M[3LRF_DP,W1OQ1-.93IAWLF47W^>8JA9AQ37R%Z_W'Z]JGCX-AN;NWKMGV1]
M7.@[->]?4=[+95Y8JIK6BE2"E6!N,!2&);@N<7X_NG\A?NR]@L6MO<(2%SF*
M0L<']),0N0Y?BHD[+T?TU2[\3V/_4_#]:"'RXQ@@N39S26A\'0FTAQ^Q2_V5
MJ>]+%IW^'Y;;&'!_JRH(M/I,4>!L)O=A)/]24-+Q4XH>!#MTP=OU>&6VKT[\
MD&/=TNZ_A)Z>!'8>#]AK_1?#33RB>RE31R ^;>"\S7$*4_JT0P#"[^D7N=^
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M@"U0]/"#S ?A;3,"L=*)UUM]RQ%Z?A?0CPX"XW7UG9XE<@>4\LP2/#;!KPN
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MH=8]2_K;:9%_L=;R!O\1C/S/(.WC?VJ)V5\()AR> FXR'[,/$T1. ;SS.J>
M,BC&-)/K%+!P'J%J!KV$6$AS0.SW$^]>*.E>1C>[D@HTE>^<8;%>LV/5AL"_
MTLS9D1\;GF%=^PM]/IAS(L%3P\03Z!&!._W9J/.6:&6=2*FM $_GP_L;X#,
M^MX-ST@.BS@%;&>2JRX]VG-5GB4'42QKW:FV#GESA@_/T!TW/7#%_A_8SH [
M'$3/2GZ=_,_Z7/'U*'*0<<P90MRI6IK%P8/.8-OPV<,;< K8+SIKW?]/ZZFP
M?P*]_[/:'\U&J$E9!K[_ *Q_>I))3T?\+?D/% GZMXZ=@<Y_UC.*&PPVE-^Y
M#[__'X.3;N8B/HHBOXXXJV_WCPO$V-Z 2J]5>#,1J*36OWR7'&M$(W]R*58T
M:VXU:DIFN:APDQSWG,4Y1;#OP#%]=+P#%"T@'&@.B-&TGSM[(@HU_Q(0RX*^
M+AQ!;?0367> 0G.)L:D54:MRQ$MG1Q [U'J',?^2%B.?[(@63C-51ARJB?CL
MW\?@+C'IJZC\_0U^-$Z GYK>0#*1XJ/"@*;^)_4$W\#%CH)'MK5V+3'RV+BH
M8NE+#7P&H:Q2P:J7).Z-%^8,NY^[]&I*TG#-S*4D?XH48EX-X7SCW:T64[I(
MZA^7*GE<^YG62#Y2SO:JO^3=O@1YEZ8]/X>:O4YE#4D[Q^\_S9Q>*(+9B7DW
MXM<-M9V+5E/24A[#"Q4-+AW1'R]]VJA2DJ30'[8"2FW"?#RT<HLO#YNS]^@O
M1L>;'9$?N5#KU''<C+7GX"7-<V:,\J)=:O*_@Z=E'I2G_TC<TF%E#R2E?C-[
M'Z+6B%6:[OYZX,53G.*Y<&0^A@[*<^9J64J:P]W]0,QS'??/!#EZ38?!\PN\
M+)7F/YP"2GQ6='0*(: .OPV@_7"E7+Y*ERVGPW"4N]5ZD,:-E2)+'3&3W!^6
MH? K:J$YQ?UC*;&V.AT'T!\&4ZOHK4RW1;!QN=D<_D9Z?[[RKCIJ3&HD#T?\
MA)8$\/,L2L4MNG\V]"9>-<@WU.P6G0G2"$YO?Y'WG'='35#G*JABFX(ISA?%
MNB0B'=WPTRA&R?&$P--Q4#U9@*M<,UERN,()E)>ST[=,DN]A6$C[;+[R:Y%V
M>Z$K'R!'[;!SSW B]63TWO#^9(.'>SUOAD%(<H,;.MFN<.T0QY$:*/)+ZZH=
MYST!H,/YHS@SJ=FB_GN?.92M,QR>(IEB/)8NU+Z Y[,8'Z+S<D18N@M?O#&6
M;X!BN)D=*#;1\/"",+[K"L@+,U'2WW)KF_*9C0R7-9N33$XBGUX,IOGUA /:
M ]C4./\@('EA:ID \PLL#2LLMB!%/1C.6+^!51Y]O=N6<6N8 BT]??DY$ZF;
M=T4O7Z;.1"+JMM%=@?J ,=>F>"$F^H[%K4.F3YU]H8UIV,_CZ]?:2(4>+];/
MW3=6NEJ(+'3<F3P%./)EG#TYBJZ;>A/]J0GP>T9WOR;ID6_ $R,4QY&I\>\H
M7/T<Z"]=<#$')NB]M"Y=,Z@G0#7B%@096L6'1T;>7'6:",NU,=!5,5X3Y-E6
M3=&WO:/K_FS[R)(2DWX94QM;B$YAMO3IN'FA_&0T58FN_3B-QK_0?JC[RL6*
MHOD+I:K.!2#'HW#-2@=>U:1'Z\%C:=:"B8?.[CSR'E&'E<2 [?'7.[H3W"+H
M#_-W%1-=4XNY$FX-[[,MG8@T9VRZ-U9:EPG4/)UNNQ=[,)U3Y_KY\;2NGZ'6
MF\BX/:GWSV>3M8U(%HQR,BL-WR7K$]AXN#SAE5R7'5SV,AGL[U&,>":_- &N
M6[B%/*G\/E+E04K-?]ZT$+)T=/?9NE9%U%1?OL97AP;WP^:,IO 7L 1EEY.O
M"I_O,][;9?IX_MAHHE$!2[H30-)KBV_CNN<3&:7W8U2Z6Z<ZJJ!Q\=PKGLW8
MRKQ"-MZ$+9/JG&*/@IIRE%[R#?P'#&5_-]!G*"77Y_A>/(!ZJ[#+Q8E??&U,
M."X8)G(\&B/9QB6.JE!.Q?BB[UV=R;(^&O;,RRA>>;:PJO8LU>QH%6I0GEUK
M$.V]N6#7+! E84&SV_M]#S"\_:U*1!0D9%0#MKOA%+0\].TY =CA-UV+J,!-
M]5\#0FAK<^@-O/7M^XQX= 7S'Y>N'S'EFC!P>,'XRX[C$ZPO1F1(QAOS#GOA
M/3W[-TQO)[/RHY@MS&<OGUQ_GU?;+S#+=+<OAOB;9R.^DMUGEXVZ7>RNWY[4
MH<*L@Q.E5T?Z?EX.VX:IRW6WJ^O]?C6N<PB.P.BI;DS#.[E;/R9W<]*4OIF[
M^5WO@]A@%X:\MP?R)2XIT+LK5-T4U$NY,X>OSZL8EMY4]T[G2K_]*_DU9VML
M9?48>U@.4FUHKSKE66^=519M955<>0P\.Z^0=?LQRGCM'I/J@<U1,-MO\9'6
MR8#&'XHI[F:S.AZD9 ?[SA5HK_@8//,*85+W^^X^B$://?/(:3XZR,N@T(#]
M1]U0B'X);^HNN5(RW[/Z7#9;/P5G\>ZC3%N&TI]O]([KA3%UM?$;,BPB7K>
M7OY&)8BKA%XM6%\C[AN^W7?JP<_^><.-0OSS?O2PP9BFKY(R-C.E+(2J<MC6
M^<MYX5- C8'ZA2G- [#]KWCN(QOY2!UU/90GO[DS2#M.&-,<A(T:\:P[YK/X
MBO9V%NAU=N*[V,4)$IH6>/[Y-N>XA5?QII0EM)U5E4P_3:L.LQ/A?C(8F+..
M5IS1K<O7!&P,^1TP:TE:GL^W_]I87'*P>Q-8)S?Q?G\_[[+IE_Y%KB\=RH'
MIY75C&MO*O4E7[(=<VLY[\?6O2CQ]7+FE6FG*;\W%S^4W5HH>Z^I_5M>V2E
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MW):=$+]00>9$;]_DPI/,7P3Y8;(2D-+M)/.]S+^V NEW'\)5]O+SK$)6M57
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M^&^!1$&:!4^/<C5ZOLH'5'TCRGF6"7MQ0C-#/C>C!1U<O=B]U8;YNKXH!<5
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M]574)=L$KX3W_D$M:X>A:VX0U[JZQM$V%7YYMU)]7;GG*L29U7. Z\-JV7,
MDTMZ(.XR!;B+"]ASA34%9X]Q[$\ZG/7>>B-E\7NDKI<SEXKQ'&#9LBD1E\=
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MU3X2?5\.^JA!?E%T,9<%>ECY#F_'F[/@_69W\7)]6FO;_E)<,<]=UNNOSXS
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M2Q?_AEE B)%45'^,_UVZ"G3OK6$L^9M>*(N-$ H?RPY?18,?0'ZB?X8)YA\
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MAIB#S[%?%!U50N,/++S_E/XN.#'?@>E"?AB5[D#$%G<C.^3Q(8^.&V5. .>
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M37&= V@GATBO0'^WLMK"\+:-:@= 0NC?CO'O!%IXGZR>&J6? W*A)3XH\C5
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MW!EN3:K%MV4W H<A<L[>)8.]^1&0/P0<0_[4P?$9'VDJK^Z8P H]@AI>@&C
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MZ\=PV[X*33]+HH?"R$+1<,G16#=?;?P-2#]#R':9YL43S20XSR7UG]HB5_<
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MGS\-W_M12LU$F)I_@#7/\.A7%1:J_<!>&_T5V-5<QR>/&)M[VLF;LR;$@[X
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MY4?T7-,C,HV.J2$@ZP5@X3.$2NXY.A5*YW<7![7,[7;GUIV<OJE@B#A+.+D
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M?!/F+=/J),..L9[^Y3*%(^K#,N31"]S+>D3DKI^*?$_X-!*A5_>JU5,H>MS
M$YO3F@+K@(1VOX@SE:J].;6H1M(3R7KR4O]7*.VY^J="[>?FO<9BHT=QORQV
MZP;C,;)=+HZF;2YQ);/I\CY*J/J-N8DJ>Z5.!0[\'U/-=XTH U;.#\Y,$V8W
MOT G<[#';=8XUPI#/\W:HSW9+AI&4O<_Y,E\RKZ?#EX 6I]Z(#_VH9[N?GDK
M.=]Q!;%IU$)+ #;!VEGEW0W&'R8[9R&O1[E_B3,:0U%4#)BD:QKN2_.:F$DZ
MJV^ZFQI<M3IP>_+MP'2EL"NGT)?'?W1RFL,6%1W"@OS@P8O7\1)@LIKY%([>
M]0"52@(_I@S,7P/]\;5RQKM9.YKM;9,[.C$4!63!LU8U8.)I+1P3F0:T(]
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ME[$/D%_7R;N M+7A=[&6*@)RX9?2]D2A/D&ZN":L\ 6@4ZESQ-Z+;?O*/1^
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MCPDL,"&] ,@KF_2]<6+'%=6G<C$FEO0GBMWPMQ4O&5B9_JQR0"0:5TY<SYC
MGEH6E5*$#]6GUV)4.4=;0) %Y)/(EM=:E*( -<<9E]UC_9:'=+!%"]%PP@.%
M6DJ.9W*,7Y9:_H<"($[@P5U\8A71R>N8]Y.?$ON["X0?Z_]$!]A-'_F1<2MH
M1:%Z*T93+IAIU0;U7C3@;CM7,UVC3>J5!UZ07E5X6",)6@#$VN__NN)JV6+S
M5P>>6(8>0L+QVW)ZQG=N1F:\?.(.$=193(1JC/.V"*:A UAIW1F$;J%8NX_(
MU21/7Q+^0RS&,-9UPRXAA;10*_V9\W$\ZE//K?>R+#F9N):V>;'R:!W,"OQ&
M93R' TVL6IH[-&O0',D2W4A>4%C],?WK!C]WG>*L[N>O%X!&D"Q%/5=VZDKG
M[Y85267$'QI?6C/FD^LY>TK)\1H"UF9\-**ZPG,<PI/*M(%Z7\^N+#7X^0R]
MGS/T^8SX\]J#%]@+0 _+&:$QC\C/*/7OYTB2X.TZB[GJK0X<%E5^YJ\2 ';F
MZ[3GTZK-H?N51,A(?0&(RQP';9;\E0ND[O?.YBJ+Z6@=56$&5_$YK3-/].?"
M]875[;"3J<GAR=ARK">+GM6&<7;Q!<!N';F/@Z;?GCC 0-#K_P][7QX/9=N_
M/5(1(45V4\F^90M9IDVR9U\S%;(E9<\R4RG*6HA2F0H),2FR)&.?-ON6?=_)
MC&4,L[W7H-)]=R\][_O\GN?WO,\?Y\>'N:[S/+_;<1S?<\PUD ,=G[0-3^K(
MFT*G@2C!C.>2"5"@[43$$<=>@555XI\!P-)1Y$LDI8UJXK(?4D"0FTL-9]7]
M?"4,32F@/*^9):)!;?3T214R?,?<DT_*_5TY&N;DEB;4*!9RX$CF^&!J([@Z
M?-]HJ$<-N_FWJ<EM0)J,#D,.2%0DJGTT,86O39!,,-<'KJ@$%F?^9RP!:_JC
M)0@K2P >B%^9J8H=2C"GSI2:O/;SR2?;1KZ/;-1YJ%=]NQAWZXO%.K^"J<XB
M"X]JW%U:V>>!UP\VPUH1#Q6_NY79;U'2T!2>!S3]2TL&M7$NK<*I'QK.\F*_
M6#[)A+M84$!UC8:D=#O UUH:=SW1A6?#,DG(TSW#\ .0KS>%[QN)]FCYN;E)
M?("Y7\.9ROTZ"3X\[O2*(Y?JG]];I9:B$B]"#7(\> X7!RP/K^LP/,O?B/!P
M9G_H@[0*3&<UY0)=J3'CS@OCZW75%\W*&/_$?-Y8^#$0BD?+\=PBG9O>[6((
M<;56ON*\9_MQ2,MR6*2"#N@Z_SBSOZ=V8GQBBJS^_=# 1N>;-;Z2E8O[<<.Y
M :B7'R!OFA/-6A2NB-D*SDE6'KGY9B0#[OSY2Y>4L7IA*KDI9^R\,1U287_0
M]4]O$J06W%Q/1K]ODT[LOW@%U9C1]?[9<:,:*8NCF_</ACFUG+M<WB.=;P7)
MDR>&$*R&3#V6:.,D"\_H/HMB],R/OAMF,3T8-T"3@S9?R)C,<*Y0+K))"@EM
MD7BA&MYLMI!^T3Y=PUM(ZDN/[HTCS%'.FHE;+ 4$^+;,G !B^OD.#Y+M!5EL
M;^NY=S0S;'W^];&%A@_<"]5^YODWLDO)77D:9MQ9-T>GM31QJ=%$DN#.TW7\
MPXEB.2WG-"$NV@9K40%<-PA<:OKM7L-,"_Z$K]'.6@O^CU,4M'B1%W6 (@1X
M%**C<??M2N#09DVE%%!T:AK<Q;G3ES%7O=DR.HGO_5C'IVN/ATR]6G)?UQ*:
MH=7)L:9:6N$Z<'4[<O;&R=WS[)(J3KP-0?H)?:]O9OI]'%R\+L_$4*N5&C]G
M1U^M?PDY>1\GW. >J$80QXL?1MU,3NP\9G+;XE1P828FC4P/$/;&<NQHI7MX
M*P1<(HCW&$#K-4D;C?2HO/.[1V][S;$'];B;1_]E8RX^MUN(ACV7\?5>V[M(
M1KG,+<U:<MT?QFH?[A\*K]CEX5HM/[,DL1U0"J/S[%//IYYGYBM/ '],-RW9
M5_LR,,4VL'"FZE):1L 1ZA= Z%L,19R)__G#'( AHVK4N6?7XKC-YNRMKN+^
M83.JI[:$7U J)4Y>:1N29"T="IM.3C'8P;N<%4J4;RAIR>*I-BCJ&WE[TG++
M+G,PYI7NOO;[\>"@0]D%A\ONY7L_%]=)U#R[(4&09Y&_CSTE(O!R_;.R"];R
M&?N?L=_LD?RCKZKX]G45KMC@J#B:LL"??E\%*OI\<L5$^]1%*\BF(7>\V;(S
MO<&7E=:OD%. )E\E<QC1T695U%CLME&1_KV[9$_]Z%-E9#I/0+IP<'1\L3FN
M'"_Z+% +(](\[QSA&\_0V&\NN7L^C>,9OV0.C5QG@9/U%]EY^;[*!SM:"R#7
M$3N,>C;AO;$;Y%)[+;);$J?Z:M$OJEW?[#;GUPE=M$I_FB^JPO*Y).X13;U1
MYJ'\Q=B,_$4]^9CB_"/US<Q4-JLD8Y(_&<PP;/CM+T]-:%6N"W?L:(9Y;:I?
M/C:]\)3T6$US].!M7E*?3 V-ER@!T&PZKA00&'SCV8N4F1XQ'=FLBQ^O "\%
M[J" Z$#P]]L: ,6P3/TVB?L5@ [;:I".;'?'*VT?Z(%<699Q#E6<9:DW']P9
M_JR]ZFP.S_52B'])M'2XG[[IV[KX3XD6V8XY*20(M[?Y@:=W37;X!V.3"485
M9%CCFW-+]RJXCLF8.X2)H7"IH412ZNZ6<QQ9C<:ON-/IFE^M*[[OJ"HSIUGH
M0D5;0+S6?8!YP5W'*:"Y6<1#H :9AS/$\G$EU.H376K\!O@KKU"76"/'1CYK
M?? L;NV%1#'DUUL:OLUJ&2H? !#KH%G3#:!T<P$(62.S%>QF^QML>&NBXP(8
M^W<6074LPXE$*GE_O>(L+^:+U1, \;_:IO++I M9>WV-*BTFEOV4.+26&M>Y
MJX8?<->W;36A\KP %R]#6X%;KDZL$29P[7PN?.VG97C'D<(S84A2)M6 QH:O
M/P$JHOK$?=J:MG'<B=P,2%1$RI-/@2MLR6=6N964+K(623C5@6H?Y=>17TF2
MOGHCZN$:A*+6P/.W($J5.' B21*\^F/GZ>G=:^8"TXX[0_(DX*, A5*]TV"*
M6OE-Y#<[^3EO/_=V!5TX;SZ7LIZ>U=;1\SJUQ>ST@RR(_DX5R3]0Q6\U@(5+
MQR4**"$U=6V[JU3_7<"LK3WM](K%V6!52U ]VV$(:(K5K09HNZ?_/.OMUE8
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M?02[C=IPOAPDZWQM_ZSY 5T6?$+>6E)/FJB%]30HNFX]<CV+9X2+ O) .;U
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M:'0>D(]L%009EQ1  \Z0E:%'# ^"52F@;X+2 '^6SP3C#L=^6.8'I.4@F2L
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MD14&=??!I 4SS3+$ABC[AB?R+,&VFP1$DS6B4T'F8.[B_4K;@2 &-0!IB:Q
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MV7KCJ?AU>&D?F8V&."=,Y',G'!;@',EOE666PUTIHQY4LA#YG F'R@\7M+)
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M._S8B5LPR H?W#X;V6(*R-%F\RD6-;7)+J='OJ(2QI$UNR7DR@>RJA8/V'4
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MMMI15<-8#$G]G-M1A$.F>NR>?MV9&QD>?>/[W\RK-T@\LD]T1S!?'&$@-K4
M,4V!<"D(VR5/<(2E/:)+F[1, ^*);:4=Z7)ML^-'D8OPA7Z%%5VMUX3:GE!
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MS^0D->$#PF0. "YEV 7[Q1??HTXK_"X%W";144<!IH<[!MH$/J!,\[J/3?I
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MZYY:+Y%8A*2/:$P/KBJ%X)BPZ*X6[X$NN#CN.  L"XCDA^>I9()5@Y>S6"\
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M!S)SL$S)RIUO*RL.^2*PWE$NE_VH/B6>ZRHZH.D/PA!J?=RQ,BR).PP4MXE
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MLB^*1-(O+8E+N8@_',('A@5I><Q_J"L!I?CLWRWJX.@.8)^- T.U:]$,R8U
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M[VZU GW6\XNT^:#5AES7RK^-X/J:8XJG&Q"5W(<:.!-I'^K'Y3""NY^:97P
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M&T684&W\&=LM^I;K2VTFM@$UQA,Q:5#\R=MEO-M+5H+C/=0YP>Q$Q? !#B6
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M]0=9^DOI6F='<9<#>X3^_J1E.6FVRF$XY]*2,#5A$6U&"EFG2 ^?(C9Z<1L
M;+%%Y$^3"Z+J62U>G"_6&CS[7<TF,_OD'CL[:DB2/5/]85Z6:8,L_&^R72!<
M_^/KQY\G'S3R&R6R^=.'NC\:?/,1<&XP9F(Y9SBFU3_P)O?_4#C"D.?:UP_5
MYT)7*GILKME_*NQO[W$Z?G5Z]0I3Z*&GL@BH:Y%IC&1:J))<:A;U-L&_,D<+
MDYNDV3-BH)SI.C&]V8NN!I*8/#H7[\GQWL<Q^Y\:>@\W25E@VD#5;!T0).26
M7Y1OD][M;:GGS<@:C2MS[Y?*X(O]#?<V&BX '#!E7"K233=K)>N>11?8B6[+
MW.ZP_8UD<8N9Q2GHR0KD]B'L\"XT4$$ZN'YW*?TW21B7LV=#?$X2KVT8W<0+
M#!I/>/%??['LOV.5000AVG65#'&\*W_U&\U+PB;Y&>12?N]2*Q'!?_2Z400!
M].[.ZN%?!<1',>NT2NU:!8K1T4@\8CER&@,.\]6Q[U$$"SX^"UQI/>>HHWN[
M!7+12ZXZLFM?Y,>M^^*@.4XZ,DW!0;[*&"R0Q"*W#(F#<=F5[*3OE;7,M7$Z
M;C1<"0WBW$%@5]%5%;.%/0I004IV6""DXP) X /N5F'1=/R\4CB6K)/=A+@C
MP US3(%OP@6@G1=D(X9N)I@[:H<L9B)6:XZ,BG#GQ>L<6HL1!VF(T_&!+?);
MX:$ROVUW*)I"\QQWYX_<@][N%($Q%8.Z9ZV*Y(\7 .><#U8LY#R5!]")KL:R
M\CT-4R9SK:/W/9,<9)$M),ME)_= MHIZM%9T(MBL8EW#OZZ2[:22-<1OEU,:
M<F:S%_YO+^4FOB[,K<!2 GQGIOL^%94S-[WR4%"#=Y_-.Q1[O[&+)6OTWWV[
MV!0%DV(M?:U%AT74I?3D)&?W]1,F]'B+W<,D2$H1IX&OSV#6A8D**W^\+&(0
M[;QH&XX *9A(S2(HAB^'Y)\/(? M[;YF-%)AGMT'[=!K@ A[T/D&JE M _1_
M3E&=-NS=@4JTY$A=/K$5:/E'D!JJ0P87T,' TKNYPZH;)U ]]R&S5OH,O%)V
MLG 0Z6<*4T6-G&84980,9BV47-(5A09_R6L%A,!E9 3KHCB!!4?L=U,96_2K
M07H)BL6_"P:ODD_*]I-"'B)_F+5D3>K4VGUY$WH ^8'[T&]U]7? @5]+S?_6
MWGM&-1FMZZ)!5(H@(B#257JW@%2)B(" 2!.BM(B(]"8MM 1!JD $!!20*+U'
M>B=T%) .H1,2 >D)-4 23KSCWA_WCKW.WN>.??;:XXSUXQF#D?8QYWS+\WQS
M?N^KQA9E;>\]7=-\L>< 1OR%A8>@V*L&HZ!<J$!/VS?"DU^>G(/I+7Q'=^^3
MOZ+LMYF)VX:S:#_E-WUWE'X*)8'[D6T+[Z"RQ%'<)K!U_NJH2&/BEB>;'J,;
MHT$I]7MX U1H*1YXX(+O>8=<9/!WSY/RDZP]>U.T 'D!GOWV]_OWAR>"HXM^
M<1D6!57W)F+$D/T&%?^A@AP$@VFO@Y(ARIF9;*MIU8K>1YK:;4*@ZEJ-/63&
M*<!E8>H1R2MT8O=QBESFU%3?[=\K" +2]GI^\M@O\9)@\N<=57>+J)LD%?.\
MQT@K:4Y,T"+![Z ?R+4I;>W,L-DI90Y4*HX?1SFX1YO7P.G"Y6"L#<_;[U9I
M*-KMK5N/8^!$T?/?8';L:M?&OMI<_3.,;0:VH? &X(@&VI*&S,_N=_PD@,?C
MQ_W$I-"*8]TOPCYTWJ7!!BM,P'.0ZDXV4\^D@Z!5<;W/77M_X%&;50+LD%3#
M2Y-$XRVLO0L7[G'L,3J;2*452[A30)RA)DOT]KGJK!V;^J@=%J>3VC;4&0H_
M491.:VCDMC)'EZ_XF9P'8BV&RHQ'30N=L=8WTG/#(R6<T&JXR""Z-L/2S=V
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M_> 2+ T^!41=C8SJG;_\?MF'&ZSD:/L3'RB<^3P,F8D=_\AF?F"^L >TA+T
M1EZ&J+0*N*0Q1_S)R1;DPK:$@S,^D.\\H]#@EVK#@V1MLMJN+(C,&>(FS1;Z
MAE@'S4\LTVEXD6+YD;H3,21X)R3L9F'ZBJFG?JV_ D6#JZ;L-X6_/34HDDF
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MIQ)-<1;NO$2V)Q-2[J:_T\;-+>_Z)JV;J3IB-^^TFI^EB*%ELV,FIKSNJ+R
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M XN(#=)4^QH$#/0,]+L5&/(]<6"E$#F*H*?T"EPBV4.E!=H54@8VW\H=K%P
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M.2P["E6M&1++BK'[9V]B_0O_0<@?4]C7G/=)$G;?T9W73O)0/$#,JKPT9P0
MN'LAZ13PP(F<)."-QKF3^/@59"/HR ]^GP*&TIJED.0#T2^?8 UW9H&8V7<S
M)_?67F006'8XCC4E/UJ?@[K#VNJ+:P\"QV\&:I+"H0F$6H1NCP"%+&@I<%)B
MD$$-'5\SSY/3@ASQ>3ONTP;J\8?Z$6,1SU_3W_6:#=NV5C^Y 'E_<(4HBE\
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M$_7U'I]B+;_H/+\7/PU[WK&$]XS[7:O]!P5W@=D@X372A9#1+G/F6:_05Z<
M??6>)? [&!ZT$ $&M/!!QV1S* ,CYN2D$Y"+UH '!IY^M96#!]J-PALASR4L
M!LJ-"T61PG'E251MV%(\#[1!$*^CNP=C46S2)'\"]N"6J_UM2U6%[QSV/8:W
M#531WW13!&2;OD#MIGB?(4ILKW-LE"R ALA"5,^0S(^50MFZ,W5@17TC-\"-
M9L8W/:H/Q#[>*)SY$&!;_09!W\))=,8LA+A >8EJG1:34R*31@$T/400B-O_
M5E2S,O=1[ZAI<;WPJ\"QK%5#G<;$[G[+4,R)R9H80.;53&C@6'6BGWQUZ/_)
M-7+^A?]:&.;/NY>R&P?2:4F21TU?/W0N.+P&--+DH/*3Z!TE@D"'==9,V\6?
ML#>HP).LO/BKOK1+L@9;PYI*08\G+*[5F]Z\*4'?DVLVDJUI/QWB-6FD:<]R
MJ!/4GTLY%%!'?^4I>,M>T77I ROW"IK="*1!-)(/1*EOT7T18-^AB7O+5Y"5
M)]#YVL"FPMS\YKG2;-&Y<^KY7>Q0Z(]D_XVZK!AC8MPI8&E:J-GT%N IOTJ,
M3;Q<I6L4'5\X^U,-(M, >/OFGF@ME<2;'IM&43#'1IH.+>P6Q"ZJ1A'[MPZ1
MBG,6'@]K F[C\A<-O_,_QU6S&[8(J<7&?8MY!@R\7"O069^OX>CTP4XZFV[L
M6E;,[.YQQ2O:7E[? G[%J6B'L=U9(TT[%NP=/]+99]4 $4#K'H<T=>:^4.?1
M^!]II3-*+<<CU A/<LA*G(NQ.O_S4-.TWM3_Y<6OI+DN=K./!TK%IX!+6I55
M)XY .SCR\-PSAV'>=_?50F,D;,;^=&Y>JC=]=?21.O3X.5:VI?_K=7O2>6J8
M6[CT>UUT)/VLPQ^%KZJ'[$9: A@1% ']3?*&%$SB;8^-#K=@&9_Z<8Q8\<EK
M^*+U.Z^I:2[_ZK]7N)45(^PN(P\^U!++*OOT$A8:V47) Y8^@S6@S,5*4$OK
MO-27\N=RLV(>57^GJOON?XM)P$ZG_@=02P,$%     @ T(%[6C\F-_6)W0,
M\K8$ !4   !C86UP+3(P,C0Q,C,Q7V<Q,"YJ<&?LNV=04V'4+AJZ@!"07H-4
M!0$+2!$(%KI([R5*+P(B'4)"$9 .HJ!(58K42!<IH:,@O81>I8E 0@F!%$[\
M;ILS<W]\W_ESSIU[WIF5R=YO]LZJSWI6V%S,7*P 6'0U=30!%)04%,<4QP#
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MC8#S,J=]F=\#*\IVO?@SGNXW0!TBP$5A=J$HL]<ZSD*^DX;9\>X/OE$)2&V
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MTC%/ -%(PIV7[GDKE1*#03$@7 (/)!.KT+Z: ,&/"%RVP/C@Z \@/)283OP
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M0D%C0 '=N<4N@L"B1V* ^*RK,@RNGL:?^&ZI[((.?F]MW MWH\*^Y-,.RLA
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MM?#W%CRR_UKGDMY#&^\?W<8LM2\+#UQW*/\R_W!DC?GZP#<?*@D)][_U2@=
MTB_8K6DAJ\]UBL_20JKDB6\($!^9LQL&OST/B/=6\Z)7B<HLTL*BFHKSULKP
MV'K&=J?QM9T%BQVVE7?V"6_-XX[V[_42[%QVBE$/C[X?8%TPH@K:GSJ_A_*>
M!V$M<!;E./,YB98F24KFI:E]/YQLM_%"A8"@('BVZJ.^A'Y= [V[2_H*_%+U
M+T2L6K'%DK7(9EV*6N_F-Q]GQ7CIHJ,YFM3:2/W$Q[D.$#D&2]<WBXU7+%V*
MP^^/4CH.AUG,]"5=+QZ P27M9X]4?U9YW?5-R+:,O9Z)@OF8]JJ%=,GXYICY
MB8K1/8Z]]T+\,HU=_-VD:7_K0@5*6=%P3TT>A93<LI+W2G[ HC3G2^P*BP4Y
MX@;%MWAJNS8=+*$-([L7@$NM/&O31_(V&B]5#7EW]M.&BTV]U#Y5S%OI>_=\
MB!\"^)'8<7JK('K[V/'G4S<5NRCLJ,<^QAZ&R5*6LBI\V/0S6N@Y8_[ O:O.
M(I<VXT*?QK']4BH:EXY7)(].]7=WYQR:GPV+6!_T:/K%BXQ,YTWW7>%A ^D"
MSL@=="4+67>YR4%'CFVS@HI4YCE)XB,-@QC;F;O*5G-5A&P=KTFU?(#./$Q]
M5_?SBWV7#I??$P.!:Q03!M@"E22O$8X^V(2K3Z? TY\I0M7# JJX>?%;MI ]
M^1C<U<HXU:L'N%&ZPQ&\4Z_H<B.I )-'6T9Q ?A1@H0A5]XH#]I!N1O&O%]?
M%V6E!(XC*<%>EDG@QG "1D&ZK+/C'WM$!L%74L7=V[FM?@JI:' =%@#!9#0=
M)X.YBLHMS,/5D].$XS86U0FM&S%1S)^S"93$;)(X[@![E5A:V#@IPSN])*#I
MTBGZ0FP-^34_81EX?! OR-\R&L#G'Q LH.Z;]PF9"\;)&A#8/AKAW-?U\GF#
M[SWVK:7-"&@-WHA0>TN!OT]NQ-W$FGJ#.;[5O#S-+^(?_[9\W*)K\$.B+>?#
M$O,CYYHU!MYKD2(\,2*D2[G_GM'&*'2"X^\N,[=J'TD6I7<\&J= I5H3*\AZ
MQQ TQ]I%23]02Q)-;O,!;T7WE'99Y2@(!-C@+0J\\T\V9@NKQ+,$4@G<J2$%
M%-TH>^M,HQY\3@.77JZ3X[L >.G%K_/#O1YI@AE(>3!*>]M^O,I]U6^2:TO\
MCHB% D9!1>)7$C=4>>KWA'R;E:-3ACM?KX,];)EL@RA?(2KR M"8""&S8;1E
M_AQDW2<*)NUQ=TGPVV14XAK7P NI=?AE&)G'UU?UY7F7-$\_X2M,A_=%@,M_
M(%<*()11D@:(I+S\5NMC<"Q<L)4"X[+HB!["O44N=E,1*LX8IN'/4^>L OC,
M]*J<:#-RM)'KD+I\M$\3>;Z-AX&;)TSZN"R*;O(E=P-WU 7)WJ#9;7+&N73=
M/R3&8\X:8-+P3@6A1!+O@V77TWY2#*21K";D74P[:W670CA9<T%K)"MR)=M=
MEB#W[MM3WU;XMF8$^(OLS((&L%OJ"GSK)SPW=&KB_@WCVI/#D4.$!#&5R[5;
MBM-YY/P*JO)[#T9'2 AT@X D4P$9>&>'T9<Q;P7X2,OZH3P:2&#UC2/([)*Y
MOXOLIN>Q!(F9MN[VMDDM\"S0Y[?GT2[I4D<L*'DZP6%D$ 2.+P#NH#K3.7'Z
M3]-3OD/A T@ZY,IJ2&GM9(.H\6W4(_CZ%+Y_%0!?-;;T6LE5!F] (L'H%]':
M4!M8ANT5I!<_Z'2;:M,'=[7T[X0S!K)^F>N\(>X]EYFW[A:NXOP%3A^MT 5A
M)HBX.KJ7]%6!^'M4*]!P$M-RG%X])N?EI=$F; H<\X<4,\9+ZA)/3DA>_$*5
M02R$Z@,C21R0/YD)->\_47-P]],B,X$X::T^+\@:J,\F^?;:2;9(N01?:A!B
M9Q<[HI6XXE)9> H2=3R4)Y#9=:=I]P+!!GGI;JM%9.3^BTF*<W*V40/)DRE8
M"TULK%HW30V:B[[EU3:3=X*_50 C%V"=0H0TK+MD2;V0BVK?XE /+_?O+#^4
ML319H<O1A#5NM> %'=VN?3("-G<!:."_\^94>=Y'L3,]F.A&=9X\#7>[ ,Q^
M7A.HF_^39:C<1/<*T;F,DSGM-HBLPZ7A\CL'"L?__F#8$Z _1KR5AGOES\&Z
MKG0;3D_F^6[*XE ?"-X8>/]!2GJ7_-LI)YI::!>S&]5Q*HD)1?RT.0ZU*W4S
M@#WR#(E@#%63.J?$R&2%8]@Z?!FAR@OS:0M8><((O).#Q(K#=X%9ZF=3<OWS
MVW\J@I80.WQ=2[<@% 2&.!N4-[673RE73ZD $P#JA7\ [[S;SA\<W3..^]SW
M_>6[WS7/P\,FEVB(11< I^59 QUE?@O#7NFBL)N/H*P0>GCG,_A*?38B5K8!
M1!TL;G'TM=-ZSCY<U?-PRP0CN^>.UUS07U.]9XIZHV3POI!'^RG9)WR8)@*7
MX\K=2"_1P.QCH<N171:=^6A# YP4L$LVF<0Z>>/IU)4'TW]I.<)0FZ6Q<"?X
M7'=?%J-[J/P*_^$OSC;K Q*]!29SL+/.\SNVM,SQ+WY@(!JUHPY2(HA.'5\
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M(%;M%ZN+W\%Y/"]Q0W[)$'\?]4CF01GFC7E.@0K$*UP^Z.<>^:R/*)B]X!1
MQY--H>84*VM\QEOS';6W"=GG.[8EGXT.^P@S3DI/K@?U8KW7T7@5=IN];UG3
M;<J=IX!./FC"?VY2_!1X>A&Q?LCJ?9Q,*O@Q1W"<U\/L'=-#3WY[GP216B2H
ML2%[K(AE*'0 LZ52/@#:"GUX^P)52RR*X$6!>SG*\.B7?(727_HN/_@>VM^Z
M%+U@3=IVP-N2&;8C1HF"GVY'SM0F(MMLOW^^Z?8G&R!27$ULRK)],TN0]"G
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MG\5@6\B@)MRNTZ)7'?ENXD4'N [Q%_4!HD=(>AC&7C98L1'JE? L,!1I3/:
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MT76D&EPQ4+>=JN<&OE[/[L(AHVJV&>9D\RBBCT:FNM9I]>AU#V0#Q -*)W_
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MD6]HGDWGH%JTN64'-B^M88PS' /6+33ZW8Y-3<#S'$#-/W/2]3_+_S\E.4?
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MO>GBJV=XKZHO-X#Q4DCB_\7>>T<U_6[IXD&0)D6D%XD"4J6#TH.%+B!=:E1
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MCC%8L]V)EK[PS]<&D]$N9QLG(/5O&/*ST-Q!7N Z7\L@KYA;LLGNXI]F2*?
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M*]W&W7=^CV>H0HDB*'WL K8/$/WP";+#7@RL?L'YN_W=LI>FZ$?ZGA=][7+
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M6CF =S[?(SQE-  $;/A;2 HGT+TKR*57@?B:7'P0>( ,=U7W-\%#HQ[BGP>
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M^V>+/_FG @_)2"9E^)\+/.!-)-7F] 21)ZX,K!0X4A$&/'W^]T:<H[J((\T
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M0;S]!GS=#BO>V5K5AX_D#N,*"K1LY6*&YX,@DU.V$B4@.5P[EIW 6NE&GV%
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MV'Z.;3ZW-RF)TOJ]0YWW6>IY'7G^KT2W;V)+V/&H!I8?5]^&<1R:2Q>++T0
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M:54T:JGQ CA@:?HG<WGR/Q)K^!FM#?Z?5(W--O 9Q]],C9Y_,C54B?!WXP*
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M7Z=DMZCX=G\-G[@BVJRO/;;OERVS!-,XI3^ YUJ6)&Q9O!*QHYQ-?Q'S\?V
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MK DF'W<##;48>YKD(OSQB><(*E44(^BS&[>J UEISL^><O&(^?:*>3E\GPW
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M,.;(#=07EUYQ][; 90_W1U]5[YKU*!K(?"X_SZ7?-LX"QZOWFWC[/4[G'3N
M-3SEL:]>K]3V&6@)S*E0?'[IT#=PKU<W/BO9=NN.CLO8:H=<B>&;)##QZI=R
MH&Q2KM>T^RD&_*3C [=6FIF&&QE*,(<V 1]2\A/-/8/JY)"E?X][F4JXW7"H
M)ZOD$HR/? $#\T>ENMJQ/_ZM;LS5-H&RZ#VX $J7\'DRX#C,M[Q#@E 8-9.<
MG4CA7=0WG[B5D<Z"5!GJ(.^#T@]U&'B)^<(%\-Q:SIS&E5I##CFM#27#4)IA
M-!TJJB*:==E[;!I<#K"K=X7S<?Z:]A&&"TKZ;]_.4J1"/ZY6>.>S2-?)',IC
M>MM"DYY-O3"1K_!);)Y9Z%X]8IA6Z/)'WSB1?]/Z0/8VQX1#)($,T_;#1PN?
M[R9IJP>)8SHOQ0IN0ZD*,&]>>G,S?/R>\:.PRA>R>USDR[J3B9/GGBOR,QOS
M/S=JM_^0T?$S)$K'VT=)<?'MMSXPK>*#8DHI]E^3=IN(:8V5IJX0G(';<C'O
M4VY!B=FRP"H8V81KX_UE%I%4E:YNHPD48R"U<,=IW--D!W?OK6/D)&+Z]H8V
MF/P!GR?ALWL2E/?3\KB@_)\W<<%>8D*4;-\1]1/SC7%>X1[*[EUEFI,4\+27
M E\31.^.?S\S1L_R^5P=:=;6\#Q-C[29[4:N@^ _(YNJ10\$\@MM#SX?&:B1
MDS]U?OJZ?B[6UWGV2]0RSW7%<F6;JOX($RO(S7&DO7EE9OFMV=N(1Z6OZN([
M(\X@HBM[T<J<:)W2?OCK*_PV*3\TL XP&8ENGO%."/)1:'0H"P%]\K6.RRTR
M3IKKDT.Q\]<7?9[E=MSQ_I XV#/\)QC#_H/YX2^[J8;TYO4;B "L(TP09>3"
M5]5S"EHU=SA)PQ@G?D156R;]!G?F^$8GL7,]2H*<<8*-5A\7?,MDTP7#ST!B
M.$OB./%P3G?N=5_.5+FSZ1@J@1?J%$8]!<54.%_7./DTH7(!B/ZI)9B<LX)V
MS=$1?FG&IJ!=<JF7##.G2]GM[M8M>K#VE,/C6LL[I98S#QSQ/K?V^=L52VF+
M&T&5QU TPZ U_\E53 .\O 0Z9_U>5Z)9!)SRYA:ZAD#5QA%O:?7[NWJ'B@BG
M/R'EB#B\JR9;F:-V]@(NPQU'<MQFN9>9XUAI2D/O*AN$7@!L=UYM6*O#^G/C
ME%;A5[XW:HB.RRG=P)'!E^-V+H!LF/!HKHZ"3G0CO#VXB5MSPB0'*]%5^?9M
MDHWJ9\+,!4#CS6HZ+A5D7=L%6K6)^.SB[Q.9*JRGF>9QCR[AE\O6*Q9%)7Y_
M-]6#Z/-4.,U8EY$/RJ83W]O]#L5C\&17*%&7PM]HTWWMLI[5V(.9WW,13($V
M!0V\!IY3^_B2TG#3H?%H$=_BWRG1S;;;,^43[E/MZCST@G=N#!AJ=CSV=]?7
M'+F=.2\8M-$8L*ITH\5"\GP@7]*YHKT_[847*[*;& 0%W7#,@[H8Q]- 5G18
M882I>/9]&3FR;6@VO*:JN>D->N!@46V^J6R=S(F[!$L,E/L^!*J._8:3.,S!
MEDB2NZ3APB-E;);,$&4_M(I_]W0_]R2T/K-YLJA27$PQ.EAH@[UT=KS92>J]
M67>?UH*<XN0?NE/<E6+E&[CK7'R3BC*W=5,-%5)5QQC\<<'XTL:KE,&!O/TY
MLZJ5&CQ1T?[2 F0G-(3+]-7BV@7:'()Y)?!'A'=E5(2VJMD+0'GX OAU&Y7%
M@)&944\]U(L8G#,FI."O.OVF#W6)U9C.O0"&U !MV_0J??-H$4%_0-UPJK6H
M, GHO)&];<@L)\LI2/? @"DOJ7CM%L&8Y(R$J*RPF&WWI0N JOD3?0X$)I*O
M&E 5R!/8MDCIM3>3=A(?HCMI(<$QF#CJA3T^9[@ *%DP%X %:G)15POLPS%0
M.S^[@>P#3X6?)(6<O,&\I8RT;S"+UNF5!C>I@$:0+:(8;K>6!FC8C,XXX5/^
MSQ'S.SQQ\'P?8B2\Y(DA>_VY#"93<'VGZBQJF?ABY.STT(AW.UY2^U8W9V??
MM=K:M&%%B+R^2UXOME&-_E,1IN :,AK7JP+Z#*6%+Z6!+C6S_Z8J4EU64JQO
M7A>L.M((P_'G^0JV2N[2Z)@9R)**V9A@[P5.$TCPV4>A#943S%K5I*0)8P2I
MW;W7G\4_\ 7=M5"[$^<)YLLGU^CAE_WCG"R?D<"MY1D4986,"@3#I-'ORIBK
M2B]/ZUZ> W<&*023'305R\35!T ^6 9.(BBLM:Q]7\$;4:LZ\)GMI9[DD/(X
M[!:\,TA)I:>F<,L*U8'U$\%=A7U%?-I)W 3]2=\8/:G B.-$&BZ .%',A$8<
MW'DQ1/7'Z<_SI8T1%>7GA*W3;(:_"<'%!7,SF.\&$G+@;?G)C<*6EJ[.$S7X
MYF]EA 6>^$2"UV$::+T818TBO<\V>SRR+!V!3C"&9+753\*9?W)!9?^DK#W8
M& S^(MLU@)A F=Z^  Q1CW!%Q)_>".>B^;HX/_HWDPWZ&[*E<NU_MAC=M+I[
MOZ!77F!R\:F:W@Q3U34;1*C)\[;5F3)-<3%]69K$ .HTW$/(-%@!M90+T&Q=
MYN0@=I5)XG]:]EP UV8#P>O%7^(P BB9P3^;YQ,HW+5YRA-7%-X;/(!20^"2
MKH.S]J$'OE^);W;S^EZM;\TE?V-.!YR@B^<'0"GT@6\&7NAP"J9Q1&?='D/Y
M0;G*5IT7)UBI$R%W7"K@*;IL,<;WT=:?(9]1]/Y1SG?)_Q=XT?V?U9Z6+V>,
M;ETO7%6A6L<.KV-'B[(IS@*/_ */?@N0-$.;N(M-NB7/-;"50,(FY23CQ !#
MF9(*V;;FTJ8DH)'A^0@/9F,$E"O!>IU!K'IZ]7>2C[ Y0:QJBMF2+[@*_MDD
M,*6D(\"R])]GS_UGSG(W"#2#&YGVIV+2,F"W,K@&]*HLNK_U BC0PY6>_21V
ML,/?,N+.IQ6A+.1=A_]D\%S]J&A)FA"R\4]9, ;<%9OIW+#V7:*R2<']P4DT
MA4UV?.WW?:4X1B0KOQ@(E]_NHX@ %%9V-TU_[,&5GBR-FB8@\%<VN6>D5='J
M[<91 EO7,K!<U8HX3<,YQ6#-<>P<F3X7 !=T/YM!K_N8<4).P=@;*48\125&
MZ@*XOXCS@W>FH%ST0HI"TZQ IR,70 S@[V@<E^A$^SF,I,,O,G"<B*6;K*Y>
M[H2_.W5LL3HX@7%^YE2VB4V[%F*88@..O 3SPI(YQNG4'AM%<"LUF%@*OQR%
M5%G.RUO_;KNYD7^]J?UYQ*5((,I@;'GXZ$Q*NX<TS]'LCW(*&H5CO$Z@KB+"
M>I"\VLYKBR]"DH*OKKW@HIQHKL7G0"S!='MAR2BY[[ GQ/A6]W?*$)_:K$08
M MUXZ<5N>6<MS//FCVY";38#&;X6OO05SM*LZ"*?&I'CPA8^G6>O=GF:10H-
M?3_X_OACWB3L/@^26XZG6VYM _5<F98(UTTVPM#P:Y@N*W1C?D="RL>4..YM
M*.("J#G=P:& *BR2NL=A73*@V5")7H!L&+R4N)]_VEYZ)8@N+:+A@ EO$M@Y
M,:R!MN\WAE-[7@ DR'55 A4)3\2^/(>73$1<-^38$LMZAD(7",OXBQ)"5+B:
M:TUP BRV&?H9V?W 5:*P?/;N:XO4(VV3&Q2/X_*MD[\XNH^-JW+D<RW%DB:=
MZU/V@=!&J/=#&,NEL+*7ENP[#/X$0V7Y7Q(P.WS9RYW<VC/>K+O("57HL :.
M&;5JDA6S1+,K,+\K[-@;C7<Y^Y:T4E430M1'YC@[R1:^HUN?IB.R&18&,;R3
MN&L*RZ+1S=<Z2GW31_7\+*;93]NR7'9H]# \E#O;=-G5RJ 1L[>33!@\%DQ\
M3BVOH62-MUR6L?!K:E<LO0WS@WX)S0;>@+?^]'>(A-WG?+<@_ [7F]#H/T2Y
MQ1"&6HI#D!PIJ4GYPG@+F6.^Y8E*'17^< MMOH'1*]#(_67Q3/]RFN-5O-!&
MW#0-@3H7O;?Z)J61+?P]MQ//#*.0J-3Q0$+1EC)_E0Y$*\V_YV?&$$6E\][A
M)J-?>. <H;)[P<N6/5I_=8/'NT.J=J2!DW_OMO)XD@L[W?V(K?310UCE3,#8
M4X"E-[9*RZR_:X%.K5<@1L_ 8+I+,)I9<C^BG'+]<7TCL\[A*T'[IE%O$37;
MM%]+SP)3+(TB%>(8YG\8/__,G:\Y4RE#YO223E6RV[@CB^/)A'&)AXZX \M8
M2)SGP2B!6@,=9=$X[B:E'>!';5LO##//P0Q"T2(-M-+7M-GSLJ47JK 16!48
MZ:@RK^/WZ3?1"MT,Z #(QF(7>,H9^R-++&"XX)Y&;?>93F!7LCL%M1]<:(Y@
ML"\:\IV6S[%BRDQ!I(LXUKZ>MHM>\=U;ZG/_#1FY-N^#%UH%S1KBO>#OC7I?
M?DAX.4NO],IE%SZUN+Q1N P-*Z:5;@<8W)PQ42>SZ,4HT4!NJ[NOZ^A>3RV=
M0RC(F,(+XU(T&ZQD<RD_KOA2,NQR\PLKG'%(O\4^AJFB%Y*%)?&OEYE\272>
M.Z/8&MU7W7G\JPO=!<"+>6AD:QS+ME%^@]DSL2.I(W K:HK!:E_[X:@3+:S/
M 9C,C^S/Y96<L4D%2_=X6$W>2\IUJCP:;V"$V\*#TPMC&O7<BJJ^)S^YK.!R
M#%Y&O'5 5X>X.99H_ FZ2;V$LKL IA\-+DU\<G/S*]Q)Y=GTP$*&HCADKY9$
M_UVIU=<F%N/2JA3W.Q98JO\HK<=TIW)1MZTR)<!:3B:R,0G-I&'Q[E[BU6LG
MA9P5Y7OWMVW(QA&%]_EU1(H0_&/#)LTSX$:PH(!@]U!.I,!-H<Q]M9VAF0$3
MJIEW^]9,GNEK*P_K:FPSNU568C4'5^PQ_L[>*>,C8"6PFV@TVTEF>7^^^8+V
M%;$LQLE^-FB$(B20S;WLL0SM,=,1$L=(LTS?4.P;:ZVM6W57,3>D$@OIU5K>
M>\_V6)C1])TK] \;KC=*C"72Q/71YG%-N(GX9)!!].W\#9MXWVJ_]JV5.VFS
MW#A!_#??JEQJ O^'_2YNG!!I*PS.0YY?+4<9%S_6[!!G$L2\2<!(G2U*PPUS
MW5/2/I_KO$@CB8$DA>)U:BKWS9=\LYXPU%X U,^8;81H36!:TEK;"02FV%,N
MY=F.NBYL6.+$7M>O]>8!WPO@R<3WOMHT!GJS_L6AVK4I-DDK;@'HV-;.$0,3
MQ6'!_K,\+/&7]&7/5]0 U/O\)PK[!*:P\\%VR ?UF[(7@-=XTWW<BXDGVB^G
MB=RO7%X.=;W^-%/CE,/WQ3<6_[F1##"09K9/$3ML-8L)TUEPWJ1<0#VZ &Q1
M-ZQ_-U/%B*X[?=K9#K,[0O8I@5IMY/?)U[1.3(4V1-%$FBB/#X/QOLG!/.)!
MQ;E<ALCAA(YBV3LWIJ(?>+KF'H)85M_Z70M.]ML;6=! L8KY:],KT5E_H'JR
M  +HD[5L:72M(B./WXE]6%52"\S(%2H87#O=R27GRL^4L8V^(E>J\7HY<F#X
M\0?@W#3%DO?E+5G6DM.!?=ROT(J9+])SL'$+PNE.0JJSV@>+S3!)!&O+"5OU
MA^A0S?;@VC*&$P.,[?+@5;XFUV5+I=_KWQ@W>3::Q!>67SX]-"H7U-9.3>4[
M5& #SE8)U*""K1FWED]3.Z[,O,P20 EX&KD&/B&\@'DUSG:=/[X SCGA-E"T
MH8\06O 0=+@N0PB!=COL[B7MU^^_OP#2/EX 1_( WO@"" F,C&J2C6TPXC]
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M[P8U$-AE&90>/=^JT+7=_^C .)((LH#5^S/>:NF.FANBK#?^[MG0&^8RQQO
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MM;QR+><W/Z1G#,4X,\N6A"[\3JI[BZ!N%W!HH1-#E*4;W MNW8(E8GS;/:\
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M"5>W[VYW_LW"/2O=(!HXN:IL>/$61FES M[B$S@N<6V?IVJ0?.-"-[>,GT(
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MF@QVX@S63T_0)?J=TJJ3TVOP6I&FT(=$3>"Q D39-9TDZ5T$B3>%%L<\125
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M24\KR<I.BE571#44?GNS;'5\?>)!S^T<7V8C%WP24+\DLP#:*1'?(AZ35_*
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M<V*$^Q 6<K.*^'E_U8F>'])*^3*G*^*5ZYARD06U 8N.O/H[HU3ZFGAJG3+
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M"FZ>;HRC&HAF5/:ETJ0IG%],5EX#*/RQI5>@PZ94IW?G*O5/?U$F\.T!EXP
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M.Z+LGBY<+D@B).$OE6#H?G8!ZUGE0G65EHD=2TCN#KR TSDDUB@YM4\6V>V
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MQC#]'C.'?K]F;WH1>8A(PD'VA?#CY;!7N+N=F.&KQYFXJ32B),J1/W-7<#S
ML*03;00EF.6\-@)X.M8&LQ6%!W2)?64]^<J./KLW<QABIK;P<>GZICJC6^+(
MYQBN"Y&[4.GOQ76K)GRG<,R#TWS!F?;EU>)[W4<Q,-^[:&V,^!/E^&MH%HXL
MZ5<\B@_I;R#M6+)DV>75/8($SQXLS#W  TQ(/\MW! VC,@4[5N*_1SJ-WF_&
M U!<VW.P*IKV0++;BY=4NKE@*SS ?]2IA@35SW>\ABKH&D[M^^+<C14%\D+1
M74>"XC7LN)FD21R;KL;EA6 C>.5N%QYP2')UF9[;?NZ+I$S!YL$.D;_@5B4W
M)=KF!;$XZDLG/("RT9P05EDLLKV1Q(8*7[60E/+MN?:MOXM!7.K)$R'I"!P
M?#O;3H@'9IJS\Z&D&TQ@'%E^ ()MEQ9)0X),']2^UCL6@&V73Z[[AG>RT,JU
M#N9=NUJ8FMVTI_U1;+-0[AQL<68_9Z6+F&\Q4Q".N]$')G ,1-?&8CT1HPC4
M&U/ZW?,M^"$R&TSI*0H_QM(L<Y<,D*,@S2+LA+A5'&Z$)6Q!Q-Y[$8S% DLP
M"A\K<)[@ZUX&,?3=\$OO:^_*M?T=HXH<7MT?OEZZEO6+9$RRY@'ZFOZW/\DL
M0^(11R==92$DT]<CL5TD*W*>?)2=:[S0[[C+;PFF/N[\L&>(:[H3[T,76US
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M&BO7/0'7A9N%4VFL@/V0JFX"YP^#$:N0J*N\VJK*'SUW.W;'T$%8,>Q7H)M
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M&A'"(#-CL1P\@(1$?J"2W]$7?#(VJ69*TS/GEMF'8EA&701;2>N&1)U]O @
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MNFAQC>F<D:K=D_ZV'9O@TXZQ*\L]Q&IRX+.GXJ R>BQ[-4ICN4"73'2+O"Y
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MA;$1_;%$M=@%M?8BXF4EE;+KP0(-[.L/9(<DO8IB3VC-T6*=^65M*Z)0JJE
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MSLH)SSEN,_5#\[-C+!QSLS(YTZ-E//5@\6M0VS^%.AXFC!I[W4A_0U3)BI6
M146TF7!ZJL0N)!]\6^8!RW?/1PYOS0!%]7F=G\ 5%WN3R^D^,T]$L,D?\[H1
MM"76I7%T1:5?"6Z%$&,%'_5Q^55$8JJZY]Z1/>IGM,*0_-R=6JT+[S-V'= =
M,RBT*_5'>6A=]E'W$D]3#2@G(>^LTO6TEA1O9-/9>+L9J OT6H';)\FE;FX6
MV52+$P\.VY'F?VVG+2)D3>-1;E,_$LY*"DTH^3:DG?<U!:  RN#)J?NI^8S5
M]6>*D\U7[JQ[=UM$?_J,?"7FN55 >6-;OOYG'SW D(=Z_%);[BV4\.O#H.<[
M9'>S.;A[?]X,$A9*&2&\;2D*J-0VM5I]].;87>M0:]9Y ,!/]2TFY=:SMV1W
M?Q)D!,FUG(H"BH:P/ \.@K1[1.=;">F_4MJG^SJQT,/6E!K^@XV2?C?%'UW5
M@['6DB'_+,O_+U5; $P$C#01O*1S)<^*O4Q'@G%*P2Q75W]+>?PQ-*^^K=C)
M><AZ6V+NLT(7NL$G9RPG/\FW"W!W+/$ -A-_]!$>8(A]<_WJA;M<Z:^#,?<1
MN!<-Y!>KN*JKDALWYX6M;NK_9][BS4-)JN66SG^L510M(_49254@DECYRF?2
M06ZCJJ/SO.-+3G^W1*<8>RSKZR3[]@H.\K0;HD7$S)_ ](&_7Z)/U-"JXB3R
MZAW.BN=U9'FUK!03KR+F53HJZ*>_/,,UK@(#5Q /K1?HJFR#\Y[[,CD:CQ9)
MJ6W_*I(!&K^X-)M\W]2FP6"WN!"^EUN<\63MII*VJ=D*>":X-<FU78$S]VO>
M*<NJ\=GA?N"R@I[.N#;S5 G+@PZ*]@;Q7_MOH>)2';H:4WT'ENUX %*G[V[1
M-=87$.NQGG)$3;I>NR?74;.:H.$$@.>@\UD)+Q[P_9NGWK"G71['><WUIT:N
MGQ?%R;B[54?1BL@GGP^]/I?Y>D.IN[%E*EEUX5O7&'1N'OI%GS#CT*X0+7)F
MNF9\Z7BIO71C)#.*+_']R0VN;5,"P?V<96X#=OKR^]ZQL] 'YYE(RX!W;V"5
M0W';+<7_#W/O'115\/T+#@(B69(D!21G1(+D09$L.0<9E3PD$8D.,R@2)$?1
M(><<):<A2):<).><9H@##,,;W[=V:W>K?OM>O:JWM7_<JIGJKGMO]SE]/I]/
M]^W3^\#[*PKTG##IU7HQF4R=68V(TNVA0\;4K6-[?97W'A9>QC(?U1YQO%XR
M'Q@[%/(<\/!W4.)C[*7SUOHJ?JWYT-]I(=,XC?MA'XLPOVBNOBA\DIDO,O"1
MJ*:6;G\&WFS"@T/^"&4VEJPPWIS)WQUAO+G]]#B(A8_@6(/!OX3)> PV[V(>
M'SI.Z +N2OV?5EY <S)Y<@@[ !;ER1^[1Q%R=Y_F&AXZF@&*4SPTE6G;>+,"
M4Y#_2;C<)J_,P)+@D9: (QM#4N)ZBN2\/879;\]H\^6#&&'/-99Y&1BR8NB'
MV;\GMCE)$]U)H5!QR K_E[DUV4N1=NJ%MH>V](&:YOF=7&T34LL75#Y=HBO4
M9*6R PL7A2_?D-D%IP2NL+%Q )0E]U4W8,7%U$0<;!ZSF4^E5HWH]'2C7PCI
MZZAF)M7R63@&C M_%%!?$YRZ)/ S3GLCE+YC4/@B,+,46ME_*F;JD#,^DZ*U
MU#G(H;NP]3<P?K'A-6R9)="70\9Q9[C&;[VM*%U(!5RI;GK"@"G&A5VK^$9[
M<D@QL85/NHQ/^3GXBY%;U2ROU&DY'\IM?W25^V?<-!M^-W7KZB>IO(CB%XA$
MX^0.+[%"^]I7L<.] E/9OSUWRGWG42@YB<!"9A5)(- &_7PMG=3253.)1'J%
M;WKQ&6KXZS*SZV;_%5]YK9P><D![0HFR2H2CBN3DX-.YW;AGQQY7TYO3CNE,
MLFG*"%"S@BIC!V,NG]77U.@D\>'9H^Y&^5[U,M?W+5 #JT(<<)]W-$^\(!TH
M%%MR[W) EY\_'%]@,G7)&:Z0V%3@N?EY5DXFEDSJZW,+<)AJ'<8SL8M2UE1H
M<^(2^7WET0&J=HWV9[HINI%F[>+RF@5UB9 N9+A_HK# PDDP)]/BB% %%CL+
MGQP\?UMPB!*Z%,6A47_LZ@V@(#K201L.<'>:F"AW1IP\) &[NZU#XTU]AA6;
M&HGI?EM>R3MS308>V,2JN:9,;^& %?=X_T_JK:H395X%^-)^9ZDTYXVC4U+Z
M+GH>42K*/E)_T@R7&LO\OS_ONO22B:PTLB;V<A'Y<U4?_J*9+F\_/+782F E
M?=9$<=+:X":G^4:@:52!QP$>\39N_[ZJQ*8<G9K; W]Q,;DJ&*$: B[C6WK1
M:O@.CMQ_&!:\U.7WL2\TCPB9L93\ZSA*]EV%J^-LSRMW4^\2Y^X_(969I/CZ
M-W$KT^PRAK]2/,W[)N.\'N9LE>ANFYX7ZP;S?-:=:UNI/2@>R= [,3SI:U&F
MXVPYZ+GSXJ# UAD>^Y>"4&6&Q)1D5@;>Q2Y&O>[ZD,FY=C2!@#?7\9K).>E)
M]].#S^KM)Y8_-<AG7.T6YB0QY:].NS2=;!O=>1FZ!.O.G:]?I>X<%.0V!85^
M^;'KY.UJ96$Y9,A#S#=@'8X>1E%B[Q\\+GMJ6!1'#@E"T9S__2[_0I-HPI0L
M=L!D-+TF,G&H=,7D"?X?EY$;I^/K-9X@UV74P\S-!,G-9>FS<@ZJ1.V2<D*/
M RGO4"E-X2)$-7\WRP='J'V9S_#J=+"<92G71&524J%]>3I6C))\]M7%@_$.
M^<"P<I?EA1>7T_0TRRPP'UAW)DJUK=B-EH9H3MBL][KU[2V Z;@8&?^[Y1UV
M[:(YO&OIWGM=O<+D#I&J!-@E1PWZD>=*4/4SFD'BQQ\4W*U.EA&S[Y96%N+:
M<Q>=#;>IBC?<*#&"+!3AO<^2\#D>]L*Z\R>3M:O">^LG;'':!'(+B'Q3K^WC
M%DR.B7IU\OL6<!<5U_)J*B')7JH8R[/]K$UDCGNOZVIV!K3[:MN&!%_"WR4+
M/*M29U?W/H@KQ')ZX]E^^TI2TU1&PY@K%Z27^'(0&H-AK4MZA=P7*E!K#\8;
MH $]_Y(I)^Z\9HURY>A"&ML^^];OU*%W\"!]W4_,3'M)C@=@H!YW]\\?M2.X
MX726Z914J#1+0AUX.@:IX 8^I=Y*R^\8?M#@\D@=.NUL>/\NM,:KP]8GD'*L
M8<=9>(4@QG=GT,6!E'^.-_:3?J&&Z-\?VA\FL["H;<=GT1J>=$E\N=-OB]1=
MJW=Y\Q*_7)#P9IRN_B#_Z^_PUU^9V^8T]Z[V:F*;)*N>-CX^[4_8<\T7WO^V
MHP3@&&\9GIJ*FD)"M=ZG #U<S/U7^HJP;2_,B=N7M@'V7 4THE]/7'$59F1,
M%(_[8Z >$_$N/."*[[/I&>W5_SB]R?_J]0:',DI-%1F$.8)$>AHR'L\!$4P
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MEP<ZR"LMLW9?OY9D/@^7B0'0<^3"C(%(;9U92GUT'[)8.VUU77V36WWXFCU
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MLI#&Q%ZXF^@-.:6)RO-$=1GF'LAGJ_NF'G4N1;"(C,MYY+/OGL1<<' H="-
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M*X;:,5H_D&'-A9FQ5ESLPY 7.)%/*L31-+I&+I%CO_G9GQ!2@S-#P4T8A*@
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MYB@3&M??AW_((TMD_@:JYC.'O3>\# L$XFU.\%34G&2.Y_*(OED7&4, $"Y
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MO(MFQFRW[ L?HPKQ ?Q4!\W%BJ%-^@UBMJV,UI\T?R[H-)&VFE07#LFC1?V
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MQWV80W@.\SBD;@ V2ZUFK^:"YO8N/+IFJV:@>W.TXZ76XRFDSK$!# 6X>??
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MR^^;(/Y]>0-R^#Y_E(OJLJQ)1&Q\ 3=H-B'!/6+PTM7,"]6Q9"//A5^R?U*
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MAOGGQB7-P[CST"- >31@&Z3!B=;*B(N$:VU[Z7&=DU@0ECKVT/<J6.Z\='7
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MZCJ@2]AC3[^"WCYZ/!+XN,LE%;7PNYZP_9DQ"3UJ>_,?1A5I,!];]M!DAGT
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M;AV!U%J%;*WW*>;:+RUI04)V'2="_D&.&&@Y'ZI;G-2'BEY?+KPB!NN",(=
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M_2YD7)'YDQLC5U<!33I\HX"CKA:]N2G@>33Y*86)]IZRQU^.S2;,'2U+Y,+
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M!J% +9'<"2%N;9SC7:C'RC?R![P@-7*"?H8BC4Z2=)#PK3<?FV2I*'A2"/+
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MV,_)!%E5,PO>D2$\1FX?(W<F-+#]6WPU@CPV$\.!)[BRLC34&5OTVFZM0:H
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M2E3-IXQH4"TG8[JZB(:&L;6440SA/[!(&</\);^/UY9UX^?7YA(Q_8A0Q)9
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M%1);81427A6=>2L-"TBV\;-"2(:A1G#RB,J7P8P4\V807/!:96YYMH/P;(3
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MW<T6ZI^-EH>Y%IM]D2>@C.5JA3^3MA"[&BH_[=N,KC=/^OV6@8R/N'#KY@6
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M3WAE+*8G^EEY\E3I.<&/RN7[[S[/A8U73[S 6R7P [[0G'HWO?^X+M&YFH-
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M]"?-9$&' W.N0%'C5$=5Q6%%1@)D 1K7;O5:_*77?NTKR'C!78J3BA"H)2C
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M8Q.&0$R#L5"HZ1CMCONW<UI@YSM0.!FX9 4#9'$8ZNYW/UA')3@:9[D!K'
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M9$5G6G65X#"^;4SQN@&"P5.C"-QOOW?(X\<ZCRSI=<0@S.L->@"(#9]N1#;
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MP\RT$AVDUYTJ6>B4W.!&!*XY%T$N+MO&*+ Y<NDBOWROR@O,MYV:"0;^!(9
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M4M"B97*W+ 6RSK1&\J*=.S)__P*?!.) 'D$1.LD/ 8GQYAP]24Y4E!2X!CC
MM7'CMD1^CS0_<Y[H:2!D9>*<\O*62:_CY7/3[X&4CW'0,)MR)_[T'FJW109M
M8B\\T)7V0!_3T^(XM^>YOIO(%:\'$L'-C4</C .%ZU*>7@,>"OI=1%VD+'L,
MKF5G$YIK)>L$"]Y/+M]PPK3>"8)_JWPB6LQ]Q#IIHKCZO.=8' \)P]SG6L8P
M4K9;O.Q^TAIWRDU(G 0:V \MW6H\V[-U+W5TBOFDUGOD'W0J<?D,!Q[VT1W%
MFXQ!$U%#K7XO'CT^  T7G,4V*V&E4SO]15T5E #2"D48._R+FYTL5_ D&T"!
M-O!Q774+5,.D9>C;X\^>YU.3_B ,S;-3OTE;S2?ECNKAGGA'&H[GCY#7@![*
MF5"-2LW,A\LZ]]B[:2\,+#1/QZ[RCQV/,W0F>+42;[TT?R^.=Y6)IEP&M0U'
M?.X1":^Q4%B:([MMG.A8,7T?RJ[IJ_30MPLB!D=J M$/(-%RCY<'@2JH^$@F
M7K=Z,=:>A9MTX].0TTCDQAX^0E/89>98\T%O?6;''T; 28Z0V(>JXJ+<,*;*
MJ*B580,BBJ\%'_MVTH($Y.^RIQBRR)3NO6^K34+KKQPX[[U2MV]1<E>:P&?P
M5.#DK@4R)G8\+*CS+DU/_*$M-%EN'UD+D"]3)6UM/_1*"3-;KISS^+N< 1N8
M7&!N:(IM4".])7!1#DN35%S.1?&T'-R>[]IQ4E;F!Z/LQ[<Z%<R?@%]@5J^J
M@0[7 !JTD'%#]=B)^HK0-P)WD(S]-:"VIS-^84ZAS%?5X+S+!XY\%1_>V'4-
MB'39W]W[&]I$KP<2LP?3H!Z+3,<VN??,25S4@C[FR<K%\6,?K@QL1#YJV,YB
MU/UY9 N3VEM#"2?URG8M0V:?:H6>GJ)V3?2*+:CG#FA74Z\!I!@=-Q]E)[]K
M@/6$)S*^J_+YJ$3>^^%YB6EMSO8ALRPPG>SRG*YSX5[91%:OR-[!RAJ#EM(F
M]&)3\"I^KW^EP9G5=L(E.1A!1WO4O$".H@UU29\/9MM-+Y?,3\EN\Z!_M$(/
MTX!2OF&<.Q1EUNQ\+\1[GCH(-0]DNJJ1<ZU %PHQE;NLAA@]^>8_M0EKC:=V
M //^<3[@K?=[?)<['1-R];69S7.9DNZIGR.#8%= P-0N\6Y=3G\>6F-!((F@
M_5?9BF\2?\=KQ!J=-_A@R<7FVSO'])_>\F7*P$V'BN:S,IW/ZL7?\_056_5_
MR_32GL^9^0#!4?8.LCC_37]SZMWP80V8R^0U_I,O,883UMNRKY,75%F([.;S
M3'6+2#RU<PY=]]0O^;M0CF;.ZJ^(11/:IY)]1; D:WX%VUM>;N;=%11WW#%E
M^R;KM69PX?RG)V^,8"<6LF,OAV>XAH8/HL[GI@0O!JUV/+#2 YNC%RT,52ML
M,:"?+S\^N)VRQC5+3[QV>F'T6?N2N:W$/-_4LM'#+)<26^._N+>$.C!$ZAL]
MLI=:^<A-(+.W9TE^*8X=QSZ8:G:EK<@#>P?EJ XG8';ZBH)[EW1&RYAJ&BZA
MY/UQ-NT'#,/[^ZDI6:I64ACJX6XIR04GHRF>(*5KP$E)+1SY$C?;!"5%]J6L
MH+C1+P?E+))+S,I[ME.9]WM1]<%X>@J,G)^^';>4KK#"AYR%O>\)$7,R,#"D
MJCS/XNK"<O=54A<92E4!%;AQ'W^0;RV_9"_$PV_3"'<KK9JK#X$Z=N7<=71W
M?JG/WN0Z&_F[\J.Q-6N=:^<H:AEB!XU@Y.LX()PSGYU7^1GT-;DCKJ$8UB[C
MS6;/TN :':@>T:E"LX)BNV<'J91HW+[M*I$XQ!P8(X]-/BW:W4#& ?$V=7IH
M9H-CO&'#D7#GX?M%G1T.Z1E!W^KQ86=EQ\].'5'8G!57@IX@X=\>D]N>Z3N]
MAXWT_@LK#=,]UX =YI]?WXJ:JJB6^FURM>[HNXA(W:)<TC&=4WLGVJ\9< <V
M3S\8)#ZK5XFVT/ J4?!-K8[T8:?-2=@6$GFFE&T8=NMCPXK[+AZ+ U-FDMD/
MRYJ'[FR3>=:Q=[];,617(0^PI$>>#X@-8T)C#S [J+Q3*F7(S#WB8>",[C5@
ML^_J9HD&C>:]!NC63%0L1W-Y9B6CS2[YT6ER5)=*72SG K$JYAOQY_:*;)-L
MF'M;X1BA65'HN1<V^7BXLS86]PV,84)!3#@WP [FVL+R(R6J7\T1W1I86;\&
MO&MI0E?YN-H@A)J*W++]OWF+XV'&(6U^#&8]IL$JPQ=FD,>6.'].P(_7HF"/
M8XG0PIOU@R8(6O@:$+5;(Q)I6E/_C:7..3YC;@J*>\*=_3[P'UDEE9BGC2Z*
MUX#"FZ4&>*APU5)A\C7 \F3<KRQFO8$M="P)V:,Q"T6?520"#F,"_A DS!%Y
M9$\!42_,H21#*1^BDZ5GC\OM.=/I'GPT-(J14RVTFR%(31];HCOPC-]09!M:
MQ-">G7*AFU"NRQ)=^VGYH%ZFA<<V-%;T$LOP2BB&"M2C(#[)K@51;7S5:3L0
MO;@%JEVLUMZSOWQ@SSAU"HFDV H<+3KKGX(Z'+O^/5LAWAU;WLR&$.W1D8'-
M^\+/[P#0?+CFAX*;'P;2\G2M?=02FUU[INCY[4KH*!Q[YR9+6>5D"XF67T"!
M_;TNYA=JUO'X\>WPLDV7ZJT'$YPO>CA1\1J80]RXS:,IVPXQ=.,2KAR$;;:]
MW/ZOB(],+CFP?[! -!4J6OL/]:M&XT&TRCF2B!"BQX94A\?YL-&VT-N/+BPP
M</O^])&$?#0Z_+!<]H9XCR+:-3Y5_W6]PL05)Z0-L'\BT,Q4^/0Q2\AL/6XD
M@X$J+1*1[&B3[[^9*]@14X<%.'=<CZJ+.KX&Q,ZT&^_X4!5_L[)Z'70$FMCH
M8A'3IO)EO 8H!]L41KL((0.P=^)Q;Y6.2NT:9MUF7(O[R'-4^/L-E<QY+ !,
M&Q^A\"29-/[>/ H[+QBHBOI+S\K=!$3*7K'\@2,^@FA=Q,]77<EC\+M?B\^"
MT!R472H)7]!V;L"-#]F40\4M_.A-E5>^49O7@-9M#A1=CVZ5*XIGX?:F)5S%
M"8+X"*%AA @WBRN<89 2H$XX\AD\XH*V>DID*?L6A\Q=UO9@H.1^C? S@WD>
M;/8A\S6 H2(#D7L.EJGLX=ISOP;('K/-/#G50%&V,47FCG__:&GI(;E<3_D!
M 64VX=CS^D?XM I[VV$;2_)#$!@E>Z47!O<(@0O"$9]TSL$DE?^(H;I_4_J"
M][J>1:!U]5U>"5WVQ?\_+8[_+O]5"*1"11/V]/>>">WW.#3(4$A>ZKW^\'3+
ML%K98\OC4QX'&7U<LBD3!DYBFFJH+L7D/TZ2VQV?6&.?'^.WVA/]R>Y'V6RY
M2H@>WVUWHY6:3^*M+"4&G+UW9+J>?5'NFU9!DU&>.=3;C9/]&+0;=J7.X7&4
M-1,>/H0Q?&]@WK)SR#1@RGEWA5$&##DFH(@[-+7OB9>\SR.C7*"=G6ECY+TS
MUE7RP,0]U.A3B6&,CUBFG,+#5&'CA8T^.!W0VE$(*K;>+C'G <:A\!VC(04Q
MM,4R%+#]X'18-A>.G-HJ'TJU=\MPR?M]8.F%4D48?<)HOSN,OJM./-J2A)<Q
M%JV3AI3I(5HZSW12B#G'1TSM44$035^/]W15WC(E<05,C;/>PH%4$2I55[R&
M"%%VJO3SJA6IW3;W?,O>XBU#,Z70&&$_BY2:%;;PF<:[%@;<;*V.LYED3>*?
M%E"'QT?F8^&.ICYK9M 24\M*VU+%JMG?Y9]E#>!R FWTL%@L"7;B(D]<4BH]
M1=;Z?E<0 \(U4FBYAL*5MNGJXCS&13.FK7:]&JC<BX;B9^AI0#M]VJHFZHON
M ]PQI3_J8V8/[HD@'(0":A,BAI0#US2P?05I)W?CY5S,'MY=3?<8*"RM3DNR
MD5@77:^-&3]1<ACXU1!D[R'O\%'*:<YZHEX=K%Y.H/X_;$D/X74)BV<+IP,,
MG.=+A8K[8;2/ .]I,I+KL\D&RUTZ/TR6.%PHUS:0U#;5D3%=3M2YD[T@6AN6
MH$E9Y=VLKY"L%$<IC%(JI>?IRB7*42[3[08L0>YO<YYJTGO"O;V-GB&K3OU&
MP6PTDH\XOV"WEW^YWS<'GWW31>2Y=@7\'!+]&L4Z].)\.U ^]56/[+;L_JNX
M1Y.N5OR_A>(<N\"BX-^L3&AHL?S:KGO@!CH5./KK[VQ.4*=7@6\!,>EH\_<F
MVMCVMWF&&95;ZWXNI%+MLO01%8:^J1W:TZ$=(+*E:2M;$FXO_6ZAT=WWGH[6
ME=V_R-\33=LL==LO6BN_RO:IV/Z[J_+PI9</'^$7F[^,HD7*)IPUS1[<:M\I
M-=)HA)@_&)KH$Y(]T7<F/HAU[UFP]?RR7$[UHZ^O9^=E0Y+'*DI;TWV*1OVV
MB^AH^3ZI;GH#L01X;C^"^E50,MYOVK<\,\'Z)TSJ'./_M][XOTO80QU/-L=V
M87V3L"=3&RTB_#=>MX55;1N#];JBQ3R71@ZVX1RT-J;L?!#GIX[,9VN+ O,]
M2/]9/C!-4?ZZSR90ENX3Z;7'J>P,-$Z7>_]WPDAKK&#B(&5RW&. F&M\:AQ8
MY8.AAG=#&1GIJD:;1SCHKZ;%\8Z^7P/N!7IRAV5T^H#.YA]C[TO% 3>M&J\!
M+3O''FQH#JG._H_W8)]\@<>M8_"E3C9JR*8)VQGB#_$&)>:!*S/D3X_7-2!H
M+&E9)"YC#41EP89F <=!.B(4< CHST_@05LA'',W?KG9>?WI4A? O]4._R@&
MHX2:<_)<?@*_W/\E<JJ-+EGIAT2G.Y'"YF539<ZONH+R1#!WDY;'NFU<R>.@
M1ZU3?I<BD#8JN8!<C%+5A 0;>3#7Y]6O:OO\^*>IV-N+Q=NRT/9^TJ;+NH2L
M'CZ_4U@=C[4)GL-Y!I9D#_GR$E$4NE=MUN].'[?XFK['X<)P_['0K:(:0.#-
MH00= ;ZVRS_PHS6^$]@J_'1% =2=\8,84Y-ZHYRR@T,/-MF:7DCO\Q#;*Z*7
MH3N@7NV]O2()6(]FL8G[9:\O\. 5\0$(PV3O5M0J&CQW%0GY#)LV+IB_K7(-
MR(*,PBFN 8A9;88.BD^-[U,%19U*\5S?@&K/SGKMWSWL#&5]M:$PCH=VO 80
MDW/-<L?D(U*'L?*@1+8?MZ.TXVNK:(G/H)?RX%Q(6R>$:G?@TXC+>.+0([:K
M;4SK#2$W5BA'-8XDD RT0/=>$9_<"&#^3N-!Z]T2H:^TA.J 7FB4X?O%@B0A
M;1+51:,MM.V'.>9_*Z3/:(^_A.Y58KX ?D#%)-MV1K/]Y)K\V'42?ZMNO11P
M=VK2Q#/P8NH<<UK4J0<*EG#'N^#&C!A+BG=)YAN^$I?I[EED/'"9Z^3TXF)J
MG:\5A.:,CZK19E:^7UY@[C3WL:RK!U0 'L'.+")U@6%0DN>-H B1-(V0?!+
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MVP22 E'FTVP7_MKK0L>+6-)RJD8418[<+FF8/Z8?31:,7O\CY?CU&I )@+R
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M]YD%/)JG<;190IS1Q>!-^&WB23@.7]7 J; B9B8.KWP]UE_C.3F'Q1]F4XY
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M7N>R_$11:Q9N*OW5L*C3N&\1[L50=REH;+FC(!MBYF@58L0$KKGDN7R$=@D
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MZ@>/C,R!!FV:9+<;/S[Q,G&84[,KXA)G5,P[\\U-JZVI=D I\&HCS-WH]FL
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M)#FO"+B5@&=A559Y.V'IZ0I-DY%,EUKB75%%2BXGW]-\>IV$\;'?!*_'6-P
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M\ Y29"MUJ1GU;GN1M8496'%8T>^I?2YVP$%2_+]_9S]_>) "",+%BAYOFPM
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M!$@WKX<5["<GQ'/OVC+Z(O+0W*QA9ND0\OERV*F[G:_NZ:6,)=&!V63)<?H
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M?WK,%DY&KZZI>QUFYMPH.J!BLVUTH.1I=@ E'>A+=)<?]W)G0W)4+-#765P
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MRTXHAH'QEI@DS/ZEI/DK(OW3X(RY>"]Y$SL+Q_XN B#,Y)^FKBV_YVWL#P7
M0:W]6X[_Z:4#L>Z'&/F/Z"WC,ILZ+;L_JL=_K1+\3YF-\7O:-IMQ3V>!%R8\
M_WO@0Y+\Z3]T!IN=-%7G)A(8]$*04H2L@JBB!#8L@%S L7@EH'B191 47<ZO
MI!\LT_&\."9 ,S\EY)Z89*275H99:Q@J&,&BSQ]"":#5\-5/:,U]>N 9XGH"
MJELB"[F[1'XY6T$!YY*PK*&G_!?-;,32#"J1/(M<*"R$VF/]VHT5M3&N66KO
M6#E"\A\9W7/_T=6C;%/'_3 _Q]]+_+^ @M"NBF?%\(SG?TTV@<3&\UV%@'Q^
M]O1/$$*[XAE22R:9T(':/Y=-*'"<]YVF_Q"OO_;Z]\'HARW^(0G]-Y1'/^UF
MS9/FK?N_NX8)_0=YX2.>=$+L?>(W/D87@IP)>K09/&(KF#;BBR?-6VK9^VAD
M0AX$)E1OT,^@:P+R8<WRO1U(R,OE#\SG N>"=(3\J90R:AH';I99 :SW'-@9
MH(M/SB5YA-VK'G"I9;W_K1]Y\]U4MF/EGDKXK;R%1JVE3@@;$5B*C16V1Y.%
M_W'G%VQAY,7*?R_KON]*O],W&ZGD:H :B072)0LY%\F2="E>^^F]?VGOTU2E
M/4PHY6P54&2HIP6J"U(PQ6-\(RLSGS;T+UR 0!Q#;@>HQ3V^ T(XZ6%$N*L_
M.QMM0#V;]ILCOUB0JERSJ;^TO<.$@&6K44$(ZC%4)<!LZ<.%0AM(%I6$K*)#
M[74+B9H53N)FE.^J1X2G@:'V(SK</Y*E7/-O(@,U<MV"BK,?XV=+%Q3@[RC]
M@VJ18M0V/^%_>F>P<8NUE?R^RO$GBU(SR/H7,DIG$5_'@,X/V&8T%1C#_6_9
M&=M"@[Y74&#)0@9F+_%'J?.'LH>.>P37Q0 SHD":Q[!4@C;R%[X\L9@O]_R"
M1JU ^E[2,06VZ3; 3PO0<R2V_@0Z"?F7&0?7X91+HU@OR '&^Q9X\.UW]8@#
MBK'CA^W,_L@S'?.L[V0%L N*Y ]+!8C^=8=NE.]%$^P!1%*_/[O(V),@M#?Z
M[#DP8_/?R,Z_8<_VII/;F9#*BD79(YR0M0" 10WT2^*)8#M1..<[/H_M/^K-
M9G;--7G- $I5-Q?KZ<WL>KINS<+J%/Y@'>\C#QYT'F.?AKJV_ZA$==X"]WS^
MGY60_YN8E/!OES\_3C=Y_G1:!R"1\%/5#2):K/XK$+1=KG^8R=;UP6#"][,R
MZ%^+:6<\JZ1@U;@!5"U6P<GRBL_.32>7M:]DDPB8Y0J+4 ^N^$A@B=,DUHX.
MPL\6N9O8.*VKZ[P!!'N&>X)F$DU^Q8X1QL1UT(O-GZO]?U2I2XG88K;M)&GB
M'?(G?6]^?A[O\MN%+GK+>@ "LY_/^SQ  <@V)HHOQK!>IV^J!&)F QYLP&O^
M_%.X*IJ.&KP+-J-*N<PY\B= Z-K=?//Z#+N4RZ#_UT],_7D!\K\$I?]/8L[P
M%:IRL9[\66;1)*F\]VA:K)(UWN!GC?5'AD12=.9'23\JH;:?SV%)WAMAB5,4
MH.37? SA;7><_3<.,HJ NC!BD=P'FXO7S:3=71F:%*6_+Q>+XNMHTAXG [S7
MJGTT."Q/#YJ:;QNL&@-AQ[/D!3W-K].<WX?Z]/1@SMF1OMP?MF_,20K=/?[$
MBIU4G9ZT'FDZ>?AU)$HIJ[^][:O?* _HO?T%/2D__7+N*?5#88>KK"OQ>OAG
MX_!7)%M*9Z)E;G^/K%-XDO_G<AO^SD/EIR>!6&&E<I[*H.OP$E9LM?U]50SJ
M =Y!?79ZI7FQSBM$*,[%(:<_@9I;Z'<G)VIT[\PZ^>P.(HC5A_4-@VQ=](8]
M\,@3$('#&$$@/]Y,4,8K3[U:73X<LV69^$>9U!X\CB-].(@P XK-CEP+>NRF
M B^,[A#?:,!AM8'*L_9AJ*=U[2,S$7']<1>RIY%*:^YU7POH?/WR7/7F:!6=
M8:5>/$6>D1K@1OKX5J*AE"HCO/=JR^RF/3GD-7SI4"CK-AVV+TOR*=K!ST='
M#2H4(+KWW&9ZH<J!4(^B&R<':^,B&-.P$Y*T3^#Y%>+8B$+(!E0VO Y?*)"
MC9X]$<N$E(\ ;?B :YX#Y*9C8T0XLN$#.0SS-@UCC/_-S>>]L-H$;$%S Q\>
MG[Z?S/.\< _<7VM$5YKY;?^W74;9[Z JPI A\@*.=#SF0N*U@UO58R?)<VT#
MJ%&HUT#/>;ND_Y<98&+\(9A(/*NE9&G^I>2(P:& MNY'$\@9@:MM#/':PO:+
MJ!!0N=7S39LQ(>Y7G*H7_ UZ,&]?OZXX:Z6T]LFWZWQ.<R&,)9%+L+T[-M&M
MSC$A-?2N;OVWR@^!&ZS67O&6,9X6JZ*Y3?K2EIR8&0T8J)Z%NW-N^>XJJ[DC
MHN>@3(Z:I6J7BINV+Z?&22- $,U=8T+G>K.KR6/M-]S76BOPD1\C*;(WE]60
M,\HM^15JHHG8@(-(VLJN#PF5;;/"NI,#\M,YE@S^#5GYZ-6;;B7@5%2_>'+-
MYU "PT.7IZ9Y/3E[T0!G,5?#6'KKR#$,?W>1W+,S 2>94* #T-="N#J2 596
MMR(:?E\2""9."T>6;LW:3_X,\),2!3%L45X7T!2O]5<]N=VHQBZI](?T#Z"9
M^-?;0KTQ*IXY<0:&1+@('8DL"*P_B&DT5$4--4;,M8WA:<M>.<J2&+?SK@K*
MS]GPC<G<$ M\L;Q.QF)Z?M_Y(TA%Z:79A[B^SHR:6E_#OT_G/B9PU9/CO=G=
M/0,R%^\9!L1?UZOG^L_>U^SGA]Y>[>4"=]Y_R9"7%Y,15+2",-IPZ<F2E=U'
MXS%9(=*"1BI!8A0DR?L 2@CON3/9?>(M^KVY/KP:=D"3[! =C<C+:&%-@?&\
M2/=S]D/)+;0<S">\@&9N!"R9HU"0=V-9H?JU'ELHM)E]BT2Q$L7]E+HWIQZM
M[LNC+M?AH\=34?V89SXI-(V2DJ)$19<3A.WHNDC:<F_&TH"44,F&,8W<Y=[K
MM2R/8U_YO'X],F;=%<<00)$FX/,.KWROY'XQ5V[N]34:=)U*0=0P(8JR1WD=
MXB@36E9@&33>[TZU.^3QJ4T)P%*RP7<:V<FW\U7,JHJ9Y]6K4:U+YP)F4B@5
MIZD[0@^[(1*.QSF=(XD6VJ&? L(Q1+>KU%A=V46.?J5HZKBO\*E;%F",'IKL
M_OL4_PSGR%)GC+>=4V-%[2-SB>K'7\YJ RJ.2/JV^8J7K[EN)91['0/F+'4T
M$*-M(3M3 O:T-3@N>7^E8+40=/:6EV;U19W0&YS^\22_KLG2L3[\!>V9X4C_
M[6^0H_&##&ZXU!PC%GJP>4_9SA:QNXF<!HV9J/20.FSQE@R:#>EPGG/EZB/1
MR3NWF4#P:A1I#T*PAHC%:N_9=1XQ9E^*VHZ^CR;Y$2JO[ ^U3/<2"N03Z"F.
M9 C44=>@*99534$7ZRS76'6]5)+8%A,*,BAW.3V';W2$[%)=$')YS=654,0M
MQD:(445;%[*"8MRTQTL]VW=5+.O&3L?%*V(V-I7%9R0)=?H*$A0UAQC\ .9-
M-'F0HN2RUI?PE =["B04? P80D<!$SJ@*8K/[Y$GJYPNWNH=<S&7N_6Q?HEK
M]4P* HM!#CLXX<=6>_E[^10SH:,W^.<=IEFWN76.L$7R!F;E9'=8QQ+H#>@Z
M:YI(P(QQ*V9KJ'-^:X'RNG0!S*JX2[/S;=/;J9*A2Y]2UI#>UUA&?3!U.^!C
M.ZK(U53LFH$3"?(=WQ$;KN>36X,":.'/Y0/%@J2+=PUW9%VLOJDUV:,1;_]-
MW5W$I ISM/Y%C*R0@D)G&(HOEB%4':U8>SZ2T8XC98DSA.HNF]$BTD#B4* I
MS?J?Y-P)Q2<I;-H2#]&D423?0#.&ZP1,B&6((BC:5J)N5'5KZ@3\%G]F5[G@
MY-R>RQ>[VU,0I:! Y!VJ%#:-4Z#/@:P,8!)8+\V$W"T!JUI3',;5#_#J= 8W
M=;R-!OKP7#]KTI>,VE@&#4=*![(E #!WRC'\+!$8&3.AI)^8K=)QUI.+Y,U8
M4XMEA .L$B(8HG"Y;A[( EIH*HFU@%,U(Z;_JE:&L=N\VF%;0V0$DBQ\#)X2
MBF/0D*04N/1E@T?2]T8DQOUHU .P6QPE4@\QS\O:'(("Y.6R02 [#*OA\5)0
M=M&_E,U';6;<#T/QPGW27U%?)53I%%3O3ICXJ?U990+[!;J8 MN:(IMM^(A5
MM.T)2#H72&]X/IKB'VTQV4LW6?4WZTK]>2MBU+K(:5%7N@F$$?QE5UA*I!9J
MGK>&O4J'<0-DLRUHR$$!U>NR+P KAAT+"T;U2;<SH:]2?US92Y87W0S],ZKK
MZ&JHWEW6%&U-CD^!0\% ):\ T[9-0I:2V%IUH8?^T\ H>&"4-9.PAP4\=AF,
M.I<Y,P0"1Z>:)&7XJF6%U<G-&6>NK'XT'S(96LS[!:^+(A;.IVF5<#6WE*)>
MZL-O0+XSH43<J^[U$^L90O#J9T5%1\USS:RDQZVEIV@^.JCL(W#F Y] \O0
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M9=K=!!TI 4AUL(3M?>)%2\UC?9PE4XU.]&%^B6[6#, C%!:'PR^KJO$AD%Y
M=!'=V(T5TM@;2/"9Z8>E@55GO@Y=>,X4_#1Z#['+3?^0"[U19D@CBADH-6H]
M6I#@]T;AXY/UVW2YM ,GTRD@3LB2&-]Y9E;1T$#&=\&E9]IF+PITF6DE4EKZ
M0*3:0%H^T[+&I7XWWY%RN85[N?ZR?UZ^4SE^Y;.H.U/J8X:-7JH 2J 6U+RY
MM";.IK$[NNY)[[3#59GH5%WGQ&=G&C5H6VA7//&\W3&>N-&NI916NPQH*5H!
M7NV=(S>ZRF/4/<C7Z(6]O;<+[!VDS4<9*LZ*;C[4][![<M0T:M?E-UT%PAZZ
MJ;= 6:JKRJZ\#A1P3R>@N5!&Z&;A?<#7+A'-BA+O*D*XD-.T;AY)?!HR*+@X
M370-!E59&HL%Z1=$LI24")D*_ZZX[3D2:Y0X1]>'$MJ>Q+DY./5(M93\4?55
M&38&B@?>%'\5,^%R:N\=5='OK5J^=_H-[K!5^&?T7:W@!]A*^?;/54\#U=5D
M:X>8XHY;R;ILWJ/3DAS(3X+.U,1O=E$M V^)*7$^2)148-HRYU5]GY;'97LA
M0#K*1=/8>IG+[:]KK;\-9J;%8YE)"L#KSQ"!*HGRS,"9\B3 \>,EK;%O03D7
M'?OF [4P8GN+ ?8L;-<3^OYTNFWPC.\#+7Q("Y"_>/E1:\,"00TVYK\Y\0;3
M/?'(PO_DYU4<A'R]^\,G->/ UB2 =@I/*$)_F$YIE$+"AZAFK)G+#Y'NQ^^2
MRQ)I;'3!SF(_0B>1B8G+PN='Y.*[LI[,AVM3?M)?EZ2O %_0; Z6H*YM)&^1
M8+WPX/OOQ-P-^!UXY3:53WBV,PYY.R3B!8C:\7!&B@PRE0*HM!4L,50H%<N]
M]$%*/J<'8?J*3ZIJ1Y$2A/J>9[#WL5'>CC4C4OM;I(K)%TV?8Z\&T(3L?0"J
M_;7?<P_[5E U3A/^@NYDV!R$^&2^'=]++9][SGY%1$B7UP<_$'L0M7B6WJCH
MJ+Q1IW*2,>[5-=<!BV-'C8P0NPQ$YW@$ <W6^FJB\_W15!C[' J@]1CS@$=F
M'E[6M>Y?;7W'8'V1:*'<7Z4@=AN9OV2DP$ X\?8+OKW;-16M!LQO9'MT/CQ]
M9<9/=?2;N"S!GF4H\(OX2&::R07@_-_=M7,8>B()*%PM//;X+M18\36COM:C
MFNQWA2.Q^FM)T2'#R".1 NB-%7E:'&*GA]X["U3#4Q%O+Y\ ON"ZM/<$D-ZD
MTU<.$[57-V,/J\K)P_YDT[S1A!IHY53.+)[/'R54GJVI\L9<G$=?@&'G]@R6
MSW^*D20&_UDAZ%O@_(4BMD=W&N*LZ9;231O."&)LB6OWD:9?#S]B9?E,.'QR
MM!U?8?>;90Z>0I.,N=EZ[F-.1(F53O(^P(WH12DB!<%7%#6PZ;*USZV (RH3
M#SKT\WE^OR(C]HJ17*2OS2.1T:C7Z7:REQYH,G5'/VK(ZS"1TS?5;$>K8XDV
M.%!9^ $*"J:WFI'4JHZV2!Z^-7@#[49+@EU?&\]J1E="XDHCE+G.3RY$O1(Q
MRWA>R; L)0NZ$(+%K++<1O)D/<8DN/$I9C$SO1"D7!_6>7#UT^N'N43EERUE
MQD@%P]NC6-0@[Z_QFM:O]49RDL\3Q8T38F'ZZ&"Z@0Q,;(8+?'UY,>K.G,[&
M8VEKFN#<%1&ZQ<S0 C\ID2:CW@1KRL9LK,$/3C5:[ .$YVA)XV/(LXW#OP.U
M=5,1+4V*!/:=Z&!0=FF5(9 7>G78-&,@5IR^I#CW\,A(2@#U-*VG+X*MS %W
MR*$JIPS=T5A)[V3Z&YH-D,$EX/19$N9^)?KQ$[ELOI-+#8'H9C7Z3>ZCC@XA
M?>M&,96WOGG,N%=]<Y6$5*$V4+W0#[VQ>)\4UFF[OO"O'OU'9P94I!XS3%+U
MB'LUK=-,/^N.6E:]JCID4@J6II./A#^W=4ZD'5NX^W7A'?KFNV;9F_ZJKY"S
ML5J!_>G'2W^>=Y3VZ(^S](_Y>V$:4JR^^>M<P-'<Y&P)1@6'>XOIIJ9$!<9/
M7RI+!$+;3J.C\Y_/3PXV:-=,3%H467-U"3#T4B^2IIX0YYJSLAM+CO6IRC5/
MIIJ*T:[#"'7[0(U$HQ'X(&S&2-PQTG):U+YM<Q:/0A/>1.X6U#3??C/H'8$^
M%G 7]GMT'4T)\!^UHYA:RS\03>+H"O76GXL HO%4?DT:V^@L7?BTI[E/^\5%
M22B7;5)OC_[")M&')=;9GFHT&3AS']E;\6(&LHU(IT\4M&$,D<:FJE*:7^EG
M_(W5=&,;L7W2IF:P*O"88&:/3LH+QSB]#@4F<)8^['&TIBF5O5Q#GS!9,7CZ
MHQ]$YQ,&8N1I\.C2ZL.W2'42&3NSZG)!\6'&^I]."]P0%%3K_+U*Z+9L%4NH
MSKQ)^OI _/[.9]S2'.%F85&4/!F3P,%18W[FXPW>\H%3)M Q_.]IDMKT+*[U
M-M<Y16K+"*4B=Q3]NJ3U)F^"/NX1FH!I5,&/-G+^]/YC@=YD^"I!QI4'^ZR7
M 37WA3KIGS\XAV]9B5F%WJW)<PM5>=V[ O]B1Q4PO83C1GI^BG(JYI+7VP?\
M\3CX>'S3!Z0)&'S+XW[D7DHS(_XI#Z@*I7LI\JTXJ+_8O>Z/EU_TN,9LF$!/
M1#F2OY,BXS])C[,^*3$05:5^.(%X3+2+-9:F#4H9I_Z*\JI-O_G+TS,WNQED
M(R9>!/%S7VTYK"O3 T=MD@_[E**H]%;)T3L?8^"=LI<S!Q7RNW9#X'&VFE&,
M F,BW2FE'1H-]KF.F(.)@H%13L]$.B"%I:@^Y DP<@9W;YS330WC??1B$P 8
M*1JRS7")SXPFK(9+<E@E:2?PBOH.BI96*VH!%3,5 [%JWS]5U&MUIV$S2X?/
MR"R^O-/1OS-<]]?##?X=H"C^YR!L)\G$<.!;P:.BUTIA385]K%Z[R'1C>VXN
M'<2EN'JGU">O%_5V/),'3[-?BO('"B1CZ^Z4!H^&GB DS2##*"I(&5+YK:II
MGIV"W<U]@'WS_5L]QKC\K7P>0>(^\%N9 O.+Y(J W"57AW+3G?4'N--$3*L=
M.WCX$!)V;4%I;^K)@)(2?\**Z2H$@HT&\E^2;W6IK\<W%<MQO[KCPBO 9]K7
M_RK9(U:3UG\LI'?A?&O#>ZL2J!=F(*^H2..."7L\.\O_2<C1OYS<963TFK2P
MJN\),7ZN8ZQ.W@]"5$YOD_-YE/;* B(DS\SHO*P&,G4T-T5I3 >E^@3,"%EM
M=ORH@0\6V<AN\<NVO6,3E.$]%&)<#G>_\E9ESN?A=*MGW#-YKP1)^ X>4 [2
M:B<>E60G=,:3PZ[A*8_,T&*L\4$Q1"Y45YYH\+V1$9IF__J W[O"T'OSA;5O
M8417=5 6>X\:-J-J!B>Z)&1\$]H'% ^)IS<.[[)0-&@]U5C(N\$S W/KF7KD
MV(>IPRMY<D3O>[,-8K:0*W'ZIU]AM35-H&WH#KNX:5Z8-P9J&#;>Q3[AGE)[
M+^$X8E.<QG:*3H;1PR@!_YM2HB2I!J4.6='+;>':VQBJX!J-3=!G;M5X'VB;
MXNW3U9$Z-6^6^@3D(N40<&V8,6QGF'@)1\ZU8!E"IDSL$,->"JT+795X!^^+
M8W6;]AM/,EQE79P^+J^]4B-V5K/MZM @TK:'!7T<3[16!Y6JZXGXRS7]6]W7
M/[U6>)H9=-)E4Y)R##5AS+WWLO+,*;^BB<KTMVJ'4VOS>2R&\#ZX>WGRN;U%
MOCD]85W0&:<RM!<Z3I?I2T9K+.;M/G O^D0SGT*ZOK'C5,Z-I*ZG"[)]D),S
MF'M3_$3.*Y8)[Y#YK2(BL,_.RX-Y5IKRQ]Y4)CA\B\T-[W:U_-RJIL"8+(9J
MEY'T/W*U*P0O6'KGIY6#W343-I&VJ[<=BP5X<P?^KM=I-<FERM6WI\#X[G.D
M5W3?->[9"S2QM$&CDP.606DO'.7=@ W,N!EA$RZ$Y(I\7:DT/_$U=FH%WA-)
M%=B@L9G/3JPE#4S[1BL<F4^[<S%LB.*RN48.OQXU]D'42GHT,VH?(%\@ZF*J
MG@Q%!!I##)>0KOD\73#PJ#"5OV)6N*6DWNXP(M,F3<1%]'YJ_ J\.OLTA^>;
MB8N%G(^.8HL8/WSB(7:V3'-OWJ_L%C];DVQQ7$ROJ11<90A1BP[/Y_F"!=5N
MOHB\3KA-&/ *R+@#[Y&/+7->(2=9*H61/]:C!T_!^VNHPC;'X*SPK[!)-GDW
MVDT4ST7Y^VB_6ND*AL>3W]C@\./VD*W+=,7A,\C'$YMM]"66PZ]5GH@K1LDC
MG8C8EN<Z=H>CDOYH7;3L?F8ZVH4GGL-)1CD2.G^7%ZZ(+98]>AJ>$& 5PX+R
MI5.5-YY0V=-=#,HT&7RQ:7=U^9P%D4D"]L+Z\(274!9J9-EDU/DO5&'5A?>Z
MRCUH=O ,C9UTL/.+(9?=+KW4/!X0IMIF*,'ZRZADW8XLM/?.6!]<F9UWN3]:
M5C'U H8W'MY30+6XL1;.!=_+S,Y*#K^C_.3LSDI]%8"*IM]=G4Z4\6(NK<&'
M+>G^AB#H+;ER] OW,$1&D").L$LT@,167JRT%>O]<K'?A.F[<^H#GVMO7E26
M#WK<5>C\,\0^_,#TC577=CZ[HXG3U0O7_&2,0]Q"+3]M%LK5J3N8<'Y(]$C5
M<%;4<P<,_O*,_7>!A46(N0!P7HBI5%4 Z+1:%(WH47P[MN/)[%1Y-=J>T<=W
M,;:I[!>=.M_=S<7-6?2Q7G0LRF>^VBENRRX2H55)7WI?[ Z"ZB0X__8.BU.$
MG #0+JJ5;%@TD90>QT!( E[%A*L&MKTME.]S$LK2U=5X)OLH$/+(?^N'_TIE
MT=%BCD@^Y"?./N;RG-O0S5+L[8'\/*NU0N&0Y,"Y;&3?2<ZK-*WI"EY>@,[)
MU LOEO-.]*MI&9T;_3;-(6\\BY>FS]12/-$JQ^Z^4';B R0LO^V,S&%3IBY1
MW/<H55<OU:3"63QD^8IZ__7^+835ZPU88VP?A.0X!QN;F,4T[0/)YWW%O'/"
M#I^9$1GS_[ZGO(VF'5(F;L^F]55.PMV?M;PK29,U1S_#O4%ITQ<&M%$\BM*)
M)3XI2Y-:K.-[7KVUN?3[(^4XB"# $V8'P^NMYM8_R_#>&8@U"NJ0?VB;)-KC
MKL96^)H#LB;B5(35T>CT#QP7$F&,94E;U'M0CG%+<R!M2/G3_<CR'@O_80"X
MZO'H/80U\^_[:@>P+?GI\&1R(SJBV*](+Y_9Y&G/>!(BI=.#D:?T8M//)-R)
MY#_MP.D6S]@_W%RNIC>)(1>\6 VMHL6>B?=<JR2R "A;='.DNIH\,68US;F9
MCSM1D+H(VEW!SJAW%HQ<L4W*.E\N,[D!'TRD"FW,;-9EM2(>@J4?3#^WS>*S
M@L>%8VK:'C[I,LWX0I<+T;'&-%(O59#21L8ROR!*Q<^RI=W+,:L,,D+,X-FB
M8+.ZJ_HD^547DFVD:EN/TWT1HEL1\A"H,1><W*A6U1^>X_J'SWK8RMF("[5%
M'\>#:9,J1)/(.$O")F^R7BX0O=L?)+$Q%:L)(QR4 K<\V:WT9; C3['_)<.<
MJV,TBXS(%FX<=J\1\@'TF;E(/>ESV.1.E..RXA0#$9YHR/#2+'\Y\T:'M&VM
M51/M0NVO'ET&$]ZV&M:Y:)BCVZ,%EZ]A&4DO@MKA04I496HX\#I0OU Y8?6,
M!;"L #1I_>U3#O_@/P=[*TG??-8ZUM>'%?2E'9?S62NMHMG]8GF3V:,"<ME-
M.[\QQAX56H%^,S]ZBAF'_[KTT]'*1*+_HQT08G+H6Q)CX.?5T_FR[NSN\J6L
M)N>$66,/D=X?5K2)'SJ?^I@_U1:0-I=D407B^_Y= E[I.)K,>9!4PN+G]Z''
M]LR:K8NG(0VJGSQD?YX'(OFM?CRO9-B@>V\G"0^13J##K>LLM3=U/A \#6?Q
M3Z?'O]+8NDG,U/#,EE[K+*^*LV-"\YA&6 >^;(UO[.=NZ<.?64GOR@JLKO>Z
M$>'"]#5IW,@?5=]FUBZ6\M@T))>G@IO:!UFHH?+B:&QRP2^GQL%7[;OL&A>L
MC<.!^1@$>:Z9QD>7?'>T<F+XS=X??GOZ%<<O5F7-F9H6#"=5I7^VHE_5T[ZX
MTD-:^44":0$/UP $&$[^)&ILO#(1;205LS0*"QY;N/^G]\KCK5;D$,.5DX8Z
MOR-+E.HM%-1>Q?DVR=_(9_F_'%_^#_X+:#(R_X])RPHL*^HD+TD,])L<<M)E
MMA>T/'5PE&AX,_]H_*/_.#'+!(3_=6OR_X640;HWQQJS\,&*,J8/B3]K',:9
M:>A\-PVRK/AR[":ECX7O<L*H_J:@[&$+^,VI&'^?J@"BHL?]%UWY;*=MON@F
MSQ48 JS Z_.'"O*9E0K3%4TZ&?\-QN8?_)_ I"F7R83C;TN3_[3X=^(=R(P%
M"/9,#E;R6K_^_B;I/_A/(OG.4+]M1A5P4F;((>V7DH$"XUF,@X5E4=%R/ML)
M(W-1R(NBGXYK[$"8!.<@0W.W<F[N>7OF^+1LQ2*[?\<CN__@OS6.S=0'JFIW
MZA?T?L7Z P$9*C&V%D$.C],M!=UVG?D$6>]:#1@-HL(9KODXBQ::RS]+NVB
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MNE $5)3_[#,FE:QOAV2F\)%X GY-%_OVM^&M%/H;I@E#SFNDQ8ENB;T&_',
M140W*\,(.5*'P%*"),QY2*O^Y@D3:U4A]%VH#>7<$HV-A5A]!BW]4R=>AA:%
MWBJ&$1[8>F%9M9[<N]%RD/*>L7'MY'SN\64%I@WA.1B55[QI=_&.H4$0]I"G
MN*<79/ G/ -?TTGE1;3!#JU6\?!]OWCN?>O'!Q>))[$VM$(IXKLWPH92RDVP
MX.FQ;1NPD'C)I3KULV&Z*? 94I[/,R=CJ[L/L#4>>>@WG%9:=GBCTPS> "6:
M3$\$;;0I%X)JMJ>?I$=<+MCC5EYWH;&C*2>A\6C^+3:6MQT=R^I,DBO3,,)T
MK]B/9;S89M0Q+!NY-0U+;@?0%ZS1_+Y,;GDK_N^N=QD/K\-74^BV4I>HWO1<
MZ=> [94A6[Y<1M"0?6LM":4[] [OLU'L^Z&:/#@OG9PW3.U'-SNCCE"C24L=
M9THY[+)OQMEI\9(CC9KR>0K0?FA0#W)E"&D6]F99-^"\HI6C1"L5T6YW<))B
M-F5RQ'RR[[R=<=0^($;"CXG3V#1(GG/D=S6[;](_Q.3'G7TDM0\XPOW]]P%B
M4&/Y#)Y9ISYFAF+_)7_IJF3%BHD$I@D-JF,?AO/PJ42O_KYGV$^K#L$LP8OW
M@?>]5,&Y@[RV"Y4#XXB8C4#1Z0SJR@YV[P/>6WPM=DHKYVS"F(?.MMRY_I]7
M#C(*O]A[584'J Z# ;#*FX$A3;!5>\@6%P4.]CH.-/)#1?TJ:N'O*S^:=3K"
M[T$K"ZE"PAUH[D:U[AFP2C].)HU6O_<N>O0/ZV,9<(<B=?>C<5A-8H]F[\F2
M'7I?QM6COD7N UR-)_P-6B[>\D_M/*)!=<WG^;$/@+)HJ@#CTMSPVU9T3,-]
MAX0,XR>[WB35[_Q+0&H5]2V='7GV@0!1FCC2K(:XU9'_68S$+]I9@+:;9C*6
M-B?)SVR5U3-/4-NA.F'?[2&6N%MNWFDZK[UG!;IP7_&@4C!58%P]GG=J^:;!
MRTY9-<NOQW@V<'W8\<A..#&6JC&LSM5D1C:=#)G"/X&#*OA5T6*0,I=0\G+B
M%\MP <''R+T/,H2M6*(*PCJQ L9*IZX%EOZP2HER4LB!C>"C8![[@*A_HQ*H
M>^W=+U[]M$=9WOIZ[%QH;3CQ=.\8U!7$D'2^NC14NAZ>2NBZTBFXI^A_;)I\
M=>^Y_41A.M%,8<?HD3TDAS9!'U][- ^JNP[9LOB+)2(9^^P]^CG*@38P381_
M_5I?7+JI:A_SA]GQ]AYB,1A4V0>H AQN8,;<!)YK_->'XWQ=4FQ&)7/H,4WR
M=1+/JMQ<4?B8L[ZS\SF):&PT0+F*;@YJ5+![]Q!7??G6J0?RO2*TB%_3'# "
MH9</##L?QS'QYOI4_EIN]!X"1\11Q9]$OJ,J&DO'MXZD*%^2B1.TGG=IV@>J
MMJE\P;/X9JYHPO=ESF+.W%LWWT5#_0%:'/XJ#%2!W&F$N4Y\_U67\MK1IOD&
M7'YG=&I*C"3U?/;VZ:'P^H),?=93YYY0PU#MC:K@!M%S]DE"UC7R_0O>^E#O
MD+XD6CZ:D(7E-;P^A[E7%TY3^.@3ALCX:+4DM<FP5;3\M_<=_\%_([Q&85.4
MZ(X5@%-LZWA!8N5.T63J5W+=!T:RX]U%^PNAO^TA,SY4X2G3S@L[L(57^X !
M]3AHQ)Q!1=:PVU'OBA>.X,/1A$9BUW,GY:NW4D97X(EPICY+TI_IVYQH7[I"
M &B%>,)]H8[I&8M,*5.[,3O(7C,<;2=SS_B\%\8&/$D[5,H))Q9M?GP49UN^
MC/XNN.VD>^)AFK@/\ZX]DPLB]VMKM+-NVWL<07FZ^C3[ZO+D[LA(<:#,>X0'
M4]#\:!9J!,O_FR9.E1Q:JSHY;YDJ;>'%1*>_Q3 :-^2R'M41?^F8?:N]Z 5)
M8W\"FI 4*:R!]!E ?;M$,[:3W@>JE7EH'"RDI,%9E_;5<Y<0+Z1U8XEC-*6U
M@Q :*7';R+ES:6P/Y<IZ8&OE)M#!Z5;8H<Y9_!TAH6RLLNHSY\E>!S@'O07E
MZLVJFNWIX*N+B!._1+ G)+:D1^D4+T13=Z/U3E><=<NM,95_:/?H!5?R8>6=
M^3T\C% !Y=/&0J\L9Z.3%H^SR=F6U&X&1/=!ECOCT4$\8VMD>[N*\8F?W"-S
M4"V3\'>P5#@Q1+=5]5++!GC[[.#F2ZNF0\+O.TM1HJY1&/*#O:)/MJ%U%R;;
M?FI2\<MEDVBQ;4P<W4Y:H5/SC@^..I*X'P^<K X-^!ZQFPUL\-!5T*I/(3*4
M%+!;_=P3X/\A=$Q:KTR&+/IAZ#KX]=HM_S\"[RF%F$_*17LXO ><EPIACU#6
M$&5>VH[:>GUP'L,< -.\Y,ZF24/!+;I+@"7:"@5&$KA2,47Z2KOG7W#U1E,/
MJJ'2M9+G5X8"_T;E054&P_5B^&L8\>Q30O!=H6-RS9>-T,]OT-MX4?VN6><^
MP+"E?+?RA-7$1P[L3#[/ H;L0G+"<^P#OAR7G')?V#HQ:J8.[UU#-RNBY#'B
M5&!0]E:KAD,>>DR0FHN\13SWBH@FWZ4@'U6:^+=_=$>SX:;70.GMU>LO;8GQ
MYP:J;%UU#T5K-:&Y@)B#L/S$O=>5L 0TQYI*AHOYK8"+QU4'2]$J^$KU^VN-
M.LCH[.TSJB%+YW*+>TFCOUVH$LJD\K7-?:!B>3=;(%N867E)!C* /X8FY.X#
MW$&-BLCHJO*/\=V<_;F!O21[R"J&>AA*#J_OVUQ1]=^V5;+H_*H^@'?:!P+7
M#ET!2P@-/6EO+-JIQ3?X)Q&Q]-Z,0O6,N[0$WQT1GAZ;U4GOT/V,>ZGM60BF
MC]@:KQOUUSUBV!9@H!Y47*5?PX='&(3.%I!+2US/)8V>-\C:["K3I+'M Q3[
M[U0.TG#UBZ)F[N]C^AF2*>A3,*)+,"A7AB5U6GP<,82]Z-BXQ1Q?J=$E",J3
M\#0V6](*77(^+'LQ6/G 603S1:@+$[;LR[3]BBQ';]8H4HIDEZCR2;%TRJ\\
MX8',D?+O'HU%).X,B@QJD"9*.9TU?O*'^Q&]PXRAYFC9UA8\%.TSL?!IO6S.
M]YS%A+[R6",[NOD2WA=S3[BZ_T=4]I]# ^;,6B?417?[(&NKA50^F9G+]+N/
MMHUSYP1\_E"A;!G<*6_\A*S[>XMXI7>&&\.=YM_H9I%CPB2X Z?[7 >A\TOR
M*8&!X7:B4=G6LC?M([^X[(RNZ#;SI!B+@NTO3[WURSJC_C2G]K$8L'F=\NKG
M&9,.O7]1O9=_\#\>O+LHK9*^&$5HX9Q- V0@5MF.5CDD-L<R<!U2Y[2Q#Y1J
M7VJ3\./#OZ03(N:@&-LWB),"G1'1!E09,!"]ET/ZH-SEI52,[(2EH%;0S>@U
MTE[1"_$]Q,UM7).J-VWM'.GR\-:[G,MJ%XNIODR[!X>5C5'?:>P@FCAJ6SVL
M7?NX]".S/G12<-MHC2J@/G.AUODR:JA<=%EY1Q@THX13;<# 0LMK"-S98C$"
M"V1PY7(RW7PZTM>0+M<G,&^.HVGGTL&%GY!<J *C,UD)FSL1BE4K[LP>NI[O
M#_Q[9;J2\F_ME!(<0JK.7+["]\'4\7BMQ)TDZE-2%E4@<A:;%![V!MUB"5,Z
M]4,</W>%?Y8'"O9VZIZ7//?G3+QR.G#>E\FE?>KH<*,ZN/I'S?N6V&($DVK>
M&[P'FC"-^Q[?-N[SL!(O9?VF>[X]5*2\1S]@'["A3N_=Q7OU"E//@_<*/RQ'
M\O#6WT\/S!&9A _;4?F%R;[]C>Q(X9JX&%7/6HTVPASDSV*LL0N];Z:1M^OI
MJC)C!G$)H_HJ[O35TGCX-U2!+)X7)>O>67SYXT:PW,Y#K[T-^!",*M1*=ANB
MR44Q;CA]J)JF?)0 GLF4HC5@(E2F69[X?8!/[>IM5\_PVL<)Z_=I2L#>)/T&
MS*A6&"?RVBLNQTOE-<_FJK@YW[-V->&^VVH2LIJG$PVL\O8!T\&9)#G18\.6
M_C0$C/ 83[S(@1E;%;=J'/IS]'"+X(Z,(?LNG-Q!Y[K$-R.?)$,\":MN&]T:
MG"KF3S-JZ!(KESX//CD09]&\EUU!;T3 NS\Z;;&>N (D ]VB;;#"'XPDO8(U
MSM%VRZ#DK+T"8R547YY,[6@$IN:,P$"6U/7Z32K"A\Q&JL(GH#0NCOD?KY-L
M>MZ$F15@V/,\B/2]C@8OZ/37=J@(\'QS^4B]"8;X'*B\WL0@:9>I=[?<R3@L
MFI I=:1\I%%@W-IGJCD:&@)WM9.HOXSLC[OKJ<5 +:%?)AQVW04,)C'_&M$Q
MUPQ?>^)^TW]GD"R[5V]H3C&::'VC]I;TSDSDQ"P>@29\0G\P?C67PAA\N-5?
MQ)*C*QV_YK(13W)IKFED)R%W3W^M>I1+2MUDV%Q;K:$$3-'Z^B;<.-;TR8+2
MQC&(:3PA'E]A43H+3:I#)ZF%=RATB?YP2?V(ZX'?;12O(\%3?JL<#G+)5>:,
MP/W$T@[)491]ZWA:8^3;7*+/)ZY;N&/(Y@ *2]4;5*W$)V9[I]\_7)!T!+CM
M#&^#\?E-\X1;#*\%F2HM99(%!Q1KJGP#2OONB(QKC'_J)=<3,^FW31C5\%O-
MY/ULPB3_IP_RS)+N"S"#^F$X=(ON;,KY]L=?[!^D72H(CS1FVWMB;& 1I.HY
M\#J=(.7<?WMTHY[^YF-@&FF"D-6V\K#[Z.XOYM194_:FX<__*TOC);N'>"[M
M,Y?@?&#FYEN#!'&)R'R>*;MQ#MJA&J+9K)=MC"<"X#MFF1686K4#HU_+@CX'
M99>G(50CV .DD<3GHM]?RP])N(Q"V?&$&3B'>Y0%_SM$^C,AP9Z?]XV4Y_"@
M8B%5&&('MN?;S5P6(_]\\NSQU7()VL$I3L*:"%A!J&F[\*%\.,A3:)N[EI^W
MOV17]>#(!VVHKC/YDY'/FQ6Q^,^HSY UV5Y_6H@6ERX<;" )7'9UM5.LK;W)
M?-K.&;>,H1TZ0CD!QK<:<&7BBL=/,/ES2YW@L8L&]AY59?14I3I0'>)WDM)?
M?<!T522I_VE[M2XH]]?W'/_!?P]H9QDFV9O "YCOC&3X-1M7,CC/V@X<5I+T
MUSR6H@/[>*[VBXVM2F%/M2_&5(%I_22- T)1BL+,.;GT^[D%I(O*>NCXC([C
M)3[9'>3J 4O5JL)">!+5/M]Z2NR&CT0F&;-%^;0O#_AG\G;59]0FS;_:>V0L
M;J?O0Z3*8_T!FB.!OAA@2->-LXZ@]ZK)<J2V$9Z0BA5(<$6>C-P'8K31SNH4
M,:IJ6@]2G^>G*:UCFJ.IF3@/+0#0BN.15-[6V?:M]0D,UR3AO82FRP"T(IAZ
MF*DSN^.C7V1)U$VBY:.+S]M<-FT1%$FJ1GFNN^7,]U/,$O,N@3-KB7G\Q&]'
MI\\-..M('A)@(,%^,]&_P7.B3U/.R=N3+N8.LB&IUV/Y'QFM_'FN;A5ODG!2
M54F0]R5+2QF$2?#UT;"@([&K36OVYA(C7TXGRAOY,J6!8T2Z<BXD?&V .E0[
MWPI\?N&F3[HR<1^@L1\<F3<9^62'FUIQLTR4;ZUXK_%"\MQME[7S5?/IF3]N
MZ'<H81]\4G\15=?]<N@W4_KQ,_:0=?G97E!FK0//N7+BDI\8URXC^,5JA5HR
MC/;&@D<A[;WB47%3:-Z?;AD=G9P?;'X;4$8WJV(HQZCJ0SZ4RZ.)1[SE]?7*
MLIKQ3$B&&5D^OSHQ"R=2LCUDUC()38B#$5.1>A3W*^*/OP6R+<K0B6B8+JZS
MH'Q4!E*#VN8T]X^W%IW,0M VY=WFD7!)3;?RP!,(]\X:7\>?5VQ+41UX[HA>
M7K3_9=_#%5)+4I4,A&FBU3[  [YJ0G._Z*\JL7 6\L?J]X:LP .L+JM5'#D2
MXHZ[9RR\#.<.+"]PE;5Z];SQ2=W4">+2]V^CX\F\::/?'K,#]+X"%3 M$^KW
M82Q;UBDO:](*=<[UHFD-:%D\T:&7Y=0,-#4Z-2=8:N!=5"?% E^, 17D5\N)
M&W3!U#*),#-8J+#6?GCT[D?)L(-:O@L^Y"T0$TP2GQO^4^&GLYEYEE-B'Y $
MPF'$<\&Q=;@V] /G$ZH/:\\T#^!+L. Q3$LF&$B$GAU<JER?Y(=&8NN423*T
M0TP471X11#E".-M/J>(5J]>NRZ8?H9?#+>IDJX:?4#D+V_<8!4:$]_5:'QF]
MH$I_DMNOD777J;>/T]AG$J*3JB3K7@>UA?HS'7H6Y_G(EVECB<:N09\.J<3M
M54'FW3=/"BJ^D#(H1>5=NRYSHZOJ]'_Q@%F$^ITRK6#N:1;G'9N*U*T]F\\9
M%G?<,\^&*C.UP]D_B<]%<4:7)7_@'ZH"T$<,LJA\T^2$ 1^*A)#!VR*]IH^/
M7*P).% &WH&5M!:(W%5[<<1;5%4YFU: VP<\]H&[PHZB<L1/S!FY\\[X!/1U
M;(*4^/7LP=;W95-/VP&4\D&!5;I/(-9Y-^+,99_V*^*YS(\T-(\$T;8H9A0=
M6B]*"E2<F8C1M*NV&M<C$RR3-E65+0>U<M ?_'10SGHBQ9DG[\M/AAPCV#'&
M:B5HM L\_!*_^B^L>_$/_D?CT-<\<TE(W_D^"PL%QN=?LAZG*R+S'VP)7FUA
MZV),FQ.9MV<YL<%4;BGH,:JXG7@LZW?;.HO1D:NA';'<D>F3)\5"DB-8<TV,
MS 6 ;Y_U&%\\7D6^C8M1ZCYQL5D\=O$@(9VSND*GA*-0F"'^:!Q#L4X%)W0D
M4^$"SV?]?-;7Y0G7I;UX;$H,-X+79T]UP]=E>FZN1P^=G[A6H^X&)$S-QW]P
MRW1]CK*R"#OM_.QD-E8%(OYXP^1P9\A1#;58I[BKCKU-+U2MG/WT/\\^O!U6
M@9#2'(C51 ;>"*3*Q2 A&A.9.+HP 1715(&O[7 @XN$>],R0(.?M]YRUN+%@
M0;].ISZU\.5>OM-.&#=J&YT=[])7HSQT;GAAZ0'?E/R)C'4!YCX(P64U\" W
M#%A/>G7QME^$*&>HE07?S_>6VHO[ (#WP8DCT:0%W/-K*B]=[=,EL+.XD>E#
M] LQOL:3=+HM6S_;VS;[1G4NP&^AZ*TAGEYCHA[+'+U4/Z"R;9FJ$QN5S\4#
MRB3^ML>S&$N,_=+T>Z,O-2SZ4!ZEO'F,/).<<VA.V[)YZO" (4=^\XN?.@B^
M]L-F-8W*-B<CTK9A,#<@?%#66Z^+TIIM?E$H5-=34C&(.>"+3F@#ES&'_>KB
M\5\*#(8KGV9D6&)^VK;]UGG+F5JE?'JEI9J%@X%)?S%6QFKD%&7@U!O#7HZ
M9"\>MZPO@=3LJ&K1KG; !?'1_OIAGY]6;X/NZT+5>/RKYM6WS:$^HI_; 2,+
M@&D@\TY3^[]!3L1_\-\*7;+* W<?U<#=%/(A_?^OUQTCL:?HOX*-XU*6^NC.
M\A&Y5"X]9&DE_4_GQC V<8O(B.Y3VD\*?NO7UJ1\7/[,)6#/:#8S*7C(:U"U
MN=>!?1^X=R9JY1JKZIQ#_'>/) 5&D6.(-E7Y:^T&HA>-F\T%&+Q,2Q.T#:^R
M-+U, CQMFHB*SA8R6@XF7*X<>MU6;7?2Z#?/Z<TO@!R\^-\F;/TO +(_]O\
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M).H>6W[(_7KOF2L\A".[!@G+7=TTF3$A-Q/XL!FY?71OS(-+J:$+EBA+:(3
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M6"$1E.PC,<]:]>![\?LOH!,NWB#05(L(C;KQ!%]M">0)$E?(![&)Y"87^O"
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M2EL>#U!45K*#,()Z<)K;<A& JF&632BS;4@+9[LS_U86<4Q[2M0?BV?G)3[
MJJS^1;*UN,_<C^AP]CU'I8_!X4AAB0QJ&+4MQN=@YE^/UQD&7$I2BYU2BM"I
MNYO(S:V7']T;-G"8@VZ+,D;MP,/8*2<FA6;?<!T_F:9XR*C[-\JIF&".8;IW
M@WN(\?4 -A:27-RV7]<V\F;/'><]6T0RTE_T<V7 <C85W#4NJG#9Z3Q++DOA
M-8ZF4SA (<%&$X:VZ=#)J2.OL&X-(U_#]P:9VJR/WC]$K1Z(0BM-IKL)9V$/
M'*\-M-RYH0!E$>A#&)3?""WVAK[6:(>Z7<7 3ETZ?GYPV<$?KNM3SOM?-@[O
MT'LLO(KF1D#/"?01=$S$8HP%RK=^=_^-U&N1QO%_"=,D'N >93$#@R+;D#:<
MTBI6],R7FD]0)E7.Z</ZT/',N&D\!['(\V[0-HRB^#"A]202X6ALP F#AD0R
M.9?JSD<\^%="J-AP.J+NLC"G8*?1H?@7A[ ]N2\K'$/];E&] B?S'(<PM84Y
M2ZAX6CDEK5YU)BLB/2$_VV5 ]>\=.OX<=2['IIK>=79HK.U:]GF&[\Y4!0 :
MI5Q%C1":216$QBZMED]A+T4R?S9<Z%=4ORD:X=W&?XI).[=>C9^@D%"@41"T
M#6LF/N$0%*^B/\CY?#Z@Q3D^RZPL@\8DTX@*V/C.5I1 X.TNPX"9VU?*M")B
MNP#"/@K3/<D!WZOP\\H5+\J*GKLQ',3SQ9$+_*\#KND5M7*UAM#TVIE#4*_)
MZ&&&-@]XJ;"$ G?K^E)\1.5=G_FQ",<!J E]_4TG3J>7F$U:V8%>.4^V1$R-
MN!XN0;!];5/&XY_M('0^1&T Y",_LP_/6<J/[1O0QJ'S'-__.O'F_IZI_5CR
M%!D2.\<M(8R;@N02CEE/96IC7;L=C5AKC8<=IM$6;S:#%B!X$R1FPUTAQR;?
MR5?3,AP\] NM7*E#Q"@NUEX(QGI)/3B$4EM4 )8I\30Q V)21&EOQ4?UQS8W
M*3L[NF[@/$'A"4)L5D>!/UNJ9<FZ5L@5N0.Y,3B*8EHY#>O6Z^/.WZF,-/I:
M'<\25JY9OUFYZLI1NKRYU1<C'GB-U1VS\NSBR)\?Z^EJH_%+?>P-!8#S%T:+
M _Z[0D*CSLB6P5,!%\;3_=^HJ84)"'O I&US4P=WK@?:BU/YL>IXZ*_Q$]]@
M^6U*R]&89N^8U5].319:97T+/U^WWI%Z(&9RV(!K1VC\C*Y2)K4ZQ9;_49AZ
MKW(7^V!'5EC$=DW$JD*7I\;=T@V%\G._<HP/U>WS&?K0D8O\'T[O_R=HJ9;R
MJD]Z =V*WOQK1??U3MB&S<9$\6<^6]!G'%1^6V;7?MBI)^/"Z(./N4CA. U%
M1SLQ&S^Y7<; Z6;#OZ* ^6_!0S#04U=1STV.N:!TWZ25O3C*LI1$6IDXY[Z(
M?WW.^C#M=!P0V 5H[I@;>/+7O@$I_>K49]]\'+]V,F!]VUTH3Z]$$/6MZ)$O
M)K;5GGT[[5#W:.IWQ-8>I/Q,SF/[T];TLV&-,0=O3U?Y)GM+H3(G5W.%=>WD
MP](/[IT55,I);+(3$^HZGI?1#E= _QW;\27B[/B=.*,ZN+HEW4&O2%T>837.
MY= I/MB+F(2L=Y3E10THQ@<!,F D%YH4+IA.-" O^U)6),X1Z$\N03TY&GUP
M]>  #Z>_>]PM#I]_SBBIH&T(OL,P3SQ]\Y*;OW)X.$K]OQ0\8MSD(8UYQO@2
M89JX(C-[^MN[YN2E[J'"&[3RA 0F8?+?GWI61LF PSI?KP8#.O]OV_P=[-T=
MZD:M\W#]I6O( X:+-M[5.W^ZQ -6X;R209ZTA<0LGWN"37_$'1TIQ0 >#W7.
M4";8SRPH7?X;X+\JY@#Z.DH<,?*5Q EU79+9W/\R*#7"CS&X7DS H)EV0]GH
MZT'B CL$OA(YH<[(Z4*.LE[)B:F>GX' $,P!E,C35LU/AX[P@!=%G+D-,YCH
M%IH9J-\?&6NX]VZ&7JI<?QP*WA\EY_S1+,EU/1F GL.Z&(Y4'1 '?IU\<VC@
M^$F+%$Q)^5$]B<F.Z&1.$#S>R^RV1S!]L^OPSP._*\Y1Z96;>^4V/K2L M_U
M#P8F!:M!%1U-S-8XB[O!%A;7+!Z=.94F>>R.^DZ^CMR\3F?-4'X;\6*#2Z4W
MFP^7H%IH%5E-Z"W^VB^Q*:WW1[\FB!#[PDH2FE$2.-3$1WY:@H%GC:L\_]WO
M#C\'JYZ&/I5WFM!:9\-K>#&5MG]2,!L]@BCDALIP^5O52I?54S576PD6!&;(
MR[,5.7;U-VCI:/JU:%2".S^L:38-^IP#O4'3QYS6#2\CN:UPV<M/T(($IJD#
MOWE =PBF'\E1A$G(GLY<'O"1L@'DBO>^Z%S-"UI]6)<U9V\JD_I!*1E@$D<W
M%/UALUQ\+]4F>/G0[V4><*F+H$BKJLN3)2FN3D9;(EU)A9MME%)Q4/,;Q7><
M!T2-/)K\^=*LR_!WR']T5D)7CI7*5K+([CE&[= @B01*Y(K[P7/JSV8]IE3>
M3CZJBY!@P<R&/*_&#C^ %\*&A:'U?+_ Q"5: 8)-24^&MO<9$$;JF_RQ\@_?
MXXAK11N;H)#28Y( !^VM>J7@!5]WWW?D.0E?MS _+W[%_;ZJ1^2IQ78-$LG
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M&*3]H$CT"[YRXQ$,J8LLY#RM!/N*=AQ\&EG0JIDMJQM\X_UY>L1W)(G0>(!
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M_K')\Z\9&: K52&!HS2\*3&3I1.P?_#KJ0]A)]!@SC(:- FYT*]/'#[Y-_+
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M_>P[Q=T)^$<BOO'M!@>67BOZ(/1:1::M:FS-SR1#GO#U)G<\1J>9, ,_C_(
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MR>*ZJON[ZEZT:[=C+7=1VF46:$+HZZ1[L$.]?QW;Z"X;TZ6ZPYI8&;'%:CO
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MZV\(8Y28P*<T*++&PTF6^%$ =>(GSFMP$+DW[^-H1K[<_1]#6'>P"._B%?.
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MK6.HWI&?S[6\]&_IQ0-V]D-_(O?8B/])?G"?W5$XM^!F[RYYL\SIK,WM6B;
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MAHN,"DB<A4@^O-.R.X;??5RN/&%'W%]=Z'%2MPXA#=-D@B!68G;CG2=XD=2
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M#1Q=*H1VQAV_3U]W 5FFGX+^?AM_;>W%C,/7Q'DD:\)5'W^7&PV94Y.N1DC
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ME[:($_&I,,>I8,7#-A8%W4\0\'@.N6U_!,DVD:KH@IV5]F@+MH1,W<4"%!E
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M"UMH5@=J,+@@/5("^0)S)TV6-%VX8H\=2_^-TGE8RO?J1@(J>1'9,TL7,7N
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M/W!46)*Y:1\PMT1]U6+G31YD0)6Q.L\@'[/OVW>;;>?==]WJ"_O91GI8=>H
MY7T4^#.L^A@3&U'Y:[?L$W(2Z"9\'$YA=\7-0D]!KL9B&B$:^5,*")_W]V[
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M(L<*YIKW ?$DW>R"#))Q4J<?%62PDPMPU,!"$PNZCE7%:Z>G7(>DFT.&QOS
M<?=06$/@>(=12D;?+*5$E*_7X";I)8P0*(U)\YERSN4=B?NARJ,KIH"I(>JZ
M(\11'F,0B^+G!R?7'C5^2]L'R#'!C(%87W0&[/;H)HZ2KY-.V@RRH["Q$:^8
MS7-PF>[,3N7?F]9?__ AY#1RA8_"6HJUZYIFI##U/0]"7LX8M^0%O-F>&6"9
M8#J]4,=>,,>!KQPZGN)O>#GQ7MD5*7\CRIO\YNKKWE)1HE$5W&X,N[U4&),*
M58*X \5]FJ1G1;:9:U(_H=,9.5L1F4-KX*/0+B#6R"P15CU\'ZHT^LI'XH+;
M4)6#G<#'SW(D:S*0EMDU1L6 JFVZK' [#\^*T O(X'Q8I&#1(:/1J-O@6""]
M#M=JED'L75$!HD[2G3()VQ?2.Z[CX:#D?<!$!_X.'!^*>^4H9G'HS8+]4;%'
MLC^H,.VQ 2Q)(]BI9RQM;_0= FO'T2L/<VN85\18MSP!J!TV"0O=!S#W?^";
M/_[LT#SHMMF:+G"P^P'QKO$-C=WSY1(I6RJ6 S;WXCUZJL]7!)?TLQ; ;0'^
M]0'5Y2KM/JUK1EIKPNU.VJNB_M<O([ME&)80A!.CR:Z$,*+:E.?!R5WGPK*<
M?4 EN*<$<WB>C61'-%_+W'O6EJJ Z7:JQ[<B5RTI'!TX)8<AU&W99J!!S=3<
M=9;WP<NRN\8$^ Q,+"AVKKCD6$6*I%D@Y!+=< X[@$P+'$"PMHLTFOZ8T"PC
M'R'S4J1=W#']W=M+J**PLID-@IH"W@%W_Z'C^YV.5<GT]N>IMP#H$12##AVL
M30GFQ?-0G.]0\L-9;=?U[QWB)AT1'\-DX\GYU&@6."Z+]SKA-V=L<O5=CTR?
M=E_4(S>&/2+YF0Z(Q$1^_B-]A'1")[="5_;0UQ,^856.?>ZW,[P7[&:.++-<
MHERD]1E%8:VF$Z:K4%W-DAVV&>4!VCF9L!955;UPD1WD*@QO3,Z_.SVN-+.0
MV:EI-._:(-(9U/.5I6XD7-NED*/Z=*_RBDW(.D,Y!/R+PE%D\3*H\O+5Q<W%
M8:,[W)]S3BPAP$403Q;289'":@6IGLM77NGN\H:#7+Z.C.E.]"(_FA'4U(TI
M_5-' H%;/XL4VFG]E/-("G?R^@**>0CT-GW36,MI@KQO+,I]'_"@$1'MY>/E
M4.%%>BUA_:/' T BT&:781_ %>C]R.#@SR(%Q-@2K4@!]HM\TPZ-DJSD"!VY
MVOA0K^::WE#)M HY$HH&44-^S3^S!82AF)/D+2.>KT7@%D_5>N[_IQ'L7T6F
M_U:/^3_06?XY+CH#,!)/YITV?'(?XX6_X8L;XPO63-DV'1[8+E9)9&G!E>Z8
MJTN-JL^#'^H<P,IG'YLJJ["5I&+84U.SYT QGC'D4I"[-L],R8.%+#O"R-6(
MVI@>1\]-(+Z(7 7QQD5UGZG-+)LT8+[NQ[A@8'\/>5_FW>HBW]LO).)#TKF^
M((_$YSB3NR!K%3!!1K6=R%'EMG/Z[%!2NY\=A9E<!14A= ?6U'[VEG3U HQ*
MH-B/XW@27'2\T7$*=#[J];ZXTFHS8-!\6TB31G-L'#)'?R*!7%I)6EM=O?,@
M+&EHF!3 -5^L$:A^S. K"D9@^6&1[UE[Z(.G=O2W*Z7+3H\.VEB]N[90M@6B
ML%&C R:!816./A SX<VL]9V&U*N,>S;+^X!8TCFG.6WQ:>O7.1IH\1F#$ ($
M:FDGU[G9#)]6<XV_(V86:5F(D7\QG%0E[L:;2)I./WNTAGVI7-7I^T>U_CO*
MR+MA>@WN+<O5W/INA6:-)SS^$"%MK[ST5N7L='Y7YIQYR7*;U'/L6FEB)Q,7
M4U$Z;[EDE[7>5_@+/N+Z<&]4!$GRP()CD="NL%<&HIS?#I4*8;BPRV?-XO)%
M*HP615RKOP7R0DL"M1!J.<'S1O5[2BV/3]^0<6F?EU3I0&*8L*OG>4A2BI9@
M? 0A1'H<<DX A-'BA"U\@_YP%X,K99(:,B<_KA_M^1!P1?\TJT!;+U&7I"Z?
M C^HEZ$M6XX=C:M&\EX/JS-JY.TAS]I:=LV6O1_(\NTMR*@%)[97>%2/.XS?
M3N*WL,MI^[];F?@W@\GE8LYN:K)>\'U,,$YC:=:LW7CCX(2],.K3 B"*TA62
MT[_P@9^;QW:WA\*><O.%!ZC*X=NARSZ;7MEQ/6I?9'5!F0KCFIU3I\FO43[Q
M3=K>Z@V;35>< *7:-OL )/C%M)AOX,877PI;V4N2YK /4_7'E,N2CJ"%-#S)
M<ZL +SFJ)3W#,[%C-:PCD1TDH&778(N=)UQM*:.ULH=Y[ ,8"'/C9FPD$.[P
MJ]HW[H:<5U-=C#:'S5D6]P'K.*RE-;E*!^0A.)+1OO#=U7XA8*39%?^#:OR"
M27KD<(A#7E!N]XBFV9GWFH_>/2&^$ZW<01:@9JBQVMA+.>.Y[P7S"/X\8^N:
MK1&CT87VYRJKU!@L0+4''3-U%"<.GT&S.%P'FX@_?L3GU9GN$L=ISC()POH@
M,<;EI.OD["90WMI>?):E\*DSP;N"* M$*-W"CPUP O48GM/1@1C566AT&,Q5
MV4^8A5.-F(]R_Y*65 TPJCTVJ3$J@F-H0_&(FF6#<1<MHN,/&;BFV!SAW*EH
M-XROY\9L)G>C)*E^:$:!<"*F""O4ZCT+9EGEX>HS'##T_M;!U2.VI2N.P950
MV*N(;!#.X2)LRTLIHKG_T^2%TU0P%SXJ,(,FR*'6@<@UMN>3')$?VX+K[9US
M8/=061QH0<K ='4FW.7MH$)-TL5)AP8N$:XZZ2*WH/E9($8.ZTF1;NR*J0$D
M[:;J,3S/XUEWFIF'HO<!8M7"32:SK 5!2W&&!1_UU4#G'-)([ 1?Z5[YM#0"
M+!JF#L)> !%.+G4"64@7:@F^\V&VWV?ED;Q3*HV/;C*S-,,N43AQAS,?:JE[
METV<>9W*>,N@,4I7V +"3/#U8:Q<N2:9,D22S1NXZ\G%J_#&O=(;/EC-5072
MN=E3I"/,>*'"C>ZB(O-,@*E#4P3A4]WBURRATKT!!DCZ-$H 3;I"M<G1]RM\
MEI6SX63!S\VGW@)]/(7F@A2PT_:@;;;Z?<"GV^$@.)P@9P:JMNYE*?HQ_6%T
ME+I27M6&.LKN6^_.<+V!V>XR4#B,6-/PB0W,]K 2-*D_+(H*JCY<H(+M.K,X
MHQS;$N S .S2%#!L[UCMQUSSLN?F7*W6AWFMH_1KSFMTG_2^8#WT(_1JT_#W
M06&;#<.E"%V>++6>#WVC1>?>S(G;DYYU^8^BJGU;WXJFN83B5"\E6ZLI5O<<
MH5A7SNX##@>!NE.R45R$A/%-E9DG=A+A6EMX.#F=<ICR"7HH4P\'3:T[\-[H
MY)=5:'Z+<C7U&6> ]K\FX+3,*2RQ'E]W46V(!<<JJB6G]0A]LH*J+$8$W@\K
ME$II76^XUV/6:=.)8*.&,MXL/6#^5Q#%P (]1E75.4E)HU86U%0>SV=$).K-
M:#LJ"GH8WM%RX),.VB<">BXY+Y2=T$/AN$]D)LD1DK!7O6&FV+WL;S'7'?49
M7BP-MJP0#N.RVQ$B)&G?.3CW:L9F8<IS60YGY\31_FGL-?!#"@_6H-6XL&4$
MDWJUZBFD#B*6DFC.LGETGNOXQJQ!5]FLPKN1QL=EW%.MB@+D$["V>D0U,W(>
M&:XA%..+-'X>#D%9"9 F2;<^QW;"$K,08T>[R5>](V /EU3(U'"GK1K%O(WB
M@!P;:-(+Y2P[^(#K%?5-"S\+FVF$84V!ARF?+UQ&M(>$&.*<%PH^JOOBD._7
MS BJ)?B,^MM&U4]8Y?THR2'00/)5\/(A\<9+J^,7+1F)+3?Z+8$\$$Y3EAB,
MU3Z@01?8ITB30@*Y!;V;+M#UARU-[@.2@L$8JH%CO$]H)JH&G=GHTI$<DC#T
MSML2>W71#UX.<T!BE]H\SND<KM7:!]Q#4?_,M$R)83/2B:J$B/)JX[LWB^]8
MP\;R>)9&*:PK(;'X[*H:1\4%OWT O0HY'(K6A4="Q70:?RDW'27Q'C*<P+?4
M'BS^W&G/L],/NS%=-4U*4>#:!_RR.=^N6./O_E[]ZYJASNS>4&;>WB]%H/*T
M/_^T.::E+6VK&G&2E@'0%OX?E6*6W*.=;>+/Y(+?S E]H24DO'^[#DJ;BS_Q
M#AL^C[5;]&BSAV;)-;G)YZU6H/?I=FBNJ,B3&6_YW[B?Z>&/O9\QF=PL:]TG
M[?GTLW\B.!28"L):[P.2#[74S15BOT;/;LXV*+YOT%9')CZOK'T@\BJ3T]1H
M!_D<-E-0NQ-BT"5:VQ(?ET%8EY==6K9_=4O?WF]@=(VD&>,I9Q^+1<75CW^I
M.%X:EO;E$8/6N>/JLFC;Z.^W !/V ;G,)^(<@]$?K4*&%F/X761EG!S?/T"Z
M2LZ-I\;$97:T2'UNXBOO>!D$]3UIG1*,[X=.4%K!_,6XG7;,&8[2OGZNN"TV
M[2UP;, EWEGNR<5SI#6\ H7-S/4^,&+$,^Z)[/7(IR39;VJ-Z8>"G"F?B+$1
M3][W:3Q3K^MS6M=^\/I.4)?6IIJ*XW6QRP<#J)$MZ^F:W:*&*P;;7E?\_"\6
M1% AN^!_D2JZ8D-#W-?^1L/UD9*\8)76M2&#V;6ZQ,TC:N6V_3@W=&S%/F M
MXD5YA;ACXF L;GX5I;2EB:_"H9.\=(YF>\I^+=OR0[_806K4X9:2;H<S-XN^
MW=X''-H >=:W$1X;'D;L)FQEL[XI2*!8?RR;.Y9CO3,%;R!W=!#LY;1B$L-R
M'.:0=]WTYJ</=T,]]P%+%&4<CJ&'2V<KC+0/Z'ZI?.-6NH0]5C;2VH_[TC9P
M*J2EA\/4_N5CZ$SLG#1<U*[. #7S'K!&4=G3)'*N'LHHP-8L#7^;I-S:VAU=
M;#+?!W1NCL)WO61_%. /F2 XA&&UJ!'4.>S'(MNQB:6T>V:ENZJ)5J=_!/G(
M'S!JD,M\BGELH0<E?(8OS/PV%UW@ZL]LZK7_H&+E=[%FRFE+8O:S\C WD1U7
M9;0YR2G^^1W$CP#1.4(0W.CH9WDBS@801EMW!4Y$@$_C7^#-SCJ?N<GZ[=!K
MT&,D03:6Q >?-VA#)>W #D)$9E<DD[U-*K2Z3C7=V&K%(U-^P!\@JGFHX7Y9
M&-^5H6_U3T=O7$V?*&8I@H%AU774:!7!6W@/)GBJ^FGAXP-E]^\E&"U55O#-
M;)#X)O"*QNF$V%D0O;MB!Q\5!28$GF137R.8L_2"7L/734JA'\"5I3BWP:QI
MRWKL0BLL$ZCZ6'<1)02QPWK.QV*TB:[R#^>X=(SF-;[A+G(F3LOXLUB /X$Q
MYZC>386< 7-UT/&-#AE!N/HQ'BTG/?E^#J!ZN P-NXD4AK7I4.0)-4V6^015
M@[K/SLWN1](K1N_<&D,KTWT'82^9C8E/X'W)B+MA9XBF1.UUCEB')SWO9==D
M;/5NG^'6M#8Y/F%B+ "_D*7DH[.1T9I0<WPCG6YO@/$)7T]-V:XWU0W MQ^2
MC>>C\;%2'VY1ON@Q^&T<@UUAME>+MOJV@UQ(HW ?L^3!B(:=*G^D4M^+)\_D
M\>13;?\DFB"-C*1($AS!HIZ--MG?''Q.86-6I[9WED@" 10V%-;)GL 0?#_?
M71;?Q5O)YE60'S7>XDH]7R#($QB-8H>R3"]/27Q>S\^Z3@<^NV)%W@@ >T,G
M]@%U/&T<&Y&9[QHIV4I-O.'QD,)-A"V  J8 +MS'+N%78SOP4MVUCB<.AG.K
M<8!'7=>5D'US9I&UJC97?/P8)2M@D:A'S1P]6<?@)'[FI:XS F=3"77]EF_#
MWQJ$4)Z#;L$F"F8RXK&7/KF,_EB^=.& S,Y+GLF] 98)CD7F;K4B__M^8&U;
M6)L^E!4,EDN$'ANZH!3-@NE#KSGVSBC$'V+IU%;VL.6:5#((O]]UY ;H)& Y
M4VWWA6/)VOG<Z7*.8;(;?7-[W;.<JS:=;X1F*^JOX<@I5">8/UXG?KI'Y=D<
M6;$&SN%Q2$/<QVLA#M;Z&+ZF"^PQ(PFFS&7C$]X&9:NA$*"G2"1LY@LQ.G;^
M653#S'C)-K(,Y&-&.)*9T*(&,4!TU@[9I:A\2.5J"YH,</Q$==HTC<B+GM-O
M7.'>V_U&<Q+"UD;FS54KNL 7(2'5XWJ%<6J;;:#R(#2)W[@G!$Y]U,FNG8<N
MOO61Z!YZ"VS_C*D%V%TWN%GU9-3'SS&8>!4B!7M(?3*W>1@!KW:T5<-8*=5T
MI!SH(!AKZ3LN?8G\7(7KY.A5/WJPC+G\%[^W*^!:%-87B5&<AR6!N.1]( [W
MG/UDQ-[;$9K7%J8345B?V$12(.[61E>&_T2^\5UD9-F V"@U&B?QEN$!+>04
MR&'YAZ6G7)ZUO:=;RQVF6Z+"6 =?@O3V*$8)>QZ_U7'6TB1HT.CHP6]^X:$V
MF_L 7,#L-!QU&YZP.3XM]=JD9#J%]<SI;^R4!:T+L\]D.\?O9ETM=SL6/1Q9
M_IU63,C.0YTB44(8\2*YK$O\X, I;Q^HNT.O?54 =>[3@%@S-$%-=*YD?73&
M#7*L?.UU=V4C8@J=%H&P<'2B3L-QZN1^))F0D:=,DWQ?%;Y^&A"WN&[V&NE"
MJ*&"Z4620^7P@H;]P\KKKWF/::^])C]#S4S XAH7R[S&?Z1X7>>O3^=W=LVM
MIMM=( *@O?L *IQU!\.SM+MBXGQ.%36#//S2$A%%,#LJP$./O1S"WR?P%1',
MUL4OU[;2L]\@#X"*@M'K#-1;>$+0(\H$0:6;L$79T^$559TV1[8QX)OG?#)*
MUC-*:UC.Z0J*%+( . \Q-6;RYBRF&[F,AUI:.+/X>24  IIN>#N!LQ'8.UZ*
MP+$A\$E36!6MEEVJ79U8\TL[*CUIDE(%JK*2>H5H<D8X*!=)D.*_C*KY6BE9
M_:>J]=!]0.JQ6=2O'7B/,,#'%R="7>/^5("YLP^0,NZ _=*HO1)XA^S>-Q!V
MHN [L/SD#P&>.X+_FK1H:4>%2@(W?F5[_S_,(/S;83A9*CY<K7KA1Q[KK41]
MT</]%[&]1V\8O+=*>*0."5=,<-+,Z^:2%FKDF)*KV@)1V-N()U?'^SKF^B5-
M3DDZG4J*U. #YPP::]EXN]X];9$ ;)U#Y?O&@[A(()QDQ];*H>Z<U-U'CQW(
M5=05JUDB\:9U6JSQ$>!M<F*G(1]NQ=$;2:OL ;EQ7"?YTP^]!?939 A^#WMN
MH:K]EQV)A1"Z\"6ONQ,OUD\Y32L_T%$36!="O=[H>B:/R?/TS.@1$5QL](V>
MQIJ:)4!51X\2@](E>&\^>#T/[VYY6>L:8=5<HDC(%8I4RVJ1NX+GW/0=HUI[
M?#.NK.?JGESTTPQ!%TF@+;F5G*IST !;-EN1[>S]P3\L3C92<[$)C5<E1Y T
ML;93$U>'?[P37U01">P.0KXH+Y^//.I-[VW8S6^S9'\NN^.PM8P7?!7(&20.
M48])][*2LZ!<?!%M&;I=TFW,S:0O==PDVU039V8@<?ZY(?)I=HT5?,2JX I[
MYWQ$@HQ8P@G^_YH&YCCSUQ\S1O2^0@NB2):C0?N 7.;J-:6NYV:Q%5B#O2@+
M.P+O#^4"DML>\@.IFUR1@X@WH#"1NH(_QVOJRU)MKF?Z.9Q,I.XLD9BP-2%@
MG:@HN85<X)RG& B0S;Y#'MJG\5#X#=?5"I-V%^/O\9[NV,I7L?^6,RHT'K]B
M1D!(-,G#ZN2H?D$[&IH&[7!&1)<C-I#;R/Z@A'V S_@,?+L==0ETLXDG^H,2
MR9/L^4.! T.N4]"'FLVKDM+N4%]1$MHS/T%V9Q?8=^ZW4]>_)\W\>X;GSV(J
M>IK<1X3^5+ "]]R3'HMK("&M,%_L=%NF!KGOY<GSWP3%'V8M/\]@M2HTCO1<
M,B.<%(JKX>&A]*MFCO *^*?1&Q C7_&TP@BR/"0!ECFA+K-QV[XV<38<T_NP
M6-O3P?<R]90Z MMVD"W[ %?PA&@WU>+"9IYDY=;,]36D61@5N+@O'L,M-*S"
MV$F)U&>2/\AN'DGB/[Y&X3.V?LK7-0^=8\'";<FT% +9T_$@.:>%Q8%TE."V
MXLW8Z.P?;#BSM1 :YL:P*8G/)_3A$/A<PL(KD]E^8_,&A8 &IP3,:W6\2CE1
MFP0F%X*<D/%[^B5SV4E71A1.&[_Q[!XW<'PPVD U@\P@UYNX+7SXV\S.$1T(
M6+9!=D)$VW,-2%#;P7L09+%NR\:S#O)J/JA*":>:8=*4.?J<+K <AC7BF1 ?
MQ3\A/U/V]MD'F-N\K3>W]^DEOO1<9Z-K=181(!11[_?M6DA%$19]?L@G)SLP
MPE!X'^!L@PG1B*@T,&4"'$EC=4[152'1KJ*3 L#%E.(Z;)H'[Y:D@Z\P78,U
M@X>=4S*%TU*F6JZ1BV SF0AZE%OS+1-PMSB?W5.IQYJ*'*/JWV48=D4(WG/
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MY85DN1P_W7E?CB"/F<4PYD^]WT=6844Z$QWC BG]Q7#O@\#):(,?98_-&6\
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M)4+<0)\#MH/FA4@VPC(V;F:G""0X19@P!]CY=63Q?0\R?.!E:*GUW?+05%:
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M2\0YP RI +*CQMY9]:LEAC1ZP9KXL1,RV/FP.H\>S["$/( 7#$?3B9G%(A:
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MXO1\N=?S=<-%P7[P@MBM0/0@I@][#F!#+("H-B(?"_V*6XV_KP@8%S_3PS>
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M<X A6D">8=BH^5[:5YD.[,2+B)':ARCP5C=:M!E)0_WIK8N,GX?PMT?N[YW
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M81] [H4K.>&&^.?%L?CJ?@1_1U[DV\EL<_(G-NX ISB9W7HU8VJJ(^EF'DB
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M46[S?6A%#1J7<4&ZX??&-AG:3']=S= .ZQSY]9;UAJWAM]].S[/?]7[WTK+
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MPVV\=8*<71X*OEVS@*08NQ<9DT(Q58 @)6DU%!?031]9[5\Q8UP]W-L0TS&
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M+#M80.QH>V/9W/2S0&&^ALCS/5[A>&-8N?RG&&#YL):[!4XCW1M\ZH@=Q=-
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MIJLDYMI7>&1EH>*$+PIZ7BN@#ZR9;<4Q2?[7E^-@GN4,PU#,/>B>"(YE#O,
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M484\[XMM85*PY6]*5$WU$R\GC5Z_G=O?),P2[G\6[9U_> +- ;E"9VS!\4K
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MH]BEC!/>J[WMKW0EZEW"%LO] JWJT*K)-VI+-G^FIPY9)*[RWGO?7"+X^'"
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M!4-(]<W*P[/S%X(DP!H?-<&;N3)(_(3L_>!(,*@?ASN]!$0KDP!SCPE.6SY
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MU2T+0$E:W8@5D-$J.!>C\>M5<+W#[/%S?I;G9$8M34[183)T6??&G!^B^VW
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M-63#J5(.&;AA0#L)T#B0W3"6 \0"K3TFOZN3/)CAP7 Z$J Y+Q==ACN\5[;
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M)D%8:&56*-,G$5_;FRMF)UOM7/&RK1^.!BGC^<@4UF$<KU)D8>)X?]Y6!7Y
M28M%;B+IXGMALU#B=6&66;X^&A(@H#T@9\:0+Z571^ZRA_D23:MI\++N#3A2
M,-WKKIQ7[LD6"?!RQ?UG-0I7'S2.9GTPY/AJ)<ZA7!O43#C"W"[?2@/2>)OL
M-Z@SN7Q>*:'DRMPJ0,M$?@DQD7:R<R8!KOYT0A_T %$&($YS/ZLYY3$FPC/S
M2_!>K\4+9"J8'F0RXL/7_+TQL8A>0TQ4S0SSW;U=QBS>-F1'JX^>K>CR>$5@
ME6C97@S3T]4@EV;N<!V'07GUY:LQQMU+W\[P+ P:Z(&F404U'Y>+D8!-]@%H
MO8(8LDVL-]/0+"W9\UM5'Z?P 5@F9A M:Y99PS F875[4#:,OO(5KQ/E4>AB
MZ 3!49;]T[O5S 0?D%FG?-W<F;_E^V82(!9TR#\/0=" CCEVA1,PXV3$'0PG
MN">3 (^A,C>)JV+*HS]!:S9:D\ T")-+H=M-J^M%1*4E[.1CAQNR%[X$Z<#Q
M_,9Y,O@VV%%EM#%N$E\&QAR>0#((XY%D1!!9B(_H=KJQT<\L)5Z8:J%W0Z:1
M(WGPKM[=?:I7<LW"A3E]6V*GL2]$N-S?Z U/M1=@G%!,3Q"M0HAQLQ[S ;HD
ME:#>HF\/OK,9#&?"?K=/8:0/,2R=7L1\8P0JG%9VWOKT(P;,6&N2S4U+_Z':
M;_@3D?%/IFOQ*7JV3_R/RIL!U*"Z^4<V\[N^M/MX7R6%1W^&B%XF8S]C/6@C
MB>)@RZB!K_H][89!(E<WQ0UY_.5-SLU/U4=$ZO.NN(0#L'#=OK:QVQT+5I(X
MT?M*W)2^Z/@=*_AMEVDS@K% &8><CZQ:+28D8--<MD).J?A87VR!N>$/]Z/_
MFQPO@STA/-?^KJ,W%9+[U4;1QZ[-0(#XBPU_WA\OV2H%?F^/7-%W>2Y#!DG:
MC[T44\ *B$2>N/"U"^W.A'JRTRR"78'9N#$,2A,;K!6[GNBF'#)Z2L(=\:X$
M*&QY?<A+;V*_)HBS:/#Z^Y]0%[$R/.T[4*&D8NKQX]<MT4^R\4F4^(I$YN:H
MXL3.-RO^T $HAK<)S[S9"^%LE:_P2^YU\_BVI)ZV?"6R'VLMLK-G&=\%P8AN
MAK8^1G]7NK[]MO%K1@/[+4F%G >-DE/O0#HBW& !]<WU*GMZ2LK.:@8*ORI5
M-#P2B9"R?"*WDKQ?;W=K:H(IPU?5V'61(I]&Z\M>;L.P7SP2_*%5\M8GPXG\
MV$_6= _C(!R+3VF.W(8@\C"4^<'<P6I\5UY<>CL0E5M6J7R5XYO0)U_ -5@)
M(.1/D _*+9P$L(>&S<(^3-GS:S6_9=JH8,&FHW#$R[XHQ,H!O R3$5BV-?B^
MS#WWOM_K8"<RHWSO&S('8VWUQ]'ZP?M^[/Z(7ISN48A(C5@]N@:7QA:@20 B
M[2CNN0.$2?1X1]O)PE"OJ[IH C="?<*_#.3&4)+Q7^@QC.Q2G&8KI^<NIZJ,
MN5\*WAF .>O.#)YZ$[XJL/N6^!5R:E5EA<]>L8"/7_2%;F@N$6EG<(9)?2X&
M5F[/^D%]I8WD'](:,OGU%ZTC!PIX,@*)!01GH*'$RU1N=N@81^*5^G'K.DM5
MF=B@"05J[@B8+60Y?:G.G_#_T/5=<4T]4;=11)J @#0I46D" H+2I 1$!$5$
M*49J_(-2I(M"@) @75H$!!2$J/0:Z9W0$>F]"B1(;PDE!%*X\?M^]^$^W)?S
M=-J>F;7V6G/F[/E*X^9DM\G6G;D$K!<3#I(]SL2O4G@#B<D80G(4)MWJXX/
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M^]!=%$4'B25C,V]3EQK__\X\*SV.%$#WG )(DI/;/EC$>QK3';[BG]*N):>
M1C<_3T3 29<)27JRO<'>IM]15T1SD-;TS"=ER5MM^O%%/T<;MDYU4:9P?*7,
M^-/$^!JG"04EF9ULHT_>R< ,6#(GA9<!>WRNPDH4@3D%3&;3S7#(=XIV0S.?
MS$1,TB2";M$;.S\Y<B69?B!R+\D+FS[KD/+95*F/K1Z2MM)_FH:%\\'L1IO%
MUS\43-V/4-&9_42(WDK9&?FO7BC9@3KD&O+DDWS.T,D=B_]LI?6>-]RVBL>I
M" R^CG_ >RNMP,?'/1Q<Q_7U9'0\2T=<*>+I>(.Y]5'";;L#V\'/"%<3E&WM
M1P3TWQ)01B_[QQI@-&T"[4IM\/%A'*F]X15,GHR=M4G1K;NIV E_]?44\.NW
MTQ9,<Z[\LV2 0?N9ZC'#@/.ES2X6Z5?>EBI@O5RN7.@/_V-;G2?.U?*#6[ !
M%PUDN97T[NO]&T77CX-D7@K9SSZ9O1?')=&&>OA<&SPS FNN^D&Z2_!>45_X
M,/J]_![P#UKQW32/TT23*B[CFY' 2K3Q@KR7[.^_M8G.7T25,*IF=G IQP !
M=?J!<VM7IA=7'C,5318R^@(T"6,8N0H1@?=/$/MQ*?NE*8K=?<9!_KFWC7)_
MZ'J)BSX__K_SZRCOK%. Q_UHF^X5?ZWUO8=E";6'Q;\D@GO_4O,]#ON-W_EY
MO#?%>0./'FBYKID: Z_8[H.ANO.)EB-<*<IW9]YQ(^4ABJ#F.Z:W9AJW]#?*
MZ+A\^CMXR#(A0O?;0+!CQ?2/R*.D/^<8ODF5:,\3-:IGA<ZB]H?>9B6?\;*Y
M>N[$S/1$*BCX<I9$?\6#Y=D_LC]!2J$C*&*1FEKF*[T=E^R/P_YY%EK7]Y,$
MSQ=*M*F):S^)%U*V8D3V*TE^ S+MA#[RU=],KPWS_\^\*O$=.Q]N0N'8A>L2
MN6[;=Z<VPX%X.^E1#L_O)T\.Q7*O&UG7_+CU6JZVIAX$!"T6H2[L'@!CXG#J
M5ZZI+=H_5R#G-NN'6?<SUW]T>@<?H/,QYM5UN#))DOQ\Y)+68&K5,^6>M:"F
MHCV>KG]E"73Q#9U^5GQU+DKB4LY*L3Z0 J^)5X^;14SK*.ZXU OCOWVB/]<(
MM7D<W;]045[Z2^W<VSR=PB' TNJ."Z172HQA\UX0] !=,)EV!)),>H.4:S.R
M]K4=J!/+L1IN-,:!6'\IV[*NZ=]&>(T_J"'FSA8X1'IHA#XLC-/?W7"Y7V+%
M>^F[)$IO$S6%IK'>6C)AA*8L&!*Z&OL]=A(*"\02O3<AQ0MLM&O."]R-BNZE
MZZ-,[!ZEW;X!T31?B3K4 TS$29]PMU(U>&H% \8L)@!%/!K]%M-+;EDTN.-_
MQO'=/U!#A^"*?V0(@VIRJT#9FM>6W.S$A*@9L1F[-;_(;:IS;S@OE=?G \;]
M,S40B98AUVEBAJ.S-OE[\KPA'(;*QP>\R+7)8DN'/HO8LD.T.O6'AUAJVWMP
M/E.)7U'@B[V8_P+2!_$KM9 9CGYY3>F?*GUG?39MIA:.I$4CP+G:7PC;?=\]
M\X '8W0D-F!3IPM9 KU'-\T/A?7S!P$V*V;]EOC!$_E2MHSV$8Q\[FPZR*W#
M]4& :&_>K5. 8]OT8HZL#>.G\SDC"1X'OV)JD7^7M-83N\00UV'3-)F#Q:0/
M./49=VXUCB_G$U=T;F2;35X:_%EH#ZE^>0KP4[XQW!IH3Q#L>'GAK#,2P^]=
M=_>BJ4$B=$#2_?5=YK7 B1O<-^J;*EW'7PJ68(2ME)O+),H'&X#=::LE.WV7
MF^K]U;5?K$XT%J*$@TSL54XJT[:""L@:WHMN0 M:U9_.=T*&]JM7)M-I T=/
MD(PL4K4L(1A98(G?AW?$ M:NST\'/VM,;DQ!_BV6C5K"+.1M.%=&-QF?&8L-
MM9!#;_^-JWY8"OZI+&3"AE*R_BY(PRH/__;A?_2+0]K.7'_>^&G\FC'=4,B@
M#0YS+.V_P'YY,"S%_8@W9QQ/L/1;C=:OO:_&>]>U5QH0M5#L<2?7OX U;[K'
MGWC!JXM^3JL2_Q2[/';3<F+RHI[H6FE8WMCEY[DU!O)'O2EK8:,/6R"WK@CV
MW[01_Z*C82$M88Y0\O>5*E@WT[TMX=>RL1C_XS-0C3:'J8S/(VNYE/CE0CZS
MZ6&ND)VJ8 :>],P50@J_??<_G(L*U9KB.@]:_/EL:#";D_3Y C5UQXF:1ODV
M^L(,4';EK,;D G["XGTWMFZCQ&0%<PF*T?[E,V[ 8I&S$E2WA"#)2B&K_IRU
M55'@-K1R?LA!O]E?)! ZVG$*X('IS%\EZ"]F]'@$?2A^7GDHR%WS^$M>3G99
M*59%!UW8OEQK(]MX#=EYJ_GZX/[OUVJ%I48U.A$:SH+1"AXR=3\3'["/<#5Q
M_C)Y/1*WN%?]4[#SZ:=?Y;2MKTY5 :XIWD]=G&%_YBQFQ^@:<3J5.$%8;;'^
M[(Z;L%*S9SCC0U/>6:6Q,2SIA*E&+?>^72["5KQ.9=]?!)H]3K[*=6RG(R70
M[Z]6',/XH6!;^)W3Y'+S%>_SEN'QHG%&^L  "EVHAA22-CM%M:N&=V#Z8C?J
M?DDTZ<,_480(RMWQFHRO<!IU?E\FU0=',&<Q3K+>_%TBZHZ03ZOBQ&77(VNB
MG;,#R3A7P",,U0"ZHJ7&B[=Y$)(57)C%^)W*BU7@<H3IWRTFF&%D1Q;$1B:9
M:P=?B]CB6M2N%1IKGM?9^\-,H(B///!-JN/J.XM 5,'2C69LJ+GNMW5Q49%$
M$3K='?_U@:0#JPTK(1_2JU'U?[1_8 QA%O[GTAC[?/>+$E@&V.'N\,ELU8Y'
MOQ3W:B#YZ%[*TVC+E^+UE?#!Q?;E <<?1),]S:[YF?E[')?&?LR?7Y2[,_2]
M!L UDB$@\)HB?9?*1;WYYW%)\G+5^_L/"=L6'K?)+N^$P"PCNE;BYP64+_P\
MCB_^RJMICY[NM.QQ_GS?-.GOJ@O*G]9N)SY\&PV($<RU^/BKMO?]IAVE67$X
M[2[2'P@\& (OHR*U%:'IK<\P#J,[JT]1BZ\K%RI1'9*??RM;MW"2+4ZZS' J
M##(M]\.P922/0*R*JOJ #.X_B\"=U8T;S9IX"DO=KM@B8O#IL[>82^L!E?9&
MZLGOUR/.8Z2K(#-@G-!-BW%/Q7BOPT/(EB !V*$MQX>9J3%[*&APTIYV8I/>
MH<GG'1\O^M6JCO#U =8#%+GW ;=Z>RL(.GG]&\]\.!V-A==.)I[)$L/G,*UI
M!DV6/Z0EKYT"G"?7UM5M#T!2OG%98T.)T*4-ET=1YWUF*O9BF/=*-1=R#)3[
MN'YE;7\KHUTXS/D=YE+2IM@I:U@4FUFEOQ*EM])_,V8JS6V_($K@U3SSW_BQ
M-]\4&@G?>M2S7:/&&3(/,UR]W3C8U_RVOJQDIVPP?U;N^WYFC5TXGYU]X[R/
M<0KVFLG-/:W"]+YP^(/RO"*.L:GEZF?'GGPF1/TG_(DOW\UQ:%>)M#5^V8LJ
M!&N\%.NKWVLZLWO7)NASU+P-^HAZO>*_%1\0#^T2-!"7&2D?CK-6O'/I15&W
MJ>PB:(:)QB+USC]_;@-^;OA'K.%6MPRG%?5:A.N[C.R(M8>&Y&^3ZH1;73.@
M]XTBB-*-78&]:_/<CP_7%V]I/KM<'BXRF(J3Y^VIV!+><+!/LGV6!HS3!E%#
M*?_A?TP8&W24M9P+\KJ)R(!Z?M@N/FB8+ ^'OW(3OGPB1=RD5I1J7R/-[[?3
M@)7.VU,9:);C *KKRI,:U;VF\5'N_L'^"8QY[Z;]QM#C)O1?Q&6"K682XY??
M$1 _YO6BYBQLF,/;QE';H0?5=Z[$Z\JS2 2.>DS#6F*Z# 71SQ1CP$Z= _*F
M8[#]*'N)2ZG= KR;D'+5K3\XDW@[U>KP Z+SUX+C)>WFPQEX)Z2<'=4M9R>[
M7A6NJ*^P>S$V'O.0^I1TABP/ Y$D<EM2?*OC-'7@A^8KS69:.%8!U[8$LF=D
MYF7<?HW1S8[[!Z-K;S$5->UL"N&9@-$#:$G'&X/77"V'_0'B9K>ZC$[&I>46
M#4-S?EET \RVYF\).CMQGUESW=L8?2>K?@0JQI,"H%:*.<:6^L]KA-<@@-%R
M0%? A)L?GPMT4&(O M1B\C!HO,/.OC'U#& ]:>(3=X!0C^S<\1*Q?4S.+0V[
M8P+(/-S_@XJNC#PG%@^:X=T$UM"^$5Q2_?B2/&R^\J)C;F,NNG+_^?T#IW.K
M6YE4P^=]R4NP\>=>W!9"STN*3;,WTB$JK,2/9C")8FE\^NTX_]7'H-U=5C39
M<'-&?S4R5H5;?@N%X]T7J8F%Z?WH;IXANL5[L=_9[:ZGU3%'$S=,03/*^]#X
MFWE6D>6?1) E+7@)*[4<2Q,'[J7'WOD/_W*\E,PA:[Z'6WV-ZV_,S+M=A:>4
M-3A3-;[L99_PFH[@[G=$7LM)Z>2>2^95JIX?0\I>-'/4YPIYO 8NGYHC,8HN
M #N M$ #RN:A7HN./I;M[,+^&NHW1@Y^=I;:@+OAM;M''!0<I+!BGE#$WHCA
M<U%GOZ*G+]XZ\894D)X"B:_K40.9JLJ'?5HI1Y2$H8XEIR\SF:,_8M.*7+S=
MROR];6Y$#EU^+Q4Y\*JVCB4I_(+KX7(9Z>[M1/./'N<_/DZ//K$0:1MX,JBP
M0ZYY_='$5<,S9-UZZK*#W''!IF&%F,J90M.YF6_7CZ*SB9(_C(*94D:V(<<;
MS@P/5N^I27ZUO;LSR)MQ 1\AR]Z2KN458+[@7!T5E&9==6$NV%BRE#&\_K[[
M-U.-<X+*9TU8*?$M9X:I+F5_NB2F>3[H:B;,I,J<I;N&K7YQ+1WE8W=ZNH:3
M<HHKK)W+YCXV_W>?24O)]5!T8V= :5AP4L.D-XU21,]73>LI_),?'TH^_]UG
M0IY+.R)Y^SC**#CL<_+EV:%8QC)4'3&+0$87:9&FX@\"':5_5Q<D2V>9IWW[
M>X^4C1Y]9IY?<%QJ.+/A$IER!KRJ&4T-\#:^_A84\SI0?Q?R3*WCVL=*/>'1
M>7!MI%M</V--?ML^\B%R:VOUVB,+"8'6SG=BTP.<:3@])W>^E5>"6NIYL]>=
MJ$>*3@F;CUR#, &OKXF:8VL\( ^M[W8I>5BH9\MGH%]G7IK$C5$4%3[U*%7P
MK+'#_^WQJ8AQ]=?TQ!*^;5X.?7#C/P<&K5;>8V/_R]7KR8H)G4'_"DQ5$90G
MX@@<;%=EE7H#?Z_.-[O>:7U2%)S\0,YDHO$F[H*O;>9HVTAJG=P.?%3WVL-S
M2]'F7YXGK%OV^'E<M?[@$:;'L*Q\N]R?4)Q0?<FGU@_= VGP13@UO)&L3]4<
M'V N!2UI_I[GKHWEN,>-6%,>-0ARNKKW7QW88>[R<K-\53W4='4@P_R8V\N$
MK-P9'X=_8V?P/5E9N M5")*'2^1[BMAYGP(4/"D;*6L3)E+"8QC>G!2%*'Y[
M1GGVI;\EIFDKRTR?4V+[MR$]AZ< ) A\C/JC)B&]^%UJ&JZ?$Z6?ZM":G_UE
ML$=P\3#W?LVMTF,&Z6XVP]P=@SVKX4] 7.<CCZ3 -+/'CY)T7L98QV4+?^'/
MFV@>)]U.>K 8\>J_FE_ D6;ID4SK($=Q:P>I7?#QY,P"8TF*YUEU56N!6622
M,K&1 U7]:6:,LMF1=QDJL+?AE:EI"+1!I*ZLIOTR@CXB<(.B'*LT_9NUW+>_
M&(+FBU,NC.A=KM9VXT.CB],ZU/U 6JV_26IK0?ID13?;"^XTTCIILL(_^!WO
M$JA\/L/=$[N]6R"K0@B7VK3#^'A?<CJ*OX2 3J[[/_)\'[,%U\K8_&(N+WNV
MKO]*,IM[ORD=$1<4&OW$JI0L2W+KKGI:6)/KT/HEG#<:4[E^+3.]3BR<N=)S
MIF+WV;6[P2'3*]G_W_I<_[_/9 _LN1.6,V4_4+_#I:QA$B0??QR+%/.S>1N>
M#;Z&!,'P5B;DP^--&JM#SD9]WM9N0+T.XF:WZIP-JL[J#&44T7H?Y'(*B,94
M=6_K^N$7[C8G0N-K)WXE#/QA)IX,$QQHS/T$'FS>UJ8_(;U36R13.=RB+_9Y
MO'D-(L<+P:QIE@/[IR5#>PM@]\J5=#1M!!L7S1V<T7,F)&FG;5T\)\Z3PN/Z
M;!3&>N._+R7V%H8[NNI[S]]^XXP]!2R&S;--T*ZMT\1(/MBU"XFMV..A;U)B
M-VMR8 _HE,! .D. $*]3"Z\0PO]4$K,7>KUR<E[<?+Q!WJ6Q-Y.*L)P10"'-
MIT4DE'EU--,HD/H6JTL=]>[W-Z (EY%-8<*D#(*G\1"%*[M3N2.E07/6:2%B
M2NLZPR$_C5F1;/\:*(IP*F$S&3_DDNOM8F,_IG%!LEPO)Z"L*"]. :$O&J^6
MNJ!8#V0W9_WY;@&6EZX$#4,J!>7:,C.<SZHX+VH8@=M U4X4+L@B9-L2=T1(
MC=I:#?S@D>(HS>?/CK(BMST?];!QQ##3XZR X,$*<: *2,?L*8"=)-MQ)[S8
M]ZB5*3'VOJI#%0">0&&AMZ$-3)2DCW<U)QDYN,M8O[[..]8=XG\R.:"M3G\=
M+X0CBA_ZVQV^:5PO^3A;=P<Q@_Z5].\C"&WL5O(7F%,Q+(OFKZ4-(JE!B#]<
MHDX!8=V6IP",B0ZP))%..U68\HU"YK>SI=I'.R"RC"5H<59A.M*I)]=FE5:+
M(%H<2_!3A"7(IA$^IP"6ZI]!C36X+Z< +A;:V(B*65?]+^)>9C#(NG*7I+)
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MU=F9YD3"X+81@=^8&GW(&<MG!R&&UW>9[RQ]LJ<_M9"B3XW19H89$\Z)BA/
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M""66UEB1G+"("&(@13E7HC89'I2QF4BV>G3Y.=@M&#^^:N_K!#\K]YPP.*M
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MXU$B*Q7=+$7QH'YZI_ A4X8KJ'D>;R Z\:M[<)OV"XUJOHQH?037VERH\BC
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MCS0Y$25)C,6DWR; 3;MSU:BGK]1KM8)<]WUHK)5#ZY/$^O-)P 1W)^VIK#5
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MF'71-94;L"4<4 R!I3:&/6S"4WY?1&%H!>X*6OO( 87<0XN[7V_-O9.H>/H
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M-EW>\\\D*H),Z%VT"&4&-B>U,[_T,M>5!4NP"6?"V4\XH.Z?V'N0D@%6/.H
M!S2HOK,RVN=QPR=\%^;%?=/>54ITK>7H!L4]K)QH1CSL6LM$.*RM H*\#BYR
MWZ4_YWDJZL&&"%UZIR8>E-_,2V7OS)U6\^<[=;^Q+4Z9@:R5LMA3;'6,:#V.
M?7H:3D5&#>0T;O+]G/UY;%?%S)=]HXJ[<]H7S4P40I/;]1:LG5(RSR6NRR5M
M6+B:RJ\QO',GWPOR7;O^^;R0^LK+N-WH\GL&'0F[X_9M/[U;%92Z!1O*IR'Z
M:HYY_/95-O /F5JQ)\<^F? 2;K@\GY&!3'+PEC'.,7G:1PW2X[7KP_K3KG_%
M3XK:+T!*/KXZ-VTH%/R#^HZ&I3QM((0UN9>.)2O=N.W04Z-(E<E-+9M2[C8R
M\!XK<I/XC5#[-7'ZQ:<;\SUO5JV"^7;664^&2&V4:3+9'-"H*--Z7!\</J8)
M2+%N<'^[2SI1>B.;CTZDW4-]@PJW4J9KL#]0PLT'!ANQ)G2E 9I"-;;E5ZNL
MD*1B7LX2ROBB2C;:A7F[([Z[)W?UQF#-Z_?Z\Z;\^5G3>+J2Y5VZMMJBXJ8H
MY4VB0'0D<?$]X+N%98D<X=Y!$*Z6^H3O0]8QW,J'G23^F1MV8!T7<8CK@G%3
MV#O^9A!Z0PTV[[W"W1J1/J<SX072TX<.ITJ4>*?2;Y=LZ%24AKD*F&8IJ2]Q
M;>:/)+4!(SHI]>R>4V,J#3OH:L@!O1RG!,.2@M)T.:#)8Q_\T;8:0.%$-?C7
M\G'8!-(3MSU!;/LD7R0J%\\!'?F!9>SL/E9-0VY>A^[&"EL"\IO2<:K7M2R>
MN6R$7EI0>M.X/TNQ'U\4K#18DW1$35%7RDYU04A/V+N'VW8JZ^O!\<JQ;I'9
M(Y8CXCVQT?.6O.?TE&H7H_P:%@T;%I1X*N22QK"4FT@.*)H_?S\-PA!$$MVA
M'ZIX 0%A.2C/PE(PC&95F 9A]NF93<Z2UT[ESW% \A1F\TU^70_T4[EK0%DO
MIDN,BI.SWOXL$<"]?G:$F.P'U&H:V)OM]IF=/D6>_'&.O#Y*=/1C)&[ 0K]N
M<4#6*#H'9+&16 N_A@ ;%N3H^\^J@HVWWP$"N_K-!FVEW6XGAFP=/#!3$T]Q
M56')MR!95)0Z0+[I?..; I8?*%N3#,+:P9>V-[;/IWRLW*DF\@].P.Y?J2B+
M[1H.+.;],]"'4< 929FV:/OPLF6WU\+?$]Y@QS*NX?;?Q79U;:IO@B/>D[/O
M0!AW.:"67JX\K.ZPTS+#WC/?@&EA715B=9]<-0O=ZS1N$+#YK#F;#[+V&YL>
M"%[6P]-O?.> ,G[:"3WCLPR'K7.;@_T$V4V02*\3*<NW9@'X<CGK,!I,O_7-
M#ML>Q0%I,VZU=MG_7D>R#D=,C@='0-8GB)TU;^Z"75GA7+<7_[)KY9$(!Y00
M) 2(;A\]K!=DX7KC=</S1'L4JRIRXSP=D81U*R8U(I4KV).LQ99[$Q+4>?MJ
MIIW0J'R%/).T/1!O^/&*7+#R^NE)P+ 8YM1"G#+E[09$8_L7\:M(![]K:.=J
M+Z) Y)IET(#+XRR_X(7WE"BL)._*?M7:5?-+P _*Q]?HVB#S^GUOV<I&K!/F
M?V: $[+]#KHL8G_55ZKT)+.YVF+".,0)]E=]^DM6&QHW 93-3O@Y9[^D__H+
M=#W B:SP[4XB%/MT'WC'#UMOP9ZBDVE<=1K_,=BJIK7WF93[$6S745;^,MV3
MW<ABQL+(9JJ[X3\N<&_+OF=.VJ;1\RC];U!=9_2OWG@$]R;U0!F#;,YI3_QK
MT*]!'6#C)[GW6K*YKS-Y:C^5[Q+7SY'OCS^HVBH[O\2C(#P:"A+&V7R5[WMK
MD-/AQ0&=?K>-G%!AB=3?YX!$5O0Y(/PZJCPP@?_T"0L.2/<_;[8=1T0]E<&V
M;Q/RQE6V)4K6()+I%0[<T>LTN-&-C-.Q.'RTM1-1?2-KZVZ0Y9[;1EY_!A;<
MQIRI4=%3%9\6;FWO=N#+R[.QLWT9XUA]2G*0=/X*>\$G4D%M^08B,Z]JAJ#V
M8&JR73;2(V-4*>WG68FX/<CRZM23M(CBFK)ANCP-32V/*QRK* U15=OU)#S;
M%RM:PU/>4"W[J>J;X+%F,*]L_IO;E:=<T^QSB&$M:OSCL@'-??TY\7>4[CKI
M-047<?UDP.M8IZOVL%XP$(HZ:'_G\-O75-1C#JA.+FLD_[O>2A<0:N\IG#_M
MG0#-;Y"&Q^8R8"ULKV'5-(O'5QQ&\2Q([)$%3!E]0Q:89#ZQW>^>XI6Z3AR&
MR]>;=!4$RH-'>>T#F$8Q= .O5;NWY"TMN3!K@ ,R^0V1N9'#O/P$P2K3!=2#
MZKD7UX.7C)N]57B07>G)6,"FWZ$DL\+@?5AM5B6>"LECWE"DNW73!(\TW(B6
M<3QIMN_1'F@[<(F+*=_U)335Y]F)I(R)ZSD/MV//SYTK>L6G=RK 4F1WW].'
MQ'N)\U<!X2Z? '!,,J!X_HG;">%8\UZ@,FJ(^@&\G +Z\IH#>I6>P_81G;X%
M* 0C;& K/1O0=G8Z=HK+U<]5-@L9%2I# \!5%)WKMFU6?U^2B6([\/_S.%]F
MYW&^X:\=8W-'&??-2%Z/Y]>29)WRB)XWLLA0V@4^S>P^1M*']^0,!AM(@W,S
M!9:E'4"IEN9\HLKO1TRD!'*7=A\/6#" GG-9B<YX_1ED%Y4)%>3ZH"80PUC^
MHIH+!U0\,-69SO?ZK:$Z@\2%T2C#1%.<RYC-3H'<MH[GT1=@==PT*N>Q]^.Z
MZX ^M88#6E0P7P;@E9C&3SVSC<EOGK9\D;L)\LJHKXFCUS$A_LX34K'&XFO9
MJD)YAR9S:81WV'M,?D^6M6[K,[&[ 0P!Y@\K:F'LN++2=-^CFR(17E4'?F?<
MLRKUWCOF2_FT-TXY;+ZG,;MM-8B!?X>5PHC\I)3; ZV7I]&;N-,(OZ9 <BUV
ML*V71/M*CUJQ!NE+Q'G9D9:?3Q:H--FK'KY=<WFTF91&D9%BV-),Z:3Q6(UZ
M_FS$8S%XI.6NB1_'HYN"[?MUW;..M[K.JC^TC)H.KW=W)0NP5"FD\5]1/9K#
MEA;]JAE)VVRJ%#*95)DXB2M-.]#P'/61+#Y6WL\Z?#;'=:ZM=G(_UR,.T)\?
M"2>EOKX.FY["==^:4LO33O3^@SLX;_A&*L;2?&-# ^8\)(-V[$7)W-U@%&"H
MF YX!UTU&\)P9N_!'$3S/.2 QCWG1^"$=1OV7W;R6Y4ZC^/A_AQ0)@$_*72<
M=P/'D]V>W(_!3CU-.2[!DS@<'3RA>P'=.R%]1<8\TO+;/D+HR^TW.1N7MS*M
M^MS[&3TF?L#Q)O_D1NS@:@-*V#?Q"[GM5JV\-")P2TMCEX <V :9H31X\EYO
MAEL()'E<3< UW?_O';6>=K4O?A:*%D)0:P_O24\<I%@CK(IO'/)MQ+2%+_U3
MS>4WHV=T+"K*7YB..,H3JC$)P%"B\SAY94I6NAKC_E-:]O[F'QR=[H[QI6M$
M6/L)GB$9W(QD:XT_<HS[^43+LA&10MX\<\2//7F6K\#P#/!D.].NA1J@WRLV
M_5RIN48T'Y)3&>?I=MLG1I;V/.K5B)*^=<G-;U/01X&6K]J/MPQ!S):-#&2?
M7'R6UV6&>H"MT[;.Z.QXSCI6H_=[P\.5OM=H!(3U&1C$4F[\,*F&CG;J)!T)
ME9RH*7_Q,'=V@RP/%6S\/!CP./269 X'M#\XRNGHU_H,$&_4%:F6*\(;.2_5
MV2?_ ##LP9>\?68W_KV#/JK&;IFJ*?9G/SCB;;KCU&N-YAZV+J9BFC:R7./Z
M0-H)IXY)R.QR[>PV%%+_L'NF5!]^2+C3C7L-+K/4:A0"?1E2RR^4ENV0R[NR
M -'T=<@E5JS;%3IU$WY"3_%Y'G8:&T_78R+5KE$'D+<@:]U8-3O'%PIF8J]P
MS3\0PY^-)NBS7V#L"\"G"O:!?E/OF]&(D$1EAU0V<??VN2(,?'LS#8Y7+Y#8
MS.6 -CYD_US^_KH9(K),ZT@Y#Y0MC4+8K]393YI\E0I$PF2->U>Q#EBQ)N#S
M;^SN0LT9D<SAQ(7 )#I*K7![7#"KL=_?X9'TL3<F[0'G/NEK$1Z4LW%H&]NM
M;U%P9A(&-DAH[#5\(.96J[AR"^MR<\79Y&5)$'E(C034.1Z/]__4.M+SG9GT
M<,7JR#F- WB;5>AQ],5^C+1=M,EO >FO$H5R$U=3^E%(&4!])#PW^Y*<(33F
M*WU6#-=/IBO8A%*F\!>O?8.T(/\\W^>5.%P#X?HD(]MSE-X*R-H2+#NX_O;%
M?1L$DN9SE%IR'KN]UBTYE++88IZCN2LQ1Z[L[-X_S%Y)[T1[BZ>5T+K"G!8\
MY6;G!9V:\T^EZ%FFGF3H)5$:B25RVN/7H_9=&(=:4:IZU7,%)V&-:=3//P%B
M);/9&_!-#BBTJGC\MDYV/BL>;5ASU[WG^LWT[Q_+XF8H$TIO=^;M5:@\D3\C
M=EL:H*M3J9^&Z8CN!V/XQHBV"FFVLDD#YE 5-;2EI-SP>*6'^J6-98>EXCVA
M:WQ;0H&0I5;GS_ )?QO:Q1'2+?5?SQK@AZ,MG64E&U(F3XZMS2.SU7TL^F#.
MB(/S%R_3ASLNV<4DVG6,[NM_<S%\"??*"^5&GQJ&"%Z.J/!4F%TG'')3LII_
MV9I6Q.7^)'^-,Z$7^I=8Y4*DH=(%]3.)NEUCB!>^T3"YI@MO5F#HE%GV9_9E
MBJXI7ZB[F,&430XJ&VU"Z>EL@XDV_R)UI>([:R8HHXCP)8JFV"(K?[5"6CGK
MV<YLXPV-2RN%'I$?9Z([<G1"S!_$A66(QTAQA4GP] 9\1JQ$TA!AUTM3R986
M[WDFG;C@HC/S/[&G+? 0_ 07UQ%7[7PR]_YZ/O^?<)6[LEMCOQ7?$>=I]6VN
M8-KC?[0*+F:IPK@VOZG.X( >"]][ J?@IU&XG:3;V,\)(S\.J.L7X%3S+A0V
M]0C7KLL5L@E0PN9OB$BS\&G(+*$4>T]:[^SJC8@[PTV**[!8GF64^!6IG<E#
MW^X)QC/Y):R:CWS&]G%/F>GL\44NO6O&'F1L_7&U,+Q[]/2O4C#=<.6O3SLZ
MHA/\&E9/A &G;C=\1OLFFUH*2@*B,L$+;%[J T5 V*T^?8+PK"I(YA?0?79.
M'\9.\D_QL%9QP9#(7FI9*O<DX<M9<\0# *E&FHI\Z>[IZ!%#F7J5,5.!C>6&
MT\+0,16!OW=L[51/J27HQ0:K4KAH;8'=,_\K1?,@>-8.M8P]&5Z;'*W:JHJ;
M<M/6##\5CUP(E*@JX3M]87;?8CL#@M>@G"E==1.<]0QD0 #^,IF0B?[T"FP[
M91$%M0_U,+0^W#U1$[JC,CL>T*MSOJ1#R3TU.,T$ZP?5X#8Z%%\\48F:9"-&
MHG<W?:Z U<.2K&OU#,[_O77WEEGS+P2A:?8+;E5)YT<$!^0SH$RU3D%?8-[&
M_2V_LGS'6M+"+J<)MRV&![Z7KWUQ99TF@P%*-2*RZD8'%^+_7&,S?1E]J9**
M%K<4<<:XQBRH? 4'5+AL,6>\-_>[Z+8!'.CC?C%7=56J7 T$$CHO5%PN:NY\
M@5=2C#?M$9=RAZWT3>_M3=VP;UD7-XNN^"21:GW^]%3=,D+@HM,; U11*\DU
MAY)"B*"2Y4X"?Y[\V?R2///0>RA,V8%$7)-V;55FSCV!1555DJ7THE#U7'HK
M;H"QY/U/>U4]90P4PT8),NPWAFB]$#;5OF7AZ5WDO#62^0)VI L[Y7CS$8_6
ML8SOI NGGO$T:2%U,Y+FY/2IW?\O,W_OWU9.TB1HL+-9\L&3B#"-0--(!_FZ
M$[LVI]U^#5MZ%QVXM'CU6WRIX^6PW3['2GFWY;AC%8MIQI:)UZ_&29%CT*J?
MW&HLA]_]E*Z3J)58M/>FV (">DP4IF-+F%2XD'%4U;;\Y_YBD"9AT792? E/
MP4_J%950[1/Y1_?=_]:&4*= EMNY9'V&Z^UE=ZTCW0)ZS/FWS]0N<D"[,L%O
M.*#[>+I6Q/#0T,,,G>[S=,N 1Q]G,W9F 3:#.1'HITBU>)S?FS58]$;^M>Q;
M[($T;WP_,04QPJ2IT%V8.@OF>-!?N[PH]/Z$:G:L/ZR6,)P\D5./E[#%UJM^
MN6%SLL8@*(<W1!_R!QQ>93&^>KA>94/OAO3;-#3A\ .IGHB#C?AZHC8'-!:*
M+44TXF+QO*6V')",IO.;<[>W0XDO Z/8$K7->T#P8_D7GSYS_>)RX>GNJ5>F
MU@E[Y-4AJ0N7<V6D0-O1@, /*G1]?&NI8"*@=*WUW-<VH_#X.L*T&H*.FN2
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M/(';//!K"S]URJ!<SCEE])GL_M"4I&:]4P8WLT3"SCU&N'I)2EP /9 +(VK
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MK"LZ</=38'_5"S='@P;]3!!, +2ACL(_=L<50+/"(,KTR+Q_+;=V(XOKKPU
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M9U-DRZK<Y+@G.5[;29/-Y6W9P YMT=X/G XKR+%!?/,9O5:*<>U#E2@N6RO
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MZPAE#TSG$D38468<T/6NM;SWS#+965;@SW]\BH5MR"/2M#-+E)[#4OB*9SS
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MAW^RY7P2A-8_J!WK \HFC+DB4_<.@A[;?JX<KCS>,)E=GHTZ;U>QW\BSXRY
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M%JZ3]!-8RC,NC3?EN:N%49:7>GV7ZB@@T_"?T0^]7L60;;)O/:]?Y%3%JK;
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MM@B'VPU[\1W8@;"5'$+AQ*@ZJ@K;'CY#;NB6O?8(_K;ZP;Q5Q6JNHPGG^UZ
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M,ISTJ9#*MU;JM0[43&[0%*3V[HGQVZPIF56"EJF0R.OF>MYN(MRV![W1%7J
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MC_NA=S%:)K<V !!JH7GAG0>-SH':G#W$1<S)E_WLHQW5'R,F+A7O2:ZXJ6V
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M=_34K[87M$P%43^1QY^P_>0"/$J4_2[]7&#U3D=_HC;@""N_]V$@*\IJS<)
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M&#@I<X\1I6,Y_P>:X",<XVW\*X+QU!W1&A6'=2]27_R#OJ'W1,%*%#0"6 Q
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M'CTB#M&?.HB<QQ]0WA';MMHBLP91<RR_$B U@KQ%*,HH\\?VZ^OD3M3T0T5
M"Y\.RPG.GN(9'O!(/X9H##'/* 8+1B.0QN[L;^T84&XF=NY%5.&3.%J;[R-:
M+UG&MH*_ZFO^^&T$OFC]&.-?(ST/E44R<$EA?NHO+ZL"Y03_4+:+G,!;GH+.
M]C_^GXJ8DP&1 + :A2_@ME4L ?;%F;856#X8WMY%\6CQ1&ZN,X+B)8WYIK77
M8WRIJ4LH>E/J9.7#?\*]2I5Y@\/878CZ(V"*[^+ONIDDU&017[\L$HN04=U'
M:8/\?"LN'^:*<=; ;@=.$G(YI!K:G*R+4+ JC6F]'\&BRZ)X ? )7AU2-@3^
M5>P_J6)X 3B*8NP%"HQBU&FCA(ID(C87^/O+;@_/V]"4Z B51=#,_5EG<8JF
M^MJ _XNW=X^+*?_CQ\>V1"ZS2>XZ""&T+LFE.FR2W ;)K- L(15"4J@YB**+
M$9O6=7))DAI)BBY'I2:Y3$H-45/-I,MTF9F:YLS,.:??^TS8V/U\OI_?]_=X
M_/YH-:=M.G/.^_VZ/,_S]7Q.$=3,CNOA.+(=U.7C-G6+9+(4(Q">\OYI5&*N
M S8..U,HAC".;#-M%GP0D4M\-3R%I8C[U/P8 1:+Q($%=KWI%K7V)LK,19[:
M%>,,G42FM#AP\HTC]%CCY,(?2D>7]S\ &"&<N&HOI?A[!$/#[H,ZUUBHAW'Y
MUT%@>[$A"R[L;'M_E%SZ$=4TP^=X&;>[:$Z@KH8*F;GP Q4>D88HWX.\X.=(
MWK'0?(;/)6T6$DJ3N-Y@NP=#\*OPP/:..W&:,DUIB A>[HDDLA(/*VSOYV,O
MP%^=@-KA">U^M1!^]G(($0!)S#O"*&CC_#^@#60\)F&[U3IH4^ERN+#B/Q$G
M4'W4W5MM7H&\ZZ)9\JJ@#R'DLH*O#K!ZX=GSN+'^_4DI"R3.Q8S,R9 4-3!J
M,]#7M.6BL'8R&=I4]%2 GTB"I9&\")**EV+,JH/WT)*K[KT9$9JR1N'@TD7R
M9=Z-+"N=0N8@4)H>=>]WM 16A;0;2Z$!L&1P%ZU5>*&J@T/4X/E'^'ET]<^H
M-E4Q/%"0S3^X8&@3.W64+^P2^92;N+2249XQ[/E^![%Z\$>FH7PVL1'$F#U?
M"!8;-UC0<1^!!?P.+<_*Z%STU6KU,!E+IK:('NKCI\9J##Y28@_QHU?H1BE6
MORP.G"+_'X@5(^1:TC%*5:H9V2S]3Z(/?73&V3.>\@E?\LX3$35-X2%2OF?:
M:S<B+WS+82E/:?E&1ZJ0K@;),1?=?XL$G0<9(NL#D\L-N$J0[1L=&NEY%FK#
M\1I.G4NDTCMV!TXEI,$6=ZEQB@T:9OYZ[)*6H*O\-6-#>.(-]Y]V#XXY_WZ$
MM/1\>9LRJX[:]KJ1.XRLA!10D)0P_]R(E,5I:[,CB:>P!-87:IBO2[IH"0Q5
M?N ;/2('$@2LH#@=WG*+8@*DI1/+D,)[(F436+KI3,(YP.9[)&,?3W,/CU[8
M14,N$<G/N(J5-43O[_4>;GS3>_ABVS$2N0<M5PDJZMLV$XQVGAY#:?>CP^HG
M?'H37)74RLAFI^8&_/U]!/UD<P*^KUL)<\C[;F',37EN4_]6Q(1_A"N@;E[%
MYM\C2/>=^F+U*-8@5.+!T0DN]:11Z.?QU"/=_I5&@>MH%+'$H3F@ ]4\UD$6
M/:=KYK7J[:3 ]M;+. C))[+ K[ZD$X&($XN7@MSS5JUB+T9R7$'4V1%"9J/Q
MO+N@.!YU2X$. X<BXXE#MF;1I/5'*<N=S&')ZR "U,/+L5P6UNZ=&,C5]D;X
M?R+*-L*\8X"4>'&$^RH;0@K+V5Q)X(AX<+K&1D3INJ_C$\(7TSD5(3DJH=1U
MAW8S4G@&W,'-(0K+Q@>!2HWP$EL(*<93 ,8X/&(]' 8YJZ^^%ZBFHC5(I%IU
M#Q0;K#A,2$U-P&IS%X1 0M4?UX-M<Q5ER'DWD>K+B&+#(]#T4',33WAX:%WW
MW 2S1#<W(?HZ-^&DLK<'2<GD!=D0SZ@TQC(P02L68%Z\5D4O?\(*ZW;H!8N4
MN=ZV1B,TE[N1]I=@Z15D:BZ:>[ &K3*46X$XOHV:5@W"F]Y0U:.EQMG;$"G,
MWP^J+WUUV34C\C>O#EZ1)Y*%.JD,X%:OMR9IMY#"69!JZKM*V""AQ_<=W%S.
MK(4T<'^F4*8UCK9_WB+6W(XF;29HG.&3MPJMJ>'". WBPD>4Q5VT3'.WKR:I
MX-IMH6MS,Y]R1RT$J2I7*XB'=W#5X*Y5NVF$CZQ<Y,@'=Q(D(6PX""@#RU''
MEXB$M1*_0 %P5PF'M_;&#=,YHR??#/WC'[FDAU_J>IM_12O88 7F((@;(PP:
MGFF_(["F_WCIF'-.IU?X/!A4IC8'Y<3/T42<=^*IW(:6"\*Y'-*2N.C/J6'D
M"4843I+#)^^W/@YG$[/SM_.:Q;+A]/%0\((U>B6FI&4,Q%\"RQPM*H*7CO70
M!TU5'.C-1B+X J?.6R ;[1A3A6Y'Y+SFK?!.P?&9\:8U%Z- !EC)P8JY*>[/
M4MKAO.D6) ')8^CBFS V(:YEL2FT<)D;']=88>^>0OA@3N=?#X35H:O&I0U5
M,SZ,PKVTOUSIW(T9JZ)K+D9WT=@<K!2IN4+^]+J=$^RR+EV;6#>:4W[,=CC8
M.@,"].2J'-;QBDEGQ),/K1CPQSQ%41>MKY)7,FGE0=QK6-[U03+1J43A:EEG
MQ,![9I6_)-$2CW'"!R-3:0GQC1LTSR<5M%C])O)G2@2X\2VRKX>;=ND8NP)T
M4(!5WW=6<]K,8^:;<CT)'V=#WJ04Y8H51]_MFG1ZP8.\^-;)>IA6CC8+M#XD
M?T%BK<?@S%\KWFBM,S8N^&E_<3DOCX%-BVZ)DYV8W'&-D3\L,G.>H'4B5([>
M8YQ!'T+/.*$+ LJ?"O):IM_^<^OM\^,=;;.\Q!3AKB]=!M<.9MQM.+(S>F>)
M^T^3&5 LC6WK[T,.FDG$S7E?9A'@?; O].D"[EF> 7KIT>R2BI,.S2963]OW
M*ZX]1"("P\0<;&[:LO.DW=;XI4/04: ,:_9$0=U>73%]WI8$5Z\I:7 ^6)-N
MBZ!K+".T.AU^S'_NCZ0<% US7;9]H?\))Z$\:5.N[7 B"_;Z6./E>WC:V\IL
M^B4/,R2>5X4<0V3>K!SO7GSON]+.IWND,_HY;K-!#;06-?1F1ZTM_FORBBVS
M:X+//5Q*&SS!;#X406,O!0MS$E)]_(@HV/(C%(J.P.</*#7^K=64)O$1V:9J
M]U?3!WF0@V2)G%,'_\J\NWNLX=3KSPXE]E]EOK2XI>#:[8T.>T9V+"N@W:E<
M4EITW7%*4+M;%NWW\WO:^S);K]^,<QHRV79?=O/^S='YO##V8&Q^S0C<J=9F
M=97QL8 J'[?'2"R;27[@R@[H![%-I'[L7V3E87L6;K)]:SV8:$6J8NA"?F;J
MCMS*YX&+]J]=UAS_.?CG(Z%D@#78E?J6HO?2WU8D]I+8C9OG,8]/*%E'V+F0
M#(3$4Z)'$65QP:F"!XWMR_L$?%B]%#%:!-T>FO2[.WR-$7EU@T.PLL4B_XA-
M=LHM$7^:$S]KI?L)\W6_+AXQAZ;Y[9EO[!W8A7:HY=-T^ZEIZZH#5\UMJF\^
M]'"+8>3(H?"QUVQO=A7H23=S#<B7V9-,1N^9U._V69]1 =C\$5TTSV.P0_;6
M%U'[E?&#[?MS9QY6\?)7L+ %>KF*)6[>!HNO=M$$#/)-%%+= />_,3G M!>?
M +5E<X->YXU%$VKMH8AI!SZS3..-L;?5$#8_+"][KCPU.K@T=TU^YYFYK8.1
M3E]-LG8&OBT5:Y==?ED[\7[_D94'#7S>0])%)J$3AO-CYXT.#]TZJM?8G1?-
M9CSY&$KS98/PDI.+*/96=-$(D-,Z78@)/_)4%D$"!CZ8)N[\9DJ;@[JG#90Y
MY1U#BG6$%/%_GY YMM#^CSX#9ZFN3-&YU#Z*_BJZ<?D3PTT11QI0[=T$%N4(
M\&PH5R[AMAEHNVC_=OAORUJ04>_'2TF'#ZP'//PH@VP 75/V/8>_]+66[0[-
M(-N;E%(2E+'_\%A9#1TJ\CABO&V$#^/QUOKC;:MT:ALL3 VYU-ODQS]CEX&^
M8JC"[GHL&L4^ZG5K019("7<H=(>I0W=:*#8\KA3"DIF4HRV]@Q=;Z/PN4LTX
MG=WBLJ';907\I[]@N;Z6K[.NW5ICV$4;/(^NM<1N4 *BH(NL!\U!M@[\,?D%
MY-TA<*N0O]^GOJ!@)<'+L0HX2PENK  EJD 580F:E/FDG'<ND/[Q(K^'Z(95
MZ._TP0^[:(]%;[(_]""G7,AG*>98:5MPJ1B+=ZVZJR5[DQ/X#0[D)#="[IIW
MX]>AR^'WQN**8?A)OE94GA5D![(E6&;[F((U&\XH,=[I1WRS.><1>HW]8$H;
MU+&JKSBD8 'KB>OBOUDI==HH"=23E%)"D5*"G1VTEAVJYK_Z%G=/QFR[</,+
M346DHZD<ZDE)J6CL04F9HZ.D]!0?O_;^B^E)W_IJV_LVZ-^>)S!^+F(3#JXQ
M<T,_T3#Z^N_!G2?R5)5:F<3I/"SF7V0IJYZ@(.$42@,IF0T&97B28:%I8Z5L
M&Z6YN>4M/B4$W(XH< 64\)),L%['%R'7RV9WL!+M:D3JH:!,M+GGWH"Z8&FW
M+\-(0PA:.:?%CESTE8)RYX?7-_:N>(]+B;B"@$.(-(79^X]#3?N,*JC!&%&W
M#.CNLF?OPYM^Y6AVHZ^8%=7H)T-<^1Q1V"2 \VI)PXTB\P(LDDW) *9:6%)_
M?39K#I(S[QG4_[Y_%RUZ(NG;@2*Y*/2Z,L4@1&5%P;$+@T$%BT>.K=YVDSW5
M)73UG<RZ^S<%-[FY 0E:%WGMBJLZ."9RT+9P+24 "G;EK,V@HSX,>J]X#E&!
MOURPX?4D]MM(I/"Z24@,/JV+M@%M0UQ:XK9FF-Q)YY[B-@F)-ND6L%P# CW6
MOC^#VTUT.E<?,Z3A=WU1Q9GL>KS/E6&?$FN2KV:;7L= SC=9SO#E3=]_6E09
MT4,%]""WZ0HA[I;8,#Q:""[5/\";__OAF/'98S?V0&V4Q[!+\VS:(M@5GE /
MF&<]73VEG?*.3:RAJSK9\\6@^0EWJR<=7@\5JXX'VH.]K!W97IWP!US_J8O6
M8"D; ,EE*$/&0U$W6&T$PJ14=[SS2;TV _Y)5FD62CG(QA<]6_ZLBW;D+[!E
M&D&];:5]5Z2^C/33U'@697L0F:BX2'*$3Y@W>DU5QW6"1H^S@J.I_Z*SP>_6
MV7C+'97<W[,7[RE<S2E"4O_JHNF8)P8ONV=B#B$ZS'SR#X".1PV(4^%\>COL
M$J(_YQ?[(8D?&UGA?!_MY2.3YFRW;::<3E:.RK63\^QY\XG;L&0=9+?YKS*2
M#YNBYGO$C4>X4)&X):U_%VW5)G69P  IW!7HT'X/=)V%OXG)#*OVA*HA(#05
M:SCUK.@\\1=)T.DV],X T.\/M DN?]&R] N<$QN==<3<[<4%CXBH$='S[K:N
MWBTQ*=O:12LCC5T1K.-"@X>@IL^3D<F2[%FP?*$OV%1>DWY=FD !.+V]_/FD
M70D;?O/P OG;1:ZRF!GEA$4J;78AE/*&1:=?_;-JCC.9*JI^&'XH2?\')0Y-
MMA%18A)2^WL]60FO== #!?7N SW&F-='435WXC'LZ#_A&U?XGRC/:K Q(@_C
MA\4,/,JK%.?L)4)0R9Z,+],PV?;CJR;96"?CIP+&:>E(X4>_+_,SX2)Y/40<
M8-5M?L+3-MG8#CA4N+4=+\HY[A-J/R^2D=5?)2BAIF3VI?HTE3Z)D)\>*IN0
M74W)N%1A(?P(7\/&?10M!0X';1M<3!W_B(' 9/HX%O1!9FH#U<.)VA?0)?](
MW,"$IYB+N@?WER.K]47J1+:<_4H/[MUQ$6JG)F5&4?I"#QI%=G@^6T&^1!7V
M<[B:.H**I","]L/+96,V]6<)\;,$X]64V6=\?O.%7$816S7,G .WFQ%[WQU;
M=HF7IPMPA:4<Y9^':WXU(YJTT.9O+!648JD@?2@7U[4X/5U##@!KWYU^,/;Y
M'X@_LESI'<R:=/Y#!\_\/VEYCNDE^7S+9I4CI9&Q):QVWH[6#S=7^)PMRP]8
MON[MU2-"+V]0Q,ZNA34II-*-Y;82YK\Z_+HVTBBTL^T]* DHEQ/_:VV?/#L%
M'_3^]CPI%IR!<--7F@.K%UE.V&P0D5T=;]K&NOW21_ZR*N_NS5"[[V)&+:D3
MQ0"K,.)05#Z.@ 30[<CZ]CN)#$'%2W)%4C*XPTA\DE_-5L'91]5P_8.DL$YP
M['SC?42X&'_MPS5 )8&EJ#2==-;Z#B7C=+C.H&Y<I[V+MA=>ECT"M.?4=,PZ
MV\2-R !$8L?YII'APVZ'V;?(-FC)+Y0LQCG!%8[Z,Q+E3$$\S7"WK.=-H=6=
M );69\H>]B\V# 7ORLZ:M0P5OYT7"^^%U?0\)5PH?.T''49$$.5+WG(RG%%?
M-9$E/^=,*4LK162_D5;8QF<MNV>#%7QJ?YTP#Q2HRSAJX[HOA)1GW'U$;S;C
M>L).(X=.7J_'F-O AJF^^!3]RCGQNID981C]F+9?P"XUVIDQSXL3S].+2+,O
M33TJ:CE:+F[R>E;317/&F)\_M.'AV0[2@"E@G^4W^;'ZGS7@;$CJ7#+Q15+_
M&J2*I9/T;%-%[+"K6>C911N]O=N']<X76]:J2<XKN6.00I"#TBE7K@PD&[EV
M1/4#WI.^WTP'[B"#^K0-X8-":_H%M?!C]E#QHF[:R;^;L9+.2NLILE?8F[E5
MD7=&&X6Z_,&ZS&7]+CCY@S?$ZH7'/IP==P!YZJ7H3QK(_+"+8Q=NH>"=:*@)
M(DI9YQ 9TZ);%2.%4L6@Q$ JH2@L)TZ_#"EOP&YD'YV4'WB-@G)NVY%_(<NQ
M_&[M3K]F<$HFR5S--B2*??Q:%^T)+OC,HJ,2+]BNH7+5LC]'OQL@WO/[NR?G
M!I0Q?_Y)1T=9<FY>^Y"CPLMLH9F)7B;<48B8NE[0'VQ1GBGHS/#&8GB#D+J_
MR*7WH'S./?S-[AUDG!-NH8!AY1*X8E9:6C? ,]&LMN ZTH@S!2,Y5N?=2[)/
M@P+5X[$HM%./Y**)@3M!$!X??P0*W^?E%08R6)@2WMM\5KJ='Q/?.9AV]^"G
MP//6R$%D:C(K#*V%JF:6]/48_IMY%)8L"+X--5LIDA+)QB2G6A0/X^BPG@V6
MY-"#6SOBAP:LJK6UMM_?LH\BH@P?L\J3#D)K(=\'!+0^MXLI9DJJ>A5#E=;$
M%GT9CSFV],H@Y,F&V^KH??<T##P(-,#[G$%]LX&=JG-@783<&W+AE^D3!+&3
M*9"GFY42CT\TL1.+U /A4DWYPF[:R2:3;YXCJ*:!\AAYAWT0A9##J@(=?Y#!
M""._%^Q<O0E<#HV[Y!)8R_4ZQ<[%N_UK[(<XT;YGP4ZII(3K?:@!J[,[>]D/
M6??#SW5?O2Y,VYW!"M>LG[EI4X&?N9%3_,:ER\F#Q6L*UYB)76BU8>%!:Y.C
M;G_D7(PNN@(CX:6YXK/D(]KA/\*-UHSRVL'^_5WR[="Z:P^GW'>60.-B>I^U
M7/IIP;HSCKM'LO4K\\>M=UU>W&MRT;9;*W987XYNLQB2NUS^FF9/< =P9TZ*
M?;XO+EIH\B@I/*^N]A2G+D\1N.NGV=Z[NFA6YTYJ8V(W^=,A]\4=BQF*)]6E
MS_1B8OJH/8?M&C[D?=G6><K8];X'GDN<MJB6S8OI^[FT]KS=OGXO[FDB*E-/
MG4S+?_!@TF:-\^<W^P:9AV-=M 3.0'R,?!"O_TG_@\)]'U1#>F$@PN@;(SDK
ME1S0%GH&F,@./=)[O3=_S8I'D@&'-,(:40X: ADB7A9G(K;N3=E<N?G-\7?+
M^>>]/B#5*:QAEMS3HE3[UY5O8DH*;CJ/Y7:>"CS:1>OS@7QS?:2<7]!/&>&W
MW#%WR<.EFY(-5M$..Q3PL+%\/N\4^*.QV*7#U=K3XK/Y,ZQS63<V:YC/D4&V
MXP,<B,O9$W,0]\-SK'YY/7S'[ >T/KP6J#,48]3PAI)OHJM&9)2N6P;*J_.6
M3@W#C/$_D9Q-I,$'W(R(]0U;->/MUK1@1M20?;8^BZ"W,/Y+1F<#4N%4,\=E
M+GJOGUGI;N.^] O7X0+4KG1@B%.!N1J4RT$>Z*Z/6N\15?Z>%?):IP/)Z8*J
M&B_-AI*=VJ67O"U4,;\AOTS^*6?L@,MAR+PAZN%N(^XN'A4RIU>(W.%YLC\K
MQ^]R..]1X.6U7*P?3V)%]F?*9T@+N(]L>=Y#;XPS]!HT9%I("1K/PR:'G*7,
M#]D"U67!9>;,HEF@S<2/DL)L4*2="M.ND2*>YQZY;=[=VAAN0$O4+B3YW)'9
MMG\E68^(?>TS.N+8$LX+O/<1<.WPP4@G[^%37^]^KVC6; 6H?-^)L/'ZIY&=
M%J?07C?D^L]'V5BV;KO6SVC+U#2Y291&#]0O%2F=@^0%V0=OW&QHRC_V29A0
M=0R^*CH!R59R*U*68/Q;KI7^&YQ/37K)G=E%RT7C&=@D^HG4+EH(_'##F1K4
M<)';T["V6T9$OC*)^XS;!]G!&39A@2AXSIZI?A4C!F859<_NX*U]V_':;/'Q
M@P/'%]L-0'R'Q<0,G->>MK]M^6U#1>G&\K%#2H^OF5UR;.B_J7G4XZ,GCN)^
M*&7M"]%;(1$3EVGD84K%%%;X;1"!^]TQF_7>HKD-M/7,/+1S(.NS%Z:AIF]^
M0;P2MM%WH7__W*G[Y[OT'M[.I+3N$6DDN?[)F-FK,DV;9X%$/TV@N)-F]!Z_
M]YTU;.\X_+"9-C>;ZF-_.!RG+?OO))4]3.( U3S/(7,S-S&XK9Q&U@I/5!K]
MC:52.A;4JJN^N,6Z=-'XA5_L3E"Y@K([.5V->*)J,V^RG5F?]*2+-BZL#43#
M6/8I=AFB6"TB/I/.:FD24KBMV^QDU;G 6PJN(4@!RS1&9+]+E%ZYX]^RH>,H
M"0_DBVRH.QYM8T: CWW#@'@@"\&/W:#&:ZQ"NVA5M>RRZFC\S%1JO.9VEG[)
M54K@@QFC<>*VC53K%Q-9NWW@GAJA_@GD4A#D ]%K@6E_@QMFH:ADE[?JHUK(
MES,9.IX*,MBMPT+=CZ-"$X_V <6QB0=9S8.*4<DDN(I,;1X)4=?TA$[=(]B\
M=L?E"224&SKABUSHC?])+M1D=1C9$FBC-4,*?_I(5*B#O[Z&L'.;D S"/",$
M%GW@Y[,44VV2+D(9CBOHE;SB#.X%?C4$<L O__0R0=3C1J:IR:'_ EWT)UI-
M[BIFB]3&&\!KG -.ZU^ BLVB<,HXMP)S?T*FEK %B\ ^\J/\3*249>O]0'K-
M2BO\3QZ.4):M/1&+D#Q4,6TI(EBN&ZB9P1JEA-G_ WZA&ZE9LU]\$VE,H1@H
M-1GK@J#V,N2OI/9.<),C)>#B[4PR<N1WAH.*YCJE0;:/U=J7/%IK"3Y%5"!2
M2(#]?>+ ,=MA[X]WT6Q7X-+&O2 4!0B[:#\WBFM\@T5J.:N>Y3C)$3>7XV)R
MJ3&]U74(I65+C=:,]PQ=?2?V[NTFKS>LP;:A2#\%KX62 IDH$&J$D18:T!Q7
M\K80B6 !;7\"MJJ+8F(7S0G2IJJO@U[,U)'[:#M+819RHP'N#Y?QM*+R#$<2
MTPB'R5((L$.R"*]'W#9.XJJ!I[G/)WS1"76ZH^6>FFN1L8GO-C_ P48^F[0V
M(D12URUFFCN4+,W=@)6?<VB4?ZO%!<()R?0*T;F9!"S[7V&,>?^SF<D;ED8B
M*D('H]5W(8739[!!VEF/GQ[KHME%DT^L%+SG/&PJ#9:EW!&3K->!?GV1PASN
M6?]2$)X$ IQS^0\0F$YID%.!A!;<F\(KX,*Y@E6WF'>LYT\XV*T]'.)76#,P
M\,YALE7PC#*F/*P#,QCD$[3JCA/XG<VB-B?SSQZXF71'PO?(10\D U3?*[MH
ML;Y_H*+Q_FJ00D*G:N!"K)R%J2 7;0K9EPI[XY9^L3$QBKY""7_P?C@<<AJ6
ML"SLVAG]$4DRV ,?^=(MYH<TZ]:E><>R9T-GH$\I'\ZX^FB7(86W;8.S1F;6
M=X)*,W)EX, #8N13TQ@U$P^?<H1K\A*\9W^.IEGTAN?O1-K9-<'7UD:3OPV#
ME&64J>L7L@K^%!JAW6!6[1KR$!2["GH(4;3Q:.G!+II:/X^L6^#J$]HQE!\Y
MG0]KT-P$L(--S@<.7"TY'.B964\,9L2N)PT%M0X7?H0L-O#"$8F-F;IM(PB8
MXU8P- WF10GX,LWU3*1R1T/@)>T"<#O"=-(>KL>^C-?\Z'"B$Q ][8:*XKH%
M1'/^9BPY.U#B\'?_)UH*L^DJV!'CV['V JYZJC!.;5+Y[T@%JP^9)U+,K03[
MF6H"ZZSPPWQPWZ/5S!E>I ;<7%BRF,Y41S';N+%0 >JRI.[-%"2"G9I7K$F_
M! V')4N0&R"!I,GII,.>%60V0V&L<9 'D4L<-% =ZPKW%[!%?=^A4E EC',E
M[?&-T"4L$A])P1<4=6O: K]B:AXO$WW8AD>N,B.?((M904A*-2Q+/]AJ@_S%
MJV)\.$HNN_.5E')=;''6K)'],Y+!)#/&*+X %VNRD)'@7]Y)9 1A5!9E*5#_
M_.EO_DD:Q3_9[L55]$L'G<'2[+E8.S\LN5E4DLT*A8^K(&J>9F5M+&5X0KEQ
M*ED@$2GZ>:N\BKJ/(=\.Q08$C];BAPH;ID2\(SPZ\MX)MV%G1^"3SXMXXLWN
MSQ&E.]'4W*(1CI"/YDQKQYTC B-V[3U<V1.IH'"+(]]>>44BA<4OS\ 2QNS&
M NV)VYRLI:*#ZR-5O)+8)UA%PX+0R;?7?"_Q ;8<Z1BAJL%UJ 6[OB:BTP;]
MATMKO6Z4IO3WKRZMQDBA-@X1[L<3;A'W%X- W'A_/VB:]=LMWP28FY)&E0O)
M# /B,4=[E9JF>38/[(3)4Q&A@$@GQF/@K<:/1D(4B2 %A<GOH\$LQ3@^ADQ]
MQ\'0D=@3?"6AX<A,&TZ8H!&;'H KABI?==&FQO>=W_@-O3C_J4J_ $Z#\) :
M#5?B]3F#DXFV<4#\)S\A"BBDB1JPF=&K2(Z[J845U4CE303>;X'_:4PE$G^0
M2)8@A3R+;DV/G[4A#>8U;=@$!Y-AT7 [1;)*=VJ%8GA%/CK'UM)J6#U15G6B
M6^%C^37$8+%JE?\YC)X<7<"Y@GI5I4%.KOIT#2\WJ[TS2[I?:5F]#[0ON'G[
M;A6YE&6JS*9DR;8I%U*MQ&%$1*:*T"K+9P$6VI>DTJ]-E3 2ZO>1B8E-VU8S
ME.BIN;8=$FJ*A+EDI><E6[##SVT$#:OPW'%M/=S"K7?-$O/4O;FJ@8<'MYL?
M)]IQ:<C@0W]D6T0FRZJ#:D_S"4M&/6N?_]<QFAI1R.+H_+5B\JA9.R\]P(Q2
M$H,UU:G*S>:R=[96E+@')PM#7%PF\Q+<<WL/6;NLAY1=W)C_/$GS%;E@R9BV
MUHP1<'L'<ND;,64X(CF;0/@ZY%,/S"R4O!3T#P$E^),.$7VR9ZZSS<55?Q_C
M@F-=--!C^ZB_<%-80K>&UY33R.;1GV/?K=YI/ H439;)VC61.OJ:7\N1Y_Y#
MFY'2F7C"NVU@@Z$N"M['7L]D]E6KX8-P%,5,6;\U3-C/"9^&S0 M7BLC-I .
MZH1R2'[HH(Y_0J:VOZX:^(G;*BP6R5;M!L5/12F?@)GE.U&%>?0-C-_' GO9
MJ'M\XST'G"9#Y:!(,&:!M,2A:#+.H?B6+MHOI*QB/%QI613 !#<8+'^*@](D
M:KTL(2F+T2>@CKZS!T\8"0J8!9,#]BMM)\LM\' _6"GS7$4G?TM8ZQ_=[8QJ
M.0-<XW'.7_@HG4U0ZXJW)GF4?2KE!/Z[M])=ZMS!5?>Q)ZOC7_29'>1Z 5O[
M^?E:\JY3]Z3F/*@R= ?_B]&(0Z3_%R?4LU\':/@<1#*GB\:0_MZFD_DX[&L[
MUZ\&;%H5]W]5]9CTMZI'\2:3>2!T//O1*/[_]/6K_N*E?7Q")R=V'WG6\?5G
M?W\'OJ8,'V R9=?>D,9% _IGA O/DI]&9C1"*?5GWH[^O&K\XJO:T$[]P"#+
M6BCM];77HF9M[93I_,H2R/IHL;Z\CGJJ]^2R2EPG+7*<Y/'$C'A*:58%N<X)
M\^(.7?G[,?LS+60.C]_VL;[%$/?-\F",]T [%A"@OPC:]/D$/.2-PG>N?A=M
MT9Q>VECYC('HP*08O4-[^*Q89"HJ8^VQ,25N^=:Z&?A=#R)26&7(\_EK FR>
M_MGQ"[V.5<3#1^L=V@M[;$&*K+UAS:@UO6',*L$Y<+;XZ6_GH^CW8L::9$Y'
M-K)-KEVQ>[@O<]0R4-D<"R67H]4BZ;!TK/WGT-EISBO)%:SRD) -"+:T^02D
M/@A*DL5#>@7,J)_6O"C?TJ7<73WI19^K01)SLW53AT]/W'-F6];J77HU*#8C
M)/]"#?W#@=:BJL7IUK=X\$&F8JW<:>V3\NQ?FU2R$SNCU^Y<1'<ZSOH X4.@
MSIE/B$02VNR_NN#%1(^-IP?UDK(N+O##1S:*(<RE7^T65MZ&B)W"*C?.M.U)
MMH]Z8?)J<^^*>^UY??@Y%7OO/MYS=D_K)8?&C4="GD,5#M7E=Y\69"5(A[Z9
MH$]G$XLU0J4/59KD0/ .]!2IS\G+-I/]:K5H1NV-F<_J,:_:-FPZ'S?4U@P,
MR?6I18-=#9?M6*3(,'9Z-K]YLAXX U,A/E3 S_Y%7G"EVF)T4Y)\\Z>3%GZV
M"IJMDAB-T['8&[B;;+N)=0EOW9*K^YSB5@IE7;2X_B@H'(</?&^[J5&HF,I=
M.=.8L$=RT"[:HZRV?/1#AEW)C%0]T\SY.=Z=O6F!;MJ5[$]=M(&H^Z0PT@@V
MW/0AQ,S[REFP7$[Y)Z;A0]LZ/=Z-*N34SN4*Q_0.0+IH^H;D:W0,:?;XG&@0
M<W*_=MJI*QQNL5"<Q<.-M)TODR_=3DO;VLY5'T3D,?3&N3 V/:2Y]OQP_>>C
M]-*RAV:#/7:B$,EAV X(V(WI)6%>>=GF*4\N?\[;=OK9F_VL2+U.D"Y77M^]
M_\&GHQ6.I"4?WTN<ZZ)Y<D/($>EE 0?I']S"#G(;6N?AJV@'(9G#7U?)\D,/
M8R;"ONW(LPCD#\KX%X]D#?PJY@%B7%_Q?AIQISEQGQ_''%:]Y37K=8)=?-Z\
M!J6,3.8,>;Q03Y4_MUTG[YGDKG82B*#E.^KQ(Q0%E((=^D%1J(P)<B (%4EP
M"0JWP.+7<!6O&,+,57@X2')"T-]SR[]P*'Q.4>VW$1:7CZK-=7UZ)ZL9?&R3
M%"0=C@V<$H\D0LO5*9W#0!#=B'R"2K(OO$/+>=K46A##J]R; N- 07DG^H;K
M#XXEWA@&N=39Y!TG[IT!=^=0%ZT-5(+7G];CI]IT<S :8ZTS]<P:45U&;7P%
MZ@$LG9=)XRQ&S4M-$]NIUDP^!0(U2LXL<()/&REEC[[,%LY)6-*;KDVEY!9U
M@S/26*2;.V'[E3M1N#\:#[_1P"ZKYN*GF_X-><!4__\A#R&-J^##'H)2^1UN
M9FH"9I@'G0Y _62\\3WF8QX2HMS,L%HS/!@BGV[XG5-]N9B<'_']- RGCO6K
M0#6,J- <[00)[5SO-&V0FNDW"$%3PL!);CBZ8QI\Z/Q%*(-UPP^>S'EF"VK&
ML3TA:%XOL)9/@"NNWST,@S)!*YFS&)$$>8H81%1"@CZII#L5"E#)VDW4DX.!
MN.<R>9U,/\M7E-( R:Y]0(1') %[0$*I4Y4_;?N@^LJ=J$4DSI =Q@"Y>N)"
M'2?TM/]1TOYW$BVYS0Y3WL5M0.%X'V'IE#V$^5D"T2V9Q>*V[T5$_RDJ&J3C
M3J 2< ,?O]X\B NNUCQ$>J^+MJ -]6A3FZ M&4R].)#G5D.:)O1-MK W66.D
MEH):1W*4*<0Y'[TQLQ%F-;YG&?@3BW9>[.N MY32*%@R6T EZTI!$3ZE<E[A
M;&_U\/7PDW0&Z?C)"F-*S@R+T:QGE,KBF=W_\F:3KDLT4W"S(C0UC2H$*!?5
M)6@3>)-#67X]/4NBB95(J_#S1@$>_OE?6!1F6K%T,RM7H/0B5<JD$B3;]M$:
MBD/!6.BS_-; ?#-?S3J>"$]PQA<C+R^ ]@@LK5M$*>'U:@=X!U';R(ZV,Y"\
M":Z$RS,+O)5[2'G2RD/U>_5N5%(FS'/8YBRWKV8DF/A?1#X^R$3:,[+1'B0>
M-D5E/WU\X-L5K$4!_C]:BQGW&'MQQX>T</!I+T"'"A>@>RR0;Y@$95J]2R1+
M 94I[W.WMBAT%J.P!U2 <RYMV[T,74[0B(CAT,\5(.#H"6I8W+?QTVRC-+VT
M(TV17$,O:CZ;TO. CPGJNVB#X*I[1TSN@M*'131%9,OC)X "$82,D1&D7*<M
MRANJ\T]]16].N,51NX,XL7 JB$K@S,XY"PD?,JKLA[&8[?_B2W+*B;01-K)\
MD>]F8O;KXV$2]IX:/_SB/.22YN/RRNP__Z3X$Q$.M0ZJ"9W;F-?8;[F*J?0;
M/'O> N(6+%D/V6U.%ZF6A["=25"@E4$FFQ%^"Y_PA=\D82M(.U-9MZSH7E@:
MGW =7*QSA3KBA)T8]M2-P:RPT"$,!HY;+]A'XT$@4A\XJ<W-ZIU<EW5BVV\R
MCVB6O&Y<9]QK%?6=V*P$%(B_?%*P1B"%.P2H\OX[/>WJ4HYZESGCZP3,>[#J
MS3RZ1V#8\S37'\&5=0V!D?\SU'!&_.]>)>!+/T\D8T+JH1_)S"Y:+/NW&_/S
MV5E(SF9$LLE;TTY&J0VX_DSIZ&Z<H:V IYX:?8N@>U/"H;LI6YE;:@-M 8(I
M..034'#ILREACRV(#F80P_AA!QU5O7O\A=L'*3Q!Z8GFJ>(QDP/RE2%M3@)-
M'<^2RS0:)K; 3Z\CX2)T+FDZVE^PAH_C(*'<YHY )+]%-R!1[#WX4K#H!6MT
M!/*$AGF(.%(=#<)!SHTF$+1\.OW UL^("Z2WNQ!B(AJ5A#5VZXF.IL9BDL#%
MLZ/&8KIH.]K4XS7=@J(FE*#HI6H';2HB3199#<S7:RL&>:2$@V+"9^@IJ/@M
M=LD!]!3G-G?1E-T2':CD($YO-^Y<F@&:MB=@04?RSMK:((5@*?:"7S%?RZUD
MAIW68TB,=#>TPE-T0I=*)-BZT0&N-*XS0E["U--\)M5MC[U%-O XS_8*BO=_
M-#V,EA?'^/"/C"+V]!=)M^S#SO:6<])H2N/G 2MU3T4_?IV%*?>-^+6+QM<)
M> C32#ZJ, YJ,'_>/1&#=E)/0Q]!BUTDB,+2] PB63N[\<71[OF7"PA=)^1!
MF8G\JWX'!$NNN!+Z"LL*YC!Y.^F8JOHF*\K_"TE_IX.N<[IH%>_IF.L"OLXY
MA$4IBU[V(_R,WU':S)M].> #6K[4C<"T4R,PM>C^&V2]CBHQU*K'"(P%-0)C
MJJ'7N;SM%92_O7L$!HXAG7G#[#IXI^/E*2H-_(P3\ZYQPT$R1>?)L&4!V]*=
M(;6B>%[KTN8>ER,M():9_@RS&EE66P[JB!*WD;TL]?!QH)U<KGXJO8ED=QM;
M59B!S4%)BE*Y0\C )D3CH7%DED,'+_T"!2N$H-7G68JID$8)2J :1CK[!#I9
M@%"*H@R01R71>4<,*(RAF)A"*7<L@&+]'V#T!]$%G*NP5PQ<,H\T=>T%?8*6
M:_0ZGS3Z@*C&%6N#&EE70?!K"Y%>_4*3X/:G?<I$C/W:"7%'DGZ-^Q>>1"EX
M>1]$QUYCHI#P0G';<J[4XPOPX#'F[.'6'?[UY&*0FC=+^7P\ -;6JX4/_GEH
MD"ER270<RUXJR@,-IO%Z=_+*_]MIF/\H*GK5KU</5L1U:X>A<+WD.\B!*V/R
MU,-!J\J[\!U90F<A$OV9<\:(M :W:1>9\SS"UK2+MA*)#=C,I31%EVL=.@>!
M57N0I:0$/$:(M'&O2'?0/)!+4SIL0]\AY9Q$.R=/6.I0?H-W81/T:% 0<8#P
M*D1WJ^=B<QL7\UM#R"#7+'T-Z#2/9/IU@C05:2L%X8CH<P]ZSKDWZSF2L5ZW
M=$_Y[:Q=>;T@&Y1F)SS=R*%UP4@]SGRSS/&Z'?F"=Q.MOKR=&_884I+F4A]F
MP#W7$/%FD\3\1V"W:;CI(_WP(W':6^KURC[7NOU#2&<;MH5%."EE]>6H5AU
MC,%"V7*!*""=R^%*RQ<X!4 <8*A&J3=89@\]6(R)FP(8M1;JX4DP!90NN+!L
M@N?+H+58&+G4G*/!X#>W2Q#)M%2UO8XH4:DC2KP_R%7WIM3[\I>?5$_0OG-A
MX"=N@ANX+99#.&J$MSL=K@P\HZ])7I4.ZO=N<U.GKU*BRUB&$A-;<&'%[&]F
MID*Y"@\9U8!<VPY_(TLT%9.#;6\3%Q$)JXMVG"-U+:[TR@=QLN=0#&%&[>?
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M4%&CYI;X(P]D5ZY. N(;DV%]*RHF$6JZ(LF?HCLTP=?8+'HXP3.263 4WZ
MBG3]A>DPU1>G&*C6*LCB$[3\1!MIO5VS7N=:,@/T1@6,V/79@^/DIB\"MH(
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M[)L7TWWSZ,R;S5"7=CFT5A@WUXMZP!U7?657;?52V[K&&>>A]Z3$#8RK5@*
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MMQP<PF *[4;9.QM7G*9F)H\=E[\%G5_75]INM0X^6!J\/_LL&ZP<"YR%8=-
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M(Z W1$"T;LXEM*3WEMV%L)-^^.2%#T3!:'$XIK+!C<WU4XG+8%2$'Q!7NW7
ME$?72(X/^!L 9@  ]";C7_<K%KJXM6..NIIB:$RIW I6]C;[:UC9^.32#E2!
MC_JU.587E>I^D1C^FVD3(\4M:$OQK3XB.^U"3219JW +GB0E1J8EO9ES<V7"
M-NM%?^D\$R_.W16[S"PL^[?E]\I<3]>OR%#*.D^X;:*QR5IKMSKWZ$ZZF_[
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MR<<;>0_U1$RDO+A=P=5@=@ZUEY+;D.<I;&8J[EK/+"RG9NW&X2.BU:C,*6_
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MZE8.4D+SV8@5-_0836C4LK5XGT@EIP: 5==.1BA;1SD^-$*9 JF)^L2&4M0
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M\VI2(N@,A:.-GOIN\(%3@.!5P!C)D9$!XOSBSI/-74Z(2A:*,BXFH0\WW.F
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M6]W!JF&&95&B&R036F,N IOB[QQ](Y+%+=K(7V0?"^TC.#2YP8Q;EQUZKKQ
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M[W6]#7E^].)!H6*R.%E(O[M!=%_68$GUHI<39GH#F-E Z&;%]_1:T5'MW8'
M4)E=*:)_&% XR%Z /_&SIB>>-T>*\32=$@XP(D]KA87JJ@Z$'OYK_2ZV!JWT
M"O=,QZ^RU]TAQ3Q!-:$^K.2#A9:CF$D!O?]) A*$UJ+9E 5%%6Q))G'W)B.Z
MFBEQ8QENLU\%:'%2&H+5R4+<:FU,D2G:9*DQU'+9EC4.WB\4F;)%=MWJ?:CU
MDD&RY!SP.;_*&%8 ,&S6[Q>8[7[/7HY_.0E>YJ3UJ"H9-1<=M-63\4E*4I<)
M,T>0I/CV?CKJG3W\^)Y_G1B)AF7+6#(C@-X",'\K)Q,U4D-9S::KK05\?&(
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MAX0H5QRG[T]W[5L R8?H &>GB#AHH<Z079P_@@YK!OEL,;W''H1F:,/;O)&
MB.)2BTU[?MIK5[=8&7I,S0WZJY?; C;.2>[E!OHQ)4R(]3%^OB4M\?)@OS<_
M'6@&ON5.!'),[PFI,FP).QJZ%9W2#4PN6.R)2$%=LZE>C@'L*&3)7X;<*I"(
M>?AT(3A!DPF&H6YN1I^22+FZ-'[X!4J;5O;KC'O,J/ %1,E: ^:DCQIS))D0
MJP[ZDS5I+S@AQ?BC6A!Y6S-,'/+.?RZE%RW$AE801[$E9=\"3P,]*&[2C$V!
M+9"-5E[!"RQ$8N&XG[Q)?SWV%T&S87,TK[9RF]Z/Q]O4>&<$8\W<9+<_L9+I
MH/Y-56!H&(SY"VP22>50PVU+= AN!MU@.Y19(C$T386S+8O+6E\^G)<U O;-
MRGD3)L5487OPLXKD8W%9P%&:@$N$<T!S?)SSKFC%(2 & O#L5,"\.\]:<NXY
M:2 V^J<FS-\CN3_ _(G]!]NWH_-O3D*[YV9\.LL1+SX"ED4B'Z0#%;[FMA,H
M):;0$!'DE=)-HTEL/%,^@_(R71>\\L<CH >R^R:B0-=EXT;(D;GF)L5\<JBB
ML""[:B2[6!X=+QA47+QR>2+8*;%N^#"-\(TT$$K25JB/1WW,D2-_;E^6H%K2
M<XC4]-U[WO9EVQ%!^)$:W.XQ,D=H=\"T54370[W<8@#60W!9(87=YQ&,9/"6
MQ?D+NXJC=>"'/TMU^&* NUIF"Y"J*1N'HRPCB5O%%X!&^E.3Y)\]ED\DH.:I
MJ\A'?X/">FPB@@WZ+QDKQO48F5G+6RS_0IFDR2B33FU+F]H4$0%X>_HZ8/#
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M9,4/)1=P@P<8J%!=)!.J7NL,839Y!H5S:* 5^3B)SX&39"&2PS68.58WN96
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MD2S MQ.FPC_V+J=H\:[8XW)Q7^A&["PU?]]D1/>7'SNBWF]S!L]\FQ&%;-)
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MZ[GWFXAF:UG*##Y&#BR%C(\M(ZH7+.\:W&&641%\AS>^_0][Z? '*Q_&KWM
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M]2TQ[2CU=")B2V;F;C$2:CO/&[<DX]8J09H[>IJQ*UO[HTX]YMRPS)=?UGJ
M]->']W*\:O$3DG\;3'X@(26W3399.LN_$M[@>R>=I3<!O&^H3,!O%((?3KA0
MX<),&UT*7.\*FPC 8OM/-/S9(5QF6M4WWD3(3&]5E2IZ*Y(\WPUZC=<W$1@X
M7GHG%;;41C($ ]!M:$SZ;YM.7XWJ9X(5=$ 3X!7P@H?W!X1JA:HRZ0HOSQR?
M665[7@:&Q@SO0>7X:+*%%)0*!W:!3VB,]79V^\1J //EZ7;-"QK4]<.', :@
M"8/DPR@J5[4I+6Q@Q,#&2R3^N)SHH-;T<G:SD\F5H2MMONT[(IW?A_DM',:L
MG16W-3$*4DZ/JE0)/9;^OYT=]C_\^]_/A1;L-B[MR+2Z>IB67WBJ^KZQ3(=H
MNT/)_9^*UW\O,*8Y(J@&(#&>HH;>1 ]R2Q5@0E&<^<=O/F=FI5N/OI3KG<;X
M5XB0D+7X;J>10[5)'U>+.MS2(ZG!C <ZUQA(W)45 N38I,9A/-?49S3/H'>3
M92 &K$0AABHT2RP:Y:75AU!5;DNE%-^KT>97A_KE&<A&)$8ZFS3E,GEI.!_'
MJ<"Y_Z<8E[G4$?67]QE%"Y;6JEP"<#PHA\50Q0W?^%CYHGL_!3R=/ Z$MU/<
MWD-5G_FDLZ7'!B0PTF+*VLB==K0>"F%5#.CA$U11VCNF3]F^B0Z=T<<__,#N
MZW,ELR(\J?M<5@]%K]J2%9Q\LQPR>6OI,1_'9$[>0WTMCZ6SWLR<,4?-17SJ
MG_IDZHX21VPB7#/[Y<./U)_-"3[7*FVZW[GMKT0.Q"?/T<&O\ZA19+4W?H?E
M]] B]7.B-9 Y N2MP^!S)/\\WC[N+&])[ X:@M8*/<2[@\3LQ0I[]=9L(M@_
MW2"IS=48*BY<4NI?M.*LP9-/R5;YG2*MU#_#616:1ET_LL<O&-6?G8N_EMV%
M/$-[428G@[WNR1/[1CAQ%-]\D<6,XD/_T0'E9U=EXEG.V>0IG]LON6>I"/Z*
M]5LVE8=SE9<<1Y&G.G6XZV>)GO&?N=WQ1-6C$F&VZN**>BO [E)V:J?9S\%"
M,RKWJZ')>:,$-;-XD=:LA; S C&'BG,(ZE.,ZU:T:##D=%P^9F[TO6Q0/IH+
M[7P'&Q<K?)]0_L!LGI]R@7J+EDZ]>;@^=-&NW"(S\C>)._[<: ?^+ET<JLK9
MT$C(U#_R:N38+ZLW6!F-MZB%SB1Z(Y+H'/VHC#M+.X.<9%)0NN]DQ;>1!67Z
M/,)'?1.Q$_!5@*579VV%<JN?N!?^3+^+G9=88Z56#[H<.D_?1ZR('6875.<^
M'Z++ [D[/2:S4)2H:K1XZLD2Y!-Y"R6/LQD76,_J+5ICF2F12VNVZA\8Q@_?
M#D9)2YT((8==\TS[BU?X7<OSN!.:NPN>^?2+9^\^R6S=?I@'@5.<BW_-8SH6
M:GZ,(4!-0_>\6\##2[\T]\4GL<P:1.A#F<)M7:*OKW$$Y#T,K=%[.=^S+'7[
MG8SK]*5?!JILT5I!"(%#,0:/.2(/\^3/&;'=,8HXSU@\$7^1NRH-@:C,?-;,
M]UB23?*N1'#8*,M7E;<NZ\18U%I5UMDFI8\$GOK#@\$N<\U<+3UZ@3.70S,?
ME\\3QI;H'$=B.NF"@OU&=WVZ49%^(< <=XIY"6F=]OK-CR7ORA8 2T4 2DU<
MXX1?,U+P((G_2;[SV2L=NJ@O(?L:-LRZ!XF:Z*[8$9:Y;\/E1PBU&\Y]S+LN
M'R_&BJ2S=J!,QY[>K#:..AFXR^'EL=B0L>D.'%>D);=F35]UN=";M8027!9;
MFZ\]PZ"BRM)99-NE5X]>B)]"+@A&]5S;#QGI-VV] ?]BS*[]%4PX$LSA-YUF
M9+KSNMV"P_=D+"Y+Y<5G%N94"\37XZZ: DKIQSF-SB*F)'0]#FH]%]_QL/7#
M>YF:KHK701Q>:4::5N$#%:\SB]18+3G/'V?1,KEQ(/7-B[BNM$MRSDJUJ@?V
MO4)Y!#P.NV8TX0W^,\YEV'-=E^?UR%@8P[G\C<L#/T[;JET*NH-K"D@6%=<>
M#1"WE%(X4[8@?]NW_3"OO?<>R:.VF&B(Z'J;5$U1(?L73W[;1'0+XHUFE];H
M;$X4.7+IZF.RW$<O[VK%4US?7/GX&RQQ)3H(2!U/U.,/1??\*'L7^( 9M9A!
M+]/@Y=M$!#F\OWT(V7T1J+$=^'<0^4@:E4MNU.YK=@\_G2O<Y73;Z&/+,[TI
MCQFJ-LR6'Q 7JI:S&:<%;U;/>_MJB%WKO\?#RF1[]]@@;F0E;9BFP_J>T]P\
MFJ>KIGHCE'EA(BK4,F1G3]*[2X$1$5IC-J\6LEN>?>8+?.=JP/DJS#@]=6&G
M\P3'<DJLB .AE93*82CAO[<!,Z%V^75HJ:&;_L4UAN0#,^)IV3R3LV1C!XZY
M!V"U%9%&AHG^I8+<'7&/PFQ"C['E*&:G2/-</"C 6Q*ZXUA*8HPSHC^-DO@Z
M,4)?1_@'L[/RM/[GC5 /W2P>2]/]ET,O"(_R'CY(&9TV<%1($ HVBC"*NN0E
MW/9[SR>)+_L?^GSP!,(,RY%.7""-CSW@@J:.X",X>Q?<8U<GVXY7,]:B*,>R
M9Q='.; :I4/><1K=;*I?AQ#J9KS47K_.3011#_L\_A3MXZ*/<ZJ7]V5O!Q^M
M268]+8:[ZA_.?[6;0U+WNO_"W_1:C<"=1(ZUKST*NG'["W,%L*T!NCXL)&0E
M".6*FL+(L8DGUTAQ>7M$&:%P7Y=;SV5BY?AX:FU&7NCRY!M=#3N=\:"6+<PG
M/[^CR8LPK,F1^':)\FN)TLPX+:0T\D:?(=[^FYK;Z=!K2BCAYEZ"A,,.[LY0
MK_W[TQK\[R [HCEGQ.V3=URGZ1QK4I;_]\G]BO#!GC*53@FW=GHDNQZ['5BK
M$>IXS/.&2U1]P;$]_=.]NBFLBF%&WP-&;FLDA@>W&7](BF2JX[TY$:\L\#XL
M[*+2_J3(7>A8D0<?9/=5-,J=0HOC(PWU&!681OF*(M0O8EN>7V8!=D&8<N\F
MB?VUA"O]N2Y=R>DK:JC[J<VS56Q+%C[L-*YIZS2X#;^O."[(@=VF8ZUJ0V=L
MP'(G,N\LIZI3/8#OQQBB >X9/H]0YZM::RW5O++_T//#>^[\A7#/8%P+/LO1
MHU[!*8I1N*G%^6;#Q/<(Y]'S3XY&,QGO%,QAL?Z2O+KCJ^)93O/3_O''#/%!
M*HES.[]F*Z5&NYC[[A<-\!=,P8J1#!-#$>*E;WR'#5.5U]/[0[^Q$N)?/RM[
MGC_$S,)3H-@QRLTY<PQDM[FXO[_B _G\[:?;A[X7R"D7]U \$>/.^R;K.@)A
MC%DTGL[N)+ZWU6/YD'*912DY37<@,NC&J1NQ.3UQ("'=>1S5]W_=I20?>1"Q
MPG/MH7&;5.F>*P2W"\<?'?FME)[+8JQK;LI]+N)%_4+G=Y!9ID\OH'+-0GJ,
MX5/E-1]NY#W" (:ITM/@=ASD@VZ5>U;''(N8C-,\$W(#%QED:5%,&%L;IG[F
M[+4Y]T98,=T92Z%@.K+G#@R2;);_2@M,U@9V*Y3NI08_<?H1>9%E_NR 1'3U
MPP]%@H\YQ(Z'73N'.T\/AVYP,CJ*,I#UDZ=B/JV\%%$1NWY@;"^35>6*<[>?
MUEJ:?WCS1=:<H3T/6U[RO_\X7LQ<NYRLRE!W;$D]_>Q^.QY_Q:W''D:%>MI\
MCN5OB9E:7U<QGDJ<#[?7S<5HG?WFRW1.YV#?-=T%)IGJ&?&VB_Q"8&$,GN!T
M))D:OI_K8E74GY(X+Q[4L*H_)7[ZE(_QU'N94]=7>$ "QIW5G+%GBV@(+PK5
MY#CN:!DX$,:I=;YRY= ^9M7/QR+$Z*P/FI12QS9BI [?8! 2;ID#372L @VK
M/9!&9T%?6M\.M40]8XY[\B;RB>";SR6^/5&AREIBH44!4)[!E^+?L>MFOX&O
M9%JJHJ6X[$Q[].EAYTJ07\K',:W^733)]1[X!Y5@]8]7R/DXD8=1(6H*P_/G
M[5/:?2J;:W;5JC*V;1RBL[^T\"!+:'P_[M>#W^ VFUN^II>H_. OO#0T%(C/
MB:Y!=E</YSK$2^:7/J*W?3(=/M&/K\-?NO(&(7%*N&5<ZQY:G,7Q8JCJQ>3(
MG:'FRA=WY_B*:S(^TN%12MVQMWNHF7'RE;Z.S!G5H$,O52[]NOQ23UM[H[FW
MZZ9#EVA Z+6S!Z4X-A%?7Q^2\M;1"'WV>7^F[%GYH00O " >\*^[-/_S-V#P
M&4[:IO /OS3_?W[TE?P)/MCC_WK$TSCI=TL.XIX$2L:JM\AU6I/W3I)N[$GB
M0+N$[D&L792 [XP;SSV1N;+FH:*&,AM_B?5]H*9%/Q_]TG/,*?BY^LMCQGVL
M!8*?E/:GYK,=HI/<-'GW6AW1LQ8J5SFVSX+@ML31?G/]:P;Q&.L'Q=P)?\GU
MO#*<E%,8J59CU.Y-#G&W2(:MX#P3L[A@G_RCW@*$UL'BQW/A6N8W3!L/\6M'
M+4B0=-0B+EP)*%JH4[??D1.U:_![/$__0N([,3T_6\&,>&8F].&R2QH3Z-B<
MA 2#8O<&$2:$27R=P"W3/L<;_4+KNYLOAX36*TT;[/)KN7)Q9TKAH_C\)+%[
MXOZ_KSYQU1=:#U2JW3ZR.$!SQB'W)P];A0.O;J:PB0 5/=S0>R-F_/V!WWMF
MZ?(,T,.-9BO=AVG,Z=<?GKHZ4'M@$Y%ZA_-WFGQ6O)LF7U%V%L.C*<?<AO[=
MJ" =Q=+DJXJ-/PUWO?%X>9%S]NHCOQ<TTG)&8<_J,R\/\YF.W\@S;P1S]08X
MO$#G;R>N#;42M+'G,WZ+M#'8"_\6#ZJXXRV8=@2??/54](,,+2&.Q'.:J;)/
MJ>IRMX/-"SR.!EUMPTT""/NUAQ/1YG8VB^98VA^QM,-U1OQ7GTM]^<6]EE,;
M"F.-TAUOG0_)>CY"+_&J9X479(ZT?-T?712]%S,F416R+W+6@/67[!%_+GD]
M_9.BZ"R54]%(I0\W/6QV7+XT4^+N7Y?PH1K@3.I+!NK4CH7*!^I372R'"FY\
M([%4?A9YY55M<%9$V_H]/5\7&&[&/I$77GB#>P^9RK1I]HR7&W2/\CRH[LF0
M2;_^0/2V2V(T_4L#Y^_4M^_<Q7P=18>LEH(+1#U\):)[.%R+)ULBC]A4:1V-
M?^U?H2R0F("[F).KV1GM6EM/S;^+BK,S&%W<:8&/=AV95][O;EJF"<79,Y>?
M/,OPY>,'OP->?,.%6J/L"H3$@01ZP1UULPL5!S\N#K\6C;?TWT1(O+W-%'&,
M42#MT).,E]^_/QC!L>7,L.OQ?4@VCIR(VO:ANQE?Z1FRF-LJJKRCF&3YNT+G
M-;]37QGQ:^#]/]QQ%Q(Z/.CY00<A<B&7B7Z_\LOC%?GKZ@;7]<&8*GN/D%+?
MI/W*O@B9O^RM\^,N5\HGW<*)@R7SM(<BWK-'?':+L9J=-4EZ>_A9TQ/W"/3I
M\ BC;ZI8\^!B?FW&2GF>G1/IAP>JOO0RMK4@N;W\#HW_S.K)Y$A(NPC%'9#]
M=1D:/D)<Q,PWHJF[,*0D.I<+QZM'GWJ@H=.;B'#S+K9VC%%.7EF1_<*\[0O1
MA&;DI%%V2#Z+JO'5@J/-AOA1X[?O2QZ_.6(FFM&=RB2ISJU;*%#8XFR2T^[<
MAFR^_/68H&;+.]XIIA./7U3P+A&TT%'JE=>60A&%0>?''UYJW\_6VUCA[<_=
MU^;I=YR8\JAV+60N ;7<,JZ[),^0HF.##1E V :14J/0!;^A<,L\TJE@=TXR
ML5/ZR";BDW$F=$B3/YV1L;GMU"DALWOQZCK:[-_NN-5GW6(J9"UK]2&]<[W8
M9[GWK4#&+\.%[JK4(D;MPQL7M8Q-QMJDYKA_X$N?\ZY$?,5VO,?P>CF.H"4&
MK?,\IGAE>'"3IDR;B..3PI<6-0(RJU7.KY_=Z2T8D[# Z#_X+:7KF.'K?/__
MQ$ 0VW/EO@ZYG[NK/OSV-4 8E/O:#U04<%Q9/I)I.2MH%;&)N-"6\$S$YYLF
M_3Z#I^W#BP+1H=]?C7 ^NJYZB_0\)JW8J0W9\1(I0I98,(BJD&I-/IIK?9">
MSY!=ML&J"48BUFZOP*9?5I#2<QXU'1M(3<^[,$R4,[C#5'_M+)/97;=B8],A
MB87(5>PE5Z-OV?;[XG)G%4-]!=UYK^G-']KS%^.<SIG[['LG'BQ[F[HU311=
M<EN_&'^0V*7F% 5IW<6/&N%#RE#B/0JS6M@-+PSI_6[G]P$*OP\].J3=S<,Y
M?JEV=]#2KI^FZ+U>=P[W]8PG;"**@C81@H=)1X.[&;4_]<AF;\"Y@G (WC_V
MJ]S724-VG[U;A+!@;5[.*-O)F,^'619R4.=_L EU=KQH2"H_\Y)9B46!=R(A
M[2I[9Q'I-(NQF#^DXF3*E*V@;K]DW/%YG+3XZ)ISGE?CA=,J3\JU:([Z+@)>
M*LOS^213G+AZ4JDV-=SDA1!#)-W<4L(SXYO:29W)W@NYLC;!"D+]GV?C?=-[
M*JT&*O*961(R7"U/S)HF*$_V^"-U>$S_XR1[6"(@$L,"FW]I[MFC>_ZNZW/'
MK(Z4M*Y-1/W\G!'4>0Y!=[?T2JN^,2\XGZ 1, S5Y3,:OO@L8J ETG?RO5?J
MGK0$TR:'W!]5)3&(O.UP7^P[/I;#(_1$Y,J2)E\U8W-+NT[)%?J#9-:*CW<E
MV++WDPVKGRUR7:F!IE-:L!/VC%I5LQ=_]FV8WB4_&^)3P@A,VW59IY';8UWV
MDCV!X\**W&F!CY-2;L='O&>VO.KP\,-?$W6[SX./]![1;:)$9 U:YA]'E5B5
M75"MWQ'F=SK%-%0@(-$.H+,,V[G[-H3&:<T]_KKB4F-MJ\,L?0H\;F?.!=DH
M3\>XQO2BK3H]CSV;F6-"6,!2-V>"U!DPU\OO)]F:A)H?. # EL19>>_SE3+;
MU!/J.P#DY7_T[Q+C,#BRLI(1X:1BL@&]=[QH$!]_.0$?J7;^[$D#_3ZV X$-
MB6^%N!SFFVGBB/[9)G&6'WUMD@<YM%92+6?-%>.AUA4+KUTSAU_++KUGBSN6
M83IPX)=L4R^[38^-2DBJ*?UL5AVE4_D]RW\YPAC>VSO.>OK]2DJB/_>U%?G@
ML>F!.(-[QQ!F8D.A[MH3R2Z4>E;UGV:O:BI$@T+U_^":[JPFOSY#&\A%QS#S
MA0B/7F=WI<.VS6+O 51'IAQPK__R?G>,)OI(I)B(W$7)R72J@^!I3I:T%,25
M!PAA$]6H4 ^*R _'AG[M/1/QN=%*+&*7/56>8V^LM\DF/'[^NX%_O=7B$8^U
M"'&.Z\$+![[8343YJCOA=V9$;^:G0:EC(CO"3-4&5(GR<KS0_ND0W8N=(:BL
MO\B]7SWO971[U1M"%Z/MH:PK0AEGCMHLIS&;S3@6%-26?W\0M1;QG?/^72A2
MK=APA?/NT6-)+QWV//+BY3:\[/-#<RVC95;E @OWS,6#RPZ:R4QML:X3R2QJ
MH4V!QJV3MRTP.D>\Q?S;']UCG),FI""NBG'DA]Z3NZ ]X:YP8/_0__A82(0>
MXY$W/^,-)"/";B6Y151M-.]XBE!FCIOD-#(YVI;?JU@[OGS"EOY0CV7I0_U3
M-47#]DZI;\O<V>1F9G^W>'M53N6,G %M%9>B.,N'F;=>S4L).=SQ/;:C"S*_
M-"IL<E7LIF6KSMCQH[%N*HD<'^<?F1^0.:".?B@0HL1[QBNI.G"<WI_?((Q5
MA^ ?^^U&!>OUN3=B*'3\J*:@$.%]TH-EWG@U@^'6ADYI%/$@5/?:"ZMI&]21
MA6YQ!]B#R/&5$U/>\6%&T#38*Z=\(MKYD.@]HCCJ0Z;+@YNN?#9Q8BR4,';E
MCE,Z+K(+S3N/F_=>W<<>^=I(7*#&-8ANXG&<]V3[5;NK[YRM*B8")9/?R$;,
M VV%.W\*IV64GY/L=_LYK^;8J\H,?@T98D&\7^>(Y#%2I^]W[*RFH#?A?8II
MP[>/LN0K XC^(CJW@:P&[@Z:E.D1+T6L_6U#J%&\-YD6?2]M71#1 F#(!6/^
M\8Y)'?G=R54)^U#?R44[$?L=S<IC%_5$#/[::Q9H]-U"G@$45@H(9N8D[_@@
M8U\;YPB.H^?;6/]L1T210?9=D+<JB%^)B07XW KTR:8%9;..4SO](H\=6%9X
MP_3O46I__S,M_#_$O7DX5.'_-SXB2[:$[$8AE5#62(:DDJ*=B*DH6\B^C3F6
M(EN2HE1&(2*-LB7,&+M4=F,W9BR)R8P8AYDYGN/S_3[7]5S/<UV_W_/[Z_>'
M/SC.N>_S7E[OU_N^S_U^PVYSP.8FS#O^G\J(EOY?]\0Y?'Q_P_'_W8*B378<
M-J$F[4<TK.0A@OY[=&5U=CC&O9_ CY'&M3K>YD\W8MB]FR4B" 8 J0F0,35@
MZEWN.41_5E P?RX\+U>:G0#G48$/]W$S_PY:I+,GN7SV3!K[G(6G)[.VF:@S
MT3^YO@,!)1(IZ4B&4SC*8U+.D\#'')C>O>S<SK/]64XNX,B%@>68J)/=8ZCU
M)J-=]_$Q,H/&W@/U$/9R7Q,.#H6MG>H7_3:B^)=OK@C52RRU ]7P])HI8"2-
MHIUP;P3WIJ@T9[WSK)@MS[PY\L:?4 W;/O7ZQ% I15YT(H[A ("'\,V;B.%(
MFEGIE([8_)^.>],\=>+4O41OS#F :FG2-AZ&G^F"Q(Y6EZ>QLIE2U8]L_% ;
M"A<$R"B&#1'4(C;C1GBIQXD)E;7!RL'4UM,OQ"]HKJ&;3-[\PN<Y.8^=KNC8
M=J3M6QRZ?8FST[%1DYC&6FZMVU<JAWR"7P@EB;4ULHX>U]J+!"FYHL9CS6^M
M;F+.,F^'R9"J<]0S/)S"UG:-;_?C9!B2YZ2793C27:S</F@;U)7-S:^&KBP[
M^*8(M-WK%IA%<Z2(D#"9NO0 )6> $@P[_?U9@^V _47.2?LD[*]-!,,?V2**
MIMJ^=/W4G"A%+B[]9GY*<[F)]1XL#&>^HJXN/59[^3XRI[2C2VT3X4CE'(\,
MGHJZ.^H8[!96()9BH=@MP%IBRT ]+%3%4N,+4V^IST^O&9BYF#QG;=B7M2%V
MW5,J80*0: &W\CTSJRE2/-[Q<;%C^-\G!W<O"B$'B1ZO;22T%4H1Y]3NUSU^
MUO$RE< )6CB7Z(OCNMIG0"/(BE-9; ,.LH8Y^"%RYJ!:DJR9V(EN 13;"3L.
M"!/OX$4[BQ<(:E7QE!/755\IEG4I<C69U:SOFXBX9YS3452G9!2?UL<R[1EQ
MH8M]CP<8:(ZT$[0CDJG*R@:S/H"1=DS5SCON$3W%1S1FVL@3=0HL:VX2X2!V
M 'NP^@N#D--K%;B'KX(O)<,<>7:K&V#L$@88#);3J1C^&_#SS8?@Z(-M37:@
M#K*M_B#=KU+HD_#)8<&UZS^C;!@RD&@ZF$H]OU>3'MH4\L,M32/(/&3-H!T:
M!A@^U2VXAQ/(5TZ,T 0Z;3EW+,0RXW6D/(*%&TJ#Q*X/3C.=JQ*9!WRT?)P\
M=']<63V*'T$.E[#*P#OL\V&GR&A&UB-*S7-Z\U,UE?MVO<0DG1047UTHPZAE
M&;1O8:4IS93<>=%\Q0T)%&"3MMH4$2E%2 FL*,:ZBB&>Q+'8\[FVSB;,U;EI
MIH&&KT0 E_G'+UV\7_HO[5M.Y2_,5;"<LA2'E:EANJ<8>-"EM<;[?OP^^\$@
M= IXK)^6Z")3P33+>(KWDU-/"\@E4]<XBENN+,)T;UH2Z: @1;U3)=4[XJU$
M(O1XAKJW ^!^#8YBI/\42O(&Z#XU795UI$FUV44WE]F"#<78P1)E<:+(P=>#
MO>7<MTXJ*?U"<$IH2P]P(J9HMAWF_'GM+LD;?XQ28SM?/_5>+6'9P)IUX_C1
M)@5&P*S6',7*3./3QBGN1]?T>99UFC81H Z*+OW6JS,PR%=1CJ=IW,U^'/<9
MR5%,HR;C)(? T#9_1Y+4 [^GE_(?6P4@*R<Y"C94? (D^)4I'EMWQ$_2<:0B
MY9J*G< ($8G5P1P$X]BF'/,H\>;#IJ%EM0_V[CTJ(,7#_03]1%;,16\US^*]
M#L8U.8[IC9T7?\&T>GQ8;Z3^]/D<SX',L"KZ46D.3"M)]0#C$EKQ-TZB;XI5
M^[&3%91X^PQCS)?/?B5YRL=B%2<VY/4]0-OGDB68TM\N:K"B=-S32_U%>.N>
M2_W1%R+\K53=!92?\0@_E?K>IN#Y81\(]1O3TB_&/Y_L>#+C0,[!]F\B%(-T
MAA>F[G2E!-O@#AZEW1?$*#XL1<P 7L31R"G[1=)4\AOW9N7]U?%3*NZ/#WSN
M4*K!MP*C.I#83:;9V])Q#\+V^$&G"]=/=C]W25 JF4H#-0&.M$S;9(5[RW'[
MQ@BC1Q,VFL=8R9VWVV9:_<D3A'!N.G ;EX2LM$_1JB *>[:>^91_+/G$F0X4
M-P*QH="&8SCC1F2<!MUJ/F=/'\!$9X5)#V!VPZJ+@8Z#J NIJWR95N*9NF/N
MZ^3^2?Y-!(6\I+R0(YI\=8!CX'4W<UO ;=[74=ZS::-YD""26<@*[-.N[/39
MI5X=KSOW/3H'Q6N.+ (8MDCPJ%,33N[OH3IQIO"ES^7IL4MJVHLYFJN7&R9W
M8@R8JN959(QQD7ISX$GD@7ET$W],*3A)D7F<N7#^32F>$GSH;'J# 9=_2T>3
MC*L^EZDSKW%B&,^//TTS_3]*Q-KRK-L!I0CL5VP?<>=?@@Q'IA_CZBKKZ=/>
M@#H%AQ3<)F(D Q(3 $L9FPB:6<F4][$[0CY'>=>B0PW8G]D1%9>QG1$5M&=/
M#?Q^RI*9/;";(,H>HT;\FB^]X[)?B__H%OA]M0WV'Z;O_F=67@_H<VLE5H4<
MQ3CF/7%=FR"!OI_2S#6.9!\D])/:-0+=_F:+4\S[-63T/I)*&"-N.0)6O[33
M@!#GI<H;,[V)6/V]350&$KL(EOH%/>UPEQ@91K37D4=19>(<1=<"COW@(F</
M4_Y/:\O<?3'*RU9_KO=R* OVF5@53C#WS<IIIL@W?6\1B8JGLO0N"YPE6O2W
MV3ZF71-ZMZCW^1>D<'?5O>4'9%7^J_E;$6C'U&DD2IL>$TCD&!<7?+_15G,V
MJ/2GW96R7OWUX..W*98BEMK3*]+K2IL(?AIV;&.NY2<_N<%,<U ^M**O8\2!
M$8)$%T0!L%!\N"6H*0L,8O"O/ILFLE3H]R">]1,1EL61(D/"45/BPVZ384XD
MQ\HW,S_+#U_UJ5E90J>CD"@*%94Z84)X,7]?]IGQZ/0/&=1SC#K[/-1-T./F
MF^T?\\YNS?<UZZ>X34]G;B(6R*-HABT*W&/4W#62< XM,?F[^Z>G_NV3DS*,
MUQ'9B']:JI!P'MO*JBC&WS]$4B,C),I['C5<"(F9@Y\I];<')QVJK??JOFOO
M:U?@59'\&25*0X(&Q$6L]-/9ML;=[Z;WCV J5_ =::-KD- <$\DZRO3ICYA]
M/C-R:&JO1&.4OSFR7V-QJV6V$XAFH\$ 676F^KN);P?#C[@>JWVLN>BPETL>
MILZ<9MHS,S81?$1N69TWVQCCW5/ZT4!.I3IRO+<X?NXU>;6:+<X)S&)%@]*%
M()NNI3I&FW7M&A?8Z!8HT]W[J4.\-R_3R=F$-SQL2B(BPP$G8:8*XV[5DPUR
MTB?IO4FZTR^W,<PJUR/AB9S=JOZ!,00O3D6=;D**U%FIF<1^6'ZIT<ZW[5AD
M-W\;9[<W)+R]$/LS1RE*G!21O\N%9'PZU6&;V4U-2MJ0)"3\G)E 0[;YH)I,
M%D72;_Q1EPK/G0E$9P*59'HH+($"YNK:(U.GCY7]DC_K W-JN@)=GL-OEALK
M1/32$38<BRE*@=G# 89]LUY8+2ED@TYJ?AJ,;JRU4N+YQ,ORK'Z(E75\D:5D
MPMT>(=9H?+Q8F6*2=)[6W5-WB<=C:S]&^":EM^^ZM;'4(.68RHI^2NW#';D7
M?DA=C9&*D<(R'VWT^S9*Z68LNZKUS5A]O93JHL/VP/;E*'.SH5U_OLW61L[8
M<%\O>5G2^("-(EX95@LLCFB,.O<9!AE>LI!SH"KI[W"HX%W>'*$E= I0B>,H
MEE-?T;%K=HQ+3C:^LH^F$Y_=)6Q54"F  <2:H [!0"RE4S%4=^9N[_!,:MYM
MNU,-2_,NZFP]J!4EB?)8VF59$.9TSE/D<=Z^;:>$<L7?$U0 4M@FPN.XS45/
MNOK7';]L=RW(EN(>3#+00)J9]+>D#?K[]!BYZ[X!*,<-/Q8&=GE7,]6PPJ:R
M/Q/:C/&/.?<.THX@PC>RIU'>1-"02)UL2MTWUZPLTJU%BSW><J(IHZV[6P">
M5ED61S'QSJ<_5=\$FKU'-=$5[9]GG?/_H?&3/"B/K@0TDG-$YE&=*KXIY,O!
MZ984MQ0R4XGI/B7P>.LHMU+GK4\C=4:&,@ZI*5;FM]#Y.,9)'?"00+/XPTF)
M%> !I,N\G"R7OYTJ9MYP4^#RDCFRUYZNR=PU-]76-#KNVV$1=FCV22!W8!\1
M@?)"@4=/TY!-DTE&$\I]%3,>]*7\-+/;*WQ)W(E!N@_1"QFM>KG[Y1VHI^SE
ME8S7?\\!CISCW$(494(GQ<P4+ DO'?I=-:M9,J_6D?!9#;;YS+9-A, >CLL9
MJXX*N\.K:/W+I[< -66&T!R'6AGPCD3#0O/$'O)T-,U.R4%6K>]\_2B*/\K[
MGR:KG/NFDC@\V;J&W3UPRV%DXG?S57NE_;PKG@"%MI0<JY,SK#<_NR,) (UE
M:#M:KQW35P/ZK/ /B+> H<YF=&7"XX\8O3S'_/?SK.B%' J<CXC$0:)O0&+@
M[6I_C]T-AVEK6]%P!3\D# F3F#:TTZT_%1I-Z._R0T-KQ=R4--?ZII8>339C
M9=*N7ZS!%<$$4X/[ *!$ U*0*,:KA^-*%=T]?OM+W<39EA3Q7\2[D!;'NANX
M@X[5!1.<7E@J"@[M:2 )FTL1O>Q&9:8*%VNFPCD65&"7A=^!F)RCLZU"2C4;
M]K33])*M&I]@[%)SJ+QX]+5!;XMZ#'@V9:?_"&'KZZ$&@&1/V(/M!20-4'R_
M7?:%'SJDX[A'00^9@<?78XCL_;#Q2@%>P.[1^0G)OA^)P7O&''>=LE[-%<^#
M]@(D."?W$'6W?TJSJZG9X:2B/B'@.&\F!) : "3F /:IE]"A)*36[)@[\DT4
MBF$$B<:!,50[(<MB[PF%2D^WF,>.*L9M-?B<380O *J<;@6&NZR_#2Y6G+DT
ML3^Y^CF/*98_&@5S/LKK28:_0 )!>V(X#$G5SG.]>T.;Y9,_S427F&T#TZ:
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M#"]PWV(LWW4=&5)WK0YEWXU&Z4'RH-]5L(89TG<^?L+ZU97^$^T4=SEI[BF
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MXW.C-X>NG+5#PQA#I+Q%,<QQ MB^3<1.-%4F%F/APW=> 9/9T>HDP"[L)>Z
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M8#M0#/]JN@8CN)0>7']VR$E$4\Z]2TG\:JYX&7:K*\T7G2D_A2:J'7A>?,.
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M1GFQ5#+M9Q7R4PERV1&J--V-AB38L@7&_+UPX)K<2WPZ":K<$-9H^VK[[^%
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MEF=@1BMJ*1-/@Q^W0XA;P+$4.JZ-^H!?M&'1OCY'W=$Z\<=J/7O"4&7CQ4]
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MJX7AFC8_;D:7;BA6S]8@Y6#X6_ _K%W(S_V=O65E)MR!Y=X^3JF2<T!C3@)
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M(R?N]SUFC_D3;X>;Y2,.T F6V'>5K-AXO?]2U%NXDO&=8*3RG7(LCW-ZG%A
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MFI&YWBOV1N1L?*P=&^1\.O;6A4GGP5GB4S#6%S?%Y?;YJF*94RH]76O%NT/
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M61HX?'U4:5!I@8U/ C8I#85P^VZDX]1QJC+EQ>Z]$M>@!EN--QAY-,*=%(8
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MLX1OXC>\J^E<^L2FWHBY$LDKO!%U,!6'^Z]Z[%N>.07DL<I-I\B$G?>U&^W
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M!ZL(K.:W]><4?JP8:-(OKU[G=$ESR-V)?RA<$QC0.C5N.WVU6_2!EW*KF+C
M:>8?EAR:XK.5%>[7G%(\Z_=ECGQ[>%3_S,=T W?92</;BG42<+7SMJ[?UYD6
M5('?&+8_/^7:FG=Z2IE]6"Z<XWDIY+Z%3$;6P5J0$><+=$4)%?'4OJ?^';);
M6T@>/;&.;4]O$U;?W-WND%-@41[Y'CY)5Q6__B?WN\\7\<TNCV+LSZFO<QSO
M"XL>*L5'\.):]DHG'RD<N3+F8V3]ZK*7Y)#(4]\,>'B?O(H"S;XKGB&]-T%Y
M5-0AX+0I@ WT/@0Z+,:KYY(_7'T?/%H5UG8(U!;%(CU\8FO#%(<>WZS7T&RU
MU.KI=U=H.3C^CYW+V46UWPPN>*.E/]MT]J3"YZ/T$, )_&XW[ZNK"=DF>5$G
M8)QP)Q\&&%=@MKWM+>%,A:L6NVHXS"=E,A1_M<-J->)]'I5S=EC8=7L%#9 _
M--ZKQ":JZ)*#PS5Y*WMS:]Z$%F/=!FKS_4__X3-4!/\';^\9U504MHD&$>D@
M39 6%124IE1I":@T$0%1HZ!$1>E%1"!"R*%(D181044A*B J0J2$#J&#!4&J
M@) $1*1)(A .I' /WZP[W\RLF;MF[KKK_CCYDW/.WOO=;WG>L_=^7M0L9:D'
MBA _.02RI]*M!N.@Z:=3#0D>BF6UE@FK"^>SHCE[U7@-I#Y;=N"N<KL!>C!_
M,Y"&TR;1>Y/8]_:P'@@(?4A4.;Y&[ =V85AM9 FLGGA*@U;H[.6S]?F9@SPY
MUX+VJ9%='XJ(>#9=X50#U$* #Y*-N>1E,]14/*EV]]^T2\0KD3F@'VV9K3A-
MMVE7-G10<V&P#WQ/4HA[$[%-1"_FTQXUIU(G4FOPBU+AM82F5S!?T@NKZNG+
M5U@>^COL;+O@&0;SALR5C6B9C<A^WS_":&_EP:B7D>=Y[)[E*\$*T)-&G[J5
M?/V;/QZB-.O7(MZ\2J.)5QKIES6\_^HEY][Y7_U_6N#^VY?=HGV^UW5CS)P]
M><<L\O5[*T5F]4>3CIS.R_653NW.\_+]J)6?J.CT*ZZ%>)CSENPM:D15B]9F
M7PC&'#!DIJEK1NFAQ;#;VZLADVX=R/G-C0K;55[5@+EYNRWU&+P_$V6!>P&U
MI1OE@//#;I][FL6:,JJ[%HCW4Z:ZG[W*VKWOUK=+&0OHUTT*P[U)E<*B=WKB
MK,(#R_^N[?1\\U74HETQ\^09/NOQU.>H0M6YCU \NDW@)RXX2L::GE=__R5F
MO=XI46LF/;]D.V@2@&^/C57>$;, ZFMR55XMZ^ ?\GA.P-?@%B7R,[W:SN.E
M$$389D,]0_=:*O3Q>M,U)3 [6 K[ZFU9S+L4H_:VT*7&\[7.3/4R1ND=M@]!
MZR[4BLY.]@]T*S'Y3W*4__YZ?[890DN*W?]1@N&_9 N'1[>S_(&/$/"RT?V?
M M#_Y@J[]E]YR?_SRGT*/6O[OVBQY'_UJO\OKNS2;1!HO-WCA_^+99^<[0RU
M^'_@5%=_8VL[-^<0R#M7GSFP^G8=N0Z<#KBD',(ZC^NK4UL<IW^;GMI5Z]O?
MFDP],FLLG#?$IFP7<*>2T#)D[UX)7RX?&.)5XC8Z>H;>4SY\(CYBK=-T9-6.
MY<_]1L?U;\$$X;2EGI\?\[OM,$_CNGE)N!#L-4B;CF 50!YZ?D>3<?TS[4"U
M@8+G1D?_[J.;$ IAN.V-?,JAYB'N'**^:<F-RX@AU:^C&;?O9?AM]G$(&06@
MRQM+(\VR?XXT].=9MM1?!5$IKI!:_IAW4L+QOV^<WAX]_HS_-/>5F0I#QQ(,
MH>_2D5P8>1 T<\G^P-^U\]OTEW0G]!@9<G(5-BU17L[/SR4HM%=2!%:B;T30
M-3;TH-XE<X>1$H"O#CZ\27O00.&=_I=W,<Y'#'\NJ[TC]O6"1QR7ZJ?QXT7,
MXGZ$ $;R]^6[K.?5%36&CY;D>!5CW*'^\TEN;^[T1I;C%\O$ZM_:[1M\W2#$
MO7V0G%C[4OP[$C1\-/J*'C6:[A3B6Q^-^((N/ZKI<;.&5\AD9)K,5I"]_@8N
MX*NY7I#A6[.3I85K<S\USFOM*-P!DY7])/])-5U"Y5S'4^JU$+0!=Q!-=R'$
M A4'/@40?2_>^2J=FQ*F1S@C]&<+%H3$+]&%J5E;L*17H9)-A.-7)^O%-#9N
M@J\8O-.S;.E(9IVRZ$?RT)YA!U\_8-6MBY<GZ8\H#+?A!Z>[(K>+@_+'!)H9
MW1*YN*S5<-]>$U0D-N(D0, ILY-"=WY@8*[,<-]K=J-DK_5.#V]B29,6T"*.
MT,'R<PA;,)IJW]K5,/L_<8&I$U_ZU->)">3K 1K.]*"EK(!7F,)?K"L(U5/7
M30,#?BA7\G!<L2K@*UI0+#0EC4WDZ:MW^O5COXE^,6\M8E?TAJ"-L)80+HPF
M>SDF-JG5T.D#_0O= 84O7WQ$9F%&V-(#5,J2#".(&9%I!;J]F;<6K.R^S42)
MO-AP']J8I=MP!?>^+,E=3T)Z \FNG1FAS,.*A1V_BF8%;)6B(+]=P?3?/M3+
MWL%Y;?#CKKGL(O-.CW;SP=J6WFGW,I8C=P(0W8)Y.HH@4]G6WQU]R_TG'[&+
M&'!7[@6#)>=MFM&Q)S8DT(,AY308X.)TPZX>NQOQAGP!\(OB[:)4\;,EQT8Z
M]U2'QV[ZC'Z*#1/%:SDZ6\"+D>64I5'Z +,X]C(6'K)#[O$>Y^-JU>#(2[8G
MV$$CQN*$:B$,$/AJMYO(QT<6C0^X6>SM0KV[R'Z -%N:\Y*$3U#6'BX]:G"!
MY!QB[+'N,MRT <DH$?"/H5)&5\[1$Q/66JME7;%WU),=2KC%XPL6<$_L;FBD
M;[#[P>5I%G$')OC&BI;UU6'_U!"N3 7+"6BQ18C@OE25;<'\)UVOF-$?[+"Y
M(SCWXAIJ"LW>#=#$VQO/L=K1<FL:2R><D8F!GBE?:^X(:XI9ZT;Y_2*/&S'S
MP"QH%HI2FK=@$FM?)HS.QIW/_O&)^::S0Y6WY:7X1*[>-F]U7F#HP8%2,X,#
M&D>5_>KYV ST#6X/N<JQE3AF9.O@V*:\[^,Y1L+NE Y-\[(<;H07)QKP)"0A
M=U '&^",X7\!P904[]*;HGT>8*/?7!"HRK\8S#J!/02FCB"#AO]6DDGOTNV6
M;]XZ'/,C!\;YZ;.[6\"XFYK\F8%.662K%3J^IQP=%=':_VGQ)6'N8L QY6<!
M 2K<5;>7^]:^?<_YMSRV::>_'#=6N6"J MSZ^4\,.?/LI?C^(%"3OSG%48X<
M1RP-N/$LT/5 _U6^7XKAI3;3.FQ9/286=)ORP1J%B.@]31=A_+SE>'S^./'W
M-#-[I.D@6,2L>=XV*<PX5*2ZXI=YQ(IO.C6WJV]D K%=-'8_UAU<9YEU,=3:
M(X8;]Q"/Z'T2'S_8W1H'S5<UO+R:+1U"[5VR:M(1FZ]RMHV^H1>FEV<JM8RV
MG,]AYK[R*4(-+M,2)BRT-,OYW)_-^VT(<S(1Q[!!D-#\]>GB2:$.MJY ZZGL
MC;KZ&T)+RD5C9 \DM6@+1D?)TBF+'H /3<E:[RWIODC"(:&-?V?O;?;Q#Q$J
MB]A[3C(C.;EK=G>7K/_V_[M4,#9I]<-C1*DX&]QV;E.<%TTZ8#K%DE0=._3[
MR8V&$5.;!73O\N(MEC+N.X7N0DQ>'R,FZY"Z_;WPWY)MB04MS6IE1'M.)4#-
MV((I ->?1P))RN)#I-&IBFJIKTOWM*6GS7M@@+.R"&,]@7O ^_"4N)CO<'_7
MOFYO+Q&32%0&KI]2O=Z*''WTI1<2I)=FS%D/V9-AUIAFXF=Q<-\Z6T:GPUV[
MSY\KABGGY/TSU?VJ]B1DUM.4HT'M!37@2UH,TRZ I)JGP-"NCKI>4-4X\^#<
M7.P&9B$:\@"?D-0IXNC@O'6_H^CQ-HE9V8!\_A&9->3B .L>]@"G<)6X!!?S
M,U3')CSYS'+-AFE'>)()O8F$C\3%,H8757%D+'R))RSTTPFYI>G:A\<.GKTG
MNI"\#H"JLXM7&2.T)QVL<0?9"\/+E9F[NM]D,T\4GG[H>"C:/)$KIKI=AWX"
MJ_^=0B/?#_6*=3C1>Z/RC.VWGR-=%+I%+ZA^J[J5\L#U)EDJU ,SZ:JQC)7T
MJ]BN1D[VF'"TJ_W.]@B."NL-*M+X7*+B@4 ;$].05#SR(SEI"^:#?A 1P'P.
M1$E^FJEAF7W-+XV4AW$K<;)8N[ZF(Y@;(^UU9A96X; ,"^.I6O)8RC0BA:Y"
MN[H%2PW5>JWA)"SZ8]%Q]3VEW*O5ARO&UNC''HL,UF@D):6E?K7[YEARFT _
MAX[9Q'=NP49G+],G<X--S)MYL$_V<8:5WO)N%WF._< =\F#B.<4&&I9WNQRY
M(P_N!^*N-GDZ(D]S-*&_7;@]0#FA'8AY<@ M[F,?,=PMCZIQ"K]Y<P7]$*AZ
MLKA4BCW.*21BE;=@WCYN+LF2WV;#7!T:%]8(7,'J+=C.#0:Q=7G4Y3*8&4KT
M+>,K=[OO$G+HJ"VBDF<<1#(50 E:T-C,[$!0Y87:$^0C[M9NRWFCQ,%E>>X
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M-_D5480=0B<G<>%%[7:!M*J*X&&?$^G;8/8\]) 6Y%\1#5=9)]EGJQCIA&!
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M._RSLX4/LPP'/ET(["0[ ]1$0G53R31YM/*/LMK0S9RIKK81W;\/\U[O4ME
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M0U:'2[;[]A&Z(]-N>\6OU@GJ]#D>V_/*K[.3#7D*Q3 %_VQ>%GUW?!8C,G_
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MZ!\\+T_S&HL@2V"1_&S%/$.V'=W"DS?@42AR]>O())H>J HEY9Y*.RMN7H\
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MV1,3]H@/87 >8R&Z$"/.&#XQ[AW\4.(>YG28]["5OOS(DVJ@FPEC-X=04("
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MSB3,1Z54[\JW8@@QTV%-DG+U%+6*@+,I//D#=^KN[((\-)K:GTE&M!M5M3;
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M,7UZAQ=WHG:BY'%$NW(,<;)FFD>"CG8K]VE"R '8:?%%[ 9!)FZ)GT'A=87
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M2"JH8D .LQY:F-011:@B*+)SU*+(1@S6\YE+?*YN.U/@;=R,)^C2:$-(&&
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M!)?DV<=LFS=8;>[74==$O1^G.%QHEXKB+*G]E'>%9B;9(7IC;_4&% ,G6N$
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M"VU5Z_5+^\5=?GIDL?2&)X57,S-?DGOEG6M<FV3S_*6HX FJ!W((5H'MV(Y
MJN.(74T$RGKHY9+?F?Y=D(Q:+$_H<F<SSSMXJ)=-;46>P$XC5R07R@I^/ !4
M0@ZEE97)Y'0&W\X4MWDS/?U1NIY\'J>"O(9JK0GX/6^/:BLG-OWJ>+)A47]E
M>S.;/<$T8)?#F-9\!/%,@AK&MPTL*M1_+(FVZ886.2-T:5]0[IA7#U:]%Q03
MICI'I?VDE.^P/EH=;MZLIXN%8)3'BH+=#R#HW)U)'E"HG, #J,$6Q\9VH'P
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M28<Y:.X:J28"GE<"XGC-JGVG+VXHWFDW)^=:);:1[^!<.95G>]"6'\@*P)5
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M^R')<VODJ;W.2,V6WF+JE5CF+HY3ZP5U.,I_K"" ^O&G6M:S$O@"Y"/19IK
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MA0O7+9T#G>-M%R!; NS%TGP;"N#G=_(NJEN 4 ;GP!0S38(Z$' ,(UR/.NC
M?H'-KX.8^J73SP%Z-RW8BZR+N[=\<9>KT<W?\1^A7.ZSXM^&N:=V%&<?\6S
M+2#]&G,XEB5TH[%/.%FM3"_%A8<C/(?-I\"H< &H=_-6224AW498]0R;G0<#
MCLV+4<I=W5.C9CJ4#XQ<IT/5+<J%2+*TJ+_HM?*)<<50_XEYH&L7%AJ;H*%F
M!4[!Z7#$A:L%?#!>N.N9_IAL$8R1N#@%'GP7GP6EG9&.?RT5:"*KEW\)L@9$
MRHV&C1^Z[><MSB5KJH3K?=NW3JC=2A@Q:Y+M9MV!"S$/-U]4,)K%^>[O=>Q-
M+G7PLT3?NEY8^4-FE443&X037R1'P5Z\RWG(/OVAIWA8T@;O>W'PG="'_%H:
M!R_#N6/^[%_6NE/WZG9^4-D5BBB5;8TFS^-V7?P/F"N<IO,<N#00WWP-$S;Y
M\X\?Z:TG-Z-V(#_)5=<Z>1R%UM%VL:-,686W_+=P'Z]4A%OI/8=-Y6'X"%/"
MF$%#X[7CUOF]*7MTQ/[O6O:$A;F$,YW^T?XZ\1 ?:C?-/[U$N>D1I#'(!>$6
MJOV\J)JDI+[/>R]W='\!9$6UN U8JW@@8Z(%=)) YWYLV"NI<[)W:^8[GZX+
M9-0MH1GD#KJL3J886W53*-5&B,26S-^:;YWVW>G/_7H<^]S2P[)."W<_OP^3
M4G#H[4'YES-1@X=[D*]S* ,(1D2W?6_2;9[.Z>H^)&E[N]9"3*#F6\%)?,Q
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M/8@79GB-FLAR7(%(DU[Z)9*!J1/&NF^57M<1)&5G*/;3BNT!<#4U+54TSC+
MQ4_\>]UA2H7TAK!U$[Z@/&I3L>MP1X/]:$GO1K]\&[83 *5%Z,*65HPLI' >
M79]2EL^ONUETFN^65"7'#+8:<+=_^('H\SJ[Q"4Y\P[I[>:. )O+])HX4/\,
M!@'UFC3 IY.-ZO5Z34T6P?F'0T+L>E@!E]R*#]$';]=X?$**G-\"ZZ[DEFT3
MYT"TS:U(^TXB0">'F1*8=(WZ^?* PH.-0->M;6R_*J@M0LT>S '[<9S5UM_,
M9T:&\P5UKZQ?$F2DOO"%!YK8!^9".%Z,>^J%E*1JI9P0]DV!E2SDQK:O1R G
MW@IY7P'$ G$6Y*L1 9,2#Q_<+KCK81; $7D2&Z>%!E72EAE9@=\1/#6O/%PJ
M F.56K]_M(43*X"294+Q7-UP4LO:O^0;Y8&<8EQ*%D,;KAZ3UL<6"<*Y UMP
M(6>3;9'UOS&/Q0YH).G1NNW.,B*0?&!K)O(IZ.=&@1K&>I<.RW+Z#4.7G*UI
M3D#]9:8HZL]VV2V41JF2CV#;QE0AO/<7G)B0;.U'XP"='5^GFRCL/->1V_;=
MQK9C05U+^X$"I"U)*,?3]F)FPAY$X2*N42Z'PZ)UM ^HKX,7O[63-.SE@7VQ
M90IST2^ST72,S@.%[U8-LN$D1 J.;*4*RKC.K123OPN^+F?J#-P_\O?PCIVZ
MR\==J.>N+T#$A[CHJ8%O"NYN[D$LTNCN?-(K:]Q O0_@AA%ICSVFUE@QM9UV
M@NF_:5>/Q1-(VBVO;#8%CWHTF(N<5BT_=0]\B)-DGMIO^<>4)3\.@WTC";X2
M932W6[Z;M&P+@G]"(K*1%QEY<.+'/4A)\LC2=GJC?:,O_V5GYV)YL3_Z1PW=
M =NELT^+C,\]>WSCVY_3/\)=],(FJSF8/#LT*P]X";I^1?MF,2[!ZU7)M%=B
M7LHC- 4+7)[ZQW _*ADK&B%_HLO!<#:PDU-GS>SC^<$OM_SU; (_)^G<_6@"
M#^G[]M-V$MI,@"#5>_(&]2]->L,X#KBV^SF?U@B!6#V%EZFNF)/@(SZD&\P+
M%%B^0-';-RX:SY1$PG;2F2B<.W94E9K%VD/QR,=I#5!^;RW5Y2IOJ\\>):-)
M8<E<!U9@D^%?4$5T/]8C.RQ!P/GS8?B&A3;SZE/E'-6/P&^!(&PXG#B'&:EJ
MWB7U2).%MW"=Q\P5S+(P3TN)B&)67!1..($TX'H%4Z-?&OSQV+4^Z>1JSH4N
M6.D\4Y=%DD[,PPO.T! </]VJ7W3VQ/M$8Z7/Q8<^S4M&$PC%:/HQ56+K"IO7
MT04'1F1ULLL#]8FO+IC[?LZ41_=K?$J-GB4UH!;BZZ$YP#EX"6*91+,"ZK68
M:OA K&&__VB\]E79/ZE;U'/$N'!?Q*_]RVXQH (T<@_BB8D.1H27,IX>'$I2
MWCY?>;!?6 (X["YREKK=A'F%-VT4Y/*4/#=P(T@TM#+5\*JZ.M<6-L9_#51%
M+Z]]652_;9Z=IE9X_9;M,$-Q D[\LK&S!RGRB7]85/D /GSU4F8]5'UH0Y9V
MEGZ8PK5B1+LBU\!3;87Z%O"4I5(LH[IVVY_#-ME-UZ18\P_?@[@9- ._"(3M
M>*9PB"7+S%NHSM\?ZXQSE[M^M-(5IZP$F0)5Y;6]TOW0R3/%M3?:H)YIZ$$,
M%UWL0>H3_06*XITC[,^Q>!9QB7*Y^FVBB4-T82XBO'G%7&EYRTM1.Y%?<_M[
M#:H"FZT/GU3F:'IN0Y@/+BC]:Y;YNOS3'1>R%KV;B2>0K7!X4ZI&-/,(@7L)
M=CJI<V+ZT3N$&1NOT1:V#$=\"9!M)=R:PY=(0+.$359UV.#@^..<L?8Z+';*
ML-)Z1.[CY6%>W]LH/3"6!&5W+_:2E!Y<7DF2?U]747FC4X\_O;N_-%]"U4KT
MT_+?-RE<O@M]6N!)%N,$LN;[AFX.=E!B$"-[$-+,-(61=L/1:5!C^2'_.&7K
ML_D=!@^XP'IR@<5-G,Y=+J&YC.J&=IZRMQ7[W/2O! KJ<E ]!DL/EB XG#\_
MY/!3>L'"*AOV+>#:!4IQQ>Y!W$/9X8?I]RD/R^\.9;JR>WV[>G.G"W')>?0;
M:T/G0[DUQY5_:A)B\,E7OEM$9MQ)XI*85_A#RZ,&L<:63>=C?+ZLF.MYZ[DW
M['Q.,_[;W/!D[;N^4F6-&[\<:]37%5^]XZ@]R2'8;L=:<'=4 [S$CGYTJ#78
M[143ZIF^-?'!PW?6ZE1-HCR+CZQ[<=8 ,1I#MM4$MXGC>B2?6']-W9(BA7?9
M3[H6!L,TW^P^Y23RBII+W&R9;MO*78]&NDGUUYCXXL/-9H?M@APB93<2!DYP
ME%I8BM0[*V+ _*E8P2@F9 #I%JK0*HGQ='W^^,4#P27#'NO)M!;X :1,M^Q@
MM2G6WO T5-WJV5? %B&.W$?8.JH+>@AIB#^6[H-_+SLR>TGM;NCZ090GRQZ7
M<=[86&BYZ<I17[(&L88QUCW!></[/#&S<P77N(5]# KN03C'//8@1U&2]F#Y
MI':SP..AZQFC[:D\CV=DX'D.O$5P$[B;('B64"^(US7+[/77LY1+*7NUJC)P
M>V-^&)LU9%.2,>"C27N9?@:NV$0*HQL#.O"R /K1OBD,_6A(ZR_D)= -NU2^
M>_X#]+U^R[I5Q(N@ PROS6TF=S,+!\*EC-S:DQ[.'$.JDZ'7Y0,ZQ,ZIP&SZ
MF9SA0=;=G!,T"3'(EG [_1K83$1'.FC^;GU=2E,$Y)%M!KV9#"MKBFKK<>!0
M-=OWP(E=8[-G2[8:5<\XI  '.AO++HG,48((\!B-5Y\C G6T?VV3U;=NZ+K6
M7_HT&CAJ*(-*HYNQGMI =>Y!#M'-Y:)_EJR5O$W[MW'Z71$&&>9<2+L U%LQ
MN5#=Z\;'7[-"&7ULV+'MF!\ 1PQ]"N1B&0X_3'< _5TGL:\)Q[2J)*YZ^:C?
M?E#U+I'YR6M.==2.R=-&&6+RY%/81R>M&W!"7OC4USG-LV-7AHJ"[A(EC> .
M7'\!TS([:AJ9KTKQ;?H9&E:,DXLB?$IH\U+]HN+&$I.[D64B230U$_3. ?EN
M5+_><B<2]"^'3RGH8NJ&YH5S<"/E&CJR._6:1S9E#C=0=D(N;/X@B 1BS<GP
MZ-72\5N+\IFE83FG3?D2.4,& 72M @@EI::=*9U2?JHG+TU;.T6TFUJC'Y=F
M\OFY9<^70P5AAST3$4%5!;,ASR'?"Z7A*9!0!OD?DQ<@YTUV-0>BQ .#CG5N
MJW+.I$DKC%J%FA6\YW/YBIUM97+[AOX,)%"S>Y$W\P/#%TT^W$R]E6#^+NSW
MG4E<SHF&1PT?NP]8H/G?RZV)%EZ+7X?==I%0\/S_7H7TW_VC.(,&%=Q6/HDL
M?Z+I+<%4>K8TO+_A55R>#$O/R)7WUN9A6PB@CO0-"IPNG=[RG@>SK/PXP&75
MS9O#$9, +]F#K,"G +SU)"QG<NWP8A3)Y\Q$=I*YUHS0PM&D@(7B8K4=LU=O
MZ/GS4%".L.P62KM'M[+F]MC-<F2D/O#@C9OVGXM 5&!X]R#$, 3_,U5N^^;\
MMGO^FF6%Q>8RR(@2J 4?_..!GBU7,3$K#$?>JB-=0:9OZVD[9F3HA 3PE$!"
M]-T'ZKF9@IKWU7QRD\=V (8G$D&^*!A1F,7AECN=4&NW!W%X,6O&=!4QQ@D%
MI>(?35YM;?,A8Q>JF-PVE8#;)W:=3-=$#\+YF5;R@ Z<R")$GC,7I:VTS!=H
M.&9I:!#M JK3 ;I,(5DB^-WS>1P#RQZ> J_)R?0L1GS^$M8;P_V?:V:E(4EZ
MO28)WXV6K%F?CE;YYPS7OBVYQOX(8<'+_^2L^V?N^%HJ0<ZF-_LF7LW2&")]
MUD!>L?(Y3I/US,&ZT0P%N$SVBY9S@@ZI,1"/B^U^O>_%']]^'R*IX" /J>OT
MB),9K]^_L5-J/"&X]QBA<?UL_[4#5XNC;,1\)[)=Q\Z-Z_7V&/+$\2N?98L2
M.':-0\C>D6.5FM?SOX\@_G\DE$[Y<W&F?DECVS[^+?F71_^;[)O3W9W?U:TN
M;_#SY_KVOI>)F>MP>2$_6U567_#SMJD=K:2T+C!YJBL">?:'>;:G;DV)#_3:
M6L?U/4@4!@S8@UPZB&'0L>=S_5)[/[Q<;-8:S^K/2WI8>C>/][H']<KF7\%+
MSFY[$ $X>8T9Q0>G[9@16 !MK,EC*O#!,!N]6;2 LWL0#(76 PR?[**#:6-_
MH:5_I9&2 ^T?RY/KZ0(H1\1WY9XCO PA1A;@#N4 T223_)R1I>-%YDJWG;!=
MP?3UBMO,;M=#,IRX#TB7%J*O?<W):U^S*X.#,;W.?'=]*_0SB@JLFC>4&=R-
M,EXEZ)K>E$M2PZT1ET]^"'CWKG6\0Q.?ZJ/115=<EV]0SQ-[]!/51%"VK_0<
MKV&_6,E;^HVD%_BA*;4IP:_9]8Z9R[4#0=L%<!YU1Z^R[?+K+V_JZ,7K"I]M
M%+*J24:\U_IF?N^[?'ZYR [T*Z'HD;E(?8=.8=<>Y+9=[IID5.USQD><.YK#
M'<'_J.1?A_, K_\8LZ&* +*8,QJZ><X>(/QECK1I5'_1L3J0;QR2_]U)<%)\
M[G3'S <[SSA,]:YV_V;'5'=/=;#H!OR_OF3"^ H3CY0)#/^71]_$VOXOB\X"
M=^>@&Y,(/P--W?1+IV.(U;*4O@:8<I6CM_;-\C?O"]=A(4.^1WFXWA4DA@P]
M%).(;&[,B'N;]F9N\E=@M?B.HE'S3I*IKOFGFM]]*1'\,3_6C\G>5,O8TJHX
MI?.S9*RT+/I\K,F6S)>8LW$F,H?.YJK)J7;EZ$218J)F29.NKZ7E FP7#,4%
M5^2F[A$%H]*"IRQ_F=+MJ5IT*I(+]/"A703J+?1M)\5R7V<5#V95C$N'-=#'
MEZA8)B]CR@I1ARC,K2F83[U^9\ST4V'S-OK/ 'V:KHQC9)="XW=_%I+G&GZ/
M!3B4D&23.M5^&XP]8,B?E>E:^+E&;0$UR$"C*#QJ:_S^41G1!T(D%=OXPJ\_
MRTD^*]IDW&1_C+[&C_K*%D.O%&RCX"%6A*,(>.->3TA**E $6[J.F$JW_$S=
M$/X;KE&^^AQ[$@PC[4%&8ZE<E,JA+1\1,"-4 >_*[H:7?J0M_7G%<,5E-U"E
M6-X]^Y;M^%4_ZW!-(9(B41"4WH/0A37,&3^K3ZE&5EL?N4WP.*PDNPJ=_514
MO04KW67SB3)<'#GPX)K<Y]E3=IQ9=WLN(W">R+^W#WD8F8@Y;GU.WOA'96F(
M\#(0H-X$7VN_5"VUSTP2RS;E;>(7:8:*LMQS%5#<VBCX\O>M;WY?[_S[MHA_
M$O(PW*E)I^L./Q7;M09>0%M'J<:)5I/ECQ@,\YI>0W8J=-&%(I@\$9-0? D\
M#J8$ICOF2\C\*"M+?W'0 IGEWL#2JNX*$RN=Z7L0YB$9$"WRNF/9H?/+[VMR
M43%&+8%SDBG;<O2C4TP^<[(7-<>QYGBH*W,T%_]>I:.IWB^RR]>)T$P 90*6
MEZ:@T4= R\M@4-:(DRY$9>KE*E1%<8?(^*(O.[4V$DO%#=8>IZM3G ;?4^-O
M*OT;.2<6(5'[]L#-$=H]&BO*KO>'B=)/# &DXV3)S.>/)_2E'0M]*P2IQLA"
M(@&\@&U)A9TUU_<M(,3K_X[3U=V>*PA)HQ_9/X:!NOT,/"T(12)_6Q\>Z_SF
M>W+ 5KF4^8B?;7C(GQ4([5\+?@4I.H02L/X:R-&@^SC-5RC)6GWP-#>$@Z!Y
M\,T6US*4]1@$-*8]!JW6D +!'08O(>,[1>&6#T($;1 7S2B./Q\\*=Q6\D5T
M1M.%^B;W(#&P@\P^T;R&*JO@YY%;A&*SF.$3)^"]N/L \1N\%$'7T%[^]#60
M^1?8_"IUBS<^:@]RRXK-)9R!@Q.+$!R ZZOI;IG^&=%P'?2V!L?&',<+1:*3
M#_.0%)@5-.GJI&K7?S6CTYS]K."_T=) KN6S-#6D$6L6/U']#IVX*=6C3O5Y
MHTX%_;Y.=[,@VBZ9V%%L-)QL@1OYT)#!'MOX&]LH<&1UWO%T: %1Y\^=HX,O
MBDP[H<7E='$)FL$2\[ 51XOV4(1##*='NNDH7=]?\O.0\7^:Y]Y#0FEF])O]
M^K*D\5L>TNAKY[X73[N@*=A$'+$80S8[ YXDZ6'1 (__O<?EMNH"VM97'ETS
MVMR#> V5!OK0#VM;_.Y#J2%&%WN*KZ:_._1 ?&[FLXX- ^K0^2!&1R1+RJ?=
M;L:-+IY/2=J^!'J0?/@"'V[*_([<'6W/_!V5?&(2=T/II-W5L ]AT]AU8?HV
M4&^/TO$$2E17(G.0I\H$-8/AL<H# U<-)=TU>5OG1>ABI61I&U"-IN?Y#_"8
M@>4%/JY=U:@9V=@=FD/0119RHJD%_>*;S/[H/,9S+5HC39ZNT0<[21?M?O1#
MN1>N9UP:Q,Z/;)&5VQDBB=!%=E?U$/A4ZCWH^ZI;+X4W&=L.; ;6@SZ@C%0Y
MP%*E%L_$]R /3)/!F$W$:#)U&O2F2=*5:RGEL:52F =MK@EWQ3(-=*G8C_ '
M!+PJ";M<2A,VFC+P:J;"/25%S3.+D^YHG#?]J[B^,667P-*C"% )OJ*$U".]
MVHK7;AAJG@IXR<$9P$8P^"KQLZL*Q@[4>VZMX1TGGX( :38OT%N@EZWF=GSV
MT"(TTK]REIQ35EK0+IPQJ.WF%W?D\S;V+8[X$4J^@H["%&V'/9(=1,)=0[XJ
M_SIRQ_PDH4HBY"8:5+1;<?2A&: Z@U=C/]_A\YIZ*%#<,.PJ9FW!_F<*\%D#
ME1'UT)&,R;4ZA\=YYP97Q%^+\CS5)3YCP:/!EH6.)I;<FZ9H!AS7+<O6I)Q_
M('FE.F_&67L/<J"7@:YF[>"#QQE?K&-1LDO:UV^/-26]]WFA "HU/=N#Z&#Q
MX]),'G^:LD?&@8B&ITCI[IE*2Z.C$R<.60(A!>S!&C,L;H.3GV#K]+ 1*_E@
MFDV5D\UM]@?)'O,A0NFK /$C@7P+?@@U@A#1PO#.ZV;W-C]4_[YZE7-L:*Z+
M?KR5R0/_AF0O'(!I!W+=\G*2[!%CRI;%''@P!<N8*/W$DERM5C(XB6IC\5]O
M3C=N'!U:O::)GK]_\D"B#&[BFL??^BCC2WEQPY<%Z>N(:85;/LKN,KY2_.GT
M>WN0"#3.:\72I,\?/;+[[X9"<5/'S..I7'@!ZL]2N;='[C_UB :W&*8[0)SR
M.8&80(T&/._2VWDXL/Z2,N N.D:38PJL,"(V"\X'@*533E*ZB^=KO:O#?#>\
ML2,?O+B]5R;#3T7&G/NJ,<S/N\/!Y![X/#+"_,,4ZO\2=NE?+KN9^-#PH[AE
M\?.0%</1_I,-237-@<!*,^UTH#4U%S3Z,1_\\ZV*UJ6\DF"7<R?L_C#?8WV5
M(O)@6\>^DLJF$\?=SU#A^Z3Q 4Z^C,9?HCHQOO^ J0:&=^(-U ?OF]\F^\ZR
MZ^WR,NS .6J-'E'PM?<8D_),++$)J/"J=;]^@9YRMW+M#F+E.!(;QI1G"YB[
M6#G'A+A+C- +0572((820B4"')ZWF,^&:D]5W;CC!J_56D8<\J>R7%4H"S#&
M_B=N2G9H&T%.F8G_66)X?6"\0K4#Q!^BRJ7]GO/,,U6=P8*$H1$H^8G=<I8K
M>8(*Q^M9E%_6=FB_6^(UXGIK:0_"_KEW;GF[#GU4+IYY& QI1KD#Y1[?SB]O
M=?A;\\. CZ8=BUY36% :O:)UCS)*E(V*]7J65!N;8WHL#"%SV)!9NAFPPD<)
ML03/DB>76M/;"UL%:@,THSDRX;WANIC7.+(3 N_$VHQ[D%A=1%V\Y$)>J*I3
MS,DO)Q]QG/&:Q+)B (\21@9, 72\J@LDRS*3#[:P3\E^,6&6;F&7X>1<Z&@$
MD]=@:DUHO%.V^%=_<[]>E!UO9L4/%A-CKO96J])N!RJ:]'DG>]=&\YNZT<Z9
MP',.0G\"9),$@(B9.#[.:.UBT!)P:CCB0NEZM1WI8!G)B>4<@%0+ALY^2Q[X
M>QH;Z&!8(89 T]PD4 ]85NT[8XD["EI<R)2>E7ZR!WEN<2 %G<M:9;SB:"PP
M<JBEC6<]OO<!BA-WG>W/'VP3&I1BR<,]"/D#]2DC=04%!?]=[YNL<DRYOZV>
MV!BQAF"M5.,$W*VCTN>$!P=S0A#L%KBS.VMJ->%XJ!2,W(-PG45JDP\ED\HI
MN9A'6;?2;-E-^36VA\J=9VO[P+S__ ,NE&AU*-3T2G_)OQWI.S]\.\UAXUXL
M<&PR"IFLH*C>J!;>\04T;; ;.J\MTJ,^ZAC_]T5;V]("_>L!U'N@OC!XM3P?
MJ4N1T<T_\L;Q:ZS4YEC*;F7%V39L/&M:B?"B!YAB=+VCTT5_->O\A5<;E^T.
M\D@1*2N(^V\9L^OT0_T\":KBT2D+5AJ%D3%D4PO;R!E3A[P")[$0+O?HQU_"
M9/W(V\Q#BHP"'WU;?4+Q?+]EZ =;F^G5K@E_!".U!LL46&>\U!3D ,]O3W+%
M:-Z;(UPL/UYTD"/IWQYD"-N!!96Y8E5^LH:2E=Z2%J!H+D+]]$NHW(A&Q1(
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M>0@RA+@"NE!=*Q1D^_Y(&P1W:U62H70Q"ODJ7 0UZ&#7+&'1%QR;G-;*T.P
M+ITG&[FP.S2=RZ\3!@OV6UP[X-LX/P10_=5#?Z V<!-8?,Y%&=F$H 4C)^N/
M..)W!!\+^J\1A7,Q)6W>U6TY96R!>Q#7?(H=DSMY,G]M9)M*Z4>>^FHUX]CH
M)JIPZ)QYHMT:8N4U?P# IE5E?DW8O;*K>VACB*QAZ\,'U%OYOUH>XGO'Q?(*
M3C*?A6C6+)CK@RRAR)VW'(V]F.9Z-9^T49Q1R7*W%O0/K,@!">,MC\%Y*:M.
MEN4]DC#N:7^W!\E]CRW'$8LFE#):J8X]]_A-\4C]JDJJUB2"[+WZP9.R4#Y[
M#K'BPMK^P2]&H*6IU%^C=;\N5]R$RF-980SQ&X+_!U.:V0I3Z,DKWY!)'3NX
M!ZEUJ$43(R(7G!UI]RZGX=BT\D\>/MP3L"O*W_^IJUX5/.T6B\6Y"8X2KI-+
MBG;4C%E33=!]?Q P%E7YA4^+5-X:?+13-FFL11^A"_</-4#)U\>=]5Q;=R-W
M@*7L%(8X$EJABVFP.FXN3=OUE SIOC.0C3( ZEUJSS+QF*-PCP^X,"BWOYO3
MD<DSBD*1?SH-%[DEEJ+(VO3##9O(DX,H57HH>5-C0D+4ZVLV-]L1A21!G35$
MV3;T .KHXBZ.+H,?"E-2\3]5]SM)';$SE,KR68923B+4YX/+FZ['*2JQ%X1:
MZS@\)L.M&S'@J9K$'L"+6_.$R*/SM5*5D2(]MYYF;0HSI)>Y*U[>QWU8 T_[
MRE%;#GQ,G@RI9MGKDMWFJT\ +^? RW^_("A-,H1HZ[)V]?]MJP!3"_G'T0N&
M/#6^Z0_*U9JJT#\5D\ "RC&Z'KFC\Y>W_M3A3H+#SB( GCUBW_[H0_U!ZO9^
M0[_\V0V4?-NZQ<>*W]6X,WL0Z?FGJ..=&_BKN8?2U)T]4&Z#)HM:4I*;6'6I
M-JWU_1.)%$4) CE<T@"]!Q%V(M3M04:/=$V)Q)[N3DA03C?:MAY:NG-;19=4
M_4](](+#6*^/E]9.5KE$7;5UVCW75TW79N*"Q^%M&9MI9\\\CVA6N)*@KG A
MW.5)JV;F34<IIC!5^U8E97<C2-!\@'!7O&_AJXB!SE;>=;O%:S;&Q^K^6Y/A
MDSZ@$F'9^QNJ%UI\M4HDO"0KX*=%1;AR#<ID53U4<24=C&7RSM#N+"**W1H*
M[.Q+*MX?K'[ 7(:N)N/#"KJ:$>"9O*8=@/@)4WHK,QOIR)/7)OO7\?<?C7 4
M8K(9,,$= #RLH^ G]$7NY0=:.HBP_9A2,10_DM4]M&Y-,T-U^])=P%B_J5>]
M1GY:?]Z:$>>>Z'0\(PC"B5F84D3#DMDFC@=I_;NT_";DM-OGA8GP90"AB_PU
MUJ0B_=1H[=;3%]Y=#DR;9UV@LN#*-Y?#8;5JB'NA:'!@_S:W$>;(@P.(V/*=
MK1U<2[BX2M=B3E;"X0</+^0V?4UP[>+* 118Y+R+'=4="TJ#G_ 9!WYK _$H
M,E O#;C#Q9'!H%9V8&Q+^EA:LK5;3?J5Z4\E?",8MZTO87W_MP7+_R45'2(1
M.+?"\G,R1UFZ#][@KJ"'^6O]?TH],T/V()ZX'3TG.V9#VQXDTV[S%,L_[^Q!
MVGX[ [6X]FX/U1<,GC70QA1HB.'?[Y;%O[_2"F+Q<:/FL[G?MZ6R,Q[R</0F
M/T7P'KWFV3M\E_#IW>1[?3Z9ASSJ'/[?>@;2GMA>ROOPYX1TC<I5CW*5; LK
M6PO,I5E,/*9PG7Z1DM)9>70,HTU+J/.'157@P(!EW 3+ >#03"WJ#=]CTUMY
M&_-P73#.#?+@-OU*_OU3'6>V86NJ%,%7ZLM*[C88);M+4ZK_Y2U-*"@WG1VZ
MU$4#]R!3B(?[;U]*4D,/5N(F3Y)Q]!T]8%*>8DIGP+C!4MK1,5"C/B"]CF9C
MEJQ<.4KWFG$K2^I='J[3*!_$V<*]]+*XZE><CXR]"V9RXE1*V;W71(F_9"CU
MV$;D]3;UL5B-+(N7JJNX=L:_AA\;ZEU%OP>\NE:8D2&O50X=T9JK/?L]2JM]
M.N*ZYG53VOJ8I*>.\&K+C:DE1(J#0EL5],<W\[+>BH7<<=$=0W'_#H=>99$[
MM6CKQ,0[1&\M"ZUSB3_]-@NPW!?SFJA%)KX=/A=/!"?'B_X^,S3K=]_M5=[5
MF^Z+O<";S=8&^/"7N68F3UE_-+[,O/M'_+S!$BN\CPXQWX,8J )K4T!\*!=-
M(6T/$FF4]Y$%YG[%W@#XCA8#\1;T:WP75Q1OD3C[6!'QAI[V'DQIJKCSMU37
M;\;"VOH]!4/7PUOO++!  HC1/<28/"MG!+O^YR>OY?$NIM6!RA-=2\[1]$NP
M$WL0C)P@W5CE;#G%^@/J(/,/@?QSRVS-U2M.YOW."!KP0QB/'BAG']<(6[K^
M4D%CM$8+HG%$I#PG]*%E\MVG%I(M8921%E]T5Z'DZ.&MXS>?2W,L76\Y5Y&K
M<01F<S5:3T=KT3@?/Y?*5([N,19V$3OU1#W\_:S21[:^ MC-AXBWDXD*396M
M<@407T"LE@>\--45KJ+/-B70TCG'N,N7T?2LJR9(KLX'/)-6I_JB5KZ"HAKU
M;"#5X_<.-<9P:BQ]!D?,0Y0=SZ2=0<KW,Z7JO9_U.)S5"3\#;[#VR0G*HQ]A
M1<P#)-71V&81I@!CIJ#CI=BGM1.Y4^47Q J-'(9I@P)BEF7QR@6;54]>?;Y[
M,2N/A- 'ZLUQK@ GLQ?*MDI7_C'?_7VT57.1/*HR>3&BWZ6W-OF@$X=)7;@Z
M]YJS',V/[D9F42@VO!P_6P7P*I5MF'#\Y9)58[@?0,_E4R%@U@]F)Z;\(XYW
M,[\\9M#GN-C=J(OJG]U87]37&:N9-)^:G& Y:M)*L4&T<RV[DM=L098C.'@(
MTQIL7-7E(QC'3YNRJC=1ZP_UV@TA]]:41;OY:,MZNT"38MB-!U+:ZG/<BYZ>
MM6"_,/GV%]?)S\D[+!$2\;(OH(76W8A>N; 'V?1&L61=O= /[V44EY',D^\B
M?8>3\N/62W>:60$O;RI<W,=PBGG&=P\RCV>PI%"X?'YYW>CU<<YWGU!?PIGU
MV^PP2DTSH((@VYPX @?/?NP]'5'5<GZ$!9S<+[BOGQ-ZV0O6=^W6UUBC%GRG
M33_V]T&K]0E'8+[>\)+?KAGC_75!T!8F<?FUK:YP[O.?\)F80;N5UT\&$5RJ
M]&Q^JQ]3_/#A L0(,A\I2EYRR8WVV(-\22V"/_KRC1S,P"1ZN[4R*(8>?CM4
M1MCR<A^35R"_2_.E7F#]*^@++ Y.G/0YO,A'TUI,US SKK)7>4+8[*QE8[ST
MS@% >5CNK!$:O"*&KK-;$*2+:Y"]FAS6EH'\P#XKDU2M8IL9DP_OF//48_QS
M<.(8.AH%[2G1P(ZTZ"_%ZZ=Y9]%2=MNK3I[_-HD3WE?[:W@.L\'24=8&_9V1
M)?$2[__^ED@2][;$)\YENQ49]68EP[K%^A>GWDY#@P]TL;/LF!#HT-5$@*C\
M6"79"Y]^_\*5"SR(T@;JQ2.KH:68V$<R;)=AIUT-N6BENS4LVST!&20@G"4)
MW@[MIN9Q6)Y*U>#^Z'/RFJ[_&B()039FR9L61 GA5;7QO4C+^,"V+2YO#M,U
MN98]2,QQ@)MY$AZG91DF7'WXYYQ<WK]TNC(CFGEDF#F,(-OZ2 3&NCA=<OU>
MT'Z%TQ"O_1!G 1"K<,<)I*%EKI_6.9Z*PLM/!#(1LWN0&R'^V#2 . 8/"VY)
MF3) 3!TJ%W(I&$G;..F+23[&XXX>P@C: RX@PKJ7\K*T,$9ZI13"3*&SUKZ^
MWG=L%-63WIF7]W-* O_;K=_,"C!NIV0>_UGY!SN'8!YB(ZBN7/JZT(-YLR7?
MCW91.W:X''9Y *; '$"4V#7:Y-W&ZWG H$4C&L9/IX02="! *2(+1WYLO:)*
M]FM\LH#A\/_W1_"5:^4!8QEYQY^Z&<'INWY,GBP:&UV4@EC.\<\K?UD0OUJ5
M*<_R/!17'7@*ZBYS',-&#V*)LR;&KP_-SMQE&3U*/=.6_\S,C7?":/^:#ZYE
M,M1&2D0.!_V"2-];)]['B<.),];'".X.#>Z#?N<2O'4L5:;V(/K-H2R6/5#'
M*-54Q0<0HZ+O,;#B^)+CCEC[W(.O6X*$U^%T<2^RWAW*XUCMI@\7[%>>,70N
M5]G"U]N!2$BY 1=38($LF<RU7$/"G>!S%=&X?.F"$::"M>RB##E[$;F_.JT3
M5.R?-5#;FIK2[>\#F=^#\)[IGPQ;*2@_,?/V[$E#76@.JKQZ\(M$MV[BU-JW
M/Y_3*M?MZ,>3&_&(&.!^**KU^NLKRA]KZS$5 SM^K%!@WB/"DO$#Z9KGD?_N
MRQV5T/-V\VET$<243R22C78$C+[RP;[4JWGL,M^3VGL[8J!?.ITEK"*\MH*0
MIC2+0*Q]V?TO@1M=M+?'RN"?/QP?=>.&;[3Y[=SXF3D4$WWUY*_8 )LC>Q"%
M%*C<0WFIZ!LE(F5''+?/QMEM.+)\RBFD?FT1H\1'2U5JY^+ .B%F:+.DQGH0
M)X4C3F%'6.\Y@Z$%]-"^9U/ZB4U_C\MOZ^R8S^NL& [.#1#()H+"PXN8(I](
M3<>@8MG:M"C$5<7E/Q'JA[? UZQY49@3#A>&5&#'P*[KQTT:1O_&JV:O5XZ.
M/E>DMEX=4"K--UM[5C6?FW"97_0LQR&3D&M'QHJ\W_)'W%C=NI?KT &@+C:R
MKS[?%'ZF>#III4Y\J!U#O@[%S]43V&%L@4D]_K3;I8J?SD9FBBB<@)D:83P/
M!#=C5\Z28^TH$/),6<V'W/EWDC@'S-3*"DOJLE5;^W*LQF^*?8IFCJ0S@W!$
MEN(LX5JY1+-@XG=188(Q/NE_)TDO/I%\E 3/L6T\P\YSM8HZ9V8R_XE.I&#_
MS=UI)HV^D<G(^Z?)1L>C6I-D\^C"7%>JE5^+-)6' &L,U!!0?X_)3F#V00N=
M:J,][LU9^O@JS7EN-&0R4\ 4VNFR+E#A_#O7&8 D6S7%'!W:K/H!WF]M(7"I
M; :4'[2*HQEMJ77;[[#M(P+I5P*JLL L1C]+@67W7,&'E9:_'M6/BIO"Y(2Z
M[;<K9_:<A_$S8K?6^#UVWU@93RF]*HA *^-:</+9'YIQA4/T8Q8&IM=^)PU9
M]U??[5S\5VI_/GF(C&4)\_!"9.@ \ B'3U6-<.;H=_!2'#<P3>:9R*9GE0^&
M86X!]37P(B:.O&8] -/QW/63IW"FKO-@Y +:$G)KC5G(B])B^XH:04&?/XHL
M;65>2*$YL?:U4@0I;=F7U"5H_DCZ=X396=43.LVH,T!]74^C*^W^_*T-@>:5
M(D'Z07D^S'ZFJ":/R;,'(7E_.@^#KXWY[V2QYF1\)S2Y"7;\A-B[3Y7[N5N&
M"FNPFB]PO[@B7RR4LMCQCO\."U=<UX.2 \OK\SF\=SJ!M=?RQ]MW0J@'6(]>
M1SHS?J*$3"D:C;I.TXG5F3<_IQOJ=&U[S=]@C3H4IGM%R*W7WR:B4\45BP6(
M>.7KL]"1(ZV60>:VSSZB.''74D^+%TOJ71,I!%V(:%#;MDE[XPO8TG?SIMQL
M>R]TUFL5/ES,Y(ZFZ:+:-QS!R4%\D']\IFO"(J3.)>\6++=V!<(1 =K^TIT,
MNS,-D_(ZCN-!'?%$2?6%MZ1;A3VK@T"XH8,X:1@K:&ETU@,#IK[1]7(6RS*N
M/&J<]<TX9*!(U6YFGBRF1$>N5:M]NR@33CTJ_G6<^P_+OX"CK2Q:P8QTM?Q>
M3A_8;J2)!,@D-8=@<B#OR?L',6FU4E]>ACK_RX"Q0G)>VOZ9-HNF% ?V(-Y8
MOJZ@G\Z-TJ%?6_1SN>*;@D-N:+ H@ _N.H3VH2M:"DQ4(LC8 $8B[BXN$E>4
MBU;Y1%(5<,2OO?NC_^5"FQP+$_,H=J#^,0QZ_O7^.=:@OKFFZUWOZP3^T#Q/
M!@NDX<Y@^56*R/(4B19RLO&#]Q&IQEZ<'IPXA1F1OM9--Y!K'5>T#)JNZ*\_
M/6'0R?Z[W*B+8L<*G#DWF>-XD5?5.M] CN;?[<^+[;^,-@HO-ZB;N1(YFSG@
M]Z)<Q<1R]%\<=5\9S%_XG9*0R=[AYB<>4W>XIT)Z\YN)M-*Z!7M8FUP.IZN5
MR^W"[LT%+>6+3HDMZBL+=YPC:"9T!8KI*TR#P]7*66<3-G>RWAP!7^O/&F\%
M<V1"%.2BZ2WM.J=-*@9NW2H5\)D9BZ];D?NL@VU3!:7G6KKP:.I;!G:5A4&2
M/(YV()5R(>C4W9>N;=.4WO!>^&-6F/'9YR!A^<.45[3/6_<K-VB/'9@(P&WM
MQ80<(P_GL04BB+0@V8S%&2KWNZ@]B'W"V#9VH8HZ$[Y]E?&JVMKKJT[04./E
M*Q-Y3X>(<G2A:%M'5?#LF1092#Y?ZAQSE)<S9#6:9:,]"#(H9G3%.MOSQ5_<
MQH;RHT!'IL B6"-3,5 R?D-:39F9K&K=B7M>?3AY;/[XMHCZ8_[WPH7Q"<+!
MUQ0Q^UE++%T,38[I<HIV!-''/\M>_-%@V*Y^**04E4IG8Z370E%=*%%TXP1W
ML7'\*:'DZ4BY$YN[=EEW.:J$A<85H:IQU\[\Q7>6>V=Z=(1^-1.R^_;#2F02
M&E8=XGL&[29CIVZBIF N^@N:X=4$)^;;$8YHXD:@=K]!Q%<K[WS^G>MUD>^0
MT;^P?]"@[/Z5/%Z30XUK>. 6&6C!B5H]*9KXP9TFD]MK*-'!T8,IQ9S$W8>&
MX\2%<"29'N_)B8HS8II[D"6[-D "1QQ'CXBT4FT1^%+B[R=FMXEU78_12XC/
MD@*4AY&3:,';B\&WL-Y/Y$IB+DUW%L3_$719<[BH33-Z^,2N-\QIC.D/]]J#
M@*>&6@@C@_BU5BCW,[W9OI*ZATFVFK$OQ=WB:':AK*AAOQP"3;]/GFLUD*.Z
M4QCX>*UL28^D^^WGZD/0P8P,QB]_'VY'9E>&@J0,KO0R\]^C9LW%G"A270>@
M#Q3KWTK'T8]]_PM$/9^5;X\OJ=/FW\GJ#5M%X^&@0@#]& HQG$<J>STE<=0F
M!KYR"\__DI\^C.WJVS]'HAN7*(OKEF;<IE?Z,H5W_2APJA*9:\6-;-GX6[#9
M^E#S5ZTXHQ<5=?6=(4.)5JRAGF.\R^$T!KWO<L\_Q9$,2V PLAQ=/&+*.Z3I
MN8-)U@\'#E]_\2L<Z,F[!@9+XW!BD2-*$_7/ =Z4=K_#ES13^=#YO0[6CJ6'
MZ(?W(-0'O5KR6M:@W7EVLX?VPF'.O(FFG@L ,1=3O'D$U9K>B<FTCRSOINM>
MOW#-;>8 OV!GV((?"0>>G]BM\\#[I[?1"*4)<.)-V@V+O':OG2662PJNU;D-
M!E QO4SAQ4>/7O^6860O0Y?4",(,KD9-;2$ERI6BK- ADS_P5Y^O;%B/L@>Z
M@ <+QC2>%#X%.!!=T76A:OKF^W>9#\(ZM5W^P'>.6##Z6:N313?NA8FC6IB*
M [,#IV(""\+,TJ^)TPNZ_;%-./"T:G0I%"_"Y.7X!J;/_K7E+[/YW:'DYE'_
M=DM3X%'H%NL/9I!_E..*#T6?;O'U(6V-KS3:Q0/UY;V.QIP?'A5L\!6VTGEK
MI_]3URZ$:<(5P:J4SD6'JC9.2W'(A7-!/Z%N O75!+$/]:SH@9E"+F_2YNP7
M*[+&7ZUG%DO,<Q4R!#EW1@WRV^%>2^^\F1Q+=@D$!>,VND"P:\%XP<SO<4>+
M(NF$DV)20YU[$/(-U5>[IHUK(QS-VNN+3YIU'6>DU5^TSCP.CY"GFY+LZE8D
M!5G2K?ZJ5M++HC .=OA^SEF,?NKU"DID_M8O5:&%>0% 'T<V!@0]@1(H_9C8
MC8&.EQ.V]B:30=)Z5_GS6'HH2U# P^H+B/IG>9$M'!)-_CP(" 4(-=-V.@5S
M ED*\%P:R(;538 7YK4RUKT(#RZK3=I@',A04-YC'>?&>'8HV@3#P61WE]IO
M4!XN![1-H6DG5UEDG)F_>_DJ+A+01I OSR+ 1[Y=]/9M8/?: ..TG -G,[I&
M]P,TV)_]_^EEYB92'.D.)O/N')\H0R\V?:#S?1ZZ6=II\HW>PC,"- ZZ=*JM
MGTSRZF/<_G4^-0,74V3X_<Q6(K'0<W^>?AS,H=RXP;!V5)WD)YS->R0;=!%F
M&@4=5B3N7AQ)?8P98WFBH70D#+0E82,QI3=T3:,?)C:\;EG;KBW=:MZL*$H,
MZ\3OI)_D8?RTR9YC(6@D?^H"^M1?]062,V^<QS]\JVL!NI@T<:JC6#?PZ^22
MQ1/J]?$%OX78\Q[WN49C4B+F+N0:BBQ_MXV+"<Z7<6O7P?9,K>5(#L*UTBK2
MMZ!\JX\>YGS]7*_3;'DKI^.)H]1^G>%_:V:9M 8JMB['8IE] &\IXI#[H*W%
MD+SA>C'FMZDG+2JK(O+A]9_J AQ76S?LX?3#').XW>%J@Z]EH?@O:":W  5E
MND/7^OK" (_+N4V56N]^<K8=>M*!RV^G $XVA,<^6-F#O/2S:<5V7/$!I4R;
M)T?M&G71T#6[S6\57USG2><,:>/RAUQV\EE/(V*- ZQ(*Y?9%AUP[BRB32,4
M2Q;2=.EG>NEZWXV4? [FMMAK9&1L;<4VG+%6,!I,U;PAZ7#H+9>:PB;40EY"
MYTOXQ?^;_H+5?M29/4@2S[<]"(:DM>S_7\N2/W]=!<[N%[%]^IF_![GWX#]7
M)!W>/]#:@TR/J\()B%FOG;7_8Z6R478MQZ8<CF0LL5^.?&[_O.4_-VM\?A&\
MW]D0CQN'IJA YO\7IFEYL+<E\=O6O2\*9^ EA*@M'V&D7O^S&H61G*#[=7Q#
M.2@4 O47<YPYV,$5^?B.W6)0N%S\E\0GGO*:^;<QKY8V,I3(-([FBDB' I."
M>51$ ^R4"WB)3T'S6S.A Y/&1U-&WOUX(+E^F^.8)4T!B3":R8M8/;\'"1'>
M??=LZ='J:,PE#PZYM/("9!?=Z$I:TNJ/LF5TOK/VG,VGFC@4%66OO9Q%<3UV
M@9S3)E>F>*D16K3='*@UK/*8KNPK^FUZ:.&?1VK^/U6+2ZZN3]5F-B<S Y7?
MXH6E'>QB:__(324\&OOV]V7HC/=("ZHCW6 /$HT2LW<?(I^81G\O=PZO.9(_
M,F+LW>05=S.&D<P6E7"4BU<MP,;<$Z4=VWRC93+/V4/NS$3&/>-C=O:=Q^X&
M\\I_YH \.V9C?-QPOZ1<6H44U^=\N:4NN&_Q9*^6N."[34TV$JZ<L%S^9;^_
M(\0?'BF:_JIY7N>]W2STK(2IP=(.K0^I33,'ZA7A'MZ(VV1"^,]14Y'OA4Y5
M]YRX#FP@^M*_)7#(=K=A3S$RX?<%PS E94F/4*<#0U;<Z\@7]R VAM ,J !+
M/HOIX=B5F*>C&OA&S8[ SX8_2#P'I"#]:<% O17@P7*P;7N02 VB(.??1Y+S
MZN.W+UR_=(YKE<;+4&3Q''$".OS0\OUC6]+G4>E4( DVQ\!354>FF#Q0VBDZ
MV^'%"3XR?.1G%H= J5[HP8-.4"V@_C!+TTI3 ?)X*UK?S^T4;N"T(WJS6>GO
M-/8B*F4WE-_\B+S$,8A"V1L7CQR/GH4RM968<?;/F\*/U8MD(>/-0>S$F(2'
M1K1Q>D+_ K_OBQ.VLF8?B0D"!S O$&0$0[#9H;75<J2@)-4=7I*E*+5&PS,D
M]U.0>Q!W;/T%Y2T^6Y&TW,\GU_Y@'X/;K "%%6YQT2XC/EE."D;5]L_:G+K@
M_'FNXN<:L;4>&HTYH!G9K<^3*^9^74VRE\MH\]BQ3V_&- Z>U*)7 _6&2(TI
M%OD3<T6T@6$TU6^2]C3)Y>O&0>!:DGAMPP5L!G+_%+^6\99Y!B0C32BF$<B5
M*TX%=6D\V_W3DL:0=-,OJ'9S)3AGM0'_MU+<KQ5U^$K2H/7*!W$6Z>:L)7%O
MJY5]X&"R.7\BK0DLP([W*6\ZJ4@DCEXLO%P;D\6Q*8QH9@KTZ?ODF6=YD7=2
M.^-X&28L.W1@EA4SP88A)B_7UPZ_+-V&"547W"A'.C,2[@Y_D2')R&3R0Z-A
M,GS4D/P'$_8:]!/,T@90D,GSGG8N4*S5%FG4JR\]LRCH3T5K>S)8%)121?-&
M]66(,Q*9W 2D/44_Z<RGO)^#Z[]?',,L& [.D:"M+![QH::R[!R"ZM$M;_*)
M<C[6#Q0+@($RD7]E8FIJ4U:<>5GNYQW <I3\@?[Z\!]T^5+'I=NI)[+>2"O1
M3#1V[0@L%9"V4DX38X42=DHR8.";ZHV%[M1/CUUM1@V:/3WWNP!;@W*SE3]5
M7ZWI'Q2[HWC<KCW4FLX9WM4*Q8]27S!*X,0OZ4ZMKZHOD2=IUKTJ'!;Q!]Y=
MU=%7)3D2R(8,L9O=*$W/WU;+_#*E ^<MJ[["E?=KETQ+5%]@?G4M?Y0BZ]LX
M-!4HJ;6*Y[])L>D.]2(20"FWZ%)<#%2<[C(E<?XX36>@O;TS+]'BFN:F'A2\
MD$>-',)6VP?1X/.T7)I5*@GR&"<O 1=EL%8PW)A^ZA=9=3F,R CR3M6K^J09
MM"AR0#1Y:HA^I)$:Q/C"U#"B ).J+R,'UD=?JJ\@?&Q6$"9T#1#(1*J2O3%A
M="WOZ>';K443<"/PVJ6'[;]DDOBB@"H\[A,+LZK/PR;C+U%_]JL\"SV;9[UR
MX9<IX[D60\C\J-HPU]_@H9=(EI (?X;JA$H@+>5B]?U)B)()<ZGGR7S]X@E9
M@^'6NJQ?7XRWJF5;>++XO.4,VCSN+L/X(<OV"!9AC*M2/X,'\QNSYGT[\CNY
M$\R^,.;&#7:'^G%\J$.!ETB<L<<CB%70TQ,7FNX%SL-2>L<N52\#E6/7M"KI
MO<PZ: FT114\D[=B[$_L<.Y==+3LN*BG(3%=>7O@5Q[;;[M50BL0-2'$* =<
MO3 "&DTK/SRNE22==DTL"9)R&1L4:?8!9;J6XRFQ+7.37+'51^<6X9XBDH_[
M:<1IR5MI4X16P6@HV9H0M7%'4WW4@WK^KR_TQ+7J9\>$*\'022 ,4QI /Y)/
M3>O7MR$OU:>G4",>"4M5!!UJ:3P?"&NRZ\'#]PN8EZZ2\8$/K:/*"H(37X47
MM5:4AFZ35:D9C$36EOXJ*1#1*)HN5O;I2ESRE4_<DEGX'SCZX6TFS_PND2)"
MEQ+Z$*;Z3J;=*12U D&=0>&!HX W,/IE8FER+@X&7;PE*?I6."4K[7#<1K=O
MM^BV#WC^:?,S "_8A#?HQI.;PP41E0@OH-Y%2S!\#U)DNGP0BU0&'6?P_R0=
MY)-N=@G]FE><)H#G]4A#K_T)"1/RE$X<GZ9VZLSDTY=NTUN:_(RY0HA],WIG
M&O<WIVXSUS#\PA$UNCS7@O7G=L4NG#LV#'62\;D6>H<.HRC9O%-!49Z-#\=L
MBA8\\5/YT]HUW*V521]E3K#VE!6 AA=IMWS [&=-2@ILEPEXRW,TF0+1HOR0
MY]B;C$\X(HF WH.P_UA!LE'XZGQ-WIQNVAA?5F*/"\".K;V&<R,E*"%FS"9*
M3C3F4"\OI9OA-8V+PY OJ0X'3#[\]7@+B+YH_T F%?^)M5?#QC6F@%>LK_7#
MQFC6\! ::D5_5:5?NW;Z>\ ):&>M!#A 05!Q^SW3D&9]0TPA;XLAZY!J"V6Y
M4Q:'0U0'<<Z; *CM0CU46&T"1$DI'#9M@V)II9NX.@PHE[=,H,%,CR#AY/*1
M]'-J#=1=W@/;,);?"#< ZM4V$2- '1YXK<705,D_*NV3H83#VB(\43T*7'5K
MQYIYZ81ANU.&:[1BI[3$LC>ONN^?T[UIY67<6VV7->:N&Z='K(S\\C[T1IR0
M(7KF']6(W!HKQN3USW-R7CCT1O#(.'WZ^<;2KC]9G-V:2S;[.WN1L-RBFK,B
M"0/*VBW'D@1?]="O]M"%BV_%D'+-R_+X6V48!(==R5:S:.NP1P5]0JKCQX2?
MH5ANH_X/HJ@6EQM8WIBA"P9]J=)\>G)5MLPI6P+;:1QH33_<2O6C=#7[C"H:
M@>BI<?7)D,L*29;/+-&UM3@+Y@NF+JH=X /<G906,$*:0*E)X3)?6!]%<JN+
MV4GX-52'&:FTJ14# Y:CM,>J5>_0>-FJ,MX<#_,F87C^Y2Y\/> [>NZFS8L+
MV+E&YB$V,NY5*1I/,*[MVYQ-E"VW82[:;5[Y<T;0Y]Q?W16X!1F; "5?51W!
M3NU!8C]3HIN@O*'?%X4;8")A88L&7V6FX,2XLNU!#-F:%4&.>IX[,7TS]"^P
M]-%_)W,/PF4RCSH]J&]/@B['*^?RSOG:],TDX;QKC])5R(AZ+.<H79=L$#VR
MN62(?%<Q)76(8.0,T(Q1#8CBH14;7Q]?BF,CW#NIBV'>0.D/X.KOYFH$R-Y1
MR?^#O/<.:RKZUH1#D29%>B<**" @(KU(4*2)&! ! 24H($U .E(2.E*C(*"@
M!*2+&$&*U- #(H+T(A":2).$&DAR^,+OEIEO[IWYYGGN/'>^>>:/?5+..?OL
ML_?:[WK7+FN5K<*J9F(TWY4;+"Q?$2:@1[)><==JBP2@U2FYQR!G: SJ"S0N
MO1W%6@VKG"KPNMNZ3J2Q1PIU"*<5I.MR@11[J)V):F5<9KQFP.!'Y;ET=(/F
MD:OZ/#14JEWCLK$\[SUE,E^$C6HR\>0V$,](#PMM>=2$. <;D-KT((& H6/0
MYRUL)C$+[WUCM*@2:>F1E3K[V&CR:4CJZU78\*W$[Y=KNLD6Q/.X@:1L#S?[
M2\--1"?3U*]4E<%B*D'@W@^D*LE40#5,U0-!0S;%JS07&(#23%[$QJFO>300
MJ52?427X1Y]A*(29:-^]9E>H&/'A#3T!YD2^2Q5S1J #S+DW3F"OP/\RT5J1
MNZ-#[6A"*_Y0HAIRG_?+B$0](LZ14]WI4&(1C!=B](=?)1N.()Y B!==NNUD
MDZAVPUKFT8,^GE=V/P(=<.Q\&*H*P:5#\*9;[/!>&+MR_QW2;?,/'^TN[#PZ
M)%0'2*UYS,+I@'8,+<;%X]Y[HL\\INIU95TL#J!M3I/,(?XY7="&P1682,![
M9U5J:IXK(_/54QC]ZCT."=3":A$-NZ:\R3Q*IB,UGH+SUWPGI8"&1" ;.$M6
MQX]W8C@>!+MT\>4&5(SHW._%RJ)"\%MQ8+P):M)E'MHI (@'&[;-ZI,],[+<
M]WZ$LC![_3E TBAQ,$V*-CO^KBGL#BI=NFMEI;A:F^#XJ-$QV8'#_?-SGYW!
M<\\WCD'/?&Y=Z6$?D*-93PR<C"GQ.0PU:S>@=UG5%=2YC"].7S05)$,^VADJ
M<X4O9ZBQD$]F7C]1.Z8T7#X,3&P,(/3AO!(0@>.VS^LSM:R<[X*.07M4ZVJ*
MY\G#'2OKI##^]\1QDW1#@HC8$ZYN,W1E'L<*8C_H) @T0*7,55>;[-D)\9'V
MEM%, R%K7=<)LRU(),#N2W!TE;"F6I^/.@8"( U3[WQ@ 2>[%Z*DX5U@OI4<
M,P)_QS%(T\WXL99%V?JHQ[<\JJ@$81XB:P[IYE]LCT0Q])PX*V=I</D=M'GB
M&<N?@CX&>?<ZX16B6T1-19N66FV[VO\R4J:.A@&FDU'$ H)"A+9=,7P0P>=/
M*E4Q*KHS-O[&BWEFMN4OD8YZ/I7R$N.R7CBBS89[Z:EYV6': HVKV1W+*+A6
M8),DS#,ME$RCJ_I1Y]OLZ6#]=PVGC+ L!;P*K]O:Z1=7#3HC_M*QCBRU0B#V
M(URJ-XS93SL<L:P LL%\V 67CG>PUH8T#MD[U9?K);2=P*MV.P9Z6WO**UQ<
MC1RB?^@.!RE-&">.%-A)Z-1N[V048YA,D$_A9/GEAOB+];^$6E"4MQ#< INA
M,9X'+D*,?.CB\:QDBC,ABN\Q7;[*41VA;O\9T8,J9!U*P88+JEG[Y5J1I!Z\
MQJ)H5YCGPAQ1;7I?@"!6KUJ(8KOF!I.[:3@ :.F"L^=J2\@\28L#U$,G"E]!
M9IQ_XU35;$$GGQY1$5F7A_XY0!0O(7-G3^][$CV+PO0(%W+'&I8^/ZF/NWL8
MQQ, 24#;4[(1N!>(*LC&<*G^ OA4L(CMS'1OBQI+-*/&1LV>:4HA7VV[K',[
M36L>N_?"7*3_7,(L[0CY= A-O%G-Y6]&/QBN 1E4^_UD 27$B8.J1*%;4^\7
M%R%MZ-,/?JWRN7^O>YI6_JZM_$C2R%SD>3PKW'VA11T^ &-KN1I\&\% UA]J
M&7WH@[JBS1Z,?>HJ](M<1,FAZN_R&:E6,Z(WMC8SL"Y0M5#M777EDR!T#L8+
M1I11PZ*)TH8)D'E;*NMLR@H))S\6%.IM%00I7(,5YLK_TYC!0RCG^I4ULS#E
M4T5A/?^H+_LRDC*UF.=.W(6^WY>W:(4S\M69&S<+T.-6KF9&?4*>,&!)ZA7:
M%ON^1+^BL)L$G4S/FE[<]M]'&3H.M*E4:)* O5>,!0]]<!LS*3E;5?.@$GW-
M.I#5S&0T9?*-6B#ZI-_%3=G/A=&/.]9$5 II$^DHP_9'S'K1]W(A^ M)A-/7
M<SJ.]C YGGZG#:\<E8D,2AQ.G2RZ)X9VJD)JP5-_JW_?@'$_V$:LSY<?Z=1Y
MJV@O=GNL4-_HA/9 )Q&XDD3,_&4\1PR\/]C+GDJ-#R;KN%OW5+8:S\=LZL7D
M,0=U7^&M+[GDTV^XW/U:?6FD0/WW?WK80P'=[0&>R@B+ET:(4:%[+<N&TZ?(
M5]ANT;@2P1TP)0-&LDH[*X(1Z(?=6D,1_AR#_HY_ITI^[Z\2BM\_!O>"&Q?;
MCT'C$V"7=N%'F'4J NFM)L&(^^";+X)X1='D4(XBHV;3\$0B1W(6 4[X&<%!
MBS*]C8G5K.;Z=_T9_D>2XN)CS[;/,KN]@M%^!Z'9(*:[]CS<F[>,OVQS)@^F
M7:F7;]V\S1GON3E=!*(5T;'9OBKS/7&B;?66C^*+3?NKKL_X>-L@2OYYC&I7
M'(3NWOEH7)I!?IU\("501M_RB#'^A2O-KIFFWW_,P?#_;G>1;(,4Z;QM15W>
M/H283(]:V K&/3A65V(LP]%2H,PD8TKV^IUT9//7G* HF?S+C:9&/.RO4@0<
MW_[\]DGKVS2GDEC,XY@ZNM\B=XM5E/-U!8K$@AOE8Z6O>VVZJ]#,C*%.+J\Q
MON?A\-\.RSYIK"7<FC!D]4,-%14ZL_JZTIYY>@QR\7D1^E/H71=-Z^:=0Y/?
MS][]N3=Z[_.6+FLJ1)KW915'A3A.8TK'?E2B6U) V5"HNU$?=+DJ.A96H?'\
M[G?'[2).Z8'FTT+H9M#9<^._[76+)=_<Z0??SI V8]<_=4V@"R1^.7AGZ'6[
ML@.7=OI(8KK#=.U+,X6;H)3Q/L^EI2/SFIQW$V6L-V'ALGD^T;J<[Y^Y;'D5
MN,W\5L*)=:.6/_G=>)E@,*8,&G]AH'NWYZII\,%F,^F*#7P,3*?"$9,59,P:
M5-_WM0<L(Q8_UDS-O'J(Z16KF*M0("0;D8CZ MNTH2JY&>)X.)I\;G"/-&W0
M;(8U?>[IS\@XG&Q=ZP;#W]^:"C+$KP4_WMD/'5^J/_-!,%LAYZP#"@.KUU$B
M0G$84=N:3_7O;8T$SMA4F"/79'N](;BW&! Z +)IK/PZ^J\4;;^B[N%+HMKB
M-=*)3QZC%DDVNDY[,$'US?O^IZF5]PVT:_K\UB=8**54W((AVJ[N<DPLSE?[
M7>F0_UW^N$++LT/6*0#GUQ7.C#_ ,7:@X_"20GRQKMJ5'>$I-(#E5'CNY0^)
M^==W03ZZ.5]'(M-!O2CWD)22S!('%^5AH?2&**$G(EX";.:]LNU?I^QFBR9H
M^F5 >SP\>HR]6<^N0!UO5(D6U:Y,O?5\4;LQG.QN=R'BXALQ+I%+06*Y&3@,
MW@P]:06>0N(NU.%>E]R[A/:,,M31<<8A]6#7#F6SS]>E.BE^[;EZC8=]94>^
MB$Q+J<3@LB%"GTKP<6\6KKJ85EO>FQI3K(R0'RX*78XG\VOMOZG!_VKAR]D/
M'\_=Z%C^V*WP6@T]A_Z%$B:+XPV1_AW%'B&\!>4NESS/I*-*T1)4ZCDW25X'
M3\,FS0]S'Y/#4Q11/R)W)/ F5D07DCNB[1;\BF%!<(<1017YWAV4H#^B]^W^
MRW&T.^4;M3X]X.U'_!M)>(QI=92Z[<%&Z*4+EAV*W1H+S>MMX%-D1IPL;^5/
M95E]YI1/\F?45A+7'*/47XA? OT!=8$F"$.)FN;7SMU*4W%\<1G1#,U+3A8"
MN5&F\$KKMQ0_+OI=$ @J"S'79;W+TFCBMWZ3UZ@7G")[ULN4GE9UD-Z3YL4*
M0NQ5B9/$TK5<8LG[& &>*!5&91H!ORMIUO06[ZU@[[)SS8W[3^D%Y#%T_WIA
MH%.=:_)LUA5^56:99W'J%2LK"\A#? ^K//8Z F[[(B)8.3D_C@UDH+JYPZMQ
M=4U\TVLZPZ]QN,:&^G3]LPG7^D$& Q)=OT^U[>9?>WKE<KC[$_;7A1?90-("
M N]37_WK/@9:S4P!A@+# '59XDBU@XMZ'M/R^=L;3B%WYN\Y&XE5_S;K8'AQ
MHZ 9I!9ZKE7PH."[QL JU/+TT N#_ ,S6O69'9G5$;-X*9_%J;<\"C<%Z<SH
MG%X4,]W_G95U6[W$P5$@#Z3. QJEL?90===P>.9L;7V1AKSV(%JC*(_A3.-V
M1TE((I^\$J-(8/_M'L' (8%7$5>E0:=1"SW%E2RW.U?&<GEH$LU  GDLZW3Q
MLX^U<S-D>AV,NV1O%/[.>'6Y+8\A1B3-;]5\1\F;]'6AF 741</#RKX+&M<Z
MX]/P1NYVJU%%<F#9]0A%$UU.+[?WN\I\9R)K?$-'<AC\C"H_O!VDXQ%DL$-6
MJ#B=)^=]I6N^=9<S$2H3N)G'D+X</MHO49;A&[Q?]E0QD8G^482$OEF1;AO6
M-EE"-\C%IQ_Z.22;-D)1E]5Z\?MT[Z:Q1'W E/I^F>HE/Y/(55TFFR!/]=(V
M#7'4LL*;WT%%3'E+9G0AW8')=SR_.VC=?34IP<4J!#) ^C &W0P_:P82>U4-
M,M?G^4],C/E=H,O'H _*E>'?7 :JHV2^V5@+E(;<,@\JUON P!8<@QIA2EBJ
MVO)%[0T<@QZCBVI 6UZM_EB5':L95,V"%$4)<L0;%L0OU1^+V-UGG'H:6Y%X
M#$);4#B*-A&+$^$7]=?<,EO#WUSMT@Y ?X;1$*H A=FKF@#/V@TZP:(*YG^=
M._I?YIG]+"4?X3% #PQXR 9_X$@[WZ>E.@@1VCLBG[CKC5^I'X;3>!QEYI3V
MG6J_$?CZ;1GXW&Z>&N0&G(OLB+?NHFKVJ>"2CNS-MPG^.6,"GS+>P/.$UI=R
M(H6"1(2 !QA<+@9_#YTX]T7MN:>R!RD![:E6"-VO/Z"W:%-7(<V0^!%M1CKL
M\.$6X6I5X%*U9O++LR3MX!]D7_6\L(]'7I(O.0;.:EL(/GJN?. G;;GB=YG&
M0ZT++OLS3+18IZX")G=96K+17P#]@VJOR3"2^1;GYUKG.&:(UO.&S^7V[";S
M73^9^S1<((?X\]!:ZQ12*B&X?# CQ)F#>68=N#!2H6#Z8;DBK_'.2O*N()6#
M3PSO8WYBW'/.$\#Q<H^CAH+#>C+UU>D$MV!]WILPDGO8'4I1F(M.,]JC;A![
MSF??W#_P##1/'?W' F"RE$'M^^))VHX^P_7PE>4\H<HC6BJ#HBOB8?H/3=)B
M(5ZPP[/9J$. VQYKKT'RI3)2>BKU',!GLZ2N;*>3+*E_3*UA]O\1F26?@Z@V
M )@.[5#V@,>8W&/0%!JX/4Z]Y',5XH\EA0G1UH+8]LI";:%WE(5,<)#KH0"/
M^1S^??2)DV^Z_]UQR?^O2 8_AJ.G,J-\>O-8,,TS<>ZAF:<3C2]C+X98% 0$
M3/ED(WV5F/V^\=]*)&,FG*;'O6T/LVG.4CZ-]VOHV)Q,/J_F?!%OG>?6MN[W
MQ@!"%+4\B^7=8U"D-=;'_T));!;4@VXC6//F1,WX)'17YW7M,0CI=&1! GCZ
MO(G[T"((9A[FT$*W=)X,:PH)_VEBA/*_,UJ1L-:>*%W\OW2C'TSVQ(7Q,>B1
MX#'( QW5@([99=,X/_)IG)-?$.R?>/3^@WMV4=Q+P>:1OT-,UEO&YUIY&$JV
MKY*>4&]3;U&!]\(EZM,[;17Y%L++EZ8KL>J;]]$;*))]F!DE*\S#[6.PEK6'
M<ATJ[ V]R,HZ;'"%S-.Q_X*2K(RD7;,2.SNLK5:Q!O6\Z)DQT:!!3]<F\AN3
M T5JYL96!.]8M."7"ZW&!A"R!B]V6>[AS.X'Z! H!1!<"P8,G ^3.0;%6!@2
M^G+&'W/Q!;;= >T=C:_,/2=?6T GS%[RM"*%=^T7^;08W)#/4OE1\3'7Z$6E
M+&7M* =@1BZ"8P !8H$;I$M>K'UMQOM5=/A;FL@_KO)%GAR&5!H%1[0)MB@#
MP_:RGPD&C?F%V=PO+A@[G'W[<GTS&TC .,(F_3KFOD#:9Y3:&FYGRR]7UVW_
M BD.\Z:3),AVE"QMZ_G3*D0+G5B7<RFT4Q,:O>H'Z&=Q1C/TI;CHP436:<G5
MDY#7_Q$-9YT*_X79OJ8"V2%?:$[]?RV+4.85'5B6VB\_!J77C"(VY%!'O(CK
M8+PWBIQ3M$):)_<CJ.;8_W"9A*MR5BL\YH L78"9UV<X046&_XPX-__7IS-,
M;51%TD'(_1!V-1_Z0<+!X(II6 &!;I^0TPY(HHR3+ (4<W4=85"RPS'H)<,!
M9>Z/Q_; 8AWY5>C6 :8,W=UT=T%[/'[Q]CWCR1Y*>GNJX#>_0ZO42_SFTWB=
M5^D BZS_3]X'-@><V._NT,F!A2:4 ,)U.MS=YGM:S^M?B%ETRO 6RY$"P#QZ
M##K?W4<9/9&-'=:D9*7O6\\_OPZSO.VJT35!L7BNKB710_3F36BW6$9]R2SY
MTV3D&&O>$&F"7"B!P-K3B1 AH,KD!G+)H^X"5F&&ISKA0%_>3-Z2"EUY#_\_
MX AD).K:T^TN6Y;-P\H="%6>F4[_;O"#\:(TK4/K6Q;>#BY&][C)6>_9#-G-
M.^7G'O%7@#3_9Q8.M7!3>_4(?%P'0GD'<9GQ.FCMAE2WOT'Z+1*A>2H'SG '
M1%O;D57E C1RZF]\WI\Z:[4KUP-/!POV'D(=I"]>W"#3$ML(I 7&;@P/%+UN
MV]5G/VORYA'_K;M494\Z\<RFTJ(.'[.7_Z+:PA>:PF5<._NC*,$<5;*'KC@&
MX3(0>#VD(-EJ5!Y^+NS&%SW'RS8M_<\$#$"^!L+9E!\4U#'(:2X:\64N7GX7
M34.\+LR?RL,M4+FC+I++6$&77GFH1P@%V&KQJD@\[R5MFL)9TP7)7_:,R9$1
M!2)+I'UT+V3*;O\&L9^D&-P2KM8=HMT09OS4:B;-@#Z2R )T?7_TU ;[K8/>
MNA]1*T7FCL?5;4+FRZ?MYACM=$KD6.7_.I_U])O+IKGY!W!'.'D3I9'=QZ!)
MDP>U8]K@,NW!J5K#*:_7R2N_A(!,#"X'4Q-80#(G<_P\<8D7HW:@FNNT+MC#
M*(AN/2%W'&3.CH5CT$9.^9Q'YN>:_7?L!]MR#CM7-)&-N:,DFF,0O=3C6B+G
M^]4LV[MC7_1+YL>"$U&-?_1I7QZQJPM0F:[D?V%5R=&#@_\L&$X!_?_<40QT
MUUS_"S..HOZB-C$S7=F)UN[9^V]T.&%@.@LPNE "(&+&*\?_*]",*J@G%P*C
MB.W !C0E-OT8=!W]1P]@VZ&BIG_3,2@<\0:]@OD?@"A#&I%CD$K;8GF"R-)Y
M;2?C6.W_KO!=N>K:(VI*+??+=0/#BI//->F>JVS_'12X=C9 ^9]!7I"N[.1V
M#KU_.?=",_ODI:D9GAP9+71/\3BQ%U/KJ4!B[+^JJ?_+D^"_2 */4\@@HPPA
M&K@A/'> R$?W05+GMLVW,+- ,<9"YS*B)SH4V"*.+Z.PWH?2!W-;" O80(O:
M,8@E@<*,\R8H@L<=D= FV3\8HI0U.4M8X<#Z1$C><5,A4O9?(?+GR:[QI28J
M=3KOQ4'V(0^,!R\"QJS61$EX"N:?H-!ZW9@,24%X7HK'+ZQIZ/PI*H0VR+C'
MU?[W1YII_ZG-_ZF]J2W[\^6P,@WO8M-301XGZ?,M&>VS8:%$M_S@1 [6^^MV
M7G\+)UZ^T("\\P77#FPB< J3L'GGE80P_5+=;5-O9?/.+RG?2$_9-??$,6\5
M$F%X2^_D;?BH3_ "A] #4?$^NV?Z7P<4=R*DZ8[R$]>,O723.>22HRT*+R;?
MX^X/0U+[:R.E)0Q,>D 6&MY[O7<OKD#GYY*I.I<_L/J[I1KII\;.3I5FJ+[@
MHD;!6=9T+%7$+1^/^<>\NCY5]-7WZ9GO]>0O5KP_XRS;Q/(&:7\:V>CV/CP<
M?5:3<F&&7+:GY>_XT]:!8R?OM++%HUS!06/6;VLA5VKUU<^$"(&D2S^AGVP\
M4K)_8,C%7B$1"Z[0\T3_L48O3ZZK5GU>DWAW#XB+D/]I7(]H@F@:/T[DG5/^
M4#":*DTS8NFJ\DY\^7O@45%3,CM+X3?H3KGR?^%.HHNH:!TN H5J=#49%TT_
M."?@^O<<>PE>96+HLE2$*QU_NST#?B"JPFI8=\BSPIR?QB%&F@Y?$='V%>0P
M*"[86V1Y/ZP:Q'7&@8691@TD;>DYJ9Q8D0;.SV.'+&2US=&3[08?#X5!\VQ^
M'3;QY<[<!]Y7M7"$T>+'VX4SPQFDYY,_C:9*3C&*9?R!\B0!A0O(BX9TWW]'
M7!!5?Q_9VG522)4D%]H(1NU'&4JI;K1^F25FM%H?6"N+NW-\6U>4J]YKSA_=
MO=._[.#-HK6T$''ACE&O0'&"2!KMB)*[E5&\FH\+T,!R;TO\'>-+<53!XXCS
M]#U%=HD>!CVO+;(M$<K+H0'%WCD_9!L303ZO<:!G[XW/WVOJNI_;GN8H<J_G
M$'GS^5P7_]_'7_7ADP[2M/?$K(1GGAJMWLS[YHOEF4!O.AWJMW-OX(:=&U+5
M.$LUO.(BI'Z=\?QA>FG9*\B_=,3!R[OYU\B5VT&19W"H[ BYM!3RW<1.L0SZ
M(4-OTJ0 O:BQ<D^-K.63YE^AT&N_66B_?Y&QNC[=8''G:67T]%C^U]GO0LPT
M2<3/;H,WG!8A#1O2M(]I'03M2HHND7VQJ)NZCLF\R(H;E@=>KY;,Z/,YYA@K
MV,[!7N^7S@)3G''U^ON79#!/:K,RW@D@JG"#](2PQ>\74.:Z7:G6?_=YY?]_
M-^5QQNOAMYV;>D9-!*,AK/!SBMO2&4CWV\*T$53 D[A&>M#C]&?=HQIYSY=Q
MJ:\>FJ5\):_=*1S%NM:$3D;<T9B!(GTTQ'-:M+<OZC_M>SF5U"9[]O;?\:\%
MP@T[)K>NGR8-_[%VK(GZ;PQ&6J6+R95=AI?9U]H:0BR*I?E71.Z Y75! :NZ
M#"M7(AC%JN>EY:,M]^0-IHV_>)376_($R$UT.:IU(ABC]#RL/LP<W"\%JFD&
MX\Y]UN"9M!</5,*-:\]QDT4]!3/#0P;H@-QTLKNI&M:>?0S6'WW_RTJQ5SK9
ME2Y(7!ODEPWVCWZX>'6MVG8LX6G;V9'-.5'5VR5'HT69:H>O5GZ9T7[B>=(O
M=7&:9MW\P8R=[8WA?O'WI;URNA\E"&KM:DR 58W[QV3#?M]W"$W0C(+2K4<R
ML:*KP%/O#/9PCUQ8HAC7O2@3M"W?%O *M6BUB^0/?K3EU_7)YNT^Z0XBA>:Q
MAW:?T(9>YNY[Z7V \'IIO]3S;W7Y&_K,.A^CF5HCCNTROGGG%]V&-T$6D@F7
M;P@REI5\BS+_HOSS[/,S^G<;1C>5M[T4+BVF:'D_A;P#V4P,]'&I[A;MV.30
M^ZS?-TQJT0GF:&=E*/LT_;!1?@B1HM5V#!(#1(@C'T-NUSU1$Z-[($4<U!(M
MY])Q7E$>"?S%DUHC6K19,W%A[*_,-9%GOG3D,GSAVVKL6X+N:.V%ZT&+(A9K
MZKWRN:/GZ?^7SDC^'Y@X?]%:1]]Z_"HE/WBO3,KI;E_B\YL3/_Y>79/,"8^2
ME[D,S8IRER5]W9CW2  S15^"/KS7HDI$SL_1NGF7>P1=Y-2,6%39AF(YIJ&=
MLU(C.1V0T^@EF"KTXFUF>G!1V#BGC_V#CA&%!SO&F[R-AV"3CB:9-SZ\B%^7
M[@6D3^QS3$'VW^ SH^?[*L#0T8<9W[;5<0L8[9:SP8E@ON#:%4LK@?1<G>*6
MMWB%C=C%K41-R6QLDOR0S7G/29GU]-FO"H) >PMD..R:2G&*4Y+0[J$L_I(:
M4M#GDIAZPD.PE+Z+WP' 6-[6))60*:1>LZE9.T"?DM$GYR)I_1.,OSWZ$JXV
MJ52L+@)7Z:_;T"?8CZFF"3NS(B8@B_9))($P'0)C!PK)EVV8\.ITAOE;5@1O
MV '3DLT8W?//&01_9Z:=H@_#?JO!V*N]2I>$NX;:K9*7>V:1#Y M"=^BC;2&
MNN*?<Z\:PR9>$I&+;D^,]7G,12.HY#OOWXR&,?5TN^;AE73/E"HZ!SF)%<<&
MI4$51-CCWOXM5HJT])Z=EQ^M<&+RZW5,E:8-8I$\->>MS1+:H^8W//;A4G[1
M#_X?34DA>Y0_9:\*R=WSZ1._(RO:2@XK^36TQS/@8^ :ZRC(8^]X-4!N/.#U
MN8::Y"MZ"CY1'J.U;4^"G%B/L@\+]G$G8T9333K(3ZN] 2[:6N?MV8.[Z&90
M2:B:8Q#6>\H$8'E&@-[!!W54L!PM&AON%*1]NR]S/RU8K+W%CAA)8@A&MJ-X
M_#GBL\G\BNZ:7:T)CUZ\^TZ4.K+>19+.(]HTX0P %F!!W<6#XUJP9<7O+O;,
M6Y=DAC..8201'@C>-=L2,L_!_)2[DI>1MMEUCFN5?X0J%S&GO1'N:*(D MN'
M$-"?][SIR=+%\ZK^]>N0Z)]?5V&-$#QT:WIG?F#S)2[4KI^[4[5JG=D=;%X5
M+QC;@%NH:]$!NL"TQR /!/TQR#GL-OY@6OQKA+> O6_+0A-ZGY%JM3XD"N^?
M(V8L<'"2-?%'DW;N7M<?ZG[;I*L;BAAVW C_P__0"WIS&S;-N)^#QVXTXEL6
MNULD1A;J+%C+F7,*U.T9?^N'2"4UF1<2I:ZE=V:3/WR>1O_HBMC<@@T,D/D-
M 1:IA0$D<'FDA2[8T"8T!0*MWSD7R?STRNS<W\&;UJIDT6/0J4UB(X%[_TL5
M7C+DK ES0'>4(.<X^UO<^%_O5HS03/!ZJ]71YM&3($M)."\Y!8ZUO5W@0KI'
MU"#KQONMX5(5)\;WLDAJ)B[.^*A95Z(Y$X2XR8"<U\X"6,Y3,Q?$NVQXXPH^
M7*AX<E!U??8^U^+Y0Y#?+KJ'@TJKVSI@U25(E4FR<3Z1/CQ[*BB%51_D( PB
M[*(O4BNG#?B9*T').P:YEZ-CU&PCLT^S!5_CN9&>_/889$OAH%YQEYJ'*,9E
M2PCH'YX-L\*'_'+G9T4*G[*/]_G+49IGRP,YF?IX&C#0I< Y':9%[')S*WSZ
MH<J(W^<QCOWJ^IZ?":'E32B.A!#4"ZQP\7GRY;"C>'@6DXDDRBAL+#XD781/
M3<6B(CZ>*LYQ_M#J\.!K]P4=U$U*/24:X^89M)BUH?+1[OQA=CBX8U7D?GH4
M"W)=-]LP"=%F=N*7D5/['.$.:=^/*)J'_3 C?4'"ZZ[&BFC(^'?XZ1.'ZO!I
MR!=HTJXG=%&JO2^'3>%^\PV3).P=U?0H WA&1QA;=2T!0N9-5-?V5_+MVU%Z
MR['7LK?+2!;Y6;2:#6Z%QL'P2$UG&Y_*R&-0)G)5=Q="92U.X"EHQUP-N,,#
M(>8JE&QQ*DY1+?WG?;3$#D-3/, R3 HP(0F'\<9WZ8AQ#H3Z/1T\E$\M+!6%
MU^RLD(6O+826(R9*K$=55@.9:LZH&6_CO-+'6BY0"UL-#((Y$1Y;4V.(253[
M44+#EZ&]\F="I_HBXKQ"0L_35NF<[$?7A(^@1! >6A3O3D!KT$MN<_-OGUW:
M,4A6YF$JRI:BBM0"757L1:,PN-RY+Y#88Y#+7&2(G.V%-_NA.3,7+C3A6%MH
M(-]:(A*J5*_2.M:6'&!L90(5BGBXY'FZW@DLJK !99[%4N\"219CD5*^_2HO
MD_ZR);[7UB]IB#?^J@QY7KV'1+QKW;IFY;Q]13'7K5$0[CF* B?XEP7;)6=;
M+&CQS*]TT3RV=Q., T$R9&E]^LU@/&Y/IOG"LH/(DB$VI.%M:;ZNC@O=4[=-
M5:]T7[_W0LM24%N_H!O^4YE(^ZG#AY=LHLUX\5>T[B<H54P?G0R<&OU@%/U#
MXZK-.LQ;^,-HH2 [T*J'%%V6Q\J1".,A2^%1'5>"4=U"7<TI5;*<Y_OFC>G4
MT=_0TZ$ NSH>W3[CM=@.9\4GVR*S9/7W<VR8R?"]I\<@O \_F<?=3M83NO\$
M#S0NS]C<5U+V,:F)D/+V0L1AQ"$NL C4&80[1T+ME/U+3Y7M7[.Q]0H2BH+D
M/S+W2 L[ +L*X<NWJ>?XT=]T(GJ88U 5.I3R H-;(G%P!J>RT77-,F]SV?"I
MYB[WG,Y5.EB7:D?A/;%Q-;"X\H]K(2JX,4'>M#,IT1D#Z%WT=^]II7T-8A))
MDFR,&=H3O62GI>ZE:M<C&JF]$/4183U' W$]!L7/B9&5&)]K\R^<-JE)XW'3
MKX[9>*3!2$!?:YC^$M\F:HK0 N-U%::QG7.L\+/WPGA& S*#]Y*V50<T'%,F
M%R&V0*2.>/#<#;Q+##K,M/3!H4_%QR*!H]@+T4I8B">"*"W5 9WD[F"\.Z9R
M6C8'>;;*KBE&\6&N)O(F&7D2'Y)1;FVJ+O$W!K\5^3N.Y['9B_JVMO6#]24.
MHJS49LXB9DIB\1-ZOG'&'.@J6$.+8C*>/KL?1+?^ $+FIIK[,HN0:8.I\6[K
M$/KA8+CQ]0'_G 1Z%%!)E20/BS^H6##>-^NY/_K,=-_'X$L+KB5O+&-2G^:]
M==D:7X_?4*""'!?1F?0P6.>J[=31MV\;XJ6U7*+?0T*RR4+43O&&"E'BVOHD
MX6#X7&<#>[RFG:GJ2)II1\H$^F1GKS5\S%Z-R$RZX1K"/+)D>G4+.:7WXZF.
MMY[N :3\YSE[T$"S(W&KNX$Q@JP2M"#O>R0<O/GPBM+-"0%>)%YI(:"D"Q7/
MUZ(Z[$5?.=#C,Q>!J( '(=K:474&!7CNUEJJK5M;R$WR'>SPV=F4T&J 7X^4
MWW@(GT7@GV9%MYPQ>8:#G2+"V<S' R]M.DG1^R";9$_"YR["!/O"+L$Z@MP3
M6S<N/440ULC;Q&OX12RJ&MGUE2P\/YH-; -63JG&-E\RR>$>N[,*1+6X[16<
M'%PSJV-<S])4Q_BO!,O$*6MEGEV= DH$!(=#,8=YCWHV<2XJ<'04-W]ON?>U
MX46RPR(D>'Q-+89L_I[8UU'I 1<>66BH?4%.UYVT&&Y&",]>Q6=U@B>_++Q]
M<;-JRM3QF?CU<ME+UVMECTXPE F8KH,)Z+"YHDX'--\U">>YMF00WG]@"&\N
M%?].D7UI[LA@K(KS-0T;)GDAV@S@@D#WT:D9 %UF\V!N6L9Y./>Z:)S2L'AS
MZ'X<,0K%"G"NSZJD.:2Y386:\H4X<0(JY"_4UKMS#'H"X8>/S(FBM<UUT!+B
M@N*3/"O>;*G1J2/L,K7A^81R@-UR/ #)]T OCRB^P&0%?=&)I4?,!03AU,@B
M91]6@8LU7P@<4<794NF_W>[C.$A_6T*IQ3^99#M+AI+L;AS5)2D+IKS*[#8Z
MC_21WUZ9^HS!%2/P-\$"0/?47O-XC+]&%M3.YWQGE=<IN%GX']$Q[*X:B8_:
MCFP0CP%FFW4A]A)G]GS?>D]5&69_ <9BZ"'OUAX9C6@3PGA"N>']<]6F+>4!
M'WODEXP6F.66T'*&>M@0  7G)@X#W,>@N"-(<D<<,%AEDR"JT4]?\]C_U=TK
MO_B2#T7JBG0$3TMS'#0.GMO]]TUK:A6Q<%A@84#GH/K_Q"9=/.5CQGO*1Q6U
MOP%W!RA[L$%OLO#").6= B/)Y!B4+\0F21G>5<#,ZY^%*(J-5 ODO4^4%OBG
MT1U]N7YA)\J<K=M].1/]&U^TMIME)-]EM(_TEOZ5;@E/*"T-ZZVCVE4'=15:
M>;<7_WC%KYK.AI\ZYY?J<_./$PM=7SU6;RPI.O.QFVKI4K:-4Q*CU$N8)# '
MPYN].XT3B_:;QS"N$=X%\CEGSO0(B%ZED*QV/U=UC9HG_'ZLD<LMWF;"^3PC
M[6\X]P(F!<7:)%"D@A:<F/ZZ=CZ+X2N&^&0NBC ;C@*X^Q6S2+//T)T#*9B:
ME4Z.9*'.<;%SH\[/FV(ZSWU]B.KC_=W1*2;!Y"@T\WO;%S($(WNLN^*;+,'A
M:W"5%$+<AXHP^?/2L]A=QWE8"I@MS#6)DK!X6G R?B;Q_KC-DS6S*SJX9_3^
M70@=, /"XQB4B&$(T'+;%5YYQ<S?SWU?L76@Q6,O=)^5@E&&I=K2VT*3 IR$
M<CQ3!5Y$IZGOHZ7 :7?;L;F:!1M$[TXYOB#+ARMB-E_6_2_VOY#9H]>/?CO2
M.)"'IC%6VM7_O"9#_5YX1573HD'@Z*+ [Q<KP5M=M#8FW*DRS:?X^X73S<VP
M3X><%-S3KG2&C6QPAGU;+'V?J"=\,>Z^$%+KN7#(W4[:RVZ-NHQ!-T&'!P"+
MR4*X1QOLBWW%P@,.B[19UR\U"^H2RRKD7V0S2B7F">8Y1C# FSF8>P'R')ON
M5\,UI@\9PA3 B!=C[!$;R H]P1]^QZ \%3@GE<_[-^OL[(^,5NR9W'MG?0?I
MFG9Y-K>:_3O.$;]%YK4/=7(F\*?..)M]"RPYN[-J8>,VA[?<%*R[\&5QB/LM
M/12/7MUJFV7%>Q"AQG[SX>JH#:)/CL#A(6.->UT46>3/-X!G&/XP&H@&'X.X
MKUE#LJ&Q$/R=@6F/?3,"/1<9-A0&?<9/I:.ZH,LZ,2'6&\>@?T1]80F8]YZ&
MSE/*O[^XM^:GF??%1>?AYO %:@_!?0#CH; 8%+\.?3 2&R2D_71F5<BNWWL_
MU-+,3GT3:4L^V=9U,<R*8-W.,=UAC$_[U6!KZ-_1YW9;_17[*X:5K;G-PX69
MH';(J0!YDVN83.;WPX\="&+76#P.2T=.3(QINP5DEZ=%>PL],6?!*G#TKWBB
MK U/KN3#R!/OLG47&JD=EF-CN-1]34]Y2GD9LY4.HU)(HQ3-/C-*?;Y=HW21
MWD)H19_DP_BCG75=B9B<#AC>,N<9J]X#PN(BL5:*>/<HZ#D$]P'#\9M_/#L^
M]:\$HQ^#?BLX V&NUP:PW=O6EB^FP#O 1*O 1OQP:_;RJX;PK=A=7/JE7TD"
M.\AO$<T#;9B) N"T"0&)X^\\K<!$#AI2T1!DNO+.LK)5XA,3^A=L<G$1'8]Q
M!<<W!*7ZR^3#ZO1^"Q0\V41W#Q#5I?9Y\!P1%2K>R2U\D;C&NH3:9XH;]F\V
MPLO_((EJ?HO>B4T>\TQDP4\F#:?9()S.O1"_V8A0<!&,%Y#\@V+1YGZV*!^X
M)AG7KZ:1\5D1]AR%-T<0Y5TZP0D8S@!P-(QF-VD\C>][4+:%TV?)R.2ZFO"3
M;0NG&H@IY<%V^W:$2UG%/RSZ*QDO+H$;PF6W,0#;,8B2TW2*T+&?*C2>(OKW
MDMA/T9@^S,NO!\JT?Y\A8P V1)L)7-/89X%-KUM,N2H6^8;5]Z)#].IVMDM"
M"P?UI X;W]A'[0>+QHOQ1'-KJCDHBE[-ZL!P- G.4\2G]3_C*<]-7*-D^%R9
MZ? %G1@VLNA"N,INWS&(X]XK>,F&&\!S:J##^V0&@^]@0:UM3L2.K$J<R9][
M )7L]9#,SG'(?\**UX<OD)6(Z?-S"0!O-0$2O\?DDOI[3./^]4DFFVO8=5@\
M#&_K3;S UXC?ZK;"\.F<^@,]O_>[..W;AR*>AR3/_G#J\^BY1N'JO\BTF,_$
MGP^7[K>II\[<^C@G7DE7*AJ1)P31+8"AGFK??=5S5XH6=>U__RS1?WH2>TL]
MWKCP%!["UGI51O6%O+%K<=SC.X;VH\(FEQ_DL8T\L&\;S$Y,5IZ^)I&[UT_6
M(Y;/(^)#[C:D-H<O?724"SX&"0UPVF?R)96;3\D&>EQ/N6]J>3.[*;=G9G3O
MM*GJ]$!3ACGCG=%%A"C$?8XY3&=HN7K(VZ&IWE_K4<)VZY%U0M@C2K7V P++
M$>PT^6*:5M'C*9TG(F):=#88!H@CC"=,=[R X-(9?.G,88LKK<'#@7'>P\?.
M6 'R-*\<@S[T7;/([,L'&WNW*"9RN+!&Z0[LY8$/OO(C?%7P<H-4JQ5+8B\)
M2HS?>&%8NCKFE_M5V!"2$JZ"I]N_CC\&16P4C(09LJJ-L[^1O[+-@19 6^(5
M.B!L1.[;IFH&U<D?:.)<(U1^1J1L&WR5&&H6$\.QJ+.@[G]?TQR=K0M5D*S5
M_B%)H*UU-EE[]D#%(,:_:N;$UR=7[;OB>ZMC<X^'-\<DZ80MBJX\X+Z9K2>Y
M;_0CI%(DNZF4]S2+?BQL1>6(7^Z.>5U?_N&*\O(SX_6YLC<![__4UF[*NE76
M,MZR_C&8\YCRR3%[;.)&"VP&=E"^ZGG[K+R("]'C]VLX;.JGA*@J8F.4\-9.
MS'9"M7;_\Y_P+,9OMW/E38!P*#I_=_E-_P>4NYF?^90BWP?&HJO!ZS#WNGI"
MVFQGM85E@KKR6N''DQ$UAW\SV2OBF"TCX$4O!/HTO'!-X%;T; L53:(^(]IL
M=U$36QU5;B$&+[+J^IX^4KR!#>X%!?$>T4F*JW_#]@F15R@U"!RR!4RI:+GT
MBXCJ^FDO_,QK"#;S5[9CI5@WSQV[(GI YH<N_AG%/I]KL^VT<B9_1[#/D=9:
M2BDOJ:IFB<+XH*8.[YT<QO["Z*GM]G+//D )-S[9(2=.>54#BW]*?$SQXNU*
MZ^[RC L^6;36B:A&DX41C/$U,LM$_B+8+P/F[9P5BR-NW<.7?S'5\601;MP<
M.YN$*1X9[]"<8_;F45=U3(;D2\H:R01@/B#,65/RX;R]BU>]C3-')T?>FXPS
M2HV,+TMM8(]!#/O!^RO80-NZ;C860#CT='4FK;W!#XVM1$H^D1-OUP&CU6;S
MGE=@E[DWQ#0:?4G#LHO&/P NCB"^@!7/GGJ%.:)!KXSOMV0!JDGX52X1NH7T
MKY% Q_@N_P)W8X?UP+JS A#A<7A(^>0$)3X[Z!CY&V8V<0QJ$8LPW*69K^%T
MK=T"0\^K@_\F#CYSC.+[^JZ]5/#QU5@S?)[B'S[ X1B4*4..]<54ER1?(O/C
MH9TMXL/WGHUE:P]UI:=>)^AZ#41A<%]/8I.$*L1".%2@$2W,C38!IC>G_?FM
MT#OYTX-^P'A1F".U;E'4]G4)SEH@-PQL<A/>_!XYVSQXZ?R-$3/.^H>!&YI+
MB434HM2F<WD8G/)AB0#K%M7%,J!*?]F1J_@>)%WXV89U1@_!8N;P=@H15(/V
M&.3"B4]J!Z1K; J&5^*],R-;7/>/?D>6-H)S<@7K*\%X\WZM]@:KUY^Q)<1:
M(TZSI[J_9(\>X6\=M A34$-_O*W.A,\13R%D[86)?9X%P,0ZH:;$G(G /?NL
M1*!M %*!T(5\7B'S?&F%U>S'>^-S#,87OX[\CD[RGZ;\"E3F&8N?1VR>_V!"
M)?)M!C4)EWB2B167[:B\R0)@SJ&I(])Y5*]0A#@H#)@<R-27FRB]$V^^:R]@
MV,\*28YTN^A5*,!<H%*- E4(,?3P?78!B'E01X(+P X:]OS8HK46\N'&>XO2
M_$>,D'793111[7SZ F,KBL>5/YG5&V3 -BP\UG*RX>X8%!PW;D9YK^+)):,D
MOF8>A;&1W?(FJI:W\XN)$DW1IG+.-PAQ@L>@9Z[L\?U@O*7WA-W"01ML*INT
MGT!4>^_.;W!>7-U_(E+J=W\P--E_:ZH/8.'X0#29STH%^(/CNJ?UFU,DZQLC
M/&6_IH6@;(&7*IC3KCKG(MK*W52'X]8>UUD!C^K[MDZ1KQ+=\MUUY)&ZGQ,\
M/:?<G.S4NP<9[5^QK*Q L6Q2'0C\+06B5&X]%1!O$)YP>E@'/OUER*-0^Z!;
MU;&;,? ?D3)BP5\NE!%@BWLKFR8$WW:3QJM6G9JFI1?N\EH_64(TR4937Q@5
MYE!/_8B S]JJM4'B;)/FW Y\KC81],_1^6[<>NBK^;NE@5(&G"<B 69CJM3A
M\ -Q9 E'MMI/CT.-8S[P?FY77D\^4&:E,&;M9U/YB<C/8*^=A;\);I(2?:F3
MGRX;:/E_FFZWU\(C4^6L[^ _-7N&GP9GV@7UJ)"'@CEPC)MV)!C1L1-3K:</
M[R_D:XSI")>^?8_]5Q#Z(P87 ZO#8M<'II1N4=(!\1@^G,S3G4Q$<]W7O$SD
M+_D2TN]$TY5!\VL2#+T6OI>&-*V7J#@5NM]&'"==#8;O+[:**69W&CZ]_LQF
M\>4?C[W(![E7!#R/6,B&5!/QE224J+\GT.%"D<&\SBNL@5P5IU9#%WQJ(]9B
M4?2/ .XAICN6^D\W,+5.2H KS*F&\V*Z6VX_^F0P/%P1HM8&C8=S$O9+V%&?
MUL5_U;=IY-5^1%(Y=3SU!B8X-&E\<JL#D:(#(<JA-O.^W4+QH[_NL0$J:R@F
M!.X5A!$XW_[%C@A82":]2^P?:Y9#M#5SK6>'SA #CX[F?5Z8-=/J/$ 0Y;PW
M<S'-U,R:CKRH*AM&#+/>+!&/P@@H&-93,]MU0N&]^9'R>:?Y4*65 ^5WZLC"
MTXOXB'=*YB(A-31_]W1\840YZ":*SJN)B E9G8%[$]!S,*(D!Q8C2O8BRA=Z
MS"J-+35F>LA_'W*1W$3WVIQX)!H "]]9+W&7/'(NWS<$F#-("G/P?@2S,IIM
MS>VBL;=;94S]P"TSJ3['M2EIT5,\9W@F54MGV]^9/OVDRJW+EO&CU5"P=/9&
M\G-1OX;"*?"!TVYAFHJ+H/8@X^]X,H\PP)10"A]#">U!$[.?9+IZ'PD^H"%U
M'NCL8O"F6T1Q]G*2>'#M06>N:GU5(]<O9OD;MV-*H-?#V>"99=Y*WURW6ZI[
MQ=T*68-/#T4(NO&H^F!=1(*9(@UQBK#(.;SO)PQ.:X<=-=\9&2"PQTNRD(RH
M.VH;L5Y7(/.<!ECX\8O[5XB>B(^]:-O:9O?ZI-LY@@^C0@%>,A:8GJOA2,2X
M8U(:2I*DGHD&F+0^K./(N ,5$)56CIREHI)8&+AB'58[$+6GY3! 'W0,:G*^
M']FSYG'$2Q63JN"_6_/6&VVJ:$]?QUGG6\@#0^+X"I0L_(9$YXXNA'1Y"Z]>
ML;L_.7N8.>N^<O$^#MG>,DX5PPCT)[ECD*/5=B_=YA5?CJK!FY <I.CW,$>2
MKKW@=-!^ZD=?NQ:JO-IB"D]<Z70D<<2C*D>L?'3S<IY/R^ZZ Q[:YY],K6 ]
M> PDCT'NR8 !IA1#E)A]/N6R4>[M="@8/ #YF\V"8$92;8M71.NB,!,BTS%H
MBJ]G86S*QOJ9"&<_XK*O1U4P_Z+GC_R'4IER-<:O/#?CQ3$?,$29KJH^/-@\
M88[&?_602KRR ;.6"[:R80;C+JG7K[L?"$+V?Y9R30!%5*E)07#!NA&?+\0N
M,/]6D-!=2A^GW,DF>U-?,18N-4<V(*)<BIM794OFKL0Z#L>=.-E6HU8;'3'J
M&<+AG3#4]Y:'XSGZ8] X+QJK0)0++%.M)QQ8Q1:J1UL]U=A79B.[^)P$TPB[
M])D@M5DVWPR[6V?SD)[!8F[%%LC82V$?XF"<<_U\@V_F8Z%N;I<1>J418/L^
M^ K^4Y.A)"VPAP&!>X3)WW2H'[H$V+-135,)W9)Z<B^B+1P0=)UCA[C:F81?
M_/F(WV[I:7,OE3C9;D!P4W-)FI^22(X<'/9S=1-#7:K=MQD)B=$ N]$IA"OE
M'#28 XB0_8[ Q01E:;ILQF7Q+45Y+@HRSI2"]0X, 99U@KLW"] _5?'N7:]>
MF>L/?D8TA.(.V!9&WQEK@@5X!N@<I/W50Q$%T7_J@-,!GWYUD+3<[.Y%7TCV
M&["WQ>0.Q 7><<=P?H>*!=T^!AWQTJ6N[)VC G  T;20*+M_ X]Z7K%I[M(P
M# 3>=\++OJ#6YD*8S)"V'>D2,:M+:5KBONWJ,:@Q4$)B6643AK_5K+4!J<1&
MOY<"W<-#+N(@N*JQ(<Q&P,+*+=P]OT,AUB/4MX,HA3UO=F)WN\=IS"7]YGBY
MJVJ)0!7BQ(,VMR0!O3$]GR/[YGN*Y_ONC\9;** 9<7Y_P7&AT7(ZXE(!A$A$
MKVX!3%D5?>5A[-51=Z OB_)$2(FGTQIUID?0'_T?DP(VR9<[FV^EG0)76'B+
M$<5U!;5=BLK^LI$1B[!L*N6QFR-*9W5R3!9CS?'(N.JAZ^WW;GZD$4'LK6^S
M((BR2&QY8TE+^IT6W95S^I/8G;Q<BZ,R,1V\C@:A.(,J9U2Q[LXZ&5RD0PRN
M%R%P[1 ">OD6M>/>!ZZZI-PYL:YI!XA#B(Y?P%7$X+_\'A0IV;,[!C%3:2GF
M3\ 0!O\03!Q_"4SK*.,#QEL]C>7)UL6-8I$*9M1K#M"_&P&Q%<(Z$)5U#"+R
M(;H_$', E@I"1Q< 3N_(.LA*87UG\\D8J&97'-E!3G4XH6J\BGQXVXU2/F"C
MDIE(LZ,4!FJ!,%>Z(2X>K:6&WS'?QW=@/@M:&/ZP&_'VF(QLFRWSUXH#6K$(
M8PS>^RU2:F,EQ$:#%7/$F2>&_>,@J-7LYE:99OWR=E[$ORQ:+5W6#^QXB0Q)
M*_B:]-V>749KESOPAI(!F0D%$ALQOBB7^+%>?4W&,;ET NH>M=K?W+@A"&]_
M*SX]<B?K[]OQZ[)H+E<KI=?>>^M&]P*,O2R-R/W*P7WM$NC$ZIUCD'<"H'(X
M3O)=Q=0$%A%@YNGS*[%[&A_[X*L5RV?%3(/-\..;F\>@ZU9UU/IC:$X4M-0V
MU0DRE\ IDKUAIQ+\6\IE[#Y R<@)-/$6&7P,TKM-9:V1"8 RHMUEGCVZ2Q,!
M,$@1QQ>Q9 E4'9K"'#('T M=FT=/#ZHNXIJ]P7MX#\3&1=C.G@B,<*8<<QAU
MXIZSAP(E'H,(\>W'( Z ;PU^L88@FM/K(;9\[].K]/'/*D08Z3[YT8B.4ICM
MB/8=!<'W7S5HD/60L6;D0FT"R;DDTMN98!VS%_QQ%!(V=-N(;K;E9DL:^3Y/
M2_+'@BT9[7%,^K+_TX%WQD;D/F1PP96!]Y^_)94('(/48,WBZ@Y1\P^*P9J4
M(3>:["FZ %FGLE639;FO3Y=XER+<;N5/<R4K##4?:AC<_T-N]PE^UD7>Y=*P
MM[SBU>;U!FU/26J1]X"=!JZXJ9F6\=3:'*C_8+3=EC%_8_BB7FS4^YI00LNU
M(@8U&\I4?EN)588FT>5'H//$6P-&Q;@+Z:-:J)^,;0HI8KR$E6CYFL,F0Z<X
M\YZT59H_5Z'-@0C\&R($B'L'H<H_-]F#8#VO%H]Y4HZDL[M/M&L_ZAQ;(J>(
M+-&U?D("G /3XT!,,Q6;:=G"1&]E)J^I?I!$W' @ZW5K*S^X)5FXV7#29(A_
MVV0X*A )^1^#R*Q0 AJ+)!I"O&%'7'L8,I-RROS<](@,!!_K$0Y9P8TA)OPQ
M*VM BPN4?./B,6CW%(3*,E^2^#T61!D W4S-T<+.7/H@EKF>T7P_TC"3Q7 %
M/!#>;C57<[4DH6*@$W;:_?*-2^R_O[YZF3S^)R6GZ25CVF7AYF?J;T5<&Z7\
M-K:U9Y^U@*=^Y,2GBPHIR]U#-5MT3F>IEUZZ3_MU<ZPXLJ-8]U/ ^\J-';^K
MV)_Z/*P&ZH+%XL;I]5]5SN$>Y[L57O&TQ F!#K$ 2_[%:7AOR'#I#R4LF:8<
MGPXPC_JX>)/<W,=M8W?-\D<<-3)U"_;0,P/$B]H^O20Y#_''K2L:QZ" \L.T
MG$XP5S5D2LL6$2\4MO/K=%NEPQ.N4#/;">"+ML0BDAX[;RJ-$EQU]$(Q7?1>
M!' '%8'$6-PYP9=DYR)IK 6"BC0[;AZ$<H#E5JWJ.KBC.:CO3"F27^J43Y>)
M0A>4*#.&\?)?A\91P?&BP7*#QN^(2M))E.Y;E": *TR$@FHRQ/5J7W,,]_NX
MJL #=FJVOC@YH&6\B^ZBHI.X=SL%L3"^N5,8/.BVHQ(]HWA%6<KU>][>JF43
M%23IMRC4%G%'\M] \2A[<[:YC@MD_6@,M+0@CF_RD[GJ .8W\Y")G7E*0:]
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M7E9."=J(O@E^\_&O@@' ]B<DSHL%IP ^.&D;T@<D?.F"C8&(*0V?1T"+ Z>
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MKNT(O+Q=VXS Z*MZC$I.WC/TSY7;A%]XX!?A,VD\>;MV/LZQKRAL;UZ>E;E
M\B?0+17-555_(#.LB0WV',9*@."WG9!.:&:5CT\4^>//OU$5'EH'#TFV@&DZ
MYF#AQYKOMK/0*8$IK1>EHU[5S>*TB5$J;*1N$G/Y $%R/M\9>=6"\R5_KC2Z
M/OWV!,>NX@6L*J-[TX."1-EE;@U*Z18[1\-8T\#%>^%_IR!*FG)D;+1\> +;
MRJV/K// K3JC !6W[H)PAO=&5_>23XQ;4+CRD< *H[]LTJ0[VZ1Y9M&-A4V"
MB9?&]C=/#&Z#*G*+XDX!TG]7A9SBAP3"EJ:1L%DPD2;D&41X39?E;RD@?:T%
MY@!,;/:OV]S=R!)X0$PV4F+XUB+G'!(^<X=B,('_G4(ZOQ+<W^J@0I7]DEJ<
M1PRVHXGQ/.1!N3RZ-PD@Z-;F/":W,G"6F4-IS*928UW\]S]3X<<:U!D4@&;Z
M-TNW/[ZJ"E-@TIF.@M\I-DPR3I(MR.V5:01=4&;'X"[7"B504%J(.'GU>*YS
MKZY$B3&PW%@H_++A7=#(LI"I]E'Q,#]MP]@G]<YZ?^@-=+S?8W/MW]Z=1S^'
M#UD,MB%58+/$K.DU9^^C_UDJA2G5OH?RQ\^?/CE7^<H'5;FE[_'IGU@3KB8M
M(IMTU1HKW3C-5C.1X%K-0V0OXX0=Z1)J@3$44<Z[VZK3<W'A]M)/+=9?KWE,
M-C]<>[?D>< R]C[[6N;<44;V5AC>NW7=GS(Q14.ESX'']Q3@=8^4\";V#8!J
M,/'M_60ACXX<E<^G -]^N9IE5(5FLQ/B SGCVU66H:_QD$N+W0;C@EGQ8POZ
M>(7PMI2\*$F"ENW\R; #,B?!3-[]*"U]Y*1Q_=KKG86T;[&$8/_##)]2T,6<
M,[]P$G\9L:#P,+"G">B01'!PALW-@(&=?BP^N-KJ]Y.K(/NDO%5P7>$W$TH/
M U77FV_8JI6"09(5YYT1"< R(($[#P-J5KE6B;6#:WQ=[8B>><.^BUAP),K@
MU3$!S4"J.D&G>?U+:(U$7.SKZ-9KIG"(B8'<SVZA02A8&_* 4EITD?<&ZX2^
M46DEJBQ Z=<5=2A-[5O&53 U:?K,(!,51(YN+$=0^4^COH?FF<\^C=)G\&5]
MY>T)W"@(>7]1][S"%1L%%E://VMX,MQ?H"#F0D %/7:8H?LC N4,#QY)Y(*3
M,#TO\=RD2]PGX"E'^QF1_D.O#R!YUSQ0+RI+_D+!^52N6U$@H>!<J 6T!82Y
MYQH*HO>JACA@K] .0*-*$[[01B^>W9 \!AXFZTIMWV]?*UCHKN9*\R#S=O/2
MC<;U@Z);MZ3H:;ZEW<@PJ;X&4\AC%5=E,0S,_F6^W*&=_M;T_ZXX_K^R:-S;
M4.?DZ+4'9$;%U&3Q%Y/??"P-_J2N,883=1N+I=A9B'-PD4T=3XQ\[=$B>5R0
M@)I^/51*9:@KV_;#0$-US?[_8&'$F6KFX3]X%>%,T'@6Q+<21#59M?+-9&P4
M;<,8X'9B<-'TF*89GX %MP 995\-5W#C.8)@WD+<U3AD#$D*.D82P7\M1%!#
M5,)PC/)J3+$O7J+2Q99NPS^4UH7QE$%&[JB[G "?M=1=2[';7WF[G#>J[RHS
MJ:(,G6A@P%PP-+.O;4X=[AV?!"Z";X/7$%PPQVA_Q?2V7L3JQ5FZ0A4](J4_
M8^/N^/?6&:'J#VU@%@G^AJ?\_EI!^O['>4T(>HC,G.X=,7W&]>Z+PTV38/;P
MKMMQ4>C65U4Y:EZ4/\'O<5[[4.ZYZCH58\?JF+( 83R?*X81IX]):J&]_4I:
MIB^H;U4(ZI)7<(BTUO$M4C&]]L!JTH@FP82ZG,'APX7)(R4;?Y,-3A>#H"ZW
MC1@N42:09(\,I$.N]>2U1=HD@9J=)C54BR+\461T/[S6=_>):I5=5S522\><
M1R2@*@">&2D2\1>=564*]0LV+X-LG/BE5KZDP9.0.88C<DIW12?R?E8_'*9+
M] '0K+["E\PK>;=LCMJ-6TKBQ^Y:/.5*(ZX+.(<W+3@9UKV<_;5> 91"-U!A
MQGYC=TX!876ZBPC),V,%YY_XEGD*E];-I^$QL$$3@E-3.?CR>OHU8N%B_5"Q
MM:?T',M'X (.^7XAZBE?Q>N;+P1F*X)Q=6*AK?UA(KWBDK;B?07;J,4)E7C2
M*2#TUCB\3/AN04M<6^ @GC$L":NR]^ D,_$L;?QNSCS\3^ZS^U>6!^?:GSEA
MA4D,1LG,S<?O[]$&%J ^(R??M-+'^,G]&2+S-.^S15P$?2+2\T.U,K<U3Z[?
M!XG#/O^+7^ K_D\3*G^]C_)J\Z=JAL/9@71HI>^!5SC1,B/]P%5PIA0Y9I4C
M*M+>5]OC4KEC3[*&]K/)]#L ]^W*'_%,,^>[,$]8>XC1"#RM3HY\(GML;W">
MIFTN7N/2;Z<6C6_TEC_)I^XC>.]%5Q3Z2%,T4JN(K5T[!5P<A [WEYB6F]^#
M;<:> KBB47-H5W27HII*M /\> G6'E2KX@S$F,#A;Q0^'T<?KU:A^_"#C'BQ
ML0ZO7Y9Z>,3Q"6@1_ B.ET_%%<66>CH]@HWQD^0L3P%S:!"Z'+13;FZQ2O(#
M8C,DX*F@^9U98//2!ON</['P%! -/3KS1E-1.-O#UN0,M,1R=PWJVU:7P^/2
M3)9OSF*<];?=681[!\5I?/@,SG83A)/OP8'4!94C?H:R.$"O8"&7/J'1?J^9
MW'NE[Z4^5<GEB1JX-_<RDN[M7V&!@B+WQE6^#'+?</#%/V<@'P9DG3F*WZ/D
MOUZ-WKAT(%O^^/Q->X0[X)CFR3G%JW^MZ'_V2I&1&Y%)7ZTALQGIQ0)(-3G)
MVLMI/#C[+@=5/ODAN!\Q;00U$KWN]HT<3",!4G<6_L6^\^Y3I"<HQTS-;:=O
M<Z> W\9G@I AY";['XJ0I(!3@"/JCY*E":FY\VQVY."LL_Z< CIKK6 -J-_]
M3I)!1.I=O($FK#F2[C(9;>G^*8L)W>]K(F[247\=GQQ\;Z,8M<]:I?B?\Z2X
M1)6? ;A#\]>;^+O:@$.6OVN1O[;,__C$=S8#UWB01:YA<.\BU2.#H/_^U?_7
M2TC_P,,. ,(1\/:1O%&#"-0F0C3M9"74=+F;Z1.],D#)2)C62JD4Y!>@\R*"
M]CQWU*"TV)Y(CUK^;)NMD^!P=&CTFPZYY>.\;2\,ZCY6@7#=Y(@>A[3CV+3@
MV&J1;%17-C:^>%*&HDA:4?Q0>24NQ1*NA17?0GL'^P1<[M:DD")00L2QKKAA
M+"(48BB$H$QE>6;I4>TMAWN+7[R'18;NH$IWXJY,RI]S7P>G@2M08=;]I&N!
M</O?A;_E3_:)3GN[+!X6+MRB61^ZOT\:E6]Z0[_/ZQD'M[T:^9$<RKTV4W\3
M7G$*L 5_L+J&CYZ?=+8BC00EW%E%U^<K1WU%P'-\?;:4LM6S"9Q#7K1YZI;A
MNU*\+";&6 I<-MY]+MQ)7&/S*+D1O=" NOI[,?C7C049FM'X02@N-1OB<]G6
MX_?MMPU B9P>#OGZ:6^['&K&I)5KG0<YSP3<%"3$8O Z6(\6V)5RHV%/!QVQ
MV*A*I]+W1Y6,+@F'OJ_5E9T%S:+B/FR7[%5'*6.,+;D&RI,".S7U[#,CUZ7_
M]P8;:P[VRE&/+]#LF'-D)X]Q^W@<9GE&XGMNO>#X,XGT?^+N-#MP91+,T/ @
MMOCREUEM)K\I#J*(0B@\G\=+J 84@>" "&-0VG'&8SMAXV4?8V0L*K L4BQI
MF[HWCE[A7ZOP\SZ['\]S-O\[?!AP5Y3"(U JFL4FSHH3>PK M?;7,=/5NH9*
M9OZLF=S3D/[D;B6(C<,5X\.QAD:NC(2;PP),=:D<4M9[B!QGR 7BAXH^YIF.
M!61DI8ALZA$;[7C:$;)K7^)63W4(V]X.,!>--@8WU_.A8H\;S)O\]!GGV:Q;
MY:X$M'_"([X-[=]VEFQ!L*$<9IDK5G[2;W^)S[X5'Q^ZF3YR,-N(G "W\ $J
MS;^/6Z<_/C<MZZ=(<!JJ \X!Z7Q%VV2GKXQU/^SHDA)S?R'ACFX(N3IGP0:6
M W-+.H"]9_+ZW*GXK#U$P4\;.R;ZS03*:74"S.T?>/=GWMCZ'OS$14N/O8+_
M*GA:V/]!Q#V/&-W 89><;E8;^#NT\J!_'"7'ND[PNCIK_KDS4/@+GO[]1'P&
MAI[%*X-1!7\XUZ/?/D-5-W@PF9R9J-Y<KJ?* ]3^(^HZOK@ 2EZ!,VWDJ51)
MDN2. @HS'Y_[$S"HP_EQ.Z8!!)J;*HO8+%C@?KK55SR_(]MSVXYA/CS29P<>
M:HZ3Q8<+!.A'>#VR)D'!!*<Z8BK(UMEI_A30&J&L\PULJ?V8+CG;.CUP<^-
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M'XMCW:P=!$>\\9PD!T%IY,#9M6544.+U!-<S\>%XSLW!H"='\"4=G"M&"+&
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M "R= LQ^#X&>I](K+)P;&9CMBERW]+U]U60$K9?*]CYW<GRB,9\_E&6;HQ?
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MMEDO9BVB+DU:Z,.4HV8L *LA*43U3]QA$578F/A8-0'<C.YX-U-8QO<L_"D
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MP6$/12U(#,H&H246GP(<8:QJ]/4-/PN>36M#)KC6/P/T1U%O0'-18,PCIU/
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M;/T$1)O<836!@WDQU7=XR;03KCJ?>J2J_^>>XC29+W*?<I#HKBR 0RQL/KS
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M.]3VD]]-<V'.@>?.B.U,/ TDD!A-T'3-]^U21QA(MPI2/5I8 IS2DX)0"Y'
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M#[Y=O?#T/#"_\<_!%Y.(O(1N\#&QJ1)/QK4T.WI" \';T3W=I &%,T"3B$0
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MB5)V*!6>F_CH/"@?YG3)MH.,LN\B,)TN>X,:^=JMJETD/]M3\[_"A*LW.EV
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M6I/B?FR0\8\[Y@S0M7O1%FW9G52[MWD8"0Q)9V$MASFTZO M6/S"CK>Z7=1
MIT8(_ BYK/3Q:A,4&60S0+]<)H&MGS@5Y9?O++VNB4[(&0?C:/^R-T64]H".
M'EF\^MF/\+_3$#EB$&ZC%".^CF8HC_W\P/0 U JG6SL&5:KEY^G1?TT4:OU"
MY>6/!^GAU-$4^:WSS\-7U!$SXI!=1AR8],.H0'$<NO7->VLK$,CFFU/C7ZG0
M&@3!&LW7U9YXH)G#FM246JW[T$7=XRH[,2A#Z(7B(Q1#Q2?+[Y%UEN];PF^4
M@EI!%W_ZW6^]IOJ P9HF*=MB/3'"Y?6=[W=HQ(X>4R]PM-1$ED<_MI.-P^]
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MH^4=[1MI_=?0_GDRP8A$<9>Z0DRQMEWF<=_MDDL. 8WU@5-XMR,/8JC:9=*
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MJ,CS;]R>NFLUG_?O[0RHD?&*/<Z2[!4[PDD +1(;K$T&(D[FS"_;R&1-X Q
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M+_UUXT-3(/<!R<TQ4RS][,D!!X_%\Y1=QM#P\#*UPN8KQBI]+'43>A^9UG^
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M1D/H:H(M*HMHBFSW\PZVX3S-CI"HO@V-JKE,HA2FHHJ@!V\SUA$C^H\#.\X
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M:YFJ-E59#O_:>PY@U+MV%><]HVPD [O3  X;K-]B#"_>5CCUK#$D-LGF]HQ
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M,P#>E& 7X!/"V>-C7"+A]-/LZ1I9L 5MT-T9(389%?O$VP;5-WU/>*A==O:
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MYDWD1GEV$V62MB<5+8*>>9%5H5_Z,%-M>YU!-\JD<O YF+GON$6FQJ3#EVK
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M=.GU!3_$99F/Q0(,  GZD+KWO;O),O,A\Q/1USD%0MQZ4:Z(V2HT8GMA.7@
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MD5*'3U; =4;A&L==YT 5"*: DHY0J0I;DXZ@3LZTO6.1L/W":BDL'?D"^ Q
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MUYZ<J/0!F8.R02(YA.Z1PE<_BU!XZ-FX-_EK:\0JY!V0S>F2/#8W]RMXZUP
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MV*MVF& >*\5/??>YU[D=QW!G.2&-;#Z1-1_),,^\C0P+Y2;Y<?=8FN$A;7>
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M/?,J"^%/U?W](<FYR:;)[ODY)TX*RUO0X92AG357RK4H94KT/,B?<<?<+3G
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MU: :L*CVJQ2Y2OAO\@<C*A P)%KB*EMK*$;L.81_!1]&>-$2F"*Y<P&HBKH
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MH(^^>WL=IXIJM:Q,CT*6X5(&0Q*[-H6*])"NN?SX<?ZF>5Q^HI7%6V<B\*'
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MO@%3ES?"=RT(5T"=;8OX5- +*FF,)\HA)]RG\;F0*_7P?)"$DJB>$T9B+$.
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M,;OQ=9J:4U+YGS7G+DV7 4=O0W J7($0GM7.?;:O8$)Y(G))\(L59\S/I5L
M/1.UA;.S6VZKKE,/'E7NL%.%N3OF@)6TM,"PGT\D%9P>=!AZQQGWAK/")HX
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M^XL3GU?A:"4/5'C#LL",W^1JFH!9;6RB0X&O>?"MC]/^+?D+!4),$7%*N?^
MMG/?\?P)"#G&=N_.HXGQ!!PHB(4BD82_CHLHK/=7-K[E\XVN"!_%L,-%'4S5
MD9)378^.:\<9+:NM=.&E2O*R!%]VN);4CZ?$[7@4EH]R) Q_+<XK"8A;H,M3
M'Q. '5)<SAXV$^=G#-^UUWE](:Z^FV@'2S,LUT?0I;&M)0*F?8B[(E_.7<#,
MKP[L4K,@S4_FI$#HXW UI#7Q[?ANO%+43@\I\OC=0R[2Q8/+Y$K!SR!VU84O
MW>BQSU\M/E+*,4J,UB@F#'L(A6D^.MDB0O;ZL':5=,EJH"[&6'P#;HW.@6F_
MAT\!:Q/7/\XIU<=\]3(]L,WXAKKP$$24*MM 3=;1.1]A$=$32NB06$MS"R_]
M\Z\]H>Q$X;T+483IMCFA)*UJ%5[[Z><W+_.<#N5:"Z'RL9U,<PV>P1=TP*ZA
M;I,F:V4S@'U2(,IEO'_4$8!PO5G2C# (DO/*J*O[P#:KH-3OMS#1##-CV,ZV
M.6WR9;S7]FX_N\_9MV\%.+C]7,*5]@T'>PFR@"==C^>/MPB&7,-?2-;(*EL9
M_RSN/KUD<OQ,^/I)#<3+1(^ARK%LLE_*PJ5Y]UCD^8RA,KC'SLN (A<YRH/=
M@[RVMAT9)6J7X7G1UN=UB;\8:%)=CIY^B&38(S:&/0H@B^(FVOV,\?>1Q48I
MG8['/YSXB3(E(,AG41NV./04<T]#>F%]2;3CZ6;KB%/8^RTM.<%&3\/*?U+-
M!%M_4D7"(!<@\QFSR&SX,?H@XS7&\%G.[!;#%>[V\P\.E-\H+)],42(A24*T
ME&KHY#YN]KEM \S]=J+&@,Y"#OL1P*51)1+SN:X#$]7@/;5ZJ/SN<X7&P"_>
M#F)7Z&..W(2S+#[3PL3)G$>Z5W\E]6R^DVP5>BQ^;JSF%4#&U[W<_L7Q=,$+
MW[D26Y-JY%C2EIK^FJT!F_F\W>'_9Z/^?R5!7Z25@SVV^>##4 X5NA@YLW]3
M9")O&>FIC4TZ CCL'L;8/T,HOT8ZL&7=H%LAL/E @CDX;KY*I<O/W1YY3=53
MP.F$FX#(X.6DL=^UB7B,"-EFSN]<7T&B^(O >ZYSF$IH(KB*OQV<)/%70W""
MKJ![J+V8TF ^-H?F@X4B,80'RQ%T^;7?WM+'1WV?Y >YR;XT%C^,,G#Z#<Y>
M!XKY--A\#"PS=GTX(])6!E<D!L<W^2IO[EF=?Q]R,S>3UN!/5L_9S-_A[UP!
M#$%2_U3^NT-#(;!S4&:8ZNBM]6[16IW/W=C-=&-(*Q?KM\D#>0:(:V.LZWOD
M"5(>^7VADW>+M!<,?)E)*\3"9$8/(4%_R]@"T,C#X-:AJ$S-#CW0]VM\;]DZ
MD6)=UPB72<YD0X+2];B.MARNRJJ4\WXIL]?;@(FAYU5-3G8;P4I6%(0G05=Q
MYJ>2S3:V32XSB;N.?^!_<2UZ6?>[3)N6>+X-SR7%O NY47M"B]U:8KFL_UV7
M+I^T- 2HLCP_OHP1ZGE6,B\Z5U*<:_-I2$E++F N)J&N_^?(2JZ[*6^CS1OW
M9"<6L$IH1AS .Y:?/G :"?\K6W'W)HN9H*P?\V+)0]4XA5RV\Z:QBWOYTXII
MRUND$H5<C@_/(Z=[V-+OW':.VAI-N\EL<U'16;A;[-8/?1Z[R,2HW(*[?4)K
M"DR-UQ_H6-4/_#O5^<=$1B2=_U!9Y_OM8' :ZG^<MTB=NO^?5MK)'88R'0K.
M$SXD_7$+%COUX=^#L_Z_DH0V(W.FT82E+,W9 7UBRS5.#E+!@.1T<;GRH8CT
MW82[F0*&#SFV;VZ?#_I\-W0D;N/D(Y,!9;&#>XUG/*S7O%H>2^_Q5+W(/Z'S
MZ\1^LQ)WUQ'@1),2MM^X<70O_LDY_JU?J5)*.C_C[+P?!.:G.+O$I#TD)U@;
M6L3YM;QT6I6V6W >Q/('N 03_4DQ!/[VL*<J-91O8CU73MH.H4XB'DA=<\AP
M9F[3T1T\4'WI]_CIWKH3L.,(\ PL M>S4$>+^+Q.[E \*-^ZS8>)AGMDAD3I
MD%]']JTVI .G* JTRTJ$@YL=YX,"K&\5M@Q-W2_J/ ),K?=@Q-#SU\CWX)N<
MX;D:H< ")S*8(NR3HS/J3N3O<@8/]&_)J;B%KZ^@HU!5P$BXM!<QO,RH-N/.
M%R_5/O75\5J;H&1:SO"HS"[ 1HR/M>N^773B4)E.\VWU1>A9O[>/YB25.W1%
M^7_<SACTQR/4W=^0?0C^[4#>CWE5A#%41G+"!?V*CK[S%[%PH5=&E@VC-8<Q
MHKRQ[=]O%[==5;J+["_#JVJ5;M4\K3??FA2K,W0N5>2Y@7GB5O"A(=2NRU#^
ML?Q.!X_TE>'/EU6$\&8GN1Z*B;U?B_ZJQLXLGG_/0^M!VB;VI-NK%CY63CL_
MJ&O9L?=?XU05?3WB@G96%.;"6>72KEJFY7Q@N4.]V=M3G)L!OQQW,P$<]Z++
MV+6QN?/Z)*1&.T*KZS0/6_ MVN+Z5/QI1P,):UN.T,Q'IQY[,WG3/1\?=)DZ
M>8@-J,8W>TE8NU1'7]=3K-"H4\J4_.2L;,PYUF"5/I;$:BM7V5ZAP"FC848T
MA:0?7T*UQ_-@K60;DJ[JZRE=L9EX4B[..X@N,?0[3M>&'FNR73@";/X@E&'G
M,O<U)!9C\BZ]/RM6U"<_$N5PL\!*,/]$3\(W@G:XIJZAH1 R-),T-<N3>J.4
M??\-%W$["5R[W38?,7[+!)\(\7EV=>-5('H(@P02;D$2P$ <RI!LBYVUZ?QZ
M/<E'JZ_GP:\Q2-0\ <(_)4AZVU W3C\-,QZ]\]+)E+1?FG<J -GH,L93D2X\
M$)>>3-":T^YT7]<1/R-OO5^+2DQ"+=11A5/Q[)WA]YJT"?SVK^_FE\;,3A1Y
M+\"$*2+P,6B-S<<<>7*6;YU(W7GN[/(A;3UXS;Y'ZSQ9'M..BB&]TBC"A4EF
MO; .OG'[5_+H!,83)/&]2?U!;>B%=*DFKWT;G8;)0E'>+1P^8840Y)]M#M'Z
M.$6_O=&RL*0RR2";800K7.)'B8P\W&Q=[_NWM2KSU+)5%#_9_09A+.[GZG%6
M:V;/+FC&:G([Q\NAT'0[%6NT3.W96IDM7TI3HU+_XU#O#(E,9*9L"/.=3TLY
MW+*L>GHK@O=>* V__]+W#4<0+:ZP'CH;^O)JFM.4_#V5'F^W;AF68/7?^STH
MLB(P%L1*'E]OG\IXEBKI'KD!T4U>WW3BIX+"6C]K('#"\4C2]!$@KF+EWI>O
MHS,E/=>6B"<=D[%+"S:E":^- T80V)+I!5KJ7M#V$#W29PE)EC$Q(L>C3TST
M:A\!6I14_OZFGQ,"78AMN\(P1%X@"<.4A2NFJO);R>LN?ZXLTZJKT9,=70V%
M->4KDBEKEX1 QH2%\>89D&-B4>I7/AU4UA+,./7V DSCG/J$C,,*=6CJ5%2S
MX7G>AXORX@;?;3N-Z=S:6 ^H*DQ%%+CYI[:@+561@>5@!/]X=<_J+ 2/4:&Q
M=>_]K4?K+J(D"Q!_YL/*P_,A([&E9BG"J8C+F^KN=7?#V87EGDX/N(5<[OQ$
MKNJH;: U;#J^8<DR]AT?56D.<'K\/$\94I!W2WCUW*M0U5U+0UG]?S:*^5<1
M="H"6S!?)]), 5+51IN@'PY ]SX(M'B)4?(/;<>M#U89<]%*RZ;:$SNPM55Y
MY+!M<W'F7W_R!,8U@BY!R=IY^,\?NE&3<ZBG"')F!H2L'84?Y4QW!LNCFC!4
M<[@AS(DLCP=&T4]G_36^:)NAK>%K,!CZI)3.2S8C KM>*Y)4.-=2C7JBI%&R
M//!C41:WX9@_I\AJ,$M59NT1!O3YTZXOBA  [GI<_]RK,_C@]1_4U!]N1;I(
M'I"J\C'#\5KUGL*K%IJA%EW\2D/ 72X"31G]+H2]/<Q M?C&+/A-KE,QC:%Z
M J!=*E5211"5GP^@]+,-_JP,-O751;'E2S3,[*DKC^]"V+$F/EH9$=4*9M&U
M)O)[$1;SJQI/GG_8Z8S$*MEV JODNV@"FA1(5*!?9:09XKY9 OPV?SIP!+P1
MS!@F!"T+XQD=I?^Z)[FV_/'5KF/G?L_OCX5'^ =*C1775_E]]2'WD<%$'SQD
MXPBPT \5\+2M6MVQOV'GGYBV#(H5IFDBVB2/ +ZK",_YR=2K65T.J<[K@A?N
MIT^G_E;Q'XP2W.2(.?Z9MO&D("+_[K<\MM>R#VPC/5\ZV_(%Z//]E^?_?]NC
MJ02DPW___?=K>;+C"4A+?9YWQ4Z5Q?;I#[^%E!0QI;Z3*%$?^'BBRGGP16Y@
M\C-ZX*5W;A60\P5*FN]UG&3?&4?9'V['J37SS58$*I)DCMD=,KEX$5&D]P1(
M>YBB_2_'UPG2ROD\B!L3_:#+Y%6BU<)XZ91'1&%338SM-.4G4 SL9-OQB%UR
M<5(99T!QP'RM&:4D1$54G5P]EXX)-(-[%,8VP )I7YH4<>DI'6TZU<&BIQ^>
M>$;I0*-#"5J[1X D1(U(U3)T=?A,6N=Q@D5'2QB3RWN"$NE$8UW('OIE\K70
MWYIO(.)MRW,MV014!Y(G1+I+&7:Y,#[0 B#\>_<2WYD%KKB* $U3%/40"76<
MWP'5HD\\[&$;(=F?%W; [.SM[D[_UG7$>FQ <$#F[LRDBN'F?D#7?>=Y3;S/
M7'4BL\6/#W8?RV4-F1,K(VQ9PGH&+QEJ6T=,^>PVH<_T/[ZA4Q!=F >4W=&=
MUOM6U;!5<2XO-;S75"WE#H%I$^)E=_W$;?>31,BI4"L>W]A'U+()KYK"V'AV
MCXK\4J/MT$!CT6\46JGI/:6]O[.,G;H3*F&5]+80S1NESW53,-/K6LZY"G3%
MJL-Y(W.S6Y$S[J<&+A7MJ$<? ;C]6Y-AGT,:;RS040P@(E$@KI?\;FVDB'BY
MZ.=<FJ^_Z1(_ ]<"^%HNC" (KD"&Y3!C/!3<&C)$/9,9I >?!Y)'2 $;'GNE
MP&\M.X4=*J>L(N0>*V6 Q72/L2%PRG\_11Y6Z=H^=N5.2*.Y^!&@B'P$Z$Y]
M_EK_L$O<[\Q^MN6,D0:].DYC3\H[*1YO+NOTPJS0^Z:3XLKW&Q7@B]Z4.TD2
M^3_,LNZ?Q1HI<(DNJ4V9S)^(^A+VW:E:?[@2W%A@PH2_<;^RR7@!RAMR_ZM9
MMK%#]8M2#P&GTM2#S -W4C+#N.;!+I-ORA,VTZLG@DLY[<__9.RCW"AGH8<U
ME5:_(AMU$SJT6A=O-U><]58X;.QT41AN4O7<G_I(=S(MB ]E@NK"0AB-I,/8
MR(]<'[D6DMOX/CQ[\?Z>RW6J#W9;",Y@0C4JFV9XQ2?^L9DY1?>\SF?IYPSJ
M:Z "XO80$5""R1$ 2*XE 86H;@VUH]P:)-[JD]+AYF%JGYLN<*&JT5=:>CK=
MOF T!\^%\:#X9J#3",(R+U&6M$TK0WAEN_BS4*\0J)H2 0$\/TRMD^#QF^L.
MP*I]JL \7K/+SPUR A9('ZZV/[-SPF;-2 Q\2VF7'7L$V'A*",!=0'%[M@@E
M219W\\09DVU+"G+KHI6Q8H9BS%.?R[+:E%RQ'Q(?PEB(UC;R6A_7S Z@[1BK
M+O@Q>@>8$\[1P?'=+V6]OXUM:48#@C</4V])='=[[W?>[3E?I$+D$>!<U6)=
MZF)'6]$%0I9=BCY:HCGT9VQH F5#FIL](K\$=R=/^&>">76T&NF^TIMN;_6;
MD&VAG-"1,4?=1Y:4HLI)SR?N\:_JSUU>C;L^> 1XV\U?H(6TO-YU\\$TQ/S5
MO*R-VT5VI9M.G5R2CWM\ M45O[W+[>+1^&3/%F!ZV3(CWV@D/J$6=(^\Q\!'
MW0P6HQ^2L]!)/S.NXI:Q^!E_<J$"T:3G,W0$P'5CJD*<@(+>;T&;1X"NB>F_
M-BE10A?E8&/C53S."@HCV<D[Y"2QWD<! 66Q5OYE((5*QES+T <=8.V!1+Y\
M\DJ%6-01 #D6OTV6B=V8+LM-K.DGDQCD5UWV0"_\C>6K V3O;F'*R$E]KN0)
M]<<# =+W6*VN";<U75QUQBX$+C+Z1RY!8&.. %4P\T7TR[T;TK_JC@"B#G-_
M(K@OT(?@O&,+XT\8Y-';7.[!1^8'/>S@>?2G/+Z/FGLE7*86&]26M!P/9%E^
MJ5.#[IF.M'G=AY7QJC!)7.+EME#>NMCJ/GM\[0NC@@:LS6*++B9ME.WG\2 >
MP;G"JD1\O$^.3Y*%A6WRKI!7=X+VZ;NO_S(S%+JE_D\O+/"O(@<J="X,Q3[$
M@^1!RPY$"?:Y^H0A?.O-3-($YA7UUM=-J7Y'@*B40&<7%;YUD8NJO\WK>Y<I
MU;Q*J*SYJOF.;&,ZESO%VL7%K*CFG0Q=.T?,^"M 6_88)O<(,'F9SEE/N(;%
M1/@JHV&R!6N"ZODWMA]YBD55>Q2CVZ#DT[:;W(R-&@$$%C80I29?UK!?OYG!
M?"9F[@C@0,^"">.=P5!"15:9W9S1CZ%[0E$"S&TW/:42XM&3%&R6?98EH<KP
M=(0DO+W)M@-*L(*09??;D7%@[CVT-/E!^PBD?F3#)01773==7S42L0W]T/>(
MF;?;NH?2WA1&&B7_P %CP4RP&X?=>1)75E46D6J!O;G"H\BE>9(D><>=(@@?
MT<@T[H1P.,S:3\VT$(O_^IC/R7XSO.Q0EFQ,. *0X+22EF-3Y,%^7$84D-05
MM1GRT38!;8DL1RB#:T4[$Y7PP5V-\R>F^UM.ZY:]0DRC5ZKH'.4+S4']))/O
M]XBLK1)^.:^&C5,3 &^W=W-+-N"ZB#:&EG5WYB<Y,#I02 Y5MU,_/I(L<>?"
MXBQRO*6>,0^^+:=G9LE5$(+\M%T7;^FKK"\KB/:FRW2^V[2")G9BV<)6,C *
MK3MRS__7P YSS&W [K[P&HK@QQ][:QY?DU$G9QPPI:",O)\+<=^/,,5PS0?E
M/$].4:SL?/DZX;%77R-0G87[OYK/]7_38[%)2>_[9=B,W@=[;OI<V)%C"F+"
M7,I]\Z[@EW9Q3RWFT^BWC16F0#"4Z059.[SR7(LV>9'B2:["S2=L[3I*6;EU
M:(R)J^_,&'360WE'$F\8#?S<UPJ."7APIG,P0_))1?A;0Q@'&/MA3J^5P2<F
MZ" O! X_I\>POM\9U'< AJ8:YHAMJ]0CWI(P1 YR435\GVX\;WVR2LUC$1WY
M#_>J(=K^@@5MIY8'T(G%J/AWJI+>]$6Z&_PX\?;(9R1CT_12?E"[I.^ P^H*
M9&ZX:@6UZ@W ?E"TZ3]MZ1<;&E*[I]Z$R+SX#*-'Z:V#%Y";0X7)9U\3YF\^
M"D@L&R+R%X0%?MF)];SG([%4[[S1,G(@S7\8U9E^&5QL)))2LTB"^^ZC7P(E
MFP0)I+9?HX$_!6X/]2XWPRJ)4:1NXD2G8RQA(E)-/D.;,P'BJZ^U5^'>CN*
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M^PPKW>DM-[@1E]:=@53W-:(1=O*6\ L]FE>H@>&FW0TYP1-'M=RU.0-J\PH
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MU^09Q;S,9B23;S?CBIXU$NXD9U19QG1OUN X8LGWSQ9^"ELMVI)N1?\T(IL
M)1[A!<Z+ICM?^2Y;V'P1$=A=+83W2!S\1ON@Q@"!N"X*)O=T520\BK/O,R)S
MT@JV*+ V4H7=R<"RP;L+"+SZ4TWJT>29TKKCT:VJ5+-:GTH+Z_-" 5@J6VVG
MNN=5I&P^:A+NE44@B60IJI^Y78P,UUJ*4"9:DGEHB7!QK_))64Q_8C#(F'Q
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MF7J:F-KJSS8>*MFJXSWAZ(*</-\<U"!.+^7V0YR EB!6CY!8R+9 NG]NJ)^
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MYU[WG(<\HL9G>XS.I4JY&!J-MU]9Q4-7G&<.[:1I]0C'96" JU+(/O2SR2,
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M^6?!;VY8R8^&_#@W_ZX02>><PT^H-D.*[./*G"L/=P@@.QWOF; ]"4/]0*U
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MUK ]P^%K=T,9(#J74K8W21T3"9,NE'QY_EOQFTT&"&8?#[R@<YI3+H4F+!;
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M!O)>E0Q0:'\'Y2[]QYD N()7U7_OR/FYIWWQ0=GCVP+1WS-03F_MSFE[;R
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M19F6IV^_I%/9^9(N*'V)MH^4R6H "9,@<YC/OR9L;7Q=Z*ZOWSEO=I;\,>V
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MVSV"+!S72)C;'.#-P0F5Q'Q$4\4&5;^0WR+'K)K0M?WOU'9VO(;VCZ?I7\,
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M/"5]1U]]OWUBD5*$^.G>9NN*+]*3_5GSNS#GR^A!=-VD8-(BQT^ST@CK;(/
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MG7"EB@\>058^(OK0Y+-R%T<6^U&K_V*QB,=B/7&[[<VHZL)CFJO[VWD[3R[
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M>SZ[S8[Y=8\J8U[]:-3JF_$1.#ZP?F.QTC'L7QZQ%Z-@>"W'K+[NJS:<B0R
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M1(]@X%8K800WZ86_X\W.6R7M3-9UB*F5-QD6G%=_,OU@Q 34'C!LLCM!Q:\
MU-F1T/9>5U0,LMF8)9JG^!$9&N9\\1&8O?(L2)5**TJ:/4UU4?QL1PI4; A<
M%UT5;/F48#KML.[E*%A>XT_9I^K]XO;^^ONAC^9_ .1;B 0#=9"7IJ4=K7<X
M[\X=N.]:O6.9U:T]GW2!6L1/> N!AWZ'@FM60[3L1(:57TJG;GZT')I7.,U
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M5]=$H%!\Y]\BD_O_"UBC_PM02P,$%     @ T(%[6BB[3CN!'@( ]\8" !4
M  !C86UP+3(P,C0Q,C,Q7V<Q,RYJ<&?LO =8D]VV+OHI*"@@TCM! 4&J4J23
M'Q40$!%I D(L% 'I+=0H2&\" M)50*2&WDGH5>E%0N\=$FH@[?+O6\Y:_[KW
M[+7O><ZSUS['F8SDR9/QC3'?^<XYYICSRPSI%VD.N*JIIJ$&G#MW#GA^]@!(
MD\ ]@.S\^3^?9X7\['F!\L(%<O(+ERDH+E)27Z:FIKI,145SA?XJS16Z*U14
M5YFOTC$P,C$Q4=.RL#(SLM(S,C'^:>0<V=DUY!<N7;APB9&&BH;Q/UQ(30 =
M)=E/BG&R<]>!\W3GR.C.D=H $ "<NW#NWPKP?Y5SY\_J>)&"\M)EJC.%RJO
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M]>/P!;78J1E A;G'F?H/[N).\K=R5E1=CW4"\"R8HR\8R2/X8(-*'E?95.5
M-+"<2-F>W?SJV1'9>IS&K@&U8X4!/^7,;=/CO5]]57?1_;1JC5H&!7RU]O[Z
MT\73)(#6S$W9[ROR#X0,_B5ZM6G:9597&23?'R[]X ]J3M4RRFZ 3;/4W+B$
MZ9%7G^Q/>Y@:NGH;@HY;?#J\=9^]P4[(^*=8>TUUS1\>G;QBN[%EV7G]/7-O
MKU!VR 4N1VD,VXH7]:VC?RCE/%3BU$QX+;RW5^F^Z0/I-?47:!HQ&@&7[C;;
M"[=A9J"]D$K37A\Y8O\K>R=DG80@]5 )V(<-L([<V;FH1-$Z6YGT7M%G4<&1
MHG^^^V+(]YJR@)5MP_N):@ITW#2YE!,=+LZQ'RX^0'V[W>$2).OJLEO<>86%
M-TB3<?-E0;[Y\)RV#,S,(";D-=R;D(.@-,7*+#C$.L[_^AK0V1;-//:#GIQA
M5]^2R^E]'=UZS5O@?..Q:2TZ9.L=^JA'2XES(R5A)(!6RC[:I_9\.4O<W4OZ
M7 "PZ-2TE.+:J1YW)<TKK>K^8)>0_.A\V/>\EJ1V88A?8=TL#"O0S+0%+D]J
M^J0LO5'W!3&273(LA13L2]Q07/?MEWRMQA/4F>CR /QH<<97%<,R;]1Y%DEV
MG1<XIA5:O;MI&2%VEC[U-]&WNB.E8N.K98%;Y)QT';-;,1@](@/\8O=G$F!)
M""'2%9B:.E;X9?W /<+P3%>_GH@1_Z8#L5V&1Q9L\0LVMQ>!DG)=QWKW%$%'
M04+NPD(?XASNZ,R4-:;H3%>=[MJ!F'W5AD1]P1BJME.S2"L.8=$G&RC*7N9)
M=LV>+('XMQ0W:E&G=HOC[3XQ4?XB@?/IW]Z_<7B#5[.GQYIY(6P,H3*L1V*#
M^P[@VTV@*._9<%_=.1(P0=O"KI:9NQ8'F9TI?,=V.3M)Y)UGMU0VO80Q%'CW
MZ[DA"3!-NT998^ZR#NM8I3@2O7Q8,!KESLXX4[;L?8?(Q%TUN5.*-F Z5LO[
MBC4Z*L6J>\)M3I^96(==,PP3XWNH=>&'+:C'!N"VL)!=)7^Q_[:5+)@0I7S5
MQ@21[K>HY-(NSLX14[Z.F6[_-/"9>I\:W<D'..]]="" QA?R>ERCTMQ>)[4F
M6(?GJ 6I"NH_ZS$3J:[;J1C^Z36Y3#B/$I[V?%2=[-DJ_<.Y;BDR[SEEUQ'\
M&]AV-R"#&FLW9R_\&#T314CW4LZNVM,XRLN9"K[)P>KY8E1=MI]I+'=;8RXF
ME"@3V&(2$TS3%^CLECAF4K@C82'R!=0K1*U5GW5Q"B!_U\6,=(@YN>$-(@2=
M+6#N]SXK:S/,N/[1D@4DO.-]4#;%Q%G.\B3AP5AED9BI;&4CW.]4ZE#Y&OP-
M]FP9<]D51Z9[UE-B2< U<"4L"]:Y>EH42(0Z'Y>/IV#D<9 CQK/YCJ(-?,0
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M@)9A^>LLYV79:\/.3YJN=GY95'S9Z'M?:"1$]*;Q\9ZR@ @\L'7\Z%.77+N
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M][?)\#*E?-VTYPD:YF9F1;#$JLN"7[-'_K/W$W_+_WS9 Z-:B0\HPF';XR1
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MAL*IF^?BD/L+;=3#Y2^!\+!G(UGN/@[5Y=Y'AMK3ZUDCF!XAK: P!_ZK"MW
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M6A&()O^Q#]'K?R.:7_8^+%-GG(BQ*4A%>W)'*Y2P9MK2Y]:P![4M_!!L/Z"
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M9$^5)(M(3XC)W3U?#053JHC_E$DM^MUADA]8:7<F8_]@L&!]WX;:T;%RHI+
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M@<47M.5+A.1+P+&-N?@8Z]1.5O_(W76Z%1ZU<4U=J6#:IW(A3,MXMP?E!F)
M@]BY4-)Q@\$'(C>J=0==F55Z Z=I^/P8_#]FL_GLY&^/2<<4CR>SF_8[( QT
M[O'V%"WDYUXV=]4/&8MYB,JC^$!5TAUC@QULO!I# ]F^;6V//?QT[>AN]E<(
M5E)7,1[FE"%WQ;:,Y95X9&E[.(L=,_@&NJX\VU;8Y948;8I1D)PSV&QY/R]
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MNV-A1<8I^V)2/CQK#\6<Y2 ;%XD:^7+OI5-UC1XVF4X,G\Z=0)1WP839T"R
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M?.\M"0PWIKZ+@B:,P^A.B.,AO60-9GZW\NR%[/F*ON[V=4].9SSXM<_$D<M
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M3GB7K_CX_F3?PB,B!;?/N3;%V+WJO9K&J^JBHXN=H*V(JY 8W:#OE<#]J\;
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M$A),\)/MP=B3QR'%HL7L%4=6,XN5K> C8MFRXEKV/&>[I[Y]EZ:KQV_.()^
MU%@1Y*C$BW(SJJ96-Z;R3,(VN\A'EB0?B$[?X[;YE@!IK@5M<QZ4U>QEV<]I
M-L5=*,:]>$<O=O\5A_<9R&P!^N4&X,C-3U[4.\*L&BN[O,]W%V+QND3$V&*8
M]#<X\[?)ST%G4N<4&-@!=0/HY0]9)95\@;X!4!H-P[E+A\.:6JIKPQ")SZGZ
M<B6Y[M#MY^TZE-"*UBH7^7#O! 1EB9]G2X&/:SAB0J*C"ARD=2].U57.VC+L
M*BY8-.;-V/,L7+QHK>)\9_6(IQ_0T9W]+H+F7(MBO>? #XM\55\A?VDM8^I!
MP1P4RLQ'_$$S:B6OM$<W/PQVP-S%'E26"XW!<#NR>2<>SY9_0]5E!<FD2XFO
M//H9\V%H,C1& >'ZJ''>K5/4T;T?7TPQ>\<,K;:[[W_ZLD1PMXF+,HVW,=/"
M,P-VL7KXYL(ZZMP8_K"?G][A!D![RO+ 5Z.'7C'DP//X_:7U3U:];'D649[M
M-<M,3APV/M]!ZAT@+@M\WVAS0UHL267Z1"!G^R*V)J%T0$&XY;T00\)'(/@9
M@G6\>/VI.N-QHI'9W'0372^CO(]LBIA@1G2BV:Y#6[WJZ*Q4<,.("[PP[3M8
M<0),,9LV9S1:>J<QMGSR)956[+D=72;Y=?D%SE2<;\5HFR_R&;/H53G8IJSI
MEB\C' W4Z^V4G^"KSTBXNMYYL@6X ?AFXDR)"R*$Q%0MH7\6F$2Q\BI\L>(@
MJM]IPP;\G2QRMU+VE_^W_^2UL']SF06@<OJD^9'6$18>:S< 8DB7L@]O?YID
M@"DV'Z;N_0TW4?R$Y1-4]GL%A5:B$VB@JU5,OXA3UIGWU!C:<NYU+0EV 2#6
M?:Z53'*NTJN$@# 61";> L8++7\#R,Z9KX^-[VGCWDOG;GQ?S'_NWDZYM9D,
MWRBKK+Y,.V==RPI YV*:\1>]7#W9V.YVJ^@MW@ @5#.QE+V?P3)>\;TYC$*F
M0@Q'1D\S47D!--ID04_:#JQ("M[>+0HF]?\MM!JV0HH22"CQM5%IN96"O,P3
M(O%Y'Q/.YU3ZM6I3I$%"+C/,)A@(_?)FE)>!W9^"&T#BV(GDW#JP@S1,_ST3
M2"F;A=9402YZ,:.F42^H<;[AE<?5FM+I2$ *&(H:7F..0.9TI:U((M4.\]9'
M=-[X?I%S<1UAB/A*26?1$+B/8&.TH#XQ^"!4C%5>TR"Q/S,.FH$4+IJJUIB[
M^*9DL$0*#4:JN^DE+R5YSWE=^3'W&3R-*.:A^M&7F:A]YJ6M5AN8U#JGXQ_%
M68&SW?6_0 &J__!J\_JK1#ED,!=S>;T$/%EW LD;C+8C->//!5E8((L1UYF\
MI4; GO@2@5*LF/_+T1O 6O+JL0OSXQM 92'B!J#,R[V_B^F_QE>[ ;"CX"R7
M],[ D\3)MM'2'@C-Z_%K1ME;/WBX_L_8L?MOV!5L24-G(?D:4:3K"9-@H,75
MMQ^!=70M.4)/SG6%U4T_'$K,Z=.H"*UM[%?XGO>*S0SO=:4[-30_+95TD+O*
MEWR9%S1RM%X:XMK&KB9@*L1#W RX' _-@"POU';NXG=V]!%K3V*?0=8A\Q$]
M1S]>H8^*5^4@5.X5L^2"Z!]%S!'#2U)R!!>$Z^U=K<*D$2O4M2B-\)KA<@^U
MRK@'#L.VSFRAQ1SV;0P?U'U%!RLN]2?VA0ZDC8G5AQ:U*M.8K6J75'DT@FFM
MWI*YO@)J<C?Y-KFF%/<?F.XMG$C2BTESD"MK4&J!%D3E#4L]N,V,#NMN *Q;
M$-(;P&"\Z@W O!1ZQ?+4U8P(5=&\!EQXL*>%//=UWI@U@QG7R(XX47X@#)E0
ME_UA,=[0+PJ%YB%'XTG"/=^>9%!-#-&.9M8-\**3$MO,A-<2U5^L)&D@ZZ+S
M[01VO,7EPU*_/G_W-*6U2I$PG-8Q%\ 81Z(HE-[;Z<'!L&*RBB3YNC&3$1)F
M9D!O-KH7< ::&1N[ 3#N95/-M3'N5,F489)ZKD52GF1H9NBD*S^N@>&YBGAM
M_-#YX^KW"&56B>+S/02^'\.K<6226WS,.O,F2G%-AOIDB854DMO!QLN&--S3
MMYSO!H" W_L9:9'Q.<B+,'P#9\Q5BLM.DGQ]L(:S1EF0F/?$-@/L[V'8YS11
MI?XZP#LDU2+3BV.V+E6<-'7"7V6+F(\9>M\X/=]%U-TV??:RU12[ZC$FS009
MA+Z%S+?R7T?Y_[D!S,M3^8KTC'QL6,WE8$S8C(&\!"D;VZ)I_(UV4M'"XW:E
M=*&&_01EC_$Z-3]8T![$Z 7B=L%$PG)3F1XJ_9Q\G%(_R!16]:IBOD])4\#-
MQ(4L2_QS?<]A@-LP>R6M_=+0]'<X]C!1VO(JN'V#!:%QL6>'+:@008-1?*5K
M1P"P]:RG4LNR^JB$\I.KU:_56PW$["N75-4>_<-C=-"J$U)\VR!JP[37$YY7
M3#:/AGAX+3XH*;@UF]/U:8!T%,+6>4F[#MQAPM%%.\3NNJ..3A:A0[=?VS)4
M-E;FZ.R94O;U:1?S@:+3;K7DRY&\!/T"56(UO>K\$F[H46&269HT?C/*)@*L
M@VR#._F 4,#(H$=+=!02=%L)!^73TFL=GMSUO#&9SX&< /H34B)?[:-^4&78
M<D4R<>]AUH]AW]EM@5'R>O$X10G&GSAL:P !A]UA_H@5FBFS]0-)H3Q8;8_U
MLW1"O,\#H=1<\V8R]V*8>V:N"+O]-<(.F.<4)O=K,@P\N&4LG#_GB0%HN'+O
MN@+&?IZ4<UG )S6C)XJ@F]L>[S#N^=;+_I'%,IT+@J>7:G6'ESD"6(&K4DF.
MM9Q@F%[L0$/.K=(&6M._[QMB[SPW40W^IL0*%<.-,9^&,&],7TM@\2<DK0JW
M#685NG:5"RN3'[A4ISPNU.FT9##X+$XC]5#HQ&FU.P=_=9?WAPD&I-#0[LTW
MI[V#$BR(9TOESOPS6P^/?!3)&DLC.GY?5^M#KB? FSJD9S),7C]9:F_5 ,,<
M/.3FA3SNA.]Q:*2E</:-J1JIU9U.67T[/FR\-,#(GJV%]>40FHA\.O1LW_\]
M%<-S5VE\W^;/BYI<MH11Q,>.,5HR7PXMI,&^,EQOYK&#0Y;Z,=,KXP$\WXD*
MW@0YDIY/W183$4&XT\*KQ-BG5L6*/Q8QQO(AFK'8GN9HC3 K_6ND:R/NJA"T
MU!9-C\[A#2^R<OHQ/QPO #M\FLK12210AB?ZB.4'U2Q7)D^Q?,&OC.:#\8@D
M>"7CGUX]=;-1S=B4Q-_ZS3-[&!8<&/;E-/@.LKYS]:$@=WWZ+D,U[]*;7#S%
M=&T!*=T4V,+&5USG[+!+4]^FX?X<HB 6WQ -L=IVOP(]-DH&1\T!I<,R.HVF
M](LV(-$V<MM&/EZY4HWQ6\S.L&/PJIT8]R;"&9\-P;0GKA'>1I:A'J$!(=B.
M?T=84VE4EX4?R?23+L5[C?)CHCB\]@)KI2W$7AL-\=@Y%@/.+$QUZW:-IVME
MOD^?0\1"GVX<E!R"NR]!-X ![G7^*[><&X!,;44&^N &D,#?#4*30:YH'+;5
M+#K;6% $1GREWW::TA>">5./)\5> Q 2(CCUAU -F1WM_VBYLX^VH7-R:JT=
M[@T7,$K)BU9Q.!O"]W,O==@%^URJ^QK.3JVG1?)_:\CH+E*I_=GL((FOX\SX
MX1=!N*7U8N9Q!.L<_5P7$'#*9*$\Y2@T1K_[D/ZC+HMUL/"QZ:<[=. /OY9N
M ,//KZ2_7J8[L?=MJ8E[SNH?[_Q^\7"!^>D+1Z:'[V@[.A#4&=]]2;NEZ1M%
MZ!4C/+.XUF+H',O>APU<E(0L77N5O<#63)L>0JNQ)Z)[KELU/4V#O<5&V FG
M4FX)P_*_569W(K2>:-% 7ASK\-2Y*J R(DFV+!CZC*6+[K& 9R"PO7XC_AX0
M */X=MQYY'>VR^$W"EK8RT8]F?.W=R68%66Y]TQ=NF$&D66]A96%AKNS'WN"
M"?<\O^( 7CF5X8UQY'@85F/%D%FS62Y%(^NQ] Z$WOS$9>E@-:HW_BG:#??6
M+#_""E,%R'27OA\17K-C6A);_=ZGB$<J5,7M+(LNEJ,G<IX'C:?6MY&@QKIN
MLW=^NZ>SL19V5D1]+R;@"07<F4A#$X0DN+ 5U_BJ2O)Y>EW"N_4L@<M>#Q!9
M1>K ^"!EXMV^DIVT]\H[_6\HLZ56 L4G?_<LJ#D0U5G),OC$" 8HRM2@XG"I
M4_(P.-W,3$W&6=S=Z0I?W1L7A;)BM$0'.COU<!-Z;4ZC=$+UWIKVH6=7_2:N
MOL9\,\I'IB1;:!4>,=3,QL$608)@%*K[+88;#F$VL0MZ7C\KJ.9/NJQ1NF@L
MZ4M TM%-W/*<U>'<J0/TA6#]!F!#&%D3'Y^P?4TPZW*ZBN?G?)8XQF#<L_W$
M46EP] 4K(/^#LBA"#%HI-/; %])SS)/>%U:X.\FUK]]6$_?^H5@'#RG=%K5T
MY'HK:[?P@4O>CK>1+I'[^\IZ)=WL $Z<1NSNK,"+[SOYRS.U/F:EJE\TV$H-
MF!AUDBV&^1SZ>)7/I1R/9F";68J:]9.>EZ5[C:^%4R<$IY1D'I/+\/AN?2#V
MU=CW*M+P6ELE\RTY44.ODME/CHX].K?4NW[DEO2G)C?SE+E?^M3+@?B@9O:,
MK-_-18!V(TJ/*"[?O!2G\YZKS _!+.9NF2GXSRF>\IH]VNK-1:/7E:^_/HVC
M?H7#EG3*WI"GI9"<FUJQZBYUT6!@\%"5;.6S]M3( F@#>I;&^3UJ2XKLOZCV
M_G\_CH2%\WJ&WJ;[!A"70X^]CY3K'80;FZH?PDSMAS4GK.KCJ)E-^_1UGHCM
MV&-@K6\]YAAO %CQC%L (I(6O %T+&I<R^?!X[$%#]=QKZ*F;@#;Y=IMHQ6-
MNEF<O3*P[<T85JW!02_1]I < L^<8!82P?C[M@8/Z_WUOV[YO;3GBY?P2Y(<
M:?A>DI.N@$,@B@,U0@!MQQ8TND U6UC6563RKOA,!)H#)CURE2#YXNA/2_DE
M=B!']-B ME]G+B9 BGJTZ"F?YZF(:W0\MQ$+[0V@N[B-X@8PWHW0P!+7W  V
MC"YRUM.Z#R36#3[4:.#;O30UL6M2:Z@+-I[3_YI,X=ZK)R.)OMODSU6D[Z&?
MU)"G3N83)<F/CKB*!]-=JCH8*13! S5,?^:\J7>P-5!N"!>RLEY2Q7_LKAZ(
M!WUZ XC0 =]^?HOHR\$PV-T"<RW:BPIAE*^71%4LJWY %_00>=4>VO(RW];;
MA2<UW2I36+-E@XZ.]574VP]W1+4R[YQ0PT$UI/L::Q"87)^W&3M*N!1.R'"I
M>F\J48H=C@=_49:HA$\AN^5MY>P1<Z<?.BZHJ^ >_3MZNEA!0-]!#L&"\1+I
M EW0@F\[_UB7@XT&6<S#GH:EM)99Q;CV518[Y]_YF#-4]#US5[VHYY!S*D::
MVF*+)0[T,^U#$!"#=J'!1!B@F+(+>%N\^W@%?J^(>N=V/)(D\1B3G"/\:_^C
M$J/U+L#%B^63I*5EN'R"G!G,_+/[R^O8 Y"EEG[IM,K0ZR;!Q689D,!?NR7!
M06!)S"J*Q>!6CI=ALJ?TIK$YXDSBN\N/0'Q48=X1'[^ *XO%+ :EQ VF//5=
M,W./'K[?Q!LQ4CJGO 5"Y!N7L!4*E'!"A>'>"G_BT9N6<#15]O%TWQA#A&:'
M\5T%79M[@?*!/O)46]HZF*RNYS'25. \%.XU?B-R#*X1)[1*M>N_%;4V+10]
MR&\3-7FX\-[ FT?V0?W[!QIT''N*W4<8]JUN8/B*Z'B+3J%#-G>.YL01:VLP
M=W.S=606[7,2FF5E.L:U^/) 4WE0?;&#!_F^W0J:X)RRE^5O0^-%"4,KS!Q6
M^...=%K2T9;!Q],*4-8T\]Q%B@=O$6Q7:K=#>\VEPD)8Z1YJ@V+=//KK!3 -
ME@@@;M!CVY47$[50*I-=?]U8-G+0LK$DCR$=R5K=K@:1__,MZE-B*NW,31$_
MB=!WM-SR+ RKD$Z>("K0RI*I,IR4#I\](=^\ON[+O<Q,2%[ G!U2!XV+@2!9
MX=3Q,9[$%CWUZ5F9[OV,1BDSS5VO/VE54=R3HD7\W@.I:!F)G])7)Q#$"AXF
MW#_]#EHP,1IXJRCHQ$"]>X=6%+N'B/^'V6.CI4605(1LIN9RR^FI !\A'Z*9
MD!S[1XA(29WU$>,>@Z:0A4'+]S-\YHF\<4,]ZX_E;O_%O=Z HBA)H M\E6CW
M@@DQS%189".4/';GKKPR61XU&QD)+>+1%;&]EHI.\JI@=EX,*[5E? QD?7H5
M'[+]#E5T_0 &.>;US]D_NZ3SY48[HH0+*GQM=.>.*H[VKWNY[.?(E&G5=L^U
M&#D]4IB4CWH#EJG=R[551C[_F(IN4I1"X78* RG I!488YU4.#'P;77BD)\3
MG;Z>HG;^-RMS$E(ZW!W0,\@_X,*E>)1FJ:C=P_<%ZI2S2BB6A46T$A*R/Q)0
M8>H+TIX]VIA!1(GU024%[I.G<E</1[XX&_7(GMD&TDC3VT%HVYCWI$EF;9KK
MIH3>SHIM_O123N8NC2U(^;"IJ"=IW03C,MG8_+62IQD5S_7/80F]>MNA*1*Z
M/V)5880!:<[R(V8VHI1'H8+:U"_""?^?#O<%]89JE4N5M]_8R?+M,/+WM8?
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MD3+F,1*AA-0/<POP*;#+]DD2_K[]I_[KRU^+45S%Y_GFS_,^B)]6J*(CK]+
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MUD/2U*_S&CF4!HKHUPM/#5ON5G,EDNA6_<2-6YL;9D&JN)R+Q)/= .:GW&X
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MAZ3U;C][B4KB,R;U2BG@G(8&;>,@[[W''%^4C!ED3FZLKSN/P 1=,3F&XU9
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M)QW;,0H/B)?"F#"K^ET2YP"O\DQJL)"?>S#X@RH\("<!ZPGK3L \$P!N(O
M%G=DI62TPL<GERI0>PP>\'4.TJUL@P< V3 (2!C;_\WYI2M-$'$$.LQJ^)J[
M6 T>\#&T!Q<"1/7C :3 ?^#<-,^#IJ38)VU/0^ <[/$ DEL16"P$$8>C^4?&
MGG7Z>P_9YFF#A >PH\,X*C**\VOA \Q8GG]BC' L^/T46,>'!B6<9Z7]P[/I
M_P-CVOYQ]:I(B*/1'HSM6$[X'YZLX!\8\\?E)]C<P_TJFPL!;OB!_N'!(F)P
M"@'4G6\_FX>T5EZ%'SQ[NLTVQYW,8_:9)9]RVB*^[07_FN[\,4Y3)^-::[[
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MB"1:]N>NV?YYIVL?]ERV,BQ,WU3D-3:&RP4%Z*FSZ/,8JA(2&)(#"-_=LK/
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MAQYF^T+RN93.?NSE'>N< APO;AQ(KDA:QXL TIDYGE&M%.52*'2Q+1WE&WO
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MY=>2=T$U$7MSI6#69!!*-U:"X=2=)2 *.]S,[K5]H_;K?7]K=W_OYE&1%(*
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MZB ]W-B_JG M\  ^>A#6K]TK6K$6A L!MD>@=4!X@!(2#^BTQ:DGX@%_HTS
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M F!-LH_DX0SPB5(W$B#?U_NX'/R'O]I4D16,P;+[$%'0X,VOO.OS7[5E+V]
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M-X/6U<EBOX4$<$(D"'\B#K21N2F&!/C>=^K43P*L'!)U_Z]7Y9XH721D1Y$
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M8K^M$*X4V5KH2A1&Z>5"+#W[N)&661.6$/O[?<J9%/-,>=4,VWV\=654IB1
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M#;B<3>N[(S$U%POG+(3-GZ0(B;WG TC%S8/S'\R3XSS[?:ZJ8X6F@3H4O,6
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ML1:*Q-3K%NN&/WEB G&/X#\_1]/AL^K+MI0W[&8%MQGX5%19V;(_L9<]&?X
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MM4277/4<O'/7T$Q^95R(Z+>2H >+O2S\C-6F5%D0;V'U(B4;'P+MY71]D8,
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M.I:NV[!AT%IP2*6J%']UUTV'A62ME:2[#L8:G;8R##/?R]*$]W14!8[2#\D
MI8L]!NZ^<DO+RYFBVFX@6EU'W!M\9%F0(3$LA,T_TP0B8]@R=3UJU>"F0PH;
M_)WS!2Z'A, DV4$?;E$)M-]6,Q)(&3(00)6T9%E^ZD9R!,^OON,?3Q'KSR_C
MD$QX$6F-/@<(L0E M0_B"HG9OE66.&>,1S<B6MYP4](I(*\M2D[\<>2L=&.3
MN<#3Y D_J92S=Y6LEFP]OQ,"\>JH80[20#8XK,Y-<#M?(&I0.TX;6-?+P\$
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M5F9]2D.F$NL][(M(5&:[#JO%6+U?3=K<?%7DN'?.2TJO%#=!U^?^LHI& 61
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MGO91[+1%AXQBA:R1RI;F F5Z8]!%T3%X-.G9B-K*R*RU=].I_=?;@('S^R3
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M>.#W:78^;3C6J^+F KBY>0^']T? H,Z/_4O3L$G-4^,%-Z".)25HC^HX6>*
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MK3=> N_3@L_LS;V+7&):NZ@9!9XXW$\*Z5?I%\,[=OQ*:CM;;]^.?%S)KF"
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M^U=[S]R&FN>P&<50L9>1D8@H%;U=?HG-A D^FEOAVB;>Q\2*>)).PL\(9V)
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M^:.=X1N-GYQN]C#T&JJT;8C!.9-97,2E0N?)0Y&4T&J9@:G;*SXKM,Q\"4\
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MT>^@/Y5E&\VYY79?QJ0S1'OXZ+8Q';;5<V&[N1:,@=.V6"?P]+S*!&FZZ'I
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M[ 4X;4Y]JMKR;2J!SLS"R"33$7RZ6U3S2W T&4 +/4-Q3KY(5$AH>" 44Y(
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M1E.T1P,11SN\<7454[R#$J5MCY_AB7'T2K_+:1*KTF-RYQN?0QK'S'A%ZO6
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M@#M%=[R $D,H;.\7@8F(5S<05+EACJ5=>%VJY2#Q>XY+\<G@R[D>T;:LBL\
MHDTIQ@L=_228W]F)=I&$$.R8-UU*,JRR,^8X'<&_>"+DF^.>W>AE6FSXV/XE
MCP%8.\V+"J.)4L+FL\W;,QG J^;6CRM#?ZN48LHW[VU-<R_X7['97;<(C7ZT
MW]^">3$K.ZH2I.<TMQD=9'%]B=:SJ1KH!"U(QS3V=9M+^\.T_=WP-"Z4UJ0V
MF#-\B@&P@Q[/NUQLWU=,T)\J6;4_#H/ZT=-#I=_(GE+:@%]YE;,8X;KBK))*
MDIC+B2K"K>IZM6,XH;CHCY$.*D0-<^_WT:W=]X(,;*(&HEQ&!1<Q=<B_3;*(
M4GSSD"DT@6EAUXJ]'6L2FGN*5U!6DR[,^]W#@],U'EJ.^[?8S*6]BC3$LHWV
M'SF8Q'/HRU,J;I+Z7]#<Z>]+5WE[?&'T-R$B?[>:\]?-V9XZ!TH>:N Q)XBT
M\WA9UH]<XF-:2S.F(?U[;7W= /%>!E0TP^N)6LI7,[G4'H6"@68.F@ZIN=2O
MV'L6(#4G%TT)#+A.>(\-6/#+1-J.LK@>/R7U? Q=7]W' ,Z 0\,S+OO\HEK1
MF_79H.()HPGXQ,:2DMNNQ_,.NC&^G_)?B)TX\<APQ<U@'.U\T _FW%21KZVE
M>!%^?4__FF*N$.7S=?VFN8!'C]QVYDO_L 9:/ H\J8./D:[ZV0:)#_^KFM3_
MG':;7E(ZG==HAYFL>;1A8_4UV$S@0PO;%FQB+8&$;TV*.> =?3>JP7>$ KLZ
M,L]=-KM2?ZVIL5O4_5F@@;&AS';WI4DKU'EZ2]*EIH7O;O_[/#^1YL+XX*/1
MXJ#KL](DOSAD]:6@FM \/SHZZ*BL56Y68)D2Z3:\+Z34[1 YEB9Q(4Z3%"-V
M+WZ@!+2Z2I(._O%0DVA2O1Z)LWH>:?]41EN.]^*$7=*DD]'FUNE0I]7! =C3
M;^B80!C=Z5;6^GY8="/*7M#W?+F&5=_$+;,6-L(16 OF3X#:D22F-Q=Z/O8*
M\3LY^K[#5VC@9L1"LJA[>AK)D"V2SWF<]3 ]!9U8I ;_.JF"K+B+:D/B@N<*
ML9+WM\U(D%AD=167.;(*PC>AXKMG4JNRWBL>U<OR+.!;<(XR^2:*@.3Q"9<9
MVVCNS(=6;P8%/UZJS''V4?]6Q>(1,7$$=K$-R=EXDJ \^1ETD4!G;4<%F"R9
MZZ<6&,)D"PQQW\0CC0VT]2-KJGP5L*[#*I7$F__B+8<W\M0@T&"!7J%N8\[Z
M"Z<C) V%WO<B@]T_P6!U!.D_C&='^CFRTJN]/[%&-TV*@\RW-UWO8_S3?$\Y
M'GG>^8LU=6)8!S=S<2C_<#[_ ,F2^IG\Q;=8E]IV(#0(TI(?L,W>2="5L#[K
M3.3UL&P0T^Z_D5D7JAQ:A%^\$?:>ON: QKKJ#AR(PR&69*U854Q%H(7>R8V'
MC86H7JM60US<UY [VARE<#0-)$O@H//A?QF/@'])-6VZ#&A@A*!:XJX5!3B?
M?<]N+KUT&A=(_9DA2W($3S=',C-3D7]B=YI>=A.5%J,22JV6HYB0MUO0DKY5
MYVA\GY@\VUG0" W$>^3@>[VX;<+W-/J>U-S8*?W\D@$(-&J14MN"]17(]_/H
MZ>^<=.5J7(U2?;WN%&MV?<3*1;04T61)VVT8OH6ZI+8#L4&:EN2@7;9&_+%2
MH_<!E;4)QNOW%O34?;['@E3SX%@SE/GX3CQ/P(VT$C//(B?Y#A6;)3,3ME,G
MCBU$*KFI:F;Q!/BOU<V!_YC)KNIS!B!.$R%CC1M'&P69/=X7NH>2]LSQ*__F
M5VZ16SUO8P6_XW]4I]CMS[QS@3RG<<UA6&Y;>,VA^:"NIRHS(9H.&EEG2SV"
M6R3>>-PZWL*J.&#;.SDUT]235(EI@HFAA<+/4R $S M4AY3Z*+)LYT6MN>7C
M/:C7UU>BQ<18L3K.Z853]BG(]C9] #E 9P!IOE<90/+:=*,U@<B*%;\SW&B2
MN](L,]P1:0DM=C0)./'H&$]9JQB0\WAZ7/X_-(T\9M-PG5.%(I]TU;1MQH<+
M4@;G"L@<44%NQ(33#Z5&IL,R'=3.1/_5X'GM(:NJ-O:2TSRV"\-.XQW\N.LG
M 0-/U(?-8"?O9*U7./NE0GUK8T43A=XF)RK_0ZJ)JN1C78FY25J.*: @(>IB
M%@4HJ&3EM6Z@N@.X]TP'ZVY)J6AIEB 3TS3#%4A[Z?.73>]MWXVR*X];U4#P
MU]E=DSDEH*YG 6GXMFC?U+L,3_I#B4ESV([//#0G4G9-;*/B!P;@\P.ELG)R
M/%GN\AO1$IYRI2^M;/[*'(>3O(R$C][QXX"J09\>37;/74D6]EZOG+I7$\UU
MJNS8,Y84,Y"_A4U3=E-OG/[0P6ZB^?QW;/\1!&?UL!>YJX$>*YR_)5\2EAB:
MI/;ZG#OU UYTNNGQ6./4'PP[.K\9DW.2$B%9&7Z6U)<T;THTUSA>,G$M\,SY
MA$ZVN"??6;77(IS':1=CVMSVY6>YF'TT?)@!) PGE=<T9G?^GLB8+O((9>TJ
M!36G=[EC5J+Y8&CP$IM7=?U6CJK:U9.*L.(O2Z:+O.G_(ISI>?I2",ZZX3MD
M[$MDF?Q(BDF56YFS<TA<]%7I&6-*U]):8M6,M^-1U%R8 MY\L'+*0O9&-?N=
M\B\1=U[(F,DIG64)D2/IIM[65V%F$P-X*>!D-I_$Z9TCES*BWK+?G,TS^%)3
MBTW]W-1;[H5/[%>6EL?OHK54LG(N'0+90%)A7"#F%!QV@WPT-FAO1M:JQKS$
M/.E\WK:L>[KO)U;NQ Y6YYA#NQX/RE_19#8_6"$TPV[_"1HF&L=E;IIQ-M?@
MPDE^ T[@!U",KJ"*_(H#,<>,?8MPH!>&BR-XQQ[LH"7@**K(K88:JLT)>N3R
M B(T;N.KY9=31:**('N^0^MS)WNU?6:'[^U)] O"P09DR6FU7Y:0$NAK%]/8
ME"<EIOD1*3<YBCZ"#^5=H;2G7\AOLAK:=\2&%*QJ,A\+# E5S((%"4"XLZYO
M&+.D$0BO(G7'40A+>DFX,$*$K$1!=KF>.\".XF94HC%[82._$N+9?0>->GOL
M%G3FF^QP. EE[U+BO*E,+-OC3H%HFUL7A%A:@,=Q2S1K4DQ+CO9(5]X\F!T>
MW"'^[)61RJZ%$M>;*T=,73:>$P3@_0&64D[4*1$56&A#SK5#&WU7TH?YTX:;
MA-_^TN\\N)L$QI4MH/D9 &SS.?HXZ'; '%H87D%5=JHV"O%%5CQ<QGW*3=M(
M5+!^;4@8X\VB(A#'1G<EG"0@DB$U]E;Y)[#TY/"&[)><ZG> >\EC3> .]%%]
M:0K6#F4SSC2\T@#K-*6>T"*H\$]!;<MH]IGCV@!+/V#+Y3?Y?<XEN\->F.E#
M-&DVLG:*CL> KVUR1/<=HQ VJ0"[IO2JFTRJ<JMJ3G#8$2>#)<-_PYTXO,*2
MU!\+<J=GE:YL% 7\ACO5C,ZK+'6G/4$70()C3>6UV<$$9#M:R&=<O*""P,>U
MNI_=PZ-'/$CP!0V]!MBS7V<06'I^L'OQ.C$[<023^NM#-E\P@(?(2"D5LC J
M%ZJO274M*9JYYLE$V%1$SH,A;2.7;X!EQAUU4U90LBO962J+Q#7W(N$#;E4<
MV9YTW &/NYXZ->/D_:2LESONJG+>L58[MB/'%OE=EG2VPN)I;2"\-PDI$#[]
M^P.-[/QYZRNCC;Y[%O8WZC/^W<!3%7[1BO+\$QLRCA1RY]\3X-56^ B_N#=.
M42-S=.KZQ6CPB85A;H]XGG"<0GK.8I=UQ+J^/S^[,AU'O*3ZS(W[4K;QVJT1
M_5/PZ_L'&_8Y\ZO?KU:EW,Z_>SM[HLM<32X%(I>9:DP1(4VU9[ZO+LRGZ9$^
MH8J<P&_8ES+B?;D'M7ZFC[)8;_"X;9168+J39O%!'K6?T56J4PL$X^0/,PXS
ME+5_ZZO2"9G@]?@]W*JI>S(+!YM4^@Y/R&[_^C;IT]:\4WS2BW"^G!#G'KER
M;\V/?1V+90J@%(C.A_]^FU@70$]]0PFE>B!D*"4+7'Q<<*=./"Z3R #>[,$@
MZ[W=P>L)^<@<4UMC?M$MDQM!G:%ZC\.E*.>84:[;V5R:"^=J%U<I\6OH:1ZN
M#(4KQOLS?>.EJ.?MB-9%@<OCT.N(FI_@$_^)9H.0W$Q),WNC*,):.@9T>AY#
M#+MOFA/TNS=&G8WZBPG.GZ4=<8?I:93)3LR^J&SC FF?9?;%J"(EC;O;-X9\
MB06<3S\$&CP*?37V/T#6:^YGNRH70FFP8 @A_\[QA^Z#<9X@^:I_3CM:%;_O
M,ULL/DMC#]RQ=*B>_3@J5VEX3<A*]/_HG]W_#Q<+8_*_ %!+ P04    " #0
M@7M:R7%5O.S.   "Z   %0   &-A;7 M,C R-#$R,S%?9S$T+FIP9^RZ!U33
MVYHWC$>LH!Y 0'HGTEM"+T<$)%0!::$=" %"2##44+U'I3?I'922B#0A";VH
ME( T(?0JO?=>E!?/O>?<N?/-S#<S[[SO^M:W[I-%UG\_Y?>4_>S]WSN+\^'S
MKQ0_:VF -2@N_41!87_QH3A?HZ!1\X0B?"@N45!24%!H7+"F*6%.'AY/Y<7$
M4.ZBMO:N=C!1J"M2#&/[5$Q"5%R,0E$%\]06BH!Y<-K!'.$H)>[-VD9N3KB]
M$K<I2%=<]^E#F!-<T]<-9N2K]P3JBX#*V7.K*',J8N0QR*=(F(<M)P;I@G*7
MQRAQ_PXN?_'\@RW&S?F[B@="B?O!#P&GF>YCSH>N;C!.&5%)$:BXN#BGC)RH
M/0PF92LC(RXES"DI+BDI)BXK)B$K(B$M#Q*7EQ+G_!MQ7SATLW>0-U33^)N[
MBY$2]]_R\O;V%O66$G5U<Q23D).3$Q.7%).4%+G0$''W07G88D10[CQ_(*C!
MW*%N\*<><%<4YX^QK9VKIX<2-_<?62"?ZNK^"?QO%@R)%/M#V]W#$.;P'VN[
M/_%Y"A,SA+F[>KI!81?J//_"U7]L^H>B/?1/O:>>;BZ_YVD/%8.YP) PE(?[
MA:[$[[H7D<OKN\$OYM#61<T5ZOE#"E93XO;TA-O+V\E*R<HXR(%$I.RE;46
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M+0S:Z../D2NA]@PG7?'2:!LR=Y7%QMT]LS[HSL)6<L_)EM.F>!PR"^1]'-9
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MW..'VX^_KV#S3<2:C""#GWSZQ9K@&B71]06>9W%[MUA;=>K0FH=VCOK4YQ2
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M-PO-M+/E;I<#1$]]?+.-#,AZ$* O.0J*^J[K_BX+I:"E<3#SWAG$Q$R38U1
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M6\<GJ1Q(R>:#97FMZ17ZLZ(2MYWRHB+-[=Q*U]'TV!U8O=6\"S_N.-3($C+
M=L#:_Z7D("_GG"*^R(9RE2Y/K]7,[U.&E#F!/)D:%CIDEKKS'NKV7=J'D7M8
M)]%=\NJ#J/H8Z(Z(HIQ1TDR8A>ZNTZL$SOY<R?51Z[+D+Q6)$^6>256+VUWE
M.JMY0\&@G>-83.HZK_+]%C2/3HC8VYUGV?F2FKV):B+Z:O*.;XI./+X@,]SE
M^'WY@4]*I;1VCI8KPY-G4K:0T%VE XXD1R.W3F67=IT).+^?5*X/-'K',*EO
M5(%41]##!KZ@>UY1[%'Y\';@43ELEB2E:-'W&672_'5HJ\[\VOV,#_E=L8'P
M7_LM>$O=%-D;BPXU+NY476="5<?CQB7W,@.Z3ND'O9.Z/DM&!KLSN$^1UEQ@
MVB]HM3?6[F_4Y5=HV0_"]5[")O:H9)?IBUQ&%]R9UN,.^LA-4N6@;$,#=<>F
M9$R L:CE^)F1:+YGDW!2M*0]VXO;J:ET)TS"&7HOU0*C^]8EF8LM8^%IZV%+
MB45R<@AH: .!^ P$?;:KM:'T6FAZ1T,H=O9G/C.H&=&T\PY;><<BU?WH6+[Y
MFI*:^P2MV%JBFH,OZHMSJ8@4.&Q*P:1TTL"2F*;6A6!&3JF00OP@+8OX5O[T
MCB*O*U@#!(QIJ;]?ILP"17DYOK]_IFW?NCM=)W( IZJDCX:!NI#<7J A " B
MO#^,T+V4,G(SG36IQ?J!-DR\'_VK?H2@UBN+Y&GQ'9/Z@N6"):OK%A7#*5NR
M1[C@_=0)AC +8EU!F/K"Q4U:QL?P<PA?<?9-PI>/Z:U[V%$M18U#Y[B!FZN'
M5\ M<!)DK[E6]K@.W67?+G6Q&_)\&9]1'%,S,Q%XY!EO;>=>YJ48N40HNY<R
MD6?2&55Z:R V_78L0W#N\O)IVF;'6+@#-\ XDFTZ9GFP@M"'P&M&>>[G$C(B
M@B=Z=]@E,G0K2J.2NZ-@-FY)O8XBUVZI::HEY'[B*^I[N0+GYED=>3TB6VQ>
M-*0;/K"P;5^B=?'ZJ5NE:_2.:)X:=+_#;K)09X&^(>U$VGI7D!A/YGM98KT(
ML="]'W9S--<@5<#"%V E'PFXM5 11C9/6MFMLCO"@J;S=)!1M828F9^MY;JW
M/U.QMA8*Q0BL/92./),KYZ)A;6O%)<V*\=U4/D@_;1^:(C^<BF?#"F%/"MS&
MN^5M>&VL6;,"LQ&NMEE?JS:XP"2, GY=T*(Q)G9.9I":7RI:("A7(Y?$Q[0$
M5M795^X[]+6]MPE/MPA,>^BQ:X8VK-I&@&8B((ZD+\.J\RY:*C(.EG\A:@M[
M'=38:][4ONJ:WG</3MAT]2H0:3.UJ>)&6RRK^]H9Q:236"=V.D\KHG@<(X;;
M9AJ>M&RM^69QS2?O:;_,#^ DL08/S%O%.QL(@"-FF/U+0RTJOTTU8.:;$#IK
M85L;+O-RG9AELQFBQQ0S6NVH)O&V%=KF%<S4E A:+B@L2UE+\7S+&RO>UY/C
MH1'&H_+2/NNEXQ>+? =B:.H J2=.TIZ8(VOGZ*XE!?_]6!V8AR9]S[*S.1+Q
M_I98MECN[SX;0)=T3N'<B%4"BP^^_Z&S$T.(.;DXGYY34$._5T\OU=9^*Q5:
ML-EY]NWM-YK51&5YU_M__)=H^HR/KI+RE4PH?APB(GG5'%5V ZFMU3_ZY%&U
M>J^2_DZ0SG"Q2P(!57*(B%V4L)UWGZD['5%F2S^ S^U4)E4?R(C)SZ[]%I(I
M/XZB-JLH81'B>],J@^+-ZS!F]"/RZ,KYM0H->H]ZB2YN*C(NROF7236%UUC8
MK^VX9O.LX5EEN$L^;PN=WKB[+YW<8],W*<-D>(-_Y1#ID[/)J+I\&/#A1$X
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MZ+J<N!I$=:');]>MW6OIRHPASGJ6VS3\;DK,J+0*OT0O"(*0(" 2F3,858=
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MR'D?:U7Z"FXUY9:$RU#M*[(%=,+,*=W*P]UWRD?DLK/5.2K&E\PCY;M-6VS
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MH;5'__NJ,XN#:6-^N-#Z8.- 40W4;)BC8LS5B6 _)2,E;]\:^8;VF"[935<
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M*]\4R&@L>_5FH_*_^KY&5CU79*NW"LYT@B^^_N8UY7\BP0DPR'X$_1!3"67
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MU$-F%5]4__!S02^H9B#MV%TQQY5RI. E?T<(9.#5L+>:X+"KO#I,V,DT8=B
MQ?^,@I %\BG,9U.+Y/:&Y>CVZ>?>6<BK,K$)+-F*V(]V-8MED6AK^_H'JZ 4
M6ZRXAX77&'V/_$)4.W,Z[DG4E*IML:IUF1[%B[XOK!4F#N7R?;]7/,9V3>EG
MJY()7!<O,K^WB*6X*7K2N4@BU5S16! 8V1\6.<'ASZ4]\"MEV"O!HULB:N+G
MM^RH^OI/2D7.8DE)KR_<&X?X1=\5-?XP.>^!M6C/5G_R]%W*':[5-W%H,,V\
M<^S3MQ*39?JY/PKD2HC0A#TM0+#-&VM.# 4X6*9%YF2('Y05U(BM[P75.EK?
M#%3IZUZT)]FR]8BU7!CM!(OR90A!4<E0JN\A5=UV0#4G3A!88U1=H_]S1[0,
M?\]:U:M#HY>6MU;"(O:')-7MF<2![J)&G /<#NI!3>716RUF&;R!YF-S!:PY
M=:TPH@*"BL'K$]CE=6]>%D6!08K-8 HUCW!>-0H$>IACN(Q18KK#D@E,P>JY
M6CHXNGC5*1[RAV%R#JH0D/6,>BY\K3PKWW_[189K!AXRRH]8K!0,56YTELS$
ME^>TUI2%$>/R.E A&.JG./EXR(%A[AL^RT[E#QG,;'*+H;6W^2I;IUK=X9&0
M;ZY]<9&+3!$.Q+71J<'X"+/- 4VM:G?/TU7R,!K1)41QA3F$,3T[YL6O3X(5
M00#[1KE72I#\7("^\"!&>Q*NSS$\ :#&[HM,/O/>=E#_I9,U]DIG7A$F4_\2
M'#<S2.1L&A#F5.,&6610ZMCS!@1*#%8+\"U?MPJ_*?!+LN_D-O>"<!]S3W$N
MP73H.2;%"$2,[HKKXA68G>0X/"N"VXWQ]V> H_]4,0<2/*R+RH:_RJ/.%B/J
M;XN5L%%;^)GX*8R>I]5HIPB"QDE[&  62WJA+?&O/U'U4^AZJ#A-L;6*+-CZ
MW5.M&;FO1Y% @*VSJ^JU\OP<:+/%W.$"A1V HJB9@NU3RDMJNBRC>-+B\NT>
M>7#)0B694KW?10(W#&E1Z*!0R%]"W^]'>M 7#LU6";JBM>/6?<*%9>V TFE0
M?7GGP5A5;AY+SXU^#X412>+-89EIQW@]5V70VL+ T&:#HM^LH]T?-ZE;>;7;
M-YM]W"?R)=$#$/A(@./OD/,"ES1H#C"5/?IFFCUW[G/&/#;&DLBY8I_Y6(7)
ML>+X%(RO#9=EX-#H@=)"MSF-$ RN5Z"G&._:%!38]R+68UOT2[IT"GPP6[^0
M$AR.A=9J(D>@L&SG]Q_4?T5LWA;JR7":-.@/..1.3=GI;<MU:O%@<-*)H55V
MYD:%.A*S'TTPY7+KKJ!/$F!]MK@:&T!I7Z=;QB0;#1^HG=ET@A'!D.__J.1O
M+Q$[S4OF#?2%9L[(.1=_7D%V%$E^TEI.36+@'E/?N7IA\&\NQB %KA@:10=_
M3HG5(V]748+X/1HJEO>4?EOQT D3Y]W!+$$3(?W%;OP0E+?:32F6EC&EP-TS
MLN!Y^IN4U%:(9$-/H (V/+-F]:U?SSE>O-6$I-[7_=LJX:G+&X*IJI3$X]PV
M^\;HJMQQW$T(+<"9:%!G2^-=+W/*6J=Q;!OAO3SJQ_?H0K(@X3TZ1=HZ1STX
M1'8NAR.+QJ)6<%D](!H):71CK E&.["#)QUO633RW@H(0"OVF-1[P8%0E9".
MT&(KKL"<$0R72ZODUM*K3W?&]AI\)C;&'OX"-RY2.D@:2,2H2/I?@%!;]ZQ4
M% TBW8M-S18!\G8O!##YB/-'M-2Z3RXF"7K(?JV154Q!Y\8 :Q7?3-[&):O*
M4/9>TQL.<UO;Z#;@^2-'?5?YH,%VM>F9>XKQ=76^2V.%![61;NVTIQCVT&S-
M/NY5 X.2,H/<[C9_</?$Q!HF:9D\I2"?J[-(UJ_8'2<T&YYET?[M5,R50][,
M[O!>%CXB>9M8<$6FEVNZ\F4 N]5P(OFI8KX:CYK2$UJ-;56D8?4-6ZKFQ-N3
M:@GS'2,&$)/%Z8%[O<#IDN-%@^J9K$CS]\608(8N7KG8D106IF^(0<L(:&@_
M1H=8R&=845-H.7#WX4*YT4R>;2=UEA.I(A(^3J6%?Z7N'4>XISLG684$PI;8
M1'X>W7UNFA@6]=[LH#MM$A?Q.YI+K^J*S#B/DXC^[SCK/\ER\MOSNO%,5S\M
M;9*7Z,;V<"("D:=>&JII]>'A =LC.J;% XNYA(27BAZ+\E#C&F&3=M_=6SU*
MGM(=:(;R6#7B07#@@]J^;,:U@CH*7_W5UK*=KI)JR9G* '(;%Q2GU9OA]@<L
MPXZC#U#_@[7WCFIJ[?I%4=$M*"@H74!*J :D=U1*(*%)A]"4$@@0(/2.6^F=
MT+M Z$U*Z&4+TD-+*!**]%ZD=SGN]WSW.^/<N^_W?N>.._]98XVQUGKFFFNN
M^?SF\\R2;"Z.0FI:*H_:B$D+SD[5.PGZ_!$C=.&@F&,R*$7YN9%2!3/AIO<B
MP^N+-6AZ4<FO5<,6!P$?":U;/M3ZZS>C3Q7XS[IK;H@\(@/L;^LW//\[:^ A
MV'X*A6.R,B.IIX2 -[;8_MZ%Z$:EI(9-4,A*AU$TI0K21^.8#P^G]Q\'YAN1
M:AVIHZ$;NZ09Y794J:%1)\<5AQZU!%:8]6QER9-;2 6B6^C^2MUH72K4VR T
M6LEJ^/$@-X3)C4L+PQ^N5#2:S8^KI FFEO 52KH2: <?R>5BO60A!R!]$R;A
M(AW4TR,:'"95VLYFQ*=6D"^]]0[6I?68]A .[<IME3QCZFEN7\*G)R]B"N+]
MHR0+]Y5M*PK6ZO9M=^S?IO6]3!;8W,PO+@^7PZ$0IS%MY=_RQKE'FKR5]*E_
M:SR%G7W*).274'OA7PNK7Y^5P^Q,JAR8>)5B7!W6-\9ADQ.38UT*/-\'N\)C
M/N+![(6[1SNO7-V*(3CA,C@Y\ !ZV 6?,)07_;?*\$C*YXTS_U,I0*3<="Q-
ML#,Y4%)DW'AB'I*1@KNZZ^G/:V.EUA!4>[Z9.9?=!%)]>79[BQ;;2/[C16(?
M?/GA>=/'2D3#N(:V0I#FZMO%/BYD+>58?1U=J8G*[BWN>NDIY9[-HN08/5R6
M6H*I7$]:0VMX\I+BH5I3+G*0TE;_2(%P?UA-Y[5<ZXG;D',I=I8J53KMMK/#
M*];.50)D=6$PC ?P"<DN(-Q[6E>07$PI3&CUH#CU#O,.?/RI-)IR3C\91G5*
M^=[82A>YB5I2AIN"WXYL,OB5+UOFQS4V*\8EY6_>>M9_!IWF@S<\.;^](^Q2
MFJMK)1)09"2J'/8STS[A$U=T6P">^R.KINO(DY*)*,90Y%08'?$8['%2*D(F
M3.X^*B&Y0>%UT)OM(>]YZF"_=O#??C$C<?]03;,[YH2@Z[,G>AAJE9RN;:2S
ME;:>^;1:<'M'\-FN=4:&:.A\[3>L@JK37C;/";F6X(1U-*LY!XS39'19:<<X
MR-$PEF &^)Z [8C30<?%-04".;22,@.K)TTH0="K6_+10M>J]6'E=D^BV:Y=
M:DPSV:YXC\L6,CSWL5"\0, 5FT,F_7"B_L\A8/";9O/EN31]].4/H>HZ,U4W
M!7\!.@>M%%81]H3:M/IDS[;5VLN:Y$[C#.@P=;.H>AI\<;\I<P^[5B=1$->)
M1B*BW,+VS[*"F:J63+0LA2B">F.K$4D#NF67]P,G.*R5%; *=CSR3)]8Z#9G
MO(>DC-0^.>NG6?L$8YIG6 &I:9/?X7BMR<K/KD"LQ5);IDB9@I?]_,+*@7M8
MZF94FQM^^7$ 3OHPT _MP!4QI_XQF?DCX]"CAXT\W]F]T[DU+R9+;H@VZ$+&
MZ@V_FA;R^?X@86)K>^A*LU)J9[67]>F!604X;=)^@TPG<IHB8G2ZR%8?UIVE
M,C YCJG1##_$6L0,DM:M-7KOM?I>7&0RJVUFJ6^N)XD"MJ)NJ\\&]"/O:RS0
MGH0/K:<>J)@YHJ\$[#Q+';M9E \T@G?A!H?/O#O&81N2!_;FM?4[SX3/8"%D
M]ZJ!@99P-AFM7$"J*\O0JD19'*KJZ>%1RY[G:8R0\=EBRBJ;B3GGH7J:^A[Q
M+\'&=TK8I:\1]^K:LE!M4LKP4%C]"@.0A1WU!E!;';U!G4GU>7TKS9N7R>M$
MAH9&S"%<OT?(T8)S5;7X."#+<A-1<Z;V-;"34:9+VC'5;^3"B]/O:I1Y\)6\
M])5AP(!!C-EC V-.D?/N?MQ7GAWYPRPYD1LB#HG:[+\8LR1AU@/;4F36BYB=
MI=I?]%*+"^()\C/CPKH2%6UL@_%;DY.-LSUG"CW\T:]>"!:R#4RZL0W07TP7
M&)@+68ZYQPXH?@_&*8/]%D<<0T-G&J%=%LI1C!\-B8@$5KZ__A!#Z5M@7C_=
M>DI)<+TL$:13A'G(F==(Q9U+1WWJUNMLB6(9^D%.'VU^0R0J(6[AZGS.>3!<
MW/32,BO$<"UN5I"'P%M*7#HO/O8'K?W !"3)GOJC?^ 1H6KEQ-:/J3'TX))"
M5J5]V<-I6G%D"<>3":',3='"+1\ -PBJ0L19FF7#ZN/P>I/9N]%&3/S%S_0F
M^VKP>9+Z*DJ/R-8,IA!V9N0UZ(LX,^L^P\ZZ.BR4H:3G+8XL-\&1\O%!AM/D
M2L1[89B#X[X/85-!&*N]#LJFH6H?EQJ3\&H?C>:9$/UA;V0X&>W1';=,.'I<
M1/A?AO#;)SM]Z\6K:5'IX5M&S >[.3_( JB,'A[)9@8+8H F^WDF@KB+GUCU
M3*T!VCHBKK0LG^KL0913""^=!J.$J)Z8?ASU(A(;W23E;/FR1F2'?3V_#C55
M7!0AO_-</?078ECB.(#=T@!QIZ%5</\P4G><3J6:5:WUD"R_4[Q:#0&RCQRV
M,$KP+EV K],#&A^Q.^L.(9Y$>6Y65#>SQZAWK6I+GCOT19BMJJ)"HPI840[-
MS29ZD*GZ8J(?2#%64ZMJ07L-H3_IVZ4[ 37D.U0#1K',#D:P(SC%X-"%UN+]
MRXBQ ?76IL>O7;+\!ZJPR5SI^OK0O6?S[E2ZACS+Q0>UJ)7BSTG+:L%JZ!0Q
M2E RI4^S&__KT7V+X4;I:-LO2U")LT0W$T2@Y"+OFC7&0D2]%H]Z0J<*4/4,
MTTK VR#!,^4/BNAE:/^Y@ OHT/<!Y3+4<@3F%EI7+-^;$#HDOJ6@49<(X)GI
M'ZD(Q- XHO\(&NVJ)5L,ZQC]IK\VU%L%!)*%D?:<)K0NU_AI,' ^Z-AU S7Y
MZ[7^M+PFG52P74V+\ZC=-%T7\!0IGC&2"%3RUF!;RN"V%AJJ!UT]"6!(^ J>
M4X[>XEB*^I*?I^T(SS8-*?J-/J*=Q%X:B'&GVJZ,=[]!\!S@OG;W?=0^""/+
M)ZN#Z(V)3BN_<3NRPW^)U/Y[HX7)*\3-P'1":$^ZPQ_F<=^\JI' _-&ES7UV
MGK+VS,>'X!WDCX\P$<_3K1A(#XD(=MWRIC7X>]],T?.&Z+=98[\A6A1E/BF\
M:VJTD#WN"/TALJ^T45E"F0/7/%B*J@Z2W,1-PX$Z&#H N^E&2ECF$XH27C')
MT/IH:@&JF> >DZ<IWD_=CXX:64PZ^!M@YIF-19,0I6=G8E[6SL=>4@IV*/\,
M3X]SWO:?/YO8S>M3>=RM3K@5R#:@MG9BHA-%FMP<2_W7YK6"1PB6J$:?E2F4
MNYN^=6% <:)7VOM,I+[C(*+-9I8I085WZ06\>=/=/+XJ;P9L[)%B9?0VD"6(
MMP'J*B0XUB.5NIME>LXK]&3/34-'\BK;W\6S"LHZ*BUE83#I6P:]TJNHUJ&+
M"[.\]A6JM!Q4S$W3S ?9 B5+=4ZBQYTF:IXP)PD?2!_7$$8%7J5Y%O9<J;B+
M"?^CDOQOQ&/J,P#<I^<1MJA^CI^VG$1RQ7!46SU2*G.0>^:TS,U'D0_A?V!+
M,K1;./:$C)-J>0H1P#V#3%),E!^VJ%<>W[9'L1N,_ C/0VF.DT/,Z=.%]/:H
M6C7<<<=T-I1\OGT(9)E<HRZ5B*AS.=\[_2?G]#HEGJ1>$".M%010*T$R&)=H
M"P6"MRH"S>EEGQ5@65;%DB6D'5[)GU2-'4TUF%M29:2:\CSR392&@:;BRB&"
MFW:"0K<\_HX4?#I9\^KB3_@OW(\;(AMQDH1/4ECUZJ]I=8N.WFR16,0Q?Y,M
M>ZF<\,:ZT'$,S0^_G2/G;JX* M;(Q-?OD>$LX]0Q<@A<-Z PJ?8 S)WZ":_]
M%:#D?6S_]0W%KA-J\X;(=+=59)0=4]2C='?QJH!G0GCIX&QMDB<)C4_OLT/,
M3_C%;08%![+4 NIP8 0Q&**20T$CQ\H4SJ:4E3K>.2S::>LUCD  BK-OB"J5
M^UEAKL%"DJ#J#H(*P& JS3"Z7ZV;X-0;B[N/$6FPQKMG>[$+87*KT%[69^MV
MOTKM0X^D=T(6:4X:#^/?X?#=!7*:@FQ#>B*'+IHZBU=EH?8[" 4,/1FB+(I'
M=ISV\,P1:R8\-"A#[VJSGY'9>-4R6TE]BF!8E9EC;!$R.-S 3[22?@)X8@M6
M^..M":&:%DJG"8NFFCY+A4>54GNKH;\<-:8.-;J2?!/+?.0Z/DM49E?59L7_
MG@=__#T/ H*$S3Y(2;MBAY,"B$_HA[OLIGO@5\+N/5^K[O>+Y*;Q1L@6--[G
M)IV<+)W&JCJ?+1UT\AP\:PU@]W*_F$X9R>E0[T42HC_MJ"BK6.VQASJ$?W,(
M:EHJ]Z<-]8A,+5'%<]>%)4Y6CR>R@3\)=(:' 7B[[,?)QHJ6TR0IZ'@+AM6S
MHD T=4P\=A5]F;X, /F4X8%K8^@@IKPP0GEV%RKC\D"V0*6&EV7 #R%YN%VW
M% V:G>>&@.G2?2ZG-48K-;.JI.P:O8%&(,RL5.HCV6_N@U/D+ 41& <N%.IR
ME8--3Y.^EO)PFX=DQ_\726-%UA.-G#41?E#W(&1RCVQT8#E[ %@5?#CZ0GN9
M)SFNK:2-,,[YO2@1![[G7[['@O:/':@AB&&5DNC\2#928G@3+1N-HZB,0GI_
MCG]O)HDS=SW5(F1K^MOX28(NSW.MO\<4*O]P%%:V[M/2@5(!7" [8RL:2/8
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MA-5!_>5A*N]0C1K=!#^M.);"6+KN,8[)M1=C.5);C%,Q>3A>^.XAMWB=Z0X
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MK*52*UP8%;_O,^N]3MQ*=/]O_[O%CKUOBZVCV[G1(+([6V5H*(1).K]I"J"
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MHO&8&R+T#5$!]7SMWR%QX?M_[\7BP#=$W^Q?[:B3MM1WOBJ9P[39+<;@S70
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MV&G:_;C>LIAL9UVQMI9US\82]';ND@?_,TID-L] )G)@YI<")U-=?;P11XF
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M&T@! .Q2$'6D1BR)4N\+DAR-6)F]!GY!F(4/U-"R3>9I<'/4NF=_U20:L*W
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MH\F:DA_^*"&CJMEW@\NH;];(?%Y794E>!*-9UW0KUS5]?'CUA&?OQGV9[V-
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MNOL7SYS_CQS\H9Q.]RL]*-^_W7([;<=H4([N&U^/9*89 "3K:W@ZXR_HM3R
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MMR)QR.ITV:Y,R04]K9?"ZD7/PS,Z]4),ZG\6YCVXKBN,D7C?+/X &%6J_.I
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M?0>_"HK,!;RY-L[Q.QM<06G<6#NV%8.#)31Q@H^*GM?C5MT45HO)5=)&+IN
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MEL."NO:APAMB4$^0YJ@6>S@.9\M"8<<T$ *C:W:>-=0]Z%SGG8R7%BN7IG%
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MJ!L$5+N_SI1E1^F*GWF6R9J-*68TD\8>@K],Q*SNG=,[95F/?-7_>&O'.&J
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M2W2^H4EQ$D;R:LKKC<6;)-E<*[3X2LL:"T?,%41'^08N@ [MI+HB37&C@[G
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M9]-1IS 84R=%+_^931E=!)^_>)UCL7]O;(:[/;+'!+1&C:O.",I]=]QGX=]
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M>D&M,*/+N*L@L Z:<_UF]@ H$?=&G</'_,J]M=#9'^YJX9SFBG'$9=*XITU
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M 545XY?IS^JRFKGN;?7T(%/W>#(B;CTI%F@F-9G\92#1Z_$J@XI5#\V^W-9
MM>*>V(2(FIY?RDM.BB].W.WXE70!SN KEV-N??CJFS<\YEA*+/&P6@X47[[
MR\TP$0:PL]D&/QYZMFH^6OH:MP3/XQ>\(C/"4Z*D!MO8IU$>S2.^S7ER:705
MWN;1][L6J-W;2G\Z1N3\LZ@\N\?98)8\A(*D$GAT_DS/E7#@EH>%*_],9&6!
MV *L(6)Z3F*?T:%-4Z+G]S/[F];W'A!O63Z^ULC3H T@($$K[W%]SEON&$H<
M[&NV.=H0.I&ZK3X]])-DE<Q"-(;93QO=K4'9/N_>.XJ^38:L_\,(U>\(SOF8
MY"KS<TRGI>#HN*=$<H\*:-_L&26R^\_A #_G]GC&A=^TYTC0LG[\.DT!N%B
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M8CYBH]1@\ 0DZRLP:>>U,BUJ8[4?Z45=GS&0F C%122\=?X[AQUU<>^]#"'
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M?) ->!-(*E]P"H^1)MF>">SY$1WJ]S?4N9.T5TI\Q>,K4$/@^//2^7<;\GW
M^Q5NL783RUG^YRA?\MI$>6@=_59RVHIV[16.1NMSYPF1G$1C]S]+%C752.C)
MS+2 MAR(SB-N/+2XT^!QBHW6 V8D]3:-"6O)&@-2#U!]$+TM_[CBI\NO6]Y3
M"I7(4SC?\HKXY*9S@PF*WQV^6:\524JN%43^&AW_Y-_I:PGG(B\12/U !6V&
MMZ.M'CX($^7#.<,(#H$;:'$IN] G9U<17_S^KT'A.1K7Y9(%K=HH8_J3^D%=
MTGUA--'^*&3W/73T=-TJXOM+W)"+4(&]'Q:VRD_JK;ZSH'MRJ R80H=UMQOA
M3XB>+#(DS;M2T&&_4C>A>1Q<#F8=R208L[X!* -;CU6FL=T,VA[H?E:[$.=(
M[26#UO7'WJ)J!QNC[KSVP7SQ(#?AY[%,6LM7#_92YF6BUE-E5=5Z-YE<S0L]
M^F]7:$QX"N/\)#".Y4:0#=1>]SUG9\@X>:(^.:PV5/2Y456HU2EPC]XW^C-*
MPW67F6&2V7%M*1U!X6(KJ K)7155V(6R\H'-4Y8K9]("%9V^.#S:.P%T'1Y<
M1:3\A[D<I&H"E(Q#;\B0M0,Y$<,L NJ!5,P5C%HS>W;SG],1)QQ^W1C9GZ9V
MV\768?%5(B3MP4M;8DUR),N4'G2\<+]@@4EKZLV&Y%Q$U!9B[LB:IK&#R9#F
M*QH?1HU$OU7$9>I-FDI% Z[\;YYG5>J]>V><HR[#^'98U@-#H@48I!##!69@
M3&S]C_J10S\+P^[BN0'0IA#1@^W<LK:'#8XLT;:-VS\]G#@4/_$B3[0L>M0@
M_8QH#IJP5A&(X-&CWW+/;[OW;'QKM@@_00:-,3-/6=WIM*K9%"'!(FM'TPU$
MY1O$;0O+NE@9B07,6C/X';3.6%H"36NF5IJ:L0[_44< _@6A6M$UH;2H:.8*
M<!%/2*GZ^=A-;M,NWV^F/1Z\.^,5ZH2;%/7'?8,;DLL7=VHE^/@KBHL,EK!,
MG%"IS*E*E!#.$.]^>>?:&.K0^0T^UZ0XCOJ3-*'J[%H!8;)(X(6WM(DHOU![
MSTI60TB+XFMZJ,)Y\[PH?Y9D+8Q[_>:HW5?M@A<'9SN<-R Q!428CG@W@F0>
M.G;XXKQ^SH'Y."]:!(TY1!A*;;!:N975X%226>\N?>[\ TAY<<5=DH-I04D,
M@9*LW_FE0:>/MU=CX_>ZJ!V_G=A+4X:IXR0VRT^?V]DZV%?Q<^ H[XBT:7.X
MLJ T+:>.-SK^*W-=O'TR@,%QKP\^!*)9T;IIDL.B8JEEY!+,^V0;,.RNGZJ=
MIE'-VQ7=M#[EXN>DA?A%6?X!V+(Y)"NH"Y V(JE&17[(LQT=];\\2U#YM\'F
MWE>23Y1+ZU*A+L^)=K/BJM[;_//_IO)$NT3W:<S1[I%L?@'H$<*S;7EW,\_P
ME=2(;L;FC]U+[>M?:G>CA%ITP5$GVSU<Y[NM]AN/AZTBLCP^KO5O  TQ;3 F
M&[7EE64V&)0.?SL[ESO3XURF)@Z>C/'H?;F*V% $#=V\=!PH86&%/)3P6BF*
M&ZS/21K_DB5PTP"F4M;VM<66,P5[HN:P".+)/G-3ZTR*>[W$)&JNQX,/4Q")
MEV *:;L0T5<<5+\<<_+ 5I$!=](9GNE)V(<SD6UU-NW_'I?4N(^U;Y.5^J8,
M0TWA?0&LUB3^B'*)YP1&0OUZ;GVZ7FJ)MV[&\@%Q'>W)WH3_A[$OCX?J#=\>
M)"%DWTV6J"39)8P6A"Q1%&6*LB;9(HTYEI ]E#5&BZ6DR1[)9$^REV4L,Y8L
M(3.6<9B9XSV^[^_]\_U\?G_,7^?,.<]RW]=]W<]YGNO&19(H@5].H*H;O_JD
M3/VW3[)V601#('*WG#W=4\VWOK>O0<_?8XZ)KYZ_B@K:V1--R\=]NI8.20BV
MR#]$30?SK1?$UC%3H)^A$DM )3,F;=DTM]@I4'\742H,<NXB.(2@5N>3%%*B
M%NHI4293O]/O4:>+7_@N@AD*1>XB7'^G(:/JKU1(S5C5+.XB;K2Y04- .="<
M0DQI2O?(/T79&:]Z2M>I2,E*UDMQW <(0 >IL4^Q4F".@;75K_LJ]^\5]<CF
M/8M!GE->[1T-AGCYF(6 VRZ";\PSU.?S+X&#MU?O[WLRPR1[+R.)6Q#/';!T
MFN<AO15NF,N@2IG^7&KJBVMDIIC#?,?*GG2=*QSY631I.3UY\]L*\\M#ET+#
M. OX^E$1L GZQALJ.8\MX"08JJ^,/7KX\Z<'Q$\5XZ_@!W81(UL0EQ:='7-]
MH*!Z4 O@W45XC+^0V_NZ.!ZZ(5-$2$,+,CC!:+)I*L9X*G>#<^OZASLV*#5;
MS GF:^PI#/>0ZV\&]T?)8V7C69WV,SB7HVST5Y3JX1BML.,&3LV4;RIOD5\\
MY*YRK)7Q_+.Z<8MW<_LJ;%.["(A$$# T8!@.,%!4C=;VG:M5)UI2>WK]PY0W
MK3@EYOAE?5_$&!5P*"0/W#;M&OF5\(OI=50^\![;VLZ5TE],#[9HYIM=Q&S:
M7]2_7<1Y= >!(2*?0J2W@K#US, IB1?4#'CL(K85ZE/H;[8E( . 7(Y<"YY4
MVD5\_.\Z8@,)RO(Q\I1B4,OJA!\$/$RMGEW;1> !9@;A&?#_O1;Y!?ECF"$5
MMXLXXC\#-<=NYX!(FM; RB:0$FKPHIGC8,?Q%OGWPR0DQ5^)\:(KA<Z%G/.>
M D;467165%XI!TX"&T<*#/N9X7M['!C\;\#'M,N4/]WYN(.V8D]5I<Y:3SA/
M-R;G#W&7.'+:J)_:?A%S%@]G#I$A%^28SQO.2-#@Z+B@[#QN=$'!1A2510+U
M3%MRW#+I=DOIUQW;D#] _G8$??+W=C5=H/L$4(6*;JB[#DP_YIBX%XP?A'TB
M8(Y9M G'J+O_;1SN8,:C9J<8*KN(VR.H/-;'.*+HLO.*4M--V;<N'73ML31@
M,0M_$R_'3$#-QBTB:0?W@K;+UX<1>Y7@_Y>_C8+]>>](^;]>\DV>_E94,T'^
M_FCE:M"*/<EB4.EK'4;N7#>N0#'<$,YW(J>@?GLT9R.KE^/-CT7O5*"TOZPU
MO/Y ,R']IH/-%_ =]>2<BLE4=M&73('3G4VA3,__CL'<9YYOA8Y54Y2>;/I0
MQWKZ;A1!47,;#.4U LV,8K G39XT9"CY*;S3H$N$._DM'#PD$$S8U2+W"M/4
M09+,=XW2(R%?KH%/3F3\&POA+8MH?RR++[H#/_Q\HV3<>:!Y/A'V"_E=!+6>
M*;)7E!0C_PF\33\*.AY3:?A2?K?F<NV(0W_/CZY:&-Q%]_YG#$DXMF\I4].4
MF@7V#V_ 1A>T7;A71!7^]P5/4KG0)\N[TZK5;Y^LG+G((;YY>1$]Y&URT-G>
ML'K; O9P>>S/0<P%\*8W?L$1R!JRMU0H]K5R8GBP;=<Q,PU/3&)DP:Z[TPMW
M/&:J_7DEV5;Y*/@E"X@S@6XRBNTG5-S%Q=Z^\\BM7]&$Z/\H,1[2US<M_"NA
M71Q4=$/6WBD6F2[!7(<;">?E/CCN\X$X'M7JJ#GBZ",W=2:G.0(<AG@/,N.U
M\%$D21,"^_-([G<*>2,G$>,Z@"/(37L(KN 9+&"4[PP/EZ=%^^*+N/)O]X8W
MJ^'>789[%P ZT!9!/^UJF<3[0<CE39%<UQ[_:L9/: R@F..3216K*:I5=-Q!
ML1,^G5SFIQ:LJ]EO[-6JB0S>J_0*L:!X3V ,J-RVE55I0]VN$\%*"O,CP[]%
M<)2;Z-'L+%-4*X\06Z>B71L@5U^3/8WD&9=TVOZ3](O,[G_ZO9U7?1_*L!"F
M2D NPT,P&%5,&'. > 5!]!2>=7($1-H.;G)\KDD[I3([_\S47WF;Q*P /"<L
M:#@P.V"Z=,RD%EU]\8K Z7VX &=T\=F/8$3&@'+V6X-3 X+.3/IAN('ZANK0
M .'0Q@3;!0HU?^"O3QHCT7JMP'281/$-7NY^Q[ !IXHGY2Y^RKK\I.!!: Z4
MLVHHU1%,D;&.57\9IXFO3#/];\EY7PS<XVL>0#DZ4G/"PK8O9^Q:Y*F*_2EB
MVP S:.OY]RL' U>-!LL994!3R-[!FDEYT(X:29_>G^IYAF@JE?PS86WV69CR
MND7SI!I5J<6:?\QK1^:505E;X0_S23MRWELI[ OF&RP)_0D7@?(F1>\DQY8L
MHCT:ZFZ^%SD5T"3,Z(8[8P&04W#"!'>4..FO'C(Z1UG04-Y5DE<CQ9QU88<.
M<:+WEL:]\@\.J.A+4D]J_&D5X#?8*)AR2&3^9>KWH\@-J$J35\4JW1TI@==>
M)MM\]]X^3.4+Q]A-<>8H@Y.*Y\[[*-A?_+5YV(_YYH%AN@[8)[^#95:@R-/X
M&)E#E.C?Q>&J@?3MHII;>!^EPY"" ]EZA4I_S#!B?H+DQD,RK_\Z.5,;]O?6
MH[.VG#3%1DQYS9!6W9-#X]VR2F*>G'@G4(DNBKD)#N//%H2@C37@P!WHXXH;
M"#\%N%E'Y.PBVGN?[F C7CE:GJ8'RK:>UV6/!AQ1%&,XR^9$P7>8N98L?CG2
M6)-\XWO6X7SO&1(H-\\XE&X.GI;&M2'CL<(>]XN>F'UN:R?K+JVBRXE'DF)>
MO!E;(/JS6WC8*R!<P]6,D!H0D42QQ;%AO_M-*!(,7F^SQRC><YCK:(53D?I!
M(S#%U;5@X="D4V^H,%%'[.K\[]+%55 %SQ#D<V"6,MA*O&7$!@KS=QR"MS4V
M5]#=OAVK(UTS#LM;,V-?5 ]Y^E_(R+SK,O&E8*>/8Q-'EX-=B 7E0WJR--TK
MWO;VK&:TT)B5NM79C=["(!0_EA?;@I6C?&6(-DI0/CUS-,LFCLQBBO-?,#(P
M>]":AAU$5P;%@P'?B"7)0K?.57TX+3SZ%T>Y@1JSLZOY//A/:_:8OJ545MX.
M?Y21S%Y5EA;0E"+Y#2=<RSA!-<E^$#V1HWS8R"[Y903: &@Z85(,T"U&VPJ;
M5Q07*O]LML\XH]_]10FB/'L%M)C4Q[FC<R[[YU!J6CMTV-H/[E6@"UE#B7GB
M)!G E)N3F:OUY+9[R3P!!LP0PIU2I\^&^\![-TLY)!SOZ/P:+C9IBF6M:) L
M< RQ:!XRE([0+JQBU1+^\/[]J:K_RN=JVQJ1W0@:>^<(!#B:#G3>@%$>1J!<
MAT5,3TF=Z_]53@KLQT4>B^JEN<ZL>W&9KL5^U%ZY3[5&+MH""R:$$A2HG6-D
M*.CI(80$,Y!,5D+FBJ^KM\Z3J"\KMJ[0CA;3$&BJ'&PG<5?]XD@M>KF+( GQ
MO=J9S!K['+]="G&IT/E!55H5:/QX:FQ";_3^]3N ?D>&DN\@L?'YBT]U!FK=
M9V<_-$4=;/]QEN%Q&#H*D%_O(LKQ\7#D)24ZUN" PANF7CL)*E7)G^UO!"%?
M^)'*@17Q:=1HQXQ)[DR9CDVV[2!T_0TYC P4 B9(RH-@AJ"&*3A*%J*2H@+Y
MM.>:?\_G#9U,RMC8&5Y'4B6_U>\B6GJ%QD,>WZA5^Y&N%\TFM;\- =Q!4\QQ
M8ZHM0%7Q-TO>*T.O,AA$T1R5T=MK4=V6\"1? GDXVM&C2ZVB HZQ@>7-)\?3
MV[!L,#@< ,B%6X3*U=8L?37\4KND&9=1_  0XK.ZB5],:6X\0LE<D:;$:U9G
M]D9"[=JYKWJ,$8 0KGJX)1<7C9+ZQ]!0>?7$Z3OO@%JB&GZ$ .K805Q("GU*
M#->4+]]86:L3<7M"P[4"SN/V=G^38/LX$I) 1]N#PY0OS1_F/"7OY5]>X'T<
MYDVM8 <KZ:K@EU[)E8\K]]7WS[$]*/ <@<8#5Y/1^X.2# U,AMLE,-$S]N3\
M&<,7<R2)780O<G1^2LBFYLW,RA$9LTCU+_GJ?HOH'RDQ!'(-H<8TYH2==<7P
M\!TOUKF'"^P/D(+ ?3[B>5I:(VG:\NKL[<//[F771^5P! *W40>!>[C1F6F5
M'(M"S/D!M]1PXM-YU(^O!OIV!7G\U2MZ?Y6>R-Y:'(S(@:P)Y%R)V)69&=4X
MO9N9X;<]J]8#:EP&S);0@SK+;\BHIP#EU0KC#-6>)R?J7-?QR,=%9_K,UF)7
M]M2NAL$P^AFOT)28&;IP=RMO_PO5[_)483*RPH$AY?T*<Q?<NDWI:*T7KJY.
M&JNA9]_P06?Q=J^BSP!-#U#D9)0 F6J\U4K:OR"HZ1#P]6?*NJM4,LF<$9;2
M@A)"N??"R6KSA=0&T8S[3=<RQ)KV*C0?@'I7@F @1$WC8\G#6DYAK)0;!VNS
M^4_CLU'DMZ3*^665$@;7L!933Y5[,=-F](^ [@$WW1V'==R4*JABNA)+3A*0
MYC8=?F[,M6+CYM4"OMLK9P[SJ#,+ 2"ZK7X2_)CN>OSG>#Q7O7XEK7@0HW&;
M6O1WN#GS69>;U"-?C@D4;!36H';\8*O_DFAS._'N4[W5.XN)*EAS!ALSU5 5
MZFM4JQG<X#GR4>;ZH;4/_MP.&U081\[OB4]Z 16U+4^K\4(+;L09FPI[A2+U
M$#A?5ZK;PL4EUD "_%D)N&,!N"WO;77X]HTW9G1+\-GW,=.QCJY=!*L6,]!+
M(M"AQJ1_6%X,_V<5XI5FIC&"7:F93M3JY.?8;C^@#NTY>[_ M =',?8]Y.&H
MNB(^M:V5NU!P^9W_G9WAS71*\0Q'\S"EX= 8V/Z]7/^HZX)!*1@%NE--VTCL
M#==YZZ86$X/M[02*%6Y'A[71%8$F-.!-$,*85%*^+!T?:K\&KN=^<8G\F++
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M)EP.+#MSSW4-<MY@6<%1C%9'6EI1@HU:"_D:7_KGZ'*6L0\OE6QW@ X;"Y!
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M?-P?D,/HVE/# F:?.@$C_PECX@?-N Z/;VZGP(XA!Q/#YK2JM5#ITW">&V;
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MF=WTD:O[.Z)U\42!LKZ*5'@BY5L48X$-?,BL-F3QQK$UGO(BNE7O*Q>O/M9
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M-4,09P7"0%F/%EF4\$I(4N^?=Q7"E+.GH/*PKTX^$ I;=C"@6C39H_GUA4M
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MF6CU^$K!080'&Q4U[<"0^!HP@Q+J+EN<//ZI-OFZ>,W=,R]W',JQWU 47XA
MEV 89[9WM-L/GGB"27V^;!"-+;I(/=PB=3F\\P7*'%%<Z$DE>CSP5 _'E(AH
MK$;$K^TM^Y4'-ZDFUU^BA!0WB3CHV.V?T&Q)NXAW2KPX6U4:R2=$%=F:M$1@
M+V#@Y"?*K4&-JM$JJE<<JZJY)/;G>96'-@4EL<X&^UH>6M/8J=U^WWRR'4-Y
M2^":B*F=/']4^['!?;%;/T?:$%A]S)Z6\ZT-5 PDEW"5:E)<3#J7=LPCN<=H
MAXLI#O+0X002R?JAS#06*S7B-&F4$#<M]4_:\C'FK(*,5SZ/]IS85D*<5'@5
M(M_Q_:-#)_L,CGU/0@I(CQ85-G>O%Q\-E7BN;>)47(8XUZ]GI6"Z#=0KAX-E
M= V&!-CMK5*<K,_O'7K32N+V^!;^'%KE[:2D[NN[?$EY <3P/<D/ JA3.17<
M_B5;D6*?6;2(=?.KE8:JUZ_@*)[8@GGY]H=L5&L*?OQ9_('.PKLN_D?9J+7D
M%(;$ZEO,Z>&97PS+]XM;_2>:$MW=Y2G".]P4/HBSFJ[)$!IXM68HOMA.._3%
MW7@^?N>,[ .Q7S[WDTZ]K+7ZQ6)W<6!C1:+90,.\^MKAQ-O\H5SUJ>?%MZ_<
MV;&UYOK^YJ7K0)J.T5OY._&(J"L#*UJZCB2;< M!5BXMS"K=%&C2!-Q]DXD^
MW^K X.*$NAD4X5G YRW\6Z'O5M<]!RXH'$X?A.U:O/$DT/111$:#NB^G-E;K
MJV&/B$J-UK%VZX'/=%]0<XUQXT1%2'L+2\3MY_,;^'%W53%BE&;=-IMN4P%?
M#VJ$!!W@I_C2L)_CE]H;I0>U=)*V[A\.I3N0&O>!/F1T3.B=4-'(*K% ^D7"
M[XY#9/M_Y%W$EV<S!FJ7S>[_P_:T'$#%ARM<5>NL&WN@%(\K.V=SJ"16ULOF
ME)H1-^RD;(KMDPY:Z\4K5+I0[4H<N6FJ9-7E24* S!WY.D."XXZZU0LQEM.*
M$:6X&&(L0R+XW;B7_]_S[?9GG$U\ZJSF#5_LF,'HO;1W#A0Y4MSR<$>_/E%#
MK.SG]13D1(?7SG/#F7#U8Q7GYZ6TC3@2;0S,LCCE.\SOF<M;G]@H?/8DY=92
M?/SEXV-)I>ON.9QJA@H@QP4P<\J"=-!;A%/]IE-6#/1R^ ]JQ14V[D%/E!16
MMG-Z]>!?>Q%^LX8LR/EMU+C#4OVGY%-.JQ+7N@@GJUC 7 H)XO&FZK20A(@A
M&2T=&5ZWZI+/'2JZ:,\Q0+@.1_1(/7P3$M$V97#>5I1/N-Y$BI\A+UTZ>--\
M[8UF:?6V= D;6SN:%R-+Y3CGP]T>JN_0=^ITLO/+>)"-UKFW'H518+ZY?^<+
M)2:J:#&M4@"-$+ *\][PFQ;0YM1\[RK?M3\<Q0-,"SYF+N,H62/2/R^>MD*9
M;_J.]D(\+RF$YI1#)XNGE[Z>N1QW35!<N2],>;/+N_5!.#+@(K^\X9VDR,<V
M''$,?F84X+X:.30TWPSP?O!1BC!9E'.VX-U<&1KJ<VR5KTT\GAQNDR(@_:J^
M;\T<R=5@LY\OV5 J1&GZ9NJ@OGN!<1COQ)<C4BZ-FDP\BAR'KMQ%=#P^D\60
M)8=I6&;<U7W L6]KKO&O[8/S)SD+?*5\IL-1A[10H!:KTU=')U#?X5;J1>S%
MM9?8%X7D55#+2H7[9NUO589I<9>0=6;*L=Y%='6 _&<VL8["8\]>D_LX?J K
M,AD"I62=Y?4I^C5%BB%.A8&X7W^Y\QL-7Q(X(3=L61YK.3!SJ(5UY8)S>.C5
M9K:B.=VBUYKN:NOY58C9$[&N :O.TO0K4 N.B^")YK,N"HEJT4[KU;RWKY)O
M6C[*>7;9?$9J\)*B,4NGF"8+B*=*0CPW:JBHN)-!ELA6B; &NYZ>$JX'G#UZ
M#IYT;:"I:L>W"1!IPO_-J8[N?/I.=ZR']S$7,YB3.358*._+\\(1,8<5PN@/
M0F*@JC6E,-'C=<^(\7.:5D ;B4__R$SWZ0U U)/?><QB:^KY ^^;<D<24&*+
MUL3HAHF)HVS3:.(83%GH*$;@H$)*BPS[X+V3=Y4T?.8W\3&;NPA0BXMN]_LN
MH9H:_<1//_K)(RL6 SV'%7JT7YHGM]KAP]]7C9"IZ$I3AN3I*=4GT*D$9^KS
M^H>%K.P_56I?(KV8<J L79;!!\J^/>M)7F6]/MHK=,M,07GKZ:ISR<_W(?):
M0DD*ER1D7^)RPL5ZHI^P2B%.\15>H6*3M0C<) _=741*U^E;O45_E)G>%QKN
MG_K<K5;\G;^@4QH.7NNT/!C\/?"-^B!MM8T"5OQ0K;ZI/W:CR&3:NO AZ1..
M(;D40#^",8UJ%S64K?I\ZGU*^GTKOD_XWWPGCHZ']BU/Z<@=[&/GXUD\WY+#
M\S$^X2?_ON^E!'=/W6=_K+W\LR57CYQ.;IL.%S^AIL_CU1^96'@]["P>!WC"
MHZ*$^[:+((J:UL4Z4(P3,VV+1#Q-#^?LB(M]ZA0:%>;LTH;1/& :SY#H+P;'
MVM*]L=)#&W1E3\/9P\52]/AN2C!#(E<I=K,DB'L7(31B*6$NGG[L.Z.4]G/%
MM5(_=/!E_:W#W0C,5?JIO8H#*'=2I,U8Y[0JVV)FK9KKUF?QF46T<XC#U&IT
M U^Q<2%H;1;?(Q;#+[_ [FUV*'C\VORGHJ837;)F#MPC?>SAIQ":EX?B$<<2
M"W&R!*XPK?1Y4@XBKMAF[."CMA#42C==^BS=D:'?2'EL*609Y/-G?[J4WZKS
M6C#'N)#48);4?3D8 58!\F#"TJC^ L;U5A0JV!^(#G. <1(VD$@Q#W0Y[:MB
M]7M+]V#5'.F;VK.'.(H'""8_VKOF-%P7K1SL(J01ZD/[/E7%#RA\2]:ZG'([
M'IUG^'!6YO<Q<=T.F6HA_R_FKG>W3<T15-4Q49IY/^"%V^<,NNP<N) I CGJ
M?YY)"6544N'!?/%HVB?4TJ2CC7;H3>"E8OP X3ZM0_Z^W<!+EYOT=2-D%O")
MCW%(%^IH/&$H7S^L<I(OOP*[C+]E ,.Z;Q&Q\,43[:<F<G%V< L>C!T[EI_G
M2361NUDP%RX-1XY]P;S\Z@Z&O^'8L8N@"YC1W4!U51[C$F,6BX<IZJGC.'19
MF)1?2DZVT&/UEJ\(K/0$T%0\O/+.XEUMX@FNA@]T_[R>,.4-;XBS^W_XOU(?
M>9 (B2<^;$=-N-(_KZ"OOGN6D@WH>1BZ+NNS# JQJ CQ[C]:P/KF8>L;@^/F
MR;9BVV'?"]@#3_@C67/_E-^N!E?C0U)FB99J5^7UU319(F9(,<X<8'I18]R,
M-9\Q<'_[A[DN/F$7X=4+RNG C.N3^:04)3_753XJYMM?;/56EFQ]LB=;VL7;
M1LBG>L,,B03M4NQ6*!#_0=:V-9I==W[1-L0"XK'2LZ\6'GHW[6-X)_FJFZW=
M,]XP91JYX;7E*]W7%R[=3=8P0A[&=J$I%X'1+K))DG3C%\KZI:_U<0[WIA[M
M"U/^2S@0HM,BLW\@W912\T(ZKPKP%]OA&KIZQ=E:6/)"6M@ P(6PC;>R<34(
M6QSCOWC#;S++^8JL-M4JG>G<]TB31?)G0=:0X1MQX34.AA \>I4ET)@(<#OA
M>ORXI@QZ56TQ>9,F)BO?*?3LQYK =5,A%C"=S =JV6\U.2LGH!NH04_Z37Y@
M"NS*>PNQ>.@'JC()O[Q(/H/B=&JXYU-VX4)'\B,:WB%#G2_G)<[\GMI4PNDV
MA"Z+@#C7;%_PSXCGT_G7K:5+KG; TS&%K,$M9^JL&) 3" =- :ESTV-=9ZB+
MZ(S&O;K9=IL& !J:3&G7/AX=,6(>.C] \,UVM7Z16X;4]'PZ+!=NN'<4XC'L
ML#J:Z!'".6V!ZJJUK'.9*=(A&SL.OW/-;,IKQ@^R6*GY2E;XG['=)[Y>.".$
M6!CA+V_W0VM#)-*GC&RZ6XC)S+F7W](Z??XHI,TDJTTVIBFX_DQYV8<7BCV\
M\?<H&Z5G'>+1^+5Z1+!EQN) >T!2)R2\U<L06((X/?F6^?<79-;6;/D$R; 9
M)W^^/+:(]JSX$.OKZ_6 &.51<& ZW?_?6+ANT]NQ/]_=I>:KE85>' SCW"A^
MZRUUF\\+\>;C0HYIW,:[JJ\!UM=7_MPP$TP6<]@KX8%C"%32[H*+4W%ERUC1
MQ1KBD]%=A/G=>5Q9F/57O8.V!V<.?I9>@.GL-!]#HD+?85HYS]J<JA+=(&!9
MKQMA_3PT\,,759@9_IV\M082K.](F^SQ>9:LDL4V$W3PCV+E\3Z.N=[E#MAO
M6$ SBI='2F*5M([=M6_[#O$"Q^FN4\"R']T HQ@I3UZ-U=:V.XS4M^@)\QZ<
MM'R_[[R2_JP-;?J267KJB 0B4(1Z_E"\%B*4BT(:<Z4Y49$K.N1'&*57(='W
M$L8T+[4FS^XPO<=;A&\$%QW@JJ&8]3HB&'N%N,F_58660J-[:C^$[/1,FRD%
ML\>[IUD7A@7\#QM4 !UH>L.Q3S?][@8?2[C_IST@4J-CB'!>YIPBO\\^"<7(
MT^%&?E'$<,GB:V.+-9>O.Q5<C6,MD0Y_EQU\T$Y;^%OG='Y!1)01PDAON!>H
MQ2_;>=)O8X[]:D"LGQ?*_"YD<5)W^^+J)KX@YX8V1]FQ<9-_&RQ@@"I#(NP=
MX:F@?6S[$,)4O?';?T:>!9O8Z5W$[3'<2/&W8,-#=;_>?-8XRO*F??\!@\87
M&T^TE],U6U^F]@V^<0OR/74+9F#S\PRA#NC \ ?L1*,285@%8^WK57OOXG5S
M:OHJ6H/!"EOWS=5&?G!RN"TT,^'>??:O S^$A%8VA.EGQ&R^/)^ULS?U_]'U
MK8!7E>S0'-+(%R*CRF7T]X)'PO/%M40'[^H\Q$3W :KIVOVEI7/*CZ*_N(0K
M2!V\;"R$N&(K_ZC96@/!^T+%](2G[,BUQ#Z$@+9_&R Q;7B&<;(>K"-[[R(X
MB<X'L,,<F6DFRG7)!@F5-7J#F.JG@CD(AB>S $4>^6HWHY2L1(V@!J4U=( _
MW#^&*2^D@$I(!K\5:J38 7>UX7?9?4?[?6(_:(B'.PX+#^0N+/96'^8^>44F
M/R9</F9"[F+9CTB!4X1G;7IBE^PR>C@*CV^7U_35;6DIBD-;0HB_1^'F&K&K
M_6[XUO19^MW&,'JZ&^$'2&&%3:G>3<%8\?%26H*G?!=0]=9A%M6&!K4JUJ>1
MR5I\HN>G2\6&_E'GCIH#_/#4#+'ONY-C? :RX8 #1!@\3UH$<I(/_1"8,=CJ
M[RTR&)9GU'KW,1PE]NM>.'4@MNC8JCC_BKD-PK)LT0@I#]]O@B+G(2E$0X'&
M_D;20;<YE>QTF:Q5=!X1)@S ^Y9W8W\IX$"[5GQ@^GT[\!K2G/F=_\FY O<E
M2^+RJ:YP/9=P0PPS''#59J8T<"L]B1[W%XV[FJ,?$ E'P WAY?USQ(O"GVYR
M02XXR<V#:O%&J$<$?1N./^XK+7!"LC4!#36B&JAAA*<K*MUMHYE;T0$[\4W,
M9P!YK)0PBI_.QU%%YMOL[7)%E [8&9Q=-BC=_$F^@Y^YK->FGH5I23<2F^2C
M4"G!3PY3(#+D*#QNT*X\10*/<S#XYV9HV\/+04^&?%:Z/SPVS:WM2][<FN42
MW%)ZQA&::B>^SX9C6BF"0/YML;H?3%;!+K4-:9A*OEMKLNJ 8_<\71LC@6+%
MBGG*L&J4)AG^/*?M*B7HG*!\H,D 6Y5F5'$T7;?#')&:)>?+;3:GK#@G_2[5
M?$VUYQ3[B?*.X]$3B:$V'*G0+URE:-0NPG.5E00ZH <*'BG5KKU)NSU .-YX
M&&AZ+Q"2VZZ^1%2*KZ([!?>,G+4ZO>.P$N!4FM3S,/K?\8N_'4^8C,I4L6SS
MT8_ $U4[J<S,Q0"BB2J81UY73V;87_L1D/CXL<-"<0=N-']IAF-Y[#'%BL84
M_U>0C%*CIKS@VD4XTAQ.%!PMY)\Z=6:GCV-:-1D@_^9Q:#=4RFVU">EIU\J.
M()K[]0XT?H'QQ@-HDD+3#L9,S?XN^W>ITM?0BG2#AN]#:./-4WYFYWI:'661
MS7:654O9__+5%5_NK9*[8B,A0IN(DQSFB.THB(N;CEA$U>##5QD:.JE"6Y>7
MK]_MD.*?)&AIP4 \!\W=/E*<^$%P;E^X7?$?].=_+,S9,%,O+[GBU1LO\W^Q
M;.]1F"VX&<B4D2^."5=]W(;\TSDY$_$?'SM4P+T_!P-FGN/J2O94*9YO)"19
M^<)G)98?9/<EM&-YLQ2OM?D];N6.FLOQ"(9!S9Y4JE:IK]CY:>44J6O?2_T5
M@G[XHXXS3>&DT.6F(.T,Z*$O>M#&[.0?7_43#WN+A[Y2#R>S.CTTVRS^N(4Z
M5<!N]WG=7%<*UY,K+_;+9_/UV3J]]7A$K,VG&&ATZL&!N_(YC%[F5[A!$8[N
M*T'3CS"F15X/[=/,'MSQ_^,/Z#$UGPI9?O L%93/D.8LX&M%L\/M?R\C1XF-
M)U.UBI.7GW^S8GW>>WEE!?T15Y'2Y$0:72?GIU):;!J=,@<'O2]^;B+SDLPW
M*OQQ1QG'2KYW>,N$'64].Q /$[?&O8\7>\7"%3X"OL A[2^\U;X^4,J?:9?&
M\. =AXGGH_+7]P\5\+7T[HD4O\N)C0TJM?2R%AWY'#EW6OL/*CIB@X8?0H_R
MT;R1E>[AARFY5FE996GZ16=<![X&="7%9N8_/S729(Q0''J6J?1'OO 1L@,_
MTDL&.L)$YKK:##DJZC_G*%[-N-V?$KI)"XN=F_*J:,N^E*;&5@OGE;L(*AWB
MB:;,M_8*=I:"MKL(J\&IAR[RDB&=6\+S1'>&1$2)I^ABT*-INO@T+^_//3[M
M-^J:&EP9N%'4W'/MU:62!4L8QJ N).5<;R1RGSUGP_4I:9W+(93@6X YW7>J
MMPD9 QP\X5I-T8E6V=A(^7="OC#HZ>Q\Z,;B.3/9= ]TYE"XF/VQ7#X9\PW-
MBS^+.VW\0[4N"FBY! REF<K91(1N%?#),,N!NSY\M!(P:!=QP+#\H#I"+$5'
MK+,->PVS)QA@SY>(N:K]Y2V8WTP\IN2N]D</V4SP'M =LK_K;Z5G>\SN^7V8
MH(K"XZN-(C_7XUL^77C=6#,C4\>^  N=N -G2IYYY247=_C,O<9>)^4F&6I=
M)6O[&?%^6XPWN2J_S^[ZT^>\O^;G_PBQ-#-<F#A#,89W_Y]/5%)T635K_\KY
M4SWL6%_L$))RGZ,%G^RL6#>$X78O6E36?EA"5.O]BOUPZW7:RX&VS$OUY#Z.
MJ0\ Q;.]T">PHGOFS'Y+4O Q2'C#87D/7#<PIT"=$Z? 08O!:F/[KCML^6&E
MFZRVK.1??JU7;GT,F S7GR</+U=27,G87.':2 R?I^L)[UH,6W6H?%*\;.(M
M5S;I]W>3KMS).1=QI0J3NF2$S$53[)"@[$M"K7N;]^K3<N^,FK6)J)^%_NH!
MXP[A& %X\)Q4&T5@.["D1J\FWKOK)-GZ\O"Q'E(SP9._4.W?7<EW1VJO/^AI
M=1T(/PU$H_CD0)\I231W:U>6RDR*_RZBHN *I GZD'%Q$H\]L)I]<E]C.?X\
M]^OV_<[]28TFE#B5Z<*7%53 %_W?0K<<ZALN^6$Z_HD^LFBQTJI8'7%:B:!%
MA:,@S&(,VM9OM$V/L9_O]\=-H6NO9Y%3!R=?).+79F",L =]X1$J/3]ES=_Q
M?@DK/_COU?4HL4ZK_#SE#0N:'>QC=["]J,J:..%:AO**GN4YE2\GG_FK;>"+
M7"4Y?GJFFXRN7\&T%!1P[;CEN;_]5A_VA/6HW;^"A>./_EU0/R&G?CZX^)%;
M2,2S6W3;$DSX=UX]/R-.!:77VAQ#SS]=^1,0;R;GB>30W7PG;&3SU<](:K55
ME4LI15\^8.K5$PWJ.A8U@T['52LQ)!V"Z&<9-WXQ +ZX>U-T[_LMSWMM'Z>$
M,B.] STOU#5)1[-TY%R),$*F[R+*W1F2E<%T%8;%(.:1:MR].6U1EUN'BH"S
MZ/=+]]I[E^_Y/_3IG8K/F^4Z-U_&TJ?][5'!Q]@Y'880$CI@$$"_&_)N<\D'
M.S3^M3>;WMS8.-W@2M[3J'^'.08FN<[$85Q=#U>='BG4^(6T]F+F9],.(9:L
M+\@&XQ4C= +]"*R&(IV4V*ED'!E5I1R6Z.H_PQ&.*@P:$$W"%"G\6[5]X6FB
M,"-%O7C]S@W33J$#C EXB+-A#^+S!?X/>V\>#F7T_P^/[#MEWZ9"*DEEJRQ#
M94M(LF2;2O:8(AF:YK:$LB8A9(E$62;9)6.7$-DCC"W$9,8RAIFY/??T^5[?
MZ_E=S_5<S_?/YX_O'\=E[IESSON\SWM[G?N^WV\_X%E0(Z*2S%]5X;P/@;:3
M5])MQZR1TD#^NU^HOG/QRNW;+LKEK\:F%*CLVO "[/#)4>2Q/O68'44N"1&6
M+KH(]2Y6#*TYVLI_!I^$D@E&4NQ$QS2'M*O7O8J*IL]D/#SS4"X\5.:<9%[,
M4=C_L+'L"_5G/^68^ZJ'4^F+J2'L4OF5$HN__(AOYA/DKX56^GRG^9)WK/=+
M7DXZQD9Y7Y3+<?B,D4A@H:M\=F7E558I4:!1S40^R4*$?,U*7_B3B;T,V>RX
MB9UPQF,1V&0Z:Y#55/0SM\3NYW>LBW*YVLREGCPE\ 08*<9U'OVJZS5TE<UJ
MO'-_L!7?T:5C7^/#R]!$R[Q0B4.&\*/M)WO\!=7_'&7YS.W;%B.AAV;^7Q)9
MOF(T6 ,;A,CX\%'"M5W=\8/F4J=+E:((C&\NXXIF"-G,$";_7GYAY8K]6Y5T
M"V/O%S$PKV>2$<)?ER\6RT5E&<+4C:LLIMX];0W;> T-LP_R-&PW36;3%]0\
M@F:82Y!(MQ..D[J>H*\']>5\J-7=IS*2?#>RT;5=+X;MPO.O]NGWC$E#'R3X
M-%1$8*&:%I8BPQ<*%Y8ANOGX?K_Z<7/A;)\#M/9^N!_W[^?M>(:'^N[1?4=J
M>L+2<@N_RC!:+?)"A00X_E966NGSWS^$.%9P5"( (EKKYD3EH&*"<_>"#,M(
M05ZH]&$Q9!JN]- -S<3,[,W=HRQ<F#AXJ4+8UQT!_O,Q,'V!7UISIN47B/N@
M)1VTBI/:%S:0&@-#I0JJC*0O=+UF;8?&/-62Z\:I;KA/'M79$S*XE,OFIC!O
M%2X.&_BASW]O/KYPY?)UN3RH%XPUS.1;Z= UZ+)P$=%BU\H0IN:*^F5^+@49
M)5)YE>6?.\X\Z'Y-9 .B7BKF@B_6\WAG.!J2#N&=<]J6DYN%7,,LZQW'H/V\
MFRSQE'_CH7KL@2>2"*T :$P^>PH\C?PVQ0VUY0LQF!\"(7]#!HINZKE")(I
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MK*B#5KZW6V<Y\#)G'@A/O;:F'Z.AP,$< 8U753YKLCZ?B"_/WE"U1)0"^A
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M^5.O41ITW]X63M 0KA2-\T@S/^EMX K*<9G,FQ%/-<:7_SRK5>%O2 AQ8@(
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MF,$.KEJ4+M#Z"?$*G=&B&@T_#99A_9<,VX-/V(K8KO0/XP,>-*CFC3--XTQ
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MBYQ+E_*EXBEF2P:4[C/??@UX>4L-R%7*75:5)K @9XAC&/(5*7UU D[4M=^
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M\$#[?83(N_,:80TUC1O#W%&T8!0YBDP<#,M[CE\X+^VR5CS]@O@!"QI0F3_
MCZR3W2^<V!8,B^]<Q!/>BJHF(P:6>$[DMTQP?B*_7F2=]H<7=_(U '6\WFR
MEDB'5UK86=S:-9$\$?[+=R9CLS]T[7^OE7NN.4GDH+'6=&!?*6(WV'4_J&>K
MB&KRGU;>:LG6S]*CC]NF?R_/1NS81^=#"[T_VGK5[Z?-%[J5S(.* Y=O&FOR
M'L^K_N43(/' <."V >80X40XXL@UH=$HB?4=;@\=/DSG'&:VZR!V365M?R$P
MUFZT[Y MKI)G:>B_4GVD<C*X9XC]I*.(B[A<_Q?.*V0402>&XKF(A4.!7$2!
MA #I_M\H#IAI]"*OSI ^#*W<P7Y&LA62X*J68:Q-5(<L206_1*Y8R-CM^#_
MI?2_97GI?_O9,J;0]DS7W8\2 YO;L[VDL7I(-(**'NEL-W#:%_>R73[V<I0A
MM5%[=AX ]V';BQ$>@SKKV[D(V!@/$ON(*82WA%;=%(5/[VH2C([ZW.C_(/_X
MP'SV# H2":#+.IQ%\PXG2]X0$+@>"4\J_9)N<N*D)[.JD>S"17"\4]"4.H+\
M][U;S]? 4/X%@>/-"H*4 ^EZ=Q8%+J3]O'L2Q9:F4@[.%-U=N(E[)!C72H/7
MVF>PV>O:VF@FD;<E[H>))Q?A5+:"!H^H=D)[![_#BB66;1:@WJ:ZK_$R)0B2
M70VAP1B)?P;4G4*.+%[\=HLL--*N=]DOF$\UEO@9"ZK.+A13" F$&E*BD>*;
MN3Z,GT#LC-6<R45T2U3?ACI J4-ME]/>71J0-K0&M\\<;D WV"B)KLKC(DB;
M#8Z"5:@.Q/]V/!+I9L.4V3S1+ >E3P-30F4<3;&":5T0Y]G.16R(F7$1 'KC
M:S6![J*;A'RIGK/17BL!PSCTQC?F+/M8-\6:BWBLTKGRP@:NH@R4>-I-<>;1
MH%<+R4@O! -E<C2S$JBO<5O5MZJ3S]-^Q)>-WJEP97?, GR)4R:B;$%Z;W//
M'AW#UM%;=GN]*H6A/]\L*7^P3EM.;^=5*?[\8_[T\^:)',;/D_\T;"Z!,/CD
M97WF(^^#IZ\1A3A""F+GS7#''TBVDA \:)(,QX4)NKLS'14SX5Y[/:E 50 G
MLS8_23JMFYPV6M%RHSF4. M DJF,;:5!# V[_FN/,GPL:0N;;@//&9XT*99E
MI.>@O_[R]'M?;=0AW_#*//&@/H6V 6@_&_>5*(CWFT[Q>JY3B:39!*5M7D0[
MN CN7&-O':-8=1)B1JL+&7PM/A''P-O3UM8>4VU[S6945I?0>$B4;<(A<!$!
M.MI-T)XOS)]RQ]KRVA\4=$\T?3X 8_1'1F8,-#.>[B;U.I3@G&CRY(G#$[;/
M+Q2H)M2\F RHF!A[O:-]^UT<+/#FU4/KW@A5\<O!']>((SI6D(@82QHW0*@X
M!I);)J7+4W]9/T_SR/VM\D$^^ PVF_"6BVA7[!V>9T[7@0[YO[24$QBF55)-
M(XJ\T:F2AG;*F)\AE+C[Z"EQNG)N*N6>3OX'_SI1[=+;F2:J9A>PDNR+'M-D
ML0N_,L-:1_^P,2DT*^7,!&6+7$.G&*%129%'@_)<4HIO/+&174>S_('F6I0H
MX(U-&HW#5]GZV"7\_HQYN,2SEK PN;KQ^X)UB.179$;W;"(_3A8)ZK52GN\7
M!J9V?3LJW_M8EXN0/7\+#>JY4Y26?4D,_]>)&(T>6'<G$0>!,22SEJZ[4$K?
M6&N##M2UZCRQ$1PYGH-OVG"D$&@I7(30H4CWK^R+(5?HJIT&Y\^HONM0C+@I
M:2AE.C@[D 8TYW,1Y3.?F3^I[\^]D\SU);%=KG@3Z-?)3881SXRSDH(]1T-5
M?!NX".KJ>O<S>)VU8>EG=0S:=8N]L7(_?*P>*.>+A(= QSB\FU<-;AZ]\+6;
M:+ZEQW4BI28F75Q.R=UFGAD:5Q!#_P%0'J/H)\@"N);!0<_6H:&#[QNN6.5<
M8';>]*&-4F$I<*<3.Y$"8^!\RUD^KZ UG@<'YI"K;UKNJ4R94:XE(D]?E^+/
M2AMK&I+[8X^N/?8 -(BEV_=& 14[:\L9Z%0=/_\=:GHW!:C+^D-P.\Q,#GBC
M!-'74%M!DGF8-+/_4X.NPD.SV7[2(^RHXC21I@^O"!Y.GG_DD6"QQS'C24L]
M/AJ,HZMZDI\X(+V(K63+.N(-:2>9/YE6R57-O/&DNN@$*XNB2W.@ES#O]L$H
M1F3Z0H#; ]U>>65KXG<J<],_1PS7#]/'Y@D4-7DM\X#5[J?,P;8+OKRM+.C;
M+Q+=% 5J!K3K2D)?% R:WH>T^3,Q-\Y;F_HJOY$;FHSR[ES9$#9O4)$P_GJ#
M<OLU7FC^BP^D'&VWW<1M9JO32Q=5':T/M$1^M0'?FC!R5/P%0EY/Y '6):#9
MLU$*]\EDEXG2(-O10SS???M%AZ#<.SX+O?$J>][22?=U]4\.CJ%&KO)IH)I\
MUE7@9C:$OEFD6M$B@J8B?-(T'D_O3E3*N?O@NC)^%)YA(:5(Y:UBT51EPVYE
MIGHP@9]$:01$3'3 CT:'BD*K6ZPR/4Q?%N>D)[+?<=(!RB0AD5 IUR++\,M@
M/FJ\]DGD,<_,UHGY.?*(%23Q&J32L=,6I.2 :P,*\F_<TP_LR969K>C;YOE;
M-ZK!62Y)3]'/34.\9K_:*ZL;ECX1!5=7WIA/R47_CMQ.J9?@75/Q*,P)5+K5
M]5+V6[$?Z="UJ#*MG^V6ED?TVG,^G'C6H=7>Q?E]70RU#V@^3YJ9U$>S!&!J
M*$A*T4U!+YUOL.(BKCS!<^1]6'OA3I=8Z0PM,(KCK6P/4G+1P_ILWTCO9!N&
M>YN'X('7XYX0I"#4]]?1^W\ 1$)LA>2F2-S  &KIQ^95I!O\+8F:>6;_VU->
M_C<MMCA2S+$'+XTM$(=4C_3H/;)L-LI.[S(-<4O+2TF=/BHC217+\ ^W=^=1
M*C/VOJAZ_I*4[?!SGM1' BM&6"8[S)YY?>B$Y&$D1Z!D:0P2MJ_&@)J+239&
M7,2U92XBLAM;3*JI%6)Z#-V%YKB(/B>2]E].:$L/L7+ L!X7,7>P3V\%[<\C
MSZ?GJ_(BZI7AV3[K)T+%+_8[^"/UU7=:Z-0K]?'Q)Q.7D\_:"M^6OLHX>TP[
M>7_!];&:*H1H<ZR%SJ[\O)9$IW^:EZ#[;&C[T0V<WHVPE6?P+T3J/>M$E6D2
M3 <I/[B($51[[H$^?7SBI$J__S[^;0MY?S26$'YB:^*%M^LWX?JX")Y().LX
M*+@XM9A"XZ_. N81IICCAISK"N-0Y.;M>>0QX"S=*G45$YV[C\ZHAGE:D%,<
M02DKF4A\;P<OCON 1X 4J#I=C6<06C(K'K%VU!]LJA6KXP.<.%OI2/86?!-)
MJ-&PEZ'1Y*J2H9K)4"-_IUQ&>6^T,IO@17@G4H]3#$GB1<"*4X=<VE]8!4B_
MXL6=&S-S0GW"MRZ".N2.WC@2'P4T\.3DOU#79L;D\-Y\!KRGG0<H660)G#K4
M3ZH*KFES.3NZ6C/_\<;24:&72D,3Z"TDRB!>ZB3U/*&E43#M-=^]UV[&AV@T
M; &);ML+JLFUHD<,3B2NG>E3$%M-.>D?C\QQ9VOR+6#NJ<AGM33RE@UXWOQ4
M779G\:KL8'Q7G>^L<7'UM'"!]:ZY1%E<E%N::W!:#3ZKBG=96=4H2--A'6-O
M$UE;_3 XG<<N#11]B-9_L%[P\\RXQE,/]?+@Z\/NOS35V AXM+(!W]YMSK]&
M=5N?;OF<-GYB<.G/''$\@:B_5,26GH>$+[[&C8]>,C'YQK8*]/0Q;I(^U74B
MI2VWR^<G 3PZP+1GO,@@7B=LN>6R_U'JM=J0'5Q$C2N,Y/@+X:%<]D&7$5L+
M0<?I4IR8LTR=H-T%WL,S(1M]^G5K@O _"*:"(I'&1@RV6W*WDF17/5;M[@#'
M!7<!1X9)@"UV&VPC#4UV-[_\&?[T6XMSO?7#EZJI[YN(7TM(X#&K*9W!)WM^
M3AHG]WY70NJ'4^>QC]%T^P!P#Q$/!)#BS^>JT <+!"8:NMS63Y\^D-IR#S_,
M18 &*.:GP4;=2-F^2)Z2@LHDZ0H;55[,!V-.R6HB28U$&4,-+[:AQ""AZRCI
MU5+]_+!=HLY"J!M "JZZ[^2XIE'R&=C0WU72Z$1%OW/LP/-A0Q4O7%T*R!^&
M+G]HC[Q+[X2$B^D8"M!F ^U]W_%4,U9Z6E6DLSL3HMV9:Q>[Z2/7$7X"Q/]1
MWS>DUAVP"V%\(LW,BQ"-ICL!H/;:_46]D^21H991B]>DD4"3W,A[)JY%0Y.-
M'O \10#NF*V19SF%>OCD:Z.A.C'4;3=(FA,[T/WO[2%18WC$A4&J%[57(3)D
M(%)5V_EDL/K2B2YP+.J0*_QU_DVWRD>A!<P#(,&#CNUTI(\ZJ0^$O;(6^AX)
MS\=N ).+_.+8BE.J_B*-.?#LTK;2#'.ER)S9JAOP>L3M]B+)X[;_)$GI&>(/
M&Q_7^459?3.I>Z3XD&2$G<UR#5NF>WHO"28IGF+OPS66/EYTC,9/R;+C<'T$
M!?T49^:K;T:V*MEK!T?G.RZD[\@\HA1,7'!G3G (5C0->C@VCN;KL>_2_3.Y
M>:+L1#J6K7A AXOHM&G 4@,$NO36]3$&P*.P4T@G46>4;.2F#^(OZ L:8;15
M)3V CK=/[9*]]&$[+QU-)@X00/4XMI)(/F[ X&VH:N=HI,*I#U$!=8&9;D>4
MMD[6]XYMA831+(UA7,_:EU!/TW3:O&B,RO%5X:!)TE,N0N[ZY'Y."N KT->@
MZ3HYJ7Q[4E\@D?&#Q[27MK5UE):54'E=W^_PE.O1J8NRZ<_XK]4"HQAF*CUN
M88BRE1H@YUW-["O)T+DQK.3.]NF"=0%63G\Q$1Z^E1YSAR<1%B],13X#]QT_
MD^DW27&1#M/8X5<12$$A \ G*$8M,&8ESRCU%P;<AUGXYGFCKYM*D[7VW>*A
MMWG?:#_GL103:&GY@B1E^ZS;#3;RL?T:O[U8SJ3>2,\YL2I.JJCI",;L5^_E
M<,(1$$QK_#'@WJ*%-88B!2J:XNAV*/S1;UN$4;C_8';O?5'(O5';^_"[FK8[
M$0Z5&4Z&I>?#[(C'Q=)=5(KINE3)+'?F>S.-I>,S/ZQ^N@)W_'>^.Z#572"U
M&Q..X&S>,WWF*Q[O%*C%1>SSZJ7X;!C]M5E],GL>4D!B$CH_,O6@*@[*#EXJ
M^8G\_[OCNOZ[%U7.P*DBTH1>%X)!&AN#;+-<N8@;P)P.-@/6G\?QZS:Z25S$
M@@*PLMUGU9S)Y"+2/89(XZ@-,<?O 'M+ 73VY#07P1(D< 2=1%D:M':9,V8[
M__D ZE:>8'%+NK6-:B#E;-B?OAHG?&.>LM\>D>'15.7+7D*-%C$KZ!H+=90G
MI.U@^?1X:5ZWA5J]#87PTY48N,O9JHZLY#B%9"N+,6;;C_F^([;2#MEE*X:5
M7D@7_W[Z-K5F\&[I9U5FY:9I0Y>;[/(^!D27^K>_LXWOJ3]PR;-&?^8V0 \B
MI;A]R C>_9'"'G=LVR39[*U),-TH(/9Z3N$E)[T-=QV4DSZJYF[L\PL/QK*8
M2=:DF5SL;]4CDUS$E)E5 )JMM$:5/KPW/!.@.,P3RF RIC\-P*M=MI(D3"YE
M);%6DV8G[J9A80K79H"JO)'4@T+J2TP^(;.UATE7R. .3&= +$INA20#QC7+
M]5EXOGQ=_Y@LSQN%?H:/SM4(D ?WC5U4R\R6)VL0M;/G;WN8:A3".IRO 15(
M(?*-SM58=S',%1YT?@ETN5<AMR-5<ZM*:<RHI=<;NYE]/,IA+^JME01<)2R"
MD1E*0YIM;U/B54 ]T<Y8W!A08=#2.QK4).<JR4A^%^Z"N=XW>C)$4T!^;3O;
M9_TWIQ&@3! 2".)&9\)*P*V.4'_5WJ4]/QDEJ:=-*8XC9/JE % +39-B[8^T
M[*/2&Q\)/'[?2GJ,?^3/9!+? I1$<G5O'."'&FF/-&=(]F)JOXY^5UWZ46-S
MJ#4<[RV8QIZX"#1KH*^S4AQNQ4<JO[9ZS/L8UQ+X<<-Q+HXM384DR(R<;!HA
M%;?KTW:_6<DK[Y*U=N0^U=Z0C9OJ;<TW&F8+Y;/V]T_U0M&.*Q-R5E^HN[I/
M5-=@K2\[H/+R=+]^1WL"T4X&3>2XP[E\7TK=$Q4#WI6MS FMO&$6W!TT54;*
MJO/'"#W+CVY2LQ/J!.@.A%&?=G(%MN4]IL-5J:+^@=/%]?MC.XW?ERP-02(]
M,-44^Y6KPRE(MP$)P<$2C^(3SW*Z--72)DE^7(0WC&999IQ\G-0O"#'D]RT3
M(G=K7+-6^<8>A9&+)4")!10AX4B;1H9!,U[<^Z"3^>[+N=N?GYI*H)GYN*^1
MF%6<"A,^#$O[E\D.$F-WQBU]%X&95&35/4O,Z<9O[$KVB<<X ]QP%UEDI2;Z
M4[8?P>/L^/J]]Z(!@D#S<9RZ%Q,M4H41]V[\0U1'YDXC]L^;=XSG5^ GCL#V
MWI!1$VVRQPLETZ@;ZOIC6T*K#?/IY_T74-,;=A+7<<]Q[8#4-.<)%W$9)?++
MU0!%JAS8_F.K\G.:G4\4: O;G$EP)\-^&LO6=M8Y/*F='LZD/$ZU.=]9&@QK
M%GO4_>PV=,4A$-WTP(:5))*I%_4(0GE#88 ;%S'<S<P=(/F5!,C^4CC\/-,.
MC/6\9G#3K_//Z[)I'+/(2,YKMB[=8&H+6%$\\GJP/7Y8G@G#4*=U]RDT6VZ(
M(M=&0J'X;'V\W'?4;PE+OR0[.Y3N6L%093K$,7,Y:;M ]VF?^C\5)9N?I45?
MS?LM;%Q"YV.._)4Z=0!;4=2NV*O -AX(KKOL3-6OY[R[+,_3&<Z#ZINE76&Y
M1$K3.YO$%N7&0ZDV=2GNY_?K_'IX\_G&T-(3E@LX!Z.5&OXU5\%^M=SMD6;^
M'_P>U?+U* U%%(=&0*(H!L$F(":\*"XXH.+T86G][4&=W3\7L1' 7[X ,8T&
M7QJ"D&U ,K3M7<+ICV=/EO9[9!&FU_(*5@]!(@+TM38TDN19KVA\4^O,;[VY
M[?P)R3<D[N@SQ*:0K5Q$XL91.@PZ)<V+G=+3Q:D[LOOHZ-A;O4*@6^?Q ;^"
M%+]2]WC^9-T)Q.W2&\\P?XYO';VW+_0ZW.<;4,?93TL&31SM0*.'1=GG-_^$
MZP@=Q@G]O+!YU6S=+NI>K>?I:R_Y)WKOPNU\CGT[N_",@HW:R"W,8Z,&2G^X
M'*84=!3MN'^$./.$JG2[FB1K9.95U+(K4<=U2M5L6$12 / @TQV =8,[]E!S
M"&J#AT@UIQJP,WJEX*GV_\O+4;!WA CJJU<PUC!"Q.$!0M/02MA?AS0P$E'G
M(C!<!%$-LL5^6>6-B)$Y8WHO\=_?#/*O\H\M_, [KT=KK!>/354,6!' Q_)Y
M\N^_]AI(D/ 9+D)+G0%PHC%0M [N)6Z2O.3[;HT5S468>;.)L/C( %TVD5A8
M+0QP$7G=9MBKG-K\1$VU?WI@X;R%4"'BD/>.2<% N]X(OVLD[_I:ZW16_Y$S
M&U]?\CX4NZJP[@F)?F,4N8#J+'W,]%.>0AN'&9Y\7Q49.Z'^@V!K<\@?[08)
MM^B.9>^3 2?V3=C\IY/<:([3<5'ZQ-1<&89*EGIAI8#XF?&.WS9G0WDJV"89
MZ_8,#"3FS#+W(DD%^QT><OF6L;-A3[U_W"ED^#2T"VB^#!UB6]'O0UL8%H//
M0GS0Y,3I&UVAQA6+IH.SOTALQ:,,JRFK*+8%.F;Q1>R8?6S3\R7;&Z]$AN_X
M,)E(Q=!]TWHYH26VZX]DN8C3^*)9;!NJ)6 ,-8UN7E2:"!UJ"2_]7N"BXE:3
MY:\]J4.B5)$J?0\\-V][U_DA#[GRAE0JX ]<'@ [6XI^AU;8HI@<% PO3F.V
M@6ZFNZH9RO=3QWF4I[?"RXT!DNG.P*B!H7.;4Q-Z=07=\7Z>R0?/9A,[!+S+
M*+&D0\02[YOM@<7Y!H]O"#>CG'@_0(6T4\E/LATNAW5E1]X=AA8H0TB6"9BZ
MV$Z0+-4_6>VWR/]'IM%2W9LINR+S;'Y#=4<=NPF;)!N/@'>[W( ]&3R('P5?
M=RW[[HY7\D^(!?A,49\[V4K+C"=-T<[]*]?*'XR+7.3S!!L!;_8*YSZ:4DR0
M1;LGA:X XJ&Y/LZR3\)2^,)9J'#.-;B9,-MO-F"KL\S P<^LL^"]O3_D+/+C
M,[M13U+E)ANE^P'*9&^\JWJ%0:/"0VB);&0K_1"=(> =_AP&<IWM]\NM51E5
ME,"AN.<!X-'>Z9^*ZHSW(T+5*+;/IP)8#(*@@VVT^I/?#J1*]D)59FBVX@25
M(Z^(EQ['CN3-'BSN0._AQX\B054YMDRK*Z?"=P4,?NKJ$Y>[H^UC?2YL41^2
MM '*?=+;4^@*V3=/BBV([WNS1-\,]A;5$K_M^3LC%;_=+CGJCY7Y2UQ$"DXA
M].2T\MTRALK36<O.C ]<A"CY\A?+-HG._H<:(?</)-^+L#/,M2W"M9(KJA^7
M[*[QI/35:.VFL[*(G&77PL+KU0KJ?Y8/N"U1[1"H$V7BI^Y7V_1ZJY]_$.:N
M.AEUD.TX9<S7OA$V$&GF-?M'USEB&=&$OKC@1U=L/5;\;84DO!Y4&=,]$ZR!
MGB Z7JA^R>\I8\"W,RA1Z.:;K!?#<TRJ[4#^B,**+)ZZ&*,B!!;X[FUP+^04
M;KDLGDJ(U^^+NFA.:R[*U!3<>C0/$_1!CSCLS SLJY+]ND(2B)\5VEFCBV7]
M>'_2LN^UGL1!'=43<=VQ4O<OK<@&)QWT5.K?_7WVS?4MB>X:OW.U+JJ8YS P
M.WB>YJ<ER7S6Y"FW^1Y50"I$/#SH)7TPKUY\XUJ,VWA&.Z+&Q&5SZYN+^%C_
MB\ 4J^4B^B0 !=1VTLR;4#S4"MN<_4-,6"4)7-B!^[SQ IB3@W%PG@*D9W(H
MD!'0]AA^\ZT32M;;MH:^AJ9\Q:_K;@"<,(TE;PA?LMZRZ7Y_%.0BB@@;09B9
M;QR5OG]1TW].L:D+2NY33++8#L/KC#X!^(]__Q#F(FX-:-'68*,D]CR43*-Q
M$;N[B4 M>F4;L8N+ '=:L9]GM7,13 GTAGC5QK-_9[/J(6&[5DC%=II!6(_=
MY*F"V66L( N9,[=VY"=JN6PZ1VW^,/B$63QSB^_E\\D\:K"*FZ=B\<B]KTZ:
M_^AT/2HY7\SFKO,:70YT/<#R@SX/HF":V7+11 D[NCWC<8+IH:\\'.WA;'O%
MA8X@<O_#BY>K'7/=$ YJ97D%]/1I7;8"IS 4WSX4/IA.*;H2>,/UK-OK*2Y"
M\.WUQ:C(;6W4O-1&SF84)M#L9B*/ZX D&K_H-/:&O709.VC9=^KD'VRFT"@)
M#5 >H>@7N8AX4B6>EOX\U-%E*, 9\^[I,O^GVVD_]J%/".XET+V_%]\IH82,
MC:WI%4 2[@.7=WZGFR<# WLX<P/Z>H.W:E<5@V("TQ+7J9"H.NN\%[DBJ^E.
MR,5LQI6&V('(O5B)@2K$XW5862I\S)\P_V%.J=YW9Q?1EO,(31GOD:.0V@Q1
MLI="+:@^ANT9SET=![ &N$]H>F U:2I@5+R9ZEQ?3]-[]3+5T?#@A>5FXECO
M\ !SE"Y'\YQ2&XQ$JS<<O)-CN*L[/1W/R#ML[#@5%XV\&WDTX)F9RO!T@IS0
ML-L[NW-EG4Z)_+=L4W;;+&+<OT<%/KR^K?".Y\7ROM=J7P,(OH')9<1,DR-
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MWCZ[?V:V^KHF]&<AYQE P8?X7F*;]_/NIZ3L0T)[*G$HZ!N:;D6,.\8^]H;
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M2 \G['X<2E.^WV\P:?V8M-/T$A1!HGQ'CIR%J)V-RHQSC>ZF >+$M":4<40
M>PN!Z<MYR YD&;XHH294&GSM_REC%A10AY]D$C<9U2.2[Z+""](5"KAHE:74
M(RH9'KFZ'L$RA@?(BG2=BQCY*$"*6JW@WW46W->:,UO%ARZ9X<2CW6.#8'(M
MO!AG;8P<[@3M%9F*G)0WJ)X R=!;LG.X]LT@G!]U (6"'6O2C-7=]N;+P,'W
M\)!1*)BQ;_YG=TZW#Y,CUO"FO;^&*-AFXGU (B]1-VY0(=),<,NH>?5[2Y(Z
M0+F+JEGKT!TMU!O#)#@1<Y>:7H-N89WO<55VYG]M&.C?$%+-CNL..GKSM-;
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M[,X\>M1I^,Q=YV=8;Y9$3UJ[U7(+YU?1UZUB$C']F51-M=G?UE<&ZI[=05G
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MPKIX]9-)V:P>1+DZ%)O@XC-R]*BR&]6JA-%4C[:;V/PPQ3^*1Z[BC% )2"!
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M=0CB]1',KWY7;E KEW$FHYDOX#Z5^U9GQR:\JO:?9E%'I9?Q^:KPU[EF/_"
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MQIS&J,&/BFN4Q[\1]WD+58[^YE3\.S$E!NZT.QS$#.1H4B\7Y3%XJ:95 4%
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MLV-W25'/#GSM"V?.I$-?S=W$K+GUA0<E_<N1V*X.DE0I!% WC58#+!-]7X^
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M6KT+"%P23@]HSJGH]'J&H-/SQT<?$Q3RM;GNM]XZVKY;BA_Y$@N>TFHBC2+
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M\& (Q[/X()#9_19P-LNZ5)[B?^/,QWH89I90,WMH653.Z$WT7:TSR8A'AGK
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M$;?,_KES5L-Z&N/U-XGU1:%4$:#17$O9?,Y+CWM"Y!U+5;YBN:EU$SX00<!
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M&=V$+*V-.1CDA-CNHEQ:XT>WXEE0RODFA1Z9$NNS"<W*J#I :5_H:T1I-*;
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M)_+N_=:9)=/KCS[A"5'XSP/9I!?3O*FK=M,&B)^QNVSLMS'/@WWREJ_C_A*
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MI4GA<BY\;E7HJ$DLIV5"KGL6Y%N"$ZTQHZ,7!E#PVP/'1]M58CM>L<S%)YH
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M\H-IRFCO(\R"-#(>2;3R%7%DP-R\*L:Y4[C=1GV>_VF0FLBX6-H/$%XFX2%
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MD+W(&V1[^DL:/U6%IM]'$YI,.-9OZ2Z<,GA<CIOG5MUU;B>="]ZJTJ?!EAN
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M&!FW<.F98L=68:GG@##OZS%#]DW5_8@?T"K;CN1'\Z!.DV)6E M0.B3[;5]
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MV,)2CFJF1:*.$\%NQ#SISNME!-&<<NT=2H5(N1^$N.L(^CT?)=<]AB#0.\7
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M1[.(FZS?Q(\QX_PP%GW<D_.'3/>_C@2(LB;  1W;QEQ=@*#REOA(.'5:4?9
M@GDUPI&:HO/F'/^K4PZS@X\!#^!IB#"&O09U[+7CPE<GCVE$5.@,EFC#@,$;
M#5N[;RHG?G&@*2_I5#XN_=U6KB5B:K9MVGD/+^IZ-4#LIUW*Y_H?5#%=R3=O
M->>X\KZSS!FTHNY 3T](1=\&&Q]CR?_6=$%*> (>/+# _POZLIG<R78!<X4V
M=6K/EBU))MH^.%<Q[ =5_&O53\>[_,9FK<^F U#^[GN/D<A%^:HOTWFXN".:
M</Z;N.QZ'IIE/_KP8M.R3:7]T=/30G-S$O)I;O9K3V)W-/J_5^%4.^_DQKS8
MR<8G<!O/'8);/ 8=[7M-9W[8:!DS8*K*LVI2IJYAUUX6?:A_],_/]L-Z,Q!<
M%"<H_J:]N8V%EFJJ-5VJ?!<7B5QWP)U%VTZMT9X?1.3BATM!,^%(Q J+[]YE
MJM7E)_37D \&&8,-)R%N!BL>QQ==GU\7VY/U-/Y;\O3_!<G3@'>/&SIAYYJD
M>4R"#+RF$135V=6!U]0CU]ZGB:=.J''F,&"<F[A2%F&V#A>A)G0WP%H&QV2R
M >Q>R_N??G?O%)6(A8%2:%VY NW6C/O>YSH">-'MJ@<D8XK"X'M!-'%M998!
MV\>;B2>],*.>]3Q\$$VRGS8D#*[@5WL8,/;)(.LV<_]B"L(^6K>81?=0C\0\
MN(/[@4S $XV1(\8$5V%M0^%3OUK4U95NG,;L7=A?QJSXY>Z=G^N;YSJ=GL2S
M/2D7PISX=G3&V0\DX&+QA"DZ-Z$BH6"HG5@\KK!ZX<V79+G+#%B*2[?#'!D#
M7_U /45Y/NO22[,H@']_DP__68U(A&)M?"O^Z<FYKJGS(Q')+D/OMAH/,V$<
MN1#7\81?7A]2*#'OS^*HV))B#H+7+N^E]6U=W,P@R%D 33?]'L0M:Z$K2V+%
M23S+@DHQ/W16,;;(6OAG8=JARDG$JG9^>RYWG6&OP[VWK&]F0+E'5[<MODG\
MOI4N?\E%BO=2WY:>ZL4>+=43 <F2+,P9NJ(?_"I?G>AQB66]].M!E=9K^4_U
M5MU?CR\O7V<C<8/[DJA':1=(KIG'20X1^M1%,[5C#IG^8UX+-D8ZM]O+30,5
M8\?=+\W><L%F:0J6&4K3JPVYP$8LDZ'X.4,YBJV%TS"\1*E+++G1L#!LF90]
M+;_:3N6@(%M[AREVS8/J9XL;F$YDQ@PK]^()\X@1Y)08Y;4IL3BN<-SI;95'
MQ5G*Q/;RQC+YRE_E#@%ZD;XTA"HC)W&RJB?[I _+0',@BL6TUP:<0)9,,6 Y
MEMF_,R8V^P&2%F_[*@-&E>P\]>J!U[/FMQL<$/&_Y@6-(BO>HS@N=UG_X7H,
MY5(P0'B,*//-+$P_5+H%O6&C0<:!G&&DM4EXJQZOECZWI[09\1%W15![M\/B
M*MH6>IX=<1/^!/%Y1LR+4B_><KQ)*&76;W01^>'E_FTN?A9-6Z,G0Z*"R<LC
MKP7\/UO7G4_?;#W5DC1K?5GH!V5BVJ$)'W.A+ZB]_="I8+MH8;YS" O88HKN
MV9BN>6JYTKY]S<=E>FLKU$;=R0XU54XZ:&T/;^4WK (5_CL.?I-X,8I=*[GY
M$C'O"0$?N>DA\LR#Q=E')L6%B6,VKPH6)<FKA:K<J8CRV5PYUIM+#+5AO>A;
MZ3W1.,3E-]YP0DJOC\PD<M'_BJ$6)8F B/FD.IB LO-Z?^[<I>(KX::S1CTU
M5]P]<W%J,>0^>K*/&EL\7$+SY*O-TWH0Q)\N7FL&U8CS<:IVMD1R">]8[6/U
M[_N^WC0:.6EZ0>%M"'^NX$'!P66*70'$J[+X4_ZU<K@6/>4_X5S_2]E0X#^F
MYME8[MU&^I]N%<$M%+(XX[Y]8<%;V">TO$Y/_LJG<>%N\E3XX<PIO2N9#Q>R
MY>JOT=\#A"*@-&;EPS2&8E0O\TUM]+Q;V[>F>)Y0N"WR?-#S0\Y\2T:T)PG
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MFB>-3,<">>O2L&YI<([H*^Y->RT\]43O\#3[Y@2DKN?9AZ)>!6BS4C2\AW:
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MS#D?-OF7U(M_APG5L^![["@*VF7/3&M? VY@)DU0'\&ZN17#AXAU4EK09@6
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M"M/\O1'#SCS=&;0'*Y62/*I^;'N,S=70DZ5&,@*F6$?F9591P;9-&[/&1'B
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MA$*.QMG'! MO$:#9._;"DM8;%9M6%6O_:(<_#4/]BG3^BG3^CT8Z0STW+8H
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M+E--#[%VH/EQ31"?O(.6P@X2^([?]^4>H_!/$$)5\I/@8[S5L!#* @2BW,J
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M#=W^+I+"-S;$NP\NDGZPCPT0,&''B#&DR9NUF[AH^[0E? &V!N3;1+1*WJ0
MA&ED[82I'$E:^?# ,-MWX.CKA%O_JD &UZO-*V&6H)'S%NS>%NS8.WU$@=T
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MNN$W>%8A_9Y%(/DILLS@TG_,<Z_",) ;EI#$LXL0;*5F2M9@',&E#XNV&I7
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M?(7S1#)ZX8W9ZA15_:L,:KQ"Q,$+W3AIZ>MA3IBN+GB=(KMZ6QI^#QP !?H
M)+'?ZDR]SUVY<[)/B@)&!LV^X(MFZ^ 18RR4!/]<"O;BI8!E12E;U9.JFOZ?
MW0\:''!%V8)+5_1=^(5FNENUIE<:^FO"5@IB-A.#QZM<K!?NZQY7=Y8E%L'0
MGM7W5?-K\2[;L'W>)2TU+,\;ZODO&YVTB2Z:^KC&O9#7'7:V%*OGH^$D@RW7
MGLD!#YF@134-V>#2T'A14^/S,Z#8/O:"OCP3(7A1O_GN]]>;7K[A5)X%JU+^
MK]]9^<YRUJTD #+"%K+'3-FSA]_Q+5RU;#HQFF)W;D$3"$Q6$IV%0P!^(KL1
M'29S:XREZTZTUH,1$^&:0&@FNX7>Y3T[L1$ UDT9"$O.K-8U:*><6^?^]2'6
MX7F*=9;3#,$]T;G-UNU(G.$S+>PHEY1\_U,]KM[G&N3/I /);L3X&872ISK.
M/Q@Y ]I[EI!QR!),G5$$_B#@]FY!3;BK7T>DS_8S;&W,/W]=AMS]%%V?KFA1
ML\8^/ES%".X[5J'2+WR,]X/("-78\M VS(K-XQ/^O;-/2C.F]X2_$%6:+HV@
M6$]5Y6TTOR:EXCW&?]*7_:KUFP)*H,SX >LA\T&+31S#=6'C=2#O?4X_V8MY
ML<C%\(MT>O.9F5"8XE6K V9QG:O7CO2'UH_SH78!]OTH1<WW\UN[[W7N^<JD
MVDK&E8%[Q)=#0.$;\\,S;W9]B[D=$/FPI;ML>.3B:Y6A=]R9("E'D=E&4+;,
M+#5]N=!7*8+$O[5PG2B<ECT_[+E'5[2>@6,;QD*QT*'L([U$*:I5#>_R?S'%
M!C$M;ZK9J-0)]"/"RU_2]@6E7+3)0<DX:B^R=2#^50VL5T"'&)4<GY5=*ZY_
M_]U^#=R/&W#^X^MNW-ZG%PPZ/5N%)XT^[K;IW&+Y'JLZ*W,$YGDXOP;.\3XS
MUO+8VJ^4LJM.>6=R#4]'I2^B3OH94JY.+>\#^_GO94T:*&D*4.([=C-NPU0'
MAO%Y<D,3_<L$LV#1M4Y9]1::ASGHCW!36NNG+*=5%^1$X2<D2F;!L8/X5.10
M5J)<H#6?L4<R"]19-,.)I_QJ>C1^/7 4[H E=[S&$XKA)>.-V"AT259'2 W/
MT&<%JE[3U9NA?,(OB>P YRQY%^T]BM/O7E\9%C[GT>0\_.2AW/'0'\,UZ?@'
MZT(2!GV35+4,UV*1G_RY<V-[B&,!QQ/X31-CY$./FU5[I)1F9MWYE2#TW?01
MZ?)'&9:0+8+9K!S :T>^2OE,FIVPS<(VL*G=S+9(;A0MG((&TUJPHK3+L3RG
M&L%N/TWG#\--KUXS$!1V8V/01'7L()[\@L(F_!8E/7_H B[GS-M-0:!R];O9
MPF(.1J!1C62"^9)C#[)U^IU?F>N7@MG$LW[OC[ZL_RD*AD*@ZQXA[K@-VTR]
M+TC_[B?3?>SUT5<)4J+/3X^/"J__0A OC@_E3WG5LC_)OD IRO[,-#YR_4/K
MHO<FOGJ=>X.,GTAF;A3G->V)=\%[>3G&Z7=YXM@;R%:GOVF%)LF>R.&9G=0&
M!-/$M"_U<-80^^]TT$!S"GZB0@_D?0H!:Q7>33-H8B4^D#\*$:Q[B%7>B&V8
M5H&?#;%""WF@/A/]E1M7/*$Z@V*>2AE$8N<\31ML\?'C/LFZVS!9-EG_H*'_
MNV\AI*A2S'1)UD"*8_^ISU'0GP$M5E9_J(MAB_U.RP%<$@UF,L=.":#GW <"
M&O$KQS<SUMSV(:;+$BCBFZ);UA2$K><VC#&C2'-SK%Y3_9?)+OS!/U;-&V*'
M-R8'EE0SO;&U$*&//V55<EZLF"&0/17WG?T)PS3%*EL>D]1"8W)U5&,A?LA_
ME& VK*=[%/NRE;Y*M*QH D[4AP<+*U,4J>)SX'[2CTK-7'6,@E"8Z _&:E^S
MYH)CVS D11\W-^P8Y^&>K7R)>2/*TY3_X?LW'.7%%V*>ATO9E9V1T19A$@B4
M/'8>WL[;"*<<8UXJR /'M]"-;.<;!B1THV9.3#JX?WNF[>RY!^^_#;N+V>LT
MQDSA3/?V;;Q:;*U^X)BI6/1]5:?W<1.S06T4/-B,Z1 2:W*^.2*;MS>]5KU+
MDU&EA=Q/3'BFXD&5]\;6@[S/JM='PVYPZWY&!*/84<U011C 1RSJ\.42@(3:
M$2+MBX,O[ZQ#ENARW/<[^/2%!;[EJ;,;+/QGJ5]\^PW*&SJ8'3;&74N[,G3Q
M-9),GS $%T6S+A3G#0>?V#O>\K3B0-_I@=5E"%R/CF[#V#:S?_WA0DOC<7)_
M5GK^J2'L&<%L-0LJ,"P&COL\ED#,G48KY6?L U?9KST6O 1-":P[:FPI_UR-
MS?U_C1H;+1[J?X4 &^4E*9^,Z%-1)(YU_:CY6/SL8LZW,]2W0OFD[/^NSW9L
MW+"D3T7!P0[-$7NL%/- >!LFB?OLCETV64=\*C;:/'@;7P?_# ^%:OX2FB*!
M6T(2D>3(7C]MTIE+'T.ZEHCO5EK1P=6:J,GY^)(1!_*'%?9$I1>* ]P6%XGH
MD%*!D$]=:Z4A6GS'TTMC#VOIQJD,2,UC$R',;S1D,=6RQ$HTIVI3--Y^56U,
MV']%].,4YE?X*HYRA'E1GZJ%ZBBOZ-V&\:Z]3CV4L[+1.DLQH38,#BP<^S11
M+6==0CV1[UB<JQ*DFTZQN$1<O#O/(W- NZV\&F91_D%GZL;(.98SR"@\T1HY
M:$/.HZS+\\)9/!UF0ZFFBE]TCVQ>RC-2GT<6VT$#3CGYXWJ>.3YX38[CHDB_
ML^G];%&O A@*8D5UK A;;!2V!.(#3@OP\ K/: .1W<R/$(V(:F3Z1E[/C2_1
MZ_:#[%_RYX:%7V;4=SJ8.K&DU!>H7+ZSTD=$E1Z8G6 'N&?!?4M4<\":,IJ]
M,,;8=4*\E+\PNEC_B, #?R84%)WJA,!=?I<IHE0$A"7\=$J\WP-S[0/W5&!C
M>/.MGFM$N1"%<MV'5K+BGN>8JAW!UQF#\R=I6*.GFO -3=CH%[6SQ;T*\'V.
MC\XZO#[6,ZM#HDT),&P-K-*H5Z%KGT4[P[E1P_S(B+6"/1/OS&[$&M3?/%4Z
M*Y2_Q7/S^E#Z[17"[%C1"16&"5G]*U;&4UJ1;8=L+=?;=JDLD(4IOI,=(=A=
MSBJ*DW.'Y>XTK]\Q(F+,>VGO .;W4.T0P+*,N:MG++^^;8V1CCW=,F_]DJUB
MQ'UO_8%PR?B3I%(SQ@<Z)[7+8&AE_#ZH]!OX![E0O*L!HEEQF+NUQWCFD=T9
MW<C#UYX/SB/QB)+V@'?>3A.HY,P%>U/ON-G=5)8!S,1L8-P5_L0Y][ 6[1:%
M2OXFM[W/N>K)C&4P/RHT*'DI!E-RX6B8BGH:Y?3H=$5*;:;>TTAL/5X(^KE$
M)-&P8Y@Z@5[R90ZONIWV73L[7?)X=ZOVF%HZ/C7BC9*;B_4PB;%Y:L9DK,AS
M?)<W0K\7-7 [+?/!-LR/!990.^R_%!JTMB#3>:GHPN[7ZY]Q,0A"$;X$UP1_
MCBZ)KTP#SA3'.GV>VB6N=;N]62A_D8)<ULJ W9?^D)&IGC.B4),:>,-B663Y
M CP<381HVZ ,U NY2:M7^FLDYDH:[/M?F3Z^J[+D=A7YP<?<B ?+=9K]M2A#
M39GV!6)"R)I,2$6W9UD@-' RRAR5%>/K^.YV,L\P [P#Y(NT-(0],I@_&%]'
MD[[Y2SPY?.]HBR#:TQ0-"."H$F GLL21$@KRWGLMBQ\6:52[^_S!H^R-FA#\
M%04AQLO][]1:"BR.?S&2[K4?X^ZL4GDWK!K8\-%OQ+=S3WC5@TA&9!B<B(0/
M"I"+*9OOZW( J2Z[Q''J/:DS@L7L+RYGTKKFD1]TI>.*3+B3WWOKJY-./U.(
M.G>/94@@AW%BG"*BN+A*0A)XZ]XL"4P6O(BVTCT8?/,PY@AFV10/\+;K])#A
MU:OM7-]/;L-:-/VS,KU]+W=.K7A&7 \^GS?0B"7>WWL:;.2-#AF)>#M-8U("
M[%\C/ %76J :LY\>"1NI8*#1P/.<F%F9%'*[F3D+]0YL0QWL ^0(0;<+FK^>
M($7K;N#B$(0(M,W-=<K[@JJ.N,/;L"<%_K\^=%GH/SMT1SC5C !<[/7PP7RC
M+83>'3,Q>,SM9SC R\_4EAS]M:PR1_B'#BYH'3?4,DF;;1YQ>>@L1CT]?J9H
M;/0<KD8\1=SO\=UI L'X[.NTCU3M0;-O@D'/G5K(,:K5D?A0<\WVJ GO K?>
M,-X<B>%<OWO=#]G0=0F/E)7C7RZ]OL!<[2DEQ6S/+/SJ;?:W'[967WS"4[Q7
M(RGG"=NPQ052D ZE;4]9[HU6V7@OL037X&#_H8DYX:^:(6/3MWL]3-Z_26N2
M>',@)6\;-M:D[%[$8#V;=5VWD7-V&U:*"2[#\WH?W.II("5$UP7#4O#!?I54
M&; #RZ.B2#HM:V)5'',;=C?!#>E##>(\*O!X:@S7>^W^H(/IZ<?Q\2("O2S9
MQF=W-;W_ZG)Z;)_:U@G^*B2YD:@8#G@0G$:0;/4=HF^YI$2+UG#V,)%QN2-K
M7/I"+[\?$XBX_\4G:.RM N])6?9H]!U\ .*0RN%)TQJ2>&88_&7?:XS- A))
MRS)N<XD&ZF *;-59P6%-+S]&KK7F1K(>7MW'/&]XG0-^"C4ROJ_FB/>&>LI(
M?7S[2DGLKB+XE_=@ W9_E1M!QB&#9%LIRD=:/:5"\!GHBC.?'T!4594?9!SL
M$L9FCT3U<^Q='30VP1SAF?)&]6:F!-;(T3ZJ[0,,2,MAD]CZ^%AEMHMGQ6]6
M,#.7^4>$CB;WANITNXH=1 Z_"[VOLM5EF.DJ\1W8<3.BF)@39;-#G?TT#M^,
M"H3QI53Z+ZP;@7N]:A;(N[JOL+^.8P1IX0 )*MN3]8ED&G@+XYCUD8"N<%I#
M@'NO71XO# D-*C]>C?[.395@EJ-H(0Y/266_P2; B28=E&/8I322-CF_E.3U
M!$"X'TM2N5C">].6T8X@0X9HG"\1.\E;!W754Q2H/Q5PSPP6OV]<,TDI6QY.
M"*B2S;E<SKMU[4'K 8TM_JZ>4HI\:^/9'&Y$A<S/A'J_S,PWY_!1_#SYDT:A
MP^\3LD0<?O3876*D-I]E7,?-_AH'][VDVL-'4GI:,!-4[&(KH'F\"9AW+XQ[
M/HB;J_P\9O'X2W&TI@VZ'D^,&'WSHROZLH (=>:UQ#FJJK<-DHA[(ELZZGBT
M)%4@0*+[X_)(^41Y)"@&\/2MN3&/E":<=H@]&BSVP&/>>L2%?>CVW@R,GJY+
M1D78Q">!F.;#1NX7X!W:BR+;L-U]M"(_3JK]H/?7QF&F>@?2ST,EE?HB?*<#
ME3%Z-)#BG^68*/&TP'-A^NA=N!(B&&%(Y'WJV78!.3@W+U@;*VC:?M@B:"V5
MO46.<@Z-("90O+R0)3L"_?B_$^A71]=]@]-M/!&K.P(>:N"?[3]!YOZOT6$J
M90:2K/\FZ;^5\!2Y8H:[A+H^N0S$'D3<PKN-#VU,;K3 !XUTND">P<_RW=YJ
MNQF$0L\S9]$W!^_F@OH:&M4'A_!',]MY<TI!>L=NSN"QN[$:X[0T9-$VK(16
MD#R[N#DA(WMQO/VYP:[OI[$&@15MK'7"/)W?+>VWC"],I>W"%UC/KO /=I4^
MGV&],273"C^):X-33G0L)I"FR &=<MB)>V^.M_97:L?_.C<"Q=-$GMO?^X1L
M&BI,*UDM',GYTHICILLZ69\VZ;;@0K0PO/WX$^'C_-@FH6/V1\[ZJL=JJRPA
MQKBWEIUCQ?8)/(\(NN;IQCIG#:^?V_*IA]4.2Z^MG+R?I]QI@A#$$ZH01<Q+
MBJ2%%I_X<F*^3J*3KN7BW9@6-%G3G^X8<8&6I";OMX=H,^)WO3!VCZ]L;O7@
M:@#M)[7!C/@\:)+IY(*R3UM*99Z_Q,4>>?M&?MN\QKQ3P9E+GB<B'Q4XD'-8
M?!_A9ME!5B1QP+P;X9@_SF&M53]L=0\6"?&[E#[:4;W@$1C(38$>A8F6."87
MQIEY<M)H:5 1FH_>?[UY!TEELIUN*\2NG,SX^3Q_XF(PQ2L]9RF;+DWUWFGB
MG,1$?[@1C7$2O-X]0#24H_W,IF!GT*E\B T]] 0R.J*7YN! %ZL:.-?Y5Z+8
MTMRF7STSVV>_L\.ZTYF5Q-@+!%32M3P2L1^>;&:#+$+'>=$'%%CMT?U\'^'$
M0]8R1%XR ^T=*.7-VC!VC+@GPETV*:%(N?CKD4T-*57F+!^Z8M(!WHAZL]CC
MKX3-P*_(=WBBYC(+!7&5%NH']_+*:!&OBQ"GTGIQ"XB]B.DWFV#HSE;XJS@B
MF)V)KE-08_6F$I;K=>3'GYEV<-<51W(L&JGX#)3Z.1/!@LGE798.B;MMLSQ=
M4N%NC@O';Y6'#-T.%,KA9?#/G3Y":[7^_>H26 #H27E[U-#&^(<78Z=[JA /
M/,DD?CV!MC@!)3(.HE=#R+H4:2*B?D%6M.D^5X6^COKNE+0]/@.WMF'L54<'
M6HSC=*+>RE:BJYV;U2[DUN?4<NTG848\)I8CU8X"8I5=*N*N'??[>V!<,7W>
M\\@P:/ #A_3)K<3RI6!X9)G+KA_.O(URISR.OQJ*6T)VMK7E63;;)+D:G]2T
MM: PUY]51+I]Z.:T':V\OY[*L@T[(.^/U"96G37/]'YY[2X\RV\3ZA&Z%/VI
MY0@$TXDU!,-P:;E1MLX3&<[/'5G^.@4S$E_K<MS6\H5,#[FA83$Z=7N>(';C
M"<^Q1$.WX2E"QY*LRQ3[,V6A1E/.GZLZBRNM6CUGM:_.(ZL+W^7N:L&\$G9"
MZ!,E@M?. 4LR>CIOSGW9ZL]HKIU6E&<X.LNHZF O=.[?$,#^AR-U5O#*;H/X
M^X/</_!EY;5L$N0(BIU$P,/(3<,;Q#.]=ZHO5%X*GIYYM7%U<Y>-=.JZ33BS
M#;&#'+4-"[("&*;&.48I&(/>=8;CW:]W7>IFP-8.M&$Y\(3!96'O1V-&E$OO
M'OJ&(#_N[E[=&EASG\)&UNPE<F<//RSP:;M@&>W:B3;?]"4'0>T_!'[!EOR\
MG")6Z13Z[""JS3L[N\N 20RMBJ7G,4+@'^ -S\2J.@&1@LF3.C(/)>>1Y[U'
M)D*7WE#5OK>F'#5X5'?4IH/\(@.&4MC:H-J@Z]JV87NJ'-C&@H@5+EK[+M@:
MMS=ZK%U%OD"4XI?PI YR,NEXM+GEV'=U=U&F7?U:A+54GI;S!#>*)&YI'[&;
MM,L;;_:B!1-O9:P!M/E#E&$W?:KO]_,F(9J$%.NVMDJC._RB2_35IB+9S2D2
MA''@D!,Y@I;Z4">ML_233:RS7\^0DB!-!]=K1!&'1IK .HDZ,1NUMBQ(&9;1
M"A=X@7UV_P)PHU/&"ELSSE1U6S%*Y9!3P?E=W>H"@K[OG?)NHKT??3#*\L"S
MJ/#4,!*3:P(YI)YS&3/G6)II\A]Y4?S<MU-VW^#[[_@LK=4ZP3VFHO:'LQ>/
M9]V=R?MY1=1A]6)0ID'DUF0 '(LEWL109$[2GE7Q"L=-])<E^AL/Q=W]DHU]
M\Q;U$ECW<X0>ZYN?%R5N:E]9#O?B9Z\1\DWR?2.J$JX03YBMA!_^"3\$*+X=
M3_ 6Q\OPB"HQSA9@*&*A  >^%E&&KGU)P4PN\7SY::1Z+<%SM-4-F<5H@65$
M -R54SU#62]I?4U? B*-/)&;O:9HXG5LI,_#^L^W'8H^MT]',V*_X%UMH8YD
M ^[6.]M"T+^@[=^U#0N^A"4ZV]5)8A+]V!U:Z%0TF.FA+$1(JY!EH8U&F(ZW
M^I/S,T=O<!57-87JT<+HY"J%GMZ!V@ALX3#?AM4KI#4YNW1*KK2ND7'OY\1_
M<7'&A$NF:FF' ^+9WOB&#36A/ANSD!_W?RY$HUF <*@&TM!U-36<E(5)(8T6
M<&_XA)O$ U,9\;N,29$N"E3NC0#5GXHW/W]VE63<?$;<  1ZJ!>](QH_ISJ1
M$U<<B 8_TA3C.$OF$VET8>$KZ#J!&@&P>5@\^]FRHEJVR]'B@F^V;WI7^K8X
MXN-)L3^QIY8-;US%+&L9P'9B!R.%-1>PIVAZ3"3OZIIVD+55%[S)UTK&->&&
M;,"]5B2;B>4E;=Y&?3S;>*;,NZ]J,U[-K''(+O5PUVN<Y=UI%@*28F,Q?HWK
MJ5YV<3=1[5O:437,V0T(GL9=SK=,+XU&YG!3MF%47_K+X0JW9U56_E-N(7&.
MIRVM+.6;9%,T8=1; \NP,(N-H&63H6M/"BY88;\N!R,(8[AA_9N]VJ$JZFZ3
M7(6/1%[CWHH>;KD\\-,..)@-[GU,7"7K51OQ+>Q='?O*WEY>E%#'2'LW,)_Z
M(?@ H73&^,+(A?>MGDMG1RX7AS</[<J\^O1*AB"#R6.;_B1E#TV8O!:3Z'Y!
MDWG< #&5_26>D$]ZC"UISEKEC#H]E;8-NS5 PI'>&J-D*%'NV[!3;S T/B>J
MS+\PLNA$#B'N(0B]SG",^?TCZ);$'9$U LQL9_O/?Y<C"%;GF[_ H"5EGWK1
M^7 ;T[5(3GU-F#;;Q^"AH$,5+R?9FQW6C"LO)$?"A2WD !'^5@D$Z3AV1P)A
MT<_+2(*\#>N*.]=>(H<L0&NFJ&[#8D1O;L,*[V[#MAAPLV93RT F*WU5TC=\
M>UZB7G%16^0 PU5LZG#HKZE:A5=>^3Q7D_J?%^I$8,S3GZ?Z]:W+WI2!I_10
M7$\NVXU]#?<\(?I VV2P6SZOA57_0>!PO8MZ\Z539Y)\]W=_2G?V+JQ\M:S3
MJOI$X;C/]:[-M\\@WID BJ+KM%7$"4(/U]Y$.'UK$M$:+A@!&6]H@RP%A-<A
MIL-4^*_R;=BA&[0[$A?K[_C K=!VEO%'&B\LM8DE7EL^?-T$*0:-(283HN#M
M:\/(Z6U8\3A@H$+?/U1UH#!!WV)B&\;@!AY+;%0/(Y#8/7W=EG)OH]38G.UU
M6-TD$,%^&W0/E[**BAZ5*Y>0IW\6$WQ 8C_S$H3@F8X0MV&-[*'XP0H_WJQ(
MPY-7,5?7<"*T +2+U7F"GT^#8WQ"3KEBAP1G8>L)HZP'OK9+[[UH2,[%Q\KP
M/+,/O"F/#VF&K.5UO+4L:N]H4%BQW0"XS6HW$N[-N^">(1;I3W6%G2*-#52<
M6DS8AFU\19,4^A>Z?R[>/RXLXNS_Z/BOKD=\%;WHH02+\N/^3M-OL!1I3$#7
M UFY;=AR/ 3K'9OIBSLTB(;Y_FR!PTC71$WUEZZ94]32ZFKX#+SO%'/?-^OO
MSE(#N0I\HS-NUDYG:E,@'/AT1,/ 6G;$-E+YUT*0Q2DM$0&!]S).22,<K3;'
M,S\Q=^/LC:),S\)?&@=V?A4MFGO[WCY-*R? 0=4TT\!:8K9E:6,5\.Q\-@5*
M1ZAAUXDO:;O!;VUX0FCPX/-$[G(P@AN@HL:V82N6:W)4_N/;L+4TF:V]M%?;
ML.E0;QNPUG1\Z[A9^V3L=:/*+P)@A[:?S:I2N]3$!9B/L02R/OE&\L*M]'!)
MOO[(,WLDLF12W0,=[%-W#WZ$D=-JZY3^3N_B7;*BT>%FA6<5Z %;7)0:[]EQ
M-HV6&Z8U7Z'('(N8AM^&6,@S_-J#@6;D?L2T11#X4=8?LX]60D0(DNN!;9A&
M1OM=^=(N^H:,_ZF=&#)"X\0K"+:W1M]=MV%++58/_T?M5111'6';,)XW^K,@
M- +5K?(EF1.G$'8=FV+#2)H'&%AIMD QFPU=UXEI9AA-*9VQ&ITSJI"R9^#>
MU7W\ML4CA]XKC!JQ[N%B5QH2-7^;KG3JNW#Y77S5Y:J%_A&#FU4$62'&)+$)
MU83U:;32PI8\B1<(<$4O1)BM0MV-:7 ;%@<4;L-P]!< 74^W88]#\U3>'X%"
MPAX)X"" 0?QOLMM!<LX]*..F&OI'MQJ"<!2?N$P190>2A:%GNYT%A5-C?)8J
M*WCA$7I]'@X&RJQ8VE%[:4:_G./ 2Z_<B-HKFN_8]1R/7":L9U^US'Y+9R1G
M=1J?F2AU9!VMY]YEEZ46#G.+/\]_9X3A&*TY*_W)Q_'C7O*8O>Y1S5@HWE]*
MA4F>PKE*0;5]$>:1*'QR^M!PLB9,]&CQ4MHUZ26H/(M!_H ]D&N?NN>=7F;,
M6 "?T./LJQ?VMO+99'<G1N=Y'8,N<VIRO\]D<N$MN2Q9+E@/?_RH_I., /T=
M2Y?;=[1D)M 4)6X/*ML8S!U\\7T;5JOIWX'<#]5#+7K%IAR[OC:^M?<M_EGP
MW66/"3?*T>PS"Q-/E# [/I?#VF)<+3X4B3\3L\,S38K[#6?G4O'[%UXT.NN)
MBDV=6T][<:K=P1['_E*8&'#A'->TB*[2@JZF8"[L4/RH7F.YN9ZDPTF&)W7/
MVJ5Z$$DCX0%K;[L,6_=\27']GN22'9?2^\*X^(+HB5]K>2R1=O)7-:/9. ,D
M7F/K7YS8=VY!7Y/G@HC &W?YB7@1_WDIDV5, 8O42;O9<8 GYAM*NO,)1$D9
MH;ZNL$7/CTA'ZE*9[>W$_+[VT.J0R>/_5-RZKVY\17P3&^[N:-QF83<4TW@J
M$O2DO) F^FZD_Y;NR,/4^Q64P5+/>FCUM;OK:YX*5K@B)29<^E.2X6SD+%?@
M2;X/T)CYWU;.8QAF1X[H::%I_WMR'C=IB7>N4Y@G!".AJ2ID'$<-K/3@:]<6
M[FM"_3?):V0_SF.3S5GDBH-8I,Y) ^5P#;[HO,A["5]-^J$.K1!SH4T1=H!)
M%9Q_FQ(TK[LF_D'QEE:M:CY1!F1=="==]^X C([\7NZ\O$'W)]P+P1J(8'R^
MCJ0>J-N&9<07-6[#/IFNV9FRTT!,GC($QE:,Y/^0N7[O-J$-Q%7S@G4DM/2\
M#$6&%UPW 8Q6$9W[X=0L!!'7JOD355I*SR<X)<W]%>\3./)E2CY?I)G=\0_Q
MZ]B-Z/[9;TCB%9L9BC%)5W3#&K\XL. %<) NT,*K))].[V5';O#@Q1"$5,2*
M]!AZ $Z+QULB"*'X%=L:;BCT>6S#4F71-[TUMF%B(^N(F"JH]6-CT*'K:D.P
M X'1.:JY]CO2UPW&)S.39N6SU/FRT@.>[>%U.:K%JS(K#_6M7;"18):/Y]J@
M@0V#U6:R,+K2__RSZ/<_>EP99>\.9S>4W%7R-6'EM<] .\02Z''2![LX2U7M
MF'(Y-CJF>1K&02!FC(_5A'M'"-%:]#870!958N+7*;O:,+]#C_=%M_[BYO(Z
MPL+R';R-=]Z&48[C6G!A*0I]5>>S%RH*GMZW+'6T^<@8Z>^_,-U/^4I2G+0N
MGZ;@)[F!SU+GH[X-+2-S\*4(0$"5:N(=U&@VID3Q)R[]**EXU58%-;/70 #R
M-* -]0 XJA]^8#+6";];_H$VEH FICK.NE/WH^LD4&Q@E\?P@O5)RKKMV\.!
ME>\6MV&6]T/PEOB[6,K1;=CB36*%@,5G4-+;R\J3I<7G'&@O0[S^:QOF9#24
M%1+'5E1^=M95\6/+O)4V-#<1\O#05-2@;YI@V/M"S$["<QGDV@_FJ_&BVL:+
M!P*[E?Q.I=JKW;%AVRT&_V'=E#7G(QSC)NBC]H;+7ON+C>5^LY5LXGGPP#%:
MCI]"KK9$I)\FBPNCUW+'.O<6*_4 %&I;E+'-2+[Y&F82(D+$[N/'&YRF5S_+
MLVJ0^^[81I_]=:K[Y9W!'ZLWX ?\[M3($ZOXOY]V7;VCU=%[KX+C'6GZN;UX
MV?T30]^]=[WVX-<5.)7 $')&+PN(IVKKA:]^5KZ&.ZQT8Q#S7I)S4WT;QLP!
MMN-9_(R(X'AS(O[9H@O.<T0K<>\TL\?'T=JI,;P$GI"$)EINP_C YNCR>HK*
M>84?+[S>>2T+Z)@>07.LXZ 00I@9'S::O"8LV:W":_OPF<1'^XNA*IB4&A@M
M#OKP!:(T>TEC D\Q0,&]KXR*Q1(G;JP\\&79@_-83V\ #R264G>U( +2S4;:
M+>T@+)1'U\#N=1_^SGJ5H)1\%^'K0Z*+7M?R8HENN*7W HK"NZ-/+@3' =+)
M'0 ',[GWM%1$;;$@ND2"<N4FC2[S=!I/R/Z _=!7G=B4H>T\P!E2'^W>TCLP
M\G(3BF&[#]$"0%GP"]$A%M#I$AZVO\4R$>3>4HTJO*+Q73(]J+5I%U^=)8 S
M.*VBX5H_ME9CV/!)N:?GT?B; MB1S3AQ]\O:MX_5)_GT8%X9GC<NE,8?F7FR
MSS*UE4LZ][",UN@7Q8<9[!N^5Q@?!?M3*6O9(:;4;/D>#E=VO>N16@?&2F%I
M82H%3+V"ARYKG')[Y:YWVW@D"J86SLS(=87! (4/5J;[Q, V[?ZE:AQRR.U?
MV<@$CM?3)97K<O K2/GEK17DM-.6&FZ6^1\TM'<70MB2XX\Q_XIO[)]2,7PZ
M3G@;UAKS#KJUTU T'UC-)VV QDQT*:5[R%DS]JE+/YK1K15I6_O>!=XA>.6Q
M<MC6J>9K7SN,$5Y/&KM%+5L_/>0#QYI0.'IX&I)FLE=%$_L6IQD/IFE@W<-#
M-[(#)3EW/:A/+6E&B:$::MA(_84*/!_+341YW*+7$<$V+5 ;3A(O2W*-6VS#
MQID!F3F%Z/I/89^$SAA:+"0@QQ)GMRH4R!3\C)K_)R@HN%$X^P2H>B,8,CO%
MA+YQT9-RN+FIMP"_' 1RK[$/N]XL;'G>FQE=^0+H];<2H?HA5^&JNM!O+!$O
MLZ1;Y#MP)=V"V#0+1+"3QMF%&84RXV-X!)<BUX'\.9Y/B9>NH7IUW:657_D^
MS%ZW=X7?;!J?5/.#Z%3@?<K1,4Y6QT=-H7=" :D@<%\'(>88:LAE&^8')^+2
M#!J7)!)]$KV&L]>X:G"ZP,6=6WY,OV4/;Y$!N"L48FK8*=>V)(!#/77*+MU6
M!4M%]J^4-MFO>,Q; ZYVJIKRWRUQHUS^UJ&WR!3<C)3W><URHFND9VOK;?Y@
M2Q^6DOU+#T^LG#RE?M"0<%EIV5CE:OW'\O=!(CE+AV]]FGGG[7_SH?CH>']^
MCO-T^*>,Z.&\.\\CPP")6?P2?4M1Q\5M6%%ZQS9,[R ^%3.$ 76\0A"+=-^G
M]":TVC:L' \D0%BW.0)!D]0# Q'W$)LB8WQ0%]GA7:N#N$GLPQ?HUFKA)\ET
MXR-ED.MG4TK@H&1ZN,;.%*I-?1L? \YGU@(*_X0EO?EKZTKA@U0[ NK<4O F
M&'I);7/+)#=C&9NE7-.TAF"Q8.*ZJO-GFEB[/3P!*?Q*.T38ZJ%K'_\9C0CP
M>?X7RH#O:Z9 %8C$/_C$/F0"&K--X#8$H #UO.J .#1 [-K@&?3=).*E^#JY
M5C#IO],E;JH:^O.Q[FW8 G:->QB/K,>K(/(T(=KD<.A7N/G..J,[OY4"'?)[
M_1TZ>DBIK[F OW:A1&NE0#-5M&P'S=T1?  %UK_;0EYQ'[M\<EW[)1;"0 @(
M".[&BW;0Z_7H$KX'D.[%^OE+XT+PTU;E6^A@\[AE3!;J [AW"][(9S5.P<X@
MRJ<TA?#\,N*]0X!;+W1CM_[LW0ECVM9U?WU0%8H)$.Z4+E2&9YGUXJ?ZC3;8
M5PI$@<-)@QA"2Y\ 7606OJFL:@,V0#PS-0NMY\,+/('FVX5N!&VWV2H45G9#
M+1V7T8]8E,=OL9BM9:>A6P]T@-6B= 4_E#X$'GVPN;2V6'1K'!NX%]0IT^0R
MDYK_M[2"V3IIDFD5\"R8]G^G+KA/^1-8BA([>/G1*E@#=0%UK@$21X()G<M@
M 3_O(! :@8OY2!_$.,*<(O<75.:W +?7!/8_!+C'_H\ ]_\1X/[_L0 WUXZ?
M^1ZS%@3Q!I;;&S]1OCBK&.EW)E>?*^Q,S/0Z@1%Y*ZRJ4(/H48L3I976, Z#
M74CF;*)J]QGFFWM9SGVVO&*,8$/?P5"4%"V)1DV^XZ%('ISK<D'-F&RO90F3
M>@"R9+QDHW%\R(E<0;QD+5X:I!VO&S@SOG2D2,SG'CZ)G2*% #C?3"&A2#-5
M8-*2<I@XEOIA0]% Z;7MP_JI'""_#7%+CB*%:T$,HB?%4V+R?O+*NK@<LW)=
M/CP0(O1&?C^8 UREBQO3,,!MKA(G.+/\UX27AF*VRPM(%3\K:)3R@AW""L_M
M@?,$JQ/?])-3&5IF3?&$9&A\W< _A9<)!]EF+:!.E!GHI@O?/17<>D?9'>EI
MWN&6:Z&9,_RUXAR',N=WSB882@J 1F'0-:,HN7O51.PS3RK7+;T<J999:P\B
M'&2;I811SP)V/0J;#TLKGH^8W#QS4(J/<=!LN;M(],@U"</"F,CB^<XS!S3X
MKF%_J,MY/*?PIEMZ&]7Q#"L,'^QJXI_&:#9YB1WF<%;*Z3IZ,MKF&GSQO10U
M7)+S@20'AO74YIL?OZ026 4LJEA2I2XB]%[&^;AT,.?F*##Q;%G6&1T]5@>P
MP5"\Z+K/6$85H1,9:90/^OE:O@[[W[]I]ECMPU!$)  N.-F5@B2*>3,V)5H]
M-=N&N0C<2_'/9/CH0QT(0]>U5(0V^^LWGS5_A,G2E\W_7APW(\P[@_NLREJ'
M%@3D<J*,-)2?LF3&%HY6[)\=#NQ8&),;22";I\#+/^?.?1.\CW<61)5QXY<&
MJ)*6L7C'KA=!S]V8*0,KP<R-1L/Q?)?<K7XV:=,NV6[#^'%RC1W#?I:[!A(+
M10M[Z6<8-:B2E$.D_ FWQD=1?FSN]Z@),F2'(+/\@4D\(." \[O>CR_.)E6.
M%I=5_#KS_<QJ^1C>45+\%S3![?K+$.ZT#DCU#BQ0KC!_1?Q_86*36=M,6@;"
M^#MH01([[VR4\7#TCR/F<K006_ AC=M[ [P490?606QK;@\^&8G!KT3+\H(-
MI[=ARA_1_!(GSH":?>R=_D:_4 I8<W[L=\!)K>:MA9S&ZD\T_:E3"__*&"M?
M60((/IA_/?D0>#%,6^L2>&AUBDRW')M-0P]V06PM:Q^R4WL1@N1BYQO@Y%T0
M9NVZ@\>B1\9!?;I6L(TF%GPACE:'E\"!Z.7]Z,'?>S,V%\U(1A5?$-/6F N&
M=,Y#AXAW.M2=H680V8E)HK0>?1TH'G;?0O'_,]7HMG^:8??_SPQ[.MR/)M7[
M/YMB%Z%*H[^H5RF 4_1=!,B_L#6W9H8F]-:2&4P7 +5[[#"2D#"--H27S *Q
M+G)T?*%NE;\.R(33L(CI. ?T>L<6RQ(2-X%,@?<=S1[E*@W;T)3=@5RG?# %
MY[90\GU_Y-0OAZ/^$@+B,XS^0FW:2LEHXY5/QA<(RT]C&Z% AHR9!?]K_MRL
M ;ER8H2&J"_0W6CIQEN@=_NS3^X_L0P8K<)'2.G/QZ.X8W\Z@XH_H;LZ^6=C
MA*&3)EV3!55',?HC^N4-(?;N_)](TH($-733- ;<W^ZL3;3Y"57./TV7;T*4
M,O DA FZ%N!D?B2-26;+I!,_S0SU,^L8J&\?Q8LWHZN->L&9SXAIW1 H6*/%
MS-/#95ZL_:5@\Y\=(7.H%_2\UA-17 B:0$!LGAKY0^KE>Q^Q Q!DAN;7\X^W
M84@#NFNZ$^69?BZQ'. T M54U'<$P<G7<=7P96R!'R]T"Q#]QF XT ,(VDNG
M96WJ[,)_&I@3Z0;FXEQ7K466_W+BE/8GK6=F06U0*ENWB/+_%[:)FT/;,"8(
M1<640'?RGI&>%]B"0L)NB(_$L77BQY TF-F2BA $&*[_1,DT85?.V V1-K(,
ML5%B.PZ+2!/XTTW-CZ57-:_\1Y6Q0U3GGP' -?@_R5$#R.;Q38Z);5@3:+=4
MLP?=NG (A*^HOJ>OYWNVA=H3#MY^WK(NB.*!^LV5/WO^ ]#PASB4K/2E!<HU
M]$KW6S0K4^^U/_-1K##)GD"R^J&A)XV$4.$B L*-&?UX8V($J+<^A_E2!4W1
ML1>UU\JI9]&?=Q%#:4\@JKK&8%7M#B^Q Z+E]J(']XS3ZW!D8#W_.ZCQ-XI(
M5ZGHZ?3?D6Q>@^L9I;'?_S/U:.JO/\6+@D;4EVY:#PGX\;FMC/?_J*3Q=V:+
M^$!WY/)U!#0"S]!@4/BJ,*&GKI_2!:5UZ/"P4/FONBP=O&:D[8!7>J99+HS-
MU:_A7TI&KR#^!79<QSQ%K!C@338%FN4VI7@I:).E1,ETO GB&+UR+OQ;@^J?
M'3$EI5/=\4&=G4Q*Z2XM2X))).T$>0\>B0W_8/TG7-$>U]=E+0R[G=O&"AX5
M:BE7)K*8)WFUP(>H$[,M>#:#-.\%+5['SA=1NH+LC?R (7V7#30L/E7$9_-D
MD.0(*7&VM^^%#YJQ&!JI/EO##1I%H*%I:'&#B+E4W5LF%ZY\(V7XZ-CE6,'I
M1_/(>'QY"R"8,,$*/_ 3S@[(3'R5->8YOIMT\ERS]B/A4C9GU'&-7%07G&C$
M_NRK+"9LZD/L\-+NM]RJ#&1'VE/HIYWHZ=D4>"61]CZ 5&E9494HKA/T./@"
MXW/"P&3YDCY5PSN"_([4-Y:;1='MRDY2;N$0QINW$B46.ZCZEO;=/\<$B2>*
M^ ROI\+0YHRMX,<:/NB*M_#WD&$)82X9R..^6X\3\L%=-8%$Q19T*)Y#Y&:I
M@<^W95@P[S-=FA.ED-@WNY1 K#2CZEMX/Q>%$P]?:%E VD#74$*[R0VC>J:T
MPJ">P#FV@+J<&*M]M.W^WF:UTH,;B/R X\=?[><3UNHQ5+K.Q'0?6S+P[!=P
MF[C5<;-:MCHUXK[-S[+OKS][\!F^V!L7^\JPC&UX\HL&0DD#^R7[:O!T+V^D
M^?"-5_=M7(TZ.YFG!P#NT"G<XD/",K_#,+(9LZ_-LWN4V[@X^/!F]94!"^H!
M5"TT"'B7@HGY((]<D)I@6LGJ=9;J1MMB#[!V#?<439@=9S)G\]7I6QOG>F7[
M_-Z#F")F!*+L,1K@- -9]1&+2&(92L [@??9B8:$3]&>3-4M!4S'4+TX*!"3
M3^\W1H3L/8FHP0*:1]%UG/@[7E&1XZP<GP$)'S2)^X>P  0+GJKM=S(7,T_N
MS\IJ.!X1'XDWZD\:)]ZWJY-G2KC9_36H?GEAJ]/X$UEN<9QZ&!"CO;$)@8?6
M"%B(!]]_PMDB7&M68M8^7M2R-#'!/ESQ97A5O>+#O61UUGT=S@-=\AP;+)*I
M*VR[]@=U=EW)X<P]_MW$]D7>XQB_L?J P2+-2YG%@5J2IK<>H4KWQD=BS&\S
MG>LPO_!&W1@H@^G&1,Z$WXI\.E*1<+^Y[UPJ\]6K/"NA;''SAH_#C]Q1)J<R
M=QD@DWZU'6 %GDP^$8KVX:?C3]'(;-,VF75 DO$']E]Y@Z-M\?\ 4R4E)L?#
M$(L*O\W#%;,P0VB* B^H/P/Q%VM]( JMW0=,H.MR93&8K0?8S16C::<MU52C
M^_]>8AB.;HU[AZ:GA1GR-_LH(!5-2/4YQ@O:0(!(N3NQVC[I8\<F[S6$^CKB
M$Z7?']F7J89DO5EC@WY4DVXA2H>C<,TSW]Q^=<TH;CBR_N??]@QK)BK-X)(P
M5/+)OWG:U--HDT7<9%6 6N9VT?FGO4Z3T%YL/<H/_%<+0U:7J;X0[&#MN#@+
MWOLCS8F^YX(G9@!R$*\_*>-&XY&9+=+?2%!;D(0JQN?\V@+%)#=W@)AMRISZ
MG_R:CF4-'B$>Q3$21\ #$*J-?AA*"SFZ\_[R, #AG1A7^!:AC.P&"&*/6(D:
MULY2[_VV3JEO&9WPAJ)[O R0O^BM;7:&*"<D\(%W=DMH[X_/7#_O?&#64\2J
M(^]U=P*R4D/V:N'W5N<DQ_R9#**7U!KFWKJI!4;-=EZ]RX.]O68"%=2"/BUF
M-2K<DGK3D9KQ>(WK)E/VH#]7&U2F:HOE>&#/XLX5I+RP>O3_B-6F!+X.^K&6
M7;(-*\'6!QTYY3_L6+OTE?O^7^5+/SBP#R%I/9:XQ7>5>$*:,#\4!.)=?D/B
M0S*V>'E4U 2K\90NXI?^"N(M_K]XK QM@=R-8(<HG&7M&W;3#N0>?MG D @0
MP3Q!K*=QU^\<Y,G[C]>SE<3N2PDI/F 3,<@HV.7XXP_8^XD?]$#_'2!^CL]@
MY_C;)Q!6KH"X@@"LIQGQ@YY-]23TD78RIB-4YH/8%?T5%>K?,+#2^5"A/%SH
M=URH;/M8GSW^VVF9]4K?Z#5$*/%[_AMDZ3;L%"WG[9GD62ZHADMT!10D).[^
MK>[/'RFELJ>_ABH4JG'-:'/_T*[+T&F!CM3T5ME_V2I9!SR&(Z K'!!B,^M%
M_TZNYF;&N9Z49KMX>; 5/8CXDGO>^/7G,+?!!L.<.30ATA+5:UZ'6#N\ Y>-
M_RM<IB]/89TE8_L?X%=_%[A"W&P/MOU; =&F+Y3<+>SH83@0=G*<@(R5[=+D
M#OCW<ZWI?XJEH9F6&4NYO=!A5%J^PC70'*C\P4_N3R'S'G0==^CR.H#NV#G'
MX_).V_KO+,VM#Z.)+[EDN<;/#&/.#%=IC MI*GXC9WR#8N55@U75'.@?0Z^)
M7X>C2H<C[.$?Q9[\6:'<C9;^US.^QN^P)Z>J6>D^YMA_NM3C(;K.X8V:=&<U
MJAVQ=@B9/DZ\> @[J*@Q2_EM8Z[-C*!H(K@F(0;,XDQ5WEG]\=8SFYZ+S4/L
M6\E_] \VYK=FFX6%6P#JSNX9[-_OGH'F\*^A:K+$;1C-=^=3=*$7@N%=P/H_
MK/?H^&.]!RN-W1F3/:%YS.>6\< JUR-$KBBQ\*\6/$W_1MA)^X2D1.ML4EZ>
MH=PXD9J,8*%83&W#@*1[?]LJLW'=[Q1ICI&J=0,]Z//W"=A.(+]I?%-,#*W_
M#Y":DWH6XFV,1,S?8/=OT;Q"Z)=#Z"-7E#9,S[L6>V;^=C ?A::K!00+L.^_
MK]S ^UNA'_?C=^$)^#!,N"3ZY]][F-] _(F'.>[I^(IA*11$.NGI5]F_EZMC
M_+?DZA1_R]4AE&9B]G[W3O/3<?*88:=(<B"(X6/0O'D<3S:GN?Z#=PM]-\O>
M.+=@5Q"Y:;.3@T4"'$L1J&9AKM9M6,+O51TW*'];U0'=76P4?57'*$1=U\^L
MV-+K:/]?N7K]VX<J&Y=PR!/IPE=Z*KC*L9J[.UYM=_O!_6!;@IHX<:DEX<'^
M)X)3%$U_I4V/E0]LWBU+V505_-)A8G75WF[)41&QCWRSC%M7S!&Q\&$$N9N6
M#BKYW>BO$GMX3DS7;5BRSQ;UE&68]GKGS7X9?(ESDFJA0)R.&QE-2JYK?Z!-
M&5@3)<J >T6)-G5J)]WX*"4-RB[4S_>/B=1V.%+=:I'% [7CH7L.JT@09&3.
MW;["/6FMQ01#J8'U>*(+ZO6$?J6+Q^1 D!5#PZD57TP!*L&;'=SWD'J& F_(
M31V<.R)S*8]06^V.U&URC&\5?<)T?8Y)\N@M[SHA-@:/'^P\T"""P-]=!$^;
M>'O^Q,K-NO8CYBN^"(I(PN(F ?&,QUJ6Z!8J9"Y0).DFR?X#F289>LO4K3GA
MP:F&8^[JS(K$CCHL,8""DF7I5BUJ#H>)=MZIT)D:_-'A$Z-S.^:R[3V;H L'
M/%8(#Q6L-[%49?NXY5<6C,3<+B-CAP).!U;%RP\D&3=[(?09AK;##?-.(J*<
M?Q#'7L^,R/8(3F"^KOJ:_;B>L"A O33::CZN<9]:*6-&?DQ2)-C5&0DSYOA=
M(E9'%ED ;>)=M;MJM&C9*"5TG1+BWLVWX4A&[WM;.M=BBRRGI_W9&"VPW][!
M"S>6C.R$6[I_L##?6==##N+(KWB=Q)0]1P+6?6CD;CSA'9IH:("\825M%+!U
M=$_T"?++HL_;,)^:3[1D*+P%/D1U#I_L]42P>5M+?6?[,#G'(T9NMI=)(R$
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MLK.SS)%V92@VD&[*X+;1B'\"1:N^Y:;!*F>Q%#[C"T7!HZLBK@T[RD;,5 <
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MD@[B@'I/\HR:.^DWYK3W)KT/U^2%KGHJ0>B 0;B#)* 0?(LNX:+0"L;Z$%"
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MCBOG>>T4OLBV(PCE?LB)C244M0_I9-9R)TU^A2O1NW?PWL7E,T>0/,()&Q&
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M1HUH;KVB^,UWWGF\]$)RVD4E!<I!SLS&IK>$OFP)+#<MHIY5D<+9$N:ULI[
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M>?91RU0!^,34\7]].=IHPMM8 E73:-NLHMP7<OC#:_UV!8VV9M3^E[FG#2S
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MH_K[[,#'_O UZVIV%],_#DRN8Z KRXRBM !78(4T64;BF0LR5.W"A ?],O^
M2HKD8?)M,YXA54@T_]L7:![N$2X,^"SV8$E6OC,^<0<Q\ZR; OB_U#!_J5@D
M]UC]J[6KP_C'KFPC;QZY1X +&=>#/VPHXD4(X.E_N=BG\V*K4Z_:S73 76;T
MAXM!6V==\X(MY\EW,"._O8*D#AG?POZ<K_6FY=:R=:?EC]S/RJ//HZ:@9,>
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M$\^:E."LJ+CPQN\94$ 1Z]F'\-*/O0':>G5313YDUEN=\('H09TAL!-T&W)
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MS>T7O!':[6?DZ9BUMG&ZO&I(H?=NV[/IW$V$PX7^"PJ1/]J]J'#&HW9=FBK
M.MCCK/(Q0'74,^!Q8A?6QQA"\$BP*%1*")9YY?;QJ6>1W9N20_;\NBQ6_Z5C
M<<9Y0^39$LPDV"HJOQ[+?OK5W#<T."H]F;!G8R"T+)/\\KEN[/AP=1!.M,,
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M%QE0>9E\B=K_VR$'67GX4/RVPQJ/QL80*@#T[0Y<_6(;.9%PX:%?JV?O=,[
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MZY8,R#"4J(A$,=E#VQJ]O\G<E_S>(8V:A'+ %'THOV1$*=75LQ8P^XR=5\
MS8RN 001W*QZ]<O3;CR8F]5Z4(.BGA(=V :Y*R</JK]5L0N>/?ZK5>'MD:YE
M2[F+&2WR&T95FU! &]U;R*P(;#7;H<3H-31OO83WT.H1SW%@&IJSW:1V,,HP
M/1V'&K)VY),=XYL'],XH[10P^6H9CPUODM&=SNA>-<'5D+EJ:M'G0\_AD[D,
M;RFX,_=;T\\\4T]*E/Z>*0_<M \T.M7Y-6CH$*_%F&K0IS43\X4\0[N?)1P:
MN.K3-](_EE\UYKW\96Z[#_;?6&E3*C=Q]>KALWV)CX"10PVW9))+?*1/2$6]
MM88BSY/Q/6A^:Q)4V#?53]C&(/E1^6=-8ZFO%NQ21=,G*-E=^@59=+$@8O7)
ML#2'S#B/R&4/' QUP%.ZT=PH&>0E:W8?_1_/@L1;O,M"FI72=D'R@"/;8V>J
M2,4%?(MM%.B5QH?&NL?ELC_'OQKNR@94%.E':4L.7= T7;38VPN/&*\9-:4Q
MCKKK_1>OS._9-],%[9@\#J3-F<'^V8AN:/K>T')3=0BM+]=-C/M;EV)6,BZF
M0P?/_(AN! /Q-UW&\/JK1<N0NR/]3(L[AW9%Z$QT%P)'R("=83Q%^H<M@2<)
MNB\X5AKB?9N47UC=K*7O0\YPY#(TD%S *F$X&R'P%AE%=+LTZXBU"S8]UEU_
MJM,P+L3-OJ5LM?![^JI^&?89[V *XBKB"RB7!)68// EZYGZ@7#\892Z6[M.
MX!F7TE]"]R0""CZ@+^(YF#J P9+#_;?M5PE#SE(3[QLM;ZN'GC>#_&NBQ0=-
M2$<= U:)U78DL1ZTP%P7^G1P#6M^O^9X-0KBXUPPD TH#@Q4")FV?G@GVOI&
MC%VE*"J.97P*UUAM]\^X=LS%^DE_SWQ=6^Y++<>,E+8CF-Q<8,C( 4XTZ\BF
MX;YP6X57&-_M,M&1O&'%&G;(#"CN#IF" 94"I%!; *. ,-+MCH??Y;.@&C_$
MW..R23*3>Z><BOYZOME$J**[].&$8AEA1B:2HP,ZNL)O?SWP4D[D,':JXXWU
M3LKWI:EXW:"KM1+S^G;(ACS=2D)A =OK4Q#^A'C!(I&9+//HT$N?WX<4AG.6
M_1NZ!*:A+.*"W&=5GR2G[MJUQ?BR8&2V\_E.WA_OD#X4MNYBR-BK*:13U8"7
MWQ'&\EBH"&5X@P6D3:\9Q1U'UP3*?#J,QFNX+PDO9SWM8_%<AS_8<D5WBZ'\
M->0%D4^DI[>:P7#F,"/I,"K#8C*='91^%%75P+-P+^$S,4SNZV0V:EZ3SME(
M4E?-JQ,>S?\@5\9P)T'6]4/M6T3_HL)T(R[+78 \,=XCUX17"/P08F*Q%\/D
M*Z5X)00PI8R2\\EF(:+%AV8>WRKBG]SK_25_7.;:]!;(9@ZE@&/\+'*<>A*H
MVH<<[J_+R'5=E-=5TLRX>)83A)3+^+J!#2(YA9I 5JC!W22MF8<GGUV3^-D7
MQ?#F&PYO>V=5Y:.\+)%VX=2OF IQN:V#/5?ZGE0; %'BU^J51E<IZ?([UZ3Q
M=2[9*4VZD#%$X>S'I[A+C]V>#(,?-96V%#H;;ABHB?BZ29?&TR*\$6),!>]%
M'L ?S?_J&:^F^.&_%G;&8$8F3,'%UY:HB:/MVL?68A]?>)+=[,Q\/'$OE2>C
MR&&;L0_A:$9]AJF.M#N]1'I/AE:\C"\U:>G8K$8;?SNF;OQ4J BJQ<_I*_@T
M^\E\XLBU]^+]ISK[U8V3]>N/?/;15<*HI"S97HV?%F81#DX5?\FJ;IWJY, ?
M<DF8W_C_:QKM]"ODTL%RK 7\.0CUS5)4X(QKM,VA&;:*5_.E%2)"%V_]4SO0
M>#-RB21P'R6S6GZ-DMQX[+'@"T_YE QNU@'SW+5K2*N6=MTWAX>'J!)!V6[)
M'4K_ZN+(_H91R!2)?$:3N@!DOEXX4['8FR7NF?8',U//Y#8BBU%SQI/R"Y:J
M)%153YQXF?'G8TFXUW;;P3[]U^6>M NKT^X*S?F1HI2/,DZ=4LZX\^"P?<.E
M(OAW!%(DH2FAWAX):USW?2#WBO- HW.>0'4Y+.J-EP 8PL*)3=FF!LWV6C6V
M,WY;>":7 BTVLIPJR7CQ]E[8V,CLG(A]FM=?SJ&?WJ>8/?_$\YN?6TW+8G;C
MKS;K[ K^MO_%AV303AU\_V!R,4?<(>/:57#)F<;O?>^B2DQW':G8&],=&LAS
MY*]/9OL;218WFDWR<[,A-BI7#]K'<^HR!V1$R0,I=X#J,I^<@9 H]'9K[GOB
M #!]4(&E#B8_&8J57EC5V67WU"^>OHK_(3*)[NH#F<[532ZD^\0]&$^DG$T3
M3G0OK5*\]M%3"#,/I-%=]9@ZW<RC,7BH[ZQ1KR"C?M@V^HBCC>8>3ZI"X-OJ
M_M$KS0GRN85:/=!V'[*G;UPT[[42EA$;$Y[NQ1LYQ7G'#\,C.9W#_O<%VG_G
M</@Q31=KI@8"@Y00PIVV&/(GX8\>W;>YSGV+5?J37]=N1_3G["N,6=5G%HA,
M'(T%ODL?S*DF8=,ZQ(!L<LS ='1$VLO('7$%UCOJ.9J8Z#^8>.A1' @&0CW9
M;+Z_9#0;6>:M?_I1-YD\S\!$<GZ<>1P(7B,Y= ^=T;OG-!LE6YNNDG1N0!8G
MA//"2_EA:E?Z?S9@4F%<3[K\WK0V.*3&'^=;-V.7F2&/,[DQM%C41W=U&CL^
M5?6$*.'T:>'W ];.$XQ*' &+TF'4M$-E<BD!CBUM^3S!I8'W!& X9\8=QF,8
M+[/GP!4P"3KZGW\NBH^'#1(+[N=KU%R369Y2Z\<".GY=SEE/PRHB/7M%?9L/
M.Y]@Y8=39B',4"U$*LCH! R#.U3(PC\6O1?2U'=!S=B.)IM: ZJ,'[54M42T
M)-):I5=TY*T]13DEY6;\M!$%(8L:P9']5_HP7+XA[I$AUSO:+JC<3SABL@\9
M\)M'$QZ"3V-BG083!.HZE"CNM5&WI54?)KU_  G?SFXSAHX,)]*=RH YTZ;I
MAB]/?A]W.H*Y*"%2^:9K5[(;""*J$W"<W[Q/7NZ?^JJ7'KUAH^GRUO C@(P9
M,>Y/?=K\Z:-[GKRM<GK>ZF5(28_TCV(1AR3Q?[\>ON2/EDUTB+%(NL5O'1F#
MM&WKV7IJ"1!&4T1JM@"/*/SK [YIO\I<V=ZKQDR76>4]\2=$8'L% 'TU:@G%
M_1%Y]QK@5'8YZ%"0:\=)TW[-[%43*SMB-G :1Q=%+$5L)%)0ULDX7L/+6E2E
M"JF84\SPV7)Y?H$/D9G#="%.*IXR&4?Y/ID32S@;4-\1V -K_(.F2]723B+%
M@&$*IR,%WP\56HUIH.4]YWBY$"@TMXCS0OO"Y]!4*$A"9:>HSHK)V@%U<V^V
MY'*SUM5HW7$3?\>9A]4/&@\!:[1S3GT4J:4+U%S'!2?!PY[O5F[NP$@=DXSW
M<$\,J/F:5GJ4&$(.66.;UZP0)\<U^P.-^U "!]_,$'@HTGKR#MFAL\U@6&#6
M98B6^]HRJ3^:]Q$"AM0%\? ]ZAN:EX[P(\$/9D-LG>4[/'LT,VM.R;P>W@"Q
MYE  HP1^:S.M8&\@22LTV[+1PV/KIF*IS)IK2B<<4.+<0--TM3H$&RDBO8(S
MJ%4;\^.=XKO8>3APTGICDZS$Y#8G,P<ZX4*&$J]AV#"9V_E [:.\S>WH:2>*
M Y/O.Z!"4>P5DY$;?635F/7+[KCCTA(TCV6"+@=T@1AQ@=&$OLM33]Y3.^+J
M.K=X4H+75IJZLXNM![-]%NA\IGB0UU+^0$5A>I%!BDT%MWO_&2'\1CR#ZW8H
M[4"I#N#K22(Y ':2@3_:A3SUJ%(J_*O\@^VO,1X=L^2!.+H$P>!"/3DE>6/]
MIDE2UH(%!!7*58?IQB7/"G1C.&<B$2:-6_F+H[)S6<^,12;,?N06:!TMT]WX
MQ/K@^_PY5QL+Q?S>.%C#LIE)DHB4:?[G3VFY+%<30HQY_MW\OZD7I\SC:Q%V
ML<535AE>@QE-L$0MEFW\Q@[M-N!"M03.O05*72?:TP=C3!7:.+NP/Q*I!U4@
M*YA3Z.:!OBH<-]V HMRL;S3Z15TD_-? R/0\.!"APQMJI I#JYO$8PJ_5?Q/
MUF_]N !7HC]?2P5IM3_\#G;F!^ #%4$I(;RWHW)4:2Y;D7K# =7LI20C72:7
M 2W K[D5G7:KUI3QFF1\N6UWJ3BV:O=?U6Z%Z!Z,YT@>OPC*G5]C8EE$Q^3
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MBJ3@ (ULW#D@B9H_1"UT]OT9< ;<5CK[ 4G=N7-Y QT:N;<_$,;(7]KGBE.
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M9\/5F&-BVW=XX*:-O@P=% 1BC%CU=]H2WOC/L9DM&%YRF4X]!@THP5JC&-J
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MKA[6@GA/>*N$)U%2O19#W8ZG<:'7WV\K()=% LG_BL6Q--+^VK*^-;F?>AE
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M.-("F&.OF9,@.G$KP[:S!&:X9\U J82+E"T>_FUGG$1-(_K;3QV\;Y'Y^1R
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M^.)O=L)H<)$=+%!MU'CJ[P#*&YA=2$Y(MCRGO[RWK[7H\^R0))9B<.@7ZW.
M]#$<ZT1\W\R!&VLQ-H_)80F-'Y&&K?)"/%!"A*O4RZOUXE/?C/453FVZ2YL"
MWJ$OEK)>CB 5:=?LXHF^E!<T+4YPT604$X%M SQ9:>94^=4&^? L1#:MY<UA
M1XT=).UA1(!*#-E%PEIGX>SJL0:?K4%Z)Z+!*SP3^2$NK^8HMYU:^7-,MN$$
MYM!NI>'HYJO;3(7*5UV#GU9#J=E.I0MW>.\2<]5$N+X??G?87Q%_^A0>@7@#
M6DY>HI0%?032K54W1MVL#P?OKQ0,>F\D?/_EF ;#+./<M?*L;W;8V-]OB\3Y
MJPX7]#N?AOU,)6%'OP.\HB8&+M6J3%AYG@,Z2E[D7XLZ+@W37]4>)XZ:I#M7
M@/A R[\X6,R@[[=!XO "%T2P^<6$M";UP^AQ_;;<S7SAOM42I!^\WJF1)%J\
MRQ0O7_WB?35M^$UK>3P_:7X%Z_4KYMJ^X(,RUE/IK9B)D\\_4*)KFK_'"4)2
M U*[B%C$W,:U]L9JD,X^?#EUB5JHZM77!_$*?&0D60P'@54,RXD&MJLJ'3S[
M_2: 7T[-$FX^FTFBD]HC?S0U];KG5)<K=K39A5@ =RGE#'AK5B11NB\088>D
MO;MC^AIGN4,3WF3QYRM!KZ.1.;+WYTC;#ZU"<PN/W(L.@'>NQWS . 8J#>T;
MA <4QMY9N69._'4.^+CS&'T0;#.EH@F]$:%PU8-W2;BTEPDG*+1[B&HXX-!$
M->QXTXGOW#;G4V8RQ\=BC_1X!]%_X+306W8Q=E56M5%QGU+V+#D';,.[\P:S
M]W!P%6.K-K51MX ^+#@PA.!PT70F01)-24CUCD-9^/( '>@+=RSE$L\!E([H
MQJDP5Z_(UP_\D'XF_6 *T/*73$Z2)+3+V:+KQ*W_:C0N2;4YO\$8L?=7B'*C
M$:>YK!Q[Q:$8PEE918\W>ZNK5KGUXD_#3X^?GQNN&0_7CI;00G^,Z$=Y533M
MPF((9,02$A?!HS*"APD< >GE4#,GV]J%])T#EK- E;,$!?3G>L-Y/KHT[_OQ
MTHL(L7/ "[U9R:Y,NF8QBT?U#>(O1/?T ]UWP'F@*KN6#_A[ <QC!)O?_/5;
MW^U\NH4D=@S#^@O6IGL.G7;]%.595Z )H8XF69\='V\/]Q><2J+. >RS.YD<
M)EWE2]*[/OC!N'YRHMC1!RPWL4EFL])9N95JF_)/=5:+Y6$GS 67UB*20S %
M4Y4S?5UZ-Q9"?C:U6?H/53 B![N<M;R_J58MB\B*BH?UOLVO4HHT>\)&T(Z[
MU/#/H<1BN*]CH![^"6E<C0T'SC7;]CN8N9PQ\8HW0'2>.>.XFS2(J#8)4A/#
MQ8@% G<5/]'[RFTB>DR&+^*FZ0]!-"G2-E>(2D)5WW8&THI83J IL(1B>S3O
MB)5!+S5>5[@VT9]G)GW,;7)U!3UO0E^E+BL(ERW#:[L6F-V.KX]\<NGRR=4Y
M-A28%^'B&@RG*;Y5WHSA?K9PX]3V!6+%" [)G+W4OFS7FA=O]D6H;BRM]X4?
M=R:ZM+L?R$)X0"PEJ:DC9V2]7M<GJ1O>:>E"*R68KIF]<G?W2"N_WYEN7B[2
MSA#R/M%A]\N98MY%7D?@G2W]Y-7@*OR+J[HXD >MC&W#03#>(UR@*X__5 .,
MR$LWP!00(%HK,EH2V3-QLW$L>-Y[?Y?TUHM<K>I0LETO G[E;QW;B-^;9\WU
MWQ=<39W#L-334\Y/2^F,F::UOY1T!Y-J[6943;5E\NR'W]1;$K?D(8)UM36G
MGT442Y,0]DLXX<?1:(\._4VII9:HPU.G:[?]IW))O2#.;[C?Z+=+G>Q_D@Y7
M5,K. 7:RIV87/NX"20.%B7C8X^(D-7N.UQL'*BX5HA;DL&JQ$;CX$IVX;AY-
M#Z'215@\CA^+Q<%_0E6/!PVMWW$SCS">EM[%E!+8X*VIC-58N=FULO!7@++G
M6ZDX+JP S@*3C/T E7%6-KPT:D)K8#JDM%)7:DLLN9A"&<(XR#(;1K7OWNN;
M45%!KU8V(:,9%D$Y$:M>;'B@JG:D0N;=WN:RC^TSLQM+H(K\O4%T\HHZ(O$[
M[IN("\U<V;T=W/7U<X +8E9+,J29N2':A?FY#T!750QS@#7!9:XP?41P%WGR
M2.K?Z?"Z5%["I  R)S[%G:"_@.PE9U9W:IX5)5]E%YQ#]#'YI>N"M>DBHS(&
M-GL42N^B8,!"!8'"!UO[,&V",6:>5PQ7<Y%U2EM74(Y3(/SY_M:P> F?V]%#
M#R4[+%\K*6Y)<'E;F*% JCI=PP"1]5!#5 +4Y17X(I_I ]@TGQ*#+Z9R9CPT
M=7*L^^Y<ZT>QWB[?C3.3JM2'=/0L4:DF9:=3E[3ES-;L-#T<3XM@23CRSM_0
M[G;CLX&G3*G2?R;_E*FJ>YP#&%5N9-"C.YL_LE*]<W.WXE L_5CX&N1C>Z;$
MD7CM4.+^@].OCEHVE P'>C^:!B7=_KLOSF6AI=6IL[,N<_;V@((#7E_X#(>R
M#+X-,&2A8C*C]I+E8EVH(;#J^_Y:E'0>!).CI#:06J-6S">+UX6[(X0+'-.(
M>FD(6U=:4]QPET^2WS>&;R^H3%2# ^OAKR3)%Q^R#2=1V?+P\R:B)5LRP^C0
M%1V&V_'L9'D+?YA>@N\-7C1W.7%1P:DDW\@(\/[B7XENDLQH;SJA9P.LO@<5
M\\306)QM3-DI0LU,4=1[P;E\Y,0!_HJ)[.E[CF@HZ+"OX> B-),30.@A&@Z]
M*&'OX?ENOU-^O;\JK)IJQ0RYR8:OUY\?S+\#@PFW,;L9=]'0B0\55R^5;RPB
MC)!%_1^EE0[- O@'>3Q!_"BGS)CR(E9V!Y&WO<>GUT%78+>A%LCCA 7(]8C.
M"L5Y2B@X$N&RQ*3^UF;T^,G79V6SM4QS=.UP5C4^:,B*.OIX3."I[LAO;J^S
M2;TVO6E@IXF?Q2(NP]_'P;9O_\8+TJU&^J5P:%>ULXJ<6:@CLT6F1J);*<6+
M/TK0QN$KZ6N-?L6Q9FC7O4[D@O':"\2$C8&>JMB<"B7&IUU-)MR@V\!$T.,=
M.!U>.=P"9R9<&Y]=;]MG>S*2_O@^Z7&3'HF&B&$R'/>*+7?TH<0P'<EVMS?Z
M?!T?0E1XA)G5O-[V=A<*->,XJR.6QANM1TSD[##%P*]GX\ O7&8?/5O;IPPJ
M5<&YXB$X_PZ,0,W99^VX(4")'O9/AG\F'0?3.> V8K19"">SR#=U0:!4<W6?
M]W+'I2KDQW@T)H?;?LCZ_.U(DZ.5Q+4Z?[]-CR<L(2JGP6Z)5X%8YVG%MVDQ
MZW@GD>&]FY+Q25OFG% ;['9SK%[MQ#<B<@-@$@J<SNE0BGT/[DC-#D[;_?[T
M$ZBK^26&,;\X0 CC,U-TNTW%95IL-["P;U!A+*K\J:48:G,VO2$CXSGR''#9
M;GS[Y2^VNGR* Y>-K<Q.X"RDE9=AK/FW0]'C5[W77H@-!"CB/7%^.Q86D#T#
M0<-;U)<:E9==V\!A0."*19/6Z:WWC^;9NJO]4R_BC6/I3+<%3MG=U1U2+B?2
M(*I:F"^]<ELA)S3F]>/0VT#M_'7W5_.4+<=E>N+%8>L=D!IM8/8B%:X5*<ES
M+SIO&\(/NI=E!.10<?Z.$WOD_ #7_:O+0DJ8'Q@=(/2_%1F^H,)A-^;LSXI/
MH=ZQR9GF9Z'8D52'9L[P'->F-QVP-\T'H="RC71%0Z".N3NB81,&[TCGY Z-
M<'@]8>&68 Q[NJHBAK>""IE/=24X8"76'U!-7^%EO/"1 +T"BQT$/6F):EZ%
M\3$5]4)IO^0[@P5X6Y^AV"MBWCG@2(DHC5X_5:/OL$1+Y()P>U!+YH[I?;Z0
MFS8LEC7F0$T4D.XU03:L#4\CMV97<#J,2=*(77F=^[8#(%\<%5L,BR3UO9V;
M(?!5U=H R,=F$8HD66E+@FO5.>#-*:(8%DP:NI^P_)'[',!$ZK=F"L%F,MO<
M2)I2J^@<\G6S)LO_[7"2[MIY#IB-;&UFQ9"-[4=GOY1;RF 3 H65/L0Q8"*?
M8-92X78"7*8QMNK /H0*R"FY&<ARK?T6: RR%8L3JFL*9+SE"W.]8U(7CU$#
M 3LG[ES5C@.CU<#A4'[QOEI)IM0VW><"R=G'\&@57^0PA5DOO! <%F3P.!#2
MTFB(]X7Z]9UIZR@;!+<I6M\K,<1VGP."DU']O0&JR/XO5UF6,X7CWL.JV@+8
MB<$J+TMFAPN@&:96"S4,+8SY\Q,8:F:,4P7XQYJ1)%MC%-0_N%9+\?J A],#
MG3W>_!(H!'OT.W_">.G9^,U'JFBQ^69>@A6ZM(/._59:05%4?SR5V'+L;"CV
MS80:ZY8'Q-C@0?:UH"M1F",91%ERE[/'8XRH T=RU,.^'X#A*BBG'N_&-/?>
MZYETB5M[?U2+IMJ'> =P?F;?34#>HAMS\,H?I@'DT)Q/1KRP$(2"C-B+)>[7
MKX%_#H&D8'!.)@\WF"!4VY06/Y(]3*!"*%8J:A'</]V"KZRK91X8P\0U2*SH
MOJFF6(W66H4UTYE#B\<(_F,Z)+/(\@X OO$;E.@5-6>K<%RBAS1[AF10CM'Y
M!A?=SE7N3E*:VO.%-R2/'8'C<+=L2UX;3I!>^8R*LQM8RE][X &FA+?>)]U>
M["X81.+IO@_$I8LV*_N;S)/$OZ#0QW-B+XJH94_A>(<=.E_,E<J/261!%P,_
MU&@T((K\HZ[%.*0CF6QXA+@LE:H8RER@:7U'A]@)GBG$>DXT"SON!!;.]MA^
M(F\06&_N0$_MFB&;Y+5,&4I\LN;-E8KQES93+1>I?C782_.K]\/8CE8H33N>
MW.VB?-W"S?Q9OP]6%O8]7^38/Q67W.T[*:26P1YL<OFANBL_<FF6&LOVZ]?8
M]ZDC.@>!E(W+K*A&_^78W1V,11M)A:,@=U[\P2JO@)-M!%%A_"A2QWADQKJS
MD;=*:ZR5EZ?<&3WSLF$R98FNO$C7CEL=N)!7G&S(7=$9L$.6T,C(?Y(^"YD>
MQ%G6%UD#(R2TI(K*?BBJ38"B2 (XP];)4KF"@K"^#Y\<X==WC)NOH(O.OLFU
M<E@'1L.\8&.(2I/P1J\53H($<E!]_+15][X*>ZE_1&T:0YN9I4W1>J7FL<IM
M9B0MP2'-J*9.]R1A-U!V16\NN2U)/IKQ?U7WYM]0__'[\+2@$-DBVR1)]I!(
MF$HHDK?$R#8*68;L&8R95/9E4J%LDX0B)OMN8C"R9-^7,2-;MAG+&&;QG3[_
MP/><^WSN^YS[A^>OKS//ZW$]K\=US6MYI'^_31=[-5C)$F--(H0IPI3)OQF5
M=QN^ L!]Z".' !>0 (Q@Y@-V2+[&6R1YQB'X(&,)Z:DV@<*CN1XX(G%#7RYW
MP+AST(:0G&$2\O1*NPMT8"$7ZX@:4/!SCZE=,^OV?((-+P][AHB'A>#KN>)*
M1AU5=^ZF_KY1!!1F(+E>-*H;U.G%%\BD-$A_Q,0= IZ@)Y7 $<ZP<*=ALWK=
MW%_X_ AY.L1!Y1#0TC#A[-_TZ19?Q,.QE5"0X-#O\KLD#ZU>L8:#<4:#+E$9
MS+^T0];)K#4U[0T&Z_3QLZ:I=AW-!PY[;XH4)%\HE5.TU]V(4OQWZ0ZZC6Z,
MQCD25L-;*\FK&R]H;V\1X\Y]0KI09->]56W"%T\09.B.3:9.!\@DBAQ_#DI"
MN+^G])U9K"I^_&.G;CHL;[?T''GLM0:LO_U)<8#"ES6FP-]F*68C7#^\2!F<
M\46Q\-5@TU@+]@Q<>U[E'&0EXV5GJWYO(GAQ;%V&#J+%$#ESM=J48V7E)4P.
M 4Y-*-;)[7E'7]OZVL$JLZ;E(F&% ^Y5(N+Z;QETMW)O;K>"#V(ILZT9^,<B
M!E2ET95N%K*0F\>V00#:IV=Z3(YG7:$I039XKWU^HD\_&16?WF:F$-AT5S6P
M?ZDI@@TIQTD:Q%VJ,N?2RVF.Y.EG#)OFFS3[PG82X33^<P<Z=,0OXK?2-LL@
M)]! B;DU I?ZCD@@9FG _.!-R;WAS+YF@^.(T>=.JC\JA_[4)S"E1/C4)RN;
M55ECD[ZOM,:&YIL3.7;; ]&\AP#74+UCQ"#*T9OB^S_B M1GFYV89?)I?1VB
M&DIAR5Q-B(\?*2 A5[@\=]6#),<S-77[".O6++5V!W<]56F+"6A5(ZHLB#!E
MA?/]K#7DY>^[%=?!9=='"Z%[C<,*V\I6.*GG'3L!+J/-ULR/K!.P(=*4V*?L
M>^=XHYT(V1%J<Z!QA 47+7[J$106W?+66)?BT AJ<PA&AROV%WJ%C*SZ_,Z1
M(R*.$?^F_MA5#'P8/^ 9@?I"I$2\MCN_"GX7E10I4_RK^2)K/.<DN3')TZ?D
MMH/_2RZ[;;7);FI<#2V$^)S\%'U=KNU"KF+@6/P^>BZ]%1D+J92/<QO.K^<_
M.OW6L-";GK%#RTOVW]&\Y%;G;6V*"@^*0,SW$D'\?F)9GT.KW:PF!IK3_Z**
M*M%32\9T6'7#\&/;0T!3I-,$N7M^[U5CQ-'\@M+DA3#>8$PJ0@[QLWXTDYC>
M.$B*DC\F\T(:;4=&16.%&GW(]B19CXRT3RWG&T[<>,#E1?&DH(5=K[U^G#GH
M_YKZ;JJ?^IBXR>U_D3-8P[3(*GY$A6DQC!7]Q44]_AWR4O, O"BZ_D7V'7XH
M]H;O3FH?<!V\#,*IQ9Y!"S:+5O^00+19>Z-=(#G8ZJ  $XKX0JX.YX(_GFZ]
M#,NTR]$\GQN?OZD ZL>UK$DYJ D_;+%Y[C]]@&&=+!1LGZ/W-@T''<0?--U0
M=QWK I'-Q6;@P-#%K+=Y^_$'9;CCD[I43!-1. ]7"4S9QTB8,JQC+?).=6D<
M67UPZW*5(_%C?*KWD^]M)YS,([3J2N3KMFK@&U-\G^,5$B]]C@?\_W;)R@I;
M#KZ0>7OYY\MKGZ],B'%F;0$TO#36YE)7XC\J!-A=6!M^U <;PC<+D%\JPM(M
M7UY(CUP*TB)A15A\#"[F%ZFU[[Y!H[59SAHF?5L83792*>&/#0N)6J]"\;BJ
M-"IO">1<MA_$ZB&?^M(N =N0,2"ADH6QX(BT_J[6>YWAES$A:MWJ0CCZ'3.K
MN=K,!+]'!FZ\9U1/MD8X_0*"_^?ITBN>%H'^7Y?#6N0B%5,4@(/--K0RM@7]
M2_M&;NO[YAGFR$AIO;LM[*>T@Y_#,X3?$4$)E;$%8UJ?!M]W,W"#94@OY!0[
MV5XB<U S78H4,FPO-V(<P$^%SF9;8=:^8(3:>FD6+\MH[G'YEW!F,R":_")D
MK8]^"VY,4Z.82O$\'%83>>+*>59N#CZ.F<).-) 4*'NX7FW+=^GAEWL"-R$O
M=3&Q3VBIE)6JF1.;\8]$/8&;X'7"FD(>P1:N/&0^^<:@M9:Q>O\<#I=B:MK3
MAY-T<]>E!6OK^C\W/\C9O&SLF/CIU2HD$TFV!;XX.%43C22J1LH*F:L_;=VZ
M)G)@\DJF_=]<-8ZX=VN' .Y<0G_=L6V1>;<J*>6'WA%]P@.X)P'BLR/>J#X@
M3;ZO909$DF\OAB846E$C;KY_=G9Y'#.-CC(X74&VB"8.E+Q<1Q5P52&N(EL4
M,LR0<852N^Q+]Z]2L;<L- 8<#\8@ D_DE.WN[:-X?MC"KYHKIM#OI3\ZYUG!
M&YPX]@?#$&'-"I&4OO%$QMHO,#@05:O7C=,-D+70+4,6SZD:>L#Z\"&@^PQ^
MP=;UEU[7J9PQJ=_ O^VPTKXM57:+%/5);YN5'=ZQG_IO(%O#R'%>]L-D+8JF
MB%IK^ H3[?"GU=P8FA$XDC(IUZ&AZ4A@"(C^=X:EF77+>+'JW"& <+%YC5F)
M=5^7G>=O75TI]6Z<B"H0CJ)B# 628*KGGD^@M5YTYF;3(NZK.(5-C=@R*I@9
M6&A!O\'I%N(II+5JL8#TP[XLJ5K,=6:F+]B*^455J]C_PT;5FWDI7>[MON1#
M *\O2YAQMY[\Q:_2C,^O,7FQ@7\\&:E)<JN?EDQM<@A<4UKQ>NPQF*OXAFZZ
MM*#C,"6:]/M'W5.9\&$WWP9#JL3\/9 W,P7C;%C[P66>-5&% ,&U*=8UD4A/
M>MTNUT.K<+']@XB_S._]C6+-!K33!\=3? 7Q0"!9B*5%(]##X$=&6+QPFP;*
MK4<?\NA>Y9>/!WGM,Y(?OLN^M@NZ3Y%.._\6MRB<.J+DP"QEIL/]\VDXXGK6
M05 G445VY@>=FX*F*5"CYJ7,B"J=Y/8F7*>KS^=C?3<AHJP6$-G*'A(]:0>S
M;PLC)@J>5F6U-O_QG0J<DV]CITZ54FQ1G+9D2IV%UU:9&-S).@$KK[ZK<V]5
MF03/2[&Q3*T:9@2/&H@CAOB+9@G9H$=W'@=,U5!0O^LNP:&4ZW<IXH_^3HXP
MO.N.ZU4=1-)OL,: Y4NO&-JAA2M[/\W\>129L^:(I_ 'E.1LBBCI))*C+%#6
MX+<^LWC]LDY,W!=FE:JU^S<:6,05=B]31/R#@]4W [>- L02L@6D=7>#G<E\
M.*E;"U^>5\IE)UO,B&PM,40. ?/!T5&?>^<HB *S;F_%C:7\"$TZSR/M:+8K
MC#B_;2WQ-,$L-?.OD-8^V\1P7*&E@MJ1B0JGLOL^4A_-@II6VN$%G"^_?>RR
MG-#<+57H]3^+Y!A:L'E/2LTY^))L0I6B$**:)6C5!'N*T(VK17]Z])5V["QH
M"H< W"^6M#F1LZ&<VSO1K,^+\8?F2Q=CF-!>$6/AAODK4<3TC1]6*X["Z'^?
MN=[R$?"T2!F+QB#56]UH]67OEY[6 ]'D#<^.1]+6XF+><D1]7_>Q/W[(*HN$
M'<QI^",#>?)(&PSWQGG^&R?6 CF7@A;%Q\'5/8DSA@^Z;WH@P+Y4Z'8@R6+-
MG2)+9"6H5A1Y9MXV?/OP %S(/F"7$;JK3ARTZ@.1F3DC"2N)IH!+O1Z6)2^=
MVF<['>0_+(::B/UR\=0Q;A@+W*V@=OH9'(7V2+QR?Q,!)1NVLX#OVB$B;H.?
MWS#:@@[&V+BOJW_%8UC=DP6?2AH0:=_O1Q@A@+"GMGFT0T ,:^L0L&S]QU5$
M+MK:SJ"[C:';!FX90+?^08710MGBW#K&SJT-$0\FS2(7<;4^7 RE_'[DW!N#
M<QG^;N&A 9&H66=D*_8.NUK+):XTE_QRXT+F<7=4&)6SJCPTTB,]A%[5;16K
M[K!Q8H_,DO(;_CJ411P "B*Z"&13BY,,C88$A^&JXQDW7]K<OM;)4%J'\-&>
MXG"3#F%/T8+G\6(.G_"F38(=,0#G",7;UD;7E?!M8$Q<ZI\^3/=6#Z>]Q3M^
M"=Z$TRB59*_2VB\KX./ _:=>;47 U#][7ZM\L./;T:L+&;^,)S4'TNOK4)U]
M-*6>+JW5K]W.^^9]"Q!]5C>AS!A#63P>S@95GW".VAO^;]*0["\4I/Y-\)9=
M$Y1U(M=?F-I9?DFG7*?S$. \-HD_JRQML@&,?K+UG?^T?^/*&'AH5T\72;L
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MAQG%@X< 5S0*(NR;]Y*E?W<$PI'#!TJ-R*4+LSOKQ9S>]49+TMQ;L?%GR4&
M@P/P#/8(0YLX5-"0S=E]79>9JLDH'KK28&;O0;6W-Q'KNWV#:\7!EK$M IFV
MDQW_I7?]%UG+YGQ>\,7ZBE:V[;VTP1*$\[%=JWTK6>>DI[+I&[Z/#N#Y]<*U
M58HA"=PQH:;VW1?^34N!STGZLOT*I)H@E1L? ?0>4$K<<>N%;>)*^&]#A/)*
M45[\&:%G5EDB.KSAK8/0M/5=W=KBZ$ONM?&20_Y)!@GN92.L#F %.@8N0@[
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M$*)9M8UIAW$T?F]@0>0T9VN%R?+MO7+W!'[!7_C7=&-&],'F0Z7R[Z=M;S&
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M[*E:RZTS5WQXZ'TJQA3]&E8R\K#$HWSK[&KD2?059"WAH&>%$'G50X/646?
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M6:R(X9!>0XB\@<1("1?N-7;A3S-DZ'&M%=MVUB%1=/CR&1/RM"*?>_B:S([
MZH)?PF4XHW7_; QJ\C.-(BF7LJ;DE@V*!6C3N&"M,'<%[=M;,S]\PE@<ZGCI
MLGPN?$R.IDS[-R$.L ASH>LT]U,MPK8[4!G:XYK]V,FRVDG1B3,N0Y;U-P%;
MA2N'TA'*\W0.&^%_Z_.\8XY4HYKP2+;#0]KC.)@@P20>N!%+^5O1 8JP1X$[
MEX20O8DKRQ1@"H>S:1S_G*GH4B?].X]7-)3L"1E*AVI$-%3T.TJ2*'G<(/0&
M1K9X5\S4S)%XG"+-P5PZ)51#X9,@/^?'1]MQ@[(WDK.-WUFJ3G]9=K1[Q;?*
MOW7J.FA4J,K?X"7JL^M8/^]WNDB/!VP0[CWP)474'#JMJVDZS;)LQ%/>9E+R
M/)ROWRE<\7?^UH.O06PH:DS@:S1B!8I^I"2(CM"(%Q481=S<NEXP)C[B_GL_
MY.XTUUNY?E&4HWHU 7%V8:)0A5\]5?\S')$!M6.8/KGMWQ(W+ZT5-S,BT>M8
MB?WI3T^/B_CF/3BBB"##1F^IK_-Z:)-U_UX,J7PWJG]W&^Z@-$$5;3[.SU]J
MO_%AW9!5?-#ZU"'>+>\BTV%DW!D/;!\K.J[W=5"AS9IL4FRQ==BXL]LY9GC
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M'/+,17HE<V\;7%WP%=>HJROJ6J$@W,NE([=87NQX&B9I4/0;(R8?[BI9B)&
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M0[D2.&]L\Q9YCP"$T1OM3G$6>. Q.F)5$RM^MJW=%J.3/-18FY*7(GY03%Y
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MZR@^KUMM%UTS\"]_V;DJQA117.<X)3]_I&:P#HD*O(%-F88_^=,BEI:QD#K
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M(?HW!MPR/TW7-\^3)ZQ_7."!+F^1W"L9C-KXJ9:R-K3S)+-Y]5[PNQSF5Y^
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M HB#M&>X@>$D,)60*@(7TN1:I /[8>98P3WN\4+G7(*<"JTF+BDD^CI&1Z5
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M6=:^CPM7-8^1U>&-%RA2^(G2;13'(O$HM.\J07NNO.!.#E=M)H;;$_NR*NN
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M3^R62N7V.5VV@0S6\^EH[;H8WE/[(M2.:[Y /-(\#^]RU-P+_YK%&.YY?ID
MF?;G3$8JW M52V9 V9@3?I[VS7S8= .Q^OT[W 5,ED8*['[M9*?XOU112QVR
M)6 BZN2"/)Q*29'7!KQDX4/6&+M6MN3-Q%3+$,\@">8',1>U ,;897WKWX(Z
MKBXZU?VQ#'8)]YSG<DVJ^M>IH6U6CXE!$<^#*P=.['7Y^H5%5]O%5?/T0)WQ
M:]TW"S7/<Q"%'5>OUQYZG"-V<NK1TE65DV%]=_K_, ZE.N!W<D] J['KC52M
MEARV48H,=M7\1J9:AA@AC//]QW!ON\-3H6])3(;8I.Q'['9Y*'XPP\N/N[0A
ME4F$Z2S0040895\)[,J(1Y74<_-6JY!D=/]OE_@O[<'"QD0ZT0<$[].&@SO:
M:[MM9W@:OIF_#GK#-/0/&K3@A[0QQM@,9J+U@EAI<B14JQ(&GT(BXW@_T;K2
M6S3U5[>4U_GW*NG^5GGN2J_(;^Q,IC[QT9 ;P<UHW1A?N;'SV/CT./04*51#
M]$;L@P+G!.X'[M!O0EHB8B(G-U/G,TFY+;E[P:Z))X)'=@I;$2 8 .90>*[I
M']M\@6WR[*"TA_0+/?:QL:$ZI/VAS=23S,+<ZD 5T:R$P$X,&5)@#-G1&L.F
MYU)7LDQ';@@I#_@)VAU:5-!7L9$,^-(GT"_]]LM:RL'WMY\4Z D\@E40UILP
M1_W@XQ5M2,5/U&S0M&[H%NA@8X';"+JSNKH\9<U@LV7TW(5K"ZN^.39W^C:9
MVRZ";\#XJ(6T0U]I70R4YMQRMS:,1!TNM6D/L'=Y?==6";O&+1;7>">^^[JD
M0%YV-+. XS0[SK.";$)1)R%P[KG[H3XZI/(I6[MA'IWW'Y%5 P5?9,]Z#Z0=
M'#V0DOPR^J3LP:/C58P!#1GC[IY"K#2ZX-O;'V3JQO$1Y_2US-_7?+ N8<EX
M;GM3I"3RP&QKJ/FZ[!0+)U/2K\:!B C-%:(<(%\AF2VWY++[84A7%:RM1P?G
M/I$%B.,N)@DZ^A6GSS5UG^C@_5$S(^#T-Y0A1)(.-'(Q:$>=85H<GH_2GC &
M.F;K/VKIW<D&,#X2,]X$ID?"$ R^0DN,"8?SQB[9X[@B"%>6^:5ONA%XFT7B
M]L2/)PPG/C!A<:B@ WMK!F"&^;2VG",0#D:W+AZWL5F\;S,/>\!^ZFQ" #K8
M!4*TO=\F-0]'&TZ9M_?%@ZH:"(G1FJS=!!YL9(1S\G@SC=^+:['&E^=<$0B5
M[IO0ZN2W>>($5\R*3H-1X1+\*.4J-:^0!'ZQQ(!GF5<D_[;"EF,6&*B#R:@,
M EL]L->P9DXU+W/O1)W.2R81-DKA&P"/&F=OG 03$*N,_KMN2.('MX'WDQR:
MC6O<'D9'C%__5)N1;PGKCGWLJJ?M>L+A9+ECA\!QC5JB"8F*+[0F'<8AN$C^
MC43X@4K4H6^VW3@4.]JMB&G0\_9CA;7^1MY-PW3>YKW?&I6FI2K!TP:%9#WH
MH6E.N].D@#PW#"=2<,*M;=)P?T^@6X&-I>TL/+A:_JUML/%&FO#\_4I[7E-J
M'-Q9PP=KV P71+0L;,6;MT".^F75.]@,R#ALEI[6&W6W>O+C^)E]WYE3FU=_
M//K6P/5'@VLWC#>>QH2 77,/V4(3L6NUC&&P/];]X0YL%.R0,WYW*:FC\X.C
MCHJE@RHS2-DF+ Y!<EP/!6WIT'9SD'(.=*"MI)T.3#W?T4\(*:!]N>"<X>15
MZ/8!PD.YY.'NXG:\E>W8Z7%)G:@7^TQO C<! )!@7K;Z72Z%(+^O"N[*I18X
MV>NG7'JG/$E]A6*HI40ZX+'\9[4TQ1Z'V<A@#P$1Q;[1@87GSD@Z\/\1UQ @
MXW)3;S^1KP3WY)PE!6*[RS2[K48TVXD!VWI":GX;B)//J]\+O^MJ:; W%/$5
M2+SSYJWGR_<A<Q\S54X96.E92"*&,H%I) M)C(PM;/0"2%K&:9-!UR_BJ1&I
M?C*OSE_>:/02,.BP-$F5?AQZ4:7MXJ)ME:*@H[;3[:[F4R$=IY__1=C"CI&M
M:+UT8 ^2%2H^K=P*CGJOC\-P0 =4C?49$!>>EXF;W&I9WLNM=NP$EYY!@$02
MVP?.^?6'E')2+=Y_VK\--+YGLQUU#,GJK@DF^;WHD1;BQ[?P3<17E5Q)V&LH
M6?N\6XSM[>,]GV]9/!MU H(8%+OW>V3KO>#VW,.Z<3G8[0?E_K&K 9O:+S-Z
MWMQE6 MF;O#8^"32AOK"%WP4&DDD$')CJC!C9"M2[13B,,D(<^-]**[G>._E
M:S:*+5X75IZ^#'QZ@-=9)MM7<=NS@@"95J=QD0+?+(!9>0Q00]OE+CA!?N,A
M^TQ]8</C'LJ'1+PER]'*^_AK0F)FD6+0:>)SDCO!NJ4,BP+<Z  7Y4"1E1SQ
M(/H.-_HNVK27O=MG[LG V^DA 8]#F\Q)%_ES6<"N#,5\@66ET(N@UEQ^:0H2
M3KQA-C=P6/7IXF!]4TM_'??2_/TTT]E++%#/2,6P7]$211:@=9ZE\%'398+Y
M89??#:@;R[[T$RLH<4LW6_1WF#O_2B30T>C]W8UI5>'UM[H7W?M1V!0D*[R?
M?S>1_KB>,4CY7AR&_!ERK=9;X+]#KKOUR+] KMX)I1Z^<TU=D2<=YI:?W%_@
MPK-0CEDGCOFWYA)5)^"+7/%!=( Q LQ3X<T6L*.@S7^]!L$\[+J[5/!W+ 0P
M?NJ>2HK&5S2!N;<"/<3;[(3>$<2R//P$5\QJ'E^^.N+8.]*XDQ36N#>45;&+
M<2O*+NYW_L3]@[$@FIHN13&QD7U'.G<W;_!F-V]0R=0*]2&*X-6%Q$DI0;@2
M0:DV/G"L7Z"'U>C5FH$TA0$K7J)D&[93W?]FMM/5DYD[IXXY:)LRF>H S,#!
MC;Z_:T7ED899S ;B'_FINWD3':B4:T()N'^H$8_4%"6!6_AZ1M8K%M%V]>X^
M]Y6&9<>%]0XI<5DFL##I+4@P?_E'TTL,/"*=+F28L!CXBD\-'1C@YR/3D(PX
MADK".TNAA;1V-03U5/D+=M3"?_8.LY"O/(B?V)CU%VR4@^RFR)5_IL@?:1;G
MQ4@P,W[W!\G_:R[]3PD:@-1#!\X\(1VC []Y]-&B1]S7=TC,T\J4UUI3NM3H
M:O".N.6_JO(/<R*9C*K(I:9!CL!76X-,(;^D*'Y/TR!Z<M$IU_&C;2B2Q+["
MYMQXI.1'?'O3JG+SF2+7#T9+>]KZ;M4Y,V7DWY7P=#[1 ?YXD+6392NS#C,-
M7IG%CQ/#!\NDD:>@U_I:DL;*W=V<W$[E"%"G4JYTGPYKNWA7@"UA'P!+94#5
MU)!Q,^0$316FC#>/6JNSQ?LT5RL-N%H]_@YRC4&[*0<\:3[)ZR2BTH6'E36O
M)P=3WVIAX4U@%A@7OC)8  ^.+*U3?B6<H=GG'"D[7U*;;#D.'/ZLU\"LLJ=F
MYV]G$9EIK&4,/U&/ZR,+K*&V8MI^T@YX*@:SX3XI30?*>Y<9)J.4$4= :L.:
M=B"<S <3I.8%[X7&ML"/UH%VF;3"'1<8K\F?NZK6[?%.IJPT)LL^@Q-;X)-\
M?M.O@9?J]O-Z=&##G2;S+Q=\L[M@]^\LZKDO%>_V_M^QMKE3O-N9_]ZZ);)X
MEY'_G45)1I?O<NM?UPVB@&@ [PGNQ>#-#$/M!$B!+QE1?V4+]5R_F3F^FO)M
M[7E9E<78=_U=$@T#IF<7DWUV0B  C('Q3]LH+(Q67YAGS'-W3J;OU'\T-P1C
MV->])KN);8(A-<$?LJ/E (&/-H#PVH8,J\A)![[.^]&!?"6%?^!>C FV9WM7
MI%1 _R12&%-EW_+N6I7S[EK5%Y9AD__(FI9Y ^@$:E8>M >\HO^)#O1?Z&'P
M 2,^SHSX=,!8&?%18L3GRO*_JO/?GRWDO 5Y!OH@UR9HC4M<M7U#D1^M,V0X
M>OAAF-S+Z\6VVM@WZK43MP9%YT!G)UB-KHK?&^<0_*1ZDWUP9Q?DQ.%MAES6
M%#M2+M[%?+A.;QK.#O7V3;DVJMAQ?>+K'OZ@JO%UCT*I\+W9\BJ\>QGU^]M6
M8+=3&+8IQ8[@\K-3M/_<*5X_%->YX;_WB9DBX_2?W BAZ<-;4;]S8^K/6, ;
MN1@C>91B_;LA2;*\^3<,B1DDID[;;8H.L+GS;=.P#@5C/4'WWSG5?7Q2>_LA
M5C_8\VOPE]RJ^40:^QU,I4OD=B++(OC("FTPT&OJTRJWGLO[ZJ1D,S>VP$XA
MFPSJ!C>Z]6)7#$!5RONX^XP09YFF$NPT/C>AM"RS]["_80Q^7/6;O;<F=!/C
MOO_$>MRHSW\ND<D#NT8M@+N2K5'1M-/X0@:3L;N"V=6!BAX%I#+/.\QR&KYM
M0$\QK:=\]6MXQ$IBAHZ_D^X B&&5VO25B:$D5:Q7U 7]6K3E\H/7QN["GJZB
MNJZSB0_VK[X7?GOO?-QT)JF:^(F$G0:C:W$,@[G2C-=+\N X2QIL^:%I6GIM
MW+GZVX73N:F$3360].W]$T2Y9JIP [Q"O!G#!%/1%!ZLA HG: A?332OCYB<
M-O[8\4W83&KNVH8F[HWF5O81;0 *:65'E^#:Z@G5[1!V&BO4O)FO@P0O;(7C
M^!E1LS'8]SDAYW9EE87%;Y<_,66O?GM[Y-N>20SY'"Q@</=+QKN $6+O[#M8
MI+/H=WO@P.&R%L_^;J$5MOBN:]E[3)\^.1_S0YD84%=%@I.=:&-GH;&W(IHL
M3U8/#TU>/9IE*&O)%B:^=KKGJ/B+CL6!DN!&S8.DEXQIL7<\&8-]7>N"3118
MVJG\_E"HL%1'",V:MB:2)=E_@]4Q8HI](L=&2',;"(XT_QOP &_*8K!Y!+S_
MP:[0>W26 =#%B7_D_+_XC3^7(\(X5"N5&<ORJ,X85V]9@*S"3^2.(U9\!P72
MW4^0/^KXG5!1^79119U@;<=)R$F?/@S20[W/UD&G/=]?Q/6T-P][,E5+^,*>
M^Z,G3IS8ZS@Z5TWA7)[Z'DVQQ27R0*N;[)B0^'ID9-X!F/9T^P@?JV*W_*-#
MBM6780.L0#++!--'M&$AO%$)>924B$TH#%".1X(F]7$:AE>JZS^0TG::(8UP
M1RR;V9VW6I=OW=]@2IG=;+A\4;.,U$^^2(),^8=!6FH::H;OY@W+5 ;8]]<5
MO8[!N9C>7!HX:>-I=$D5" NS"_=Z@[:=L!F_Y,<VREU@!G5X<K[%PDDKI&O&
M^SP:!8)/O<C=2W$(FL9PDT:;)EF0) @V6K';%FPTY%E5> !GO2BVYU#+A[AW
MICIJU8$I\3^XB.T4#C+6N0*?THR4[E<WQ\]M-DV>3UB26X5P?5MJ-S+DZ- Z
MYIU<_@U@6;N]#]/WV0)@+_W?R:H?QCCS%A3:P894B*/R8U%A%!DLBA7J.>P2
M9DLH-3<Z[*W_R2FL\_8Q+1;C[.Q]=^._,A362@!95Y=L##LTH.[M.SO@QY-F
M+7.Y2TE&P/Q<ME)3@$1#"=N&\NV4N-Q,E&<BVK]U4HT4@ZJ0:_22HQWOL9.3
M:K':>A^%'?1X+D\(R&TD?_B<&'K1Z<IA8?O@6)(R%A4)+H]L,#Q ,MMLK7&*
M2-G;U+&T$S]PN7KG<6W!O0,JWUI433I/F1RYGPE@:8JT?@B'HA=:22X4M$^:
M<E9=W^FE<I1B/*0U)]"JD7O6 GLE<N[;C:3C[<+'CZ@H?@MN8RC?\+[5<_B\
M::L1A6>5(*X%=/:.V*?7UI]<7];&NHG)ZZE9VAH:AWWR5_J6FULG1?2*Q.#-
M45$[$:@WS:_1I,2&6X:%&BNA(O<BVI1,G57 A'FU!^2RQ>0^DE@A R./4DZ2
MUDNA@58>;*3<UIH77Q3[WLLT79ZT.#8I8G"YB^N;8-FC-OG\[086#,-BKQP:
M)28P2*D'!Z96OZ*=8%@Z.O"*06J?W0OH *&KDS&I[BZB7R=BO1(^\$TB=@52
ME3O!Q3:4;$Z6'P^J\;MNF@P7E2]?OVW]&[[VG0HG$_%/?-> "?QYZ>[=2__D
MNU]RW3]7Q_ L;5X_;D0V))(Y/.%;!A4_F>8/_ HP2$6;\R83H[#\C16:7Y3O
MGWB?(5CV29.T\.ZMN0?\0-RPB[45_>H.!8OIYT@/Z< J;F1NR4G']\-!P_6G
MGWHG\N/;]_D+4-,A*1C\S=DO6Y#=S9TB6VNOQR(.86#JGS[@U?LX.MWVO^&)
M;_16]I+?T-U_5:^!Z1'+9.Y[PR;#Q^"#FKS2$!99Z2H(^]+QC,(1#Z^T[76G
M6W&=\ME.NOS[]VQNA!H$?4!IT(&IS/N+-9%MJ,0+F&8IM1[PE.WL[/N%\F\Z
MA&91=-&F%5>PR>V44*:#_<QQ /CR7Q8K$8F4(/(MF(\7%^R:YGZ2A@LHC+)7
M<,U/CM?&YJM^:?Z=5>&Q,W%G(!/($=&G\?&Y6:[D/2@PV .%UFT#\=!.V01W
MHYAE#%[BX@V$66(4ZU+#]*MNJW^->W;JHJ[0W>QI:+S6U:\W?WY^R"L>;;[*
MPY#L\*,*@0'297ZN%ITNY[X1-X4KO=L,]C^H.7LX)"DL)!._'I-;U=X2F!NO
MJ4@*PGLU6!G&.N'%,H0*</Q4EYM0KAG?R0]I2V$9U[:<5;X)'%6:K8^=0CV"
MB9*E82 \I!FS.JYV57J:^Y[-'9X#S)B)CCF]:U)"EC,/3NV_VB& 0YI1LPH,
M#]#&,!],^'J6+IV+&3?J:9Z*A<BZ*6]2))-;^RZROF O13FC$M NJZ*,"^8>
M5:C5&4PQC@YO#>N<4V30DY%%]6U/IJ?8=\IGC$.RS0O-Y_U7#F%!T3N1%([@
M.?:(A]OI$75>Q>X\/'Q"124O EV%K3\FWRW1ECB5)A4.J@6??P ^.T 'PI49
MPXF-(>E7?UIPP)X.S)H"?T,4!<-W\[&,L<E6BZO;I@./_^0ZMO8\.KAK41BS
M2 R%P_QN4;K^;%%^L13K.W]8S3N)+*\>6GDKO8:]'FL=A3YC_\3)EM?^:<)4
MJ#:,BW'SO0T$T>=IA5.)[+"'A"/1>(A1C3('Z=+=EN3\N^0<SNR._0.!*XU+
M7?,BU!_:P&]0X<8:PV84RP*2]XN'=EI\OI6VDQN@.L9YA^N2>/(]5?%D;W?/
M/Z^2U_GCVE=#\%Y3_E'8+^H>TQ/*VB/Y!S'VX](;+;Q.-V*/*S]EG>$9?W()
M<0O_/:H2P;V09M4;_0:]A-9?^<W=??Q,FH6S5G_JTR>Z X\47/]=0XWB@]_U
MXE]B"))UN&N92RN(:QMT>#F8:=1^0%T.CT-_7RG_A@YZ*Z$_G_[$&<.?X?WB
M??;Q<26&_$O+0RJ3F A*M@Y$/*D*V\<&Q9/(V.VUL/VUJJ$S-E:NZ!<9)\G2
MLOF('J%YCWRVN&.?#@<Y^>#J3P^VC&@*9MV,T/#<0;MWNW-[35YGNQ$K_&;+
M6/HV':B38+:*Z<07QFPE"I!\#$>W#E\6--<9.LV!GAS_L# 7M^6DT>I^D^4S
M'XK"H4;T&*VRGC"@ ]AN6\AD[W=E#F1]T5JR[F^?VWDT]$1&_9W()V$,K0:*
MK)%!/:ZK/]_ %WMGDB^,?&V%&KI82-;2^]B= 0_<]'A20VQ303CF/5*/G>99
M2<''3A.K'$I(WQNY+]!*'(N3[#*<JY_E)9L*8GWE3TH'ZW9M0!$&7WP%E9O0
MH@F)K[Z.+V::/C[CX>[DQIL@<?I6^)5;#0  < 7_AU,BB/#@@_#&B\ASP?V:
M7#4$AMP<2Z0=/\P]LKWUXRT<"Z[X,'XAWUO>(W.O0WC:^2?G-OTZ5+;82:YP
MM#\MGB$LY<W2&0IXX4\/5/WQ,!V(B*06PA?Z49NB;G"*YVZN!&GZQZ.)OUYN
ML0S>O .)J72O%[8>O+L=+[9QGJLGG') G>/E$H(_M%0CJD1)20GME%K__'F=
M65H:H?3L>$.(<#2GO:G)/48D6("#/WQH?*"?M*?#H+W47=JK 6-?,K0N9D?!
MB])I!:$#_"_8"]3UL8*'VFKN+$Z>ZO==#32T-+KO5H1N]SF:=.064478.^=2
MVZ5%J^$-!$4!O*I&!W3BZ4"&U'4Z,.T+;]:B#:*V7#$_DBM1-.6+(--;NVLV
M?WU4]]?SF+9-N?[3U[.\D+N:1(AMF#R#%XQLD1MKIAWMX6G-$7N';[F HH@K
M^=-N?#<P-4QE$\TZ^%Y9[=)8?$/21=#M?[T]YQ12BOH8R4R:;T$71OFM1YKQ
MY505V]1/S,Y\5^:?2_U:<:[EF4!.&. +'$3'$K5(8)9F,FBO>,A*>M.'"V]&
M9;8:%<:%ZUEOWCA"'4.W.*C,%P3NXV2:S^5F\ LJ$B18MH(CK(=M]7$$Q8*=
M,]?DQ1X+>!XX_62ID%GRR)']NEPC).,F*[D0=36'%R3_:Q7]"M:<&ZNETJ<L
M7D9[ZQTL!DZ(I"SIB:=8#=UD@C $1SW<=9TL/2E,!\8?[A0C3:DA#VF[>J-N
M5V]L,8+Y7RM,SDPS. +)2V(,'=9YBLB."S&7(ES34QVET+<5_1M9@XI<%_.:
M>+\V7H\TZ\K>..SGMU'(D(.D,RS-[*'!X"%U/K17-,RIS$T*90YALQ!M>>@]
MQ;UI.W/I"6N'S2/O WN/V6WB(W'?PX,O0%EN$-+#_!2'%=2VU430MZ;]5* S
M6ETU3RZQ+,FSBC"__RD6!*GO?&64;:G/:&*R!87HI4->6/)RE-D2UU-MR899
M1]L&;,C,L0[$;PA):@EX9@PI"?]:\0:^J/:%)=\5K92+797%& R4>E1.:$X\
MT')S.=C*>7WT8 S O""Y>G+AC.M?5,DS10A);+XAWJ75"A4MJZY1_+:ZQ*;'
M/R!@/RJ(HUODK>.3Y^\32GT24K>HG$RX0J(ZR8[&A8=$.@W(>2J@6)8PXP\O
M]!7;=(HH![MDU.>[R)S\%KQ\7,V!$^9.C4<>I7W).5DUJNZ%51SR>W:*K#Q>
MYN4I/9LF,-_]I&EQ3N[U2M+7N$QBL02S7+,0[P",![NJ=OE+)3E(2G?PA;7[
M=2F3 P+GWC05AU@]9?3_;FH"-3-:9_FGS(3%*&;[9WZ?IA_XU_G]GUD0<SJ0
M B%X_9X%<?I3%@3^0Y$.</_9?)J9_#G/8YY*&\H]@2$^)#%-@Z/.CKU^Z??*
M2LK:^GJNS'SRE0@9TOSM@*,?6%58DD8>:1C%4#H([*UT (U@G&"/!2=.*A"(
MX=-RK.X<EGU%)%D93=[@/G=O9IWR:^5%DYPA3]K9+FFZ[AU=# I?L4J-K_\F
M\LPEWNERE\FJ?=*3 $'7/:V,2IRPDZ@843Q\9 YS:6BUTL.4^$.Y^H'SF@KM
MMO6Y \(3J1V@LXVJ\[R:HG"Y-BEP+)]X6&2+X9$ZJX18> D_BG3E&:?2)OH*
MA]=XP&%BGD^.TI$CT)V#=24VC# 4X"'4:/0\+6W1A.D;2<V L#_CU0\AT9$R
MQ57=SP[$6AGU,;'>LTC+- -=];7Y! W_/\D6L)AOGP!,BII) P=_>0"I+ PI
M&-W&'%T:7.*3+0IZ5;;EOQ-8\33A&_)* %MV$7"L\OVS!D0Q?"IMDH6@&X)R
M^IA'$$V=2_%ZLZS\,"'^-63M.-I"KZ+[<EG'MV7IL)..5]D?[O1NWJ@8LMM?
M6QFZ^ (N+Y:IZ,,/#_!6T<25_9R;_V:!/,54Z;:!(T#<FFJD5\W!DM2GZL;3
M(![HPR5WL6%?]]HL]Y)NUWQ7W$>GT+-VXB;[3GP_G _<AY0H_AB^3^"8%E\Q
M)JSC9GOF&ZD^N-''=7YOD?6%RS20GF/F!&N3]34CU7OE+Z\.@YR5SMDVO@-4
M$&.;1#+)&L^B,W17'4Q6@68U"!W[4)\P;CM2=GU2HY(<^J8F6?N(I7^V,%)G
M19+R%5$ =NO1V49*47@)_B$T,:A_4R;QDTO RX4G=] VZ*AAHP7T9SN%N/BH
M/-[.I'>O'H9>NLW>)21ER$ YSKM()8I)'>E\,308@U.*=ILJ4VN\?$!HS6UL
M2/:ERKD2&E8XZ_@%'3#LF9I)52"#5/O"^1"/*""R.LE=EQ2>3[J.,PD6@$>F
MN0>][H96=RL65/K+-\_.M!#X_>Z?^K$?S[O!!'110VCB=HD<BZ!#"HAX.TY"
M=43=N4)]MH=.D9&R9;*R>5%/CVOYR77*YS]V?.VM*N #"1IM ^]'<I <&B"5
M[2$P($>U(FT:"PD32;R*;UKLVS?\.1UI48<*2.S 9H"'Q7 %&U?G_<>&_O(.
MQJ\Y((;R_AO9Y(L@>#^#RG:GN#%-WZ$5_'.*'X[_<YKRKQZ;&,5L_1MO?:"J
M1PW'NFG=RK\_1HO@I!8&'W3/Y=-M@J]<+],<I1T#1_$9QJRC*D5\-V4\8)AS
M_XNV]XQJ,NRV18,@*!WI-2@(*DWI/5AH(J ((C4* D)$1%J 0)#>$5!04")-
M0(1([PF]B$KO2 D"TA.$\$+:P>_;>]]]=KEGGW''S>^4,?*L=ZXYUYIK/><F
MD]Z:OU&-GBYBDKU /_U?54'^?V@<-9#F8S"\H\TN#W$;6-;?!XZR7R)G;#:J
M[M\X&!_B7.@160[(2Y6->"P>2L V^U2%!#-FNW@'^%UJ\_02-I$M?\;%XQ)'
M! F1#[UFCMD&-JD94DZV  +QUJ9CNJ<?IYNO.JZK+:O(-,$Y=EP33S,.\IS1
MB]=K3JP=_\ Q."V3"*@1[AH"/_'8CE#-041;X89_@A_/\Y0<J3[KI*:GAO?N
M)BL6\4X-TNGSBOSI@;&FFY[K8O5P^.7/_.G#HS1SO9.@T.>/LV*ZH).P)6BW
M-PQ_UQ&HR(63;-/MA_T&."2^S12XBUQ];J'!'*7X,N#DLDW8 W+P/)F[:,$P
M/I2>S-A<37C]V?9>"T[TZ:ICIN&+%Z8:+D9##P4D3S!<C658\M>,<.RC@=A.
MXZNH\= (&@@? J.!>F2"VU%<B(M+=0WF;'"4 8'%[J12^>MB?5\GMO=-S;5:
M/A&)^VU[']CC_YH58K$>V5N.)&)JTX@$P3!>N4QUHCW(ZMN](.E8=/4D8LI+
M127M6L8? \&W#V.?/C#C9 9*B6E (:[>RP\%@D-M"-$UFK^KH!M*'CFJ8RMU
MX:,EK!^E&Z=_A:L_^!I0//W<FXC:.LXPTB:ER,FW>330FC\:*AHZC&6JR:B?
MT#T+-[>.,&ORY(.).OU8.VW2=#NR=IBN8]$ZXL5N26_; $Y]<[B,_5+9M?)C
MPI_?+^9>[*/>/G$G6 >!AJWY$%G%[,SJV"S*;D:Z:/6_W>T:>'W3N@KF5_2^
M=KS'!'\=EQ*O'5 "C^APE"$P)5>;\_\^<^EG&VSIIWON:^'M1E=\ZDQB#O/+
MP%92!)&/OVH-Q;V"G4!<+3?VQ#W>(_F4;V1F9::>6,NX&YFR=0;SK<]'Z4R]
M7,-5R7,G >2B6\<QW[D[#$1T0SG)5A^_XQR"+/D#=K_6$BLNK3YY/%"GT\3.
M U+O([D1Z<:>U RPD.]@1M!R^RP7FYU8 U0K/Z?64WN&NZU>O0QD\%YS("NE
ME"4>ITBK5[])NI79,3J+W_N_$5NV0CQ_>7NS,V?P2Q5^OWFY=&!(WSQS?GEE
M>0,&+20/E!3GQ5,0Y"__G[J'?]43EIQ% R7\BWR2N?0O\DF&!NI# W7_T$_G
M*O]%/\ED ZGX@QL >D$GH(TJ44-RC?L\W5(XJK?E^5EW-^=;$2N'$]V6P_EC
MH$+'0!8R$Q7VV"2Z44+:=Y;0451PHTF94AO_T),7JF[]R<;:X]9ZI^UEW7<S
M6*J%2 6@#Z#+3""+(;V35Y%(S\+)6<<Y<]&RPFI/Y9&O;1;*=S)<I<- #.EW
M)[0(X+8A\G4@$)?"_/T9T1O6Z##^YH KL=I$64[P8>^OIP-WAL-T55!49NQB
M;J!N#0Q?VF.-91%O)(E@=.([*:G09_9;,G6".JPOCA -ZN@\;L<1\EW2#83F
MN&]V_<Y>BV'K=-?/PE'IB\KF 065FJAK!>!NC, 7?-&6X>+ U/@&T2%FH29I
MN;I$]2U_,K_%U0>RO][T#O-VJR$VKY\1+MKN9P\MPV=&V"TPQ6+X@>=JZ?;9
M[4B6FC<LXF?+?X5[RFA=E19^:\;TY,5TF&Y.'E926W01&0L6A;@B!:@C1Z@M
M)IP.1[>M#193->Q+6N)[[R0W^;KJ<<3#6TT\EQ+I5PQ?_GI'3:!^17+O>R7.
M5Z'#FMW0>N+C?IY7SC<Q9_,N,^0;E4YJ."SXLUZ@'[\DTW3?:\NUMC[.K>ZM
MD,8Y[]=^$@Q<LYP>MH")/:4*HTVV) PD/P#H\$W7"6H1S?PA4MG!)1MUK%*C
M3R6DOYFX<.M'A!F!-;J'G]G+@0(SMZX2JHYYGC?A[BU\3#2&QQ27/<\*NZ@0
MA^HX<E)I[)3;II_FFU5KK!4IH3-,:ZVU?$&LVVP)QF=V0SC*R-[X=*,O([Y)
MGM>^>99%<C,E?KER"]O>:\+JNRK^\BHDXSCM8>3(9OC]_8%DA"#^HY?@8XPB
M83-KZT7\AI+=>O@< 6S^/CSC6=Y"KT#4;+%=^"9W"25.>6?Z_1XZ-H<1L/D$
MMV[G J"..4NV0ITF:J@2]5/$5,ZT2WD4%/B"U0^CY\)A').:,JL#DRG$M%&L
M>TJDFF9=K&^O+Y+OMVW!M%@-S)-:,-O)E=!]6E)&!LWP[O*#TR"A(_;_=WLZ
M>3,Q= 1;8]V]DU"Z"([_@I ]/GYM?4C,D[WE:@[)N3LX"]6G9T>>9+^-I:SP
M/+#^_3[4!@$#O-%D&4H!1AR> 9FA[\"RU0QPS;5\F]9BY#;TN)]MM"UQMR9+
M_>:YIO*M%G8V4(@G28G,"JSB^WL"CHHZYY/ ^(IJP>HIN0_#U)Y?A]92]]^Z
M#E1*)J00-PHH'T*Y@1$[0EVXKB19-5L_L]N1)WEWT-WQG.+Y]Y3"P<2;F$</
MJBW0KPH%3F@\F+4.IW;,J4S40),:,])+J2,98&$)7;'Z1@=NLTH_.Z<ZU7YB
M=.;CVP:[+Y325[@3Z:%0!!0O.\^CRPOO:",>O<N2/2*F^WWL*>XN3&HRX18/
M^1#>^K1/\/@E^IB^0U<(KH:#=@ZD. H#"00]0*MC;=%!]:A??[!9H=@XV%N[
M+O1^CEW<_4N;EE'^Y\*?=Z9=&1BU(D W__SUB9F'@:MOB&D."W>,SXDF#UMD
MW#;T.[_'SVVGSS-84&EDV2J9;,SY>H[A<XO,UDW0*AE&H.^ L.WUJH!Y8=,!
M,9^EZTV,GOK)O'HA^7;70D76X/[6$[H!IN%&9O*[8Y3+).L >=I6B_,B\-6N
M>R/P!\"XJ'0[E7]D-':K[%0 Z59/F*N7+ =.7<?P)_BS+]TJ#<0)><P1C6)6
MB55&"<+_=%#Y1U?#'/3=/JU?L?N*SW Y<]*)?;AW24>Q:+C1_"2PVC'/U:SC
MA8;;V580&!.>_?BR+N2[H:S(Z_29OD1\\073K'4;1$B;EV"[05PEH#MES,.>
M(>[BRU,7X<KOY51*^X.#W9GZE-,ZSUO_.<_^5.)4OKBJF1HH-!)0(]DBI)HI
MKYV !K9F71#^_*L<LUP7MKB'1?;*&USF\C]/>P[?C%1$G]/K9']&M^?W7Y!*
MQ]+_;$W;1?_7[4:.OQD$M0L3N_BO&>3)/WP\U%,E?ZWO.-0_DDWTWV3SW\]"
M-"@(DQWP"AT:GN<(R$0R9-']Z3$UF].!W0T?^K@*%D^-7D3=W(#MQCD!$MZD
MAZ%#8/R8A?A8QJ%AC$'EA(P7)?//8:AA.CG4.C69_+YYYP/'&$QF)N3F#^$F
M8UQCS7N&5'.6&&.>Q.A[(IR&WG<G.E%XX_02U!2I\X7M83.G]EV$]@4_D4/4
M@\,@9-6*UQHYU"6D[M^:XB(T4#(9N3@0+<;?1  GJ&2;TE^OOB"-Q;R4-'((
MOR ]6@72K:ER#F8L=/$*@%T:\/06ZN<I&1J*OBK6R05]@\7?0T8BN50&6(',
MGKESA%<P_,[UYB]U^('(S7P)W\H>(7L'^UJ0K,BW8ETGWOH++$P4$<"-!I)<
M:L<2F6MHH"$9/0$L3Z@N0@NX*/4>G-S\L!!P-+UA-)Y0;/KE&_?3W?R9(*I?
M/GX -Q&!47Q\=\/Q%($W):ZZ6-[VAUV+KNGO]$NEKZ1'96.1"]<P^L>L7I#L
M2/#:JEA "<#O+N:@EJ"L<+N.]*XGT]NYO#41CJ8KGPNK&MY$PMO+!YK5W%A2
MU[%5'%NFB]!8Z$F$,Z[,I.,.0@759JV6"D<;12NHR#ZJ34$,*[P*ZU4]NW#Q
M2:[CL].@([/_6*!"=@S10*X*1Q>QAWICD$.A2N1"MN[%8;+/HE<R1G)('C.3
MMP'F\_MYK7NU_S'Y]WD3&XF0<GIYJQ<=((- T"#3Y/_-8#:=^?W:JI9AA;)]
MSJ2B?OJ>9Y+J=P4MP-)?NF%_><I[0D<[!(21A-LMB@B--Y$T.H*#/;3-?7*+
MILLV"Z2WA-EIH$:K-U7^L\:[<>*AD_"=ZU@")*(F2>)6<]7(CE=9SI2\'XMA
MTPOZI+)&R0PIKU=?</IMXJN)X.]LD$7IK8=XZ0X?ZC==[CJ\6ZSV69R)PUT2
MI// )AHGP_1X?.WK6ZR_Y<]RRQX9>HDG\CR<= =NFR\* ,/KE+>A(E, WY&G
M>7M_03<Q,_-*[/*;"@49H["7R8_<U2Y(N_?V=<,F87T0%V1X(VJ3@#?4 Y E
M,']-8&ALF*54^+0<8X^SA$Q,EL/6BG8,?/+4)55YC?U&T,53K*?$.>'BPT-Z
MX+=@8>1C<!Q*,/2RXV/H2:H88-JLM>#%WU4H55AV@WX]J-)0?5>/->R&_ZTK
MFXD. 2#=1DH\57?R^"Q/"7?V+_8C6>#17ZD.8/L1N7SF5,=K/.^+!"_=TW_
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MD&5]!+D"GVIR94CGWKIP#G,, >&/$$+U^)5\@G./[J51&J@.$>+]V3!W=MY
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MG2*KX4>1TU5MG(3X]1W<61_1AA/J'6>^IK#,"D)7*0L"]"H'^_\V;<O[/W/
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M,:WY\9/>&'!VSK._I?VQGZ7XI>9)\!40N?7!/GKP[^#Y:P@,.4-J1U49-'R
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M8?Y':P_=?QGX=#^HQG+OJ76C\4^I'=%@5/Y$AR7:+#NZ---UNLK=9FUR$$O
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M(B4*N,,.Y@C.I*Q#^E(]7X_[AC5I]M8-.*VV."ZG_BF-]PYN[](G!XZG%?T
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MQ2E-;BX9LR]=+K.@##B<1W'[UP7)AHH)JAGR'FQCN(2DR=89AF2 UHP1J?6
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M\6QW7W0W142ZDFQBJ]KA7>PD!O<=7+K(62FQ*\7\LQHU@_^N47OT#VO4H#N
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MNI1Z?Z._J,(ARRF0@?G%;9]\A8J2BL0*%^Z6BB5H3D7/F.IHD ?YZSR4K>B
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M(:K\-7HQ4P:I3H7EZ!0]?<_PZ;L]T.(F0W#2B:_3.WE2871>]E.+$3*/S!^
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MOGM7;[9A'9X7ILPAK$/R$;4$,98RW9N[IIR7_ "S(V2D\TU.@@$^2MDO?8_
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M.\:B\7W@%75>J.*%"JZ.375'-F-J7?JYZ^+QPBS$,/]S_"Z%,A_OX10U-;C
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MF,;WHVND(S3#;(+=S>W5VZ0 _*(JQ5$(-_: ++@W2<(:Q41)Z;X>$#@1^8C
M2I3>- 8M&#[<[6Q$?EWHW""\:0UJU5@A32!;5F/(JDW64/ASK:M?Q.\WZPFO
MK;5L)^Y;O22V#3(!*>*U@X)$EF,;=XV 5^W KU9;J\A8G65@+>I%- <&1 ;^
M/_\NOO$]T44F-\TT%GP^L'JY]GAG<G3I1=+=*PM2=!(:QUKI\(!B5O+DNK-V
MS!+YU^GT ]#M4EE6^$B6HH;MK(VQR0)H_.XUL;!$Q;$6(VU10!2O*32L;W5Q
M?  I&(SD'2CU$2 5KMLPU,!]\?(N+5;6=D!?F7?..+:-Q[5=+&:[[=R_92\
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M)+4O*!!@6X3/L:5HW#3_;\CS;8MTYWS1$M@&YQ<OP1?Z;TQZ!('W\?%D"YE
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M*2']6-.*>6P&OX6-..B*I"Z&MJ]G6%UO^C19UZ_ ^B)?UO I5RBQI5?SO<Z
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MW+TD\.EZ)G*(S($XHV?!PD? 17^<#]X9X]@7*I W/O2&L*RHU*6H]$:?TS=
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MC$=V=N4UX[,X"J+\'S@CU,8$HYG@7PJ%F$T30:6+>P3#PHK%BN8NO9>=CS(
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M+RRM]V03+(@JS=B5>*\0C[(5MV57,NBG^O[\ZR3M/57>T*^[GX<CYBH=^R\
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M*7OOZ\B310C8K0F_FMM>F<;:Z?%*/1ZQF9<+;,S$5Y+WUY5 -<]P[NA8EW/
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MEQS9>G<QN1!$%Z*\W35MISPHC P)+38-$'GZ%U4;46HN>=-5LQSN7:0BWB6
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M_@HHW<3R](7@L(<Q)6]G'2^VV@9NGA;D^,0F)FWDU[AQUYIC0!*]J;P,9D-
M;<E\42A#N(L@8%,FT4F>6_O@XFS?;]!N(5*U>SY;WH R6,L1Y!DD!&5<.'BB
M?>9(70R.$DN3=<#Q,HJ 7YUB0@C-WG;?=3@H4$W6M5SCA1HTE[7=742!;U+8
MFF/81?H@/:07H"S!4@K. >5EB-'> BF:TVUY@J/C["?6Z4!HI2W9]/0<4KM*
M66.7ZR4?1J+JE3K5<*R MMR-B'5\83_6H3QZHEG7EOICVH+-_OFYNAW?K3QN
M\?=1=FSV#S[^FF9,_ZD6)?R0BF_.Q)]+OM1W <1:Y%9T+S9V5&ZZTIKCDZ/G
MIC.%=[?+%L>'M*%=@1-P^//!BYOEVL[JQ@T3.]6^,:SV'AVG[;RHS'&78P8?
MV?^N*#AQD"#_!<M"YL/?!N;]H$27)D)+NZ7<D.0SS?;$IK#53[+GV>K^R!E<
M>V14_G[?CMJDZM>L=VZNL2=&_&H=FZ:9\4FQBU#02UZ$T5,F5VQS#X05THSS
MJCF&O,,@_()\T(:.R-$4-]NQAZ"+N=A1/<1<L__\UZ""MQ^O5W2AX2%!0?X\
MPYK?H"(.)',6PZME'MP<9\UD4ZD77O-I FQD=89P*%T%_6^(I>\AJ/O^\D6+
MWD7*3RJZ+K)FZ!!D2MO!>6+V&4ZKVZEVL4A/(. U8_@0Q +QL?1TI%2EUB,M
MFJ=V-A_ZC1OHI8=5R2?Y%LV?V9T+3AF,"J-]5-Y<7T5"R:O=*".,)::'(3:&
M-55[KE[H^K>I4&3"T;QK42#K9M\?N]RN/Z8E(.1N$6J88->_^'5WR2^EVMFG
M0(P"3@CFX;HUWIAV,56OS69/-Y/>!4V-X3R+CQW @ZYL0=Q&)1&C/1U\'0".
M4G\;R"H"'+<O7AN]4C]V<JQJM3U#YL8^NX1$B?O]=M;H@F=L^$@+$Q#R-T6/
M>G>R,2-5#"S,D$0:MP%NRY&7>[6W7#S&29.;C68Y7FGOFK-R]A/?OS^A>\E&
MIKT1XGD(FO7K7UIH)<'$X LGVX$XBES/#/^W]86S4[Y%\=<T>ERO-B<9V<L=
M_\Q<3BM6N_X^>EO;FJ-O'T*V2KNL'B4# 93?T:VS%XD+K89::X_%'+F#K-YL
M=:1OFVBI#,R<3!:1HN;.OWQY[^]J/V2V0#VY0^4+,H18(P)#&@"8UW,CWJ5
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MGJX8 P8L0I1;5*X574CQP_C*D2(ZZ_0YO"84[OHIU/YJ/H7E($VG5*$^H<X
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M&\:EC@TAO8@\O6C3J$MHL,W$^EGE[_.=\HTYSS#&J3D4VW#EV':(H*;S=WK
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M6^<_@XE<&?R=:FLOPO(F"/"_J<MHW,:"X'V1NH"^ZSB#NJG'0BU)H--.$3O
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M'E7^^)>*G_].<'2]\6.%H)(0Q"@I;7_OQ^(>1\*ID6F@V4>*I;K'FYW.W*@
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M/RN//'*"-3.G^>5<^('OP,$:HC\DBI/U_S6GM/]<Z)S/_@=02P,$%     @
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M7[?Y=BG.JLSN(B\>#<+]Y!?SZ)TUMKY(^+,_.@PC-S\V4Z$$+$P3--0S>V6
M+)PO2A'#;8;/DH^>_D:#TAG;[UD\C5K'-?<+ER[B]##>Q3D5[N.00KL8TYFG
M[H&J^B?7,\0W?=LF/WOIF_K_V$C]/%V_![!)>-G[+#;#Q/I5=9AM'J[_?]]<
M435_"_%'Z#M\7AE\;C<-+#JF ).8:\ '2 )PT-/?P[^XZV)-F&NZL(T,.A ?
M74&X[0=M<FRR1!GZA(5\:O*ZFQ]6OIVW!#_2:,%_/ E;82)T.]<E[I<&2NY-
M+TUEU@X*^!^U/3^X>2I!HM%4=0_H1?)Q0+6G$*[JSY#AN:4AJQ>JJL*)Q[TN
M5S\.//I]E"ZH][;SKO-%4MO'.-S.1%L@RI%*<^JENF*/RK=/!1Y@S$7Q@M,P
M2_TL.W[7H],Y2>.1Q_XKC$W?,O/XGU\O3=D]SS42[V0)3E;(*Z\V!BF1)SSO
M-%#B$ SB39=*:Y\]*4ITB4_F?Y,V#Z/=W&Z,AZ\W$"8O9\QT#WZ<L=$!P_A&
MM]E@^+!J^(]Y2/+$F<\+&N7Q R^;J.J+BRN"?AM^YHFK"1EYZB7*6*IVNRK!
M#1A<NXC?L\ Z<T-2C4:M?]MYL-&5_^:0O@%ZQ5R)D+U!W>WY]%&N<MEEO9^W
MQA=3O:2']&7US.5,^JO<02JYU/BYL/BGHAXO11<1CJTTBZ]-)X1*%X,U 85)
MDY^$EM8\&!0,J*+^*L%_ED^.RVSI[TWFW,(L+"Y#I+N=!')G)"U$+ 5]^1?2
M_5LYM9@EV2D[GC.D#C>V -4:^260&*QBGM-X!4X2%F@5O:D_^?E0LL(M5370
MEH&*)X(IHEGP49*?\X<6NAY?5HB-<_OL2V=F3Q6-QE >GWIQFKNV4L]HD;_5
MWG;F!(BZI/IKBJ283!&$ (3]Y%Z%/!_+3C!6H=$73EX_4RB7HNV___.HH):^
MYDYKM=^@5,_'-.V"Q5;X=(50PAN7H0(BJ 1N>;R"W(R1]^;#_@&(H'!XT?+<
MO(<39X:]>$Y.<)+J%W.OBE\R("6*US8W>,6[#G"*55 3(NBU%X3*$ @L7O:T
ML8._%>:].?'R]BR;Q+)KI^YE\%,Z6PUO4J*.87=(?K\)G&(4MD_WTJ"ZF*>S
MN=H+^ )C_ZTOA[:O?^U+?WI3EMI^_3(OJ-W$4/4ZTY4TY74M"\^HR<L/O<DU
MYB?8ZZ9K#5"[/+(EG9M\D#V#1Y 8L5$$/GL&[RTYYRL/I9ZP@TW":S=BJAR*
M9GMX[OS(-$!1R%YW8V3GIQ3T.TTZ:0*C^>'Q(IT:Y#ML"RO=*XN0E673X _/
MFGIJ&-7Z.),V2#\+\I/NEJE2 F%&P"M4(EW/*:_@)-2@?(O WQ0BF&-3WY$A
MWFQW]W["I#B%4*Q0K-KZ1J(JBB).+LS;?[F[)[O]/>=V^G1!0T>&_!3)4LH+
M4A)1_!H>A\>>R*6S9N 1JHEKENZ+"%3%(W,=EID0+1UF,Y++DZ(8*"$8KR!7
M\#$G!WBFXK]KS7_N>=#_/P*"> T@0P0)Q?Q 8'F_$T$3;[XI%->T-TWZWFBM
MR[6W;PUAM7T6-:3F4R(VU/U."_1:Y4G.-$?O?#&LR'.9O!%S@&-N=6IHG@X,
MEY=H$^+9[BW83MV:=/K.<"-BE$G\C>HI?87&ZB;'-QM4G>(E_^]4;GLDI<'>
MC\[^X1G4;8+>'X1-- RKUYPU2HHRJE7>R-QTM7B@U[F:-[:3%]MQNQWS5.-6
M$\:I&1R;#]*I-/HZ,EL=4:0['^_+3I9$IQW76(Y[^O>G9EZ!XI*6_;R"4Q4G
MZGD^C6W3^T)).SX*9V4_M=<\UH+\ZD)MI*M#/>L1I%.0 7EP, JQ1M!;6&DT
M?;OZ'=_>P=S1".%'$[+PR7ZWF]+HN]D6EXH#TJ*&JD8@2-U0FXKG<-H.$3TB
MB%Q^JLU&**,X]UJX_*MIP=]>Q;4*'J6^7/BEKDW/,\WH,PY,0MI9\E<($62-
M>18OM^?;EWF>G)B]A&(2KOXZ*I%)+[!_.Z0WON"=K:LI5RSW['PVVUX*6K53
M928&Y4NW!69YVH$^B=0K!+0M9\G[(MU?>"_3#+CF&C Q#&"B24E,&2)[[Y4.
MR1AX%B66/KEI\:5$T74DEPA"TSUL"F=SQ']H<W;U1$\<H!9MH?>FX0TX^<+M
M8 4V#1>GGRY942UU:>1ZD>N=[-WP82EY#4[@PA$CO=>-5 6S0E7Y:$^&3<E^
MV_=[G:_;5<RR;E@]3TC]3,90XYP^Z&.@[@^7\R+<ADSJ84R:43QL/>>-,?+&
M'BBCG*TZHRTOW$:PE-;A'*.BS U&OX?FP$[/.Z "* #3;Y>B7&Y]V!$/$VT[
MNM8)5PW"]S#>^7ADM:MXY_S01%*R<K%DB B*+<$$=[=411&$(1G]#R>EY>)_
MP>40;I=*>3JW_Y#+$_1B2(NBZ4;<NKA]#T%R5LV[7*,4)?G,;+9>T4JW?6K_
M2W/6>VI1J?6/).-N-9Z5WJ5_#$J$QVV*"1/.A[8G>>>GU9=VK?3WYBZXN_29
M1.@8/FR."-KB9I%&Z50A$5;GN:XZS%99/. W&JS )(JFO8? BDYJ1]E*?A \
M=.=\.NO)Q/".O>_++8'J+YB8;CIVG'K2C"DS8.J G@K6R5BJ3U3PU))Q\+GV
MU+R5@Z/_?MQ%-^%ZZ6-4HN6J=.^%*;F'=8M>W$;SJY>+.],TU$PAQO4?F5_H
MX4@ZTF<($Y/ V ]X=6-"G71RQYUQ-<LUR2?GPNA=.XLO%K+]0LU"FM$\B[38
M)TQ1+ZAXM@M39CR@"/1F*3>W(YUG<"W,[B586K1JW'E!>M6W,YD"9XU&=*Y0
MX.2>XQQ1%YZ6;&^_R2\V1.HQCOPZ*R<UA&*MDFS$1@K?].VF.$557+JCAAI'
MQ2 *3C$'E9G"2?L^+A%_OL)8C!%;ZLA_^?5-;$4PZO9/6^X;9+?Z,PRGPY\H
M&)^(;+/8^\6;++=B%PD466=^]BILKW%:J'@>BU/=\7IUIS'#B-_;;*RL_J8\
M'S5E9.\/74M\41&L<)7YG/-\N-N94H,.1P4PH&?[X"QJ(@%KX9;]F?D-PN5^
MSVC3'RF[O].*%'\#F2L,E(RP<5^:AXUA">3UZ-,]6![-MX,#*!<1="VAK\]8
MES^5_$)^X^[Z_JV/>U(LV+47 X*--KH3A&_/J,7]#2WLCG?JQV("?4F!9*WQ
MXR5/2S2AM.3Y^0?A?O/6FE3QL/P$PK:N657_J4&%X<6%!6"$'*.'2N%3]N3O
M3<MS\3%LOUC85K )G=YMV./RIJZ^-\D<>8,(&KX1W9*HB(7@\]3\,&LH<&>X
M.'*_J&A[0>']*98@Q/EG)/=!SF-R@:@<'_J?7]A66FD^4EM@MWSBS]_G_/J6
M%V:S"PL97LUCT$+:0DV%7Y7I(9N++]1"AQ\.2"P[P71R?+I6Q%_00C32YW J
M^"\=@C@A=% 5TO<:4!!.=6_:<;TU>GF924"U3\#-X"%U2L.T&:5L2H0NG?P!
M&G<[N9?O.T7$T\E]>;J]49<^]Z)>EKZJ8"QHPECEUL6M=UTQ2L,582U'@S^)
MH!XBB(PPG'<5ZEL%O871BZ[_,B473F8LG5AYPI4E+3)E)Y^AY%+'US0L&*?=
M0,^77CT\&<CTJYP(^L'8_9/UH^MPP0QV)1]=[PWX_B (8%*=%6-PX#+/^,=L
M>4$+WN\SKRQKP$(4;LVU\9I07.V8Q&<00<^<09 J9$QT8#(][M845,NW;#O1
M%XXB@I@A;Y_;>5?HFDH)U2=QC#22?_CB0?U([IO-" C:D8PV1?HDHIW7\O8,
M5HD@NBPBJ+I"39X[8_#%Q;)\]NS8?&LII:O8]<&NA%1_=\,:&Z.7*I!;1AD6
MH>!#+]Q009SXEZ/7_\Y>CQB,@#Z.\8SW'V$@ZCD00-#ED29T7%*8\=YGEH4I
MR!3!Q'G!NQP/3:X)Y%]])W!BB?V!+\>QH>^L)>;FE4.9QR_GTGYNT7D1B,;:
MNK2\.?"/2YBID=UU_7T-=GV5\@@Q+[T6$PN3\G2NJ^I1-WF^6S\/O9VF*=$H
M$93[@.EMQNV>=VR/U$.415(]_UXX&W;&S'R5EV;TS,Y\&\C 'K^77?D[\XX7
M1]>!O\E54XY]]V5>3./;-@'?KYWYGN?%\5>+Z.8/"B:K!%_Y%'1R"5W[H8+,
MB1Y8/Y^5_?Q>HE%=+^E]V1$BQE%NSV7?.:I%!5)%N/[KBWMF]ON6E])KY48O
M.VPZ:Q]*/[9.N7[1"NWWD?EI6AEN@![N4LREQQ>U617-056FF/0:QEV2X+&\
M-Z>^!:KN/;G[G1T9YSYWYD&7UR$W(*PT>#V* H-4"T3IXT0);,[TV^7(S,R?
MX>Q.0Q(+]R/;NEL?>T4$)*#%0S34H???VI(!\:@>PIAC0UC@< KV<:.;P!E!
MJ_'/&K??1/$#5_&=]N&2Q#?*OCRI.&G"LSGX%5^IDY7Y@"Y>=B +S>< I*$7
M9@BH@WO3.+80;'FUN,'-6_+U;<-B>[*_7^\.(;:GBC4]3J7) --N9SJ$Y\&5
MI<OITI8<B\5QA"CD(/,XMGT#P@H&G"CTZ0?V,:3L3<9%'Z*CS3A:84Z +^H@
MJ8WS=!1)!'%"8K0]SZ 7#9.!#_=&>S[B#KW\VIO5/N8:/]W.E9D]&6/D8_"P
MVRCZ"HD82..QWMXW\(G_3,(U^L1>C$53>6!!9B*G8'VY-8WZZ:/"_:7RH*VM
M\]WP08QES\+!&[B;;VPH(VRT);G[@-K#+NY;89FGDU3J7A01E,,J$B?^_DAD
M6 QVR&_UW03%O(:D47PX)>?6K!)^,AK;_&KOF<*D',Q+ZC:F84)1@)8RERYT
M 1-SZ=CLN+M),V!FH-8!(Q%4E+T4F&CH67W=RT=4T*51B:/?@7+#\[EVNH??
M;.7>T^S+X0B&)UZ\)((&&?&9\%VC>"+(H&)G+7M^%NJ.HF.VW0JR^]E:NHT-
M?7!ET;01T98*V461:":Q/+GG&65>_^)VX;BUO))>A@)_O8ZUC^?PX?=+&IK_
M]I)LEA.,UY"S^)CZ%3Q+\6S6/_=,J?^JT. (A7T]$A,MJ!BXK$E!> 4,71^"
M$L>*3X21.P(ER*1DC +5C@ SZT+S6\ERL:<M9^\,9;7Z02]WG,+1IMA/4^#G
M1-"BR^JY=,RNFA 23ML9[E[XW)I,UJYO ?KJ$/F ^TP?],#*2@?TE-4W-M"7
M&Y+L=)D*V"PQ5TN__G7^B+_?I+4]U3[,/ &VK?"DM/]4LZR#%R-<B>1YLF(]
M7F^TQ&;5\/MQQ^0WWNNHWT7VGOG4LA5:G>N,JK.R!:GA2T00TP1D7EGOS*IN
M,O^<#GUW>[.G0PC?)##EL]E\8?PMGZFUV:7>^/P&Q]B2@UA2!(B"90XGC*9>
M9D ?[(X&%D#X+("L4H^9\:515'B8>4O;=W0;#3;$AY4+>D:OE%#3MW)SB9((
MJE!F.:LMQNEC?!(5&B5CX@++.0)_=%N%>=]]OFA&T]28JTVGJ+JB>O1I=-NC
M+P7SK)^7#WW^7,4Y :=5_-=SPI.MC.PO&/NK*X@7L0Y2P:#Y?O/<>JGX,/#V
MC!C[0*]XOR<A&*PO[\L$R1A;\]VC^VR KO&-XZ.5I[I@F=U[F7A7;FK/:A?)
M5=A *Y3CG_!5$R'G'<-E(B='!%V!\"%G^XF@^<N$LK( N_5+#O]$?)B'J]-)
M;DHPO4[14SY)*.[64[<8ORNR47FGJ??8?,8I-A+ ;-! 7U0ISI0M$:K#%_OL
MK?UP17&Y4ENJ&DEU\4K;-Q:(")_H<475OQ$$PRA62K:>=+3RG/D<!(8%(TK/
M>3"F/=FG$6H,%YKV[D10;=%I]+&W[9+V-TC) TQDCF>6JSNK^,"3%DTAMQ!2
M\HCU#!T151VH)/K.ZGXU9@<%2UQM9\F@BC]UD?S]UD[5UMS(0-SEN]D+6=E>
MFQO?*U98H0\Q_<DO 2\UXS5I>DA<'P?9+[OMA2^GYKJK+-3E N]HV1.27IA6
MN@&6?;DWT,+%"YG1]4NFW0OQNH\50ZW6,VK>"S*VKMU8?4=[)XG<\YJ2SF)
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MHWUTQ];BB@V:5B\4^ %?!&-L6"X:U5RB5E%7YR&6A;B:V"%( /IX%/R$"6M
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M_>K*IQ&?1AE]E)HC@U0/_9KP*_IKTM??G[HV],PN_ ^*E#CG?J5^F=#87?M
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MB)#,WTJ_B?F;MMV9_EFG<?(/LJB),3*T_-&9.B^['=_Y_-_^SZ>-EFSU;KE
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MNVB6:\-0 =&M&FN"HE-(*H!G :+8$>)=]B3'/?5((.]M&G?$7*??EQ'1R;,
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MB1X:;,J[()+H-,AEAR_PF>SVQM#LX84KL[&.;_'6&)FO0CQ4@ <S=[<#=V*
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MF74S3&C\1 =&M=M@=LB^''G87(VLO==OJ-SLPPMA=]%]S /0<VQ3LI(-=:R
M/L:YI.#0G9KJE7BNQ/)5/B7VYCJ;P!RF2O7B=Z4GKW?=BK=1-A<7Z<TY%VU_
M=CDH+  8@1&*JP&>=;/1C"G6%93="K#2KC+J-[@N]I SZW9C8GN_*@V=T+4O
MZO,J+80Y++-4YY%/G.GW-E4^Y\W#L#VQVG'O\JE+-J<4,V<H8_Z)O6W%ES!)
M[Z19.%: '*^@7CB?;E8(N@,#"C^/TQK?VV9?3RTK_)&:43AS4,B4.'<C=;=9
M@D,1-7@Q$2 >'<B(L)V'WL259RW-&L*V.S$:Y>&0IK(:_0JL@75W-S0WK_;C
MY_@O@M'&USWBW^-CVFQTP@L\+>=5<=]2XXJXN&SBNLM\!%JF)B)V<F4Y<2&;
MXIP[%U='OQ \VZO)90%9-!:$(>=05Y$0U8- A+Q;[J[@L%A]5L;<5XO[@]==
M9*]+:FG6%4)B;A <B?<(U39X\GYV>)Y'*Q^R%D<I*>[]B'FD[^PYZYR(:W74
M&^TUN_ &\-CW=2FW1DXGBD.=?[')4'.]4U-F%"EEKV4P,U*T=G<VK_]9[IN9
MSW0 A;>QY*7UNZL@;B@C-MU+> SJOK3I8-" P<Q)*UN)*]XN:LFY7AXD;_RF
M\"M+B.6 ("<!+=<.?J$&BI39WH!*E4'0-I^$.@HZDT2SRA-R:]#-06;2N8_B
MA.\[1C4$.MVM'U;;9H,8='!1 =5O&@G6%>[S"I](](6ZV/#)4I^EEHR#([%=
M[PSL+7'_ZLZ)D_0499IGM%R,"-TY DKK8Z9YQ+KM1%G>N%?XUOMS=;XEUK.O
M.PWDQ0_=;ES]\IG'XGN8-863\'YQ0<".1UT5.\?8J?C2_8Z-11[SP"G3]YEG
M.A>YKQL_1$]:]F/*WK9>(JA1 1S[C/K;2L"SD#5T9\8D>X[!-X(?QCD>J'*>
M934G7F)+X/%CQM1>LQB8]#0R(0J%!';24WC ,QZ-<],=)<1;G_8BK2]D'XYH
ML9?V!C9'\YY>-/I2" IRD^;6?#?:*@8!=?&1M\)S(!6W/NTWG5]9-ZR<?)"]
M HAG&^@NM0ZL9/ [30_8\?R%\(!X$Z*+?>F@F-UC.;Y4BQM^KX'<93;BI;&]
M]8Y<^?'QZ\I=^<[7MYR^%PIRNF*!#(21#GCU=H0ZK0@[!(7&=&=IK*0Y/0.[
MI7X43RMBK%DJF_S:27%1[PF@\;W8 .=O3ING(R3F:CUQ6[Y#^!B 8/M1Q[49
M,KI*<?(YR(R1F!--_7(E6@?PS%3E:D=&(.<(4EUT>82)<#3LB6*"Q.CC!4K9
M@TU'<A>T_1-;3V"&^%E9SES1K#'K ',T\RX3,V/@C(0F+;QH5R.]6(S>Y%(C
M9/+MZ0?\[*<A?149#Q/T"5GXL]V_&JEX@KC=S B2ZWK3^Z#(5L%$+R8%^<]Q
M:O/V2G5ZK0^..4ROCM?G4S0EN*<]W>#HUM.X;X@H$B\^HLL_IA/,OIKQ4*O8
M[7&A3JQ=LZD^>\_Y&:[1CZGW"]PQ[E9!FD4?HB5U?A7C_NC@9/['*!M_RE[V
M$@)$STL3:$L@!3H?<:%40)RZ<+''--]4FN\'^YD>7R=O'O7:"=T =6&/AH?Q
ML3_ICM$5O/T*P4@1A9H0+/,PA,9^M/4G.777!R4C2ZL.=+7C>WE9!C;(V$+9
MVSK\3UF#JN7O6G+N=7%L29U#O*2P0_C;;&(S(B.@O$O;+ M];,^WD%F2C-8.
M"C<Y9/A.WDLQBT\W^>'@66Y-:,Y'+6V?(RD)\2J9A8J]_S"O3?[EH54ZHK^N
M_L6/)7J1FXPK%WMYP5?G&CSG"C\LJR\<!!)\BZ"B!(UW$$OS[*L5TM#=;^W7
M1CB;?=23=$_J+2J6NJWSN'S=V)"G%9IQ;.>;1L-GB.W'HCMGVD%@78&-DJ5%
MJX?!M\J46?[$=.-3_F(M-M&RQU R!?QNL9;]UV0]_SC,P>]'L9/[M 5SR91&
MU=UW].MM<,^*F,BV>28JX"7<Z&U^=6G.!2<1)16R0)4:%S$'7^&%9VEQ7@IE
M(5I,.K-:6W=.W/Y>]9Q$M%P!=VX+.4 -\/EY%?-)^4MX)MU<$Q8VNE%80P58
M!OW4X^T.!I2.AYIDD'49-RZA8/G9,25D;A+-ZY R\9"J?1NC_0,FDJDH[U'&
M>]_QBI')3XSQ*<G7W-.#0/Y3AM-F-M,@_T]>(-UF/$N%>[X[3N/3_M>!4_+O
M^H(<GX%LNFT$LSAF]07?$V4H0]-@(9+UXVF6J5:!\8Q+<N+MY!^R#>%&:K^P
MA'[4\-Q_T=W-K- _/SPE^F)J7CE:XO4#$XX']YX" .5TB]P=4J 7"*8]%,OL
MRZ==8+6C)1VF:2:%[ZMJP/M28YY?+YO/!?^H^DS.E&R3YCR5<3A/!7S;.09G
M?8+3[Y:$?S#+_7/T]#^]O*-?_0?)@26!/V%40"U\JN#WP!7_V CQ#V>QI;^[
M^=REXS^6%#/@$>J&7DN9S.+F>-=HE\A-5YTQX5<#M'6#ZC^=LO7>1S%>,FF]
M/@@Q?W1.>PD1%W*ZB8SR*;P9NF3O>/W9W%J&9@.?[A-/GUTV3<>@>*M7-VYV
M;K5$,2?: =%%TQV@&N.N61D_7^;#**^]%H-;"@$MR!<S'U*O1.)Y<EFLZ:[\
MHJ+I:!4"ZF3FQ@9MVN<1PCJFO603ERH8%C"0Z".($Y++^U#JVZR==''9N>BI
MG09=P+/<UY*EPJ/^0ABYVY\JU)4/MID(">A&4%0>JUO&?!EM(V:AMPVI=^J)
M>J52(>/YC"L[IZ\\HIDAW2*$Y9(NX\J&6TJ1FS[\/:=4IA)YO64+$CM]M=B!
MS5L;Q70 5Y'P4PD7QKP#@!AXMX,@7EI^( \JA1O.(>?E&2AP-.!IOWKT";29
M*@H4^SQL6+GYXCK LA)"!?0TBJ/ESJQIBN*9/U>-E]Y5BN>H5F3G-.'P&QZ\
M41RO?]Z4AJ:#"N"55D9QSD$<+<<"?$X3(OB%-I4^3L.&B,2[LS9NW^HRK%Y9
MM#UH5OC*+J]5FL ,&\L0BO)!LC<*MA2X"5[(VO0W9G=H9_CLH< \RZG2/Z&[
M<BHP=NC<@PZ<WSU!R9XV!WE" EV<I@@AJ=N0T7:2=#GH/<$53<.LDN4IN;W@
M]_3+P,7NVW)LQ>$#[)^_UC [#'0>\VRYC?4"MT.VD<(YCWG^",R95[M<!BJQ
M<Z2<Q*^O1!<2FCZ&&?4";3]1 >ZAC+=C'"8GT)0+D^JB[Q8T$<6$_/$S?-U3
M5C,6CI7YW.PB=SX'17.;U.",IKH7HC45;%=A\A.DR[D0'VM\?$5POLI'X=&O
M5?0"A8F.[(I?[&X4/)%O,WWRXJGE"3S(;A+DUF( )I@M8J?FS]4F;VA>QGO*
M;2WRFHEENJ@9^*WY"@LE<7C[;13+>5 !S!0!2,PR2VTUI*23SR=J;X3%QK8O
MW\HSR.9>8 8D^,X3'=R;P6)^&-8I\=[F%X[$UT"GT0"I.+!^77/3>/F>0926
M7,%"LXR2>F*$?)^(ZY61_N\OKGVU" ^6VZC$#CWI1M$J>9F!FY)-Z]VW%FLG
M"^Y6@6UZ?$4>&WT&L..+LS[SMQ[B+<ONQ?ZOENB+/^3/F/S#<<PS]9L'200J
MH! J[0,DF+5C;D"2L9;1>6Y*H;(ZG2;%9&+4*W4=A,E;P>NGIGE]B(I0)SQS
MX214GWC+\PC^2H1_J"YRXT&D\7-48^%C)Y.UQX:FL=THG&D1O/9R0_.9TU$K
M_B,(XEPV8??)9L91:Z-=2])M#?-A_Y8<;WO@6_\6<6QV&JX'*_L<'](]@%6)
M<RU(+@"[\=:AIEA+N**6[IZ\TD%"%ZF?7G?(PB',Q_=\7C@(3<(KMYKY<S#N
M!M?<&W.$U+I%3*WT;+,!XN)O P6D1J6PB 0*[214^)@7,/C+\7AF'*#P:9TN
M^I:FB"$^G3<HC9E7<(93'<0*@<*$[=#I@OW"W);,[S9[LI0^.'(D&@K'ASE,
MD!XF8]RRE2/LX>WZ?CI<X[Q\7.&A_1?[PE8WQ\)#&9=#07?J"9F+15O-JO"B
M^<Z)8+ZL)OF(D82?;G1T>'*(Y2"<7[9"V9C>85T0B).M7HJS7!0KH?FAN'"S
M2L;6^-:,W^NWT-Z'UWO*[UT:MGJ^K]J1-D'2SE.-\\]RV;TWH6["H1:'M&3W
MUF-+NW OL/NQKE?]IMWGST;0[#YKU7*,K3TBP/G;TSVUC]G]$P?#FS)<C74%
M_2/@E,9L.GSD0<(DZ031"PK"%;9DJ0MI9J?:((7)-^SF]2_.7LL>Y!-IUTA?
M_['- _G0TRYX=@IZLTCOXL1>R54?UX>^+^,8A7I.MDI,P\X-$&\ZP*;4XCZD
M3I9MER+GV)V(?4_R;ZX (BL5?*F D\IU>$OL!@)IN?$=%]F!<>I2AD<'U4[Q
MO4K8UJ)M !;6"9Q\TWND''0[(TW27I5808'[=O'%/5&=]AD@M>[6D9]K*A B
ME[G1QNQ?".4KV-"0$8>W57:X,=OA*'4).N>3-[C)KR7(E22#92EC;N@Y7-U+
M=7#P8@_>J$X%$01W9KC=#JV1#*S_?BI;06T,%WT&>H+H ;7"Y2$-/ O60UA2
MRJW;FB5?66Y4(&'@E"=40)WE*UGH);S0 6Q*>N_I"*N]-20>Z[;7HD[CZ]\A
M\E.8[D7WR^0R_SI+THG:(NL6),E \!)!BW@#*C,F2S)9JHA+AJSMWHDK=\)1
M6G+0YU0KWWT9*WDO:O7,-_;)%\M6*)!0Y(JO7M*-('DYTMAHE]@&5SSJ$>,U
MC]9+WXZT !P"^'!RW+!1% ]%=)4[FP=GV89B)_A8?[KH:5(&R5JN0U;J\MN8
MD;$G1(!VC^> 5D>U*416RE K#V[R*I[[U<,X_SEQPYAO:<<2S,-.B;6S3ZO9
M86O$9<4K#=J7;#/(,G6]A35<&)1<%A5@FK:91C3P -.K7PY:&J'1/: "7EFJ
M^1]%7?[0VV@8>_M.75)86_>9ZW.VTSR:18N]-7!!J"S.J$RV)>!!T=QJ;9JJ
MJLI:0ZKUA:B9Z,2Z\JW+"6^6.1<%+Q(,C]?4[H$MH0LKQ^E1V_B]<YMCU3+-
M9BL_Z1+#O,$C9!@BE2>R'[ >>W1B3[>M:#ESL>(9M(&MGP W9N)\WDY4@O*E
M%W8SIN5\*6RXVNH]*U"&-&1&FC1'N-YB&%>U..\'YTN-EOIE]=^,?R"O[HM#
MMZ/.EI5YD1R79!B[7MM<39J7>6(8L?_@H;SUJ>)V?<!)[2='NANSN 3TMO\1
MN&.!UKTLR$LT"VT#"1D75F)GKKI%=.1/C&0J>*$6O><A07-ZN4V3IPDYZN6*
M6TE6KGTN\L2=M<_QK-A;?'DO9NXV]F+)3M$=UBOG+-^2&,EIZOPXL-9HD!N&
MJV:9^9)X'-3.W^K^I(!3D@Y&]&?N778S0=6WA7M7*IP^/+LJX+-(!3PC&6*;
MC#D\!>EQ*R583V/IV755S)VS#C<_?E.YTVL?F)P8UO[#TM\G,IL3][71KM$X
MPC]4UEYR;$/IL/IC-%=U;2 3KM-<-XV?T]3D,?U=WRY_I;MTEXM)LCB7I@\>
M(2H%2P*,)F/[!M5P>,'<CX\#/D%^>HY*E54IP?3FUSZ?3:%3OZ?FTR%W<I7"
M>2P9NZ#;88*5N 4,US91</;VBVL@#7M[YYT;I^8%V,(<SQ=>[>6<&KM^#A&M
MR4X0ZN';0I01$MJSA:;WLT!NU9,!AK*,F3%>92W0!@%&,?X5?KWV[V5>=9%*
M:7@&S\V\&8' :Q:5AG=F"S 6<UGV[]F7'\<VEG .'X\ZT4;I[FE8W!)9#EUI
MKYOG7AOB%&2I,/]%]"W]F0RLA9QT.0?S\(:!HJ!5DKX8\G^'=TT#XA6,G@H(
MCUR*R:+?'S*[4=W$S/DE0S_<N?YY8N*2C+3I(POFPQS,XO.:Z;=[DW?IY,I(
MH.ICIO%@:5/Q[F2SC%=!*&*#FX]S)%'F8Z2@S;.;(E'A#(Z)]CR/^STBPV"<
M-@3+SK1YX=:I?3 G)&EK1MJHI#335\2B>/8E6UZSR:V2YE01L17QU/,2 BW_
MU6 96LY4@.# /FCP6.5)(SV5FZ0"%/\#OB=<B$#CH]6%X8)"&<T-Q/X8*@O@
M#.EI#P$E('7'E6<M6B9R X*>NR;)=/KWZ9CJUOHZP*D )@2NA!+N0RJ<HP+P
MF/U^*3>+$D,;=O=@Q>A:.L97:1H>)LE;V$R2R5?=@SL$TQ"")14@J0HG!;Z!
M.R6\_%X1#MK)"3H6/ST_2Y0<#<%_$B@'#\@I:53 J#H(QT,%)"['$<^31+Q;
MSXZ0.\NI ,*FSD+E= ?=^M*Y8Q7Z]NZQ(FA9/6:PKDP%9)$W*C8&&3 O03A.
MBFY4W88CSO>(  (=GFT^UDX^52R.S#Q9@J.I ':;=0QWN&/UI[(@'EF1YGK$
M@ BKGK6(\S#]=UZ!DD]NN>N?DJHSB3.YCWGTE"5,HCV)):07T1*E+(M_$W3O
MGR!:'^^\% X<V1R4GY^%M6>\@V?)3HI*G3"OCE\3?7V2YN5K5I[3#]ZZ)J_;
MU21L[.)Z;D^&'R 6Y8#NR9GN&]_X8%F<R"#6.TW.T6[+)UQTSGF]EM\[V<(0
M#5A$+CP38MSSTIF^.T'A)^AT4\;O9<^OS=ZHB;=R,N6UYW6DM6(](_Q:VW]>
M @<+6XZ3(ZIVAHAE5?R8[40Y?I(1;HB$#/,[OE!0>.P[7[/ZCN7FL>I !Z59
MC+OKX2" TXU48KYU(=;!/<2P!3D+-)]_Q<)R6L=C)0VWW&%SK#"H:Q= P-H3
M)*U@U*9:33F"*>C)U@4$M/C]K,A)O^#SEKK:@.#]A>,)E5/6/#,1$3!@?4,Z
M1M\E3:O&-;&OST5,/4E?)-E64(1@N5C!:^->>ZPTOE02\)LUO,D9JY::3MMA
M\YZ!H;,\]_P%U@>^AY:CEF;:UY[U?C" )$DD.L9Q2'Y@HJ5Y1_.Q8$S[_/_2
M=^^O]Y+[M(BC9 J1"EC5*7@'9"?GHEP'4#%1[R#)'8UMN)Y....@M[_]_7+'
MJT3<'<#5N,I5WY%3[$ V3^)-$@2W6?4C^P(Y>[LFR^]R]>;1Z0KZC_4:;[GZ
M8@7K11+!IB:VDJEV598*CZ?P@>HQBU<)Z**ALG4$QW!"KA;4D3*(ZT[]8#&1
M\J2^[S%P>"@QL9=G,3YED"1/\,*"66$3@IJ$]\LR,GN?'RV#60BF&'>VWBJS
M1MO7'%FMCCN*82_:HH]8HAW&UIWK?W*E/66=P]R$NRN7#>IK-*^.]9V-+2GB
M.1^_&.; 2)2 G.U"G$8N\$%H+"=<X8RKC:7)$%M3=Y/PH=C.W@L E9LZ,W2/
MSZ'.,1R=C$X1^[#\I8 #D^;8#G<$1CH($Y[B,N_Z</\8R2.DV4W7,'L<3.GJ
M^KL[=WPM.O_-W-AA?V6A&K714@:]1BXB!91[R-]I91H;W%Y23GP>Q4RD]U9_
M/WO?C)<*"&E%?T >C#<CGH"<^;4#U1E[$$!U/40M$ T6=#MR2@L1.I"AQ)3-
MZ5Z4J+M)[&4\J76^U[=-XQ+(;2%24QA?T%7Q7*TV)E_C(&N)"F =""X:KKH8
MXW;G/MV%5R).;#LO/!<*B\SYW \L+DT8*B_<+3^+A;>-G(2Z4H:.*6@:G8KY
M.1$;,3J\E2] #%IV9&GBKL@+\K=PKV_Z@#&T1ER">I,C8'RJ'7+<P%/0:\CC
M.BBBBL]&A1CV+A7@-KOCM2#VY?MT]#YB9F2Q-@SGN325XI4/@0G06+=.;"S8
M6'VI-O#_^.Q;U$,%'M3<<L;^;2E+"[\$*1>/MXZR3K_N0(9Z_!10,J6A;M=&
MXG>)YQTP#;64KVY+!:@KC1!W?LT?)H2;$)2A K+Y7,D_X139YNQHDB7149X*
M0 Q2COF@I1_BB"YJ_>]*)1#<$[BH@!%F10KIUX1I#L;:0K.\D23* TKY-] >
M\.P4Z!]V ZI5!/XDH<GV_?!50?%2./H.I(X"<4<<?CO>NAO_OGZP!@?\D8O0
M[L_(HZ9??MWRC:VH@(@W>!\2;@*T/?!;BKF_;6$G1(+R>1#T?1>X'W2)"G@'
MR:X\5J8O8Q=^+N7#%]+^E"#N;UH(^+IG0JY\ Q]9$5K;,J,"KN,U'"E\CEVH
M7?0=*@ E]Z=L='_3Q'K?:LZ?H07Z]*6 \AP;TD-2ZHF!?X](IP)@X-]2POUM
M$]/)8[H'W0^H - ;>$F#,9FF<__OP:G[=TU4B'](V(Q%4^#R_WT(*4G F'4]
M&#BC--0),$XBHQ;]4?^#PG\M%/Z3(L0.-IXMQ6)E^R/S%0 A2H2WD7_ _SE&
M]J]"*HD@=V/.[O<6S/(G9OM^Q?R'?PW,_ZO ]__\4KQ%SE.W>+89=H=7!/$%
M!29N_0\*_]50J$6\32B]^N!T>OTS^AUP'0DX_S\X_%?#H3'!'<RYO?#5/;,R
M]J?<!(58(?%_?U#_0R7_*2IY33D6)V1Y9G]D/CLO)'JL6[>M]TO\4XSL?TCE
MGXQ4_B%"/DT<I.#M'!E]\D\DP2=1,#C*X%]U*O_OTE:H.4X7JUF"9[$W,C21
M22R[(0UWO8%Z>G58?X_#4HHHY8^G(U=1 3.%%9-^(9^D%MTGB[?%0V&/2-=>
M/=[[V)#GH20\P.DI2N$8%EIR>9XG%HZ5X_3D,BAJS_D0S&4J--<G):@:OPC-
MH1-.?NU[+V!;P,U!#-<\^H5@TV,TG61RX)DE>,&+H=NW*>3K%DCV]%/54_=7
M4&B4P"SAKD<(K,@)$Q]9W%UIC^;?3'QL)*#1)AZOV"/,Z6D[W0QT7_*,4T0?
M*9,_;0Z^'\XI?=/Y\43L&5)U+_'+N8#O00"8.]_KHUQ'(]_XA'3EP+FYL@)/
MVYH$C*M.P?0W->1WJ7[U>-D^G?X?:V5ELQ:'R;4%.9#=I>S,,NC5\7*DK=13
M+[\>HX@#J[+W9Z8O*S!W+C(/,B1G&YN0;E2UGG>#\4YH*J^JI$W59GB_/!A3
M^L'QD"?FK!BC%P!@)2$^4=3EY !UB9[M%&2;W"LLO^=N0>\<S+%6+.9 $XX^
M%Z] W_/_L??><4UV6[YX! 24)KV#2A"E*E5:(B!-1$#I512DB1%I 0*A2.\@
M(""@%.F]U]"K@A1!.DD$I"?4 "'Y\9Z9\\Y[[KPS<^Y\[OW=F7O/'SN?AQUV
M67NO\MT[SUKK*I>++K0/E1Q;AM>JP#*9*DU(_A"9O/32_6;.V>KB".]M].NK
M)Q$'+FP?J%'+5+=<E4_LQS9P,UK]F(KW"F,?W@FZWMW]7E?G,#@9O9B'6IC:
ME2N/Y.&)U,%D%O.OOBT149[C<TAK"R 1OG[#.@#$)JV!EO=8#I&W&X1=6$J/
MY84&2_8+:-VGKQF?TQ"_'NV2W,>^3BXN=\#M5-6&BT4Z,W8N7!O#"]D54TRF
M,Z@72CZCLI6=7RYB'*;4R[JG*?_:*S:8(!/9;BEPZONUVF):A]1T3IV]Z_BE
M$K_WF\LQ:%!.Z>MGJV]+HW)7^8<.2\>-OO/[*I0EAQ;ZY\=V+7]'/Q++L$HX
M1;C[)B\[0_(V%^HT,UIW@O"*>7@V+,U*.MP.Q<ZR>XTG6QA?F'V,ILZ2-J;-
M#PKD^(R5Z=2$J6*O$P$ZK!Q^Z<ZV3U.>@%(^5U&[^B>O;YJ$[RN<V %0C@MR
MF.#\K@RS+A!OS??1<H&8)6WX\H>X00UY,W^2I:>\WLTE,!,,H1Q+OF'BHVW)
M*13)7VN6+I_H[/6RG3>5!#1)A@ZYN\3S0S$AD_S![2S1;TW:LUZ+%E8&!%\=
M$-.>ANQ$_HC'NN1,]&&>LZ0%OTW;RK[LUA.D"1'P-O_!J*3BJW&3-"+ &S_X
M-&$Z,<4D&U@#!7S@@?*Q,\/[>"_:8O)#R]PCM1]9*,^,6=,,SJWM3E?]#*9.
MWVM]<Z\?_5EB]KDI;MGNK!EI5BHWO$M09/VRZ%Y415785:C<^(ABT/M @)V+
MP>$W[@DO=-A3^DP$=*KX'<D\\THQF> =B+G=T?(NW+SX5B_HJ0;W"-MJAD*E
M<KF0T5I)S:CI[.)"DR>B:&X]WTS>_::K:L%9Z?6='?E%58C'5].9ULP.BO99
M7Q65UJ9QO!YYCI?=RQ?)\DYJ/A9(%<EG/^\HM].WK\;'753/@S$$HCM//,H+
M<0DB EM8]F=[PO-;W^"4R;#@J \!>YYWV:4FY_ PS'S/=WPO^$I26[7TY^]I
M?!#G7?212P@[,#'Y>=:CNVR@"[A:Y.+EM::G"> K)A8F.<#D.B-E)_D2M.B
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MEKAB@CZR'Y0G(>S"8!:G"G@3#"1,P<57>!+.\=&K]HX8U?,25H=2-"@].TY
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M89:)@& 01X^"-YDI\$ED<:_M)<YY+W_!)%5E$L9!](=D4"HV9:FL'LN(-NI
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M[/MYI)!'VX'R7'Q84U:\*E5>)FB,!G>(7YR1$=68:\PK@,$QM*E+I4(]B;@
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M_8)2#U5S\^+;+%Z8"\K73&G2W9>T>T;;O[+MFUMQ] ,-NQJ&DN0J=1+YST2
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M;V3[_\$8S'\%[(7K5#K- F=ND-6_(VO07_SC%G^[*_AG7[F_//\=#7EWSXB
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MSQB_CE?')9#KQ6VIF<MN\W"DG93G6^5I<$9WVXBKD[6\C-6>%;ZPBS<C_BL
M4&:H.*0 1*J56?;@[ [>+QS3%/=&\B$3H@CMLGOGKG".&FD\/LE8!L@)\5#'
M-5O<1N&I4FTQ/;:)3ON!F3]RJWU2N$QCXD@%9]*=!ZC4[@V1+3/V$'2Q"Z'-
M@84]!03'KF N/"/1BW5^4G/<JC&5AU3@947#315[UO4TKIJR<DC3 US_0*9'
M*=@D.,6K:%8D+]YX4K_]T%OBDDVTQ)799(!AST\]LAH&0Q$>T]%F%:=)$_/3
M\CR7RIYK&2/VJ:31G9QR CPO*RN3QFA4?NI=F?X#I.5(MW.!K=DQ%U+PO*)J
M III"N[)B56N;)]Y)@^P^\R/1Y0(80:CE7>5(%'_>)AH"9+1XL+@W"CEY=:2
M::X(&X:(441UVKATTVIKWRD;"8+V=Y]^4@RX!UXXXO?X ]KIXT*U<@<#.1=W
M]VG#GY!26-[2D\1(E'R:_1\G;?;. :WP(W@%FJ\/2$0_O?C%<Z;NYOT'E!1,
M :H*._'Z$Q#JM]SF%CY6-P8)S!A]]L&R@XG\\*=@01:KLO#K&Y?6/,D]3 B-
M>RW/<7*).\'LA"ZT>86\$Y"N<_HY;/[A/K!<*%=TL.*NXC-'BR]YY+G:=06^
MP25GEWH^>I932+0.I-'%6^N#F5GRBM<VTV >W9^/=57M"8X=?B"1(6'?A'OZ
M,JD_'SS_$<#UZ23\;7!JD66=FO['9]CM#\2^NX_?S?*53B3X6:LR&-+\GT7Y
M?[XHS[BRP!FL" E<!$9\&O=]UX!"(=^;. ?(9F?;SW_V#%!G.^/A__1M0X.\
M3Z39\L20D#%Z8H%NLP#@.G-ADIS,IJB&C-\(/4YLNY!M'<N.25=F,K+O>W\_
MO]O4[^57#'!:116\[/;&*.:([<DT66.M"1I\X!JG*)1UIL(ZJ&L[FJ_V2HE_
M2?G",<?-8)FREDY)C GRY6M,MQ$RW\BG2]LE*^BG>U&_KDZ_S$U*&@@(J&L[
MM1@T(AACRAX,=A@0\@>TKD[Y-GV1Z/$#M"6-[1:$OWVUE!PPGK>9XF9^!OPY
M8#*<=K-034?BEQNP9[MF=U?^U+(=2/=[1IEI\!,!.7&B-^:1FZD5_JRVXQ[T
M4B*A#?#S[?T!Y2@E'7 N+J0#K,L(B;/$'<]8J!<YB3 8I_2YVH89VP_8\'Z,
M#Y^LI;[5''+@=EJ^%:Q(U,8O1&I_\3-JA.:OH@\OO=#)M2JW3G:M0-,*K@IU
M<5 5:P>$)(A^BL+JAMN$,,VN[39IU:G'WAK>X/#QX[@1N#I#GM%';SP5PM3G
MWA=X^]1_CPEX3=176/K+1)W.[K"W'+A%KBDHV90K7!7"#PMQ?H=3WC)>M(SP
M[@2?9F$I937S&H/F78V??!<9XE@"O]*IYY'W_>E_***E7SLB_:ODI,>(0NMY
M]JL\[]?1GZHD#@#T#\,3$&-;!@8MC4Q.",K3)&6G5RAGY:@,5'2YF]MF?O5$
MN:L!11":AA)QR35ECV7N90 =%6#=$.5"G<@E2= OA2H,$:ESUXZ[:K!;C\WO
M24_8)=U2>V9D^>%JEW>/?/'!R]6?&[K5,#'EA_-KB'?[.PGPZA TI:P'+:$/
MXQCI"Z.8$DC7LZ1P29;Y29-H8J@IR7*GAYLJO)!C<GB>!(],PO.W-2K'2K/#
M:]:.RQIG9[3BZ0HJ.-]SA"G0J H\]3)>H\U(J6A1A:QNJ9QHK .K/-!',G'1
M:D4(\RC8X^'QKY,&@ML.KG:E3B '5T_Q>TGF#E%8#UI(4ZL%,YXL!5S0[56\
MGG8X:FHNM:F6=G?!R<H[M*&A;4W@I5:JYF;W=T3?V-9:85E\_CS/7</WG^;I
M/[EZPUS':J[\FWN5#+XAUYVRN5&C8C7:0-TQA$_#DPEF.;\BX;1D#GNL VDN
M!Y4Q>:C^'$$,/7G&7XF_/1"1;P:)[>6A+$>(?'3S]V"]<5U=@GU<PY_T,OG
M?#[2\[3R3/B"6$L:$"TD! VG<0MF=\[FS=2/>SJ!*"USMXZP,?5FKYLF UR9
M]>S+FEV]W( (AP.)YE_.AN3.KH\A^9V5V8EBYX"KFXVSTQ,Q!::FM1E#:;T.
M<_%VLL\XO\]60P2^N535='IO!,(B051->!=(?LBU-6](%NL+WR+I'R:_&<UC
M'W7Z_[QS77[1RW@?1KX&NCDNW:)E."R]I:L_DI4WNB,FPI,&EG-KRF"V>F*W
M99;*HZ#^"4%-\#WQA/!C04F!Y2J8/Y*(D8Q?*[,/#CLRD&D5ZQ/S^N@']II
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M5F-%=&:3UF',N.A-P^=]Q4T\TC9*:&>]A/Z S9 JXTCI<P E05=G>&<_@=P
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M@($$M,LVD#RX&]E7<&T2"4PB.C8R0J$#AQD<-A*'GI+4%BW@P>8KGS;@S.<
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M8M W<]3_=^![]B:W!'#JAH0J?,EB9(ZB/!@+O.9D'!#WJPAJ!;%-?/9:O5%
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M[18-0%7UN1,"5?59Y97!A%]W+9L,V[.H^ J>ZLWU)M]+N"E.R&ITLD?DZQ?
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ML*CE'?5[MG1IJ&Y8:5?!UOMMU:)-.;)?UI4IW#=//R@]6'C]7CV)/>F-HG>
MOQM:HN,2\,! WY=/'R=1W#X)O5<M*[6J8O;HJ\!7A0J"/EP% P/K:10II?GB
MF\DR_ -??JQ:F:V<T(@OGXR0E6!8-2$IB9TN^1Q/Y-LM98<EZ\@,@B&+"%8>
M$OT/'I3#F6ZDD0L,F);B)7T9()+']!5&AOI@>M;8=@HDEU6S+"&C*==V+],^
M0XA^@$B<+. 5$\U%OAP]MMN8""1U>$*%F&]'@,X^I6BOBNM2W])/O.:&+F'3
MI/P04>?7X2CA;)18["BCAAE?<JQ<GB?0KD$/)>?O'%>((O@'/WFP=-G%LO?P
M*9L3_PBX_89&L#^&=TA&;$F0;-:_.X- 5 F]6TCUPPQ)S.;3+%EB:1CNIJ;J
M&\WAX\FB?1K* I 4+0GV.8D VF8 (!1:O^S=TZPA.6/D$A,;U>,"NZ4E,D,:
MCMS!7%%49@&4,WJ[)G)FZ7LO)NUQ2EG3=@BW1=OQ/=1*0TTJ6 ";]IS=[ ,[
M2V# -5B"KT:1B>]#K/OY4ZR3(;J[L6 >[&G0#<LWG@%IJ5MX@3T=Y9,%$EZ]
M.374MZ00OE]P+[@O\)"Y3>$A&MQJUUI,?+WUOG?T(633EI0/J[&2$0&D\B?9
MPC^IG&HBS3<RG9U3(TEV7FZL4;!=C:4T@*+(/KPDJAD2&5E)CW]QD>4@IC[C
M#PP?WT)9EF8W7P*.G3G#C00TS+3:'/8_%$&&UK9,N)=(9WQT,,#?(7E;Z$5(
M93M>% Q.<N Z,9HH+=E53Y,X8^Q*3M9\8BU/6?/H,6D=Q4_'<-U />QY#HX#
M;9S_2>PJ_TR1+<G6FXIU<ZI\GJ=B#@@88I9BO_EY_(L[/:W!DX^S)U]D;WHG
M_3[!J'::R)5C2*)7?&2!KS##(4X6@1H5XYHO/BF(/A1K*BH;:!5N%.3>4[S@
MC<2Z8JB1>YW1 2O(6V6U2ZE4<?1;66/6:-0L41O?CR*QGN,/W7L\Y NF_8V[
MWUQ.L% D\R=XE7JPK^'M?"2086N!MP9*"IZB%M?Y/:D ]+%YWSZTP'F'1I5>
M.OJ+LO \H.\B]1)@8\RKA;V;HX_M[N_2\4Q2Q$NCZ#8ZZ4J_$-//#XG+I@S%
M?H+\Y/0P"[0,K(NKHMUEOM/"VH6Q68X.]C4CCM\J+)GN\;!?]5NG,CO@^DW<
MRO!AFI;F"6V7%[#]$L" T\<V+S<NW@<A%@-%,W@U)DKX[1V;I#WE%)H[7N2N
M&QZ=SU[CX*:5H3NY *I7C]GSE]@[9%96U(2:!2 6A!B<%;_?4M!H+P  " #W
M3D.._2XR2MR= -L:D(;QKA2'KMWJDM,&KZDC8W%:%I]Z\8S*'AE0]4A@3-U[
M%]<4P"+6ZEQM&THA-ARX<SL>E ]J$1FM5CV?SN'G&U&SW:+1R[GY4+YKZ.6W
MR+H>Z+-QJ*WZM6U$39J%0XF1\+9NB/J/B9RQW95Q)X';2VS!IUE4^Y4T<SPJ
M),@ZHW3> ,S)1R>WZ"@XD7I0T^/2+! 3W10_6QB]?,U]:25   '+S:=KRH#8
M&-),V)T&]%ZH6/1M7V%A4 89#*>;!_;F:$B,O@@53\[:O#\[OVY:.=MV\_%K
MB2<=L/3E^^*KVI(>KY3*(/''W7[T[::T[GI5]%/U:+\=?9!&;];V]8?JL62Z
M]?']]S*:/3E5U.-M@,*-WERAF.%7HS+ ;%(JNW$[.=:)4LL)\OX7Z/1<RKY9
MWD_"S5'<Z1Q$\J=Q9GJQ4=5(4[(F?E@O^N0X$[UJPCBY*^8 ?B.5F,S8DN3,
MYUDNUIQU@Z@H6)+9I5RHF)K^]=MW4]\-+QJ7)7I*?;JDA@)+MU-(/^.D\PT-
M3#<1VMU9QUJ(TP!5$-M'IA>DZ\7!O%4)[._9'^@3'?J9KBQ^.#2F[S H:=B?
MU\/&)(RNCCO8-(/7">MRP/>DJ7KHG>,@W9 2O^?'>5BGW/["+N=B.U7QA)NZ
M!E]4EB\4E<J#E34MXY9UYKZ^[6'[UEM%^I6!\IV,:AN04$8K:P=Z:T\0)^MG
M%P_I-YG:M>]4U,B9G7\NW1K_Y18;4)C(YEHJ[: GM1SYKZ'J<\VA!OXMJ5^Y
M3=YN ;\N >/'FX5,TZ^!/J$27-1/[*.J2CX<"9+X.J-UPWU5P)E;!AUS)@M=
MHL?"U0F=.BD!+W0'P(9)$<]=:R'<?9XKW-\Y/-T/TI*"Q#Y7J\_81M*=LHTZ
M<*N]N$AHGX[/ZKU/X7P.__:IPV+]R4Z7'ZW*A[_V9OE/7<AD(.B&12[08(F7
M-C"DH64<=_8)?53IWQX(.-D /7CBL5_Q3]W%5A(O =27 %#& T2DQ7.LR'<0
MW:M 7SKH9[&*E$^ALRYE5.)RD1$Z'O4VU)TP+$]B4AZ812T/R]V>@4 XY#1E
M-B9::8F3OJ=][T,S<0PKV<G='U=5K2T,6"]8J%$^7;SRDLQ'I*$9I'(L(,1Q
M4K$O#<8SI"3<CMK[BYQ[]7<K\\J.Q]<LM:J^D?B)M,'TL4I^5+GHX8ZD6&PP
MD(IO4J,1'-NS%CX>02LT_<US(\JK+%Y[K*1Z7GCG]82#64MY0V1F.F+Y1L^C
MQVTZ6FTW/6"Q>#[(,%*W73!P@1==^BLDY!"EVNG=AS5=1H6$/,A4!55\3(-^
MRK)<=7-L,H][F=_(*(9OZKS*44]SRS*F8C=-*X=1H%Q?;VP"AJ!]L@9CR!7H
MFO9HF28#1?]X06MP.*?(V[EZO 4\@C/EB\$IHL.4D!.CFHI) Z,#3].4UFA.
M&RT6T>LMBIA<6&#+-07T03<SJ3O8V #ZR;5K.9IN=CK.\IRRE\WFBR>OD"?C
M^P%H@_,Q=\CA^?!]\(E4]P]PCLFT_(Y H(_CQS4]8Q=#YZW8VGRXO:Z V)/]
M1[Q(?V]#71]/0Z\J=S,SNA^II8)!ICX2?J4+PU".(>IN>%5D;2 0M'@3]ZBN
MMO8<^+FJMRQR1Y)<P;G^$]E*'H,"SU&OP;%/?YW;N<INV57(N:28J,*PK/&T
MEWOZFFD&,X,OOP]&&JF$NH8A>$%T=M*A(JHXRFGRLM>VU-DM<)MV7_8I[/U%
M;HL0M%W_G-]V>%G2M=A7C<I (.Y'C;[:$I/3Q0'S5]+,LAE-]5BELDM Q@Z6
MP;EH2@0J^!,%MS)%D$%!@@"[%@ZJ]]-^2?H-XV,T7[^UYQI0VU\"*!0WU>TW
M*)6.4[!'2*? E.@/5=%WL.;#772+X6)WW<Y]P+,=]D7;'T,& R2'70@H._!]
M"W3E6(GS9[YF6(M\P?C<#H<<,)VOGW"D/6ORCVUC:KGU[Q<U,DIYD.?(VM][
MI6#=D:T&M9!0F_3MW>6:GGMWXOEZRO-[F1TLJQ;1=:ZJ,\;-T*7I5(.+7/P3
M7^$*!Q\D0>MF)CJM=A#JLXQRE.Y%6>P]_.RW=B-^Q#O65!6KU)6B&X43S,6&
M/&]41;%KU:H6&W[:W.Q@C^KY01#S[':+'_;'N;,O6P6:"^:4"4D<[FY '54E
M>M!1Q92Z\L^-/=26!RRKR,3//NE%UO@#$$KG_/B?)DS ^P)3+^FHTC@7,M<9
MOA+%R63=EZX[N'Z+T?"CUA.3A_LSBWL,G"##E.T>[7-E_$@#]>]%]/9*9TJ%
M7\V9O-FX6TZ\95+EBO2S-L1WWX'I)S?J69A"E#$>C<CHFQ";3BGQ!#M4,:C<
MM!?D_/ZMHI7R'$L,25MJ6A.*4<24!S+>ZKW8.1R8\:#EB:]\A8^LP5X']0A$
MMV.*(9+TM:TA20?>GY-9A.D[@P]IL3^!*_J/!XHNPA%0?+S2R_<1+*7-1X^$
MO^3L_9@Q%(4Y4+P*D R[OIG/:L@0/92;%;8NP>*$Q:N?K2\.VF;"5TZ!.ZE0
ML:P/<ER7@( 0?=N&D"[3#QX+K.CU8B2*2C7-R-@VA<.)<PV!JCIE>^MF/M.V
M' *8-/U]OE2\2(!SQ)"&R]'[2F&@[7O!->ET2>>JKS Q*60%IBP>GW*$E7_/
MNJ;-?G[#8$7X8?&-KP:6_A) R(V$7844M)< AZN@!=I.X>KE?,Q<X05W.)CD
M[+[864/M-Z#L-VHD#XU]5/&S(T>,TH/[_E,.G/#D6H_!;=TG/X=$QL4\Q]I_
M8"X!'=&(#63:<.M5_!-I(CZ"XR;]@.+;N#\#8ML2H]]I<^%?OF><_B13^+&B
M17-P][LZEJO$EQ@_^L>%!7KD8C#&5Q<]%?0=O1&]$=6OGM'A^EJ@:B=9^Y70
M7$E)WUIX40;?DF^/<ZO.(>DM?-^9>/BYH ):JY,NI^$X?G68"!'9='U21]A8
MMD^*5?B6I;6197G?=:4G93:MBQ4DU1;(80([?R VNP G/RY#&X(^CN=*90PS
M?)FI(\GEY@&:N5YXJ]REGB/@;0JA5N3$)<!N+]R?==S_(62\38X&G0,GE;E2
M33Y9\>"3B;*\ )FF(K( >\U>5D7$R[BBKOJ[/N<ZOKI3U8(!#<R?1-7OSNVT
MR*'/MUW3- 0L:FJ2-=*^/OA2'JFM\NBY4/>U7LJK'4(N0X^1:/=_A!U<0A&V
MP\D.87>Q*?M(\)57;WCEG9=:H/Z8Y?7)VMO9%SW]_.2\XG/=O\776_*Q^N<"
M=E)<Q>CG75(MY8D&L(]-X@CMR6C&N@3K1#U:>HK0Q^+4LI0?9]O64RN(U8$7
MW^%@]3#FFV54[>O08&^_XXS<-OZ]XZ!?79T-"0?=QMD550$ZZ3P?-0-4$Q0L
M O2?418B21&+2!*8.UI^N,V$\8_G@<C<BL.3 O7CH *3[A&49AR6S/ROC8/;
M!XJK*+G?;\JQ^'>=A83AN2 ;G0T2G<6+1*!TB0I#1L]7X2H!2- *F9<5>[UK
M \_TK;FB^B<L->*H,33L=RAWB-AB .);BZ!A-];)QMV:W5BP'S^BGY#PVG=E
MS>$F%/H$E6)P.S^Z%A6-Z<'?AWZFJT/G?YQT"J$K28%^S@/MAIG$2B34#/'/
M:*;J5?[$LGXI6J4LBU_90^4C,VY  EOI/$/L?<66^]4I;._O6.AAOC?&C:Y^
M^5!3,-FQ:KE4V4)-DEM#1(6:/98:#I03VV1&)T%[57ZM_?(?_2. 9T$=T/HV
MMWCN.7]S[/->J3;!1/_N1Y8JO4(?P8/D^+;]J<2EB$R8)_@<JZ:/U'@U@MCO
M&$T/X0VDKP4#Q76C]ZA$B=65L<PKJ.=(:/L\06=*:4)0<*X7??CGJM*7Q/)3
M TJV,UGIU&Y6G'=;S743N!^!&V%B%^G^!%N7@,JI#GIF@JVS3V>P!/:Y.9.A
M *"49YN'7O<+4&S[ZI([QVK&RT*K6P\TE/]:6?/./_J.&V6$R]V'&'9[_Y::
MOTB;+ZNEK*^BRXLNG <E.5U[=^6TP1Q.'&8?WD6\#(P#<$SI_^L3S^E?&6BP
MM$M66"_7)7<T3F4YM5 'N3[*E6""U&#K7>]_#!56(<PB_]V5ZL01-HJ-15>V
MPZG=:-R<J$%D.U)NU!H+710_,5\W7J'<+:W>/;5F8'I^W^5N65F8  'CBN G
M?RK,.LRBV*Y&@FQ'7*-*_*PLJ<!H:RJ4PD;(ZWA,B34B[G5[E^N0B($<(9HD
M$'VBEM[_;+SKFR=%\Z^!L9<'<\:O>M8303G6<;HRQ+L#[P%# ,H1#642WJLL
M7.;A"LJ:T52[HC%<-VST-[!*M/3USNNZN)FO0@$J_+F1.='OY\AZWZBP7'^M
MU0J_U42&[GC;-"'#N=P()%'W<2#.[0-E9@9;?OX1T?320R1R[[R]<0A)2&9<
M_>#:\/ 2X_6-;A%(GH,DUQ37./!'3EWL?,)O7 ?W%PMN,_I0R=ETYV_.>@V>
MK9> FR Y2C0L^/>A6.VHC* ?4VZ.06[G=$V=_)KE/-SUV\_5$+Z[CL_*ML,
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M?RX(^ZKYB<=@Z\ACTP]^;WW:**OYY=>\L;B*"KC6BIJ:*JZ(4&CIVL34 I0
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M,NP,BGJEZW["E#&Y?2)W[\IX4F!#+@% //,EH+47BOW%C&Z'WK\$;%SE(I<
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M=)E/MU&@7#>MX@[V54)F7)^=Q;ITB>6'O E 7@*>^RQ6$!N,>M[E?Y4?1)K
M[=DG'^-"0CI::^4ZXMBWD3=J*H.3G/ EI>ZB+!]MXB_!L6' AD:&7.'NN3TV
M^3LF>KWQ]AQ=KJOD+RND:AC+7Z9+JH>8 #&U 2WDMIH(X\VSLFPD,Z.Q;2\G
MZENKO'5#XP&7"S>7^@++>[A@?T(O-V08P28Y7&(+(\/4=CF1002-JT>.3,D@
MN@IUAGHYYT8-;E.U4E4'KT=[*/.2B1<1@#?4KA1<ZQ8?K@N5,:T@N4/]^8"M
M@O<11GJVT05V)[VRWQ+CU6GJ P@+TM!6$0FL'(B(&P_?JS+<5]+@OS;(3UI8
M $L^RD 4605VI?R*_NQ+:F7V?4'=R6FY5// L;"HQW'-R@TJZ1MW;MBG1?1I
MV?6D;G<9FX1T^KSP<$)T\9I*-NA8RB0)Y">[W@SB;VM(V1;ANY^EP.=O4 ).
MBDF2C %D/.0LBO4A39.--LYJ\41'=ZLI=9/CJ'Z)#1*^4+WPV#-0#0VJ5.'*
M.(:4W7;X]H-'[P7EL/3'=X!A1NX .59?>4Q+8"9DJ./5:!E.K'C^H3$)A^W>
MT@_K1P+$_0/L-B8,G6S,#Q_1E--2OCB^)7HL&Q=V (NZ!-ROC@YN(:J<.)0&
M\Y;*KVA7C$]*H]?9N)(M@.X?"=))GQS*\D9@=+M++=K3)2K1K_.1>S<WI;[I
M$&C!IZI3/6NK+;T860,(;1IU0'>,![K- 8PDBO0IKP<<5:29, J^VY> JK6U
MQ8X+0?TP-6;U%Y,;(T<P"@XM.P.%\*YV(Y[0A)2'_?+W*PN>\Q -1M3T?/:7
M68 H+?M*39Q-!8K-7B@9T'$EEVS5=LNR"UN6G' TGLJ+Z=I$6OK^IGEONF8R
MQK81NOM6-QBK>OS!9Y$"$MC1HX^NC8+QBZJX]],O$LYS-HG<^:E;\T5FOT2]
MKI#$$J%=(8_B6(&8'D=/.#:Y+C.RK>BC-T)+JWOQ79 6QO)Z,I G/\&W L&F
MF7?U[+?NE76OB@/Z1E%L#)MG F&G>RK8/>01FB!,QKEP=K-BRT"GT#T;L25>
M,\YQ(D)875/KD99KI<"W3>/E<*)Z8^C7"#;7%7.[9]FIDY"9HB/;[LRX)_#H
M(;3:39EIU'Y79_Z L(MO7S2LK:)"0*@\6"/&]CALZME0J>L\#^P6%KH238U5
MD:, >6-&G=R<*&;\XNZXG8/,Z\O=JBA>F.@D)+[7H#6\RT03('R-8*2%#[M[
MWD;W.IHDUL')M72G(4=*/.-XK'WA88ZND_ ;N)"V\GQ- .$[@*(+78K=BJ::
MT2X/C $#[5RD]Q4<.0J>JDH3,6KP"9=6(]08_UA9TU17[WP_6,] WS*B>U'H
MW4!9C@7X^B/@?<A*YP+]Y&(;7L"/5PN_, +;K4*I*E4ECG#4;!*-]#Z(?ZD\
MRR;\D\9RE7)/28I:6#8][)1ZR7T@T80;J^3\X/:Z7@O-G'(,P5MA,M&; NLL
M1(>]+"1'$[;0JI9\P5 9=B>YTN4T;WZG-P'M)^KHB]S._ISF]L87D84<%89J
M;%\0/RD)7?JNAP5I&VH\"B\\3*#</_GH^WP%1H#50L)"13\?2KKQTW=YS^]L
MU9;W.<)6HE +*Y8[;#D$[UA%&)*M-@"8S7+<:PQU)Y#69#/]MI^@6M6X:*J:
MXI[&%-]:PP%'HR;Z::R2J*$S7:(-WUSY-9\4;0JZ%)LR#5.Y&9P_1BF"&^N7
MMZEC\#J^:.>D(2^U4#S[0:V&_K"E"+LBN?) F$?--19<?]QCETO 9U/Z)H5E
M1MVW8SE3,KPYVXE4H_REGQ(IMI-2NMIJ09:Q_ YEOCMZUS2OQ1HM47'3S/DH
M(Y:':F7Q8:<-P]W>BYU.$::WFA0L/,%YH!1XB* 819ZZ$\<Z7[B%L%? 6Z+I
M=P7GM^?(M6O?J:!W5DA@I1#=5BG2X,-HTDWOC<]E8EYZ798KZN4UU4T)3,\<
MXWBE?WI@UGD$ACJ/'[[5Q3?!!XQVSDZAR8<.E =[X2U ;'9;"RTF-^?,/]YO
MA91P.\4ANY>NGS+RJ/EWZ)IRD7$Z-6*H)/<;+]>2'H,N>#F:#E+4@^S!L9IP
MQRM-1 X%(WY5'\>#^/._6*29Q5&K<"9!SZ;[ZJPV6V'/W^:EEI].]N2-FHA@
M=+9YF1$WEHX&=MD#Z/T\5!@N ??"]4*!,644:A>E"\8W5#$.D_"EO+$])_,H
M]3NS\X&E!@A5ED@K8:]5F>)ZXZQ]W;4YB0!AK8)X4.@@M[7?<P5(8C-F7 ==
M&]+"U0.UL9((DQ'S8FQ)!M\3[O%.>N;?^C*)(]&#9YJ=2[Q[82:=#7M:, L9
MUT=78&M;3<A:1OA076M3H98.22=CG17V <"J%Z/MWR.'7H4(W)XK_+FM0)K&
M_%3#Y(8-YJ23"9BT;.1/%J@\3MVM@_A6*V+GW.M;HVX]&GQWK9<ZA9"66M)H
MS3""4LR?%>>+(0V$59_K_&KBMRC<(G,(?'K^X"P7G]?KL-$KJ:K?K_^T(T@X
M&T78'$6KP#0F7N=:.IQU=2)_8'\@@9];6,:JH@D$XG-H9:3!2,*=0>L%PZX(
MHXW>6N4Q914@+Y7+] T:394>]AR<Y92,>A[V^DZG"3/Z,*6T)\K1[>%;PZ9^
MF]70J<%::_N2[/Z>Y#FJ4T6(;!:)FQ^[@N\B<X\3<W1("QOF=PSDO6T*2:7L
MIP8#Q/!QZD^VQOT4A8RA60H4RRVA.LZ[/XFK?5*'&2'#72;B&/_8I5\CJ-(F
M@1_/!8^;F\;E,CTYV,S(A5\&W+S7ER?/L19Z3W[_46B(E$WQJ!&PC91A$:>*
M55_.>&#W?K8-6HBXNQXUJF^N,Z?X0$3H1M3J5)HO*[HE!%,MHXY<I -1I7,U
M.WB<JU=63[(8%KCMV'+LC_&8O]>^>X=V&C#0DPZX=F RN2WG4#IQ@N#]V:0.
M)?T]C!;LI(8B3KQ+Z.P&W!(FULEE%'5G'1S6)?O9I(N"792?;7[73<8/TDV%
MM##B7D*OV>(?CN'40&6;(W8HUWP[LGG!XY*7[$T$%N+CCSY]L:F0,'CM8<?W
MV@,DLIW"N^8T<Z"=VFY*C;.KG%=.$0QM4D'>Z51GW3=OKFH0=FI;?A6C?,I>
M4&-T,?I6]+P_S17IU$EZ?UY%2.JDP\N=A^WK-P7[*0E>QZ+\7?P:F_EM.6N+
MB90$G2U;]:IQBYTPWA5C8,<"X234&G5]JOTJ1!<T18J>$7\H_^5V";AK-#/0
M$)U$9I@P\>HNW4?N/:(%VYO7/1D.MDP9JDM]=-$"N4NRP#=6O_AEI+DRD7[6
MX[G_%W7G&0UW\/_[)4)$[YU$C>B]$Q$M@BC1V41GLWI9/8C>"1*"1.^]VQ"L
M'D1GU5V][ZH;%M?O?\Z]]YQ[[H/[?W@?S#GS?3CSG7F_7^_/G#,#U7IP&*/)
MMB_(J09@IJ!/J<MIH]$6^G"ZZ[GSF&]8D1&B*.#Y&T@@,42L>L9"2HA(.MB;
M[!AY7XNPXWG687E2<,SRC<-5_K(G+^%J#D;BJ1.Y;H%**#J8HU(MA8AN,<4)
M@+3A1<T/.#\OB1*[L--/U,*$^Y__N^C2.P5[KCRKH;JI>T6"DL18]&TOLNB^
M.;4^B>^8.ZS=] %HV;I_(O6WAM[3=L8*_@ST'<*2"&'\.2HJF*.[S-RY3*$K
MTG["MK'6F-==?)1?A"XT&6JG^/Z@VR?-@/>D@W!L;&#FB_%H7N-6#2*$&;+X
M N.$!%+LMN/'\E=[5^E8JEW(O?,Y@1-IS'R+-/_C^R5)X\OEX#;6"<V@R!O<
MV\)8A$T!KIHO.5T%EVVR-?*G]9:9%\:+Y"!?/(AW8%?6G-9LFF>>!/LH-N1W
M.J"E(N7ERD$K)'> B'=KYEW$F-A%BY:VMIGWJ*K^&&JCY[IP6B?;L*?LLBR=
M1B9U'(EBEBV'(2VW# /] 9&;)^\'^ST4I^A<SBVNI.8#X5+S%\_YMG09,,!>
MLZ:!2"J$[J<CJ!1RQ[O#=,ZH!94S%IW1/*S9*J;+2<'WRF8IDK_.8PWL,HGQ
M[9?J))A6E' V8EMP^[,B'+:TLF^< E\PK<Q \>8:^5H.?QO/J&08HZ;X'G$H
M,6UQE:>E!Y18Q'K.!CHXK(^3+H!DC8HX61FRC:>PZA\*K$Q?[%6C-2J8&]C$
M[706D%^*=8,*C>]CUJ.5-J3W3=:9MM5I;WMU@E_1D/#4\1E/[M(_?XB=:/\<
ME^T'IH=&/8=!XV&DOW.L!JVFZO[S(-%IH"L:%"C1A2FP<\B_ _20.+CSQKT"
M^:G]5/BL_]7,W7TK>O;EN^^JFQ0M1%T\WBXJ:+&^E:>8S'5M'K4TE:;_7)0/
MKG0E;O$QT':'9))_>\U+]23^4](IC2NTP!5O)N"5L:Q"1NR_+G7,!%KRN#N$
M!*HISTKCA:Z:-O-PV@6Y,YEJ\HM"/;\%;E$6LPM:ST=M/6)+.-_M(@D$5>^S
M\J'S(K"OO*YSU'NGS Z[I@0V6F*1O(A3.A'Y5&J[IZ'_!N6]MB+$N[7%_N[4
ML&/*T,YW@'N8"5?7=NB]96@"F13%!NDOG\LMJ_G9GZ0262JN0+8_LE8_L*W%
M"3:2"$< D^"7,#)BK%++Q('7H5R?(G?JK<Q69ZR3 /]LOW8FY2-/YGB++PL,
MWGQ;@7]\F',G>>=E9@X"EFE.#EOBL.:H15@7 U8S #\SQ+=H3U;\*F_A_1=U
MQ5R!&;L,:D$S&3R@(L-WW'C%#^%6F958BQEK=&9<E9<6$0OP%6H\*DVOS;?-
MW"?KPG)2A;S5ET*=+35[>9Z9P.! 5<_[MJL"-TO!*O;?_8#8&FENR]!BO:P,
M>>;W$QX';OKIZ2IQ'.4U4BI069W?;)XG()AE^J&=B8@/S\Y.3I,YG=K+-3%7
M*1MAEP<+P,C+W$1*N)>,%RF#I-LRJ$(NE"2XQ6C4B)7G;=Z_3&MUP3%NC&Z;
M./.FV?#$7/;?"J%YX@_EZ6AC'I9$;)ESL-;@U8^4+?_3XE.K3.T7^$N@2MKS
M)E7G+X$\,"%8',1*.MW)M5<+ :I->?]BZH&[E-RF$7SSL$OY+O$+-M%*66A+
M+IDLEDJ(GUV:4>"I<?4R]H0^F M2T;,BB=K*08X?@'*D8(S@36S(@M&4JD#X
M8OYK=(=\(H]ES2>$#6>U3_R:A^\JHR)']QH9$>1"SI6$A #&F/"%MTBA<6MO
M;';+6V/#";9H%Q0OFB_^&"CSOE#DD)+4*RF_M)IM/231]98QD <M%2L^"-Z^
M7SW$J &?R@DQEP?$-%]2QJWYLILP2<@:$LA^KQDPCNE5]ALT:8YO )-3QI0*
M]_>+G51YEW&.F#G0.L1DB"\G7)IZ(ZUV*=5'P2,61:\H#>E91?1GHM5NQ]6!
M^%9+/9..=>;#$D0@WB(*=2DX<;$,Y\.4/]9<>)0/-FQW]E=9)%R)( '(C[X7
M/@:0@E[CE,7=C-H"?M\R+[H#O#(/30?KA#!1FX_@0\7['*3>/ %4PL2M;Q6
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MRZ,HKE>#3GT?<C[V]=W2B9^2.O;E?3;/](#<-R\KL]'RX2'%>3K-:=%Q_QV
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MQB#_RJM62"9YVO$0@G]JC)"D=[/UO"JMKSO+VP>J!WIMKV7"B+WO%>;>N>\
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M1ND4XRBO70D)5\\*TN,B"2@;X8@1'(5]$Q C] -O'+@!%B?+EG9;@I_][12
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MXXQG=-WU+/5:Z_1$@FLEP^-EK7@9O0^U <+A,XP]:P3&8\_H&'Q+=K% G$I
M(.4BE5+9R)9A<\O0:IT.U,)'Y^4/B5 8" Y?.98?_N[ J/9%I8*?U41MJP=M
M[5DA?QUI[Z*Z$K50OA(AEQU[+&,/C[2O&H#-]ULE+%VC=/%2F.C1BS\M>8J7
M=LCG4#('9T=<Z7!QJ1AB[9],GN)2#^N?8@Z'3HXN,+J+??OP%?$SX$[FBG$!
M'3K&H 12S5K"J!(4R3PD%/Z&Y=:<QYYN8%6FN4;.HW@XU!IF7QH>ZK]-\STV
M=]V>Z'79[N[TSOKFD;JBP%7-!X=? @TQN30*_5R1H[VEC/'2.4A<3T9FBR)(
MK A=,QT;6WXM<*YCVG%"?L/@"OXC\A-<5A,B-R(B^4C[\"'64/I>O^;WHPZM
M7!F8Y<A 1>4/?E 23111*[+E=3"*:K:L@*T#6TXC#P&#"6*36;?)GZJV?V?U
M^XYZ4D);SIA5;@D?-\/T9+U1U0>E?C2'0_5!?=W+^@16O2?V7&C.*Z2_"-0&
M4CG/2;5\^T2ETI*%*2K6R?.I$Z^[?]FBES+XTA,EGS?^"L-734..(06AWWFJ
MHIZ6#9:/WX*EO8PCKLMDC[3=RQ,YEO&]3UM:-">" 1Q,OWUM_^NG560PV?]\
M;U @9?_&S$:BN+_)]!&W7?F,9\+H$]:Q1O9)4L5[2E2?(2%?7CEW8$/Z*+*)
MH'UY8P\Y7XUP/@-87ZVOY?$P5G0Q='SW[_V!BT">.;XMF)2CTSX1Z?O%[[X=
M4* -RK!ONG?([?-Z/"\OR-"3'^])$:@R4CLQ(QQSM\03=3O ;H*RE'!W+_]9
M;27K8WH)BW(R\T2U@6+.72B=N$7'#YZDW?6OCEDJ.OGMR_F>!FOK(.0 ,2\?
M=7FXA#K["_<51\\Q\5IC*U$FMSB&/9\O=ELQ[F:([E'$N],/:WF[3)^I!75J
M2YK!)S+U<05!&94/= YY"B55G3!,6G@4L#(4PW7M4B_I268Z)32PXQY;3SG\
MT0.;X1/E&G]";"S>6%]:<-TE<=F'VVAFP*7;%)\?Z_#0RA*?5Y26.%36!'R1
MV^U[S-VPTC^DCL5*<$3[I;G;&QGYC\BYB&,'L]65^FG7O$L(S"4F!M""K)+4
M,X!V]#"D1%^58BG=$J$Z<75W*S(R>\8ST<XN*J13G,'ZQ1_FB62VET1Q$2\^
M(@C.YPRTYN&+B9<^3NC&_:1LHQKBEE<C,/+P5'+ZN.@*U/=)?\G'3YZTB7OO
M>BV=F TSAN97_OCGG#>9#WK85;5D,=SA.E:U_[%ROGE=*(/@;E ;O)9_T\XD
M-G?SU!V/#RJ6V"189%J=).>ZI$8K0+7NB6@+HX2%K48*"0,V'W*#ZI6N6^0H
MWMAJXWB+>QMIIA&5=W61>4%X@MN.:]JIG('U&]; 1:D[?7WZ3I(=T9! S70G
M6BW,32U1K-/RWBS-707^(!-7RQ4 14/WLC8V34O*GBM>;2O88<0]IME<P?<3
MX6;;>$!XW5,WSNLO$['7>+>)8P;7.?.\S2>R>*65AIO\_20O<S4P*R2\ZOLP
MFE?R<SX*Z;' ,\.G1!]1JV37.&6_V49_^*A]68N-3NOSB52'I'UY&<WHVV%9
M$WS19>)'QZ>6K9+/F.3;%06W[BIZ*[;@UT5/T3%#?GKLE$ZT4S?L/PWM70Z;
M_M+=/^4M_Z1,VN-]/&\6.C7*N7BL+WE%.-E/3Y<M8K.M5?C>8',DH)6,QNQ!
MC+GF#89C1ZN6RH=8)EC=K]U%.R^Q-T';@D_/  4E%:2#^43ON=!^W4!R#>LS
M "UNH\*K]O/G-0$3E?X;^MV0.([O &$P;VA22\3IRZ;8P6'!-]:])65!@T+4
MF2/O(W_V"&VV_;@6SJ](!Z3*R+K5TRV),J2E6RP9^XKIL5'3RSRD0*0B)!@=
M3U!"PVKOL]^GR)G7%U57SXQU.+.UZ/-A#E$B[)7%DA=^R">*)T5V.%G1]7]X
M!1;4ZE6/03#!QF_P\R:E10CD,""1X.C[@GR.7GDG[TO=]L07A'%0SN/KC<]?
M0.8:_&:" F*Y2A_U#JT^44O<R/[)^_%7]U)/C]+XOB"5VILG;=P,;5/UZY0+
ML4I"6MEZMMJ)[\MJ4VN0H]Z2=[@?]DK PG.KAN?BVGG$.]_>SQ7GK_[AB" '
M5QQ[LTO=T@_C>[!^^RX((F.15E)=O*^3H6XQ%&FGE()(:542-PV-IPP>^OQH
M*03R)#M*_*2\!$J;EX^FCH&P]]L]\$II]EJY(?@*I_L_BU-T#KO:B8GW*NOI
MFWL'(S[-8@8_>]A@#KNNR?NX-HUU&2:ID*NFC>B@7::V!W)P1=XI\##KL?19
M8JTNW"I+FRY>NA1+L;'\$PVUTB^C<U!(07A-UDL@-Q3K]9[\^;'(]F*9/[<H
M:1;[M\OD=JRLF:#+%/!U\@H&"JYJ[.LAF97!#\G[1S<5Q>Z,<YC<@*8L,U35
MJ2PZ-=$"$;717].HM>*K<U2MECUTE-"5)6+*O<>\A$A"YGR8HQZG6,)]$:$U
MZ/ S2("^_.MGF_><>Q>0H;%BU][#*-;8\O$LTTW-C&YWLF*9L:]^Z[)#O==B
M1#S<D%2%-79'Z=0KH@:Y;"2QISDZUN*(ZOF*]U$T4'44LU<CZG.>CN@$HR_V
M";, /)ESBA8.&1>IO+>KF6BN2DA8.12DSCA7AR/&\HX'=M\8Z)C.O"=?X%F4
M>Z1Z:U:@AO)7B06G/1"$^3%S!JCFLI[?6);]10"F@F-FH %)!:2Y"(I#TWW_
MP*JW2JU5PN$;P]!X[!F@E\36UG@;A;K=O9<:LS\/@B3GI83_:2>1?H(5<6S=
MKVJ42##/S0WU&76AZB8^Y3(<+Z#Z-=LI73@^/+GI>K-RN]U+E!@*%C!U.=90
M+;1_J)C=LA(UN\)7B^P^_)&YEG\0<X^[66\@UTTBY],\^U*G1]!@A:/?[W'E
M0SFA3D@\Z61B:R2__<"4^S2)_*2#87R,!;:O\V'S+$,&G5,JDB_QG7M>CDOT
MDY]IXC>KUKUHB&EU7.VDC[?I@L(?^URG>?#13\+Q@'G-^W;/H2>-H.C/S/"J
M;'X!U"J=6V?/[-&2_T.HI.KZ^!#K&IO1B*RUU29^A[YUUK1KHTA?OIEY!^<%
M^O#.HHWT7:' _8+5_*;RO,[5TR,]J>(Q?E[FE1WT\KTS +O3O4E[M<&P*U:-
M::@PGYNX#6BYEQ-6L"_H;>6#"(F>W;G04*HUTJ3(#ZU9HP:79Q3D\5)M#V.B
M#>-,^JXP$N<*V]\(G2!4%.!]'J[NF0?#+I&;'1!1[ACE&U(4[?GU-VCI[R7*
MC#QRC%=L^AI*&G]K4POJG&5&_0AF?8!DZ->UK36O>L3%2U-N@EM\-^V_)QHU
M:-)>TZA(U5AF(I![69?=12(-S[3(1*8BT/NB'<5L^;<3/PWMO#<NW=?8X ',
M/=,G]TA\1Q,,LKN5MNV"8WQI[MG80A^T80;NDGEP#E"'@(;MW1=->X4]\-"F
MA(L:HLV;%$H*/O8-A]32-"\$60U0FP9C7J42"9(],I)"']2N?^^D@P9U@'OL
M>V8;S&D?9;Y]G:55VR1VQ]," <(RXDR5S:X.3JX0(O<)DOM[2^(DR&!TLW+R
M75Y3:<:RW-FRB;9JT_J'TD(F3:MMFY!G*W<I4;&E&0H+$F$G<6KV^H5?; S"
MQ2P@'@H++R5B,< !2R:C(EJP?\B+/9 DD=&C/%7U\..TX\(GW]$&P5KPTP-*
M@&JDFG:*1EO^%NT0>IVB_"Y/L] X)Y93,*9LA@ZGT-9JD!0<UOV^F/)VFDUM
M!Q:Z;QQS7%JR&GLY9DWW@;1T=M-@Y^&\>IXXS:ILCA8:N[Y<?IK?9#-HS[4!
MCPH, 5-<9@5=TNS7B]&<^)^ W24!G.]AF$N23E*&&3K%2.Y8=T1*AY)X+6H
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M3\WEJ/*]-0@4/!\6TFGZI_:4;@<?8G6^=I9.K]%;;-'*]O9T,%]T#/5JP'0
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M[?!+! /\(DT9F_((MEU^ &(1I[+]XH(%P+NBRZ/T-'/)LW$0NRTLF+S9<Q=
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MESE#[!9^/W&X4^!\"([G> =WOZ$3L/8FA]7R-O*4#<]E@DFRDAH^Y&):F&U
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M)-D_&$U:QX-K\;EF3LHKAD)9#!>5,1@,T'HKP?PT;SR.([#FN*8$%$+4@*7
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M;1=Q+*$I+' :AJ()G9K^&].$IMV(:7K0:W2Y<W-R=!X2OH!QW"LE+N'!1D=
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M'):6[<WF>YFY'6EAK+\A-Q(P2</] 8?!42+D4=Y6[=O*?E;6FT:.45'#L,H
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MCW8<L%U7/CIE9#EZVYE%8IIWR"^'_JWF+$1;_='DM]LOHJ]LL 3@L[77[\[
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MMK?G,$6!I&[(AH5_X:M=A-#K]V>\/+LN[KZJ"9]^P\CUK9:EKP=Z^GW;SW!
MUBEY76BXIEIOZ?<^$#<_HUL[;!XPR\0DGLR[Q/2LT@@,"?1LG;X.NOE(^2J'
M+LP:OIQ> GZW[W+C+"R6&^;*S]<O6->\D-MG)M_/+P'VIT4')VS(S</;J@-=
ML?]EA^C&#D=*ZROCYVU*\Y^5ZZ) ;XJOD=[V_*389?[,HZI@? :FO5RS%3]*
MD\3^=OY0=O7VO1N*H7?'A.WIJNQ:,?Q EC'8R:=5T##T:Y-C%*H*Q50<7K1I
MSL_,U1VVAEBA,?G%>$R[+L/,>)S.?!ZP-C5D<![C$*I,^J#WJP!=8EYHJ]<@
MPKJ,3HWZ(OM:\,/=^<A/15I)F0)6NQ(D]1B[D?SU7EJN+S_W'F9Q]2DQ<[VP
M<UX:37C:8R4K<FQ!"S-O13T LB Z78.0_0=3JQZH81R6 E1)HNU:GL.(<^2\
M3E!%6N=Y#^%/CV-D>8T;B7UD!9I*&YF*J!\D4SR/5;8$2],!(+( 8@ @4_[_
M^9^+/3RO]L,E2RC#8*_#M;O[UTT+DI3S-+4$4]EKDU+4YZ^E*92<)49->!N<
M*R5 36G"7_IF555M5$32\!@>G^>HM'+PY[XT"!GH7F*8D\.K^I/%<C@%9L=1
M;''++A09J1T6'6?*&O )_-G3_$>K,W0BQ,ABT#OR0)X"3"HU_K._U>"!SE//
M,(W[IR'TPZL#'.K/;>)RT7##B86OP<+X)'K<JBM!VU O-.:'Z9NFM;\07F_M
M>BSICP=?TQOUGD")Y)N^"9@%6I2G+KDP-V/5GW2>[IT.(%1Y)4LK/4H^?]32
MB!->=^'-O_/O8/T!09*U M9=_2?6V\[\!]:_W/R.&1"<(-ZTD.TCH6#!.ET)
MR8C_$I*]_TU(.NBO?--?J?YCZ,:C.V7D2);(IZ(*AK1 (N?TQ:"@R.P8;\ K
M7^6+#^>]<V>91EQ543A@67DNG \G6FOG ][@&VZVZ "'R?</3W_SUOFU?B<N
M:%E AG797_82D&O28&4U3 ?>%M7,ML*T(V7D-+]KH06*FQ?<(3D6JMRDX=X)
MOU1H:/B6Q4;]K)S#F0HG>M D4$@+9SFJY+J!U^ CB*VH9T1N@C! C,4SI-'[
MY6C/E WK"]O>IM.ZO+P)5YIG.6ZW?&I]*(F/KIO+,5B"0T&R3\M_?IL3*O\!
M /H/O'<Q)D=,ZV'#"P%_7:O\2T W%^GY./+W)<"_Z7RB@1^!A71Z@HM4V8I.
MI%$H],4EX)=(R?6\YEOZ:=;D1JJ5OK/K$>O/-Y2P-FL*OR8-X!]Z"ZF?]1[/
MQRAD0[^"[%591IKR<:2DL9#?SW8IQ+*&;0X?*'OX!=CU8$NL-,/+PP,L41D/
M>IM]1$07M_7"?VW< %E+_(*U"AI@\7N1,*.S#W#;CY(2!93).=94J,[[O7S2
M1<H<V4_EJCU<-JBOI&U3>UTB?C849SJS5MD0UZ!9.\B4!./TRGVO?W4J32PE
MH5QS\J</)94H; ,,9+!'=Q<-@^V[7)(O 5UV527;Z+>=N3R*>[A5\=>KB>A5
ML<+4MC^\1PQ32"0ML*4WC@#:XC UALT'A 8VQZAX>+5TK32;_VX'T;Z]FZ02
MN[(99:T]QHZLI?*(7Y2<2O^T+LI]]Z&9586M>^0X&65JW5X Q<LCQJ]+$_S"
M5;"+F9VZ%"%Z=_4-S$.P-]7'^-'"U[6\X!IAV@]Z0*"*^$/2-;FG38^V;8^5
MJ@NKQ2IW&9^>W,:-'BFLTQJ!]V6NF.@28'!XP4T56C-")UZ(9K)'YO8?]S\>
M\<+HO.'HMZL+>Y"=3G(L)U+,XELH]RU6>$]=P_+>)6#*ES7<[V9IU'Q&(^CF
M)0!?M+HW ]K87\K2)OOC?S2"PX8O :7H2\#Y9@/AU_>DSXK/DOYF N)Z@6M)
MBRG\_L?P$V$/[Z;=ZZ\=PD?I\C^B8@*+C&BU)G9%?G E&&YK<S-)M6\RF>X;
MHE!/R_TQY2,:OSW<OJ6G)"ZT5\*QPL[T+^=\6[,41?ER\@4T/T(TOR+ ".O7
M30*YI.!UB[?5&?37S=0,S#2*IZ-/\DAS:&)?X=BPK(;12N:MVB9QDQ5ZU\"T
MSNTCOHVWHN_Y1$+0],U3E/Y: YW?KKV<_ M4LO\OFER/(4]O5+_Z;A9F%E2C
M,B[*/+>=WV"Y:T"=0:Q^YA'#83;R;S3#F5UK.+4SQWZO(% 097C*ODZ+69 "
MN*JR<S)]8)7H,-Y_RBOU.^G2]HK.-"8%NS4SMEM($:4LTU0;U/,F6+="]$+W
M[B5 ATGE$H!V5QW=7*MQ&Y65? $CU _#RS&ED7)/QZT*(KL2V!&*498/HS.D
MV.:\HR;JG@ZV.4"$#*-H3@N6SBR[(IZUDS8/^4P13%^\$X.T%HG VL129'7P
M(.8ND3T>/.B@R! C$$Z[A#@W$O%P'Z/<UE@W;D[?\ESE'I-4MD-_;W/[8^S"
M=1K&OTB$C<YB(_VU 3=>67H9(Q$YGJ5;_1W;JX%7.S4Y>7/Q7L3B^70W-@.$
M>CHV6,I:3#'3A*O<[I[KOM:_&[LNF<6X7;CNP'+0'C^-':'.]@+B*Q>B)KJ3
MK?]E=Q+L,@AK63HCU21AMKPHI)S1MOR0%VCN][3J5-N2,B.YG$ .RGG&?GTU
MJIUF9OB"_T=^3AX<D&%)CQL'EK2[JY[^&LRZ&?LJ@)=":E^-Y6^/8C4]IE$_
MI1NUR12D?>!!&-7AE/5,0#>(V4]_M,-%3HO7!8Y_\H7)C9#V-BP88E*LY%ZH
M3<!K/^]X\/+VFEJCYO<=NHUV''8TB\CC93N!KD4D/<6X]F&@ C?HO7:>>NX'
M7W1A+=W9>>"9M=G-"(LBTZ?RT_=OXL)!667>7I[/Y..4=QY(K5U_PE9&+7^5
M=B_-B*[(K.R*W-#4\HBK? R)Y]6=PQ]7+BN_?ZU;<)_< 2H=[$]K8)6*_^6C
M]_)_[_%*WJ!<T<X?VCJA[OYH.XVWG2X7[Y>TC]$1:3^(P]I!$4.&T9N<!0;R
ME4=.T)V.7I+?=(LLO)4#Y;T.I,3W[LBSK2#\N$,5U6R5:D^"]@^O]SJ%#[EM
M'+^H;\@>*NSW)*5W'-Z7@/2[RV^59XHX[CX\9;&?'+7A;/GY>7 E9]@&QQ12
ME9#23;7Z^"2B2ZS7@=_,-DB!V4')%P'>>!1\NS)_.B;U9<NA21YB6.=\:>P[
M >E^UW>0MO("NX,:,7Q;-*U9<@EX>XA-E[H=+GP,7[I3G8*R0B<XXNS;RBT.
MJ3SO?_W[DV=DXM ;;IT%?&I<9$EG6S^FO,[^,/^P[/-+Z)V?L=N9MS3?M9KG
M)].TM)_:.30Z[%X"1K__LASY<309\MN4,)&&7N )/+T)ROF8R*,]7O^<N_X=
MSX?.Y!?TY]?#[4W\.R3N90:736ZF-BZ0IJAJ9R")JHP)+$]$@O.>KX',SK_(
M9 G\V>W[N]CN'@E0%=]G)LT!8:L:,Q+W-0W+:=WXK,=6WC7S.Y^W97H!Y2KD
M>R*^>Q5#]0VG[@>.,XB><(H8?.<3?5<'3#*'ACY;L(S>LO$XXW8@W]QC?5.>
M(=/6SF'&1\K/],O=@OF@:%V673FR3BZY)$C5UKKS_L0MV=O^A2Q B4_9;_!_
M=%+WOW]^5R(H_ZY-!UWVJYE?EX#L-N^:J++"N6.Z<6T!0:TO_\9, NE^?_RN
MDB%P*NT20.?\LFW2I]C37;8^+=/LZ^H2P\1V(L<DMF'/MBVU?%L.[#SRN KM
M4:R=J)'RY!)0M[V8,&D SHZ!J:K3/G-P]K/CE;U!&#OC-D2L.S,.KV P8K8;
MSIABRCCK.GJRN.)^IN7D$K2&G)M@%>](7'4RWSZX)@I>Z*G"I\L(AIA?]!T:
MO3\&585NBPA>6*,+[?*(L-?3)MBJJU#"&W"[(:ZO!!JYZ>DIW5&GN&)> 8DP
M_,*L\&IR)"]W?VG"2(:INX74><5X:!GOS>8I"A;N+<"9O"%DO!:HE9G/V3<-
M9F/3]KW $T-1LSO0^SB\.G9:Q\HMCCPMWE\BU'4&")R1"V%#%2RY&JA5>47K
M0QXB4/HM\S9<BFXIL:5U+!D?8N77=R=+^6-D'A3%Z*K:]( #4W][S3<R9G@M
MOUM+TOZ[)09+L;00;^_^)K.F0D63'O@VEASK;B>%Z^K6?'S36M:*+8 9O7K[
M3%PUDOIF.LGOTK 0R^/H^<5S745BE@2.EL8C<=<=XGR1#5'OL=O10_99D>:D
MKW?U%L_M\9$W&H_?'ZI]KZQ5,B57J-R5W<+<H-7MO_\9>0HF/[=P70.]3KNE
MK*]JR^Z7A)@;%D,EB_?)#9&\$@&A]4P902%39= "=>Y 84HW62GLAKAXR/E-
M*8W[>)HLBIA1TAND*;R& -S>Y@Y3CGD099$/=##AM^_/P=V,EAMKO@.4;R.3
M7ED4NQY./:YPI@DTD^0\88KA-\\NC7KWP^QOV31D"6/EXJ4$E2\0W2^$58^;
M$C,W(ELN"KV-]O042P(J6Q8K$6(^RPD3Z-Z;D:^-'KQ["2\G]2V4$G[DK:J)
MA$5--R+&\$HW/]3Y69D7%I<J_&YDK*Q_P4N$GDUDHNK[3F_$2*I" Q;0K8GE
M+THB)'%)J(V ?S!? M1+U'Y:F^^0 3KH*J1@$[?>J+Y_$6V#_R/Z/N9U-'7/
MIQ??K@KJ???=+0_W=765\!+=+!\;NI^ 5])[MX0XM0_SM_+&16$LT;,)=S,T
MR#LHMB&U/$O924&A?5%6[@9M!7OG?5TSO\5X9%DR@7<A)OS^G\I(*F,D1T5D
M2[Z6\&86OKAGCTC_S!4H9:?$Y]XPX/PSJD)0#%"'<[=T#G[7ER/%VI-B'_UI
M7_1I9,V6EDT7-KR_H*L(_+8G_1%N123;?Z RBBFY+_PM1#,_HG;HV88-Z^2[
M]+AIFV^MG&P/EZ#3E@N,[?#I!K7]?IDT^G#(BIU0=$TQL,H]^>30)GNL[GPY
M5O#51<3=&K8[J_>'JQ;*\^AO6C??O^:=.\P^504;PHPW:Z.*X4.),TQ <8-X
M87P#@4M9>)"/KJSUH=ELMR,ZZ5S,"XW?YJ7#0I]PP8"9SA>(&*6'?D/*(J&)
M2ZO*-KPS46I.RLH*9D&'<\S8L"%/<"IP>@H?;A8?&<9.3YP4+ZG@9:=]+LTN
M[QJ4]32RXS;S)I<D @I;_R;VJ@U:KT3G@XXP/KRMZ:GT:'"#X2&\&FT3> EX
M?M/&494[=\%P=>[KQ%C4_;@TX7H2 =.>/L]B^5]Z,*>XY"/+?G)HS<)8C9MH
M\Z?P*E)XKYO3T/ H6"K-?*PTNAX_9"LS[7*Z:1NV+X 1 7\N<W=S)P:F!5#P
M#H^:MH7F:A:LO=DW2JUT\]+?QH!42V$G&;WZ%A;A-E;O3]'S(ZG/I;3$V67M
M(L#27!FVM_FQ$V/8%WO(:]%O'H>_,0).48A^:AS+H!&9N3$F\J[+PT+#J8&K
M8,)-!3,>JV>AWM;M5)M3P:3R2HF^75;>P>TESTIYWK?1?O\51B58,AFO0ONV
MMO,C0?;@4Y7#5^MHATO SW-G]-(0\@M;Q^#HOABOI6N\W;ODMDUPXL;(9YZ&
M1$Y[:(ZY49 LT8:QMB&/=_CSN8S[[H1E;4Z[MN6-V!%4P=89ONZ\)"Y3G9C^
M]S :CY*XP4''PU=(O%5;T&RD7^D51H$VY*TIOLGT0)UN!\Q;BYRP<WHYVQ(J
M^6EY_2D</^N5]:);7]])[/'A%H#%BI14(CM \AICP8L8P?A_\!]3FL\1'"OT
M&".M8]J=;XD<"Q<%V%1(WU],0*B^=B\/!MR?FAEG'%)5*1QPP20@+O8#O[,M
M^W?-M@G-8?-_52\JSJ_*L98JR74*\ U50+"6;0OC"L92S ;,?OHB!@'#.Q)\
M.\9-5BB*-N^^LQ*L_3RN>^C*M271,R7O7B@T8T&FQ1G[7E^G##&W+3]^!:8'
MO/6DQ#!RQ'GU=GNT4VU*1@W;8X4<AYU$+69Q#5PR?C(:*80XE"VC2!&\?JH?
M/7ZK_$C@A^G/(5#6P\&5U3LTDKC-\*3-%VTS,W2FGU77V,I\&_VZ+I@K@&$\
MO7TB#RB"+=PH\[\O.-_XZ$'O8$BGZCP]C)Q]^N5W78USLO?]CJ$ZT-UO^AEF
M=9NQJ@;^TRN'PJM5E= L4"-S- H278OL/WSJ86_OZ=G',+\P5%4EAKE?C6OC
M[#+<DQ.R,M<N?J90ZGZK1*)NQ=[FF(E^;N9D9G&*-O[)Z'IE&N%D2R^F)X';
M**X$G,V"#Q;XX4).W*KGNY13KN+9Y;O]0>G>U\5:%T)9>]_.@=JIRLZ%5ALS
MIBJJP5D&-7Y@5S89MO_F>'$(M[USPD4'%V)0$'7.)57H9%-<4"KH_/\*+!9?
MR>CCJ,-'+Y4.7A]YTZGX+C_AG+/6@B[D/;"Y\J \;/V+4;RJ:QR\/25C=X4^
MY#\ <S%L2[).>_VB8;(YY?R"@Q*C!U/?NW(\O>'Q\'V,F,9+D9C8*<IXU2CC
MP%+C EE* Y2C8%[6I]48,N"G5^V8X2W-J=]/>S]/=1PI, A56+AUG1&],#FT
MQ381+AYY<NSISD$&D:8A\X3088R@;=LZ,ZV-0^0/HL78R"SA->_3@EKYI21W
M?V?1^U2>C 6=MWE/N5DH)H,M#"UH=]8R2V1BXD+:_;EN2#):?[Q&LA*67VW[
M#-!>WMC3%AG)")@#@\Q?;<;Q']^Q3DSAMG'[\?%K&3CN9^\&952\7.2=Z$TC
MJ\%:C<0#T(:A']ZO)>+AV[AW?V<ZB':WS"*<&0=6A*F1);37&#_?>4</B]FL
M[K\6. 9^83AA +T$!&T&HL /123ZB+-HHU?CRF\JZC[HXI%AOWG^>RK^*PX!
MXXNO%(GFOWW\_@]Y'>'<7UU@-AK--1.!(CKKW91M(<%(^S-E___#UW>&-;5P
M68>+BD@3E0Z)"H@" >D=;'0!*:'WW@*$T$,3!*2&CG3ITH*TA(Z($'KOO9>0
M4*47OWOGG9GOQ\P[?_9S_I[SG+WW6KNL_?L=L^\72@60C-!@?8WSLG@RIO2%
MCS*%75[EPV=1ZQ4@)ZHOAJ>TF0S#&FJLIK=>(FSUGD[C_^8BZ)"GX%1&6@7@
MWX3D;QX<K?8W7!3.]= E^;)5'OEC,OY75_Z[QR_GHH^TLN@/%MF<+>!#5OV/
M'W."YLLQIP_"0 3D61)<MVOA#R#O5#.<)<RBXE796*U6A?+H6X> HD8';P-S
MVVAT?5(?1>'V)V#4^O7"=\HM/&9[\/.AKAHQV-S.0;1EH=SOD6N5<$-H3W\C
M417=1_*?KQ9&Y S]<U;RUS(5OC51[*1!/S9W@>]!3FC0W(5=Q5,!#E:68+C5
MK9.LT<EMCGY9R7"A5!J3SP3N#S.:H:S?"DQ?73SB^.XD+ %9.Y9Z'X30Q0L5
M?,V.2(__$1'Y*[%N0;-I#'\\<1RK+J 93X_<>%>H3$5/3W!B'#QLN$J$/'S?
M6ZK")/+[M$PDYFXPZ81NA(&WQ\N)-QO A4R?I$]'_..VVD*LL?-#CK7B);&*
MQM>-^_Y^1W<^,[$-.(8<Q"I_OG5R<HUS"B]\#2EL[+WEXQ>#B1W/RO]KH')F
MZ[BJSY+<5SHRG HL\_F^;R)G&H=<*D@Y9L_M=XV(?3M-=#**H=0PUY+B0;O$
M9:OG$WI*.\#QEE9&0C$-[3?OVL[366&3:;T(SDN6D+3;B9\R5QC'K*@N\HDI
MO7$^;H<JBJ:"F' S?_1LO:6!"],Y[0<_'>9K_])"!ZQ:*$E$B$N.N(4F<%+=
M^O3),)ZQ4SJ:VE:?2BK C][AY0BESR?5\-"2X<C$;4?C F,I-^YX44>L5+^7
MYWK'-]V[?"E15 ]8)G.PD"\]4;_R-"@R9,P<G=.XL"7!5L:E=K(XGYN,\0QC
MB1];)![B(H6/:D<^N6D71(3$*'MUF]B5AWX"1GXY-Y I,^';3OX[RF9QX'!?
M1_3X[5J>HW;<,I)#I,"%ZI%GH2%5H^XVJB.S[@4 NLHELYC;7P/WFE6ZA2\5
MGM>DF"7_ 3 O[+[8<YX)Y9Q5R8#L:.6S[SFZ3"2T\BO<(<M0E)*4I%;D9( Y
MY;>^F.BNI)DB"!KXE.URG/X!)%<_RE*-WF3AR[A^+<>386NMU$2! K^U*A^3
MU[%[$>]RVB#<\%8@-V3@F6CF$T!39;-$,MNH%T-$[C,MQ;_]6'[S;Z+J#/U*
MN=9X?_Y3]%YY,4K*H2IJ%?R9^N-U43)F ^T(11F[19S0Z5=SQ<3),Z:?MZ%V
M-[66T2H!X\F(RG=[<6!R%] V3\JZVJ9QJ'-OT38D,7Y/C,6+$TZW,#4/%WYH
MDJ;,!,#3A5O#O-ELP =;.E4UY8WV?-V<(':<,ZRFZ0I2@-':^=3J?K@D-WXR
MF63O"1ML0T-6A:7C3"S,DM+@?P!:IXJA"E2XS=OV\Y_*P+!20PUL-W5E2V5S
M0?IOC:5#"-X79/U^UWCB4JK'>KV2(-6UNC^:\X:D2<MMR+C<NB^XLIG1Z+<@
MG0054-30Z!02TBL.Q11OSOFHA+W/C$Q*>L&,'$[KERY2)BHMS#$QTLI:O:U@
M$<2_NCG+I,_?U.@NQ>HNHDU^BX1Z_:;+M7^2<XX@BI6H[OCMFS34VUJAU*C2
M_9[ZXG6<VMQ(9ZQBU]EQSP[XM^3SGQ_&GVMG?+ND4-"%-;XH^K0-F?G>5X H
MP&.)3XH")Q<.I'RS%S@;_7RK]J#*[)&'&[Z-+1JO&+:S)FK -RGUF;,#_%ZB
MRI0,C)E*+_0U"CG5_P#"084\^..9AM"3D3'!%QA@0:2&\-T9HR6RK%>@ N^Z
MCNYASNJRF;=&-1.$'>'=DC61XKID=(<=D^"[FJ7 C0?\CXI(7X\H(6NB+/-+
M,E5J__JO!:Q7CF(53!.NS?*DC?#1M?2I,MT)3;SW,>NWA7-2+Y;R'[>BLNHX
M.YQ4>11-H[2R(:G_)9X=&J06^,K<=!<&.SC2>^F+YM,W.52[R;I-:\V>('@,
M/08@FN@!SC>9,M^X>_EI;QXYJ5F+RH_Y9-]!/OBN+Z_7R#S4'/SD%SDQ,NZH
M2U/=DCE>L&S69ITA.5X/F4^>@0R334Y[F9]U2R =C)7N2$48OQ8[ %!^]8MH
ML-"S#!^NVXHL*\"&I?!PL9(+2.W%%&1M=D^166X11P:TGW@_#0O?DRRQZ=AG
M*]>N*N0_W,2)7$[U2']VD#.*6BYB75(.U+8S_%R/^35HH?>FW_7'C^FTQ>,L
MI\>6I[[P$(;7RH)Z9-6A?-84TLL7V*J"GRIV=\QA5RIBY\=B'!7!\O$Y'*1V
M2XX]*:8;28R#O=U5JC?K1\.IA5$MZ;.S&99!&RF4F?E>,>/N?(+I/_KS,?H3
M+7=9/?=6S7:C,AIK)%C:OW8-OE^V6OKI!7)ZY?NZ/>R#?!S9<WZED(I^'2K/
MBXEK?BH"U<$WH;?/IW7_YVVR_TS"I#UU>.84K0M^LV1Z/_V$[(OZ]"7_]J6]
M^$2K@K%VB*S8G"L/.RK%H76J@T5_R?.NKN%I8W?4+BL/;(L&M^ZB4#!;Z+AY
M=%1^L]$6J8FR-E2($>8[8<>F>!K/74&VOFY+VAW8"?6'Q4X+"Z< I[D_,S+=
M-HRZ$R2I< V?O* MGW7: #-YH+:ZDXM?2 4J4A^;L3[IQ[GXK,,+[/(*F'KT
MELR)M/411 J1UJ_^.Q-'_D=I\(?>4RMDSCF-X!LY*_ZO_\63R7DQ^A)\FK[E
MT.*T35G2QU+]UA*?@5Z#6G=80B<-2J+C\>4=&B)9$](VH7^]&B#B>B$2%SK2
M=U#26MCZ<+ZPTMA+?\7RJOK+$G WOQ'3EZ=B_5"-U<^TZ]5]>DN,/M?]\7CM
MJO[ U5OO C<_=QK-2.Y+?F"(!1&GX4-C%;9@:Q] '_[[ZW[P6SM]P.M8QWXC
M-S0M7-$A)4EYQ=LH^I1?/EV7**Z]3S"DMK9RU5!]&5O7T%_DJLBZK]V"FDR
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MR2S7@VKKEPG0DY/](TLW]D&1_YC-\CT-'=Z<T_\#H&OEVNEP$<3:\U2$VF:
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ME799T'G"Q*H#9YIW,)+-5ZGH-&#@>.;Q\:S!S<.7)"RM82S^!PI63%V*$&S
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M;29]*41NUM8DI\\-9C0E8SZJOQVCEV?![E )<N&) KP^I-^JU%KI&RYF792
MI\*CFY,"Q$\6/:&O9\C#A@/>MVZ?'RO =A\N+[P1L>,6%I'LS*I/Z\3A,MT2
M26V3E:WEDANLY8>$,MM97.6#DO@AC[-<V6L;56J8.+FO.@A)#NQ]TV2")D9Q
M$M_KJSJ7F=X:Q,W.*!Y\L/N0YE28@&9.ORSQCA2Y7:V+C_UPOQ-WT,[6]C&Z
M:W</< SCJ(A/HBUGL_^-XQ[S$+%9..344)S7#^9,BZ( U/229>WF%7<#[2E,
MPXLB95U#>Q 3=<:35L_=#K6GE,W-B4D40E7O .CO0=45GY*.%_H6-T^C=W/G
M/%$SI97HF1$F=SWC_*$>9OTS"?]""T#,ZO&MW+PWJ&_M&@N#KW62'?/JH&HL
M?P!O1#>BHR./'OIP.PYPMP$\36O<?IP5/+2[5Y/^+"H=)84>:X?;7I<;U:!*
MS<7R8D3D1<SBJF2W/X9>L]%F?%L:98^P=.=J:MEC\C]D0F*L[8SNEAK3IYV5
M8LWZ$*N4/WR;R[?G8(<]"8I*H0^A6ADKZ;2&5VO$9M9CL6(YX\+W[X(GNZ1
MH9@ZB:[5O0]I['0:75__=4;@JO1J34URU*5<YP_@DV^*8Y,W _U4VMSUQX%K
MKL81%[C?9[S;5$GWH>C\7;:(P-#OA'CGKUTRD"(L2&"M4<)!B3#3E!<M]@?P
M<?#Z;6OR1 >K_N"]?1.')3MH"9SBMEG-,)Y;N2)LIUKNC8WC*Z\ZH?->&5MO
M<&^C%:E7K)9-(&9L8H7*V0<2]1T+W-WL3E:1D<SK$BJBKF(*DNX=RSRN"2-_
M,'?S?/X:>!LZTX1Z=W0JKE4V/U!2J\:[;T.ZV62AK.QR5,@2VS/*A4/>!:K)
MU5Q1?08JI]17TO"Z76#?M?J?+&!@#K=YTWLG_"MOWD =F3J]L[*\#:^A*B$&
M-$\YP);)9EXIF.5LQ<@^YU5%5@?78M;CE8VTC_^"B /GBU72BXCH:B2T>ZL7
M7-CY=^HYZM9+?AH]W^?XDU_BTK?I#R#'>6IQOI;D[DCJ2JGJJK&!EY)]@$_B
MD<>7^E;TS.?KO#5F4 C.86<Y.>$/@$,I__7'H[>SK *SXWLP4Y8!MH05+30B
MA:*/1V6MRYG[#,UQ._W]6G B(F5/.EN%4'$WY_O*S%V[-H-TN,2P. E23KC*
MON;P-7P^B-E'] PXL9;9>/($4_]"L=A\3@,[T#FS%PD5%PH5:DMXL _DQ6/J
MC6> 3[2&QZ&WFVD.-U.ZS>U8'5+9!CAPB,Q37X#V3+/4P 3>>J<PWBACRWXA
M E./$3HMI=LJJ?B:<:H\AU*K67?W2SN)T/T#:)E(XUB3P(J,!RM7;*?4N0.K
M@\-LI1GH+S)&Q&81ZA$'3KZ2='UN!3%W)R=-UJ7[X"S:D4E[A$-IDN[/I3KN
M55*C(S.!+[&M'-0]OG=<! [%MI2$3Y,-<VC(8CL*$O,&,H9[-;)F<%'YZT[>
M(AE6W2UJ87;(\Q+8S,' DS:SWC+7 96*_ URTS:FR/P!M81(VE LJ5( M]Y8
MW'#SKY-!^5W:0L9D0X+'1/"G!K^.#TS6^?U7[)\LP%O\<W\ 2J&#WE)-N$HU
MP4/;/#@Z^FQX:4+%.MM,95EZXB@,$:8S)P-'CWL82%'6S_B1/1?JLW.L/^;N
M81X^KD>!_P"VR"S<ZV;K[*II:\4;]O'OA/=;LH\8_7HG!H;JGVW]"_2:@;3R
M_P"VAQ7:4M]UYYDR&#TYC')C43M^L1:QK>V ?^HXUNRTIVH[G:SP\J4OE<G^
M.7?'<&PC8V<]/["Z((8*)5S?&OV5N6[S-[+2<&NZ&-K#5ZI+;U4]SS37>=]@
MB.3FTV@HVY6.?H>YO=KCB/L3RPE*_$N^L!"-\EHEK6D[HU*H["CG:AR()=2G
M[!-P)6 "Q+SY#<C*V>N27,01QJI$V'HNUV?DA5E?^[QJ%ET)UI!P76$:(@=E
M\0,@QJHERH+N'C'WQ('WY'YX?PY]I^B"VZ;"_B*:[(9P[:AX);^%BG@J%Z;)
MR-C4G$PWFY-_$L7D ($R,F''2;Z"AI#L7W:+!V5*R2GUV-;6^"6HN;+'+?\$
M/68_"<,[+!N(IL_2_F8?"/5J"UH*6UP]M#NDVAK' 6&4UNULK5B"K#T_>Y%9
M1_R[T8SLCD.&SI>KRTLE\=KKD 2>3YEG@MLEHD7KZX;*%-=-M+^K+L2.LR];
ME0\D<BXRAA90MH]CEFC[^<222M@YV[;4*\C">1RAM[**1'?6:$FI4SY&A1L,
M#\<N!72+:;Q3/!&5BD8$D 6RXCFK;/+_75_[+Z(#7."Z,=[. XW7G%8ZDF%!
M$;/HI=J&>C+[((D/2*CR)8[]C_T*JU8@, &=R-'0)LJL9H\.8UJZ?@E=QHG*
M/!YX]C[Q1@64U:CP\(GPU9X"\\:P)<;595*H)9U9+92L(>,ZPFZ(M1C67U-3
M*UCJ^F(US.XY XKTV9W&?7E6Y [14,)&S3KMK)TIE*-M0U_2!]3$&?X%I%=4
M*IVP?PBIHRU%AG^J[!=U:?M00,:E.43VC,KT!;7C[W^ PM_/4(VG@]_^$7S^
MZ^DI*&BCK5$!/U4$'_W-'E_:+J7[<9?""VY(22K*^DT#]8COO;UY48>0FT&Y
MY1US(5<5(8USLG"_F-V;0_GQLP@Q83-9UGD4;W$#(:<*VP3])9/.LF8ZZ>SH
MA 1]0C)?J2M^74F-"'M4I&QV9T0YA6<1A>U@GM@X5HAY;U4'H.(-]>?B44V\
M)SJV.&7/Z5CVH=:T=7Q2Y3SB.H; <EV0_>&(GO/%4"]$:&,UK9?.R3@UQGOJ
MQPQFB>>ZK\_IK>&&_Q )47NWC2:C^JH!EJ$\ZT5Z5:M5K&#5O1.;XZ<."M@/
MC&2?@;?7EIE+S.1"I"=IZMVZ4>7%E;()N@^D!AO8)G[<^KB;3/^Q&_%C:V3N
M+TB$6V>!$\T/M/%*HA/>>II,>T?1+BH&#RGDDY6PN"721)05N+K]1#M_^PV6
M1C]KY\ (8NW :AHWC,M-NU>&:/P8TXXP!HWBMM*^C$31G+G3R["UNZZ-UU:A
M?6@*TOG>6=P2-!5\ !!E^;7$O</WM6?W19E?=&)\@QTGX2.=K=1YV6:=( ,Q
M+/9*T)U2=VP?+U!@,>,["5/2XGGKKZR]-U76SB+@XZS[:I)<XKM9L\+VG*M+
MU=HC6TMG^CS:S#3[H^F*6QJI*VD,RAR.,=X)3WZX,\"VY&B%+-2+[C&XZW->
MU.,-CS?K?88LK&OME@]IY;,F*(>&&/E5 4=RN <YG+D*_\KWUU>3L,KJE0O5
MMP\SSZ.E]A1JR^ S9@T+DW1BS4QA?,U&H[U8LOKAZQT4B/^"],84[9(X@P*V
MT. W_(VG)M8:2N1AW[Z?RM[=Q4#Z'_"5_0'8,LH'7EMM[T'']#->VAXJEPWL
M)*6/C#,EM:W/3T\9>*6(3^YNG2AT3LZ_65R<N%9DNAF1/*NYJ?9MZ<!8'Z81
M)#V."@UK)7?H$BZR84IK,^76U>8BXIA[Y?%J)8U4MHXQ.#^^2Y+^%J7B676?
M7,1 Z'(#\J,_3;RNBNLU:N']9OI\(G+.7X.>?'F8B39_9PX1PS3C*VY1,I)1
MR@E<4&N+,KL+86__?IUPE1 -=F)O#DF@=57&R#9JL5E\.1FQA,:0DK@0]<,C
M;PKCZ3)Q'FOY!:>N%<XT"ZY.3JRNJ\IWJHTV<;(=3_^[:G14XRMM>Z^BCIE$
M;Y<V"VQT^7"X4L/#<!)O5\??CZ#VDOH4O.93WH_"&7CC%,5+_LXW$W.Z.GD%
MZ,H2!\%^$-2O>.5F<H<P/AQ.<!36N+& UK7\ 1@?US?!V;ZPW%%SD/^5E1]O
MYG^%ZJFXW<8=YVLAVY>\:2@ &:SKV!5 ]YK6#)E__T$>J\:P&Z,=8)?OMYH+
MQ3RHA*F*57#2F%0S#;DDOU^[@L\,NIXR[T0Z^PU-C6)*ENX/ I&'!8/)U\6S
M4]R#L1+*^A->YS6^AMHWFS#,*.]MP<TT;_G*1] \/S./F QMYV9-XF:46--_
MOW0$3ZM/PDLK=7X[;3N$]:UKGB[L>\NKQ#4=RF<Y\.R'I1)8'&7;SNCR4G[*
M W[W-NJHU I;>@)".O[GR^4C[-GXEV<./U65:UV$A&\3/EZG[@7$XA#RX9KJ
M3R3BEU,91-91;YDBYZ8M6% .KBN^=\3/D]B?-B8G0H#@M+B[7'K\[]X/8(>?
MR"@S^HBN15DRV^1L:5MQTE="A63[D+!R[=[RZ6RT7-/JMXNW+=D5-5[$JQ^7
M:EFZYXQQ>S9R\Y$([Q'7LRID2E[=I2":]:'8=#ML*U"\#IC'6F$2GZMMGJ:'
M=IZ=5]5(K(J"T"6)6J4>:FQH.K"[Q/0.QI"D#CI_QI5'!&51C[\U@$G$U^I(
MW=/SRVZ.$"F9%?(349CT@;(4].]D9<ND1;:R'\B%#$__3,1PCF:G<'>K%/14
M[="_B_;RC083"!S@P82T):JYTE;VYYQPGIE.];K1MGRK^EN30 )>:);%/E0@
M2  7:NI)OIP?8'O_KQE=4SA0-'?S]I==2,28):W2T/(,(JSO+TD7B&R^^\DZ
MZCQ$T"R>$9.RLU-W=K+ZV^V#=ZK<3%OLOZ7 ?7%8+I9'9531_QQ#ARM(OWM$
M(G1JWSDBY:X"?LYBH&C7?H2Q(,9LR[RG!X4U'C"?G?E")N(=2]9MM;U0*3H:
M<JI3C)<4%Y]&S7:=Q-=L\ES0*AZ(-<E>6?5#?M( &1'CC4E<W]6"CW]4,2L9
M<0ZL/'^FG^9M-X>CCLVOZ!+^4YWP,[S%H&8R\I=:T%BB8::&<$+NK]I*0EP.
M_DF?RVT4R>/@I=?WXMNW 5' '**HCICRZWOBBCAI,]/N_QCXIWT/>J7W]/_0
MU-,ZKZ@WY)CMZ:_N]1A6]RWGJ= I0UM3_ '8/#(;9)42B/(=/RDS;-B^K=%E
MD#C_0'2\8I,L,IT7">GT\.2DC*YD74(9'9'S>*K5H.*W-0OY%;;DBU3*]-]=
M@S;2 PW'#:K9'<9.A59X*XHK[^]5<P3&O- U'&2V;*1GT;(8V>VQYTST]68T
MF.6?F?5DC])AC2!(;9_:#$\3;-RE!D(/$&A)>P*,77='T@)-)U#U80*#Q<G4
M-)Z*0^IDE>:U\K!([U76<7>5G^N,*92@QALV3^JU!NA&@P-DA:8HI*-ZQ_@/
MP* RYDH4!FCA%[<\/D-UI+>PP0;#5QM"!SQ0VR9DO8TI/L<9:G/W&BD9&IB@
MW)DSROPI/ZATQK[$OS=J!\GC;7IS-YR><&F,,[<$;TEQ_%S0W]]=A@44N_C]
M >@93ATA)(I7*RW1,BH?RZ,_G01?#.QL0#3FQ4:*2J;PY82G(RL'-CHG;Z=1
MBGN4,V0:;6 >,F/MS*SU?NZ'?)_H=,I6I.N9Q3W):[,X4$3#<WM)M;('3'28
M1UKR6PNW=VW0S)KP'N\ KK5'-17\&.26F]6 >UH#5&0WQ[:"'G&#L;RA43WI
M[Z?%=XC(%K>XIMBMH^,/.%QWO#!%_<S2:=6E^U0^HC+U(F4.7OB)5(^[?P O
MNRH@R3E9Y$N]5-](X*]9I?UTGNT.K-<Y>&MGP;V-8IJ9[4SXAK13;?_-'C_+
MF=I4X.0=PSN=XJN_SEY0NR^!N(>#<2+@QX'+!WJYWO2E>E^>\(24QQ['O(_)
M,KGP38:S[C=\(70L^,D!\[V0*6U6TG?8,NT_>R\Y6+FM/MD48]A2&R1H<WQ\
M5XX!*]^Q8Y"RJ;+.GH\*8DKYBP1;$7?./BWZ\UO)R*0K\JG8K*[Q$<AS?:T;
M']<.%GOLSKHF?<R@'U7=EDZ+4A+M*(RB-:/,XM(P%XG9J ]IJ]^EQY%$-AS;
MLOPUF?6MB-0[.I*39Z6>2H87U=Q-X_G!?\ [-T+N%\,S[I2EYKPNP8<K)&\6
M@Q;UM6@H#6U$?#3J*B_XBLX>'L@;F#QZE =.5@-8NNSZ2U=PGZT2DV7+NT(T
M<B;LY!:;:2)+">LX(<=1Q^_A9NS(D"G$ZUO$FTC>:DRWZOBFTVZJ12ER^"3M
MU,/^.NFY" O5[6S$^KSLQPCT@D)X*1OH2VS\R/*(P-#95?5O5%19"60I1J@E
M#VX2FH=R+] VAOR8,DN64&FF^&!A,;5*G %;@P6ZPB9S5WK&.8IY/7N[6:?:
M7><S'Q:BOU^:C'(SV!?TN:,?NTOERQNQ'4B,.F::/ZX=V'JU/4.L'/.2E%C,
MZ(6>-_:1=Z/?&YI1F*U?O8]_2O+SS-45;9R%X_S\]0!K:ZLH1]'J3@CJ2%R9
M=1QO6ORX/U/F#P#3<=((VJ8A24UT_I_K]O_?D&L[Z-3?2H+*39?V2%A&KX)=
M9.X';@*7[=>&80'=L!EK3G3VMN,>YC1>UJ3O@2M>9C]AB009T4*EV9&DJ&ZJ
M6=>"A-R*ZS-U'(VBE3:4(>FM;2'^#0XVRG5(=(5J%[;C=!$;4X)4&F46/'8N
M@Q.K0P^H9JJ^R%;,DJ5+)<=#DSHOQ,\+P),ZW9Z.ZK_AE\B$S&S*3-KRC5HF
MX9TWNY-"/\3R:;.^QN1HZ/J]NDO207142SYV^>FEO+-(6HM8>3H4\WWF]S*+
MH4^*Z)G05W<>Z5=@O\Z-^<]B<VX*,S,$IUTG+H^)8@'E\$,Q;UD2?&9Y93G*
M$EP"#ISLIR5Z ) DZLFS:D1\<1A:JM.)V#!IG0:7]S.NBKQWV_<-7V^!_YM[
M=T67.8.VE]"?)Y*%J^]&7PW3W(L1/=Y5_MT!FE+3\64D-6!"\!QW/#*PGZUG
M?Q0@4^!QFK%7[NJD8G6*/LW&*7-=,<I HIR#=8>'RUD QK5UTS%?N*FW";/1
MWX9IO055QH>$%XT&B6N$RH%.6Z32;S=JRS ^&XE;MGN8UM":7<%YR4H\U^6U
MTP2JR:FD<?MC^Y%ZZ'J9G8PR]DO;EHXY(03*04D26'L1=-Q;]6DFOOY4_Q01
MV7IG[9&(#_;]S=0)!& UT_(X>$CJZUGEXI /N%$$TC'C95R,R2RM@8SRADTO
M1 ^ "928) (^BZ;+(&^],J5'L/&.YX=:R";/;\NHTYC1LSRPASCU:'M<8Z-4
MV?&W":KQ]1_'$G?+Y[,I5T]7L>(HJM;415'0X6GGMBWX[>ZSENS'L_A.\&L!
M/_O:%;M>!BH7DL;^$0!+-F5P!4G 6(&_XIL2KLD%'W#,Z#ZNU?O\0\9$ $\6
M%@<67N>A*!.H+E7Y/&\7^ <0)Y'O_)O'H%4DW4;S5XI @7:I?@;U>/'#Q^5D
M[US:'KYEM6 :$BJW!1 =:B7%A@7M%T%-FCV9)R0\3CU;+7&0_ES\YC.- ?SF
M(.>DSVI,IFIDB,*W?%Q<IVA*70;S$25D-T5TK>'Z@V45;%>LHM8J*@OL3I?
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M3_^',Q@1"85G133R0..\'XX-39LO]#)JBXL^U1WM'OZHWZK B3"[2G1$^SG
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MWA.>2+=[V,HN45X6V5PHR^T<8SO+IKIUMD;4[W(>/%266YB@9>7HL&V/B_9
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M;!7LX^Y-<J_@@4)T<NBXSN)MQ@U8J*05:ER?4E38)ZB.^.'$Z-[%Q$2?!X@
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M2E.";9^A_)I56(BLO0 I?.I1ZG(13$,+=R#;*J:N1VU8CVGS:PFT,S2Q^O&
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MJQ!BA8@1O]@ZY8I+)),'^D$9?/]F:OA_ 'PF[5SJ>B:MD'^P8_5&3^:#=29
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M7*+15->[UJ7FYT\^4'!05$0-;.64Y?%4K<:I_US?7K0;GQFOKBA>"62"U$4
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M1Q) IW=Y]HK;:Z8,XN=)7S^<KB4-PT*9Q4C5_O_QR_DZ8D\ JIP>8*3R_%F
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MP>ZD]F-I$3"]0I+^N9Y-Y530'*'2KJF7BJR]]_(E),AQW-]>Z1DTP7(-#U]
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M"BHS-ZSD2?WY"&<B*+O4AVR_KIM:$I*1G*!ZPK,>6T(*G*UA<7BY4OFD<<6
MQW >X^U!R3W?1Y:>7S,/[HHS-F6X4%N=1227 D.RG^FE9O<K&ZW9AS5W+,L^
M>)&GYC$+74"Y8T,!0S>CV-#[+"$B16N%/\AS@RUJ$!4%-E9ZG<C*6A&AH(^4
M#T,=SOG,VC)R-/'^6D+\.DW-Y-1R>V5,BDT-:7$4#W1^K0=.(10B^BXM*\HK
M&+1XJLXH@(6*Q?G/#,GBOW0*<Y)(4M U:BM,5YM->26BF-^\7\!NS(7Y+JY
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M6BGWRV7#TP*W/4HZC#C0O?IKF9=5<WB%X0$G@*=V^(TD*NL)@$TTXS=B-UD
M039MJ@&.3P:T:J0UK&_ ]A?"'61\>[)Y20\9-C6L#0%"=LFTKZO-0_$G %\D
M'_G B-A=7&OO E/;4C37_PT[FW$^7/KQ7?Y,NTOJ07^61=^31H9:K1@,A>@0
MQB&;O'<SL):+Y;;$GREU3OZE9TC@9&>Y8MP>MWU:YW9Z6X:)T6.@^K/WVD'N
MS\JP6+J1U$)Q0QDHG#M,_A8)>,C3BLMJ'1P_SL7K@AL@2VZ+P1I.Q6ZZ(2R6
M3-*_I_[]=_X#V(/43@#/G"&_%Q _E)QFXPDJ?Y@'3@ N2;2XF3E\I.2,M>'9
MA/^KO?P' !: B1992TE89$_6(M*26)4)]S].JAMXY[)\K>K09G>0?UE(%Y\P
MG[VD4U='#:2XDB,=CO/@H20$#E3IC4_6D SO'C]_G/?ELB8ZDE-F$'^1C6%(
M1@JFN8XBFJ#^J)O+T_I%3P!_+]MU1,^[LLUVR]"^H 2ZM%\YCD1]V)*X1,(X
MHAG"UQA#!MO/>*9B'ZW$2-51G>8TZA:UK<FOA)O3_ ]7V'+1[P)([<W:BO>#
M3@GS=HZNJ&;\&2)Y%Y%X3],6( */_5460\#<,#M]$DLSR?]F_O[?SU[Y*U>4
MN_O]U33N0*'*0CEK)?V7TMW3$_ZT@X+?TQ:[>4A).[KOJ7K$W_G-[^"W+5E-
M<5%F??%F)4$:(_DC9>WY89[W3,K990J4)@#7 ]Y.$UNISR%D>>!Q2E$=K7RN
MB6&S0V67G52 0PQE):%XNS5\HKG;IKL>%_#[KIPA.G2:!-:=S0J/,]E0'D,^
M8^EC7&>D\F: ):(G(?SP1Z0--) CFMV')M'12:RLT):6)6FGKH1];"IUZY"T
M)[2>+;U1EA-V7_CA0ZOX%(H;8N1K],@)X% =<@+8U O]8D^],0U^< + 5!/D
M*DD*BL<R/6"^]>G?@9(#]0OFP9Y2?4:38_ZZZ)JU[L//<:K-(2;+%Q@E#RO(
M6:1J-+)AGFXO'.2AW@YPXN\:GBGMF=]+)K55DYHEUW!<&Q9Y+6K.E\;$%)77
M;'B/D@D60&G8*NX$L/.'0C>\OD=E<##IVEPKH8[+YV_0-ZWP:8N/1=-'VA?7
M1Y[/R"B0"Z.M.Q.^3W?+4-U)B%THD?'P*90-9K2.2/0M2X8KOA]SU_QT^.EJ
MHG]5G+Q.#A\?4Y^BX#ZN.*1*D7 "2"D5)Q<3.0\-"_H=7V_YOZ;:$!/3WL8*
M93<W[VC5K/?USEJLK;3OCCL"CE22(4TJZ'$1^..Y:"&X '$O<2\4R(U9<H&E
MH6E*;2\V#[FO*$E]3%Q.D;:];@_O+S\%$*]&,H-]@:+?J-XHLBHILK_((I8D
MP'TQM%/*H+] S;S2[S#ALWK?^5/VA?:7,7_DW4L!DEW=2P,MD/JLW6!2%AK!
M]ZIMJOLTW,A<]^YTEPVT:OQ1(#24XX5'2SLLNTC.N[ P#/ZBE]F,WQ',3;V!
M:H;LOJN@6A&;$\N07%16'*5$:QH=9CO&Y#AV/,*0SYS+-2D;8$$$[6=^K8AY
M0#UU7(GP4\'88;\E95+E<<!$3&B78IC0Y-:4:XIF"CZ[I>;UI>+[YFWI35-:
M'K97.%-_UR4BF@>.T,A% 4BZ!"3FMY(W.K_>DFN%>^IFSK)II-"*:0I;>LOT
M?OM9L??UPP\J;%6H ANTVW=QR&/T">#71AA$ARI#0J!53B%ZU;M<:N :9K%X
M3H3 EE%DM6)H6UM3(\7N[TV2D0ESMMJCKRQ.Z4$ Z262(J%@%TRTPY6LT@<1
M(AOCNJMP-: +M;]YN7SMM$E;+1.Z%]P.D[X83H>-)1-!#[0#_Q03 B/F!R!$
M*Y7%4<?Z2P'-*JQ;K<]$!N'M9Y3;>V7*>9YF1?PQ)OB2Q?'@&&FE9J)Q"DB>
M&DGZ79I_U#!>Z[)5H.I3EC/MZLIR,TY%2<15ROZGX6GM<=<3 ,ZAO/WXW0G
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M@O'CTMJ9J[8M%+N$2Q)_7:3G1E:/SZS6?'83$@8D/ND]76<$F5, 4&LF4+Y
MS"K!>%>7'M/M^L&"/T@8'\PNU?9O;>,;)]F(\R6?#M"I#9>4NMHP+[+/APCE
M]7+-[H+KY7?=2680\@8!& L\C6V&2OD\6=]?NMN2> 7^&Z(2HC9X2NM7OHYU
MGMW:M^P)NU$P$\)7E7(Y&K/:-)ZJ:<FZ72I/?%YZ=O;L;)T&FZUOTSBYT,(M
M;[;0;M3[#[N7%:>*+,YI_@3@9J;"3YM:;1E'6V)L77@.^FGL[<V12DIU5M6N
M6@LUY??.!$1E.ZD^JY:JM0E9E 4\I.O+72F*.VW^V=9?NZ=="-P2"_'W%^V(
MTD\UFRWUC8:7%87?#PDWG@(_TOU^1N_^,.H":(AD=OB*?$!J/'P^'\U*&Y^/
M ,5J/\5^;<1_\OK&GF/_678H('OX;:E'[*D/05]L7DA]NG("()_=H*:"11#;
M%(L3P.2CN:!ZO$LDC7V,XD>]0]I(IDK6P.)QWEGG<ZC;$<ZGO!)-JPY2DRYE
MOW.HR-9K9WN@Q1<^"H@4W4%17.#6$PB?%)0W"L.Q9%DP&-+C/:6G7_E:-JPM
MHW+IS'5!7HEZ6YO;0A=&VQ/UY''RN^)T=I,G #[:>9@*;B/UETG91*B.;%2D
MW;22.VT\Q;/P7/.=CVKU!6X4DF[TMNY$T+@GY>H 'KAD=[@??YB0U8?)2NR6
M(+NB%WT?^949G]\.5QOBDZ2G;7N*S)?>)=P9R^Y$@]T1F):E0VMR%>7Z=L11
M/%P?#V19]>=_\ZK:A^_2V)NOK=H/OGGR#,=Z'IQG2,MT!S"6 D#-QVG@0$L)
M6*X]N8I((;SD<R3/X]8J.A)F?U=VE#L[+E$++DU6?79P<E<<U.KX<AD :,TG
M"Q)6=[,I'H[;-!!9/Q*'8B3+W/Z4\W74^%,JNURW!P<-4JBA)A)5&]/M=CN'
MA>U*%46(>H:DO6M(V,/($*0_O?E&MNM'"&B86_9'V!=R-#U;45LW67@CRR^K
M^NH9E_I/[+/K&V OZ!+G/;K/C8)QVI$-2-ZX@A1!IZ89Y<I)H$6KM3"E12W1
MX33+C>\/[.,S:D%W(F*BN(G&ASOSW5JTSZL2OW4[3>!*)"AN/?ZM^9.62988
MB_QY;F9T\$A;L"R7A-8R@P7LH>(PV .9AF@QWGV$BX3P^2#XNM3IWM8 E7M[
MYC>WF3D]O%2IGK)=$G!2JRLX_?'M4#Z/ONY7+)"B014D(1)0'@A,-;XN4Z-0
M0\D.+Y\4ZK_M<A4KE*\;[!]^,;O\C##/0<FK=DP,ED7\=QU9IH!:I#ETG-Z*
M^JO, ?@#/A0A(H?\D4M.^-N.X P-7?.[9B2YO63U,0ZAN;/FI@GX)42YUM2.
MG&(LCS:/7>O4*@ <@!0?(<T?OLW"LR;+SG;Q$O$NMP@6T_B/K1F[V-:N$F%A
M0H;+U^%9_2?0.Q%%I+U8I/#\X5WZ'*92W:?@WK@QGU8T4& $6K'LZ.1UN4 B
M)4\^:LTTV1"T[L%EM'Q_XQQJYS?Q*R0=V<2Z.XLMIN=*836CU1BG6R8<C25&
MV('.^/T]SE+R5]6YF*LH1KCW<2O"#\CN1P\ (,D5LGL_B"_3]/4T7.%^G&D=
MVO/Y'ZB&\A<LM;+4)*^09Y8Q]3<O2_2J!&KP!+!@B;=#F_.[$:O02':'IK"4
M0($QIKLX1]WD.U;806R+\)'PA9Z? '68W0Z!$K8%J??N#24KD3AQ=BD$TGI2
M<!A+O"_W1Y,ZC&^IC8,+,E@Z ,V:X,&5GJ"_A0&RH;SI6H\J2>?M"P\CL68$
M5$Q1#0BZMC,)S_L#)AW?USWWO,VKM%AJNSAS\39V[1ZCR-+AB^-&N#M%Q8!4
M9T*2BW\#,^O?FG1%UCN:O?77]697&KT9B-&X^>"NWXO,&?=$7-;\"M_QZV@E
MJN=Q(E6;)(EKC0\(74WI^&X9<,EU73'27C83;R_7CIXJ4WSAD'_MSVAM",/X
M4ZK*">"Y/%T(+@C:GP"F:\9@&ZE[W6<7$+UGN@7-L$DS95/S-C/%:&T)@^&&
M2N02M$= "+S%R8_2\S N57_&:TD>IYC"X<?976'$V2YK4F[_"4"@ *W-*=*.
M$Y[8J?&:LB#?3JYAA :P9HL8W5=K5_C6#,:^0NY'(QH0QXD[X%^;S/ $BO4W
M.-M'(K@OR@SK_304]LN?,Z\ [2K;4=_QI[;0NKPI,F5&<9Q27* HSD^M\KJN
M"VJCSV2LBT$4Y3%M1%MKVC@8JE5?92HT>=DC]&I).U?%0WW6,ZF 8\EYW(RR
MAI*1DAQLM]FX)3M0_KFGS(MW;&.]6"UV[#%WM%YTWXH@>?<1Q1]NFF9,>I/D
M^]XW6O8;B27\U8TB],5WE[N<H+^\,"Y/!QZ>'<1]/CS.KQM9C5D5>7V<C\"6
MH\2;@*)DJ&M;)SD6?_'LY&"A7ZU)^XRT_?G[.X7)%>W*Q?5-6.D>J1E$T\:N
M"L6#>I<T6$C1V[K*&]LECN-$-DI9VL5IYY-SS[UROZ1^'_5\1]C=)>;MD^^"
MVR> >N!N"GXO51I$"NL=3RNRJ<TCW>U+W3>]ELS)_.O"R.FG,;=2A$LD+SSI
MZ+Y1.XTL #'!'6? V#R:+CD-FY7BRDH2/HK]?>VV93DLZ5:+J?FP59_ZNNZ0
MX,_DBPIL'IX/C=VVD43+$\ I,@J_NJM*TCXL)&DG_H0KEI-363].7H*:.GC<
M(<9A ^]\SEYZ#3W#XAW@[=O#^N._\G'D?_G1I'"U47Z7OATX+ G 74TW^@4*
M;YP5O40"WD/N@MB(]&3]N1:Y+>_)K94'N^XS/+"Z>K@XQ6"9>H\<2BAY,-KC
MJDL.#7^U,"H+)K[T<;<,7QW)SL/=^2G+814TSB@37W1@N0#I!9TC9M$#ON.&
MRX2FN<BJ+3GE+<1WVD\KY'I!RZY&I=?3CMAS?/I<[:PR17^S!JYJ4V5=Q69_
ME2R!5KTU:W<(DA.UC^*W?_@PCJ >U"6OG*-K>V4RZ\#*I1EP,]S@O:.9TK>-
M[-,@?\X4*ZGL]V5_;(P!C^M>).TZD3P1V&+0*7*-?\T)P)=J--,\T%2TL:,U
M>HBFS90R\.;+[,\_#G[M>4_ZS[AF#443;D&N) *Q 4#FVFY6\F<*7B41?2@1
M5.7O@R)F0<)SU0=T4.YKK]\^%Q&#MD7FWUQK CZ5UIHZ 6"+(1QZ0)6GOUM(
M6H4$-L_.J5SSE\L# ML% N*.YXKGP)>J?RJPS'%/3+!"22> 07"3Y0X2.Z:-
M;TT&7?A!NS)1\YO3OLL0=P6NR5SYJ4OP5NKJ@Q?:+W<J=NXJ[DL&,TKZ3W6K
MPYW)*01>C/00-JROQ.XV\<TK8-(J6N($D!8JR=O:@N0T_=XOW,6<)_T K2H
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M]LC0?6^X]K7Q[/578B*,_CGZWSD.+-EHX\"FJEY44BN$4X^!L,?\#28N M-
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MUL4:[VCB5@$PT&Y-G1WZKW%AS2WV_ VK')S!BFG.T".0I/@5P 4LQR\4*VW
MG- 6?=$?(K4^#;?!CP,OUGM.E9J>F6A:6(WZU/R\\=Q'!=QYI7K]QW=L/IJ%
MB^Z>)Z[BP?$(MRQ>,B\>F!R@R?V@?Z#(J*"*G&O07E)[OHERZX.@V?JYYR4,
M0Y^_@ QU4\8 ?M$SR :[!(37ZM.K58.0!+N_=0G=%V"&9[L1_*[^VJ)J_NSK
MK\>E?N25G#\P4.VQX>H5?8KU(A_T=B!V14\ S"Q$[C?=T+/$PT9BW*K5[.-J
MIW>!MG]%NHOT [66=0W7-0*L\L;S&0@*46 \<(=$VB,<9G@23P!XN\PN&7_B
MLCFGORA-N+$MWF[^01;WFDE.4.K2H[>7W+V8TF-$OX-B57:./PQ1?'R!(I?6
MIVJZ9-RPEF1#.\N,$N6<X"<'%TW0T?;),A<HV._N03IEO+G15[7BRZ.G,*P]
M;XAA&;_!L2O<Q-7#8K)*C]9\1+R?MIU@/C" OPW16$N-L8\9S<R*G81S=K61
MPRD69$D+\C7B$+XU'B2R_7$% RLW)"6F('CRW,\8%:UL+;[QYNLT<7$.XC "
M %J,)Q 2*&^(R!98K F5#F&GFE;2,U+ATESEE'!/O*)OD,:8ZY?6PM-J?P*D
MI1H 2X21*Z>#X^B*:943I.D/$?W0%4YR&G(,S<O,]3W?@L0B3XT_+KHW9?*A
M[AKAMG"M&&.>K;,BLV)<%8QUP%5C@LJ)&Y> WT)@&G%V64%4P]#J;V-OJ&93
MI5O;EJG]X?Z&S3DZI_37+MYYUUS_TD24F?4MU:R>))^!< <F^.-X^?W!306Q
M 9KW+$6TXJ8V_]:VO[F0#4_*L/_R1,00=K#>,J,T^5WZDQNQ\;"$;/MW, T+
ME889#*Z<[OP462QEB;_9\133'&>RZ)-FF/?B@JSR+8;8'E9&[7Y$O5T&2 @N
M31S,)>[A2^:*"2623NTDYK4!M"5+1LUX<.M8XOJ4"+"#X>Y]IH2SF:LO @'[
M_R@T,KL;Q=R'$6?1BH?$=0P,O)SPHVOB+O,J9T.>MB^H3IFQO)R+Y1C+SVC4
M:-/]6])SU20[&[(\CG<I;?"JP'!H-2]_O_#+CV^]6HM@9V+E 7&\SST%[L>!
M+&!UKO&'X604*0M_%*OG1D(Z$FU+*F$B?YJOR=\DZHFJ?9H=L6&H:F_G^/S^
M,P_:^3)VGT&R2'2G"--*U5#.(Y@&0/5T2.HVHD\F%\S.%JV</76NJ="0\UP'
M*X,9#XNE'^!@G ?1J]/%_H$JVS*':M;35QE4LKS=B@+S.Z%%$5#:U/[LW/UM
M&>5>N2O]4F7P@3QGNJ?@30')'5>A'B 6']G.:J9EZ Y@Z@:N*9H6.S4N"4TN
MRZPZ54X)B]GUF*JQ,'HSBM65V6'K=HTKX-KQ.-<LP@D T(\SBU3924.(FWG"
M-,D?;#B,]&)?</6>JBKL"LX]&B1,PN8/K_E#$E ,>NQ8W6K=0'G<4$93%K_S
MR/OV3+-J?Z_"6HX_UL^FAP]$>SDJ\D=YL-**%&O:UU*>XYQ<' *=E<#O)RU"
MDG75GMYIOFA4%?I0\X6R5/K($X]G3<6I?S.E]3/U(1.I1!3F".OZB70"Z(D6
MF]2[%E;E\&VS],+T[W;DW7R3R;+8EQWO;H8X_Q1C8M@RC*S\;R6S_QG @+N[
M)P"Y1R1O6D_.">"'F2L[Z0BWDD&R(R!V#'!(OB6EGQFA5=OJSIB1G-P/5P,K
M:$[I&<.#9SY4Q57$L<D":Z.O415/  FKQ$<#I8RT&=H ;:7>'[S+V_B'9F2B
MV_5IM+/*O'_;N;:5<N4$$ "W)(L3>,DF<"395BLBHVJA>Z"38K9K:XWYN;K.
M*^]=@!*#;YQVUV# K@*CQ6!W<;R["13E[6[6"8T]MI75K:N):; BS8HG$\Z.
M42_=)&2MD!=RKK,!J-^B;9; ?1 FLO]ATG$SRH<;BF?)K2(W6#*;O_%Q9"FH
MOM%J^S> 6RA+-D5P+<Q4-K)?^',)SH*'%05W(S.> #C=\6%]"+H;#CH!>"+Z
M6-\M^X'=*<"2PSTM3?-BZL ^J56GW_L:<PA=_" \S<WLR;W@ 7 BDB^H6XR\
M:E5OKFM7^+BM65?ICBQ&QK?FN\<Q7N%]$O<S8>-:+&\)?=BZIV">:![:%U23
M7C3G+&&Z687_!/!@*R(I7FG/C:*4*U?ID[C.:<B .] ;6%G$#'DSGFI!!"!8
M-A&-=3M2X?+])8*WB3^;$?\'>^\!U-3WK0T?I"J]-R4H5:I2E181:2("(B!=
M0'J)] "!4*0W 0$%I0J( A'I14+O2!6DA@0!%9 $) 0(R<OOON][[_]^M[?Y
MYIOY)K,R22:SLW/.VNMYGKW.6L?5H7AEJS%GB/-[SB&;+CY&9$B5#(3V,$U=
M_[*G_X4G*/20R/[EKP(^NHBK;E;CO9([$(Q8;TC 42#RDH>5ARIF"NJL5]R@
MJYTFN\Q)A^B4D+OC1CM!!E@CF*#^F+GNY-UXDF0#:6I2UFMVZ@%@R?F",;/_
M?E#K1X:*URPJ$[0]&LH$;HRW_^H' DCS--D!2ZIPKCCB$TMTP/DDM:;&+@ .
MK<IT6Y+7,DQ0&_Q8S2W;\8$Q@^X<,L 4 5B3)OAT$XB^N+O='.U&\7;\C3$F
MX?[&UL[ZWUL:C2>'$[24S++OVP!;+9Z?9O^J@TTHD,"V8$$)9, -P>H)8K!T
M;,K55Y&NMRKK>T]-LV*K;QV0]$TU,=V?,DY*CMD!9X_7:L#=+\6NV1#",?F(
M. %Q+'7QM(+UEK4)W*>1!B2Y/64]O*H2R9TYW[_]/=L9.#+%B(P^CYBQKTM/
MJD=&[L-X3#'P[:AW2^IOJOM++_YX\"AO82:KX6''I47:4<%SO+63T IT?"J)
M"69!0%1"F_"!4T@W>QI"FT7S7 F.,6]QR:,Q:/U6TL#VOJ3JT646B7[:%:FJ
M@75[RQFXPRX[=&  R:P6LE:8RH=(47-8/0V5OD]3J!,]=X\KJDG?F_JM5/E5
MD)?EF[?/23_]XAITMV/7F"F@'WJ#R0 M20X%NS$!TXTX+B@MLOVAM#!Z-> G
MGT+CN#S-,PRX-1BQS!]4D@0<I0^@.(GR:"."*#PE8#<F+SXI(-FMX2OVZ^P;
MS-"ST+AG^_K\-O/?HQK5J[8R[ZO-:SRVH*_#T:[*)K3K8S7. I* P&E2-5$V
MJ#$JX'/H7%^>>$=#>ZINEM]^/-M@5W9PYGS@TOF-CD)L_+;1JC?S*BBI@WLK
MV*HP:8=H'RA:@5&'&!=RM\85"PDUS**[.3,5 NQN22A#1)*?YH)KQ7K#X5V-
M2.9VW1/MK05$#P_&6O^/FX)D6+C.[QFY#*K6.'R0;5'QD<Y#=!0'12<4KMU!
M0)VXP!2P\?UCHO356EUG:[5H=GU"=B-M8R'<1[\T";-:DI-TBP8ZU"/HT,R0
MBF0YD\3*W0C"5;&N9:.N8\[T>)_ 4V:K+).Z::='WLLE,>?%8V\]=&'J2@"N
MVQPL&=7#3$\S_XQSV4/!O0*TN$N'/;(7"5KW5712,8Q*=+M*\R'.7 L;5_=D
MKMC\OK IF",8W3MW?17^;;%717?G/+HP14.6T/ .NMF[8%N]_!IG\_/ZPJ+:
M@[[U@4OMOD.-R\:O>%)N^AV)W12F7.JX1FC=1Y.!;C _H=2HX<2;E%B,\@C"
M]Y"L]1G;!A,G#B1HM>:*$;EP)S(PKX4V2@>?O6 RPAC1/X(BS''EKQ=R6A"_
M<C"V=S<V@ER#3@R8K]^]WIWM$-W6XN("=MRRL\"KDX'")PLO!.X4.&?J?.*/
M7?#G,1>\[M!_OFM<\>@S]L04&XCH3C4_Z;)OB"O&HE;7QH/VH.SFTW_P<P&U
M+;/6CT0S1I]_N,F0("0L*<.TX2(H8$L&S@M4HV4)HG%9Z$+FI<9/!1*$?-DX
M'^&F&7/V=]9JTWJ#,D87ZL+?&+=T2@JYK@N#; EM6*W^""6"&7=<^^43_D6B
M!H[FA4/SA)K!6T+A'>O/*AO<%KIRM,R"CLWAHP:NOJJ=#HND03+P:38+9THZ
M?P!9!5UT5XG+*H,F[>V;U<7=ZPEVY?\RYB[WO2#HF6_;Y1@_.C5\WL"V!8X6
MPQ7KBF8^"Q'U7"UKH/CG2V]S^815I+B4K5+HUC/IVV:>#XF?%#WG#I)/7;P;
MZ8ODUN!;(#J?UL-=JU4Q&NF0 ">L]^^R#VX6_"Z->3_5/CF\H/QTQS+!RZ_*
MB9?:T HWU[/+!!,B ]'/B52M6+MD)S2<</=/N-^ 98Q!H][EMJ25R;+D (]S
M<4PL.0![K>:9JM.HQO)):^$CL:Z]S8'IGWK0GYEV[QB"MLN(ZZ]>Q.\G$]MN
M._'?]Y\Q@X-(XRCL:](D^ +I*AF A">36-P";R _10QLA#?M!&U</.IXO(=W
M#5[R7KZQ=0O$2!K/[1 AY*Z-)Z-8(6!72:,TJ\^;9Z*1T+"L:SO-&C#B=J[*
M_+IFD+] +[RCB,OBEGY?..\) U&)$(5%]A5R22LBXME@<H2P*@^N!61\ />L
MM"*%JVK_2 @??[!W;<ZC>8L+'(\9]CR=;$[3B+IH9**&#"Z]:SQ9&4GOB@NH
M#JYVS_HQZ:GT8+E6Y'=)DCN'KA![9H3#",/C2'5Z?,CIFRH2Y0(T;6^MUZHB
MI=T>$S8)KR&DF\/T0R2B:]_W5CS12](SLXM<NW&!@[(?N5JI(3U;#YH?UYVH
M?_3]#=$!4PWN:3*?6*'7;6[*<,XN8A<08N/A4G*\M;#SND9SCSD92:7FN@:)
M-8%Z=H-J/R-[=EG<=?A3*7M;C1+_:+=-US@$!O@+/MVCD8Q?ZFT,9F^G 3V%
MA1(NH1$+DN@(Q*H]I^[U:45JAKI%C:'J<M.7ZUK3?HU,=()[=((9=IQ5$7UP
MEHC+;N81+(3T$TW/@NN$$,9A?=\2K9(NI\!WG6F6@FV?]1DRTUO/4P0[W5BN
M?T?+>N+7\XXHBZWH)@/IH0[QMPG[92-.;T73,A2'"5$UW.P_TYY?DXMUR9CY
MX'2A*\+UMC+8:9S>C9TT:"=)R&)J8DZ&>:^-G45="YQ,6QU;]63BOO/X:"7D
M\%Q6RF_G[M:H[:LG<N45)WJ/8&8X[H3\1TU8?/YI/MJ(2??)Y1@]IC:75]_E
M;A987*3I?NP;UYTQUG6B>!9?<KYV*!#RNTF":2-==C)3OR$U,!X%,K"\<*:I
MXUNBX<K?V1R2==<S,J_=,@,H1\^8"&*>'JV<"G;<I9--)+*7$N*-<3*OYZSB
M$.%NZ3#+D?<A_L^?) ^G>XCVVQ;[7;-,//K0:Z&2WIO^S6(U/JY=J\K6\[DE
MS+D1.ZKR=CW3<GMZ)Z._,WZE66>!9G68 X#2?![ &YV^(H9AC.9!G?@"=L)Z
M#52RV^[RU%@?*5D@&Q(HW7;7*$^J)M%2.J81+[39H\KY35]LN=WSA(,09D;0
MQY:B4;&*EFJ2140P3C$]88>XZ!\F,A\Y.LZ?=<7;W2[8;TV0[>E+08!9[*\:
MOA]6KEV%\Q5WL>,]A1?<\S@B%'!*N>C\+4-6AZD%_$S5%!U?H#&'<O9ZCE/D
M)PVH%/-Y7/!J? K1&_M>EA&JA5=N.B,0C.(]OD707'V<1D)3:."H3$W:$R:!
M6WU/3U[F?,$$1_;\9DZWIVQ7/-&&R7XETF/>;:BX%!7GA+G.*]8/^U]\%^IC
MWM5%):!)Q2;9W9#^#8%A[I6^,-X-.B-^;M+^_6#FRRWZ,@IZ 8^D?!IX6$>$
MN8,K+V>:'&H*RFR[\C=F Y@(>=AU J+B;%*[?2.HF#SF_F6ES6[S/+LR=/+B
M!]_@HI6KLJK6Y[7NH%^-C_&X0%Y%:%.\ KM<7H5S50R,4\-4)F&V6"V, +)B
M2'$\!J;E(U@WN9&Y7!2'[^<PJ:5747V<DEFLTY<N,(ZCQYO,U)#$]7'\Z/A>
MR?$X#>FV:<RTHK*WDKK5,(GNA93J:O:<YY5("HM+%$*JR5K8$_SU:87)M513
MC'*RHE&2P'5<>4&>>6WUBDY>:/7[\&_5#I%1/G*<'>9B?M%T-P=I!_B0,3LD
M+AA+/18\ )Z_CQG7P^YINZ'82!>3/?.+GK_9?<?+"?L6'.+Q^W>G$I[AW2VK
M8]$>^RFBV8ESQ'CHE\3W2UMY9]C6DWR2;'C_#QEX:WMG1=_2&0V'=D;WN!TE
MK@9\&, +$Q)E>\@ P?P!:9(/37@@[335GPJ*KYI^0/IB]M#3J"GF31FE#*Q]
MY_+]=6KK&07$//PN=JZO,(XD.=$ VA[C[B3QYO<HA7+/C\;IV0CJRK^2NY#0
M[U?U*%-_#( =GE# A,^F#X\G21,0..;N4+%D8C@&PNZA^R#+NC'=Y.1<'%VC
M[WFS:)W*R'.;ZT_EZZGM='OX@HD2RY3XWP1PB9'""@5V/&YC)L!:2ZC=RN'S
M5(UHWC(]5_?O&Y3J3OXIM8AB"!EX8L]!D.TM$)WIH(=9MQ LG##633,-ZFSV
MS(L>^"NX?@',RDU>M1Q!<4&V"K?!&\9M&JRGZ7\@5$1:0NHJO2RKAU5<T]J(
MH:8B@FM+;,<B6%G9N-TNK'R=2M#W&;5_4U:F5:2:01?\4V'W3_#JZ^LVME#P
MW=;90'#\2/629[I;O+&RM#/^W9(-RY/3Q>P++0N<M]=\S#^?X"_/0@+/> D(
MK;Y1_'3.0O=68\(P8<E<<6_ZQJ_;[U,*[LOY^7F63W8PP9^0OG"!+\ ;B*@Z
MJ*&:["D"[]W6.)\, 0^A^GW;7,B ]_(O5*=1+!S[5H,):M0)7RA<M/^F).EZ
M6HR'"XUWB07GMC0>_&P^=:/L^'^_,=^_SQC2N:%:VKC=N 9F9D*Z0<-LO>%M
M(<:OL=NW]<KLF@6/6>C4-8$4%LE!V/D3)B(+P7N-4;6/CSG*(=YJ6M^3%Z%(
MWS:XP[.V$7=U [KF$%7_/KJ9IR^L^I\V4+.0QG&CX^,BI'X$'8.3_J!V;)56
M\(RW;\".'!;59 3$EOFOJCZBC'X:%F-K^-_4LNV_R2QHJV"4!"<,B!7>K?F>
M>!.;4X$(*8'L&(PQS5HCKBFMDCQUK)^J;=X<5USY9Q+_VH&>C =5LW/7!GPA
M<CSK<68,:6\??Z#LHKK(XF$E?BXN"GTJVYVG6)Y1XMX8JI'E$BWI24_'1B>H
M.?E @>)A&(7%C_]G0[/_I/UCIUKY6X\K;V+_ME*2=)7A'RZ=^__MO],D:?OM
M]^B326W,I]0?0C_"G,F 8#-RZR,9F+#*6S)R"DT2?WOM;^,!XCF,]N2V6P3M
M:1W<79W]#(4_@WN.I1%$(?MO5L&)@=\;F^*#7H_[XQ]M/)=8SU,*C\D<MLZ4
MW/I%0*&Y(]5DUQ"+"'P-&7B6U1.JFQ Q0@;H"N?)0(.78\M>L'MZF\N!JG^#
M?UJ;;AD0T H94.?'*._4H2])=MFS>*D9H<NP=F7J!SDQU2+++UNXS3'*V5>"
MC*Y)7J..>WK_AF(9> >]"MV8D5W%#J0BVNDK[#ZG;J97!Q@>7V1(>Z"['WR$
M8%/)=F<3-0Y;R_M.M,3.W9F$>X.9?A1P3"F,T\/=83?FA+[DNN0,BG@F/['D
MT:'1&]Q$<.[3QNZVWUPMG.]@CB>)$M)Q00.8.TIRT! 2T^*0*[\'MY05Z,JR
M7;?Q;&:FK\Q/;@=(QTA]9$0,T?"T5$T=NV8Q$6#@+6:+:THX&-%79 3K8-_D
M+8\I5CE3?K%]<T6O_Z!'+;GMADTF!6X\#5E_4)A&!ER8TPS1KCBQ*&+@ZNEU
M<+W"LH[2QZ\*+:(FPLRMRH^5WSE6\Q=0;%*Y/B<4XIB-"2((F#!!&P%=,R%<
MQO9/=W[DA9FR=04'A\$AZXMGP]$/-+EE3(FPU5?RY0QV&G=:Q!J\=S_LH#YM
M+.@G WU\J6\VXP)N5@4R\^L+?@W4,[9]FZMSTXQ72.[)E6?:#Z^C65B**'\Q
MVN.C<#JO3EQ@RMB[/P2N=V"))!Y?\/SEJ&J9BE<[8,SCWE'>XDAYH3K&X;Y&
M(9^A=;@K\Z*<+ -1!$?5(32E(0A%P]1K/.T7.X3K/H8MVHIRM.7=T7?-TW8]
M[^/D_3%1K5ZRS>U**XH+6FJ E=W)Q6H9S_V.RW6H@LILW?[8^H9'VQ<N/5:1
MZU5#H]:_+;\4FC1T6GA%CPP\3D]B>/=^2G^-QH^&'E1OQU!H&DF[*D[Y(T1#
M@^"@(0SE[^JT;5]1G/)1#*=_2,]3UZYG)IPI(M);X):FG<5_O4GL)I49&6"$
MV4VI6>(L^B/.36_O+C[ OE!Z\"OX2T:R=MB[T8S;J<@P_=I@UH\ ;\AWBV'2
M]6F?>O@W WPHX57Y>7"#!K][ 1_N,DNLM'1"?1S_CS1=">^R[+1KJ#:>FZLG
M%ML0=(AW!/O06NK]P05H/D:F&)S<($C\)#WBTQ!?*5&[&'*^/BOZXH'3+8'Y
M#QZS*C39(96_@G..@_*=Z9>6[6R':[6H],H*=(,$)=Y'&[ !0):E2G OB.G7
M,?^6.5\]]\*MZ]3(QM'G>B)TDPH^18F<SVJ?#^M=CAKSA3?$$_/&^XU.V!4+
M3R_GI<^#28:NJZC3Q#QETO.>6P+QX(0_6^Z!XNO-X@L!5S _7BYZ^3Y_='&-
M-E:,4BPIP.H@9>[IHO!1GC6D45"\D^<3#4:O<SV>:G,QQHK#=$+'K"(IH.W/
MM,#*UIBA4? \KY.7?H.!LL\-VAKQY#Z5AQ-2D\OQB0C&2&<=,)+!U-7(9*X"
MAFEP*[TU,PSG=#>I>3L6Q.'^22HX1.=TFH5N_"*V)R/CB"^,D&R4;ORYUC.U
MR?PI_:M2<924ZXW'OC$3?\;<370B72H2Z@]GI+9C!XX-O]-L4(GWC*8X"5]T
M:E[='[_K"*VXEQ$P:QV3JJ.3-//R->3Q>4'<'K9BUZG,[*O,>A+)S-+VH1-P
MG;+H?2&DD!0V1 ;"^8(XQRQAIN7:E/?F:$>LNQ[?[=UDSZ%C!^#0J(+7!R6[
M?2JV21X0Q=G)<N\3NV_S*6$OY+ 47S1I4PZJ$$WC9$#].QGH2 7]_7A2W$IE
M<U4.;7E?-Q=]&9L6A5-*G1V'^-,%WD.W!N[JJ6E7+&F\3/3-G2F67ZC4H;ES
MH>H^W1I%;DS,F%-X!_QH5^STC]L)C SLKQB=_)A\W%+)G?2GLNCC*Y^!7/C3
MV<:^C!=#5WX/=O&"?%O4GM[\[BR&\\GRA/BK-478*,T9.$O60V)?9E.$^H\@
MA-)"L9[R._MD8#P$O%NJN[A)!@KVX"B=9.HQSUWVGZT>'D:^3YULE11SMEC;
M0CPZGT-IU2BG%67QZ^FOK[#'/5\,KY*H%.Z;?MJY^6ZMVO&?G1[" 6.H_##F
M?M[L=P.!HC@#%[J>46.YT+0;!WVZGIAET;T57G3;\L4YG3[FG-5748+%5$_"
MIX<P%9,N(=6V;^:_[,D-J,>Z/9APN=,A/?4XV3C'X'.B@XJU34YJ_Q"_S]>?
M7X(10D)Y.6N]H8%5"RFF-CRH^TW<%I:IM1>?7&=\_1B;VCFT.IO-X<;W"KLU
MJ\P]B_<='??UA>#?S>A\N_Z$L7>-,O.&F"+GO^BKDN9)"I0B,(LRM7-/VIA9
MVTGC# FC:J>+04_5H>-&H99$TS+K\O(]V\A63PE;-,^1]HMK%YF@#M/@XFHK
M\0E%^;<XFD+.T^4L&XI =Q^9\G1/9\>;/0%=)Q51XYOZW(D*/Q%57E/?%?MV
M6EJ;;%,3A7B&:'E(E_O]Q^].E:0"PQI7ISJG$UL[9YRO+63Q.^H"F2J^AT8V
MKAPV9[Y<WQBRWGR5S99>%'+UBZ@4AZS1 YI0_]F_6T,CGW$:^15]E4.^3TT4
M^LS;KBA#I#B7F"D+F*!C^C*?G1B79A$:BPG>'?/"SOR27'I+T /3 3L5\U@.
M-QIOY-G"+Y\V5XU!/DBL:#!/?3&81"%&Y=LC:Q-8KHUY(^-I()G=>CJVT]70
MY,3/+&?\B/-_^YNO5;U)D<>3,<QGB96%7QCKVHM*36<N]^D:_76)<W\V<^UT
M=,4*F"Z%8,*5C4C3RMPTU\OOU"T72@^F\K Q4VZ@C2C%]CDKM?EHRD/FJNY@
M6#5^6GU;H7[H]#**\FGGX<5 ?/DC0OZ]F>)IY\96MH%WE6&F#?$O@:%?-SJW
M?:T"3(IXS2.N3NWN.#5';\&,_+QFCKR87Y^GIA,2>AZ*,X1S_;Q>7C(6'%4Q
M^M%F0WG49S$HQ>GU[XLI:9YV20J,]T;2V7XVYO*EL-L<^;GC,;^_RRD))<2I
MUJ6 6I?EIPJY/CNI'U3GW;/";"PMW^FP=BBAUO1:H\RQ.S]^I5Z\]):<]YF3
MK R4#5$/92O*=4]FBETQ+,H,?7J-68P#B7WQ,\+BI4R3V"*\;J^V]I2TTW9#
MH-VUXK/'I$Y495;@V0'[HFZRWL8?T%VRZRC/DPS<ZJ05HWHJ;VJ >*05'NAR
M"-@L6B=7EB[H/TI\S%\!#L#>_/E+\O:9;RJ!V-SGN,VYAOP8#O$;O^8O7-L7
MHM!72]/ KN[O=+T;2/I3TNI/_]'".+NHT3LU\9)_]I<;8,G @;NS):F4QO]3
M'%I2T@3G$O_6LU4G$5[U$V\U6[L)=_DYQZU_J>_P1?'ZGI.P0CY'G'?1#JW8
MN0;/=<@"B&2$P.N2@98V,F"8,4'[5>%_*!?[;YO-/3+ KT8-X4Y>/_,9#:-G
M@ KQ@U]5GOOEM/F73Q%[RD.'43S]>D5,"_^8%[<41B/K97O&%\1NM\]J"$#S
M4+U!YJ;A!9M/'G1)R>CH$,KN!%*Y,EC0TE*MKI7_AQ4SL_!ID08]-&8M[HT3
M^@0BL$2PZ,J]BR>)3$G]^9/I[?CUU?DHF> /BS1FF4H2_'Z#.C1,X5:SL_S\
MC[RKB]-65CA8^QCN<K+>ZC2CC 1X@(?UQK39$;.@/4\P+WC[WBS\3YP'^ D9
M.%(LC('C1=U0QUJ,H'^#(7SXF]HP6MEJ)<6;R%7P,=U[U8X&5ULOCSHRT G_
MP_I0>38AVAMEI1SN<>D/I/S*W[\L.M\4[K9\\"YXLB-2=/F@-'BV&*5S#/Q2
M4_$_F\C!!!FX;)6=@<[*/P_>JB3=;MA2;O%\_%_U6,EU0_LUV81%?#:AKO*7
MAE#6;8(U%G*[J1DY61+%LZ5LH21GJU M>-29))?$3B7_."KOT"@9SM?.CA7J
M"5H@ ^F*!+6;;VV6JU,L3 >$/GP9_%WYS/RF)'_!RR-/M&RZQO73YQ%JA%DR
MT-L$!@7N7K#QP#?B^7;2XV5\O'<4\Z'ZWW*OYP>MW%+5_ * @M4FJ--C5L0)
M=:OAH%7D (@+9O(5=IL,<,+,W$L\[.C;G4ZSO3TC]NA=ZE(3]MZFCZ1^F9"K
MZI'B> 76E41O,2?#/QWV(E+MSQ<:$!#X!)B4]!_$!2C?%/^S:>U]%_H02SXI
MA:1/5W3T^8-B"AH.&?_;E@GG7M,.,QD0FSL1(@-+RV2@?'#K5]Z1-3Z>#&1M
MG6:0@=\^9&#Z20#%@>%_MB#POVH1FFX"EZ?: [$67?9U,MD52[8P6YQLFA%1
MZIM/P%%)"_1R1PXF++'B0E0G/?LYGH]Z@YV.C!'/B $XT,[Y4D+C%.C9"BO6
M!XGNK]5M;L$Q$C_>;[)[$I5AQG,NBNH.R!QR=]^>8(#T0C6$5Y XX[N1]=M[
MQ-T=R\.=+T&;$;X%OK?886*%FG-@"(I_:/62RNQXCP8W]H[ 11Q5#A?2)>;D
MD3UW]*5B,\N2*&';D><4],0K'7G_*"[LR9YIX(>$0W#2 3T\<>4\5C>6J(2?
M6AKP12>W"!=8;^2 .ZKT>JYF)P<.VH4@;/]3VW#,$J=5X.^S$7+P;Z^JR,!/
MAIF_NF6?Q04:,K!];Q+Y)XX/[,E\%A=2"O&BGN!C+470)_A97.A"GK K0$XO
MQT6JF__-<$S*O8RI=FLD2C)0E/0%M6L!T_DVZP/^*S!4C:&LOGJY'(JB=G7(
M0&A\\&PJRLKQ_[Q;)X:L[<BC?\>*EE7J__JX6'FT&3%<>E3P=;_I&=C]C<=<
M?S!WZ,_]/P8#%-6.(-P/%4I0#:UQZ,&6O7KZ^%-+;Z@Q0C;4ME5F]Q,9B-=H
MDD##1F[V/.QS</C=X_ES]$2WC:CB$^Z$7$DE'>C>_RH=&$8GZU5AD&\YH>;7
M[U=5T?R!OZ-AM_SMBY+?K_8R4XJ6GE1-*IU-2_ED1K6CWN?X*UN0 .?-Z3,V
M7U-Q=&&^RHCN]<]/\#E38D[CEEA+R;>SV*+U7]GN$O=4H7F%D31K_%J_97A_
M^:+>QY5;=8*/Z1@HS\E'ZX2/P=)/=(D/(=2$K-X(3H(1UK][Y=H<3+(4WJV)
M43VUFA67"AAQS%1[^EHBMT []=7#:ZOLW]:V0PG!^!<3':(P#D(\+JQWA0-+
M4X%3[@)S!HA[!8K_4=.O=&M-,4]WY2]KK0PIAHXZUT[$"1<9"P,_B-=Q2,-)
MF":6[:07?"'@DFR//=L?=:4P(T[WQHGWCZ#1&%EUK_E'SF:YD)S%)JY! )UT
M"K<O+*3>B1"#A4_"77<I?L'I%7?C"\X3G@2DFEK/$DW/US?/R"J<0&16^!_Q
M,]>6WQ[M?5JLO_C\4T34Q+^K_OC?8_:2$6?(L1<._P0^'4,=>Z5U5"*RD6[P
M(PWD/(BTL7NJI'L+]/"_[3X;_]'-V?5=O.)A7R$3D?ZTM '%N<5-$L99]-F*
M+HS?C3O(-9SZTU.ISS?_]J9@QO>X(#'5Q(NK.:>W$<.UJ^.QA?PDX2%7["(^
M$D?;.>:X9A_3NT^\@<M)WIO?TFS_L=X0YRZ4IKR<:<)W;UUWZ5L]Q4%A=^]<
M!'?$HH :(:+CRHR:)IJ9PXUY[9NT(F_[["1"X&0PC^Z+W.7GM0$VD1W6P-LX
MIS^@?RCTLGA%&@?522,Z%U&LA!@SG'DUCG*@0\@M[@,FW"M**D.[68M!3^Y*
MZL,]"M5TX54)1#GT;VK&%)L+^@\X3/0<_O[D0)%=NXN@53(P('L%U2.@--W?
M(/K5F]X47NO!.@R]'L*VX^H,>7$4EJM^GHI]YY\]?A3K]O\J)]'=.?MMT3I<
M%JEWS)4,Z+F4XHW. ,F2H$P&'%U2R<#;:Q.T[__FY%-T$U[55B_];Z9B&=;1
M4(R)ZV_S)P,49Y1.V]GG>';$2:Q%9K?:GZ2,^Y*_JLYFJ&O\G P$\7 0]\'.
M]K_"S%=VJT.X4R-H?@FHSKZ=401QNA(<H[PT]$Q/WJNA1@\1DG(?4LHT3W4*
MU586WN;FMUG\41_-B[.WYT#6;X6I&%B\S8^X.[0XALS8WTQK=ZTDWIH3GFFX
M"IZ/HP8+7YU_")=?:4$)+;1". E/H$Z]P<<6A?C"3X-.^XU>R[LIKR,"L_"^
M]E^:LZW,-G!,^VV?3P[ B(\/>GH8#1W8'FZW>)<TU$\?AW_973WL&T'&!Y=\
MP7[^$J.ZH1<O30'N+YP)/IZ;S8LH\WX_KQ7BJK)D-5J\EB.?_3AL;K"0H8.7
M.:'IL'' F/3E1,'1<$4WOTV,IW^]+YP".XWN+\9NC34)7%9)>R5JO9WN7N=$
M!D*L1V\<\FP@'Z)5YE/<^MGC%6GK:Q"@[%U(SAOF;L(A<]8XJ\2+]^\<S5I*
M1R3O;ND&5)7Y-,W55!3_/IYLVS+Q^>O9OJPPY4U33%K $'RK]NPLF#=Y4G:Y
MJM@@#[Z1@1^2U@=92Y->'/^53@-_&6P1A\";??JJ9ET#NX^=ZTOG@ GBU+O/
M'S#>'3$QGW)QVYFBROPUY2CTM)+#:5=0U2^D"Z1OT8UJC(C!RG:C6%&]8/YV
M_34X?WBKXN=ITL6?<_[Z%?/6VA?>YEY9N))O 3,4&MP#]/OI3&_Q(.G@D%W^
MPC05V>XW]U$]8'ZA]ID'740'[-J.H&7G%U:?FK7K"F(@^9:D6TGO>]DXN$XI
M$8P$6]P<FJ;P/8&_LX"[J0X+(\E@UY%)]=)7I&]*";8TO-*_$ 6DCU]XY=:U
M7/_DR85#B?\8%W[?6E/*E5%N9S_Z24WI8_OOVLNN$N\?Q5)6=JY:O"3RG+Z/
MX"+"M4#11%M7>*7NWECI4EP#,C92)+MZ_<*F#YU4$6+XJ2$0VO<O'N#J$RTR
M,'3PUP5'A\KPGY]4CLL[S$^+R<#W8S+P!'Z2C_PS?PD(-_WO"OS_8:"@)]J=
MEA#I3RPM#<^"4CR82@;IIO-<GV*V@5Z^W U/57INS?@5YYKO_MK(M[$XNB,A
M<(!%9ZY]?6Z_$>LO>T:U<+3U&]IN)%4@"N2^PCRM8.*8:>^A$K;"P[?S,NZ1
M67O3PSN2L3U,?9&JB&]PO 6A$LO>R]?Q84V6SWH G3RF9NU.!I@#VK9&3ABE
M#W7,IJQS12Q9>2\476[OV7?@L)B)^)MF&W::V+HUYE13? 9NL]L>-/]SX]&.
M?9\ Y]> SBZ?>I?FO3NF5WG8;V\G# @V;L?V\WZ&_T,"I[*Z%Z_\[N_Y">(B
MX6@-E1)!VS)EC89W+S(G!N7287 N<^AIT?JG.M.)'VNJF+&OHRN$J/B H^0U
MHX'T,Q:*+_X*(8+1H.A<,E!OD8@>-H"7N*<Z<=91.VLJO>L23N1WOS#2<O^+
M?.PH&:#I.$^:._MS5;(-GU7[K>S>E-<,3)/XH<@'67:+; .DX@;&XA)!XH?U
MVOLZ]SE<F?'FA*$3$P)\%?2L2@$^W]W3:P6[IG_1JAA''9<R_7[X5ULUTS2K
M<?&UAZXN3^7M3K%,N_AHW'C_F%$?D@,F#<'.=<VVTN)M<V.K#YH;0 TKZMUZ
MD/.)2>?>I8)4[U]T$A(&0NVWYW UB_@DPB4T."&GD;&LIL%G1R1+XPPOW-:A
MSK>^\;_0YU]=??)XU:+\[X6._6LDG0,2RTWD4.V/D$M:[X_'('D\-&AG,)D/
M:G6O33]&?@HT?BM?UZ4&RXCLN60M""I]:+'I2N3@MFK'(79HL76&]2_(@ .!
MO3>/'L6QJE'Z;L6%9U$]R'J^C5B:7B]C)&A>L0.I(02;8.-W+"O<"[A)@W,!
MIZY=!A^V[!?8#$^KQA5CNE<,&#^&F&0(L+SYMA12Q(S\@6#$H7:XJZV))C,1
M()@2EI^H@^.*]Z;>3##XA7//:7WH_T&!]=4E$&Q/(N<1/JJ)JGFG&]ZET7YW
MY=J4AHJGG'MNGO <G*/!-==PYEQRLB5UPTOHVX71MNPH6JHT<<K9?YWPIR_T
MG('NFM@9Z(Z3GH_I;A?^!;I8R!GH\I^!KD,1L]G?Y 8IQ]7,O\W]CC\I/ :J
MWAR48C8&$LZTX2KH^-RLQO&RUY-#L3/9'Q/._S-JK["/9P2F.6=4W46ZW0(1
M/[%PQDFHKZC.IO_=!PA19#X.1P:\JDE7([Q(/<,59. \ 8[5)0/ZNI6DL:WU
MK="!SZWP'V:[^5M=9,"U;^_@C?7*,OR/Q.&E@Q,0O:1SP*GS4=W16MJE_>&.
M,Y$Z9:)QK#S#_P-E;P7C11$N;NKGDMH*3ZD]BVL@G:XJ=U '2W]ACJW(XT,%
MZXNT.Y1KL01/K"R&-NE>M/)4@.1B<^*-98GN?D6!=7S4;\]],H"V[P1_L]8G
ML*)M[3$T3:N+*(Z!HL45SP*C5!^^[TLOS3:T&YO:EK[P?'J6*J?7:?/:8I8,
M-%7$*Y*!2Z1Q"SL&[._<=[^"(\1G%<:N^)<OJHUY>QWZMN]KC+?PZ'V3;QJF
M]-/QMYW-/9$A\DW*>LLJD(%G';2?/M=GB#:UQO3DN$L]N$QM:Z/;?$V0I7-3
M2"$.UH5EQZ?BF+M!\Z5HUSAIF#0&G AG4[O7Y$^P[I[+O0J!*CQL@=2-AP=T
M#C!X>CDM?&>9UP;$78R,)Y!>8!8[J#SF6>AF]PCR M$(*Y"GZ(FDM?>\IL:M
ME%+U4\T"?<<KW^201>-!68AB%B[+# ?N3%]HACTB [&^&'BB /LL3(0Y+A@J
M-VC_R\J[U^+!DK=G^/ ].1K:T4&*7-K,MO:1@15F0BV.&:V\0X_S.&-BQS7I
M-=#I6W585!R1WYO[S8>NTD2Z/'V,Z>CO7+:;,;LU_???&M,@M]$G.M VM/)V
M[>HS7'KD074P!IPLLPFG=V?Y5;N"(E16F$(A(C#0I^X2+]6[C_KX:(1X.'^#
MJ<'NZF'])-49(BU."-V'ZBZ\:/V3#"R:M\(6ZOG*&GX77-29UO6G._]9^(;;
MX"!#A9BP[!<RT #J/I7$6,,X"3$U1#9<19H&K_NQR)=78:O)-YR;YO[$90TK
M3>4_<K9P5"M)*W#A8#&Z9P[O'H]20C%V\, \"(6K]E%\\3UA;2A&VQ\KK),^
MPC.0=OV@3SKRTGUM-L.U/B^U&Q4UKR0LY2QH/F9"W/OKWBZ$7!O"(R2' BHR
M='V\QYI_2' 6IG.\WFY )>EW9;_:(8!M.;6*WL'$K.<R)..US]FOO,'QFYVV
M:+ 3M'H$Z)KG8#=+'AEB^)&RO:Q66H$0_T\3*X;T3#GE^A>$SOWN?=&_]'4W
M&4D3:, \K[6ZV?5&5KL#V=C^54VU9"O5F7)0V@L=4+"',3>)M>GTLP9> ;^I
MK2%LT/3NP@8RT._MN(O^JPFTH@#3I^2>T*\Y.:[397&SO#4N3991XV]$>D^X
M6,H24PJ>&5,CJ6 N4P%(.N)=PANT;&SH;"V&,:R?FX^#2^52;].TY_0"O$0S
M4.@:ZWQ7PDMYOXSW/B(O=]2YNY +]OT"TH3W9("))$(4:2588PS>B!IZ&M C
MK#U9[*P')/JNN5^F7V]V9XD5_.XS9",.>0DSQ>;W%="?YITM?WMF:$R7A@K.
MJ,?7/3!P;?<"].H36ZN-O76-289@%B'A=)8\_3L)O$JOV30?FIKB@PB/4/0=
MXD1[0OQJ>I2 #,&I=(&HE@EF=%=Y%AR<N_"F9W#/1V+\:MIZ'D_6-OI0_,)3
MY<Q;&OFG\7!,Z5^MQD&U^V"T NX+HM)Z,(0,:,=!:CLC#P2E*[>6"H#.2@UA
MTBS?9CSI&B$=G1ZEP6L'T\4%99=9>DAZ>W[0=N*55SV*#G$QDJ'2F^11VG!U
M+[T5Z1.X0P:<P?%31*G3_ A^J-W&\HYLE8*D20A5DEEI2P#;_;<L=%=T(^AH
M6L#SB.Z\5@(96!M/:_"^LJG_54T7T_^IEB^U_6/]<7AL>Q#^4^0J.[_RZ^&'
MC^,&Q=0 1YCF:66'Q(_0@B8R0!>_O5,-16ABCUL]6E>*:[I*[[BD!AOA;VRF
MC[;%TIYS-F/JBDX!#!&)X,;9K%44#>PB3C1V=0?2STJ\EW>YXJ>2B-",8^(J
MV^;(3=U J:21#8F4.LCE$()J_]G@BLR\1 6<,S(5[BJ;A&2!NTTR'B["'-X;
M!00DO%1]ECG\://L,5&J[9-Q:> [_PM_?'H//#8O&WD&H1Y?;.F-F[!-/?"X
M*_2&MS%3CU;YLH?BEHLMGE(\U_3I&UCAGU.' K\BV$FS*@5-U81=+0)B];P&
MBZ<&ZU3)W.^UYEF'K]Z+]WU%7?>+C2E,V9UOB:%N4HZU&Y !:D:<[C/B>5\<
MMQF!&J.NBH[=:5.*PO!7FU.H_QE]NR@]EB<YXL[1=[=J('0=_4N8RARWV8G@
M@7E-(ST7\[WE3@QG87JS$0+8/\$_\!^"J6/K_2C9]>MY-O+T+49/GFUN=#K9
M0/H*TU?$3XMR5P>Z=PFF*Q($WS+/CJO3CG/"N,"7]0\:8V7>-GU*#WZE]OAV
M[Q>S6W1%D4^.;FG$$[+/*%&N'JYWA9+@CCU;!)C<M( V/=EV36<:!$V^4^G;
M]WPWOK>_NJNPTV+I2"F5__KI6XMP+.V:+6+ GG*LBE%@O\=JY56X4GJ-F_(V
M0NG5NYZF+Y&MN"NIP\-K_!DS:'T)#2["V D8:JU[6M0A;D^\>_JZ'8++V>Q=
M2 DMC#TX ]>Q &]84Q3+@IV"?']CR4UCYNO90Q8N_2P^)]QX=8(0J!,2'1J1
M1.*9@EW^X,'>\:'R)Y_(V%C?Y\^]21_J1IL+7((?K27RQFQ+/7L'[%%8KZ7O
M*(9C]P=4C'IV*:!,)YC"WOP3G9E%S;J.M&YZ24Z1>X?*#Z(S:!Z;48"N\PQ*
MY3</G:']:2@\"LY!O%W(X/,'D0AGTK=G@8J9?"TV<><U4O3)W/49*ME3OMMF
MX?]R_B&+R:)0'TD<I[L]?F)*U,8U[':3 1ZB+A:1]F?LJL()&3CWL_1!RW19
M79K>]\:"2[],K$?W*;]3/J=9:W,M)#2A+?K 7$1ZPF<,F!5JM:6+F^M/A>M-
M@]$"4S%V!B5NN)%+K8H].A=^<Y'\VUZ++Y4UONXONK1)9+?^JU8+?:= #L<=
MZ8)%I+?KL=EJ67V>XS=IGBMZ*L.&F[AN[3BF6IE,L2]@+YSTLQU^8D=H(K$;
M<;B!Z#08/>#<3M@7J9X8Q@?JCHPRLPL_Q/V]*3(N+@V7JD[2K*OJ,*'M[RU8
M]3AY,C:T>W*PE Q<]+C&>:N3\@<U3!:[A6'N,YI?U,&E=W_F7RU,)!JMG:#8
M/(*/91/-)^#=\D&YP8Q2P1;!Q0.YM3PYR?SI.94M].NW5';Y8$:3<'=X@OVG
M#"P9*%@1F VD'^=OM7E?-2&=6BIE<"5ZI-G&1N+U]:X'FC?&GNB>6$$MT-P]
MYH2*$J+\C*P+(1['9\ORS5TE)3>WM39-7SIB\8+<XS;I<K9YI4K'#^UL5DU$
M;=>U9/@"[<"*6ON$HO1=,M %IV<WFBZ\.^W#M6CZM<)=QM6:TWO%8?1:D?&H
MA=^')_LVJ"YDM,I*/ 8RK]M]:"<P(ZV0?HYP^Z27KVK*2B^GUJ.)59LEZJV0
MZ^M/1GXG\FW1W_K=*&<[F"*F-<1QN?W2KFAD+RBVR9Y!\22<F\0FK3PVNW.@
MM^M%W16M&QSIE?AU%"ZZ><-%.)(#F4]@QQ=@YV(BV-PZ1+&Z/9=N'_:CN-6T
M*W]9&<4HG!J6%SYLMKSW &7H>XW>FR*-[DT"M9#%/08:!^7T/TAN1"]R(68
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M9+8XJL,R*01_>7_\UZ;?G<73'ZA=X[]+'MD_A%W_@63^$N".W$(C_W#6Y+7
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M],N74!_T4E3MWE-!DN71"('5,:B8BZ_NW,E^J6VF4X;E8_*USPIQB:*/5'L
M/F RYQN @QOISH52:M_MG@E=9$.5IB<*%=X [E[W+.AQ%?E0B:O>X_5)\/T%
MZ<<K"-( ?\RYBV7] V5 C>ZBT>V8%+-63 E:I:<I*#UR<7\M6]!4:Q+:^_#7
M(6X/50\?W.KK5:-"3J'W?R5K"L?(8-)J7'QHZ#Q-)7R:/FN:4V#-0.->KL]C
M%F+,93>8IDT*.V5B=TH8TD9L#)%MSPQY<VF"&;"OV.AEL:36T.VNQYGZNA 7
M7W)8>7$$GK9$[8<5;<_P<\S_-E7SX>O&\2PJB-1696Q?X33:2 C[@KX!1$+5
M+J6OWJ#!W3 J\VWPO2O]TD6JVM9#;U99K>0Y_]P06=O+W;R'1QPL]6C<]D;
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MOHOITZI%2[V7H[5/,S$+CPL.1PX<E,\,^V=S7\_:=H^E6LS'>M3!?!_A[-T
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MW] 5D2 U9%$;$Y2U&7T6UB(2R)T%JY!LOA,Q5V[%L4=IW-F_OMR7]CI-2:A
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ME8UXF?K'9#N@I@Y5,R>5)&;&8).PI]KQ !]IX3&B !0FS'%$@W_G8-7,2VX
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MGQO9(H6!#FWW9MK(,?7@Y>U@UL# G<T507;":#J*MZ(*_LSO1AA_$"UC;HE
ML(2#2<[[%B4$F&UN6\K$L"1@+M-LLU?$ W^/O?GA*SFS4D7I;5%E\MUR^MZ#
MZ!]76C/BZ&^S X7V,@9%U3]J/[FB\DOJ'N._S0<DXB8$K,13%:BWI%H7K,X?
M)FMH[7R9%3"0\3[?:G6A2<_TF[G8#GR940QQ,I!CG1(?BFI1RX?*C$?&[^UE
M4Q8Y4M&:VNM*,E<W*C)L^OI4W,5\0FWT+M(VN[CUS+VH<RMYK<;;<,219&XH
M^YLU]FE*LL)C'D)6<AE;3$H>1*5+GJ)&D\ZNK;X:'@&>,7^<P:21N/T<SU?*
M6:GO3&U.<<>,IP\8+4<U#6(L=K@=?6.F7*+,?8>JIJ[J:9TZN_YA+TJ*2N4.
MI'=W)?8/P_07$SX15\':[],SYUR^\_-FE%EVZK7<:YQ?2X\#S)<"J]3<OI6>
M'T8_K,@%<>S!_A]4X_J2^I;?\$_!=B6$L9$A;>\J?GH)GS5E%VXQPB[+Y!7R
MHOF'G_R?Y0E'RSLLO;LX?8<.U<<TW@#(U&Q1S[2F[M>.E^W9C;FDLEHI=/*D
MEG-<ZKE1JTJ5B/)7A?Y@NC1OXVU#2;UML;L,@"H!F5R.XUSRQ[QK4&Q92..5
MY+[=-]R7[G' ,\\70@PB1G>F;'3AO.<*C"CJ3M@]+#LF5'6F!CBO.X%\&?9M
M2=&C>',.%NZ<6GY?31'"Q2\-@?88FO5XA2_@(-MF*\+;Y"%2"'!7PAS%LE A
MJK-/ ;71O3-*TT?;4Q%QIS7O]69L%:NZTU?-HJ?=S$Y2(\:)S3\4+EW[#*HF
MSZ[C#Q</WDB=4Y7LC;Y81O_"ZN,X_E<:-1]0<>?S1/@\'V>UFLJ<UGES$"LP
M3Y'V4I'A3WQN]%4WQA:MA0@/19V=FJ(FF?93<R'Y7<&/1V..]U[:[[D)5O34
M3OI1OW:[_T,T58>7TS/ZI3+A]I.I24/#ZM<OYA^$D<;_YB$F4&L_K1B%1]\
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M8B+B8 ["^-@9>(W*[O7R :#''TE!MH6]_ZDG/9BK8:*PII;:V%1==Q$H)^'
M:O[<KKWS("+9>/<<<XNU(]BX,!E?(,U(N[X$$JAU*_IE(<QM&8RSM&"JA.3.
MM'(I=WGN.\Y+U;<6LG\)]W6_2WR7<#NB"QYI#L24+6=Q]+313N9/M<B7* @)
M"JW<>5:N>K\$8!"*6Z"*?T\1$'UX XA=JMT(DZ. #"YU_(+ >G+N7=F<PMUR
MNA;OC),7^MLY)>;YSWB^?_HSURLGX^6C]JR#V4"$S!4UAAX!(V8.W#']R)&V
MOT^FI:NIC)2-B3+WU]G7?9BF6\$OM*9$R(I%G^=T 6N,0F VHW%+;/<QE03%
M>9CZ'C8.,[WGC1%JV9L[%_9U\;*/!0OB&,24.Y_/[7XODQ1]=*D@NQ0'JY=\
M5X#MNRCL2<";=9K+7^R33"6</5ZV_>7#'37U,B]6(<SJDY7($(%=K-")>U_1
M=?@5?_$F''_7Q\7+")-5Y)39-BM<%LS[NAELHL5PN'JO^_Q1^TCI)D,:WZ#:
M%OCQ#:#S 5(#_MZ<80RD]T4#409>\>M]CN8Z"R\/YZJ<""V;4!+U65HS?OZS
M$%\\1W*<..%7G*-LH[?3\0];C?7Z))?9>$!B\9S:!?*MG =ZYHJ&'K$1 M4K
MW?J!">Q=Y!T39TZRJX T=P60F-LW@3HJ^5Z_=L5GZ""]I,58$*P/QLA)8%(D
M:R]?74E/'+<&[R]U!@!#3K08M\=F%YKFP1TBT7.3@]$*B<('67BXHD1X_$G+
M2]4Y>Q((,.X5#JJB?5BLO2DG!BM:D?'5*8=">)>[WB#MU6>SA:77+<+WZOG6
ME=T6J:IR^4-ZK# =Y8IY)MC?<CQC>ROUU>/B3S@0Z1%[-9A4.CQ.',YPVM?.
M\Q*'#PW:S3). 6P=7[ S\N18XJM'&,NB[;-%N>DR++>6/RPORU%BLO9%LW\)
MB0H)=4W&EVC.2#E0?T?[$/D-X&_M6(16])Q\_/XG1;16R(DP?F>]R708<D_
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M($NT_+,+3NXO+MBI12I@J_KX1,RE<OG=_]>9!7^YJ!0FU6&'ID8[835F45[
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M+3)^.:-NTJ4\O*<$;_<*)>H+!>.?/4Y.[ID5I1^' FF@F8D BH>"LWS]1]M
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MA[#E,ZU[B3H ]1J3>R0C!SPP*D6$G^ >-=II.LG^>]39P[S7\2W@/CF;\S[
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M''3UUEZ7@)D[_SP-6>;RB?[_TOW_DXX5+W8N?0GHRL":3#9<Z:0]&I% '''
M(:87Y+% 7/S'P!S%0R.0A->= US$,-6>]%"@R;]=34RAAN5P7MZ/[J_*N(K
M\C/;6,Z5CI MJKX>$ALAJH_(&%7'!HNM!;RTBC[\[ND 4 BDSK2I7K'CA\X]
M8T,E$@!7X64T\J?2Y[BMR<)EMJ- *5F<.GF/44%$19F^V,"KT3_/\-X ($/+
M7:^Q9Z@KM2H'^YKUYUS' */%"9#ES0T,KIR&T4UA7Z#&0J<L1M!(5] 3P+N]
M(TQC&,)0F4#)";@0^[7L9ERD59;I;M*>MXH=<O.MEK.Y)^S2FGV62[;5SM2B
MNSQ,3AQ%,+5PWXOMYQ/!7B!#8%)"_.]5TX?(<RDU?!WX ZV_D/$L??3.W'H%
MEX:97^3 );9)K^1VU,[W1[CC+"-.RL<&^%!?78VQLC#:B-N_036EG_\;MOPO
M/=Y/2?>0FIC(G2A5Q25$6!M7$Q:,>Z=.B14@BK;EGLMIS/3N1&Q.) BJZUA(
M#MIO?-/D\>4%QB"</(3[B?+X#Q7X N,,HR_8W(C=%O'TNX]6!XHM^C?JL@3G
M9C^L?ORJ<M\H- +9 ))1D@HG<EX4^ZH9=,%5IH@"4#</*=-TZFRKY<$_8A#(
MY^GO,MO7#_9R]*+&2ZF6^-67K%S(\(M1(-=+0&P3>Q>2F>#=BHV/^'#E\/2P
MDL5VG_"O;6Z+9-G$[V5._AKVC&WBAG)J1 X:B^<)7R>ZU)\O=M-/%Z.UPWTY
M)&%VV),>/H50W9J4L0=?(I\D/FZH=TH<9%H09W*Z>$<FMJ% 0O=;L*99%OX]
MTV9XIWMY/TRB:GYV.,_2(@O(--W#G\.K-9UNOF\J8TZZ(7D0GO"(=3ZUZ:VZ
MPT4FR(/[(G!E.$Q5Q N[\1=^PA6-:HHY- CMK/FC?3]=S.^K=H1SO/H(HW2+
M\X]NDNJWYQ/]!(V+%IBF<+2J)AIX _Y+F:[ OVB+1%R=_0^<ZFMK3=M;ZT+I
MPIF6:NVZ@58_G3C^N?OQ48[#TR :D/,PEZM94]%5U"D5%[#8*U9>+N+S6^)V
M3:+&6%Y#DMV@I97"@-.]FX]7TR@ =*@UMMPO!@E.OV#2RS80W-L)7R0)WLIP
M;.\(<N7ONNZY0Y@Z7654/6UTN2,;^2RO7X\B>1M43.)"6G-1I^J(->B*['1?
MRO8VQ!B$50DU(1CPW9J83UB)GQ^-;OX2K_>?J_^A>G H>L\TX>YC\E." ;IX
M-QL-"6^G;N-QX6KO7;S16PYMLAJ,(HJYSLB=8"23J>_$;)RK*WV/G;:H?]_F
MDM1_4\"!\0C8NS]=T*<NB"^0ZJ&/ ++MJ[-"0PW'7HP>IQ&[ZB<ED.CP^4\(
MT1=MUK'K.D7!]XP U(=L&U6@%]R)U%"]CA&8+/Y#.92];X$] C=+9&K.NN&K
M-7Z[)6.XV2K67T=K7D' .#=I(\3S/CED1_A<SX;@-@[S7P[,C3)M9WN.6?Q=
MY:'J#,E3CSEQ?2TX3U,?5\:8#]6A":6I*/P8JKW+O@3AACV]^ *G=^7CQFX0
M^ .<(X]FVUGF++/YN*M9DA^GSYZHO![3]A-X?*,';J4<87]PWMZ9&Q'0T VB
MNXK=@-S;8 953<2]IG'Y>!N<UF@2^6R@B;I)Q2,>;8Y^8<%$^9_;BR3'-O:X
MF$BTJJU\^E3W%!_?)2 LT!23//;"=_RVZ5>?VW^R,6]/5*(>I-\A\6B_ \ G
MHA-WUY"*T:J&2#P(%_Y+J'$$:>ZZ2"L'(IMS,PV(8_Q9G3]<-L#D(;/7W:*_
M%I<H\?,1L! N MU'#R> 7, ,>-+E*Z6J5"7YY&++@!I'M<*W]4*-B4/-F?XV
MJE_?TQ[(/?4@^7U3*ZT^G7$C*Q9'BNT=#C\"D;LMUI&7EQ%4,;O':3_CEPN6
M!\T9[>JS;94DU^*[YZ72F^$>G]2G%;*#W1>/0!$B5YIJA6]8X=ZL@IF 8M;U
M-L8\7DXXZKD'"H2H*'7"=/H=PIB>LF5P\%0#3A5[$.P@E\UVY_(KQ\#]!/LS
MK0CJM4,S8]9]>G1'*#U0ESX9XBN_-$A=+R/>)0"^\T7S)KDC)YBWW2/(X"$^
MSQLS>;C2&MGI#Q,NMM L<Q]:.I7?'G(W@C*N4S-IV$6PS ]P>!#NB(W]:"%U
M+H:Y3ZESPX3Q"&QBGZT:YE4&6DQ""W'-C8]+&8KYF0$1,Q"W3-L6/C.^17U-
M:#<8MTOA1G5NU=]>,QS_ZLIP1?8LTL)EM\ T5Y$9RP -\=;HS5^[*$9?9:TO
M'RK7WH>^W&4J$?]$^,[]A87D\"2.X+>"F)5:HN^P4N/N>Y-)7HI&L!O8E<Q;
MN QZ>\#DUG-\VLT_BPYR*.A*I70X?J;Z31UZO-AO$&,9V0$*-EO@/S"((>BZ
MTE;E.E.+=LCS/O3G;XCT)!,5T[M="[A/_?%-A10+<>BL=S^ZC<&MC0>?7.%R
M"< $<^8W>EA>GY1$E?NW)"OK>:F\TN5]X7AX7U CTL6:*A$WH\X&F5ZTC>SS
M0/[&PZUB'R@T+#=[RT]&;7LFLGVZ?ZO'\UO4GK%$'0/)$,!??N@2L,N+*4?W
M=[52]()9ZB <%M -\_D2J]_X &JI'9==N\"LK$"_3EFK%KL5F>]L)@=HT6>U
MSAL(1D3G8Y04HWX5=$,7OYT/?2!W_F%6&_^,2-W8RH6JDX3E^9:\#XYP?TO/
M6-]#KEI3?]%6>G[;R@W$!W*%$OF'L2!+_,CR,!7^S8I^8J\BD8^+[Z/4GJ/U
MK*7E2W#V<U-9W0%UAYM+'L.5>#V<'#8C=%\<=L\>N](SB:"0.V]7'^X,\(@S
M]:M^*"@K@<35O92$9:^64J-::K_(+'$!D"N+T4 V=0F"W]5>#2:R0#_W=YS=
MPSR=.KZP,APM&,\<V"OL?1\C8^:S\ATFII1HK],C*RJ"762!SZG?Q;MBZ+LG
M^02Q?<GNZ"&_WJ:IB%WB[?D_5;CM8O,G(X-E$O%-2OZO#9DD\JAE]D\?,>.T
MP]7IYZ!6:,5>()=V5<590[QZ3Q*I<]C8"U2]],/W"[#%[+6DW QU.PZ 4TO;
M-DZZ<93(#)/ZU<*+I3KLXE/!![$,?,;W\<JHY,E:QX'])U,:S2P2P*ZO34(4
MK" W>2)W[IT_M8698_=C8<R@7C%PO&D /)L<Z8[^!E,XHQEA3\Y/'[5Z45;!
MSMC4E+CR7'=):EI^/9=,G<7]"@4=S1NM]"XRRK='JXM,%.E"?/5UJ-UUND3,
M5^JJX]Y[&$,D:M??"'Y(_,X^^N<?.^NP7N2!'#WH<5%3,.[*17QS'Q_-9(LP
M;G%G7KMS)L5\3FHF72Y#AB,[PO1FNX@M;^<WU:N C>2@X1^!%A#3L7CLU0[\
M^[[GJ^W&>JS_OY F?)' O$?[<-3="CG#O3(_5/=G9)!F08$NY1:'H^/=YR&4
M9%SK[<L3.5<@*A^%15P"J'1 IVQMX_E5\L+TX74:>9RPQQO_80QF<N[6_H-X
M\%]Q$1;\SS0C_PRP4+@BEL"_IV'^/X+X4!-73R)%3/01KL31=87 ZLPFY)X]
M?IW;LV=MQP$3[?^^^(^29D'\,SG;_P&P_G^I_O=0V5ZM>W,'"%-.H/P,=28R
M@1B@#3OJ$,(35>,@W+S6"@PIO.\TTUR__[N%1K1DU\;DW_]^RY3^?QPWF1X_
MQP\2'W@AINPN 9]0\E]S^HY9_A]2/_]F2D@,1HN?7C'@(/[.95.E+]\&N6/:
M(DG;<NUPYL;?;IN_ TH_5?'</7E_C"QS/Y32PVNB#>+ #11]^K+=($9Y<"3[
MFTK!'TT1*0(R3W(<]-84,^2T.9_/I<@4)!R/:4FG9"C:Y]1]M/:8.Y-:R>@;
MYH*JX'KP!DM!_!;GPN''WQB/J>EKNHC^,M\+3^/"I\+ 3=U%0>SH=B#>OL.S
M6RJZ1;L0^D;DQ-^@'*SI5F-/4O^!PYD[0XF(.4;^S#9>9H]6IR/. <F/AIEA
M&A-P_OEY.3]I-ZXO2;K7_%.0[]H<1C\ZZGG>'^13F0K"V@:!T)&[@6@QT W\
M=:(XM/;1Z.2D.X)]RQ3[1_D)E1C'+M_-P^?5 S+ '+-;.B9V=:6:!T6HAM,/
MHC764PL;<S/L43Y(%M=J-V6%8N?RS8.X?C][90/F..=(HP=+"1?;&9"$7-I4
MK40S2)0M*]>S#%JWC'[+^@,N1Q.G.-UV5\^*"K-[),%[8JO#>,&Z##8<@DUN
MDVO>KGYBR3'B1^JK!(WO?:J'=6%/9:<UO1 8?7#H @"?BSGIUT<CZ387^-OU
M>E"4)1J""K]4P0'BEX RIUM$GVY8:'+=,V7IV+2%28*>B:,@M\0^'F@!GP(R
M'R,B%VN%HPFN2ZVV8AZ/;^P4?1G_I%-E+R(Q=\/B4806+4]\:,C=:=YXGW9
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M]G@WA'@&I-J&+B6>/D;V ,])>B\!A:9RK2FA*8OS7P.U!?ERCA.+0*[MG.Y
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MWN#&-.I' 7O=/TSCJM>&M7C+)^[D361M47UD?_0=!9[N[[9LWR4I(( SSTW
M3)MOXIUIR_09:AVD]1C%(V16=S\T*:W2*8?4_KW?O^(O 1!L$!)EB#:7H,V<
MB<X_YS00*1@PD()[]N//<,AG^<4Y-H2V1ZN)$-DNU:!S'KQB7X[\>(O%YVW;
M.QB^YC+M-3<S=?IQ8C=NR1\B_^:N2M3UZO@>A]75K!KX-P3]"SQG&4%DS ,B
M!Z';2M&6GY]X5XZ;+M1->;HK5D!^+]XL3<F67*D?96@P8Z 9%+ZS7!49CR_
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M$-?/#0W,9$F<Y&IMEJ+1MUF_QPY)ZM8[ABDW '__<C%#?%=;,2+P$A"N@KL
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M_Y)W7W&R=H*9_T.@-,SI7Z+_>C!$829VEO<V<YN96Y@XP^Z=) UQNG>.,5!
M0$1(B$\$9 PREI%6U1#@]@'^S_K^+HSW?U#!^S\MCG\VW:^XOXK_6NWWE7_%
M"W.[^R#A>!\-[G8!"AI6]D[V""M[!T9^'CZ R"M%52RLO\4D8EH,/0 F#:L\
M[0, X,']];<^UK_UD5PO,@1U5G6Y\0J8"N#JN&[?[0&(_A8M &;-]_T8=].
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MR@RH!+R<\89!XS69TAF7?][R3#>#5;P+6PZK<[7%/_MKT9PR.O624GZOO*@
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MX\I$P=SV:'%S 3QO^RRF6A'QUH*,ND/EHS.F.-.DGRMC!B.]/I@/W:M 2V[
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MJE&G'#,]L(;Y]AUT^[!E\D%$H+*$.1N3A%CC3]^P@:"-]Q%ETCKM@[P'E)X
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M(FZU410/M+EI,U*2.9MV1M1E%)(3E5:)I(,QH8V4\%5A3H5+F4F7!B5?_H8
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MP-V#B$1*6L5*92AA'=X@OP) =C(-&<LG[T.-YV,/3@H.VI'7@*AB;-#FUQN
M0.)A(%5@>R;P;FR2_NJK$AVOOO+NFWP1>T!PU!.>G>QJE".*P=0*-SB*8)CF
MW <AVP?Q;AE/B!\H)K6/W4,AFF6BS7Y2=Z&SGL!OPDF.Q8#@YEO<*SNQ0J&X
M'S0B*1U/D-0S:\I%Y,>UR93E^9%D_M< UY/IYZ<D=AU.:M%UA-*XQU+IZ5S)
ME8]W"P"E].X>%=0+5!:F_N\;R4]O?/KALBM9IF[F>4E7D_^4]-CAI@^)PKI]
MW_T&F^*Q!H-'VDGA?)VB#I%/MP'H9(#[WD#V,;<VZ]WP1VIV= 9ETR/9D*([
MJH.C.J)P([E<>IM_U-@G)--_*/#BTIVY ACT5518LS*QEM>/P(7\8H%H4:D5
MS-<N3BA4Q$8.\.>$9'[Z^R;PUSPJN9JH]K@&0(:O 8NZ8)Z#E5:<]EG<XMEL
MT>^U;WKH<WP-</#=OP8@U*\!<\89<KE24I=>D("^%H:KJ:,YJ2\M"UKAH]>
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M:)QVK=.7,HT/[CX.SST:;[_M (OX6$09 2LE0XH+3^NO7GY9"/)$YB$ \%:
MF!S/,V+O?]!19Q?]1 M)R+18F+$X$*\&U%<1M];W51)X4.[7P;Q4#6P;H3,_
M_)+$X?O//YRJ3/GS=\C(3/L,?_ #5]<GS]3[;Z1O]1KU;HPF-BKYJ_\$$=^#
MVMHTR#/'Q9>KG[J'J2ON+T8QO#QG$1_$?7T\^HSU>^/OK?1T;@_TI-<;/Z8)
M%]LW:"*1WAZ;./F.@8X^?N<BF]4 '[*T*E\0F<KB=+)8BLA]=E-8K=%6E0D/
M$X<P71*T.4R8L\IJ/&_%-<6, $&E*H;ASI$[5?9"%ODP\7.FB=H;)X&8)9#M
MKH14B8YL@"'OZ;UK #)=_A)Z#;@*YJ4 C^Z)+#6HR%PL[DQE ;>F89JK6E/U
MWXBY\\!/S4_2D.(D7]PJ5K?=2S#[1I4U8"6,YK<2$?TH,#8'C<SB2:X^D*)0
M^(0[*=HW S)&W/'N.VSQFR==+#983CA2<SZ#J&LZ0&V4WJ5< Y8J942:Z]2M
M(UTU-Z!VOHM2F32LB7FFC DHVO)FV40<5</@,P;IC@$@'0QCDLG^0WCBK,VA
M!AE9@8DLMMC<DJEB; 2;-$'W$LRKAP>Z^2I35B1&&KY/="[=Z#,W+HR 9H*D
MP3^FN\7##PPDOY;+)<_S-AXLU+T-77(9Q!/JV)>PW*V:@L1"D(HN_="B4!54
M2"\_.0^Z) U-.V,^--/-]YIGT#_8MR9@S.G6-6#-)2"D.SE]-(LY+VHXEE8\
ML,#F[[)-\CG^A<[*PD\.]8KWGS[BS-Q21S<,JZT']QJU]TWDV*"5Y[\1M#U@
M"3%2PIWW#FSR"F_>]+.L^%"_0=TS;R)#<Z"N_3$6?2GV:$M>/Z*VV*)]=-;K
M!?S;;<-BI)Q%5^C [RZ:(SG84Y#?K *QG=E33-Z?*&'AH&QVF_^$*58[RU19
M0Q9:I]4:1,EV@Z7YUA8GV%\P6_(:\%2@94,8XAC^SS@EYS)I0C,5[2-4CZ$D
M?$V,<O?BO)7P:X6<)%*'KB%+E4AQN1RQ7%ZDSJS#S_1"]+Q1[9S/WKME.Q2]
MN+-PO'X-^":\?=IU#8BLC0W-UX57>@+MJGGLUSJU0MY_:4_]28?P&9I(USI,
M4%7O.!/#K+XQ.:H\-3;009;1GL=-^--/>[]YX/8\?A(1DXI]),Z(*S;D&"^-
M-^<PR1S^IJ[MXOTL1\T$>EQE]-^(>^^PIKHN?3A6\*&)2&]"*"*"TB&A/ H"
M4A6D-P4$0NB]1T'I >D=1)I(B0%"@%!42N@MD-![AU!"[Y_/O//._.:;F6_>
M=Z[ONG[KSWV=:YV3G;//7O?:][V6">J(<:>1RURM)F4D?OY+LD'OEO'K_OFZ
MIUKIXA[J4XZ@3JAA*>06M4&+S[14LR;VV%R2LIS#C9W7A&J(3.KGA@M7MPLA
M+_W)R[_.Q31:-"!"]RX!\=F=C:,5^,7Y#UE!5.@F';+*TK<GL,)J>3XB++1(
MUV7;:=*E=]R*,V+6)]S5DU<H,$REI#"+R$*F+MCAWSZT6KRZ\!6UA"M%E%DB
M\Q6-24V)V3UN$T.CHSL'R&2B;)<3FUYL*.)A#*BVC9L0&A_@Y:A/2&VP>J;_
M4UVK3M#B6'/#ZVG#'XCYK6 V#V$$3;-Q-K^LW/C$L2E[R93V(KCK\\H7F2BL
MFNT-_ER4#X*IQ:57+G;NB&F2FI.1 JH;L>51[N X],Y\[OG.[JN_LNO5W-SB
M'WY]^/M_*T-8XI"KCR6[YVR 2RN'Q8T#/5B")- A'L><$L>_FGJ:G6_,7P*8
M[>G]FQMIO]X[NLLGX=EDSRMZL![3@#4(8&71/JY#GZFK\)?)2XV!8\9(3+9[
M@D=I\65C_XNC@4N ?L89%O:>%IP:OJTB_@06QC+E?%S^;"301@T^\/^%/LCD
MSUIO!BYCS2X!FJLCUWTWAF!PQ]>K 5O+G.<<X""^-!.:J_?6.?HVY=#SI_5!
MG$7##6.PIP-=ZWWP _.92\#9F4(QY:3^9OA_%:;]-W9_%&6>*%SII/_$+,2(
M-^EGM-U!O-_U9V7T<%OKQR9FRS,NW2L/)C*XC0:V<HVAM+%[([\4"DQ&C981
MNS1 N@)GJ7.UL8&]%HW[,- 1["0S98-!X0E8,(B.$C92JXV[F/P=X%UX;E\"
M]F4>C3P,"O;2/^.C.1#6W;L$H&&3"ED!"N=:Z@<4G)^SDIINA9Q')9XK$*</
MS:VWM&G\V?I4@%M7%=889+''$:,FVZD*([Y_<^EY$YS5ZG$JPWD4< GXDI54
MSZFNOM5K\B].BP^/<UIA4L!+ $W.GFX%.F15>SH3O7H)<+H$Z#0(K[NJ59N(
MI<4) =;DKV)S3@1&37[NE6*G)TJU&G,.MO9%,Z4\:^2=NNR:X^G=:%8ZT88G
MO\-"UK70D*.[6F 5Q8(N[VG^[#/ZQN13R8C2<X:!M!!$6'#96."_;I5=36*<
M8OJGOB[;PF2KF%2F#&%M?D$EY/Q\HGV;J-C KDSC8<,FJLZ#9V_\9TB4PZ;]
M4D]SA53M4[CPQ:%>Q;+K):"^/IU\2G&K]>$2X&!?R HM\B&VQW(JNS>#7Q6"
MA00B2XND&;NEO/P5<X[8]C&CLGH"@6Q-S#VU%U6.9%.T((L@9K(H&$_.[:=M
M1P(^(^G+*'[HGG\42</B\?S(E/8'__R612C6*6\! C_E85E9RLYM_A%KOS#&
MQ__<D]L3KK-VY]Z15KB HGT#?)I&D'?$P[MPADB#R[TO([CLG^26+<9_D\U9
M"D8MQ);3<CYMHS:%*!1TG%Z-*Y_42C_5WQ)4&S>STL\1\S?0Y%?&'QMV+59F
M)<P?RTZN,S],[$.O3: %B]).'=H':K=XL@#]#]Q;GBUQ>3&GY6N@*7&M9MGY
M6PZN,1^W7*">)[V1'_LT_'E>!SA16X66N:O>B_W\@>/?$(0[HAM\Z,9VUR_6
M+7]3"/>53WG%\PSJ?',U8'R9 B9%%<"8<_;FJ]X6Y9%6B(7EG74G7)L5L8\=
MLB/!M'5LG+-3QI9=?S1MNWD?A]F^*(#1B>EA_IL#I?_*:#Z$PK6?$)]\?8U]
M/KFIXK:II7()>/0XF4K-\* &54OADH-_SL4"9=7^4_82P-)D3C[:&-#'/MKG
M;XMF^[U01\KR#:;,I7J:E"OK0&]1=E9VENL5A9*E>@_:KAE14CHX #S86:X6
MVMCZXRV;-?0B![F1[+0LPHE"MXVL*X9$:!4EG^K>]>*/*542V<)#LE#P@7=Q
MQ;MR=UOL\R3]+,,SM-*[59*]E!=93<,HM/BU;?8T(L$/<X$AZ)OCGU!E$>.>
M RVU#30H\62I):2.1(;R$8*HM;)#_!A0J)/,\F%4-CKT@=X/C\&;M0M7%57J
M?CQ?"PA6LN^3M'^3/[6;KS+;CX&&O',YY;&GZ7\E%!&HE.O+2#<_\2TQT;V*
M&T7W\^K3?MXW.*+(_!2$\XF1/LYHI']9AI)MDB\-RA!Q$I#0_ZOF63WZ]D*E
MU[B"(^%;W37WZ(6W%X/&/2!YQARIRK,_NEHT7!5C)VO=W4:7$WJ<Y#(-M\!$
M\_3QO9+ET+Y7#=+_FGO157AXMHLQHHM/P:5\(LG<0W*!'*P/Y=CEX64KC$YR
M+#ZY6'1!8(/HN5GSFYU,?T;M6Q]+V!]JDJ>99ZF&1L?<;WM'LRZGG3[WUXZR
MW@)!1MOZJX_W:G?:NVL]>U<2O_#J#?WZ:,6O P<H6KQ1U$NN9XCX"#+PEK%*
M.0Y,*QZ192-9"UZ&1EIO!T21]2(9B/JM-J]/R\_TEM/OISE]Q@-1,51.1S']
M9$M"4_J6EI;& ;W(_!:TE"VFRQB6<J5W5RS">8=%;*#3+ZPT&4D<)^<OYM-/
MK3NN[8Q.W>O(]T!@$XQ=U9/E35S9HNK8EXN\Q>(QPF"F8U\.9\^T!M&ECCI)
MVB9-=L&,KV?]^DM!++I6NM?'#O%OU^OE5I>SB,O:<YEJ4->=HDGILYO449-T
MFPV(AW1:QLIS)(IWKF-M%W<,D?I)>.\\/A/SB<<JI.E=KE]NJ1DC#Q(,.DR_
MM[_!A+4['QE9$ +C!R7; .!LQ8S%);KJ5L=EJV1,$ZO<\4!9=E$(T='\I=_#
M%.Y0RBA1[W65%46)=V.8J3;?J[!=FAL&@H75 [82=67PT2!?[6J8@(1O6?LY
M#,/L.?QM'8VOY,5B[\)TLV<1 \5ZBP@&,X:Y*H.[&OLRB&LAF^CN+>Y.:])$
M<H/?7I1FB9&Z%B*VU'9B91U?_NOY"B$P>6_'=6A_/*WP_L1PJ87XEIGN GO?
ML?[R\->^Y%C^CVFE*,LD=1N\&)>B+WSSM2N?@+'BN^'<'Z?&?BWXVI)9;?KO
MXP[K- -GROK9[O0J8K&^\:'*]08/VI4_]H^\C@O3%O[H5BCN0?AVY88@P^MB
MBHW1N.^$B )2%Q>5E?% ,4_V.VXANU(HF*ML>O)AC!<DEWC(5ID=RN\'\U-]
M9LP[V^)?(1L\(TXR\/+SP^5UGQ_+%%HEMCH,<&955*V-0J87PA!-IX0SKNA+
M0/B-F*3U7:&C1M(E@*-I\H)NZV(?1FZE,,<ECK!(_4>&+P'_>9SA6L^1BF=M
MFW&C\=+-@N?0G]N_[CLK+\758[SK _Q*5OWTQ8>7P-,83%=.ETGO T)H)8M7
M^E:67^HTR:(6-ODB:)1FO_34V,<4MM^[<TI_< F8W3E/VC1)78HV!=30(MH4
M<1:_"L5T?[5-"WE'MV!O!#8=.9I*-.[,BH@CZ6N2);8'@T$;_A54-WY)AF[>
M\QA:_89/+>V]!(A-D([]L=0/YF/,&Z.58 8E!P;3L,.2(T7F2P M!;L@8<DA
MP,(7%FNQ>0FX=7@)\&OZ()*S<SO= -']?WW\C\S,W1K#/QW<LN_NQCH;.<S9
M.E:RRG;88&(B?;B]U2F\BZ3"G)S,)^0\JBRT^3I.F)M8%IG,3> V)C>LC;[.
MH\8\_#D+"Q"0-0*-Y:_AU"S>T469;EF\=$?D@'W?++KX,=+I?X[8@+[7EFUH
MN$_&SA2A:E;C0YMC'@-,UH10C[5DH='"/WO'7E,%RAV9'ZNNEY8G+2Z<@TK<
M3D@S9QCZF*W69IR%/"9@HPO(FVIGG)X8A!J9C=O_HI B:*S.>J16SCY1:9??
M8V6$LX5_]6GS\W7:*7JY(%DQJM$ U7&K#R Y.VI^DEF\2+TV&ZU[A<X$YW)P
M5!9%L-X8[=^1#9."6M!0FU@WJE8MEEXXYPT?9TH-(MG!WMWV1?"@5]OR=%Y:
M3^(\+Q03L8KVN%(HT,K?!B^-8K'[<[T\_R@Q2[K(9OY&Q1FC$*0KZ"$:6[J.
M=M!J/^/S,T<L5(QXD=ADF:%NA#;2PX?TO-G>S]]\G]SC21;C.HQZ[E['R4M+
M"](.A@D^3*N8BZZ9.T@M#'C)TEM94,-G97;BF"A4YU&BM^CQNDE,5*%A#^BA
MG=GQ\$6CWV;,CYBG@<LRO5>?@D+?SS#X;>YH+[HC8I)B+)&0N:-H6%9IBV:Q
MB"-_LQBZD!OHP5?K6)_#A.K8>55ID//*"NE+/FW_,]ZP5#M^CT>D?L68@/K,
M$!/U1QN2%70)H,OKL^[HLI 0C!]SL:P>A^:/\^ ]LN&60,M37OHS>/G\6) [
M4*^&7]+!@]XAU3)4=6<CQ^N=_1/OJ.?C>SP.LZ-']A@)Y_B)R2+>=:9EXU5'
M[CJK,M2)=\O&-G<E6YA8$%&59*1B!65C9SU:Y_1!T]ZMMHVN@W1%.],Q@.WV
MS@!G"=_^TH)+C,_;N\M.::2$-VKU-B0)&1'!TAE:]?J3LJ9@.?9QKY:U\:-;
MHF)O7$EO)^^F21$B\ NEGA])R?#>-_W^Y3L4YF-0)%'&J$,:*B,^/RB!\VH
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MZ$S(9M0E("%C+';28M;?HFW3G*$2_\BVC#"HVKCW?35OR/<DD/5;1)<<*VL
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M?8)R3SP7O(^%K-B[L^]VS,2J\WJN1>!M6VE143-V2Z?O.^S=S574-&S96\G
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MX1.<"+EF0Y1@6?MLIM*#F.@T=9*B=G M-=TL3NJ6;[844:>[MOCP ]R\_?W
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M3&VC"/I2@:/53 /:]HOTE=FY*T/V#/Y.*\&/W@$$P9BAOOCZ.J\(QAW4.%P
M2JAN (WIT:RTXQ)._4NZS;2@4F8G-+VW1:& K=A@M72[SJS/?]^*SCURH-SN
MD0<N/'08!<;8!_K2.QH_([5IBH-LC3?4^I+(0SLK2>%ZEG77:8+WHD(]3S$'
M]NL,^G4?V%0ZF^"ER 'X(ZE+B819#N#G)(SP.)LT>&ZBT_RG:W1$?ALE:TDX
MK3*T>OWE2T ]OG,,FXWF+O&F(6H"0P]UYP#L)"YFZ>A^7.=B#@=(_(-ONHQ?
MCQ+HK.4 (D&%23;MQS/]<-X,[9M718Q_Z1<I9K;^'(WV 1#0#+T.$>XO,T#O
MZC5(0\LZEL0!%!Q(P;(+ :>24@DSWSM;"W;<TNTC3/.&/N9@M&&9,[=X+N9Y
M:7 ;-5'IR;1V0N0@5-H+\6%@LH\#R)EZUSJ1L"(S_<?O(FP\*@L,FPM.YAH?
MBY^0(=YK_LA[ULB8K< !NIVV< FH?;3@[C%06[#*G^"TV^_4]UZ_Z>8=B;G5
MN>6\P;S0@*$#AZ*_R>;E\RWOJH6S1?HK$>FD/Y0KM!;ZCPFF8C4BL@LO=6#R
M5<?>H!IWE:B(FTT/; ]P@$<A5N\</RQ^_&20'P 030VI8?3G8 Y5EZBX+D_*
MGFWQH*[C=C%]7RPA6@9;8*Z#-H6.D\LY$P[:,J?W_S[W_$B9^Z/]O[J&X7:@
M+RV9Z)O=:8IH8(O*TW"D73GE3"BU8Q*A23Q ;T(^G%\0"&-55/>Y$9>B'O8K
MP1_W\\4?+=Z"@EJ0?DE%?XSD%GH61Q0LOT[;Z*<X=D#+1]4=_*=\C .44_F$
M;BO,9UD.15J=@N6@)LIX05O&,=0$_.U4$3GE53CN@?FNUU.-C_4-ZQ*<WGP9
M3=.K;+E#'KFB6GMLB*5J\HV+N^N09(P,"L+TH):V9+%W(R;/T00S$9*S36;[
MMC63K';M%K2RL21DE6=(201-#Z.ICB>/!X61\!0A,CY15P0,JF/:Q#$U0JO*
M/73;'U.L F3GO;_[S7EB3B%?P>)#X>Y<6?./M E#RYD?16J#FL06&KH?G])F
MG+3UY=/A[5(KDXB[0HN.WQ2#K:_FS<!B_:%4ET .D*5^H/DS^@9^-GT (KTU
MB<Q94S_>D<Y0.9.D1K"C7?4$?",\!T=$*VGQ819J@TPY77HQS7<=S=!&))-7
MXH]+F%S\TIA>LIO0\/5,V>G47Z3$]*C;=3U#=MUK FZL1 X0N"&*FL,!Q_'I
MT?NE9];>O'E+LTE1+9B,X.?[F%UV3S79*DJ+;)K$-X(CM$(V,\=4., T.X<#
M5.E&_X9G*'L]YZ;M%]8S))01@MC7XTW%DJS?%Q31TNT:,QY-;GC:YKU\J7^N
M0690]4U.6%M$E]!GMA2KUM2;! &U(M,X@/<\=M=JZM,?$,FZ;4;0^:.:<]_*
M[.L^#\P&E0!%V:*2?,5-C"CV%_8>5CY*RG\'WSLF,1M89D"S33MD"B4L[F+-
M6$?=#]7:'9-1UVA3?U?X;QIO%%85//G2OVV%J3!&$FRI@/=&^D91]9W*)M:6
M+&BCL@MN;]M>$Q_%"VO$2X1P.;.% J6*]:&IKA@Q1!@YN]]3UX*:W,7B#;(\
M7W54>@F1M.JMD^!W\J@-M17:0^5".[!309=CU2C2<:R2K>P,Q9TSIVXU^F*<
M:$;9@NMN 5)V+FZO^][&&]GQ[$_,N1MV!=)<2'G_ O6AMW>)EXKN_8E71=K0
MZB8]$-#NZ)L]QN]T,R='#TKFBZX4#)XPD_><7,;-.-'SP -$"*B-Z</'<0#!
MS@.KQ1OQYH?VT)R2GD^^.*@;Y./\_GLKO\0KPGEP<#%IC^X;:GP_"0/J*Z;-
M#XCNS^N%"Q YP -'7PY0<'9S[B]6_?[R\G?$.L5"!59FSJ6EN=53WH@U,J&P
M:]%J5N,8+N&VH<?VEP]9R*;2[XR3>:J^H1=G8%C4$+K9-Y:;)9"X::@B)3P=
M(['P(S)2P5S_LZ'-QSF][VU)Q9HG!!YIBZOX[5>5>J5T!M^X03$D!\]N_K9I
MHF:O-Y''4D9>VIHXZ2<<<O5Y??01C\^"C=C& ?1" ($#7-^8<R(:4R[6(%VI
MN](9AQ>8)IWC37:3 W.WJKP%W@]41" /FPZVNEEX:TMW+M]UV_AIH2K9RP'F
M&&Q1>X:WORSS"BNS4Q1I^!FE/AQCJBQ82SNV0]LP?)!T6N5LSMP1:6T?'YTN
M0CS?DUOO)>E6K";V :8C.$*"SIIP,<S1GS"6NJ0\*7MQ,[QDTKSTE9N!#NO%
M[./<<D4+YP;(XTW1-FPNXC3=@SM=I:CN4^&= JQ,9C"W$727'E83<X::G.D\
M'Z @<BA3XTR>KDWR\BV3C*<.,DONO_:]YZ.?9S4W<H!T?*/G6#=T[B+=(S@)
MHD0)USA0Z]4OW_4U?.N&FX?G W%G-<KW^.'$NVIIKP$([))RV?/K%?XMR@.U
M]PKHS0]-IPT^S+B1G:\\+NL"G(@7O\":7:/SG[3=J_"7H__N&Q_C'T^VETY2
MNN+$+V6WAQIF 5%'0EEO<81R:-.]A$A:"=V25<H4$NK]^KXUV>(=&%>WT%\-
MQI_PK/"_;G?D(>_:!_YD(-Y85<;$*1%#O; A N+I5K0QBC8)ESS=IM!$'=]8
M[_ G#/\Z[1!8,U<]^G:XT<>S2.[DA7@WZ<WB.58--S<D$]"O"WOK3+K+)*E!
M31MIAD%32SR@+_'^ ?LFE2)5\DTI[*^GOW<7A'3D6B6%)72S1S!4)[RT!WN
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M:<G)P?K>M/2 $T>]/ Z-':A^H+WXP&WWFSTH9C3LM;/0&+PY<OT[]>P@87H
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M[DB%\3MZWSWZJM^940%Y,SG@@G44=GV48?\#T]B<3JJ[:$?]NI1G_  948.
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MDJDCS< ER+$WHB\$^NN"Y7>;'AB?1'^,8E!0D$^P6FEIF[6<G8S6,XN7:8(
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M$1)&Q$67:[F':G,?'.E]UL(?CI5@=:"Y_;)'X2)$%J93X0=T'B_= :]L3B=
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M4$[,B\4]/-DZRUFDF4VY8](Z7_Q+4N/UF_AC>6[3?@<]1'V3FE GV,3A#J2
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M"Q]:MGBBLCA187/C^M,OAZ59YIR>^PJ7!!S%/I+] P9DE-=H#!!'Q*MU+37
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MU2-+D3LK>?3$OD\$Z)[,"_#.?BH]E6_+BAG=%R0I+V3)5Y@RG?EB1:RF.S!
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M%ARC%[-?++5.7V(C%C]W%U+Y);?4O0X!/+YG%NNFF?WT#CRS$C24B"C(WRO
M?*"Q#=A@F-$D6LVBH^^-F#!0FGWDH1)-0KC\Y,>]*U=05R#Y6O-:*Z[YF,X\
MCOOIL=56X,EAV?MM)G%6[J1$(ZWE@B_,,*[_]=\+@A;M,**G #5K;(Z-ULT
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M=N2"0T</7H A-,WB"Z/K0GU2V>*?PP3 >$!&)GMB[O>_QV-,L+:O>P G<AM
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M5SL=_0]*?Y2^K'R[>#_-S5*+Z,B/5_C4?3GM344)7D^F5&7<T7&T8M;;C9R
MQS*$7(@"W;;)8+&GB+@BG:8F6I0G).R=LRNMX*UJ3JBZG83C9^E!_>\&+\G
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MT@S#0B0ZS!6ZS'HP584E)NI+[W&WA^SN[LQ;^1K+"D"#R\:7L7R@$RG2A9Y
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MY@)1;7^%BS.!=VU,0'X'0KO; *M^P 1VZ3PT#E3Z%#TE@PE\UV,") [42_R
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MJJ:G79=>&@HTXS;[IMX<\*>8',+<=F1$$9\KB >WZ8P4YKG=:RI;5[IK=[M
M7+7\:33D$CR'"52HK,22G"A)] \P;Q@_#4&J1.1V701[/UQX]TLD_]NH9E6O
M>F$86N:,\>N1DV9?N0^$!Y4O,C@69\M$*1&L&/<(.3!3Q=-V02/M22!F1=S)
M^#N>\#.N,ZQ$(Q6N$B)[0765"3Q49U^+ Z@^_U&O43^#9R>X8#K13T46VQJ>
M<&#N]#I<IDLW7,*>ZK_YZ;Q!>^+VN*4#4<ZJXUJV2!PYV1MSJO1;PBD%++L
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M5 ;SFD GA,XG]MEW"4F9WEK>-"YJO7Y+;&MZP02&MSZQHKB90G$#14L9 TQ
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MKWE/VY2U7C4:Z<_\:L0UK[+\:AJ:9/&2!+D4.=??>50,U>I5C&<"[1B+>O-
M)R^QGQ)IW$4+:W$/[YG&44_%*6XT>ZK6ZAY;M@W%M3PTWAXU3IY%H)2C.3E$
MC72QE1'NU#HFL.]V\A&YW 8+AW\7UZ.-=?U\2 6:IB=$42&C5V)8ZB3-X(6
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M>\^AD@?K.?<G(E [F%?"Y)=#M3%:2>+HK*IQDK=2*^JF=/2/(0Q',4[9-_,
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MK13)Z^/RYHYU6?.H!LN5$17;/[>NK:5 $%L?D3H$G4'K"RY"HD$;]BBDP,X
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M'Z3.-*A-%\GQ$J=%>):X<_=!X#**>;!E3-!*AS\@D=<BB4\GT*AZ;WGD] 9
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M>V!]041V&D %W@0E&CE,IZA12]3-C_JJO(W#)E/_Y0T *[;YW#;\$YH]AR#
MBN5,CH.6M'K<-VXLMC0F[,?]!4FYD8\O!$H RSLN,[;E"E7N+L(.9H+F_!1>
M3ZUAP?6/G1CR(W?46!C]!5"TT&TEGA/?^(BX_6 _X_>&*?[$]&$-.FRE?4_4
MWQZ1/S-/'$<C\CHS28J@MHFYYPG%5 2Y> H.RVN@.9'3-/'K&+L?\ZJ/%H[^
MC5AVTA]/2L%X58^.^*0:/A,71Q-V_EA)!B)TQ,V2#2PVI=O<[>@H;JQ*2BG8
M&/\RZ#@4+3E"UJS4\#Y C7XQ&:79K520#"X.BC34*FVP*L ]RL,><-2U[7[F
MP<U6SGZ@SWNV566V=K15O^^M(9PRL JS( AA7-J+&ULHGLT,[,@>:1W]JD<E
M:6@%J9N&Y (996*A\;?Y4&Z8MS8C(S"BH)^1D;%OQQWO_5_Z'KJE\QDPXL5<
MY$'&XSN#G3];7-.(9[AU!6X%(OB4/G8A#\P\[8B?]_$#DX/<61N6&8&6$CPK
M0*'I;(@3,D1)+L'[L5I:NN_BTE34G(L&7ITYLT/)P",?M<#>\1U%X%2YL(U\
M0^YH7UTL](I<]6F\P!\!4_;LR4S&@/=/I>OI*/-76'\H0^Y=Q0$([_Z@6"?4
M7O]XE@O=5A6XH+_EYZO6PPNRYJ%O0<;EAIWK?,2T_QO+8Q3L^XG<6?$SR$:^
MG;.[KY>3WJ>>Z<C&JQ@P.5Q KD=JS"KW58?:'FLI74A!Y5.65<%[S)._$7/7
M%\5NN++OCF=% 8W3+4V:-WE.E+WXE,E(<Q4UH3=N\?@&0(*^W3[H0*D!YMD9
M9,NJ"TPJ(EV-N7I0[W"AH,A/QCG%V)+??+L&LDP3&AK79\\H&^O"RJM-Z!*I
M>E"%O:,Q4LY (87/3Z@!7+._=NA5C@96#" ]#V<=G43(XNJB"E2-]TO[\ZZQ
M,+<Q!)9O .KN!\F,WV7P.IR[KZEJW$F0130=C/\=#C&G&-EUPRF(R9!26##X
M1!'#N\$F >:P0-S#K7+V8EJS+^-?9!@TE6H&.Z^:R-,4J*)U_<=\ZR!\:G>(
MHI8M;* LRG)%T59;0@[D(B+Y#R]0/8ZIPG$^29<[=MQ@M^65,=$?90<S/PKV
ML^JS[EOA(&IB*"2(5/WBB: <=R'2HQ#^,4)"&(H'# ;;?F\)>/F76I84>0$6
M@G$47E[4_)XX\8^G&CFD"#7 -7RYT0Q8\@ZM0HHE>F^^6!$>][I>!G"<>?!Z
M"UM%TIH/@UT<482S?KX.WU"38OGCB&BW7E[K0_5WZ]NB'X+%2,G@IAO1I+K@
MZMB0WO&XYV#5H]0@%/U\0CJC/WVL-)5"D$"=ZN\*$%YW??]2M?PZ]C4JE^PE
MQA_S&:L1ZYMU=(IA:=A<'K=K(!'XN (IM=$9,Y%?AL_/=@-04QK=CFR\ <CA
MA_V-K;'J,Y80 C_9A/8\J^4_H)_R07<TG[Z&RCE/'S]*YQY9V5*+&9FEK7B#
MU1U;1#@>S^'[^>^#+UYOT."PGX'BX%T[^\M1VY^+J94,2R'?/9%%;$IQ(6;S
M _O:-<D\OA508+NX)5GEA[U3[5.G@'G'/M+ZTG)#/8T;@(P\F#]9A1NJG,.3
ML\) 7^&[@D7!_)MLG.X;P(_8$:\^_F(N.$4^_]>]G-X<U/]H)23?%5<J7[+S
MG>XE+^7@)]J@V$%4NK$+?]_/JL0O4?^/=H?NK/K*S]GX)G.3B?W'8T%;:[N
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MZ2^A&L&I^K_LE5\B6 ]3)1$*C1F0A36%8^I-AE1X[I.!A@UF:W'?%U3/\/X
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M&9-?5A-R'U;G9/N\_H3L.2:;Z8T= U,GFT*T^]CCVB755UA8/X<SG?%0OQB
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M>3EX^MQC6L"Y,.Z]NWCYTK=(NM.]@<R[#[32A'7C46!AZI2K+*'SMR-4_VB
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MQ5)]QFX BB+3S32W=LPFM2UH8#EX[#,,N+K<!/8B3\7#O=+$)IS6<I(T8?5
MC^Y[^V#07T)OH%[QKN%;S,E S(Y71LW&GX#[S<\!QB!\H1-2S#O'_ZMAPWBS
M>30!-\WYI5J!Y>HOM^E^B?7!=].=WQR5/MUBQ2ONO6W0GW_,GXHL9"2+F9GS
M;W. ?+3%(3LU/KYD8T4^3YN72 _6<E[X+^ ANK2=-%E7FS$S10C%#UI](W$<
M.NMY@D/K??Q%U:FF,Q.NUR!Q6R-9-$,-62RI^I:NN%46:%0=N<[SK#5CM%Q,
M7:51,A;I,(Y=X!EU\9]OA#O,UO'$B-(H1D+XCFPUR!P/,H8(9^;+2_;H%H!G
M(?JS-O1!'G:*09@VO]"1'!K>B@HC.Z'4C[D?D,K0D(=Z?Y@?F)2<%A(U757O
MNE#@C"V88T0L\\R#NL$L\>A:*V1!1$B!']OM+42;1&#]3"BB*/0%5#T'+I!/
M1>5)B-_D/$O[H%\<9[+,48G;M:=Z/(2>92J[)%($,VD[B($Y8V+B5#_CMRF#
MF;34<WQ?]'[NNA/@Y.>U7;.PLC 'Q]<#_$=7@!<0:MM2B9HM.2PMB(T"1](E
M/KWH@!.$72F7V+4_BX9>Q/&2&]__QUC_D+]JA;+/VZ22HH6+JED*06LWPE0M
MKH:D T\H]G:\^)LKUIE5O0\8('\1$K'I__BO .\M\^9?0?RK_2?JH?2VB_ 6
MF@)#YP0J478_8/,/\\C8)7;+^&Q$G1,4;*)!SMB&YI3O:I30472E*;)'BQ?E
M[NB.Z_)?^Q-1X#L781S/X!O)MNG1S3+\UX^"L2Y2#N;M#EPDPE V"S-Y0Z')
M12JN3EZ7%Q=-OI6I85?EI/QG. I_V>[C>J\49B$/3'[H#2"A0>070[_+UW*1
M,MQM/53#(!+-<1$=\S+^"%6"W&<)"67=)<G>\/:U*F,F9IO>2KIH1A3:"J9W
MIJIR1Q58KM(5<]DUB0PTEIOX?/.06Q84;1Q_7OV_ /&&%.NO[A7HKPWZSC0M
MTWFF4TUMMQXHC[7^U=:VO?V[9ERQMLL6GE91\%#QQ>WXFN;N6(>@&\!RBBH-
M9T;D,F39KHM>TA855Z)OZQ>6A\RQ_3[#D7=M1IVJ0]CZ:K?[$^Q%1OJ.@Z.[
MJ9PLH+:<XN[J9?Z9!5@UYX,6RE9S*&D,BD)3% L+,-TR>4#(2C/>;* W/+,0
MCF35XGW\O<M_V-8M.$KH1 1*%. '%)NQM07QZLL]C^@-$7RT\B%A-FG+V_DL
M&V+#:BR?OD;Q<99X/B6TND\L<(//C+W_0)BL6V@9(H67GN" D-$R+)FU-)1'
MP"M$G0-QD="4:VVBG/[[JOZ<4A .9I4P4R!>>T;S,I8V:[Y0'60?[H[E@#N]
M_"$02IB,DT K!]_OR?$#,%XMSB70#_#E3+LOM;[J%"!+[OMH+,G$I"<)-P0V
M6\%TFMERTCC4 7W@TIJGTH6.!S0P6<?W#YY@+#H@X[TN'-;Y@LGF1!(7PQS"
MU/T,!*;\YW)!C_^%-!%)JP"(&F4%8LI/VF=B(DBY'PZ588V=<JA35VYO=G&4
M9)V@BT+FNSSJ@^$,/_>%ZSY1&=X])FB2E'T?F=P1QAF:C$F*3D.U03)TV;(_
M=7[M^=[OVJ?$KZ/1,X.Q6,CV>A):]L^E<;V[%73L?PD0I- _!8A)B?^O! CA
M><2,WH#!XLKAP71"HY_C(0_R<^V,[D,3 G3QPW.0DTI6/5+1E7.LBRHHS6(O
MO(+2@Y1^V3DIJA<*,DYI9(=BLI@YBY%>=Y15M 3U_Z  QAN-YS)5MS=-883?
M5$%4!%BZ-MFIG<@%"G1,I,#OOC&F;9MY$.8"Z\V.Q/EC8ON=N&HS/0+"LJ!&
M8&V]T)6- Y , #86R_%-I!0NRF"W2\/HB=%UZ6(V*M%+3'A<RWBE\Y&,01M=
M#$,=L!Q(T*E=:FL)['QR<O[AQRV!:'78K8MH_ "' HGD;/'Y!N(S:2<QZ!K6
MYJR"-'W@W'VYH1CPN1I5,&CJK3E.*B:J^%EKI&"$('<K#RZ@T3#]<:AUK<_D
M_#!K2GAA@B>D)CFD_XGUY\CXO#AF+3WE@O/GBL3J44TV1HFCY71?W5<;8VD2
MB*5J:T0=8XKM!/PJ3 .BMHB?5\7$Z+_D2U?M$KS:O4)PV(A9>H8QIRN^>3(W
M'=X"U]I!0=62X"6F'Y@DTNQ>TCW[SZQDN%\AG:5XH\G2G+$/:QPQE_Y#>4Q*
M<6?4="%JR<)61K,T.CJW([?AY?27?W ][6@"[#IY#5!7#H9N)O'?#LJ<2R"0
M2WY$,H/\,$@B-ENKFV-C&>KYAWUW)DM(%%K]WNBOLO^V$<_"R=HH7 0U,S[P
M;4&K=\VB^KSC$&E[>1[U #+$7SWN_<B_*PUUD^?<Q0M SJX:!99_)B^CK8PR
MW]'GFZ5(']F>1;@M>=I85I*TTV@3!1U;+*YN;1J17N>VZK_M!?>FU";SN/?D
M 4F?$;OO$52=1_[NFZIVB2:=K!&G+T+Z#8J=D]SNJX[Y36JA6#GAX]QC%YM#
MJT*C[UT#^#+^F(XZ3 %],BY-U/. -<\>!AOM[)C*@$W:IT(-:[[)&Q>,Q)5^
MEU%1_P2;U/ZN54F0^+% W8\HA.K#C"PZ2U% ^[X7EY:J'-J!G(@E[HWA<4#X
M0MQB;8<3W+\[SNAI'6Y%9)DM^)-R%>O*AF;5HF=_089K "MEQ6T:Q$Q_314N
M"[JX%%_2?3=^F;\_J'7 >1K$*#'K]  Z+K^$?C[FQ^:&AQ7!V6.#DN5$1JU
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MXAYI]ZY_VC&3HG:D#V>,T:KM H^-@T/UWYWH2M@2-M32_JX@_RP32<RX>@.
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M(L0^ ]3N^0G5B(U;RG\NE/RZA-R0=%\0W_RJ'A<Z5^KLGN5KUZ%JGX" ":Q
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M@&>T+HW.T>#VNS.,;H_>NE6GJU;_&H8CGJRE+F*:5 #$BT<ME'$\IK6:Q?R
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MR0&P/GK:_ O<HOCWMC4QJ;0Q3SF,-(!3D$=]8I&)H5FRYTB1DG-%,(WP)R=
M&9,S8#NK5]J3KTW/&+0[IMG0X%:1X"WZJ3,SGY#"*B/?,X/V>= <RC8K6Y-*
M]?[7CZOT7 %MA4ZN%KU@[KL2XZ:Z4X1>I:@<XK@7 *!R=!%^@6X!A*^(E2\E
MG3\CY<T*/E/3-3R\>P!P'&8GS7HUP0@GP'$4O![/:L56,ISQX4EX3S$H'/J^
MC(SB/M'R!L<V^38!JG^Q?CU!H?,9%4-UY9S(]-<U<J^02H%!%P;&1/&MNWK7
M"Y2TI'J+IA^=PRNFSI4%!\/!/!P GAZ^E^NA0<8"J)#!N*S$U.$,D%I(ML?#
MYT+5JCM8@UK$QJ7#&^3LD:+SO/Z2,*6VMZU\AEU;M8LF>4+P</8.!;54DAYW
MD]#AIX&"BG^I6>?G[->,?6^H'<M7F&H?J"!S;BW^+F?<HB^2N6N&8"N ?+G\
MJ'\5:&SGXYUQKU_%'=$./3"!YJIH:A$P*[0EP*P9=U:))[P(A&J%.B[Z-_K
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MZQM$#PB@+=EF(8[U56X+:W:GL<'&0%!.GFPIHY49EHU6X3E)P;6?KSEPEYU
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M-&"MKD76\C%0,2G#D_-GN8XOEM;::="4O)VH<^Q>5WI<B7(=ZK1H.MN)RKA
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M_ZYEXT]-]*^WK=JGN]]9"+81@K1%O^7\](3L_%')T4%&+T1J-J&>8;G,-12
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MKB7W/W)[R+::>+9 "W=A;) _':G1"\\SUDK6!:[U)732'#.2IXKXM]0H'+6
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M0:B!^ERAQ>7,035UN8\\)>K4H$=S=GZ"9]K6ZL7,^@MZU.2QG5).1N7<=-0
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M7O]H<78[KZ[.9:9E0QI/='_#-L NSEAS?LY(-X66\9?J4E)**A!&F[\?,4;
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M6FJZ?&GZA:\OFP9;)?# =IRX0DAUC>W%P]]>_+ORE!+H785CSFRW\#'PV5R
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M,>!8TLVQ^.$JF,I];8*1>LV-*S;(>QK5+&D97H:0F2D#./:>QU:Z5Z=J8G#
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MVY\%?=6@M*Q=\"LMKWK5V*!T2"O[G@5SWU!V=4J,G7:L89.M/_^9M]T7%^>
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M120$Q26 XOS"0D K,-@6:"TB*G8GVD943$"0A>]NBGS_S6/^2;ISP[_0?X7
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M;8#]-92-5!+P+"3"'JMN7TLN6JK>Q>0X:I6E%,DRK0&7:>G@Q%"Z*^Q]X1R
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MPAE-<^W$9;_1Z,F_(R+'Q]DPR4$][96]2R3PO3>DK74F,!E)JEV%*;.0QXX
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M$C+*G2>U^T_,D(CNA+.S63(RB)T91*=^!1T'-8,U7XDM+?H/V!&9,3U5BP_
MU>0*=\T(HL\ 5FVEHI+@H@*S#5\#NKQ&N [/?A?AA@.D&6CJ.#3^P[3B)9(?
MPE,8^@1XJ-IWGW:+=[GYES(#O'ML[<SMK[];I>)BXT3$WR_"BM[Q7'U.*,1/
MPI26+6V/U9=/!DCL*KI\+?YQ# LG>!?G [[7NP&;+HD71'*;7=$OL9[*VA^]
M>!0;K_(HAQQK .=>#,%]-F:6%VDOA,\T!@2[:;%U/YH$O[!1.?!=$AK!><1
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M,V>8Q#&8&2S$G\$;[2JZ5G594*?8&F#U[7]PK*Y>WIE[-,===C+__I+,$?O
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MHR[N;BU=&&N6%LJG1K8I)*X!@HTI" \/S_3[T"7-^^X3<(*T9KZ.0#ERKXK
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M2::PS\<^U1@=+#+'R<FN@\5U09GA :]34XYFC<F&!K(NWB=[M[CT,)9WY=J
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M0<A%3>3F+E;1SX6 -U]:1>_)#\)V^0B/CXLZ\'U$"0R;]B_IQ=#A%G<D<<*
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M@V/&;T=W^A='+W#_%T?_/LE+\W_+$"E_'#TEZI^./O&OD_[OEGZ:M"Z6_?I
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M=]R3XL@1_.$1>O9-_^5YCZ^&U17/^\R%FK^E] ^"_EM#-OO?(*@2R^_8?#_
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MMX'> 8[7-+$$[7F^)G QR]9#21DKAR3#0=?>ID_H5.0JPUC,37#?O>"IVP?
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MC;[_=D/Q9],RS8ODZ>>K=/61-8L_%Q]LZ?E&E_F"H<V]=]A!-E62:N+)F%"
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M?$[/:OFJ;2L#AB!*\JX!-AJ7 C4Y)N@ON<S1N[Y2/X0<W4JZ/<\_X??B4JU
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M%*]./AB,#5K[MV1@XSO_=\3YZT'G5R$AN3=.86E8+,ABRJN>[5%Q&=.UJVL
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M]8>+-*EDN>5_*43]B^!O4$L#!!0    ( -"!>UK@30;M8A &  35!@ 4
M8V%M<"TR,#(T,3(S,5]G.2YJ<&?LNW=8$]^W/CI(%41Z+U%!D2((@@@B 94F
M(B!(EZA(ER:@U(0B':D*"D) FH 0::* A(XH"-([H8GT!# ,I/W&<\[OEN<Y
MMWS./7_<^]SO?IXU3S*S9V>MO?9:ZWUW9FCC-!S >4/70!>@.T)'MT>W!P"T
M*> : 'V!VM_CD;^-@?[OD9&!@9Z!B9&)Z=^$^2@+),Q,3"QL+$=9_S;HTS$V
MUF-_O_P=Y-]O/<)(3\_(RLS$S/J/&ZT%X&)A)+!&T=.= HYPT=%ST=$Z !@
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MCH0?\@%^MMWY1649PL6992WRM5]NS*Y=^+GYRQ+V2D6CWD1;*"/P#J^_\SV
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MNA"N_H_N U &^T0#CI*=2:>HHW,<*!=#;(Q"Y6\B4L! )>:U=X2%E57TB:0
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MX.Q)T8S!)-9#$P'GQ?H-B \SRTR$R%#0?G"@%2_3OSEY\=6'A/MJC..*EVB
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M'<#F98#SA6OR9,M@*;+RVB^BX9]?R5"E\9U5V[*?)4E?)>JRT^L/I@@W23&
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M/RKWS7?@I=GDD'O=+K:C"(=?1<7+NR#&V0A_%YDF@W'RZR&U\^3= RR85F$
M1R?\%/SQJC6T31U6A\M4E+#C:G"[2IT!S+:6#B$G$\@&\+BF74 ,R]N5.VSA
M@9;'6AQ#68-%U>N;%'E(K5)GT"-R6 Y8C.@N)ESI:RQR]UI!L*):06)7L=D)
M%_3G_C&';9]<_54]H##J4E5C7)726*85 @;U\2U LO,0 CV$V)'?P;B7>93D
MW[W1K:TW_.0?2):8[V[%LM+ZX2>KX5%9$N6)<R,TF+1YWL+I30U8NUOJ/$X
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M"E_;]RE5-]"PS/XMVQ.L1V8!#>#<P#V&3MPWIF;/#>\L69)-HYY6%J/>H7)
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M9Y^9*W#,8@HHP:+)#JS,8_TLCXB:><+^==1=@PQ IP 4QA'-MWS M+W!"3.
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M-4RA44<PHN6_/4+_/U9N;]C/_*>U;795"F/ORCRIOG?%88VEK,#0Q:8@7GU
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MI\\/!&>T/[';.WCCQ-<CU382)HO)"M!V%<[K)E0X5,#=**()!%?RRYOK86/
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MQ^^!UG^[RR)]8QNO$UUN>\.^+:F"R_-)95L([VBND:KNW"&#-4G-GC='"N?
MAR3TE##5Q&MB0"'BY?4RWK.IW$=C;S_;6U&!1Q+;JE"W>A1BI_=<=KUR1&S&
M3*Q5.?X :W5>@QOG;$B5]_.99+H(_5X!+KA(DRO'<)>OQ973W4???E"T),B]
MO]99ZG+O=*K"QG[!)C+2;>!R+T__YS-A&<&5NV(,?*T=\$^)B'"(U\^6^.G"
MP*)!>="^]Y[& 7)'^E%3@B1$OWB9"U_;E8N%<V;6K #0H+1L/@BR>!D,"(6]
MS*^UR/ ,#W]WY69;!4((O( *S_&"R'NV;WT12&]Z?#0FLR2OG.>3U[6KU<,)
M4B:R4YX-*J%^6N\IM2F7Q=WU#\Q[NDABWY0#?E;-F#U>NWIM"M^82JQ77-O@
M-._ TM5:;DD/A@0HH_T)D6>\@O3.VO&$=^S[+#>N*LE^34V0JGD\O.;"M4[W
M:KW$T^V0[\")M?SRGW>95!GJ"[UQ=CF>>_!2I-/L#1$/G[J;_U O$*-E8KA'
M,D!@&QPS1X9AW30TIY0DCMOV(HW?2S:G"GBU#/5[OW"-L)RE./=/%P_(=/'8
M9:!4I7,LWD-W6$B\M,WF$-=,7T,[?W_"=$K&N#VT:4V)[>9IL8 JUF$@=8'V
M"=,*$DUQG;;D')+A=-Z@@LAQJ?R\8]M.R=_41;'.^%PHF:'L,9^R'B!TNI(+
M6_!7E(Y+%D9W=I_?M+78O*LYRVD!]L"2'+2-834,H*@V47.;5Y%AK)\23WOH
M]+%AF;XXMQ@]NP,"V/H2NGOU#?=[TPNBE9^O&9R@007T-6 %_DT3Q99\E8(?
M,/@8(>PROV7HVN?C"'7- E(83<@>XCQ+=(4XVU1"KS>$'9ZH+VN.BO=_9-B[
MMZ%X'E^$[&N=8=<C(<D8"J[/FY/5K%$BI/"!N T_749X*9[J#G7A!,N%8/MR
M5(D!1((\-./=?#L?Q=5FZJIR??)A19<BB(<)E-VA251/KYT?^PG5+LZ?2"YE
MSPW<#N!S]'<1@2L,0'8&?1M!M,)1)%QKD!W.-45HT0-TU?+89]V"D7IW2LYM
M\IZ(*9@;I?'9#]9%8-9 ;:=%RE.>&HCT&/"DZTJI5AT[16( :])X)\M[=!)4
MI(VJ;V2U(@,4[IL2-;%/U3Y:.9Z>S5ETN,, +-O3DEX;_XUG4.?G6/E39;;(
M6'CL>%3RH*MV[K->8K"TX"QZBOD.P71Z#&C7$'X#Y(&D*9$CW%1%MJ<BK%%Q
M&OY/6,<51'0;*?QG#NN"N3].(-^#6SA:))%+OO*U#(W?0"X?,)_'#N HJC#H
M<\\HSB;Y!22/?L?YI?2H+6V)%[?=6,2/H"$N)$FO"KV%X&C0(.1E,_BI()5L
M'X'U<&1!9+#JS9]A &OK-C. T/,M@+K+K27SL=G $JPEC<  @B_LW(3Y)!(W
M.AT>@L$]ZL]+S0S,M?QGAN.LR-7%>#U?!K"=D]"+M_JYDM/# -X==EV<T+=7
M<GGW_5%DQP,'&.XC_Y$%6$GFD@?W%__5 ?_P[$SM("0P[N1!DVT!3-'X?J-,
M KHRX+?U?A,X)'XRSGP\]EOTOO7U4IA T_8Z;B,)=>/\P(!\#B4ETGH):EIC
MD;IBLO><7K>Q[M+]H/39-*N6U'?VB;AN)_5\:,)T3F&18UC7#NJC/2NVJ&4_
MO[B6HTQF/8:TW!)YL98K4K?[VZF AN[@(-D-^V>;R4_5F]=Q7<V$X_F_@>!O
M#]Y.%K$L@S1,';3@T_MC+;\T'L4 F+=W_;92<ZJ58O1 #1,I\\+HU3]G7>X?
M>^<C8CHY:.!ZN,LY(_]=-ZB9SZP#[ Z#EH89K^\;?XV0?^CBNF63_M/4D+M<
M<]A.E9-Y\?WU1*$O1<L''NP.8  \W@Q@JH#$/^ :?#T<\=:S_UL\37)YF6M)
M<W$0.;5]@ >H&'B^[?;!VW7.&_8U.%&,I >BQ+D[^Z6$U92:7>\MHSFO*A\Z
MD+"[,L5"1G:/:,N< ,N"<V@=K0@<<6IB "\0^I$R'VP*)Z]()BZWX*%7YG/5
M&0WR5T87HLZ_%Q2OZB"^-3U5MSO0;F'@[E#HVCNU4E&OU;$^EM\P([-\^D?<
M=N!>>[WL(EL&=6/VOACO-Q]Z?XD!.+3Q#P>*Y-<)SYRFJ3R9L-R0JX3@E)^(
MBDYK\UQ;4CDH\T&C0>'0P]T84TO.KFZDQ7PVRO!UTY[F*6+ =J/UZ1KL#D=D
MY9_%<,6VB+6-W$0BD,Z27UT>6FL<%?UR-;I9HK,<HG#@O6ZAB89EL#F6X'8?
MWGE5HQ@_MCXIG.B=/[7N/7+_DEP$16%KE877Z6Q+_FN]"=^F!7,I DL^&(&:
MD_C8;\W#8Q3S)BFY$MR63M?#(G/XSH2[?ON*.^AU#."+<Z/S9X+3\4W(4"&I
MY2V]S+Q'Y:#GAW'"=%[KNR1E-VW0&Y$H)"?F4]82I'Q.B4-:C $(XTLT63"M
M")Y2J3Y1__W&\E+'C(_U?N/-\--P]N I?^@7]]+ YF.,AE4KE$24&R@*_S">
MO'N3J/N[JKU];7-8WI'B<M2MY^IL:EUZ"X3-0\*(C7W?FSZ-7],5]7]'#:XE
M%/56TD6/WLMOP4WI(*^]';*?Q4>4J_FA")2< 0/L)AM4L<AATM.^KX_I=S'R
M:*O:*[N'5-77U$?.E M %8A-ZF>S(PHFMA4^>?M C4-P>L3K\[Z!)U6\EMC=
M-LL(E;CA!^P57%YOO.YTYW]%-XJ 1"/\FG&1NA@[DFR>1_14K?"7F'MXV(<%
M11XG@R$7%#7/*ZX?'+,I)IKW]8:5;Z!<XI$P+.+>;<M>&#6_@(>SYJ"H04CP
M["';&YU"V"MR,QEQ9N]5=Q6(GNUVP=TU'5 E28>W^^G(4$O?Z_@@N!U\:MI"
MU8\(1>1]TMBK44<Q)S@BB2;6H'YC7[-+UEW_Y&VX<:QK9:E$Q6ECKY)J(L5F
M\''O +*V_-$7.,&[;XG)>M0U[E8Y.L7'P0#.3%#:AA](&(0[?WFN_K1C3T.G
M:AM?Q;R=MOW\C)R#6RKS'J08KSGC9JCJ/&;\BKGP/G&Y6B6Y*=N!K%LUK66>
MN<<]9#8,]7G@,SU0E)TW\9<&:M<JABRQ)!%&;=A)[GWXJ'+V<="VI*C]X\Z6
MR_$-K6]4P]AK;J>++!41#,5HLG>)>_2;,V(SC%XD%$Q\]R^B"OIQ$?%5(+?V
M2XOCK.CCPN;[/F77:I07C!/X_:0YL'X*;OT?OYY6$)9(/6A>1<AQG5(8T."N
M=>Q7X.N&AM).B48,#9GWX)QR0C_LT9T=VUCJU+L_8*^N,UF3K\[N3*+.EI.>
MD:>="QI&H8,?]W_"1DB%U^@OB!4_HC[')2&W:O)0</V\45<29PP3)C/N#6F>
MD"3AC*W:0LIW4/"5*DA'8L%$EUWNZ0MZ8S48G!<#J&0 7!B9$^6(-O'N5+M:
MTTO@01(Z'$<TX@7&AZ=+E:5[O(U'SF%""<AZ=61=;2G)V]J@&_=\*'7714J4
MV-Z.[JV7"YSO8:0;(!;Z&SAP.-@'.H_76E##OR0O<_3UT@3X*S%*Y8:'JO<=
M?-<N.FR8+CTN5U.^#0ZMD)"$ETG'S+PSF]<@&^TS2K _&7;]"PW<3B[.S\**
MWA2I[5 T3R8]Q+FA>4X9"'T:2"UJ)S\C$@"W!Y)$9=/"!XDH(M)*7>/%6(]D
MLZEQDU3(0[>ZQ+<,8%=;[LG8OI@%$I;&3Q@L+'G^$1&PX)L](;*?ISZ^MVT,
M;7_V]H<7O&R7"*[OW2W5/J/%S/;@1D!5TH8C9\/FSO3ONMY)CVB_L%\?=]W4
M(NB^GI5ITG0D^73=S7]O]^1_J$@ IX*9NS>2A@;3QJQ4ID0%/^%8_*S(P0H,
M8-WP#"OTNL!S<C9Q7SAEX86KF(-T=>KZKS1E*USA6+.6'O6=WD(:[P W.3-N
MO)<<WW)%R:RVV\>P;VYV:52)CH31?9TJ1Q0*)]B>2:J(JSQ]Z+5)WR/VZOMH
M#8TY=#!(M,&UI]<R@#S4U-DGXX[]2[:-&6O1!0F5,YX-"_@#L,: <!=F&%6H
M\N GA7[#"^0Y W[O/$>"0Y?H@]'8I2\F2"-"W\Q'0Q/$%LKQEQ+T+L<8L[RN
M$3P<P05KM?"NI71)8U_I,("'.NCX7N(I5XI<5@2LNH_!=E.OK,I81]3C,UNT
MC]_POM<@'3]AG43C1T#<Z&QX3#5(G'*KJER(:%V>H9QS,8?3QOK%30$U,>ST
ME_UD++3!EE)''(5YG+N0F#"@EK;?^OCNDQ$;]ZW7$KM$>#!#D<XH<4(4G([9
MK?C!X_DE!$K=C %TX2 N;=)]\A3IU')#C-*MUY>3795[C;P7]?@:G);W0SPC
M],A2:ZH6IF7S\L3WIA3-3H'7!@'%; \OP6D0_:S?MM!CFD(4;\G/8,Z>@PR@
M3>!E7!Y-+HL!7*0XHYH(HZT?9,(9@ < )3S4YKWZ=];&0XO8"!USX=>ZO@R)
M0+9@7SF8HS)E3I(CSY)047ZL_=2G^?<3M9UW&/7QES5H:=2 J"*6N^S<MU%*
M'REA?=A*O&!OX=,!5S8+FQ.CN^=JXK40M>>9!S$QO9P.LX1@_%&'D'OES=):
M^^F=1)RH%Z)6<PU)\7NJ2N!@^?&])KJ21%V?MD7!063':-]C3=[6G<']Y7=+
MKC\/>GSD2WA7#P&+I\CQE-][#+4>3(A)<HC5?1/]UDS[;?6CP/1E=IC!Z/14
MA0ZL&;_TGF%!NMS"MNV7+UX@["7TM>=+D,^U2+K3]B;3-<_P?19\LG;AG[BW
M2L8G\$CUVY0=)WS,;S,C<EUCJ-N' <"\&>)7:"H-FH,.7V, !'.>#59''!QU
MF0=@OF<;Z;RJCQX[IBTF$L?<2[M6F;G+B NUS3BG3/;]HLX>8+^MC\FIA*UP
M1JU?IM?Z\R!+H];Z77J2)JO[7O\B^597#&1>0W_B40"BS-^AISS_@PP+M:TU
M]BY?@&/^2N"^YBDP9_3;#\E#_#52OS]_-ZV2V>IXYR3K(CY;M*WUGN[^&N#8
M.HD=\3ZCPH_[A8"F7=-J]<H%VPO#K$X4;AXA#]ZT>=PFY$O5]Y-K=I7,?=-V
MQX#?Q:-3%9GB\8:<J#0E;B@ZI:NPUW]A"JWL%4\6;UU(\9PP#:X1\KUXMQ!@
M !/F]6Z;]X?O-4)VY L>72R96$R?5CVRIX_V83_44?W&Y*SD&_]/9#ZJ*4VR
M.Q OBYS&DC)@6YU!.7'VHXN'(@HAPP!$2*?H04K% 2!%_V7%5MBS3)@A^:&:
MSMZPZV<64)1C\@^JA/UBX2CLXZD&K^5H-2,OU>]XNI/_2T1(J5R-:F7B>7G'
M0RX,H#-U#CFUG_BL]YY'-8+(!REMI#_%\,5CI^890+D>I:VNEQNSQ8D!;%2W
ME@XC%-E+:8\UN-L4N5-9O!)>;KI(VMIN$C#H"F?%Q8H]>P8O=^+R'][$RO<B
M2^?=C=80)R2K?<4N:3J=)BQ,IWX&G11NLLY00O0:]2BM13<Q^[QXZQ9YG/NS
M+8S&KVJQ!B^U!2 GMV:C9E4BY>_$9"'H3C/E;)B/;01.#_<GW5ZAWMJWE3LX
MFCO+2O%*@Y;M->LO;=X7/$[H;[A7GXO8\&K)[]DY4FZ"4<34DOC[W;X7]Q5O
MBWET/Y_\=$;A43)JEVJ%Y*"'[@X'O<3J. WGF4L/+B7%+AFJGB*[U&?/%YV_
MOW)^"?4H,+91OQO5^N^LM[E1?VQ[ Y#,;.K=CVRJD57OUIC-<=A6U4V",^;9
M7NZ0%K'5_8J!Z?,-T7"SO(-!_^V'7?_CA>U\;* 9_L*EMZRI7YWN[P@.U7A2
M=K/)-UV> 52]T<S>M!.?J:W9$^10!1Z<4^@TJ! 7N-5?UA&LE5\DZ[K]="2P
MP;,-/XR\1<0?H#\AXGA>=JDR +WX)?.(%)/'LV_FGK)UXXYTO7-J/5.P[K#1
MMX\&WS$V6M#IC*L9$6MNL")-3[=OK:">]BMR4\ZX:BLA[CN__#7=+Q5MC/XP
M.V3BZ !>-;F9H&3W4.[V-)!QRSE.Y?J$6>*4"FNLB5+WF]N;M83?1"8I"3AN
M.>5Z?C;_<K;85 %X,W(2:??\K&_OK>/G/39]7">CY?9@UCF2:OWPPWN9@1)4
MAY'#,*7UUOI2S&046.K<]/ZK2K))5&J2^I4=T18752/T=!]ADBS\-(C7$Y4;
M5$(OATUOG*8>'%45++.SXXE[L5GY>VS@6[.:S7(I\NW8I444G<WL^?6W[_'C
MG:>>-.N?C-0CTBT3I%4^=RU<OJQ3U5^'D9V=S]H[).;OI":ZD/WF'M^T:4_I
M!/FQ67Q_]+N&HR!];9FPF7N]=\.42:-"Y00.AY#H8P!OG3]^SJ8GG2$,VS^/
M[:7:A!#N(1)-U.NSK;"[P7=P,#!_'M^LT('6:Y3'B'3>R[]_P_;*O9W;?,U'
M#AMX"X7+;]],S7M2S &M=88UG:SOBNSW8ZL+W9@UBZ\K5<P<?& >U9HBC^TM
M=7B1:'AS*/%I&2[NV_P3=96TW!&-35T2T-W('-=,/:<,%Y=-VZHX+@2:C-5O
ME]^Z+[C&$O]M4,3)L$9BJ?#*XSB3>.JGP?/N+&NWH35NP$$\Q+5_"RITSVM:
MC\\0QFQAJQ^<8K+OM$>%7FG4*2[_4HHQF_MFMC-7A.3J83NARG?VUMX';WS'
M1ZL(ZSZ9^EGDQ*GQ"HOYGR:8J;,/[-G5^[;S1HI'4&+D!D/,"8NRA>PO7Z]3
MHJ[57N42=\[$D@,H>6R.MN(%7CEIG4!2 4:VPLHTK/^-:;2%?OT\FLC[W4:S
M[]DW^XC'8VV15YO1%/<%)+2IC(_5VO^5BXUE.2RG04&T$T1TQ$T?Y> #)MU5
M:G.OTK?Y.X\:8+'(S=,;JS83?(/V:B7F9*&W4@H'KR<V6Z/4:D?4U/#H"%5(
M>)IW_+7EIKQI+$=(J:P?\K[>UHB:FEGGB_7X ')NMY]^0=!FS0O?CEI@#;^2
MI?\_ZMX[KJEOVQ==BH(@19ITHJ(@(")-.J%(57J3&A4!:2*BTA,LB-(B71$(
MO8JA(S7T7J3W#M(AH0;27OCM??8YY[Y][]OWO?/N?>^/]?G 9&6%,>>:<WZ_
M8X[Q'5M-KS$4][#&E/GS%OQ&<;_?&1FAZB4&?D'&K [51UP/3# 582)+\%<P
MH<Y*#HYK=4785/1NTP+;^^OHS*G'FO%!,AUSC\Q_O\BF7RS$R]J*'=D;"OM8
MDH __J,\& <*YM:'OIW#?!KKYA.]LTO0IW@%+&'Q5'UV9-)B^+7?QY"S]V;L
M&ZYPPRT)@MBK&+LF,&,-C[U24BZU T[N>#&"$R5'E"'VS(A@+1:J@W&T Q,=
MPK\<N.W($$EM4;-9-'B4X3(BW[H^M>[A,%IX60;VN42)L<6D\0_W0'C?KP6]
MBYW>1V<TN6)[+R653Z+!%@?E ZX_^&N&:;[RZ0Y<!N;,5T!;)3^QQLT0QAU(
M8Q;X9E=B:XI'])HU_!/863]$;CE[['NS5TAQF-QQK;KG92@CIJTY0.>BFQ)U
M=I2%LL^9CBL)@R$R(PBFQR,,U"IUCM56W%/,\\M0NNX;7Q<QU"\+F'S]CQ01
M1&I,)@36.,;LU) ,+DF,@I:=B#WB^/&;L=T0T5GG30@E 8X^2DS8)W00JPIA
M[_J/3*(R9+J-A*BK>'*$N0)^YNO6;'%/Q'^$L B[YQ]+8/H8)6J4?)K+Q%AX
M%I\B5Q_DJ72PK+L^AY3),/B>-,UMY9#A!>W_XT#$E$MZ5,YDT/5.F4/2X(SV
MM7C5O#&!U-/H'$HAF="N/?'ZUUD7&I$S71'ZN=E:W(_(Y&3$*^2U-UYV'C?+
M>+^]N,QG"=CMS-,&90+^_>0)1P80[USQ(H2Z.L89K*=U?X%(V4?:_G5F#8M?
MME1J:Y >T%8?"3@G0LB%.4 8UR6\C1ODRE'9/W85/"VMZ$(JYSPCAG&F.!U8
M _FVDJ-Z\.<]O/P0D6?=4__YLNW#/_4RKG^IMSF2O\N6$'W*19)9 X3=ZI+W
M'ER3"SA8.(YZS0' ]Q(HO^&_.$-*1-MJY=SY#+$6><W]B7(U:N^/!UW!#J(1
M)TGU%8-0#N>7U8G7KJO=@LD1>\H06'[$ILM")9=Q'?:Q^XO;>H=?Q.=+9K<'
M5A'H!Y"QT2;SPG4YS<:O?''\T\QG:T"X/V^G0=ULFX)D@P0)>6 GT<M.\=#;
M:'[D/$%<NS_9K]I^K"M9DP.Y%DRD[B+?M(2UP9W%\Q6B4<&EH=H'7].;3S(N
MJ(G' A'O9\O\'?^NW%'MC$#K]I7X*V$=W?SLZ<K6@J"]>F*);T[,^\!H_3ZL
MS.)"]A8/IG5RGECIEZO-TL,9R;_IWQ-""3T<Y^F/KE88&DZ:EV_(P;YL,YY0
MJ2P),4:8*<,*GOU6F_I7W@D7L28WA;<#7XO/7!*/J"O=1=Q=ENFS=&ND NQ2
M4VA1(+*U']@L&!-AS7FG%6RD8.PD &T6KT[X6:9L#L9(5*X0)T*(O0IO'GKS
M/;0;Q/$OPG%/A_%/80U6"WR'5<,@]K_JW% 1JT(H?\)49M&NGWU@#A</5N^J
M0;)S(IM?:'4@N_6Q=U5*<**0.;NEX&/SM;$+FQ>1?*DIO$LQ_X/JZ__5UTTL
MG*@B3A!N%P4O"8CB#C:(Y!G[Y0%*9_=BWS%U%Y%@K?= K[%?2XN"/WSQ]TBV
MT)BERP%>T NNIFL7G4!YX]]*A.;-T3+>K_'E!"PCDFI\C9\!F;;I&]I_T1#0
M*8$ 3TMV^M&&&;DJI05RJ<L_/F )TMI0IO[K8. VO3A8R!3^HG=.</RSY/3'
MP2$Z,J%AK>2(PC"/A\N:-=/R:%PE 6>STB8+EQ+MWB354C[RI=%-'\A^^(/&
M72Z#CWA>Z_/3=6MGL4>@'9-\Z?2+VE::R&AA7OJ;N3:N,4OK8K!9DPL_0MR)
M_:&@'>/":/=TW#=6%FQ03'.>,^/3-],/8MA[@>GMF\[U28TA!A^R2,! Y,M.
MJRRZJT'_U"-B].&Z0R#3VX9LLC5?4BDD =F5:XG!?*Q<9S4I8U_6ZAI5W)3\
M*G'I6.3MAMGYJ;A.5NLOPS;X<FOQ@<0=5?U.N9!/E?*RMVL[PF/*:SM:IH<"
MCXT8(\J",0[$>UA/W_?R/>E+1-8?FZO:0>4??\!#\D%XX:[&C3B<\#8XR#XL
M;X:^)I-'UJ8L(&(J[5*$ARJU4P^H^UCS4,U+/[2D)MJSJ(I@6=?_W:B.34QT
M@LL]1F;KMWD+"2@NU2(![/QCOX[U]Z0.H3F?D)?)K7'"^"!_T8]D,I,?[S7B
M2I!N_33@;\K*6[K8?^E[Y8!J_FTOWC*>H2WAVXZ]\@9YK,5R7AF7&MG+>_75
M("F5G;;;>=/Z';(L!=?WMY[>RDDVJG%Y)Q>I*B&W;1>]<>]Q3&*YRJK@&9-C
M#[5#I(7>H@<<+,ZCSH]9?3:C2'?M8X7Q049*8F+_/^OC((%,X ;+5O"08>%)
M".#&\K.:18POP52U278A-):]4KW#M8+KKP"IV*N%OKZ#1;$-DA,>EL'"2RNK
MX'\<TEBB5_!OYY%\A=%LF)L<QU6C!<^8/NU[OY1X*/W*_6.,CT\5IXF)P[PF
M.D'M5;77>8$U8Y#/L]?:.?G%EH*AXLE#6S.M;PM,6]*B7QQDMBO2_6^/E/J?
MBJIB[2[@O5.9ZRS[Q(>=U?7,2#0+THU2@^B,[WAO'=R*I+3V7FQD7BW?<W.Z
M]KI74?W-$_Z#+>WKMYJ6I>+XP\1,EG5@%Z53/R4S517HO]KVIT2A]=R9=!5*
M?A:;*/RH]X%FKQF!L ("GXM:ZV [LV026X=]>#?,X_ZR'\VQ_@%7,*1%9Z?R
M*+1Y1C"DU'G\3;'2>1!:3Y]YA:C61B3 #G(9\,SQS6^;2( ;<P2J^I38ST+-
M"[.^<CO:V4DJG9^O8,-%HEADRL7>%&#YYMRQ7M*?EB/[#CNX87U@8MDK$ 4)
M>,QPR9MY@7TT<_B[LQMX_60N>@WB^N,<O[3_3.EPV:/ECJ6(LH+;-//K4G8R
M_</<PWC-A40S7I,\TP&=R6M<-\0LFI[KBS7GP<Z$_$H"<P:)6&AWY,8^Y"T[
M<+K^PU_"K;K(699O6TA'\%.NH,>1IP7O+70//'2_=4#JH9G65^[@-1N*>]DI
M.3-#O+',88Z4&3^KZ71>^/>_<?PLNGD?73C#!=]TT>VYZK^EZ)EP *+&:NJB
M-9(3].)I,G12'E-QFRV]2:77AUARCGKY+C<]NO-5+N*54\;XZI,2ZS=2-Q>$
M9&^4C5E>>JF<FR?S1,PAX^=@=]!6CCD7QGC^>1!&4U^.O\2-*_51F_?/SO2H
M*?GCT$ /B^%,O3)IZM:U?8=]%Y.F(=,K$RX.< ;XX2VLO?,;NFM#*U%G$V!X
M,5ACZM[=8"=L+M+I_MW>-7;F!(U"\W-W%?-[?>Y:;0Z9LA/:_$MJ)G3O3_9(
M$5:(CN'J. Z\H,9Y?WFGOH RU#QJ/'H>\C&3&4%G68(4>K-+YZMC)?YS*D+.
MB$M%X&1&WWF 0^\A:KD3<LW9T:)6"\8+P3)+W'(3V4^Y]0H'OL:"J_8UV9,H
M.F;9:;'&"<M,"K9OZ;K(4L]$4-!_K+U@>?>#:93"J #_BLC,BM0"ZB.1"3.=
M;H4-U@AQ% Y\RKHTPT?X .5Q/A*1O&Q6M"T+(F\.-"=GW+AVM%0>__XM(MO%
MN5=DH6<>GHL[T3X>VT=SM#K%D?>/TB@K883<Q*D[7PFD638C;S;V4J.)R+I:
M!Q 2ZSBQEUG];.C'^MCGAWUZ? 7&N>\ND4&!^Q@E825WPV+^I74^'7BZ7V?:
M-2+1G''EZ^K+T69MI)EI13EMX*(S_5G3KF>IAH'G%=W0LV+M^YE:K/3*2%//
MUPKLDX8D0(C^/,U+B1":]T-&@S?_*])KU->AI:4C\K(\:PKS6\KT4$2XB)15
M]X9>RMEWXF+J+,#4IWICZ]G6"P.0("A?.WCW7.5I$JH-W]LO+HE8E! #N96*
M&!@//A',H<"VDQ%9 07#EF-^U*9Y;WS@[%;"[L[X[&$6M@1WQ_NPKPU&4Z-R
MHV YWUY:GG6=>@[D?," %1JC.JP8CN*+VFNG#%B26O8@=J-8VIK\X*%O$IC[
M,B?$?Q2W<-VE/G?(VQH(SA3%7D/BV?+KP67N'S>);/X6HP]\]U7E[1/659C8
M%@56MOH*H#E6SG=LFEB'PX<\K3HEN M_V?,-,38@YQGFD<U(;CP(8U,15G,U
M;VI\VE*[YKIGJ3_N+>0W$G\)1Z1G'%"ZY93@N'F$4]V(5/=CTG3,T J1ED\$
M?8M@>/#[HN>?/JS\;4DEQ4\Y&S]X87.FZ#X\H\8%$C!?M/G8(Y;RK-A&S>@T
M OWF?%"7RUWHM?)?'ZVXDJR/F=2O//$Y1'Y S7U:T"04NNHD2ZN-$O94 O0W
M'>O/!+^3#+(;O%_11L!9COY G GS%B#OL(4V*&*HY4A*X+_B7<\\6(N0]NY5
M2(WC1]T!SZ7"T"^.&MW'_!9[L]%>S1AG)FNG[3P28/_YZ\OF-\9KD.R)%OC$
M)O\[)<Y[5YZ@DF>QM[+QEU8.?YQ&V+O!F/Q-L &I-UH1_@;- WK327WZK8&*
MH>37[WUAW=D-*&]M4=2D.<BI..X&'06]Q07B2BWT,G$2PKL/GN!;#.J#[S^-
M[_I5':>^QY8H\1YB-PUKJ "59Y:%'1TE<X2;S5!&8EY.LS#!8OW9,&US([5H
MT04^;PF;]V[-S,5:F26=A50%%)K[.R2 LAFBYH,37=?FC"R\1Z]9B!P"Z)59
MC[W(?ZF?5$1MMN1)A+GOPM<@.>_?*XOKW$Q[^U]V4O5_I1GBKWF:D :-76+[
M>T(:"6 D >W\D$R?\W]7LO@IP"_PZ#0B.YD YK1W?JGYB#Q2_VG2_A6B;H0T
M/$BA^K?2"T9@_=:XR!.H)-!)1M7<>8M'@1%"?NS7JK1YB.BUZ) 02;>/#] ,
MDH/,%'77-.3V3-EQYY9AH6CJ5JD;7*^47 D92E?\G= KG^F0[[N.E3PH7&FG
M/-=L_:&BQ'XEH\_W3JN;A)HCRSF;5&M#7V]]$->B,@_2!\>:V? UY2@%7!LE
M 6=&\<)S>[RT/1*T[B-7X1[Z:20@&&S:@5=K+YZJ?"RTW)\8;^X&HUCDPY@?
MAL6JF,531!/##O16#L.Q+9G3X?SK.-<PB?=<#!N0Y_R1\SX%R\89D_#IN^#^
MT<$U"!O^=<@%J-*D4Z%56FM'U-DSTRZ+,O'!>Z[!U#K9HRL[G=.P;@+5>VQ)
M\*\V-J/@0U>^S;GEXM7:L^ZA)*#T5C]UVIY.86>D*T$P%^-W&+(+/]G!G_?%
M76R8$ V>;93SCM8I%SDT[;B[T0?2J4L !7^ZLGHXBZ5'S4-4[K^5<(Z)094Z
MYNE[$1T[]5MHT\(MC(GM'\,+XO5QKXXIYH]:1.$5MB+%%4/XV:O;+/>)88LA
M.&:-LXNZ%ORX23^"T,U2=X;FAVV9D^_'/K'8[>>>$5/_%,QZD B.7"C6,0[R
M5\OO'M3=K^A!G&E)U U:L-Q?-VC4"+[FE'-0/?M42GOO[F%J!UWI*\DB_XY?
M!SV2+ZFE]@4Z_BDYT*JE&DC/94LY,3BC]@JL<_-Y\)HRX^E; C_2E2'TZ\*J
MG-JV0Y#%C-B@Y^_7+$"7P4O),R1@-/_T+/C_U++<#5ZR,L??VNH$+WD&DP 6
MF,2R_K@:\3XM"=@&_7'9W#+>42<!UN;'--BV0P,2$-4$Q@4?)^#D37#]L%%6
MHFJ=0)/^,3]XZQ :ORB C_U- I NNT+]ZJQ'?0N.2T58U:\DP'MP#7X4;J[Z
M(2U$2/F?[39_U:LV'LQ>_"M-BL(^*-LF!5VSI_/#$=[^B3M$Y<]GJE29GWX+
M.W#8_$-OFX/JIU-=Z]]^Y(^F?FCJ+ N(MTNGCA_M%HML^CWBV7\[6*>H,JQY
M,>&^]_!P4"<W1>MY_VP&/ N7L</7  3!.E/S!%QYF'L:J/%APXW9O<2 ZH'5
M:X+P4CSH15Y2K+;G[3@E E:S-5P0QXXD3V?@)*^1 ?NU;2GU8O4OI%F_&IW0
M)?87LLC 3=A<JEQQ.VU<9PHO=47;?D$E>"[+]MK@EEU$+\L+!OE'?:!8>TBS
M'FM,[7C=\Q&Y-:Q^:VF\?$H= <RWW9IPZ]A;:5_#+KRF;*?'GW<6;3+]<OQ]
MG_-+;S*Y@!#+3D/KSAN/N#5VG<^]\8E[(ID$!#WZM?<QK^-FK^4QCS@:$;8=
M\RQ[!8:EFO'4>@SUY4R@OA?:XGVTV8,Y7%F,__C=K [N\AR [KA#&FM]AX1N
MG]F"/ YN-FKN-Q7<['O7]LAE^5?E_(;3S6JQ[6POGAY9D_?1N@[7WPEV-B>K
MN[X,_=]=7>?_#Y?*E9?/T@+9K]OQ3WGH6!R]K0BQ_BE]9B"UZDW[O?5G9S7C
M'UW?9^WQ5\.BYF!!5<]&%)SR10JJ'5V^R$.E%F!H(\BD?B,)* JN#S!N3>A-
MIX&0 (>:\LN[Y;3=#"K'G,2'*#<8]I;TEC;. 'M" LS[B5>=3_22KF>F%5=4
M<5WRK-]0'M \@.3 &O1(@-WT74^WUYB[4J\5PLF3N\68F4CS&<<ETXDW""4>
MGZ;;A6G#G!!P<PG)>!"KE)G=5#>X,8B0 9772';$BXB8(_5E8$$4Q>"26:S/
MSJ;W#T:B@'KTX#+YD_DSL 8C\C<DB=!6Q3>OINOEO4'R$4^0BU(H)T3$=B4L
MQ#*'+W4O&&MB#BKU:G,9N%J)1>05[Q]G@>:5+4##)*!-'RLC?"B"-@][!3M'
M)E6O,P\.T[V6%(R$GG+S(L3VD45$"G^34FP/>J%I@34_]]V!)Y> 6CUX!/49
M,5[=PGGT&>SD3MFWP//$:H0XH=KJT.> W$01J0G<@CA1;U^M+^>>RAN\ @G]
MUM["X+.I,K4-W6G>H"A&,C>4S_/940FPE#)&OE>FG=S=MG5)QI+1ZO7L9OL8
M1QS3RJD#[M6]6"[-%>O1EKDK6/,%Z:@'*_<JY\AK)'\*PZ( D:;H"F1BP^21
M+)LX;+4)4DP"T&[N]? @\L9SA&?>: '1UUW'.G<N/S\8-GPM55P30I5XA_ID
M=!&,9WUB,UN6_(/S#GC@^@IQ@I-01P9+]W;BW,>M+(W2*9H!.TQ<(%@1-5<,
M0:N 0R#%V9_+]$-A- I@'[_YW*=1Z[M.:D+*M8'L?-SF?X+?XQT72,"'9/$R
M#'^0GU325E!])*TXJWS@ 2MA!&^.-9QC""6R5*(1<,F+5KC[7P^U63N?&PD?
MX\A+'7G%;ZB56WF[<YLH0^R3>W!TR%0];3MNH?)IB_D+E5X26 [ %Q,R4.ZB
M(;!2$M"T)=V 8OPCP8\0C)+_['![TWM=?Z!6F'@AG :U]=GNVP6;WXN@G81C
M^18ET(@"7X'^_#1,W\7O*STOVWI67=&IKKS-3P3NT9C\E9<]%R;\_/\$@HMF
MS^9 SJW.@8Z#)DG :EF!90>:%S9/W3^67&5#'I%V%\NA?RE]^]*%/"]+^FAO
MHEM/F-[Q\K<S_#\-E;EW(O#RJ?!S+N=?Y9SA-&V]$ ;KXT<NJA%I1BZ#)U9,
M(FZ^RQGZ"5TE 5EIJ)(^'LQ<P%,2,"3T=P<L FV638>S=48=,I]2F=/X#B;R
M6-D9:F[60E]"E\"=*+U#8>Z/:Y"O"+3K%W>L_;3R3>(%E_W=.\I+!@P>0__K
MG*K18S2\UV7ZE_D&:D+0L.9.8^*T[\Y_DQ]IJ?P'F3.Z%N*F'>@;<D?QO'.O
MI*:>Z;FG@X6*YUEH==\/]1?Z)IS*V3 8:S2L.SU+H=SD+9V(2D\Y&Q%CJ$S_
MM^STK/[_YJ>K3WP'_H9#Z!\L[D!9%B2T3@5S+L-5))/G* 5_G2_4U'E]!;>R
MIM.A]#Q=M^W),U-+CD #L8N\2K$8\ZVSDZAG%YWJ&TS:0*;(L@+44!\96G =
M<V+3R8. C_\..X+E( ,QPC.=+X[6I$Y /[%*\8<SXHJ*H7AXH<)EL;EJJCY\
M5?9NP87I\LM]SJES?<=,MV ;_>!86SC!\,1\^O'WDQI%MB6H:<@@J]%L-PD0
MN["H5.MDI!IY[-U^E %^960V6MGS-(A64^<!)N1FRN-_",.==HT3&86D4#PZ
MD'3ES8H+ >QHN8V,4#.2,8!1\)4G42' F[U5P8M18MI_<W^=\?+0>-EP*O&6
M10(X"<YU[1E;7*D#@9EFQ=!;#-B*^*=>9;!ERR-0 +0L$F-'U%Z>)?B!=W]:
M-Q'5RV"-O?ALHB:[.T:T^UC_/P,K[F;86@@)N IA)W:"=A\ZDH 7)$ "XKB>
M])@$_#QUI^I_1.T^( &3FP315O"Q<"H)L!U=,G9H.QOML\\"AC1^A_@3^:$/
M2GEJ3FB<9&73R'"0;*5)X#^;2T8?^3)OL NDI%!175]D67]TCE<=S#=D<%9.
M?LXQ;(CW*GH[?J'V^NI)C7-_T5+QG^R9R4(JWE+T#TW^S\;91M\_Q [>9A4R
MR,DS>A,UGOZ^F! +96FH#6-,VG[XAW%H: <GBN=7O:O"V&>X%+)U@>]'5L+C
M1_7'&:-)]* .G^.D"[._#U-;IO32Y@]R)X>.-P[+L3?F$ "6#V>G5AJF=46D
M6=FW'P?@F=!>+>ZT_-D+PC+C2Q6]G%>497ZF'V[<1EV,H :OAN-[Y(G4]G](
M0.-%ZA6B(BP%V5TD^_QL/*@Q3#"3C:O,7>WP0;5,C["WL8+UAO:0<87407EV
M$6KS/CI*OS9+%;8U97P;]D3_0['&)2<##Q*@UUCKW7<- Q^(WWJ*5H<&$4)C
M+6=:P1['KM[1BN$%G^*2'4]UK.?C@M S#:73],-,XIZQ#\SO,S[RD;KZ^$J#
MK=./(!^D1I*,44B8:91"2)FS>=ZZB5?T=!P?7ZU22F#T2':^Q/]VG;O_F]>E
M..[%$(.7$NJ2=?1BRO1I7RZI_P>AV7&+&/^TI ??O$2IN'^S%5:WZ_:H:G$I
M#3D*!E:V.3]^ XE1#Z&N=E=9[_:,W,_L .)86AX?/9Q+>/'@I>6[MT_IQ6N?
M:?@[J(3H8G*.Q;0X$%%@&L!H*^(\I5%H98ODO8=+BH+<CT+.CH[Y%KZFE1\8
M$)AF^>_K@3@F^AF)U?>PRY=LW5>^\,.J0" A8][O=09=:;+@#YS>/;OD_>^%
MWPL)B[S[5(N1NG1X9<>)KR6RK@H/>4LKWZU&)C7-:ZC+OVBG*KA6"/)[/Q&3
M<XM+2HUSZ^8+5N]MI_V@B!>4 4[/_KL>F)1%[GZM1>&!0$:6LU#7(?%W1SKF
M*;DF'W'I",OP2/SRS1?ROZGVCDD E3-QR#?,''H9ZY7=2;3JN,7L]AQH#D[
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M2I+0SI-.)Q@3GC7GX7'&L;C-/;87/&W+D)%1/&/V8<PP^!EB7.+!\('5Z*\
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M7$>!-_=XXE\F:$_353,;FAHM:$9S%5+9Z?M]5(O0_Y7GE!*]-)4<$L'')^@
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MV=\^>JDMX+%CF\T9^X$"(B"3T]/R"OR\8?@UNC#G*$I_YUZID>@TBTG2M;^
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M\!Q!2[((^5EQ5G)%(E</D"BSO0V.AE+4>$0]=/;7G:EG\MF!2^]J]"4J!@U
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ME^]B>3L#[RPFXW)-'_:7IBP$9[=1WS6,1LG.[)K04_V^2Q,\+4V!/ V8X_"
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M9(,NZF5+T*M2QU1?1)2O52/QK_HFNH$+YV,*\^(>ZQ\ZZO6=3_]X4V%?5#[
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M9N;O(9GGGN@RG:RG&>9KN-GKWVL(+SC;7&Q1#[(1*WO5^&,\?PEX9KRS#W3
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MDB /6YRW,BTXU?=9$%X3L65.8MJ([33!<PUPQ?!>1PBIOS@?B71:+U[6-!@
M#L%VI?$R01E'KKB14,R77@;>CR'K4>]4(6V'ITQX"5C'5R '[ DH@M>M!TYM
MM^G-F>\@)<C\HCE,F#]ASI*6P-^,5]HB QA [K,P=LG7<6H&UFY22M_]P25
MC"=HEVZ!7?W"E@!-XT2ZUJ=-T^LZ^VY V6"B.T,^QOSHE#(>=X@/,0H2X)L+
MT1B[^"5Q>4C?"_VX.'6TD>-4A@R@&80. +\ >Z2Y;(,6+!S:! W-]B7J#5I$
MA"#%.8V(,3( IW1G$=@U\AI>4]#4UIH_TQ/H>&&\3\7V4Z #K>5B)BD$M)@
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MM5@M9K,JUPY%L:;;^_Y!W,#)>.<-+<\P-2??$M.C2BQJI3HJ2AR 2#.>EK-
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M-O4@VT=3ZI?LNKR\R@6'KDFV=Y !KLAR,N GHA.U'HETJV3K:A/ZHG#L<^V
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M'.@SWW.KTQEG^7D1;J/X&?)II Y@6,O\/LNL7)RQM.3FB^_Z!+&'W#7.12A
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M3@+LD:86%&-8?F_(D?$^9M?=)Z^2U%6O#^H*!V3(WJB):#U(!E^,-(->'2(
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MSC]9FT)$NV)U<#::K3*Z7#\ASLT$D472ZU=4#+BGR\ W) Q06$/-2.)N16H
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M7MUA?J/8X):>>F  AT?N#Z3CO:DG:E-&UC?I>#I8>KGNI=QD%!(35B[@FGS
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M;TRU& Y#G9Y5F?/<XLNJ[VRR?$BVHS=#F!<W?,>?Q/*9+(-^?&P(31=2I%-
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M;?+SZQ</->^3AQ[NR,<4LN[=+X\]VXAY$M):4\EB1^"0\%R \8$P#;HD5:O
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MSE*_4NZ0Q8' /!D,(8'CL<5M5/\,U)8:J$P29&_*88+G,3RY[I<#Q@V;*LH
M/"("_@&9(LZ6,(]"X$A .D.?D2AP#3;'KTX"P&^P.T=V#O/_8ODO"&>0E,0!
M.E#O__/?R,3]069)F9=Y.', *74GB+B3U!D>BVWEF;7K_6VUGD\$.)Z)\!]*
MJ!R-DV3[[I]K_K'KQ@Z<<2(F.\4304HMY$DT@.T@J$G3]MFO[X?_& W^ 0X1
M0$9J#^J(L2$$D1-.Z:'.7D\]1RE6_Q#QC#C#Q43 RDS+JMS9H> #.[M49ZU
MH'@?FN9%/2%\)@A$:/Z+6O3>&*EA-VQ*PL$&9I2W%/,\PY/S#U-&NFH7 P1%
M_WG1+$ :G=!M4DY[UNO&W)K>3JL-\#7"9&PG5\?]6GYW=J.I7U+'H88+=$4T
M\#G2V-,3QN/YQF'7-_N"BU6GM1SVR^G,N5&G(9PW>8\WLD['@^V;^;G=*DT\
M#7][1U<5WNQ1#6?UR(UC4%.4HM&VU)^F]_H9!V"Y%2I2+#D;GT;P>+H^:U<\
M0ZCVE%R>R<'$F=W>4P0(I06)OL)&@JYI[74?PP;37);2=.U_2QVPWEN:K4*D
M:C^MGKWF=E.BO 9JU?/R_;>'@(M^B81$M.:)]!L!#A))RB=YS8<_^[$ZEI<]
M$F[+*60XU0Z-#?&*J,U>P6EWR]BOPJG;4^NEMZME;95';MC!G$W8Y2,9M.F[
MQILDLA+F"P].PC'#K:48\/,KA:1(-9'@FB595!Z9C1U881PN9W8L_#$^Y/;U
M0 _JZ 4F!%W^(PBYA%E4+?[\S3,<:!V <4VP.<V2/V!2/MNGYA>:-H1,<C3\
M#/SQA.O 2]!!U3,,VLTE[W?O*F&E_D&H1<Z6=B%H\0XJ@ A(^? G2B2,M*DM
M"IQ2_D'TS3P<&COH^X_]O>PL4N(0WP8^H/LK1101,ISP$\I@(N <$*FT 25I
M'5O_7P$O)*G4(CL*AC]/<>8%#*.*8R?I&=G?>;Q/Y01Y_/ZOUO_9"U\9?3/$
ME/#B#[!)*08E10CTOZ'=_M>X6W^D *D+;5-8!)Y>^N,B#R:X+>7$$P!=('%L
M-8>DKNS'X9S0,Q[$#9&N=<: "= _(P';(0)(PS> ^I>*G_F0]%?$2TJ^OW *
MT+,7EI'B_,D=Y4T[C8_7K:E?_.+7U:+3'$,2TND=]W;:[)G:Z6Y!.3E+_,CN
ML]&,6\KE(HGUONGZ><\,@Z,E35,];-;&.UD>LTDW-CY_R,^Q0QA[69M<3YLD
MY6.(Z&AW(H :5#^FI"T]TH).?485,?YPDWZ%^"!\:23)TL!Q5QB[S^]&^)DS
MG^@Y$?K"-G^?O9M+9C2^Q$)L\A&N(%+MYD_)'L;\#XI7*<N<C+O>1LQ+G^%D
M.G+3X-'V>?(-C<7[5LG=-1^MUL"KW*]LJJNO.[)$M/:!6ON!74>UFFWA9O .
MPPD)"62.:/507U2B=N&8EHE;,VP,%HP0"!3IJ_M6"3LQ>D9*#Q<@#%X%[6($
MBI$@>][.7-]VB07DECD7[M[<6=Z9 /T3>T)EFT%P6[M!Q03A9N=@":NY)LMQ
M!B'_%WK=[G(1:V07"2G3)%$[N X[BZFJG\.B.Q$@)$(:^V[,N$I5Q,!V\=&K
M_G5$3\Y9_2+^?Q0E9]?2_:G&V(;OG-D.>I!'FI-JHMOH\C *7 <)KM^Z_\#5
M?1%^>JG@K'XI4A/ATG+($6O]_CW[JTH,[F&SZ/D_-SPS\_^WV?LL-^U*,=O/
MSACMIK/\EE1A[7XEB$!))K#32]U_)N?L=4FNR7010W$<5POS62+P+\>.V\$'
M5__X=5.A1^[G9/97Q*(L:AQ_GNYO<OZ?Y@TT:D>O^MCQ4]W_=2%'AARJK<Q4
M5QXT3Z+-X)DS5P-<M]0[R X_ZR.A-#LTHI=0OKND49/Q7JR5( QI_YDSOD/Z
MWS2G+D-K']L)M,VH/A27@]X!?S1Y\F9(\X%+9G?:+"0?\1CAZ'S5CCF\79'^
MIGV[0)3@ </)_$M@PLOHB^Z\SPFB&*Z(,KK^Y_%C'- G&%$@IIN7"_H>UY,[
M\FRT\4N_U[F/COTW&+]6P=)%V!FMKS_IEEC0KQ'BG)8Y*._S+E;C\O>GG4B8
MA2?/W:FY&KL*D-^(=.RX;G;;>OJK+W.B<9GOVJ_LA ^3 SX<V8=8BS W6%6<
MFT]YQXK</5#D@2/#V?%G15Q'(0^=_2.U?]3)(IB/RB<N$ZBJ"]?'8_TD,2NN
M=\53GMYX5PY8<&NK EE-:]-N >GY/>!TK713?3:5US.?/V1\6P*JA>*N(]NE
M\AIQ&AAM3Q[S2^WG@\ /;)@(=. 1B^N_6EM8DUBNO13GG2$PG:JN-&F&(J6>
MU>CK]BA?3H-K0!"NIQ2HK27:T);;=CV?,:9/PXPYR6HH$S*\MQW*]QGD+R*N
M0&T&IO61VMNZZ(M :J\N0U_ZE"1Q.I&/YT!-LEN'T"-G?$7+#<(@V_7:L0-_
M&\]O$9H_&*C(@5H.N\*L+1(\'X<*\VY6IYZL779UI+D;G,?C],G63]=^WG4G
M<"Q,(=?NW,=7I%QL46B(G;,_BZU_7H)$)TOT0-@KQR^;ZJK+*R2")._801_*
M=4^.V;48%<0..O]=#J#S(N%X8Z\F]VS-0@_:]@WU8^\TS@I/DB=?8[F<(_=M
MYXOGEY*^C'1GL+Q@\J3OQK;!26*Z&X98O_UW,:#Z?G-*_?]?P&:(_N_&0?]A
M_Q?6?SAV=EJXPE\>#I$N. XC2?O?"_B#X_Q3*Y6L_HMY.02Z75+RH@SZMRNC
M+U] +(++'/:)  *5+"68WK0>$.SA?CH^,^*UVV[-0!AZ(IX#(\D":"'+)#JF
MH,Q4+%4P_N;Y#/<M,&VW7O232#>3"?S--H*MJ\&]\1.@]*/U%[KTBG"#@EZ
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M$[2GG)HE\S:[#^S0 GR^9;H$"O5PE-+4UAV-M52(4Z2!?_*CPWH0 :V6#PC
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M0?:[M!-*!;T%58LWV5XGAW/-50,)-*[X8J8W5\B\UB&_');ISTXO@$Q?.(]
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MH%IBRBKH-& >#%P#^E]7N"L[("*D$S<G!IG6ITMLJS%8,^D?=D#7=T]Q_'0
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MN_:9U222A3,]O06G!(5SO4+<H2F+RO>/!^DB0H5(W[_?YUT,##"QO5FK KU
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M-KH4A L%!R8LOYT$9&_H;UA&SQ'6#Z*96^^-WLU]>F+\!J+3@VJ"AC+V]="
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MXYL>YW:_9%%I0H%Z ><Z1@:X20!H<910ZD)?Q?W1^.7Q![!M5OUM(-/(,T0
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M6)Z!_K-YT__O%A+D7VTAOFW 5!U@Q@"_W;3;YGJ.N@)L^QVDQ=^%<B-0=>^
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MQQ$$AON:"56BXUDI5A#9S0_DLQ GW1*Y-?D (95.5+VOA"T67157V])5(8W
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M#SQRQ?[=>1/H5=!7<N-++>Z/[]2A@U9BJ,4XJ]UO>]CG4&+)*"R#$<!;''9
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M:9B.G">&*Y;E8O_N;?V$;TSV&YZ'*?<(0]ATFTH3HQG4&^NIJTH1Q1V#\>>
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M.TBEGZ ?N8WCE,]MU?\RZM4 -" HD^FXL!+&JF^^DK^J_X[\Z%!ZS T:;JK
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MZ_"LS'XI$)G[2/Q9YOW4JRRCJ8@6GWC03R!&K@3B"+<;\0]0W0ND7Q,'=9K
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M>38?-K#8:QF95)MN-F??]4M 'K_P2F-9VO,HY2ZIXASP!,:$JC4DM'QK5?[
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M.GW>/WH11[]V#L@VS-\.O0+DARTBX)Q0^6TN01Z"6TX14V GOO+Q@0-SV#G
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MY0'H^,.+G%R9,_-%3FN*(F5PL-=[X*EHDC:%7HYEPV6-X"T2\&5]!*D)_K6
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MT#?9OB6'GC0 ,PP'H[ I3Q\<H8@66$[LLN?Q/MCA(Q0-<+XX*( &^-A( ]
M=-HT (<V^6XU88D:R4P#D,\"R9IT'P_W2->#H 0R#5#F%XI#MQP4%WW+=G .
MQ+N29"BO"[)(^S9X\D[[@*I&BEWOI 45264XZ0-* P@&T1%"FZ9D:@F::]H%
MJY*2H<]NW&&@9%#?8!W0D<K3C/6,*];GZN.S7$TOIT<PSK"OW$%IBBI<4K;P
M7VG1^OH1X9EH_(!.9_YK0HYH2FB,]QT.A6PM?O77KJG$_J\]'\DB!)GRI\@
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MBTXHBC0!;O'#;XYE&!JZU+ <6\V[?[G AZ3&A! /[SN<1@8[:I^/_^C@)^5
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MMF9H4%PDZM4/>4''E7O%<_:RON(5!Y)K%O7IN7\4-S&?M<](=H&*0N2L77'
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MY) *O>%6_IXX8Z98&X2_! "M5J2-LPY>0B\2E\ 5%?V6(65,15G5MZ+F<QG
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M[K^S^@KPZ_&'Y\*!?FD;)-%N=8U?[LG?*<?46BC(G*GS:"UD-M+I$NU($".
M$MR[MTQQHD\Y*20?BA2]QS+DHP:CQ/B3/ICC>WF@4_3;,._W64U%*A?:3+?@
MH9I]D-?\T,.7-A$_4;+M3U>'R:I/[=^MKB>6_!4I?A."MXNWF6S64[K]DOE0
MYVWB/5;Y<P^<,&$*20=S U/97 *<MW_0&#TURR"/MPG<=8?,PC'&*)8]Y:6!
M3*O2LMP).X4NGWX]6KIR#&)@D2$ LOH.?W-GY=S=^EG0FZU+@+O$2R&S1"WH
M0NJQ3T'DX-<%[CV-YO-S8+*&"Y3+(=#Q-\KD]?Y*PJAWPE_Y/ #>#:V:S8NF
MS>6%#RVT=GW.6.4@4#"ATK3?)GP7B9]^=PDHLX_!B4)GB41X%849.[5NB!Q#
MBW<8C/6E.1Q,-BM#18+5GAJO=IN_9PRN=^C#E[1F>ZC2:$5F:7?K#0+SQY=+
MX>".'J >A7"[A]: (*P>*#]P";CV'FLN;JT'HW?*,UXB#U$^1G"AO5LO.)9[
MXE=1 ODK&KZQJ3UL).=3"QTKR(Y/GOQDW36^X+16IV'5%UL03KSGU O<04+:
M%":=@I\'/%F\^FVJ-2 NP[33*86'<C1YW5"S*6%&E659C-LJ:Z7$I+U?]==G
M?_T7+G8YL#9A$.M.QD/[6TT39O:'TJ+A=/?=K<!+21 *@6&\@04!/S4*HL<6
M+PFI\CVY1A"OMK QI8Y(( /J5GNB;99'G8]4;5R5]S?PHOM29[O<[%0[5$X3
M+\'"72ANB-BSWS\DK< 5N.PK2TBB?VY'4.Q,SEY\_Q%IH_/@O6KV2DO2^#B.
M3E^?<FJ#/M;EN'2:P(N]^>CSW'1 RT3^YM?8YX9KUE+(3[CETP28=?'3-%&(
M:Y'7$$:NP[$N.+4_2X0V]72TY&*ERI/Q-6MPSV=3=ZO(#5:^ZH>X&47IC<D\
M\]]%@DK%*C8_4OYMM>*B4"FE'%(CX\=!E%)JUP%:&CI$FVD]9KS"I:/XVUH3
M('DUL>^6X\C$RNWZU-!+ (UC\#\JC+[ZYW$O!R[B#9O5Y?_,5PTFF ^X_]UN
MKO4E51)KV4$DDU"7?MB_35#%7 (<Q^&QE40@*8N?;1GZA9SH-L0?0?Z(KC3)
M$_MP(2RZ;(&DW;K^GO_R.!1!0MHS#:"_9G&G]6<RTT2D_$\ (;Q$32OL\X]'
M5PMM6_E[QLOXZX#?78K__2:,&P#:ZPK_>FEFL]@'!9!UYVZ1]!B\62Y>>8S#
M:DK"Z(:_I(4 R#@_4A4_D8 V;%6X!# &@V;-NL:Z.7 =\O'**VY+L^T>"OYK
MQRCY(R$M]CW#X@T8:@Y,13/ ']1<+-1)#P_ZA/0TC'SP'FY2PW&Q\^$2\"YX
M4UHU'3+G0S-DH,!-'!EYY.,XH=[2V?P'M.^>7 (H\:L[!+YO\=*%95R?SL?[
M\5PIRB[6OD&>EP!J9^@8D=,7A1'XL:J;UII?J.I"$;V!.T;0KL6JVC<MY)M4
M13L-L=*IX=X'=-6><]#6(-M:UZBR!XV9<&+/$?[$<6N3D5/3'.1/[I1R//GI
M0IP-Q-5"FQ[9P320Z91:V3A^^%O'Q@+;,C9DC;%D8*;VU8M+0.^N#8%2$O6A
MFY]]OC#$CS@[7[V02_E *O%'8$Q7\;6P4^3YR4])/$-'1Z'T)8!)H([M$I#]
MM^VO^\BE5'ONQEGP\NW:]@^^:]F+*/83:'E/<D9L;I(J4P2J7%G1&FH-/@1%
M8^^@$1UPEF.',M=7OKV,8;C*';N*X6Q9>P>4X)( O(U&S+7F51]O$EUOW1"8
M\KBN?^.:Q6:=8G1 P,43:SO#@<KKH99]I9R?BQ?UTN@KA-V^:DH)3V\H?\_[
MI_)KSJ'*F!!?B7,H<V[F>J\@*^/A]#/N5,;W@\(;T?J"=8PG5)W5X^O-B2C>
MN,\;TR[G%JM3>*;7F"]34!6\5<*RUINEH[*?XM1]5"@K703?$0*)7,I;K/J>
MA;JYM+?6E5V:N-CB0"^Z_*,#.(E4A2U]@E<.->(TH:-1:+\N#X&A[(S8EJ</
MZTWJVS@)3,=6:NP^A6@SYI@BOT,OM9_E;-DBD??>3IH!#]BWN.3QP\VPI8_(
MBK7TUH/PD>W:E_>\Y#T</PW<IH0?BFZ3B\]J#6RX7XSKY&RE9=R.H8US 6B7
MY5&PTWYD<I>S)+CQMZHQ-W'J!UIX>;_>A*:F/Q9:.PL1$Y=WND8>FY_F$#_Q
M!U8#WJ/+)0PMDDOBS;X-L-ZT&:#65$_X6$@*9A"=. G1G=(>VYB06*.BIF=Q
M5@,P8>O_(1I9<K*8 &,S66+I&+37B[GW]>Y#\^%4M@\D;><6E1V?'E8^Z[\!
MNSIIV+N% &E;@0.S0W \P1QHPSTTSOX2T-Z*?C ^4-@3*//.^]-=!A28!](
MIFUB*PQ@:<-PLX^5)?%75VOW:73[2$/D86V28$=Q(.8%EL]3(2__UJ_]:-O
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MSY4[ZBCU>9$#:\G19T.P.5S;+1*NZDGP;_"R?3CJ-28&A>PFVN"*$77O,H:
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M)"I)%Q#ME+0N&M!1P1D; 9CJWP@$D4@4,VDV%/NY_GJ>UO-XN/'4T7_+6 @
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MD2C0L+H7/Q88$E/^X @QP8S;&O+G@&L/LWDOUV,CCQ"6Q$^2V\4XQ^?Q-9;
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MM-(UVU2K YP)?8ZX%D_)\_[[=]<5QZ>FGIF;# ")XZ."T)#1^U&^T?K3OKD
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MDC/J[_7KIS[Q)3B(K^\%IO'JQK:5N'S6N*6L)/9@5U=;Q^&>/ 5O-,!J[*2
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MG^V7B&WFVQ2GO7'^H_Y; 4&/Y,_V/2^NZQ[C$TZ.YJ,RLGE-A J_,D766[[
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M+S)> 'B9=UDZ!3B.<78D,D,.Q!\G1L *64AZ^M>,&^)[JZ,?-C&C(T"O!;+
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MZYMP"[[V?;>*T7237/*VVN020^<@4'Q,-D]B /MJZQQN;,ZY0:_P,T\)*]G
M-ZHM^E?'!?1;0>7P**\.M$IP::/]NY W96NFF:A+0&B ^0H<PZ]4&KOR9(!J
MKO5TE-KXES^N?1#,BJ5;?9<*CI2C<H R_=05&&BE$%7H749V(9EQWE@&P@CH
MX(EA8S4Z+/_T<$GDOI'R543.\J\\RF]Y?&,:IL85OS&I=)VZD8GZDIV^^QX[
M(W]=;A%EEP#&[[6RW=]\\/:PY4.#C3,8^M-<W!-?)-X/\T-KNO_TPX=$"& K
M.AU>QV3X$O\%*NT#':D:L&VY^'JC*^?[[X]6I >(;#C56MI 5W&@8$#"6W"$
M3P!'B32ZW- /UB*W#,'P.P"1RR WXDX#OC@&8O@3TQO!80+OCX^T,%,M=X%H
MRH_0>TM .A^3-F/$[6+74E/<@?D#:,=2I33M&>QZE6ZMM7"0)VX35ECG">3?
M4@+K]O2("()7^&]/NIYD]GVOO@0$!5;"4.4W@JE\E&<JAO_._00YHT&@NIU#
M&#4Y3@<&7E\<??9-65Q.;7-_'Y),C;T#'8Y4@Y X) ,]?3EPCEM #%?23LV!
MRW)>1W*CPJK+]<6Y-A?][MD' *LKM17\(0)MK[ATQ&X&\@\5]:&A]W2[E5;Y
ME,8.P6JEEH>"*?<D*4.T&V$2)@VE TP3<VQOIDEV]5I:6J7.$,'!9VQ.>]!H
MD]10_=DE4/0A_L\A?G-<ES,*[:8$\@*;J ,H*47W1693E0!/?IUFO=M/8IS5
MP[8%W?ZW9$>:-[,B*>K^QSC[K__+H%J!EKAN OCU)0#:Y/$OM28M5*PN < R
M&-*B;AEQ3MIY7%""_FX$S;G@^5$F'9PR2/4]G/-='@.C=9J>6UY2W5%:VC#I
MLV]DO9T*'J):MVY<<?!E5(N_#_"?$%#V-W_<%_CT-=G+9^;?CEL8D]-2RU9A
MU8:[U#G0(1BEBXR&O[1O>59;_F[4+3/2BZDUPYU7Z'!C? 7,07O%A5ZF?+/K
M K8D.5^$G7]_80@C2MQK?*X8)&KI%GA9$Z-NSU7N^"WL_MM2C2#'73K,0[J=
MS#PB+%.X59)O'RFT9R[(\+36\LXM0M7QSZC'.S5S@77 &*OQVJ6HU?#<_;!V
MEYG^&E2@! I)/8N1:*N68QW3(ZNH-GJO';52]86EE3\M)BRSNM9K_O"^=OKQ
M=FJ_D^"DN?K%@56H\OJ[/S^:'?+$U!I<SN'E.A]XQWZ;>LKDG79BSK(" !C%
M I]P_695[K@^K0H7R?GV420[\LU^V-_HF>!PZ/04^$: T4,G,=8G'].UDHVR
M*JR.F3;A:"/P[(899O7@'7!FH\7[\;Q ==[O"M-JQ3#NJD"BFI$EX#\70Z\$
M4(Z>F,/4C:J,Z3_D/FM'Y6^?I^!O4SK?6KX$E(P;E!@J+2A= E37D)/"MS9O
M;FF1^ AIHB5"=G"R&=-<C:ZMK%\_6C(PTDQN!9>M]F_47XPM:CV\MQP82L;0
M]M*G6QVWP#OQM;"F.(908UU6>CM7MJ#[2R0EAZA^=@2]H8N?"4\NB0(@BIXH
M/ZDJSG)?9Q[ENXV?Y8T]Q%:F/*?J&S@S>4&Y;9;4"8],!V(<?_07+BUT117*
MT_BO5 ;XK\ PSXZIHU^:)E,]ZR#9 1UMKRYU@QEP^@=FLWIC_2X.)82<H3M
M0I6_L:"N3%=58K_'JF3_IT<X@> -OXGT+^;3^S%(MJI+0!2!T\/1E_.6@S$U
MAZNK&Q[TI2J,N;KM 4LW-Y9P;#*K\.IV$D-07B)I78Y=LMX"Y9K<'\18OD[6
MAQ\%"L90VZ-;(NR??KG=['C]?4.H)9C%BXYNFW[;1.EH3D:HL=B6K6@+\AY6
M'1AUE\W\26?\CUXRR#87U&CJE^!(H^GZ)[=7HP5+,\6/\!DJ9::%*W5N4N^
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M&65\;/R0Y@HZ@!.HK [.=/#9EP [.$;_+F.Z6N7:! ?]CRNN+#V[QP@5WK9
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M,*E0M$_!OS:B518C]J?<=@J=GWT#8)S5"8":$F:6T$[<.V<'6T1 U@$E;:I
M'_6SB;X[-<@+"7;K2\&%XHO!J'GPK"DJ$/_[$D!W;&X*J8A.3ER^#_ :E/N#
MV*JQ.# (7]80GPA0+.A\8Y>1F&C3%B0]E;1--"VQ.^;YK8*?BG&>Z%6EN J.
MA;MT3^D8:9UA3,B;2%M8%)#2V=GS$G#7Y^%6>^^7$)8N:4,ZAL+FYZFJ>!"6
M"0/'WH.U"H&=HA_OM\NQ)+75#Y8%=*@(-.:DRFS4%" &$7.F!%H5@[*F ZTV
MK=O&ICPT!\9SIK^Q= WR._7 :%B94!<R<I$.GXGCRO6QZI:8_*E1]$/MSF,
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MZJ!+ETRECTIN%!Z5 JBM&=LGT.L@27/JX>'45W27PDX=T<T>2@E_=Y&=?6#
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M<YQ?8KB6U <'EJP(H/A)!#/[3M;6%-PM5U:.(6A(*$^8V??KRG?!<$X9(PY
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MV[;@.TX:,JN9)Z-RD;&[=%.()D%\ZVX8RLR-TH\/>(WT;(+2+LIN%);9&1^
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M9QRHWP<X??RML)SHM@F7UY/<N+@W#YSM\V@1 F&&S#RI@/[C6>'5 -LWJ]<
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MGCS4@VM9TR_H4FR;OGLP*LXJJ]V1 '&*2[@&0(-,O](6<7EF9L=E+S9ZPO,
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M(%[GX\?L7B%UYW/O__(+?IB .=/C?)WC@P[^$&LE"J<*G0Y)SC.-;G30:T3
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M8\A&GKHP<&\<OBK+[,6KS+=5# 7-IT_P41R#R7QT">1)&'[PZYB3;E9O>>A
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MY7=<X6_P(+BB\P-_G70??=+;6>VJ2GOB^>S9EL0)W=*^1'O@%UMZ_->=E_V
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ML3X#:V6AE F=1_Q?C'F([U:W;TG_YRFU)E*Q62 X=URQ*B2(O)G QRMK^DQ
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MV8:$=MUIT1T 5S^9RIC(]'[-WGU;G Z=\8I8W ID0UUI^TW$W TYNL IW'!
M+M[Z"76)35(U%C:T0.1PYO/ (-!_5867( E=U(OTRZ^_%AM]N*T)><K(9)>-
MF<PZ!W)GF^Q>3NBF1!5._QDD#DWM/GP+R[;,(OO2[GH(&P+QN*[5XS*3Q'CE
M"];D+[E39)>!L7#<O5T$_*QC8@?\@L<? W[Y$/?).I'6XMQ)3YAKZ8."\K2_
MI/??K&7G'+>$G/*<7YT"[(D)OU8-1'LR;$#QWU7?;ZX*\/#MZ,%4B:($%*42
M[D#"LT5=K8.X];#"^D1Q('JP.75H'F>SRTC\MO236,X]YMXB&^]LGIDQT31C
M>7:->$]K#![$-)G(^F2G2G?3ZJ7C9!>L6E#M/$+(4@&72_A$Y,2'CBLT22+O
M(BXO/'N6DTZ5:$S\;G#M]=H(X;QY;9*4QXK+ZJ9YAN;>(#XX5:Z+8B3XLTXL
MR.*IO^OUY6H3\<_#J+4[""\3/[GP,_F=\P8^\D^/Z!I4 .J+1B@7$3:N=V>!
M4FLI_8FC![E37;(I7D^15^]EVCAI_YD^:X&I]4N=K2_'+'-TZ#,O5S^^T/^V
M#2&M'E!0F%>OB>0:E?[U0*AD 25)[0%7#G6Z2%8UXC[P<A0Q&OC2@XX&H.7X
M;NJY]H+\O-3:]J@2M]D*"X^SB)YH4AQ>8<[5_KN,C<VQG&ER:5V@NNK?A_U>
M*KJ\1YM0@E/;)(^'X$LI?<J((65]13(:]!H^-41P-?//<>:X%X]BFL1F- 0+
M--!6-0MG#IPR6!3_M0&\Q%@@G@<.T"L).UY#FQ_*!K-UJ*%?8*K^B$4B3Y*&
M]I"JQ!@2'VQHGK/TE:&*ON&KLPYFEB>6N09:[9B8 NM4VUD$(H5NS>J"056O
MXMMH&WWK_-7Z%?!9^$()_!Q*M.'.LB#+E]6+/ZL[&IDV9?_N,I$]B'I+S5=-
MN3=@$C^ML!'07$AC\1(R%HS3=XG2WD*$[XCZBW\23/<]$3@&+Q6TP:?H"0:9
M)KQ/)J*[-27?U-M_ @D4.A OV%>?GYISY)&-U>@+/P6L>$6N1Z/1PCQ33O;^
M5.8[> I*$?HRZ^Z(/-_4AO]VB6&/0^M?N #.QF^\S,/-1Y"E.=[VUU6SS*^'
MA8<NI RCU>J@8_4A3_][DX,FMQA6"-ZM/V[#7/PYY V\P X&+,Q\(@_<X)S'
MR\J#Q:_KF\J3Q//R?VRY=V\/D3DB"2XCNIQDWG(\M+QCZOUB@N&RZ"<+KY/4
M$X(FNVB_H^P,,S&(>IZ%]-"&;$I\X8B;-T/?\G='B,I>%V(X.K&<U%7 JR4M
M*+#,;#5DM.4IWAVH3V?U2P1_??VI5.C^YYW58#:L"&M12'$['[QP@T7<8W!]
M"(0S-YVFUZ.DHI@VT9.6K^5L%_;E?H%$5W6*]U.HYYU(\I!B0@XEQP.F#?EU
M1;Q*H*[>0TN;]ZS"?8PBR0OJBD=@ITE/IJ$RN)(A+WN4C1,W7=<=&<(2VN84
M\ (XF=A.DU%'K;/R;1/=OQKKRDVK<)K/X2?CA$,A"#@R.'&D^;'_WU. Z%23
M%W?5I,AX[M] >*0/L:I4XM(G?;4?K&U5]H(/ALWTR\IN@>Z/%=4ISL9BUG!N
MQ<V#&S[WO*54JLR>7,Z)E@(4SBV:$;A!U@G9Z>39NK74ZH[57S7U5P?S:T94
M?\DD7\8_-!![F]%Q\+UIV#>^Q6PLT;#1XF?2W."JPB47 ;_P-U.EJVUW/R@9
MUS! ^4E64 C>M&OHPW6R$LZG4OO,WW;EJ\F/\D26<<A;E#JTT_GU:-/(S',-
M<KY:*HZ.(/5%2_@+Q&3R^H/*4\#[W6Z>'T?J4A7?W!_LZ+ALOTU5>7O_1K>E
MY6<4UPD4T4TL%HY>OH:A/.N36#;2&D_%HN7()R<9Z]O>)*6_\TQ-JHRYP2_1
M'LERE??JUJ./$NI. 98MG7?=<#PW?.FX#CJM[PH#L&#9F(['G9@DHS)L5I%#
MP&M.Z3ZG%Y[#9N\Y#.743@&*\?H/5R%<Q$07\S;6@V\W-<_\O+$=3ILFOO_N
M0&^\GKZA:Q?EY"%][#L?_N_YO[0CM-D_KGTJ^9'V$.$ZP=2!Y.I<0$8V=$>7
M.=X;S"KHTUV[S);D?1.8 ,+YH+%=66PHAEZ<:5M@V*UBN3V5,N#EKLY;?">O
MT:DL6\5I6_6[:XERVEC1Q)D$0]4C7C*O 6$(SX0U(UD[[\&=2FK8%V\^69;I
M@!L1W;K3+D?3=VD.E0)HT8(.)><,IH=).V6Q5SG-:6Z#WRHYBA80+0F6-/:
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M2^IQ5HY"1SI;^XG+".PAR9CZ!W8YI1W-BE6;-L(*773&\LO^(1?_.\LC2>9
M+J]CZ4L-ED&Q1UH_; :D_3CK?5LU=V0//!9XM\UPI@3_T2O&<CR#)YNJ#%-!
M7I_:4#FJ$._PY9W.)\CQ U)OY(W&(.!YV"\@SL!4!'H;%=D]#Q0YONS'R>&>
M0?P+>2E[8+PPM'V,@R^P?FKP:,>*3&W>6YX:\GT3'HEZX%*6]D@).>E#?#)W
MZ;IH3$@T4DSI@FL/%2^\M:+\0&S ^T=MQX/?&]SE;GE6C6,[AR+BMS@"]5HH
M,LB$Z%- W<ONN62K&>39:+T 'M U P0A/$!^/^M:<L:P_"S3@Y%SA(:0^*FO
M6;.?@J+UXD+:ZS4/\_?^(!I;CGXT9T0]F%+LH;N5NH)VCD>\"_QV"BC\]QK!
MMS.7[@EGXHRE),GB2^3V*:"H&#1$R5 S(#/6M.HU=:7MWW'^2Z8%B5 PO'?4
MEM:)^1-.RZVR^B,L>FL2=, .C@?CC+%%I$>S7UEU#4X!OU/1MKZ_6TN_((&O
M32EG+<?QJ/HF7L@W%\& S^8%R\8FL2O 4H8>C4ZHDXG*ME;NF^7DV_D]A_P%
MQ3Q;)K FMJY4PYTK]Q4[=)^RK1L+7GH[J[,I?EO0ZV5PG*[^/J^[XD'.H7B!
MZKND H>XSSV]F6DF3V,L+6I(J@.?U<_UA:UW"1Z'/;X4$MHBQ'KP\=NTOZES
MRO:N/PMJ^5&*.4LWF@YV ?IH5&2H8XHAW43KTP!WM&/6+]0CXB$M7C\EOEB:
MUG2'B<S,Y>4EFTK'0@FD4K"#42/..]:[\UZ*Y7,V^<7N&I?AUK7C[V!=J.J3
MILQ"<3Z+^3OXH27+[8LD>UB_5IBS+IW6^QI<S>J^*K]7['J!:CTNALK\E70?
M-C25)Z#0H7/U8KSG&A1M>I2,MC590T C,+:_W7;&(]@RTXK[=15@[?, 7?6[
MV*(W$]9!#0N]%PM[D#\*.NN$NK(D',--#A/FQQ .##\",V_A1*DL%W$*2R^[
M"\BW)A)&%G&*%Y@9X8K@^Y ;2PIM'A\(,<$+\$N4['OU#W>8#E5Q;%@ZVC!-
MQ\223<P7&8OA5YXED;2PZSADNNI0!*C68#NJJ'BCIJ&Y_Q+ZJDTR/3TNYYE.
M^W'.>M_6'FI$1BG=K@ K/)<4_&9-_]POT[-"8Q=ENZ[W@&3(+43!?X7?B9&X
MQ=Q1F!P1-J=V633MJ[\;>6L;'9*%>P2?;%\63W<K)OX:&0E@4NQB8MI'LEQ?
M[%^7;RHP3=59_D$^8_[ H+YD\2.#?.=K)E"X &ON(E"@14&;NR2XG,_SR?>Z
MX4,;Z9OUM3(9?PA(^JD^)]G . F"='^[WX0&URE ^I'<!+GFQF_QJ!7%-OI/
M3FV:YZ_>JN0ND#5K9$SEC^IG$5M@E/PD8ZYQ=YKNN'PJ%_S)8[91AZY B@/P
MS.WEK/2O$<.SMH]-MM KX&'?Q&Q12*1MBEO3Y8AKDT#D"/HJ:"$/6)6'YD/)
M#>1NQ+>XE3A"C/6S@2,HFMF$?H3]5B1?(LK!<ZUF"M&9X@EB@ZS,67CN8X9B
M%__4M=* 4KNXH2#I3Y5""ZDG#X1:1S,,S(I%<?-\Q*\O/,M_29FH':84W"ZJ
MA5Y:B9]6N7W,*"EDGVI+,DK69@ZL4)1_Q^&"1;^MBO4!I0I6K"9O'^[^L5_^
MF(L370Y&E;O!>MT\AUM^/</2I3$ANE TC1Y: 9N;4H^@Z?D#7%:HZJ>3.&S3
MQ?#G;(-AVA^#,&L7,_:<4F!0;[>D@/LBM["VZ]N[N)@E!-8#CWF *ZLXLDQ^
M)RTX\W.J!-165[CZ1>#/.*)#Y3/HSHE@:YET!J_V]\K +<ZM4P#Q"DWD/O4J
MW*R@_L[4&ITSSA^#_KV_4'?EX^[2B>7F896$ZMZ$N-X#T<=\ $M.G.3BQRA<
MS"+JZZ*)1-<-;^%TE^MWNZP4 G>2'A/J$ODV&6"^66M)WB5=OFL'DX&B)_KA
M?&9Y.9%2EMJ9!M9OP^>L'"72..0)SP-'V]Z]E>V-&>G*&=;C?LYE+CQI!6CR
MSU?8T%]ZL.VK)R9C5;-C(IU.'ZJGYO_P6XS]Q,=<S#<S[,POKR.O!&\[3M(+
MV*B61YO"N9E))]YHCTEE 36=B_ZG &&8RILL9JBLUP]3GTS82+$@T*P3JKF
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M?KJ,0^5'?;< J1=UET+S(.H?1$UZ6]WV)9Z@(C=\XF>L^]9F./F/BA;'W7.
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M]^E#>QTFC<*9Y^L3!6]>/-YW6[F00/YED']'DHG[N.-9ZE&M;FY2M_&,GJL
MWVI=7LZ7?WFQ.11N'>2$_]7]_/#,=;%+,BI*!F,"\5',][@Y>D73*S*K &MT
M0]J/(H-\YH!^H(B$]_=1X!W2L,M?0=[M0\$MC0M1A4H1_'N;F=_RB((=P[W
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MD2:=J( @5:378 $$A @(" @1Z2 @(M)"HBA5( *"2@M*4RF1WHG4 (KT+B6
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M^!Y>[_6<!O %3@=VSNN.0_W<*"7A[#[8+#SSRS\V_>FI$^@T]"R8($VL)5V
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M%'XNX!"<+"HM"N]4AKQ[;'@K3. DE+,@[6L)PI'<21\6;I(:"]6L!2V4/W'
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M.2_IWJGUUX+)#O06,:-Y:XP&<*?[N/>;]#_I.8;C;<M<'N**H#VH#2<L./D
M*0K5'X6:%-U.ZU8L>Z CEK3E2(U$+ZZ"7@@BV4$^<_*$N+IJV?KY2R;[T31
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M#433;1D;93=Y#.<6BZRF(7W@/O&U.@M)+=K=X!1(C7/^.R1V%$87R B8!+S
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M!FS.#:>'C%*?5I>F4*LSF'O'1PGM0#71AG2C%M_;6N^]_:CVXRMC;J\$7[8
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MR0HVH_.1($GS_*.!.QIL=VY/3U=X>%B"O,B#MW,N&M$._/L/I(?R,3')F^8
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M;).W/AU+HXHB;-2Q\ H#@,IVXFA.4),3XF'7A/&86DU=IA0D/.JZ#7>;Q5@
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M 0\BD[G=XF,A<A:ITVNN1OF"0?@FF 6K6* T8P:OR;D2?KCN/3:HA2&,2:S
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MKX)FL?H;D-;+&Y"K*!J/!64'^K((#[&: ]Z]Z8V/$\M>;_4VI]*:J<#-^0&
M?'$]]A7H&\3:45E!0>D^_JWQ;2W)W,.['_JMN3LI=PFR+T+:(?E"U9[0I1@+
M6.\\UA;7NAMW38=&9L [ NGR?"007'0HSG/L04U#_&&3W#KB61:.44WGG*>/
MF+ V(&QX/H@7NB:\OKN#Z;%<G\C+ED<SB2I-)=S4<S<\.2_+([9G* #F7M-?
MZ')8$;[;$([QA,W1LQLJ=Z;8M/D'Z&3A[D^+PE@J@9,]X#Z->2.>*[:+((7Q
MC03H'<99\W*W7]4:5&[=$IM[W#0-6UG=C!;-\@2Z(5A=7*L+CD& UHEUX$<R
MS-2$=N#AN[T/__[97=C4N*\@0$WM)>O[$(V@A+M1D::X 9DWD&L;TZ.L:GBD
M;W9CRTRCQC:E>O>[#IOYJX2N77BK//G=I'IIAV!;%D]<,$C:W'P4">8PAU)J
M];S72^Y9E8V:BTIH/AHSA>?>V8!P+A% C45V#N#-_<A93<8JHNF7/$VE.SN#
MMFFJVK;,(&L>O_N=(*N0(=L2ON6OH]S-+R3Y9C&^VR".\?PQ7[E7OR&#Z<(A
M#.?-R*RF:2^%IH91,+D;$%$^EHRK#9_O!F0HBA54A$* J\NS>P%U/\;;]XA0
MSVU?OW$S?7\N*;+V*(9\)]51[A.8+\2WHQ!.][ TI#R)D0_E$,T4T(LN"61$
MR97Z8??3.P-*C&Y,J\9C+ZW"V24\8\Q-,(8GWLKI:\T[7)_@:8\F>K2_"$V,
M/BB_4E&U)<&P^Q#Y1+G59K@ZB9$ KX2RKW"4*/4//P$)E/I,M[0;+CRM27/Q
M/0U2$;B70SO^>]EQ;)1@&"Y#NH62!,DM7OH#SF?=WZET2<5F'/DM*<LS+NPV
MQ;08]4R9+_2DP/T6AXM8"<EP1MX<IY/LI=V0XIE 3MO2:TV ]0;WG NKR/UW
M2=WBSR)N[GHVQKTT@* "LRP>)8>\39Q(Y^YK<!?[[CH[?%,$)KBD],R;OO1*
MZ1,HW/];783+B!30X(IP1GXEQA5T9^6Z#9%C_WY)JZW91ZW5V#G*ZFV>%?Y1
M,D8$; 6<N5OC)ER%:M;3;6[N6D!9V.98WE,II=2(H:$?E2+9@4>^,4+,\5\W
M(.!^Q/P5W@5L#[&^:;6#)!]PHCWL\=S6>0L,9?0^P_6Q8(S 01!&]*A(HF@"
MB[X-W>,2I,2[-J6Y<U^!75RK807-W^/KA)B82H!3GIQR^I]=\V 1MV+]I9D^
MV,=5J /#)O"[/=\21?%J=[H5-R\9S71HML 9<3AAYJUXIV;KGU8#%93LM#9/
M?ZV=Q[W.R'5&E?6(C+K.OMM5]GCX5\(7:-IFN!2)443ZMQUQ3#J;YP]H3@SA
MP]!_+GZLO>F.MG H.?I4Q51S$04>P;7 4^E[28QLD0D-LJ24)PV=SSOZ%5X[
M\M9G])%LL.X<TO<@$$<Y#E$VA6"1N-;-<&\X+8Y[ZP?,W,P837;\9*#X/&.W
ML I#'%GACJ\C\&7(W%Z@A[W\EF_)*4I=\7Y-3*1=S3B]W5*US9A5B!V#][3L
MH61>&TZ&@ CNU/JS9A/T*E>K#ZL*ZE'"DTK=KGS6R-ZS=4IMU\]_5UO'R@DZ
MZ#7"G;I>A$0 .92(U!\];Q%[3JUF;/TY)2_*B,A8<YVU5AB1?W-FA!8SRC^]
MWB!$2QZT;JA=<H3;T]&\ ^@H/^DK76V_<]^K3?T9?=]=QX1[]4+/,)T%I2R"
MZEVD[68J@427<34!I3;>H^5%9D3;5ZH0^=4_\!L0KXSS@TLO;\(F'25&^;W_
MKF;8@/CHT%RY5SC$E&-84S#?L=^G7WN@3%&8@CU!,S'S@=.2-)) ?(P7@.X1
M;+<+!.S;QH\/L#@\= &BZK!%V@':&-!+"NYN.SU^,7U7Q,[O555F>A]5H^^]
MLFG_MS#H,(&%%WX:5N]L04KRKX2KEMVJ>E$4<Z+7UUH,$;"$ @](SH?R[/B;
M012:) ]SQ1WL1H4IWR.&1%]Z<5GS[LH!DH-XCWJJS'='DVK.*K?HWY<<8$=4
M-=>;2C'A$STJ =.VCE<*TJ6<K/\8?C/57$"!A^GS %#!%):N%R74')+Z<Q_Y
M%NL/]AR(O+N5WY(JWF$:R"9*$J<,S=X^5S6\?KW1 !>Q905^"LZ@$X;EN%GK
M+QKU6/8(//8PJ2G3T:_[V8CW=N?-,);(SZ%.(:%)\F5RN'0@G"^[5:"-1G7\
M;4/[\Q'*,SMOQREVZ.6%]))"? ,3?@+G(0NF 9=IYWQIT6;RPE57"3KI4#,#
M ;4>$6TFB^Y8ZKM24^^OK:V5OW7*LY+?9(J?]O+_=Z?D^B.2/RH&OEWG[@8D
M556]7RT;47O4*EQ>[)B\2,NJ[%___[Y=MVN>;P@."?^!OEZSL@@>MLYE-1WL
MR/[XH_5%MD_\+7.?TZ(A,]F\0,%V9YX6Y@[8Q)/$;^$; YZCBI2ZV ^&L;#&
M*LB="->QZ$^/E ''DU,*3X];=&_JZNG^UQ/$YI-XMH)O9F+ )3P5OA<Y;E]\
MY<W/'9_;GMOJ3BM'*J[%<1/_E4(P(M 4_BZR T+) N.!/O+!]MOG?Z@=[/0C
M5QXTG$E>)QL<+BYL]J;O23-QB-D1A&+NV=HC;(XUA.KPC@J:#->BE[^)X^[5
M\&&@K#S_L7^9U%[?S;#TO(Z/<'!_PCR!=P;;0ZH>+WR-\0.T_JQ6>7D\L?_<
M5J>$E13VB-^?=K^?*GB[]@*G=3%NSAS?3H+B6HTW($&F]H+M6F_1LYU4XP_?
M:;/^BI?B[X>\"]MW4S5KA<Z7-> BP74@D(NHXB#("-EQ2O&('_;<!N1&ZMX7
M2Z-_5F572_$GIOI9*L5RVU*;KXTB<&?%[F%#<*W2<!\"38\;!?J6^Q,4, ZX
M$/V%YY6TLM%KYQRR9JB5%=E8$Z%L@0F7@)<2?CB_T'SD=Y[^P! 9-[*W-[%7
M>NK)E<L9+R,4UZOO3'6^> B/CW"L]A#YYB?-(?'WSG%O@-,\2T&',3):L#UP
MZ*E;E\$IMMI@HL)GQQ?L^4 EP38$[PCV.Z$Z8?Y+"8AD/4M&580IU![).WA?
MWH5V[CE[0?//WB,^WG'9CUUH+SK\1#CD?YOP?,_(#;I@NYX_< *N-#MM'N3E
M7[5?U</OLI1>\M^;@NUC/#U,!+C*V4%N5@2-F"6?]55T[/T6!5]4W<)'I_-,
MJ5/(@GI^B>J+_2]]I'L;WX^X-OQ8"<S)$;_W$,.XU#Y58J  W8UKW8^[ <5#
M-PE$9^LU.A!2XYU1D?GR5^T_<GXTBYEJ3B$5_U.;6R-"K.XAR=0LRLU^>;5>
M1SOM(CU555K:I8<_NYY((O6'4>6>R5D>#K^Z\NXZX%4<U/PU&)&9OKN,0OR4
M4KY8"23P]SIS4> 8[[2@ZZG77O 0<T=#E+4A.XN2+7KK_6'OSRNB0JT?JXS]
M1E*&^_8,LZYP<%2ZC.>LXH/QHE\M*$?-H]CE=+&/%1]J>.S3;=XA1:/WS:</
M/+LXX-O_O?LN[Y>RY@5'HM.G<1-H>D3XO_X_E"#8;H;5(L@+V9631DHL^'AQ
M2>QIAO+5FRJ:<PCP&')^#%AFK;;@=H!(QFKBXO7FOC)/5#-5_L:37/";S<<*
M(AMF5V(:=[EQ<K]\:W&IOE+94>L\\0_47L+1K1?&_EU2^IA>74&5C"94\<=E
M06+YN%WQJ%_%%B?/5Y+*#\S%DM<,_Z&*=&MX X+ZU'R0S&2[J<AU)_'I:O=O
MO3E-"16F+J:A7UO?/C^L^,O'N*R>LBM(F=D+[E$/B@X<-Q1-OW )MT#8+1SC
M.NX&(6T#4B,WOQ+X"B,_A-):D2]E>]^M3MU[XW*_WMT542*)D4JJ7NQ #(]P
M[P[RCP!4S_K&_O+R 7;W[%9?9$Y,S"+RBG]V&3?G7G!9X;[EEQ=FW0J_E1EF
MWS1)..W_\Y!9< *+&/=?TGKZ3*A;]."*%9AK):0'^&2WN?D.Z:G[)N8=(;W-
MC<(B#0JZ2<HX?YVX9N4?6%$P=NG;PN=/#7O]Y#\:,28CAV@]3 >'>6Q;,-;A
M(\6EKS:PZ<@P(_130_(Q[1L]&4*5C:NNZ(#'("N3.$@*4MK3OK0[OV>S5N\U
M5L8;B&I>+3 D=""@!IY->(,=O\"W'&ST+$'D/]561UMWW8]G"^EB9=FQ/[BB
M4,[@Q$+4<+=;#L7XZY44BSNG_[3F9\D>'1R&[L2U^I*$N,;5Z+3\/DF(\U)O
M3)]5.453T"IEC7Z;D]^R9&I1)IQ$;7J>#0A=]CR1"17!7 "VTKFU@*7_H5[(
M3,Q(\E\!^5+#]ZGE:X\643FW5XN0L^'U6:/ACQV>.CEH[M)?J(,K"V1PK<+>
M$20A(]ANJ4$I<Z?0/G%FT?GL7?AM2Y,I-XQ9;P/G)$%MPCP9V(!P7X.>$V-*
M#,DDU*W@4ATW^XH/'?)5?Y63>>G(W;.A-'UBWNV2Y+*W 7_S'C-_T>[L?&EV
M^/>NPG'J5R1':!AC2')842SE L8,;"@90Y0U/PO?G5-#3O"[]XX_QX)&(SF(
MGA$]8?*(@7P[ )I<&_YC9V_5B_V;("<>"UD%69'=_>=O*G.QJW-!3/]D\Z'!
MX&."]M4M1:\+OSY@P_ QPOY.K\*SI7EG^ :5F0Q"LL[KISW6Z>)EMU@[?1[M
M$R:M1*AK8F]@OVU % 12@LZ(H7CLD<"A"X%R]Q+K[GCNDY26_V9845'3?6'.
M-FJPEQ7RA:)>5.P5L+NL/=/WV5O_.Z]YR(-+.Q@DO@R+^_4'G/%Z%2FGCY>=
M[9Q8 ;9[2''PVK9M+ 7JV;^N@AVU0O[#K;_#B!6X8;8"INQ2SNP-.ZO4:^E=
M>"=D.$%FEK@7.EQA-$P,UG7T=WOP*R$#=<J0NF=^UYMY3(F08 M!"2"<X3JO
M9T"&IKA-#7QK'"0&5(VI0[6D=W28.F"0/'7AUC(CW2)MQM*U  .*4"$1S V(
M)VX]E3JXO2_8J:^7Y(FJ6$0M"(:/T4]9_"H;!?$7FFIXRIFY'T6RCVF'_>3S
MA.D8%GPEU>BP#TUX:G<RGC;AI.MZMQA(#ULK1;(4)EW?_@<?-RM2Z3O@/FFN
M$_1VU&Y/NY)Q_R.R^:/JBG*??^O.!\YIF;@T<W@+-3E*Z>>/$&D/IB:9*V_7
M8GI.?G)<?S./M1'T"'L8@CXBV08G?LL'#GH!V)+U^.S&T.#'TE-?XXJ_:=+A
MC$^XJFFV".\\&G$NCG&^*6I+Y6SB0IW3P_T6".3KBN8;@'I1Z"VM0T_F.R0L
M"V>)]2>G2GV/;J/N67.,O/1SC2 0#^-8,O]]#<7/&\L3"92QB%]SGAG:F$_!
MF;L,K%O1?S.0XH)_Q(30&7&>Z.'O\<-X *2TL/LPD_5WX4>37F_6MWY^(I75
M2[I:ZV"][-PHY]R9.1O034VL=2^Y5@2;;#,?-7'Z&D<KITX/\>7@W'/K;TC^
M[I*[H#$1*^N?*GN[P@-]Y5&Z:Y._FG#< ^!^('+BV;QI)(?:(=A7'Q6\3&X;
M/Z)Q#G8'Y?P2*]K\NF^ES-W^4<[]SQ[<MYY(CP"Y PM73K1,G[SSBEM2N2;#
M._JOND+F0HIB1XWQZ1@;IJ<[3T'GP"-[M7UJ[^4G;\K.DSCN%<.2W*?K;ZP)
MD1Q$NW&\7_V#RL# P^1;VV<R/W/U_^H:)*_<W[=7]-[AIJWJ6>7TF5*?A[=V
MZU*T+ZH.W#/S_F?N,%)@!2>.J]D(7@,TO3Y]'/JUO#/<0#S!T2E:GF^%T>>)
MX5I-2;<J'L(Y3J#@.+C<H5B-]@WK3,H>1YNG911>,**^JA@JLUY8=6J0>]RY
MO.M7V1@ZQ;'_&)9\;-I/OO5MUG]25L27R^?:K[_9@ 0X3RC@;E9(TW^6O[@Q
M4WPH]5KC8.?*YU79>7IE10LA157LWY5'HQA-(*_ISOA^G$1MXX6NYQF^GZ?E
MYRA1\((Y.9K1M9WMP3#FBY"HT)#[W#Z#[@98GV1  S0#^H'*EZ%SOX+W>;ZS
MJB>!GI0P[T(1&?&B^"V9.]M3F4T$P0Y7G@JVEU3C]=HWBA-*<9W9&4I;(%8G
MGCKUY,MDI.OOIJ%D_93?#IG?1BZ&9.//#-9*:)_>&_J]M^K?!'J"=N3F9FW,
MR?4D5+,<FM6^>B(P\X-?N?HYX[1TW=3(9)#(W;0>0PK<@ A- ,=1#,P%1-K_
MEJ C!;O%;^CV;).N\8U1%CJX:H]9.0/7-_<+9N9<Z.UNN>S\*Y[?SFYZ(-8;
M7RKL -C0_US+[(.B(;GY_1BAAZL6+FO'GCZ1E!_>\B@]LQMZCZ*LHL1X^_E*
M8"YG42!>11+C^Y9ZV#-?8$P.57[,"CG\)"8.[_87[C"P>#>*2;N%^E/</&(Z
M-=/TZ9GVKHL$M^O3GO@O"% =/K^#=PUS8+VV%K\7@P""W],LW424B<>C\<NV
MMPU796?I''?)GW/<)^MO^%8W2S"[@;VO90M.#WL-?MW7DJ7YZ9-J!\EFL=$R
MZKY89IBN]Z*C?_:ODH**OVJ3NR(N3%D*P;Q$G?_$$6$*C1_IFH/]!#RYT?+.
M^+Y/2ZDR7Y]G0&RV>*LRFRV%-0_#MD%K%]M((U[33)MVG/1LQ6L;IFC.UX_Q
M6QZ;F0B3]N%+\3CBKOX17W6KWP$#TTEA0=9#\X_/G\VB_N^N^?<28_=Z.D[H
M:&B1[5[*#: LL\R:IF1/O/_TZ[X1"\FA@Z.N/PA5X:V2R<U;A5->M^ @*,W[
M/^)DR^-@DJ%'F<X'K5^%K,C^&<PHH?M-Q,M ">5'F]C= Y15;DR.MKO1HLW1
M?SAX+"RN706HT<-.XT"YG_IA.,"5&E&0[5%I*\=VC"XZQO>1#/'*$BZ'LBY4
M/OX5- .F2PX3%S.^O]^[.O;KN-&KJL3C-QRC\VPJ*WISUD.=!K2VUO2]E'1+
M.0>(%N9W7$T.C8V\,&7!=O6>$B8.MPFKA?;F;F\&74O13Z<:+<-N;GMX$S&^
M?UM+JO=X\VEA* '85GIM3QN"1G<14G4[4B: \+.[/*FQ(='<SIO6!+"1)2?&
MQCQZUM_<6.M?*7%M/MQ?JR1]O4]YZ__+GM"J;\U?3R8%2-)DF"Y)97QYP.S-
MTZ3W"HHFAG';AG[-92 O8;]!Q9HUT!H"\2:Q5I3,W#,9,/=DP_/L7V?:<VB'
M+AG^C4-:S410!/C@+\KMNS\RWW?CPDZ2'9=Q&'>UU:+_=,\I''^W 5=LO0)^
MLV=$>P/"=.U *LV&1RC_&-W&7IC8M.G&'2.AS1(B8NO7]21AOX#23%AFSYBD
M&%6U_NN5<0[I1M<J$X\?VW)_UC0-^Q*)3KG87V95VS49\[/WREQ]'C[X0L>=
M@I? ?RMU'"W'0%#6303BBY$<@@M@VHE.9]DF&VK<79^\M:E'ON(QG/&4\*&'
M?9.#Y.8,P:X!<(IQCC_^?6E&RO/H*XY'_[!H).=RE,YTO3W=\-EL0$=AQ:SQ
M@WKW1NIV7?LLL5I/?!<2/$:8M^%=%/J9OK?HZ@G)I%J=>>[@F3R' HMXS<R>
MLW]S)N!"R.4I"NN$M>+@KP"R[7F'[$VB5X,)C=>_1XOJSDI$:5UC.B#LB$O[
M7S+*=QVM>49TE4,&/D;E[%M&_&>:KSJ@FMR\$N\J1F2].ABKCKD&/"PY%=WK
M&533$+_%I.!ZT;X(1:%6C_TE:(?7/F.; '-G &2+4)[<HX65/_?.TSP<=P25
M62Y$7#_;!MG<SWY06KT[7\7_9/>=#8A5?&%CN\]TLD>Q5Y\G/J>L>3O?L>Z?
MUS9H+1Q:@$]HY)"3@HDF</3CV#LA<TBHL#^IXZ[A:"2&!EN,*;D;<P6P+M+/
M&O@J/SXK)1L]PF8CB]]P_]!Q?O?II^8'FFS:C=.+%"FPZ1U])]<<U]_/8SV$
M0R!QUTBT?!:>?3"(I1/??*"?5*WDGHXXVKOODI29W:3KH!N\I2+E%/W#'?Y^
MW)[1HL3=XG:?CBS778=HZ\XA[=W0F1=[KTJ1C2  Y5+>WY5%J]6<;U;*Q:;"
MX=V$PRO!K^-H9(88VSZ$A4R-X!:IIX8IU?%,)RV<XLY2$*H#.,&.:SPIP0"A
MYB9U3(2"$X$YOW/SY]:E5J<<CCNL(?_-"OLFX*\@_WW+?O\DR*9S?;7K"'MD
M%=GHYP8D<L^G_R@/7KMP2QSH%DJV;WA&65VU"?H]8OL.9.U1+'!C_'S(7/*:
MC&!;"6\/=@!>C>K 2<\1E/GV[[RNC%K'_AP_(WM'MV\SZ;PBUV_QP9\+&%YU
M-E8(,-J[R^7:XHZ1/[X*>1JN36*4;T JY=B^/'-L'P N3D"3PPQK'@X$35[6
M.K"SN$3=[HMJUHHJD2/'@I$^F(-V@<R2?*;#JYP/A$;JLU1OV97SN4S-;A6)
M&CUIU='M[W;E8[*?<6,=>LK,_@D!N"Z.D?[O4/H29P<WED"AR_'MWJD8\%R8
MEA*3%I<&"M14Q0J=A6"H%Y!)M>%4.$W& D"TX?;,!A:Y+RX/#NZ[>/,M6H@J
M1'O$T]J4^V\-.XS>4+WZ3Q:KCMK>[E=3':HR"P-P;80DXV=\F0O0V/K@_!!H
M4L*#M'<?+ZU/YY",J.6:OTC@/H-Y#=X501=='F/)U$G''N]?O+7P9\7^;F,B
M1"GON>Q?G2*/T0U(X*'1M%4";*C,KUHI5_M(SL?2R5)40E9/!PD\AN?+"'T*
M&9SB^5H"T F#E-K+=U%LS5-[ZS[$OM][]?*T:A;7H ,Z7,(B).&N[N=TG@-\
M:6C\/(<).*_&25]-]1YL'AXE-RF-#+Z::8 ?Q#&2D1^FV=<X.LS!UTQ\JI=F
M_U2UPQT;*<]V2,:.:=AVH=Z,)>):X4*EII.*K"$\Q#ASB%3C@GM'[BYJ#%_?
M>ETLW$N3>Z82)F-G[@'V=""KBSI*%D'U>HQF#> PQ%=[A ZV]7VIL:C^*"-=
M=[!9"-NX*/AU'1J)ZP=^*@4;6$/)M28E.YHTOA*KFQ,/IW%&.:84[,<^7\^6
M?^>I7L+YN_\[?P4>2@PJ:E^,5STY$,0W(^[-*=/:OU5T^&+EOR-*) W%#05)
M+#BH\89_D+.85.X-B,S4Q;%#BKZ5?KCV4+B?O"K&WOE)KUD)H6RYG@@/0$:/
M'P-VO0-2*/6ICW+]&G7'VL6>OY@]KME)8KR%<A"H$0UF!3OL-9K:8J8WX'K.
MT[? [,R^TB.U327<^N=CB,&84;"(.30_ )"N_.M\[ICC?3#DO>9]=3^F[()E
MS>Y?CDG71?X[91 E74?1JKGA8-H[,(>%2]'7S'%/.W696=>4>-AE/R<B,GG=
M>Y]TLOEQ7?-RK":NU>L_#ZC"J?B1' 28PLGIJ*_-2Y*J6]Y?%[_'Q%.<_5LB
M:H3GRQ<%R:P>4/T%:,-8E/*T9"+F(VT?=!UY85!ZK*S#U+:BPN^5Y%<4N!\Y
M[\1S$GS[.Y2T(IGF=;@_>'?4.;O-7F?D[O";CFM^%1H]PK]H;9A0-CD?8\6Q
M2=/W?D-*Y"^J;[.P/4@CEQN[LA-O*-](8\^9+V#L> AL%TX5YLV3&L&8<.AI
MVGWNQ*KG]C"_'5_/"GL]&VDJ#%E\ W(=2<OA1@!!7!)0TDY+'5RFC5JIU$Y:
MW*L6V_11E4ER[:PS/#FV%*&X9:R'4@$>??;O7*@3)/'"_<V,0%]6FHN*HLEE
M?H<P:'F_+PK4RHJ/N&#ZOT-YH<\!U8^1ML'$F)HE2!F\9"ND_H&>QO/*#QKR
M*_I<]353":7)/R<WK5T2UEI\/1D>0!ANYE$>8^X #POO$ ULO^_X&;L(T3@G
MZ>UER@O#M9KA@I")!([3#E12GA3PL!PF=(7B)\Y_L-RF2X6: KVD(.*7WWYT
MC=>OPF]V0(G0^3Z@B F?O^G/66WU.EH?=X5XY1Q16MW+W,E<Q30-(U0H6XS7
M$X3*:#':K7"A LBDN,57VFI?TEH\L"-VI([X[UG,AYOPB*<QP5A-8;:L</^.
M=A#MBR,-U@ IEH]ZGWO Q)JN=CPV:=DZI._GT B<B)B? O*9"+Y,+.*!F1AP
MJ%_Q+WC/$/;3^<3):.67WF51A+/B*A(0['7A>(W02BI;CZ=9E Z?> US+@XX
MZ&0K:"'^>+ $3-V4%_D^%"<8_>\A)H()Y^]IQWAQD.FU?HTGQM4>AM4^E/*V
M)>O"A))T&(5R,R"603"N0KER?#U'</)_V'OS>*C?]W]TD&PQ]IU)%+++4LB0
MLB2A;429BK*%A) Q@T)9DU#$*"1O,=F39>PJR9J=V90LDYDP7IG%>7E_SO=W
M'N?Q^)W?]SP>YX]S_CA_O/[@-7/?UW7=U_:\Y[ZO"W69G:9MJ8PR!PDP^RH>
ME$.>,_QJ4B8+KHX8: 3RG%YD76,[E!^)3;74'%-;U_W=,'.UE\L\A;AKUZ\A
MLM[))GJE/$U '#,$)'1W8UE/@3-['Y%F(4<)=/-SR\ZSO\ZKROLD;J1MA-T*
MOX5)QXMCKCDZ)W+XZ,8+[F.6"J)G:45Z:B^"0M);)N::949>'WQPYVB10M/?
M%Z#8][(SX'[0J>(S=#-6*%V)O3CS+E/G'$._6>1\F7)O6SB[&4Y\B6THZ]8#
M#DMBY2SX*('NT'WX1SH_/7Q5]AK(?^E>S[!!-B[W-9S2")V/@^UN\+G!;V'3
M"(KX&VEPTD0G0?+J=, 3(R>=[S4W)P\?LC58#>C#$!/@U8W48S0>TL\W6/F6
MJV\=5?T1O/M;'FE><S^CS/<!-SI 7;%E;(+Z0]JBJH"$$MGU*#MF]%+;\2&+
MT J,5_Z4-T%1U=O?3=0,,0VGN01/Y5/ZNN&3R:/MEKQT8_(R+3*RR]Q:5D\[
M?W([.IG9+=ZW9V05>9I[E;7;!% .W4>H:US=@1 #/6<HSLEKB]&MVG8!4@O7
MS^CT60C^S6 ,@I\*Y,QZ@M89#Z;NG0.TC&ZEZQ:6>?4OR[X\E)V2OG=+KJ\4
MO70;>?KV ]^_I[A"R1A &[JZ0J^E-*[*7*?UDV"/JJC&OQ)P+T+]8YMFY/=2
ME(LF0#B[1XZ=#?=%3N&(08TD?+JG:EMKVX?O>?;>+:F: B^.@]P/*^+Q/VR1
MA#]%=J3!'CU 79U:^0[38?L.K3H)3" XG8%!E^/<['+%%:_Y2#'Z6)+-# ]@
MD^[!<!QMD:&M]$P\6;[D[M@7SHC\,]K@W/B!5?%[4_O^R)#1*OHVID-J!^(-
MG=8C.G<P4Z#)\QIM?K^-LB1=YFRYTAB;2TA]],A_=-VK!P3YO4!*T;]3RERJ
M<C]JEW/QUJQMR!+RPUB"]4(RSPNL).A^=WLKIR$5X=?XT3(HU8D@JO&/^&&G
MGG]N_JF&S'J-?\ !^_E6*W>W#&\"!\G"$A3"8[W@M2ICUX/-GKU2\3<_AOS6
MVCAR8]NU.D9#Y!9:,3*+(]### 37B=>J 2B'IAO?HRUP-*(37/G_D![ASE!*
M8TK!=Q'L[#8XZA:[( PGR#I$CUF03\NNBU]VO-#O_'([F3D3PB,Y-UB(+>6&
MF^")*=@:*%6!9D/<MPWO(8@3/D=8IFD;]$7("BL\IT&=W?]BR#(LB13&W&Z-
MLX?@>@>^ 181\AI/30W?J?;O=WC:!"XV)?$H.3?Z_A!?.Y;FIC<5P8@#*$S8
M*6+&PS:-UH8QB3-UZ2?K4Z4CW*R\1B>,95BBYQF> )MI#&(GD3CZ1#>B<2(W
MXA$#%RU[+ME\GR ;\K_7O63IX<%9@]$SZZ#Y(& 4\\A%-TL92P-3A^"%#)WK
M?^BIE#<!5"R@D[3:15^C;+7'R'0A][+LH@-C_'\'*0]SZ1[_H[46\Q^3@7[+
M %01JYE,6Q0_^^6/H38=H&$[NLFH__E3A;>=->:V5A;0\TB]W4)V9O! <P*@
MD1S)@"DM#_]JESX2I7K+XNONKC3CAX-78NEDVS-A<Q@61G.#3IVG;/5BI]0
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M 3":B?U^^F!*8'%T_ DU!+]][_U4^DCL\?."+2-!=A3C=I8^N[A-FN7SWH/
M ^1-WPS_4O[!B?#$>-+CS,_5F<6?/$9<,:Z(HK=54MTG9\R25AW*#V:J//JL
M0D(<:I,!95^,Z?"V%.!T>HHWTUK?5!@5ZN=!39T;W/8D=RDNXNZ:N_ -$R0P
M_H,/8/M05\LB;;K;5.O,LND'9(M;G::V?8Q_<:2_5]9338X'#31:WVTN7K1
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M>O<D)TJ'?B^)HF0[XY)[)G.Q4.$-(G1]4[42!2K(GD7V8WP0%-!,ZNP71O;
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MR7'\U"9NC""-'L#PL?S(<12\5.25*_ZW3H6$9&X]6U NK/\+*A@OGHW#!.U
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M_[(F:*6\E2[UPIU,9 M9>81G+UH&?=@H,82H7(D(5IQE4Q5I>">>_-+EXN'
M3N;R60RC>!03 4SZ-(P;:9;S\%6E5NE>Y=/7?]D8@/V,M@<>X;*$6J:.#33R
MO>_XYIGO^%SA&O*D\0'H4[5B0(W(Y#7EK?+[=P;*"MZ>>.R@ ZYOI2]903PG
M!SY[1^P%EZ9"1)6[=,$UT9_YJ$4B;&(O:D,IHZ[0RU,Q+^_WTO :>23ZE<#%
MKSLYAS]A\G]/9ZE]OUF5LF3D(/7%=G2?.:,YQT2G4WCUL3S1G#1&K<9X]@#2
M2A3^TZ&F93('H&>*>VNK_=YO1;KV7";Z(B =\B0AW'0'%3([TGY+NFO\]&\_
MA?5,7YTR$9;#@>T\V+H+A^<7XL2-TN7.Z20-S=6C4@7FXIE.9U8'3]70<9OL
MZ^<L^*8@A55OB9(+69:TG8>#?]#\EYM-GK/9K5G69LS*FC[G?N:<\?#QZIA-
ME)XA2*9'8J>^.DFC\X:5HN_YN1/!O14=C9_WL/#!?M.P/<TNK7XY5OVHNI]'
MAR%R$-&?#\VZ6OAZ,UQDQ7S/F$YE63F;G[FEOR L;L@V;UU4NV(K5LRA\FDO
MEGM7;\W6",WZ:2:!5@TIJC4[3\:K!4D*KUU[(E9L<M6L\+&6V%7BFV2N<WLA
M@QI[G$^E+RPD:*U)]07&RDE(U]VQKMASW^HT%AP5?QO;/:EL5LXJS-+;S;YO
M0[\N^OG[HY-'\-VW]2YZ>!=/[RK'@(+CM>=X=5]MG/_3U;K3:5)GP_M5ZGFM
M)MNAPD/*@C3:]O#]A#OPJXE;1_CT^C\GR\N_A15H3O_PF:HZGV:1/3AD75IE
MK>SQ-X^+I5U#E5?*S/R@?=F&GIR\H&U^4"(#Q:_\ ZX&X>:L65[9!: N&6TM
MRC#!Z.BZX*R5@]G_/@8NDCMTWIP1Q^C*3XT:'&!O[?S?R-PV(C7^*2.RD0[$
MP78FW:"O.8?[_JW7B"4[^T_%O__(Z*]/]$=KW]FY$*U/:0L7-U2G=\U7-S)<
MS(3Y3&K@]H7^CIW\'+8-B9B,#KYDTW]@ EN[4$Y7;4W]BS*.$6=0!R!(^0&H
MZ7;M#'J/N7,;+5FNT?2"NK_3PXWX*J%48.'[;*D]?3$WOF/E?SZ]US^;K%>O
MNV7=9MS9OFSYO4 &7J9]G:[V3<+@<IK/$I$1%QR7JAIB+K&EGV<E;SX1WA6@
M&C?W.FIH+LLG$=U;$%%3:DT^CAT'H*/;*Q-%FBFF^-/(%3U(UUUJ#.)!R=!\
M;-O^R\L)E<G:V\S90[,2:H2 1!W)V6O]H9X^4@&>BB(N]RPO+90A'L*5J&^:
M0>.!TM>_5 %6!9*?WCZ\^M$X4M(WF'8)@2L-?OJVD#:T_SKI[;VT\L*\AZ7\
MS@D<ALPF5 :$C[I]>8-\;IGXJ\%JO2:#U /(0RD"I3.,0"5L"Y&:0?H5AK".
MZ$*Y^T?,FYW'SA4V9M*XDP,1,V_0PQ= J[%2P;,8=2BN\/:I9FH!%/=IBA>
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M#>-^^'2:<&T:D$VG2^!.DM;(FB0A6N%)7)]T1@BY\,X'X,&BMBC)"E!=(%D
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MKB&/BR0) CM6"3H*>8%8O2^$^0:O,]7UT3,9T*MW(Z&2>I!(&,$ %8\A6!Z
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MLC=X'[,*Z\:$\\8[00S^)KR_Z,8D0 ST. R%)8OS6+;Y039&X(+_OG([VTM
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M"3W/SS:NW.S=2-C%'8 2$1(0@@-D3.T 1'*E?J@FQVVGQ8PX#A5FC_#@[A^
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MV\<5RT+X![0^5+=RUDF+FPB0T!&T,X#VK%'JT<J9B\&_UF5G[2^Q]FN"$@Y
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M%7]V[/PN18Q1SA$-7$8QYP,;A,HV4H8_>>I9B#F7=?R' E.=, N$YOCMO&+
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M87'8P:(A!^FV$?20.^_.XY:9@OB; 3"_%XW?9AZU&%U4K _K#CLG?EYG'9:
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M.(1:.J/AQ9AE=T10;58O/UQ(9/%U_S00CGZ;08-J[Z?V33_5; Z?*/TC&^I
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M:YR=-'N,S"&,S4#!OKH5";821314-@0;?.EO_,[_3F9_!NOKE-M'SOY0U%N
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MWE06_++390<QL74 2;.C1S#V!E_J8B)&YS;-6?93&B2%@Q"62GTHMF7/(''
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MOJ];&"L53AS!!/,8-O%\5M^R>>^E:]HI(@I7&J]I<_2'[CPYEF(?=V3SDZJ
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M9&1]VJF!VN%-12R'.:L3(JW[+'A.:6?!L)\RM1KMCY7K<I_(ECO4X W 0=T
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M+#34">128FRF8WB!J)1-TJA"V758FP$@C:$89"$I S>5]*^5\P#S3S&]4[7
MZN[WXNNP'&?4&BPC1+#KZ&U.-'\X.D^P,\3-=1=[US+.OSM[52,7?7SFU MA
M4T=SSC3_?4J?B%"RQFEYS791U&SH3U^93C1<CO!W>F<CMVJ;NQF^NVHO5"&M
MI/:AR&DR>R0"'4%WQZ<U#-RT?O?4P@BD.0E6,:B"[486Z96_HB?6%[*B6T^G
M:&\<>7?=2B;@0XN@+S%_:E:62J*U4Z^DB-5Y;C5.4:PUW?EA(! VA8H+M(VG
MRL=>/Z(3*R_F&3:#Z2 P)5&4U!'EJ%FPGQ6)NZ27K9>Z95 G*<<.HS2<QXV\
M Q3W,#=QTDI8#X+5JY2I_I%C'EZ/DHH%QCEF8D>KSM*MJ$8D/%S'UVT4@?"P
MO9&\U=;GP[=2H5L;^QHY:(2Y&-H'BEB8C@'C8$!EL,5(GMXE,Z%K,D'.%Y]<
M%Y>2 />CKK"VU/4CYCA>NPV)>'M:'K5U#]5CW#07 *'RF1PZ3#%?9%P$/V_U
MIA>:+UY_M'L!!K5*'.?9CU)$SM^:QK3:,B4<A_:DUA]L:XQ7SVO_X4V2+ BR
M7=J3Z1[1XJVP*\;@[^S7FT%1,Q#A.#>Q6,/Y U%IO/.^/F=%3CZBHJ5W-"L!
MXWW\2-$RX3;[;/MU6&EK/1)*CKI0!JDKEW1[<U5]\I[X ->F]"@X5"_7T899
M1#U>;..PX)N*<V. B,-JTY56#^G*6NVK,AD2X%DBF3!,L8%B+A3 CF+ESO6Z
MI92OPVI5I8?3+N8^\*I,3" Y*M4 ;L,#3;10UIL*_?ZH^ H+[#.WF)#[DJL2
MJNF]Y(OOM(E]Y:-=N%#E*MGS=#]2YJ#+[(K\]A*87OI8):>1(OE;.UIJ6O@X
MUNJ5PWTTR\\>;""2[]+R'; ?;@9;(!^0KJ)1LQ+@X>!MSH"TFRI'N(:#M\\Z
M[)P-,;^5OJ/($-D'1Y]\\BAO';9DEW'S#$/PKIPCRF2J2BG@00!J!,P>-73,
M=;EZ[N[<9S^'!\*5U/,J$!PW4$T"U&C'J2UEBU=<_6[X0>G!U=R8F0S)Z88]
M<#[X)*N\P@.0GE$WR[GD39(V"^X@XR*'M*C,S_#;2P,#2;QEJQ;:5+KM,<;9
M@ *T='!03[#A@I?FEA]?GTSE8=F;U;PA%N#JB*)T/I6[P"8=C>RO#J8O/O@/
M.<@M".-'U]K@HX=8*> A \VDJLU=_DY@,-3?\,6/T6[22=FP'CWAKL>E0DF6
M"<Q<QK[V*B%LX]#.SF@WO8V4\=CG3Y%]YM>E;(V]&-O SV(V#6-TIY'53?&F
M@/-1GS5S>"V* KEJN([1"*)OW@&]V6U%V%CE@85+W /:,J&S<U'BV&1"6/N[
MX2BD0,4F2G>+F79-BD;QDP-.UQP<7CLMB'[YF-_"Z3>CO]GB1"@W3*K]OTXG
MGGS89=@]CW[Q05\:7N+*P>4I,8?+KK3LQGZ^Y*F7YTT2UF\YH1O:NI0;+8YK
MK6FXAI'P6D[3')E\E2*RP>'NWLO';72;740XF$M S0<,Q08G%I!+*@SFI'N.
MBF]O'R\)\++GY3N4L+]"="V%Z4OY<7>,&(/==ZMNS>'K\/EAXSMUA1_.@,4T
M)(1IQD:P5^\P?644+8H)D,Z*-#L_D>&KA+_W3HX>HO0=2=?,!'DS1YN&^X5:
M2</B.MM>O3^8DR>B9E IY7A= ):1E;_ ;F@CADN&[^@(!0.(B-&M@,MB>,';
M$*+):N*H;2U.DBE(3>NYK>/BXG\IR+UW;\[THO/*6#OQ_4XZ0"[7OM0^IR/^
M0KGDX*.DSQO&.K81IJ""^RWK$;@M@&\!=7=(IMUS]LVR])E<DN>5'&+0P(Q^
M.NDC0#F&H>]!UZ_#^HS&6O CYVSKVYN>?Q4IL7Z?]GS2L(]IMTSX/E,CH]!1
MX4!60FRKV^_\KGWTW;5L7,K^J=4>RF-*N7FG^OS=]YQ]G[[-Y/6/)-Q!S201
M"[QZ'1K/[^U:AUWTT)XXIO'ABVS\_EDTLYQL+K>P!12".H#PXH!"<ZHOI&OC
M49XH]/T^<F>*(J3K #*ALV?TS=T7]-;1GFC9+WF7*XG$JN0K%]+&=U6N]?01
M*1;H7C5:"Y4TMVL4$'7'\@1Z7NZ^*M/5_&98]@J.3,@@DH?GZ;M)<9!SN?;J
M6%-]:Q1VM%\_[1<?$),KH&)>-Q2J9T_)9@IWT :I1F%PW!6FRL9"5X%7;UXC
MD2:KJ:/$&N(= *;CYC.B(ME[MN^\@[#T0W&>:T9P"N&'_RFZ/SEFF\,)7$W_
ME1NORDZT_])U[3Q=:XIVE&X]@N$^0HVJTSI7F9X5DKOJ:^1Y->?I,=DYD)KA
M2I<#-^(@CS]*CV/(@6U:5Z-RZ$ENZG9]%P:N:Z.:YTHSG?T),Y(C1G&>>K)T
MY EJQ/-/H^LP=.0U\]A+;9K+A!&EZBWGS@3,F*0/^<>^R.7I-JP9M2;,MH*\
M\%%EWWJ@ (OS>7.BA=K;__S2(#ZY2:\(\73YG(C%$=F_GKH^N-]77\:-815\
MHPWE,G_[)BE>8^"I6$+V6=U"5:D/^?>U&*/$!"1]CQA3!#_:,U=()9TF5E"5
M:\_4Z=S;:7Y62W'C..*!L!8?> ]%)@,<3'=Z#$-VX!N&VZ_[7:5F>^#W^P6)
MXKSIH5.Q/8O\HRBZ/#!G=HGPT3^7OBDST*N%]9HUC!_)$$+3_%@XK":V*V7-
M%2^XY/8F*^EHNE_^NW-]).7S)"H>W%C#< H6I60&D.JKMAWSX-)S3C]YA23*
MF%^'\8R"=6N(&@B_2?,6U*GPO2TO=ZV=N#_8KW0('GAHK]HTYBE6EZY(Z1@U
MBOQ1H3CJQ3L-=2]I![?0U ^Q9XL$DFZVQE2)TQ_+=Q1+EFO/\%[[5J@3="9H
M@]*:"-3JN!');]:F&CYKH"ZOPZ+[AY^HQW SU#[TW;BQ;2(UL9TH"Y +B1N8
MLA0K6B_U1?*(D=+5M8Z]/MQ\KP[28-3V]UYT6:'RW&_XXI+TE'/-"8^]E+O-
MXPT-Y]TYK@)VPT7RC7B!8%XZYF6P?O>;X\9">/5[JG*2W0?J"%5*JTIL)P%J
M3H.*8/^P1+&:_)TI'+HXW>%X]-#EN!-&_8>VP2,(PWCZH=31R$PRJG=?N]GN
MN<QT-\O#?(<MCQSG\EDFC(.K/7;4UY^O!91UIOH*33Q?A\VTV7TC%GK->E*;
M:.^HFR&%JP>^R4XY%^Z6\.E6^MRYGCDYJ-#+9;T"+H6(7I^_4R714'[<6<53
M\F";6B=M&M-6RI0,8>QDZM(]&:KH47XB?]]7#,98M-[JJ[V2UOB6&KD=5>VL
M(N(E?"0@!;BT;@Y 65,>WC+U=W0R-K@OAL./Z!IL:)^BAE"0M%N0(Z#H-%(#
MN+F'H)Q5\,XNF%BD=2N^GA/3A6(*QX!\/DZ,*TS>]@JUT:^GC4=-':PTOK^L
M;OR"&_=8O<TB8C<"M:&L'!TTY7O[AI+WUZ?CI>NXHAE*H.!KUBL-W"U,L=_:
M\9X&3X+GQ9)XS<2))C$I1&.8+N+[.JS9;GR3;ZR+.M.PWCB1).IP_%T2P["X
MTED\I0\I]_7(R]'ZPX;SK>H;'_D]BR_ZB]];7!P)0_I7:J7NB#IW>TP=]OG'
M\Z(T5)0HM92YU8DV&4/38*46"QJ2K$YX+0?Q7BP<K)NG@=:TS6;7?GQYM4&X
M9S*9*98-\MZE]H!\6T;BX$9T3Y? /=.EGCL3!@:U-@C=G(/R\B*"VC0V7]_:
MKSFJ/(4+#AF5?#>O,MY_P2%9,8VT[2RCYPVV"44QQO7'T/+:H:YP!SUDI-:3
M+Q_A'?NN6I[87E5&P3$E=1G.=*.QK3&H.UAI$_6 8H\;Z3:/6S_LE"Q3FL9\
M:9TE,'8SU5BI59NFTS=2>B*NG$SHKW?Q+]0?*!&L0YUM@U/3&*9@ R"!<L9L
M2D.,)N&4BYZ:ODZ0X^93':823""07@2'\2)$)P(N91\QBYXR-LL?L#/E\(]S
MR5(WY$494,2#&P7OIO,0"ZI*1V>:3$UU;_('='_UG#/?S'?PU!'X6\*DC=@[
M!XIZ]T5KXHUJ<AM\Y0AC5[!WS-@Z;'9EA!ACB9:Z[R'A7?: %/\\H;\$J\&T
M; >W,%6ZL=O=_7WJ9-*R/WI'&G)J&P8MLW_!2;[5G;[O%DV<XAN0&Q 9L@%5
M*';-=S&HYR%4"C4-%PF54U TZ_P.YN$<=7EK-\_) 47+TZ':YO!1)',K /*5
M4YUHC?3A5P%.AE3U!/HUQ5M'E;-=>PO>M7XE91 204ZP:5@,<,>+&XR@(F]Z
M-LPU#ZYV*!5,Z3"[IO)7P9U4$P,?[_E=7RE'&^[*^XZM]2PQH##5CJU%\8%(
ML"D_V)3*<]?+)U>#JK"2](GD<577/KP(!0?<T/2=FG,7H#)?$]SBA0SP-'A^
M8]30=5,J++8G+%B;3AC#A ^I%U(U(Z['E#M\UO(<V.I_I'R0$S-@-&? V!^L
MS'H&"G]'"2RGP4_QW@P[GC#P]/HV.5P+D:\B$&(@CVE.!1H^^UOGMWG9FI1U
MBN<Y1QN*XSC?9J!]EZ) 029DR,A!;"^^<"+[ML97HY8N=6E5LSY=_\W:Z94>
M2Z=VG'%>)K3,T^6\F)MW '1YB\YY0?"9<V=>U^[H2<,]90,=\OW$XYON7H.-
MAOVW<Y<93P3685I[M-,B=TC?D?Z0P6/LS2C 7\<N&^1\MTFRL707N\85O6NP
MY11,5&ECRB9>5(!WB >90%?N88KDUB'SX;.LH(R^&=7=+PEVIIY7I.)J&([+
MT@J<BTV@T 5(@'>8@]F!#.5@=:K0S@X5WC*/P/WBV^;DKBTS7A!YKBOE?K4,
MU##]V#>>=+2YN>^PO$9?L!']%A5!NT=/"!HSNV;GI<%?^+CT4VNC\7?LBW?H
M30$W5NK\,7UK]P^8AII<#LO##:#IZGGB.A@."Q(M]C&*HH;Y<NCVKFI.E.HD
M,6V8KO[TH8XUE_/"=7D4?97P[27>B^\ *5M$$'\/0[F&9XJ>6H?1W"G<N%ID
MY/MVTG5"S:X\JN'JO?"I\,-(/]O%"SD>Z5KTAK%=IG-':> :Z!@M89NX%]!B
M@9!LU4 -+]&-,( <,VN-K]B4B7$_^!F[N$>W8RY6V(@3+NU1322GH2A>+G-'
M*#&T[))N4#58]?27H@%Z5L3DY7MZB,,"S\+1=T%IH$8(\%2Y PA%U:?)U7[)
MR_S_B'NO@":B;WTT"$@1B"*]105$I:DTJ0$+B A!%%!0HB"]1$6DA0R]0P14
M%*2)@*@8Z5)#+R(BO4,(*M(DH82!%.YXSN/]G7N>_O?_,#PPR63VVFM]Z_OV
MK+WFXEK5#6?LJ;]Z" ^(_N!;X/_HCZ="E)Z]NZ\3P*802MW4]VT'?'446@'V
M18F+=M*$B(HNY518X8F5?MN_)&H\ZP% 6MZ#[<.>I12MGNN;Z]4<^/IG,27G
MU/?I:Q;G-]9_V)4N$"F8!89P3&<.FX'^'P@3ZA^2M0M^J'ZJG@I<+__,%@H3
M^7[N./$=$09F]W4Z'!RLOU?89<=_?LS\D'XS86Z>IB-1.=K9*V%^XNS7C^=?
M=G.MJ19 45CJ_AKW=8;3_@UV=D6L^N_RZPP>UW<"^T^*"9XK>!/V'U<#.<*Z
MWV2>D'NX;,B7=1Y+)B*(I*6U1-E68GGR!\HO3(:V!K_2V3>-:NL(*F%,7(Y-
M8*.E6(ZIN -!;$0M3NW">\:=_OJC10Z_-?M?W3><;KIFB(C-""DDO+\M)W+V
MROJ9EO>E<CDM=;%(5T22J,WII6L!]M8!?[637@Q8P1<=LJ#L6@@>173LP2:O
M-\O A[W;7F@%E74^^'CV#/X">L0V"NFJ.K8]IQKQF, !)C3O'C#WR+:KG[BO
M]"VD._=M!3*YBOD*IW7P1@#*>DH'7]K#$MY:8QQ2))FTARC2VDM#T*U!D:??
MNIGU>![#UX=< J[IV*YDTE4"X@]]7)R%U^M1>[8?%K3V+=H[B#.?&_""B%LR
MLI2BUM5C,\MBLP*9$E(AAKE!TOY1@B?T> I-'W"O/_YR(6)5#-*$C'^M8IXC
M21\S?C7F0JD]*HC>ZNWG0?'@EWSNY]=%(EA4TO%4.MD[IP4>F8%/\'ERS'ZR
MC"\L;!U!(<RKL7@O4'$+\Z*K%\A9#KM;;P\M7X\U9H2J382.K2/YW63TP,%Y
M,PS<O<0WY!T:588\DW'^9O)"QJYB)X)B@H>$;!."WZ1=V:GEO=)5?L75N 1.
MZ8#V$ T(V_IP/=GBX#C=T)R\)KQ8?.Z'W[F?47*Q.M5?&XSV8$'$0E0"P*G'
M.8^(MAL-_ZMWJ/" 9R97W+YQA9X<HWA.)]"'LIV@=XNRUO9DMS"M>&;<X=8=
MI4PK5_RSNX9'#G5< LP!BC? $!JU8[XU.#3.D <3/BK53CTZ;=B;ZF1I^'-C
MS';.E2'B3\-$T!XQJ[&72*O[FRX57:AHC9SL]E_=L?T(-#<@*GS**4ZTL<&C
M+_YT8N1+44K$GA?G%L$?"C7,1R'%V'[,"6T?(^&S]_T8BJ+-&=^"UJ(?KU[!
M8NK*DZV//''>7Y6BR><2]C\6@][ FF$?3^];!Z4"-<L,</'F#I\\YT6*1%(H
M']K\UQMG%<_7W0UI4W)CW[GV;Q(;SW93%6A3K]XTNMY<X7"V!N?=6,]W-N;P
MW %%'1EO=3#12I_^WG]Z5^E,W09H6PUESJN-1Z<8%YCO_$H>!3+ZI7^U&26X
MOHT$KC YH>O=)KH@>!G6U#:<+I40XT506MFR2@TIXWR8-).TF0OO<0=<$,G7
M#.Y3LC]L/&Y_39RS1+.^(\17E>V>4)(_61O?#HEWZOR%'H\J@IC\V-?EV]XB
MD\W9,L&Q/\?^3-R0DO@S2--D9OI$F+M3.EL'WLX&L^0MGW+],D2D("CN_F'U
MGG,]RY,$07=1FZK>-V%B-6%/%]Q9%.$_1(H?)A22@'":_QVMYMH[P^U?ETK/
M'&SK;;K/^D,8)L9 P8B3P)XYCH"!+IVH4U\475U2'BZN#\]*8D]2T&W+;(7@
M9*N(5JG/=Q5O&PN =#X4&4.EGV4\U'X*FMS@D'KHK K>,*$Y@K_7H_9@D6;6
MW8NL&%70EE8&.$*:9%K4 ZOR(TX!N<Z=P#C92=-F9LW#""T-[ \@%2(82VP)
M1<8'YXSGS%^*BJS>QDD-W8L7_E9F[GTLU."M+>>[9O^B.XTY^M_"+YY#:A/^
MY+ $%)@5@ MF?&%N'7L0-"<1!/BOVU:D3C#3KD3)*'#BOQHJ?-XD-!/&^TA
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MT;.I#"GFI7W(9R&V-IEW1@J&_SZZ-:D$#]K&1*(IUQ#)L^P&TNTD3(S!">+
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MFR=(+X^8 1YA)9L]<;SU[V^\QG?YKZ&_KC&$+[!X2Z@ [2]8'.RAT3.IO^_
M*]GXL:\26HF;G0K);M)X;F8MT:UG;2*8]I2JVFX6AT][[W$\X)FF]:,S[;AP
MR%RE0.F+.JH_+:R6.KQ:4>SJBI'^=C:JR[M&8V>>?A+WS4"?^<[@]")2@'%H
MCI[95=1XT^>O]X]#W$=>OV8ALH#;:,KE-5!A+1KIB!H?O$39=3]S_$M5H_7J
M&-ZSZ[0.=2M7V:D98C]KW X.K)87O>Z29Y*9-T+U.?P8'U^8P45VM!2K70IJ
M7M+:GC/K<5/(<LTD^C4LUW"C]/+##KK2)_FJ#5'MM![=AYVWP]"=F-5%NBCV
M&C/%0-MC1I+:&!;(<1:-TCN,$KOVN>O*_"2'I:CKYC3D"'\9%C]8<KANCC_;
M/ JTH&:^J."#W(0O!BJ>&>@H'&(IB%9^MM,;P^9^J]:1F*(*R@,,$07R*./P
M<AOU9KMO,)#7_4B^9M#&LO@X'&?2$!(&N307)*1R&+;TBXSC" $#25!DX6+&
M;ENK?GM#D[9<-NI[R#N)OUAAZ(-Q5%;2/&KR0Z=.<MRO;N_C[ZY:9''_+B62
M7A@<J:5LK]K/]22<O(6==NQ'NW?*> < B5O 0;#(-J<]6[DF-;AN9%JN/.2W
MQC*:8J&JCAO*%EN_$3XQG=NT!_OT)M25UDRRCR12'%+\I,:YKE9W;Z^/5%UP
M#G66Z:@A1%IV>U/63*J_. #ERGW(K5[/MP[HX ><'*G])G;_[^6^PJZP#K4(
MB\(K EKL Z$PCONG5'R'!O4^RRLYZV4_5[C8)35PL.#LU.&I'QRBM38Y3XI6
M1;HZ05-I> GN$=!L\Z]N@ 90S/M$IA@:E3]6MA3G/!L$YRA-I^>)#;@$#__#
MEXIN<_\H?ZOD9% DS&!!WH9!DE[.5BJL5M/MI@-&#2F?/GGQ9W24=?*6I2*9
M-]AV")#YE"$P+L/:07_# \KL2P)Z[A65J;NTG-R03(:=8R#MEI"D5 3E"CP)
M7>7?KJ]K&]-<;17@,?-')1^7\#S.0EO/-@,WBJ:8X2<NT*Z6>V,Z9&##3I^C
M3Z\[H'BC'-0<TB&P[8&NWLHP9T8P;#V+;C4'JKS8B*XO-SW_]F4G5XHA8L1V
MI93B9 :R4W1;]V"\C_]$3TNT&994<Y!^$P\126NJ"79)"]$5*,[)F;(#=^Y5
MGZKV&EU16)&DNX**M&Y0,1][GE+YD]_?U[$</=[V*V,J+5'K-U*'H0FY4*4@
M!KQ*<NSDNGD.$9<+[P!B]D.DNW!))W'R6!4QVIWGS_DNL3W8*:87M9HA)0$9
M9 _F<LY@'X-[8/5B I_2*.W12LKM(QQ^6[TXPYL]<EY'+EMLZQKKO*:B"Y 4
M8R1XM#,!\.EYB3L2\&;]CI;)V0J?C>::LSR;UQ<-UYR^>P&D!F+EK^Q2&HUJ
M\V[Y2X[2#!5=F$.YL@9J?Y\DP^/4UZ)R9%:\-M]F6$>L;O36C#U\L7R[B"&D
MRN)_7 GZ42Y84M=:\,+M(>_&)O&JJ+(JW5^ZJ/=PE!U#G8J.UC.G &1^6H1>
MZMA2AG)_;.KII?D]V*BA1]_?SB8';4I?&YYW(F"R.>/-S&(U=:WJBT6RON<C
M/2<Q0OL:J GE%^42[#V*^6PS(5;F9.#LA<^75VU^7_T5Y_!R=W1ETZ*]2Q$?
MM*_M/V(V#WN)$'Z0FLM96-6YPU-DK6QO.UBAZS]4:5\1SLUB) <(L;6Q!A R
M>KIT'8;<".X$^"8@+\*T4LW%(9*7=9%(^HR E)P0:Q)=T5&I_ZE4;O>8A_QF
MU\CM#K8^(W#TCP)#"G(=SL0O8%@)?GR>1*MWJHSH+1NY]&Q<,&1^8U](.\[O
MG_0!2#EH0< ;,P&_4E%.61W:]7Z1)[FD]O%>6H^^6;"O(<(%:.8%2*DZZ6WX
M&)GCS+?0G3PD?BZD%+35^K6WV:<47,[Z,C_MN0'0)BH'E1OUEC*\G_%P:&YT
M2WB)(113F(IT.(6P,C^'&;>ER8X:"( 6 T*5@_4:_K\J%*.T(Q #Q&3\9.1E
M8H5(57(DHAH5"BSG6UJ-,3TA[[OR+$>D^?C9_05'N%C[/7=5#'F^*^X,_3MQ
M]XO,\<CZ^_!5A676#N%/KDZT&"ZKP6W_L?=QDNQ/<%O.8.WR94I'6 CYE;)L
M[UM^Q3,.7TILK6Z??<A<"_J%TW7?3:ZFQ+39:2:QZ_=^3U=ZH!1B=JCCA!PC
M 8JU1*#YFRJ%J\-NM 7. ]JT!,<J3PL^5)$2%#=:7D7_*R2'KP93D;0!L%PK
MF8$!'JIO"XK-Q9M6/[#_Q;Y):-R#>4*.O;V*H7;2PD?UW!4BM@BG;H[G^_J\
M/<,9*TPQ656@2S%\F,EZ3VI=V_K8/33/[[\E8O^E9?-(<G38%%,$&B$.PJL$
MA)"! L.A'X=DV%!6IY.3G,^UF,HXI8B'\05L"C-50,E6FLPA2F]ZY.;'0 GL
MOA,MB7R\+"<DZ6D.!=TGA/O>J-_?* FN=P0^Y@O32S\<)AAU!(;#G/?<O0W*
M4NU; 7&6U")"4$]5#[6_Q*6:S5&;5\#MT/@']H[ O/+DDP)G!CF+A:\&S,K_
MYQ?NO9+=]R2B:QGU[M/A1 )732ZW1EU4Q/GZ6O2.JZ?LX<4H#48"T-R"%,>W
MHR<&+J]6LNNXK^G!-US=^?8CK[ J&H]-H&<#5"W+^G]A=.Q-KSWQZSZON.,#
MV3\":(8PQ6M6G.%*5<!7X&'+M<_4ELI[N).G+Y_Z=KD=AL,QN,$-,A J<[**
M&A,Y/=]8]<R4H[]JQ(:FL>0 X59X,6X$=V8D\T8M6/S)V/_O#=$&_I!_B^5C
MD&DQC=I8?ZH3FN%32J2TEV1]C4JPJA)[%;#)OXPNP*G]ZP_2R#:+-4B_.* 1
MHJS!404)[BKO]@;<+_8ZI##1!06J:*W:4Y#M&;CB#^"@]7"); W^6W5=PU=O
MK@Q6,D!Z1J38]$7G4"S[V&X9,?/=W<D8Q>W:J_RIPK9K?C0-1AO0;$DD9<VH
M,2,,=)8:]PTECNHX?R3KAES*GTB5;GO8M"G]'@W*HU9?S>>,B]+2!K!&>6!X
M0(G/IZ.5]Y.:Q/QY@<U3^[/ZE@@LWE\?JR%1ZT@\N'3ZRK5G84^!L2"61J/V
M[2P3\G;LI]_/?FV96@ 2K%HDJ0BG4PW^6Z-LR&Q_8KO/M6Z@1/Y9<=\WVB_\
MDN<.']@HSCKNZ5W-13>^RGH,SZ-70LPD.4#D*S?VWH=NGT\KCO?E@-%3S-6Z
MV-G);B];CD_<6X36-5 ]\2)6F3PJYW.3W+4'(UK34^_<",Q]-'38=^<.9,HW
M6-W]>+J'Y[H<FU3W03D!'-VV@T@Q1PI.!YC1"OK]3IBZJK5]42A]:CN-I/A=
MOP@%ET5]&V/&"[TK:;NPO;+/.8V6TB_'>YE^'[E[VE*6?AN4/D($U>:"QXTE
MS'G'JT.<A$<ZHDR4,R#D=J4A*&_UY"+]*$P"*\%NY49:QYGX_[BC^=#T-?\S
M34)<5GGES7GA97,Q0EW3DB>KV=SV&1J)[V_TAUPH@V&%B0+*]]=\>$OG[\CT
MY];NO!G+JMS49&<K+=TDX)&D2N0^G#SK!['L!\6D95P%TD43=][:7^)\==E!
M>U<"QM+'J8#1]'9 2*/7.-#.V-OQ5[1%P(9=@Q8-8#8:G&9]-Q#]0B&VZELM
MFZM=D2XHS[G'WX<L";:%+AT+5._/(O=$E8.J9'&KX [E1U6+^%>[6]N$_ASP
M^"A#8E6&0&J>Q^ E=NVG N,74$/>R2M2J>=0RX8K.)-)"-DMB)Z7_=*'CX(U
MGW;*NK^0MY\"I^B=+)ZP?RU\L7:@T;P]FAOK6A=R 57[ZFC&ME7ME)/#ZJ[M
MR!ZL>HTA>8AD#X\(RDDR$/0429EUISF_J8229Z%/D+/BS@[82NF[ ZI2%:W
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M\F-.7UD20KA<>)Z>,\3&C1B^5'2D'P+NX+&;?^G=N*G/M9>;?K*C,T05 ^4
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M]9>N.'5=#(/E\JY\(BE_[E&X/=J=0['!@PJ=,4@?0NBVA$!QH5S&BTQWN8Q
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MM,]A[#,,J(:BBCXC5]#0*#^>QH.S[A,^U1D7+0YHKS9'N6ZE8MI+6_^T76(
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MH<OE<S+&?]SB+"N7!^KW?4X*68?G-YDP?2E6=GC-SH,/=_B%KE=6MGK+(@.
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MAG)O,XD%D+56<C0I(3>3S@<&MVEY%+7_L8GSXZV-].E&"J):F*P\E_^J/"(
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M[^4:BQ8'!#U]]*(Q,T#S4?V/I!+C3;B;G93V%'9^396SEB-U(CVI7F:)#60
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M907<X]8';HQJYZN>8]\GJ:]Q*\7M/YU.^A=_\1?_GF",_0]02P,$%     @
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MH!@O>EU)':W\D^1F7?ZZPC_7 =KOV12=ZMJ<J@3IZGF3>I\AC -$8<1B+#6
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M6K,USCQA?]@T\_27\-9Z]WS]B3QJE2(-/N[X^W[_[LY39/2;W/5BC'^O#26
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M..X@Z9UV)3ZF^0-T)+X @UXWXDL/&X8-VW3(^DXTL\+Z:6#-1,A%[F>4QDF
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MCSXJEFZ[[OOONB5! ^<OK&7LKX!M2H6I\G:6NZ6@]7NJRU#?=]_K+YV/]:]
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MY'I-UVTSBSAF@A<!I"%B$(58P +'&&*&*0[C0B[.1J<%,W(CFY0M Z"I1+G
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MA).3I-XD[:1/Z'/))[WO.-[VW/8I455.6U=#E&0BBA,.21YSB+ 0D(11"O-
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MG1WF]WK,X;66WU<6KSGA:?-XK0$YRN2U'\'Q3*,2 SL9#9_7JS9=9IX*E+,
M<1@' 8*(!P4L1(X@31'#G&6D0'9%;<^2&OM4H]-3E^O5 Y1O/[KG ?6 97C&
M\0*!Y2%'2W^0';0GZ_&,,RB:KT/.>4+3GG(&!3XZY@R_,7%'WSM>*E\)?N"W
MHM-[LNF)A7\L'C>/\X+FB$28P#S,2=,4O,!%! DM0H&B!,6IU:V@,9D=V9#L
M.7C=X5=G H#'AHN)^OR:3)Z96?I9IL3.L'FH<'4XH=W&OTV2\Z\#$SI=WU\+
MI-^Z^Z\)JW^.'L 6H'OK!&Q#TS[=]*/$<+WB\L2J<O]>KC?\?OV/Q7JIN;L5
M_W?]R-^K2''Y\@G_<?58FV:;VHX[LJ%NV0%;?@#;Z*R&'4M*W153H.4*2+9F
M;3*$>7JI-9K]YGAL("W=6Z-@:)5%Z@J&4Q*I-;')<DA=8>BFD#J/X1H7?WQ<
M-,57Y&'U_7JE\I3YBNJ6XU1$64PSN8T,A(J+)[!(<02S),YXS-(0V3G9>VB-
M'A??4=:^%=JE#7[YK$IG9Y:]#_N0,PV0>\'#-D!^",4!69\A\$'9O(7 SU.:
M. 0^*/)Q"'SX%9\GS29D)TG=Z-#[XIDK-U75Y$+,\R3(@PASF AUBRQ+5><T
M4<!$)?IBF@88QY<?('MY&#NNIC9G)TXB/@Z"_=A><K[SAIC[L6UW'.N<V$9-
MH;D B5&/5?T<_ 2G)2.(S Y!9D-=>B?]@Q#-109)16YN[O&/+[C6^Q]I!Y=-
M.V@=D=T'H+,L(GF29) R%?T7@D+,: 33*$0Q%GF0Y<3MTKH],Q-F NR8 PUW
M0+('%'_@D$'7R^X.,V%HUB;"U]*^.4 [:G* #YB\W[QW8.6-KN:[@W;^[OX%
M8SK44OSPR,L'N0/\>[G^H_ZN3#%>O7RM<;VI7E>NXC$E+"4$IBE)(0HCU>"6
M8ABQ@D51E'!&C$R@)=V1K=V6$=!P EI60,.+1;E "R3[3=B(^-A9JWYHK#9C
M%\%E46%Q'-C<JBQVFO9(<]\6XE9P/C6XJ:PZOH7XH8&8MA!7FF5?%1;M4>FM
MLF@QW'25%NUE/*BVZ/"Z@[5545U<?=<%\3\TQ=?G<D.9DDR>>;,DYE#54H18
M!!R&C%.4ISGB@5%^^#D"(]M/21'JGL"ZY<2VI+R%(3B%B8&!O%!2.TO8$FOZ
M2X /7F2TL&H7RNIFONZ_*Y>^N@6W:J4_F&%5.G9;(?\%U/)A=5ZK52A )[:J
M?VDN[?JR8CTH])JK4^]-9Y=ZN#XP0'W/V<?R[DMV59;WO'Q<K/2TJS(@I@&[
MDR^/;$8ZU'3)$O- VVE1AZ-I%TMI9T+N2ZR3![KN+&.AK2)CO8(YA;].CSA9
MC*M7H&X@J_]!ITKS2_GS6MT7>^:=F;M?J.(X7]8O>*F2M5I79=/%ZDK(S__C
MHJQJY6KG)5W@Y5>\Y/,@R@J>Q07$<<H@2N,4DB"5QRF*A1 X"EE@?G[RR=GX
MF5&2N,[0;EVZ\L=:\PG*+:, *^: 4-RI77#+'J@D?U8UVSU.F,$NY*VFP38
MU^&R:X%FH&$4[#C=NMUG;5L_H+D%FEVPYQ=\?<-YL:JX_S;SX[;ENEA3@"X-
MK_=>]&#.\5YT;Z?*,; =J.[OD>"4/0#\X_2J4\ (!"Z-L>@F\BI]K:Q?Y-YG
M56&J=*%Z]W+P&UW@-LPQ*@(J("M0#A'*8U@D@L,B#G%(L@)Q&K@%5RRX&'D5
M;.D!31!T>+FT7K -T+:QDY'@LUN]W)&[(!SB(+GW.(@-#V\4 '& Z7SDPV6P
M43?UBM+MZC.OE66LV@S;3^L_>/E%O=2FX\ZC@!5,T A&J(@ABE5I\T"$TGSA
M)$C"#*/$*(EE%.Y&-FLM6;!4=('F]GC'(E5UQ6N]0ZF44ZA-8AYE_V@X9U[W
M]OYG8M3]O0XGWZY4DQN]CZ]FV\L,0#,--->[&Q!O.4VC;/7]3Y>[A_7QA/X\
M'=P\Z=>FGW/#;X>PITV_(=&?<>-OAY?CYM^2B)>R*E<KUKG4>*(L@GS@\WI5
M'E1)^+18\9N:/U;S)$GS(HM3B!'-("(QAKD("(PQE_\<"(PR<4'-E<NX&WEE
M[11<:3G3RGQ1H94+I\/L^/!F(-LMFB=*M*CD] ZO9TJVJ*>Z#&]KN"B>@69Z
MO.HM?L <I[3+A;R]9=T7/[ .%(7Q1,3-+G_ASWRUX=*DYKS@$8MA$2 $49YG
ML,C3$)(DSV-"$IJG5I4GMP./[CZIN!3Z>WN79K?F2<TL&P[L#.,.#S.;YB*E
MK9>CH>#/=+SFV9/6[X:=5&%?"_-:UXY^[]CHB$M5Y;=R!XY5JI:.QF^5]F5;
M>.5ZPU5;C/L_UG,6"Q2E>0*E3F&(*$,P5[D\O"!<Q$7.L]2JN*,E_9&53LY]
M:MD-R1(_,^T;$14[)6T8F8$=*TU&T&RW:WB9J6NPA.O^A[.F>XKDR&.O)3<H
M?#5BLJ0^;9<F-VB.6C@Y#N-F</9)HK>B>Q&F]7B^7U=U=50,H%,84;5CC@22
M%B=4RWD8,)ASDD/,.&9)Q%B862WG%_(SLD'R<YGN4LS-C-:$2-H9L<%+=J/<
M-/$$AR=#=BDWDQHV3]"]-G2^AK4S?(POYA]TIN@58_(KK=[+'V_+^_4?JWD0
M9X2P(( LIP2B+%&!%!3!@",4$E$4(DM,C%D/C9$-5$,5M&1G0!&6L !%VLQ(
M]>'3;W@\26UG3)P$-C8>!B+U)#3*MQM;('_8FX"^,2=1:P.AMJIJ\JCCOJ/M
M4W:/?S3>B;^7ZZJZ(E5=8EK/BZP@"9.;B3##.41)4, <B122F&0\#5@>Y]1J
M6]%+;F2EW!('-?[1MG3Y3\L=0S]:AAL";QC8J>A.?'7!M*$\ YHV^+:E[G.A
M-Q+3USK>3VS:9=I(\*-5V.RM2]P9^@AS=*M.)$&<8Q)"DJ<11 7BD)"<PU N
MLD5&DIA@JQOM/;1&UN^&IHNCXC0R-DZ)B^5U<T T9,>MAV$@H%>WPFE*;^!"
MZ!7YM+N@_Y5+<RE/U\K0A^&F8$9UI6Z,+]KDJ,[-V0@'1<I"B&D22!T7&<0I
MSB OPAC'+*:BL%K&+V=I; =!I\!"4Z:S;=RRY<8UR])Y"LR,R;3 >O47S%J(
M9SN,)ZI8<2E2WO,UG1EZH^3-2P$\G\EY\<A>>E._TD0>1B2-Y XGR(($HIP@
MB%&2JXZ4$<99@%ED90Q[J8UMYS:/CZIGJ^JWUVD_?;=K/ZVQOJC9K9,=\X:)
MG8EZW<1V5 MD).,XK6G?TFX8B3W0<M:KMCN746Y-T(<?ZMJ+W+;=K)H[,;KG
MZ\VJ+A>K:D%UYL8\I@4E J<PC:@T&BD/(*%!".7I2$5[LRBS:]0Y!=,CVYZ6
M$\!;5MA$->UMILUPU_6338;[OLRQQGTKQPSL) &+57OS<P9V@C1I<C]!I7L'
MW-^ZXKT-RS]!+<=Q)L%;!7P7VH[-RY?Z.^;L-*_;*BX92?,DX1%$C*@"M@&"
M!0T13!!-"DJ%/'A;)0"9D9TDS$ZTQ:!=R]+6?@$EIPI+2\MO""E)4YKR2, (
MY1)7DF<P3XH )A%'$NX8%7$VEUM>LGX[4+ODS7>INII.-0#N*)B:K8?^<?+L
M:1BJO&3?S]Y*8E_][LV(3KH:V 'QVIY;ONUFD3_SNBF)^6E=5?,X2\,H$0E,
MTD):B;B@, \Y@B'")):&E\1Y,-?UJ\QLQ,'H5O9U1\/X.U<7[Y8J_H9KN6*1
M3:T/J_5:EW.0ED";B._KI<3&,JQQB%%:% RA.(<XHQ0B$0N8"XE1DHLX(ASA
M.(EL%B=WC!SJRK4872)_1.,T+T(!!8J8DA_#0OX=QD621C@*TRR+['J?VB-P
M27M3+QAPG$4!8S#@02!W*2&&>1PD,&<)#1*>R_]AN]74^2MP6C2GTA6S%=)9
M=KN%4 G=5H7^15'Z*[AZ)?T=]MNB\:1@GM:[P[$G7=9.BO5Z]3K]D$O1/5WB
M3>Y8KGXL*O-J>]VW1K:J)ZK0&:;"G!"P7V4ND\W2_WNBN-XW1=*#V_>\'(ZU
M] Z&FK"(WBD1#JOGG7S"H<+&Q\4*2X9T4/S+XN%[?2M^JYI;<&VT@LL3^\?%
M#\[T/\Y#'L1I$B:0\2B'B&<%S+E<LC..>(CC,)3KN'$%#5OJ(ZM<RTY;/;54
M#,&U@!OY%YV+ICI#-4PINRX46\TO+.HN6 />K[JCPVBGW5L$F^J[FA=X*Z#D
MIDEG SM^P/T::(Z:7XR)H$5EBC&1=*L\X1]1NTH2KHCT5HJP'G2Z2A"N\AY4
M>G >Q#&\IC;6-U6UX>Q:EW1N/*W:M]K0JW1[P$[\^:NZNJQO-\^3- @"GB 8
M9<HY&@AY]"JB#'+"0WG\3$*,D57<[!)N1K;P>_HJ'D\[\?BG73R^:0*]6+TZ
MN(#-D_QQL9)LXB5XVI#E@LI!Y$M21,NXVD7S91@PFVH6+/V&&LJ&+] PM@MB
MM14>#N>HFS.Q9]!C@,L'3KXB5Q?Q,FU(R@=L1[$F+X..E*)0#02Z_BZ?K'=1
MKO_BRNQ+\RX9Q0]\&P6[*Q>4SQF.PB A*>1%AB'",8:$ZUHY29 3*G)./;12
M'(7WB1(6'A1#TD+\LEB!W[Y>JSI;H%(26+9AG7)6#>WRSSE7[M&?<_D,E6E"
M0R-0-YMA*Q1HI=KE/  MUX39#?XG8ZHD!X^<_URY#OZGQ#KE8006[%V8=\]/
MK_(^#;V81R^.;-,E0."Y4LHMUN6C/LSN[S//@.;%W+%Y+/:P;_,BB>TLXPEA
MQTAP[97*R=EY/-ID_LZS@G1=GN<?LE>=#_]3OUS]4;+JBOU>??A!EP]RB_GE
MJ:S9S4JE:Y<O2O&K>G5/EK_R1\)+4]VR'WEDY6N3K+5UJH#D:E,U'<55A@9=
M;K0OOBE=^(4_K;4?2:[$!XNZI88ZH#NLPN,":Z?CCIBJRJ_'N()O#;N>C(([
M3DY6PX'<9&;%'8JNW;E@%'O#=/W,6'5;WM;?RP_EZJ&Z8[>K'0.?:_7O?U1?
MQ)(JZO?U4I'^N"[?/Y?LGZ6=I?) :F33=;UX7C"^DBJV+H'D1QX!/^!R)96K
MTC6[5*G/0U5<K>OFP3_46>$+%TM.6^5K$OH.U$\U]7R_?M8EFU6%*',+YV.:
MADW>Q#-D9P.GGAS/9M(CMDYVTP?]R0RI1["ZEM7GL Z1[ULAY %,57IMZI.N
MRY>O3YCRF]6[]4;E*+6*&N9I$,=1"-. ,XA(J%M&!# J,,U8RB+*S9N^&A(=
MV\NFN=#U625GH%(<*#UL>5 N^*7DCITOAN@.IT$X>P20[(Q;B\^5JC&]8P%H
M'L#-#J9AD^2.DD7(>@2TW"+5<J\K?\L;7YX^_6I+_L3+&B]6NM'LNDVM6 L5
M.>M\@UN,7W^*OOHA6(+4&[PV'6NZF+6E= >A:MMW74O(?5PL^>>-_KBS((PR
MG&=09 &6%C7AD"@#BPN*>(%2G!9&K0).#3[V<;JIH:;H@8:@;:FX#@[]IO!2
MZ2S/M.:".92$.Y;@@EIPG<$F+@)W+,9Q];<3SUQ<]JU3BUZEE#29?SMG]!RA
M*(Z3((%ICM3%-A;!G%'Y1QK'.,QQR&QSYXUI&WV0E^35[\LW-RO'E]O?VKIP
MSF7A!M#LU\IQ$+J\6%R'B:;DU*L<6X\9$]:B^R\@-T#WK6K)F<'14U;.< "'
MT\X'(;BJX\*;]'E)ZXM4QB]<"2DIZJW:'5<1"TGI>J'2FK@4O]IV]XJS((J"
MA," L1 BFD2PR-(<$H9R>0A*61:;=\2^D)FQXU5;RH#M25OL\2^%VN"$-"&
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M8X!ENYQ>@I/#RFHKLK?5UICPQ"NP+2#'J[+U".,V.%?^4SHO DH"GH80\X1
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M-2#>47^NH><=W"X?EHM/B^7RY6JEJV'AU4N;0!N@, EI%L,X21!$0EU(QYS
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M;5O8-=&RU-\81:RFDL@D2AX<4 +*!4,554H]E7I\"H*>)&B<Z10#0*@>VQO
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MG:L^ N( *9VP5'WZVWA8.D$ +>)HUX14B29PR1#%2_F-,T"\P0WQ4CHA8@K
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MQP8 >UT;L*G[3-OA:.@C7A5*?KM:OUVL_S>L2[7]Q >FT#ZAA#E [] $W%?
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M6*ZMRKI3-_H30$7L' Z^5I51@ZIMIRS>[Y7%GZ[,GO_0_H.-CR*[DL)ZHH?
M(W.,0A1* R).48FPLY&1$*PFB2JKDBW%; -T5^I.8/]*<;^"DH6^=R+0U5%.
MY$RL3JZ$==",T,&1K*E/: 3XJ&K;G0=(&5=%#8>6AS7C_271P OEMO3]'1J3
MOK!JLZL;Q?OC+WY]M2RCF.]O43J5;2IO'#PK(O%#B0<KB&)6)*&--Z'V(3N!
MS'%?*,\)Q&$EV !(MP7UT&EK5)ED<G8D:5K:2&^*F4,@8/#L@78FA-J5ET>0
M-^X+YOE .93$FK3FYM_0%9\^R%3W]Z?:E^FJ<=HCFG;:0OVMOM[;ZVD);N*R
M!\FX>)2,N\&6C**3X,N<%([@DM$3K\M?0Z;.:\5IZE;Q>"(!?57?)[C\NECZ
MY8]M9<2^L9$E )6>.!],B?$X$D30Q$C/.=H;0*L/P'B2H'&,O[,!9%_+U1-.
M Y?L3B;>AI6KTECK7=[P;G<"8TC)<4-8X&@Y,.])F<V &EN&E 67EN;*B.M$
MV#C6WFC(JR^L!F_6S6X>5+[V2/-^ZO-ZIW5W)K928.3.8BL@N%OR>I38IE1]
M4]X4"E'O_8^MW7=;?R <!\LCR4J7N@!/B;,J$L%4T#P*1Z%V>_Y^%-?3;W<5
MU==K7/SAE]NCNBVK7I4LEZWR6*VN+K??V]/N(>))"JZD?$;\@])$G-L\."OA
MP!DEJX_=K+N#<0,U9T3O8=UY=B T=<T_WEA@=_<7<3W]]HC#9H+-.:*;QH 1
MZ<J Y](<42E0+H/1V=?.T>E/];CAH,;@/J# FX+XVV(<K9#!=_G\F^W^=3Y=
M']JLB2!!&4],=K2T95<D@)?$4LC64P=,P&#H/H'@<4-*30![:#$WA>G?T=1=
M_ #X",MOTPB/'^J+V>8C2Z.8_ 'BXO-\^M_(?EA.%UN9[#!")QU-CGBX#=Y?
MOO0[4RP2Q:35P6MT%FI'\P?;S+C3PYHX"V/"HT$?\K;!39^W]8<?TM=;?(:L
M2B[B[2J/1/=S-AD%8(@2,1&9$A";!"4^^T0%,QH_KO*Q?X*<BNHQ9R@:'VY7
M^^!+-YFXF,?I;'KGE>^8-SIPJK@FT5*.K+"!>"T]0>1S#]([FVI/R.E#[[B.
M6RU,/:'!AI5@4Y?YRVL"<)/;C/*+^1-Y3Y"9-KK4/.O2RZ&\R#F;2QTTJF+K
MO?-BN.#K4:2.ZVT-C]'AY-;@'?H1/A=+Y0-\72S+BW&/".SCG]0[]MJ!P$I7
MZOY2M[BB%"TB81,1-$:TDZPC@>DR/LXJ9AAGD5?/&SU 2\40T=X*K^=YL;S<
M".>W']<_W&F$*JP00:*!J$O1#93G!F<,,4%8[8%1U,7#Q86.(77<*[0*AIX(
M\PPFM 9UTUM8OUFL;ENY7:S1_P]7ZZ( UHN2[W(=X+I^@SM==9VV4%_-5F%[
ME13??M.\NPL5[S:#=A?A+ !>:9$31[-'!Q&OO&BX#ZIV \U#M%3T(O96*(7-
ML8PUF,ZNUN7:OQ]+,LPD2U5IM^N)I+Z\^8,GB98V7B8P=-V'<R".(75<Q5<%
M0T\X#H,)K2F?X6*^GJ:R)721/I;*^XW)^?OW.+O"8[X=]7+Y]6I]'=_9Y\J.
M66H=2' .N2Z1ZX:7 +])9?!>B$&&G'/M?J/U=S&NIS$PHD<1=8.W_$M8Q>5T
M\T:UR+]=K:9S6)4BE$V_B44IU;Y=X26L_71VTA5_PBI][_>^&ZMTN;];?O;S
MZ7]OUGFQF*\6LVGRUPWF=VEXEZ]GF_E9:7D*]P/8@@:31:+$(:*(S)H1FY4A
M5*GLG91,T=J60!7">W5UV)'@NUL)7EQ+\-T]"6XNH(FAC&F7#&':(Y<,C22(
MJ(E05$**TH'MEI%Z[,KCWOWGA]B]O@Z#BJD%\^ JK/"J\,L?9<C@=2;@Q??I
M:D)E3"8!>G3 ^7;,N'/!$A6#"H&!4*)Z7\M#Q(R8'SPL /9O\"K2: %6=^2_
M]9?XY:>EGZ_P))8+:7'II_,)T\&CX<R(YB6 $&CI8&!*U1L7#HT,RVWUUY-G
MJ1HYP%-'_/N@JBN+!M#U^OV[O\!E@.7$2&%53)FX5 8V\\")IPK-51 9O(Z"
MR]H@NEU\9*Q4ENK^@)>36-P -MY]@V5)4]B4JVW3TVXVHB#*E 0!!0[/$-5X
MAJPA$: DJ:&G8VMGWAXD9ESO<V#LU!'!V$UOC[CXT6V#UVARKB8Y2ATM&I:>
MX1\R9D&<\4!""$!1@7,;N\W$/F7U$6M9SF(EG4<L#>BPQR<;;;[[\>MLNKZK
MW?E0-LHFW%%I- .20L9S)2PG(7E-%%-24..#E]7G[!U)X\]API\(F4Z3J2K)
MKQ5\;@9JI9=7I7_K-@-P$SM<O84_-C]:E5UI)8PA@&XVLE"49,!8JLJ249HI
M/._5AQEWHNSG4)05L5A75BT@<$/^=EOOE],(-Z'K2<Q>1)5B"5&;Z[Q3;SW)
M(NL(AJH4:G>T.4C,."GV(^&LBD0:@-;[Y0+-T;0JKR1E.Z4?Q;OEUF3>*O-)
MY""S#XZHC-Z0=!1=(D45JFNN@=,<%*L=&GN>JG%RV,<!6V49C>UJW*3TO\M_
MG:.8_BC/=?//)0FQ#([8]ERYO)RN-M7:$V!1ZVPLB:4)J$0_#7F&?^6).Q6,
M,LYU:^E\U+*=X*5^;G@-+(P6E-OMYF[M@G)V-K4;DS)?D ?GB:5E?B5CGCC*
M##&,T@C!,5N]@^=3]'1"G/ZY$5==+@U@;">];&L47%RMORR6I5)HH@3CD',@
MM#1NDBQ9XJ2U)(!10H/UB=9.'7F"G$X(,_\8"*LEE;8 ]MXO\=XO[[UI,V'D
MUN@,R@;021*9>>F4$AWQ4J UP"B:G7AF6/62APYD=0*<_8<#7!4I-0"\^VUZ
M'ARC""D%)0+15I1"3!V(M8X2!RIK:[2NWP'[:8HZP<W]8\"MHFR:0]K!\Z-0
M/TLF*6&I]..4&7!7^)4W0EMT<AB-M3.GNE'6+=I+_Q&A5T58#4#P\0&6%^L7
M?KG\@1[19G,39ZD.-%J2/2]\ TF<Y>C_&!5PPTRG5-V@ZT)8-P#^@[PWU!?5
MR?C[!LNPJ!$3^=MB^7<D_87_.EW[V<2D)(1-0,![3Z0J60@Z48);TCH$G3W;
MTW0'@A[W/[<;3'[RIX"^_&Q &7TH2<QS2#>9ZA<Q7EU>;=IC7+='G%C@(@+J
MT^PMJE>'9J1+WA$=@6I-@V>^=BK0\U1UP]<_R!- 92&-JH-N]O06UMNJ\%).
M-Z%(8F92E GB>&J,MWB%:R ^>B54<#3YVH'_>P1T@],_2)#_=-8?CQRW1<X<
M/A>TUD).N9#?+Q??I@G2;S_^NH+T>G[;</^ZO]045A/&L]:1*;R/72YI49Q8
M4)[@O^89QXLZJ=J-\;I3UPUS/WGD?V"A501DQ?8,5Y>7?OECD3]./\^GJ)_+
M2+@'L\IOBLH6N3!FS\3T\YW6:>5G/:JHAB2G=Z.(<[&JWK2V0R/G96:&91^V
M'9UEP&O8^<P(YUP()Y6+HK;#=IB:OCKV)7Q=K$JOODTOE8D/AAN/UH6AN1S)
MTJ/%HG5A)(]*9\U2JMZ;^!X%H\]9JR'U?9W8@\D-> [EJ$W 6;P&%,6+H%35
MXG5 @K6)^*0-DS90":PR,,JZXV9Y#P2'HQG:" B>#Y  5RFKZ$@T,1 I#9H0
MBFFB\3JF@@LC>.WX?;U8UF"=6@>$45V1-("S^S?\V\4\;@==3F1Y>P#MB>/!
MX7FQEKAR?'2R60K#I?2UNSP=HF7<7J<#H:D*XQL T".&X_VM7>R;D3N_.0G4
M!!IL(,([C5=S&=FQ[4T<M2OU-6"J3['L0_ X.65G4&SG$>'I>%VL_:P!G_)F
M&KG?&42.'CCZW/EJ]F;Z#59G\R>[DW)>7_)$%@WO1]KDHT]<D2 !;V9!#;$.
M]:P4*8 R-*90VZ0>SH^\ZYQSP^_WLR*6':9OR];P HG!@256E,E(UI7F3]J2
M9*5 @\1ZI8=K??0T;<WZGL<@Y7!+HXJ":>">/[B;WWY\PH_8U/R# )9<R5%Q
MSA*9I2.>,T5RHMZADT5=]:?U#F2-7/4^"!X>5A=4%4[+>"L;NB[YYEH8'V@F
M0D9))!.46 Z11!U!6A^3K)XRV8&L<?%6'0I=H7:B7,:N9-FVE8-E&6&XR.L_
MD,G7I?]"&,.-0M<=-IZ\Y 2=L4@L$S9DZVQFW2KC#R[1*%).E>2B.EO'!@=^
MPF)9?N''+7.N=Z&U<-FQTO50E"<[E_$(95393&B0B?('#>H/@./@$N.&8@<%
M1QVV-G!)O;I:SJ?KTG1_GEY-OY>O5M<[H6"HM4D36B;ARN@C<=$RX@P3$13C
M9K_FK??==)B:<>.Q0V&ILA0:P--!3KVYS17PFMDD=2":1=R1!%T*$'@9Z<6R
M5M;%ZJTGGZ=JY.9 HYK8IXFF9;#=A&HR3(P&G[33Q$!I'1UT)"%*17RVTGAG
M9:B>HMB!K$;MIA.1T!5H)XJEP2;'W0**;_VRI#!]@\%#J@]6.D_$].D-#A\0
M==S%&%D@WMM-/I@@^ 40ZGQ"IU!*%6IWNZD?$-T8E&^ORFW_+O_%_Y_%\K:K
M[NOY:HUV09'<ZF_3]9=''W!O<D4FEC)IM-0DE/%:4CN!+HFTA 7I@$>:6?"=
M+/H*Q#0;&3T&,O=,_G-+J('[]69RUK8DWC+J35*2Q.+Q2D\]<LY;H@U3+I8'
M.E;[L-TCH-G,GE,@U9_%#>#CP,!2O!/FGV$;L7M\;/LK/UUNDDUV1K7__OTK
ME-?9E].2!CQ/99 @,L1$3PT0H3PR))M,G,J.H"M=&O!Z[ZMG3@Z^J693B_K@
MN"TH-&@QWN[S+^#+D,--ZY$>=N&3G]?7^NM.;"4;[W;!NRF0=[@TPKL4?"!)
MX-4I#8O$6<-(]L:"DS*X_3K$_H&H)^CI'7+;0?R#:937#$_OYA_*#)G2/!!_
MX>UBOKSYZZ8.8QL-2"Q)&C:N&5X2TJ5$'-.&!,YTMAQD5+5OY&K$CVL@5L/;
M@TC>*,)MP!:XW?AO/W:4QJLE_-<5S../S:M=,B"<MN7!KE1#>Y>)Y=D0!R''
M,K,\N-H9F1W(:@2)YP7,(=A6DEY+@'QL0]<Q>V? <<4I<:D,& Z"(K>2)$(R
M9X.E,E [%" /D]4((&M!X1#4*LFE4:BM;D_LS<.@<")XI4@$)HFTRI.0HB/)
MZAR3+ND,M0/17>AJ!&RUP- !;+TDTQ+:?OMQ^^7_G,(2B?KRXPU\@]GFC :G
MF;**XO$L9U0K2:P%B;<#35QX8(;6;LK<C;)QXSC-W;>U9-@2,G=/V\/]W3R8
M.Z"NN/&@DR.22DN\Y8)XKZ/%0ZAH]0K\HPAL1#-61$@7Y5A%7"UA\?7\Z]5Z
MM>$8N\FI\#08))A$#7BC>*/Q;G&&@$V>*B,I2X-=Q0_):01G]4%P"&X])=(H
MN/CM["YDAC:.&)L$D;+4:F>\(!R3>#S!)UH]I?<)<AJY;$<!URD2:11<XGHK
M7HL0I.$D:5OJ.DHS'H[>%UX"60CD'X/!(GX/R1GW)6-<<)TBD9; U</\?7.;
M):2"!\$CD,0$$)DR6A\@%'&1148#U6T&H-\<E?4W/(#;<$7.CH@&CL-VSX^\
M!MR5)9OLLJ"99!Z1M7+S/$H5H=%P9JSTT=4.$3Y+5",6X_D!LQA2>@W \?$&
M'8]L$ UFQ24MZ>4VH_.7>"!6,D>H X,\5%3(VH-5.Q,W<NY775!T:J'25T(-
MYBN\7\)7/TTE%6.^@G+*WZV_P/+%ML?'ELD]TA>.^?B^V0PG;Z52<L/]]6^6
MWZY[0\0--J.(0C.N41UZ5V8"*O154B9,&&T2:$_WA]G6Z"[?E;Q^$[>VZWQ
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M#))'EBWGWE4_FGUI'!>50V&E2]*VEN#. )@W#Z$(\2)'4D8!EQY0BB?<EHC
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M%"=.,>><LN ]->B\< G6E2)N&HW+5@EO!VO<6GLSG8"OGRGPVX#(<SXKUQ$
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M)DL@:"]Y+HFDJC;NNU$V[K4_*G@>UQW5EV3%M'F]T.H-SW_!^RI/5Z7.X(B
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MQ0Z.*-PJ812MXQR!4F6XCTEK=R"D>M$Q;K3X9& ;3C8MWJ3K 723K,J 8)^
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M;A3O),@YA.D-3LP\."3U^J]P<151,\]6TUAX,?V6/J9PM3BV(?S %(T6PSN
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M+R[G5[/5A!@J*,TE9T\#""-8&5>&_I://C#AM!"UG88JA+?H6@R-N;K /P
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M?4TX=.5K6Y! -7;A9AN"?[W\6B:LX ;\]&*Z^E['=CMLQ?%J RJ!HA]GV_'
M:IIX>SX[7@%!!2>L35MO"X&5_>C'G^TDQ*9B74_SJ*&LP#PMT2_\D/Y[-5W<
MZI4Z2KG',IV$W%3HJS\/6ZT">O]MJ J@AU^N4OVSA]@*E3_OW?<_R@Q)]+8N
MW2RDVH4_7;Y_Q+E&YAQ?ZW/[D=$2KCVD</]$/M[]V FAV_[\J"8^SQ??CRX=
MV?[%\<3TF-_SCIL?.Y!\<?&8O&FJ5$2R^\/C55_M%<6\'U]&%MW[-*\@I[NO
MC%E3\C2OYWLV/GZ1#Y+TMHHX'G]KO+?0/86R@PD_:Q5/>=/\K$_\69_83S;Q
M_WV:K_WQ8X_'PR^-5D:U[W1LW>S8 KBXN"6KSM%X_+GQKO6M[)YWV?O80OG\
M>;5^M31;SOYP>'@_7EU>7L>MEJO9)W_Q9KYX\?7"7_Q[44-FO5<;TU+;);%Y
M!?8U(/9",VYQ^?%;>+E<59+NUH^.:=EU%.(^9HSM_-26T\$R&N:@/<7]>3=6
M-"*E]XM%=4$]_N9XY^D 6>U@R-A1NO^NOK_X<Q&7A<0*HMKVO?$Z+'=2>WM8
MT(IP!C9'^JPS7AQOCYBV2?-L;) '&WO]5[CXC!;4AZ^+5?QQ"[5/:+?EQGND
MV5/FO3DXLNC_O7@]BV]*NXMW^783_UC,"N$OORWBOQ<EEQYGGU_,XC]GWY:K
M6 $ !R_:QM'O)]]Y/6:/C)7B7OW_]JZHM6T8"+_OUW1E>QVD35L"I0YM*.S1
MM9W$H-A%EK/UWT]R'#=V9$F6+MP-^E)*"Y_NOD\^RZ<[:5&T]@\M'?HC%QN_
M.<3[W']4&D'#>[8$TXT\75ZE@YNYT,YWZ8?\=S?M :;)]-'0%H4PT\.;7CI1
M9%9%Z]:-:-W,X,X-X-GA/2A:FR=X#/$B&[N,^6CXP=XB/7]O'@+?/4L;WV[+
M(JWF7/X"-7. 3$!K+(691[!"(,^J^3Y-JXA'8LOOI(75,HV*SILGH?[^IWI>
MLT2YM1),$:0N]H":4A#CHS6WPLPG0 FP+\7)8E47%[R5>8J#]M(Q;61J',5.
M]+;6PM1*GZ/A55N$E5]2:SNY+5\REB4B2]LY%-QQHD?$V__WT\O("W9YF30E
M[6JQHO4Z3R3N?0'SK-G1\4*@GY;.?&''S"SC#[RLWQ=550,J:L)%6_OZQE$[
M1]@1=:O.[D\[0Z%4-.&BK3A]HZN=(_1GL5R5(F80[7M#++134KR?.2T7^ K-
M$E''C'TLXSP%$DH'B78>BK]>!F:P:ZK4EKNTL/EJ! J-8YAHQYQX"F?A!GO9
M>2SHG^TW8+%Q%!3OA!+?5::%'D+J-9:=1 A($778>,>+ &AI((M"*.U,!0^H
MH\AX!X.$Q%4;4>AU/G4N/M35)@<JY>?-KKG";9ZOI3&9]!9*W8E#X9T3XBFW
M'Y78GXV#,/-:-2^1YO*W;<DDR\\"ZDMRVE!X1XQXY^Y\J"2G_U,F%D52[H!R
MZ$X#X)TT J;U.&WD%#Y+,E]*:<- 3HJ3RAUYT(BLO";\*,_;Y!>,Z*YC..E-
M*?LTD3QR#WDDMAF_\/.M'\-):DJ)JXGD83_5\5O-8OZ85P)PJWL<U4E.2NDL
M*T'8 IY'EM!,R BD4[4"I626F1KTS/\Q^,,+:,-V4I)2*LN1+$1)C_>3=POW
MQ[(RU6OY7 /?QW82D4H"RT@/^FIGL/(.??RT@$YR44I F6C!/J%6+:B41T""
MZ?"<]**4,#*00B'%#W*KV2F0DT"4LCPZ&M 7(65PJ>01PTD/2CF8@?,TRKR#
MY9A:KWI-*4U"L$RU+![DPJ4U;)Y5"<^;;1B@.E4[O).(E!(@[I2AOY?27-D5
MLQ]7U_M/[Z"VGVWH3LI2RH4X$X;]6BNJXJ98"]5"!%9_/(+IU!- *2MB(0>]
M@N"S^PNN5$"/Z20=I32(A1RJMP\LBBJ79*YXW-P\R;FJFU:W*@PR (%7$1B&
M ;F7P-4-@$L*SH8ZFQ:>A_V.PH9DH#NX&W633?CU!%I Q)-P;5KT<LX&,K!W
M"CK3@GM)!U!HVAC9UJI"J+MTQI@FEL <ESL.3$ KP\FY5D*^3E['>H:^3F'_
M.H5]6D9+<+;*^*Z*UBN>ROD%LYHWP*(]0]/6"'9BT%<*RBJ(FQO[2&C]\U/7
M<!KWJ4BRRD7P\KH'A=8([RE*CP!D59YKEGV_>OOY7:UJTO)=9.D]BS=!\HQA
MHC6Y3]/)0@E^.O\2FAE@T;K:I\EF)X9$ &SL4DTPL8 (@CTXM(YVGT"H(X)0
M,%SQ72%@8^$))%HONW\H/">$5B0$$FP<%:V-/2@.DI/M^,' =_GA4GB@2#A$
MQ.M<]XF&(WR0T.KN[WO.(:4: .+UI?LHI6>#A%#S^F 8@$0=%%Z7N8\X0P9(
MR/*2)37/19Y5L\UFMH]S%MS?8,#%ZQ/W$<S(S?^Q';PL69Y(!Y:\3"ZX'=P;
MY@+;P>-N@&\'GPYU-D< ]H7U^$&;)BU\>@H-]>UM1R>R=6S4K;_3XL@7^F:8
MSLZG4K2FPN3[W4<ADOX/U-G W^4C>OL/]>,MKK)?W_X!4$L#!!0    ( -"!
M>UK?'%"6\Q\   ['   >    97AH:6)I=#$Y,2UI;G-I9&5R=')A9&EN9W N
M:'1M[3W;<MLXEN_[%=Q,[8Q3):LC7^,DDRI/DIY)U73'&[LGM4];$ E):%,$
MFR"MJ+]^SP4 08JRY+0FHK<\#SVQ38+ P;E?W\S*>?KVS4R*Y.U_O/G/P\/H
MO8ZKN<S**"ZD*&42549ET^A+(LUM='AHGWJG\V6AIK,R.GIQ=!I]T<6MNA/\
M]U*5J7SKUGGS __\Y@?ZR)NQ3I9OWR3J+E+)7Y^IT?'Y.)F()#X='9\<G9^.
MC^1H'$].SH[EZ=')Z/Q_1\_@57B<WS'E,I5_?397V>%,XO=?G9T/SU[FY>N%
M2LK9J]&+%__UK/%H*;^6AR)5T^P5;1C^.M%P//OG6*>Z>/6G%_2_U_B7PXF8
MJW3YZB\W:BY-]+-<1)_U7&1_&1B1F4,C"S7A!XWZ7;X:C>#C].."-W0.ZZ0J
MDVZ#O*4/7V=JK,IH=#$<O?D!GW?'6CV<**9POE+GKXZ'%Z>P?"Z2!"[A,)43
M6&]T-KP(?EGP5^QO@^/& 'U9\&]4EL!/KPZ/SX?'L.+.@7"T 0A'HW, PKO+
MGZY.HIM_?/A\>?7AEYN/[ZZC=Y\^7WWZ?'GS\=//T<>?KS^^__ YNOE\^?[C
MSW^/KC[]\^.[_VE"*X!3 RJG*Q Y&QZ=.H#8XQ^??8>CG[3O_PCO?S1TY_C^
M7V_BS]&1@THB8UV(4NGL504 *O"]9V^OJB+71NYON\_>#J.;F3+1Q\PHV%9T
M4PC<?G2E4Q4OHX,2__CG/[T\.GKQ>H]0O0^&M--]@I# ,WK]/,H+?0=0--&T
M@O_#!TVT4.4L*J3)95Q&I8[* KXD8CR%B506E3,9&1E7A2H5/*XGD:7<F2Q$
M+JM2Q09$ . )'QVO1/;[1M[I>2ZR?ER)R!("\0S^D2)B X!CG4T4,BDE4KB"
MB2[F#%HQUE5)C]LC^-=C^EFY^US,5#QK/)AH^-L8Y;<T!FG*_PFW,CI_;:*_
M:5$D^/WWJ@!DT(5Y!'=)F^[%3<Z$B42B<]23B"M9%@4T!70WUR7?4JI$%DN^
MIE^&U\-H(N$P<-%XE:8$-2LDMU0L#*PF2ER#M898%J4 PLQE89!&%S,=B4)&
M8H'_A>L#9(&CP(J9SO)J#)OH0")A468936!S?_[3Z<O7T8%ZCN1/_!4^T*1Z
MVD3L4.;TXG6D"WA#.:Z"+YD*L&[#YP$<&K"J:.Q_+I;T9=@_<YRQ,*K^;/#^
M /<PUUFZC&XSO8#C>/9?JCR'70SMC8#(B%#6\5L .&5HZ9ROA=:NZ0.V1;>S
MY)L1*5Q(#I<5BW&Z>B.+F<QJ3LG@4B5L>!&";;A670G4.D*S#>K+T='PK#_J
MR]'C45\LBEU7XU^=>*LILP=:C641A&FP..P/$2]Q_'< 6#I10/"&N(,$_-1+
MZ>BQ*040_4PU!BU)B6*7R/=R..H/[C6@EAH=@JZAN8R7-4\CMN2!:N5=#5O[
MBR:(W2_Y%-%<SL=X#<BL0%D"Z<Q\ FYASMR06"%<ALYD)%,CZ=%4W4FG1:DB
MFNG*R)E.$_\*O]/UE40# RUIA8X%0)27^!A\IZVP.:2XKGG6 3#)1$X FO"B
M3/7B.4D,!@G^;DD'08Z.OS<AN>!G@?^FE42Q!4^ =E(6.HT."*RP<@[O9,C\
MX&\SE2;P$YT 'C156M: @F\#'Y?X;\?N._?[G,&#]W&@[IX[Z)1%94J@"?LC
M?+;, %HSE3-Y& 6_%T6$BA,=V^XT;9T0OL6R!V!BXD*-X>^PCS@5 %R#&'/(
M-W,0X\L V3N9+@?]UH,^D4Q]I^]D <>QC*\/>M&P5B?7LC-$.C1!8,L*Q2U@
M29N:H\X#TCKX-&L(*(GYFB<AH]\9*SP?]LB+<!,* &2%J$0E$I0O@(-DQ:FI
M:1E@'\@Z6A3NX32('$D3Y0BV 9CDD9(%4CE2]DP 4Q)Q#*8$+G&_QC>,+F&'
MM')+\5,@ZV SP.;41'DBI4-9+?D3XTN#@0&I7DO"B^BT=='/=Z=QC88O>W37
MQX]&Y;H)R?81Z5U=;H^V@5QK]F!/9'%:)9;AK#S)-@H<3L>WP/5R7A8MP:J(
MP5"4K2> ^96%(EE,OXFJ3+%$1>IFLBF7.9EW=A=+IO!0#40&H(RIY*.27*OR
MOP]B:^"@/A-9$SD(["BQY-<<[LV *B*_(C+ Y:$MW3#^!6)-B2(*="!83ZIL
M9SSJHG;R[Y]#G3P:#O4Q Y"KI )Y]=GI'"H%@MHO7W(:3;=H9I$KX3>Q=16E
M<@K_TB!MI\*SE[E0&3F'V"=8NQ&17P#OV,*9R&:'S*9BRH;'9O-B 5H_/9MK
M QJTP=4W^J&&T0<!*H&J;P,.VU8"Y^*6_4J%56AF9(*8F?.E.8=G0XMAIRA2
M:=:M-W993BN&3[@@:!_*Q!6<+D&XW<D!JUQK-S$D[Q/H-S$P>Q 7".:B@6UT
M/J>NX2$7,TE;!7[3!,H# 4O"Q.^(O&=N-08-734K4-;;AJ94RZ<P6*>*-622
M4^'QM\[ 1AEG*M 5VRA\ '^CUQ;*R.?LD49<@_/AB@N07JAH@O%6E=+BMTCN
M%)N="E50](X"?-9RT%8<&,!&[K]7A81701BNC0R/=5GJ^:L7]2MB;'0*&UEY
MA1G$VS?CXFU7\);_.ROJR.14'HX+*6X/Q03N[95(X:3FV8YCV&OW\P?ERY[$
M24 !)%,!"2W9$">_QS>[D9/&'4:0D<@>+,[E,A,IK8?4@H2OX&.9*#S9!(8*
M>6\L30#V)E5<N^J=25-_6]^W<^8SWB5!CAHDCCGZ3(!3")7:TU/ 2+*CWNIV
M[^#$\C=RTI![\%]*IRP7G#]\5VK'Z?"T1Y;1Z:/1.RX39/2@YS.7;EJN^[:)
M )EG2DZB'P'/LQAE2\#O ]O=.G 04Q4A*_ A40:V.ZWRX2M@-O);OPK9^K _
ME)SH:[,.!8*$\P^N>YGH8HTT(D\12C!.5# ML++ PU@6'J'0*7S>N1U6'$ZP
MC+COCG;G7'C1IW#.V:.AH&N,CE(^&EQ,'^CFTBL]WK6)]%)K1<TP#6HQK2@-
M*46U/E7[I1U=B75R[#EYXN#';>.^K .APT*O> U0#>.CI+S-S/]4S@I=36?=
M_E>*L6Q#%F=MJKCH$BP7;<%R.'JY-[H@L7FV3Z=),]7O>$BP>(AE-D#/A,Q+
MQ"*O>4>8ZL,.5S(4:^UD1;GPH?6&5^]G0)9NSYZ+O"/3M6]^KH"]CEZ,3P]'
MT54J,F.?H1#/-IASVI'VV($\1V>K#MLG[%G!'B!J/0<62H:^C59:^<E^213W
M(B5^@KAD0BM?9ARZ6YMM<KC*=AYRSUM<\\6*Y'RZY)5+1I,E10?'YE2<.A8#
M9-SP>EL?R:]Z;%PLN@ #0W'\=HXODT]J-4&')1IBEJY*"I6W70M5EF+H2+BX
MD-TP>GF E\QM8%C$H 0D=;94EZ.=DGD0.PLPW0KOCP?\D 58<>'*F+EHC];&
M3]CR5D*,,B&:*'K2);3.Z9=/2&F1\IR (8P!S=JG2) 82URHA9QJ9%[?,;>!
MW]\Y$_9;]/#3X<O-BOBH3ZDMC70U.FZ^$J5Z8&K?-KF@82@+WJQ,J>?.[*,/
M%RWRW;?:Z_15GT#2S$Q<B=4!MRE52CL*835&20A_M6#$3:([,DIU-I6%A_26
M1M_PQ8J2<G[6P1J.3_?)&L[[8^J%P.FV]MYCO%\Y^O_)8?[/'O,_UK>Y5S/P
MV]P")Z,. ZA';H'S87_*5$;']Z.*1XZ^H$2X$>0KZ._"\A7I[2+'7YS)I(AG
ML@(DB%=BN@V>*56W,E4SK5U0"W0= >R27,@JNY,&@RX+\FJ[[ZQP.S7/=8$K
MDD.9HVH"&&ZLC-4$QQ4H9I1:B*Q?DKO.)S(WSB._YIPVB";$9$(\NBM;@A(9
M\@+$P\ 'MSB\<D=V1B:G%)09!(E) : \!P:2C\9$(8<(:DR2SQ(L59!?%4:Z
MR/W.\3$XE7M-E39-'=!EAD[$X \(Y+' 8!X*S<R^[3Q+&+:S(FP"&@F' 6)5
MQ-4</QW;P(">E)(N5]Z)M').4(F BME+):IRIIWUY#38L<R L=&'0.-.#)YK
M=RSD9'C2'Q;RA>+"E+=%^$;AT%).=6%K"KPZHYKD@N(=0Y[HF^5 Y$2GJ5[0
M*ABG!<D-MR] X>"%&E8-);ZA+0"J!N;S.]QB$X&5BYK\NAQ8:T-J3Z'&#:'&
M;2#7K&G=QK<#LJA?OIV+LY.C_EE836]O: _GA9YBKA*R73 16/-MJNEU[AI\
MC;),2B20AGU0+VK$1):<,2+1 A#Q<FM/SV,QHWMWR0B+$C[ A9N</W(G4YT[
MR97!=^&J,0AM6,(NR)4?<R3X#_GBGFYHRQM"&U8A263H,9MBTHHNEN%5/>@B
M5IW?3S>QY4T *?PJ;= "J&-2E>@'E*+(*+8!!))27A6Y+-D3,?'Q;RR11F5O
MUX&*D^.>N;![=W6$Q_%,9%-V>N6%O%.ZPD1;D66Z@DM).BZ*;A$%6FC5F,KD
M&.WX _=ZUN';>:+!;6E08#H5J0R8&5AHS-( VTX64TKLB'^KE+%.'K@]21%(
M#49E\<0C]W@_K7M)E''&"AG(42CCT'@NGVYKC[<5WL:O6L%_[P"$%/,"$:=B
MF1FVG ODJ:B!/&F"W^>V7 B$ZGM *Z\*>.@!P'^YC48Q>CD\>S*/MPA 1JQ4
MH N4LHM1,<AMGJ!5'%)1I_X)Z\(T>8K^.LK,)]%DV[2X:)T(7:4/L8*?&.$W
MD]989+?16!<%.07-B@*/?H\@9^E)/'T?YP2F7IA2C%-E9MZ=#MS/IQ>1(TK,
MR7FQFJ_V=$W?22[5C! ^(!ZN$SP!_]N=$K4"5\ZHK6;64N% VMB:/F_2@OZ
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MCR<PT4?$\4,[8MM@O#4X [E1,%:#F""U$+5*<3-8UIYIWUEIY(;#8BR8.>C
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M4G# "N?F"I_ ;!X#EQJ]&$1'+XY.^N];_&&LDR7\WZR<IV__#U!+ P04
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M\?'1B+2GF(\0Y"LGSN4NY,TMK-=V^[W_DX-MK]O6M?HFZ.AOD1]02P,$%
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M+S-EZ'?MCOU%9RQ6OHU96M>8#>%#,+/(%X>L-.+1IWV7=(_>8?T74$L#!!0
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MY,-0"&**$ Y -%K0%+$!9P";4@+,BXXIHP\FIS-=$:$M7_!TL3ID>1$8R_K
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MUC470Z@/9A;YZI"-1CSZM"^+'N%+JO\"4$L#!!0    ( -"!>UJ4"W/TRP0
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M#30\!951F!&Q("65UO0^IRL8Q4I+-#1M(U^6"142:XH6>)JRF J]8#QZ=QG
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MY?3YB9H\E2\F\OG+/)].9^7)Y G\D/_OD^>/X%D8SP^Y=E.IOSVJ=7.T4$C
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M0J+CXA:%>R?:0BP<I0Z3 7N"*$V3J$K#0+2'I:KD!C&2,X4FW4,] %27JD%
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MHS9R$'5&3F<<O^&ETHR2>7SG\+Z'-G?O7YB!2"QV4JQTJEYJN%D?^$'B$^L
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MDU.JG3H:G"&1\IV[?$C<S(%_QC<'Q$W>0B!'I8I:.Y*;">WX&T1&6$X[ZDL
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MSOTR<X_YM;R/Z77 _P102P$"% ,4    " #0@7M:VR)3!&G- P A,AP $0
M            @ $     8V%M<"TR,#(T,3(S,2YH=&U02P$"% ,4    " #0
M@7M:JB*/(&H5  ";^P  $0              @ &8S0, 8V%M<"TR,#(T,3(S
M,2YX<V102P$"% ,4    " #0@7M:-C$O>@4=  !P%P$ %0
M@ $QXP, 8V%M<"TR,#(T,3(S,5]C86PN>&UL4$L! A0#%     @ T(%[6E,!
MPP=N3P  Y+,# !4              ( !:0 $ &-A;7 M,C R-#$R,S%?9&5F
M+GAM;%!+ 0(4 Q0    ( -"!>UIS>KT==K % +O@!@ 4              "
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M2P$"% ,4    " #0@7M:=^9.J^S, 0"_8@( %               @ $@$AX
M8V%M<"TR,#(T,3(S,5]G,BYJ<&=02P$"% ,4    " #0@7M:T!,1G@TB 0"Q
M. $ %               @ $^WQ\ 8V%M<"TR,#(T,3(S,5]G,RYJ<&=02P$"
M% ,4    " #0@7M:QQJ]>^!  0#?:0$ %               @ %] 2$ 8V%M
M<"TR,#(T,3(S,5]G-"YJ<&=02P$"% ,4    " #0@7M:!D$)5#_2  #OZ
M%               @ &/0B( 8V%M<"TR,#(T,3(S,5]G-2YJ<&=02P$"% ,4
M    " #0@7M:[=QOE@3X  #\$0$ %               @ $ %2, 8V%M<"TR
M,#(T,3(S,5]G-BYJ<&=02P$"% ,4    " #0@7M:K-FK=^@X 0!B=@$ %
M            @ $V#20 8V%M<"TR,#(T,3(S,5]G-RYJ<&=02P$"% ,4
M" #0@7M:'P_<RH#-  #HVP  %               @ %01B4 8V%M<"TR,#(T
M,3(S,5]G."YJ<&=02P$"% ,4    " #0@7M:X$T&[6(0!@ $U08 %
M        @ $"%"8 8V%M<"TR,#(T,3(S,5]G.2YJ<&=02P$"% ,4    " #0
M@7M:/;9!;FT: 0#"^ H %0              @ &6)"P 8V%M<"TR,#(T,3(S
M,5]L86(N>&UL4$L! A0#%     @ T(%[6HR^(CU8IP  M?T' !4
M     ( !-C\M &-A;7 M,C R-#$R,S%?<')E+GAM;%!+ 0(4 Q0    ( -"!
M>UK?'%"6\Q\   ['   >              "  <'F+0!E>&AI8FET,3DQ+6EN
M<VED97)T<F%D:6YG<"YH=&U02P$"% ,4    " #0@7M:1R?.EJL#  "2#
M%@              @ 'P!BX 97AH:6)I=#(S,2UC;VYS96YT+FAT;5!+ 0(4
M Q0    ( -"!>UJ#VP0(D@@  ,HJ   ;              "  <\*+@!E>&AI
M8FET,S$Q8V5R=&EF:6-A=&EO;BYH=&U02P$"% ,4    " #0@7M:JH%0?8((
M  "K*@  &P              @ &:$RX 97AH:6)I=#,Q,F-E<G1I9FEC871I
M;VXN:'1M4$L! A0#%     @ T(%[6I0+<_3+!   _!,  !L
M ( !51PN &5X:&EB:70S,C%C97)T:69I8V%T:6]N+FAT;5!+ 0(4 Q0    (
M -"!>UH;F!BQVP0  *D4   ;              "  5DA+@!E>&AI8FET,S(R
M8V5R=&EF:6-A=&EO;BYH=&U02P$"% ,4    " #0@7M:S6KW'PL4   56
M'@              @ %M)BX 97AH:6)I=#0Q+61E<V-R:7!T:6]N;V9R96<N
9:'1M4$L%!@     = !T L0<  +0Z+@    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>camp-20241231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:camp="http://camp4tx.com/20241231"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="camp-20241231.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
        </entity>
        <period>
            <instant>2025-03-13</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-15</startDate>
            <endDate>2024-10-15</endDate>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-15</instant>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-01</endDate>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-01</endDate>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-15</startDate>
            <endDate>2024-10-15</endDate>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
        </entity>
        <period>
            <instant>2024-10-15</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
        </entity>
        <period>
            <startDate>2024-10-03</startDate>
            <endDate>2024-10-03</endDate>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">camp:ComputerAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">camp:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">camp:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">camp:ComputerAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">camp:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">camp:OfficeAndLaboratorySpaceInCambridgeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">camp:OfficeAndLaboratorySpaceInBoulderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">camp:OfficeAndLaboratorySpaceInCambridgeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">camp:OfficeAndLaboratorySpaceInBoulderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-01</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:ChildrenMedicalCenterCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="camp:MilestoneTargetsAxis">camp:UponAchievementOfFirstLicensedTargetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:ChildrenMedicalCenterCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-04-30</instant>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="camp:MilestoneTargetsAxis">camp:UponAchievementOfSecondLicensedTargetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:ChildrenMedicalCenterCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-04-30</instant>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="camp:MilestoneTargetsAxis">camp:UponAchievementOfThirdLicensedTargetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:ChildrenMedicalCenterCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-04-30</instant>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:TheWhiteheadInstituteForBiomedicalResearchMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:TheWhiteheadInstituteForBiomedicalResearchMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:TheWhiteheadInstituteForBiomedicalResearchMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:FulcrumTherapeuticsInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:FulcrumTherapeuticsInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">camp:TierOneProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:FulcrumTherapeuticsInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">camp:TierOneProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:FulcrumTherapeuticsInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:FulcrumTherapeuticsInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:FulcrumTherapeuticsInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:EliLillyAndCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:EliLillyAndCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:EliLillyAndCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:BioMarinPharmaceuticalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:BioMarinPharmaceuticalInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-26</instant>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:BioMarinPharmaceuticalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-26</startDate>
            <endDate>2024-09-26</endDate>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:BioMarinPharmaceuticalInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-26</startDate>
            <endDate>2024-09-26</endDate>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:BioMarinPharmaceuticalInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-26</startDate>
            <endDate>2024-09-26</endDate>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:BioMarinPharmaceuticalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:BioMarinPharmaceuticalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:BioMarinPharmaceuticalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:TheWhiteheadInstituteForBiomedicalResearchMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:TheWhiteheadInstituteForBiomedicalResearchMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:EliLillyAndCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:ChildrenMedicalCenterCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-04-30</instant>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">camp:MarauderTherapeuticsInc2016StockOptionAndGrantPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-31</endDate>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">camp:A2024EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-31</endDate>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">camp:A2024EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-31</endDate>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">camp:A2024EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-31</instant>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">camp:A2024EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-31</instant>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-31</endDate>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:CertainExecutivesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:CertainExecutivesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">camp:CertainExecutivesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">camp:RDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">camp:RDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">camp:ConsultingAgreementsWithFoundersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-09-01</startDate>
            <endDate>2015-09-30</endDate>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">camp:ConsultingAgreementsWithFoundersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">camp:ConsultingAgreementsWithFoundersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">camp:ConsultingAgreementsWithFoundersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">camp:ConsultingAgreementsWithFoundersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">camp:ConsultingAgreementsWithExecutiveConsultantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">camp:ConsultingAgreementsWithExecutiveConsultantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">camp:ConsultingAgreementsWithExecutiveConsultantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">camp:ConsultingAgreementsWithExecutiveConsultantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001736730</identifier>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="majorfinancialinstitution">
        <measure>camp:majorFinancialInstitution</measure>
    </unit>
    <unit id="sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="performanceobligation">
        <measure>camp:performanceObligation</measure>
    </unit>
    <unit id="vote">
        <measure>camp:vote</measure>
    </unit>
    <unit id="segment">
        <measure>camp:segment</measure>
    </unit>
    <unit id="founder">
        <measure>camp:founder</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-35">0001736730</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-36">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag contextRef="c-1" id="f-37">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-38">2024</dei:DocumentFiscalYearFocus>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 contextRef="c-32" decimals="5" id="f-278" unitRef="number">0.08916</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <camp:CollaborativeArrangementUpfrontLicenseIssuanceFeePayment contextRef="c-78" decimals="-5" id="f-486" unitRef="usd">0</camp:CollaborativeArrangementUpfrontLicenseIssuanceFeePayment>
    <camp:CollaborativeArrangementFeesIncurredDuringPeriod contextRef="c-79" decimals="-5" id="f-487" unitRef="usd">0</camp:CollaborativeArrangementFeesIncurredDuringPeriod>
    <us-gaap:UnbilledContractsReceivable contextRef="c-80" decimals="-5" id="f-488" unitRef="usd">0</us-gaap:UnbilledContractsReceivable>
    <camp:CollaborativeArrangementTieredRoyaltiesPayableOnNetSalesMaximumLowerRangePercent contextRef="c-60" decimals="2" id="f-489" unitRef="number">0.01</camp:CollaborativeArrangementTieredRoyaltiesPayableOnNetSalesMaximumLowerRangePercent>
    <camp:PercentageOfUpfrontPaymentRequiredUponFirstInvestigationalNewDrugStudy contextRef="c-81" decimals="2" id="f-490" unitRef="number">0.10</camp:PercentageOfUpfrontPaymentRequiredUponFirstInvestigationalNewDrugStudy>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c-1"
      decimals="INF"
      id="f-676"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <dei:DocumentType contextRef="c-1" id="f-1">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="c-1" id="f-2">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2024-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-4">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-5">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-6">001-42365</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-7">CAMP4 Therapeutics Corporation</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-8">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-9">81-1152476</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-10">One Kendall Square</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-11">Building 1400 West</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="c-1" id="f-12">3rd Floor</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-13">Cambridge</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-14">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-15">02139</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-16">617</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-17">651-8867</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-18">Common stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-19">CAMP</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-20">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c-1" id="f-21">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c-1" id="f-22">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-23">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-24">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-25">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-26">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-27">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c-1" id="f-28">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag contextRef="c-1" id="f-29">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c-1" id="f-30">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="c-1" id="f-31">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="c-2" decimals="INF" id="f-32" unitRef="usd">0</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-33" unitRef="shares">20161072</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="c-1" id="f-34">Portions of the registrant&#x2019;s definitive proxy statement for its 2025 annual meeting of stockholders (the &#x201c;2025 Proxy Statement&#x201d;) are incorporated by reference into Part III of this Annual Report on Form 10-K. The 2025 Proxy Statement will be filed pursuant to Regulation 14A with the Securities and Exchange Commission not later than 120 days after the registrant&#x2019;s fiscal year ended December&#160;31, 2024.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock contextRef="c-1" id="f-39">&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have certain processes for assessing, identifying, and managing cybersecurity risks, which are built into our information technology function and are designed to help protect our information assets and operations from internal and external cyber threats, protect information belonging to our stakeholders from unauthorized access or attack, as well as secure our networks and systems. Such processes include physical, procedural, and technical safeguards, response plans, regular testing of our systems, and routine review of our policies and procedures to identify risks and adapt our practices. We engage certain external parties, including independent privacy assessors, computer security firms, and risk management and governance experts, to assist with assessing and managing our cybersecurity oversight functions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of the date of this Annual Report, we have not experienced any cybersecurity incidents that resulted in a material effect on our business strategy, results of operations, or financial condition, but we cannot provide assurance that we will not be materially affected in the future by such risks or any future material incidents. See Part I, Item 1A. &#x201c;Risk Factors&#x201d; in this Annual Report for additional information on cybersecurity risks we face.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock contextRef="c-1" id="f-40">We have certain processes for assessing, identifying, and managing cybersecurity risks, which are built into our information technology function and are designed to help protect our information assets and operations from internal and external cyber threats, protect information belonging to our stakeholders from unauthorized access or attack, as well as secure our networks and systems.</cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag contextRef="c-1" id="f-41">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag contextRef="c-1" id="f-42">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag contextRef="c-1" id="f-43">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag contextRef="c-1" id="f-44">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock contextRef="c-1" id="f-46">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Audit Committee of the board of directors is responsible for reviewing and assessing the integrity of our information technology systems, processes and data, and is charged with meeting periodically with management to review and assess our cyber and technology-related risks, including network security, information security, and data privacy and protection, our technologies, policies, processes, and practices for assessing, monitoring, managing and mitigation those risks, and the steps management has taken to identify, assess, monitor, manage and mitigate those risks, among other matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Chief Business Operations Officer oversees our company-wide cybersecurity strategy, policy, standards, and processes across relevant departments. The Chief Business Operations Officer has over 15 years of experience overseeing key operational activities in the life sciences industry and works closely with our experienced information technology consulting firm, which helps to assess and prepare us and our employees to maintain awareness of cybersecurity risks, including email, web, and data security. Our outside information technology consultants have extensive experience designing, implementing, and running information technology and cybersecurity programs and processes using the National Institute of Standards and Technology Framework.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To deter and detect cyber threats, we provide all employees with a data protection, cybersecurity and incident response and prevention training and compliance program, which covers timely and relevant topics, including social engineering, phishing, password protection, confidential data protection, asset use and mobile security, and educates employees on the importance of reporting all incidents immediately. To mitigate cybersecurity risks and bolster our employee-based cybersecurity programs, we monitor all user traffic and restrict access by country. In addition, access to web sites is filtered and monitored, and credentials for systems and services require multi-factor authentication whenever possible.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock contextRef="c-1" id="f-45">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Audit Committee of the board of directors is responsible for reviewing and assessing the integrity of our information technology systems, processes and data, and is charged with meeting periodically with management to review and assess our cyber and technology-related risks, including network security, information security, and data privacy and protection, our technologies, policies, processes, and practices for assessing, monitoring, managing and mitigation those risks, and the steps management has taken to identify, assess, monitor, manage and mitigate those risks, among other matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Chief Business Operations Officer oversees our company-wide cybersecurity strategy, policy, standards, and processes across relevant departments. The Chief Business Operations Officer has over 15 years of experience overseeing key operational activities in the life sciences industry and works closely with our experienced information technology consulting firm, which helps to assess and prepare us and our employees to maintain awareness of cybersecurity risks, including email, web, and data security. Our outside information technology consultants have extensive experience designing, implementing, and running information technology and cybersecurity programs and processes using the National Institute of Standards and Technology Framework.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To deter and detect cyber threats, we provide all employees with a data protection, cybersecurity and incident response and prevention training and compliance program, which covers timely and relevant topics, including social engineering, phishing, password protection, confidential data protection, asset use and mobile security, and educates employees on the importance of reporting all incidents immediately. To mitigate cybersecurity risks and bolster our employee-based cybersecurity programs, we monitor all user traffic and restrict access by country. In addition, access to web sites is filtered and monitored, and credentials for systems and services require multi-factor authentication whenever possible.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock contextRef="c-1" id="f-50">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Audit Committee of the board of directors is responsible for reviewing and assessing the integrity of our information technology systems, processes and data, and is charged with meeting periodically with management to review and assess our cyber and technology-related risks, including network security, information security, and data privacy and protection, our technologies, policies, processes, and practices for assessing, monitoring, managing and mitigation those risks, and the steps management has taken to identify, assess, monitor, manage and mitigate those risks, among other matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Chief Business Operations Officer oversees our company-wide cybersecurity strategy, policy, standards, and processes across relevant departments. The Chief Business Operations Officer has over 15 years of experience overseeing key operational activities in the life sciences industry and works closely with our experienced information technology consulting firm, which helps to assess and prepare us and our employees to maintain awareness of cybersecurity risks, including email, web, and data security. Our outside information technology consultants have extensive experience designing, implementing, and running information technology and cybersecurity programs and processes using the National Institute of Standards and Technology Framework.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskRoleOfManagementTextBlock contextRef="c-1" id="f-49">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Audit Committee of the board of directors is responsible for reviewing and assessing the integrity of our information technology systems, processes and data, and is charged with meeting periodically with management to review and assess our cyber and technology-related risks, including network security, information security, and data privacy and protection, our technologies, policies, processes, and practices for assessing, monitoring, managing and mitigation those risks, and the steps management has taken to identify, assess, monitor, manage and mitigate those risks, among other matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Chief Business Operations Officer oversees our company-wide cybersecurity strategy, policy, standards, and processes across relevant departments. The Chief Business Operations Officer has over 15 years of experience overseeing key operational activities in the life sciences industry and works closely with our experienced information technology consulting firm, which helps to assess and prepare us and our employees to maintain awareness of cybersecurity risks, including email, web, and data security. Our outside information technology consultants have extensive experience designing, implementing, and running information technology and cybersecurity programs and processes using the National Institute of Standards and Technology Framework.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskRoleOfManagementTextBlock>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c-1" id="f-48">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Audit Committee of the board of directors is responsible for reviewing and assessing the integrity of our information technology systems, processes and data, and is charged with meeting periodically with management to review and assess our cyber and technology-related risks, including network security, information security, and data privacy and protection, our technologies, policies, processes, and practices for assessing, monitoring, managing and mitigation those risks, and the steps management has taken to identify, assess, monitor, manage and mitigate those risks, among other matters.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c-1" id="f-47">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Audit Committee of the board of directors is responsible for reviewing and assessing the integrity of our information technology systems, processes and data, and is charged with meeting periodically with management to review and assess our cyber and technology-related risks, including network security, information security, and data privacy and protection, our technologies, policies, processes, and practices for assessing, monitoring, managing and mitigation those risks, and the steps management has taken to identify, assess, monitor, manage and mitigate those risks, among other matters.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag contextRef="c-1" id="f-51">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag contextRef="c-1" id="f-52">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag>
    <cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock contextRef="c-1" id="f-53">The Chief Business Operations Officer has over 15 years of experience overseeing key operational activities in the life sciences industry and works closely with our experienced information technology consulting firm, which helps to assess and prepare us and our employees to maintain awareness of cybersecurity risks, including email, web, and data security.</cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock>
    <dei:AuditorName contextRef="c-1" id="f-54">Ernst &amp; Young LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="c-1" id="f-55">Boston, Massachusetts</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-56" unitRef="usd">64039000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-5" decimals="-3" id="f-57" unitRef="usd">38380000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-58" unitRef="usd">2344000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-5" decimals="-3" id="f-59" unitRef="usd">1633000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-3" id="f-60" unitRef="usd">66383000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-5" decimals="-3" id="f-61" unitRef="usd">40013000</us-gaap:AssetsCurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-4" decimals="-3" id="f-62" unitRef="usd">1624000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-5" decimals="-3" id="f-63" unitRef="usd">1624000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-64" unitRef="usd">3858000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-5" decimals="-3" id="f-65" unitRef="usd">4797000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-66" unitRef="usd">6015000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-5" decimals="-3" id="f-67" unitRef="usd">7764000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-68" unitRef="usd">427000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="c-5" decimals="-3" id="f-69" unitRef="usd">748000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:Assets contextRef="c-4" decimals="-3" id="f-70" unitRef="usd">78307000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-5" decimals="-3" id="f-71" unitRef="usd">54946000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-4" decimals="-3" id="f-72" unitRef="usd">1210000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-5" decimals="-3" id="f-73" unitRef="usd">1042000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-74" unitRef="usd">4833000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-75" unitRef="usd">3302000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-4" decimals="-3" id="f-76" unitRef="usd">385000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-5" decimals="-3" id="f-77" unitRef="usd">0</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-78" unitRef="usd">2994000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-5" decimals="-3" id="f-79" unitRef="usd">2704000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-80" unitRef="usd">91000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="c-5" decimals="-3" id="f-81" unitRef="usd">354000</us-gaap:FinanceLeaseLiabilityCurrent>
    <camp:FinanceLiabilityCurrent contextRef="c-4" decimals="-3" id="f-82" unitRef="usd">85000</camp:FinanceLiabilityCurrent>
    <camp:FinanceLiabilityCurrent contextRef="c-5" decimals="-3" id="f-83" unitRef="usd">405000</camp:FinanceLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-84" unitRef="usd">9598000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-85" unitRef="usd">7807000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-86" unitRef="usd">5493000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-5" decimals="-3" id="f-87" unitRef="usd">8487000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-88" unitRef="usd">70000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-5" decimals="-3" id="f-89" unitRef="usd">148000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <camp:FinanceLiabilityNonCurrent contextRef="c-4" decimals="-3" id="f-90" unitRef="usd">0</camp:FinanceLiabilityNonCurrent>
    <camp:FinanceLiabilityNonCurrent contextRef="c-5" decimals="-3" id="f-91" unitRef="usd">85000</camp:FinanceLiabilityNonCurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-4" decimals="-3" id="f-92" unitRef="usd">2000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-5" decimals="-3" id="f-93" unitRef="usd">2000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-4" decimals="-3" id="f-94" unitRef="usd">15163000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-5" decimals="-3" id="f-95" unitRef="usd">16529000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" id="f-96" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-5" id="f-97" unitRef="usd" xsi:nil="true"/>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-98"
      unitRef="usdPerShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="c-5"
      decimals="INF"
      id="f-99"
      unitRef="usdPerShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized contextRef="c-4" decimals="INF" id="f-100" unitRef="shares">25000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized contextRef="c-5" decimals="INF" id="f-101" unitRef="shares">149673284</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued contextRef="c-4" decimals="INF" id="f-102" unitRef="shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding contextRef="c-4" decimals="INF" id="f-103" unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding contextRef="c-5" decimals="INF" id="f-104" unitRef="shares">130648426</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued contextRef="c-5" decimals="INF" id="f-105" unitRef="shares">130648426</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityLiquidationPreference contextRef="c-4" decimals="INF" id="f-106" unitRef="usd">0</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityLiquidationPreference contextRef="c-5" decimals="-3" id="f-107" unitRef="usd">162885000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c-4" decimals="-3" id="f-108" unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c-5" decimals="-3" id="f-109" unitRef="usd">162147000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-5"
      decimals="INF"
      id="f-110"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-111"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-112" unitRef="shares">175000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-5" decimals="INF" id="f-113" unitRef="shares">210000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="INF" id="f-114" unitRef="shares">20161072</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="c-5" decimals="INF" id="f-115" unitRef="shares">1026057</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-116" unitRef="shares">20145129</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-5" decimals="INF" id="f-117" unitRef="shares">460704</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-3" id="f-118" unitRef="usd">2000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-5" decimals="-3" id="f-119" unitRef="usd">1000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c-4" decimals="-3" id="f-120" unitRef="usd">274895000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c-5" decimals="-3" id="f-121" unitRef="usd">36231000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-3" id="f-122" unitRef="usd">-211753000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-5" decimals="-3" id="f-123" unitRef="usd">-159962000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-124" unitRef="usd">63144000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-5" decimals="-3" id="f-125" unitRef="usd">-123730000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-3" id="f-126" unitRef="usd">78307000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-5" decimals="-3" id="f-127" unitRef="usd">54946000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues contextRef="c-1" decimals="-3" id="f-128" unitRef="usd">652000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-6" decimals="-3" id="f-129" unitRef="usd">350000</us-gaap:Revenues>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-3" id="f-130" unitRef="usd">38817000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-6" decimals="-3" id="f-131" unitRef="usd">40616000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-132" unitRef="usd">14923000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-6" decimals="-3" id="f-133" unitRef="usd">11613000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="c-1" decimals="-3" id="f-134" unitRef="usd">53740000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-6" decimals="-3" id="f-135" unitRef="usd">52229000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-3" id="f-136" unitRef="usd">-53088000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-6" decimals="-3" id="f-137" unitRef="usd">-51879000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest contextRef="c-1" decimals="-3" id="f-138" unitRef="usd">1330000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-6" decimals="-3" id="f-139" unitRef="usd">2808000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:OtherNonoperatingExpense contextRef="c-1" decimals="-3" id="f-140" unitRef="usd">33000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingExpense contextRef="c-6" decimals="-3" id="f-141" unitRef="usd">220000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-142" unitRef="usd">1297000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-6" decimals="-3" id="f-143" unitRef="usd">2588000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-3" id="f-144" unitRef="usd">-51791000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-145" unitRef="usd">-51791000</us-gaap:NetIncomeLoss>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-6" decimals="-3" id="f-146" unitRef="usd">-49291000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-147" unitRef="usd">-49291000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-148"
      unitRef="usdPerShare">-11.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-149"
      unitRef="usdPerShare">-11.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-6"
      decimals="2"
      id="f-150"
      unitRef="usdPerShare">-124.80</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-6"
      decimals="2"
      id="f-151"
      unitRef="usdPerShare">-124.80</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-152" unitRef="shares">4690094</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-153" unitRef="shares">4690094</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="0" id="f-154" unitRef="shares">394976</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="0" id="f-155" unitRef="shares">394976</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:TemporaryEquitySharesOutstanding contextRef="c-7" decimals="INF" id="f-156" unitRef="shares">130648426</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c-7" decimals="-3" id="f-157" unitRef="usd">162147000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesIssued contextRef="c-8" decimals="INF" id="f-158" unitRef="shares">356759</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity contextRef="c-8" decimals="-3" id="f-159" unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-9" decimals="-3" id="f-160" unitRef="usd">33139000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-10" decimals="-3" id="f-161" unitRef="usd">-110671000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-7" decimals="-3" id="f-162" unitRef="usd">-77531000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-11"
      decimals="INF"
      id="f-163"
      unitRef="shares">60919</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-11"
      decimals="INF"
      id="f-164"
      unitRef="shares">43026</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-12" decimals="-3" id="f-165" unitRef="usd">185000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-6" decimals="-3" id="f-166" unitRef="usd">185000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-12" decimals="-3" id="f-167" unitRef="usd">2907000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-6" decimals="-3" id="f-168" unitRef="usd">2907000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss contextRef="c-13" decimals="-3" id="f-169" unitRef="usd">-49291000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-170" unitRef="usd">-49291000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding contextRef="c-5" decimals="INF" id="f-171" unitRef="shares">130648426</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c-5" decimals="-3" id="f-172" unitRef="usd">162147000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-14"
      decimals="INF"
      id="f-173"
      unitRef="shares">460704</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity contextRef="c-14" decimals="-3" id="f-174" unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-15" decimals="-3" id="f-175" unitRef="usd">36231000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-16" decimals="-3" id="f-176" unitRef="usd">-159962000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-5" decimals="-3" id="f-177" unitRef="usd">-123730000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-17"
      decimals="INF"
      id="f-178"
      unitRef="shares">58300</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-17"
      decimals="INF"
      id="f-179"
      unitRef="shares">513781</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-18" decimals="-3" id="f-180" unitRef="usd">113000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-1" decimals="-3" id="f-181" unitRef="usd">113000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <camp:TemporaryEquitySharesConversionOfConvertibleSecurities contextRef="c-1" decimals="INF" id="f-182" unitRef="shares">130648426</camp:TemporaryEquitySharesConversionOfConvertibleSecurities>
    <camp:TemporaryEquityValueConversionOfConvertibleSecurities contextRef="c-1" decimals="-3" id="f-183" unitRef="usd">162147000</camp:TemporaryEquityValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c-17"
      decimals="INF"
      id="f-184"
      unitRef="shares">11648582</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-17" decimals="-3" id="f-185" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-18" decimals="-3" id="f-186" unitRef="usd">162146000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-1" decimals="-3" id="f-187" unitRef="usd">162147000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-1" decimals="-3" id="f-188" unitRef="usd">9727000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-19"
      decimals="INF"
      id="f-189"
      unitRef="shares">7463762</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-20" decimals="-3" id="f-190" unitRef="usd">72373000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-21" decimals="-3" id="f-191" unitRef="usd">72373000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-18" decimals="-3" id="f-192" unitRef="usd">4032000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-3" id="f-193" unitRef="usd">4032000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss contextRef="c-22" decimals="-3" id="f-194" unitRef="usd">-51791000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-195" unitRef="usd">-51791000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding contextRef="c-4" decimals="INF" id="f-196" unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c-4" decimals="-3" id="f-197" unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-23"
      decimals="INF"
      id="f-198"
      unitRef="shares">20145129</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity contextRef="c-23" decimals="-3" id="f-199" unitRef="usd">2000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-24" decimals="-3" id="f-200" unitRef="usd">274895000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-25" decimals="-3" id="f-201" unitRef="usd">-211753000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-202" unitRef="usd">63144000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-203" unitRef="usd">-51791000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-204" unitRef="usd">-49291000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-3" id="f-205" unitRef="usd">1696000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-6" decimals="-3" id="f-206" unitRef="usd">1678000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-207" unitRef="usd">4032000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-6" decimals="-3" id="f-208" unitRef="usd">2907000</us-gaap:ShareBasedCompensation>
    <camp:NoncashLeaseExpense contextRef="c-1" decimals="-3" id="f-209" unitRef="usd">1749000</camp:NoncashLeaseExpense>
    <camp:NoncashLeaseExpense contextRef="c-6" decimals="-3" id="f-210" unitRef="usd">1728000</camp:NoncashLeaseExpense>
    <us-gaap:PaidInKindInterest contextRef="c-1" decimals="-3" id="f-211" unitRef="usd">83000</us-gaap:PaidInKindInterest>
    <us-gaap:PaidInKindInterest contextRef="c-6" decimals="-3" id="f-212" unitRef="usd">92000</us-gaap:PaidInKindInterest>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-1" decimals="-3" id="f-213" unitRef="usd">711000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-6" decimals="-3" id="f-214" unitRef="usd">420000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-1" decimals="-3" id="f-215" unitRef="usd">168000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-6" decimals="-3" id="f-216" unitRef="usd">-1115000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="c-1" decimals="-3" id="f-217" unitRef="usd">1531000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="c-6" decimals="-3" id="f-218" unitRef="usd">-136000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <camp:IncreaseDecreaseInOperatingLeaseAssetsLiabilities contextRef="c-1" decimals="-3" id="f-219" unitRef="usd">2704000</camp:IncreaseDecreaseInOperatingLeaseAssetsLiabilities>
    <camp:IncreaseDecreaseInOperatingLeaseAssetsLiabilities contextRef="c-6" decimals="-3" id="f-220" unitRef="usd">-402000</camp:IncreaseDecreaseInOperatingLeaseAssetsLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-1" decimals="-3" id="f-221" unitRef="usd">385000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-6" decimals="-3" id="f-222" unitRef="usd">0</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-223" unitRef="usd">-45562000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-6" decimals="-3" id="f-224" unitRef="usd">-44155000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-225" unitRef="usd">441000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-6" decimals="-3" id="f-226" unitRef="usd">678000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-227" unitRef="usd">-441000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-6" decimals="-3" id="f-228" unitRef="usd">-678000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-1" decimals="-3" id="f-229" unitRef="usd">76353000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-6" decimals="-3" id="f-230" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-1" decimals="-3" id="f-231" unitRef="usd">113000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-6" decimals="-3" id="f-232" unitRef="usd">185000</us-gaap:ProceedsFromStockOptionsExercised>
    <camp:ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction contextRef="c-1" decimals="-3" id="f-233" unitRef="usd">0</camp:ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction>
    <camp:ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction contextRef="c-6" decimals="-3" id="f-234" unitRef="usd">706000</camp:ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction>
    <camp:PrincipalPaymentsOnFinancingObligationsFailedSaleLeasebackTransaction contextRef="c-1" decimals="-3" id="f-235" unitRef="usd">460000</camp:PrincipalPaymentsOnFinancingObligationsFailedSaleLeasebackTransaction>
    <camp:PrincipalPaymentsOnFinancingObligationsFailedSaleLeasebackTransaction contextRef="c-6" decimals="-3" id="f-236" unitRef="usd">268000</camp:PrincipalPaymentsOnFinancingObligationsFailedSaleLeasebackTransaction>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-1" decimals="-3" id="f-237" unitRef="usd">364000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-6" decimals="-3" id="f-238" unitRef="usd">322000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-1" decimals="-3" id="f-239" unitRef="usd">3980000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-6" decimals="-3" id="f-240" unitRef="usd">0</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-241" unitRef="usd">71662000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-6" decimals="-3" id="f-242" unitRef="usd">301000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-243" unitRef="usd">25659000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-6" decimals="-3" id="f-244" unitRef="usd">-44532000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-3" id="f-245" unitRef="usd">40004000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-7" decimals="-3" id="f-246" unitRef="usd">84536000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-247" unitRef="usd">65663000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-3" id="f-248" unitRef="usd">40004000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-1" decimals="-3" id="f-249" unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-6" decimals="-3" id="f-250" unitRef="usd">1397000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability contextRef="c-1" decimals="-3" id="f-251" unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability contextRef="c-6" decimals="-3" id="f-252" unitRef="usd">504000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-1" decimals="-3" id="f-253" unitRef="usd">0</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-6" decimals="-3" id="f-254" unitRef="usd">12000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:ConversionOfStockAmountConverted1 contextRef="c-1" decimals="-3" id="f-255" unitRef="usd">162147000</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:ConversionOfStockAmountConverted1 contextRef="c-6" decimals="-3" id="f-256" unitRef="usd">0</us-gaap:ConversionOfStockAmountConverted1>
    <camp:FinanceLeaseRightOfUseAssetConvertedToFixedAsset contextRef="c-1" decimals="-3" id="f-257" unitRef="usd">127000</camp:FinanceLeaseRightOfUseAssetConvertedToFixedAsset>
    <camp:FinanceLeaseRightOfUseAssetConvertedToFixedAsset contextRef="c-6" decimals="-3" id="f-258" unitRef="usd">0</camp:FinanceLeaseRightOfUseAssetConvertedToFixedAsset>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c-1" id="f-259">&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1. &#160;&#160;&#160;&#160;Description of Business and Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Description of Business&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CAMP4 Therapeutics Corporation, formerly Marauder Therapeutics, Inc., and its subsidiary (collectively, the &#x201c;Company&#x201d;), is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new class of RNA-based therapeutics with the goal of upregulating gene expression and restoring healthy protein levels to treat a broad range of genetic diseases. The Company is currently focusing on metabolic diseases and diseases of the central nervous system. The Company was organized in September&#160;2015 and began operations in 2016.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;). Any reference in these notes to applicable guidance is meant to refer to the authoritative standards of U.S. GAAP as found in the Accounting Standards Codification (&#x201c;ASC&#x201d;) and Accounting Standards Updates (&#x201c;ASU&#x201d;) of the Financial Accounting Standards Board (&#x201c;FASB&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company&#x2019;s consolidated financial statements include the accounts of CAMP4 Therapeutics Corporation and its wholly owned subsidiary, CAMP4 Therapeutics Pty Ltd (&#x201c;CAMP4 AUS&#x201d;), which was established on September&#160;15, 2023. All intercompany balances and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Reclassification of Prior Year Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations or balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reverse Stock Split&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October&#160;3, 2024, the Company effected a one-for-11.2158 reverse stock split of its issued and outstanding shares of common stock and a proportional adjustment to the existing conversion ratios for each series of the Company&#x2019;s convertible preferred stock. Accordingly, all share and per share amounts for all periods presented in the accompanying consolidated financial statements and notes thereto have been adjusted retroactively, where applicable, to reflect this reverse stock split and adjustment of the preferred stock conversion ratios. The par value and the number of authorized shares of the convertible preferred stock and common stock were not adjusted in connection with the reverse stock split.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Initial Public Offering&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 15, 2024, the Company completed its initial public offering (&#x201c;IPO&#x201d;), pursuant to which it issued and sold an aggregate of 6,820,000 shares of its common stock at a price to the public of $11.00 per share, resulting in net proceeds of $65.8 million, after deducting underwriting discounts and commissions of $5.3 million and other offering expenses of $4.0 million. In addition, on November 1, 2024, the Company received additional proceeds of $6.6 million, after deducting underwriting discounts and commissions of $0.5 million, pursuant to the partial exercise by the underwriters of their option to purchase additional shares in the IPO. Collectively, the Company received aggregate net proceeds of $72.4 million. Upon the closing of the IPO, the Company&#x2019;s outstanding convertible preferred stock automatically converted into 11,648,582 shares of common stock (see Note 9).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the completion of its IPO, on October 15, 2024, the Company&#x2019;s certificate of incorporation was amended and restated to authorize 175,000,000 shares of common stock, par value $0.0001 per share and 25,000,000 shares of preferred stock, par value of $0.0001 per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liquidity and Going Concern&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As of December&#160;31, 2024, the Company had approximately $64.0 million of cash and cash equivalents and working capital of approximately $56.8 million. The Company has a relatively limited operating history, and the revenue and income potential of the Company&#x2019;s business and market are unproven. The Company has experienced net losses and negative cash flows from operations since its inception and, as of December&#160;31, 2024, the Company had an accumulated deficit of $211.8 million. During the year ended December&#160;31, 2024, the Company incurred a net loss of $51.8 million and had negative cash flows from operations of $45.6 million. The Company will continue to incur significant costs and &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;expenses related to its ongoing operations until it successfully develops, obtains regulatory approval for and gains market acceptance of a product candidate and achieves revenues adequate to support the Company&#x2019;s operations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From inception to December&#160;31, 2024, the Company has funded its operations primarily with proceeds from the sale of convertible preferred stock and common stock, including in its IPO, as well as through revenues from its license and collaboration agreements. Based on its current operating plan, the Company estimates that its cash and cash equivalents as of December&#160;31, 2024 will be sufficient to fund its operating expenses and capital expenditure requirements into the second quarter of 2026. However, the Company has based this estimate on assumptions that may prove to be wrong, and could deplete its capital resources sooner than it currently expects. The Company's capital resources may not be sufficient to fund operations through at least the next twelve&#160;months from the date that these audited consolidated financial statements as of December&#160;31, 2024 are issued based on its expected cash needs, which raises substantial doubt about the Company's ability to continue as a going concern. As the Company continues to pursue its business plan, it expects to finance its operations through potential public or private equity offerings, debt financings or other capital sources, including current or potential future collaborations, licenses and other similar arrangements. However, there can be no assurance that any additional financing or strategic arrangements will be available to the Company on acceptable terms, if at all. If events or circumstances occur such that the Company does not obtain additional funding, it may be necessary to significantly reduce its scope of operations to reduce the current rate of spending through actions such as reductions in staff and the need to delay, limit, reduce or terminate product development or future commercialization efforts or grant rights to develop and market product candidates that it would otherwise prefer to develop and market itself, which could have a material adverse effect on the Company&#x2019;s business, results of operations or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the ordinary course of business. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-26"
      decimals="INF"
      id="f-260"
      unitRef="shares">6820000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c-27"
      decimals="2"
      id="f-261"
      unitRef="usdPerShare">11.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="c-26" decimals="-5" id="f-262" unitRef="usd">65800000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <camp:PaymentsOfUnderwritingDiscountsAndCommissions contextRef="c-26" decimals="-3" id="f-263" unitRef="usd">5300000</camp:PaymentsOfUnderwritingDiscountsAndCommissions>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-26" decimals="-3" id="f-264" unitRef="usd">4000000.0</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="c-28" decimals="-5" id="f-265" unitRef="usd">6600000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-28" decimals="-5" id="f-266" unitRef="usd">500000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="c-29" decimals="-5" id="f-267" unitRef="usd">72400000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c-30"
      decimals="INF"
      id="f-268"
      unitRef="shares">11648582</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c-31"
      decimals="INF"
      id="f-269"
      unitRef="shares">175000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-31"
      decimals="INF"
      id="f-270"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c-31"
      decimals="INF"
      id="f-271"
      unitRef="shares">25000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-31"
      decimals="INF"
      id="f-272"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-5" id="f-273" unitRef="usd">64000000.0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <camp:WorkingCapital contextRef="c-4" decimals="-5" id="f-274" unitRef="usd">56800000</camp:WorkingCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-5" id="f-275" unitRef="usd">-211800000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-276" unitRef="usd">-51800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-5" id="f-277" unitRef="usd">-45600000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-279">&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2. &#160;&#160;&#160;&#160;Summary of Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates assumptions, and judgments that affect the reported amounts of assets, liabilities, expenses and related disclosures in the accompanying notes. The Company bases its estimates, assumptions and judgments on historical experience when available and on various factors that it believes to be reasonable under the circumstances as of the date of the accompanying consolidated financial statements, including the fair value of common stock prior to the Company&#x2019;s IPO, stock-based compensation expense, accrued expenses, lease accounting and the recoverability of the Company&#x2019;s net deferred tax assets and related valuation allowance. In addition, other factors may affect estimates, including the expected business and operational changes, the sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process often may yield a range of potentially reasonable estimates of the ultimate future outcomes, and management must select an amount that falls within that range of reasonable estimates. Actual results could differ materially from the estimates and assumptions used in the preparation of the accompanying consolidated financial statements under different assumptions or conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all highly liquid investments and instruments with original maturities of 90 days or less that can be liquidated without prior notice or penalty to be cash equivalents. Cash equivalents primarily represent funds invested in readily available money market accounts. As of December&#160;31, 2024 and 2023, the Company had cash and cash equivalents balances deposited at one major financial institution.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with its operating leases, the Company is required to maintain security deposits totaling $1.5 million, which were issued in the form of letters of credit with a bank. As of December&#160;31, 2024 and 2023, the Company held cash in this amount in separate restricted bank accounts as collateral for the letters of credit. The restricted cash balance is classified as long-term restricted cash on the accompanying consolidated balance sheets. In addition, the Company held less than $0.1 million in money market accounts as of each of December&#160;31, 2024 and 2023 as collateral for the Company&#x2019;s credit card obligation and increased letter of credit due to an amendment to the leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheets to the corresponding amounts shown in the consolidated statements of cash flows as of December&#160;31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;64,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;38,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;65,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;40,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Concentration of Credit Risks&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. The Company deposits cash and cash equivalents with high credit quality financial institutions in the United States. These deposits are held in checking and money market accounts and may, from time to time, exceed the federally insured amounts. The Company has not experienced any losses in such accounts. The Company believes it is not exposed to any significant risk in its cash and cash equivalents. The primary objectives of the Company&#x2019;s investment portfolio are the preservation of capital and maintenance of liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to risks common to companies in the biopharmaceutical industry, including, but not limited to, risks related to the successful development and commercialization of product candidates, fluctuations in operating results and financial risks, the ability to successfully raise additional funds when needed, protection of proprietary rights and patent risks, patent litigation, compliance with government regulations, dependence on key personnel and collaboration partners, dependence on third-party manufacturers and competition from competing products in the marketplace.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company applies fair value measurements to record fair value adjustments to certain assets and liabilities and to determine fair value disclosures. Fair value is measured as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A fair value measurement assumes that the transaction to sell the asset or transfer the liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market. A framework is used for measuring fair value utilizing a three-tier hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level&#160;1) and the lowest priority to unobservable inputs (Level&#160;3).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The three levels of the fair value hierarchy are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;padding-left:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Level&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Observable inputs such as unadjusted quoted prices in active markets that are accessible at the measurement date for identical unrestricted assets or liabilities the Company has the ability to access;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;padding-left:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Level&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Inputs (other than quoted prices included within Level&#160;1) that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;padding-left:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Level&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments are categorized in their entirety based on the lowest level of input that is significant to the fair value measurement. The assessment of the significance of a particular input to the fair value measurement requires judgment and considers factors specific to the investment. To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level&#160;3. The Company reviews the fair value hierarchy classification at each reporting date. Changes in the ability to observe valuation inputs may result in a reclassification of levels for certain assets or liabilities within the fair value hierarchy. The Company did not have any transfers of assets and liabilities between the levels of the fair value measurement hierarchy during the&#160;years presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currency Remeasurement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s reporting currency and the functional currency of its foreign subsidiary, CAMP4 AUS, is the United States Dollar (&#x201c;USD&#x201d;). At the date a foreign currency denominated transaction is recognized, each asset, liability, revenue, expense, gain or loss arising from the transaction is measured initially in USD based on the exchange rate in effect at that date. Subsequently, at each balance sheet date, balances related to monetary assets and liabilities are adjusted to reflect the current exchange rate, which is the rate at which the related receivable or payable could be settled at that date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign exchange transaction gains and losses are included in other income, net in the accompanying consolidated statements of operations and comprehensive loss and were de minimis for the&#160;years ended December&#160;31, 2024 and 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Comprehensive Loss&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no differences between net loss and comprehensive loss presented in the consolidated statements of operations for the&#160;years ended December&#160;31, 2024 and 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property and Equipment, Net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, which are all located in the United States, are stated at cost less accumulated depreciation. Expenditures for maintenance and repairs are charged to expense as incurred, whereas major betterments are capitalized as additions to property and equipment. Depreciation is calculated using the straight-line method over the following estimated useful lives of the assets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Computer and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Three years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Five years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Seven years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shorter of asset life or remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates its long-lived assets, which consist of property and equipment, operating lease right-of-use (&#x201c;ROU&#x201d;) assets, and finance lease ROU assets, for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant underperformance of the business in relation to expectations, significant negative industry or economic trends and significant changes or planned changes in the use of the assets. If the asset is impaired, the amount of any impairment is measured as the difference between the carrying value and the fair value of the impaired asset. The Company recognized no impairment losses for the&#160;years ended December&#160;31, 2024 and 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Commitments and Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contractual Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company enters into contracts in the normal course of business with contract research organizations (&#x201c;CROs&#x201d;), contract manufacturing organizations (&#x201c;CMOs&#x201d;), academic institutions and other third parties for preclinical and clinical research studies, testing and manufacturing services. These contracts generally do not contain minimum purchase commitments and are cancellable by the Company upon prior written notice, although purchase orders for preclinical materials are generally non-cancellable. Payments due upon cancellation consist primarily of payments for services provided or expenses incurred, including non-cancellable obligations from the Company&#x2019;s service providers, up to the date of cancellation or upon the completion of a manufacturing run.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Indemnifications&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Indemnification Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has entered into indemnification agreements with its officers and directors that require the Company to indemnify such individuals for certain events or occurrences while each such officer or director is, or was, serving at the Company&#x2019;s request in such capacity. The maximum potential future payments the Company could be required to make is, in many cases, unlimited. The Company has directors&#x2019; and officers&#x2019; liability insurance coverage that limits its exposure and enables the Company to recover a portion of any future amounts paid.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases office and laboratory space under operating leases. The Company has standard indemnification arrangements under the leases that require it to indemnify the landlords against all costs, expenses, fines, suits, claims, demands, liabilities and actions directly resulting from any breach, violation or nonperformance of any covenant or condition of the Company&#x2019;s leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the ordinary course of its business, the Company enters into indemnification agreements with certain suppliers and business partners pursuant to which the Company has certain indemnification obligations limited to the costs, expenses, fines, suits, claims, demands, liabilities and actions directly resulting from the Company&#x2019;s gross negligence or willful misconduct, and in certain instances, breaches, violations or nonperformance of covenants or conditions under the agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2024 and 2023, the Company had not experienced any material losses related to these indemnification obligations, and no material claims with respect thereto were outstanding. The Company does not expect significant claims related to these indemnification obligations and, consequently, concluded that the fair value of these obligations is negligible, and no related reserves were established.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to the possibility of loss contingencies arising in the ordinary course of business. Management considers the likelihood of loss related to an asset, or the incurrence of a liability, as well as its ability to reasonably estimate the amount of the loss, in determining loss contingencies. An estimated loss contingency is accrued when it is probable that an asset has been impaired, or a liability has been incurred and the amount of loss can be reasonably estimated. The Company regularly evaluates current information available to determine whether such accruals should be adjusted and whether new accruals are required.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company may become involved in litigation relating to claims arising from the ordinary course of business. Management believes that there are no claims or actions pending against the Company currently, the ultimate disposition of which would have a material adverse effect on the Company&#x2019;s consolidated results of operations, financial condition or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with ASC 842,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company determines if an arrangement is or contains a lease at inception. A contract is or contains a lease if the contract conveys the right to control the use of an identified asset for a period in exchange for consideration. The Company classifies leases at the lease commencement date as operating or finance leases and records a ROU asset and a lease liability on the consolidated balance sheet for all leases with an initial lease term of greater than 12 months. Leases with an initial term of 12 months or less are not recorded in the balance sheet, but payments are recognized as expense on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A lease qualifies as a finance lease if any of the following criteria are met at the inception of the lease: (i)&#160;there is a transfer of ownership of the leased asset to the Company by the end of the lease term, (ii)&#160;the Company holds an option to purchase the leased asset that it is reasonably certain to exercise, (iii)&#160;the lease term is for a major part of the remaining economic life of the leased asset, (iv)&#160;the present value of the sum of lease payments equals or exceeds substantially all of the fair value of the leased asset, or (v)&#160;the nature of the leased asset is specialized to the point that it is expected to provide the lessor no alternative use at the end of the lease term. All other leases are recorded as operating leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company enters into contracts that contain both lease and non-lease components. Non-lease components may include maintenance, utilities and other operating costs. The Company combines the lease and non-lease components of fixed costs in its lease arrangements as a single lease component. Variable costs, such as utilities or maintenance costs, are not included in the measurement of ROU assets and lease liabilities, but rather are expensed when the event determining the amount of variable consideration to be paid occurs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance and operating lease assets and liabilities are recognized at the lease commencement date based on the present value of the lease payments over the lease term using the discount rate implicit in the lease. If the rate implicit is not readily determinable, the Company utilizes an estimate of its incremental borrowing rate based upon the available information at the lease commencement date. Operating lease assets are further adjusted for prepaid or accrued lease payments. Operating lease assets are expensed using the straight-line method as an operating expense over the lease term. Finance lease assets are amortized to depreciation expense using the straight-line method. Finance lease payments are bifurcated into (i)&#160;a portion that is recorded as imputed interest expense and (ii)&#160;a portion that reduces the finance liability associated with the lease.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of the Company&#x2019;s leases provide a lease incentive in the form of reimbursable leasehold improvements. Due to the unpredictability of the payout of leasehold improvement reimbursements, the Company recognizes a reduction to the ROU asset and the lease liability once it has incurred costs that qualify as reimbursable by the lessor. The reduction to the ROU asset is recognized prospectively over the remainder of the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of the Company&#x2019;s leases include options to extend or terminate the lease. The amounts determined for the Company&#x2019;s ROU assets and lease liabilities generally do not assume that renewal options or early-termination provisions, if any, are exercised, unless it is reasonably certain that the Company will exercise such options.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the Company examines other contracts with suppliers, vendors and outside parties to identify whether such contracts contain an embedded lease and, as applicable, records such embedded leases in accordance with ASC 842,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Financing Obligation (Failed Sale-Leaseback)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with ASC 842,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for potential sale-leaseback transactions, the Company assesses the contract to identify if a sale occurred in accordance with ASC Topic 606,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASC 606&#x201d;). Sale-and-leaseback transactions occur when the Company sells assets to a third-party and simultaneously leases them back. The resulting leases that qualify for sale-and-leaseback accounting are evaluated and accounted for as operating leases. A transaction that does not qualify for sale-and-leaseback accounting as a result of finance lease classification or the failure to meet certain revenue recognition criteria is accounted for as a financing transaction. For a financing transaction, the Company will retain the assets sold within Property, plant and equipment, net and record a financing obligation equal to the amount of cash proceeds received. Rental payments under such transactions are recognized as a reduction of the financing obligation and as interest expense using an effective interest method. To date, the Company has entered into one failed sale-leaseback transaction. See additional discussion in&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 7. Commitments and Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition and Accounting for Collaboration Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue in accordance with ASC 606. The Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. In determining the appropriate amount of revenue to be recognized as it fulfills its obligations under its agreements, the Company performs the following steps: (i)&#160;identification of the promised goods or services in the contract; (ii)&#160;determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii)&#160;measurement of the transaction price, including the constraint on variable consideration; (iv)&#160;allocation of the transaction price to the performance obligations; and (v)&#160;recognition of revenue when (or as) the Company satisfies each performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses judgment to determine: (a)&#160;the performance obligations based on the determination under step (ii)&#160;above; (b)&#160;the transaction price under step (iii)&#160;above; and (c)&#160;the recognition of revenue as services are performed under step (v)&#160;above. The Company also uses judgment to determine whether development milestones or other variable consideration except for royalties and sales-based milestones, should be included in the transaction price as described further below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company applies the five-step model to contracts when the arrangement is not a collaboration pursuant to ASC Topic 808,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Collaborative Arrangements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;(&#x201c;ASC 808&#x201d;), and it is probable that the Company will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Collaborative Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company analyzes its collaboration agreements to assess whether they are within the scope of ASC 808 by determining whether such arrangements involve joint operating activities performed by parties that are both active participants in the activities and exposed to significant risks and rewards that are dependent on the commercial success of such activities. To the extent the arrangement is within the scope of ASC 808, the Company assesses whether aspects of the arrangement between the Company and the collaboration partner are within the scope of other accounting literature. If the Company concludes that some or all aspects of the arrangement represent a transaction with a customer, the Company &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;accounts for those aspects of the arrangement within the scope of ASC 606. If the Company concludes that some or all aspects of the arrangement are within the scope of ASC 808 and do not represent a transaction with a customer, the Company recognizes the Company&#x2019;s share of the allocation of the shared costs incurred with respect to the jointly conducted activities as a component of the related expense in the period incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Research and Development Expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development (&#x201c;R&amp;amp;D&#x201d;) expenses are recorded to operating expenses when incurred. The Company&#x2019;s R&amp;amp;D expenses consist primarily of costs incurred in performing R&amp;amp;D activities, including personnel-related expenses such as salaries, stock-based compensation and benefits, facilities costs, depreciation and external costs of outside vendors engaged to conduct clinical and preclinical development activities and to manufacture a product candidate. The Company accrues expenses related to development activities performed by third parties based on an evaluation of services received and efforts expended pursuant to the terms of the contractual arrangements. Payments under some of these contracts depend on preclinical trial milestones. Non-refundable advance payments for goods and services that will be used over time for R&amp;amp;D are deferred and capitalized as R&amp;amp;D prepaid expenses on the Company&#x2019;s consolidated balance sheets. The capitalized amounts are recognized as an expense as the goods are delivered or as the related services are performed. In accruing service fees, the Company estimates the period over which services will be performed and the level of effort to be expended in each period. If the actual timing of the performance of services or the level of effort varies from the estimate, the Company will adjust the accrual or prepaid expense accordingly. Costs to acquire technologies to be used in R&amp;amp;D that have not reached technological feasibility and have no alternative future use are also expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;General and Administrative Expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;General and administrative (&#x201c;G&amp;amp;A&#x201d;) expenses consist primarily of personnel-related expenses, including salaries, bonuses, benefits, travel and stock-based compensation expenses for employees in executive, accounting and finance, business development, human resources, legal, and other administrative functions. Other significant G&amp;amp;A expenses include allocated facility-related costs, legal fees relating to corporate and intellectual property matters, professional fees for accounting, audit and tax services, consulting fees and insurance costs. G&amp;amp;A costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Patent Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All patent-related costs incurred in connection with filing and prosecuting patent applications are expensed as incurred due to the uncertainty about the recovery of the expenditure. Amounts are classified as G&amp;amp;A expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Offering Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company complies with the requirements of ASC 340,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Assets and Deferred Costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, with regards to offering costs. Prior to the completion of an offering of common stock, direct offering costs are capitalized as deferred offering costs. The deferred offering costs are charged to additional paid-in capital for offerings of common stock or as a reduction in the carrying value of preferred stock for offerings of preferred stock. As of December&#160;31, 2024 and 2023, the Company had no deferred offering costs recorded. During the year ended December&#160;31, 2024, the Company recorded $4.0 million of offering costs related to the issuance of common stock in the IPO and recognized this amount as a reduction in the carrying value of the common stock issued in the IPO.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company periodically grants equity-based awards in the form of stock options and restricted stock to employees, directors and non-employees and records stock-based compensation expenses based on their estimated fair value at the grant date. The Company estimates the fair value of stock options using the Black-Scholes option-pricing model as of the grant date. Stock-based compensation expenses are recognized in the accompanying consolidated statements of operations and comprehensive loss on a straight-line basis over the requisite service period, which is typically the vesting period. Determining the appropriate fair value model and related input assumptions requires judgment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the IPO, the fair value of the Company&#x2019;s common stock was determined by the Company&#x2019;s Board of Directors (the &#x201c;Board&#x201d;) at the time of each option grant by considering several objective and subjective factors. These factors included the valuation of a select group of representative public companies within the industry that focus on biotechnology that the Board believed was comparable to the Company&#x2019;s operations; operating and financial performance; the lack of liquidity of the common stock and trends in the broader economy and biotechnology industry also impact the determination of the fair value of the common stock. For awards granted after the Company&#x2019;s IPO, the grant date fair value of common stock was determined by using the closing price per share of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The other inputs to the Black-Scholes option-pricing model include the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The risk-free interest rate used is based on the published U.S. Department of Treasury interest rates in effect at the time of stock option grant for zero coupon U.S. Treasury notes with maturities approximating each grant&#x2019;s expected term;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The dividend yield is zero as the Company has not paid dividends and does not anticipate paying a cash dividend in the foreseeable future;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The expected term for options granted is calculated using the simplified method and represents the average time that options are expected to be outstanding based on the mid-point between the vesting date and the end of the contractual term of the award; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Expected volatility is derived from the historical volatility of a select group of representative companies, for a look-back period commensurate with the expected term of the stock options, as the Company has limited trading history of common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company recognizes forfeitures related to stock-based compensation awards as they occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company classifies stock-based compensation expense in the consolidated statement of operations and comprehensive loss in the same way the award recipients&#x2019; payroll costs are classified or in which the award recipients&#x2019; service payments are classified.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for income taxes in accordance with ASC 740,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;(&#x201c;ASC 740&#x201d;). ASC 740 requires the use of the asset and liability method of accounting for income taxes. The current or deferred tax consequences of a transaction are measured by applying the provisions of enacted tax laws to determine the amount of taxes payable currently or in future&#160;years. Deferred tax assets and liabilities are determined based on the difference between the consolidated financial statements and tax basis of assets and liabilities and expected future tax consequences of events that have been included in the consolidated financial statements or tax returns using enacted tax rates in effect for the year in which the differences are expected to reverse. Under this method, a valuation allowance is used to offset deferred tax assets if, based upon the available evidence, it is more likely than not that some or all of the deferred tax assets may not be realized. Management evaluates the recoverability of deferred taxes and the adequacy of the valuation allowance at each reporting period (see Note 12,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company follows the provisions of ASC 740 relative to accounting for uncertain tax positions. These provisions provide guidance on the recognition, de-recognition and measurement of potential tax benefits associated with tax positions. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company had no reserves related to uncertain tax positions as of December&#160;31, 2024 and 2023. As applicable, the Company recognizes accrued penalties and interest related to unrecognized tax benefits in the provision for income taxes. As of December&#160;31, 2024 and 2023, the Company did not accrue any potential interest or penalties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is required to file federal and state income tax returns in the U.S. and foreign income tax returns in Australia. The preparation of tax returns requires the Company to interpret the applicable tax laws and regulations in effect in such jurisdictions, which could affect the amount of tax paid by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s income tax returns are based on calculations and assumptions that are subject to examination by the Internal Revenue Service and other tax authorities for the tax years ended December 31, 2020 through December 31, 2024. In addition, the calculation of the Company&#x2019;s tax liabilities involves dealing with uncertainties in the application of complex tax regulations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Classification of Convertible Preferred Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s convertible preferred stock was classified as temporary equity in the accompanying consolidated balance sheet as of December&#160;31, 2023 and was excluded from stockholders&#x2019; equity (deficit) as the potential redemption of such stock was outside the Company&#x2019;s control. The convertible preferred stock was not redeemable except for in the event of a liquidation, dissolution or winding up of the Company. The Company did not accrete the carrying values of the preferred stock to the redemption values since the occurrence of these events was not considered probable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net Loss Per Share Attributable to Common Stockholders&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined all of its convertible preferred stock qualified as participating securities, as defined in ASC 260,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Earnings Per Share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;(&#x201c;ASC 260&#x201d;). Under ASC 260, securities are considered participating securities if the securities may participate in undistributed earnings with common stock, whether that participation is conditioned upon the occurrence of a specified event or not. In accordance with ASC 260, a company is required to use the two-class method when computing net income (loss) per share when a company has securities that qualify as participating securities. The two-class method is an earnings allocation formula that determines net income (loss) per share for each class of common stock and participating security according to dividends declared (or accumulated) and participation rights in undistributed earnings. Diluted net loss per share for the Company&#x2019;s common stock is computed using the more dilutive of the two-class method or the if-converted method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period. Diluted net loss attributable to common stockholders is computed by adjusting net loss per share attributable to common stockholders to reallocate undistributed earnings based on the potential impact of dilutive securities. Diluted net loss per share attributable to common stockholders is computed by dividing the diluted net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period, including potential dilutive common shares. For purpose of this calculation, outstanding options to purchase common stock, unvested restricted stock awards, and shares of convertible preferred stock are considered potential dilutive common shares. The Company has generated a net loss in all periods presented, and therefore the basic and diluted net loss per share attributable to common stockholders are the same as the inclusion of the potentially dilutive securities would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Emerging Growth Company Status&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is an emerging growth company (&#x201c;EGC&#x201d;) as defined in the Jumpstart Our Business Startups Act of 2012, as amended (the &#x201c;JOBS Act&#x201d;), and may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not an EGC. The Company may take advantage of these exemptions until it is no longer an EGC under Section&#160;107 of the JOBS Act and has elected to use the extended transition period for complying with new or revised accounting standards. As a result of this election, the Company&#x2019;s consolidated financial statements may not be comparable to companies that comply with public company FASB standards&#x2019; effective dates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In November 2023, FASB issued ASU 2023-07, &#x201c;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.&#x201d; The standard expands reportable segment disclosure requirements for public business entities primarily through enhanced disclosures about significant segment expenses that are regularly provided to the chief operating decision maker (&#x201c;CODM&#x201d;) and included within each reported measure of segment profit (referred to as the &#x201c;significant expense principle&#x201d;). The Company has adopted this standard for the fiscal year 2024 annual financial statements and has applied this standard retrospectively for all prior periods presented in the financial statements (see Note 13).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounting standards not listed below were assessed and determined not to be applicable or are expected to have minimal impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU 2023-09, Income Taxes (&#x201c;Topic 740&#x201d;):&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Improvements to Income Tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The guidance includes the requirement that public business entities, on an annual basis, disclose specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold (if the effect of those reconciling items is equal to or greater than 5% of the amount computed by multiplying pretax income (or loss) by the applicable statutory income tax rate). It also requires that all entities disclose, on an annual basis, the amount of income taxes paid (net of refunds received) disaggregated by federal (national), state, and foreign taxes and the amount of income taxes paid (net of refunds received) disaggregated by individual jurisdictions in which income taxes paid (net of refunds received) is equal to or greater than 5% of total income taxes paid (net of refunds received) and requires that all entities disclose income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign and income tax expense (or benefit) from continuing operations disaggregated by federal (national), state, and foreign. Lastly, the guidance eliminates the requirement for all entities to disclose the nature and estimate of the range of the reasonably possible change in the unrecognized tax benefits balance in the next 12 months or make a statement that an estimate of the range cannot be made. For public business entities, the guidance is effective for annual periods beginning after December&#160;15, 2024. Early adoption is permitted for annual &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;consolidated financial statements that have not yet been issued or made available for issuance. The guidance should be applied on a prospective basis. Retrospective application is permitted. The Company is currently evaluating the impact that this guidance may have on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In November 2024, the FASB issued ASU 2024-03, &#x201c;Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses.&#x201d; The standard requires that public business entities disclose additional information about specific expense categories in the notes to financial statements for interim and annual reporting periods. For public business entities, the guidance is effective for interim and annual periods beginning after December&#160;15, 2026. Early adoption is permitted for annual consolidated financial statements that have not yet been issued or made available for issuance. The guidance may be applied on a prospective basis or retrospectively for all prior periods presented in the financial statements. The Company is currently evaluating the impact that this guidance may have on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-280">&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates assumptions, and judgments that affect the reported amounts of assets, liabilities, expenses and related disclosures in the accompanying notes. The Company bases its estimates, assumptions and judgments on historical experience when available and on various factors that it believes to be reasonable under the circumstances as of the date of the accompanying consolidated financial statements, including the fair value of common stock prior to the Company&#x2019;s IPO, stock-based compensation expense, accrued expenses, lease accounting and the recoverability of the Company&#x2019;s net deferred tax assets and related valuation allowance. In addition, other factors may affect estimates, including the expected business and operational changes, the sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process often may yield a range of potentially reasonable estimates of the ultimate future outcomes, and management must select an amount that falls within that range of reasonable estimates. Actual results could differ materially from the estimates and assumptions used in the preparation of the accompanying consolidated financial statements under different assumptions or conditions.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c-1" id="f-281">&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all highly liquid investments and instruments with original maturities of 90 days or less that can be liquidated without prior notice or penalty to be cash equivalents. Cash equivalents primarily represent funds invested in readily available money market accounts. As of December&#160;31, 2024 and 2023, the Company had cash and cash equivalents balances deposited at one major financial institution.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <camp:NumberOfMajorFinancialInstitutionsWithCashAndCashEquivalentDeposits
      contextRef="c-4"
      decimals="INF"
      id="f-282"
      unitRef="majorfinancialinstitution">1</camp:NumberOfMajorFinancialInstitutionsWithCashAndCashEquivalentDeposits>
    <camp:NumberOfMajorFinancialInstitutionsWithCashAndCashEquivalentDeposits
      contextRef="c-5"
      decimals="INF"
      id="f-283"
      unitRef="majorfinancialinstitution">1</camp:NumberOfMajorFinancialInstitutionsWithCashAndCashEquivalentDeposits>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="c-1" id="f-284">&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with its operating leases, the Company is required to maintain security deposits totaling $1.5 million, which were issued in the form of letters of credit with a bank. As of December&#160;31, 2024 and 2023, the Company held cash in this amount in separate restricted bank accounts as collateral for the letters of credit. The restricted cash balance is classified as long-term restricted cash on the accompanying consolidated balance sheets. In addition, the Company held less than $0.1 million in money market accounts as of each of December&#160;31, 2024 and 2023 as collateral for the Company&#x2019;s credit card obligation and increased letter of credit due to an amendment to the leases.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:DepositsAssets contextRef="c-4" decimals="-5" id="f-285" unitRef="usd">1500000</us-gaap:DepositsAssets>
    <us-gaap:Cash contextRef="c-5" decimals="-5" id="f-286" unitRef="usd">100000</us-gaap:Cash>
    <us-gaap:Cash contextRef="c-4" decimals="-5" id="f-287" unitRef="usd">100000</us-gaap:Cash>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock contextRef="c-1" id="f-289">&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheets to the corresponding amounts shown in the consolidated statements of cash flows as of December&#160;31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;64,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;38,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;65,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;40,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock contextRef="c-1" id="f-288">&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheets to the corresponding amounts shown in the consolidated statements of cash flows as of December&#160;31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;64,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;38,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;65,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;40,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-290" unitRef="usd">64039000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-5" decimals="-3" id="f-291" unitRef="usd">38380000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-4" decimals="-3" id="f-292" unitRef="usd">1624000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-5" decimals="-3" id="f-293" unitRef="usd">1624000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-294" unitRef="usd">65663000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-3" id="f-295" unitRef="usd">40004000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c-1" id="f-296">&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Concentration of Credit Risks&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. The Company deposits cash and cash equivalents with high credit quality financial institutions in the United States. These deposits are held in checking and money market accounts and may, from time to time, exceed the federally insured amounts. The Company has not experienced any losses in such accounts. The Company believes it is not exposed to any significant risk in its cash and cash equivalents. The primary objectives of the Company&#x2019;s investment portfolio are the preservation of capital and maintenance of liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to risks common to companies in the biopharmaceutical industry, including, but not limited to, risks related to the successful development and commercialization of product candidates, fluctuations in operating results and financial risks, the ability to successfully raise additional funds when needed, protection of proprietary rights and patent risks, patent litigation, compliance with government regulations, dependence on key personnel and collaboration partners, dependence on third-party manufacturers and competition from competing products in the marketplace.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="c-1" id="f-298">&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company applies fair value measurements to record fair value adjustments to certain assets and liabilities and to determine fair value disclosures. Fair value is measured as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A fair value measurement assumes that the transaction to sell the asset or transfer the liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market. A framework is used for measuring fair value utilizing a three-tier hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level&#160;1) and the lowest priority to unobservable inputs (Level&#160;3).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The three levels of the fair value hierarchy are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;padding-left:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Level&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Observable inputs such as unadjusted quoted prices in active markets that are accessible at the measurement date for identical unrestricted assets or liabilities the Company has the ability to access;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;padding-left:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Level&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Inputs (other than quoted prices included within Level&#160;1) that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;padding-left:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Level&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments are categorized in their entirety based on the lowest level of input that is significant to the fair value measurement. The assessment of the significance of a particular input to the fair value measurement requires judgment and considers factors specific to the investment. To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level&#160;3. The Company reviews the fair value hierarchy classification at each reporting date. Changes in the ability to observe valuation inputs may result in a reclassification of levels for certain assets or liabilities within the fair value hierarchy. The Company did not have any transfers of assets and liabilities between the levels of the fair value measurement hierarchy during the&#160;years presented.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="c-1" id="f-297">&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company applies fair value measurements to record fair value adjustments to certain assets and liabilities and to determine fair value disclosures. Fair value is measured as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A fair value measurement assumes that the transaction to sell the asset or transfer the liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market. A framework is used for measuring fair value utilizing a three-tier hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level&#160;1) and the lowest priority to unobservable inputs (Level&#160;3).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The three levels of the fair value hierarchy are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;padding-left:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Level&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Observable inputs such as unadjusted quoted prices in active markets that are accessible at the measurement date for identical unrestricted assets or liabilities the Company has the ability to access;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;padding-left:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Level&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Inputs (other than quoted prices included within Level&#160;1) that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;padding-left:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Level&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments are categorized in their entirety based on the lowest level of input that is significant to the fair value measurement. The assessment of the significance of a particular input to the fair value measurement requires judgment and considers factors specific to the investment. To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level&#160;3. The Company reviews the fair value hierarchy classification at each reporting date. Changes in the ability to observe valuation inputs may result in a reclassification of levels for certain assets or liabilities within the fair value hierarchy. The Company did not have any transfers of assets and liabilities between the levels of the fair value measurement hierarchy during the&#160;years presented.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="c-1" id="f-299">&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currency Remeasurement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s reporting currency and the functional currency of its foreign subsidiary, CAMP4 AUS, is the United States Dollar (&#x201c;USD&#x201d;). At the date a foreign currency denominated transaction is recognized, each asset, liability, revenue, expense, gain or loss arising from the transaction is measured initially in USD based on the exchange rate in effect at that date. Subsequently, at each balance sheet date, balances related to monetary assets and liabilities are adjusted to reflect the current exchange rate, which is the rate at which the related receivable or payable could be settled at that date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign exchange transaction gains and losses are included in other income, net in the accompanying consolidated statements of operations and comprehensive loss and were de minimis for the&#160;years ended December&#160;31, 2024 and 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="c-1" id="f-300">&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Comprehensive Loss&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no differences between net loss and comprehensive loss presented in the consolidated statements of operations for the&#160;years ended December&#160;31, 2024 and 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c-1" id="f-301">&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property and Equipment, Net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, which are all located in the United States, are stated at cost less accumulated depreciation. Expenditures for maintenance and repairs are charged to expense as incurred, whereas major betterments are capitalized as additions to property and equipment. Depreciation is calculated using the straight-line method over the following estimated useful lives of the assets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Computer and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Three years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Five years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Seven years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shorter of asset life or remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <camp:ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock contextRef="c-1" id="f-302">Depreciation is calculated using the straight-line method over the following estimated useful lives of the assets:&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Computer and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Three years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Five years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Seven years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shorter of asset life or remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</camp:ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-33" id="f-303">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-34" id="f-304">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-35" id="f-305">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="c-1" id="f-306">&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates its long-lived assets, which consist of property and equipment, operating lease right-of-use (&#x201c;ROU&#x201d;) assets, and finance lease ROU assets, for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant underperformance of the business in relation to expectations, significant negative industry or economic trends and significant changes or planned changes in the use of the assets. If the asset is impaired, the amount of any impairment is measured as the difference between the carrying value and the fair value of the impaired asset. The Company recognized no impairment losses for the&#160;years ended December&#160;31, 2024 and 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock contextRef="c-1" id="f-307">&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Commitments and Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contractual Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company enters into contracts in the normal course of business with contract research organizations (&#x201c;CROs&#x201d;), contract manufacturing organizations (&#x201c;CMOs&#x201d;), academic institutions and other third parties for preclinical and clinical research studies, testing and manufacturing services. These contracts generally do not contain minimum purchase commitments and are cancellable by the Company upon prior written notice, although purchase orders for preclinical materials are generally non-cancellable. Payments due upon cancellation consist primarily of payments for services provided or expenses incurred, including non-cancellable obligations from the Company&#x2019;s service providers, up to the date of cancellation or upon the completion of a manufacturing run.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <camp:GuaranteesAndIndemnificationsPolicyTextBlock contextRef="c-1" id="f-308">&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Indemnifications&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Indemnification Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has entered into indemnification agreements with its officers and directors that require the Company to indemnify such individuals for certain events or occurrences while each such officer or director is, or was, serving at the Company&#x2019;s request in such capacity. The maximum potential future payments the Company could be required to make is, in many cases, unlimited. The Company has directors&#x2019; and officers&#x2019; liability insurance coverage that limits its exposure and enables the Company to recover a portion of any future amounts paid.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases office and laboratory space under operating leases. The Company has standard indemnification arrangements under the leases that require it to indemnify the landlords against all costs, expenses, fines, suits, claims, demands, liabilities and actions directly resulting from any breach, violation or nonperformance of any covenant or condition of the Company&#x2019;s leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the ordinary course of its business, the Company enters into indemnification agreements with certain suppliers and business partners pursuant to which the Company has certain indemnification obligations limited to the costs, expenses, fines, suits, claims, demands, liabilities and actions directly resulting from the Company&#x2019;s gross negligence or willful misconduct, and in certain instances, breaches, violations or nonperformance of covenants or conditions under the agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2024 and 2023, the Company had not experienced any material losses related to these indemnification obligations, and no material claims with respect thereto were outstanding. The Company does not expect significant claims related to these indemnification obligations and, consequently, concluded that the fair value of these obligations is negligible, and no related reserves were established.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to the possibility of loss contingencies arising in the ordinary course of business. Management considers the likelihood of loss related to an asset, or the incurrence of a liability, as well as its ability to reasonably estimate the amount of the loss, in determining loss contingencies. An estimated loss contingency is accrued when it is probable that an asset has been impaired, or a liability has been incurred and the amount of loss can be reasonably estimated. The Company regularly evaluates current information available to determine whether such accruals should be adjusted and whether new accruals are required.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company may become involved in litigation relating to claims arising from the ordinary course of business. Management believes that there are no claims or actions pending against the Company currently, the ultimate disposition of which would have a material adverse effect on the Company&#x2019;s consolidated results of operations, financial condition or cash flows.&lt;/span&gt;&lt;/div&gt;</camp:GuaranteesAndIndemnificationsPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c-1" id="f-309">&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with ASC 842,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company determines if an arrangement is or contains a lease at inception. A contract is or contains a lease if the contract conveys the right to control the use of an identified asset for a period in exchange for consideration. The Company classifies leases at the lease commencement date as operating or finance leases and records a ROU asset and a lease liability on the consolidated balance sheet for all leases with an initial lease term of greater than 12 months. Leases with an initial term of 12 months or less are not recorded in the balance sheet, but payments are recognized as expense on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A lease qualifies as a finance lease if any of the following criteria are met at the inception of the lease: (i)&#160;there is a transfer of ownership of the leased asset to the Company by the end of the lease term, (ii)&#160;the Company holds an option to purchase the leased asset that it is reasonably certain to exercise, (iii)&#160;the lease term is for a major part of the remaining economic life of the leased asset, (iv)&#160;the present value of the sum of lease payments equals or exceeds substantially all of the fair value of the leased asset, or (v)&#160;the nature of the leased asset is specialized to the point that it is expected to provide the lessor no alternative use at the end of the lease term. All other leases are recorded as operating leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company enters into contracts that contain both lease and non-lease components. Non-lease components may include maintenance, utilities and other operating costs. The Company combines the lease and non-lease components of fixed costs in its lease arrangements as a single lease component. Variable costs, such as utilities or maintenance costs, are not included in the measurement of ROU assets and lease liabilities, but rather are expensed when the event determining the amount of variable consideration to be paid occurs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance and operating lease assets and liabilities are recognized at the lease commencement date based on the present value of the lease payments over the lease term using the discount rate implicit in the lease. If the rate implicit is not readily determinable, the Company utilizes an estimate of its incremental borrowing rate based upon the available information at the lease commencement date. Operating lease assets are further adjusted for prepaid or accrued lease payments. Operating lease assets are expensed using the straight-line method as an operating expense over the lease term. Finance lease assets are amortized to depreciation expense using the straight-line method. Finance lease payments are bifurcated into (i)&#160;a portion that is recorded as imputed interest expense and (ii)&#160;a portion that reduces the finance liability associated with the lease.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of the Company&#x2019;s leases provide a lease incentive in the form of reimbursable leasehold improvements. Due to the unpredictability of the payout of leasehold improvement reimbursements, the Company recognizes a reduction to the ROU asset and the lease liability once it has incurred costs that qualify as reimbursable by the lessor. The reduction to the ROU asset is recognized prospectively over the remainder of the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of the Company&#x2019;s leases include options to extend or terminate the lease. The amounts determined for the Company&#x2019;s ROU assets and lease liabilities generally do not assume that renewal options or early-termination provisions, if any, are exercised, unless it is reasonably certain that the Company will exercise such options.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the Company examines other contracts with suppliers, vendors and outside parties to identify whether such contracts contain an embedded lease and, as applicable, records such embedded leases in accordance with ASC 842,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <camp:FinancingObligationFailedSaleLeasebackPolicyTextBlock contextRef="c-1" id="f-310">&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Financing Obligation (Failed Sale-Leaseback)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with ASC 842,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for potential sale-leaseback transactions, the Company assesses the contract to identify if a sale occurred in accordance with ASC Topic 606,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASC 606&#x201d;). Sale-and-leaseback transactions occur when the Company sells assets to a third-party and simultaneously leases them back. The resulting leases that qualify for sale-and-leaseback accounting are evaluated and accounted for as operating leases. A transaction that does not qualify for sale-and-leaseback accounting as a result of finance lease classification or the failure to meet certain revenue recognition criteria is accounted for as a financing transaction. For a financing transaction, the Company will retain the assets sold within Property, plant and equipment, net and record a financing obligation equal to the amount of cash proceeds received. Rental payments under such transactions are recognized as a reduction of the financing obligation and as interest expense using an effective interest method. To date, the Company has entered into one failed sale-leaseback transaction. See additional discussion in&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 7. Commitments and Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</camp:FinancingObligationFailedSaleLeasebackPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="c-1" id="f-311">&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition and Accounting for Collaboration Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue in accordance with ASC 606. The Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. In determining the appropriate amount of revenue to be recognized as it fulfills its obligations under its agreements, the Company performs the following steps: (i)&#160;identification of the promised goods or services in the contract; (ii)&#160;determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii)&#160;measurement of the transaction price, including the constraint on variable consideration; (iv)&#160;allocation of the transaction price to the performance obligations; and (v)&#160;recognition of revenue when (or as) the Company satisfies each performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses judgment to determine: (a)&#160;the performance obligations based on the determination under step (ii)&#160;above; (b)&#160;the transaction price under step (iii)&#160;above; and (c)&#160;the recognition of revenue as services are performed under step (v)&#160;above. The Company also uses judgment to determine whether development milestones or other variable consideration except for royalties and sales-based milestones, should be included in the transaction price as described further below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company applies the five-step model to contracts when the arrangement is not a collaboration pursuant to ASC Topic 808,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Collaborative Arrangements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;(&#x201c;ASC 808&#x201d;), and it is probable that the Company will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Collaborative Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company analyzes its collaboration agreements to assess whether they are within the scope of ASC 808 by determining whether such arrangements involve joint operating activities performed by parties that are both active participants in the activities and exposed to significant risks and rewards that are dependent on the commercial success of such activities. To the extent the arrangement is within the scope of ASC 808, the Company assesses whether aspects of the arrangement between the Company and the collaboration partner are within the scope of other accounting literature. If the Company concludes that some or all aspects of the arrangement represent a transaction with a customer, the Company &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;accounts for those aspects of the arrangement within the scope of ASC 606. If the Company concludes that some or all aspects of the arrangement are within the scope of ASC 808 and do not represent a transaction with a customer, the Company recognizes the Company&#x2019;s share of the allocation of the shared costs incurred with respect to the jointly conducted activities as a component of the related expense in the period incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="c-1" id="f-312">&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Research and Development Expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development (&#x201c;R&amp;amp;D&#x201d;) expenses are recorded to operating expenses when incurred. The Company&#x2019;s R&amp;amp;D expenses consist primarily of costs incurred in performing R&amp;amp;D activities, including personnel-related expenses such as salaries, stock-based compensation and benefits, facilities costs, depreciation and external costs of outside vendors engaged to conduct clinical and preclinical development activities and to manufacture a product candidate. The Company accrues expenses related to development activities performed by third parties based on an evaluation of services received and efforts expended pursuant to the terms of the contractual arrangements. Payments under some of these contracts depend on preclinical trial milestones. Non-refundable advance payments for goods and services that will be used over time for R&amp;amp;D are deferred and capitalized as R&amp;amp;D prepaid expenses on the Company&#x2019;s consolidated balance sheets. The capitalized amounts are recognized as an expense as the goods are delivered or as the related services are performed. In accruing service fees, the Company estimates the period over which services will be performed and the level of effort to be expended in each period. If the actual timing of the performance of services or the level of effort varies from the estimate, the Company will adjust the accrual or prepaid expense accordingly. Costs to acquire technologies to be used in R&amp;amp;D that have not reached technological feasibility and have no alternative future use are also expensed as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock contextRef="c-1" id="f-313">&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;General and Administrative Expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;General and administrative (&#x201c;G&amp;amp;A&#x201d;) expenses consist primarily of personnel-related expenses, including salaries, bonuses, benefits, travel and stock-based compensation expenses for employees in executive, accounting and finance, business development, human resources, legal, and other administrative functions. Other significant G&amp;amp;A expenses include allocated facility-related costs, legal fees relating to corporate and intellectual property matters, professional fees for accounting, audit and tax services, consulting fees and insurance costs. G&amp;amp;A costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock>
    <camp:PatentCostsPolicyTextBlock contextRef="c-1" id="f-314">&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Patent Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All patent-related costs incurred in connection with filing and prosecuting patent applications are expensed as incurred due to the uncertainty about the recovery of the expenditure. Amounts are classified as G&amp;amp;A expenses.&lt;/span&gt;&lt;/div&gt;</camp:PatentCostsPolicyTextBlock>
    <camp:OfferingCostsPolicyTextBlock contextRef="c-1" id="f-315">&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Offering Costs&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company complies with the requirements of ASC 340,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Assets and Deferred Costs&lt;/span&gt;, with regards to offering costs. Prior to the completion of an offering of common stock, direct offering costs are capitalized as deferred offering costs. The deferred offering costs are charged to additional paid-in capital for offerings of common stock or as a reduction in the carrying value of preferred stock for offerings of preferred stock.</camp:OfferingCostsPolicyTextBlock>
    <us-gaap:DeferredCosts contextRef="c-4" decimals="-5" id="f-316" unitRef="usd">4000000.0</us-gaap:DeferredCosts>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c-1" id="f-317">&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company periodically grants equity-based awards in the form of stock options and restricted stock to employees, directors and non-employees and records stock-based compensation expenses based on their estimated fair value at the grant date. The Company estimates the fair value of stock options using the Black-Scholes option-pricing model as of the grant date. Stock-based compensation expenses are recognized in the accompanying consolidated statements of operations and comprehensive loss on a straight-line basis over the requisite service period, which is typically the vesting period. Determining the appropriate fair value model and related input assumptions requires judgment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the IPO, the fair value of the Company&#x2019;s common stock was determined by the Company&#x2019;s Board of Directors (the &#x201c;Board&#x201d;) at the time of each option grant by considering several objective and subjective factors. These factors included the valuation of a select group of representative public companies within the industry that focus on biotechnology that the Board believed was comparable to the Company&#x2019;s operations; operating and financial performance; the lack of liquidity of the common stock and trends in the broader economy and biotechnology industry also impact the determination of the fair value of the common stock. For awards granted after the Company&#x2019;s IPO, the grant date fair value of common stock was determined by using the closing price per share of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The other inputs to the Black-Scholes option-pricing model include the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The risk-free interest rate used is based on the published U.S. Department of Treasury interest rates in effect at the time of stock option grant for zero coupon U.S. Treasury notes with maturities approximating each grant&#x2019;s expected term;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The dividend yield is zero as the Company has not paid dividends and does not anticipate paying a cash dividend in the foreseeable future;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The expected term for options granted is calculated using the simplified method and represents the average time that options are expected to be outstanding based on the mid-point between the vesting date and the end of the contractual term of the award; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Expected volatility is derived from the historical volatility of a select group of representative companies, for a look-back period commensurate with the expected term of the stock options, as the Company has limited trading history of common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company recognizes forfeitures related to stock-based compensation awards as they occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company classifies stock-based compensation expense in the consolidated statement of operations and comprehensive loss in the same way the award recipients&#x2019; payroll costs are classified or in which the award recipients&#x2019; service payments are classified.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-1" decimals="INF" id="f-318" unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c-1" id="f-319">&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for income taxes in accordance with ASC 740,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;(&#x201c;ASC 740&#x201d;). ASC 740 requires the use of the asset and liability method of accounting for income taxes. The current or deferred tax consequences of a transaction are measured by applying the provisions of enacted tax laws to determine the amount of taxes payable currently or in future&#160;years. Deferred tax assets and liabilities are determined based on the difference between the consolidated financial statements and tax basis of assets and liabilities and expected future tax consequences of events that have been included in the consolidated financial statements or tax returns using enacted tax rates in effect for the year in which the differences are expected to reverse. Under this method, a valuation allowance is used to offset deferred tax assets if, based upon the available evidence, it is more likely than not that some or all of the deferred tax assets may not be realized. Management evaluates the recoverability of deferred taxes and the adequacy of the valuation allowance at each reporting period (see Note 12,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company follows the provisions of ASC 740 relative to accounting for uncertain tax positions. These provisions provide guidance on the recognition, de-recognition and measurement of potential tax benefits associated with tax positions. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company had no reserves related to uncertain tax positions as of December&#160;31, 2024 and 2023. As applicable, the Company recognizes accrued penalties and interest related to unrecognized tax benefits in the provision for income taxes. As of December&#160;31, 2024 and 2023, the Company did not accrue any potential interest or penalties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is required to file federal and state income tax returns in the U.S. and foreign income tax returns in Australia. The preparation of tax returns requires the Company to interpret the applicable tax laws and regulations in effect in such jurisdictions, which could affect the amount of tax paid by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s income tax returns are based on calculations and assumptions that are subject to examination by the Internal Revenue Service and other tax authorities for the tax years ended December 31, 2020 through December 31, 2024. In addition, the calculation of the Company&#x2019;s tax liabilities involves dealing with uncertainties in the application of complex tax regulations.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:StockholdersEquityNoteRedeemablePreferredStockIssuePolicy contextRef="c-1" id="f-320">&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Classification of Convertible Preferred Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s convertible preferred stock was classified as temporary equity in the accompanying consolidated balance sheet as of December&#160;31, 2023 and was excluded from stockholders&#x2019; equity (deficit) as the potential redemption of such stock was outside the Company&#x2019;s control. The convertible preferred stock was not redeemable except for in the event of a liquidation, dissolution or winding up of the Company. The Company did not accrete the carrying values of the preferred stock to the redemption values since the occurrence of these events was not considered probable.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteRedeemablePreferredStockIssuePolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c-1" id="f-321">&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net Loss Per Share Attributable to Common Stockholders&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined all of its convertible preferred stock qualified as participating securities, as defined in ASC 260,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Earnings Per Share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;(&#x201c;ASC 260&#x201d;). Under ASC 260, securities are considered participating securities if the securities may participate in undistributed earnings with common stock, whether that participation is conditioned upon the occurrence of a specified event or not. In accordance with ASC 260, a company is required to use the two-class method when computing net income (loss) per share when a company has securities that qualify as participating securities. The two-class method is an earnings allocation formula that determines net income (loss) per share for each class of common stock and participating security according to dividends declared (or accumulated) and participation rights in undistributed earnings. Diluted net loss per share for the Company&#x2019;s common stock is computed using the more dilutive of the two-class method or the if-converted method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period. Diluted net loss attributable to common stockholders is computed by adjusting net loss per share attributable to common stockholders to reallocate undistributed earnings based on the potential impact of dilutive securities. Diluted net loss per share attributable to common stockholders is computed by dividing the diluted net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period, including potential dilutive common shares. For purpose of this calculation, outstanding options to purchase common stock, unvested restricted stock awards, and shares of convertible preferred stock are considered potential dilutive common shares. The Company has generated a net loss in all periods presented, and therefore the basic and diluted net loss per share attributable to common stockholders are the same as the inclusion of the potentially dilutive securities would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <camp:EmergingGrowthCompanyStatusPolicyTextBlock contextRef="c-1" id="f-322">&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Emerging Growth Company Status&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is an emerging growth company (&#x201c;EGC&#x201d;) as defined in the Jumpstart Our Business Startups Act of 2012, as amended (the &#x201c;JOBS Act&#x201d;), and may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not an EGC. The Company may take advantage of these exemptions until it is no longer an EGC under Section&#160;107 of the JOBS Act and has elected to use the extended transition period for complying with new or revised accounting standards. As a result of this election, the Company&#x2019;s consolidated financial statements may not be comparable to companies that comply with public company FASB standards&#x2019; effective dates.&lt;/span&gt;&lt;/div&gt;</camp:EmergingGrowthCompanyStatusPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-323">&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In November 2023, FASB issued ASU 2023-07, &#x201c;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.&#x201d; The standard expands reportable segment disclosure requirements for public business entities primarily through enhanced disclosures about significant segment expenses that are regularly provided to the chief operating decision maker (&#x201c;CODM&#x201d;) and included within each reported measure of segment profit (referred to as the &#x201c;significant expense principle&#x201d;). The Company has adopted this standard for the fiscal year 2024 annual financial statements and has applied this standard retrospectively for all prior periods presented in the financial statements (see Note 13).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounting standards not listed below were assessed and determined not to be applicable or are expected to have minimal impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU 2023-09, Income Taxes (&#x201c;Topic 740&#x201d;):&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Improvements to Income Tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The guidance includes the requirement that public business entities, on an annual basis, disclose specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold (if the effect of those reconciling items is equal to or greater than 5% of the amount computed by multiplying pretax income (or loss) by the applicable statutory income tax rate). It also requires that all entities disclose, on an annual basis, the amount of income taxes paid (net of refunds received) disaggregated by federal (national), state, and foreign taxes and the amount of income taxes paid (net of refunds received) disaggregated by individual jurisdictions in which income taxes paid (net of refunds received) is equal to or greater than 5% of total income taxes paid (net of refunds received) and requires that all entities disclose income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign and income tax expense (or benefit) from continuing operations disaggregated by federal (national), state, and foreign. Lastly, the guidance eliminates the requirement for all entities to disclose the nature and estimate of the range of the reasonably possible change in the unrecognized tax benefits balance in the next 12 months or make a statement that an estimate of the range cannot be made. For public business entities, the guidance is effective for annual periods beginning after December&#160;15, 2024. Early adoption is permitted for annual &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;consolidated financial statements that have not yet been issued or made available for issuance. The guidance should be applied on a prospective basis. Retrospective application is permitted. The Company is currently evaluating the impact that this guidance may have on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In November 2024, the FASB issued ASU 2024-03, &#x201c;Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses.&#x201d; The standard requires that public business entities disclose additional information about specific expense categories in the notes to financial statements for interim and annual reporting periods. For public business entities, the guidance is effective for interim and annual periods beginning after December&#160;15, 2026. Early adoption is permitted for annual consolidated financial statements that have not yet been issued or made available for issuance. The guidance may be applied on a prospective basis or retrospectively for all prior periods presented in the financial statements. The Company is currently evaluating the impact that this guidance may have on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-324">Fair Value Measurements&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the financial instruments carried at fair value on a recurring basis as of December&#160;31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;60,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;60,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;37,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;37,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts reflected in the consolidated balance sheet for prepaid expenses and other current assets, accounts payable and accrued expenses and other liabilities are shown at their historical values which approximate their fair values.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="c-1" id="f-325">&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the financial instruments carried at fair value on a recurring basis as of December&#160;31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;60,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;60,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;37,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;37,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-36" decimals="-3" id="f-326" unitRef="usd">60819000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-37" decimals="-3" id="f-327" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-38" decimals="-3" id="f-328" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-39" decimals="-3" id="f-329" unitRef="usd">60819000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-40" decimals="-3" id="f-330" unitRef="usd">37074000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-41" decimals="-3" id="f-331" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-42" decimals="-3" id="f-332" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-43" decimals="-3" id="f-333" unitRef="usd">37074000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <camp:PrepaidExpensesAndOtherCurrentAssetsDisclosureTextBlock contextRef="c-1" id="f-334">Prepaid Expenses and Other Current Assets&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other current assets consisted of the following as of December&#160;31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;R&amp;amp;D expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Insurance expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Software and subscriptions expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Variable lease expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Federal R&amp;amp;D tax credit receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</camp:PrepaidExpensesAndOtherCurrentAssetsDisclosureTextBlock>
    <camp:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock contextRef="c-1" id="f-335">&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other current assets consisted of the following as of December&#160;31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;R&amp;amp;D expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Insurance expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Software and subscriptions expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Variable lease expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Federal R&amp;amp;D tax credit receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</camp:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock>
    <camp:PrepaidResearchAndDevelopmentExpenseCurrent contextRef="c-4" decimals="-3" id="f-336" unitRef="usd">979000</camp:PrepaidResearchAndDevelopmentExpenseCurrent>
    <camp:PrepaidResearchAndDevelopmentExpenseCurrent contextRef="c-5" decimals="-3" id="f-337" unitRef="usd">480000</camp:PrepaidResearchAndDevelopmentExpenseCurrent>
    <us-gaap:PrepaidInsurance contextRef="c-4" decimals="-3" id="f-338" unitRef="usd">591000</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance contextRef="c-5" decimals="-3" id="f-339" unitRef="usd">74000</us-gaap:PrepaidInsurance>
    <camp:PrepaidSoftwareAndSubscriptionExpenseCurrent contextRef="c-4" decimals="-3" id="f-340" unitRef="usd">337000</camp:PrepaidSoftwareAndSubscriptionExpenseCurrent>
    <camp:PrepaidSoftwareAndSubscriptionExpenseCurrent contextRef="c-5" decimals="-3" id="f-341" unitRef="usd">287000</camp:PrepaidSoftwareAndSubscriptionExpenseCurrent>
    <camp:PrepaidVariableLeaseExpenseCurrent contextRef="c-4" decimals="-3" id="f-342" unitRef="usd">118000</camp:PrepaidVariableLeaseExpenseCurrent>
    <camp:PrepaidVariableLeaseExpenseCurrent contextRef="c-5" decimals="-3" id="f-343" unitRef="usd">105000</camp:PrepaidVariableLeaseExpenseCurrent>
    <camp:PrepaidFederalResearchAndDevelopmentTaxCreditCurrent contextRef="c-4" decimals="-3" id="f-344" unitRef="usd">108000</camp:PrepaidFederalResearchAndDevelopmentTaxCreditCurrent>
    <camp:PrepaidFederalResearchAndDevelopmentTaxCreditCurrent contextRef="c-5" decimals="-3" id="f-345" unitRef="usd">442000</camp:PrepaidFederalResearchAndDevelopmentTaxCreditCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-346" unitRef="usd">211000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-5" decimals="-3" id="f-347" unitRef="usd">245000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-348" unitRef="usd">2344000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-5" decimals="-3" id="f-349" unitRef="usd">1633000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="c-1" id="f-350">Property and Equipment, Net&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net consisted of the following as of December&#160;31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Computer and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4,505)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2024, title of a finance lease ROU asset for laboratory equipment with cost totaling $0.3 million transferred to the Company. The laboratory equipment had accumulated depreciation of $0.2 million. The Company incurred depreciation and amortization expense of $1.5 million and $1.6 million for the&#160;years ended December&#160;31, 2024 and 2023, respectively. Depreciation and amortization expense for the&#160;years ended December&#160;31, 2024 and 2023 includes $0.2 million and $0.1 million of finance lease ROU asset amortization, respectively (see Note 7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-351">&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net consisted of the following as of December&#160;31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Computer and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4,505)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-44" decimals="-3" id="f-352" unitRef="usd">4518000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-45" decimals="-3" id="f-353" unitRef="usd">4518000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-34" decimals="-3" id="f-354" unitRef="usd">4078000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-46" decimals="-3" id="f-355" unitRef="usd">3322000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-33" decimals="-3" id="f-356" unitRef="usd">969000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-47" decimals="-3" id="f-357" unitRef="usd">938000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-35" decimals="-3" id="f-358" unitRef="usd">524000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-48" decimals="-3" id="f-359" unitRef="usd">524000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-4" decimals="-3" id="f-360" unitRef="usd">10089000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-5" decimals="-3" id="f-361" unitRef="usd">9302000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-4" decimals="-3" id="f-362" unitRef="usd">6231000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-5" decimals="-3" id="f-363" unitRef="usd">4505000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-364" unitRef="usd">3858000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-5" decimals="-3" id="f-365" unitRef="usd">4797000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability contextRef="c-49" decimals="-5" id="f-366" unitRef="usd">300000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization contextRef="c-34" decimals="-3" id="f-367" unitRef="usd">200000</us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-1" decimals="-5" id="f-368" unitRef="usd">1500000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-6" decimals="-5" id="f-369" unitRef="usd">1600000</us-gaap:DepreciationAndAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c-1" decimals="-5" id="f-370" unitRef="usd">200000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c-6" decimals="-5" id="f-371" unitRef="usd">100000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock contextRef="c-1" id="f-372">&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;6. &#160;&#160;&#160;&#160;Accrued Expenses and Other Current Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses and other current liabilities consisted of the following as of December&#160;31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Employee compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;External R&amp;amp;D expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="c-1" id="f-373">&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses and other current liabilities consisted of the following as of December&#160;31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Employee compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;External R&amp;amp;D expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-374" unitRef="usd">3111000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-375" unitRef="usd">1937000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <camp:ProfessionalFeesAndOtherGeneralAndAdministrativeExpensesCurrent contextRef="c-4" decimals="-3" id="f-376" unitRef="usd">661000</camp:ProfessionalFeesAndOtherGeneralAndAdministrativeExpensesCurrent>
    <camp:ProfessionalFeesAndOtherGeneralAndAdministrativeExpensesCurrent contextRef="c-5" decimals="-3" id="f-377" unitRef="usd">475000</camp:ProfessionalFeesAndOtherGeneralAndAdministrativeExpensesCurrent>
    <camp:ResearchAndDevelopmentExpensesCurrent contextRef="c-4" decimals="-3" id="f-378" unitRef="usd">524000</camp:ResearchAndDevelopmentExpensesCurrent>
    <camp:ResearchAndDevelopmentExpensesCurrent contextRef="c-5" decimals="-3" id="f-379" unitRef="usd">601000</camp:ResearchAndDevelopmentExpensesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-380" unitRef="usd">537000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-381" unitRef="usd">289000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-382" unitRef="usd">4833000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-383" unitRef="usd">3302000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-384">&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;7. &#160;&#160;&#160;&#160;Commitments and Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company currently leases approximately 30,000 square feet of office space and laboratory space in Cambridge, Massachusetts (the &#x201c;Cambridge Lease&#x201d;) and approximately 5,300 square feet of office and lab space in Boulder, Colorado (the &#x201c;Boulder Lease&#x201d;). The Cambridge Lease expires on June&#160;30, 2027. The Cambridge Lease provided a lease incentive in the form of reimbursable leasehold improvements of up to $3.6 million. As of December&#160;31, 2024 and 2023, the Company had capitalized $4.5 million of leasehold improvement costs under this lease. $3.6 million was reimbursed through the lease incentive of which the final $2.7 million was received during the&#160;year ended December&#160;31, 2023. Amounts received for lease incentives were included in the changes in operating lease assets and liabilities line in the consolidated statement of cash flows. As of December&#160;31, 2024, the Cambridge Lease accounted for $4.9 million of operating lease ROU assets, $2.7 million of current operating lease liabilities and $4.6 million of non-current operating lease liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Boulder Lease is a five-year lease that commenced on September&#160;1, 2023 and expires on September&#160;30, 2028. As the rate implicit for the Boulder Lease was not readily determinable, the Company used its incremental borrowing rate of 7.12% as of the commencement date. At commencement of the Boulder Lease, the Company recorded $1.4 million of operating ROU assets, $0.2 million of current operating lease liabilities and $1.2 million of non-current operating lease liabilities. As of December&#160;31, 2024, the Boulder Lease accounted for $1.1 million of operating lease ROU assets, $0.3 million of current operating lease liabilities and $0.9 million of non-current operating lease liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the Company&#x2019;s operating lease costs for the&#160;years ended December&#160;31, 2024 and 2023 (in thousands except for lease terms and borrowing rates):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Variable lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.64pt;text-align:left;text-indent:-8.64pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating cash flows used for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average remaining lease term in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average incremental borrowing rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of operating lease liabilities as of December&#160;31, 2024 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.718%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.082%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: amount representing imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(769)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total future minimum lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Finance Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases certain specialized lab equipment under several finance lease agreements with maturities ranging from April 2025 to November 2028. As of December&#160;31, 2024, these finance leases account for $0.4 million of finance lease ROU assets, $0.1 million of current finance lease liabilities and $0.1 million of non-current finance lease liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the Company&#x2019;s finance lease costs for the&#160;years ended December&#160;31, 2024 and 2023 (in thousands except for lease terms and borrowing rates):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.454%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.757%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.153%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.434%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.434%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.713%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of ROU assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;text-indent:-10.8pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating cash flows used for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average remaining lease term in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average incremental borrowing rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of finance lease liabilities as of December&#160;31, 2024 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.718%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.082%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: amount representing imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total future minimum lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Financing Obligation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2023, the Company (seller-lessee) sold certain laboratory equipment to an unrelated third-party (buyer-lessor) and simultaneously entered into a 26-month lease agreement for the laboratory equipment with the buyer-lessor through June 2025. The lease requires monthly payments of less than $0.1 million and provides a fixed price repurchase option at the end of the lease term of $0.1 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The repurchase option precludes accounting for the transfer of the asset to the buyer-lessor as a sale under ASC 842 since the exercise price of the repurchase option is fixed and, therefore, is not the fair value of the asset on the exercise date of the option. Thus, the agreement is considered a financing transaction (i.e., failed sale-leaseback) as the Company is reasonably certain to exercise the repurchase option at the end of the lease. The net proceeds received amounted to $0.7 million, which is recorded as a financing liability in the Company&#x2019;s consolidated balance sheet. The Company imputes &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;interest at a rate of 0.86% monthly. For each of the years ended December&#160;31, 2024 and 2023, the Company recorded less than $0.1 million of interest expense related to this financing transaction in other expense in the consolidated statement of operations and comprehensive loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A liability for loss contingencies arising from claims, assessments, litigation, fines, penalties and other sources is recorded in the consolidated financial statements if it is determined that it is probable that a loss has been incurred and the amount (or range) of the loss can be reasonably estimated. There are no matters currently outstanding for which any liabilities have been accrued or require disclosure.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:AreaOfLand contextRef="c-50" decimals="-4" id="f-385" unitRef="sqft">30000</us-gaap:AreaOfLand>
    <us-gaap:AreaOfLand contextRef="c-51" decimals="-2" id="f-386" unitRef="sqft">5300</us-gaap:AreaOfLand>
    <camp:MaximumReimbursableIncentiveFromLessor contextRef="c-50" decimals="-5" id="f-387" unitRef="usd">3600000</camp:MaximumReimbursableIncentiveFromLessor>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-52" decimals="-5" id="f-388" unitRef="usd">4500000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-50" decimals="-5" id="f-389" unitRef="usd">4500000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:IncentiveFromLessor contextRef="c-50" decimals="-5" id="f-390" unitRef="usd">3600000</us-gaap:IncentiveFromLessor>
    <us-gaap:IncentiveFromLessor contextRef="c-52" decimals="-5" id="f-391" unitRef="usd">2700000</us-gaap:IncentiveFromLessor>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-50" decimals="-5" id="f-392" unitRef="usd">4900000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-50" decimals="-5" id="f-393" unitRef="usd">2700000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-50" decimals="-5" id="f-394" unitRef="usd">4600000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="c-53" id="f-395">P5Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <camp:LesseeOperatingLeaseIncrementalBorrowingRate contextRef="c-53" decimals="4" id="f-396" unitRef="number">0.0712</camp:LesseeOperatingLeaseIncrementalBorrowingRate>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-53" decimals="-3" id="f-397" unitRef="usd">1400000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-53" decimals="-3" id="f-398" unitRef="usd">200000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-53" decimals="-3" id="f-399" unitRef="usd">1200000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-51" decimals="-5" id="f-400" unitRef="usd">1100000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-51" decimals="-5" id="f-401" unitRef="usd">300000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-51" decimals="-5" id="f-402" unitRef="usd">900000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LeaseCostTableTextBlock contextRef="c-1" id="f-403">&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the Company&#x2019;s operating lease costs for the&#160;years ended December&#160;31, 2024 and 2023 (in thousands except for lease terms and borrowing rates):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Variable lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.64pt;text-align:left;text-indent:-8.64pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating cash flows used for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average remaining lease term in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average incremental borrowing rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the Company&#x2019;s finance lease costs for the&#160;years ended December&#160;31, 2024 and 2023 (in thousands except for lease terms and borrowing rates):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.454%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.757%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.153%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.434%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.434%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.713%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of ROU assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;text-indent:-10.8pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating cash flows used for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average remaining lease term in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average incremental borrowing rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost contextRef="c-1" decimals="-3" id="f-404" unitRef="usd">2436000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-6" decimals="-3" id="f-405" unitRef="usd">2489000</us-gaap:OperatingLeaseCost>
    <us-gaap:ShortTermLeaseCost contextRef="c-1" decimals="-3" id="f-406" unitRef="usd">54000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost contextRef="c-6" decimals="-3" id="f-407" unitRef="usd">119000</us-gaap:ShortTermLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-1" decimals="-3" id="f-408" unitRef="usd">1362000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-6" decimals="-3" id="f-409" unitRef="usd">1213000</us-gaap:VariableLeaseCost>
    <camp:LeaseCostExcludingFinanceLeases contextRef="c-1" decimals="-3" id="f-410" unitRef="usd">3852000</camp:LeaseCostExcludingFinanceLeases>
    <camp:LeaseCostExcludingFinanceLeases contextRef="c-6" decimals="-3" id="f-411" unitRef="usd">3821000</camp:LeaseCostExcludingFinanceLeases>
    <us-gaap:OperatingLeasePayments contextRef="c-1" decimals="-3" id="f-412" unitRef="usd">3390000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-6" decimals="-3" id="f-413" unitRef="usd">601000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-4" id="f-414">P2Y8M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-5" id="f-415">P3Y8M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-4" decimals="4" id="f-416" unitRef="number">0.0672</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-5" decimals="4" id="f-417" unitRef="number">0.0672</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-418">&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of operating lease liabilities as of December&#160;31, 2024 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.718%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.082%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: amount representing imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(769)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total future minimum lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-4" decimals="-3" id="f-419" unitRef="usd">3455000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-4" decimals="-3" id="f-420" unitRef="usd">3558000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-4" decimals="-3" id="f-421" unitRef="usd">1980000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c-4" decimals="-3" id="f-422" unitRef="usd">263000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-4" decimals="-3" id="f-423" unitRef="usd">9256000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-4" decimals="-3" id="f-424" unitRef="usd">769000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c-4" decimals="-3" id="f-425" unitRef="usd">8487000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="c-4" decimals="-5" id="f-426" unitRef="usd">400000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="c-4" decimals="-5" id="f-427" unitRef="usd">100000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-4" decimals="-5" id="f-428" unitRef="usd">100000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c-1" decimals="-3" id="f-429" unitRef="usd">189000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c-6" decimals="-3" id="f-430" unitRef="usd">146000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense contextRef="c-1" decimals="-3" id="f-431" unitRef="usd">26000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense contextRef="c-6" decimals="-3" id="f-432" unitRef="usd">33000</us-gaap:FinanceLeaseInterestExpense>
    <camp:LeaseCostFinanceLeases contextRef="c-1" decimals="-3" id="f-433" unitRef="usd">215000</camp:LeaseCostFinanceLeases>
    <camp:LeaseCostFinanceLeases contextRef="c-6" decimals="-3" id="f-434" unitRef="usd">179000</camp:LeaseCostFinanceLeases>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability contextRef="c-1" decimals="-3" id="f-435" unitRef="usd">364000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability contextRef="c-6" decimals="-3" id="f-436" unitRef="usd">322000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-4" id="f-437">P2Y6M</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-5" id="f-438">P1Y9M18D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent contextRef="c-4" decimals="4" id="f-439" unitRef="number">0.0828</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent contextRef="c-5" decimals="4" id="f-440" unitRef="number">0.0814</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-441">&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of finance lease liabilities as of December&#160;31, 2024 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.718%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.082%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: amount representing imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total future minimum lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-4" decimals="-3" id="f-442" unitRef="usd">111000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo contextRef="c-4" decimals="-3" id="f-443" unitRef="usd">31000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree contextRef="c-4" decimals="-3" id="f-444" unitRef="usd">31000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue contextRef="c-4" decimals="-3" id="f-445" unitRef="usd">173000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount contextRef="c-4" decimals="-3" id="f-446" unitRef="usd">12000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiability contextRef="c-4" decimals="-3" id="f-447" unitRef="usd">161000</us-gaap:FinanceLeaseLiability>
    <camp:FinancingObligationsLeaseTermOfContract contextRef="c-1" id="f-448">P26M</camp:FinancingObligationsLeaseTermOfContract>
    <camp:FinancingObligationsLeaseMaximumMonthlyRentalPayments contextRef="c-1" decimals="-5" id="f-449" unitRef="usd">100000</camp:FinancingObligationsLeaseMaximumMonthlyRentalPayments>
    <camp:FinancingObligationsLeaseFixedRepurchasePrice contextRef="c-1" decimals="-5" id="f-450" unitRef="usd">100000</camp:FinancingObligationsLeaseFixedRepurchasePrice>
    <camp:ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction contextRef="c-6" decimals="-5" id="f-451" unitRef="usd">700000</camp:ProceedsFromFinancingObligationsFailedSaleLeasebackTransaction>
    <camp:FinancingObligationsLeaseMonthlyInterestRatePercent contextRef="c-1" decimals="4" id="f-452" unitRef="number">0.0086</camp:FinancingObligationsLeaseMonthlyInterestRatePercent>
    <camp:FinancingObligationsLeaseMaximumInterestExpense contextRef="c-1" decimals="-5" id="f-453" unitRef="usd">100000</camp:FinancingObligationsLeaseMaximumInterestExpense>
    <camp:FinancingObligationsLeaseMaximumInterestExpense contextRef="c-6" decimals="-5" id="f-454" unitRef="usd">100000</camp:FinancingObligationsLeaseMaximumInterestExpense>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock contextRef="c-1" id="f-455">&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;8. &#160;&#160;&#160;&#160;Collaboration and License Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;In-License Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Children&#x2019;s Medical Center Corporation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2018, the Company entered into a development and license agreement (the &#x201c;CMCC Agreement&#x201d;) with Children&#x2019;s Medical Center Corporation (&#x201c;CMCC&#x201d;). The CMCC Agreement allows the Company to use CMCC&#x2019;s proprietary intellectual property to conduct research, development and commercialization of products utilizing CMCC&#x2019;s proprietary intellectual property in return for specified payments. The proprietary intellectual property licensed pursuant to this agreement is related to certain legacy programs the Company is not pursuing which were subsequently sublicensed to Fulcrum Therapeutics, Inc. (&#x201c;Fulcrum&#x201d;), as described below. As part of the CMCC Agreement, the Company issued a total of 15,123 shares of common stock to CMCC and its affiliates based on the fair value of the common stock on the date of issuance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is obligated to pay potential development milestone payments under the terms of the CMCC Agreement of up to $7.7 million for the first licensed target, $3.9 million for the second licensed target and $1.9 million for the third licensed target upon the achievement of certain specified contingent events. If commercial sales of a licensed product commence, the Company will pay CMCC royalties at&#160;percentage rates ranging in the low- to mid-single digits on net sales of licensed products in countries where such product is protected by patent rights. The Company incurred de minimis royalties owed to CMCC for each of the years ended December&#160;31, 2024 and 2023 under the CMCC Agreement and recorded the amounts in R&amp;amp;D expense in the consolidated statement of operations and comprehensive loss. Further, under the terms of the CMCC Agreement, the Company is required to pay ten percent of any upfront payment received under a sublicensing agreement entered into prior to the initiation of the first investigational new drug study. As such, the Company recorded de minimis amounts for each of the years ended December&#160;31, 2024 and 2023, which is presented in R&amp;amp;D expenses on the consolidated statements of operations and comprehensive loss. The Company re-evaluates the likelihood of achieving future milestones at the end of each reporting period. As of December&#160;31, 2024, the Company determined that the likelihood of achieving future milestones was not probable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Whitehead Institute for Biomedical Research&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2019, the Company entered into a patent license agreement (as subsequently amended, the &#x201c;Whitehead Agreement&#x201d;), with the Whitehead Institute for Biomedical Research, (&#x201c;Whitehead&#x201d;). Under the Whitehead Agreement, the Company was granted a worldwide, royalty-bearing, sublicensable license under certain patent rights owned or controlled by Whitehead. Upon entering into the Whitehead Agreement, the Company paid an initial $0.1 million license issuance fee, and paid de minimis additional fees in connection with subsequent amendments to the Whitehead Agreement. The Company is obligated to pay annual license maintenance fees for the term of the Whitehead Agreement. In addition, the Company is obligated to pay certain filing, prosecution and maintenance fees with respect to certain patent rights licensed. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is also obligated to pay potential development milestone payments to Whitehead of up to $1.9 million upon the achievement of certain specified contingent events. In addition, if the Company successfully commercializes a product under the Whitehead Agreement, it is obligated to pay tiered royalties at percentage rates ranging from less than one percent to the mid-single digits of net sales or of running royalties of net sales, subject to specified reductions, until either the last-to-expire valid claim of a Whitehead patent covering the product or seven years after the first commercial sale, in each case on a product-by-product and country-by-country basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company incurred fees of $0.3 million under the Whitehead Agreement during the year ended December&#160;31, 2024. During the year ended December&#160;31, 2023, the fees were de minimis. These fees are recorded in R&amp;amp;D expense in the Company&#x2019;s consolidated statement of operations and comprehensive loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Out-license&#160;Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fulcrum Therapeutics, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2023, the Company entered into a license agreement (the &#x201c;Fulcrum Agreement&#x201d;) with Fulcrum. Under the Fulcrum Agreement, the Company granted an exclusive license related to the Company&#x2019;s intellectual property (&#x201c;IP&#x201d;) and granted a non-exclusive sublicense for IP obtained through the CMCC Agreement. In exchange for the license rights, Fulcrum paid the Company a $0.4 million upfront payment. In the event that Fulcrum achieves certain development and commercial milestones, Fulcrum will be obligated to pay the Company one-time milestone payments ranging from $0.6 million to $20.0 million depending on the product and milestone achieved. In addition, under the Fulcrum Agreement there are potential de minimis minimum annual royalty payments as well as sales-based royalties of up to the low-double digits upon commercialization.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assessed this arrangement in accordance with ASC 606 and concluded that the contract counterparty, Fulcrum, is a customer. In accordance with ASC 606, the Company determined that there is one performance obligation in the Fulcrum Agreement, consisting of the exclusive and non-exclusive license rights granted to Fulcrum. The transaction price was comprised of the fixed consideration of $0.4 million and was recognized upon transfer of control of the licenses at a point in time upon contract execution. The arrangement includes significant variable consideration primarily in the form of milestone payments, which is fully constrained at the inception of the contract. All variable consideration is remeasured and reassessed each reporting period. As of and for the years ended December&#160;31, 2024 and 2023, the Company determined the variable consideration was fully constrained.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The sales-based royalty fee is considered variable consideration and will be recognized as revenue as such sales occur. The sales-based royalty fee qualifies for the royalty constraint exception and does not require an estimate of the future transaction price.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2023, the Company recorded $0.4 million in license revenue pursuant to the Fulcrum Agreement and none in the year ended December&#160;31, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Collaborative&#160;Arrangement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Eli Lilly and Company&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2023, the Company executed a Material Transfer Agreement (as amended, the &#x201c;MTA&#x201d;) with Eli Lilly and Company (&#x201c;Eli Lilly&#x201d;). As part of the MTA, the Company and Eli Lilly agreed to perform R&amp;amp;D activities to generate up to three antisense oligonucleotides (&#x201c;ASOs&#x201d;) in accordance with a prescribed workplan. The Company evaluated the MTA under ASC 808 and concluded that it is a collaboration arrangement. The Company and Eli Lilly are jointly overseeing the R&amp;amp;D activities under the MTA. In addition, both parties are exposed to significant risks and potential rewards under the MTA. During each of the years ended December&#160;31, 2024 and 2023, the Company recorded $0.5 million as a reduction in R&amp;amp;D expense in the consolidated statement of operations and comprehensive loss as a result of the earned R&amp;amp;D reimbursement from Eli Lilly. Additionally, the Company had an unbilled receivable of $0.1 million recorded within prepaid expenses and other current assets on the consolidated balance sheet as of December&#160;31, 2023 and a de minimis deferred liability as of December&#160;31, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Research and Collaboration&#160;Arrangement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;BioMarin Pharmaceutical Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2024, the Company entered into a Collaboration and License Agreement (the &#x201c;BioMarin Agreement&#x201d;) with BioMarin Pharmaceutical Inc. (&#x201c;BioMarin&#x201d;). Under the terms of the BioMarin Agreement, BioMarin paid the Company an upfront, nonrefundable payment of $1.0 million, and will reimburse the Company for certain research activities. On a per-program basis, the Company will be eligible to receive up to $5.0 million in future contingent preclinical milestones, up to $75.0 million in future contingent development and regulatory milestones and up to $105.0 million in commercial sales milestones. The Company will be further eligible to receive tiered royalties at percentage rates ranging from low to high single digits of net sales, subject to specified reductions, until either the last-to-expire valid claim of a patent covering the product, ten years after the first commercial sale, or the expiration of any applicable regulatory exclusivity obtained for the product, in each case on a product-by-product and country-by-country basis. The agreement may be terminated in its entirety or on a program-by-program basis for convenience by BioMarin. The agreement may also be terminated by either the Company or BioMarin under certain other circumstances, including material breach, as set forth in the agreement. The notice periods for termination provisions range from 30 days to 270 days depending on the reason for termination. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assessed this arrangement in accordance with ASC 606 and concluded that BioMarin is a customer and there is one performance obligation, which includes performance of R&amp;amp;D activities in accordance with a contractual work plan, participation in a joint steering committee, the grant of an exclusive license to BioMarin, the grant of a non-exclusive license to the data resulting from performance of the R&amp;amp;D activities, and providing quarterly progress reports. The transaction price was determined to be fixed consideration of $3.8 million, comprised of $1.0 million upfront consideration and expected $2.8 million reimbursable R&amp;amp;D expenses, and will be recognized over time based upon a cost-to-cost method. Any deferred revenue recorded will be classified as short-term. The Company believes this work will be completed within 12 months of contract execution and thus, the related revenue will be recognized over that period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The arrangement includes significant variable consideration primarily in the form of milestone payments, which is fully constrained at the inception of the contract. All variable consideration is remeasured and reassessed each reporting period. As of and for the year ended December&#160;31, 2024, the Company determined the variable consideration was fully constrained.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:11pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2024, the Company recognized $0.7 million in collaboration revenue under the BioMarin Agreement. Additionally, the Company had deferred revenue of $0.3 million recorded on the consolidated balance sheet as of December&#160;31, 2024.&lt;/span&gt;&lt;/div&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-54"
      decimals="INF"
      id="f-456"
      unitRef="shares">15123</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <camp:CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation contextRef="c-55" decimals="-5" id="f-457" unitRef="usd">7700000</camp:CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation>
    <camp:CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation contextRef="c-56" decimals="-5" id="f-458" unitRef="usd">3900000</camp:CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation>
    <camp:CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation contextRef="c-57" decimals="-5" id="f-459" unitRef="usd">1900000</camp:CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation>
    <camp:CollaborativeArrangementUpfrontLicenseIssuanceFeePayment contextRef="c-58" decimals="-5" id="f-460" unitRef="usd">100000</camp:CollaborativeArrangementUpfrontLicenseIssuanceFeePayment>
    <camp:CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation contextRef="c-59" decimals="-5" id="f-461" unitRef="usd">1900000</camp:CollaborativeArrangementMaximumDevelopmentMilestonePaymentObligation>
    <camp:CollaborativeArrangementTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale contextRef="c-60" id="f-462">P7Y</camp:CollaborativeArrangementTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale>
    <camp:CollaborativeArrangementFeesIncurredDuringPeriod contextRef="c-60" decimals="-5" id="f-463" unitRef="usd">300000</camp:CollaborativeArrangementFeesIncurredDuringPeriod>
    <us-gaap:ContractWithCustomerLiability contextRef="c-61" decimals="-5" id="f-464" unitRef="usd">400000</us-gaap:ContractWithCustomerLiability>
    <camp:RevenueRemainingPerformanceObligationVariableConsiderationAmount contextRef="c-62" decimals="-5" id="f-465" unitRef="usd">600000</camp:RevenueRemainingPerformanceObligationVariableConsiderationAmount>
    <camp:RevenueRemainingPerformanceObligationVariableConsiderationAmount contextRef="c-63" decimals="-5" id="f-466" unitRef="usd">20000000.0</camp:RevenueRemainingPerformanceObligationVariableConsiderationAmount>
    <camp:RevenuePerformanceObligationNumberOfPerformanceObligations
      contextRef="c-64"
      decimals="INF"
      id="f-467"
      unitRef="performanceobligation">1</camp:RevenuePerformanceObligationNumberOfPerformanceObligations>
    <camp:RevenueRemainingPerformanceObligationFixedConsiderationAmount contextRef="c-61" decimals="-5" id="f-468" unitRef="usd">400000</camp:RevenueRemainingPerformanceObligationFixedConsiderationAmount>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-65" decimals="-5" id="f-469" unitRef="usd">400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-66" decimals="INF" id="f-470" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <camp:CollaborativeArrangementReductionInResearchAndDevelopmentExpense contextRef="c-67" decimals="-5" id="f-471" unitRef="usd">500000</camp:CollaborativeArrangementReductionInResearchAndDevelopmentExpense>
    <camp:CollaborativeArrangementReductionInResearchAndDevelopmentExpense contextRef="c-68" decimals="-5" id="f-472" unitRef="usd">500000</camp:CollaborativeArrangementReductionInResearchAndDevelopmentExpense>
    <us-gaap:UnbilledContractsReceivable contextRef="c-69" decimals="-5" id="f-473" unitRef="usd">100000</us-gaap:UnbilledContractsReceivable>
    <us-gaap:ContractWithCustomerLiability contextRef="c-70" decimals="-5" id="f-474" unitRef="usd">1000000.0</us-gaap:ContractWithCustomerLiability>
    <camp:RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentPreclinicalMilestones contextRef="c-71" decimals="-5" id="f-475" unitRef="usd">5000000.0</camp:RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentPreclinicalMilestones>
    <camp:RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentDevelopmentAndRegulatoryMilestones contextRef="c-71" decimals="-5" id="f-476" unitRef="usd">75000000.0</camp:RevenueRemainingPerformanceObligationVariableConsiderationAmountContingentDevelopmentAndRegulatoryMilestones>
    <camp:RevenueRemainingPerformanceObligationVariableConsiderationAmountCommercialSalesMilestones contextRef="c-71" decimals="-5" id="f-477" unitRef="usd">105000000.0</camp:RevenueRemainingPerformanceObligationVariableConsiderationAmountCommercialSalesMilestones>
    <camp:RevenueRemainingPerformanceObligationTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale contextRef="c-72" id="f-478">P10Y</camp:RevenueRemainingPerformanceObligationTieredRoyaltiesPaymentPeriodAfterFirstCommercialSale>
    <camp:RevenueRemainingPerformanceObligationNoticePeriodForTermination contextRef="c-73" id="f-479">P30D</camp:RevenueRemainingPerformanceObligationNoticePeriodForTermination>
    <camp:RevenueRemainingPerformanceObligationNoticePeriodForTermination contextRef="c-74" id="f-480">P270D</camp:RevenueRemainingPerformanceObligationNoticePeriodForTermination>
    <camp:RevenueRemainingPerformanceObligationFixedConsiderationAmount contextRef="c-75" decimals="-5" id="f-481" unitRef="usd">3800000</camp:RevenueRemainingPerformanceObligationFixedConsiderationAmount>
    <us-gaap:ContractWithCustomerLiability contextRef="c-70" decimals="-5" id="f-482" unitRef="usd">1000000.0</us-gaap:ContractWithCustomerLiability>
    <camp:RevenueRemainingPerformanceObligationExpectedReimbursableResearchAndDevelopmentExpenses contextRef="c-75" decimals="-5" id="f-483" unitRef="usd">2800000</camp:RevenueRemainingPerformanceObligationExpectedReimbursableResearchAndDevelopmentExpenses>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-76" decimals="-5" id="f-484" unitRef="usd">700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerLiability contextRef="c-77" decimals="-5" id="f-485" unitRef="usd">300000</us-gaap:ContractWithCustomerLiability>
    <camp:TemporaryEquityDisclosureAndStockholdersEquityTextBlock contextRef="c-1" id="f-491">&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;9. &#160;&#160;&#160;&#160;Convertible Preferred Stock and Stockholders&#x2019; Equity (Deficit)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Convertible Preferred Stock &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon the closing of the IPO, all of the currently outstanding convertible preferred stock automatically converted into 11,648,582 shares of common stock. As of December&#160;31, 2023, the Company&#x2019;s convertible preferred stock consisted of the following (in thousands, except share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Authorized&lt;br/&gt;shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Shares&lt;br/&gt;issued and&lt;br/&gt;outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liquidation&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Common stock&lt;br/&gt;issuable&lt;br/&gt;upon&lt;br/&gt;conversion&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Series&#160;A Prime&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;68,173,692&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;62,389,791&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;62,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,562,653&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Series&#160;B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;81,499,592&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;68,258,635&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,085,929&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Common and Preferred Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company&#x2019;s amended and restated certificate of incorporation authorizes the issuance of up to 175,000,000 shares of $0.0001 par value common stock and up to 25,000,000 shares of $0.0001 par value undesignated preferred stock. The Board may designate the rights, preferences, privileges and restrictions of the preferred stock, including dividend rights, conversion rights, voting rights, terms of redemption, liquidation preference, and number of shares constituting any series or the designation of any series. The issuance of preferred stock could have the effect of restricting dividends on the Company&#x2019;s common stock, diluting the voting power of the Company&#x2019;s common stock, impairing the liquidation rights of the Company&#x2019;s common stock, or delaying or preventing a change in control. As of December&#160;31, 2024, no shares of preferred stock were outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Each share of common stock entitles the holder to one vote, together with the holders of any preferred stock, on all matters submitted to the stockholders for a vote. Common stockholders are also entitled to receive dividends. As of December&#160;31, 2024, no cash dividends have been declared or paid. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2024, the Company has reserved the following shares of common stock for future issuance:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.718%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.082%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares reserved for future issuance under the 2024 Equity Incentive Plan and ESPP &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,293,348&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock options outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,119,425&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted stock vesting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,943&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Warrant outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;142&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,428,858&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</camp:TemporaryEquityDisclosureAndStockholdersEquityTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c-30"
      decimals="INF"
      id="f-492"
      unitRef="shares">11648582</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:TemporaryEquityTableTextBlock contextRef="c-1" id="f-493">As of December&#160;31, 2023, the Company&#x2019;s convertible preferred stock consisted of the following (in thousands, except share amounts):&lt;div style="margin-bottom:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Authorized&lt;br/&gt;shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Shares&lt;br/&gt;issued and&lt;br/&gt;outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liquidation&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Common stock&lt;br/&gt;issuable&lt;br/&gt;upon&lt;br/&gt;conversion&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Series&#160;A Prime&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;68,173,692&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;62,389,791&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;62,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,562,653&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Series&#160;B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;81,499,592&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;68,258,635&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,085,929&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:TemporaryEquityTableTextBlock>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="c-82"
      decimals="INF"
      id="f-494"
      unitRef="shares">68173692</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c-82"
      decimals="INF"
      id="f-495"
      unitRef="shares">62389791</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="c-82"
      decimals="INF"
      id="f-496"
      unitRef="shares">62389791</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityLiquidationPreference contextRef="c-82" decimals="3" id="f-497" unitRef="usd">62381000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="c-82"
      decimals="INF"
      id="f-498"
      unitRef="shares">5562653</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="c-83"
      decimals="INF"
      id="f-499"
      unitRef="shares">81499592</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c-83"
      decimals="INF"
      id="f-500"
      unitRef="shares">68258635</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="c-83"
      decimals="INF"
      id="f-501"
      unitRef="shares">68258635</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityLiquidationPreference contextRef="c-83" decimals="3" id="f-502" unitRef="usd">100504000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="c-83"
      decimals="INF"
      id="f-503"
      unitRef="shares">6085929</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c-31"
      decimals="INF"
      id="f-504"
      unitRef="shares">175000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-31"
      decimals="INF"
      id="f-505"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c-31"
      decimals="INF"
      id="f-506"
      unitRef="shares">25000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-31"
      decimals="INF"
      id="f-507"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-508" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <camp:NumberOfVotesPerCommonShare contextRef="c-4" decimals="INF" id="f-509" unitRef="vote">1</camp:NumberOfVotesPerCommonShare>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-1"
      decimals="INF"
      id="f-510"
      unitRef="usdPerShare">0</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:PreferredStockDividendsPerShareDeclared
      contextRef="c-1"
      decimals="INF"
      id="f-511"
      unitRef="usdPerShare">0</us-gaap:PreferredStockDividendsPerShareDeclared>
    <us-gaap:ScheduleOfConversionsOfStockTextBlock contextRef="c-1" id="f-512">&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2024, the Company has reserved the following shares of common stock for future issuance:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.718%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.082%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares reserved for future issuance under the 2024 Equity Incentive Plan and ESPP &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,293,348&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock options outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,119,425&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted stock vesting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,943&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Warrant outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;142&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,428,858&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfConversionsOfStockTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-84"
      decimals="INF"
      id="f-513"
      unitRef="shares">2293348</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-4" decimals="INF" id="f-514" unitRef="shares">2119425</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="c-4" decimals="INF" id="f-515" unitRef="shares">15943</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c-4" decimals="INF" id="f-516" unitRef="shares">142</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="c-4" decimals="INF" id="f-517" unitRef="shares">4428858</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-518">&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;10. &#160;&#160;&#160;&#160;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024 Equity Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2024, the Company adopted the 2024 Equity Incentive Plan (the &#x201c;2024 Plan&#x201d;), which became effective in connection with the Company&#x2019;s IPO. The 2024 Plan provides for the grant of stock options, stock appreciation rights, restricted and unrestricted stock awards, restricted stock unit awards, and other stock-based awards to employees, directors, and non-employee service providers of the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Awards granted under the 2024 Plan expire no later than ten years from the date of grant. The price of stock options shall not be less than 100% of the estimated fair value on the date of grant and typically vest over a four-year period, although awards may be granted with different vesting terms. The 2024 Plan initially reserved 2,143,039 shares of common stock for the issuance of future awards and provides for an automatic annual increase in the number of shares of common stock reserved for future issuance by the lesser of (i) 5% of the number of shares of the Company&#x2019;s common stock outstanding as of the close of business on the immediately preceding December 31 and (ii) the number of shares determined by the Company&#x2019;s Board of Directors on or prior to such date for such year. As of December&#160;31, 2024, there were 2,079,045 shares of common stock reserved and available for issuance pursuant to the 2024 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024 Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2024, the Company adopted the 2024 Employee Stock Purchase Plan (the &#x201c;2024 ESPP&#x201d;), which became effective in connection with the Company&#x2019;s IPO. The 2024 ESPP initially reserved 214,303 shares of common stock for the issuance of future awards and provides for an automatic annual increase in the number of shares of common stock reserved for future issuance by the lesser of (1) 1% of the number of shares of the Company&#x2019;s common stock outstanding as of the close of business on the immediately preceding December 31 and (2) the number of shares determined by the Company&#x2019;s Board of Directors on or prior to such date for such year. As of December&#160;31, 2024, there were 214,303 shares of common stock reserved and available for issuance pursuant to the 2024 ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2024 ESPP permits eligible employees to enroll in six-month offering periods. Participants may purchase shares of the Company&#x2019;s common stock, through payroll deductions, at a price equal to 85% of the fair market value of the common stock on the first or last day of the applicable offering period, whichever is lower. Purchase dates under the 2024 ESPP occur on or about January 1 and July 1 each year. As of December&#160;31, 2024, there have been no offering periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2016 Equity Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2016, the Company adopted the Marauder Therapeutics, Inc. 2016 Stock Option and Grant Plan (the &#x201c;2016 Plan&#x201d;) that provided for the grant of stock options, restricted stock units, and other stock-based awards to employees, directors, and non-employee service providers of the Company. The 2016 Plan was suspended in connection with the Company&#x2019;s IPO and no further grants will be made. The 2016 Plan continues to govern the terms and conditions of outstanding awards granted under the 2016 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Option Activity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates the fair value of stock options using the Black-Scholes option pricing model. The weighted-average assumptions used to estimate the fair value of the stock options granted during the years ended December&#160;31, 2024 and 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;97.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;92.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.98%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.84%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected term (in&#160;years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.99&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.97&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average fair value of stock options granted during the&#160;years ended December&#160;31, 2024 and 2023 was $8.09 and $6.73 per share, respectively. The total intrinsic value of options exercised during the&#160;years ended December&#160;31, 2024 and 2023 was $6.6 million and $0.2 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company issued $1.0 million of promissory notes to certain executives during the year ended December 31, 2021 in order for them to early exercise stock options. Management concluded the promissory notes are recourse in form but non-recourse in substance as the Company does not intend to seek repayment beyond the shares issued. The promissory notes are therefore treated as an option for accounting purposes and are not recorded on the consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense is recorded, accordingly. The exercise price used in determining the fair value of the stock options includes the interest earned on the notes and the expected term is five years, reflecting the term of the notes. The early exercised shares were not outstanding for accounting purposes before repayment of the notes. During the year ended December&#160;31, 2024, the promissory notes were forgiven, resulting in 491,110 shares of common stock that had been exercised early being treated as outstanding for accounting purposes. These shares are included in the exercised options in the table below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock option activity for the year ended December&#160;31, 2024 (in thousands, except share and per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Number of outstanding options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;remaining&lt;br/&gt;contractual&lt;br/&gt;term in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Aggregate intrinsic value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,273,221&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.05&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;462,206&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forfeited/Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(102,221)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Exercises&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(513,781)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,119,425&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.98&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vested and expected to vest as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,119,425&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.98&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Exercisable as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,221,427&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.57&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded stock-based compensation expense related to stock options of $3.8 million and $2.8 million for the&#160;years ended December&#160;31, 2024 and 2023, respectively. As of December&#160;31, 2024, there was $6.8 million of unrecognized stock option stock-based compensation expense which is expected to be recognized over a weighted average period of 2.7 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of restricted stock award activity for the year ended December&#160;31, 2024 is a follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Number of shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted average&lt;br/&gt;fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unvested as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;74,243&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(58,300)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unvested as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,943&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All restricted common stock awards were initially issued at a price determined to be fair value on the date of grant. The Company recognizes forfeitures of restricted common stock as they occur. As of December&#160;31, 2024, there was a de minimis amount of unrecognized restricted stock-based compensation expense which is expected to be recognized over a weighted average period of 0.3 years. The fair value of shares that vested during the&#160;years ended December&#160;31, 2024 and 2023 was $0.1 million and $0.5 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense related to stock options and restricted stock recorded in the accompanying consolidated statements of operations for the&#160;years ended December&#160;31, 2024 and 2023 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;G&amp;amp;A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has not recognized and does not expect to recognize in the near future, any tax benefit related to employee stock-based compensation expense as a result of the full valuation allowance related to its net deferred tax assets.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="c-85" id="f-519">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <camp:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfEstimatedFairValueOnGrantDate
      contextRef="c-86"
      decimals="INF"
      id="f-520"
      unitRef="number">1</camp:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfEstimatedFairValueOnGrantDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-87" id="f-521">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-88"
      decimals="INF"
      id="f-522"
      unitRef="shares">2143039</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
      contextRef="c-87"
      decimals="INF"
      id="f-523"
      unitRef="number">0.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-89"
      decimals="INF"
      id="f-524"
      unitRef="shares">2079045</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-90"
      decimals="INF"
      id="f-525"
      unitRef="shares">214303</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
      contextRef="c-91"
      decimals="INF"
      id="f-526"
      unitRef="number">0.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-92"
      decimals="INF"
      id="f-527"
      unitRef="shares">214303</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate
      contextRef="c-91"
      decimals="INF"
      id="f-528"
      unitRef="number">0.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c-1" id="f-529">The weighted-average assumptions used to estimate the fair value of the stock options granted during the years ended December&#160;31, 2024 and 2023 were as follows:&lt;div style="margin-bottom:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;97.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;92.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.98%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.84%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected term (in&#160;years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.99&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.97&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-93" decimals="4" id="f-530" unitRef="number">0.9720</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-94" decimals="4" id="f-531" unitRef="number">0.9224</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-93" decimals="4" id="f-532" unitRef="number">3.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-94" decimals="4" id="f-533" unitRef="number">3.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-93"
      decimals="INF"
      id="f-534"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-94"
      decimals="INF"
      id="f-535"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-93" id="f-536">P5Y11M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-94" id="f-537">P5Y11M19D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-1"
      decimals="2"
      id="f-538"
      unitRef="usdPerShare">8.09</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-6"
      decimals="2"
      id="f-539"
      unitRef="usdPerShare">6.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-1" decimals="-5" id="f-540" unitRef="usd">6600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-6" decimals="-5" id="f-541" unitRef="usd">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <camp:UnrecordedNotesPayableIssuedForStockOptionEarlyExercise contextRef="c-95" decimals="-5" id="f-542" unitRef="usd">1000000.0</camp:UnrecordedNotesPayableIssuedForStockOptionEarlyExercise>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-96" id="f-543">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <camp:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAfterEarlyExerciseDueToNotesPayableForgiveness
      contextRef="c-97"
      decimals="INF"
      id="f-544"
      unitRef="shares">491110</camp:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAfterEarlyExerciseDueToNotesPayableForgiveness>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c-1" id="f-545">&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock option activity for the year ended December&#160;31, 2024 (in thousands, except share and per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Number of outstanding options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;remaining&lt;br/&gt;contractual&lt;br/&gt;term in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Aggregate intrinsic value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,273,221&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.05&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;462,206&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forfeited/Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(102,221)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Exercises&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(513,781)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,119,425&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.98&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vested and expected to vest as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,119,425&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.98&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Exercisable as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,221,427&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.57&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-5" decimals="INF" id="f-546" unitRef="shares">2273221</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-5"
      decimals="2"
      id="f-547"
      unitRef="usdPerShare">6.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-6" id="f-548">P8Y18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-5" decimals="-3" id="f-549" unitRef="usd">6893000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c-1" decimals="INF" id="f-550" unitRef="shares">462206</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-551"
      unitRef="usdPerShare">10.20</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="c-1" decimals="INF" id="f-552" unitRef="shares">102221</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-553"
      unitRef="usdPerShare">6.43</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-1" decimals="INF" id="f-554" unitRef="shares">513781</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-555"
      unitRef="usdPerShare">0.22</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-1" decimals="-3" id="f-556" unitRef="usd">6581000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-4" decimals="INF" id="f-557" unitRef="shares">2119425</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-4"
      decimals="2"
      id="f-558"
      unitRef="usdPerShare">7.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-1" id="f-559">P7Y11M23D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-4" decimals="-3" id="f-560" unitRef="usd">751000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="c-4" decimals="INF" id="f-561" unitRef="shares">2119425</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-4"
      decimals="2"
      id="f-562"
      unitRef="usdPerShare">7.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="c-1" id="f-563">P7Y11M23D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue contextRef="c-4" decimals="-3" id="f-564" unitRef="usd">751000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="c-4" decimals="INF" id="f-565" unitRef="shares">1221427</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="c-4"
      decimals="2"
      id="f-566"
      unitRef="usdPerShare">6.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="c-1" id="f-567">P7Y6M25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c-4" decimals="-3" id="f-568" unitRef="usd">739000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-93" decimals="-5" id="f-569" unitRef="usd">3800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-94" decimals="-5" id="f-570" unitRef="usd">2800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c-98" decimals="-5" id="f-571" unitRef="usd">6800000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-93" id="f-572">P2Y8M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock contextRef="c-1" id="f-573">&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of restricted stock award activity for the year ended December&#160;31, 2024 is a follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Number of shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted average&lt;br/&gt;fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unvested as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;74,243&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(58,300)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unvested as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,943&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="c-5" decimals="INF" id="f-574" unitRef="shares">74243</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-5"
      decimals="2"
      id="f-575"
      unitRef="usdPerShare">2.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="c-1" decimals="INF" id="f-576" unitRef="shares">58300</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-1"
      decimals="2"
      id="f-577"
      unitRef="usdPerShare">0.82</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="c-4" decimals="INF" id="f-578" unitRef="shares">15943</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-4"
      decimals="2"
      id="f-579"
      unitRef="usdPerShare">1.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-99" id="f-580">P0Y3M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-99" decimals="-5" id="f-581" unitRef="usd">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-100" decimals="-5" id="f-582" unitRef="usd">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c-1" id="f-583">&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense related to stock options and restricted stock recorded in the accompanying consolidated statements of operations for the&#160;years ended December&#160;31, 2024 and 2023 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;G&amp;amp;A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-101" decimals="-3" id="f-584" unitRef="usd">1876000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-102" decimals="-3" id="f-585" unitRef="usd">1555000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-103" decimals="-3" id="f-586" unitRef="usd">2156000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-104" decimals="-3" id="f-587" unitRef="usd">1352000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-3" id="f-588" unitRef="usd">4032000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-6" decimals="-3" id="f-589" unitRef="usd">2907000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:DefinedContributionPlanTextBlock contextRef="c-1" id="f-590">Employee Benefit Plan&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January&#160;1, 2017, the Company&#x2019;s board of directors approved the Company&#x2019;s 401(k) retirement plan (the &#x201c;401(k) Plan&#x201d;). Employees of the Company are eligible to participate in the 401(k) Plan. Participants may contribute up to 100% of their annual compensation to the 401(k) Plan, subject to statutory limitations. Effective January&#160;1, 2022, under the 401(k) Plan &#x201c;Safe Harbor Match,&#x201d; the Company matches 100% of the first 3% of employee contributions and these contributions vest in full at the time of match.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2024 and 2023, the Company made matching contributions of $0.3 million and $0.4 million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:DefinedContributionPlanTextBlock>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent contextRef="c-1" decimals="2" id="f-591" unitRef="number">1</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch contextRef="c-1" decimals="2" id="f-592" unitRef="number">1</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent contextRef="c-1" decimals="2" id="f-593" unitRef="number">0.03</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-1" decimals="-5" id="f-594" unitRef="usd">300000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-6" decimals="-5" id="f-595" unitRef="usd">400000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-596">Income Taxes&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2024 and 2023, no income tax expense was recorded due to the Company&#x2019;s net operating loss (&#x201c;NOL&#x201d;) and full valuation allowance. The Company&#x2019;s effective tax rate of zero differs from the U.S. statutory tax rate of 21% primarily because of the valuation allowance maintained against the Company&#x2019;s net deferred tax assets. A reconciliation of the expected income tax benefit computed using the federal statutory income tax rate to the Company&#x2019;s effective income tax rate is as follows for the&#160;years ended December&#160;31, 2024 and 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax computed at federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;State taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.06)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;R&amp;amp;D credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(29.63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(31.99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Permanent differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.07)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.57)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s net deferred tax assets as of December&#160;31, 2024 and 2023, consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;NOLs&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;27,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Capitalized R&amp;amp;D costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;R&amp;amp;D credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Capitalized Sec. 59 (e ) R&amp;amp;D expenditures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 22.6pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total gross deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;66,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;51,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease ROU assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,653)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,118)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total gross deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,653)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;64,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(64,921)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(49,594)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net deferred tax asset less valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2024 and 2023, the Company had U.S. federal NOL carryforwards of $102.3 million and $69.8 million, respectively, which may be available to offset future income tax liabilities. Of the $102.3 million carryforwards, approximately $4.8 million will begin to expire in 2036 and approximately $97.5 million are carried forward indefinitely. As of December&#160;31, 2024 and 2023, the Company had state NOL carryforwards of $97.6 million and $66.7 million, respectively, which will begin to expire in 2036.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2024 and 2023, the Company had U.S. federal R&amp;amp;D tax credit carryforwards of $6.7 million and $5.2 million, respectively, which begin to expire in 2036. As of December&#160;31, 2024 and 2023, the Company had state R&amp;amp;D tax credit carryforwards of $3.3 million and $2.6 million, respectively, which begin to expire in 2036. As of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2024 and 2023, the Company had capitalized R&amp;amp;D costs of $22.1 million and $17.4 million, respectively, as required by the Tax Cuts and Jobs Act of 2017.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future realization of the tax benefits of existing temporary differences and NOL carryforwards ultimately depends on the existence of sufficient taxable income within the carryforward period. As of December&#160;31, 2024, the Company performed an evaluation to determine whether a valuation allowance was needed. The Company considered all available evidence, both positive and negative, which included the results of operations for the current and preceding&#160;years. The Company determined that it is more likely than not that all of the deferred tax assets will not be realized. Accordingly, the Company maintained a full valuation allowance as of December&#160;31, 2024. During the&#160;years ended December&#160;31, 2024 and 2023, the valuation allowance increased by $15.3 million and $15.8 million, respectively, due to the increase in the deferred tax assets by the same amount, primarily due to increases in the NOL carryforwards, capitalized R&amp;amp;D costs and R&amp;amp;D tax credit carryforwards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The utilization of NOLs and tax credit carryforwards to offset future taxable income may be subject to an annual limitation because of ownership changes that have occurred previously or may occur in the future. Under Sections&#160;382 and 383 of the Internal Revenue Code of 1986 (&#x201c;IRC&#x201d;), a corporation that undergoes an ownership change may be subject to limitation on its ability to utilize its pre-change NOLs and other tax attributes otherwise available to offset future taxable income and/or tax liability. An ownership change is defined as a cumulative change of more than 50% in the ownership positions of certain stockholders during a rolling three-year period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has not completed a formal study to determine if any ownership changes within the meaning of IRC Section&#160;382 and 383 have occurred as of December&#160;31, 2024. An ownership change would restrict its ability to use its NOLs or tax credit carryforwards and could require the Company to pay U.S. federal or state income taxes earlier than would be required if such limitation were not in effect.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the year ended December&#160;31, 2024, the Company generated research credits but has not conducted a study to document the qualified activities. This study may result in an adjustment to the Company&#x2019;s R&amp;amp;D credit carryforwards; however, until a study is completed, and any adjustment is known, no amounts have been recognized as an uncertain tax position. A full valuation allowance has been provided against the Company&#x2019;s R&amp;amp;D credits and, if an adjustment is required, this adjustment would be offset by an adjustment to the deferred income tax asset established for the R&amp;amp;D credit carryforwards and the valuation allowance.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-597" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-6" decimals="-3" id="f-598" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-1" decimals="4" id="f-599" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c-1" id="f-600">A reconciliation of the expected income tax benefit computed using the federal statutory income tax rate to the Company&#x2019;s effective income tax rate is as follows for the&#160;years ended December&#160;31, 2024 and 2023:&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax computed at federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;State taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.06)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;R&amp;amp;D credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(29.63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(31.99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Permanent differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.07)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.57)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c-1" decimals="4" id="f-601" unitRef="number">0.2100</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c-6" decimals="4" id="f-602" unitRef="number">0.2100</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c-1" decimals="4" id="f-603" unitRef="number">0.0678</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c-6" decimals="4" id="f-604" unitRef="number">0.0749</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="c-1" decimals="4" id="f-605" unitRef="number">0.0006</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="c-6" decimals="4" id="f-606" unitRef="number">-0.0004</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch contextRef="c-1" decimals="4" id="f-607" unitRef="number">-0.0298</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch contextRef="c-6" decimals="4" id="f-608" unitRef="number">-0.0403</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-1" decimals="4" id="f-609" unitRef="number">-0.2963</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-6" decimals="4" id="f-610" unitRef="number">-0.3199</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <camp:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent contextRef="c-1" decimals="4" id="f-611" unitRef="number">-0.0107</camp:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent>
    <camp:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent contextRef="c-6" decimals="4" id="f-612" unitRef="number">-0.0057</camp:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-1" decimals="4" id="f-613" unitRef="number">0.0000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-6" decimals="4" id="f-614" unitRef="number">0.0000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c-1" id="f-615">&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s net deferred tax assets as of December&#160;31, 2024 and 2023, consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;NOLs&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;27,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Capitalized R&amp;amp;D costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;R&amp;amp;D credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Capitalized Sec. 59 (e ) R&amp;amp;D expenditures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 22.6pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total gross deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;66,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;51,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease ROU assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,653)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,118)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total gross deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,653)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;64,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(64,921)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(49,594)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net deferred tax asset less valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-4" decimals="-3" id="f-616" unitRef="usd">27667000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-5" decimals="-3" id="f-617" unitRef="usd">18936000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment contextRef="c-4" decimals="-3" id="f-618" unitRef="usd">22059000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment contextRef="c-5" decimals="-3" id="f-619" unitRef="usd">17413000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="c-4" decimals="-3" id="f-620" unitRef="usd">9299000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="c-5" decimals="-3" id="f-621" unitRef="usd">7239000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <camp:DeferredTaxAssetsLeasingArrangements contextRef="c-4" decimals="-3" id="f-622" unitRef="usd">2307000</camp:DeferredTaxAssetsLeasingArrangements>
    <camp:DeferredTaxAssetsLeasingArrangements contextRef="c-5" decimals="-3" id="f-623" unitRef="usd">3052000</camp:DeferredTaxAssetsLeasingArrangements>
    <camp:DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures contextRef="c-4" decimals="-3" id="f-624" unitRef="usd">1833000</camp:DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures>
    <camp:DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures contextRef="c-5" decimals="-3" id="f-625" unitRef="usd">2337000</camp:DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures>
    <us-gaap:DeferredTaxAssetsOther contextRef="c-4" decimals="-3" id="f-626" unitRef="usd">3409000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther contextRef="c-5" decimals="-3" id="f-627" unitRef="usd">2735000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-4" decimals="-3" id="f-628" unitRef="usd">66574000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-5" decimals="-3" id="f-629" unitRef="usd">51712000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements contextRef="c-4" decimals="-3" id="f-630" unitRef="usd">1653000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements contextRef="c-5" decimals="-3" id="f-631" unitRef="usd">2118000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-4" decimals="-3" id="f-632" unitRef="usd">1653000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-5" decimals="-3" id="f-633" unitRef="usd">2118000</us-gaap:DeferredIncomeTaxLiabilities>
    <camp:DeferredTaxAssetsLiabilitiesGross contextRef="c-4" decimals="-3" id="f-634" unitRef="usd">64921000</camp:DeferredTaxAssetsLiabilitiesGross>
    <camp:DeferredTaxAssetsLiabilitiesGross contextRef="c-5" decimals="-3" id="f-635" unitRef="usd">49594000</camp:DeferredTaxAssetsLiabilitiesGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-4" decimals="-3" id="f-636" unitRef="usd">64921000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-5" decimals="-3" id="f-637" unitRef="usd">49594000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="c-4" decimals="-3" id="f-638" unitRef="usd">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="c-5" decimals="-3" id="f-639" unitRef="usd">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:OperatingLossCarryforwards contextRef="c-105" decimals="-5" id="f-640" unitRef="usd">102300000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-106" decimals="-5" id="f-641" unitRef="usd">69800000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-105" decimals="-5" id="f-642" unitRef="usd">102300000</us-gaap:OperatingLossCarryforwards>
    <camp:OperatingLossCarryforwardsSubjectToExpiration contextRef="c-105" decimals="-5" id="f-643" unitRef="usd">4800000</camp:OperatingLossCarryforwardsSubjectToExpiration>
    <camp:OperatingLossCarryforwardsNotSubjectToExpiration contextRef="c-105" decimals="-5" id="f-644" unitRef="usd">97500000</camp:OperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:OperatingLossCarryforwards contextRef="c-107" decimals="-5" id="f-645" unitRef="usd">97600000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-108" decimals="-5" id="f-646" unitRef="usd">66700000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="c-105" decimals="-5" id="f-647" unitRef="usd">6700000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="c-106" decimals="-5" id="f-648" unitRef="usd">5200000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="c-107" decimals="-5" id="f-649" unitRef="usd">3300000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="c-108" decimals="-5" id="f-650" unitRef="usd">2600000</us-gaap:TaxCreditCarryforwardAmount>
    <camp:CapitalizedResearchAndDevelopmentCosts contextRef="c-4" decimals="-5" id="f-651" unitRef="usd">22100000</camp:CapitalizedResearchAndDevelopmentCosts>
    <camp:CapitalizedResearchAndDevelopmentCosts contextRef="c-5" decimals="-5" id="f-652" unitRef="usd">17400000</camp:CapitalizedResearchAndDevelopmentCosts>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-1" decimals="-5" id="f-653" unitRef="usd">15300000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-6" decimals="-5" id="f-654" unitRef="usd">15800000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-4" decimals="INF" id="f-655" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-656">Segment Reporting&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company manages its business activities on a consolidated basis and operates as a single operating segment: R&amp;amp;D, which engages in the business of developing a new class of RNA-based therapeutics to treat a broad range of genetic diseases. The Company's operations are primarily in the United States.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company&#x2019;s CODM is its Chief Executive Officer. The CODM uses net loss, as reported on the Company&#x2019;s consolidated statement of operations and comprehensive loss, in evaluating performance and determining how to allocate resources. The CODM does not review assets in evaluating the results and therefore, such information is not presented. The following table provides the revenue and significant and other segment expenses for the&#160;years ended December&#160;31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: Significant segment expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Personnel-related expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Clinical and preclinical expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Facilities-related and overhead&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Professional and consulting fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Travel and entertainment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Plus: Other segment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(51,791)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(49,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other segment income includes total other income, net on the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c-1" id="f-657">The following table provides the revenue and significant and other segment expenses for the&#160;years ended December&#160;31, 2024 and 2023 (in thousands):&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: Significant segment expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Personnel-related expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Clinical and preclinical expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Facilities-related and overhead&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Professional and consulting fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #cceeff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.8pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Travel and entertainment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Plus: Other segment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(51,791)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(49,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues contextRef="c-109" decimals="-3" id="f-658" unitRef="usd">652000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-110" decimals="-3" id="f-659" unitRef="usd">350000</us-gaap:Revenues>
    <us-gaap:LaborAndRelatedExpense contextRef="c-109" decimals="-3" id="f-660" unitRef="usd">20299000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense contextRef="c-110" decimals="-3" id="f-661" unitRef="usd">19433000</us-gaap:LaborAndRelatedExpense>
    <camp:ClinicalAndPreclinicalExpenses contextRef="c-109" decimals="-3" id="f-662" unitRef="usd">18049000</camp:ClinicalAndPreclinicalExpenses>
    <camp:ClinicalAndPreclinicalExpenses contextRef="c-110" decimals="-3" id="f-663" unitRef="usd">20012000</camp:ClinicalAndPreclinicalExpenses>
    <camp:FacilitiesAndOverheadExpense contextRef="c-109" decimals="-3" id="f-664" unitRef="usd">7625000</camp:FacilitiesAndOverheadExpense>
    <camp:FacilitiesAndOverheadExpense contextRef="c-110" decimals="-3" id="f-665" unitRef="usd">6979000</camp:FacilitiesAndOverheadExpense>
    <us-gaap:ProfessionalFees contextRef="c-109" decimals="-3" id="f-666" unitRef="usd">5984000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="c-110" decimals="-3" id="f-667" unitRef="usd">4029000</us-gaap:ProfessionalFees>
    <camp:CorporateExpenses contextRef="c-109" decimals="-3" id="f-668" unitRef="usd">1175000</camp:CorporateExpenses>
    <camp:CorporateExpenses contextRef="c-110" decimals="-3" id="f-669" unitRef="usd">1185000</camp:CorporateExpenses>
    <us-gaap:TravelAndEntertainmentExpense contextRef="c-109" decimals="-3" id="f-670" unitRef="usd">608000</us-gaap:TravelAndEntertainmentExpense>
    <us-gaap:TravelAndEntertainmentExpense contextRef="c-110" decimals="-3" id="f-671" unitRef="usd">591000</us-gaap:TravelAndEntertainmentExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-109" decimals="-3" id="f-672" unitRef="usd">1297000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-110" decimals="-3" id="f-673" unitRef="usd">2588000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss contextRef="c-109" decimals="-3" id="f-674" unitRef="usd">-51791000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-110" decimals="-3" id="f-675" unitRef="usd">-49291000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-677">Net Loss Per Share Attributable to Common Stockholders&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted net loss per share was calculated as follows for the&#160;years ended December&#160;31, 2024 and 2023 (in thousands, except share and per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net loss attributable to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(51,791)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(49,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average common shares outstanding, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,690,094&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;394,976&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net loss per share attributable to common stockholders, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(11.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(124.80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s potentially dilutive securities, which include or have included convertible preferred stock, outstanding stock options, unvested restricted common stock, and warrants to purchase stock, have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted-average number of common shares outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company excluded the following from the computation of diluted net loss per share attributable to common stockholders as of December&#160;31, 2024 and 2023 because including them would have had an anti-dilutive effect:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Conversion of preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,648,582&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock options outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,119,425&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,273,221&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted stock vesting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,943&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;74,243&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Warrant outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;142&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;142&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,135,510&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13,996,188&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-678">&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted net loss per share was calculated as follows for the&#160;years ended December&#160;31, 2024 and 2023 (in thousands, except share and per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net loss attributable to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(51,791)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(49,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average common shares outstanding, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,690,094&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;394,976&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net loss per share attributable to common stockholders, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(11.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(124.80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-679" unitRef="usd">-51791000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-680" unitRef="usd">-49291000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-681" unitRef="shares">4690094</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-682" unitRef="shares">4690094</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-6" decimals="0" id="f-683" unitRef="shares">394976</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="0" id="f-684" unitRef="shares">394976</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-685"
      unitRef="usdPerShare">-11.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-686"
      unitRef="usdPerShare">-11.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-6"
      decimals="2"
      id="f-687"
      unitRef="usdPerShare">-124.80</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-6"
      decimals="2"
      id="f-688"
      unitRef="usdPerShare">-124.80</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c-1" id="f-689">&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company excluded the following from the computation of diluted net loss per share attributable to common stockholders as of December&#160;31, 2024 and 2023 because including them would have had an anti-dilutive effect:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Conversion of preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,648,582&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock options outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,119,425&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,273,221&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted stock vesting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,943&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;74,243&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Warrant outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;142&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;142&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,135,510&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13,996,188&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-111"
      decimals="INF"
      id="f-690"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-112"
      decimals="INF"
      id="f-691"
      unitRef="shares">11648582</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-113"
      decimals="INF"
      id="f-692"
      unitRef="shares">2119425</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-114"
      decimals="INF"
      id="f-693"
      unitRef="shares">2273221</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-115"
      decimals="INF"
      id="f-694"
      unitRef="shares">15943</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-116"
      decimals="INF"
      id="f-695"
      unitRef="shares">74243</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-117"
      decimals="INF"
      id="f-696"
      unitRef="shares">142</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-118"
      decimals="INF"
      id="f-697"
      unitRef="shares">142</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-1" decimals="INF" id="f-698" unitRef="shares">2135510</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-6" decimals="INF" id="f-699" unitRef="shares">13996188</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c-1" id="f-700">Related Parties&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2015, the Company entered into consulting agreements with its two founders, related parties who hold shares of the Company&#x2019;s common stock, to provide R&amp;amp;D and strategic planning services. For the&#160;years ended December&#160;31, 2024 and 2023, the Company recognized R&amp;amp;D expense totaling $0.3 million and $0.3 million, respectively, related to work performed under the founder agreements. The Company had no amount due to the founders at both December&#160;31, 2024 and 2023, respectively. For the&#160;years ended December&#160;31, 2024 and 2023, the Company recognized stock-based compensation expense totaling $0.2 million and less than $0.2 million, related to consulting agreements, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March&#160;2019, the Company entered into a consulting agreement with an executive consultant, a related party who holds shares of the Company&#x2019;s common stock. For the&#160;years ended December&#160;31, 2024 and 2023, the Company recognized G&amp;amp;A expense totaling $0.1 million and $0.1 million, respectively, related to work performed under the consulting agreement. The Company had no amount due to the consultant at both December&#160;31, 2024 and 2023, respectively. For the&#160;years ended December&#160;31, 2024 and 2023, the Company recognized stock-based compensation expense totaling $0.2 million and less than $0.2 million, respectively, related to the consulting agreement.&lt;/span&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <camp:NumberOfFounders
      contextRef="c-119"
      decimals="INF"
      id="f-701"
      unitRef="founder">2</camp:NumberOfFounders>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-120" decimals="-5" id="f-702" unitRef="usd">300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-121" decimals="-5" id="f-703" unitRef="usd">300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:AccountsPayableCurrent contextRef="c-122" decimals="INF" id="f-704" unitRef="usd">0</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-123" decimals="INF" id="f-705" unitRef="usd">0</us-gaap:AccountsPayableCurrent>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-120" decimals="-5" id="f-706" unitRef="usd">200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-121" decimals="-5" id="f-707" unitRef="usd">200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-124" decimals="-5" id="f-708" unitRef="usd">100000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-125" decimals="-5" id="f-709" unitRef="usd">100000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:AccountsPayableCurrent contextRef="c-126" decimals="INF" id="f-710" unitRef="usd">0</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-127" decimals="INF" id="f-711" unitRef="usd">0</us-gaap:AccountsPayableCurrent>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-124" decimals="-5" id="f-712" unitRef="usd">200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-124" decimals="-5" id="f-713" unitRef="usd">200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-128" id="f-714">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-128" id="f-715">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-128" id="f-716">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-128" id="f-717">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c-1" id="f-718">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <dei:AuditorFirmId contextRef="c-1" id="f-719">42</dei:AuditorFirmId>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
